Citrus Sinensis ID: 016594

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380------
Protein Sequence
MKYIRTNSLKRLFSLKRRSFDGDNAAVSPNGFTEESLENVVVACESETTKPTWRCFSFEEISIATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEGDQIDKERWKMPEEEEEDQEEFWGFDDLEYECDSSFSVSPQDSISTGSS
Secondary Structure (PSIPRED)
cHHHHcccccccccccccccccccccccccccccccccccccccccccccccccEEcHHHHHHHHcccccccccccccccEEEEEEEccccEEEEEEcccccccHHHHHHHHHHHHHHHHccccccccEEEEEEcccEEEEEEEcccccHHHHHcccccccccHHHHHHHHHHHHHHHHccccccccccEEccccccccccccccccccccccccccccccccEEEEcEEccccccccHHHccccccccccccHHHHHHHHHHHHcccccccccHHHHHHHHHHHHcccccccccccccccccHHHHHHHHHHHHHHccccccccccHHHHHHHHHccccHHHHHccccccHHHHHHHHccccccccccccccccccccccccccc
Secondary Structure Prediction (SSPRO)
cccHHHHHHHHHHHccccccccccccccccccccccccccccccccccccccccEEcHHHHHHHHccccHHcccccccccEEEEcEcccccEEEHHHHHHcccccccHHHHHHHHHHHHHHHHHcHHHEEEEEEcccEEEEEEEcccccHHHHHcccccccccHHHHHHHHHHHHHHHHHHHHcccccEEEEcHHHHHEEcccccccHHcHccHHEEcccccccEEEEEEEEccccccHHHHHccccccccHHHHHHHEHHHHHcccccccccHHHHHHHHHHHHHcccHHHHccHHHcccccHHHHHHHHHHHHHHHcccHcccccHHHHHHHHccccccccccccccccccccccccccccccccccccccccccccccccccc
Coil and Loop (DISEMBL)
MKYIRTNSLKRLFSLKrrsfdgdnaavspngfteeSLENVVVACEsettkptwrcfsfeeisiatnafssenlvgrggYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIgtighvchpnvlsllgccvdnglYLIFQfssrgsvaslfhdvnspgvewkVRHKIAVGTARglhylhkgcqrriihrdikssnilltadfepqisdfglakwlpsqwthhsiapiegtfghlapeyfmhgivdekTDVFAFGVFLLEIIsgrkpvdgshqslhswakpilnqgeieklvdprlqgaydvtQLNRLAFAASLCirasptwrpTMSEVLEVMLEgdqidkerwkmpeeeeedqeefwgfddleyecdssfsvspqdsistgss
Flexible Loop (DISEMBL)
mkyirtnslkrlfslkrrsfdgdnaavspngfteesLENVVVACESETTKPTWRCFSFEEISIAtnafssenlvgRGGYAEVYKGvlqdgeeiavkrltkvvtddrkEKEFlteigtighvcHPNVLSLLGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEGDQIDKERWKMPEEEEEDQEEFWGFDDLEYECDssfsvspqdsistgss
Low Complexity Region (SEG)
MKYIRTNSLKRLFSLKRRSFDGDNAAVSPNGFTEESLENVVVACESETTKPTWRCFSFEEISIATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEGDQIDKERWKMPeeeeedqeeFWGFDDLEYECDSSFSVSPQDSISTGSS
Disordered region (IsUnstruct)
***********************************SLENVVVACESETTKPTWRCFSFEEISIATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNGLYLIFQF****************GVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVML**************************************************
Disordered Region (DISOPRED)
****************************************************WRCFSFEEISIATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVK**T***********FLTEIGTIGHVCHPNVLSLLGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEGD***********************************************
Disordered Region (DISEMBL)
MKYIRTNSLKRLFSLKRRSFDGDNAAVSPNGFTEESLENVVVACESETTKPTWRCFSFEEISIATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEGDQIDKERWK***********FWGFDDLEYECD****************
Disordered Region (DISPRO)
*KYIRTNSLKRLFSLK***********************************TWRCFSFEEISIATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG************************************************
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
SSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MKYIRTNSLKRLFSLKRRSFDGDNAAVSPNGFTEESLENVVVACESETTKPTWRCFSFEEISIATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEGDQIDKERWKMPEEEEEDQEEFWGFDDLEYECDSSFSVSPQDSISTGSS
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	386	2.2.26 [Sep-21-2011]
Q5XF57	579	Probable receptor-like se	no	no	0.779	0.519	0.569	1e-106
Q8RXC8	460	Receptor-like cytosolic s	no	no	0.860	0.721	0.519	1e-94
Q8H1D6	467	Receptor-like cytosolic s	no	no	0.740	0.612	0.519	3e-90
Q9C660	762	Proline-rich receptor-lik	no	no	0.715	0.362	0.468	4e-66
Q9LK03	717	Proline-rich receptor-lik	no	no	0.727	0.391	0.442	3e-65
Q93ZS4	632	Protein NSP-INTERACTING K	no	no	0.746	0.455	0.456	2e-63
Q9LV48	652	Proline-rich receptor-lik	no	no	0.725	0.429	0.433	8e-63
Q94F62	615	BRASSINOSTEROID INSENSITI	no	no	0.777	0.487	0.428	3e-62
Q94AG2	625	Somatic embryogenesis rec	no	no	0.777	0.48	0.421	3e-61
Q9SKG5	620	Somatic embryogenesis rec	no	no	0.787	0.490	0.421	3e-61

>sp|Q5XF57|Y5576_ARATH Probable receptor-like serine/threonine-protein kinase At5g57670 OS=Arabidopsis thaliana GN=At5g57670 PE=2 SV=1

 Score =  385 bits (988), Expect = e-106,   Method: Compositional matrix adjust.
 Identities = 172/302 (56%), Positives = 226/302 (74%), Gaps = 1/302 (0%)

Query: 50  KPTWRCFSFEEISIATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEK 109
           +P  +CF++ EIS ATN F   N+VG GGY+EVY+G L DG  IAVKRL K   D  KEK
Sbjct: 249 QPLIQCFTYNEISKATNDFHQGNIVGIGGYSEVYRGDLWDGRRIAVKRLAKESGDMNKEK 308

Query: 110 EFLTEIGTIGHVCHPNVLSLLGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHK 169
           EFLTE+G I HV HPN   LLGCCV+ GLYL+F+FS  G++ S  H+  +  ++W VR+K
Sbjct: 309 EFLTELGIISHVSHPNTALLLGCCVEKGLYLVFRFSENGTLYSALHENENGSLDWPVRYK 368

Query: 170 IAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAP 229
           IAVG ARGLHYLHK C  RIIHRDIKSSN+LL  D+EPQI+DFGLAKWLP++WTHH++ P
Sbjct: 369 IAVGVARGLHYLHKRCNHRIIHRDIKSSNVLLGPDYEPQITDFGLAKWLPNKWTHHAVIP 428

Query: 230 IEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGE 289
           +EGTFG+LAPE  M G +DEKTD++AFG+ LLEII+GR+PV+ + + +  WAKP +  G 
Sbjct: 429 VEGTFGYLAPESLMQGTIDEKTDIYAFGILLLEIITGRRPVNPTQKHILLWAKPAMETGN 488

Query: 290 IEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEGDQID-KERWKM 348
             +LVDP+LQ  YD  Q+N+L   AS C++ SP  RPTM++VLE++  G++ +  + W+M
Sbjct: 489 TSELVDPKLQDKYDDQQMNKLVLTASHCVQQSPILRPTMTQVLELLTNGNEAEIAKSWRM 548

Query: 349 PE 350
           P+
Sbjct: 549 PK 550

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q8RXC8|RBK2_ARATH Receptor-like cytosolic serine/threonine-protein kinase RBK2 OS=Arabidopsis thaliana GN=RBK2 PE=1 SV=1

 Score =  347 bits (889), Expect = 1e-94,   Method: Compositional matrix adjust.
 Identities = 174/335 (51%), Positives = 229/335 (68%), Gaps = 3/335 (0%)

Query: 2   KYIRTNSLKRLFSLKRRSFDGDNAAVSPNGFTEESLENVVVACESETTKPTWRCFSFEEI 61
           K  +  S+KRL S    S  G    +     + +   N +V  +    + + + FS  +I
Sbjct: 79  KLWKRRSMKRLSSFPPLS--GAAPPIIKQNKSADPNMNGMVLHDIYDFQSSLQNFSISDI 136

Query: 62  SIATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHV 121
            IAT+ FS EN++GRGGYA+VY+G+L +G+ IAVKRLTK  T D +  EFL+E+G I HV
Sbjct: 137 EIATDNFSPENIIGRGGYADVYQGILPEGKLIAVKRLTKG-TPDEQTAEFLSELGIIAHV 195

Query: 122 CHPNVLSLLGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYL 181
            HPN    +GCC++ G++L+F+ S  GS+ SL H  +   + W  R+ +A+GTA GL YL
Sbjct: 196 DHPNTAKFIGCCIEGGMHLVFRLSPLGSLGSLLHGPSKYKLTWSRRYNVALGTADGLVYL 255

Query: 182 HKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEY 241
           H+GCQRRIIHRDIK+ NILLT DF+PQI DFGLAKWLP Q THH+++  EGTFG+ APEY
Sbjct: 256 HEGCQRRIIHRDIKADNILLTEDFQPQICDFGLAKWLPKQLTHHNVSKFEGTFGYFAPEY 315

Query: 242 FMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGA 301
           FMHGIVDEKTDVFAFGV LLE+I+G   +D S QSL  WAKP+L +  I++LVDP L   
Sbjct: 316 FMHGIVDEKTDVFAFGVLLLELITGHPALDESQQSLVLWAKPLLERKAIKELVDPSLGDE 375

Query: 302 YDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVML 336
           Y+  +L RL   ASLCI  S   RP MS+V+E++L
Sbjct: 376 YNREELIRLTSTASLCIDQSSLLRPRMSQVVELLL 410

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8H1D6|RBK1_ARATH Receptor-like cytosolic serine/threonine-protein kinase RBK1 OS=Arabidopsis thaliana GN=RBK1 PE=1 SV=1

 Score =  332 bits (851), Expect = 3e-90,   Method: Compositional matrix adjust.
 Identities = 150/289 (51%), Positives = 210/289 (72%), Gaps = 3/289 (1%)

Query: 49  TKPTWRCFSFEEISIATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRL-TKVVTDDRK 107
            KP+WR F++EE+++AT+ F+ EN++G+GG+AEVYKGVL +GE +A+K+L +    ++ +
Sbjct: 134 AKPSWRNFTYEELAVATDYFNPENMIGKGGHAEVYKGVLINGETVAIKKLMSHAKEEEER 193

Query: 108 EKEFLTEIGTIGHVCHPNVLSLLGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVR 167
             +FL+E+G I HV HPN   L G   D GL+ + +++  GS+AS+    +   +EWK+R
Sbjct: 194 VSDFLSELGIIAHVNHPNAARLRGFSSDRGLHFVLEYAPYGSLASMLFG-SEECLEWKIR 252

Query: 168 HKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSI 227
           +K+A+G A GL YLH  C RRIIHRDIK+SNILL  D+E QISDFGLAKWLP  W HH +
Sbjct: 253 YKVALGIADGLSYLHNACPRRIIHRDIKASNILLNHDYEAQISDFGLAKWLPENWPHHVV 312

Query: 228 APIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVD-GSHQSLHSWAKPILN 286
            PIEGTFG+LAPEYFMHGIVDEK DVFAFGV LLEII+ R+ VD  S QS+ +WAKP L 
Sbjct: 313 FPIEGTFGYLAPEYFMHGIVDEKIDVFAFGVLLLEIITSRRAVDTASRQSIVAWAKPFLE 372

Query: 287 QGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVM 335
           +  +E +VDPRL   ++ T++ R+   AS+C+      RP M+ +++++
Sbjct: 373 KNSMEDIVDPRLGNMFNPTEMQRVMLTASMCVHHIAAMRPDMTRLVQLL 421

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9C660|PEK10_ARATH Proline-rich receptor-like protein kinase PERK10 OS=Arabidopsis thaliana GN=PERK10 PE=1 SV=2

 Score =  252 bits (643), Expect = 4e-66,   Method: Compositional matrix adjust.
 Identities = 135/288 (46%), Positives = 182/288 (63%), Gaps = 12/288 (4%)

Query: 56  FSFEEISIATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEI 115
           FS+EE+ IATN FS ENL+G GG+  VYKGVL D   +AVK+L   +   + ++EF  E+
Sbjct: 418 FSYEELVIATNGFSDENLLGEGGFGRVYKGVLPDERVVAVKQLK--IGGGQGDREFKAEV 475

Query: 116 GTIGHVCHPNVLSLLGCCV-DNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGT 174
            TI  V H N+LS++G C+ +N   LI+ +    ++    H   +PG++W  R KIA G 
Sbjct: 476 DTISRVHHRNLLSMVGYCISENRRLLIYDYVPNNNLYFHLHAAGTPGLDWATRVKIAAGA 535

Query: 175 ARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTF 234
           ARGL YLH+ C  RIIHRDIKSSNILL  +F   +SDFGLAK      TH +   + GTF
Sbjct: 536 ARGLAYLHEDCHPRIIHRDIKSSNILLENNFHALVSDFGLAKLALDCNTHITTR-VMGTF 594

Query: 235 GHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSH----QSLHSWAKPILNQG-- 288
           G++APEY   G + EK+DVF+FGV LLE+I+GRKPVD S     +SL  WA+P+L+    
Sbjct: 595 GYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSNATE 654

Query: 289 --EIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEV 334
             E   L DP+L   Y   ++ R+  AA+ CIR S T RP MS+++  
Sbjct: 655 TEEFTALADPKLGRNYVGVEMFRMIEAAAACIRHSATKRPRMSQIVRA 702

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LK03|PERK2_ARATH Proline-rich receptor-like protein kinase PERK2 OS=Arabidopsis thaliana GN=PERK2 PE=2 SV=3

 Score =  249 bits (635), Expect = 3e-65,   Method: Compositional matrix adjust.
 Identities = 130/294 (44%), Positives = 192/294 (65%), Gaps = 13/294 (4%)

Query: 55  CFSFEEISIATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTE 114
            F++EE+S ATN FS  NL+G+GG+  V+KG+L++G+E+AVK+L +     + E+EF  E
Sbjct: 341 TFNYEELSRATNGFSEANLLGQGGFGYVFKGMLRNGKEVAVKQLKE--GSSQGEREFQAE 398

Query: 115 IGTIGHVCHPNVLSLLGCCV-DNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVG 173
           +G I  V H ++++L+G C+ D    L+++F    ++    H    P +EW  R KIAVG
Sbjct: 399 VGIISRVHHRHLVALVGYCIADAQRLLVYEFVPNNTLEFHLHGKGRPTMEWSSRLKIAVG 458

Query: 174 TARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGT 233
           +A+GL YLH+ C  +IIHRDIK+SNIL+   FE +++DFGLAK      TH S   + GT
Sbjct: 459 SAKGLSYLHENCNPKIIHRDIKASNILIDFKFEAKVADFGLAKIASDTNTHVSTR-VMGT 517

Query: 234 FGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSH----QSLHSWAKPILNQ-- 287
           FG+LAPEY   G + EK+DVF+FGV LLE+I+GR+P+D ++     SL  WA+P+LNQ  
Sbjct: 518 FGYLAPEYASSGKLTEKSDVFSFGVVLLELITGRRPIDVNNVHADNSLVDWARPLLNQVS 577

Query: 288 --GEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEGD 339
             G  E +VD +L   YD  ++ R+   A+ C+R++   RP M +V  V LEG+
Sbjct: 578 ELGNFEVVVDKKLNNEYDKEEMARMVACAAACVRSTAPRRPRMDQVARV-LEGN 630

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q93ZS4|NIK3_ARATH Protein NSP-INTERACTING KINASE 3 OS=Arabidopsis thaliana GN=NIK3 PE=1 SV=1

 Score =  243 bits (620), Expect = 2e-63,   Method: Compositional matrix adjust.
 Identities = 137/300 (45%), Positives = 189/300 (63%), Gaps = 12/300 (4%)

Query: 56  FSFEEISIATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEI 115
           ++F+E+  ATN F+S+N++GRGGY  VYKG L DG  +AVKRL K       E +F TE+
Sbjct: 289 YTFKELRSATNHFNSKNILGRGGYGIVYKGHLNDGTLVAVKRL-KDCNIAGGEVQFQTEV 347

Query: 116 GTIGHVCHPNVLSLLGCCVDNG-LYLIFQFSSRGSVASLFHD--VNSPGVEWKVRHKIAV 172
            TI    H N+L L G C  N    L++ +   GSVAS   D     P ++W  R KIAV
Sbjct: 348 ETISLALHRNLLRLRGFCSSNQERILVYPYMPNGSVASRLKDNIRGEPALDWSRRKKIAV 407

Query: 173 GTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEG 232
           GTARGL YLH+ C  +IIHRD+K++NILL  DFE  + DFGLAK L  + +H + A + G
Sbjct: 408 GTARGLVYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTA-VRG 466

Query: 233 TFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVD---GSHQS--LHSWAKPILNQ 287
           T GH+APEY   G   EKTDVF FG+ LLE+I+G+K +D    +HQ   +  W K +  +
Sbjct: 467 TVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQKALDFGRSAHQKGVMLDWVKKLHQE 526

Query: 288 GEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEGDQIDKERWK 347
           G++++L+D  L   +D  +L  +   A LC + +P+ RP MSEV++ MLEGD +  ERW+
Sbjct: 527 GKLKQLIDKDLNDKFDRVELEEIVQVALLCTQFNPSHRPKMSEVMK-MLEGDGL-AERWE 584

Involved in defense response to geminivirus infection.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LV48|PERK1_ARATH Proline-rich receptor-like protein kinase PERK1 OS=Arabidopsis thaliana GN=PERK1 PE=1 SV=1

 Score =  241 bits (614), Expect = 8e-63,   Method: Compositional matrix adjust.
 Identities = 127/293 (43%), Positives = 187/293 (63%), Gaps = 13/293 (4%)

Query: 56  FSFEEISIATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEI 115
           F++EE+S ATN FS  NL+G+GG+  V+KG+L  G+E+AVK+L       + E+EF  E+
Sbjct: 268 FTYEELSRATNGFSEANLLGQGGFGYVHKGILPSGKEVAVKQLK--AGSGQGEREFQAEV 325

Query: 116 GTIGHVCHPNVLSLLGCCVDN-GLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGT 174
             I  V H +++SL+G C+      L+++F    ++    H    P +EW  R KIA+G+
Sbjct: 326 EIISRVHHRHLVSLIGYCMAGVQRLLVYEFVPNNNLEFHLHGKGRPTMEWSTRLKIALGS 385

Query: 175 ARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTF 234
           A+GL YLH+ C  +IIHRDIK+SNIL+   FE +++DFGLAK      TH S   + GTF
Sbjct: 386 AKGLSYLHEDCNPKIIHRDIKASNILIDFKFEAKVADFGLAKIASDTNTHVSTR-VMGTF 444

Query: 235 GHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSH----QSLHSWAKPILN---- 286
           G+LAPEY   G + EK+DVF+FGV LLE+I+GR+PVD ++     SL  WA+P+LN    
Sbjct: 445 GYLAPEYAASGKLTEKSDVFSFGVVLLELITGRRPVDANNVYVDDSLVDWARPLLNRASE 504

Query: 287 QGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEGD 339
           +G+ E L D ++   YD  ++ R+   A+ C+R S   RP MS+++   LEG+
Sbjct: 505 EGDFEGLADSKMGNEYDREEMARMVACAAACVRHSARRRPRMSQIVRA-LEGN 556

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q94F62|BAK1_ARATH BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 OS=Arabidopsis thaliana GN=BAK1 PE=1 SV=2

 Score =  239 bits (610), Expect = 3e-62,   Method: Compositional matrix adjust.
 Identities = 134/313 (42%), Positives = 195/313 (62%), Gaps = 13/313 (4%)

Query: 56  FSFEEISIATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEI 115
           FS  E+ +A++ FS++N++GRGG+ +VYKG L DG  +AVKRL +  T    E +F TE+
Sbjct: 277 FSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQG-GELQFQTEV 335

Query: 116 GTIGHVCHPNVLSLLG-CCVDNGLYLIFQFSSRGSVASLFHDV--NSPGVEWKVRHKIAV 172
             I    H N+L L G C       L++ + + GSVAS   +   + P ++W  R +IA+
Sbjct: 336 EMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIAL 395

Query: 173 GTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEG 232
           G+ARGL YLH  C  +IIHRD+K++NILL  +FE  + DFGLAK +  + TH + A + G
Sbjct: 396 GSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA-VRG 454

Query: 233 TFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQS------LHSWAKPILN 286
           T GH+APEY   G   EKTDVF +GV LLE+I+G++  D +  +      L  W K +L 
Sbjct: 455 TIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK 514

Query: 287 QGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEGDQIDKERW 346
           + ++E LVD  LQG Y   ++ +L   A LC ++SP  RP MSEV+  MLEGD +  ERW
Sbjct: 515 EKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVR-MLEGDGL-AERW 572

Query: 347 KMPEEEEEDQEEF 359
           +  ++EE  +++F
Sbjct: 573 EEWQKEEMFRQDF 585

Dual specificity kinase acting on both serine/threonine-and tyrosine-containing substrates. Controls the expression of genes associated with innate immunity in the absence of pathogens or elicitors. Involved in brassinosteroid (BR) signal transduction. Phosphorylates BRI1. May be involved in changing the equilibrium between plasma membrane-located BRI1 homodimers and endocytosed BRI1-BAK1 heterodimers. Interaction with MSBP1 stimulates the endocytosis of BAK1 and suppresses brassinosteroid signaling. Acts in pathogen-associated molecular pattern (PAMP)-triggered immunity (PTI) via its interaction with FLS2 and the phosphorylation of BIK1. Involved in programmed cell death (PCD) control. Positively regulates the BR-dependent plant growth pathway and negatively regulates the BR-independent cell-death pathway.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q94AG2|SERK1_ARATH Somatic embryogenesis receptor kinase 1 OS=Arabidopsis thaliana GN=SERK1 PE=1 SV=2

 Score =  236 bits (601), Expect = 3e-61,   Method: Compositional matrix adjust.
 Identities = 132/313 (42%), Positives = 192/313 (61%), Gaps = 13/313 (4%)

Query: 56  FSFEEISIATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEI 115
           FS  E+ +A++ FS++N++GRGG+ +VYKG L DG  +AVKRL +  T    E +F TE+
Sbjct: 290 FSLRELQVASDGFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTPG-GELQFQTEV 348

Query: 116 GTIGHVCHPNVLSLLG-CCVDNGLYLIFQFSSRGSVASLFHD--VNSPGVEWKVRHKIAV 172
             I    H N+L L G C       L++ + + GSVAS   +   + P ++W  R +IA+
Sbjct: 349 EMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQPPLDWPTRKRIAL 408

Query: 173 GTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEG 232
           G+ARGL YLH  C  +IIHRD+K++NILL  +FE  + DFGLAK +  + TH + A + G
Sbjct: 409 GSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA-VRG 467

Query: 233 TFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQS------LHSWAKPILN 286
           T GH+APEY   G   EKTDVF +G+ LLE+I+G++  D +  +      L  W K +L 
Sbjct: 468 TIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK 527

Query: 287 QGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEGDQIDKERW 346
           + ++E LVDP LQ  Y+  +L ++   A LC + SP  RP MSEV+  MLEGD +  E+W
Sbjct: 528 EKKLEMLVDPDLQTNYEERELEQVIQVALLCTQGSPMERPKMSEVVR-MLEGDGL-AEKW 585

Query: 347 KMPEEEEEDQEEF 359
              ++ E  +EE 
Sbjct: 586 DEWQKVEILREEI 598

Dual specificity kinase acting on both serine/threonine-and tyrosine-containing substrates. Phosphorylates BRI1 on 'Ser-887' and CDC48 on at least one threonine residue and on 'Ser-41'. Confers embryogenic competence. Acts redundantly with SERK2 as a control point for sporophytic development controlling male gametophyte production. Involved in the brassinolide signaling pathway.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SKG5|SERK4_ARATH Somatic embryogenesis receptor kinase 4 OS=Arabidopsis thaliana GN=SERK4 PE=1 SV=2

 Score =  236 bits (601), Expect = 3e-61,   Method: Compositional matrix adjust.
 Identities = 136/323 (42%), Positives = 193/323 (59%), Gaps = 19/323 (5%)

Query: 56  FSFEEISIATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEI 115
           F+  E+ +AT+ FS++N++GRGG+ +VYKG L DG  +AVKRL +  T    E +F TE+
Sbjct: 282 FTLRELLVATDNFSNKNVLGRGGFGKVYKGRLADGNLVAVKRLKEERTKG-GELQFQTEV 340

Query: 116 GTIGHVCHPNVLSLLG-CCVDNGLYLIFQFSSRGSVASLFHDV--NSPGVEWKVRHKIAV 172
             I    H N+L L G C       L++ + + GSVAS   +    +P ++W  R  IA+
Sbjct: 341 EMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPEGNPALDWPKRKHIAL 400

Query: 173 GTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEG 232
           G+ARGL YLH  C ++IIHRD+K++NILL  +FE  + DFGLAK +    +H + A + G
Sbjct: 401 GSARGLAYLHDHCDQKIIHRDVKAANILLDEEFEAVVGDFGLAKLMNYNDSHVTTA-VRG 459

Query: 233 TFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQS------LHSWAKPILN 286
           T GH+APEY   G   EKTDVF +GV LLE+I+G+K  D +  +      L  W K +L 
Sbjct: 460 TIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQKAFDLARLANDDDIMLLDWVKEVLK 519

Query: 287 QGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEGDQIDKERW 346
           + ++E LVD  L+G Y  T++ +L   A LC ++S   RP MSEV+  MLEGD +  ERW
Sbjct: 520 EKKLESLVDAELEGKYVETEVEQLIQMALLCTQSSAMERPKMSEVVR-MLEGDGL-AERW 577

Query: 347 KMPEEEEEDQEEFWGFDDLEYEC 369
                 EE Q+E     D  Y+ 
Sbjct: 578 ------EEWQKEEMPIHDFNYQA 594

Dual specificity kinase acting on both serine/threonine-and tyrosine-containing substrates. Positively regulates the BR-dependent plant growth pathway and negatively regulates the BR-independent cell-death pathway.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	386
225446028	386	PREDICTED: probable receptor-like serine	0.987	0.987	0.773	1e-168
449457175	382	PREDICTED: probable receptor-like serine	0.950	0.960	0.76	1e-166
356545735	380	PREDICTED: probable receptor-like serine	0.981	0.997	0.751	1e-164
357479611	381	Receptor-like protein kinase [Medicago t	0.984	0.997	0.731	1e-161
226815614	381	Rop-interacting receptor-like cytoplasmi	0.984	0.997	0.725	1e-161
351724607	380	protein kinase family protein [Glycine m	0.981	0.997	0.751	1e-158
356556186	371	PREDICTED: probable receptor-like serine	0.958	0.997	0.728	1e-156
356530292	371	PREDICTED: probable receptor-like serine	0.955	0.994	0.731	1e-156
224143691	340	predicted protein [Populus trichocarpa]	0.849	0.964	0.812	1e-155
297836744	392	kinase family protein [Arabidopsis lyrat	0.974	0.959	0.723	1e-147

>gi|225446028|ref|XP_002269944.1| PREDICTED: probable receptor-like serine/threonine-protein kinase At5g57670 [Vitis vinifera] gi|297735406|emb|CBI17846.3| unnamed protein product [Vitis vinifera]

 Score =  598 bits (1542), Expect = e-168,   Method: Compositional matrix adjust.
 Identities = 300/388 (77%), Positives = 333/388 (85%), Gaps = 7/388 (1%)

Query: 1   MKYIRTNSLKRLFSLKRRSFDGDNAAVSPNGFTEESLENVVVACESETT---KPTWRCFS 57
           M+YIR+ S KRLFS KRRSF+ ++   +P G   +          +ET    KPTW+CFS
Sbjct: 1   MRYIRSGSFKRLFSAKRRSFEEESQ--TPGGCAHDDGNEAFGVGGNETKHPQKPTWKCFS 58

Query: 58  FEEISIATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGT 117
           +EEI  AT+ FSS+NLVG+GGYAEVY+G L+DGE +AVKRLTK  TD+RKEKEFLTEIGT
Sbjct: 59  YEEIFHATSGFSSDNLVGKGGYAEVYRGTLEDGEAVAVKRLTKASTDERKEKEFLTEIGT 118

Query: 118 IGHVCHPNVLSLLGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARG 177
           IGHVCHPNV SLLGCC+DNGLYLIFQF SRGSV+S+ HD NS  ++WK+R+KIAVGTARG
Sbjct: 119 IGHVCHPNVSSLLGCCIDNGLYLIFQFFSRGSVSSVLHDENSLSLDWKIRYKIAVGTARG 178

Query: 178 LHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHL 237
           LHYLHKGCQRRIIHRDIK+SN+LLTAD+EPQISDFGLAKWLPSQWTHHSI PIEGTFGHL
Sbjct: 179 LHYLHKGCQRRIIHRDIKASNVLLTADYEPQISDFGLAKWLPSQWTHHSIVPIEGTFGHL 238

Query: 238 APEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPR 297
           APEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWA+PILNQGEIEK+VDPR
Sbjct: 239 APEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWARPILNQGEIEKVVDPR 298

Query: 298 LQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEGDQIDKERWKMPEEEEEDQE 357
           L G YDV QL RL FA+SLCIR+S  WRPTMSEVLE ML G +ID+ERWKMPEEEEE QE
Sbjct: 299 LGGIYDVAQLKRLTFASSLCIRSSSIWRPTMSEVLEAML-GGEIDEERWKMPEEEEE-QE 356

Query: 358 EFWGFDDLEYECDSSFSVSPQDSISTGS 385
           EFWGFDDLE E DSSFS SP DSIST S
Sbjct: 357 EFWGFDDLECESDSSFSTSPHDSISTRS 384

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449457175|ref|XP_004146324.1| PREDICTED: probable receptor-like serine/threonine-protein kinase At5g57670-like [Cucumis sativus] gi|449502939|ref|XP_004161785.1| PREDICTED: probable receptor-like serine/threonine-protein kinase At5g57670-like [Cucumis sativus]

 Score =  590 bits (1520), Expect = e-166,   Method: Compositional matrix adjust.
 Identities = 285/375 (76%), Positives = 317/375 (84%), Gaps = 8/375 (2%)

Query: 1   MKYIRTNSLKRLFSLKRRSFDGDNAAVSPNGFTEESLENVVVACESETTKPTWRCFSFEE 60
           MKYIRTNS KRLFSLKRRS   D    SPN     + +++V      + +P W+CFSF++
Sbjct: 13  MKYIRTNSFKRLFSLKRRSLGDD----SPNPDASPNTDSIV---SHHSPRPFWKCFSFQQ 65

Query: 61  ISIATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGH 120
           +  AT+ FSSENLVG+GGYAEVY+G+L DGEEIAVKRLTK   D+RKEKEFLTEIGTIGH
Sbjct: 66  VFEATDGFSSENLVGKGGYAEVYRGILNDGEEIAVKRLTKTSIDERKEKEFLTEIGTIGH 125

Query: 121 VCHPNVLSLLGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHY 180
           V HPNVLSLLGCC+DNGLYLIF FSSRGSVASL HD N   ++WK R KIA+GTARGLHY
Sbjct: 126 VQHPNVLSLLGCCIDNGLYLIFHFSSRGSVASLLHDDNMCPIDWKTRFKIAIGTARGLHY 185

Query: 181 LHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPE 240
           LHK CQRRIIHRDIKSSNILLTADFEP ISDFGLAKWLP+QW+HHSIAPIEGTFGHLAPE
Sbjct: 186 LHKDCQRRIIHRDIKSSNILLTADFEPLISDFGLAKWLPTQWSHHSIAPIEGTFGHLAPE 245

Query: 241 YFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQG 300
           Y+MHGIVDEKTDVFAFGVFLLE+ISGRKPVDGSHQSLHSWAKPILN+GE EKLVDPRL  
Sbjct: 246 YYMHGIVDEKTDVFAFGVFLLEVISGRKPVDGSHQSLHSWAKPILNRGEYEKLVDPRLGS 305

Query: 301 AYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEGDQIDKERWKMPEEEEEDQEEFW 360
           AYDVTQL R + AASLCIR S  WRPTM+EVL +M E   +D ERWKMPEEE E ++EFW
Sbjct: 306 AYDVTQLKRFSLAASLCIRESSIWRPTMTEVLNIM-EDRYVDTERWKMPEEEAEAKDEFW 364

Query: 361 GFDDLEYECDSSFSV 375
           GF+DLEYE DSSFS+
Sbjct: 365 GFEDLEYEWDSSFSI 379

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356545735|ref|XP_003541291.1| PREDICTED: probable receptor-like serine/threonine-protein kinase At5g57670-like [Glycine max]

 Score =  583 bits (1502), Expect = e-164,   Method: Compositional matrix adjust.
 Identities = 288/383 (75%), Positives = 326/383 (85%), Gaps = 4/383 (1%)

Query: 1   MKYIRTNSLKRLFSLKRRSFDGDNAAVSPNGFTEESLENVVVACESETTKPTWRCFSFEE 60
           M+YIR+NS KRLFS +RRS       +SPN   EE+ E +    E  + +P+W+CFS+EE
Sbjct: 1   MRYIRSNSFKRLFSFRRRS--SREQILSPNSKGEENYE-IFPHEEEPSRRPSWKCFSYEE 57

Query: 61  ISIATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGH 120
           +  ATN FSSENLVG+GGYAEVYKG +   EEIAVKRLTK   D+RKEKEFLTEIGTIGH
Sbjct: 58  LFDATNGFSSENLVGKGGYAEVYKGTMSGSEEIAVKRLTKTSRDERKEKEFLTEIGTIGH 117

Query: 121 VCHPNVLSLLGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHY 180
           V H NVL LLGCC+DNGLYL+F+ SS GSVASL HD   P ++WK RHKIA+GTARGLHY
Sbjct: 118 VNHSNVLPLLGCCIDNGLYLVFELSSTGSVASLLHDERLPPLDWKTRHKIAIGTARGLHY 177

Query: 181 LHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPE 240
           LHKGC+RRIIHRDIK+SNILLT DFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPE
Sbjct: 178 LHKGCKRRIIHRDIKASNILLTKDFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPE 237

Query: 241 YFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQG 300
           Y++HG+VDEKTDVFAFGVFLLE+ISGRKPVDGSHQSLHSWAKPILN+GEIE+LVDPRL+G
Sbjct: 238 YYLHGVVDEKTDVFAFGVFLLEVISGRKPVDGSHQSLHSWAKPILNKGEIEELVDPRLEG 297

Query: 301 AYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEGDQIDKERWKMPEEEEEDQEEFW 360
           AYDVTQL   A AASLCIRAS TWRPTMSEVLE+M EG + D E+WKMPEEE+E +EEFW
Sbjct: 298 AYDVTQLKSFACAASLCIRASSTWRPTMSEVLEIMEEG-ETDIEKWKMPEEEKEQEEEFW 356

Query: 361 GFDDLEYECDSSFSVSPQDSIST 383
           GF+DLEYE DSSFS+S  DSI +
Sbjct: 357 GFEDLEYEYDSSFSMSLLDSIGS 379

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357479611|ref|XP_003610091.1| Receptor-like protein kinase [Medicago truncatula] gi|355511146|gb|AES92288.1| Receptor-like protein kinase [Medicago truncatula]

 Score =  574 bits (1480), Expect = e-161,   Method: Compositional matrix adjust.
 Identities = 280/383 (73%), Positives = 323/383 (84%), Gaps = 3/383 (0%)

Query: 1   MKYIRTNSLKRLFSLKRRSFDGDNAAVSPNGFTEESLENVVVACESETTKPTWRCFSFEE 60
           M+YIRT S KRLFS  +R        +SP G   E    ++   E    KPTW+CFS+EE
Sbjct: 1   MRYIRTGSFKRLFSFTKRGLG--EPVLSPKGEENEKSLKILPYEEETCQKPTWKCFSYEE 58

Query: 61  ISIATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGH 120
           +  ATN F+SEN+VG+GGYAEVYKG L++GEEIAVKRLT+   D+RKEKEFLTEIGTIGH
Sbjct: 59  LFDATNGFNSENMVGKGGYAEVYKGTLKNGEEIAVKRLTRASKDERKEKEFLTEIGTIGH 118

Query: 121 VCHPNVLSLLGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHY 180
           V H NVLSLLGCC+DNGLY +F+ S+ GSV+S+ HD     ++WK RHKI VGTARGLHY
Sbjct: 119 VRHSNVLSLLGCCIDNGLYFVFELSTTGSVSSILHDEQLAPLDWKTRHKIVVGTARGLHY 178

Query: 181 LHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPE 240
           LHKGC+RRIIHRDIK+SNILLT DFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPE
Sbjct: 179 LHKGCKRRIIHRDIKASNILLTKDFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPE 238

Query: 241 YFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQG 300
           Y++HG+VDEKTDVFAFGVFLLE+ISGRKPVD SHQSLHSWAKPILN+G+IE+LVD RL+G
Sbjct: 239 YYLHGVVDEKTDVFAFGVFLLEVISGRKPVDVSHQSLHSWAKPILNKGDIEELVDARLEG 298

Query: 301 AYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEGDQIDKERWKMPEEEEEDQEEFW 360
            YDVTQL RLAFAASLCIRAS TWRP+M+EVLE+M EG ++DKE+WKMPEEEEE +EEFW
Sbjct: 299 EYDVTQLKRLAFAASLCIRASSTWRPSMTEVLEIMEEG-EMDKEKWKMPEEEEEQEEEFW 357

Query: 361 GFDDLEYECDSSFSVSPQDSIST 383
           GF+DLEYE DSSFS+S  DSI +
Sbjct: 358 GFEDLEYEYDSSFSMSLIDSIES 380

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|226815614|emb|CAT79815.1| Rop-interacting receptor-like cytoplasmic kinase 1 [Medicago truncatula]

 Score =  572 bits (1475), Expect = e-161,   Method: Compositional matrix adjust.
 Identities = 278/383 (72%), Positives = 323/383 (84%), Gaps = 3/383 (0%)

Query: 1   MKYIRTNSLKRLFSLKRRSFDGDNAAVSPNGFTEESLENVVVACESETTKPTWRCFSFEE 60
           M+YIRT S KRLFS  +R        +SP G   E    ++   E    +PTW+CFS+EE
Sbjct: 1   MRYIRTGSFKRLFSFTKRGLG--EPVLSPKGEENEKSLKILPYEEETCQRPTWKCFSYEE 58

Query: 61  ISIATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGH 120
           +  ATN F+SEN+VG+GGYAEVYKG L++GEEIAVKRLT+   D+RKEKEFLTEIGTIGH
Sbjct: 59  LFDATNGFNSENMVGKGGYAEVYKGTLKNGEEIAVKRLTRASKDERKEKEFLTEIGTIGH 118

Query: 121 VCHPNVLSLLGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHY 180
           V H NVLSLLGCC+DNGLY +F+ S+ GSV+S+ HD     ++WK RHKI VGTARGLHY
Sbjct: 119 VRHSNVLSLLGCCIDNGLYFVFELSTTGSVSSILHDEKLAPLDWKTRHKIVVGTARGLHY 178

Query: 181 LHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPE 240
           LHKGC+RRIIHRDIK+SNILLT DFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPE
Sbjct: 179 LHKGCKRRIIHRDIKASNILLTKDFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPE 238

Query: 241 YFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQG 300
           Y++HG+VDEKTDVFAFGVFLLE+ISGRKPVD SHQSLHSWAKPILN+G+IE+LVD RL+G
Sbjct: 239 YYLHGVVDEKTDVFAFGVFLLEVISGRKPVDVSHQSLHSWAKPILNKGDIEELVDARLEG 298

Query: 301 AYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEGDQIDKERWKMPEEEEEDQEEFW 360
            YD+TQL RLAFAASLCIRAS TWRP+M+EVLE+M EG ++DKE+WKMPEEEEE +EEFW
Sbjct: 299 EYDITQLKRLAFAASLCIRASSTWRPSMTEVLEIMEEG-EMDKEKWKMPEEEEEQEEEFW 357

Query: 361 GFDDLEYECDSSFSVSPQDSIST 383
           GF+DLEYE DSSFS+S  DSI +
Sbjct: 358 GFEDLEYEYDSSFSMSLIDSIES 380

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|351724607|ref|NP_001238599.1| protein kinase family protein [Glycine max] gi|223452335|gb|ACM89495.1| protein kinase family protein [Glycine max]

 Score =  563 bits (1450), Expect = e-158,   Method: Compositional matrix adjust.
 Identities = 288/383 (75%), Positives = 327/383 (85%), Gaps = 4/383 (1%)

Query: 1   MKYIRTNSLKRLFSLKRRSFDGDNAAVSPNGFTEESLENVVVACESETTKPTWRCFSFEE 60
           M+YIR+NS KR FS +RRS       +SPN   E + E ++   E  + +P+W+CFS+EE
Sbjct: 1   MRYIRSNSFKRFFSFRRRSSR--EQILSPNSKGEGNNE-ILPHEEEPSRRPSWKCFSYEE 57

Query: 61  ISIATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGH 120
           +  ATN FSSENLVG+GGYAEVYKG +  GEEIAVKRLT+   D+RKEKEFLTEIGTIGH
Sbjct: 58  LFDATNGFSSENLVGKGGYAEVYKGTMNGGEEIAVKRLTRTSRDERKEKEFLTEIGTIGH 117

Query: 121 VCHPNVLSLLGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHY 180
           V H NVL LLGCC+DNGLYL+F+ SSRGSVASL HD   P ++WK RHKIA+GTARGLHY
Sbjct: 118 VNHSNVLPLLGCCIDNGLYLVFELSSRGSVASLIHDEKLPPLDWKTRHKIAIGTARGLHY 177

Query: 181 LHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPE 240
           LHK C+RRIIHRDIKSSNILLT DFEPQISDFGLAKWLPSQWTHHSI PIEGTFGHLAPE
Sbjct: 178 LHKDCKRRIIHRDIKSSNILLTKDFEPQISDFGLAKWLPSQWTHHSIGPIEGTFGHLAPE 237

Query: 241 YFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQG 300
           Y++HG+VDEKTDVFAFGVF+LE+ISGRKPVDGSHQSLHSWAKPILN+GEIE+LVDPRL+G
Sbjct: 238 YYLHGVVDEKTDVFAFGVFMLEVISGRKPVDGSHQSLHSWAKPILNKGEIEELVDPRLEG 297

Query: 301 AYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEGDQIDKERWKMPEEEEEDQEEFW 360
           AYDVTQL R AFAASLCIRAS TWRPTMSEVLE+M EG + D E+WKMPEEEEE +EEFW
Sbjct: 298 AYDVTQLKRFAFAASLCIRASSTWRPTMSEVLEIMEEG-ETDIEKWKMPEEEEEQEEEFW 356

Query: 361 GFDDLEYECDSSFSVSPQDSIST 383
           GF+DLEYE DSSFS+S  DSI +
Sbjct: 357 GFEDLEYEYDSSFSMSLLDSIGS 379

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356556186|ref|XP_003546407.1| PREDICTED: probable receptor-like serine/threonine-protein kinase At5g57670-like [Glycine max]

 Score =  558 bits (1439), Expect = e-156,   Method: Compositional matrix adjust.
 Identities = 279/383 (72%), Positives = 322/383 (84%), Gaps = 13/383 (3%)

Query: 1   MKYIRTNSLKRLFSLKRRSFDGDNAAVSPNGFTEESLENVVVACESETTKPTWRCFSFEE 60
           MKYIR+NSLKRLFS  R  F  +N            +  VV  CE    +P+W+CFS+EE
Sbjct: 1   MKYIRSNSLKRLFSFGRHGFGEEN-----------DVGLVVFPCEEHPPRPSWKCFSYEE 49

Query: 61  ISIATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGH 120
           +  ATN FSSEN++G+GGYAEVYKG+L  GEE+AVKRLT+   D+RKEKEFL EIGTIGH
Sbjct: 50  LFDATNGFSSENVIGKGGYAEVYKGILNGGEEVAVKRLTRTSRDERKEKEFLLEIGTIGH 109

Query: 121 VCHPNVLSLLGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHY 180
           V H NVL LLGCC+DNGLYL+F+ S+ GSVASL HD + P ++WK R+KIA+GTARGLHY
Sbjct: 110 VRHSNVLPLLGCCIDNGLYLVFELSNVGSVASLIHDEHLPHLDWKTRYKIALGTARGLHY 169

Query: 181 LHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPE 240
           LHKGC+RRIIHRDIK+SNILLTADFEP+ISDFGLA+WLPSQWTHHSIAPIEGTFGHLAPE
Sbjct: 170 LHKGCKRRIIHRDIKASNILLTADFEPKISDFGLARWLPSQWTHHSIAPIEGTFGHLAPE 229

Query: 241 YFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQG 300
           Y++HG+VDEKTDVFAFGVFLLE+ISGRKPVDGSHQSLHSWAKPILN+GEIEKLVDPRL G
Sbjct: 230 YYLHGVVDEKTDVFAFGVFLLEVISGRKPVDGSHQSLHSWAKPILNKGEIEKLVDPRLGG 289

Query: 301 AYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEGDQIDKERWKMPEEEEEDQEEFW 360
           AYDVTQ NR+AFAASLCIRAS T RPTMSEVLEVM E  ++DK +W+M  EEEE +EE W
Sbjct: 290 AYDVTQFNRVAFAASLCIRASATCRPTMSEVLEVMEEW-EMDKGKWEM-PEEEEQEEELW 347

Query: 361 GFDDLEYECDSSFSVSPQDSIST 383
           GF+DLEYE DSSFS+S  DS+ +
Sbjct: 348 GFEDLEYEYDSSFSMSLPDSVGS 370

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356530292|ref|XP_003533716.1| PREDICTED: probable receptor-like serine/threonine-protein kinase At5g57670-like [Glycine max]

 Score =  557 bits (1436), Expect = e-156,   Method: Compositional matrix adjust.
 Identities = 281/384 (73%), Positives = 324/384 (84%), Gaps = 15/384 (3%)

Query: 1   MKYIRTNSLKRLFSLKRRSFDGDNAAVSPNGFTEESLENVVVA-CESETTKPTWRCFSFE 59
           MKYIR+NSLKRLFS  RR            GF EE+   +VV+ CE    +P+W+CFS+E
Sbjct: 1   MKYIRSNSLKRLFSFGRR------------GFGEENDVGLVVSPCEEHPPRPSWKCFSYE 48

Query: 60  EISIATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIG 119
           E+  ATN FSSEN++GRGGYAEVYKG L  G+E+AVKRLT+  TD+RKEKEFL EIGTIG
Sbjct: 49  ELFDATNDFSSENVIGRGGYAEVYKGTLNGGDEVAVKRLTRTSTDERKEKEFLLEIGTIG 108

Query: 120 HVCHPNVLSLLGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLH 179
           HV H NVL LLGCC+DNGLYL+F+ S+ GSVASL HD N P ++WK R+KIA+GTARGLH
Sbjct: 109 HVRHSNVLPLLGCCIDNGLYLVFELSTVGSVASLIHDENLPPLDWKTRYKIALGTARGLH 168

Query: 180 YLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAP 239
           YLHKGC+RRIIHRDIK+SNILLTADFEP+ISDFGLA+WLPSQWTHHSIAPIEGTFGHLAP
Sbjct: 169 YLHKGCKRRIIHRDIKASNILLTADFEPKISDFGLARWLPSQWTHHSIAPIEGTFGHLAP 228

Query: 240 EYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQ 299
           EY++HG+VDEKTDVFAFGVFLLE+ISGRKPVDGSHQSLHSWAKPIL++GEIE LVDPRL 
Sbjct: 229 EYYLHGVVDEKTDVFAFGVFLLEVISGRKPVDGSHQSLHSWAKPILSKGEIENLVDPRLG 288

Query: 300 GAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEGDQIDKERWKMPEEEEEDQEEF 359
           GAYDVTQ NR+AFAASLCIRAS T RP MSEVLEVM E  ++DK +W+M  EEEE +EE 
Sbjct: 289 GAYDVTQFNRVAFAASLCIRASATCRPIMSEVLEVMEEW-EMDKGKWEM-PEEEEQEEEL 346

Query: 360 WGFDDLEYECDSSFSVSPQDSIST 383
           WGF+DLEYE DSSFS+S  DS+ +
Sbjct: 347 WGFEDLEYEYDSSFSMSLPDSVGS 370

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224143691|ref|XP_002325042.1| predicted protein [Populus trichocarpa] gi|222866476|gb|EEF03607.1| predicted protein [Populus trichocarpa]

 Score =  554 bits (1427), Expect = e-155,   Method: Compositional matrix adjust.
 Identities = 269/331 (81%), Positives = 288/331 (87%), Gaps = 3/331 (0%)

Query: 1   MKYIRTNSLKRLFSLKRRSFDGDNAAVSPNGFTEESLENVVVACESETTKPTWRCFSFEE 60
           MKYIRTNSL+RLFSLKRRS + D       G   E+  + +V     + +P+W+CFSFEE
Sbjct: 1   MKYIRTNSLRRLFSLKRRSLE-DIVYTDEEGKNNEN--SKIVQEPQHSPRPSWKCFSFEE 57

Query: 61  ISIATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGH 120
           IS ATN FS ENLVGRGGYAEVYKGVL DGEEIA+KRLTK   D+RKEKEFLTEIGTIGH
Sbjct: 58  ISDATNGFSPENLVGRGGYAEVYKGVLGDGEEIAIKRLTKACRDERKEKEFLTEIGTIGH 117

Query: 121 VCHPNVLSLLGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHY 180
           VCHPNVLSLLGCC DNGLYLIF FSSRGSVASL HD N P ++WK+R+KIA+GTARGLHY
Sbjct: 118 VCHPNVLSLLGCCTDNGLYLIFHFSSRGSVASLLHDENLPVMDWKIRYKIAIGTARGLHY 177

Query: 181 LHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPE 240
           LHKGCQRRIIHRDIKSSNILLTADFEP ISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPE
Sbjct: 178 LHKGCQRRIIHRDIKSSNILLTADFEPLISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPE 237

Query: 241 YFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQG 300
           Y+MHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQS+H WAKPILNQGEIE+LVDPRL G
Sbjct: 238 YYMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSIHVWAKPILNQGEIERLVDPRLGG 297

Query: 301 AYDVTQLNRLAFAASLCIRASPTWRPTMSEV 331
            YD TQ  RL FAASLCIRAS TWRPTMSEV
Sbjct: 298 TYDATQQKRLGFAASLCIRASSTWRPTMSEV 328

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297836744|ref|XP_002886254.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] gi|297332094|gb|EFH62513.1| kinase family protein [Arabidopsis lyrata subsp. lyrata]

 Score =  528 bits (1360), Expect = e-147,   Method: Compositional matrix adjust.
 Identities = 277/383 (72%), Positives = 321/383 (83%), Gaps = 7/383 (1%)

Query: 1   MKYIRTNSLKRLFSLKRRSFDGDNAAVSPNGFTEESLENVVVACESET-TKPTWRCFSFE 59
           MKYIR+NSLKRLFS KRRSFD D++  S    T  S + V    E+E   +P W+CFSFE
Sbjct: 1   MKYIRSNSLKRLFSFKRRSFDSDSSENS-TPHTASSTKCVEGFQETEQFQRPKWKCFSFE 59

Query: 60  EISIATNAFSSENLVGRGGYAEVYKGVL-QDGEEIAVKRLTKVVTDD-RKEKEFLTEIGT 117
           EI  ATN FSSENLVGRGG+AEVYKG+L ++GEEIAVKR+T+   DD R+EKEFL EIGT
Sbjct: 60  EIYDATNGFSSENLVGRGGFAEVYKGILSRNGEEIAVKRITRGGRDDERREKEFLMEIGT 119

Query: 118 IGHVCHPNVLSLLGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARG 177
           IGHV HPNVLSLLGCC+DNGLYL+F FSSRGSVASL HD+N   +EW+ R++IA+GTA+G
Sbjct: 120 IGHVSHPNVLSLLGCCIDNGLYLVFIFSSRGSVASLLHDLNQAPLEWETRYRIAIGTAKG 179

Query: 178 LHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHL 237
           LHYLHKGCQRRIIHRDIKSSN+LL  DFEPQISDFGLAKWLPSQW+HHSIAPIEGTFGHL
Sbjct: 180 LHYLHKGCQRRIIHRDIKSSNVLLNQDFEPQISDFGLAKWLPSQWSHHSIAPIEGTFGHL 239

Query: 238 APEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPR 297
           APEY+ HGIVDEKTDVFAFGVFLLE+ISG+KPVD SHQSLHSWAK I+  GEIEKLVDPR
Sbjct: 240 APEYYTHGIVDEKTDVFAFGVFLLELISGKKPVDASHQSLHSWAKLIIKDGEIEKLVDPR 299

Query: 298 LQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEGDQIDKERWKMPEEEEEDQE 357
           +   +D+ QL+R+AFAASLCIR+S   RP+M EVLEV L+G+ I+KE+    EEEEE +E
Sbjct: 300 IGEEFDLQQLHRIAFAASLCIRSSSLCRPSMIEVLEV-LQGEDIEKEK-WKMEEEEEVKE 357

Query: 358 EFWGFDDLE-YECDSSFSVSPQD 379
           EFWG++DLE  ECDSS S+SP D
Sbjct: 358 EFWGYEDLEDCECDSSISLSPPD 380

Source: Arabidopsis lyrata subsp. lyrata

Species: Arabidopsis lyrata

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	386
TAIR|locus:2044420	392	AT2G18890 [Arabidopsis thalian	0.992	0.977	0.705	3.6e-144
TAIR|locus:2172555	579	AT5G57670 [Arabidopsis thalian	0.849	0.566	0.539	1.8e-96
TAIR|locus:2144970	511	AT5G18910 [Arabidopsis thalian	0.759	0.573	0.553	3.5e-91
TAIR|locus:2096209	460	RBK2 "ROP binding protein kina	0.873	0.732	0.508	4.7e-87
TAIR|locus:2155700	456	AT5G65530 [Arabidopsis thalian	0.764	0.646	0.536	1.6e-86
TAIR|locus:2142514	467	RBK1 "ROP binding protein kina	0.761	0.629	0.515	8.2e-83
TAIR|locus:2162848	429	AT5G35960 [Arabidopsis thalian	0.740	0.666	0.529	2.5e-81
TAIR|locus:2195975	794	AT1G77280 [Arabidopsis thalian	0.803	0.390	0.448	5.2e-65
TAIR|locus:2028756	762	PERK10 "proline-rich extensin-	0.709	0.359	0.479	1.4e-64
TAIR|locus:2036636	632	NIK3 "NSP-interacting kinase 3	0.746	0.455	0.456	9.9e-64

TAIR|locus:2044420 AT2G18890 [Arabidopsis thaliana (taxid:3702)]

 Score = 1409 (501.1 bits), Expect = 3.6e-144, P = 3.6e-144
 Identities = 275/390 (70%), Positives = 321/390 (82%)

Query:     1 MKYIRTNSLKRLFSLKRRSFDGDNAAVSPNGFTEESLENVVVACESET-TKPTWRCFSFE 59
             MKYIR+NSLKRLFS KRRSFD D++  S +     S + V    E++   +P W+CFSF+
Sbjct:     1 MKYIRSNSLKRLFSFKRRSFDSDSSENS-SPLAASSTKCVEGFQETDQFQRPKWKCFSFQ 59

Query:    60 EISIATNAFSSENLVGRGGYAEVYKGVL-QDGEEIAVKRLTKVVTDD-RKEKEFLTEIGT 117
             EI  ATN FSSENLVGRGG+AEVYKG+L ++GEEIAVKR+T+   DD R+EKEFL EIGT
Sbjct:    60 EIYDATNGFSSENLVGRGGFAEVYKGILGKNGEEIAVKRITRGGRDDERREKEFLMEIGT 119

Query:   118 IGHVCHPNVLSLLGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARG 177
             IGHV HPNVLSLLGCC+DNGLYL+F FSSRGS+ASL HD+N   +EW+ R+KIA+GTA+G
Sbjct:   120 IGHVSHPNVLSLLGCCIDNGLYLVFIFSSRGSLASLLHDLNQAPLEWETRYKIAIGTAKG 179

Query:   178 LHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHL 237
             LHYLHKGCQRRIIHRDIKSSN+LL  DFEPQISDFGLAKWLPSQW+HHSIAPIEGTFGHL
Sbjct:   180 LHYLHKGCQRRIIHRDIKSSNVLLNQDFEPQISDFGLAKWLPSQWSHHSIAPIEGTFGHL 239

Query:   238 APEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPR 297
             APEY+ HGIVDEKTDVFAFGVFLLE+ISG+KPVD SHQSLHSWAK I+  GEIEKLVDPR
Sbjct:   240 APEYYTHGIVDEKTDVFAFGVFLLELISGKKPVDASHQSLHSWAKLIIKDGEIEKLVDPR 299

Query:   298 LQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEGDQIDKERWKMPXXXXXXXX 357
             +   +D+ QL+R+AFAASLCIR+S   RP+M EVLEV L+G+ I+KE+WKM         
Sbjct:   300 IGEEFDLQQLHRIAFAASLCIRSSSLCRPSMIEVLEV-LQGEDIEKEKWKMEEEEEVKEE 358

Query:   358 XFWGFDDLE-YECDSSFSVSPQDSISTGSS 386
              FWG++DLE  ECDSS S+SP DSIS  SS
Sbjct:   359 -FWGYEDLEDCECDSSISLSPPDSISNRSS 387

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2172555 AT5G57670 [Arabidopsis thaliana (taxid:3702)]

 Score = 959 (342.6 bits), Expect = 1.8e-96, P = 1.8e-96
 Identities = 179/332 (53%), Positives = 234/332 (70%)

Query:    50 KPTWRCFSFEEISIATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEK 109
             +P  +CF++ EIS ATN F   N+VG GGY+EVY+G L DG  IAVKRL K   D  KEK
Sbjct:   249 QPLIQCFTYNEISKATNDFHQGNIVGIGGYSEVYRGDLWDGRRIAVKRLAKESGDMNKEK 308

Query:   110 EFLTEIGTIGHVCHPNVLSLLGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHK 169
             EFLTE+G I HV HPN   LLGCCV+ GLYL+F+FS  G++ S  H+  +  ++W VR+K
Sbjct:   309 EFLTELGIISHVSHPNTALLLGCCVEKGLYLVFRFSENGTLYSALHENENGSLDWPVRYK 368

Query:   170 IAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAP 229
             IAVG ARGLHYLHK C  RIIHRDIKSSN+LL  D+EPQI+DFGLAKWLP++WTHH++ P
Sbjct:   369 IAVGVARGLHYLHKRCNHRIIHRDIKSSNVLLGPDYEPQITDFGLAKWLPNKWTHHAVIP 428

Query:   230 IEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGE 289
             +EGTFG+LAPE  M G +DEKTD++AFG+ LLEII+GR+PV+ + + +  WAKP +  G 
Sbjct:   429 VEGTFGYLAPESLMQGTIDEKTDIYAFGILLLEIITGRRPVNPTQKHILLWAKPAMETGN 488

Query:   290 IEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEGDQID-KERWKM 348
               +LVDP+LQ  YD  Q+N+L   AS C++ SP  RPTM++VLE++  G++ +  + W+M
Sbjct:   489 TSELVDPKLQDKYDDQQMNKLVLTASHCVQQSPILRPTMTQVLELLTNGNEAEIAKSWRM 548

Query:   349 PXXXXXXXXXFWGFDDLEYECDSSFSVSPQDS 380
             P            +DD  Y     + V P DS
Sbjct:   549 PKDMTNDDDDNNEWDD--YSMIFGYDV-PSDS 577

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0002238 "response to molecule of fungal origin" evidence=RCA

TAIR|locus:2144970 AT5G18910 [Arabidopsis thaliana (taxid:3702)]

 Score = 909 (325.0 bits), Expect = 3.5e-91, P = 3.5e-91
 Identities = 165/298 (55%), Positives = 229/298 (76%)

Query:    50 KPTWRCFSFEEISIATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEK 109
             KP+WR FS  +I  ATN +S ENL+G GGYAEVYKG + DG+ +A+K+LT+   ++    
Sbjct:   174 KPSWRNFSLRDIQTATNDYSRENLIGEGGYAEVYKGQMADGQIVAIKKLTRGSAEEMT-M 232

Query:   110 EFLTEIGTIGHVCHPNVLSLLGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHK 169
             ++L+E+G I HV HPN+  L+G CV+ G++L+ + S  GS+ASL ++     + W +R+K
Sbjct:   233 DYLSELGIIVHVDHPNIAKLIGYCVEGGMHLVLELSPNGSLASLLYEAKEK-LNWSMRYK 291

Query:   170 IAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAP 229
             +A+GTA GL+YLH+GCQRRIIH+DIK+SNILLT +FE QISDFGLAKWLP QWTHH+++ 
Sbjct:   292 VAMGTAEGLYYLHEGCQRRIIHKDIKASNILLTQNFEAQISDFGLAKWLPDQWTHHTVSK 351

Query:   230 IEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGE 289
             +EGTFG+L PE+FMHGIVDEKTDV+A+GV LLE+I+GR+ +D S  S+  WAKP++ + +
Sbjct:   352 VEGTFGYLPPEFFMHGIVDEKTDVYAYGVLLLELITGRQALDSSQHSIVMWAKPLIKENK 411

Query:   290 IEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEGDQ--IDKER 345
             I++LVDP L+  YDV +L+RL F ASLCI  +   RP MS+V+E+ L GD+  +DK R
Sbjct:   412 IKQLVDPILEDDYDVEELDRLVFIASLCIHQTSMNRPQMSQVVEI-LRGDKCSLDKLR 468

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005777 "peroxisome" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

TAIR|locus:2096209 RBK2 "ROP binding protein kinases 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 870 (311.3 bits), Expect = 4.7e-87, P = 4.7e-87
 Identities = 173/340 (50%), Positives = 232/340 (68%)

Query:     2 KYIRTNSLKRLFSLKRRSFDGDNAAVSPNGFTEESLENVVVACESETTKPTWRCFSFEEI 61
             K  +  S+KRL S    S       +  N   + ++  +V+  +    + + + FS  +I
Sbjct:    79 KLWKRRSMKRLSSFPPLS-GAAPPIIKQNKSADPNMNGMVLH-DIYDFQSSLQNFSISDI 136

Query:    62 SIATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHV 121
              IAT+ FS EN++GRGGYA+VY+G+L +G+ IAVKRLTK  T D +  EFL+E+G I HV
Sbjct:   137 EIATDNFSPENIIGRGGYADVYQGILPEGKLIAVKRLTKG-TPDEQTAEFLSELGIIAHV 195

Query:   122 CHPNVLSLLGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYL 181
              HPN    +GCC++ G++L+F+ S  GS+ SL H  +   + W  R+ +A+GTA GL YL
Sbjct:   196 DHPNTAKFIGCCIEGGMHLVFRLSPLGSLGSLLHGPSKYKLTWSRRYNVALGTADGLVYL 255

Query:   182 HKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEY 241
             H+GCQRRIIHRDIK+ NILLT DF+PQI DFGLAKWLP Q THH+++  EGTFG+ APEY
Sbjct:   256 HEGCQRRIIHRDIKADNILLTEDFQPQICDFGLAKWLPKQLTHHNVSKFEGTFGYFAPEY 315

Query:   242 FMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGA 301
             FMHGIVDEKTDVFAFGV LLE+I+G   +D S QSL  WAKP+L +  I++LVDP L   
Sbjct:   316 FMHGIVDEKTDVFAFGVLLLELITGHPALDESQQSLVLWAKPLLERKAIKELVDPSLGDE 375

Query:   302 YDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEGDQI 341
             Y+  +L RL   ASLCI  S   RP MS+V+E++L  + +
Sbjct:   376 YNREELIRLTSTASLCIDQSSLLRPRMSQVVELLLGHEDV 415

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005737 "cytoplasm" evidence=IDA

GO:0051020 "GTPase binding" evidence=IPI

TAIR|locus:2155700 AT5G65530 [Arabidopsis thaliana (taxid:3702)]

 Score = 865 (309.6 bits), Expect = 1.6e-86, P = 1.6e-86
 Identities = 160/298 (53%), Positives = 220/298 (73%)

Query:    50 KPTWRCFSFEEISIATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTD-DRKE 108
             KP+WR F+F+E+  AT+ F+ EN++G+GG+AEVYKGVL DGE +A+K+LT+   + + + 
Sbjct:   126 KPSWRNFTFDELVAATDNFNPENMIGKGGHAEVYKGVLPDGETVAIKKLTRHAKEVEERV 185

Query:   109 KEFLTEIGTIGHVCHPNVLSLLGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRH 168
              +FL+E+G I HV HPN   L G   D GL+ + ++SS GS+ASL    +   ++WK R+
Sbjct:   186 SDFLSELGIIAHVNHPNAARLRGFSCDRGLHFVLEYSSHGSLASLLFG-SEECLDWKKRY 244

Query:   169 KIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIA 228
             K+A+G A GL YLH  C RRIIHRDIK+SNILL+ D+E QISDFGLAKWLP  W HH + 
Sbjct:   245 KVAMGIADGLSYLHNDCPRRIIHRDIKASNILLSQDYEAQISDFGLAKWLPEHWPHHIVF 304

Query:   229 PIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVD-GSHQSLHSWAKPILNQ 287
             PIEGTFG+LAPEYFMHGIVDEKTDVFAFGV LLEII+GR+ VD  S QS+  WAKP+L +
Sbjct:   305 PIEGTFGYLAPEYFMHGIVDEKTDVFAFGVLLLEIITGRRAVDTDSRQSIVMWAKPLLEK 364

Query:   288 GEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEGDQIDKER 345
               +E++VDP+L   +D T++ R+   AS+CI    T RP M+ +++++   DQ+ +++
Sbjct:   365 NNMEEIVDPQLGNDFDETEMKRVMQTASMCIHHVSTMRPDMNRLVQLLRGDDQLAEQK 422

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005737 "cytoplasm" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0046777 "protein autophosphorylation" evidence=IDA

TAIR|locus:2142514 RBK1 "ROP binding protein kinases 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 830 (297.2 bits), Expect = 8.2e-83, P = 8.2e-83
 Identities = 154/299 (51%), Positives = 215/299 (71%)

Query:    44 CESE-TTKPTWRCFSFEEISIATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRL-TKV 101
             CE+    KP+WR F++EE+++AT+ F+ EN++G+GG+AEVYKGVL +GE +A+K+L +  
Sbjct:   128 CEAFFMAKPSWRNFTYEELAVATDYFNPENMIGKGGHAEVYKGVLINGETVAIKKLMSHA 187

Query:   102 VTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNGLYLIFQFSSRGSVASLFHDVNSPG 161
               ++ +  +FL+E+G I HV HPN   L G   D GL+ + +++  GS+AS+    +   
Sbjct:   188 KEEEERVSDFLSELGIIAHVNHPNAARLRGFSSDRGLHFVLEYAPYGSLASMLFG-SEEC 246

Query:   162 VEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQ 221
             +EWK+R+K+A+G A GL YLH  C RRIIHRDIK+SNILL  D+E QISDFGLAKWLP  
Sbjct:   247 LEWKIRYKVALGIADGLSYLHNACPRRIIHRDIKASNILLNHDYEAQISDFGLAKWLPEN 306

Query:   222 WTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVD-GSHQSLHSW 280
             W HH + PIEGTFG+LAPEYFMHGIVDEK DVFAFGV LLEII+ R+ VD  S QS+ +W
Sbjct:   307 WPHHVVFPIEGTFGYLAPEYFMHGIVDEKIDVFAFGVLLLEIITSRRAVDTASRQSIVAW 366

Query:   281 AKPILNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEGD 339
             AKP L +  +E +VDPRL   ++ T++ R+   AS+C+      RP M+ +++ +L G+
Sbjct:   367 AKPFLEKNSMEDIVDPRLGNMFNPTEMQRVMLTASMCVHHIAAMRPDMTRLVQ-LLRGE 424

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005737 "cytoplasm" evidence=IDA

GO:0005829 "cytosol" evidence=IDA

GO:0009623 "response to parasitic fungus" evidence=IEP

GO:0009814 "defense response, incompatible interaction" evidence=IEP

GO:0012505 "endomembrane system" evidence=IDA

GO:0051020 "GTPase binding" evidence=IPI

GO:0071369 "cellular response to ethylene stimulus" evidence=IEP

GO:0009612 "response to mechanical stimulus" evidence=RCA

GO:0019722 "calcium-mediated signaling" evidence=RCA

TAIR|locus:2162848 AT5G35960 [Arabidopsis thaliana (taxid:3702)]

 Score = 816 (292.3 bits), Expect = 2.5e-81, P = 2.5e-81
 Identities = 153/289 (52%), Positives = 213/289 (73%)

Query:    54 RCFSFEEISIATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLT 113
             R F+F ++  ATN FS ENL+G+GGYAEVYKG+L +G+ +A+KRL +  +++    +FL+
Sbjct:   120 RIFTFSDLKSATNNFSLENLIGKGGYAEVYKGMLPNGQMVAIKRLMRGNSEEIIV-DFLS 178

Query:   114 EIGTIGHVCHPNVLSLLGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVG 173
             E+G + HV HPN+  LLG  V+ G++L+ + S  GS+AS+ +  +   ++W +R+KIA+G
Sbjct:   179 EMGIMAHVNHPNIAKLLGYGVEGGMHLVLELSPHGSLASMLYS-SKEKMKWSIRYKIALG 237

Query:   174 TARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGT 233
              A GL YLH+GC RRIIHRDIK++NILLT DF PQI DFGLAKWLP  WTHH ++  EGT
Sbjct:   238 VAEGLVYLHRGCHRRIIHRDIKAANILLTHDFSPQICDFGLAKWLPENWTHHIVSKFEGT 297

Query:   234 FGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKL 293
             FG+LAPEY  HGIVDEKTDVFA GV LLE+++GR+ +D S QSL  WAKP++ + +I +L
Sbjct:   298 FGYLAPEYLTHGIVDEKTDVFALGVLLLELVTGRRALDYSKQSLVLWAKPLMKKNKIREL 357

Query:   294 VDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEGDQID 342
             +DP L G Y+  Q+  +  AA+L I+ S   RP MS+V+E+ L+G+  D
Sbjct:   358 IDPSLAGEYEWRQIKLVLLAAALSIQQSSIERPEMSQVVEI-LKGNLKD 405

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2195975 AT1G77280 [Arabidopsis thaliana (taxid:3702)]

 Score = 662 (238.1 bits), Expect = 5.2e-65, P = 5.2e-65
 Identities = 148/330 (44%), Positives = 207/330 (62%)

Query:    28 SPNGFTEESLENVVVACESETTKPTWRCFSFEEISIATNAFSSENLVGRGGYAEVYKGVL 87
             SP    EE LE +      E    T R F ++E+   T+ FS++N +G+GG + V++G L
Sbjct:   411 SPRKLPEE-LEGLY-----ERFSSTCRFFKYKELVSVTSNFSADNFIGKGGSSRVFRGCL 464

Query:    88 QDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCV-DNGLYLIFQFSS 146
              +G  +AVK L +  T+D    +F+ EI  I  + H N++SLLG C  D+ L L++ + S
Sbjct:   465 SNGRVVAVKILKQ--TEDVLN-DFVAEIEIITTLHHKNIISLLGFCFEDHNLLLVYNYLS 521

Query:   147 RGSVASLFH-DVNSP-GVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTAD 204
             RGS+    H +   P    W  R+K+AVG A  L YLH    + +IHRD+KSSNILL+ D
Sbjct:   522 RGSLEENLHGNKKDPLAFCWSERYKVAVGVAEALDYLHNTASQPVIHRDVKSSNILLSDD 581

Query:   205 FEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEII 264
             FEPQ+SDFGLA+W     TH   + + GTFG+LAPEYFM+G V++K DV+AFGV LLE++
Sbjct:   582 FEPQLSDFGLARWASISTTHIICSDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELL 641

Query:   265 SGRKPVDGS----HQSLHSWAKPILNQGEIEKLVDPRLQGAYDVT--QLNRLAFAASLCI 318
             SGRKP+        +SL  WAKPIL+ G+  +L+DP L+   +    Q+ R+A AA+LCI
Sbjct:   642 SGRKPISSGCPKGQESLVMWAKPILDDGKYSQLLDPSLRDNNNNNDDQMQRMALAATLCI 701

Query:   319 RASPTWRPTMSEVLEVMLEGDQIDKERWKM 348
             R SP  RP MS VL+ +L+GD+ D   W M
Sbjct:   702 RRSPQARPKMSIVLK-LLKGDE-DTLEWAM 729

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0002238 "response to molecule of fungal origin" evidence=RCA

TAIR|locus:2028756 PERK10 "proline-rich extensin-like receptor kinase 10" [Arabidopsis thaliana (taxid:3702)]

 Score = 631 (227.2 bits), Expect = 1.4e-64, Sum P(2) = 1.4e-64
 Identities = 137/286 (47%), Positives = 183/286 (63%)

Query:    56 FSFEEISIATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEI 115
             FS+EE+ IATN FS ENL+G GG+  VYKGVL D   +AVK+L   +   + ++EF  E+
Sbjct:   418 FSYEELVIATNGFSDENLLGEGGFGRVYKGVLPDERVVAVKQLK--IGGGQGDREFKAEV 475

Query:   116 GTIGHVCHPNVLSLLGCCV-DNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGT 174
              TI  V H N+LS++G C+ +N   LI+ +    ++    H   +PG++W  R KIA G 
Sbjct:   476 DTISRVHHRNLLSMVGYCISENRRLLIYDYVPNNNLYFHLHAAGTPGLDWATRVKIAAGA 535

Query:   175 ARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTF 234
             ARGL YLH+ C  RIIHRDIKSSNILL  +F   +SDFGLAK L      H    + GTF
Sbjct:   536 ARGLAYLHEDCHPRIIHRDIKSSNILLENNFHALVSDFGLAK-LALDCNTHITTRVMGTF 594

Query:   235 GHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSH----QSLHSWAKPIL-NQGE 289
             G++APEY   G + EK+DVF+FGV LLE+I+GRKPVD S     +SL  WA+P+L N  E
Sbjct:   595 GYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSNATE 654

Query:   290 IEK---LVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVL 332
              E+   L DP+L   Y   ++ R+  AA+ CIR S T RP MS+++
Sbjct:   655 TEEFTALADPKLGRNYVGVEMFRMIEAAAACIRHSATKRPRMSQIV 700

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2036636 NIK3 "NSP-interacting kinase 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 628 (226.1 bits), Expect = 9.9e-64, Sum P(2) = 9.9e-64
 Identities = 137/300 (45%), Positives = 189/300 (63%)

Query:    56 FSFEEISIATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEI 115
             ++F+E+  ATN F+S+N++GRGGY  VYKG L DG  +AVKRL K       E +F TE+
Sbjct:   289 YTFKELRSATNHFNSKNILGRGGYGIVYKGHLNDGTLVAVKRL-KDCNIAGGEVQFQTEV 347

Query:   116 GTIGHVCHPNVLSLLGCCVDNG-LYLIFQFSSRGSVASLFHDV--NSPGVEWKVRHKIAV 172
              TI    H N+L L G C  N    L++ +   GSVAS   D     P ++W  R KIAV
Sbjct:   348 ETISLALHRNLLRLRGFCSSNQERILVYPYMPNGSVASRLKDNIRGEPALDWSRRKKIAV 407

Query:   173 GTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEG 232
             GTARGL YLH+ C  +IIHRD+K++NILL  DFE  + DFGLAK L  + +H + A + G
Sbjct:   408 GTARGLVYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTA-VRG 466

Query:   233 TFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVD---GSHQS--LHSWAKPILNQ 287
             T GH+APEY   G   EKTDVF FG+ LLE+I+G+K +D    +HQ   +  W K +  +
Sbjct:   467 TVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQKALDFGRSAHQKGVMLDWVKKLHQE 526

Query:   288 GEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEGDQIDKERWK 347
             G++++L+D  L   +D  +L  +   A LC + +P+ RP MSEV++ MLEGD +  ERW+
Sbjct:   527 GKLKQLIDKDLNDKFDRVELEEIVQVALLCTQFNPSHRPKMSEVMK-MLEGDGL-AERWE 584

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0007020 "microtubule nucleation" evidence=RCA

GO:0010075 "regulation of meristem growth" evidence=RCA

GO:0048653 "anther development" evidence=RCA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.824
3rd Layer	2.7.11	0.766

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input:
	GSVIVG00031352001	SubName- Full=Chromosome chr11 scaffold_56, whole genome shotgun sequence; (340 aa)
		(Vitis vinifera)
Predicted Functional Partners:
	GSVIVG00011963001	SubName- Full=Chromosome undetermined scaffold_2647, whole genome shotgun sequence; (414 aa)			•						0.424

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	386
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	2e-42
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	6e-42
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	1e-41
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	1e-41
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	3e-41
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	2e-40
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	7e-37
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	4e-34
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	5e-34
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	4e-27
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	4e-27
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	3e-26
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	3e-26
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	2e-25
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	6e-25
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	8e-25
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	2e-24
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	1e-23
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	2e-23
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	5e-23
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-22
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	2e-22
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	2e-22
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	2e-22
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	3e-22
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	4e-22
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	7e-22
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	9e-22
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	1e-21
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	2e-21
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	4e-21
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	1e-20
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	2e-20
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	2e-20
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	2e-20
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	3e-20
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	3e-20
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	4e-20
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	1e-19
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	1e-19
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	2e-19
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	2e-19
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	2e-19
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	3e-19
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	3e-19
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	4e-19
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	4e-19
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	5e-19
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	5e-19
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	6e-19
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	6e-19
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	7e-19
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	2e-18
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	2e-18
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	3e-18
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	3e-18
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	5e-18
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	5e-18
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	7e-18
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	1e-17
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	1e-17
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	1e-17
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	1e-17
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	1e-17
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	1e-17
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	3e-17
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	5e-17
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	5e-17
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	7e-17
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	9e-17
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	9e-17
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	1e-16
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	1e-16
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	2e-16
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	2e-16
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	2e-16
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	2e-16
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	2e-16
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	3e-16
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	4e-16
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	5e-16
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	7e-16
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	8e-16
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	1e-15
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	1e-15
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	1e-15
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	2e-15
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	2e-15
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	3e-15
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	3e-15
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	4e-15
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	4e-15
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	4e-15
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	5e-15
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	5e-15
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	6e-15
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	7e-15
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	8e-15
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	2e-14
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	2e-14
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	2e-14
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	2e-14
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	4e-14
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	4e-14
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	6e-14
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	6e-14
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	8e-14
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	1e-13
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	2e-13
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	2e-13
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	2e-13
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	2e-13
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	2e-13
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	2e-13
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	3e-13
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	3e-13
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	3e-13
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	4e-13
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	5e-13
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	6e-13
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	6e-13
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	6e-13
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	6e-13
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	6e-13
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	8e-13
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	1e-12
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	1e-12
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	1e-12
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	1e-12
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	1e-12
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	2e-12
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	2e-12
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	2e-12
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	3e-12
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	3e-12
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	3e-12
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	3e-12
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	3e-12
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	3e-12
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	4e-12
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	4e-12
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	4e-12
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	4e-12
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	5e-12
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	6e-12
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	6e-12
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	6e-12
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	7e-12
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	9e-12
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	9e-12
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	1e-11
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	1e-11
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	1e-11
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	2e-11
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	2e-11
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	2e-11
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	2e-11
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	3e-11
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	3e-11
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	4e-11
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	4e-11
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	5e-11
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	5e-11
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	5e-11
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	6e-11
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	6e-11
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	7e-11
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	7e-11
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	9e-11
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	9e-11
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	1e-10
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	1e-10
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	1e-10
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	1e-10
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	1e-10
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	1e-10
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	1e-10
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	1e-10
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	2e-10
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	2e-10
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	2e-10
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	2e-10
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	2e-10
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	2e-10
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	2e-10
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	2e-10
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	3e-10
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	4e-10
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	5e-10
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	5e-10
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	7e-10
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	7e-10
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	7e-10
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	7e-10
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	9e-10
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	1e-09
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	1e-09
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	1e-09
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	2e-09
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	2e-09
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	2e-09
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	2e-09
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	2e-09
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	2e-09
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	3e-09
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	4e-09
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	4e-09
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	4e-09
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	5e-09
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	5e-09
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	5e-09
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	6e-09
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	7e-09
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	9e-09
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	1e-08
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	1e-08
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	1e-08
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	2e-08
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	2e-08
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	2e-08
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	2e-08
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	2e-08
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	2e-08
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	2e-08
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	2e-08
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	3e-08
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	3e-08
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	5e-08
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	6e-08
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	7e-08
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	8e-08
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	8e-08
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	8e-08
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	8e-08
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	9e-08
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	9e-08
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	1e-07
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	1e-07
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	1e-07
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	2e-07
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	2e-07
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	2e-07
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	2e-07
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	2e-07
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	2e-07
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	2e-07
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	3e-07
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	3e-07
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	3e-07
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	3e-07
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	4e-07
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	4e-07
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	4e-07
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	4e-07
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	4e-07
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	4e-07
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	5e-07
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	6e-07
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	7e-07
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	2e-06
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	2e-06
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	2e-06
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	2e-06
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	2e-06
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	2e-06
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	2e-06
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	2e-06
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	3e-06
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	6e-06
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	7e-06
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	7e-06
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	7e-06
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	7e-06
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	8e-06
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	1e-05
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	1e-05
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	1e-05
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	2e-05
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	2e-05
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	2e-05
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	2e-05
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	3e-05
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	3e-05
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	3e-05
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	4e-05
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	4e-05
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	4e-05
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	6e-05
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	7e-05
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	2e-04
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	2e-04
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	4e-04
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	5e-04
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	8e-04
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	0.001
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	0.002
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	0.003
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	0.003
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	0.004

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  146 bits (372), Expect = 2e-42
 Identities = 65/194 (33%), Positives = 102/194 (52%), Gaps = 11/194 (5%)

Query: 74  VGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC 132
           +G GG+  VY     + G+++A+K + K  +    E E L EI  +  + HPN++ L G 
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLE-ELLREIEILKKLNHPNIVKLYGV 59

Query: 133 CVDNG-LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIH 191
             D   LYL+ ++   GS+  L  + N   +      +I +    GL YLH      IIH
Sbjct: 60  FEDENHLYLVMEYCEGGSLKDLLKE-NEGKLSEDEILRILLQILEGLEYLH---SNGIIH 115

Query: 192 RDIKSSNILLTAD-FEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMH-GIVDE 249
           RD+K  NILL +D  + +++DFGL+K L S  +      I GT  ++APE  +  G   E
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLK--TIVGTPAYMAPEVLLGKGYYSE 173

Query: 250 KTDVFAFGVFLLEI 263
           K+D+++ GV L E+
Sbjct: 174 KSDIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  147 bits (374), Expect = 6e-42
 Identities = 82/284 (28%), Positives = 128/284 (45%), Gaps = 47/284 (16%)

Query: 72  NLVGRGGYAEVYKGVLQDGE----EIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVL 127
             +G G + EVYKG L+  +    E+AVK L K    + + K+FL E   +  + HPNV+
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTL-KEDASEEERKDFLKEARVMKKLGHPNVV 59

Query: 128 SLLGCCVDNG-LYLIFQFSSRGS-------VASLFHDVNSPGVEWKVRHKIAVGTARGLH 179
            LLG C +   LYL+ ++   G           +F       +  K     A+  A+G+ 
Sbjct: 60  RLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGME 119

Query: 180 YLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPS----QWTHHSIAPIEGTFG 235
           YL     ++ +HRD+ + N L+  D   +ISDFGL++ +      +       PI     
Sbjct: 120 YLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR---- 172

Query: 236 HLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGEIEKLV 294
            +APE    GI   K+DV++FGV L EI + G  P  G           + N+  +E L 
Sbjct: 173 WMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPG-----------LSNEEVLEYLR 221

Query: 295 D----PRLQGAYD-VTQLNRLAFAASLCIRASPTWRPTMSEVLE 333
                P+ +   D + +L         C +  P  RPT SE++E
Sbjct: 222 KGYRLPKPEYCPDELYELML------SCWQLDPEDRPTFSELVE 259

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  146 bits (371), Expect = 1e-41
 Identities = 81/268 (30%), Positives = 125/268 (46%), Gaps = 26/268 (9%)

Query: 74  VGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC 132
           +G G +  VYK   +  G+ +AVK L K     +K++    EI  +  + HPN++ L+  
Sbjct: 7   LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDA 66

Query: 133 CVDNG-LYLIFQFSSRGSVASLF-HDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRII 190
             D   LYL+ ++   G    LF +      +      KIA+   RGL YLH      II
Sbjct: 67  FEDKDHLYLVMEYCEGGD---LFDYLSRGGPLSEDEAKKIALQILRGLEYLHS---NGII 120

Query: 191 HRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIA-PIEGTFGHLAPEYFMHGI-VD 248
           HRD+K  NILL  +   +I+DFGLAK         S      GT  ++APE  + G    
Sbjct: 121 HRDLKPENILLDENGVVKIADFGLAK---KLLKSSSSLTTFVGTPWYMAPEVLLGGNGYG 177

Query: 249 EKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGE-IEKLVDPRLQGAYDVTQL 307
            K DV++ GV L E+++G+ P  G         + IL+Q + I +++ P L+        
Sbjct: 178 PKVDVWSLGVILYELLTGKPPFSG---------ENILDQLQLIRRILGPPLEFDEPKWSS 228

Query: 308 NRLAFAASL--CIRASPTWRPTMSEVLE 333
                   +  C+   P+ RPT  E+L+
Sbjct: 229 GSEEAKDLIKKCLNKDPSKRPTAEEILQ 256

Length = 260

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  146 bits (371), Expect = 1e-41
 Identities = 78/285 (27%), Positives = 122/285 (42%), Gaps = 58/285 (20%)

Query: 75  GRGGYAEVYKGVLQDG-----EEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSL 129
           G G + EVYKG L+        E+AVK L K    +++ +EFL E   +  + HPN++ L
Sbjct: 8   GEGAFGEVYKGTLKGKGDGKEVEVAVKTL-KEDASEQQIEEFLREARIMRKLDHPNIVKL 66

Query: 130 LGCCVDNG-LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRR 188
           LG C +   L ++ ++   G +           +        A+  ARG+ YL     + 
Sbjct: 67  LGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE---SKN 123

Query: 189 IIHRDIKSSNILLTADFEPQISDFGLAK-------------WLPSQWTHHSIAPIEGTFG 235
            IHRD+ + N L+  +   +ISDFGL++              LP +W             
Sbjct: 124 FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRW------------- 170

Query: 236 HLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDG-SHQSLHSWAKPILNQG---EI 290
            +APE    G    K+DV++FGV L EI + G +P  G S+  +  + K    +G     
Sbjct: 171 -MAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLK----KGYRLPK 225

Query: 291 EKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVM 335
                P L   Y +            C    P  RPT SE++E++
Sbjct: 226 PPNCPPEL---YKL---------MLQCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  145 bits (368), Expect = 3e-41
 Identities = 84/283 (29%), Positives = 125/283 (44%), Gaps = 59/283 (20%)

Query: 75  GRGGYAEVYKGVLQD-----GEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSL 129
           G G + EVYKG L+        E+AVK L K    +++ +EFL E   +  + HPNV+ L
Sbjct: 8   GEGAFGEVYKGKLKGKGGKKKVEVAVKTL-KEDASEQQIEEFLREARIMRKLDHPNVVKL 66

Query: 130 LGCCVDNG-LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRR 188
           LG C +   LY++ ++   G + S     N P +        A+  ARG+ YL     + 
Sbjct: 67  LGVCTEEEPLYIVMEYMEGGDLLSYLRK-NRPKLSLSDLLSFALQIARGMEYLE---SKN 122

Query: 189 IIHRDIKSSNILLTADFEPQISDFGLAK-------------WLPSQWTHHSIAPIEGTFG 235
            IHRD+ + N L+  +   +ISDFGL++              LP +W             
Sbjct: 123 FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRW------------- 169

Query: 236 HLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDG-SHQSLHSWAKPILNQG---EI 290
            +APE    G    K+DV++FGV L EI + G +P  G S++ +  + K     G     
Sbjct: 170 -MAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLK----NGYRLPQ 224

Query: 291 EKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLE 333
                P L   YD+            C    P  RPT SE++E
Sbjct: 225 PPNCPPEL---YDL---------MLQCWAEDPEDRPTFSELVE 255

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  143 bits (362), Expect = 2e-40
 Identities = 68/271 (25%), Positives = 113/271 (41%), Gaps = 26/271 (9%)

Query: 68  FSSENLVGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNV 126
           +     +G G + +VY     + G+ +A+K + K     +  +  L EI  +  + HPN+
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVI-KKKKIKKDRERILREIKILKKLKHPNI 59

Query: 127 LSLLGCCVDNG-LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGC 185
           + L     D   LYL+ ++   G +  L         E + R          L YLH   
Sbjct: 60  VRLYDVFEDEDKLYLVMEYCEGGDLFDLLKK-RGRLSEDEARF-YLRQILSALEYLHS-- 115

Query: 186 QRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHG 245
            + I+HRD+K  NILL  D   +++DFGLA+ L       +     GT  ++APE  +  
Sbjct: 116 -KGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFV---GTPEYMAPEVLLGK 171

Query: 246 IVDEKTDVFAFGVFLLEIISGRKPVDGSHQS---LHSWAKPILNQGEIEKLVDPRLQGAY 302
              +  D+++ GV L E+++G+ P  G  Q         KP       E  + P    A 
Sbjct: 172 GYGKAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPE---AK 228

Query: 303 DVTQLNRLAFAASLCIRASPTWRPTMSEVLE 333
           D+  + +        +   P  R T  E L+
Sbjct: 229 DL--IRK-------LLVKDPEKRLTAEEALQ 250

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  134 bits (339), Expect = 7e-37
 Identities = 77/281 (27%), Positives = 126/281 (44%), Gaps = 50/281 (17%)

Query: 75  GRGGYAEVYKGVL-----QDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSL 129
           G G + EVYKG L         ++AVK L K    + + +EFL E   +  + HPN++ L
Sbjct: 8   GEGAFGEVYKGTLKGDGEGTETKVAVKTL-KEGASEEEREEFLEEASIMKKLSHPNIVRL 66

Query: 130 LGCCVDNG-LYLIFQFSSRGSVASLFHDV-NSPGVEWKVRHKIAVGTARGLHYLHKGCQR 187
           LG C     LY++ ++   G +            ++  +  ++A+  A+G+ YL     +
Sbjct: 67  LGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLL--QMALQIAKGMEYLE---SK 121

Query: 188 RIIHRDIKSSNILLTADFEPQISDFGLAKWLPS----QWTHHSIAPIEGTFGHLAPEYFM 243
             +HRD+ + N L+T +   +ISDFGL++ +      +       PI+      APE   
Sbjct: 122 NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWM----APESLK 177

Query: 244 HGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGEIEKLVD----PRL 298
            G    K+DV++FGV L EI + G +P  G           + N+  +E L D    PR 
Sbjct: 178 DGKFTSKSDVWSFGVLLWEIFTLGEQPYPG-----------MSNEEVLELLEDGYRLPRP 226

Query: 299 QGA----YDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVM 335
           +      Y++            C    P  RPT SE++E +
Sbjct: 227 ENCPDELYELML---------QCWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  126 bits (319), Expect = 4e-34
 Identities = 63/206 (30%), Positives = 100/206 (48%), Gaps = 17/206 (8%)

Query: 72  NLVGRGGYAEVYKGVLQD-GEEIAVKRLTKVVTDDRKE-KEFLTEIGTIGHVCHPNVLSL 129
            L+GRG +  VY  + +D GE +AVK + ++  D  +E +    EI  +  + HPN++  
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSV-ELSGDSEEELEALEREIRILSSLQHPNIVRY 64

Query: 130 LGCCVD---NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTA---RGLHYLHK 183
            G   D   N L +  ++ S GS++SL        +   V   I   T     GL YLH 
Sbjct: 65  YGSERDEEKNTLNIFLEYVSGGSLSSLLKKF--GKLPEPV---IRKYTRQILEGLAYLH- 118

Query: 184 GCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFM 243
                I+HRDIK +NIL+ +D   +++DFG AK L    T      + GT   +APE   
Sbjct: 119 --SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIR 176

Query: 244 HGIVDEKTDVFAFGVFLLEIISGRKP 269
                   D+++ G  ++E+ +G+ P
Sbjct: 177 GEEYGRAADIWSLGCTVIEMATGKPP 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  126 bits (318), Expect = 5e-34
 Identities = 66/205 (32%), Positives = 110/205 (53%), Gaps = 13/205 (6%)

Query: 68  FSSENLVGRGGYAEVYKG-VLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNV 126
           F     +G+GG+ EVYK    + G+E+A+K + K+ + ++KEK  + EI  +    HPN+
Sbjct: 2   FEILEKIGKGGFGEVYKARHKRTGKEVAIKVI-KLESKEKKEK-IINEIQILKKCKHPNI 59

Query: 127 LSLLGCCVDNG-LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGC 185
           +   G  +    L+++ +F S GS+  L    N    E ++   +     +GL YLH   
Sbjct: 60  VKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIA-YVCKELLKGLEYLHS-- 116

Query: 186 QRRIIHRDIKSSNILLTADFEPQISDFGLAKWL-PSQWTHHSIAPIEGTFGHLAPEYFMH 244
              IIHRDIK++NILLT+D E ++ DFGL+  L  ++  +  +    GT   +APE    
Sbjct: 117 -NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMV----GTPYWMAPEVING 171

Query: 245 GIVDEKTDVFAFGVFLLEIISGRKP 269
              D K D+++ G+  +E+  G+ P
Sbjct: 172 KPYDYKADIWSLGITAIELAEGKPP 196

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score =  108 bits (271), Expect = 4e-27
 Identities = 77/276 (27%), Positives = 133/276 (48%), Gaps = 21/276 (7%)

Query: 65  TNAFSSENLVGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKE-FLTEIGTIGHVC 122
              F  E  +G+G ++ VYK + L DG  +A+K++      D K ++  L EI  +  + 
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60

Query: 123 HPNVLSLLGCCVDNG-LYLIFQFSSRGSVASLFHDVNSPG--VEWKVRHKIAVGTARGLH 179
           HPNV+  L   ++N  L ++ + +  G ++ +          +  +   K  V     L 
Sbjct: 61  HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120

Query: 180 YLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTH-HSIAPIEGTFGHLA 238
           ++H    +RI+HRDIK +N+ +TA    ++ D GL ++  S+ T  HS+    GT  +++
Sbjct: 121 HMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV---GTPYYMS 174

Query: 239 PEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRL 298
           PE       + K+D+++ G  L E+ + + P  G   +L+S  K      +IEK   P L
Sbjct: 175 PERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCK------KIEKCDYPPL 228

Query: 299 QGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEV 334
              +   +L  L    S CI   P  RP +S VL+V
Sbjct: 229 PADHYSEELRDL---VSRCINPDPEKRPDISYVLQV 261

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  107 bits (270), Expect = 4e-27
 Identities = 60/208 (28%), Positives = 100/208 (48%), Gaps = 32/208 (15%)

Query: 73  LVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC 132
            +G+G + +V  G  + G+++AVK L    T  +    FL E   +  + HPN++ LLG 
Sbjct: 13  TIGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQA---FLAEASVMTTLRHPNLVQLLGV 68

Query: 133 CVD-NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIH 191
            +  N LY++ ++ ++GS+           +    +   A+    G+ YL    ++  +H
Sbjct: 69  VLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE---EKNFVH 125

Query: 192 RDIKSSNILLTADFEPQISDFGLAK---------WLPSQWTHHSIAPIEGTFGHLAPEYF 242
           RD+ + N+L++ D   ++SDFGLAK          LP +WT              APE  
Sbjct: 126 RDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVKWT--------------APEAL 171

Query: 243 MHGIVDEKTDVFAFGVFLLEIIS-GRKP 269
                  K+DV++FG+ L EI S GR P
Sbjct: 172 REKKFSTKSDVWSFGILLWEIYSFGRVP 199

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  108 bits (269), Expect = 3e-26
 Identities = 82/281 (29%), Positives = 120/281 (42%), Gaps = 25/281 (8%)

Query: 73  LVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKE-FLTEIGTIGHV-CHPNVLSLL 130
            +G G + EVY    +D + +A+K L K +    KE E FL EI  +  +   PN++ L 
Sbjct: 7   KLGEGSFGEVYLA--RDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLY 64

Query: 131 GCCVDNG-LYLIFQFSSRGSVASLFHDVNSPGV-EWKVRHKIAVGTARGLHYLHKGCQRR 188
               D G LYL+ ++   GS+  L   +   G         I       L YLH    + 
Sbjct: 65  DFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH---SKG 121

Query: 189 IIHRDIKSSNILLTAD-FEPQISDFGLAKWLP----SQWTHHSIAPIEGTFGHLAPEYFM 243
           IIHRDIK  NILL  D    ++ DFGLAK LP    +       +   GT G++APE  +
Sbjct: 122 IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLL 181

Query: 244 HGI---VDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQG 300
                     +D+++ G+ L E+++G  P +G   S  S     L    I +L  P L  
Sbjct: 182 GLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS--SATSQTLKI--ILELPTPSLAS 237

Query: 301 AY--DVTQLNRLAFAASL--CIRASPTWRPTMSEVLEVMLE 337
                  +L   A +  L   +   P  R + S  L   L 
Sbjct: 238 PLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLL 278

Length = 384

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  105 bits (264), Expect = 3e-26
 Identities = 60/205 (29%), Positives = 108/205 (52%), Gaps = 19/205 (9%)

Query: 72  NLVGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKE--KEFLTEIGTIGHVCHPNVLS 128
           +L+GRG +  VYKG+ L+ G+ +A+K++   +   ++E  K  + EI  + ++ HPN++ 
Sbjct: 6   DLIGRGAFGVVYKGLNLETGDFVAIKQI--SLEKIKEEALKSIMQEIDLLKNLKHPNIVK 63

Query: 129 LLGCCVDNG-LYLIFQFSSRGSVASL---FHDVNSPGVEWKVRHKIAVGTARGLHYLHKG 184
            +G    +  LY+I +++  GS+  +   F       V   V         +GL YLH  
Sbjct: 64  YIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQ-----VLQGLAYLH-- 116

Query: 185 CQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMH 244
            ++ +IHRDIK++NIL T D   +++DFG+A  L         A + GT   +APE    
Sbjct: 117 -EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDV--SKDDASVVGTPYWMAPEVIEM 173

Query: 245 GIVDEKTDVFAFGVFLLEIISGRKP 269
                 +D+++ G  ++E+++G  P
Sbjct: 174 SGASTASDIWSLGCTVIELLTGNPP 198

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score =  103 bits (258), Expect = 2e-25
 Identities = 73/231 (31%), Positives = 107/231 (46%), Gaps = 51/231 (22%)

Query: 72  NLVGRGGYAEVYKG----VLQDGEE---IAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHP 124
           N +G G + EVY+G    +L  G     +AVK L K  TD  K KEFL E   + +  HP
Sbjct: 1   NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEK-KEFLKEAHLMSNFNHP 59

Query: 125 NVLSLLGCCVDN-GLYLIFQFSSRGSVASLFHDVN-----SPGVEWKVRHKIAVGTARGL 178
           N++ LLG C+ N   Y+I +    G + S   D        P +  K    I +  A+G 
Sbjct: 60  NIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGC 119

Query: 179 HYLHKGCQRRIIHRDIKSSNILLT-----ADFEPQISDFGLAK--------------WLP 219
            YL    Q   IHRD+ + N L++     AD   +I DFGLA+               LP
Sbjct: 120 VYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLP 176

Query: 220 SQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKP 269
            +W              +APE  + G    ++DV++FGV + EI++ G++P
Sbjct: 177 VRW--------------MAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQP 213

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  101 bits (254), Expect = 6e-25
 Identities = 60/211 (28%), Positives = 103/211 (48%), Gaps = 9/211 (4%)

Query: 68  FSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNV 126
           F   N +G+G +  V+K V + D    A+K++     + R+ +E + E   +  +    +
Sbjct: 2   FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61

Query: 127 LSLLGCCVDNG-LYLIFQFSSRGSVASLFH-DVNSPGVEWKVRHKIAVGTARGLHYLHKG 184
           +      +D G L ++ +++  G +  L       P  E +V  +  +    GL +LH  
Sbjct: 62  IRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQV-WRFFIQILLGLAHLHS- 119

Query: 185 CQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMH 244
             ++I+HRDIKS N+ L A    +I D G+AK L       +   I GT  +L+PE    
Sbjct: 120 --KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT--IVGTPYYLSPELCED 175

Query: 245 GIVDEKTDVFAFGVFLLEIISGRKPVDGSHQ 275
              +EK+DV+A GV L E  +G+ P D ++Q
Sbjct: 176 KPYNEKSDVWALGVVLYECCTGKHPFDANNQ 206

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  101 bits (254), Expect = 8e-25
 Identities = 68/271 (25%), Positives = 125/271 (46%), Gaps = 31/271 (11%)

Query: 72  NLVGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEF-LTEIGTIGHVC-HPNVLS 128
             +G+G + +VY      DG+   +K +  +     KE+E  L E+  I     HPN++ 
Sbjct: 6   KQIGKGSFGKVYLVRRKSDGKLYVLKEI-DLSNMSEKEREDALNEV-KILKKLNHPNIIK 63

Query: 129 LLGCCVDNG-LYLIFQFSSRGSVASLFHDVNSPGV---EWKVRHKIAVGTARGLHYLHKG 184
                 + G L ++ +++  G ++         G    E ++     V     L YLH  
Sbjct: 64  YYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILD-WFVQLCLALKYLHS- 121

Query: 185 CQRRIIHRDIKSSNILLTADFEPQISDFGLAKWL--PSQWTHHSIAPIEGTFGHLAPEYF 242
             R+I+HRDIK  NI LT++   ++ DFG++K L          +    GT  +L+PE  
Sbjct: 122 --RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV----GTPYYLSPELC 175

Query: 243 MHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAY 302
            +   + K+D+++ G  L E+ + + P +G  ++L   A  IL  G+      P +   Y
Sbjct: 176 QNKPYNYKSDIWSLGCVLYELCTLKHPFEG--ENLLELALKILK-GQY-----PPIPSQY 227

Query: 303 DVTQLNRLAFAASLCIRASPTWRPTMSEVLE 333
             ++L  L    S  ++  P  RP+++++L+
Sbjct: 228 S-SELRNL---VSSLLQKDPEERPSIAQILQ 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  100 bits (252), Expect = 2e-24
 Identities = 78/277 (28%), Positives = 123/277 (44%), Gaps = 39/277 (14%)

Query: 74  VGRGGYAEVYKGV-LQDGEEIAVKR--LTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLL 130
           +G G  A VY  + L + E++A+KR  L K  T      E   E+  +    HPNV+   
Sbjct: 9   IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTS---VDELRKEVQAMSQCNHPNVVKYY 65

Query: 131 GC-CVDNGLYLIFQFSSRGSVASLF-HDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRR 188
               V + L+L+  + S GS+  +        G++  +   +     +GL YLH   Q  
Sbjct: 66  TSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQ-- 123

Query: 189 IIHRDIKSSNILLTADFEPQISDFGLAKWL--PSQWTHHSIAPIEGTFGHLAPEYF--MH 244
            IHRDIK+ NILL  D   +I+DFG++  L      T        GT   +APE    +H
Sbjct: 124 -IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVH 182

Query: 245 GIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDV 304
           G  D K D+++FG+  +E+ +G  P   S         P+       K++   LQ     
Sbjct: 183 G-YDFKADIWSFGITAIELATGAAP--YSKY------PPM-------KVLMLTLQNDPPS 226

Query: 305 TQLNR--LAFAAS------LCIRASPTWRPTMSEVLE 333
            +       ++ S      LC++  P+ RPT  E+L+
Sbjct: 227 LETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 98.6 bits (246), Expect = 1e-23
 Identities = 66/218 (30%), Positives = 108/218 (49%), Gaps = 39/218 (17%)

Query: 75  GRGGYAEVYKGV-LQDGE----EIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSL 129
           G G +  VYKGV + +GE     +A+K L +  T  +  KE L E   +  V HP+V+ L
Sbjct: 16  GSGAFGTVYKGVWIPEGEKVKIPVAIKVL-REETSPKANKEILDEAYVMASVDHPHVVRL 74

Query: 130 LGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGT----------ARGLH 179
           LG C+ + + LI Q    G +     +           HK  +G+          A+G+ 
Sbjct: 75  LGICLSSQVQLITQLMPLGCLLDYVRN-----------HKDNIGSQYLLNWCVQIAKGMS 123

Query: 180 YLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIA----PIEGTFG 235
           YL    ++R++HRD+ + N+L+      +I+DFGLAK L      +       PI+    
Sbjct: 124 YLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIK---- 176

Query: 236 HLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDG 272
            +A E  +H I   K+DV+++GV + E+++ G KP +G
Sbjct: 177 WMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEG 214

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 97.7 bits (243), Expect = 2e-23
 Identities = 61/197 (30%), Positives = 105/197 (53%), Gaps = 14/197 (7%)

Query: 74  VGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCC 133
           +G G +  V +G    G+++AVK +   VT     + FL E   +  + H N++ LLG  
Sbjct: 14  IGEGEFGAVLQGEYT-GQKVAVKNIKCDVT----AQAFLEETAVMTKLHHKNLVRLLGVI 68

Query: 134 VDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRD 193
           + NGLY++ +  S+G++ +         V      + ++  A G+ YL     ++++HRD
Sbjct: 69  LHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE---SKKLVHRD 125

Query: 194 IKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDV 253
           + + NIL++ D   ++SDFGLA+ + S    +S  P++ T    APE   H     K+DV
Sbjct: 126 LAARNILVSEDGVAKVSDFGLAR-VGSMGVDNSKLPVKWT----APEALKHKKFSSKSDV 180

Query: 254 FAFGVFLLEIIS-GRKP 269
           +++GV L E+ S GR P
Sbjct: 181 WSYGVLLWEVFSYGRAP 197

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 97.0 bits (241), Expect = 5e-23
 Identities = 70/273 (25%), Positives = 132/273 (48%), Gaps = 21/273 (7%)

Query: 68  FSSENLVGRGGYAEVYKGV-LQDGEEIAVKRLTKV-VTDDRKEKEFLTEIGTIGHVCHPN 125
           F  E  +GRG ++EVY+   L D + +A+K++    + D +  ++ + EI  +  + HPN
Sbjct: 4   FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPN 63

Query: 126 VLSLLGCCV-DNGLYLIFQFSSRGSVASLFHDVNSPG--VEWKVRHKIAVGTARGLHYLH 182
           V+  L   + DN L ++ + +  G ++ +          +  +   K  V     + ++H
Sbjct: 64  VIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH 123

Query: 183 KGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWT-HHSIAPIEGTFGHLAPEY 241
               RR++HRDIK +N+ +TA    ++ D GL ++  S+ T  HS+    GT  +++PE 
Sbjct: 124 ---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV---GTPYYMSPER 177

Query: 242 FMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGA 301
                 + K+D+++ G  L E+ + + P  G   +L S  +      +IE+   P L   
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQ------KIEQCDYPPLPTE 231

Query: 302 YDVTQLNRLAFAASLCIRASPTWRPTMSEVLEV 334
           +   +L  L    S+CI   P  RP +  V ++
Sbjct: 232 HYSEKLREL---VSMCIYPDPDQRPDIGYVHQI 261

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 99.5 bits (248), Expect = 1e-22
 Identities = 78/286 (27%), Positives = 136/286 (47%), Gaps = 31/286 (10%)

Query: 62  SIATNAFSS----ENLVGRGGYAEVYKG-VLQDGEEIAVKRLTKVVTDDRKEKEFLTEIG 116
           SI  N   S    EN++ RG     YKG  +++G +  VK +  V +         +EI 
Sbjct: 682 SITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIP------SSEIA 735

Query: 117 TIGHVCHPNVLSLLGCCVDN-GLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTA 175
            +G + HPN++ L+G C    G YLI ++    +++ +        + W+ R KIA+G A
Sbjct: 736 DMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR-----NLSWERRRKIAIGIA 790

Query: 176 RGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFG 235
           + L +LH  C   ++  ++    I++    EP      L   LP      +   I   + 
Sbjct: 791 KALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPH-----LRLSLPGLLCTDTKCFISSAY- 844

Query: 236 HLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVD---GSHQSLHSWAKPILNQGEIEK 292
            +APE      + EK+D++ FG+ L+E+++G+ P D   G H S+  WA+   +   ++ 
Sbjct: 845 -VAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDM 903

Query: 293 LVDPRLQGAYDVTQLNRLAFAASL---CIRASPTWRPTMSEVLEVM 335
            +DP ++G   V Q N +    +L   C    PT RP  ++VL+ +
Sbjct: 904 WIDPSIRGDVSVNQ-NEIVEVMNLALHCTATDPTARPCANDVLKTL 948

Length = 968

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 95.2 bits (237), Expect = 2e-22
 Identities = 63/212 (29%), Positives = 108/212 (50%), Gaps = 19/212 (8%)

Query: 68  FSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVL 127
           F+ E  +G G + EV++G+ ++   +A+K L     D  K+++F  E+  +  + H +++
Sbjct: 8   FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKS--DDLLKQQDFQKEVQALKRLRHKHLI 65

Query: 128 SLLG-CCVDNGLYLIFQFSSRGSVASLFHDVNSP-GVEWKVRHKIAVGT--ARGLHYLHK 183
           SL   C V   +Y+I +   +GS   L   + SP G    V   I +    A G+ YL  
Sbjct: 66  SLFAVCSVGEPVYIITELMEKGS---LLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE- 121

Query: 184 GCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWL--PSQWTHHSIAPIEGTFGHLAPEY 241
             ++  IHRD+ + NIL+  D   +++DFGLA+ +      +     P + T    APE 
Sbjct: 122 --EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWT----APEA 175

Query: 242 FMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDG 272
             HG    K+DV++FG+ L E+ + G+ P  G
Sbjct: 176 ASHGTFSTKSDVWSFGILLYEMFTYGQVPYPG 207

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 94.5 bits (235), Expect = 2e-22
 Identities = 59/211 (27%), Positives = 98/211 (46%), Gaps = 38/211 (18%)

Query: 73  LVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC 132
            +G+G + +VYKGVL+   E+AVK     +  D K K FL E   +    HPN++ L+G 
Sbjct: 2   KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRK-FLQEAEILKQYDHPNIVKLIGV 60

Query: 133 CVDNG-LYLIFQFSSRGSVASLFHDVNSPGVEWKVRH--KIAVGTARGLHYLHKGCQRRI 189
           CV    +Y++ +    G   SL   +        V+   ++++  A G+ YL     +  
Sbjct: 61  CVQKQPIYIVMELVPGG---SLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLE---SKNC 114

Query: 190 IHRDIKSSNILLTADFEPQISDFGLA--------------KWLPSQWTHHSIAPIEGTFG 235
           IHRD+ + N L+  +   +ISDFG++              K +P +WT            
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWT------------ 162

Query: 236 HLAPEYFMHGIVDEKTDVFAFGVFLLEIISG 266
             APE   +G    ++DV+++G+ L E  S 
Sbjct: 163 --APEALNYGRYTSESDVWSYGILLWETFSL 191

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 94.6 bits (236), Expect = 2e-22
 Identities = 59/208 (28%), Positives = 100/208 (48%), Gaps = 20/208 (9%)

Query: 68  FSSENLVGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVC-HPN 125
           F     +G G Y  VYK +  + G+ +A+K    VV  +   +E + EI +I   C  P 
Sbjct: 5   FDILEKLGEGSYGSVYKAIHKETGQVVAIK----VVPVEEDLQEIIKEI-SILKQCDSPY 59

Query: 126 VLSLLGC-CVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAV---GTARGLHYL 181
           ++   G    +  L+++ ++   GSV+ +    N    E     +IA     T +GL YL
Sbjct: 60  IVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTE----EEIAAILYQTLKGLEYL 115

Query: 182 HKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEY 241
           H     + IHRDIK+ NILL  + + +++DFG++  L    T      + GT   +APE 
Sbjct: 116 H---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQL--TDTMAKRNTVIGTPFWMAPEV 170

Query: 242 FMHGIVDEKTDVFAFGVFLLEIISGRKP 269
                 + K D+++ G+  +E+  G+ P
Sbjct: 171 IQEIGYNNKADIWSLGITAIEMAEGKPP 198

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 94.7 bits (235), Expect = 3e-22
 Identities = 73/273 (26%), Positives = 133/273 (48%), Gaps = 21/273 (7%)

Query: 68  FSSENLVGRGGYAEVYKGV-LQDGEEIAVKRLTKV-VTDDRKEKEFLTEIGTIGHVCHPN 125
           F  E  +GRG ++EVY+   L DG  +A+K++    + D +   + + EI  +  + HPN
Sbjct: 4   FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 63

Query: 126 VLSLLGCCV-DNGLYLIFQFSSRGSVASLFHDVNSPG--VEWKVRHKIAVGTARGLHYLH 182
           V+      + DN L ++ + +  G ++ +          +  K   K  V     L ++H
Sbjct: 64  VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH 123

Query: 183 KGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWT-HHSIAPIEGTFGHLAPEY 241
               RR++HRDIK +N+ +TA    ++ D GL ++  S+ T  HS+    GT  +++PE 
Sbjct: 124 ---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV---GTPYYMSPER 177

Query: 242 FMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGA 301
                 + K+D+++ G  L E+ + + P  G   +L+S  K      +IE+   P L   
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCK------KIEQCDYPPLPSD 231

Query: 302 YDVTQLNRLAFAASLCIRASPTWRPTMSEVLEV 334
           +   +L +L    ++CI   P  RP ++ V +V
Sbjct: 232 HYSEELRQL---VNMCINPDPEKRPDITYVYDV 261

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 94.6 bits (236), Expect = 4e-22
 Identities = 57/202 (28%), Positives = 94/202 (46%), Gaps = 19/202 (9%)

Query: 74  VGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC 132
           +G G   EVYK      G+E+A+K++   +    KE   + EI  +    HPN++     
Sbjct: 27  IGEGASGEVYKATDRATGKEVAIKKMR--LRKQNKEL-IINEILIMKDCKHPNIVDYYDS 83

Query: 133 CVDNG-LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAV---GTARGLHYLHKGCQRR 188
            +    L+++ ++   GS+  +         E     +IA       +GL YLH    + 
Sbjct: 84  YLVGDELWVVMEYMDGGSLTDIITQNFVRMNE----PQIAYVCREVLQGLEYLH---SQN 136

Query: 189 IIHRDIKSSNILLTADFEPQISDFGLAKWL-PSQWTHHSIAPIEGTFGHLAPEYFMHGIV 247
           +IHRDIKS NILL+ D   +++DFG A  L   +   +S+    GT   +APE       
Sbjct: 137 VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVV---GTPYWMAPEVIKRKDY 193

Query: 248 DEKTDVFAFGVFLLEIISGRKP 269
             K D+++ G+  +E+  G  P
Sbjct: 194 GPKVDIWSLGIMCIEMAEGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 93.8 bits (233), Expect = 7e-22
 Identities = 67/208 (32%), Positives = 108/208 (51%), Gaps = 16/208 (7%)

Query: 71  ENLVGRGGYAEVYKGVLQD-GEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSL 129
           ++ +G G Y EVY+GV +     +AVK L +   D  + +EFL E   +  + HPN++ L
Sbjct: 11  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE---DTMEVEEFLKEAAVMKEIKHPNLVQL 67

Query: 130 LGCCV-DNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRR 188
           LG C  +   Y+I +F + G++     + N   V   V   +A   +  + YL K   + 
Sbjct: 68  LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK---KN 124

Query: 189 IIHRDIKSSNILLTADFEPQISDFGLAKWLPSQ-WTHHSIA--PIEGTFGHLAPEYFMHG 245
            IHRD+ + N L+  +   +++DFGL++ +    +T H+ A  PI+ T    APE   + 
Sbjct: 125 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT----APESLAYN 180

Query: 246 IVDEKTDVFAFGVFLLEIIS-GRKPVDG 272
               K+DV+AFGV L EI + G  P  G
Sbjct: 181 KFSIKSDVWAFGVLLWEIATYGMSPYPG 208

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 93.0 bits (232), Expect = 9e-22
 Identities = 60/200 (30%), Positives = 98/200 (49%), Gaps = 15/200 (7%)

Query: 75  GRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCC 133
           G+G    VYK   +  G+  A+K++  V  D+   K+ L E+ T+     P V+   G  
Sbjct: 10  GQGSSGVVYKVRHKPTGKIYALKKI-HVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAF 68

Query: 134 VDNG-LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHR 192
              G + ++ ++   GS+A L   V    +   V   IA    +GL YLH   +R IIHR
Sbjct: 69  YKEGEISIVLEYMDGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLHT--KRHIIHR 124

Query: 193 DIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAP---IEGTFGHLAPEYFMHGIVDE 249
           DIK SN+L+ +  E +I+DFG++K L +     ++       GT  +++PE         
Sbjct: 125 DIKPSNLLINSKGEVKIADFGISKVLEN-----TLDQCNTFVGTVTYMSPERIQGESYSY 179

Query: 250 KTDVFAFGVFLLEIISGRKP 269
             D+++ G+ LLE   G+ P
Sbjct: 180 AADIWSLGLTLLECALGKFP 199

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 93.2 bits (232), Expect = 1e-21
 Identities = 76/296 (25%), Positives = 127/296 (42%), Gaps = 59/296 (19%)

Query: 73  LVGRGGYAEVYKGVLQDGEE------IAVKRLTKVVTDDRKEKE---FLTEIGT---IGH 120
            +G G + +V K      +       +AVK L     DD  EK+    ++E+     IG 
Sbjct: 19  PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLK----DDATEKDLSDLVSEMEMMKMIGK 74

Query: 121 VCHPNVLSLLGCCVDNG-LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKI--------- 170
             H N+++LLG C   G LY++ ++++ G++         PG                  
Sbjct: 75  --HKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQK 132

Query: 171 -----AVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHH 225
                A   ARG+ +L     ++ IHRD+ + N+L+T D   +I+DFGLA+ +     HH
Sbjct: 133 DLVSFAYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDI-----HH 184

Query: 226 SIAPIEGTFGHL-----APEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHS 279
                + T G L     APE     +   ++DV++FGV L EI + G  P  G    +  
Sbjct: 185 IDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI--PVEE 242

Query: 280 WAKPILNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVM 335
             K +L +G     ++       ++  L R       C    P+ RPT  +++E +
Sbjct: 243 LFK-LLKEGY---RMEKPQNCTQELYHLMR------DCWHEVPSQRPTFKQLVEDL 288

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 92.6 bits (230), Expect = 2e-21
 Identities = 61/209 (29%), Positives = 103/209 (49%), Gaps = 17/209 (8%)

Query: 73  LVGRGGYAEVYKGV-LQDGEEIAVKRL----TKVVTDDRKEKEFL----TEIGTIGHVCH 123
           L+G+G Y  VY  + +  GE +AVK++    T     D ++K+ +    +EI T+  + H
Sbjct: 8   LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67

Query: 124 PNVLSLLGCCVDNGLYLIF-QFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLH 182
            N++  LG         IF ++   GS+ S          E  VR         GL YLH
Sbjct: 68  LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRT-YGRFEEQLVRF-FTEQVLEGLAYLH 125

Query: 183 KGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPE-- 240
               + I+HRD+K+ N+L+ AD   +ISDFG++K     + +     ++G+   +APE  
Sbjct: 126 S---KGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVI 182

Query: 241 YFMHGIVDEKTDVFAFGVFLLEIISGRKP 269
           +        K D+++ G  +LE+ +GR+P
Sbjct: 183 HSYSQGYSAKVDIWSLGCVVLEMFAGRRP 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 91.3 bits (227), Expect = 4e-21
 Identities = 76/271 (28%), Positives = 124/271 (45%), Gaps = 33/271 (12%)

Query: 73  LVGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLT----EIGTIGHVCHPNVL 127
           L+G G +  VY+G+ L DG+  AVK +  +  D +  +E +     EI  +  + HPN++
Sbjct: 7   LLGSGSFGSVYEGLNLDDGDFFAVKEV-SLADDGQTGQEAVKQLEQEIALLSKLQHPNIV 65

Query: 128 SLLGCCVDNG-LYLIFQFSSRGSVASLFHDVNS---PGVEWKVRHKIAVGTARGLHYLHK 183
             LG   +   LY+  +    GS+A L     S   P +    R  +      GL YLH 
Sbjct: 66  QYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILL-----GLEYLH- 119

Query: 184 GCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFM 243
              R  +HRDIK +NIL+  +   +++DFG+AK +       S    +G+   +APE   
Sbjct: 120 --DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKS---FKGSPYWMAPEVIA 174

Query: 244 H-GIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAY 302
             G      D+++ G  +LE+ +G KP     + + +  K I    E+  + D     A 
Sbjct: 175 QQGGYGLAADIWSLGCTVLEMATG-KPPWSQLEGVAAVFK-IGRSKELPPIPDHLSDEAK 232

Query: 303 DVTQLNRLAFAASLCIRASPTWRPTMSEVLE 333
           D             C++  P+ RPT +E+LE
Sbjct: 233 DFI---------LKCLQRDPSLRPTAAELLE 254

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 90.6 bits (225), Expect = 1e-20
 Identities = 78/293 (26%), Positives = 120/293 (40%), Gaps = 62/293 (21%)

Query: 72  NLVGRGGYAEVYKGVL--QDGE----EIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPN 125
             +G G + EVY+G+   +DG+    ++AVK L +  ++ + E +FL E   +    H N
Sbjct: 12  RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSE-QDESDFLMEALIMSKFNHQN 70

Query: 126 VLSLLGCCVDNGLYLI-FQFSSRGSVAS-LFHDVNSPGVEWKVRHK----IAVGTARGLH 179
           ++ L+G   +     I  +  + G + S L  +   P     +  K     A   A+G  
Sbjct: 71  IVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCK 130

Query: 180 YLHKGCQRRIIHRDIKSSNILLT---ADFEPQISDFGLAK--------------WLPSQW 222
           YL    +   IHRDI + N LLT        +I+DFG+A+               LP +W
Sbjct: 131 YLE---ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKW 187

Query: 223 THHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWA 281
                           PE F+ GI   KTDV++FGV L EI S G  P  G         
Sbjct: 188 M--------------PPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRT------- 226

Query: 282 KPILNQGEIEKLVD-PRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLE 333
               NQ  +E +    RL           +    + C + +P  RP  + +LE
Sbjct: 227 ----NQEVMEFVTGGGRLDPPKGCP--GPVYRIMTDCWQHTPEDRPNFATILE 273

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 89.7 bits (223), Expect = 2e-20
 Identities = 71/266 (26%), Positives = 132/266 (49%), Gaps = 26/266 (9%)

Query: 75  GRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCC 133
           G G    V K + +  G+ +AVK + ++  ++  +K+ L E+  +     P ++   G  
Sbjct: 10  GAGNSGVVSKVLHRPTGKIMAVKTI-RLEINEAIQKQILRELDILHKCNSPYIVGFYGAF 68

Query: 134 VDNG-LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHR 192
            +NG + +  ++   GS+  +  +V     E ++  KIAV   +GL YLH+  + +IIHR
Sbjct: 69  YNNGDISICMEYMDGGSLDKILKEVQGRIPE-RILGKIAVAVLKGLTYLHE--KHKIIHR 125

Query: 193 DIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIA-PIEGTFGHLAPEYFMHGIVDEKT 251
           D+K SNIL+ +  + ++ DFG++  L +     S+A    GT  ++APE         K+
Sbjct: 126 DVKPSNILVNSRGQIKLCDFGVSGQLVN-----SLAKTFVGTSSYMAPERIQGNDYSVKS 180

Query: 252 DVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVD---PRL-QGAYDVTQL 307
           D+++ G+ L+E+ +GR P    +         I     ++ +V+   PRL  G +     
Sbjct: 181 DIWSLGLSLIELATGRFPYPPENDP----PDGIFEL--LQYIVNEPPPRLPSGKFSPDFQ 234

Query: 308 NRLAFAASLCIRASPTWRPTMSEVLE 333
           + +    +LC+   P  RP+  E+LE
Sbjct: 235 DFV----NLCLIKDPRERPSYKELLE 256

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 89.6 bits (222), Expect = 2e-20
 Identities = 59/207 (28%), Positives = 108/207 (52%), Gaps = 14/207 (6%)

Query: 72  NLVGRGGYAEVYKGVLQDGEEIAVKRL----TKVVTDDRKEKEFLTEIGTIGHVCHPNVL 127
            ++G+G Y  VY G+   G+ IAVK++    + V+  +++ ++   E+  +  + H N++
Sbjct: 6   EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65

Query: 128 SLLGCCVDNGLYLIF-QFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQ 186
             LG C+D+    IF +F   GS++S+ +    P  E  V  K       G+ YLH  C 
Sbjct: 66  QYLGTCLDDNTISIFMEFVPGGSISSILNRF-GPLPE-PVFCKYTKQILDGVAYLHNNC- 122

Query: 187 RRIIHRDIKSSNILLTADFEPQISDFGLAK---WLPSQWTHHSI-APIEGTFGHLAPEYF 242
             ++HRDIK +N++L  +   ++ DFG A+   W+    TH ++   + GT   +APE  
Sbjct: 123 --VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVI 180

Query: 243 MHGIVDEKTDVFAFGVFLLEIISGRKP 269
                  K+D+++ G  + E+ +G+ P
Sbjct: 181 NESGYGRKSDIWSIGCTVFEMATGKPP 207

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 89.4 bits (222), Expect = 2e-20
 Identities = 62/234 (26%), Positives = 101/234 (43%), Gaps = 24/234 (10%)

Query: 73  LVGRGGYAEVYKGVLQD--GEEIAVKRLTKVVTDDRKEK---EFLTEIGTIGHVCHPNVL 127
            +G G +  V +G      G+ I V    K +  D+      +FL E   +  + H N++
Sbjct: 2   KLGDGSFGVVRRGEWSTSGGKVIPVA--VKCLKSDKLSDIMDDFLKEAAIMHSLDHENLI 59

Query: 128 SLLGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQR 187
            L G  + + L ++ + +  GS+                    AV  A G+ YL     +
Sbjct: 60  RLYGVVLTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE---SK 116

Query: 188 RIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAP-IEGTFGHLAPEYFMHGI 246
           R IHRD+ + NILL +D + +I DFGL + LP    H+ +   ++  F   APE      
Sbjct: 117 RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRT 176

Query: 247 VDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQ 299
               +DV+ FGV L E+ + G +P          WA   L+  +I K +D   +
Sbjct: 177 FSHASDVWMFGVTLWEMFTYGEEP----------WAG--LSGSQILKKIDKEGE 218

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 89.3 bits (222), Expect = 3e-20
 Identities = 62/209 (29%), Positives = 107/209 (51%), Gaps = 19/209 (9%)

Query: 74  VGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC 132
           +G G Y +VYK   +  GE +A+K +     DD +  +   EI  +    HPN+++  G 
Sbjct: 11  IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQ--QEISMLKECRHPNIVAYFGS 68

Query: 133 CVDNG-LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIH 191
            +    L+++ ++   GS+  ++     P  E ++ + +   T +GL YLH   +   IH
Sbjct: 69  YLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAY-VCRETLKGLAYLH---ETGKIH 124

Query: 192 RDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIE---GTFGHLAPEYF---MHG 245
           RDIK +NILLT D + +++DFG++    +Q T  +IA  +   GT   +APE       G
Sbjct: 125 RDIKGANILLTEDGDVKLADFGVS----AQLT-ATIAKRKSFIGTPYWMAPEVAAVERKG 179

Query: 246 IVDEKTDVFAFGVFLLEIISGRKPVDGSH 274
             D K D++A G+  +E+   + P+   H
Sbjct: 180 GYDGKCDIWALGITAIELAELQPPMFDLH 208

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 88.9 bits (221), Expect = 3e-20
 Identities = 62/227 (27%), Positives = 99/227 (43%), Gaps = 34/227 (14%)

Query: 64  ATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVC- 122
            T  F    ++G G Y +VYK   +   ++   ++  ++ D  +E+E   E   +     
Sbjct: 4   PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED--EEEEIKEEYNILRKYSN 61

Query: 123 HPNVLSLLGC-------CVDNGLYLIFQFSSRGSVASL---FHDVNSPGVEWKVRHKIAV 172
           HPN+ +  G          D+ L+L+ +    GSV  L            E      IA 
Sbjct: 62  HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKE----EWIAY 117

Query: 173 ---GTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWL--PSQWTHHSI 227
               T RGL YLH   + ++IHRDIK  NILLT + E ++ DFG++  L       +  I
Sbjct: 118 ILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFI 174

Query: 228 APIEGTFGHLAPE-----YFMHGIVDEKTDVFAFGVFLLEIISGRKP 269
               GT   +APE            D ++DV++ G+  +E+  G+ P
Sbjct: 175 ----GTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPP 217

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 88.8 bits (221), Expect = 4e-20
 Identities = 71/275 (25%), Positives = 119/275 (43%), Gaps = 38/275 (13%)

Query: 68  FSSENLVGRGGYAEVYKGV-LQDGEEIAVKRL-----TKVVTDDRKEKEFLTEIGTIGHV 121
           F+    +G+G + EVYK +  +  + +A+K +        + D ++E +FL++       
Sbjct: 3   FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQ------- 55

Query: 122 CH-PNVLSLLGCCVDN-GLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLH 179
           C  P +    G  +    L++I ++   GS   L   +    ++      I      GL 
Sbjct: 56  CRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDL---LKPGKLDETYIAFILREVLLGLE 112

Query: 180 YLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIE--GTFGHL 237
           YLH+      IHRDIK++NILL+ + + +++DFG++     Q T          GT   +
Sbjct: 113 YLHEE---GKIHRDIKAANILLSEEGDVKLADFGVS----GQLTSTMSKRNTFVGTPFWM 165

Query: 238 APEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPR 297
           APE       DEK D+++ G+  +E+  G  P       LH    P+     I K   P 
Sbjct: 166 APEVIKQSGYDEKADIWSLGITAIELAKGEPP----LSDLH----PMRVLFLIPKNNPPS 217

Query: 298 LQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVL 332
           L+G              SLC+   P  RP+  E+L
Sbjct: 218 LEGNKFSKPFKDF---VSLCLNKDPKERPSAKELL 249

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 87.6 bits (218), Expect = 1e-19
 Identities = 44/161 (27%), Positives = 74/161 (45%), Gaps = 33/161 (20%)

Query: 74  VGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEF----LTEIGTIGHVCHPNVLS 128
           +G G Y +VYK    + GE +A+K++      + +++ F    + EI  +  + HPN++ 
Sbjct: 7   IGEGTYGQVYKARNKKTGELVALKKIRM----ENEKEGFPITAIREIKLLQKLRHPNIVR 62

Query: 129 LLGCCVD---NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTAR--------G 177
           L           +Y++F++          HD+   G+      K      +        G
Sbjct: 63  LKEIVTSKGKGSIYMVFEYMD--------HDLT--GLLDSPEVKFTESQIKCYMKQLLEG 112

Query: 178 LHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWL 218
           L YLH      I+HRDIK SNIL+  D   +++DFGLA+  
Sbjct: 113 LQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPY 150

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 87.5 bits (217), Expect = 1e-19
 Identities = 74/269 (27%), Positives = 117/269 (43%), Gaps = 32/269 (11%)

Query: 73  LVGRGGYAEVYKGV-LQDGEEIAVKRLT-----KVVTDDRKEKEFLTEIGTIGHVCHPNV 126
           L+GRG Y  VY+G  +  G  +A+K +        V+D ++E   L+++        PN+
Sbjct: 8   LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLR---QSQPPNI 64

Query: 127 LSLLGC-CVDNGLYLIFQFSSRGSVASLFHDVNSPG-VEWKVRHKIAVGTARGLHYLHKG 184
               G       L++I +++  GSV +L       G +  K    I       L Y+HK 
Sbjct: 65  TKYYGSYLKGPRLWIIMEYAEGGSVRTLM----KAGPIAEKYISVIIREVLVALKYIHKV 120

Query: 185 CQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMH 244
               +IHRDIK++NIL+T     ++ DFG+A  L    +  S     GT   +APE    
Sbjct: 121 ---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRST--FVGTPYWMAPEVITE 175

Query: 245 GIV-DEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYD 303
           G   D K D+++ G+ + E+ +G  P        +S          I K   PRL+    
Sbjct: 176 GKYYDTKADIWSLGITIYEMATGNPP--------YSDVDAFRAMMLIPKSKPPRLEDNGY 227

Query: 304 VTQLNRLAFAASLCIRASPTWRPTMSEVL 332
              L    F A+ C+   P  R +  E+L
Sbjct: 228 SKLLRE--FVAA-CLDEEPKERLSAEELL 253

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 86.6 bits (215), Expect = 2e-19
 Identities = 72/281 (25%), Positives = 121/281 (43%), Gaps = 45/281 (16%)

Query: 72  NLVGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLL 130
           N +G G + +VY  V L  GE +AVK +     D +  KE   E+  +  + HPN++   
Sbjct: 6   NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65

Query: 131 GCCV-DNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRI 189
           G  V    +Y+  ++ S G++  L    +   ++  V     +    GL YLH      I
Sbjct: 66  GVEVHREKVYIFMEYCSGGTLEELLE--HGRILDEHVIRVYTLQLLEGLAYLH---SHGI 120

Query: 190 IHRDIKSSNILLTADFEPQISDFGLAKWLPSQWT--HHSIAPIEGTFGHLAPEYFMHGIV 247
           +HRDIK +NI L  +   ++ DFG A  L +  T     +  + GT  ++APE    G  
Sbjct: 121 VHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKG 180

Query: 248 DEK---TDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDV 304
                  D+++ G  +LE+ +G++P          W++           +D   Q  + V
Sbjct: 181 KGHGRAADIWSLGCVVLEMATGKRP----------WSE-----------LDNEFQIMFHV 219

Query: 305 TQLNRLAFAASL------------CIRASPTWRPTMSEVLE 333
              ++     SL            C+ + P  RPT SE+L+
Sbjct: 220 GAGHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 87.1 bits (216), Expect = 2e-19
 Identities = 61/205 (29%), Positives = 95/205 (46%), Gaps = 22/205 (10%)

Query: 75  GRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVC-HPNVLSLLGCC 133
           G G    V K  L++   I   +      +   +K+ L E+  I   C  P ++   G  
Sbjct: 10  GEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILREL-EINKSCKSPYIVKYYGAF 68

Query: 134 VDNG---LYLIFQFSSRGSVASLFHDVNSPG--VEWKVRHKIAVGTARGLHYLHKGCQRR 188
           +D     + +  ++   GS+ S++  V   G  +  KV  KIA    +GL YLH    R+
Sbjct: 69  LDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH---SRK 125

Query: 189 IIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFG----HLAPEYFMH 244
           IIHRDIK SNILLT   + ++ DFG++  L        +  + GTF     ++APE    
Sbjct: 126 IIHRDIKPSNILLTRKGQVKLCDFGVSGEL--------VNSLAGTFTGTSFYMAPERIQG 177

Query: 245 GIVDEKTDVFAFGVFLLEIISGRKP 269
                 +DV++ G+ LLE+   R P
Sbjct: 178 KPYSITSDVWSLGLTLLEVAQNRFP 202

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 86.9 bits (216), Expect = 2e-19
 Identities = 56/228 (24%), Positives = 95/228 (41%), Gaps = 27/228 (11%)

Query: 68  FSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKV-VTDDRKEKEFLTEIGTIGHV-CHP 124
           F    ++G G ++ V     +   +E A+K L K  +  ++K K    E   +  +  HP
Sbjct: 3   FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHP 62

Query: 125 NVLSLLGCCVDNG-LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHK 183
            ++ L     D   LY + +++  G +        S   +   R   A      L YLH 
Sbjct: 63  GIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKC-TRFYAA-EILLALEYLH- 119

Query: 184 GCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPS----QWTHHSIAPIE-------- 231
              + IIHRD+K  NILL  D   +I+DFG AK L      +        I+        
Sbjct: 120 --SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRR 177

Query: 232 ------GTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGS 273
                 GT  +++PE        + +D++A G  + ++++G+ P  GS
Sbjct: 178 RFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGS 225

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 86.4 bits (214), Expect = 3e-19
 Identities = 65/213 (30%), Positives = 107/213 (50%), Gaps = 24/213 (11%)

Query: 73  LVGRGGYAEVYKGV-LQDGEEIAVKRL----TKVVTDDRKEK---EFLTEIGTIGHVCHP 124
           L+G G +  VY G+    GE +AVK++        + DRK         EI  +  + H 
Sbjct: 7   LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66

Query: 125 NVLSLLGCCVD-NGLYLIFQFSSRGSVASLFHDVNS---PGVEWKVRHKIAVGTARGLHY 180
           N++  LG  +D + L +  ++   GSVA+L ++  +     V   VR        +GL+Y
Sbjct: 67  NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQ-----ILKGLNY 121

Query: 181 LHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLP----SQWTHHSIAPIEGTFGH 236
           LH    R IIHRDIK +NIL+      +ISDFG++K L     S  T+ +   ++G+   
Sbjct: 122 LH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFW 178

Query: 237 LAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKP 269
           +APE         K D+++ G  ++E+++G+ P
Sbjct: 179 MAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 87.0 bits (215), Expect = 3e-19
 Identities = 61/211 (28%), Positives = 111/211 (52%), Gaps = 11/211 (5%)

Query: 68  FSSENLVGRGGYAEVYKGV-LQDGEEIAVKRLTKVV---TDDRKEKEFLTEIGTIGHVCH 123
           F    ++G G +  VYKG+ + +GE++ +    K +   T  +  KE L E   +  V +
Sbjct: 9   FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68

Query: 124 PNVLSLLGCCVDNGLYLIFQFSSRGSVASLFHD-VNSPGVEWKVRHKIAVGTARGLHYLH 182
           P+V  LLG C+ + + LI Q    G +     +  ++ G ++ +     V  A+G++YL 
Sbjct: 69  PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLL--NWCVQIAKGMNYLE 126

Query: 183 KGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYF 242
              +RR++HRD+ + N+L+      +I+DFGLAK L +    +     +     +A E  
Sbjct: 127 ---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESI 183

Query: 243 MHGIVDEKTDVFAFGVFLLEIIS-GRKPVDG 272
           +H I   ++DV+++GV + E+++ G KP DG
Sbjct: 184 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 214

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 86.6 bits (214), Expect = 4e-19
 Identities = 79/268 (29%), Positives = 122/268 (45%), Gaps = 51/268 (19%)

Query: 92  EIAVKRLT-----KVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQFS 145
           ++AVK L      K ++D   E E +  IG      H N+++LLG C  +G LY+I +++
Sbjct: 52  KVAVKMLKSDATEKDLSDLISEMEMMKMIGK-----HKNIINLLGACTQDGPLYVIVEYA 106

Query: 146 SRGSVASLFHDVNSPGVEW--------------KVRHKIAVGTARGLHYLHKGCQRRIIH 191
           S+G++         PG+E+              K     A   ARG+ YL     ++ IH
Sbjct: 107 SKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYL---ASKKCIH 163

Query: 192 RDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHL-----APEYFMHGI 246
           RD+ + N+L+T D   +I+DFGLA+ +     HH     + T G L     APE     I
Sbjct: 164 RDLAARNVLVTEDNVMKIADFGLARDI-----HHIDYYKKTTNGRLPVKWMAPEALFDRI 218

Query: 247 VDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVT 305
              ++DV++FGV L EI + G  P  G          P+    E+ KL+    +      
Sbjct: 219 YTHQSDVWSFGVLLWEIFTLGGSPYPGV---------PV---EELFKLLKEGHRMDKPSN 266

Query: 306 QLNRLAFAASLCIRASPTWRPTMSEVLE 333
             N L      C  A P+ RPT  +++E
Sbjct: 267 CTNELYMMMRDCWHAVPSQRPTFKQLVE 294

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 85.6 bits (212), Expect = 4e-19
 Identities = 70/275 (25%), Positives = 124/275 (45%), Gaps = 31/275 (11%)

Query: 68  FSSENLVGRGGYAEVYK-GVLQDGEEIAVKRLTKVVTDDRKEKE-FLTEIGTIGHVCHPN 125
           F     +G+G Y  VYK   L D +  A+K    + +  +KE+E  + EI  +  V HPN
Sbjct: 2   FKVLKKLGKGSYGSVYKVKRLSDNQFYALKE-VDLGSMSQKEREDAVNEIRILASVNHPN 60

Query: 126 VLSLLGCCVD-NGLYLIFQFSSRGSVASLFHDVNSPG--VEWKVRHKIAVGTARGLHYLH 182
           ++S     +D N L ++ +++  G ++            +  +   +I +   RGL  LH
Sbjct: 61  IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120

Query: 183 KGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYF 242
              +++I+HRD+KS+NILL A+   +I D G++K L        I    GT  ++APE +
Sbjct: 121 ---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQI----GTPHYMAPEVW 173

Query: 243 MHGIVDEKTDVFAFGVFLLEIISGRKPVDG-SHQSLHSWAKPILNQGEIEKLVDPRLQGA 301
                  K+D+++ G  L E+ +   P +  S Q L           ++++   P +   
Sbjct: 174 KGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRY---------KVQRGKYPPIPPI 224

Query: 302 Y--DVTQLNRLAFAASLCIRASPTWRPTMSEVLEV 334
           Y  D+    R        ++  P  RP   ++L  
Sbjct: 225 YSQDLQNFIR------SMLQVKPKLRPNCDKILAS 253

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 85.6 bits (212), Expect = 5e-19
 Identities = 59/222 (26%), Positives = 101/222 (45%), Gaps = 32/222 (14%)

Query: 67  AFSSENL-----VGRGGYAEVYKGVLQDGEE------IAVKRLTKVVTDDRKEKEFLTEI 115
           AF   NL     +GRG + EV+    +  EE      + VK L K   D+  + EF  E+
Sbjct: 1   AFPRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKT-KDENLQSEFRREL 59

Query: 116 GTIGHVCHPNVLSLLGCCVD-NGLYLIFQFSSRGSVASLFHDVNSPGVEWK------VRH 168
                + H NV+ LLG C +    Y+I +++  G +   F        E         + 
Sbjct: 60  DMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQ-FLRATKSKDEKLKPPPLSTKQ 118

Query: 169 KIAVGT--ARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHH- 225
           K+A+ T  A G+ +L      R +HRD+ + N L+++  E ++S   L+K + +   +  
Sbjct: 119 KVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKL 175

Query: 226 --SIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS 265
             ++ P+      LAPE         K+DV++FGV + E+ +
Sbjct: 176 RNALIPLR----WLAPEAVQEDDFSTKSDVWSFGVLMWEVFT 213

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 85.5 bits (212), Expect = 5e-19
 Identities = 63/207 (30%), Positives = 99/207 (47%), Gaps = 22/207 (10%)

Query: 74  VGRGGYAEVYKGVLQ--DGEEI--AVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSL 129
           +G G +  V KGV     G+E+  AVK L K       +KEFL E   +  + HP ++ L
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTL-KQEHIAAGKKEFLREASVMAQLDHPCIVRL 61

Query: 130 LGCCVDNGLYLIFQFSSRGSVAS-LFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRR 188
           +G C    L L+ + +  G +   L      P  + K    +A   A G+ YL     + 
Sbjct: 62  IGVCKGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKE---LAHQVAMGMAYLE---SKH 115

Query: 189 IIHRDIKSSNILLTADFEPQISDFGLAKWLPS-----QWTHHSIAPIEGTFGHLAPEYFM 243
            +HRD+ + N+LL    + +ISDFG+++ L +     + T     P++      APE   
Sbjct: 116 FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLK----WYAPECIN 171

Query: 244 HGIVDEKTDVFAFGVFLLEIIS-GRKP 269
           +G    K+DV+++GV L E  S G KP
Sbjct: 172 YGKFSSKSDVWSYGVTLWEAFSYGAKP 198

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 85.0 bits (210), Expect = 6e-19
 Identities = 61/210 (29%), Positives = 98/210 (46%), Gaps = 39/210 (18%)

Query: 73  LVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC 132
           L+G+G + EV+KG L+D   +AVK   + +  + K K FL+E   +    HPN++ L+G 
Sbjct: 2   LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIK-FLSEARILKQYDHPNIVKLIGV 60

Query: 133 CVD-NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRH--KIAVGTARGLHYLH-KGCQRR 188
           C     +Y++ +    G   S          E K +   K A+  A G+ YL  K C   
Sbjct: 61  CTQRQPIYIVMELVPGGDFLSFLRKKKD---ELKTKQLVKFALDAAAGMAYLESKNC--- 114

Query: 189 IIHRDIKSSNILLTADFEPQISDFGLA-------------KWLPSQWTHHSIAPIEGTFG 235
            IHRD+ + N L+  +   +ISDFG++             K +P +WT            
Sbjct: 115 -IHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWT------------ 161

Query: 236 HLAPEYFMHGIVDEKTDVFAFGVFLLEIIS 265
             APE   +G    ++DV+++G+ L E  S
Sbjct: 162 --APEALNYGRYSSESDVWSYGILLWETFS 189

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 85.5 bits (212), Expect = 6e-19
 Identities = 56/203 (27%), Positives = 93/203 (45%), Gaps = 14/203 (6%)

Query: 72  NLVGRGGYAEVYKGVL-----QDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNV 126
             +G G + +V            GE++AVK L     +++   +F  EI  +  + H N+
Sbjct: 10  KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSL-NHSGEEQHRSDFEREIEILRTLDHENI 68

Query: 127 LSLLGCCVDNG---LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHK 183
           +   G C   G   L LI ++   GS+   +   +   +  K     +    +G+ YL  
Sbjct: 69  VKYKGVCEKPGGRSLRLIMEYLPSGSLRD-YLQRHRDQINLKRLLLFSSQICKGMDYLG- 126

Query: 184 GCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLP-SQWTHHSIAPIEGTFGHLAPEYF 242
              +R IHRD+ + NIL+ ++   +ISDFGLAK LP  +  ++   P E      APE  
Sbjct: 127 --SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECL 184

Query: 243 MHGIVDEKTDVFAFGVFLLEIIS 265
                   +DV++FGV L E+ +
Sbjct: 185 RTSKFSSASDVWSFGVTLYELFT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 85.5 bits (211), Expect = 7e-19
 Identities = 72/267 (26%), Positives = 119/267 (44%), Gaps = 21/267 (7%)

Query: 68  FSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVL 127
           F+    +G+G + EV+KG+    +++   ++  +   + + ++   EI  +     P V 
Sbjct: 6   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65

Query: 128 SLLGCCV-DNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQ 186
              G  + D  L++I ++   GS   L      P  E ++   I     +GL YLH    
Sbjct: 66  KYYGSYLKDTKLWIIMEYLGGGSALDLLEP--GPLDETQIA-TILREILKGLDYLH---S 119

Query: 187 RRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGI 246
            + IHRDIK++N+LL+   E +++DFG+A  L    T        GT   +APE      
Sbjct: 120 EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD--TQIKRNTFVGTPFWMAPEVIKQSA 177

Query: 247 VDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQ 306
            D K D+++ G+  +E+  G  P    H  LH      L    I K   P L+G Y    
Sbjct: 178 YDSKADIWSLGITAIELAKGEPP----HSELHPMKVLFL----IPKNNPPTLEGNYS--- 226

Query: 307 LNRLAFAASLCIRASPTWRPTMSEVLE 333
              L      C+   P++RPT  E+L+
Sbjct: 227 -KPLKEFVEACLNKEPSFRPTAKELLK 252

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 84.5 bits (209), Expect = 2e-18
 Identities = 64/199 (32%), Positives = 92/199 (46%), Gaps = 9/199 (4%)

Query: 74  VGRGGYAEVYKGVLQD-GEEIAVKRLTKVVTDDRK-EKEFLTEIGTIGHVCHPNVLSL-L 130
           +G+GG+ EV    ++  G+  A K+L K     RK E+  L E   +  V    ++SL  
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60

Query: 131 GCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRII 190
                + L L+    + G +    ++V  PG         A     GL +LH   QRRI+
Sbjct: 61  AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLH---QRRIV 117

Query: 191 HRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEK 250
           +RD+K  N+LL      +ISD GLA  L         A   GT G++APE     + D  
Sbjct: 118 YRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRA---GTPGYMAPEVLQGEVYDFS 174

Query: 251 TDVFAFGVFLLEIISGRKP 269
            D FA G  L E+I+GR P
Sbjct: 175 VDWFALGCTLYEMIAGRSP 193

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 83.3 bits (207), Expect = 2e-18
 Identities = 62/211 (29%), Positives = 96/211 (45%), Gaps = 26/211 (12%)

Query: 74  VGRGGYAEVYKGVLQDGEEI-AVKRLTKVVTDDRKEKEF-LTEIGTIGHVCHPNVLSLLG 131
           +G+G + +V     +D  ++ A+K L K     RKE E  LTE   +  + HP ++ L  
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60

Query: 132 CCVDNG-LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTAR--------GLHYLH 182
                  LYL+ +++  G    LF  ++          + +   AR         L YLH
Sbjct: 61  AFQTEEKLYLVLEYAPGGE---LFSHLSK-------EGRFSEERARFYAAEIVLALEYLH 110

Query: 183 KGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYF 242
                 II+RD+K  NILL AD   +++DFGLAK L S           GT  +LAPE  
Sbjct: 111 ---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSS--EGSRTNTFCGTPEYLAPEVL 165

Query: 243 MHGIVDEKTDVFAFGVFLLEIISGRKPVDGS 273
           +     +  D ++ GV L E+++G+ P    
Sbjct: 166 LGKGYGKAVDWWSLGVLLYEMLTGKPPFYAE 196

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 83.6 bits (207), Expect = 3e-18
 Identities = 56/208 (26%), Positives = 102/208 (49%), Gaps = 17/208 (8%)

Query: 73  LVGRGGYAEVYKGVLQD--GEEI--AVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLS 128
            +G G + +VY+GV      E+I  AVK      +   +EK FL E   +    HP+++ 
Sbjct: 13  CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREK-FLQEAYIMRQFDHPHIVK 71

Query: 129 LLGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRR 188
           L+G   +N ++++ + +  G + S +  VN   ++       +   +  L YL     +R
Sbjct: 72  LIGVITENPVWIVMELAPLGELRS-YLQVNKYSLDLASLILYSYQLSTALAYLE---SKR 127

Query: 189 IIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIA---PIEGTFGHLAPEYFMHG 245
            +HRDI + N+L+++    ++ DFGL+++L  +  + +     PI+     +APE     
Sbjct: 128 FVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIK----WMAPESINFR 183

Query: 246 IVDEKTDVFAFGVFLLEIIS-GRKPVDG 272
                +DV+ FGV + EI+  G KP  G
Sbjct: 184 RFTSASDVWMFGVCMWEILMLGVKPFQG 211

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 83.5 bits (207), Expect = 3e-18
 Identities = 73/284 (25%), Positives = 123/284 (43%), Gaps = 55/284 (19%)

Query: 71  ENLVGRGGYAEVYKGVLQ----DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNV 126
           E ++G G + EV +G L+       ++A+K L K  + D++  +FLTE   +G   HPN+
Sbjct: 9   EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTL-KAGSSDKQRLDFLTEASIMGQFDHPNI 67

Query: 127 LSLLGCCVD-NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGC 185
           + L G       + +I ++   GS+   F   N           +  G A G+ YL +  
Sbjct: 68  IRLEGVVTKSRPVMIITEYMENGSLDK-FLRENDGKFTVGQLVGMLRGIASGMKYLSEMN 126

Query: 186 QRRIIHRDIKSSNILLTADFEPQISDFGLAKWL--------------PSQWTHHSIAPIE 231
               +HRD+ + NIL+ ++   ++SDFGL++ L              P +WT        
Sbjct: 127 ---YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWT-------- 175

Query: 232 GTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGEI 290
                 APE   +      +DV++FG+ + E++S G +P          W     NQ  I
Sbjct: 176 ------APEAIAYRKFTSASDVWSFGIVMWEVMSYGERPY---------WDMS--NQDVI 218

Query: 291 EKLVDP-RLQGAYDVTQ-LNRLAFAASLCIRASPTWRPTMSEVL 332
           + + D  RL    D    L +L      C +     RPT S+++
Sbjct: 219 KAVEDGYRLPPPMDCPSALYQLMLD---CWQKDRNERPTFSQIV 259

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 82.9 bits (206), Expect = 5e-18
 Identities = 47/154 (30%), Positives = 73/154 (47%), Gaps = 13/154 (8%)

Query: 68  FSSENLVGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKE---KEFLTEIGTIGHVCH 123
           +     +G G Y  VYK    + GE +A+K   K+  D+ +E      L EI  +  + H
Sbjct: 1   YEKLEKLGEGTYGVVYKARDKKTGEIVALK---KIRLDNEEEGIPSTALREISLLKELKH 57

Query: 124 PNVLSLLG-CCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLH 182
           PN++ LL     +  LYL+F++     +         P     ++  I     RGL Y H
Sbjct: 58  PNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKS-IMYQLLRGLAYCH 115

Query: 183 KGCQRRIIHRDIKSSNILLTADFEPQISDFGLAK 216
                RI+HRD+K  NIL+  D   +++DFGLA+
Sbjct: 116 ---SHRILHRDLKPQNILINRDGVLKLADFGLAR 146

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 82.7 bits (205), Expect = 5e-18
 Identities = 66/273 (24%), Positives = 118/273 (43%), Gaps = 32/273 (11%)

Query: 74  VGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLT-EIGTIGHVCHPNVLSLLG 131
           +G+G +  V K     DG+ +  K +        KEK+ L  E+  +  + HPN++    
Sbjct: 8   IGKGSFGTVRKVRRKSDGKILVWKEI-DYGNMTEKEKQQLVSEVNILRELKHPNIVRYYD 66

Query: 132 CCVDNG---LYLIFQFSSRGSVASL---FHDVNSPGVEWKVRHKIAVGTARGLHYLHKGC 185
             +D     LY++ ++   G +A L           +E +   +I       L+  H   
Sbjct: 67  RIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKY-IEEEFIWRILTQLLLALYECHNRS 125

Query: 186 Q--RRIIHRDIKSSNILLTADFEPQISDFGLAKWLP--SQWTHHSIAPIEGTFGHLAPEY 241
                ++HRD+K +NI L A+   ++ DFGLAK L   S +    +    GT  +++PE 
Sbjct: 126 DPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV----GTPYYMSPEQ 181

Query: 242 FMHGIVDEKTDVFAFGVFLLEIISGRKPVDG-SHQSLHSWAKPILNQGEIEKLVDPRLQG 300
             H   DEK+D+++ G  + E+ +   P    +   L S  K    +G+       R+  
Sbjct: 182 LNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIK----EGKF-----RRIPY 232

Query: 301 AYDVTQLNRLAFAASLCIRASPTWRPTMSEVLE 333
            Y  ++LN +       +   P  RP+  E+L+
Sbjct: 233 RYS-SELNEV---IKSMLNVDPDKRPSTEELLQ 261

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 82.8 bits (204), Expect = 7e-18
 Identities = 54/205 (26%), Positives = 107/205 (52%), Gaps = 9/205 (4%)

Query: 73  LVGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEK---EFLTEIGTIGHVCHPNVLS 128
           ++G G +  VYKG+ + +GE + +    K++ +    K   EF+ E   +  + HP+++ 
Sbjct: 14  VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73

Query: 129 LLGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRR 188
           LLG C+   + L+ Q    G +    H+ +   +  ++     V  A+G+ YL    +RR
Sbjct: 74  LLGVCLSPTIQLVTQLMPHGCLLDYVHE-HKDNIGSQLLLNWCVQIAKGMMYLE---ERR 129

Query: 189 IIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVD 248
           ++HRD+ + N+L+ +    +I+DFGLA+ L      ++    +     +A E   +    
Sbjct: 130 LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFT 189

Query: 249 EKTDVFAFGVFLLEIIS-GRKPVDG 272
            ++DV+++GV + E+++ G KP DG
Sbjct: 190 HQSDVWSYGVTIWELMTFGGKPYDG 214

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 81.9 bits (202), Expect = 1e-17
 Identities = 60/213 (28%), Positives = 105/213 (49%), Gaps = 21/213 (9%)

Query: 73  LVGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIG----TIGHVCHPNVL 127
           L+G G +  V+KG+ + +G+ I +    K +  DR  ++   EI      +G + H  ++
Sbjct: 14  LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTI-QDRSGRQTFQEITDHMLAMGSLDHAYIV 72

Query: 128 SLLGCCVDNGLYLIFQFSSRGSVASLFH---DVNSPG--VEWKVRHKIAVGTARGLHYLH 182
            LLG C    L L+ Q S  GS+        D   P   + W V+       A+G++YL 
Sbjct: 73  RLLGICPGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQ------IAKGMYYLE 126

Query: 183 KGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYF 242
              + R++HR++ + NILL +D   QI+DFG+A  L      +  +  +     +A E  
Sbjct: 127 ---EHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESI 183

Query: 243 MHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSH 274
           + G    ++DV+++GV + E++S G +P  G  
Sbjct: 184 LFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMR 216

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 81.8 bits (202), Expect = 1e-17
 Identities = 59/212 (27%), Positives = 95/212 (44%), Gaps = 31/212 (14%)

Query: 73  LVGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLG 131
           ++G+G Y  VY    L     IA+K +     D R  +    EI    ++ H N++  LG
Sbjct: 15  VLGKGTYGIVYAARDLSTQVRIAIKEIP--ERDSRYVQPLHEEIALHSYLKHRNIVQYLG 72

Query: 132 CCVDNGLYLIF-QFSSRGSVASLFH------DVNSPGVEWKVRHKIAVGTARGLHYLHKG 184
              +NG + IF +    GS+++L          N   + +  +  +      GL YLH  
Sbjct: 73  SDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQIL-----EGLKYLH-- 125

Query: 185 CQRRIIHRDIKSSNILL-TADFEPQISDFGLAKWLPSQWTHHSIAPI----EGTFGHLAP 239
              +I+HRDIK  N+L+ T     +ISDFG +K L        I P      GT  ++AP
Sbjct: 126 -DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA------GINPCTETFTGTLQYMAP 178

Query: 240 EYFMHGI--VDEKTDVFAFGVFLLEIISGRKP 269
           E    G        D+++ G  ++E+ +G+ P
Sbjct: 179 EVIDKGPRGYGAPADIWSLGCTIVEMATGKPP 210

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 82.0 bits (202), Expect = 1e-17
 Identities = 71/268 (26%), Positives = 117/268 (43%), Gaps = 23/268 (8%)

Query: 68  FSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVL 127
           F+    +G+G + EVYKG+    +E+   ++  +   + + ++   EI  +     P + 
Sbjct: 6   FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65

Query: 128 SLLGCCVDNG-LYLIFQFSSRGSVASLFHDVNSPG-VEWKVRHKIAVGTARGLHYLHKGC 185
              G  +    L++I ++   GS   L      PG +E      I     +GL YLH   
Sbjct: 66  RYYGSYLKGTKLWIIMEYLGGGSALDLL----KPGPLEETYIATILREILKGLDYLH--- 118

Query: 186 QRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHG 245
             R IHRDIK++N+LL+   + +++DFG+A  L    T        GT   +APE     
Sbjct: 119 SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD--TQIKRNTFVGTPFWMAPEVIKQS 176

Query: 246 IVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVT 305
             D K D+++ G+  +E+  G  P    +  LH    P+     I K   P L+G Y   
Sbjct: 177 AYDFKADIWSLGITAIELAKGEPP----NSDLH----PMRVLFLIPKNSPPTLEGQYS-- 226

Query: 306 QLNRLAFAASLCIRASPTWRPTMSEVLE 333
                      C+   P +RPT  E+L+
Sbjct: 227 --KPFKEFVEACLNKDPRFRPTAKELLK 252

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 81.2 bits (200), Expect = 1e-17
 Identities = 59/208 (28%), Positives = 94/208 (45%), Gaps = 35/208 (16%)

Query: 74  VGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC 132
           +GRG + EV+ G L+ D   +AVK   + +  D K K FL E   +    HPN++ L+G 
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAK-FLQEARILKQYSHPNIVRLIGV 61

Query: 133 CVD-NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIH 191
           C     +Y++ +    G   + F     P ++ K   ++    A G+ YL        IH
Sbjct: 62  CTQKQPIYIVMELVQGGDFLT-FLRTEGPRLKVKELIQMVENAAAGMEYLESKH---CIH 117

Query: 192 RDIKSSNILLTADFEPQISDFGLA--------------KWLPSQWTHHSIAPIEGTFGHL 237
           RD+ + N L+T     +ISDFG++              K +P +WT              
Sbjct: 118 RDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWT-------------- 163

Query: 238 APEYFMHGIVDEKTDVFAFGVFLLEIIS 265
           APE   +G    ++DV++FG+ L E  S
Sbjct: 164 APEALNYGRYSSESDVWSFGILLWEAFS 191

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 82.0 bits (203), Expect = 1e-17
 Identities = 55/200 (27%), Positives = 90/200 (45%), Gaps = 16/200 (8%)

Query: 74  VGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC 132
           +G G Y  VYK      GE +A+K++      +   K  L EI  +  + HPN++ LL  
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66

Query: 133 CVDNG-LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIH 191
               G LYL+F+F     +  L  D      E  ++        +GL + H      I+H
Sbjct: 67  FRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKS-YLYQLLQGLAFCHS---HGILH 121

Query: 192 RDIKSSNILLTADFEPQISDFGLAKWLPSQ---WTHHSIAPIEGTFGHLAPE-YFMHGIV 247
           RD+K  N+L+  +   +++DFGLA+   S    +TH+ +     T  + APE        
Sbjct: 122 RDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVV-----TRWYRAPELLLGDKGY 176

Query: 248 DEKTDVFAFGVFLLEIISGR 267
               D+++ G    E++S R
Sbjct: 177 STPVDIWSVGCIFAELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 81.1 bits (200), Expect = 1e-17
 Identities = 65/266 (24%), Positives = 122/266 (45%), Gaps = 32/266 (12%)

Query: 74  VGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCC 133
           +G G +  V+ G   +  ++A+K + +       E++F+ E   +  + HP ++ L G C
Sbjct: 12  IGSGQFGLVWLGYWLEKRKVAIKTIREGAM---SEEDFIEEAQVMMKLSHPKLVQLYGVC 68

Query: 134 VDNG-LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHR 192
            +   + L+F+F   G + S +          +    + +    G+ YL       +IHR
Sbjct: 69  TERSPICLVFEFMEHGCL-SDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIHR 124

Query: 193 DIKSSNILLTADFEPQISDFGLAKW-LPSQWT--HHSIAPIEGTFGHLAPEYFMHGIVDE 249
           D+ + N L+  +   ++SDFG+ ++ L  Q+T    +  P++ +    +PE F       
Sbjct: 125 DLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWS----SPEVFSFSKYSS 180

Query: 250 KTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRL--QGAYDVTQ 306
           K+DV++FGV + E+ S G+ P +      +S     +N G   +L  PRL  Q  Y++ Q
Sbjct: 181 KSDVWSFGVLMWEVFSEGKTPYENRS---NSEVVETINAG--FRLYKPRLASQSVYELMQ 235

Query: 307 LNRLAFAASLCIRASPTWRPTMSEVL 332
                     C +  P  RP+ S +L
Sbjct: 236 ---------HCWKERPEDRPSFSLLL 252

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 80.8 bits (200), Expect = 3e-17
 Identities = 47/156 (30%), Positives = 79/156 (50%), Gaps = 16/156 (10%)

Query: 72  NLVGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVC---HPNVL 127
             +G G Y  VYK   L  G  +A+K++   ++++      L EI  +  +    HPN++
Sbjct: 5   AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIV 64

Query: 128 SLLGCC----VDNG--LYLIFQFSSRGSVASLFHDVNSPGV-EWKVRHKIAVGTARGLHY 180
            LL  C     D    L L+F+   +  +A+       PG+    ++  +     RG+ +
Sbjct: 65  RLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKD-LMRQLLRGVDF 122

Query: 181 LHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAK 216
           LH     RI+HRD+K  NIL+T+D + +I+DFGLA+
Sbjct: 123 LH---SHRIVHRDLKPQNILVTSDGQVKIADFGLAR 155

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 79.9 bits (197), Expect = 5e-17
 Identities = 57/205 (27%), Positives = 103/205 (50%), Gaps = 18/205 (8%)

Query: 74  VGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCC 133
           +G G + EV+ G      ++A+K L +        + FL E   +  + HP ++ L    
Sbjct: 14  LGAGQFGEVWMGYYNGHTKVAIKSLKQGSMS---PEAFLAEANLMKQLQHPRLVRLYAVV 70

Query: 134 VDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKI--AVGTARGLHYLHKGCQRRIIH 191
               +Y+I ++   GS+          G++  +   I  A   A G+ ++    ++  IH
Sbjct: 71  TQEPIYIITEYMENGSLVDFLK--TPEGIKLTINKLIDMAAQIAEGMAFIE---RKNYIH 125

Query: 192 RDIKSSNILLTADFEPQISDFGLAKWL-PSQWTHHSIA--PIEGTFGHLAPEYFMHGIVD 248
           RD++++NIL++     +I+DFGLA+ +  +++T    A  PI+ T    APE   +G   
Sbjct: 126 RDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWT----APEAINYGTFT 181

Query: 249 EKTDVFAFGVFLLEIIS-GRKPVDG 272
            K+DV++FG+ L EI++ GR P  G
Sbjct: 182 IKSDVWSFGILLTEIVTYGRIPYPG 206

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 79.8 bits (197), Expect = 5e-17
 Identities = 62/208 (29%), Positives = 104/208 (50%), Gaps = 25/208 (12%)

Query: 72  NLVGRGGYAEVYKGVL--QDGEEI--AVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVL 127
            ++G+G +  VY G L   DG++I  AVK L ++ TD  + ++FL E   +    HPNVL
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI-TDLEEVEQFLKEGIIMKDFSHPNVL 59

Query: 128 SLLGCCVDN-GLYLI-FQFSSRGSVASLFHDVNSPGVEWKVRHKIAVG--TARGLHYLHK 183
           SLLG C+ + G  L+   +   G    L + + S      V+  I  G   A+G+ YL  
Sbjct: 60  SLLGICLPSEGSPLVVLPYMKHGD---LRNFIRSETHNPTVKDLIGFGLQVAKGMEYL-- 114

Query: 184 GCQRRIIHRDIKSSNILLTADFEPQISDFGLAK------WLPSQWTHHSIAPIEGTFGHL 237
              ++ +HRD+ + N +L   F  +++DFGLA+      +        +  P++     +
Sbjct: 115 -ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVK----WM 169

Query: 238 APEYFMHGIVDEKTDVFAFGVFLLEIIS 265
           A E         K+DV++FGV L E+++
Sbjct: 170 ALESLQTQKFTTKSDVWSFGVLLWELMT 197

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 79.5 bits (196), Expect = 7e-17
 Identities = 53/218 (24%), Positives = 100/218 (45%), Gaps = 20/218 (9%)

Query: 73  LVGRGGYAEVYK------GVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNV 126
            +G G ++  Y+      G L   +++   R T    ++  E     EI  +  + HP++
Sbjct: 7   QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVE-ALRKEIRLMARLNHPHI 65

Query: 127 LSLLGCCVDNGLYLIF-QFSSRGSVASLFHDVN--SPGVEWKVRHKIAVGTARGLHYLHK 183
           + +LG   ++  + +F ++ + GSV+ L          V      ++     RGL YLH 
Sbjct: 66  IRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLL----RGLSYLH- 120

Query: 184 GCQRRIIHRDIKSSNILLTADFEP-QISDFGLAKWLPSQWTHHSI--APIEGTFGHLAPE 240
             + +IIHRD+K +N+L+ +  +  +I+DFG A  L ++ T        + GT   +APE
Sbjct: 121 --ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPE 178

Query: 241 YFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLH 278
                      DV++ G  ++E+ + + P +    S H
Sbjct: 179 VLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNH 216

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 79.0 bits (195), Expect = 9e-17
 Identities = 61/206 (29%), Positives = 103/206 (50%), Gaps = 19/206 (9%)

Query: 74  VGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCC 133
           +G G + EV++G+  +   +AVK L K  T D   K+FL E   +  + HP ++ L   C
Sbjct: 14  LGAGQFGEVWEGLWNNTTPVAVKTL-KPGTMD--PKDFLAEAQIMKKLRHPKLIQLYAVC 70

Query: 134 -VDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKI--AVGTARGLHYLHKGCQRRII 190
            ++  +Y++ +    GS+          G   K+   I  A   A G+ YL     +  I
Sbjct: 71  TLEEPIYIVTELMKYGSLLEYLQ--GGAGRALKLPQLIDMAAQVASGMAYLE---AQNYI 125

Query: 191 HRDIKSSNILLTADFEPQISDFGLAKWL-PSQWTHHSIA--PIEGTFGHLAPEYFMHGIV 247
           HRD+ + N+L+  +   +++DFGLA+ +    +     A  PI+ T    APE  ++   
Sbjct: 126 HRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWT----APEAALYNRF 181

Query: 248 DEKTDVFAFGVFLLEIIS-GRKPVDG 272
             K+DV++FG+ L EI++ GR P  G
Sbjct: 182 SIKSDVWSFGILLTEIVTYGRMPYPG 207

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 78.9 bits (194), Expect = 9e-17
 Identities = 58/214 (27%), Positives = 104/214 (48%), Gaps = 14/214 (6%)

Query: 63  IATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVC 122
           I   +      +G G + EV+ G      ++AVK L          + FL E   +  + 
Sbjct: 3   IPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKP---GTMSPESFLEEAQIMKKLR 59

Query: 123 HPNVLSLLGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLH 182
           H  ++ L     +  +Y++ ++ S+GS+     D     ++      +A   A G+ Y+ 
Sbjct: 60  HDKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE 119

Query: 183 KGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLP-SQWTHHSIA--PIEGTFGHLAP 239
           +      IHRD++S+NIL+      +I+DFGLA+ +  +++T    A  PI+ T    AP
Sbjct: 120 R---MNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWT----AP 172

Query: 240 EYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDG 272
           E  ++G    K+DV++FG+ L E+++ GR P  G
Sbjct: 173 EAALYGRFTIKSDVWSFGILLTELVTKGRVPYPG 206

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 79.0 bits (195), Expect = 1e-16
 Identities = 54/231 (23%), Positives = 94/231 (40%), Gaps = 54/231 (23%)

Query: 74  VGRGGYAEVYKGVL------QDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVL 127
           +G G + +V+ G         D E +AVK L K    +   K+F  E   + +  H N++
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVKTL-KETASNDARKDFEREAELLTNFQHENIV 71

Query: 128 SLLGCCVDNG-LYLIFQFSSRGSVASLFHDVNSPGVEWKVR-------------HKIAVG 173
              G C +     ++F++   G +       + P   +                 +IAV 
Sbjct: 72  KFYGVCTEGDPPIMVFEYMEHGDLNKFLR-SHGPDAAFLKSPDSPMGELTLSQLLQIAVQ 130

Query: 174 TARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAK--------------WLP 219
            A G+ YL     +  +HRD+ + N L+  D   +I DFG+++               LP
Sbjct: 131 IASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLP 187

Query: 220 SQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKP 269
            +W              + PE  M+     ++DV++FGV L EI + G++P
Sbjct: 188 IRW--------------MPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 79.0 bits (195), Expect = 1e-16
 Identities = 55/211 (26%), Positives = 106/211 (50%), Gaps = 19/211 (9%)

Query: 75  GRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCV 134
           G G + +VYK   ++    A  ++ ++ +++  E +F+ EI  +    HPN++ L     
Sbjct: 14  GDGAFGKVYKAQHKETGLFAAAKIIQIESEEELE-DFMVEIDILSECKHPNIVGLYEAYF 72

Query: 135 -DNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRD 193
            +N L+++ +F   G++ S+  ++     E ++R+ +       L++LH     ++IHRD
Sbjct: 73  YENKLWILIEFCDGGALDSIMLELERGLTEPQIRY-VCRQMLEALNFLH---SHKVIHRD 128

Query: 194 IKSSNILLTADFEPQISDFGL-AKWLPSQWTHHSIAPIEGTFGHLAPEY-----FMHGIV 247
           +K+ NILLT D + +++DFG+ AK   +     +     GT   +APE      F     
Sbjct: 129 LKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI---GTPYWMAPEVVACETFKDNPY 185

Query: 248 DEKTDVFAFGVFLLEIISGRKPVDGSHQSLH 278
           D K D+++ G+ L+E+     P    H  L+
Sbjct: 186 DYKADIWSLGITLIELAQMEPP----HHELN 212

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 78.2 bits (192), Expect = 2e-16
 Identities = 65/222 (29%), Positives = 103/222 (46%), Gaps = 24/222 (10%)

Query: 68  FSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKE-KEFLTEIGTIGHVCHPNV 126
           F    LVG G Y +VYKG      ++A  ++  V  D+ +E K+ +  +    H  H N+
Sbjct: 8   FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSH--HRNI 65

Query: 127 LSLLGCCV-------DNGLYLIFQFSSRGSVASLFHDV--NSPGVEWKVRHKIAVGTARG 177
            +  G  +       D+ L+L+ +F   GSV  L  +   N+   EW     I     RG
Sbjct: 66  ATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY--ICREILRG 123

Query: 178 LHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHL 237
           L +LH   Q ++IHRDIK  N+LLT + E ++ DFG++  L       +     GT   +
Sbjct: 124 LSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT--FIGTPYWM 178

Query: 238 APEYFM-----HGIVDEKTDVFAFGVFLLEIISGRKPVDGSH 274
           APE            D K+D+++ G+  +E+  G  P+   H
Sbjct: 179 APEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH 220

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 78.9 bits (194), Expect = 2e-16
 Identities = 80/302 (26%), Positives = 135/302 (44%), Gaps = 75/302 (24%)

Query: 74  VGRGGYAEVYK----GVLQDGEEIAVKRLTKVVTDDRKEKEF------LTEIGTIGHVCH 123
           +G G + +V      G+ +D  + AV    K++ DD  EK+       +  +  IG   H
Sbjct: 23  LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK--H 80

Query: 124 PNVLSLLGCCVDNG-LYLIFQFSSRGSVASLFHDVNSPGVEW----------KVRHKIAV 172
            N+++LLG C  +G LY+I +++S+G++         PG+E+          ++  K  V
Sbjct: 81  KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLV 140

Query: 173 G----TARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAK------------ 216
                 ARG+ YL     ++ IHRD+ + N+L+T +   +I+DFGLA+            
Sbjct: 141 SCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTT 197

Query: 217 --WLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGS 273
              LP +W              +APE     +   ++DV++FGV + EI + G  P  G 
Sbjct: 198 NGRLPVKW--------------MAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI 243

Query: 274 HQSLHSWAKPILNQGEIEKLVDP--RLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEV 331
                    P+    E+ KL+    R+    + T  N L      C  A P+ RPT  ++
Sbjct: 244 ---------PV---EELFKLLKEGHRMDKPANCT--NELYMMMRDCWHAIPSHRPTFKQL 289

Query: 332 LE 333
           +E
Sbjct: 290 VE 291

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 78.5 bits (193), Expect = 2e-16
 Identities = 59/205 (28%), Positives = 103/205 (50%), Gaps = 9/205 (4%)

Query: 73  LVGRGGYAEVYKGV-LQDGEEIAVKRLTKVV---TDDRKEKEFLTEIGTIGHVCHPNVLS 128
           ++G G +  VYKG+ + DGE + +    KV+   T  +  KE L E   +  V  P V  
Sbjct: 14  VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73

Query: 129 LLGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRR 188
           LLG C+ + + L+ Q    G +     + N   +  +      V  A+G+ YL    + R
Sbjct: 74  LLGICLTSTVQLVTQLMPYGCLLDYVRE-NKDRIGSQDLLNWCVQIAKGMSYLE---EVR 129

Query: 189 IIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVD 248
           ++HRD+ + N+L+ +    +I+DFGLA+ L    T +     +     +A E  +H    
Sbjct: 130 LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFT 189

Query: 249 EKTDVFAFGVFLLEIIS-GRKPVDG 272
            ++DV+++GV + E+++ G KP DG
Sbjct: 190 HQSDVWSYGVTVWELMTFGAKPYDG 214

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 78.9 bits (194), Expect = 2e-16
 Identities = 79/315 (25%), Positives = 132/315 (41%), Gaps = 80/315 (25%)

Query: 68  FSSENLV-----GRGGYAEVYK----GVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIG-- 116
           F  + LV     G G + +V +    G+ +   +  V    K++ D+  +K+    I   
Sbjct: 9   FPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEM 68

Query: 117 ----TIGHVCHPNVLSLLGCCVDNG-LYLIFQFSSRGSVASLFHDVNSPGVE-------- 163
                IG   H N+++LLG C   G LY+I +++++G++         PG +        
Sbjct: 69  ELMKLIGK--HKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKV 126

Query: 164 ------WKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAK- 216
                 +K     A   ARG+ YL     RR IHRD+ + N+L+T D   +I+DFGLA+ 
Sbjct: 127 PEEQLSFKDLVSCAYQVARGMEYLE---SRRCIHRDLAARNVLVTEDNVMKIADFGLARG 183

Query: 217 -------------WLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEI 263
                         LP +W              +APE     +   ++DV++FG+ + EI
Sbjct: 184 VHDIDYYKKTSNGRLPVKW--------------MAPEALFDRVYTHQSDVWSFGILMWEI 229

Query: 264 IS-GRKPVDGSHQSLHSWAKPILNQGEIEKLVDP--RLQGAYDVTQLNRLAFAASLCIRA 320
            + G  P             P +   E+ KL+    R+    + T  + L      C  A
Sbjct: 230 FTLGGSPY------------PGIPVEELFKLLREGHRMDKPSNCT--HELYMLMRECWHA 275

Query: 321 SPTWRPTMSEVLEVM 335
            PT RPT  +++E +
Sbjct: 276 VPTQRPTFKQLVEAL 290

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 78.1 bits (193), Expect = 2e-16
 Identities = 61/210 (29%), Positives = 100/210 (47%), Gaps = 25/210 (11%)

Query: 75  GRGGYAEVYKGVLQDGEEIAVKRL---TKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLG 131
           G G + EV+ G      ++AVK L   T           FL E   +  + H  ++ L  
Sbjct: 15  GAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEA------FLQEAQIMKKLRHDKLVQLYA 68

Query: 132 CCVDNG-LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKI--AVGTARGLHYLHKGCQRR 188
            C +   +Y++ ++ S+GS+          G + ++   +  A   A G+ YL     R 
Sbjct: 69  VCSEEEPIYIVTEYMSKGSLLDFLKS--GEGKKLRLPQLVDMAAQIAEGMAYLE---SRN 123

Query: 189 IIHRDIKSSNILLTADFEPQISDFGLAKWL-PSQWTHHSIA--PIEGTFGHLAPEYFMHG 245
            IHRD+ + NIL+  +   +I+DFGLA+ +   ++T    A  PI+ T    APE   +G
Sbjct: 124 YIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWT----APEAANYG 179

Query: 246 IVDEKTDVFAFGVFLLEIIS-GRKPVDGSH 274
               K+DV++FG+ L EI++ GR P  G  
Sbjct: 180 RFTIKSDVWSFGILLTEIVTYGRVPYPGMT 209

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 78.2 bits (193), Expect = 3e-16
 Identities = 64/210 (30%), Positives = 103/210 (49%), Gaps = 22/210 (10%)

Query: 68  FSSENLVGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKE-----FLTEIGTIGHV 121
           F   N +G G Y  VY+      GE +A+K   KV  D   E++      L EI  + ++
Sbjct: 9   FEKLNRIGEGTYGIVYRARDTTSGEIVALK---KVRMD--NERDGIPISSLREITLLLNL 63

Query: 122 CHPNVLSLLGCCVDNGL---YLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGL 178
            HPN++ L    V   L   +L+ ++  +  +ASL  ++ +P  E +V+  + +   RGL
Sbjct: 64  RHPNIVELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFSESQVK-CLMLQLLRGL 121

Query: 179 HYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLA 238
            YLH+     IIHRD+K SN+LLT     +I+DFGLA+          + P   T  + A
Sbjct: 122 QYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLAR--TYGLPAKPMTPKVVTLWYRA 176

Query: 239 PEYFMHGIV-DEKTDVFAFGVFLLEIISGR 267
           PE  +         D++A G  L E+++ +
Sbjct: 177 PELLLGCTTYTTAIDMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 77.4 bits (190), Expect = 4e-16
 Identities = 56/202 (27%), Positives = 105/202 (51%), Gaps = 13/202 (6%)

Query: 74  VGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCC 133
           +G G + +VYK   ++   +A  ++    +++  E +++ EI  +    HPN++ LL   
Sbjct: 13  LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELE-DYMVEIDILASCDHPNIVKLLDAF 71

Query: 134 V-DNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHR 192
             +N L+++ +F + G+V ++  ++  P  E ++R  +   T   L+YLH   + +IIHR
Sbjct: 72  YYENNLWILIEFCAGGAVDAVMLELERPLTEPQIR-VVCKQTLEALNYLH---ENKIIHR 127

Query: 193 DIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGI-----V 247
           D+K+ NIL T D + +++DFG++    +  T        GT   +APE  M         
Sbjct: 128 DLKAGNILFTLDGDIKLADFGVSA--KNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPY 185

Query: 248 DEKTDVFAFGVFLLEIISGRKP 269
           D K DV++ G+ L+E+     P
Sbjct: 186 DYKADVWSLGITLIEMAQIEPP 207

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 76.9 bits (189), Expect = 5e-16
 Identities = 57/208 (27%), Positives = 96/208 (46%), Gaps = 34/208 (16%)

Query: 74  VGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCC 133
           +G+G + +V  G  + G ++AVK     + +D   + FL E   +  + H N++ LLG  
Sbjct: 14  IGKGEFGDVMLGDYR-GNKVAVK----CIKNDATAQAFLAEASVMTQLRHSNLVQLLGVI 68

Query: 134 VDN--GLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIH 191
           V+   GLY++ ++ ++GS+           +      K ++     + YL        +H
Sbjct: 69  VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVH 125

Query: 192 RDIKSSNILLTADFEPQISDFGLAKW---------LPSQWTHHSIAPIEGTFGHLAPEYF 242
           RD+ + N+L++ D   ++SDFGL K          LP +WT              APE  
Sbjct: 126 RDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT--------------APEAL 171

Query: 243 MHGIVDEKTDVFAFGVFLLEIIS-GRKP 269
                  K+DV++FG+ L EI S GR P
Sbjct: 172 REKKFSTKSDVWSFGILLWEIYSFGRVP 199

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 76.9 bits (190), Expect = 7e-16
 Identities = 55/210 (26%), Positives = 97/210 (46%), Gaps = 25/210 (11%)

Query: 74  VGRGGYAEVYK-GVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC 132
           +G G +  V+K    + GE +A+K++     +     + L EI  +    HP V+ LL  
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67

Query: 133 C-VDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIH 191
               +G  L+ ++     ++ +  D   P  E +V+        +G+ Y+H      I+H
Sbjct: 68  FPHGSGFVLVMEYMPS-DLSEVLRDEERPLPEAQVK-SYMRMLLKGVAYMHA---NGIMH 122

Query: 192 RDIKSSNILLTADFEPQISDFGLAKWL----PSQWTHHSI-----APIEGTFGHLAPEYF 242
           RD+K +N+L++AD   +I+DFGLA+      P  ++H        AP E  +G  A +Y 
Sbjct: 123 RDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAP-ELLYG--ARKY- 178

Query: 243 MHGIVDEKTDVFAFGVFLLEIISGRKPVDG 272
                D   D++A G    E+++G     G
Sbjct: 179 -----DPGVDLWAVGCIFAELLNGSPLFPG 203

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 76.6 bits (189), Expect = 8e-16
 Identities = 74/306 (24%), Positives = 116/306 (37%), Gaps = 62/306 (20%)

Query: 66  NAFSSENLVGRGGYAEVYKG-VLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHP 124
           N +    +VG G Y  V K      GE +A+K+  +   D+  +K  L E+  +  + H 
Sbjct: 1   NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHE 60

Query: 125 NVLSLLGCC-VDNGLYLIFQFSSRGSVASLFHDVN-SP-GVEWKVRHKIAVGTARGLHYL 181
           N+++L         LYL+F++  R    +L   +  SP G+             + + Y 
Sbjct: 61  NIVNLKEAFRRKGRLYLVFEYVER----TLLELLEASPGGLPPDAVRSYIWQLLQAIAYC 116

Query: 182 HKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPE- 240
           H      IIHRDIK  NIL++     ++ DFG A+ L ++        +  T  + APE 
Sbjct: 117 HS---HNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYV-ATRWYRAPEL 172

Query: 241 ---YFMHGIVDEKTDVFAFGVFLLEIISGRK-------------------PVDGSHQSL- 277
                 +G   +  DV+A G  + E++ G                     P+  SHQ L 
Sbjct: 173 LVGDTNYG---KPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELF 229

Query: 278 ------HSWAKPILNQGE-----IEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRP 326
                    A P  +Q E         V               L F  + C+R  P  R 
Sbjct: 230 SSNPRFAGVAFPEPSQPESLERRYPGKVSSPA-----------LDFLKA-CLRMDPKERL 277

Query: 327 TMSEVL 332
           T  E+L
Sbjct: 278 TCDELL 283

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 77.0 bits (189), Expect = 1e-15
 Identities = 73/276 (26%), Positives = 117/276 (42%), Gaps = 69/276 (25%)

Query: 93  IAVKRLTKVVTDDR-----KEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQFSS 146
           +AVK L    TD        E E +  IG      H N+++LLG C  +G LY++ +++S
Sbjct: 47  VAVKMLKDDATDKDLSDLVSEMEMMKMIGK-----HKNIINLLGACTQDGPLYVLVEYAS 101

Query: 147 RGSVASLFHDVNSPGVEW--------------KVRHKIAVGTARGLHYLHKGCQRRIIHR 192
           +G++         PG+++              K     A   ARG+ YL     ++ IHR
Sbjct: 102 KGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYL---ASQKCIHR 158

Query: 193 DIKSSNILLTADFEPQISDFGLAK--------------WLPSQWTHHSIAPIEGTFGHLA 238
           D+ + N+L+T D   +I+DFGLA+               LP +W              +A
Sbjct: 159 DLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKW--------------MA 204

Query: 239 PEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGEIEKLVDPR 297
           PE     +   ++DV++FGV L EI + G  P  G          P+    E+ KL+   
Sbjct: 205 PEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI---------PV---EELFKLLKEG 252

Query: 298 LQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLE 333
            +        + L      C  A P+ RPT  +++E
Sbjct: 253 HRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVE 288

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 76.2 bits (187), Expect = 1e-15
 Identities = 56/226 (24%), Positives = 107/226 (47%), Gaps = 50/226 (22%)

Query: 71  ENLVGRGGYAEVYKGVLQ-DGEEI-AVKRLTKVVTDDRKEKEFLTEIGTI---GHVCHPN 125
           E+++G G + +V + +++ DG ++ A  ++ K    +   ++F  E+  +   GH  HPN
Sbjct: 7   EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGH--HPN 64

Query: 126 VLSLLGCCVDNG-LYLIFQFSSRGSVASLFHD--VNSPGVEWKVRH------------KI 170
           +++LLG C + G LY+  +++  G++        V      +   H            + 
Sbjct: 65  IINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQF 124

Query: 171 AVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKW-----------LP 219
           A   A G+ YL    +++ IHRD+ + N+L+  +   +I+DFGL++            LP
Sbjct: 125 ASDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRLP 181

Query: 220 SQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS 265
            +W              +A E   + +   K+DV++FGV L EI+S
Sbjct: 182 VRW--------------MAIESLNYSVYTTKSDVWSFGVLLWEIVS 213

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 76.2 bits (187), Expect = 1e-15
 Identities = 75/304 (24%), Positives = 135/304 (44%), Gaps = 83/304 (27%)

Query: 71  ENLVGRGGYAEVYKG-VLQDG--EEIAVKRLTKVVTDDRKEKEFLTEIGTI---GHVCHP 124
           ++++G G + +V K  + +DG   + A+KR+ +  + D   ++F  E+  +   GH  HP
Sbjct: 12  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKD-DHRDFAGELEVLCKLGH--HP 68

Query: 125 NVLSLLGCCVDNG-LYLIFQFSSRGSVASLF---------------HDVNSPGVEWKVRH 168
           N+++LLG C   G LYL  +++  G++                   +   S     ++ H
Sbjct: 69  NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 128

Query: 169 KIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKW----------- 217
             A   ARG+ YL    Q++ IHRD+ + NIL+  ++  +I+DFGL++            
Sbjct: 129 -FAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGR 184

Query: 218 LPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGS--- 273
           LP +W              +A E   + +    +DV+++GV L EI+S G  P  G    
Sbjct: 185 LPVRW--------------MAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA 230

Query: 274 --HQSL---HSWAKPILNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTM 328
             ++ L   +   KP+    E+           YD+ +          C R  P  RP+ 
Sbjct: 231 ELYEKLPQGYRLEKPLNCDDEV-----------YDLMR---------QCWREKPYERPSF 270

Query: 329 SEVL 332
           +++L
Sbjct: 271 AQIL 274

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 75.5 bits (185), Expect = 2e-15
 Identities = 66/267 (24%), Positives = 118/267 (44%), Gaps = 21/267 (7%)

Query: 68  FSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVL 127
           F+    +G+G + EV+KG+    +++   ++  +   + + ++   EI  +     P V 
Sbjct: 6   FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65

Query: 128 SLLGCCVD-NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQ 186
              G  +    L++I ++   GS   L      P  E+++   +     +GL YLH    
Sbjct: 66  KYYGSYLKGTKLWIIMEYLGGGSALDLLR--AGPFDEFQIATMLK-EILKGLDYLH---S 119

Query: 187 RRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGI 246
            + IHRDIK++N+LL+   + +++DFG+A  L    T        GT   +APE      
Sbjct: 120 EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD--TQIKRNTFVGTPFWMAPEVIQQSA 177

Query: 247 VDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQ 306
            D K D+++ G+  +E+  G  P    H        P+     I K   P L G +    
Sbjct: 178 YDSKADIWSLGITAIELAKGEPPNSDMH--------PMRVLFLIPKNNPPTLTGEF---S 226

Query: 307 LNRLAFAASLCIRASPTWRPTMSEVLE 333
                F  + C+   P++RPT  E+L+
Sbjct: 227 KPFKEFIDA-CLNKDPSFRPTAKELLK 252

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 75.7 bits (187), Expect = 2e-15
 Identities = 59/227 (25%), Positives = 97/227 (42%), Gaps = 58/227 (25%)

Query: 71  ENLVGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRK------------EKEFLTEIGT 117
              +G G YA VYK    + G  +A+K   K+   +RK            E + L E+  
Sbjct: 5   GKKLGEGTYAVVYKARDKETGRIVAIK---KIKLGERKEAKDGINFTALREIKLLQELK- 60

Query: 118 IGHVCHPNVLSLLGC-CVDNGLYLIFQFSSRGSVASLFHDVN---SPGVEWKVRHK--IA 171
                HPN++ LL      + + L+F+F     +  +  D +   +P             
Sbjct: 61  -----HPNIIGLLDVFGHKSNINLVFEFME-TDLEKVIKDKSIVLTPA------DIKSYM 108

Query: 172 VGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPS---QWTHHSIA 228
           + T RGL YLH      I+HRD+K +N+L+ +D   +++DFGLA+   S   + TH  + 
Sbjct: 109 LMTLRGLEYLHS---NWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV- 164

Query: 229 PIEGTFGHLAPEYFM------HGIVDEKTDVFAFGVFLLEIISGRKP 269
               T  + APE          G+     D+++ G    E++  R P
Sbjct: 165 ----TRWYRAPELLFGARHYGVGV-----DMWSVGCIFAELLL-RVP 201

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 74.7 bits (183), Expect = 3e-15
 Identities = 67/273 (24%), Positives = 123/273 (45%), Gaps = 31/273 (11%)

Query: 71  ENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLL 130
           E  +G G + EV+        ++AVK +          + FL E   +  + H  ++ L 
Sbjct: 11  EKKLGAGQFGEVWMATYNKHTKVAVKTMKP---GSMSVEAFLAEANVMKTLQHDKLVKLH 67

Query: 131 GCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRII 190
                  +Y+I +F ++GS+                    +   A G+ ++    QR  I
Sbjct: 68  AVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYI 124

Query: 191 HRDIKSSNILLTADFEPQISDFGLAKWLP-SQWTHHSIA--PIEGTFGHLAPEYFMHGIV 247
           HRD++++NIL++A    +I+DFGLA+ +  +++T    A  PI+ T    APE    G  
Sbjct: 125 HRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWT----APEAINFGSF 180

Query: 248 DEKTDVFAFGVFLLEIIS-GRKPVDG--SHQSLHSWAKPILNQGEIEKLVDPRLQGAYDV 304
             K+DV++FG+ L+EI++ GR P  G  + + + +     L +G      +   +  Y++
Sbjct: 181 TIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRA-----LERGYRMPRPENCPEELYNI 235

Query: 305 TQLNRLAFAASLCIRASPTWRPTMSEVLEVMLE 337
                       C +  P  RPT  E ++ +L+
Sbjct: 236 M---------MRCWKNRPEERPTF-EYIQSVLD 258

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 74.9 bits (184), Expect = 3e-15
 Identities = 75/293 (25%), Positives = 122/293 (41%), Gaps = 59/293 (20%)

Query: 73  LVGRGGYAEVYKGVLQDGE----EIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLS 128
           ++G G +  V +G L   +    ++AVK +   +    + +EFL+E   +    HPNV+ 
Sbjct: 6   ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65

Query: 129 LLGCCVDNGLYLIFQFSSRGSVAS----------------LFH---DVNSPGVEWKVRHK 169
           L+G C        F+ SS   +                  L +         +  +   K
Sbjct: 66  LIGVC--------FEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLK 117

Query: 170 IAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPS----QWTHH 225
             V  A G+ YL     R  IHRD+ + N +L  D    ++DFGL+K + S    +    
Sbjct: 118 FMVDIALGMEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRI 174

Query: 226 SIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDG--SHQSLHSWAK 282
           +  P++     +A E     +   K+DV+AFGV + EI + G+ P  G  +H+       
Sbjct: 175 AKMPVK----WIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYD---- 226

Query: 283 PILNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVM 335
             L  G        RL+   D   L+ L      C RA P  RPT +++ EV+
Sbjct: 227 -YLRHGN-------RLKQPEDC--LDELYDLMYSCWRADPKDRPTFTKLREVL 269

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 74.7 bits (184), Expect = 4e-15
 Identities = 62/295 (21%), Positives = 124/295 (42%), Gaps = 62/295 (21%)

Query: 74  VGRGGYAEVYKGVLQD------GEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVL 127
           +G+G +  VY+G+ +          +A+K + +  +  R+  EFL E   +      +V+
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASM-RERIEFLNEASVMKEFNCHHVV 72

Query: 128 SLLGCCVD-NGLYLIFQFSSRGSVASLFH-----DVNSPGVEWKVRHKI---AVGTARGL 178
            LLG         ++ +  ++G + S          N+PG+      K    A   A G+
Sbjct: 73  RLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGM 132

Query: 179 HYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAK--------------WLPSQWTH 224
            YL     ++ +HRD+ + N ++  D   +I DFG+ +               LP +W  
Sbjct: 133 AYLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW-- 187

Query: 225 HSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDG-SHQSLHSWAK 282
                       +APE    G+   K+DV++FGV L E+ +   +P  G S++ +  +  
Sbjct: 188 ------------MAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKF-- 233

Query: 283 PILNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLE 337
            +++ G ++   +            ++L     +C + +P  RPT  E++  + +
Sbjct: 234 -VIDGGHLDLPENCP----------DKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 74.6 bits (183), Expect = 4e-15
 Identities = 57/220 (25%), Positives = 109/220 (49%), Gaps = 24/220 (10%)

Query: 63  IATNAFSSENLVGRGGYAEVYKGVLQ-DGEE---IAVKRLTKVVTDDRKEKEFLTEIGTI 118
           I  +  + + ++G G + EV++G+L+  G +   +A+K L    T+ ++ ++FL+E   +
Sbjct: 2   IHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTE-KQRQDFLSEASIM 60

Query: 119 GHVCHPNVLSLLGCCVD-NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAV--GTA 175
           G   H N++ L G         +I ++   G++     D +    E+     + +  G A
Sbjct: 61  GQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDG---EFSSYQLVGMLRGIA 117

Query: 176 RGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLP-----SQWTHHSIAPI 230
            G+ YL        +HRD+ + NIL+ ++ E ++SDFGL++ L      +  T     PI
Sbjct: 118 AGMKYL---SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPI 174

Query: 231 EGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKP 269
             T    APE   +      +DV++FG+ + E++S G +P
Sbjct: 175 RWT----APEAIAYRKFTSASDVWSFGIVMWEVMSFGERP 210

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 74.3 bits (182), Expect = 4e-15
 Identities = 54/203 (26%), Positives = 104/203 (51%), Gaps = 14/203 (6%)

Query: 74  VGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCC 133
           +G+G + EV+ G      ++A+K L          + FL E   +  + H  ++ L    
Sbjct: 14  LGQGCFGEVWMGTWNGTTKVAIKTLKP---GTMMPEAFLQEAQIMKKLRHDKLVPLYAVV 70

Query: 134 VDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRD 193
            +  +Y++ +F  +GS+     + +   ++      +A   A G+ Y+ +      IHRD
Sbjct: 71  SEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIER---MNYIHRD 127

Query: 194 IKSSNILLTADFEPQISDFGLAKWLP-SQWTHHSIA--PIEGTFGHLAPEYFMHGIVDEK 250
           ++++NIL+  +   +I+DFGLA+ +  +++T    A  PI+ T    APE  ++G    K
Sbjct: 128 LRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWT----APEAALYGRFTIK 183

Query: 251 TDVFAFGVFLLEIIS-GRKPVDG 272
           +DV++FG+ L E+++ GR P  G
Sbjct: 184 SDVWSFGILLTELVTKGRVPYPG 206

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 74.1 bits (182), Expect = 5e-15
 Identities = 62/221 (28%), Positives = 113/221 (51%), Gaps = 27/221 (12%)

Query: 71  ENLVGRGGYAEVYKGVL-QDGEE---IAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNV 126
           E ++G G + EV +G L   G+    +A+K L K    +++ ++FL+E   +G   HPN+
Sbjct: 9   EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTL-KSGYTEKQRRDFLSEASIMGQFDHPNI 67

Query: 127 LSLLGCCVDNGLYLIF-QFSSRGSVASLFHDVNSPGVEWKVRHKIAV--GTARGLHYLHK 183
           + L G    +   +I  +F   G++ S     +    ++ V   + +  G A G+ YL  
Sbjct: 68  IHLEGVVTKSRPVMIITEFMENGALDSFLRQNDG---QFTVIQLVGMLRGIAAGMKYL-- 122

Query: 184 GCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWL---PSQWTHHSI----APIEGTFGH 236
             +   +HRD+ + NIL+ ++   ++SDFGL+++L    S  T+ S      PI  T   
Sbjct: 123 -SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWT--- 178

Query: 237 LAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPV-DGSHQ 275
            APE   +      +DV+++G+ + E++S G +P  D S+Q
Sbjct: 179 -APEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ 218

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 74.1 bits (182), Expect = 5e-15
 Identities = 55/205 (26%), Positives = 97/205 (47%), Gaps = 15/205 (7%)

Query: 73  LVGRGGYAEVYKGVLQD-GEEIAVKRLT--KVVTDDRKEKEFL-TEIGTIGHVCHPNVLS 128
           L+G+G +  VY     D G E+AVK++       + +KE   L  EI  + ++ H  ++ 
Sbjct: 9   LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68

Query: 129 LLGCCVDNG-LYLIFQFSSRGSVASLF--HDVNSPGVEWKVRHKIAVGTARGLHYLHKGC 185
             GC  D+  L +  ++   GSV      +   +  V  K   +I      G+ YLH   
Sbjct: 69  YYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQIL----EGVEYLHS-- 122

Query: 186 QRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHS-IAPIEGTFGHLAPEYFMH 244
              I+HRDIK +NIL  +    ++ DFG +K L +  +  + +  + GT   ++PE    
Sbjct: 123 -NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISG 181

Query: 245 GIVDEKTDVFAFGVFLLEIISGRKP 269
                K DV++ G  ++E+++ + P
Sbjct: 182 EGYGRKADVWSVGCTVVEMLTEKPP 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 73.6 bits (181), Expect = 6e-15
 Identities = 58/265 (21%), Positives = 119/265 (44%), Gaps = 25/265 (9%)

Query: 74  VGRGGYAE--VYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLG 131
           +G+G + E  +Y+   +D   +  K +      +++ ++ L EI  +  + HPN+++   
Sbjct: 8   LGKGAFGEATLYRRT-EDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYN 66

Query: 132 CCVDNGLYLI-FQFSSRGSVASLFHDVNSPGVEWKVRHKIAV--GTARGLHYLHKGCQRR 188
             +D+   LI  ++++ G++      V   G  ++    +         + Y+HK     
Sbjct: 67  HFMDDNTLLIEMEYANGGTLYDKI--VRQKGQLFEEEMVLWYLFQIVSAVSYIHKA---G 121

Query: 189 IIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVD 248
           I+HRDIK+ NI LT     ++ DFG++K L S+++      + GT  +++PE       +
Sbjct: 122 ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAE--TVVGTPYYMSPELCQGVKYN 179

Query: 249 EKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQLN 308
            K+D++A G  L E+++ ++  D ++          + QG    +V         +    
Sbjct: 180 FKSDIWALGCVLYELLTLKRTFDATNPLNLVVK---IVQGNYTPVVSVYSSELISLV--- 233

Query: 309 RLAFAASLCIRASPTWRPTMSEVLE 333
                    ++  P  RPT  EVL+
Sbjct: 234 ------HSLLQQDPEKRPTADEVLD 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 74.0 bits (182), Expect = 7e-15
 Identities = 63/236 (26%), Positives = 110/236 (46%), Gaps = 36/236 (15%)

Query: 60  EISIATNAFSSENLVGRGGYAEVYKG-VLQDGEE-----IAVKRLTKVVTDDRKEKEFLT 113
           EI ++   F  E  +G G + +VYKG +    E      +A+K L +      ++ EF  
Sbjct: 1   EIPLSAVRFLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQ-EFRQ 57

Query: 114 EIGTIGHVCHPNVLSLLGCCV-DNGLYLIFQFSSRGSV------ASLFHDVNSPGVEWKV 166
           E   +  + HPN++ LLG C  +    ++F++ + G +       S   DV +   +  V
Sbjct: 58  EAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETV 117

Query: 167 RH--------KIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWL 218
           +          IA+  A G+ YL        +HRD+ + N L+      +ISDFGL++ +
Sbjct: 118 KSSLDCSDFLHIAIQIAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDI 174

Query: 219 PS----QWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKP 269
            S    +    S+ P+      + PE  ++G    ++D+++FGV L EI S G +P
Sbjct: 175 YSADYYRVQSKSLLPVR----WMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQP 226

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 73.7 bits (181), Expect = 8e-15
 Identities = 70/237 (29%), Positives = 112/237 (47%), Gaps = 22/237 (9%)

Query: 100 KVVTDDRKE---KEFLTEIGTIGHVCH-PNVLSLLGCCV-DNGLYLIFQFSSRGSVASLF 154
           KVV    K    K+ L E+  I H C  P ++S  G  + +N + +  +F   GS+  ++
Sbjct: 36  KVVHIGAKSSVRKQILRELQ-IMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIY 94

Query: 155 HDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGL 214
                  VE  +  KIAV    GL YL+     RI+HRDIK SNIL+ +  + ++ DFG+
Sbjct: 95  KKGGPIPVE--ILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGV 150

Query: 215 AKWLPSQWTHHSIA-PIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGS 273
           +  L +     SIA    GT  +++PE    G    K+DV++ G+ ++E+  G+ P   S
Sbjct: 151 SGELIN-----SIADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFS 205

Query: 274 HQSLHSWAKPILNQGEIEKLVD---PRLQGAYDVTQLNRLAFAASLCIRASPTWRPT 327
           +        P+     ++++V    PRL  +     L         C+   PT RPT
Sbjct: 206 NIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPEDLRDF---VDACLLKDPTERPT 259

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 73.1 bits (179), Expect = 2e-14
 Identities = 55/203 (27%), Positives = 105/203 (51%), Gaps = 15/203 (7%)

Query: 74  VGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCC 133
           +G G + +VYK   ++   +A  ++ +  +++  E +++ EI  +    HP ++ LLG  
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELE-DYMVEIEILATCNHPYIVKLLGAF 78

Query: 134 V-DNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHR 192
             D  L+++ +F   G+V ++  +++    E +++  I       L YLH     +IIHR
Sbjct: 79  YWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQ-VICRQMLEALQYLH---SMKIIHR 134

Query: 193 DIKSSNILLTADFEPQISDFGL-AKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIV---- 247
           D+K+ N+LLT D + +++DFG+ AK + +     S     GT   +APE  M   +    
Sbjct: 135 DLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI---GTPYWMAPEVVMCETMKDTP 191

Query: 248 -DEKTDVFAFGVFLLEIISGRKP 269
            D K D+++ G+ L+E+     P
Sbjct: 192 YDYKADIWSLGITLIEMAQIEPP 214

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 72.4 bits (177), Expect = 2e-14
 Identities = 59/225 (26%), Positives = 102/225 (45%), Gaps = 50/225 (22%)

Query: 72  NLVGRGGYAEVYKGVLQ-DGEEI-AVKRLTKVVTDDRKEKEFLTEIGTI---GHVCHPNV 126
           +++G G + +V K  ++ DG  + A  +  K        ++F  E+  +   GH  HPN+
Sbjct: 1   DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH--HPNI 58

Query: 127 LSLLGCCVDNG-LYLIFQFSSRGSVASL------------FHDVNSPGVEWKVRH--KIA 171
           ++LLG C   G LYL  +++  G++               F   NS       +     A
Sbjct: 59  INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 118

Query: 172 VGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKW-----------LPS 220
              ARG+ YL    Q++ IHRD+ + NIL+  ++  +I+DFGL++            LP 
Sbjct: 119 ADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPV 175

Query: 221 QWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS 265
           +W              +A E   + +    +DV+++GV L EI+S
Sbjct: 176 RW--------------MAIESLNYSVYTTNSDVWSYGVLLWEIVS 206

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 72.4 bits (177), Expect = 2e-14
 Identities = 52/203 (25%), Positives = 100/203 (49%), Gaps = 14/203 (6%)

Query: 74  VGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCC 133
           +G+G + EV+ G       +A+K L          + FL E   +  + H  ++ L    
Sbjct: 14  LGQGCFGEVWMGTWNGTTRVAIKTLKP---GTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 70

Query: 134 VDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRD 193
            +  +Y++ ++ S+GS+           +       +A   A G+ Y+ +      +HRD
Sbjct: 71  SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRD 127

Query: 194 IKSSNILLTADFEPQISDFGLAKWLP-SQWTHHSIA--PIEGTFGHLAPEYFMHGIVDEK 250
           ++++NIL+  +   +++DFGLA+ +  +++T    A  PI+ T    APE  ++G    K
Sbjct: 128 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT----APEAALYGRFTIK 183

Query: 251 TDVFAFGVFLLEIIS-GRKPVDG 272
           +DV++FG+ L E+ + GR P  G
Sbjct: 184 SDVWSFGILLTELTTKGRVPYPG 206

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 72.1 bits (177), Expect = 2e-14
 Identities = 51/207 (24%), Positives = 97/207 (46%), Gaps = 22/207 (10%)

Query: 74  VGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCC 133
           +G G +  V+ G  +   ++A+K + +       E +F+ E   +  + HPN++ L G C
Sbjct: 12  LGSGQFGVVHLGKWRGKIDVAIKMIREGAMS---EDDFIEEAKVMMKLSHPNLVQLYGVC 68

Query: 134 VDNG-LYLIFQFSSRGSVASLFHDVNSPGV---EWKVRHKIAVGTARGLHYLHKGCQRRI 189
                ++++ ++ + G + +   +    G    EW +   +       + YL        
Sbjct: 69  TKQRPIFIVTEYMANGCLLNYLRE--RKGKLGTEWLL--DMCSDVCEAMEYLESNG---F 121

Query: 190 IHRDIKSSNILLTADFEPQISDFGLAKW-LPSQWTHHSIA--PIEGTFGHLAPEYFMHGI 246
           IHRD+ + N L+  D   ++SDFGLA++ L  Q+T       P++       PE F +  
Sbjct: 122 IHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWA----PPEVFDYSR 177

Query: 247 VDEKTDVFAFGVFLLEIIS-GRKPVDG 272
              K+DV++FGV + E+ S G+ P + 
Sbjct: 178 FSSKSDVWSFGVLMWEVFSEGKMPYER 204

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 72.0 bits (176), Expect = 4e-14
 Identities = 63/221 (28%), Positives = 104/221 (47%), Gaps = 22/221 (9%)

Query: 68  FSSENLVGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCH-PN 125
           F    +VG G Y +VYKG  ++ G+  A+K +   VT+D +E+E   EI  +    H  N
Sbjct: 18  FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMD--VTED-EEEEIKLEINMLKKYSHHRN 74

Query: 126 VLSLLGCCV-------DNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGL 178
           + +  G  +       D+ L+L+ +F   GSV  L  +     ++      I     RGL
Sbjct: 75  IATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGL 134

Query: 179 HYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLA 238
            +LH     ++IHRDIK  N+LLT + E ++ DFG++  L       +     GT   +A
Sbjct: 135 AHLHA---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT--FIGTPYWMA 189

Query: 239 PEYFM-----HGIVDEKTDVFAFGVFLLEIISGRKPVDGSH 274
           PE            D ++D+++ G+  +E+  G  P+   H
Sbjct: 190 PEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMH 230

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 71.7 bits (176), Expect = 4e-14
 Identities = 54/200 (27%), Positives = 91/200 (45%), Gaps = 39/200 (19%)

Query: 92  EIAVKRLTKVVTDDRKEKEFL-TEIGTIGHV-CHPNVLSLLGCCVDNG-LYLIFQFSSRG 148
           ++AVK L    T    E+E L +E+  + H+  H N+++LLG C   G + +I ++   G
Sbjct: 67  KVAVKMLKP--TAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYG 124

Query: 149 SVASLFHDVNSPGVEWKVRHKIAVGTARGLHYL-HKGCQRRIIHRDIKSSNILLTADFEP 207
            + +         +  +     +   A+G+ +L  K C    IHRD+ + N+LLT     
Sbjct: 125 DLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNC----IHRDLAARNVLLTHGKIV 180

Query: 208 QISDFGLAK--------------WLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDV 253
           +I DFGLA+               LP +W              +APE   + +   ++DV
Sbjct: 181 KICDFGLARDIMNDSNYVVKGNARLPVKW--------------MAPESIFNCVYTFESDV 226

Query: 254 FAFGVFLLEIIS-GRKPVDG 272
           +++G+ L EI S G  P  G
Sbjct: 227 WSYGILLWEIFSLGSNPYPG 246

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 71.2 bits (174), Expect = 6e-14
 Identities = 65/218 (29%), Positives = 100/218 (45%), Gaps = 27/218 (12%)

Query: 74  VGRGGYAEVYKGV-LQDGEEIAVKRLTKVV-TDDRKEKEF--LTEIGTIGHVCHPNVLSL 129
           +G+G Y +VYK    +DG   AVK L  +   D+  E E+  L  +       HPNV+  
Sbjct: 30  IGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPN-----HPNVVKF 84

Query: 130 LGC------CVDNGLYLIFQFSSRGSVASLFHDVNSPG--VEWKVRHKIAVGTARGLHYL 181
            G        V   L+L+ +  + GSV  L   +   G  ++  +   I  G   GL +L
Sbjct: 85  YGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHL 144

Query: 182 HKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEY 241
           H     RIIHRD+K +NILLT +   ++ DFG++  L S     + +   GT   +APE 
Sbjct: 145 H---NNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV--GTPFWMAPEV 199

Query: 242 FM-----HGIVDEKTDVFAFGVFLLEIISGRKPVDGSH 274
                      D + DV++ G+  +E+  G  P+   H
Sbjct: 200 IACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMH 237

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 70.9 bits (174), Expect = 6e-14
 Identities = 72/274 (26%), Positives = 123/274 (44%), Gaps = 31/274 (11%)

Query: 71  ENLVGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIG-TIGHVCHPNVLS 128
           E L GRG Y  V K   +  G  +AVKR+   V + +++K  L ++  ++  V  P  ++
Sbjct: 7   EEL-GRGAYGVVDKMRHVPTGTIMAVKRIRATV-NSQEQKRLLMDLDISMRSVDCPYTVT 64

Query: 129 LLGCCVDNGLYLIFQFSSRGSVASLFHDVNSPG--VEWKVRHKIAVGTARGLHYLHKGCQ 186
             G     G   I       S+   +  V   G  +   +  KIAV   + L YLH   +
Sbjct: 65  FYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS--K 122

Query: 187 RRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIE--GTFGHLAPEYF-- 242
             +IHRD+K SN+L+  + + ++ DFG++ +L       S+A     G   ++APE    
Sbjct: 123 LSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD-----SVAKTIDAGCKPYMAPERINP 177

Query: 243 ---MHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQ 299
                G  D K+DV++ G+ ++E+ +GR P D       SW  P     ++ +   P+L 
Sbjct: 178 ELNQKGY-DVKSDVWSLGITMIELATGRFPYD-------SWKTPFQQLKQVVEEPSPQLP 229

Query: 300 GAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLE 333
              +        F    C++ +   RP   E+L+
Sbjct: 230 A--EKFSPEFQDFVNK-CLKKNYKERPNYPELLQ 260

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 70.9 bits (174), Expect = 8e-14
 Identities = 61/221 (27%), Positives = 106/221 (47%), Gaps = 25/221 (11%)

Query: 68  FSSENL-----VGRGGYAEVYKGVLQD-GEEIAVKRLTKVVTDDRKEKEFLTEIGTI--G 119
           F++E+L     +GRG +  V K + +  G  +AVKR+ +   D++++K  L ++  +   
Sbjct: 1   FTAEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRI-RSTVDEKEQKRLLMDLDVVMRS 59

Query: 120 HVCHPNVLSLLGCCVDNGLYLI---FQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTAR 176
             C P ++   G     G   I       S        ++V    +  ++  KIAV T +
Sbjct: 60  SDC-PYIVKFYGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVK 118

Query: 177 GLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIE--GTF 234
            L+YL +  + +IIHRD+K SNILL  +   ++ DFG++  L       SIA     G  
Sbjct: 119 ALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD-----SIAKTRDAGCR 171

Query: 235 GHLAPEY---FMHGIVDEKTDVFAFGVFLLEIISGRKPVDG 272
            ++APE          D ++DV++ G+ L E+ +G+ P   
Sbjct: 172 PYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPK 212

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 70.4 bits (172), Expect = 1e-13
 Identities = 55/208 (26%), Positives = 96/208 (46%), Gaps = 19/208 (9%)

Query: 74  VGRGGYAEVYKG--VLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVC---HPNVLS 128
           +G G Y +V+K   +   G  +A+KR+     ++      + E+  + H+    HPNV+ 
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68

Query: 129 LLGCCV------DNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLH 182
           L   C       +  L L+F+   +  + +    V  PGV  +    +     RGL +LH
Sbjct: 69  LFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 127

Query: 183 KGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYF 242
                R++HRD+K  NIL+T+  + +++DFGLA+    Q    S+     T  + APE  
Sbjct: 128 ---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV---TLWYRAPEVL 181

Query: 243 MHGIVDEKTDVFAFGVFLLEIISGRKPV 270
           +        D+++ G    E+   RKP+
Sbjct: 182 LQSSYATPVDLWSVGCIFAEMFR-RKPL 208

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 69.7 bits (170), Expect = 2e-13
 Identities = 55/208 (26%), Positives = 101/208 (48%), Gaps = 15/208 (7%)

Query: 74  VGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCC 133
           +G G + EV+ G   +  ++AVK L          + FL E   +  + H  ++ L    
Sbjct: 14  LGAGQFGEVWMGYYNNSTKVAVKTLKP---GTMSVQAFLEEANLMKTLQHDKLVRLYAVV 70

Query: 134 V-DNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHR 192
             +  +Y+I ++ ++GS+           V        +   A G+ Y+ +   +  IHR
Sbjct: 71  TKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIER---KNYIHR 127

Query: 193 DIKSSNILLTADFEPQISDFGLAKWLP-SQWTHHSIA--PIEGTFGHLAPEYFMHGIVDE 249
           D++++N+L++     +I+DFGLA+ +  +++T    A  PI+ T    APE    G    
Sbjct: 128 DLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWT----APEAINFGSFTI 183

Query: 250 KTDVFAFGVFLLEIIS-GRKPVDGSHQS 276
           K+DV++FG+ L EI++ G+ P  G   S
Sbjct: 184 KSDVWSFGILLYEIVTYGKIPYPGMSNS 211

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 69.8 bits (171), Expect = 2e-13
 Identities = 55/209 (26%), Positives = 95/209 (45%), Gaps = 29/209 (13%)

Query: 73  LVGRGGYAEVYK---GVLQD--GEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVL 127
            +G+G +  V       LQD  GE +AVK+L     +    ++F  EI  +  + H N++
Sbjct: 11  QLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAE--HLRDFEREIEILKSLQHDNIV 68

Query: 128 SLLGCCVDNG---LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKG 184
              G C   G   L L+ ++   GS+            ++  +H+  +   + L Y  + 
Sbjct: 69  KYKGVCYSAGRRNLRLVMEYLPYGSL-----------RDYLQKHRERLDHRKLLLYASQI 117

Query: 185 CQ-------RRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSI-APIEGTFGH 236
           C+       +R +HRD+ + NIL+ ++   +I DFGL K LP    ++ +  P E     
Sbjct: 118 CKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFW 177

Query: 237 LAPEYFMHGIVDEKTDVFAFGVFLLEIIS 265
            APE          +DV++FGV L E+ +
Sbjct: 178 YAPESLTESKFSVASDVWSFGVVLYELFT 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 69.6 bits (170), Expect = 2e-13
 Identities = 50/180 (27%), Positives = 93/180 (51%), Gaps = 9/180 (5%)

Query: 90  GEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVD---NGLYLIFQFSS 146
           GE++AVK L K  +      +   EI  + ++ H N++   G C +   NG+ LI +F  
Sbjct: 33  GEQVAVKSL-KPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLP 91

Query: 147 RGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFE 206
            GS+   +   N   +  K + K AV   +G+ YL     R+ +HRD+ + N+L+ ++ +
Sbjct: 92  SGSLKE-YLPRNKNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQ 147

Query: 207 PQISDFGLAKWLPSQWTHHSIA-PIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS 265
            +I DFGL K + +   ++++   ++      APE  +       +DV++FGV L E+++
Sbjct: 148 VKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 69.6 bits (170), Expect = 2e-13
 Identities = 75/299 (25%), Positives = 131/299 (43%), Gaps = 70/299 (23%)

Query: 74  VGRGGYAEVYKGVLQD---GE---EIAVKRLTKVVTDDRKEKEFLTEIGTI-GHVCHPNV 126
           +G+G +  VY+G  +D   GE    +AVK + +  +  R+  EFL E   + G  CH +V
Sbjct: 14  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASL-RERIEFLNEASVMKGFTCH-HV 71

Query: 127 LSLLGCCVDNG--LYLIFQFSSRGSVASLFHDV-----NSPGV---EWKVRHKIAVGTAR 176
           + LLG  V  G    ++ +  + G + S    +     N+PG      +   ++A   A 
Sbjct: 72  VRLLGV-VSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIAD 130

Query: 177 GLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAK--------------WLPSQW 222
           G+ YL+    ++ +HRD+ + N ++  DF  +I DFG+ +               LP +W
Sbjct: 131 GMAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 187

Query: 223 THHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWA 281
                         +APE    G+    +D+++FGV L EI S   +P  G         
Sbjct: 188 --------------MAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQG--------- 224

Query: 282 KPILNQGEIEKLVDPRLQGAYDVTQLN---RLAFAASLCIRASPTWRPTMSEVLEVMLE 337
              L+  ++ K V   + G Y     N   R+     +C + +P  RPT  E++ ++ +
Sbjct: 225 ---LSNEQVLKFV---MDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKD 277

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 69.5 bits (170), Expect = 2e-13
 Identities = 66/273 (24%), Positives = 119/273 (43%), Gaps = 30/273 (10%)

Query: 73  LVGRGGYAEVYKGVLQDGEE--IAVKRLTKVVTDDRKEK--------EFLTEIGTIG-HV 121
            +G G +  VYK   ++  +  +A+K +        K+K        + ++E+  I   +
Sbjct: 7   HLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66

Query: 122 CHPNVLSLLGCCVDNG-LYLIFQFSSRGSVASLFHDVNSPGVEWKVRH--KIAVGTARGL 178
            HPN++      ++N  LY++        +   F+ +      +       I V     L
Sbjct: 67  RHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLAL 126

Query: 179 HYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLA 238
            YLHK  ++RI+HRD+  +NI+L  D +  I+DFGLAK    +    S+    GT  +  
Sbjct: 127 RYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVV---GTILYSC 181

Query: 239 PEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRL 298
           PE   +    EK DV+AFG  L ++ + + P   +  ++ S A  I     +E + +P  
Sbjct: 182 PEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYST--NMLSLATKI-----VEAVYEPLP 234

Query: 299 QGAYDVTQLNRLAFAASLCIRASPTWRPTMSEV 331
           +G Y       +    + C+      RP + +V
Sbjct: 235 EGMYS----EDVTDVITSCLTPDAEARPDIIQV 263

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 69.6 bits (170), Expect = 2e-13
 Identities = 59/239 (24%), Positives = 97/239 (40%), Gaps = 69/239 (28%)

Query: 73  LVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC 132
           L GR GY  V           AVK L K      + ++ L+E   +  V HP+V+ L G 
Sbjct: 24  LKGRAGYTTV-----------AVKML-KENASSSELRDLLSEFNLLKQVNHPHVIKLYGA 71

Query: 133 CVDNG-LYLIFQFSSRGSV-----------------------ASLFHDVNSPGVEWKVRH 168
           C  +G L LI +++  GS+                       + L +      +      
Sbjct: 72  CSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERA-LTMGDLI 130

Query: 169 KIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAK------------ 216
             A   +RG+ YL    + +++HRD+ + N+L+    + +ISDFGL++            
Sbjct: 131 SFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRS 187

Query: 217 --WLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDG 272
              +P +W              +A E     I   ++DV++FGV L EI++ G  P  G
Sbjct: 188 KGRIPVKW--------------MAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG 232

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 68.9 bits (168), Expect = 3e-13
 Identities = 59/207 (28%), Positives = 98/207 (47%), Gaps = 36/207 (17%)

Query: 74  VGRGGYAEV----YKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVL-- 127
           VG+G Y EV    ++    DG++  +K+L       R+ K    E   +  + HPN++  
Sbjct: 8   VGKGSYGEVSLVRHR---TDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAY 64

Query: 128 --SLLGCCVDNGLYLIFQFSSRGSVASLFHDVN---------SPGVEWKVRHKIAVGTAR 176
             S  G   D  LY++  F   G    L+H +          +  VEW V+       A 
Sbjct: 65  RESWEG--EDGLLYIVMGFCEGGD---LYHKLKEQKGKLLPENQVVEWFVQ------IAM 113

Query: 177 GLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGH 236
            L YLH   ++ I+HRD+K+ N+ LT     ++ D G+A+ L +Q    S   + GT  +
Sbjct: 114 ALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAST--LIGTPYY 168

Query: 237 LAPEYFMHGIVDEKTDVFAFGVFLLEI 263
           ++PE F +   + K+DV+A G  + E+
Sbjct: 169 MSPELFSNKPYNYKSDVWALGCCVYEM 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 68.8 bits (169), Expect = 3e-13
 Identities = 58/216 (26%), Positives = 92/216 (42%), Gaps = 36/216 (16%)

Query: 74  VGRGGYAEVY---KGVLQDGEEIAVKRLTK-------VVTDDRKEKEFLTEIGTIGHVCH 123
           + +G Y  V+   K     G+  A+K + K        V     E++ L+          
Sbjct: 1   ISKGAYGRVFLAKKK--STGDIYAIKVIKKADMIRKNQVDQVLTERDILS------QAQS 52

Query: 124 PNVLSLLGC-CVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLH 182
           P V+ L         LYL+ ++   G +ASL  +V S   +   R  IA      L YLH
Sbjct: 53  PYVVKLYYSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDV-ARIYIA-EIVLALEYLH 110

Query: 183 KGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKW-LPSQWTHHSIAP-----IEGTFGH 236
                 IIHRD+K  NIL+ ++   +++DFGL+K  L  +  + +        I GT  +
Sbjct: 111 ---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDY 167

Query: 237 LAPEYFM---HGIVDEKTDVFAFGVFLLEIISGRKP 269
           +APE  +   H    +  D ++ G  L E + G  P
Sbjct: 168 IAPEVILGQGHS---KTVDWWSLGCILYEFLVGIPP 200

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 69.3 bits (169), Expect = 3e-13
 Identities = 71/274 (25%), Positives = 117/274 (42%), Gaps = 46/274 (16%)

Query: 74  VGRGGYAEVYKGVLQDGEEI-AVKRLTKVVTD-DRKEKEFLTEIGTIGHVCHPNVLSLLG 131
           +G G +  VY        E+ AVK+++      + K ++ + E+  +  + HPN +   G
Sbjct: 29  IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88

Query: 132 CCV-DNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRII 190
           C + ++  +L+ ++   GS + L      P  E ++   I  G  +GL YLH      +I
Sbjct: 89  CYLKEHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIA-AITHGALQGLAYLHSHN---MI 143

Query: 191 HRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIE---GTFGHLAPEYFM---H 244
           HRDIK+ NILLT   + +++DFG A            +P     GT   +APE  +    
Sbjct: 144 HRDIKAGNILLTEPGQVKLADFGSAS---------KSSPANSFVGTPYWMAPEVILAMDE 194

Query: 245 GIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLV------DPRL 298
           G  D K DV++ G+  +E ++ RKP             P+ N   +  L        P L
Sbjct: 195 GQYDGKVDVWSLGITCIE-LAERKP-------------PLFNMNAMSALYHIAQNDSPTL 240

Query: 299 QGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVL 332
           Q                 C++  P  RP  +E+L
Sbjct: 241 QSNEWTDSFRGF---VDYCLQKIPQERPASAELL 271

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 68.7 bits (168), Expect = 4e-13
 Identities = 68/271 (25%), Positives = 123/271 (45%), Gaps = 37/271 (13%)

Query: 74  VGRGGYAEVYKGVL----QDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSL 129
           +G G +    K +L    +DG++  +K +       ++ +E   E+  + ++ HPN++  
Sbjct: 8   IGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQY 64

Query: 130 LGCCVDNG-LYLIFQFSSRGSVASLFHDVNSP-GVEWKVRHKIA--VGTARGLHYLHKGC 185
                +NG LY++  +   G    L+  +N+  GV +     +   V     L ++H   
Sbjct: 65  QESFEENGNLYIVMDYCEGGD---LYKKINAQRGVLFPEDQILDWFVQICLALKHVH--- 118

Query: 186 QRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHG 245
            R+I+HRDIKS NI LT D   ++ DFG+A+ L S  T        GT  +L+PE   + 
Sbjct: 119 DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNS--TVELARTCIGTPYYLSPEICENR 176

Query: 246 IVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVT 305
             + K+D++A G  L E+ +                K     G ++ LV   ++G+Y   
Sbjct: 177 PYNNKSDIWALGCVLYEMCT---------------LKHAFEAGNMKNLVLKIIRGSYPPV 221

Query: 306 QLN---RLAFAASLCIRASPTWRPTMSEVLE 333
             +    L    S   + +P  RP+++ +LE
Sbjct: 222 SSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 68.8 bits (168), Expect = 5e-13
 Identities = 59/188 (31%), Positives = 92/188 (48%), Gaps = 23/188 (12%)

Query: 93  IAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCV-DNGLYLIF--------- 142
           +AVK L   VT   +  +FL EI  +  + +PN++ LLG CV D+ L +I          
Sbjct: 47  VAVKMLRADVTKTAR-NDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLN 105

Query: 143 QFSSRGSVASLF-HDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILL 201
           QF S+  + S F H  N P V       +AV  A G+ YL        +HRD+ + N L+
Sbjct: 106 QFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLV 162

Query: 202 TADFEPQISDFGLAKWLPS----QWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFG 257
              +  +I+DFG+++ L S    +    ++ PI      +A E  + G     +DV+AFG
Sbjct: 163 GNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIR----WMAWESILLGKFTTASDVWAFG 218

Query: 258 VFLLEIIS 265
           V L E+ +
Sbjct: 219 VTLWEMFT 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 68.3 bits (167), Expect = 6e-13
 Identities = 67/291 (23%), Positives = 126/291 (43%), Gaps = 54/291 (18%)

Query: 74  VGRGGYAEVYK----GVLQDGEE--IAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVL 127
           +G+G +  V++    G+L       +AVK L +  + D +  +F  E   +    HPN++
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQ-ADFQREAALMAEFDHPNIV 71

Query: 128 SLLG-CCVDNGLYLIFQF--------------------SSRGSVASLFHDVNSPGVEWKV 166
            LLG C V   + L+F++                     S  + ++    +N   +    
Sbjct: 72  KLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTE 131

Query: 167 RHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQ----W 222
           +  IA   A G+ YL    +R+ +HRD+ + N L+  +   +I+DFGL++ + S      
Sbjct: 132 QLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKA 188

Query: 223 THHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDG-SHQSLHSW 280
           + +   PI      + PE   +     ++DV+A+GV L EI S G +P  G +H+ +  +
Sbjct: 189 SENDAIPIR----WMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYY 244

Query: 281 AKPILNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEV 331
            +     G +    D      Y++ +         LC    P+ RP+ + +
Sbjct: 245 VR----DGNVLSCPDNCPLELYNLMR---------LCWSKLPSDRPSFASI 282

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 68.4 bits (167), Expect = 6e-13
 Identities = 73/279 (26%), Positives = 119/279 (42%), Gaps = 54/279 (19%)

Query: 74  VGRGGYAEVYKG-VLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC 132
           +G G    VYK   L     +AVK +   +T +  +K+ ++E+  +     P ++     
Sbjct: 9   LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVEL-QKQIMSELEILYKCDSPYII----- 62

Query: 133 CVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWK----VRHKIAVGTARGLHYLHKGCQRR 188
               G Y  F   +R S+ + F D  S  V  K    V  +IAV   +GL YL      +
Sbjct: 63  ----GFYGAFFVENRISICTEFMDGGSLDVYRKIPEHVLGRIAVAVVKGLTYL---WSLK 115

Query: 189 IIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIE-GTFGHLAPEYFMHGIV 247
           I+HRD+K SN+L+    + ++ DFG++  L +     SIA    GT  ++APE       
Sbjct: 116 ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN-----SIAKTYVGTNAYMAPERISGEQY 170

Query: 248 DEKTDVFAFGVFLLEIISGRKP---VDGSHQSLHSW---------AKPILNQGEI-EKLV 294
              +DV++ G+  +E+  GR P   +  +  SL              P+L  G+  EK V
Sbjct: 171 GIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFV 230

Query: 295 DPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLE 333
                    +TQ          C+R  P  RP    +++
Sbjct: 231 H-------FITQ----------CMRKQPKERPAPENLMD 252

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 68.1 bits (167), Expect = 6e-13
 Identities = 33/104 (31%), Positives = 48/104 (46%), Gaps = 6/104 (5%)

Query: 177 GLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGH 236
            L YLH    + IIHRDIK  NILL       I+DF +A  +       S +   GT G+
Sbjct: 112 ALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTS---GTPGY 165

Query: 237 LAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSW 280
           +APE           D ++ GV   E + G++P  G  +++   
Sbjct: 166 MAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQ 209

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 68.5 bits (168), Expect = 6e-13
 Identities = 47/177 (26%), Positives = 77/177 (43%), Gaps = 58/177 (32%)

Query: 74  VGRGGYAEVYKGVLQ---DGEEIAVKRLTKVVTDDRKEKEFLT--------EIGTIGHVC 122
           +GRG Y  VYK   +   DG+E A+K+        + +KE  T        EI  +  + 
Sbjct: 8   IGRGTYGRVYKAKRKNGKDGKEYAIKKF-------KGDKEQYTGISQSACREIALLRELK 60

Query: 123 HPNVLSLLGCCVDNG---LYLIFQFSSRGSVASLFHDVNSPGVEWKV----RHKIAVGTA 175
           H NV+SL+   +++    +YL+F ++         HD+      W++    R    V   
Sbjct: 61  HENVVSLVEVFLEHADKSVYLLFDYAE--------HDL------WQIIKFHRQAKRVSIP 106

Query: 176 R------------GLHYLHKGCQRRIIHRDIKSSNILLTADFEPQ----ISDFGLAK 216
                        G+HYLH      ++HRD+K +NIL+  +   +    I D GLA+
Sbjct: 107 PSMVKSLLWQILNGVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLAR 160

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 68.0 bits (167), Expect = 6e-13
 Identities = 55/211 (26%), Positives = 93/211 (44%), Gaps = 27/211 (12%)

Query: 74  VGRGGYAEVYK-GVLQDGEEIAVKRLTK-VVTDDRKEKEFLTEIGTIGHVCHPNVLSLLG 131
           +G GG+  V    V       A+K + K  + +  +++   +E   +    HP ++ L  
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60

Query: 132 CCVDNG-LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRII 190
              D   +Y++ ++   G + ++  D      E+  R  IA        YLH    R II
Sbjct: 61  TFKDKKYIYMLMEYCLGGELWTILRDRGLFD-EYTARFYIA-CVVLAFEYLH---NRGII 115

Query: 191 HRDIKSSNILLTADFEPQISDFGLAKWLPSQ---WTHHSIAPIEGTFGHLAPEYFMHGIV 247
           +RD+K  N+LL ++   ++ DFG AK L S    WT        GT  ++APE     I+
Sbjct: 116 YRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWT------FCGTPEYVAPE-----II 164

Query: 248 DEK-----TDVFAFGVFLLEIISGRKPVDGS 273
             K      D ++ G+ L E+++GR P    
Sbjct: 165 LNKGYDFSVDYWSLGILLYELLTGRPPFGED 195

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 68.3 bits (168), Expect = 8e-13
 Identities = 47/163 (28%), Positives = 73/163 (44%), Gaps = 35/163 (21%)

Query: 72  NLVGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLL 130
             +G G Y  V   V  + G ++A+K+++ V  D    K  L EI  + H+ H N++ LL
Sbjct: 6   KPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLL 65

Query: 131 GCCVDNGLYLIFQFSSRGSVASLFHDV---------------NSPGV--EWKVRHKIAVG 173
                     I +  S       F+DV                SP    +  +++     
Sbjct: 66  ---------DILRPPSPED----FNDVYIVTELMETDLHKVIKSPQPLTDDHIQY-FLYQ 111

Query: 174 TARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAK 216
             RGL YLH      +IHRD+K SNIL+ ++ + +I DFGLA+
Sbjct: 112 ILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLAR 151

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 67.6 bits (165), Expect = 1e-12
 Identities = 52/199 (26%), Positives = 99/199 (49%), Gaps = 14/199 (7%)

Query: 74  VGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC 132
           +G+G    VY  + +  G+E+A+K++   +    K++  + EI  +    HPN+++ L  
Sbjct: 27  IGQGASGTVYTAIDVATGQEVAIKQMN--LQQQPKKELIINEILVMRENKHPNIVNYLDS 84

Query: 133 -CVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIH 191
             V + L+++ ++ + GS+  +   V    ++      +     + L +LH     ++IH
Sbjct: 85  YLVGDELWVVMEYLAGGSLTDV---VTETCMDEGQIAAVCRECLQALEFLH---SNQVIH 138

Query: 192 RDIKSSNILLTADFEPQISDFGL-AKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEK 250
           RDIKS NILL  D   +++DFG  A+  P Q    ++    GT   +APE         K
Sbjct: 139 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV---GTPYWMAPEVVTRKAYGPK 195

Query: 251 TDVFAFGVFLLEIISGRKP 269
            D+++ G+  +E++ G  P
Sbjct: 196 VDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 67.6 bits (165), Expect = 1e-12
 Identities = 66/213 (30%), Positives = 92/213 (43%), Gaps = 34/213 (15%)

Query: 74  VGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRK-------EKEFLTEIGTIGHVCHPN 125
           +G+GG+ EV    ++  G+  A K+L K     RK       EK  L ++       H  
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKV-------HSR 53

Query: 126 VLSLLGCCVDN--GLYLIFQFSSRGSVASLFH----DVNSPGVEWKVRHKIAVGTAR--- 176
            +  L         L L+    + G +   +H    D  +PG       +    TA+   
Sbjct: 54  FIVSLAYAFQTKTDLCLVMTIMNGGDLR--YHIYNVDEENPGFP---EPRACFYTAQIIS 108

Query: 177 GLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGH 236
           GL +LH   QRRII+RD+K  N+LL  D   +ISD GLA  L    +        GT G 
Sbjct: 109 GLEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTKGYAGTPGF 163

Query: 237 LAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKP 269
           +APE       D   D FA GV L E+I+ R P
Sbjct: 164 MAPELLQGEEYDFSVDYFALGVTLYEMIAARGP 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 67.6 bits (166), Expect = 1e-12
 Identities = 52/208 (25%), Positives = 94/208 (45%), Gaps = 31/208 (14%)

Query: 74  VGRGGYAEVYKGVLQDGEEI-AVKRLTKV-VTDDRKEKEFLTEIGTIGHVCHPNVLSLLG 131
           +G G +  V     +   +  A+K L+K  +   ++ +  L E   +  + HP +++L G
Sbjct: 9   LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYG 68

Query: 132 CCVDNG-LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTAR--------GLHYLH 182
              D+  LYL+ ++   G + S            +   +     AR         L YLH
Sbjct: 69  SFQDDSNLYLVMEYVPGGELFSHL----------RKSGRFPEPVARFYAAQVVLALEYLH 118

Query: 183 KGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQ-WTHHSIAPIEGTFGHLAPEY 241
                 I++RD+K  N+LL +D   +I+DFG AK +  + +T      + GT  +LAPE 
Sbjct: 119 ---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYT------LCGTPEYLAPEI 169

Query: 242 FMHGIVDEKTDVFAFGVFLLEIISGRKP 269
            +     +  D +A G+ + E+++G  P
Sbjct: 170 ILSKGYGKAVDWWALGILIYEMLAGYPP 197

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 67.4 bits (164), Expect = 1e-12
 Identities = 51/199 (25%), Positives = 99/199 (49%), Gaps = 14/199 (7%)

Query: 74  VGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC 132
           +G+G    VY  + +  G+E+A+K++   +    K++  + EI  +    +PN+++ L  
Sbjct: 27  IGQGASGTVYTAIDIATGQEVAIKQMN--LQQQPKKELIINEILVMRENKNPNIVNYLDS 84

Query: 133 -CVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIH 191
             V + L+++ ++ + GS+  +   V    ++      +     + L +LH     ++IH
Sbjct: 85  YLVGDELWVVMEYLAGGSLTDV---VTETCMDEGQIAAVCRECLQALDFLH---SNQVIH 138

Query: 192 RDIKSSNILLTADFEPQISDFGL-AKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEK 250
           RDIKS NILL  D   +++DFG  A+  P Q    ++    GT   +APE         K
Sbjct: 139 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV---GTPYWMAPEVVTRKAYGPK 195

Query: 251 TDVFAFGVFLLEIISGRKP 269
            D+++ G+  +E++ G  P
Sbjct: 196 VDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 67.9 bits (166), Expect = 1e-12
 Identities = 59/212 (27%), Positives = 108/212 (50%), Gaps = 17/212 (8%)

Query: 68  FSSENLVGRGGYAEVYKGVLQDGEEI-AVKRLTK--VVTDDRKEKEFLTEIGTIGHVCHP 124
           F+   ++G+G + +V     +  +E+ A+K L K  ++ DD  E   + E   +     P
Sbjct: 2   FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECT-MVEKRVLALPGKP 60

Query: 125 NVLSLLGCCVD--NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKI--AVGTARGLHY 180
             L+ L  C    + LY + ++ + G +  ++H +   G ++K  H +  A   A GL +
Sbjct: 61  PFLTQLHSCFQTMDRLYFVMEYVNGGDL--MYH-IQQVG-KFKEPHAVFYAAEIAIGLFF 116

Query: 181 LHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPE 240
           LH    + II+RD+K  N++L A+   +I+DFG+ K   + +   +     GT  ++APE
Sbjct: 117 LHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCK--ENIFGGKTTRTFCGTPDYIAPE 171

Query: 241 YFMHGIVDEKTDVFAFGVFLLEIISGRKPVDG 272
              +    +  D +AFGV L E+++G+ P DG
Sbjct: 172 IIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDG 203

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 67.0 bits (163), Expect = 2e-12
 Identities = 63/252 (25%), Positives = 120/252 (47%), Gaps = 35/252 (13%)

Query: 90  GEEIAVKRLTKVVTDDRKEKE---FLTEIGTIGHVCHPNVLSLLGC-CVDNGLYLIFQFS 145
           G+++AVK++     D RK++       E+  +    H NV+ +     V + L+++ +F 
Sbjct: 47  GKQVAVKKM-----DLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFL 101

Query: 146 SRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADF 205
             G++  +   V    +  +    + +   R L YLH    + +IHRDIKS +ILLT+D 
Sbjct: 102 EGGALTDI---VTHTRMNEEQIATVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDG 155

Query: 206 EPQISDFG----LAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLL 261
             ++SDFG    ++K +P +        + GT   +APE         + D+++ G+ ++
Sbjct: 156 RIKLSDFGFCAQVSKEVPKR------KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVI 209

Query: 262 EIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRAS 321
           E+I G  P        +    P+     I   + PR++ ++ V+ + R  F   + +R  
Sbjct: 210 EMIDGEPP--------YFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLR-GFLDLMLVR-E 259

Query: 322 PTWRPTMSEVLE 333
           P+ R T  E+L+
Sbjct: 260 PSQRATAQELLQ 271

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 67.0 bits (163), Expect = 2e-12
 Identities = 76/282 (26%), Positives = 129/282 (45%), Gaps = 42/282 (14%)

Query: 68  FSSENLVGRGGYAEVYKGV-LQDGEEIAVKRLT-KVVTDDRKEKEFLTEIGTIGHVCHPN 125
           F+    +G G +  VY    ++  E +A+K+++      + K ++ + E+  +  + HPN
Sbjct: 27  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86

Query: 126 VLSLLGCCV-DNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKG 184
            +   GC + ++  +L+ ++   GS + L      P  E ++   I  G  +GL YLH  
Sbjct: 87  SIEYKGCYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIA-AITHGALQGLAYLH-- 142

Query: 185 CQRRIIHRDIKSSNILLTADFEPQISDFGLAKWL-PSQWTHHSIAPIEGTFGHLAPEYFM 243
               +IHRDIK+ NILLT   + +++DFG A    P+           GT   +APE  +
Sbjct: 143 -SHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPAN-------SFVGTPYWMAPEVIL 194

Query: 244 ---HGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLV------ 294
               G  D K DV++ G+  +E ++ RKP             P+ N   +  L       
Sbjct: 195 AMDEGQYDGKVDVWSLGITCIE-LAERKP-------------PLFNMNAMSALYHIAQNE 240

Query: 295 DPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVML 336
            P LQ + + +   R  F  S C++  P  RPT  E+L+ M 
Sbjct: 241 SPTLQ-SNEWSDYFR-NFVDS-CLQKIPQDRPTSEELLKHMF 279

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 66.9 bits (163), Expect = 2e-12
 Identities = 52/207 (25%), Positives = 93/207 (44%), Gaps = 18/207 (8%)

Query: 74  VGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIG---HVCHPNVLSL 129
           +G G Y  VYK      G  +A+K +     +D      + E+  +       HPN++ L
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67

Query: 130 LGCCV------DNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHK 183
           +  C       +  + L+F+   +  + +    V  PG+  +    +     RGL +LH 
Sbjct: 68  MDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHA 126

Query: 184 GCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFM 243
            C   I+HRD+K  NIL+T+  + +++DFGLA+         ++ P+  T  + APE  +
Sbjct: 127 NC---IVHRDLKPENILVTSGGQVKLADFGLARIYS---CQMALTPVVVTLWYRAPEVLL 180

Query: 244 HGIVDEKTDVFAFGVFLLEIISGRKPV 270
                   D+++ G    E+   RKP+
Sbjct: 181 QSTYATPVDMWSVGCIFAEMFR-RKPL 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 66.2 bits (161), Expect = 3e-12
 Identities = 63/240 (26%), Positives = 113/240 (47%), Gaps = 38/240 (15%)

Query: 60  EISIATNAFSSENLVGRGGYAEVYKGVL-----QDGEEIAVKRLTKVVTDDRKEKEFLTE 114
           E+ ++   F  E  +G   + ++YKG L        + +A+K L K + + ++  EF  E
Sbjct: 1   ELPLSAVRFMEE--LGECAFGKIYKGHLYLPGMDHAQLVAIKTL-KDINNPQQWGEFQQE 57

Query: 115 IGTIGHVCHPNVLSLLGCCV-DNGLYLIFQFSSRGSVASLFHDVNSP------------G 161
              +  + HPN++ LLG    +  + ++F++ ++G +   F  + SP             
Sbjct: 58  ASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHE-FLIMRSPHSDVGCSSDEDGT 116

Query: 162 VEWKVRH----KIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKW 217
           V+  + H     IA+  A G+ YL        +H+D+ + NIL+      +ISD GL++ 
Sbjct: 117 VKSSLDHGDFLHIAIQIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSRE 173

Query: 218 LPS----QWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDG 272
           + S    +    S+ PI      + PE  M+G     +D+++FGV L EI S G +P  G
Sbjct: 174 IYSADYYRVQPKSLLPIR----WMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYG 229

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 66.3 bits (161), Expect = 3e-12
 Identities = 49/198 (24%), Positives = 98/198 (49%), Gaps = 12/198 (6%)

Query: 74  VGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC 132
           +G+G    VY  + +  G+E+A++++   +    K++  + EI  +    +PN+++ L  
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMN--LQQQPKKELIINEILVMRENKNPNIVNYLDS 85

Query: 133 -CVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIH 191
             V + L+++ ++ + GS+  +   V    ++      +     + L +LH     ++IH
Sbjct: 86  YLVGDELWVVMEYLAGGSLTDV---VTETCMDEGQIAAVCRECLQALEFLH---SNQVIH 139

Query: 192 RDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKT 251
           RDIKS NILL  D   +++DFG    +  + +  S   + GT   +APE         K 
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS--TMVGTPYWMAPEVVTRKAYGPKV 197

Query: 252 DVFAFGVFLLEIISGRKP 269
           D+++ G+  +E+I G  P
Sbjct: 198 DIWSLGIMAIEMIEGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 66.2 bits (161), Expect = 3e-12
 Identities = 69/230 (30%), Positives = 99/230 (43%), Gaps = 17/230 (7%)

Query: 68  FSSENLVGRGGYAEVYK-GVLQDGEEIAVKRLTKVVTDDRK-EKEFLTEIGTIGHVCHPN 125
           F    ++G+GG+ EV    V   G+  A K+L K     RK E   L E   +  V    
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61

Query: 126 VLSL-LGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKG 184
           V+SL       + L L+    + G +    + +   G E       A     GL  LH  
Sbjct: 62  VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLH-- 119

Query: 185 CQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMH 244
            Q RI++RD+K  NILL      +ISD GLA  +P   T   I    GT G++APE   +
Sbjct: 120 -QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT---IKGRVGTVGYMAPEVVKN 175

Query: 245 GIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLV 294
                  D +A G  L E+I+G+ P            K  + + E+E+LV
Sbjct: 176 ERYTFSPDWWALGCLLYEMIAGQSPFQQR--------KKKIKREEVERLV 217

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 66.0 bits (161), Expect = 3e-12
 Identities = 46/205 (22%), Positives = 99/205 (48%), Gaps = 9/205 (4%)

Query: 73  LVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKE-FLTEIGTIGHVCHPNVLSLLG 131
           +VGRG +  V+    +  +++ + +   V    + E+     E   +  + HPN++    
Sbjct: 7   VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYE 66

Query: 132 CCV-DNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRII 190
             + D  L ++ +++  G++A       +  ++        V     LH++H    + I+
Sbjct: 67  NFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVH---TKLIL 123

Query: 191 HRDIKSSNILLTA-DFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDE 249
           HRD+K+ NILL       +I DFG++K L S+   +++    GT  +++PE       ++
Sbjct: 124 HRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVV---GTPCYISPELCEGKPYNQ 180

Query: 250 KTDVFAFGVFLLEIISGRKPVDGSH 274
           K+D++A G  L E+ S ++  + ++
Sbjct: 181 KSDIWALGCVLYELASLKRAFEAAN 205

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 66.0 bits (161), Expect = 3e-12
 Identities = 63/289 (21%), Positives = 132/289 (45%), Gaps = 35/289 (12%)

Query: 74  VGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC- 132
           +G+G Y  VYK + +        +  ++  D+ K  + + E+  +     P ++   G  
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68

Query: 133 CVDNGLYLIFQFSSRGSVASLF-HDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIH 191
            ++  +Y+  ++   GS+  L+   V + G+   V  +I     +GL +L +  +  IIH
Sbjct: 69  FIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHNIIH 126

Query: 192 RDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDE-- 249
           RD+K +N+L+  + + ++ DFG++  L +     +I    G   ++APE    G  ++  
Sbjct: 127 RDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNI----GCQSYMAPERIKSGGPNQNP 182

Query: 250 ----KTDVFAFGVFLLEIISGRKPV-DGSHQSLHSWAKPILNQGEIEKLVD---PRLQGA 301
               ++DV++ G+ +LE+  GR P    ++ ++ +         ++  +VD   P L   
Sbjct: 183 TYTVQSDVWSLGLSILEMALGRYPYPPETYANIFA---------QLSAIVDGDPPTLPSG 233

Query: 302 YDVTQLNRLAFAASLCIRASPTWRPTMSEVLE----VMLEGDQIDKERW 346
           Y     + +    + C+   P  RPT +++LE    V  +   +D   W
Sbjct: 234 YSDDAQDFV----AKCLNKIPNRRPTYAQLLEHPWLVKYKNADVDMAEW 278

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 66.4 bits (162), Expect = 3e-12
 Identities = 57/205 (27%), Positives = 103/205 (50%), Gaps = 24/205 (11%)

Query: 74  VGRGGYAEVYKGV-LQDGEEIAVKRLT---KVVTDDRKEKEFLTEIGTIGHVCHPNVLSL 129
           +G G +  VY    ++  E +A+K+++   K   +  K ++ + E+  +  + HPN +  
Sbjct: 23  IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNE--KWQDIIKEVRFLQQLRHPNTIEY 80

Query: 130 LGCCV-DNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRR 188
            GC + ++  +L+ ++   GS + +  +V+   ++      I  G  +GL YLH   +  
Sbjct: 81  KGCYLREHTAWLVMEYCL-GSASDIL-EVHKKPLQEVEIAAICHGALQGLAYLHSHER-- 136

Query: 189 IIHRDIKSSNILLTADFEPQISDFGLAKWL-PSQWTHHSIAPIEGTFGHLAPEYFM---H 244
            IHRDIK+ NILLT     +++DFG A  + P+           GT   +APE  +    
Sbjct: 137 -IHRDIKAGNILLTEPGTVKLADFGSASLVSPAN-------SFVGTPYWMAPEVILAMDE 188

Query: 245 GIVDEKTDVFAFGVFLLEIISGRKP 269
           G  D K DV++ G+  +E ++ RKP
Sbjct: 189 GQYDGKVDVWSLGITCIE-LAERKP 212

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 66.4 bits (162), Expect = 4e-12
 Identities = 62/220 (28%), Positives = 99/220 (45%), Gaps = 27/220 (12%)

Query: 72  NLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLL 130
           N +G G    VYK + +  G   A+K +     +D   ++   EI  +  V HPNV+   
Sbjct: 80  NRIGSGAGGTVYKVIHRPTGRLYALKVIYGN-HEDTVRRQICREIEILRDVNHPNVVKCH 138

Query: 131 GCCVDNG-LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRI 189
                NG + ++ +F   GS+      +        V  +I      G+ YLH+   R I
Sbjct: 139 DMFDHNGEIQVLLEFMDGGSLEG--THIADEQFLADVARQIL----SGIAYLHR---RHI 189

Query: 190 IHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIE---GTFGHLAPEY----F 242
           +HRDIK SN+L+ +    +I+DFG+++ L       ++ P     GT  +++PE      
Sbjct: 190 VHRDIKPSNLLINSAKNVKIADFGVSRIL-----AQTMDPCNSSVGTIAYMSPERINTDL 244

Query: 243 MHGIVDEKT-DVFAFGVFLLEIISGRKPVDGSHQSLHSWA 281
            HG  D    D+++ GV +LE   GR P     Q    WA
Sbjct: 245 NHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQG--DWA 282

Length = 353

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 65.8 bits (160), Expect = 4e-12
 Identities = 61/213 (28%), Positives = 93/213 (43%), Gaps = 9/213 (4%)

Query: 68  FSSENLVGRGGYAEVYK-GVLQDGEEIAVKRLTKVVTDDRK-EKEFLTEIGTIGHVCHPN 125
           F    ++G+GG+ EV    V   G+  A KRL K     RK E   L E   +  V    
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61

Query: 126 VLSL-LGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKG 184
           V++L       + L L+    + G +    +++ +PG E +     A     GL  LH  
Sbjct: 62  VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLH-- 119

Query: 185 CQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMH 244
            +   ++RD+K  NILL      +ISD GLA  +P      SI    GT G++APE   +
Sbjct: 120 -RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG---ESIRGRVGTVGYMAPEVLNN 175

Query: 245 GIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSL 277
                  D +  G  + E+I G+ P  G  + +
Sbjct: 176 QRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKV 208

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 65.5 bits (160), Expect = 4e-12
 Identities = 53/227 (23%), Positives = 107/227 (47%), Gaps = 35/227 (15%)

Query: 61  ISIATNAFSSENLVGRGGYAEVYKGVLQD---GEEIAVKRLTKVVTDDRKEKE---FLTE 114
           I+I+ +  +  +L+  G +  ++ G+L D   G+E  V    K V D   E +    L E
Sbjct: 1   IAISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEV--FVKTVKDHASEIQVTLLLQE 58

Query: 115 IGTIGHVCHPNVLSLLGCCVDNGL--YLIFQFSSRGSVASLFHDVNSPGVEWKVRHKI-- 170
              +  + H N+L +L  C+++G   ++++ + + G++            E      +  
Sbjct: 59  SCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQ--QCRLGEANNPQALST 116

Query: 171 ------AVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWL-PSQWT 223
                 A+  A G+ YLHK   R +IH+DI + N ++  + + +I+D  L++ L P  + 
Sbjct: 117 QQLVHMAIQIACGMSYLHK---RGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDY- 172

Query: 224 HHSIA-----PIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS 265
            H +      P++     +A E  ++      +DV++FGV L E+++
Sbjct: 173 -HCLGDNENRPVK----WMALESLVNKEYSSASDVWSFGVLLWELMT 214

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 65.5 bits (160), Expect = 4e-12
 Identities = 61/254 (24%), Positives = 116/254 (45%), Gaps = 39/254 (15%)

Query: 90  GEEIAVKRLTKVVTDDRKE--KEFL-TEIGTIGHVCHPNVLSLLGC-CVDNGLYLIFQFS 145
           G ++AVK++     D RK+  +E L  E+  +    HPN++ +     V + L+++ +F 
Sbjct: 44  GRQVAVKKM-----DLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFL 98

Query: 146 SRGSVASLFHDV--NSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTA 203
             G++  +      N   +       + +   + L +LH    + +IHRDIKS +ILLT+
Sbjct: 99  EGGALTDIVTHTRMNEEQIA-----TVCLAVLKALSFLH---AQGVIHRDIKSDSILLTS 150

Query: 204 DFEPQISDFG----LAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVF 259
           D   ++SDFG    ++K +P +        + GT   +APE         + D+++ G+ 
Sbjct: 151 DGRVKLSDFGFCAQVSKEVPRR------KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIM 204

Query: 260 LLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIR 319
           ++E++ G  P        +    P+     I   + P+L+  + V+   RL       + 
Sbjct: 205 VIEMVDGEPP--------YFNEPPLQAMKRIRDNLPPKLKNLHKVSP--RLRSFLDRMLV 254

Query: 320 ASPTWRPTMSEVLE 333
             P  R T +E+L 
Sbjct: 255 RDPAQRATAAELLN 268

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 65.8 bits (160), Expect = 5e-12
 Identities = 58/211 (27%), Positives = 103/211 (48%), Gaps = 24/211 (11%)

Query: 68  FSSENLVGRGGYAEVYKGV-LQDGEEIAVKRLT-KVVTDDRKEKEFLTEIGTIGHVCHPN 125
           FS    +G G +  VY    +++ E +A+K+++      + K ++ + E+  +  + HPN
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 126 VLSLLGCCV-DNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKG 184
            +   GC + ++  +L+ ++   GS + L      P  E ++   +  G  +GL YLH  
Sbjct: 77  TIQYRGCYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIA-AVTHGALQGLAYLH-- 132

Query: 185 CQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIE---GTFGHLAPEY 241
               +IHRD+K+ NILL+     ++ DFG A           +AP     GT   +APE 
Sbjct: 133 -SHNMIHRDVKAGNILLSEPGLVKLGDFGSAS---------IMAPANXFVGTPYWMAPEV 182

Query: 242 FM---HGIVDEKTDVFAFGVFLLEIISGRKP 269
            +    G  D K DV++ G+  +E ++ RKP
Sbjct: 183 ILAMDEGQYDGKVDVWSLGITCIE-LAERKP 212

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 65.1 bits (158), Expect = 6e-12
 Identities = 60/206 (29%), Positives = 102/206 (49%), Gaps = 14/206 (6%)

Query: 74  VGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC 132
           VG G Y +VYK   L  GE  AVK +     DD    +   EI  +    H N+++  G 
Sbjct: 17  VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQ--QEIFMVKECKHCNIVAYFGS 74

Query: 133 CVD-NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIH 191
            +    L++  ++   GS+  ++H V  P  E ++ + +   T +GL YLH    +  +H
Sbjct: 75  YLSREKLWICMEYCGGGSLQDIYH-VTGPLSELQIAY-VCRETLQGLAYLH---SKGKMH 129

Query: 192 RDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFM---HGIVD 248
           RDIK +NILLT + + +++DFG+A  + +  T        GT   +APE      +G  +
Sbjct: 130 RDIKGANILLTDNGDVKLADFGVAAKITA--TIAKRKSFIGTPYWMAPEVAAVEKNGGYN 187

Query: 249 EKTDVFAFGVFLLEIISGRKPVDGSH 274
           +  D++A G+  +E+   + P+   H
Sbjct: 188 QLCDIWAVGITAIELAELQPPMFDLH 213

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 65.0 bits (158), Expect = 6e-12
 Identities = 55/211 (26%), Positives = 96/211 (45%), Gaps = 24/211 (11%)

Query: 74  VGRGGYAEVYKGVLQ---DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLL 130
           +G G +  V KG+ +     + +AVK L     D   + E L E   +  + +P ++ ++
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62

Query: 131 GCCVDNGLYLIFQFSSRGSVASLFH---DVNSPGVEWKVRHKIAVGTARGLHYLHKGCQR 187
           G C      L+ + +  G +         V    +   V H++++G    + YL    + 
Sbjct: 63  GICEAESWMLVMELAELGPLNKFLQKNKHVTEKNITELV-HQVSMG----MKYLE---ET 114

Query: 188 RIIHRDIKSSNILLTADFEPQISDFGLAKWLPS-----QWTHHSIAPIEGTFGHLAPEYF 242
             +HRD+ + N+LL      +ISDFGL+K L +     +   H   P++      APE  
Sbjct: 115 NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVK----WYAPECM 170

Query: 243 MHGIVDEKTDVFAFGVFLLEIIS-GRKPVDG 272
            +     K+DV++FGV + E  S G+KP  G
Sbjct: 171 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYKG 201

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 64.9 bits (158), Expect = 6e-12
 Identities = 57/213 (26%), Positives = 103/213 (48%), Gaps = 26/213 (12%)

Query: 71  ENLVGRGGYAEVYKGVL--QDGEEIAVKRLT-KVVTDDRKEKEFLTEIGTIGHVCHPNVL 127
           E ++G G + EV  G L      EI V   T K    +++ ++FL+E   +G   HPN++
Sbjct: 9   EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNII 68

Query: 128 SLLGCCVDNG-LYLIFQFSSRGSVASLF--HDVNSPGVEWKVRHKIAV--GTARGLHYLH 182
            L G    +  + ++ ++   GS+ +    HD      ++ V   + +  G A G+ YL 
Sbjct: 69  HLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDG-----QFTVIQLVGMLRGIASGMKYL- 122

Query: 183 KGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWL-----PSQWTHHSIAPIEGTFGHL 237
                  +HRD+ + NIL+ ++   ++SDFGL++ L      +  T     PI  T    
Sbjct: 123 --SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT---- 176

Query: 238 APEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKP 269
           APE   +      +DV+++G+ + E++S G +P
Sbjct: 177 APEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 209

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 65.4 bits (159), Expect = 7e-12
 Identities = 57/209 (27%), Positives = 103/209 (49%), Gaps = 15/209 (7%)

Query: 73  LVGRGGYAEVYKGVLQDGEEI-AVKRLTK-VVTDDRKEKEFLTEIGTIGHVCHPNVLSLL 130
           ++G+G + +V     +  +E+ A+K L K VV  D   +  + E   +     P  L+ L
Sbjct: 7   VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQL 66

Query: 131 GCCVD--NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKI--AVGTARGLHYLHKGCQ 186
             C    + LY + ++ + G    L + +   G  +K  H +  A   A GL +LH    
Sbjct: 67  HSCFQTMDRLYFVMEYVNGGD---LMYQIQQVG-RFKEPHAVFYAAEIAIGLFFLH---S 119

Query: 187 RRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGI 246
           + II+RD+K  N++L ++   +I+DFG+ K   + W   +     GT  ++APE   +  
Sbjct: 120 KGIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENMWDGVTTKTFCGTPDYIAPEIIAYQP 177

Query: 247 VDEKTDVFAFGVFLLEIISGRKPVDGSHQ 275
             +  D +AFGV L E+++G+ P +G  +
Sbjct: 178 YGKSVDWWAFGVLLYEMLAGQAPFEGEDE 206

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 64.7 bits (157), Expect = 9e-12
 Identities = 68/278 (24%), Positives = 115/278 (41%), Gaps = 36/278 (12%)

Query: 74  VGRGGYAEVYKGVLQDGEEI---AVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLL 130
           +G G +  V +G L   + I   AVK +   +    + ++FL+E   +    HPNV+ L+
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66

Query: 131 GCCVDN-------GLYLIFQFSSRGSVAS--LFHDVNSPGVEWKVRH--KIAVGTARGLH 179
           G C+            +I  F   G + S  L+  +         +   K     A G+ 
Sbjct: 67  GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126

Query: 180 YLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAK--WLPSQWTHHSIAPIEGTFGHL 237
           YL     +  IHRD+ + N +L  +    ++DFGL+K  +    +    IA +   +  +
Sbjct: 127 YL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKW--I 181

Query: 238 APEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQS-LHSWAKPILNQGEIEKLVD 295
           A E     +   K+DV++FGV + EI + G+ P  G   S ++ +    L QG   K   
Sbjct: 182 AIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDY----LRQGNRLKQPP 237

Query: 296 PRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLE 333
             L G Y +          S C   +P  RP+   +  
Sbjct: 238 DCLDGLYSLM---------SSCWLLNPKDRPSFETLRC 266

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 64.7 bits (157), Expect = 9e-12
 Identities = 49/199 (24%), Positives = 100/199 (50%), Gaps = 14/199 (7%)

Query: 74  VGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC 132
           +G+G    V+  + +  G+E+A+K++   +    K++  + EI  +  + +PN+++ L  
Sbjct: 27  IGQGASGTVFTAIDVATGQEVAIKQIN--LQKQPKKELIINEILVMKELKNPNIVNFLDS 84

Query: 133 -CVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIH 191
             V + L+++ ++ + GS+  +   V    ++      +     + L +LH     ++IH
Sbjct: 85  FLVGDELFVVMEYLAGGSLTDV---VTETCMDEAQIAAVCRECLQALEFLHAN---QVIH 138

Query: 192 RDIKSSNILLTADFEPQISDFGL-AKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEK 250
           RDIKS N+LL  D   +++DFG  A+  P Q    ++    GT   +APE         K
Sbjct: 139 RDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV---GTPYWMAPEVVTRKAYGPK 195

Query: 251 TDVFAFGVFLLEIISGRKP 269
            D+++ G+  +E++ G  P
Sbjct: 196 VDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 64.5 bits (157), Expect = 1e-11
 Identities = 69/291 (23%), Positives = 111/291 (38%), Gaps = 55/291 (18%)

Query: 74  VGRGGYAEVYKGVLQDGEEIA---VKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLL 130
           +G G + +V  G    G   A   VK L    T D ++  FL E+     + HPNVL  L
Sbjct: 3   IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPD-EQLLFLQEVQPYRELNHPNVLQCL 61

Query: 131 GCCVDNGLYL-IFQFSSRGSVASLF---HDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQ 186
           G C+++  YL + +F   G + +       + +   +  V  ++A   A GL +LH   Q
Sbjct: 62  GQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH---Q 118

Query: 187 RRIIHRDIKSSNILLTADFEPQISDFGLA--------------KWLPSQWT--------H 224
              IH D+   N  LTAD   +I D+GLA                +P +W          
Sbjct: 119 ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRG 178

Query: 225 HSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPI 284
             + P + T               +K+++++ GV + E+ +                + +
Sbjct: 179 QDLLPKDQT---------------KKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVV 223

Query: 285 LNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVM 335
             Q    KL  P+L   Y       + F         P  RPT  EV E++
Sbjct: 224 REQD--IKLPKPQLDLKYSDRWYEVMQFCW-----LDPETRPTAEEVHELL 267

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 64.5 bits (157), Expect = 1e-11
 Identities = 52/188 (27%), Positives = 84/188 (44%), Gaps = 27/188 (14%)

Query: 90  GEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG---LYLIFQFSS 146
           GE +AVK L K     +    +  EI  +  + H N++   GCC + G   L LI ++  
Sbjct: 33  GEMVAVKTL-KRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVP 91

Query: 147 RGSVASLFHDVNSPGVEWKVRHKI--------AVGTARGLHYLHKGCQRRIIHRDIKSSN 198
            GS+            ++  +HK+        A     G+ YLH    +  IHRD+ + N
Sbjct: 92  LGSL-----------RDYLPKHKLNLAQLLLFAQQICEGMAYLH---SQHYIHRDLAARN 137

Query: 199 ILLTADFEPQISDFGLAKWLPSQWTHHSIAPI-EGTFGHLAPEYFMHGIVDEKTDVFAFG 257
           +LL  D   +I DFGLAK +P    ++ +    +      A E          +DV++FG
Sbjct: 138 VLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFG 197

Query: 258 VFLLEIIS 265
           V L E+++
Sbjct: 198 VTLYELLT 205

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 64.3 bits (156), Expect = 1e-11
 Identities = 66/219 (30%), Positives = 102/219 (46%), Gaps = 29/219 (13%)

Query: 74  VGRGGYAEVYKGVL--QDGEEIAVKRLTKVV-TDDRKEKEF--LTEIGTIGHVCHPNVLS 128
           +G+G Y +V+K VL  ++G + AVK L  +   D+  E E+  L  +       HPNV+ 
Sbjct: 26  IGKGTYGKVFK-VLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSD-----HPNVVK 79

Query: 129 LLGCC----VDNG--LYLIFQFSSRGSVASLFHDVNSPG--VEWKVRHKIAVGTARGLHY 180
             G      V NG  L+L+ +  + GSV  L       G  +E  +   I      GL +
Sbjct: 80  FYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQH 139

Query: 181 LHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPE 240
           LH     + IHRD+K +NILLT +   ++ DFG++  L S  T        GT   +APE
Sbjct: 140 LH---VNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTS--TRLRRNTSVGTPFWMAPE 194

Query: 241 YF-----MHGIVDEKTDVFAFGVFLLEIISGRKPVDGSH 274
                  +    D + DV++ G+  +E+  G  P+   H
Sbjct: 195 VIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLH 233

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 64.6 bits (158), Expect = 2e-11
 Identities = 56/220 (25%), Positives = 96/220 (43%), Gaps = 43/220 (19%)

Query: 68  FSSENLVGRGGYAEVYKGVLQD-GEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNV 126
           + + + VG G Y +V        G ++A+K+L++        K    E+  + H+ H NV
Sbjct: 17  YQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENV 76

Query: 127 LSLLGC-CVDNGL------YLIFQFSSRGSVASLFHDVNSPGVEWKVRHK---------I 170
           + LL      + L      YL+              D+N+      V+ +         +
Sbjct: 77  IGLLDVFTPASSLEDFQDVYLVTHLMGA--------DLNN-----IVKCQKLSDDHIQFL 123

Query: 171 AVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPI 230
                RGL Y+H      IIHRD+K SNI +  D E +I DFGLA+    + T +     
Sbjct: 124 VYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYV---- 176

Query: 231 EGTFGHLAPE---YFMHGIVDEKTDVFAFGVFLLEIISGR 267
             T  + APE    +MH   ++  D+++ G  + E+++G+
Sbjct: 177 -ATRWYRAPEIMLNWMH--YNQTVDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 63.9 bits (156), Expect = 2e-11
 Identities = 42/151 (27%), Positives = 73/151 (48%), Gaps = 18/151 (11%)

Query: 74  VGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKE---KEFLTEIGTIGHVCHPNVLSL 129
           +G G Y  VYK      GE +A+K   K+  +   E      + EI  +  + HPN++ L
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALK---KIRLETEDEGVPSTAIREISLLKELNHPNIVRL 63

Query: 130 LGCCV-DNGLYLIFQFSS---RGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGC 185
           L     +N LYL+F+F     +  + S       P +     +++     +G+ Y H   
Sbjct: 64  LDVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLL----QGIAYCH--- 116

Query: 186 QRRIIHRDIKSSNILLTADFEPQISDFGLAK 216
             R++HRD+K  N+L+  +   +++DFGLA+
Sbjct: 117 SHRVLHRDLKPQNLLIDREGALKLADFGLAR 147

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 64.9 bits (158), Expect = 2e-11
 Identities = 43/162 (26%), Positives = 75/162 (46%), Gaps = 33/162 (20%)

Query: 178 LHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHL 237
           +H++H    + +IHRDIKS+NILL ++   ++ DFG +K   +  +        GT  ++
Sbjct: 156 VHHVH---SKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYV 212

Query: 238 APEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPR 297
           APE +      +K D+F+ GV L E+++ ++P DG                 +E+++   
Sbjct: 213 APEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGE---------------NMEEVMHKT 257

Query: 298 LQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEGD 339
           L G YD                  P+  P M E++  +L  D
Sbjct: 258 LAGRYDPL---------------PPSISPEMQEIVTALLSSD 284

Length = 496

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 64.2 bits (157), Expect = 2e-11
 Identities = 62/255 (24%), Positives = 98/255 (38%), Gaps = 59/255 (23%)

Query: 73  LVGRGGYAEVYKGVL----QDGEEIAVKRLTKV-------VTDDRKEKEFLTEIGTIGHV 121
           ++GRG + EV+   L      G+  A+K L K        +   R E++ L +  +    
Sbjct: 8   VIGRGAFGEVW---LVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS---- 60

Query: 122 CHPNVLSLLGCCVD-NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHY 180
             P ++ L     D   LYL+ ++   G + +L    +    E   R  IA      L  
Sbjct: 61  --PWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEET-ARFYIAELVL-ALDS 116

Query: 181 LHK-GCQRRIIHRDIKSSNILLTADFEPQISDFGLAK----------------------- 216
           +HK G     IHRDIK  NIL+ AD   +++DFGL K                       
Sbjct: 117 VHKLGF----IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDN 172

Query: 217 -----WLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVD 271
                    Q    + + + GT  ++APE         + D ++ GV L E++ G  P  
Sbjct: 173 VLVRRRDHKQRRVRANSTV-GTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPF- 230

Query: 272 GSHQSLHSWAKPILN 286
               +L      I+N
Sbjct: 231 -YSDTLQETYNKIIN 244

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 63.8 bits (155), Expect = 3e-11
 Identities = 54/211 (25%), Positives = 98/211 (46%), Gaps = 26/211 (12%)

Query: 68  FSSENLVGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNV 126
           ++S   VG G Y  V   +  + GE++A+K+L++    +   K    E+  + H+ H NV
Sbjct: 17  YTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENV 76

Query: 127 LSLLGCCVD-------NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLH 179
           + LL               YL+  +        + H ++   V++ V          GL 
Sbjct: 77  IGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQ-----MLCGLK 131

Query: 180 YLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAP 239
           Y+H      IIHRD+K  N+ +  D E +I DFGLA+   ++ T + +     T  + AP
Sbjct: 132 YIHSA---GIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVV-----TRWYRAP 183

Query: 240 EY---FMHGIVDEKTDVFAFGVFLLEIISGR 267
           E    +MH   ++  D+++ G  + E+++G+
Sbjct: 184 EVILNWMH--YNQTVDIWSVGCIMAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 62.7 bits (152), Expect = 3e-11
 Identities = 68/266 (25%), Positives = 125/266 (46%), Gaps = 26/266 (9%)

Query: 74  VGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEF-LTEIGTIGHVCHPNVLSLLGC 132
           +G G + ++Y    +   E  V +   +     KEKE    E+  +  + HPN+++    
Sbjct: 8   IGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFAS 67

Query: 133 CVDNG-LYLIFQFSSRGSVASLFHDVN-SPGVEWKVRHKIA--VGTARGLHYLHKGCQRR 188
             +NG L+++ ++   G    L   +N   GV +     ++  V  + GL ++H    R+
Sbjct: 68  FQENGRLFIVMEYCDGGD---LMKRINRQRGVLFSEDQILSWFVQISLGLKHIH---DRK 121

Query: 189 IIHRDIKSSNILLTAD-FEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIV 247
           I+HRDIKS NI L+ +    ++ DFG+A+ L    +        GT  +L+PE   +   
Sbjct: 122 ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND--SMELAYTCVGTPYYLSPEICQNRPY 179

Query: 248 DEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQL 307
           + KTD+++ G  L E+ + + P +G+  +LH     I  QG     + P    + D+  L
Sbjct: 180 NNKTDIWSLGCVLYELCTLKHPFEGN--NLHQLVLKIC-QGYFAP-ISPNF--SRDLRSL 233

Query: 308 NRLAFAASLCIRASPTWRPTMSEVLE 333
                  S   + SP  RP+++ +L+
Sbjct: 234 ------ISQLFKVSPRDRPSITSILK 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 63.1 bits (154), Expect = 4e-11
 Identities = 46/201 (22%), Positives = 79/201 (39%), Gaps = 37/201 (18%)

Query: 90  GEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQFSSRG 148
              +AVK++          K    EI T   + HPN+L  +   + +  LY++    + G
Sbjct: 25  NTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG 84

Query: 149 SVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLH-KGCQRRIIHRDIKSSNILLTADFEP 207
           S   L       G+       I       L Y+H KG     IHR +K+S+ILL+ D + 
Sbjct: 85  SCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGF----IHRSVKASHILLSGDGKV 140

Query: 208 QISDFGLAKWLPSQWTHHSIAPIEGTFGH----------------LAPEYF---MHGIVD 248
            +S              +S++ I+                     L+PE     + G  +
Sbjct: 141 VLSGL-----------RYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQG-YN 188

Query: 249 EKTDVFAFGVFLLEIISGRKP 269
           EK+D+++ G+   E+ +G  P
Sbjct: 189 EKSDIYSVGITACELANGHVP 209

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 62.8 bits (153), Expect = 4e-11
 Identities = 68/276 (24%), Positives = 116/276 (42%), Gaps = 26/276 (9%)

Query: 66  NAFSSENLVGRGGYAEVYKG-VLQDGEEIAVKRLTKVVTDDRKE-KEFLTEIGTI--GHV 121
           N   +   +G G   +VYK    + G  +AVK++ +  T +++E K  L ++  +   H 
Sbjct: 15  NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRR--TGNKEENKRILMDLDVVLKSHD 72

Query: 122 CHPNVLSLLGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYL 181
           C P ++   G  + +    I        +  L   +  P  E  +  K+ V   + LHYL
Sbjct: 73  C-PYIVKCYGYFITDSDVFICMELMSTCLDKLLKRIQGPIPE-DILGKMTVAIVKALHYL 130

Query: 182 HKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEY 241
            +  +  +IHRD+K SNILL A    ++ DFG++  L         A   G   ++APE 
Sbjct: 131 KE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSA---GCAAYMAPER 185

Query: 242 F----MHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPR 297
                 +   D + DV++ G+ L+E+ +G+ P            K IL +        P 
Sbjct: 186 IDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTK-ILQEEP------PS 238

Query: 298 LQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLE 333
           L      +     +F   LC+      RP   E+L+
Sbjct: 239 LPPNEGFSPDFC-SF-VDLCLTKDHRKRPKYRELLQ 272

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 62.4 bits (151), Expect = 5e-11
 Identities = 56/206 (27%), Positives = 103/206 (50%), Gaps = 14/206 (6%)

Query: 74  VGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC 132
           +G G Y +VYK   +  GE  A+K +     +D    +   EI  +    H N+++  G 
Sbjct: 17  IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQ--QEIIMMKDCKHSNIVAYFGS 74

Query: 133 CVD-NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIH 191
            +  + L++  +F   GS+  ++H V  P  E ++ + ++  T +GL+YLH    +  +H
Sbjct: 75  YLRRDKLWICMEFCGGGSLQDIYH-VTGPLSESQIAY-VSRETLQGLYYLH---SKGKMH 129

Query: 192 RDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFM---HGIVD 248
           RDIK +NILLT +   +++DFG++  + +  T        GT   +APE       G  +
Sbjct: 130 RDIKGANILLTDNGHVKLADFGVSAQITA--TIAKRKSFIGTPYWMAPEVAAVERKGGYN 187

Query: 249 EKTDVFAFGVFLLEIISGRKPVDGSH 274
           +  D++A G+  +E+   + P+   H
Sbjct: 188 QLCDIWAVGITAIELAELQPPMFDLH 213

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 62.4 bits (151), Expect = 5e-11
 Identities = 61/239 (25%), Positives = 107/239 (44%), Gaps = 36/239 (15%)

Query: 60  EISIATNAFSSENLVGRGGYAEVYKGVL------QDGEEIAVKRLTKVVTDDRKEKEFLT 113
           EI+++T  F  E  +G   + +VYKG L      +  + +A+K L        +E EF  
Sbjct: 1   EINLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLRE-EFKH 57

Query: 114 EIGTIGHVCHPNVLSLLGCCV-DNGLYLIFQFSSRGSVASLF------HDVNSPGVEWKV 166
           E      + HPN++ LLG    +  L +IF + S   +           DV S   +  V
Sbjct: 58  EAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTV 117

Query: 167 RHK--------IAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWL 218
           +          I    A G+ +L       ++H+D+ + N+L+      +ISD GL + +
Sbjct: 118 KSTLEPADFVHIVTQIAAGMEFLS---SHHVVHKDLATRNVLVFDKLNVKISDLGLFREV 174

Query: 219 PS----QWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDG 272
            +    +   +S+ PI      ++PE  M+G     +D++++GV L E+ S G +P  G
Sbjct: 175 YAADYYKLMGNSLLPIR----WMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCG 229

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 62.7 bits (152), Expect = 5e-11
 Identities = 59/216 (27%), Positives = 106/216 (49%), Gaps = 19/216 (8%)

Query: 68  FSSENLVGRGGYAEVYKGVLQDGEEI-AVKRLTK--VVTDDRKEKEFLTEIGTIGHVCHP 124
           F+   ++G+G + +V     +  +E+ A+K L K  V+ DD  E   + E   +     P
Sbjct: 2   FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECT-MVEKRVLALQDKP 60

Query: 125 NVLSLLGCC---VDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKI--AVGTARGLH 179
             L+ L  C   VD  LY + ++ + G    L + +   G ++K    +  A   + GL 
Sbjct: 61  PFLTQLHSCFQTVDR-LYFVMEYVNGGD---LMYHIQQVG-KFKEPQAVFYAAEISVGLF 115

Query: 180 YLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAP 239
           +LH+   R II+RD+K  N++L ++   +I+DFG+ K         +     GT  ++AP
Sbjct: 116 FLHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCK--EHMVDGVTTRTFCGTPDYIAP 170

Query: 240 EYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQ 275
           E   +    +  D +A+GV L E+++G+ P DG  +
Sbjct: 171 EIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE 206

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 62.1 bits (151), Expect = 6e-11
 Identities = 61/267 (22%), Positives = 111/267 (41%), Gaps = 40/267 (14%)

Query: 75  GRGGYAEVYKGVLQ---DGEEIAVKRLTKVVTDDRKEK-----EFLTEIGTIGHVCHPNV 126
           G+G +  +YKGVL+   D + +   +   VV             F      +  + H ++
Sbjct: 4   GQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHL 63

Query: 127 LSLLGCCVDNGLYLIFQFSSRGSVASLFH-DVNSPGVEWKVRHKIAVGTARGLHYLHKGC 185
           + L G CV +   ++ ++   G +    H + N+  + WK+   +A   A  LHYL    
Sbjct: 64  VKLYGVCVRDENIMVEEYVKFGPLDVFLHREKNNVSLHWKL--DVAKQLASALHYLE--- 118

Query: 186 QRRIIHRDIKSSNILLT---ADFEPQ----ISDFGLAKWLPSQWTHHSIAPIEGTFGHLA 238
            ++++H ++   NIL+     +        +SD G+   + S+       P       +A
Sbjct: 119 DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVERIP------WIA 172

Query: 239 PEYFMHGIV--DEKTDVFAFGVFLLEIIS-GRKPVD--GSHQSLHSWAK----PILNQGE 289
           PE   +G        D ++FG  LLEI S G +P+    S +    +      P+ +  E
Sbjct: 173 PECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQHRLPMPDCAE 232

Query: 290 IEKLVDPRLQGAYDVTQLNRLAFAASL 316
           +  L++      YD T+  R +F A L
Sbjct: 233 LANLINQCW--TYDPTK--RPSFRAIL 255

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 62.2 bits (151), Expect = 6e-11
 Identities = 48/203 (23%), Positives = 95/203 (46%), Gaps = 16/203 (7%)

Query: 74  VGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCC 133
           +G G +  V  G  +   ++A+K + +       E EF+ E   +  + H  ++ L G C
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIKE---GSMSEDEFIEEAKVMMKLSHEKLVQLYGVC 68

Query: 134 V-DNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHR 192
                +Y++ ++ S G + +   +      +     ++      G+ YL     ++ IHR
Sbjct: 69  TKQRPIYIVTEYMSNGCLLNYLREHGK-RFQPSQLLEMCKDVCEGMAYLE---SKQFIHR 124

Query: 193 DIKSSNILLTADFEPQISDFGLAKW-LPSQWTHH--SIAPIEGTFGHLAPEYFMHGIVDE 249
           D+ + N L+      ++SDFGL+++ L  ++T    S  P+  +     PE  ++     
Sbjct: 125 DLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWS----PPEVLLYSKFSS 180

Query: 250 KTDVFAFGVFLLEIIS-GRKPVD 271
           K+DV+AFGV + E+ S G+ P +
Sbjct: 181 KSDVWAFGVLMWEVYSLGKMPYE 203

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 61.9 bits (150), Expect = 7e-11
 Identities = 59/245 (24%), Positives = 111/245 (45%), Gaps = 28/245 (11%)

Query: 91  EEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQFSSRGS 149
           +EI + + +  V D RKE   L ++       HPN+++       +G LY++ ++   G 
Sbjct: 31  KEIRLPKSSSAVEDSRKEAVLLAKMK------HPNIVAFKESFEADGHLYIVMEYCDGGD 84

Query: 150 VASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQI 209
           +                  +  V    G+ ++H+   +R++HRDIKS NI LT + + ++
Sbjct: 85  LMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHE---KRVLHRDIKSKNIFLTQNGKVKL 141

Query: 210 SDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKP 269
            DFG A+ L S   +       GT  ++ PE + +   + K+D+++ G  L E+ + + P
Sbjct: 142 GDFGSARLLTSPGAY--ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHP 199

Query: 270 VDGSHQSLHSWAKPILN--QGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPT 327
              +     SW   IL   QG  + L       +Y++  L +  F      + +P  RP+
Sbjct: 200 FQAN-----SWKNLILKVCQGSYKPL---PSHYSYELRSLIKQMF------KRNPRSRPS 245

Query: 328 MSEVL 332
            + +L
Sbjct: 246 ATTIL 250

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 62.0 bits (151), Expect = 7e-11
 Identities = 43/150 (28%), Positives = 78/150 (52%), Gaps = 13/150 (8%)

Query: 74  VGRGGYAEVYKGVLQD-GEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC 132
           +G G Y  V+K   ++ G+ +A+K+  +   D   +K  L EI  +  + HPN+++L+  
Sbjct: 9   IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEV 68

Query: 133 CVDN-GLYLIFQFSSRGSVASLFH--DVNSPGVEWKVRHKIAVGTARGLHYLHK-GCQRR 188
                 L+L+F++       ++ +  + N  GV   +  KI   T + +++ HK  C   
Sbjct: 69  FRRKRKLHLVFEYCDH----TVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNC--- 121

Query: 189 IIHRDIKSSNILLTADFEPQISDFGLAKWL 218
            IHRD+K  NIL+T   + ++ DFG A+ L
Sbjct: 122 -IHRDVKPENILITKQGQIKLCDFGFARIL 150

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 61.7 bits (150), Expect = 9e-11
 Identities = 49/169 (28%), Positives = 80/169 (47%), Gaps = 29/169 (17%)

Query: 66  NAFSSENLVGRGGYAEVYKGVLQD-GEEIAVKRLTKVVTDDRKEKEFLT---EIGTIGHV 121
           + F     +G G Y +VYK   +D GE +A+K   KV  D+ KE   +T   EI  +  +
Sbjct: 7   DKFDIIGQIGEGTYGQVYKARDKDTGELVALK---KVRLDNEKEGFPITAIREIKILRQL 63

Query: 122 CHPNVLSLLGCCVDN-----------GLYLIFQFSSR---GSVASLFHDVNSPGVEWKVR 167
            H N+++L     D              YL+F++      G + S     +   ++  ++
Sbjct: 64  NHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMK 123

Query: 168 HKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAK 216
             +      GL+Y HK   +  +HRDIK SNILL    + +++DFGLA+
Sbjct: 124 QLL-----EGLNYCHK---KNFLHRDIKCSNILLNNKGQIKLADFGLAR 164

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 62.0 bits (151), Expect = 9e-11
 Identities = 57/206 (27%), Positives = 98/206 (47%), Gaps = 15/206 (7%)

Query: 73  LVGRGGYAEVYKGVLQDGEEI-AVKRLTKVVTDDRKEKEF-LTEIGTIGHVCHPNVLSLL 130
           ++G+G + +V    L+  +E+ AVK L K V     + E  +TE   +        L+ L
Sbjct: 2   VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQL 61

Query: 131 GCC--VDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRR 188
             C    + L+ + ++ + G +  +FH   S   +       A     GL +LH   +R 
Sbjct: 62  HSCFQTKDRLFFVMEYVNGGDL--MFHIQRSGRFDEPRARFYAAEIVLGLQFLH---ERG 116

Query: 189 IIHRDIKSSNILLTADFEPQISDFGLAK--WLPSQWTHHSIAPIEGTFGHLAPEYFMHGI 246
           II+RD+K  N+LL ++   +I+DFG+ K   L    T    +   GT  ++APE   +  
Sbjct: 117 IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTT----STFCGTPDYIAPEILSYQP 172

Query: 247 VDEKTDVFAFGVFLLEIISGRKPVDG 272
                D +A GV L E+++G+ P +G
Sbjct: 173 YGPAVDWWALGVLLYEMLAGQSPFEG 198

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 61.6 bits (149), Expect = 1e-10
 Identities = 62/231 (26%), Positives = 103/231 (44%), Gaps = 52/231 (22%)

Query: 74  VGRGGYAEVY----KGVLQDGEE--IAVKRLTKVVTDDRKEKEFLTEIGTIGHV-CHPNV 126
           +G+G +  VY    KGV++D  E  +A+K + +  +  R+  EFL E   +    CH +V
Sbjct: 14  LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASM-RERIEFLNEASVMKEFNCH-HV 71

Query: 127 LSLLGCCVDNG--LYLIFQFSSRGSVASLFHDV-----NSPGVEWKVRHKI---AVGTAR 176
           + LLG  V  G    +I +  +RG + S    +     N+P        K+   A   A 
Sbjct: 72  VRLLGV-VSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIAD 130

Query: 177 GLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAK--------------WLPSQW 222
           G+ YL+     + +HRD+ + N ++  DF  +I DFG+ +               LP +W
Sbjct: 131 GMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 187

Query: 223 THHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDG 272
                         ++PE    G+    +DV++FGV L EI +   +P  G
Sbjct: 188 --------------MSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG 224

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 61.6 bits (149), Expect = 1e-10
 Identities = 59/252 (23%), Positives = 112/252 (44%), Gaps = 27/252 (10%)

Query: 86  VLQDGEEIAVKRLTKVVTDDRKEKE---FLTEIGTIGHVCHPNVLSLLGC-CVDNGLYLI 141
           V   G+ +AVK++     D RK++       E+  +    H NV+ +     V + L+++
Sbjct: 41  VKSSGKLVAVKKM-----DLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVV 95

Query: 142 FQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILL 201
            +F   G++  +   V    +  +    + +   + L  LH    + +IHRDIKS +ILL
Sbjct: 96  MEFLEGGALTDI---VTHTRMNEEQIAAVCLAVLKALSVLHA---QGVIHRDIKSDSILL 149

Query: 202 TADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLL 261
           T D   ++SDFG    +  +        + GT   +APE         + D+++ G+ ++
Sbjct: 150 THDGRVKLSDFGFCAQVSKEVPRRK--SLVGTPYWMAPELISRLPYGPEVDIWSLGIMVI 207

Query: 262 EIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRAS 321
           E++ G  P        +    P+     I   + P+L+  + V+   +  F   L +R  
Sbjct: 208 EMVDGEPP--------YFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLK-GFLDRLLVR-D 257

Query: 322 PTWRPTMSEVLE 333
           P  R T +E+L+
Sbjct: 258 PAQRATAAELLK 269

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 62.0 bits (150), Expect = 1e-10
 Identities = 55/205 (26%), Positives = 97/205 (47%), Gaps = 15/205 (7%)

Query: 73  LVGRGGYAEVYKGVLQDGEEIAVKRLTK--VVTDDRKEKEFLTEIGTIGHVC-HPNVLSL 129
           ++GRG YA+V    L+  E I   ++ K  +V DD       TE         HP ++ L
Sbjct: 2   VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61

Query: 130 LGCC-VDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRR 188
             C   ++ L+ + ++ + G +  +FH      +  +     +   +  L+YLH   +R 
Sbjct: 62  HSCFQTESRLFFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSAEISLALNYLH---ERG 116

Query: 189 IIHRDIKSSNILLTADFEPQISDFGLAK--WLPSQWTHHSIAPIEGTFGHLAPEYFMHGI 246
           II+RD+K  N+LL ++   +++D+G+ K    P   T    +   GT  ++APE      
Sbjct: 117 IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT----STFCGTPNYIAPEILRGED 172

Query: 247 VDEKTDVFAFGVFLLEIISGRKPVD 271
                D +A GV + E+++GR P D
Sbjct: 173 YGFSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 62.9 bits (153), Expect = 1e-10
 Identities = 58/230 (25%), Positives = 102/230 (44%), Gaps = 41/230 (17%)

Query: 73  LVGRGGYAEVYKGVLQD---GEEIAVKRLTKVVTDD-RKEKEFLTEIGTIGHVCHPNVLS 128
           L+G+GG  EVY     D      +A+K++ + ++++   +K FL E      + HP ++ 
Sbjct: 9   LIGKGGMGEVYLA--YDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVP 66

Query: 129 LLGCCVD-NGLYLIFQFSSRGSVASLFHDVNSPGVEWK---VRHKIAVGTARG--LHYLH 182
           +   C D + +Y    +    ++ SL   V      W+   +  ++A  T+ G  L   H
Sbjct: 67  VYSICSDGDPVYYTMPYIEGYTLKSLLKSV------WQKESLSKELAEKTSVGAFLSIFH 120

Query: 183 KGCQ-------RRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQ-------------W 222
           K C        + ++HRD+K  NILL    E  I D+G A +   +              
Sbjct: 121 KICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNI 180

Query: 223 THHSI---APIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKP 269
            + S+     I GT  ++APE  +     E TD++A GV L ++++   P
Sbjct: 181 CYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230

Length = 932

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 62.0 bits (151), Expect = 1e-10
 Identities = 55/212 (25%), Positives = 97/212 (45%), Gaps = 28/212 (13%)

Query: 74  VGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC 132
           +G G Y  V   +  + G+++A+K++          K  L E+  + H  H N++++   
Sbjct: 13  IGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDI 72

Query: 133 CVDNG-----LYLIFQFSSRGSVASLFHDVNS--PGVEWKVRH---KIAVGTARGLHYLH 182
               G     +Y++         + L H ++S  P  E  +R+   ++     RGL Y+H
Sbjct: 73  LRPPGADFKDVYVVMDLME----SDLHHIIHSDQPLTEEHIRYFLYQLL----RGLKYIH 124

Query: 183 KGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIE--GTFGHLAPE 240
                 +IHRD+K SN+L+  D E +I DFG+A+ L S  T H     E   T  + APE
Sbjct: 125 SAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPE 181

Query: 241 --YFMHGIVDEKTDVFAFGVFLLEIISGRKPV 270
               +        D+++ G    E++ GR+ +
Sbjct: 182 LLLSLPE-YTTAIDMWSVGCIFAEML-GRRQL 211

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 61.0 bits (148), Expect = 1e-10
 Identities = 48/201 (23%), Positives = 96/201 (47%), Gaps = 16/201 (7%)

Query: 74  VGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCC 133
           +G G +  V+ G  +   ++A+K + +       E++F+ E   +  + HP ++ L G C
Sbjct: 12  LGSGQFGVVHLGKWRAQIKVAIKAINE---GAMSEEDFIEEAKVMMKLSHPKLVQLYGVC 68

Query: 134 VDNG-LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHR 192
                LY++ +F   G + +         +   +   +      G+ YL    +   IHR
Sbjct: 69  TQQKPLYIVTEFMENGCLLNYLRQ-RQGKLSKDMLLSMCQDVCEGMEYLE---RNSFIHR 124

Query: 193 DIKSSNILLTADFEPQISDFGLAKW-LPSQWTHHSIA--PIEGTFGHLAPEYFMHGIVDE 249
           D+ + N L+++    ++SDFG+ ++ L  ++T  S A  P++ +     PE F       
Sbjct: 125 DLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWS----PPEVFNFSKYSS 180

Query: 250 KTDVFAFGVFLLEIIS-GRKP 269
           K+DV++FGV + E+ + G+ P
Sbjct: 181 KSDVWSFGVLMWEVFTEGKMP 201

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 61.8 bits (151), Expect = 1e-10
 Identities = 53/160 (33%), Positives = 81/160 (50%), Gaps = 36/160 (22%)

Query: 74  VGRGGYAEVYKGV-LQDGEEIAVKRLTKV------VTD-DRKEKE--FLTEIGTIGHVCH 123
           +G+G Y  V+K +  +  E +A+K   K+       TD  R  +E  FL E+G      H
Sbjct: 15  LGKGAYGIVWKAIDRRTKEVVALK---KIFDAFRNATDAQRTFREIMFLQELG-----DH 66

Query: 124 PNVLSLLGCCV-----DNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHK--IAVGTAR 176
           PN++ LL   V     D  +YL+F++     + +  H V    +   V HK  I     +
Sbjct: 67  PNIVKLLN--VIKAENDKDIYLVFEY-----METDLHAVIRANILEDV-HKRYIMYQLLK 118

Query: 177 GLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAK 216
            L Y+H G    +IHRD+K SNILL +D   +++DFGLA+
Sbjct: 119 ALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLAR 155

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 61.6 bits (150), Expect = 1e-10
 Identities = 57/208 (27%), Positives = 87/208 (41%), Gaps = 22/208 (10%)

Query: 75  GRGGYAEV----YKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTE----IGTIGHVCHPNV 126
           GRG + +V    YK     GE  A+K L K     R E E L        T     HP +
Sbjct: 8   GRGHFGKVLLAEYKK---TGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFL 64

Query: 127 LSLLGCC-VDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKI-AVGTARGLHYLHKG 184
           ++L  C   ++ +  + ++++ G +    H      V  + R    A     GL YLH  
Sbjct: 65  VNLFACFQTEDHVCFVMEYAAGGDLMMHIHT----DVFSEPRAVFYAACVVLGLQYLH-- 118

Query: 185 CQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMH 244
            + +I++RD+K  N+LL  +   +I+DFGL K           +   GT   LAPE    
Sbjct: 119 -ENKIVYRDLKLDNLLLDTEGFVKIADFGLCK--EGMGFGDRTSTFCGTPEFLAPEVLTE 175

Query: 245 GIVDEKTDVFAFGVFLLEIISGRKPVDG 272
                  D +  GV + E++ G  P  G
Sbjct: 176 TSYTRAVDWWGLGVLIYEMLVGESPFPG 203

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 61.2 bits (148), Expect = 2e-10
 Identities = 58/209 (27%), Positives = 101/209 (48%), Gaps = 23/209 (11%)

Query: 73  LVGRGGYAEVYKGVLQDGEEIAVKRLTK--VVTDDRKEKEFLTEIGTIGHV-----CHPN 125
           ++GRG YA+V    L+  ++I   ++ K  +V DD    E +  + T  HV      +P 
Sbjct: 2   VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDD----EDIDWVQTEKHVFEQASSNPF 57

Query: 126 VLSLLGCC-VDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKG 184
           ++ L  C    + L+L+ ++ + G +  +FH      +  +     A      L++LH  
Sbjct: 58  LVGLHSCFQTTSRLFLVIEYVNGGDL--MFHMQRQRKLPEEHARFYAAEICIALNFLH-- 113

Query: 185 CQRRIIHRDIKSSNILLTADFEPQISDFGLAK--WLPSQWTHHSIAPIEGTFGHLAPEYF 242
            +R II+RD+K  N+LL AD   +++D+G+ K    P   T    +   GT  ++APE  
Sbjct: 114 -ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTT----STFCGTPNYIAPEIL 168

Query: 243 MHGIVDEKTDVFAFGVFLLEIISGRKPVD 271
                    D +A GV + E+++GR P D
Sbjct: 169 RGEEYGFSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 61.0 bits (148), Expect = 2e-10
 Identities = 61/205 (29%), Positives = 92/205 (44%), Gaps = 9/205 (4%)

Query: 68  FSSENLVGRGGYAEVYK-GVLQDGEEIAVKRLTKVVTDDRK-EKEFLTEIGTIGHVCHPN 125
           F    ++G+GG+ EV    V   G+  A K+L K     RK E   L E   +  V    
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61

Query: 126 VLSL-LGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKG 184
           V+SL       + L L+    + G +    +++ +PG + +     A     GL  LH+ 
Sbjct: 62  VVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHR- 120

Query: 185 CQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMH 244
              RI++RD+K  NILL      +ISD GLA  +P   T   I    GT G++APE   +
Sbjct: 121 --ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET---IRGRVGTVGYMAPEVVKN 175

Query: 245 GIVDEKTDVFAFGVFLLEIISGRKP 269
                  D +  G  + E+I G+ P
Sbjct: 176 ERYTFSPDWWGLGCLIYEMIEGKSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 60.7 bits (147), Expect = 2e-10
 Identities = 60/200 (30%), Positives = 90/200 (45%), Gaps = 11/200 (5%)

Query: 74  VGRGGYAEVYK-GVLQDGEEIAVKRLTKVVTDDRK-EKEFLTEIGTIGHVCHPNVLSL-L 130
           +G+GG+ EV    V   G+  A K+L K     +  EK  L E   +  V  P +++L  
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60

Query: 131 GCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEW-KVRHKIAVGTARGLHYLHKGCQRRI 189
                  L L+    + G +    ++V   G+E  +V H  A  T   LH LH      I
Sbjct: 61  AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILH-LH---SMDI 116

Query: 190 IHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDE 249
           ++RD+K  N+LL      ++SD GLA  L       +I    GT G++APE         
Sbjct: 117 VYRDMKPENVLLDDQGNCRLSDLGLAVELKDG---KTITQRAGTNGYMAPEILKEEPYSY 173

Query: 250 KTDVFAFGVFLLEIISGRKP 269
             D FA G  + E+++GR P
Sbjct: 174 PVDWFAMGCSIYEMVAGRTP 193

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 60.8 bits (147), Expect = 2e-10
 Identities = 51/205 (24%), Positives = 89/205 (43%), Gaps = 13/205 (6%)

Query: 73  LVGRGGYAEVYKGVLQD-GEEIAVKRLTKVVTDDRKEKE---FLTEIGTIGHVCHPNVLS 128
           L+G+G +  VY     D G E+AVK++          KE      EI  + ++ H  ++ 
Sbjct: 9   LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68

Query: 129 LLGCCVD---NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGC 185
             GC  D     L +  +    GS+        +  +   V  K       G+ YLH   
Sbjct: 69  YYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGA--LTENVTRKYTRQILEGVSYLH--- 123

Query: 186 QRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQ-WTHHSIAPIEGTFGHLAPEYFMH 244
              I+HRDIK +NIL  +    ++ DFG +K L +   +   +  + GT   ++PE    
Sbjct: 124 SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISG 183

Query: 245 GIVDEKTDVFAFGVFLLEIISGRKP 269
                K D+++ G  ++E+++ + P
Sbjct: 184 EGYGRKADIWSVGCTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 60.9 bits (148), Expect = 2e-10
 Identities = 77/298 (25%), Positives = 120/298 (40%), Gaps = 60/298 (20%)

Query: 73  LVGRGGYAEVYKGVLQD-GEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLG 131
           LVG G Y  V K   ++ G+ +A+K+  +   D   +K  + EI  +  + H N+++L+ 
Sbjct: 8   LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67

Query: 132 CCVDNG-LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRII 190
                  LYL+F+F     +  L    N  G++     K      RG+ + H      II
Sbjct: 68  VFRRKKRLYLVFEFVDHTVLDDLEKYPN--GLDESRVRKYLFQILRGIEFCHS---HNII 122

Query: 191 HRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIE------GTFGHLAPEYFMH 244
           HRDIK  NIL++     ++ DFG A+ L         AP E       T  + APE    
Sbjct: 123 HRDIKPENILVSQSGVVKLCDFGFARTLA--------APGEVYTDYVATRWYRAPELL-- 172

Query: 245 GIVDEK----TDVFAFGVFLLEIISGRK--PVDGSHQSLHSWAKPILNQGEIEKLVDPRL 298
            + D K     D++A G  + E+++G    P D     L+   K + N       + PR 
Sbjct: 173 -VGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGN-------LIPRH 224

Query: 299 QGAYDVTQLN---RLAFA--------------------ASLCIRASPTWRPTMSEVLE 333
           Q  +    L    RL                       A  C+R  P  RP+ S++L 
Sbjct: 225 QEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 60.9 bits (148), Expect = 2e-10
 Identities = 37/133 (27%), Positives = 67/133 (50%), Gaps = 20/133 (15%)

Query: 169 KIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIA 228
           KI++   RGL YL +  + +I+HRD+K SNIL+ +  E ++ DFG++  L       S+A
Sbjct: 103 KISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL-----IDSMA 155

Query: 229 -PIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQ 287
               GT  +++PE         ++D+++ G+ L+E+  GR P+            P  + 
Sbjct: 156 NSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPI------------PPPDA 203

Query: 288 GEIEKLVDPRLQG 300
            E+E +    +  
Sbjct: 204 KELEAMFGRPVSE 216

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 60.9 bits (148), Expect = 2e-10
 Identities = 47/163 (28%), Positives = 85/163 (52%), Gaps = 35/163 (21%)

Query: 74  VGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEF----LTEIGTIGHVCHPNVLS 128
           +G+G + EV+K    +  + +A+K   KV+ ++ KE  F    L EI  +  + H NV++
Sbjct: 20  IGQGTFGEVFKARHKKTKQIVALK---KVLMENEKEG-FPITALREIKILQLLKHENVVN 75

Query: 129 LLGCCVDNGL---------YLIFQFSSRGSVASLFHDV----NSPGVEWKVRH--KIAVG 173
           L+  C              YL+F+F          HD+    ++  V++ +    K+   
Sbjct: 76  LIEICRTKATPYNRYKGSFYLVFEFCE--------HDLAGLLSNKNVKFTLSEIKKVMKM 127

Query: 174 TARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAK 216
              GL+Y+H+    +I+HRD+K++NIL+T D   +++DFGLA+
Sbjct: 128 LLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLAR 167

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 60.2 bits (146), Expect = 2e-10
 Identities = 53/204 (25%), Positives = 87/204 (42%), Gaps = 23/204 (11%)

Query: 74  VGRGGYAEVY--KGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHV--CHPNVLSL 129
           + +G +  VY  K     G+  A+K L K     + +   +     I  +    P V  L
Sbjct: 4   ISKGAFGSVYLAKKRST-GDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKL 62

Query: 130 LGCCVDNG--LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQR 187
                 +   LYL+ ++ + G  ASL   +     +W  +  IA     G+  LH   QR
Sbjct: 63  Y-YSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDW-AKQYIA-EVVLGVEDLH---QR 116

Query: 188 RIIHRDIKSSNILLTADFEPQISDFGLAK--WLPSQWTHHSIAPIEGTFGHLAPEYFMHG 245
            IIHRDIK  N+L+      +++DFGL++      +          GT  +LAPE  +  
Sbjct: 117 GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKK--------FVGTPDYLAPETILGV 168

Query: 246 IVDEKTDVFAFGVFLLEIISGRKP 269
             D+ +D ++ G  + E + G  P
Sbjct: 169 GDDKMSDWWSLGCVIFEFLFGYPP 192

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 60.6 bits (147), Expect = 3e-10
 Identities = 63/217 (29%), Positives = 104/217 (47%), Gaps = 39/217 (17%)

Query: 73  LVGRGGYAEVYKGVLQDGEEI-AVKRLTK-VVTDDRKEKEFLTEIGTIGHV-----CHPN 125
           ++GRG YA+V    L+    I A+K + K +V DD    E +  + T  HV      HP 
Sbjct: 2   VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDD----EDIDWVQTEKHVFETASNHPF 57

Query: 126 VLSLLGCC-VDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTAR-------- 176
           ++ L  C   ++ L+ + +F S G +  +FH         + + K+    AR        
Sbjct: 58  LVGLHSCFQTESRLFFVIEFVSGGDL--MFH--------MQRQRKLPEEHARFYSAEISL 107

Query: 177 GLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAK--WLPSQWTHHSIAPIEGTF 234
            L++LH   +R II+RD+K  N+LL A+   +++D+G+ K    P   T    +   GT 
Sbjct: 108 ALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTT----STFCGTP 160

Query: 235 GHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVD 271
            ++APE           D +A GV + E+++GR P D
Sbjct: 161 NYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 59.8 bits (145), Expect = 4e-10
 Identities = 55/204 (26%), Positives = 95/204 (46%), Gaps = 23/204 (11%)

Query: 74  VGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKE---KEFLTEIGTIGHVCHPNVLSL 129
           +G G Y  VYK      GE +A+K   K+  D   E      + EI  +  + HPN++ L
Sbjct: 8   IGEGTYGVVYKARNKLTGEVVALK---KIRLDTETEGVPSTAIREISLLKELNHPNIVKL 64

Query: 130 LGCC-VDNGLYLIFQFSSRGSVASLFHDVNSP-GVEWKVRHKIAVGTARGLHYLHKGCQR 187
           L     +N LYL+F+F  +      F D +   G+   +         +GL + H     
Sbjct: 65  LDVIHTENKLYLVFEFLHQD--LKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCH---SH 119

Query: 188 RIIHRDIKSSNILLTADFEPQISDFGLAK--WLPSQ-WTHHSIAPIEGTFGHLAPEYFMH 244
           R++HRD+K  N+L+  +   +++DFGLA+   +P + +TH  +     T  + APE  + 
Sbjct: 120 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-----TLWYRAPEILLG 174

Query: 245 G-IVDEKTDVFAFGVFLLEIISGR 267
                   D+++ G    E+++ R
Sbjct: 175 CKYYSTAVDIWSLGCIFAEMVTRR 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 59.2 bits (143), Expect = 5e-10
 Identities = 52/221 (23%), Positives = 94/221 (42%), Gaps = 50/221 (22%)

Query: 74  VGRGGYAEVYKGVLQDGE---EIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLL 130
           +G G +  V KGV +  +   ++A+K L K   +     E + E   +  + +P ++ ++
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDVAIKVL-KNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61

Query: 131 GCCVDNGLYLIFQFSSRG----------------SVASLFHDVNSPGVEWKVRHKIAVGT 174
           G C    L L+ + +S G                +V  L H V                 
Sbjct: 62  GVCEAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQV----------------- 104

Query: 175 ARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTF 234
           + G+ YL     +  +HRD+ + N+LL      +ISDFGL+K L +  +++       + 
Sbjct: 105 SMGMKYLE---GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR----SA 157

Query: 235 GH-----LAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKP 269
           G       APE         ++DV+++G+ + E  S G+KP
Sbjct: 158 GKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKP 198

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 59.7 bits (144), Expect = 5e-10
 Identities = 35/125 (28%), Positives = 70/125 (56%), Gaps = 8/125 (6%)

Query: 169 KIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIA 228
           K+++   RGL YL +  + +I+HRD+K SNIL+ +  E ++ DFG++  L     +  + 
Sbjct: 107 KVSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV- 163

Query: 229 PIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPV-DGSHQSLHS-WAKPILN 286
              GT  +++PE         ++D+++ G+ L+E+  GR P+     + L + + +P+++
Sbjct: 164 ---GTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVD 220

Query: 287 QGEIE 291
             E E
Sbjct: 221 GEEGE 225

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 59.2 bits (143), Expect = 7e-10
 Identities = 59/205 (28%), Positives = 91/205 (44%), Gaps = 9/205 (4%)

Query: 68  FSSENLVGRGGYAEVYK-GVLQDGEEIAVKRLTKVVTDDRK-EKEFLTEIGTIGHVCHPN 125
           F    ++G+GG+ EV    V   G+  A K+L K     RK E   L E   +  V    
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61

Query: 126 VLSL-LGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKG 184
           V+SL       + L L+    + G +    +++ +PG + +     A     GL  L + 
Sbjct: 62  VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQR- 120

Query: 185 CQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMH 244
              RI++RD+K  NILL      +ISD GLA  +P   T   +    GT G++APE   +
Sbjct: 121 --ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET---VRGRVGTVGYMAPEVINN 175

Query: 245 GIVDEKTDVFAFGVFLLEIISGRKP 269
                  D +  G  + E+I G+ P
Sbjct: 176 EKYTFSPDWWGLGCLIYEMIQGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 59.6 bits (144), Expect = 7e-10
 Identities = 50/178 (28%), Positives = 79/178 (44%), Gaps = 47/178 (26%)

Query: 175 ARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAK--------------WLPS 220
           ARG+ +L     R+ IHRD+ + NILL+ +   +I DFGLA+               LP 
Sbjct: 184 ARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPL 240

Query: 221 QWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHS 279
           +W              +APE     +   ++DV++FGV L EI S G  P  G       
Sbjct: 241 KW--------------MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQ----- 281

Query: 280 WAKPILNQGEIEKLVDPRLQGAYDVT--QLNRLAFAASLCIRASPTWRPTMSEVLEVM 335
                +N+   ++L D     A +    ++ R+  A   C +  P  RPT S ++E++
Sbjct: 282 -----INEEFCQRLKDGTRMRAPENATPEIYRIMLA---CWQGDPKERPTFSALVEIL 331

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 59.6 bits (144), Expect = 7e-10
 Identities = 54/212 (25%), Positives = 97/212 (45%), Gaps = 27/212 (12%)

Query: 74  VGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC 132
           VG G Y  V   +  + G ++A+K+L +    +   K    E+  + H+ H NV+ LL  
Sbjct: 23  VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDV 82

Query: 133 CVD-------NGLYLIFQFSSRGSVASLFHD-VNSPGVEWKVRHKIAVGTARGLHYLHKG 184
                     +  YL+  F        + H+ ++   +++ V   +     +GL Y+H  
Sbjct: 83  FTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQML-----KGLKYIHAA 137

Query: 185 CQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEY--- 241
               IIHRD+K  N+ +  D E +I DFGLA+   S+ T + +     T  + APE    
Sbjct: 138 ---GIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVV-----TRWYRAPEVILN 189

Query: 242 FMHGIVDEKTDVFAFGVFLLEIISGRKPVDGS 273
           +MH    +  D+++ G  + E+++G+    G 
Sbjct: 190 WMH--YTQTVDIWSVGCIMAEMLTGKPLFKGH 219

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 59.4 bits (144), Expect = 7e-10
 Identities = 54/228 (23%), Positives = 98/228 (42%), Gaps = 42/228 (18%)

Query: 74  VGRGGYAEVYKGVLQD-GEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC 132
           +G G    V+  V  D  + +AVK++  V+TD +  K  L EI  I  + H N++ +   
Sbjct: 13  LGCGSNGLVFSAVDSDCDKRVAVKKI--VLTDPQSVKHALREIKIIRRLDHDNIVKVYEV 70

Query: 133 CVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTA-------------RGLH 179
              +G  L     S   + S++  +    +E  + + +  G               RGL 
Sbjct: 71  LGPSGSDLTEDVGSLTELNSVY--IVQEYMETDLANVLEQGPLSEEHARLFMYQLLRGLK 128

Query: 180 YLHKGCQRRIIHRDIKSSNILL-TADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHL- 237
           Y+H      ++HRD+K +N+ + T D   +I DFGLA+ +   ++H          G+L 
Sbjct: 129 YIHSA---NVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHK---------GYLS 176

Query: 238 ---------APEYFMHGIVDEKT-DVFAFGVFLLEIISGRKPVDGSHQ 275
                    +P   +      K  D++A G    E+++G+    G+H+
Sbjct: 177 EGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHE 224

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 58.8 bits (142), Expect = 9e-10
 Identities = 33/94 (35%), Positives = 50/94 (53%), Gaps = 8/94 (8%)

Query: 177 GLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGH 236
           GL ++H    R +++RD+K +NILL      +ISD GLA     +  H S+    GT G+
Sbjct: 109 GLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GTHGY 161

Query: 237 LAPEYFMHGIV-DEKTDVFAFGVFLLEIISGRKP 269
           +APE    G+  D   D F+ G  L +++ G  P
Sbjct: 162 MAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 58.5 bits (141), Expect = 1e-09
 Identities = 56/220 (25%), Positives = 103/220 (46%), Gaps = 34/220 (15%)

Query: 74  VGRGGYAEVYKGVL------QDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVL 127
           +G G + +V+          QD   +AVK L      D   K+F  E   + ++ H +++
Sbjct: 13  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKD--ASDNARKDFHREAELLTNLQHEHIV 70

Query: 128 SLLGCCVD-NGLYLIFQFSSRGSV----------ASLFHDVNSPG--VEWKVRHKIAVGT 174
              G CV+ + L ++F++   G +          A L  + N P    + ++ H IA   
Sbjct: 71  KFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLH-IAQQI 129

Query: 175 ARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTH----HSIAPI 230
           A G+ YL     +  +HRD+ + N L+  +   +I DFG+++ + S   +    H++ PI
Sbjct: 130 AAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 186

Query: 231 EGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKP 269
                 + PE  M+     ++DV++ GV L EI + G++P
Sbjct: 187 R----WMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 58.3 bits (142), Expect = 1e-09
 Identities = 51/217 (23%), Positives = 92/217 (42%), Gaps = 50/217 (23%)

Query: 74  VGRGGYAEVYKGV-LQDGEEIAVKRLTKVVT--DD---RKEKEFLTEIGTIGHVCHPNVL 127
           +G G +  VY     + GE +A+K++ K     ++    +E + L ++       HPN++
Sbjct: 7   LGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNE-----HPNIV 61

Query: 128 SLLGCCVDNG-LYLIFQFSSRGSVASLFH----DVNSPGVEWKVRHKIAVGTARGLHYLH 182
            L     +N  LY +F++       +L+         P  E  +R  I     +GL ++H
Sbjct: 62  KLKEVFRENDELYFVFEYMEG----NLYQLMKDRKGKPFSESVIRS-IIYQILQGLAHIH 116

Query: 183 K-GCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQ----------WTHHSIAPIE 231
           K G      HRD+K  N+L++     +I+DFGLA+ + S+          W         
Sbjct: 117 KHG----FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVSTRW--------- 163

Query: 232 GTFGHLAPEYFMH-GIVDEKTDVFAFGVFLLEIISGR 267
               + APE  +         D++A G  + E+ + R
Sbjct: 164 ----YRAPEILLRSTSYSSPVDIWALGCIMAELYTLR 196

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 58.9 bits (142), Expect = 1e-09
 Identities = 58/211 (27%), Positives = 92/211 (43%), Gaps = 25/211 (11%)

Query: 74  VGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC 132
           VG G Y  V      + G  +AVK+L++        K    E+  + H+ H NV+ LL  
Sbjct: 25  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 84

Query: 133 CVD-------NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGC 185
                     N +YL+         A L + V    +       +     RGL Y+H   
Sbjct: 85  FTPARSLEEFNDVYLVTHLMG----ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 139

Query: 186 QRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEY---F 242
              IIHRD+K SN+ +  D E +I DFGLA+    + T +       T  + APE    +
Sbjct: 140 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYRAPEIMLNW 192

Query: 243 MHGIVDEKTDVFAFGVFLLEIISGRKPVDGS 273
           MH   ++  D+++ G  + E+++GR    G+
Sbjct: 193 MH--YNQTVDIWSVGCIMAELLTGRTLFPGT 221

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 58.1 bits (141), Expect = 2e-09
 Identities = 46/153 (30%), Positives = 74/153 (48%), Gaps = 17/153 (11%)

Query: 75  GRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCC 133
           G G + EVYK   ++ G  +A+K++      D      L EI  +  + HPNV+ L+   
Sbjct: 17  GEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMA 76

Query: 134 VDNGLYLIFQFSSRGSVASLF----HDV----NSPGVEWKVRH--KIAVGTARGLHYLHK 183
           V+       +   RGSV  +     HD+     +P V+          +    G++YLH 
Sbjct: 77  VERPDKSKRK---RGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLH- 132

Query: 184 GCQRRIIHRDIKSSNILLTADFEPQISDFGLAK 216
             +  I+HRDIK++NIL+      +I+DFGLA+
Sbjct: 133 --ENHILHRDIKAANILIDNQGILKIADFGLAR 163

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 57.8 bits (140), Expect = 2e-09
 Identities = 45/172 (26%), Positives = 74/172 (43%), Gaps = 35/172 (20%)

Query: 108 EKEFLTEIGTIGHVCHPNVLSLLGCCVD-NGLYLIFQFSSRGSVASLFHDVNSPGVEWKV 166
           EK  L E+       HP ++ L     D   LY++ ++   G + S            + 
Sbjct: 51  EKRVLKEVS------HPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYL----------RN 94

Query: 167 RHKIAVGTAR--------GLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWL 218
             + +  T           L YLH    + I++RD+K  NILL  +   +++DFG AK L
Sbjct: 95  SGRFSNSTGLFYASEIVCALEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKL 151

Query: 219 PSQ-WTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKP 269
             + WT      + GT  +LAPE       ++  D +A G+ + E++ G  P
Sbjct: 152 RDRTWT------LCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPP 197

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 57.7 bits (139), Expect = 2e-09
 Identities = 51/204 (25%), Positives = 99/204 (48%), Gaps = 8/204 (3%)

Query: 66  NAFSSENLVGRGGYAEVYKGVLQDGEEI-AVKRLTKVVTDDRKEKEFLTEIGTIGHVCHP 124
           N F    +VG G Y  V K   ++ +EI A+K+      ++  ++  L E+  +  +   
Sbjct: 1   NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60

Query: 125 NVLSLLGCCVDNG-LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHK 183
           N++ L       G LYL+F++  + ++  L  ++ +     KVR  I     + +H+ HK
Sbjct: 61  NIVELKEAFRRRGKLYLVFEYVEK-NMLELLEEMPNGVPPEKVRSYI-YQLIKAIHWCHK 118

Query: 184 GCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFM 243
                I+HRDIK  N+L++ +   ++ DFG A+ L S+ ++ +      T  + +PE  +
Sbjct: 119 N---DIVHRDIKPENLLISHNDVLKLCDFGFARNL-SEGSNANYTEYVATRWYRSPELLL 174

Query: 244 HGIVDEKTDVFAFGVFLLEIISGR 267
                +  D+++ G  L E+  G+
Sbjct: 175 GAPYGKAVDMWSVGCILGELSDGQ 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 57.6 bits (139), Expect = 2e-09
 Identities = 54/226 (23%), Positives = 97/226 (42%), Gaps = 21/226 (9%)

Query: 68  FSSENLVGRGGYAEVYKGVLQ----DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCH 123
           F+   ++G+G +  V +  L+      +++AVK L   +      +EFL E   +    H
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60

Query: 124 PNVLSLLGCCVDNGL-------YLIFQFSSRGSV-----ASLFHDVNSPGVEWKVRHKIA 171
           PNV+ L+G  + +          +I  F   G +      S   +     +  +   +  
Sbjct: 61  PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGE-EPFTLPLQTLVRFM 119

Query: 172 VGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIE 231
           +  A G+ YL     +  IHRD+ + N +L  +    ++DFGL+K + S   +      +
Sbjct: 120 IDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASK 176

Query: 232 GTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQS 276
                LA E     +    +DV+AFGV + EI++ G+ P  G   S
Sbjct: 177 LPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS 222

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 57.3 bits (138), Expect = 2e-09
 Identities = 76/290 (26%), Positives = 121/290 (41%), Gaps = 61/290 (21%)

Query: 74  VGRGGYAEVYKGVLQDG---EEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLL 130
           +G G + +V  G +  G    ++ VK L +V    +++ +FL E      + H N+L  L
Sbjct: 3   IGNGWFGKVILGEVNSGYTPAQVVVKEL-RVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61

Query: 131 GCCVDNGLYL-IFQFSSRGSVASLFHD---VNSPGVEWKVRHKIAVGTARGLHYLHKGCQ 186
           G C +   YL + +F   G +               +     ++A   A GL +LHK   
Sbjct: 62  GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK--- 118

Query: 187 RRIIHRDIKSSNILLTADFEPQISDFGLA--------------KWLPSQWTHHSIAPIEG 232
              IH D+   N LLTAD   +I D+GL+               W+P +W    IAP   
Sbjct: 119 NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRW----IAP--- 171

Query: 233 TFGHLAPEYFMHG---IVDE--KTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILN 286
               L  E  +HG   +VD+  +++V++ GV + E+   G +P    H S        + 
Sbjct: 172 ---ELVDE--VHGNLLVVDQTKESNVWSLGVTIWELFELGSQPY--RHLSDEQVLTYTVR 224

Query: 287 QGEIEKLVDPRLQGA-----YDVTQLNRLAFAASLCIRASPTWRPTMSEV 331
           + ++ KL  PRL+       Y+V Q   L           P  RP+  EV
Sbjct: 225 EQQL-KLPKPRLKLPLSDRWYEVMQFCWL----------QPEQRPSAEEV 263

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 58.7 bits (142), Expect = 2e-09
 Identities = 47/199 (23%), Positives = 87/199 (43%), Gaps = 20/199 (10%)

Query: 88  QDGEEIAVKRL-TKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLL--GCCVDNGLYLIFQF 144
             G E+A+K L T    ++ +   F  E      + HPN+++LL  G      L+ +F++
Sbjct: 1   MTGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEY 60

Query: 145 SSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTA- 203
               ++  +     +       R  + V     L  L     + I+HRD+K  NI+++  
Sbjct: 61  VPGRTLREVLAADGALPAGETGRLMLQV-----LDALACAHNQGIVHRDLKPQNIMVSQT 115

Query: 204 DFEP--QISDFGLAKWLPSQWTHHSIA-------PIEGTFGHLAPEYFMHGIVDEKTDVF 254
              P  ++ DFG+   LP      +          + GT  + APE      V   +D++
Sbjct: 116 GVRPHAKVLDFGIGTLLPG--VRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLY 173

Query: 255 AFGVFLLEIISGRKPVDGS 273
           A+G+  LE ++G++ V G+
Sbjct: 174 AWGLIFLECLTGQRVVQGA 192

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 57.3 bits (138), Expect = 3e-09
 Identities = 33/94 (35%), Positives = 49/94 (52%), Gaps = 8/94 (8%)

Query: 177 GLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGH 236
           GL ++H    R +++RD+K +NILL      +ISD GLA     +  H S+    GT G+
Sbjct: 109 GLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GTHGY 161

Query: 237 LAPEYFMHGIV-DEKTDVFAFGVFLLEIISGRKP 269
           +APE    G   D   D F+ G  L +++ G  P
Sbjct: 162 MAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSP 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 57.1 bits (138), Expect = 4e-09
 Identities = 61/235 (25%), Positives = 100/235 (42%), Gaps = 42/235 (17%)

Query: 49  TKP---TWRCFSFE-EISIATNAFSSENLVGRGGYAEVYK-GVLQDGEEIAVKRLTKVVT 103
           TKP   +W+   FE   ++ T +F    +    G  E Y    L+  E + +K++  V  
Sbjct: 8   TKPDTSSWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVA- 66

Query: 104 DDRKEKEFLTEIGTIGHVCHPNVLSLL-GCCVDNGLYLIFQFSSRGSVASLFHDVNSPGV 162
              +EK  L E+       HP +++++     +N +Y + +F   G    LF  +   G 
Sbjct: 67  ---QEKSILMEL------SHPFIVNMMCSFQDENRVYFLLEFVVGGE---LFTHLRKAG- 113

Query: 163 EWKVRHKIAVGTARGLH--------YLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGL 214
                 +     A+  H        YLH    + II+RD+K  N+LL      +++DFG 
Sbjct: 114 ------RFPNDVAKFYHAELVLAFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGF 164

Query: 215 AKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKP 269
           AK +P +        + GT  +LAPE        +  D +  GV L E I+G  P
Sbjct: 165 AKKVPDR-----TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPP 214

Length = 329

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 57.2 bits (138), Expect = 4e-09
 Identities = 53/209 (25%), Positives = 95/209 (45%), Gaps = 15/209 (7%)

Query: 73  LVGRGGYAEVYKGVL-QDGEEIAVKRLTK-VVTDDRKEKEFLTEIGTIGHVCHPNVLSLL 130
           ++G+G + +V    L + G   AVK L K V+  D   +  +TE   +    +   L+ L
Sbjct: 2   VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61

Query: 131 GCCVD--NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRR 188
            CC    + L+ + +F + G +  +FH   S   +       A      L +LH    + 
Sbjct: 62  YCCFQTPDRLFFVMEFVNGGDL--MFHIQKSRRFDEARARFYAAEITSALMFLH---DKG 116

Query: 189 IIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSI--APIEGTFGHLAPEYFMHGI 246
           II+RD+K  N+LL  +   +++DFG+ K    +   +    +   GT  ++APE     +
Sbjct: 117 IIYRDLKLDNVLLDHEGHCKLADFGMCK----EGIFNGKTTSTFCGTPDYIAPEILQEML 172

Query: 247 VDEKTDVFAFGVFLLEIISGRKPVDGSHQ 275
                D +A GV L E++ G  P +  ++
Sbjct: 173 YGPSVDWWAMGVLLYEMLCGHAPFEAENE 201

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 56.9 bits (137), Expect = 4e-09
 Identities = 58/221 (26%), Positives = 101/221 (45%), Gaps = 32/221 (14%)

Query: 71  ENLVGRGGYAEVYK-GVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSL 129
           E   G+   AE Y     +D   +AVK L       RK+  F  E   + ++ H +++  
Sbjct: 15  EGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKD--FQREAELLTNLQHEHIVKF 72

Query: 130 LGCCVD-NGLYLIFQFSSRGSVASLFHDVNSPG----VEWKVRHK-----------IAVG 173
            G C D + L ++F++   G +   F   + P     V+ + R             IA  
Sbjct: 73  YGVCGDGDPLIMVFEYMKHGDLNK-FLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 131

Query: 174 TARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTH----HSIAP 229
            A G+ YL     +  +HRD+ + N L+ A+   +I DFG+++ + S   +    H++ P
Sbjct: 132 IASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 188

Query: 230 IEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKP 269
           I      + PE  M+     ++DV++FGV L EI + G++P
Sbjct: 189 IR----WMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 225

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 56.8 bits (137), Expect = 5e-09
 Identities = 48/187 (25%), Positives = 85/187 (45%), Gaps = 22/187 (11%)

Query: 93  IAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCV-DNGLYLIF--------- 142
           +AVK L +   +     +FL EI  +  +  PN++ LL  C+  + L +I          
Sbjct: 49  VAVKML-REDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLN 107

Query: 143 QFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLT 202
           QF SR          +   + +     +A   A G+ YL        +HRD+ + N L+ 
Sbjct: 108 QFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS---SLNFVHRDLATRNCLVG 164

Query: 203 ADFEPQISDFGLAKWLPS----QWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGV 258
            ++  +I+DFG+++ L S    +    ++ PI      ++ E  + G     +DV+AFGV
Sbjct: 165 KNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIR----WMSWESILLGKFTTASDVWAFGV 220

Query: 259 FLLEIIS 265
            L EI++
Sbjct: 221 TLWEILT 227

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 57.0 bits (137), Expect = 5e-09
 Identities = 60/249 (24%), Positives = 103/249 (41%), Gaps = 20/249 (8%)

Query: 90  GEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDN-------GLYLIF 142
           G  +AVK+L++   +    K    E+  +  V H N++SLL              +YL+ 
Sbjct: 46  GINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVM 105

Query: 143 QFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLT 202
           +         +  +++   + + +   +      G+ +LH      IIHRD+K SNI++ 
Sbjct: 106 ELMDANLCQVIHMELDHERMSYLLYQMLC-----GIKHLHSA---GIIHRDLKPSNIVVK 157

Query: 203 ADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLE 262
           +D   +I DFGLA+   +  T+  + P   T  + APE  +     E  D+++ G  + E
Sbjct: 158 SDCTLKILDFGLAR---TACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 214

Query: 263 IISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASP 322
           ++ G     G+   +  W K I   G        RLQ        NR  +         P
Sbjct: 215 LVKGSVIFQGTDH-IDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFP 273

Query: 323 TWR-PTMSE 330
            W  P+ SE
Sbjct: 274 DWIFPSESE 282

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 56.8 bits (137), Expect = 5e-09
 Identities = 80/334 (23%), Positives = 133/334 (39%), Gaps = 51/334 (15%)

Query: 65  TNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCH 123
           TN +     VG G +  V     Q  G+ +A+K++ K  +     K    E+  + H+ H
Sbjct: 9   TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRH 68

Query: 124 PNVLSLLGCCVD--NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYL 181
            N++SL    +     +Y + +         L   + S  +E +          RGL Y+
Sbjct: 69  ENIISLSDIFISPLEDIYFVTELLG----TDLHRLLTSRPLEKQFIQYFLYQILRGLKYV 124

Query: 182 HKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEY 241
           H      ++HRD+K SNIL+  + + +I DFGLA+    Q T +       T  + APE 
Sbjct: 125 HSA---GVVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYV-----STRYYRAPEI 176

Query: 242 FMH-GIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEI--EKLVDPRL 298
            +     D + D+++ G    E++ G+    G         K  +NQ  I  + L  P  
Sbjct: 177 MLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPG---------KDHVNQFSIITDLLGTPPD 227

Query: 299 QGAYDVTQLNRLAFAASLCIRAS-------PTWRPTMSEVLEVMLEGDQIDKER------ 345
                +   N L F  SL  R             P+  ++LE ML  D   ++R      
Sbjct: 228 DVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDP--QKRISAAEA 285

Query: 346 --------WKMPEEEEEDQEEF-WGFDDLEYECD 370
                   +  P +E   +E+F W F+D +   D
Sbjct: 286 LAHPYLAPYHDPTDEPVAEEKFDWSFNDADLPVD 319

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 56.6 bits (136), Expect = 6e-09
 Identities = 61/255 (23%), Positives = 111/255 (43%), Gaps = 41/255 (16%)

Query: 90  GEEIAVKRLTKVVTDDRKEKE---FLTEIGTIGHVCHPNVLSLL-GCCVDNGLYLIFQFS 145
           G ++AVK +     D RK++       E+  +    H NV+ +     V   L+++ +F 
Sbjct: 46  GRQVAVKMM-----DLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFL 100

Query: 146 SRGSVASLFHDVNSPGVEWKVRHKIAV---GTARGLHYLHKGCQRRIIHRDIKSSNILLT 202
             G++  +               +IA       + L YLH    + +IHRDIKS +ILLT
Sbjct: 101 QGGALTDIVSQTRL------NEEQIATVCESVLQALCYLH---SQGVIHRDIKSDSILLT 151

Query: 203 ADFEPQISDFG----LAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGV 258
            D   ++SDFG    ++K +P +        + GT   +APE         + D+++ G+
Sbjct: 152 LDGRVKLSDFGFCAQISKDVPKR------KSLVGTPYWMAPEVISRTPYGTEVDIWSLGI 205

Query: 259 FLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCI 318
            ++E++ G  P        +    P+     +     P+L+ A+ ++ + R  F   +  
Sbjct: 206 MVIEMVDGEPP--------YFSDSPVQAMKRLRDSPPPKLKNAHKISPVLR-DFLERMLT 256

Query: 319 RASPTWRPTMSEVLE 333
           R  P  R T  E+L+
Sbjct: 257 R-EPQERATAQELLD 270

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 56.6 bits (136), Expect = 7e-09
 Identities = 30/106 (28%), Positives = 61/106 (57%), Gaps = 6/106 (5%)

Query: 165 KVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTH 224
           ++  K+++   +GL YL +  + +I+HRD+K SNIL+ +  E ++ DFG++  L     +
Sbjct: 103 QILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN 160

Query: 225 HSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPV 270
             +    GT  +++PE         ++D+++ G+ L+E+  GR P+
Sbjct: 161 SFV----GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPI 202

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 55.8 bits (135), Expect = 9e-09
 Identities = 53/197 (26%), Positives = 87/197 (44%), Gaps = 42/197 (21%)

Query: 93  IAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCC-VDNGLYLIF--------- 142
           +AVK L    +D+ +E +FL E+  +  +  PN+  LLG C VD  L +I          
Sbjct: 49  VAVKVLRPDASDNARE-DFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLN 107

Query: 143 QFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLT 202
           QF  +    +     NS  + +     +A   A G+ YL        +HRD+ + N L+ 
Sbjct: 108 QFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRDLATRNCLVG 164

Query: 203 ADFEPQISDFGLAK--------------WLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVD 248
            ++  +I+DFG+++               LP +W              +A E  + G   
Sbjct: 165 KNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRW--------------MAWESVLLGKFT 210

Query: 249 EKTDVFAFGVFLLEIIS 265
            K+DV+AFGV L EI++
Sbjct: 211 TKSDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 55.5 bits (134), Expect = 1e-08
 Identities = 56/208 (26%), Positives = 103/208 (49%), Gaps = 25/208 (12%)

Query: 74  VGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC 132
           +G G Y  VYKG   + G+ +A+K++     ++      + EI  +  + HPN++ L   
Sbjct: 8   IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67

Query: 133 CV-DNGLYLIFQFSS---RGSVASLFHDVNSPGVEWK-VRHKIAVGTARGLHYLHKGCQR 187
            + ++ LYLIF+F S   +  + SL           K   ++I     +G+ + H    R
Sbjct: 68  LMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQI----LQGILFCH---SR 120

Query: 188 RIIHRDIKSSNILLTADFEPQISDFGLAK--WLPSQ-WTHHSIAPIEGTFGHLAPEYFMH 244
           R++HRD+K  N+L+      +++DFGLA+   +P + +TH  +     T  + APE  + 
Sbjct: 121 RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVV-----TLWYRAPEVLL- 174

Query: 245 GIVDEKT--DVFAFGVFLLEIISGRKPV 270
           G     T  D+++ G    E+ + +KP+
Sbjct: 175 GSPRYSTPVDIWSIGTIFAEMAT-KKPL 201

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 55.5 bits (134), Expect = 1e-08
 Identities = 40/148 (27%), Positives = 71/148 (47%), Gaps = 13/148 (8%)

Query: 74  VGRGGYAEVYKGVLQD-GEEIAVKRLTKVVTDDRKE---KEFLTEIGTIGHVCHPNVLSL 129
           +G G Y  V+K   ++  E +A+KR   V  DD  E      L EI  +  + H N++ L
Sbjct: 8   IGEGTYGTVFKAKNRETHEIVALKR---VRLDDDDEGVPSSALREICLLKELKHKNIVRL 64

Query: 130 LGCC-VDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRR 188
                 D  L L+F++  +  +   F   N   ++ ++         +GL + H      
Sbjct: 65  YDVLHSDKKLTLVFEYCDQ-DLKKYFDSCNGD-IDPEIVKSFMFQLLKGLAFCH---SHN 119

Query: 189 IIHRDIKSSNILLTADFEPQISDFGLAK 216
           ++HRD+K  N+L+  + E +++DFGLA+
Sbjct: 120 VLHRDLKPQNLLINKNGELKLADFGLAR 147

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 55.8 bits (134), Expect = 1e-08
 Identities = 50/174 (28%), Positives = 74/174 (42%), Gaps = 43/174 (24%)

Query: 175 ARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAK--------------WLPS 220
           A+G+ +L     R+ IHRD+ + NILL+ +   +I DFGLA+               LP 
Sbjct: 189 AKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL 245

Query: 221 QWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHS 279
           +W              +APE     +   ++DV++FGV L EI S G  P  G       
Sbjct: 246 KW--------------MAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF 291

Query: 280 WAKPILNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLE 333
             +  L +G   +  D      Y  T L+        C    P+ RPT SE++E
Sbjct: 292 CRR--LKEGTRMRAPDYTTPEMYQ-TMLD--------CWHGEPSQRPTFSELVE 334

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 55.0 bits (132), Expect = 2e-08
 Identities = 52/205 (25%), Positives = 91/205 (44%), Gaps = 13/205 (6%)

Query: 73  LVGRGGYAEVYKGVLQD-GEEIAVKRLTKVVTDDRKEKE---FLTEIGTIGHVCHPNVLS 128
           L+GRG + EVY     D G E+AVK++          KE      EI  + ++ H  ++ 
Sbjct: 9   LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68

Query: 129 LLGCCVD---NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGC 185
             GC  D     L +  ++   GS+        +  +   V  +      +G+ YLH   
Sbjct: 69  YYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGA--LTENVTRRYTRQILQGVSYLHSN- 125

Query: 186 QRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHS-IAPIEGTFGHLAPEYFMH 244
              I+HRDIK +NIL  +    ++ DFG +K + +     + I  + GT   ++PE    
Sbjct: 126 --MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISG 183

Query: 245 GIVDEKTDVFAFGVFLLEIISGRKP 269
                K DV++    ++E+++ + P
Sbjct: 184 EGYGRKADVWSVACTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 55.2 bits (133), Expect = 2e-08
 Identities = 58/216 (26%), Positives = 93/216 (43%), Gaps = 20/216 (9%)

Query: 66  NAFSSENLVGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTI-GHVCH 123
             F  ++LVGRG + EV        G+  A+K + K V   ++   F  E   I      
Sbjct: 1   KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60

Query: 124 PNVLSLLGCCVDN-GLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLH 182
           P +  L     D   LYL+ ++   G + SL +       E   +  +A      +H +H
Sbjct: 61  PWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVL-AIHSVH 119

Query: 183 KGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYF 242
              Q   +HRDIK  N+L+      +++DFG A  L +    +S  P+ GT  ++APE  
Sbjct: 120 ---QMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPV-GTPDYIAPEVL 175

Query: 243 ---------MHGIVDEKTDVFAFGVFLLEIISGRKP 269
                     +G+   + D ++ GV   E+I GR P
Sbjct: 176 TTMNGDGKGTYGV---ECDWWSLGVIAYEMIYGRSP 208

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 55.2 bits (133), Expect = 2e-08
 Identities = 48/178 (26%), Positives = 77/178 (43%), Gaps = 47/178 (26%)

Query: 175 ARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAK--------------WLPS 220
           ARG+ +L     R+ IHRD+ + NILL+ +   +I DFGLA+               LP 
Sbjct: 183 ARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL 239

Query: 221 QWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHS 279
           +W              +APE     +   ++DV++FGV L EI S G  P  G       
Sbjct: 240 KW--------------MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQ----- 280

Query: 280 WAKPILNQGEIEKLVDPRLQGA--YDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVM 335
                +++    +L +     A  Y   ++  +      C   +P  RPT SE++E++
Sbjct: 281 -----IDEEFCRRLKEGTRMRAPEYATPEIYSIMLD---CWHNNPEDRPTFSELVEIL 330

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 54.7 bits (131), Expect = 2e-08
 Identities = 53/205 (25%), Positives = 89/205 (43%), Gaps = 13/205 (6%)

Query: 73  LVGRGGYAEVYKGVLQD-GEEIAVKRLTKVVTDDRKEKE---FLTEIGTIGHVCHPNVLS 128
           L+G+G +  VY     D G E+A K++          KE      EI  + ++ H  ++ 
Sbjct: 9   LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68

Query: 129 LLGCCVDNG---LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGC 185
             GC  D     L +  ++   GSV        +  +   V  K       G+ YLH   
Sbjct: 69  YYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGA--LTESVTRKYTRQILEGMSYLHSN- 125

Query: 186 QRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQ-WTHHSIAPIEGTFGHLAPEYFMH 244
              I+HRDIK +NIL  +    ++ DFG +K L +   +   I  + GT   ++PE    
Sbjct: 126 --MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISG 183

Query: 245 GIVDEKTDVFAFGVFLLEIISGRKP 269
                K DV++ G  ++E+++ + P
Sbjct: 184 EGYGRKADVWSLGCTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 54.6 bits (131), Expect = 2e-08
 Identities = 31/87 (35%), Positives = 50/87 (57%), Gaps = 6/87 (6%)

Query: 177 GLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGH 236
           G+HY+H   QRRI+HRD+K+ NI L  +   +I DFG+++ L       +     GT  +
Sbjct: 118 GVHYMH---QRRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATT--FTGTPYY 171

Query: 237 LAPEYFMHGIVDEKTDVFAFGVFLLEI 263
           ++PE   H   D K+D+++ G  L E+
Sbjct: 172 MSPEALKHQGYDSKSDIWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 55.0 bits (132), Expect = 2e-08
 Identities = 61/204 (29%), Positives = 93/204 (45%), Gaps = 17/204 (8%)

Query: 73  LVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKE-KEFLTEIGTI-GHVCHPNVLSL 129
           ++G+G + +V     + DG+  AVK L K +  +RKE K  + E   +  +V HP ++ L
Sbjct: 2   VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61

Query: 130 -LGCCVDNGLYLIFQFSSRGSVASLFH---DVNSPGVEWKVRHKIAVGTARGLHYLHKGC 185
                    LY +  F + G +   FH   + + P  E + R   A   A  L YLH   
Sbjct: 62  HYSFQTTEKLYFVLDFVNGGEL--FFHLQRERSFP--EPRARFYAA-EIASALGYLH--- 113

Query: 186 QRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHG 245
              I++RD+K  NILL +     ++DFGL K   +Q    +     GT  +LAPE     
Sbjct: 114 SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ--SDTTTTFCGTPEYLAPEVIRKQ 171

Query: 246 IVDEKTDVFAFGVFLLEIISGRKP 269
             D   D +  G  L E++ G  P
Sbjct: 172 PYDNTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 54.9 bits (132), Expect = 2e-08
 Identities = 29/90 (32%), Positives = 45/90 (50%), Gaps = 6/90 (6%)

Query: 176 RGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFG 235
            GL YLH    +RIIHRD+K+ NI +    +  I D G A++         +A   GT  
Sbjct: 168 EGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLA---GTVE 221

Query: 236 HLAPEYFMHGIVDEKTDVFAFGVFLLEIIS 265
             APE       + K D+++ G+ L E+++
Sbjct: 222 TNAPEVLARDKYNSKADIWSAGIVLFEMLA 251

Length = 357

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 54.8 bits (132), Expect = 2e-08
 Identities = 50/163 (30%), Positives = 71/163 (43%), Gaps = 16/163 (9%)

Query: 177 GLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIA-PIEGTFG 235
           GL +LHK   + II+RD+K  N+LL  D   +I+DFG+ K           A    GT  
Sbjct: 108 GLQFLHK---KGIIYRDLKLDNVLLDKDGHIKIADFGMCK---ENMNGEGKASTFCGTPD 161

Query: 236 HLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGE-----I 290
           ++APE       +E  D ++FGV L E++ G+ P  G  +     +  ILN        I
Sbjct: 162 YIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDS--ILNDRPHFPRWI 219

Query: 291 EKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLE 333
            K     L   ++     RL       IR  P +R    E LE
Sbjct: 220 SKEAKDCLSKLFERDPTKRLGVDGD--IRQHPFFRGIDWERLE 260

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 54.6 bits (131), Expect = 3e-08
 Identities = 54/215 (25%), Positives = 101/215 (46%), Gaps = 35/215 (16%)

Query: 74  VGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCC 133
           +G G YA V+KG  +  E +   +  ++  ++      + E+  +  + H N+++L    
Sbjct: 14  LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIV 73

Query: 134 -VDNGLYLIFQFSSR---------GSVASLFHDVNSPGVEWKVRHKIAV-GTARGLHYLH 182
             D  L L+F++  +         G++ S+ H+V           KI +    RGL Y H
Sbjct: 74  HTDKSLTLVFEYLDKDLKQYMDDCGNIMSM-HNV-----------KIFLYQILRGLAYCH 121

Query: 183 KGCQRRIIHRDIKSSNILLTADFEPQISDFGL--AKWLPSQWTHHSIAPIEGTFGHLAPE 240
           +   R+++HRD+K  N+L+    E +++DFGL  AK +P++   + +     T  +  P+
Sbjct: 122 R---RKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV----TLWYRPPD 174

Query: 241 YFMHGIVDEKT--DVFAFGVFLLEIISGRKPVDGS 273
             + G  +  T  D++  G    E+ SGR    GS
Sbjct: 175 VLL-GSSEYSTQIDMWGVGCIFFEMASGRPLFPGS 208

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 53.9 bits (129), Expect = 3e-08
 Identities = 54/215 (25%), Positives = 104/215 (48%), Gaps = 23/215 (10%)

Query: 74  VGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCC 133
           +G G YA V+KG  +  E +   +  ++  ++      + E+  + ++ H N+++L    
Sbjct: 13  LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72

Query: 134 -VDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAV---GTARGLHYLHKGCQRRI 189
             +  L L+F++      + L   +++ G    + H + +      RGL Y HK   R+I
Sbjct: 73  HTERCLTLVFEYLD----SDLKQYLDNCGNLMSM-HNVKIFMFQLLRGLSYCHK---RKI 124

Query: 190 IHRDIKSSNILLTADFEPQISDFGL--AKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIV 247
           +HRD+K  N+L+    E +++DFGL  AK +P++   + +     T  +  P+  + G  
Sbjct: 125 LHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV----TLWYRPPDVLL-GST 179

Query: 248 DEKT--DVFAFGVFLLEIISGRKPVDGS--HQSLH 278
           +  T  D++  G  L E+ +GR    GS   + LH
Sbjct: 180 EYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELH 214

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 53.6 bits (129), Expect = 5e-08
 Identities = 39/114 (34%), Positives = 58/114 (50%), Gaps = 12/114 (10%)

Query: 178 LHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWL--PSQWTHHSIAPIEGTFG 235
           L +LH   Q  II+RDIK  NILL ++    ++DFGL+K      +   +S     GT  
Sbjct: 118 LDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFC---GTIE 171

Query: 236 HLAPEYFMHGIV--DEKTDVFAFGVFLLEIISGRKP--VDGSHQSLHSWAKPIL 285
           ++APE    G    D+  D ++ GV   E+++G  P  VDG   S    ++ IL
Sbjct: 172 YMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRIL 225

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 53.1 bits (127), Expect = 6e-08
 Identities = 37/113 (32%), Positives = 58/113 (51%), Gaps = 8/113 (7%)

Query: 177 GLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGH 236
            L +LHK     II+RDIK  NILL ++    ++DFGL+K         + +   GT  +
Sbjct: 117 ALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYS-FCGTIEY 172

Query: 237 LAPEYFMHGIV--DEKTDVFAFGVFLLEIISGRKP--VDGSHQSLHSWAKPIL 285
           +AP+    G    D+  D ++ GV + E+++G  P  VDG   S    ++ IL
Sbjct: 173 MAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRIL 225

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 53.4 bits (128), Expect = 7e-08
 Identities = 63/216 (29%), Positives = 95/216 (43%), Gaps = 40/216 (18%)

Query: 74  VGRGGYAEVYKGVLQDGEEI-AVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVL--SLL 130
           +G+G + +VY+   +D   I A+K L+K     +KE        TIG     N+L  +LL
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAH-----TIGE---RNILVRTLL 52

Query: 131 GCC-----------VDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGT-ARGL 178
                          D+ LYL+  + S G    LF  +   G   + R K  +      L
Sbjct: 53  DESPFIVGLKFSFQTDSDLYLVTDYMSGGE---LFWHLQKEGRFSEDRAKFYIAELVLAL 109

Query: 179 HYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLA 238
            +LHK     I++RD+K  NILL A     + DFGL+K   +   + +     GT  +LA
Sbjct: 110 EHLHK---YDIVYRDLKPENILLDATGHIALCDFGLSK--ANLTDNKTTNTFCGTTEYLA 164

Query: 239 PEYFMHGIVDEK-----TDVFAFGVFLLEIISGRKP 269
           PE  +    DEK      D ++ GV + E+  G  P
Sbjct: 165 PEVLL----DEKGYTKHVDFWSLGVLVFEMCCGWSP 196

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 53.0 bits (128), Expect = 8e-08
 Identities = 55/199 (27%), Positives = 93/199 (46%), Gaps = 20/199 (10%)

Query: 75  GRGGYAEVYKG-VLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVC-HPNVLSLLGC 132
           G G ++EV K    + G+  A+K + K      ++   L EI  +  +  HPN+L L+  
Sbjct: 8   GEGTFSEVLKAQSRKTGKYYAIKCMKKHF-KSLEQVNNLREIQALRRLSPHPNILRLIEV 66

Query: 133 CVDNG---LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRI 189
             D     L L+F+     ++  L      P  E +V+  +     + L ++H   +  I
Sbjct: 67  LFDRKTGRLALVFELMD-MNLYELIKGRKRPLPEKRVKSYM-YQLLKSLDHMH---RNGI 121

Query: 190 IHRDIKSSNILLTADFEPQISDFGLAKWLPSQ--WTHHSIAPIEGTFGHLAPEYFM-HGI 246
            HRDIK  NIL+  D   +++DFG  + + S+  +T + I+    T  + APE  +  G 
Sbjct: 122 FHRDIKPENILIKDD-ILKLADFGSCRGIYSKPPYTEY-IS----TRWYRAPECLLTDGY 175

Query: 247 VDEKTDVFAFGVFLLEIIS 265
              K D++A G    EI+S
Sbjct: 176 YGPKMDIWAVGCVFFEILS 194

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 53.0 bits (127), Expect = 8e-08
 Identities = 47/195 (24%), Positives = 87/195 (44%), Gaps = 30/195 (15%)

Query: 93  IAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCV-DNGLYLIFQFSSRG--- 148
           +AVK L      + +  +FL E+  +  +  PN++ LLG CV ++ L +I ++   G   
Sbjct: 49  VAVKILRPDANKNAR-NDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLN 107

Query: 149 --------------SVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDI 194
                            ++      P + +     +A+  A G+ YL        +HRD+
Sbjct: 108 QFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDL 164

Query: 195 KSSNILLTADFEPQISDFGLAKWLPS----QWTHHSIAPIEGTFGHLAPEYFMHGIVDEK 250
            + N L+  +   +I+DFG+++ L +    +    ++ PI      +A E  + G     
Sbjct: 165 ATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIR----WMAWECILMGKFTTA 220

Query: 251 TDVFAFGVFLLEIIS 265
           +DV+AFGV L EI+ 
Sbjct: 221 SDVWAFGVTLWEILM 235

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 53.2 bits (128), Expect = 8e-08
 Identities = 61/207 (29%), Positives = 94/207 (45%), Gaps = 21/207 (10%)

Query: 74  VGRGGYAEVYKGVLQDGEEI-AVKRLTKVVTDDRKE-KEFLTEIGTIGHVCHPNVLSLLG 131
           VG+GGY +V+    +D  EI A+KR+ K +     E +  LTE   +       ++ LL 
Sbjct: 9   VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68

Query: 132 CCVD-NGLYLIFQFSSRGSVASLFHDVNSPGV--EWKVRHKIA--VGTARGLHYLHKGCQ 186
              D   LYL  ++   G   +L   +N+ GV  E   R  +A        LH L     
Sbjct: 69  AFQDDEYLYLAMEYVPGGDFRTL---LNNLGVLSEDHARFYMAEMFEAVDALHELG---- 121

Query: 187 RRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGI 246
              IHRD+K  N L+ A    +++DFGL+K + +    +S+    G+  ++APE      
Sbjct: 122 --YIHRDLKPENFLIDASGHIKLTDFGLSKGIVTY--ANSVV---GSPDYMAPEVLRGKG 174

Query: 247 VDEKTDVFAFGVFLLEIISGRKPVDGS 273
            D   D ++ G  L E + G  P  GS
Sbjct: 175 YDFTVDYWSLGCMLYEFLCGFPPFSGS 201

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 52.7 bits (126), Expect = 8e-08
 Identities = 53/219 (24%), Positives = 105/219 (47%), Gaps = 37/219 (16%)

Query: 66  NAFSSENL--VGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVC 122
            A S  NL  +G G YA VYKG+ + +G+ +A+K +  + T++      + E   +  + 
Sbjct: 3   AATSYLNLEKLGEGSYATVYKGISRINGQLVALK-VISMKTEEGVPFTAIREASLLKGLK 61

Query: 123 HPNVLSLLGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTA------- 175
           H N++ L         + I    ++ ++  +F  +++   ++ ++H   +          
Sbjct: 62  HANIVLL---------HDIIH--TKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMF 110

Query: 176 ---RGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLA--KWLPSQWTHHSIAPI 230
              RGL Y+H    + I+HRD+K  N+L++   E +++DFGLA  K +PSQ     +   
Sbjct: 111 QLLRGLAYIHG---QHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV-- 165

Query: 231 EGTFGHLAPEYFMHGIVDEKT--DVFAFGVFLLEIISGR 267
             T  +  P+  + G  D  +  D++  G   +E++ G+
Sbjct: 166 --TLWYRPPDVLL-GATDYSSALDIWGAGCIFIEMLQGQ 201

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 53.1 bits (128), Expect = 9e-08
 Identities = 37/107 (34%), Positives = 56/107 (52%), Gaps = 15/107 (14%)

Query: 176 RGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFG 235
           RGL Y+H      ++HRD+K SN+LL A+ + +I DFGLA+   +      +     T  
Sbjct: 119 RGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLAR--TTSEKGDFMTEYVVTRW 173

Query: 236 HLAPEYFMHGIVDEKT---DVFAFGVFLLEIISGRKPV----DGSHQ 275
           + APE  ++    E T   DV++ G    E++ GRKP+    D  HQ
Sbjct: 174 YRAPELLLN--CSEYTTAIDVWSVGCIFAELL-GRKPLFPGKDYVHQ 217

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 53.0 bits (127), Expect = 9e-08
 Identities = 54/205 (26%), Positives = 94/205 (45%), Gaps = 13/205 (6%)

Query: 73  LVGRGGYAEVYKGVLQ-DGEEIAVKRLTK--VVTDDRKEKEFLTEIGTIGHVCHPNVLSL 129
           ++G+G + +V+   L+   +  A+K L K  V+ DD  E   + +        HP  L+ 
Sbjct: 2   MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP-FLTH 60

Query: 130 LGCC--VDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQR 187
           L C       L+ + ++ + G +  +FH  +    +       A     GL +LH    +
Sbjct: 61  LYCTFQTKENLFFVMEYLNGGDL--MFHIQSCHKFDLPRATFYAAEIICGLQFLH---SK 115

Query: 188 RIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIV 247
            I++RD+K  NILL  D   +I+DFG+ K   +           GT  ++APE  +    
Sbjct: 116 GIVYRDLKLDNILLDTDGHIKIADFGMCK--ENMLGDAKTCTFCGTPDYIAPEILLGQKY 173

Query: 248 DEKTDVFAFGVFLLEIISGRKPVDG 272
           +   D ++FGV L E++ G+ P  G
Sbjct: 174 NTSVDWWSFGVLLYEMLIGQSPFHG 198

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 52.7 bits (126), Expect = 1e-07
 Identities = 53/215 (24%), Positives = 101/215 (46%), Gaps = 23/215 (10%)

Query: 74  VGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCC 133
           +G G YA VYKG  +  + +   +  ++  ++      + E+  +  + H N+++L    
Sbjct: 14  LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 73

Query: 134 -VDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAV---GTARGLHYLHKGCQRRI 189
             +  L L+F++  +     L    NS  +     H + +      RGL+Y H+   R++
Sbjct: 74  HTEKSLTLVFEYLDKDLKQYLDDCGNSINM-----HNVKLFLFQLLRGLNYCHR---RKV 125

Query: 190 IHRDIKSSNILLTADFEPQISDFGL--AKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIV 247
           +HRD+K  N+L+    E +++DFGL  AK +P++   + +     T  +  P+  + G  
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV----TLWYRPPDILL-GST 180

Query: 248 DEKT--DVFAFGVFLLEIISGRKPVDGS--HQSLH 278
           D  T  D++  G    E+ +GR    GS   + LH
Sbjct: 181 DYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLH 215

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 52.4 bits (126), Expect = 1e-07
 Identities = 34/102 (33%), Positives = 55/102 (53%), Gaps = 12/102 (11%)

Query: 176 RGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGL--AKWLPSQWTHHSIAPIEGT 233
           RGL Y H   QRR++HRD+K  N+L++   E +++DFGL  AK +PS+   + +     T
Sbjct: 114 RGLAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVV----T 166

Query: 234 FGHLAPEYFMHGIVDEKT--DVFAFGVFLLEIISGRKPVDGS 273
             +  P+  + G  +  T  D++  G    E+ +GR    GS
Sbjct: 167 LWYRPPDVLL-GSTEYSTSLDMWGVGCIFYEMATGRPLFPGS 207

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 52.4 bits (125), Expect = 1e-07
 Identities = 55/211 (26%), Positives = 93/211 (44%), Gaps = 25/211 (11%)

Query: 74  VGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC 132
           VG G Y  V      +  +++AVK+L++        +    E+  + H+ H NV+ LL  
Sbjct: 23  VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDV 82

Query: 133 CVD-------NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGC 185
                     N +YL+         A L + V    +  +    +     RGL Y+H   
Sbjct: 83  FTPATSIENFNEVYLVTNLMG----ADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHSA- 137

Query: 186 QRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEY---F 242
              IIHRD+K SN+ +  D E +I DFGLA+    + T +       T  + APE    +
Sbjct: 138 --GIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYV-----ATRWYRAPEIMLNW 190

Query: 243 MHGIVDEKTDVFAFGVFLLEIISGRKPVDGS 273
           MH   ++  D+++ G  + E++ G+    G+
Sbjct: 191 MH--YNQTVDIWSVGCIMAELLKGKALFPGN 219

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 52.1 bits (125), Expect = 2e-07
 Identities = 60/211 (28%), Positives = 94/211 (44%), Gaps = 18/211 (8%)

Query: 73  LVGRGGYAEVY---KGVLQD-GEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLS 128
           ++G+G + +V+   K    D G+  A+K L K     R       E   +  V HP ++ 
Sbjct: 3   VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVK 62

Query: 129 LLGCCVDNG-LYLIFQFSSRGSV-ASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQ 186
           L       G LYLI  F   G +   L  +V     E  V+  +A   A  L +LH    
Sbjct: 63  LHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMF--TEEDVKFYLA-ELALALDHLHS--- 116

Query: 187 RRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIE--GTFGHLAPEYFMH 244
             II+RD+K  NILL  +   +++DFGL+K    +   H        GT  ++APE    
Sbjct: 117 LGIIYRDLKPENILLDEEGHIKLTDFGLSK----ESIDHEKKAYSFCGTVEYMAPEVVNR 172

Query: 245 GIVDEKTDVFAFGVFLLEIISGRKPVDGSHQ 275
               +  D ++FGV + E+++G  P  G  +
Sbjct: 173 RGHTQSADWWSFGVLMFEMLTGSLPFQGKDR 203

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 52.0 bits (124), Expect = 2e-07
 Identities = 58/229 (25%), Positives = 95/229 (41%), Gaps = 63/229 (27%)

Query: 74  VGRGGYAEVYKGVLQDG---EEIAVKRL--TKVVTDDRKEKEFLTEIGTIGHVCHPNVLS 128
           VGRG Y  VYK   +DG    + A+K++  T +     +E   L E+       HPNV+S
Sbjct: 9   VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELK------HPNVIS 62

Query: 129 LLGCCV---DNGLYLIFQFSS-----------------------RGSVASLFHDVNSPGV 162
           L    +   D  ++L+F ++                        RG V SL + +     
Sbjct: 63  LQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQI----- 117

Query: 163 EWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEP----QISDFGLAKWL 218
                         G+HYLH      ++HRD+K +NIL+  +       +I+D G A+  
Sbjct: 118 ------------LDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLF 162

Query: 219 PSQWTHHS-IAPIEGTFGHLAPEYFMHGIVDEKT-DVFAFGVFLLEIIS 265
            S     + + P+  TF + APE  +      K  D++A G    E+++
Sbjct: 163 NSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 51.9 bits (124), Expect = 2e-07
 Identities = 54/202 (26%), Positives = 92/202 (45%), Gaps = 13/202 (6%)

Query: 73  LVGRGGYAEVYKGVLQDGEEI-AVKRLTK-VVTDDRKEKEFLTEIGTI-GHVCHPNVLSL 129
           ++G+G + +V     +  E+  AVK L K  +   ++EK  ++E   +  +V HP ++ L
Sbjct: 2   VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61

Query: 130 -LGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKI-AVGTARGLHYLHKGCQR 187
                  + LY +  + + G    LF+ +       + R +  A   A  L YLH     
Sbjct: 62  HFSFQTADKLYFVLDYINGGE---LFYHLQRERCFLEPRARFYAAEIASALGYLH---SL 115

Query: 188 RIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIV 247
            I++RD+K  NILL +     ++DFGL K   +   + + +   GT  +LAPE       
Sbjct: 116 NIVYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNGTTSTFCGTPEYLAPEVLHKQPY 173

Query: 248 DEKTDVFAFGVFLLEIISGRKP 269
           D   D +  G  L E++ G  P
Sbjct: 174 DRTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 52.0 bits (125), Expect = 2e-07
 Identities = 60/222 (27%), Positives = 91/222 (40%), Gaps = 45/222 (20%)

Query: 74  VGRGGYAEV----YKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHV-CHPNVLS 128
           +G+G Y  V          + E +A+K++T V +     K  L E+  + H   H N+  
Sbjct: 8   LGQGAYGIVCSARNAET-SEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNIT- 65

Query: 129 LLGCCVD---------NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLH 179
              C  D         N LYL ++      +  +      P  +   +  I      GL 
Sbjct: 66  ---CLYDMDIVFPGNFNELYL-YEELMEADLHQIIRS-GQPLTDAHFQSFI-YQILCGLK 119

Query: 180 YLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHL-- 237
           Y+H      ++HRD+K  N+L+ AD E +I DFGLA+         S  P E   G +  
Sbjct: 120 YIHSA---NVLHRDLKPGNLLVNADCELKICDFGLARGF-------SENPGENA-GFMTE 168

Query: 238 --------APEYFMHGIVDEKT-DVFAFGVFLLEIISGRKPV 270
                   APE  +      K  DV++ G  L E++ GRKPV
Sbjct: 169 YVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKPV 209

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 51.9 bits (124), Expect = 2e-07
 Identities = 43/163 (26%), Positives = 73/163 (44%), Gaps = 13/163 (7%)

Query: 123 HPNVLSLLGC-CVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYL 181
           HPN+++        + L++I  F + GS  SL       G+   +   I  G  RGL+YL
Sbjct: 58  HPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYL 117

Query: 182 HKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGH----- 236
           H   Q   IHR+IK+S+IL++ D    +S       L        +      F       
Sbjct: 118 H---QNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPW 174

Query: 237 LAPEYF---MHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQS 276
           L+PE     ++G  + K+D+++ G+   E+ +GR P     ++
Sbjct: 175 LSPELLRQDLYG-YNVKSDIYSVGITACELATGRVPFQDMLRT 216

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 51.7 bits (124), Expect = 2e-07
 Identities = 42/149 (28%), Positives = 73/149 (48%), Gaps = 14/149 (9%)

Query: 74  VGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCC 133
           +G G YA VYKG  +   EI   +   +  ++      + EI  +  + H N++ L    
Sbjct: 8   LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVI 67

Query: 134 -VDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHY-LHKG---C-QR 187
             +N L L+F++  +     L   +++ GV    R  +   T +   Y L KG   C + 
Sbjct: 68  HTENKLMLVFEYMDK----DLKKYMDTHGV----RGALDPNTVKSFTYQLLKGIAFCHEN 119

Query: 188 RIIHRDIKSSNILLTADFEPQISDFGLAK 216
           R++HRD+K  N+L+    E +++DFGLA+
Sbjct: 120 RVLHRDLKPQNLLINKRGELKLADFGLAR 148

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 51.9 bits (124), Expect = 2e-07
 Identities = 28/89 (31%), Positives = 48/89 (53%)

Query: 187 RRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGI 246
           R+++HRD+KS+NI L      ++ DFG +K      +    +   GT  +LAPE +    
Sbjct: 188 RKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKR 247

Query: 247 VDEKTDVFAFGVFLLEIISGRKPVDGSHQ 275
             +K D+++ GV L E+++  +P  G  Q
Sbjct: 248 YSKKADMWSLGVILYELLTLHRPFKGPSQ 276

Length = 478

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 51.6 bits (123), Expect = 3e-07
 Identities = 50/222 (22%), Positives = 94/222 (42%), Gaps = 26/222 (11%)

Query: 75  GRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCV 134
            +G     Y  VL     +A+K+L++   +    K    E+  +  V H N++SLL    
Sbjct: 29  AQGIVCAAYDAVLD--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFT 86

Query: 135 DN-------GLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQR 187
                     +YL+ +         +  +++   + + +   +      G+ +LH     
Sbjct: 87  PQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLC-----GIKHLHSA--- 138

Query: 188 RIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIV 247
            IIHRD+K SNI++ +D   +I DFGLA+   +  T   + P   T  + APE  +    
Sbjct: 139 GIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMGY 195

Query: 248 DEKTDVFAFGVFLLEIIS------GRKPVDGSHQSLHSWAKP 283
            E  D+++ G  + E++       GR  +D  ++ +     P
Sbjct: 196 KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP 237

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 51.6 bits (123), Expect = 3e-07
 Identities = 55/212 (25%), Positives = 96/212 (45%), Gaps = 29/212 (13%)

Query: 74  VGRGGYAEVYKGVLQDG---EEIAVKRL--TKVVTDDRKEKEFLTEIGTIGHVCHPNVLS 128
           VGRG Y  VYK   +DG   +E A+K++  T +     +E   L E+       HPNV++
Sbjct: 9   VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELK------HPNVIA 62

Query: 129 LLGCCV---DNGLYLIFQFSSRGSVASL-FHDVNSPG-----VEWKVRHKIAVGTARGLH 179
           L    +   D  ++L+F ++       + FH  +        +   +   +      G+H
Sbjct: 63  LQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIH 122

Query: 180 YLHKGCQRRIIHRDIKSSNILLTADFEP----QISDFGLAKWLPSQWTHHS-IAPIEGTF 234
           YLH      ++HRD+K +NIL+  +       +I+D G A+   S     + + P+  TF
Sbjct: 123 YLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTF 179

Query: 235 GHLAPEYFMHGIVDEKT-DVFAFGVFLLEIIS 265
            + APE  +      K  D++A G    E+++
Sbjct: 180 WYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 51.3 bits (123), Expect = 3e-07
 Identities = 58/207 (28%), Positives = 86/207 (41%), Gaps = 25/207 (12%)

Query: 74  VGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKE-KEFLTEIGT-IGHVCHPNVLSL- 129
           +G+G + +V       DG+  AVK L K     +KE K  + E    + +V HP ++ L 
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62

Query: 130 LGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKI-AVGTARGLHYLHKGCQRR 188
                 + LY +  + + G    LF  +       + R +  A   A  L YLH      
Sbjct: 63  YSFQTADKLYFVLDYVNGGE---LFFHLQRERSFPEPRARFYAAEIASALGYLH---SLN 116

Query: 189 IIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIE------GTFGHLAPEYF 242
           II+RD+K  NILL +     ++DFGL K          I   +      GT  +LAPE  
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCK--------EGIEHSKTTSTFCGTPEYLAPEVL 168

Query: 243 MHGIVDEKTDVFAFGVFLLEIISGRKP 269
                D   D +  G  L E++ G  P
Sbjct: 169 RKQPYDRTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 51.1 bits (122), Expect = 3e-07
 Identities = 56/205 (27%), Positives = 94/205 (45%), Gaps = 13/205 (6%)

Query: 73  LVGRGGYAEVYKGVLQ-DGEEIAVKRLTK--VVTDDRKEKEFLTEIGTIGHVCHPNVLSL 129
           ++G+G + +V    L+  GE  AVK L K  V+ DD  E   + E   +        L+ 
Sbjct: 2   VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECT-MVEKRVLALAWENPFLTH 60

Query: 130 LGCC--VDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQR 187
           L C       L+ + +F + G +  +FH  +    +       A     GL +LH    +
Sbjct: 61  LYCTFQTKEHLFFVMEFLNGGDL--MFHIQDKGRFDLYRATFYAAEIVCGLQFLH---SK 115

Query: 188 RIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIV 247
            II+RD+K  N++L  D   +I+DFG+ K   + +  +  +   GT  ++APE       
Sbjct: 116 GIIYRDLKLDNVMLDRDGHIKIADFGMCK--ENVFGDNRASTFCGTPDYIAPEILQGLKY 173

Query: 248 DEKTDVFAFGVFLLEIISGRKPVDG 272
               D ++FGV L E++ G+ P  G
Sbjct: 174 TFSVDWWSFGVLLYEMLIGQSPFHG 198

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 50.8 bits (121), Expect = 4e-07
 Identities = 49/197 (24%), Positives = 90/197 (45%), Gaps = 13/197 (6%)

Query: 74  VGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCC 133
           +G G YA VYKG  +   ++   ++ ++  ++      + E   +  + H N++ LL   
Sbjct: 13  LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIV-LLHDI 71

Query: 134 VDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRD 193
           +     L   F    +    + D +  G+  +          RGL Y+H   QR I+HRD
Sbjct: 72  IHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIH---QRYILHRD 128

Query: 194 IKSSNILLTADFEPQISDFGL--AKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKT 251
           +K  N+L++   E +++DFGL  AK +PS    + +     T  +  P+  + G  +  T
Sbjct: 129 LKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVV----TLWYRPPDVLL-GSTEYST 183

Query: 252 --DVFAFGVFLLEIISG 266
             D++  G   +E+I G
Sbjct: 184 CLDMWGVGCIFVEMIQG 200

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 51.3 bits (123), Expect = 4e-07
 Identities = 32/96 (33%), Positives = 47/96 (48%), Gaps = 11/96 (11%)

Query: 176 RGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLA-KWLPSQWTHHSIAPIEGTF 234
           RGL YLH      I+HRDIK  N+L+ ++   +I DFGLA    P +  H +   +  T 
Sbjct: 114 RGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVV--TQ 168

Query: 235 GHLAPEYFM---HGIVDEKTDVFAFGVFLLEIISGR 267
            + APE  M   H       D+++ G    E++  R
Sbjct: 169 YYRAPEILMGSRH--YTSAVDIWSVGCIFAELLGRR 202

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 51.0 bits (122), Expect = 4e-07
 Identities = 59/207 (28%), Positives = 97/207 (46%), Gaps = 20/207 (9%)

Query: 73  LVGRGGYAEVY---KGVLQDGEEI-AVKRLTK--VVTDDRKEKEFLTEIGTIGHVCHPNV 126
           ++G+GGY +V+   K    D  +I A+K L K  +V + +       E   +  V HP +
Sbjct: 3   VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62

Query: 127 LSLLGCCVDNG-LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVG-TARGLHYLHKG 184
           + L+      G LYLI ++ S G    LF  +   G+  +      +   +  L +LH  
Sbjct: 63  VDLIYAFQTGGKLYLILEYLSGGE---LFMHLEREGIFMEDTACFYLSEISLALEHLH-- 117

Query: 185 CQRRIIHRDIKSSNILLTADFEPQISDFGLAK--WLPSQWTHHSIAPIEGTFGHLAPEYF 242
            Q+ II+RD+K  NILL A    +++DFGL K        TH     IE    ++APE  
Sbjct: 118 -QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIE----YMAPEIL 172

Query: 243 MHGIVDEKTDVFAFGVFLLEIISGRKP 269
           M     +  D ++ G  + ++++G  P
Sbjct: 173 MRSGHGKAVDWWSLGALMYDMLTGAPP 199

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 51.0 bits (122), Expect = 4e-07
 Identities = 36/114 (31%), Positives = 53/114 (46%), Gaps = 34/114 (29%)

Query: 175 ARGLHYL-HKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAK--------------WLP 219
           A+G+ +L  K C    IHRD+ + NILLT     +I DFGLA+               LP
Sbjct: 224 AKGMSFLASKNC----IHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLP 279

Query: 220 SQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDG 272
            +W              +APE   + +   ++DV+++G+ L EI S G  P  G
Sbjct: 280 VKW--------------MAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPG 319

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 50.6 bits (121), Expect = 4e-07
 Identities = 70/283 (24%), Positives = 115/283 (40%), Gaps = 48/283 (16%)

Query: 74  VGRGGYAEVYKGVLQDGEEIA---VKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLL 130
           +G G + +V    +     +A   VK L K     +++ EFL +      + HPN+L  L
Sbjct: 3   IGNGWFGKVLLSEIYTDTGVARVVVKEL-KANASSKEQNEFLQQGDPYRILQHPNILQCL 61

Query: 131 GCCVDNGLY-LIFQFSSRGSVASLFHDVNSPGVEWKVR-------HKIAVGTARGLHYLH 182
           G CV+   Y L+F++   G + S          +W  R        ++A   A G+ ++H
Sbjct: 62  GQCVEAIPYLLVFEYCELGDLKSYLSQ-----EQWHRRNSQLLLLQRMACEIAAGVTHMH 116

Query: 183 KGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSI-------APIEGTFG 235
           K      +H D+   N  LT+D   ++ D+G+    PS++    I        P+     
Sbjct: 117 K---HNFLHSDLALRNCFLTSDLTVKVGDYGIG---PSRYKEDYIETEDDKCVPLRWLAP 170

Query: 236 HLAPEYFMHGIVDEKT---DVFAFGVFLLEIISGRKPVDGSHQSLHSWA-KPILNQGEIE 291
            L  E+    I  E+T   +V+A GV L E+       + + Q     + + +LN    +
Sbjct: 171 ELVGEFHGGLITAEQTKPSNVWALGVTLWELF------ENAAQPYSHLSDREVLNHVIKD 224

Query: 292 ---KLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEV 331
              KL  P+L+  Y       L F        SP  R T  EV
Sbjct: 225 QQVKLFKPQLELPYSERWYEVLQFCW-----LSPEKRATAEEV 262

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 51.0 bits (122), Expect = 4e-07
 Identities = 47/173 (27%), Positives = 72/173 (41%), Gaps = 45/173 (26%)

Query: 175 ARGLHYL-HKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAK--------------WLP 219
           A+G+ +L  K C    IHRD+ + N+LLT     +I DFGLA+               LP
Sbjct: 222 AQGMDFLASKNC----IHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLP 277

Query: 220 SQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLH 278
            +W              +APE     +   ++DV+++G+ L EI S G+ P  G      
Sbjct: 278 VKW--------------MAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPG------ 317

Query: 279 SWAKPILNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEV 331
                IL   +  K+V    Q +        +     +C    PT RPT S++
Sbjct: 318 -----ILVNSKFYKMVKRGYQMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQI 365

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 50.3 bits (120), Expect = 5e-07
 Identities = 51/214 (23%), Positives = 98/214 (45%), Gaps = 17/214 (7%)

Query: 71  ENLVGRGGYAEVYKGVLQDGEE----IAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNV 126
           E ++G G + E+ +G L+   +    +A+  L +    D++ + FL E  T+G   H N+
Sbjct: 10  ERILGTGRFGELCRGCLKLPSKRELPVAIHTL-RAGCSDKQRRGFLAEALTLGQFDHSNI 68

Query: 127 LSLLGCCV-DNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGC 185
           + L G     N + ++ ++ S G++ S         V  ++   +  G A G+ YL    
Sbjct: 69  VRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLP-GLASGMKYL---S 124

Query: 186 QRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHL--APEYFM 243
           +   +H+ + +  +L+ +D   +IS F     L    +      + G    L  APE   
Sbjct: 125 EMGYVHKGLAAHKVLVNSDLVCKISGFRR---LQEDKSEAIYTTMSGKSPVLWAAPEAIQ 181

Query: 244 HGIVDEKTDVFAFGVFLLEIIS-GRKPV-DGSHQ 275
           +      +DV++FG+ + E++S G +P  D S Q
Sbjct: 182 YHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ 215

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 50.3 bits (121), Expect = 6e-07
 Identities = 47/155 (30%), Positives = 83/155 (53%), Gaps = 21/155 (13%)

Query: 72  NLVGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKE-F----LTEIGTIGHVCHPN 125
           N +  G Y  VY+    + GE +A+K+L K+     KEKE F    L EI  +  + HPN
Sbjct: 11  NRIEEGTYGVVYRARDKKTGEIVALKKL-KM----EKEKEGFPITSLREINILLKLQHPN 65

Query: 126 VLSL----LGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYL 181
           ++++    +G  +D  +Y++ ++     + SL   +  P ++ +V+  + +    G+ +L
Sbjct: 66  IVTVKEVVVGSNLDK-IYMVMEYVEH-DLKSLMETMKQPFLQSEVK-CLMLQLLSGVAHL 122

Query: 182 HKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAK 216
           H      I+HRD+K+SN+LL      +I DFGLA+
Sbjct: 123 H---DNWILHRDLKTSNLLLNNRGILKICDFGLAR 154

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 50.4 bits (120), Expect = 7e-07
 Identities = 57/248 (22%), Positives = 106/248 (42%), Gaps = 30/248 (12%)

Query: 57  SFEEISIATNAFSS----ENL--VGRGGYAEV---YKGVLQDGEEIAVKRLTKVVTDDRK 107
           +F  + I  + F+     +NL  +G G    V   Y  +L+    +A+K+L++   +   
Sbjct: 9   NFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTH 66

Query: 108 EKEFLTEIGTIGHVCHPNVLSLLGCCVDN-------GLYLIFQFSSRGSVASLFHDVNSP 160
            K    E+  +  V H N++ LL              +Y++ +         +  +++  
Sbjct: 67  AKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHE 126

Query: 161 GVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPS 220
            + + +   +      G+ +LH      IIHRD+K SNI++ +D   +I DFGLA+   +
Sbjct: 127 RMSYLLYQMLC-----GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR---T 175

Query: 221 QWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSW 280
             T   + P   T  + APE  +     E  D+++ G  + E+I G     G+   +  W
Sbjct: 176 AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDH-IDQW 234

Query: 281 AKPILNQG 288
            K I   G
Sbjct: 235 NKVIEQLG 242

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 49.2 bits (117), Expect = 2e-06
 Identities = 48/204 (23%), Positives = 88/204 (43%), Gaps = 22/204 (10%)

Query: 74  VGRGGYAEVYKGVLQDGE--EIAVKRLTKV-VTDDRKEKEFLTEIGTIGHVCHPNVLSLL 130
           +G G +  V     ++ +   +A+KR  K  +   ++     +E   + ++ HP  ++L 
Sbjct: 38  LGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLY 97

Query: 131 GCCVDNG-LYLIFQFSSRGSVASLFHD----VNSPGVEWKVRHKIAVGTARGLHYLHKGC 185
           G   D   LYL+ +F   G   +         N  G  +      A        YL    
Sbjct: 98  GSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFY------AAQIVLIFEYLQ--- 148

Query: 186 QRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHG 245
              I++RD+K  N+LL  D   +++DFG AK + ++        + GT  ++APE  ++ 
Sbjct: 149 SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR-----TYTLCGTPEYIAPEILLNV 203

Query: 246 IVDEKTDVFAFGVFLLEIISGRKP 269
              +  D +  G+F+ EI+ G  P
Sbjct: 204 GHGKAADWWTLGIFIYEILVGCPP 227

Length = 340

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 49.2 bits (117), Expect = 2e-06
 Identities = 50/204 (24%), Positives = 89/204 (43%), Gaps = 14/204 (6%)

Query: 73  LVGRGGYAEVYKGVLQDGEEI-AVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLG 131
           ++GRG + EV     +  +++ A+K L+K     R +  F  E   I    +   +  L 
Sbjct: 50  VIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 109

Query: 132 CCV--DNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRI 189
           C    D  LY++ ++   G + +L  + + P  +W   +   V  A  L  +H      +
Sbjct: 110 CAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPE-KWAKFYTAEVVLA--LDAIH---SMGL 163

Query: 190 IHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMH----G 245
           IHRD+K  N+LL      +++DFG    +           + GT  +++PE        G
Sbjct: 164 IHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAV-GTPDYISPEVLKSQGGDG 222

Query: 246 IVDEKTDVFAFGVFLLEIISGRKP 269
               + D ++ GVFL E++ G  P
Sbjct: 223 YYGRECDWWSVGVFLFEMLVGDTP 246

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 48.9 bits (116), Expect = 2e-06
 Identities = 58/213 (27%), Positives = 96/213 (45%), Gaps = 19/213 (8%)

Query: 73  LVGRGGYAEVYKGVL----QDGEEIAVKRLTKVVTDDRKE-KEFLTEIGTIGHVCHPNVL 127
           L+G+G + +V   +L      G+  A+K L K V   + E    LTE   + +  HP + 
Sbjct: 2   LLGKGTFGKV---ILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLT 58

Query: 128 SL-LGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKI-AVGTARGLHYLHKGC 185
           SL       + L  + ++ + G    LF  ++   V  + R +         L YLH G 
Sbjct: 59  SLKYSFQTKDRLCFVMEYVNGGE---LFFHLSRERVFSEDRTRFYGAEIVSALDYLHSG- 114

Query: 186 QRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHG 245
             +I++RD+K  N++L  D   +I+DFGL K   +     ++    GT  +LAPE     
Sbjct: 115 --KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA--TMKTFCGTPEYLAPEVLEDN 170

Query: 246 IVDEKTDVFAFGVFLLEIISGRKPV-DGSHQSL 277
                 D +  GV + E++ GR P  +  H+ L
Sbjct: 171 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL 203

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 49.0 bits (117), Expect = 2e-06
 Identities = 50/206 (24%), Positives = 89/206 (43%), Gaps = 18/206 (8%)

Query: 73  LVGRGGYAEVYKGVLQDGEEI-AVKRLTKVVTDDRKEKEFLTEIGTI-GHVCHPNVLSLL 130
           ++GRG + EV     +  +++ A+K L+K     R +  F  E   I  H     ++ L 
Sbjct: 50  VIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQL- 108

Query: 131 GCCV---DNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQR 187
                  D  LY++ ++   G + +L  + + P  +W   +   V  A  L  +H     
Sbjct: 109 -HYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPE-KWARFYTAEVVLA--LDAIHS---M 161

Query: 188 RIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFM---- 243
             IHRD+K  N+LL      +++DFG    + +         + GT  +++PE       
Sbjct: 162 GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAV-GTPDYISPEVLKSQGG 220

Query: 244 HGIVDEKTDVFAFGVFLLEIISGRKP 269
            G    + D ++ GVFL E++ G  P
Sbjct: 221 DGYYGRECDWWSVGVFLYEMLVGDTP 246

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 48.7 bits (116), Expect = 2e-06
 Identities = 55/215 (25%), Positives = 97/215 (45%), Gaps = 27/215 (12%)

Query: 73  LVGRGGYAEVYKGVLQDGEEI-AVKRLTK--VVTDD-----RKEKEFLTEIGTIGHVCHP 124
           ++G+G + +V    L+  +E+ A+K L K  ++ DD       EK  L          HP
Sbjct: 2   VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAK-----HP 56

Query: 125 NVLSLLGCC--VDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLH 182
             L+ L CC    + L+ + ++ + G +  +F    S   +       A      L +LH
Sbjct: 57  -FLTALHCCFQTKDRLFFVMEYVNGGDL--MFQIQRSRKFDEPRSRFYAAEVTLALMFLH 113

Query: 183 KGCQRRIIHRDIKSSNILLTADFEPQISDFGLAK--WLPSQWTHHSIAPIEGTFGHLAPE 240
              +  +I+RD+K  NILL A+   +++DFG+ K   L    T        GT  ++APE
Sbjct: 114 ---RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTT----TTFCGTPDYIAPE 166

Query: 241 YFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQ 275
                      D +A GV + E+++G+ P +  ++
Sbjct: 167 ILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNE 201

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 48.8 bits (117), Expect = 2e-06
 Identities = 36/118 (30%), Positives = 53/118 (44%), Gaps = 28/118 (23%)

Query: 176 RGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFG 235
           RGL Y+H      ++HRD+K SN+LL  + + +I DFGLA+            P     G
Sbjct: 117 RGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLAR---------IADPEHDHTG 164

Query: 236 HL----------APEYFMHGIVDEKT-DVFAFGVFLLEIISGRKPV----DGSHQSLH 278
            L          APE  ++     K  D+++ G  L E++S R P+    D  HQ   
Sbjct: 165 FLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR-PLFPGKDYLHQLNL 221

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 48.6 bits (116), Expect = 2e-06
 Identities = 37/164 (22%), Positives = 70/164 (42%), Gaps = 30/164 (18%)

Query: 72  NLVGRGGYAEVYKGV-LQDGEEIAVKR--LTKVVTDDRKEKEF----------LTEIGTI 118
             +G G Y +V K      G+ +A+K+  + ++  D  K+++           L E+  +
Sbjct: 15  AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74

Query: 119 GHVCHPNVLSLLGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVR----HK--IAV 172
             + H N++ L+   V+     +        V  +        V+ K+R        I +
Sbjct: 75  NEIKHENIMGLVDVYVEGDFINL--------VMDIMASDLKKVVDRKIRLTESQVKCILL 126

Query: 173 GTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAK 216
               GL+ LHK      +HRD+  +NI + +    +I+DFGLA+
Sbjct: 127 QILNGLNVLHK---WYFMHRDLSPANIFINSKGICKIADFGLAR 167

Length = 335

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 48.6 bits (116), Expect = 2e-06
 Identities = 39/155 (25%), Positives = 68/155 (43%), Gaps = 17/155 (10%)

Query: 71  ENLVGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSL 129
           + ++G+G Y  V   +    GE++A+K++  V          L EI  +  + HP+++ +
Sbjct: 5   QEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEI 64

Query: 130 LGCCVD------NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHK--IAVGTARGLHYL 181
               +         +Y++F+      + S  H V     +    H         R L Y+
Sbjct: 65  KHIMLPPSRREFKDIYVVFEL-----MESDLHQVIKANDDLTPEHHQFFLYQLLRALKYI 119

Query: 182 HKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAK 216
           H      + HRD+K  NIL  AD + +I DFGLA+
Sbjct: 120 HTA---NVFHRDLKPKNILANADCKLKICDFGLAR 151

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 48.5 bits (115), Expect = 3e-06
 Identities = 64/244 (26%), Positives = 100/244 (40%), Gaps = 53/244 (21%)

Query: 68  FSSENLVGRGGYAEVYKGVLQD-GEEIAVKRLTKV-------VTDDRKEKEFLTEIGTIG 119
           F S  ++GRG + EV     +D G   A+K L K        V   R E++ L E  ++ 
Sbjct: 3   FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLW 62

Query: 120 HVCHPNVLSLLGCCVDN-GLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGL 178
                 V+ +     D   LYLI +F   G + +L    ++   E + +  IA  T   +
Sbjct: 63  ------VVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTL-TEEETQFYIA-ETVLAI 114

Query: 179 HYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWL----------------PSQW 222
             +H   Q   IHRDIK  N+LL +    ++SDFGL   L                PS +
Sbjct: 115 DSIH---QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDF 171

Query: 223 THHSIAPIE-----------------GTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS 265
           T  ++                     GT  ++APE FM    ++  D ++ GV + E++ 
Sbjct: 172 TFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLI 231

Query: 266 GRKP 269
           G  P
Sbjct: 232 GYPP 235

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 48.2 bits (114), Expect = 6e-06
 Identities = 51/227 (22%), Positives = 96/227 (42%), Gaps = 36/227 (15%)

Query: 74  VGRGGYAEVYKGVLQDGEEIAV-KRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC 132
           +G G + EV+    +  +E    K ++     +R++ + + E+  +  + H N++  +  
Sbjct: 21  IGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDR 80

Query: 133 CVDNG---LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGL-------HYLH 182
            ++     LY++ +F   G ++          +  K+     V   R L       H L 
Sbjct: 81  FLNKANQKLYILMEFCDAGDLSRNIQKCYK--MFGKIEEHAIVDITRQLLHALAYCHNLK 138

Query: 183 KGCQ-RRIIHRDIKSSNILLTADFE-----------------PQISDFGLAKWLPSQWTH 224
            G    R++HRD+K  NI L+                      +I DFGL+K +  +   
Sbjct: 139 DGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMA 198

Query: 225 HSIAPIEGTFGHLAPEYFMHGI--VDEKTDVFAFGVFLLEIISGRKP 269
           HS     GT  + +PE  +H     D+K+D++A G  + E+ SG+ P
Sbjct: 199 HSCV---GTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTP 242

Length = 1021

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 47.3 bits (112), Expect = 7e-06
 Identities = 28/92 (30%), Positives = 42/92 (45%), Gaps = 4/92 (4%)

Query: 176 RGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFG 235
           R + YLH   + RIIHRDIK+ NI +    +  + DFG A + P     +      GT  
Sbjct: 193 RAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACF-PVDINANKYYGWAGTIA 248

Query: 236 HLAPEYFMHGIVDEKTDVFAFGVFLLEIISGR 267
             APE           D+++ G+ L E+ +  
Sbjct: 249 TNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280

Length = 391

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 47.1 bits (112), Expect = 7e-06
 Identities = 49/183 (26%), Positives = 81/183 (44%), Gaps = 11/183 (6%)

Query: 90  GEEIAVKRLTKVVTDDRKE-KEFLTEIGTIGHVCHPNVLSL-LGCCVDNGLYLIFQFSSR 147
           G+  A+K L K V   + E    LTE   + +  HP + +L       + L  + ++++ 
Sbjct: 20  GKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANG 79

Query: 148 GSVASLFHDVNSPGVEWKVRHKI-AVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFE 206
           G    LF  ++   V  + R +         L YLH      +++RD+K  N++L  D  
Sbjct: 80  GE---LFFHLSRERVFSEDRARFYGAEIVSALGYLHS---CDVVYRDLKLENLMLDKDGH 133

Query: 207 PQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISG 266
            +I+DFGL K   S     ++    GT  +LAPE           D +  GV + E++ G
Sbjct: 134 IKITDFGLCKEGISD--GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 191

Query: 267 RKP 269
           R P
Sbjct: 192 RLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 47.3 bits (112), Expect = 7e-06
 Identities = 32/93 (34%), Positives = 46/93 (49%), Gaps = 7/93 (7%)

Query: 178 LHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAK-WLPSQWTHHSIAPIEGTFGH 236
           L YLH    R +++RDIK  N++L  D   +I+DFGL K  +    T  +     GT  +
Sbjct: 108 LEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC---GTPEY 161

Query: 237 LAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKP 269
           LAPE           D +  GV + E++ GR P
Sbjct: 162 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 47.4 bits (113), Expect = 7e-06
 Identities = 31/91 (34%), Positives = 48/91 (52%), Gaps = 6/91 (6%)

Query: 177 GLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGH 236
           G+ +LH      IIHRD+K SNI++ +D   +I DFGLA+   +  T   + P   T  +
Sbjct: 130 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYY 183

Query: 237 LAPEYFMHGIVDEKTDVFAFGVFLLEIISGR 267
            APE  +     E  D+++ G  + E+I G 
Sbjct: 184 RAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 46.9 bits (111), Expect = 8e-06
 Identities = 50/224 (22%), Positives = 98/224 (43%), Gaps = 40/224 (17%)

Query: 74  VGRGGYAEVYKGVL------QDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVL 127
           +G G + +V+          QD   +AVK L +     R++ +   E+ T+  + H +++
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTV--LQHQHIV 70

Query: 128 SLLGCCVD-NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHK----------------I 170
              G C +   L ++F++   G +      + S G + K+                   I
Sbjct: 71  RFYGVCTEGRPLLMVFEYMRHGDLNRF---LRSHGPDAKILAGGEDVAPGQLTLGQMLAI 127

Query: 171 AVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTH----HS 226
           A   A G+ YL        +HRD+ + N L+      +I DFG+++ + S   +     +
Sbjct: 128 ASQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRT 184

Query: 227 IAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKP 269
           + PI      + PE  ++     ++D+++FGV L EI + G++P
Sbjct: 185 MLPIR----WMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 46.7 bits (111), Expect = 1e-05
 Identities = 61/229 (26%), Positives = 104/229 (45%), Gaps = 33/229 (14%)

Query: 66  NAFSSENLVGRGGYAEVY----KGVLQDGEEIAVKRLTK--VVTDDRKEKEFLT-EIGTI 118
             F +  L+  G Y  VY    K   Q     A+K++ K  ++  ++ ++ F+  +I T 
Sbjct: 1   EDFETIKLISNGAYGAVYLVRHKETRQ---RFAMKKINKQNLILRNQIQQVFVERDILTF 57

Query: 119 GHVCHPNVLSLLGCCVDNGLYL--IFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTAR 176
               +P V+S+  C  +   +L  + ++   G  A+L  ++ +  V+   R   A  T  
Sbjct: 58  AE--NPFVVSMF-CSFETKRHLCMVMEYVEGGDCATLLKNIGALPVD-MARMYFA-ETVL 112

Query: 177 GLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKW-LPSQWTHHSIAPIE---- 231
            L YLH      I+HRD+K  N+L+T+    +++DFGL+K  L S  T+     IE    
Sbjct: 113 ALEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTR 169

Query: 232 --------GTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDG 272
                   GT  ++APE  +     +  D +A G+ L E + G  P  G
Sbjct: 170 EFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFG 218

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 46.6 bits (110), Expect = 1e-05
 Identities = 31/102 (30%), Positives = 50/102 (49%), Gaps = 5/102 (4%)

Query: 177 GLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGH 236
            L YLH   ++ +++RD+K  N++L  D   +I+DFGL K         ++    GT  +
Sbjct: 107 ALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGTPEY 162

Query: 237 LAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPV-DGSHQSL 277
           LAPE           D +  GV + E++ GR P  +  H+ L
Sbjct: 163 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL 204

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 46.6 bits (110), Expect = 1e-05
 Identities = 37/136 (27%), Positives = 57/136 (41%), Gaps = 33/136 (24%)

Query: 145 SSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYL-HKGCQRRIIHRDIKSSNILLTA 203
           S+   V +L  D  S G+            ARG+ +L  K C    +HRD+ + N+LL  
Sbjct: 217 SNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNC----VHRDLAARNVLLAQ 272

Query: 204 DFEPQISDFGLAK--------------WLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDE 249
               +I DFGLA+              +LP +W              +APE     +   
Sbjct: 273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKW--------------MAPESIFDNLYTT 318

Query: 250 KTDVFAFGVFLLEIIS 265
            +DV+++G+ L EI S
Sbjct: 319 LSDVWSYGILLWEIFS 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 46.1 bits (109), Expect = 2e-05
 Identities = 54/202 (26%), Positives = 85/202 (42%), Gaps = 13/202 (6%)

Query: 73  LVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKE-KEFLTEIGTI-GHVCHPNVLSL 129
           ++G+G + +V     + DG   AVK L K     +KE    + E   +  ++ HP ++ L
Sbjct: 2   VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61

Query: 130 -LGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKI-AVGTARGLHYLHKGCQR 187
                    LY +  + + G    LF  +       + R +  A   A  + YLH     
Sbjct: 62  HYSFQTAEKLYFVLDYVNGGE---LFFHLQRERCFLEPRARFYAAEVASAIGYLH---SL 115

Query: 188 RIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIV 247
            II+RD+K  NILL +     ++DFGL K         + +   GT  +LAPE       
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCK--EGVEPEETTSTFCGTPEYLAPEVLRKEPY 173

Query: 248 DEKTDVFAFGVFLLEIISGRKP 269
           D   D +  G  L E++ G  P
Sbjct: 174 DRTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 46.2 bits (110), Expect = 2e-05
 Identities = 53/164 (32%), Positives = 75/164 (45%), Gaps = 24/164 (14%)

Query: 66  NAFSSENLVGRGGYAEVYKGVLQDGEEI-AVKRLTKV-------VTDDRKEKEFLTEIGT 117
           + F S  ++GRG + EV     +D   I A+K+L K        V   R E++ L E   
Sbjct: 1   DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAE--- 57

Query: 118 IGHVCHPNVLSLLGCCVD-NGLYLIFQFSSRGSVASLF--HDVNSPGVEWKVRHKIAVGT 174
                +P V+ L     D N LYLI ++   G + +L    D  +   E + R  IA  T
Sbjct: 58  ---ADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFT---EEETRFYIA-ET 110

Query: 175 ARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWL 218
              +  +HK      IHRDIK  N+LL A    ++SDFGL   L
Sbjct: 111 ILAIDSIHK---LGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGL 151

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 45.8 bits (108), Expect = 2e-05
 Identities = 49/205 (23%), Positives = 89/205 (43%), Gaps = 16/205 (7%)

Query: 73  LVGRGGYAEVYKGVLQDGEEI-AVKRLTKVVTDDRKEKEFL-TEIGTIGHVCHPNVLSLL 130
           ++GRG + EV     +   ++ A+K L+K     R +  F   E   +     P V+ L 
Sbjct: 50  VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 109

Query: 131 GCCVDNG-LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTA-RGLHYLHKGCQRR 188
               D+  LY++ ++   G + +L  + + P  +W   +   V  A   +H +       
Sbjct: 110 YAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPE-KWARFYTAEVVLALDAIHSMG------ 162

Query: 189 IIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMH---- 244
            IHRD+K  N+LL      +++DFG    +  +        + GT  +++PE        
Sbjct: 163 FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGGD 221

Query: 245 GIVDEKTDVFAFGVFLLEIISGRKP 269
           G    + D ++ GVFL E++ G  P
Sbjct: 222 GYYGRECDWWSVGVFLYEMLVGDTP 246

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 45.3 bits (107), Expect = 2e-05
 Identities = 34/114 (29%), Positives = 60/114 (52%), Gaps = 13/114 (11%)

Query: 178 LHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHL 237
           L +LHK     I++RDIK  NILL ++    ++DFGL+K   S+    + +   GT  ++
Sbjct: 118 LEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYS-FCGTIEYM 173

Query: 238 APEYFM----HGIVDEKTDVFAFGVFLLEIISGRKP--VDGSHQSLHSWAKPIL 285
           APE       HG   +  D ++ G+ + E+++G  P  ++G   +    ++ IL
Sbjct: 174 APEIIRGKGGHG---KAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRIL 224

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 46.0 bits (109), Expect = 3e-05
 Identities = 29/81 (35%), Positives = 45/81 (55%), Gaps = 5/81 (6%)

Query: 136 NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIK 195
           N +YL+ ++   G V SL H       E  V++   V  A  L YLH   +  IIHRD+K
Sbjct: 77  NNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALA--LDYLH---RHGIIHRDLK 131

Query: 196 SSNILLTADFEPQISDFGLAK 216
             N+L++ +   +++DFGL+K
Sbjct: 132 PDNMLISNEGHIKLTDFGLSK 152

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 45.0 bits (106), Expect = 3e-05
 Identities = 64/244 (26%), Positives = 97/244 (39%), Gaps = 53/244 (21%)

Query: 68  FSSENLVGRGGYAEVYKGVLQD-GEEIAVKRLTKV-------VTDDRKEKEFLTEIGTIG 119
           F S  ++GRG + EV     +D G   A+K L K        V   R E++ L E     
Sbjct: 3   FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAW 62

Query: 120 HVCHPNVLSLLGCCVDN-GLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGL 178
                 V+ +     D   LYLI +F   G + +L    ++   E   +  IA  T   +
Sbjct: 63  ------VVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEE-ATQFYIA-ETVLAI 114

Query: 179 HYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWL----------------PSQW 222
             +H   Q   IHRDIK  N+LL A    ++SDFGL   L                PS +
Sbjct: 115 DAIH---QLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDF 171

Query: 223 THHSIAPIE-----------------GTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS 265
           +  ++                     GT  ++APE FM    ++  D ++ GV + E++ 
Sbjct: 172 SFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLI 231

Query: 266 GRKP 269
           G  P
Sbjct: 232 GYPP 235

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 45.1 bits (106), Expect = 3e-05
 Identities = 53/215 (24%), Positives = 88/215 (40%), Gaps = 23/215 (10%)

Query: 68  FSSENLVGRGGYAEVYKGVLQDGEEI-AVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNV 126
           F    ++GRG + EV    L++ +++ A+K L K     R E     E   +        
Sbjct: 3   FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQW 62

Query: 127 LSLLGCCV--DNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHK-----IAVGTARGLH 179
           ++ L      +N LYL+  +   G + +L         E   R       IA+ +   LH
Sbjct: 63  ITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH 122

Query: 180 YLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAP 239
           Y         +HRDIK  NIL+  +   +++DFG    L    T  S   + GT  +++P
Sbjct: 123 Y---------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-GTPDYISP 172

Query: 240 EYFM-----HGIVDEKTDVFAFGVFLLEIISGRKP 269
           E         G    + D ++ GV + E++ G  P
Sbjct: 173 EILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 44.9 bits (106), Expect = 4e-05
 Identities = 60/204 (29%), Positives = 89/204 (43%), Gaps = 20/204 (9%)

Query: 74  VGRGGYAEVYKGVLQDGEEI-AVKRLTKVVTDDRKE-KEFLTEIGTIGHVCHPNVLSLLG 131
           +G+G + +V +   +D + I A+K + K     R E    L E   +  V  P ++ L  
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60

Query: 132 CCVDNG-LYLIFQFSSRGSVASLFHDVNSPGV--EWKVRHKIAVGTARGLHYLHKGCQRR 188
                  LYL+  F + G    LFH +   G     + R   A      L  LHK     
Sbjct: 61  SFQSPEKLYLVLAFINGGE---LFHHLQREGRFDLSRARFYTA-ELLCALENLHK---FN 113

Query: 189 IIHRDIKSSNILLTADFEPQIS--DFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFM-HG 245
           +I+RD+K  NILL  D++  I+  DFGL K               GT  +LAPE  + HG
Sbjct: 114 VIYRDLKPENILL--DYQGHIALCDFGLCKLNMKD--DDKTNTFCGTPEYLAPELLLGHG 169

Query: 246 IVDEKTDVFAFGVFLLEIISGRKP 269
              +  D +  GV L E+++G  P
Sbjct: 170 YT-KAVDWWTLGVLLYEMLTGLPP 192

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 45.0 bits (106), Expect = 4e-05
 Identities = 33/140 (23%), Positives = 59/140 (42%), Gaps = 35/140 (25%)

Query: 141 IFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYL-HKGCQRRIIHRDIKSSNI 199
           +     R    +L ++  SP + +      +   A G+ +L  K C    +HRD+ + N+
Sbjct: 217 LPSAPERTRRDTLINE--SPALSYMDLVGFSYQVANGMEFLASKNC----VHRDLAARNV 270

Query: 200 LLTADFEPQISDFGLAK--------------WLPSQWTHHSIAPIEGTFGHLAPEYFMHG 245
           L+      +I DFGLA+              +LP +W              +APE   + 
Sbjct: 271 LICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKW--------------MAPESIFNN 316

Query: 246 IVDEKTDVFAFGVFLLEIIS 265
           +    +DV++FG+ L EI +
Sbjct: 317 LYTTLSDVWSFGILLWEIFT 336

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 44.3 bits (105), Expect = 4e-05
 Identities = 43/204 (21%), Positives = 92/204 (45%), Gaps = 28/204 (13%)

Query: 82  VYKGVLQDGEEIAVKRLTKVVTDDRKEKE-FLTEIGTIGHVCHPNVLSLLGCCVDNG--- 137
           +YKG+  + +E+ ++   K     +   +    EI  +  +   N+L + G  +D     
Sbjct: 36  IYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94

Query: 138 --LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIK 195
             L LI ++ +RG +  +        + +K +  +A+   +GL+ L+K   +   ++++ 
Sbjct: 95  PRLSLILEYCTRGYLREVLD--KEKDLSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNLT 150

Query: 196 SSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVD------- 248
           S + L+T +++ +I   GL K L S        P       +   YF + +++       
Sbjct: 151 SVSFLVTENYKLKIICHGLEKILSS--------PPFKNVNFMV--YFSYKMLNDIFSEYT 200

Query: 249 EKTDVFAFGVFLLEIISGRKPVDG 272
            K D+++ GV L EI +G+ P + 
Sbjct: 201 IKDDIYSLGVVLWEIFTGKIPFEN 224

Length = 283

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 44.2 bits (104), Expect = 6e-05
 Identities = 57/219 (26%), Positives = 88/219 (40%), Gaps = 31/219 (14%)

Query: 68  FSSENLVGRGGYAEVYKGVLQDGEEI-AVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNV 126
           F    ++GRG + EV    ++  E I A+K L K     R E     E          NV
Sbjct: 3   FEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFRE--------ERNV 54

Query: 127 LSLLGCCV-----------DNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTA 175
           L + G C            +N LYL+  +   G + +L         E   R  IA    
Sbjct: 55  L-VNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIA-EMV 112

Query: 176 RGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFG 235
             +H +H   Q   +HRDIK  N+LL  +   +++DFG    +    T  S   + GT  
Sbjct: 113 LAIHSIH---QLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAV-GTPD 168

Query: 236 HLAPEYFM-----HGIVDEKTDVFAFGVFLLEIISGRKP 269
           +++PE         G    + D ++ GV + E++ G  P
Sbjct: 169 YISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 43.7 bits (104), Expect = 7e-05
 Identities = 31/108 (28%), Positives = 47/108 (43%), Gaps = 12/108 (11%)

Query: 169 KIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQI--SDFGLAKWLPSQWTHHS 226
           KI       L+ LHK     IIH DIK  N+L     + +I   D+GL K + +   +  
Sbjct: 113 KIIRQLVEALNDLHK---HNIIHNDIKLENVLYD-RAKDRIYLCDYGLCKIIGTPSCY-- 166

Query: 227 IAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSH 274
               +GT  + +PE       D   D +A GV   E+++G+ P     
Sbjct: 167 ----DGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDE 210

Length = 267

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 42.7 bits (101), Expect = 2e-04
 Identities = 55/241 (22%), Positives = 86/241 (35%), Gaps = 53/241 (21%)

Query: 73  LVGRGGYAEVYKGVLQD-GEEIAVKRLTK-VVTDDRKEKEFLTEIGTIGHVCHPNVLSLL 130
           L+G+G    V+   L+  G+  A+K L K  +    K K  LTE   +  + HP + +L 
Sbjct: 8   LLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLY 67

Query: 131 GCC-VDNGLYLIFQFSSRGSVASLFHDVNS-PGVEWKVRHKIAVGTAR--------GLHY 180
                +  L L+  +   G    LF  +   PG        ++   AR         L Y
Sbjct: 68  ASFQTETYLCLVMDYCPGGE---LFRLLQRQPG------KCLSEEVARFYAAEVLLALEY 118

Query: 181 LH-KGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWL---PSQWTHHSIAPIEGTFGH 236
           LH  G    I++RD+K  NILL       +SDF L+K     P   +         +  +
Sbjct: 119 LHLLG----IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVN 174

Query: 237 LAPEYFMHGIVDEKTDVF------------------------AFGVFLLEIISGRKPVDG 272
             P          +++ F                          G+ L E++ G  P  G
Sbjct: 175 SIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKG 234

Query: 273 S 273
           S
Sbjct: 235 S 235

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 42.5 bits (100), Expect = 2e-04
 Identities = 34/154 (22%), Positives = 61/154 (39%), Gaps = 14/154 (9%)

Query: 74  VGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC 132
           +G G Y +VYK      G+ +A+K+    + ++      L EI  +  +     +  L  
Sbjct: 9   IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLD 68

Query: 133 CV----DNG---LYLIFQF--SSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHK 183
                  NG   LYL+F++  S                +  K          +G+ + HK
Sbjct: 69  VEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK 128

Query: 184 GCQRRIIHRDIKSSNILLTADFEP-QISDFGLAK 216
                ++HRD+K  N+L+       +I+D GL +
Sbjct: 129 ---HGVMHRDLKPQNLLVDKQKGLLKIADLGLGR 159

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 41.9 bits (98), Expect = 4e-04
 Identities = 48/195 (24%), Positives = 82/195 (42%), Gaps = 25/195 (12%)

Query: 90  GEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVC----HPNVLSLLGCCV-DNGLYLIFQF 144
           GE + V+R    +  +    E +T +    HV     HPN++      + DN L+++  F
Sbjct: 25  GEYVTVRR----INLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF 80

Query: 145 SSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTAD 204
            + GS   L       G+       I  G  + L Y+H       +HR +K+S+IL++ D
Sbjct: 81  MAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVD 137

Query: 205 FEPQISDFGLAKWLPSQWTHHSIAPIEGTFGH--------LAPEYFMHGI--VDEKTDVF 254
            +  +S  GL   L S   H     +   F          L+PE     +   D K+D++
Sbjct: 138 GKVYLS--GLRSNL-SMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIY 194

Query: 255 AFGVFLLEIISGRKP 269
           + G+   E+ +G  P
Sbjct: 195 SVGITACELANGHVP 209

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 41.8 bits (98), Expect = 5e-04
 Identities = 47/164 (28%), Positives = 72/164 (43%), Gaps = 30/164 (18%)

Query: 66  NAFSSENLVGRGGYAEVYKGV--LQDGEEIAVKRLTKV-------VTDDRKEKEFLTEIG 116
             F +  ++G+G + EV + V     G+  A+K L K        +   + E++ L E  
Sbjct: 1   EDFHTVKVIGKGAFGEV-RLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESD 59

Query: 117 TIGHVCHPNVLSLLGCCVD-NGLYLIFQFSSRGSVASLF--HDVNSPGVEWKVRHKIA-- 171
           +      P V+SL     D   LYLI +F   G + ++   +D  S  V    R  +A  
Sbjct: 60  S------PWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDV---TRFYMAEC 110

Query: 172 VGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLA 215
           V     +H L        IHRDIK  NIL+      ++SDFGL+
Sbjct: 111 VLAIEAVHKLG------FIHRDIKPDNILIDRGGHIKLSDFGLS 148

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 40.6 bits (95), Expect = 8e-04
 Identities = 53/207 (25%), Positives = 93/207 (44%), Gaps = 28/207 (13%)

Query: 74  VGRGGYAEVYKGVLQD---GEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLL 130
           +G G Y  VYK   +D    E IA+K++     D+      + EI  +  + H N++ L 
Sbjct: 10  IGEGTYGVVYKA--RDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQ 67

Query: 131 GCC-VDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAV---GTARGLHYLHKGCQ 186
                +  LYL+F++        L   ++S     K    I        RG+ Y H    
Sbjct: 68  DVVHSEKRLYLVFEYLD----LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCH---S 120

Query: 187 RRIIHRDIKSSNILLTADFEP-QISDFGLAK--WLPSQ-WTHHSIAPIEGTFGHLAPEYF 242
            R++HRD+K  N+L+       +++DFGLA+   +P + +TH  +     T  + APE  
Sbjct: 121 HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV-----TLWYRAPEIL 175

Query: 243 MHGIVDEKT--DVFAFGVFLLEIISGR 267
           + G     T  D+++ G    E+++ +
Sbjct: 176 L-GSRHYSTPVDIWSVGCIFAEMVNQK 201

Length = 294

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 40.2 bits (94), Expect = 0.001
 Identities = 18/37 (48%), Positives = 23/37 (62%), Gaps = 2/37 (5%)

Query: 190 IHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHS 226
           IHRDIK  NIL+  D   +++DFGL      +WTH S
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGF--RWTHDS 157

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 39.8 bits (93), Expect = 0.002
 Identities = 31/99 (31%), Positives = 42/99 (42%), Gaps = 11/99 (11%)

Query: 178 LHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAP----IEGT 233
           L YLH    R IIHRD+K+ NI L       + DFG A     +   H   P      GT
Sbjct: 198 LAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAA----CKLDAHPDTPQCYGWSGT 250

Query: 234 FGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDG 272
               +PE         KTD+++ G+ L E+      + G
Sbjct: 251 LETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFG 289

Length = 392

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 39.3 bits (91), Expect = 0.003
 Identities = 27/86 (31%), Positives = 43/86 (50%), Gaps = 4/86 (4%)

Query: 180 YLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAP 239
           Y+H    +++IHRDIK  NI L  D +  + DFG A     +        + GT    +P
Sbjct: 282 YIH---DKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWV-GTVATNSP 337

Query: 240 EYFMHGIVDEKTDVFAFGVFLLEIIS 265
           E        E TD+++ G+ LL+++S
Sbjct: 338 EILAGDGYCEITDIWSCGLILLDMLS 363

Length = 501

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 38.8 bits (90), Expect = 0.003
 Identities = 32/127 (25%), Positives = 48/127 (37%), Gaps = 49/127 (38%)

Query: 190 IHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHS----------------------- 226
           IHRDIK  NIL+  D   +++DFGL      +WTH S                       
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGF--RWTHDSKYYQSGDHVRQDSMDFSNEWGDP 180

Query: 227 --------IAPIE----------------GTFGHLAPEYFMHGIVDEKTDVFAFGVFLLE 262
                   + P+E                GT  ++APE  +     +  D ++ GV L E
Sbjct: 181 ANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 240

Query: 263 IISGRKP 269
           ++ G+ P
Sbjct: 241 MLVGQPP 247

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 39.1 bits (91), Expect = 0.004
 Identities = 25/83 (30%), Positives = 38/83 (45%), Gaps = 3/83 (3%)

Query: 180 YLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAP 239
           Y+H      IIHRDIK+ N+L+    +  + DFG A +    W+      I GT    AP
Sbjct: 275 YIHG---EGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAP 331

Query: 240 EYFMHGIVDEKTDVFAFGVFLLE 262
           E           D+++ G+ + E
Sbjct: 332 EVLAGDPYTPSVDIWSAGLVIFE 354

Length = 461

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	386
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	100.0
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	100.0
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	100.0
KOG1152	772	consensus Signal transduction serine/threonine kin	99.98
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.98
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.97
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.97
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.97
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.97
PLN00181	793	protein SPA1-RELATED; Provisional	99.96
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.96
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.95
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.94
PRK09188	365	serine/threonine protein kinase; Provisional	99.94
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.94
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.93
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.93
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.91
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.91
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.91
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.9
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.9
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.89
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.88
PRK12274	218	serine/threonine protein kinase; Provisional	99.88
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.87
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.86
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.84
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.84
smart00090	237	RIO RIO-like kinase.	99.83
PRK10345	210	hypothetical protein; Provisional	99.83
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.82
PRK14879	211	serine/threonine protein kinase; Provisional	99.79
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.78
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.77
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.76
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.76
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.73
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.68
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.68
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.62
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.56
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.5
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.49
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.46
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.44
KOG1243	690	consensus Protein kinase [General function predict	99.42
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.38
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.37
KOG3087	229	consensus Serine/threonine protein kinase [General	99.27
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.27
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.25
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.24
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.11
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.07
COG4248	637	Uncharacterized protein with protein kinase and he	99.05
KOG2137	700	consensus Protein kinase [Signal transduction mech	99.05
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.93
PRK09902	216	hypothetical protein; Provisional	98.88
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.85
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.81
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.69
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.55
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.54
PF01636	239	APH: Phosphotransferase enzyme family This family	98.51
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.46
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.42
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.33
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.26
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.25
PLN02876	822	acyl-CoA dehydrogenase	98.2
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.13
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.09
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.93
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.89
PRK10593	297	hypothetical protein; Provisional	97.82
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.82
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.82
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.8
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.68
PRK05231	319	homoserine kinase; Provisional	97.66
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.65
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.62
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.6
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	97.49
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.48
KOG2270	520	consensus Serine/threonine protein kinase involved	97.38
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	97.24
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	97.18
PLN02236	344	choline kinase	97.16
PLN02756	418	S-methyl-5-thioribose kinase	97.09
PRK12396	409	5-methylribose kinase; Reviewed	96.86
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	96.68
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	96.42
KOG1093	725	consensus Predicted protein kinase (contains TBC a	96.33
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	96.22
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	95.98
KOG1236	565	consensus Predicted unusual protein kinase [Genera	95.93
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	95.81
PRK06148	1013	hypothetical protein; Provisional	95.52
PF03109	119	ABC1: ABC1 family; InterPro: IPR004147 This entry	95.43
PRK11768	325	serine/threonine protein kinase; Provisional	95.07
COG4499	434	Predicted membrane protein [Function unknown]	94.71
PF04655	253	APH_6_hur: Aminoglycoside/hydroxyurea antibiotic r	94.43
PTZ00384	383	choline kinase; Provisional	94.17
PF05445	434	Pox_ser-thr_kin: Poxvirus serine/threonine protein	94.15

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-54  Score=380.77  Aligned_cols=260  Identities=27%  Similarity=0.404  Sum_probs=218.9

Q ss_pred             HHhcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc--eE
Q 016594           63 IATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG--LY  139 (386)
Q Consensus        63 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~  139 (386)
                      +...+.+..+.||+|..|+||++.++ +++.+|+|++. ...+....+++.+|+++++..+||+||.+||+|..++  ..
T Consensus        76 i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~-~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~is  154 (364)
T KOG0581|consen   76 ISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVIL-LNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEIS  154 (364)
T ss_pred             cCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeec-ccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEE
Confidence            33446777899999999999999988 78899999994 3566778899999999999999999999999998765  89


Q ss_pred             EEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCC
Q 016594          140 LIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLP  219 (386)
Q Consensus       140 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~  219 (386)
                      ++||||.+|+|++++...+  .+++.....|+.++++||.|||.  .++||||||||+|||++..|.|||||||.+..+.
T Consensus       155 I~mEYMDgGSLd~~~k~~g--~i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lv  230 (364)
T KOG0581|consen  155 ICMEYMDGGSLDDILKRVG--RIPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILV  230 (364)
T ss_pred             eehhhcCCCCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCEEeccccccHHhh
Confidence            9999999999999998763  49999999999999999999995  2899999999999999999999999999999875


Q ss_pred             CCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccC
Q 016594          220 SQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQ  299 (386)
Q Consensus       220 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (386)
                      ..    ...+++||..|||||-+.+..|+.++||||||++++|+++|+.||.........+..      -+..+++... 
T Consensus       231 nS----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~------Ll~~Iv~~pp-  299 (364)
T KOG0581|consen  231 NS----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFE------LLCAIVDEPP-  299 (364)
T ss_pred             hh----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHH------HHHHHhcCCC-
Confidence            44    456788999999999999999999999999999999999999999875221111111      1122333221 


Q ss_pred             CCCCH-HHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          300 GAYDV-TQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       300 ~~~~~-~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                      +..+. .++.+++.++..||++||.+||++.++++|-+-.
T Consensus       300 P~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~  339 (364)
T KOG0581|consen  300 PRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIK  339 (364)
T ss_pred             CCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHh
Confidence            12222 4788999999999999999999999999986543

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-52  Score=389.87  Aligned_cols=282  Identities=48%  Similarity=0.858  Sum_probs=247.3

Q ss_pred             CccccCHHHHHHHhcCCCCCCeecccCCcEEEEEEECCCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecc
Q 016594           52 TWRCFSFEEISIATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLG  131 (386)
Q Consensus        52 ~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~  131 (386)
                      ..+.|++.++..++++|.-.+.||+|+||.||+|...+|..||||++.......  ..+|.+|+.++.+++|||+|+|+|
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~--~~eF~~Ei~~ls~l~H~Nlv~LlG  138 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG--EREFLNEVEILSRLRHPNLVKLLG  138 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc--hhHHHHHHHHHhcCCCcCcccEEE
Confidence            578899999999999999999999999999999999988999999887543322  456999999999999999999999


Q ss_pred             eEEeCc--eEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEE
Q 016594          132 CCVDNG--LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQI  209 (386)
Q Consensus       132 ~~~~~~--~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl  209 (386)
                      ||.+.+  .++||||+.+|+|.+.+.......++|..+++|+.++|.||+|||..+...||||||||.|||||.++++||
T Consensus       139 yC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKl  218 (361)
T KOG1187|consen  139 YCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKL  218 (361)
T ss_pred             EEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEc
Confidence            998755  899999999999999987655436899999999999999999999988778999999999999999999999


Q ss_pred             eecCccccCCC-CCcccccccc-ccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCC----chhhhhhhhh
Q 016594          210 SDFGLAKWLPS-QWTHHSIAPI-EGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGS----HQSLHSWAKP  283 (386)
Q Consensus       210 ~Dfg~a~~~~~-~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~----~~~~~~~~~~  283 (386)
                      +|||+|...+. ...   .... .||.+|+|||++..+..+.++||||||++|+||++|+.|.+..    ......|...
T Consensus       219 sDFGLa~~~~~~~~~---~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~  295 (361)
T KOG1187|consen  219 SDFGLAKLGPEGDTS---VSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKP  295 (361)
T ss_pred             cCccCcccCCccccc---eeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHH
Confidence            99999976654 211   1112 6999999999999999999999999999999999999988753    3346788888


Q ss_pred             hhcccccccccCCccC-CCCCH-HHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          284 ILNQGEIEKLVDPRLQ-GAYDV-TQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       284 ~~~~~~~~~~~~~~~~-~~~~~-~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                      ......+.+++|+.+. ..+.. .....+..++..|++.+|..||+|.+|++.|+..
T Consensus       296 ~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~  352 (361)
T KOG1187|consen  296 LLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGI  352 (361)
T ss_pred             HHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhh
Confidence            8888899999999987 55654 5778899999999999999999999999988443

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9.6e-53  Score=391.07  Aligned_cols=252  Identities=24%  Similarity=0.400  Sum_probs=215.0

Q ss_pred             cCCCCCCeecccCCcEEEEEEE-CCCcEEEEEEeccccC-ChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEE
Q 016594           66 NAFSSENLVGRGGYAEVYKGVL-QDGEEIAVKRLTKVVT-DDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIF  142 (386)
Q Consensus        66 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~  142 (386)
                      ..|..++.||+|||+.||.++. .+|..||+|++.+... .......+.+|+++.+.|+|||||+++++|++.+ .|+|.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            5799999999999999999997 6899999999987443 3445567889999999999999999999999866 99999


Q ss_pred             EeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCC
Q 016594          143 QFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQW  222 (386)
Q Consensus       143 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  222 (386)
                      |+|..++|..++.++  +.+++.+++.++.||+.||.|||+   ++|+|||||..|+||+++.+|||+|||+|..+... 
T Consensus        98 ELC~~~sL~el~Krr--k~ltEpEary~l~QIv~GlkYLH~---~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~-  171 (592)
T KOG0575|consen   98 ELCHRGSLMELLKRR--KPLTEPEARYFLRQIVEGLKYLHS---LGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD-  171 (592)
T ss_pred             EecCCccHHHHHHhc--CCCCcHHHHHHHHHHHHHHHHHHh---cCceecccchhheeecCcCcEEecccceeeeecCc-
Confidence            999999999999854  459999999999999999999999   99999999999999999999999999999988643 


Q ss_pred             ccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCCCC
Q 016594          223 THHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAY  302 (386)
Q Consensus       223 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (386)
                       .....+.||||.|+|||++....++..+||||+||++|.||.|++||+...-..           ....+...  .-..
T Consensus       172 -~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vke-----------ty~~Ik~~--~Y~~  237 (592)
T KOG0575|consen  172 -GERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKE-----------TYNKIKLN--EYSM  237 (592)
T ss_pred             -ccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHH-----------HHHHHHhc--Cccc
Confidence             234567899999999999999999999999999999999999999998753210           00111110  0112


Q ss_pred             CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 016594          303 DVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLE  337 (386)
Q Consensus       303 ~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~  337 (386)
                      |...+.+..+||.++|+.||.+|||+++||.+-..
T Consensus       238 P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff  272 (592)
T KOG0575|consen  238 PSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFF  272 (592)
T ss_pred             ccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhh
Confidence            23456779999999999999999999999998555

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.1e-53  Score=374.74  Aligned_cols=259  Identities=22%  Similarity=0.299  Sum_probs=212.2

Q ss_pred             HHhcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCCh-----HhHHHHHHHHHHHhccCCCceeeecceEEeC
Q 016594           63 IATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDD-----RKEKEFLTEIGTIGHVCHPNVLSLLGCCVDN  136 (386)
Q Consensus        63 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~  136 (386)
                      ...+.|.+.+.||+|+||.|-+|..+ +|+.||||++++.....     .......+|+++|++|+|||||+++++|...
T Consensus       169 s~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~  248 (475)
T KOG0615|consen  169 SFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVP  248 (475)
T ss_pred             hhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecC
Confidence            35678899999999999999999965 79999999998743322     1233457999999999999999999999876


Q ss_pred             c-eEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCC---CCeEEeec
Q 016594          137 G-LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTAD---FEPQISDF  212 (386)
Q Consensus       137 ~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~---~~~kl~Df  212 (386)
                      . .|+||||+.||.|.+.+.....  +.+..-..++.|++.|+.|||+   +||+||||||+|||+..+   ..+||+||
T Consensus       249 ds~YmVlE~v~GGeLfd~vv~nk~--l~ed~~K~~f~Qll~avkYLH~---~GI~HRDiKPeNILl~~~~e~~llKItDF  323 (475)
T KOG0615|consen  249 DSSYMVLEYVEGGELFDKVVANKY--LREDLGKLLFKQLLTAVKYLHS---QGIIHRDIKPENILLSNDAEDCLLKITDF  323 (475)
T ss_pred             CceEEEEEEecCccHHHHHHhccc--cccchhHHHHHHHHHHHHHHHH---cCcccccCCcceEEeccCCcceEEEeccc
Confidence            6 6999999999999998876554  7777888999999999999999   999999999999999866   67999999


Q ss_pred             CccccCCCCCccccccccccccCccChhhhccCC---CCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccc
Q 016594          213 GLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGI---VDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGE  289 (386)
Q Consensus       213 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~  289 (386)
                      |+|+....   ...+.++|||+.|.|||++.+..   +..++|+||+||+||-+++|.+||.+...+..          -
T Consensus       324 GlAK~~g~---~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~s----------l  390 (475)
T KOG0615|consen  324 GLAKVSGE---GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPS----------L  390 (475)
T ss_pred             chhhcccc---ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCcc----------H
Confidence            99998763   35678899999999999998654   34588999999999999999999987543210          0


Q ss_pred             cccccCCccC--CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCC
Q 016594          290 IEKLVDPRLQ--GAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEGD  339 (386)
Q Consensus       290 ~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~~  339 (386)
                      ..++......  +......+++..+||.+||..||++|||+.++|+|.|...
T Consensus       391 ~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~  442 (475)
T KOG0615|consen  391 KEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKD  442 (475)
T ss_pred             HHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhc
Confidence            1111111111  1223456789999999999999999999999999987663

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-51  Score=380.89  Aligned_cols=260  Identities=29%  Similarity=0.500  Sum_probs=216.8

Q ss_pred             HHhcCCCCCCeecccCCcEEEEEEECCCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc--eEE
Q 016594           63 IATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG--LYL  140 (386)
Q Consensus        63 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~l  140 (386)
                      +......+.+.||.|+||+||+|.|+....||||++.....+......|.+|+.+|.+++|||||+++|++.+..  +++
T Consensus        38 i~~~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~i  117 (362)
T KOG0192|consen   38 IDPDELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCI  117 (362)
T ss_pred             cChHHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEE
Confidence            334455556779999999999999984444999999876555555789999999999999999999999998874  899


Q ss_pred             EEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC-eEEeCCCCCCeeEcCCC-CeEEeecCccccC
Q 016594          141 IFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRR-IIHRDIKSSNILLTADF-EPQISDFGLAKWL  218 (386)
Q Consensus       141 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~-ivH~dlkp~Nill~~~~-~~kl~Dfg~a~~~  218 (386)
                      ||||+.+|+|..++.......+++..++.++.||+.||.|||+   ++ ||||||||+|||++.++ ++||+|||+++..
T Consensus       118 VtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~---~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~  194 (362)
T KOG0192|consen  118 VTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHS---EGPIIHRDLKSDNILVDLKGKTLKIADFGLSREK  194 (362)
T ss_pred             EEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhc---CCCeeecccChhhEEEcCCCCEEEECCCccceee
Confidence            9999999999999987545669999999999999999999999   78 99999999999999997 9999999999876


Q ss_pred             CCCCccccccccccccCccChhhhc--cCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCC
Q 016594          219 PSQWTHHSIAPIEGTFGHLAPEYFM--HGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDP  296 (386)
Q Consensus       219 ~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (386)
                      ....  .......||+.|||||++.  ...|+.|+||||||+++|||+||+.||.+....  ..         ...+...
T Consensus       195 ~~~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~--~~---------~~~v~~~  261 (362)
T KOG0192|consen  195 VISK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPV--QV---------ASAVVVG  261 (362)
T ss_pred             cccc--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHH--HH---------HHHHHhc
Confidence            5432  2233467999999999999  569999999999999999999999999886541  11         1112222


Q ss_pred             ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          297 RLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       297 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                      ..+...+..++..+..++..||..||..||++.+|+..|...
T Consensus       262 ~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~  303 (362)
T KOG0192|consen  262 GLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESI  303 (362)
T ss_pred             CCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHH
Confidence            333444444678899999999999999999999999988755

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.6e-53  Score=361.09  Aligned_cols=257  Identities=24%  Similarity=0.386  Sum_probs=213.6

Q ss_pred             cCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecce-EEe-Cc-eEEE
Q 016594           66 NAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC-CVD-NG-LYLI  141 (386)
Q Consensus        66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~-~~~-~~-~~lv  141 (386)
                      .+|++.++||+|+||.||++... +|..||.|.++....+.........|+.+|++|+|||||++++. +.+ .. +++|
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv   98 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV   98 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence            45778899999999999999954 89999999999877888888899999999999999999999994 433 34 8999


Q ss_pred             EEeccCCCHhhhhhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC-eEEeCCCCCCeeEcCCCCeEEeecCccccC
Q 016594          142 FQFSSRGSVASLFHDV--NSPGVEWKVRHKIAVGTARGLHYLHKGCQRR-IIHRDIKSSNILLTADFEPQISDFGLAKWL  218 (386)
Q Consensus       142 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~-ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~  218 (386)
                      ||++.+|+|..+++..  ..+.+++..+|+++.|++.||.++|+..+++ |+||||||.||+++.+|.|||+|||+++.+
T Consensus        99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l  178 (375)
T KOG0591|consen   99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL  178 (375)
T ss_pred             HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence            9999999999988754  3455999999999999999999999844333 899999999999999999999999999998


Q ss_pred             CCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCcc
Q 016594          219 PSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRL  298 (386)
Q Consensus       219 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (386)
                      ....  ....+.+|||.||+||.+.+.+|+.++||||+||++|||+.-++||.+...  .....          .+...-
T Consensus       179 ~s~~--tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~--~~L~~----------KI~qgd  244 (375)
T KOG0591|consen  179 SSKT--TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNL--LSLCK----------KIEQGD  244 (375)
T ss_pred             cchh--HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccH--HHHHH----------HHHcCC
Confidence            7643  345678899999999999999999999999999999999999999998632  11111          111111


Q ss_pred             CCCCC-HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 016594          299 QGAYD-VTQLNRLAFAASLCIRASPTWRPTMSEVLEVML  336 (386)
Q Consensus       299 ~~~~~-~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~  336 (386)
                      ..+.+ ..++..+..+|..|+..||+.||+...++..+.
T Consensus       245 ~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~  283 (375)
T KOG0591|consen  245 YPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQ  283 (375)
T ss_pred             CCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence            11222 567889999999999999999998655555443

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-51  Score=365.06  Aligned_cols=253  Identities=25%  Similarity=0.429  Sum_probs=209.8

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEE
Q 016594           65 TNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIF  142 (386)
Q Consensus        65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~  142 (386)
                      ..+|.+.+.||+|+||+||+|+++ ++..||||.+.+..........+..|+.+|+.++|||||++++++.+++ .|+||
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM   88 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM   88 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence            457888999999999999999987 6899999999887667778888999999999999999999999998866 89999


Q ss_pred             EeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCC------CCeEEeecCccc
Q 016594          143 QFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTAD------FEPQISDFGLAK  216 (386)
Q Consensus       143 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~------~~~kl~Dfg~a~  216 (386)
                      |||.||+|.++++....  +++..+..++.||+.||++||+   ++||||||||+||||+..      -.+||+|||+|+
T Consensus        89 EyC~gGDLs~yi~~~~~--l~e~t~r~Fm~QLA~alq~L~~---~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR  163 (429)
T KOG0595|consen   89 EYCNGGDLSDYIRRRGR--LPEATARHFMQQLASALQFLHE---NNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR  163 (429)
T ss_pred             EeCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence            99999999999987654  9999999999999999999999   999999999999999864      468999999999


Q ss_pred             cCCCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCC
Q 016594          217 WLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDP  296 (386)
Q Consensus       217 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (386)
                      .+...   ....+.||++-|||||++..+.|+.|+|+||+|+++|++++|+.||........-.  .+..        +.
T Consensus       164 ~L~~~---~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~--~~~k--------~~  230 (429)
T KOG0595|consen  164 FLQPG---SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLL--YIKK--------GN  230 (429)
T ss_pred             hCCch---hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHH--HHhc--------cc
Confidence            98743   34567889999999999999999999999999999999999999998543221110  0000        01


Q ss_pred             ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 016594          297 RLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVM  335 (386)
Q Consensus       297 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l  335 (386)
                      ......+...+..+.+++...++.+|.+|-++.+-..+.
T Consensus       231 ~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~  269 (429)
T KOG0595|consen  231 EIVPVLPAELSNPLRELLISLLQRNPKDRISFEDFFDHP  269 (429)
T ss_pred             cccCchhhhccCchhhhhhHHHhcCccccCchHHhhhhh
Confidence            111122233344566778888888888888887776653

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-52  Score=384.11  Aligned_cols=315  Identities=23%  Similarity=0.343  Sum_probs=245.1

Q ss_pred             cccccccee--eecccccCCCCCccCCCCCChhhhcceeeeccCCC--CCCCccccCHHHHHHHhcCCCCCCeecccCCc
Q 016594            5 RTNSLKRLF--SLKRRSFDGDNAAVSPNGFTEESLENVVVACESET--TKPTWRCFSFEEISIATNAFSSENLVGRGGYA   80 (386)
Q Consensus         5 ~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g   80 (386)
                      |....+.+.  ...+..|+.....+.........+...........  ..|....+....+.+....+.+.+.||+|.||
T Consensus       141 ~~~~~~~~~~~~~~~~~F~~l~~lv~~~~~~~~gl~~~l~~p~~~~~~~~p~~~~~~~d~wei~r~~l~l~~~LG~G~FG  220 (468)
T KOG0197|consen  141 RQLDGGGLYPYIDERELFSSLQQLVNYYSKNADGLCTRLRDPCSKQGHTKPQTPDLARDPWEIPREELKLIRELGSGQFG  220 (468)
T ss_pred             eEcCCCCeecCCCHHHhhhhHHHHHhhhhccCcchhhcccCchhccCCCCCCCCccccCCeeecHHHHHHHHHhcCCccc
Confidence            333344344  34444455444444444444444433332222111  23333333344455666777888999999999


Q ss_pred             EEEEEEECCCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEEEeccCCCHhhhhhhcCC
Q 016594           81 EVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQFSSRGSVASLFHDVNS  159 (386)
Q Consensus        81 ~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~~~~~~L~~~~~~~~~  159 (386)
                      .||+|.|+....||+|.++..   ......|.+|+++|++|+|+|||+++++|..+. +++||||+..|+|.++++....
T Consensus       221 ~V~~g~~~~~~~vavk~ik~~---~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsLl~yLr~~~~  297 (468)
T KOG0197|consen  221 EVWLGKWNGSTKVAVKTIKEG---SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSLLDYLRTREG  297 (468)
T ss_pred             eEEEEEEcCCCcccceEEecc---ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcHHHHhhhcCC
Confidence            999999997779999999854   334467889999999999999999999998866 9999999999999999998777


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCccccccccccccCccCh
Q 016594          160 PGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAP  239 (386)
Q Consensus       160 ~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  239 (386)
                      ..+.....+.++.||++|++||++   +++|||||..+|||++++..+||+|||+|+...+.... ......-...|.||
T Consensus       298 ~~l~~~~Ll~~a~qIaeGM~YLes---~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~-~~~~~kfPIkWtAP  373 (468)
T KOG0197|consen  298 GLLNLPQLLDFAAQIAEGMAYLES---KNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYT-ASEGGKFPIKWTAP  373 (468)
T ss_pred             CccchHHHHHHHHHHHHHHHHHHh---CCccchhhhhhheeeccCceEEEcccccccccCCCcee-ecCCCCCCceecCH
Confidence            779999999999999999999999   99999999999999999999999999999955443211 11112234569999


Q ss_pred             hhhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCchhhhhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHcc
Q 016594          240 EYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCI  318 (386)
Q Consensus       240 E~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl  318 (386)
                      |.+..+.++.|||||||||+||||+| |+.|+.+..            ..++.+.+....+-+.|..++..+.+++..||
T Consensus       374 Ea~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~ms------------n~ev~~~le~GyRlp~P~~CP~~vY~lM~~CW  441 (468)
T KOG0197|consen  374 EALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMS------------NEEVLELLERGYRLPRPEGCPDEVYELMKSCW  441 (468)
T ss_pred             HHHhhCCcccccceeehhhhHHHHhccCCCCCCCCC------------HHHHHHHHhccCcCCCCCCCCHHHHHHHHHHh
Confidence            99999999999999999999999999 999998743            33455666777777788889999999999999


Q ss_pred             ccCCCCCCCHHHHHHHHhcC
Q 016594          319 RASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       319 ~~dP~~Rpt~~~il~~l~~~  338 (386)
                      ..+|++|||+..+...+...
T Consensus       442 ~~~P~~RPtF~~L~~~l~~~  461 (468)
T KOG0197|consen  442 HEDPEDRPTFETLREVLEDF  461 (468)
T ss_pred             hCCcccCCCHHHHHHHHHHh
Confidence            99999999999888877653

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-51  Score=363.79  Aligned_cols=254  Identities=20%  Similarity=0.294  Sum_probs=211.8

Q ss_pred             HHhcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCC-hHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eE
Q 016594           63 IATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTD-DRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LY  139 (386)
Q Consensus        63 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~  139 (386)
                      +...+|++.++||+|+||+||.++.+ +++.||+|++++...- .........|..+|..++||+||+++..|.+.+ +|
T Consensus        22 ~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLy  101 (357)
T KOG0598|consen   22 VGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLY  101 (357)
T ss_pred             CChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEE
Confidence            34568999999999999999999966 6899999999875433 345678899999999999999999999998866 99


Q ss_pred             EEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCC
Q 016594          140 LIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLP  219 (386)
Q Consensus       140 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~  219 (386)
                      +|++|+.||.|.-.+++...  |++..+..++.+|+.||.|||+   ++||||||||+|||||.+|+++|+|||+++..-
T Consensus       102 lVld~~~GGeLf~hL~~eg~--F~E~~arfYlaEi~lAL~~LH~---~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~  176 (357)
T KOG0598|consen  102 LVLDYLNGGELFYHLQREGR--FSEDRARFYLAEIVLALGYLHS---KGIIYRDLKPENILLDEQGHIKLTDFGLCKEDL  176 (357)
T ss_pred             EEEeccCCccHHHHHHhcCC--cchhHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHeeecCCCcEEEeccccchhcc
Confidence            99999999999999886544  9999999999999999999999   999999999999999999999999999998643


Q ss_pred             CCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccC
Q 016594          220 SQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQ  299 (386)
Q Consensus       220 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (386)
                      ..  .....++|||+.|||||++.+..|+.++|+||||+++|||++|.+||.+.+....           +.++.... .
T Consensus       177 ~~--~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~-----------~~~I~~~k-~  242 (357)
T KOG0598|consen  177 KD--GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKM-----------YDKILKGK-L  242 (357)
T ss_pred             cC--CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHH-----------HHHHhcCc-C
Confidence            32  2244568999999999999999999999999999999999999999988653211           11111111 1


Q ss_pred             CCCCHHHHHHHHHHHHHccccCCCCCC----CHHHHHHHH
Q 016594          300 GAYDVTQLNRLAFAASLCIRASPTWRP----TMSEVLEVM  335 (386)
Q Consensus       300 ~~~~~~~~~~l~~li~~cl~~dP~~Rp----t~~~il~~l  335 (386)
                      ...+...+...++++..+|+.||++|.    ++.+|-+|-
T Consensus       243 ~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~Hp  282 (357)
T KOG0598|consen  243 PLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHP  282 (357)
T ss_pred             CCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCc
Confidence            223333567899999999999999995    566666553

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=7.2e-51  Score=348.28  Aligned_cols=266  Identities=22%  Similarity=0.300  Sum_probs=213.4

Q ss_pred             cCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEEE
Q 016594           66 NAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQ  143 (386)
Q Consensus        66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~e  143 (386)
                      +.|+...++|+|+||.||+|+++ +|+.||||++.....++...+-.++|+++|++|+|+|+|.++++|.... +++|+|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE   81 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE   81 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence            35778899999999999999987 6999999999877666777778899999999999999999999997655 999999


Q ss_pred             eccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCc
Q 016594          144 FSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWT  223 (386)
Q Consensus       144 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~  223 (386)
                      |++..-|.++ .. ...+++...+..++.|++.|+.|||+   +++|||||||+|||++.+|.+||||||+|+.+...  
T Consensus        82 ~~dhTvL~eL-e~-~p~G~~~~~vk~~l~Q~l~ai~~cHk---~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p--  154 (396)
T KOG0593|consen   82 YCDHTVLHEL-ER-YPNGVPSELVKKYLYQLLKAIHFCHK---NNCIHRDIKPENILITQNGVVKLCDFGFARTLSAP--  154 (396)
T ss_pred             ecchHHHHHH-Hh-ccCCCCHHHHHHHHHHHHHHhhhhhh---cCeecccCChhheEEecCCcEEeccchhhHhhcCC--
Confidence            9999655544 33 34569999999999999999999999   99999999999999999999999999999988642  


Q ss_pred             cccccccccccCccChhhhcc-CCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhh-------------hhcccc
Q 016594          224 HHSIAPIEGTFGHLAPEYFMH-GIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKP-------------ILNQGE  289 (386)
Q Consensus       224 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~-------------~~~~~~  289 (386)
                      ....+..+.|.+|+|||.+.+ .+|+.++||||+||++.||++|.+.|.+..+-..-+...             +..+..
T Consensus       155 gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~  234 (396)
T KOG0593|consen  155 GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPF  234 (396)
T ss_pred             cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCc
Confidence            334567789999999999988 689999999999999999999999999876432222111             111111


Q ss_pred             cccccCCccCCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          290 IEKLVDPRLQGAYD-----VTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       290 ~~~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                      ..-+.-|......+     +..+.-+.+++..||..||++|++-++++.|-...
T Consensus       235 F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd  288 (396)
T KOG0593|consen  235 FHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFD  288 (396)
T ss_pred             eeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHH
Confidence            11111111111111     12245789999999999999999999999875443

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-50  Score=370.85  Aligned_cols=260  Identities=24%  Similarity=0.354  Sum_probs=217.0

Q ss_pred             HHHhcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCC-hHhHHHHHHHHHHHhcc-CCCceeeecceEEeCc-
Q 016594           62 SIATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTD-DRKEKEFLTEIGTIGHV-CHPNVLSLLGCCVDNG-  137 (386)
Q Consensus        62 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~-  137 (386)
                      ....++|.+++.||+|+|++|++|+.+ +++.||||++.+.... ....+...+|-.+|.+| .||.|++||..|.|.. 
T Consensus        69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s  148 (604)
T KOG0592|consen   69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES  148 (604)
T ss_pred             cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence            455678999999999999999999966 7999999999874332 33445567889999999 6999999999998865 


Q ss_pred             eEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCcccc
Q 016594          138 LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKW  217 (386)
Q Consensus       138 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~  217 (386)
                      +|+|++|+++|+|.+++.+.+.  |++..++.++.+|+.||+|||+   +|||||||||+|||||.++++||+|||.|+.
T Consensus       149 LYFvLe~A~nGdll~~i~K~Gs--fde~caR~YAAeIldAleylH~---~GIIHRDlKPENILLd~dmhikITDFGsAK~  223 (604)
T KOG0592|consen  149 LYFVLEYAPNGDLLDLIKKYGS--FDETCARFYAAEILDALEYLHS---NGIIHRDLKPENILLDKDGHIKITDFGSAKI  223 (604)
T ss_pred             eEEEEEecCCCcHHHHHHHhCc--chHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeEcCCCcEEEeecccccc
Confidence            9999999999999999987754  9999999999999999999999   9999999999999999999999999999998


Q ss_pred             CCCCCcc-----------ccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhc
Q 016594          218 LPSQWTH-----------HSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILN  286 (386)
Q Consensus       218 ~~~~~~~-----------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~  286 (386)
                      +......           ....+++||..|.+||++..+..++.+|||+||||||+|+.|++||.+.+.-..        
T Consensus       224 l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Neyli--------  295 (604)
T KOG0592|consen  224 LSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLI--------  295 (604)
T ss_pred             CChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHH--------
Confidence            8644222           112568999999999999999999999999999999999999999987543210        


Q ss_pred             ccccccccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCC
Q 016594          287 QGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEGD  339 (386)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~~  339 (386)
                         ..+++.  +.-.++...++.+.+|+.+.|..||.+|+|..+|.+|.....
T Consensus       296 ---FqkI~~--l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~  343 (604)
T KOG0592|consen  296 ---FQKIQA--LDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEG  343 (604)
T ss_pred             ---HHHHHH--hcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCccccc
Confidence               011111  112233344578999999999999999999999999865443

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-49  Score=359.61  Aligned_cols=266  Identities=25%  Similarity=0.360  Sum_probs=216.7

Q ss_pred             HHhcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccC-CCceeeecceEEeCc--e
Q 016594           63 IATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVC-HPNVLSLLGCCVDNG--L  138 (386)
Q Consensus        63 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~--~  138 (386)
                      +..++|.+.++||.|+||.||+|+.+ +|..||||.+++.... ..+..-+||++.|++|+ |||||++.+++.+..  +
T Consensus         7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L   85 (538)
T KOG0661|consen    7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRIL   85 (538)
T ss_pred             hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceE
Confidence            45678999999999999999999965 7899999999875433 44556689999999999 999999999998755  8


Q ss_pred             EEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccC
Q 016594          139 YLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWL  218 (386)
Q Consensus       139 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~  218 (386)
                      ++|||||.. +|.+++..+ .+.|++..+..|+.||++||+|+|.   +|++|||+||+|||+.....+||+|||+|+..
T Consensus        86 ~fVfE~Md~-NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk---~GfFHRDlKPENiLi~~~~~iKiaDFGLARev  160 (538)
T KOG0661|consen   86 YFVFEFMDC-NLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHK---HGFFHRDLKPENILISGNDVIKIADFGLAREV  160 (538)
T ss_pred             eeeHHhhhh-hHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHh---cCcccccCChhheEecccceeEeccccccccc
Confidence            999999988 899999987 6679999999999999999999999   99999999999999998889999999999987


Q ss_pred             CCCCccccccccccccCccChhhhcc-CCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhh-hhhcccc-------
Q 016594          219 PSQWTHHSIAPIEGTFGHLAPEYFMH-GIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAK-PILNQGE-------  289 (386)
Q Consensus       219 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~-~~~~~~~-------  289 (386)
                      ...   ...+..+.|.+|+|||++.. +.|+.+.|+|++|||++|+.+-++.|.|.......+.. +++....       
T Consensus       161 ~Sk---pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg  237 (538)
T KOG0661|consen  161 RSK---PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEG  237 (538)
T ss_pred             ccC---CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhH
Confidence            643   45667789999999999875 67999999999999999999999999987654333211 1111100       


Q ss_pred             --cccccC---C-----ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          290 --IEKLVD---P-----RLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       290 --~~~~~~---~-----~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                        +...+.   +     .+....+ ..+.++.++|.+|+++||.+|||+.+.+++....
T Consensus       238 ~~La~~mnf~~P~~~~~~l~~L~p-~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq  295 (538)
T KOG0661|consen  238 YNLASAMNFRFPQVKPSPLKDLLP-NASSEAASLIERLLAWDPDKRPTASQALQHPFFQ  295 (538)
T ss_pred             HHHHHHhccCCCcCCCCChHHhCc-ccCHHHHHHHHHHhcCCCccCccHHHHhcCcccc
Confidence              000111   1     1111111 2567899999999999999999999999986443

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.3e-49  Score=351.53  Aligned_cols=260  Identities=24%  Similarity=0.386  Sum_probs=209.9

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEE-eC--ceEE
Q 016594           65 TNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCV-DN--GLYL  140 (386)
Q Consensus        65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~-~~--~~~l  140 (386)
                      ..+|..++.||+|+||.||++... +|...|||.+....  ......+.+|+.+|.+++|||||+++|... ..  .+++
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~--~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i   93 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELED--SPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNI   93 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecCCCcceeeeeeeccc--chhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEe
Confidence            345778899999999999999976 48999999987542  222667899999999999999999999743 33  4899


Q ss_pred             EEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcC-CCCeEEeecCccccCC
Q 016594          141 IFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTA-DFEPQISDFGLAKWLP  219 (386)
Q Consensus       141 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~-~~~~kl~Dfg~a~~~~  219 (386)
                      +|||+.+|+|.+++.+... .+++..+..++.||++||+|||+   +||+||||||+|||++. ++.+||+|||++....
T Consensus        94 ~mEy~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs---~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~  169 (313)
T KOG0198|consen   94 FMEYAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHS---KGIVHCDIKPANILLDPSNGDVKLADFGLAKKLE  169 (313)
T ss_pred             eeeccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHh---CCEeccCcccceEEEeCCCCeEEeccCccccccc
Confidence            9999999999999998776 69999999999999999999999   99999999999999999 7999999999998776


Q ss_pred             C-CCccccccccccccCccChhhhccC-CCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCc
Q 016594          220 S-QWTHHSIAPIEGTFGHLAPEYFMHG-IVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPR  297 (386)
Q Consensus       220 ~-~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (386)
                      . ...........||+.|||||++.++ ....++|||||||++.||+||+.||... .....+..         .+....
T Consensus       170 ~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-~~~~~~~~---------~ig~~~  239 (313)
T KOG0198|consen  170 SKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-FEEAEALL---------LIGRED  239 (313)
T ss_pred             cccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-cchHHHHH---------HHhccC
Confidence            4 1122234457799999999999863 3346999999999999999999999863 11111111         111111


Q ss_pred             cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCCc
Q 016594          298 LQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEGDQ  340 (386)
Q Consensus       298 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~~~  340 (386)
                      ..+.++...+....+++..|+..||+.||||.++|+|..-...
T Consensus       240 ~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~  282 (313)
T KOG0198|consen  240 SLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQN  282 (313)
T ss_pred             CCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcc
Confidence            1124445567889999999999999999999999999765443

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.6e-48  Score=353.31  Aligned_cols=268  Identities=22%  Similarity=0.300  Sum_probs=213.5

Q ss_pred             HHhcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeC---ce
Q 016594           63 IATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDN---GL  138 (386)
Q Consensus        63 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~---~~  138 (386)
                      ...+.|+..++||+|+||.||+|+.. +|+.||+|++..............+|+.+|++|+||||++|.+...+.   .+
T Consensus       114 r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~si  193 (560)
T KOG0600|consen  114 RRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSI  193 (560)
T ss_pred             cchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceE
Confidence            34456788899999999999999954 799999999998777777788889999999999999999999999875   49


Q ss_pred             EEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccC
Q 016594          139 YLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWL  218 (386)
Q Consensus       139 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~  218 (386)
                      |+|+|||++ +|.-++.. ..-.|++.++..++.|++.||+|||+   +||+|||||..|||||.+|.+||+|||+|+++
T Consensus       194 YlVFeYMdh-DL~GLl~~-p~vkft~~qIKc~mkQLl~Gl~~cH~---~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y  268 (560)
T KOG0600|consen  194 YLVFEYMDH-DLSGLLSS-PGVKFTEPQIKCYMKQLLEGLEYCHS---RGVLHRDIKGSNILIDNNGVLKIADFGLARFY  268 (560)
T ss_pred             EEEEecccc-hhhhhhcC-CCcccChHHHHHHHHHHHHHHHHHhh---cCeeeccccccceEEcCCCCEEeccccceeec
Confidence            999999998 77777754 33349999999999999999999999   99999999999999999999999999999988


Q ss_pred             CCCCccccccccccccCccChhhhccC-CCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhh-hhhhhcccc-----cc
Q 016594          219 PSQWTHHSIAPIEGTFGHLAPEYFMHG-IVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSW-AKPILNQGE-----IE  291 (386)
Q Consensus       219 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~-~~~~~~~~~-----~~  291 (386)
                      ..... ...+..+-|++|.|||++.|. .|+.++|+||+||||.||++|++.|.+...-.+.. +........     ..
T Consensus       269 ~~~~~-~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~  347 (560)
T KOG0600|consen  269 TPSGS-APYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVS  347 (560)
T ss_pred             cCCCC-cccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccc
Confidence            66533 336677789999999999985 69999999999999999999999999875321111 000000000     00


Q ss_pred             ccc---CCccCCCCCH-------HHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 016594          292 KLV---DPRLQGAYDV-------TQLNRLAFAASLCIRASPTWRPTMSEVLEVML  336 (386)
Q Consensus       292 ~~~---~~~~~~~~~~-------~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~  336 (386)
                      ++.   .-.....+..       ..+....+|+..+|..||.+|.|+.++|++-.
T Consensus       348 kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~sey  402 (560)
T KOG0600|consen  348 KLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEY  402 (560)
T ss_pred             cCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcc
Confidence            110   0011111111       12456889999999999999999999998643

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-47  Score=353.81  Aligned_cols=257  Identities=22%  Similarity=0.326  Sum_probs=213.0

Q ss_pred             HHhcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCC---hHhHHHHHHHHHHHhccC-CCceeeecceEEeCc
Q 016594           63 IATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTD---DRKEKEFLTEIGTIGHVC-HPNVLSLLGCCVDNG  137 (386)
Q Consensus        63 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~  137 (386)
                      ...+.|.+++.||+|+||+|++|.+. ++..||+|++.+....   ......+.+|+.+++.+. ||||+++++++....
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~   93 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT   93 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence            45678999999999999999999865 7899999977764111   234556778999999999 999999999997754


Q ss_pred             -eEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCC-CCeEEeecCcc
Q 016594          138 -LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTAD-FEPQISDFGLA  215 (386)
Q Consensus       138 -~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~-~~~kl~Dfg~a  215 (386)
                       .++||||+.+|+|.+.+..  ...+.+..+..++.|++.|++|||+   +||+||||||+|||++.+ +++||+|||++
T Consensus        94 ~~~ivmEy~~gGdL~~~i~~--~g~l~E~~ar~~F~Qlisav~y~H~---~gi~HRDLK~ENilld~~~~~~Kl~DFG~s  168 (370)
T KOG0583|consen   94 KIYIVMEYCSGGDLFDYIVN--KGRLKEDEARKYFRQLISAVAYCHS---RGIVHRDLKPENILLDGNEGNLKLSDFGLS  168 (370)
T ss_pred             eEEEEEEecCCccHHHHHHH--cCCCChHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEecCCCCCEEEeccccc
Confidence             9999999999999999987  3448899999999999999999999   999999999999999999 99999999999


Q ss_pred             ccCCCCCccccccccccccCccChhhhccCC-CC-cccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccc
Q 016594          216 KWLPSQWTHHSIAPIEGTFGHLAPEYFMHGI-VD-EKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKL  293 (386)
Q Consensus       216 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  293 (386)
                      ....  .......+.+||+.|+|||++.+.. |+ .++||||+|++||.|++|..||..........           .+
T Consensus       169 ~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~-----------ki  235 (370)
T KOG0583|consen  169 AISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYR-----------KI  235 (370)
T ss_pred             cccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHH-----------HH
Confidence            9874  1234567789999999999999877 76 89999999999999999999998743221111           11


Q ss_pred             cCCccCCCCCHHH-HHHHHHHHHHccccCCCCCCCHHHHHHHHhcCC
Q 016594          294 VDPRLQGAYDVTQ-LNRLAFAASLCIRASPTWRPTMSEVLEVMLEGD  339 (386)
Q Consensus       294 ~~~~~~~~~~~~~-~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~~  339 (386)
                      ....  ..++... +..+..|+.+||..||.+|+++.+|+++-|...
T Consensus       236 ~~~~--~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~  280 (370)
T KOG0583|consen  236 RKGE--FKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK  280 (370)
T ss_pred             hcCC--ccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence            1111  1122222 678999999999999999999999998876654

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-47  Score=342.62  Aligned_cols=266  Identities=24%  Similarity=0.365  Sum_probs=215.2

Q ss_pred             HHhcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEE
Q 016594           63 IATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYL  140 (386)
Q Consensus        63 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~l  140 (386)
                      ...+.|++...||.|..++||+|+.. .+..||||+++...-+. ....+.+|+..|+.++||||++++.+|..+. +++
T Consensus        23 ~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~-~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWv  101 (516)
T KOG0582|consen   23 LNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNN-DLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWV  101 (516)
T ss_pred             CCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhh-hHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEE
Confidence            56678999999999999999999965 68999999998643222 3678899999999999999999999997655 999


Q ss_pred             EEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCC
Q 016594          141 IFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPS  220 (386)
Q Consensus       141 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~  220 (386)
                      ||.||.+|++.+++...-..++++..+..|++++++||.|||.   +|.||||||+.|||++.+|.|||+|||.+..+..
T Consensus       102 VmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~---~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~  178 (516)
T KOG0582|consen  102 VMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQ---NGHIHRDVKAGNILIDSDGTVKLADFGVSASLFD  178 (516)
T ss_pred             eehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHh---cCceecccccccEEEcCCCcEEEcCceeeeeecc
Confidence            9999999999999998888889999999999999999999999   9999999999999999999999999999877654


Q ss_pred             CCccc--cccccccccCccChhhhcc--CCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCC
Q 016594          221 QWTHH--SIAPIEGTFGHLAPEYFMH--GIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDP  296 (386)
Q Consensus       221 ~~~~~--~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (386)
                      .....  ...+++||++|||||++..  ..|+.|+||||||++..||.+|..||.....--.-..+   -++......-.
T Consensus       179 ~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~t---Lqn~pp~~~t~  255 (516)
T KOG0582|consen  179 SGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLT---LQNDPPTLLTS  255 (516)
T ss_pred             cCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHH---hcCCCCCcccc
Confidence            43222  1267789999999999654  57999999999999999999999999875432111110   01111101111


Q ss_pred             ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 016594          297 RLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVM  335 (386)
Q Consensus       297 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l  335 (386)
                      .+...........+++++..||..||.+|||+++++++-
T Consensus       256 ~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~  294 (516)
T KOG0582|consen  256 GLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHA  294 (516)
T ss_pred             cCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccH
Confidence            111112223456899999999999999999999999764

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-47  Score=326.49  Aligned_cols=251  Identities=23%  Similarity=0.311  Sum_probs=212.0

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEecccc-CChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEE
Q 016594           65 TNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVV-TDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLI  141 (386)
Q Consensus        65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv  141 (386)
                      -.+|+..+.||.|+||.|.+++.+ +|..+|+|++.+.. ...........|..+|+.+.||+++++++.+.+.. +++|
T Consensus        43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv  122 (355)
T KOG0616|consen   43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV  122 (355)
T ss_pred             hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence            357888999999999999999987 68899999998632 22334456788999999999999999999998865 9999


Q ss_pred             EEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCC
Q 016594          142 FQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQ  221 (386)
Q Consensus       142 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  221 (386)
                      |+|..||.|..++++...  |++..++.++.||+.||+|||+   ++|++|||||+|||+|.+|.+||+|||.|+.+...
T Consensus       123 meyv~GGElFS~Lrk~~r--F~e~~arFYAAeivlAleylH~---~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r  197 (355)
T KOG0616|consen  123 MEYVPGGELFSYLRKSGR--FSEPHARFYAAEIVLALEYLHS---LDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR  197 (355)
T ss_pred             EeccCCccHHHHHHhcCC--CCchhHHHHHHHHHHHHHHHHh---cCeeeccCChHHeeeccCCcEEEEeccceEEecCc
Confidence            999999999999987554  9999999999999999999999   99999999999999999999999999999987543


Q ss_pred             CccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCCC
Q 016594          222 WTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGA  301 (386)
Q Consensus       222 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (386)
                           ..+.||||.|+|||++...+|+.++|+|||||++|||+.|.+||..... +.          ...+++...+  .
T Consensus       198 -----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~-~~----------iY~KI~~~~v--~  259 (355)
T KOG0616|consen  198 -----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP-IQ----------IYEKILEGKV--K  259 (355)
T ss_pred             -----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh-HH----------HHHHHHhCcc--c
Confidence                 4578999999999999999999999999999999999999999987643 11          1223333332  2


Q ss_pred             CCHHHHHHHHHHHHHccccCCCCC-----CCHHHHHHHHhcC
Q 016594          302 YDVTQLNRLAFAASLCIRASPTWR-----PTMSEVLEVMLEG  338 (386)
Q Consensus       302 ~~~~~~~~l~~li~~cl~~dP~~R-----pt~~~il~~l~~~  338 (386)
                      ++...+..+++|+..+|+.|-.+|     ....+|..|-+..
T Consensus       260 fP~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~  301 (355)
T KOG0616|consen  260 FPSYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFK  301 (355)
T ss_pred             CCcccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCcccc
Confidence            445567789999999999999999     3455666665443

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=3.9e-47  Score=320.00  Aligned_cols=265  Identities=23%  Similarity=0.291  Sum_probs=210.1

Q ss_pred             cCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeC-ceEEEEE
Q 016594           66 NAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDN-GLYLIFQ  143 (386)
Q Consensus        66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e  143 (386)
                      .+|...++||+|.||.||+|++. +|+.||||+++.....+......++|++.|+.++|+||+.++++|... ++.+|+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            46778899999999999999964 799999999987655555567889999999999999999999999764 5999999


Q ss_pred             eccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCc
Q 016594          144 FSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWT  223 (386)
Q Consensus       144 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~  223 (386)
                      |++. +|...+++.. ..++...+..++.++++||+|||+   +.|+||||||.|+|++.+|.+||+|||+|+.+.....
T Consensus        82 fm~t-dLe~vIkd~~-i~l~pa~iK~y~~m~LkGl~y~H~---~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~  156 (318)
T KOG0659|consen   82 FMPT-DLEVVIKDKN-IILSPADIKSYMLMTLKGLAYCHS---KWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR  156 (318)
T ss_pred             eccc-cHHHHhcccc-cccCHHHHHHHHHHHHHHHHHHHh---hhhhcccCCccceEEcCCCcEEeecccchhccCCCCc
Confidence            9987 8888887644 448888999999999999999999   9999999999999999999999999999999876543


Q ss_pred             cccccccccccCccChhhhcc-CCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhh--hcccccc------cc-
Q 016594          224 HHSIAPIEGTFGHLAPEYFMH-GIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPI--LNQGEIE------KL-  293 (386)
Q Consensus       224 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~--~~~~~~~------~~-  293 (386)
                      .  ....+-|.+|.|||.+.| ..|+..+|+||.|||+.||+-|.+-|.|..+- .+....+  +......      .+ 
T Consensus       157 ~--~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDi-dQL~~If~~LGTP~~~~WP~~~~lp  233 (318)
T KOG0659|consen  157 I--QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDI-DQLSKIFRALGTPTPDQWPEMTSLP  233 (318)
T ss_pred             c--cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchH-HHHHHHHHHcCCCCcccCccccccc
Confidence            2  223368999999999887 56999999999999999999999999886542 1111111  1110000      00 


Q ss_pred             -------cCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          294 -------VDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       294 -------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                             .........-...+..+.+|+..||..||.+|+++++++++-...
T Consensus       234 dY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~  285 (318)
T KOG0659|consen  234 DYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFK  285 (318)
T ss_pred             cHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhh
Confidence                   011111111123356679999999999999999999999875443

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=3.6e-47  Score=348.67  Aligned_cols=262  Identities=22%  Similarity=0.294  Sum_probs=211.2

Q ss_pred             HHHhcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCC-hHhHHHHHHHHHHHhccCCCceeeecceEEeCc-e
Q 016594           62 SIATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTD-DRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-L  138 (386)
Q Consensus        62 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~  138 (386)
                      .+..++|+++++||+|+||.||+|+-+ +|..+|+|++++.... .......+.|-.+|....+|.||+||-.|.+.. +
T Consensus       137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~L  216 (550)
T KOG0605|consen  137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYL  216 (550)
T ss_pred             cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCee
Confidence            345678999999999999999999966 7999999999985433 345677889999999999999999999998865 9


Q ss_pred             EEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccC
Q 016594          139 YLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWL  218 (386)
Q Consensus       139 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~  218 (386)
                      ||||||++||++..++.+...  +++..+..++.+++.|++.||+   .|+|||||||+|+|||..|++||+|||++.-+
T Consensus       217 YLiMEylPGGD~mTLL~~~~~--L~e~~arfYiaE~vlAI~~iH~---~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl  291 (550)
T KOG0605|consen  217 YLIMEYLPGGDMMTLLMRKDT--LTEDWARFYIAETVLAIESIHQ---LGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGL  291 (550)
T ss_pred             EEEEEecCCccHHHHHHhcCc--CchHHHHHHHHHHHHHHHHHHH---cCcccccCChhheeecCCCCEeeccccccchh
Confidence            999999999999999986544  9999999999999999999999   99999999999999999999999999998543


Q ss_pred             CCC-----------------------Ccc----c------------------cccccccccCccChhhhccCCCCcccch
Q 016594          219 PSQ-----------------------WTH----H------------------SIAPIEGTFGHLAPEYFMHGIVDEKTDV  253 (386)
Q Consensus       219 ~~~-----------------------~~~----~------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv  253 (386)
                      ...                       ...    .                  .....+|||.|||||++.+..|+..+|+
T Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDw  371 (550)
T KOG0605|consen  292 DKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDW  371 (550)
T ss_pred             hhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccH
Confidence            210                       000    0                  0113569999999999999999999999


Q ss_pred             HHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCC---HHH
Q 016594          254 FAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPT---MSE  330 (386)
Q Consensus       254 wslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt---~~~  330 (386)
                      ||||||+||||.|.+||.+..... .|.+ +++.       ...+..+.....+.+..+||.+||. ||+.|..   +.|
T Consensus       372 WSLG~ImyEmLvGyPPF~s~tp~~-T~rk-I~nw-------r~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~E  441 (550)
T KOG0605|consen  372 WSLGCIMYEMLVGYPPFCSETPQE-TYRK-IVNW-------RETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEE  441 (550)
T ss_pred             HHHHHHHHHHHhCCCCCCCCCHHH-HHHH-HHHH-------hhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHH
Confidence            999999999999999998865431 1111 1111       1112222333445789999999999 9999975   778


Q ss_pred             HHHHHhcC
Q 016594          331 VLEVMLEG  338 (386)
Q Consensus       331 il~~l~~~  338 (386)
                      |.+|.+..
T Consensus       442 IK~HPfF~  449 (550)
T KOG0605|consen  442 IKKHPFFK  449 (550)
T ss_pred             HhcCCccc
Confidence            87775443

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=1.9e-47  Score=351.24  Aligned_cols=249  Identities=23%  Similarity=0.386  Sum_probs=215.6

Q ss_pred             cCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEEE
Q 016594           66 NAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQ  143 (386)
Q Consensus        66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~e  143 (386)
                      ++|.+.+.||+|+||.||+|+.+ +.+.||+|.+.+........+.+.+|+++++.++|||||.++++|+... +++|.|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            57888999999999999999976 6889999999988777888899999999999999999999999998765 899999


Q ss_pred             eccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCc
Q 016594          144 FSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWT  223 (386)
Q Consensus       144 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~  223 (386)
                      |+.| +|..++.....  ++++.+..++.+++.||.|||+   ++|+|||+||.|||++..|.+|+||||+|+.+...  
T Consensus        82 ~a~g-~L~~il~~d~~--lpEe~v~~~a~~LVsaL~yLhs---~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~--  153 (808)
T KOG0597|consen   82 YAVG-DLFTILEQDGK--LPEEQVRAIAYDLVSALYYLHS---NRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN--  153 (808)
T ss_pred             hhhh-hHHHHHHhccC--CCHHHHHHHHHHHHHHHHHHHh---cCcccccCCcceeeecCCCceeechhhhhhhcccC--
Confidence            9988 99999976444  9999999999999999999999   99999999999999999999999999999987653  


Q ss_pred             cccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCCCCC
Q 016594          224 HHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYD  303 (386)
Q Consensus       224 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (386)
                      ........|||.|||||+..+++|+..+|+|||||++||+++|++||....  +...++.+..+         .  ..++
T Consensus       154 t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s--i~~Lv~~I~~d---------~--v~~p  220 (808)
T KOG0597|consen  154 TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS--ITQLVKSILKD---------P--VKPP  220 (808)
T ss_pred             ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH--HHHHHHHHhcC---------C--CCCc
Confidence            234556779999999999999999999999999999999999999997532  22222222211         1  1233


Q ss_pred             HHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 016594          304 VTQLNRLAFAASLCIRASPTWRPTMSEVLEVM  335 (386)
Q Consensus       304 ~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l  335 (386)
                      ...+..+.+++...|.+||.+|.+-.+++.|-
T Consensus       221 ~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~Hp  252 (808)
T KOG0597|consen  221 STASSSFVNFLQGLLIKDPAQRLTWTDLLGHP  252 (808)
T ss_pred             ccccHHHHHHHHHHhhcChhhcccHHHHhcCh
Confidence            45677899999999999999999999999874

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=6.5e-47  Score=336.79  Aligned_cols=282  Identities=23%  Similarity=0.257  Sum_probs=231.6

Q ss_pred             HHhcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCC-hHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eE
Q 016594           63 IATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTD-DRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LY  139 (386)
Q Consensus        63 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~  139 (386)
                      +.-..|++.+.||.|.-|+||++..+ ++..+|+|++.+.... .....+...|.+||+.++||.++.||..|+.+. .|
T Consensus        74 l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~c  153 (459)
T KOG0610|consen   74 LGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSC  153 (459)
T ss_pred             cCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeE
Confidence            34456888999999999999999987 4689999999875433 455667788999999999999999999998766 89


Q ss_pred             EEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCC
Q 016594          140 LIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLP  219 (386)
Q Consensus       140 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~  219 (386)
                      ++||||.||+|..+++++..+.|++..+..++.+++.||+|||.   .|||+|||||+|||+.++|++.|+||.++..+.
T Consensus       154 l~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHm---lGivYRDLKPENILvredGHIMLsDFDLS~~~~  230 (459)
T KOG0610|consen  154 LVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHM---LGIVYRDLKPENILVREDGHIMLSDFDLSLRCP  230 (459)
T ss_pred             EEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHh---hceeeccCCcceeEEecCCcEEeeeccccccCC
Confidence            99999999999999999999999999999999999999999999   999999999999999999999999999975431


Q ss_pred             CC---------------------------------Cc---------------------cccccccccccCccChhhhccC
Q 016594          220 SQ---------------------------------WT---------------------HHSIAPIEGTFGHLAPEYFMHG  245 (386)
Q Consensus       220 ~~---------------------------------~~---------------------~~~~~~~~gt~~y~aPE~~~~~  245 (386)
                      ..                                 ..                     ......++||-.|+|||++.|.
T Consensus       231 ~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~  310 (459)
T KOG0610|consen  231 VSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGE  310 (459)
T ss_pred             CCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecC
Confidence            10                                 00                     0112346799999999999999


Q ss_pred             CCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHccccCCCCC
Q 016594          246 IVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWR  325 (386)
Q Consensus       246 ~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R  325 (386)
                      ..+.++|+|+|||++|||+.|..||.+.+.           ...+..++.+.+...-....+..+++||+++|.+||.+|
T Consensus       311 GHgsAVDWWtfGIflYEmLyG~TPFKG~~~-----------~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kR  379 (459)
T KOG0610|consen  311 GHGSAVDWWTFGIFLYEMLYGTTPFKGSNN-----------KETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKR  379 (459)
T ss_pred             CCCchhhHHHHHHHHHHHHhCCCCcCCCCc-----------hhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhh
Confidence            999999999999999999999999998643           234555566555555555677889999999999999999


Q ss_pred             CC----HHHHHHHH-hcCCcccccccCCCCcccchhhc
Q 016594          326 PT----MSEVLEVM-LEGDQIDKERWKMPEEEEEDQEE  358 (386)
Q Consensus       326 pt----~~~il~~l-~~~~~~~~~~~~~~~~~~~~~~~  358 (386)
                      ..    +.||-+|- .+..++...+..-|...|...+.
T Consensus       380 lg~~rGA~eIK~HpFF~gVnWaLir~~~PP~iP~~~d~  417 (459)
T KOG0610|consen  380 LGSKRGAAEIKRHPFFEGVNWALIRCARPPEIPKPVDG  417 (459)
T ss_pred             hccccchHHhhcCccccCCChhheeccCCCcCCCcccc
Confidence            98    88888873 34445554444445554544443

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=1.1e-46  Score=352.30  Aligned_cols=262  Identities=24%  Similarity=0.414  Sum_probs=205.5

Q ss_pred             HHHhcCCCCCCeecccCCcEEEEEEEC------CCcEEEEEEeccccCChHhHHHHHHHHHHHhcc-CCCceeeecceEE
Q 016594           62 SIATNAFSSENLVGRGGYAEVYKGVLQ------DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHV-CHPNVLSLLGCCV  134 (386)
Q Consensus        62 ~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~  134 (386)
                      .+..++|++.+.||+|+||.||+|.+.      ++..||||++... ........+.+|+.++..+ +||||+++++++.
T Consensus         3 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~   81 (338)
T cd05102           3 EFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEG-ATASEHKALMSELKILIHIGNHLNVVNLLGACT   81 (338)
T ss_pred             ccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccc-cchHHHHHHHHHHHHHHHhccCcceeeEEeEec
Confidence            355678999999999999999999741      3567999998753 2233456789999999999 7999999999887


Q ss_pred             eCc--eEEEEEeccCCCHhhhhhhcC------------------------------------------------------
Q 016594          135 DNG--LYLIFQFSSRGSVASLFHDVN------------------------------------------------------  158 (386)
Q Consensus       135 ~~~--~~lv~e~~~~~~L~~~~~~~~------------------------------------------------------  158 (386)
                      ..+  .+++|||+.+|+|.+++....                                                      
T Consensus        82 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (338)
T cd05102          82 KPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQ  161 (338)
T ss_pred             CCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccch
Confidence            533  789999999999999886432                                                      


Q ss_pred             ------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCcccccccccc
Q 016594          159 ------SPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEG  232 (386)
Q Consensus       159 ------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g  232 (386)
                            ...+++..+..++.|++.||+|||+   ++|+||||||+|||++.++.+||+|||++................+
T Consensus       162 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~  238 (338)
T cd05102         162 ETDDLWKSPLTMEDLICYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL  238 (338)
T ss_pred             hccccccCCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCC
Confidence                  1237788899999999999999999   9999999999999999999999999999986543322222223346


Q ss_pred             ccCccChhhhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCchhhhhhhhhhhcccccccccCCccCCCCCHHHHHHHH
Q 016594          233 TFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQLNRLA  311 (386)
Q Consensus       233 t~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  311 (386)
                      +..|+|||++.+..++.++|||||||++|||++ |..||.+...... ... ....+.         ....+...+..+.
T Consensus       239 ~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~-~~~-~~~~~~---------~~~~~~~~~~~l~  307 (338)
T cd05102         239 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE-FCQ-RLKDGT---------RMRAPENATPEIY  307 (338)
T ss_pred             CccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH-HHH-HHhcCC---------CCCCCCCCCHHHH
Confidence            678999999999999999999999999999997 9999986432111 001 011110         0111223456799


Q ss_pred             HHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          312 FAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       312 ~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                      +++.+||+.||++|||+.+|++.|+..
T Consensus       308 ~li~~cl~~dp~~RPs~~el~~~l~~~  334 (338)
T cd05102         308 RIMLACWQGDPKERPTFSALVEILGDL  334 (338)
T ss_pred             HHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.9e-47  Score=357.51  Aligned_cols=250  Identities=22%  Similarity=0.280  Sum_probs=213.0

Q ss_pred             cCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccc-cCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEE
Q 016594           66 NAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKV-VTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIF  142 (386)
Q Consensus        66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~  142 (386)
                      +-|++++.||.|+.|.|.+|++. +|+.+|||++.+. .........+.+|+-+|+-+.||||+++|+++++.. +|+|.
T Consensus        12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl   91 (786)
T KOG0588|consen   12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL   91 (786)
T ss_pred             cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence            56889999999999999999976 8999999999875 333444566889999999999999999999998765 99999


Q ss_pred             EeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCC
Q 016594          143 QFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQW  222 (386)
Q Consensus       143 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  222 (386)
                      ||+.+|.|.+++.+.+  ++++.++.++++||+.|+.|||.   .+|+||||||+|+|||.++++||+|||+|..-..  
T Consensus        92 Eyv~gGELFdylv~kG--~l~e~eaa~ff~QIi~gv~yCH~---~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~--  164 (786)
T KOG0588|consen   92 EYVPGGELFDYLVRKG--PLPEREAAHFFRQILDGVSYCHA---FNICHRDLKPENLLLDVKNNIKIADFGMASLEVP--  164 (786)
T ss_pred             EecCCchhHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHhh---hcceeccCCchhhhhhcccCEeeeccceeecccC--
Confidence            9999999999887644  49999999999999999999999   9999999999999999999999999999986433  


Q ss_pred             ccccccccccccCccChhhhccCCCC-cccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccC--
Q 016594          223 THHSIAPIEGTFGHLAPEYFMHGIVD-EKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQ--  299 (386)
Q Consensus       223 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--  299 (386)
                       .....+.||.+.|.|||++.|.+|. .++||||+|||||.||+|+.||++.+..               .++.+..+  
T Consensus       165 -gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir---------------~LLlKV~~G~  228 (786)
T KOG0588|consen  165 -GKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIR---------------VLLLKVQRGV  228 (786)
T ss_pred             -CccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHH---------------HHHHHHHcCc
Confidence             2345678899999999999999885 8999999999999999999999864322               11111111  


Q ss_pred             CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          300 GAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       300 ~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                      ...+...+.++++|+.+||..||+.|.|+.+|++|.+-.
T Consensus       229 f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~  267 (786)
T KOG0588|consen  229 FEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLS  267 (786)
T ss_pred             ccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhh
Confidence            123345567899999999999999999999999997654

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.1e-46  Score=326.59  Aligned_cols=266  Identities=22%  Similarity=0.284  Sum_probs=212.2

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc---eEE
Q 016594           65 TNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG---LYL  140 (386)
Q Consensus        65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~---~~l  140 (386)
                      .+.|+..+.|++|+||.||+|+++ +++.||+|+++.......-....++|+.+|.+.+|||||.+-.+.+..+   .|+
T Consensus        75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~  154 (419)
T KOG0663|consen   75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI  154 (419)
T ss_pred             HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence            346788999999999999999976 7889999999865443444456789999999999999999999987644   899


Q ss_pred             EEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCC
Q 016594          141 IFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPS  220 (386)
Q Consensus       141 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~  220 (386)
                      ||||+.. +|..++.... .+|...++..++.|++.|++|||.   +.|+||||||+|+|++..|.+||+|||+|+.+..
T Consensus       155 VMe~~Eh-DLksl~d~m~-q~F~~~evK~L~~QlL~glk~lH~---~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygs  229 (419)
T KOG0663|consen  155 VMEYVEH-DLKSLMETMK-QPFLPGEVKTLMLQLLRGLKHLHD---NWILHRDLKTSNLLLSHKGILKIADFGLAREYGS  229 (419)
T ss_pred             eHHHHHh-hHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHhh---ceeEecccchhheeeccCCcEEecccchhhhhcC
Confidence            9999998 8999988766 459999999999999999999999   9999999999999999999999999999999876


Q ss_pred             CCccccccccccccCccChhhhccC-CCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccC----
Q 016594          221 QWTHHSIAPIEGTFGHLAPEYFMHG-IVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVD----  295 (386)
Q Consensus       221 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~----  295 (386)
                      .  ...++..+-|++|.|||.+.+. .|+.++|+||+|||+.||+++++.|.+...-. +..+.+...+...+.+-    
T Consensus       230 p--~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~d-Ql~~If~llGtPte~iwpg~~  306 (419)
T KOG0663|consen  230 P--LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEID-QLDKIFKLLGTPSEAIWPGYS  306 (419)
T ss_pred             C--cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHH-HHHHHHHHhCCCccccCCCcc
Confidence            5  3456677889999999999875 59999999999999999999999998865311 11111111111000000    


Q ss_pred             ---------------CccCCCCCHH-HHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          296 ---------------PRLQGAYDVT-QLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       296 ---------------~~~~~~~~~~-~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                                     ..++..+... .++.-.+|+..+|.+||.+|.|+++.|++=+..
T Consensus       307 ~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~  365 (419)
T KOG0663|consen  307 ELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFR  365 (419)
T ss_pred             ccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccc
Confidence                           0011111111 346788999999999999999999999885544

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=8.4e-47  Score=350.18  Aligned_cols=267  Identities=26%  Similarity=0.403  Sum_probs=223.8

Q ss_pred             cCHHHHHHHhcCCCCCCeecccCCcEEEEEEECCCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEe
Q 016594           56 FSFEEISIATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVD  135 (386)
Q Consensus        56 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~  135 (386)
                      ...++|++..+.+.++..||+|.||+||+|.|- | .||||+++.....+...+.|..|+..+++-+|.||+-+.|+|..
T Consensus       382 ~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh-G-dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~  459 (678)
T KOG0193|consen  382 DSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWH-G-DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMN  459 (678)
T ss_pred             ccccccccCHHHhhccceeccccccceeecccc-c-ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcC
Confidence            444778899999999999999999999999996 3 69999999887778888999999999999999999999999999


Q ss_pred             CceEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCcc
Q 016594          136 NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLA  215 (386)
Q Consensus       136 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a  215 (386)
                      ..+.+|..+|.|.+|+.+++.... .|.......|++||++|+.|||.   ++|||||||..||++.+++.|||+|||++
T Consensus       460 p~~AIiTqwCeGsSLY~hlHv~et-kfdm~~~idIAqQiaqGM~YLHA---K~IIHrDLKSnNIFl~~~~kVkIgDFGLa  535 (678)
T KOG0193|consen  460 PPLAIITQWCEGSSLYTHLHVQET-KFDMNTTIDIAQQIAQGMDYLHA---KNIIHRDLKSNNIFLHEDLKVKIGDFGLA  535 (678)
T ss_pred             CceeeeehhccCchhhhhccchhh-hhhHHHHHHHHHHHHHhhhhhhh---hhhhhhhccccceEEccCCcEEEecccce
Confidence            999999999999999999876553 48899999999999999999999   99999999999999999999999999999


Q ss_pred             ccCCCCCccccccccccccCccChhhhcc---CCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhccccccc
Q 016594          216 KWLPSQWTHHSIAPIEGTFGHLAPEYFMH---GIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEK  292 (386)
Q Consensus       216 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  292 (386)
                      ..-..-..........|...|||||++..   .+|++.+|||||||++|||++|..||.....+            .+.-
T Consensus       536 tvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~d------------qIif  603 (678)
T KOG0193|consen  536 TVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRD------------QIIF  603 (678)
T ss_pred             eeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChh------------heEE
Confidence            75433222233344458889999999974   47999999999999999999999999843222            1111


Q ss_pred             ccCCcc-CC---CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCCc
Q 016594          293 LVDPRL-QG---AYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEGDQ  340 (386)
Q Consensus       293 ~~~~~~-~~---~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~~~  340 (386)
                      ++.... ..   .....++.++.+|+..||.+++++||.+.+||..|++...
T Consensus       604 mVGrG~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~  655 (678)
T KOG0193|consen  604 MVGRGYLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP  655 (678)
T ss_pred             EecccccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence            222210 00   1123456789999999999999999999999998887755

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.8e-47  Score=339.01  Aligned_cols=252  Identities=20%  Similarity=0.374  Sum_probs=214.3

Q ss_pred             HhcCCCCCCeecccCCcEEEEEEE-CCCcEEEEEEecccc-CChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEE
Q 016594           64 ATNAFSSENLVGRGGYAEVYKGVL-QDGEEIAVKRLTKVV-TDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYL  140 (386)
Q Consensus        64 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~l  140 (386)
                      ..-+|++.+.||+|+||+|-+|+. ..|+.||||.+++.. .+..+...+.+|++||..|+||||+.+|.+|+..+ ..+
T Consensus        51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvi  130 (668)
T KOG0611|consen   51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVI  130 (668)
T ss_pred             hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEE
Confidence            345788999999999999999995 579999999998743 44566778999999999999999999999998765 999


Q ss_pred             EEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCC
Q 016594          141 IFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPS  220 (386)
Q Consensus       141 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~  220 (386)
                      ||||..+|.|++++.+...  +++.++..+++||+.|+.|||.   ++++|||||.+|||||.++++||+|||++..+..
T Consensus       131 vMEYaS~GeLYDYiSer~~--LsErEaRhfFRQIvSAVhYCHk---nrVvHRDLKLENILLD~N~NiKIADFGLSNly~~  205 (668)
T KOG0611|consen  131 VMEYASGGELYDYISERGS--LSEREARHFFRQIVSAVHYCHK---NRVVHRDLKLENILLDQNNNIKIADFGLSNLYAD  205 (668)
T ss_pred             EEEecCCccHHHHHHHhcc--ccHHHHHHHHHHHHHHHHHHhh---ccceecccchhheeecCCCCeeeeccchhhhhcc
Confidence            9999999999999987655  9999999999999999999999   9999999999999999999999999999988754


Q ss_pred             CCccccccccccccCccChhhhccCCCC-cccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccC
Q 016594          221 QWTHHSIAPIEGTFGHLAPEYFMHGIVD-EKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQ  299 (386)
Q Consensus       221 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (386)
                      .   ....++||++-|.+||++.|.+|. +.+|-||||++||.|+.|.+||++.+...  .++++ ..+..        +
T Consensus       206 ~---kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~--lvrQI-s~GaY--------r  271 (668)
T KOG0611|consen  206 K---KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKR--LVRQI-SRGAY--------R  271 (668)
T ss_pred             c---cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHH--HHHHh-hcccc--------c
Confidence            3   356789999999999999999885 89999999999999999999999865421  11111 11111        1


Q ss_pred             CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 016594          300 GAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLE  337 (386)
Q Consensus       300 ~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~  337 (386)
                      .   +..+....-||++||..||++|.|+.+|..|-|-
T Consensus       272 E---P~~PSdA~gLIRwmLmVNP~RRATieDiAsHWWv  306 (668)
T KOG0611|consen  272 E---PETPSDASGLIRWMLMVNPERRATIEDIASHWWV  306 (668)
T ss_pred             C---CCCCchHHHHHHHHHhcCcccchhHHHHhhhhee
Confidence            1   1123456779999999999999999999998653

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-47  Score=342.16  Aligned_cols=249  Identities=26%  Similarity=0.417  Sum_probs=213.9

Q ss_pred             cCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEEE
Q 016594           66 NAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQ  143 (386)
Q Consensus        66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~e  143 (386)
                      ..|.....||+|+||.||+|.+. +++.||+|++.... .......+.+|+.+|.+++++||.++|+.+..+. ++++||
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~-~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMe   91 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEE-AEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIME   91 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhh-cchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHH
Confidence            45677789999999999999965 78999999998643 3345667889999999999999999999998766 899999


Q ss_pred             eccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCc
Q 016594          144 FSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWT  223 (386)
Q Consensus       144 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~  223 (386)
                      |+.||++.+++.....  +.+..+..++++++.||.|||.   ++.+|||||+.|||+..+|.+||+|||++..+.....
T Consensus        92 y~~gGsv~~lL~~~~~--~~E~~i~~ilre~l~~l~ylH~---~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~  166 (467)
T KOG0201|consen   92 YCGGGSVLDLLKSGNI--LDEFEIAVILREVLKGLDYLHS---EKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK  166 (467)
T ss_pred             HhcCcchhhhhccCCC--CccceeeeehHHHHHHhhhhhh---cceecccccccceeEeccCcEEEEecceeeeeechhh
Confidence            9999999999875432  4788888899999999999999   9999999999999999999999999999988765432


Q ss_pred             cccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCCCCC
Q 016594          224 HHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYD  303 (386)
Q Consensus       224 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (386)
                        ...+++||+.|||||++.+..|+.|+||||||++.+||++|.+|+...++            ..+..++.+...+...
T Consensus       167 --rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hP------------mrvlflIpk~~PP~L~  232 (467)
T KOG0201|consen  167 --RRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHP------------MRVLFLIPKSAPPRLD  232 (467)
T ss_pred             --ccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCc------------ceEEEeccCCCCCccc
Confidence              33788999999999999999999999999999999999999999987533            3344444444444455


Q ss_pred             HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 016594          304 VTQLNRLAFAASLCIRASPTWRPTMSEVLEV  334 (386)
Q Consensus       304 ~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~  334 (386)
                      ..++..+++++..||.+||+.||++.++|+|
T Consensus       233 ~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh  263 (467)
T KOG0201|consen  233 GDFSPPFKEFVEACLDKNPEFRPSAKELLKH  263 (467)
T ss_pred             cccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence            5677889999999999999999999999976

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-46  Score=338.07  Aligned_cols=265  Identities=27%  Similarity=0.348  Sum_probs=212.7

Q ss_pred             HHHhcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCCh------------HhHHHHHHHHHHHhccCCCceee
Q 016594           62 SIATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDD------------RKEKEFLTEIGTIGHVCHPNVLS  128 (386)
Q Consensus        62 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~------------~~~~~~~~e~~~l~~l~h~niv~  128 (386)
                      ...-++|++.+.||+|.||+|-+|+.. +++.||||++.+.....            .......+|+.+|+++.|||||+
T Consensus        93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~  172 (576)
T KOG0585|consen   93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK  172 (576)
T ss_pred             ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence            345688999999999999999999965 78999999998632111            11346789999999999999999


Q ss_pred             ecceEEeC---ceEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCC
Q 016594          129 LLGCCVDN---GLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADF  205 (386)
Q Consensus       129 l~~~~~~~---~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~  205 (386)
                      |+.+..+.   .+|+|+||+..|.+...-..  ...+.+.+++.++++++.||+|||.   +|||||||||.|+||+.+|
T Consensus       173 LiEvLDDP~s~~~YlVley~s~G~v~w~p~d--~~els~~~Ar~ylrDvv~GLEYLH~---QgiiHRDIKPsNLLl~~~g  247 (576)
T KOG0585|consen  173 LIEVLDDPESDKLYLVLEYCSKGEVKWCPPD--KPELSEQQARKYLRDVVLGLEYLHY---QGIIHRDIKPSNLLLSSDG  247 (576)
T ss_pred             EEEeecCcccCceEEEEEeccCCccccCCCC--cccccHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEEcCCC
Confidence            99998763   49999999999987654321  2228999999999999999999999   9999999999999999999


Q ss_pred             CeEEeecCccccCCCCC---ccccccccccccCccChhhhccCC----CCcccchHHHHHHHHHHHhCCCCCCCCchhhh
Q 016594          206 EPQISDFGLAKWLPSQW---THHSIAPIEGTFGHLAPEYFMHGI----VDEKTDVFAFGVFLLEIISGRKPVDGSHQSLH  278 (386)
Q Consensus       206 ~~kl~Dfg~a~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwslG~il~ell~g~~pf~~~~~~~~  278 (386)
                      +|||+|||.+..+....   .........|||.|+|||...++.    .+.+.||||+||+||.|+.|+.||-+....  
T Consensus       248 ~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~--  325 (576)
T KOG0585|consen  248 TVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFEL--  325 (576)
T ss_pred             cEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHH--
Confidence            99999999998773321   112223467999999999987632    358899999999999999999999764221  


Q ss_pred             hhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCCccc
Q 016594          279 SWAKPILNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEGDQID  342 (386)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~~~~~  342 (386)
                               ....+++...+..+...+..+.+.+||.+||.+||+.|.+..+|..|.+-....+
T Consensus       326 ---------~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g~  380 (576)
T KOG0585|consen  326 ---------ELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDGD  380 (576)
T ss_pred             ---------HHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccCCC
Confidence                     1223444444444444456788999999999999999999999999988765543

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.5e-46  Score=312.08  Aligned_cols=253  Identities=26%  Similarity=0.371  Sum_probs=215.7

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEecccc-CChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEE
Q 016594           65 TNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVV-TDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLI  141 (386)
Q Consensus        65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv  141 (386)
                      -++|++++.||+|-||.||.|+.+ ++.-||+|++.+.. .......++.+|+++...|+||||+++|++|.+.. .|++
T Consensus        21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi  100 (281)
T KOG0580|consen   21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI  100 (281)
T ss_pred             hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence            357889999999999999999976 67889999987643 22345678899999999999999999999998866 9999


Q ss_pred             EEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCC
Q 016594          142 FQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQ  221 (386)
Q Consensus       142 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  221 (386)
                      +||..+|.+...+.......+++...+.++.|++.||.|+|.   ++|+||||||+|+|++..+.+||+|||-+..-+. 
T Consensus       101 lEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~---k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~-  176 (281)
T KOG0580|consen  101 LEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHL---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-  176 (281)
T ss_pred             EEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhcc---CCcccCCCCHHHhccCCCCCeeccCCCceeecCC-
Confidence            999999999999997777779999999999999999999999   9999999999999999999999999999876542 


Q ss_pred             CccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCCC
Q 016594          222 WTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGA  301 (386)
Q Consensus       222 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (386)
                         ....+.|||..|.|||...+..++..+|+|++|++.||++.|.+||....... .          ..++..  ....
T Consensus       177 ---~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~e-t----------YkrI~k--~~~~  240 (281)
T KOG0580|consen  177 ---NKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSE-T----------YKRIRK--VDLK  240 (281)
T ss_pred             ---CCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHH-H----------HHHHHH--cccc
Confidence               34457889999999999999999999999999999999999999998754211 1          111111  1122


Q ss_pred             CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 016594          302 YDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLE  337 (386)
Q Consensus       302 ~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~  337 (386)
                      ++...+....++|.+|+.++|.+|.+..+++++-+-
T Consensus       241 ~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI  276 (281)
T KOG0580|consen  241 FPSTISGGAADLISRLLVKNPIERLALTEVMDHPWI  276 (281)
T ss_pred             CCcccChhHHHHHHHHhccCccccccHHHHhhhHHH
Confidence            334556789999999999999999999999998764

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-46  Score=350.96  Aligned_cols=252  Identities=23%  Similarity=0.349  Sum_probs=210.7

Q ss_pred             HHHhcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEecccc-CChHhHHHHHHHHHHHhccC-CCceeeecceEEeCc-
Q 016594           62 SIATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVV-TDDRKEKEFLTEIGTIGHVC-HPNVLSLLGCCVDNG-  137 (386)
Q Consensus        62 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~-  137 (386)
                      .+.-.+|.+.++||+|+||+|+++..+ +++.||||++++.. .........+.|..++.... ||.++.++.+|.... 
T Consensus       364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~  443 (694)
T KOG0694|consen  364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH  443 (694)
T ss_pred             cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence            456678999999999999999999987 68899999999853 34455667888988888776 999999999998765 


Q ss_pred             eEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCcccc
Q 016594          138 LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKW  217 (386)
Q Consensus       138 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~  217 (386)
                      +|+||||+.||++..+   .....|++..+..++..++.||.|||+   ++|||||||.+|||||.+|++||+|||+++.
T Consensus       444 l~fvmey~~Ggdm~~~---~~~~~F~e~rarfyaAev~l~L~fLH~---~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe  517 (694)
T KOG0694|consen  444 LFFVMEYVAGGDLMHH---IHTDVFSEPRARFYAAEVVLGLQFLHE---NGIIYRDLKLDNLLLDTEGHVKIADFGLCKE  517 (694)
T ss_pred             EEEEEEecCCCcEEEE---EecccccHHHHHHHHHHHHHHHHHHHh---cCceeeecchhheEEcccCcEEecccccccc
Confidence            9999999999994333   344559999999999999999999999   9999999999999999999999999999987


Q ss_pred             CCCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCc
Q 016594          218 LPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPR  297 (386)
Q Consensus       218 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (386)
                      .-..  .....++|||+.|||||++.+..|+.++|+|||||+||||+.|..||.+.+....           ...++.. 
T Consensus       518 ~m~~--g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~-----------FdsI~~d-  583 (694)
T KOG0694|consen  518 GMGQ--GDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEV-----------FDSIVND-  583 (694)
T ss_pred             cCCC--CCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHH-----------HHHHhcC-
Confidence            5432  2356789999999999999999999999999999999999999999998654211           1111111 


Q ss_pred             cCCCCCHHHHHHHHHHHHHccccCCCCCCCH-----HHHHHH
Q 016594          298 LQGAYDVTQLNRLAFAASLCIRASPTWRPTM-----SEVLEV  334 (386)
Q Consensus       298 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~-----~~il~~  334 (386)
                       ...|+...+.+...+++++|..+|++|..+     .+|..|
T Consensus       584 -~~~yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~h  624 (694)
T KOG0694|consen  584 -EVRYPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKH  624 (694)
T ss_pred             -CCCCCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhC
Confidence             123566677889999999999999999854     566665

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.4e-46  Score=343.38  Aligned_cols=251  Identities=24%  Similarity=0.378  Sum_probs=210.3

Q ss_pred             cCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEe-CceEEEEE
Q 016594           66 NAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVD-NGLYLIFQ  143 (386)
Q Consensus        66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~lv~e  143 (386)
                      ..|....+||+|+.|.||.|+.. +++.||||.+...  ......-++.|+.+|+..+|+|||.+++.|.- +.++.|||
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~--~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVME  350 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLR--KQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVME  350 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCceEEEEEEEec--cCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEe
Confidence            46888899999999999999954 6889999999853  34445678899999999999999999998855 55999999


Q ss_pred             eccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCc
Q 016594          144 FSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWT  223 (386)
Q Consensus       144 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~  223 (386)
                      |++||+|.+++....   +++.++..|.+++++||+|||.   ++|+|||||.+|||++.+|.+||+|||++..+.....
T Consensus       351 ym~ggsLTDvVt~~~---~~E~qIA~Icre~l~aL~fLH~---~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~  424 (550)
T KOG0578|consen  351 YMEGGSLTDVVTKTR---MTEGQIAAICREILQGLKFLHA---RGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS  424 (550)
T ss_pred             ecCCCchhhhhhccc---ccHHHHHHHHHHHHHHHHHHHh---cceeeeccccceeEeccCCcEEEeeeeeeeccccccC
Confidence            999999999987543   8999999999999999999999   9999999999999999999999999999988866533


Q ss_pred             cccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCCCCC
Q 016594          224 HHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYD  303 (386)
Q Consensus       224 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (386)
                        ...+.+||+.|||||++....|++++||||||++++||+.|.+||-....-...|.        +..  ...+....+
T Consensus       425 --KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyL--------Ia~--ng~P~lk~~  492 (550)
T KOG0578|consen  425 --KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL--------IAT--NGTPKLKNP  492 (550)
T ss_pred             --ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHH--------Hhh--cCCCCcCCc
Confidence              44567899999999999999999999999999999999999999976432111110        000  111122233


Q ss_pred             HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 016594          304 VTQLNRLAFAASLCIRASPTWRPTMSEVLEVML  336 (386)
Q Consensus       304 ~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~  336 (386)
                      ...+..|++++.+||..|+.+||++.++|+|-.
T Consensus       493 ~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpF  525 (550)
T KOG0578|consen  493 EKLSPELKDFLDRCLVVDVEQRASAKELLEHPF  525 (550)
T ss_pred             cccCHHHHHHHHHHhhcchhcCCCHHHHhcChh
Confidence            456788999999999999999999999999843

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.4e-46  Score=342.58  Aligned_cols=253  Identities=23%  Similarity=0.356  Sum_probs=221.0

Q ss_pred             cCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc--eEEEE
Q 016594           66 NAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG--LYLIF  142 (386)
Q Consensus        66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~lv~  142 (386)
                      ++|..++++|+|+||.+++++++ +++.|++|.+..............+|+.+++++.|||||.+.+.|.+++  .++||
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm   83 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM   83 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence            57889999999999999999977 6889999999876666666778899999999999999999999997765  79999


Q ss_pred             EeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCC
Q 016594          143 QFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQW  222 (386)
Q Consensus       143 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  222 (386)
                      +|++||++.+.+.+.+..-|+++.+..++.|++.|+.|||+   ++|+|||||+.|||++.++.|||+|||+|+.+....
T Consensus        84 ~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~---~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~  160 (426)
T KOG0589|consen   84 EYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHE---NRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED  160 (426)
T ss_pred             eecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHh---hhhhcccchhhhhhccccCceeecchhhhhhcCCch
Confidence            99999999999988887779999999999999999999998   999999999999999999999999999999987653


Q ss_pred             ccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCCCC
Q 016594          223 THHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAY  302 (386)
Q Consensus       223 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (386)
                        ....+..||+.||+||.+.+.+|+.|+|||||||++|||++-+++|...+-..           -+.++.. ....+.
T Consensus       161 --~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~-----------Li~ki~~-~~~~Pl  226 (426)
T KOG0589|consen  161 --SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSE-----------LILKINR-GLYSPL  226 (426)
T ss_pred             --hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHH-----------HHHHHhh-ccCCCC
Confidence              24556789999999999999999999999999999999999999998764321           1111111 123345


Q ss_pred             CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 016594          303 DVTQLNRLAFAASLCIRASPTWRPTMSEVLEVM  335 (386)
Q Consensus       303 ~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l  335 (386)
                      +..++.+++.++..||..+|..||++.++|.+.
T Consensus       227 p~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P  259 (426)
T KOG0589|consen  227 PSMYSSELRSLVKSMLRKNPEHRPSALELLRRP  259 (426)
T ss_pred             CccccHHHHHHHHHHhhcCCccCCCHHHHhhCh
Confidence            556778899999999999999999999999864

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=2.1e-46  Score=361.38  Aligned_cols=263  Identities=24%  Similarity=0.404  Sum_probs=217.7

Q ss_pred             HHHhcCCCCCCeecccCCcEEEEEEEC------CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEe
Q 016594           62 SIATNAFSSENLVGRGGYAEVYKGVLQ------DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVD  135 (386)
Q Consensus        62 ~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~  135 (386)
                      .+...+....+.||+|+||+||+|...      +...||||.++.. .+.....+|.+|++++..++|||||+|+|+|.+
T Consensus       482 ~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~-a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~  560 (774)
T KOG1026|consen  482 EIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDK-AENQARQDFRREAELLAELQHPNIVRLLGVCRE  560 (774)
T ss_pred             EechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhccc-ccHHHHHHHHHHHHHHHhccCCCeEEEEEEEcc
Confidence            455667778899999999999999842      3467999999864 334467899999999999999999999999987


Q ss_pred             Cc-eEEEEEeccCCCHhhhhhhcCC------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEc
Q 016594          136 NG-LYLIFQFSSRGSVASLFHDVNS------------PGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLT  202 (386)
Q Consensus       136 ~~-~~lv~e~~~~~~L~~~~~~~~~------------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~  202 (386)
                      ++ +++|+||+..|+|.+++.....            ++++..+.+.|+.|||.|+.||-+   +.+|||||-.+|+|+.
T Consensus       561 ~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~---~~FVHRDLATRNCLVg  637 (774)
T KOG1026|consen  561 GDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSS---HHFVHRDLATRNCLVG  637 (774)
T ss_pred             CCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh---Ccccccchhhhhceec
Confidence            66 9999999999999999875532            238889999999999999999999   9999999999999999


Q ss_pred             CCCCeEEeecCccccCCCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCchhhhhhh
Q 016594          203 ADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWA  281 (386)
Q Consensus       203 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~  281 (386)
                      ++..|||+|||+++..-..........-.-..+|||||.|..++|+.+||||||||+|||+++ |+.||.+...      
T Consensus       638 e~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn------  711 (774)
T KOG1026|consen  638 ENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSN------  711 (774)
T ss_pred             cceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccch------
Confidence            999999999999987644332222212223568999999999999999999999999999999 9999987432      


Q ss_pred             hhhhcccccccccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCCc
Q 016594          282 KPILNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEGDQ  340 (386)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~~~  340 (386)
                            .++.+.+....-...+..++.++..|+..||+.+|++||+++||-..|+...+
T Consensus       712 ------~EVIe~i~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~  764 (774)
T KOG1026|consen  712 ------QEVIECIRAGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQ  764 (774)
T ss_pred             ------HHHHHHHHcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHh
Confidence                  23333333332356677788999999999999999999999999999876543

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-45  Score=323.16  Aligned_cols=269  Identities=23%  Similarity=0.363  Sum_probs=213.4

Q ss_pred             HhcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEe------C
Q 016594           64 ATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVD------N  136 (386)
Q Consensus        64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------~  136 (386)
                      ....|...+.||.|+||.|+.|..+ +|+.||||++..........++.++|+++|+.++|+||+.+++++..      +
T Consensus        20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~   99 (359)
T KOG0660|consen   20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN   99 (359)
T ss_pred             ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence            3456666899999999999999976 79999999999877788888999999999999999999999999854      3


Q ss_pred             ceEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccc
Q 016594          137 GLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAK  216 (386)
Q Consensus       137 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~  216 (386)
                      +.|+|+|+|. .+|...++....  ++...+..++.|++.||.|+|+   .+|+||||||.|+|++.+..+||+|||+|+
T Consensus       100 DvYiV~elMe-tDL~~iik~~~~--L~d~H~q~f~YQiLrgLKyiHS---AnViHRDLKPsNll~n~~c~lKI~DFGLAR  173 (359)
T KOG0660|consen  100 DVYLVFELME-TDLHQIIKSQQD--LTDDHAQYFLYQILRGLKYIHS---ANVIHRDLKPSNLLLNADCDLKICDFGLAR  173 (359)
T ss_pred             eeEEehhHHh-hHHHHHHHcCcc--ccHHHHHHHHHHHHHhcchhhc---ccccccccchhheeeccCCCEEecccccee
Confidence            3899999994 489888875443  8999999999999999999999   999999999999999999999999999999


Q ss_pred             cCCCCCccccccccccccCccChhhhcc-CCCCcccchHHHHHHHHHHHhCCCCCCCCchhhh-hhhhhhhcc---cccc
Q 016594          217 WLPSQWTHHSIAPIEGTFGHLAPEYFMH-GIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLH-SWAKPILNQ---GEIE  291 (386)
Q Consensus       217 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~-~~~~~~~~~---~~~~  291 (386)
                      ..........++..+.|.+|.|||++.. ..|+.+.||||+|||+.||++|++.|.|.+.-.+ .........   ..+.
T Consensus       174 ~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~  253 (359)
T KOG0660|consen  174 YLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQ  253 (359)
T ss_pred             eccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHH
Confidence            8865423344567789999999998864 6799999999999999999999999998763211 111111100   0000


Q ss_pred             cc-----------cCCccCCCCCH---HHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          292 KL-----------VDPRLQGAYDV---TQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       292 ~~-----------~~~~~~~~~~~---~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                      .+           .....+..+..   .......+|+.+||..||.+|+|+++.|+|....
T Consensus       254 ~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~  314 (359)
T KOG0660|consen  254 KIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLA  314 (359)
T ss_pred             HhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhh
Confidence            00           01111111111   2245688999999999999999999999986443

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=5.1e-45  Score=332.82  Aligned_cols=256  Identities=24%  Similarity=0.327  Sum_probs=205.4

Q ss_pred             CCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCC-hHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEEE
Q 016594           67 AFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTD-DRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQ  143 (386)
Q Consensus        67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~e  143 (386)
                      .|++.+.||+|+||+||+|.+. +++.||+|.+...... ......+.+|+.+++.++|+||+++++++.+++ .++++|
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence            3677899999999999999975 7899999998753222 233456789999999999999999999987655 899999


Q ss_pred             eccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCc
Q 016594          144 FSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWT  223 (386)
Q Consensus       144 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~  223 (386)
                      |+.+|+|...+.......+++..+..++.|++.||+|||+   ++|+||||||+|||++.++.+||+|||++....... 
T Consensus        81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~-  156 (285)
T cd05631          81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQR---ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE-  156 (285)
T ss_pred             ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC-
Confidence            9999999888765555568999999999999999999999   999999999999999999999999999998754321 


Q ss_pred             cccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCCCCC
Q 016594          224 HHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYD  303 (386)
Q Consensus       224 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (386)
                        ......|+..|+|||++.+..++.++|||||||++|+|++|+.||..........        .+...+. .....++
T Consensus       157 --~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~--------~~~~~~~-~~~~~~~  225 (285)
T cd05631         157 --TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKRE--------EVDRRVK-EDQEEYS  225 (285)
T ss_pred             --eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHH--------HHHHHhh-cccccCC
Confidence              1234568999999999999999999999999999999999999998653221000        0000000 0111223


Q ss_pred             HHHHHHHHHHHHHccccCCCCCCC-----HHHHHHHHhc
Q 016594          304 VTQLNRLAFAASLCIRASPTWRPT-----MSEVLEVMLE  337 (386)
Q Consensus       304 ~~~~~~l~~li~~cl~~dP~~Rpt-----~~~il~~l~~  337 (386)
                      ...+..+.+|+.+||+.||.+||+     +++++++-+.
T Consensus       226 ~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~  264 (285)
T cd05631         226 EKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIF  264 (285)
T ss_pred             ccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhh
Confidence            334577999999999999999997     8999987544

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=1.4e-44  Score=330.30  Aligned_cols=264  Identities=21%  Similarity=0.299  Sum_probs=203.9

Q ss_pred             cCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEEE
Q 016594           66 NAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQ  143 (386)
Q Consensus        66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~e  143 (386)
                      ++|++.+.||+|+||.||+|+++ +++.||+|++............+.+|+.+++.++||||+++++++..++ .++|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            47899999999999999999987 6889999999765444445567889999999999999999999997655 899999


Q ss_pred             eccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCc
Q 016594          144 FSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWT  223 (386)
Q Consensus       144 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~  223 (386)
                      |+.++.+..+...  ...+++..++.++.|++.||.|||+   ++++||||||+||+++.++.+||+|||++........
T Consensus        81 ~~~~~~l~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  155 (287)
T cd07848          81 YVEKNMLELLEEM--PNGVPPEKVRSYIYQLIKAIHWCHK---NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN  155 (287)
T ss_pred             cCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccCccccccccc
Confidence            9998776655432  3458999999999999999999999   9999999999999999999999999999987643221


Q ss_pred             cccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhh-hhhh------------hccccc
Q 016594          224 HHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSW-AKPI------------LNQGEI  290 (386)
Q Consensus       224 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~-~~~~------------~~~~~~  290 (386)
                       .......|++.|+|||++.+..++.++|||||||++|+|++|++||.+........ ....            ......
T Consensus       156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (287)
T cd07848         156 -ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRF  234 (287)
T ss_pred             -ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchh
Confidence             12234568999999999999899999999999999999999999998654321100 0000            000000


Q ss_pred             ccccCCccCC------CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 016594          291 EKLVDPRLQG------AYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVM  335 (386)
Q Consensus       291 ~~~~~~~~~~------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l  335 (386)
                      .....+....      .+....+..+.+++.+||+.||++|||++++++|-
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp  285 (287)
T cd07848         235 HGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHP  285 (287)
T ss_pred             cccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCC
Confidence            0000000000      01112356799999999999999999999999763

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=1.1e-44  Score=342.78  Aligned_cols=261  Identities=22%  Similarity=0.388  Sum_probs=204.1

Q ss_pred             HHHhcCCCCCCeecccCCcEEEEEEE------CCCcEEEEEEeccccCChHhHHHHHHHHHHHhcc-CCCceeeecceEE
Q 016594           62 SIATNAFSSENLVGRGGYAEVYKGVL------QDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHV-CHPNVLSLLGCCV  134 (386)
Q Consensus        62 ~~~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~  134 (386)
                      .+..++|++.+.||+|+||.||+|++      .++..||||++.... .......+.+|+.++..+ +||||+++++++.
T Consensus        31 ~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~  109 (375)
T cd05104          31 EFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHINIVNLLGACT  109 (375)
T ss_pred             ccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc-CcHHHHHHHHHHHHHHHhcCCcceeeeeeeec
Confidence            34456799999999999999999974      235689999987432 233456788999999999 7999999999997


Q ss_pred             eCc-eEEEEEeccCCCHhhhhhhcC-------------------------------------------------------
Q 016594          135 DNG-LYLIFQFSSRGSVASLFHDVN-------------------------------------------------------  158 (386)
Q Consensus       135 ~~~-~~lv~e~~~~~~L~~~~~~~~-------------------------------------------------------  158 (386)
                      +.+ .++||||+.+|+|.+++....                                                       
T Consensus       110 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~  189 (375)
T cd05104         110 VGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSV  189 (375)
T ss_pred             cCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccc
Confidence            755 899999999999998886432                                                       


Q ss_pred             ------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCC
Q 016594          159 ------------------SPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPS  220 (386)
Q Consensus       159 ------------------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~  220 (386)
                                        ...+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||++.....
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~  266 (375)
T cd05104         190 RSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIRN  266 (375)
T ss_pred             ccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCchhhEEEECCCcEEEecCccceeccC
Confidence                              1236788899999999999999999   9999999999999999999999999999987644


Q ss_pred             CCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCchhhhhhhhhhhcccccccccCCccC
Q 016594          221 QWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQ  299 (386)
Q Consensus       221 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (386)
                      ...........++..|+|||++.+..++.++|||||||++|+|++ |..||.........+ . ....+         ..
T Consensus       267 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~-~-~~~~~---------~~  335 (375)
T cd05104         267 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFY-K-MIKEG---------YR  335 (375)
T ss_pred             cccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHH-H-HHHhC---------cc
Confidence            322111222335667999999999999999999999999999998 899997643221110 0 01111         01


Q ss_pred             CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 016594          300 GAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLE  337 (386)
Q Consensus       300 ~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~  337 (386)
                      ...+...+..+.+++.+||+.||++||++.+|++.|++
T Consensus       336 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~  373 (375)
T cd05104         336 MLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ  373 (375)
T ss_pred             CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence            11111234679999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=6.5e-47  Score=315.06  Aligned_cols=258  Identities=22%  Similarity=0.271  Sum_probs=211.2

Q ss_pred             HhcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEE
Q 016594           64 ATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLI  141 (386)
Q Consensus        64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv  141 (386)
                      ..++|++.+.||+|.|+.|+++... +|+.+|+|+++........-+.+.+|+.|-+.|+||||+++.+.+...+ .|+|
T Consensus         9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv   88 (355)
T KOG0033|consen    9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV   88 (355)
T ss_pred             cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence            4567888899999999999999876 7999999998765555556778899999999999999999999987766 8999


Q ss_pred             EEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcC---CCCeEEeecCccccC
Q 016594          142 FQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTA---DFEPQISDFGLAKWL  218 (386)
Q Consensus       142 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~---~~~~kl~Dfg~a~~~  218 (386)
                      +|++.|++|..-+..+  .-+++..+-.+++||++||.|+|.   ++|||||+||+|+++..   ..-+||+|||+|..+
T Consensus        89 Fe~m~G~dl~~eIV~R--~~ySEa~aSH~~rQiLeal~yCH~---n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l  163 (355)
T KOG0033|consen   89 FDLVTGGELFEDIVAR--EFYSEADASHCIQQILEALAYCHS---NGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEV  163 (355)
T ss_pred             EecccchHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeeeeccCCCceeecccceEEEe
Confidence            9999999997654433  237888999999999999999999   99999999999999963   345999999999988


Q ss_pred             CCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhh-hhhhhhhhcccccccccCCc
Q 016594          219 PSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSL-HSWAKPILNQGEIEKLVDPR  297 (386)
Q Consensus       219 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~  297 (386)
                      ...   .....+.|||+|||||++...+|+..+|||+.|++||-|+.|.+||.+.++.. ...+.    .+.    .  .
T Consensus       164 ~~g---~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~----~g~----y--d  230 (355)
T KOG0033|consen  164 NDG---EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIK----AGA----Y--D  230 (355)
T ss_pred             CCc---cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHh----ccc----c--C
Confidence            733   34556789999999999999999999999999999999999999998854321 11100    000    0  1


Q ss_pred             cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCC
Q 016594          298 LQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEGD  339 (386)
Q Consensus       298 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~~  339 (386)
                      ....+-...+++.++|+++||..||.+|.|+.|.|+|.|-.+
T Consensus       231 ~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~  272 (355)
T KOG0033|consen  231 YPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICN  272 (355)
T ss_pred             CCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcc
Confidence            111222345678999999999999999999999998876543

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-45  Score=339.61  Aligned_cols=244  Identities=28%  Similarity=0.482  Sum_probs=206.4

Q ss_pred             cCCCCCCeecccCCcEEEEEEECCCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEEEe
Q 016594           66 NAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQF  144 (386)
Q Consensus        66 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~  144 (386)
                      +...-++-||.|+.|.||+|+.+ ++.||||+++..         -..+++-|++|+||||+.+.|+|.... +|+||||
T Consensus       124 e~IsELeWlGSGaQGAVF~Grl~-netVAVKKV~el---------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEf  193 (904)
T KOG4721|consen  124 EEISELEWLGSGAQGAVFLGRLH-NETVAVKKVREL---------KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEF  193 (904)
T ss_pred             HHhhhhhhhccCcccceeeeecc-CceehhHHHhhh---------hhhhHHHHHhccCcceeeEeeeecCCceeEEeeec
Confidence            33344677999999999999987 789999987631         125678899999999999999998865 8999999


Q ss_pred             ccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCcc
Q 016594          145 SSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTH  224 (386)
Q Consensus       145 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  224 (386)
                      |..|.|..+++...  .+.......|..+||.|+.|||.   +.|||||||.-|||+..+..|||+|||.++.....   
T Consensus       194 Ca~GqL~~VLka~~--~itp~llv~Wsk~IA~GM~YLH~---hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~---  265 (904)
T KOG4721|consen  194 CAQGQLYEVLKAGR--PITPSLLVDWSKGIAGGMNYLHL---HKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK---  265 (904)
T ss_pred             cccccHHHHHhccC--ccCHHHHHHHHHHhhhhhHHHHH---hhHhhhccCCCceEeeccceEEeccccchHhhhhh---
Confidence            99999999998644  48888899999999999999999   99999999999999999999999999999987654   


Q ss_pred             ccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCCCCCH
Q 016594          225 HSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDV  304 (386)
Q Consensus       225 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (386)
                      ...-.++||..|||||++...+.+.|+|||||||+|||||||..||.+.+.....|.           .-...+....+.
T Consensus       266 STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwG-----------VGsNsL~LpvPs  334 (904)
T KOG4721|consen  266 STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWG-----------VGSNSLHLPVPS  334 (904)
T ss_pred             hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEe-----------ccCCcccccCcc
Confidence            233467899999999999999999999999999999999999999987544321111           111234445566


Q ss_pred             HHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          305 TQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       305 ~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                      .+++.+.-|+++||+-.|..||+|.+|+.||...
T Consensus       335 tcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa  368 (904)
T KOG4721|consen  335 TCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIA  368 (904)
T ss_pred             cCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence            7789999999999999999999999999998654

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=4.5e-44  Score=329.66  Aligned_cols=262  Identities=22%  Similarity=0.330  Sum_probs=202.6

Q ss_pred             hcCCCCCCeecccCCcEEEEEEECC-----------------CcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCcee
Q 016594           65 TNAFSSENLVGRGGYAEVYKGVLQD-----------------GEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVL  127 (386)
Q Consensus        65 ~~~~~~~~~lg~G~~g~V~~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv  127 (386)
                      .++|++.+.||+|+||.||+|.+++                 +..||+|.+... ........+.+|+.++.+++||||+
T Consensus         4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv   82 (304)
T cd05096           4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPD-ANKNARNDFLKEVKILSRLKDPNII   82 (304)
T ss_pred             hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCC-CCHHHHHHHHHHHHHHhhcCCCCee
Confidence            4678999999999999999998542                 336999988753 2344566789999999999999999


Q ss_pred             eecceEEeCc-eEEEEEeccCCCHhhhhhhcC-----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 016594          128 SLLGCCVDNG-LYLIFQFSSRGSVASLFHDVN-----------------SPGVEWKVRHKIAVGTARGLHYLHKGCQRRI  189 (386)
Q Consensus       128 ~l~~~~~~~~-~~lv~e~~~~~~L~~~~~~~~-----------------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i  189 (386)
                      ++++++.+.+ .+++|||+.+++|.+++....                 ...+++..++.++.|++.||.|||+   ++|
T Consensus        83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i  159 (304)
T cd05096          83 RLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS---LNF  159 (304)
T ss_pred             EEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH---CCc
Confidence            9999997655 899999999999999875432                 1236788899999999999999999   999


Q ss_pred             EEeCCCCCCeeEcCCCCeEEeecCccccCCCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHh--CC
Q 016594          190 IHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS--GR  267 (386)
Q Consensus       190 vH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~--g~  267 (386)
                      +||||||+|||++.++.+||+|||++..+.............++..|+|||++.+..++.++|||||||++|+|++  +.
T Consensus       160 vH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~  239 (304)
T cd05096         160 VHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKE  239 (304)
T ss_pred             cccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCC
Confidence            9999999999999999999999999986644322222233446788999999998899999999999999999987  66


Q ss_pred             CCCCCCchhh-hhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 016594          268 KPVDGSHQSL-HSWAKPILNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVML  336 (386)
Q Consensus       268 ~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~  336 (386)
                      .||.+..... ............      .......+..++..+.+++.+||+.||++|||+.+|.+.|.
T Consensus       240 ~p~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~  303 (304)
T cd05096         240 QPYGELTDEQVIENAGEFFRDQG------RQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT  303 (304)
T ss_pred             CCCCcCCHHHHHHHHHHHhhhcc------ccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence            7887643221 111111111000      00001112234567999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=4.1e-44  Score=326.32  Aligned_cols=246  Identities=19%  Similarity=0.291  Sum_probs=199.2

Q ss_pred             CeecccCCcEEEEEEECCCcEEEEEEeccccCCh-HhHHHHHHHHHHHhccCCCceeeecceEEe--C---ceEEEEEec
Q 016594           72 NLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDD-RKEKEFLTEIGTIGHVCHPNVLSLLGCCVD--N---GLYLIFQFS  145 (386)
Q Consensus        72 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~---~~~lv~e~~  145 (386)
                      ..||+|++|.||+|.+ +|+.||||.+....... .....+.+|+.+|.+++||||+++++++.+  +   ..+++|||+
T Consensus        26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~  104 (283)
T PHA02988         26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC  104 (283)
T ss_pred             eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence            6799999999999998 48999999997643322 224678899999999999999999999876  2   378999999


Q ss_pred             cCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCccc
Q 016594          146 SRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHH  225 (386)
Q Consensus       146 ~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  225 (386)
                      .+|+|.+++...  ..+++.....++.|++.||.|||+.  .+++||||||+||+++.++.+||+|||++..+....   
T Consensus       105 ~~g~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lH~~--~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~---  177 (283)
T PHA02988        105 TRGYLREVLDKE--KDLSFKTKLDMAIDCCKGLYNLYKY--TNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP---  177 (283)
T ss_pred             CCCcHHHHHhhC--CCCChhHHHHHHHHHHHHHHHHHhc--CCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc---
Confidence            999999998754  3488999999999999999999971  388899999999999999999999999988654321   


Q ss_pred             cccccccccCccChhhhcc--CCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCCCCC
Q 016594          226 SIAPIEGTFGHLAPEYFMH--GIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYD  303 (386)
Q Consensus       226 ~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (386)
                        ....|+..|+|||++.+  ..++.++|||||||++|||++|..||.+.....  ......         ........+
T Consensus       178 --~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~--~~~~i~---------~~~~~~~~~  244 (283)
T PHA02988        178 --FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKE--IYDLII---------NKNNSLKLP  244 (283)
T ss_pred             --ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHH--HHHHHH---------hcCCCCCCC
Confidence              23457889999999976  689999999999999999999999998654221  111111         111111222


Q ss_pred             HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          304 VTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       304 ~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                      ...+..+.+++.+||+.||++|||+.++++.|...
T Consensus       245 ~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~  279 (283)
T PHA02988        245 LDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLY  279 (283)
T ss_pred             CcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence            23567899999999999999999999999988653

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-44  Score=331.19  Aligned_cols=250  Identities=20%  Similarity=0.234  Sum_probs=204.9

Q ss_pred             cCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccC-ChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEE
Q 016594           66 NAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVT-DDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIF  142 (386)
Q Consensus        66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~  142 (386)
                      ++|++.+.||+|+||.||+|... +++.||+|++..... .......+.+|+.+++.++||||+++++++.++. .+++|
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            36889999999999999999976 689999999875321 2234456789999999999999999999987765 89999


Q ss_pred             EeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCC
Q 016594          143 QFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQW  222 (386)
Q Consensus       143 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  222 (386)
                      ||+.+++|.+++....  .+++..+..++.|++.||+|||+   ++++||||||+|||++.++.+||+|||++...... 
T Consensus        81 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~-  154 (291)
T cd05612          81 EYVPGGELFSYLRNSG--RFSNSTGLFYASEIVCALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR-  154 (291)
T ss_pred             eCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEEecCcchhccCC-
Confidence            9999999999887543  48899999999999999999999   99999999999999999999999999999866432 


Q ss_pred             ccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCCCC
Q 016594          223 THHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAY  302 (386)
Q Consensus       223 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (386)
                          .....|++.|+|||++.+..++.++|||||||++|+|++|..||.+......  ...         +....  ..+
T Consensus       155 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~--~~~---------i~~~~--~~~  217 (291)
T cd05612         155 ----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGI--YEK---------ILAGK--LEF  217 (291)
T ss_pred             ----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHH---------HHhCC--cCC
Confidence                2235689999999999999999999999999999999999999987543210  010         01100  112


Q ss_pred             CHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHHHhcC
Q 016594          303 DVTQLNRLAFAASLCIRASPTWRPT-----MSEVLEVMLEG  338 (386)
Q Consensus       303 ~~~~~~~l~~li~~cl~~dP~~Rpt-----~~~il~~l~~~  338 (386)
                      +...+..+.+++.+||+.||.+||+     +.+++++.+..
T Consensus       218 ~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~  258 (291)
T cd05612         218 PRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFK  258 (291)
T ss_pred             CccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCcccc
Confidence            2223567899999999999999995     99999886553

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=3.7e-44  Score=327.93  Aligned_cols=263  Identities=22%  Similarity=0.366  Sum_probs=199.3

Q ss_pred             cCCCCCCeecccCCcEEEEEEEC--CCcEEEEEEeccccCChHhHHHHHHHHHHHhcc---CCCceeeecceEEe-----
Q 016594           66 NAFSSENLVGRGGYAEVYKGVLQ--DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHV---CHPNVLSLLGCCVD-----  135 (386)
Q Consensus        66 ~~~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~-----  135 (386)
                      .+|++.+.||+|+||.||+|...  +++.||+|.+............+.+|+.+++.+   .||||+++++++..     
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            36899999999999999999863  467899999876443333344566777777665   69999999998852     


Q ss_pred             -CceEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCc
Q 016594          136 -NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGL  214 (386)
Q Consensus       136 -~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~  214 (386)
                       ...++++|++. ++|.+++.......+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~---~~iiH~dlkp~Nil~~~~~~~kl~Dfg~  156 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGL  156 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEcCCCCEEEccccc
Confidence             23789999997 589888877666678999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhh-hhhhhhhc---cccc
Q 016594          215 AKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLH-SWAKPILN---QGEI  290 (386)
Q Consensus       215 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~-~~~~~~~~---~~~~  290 (386)
                      +......   .......|++.|+|||++.+..++.++|||||||++|+|++|.+||.+...... ........   ....
T Consensus       157 ~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~  233 (290)
T cd07862         157 ARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW  233 (290)
T ss_pred             eEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhc
Confidence            9865433   223345689999999999999999999999999999999999999987543211 00000000   0000


Q ss_pred             -------ccccCCccCC---CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 016594          291 -------EKLVDPRLQG---AYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVM  335 (386)
Q Consensus       291 -------~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l  335 (386)
                             .....+....   ......+..+.+++.+||+.||++|||+.+++++-
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp  288 (290)
T cd07862         234 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHP  288 (290)
T ss_pred             hhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCC
Confidence                   0000000000   00012345688999999999999999999999753

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=1.2e-43  Score=330.62  Aligned_cols=266  Identities=19%  Similarity=0.314  Sum_probs=207.5

Q ss_pred             HhcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEE
Q 016594           64 ATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLI  141 (386)
Q Consensus        64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv  141 (386)
                      ..++|++.+.||+|+||.||+|.+. ++..||+|.+.... .......+.+|+.++++++||||+++++++.+++ .+++
T Consensus         3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   81 (331)
T cd06649           3 KDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC   81 (331)
T ss_pred             CcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence            3578999999999999999999977 68899999887532 3344567899999999999999999999997765 8999


Q ss_pred             EEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCC
Q 016594          142 FQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQ  221 (386)
Q Consensus       142 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  221 (386)
                      |||+.+++|.+++....  .+++..+..++.|++.||.|||+.  .+|+||||||+|||++.++.+||+|||++..+...
T Consensus        82 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  157 (331)
T cd06649          82 MEHMDGGSLDQVLKEAK--RIPEEILGKVSIAVLRGLAYLREK--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS  157 (331)
T ss_pred             eecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhc--CCEEcCCCChhhEEEcCCCcEEEccCccccccccc
Confidence            99999999999987543  488999999999999999999971  36999999999999999999999999998766432


Q ss_pred             CccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhh-hh-hhhcc-ccc--------
Q 016594          222 WTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSW-AK-PILNQ-GEI--------  290 (386)
Q Consensus       222 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~-~~-~~~~~-~~~--------  290 (386)
                          ......|++.|+|||++.+..++.++|||||||++|+|++|+.||.......... .. ..... ...        
T Consensus       158 ----~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (331)
T cd06649         158 ----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRP  233 (331)
T ss_pred             ----ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCccc
Confidence                2234568999999999999999999999999999999999999997643321110 00 00000 000        


Q ss_pred             ------------------------ccccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          291 ------------------------EKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       291 ------------------------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                                              ..+.............+..+.+++.+||+.||++|||+.+++++.+..
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~  305 (331)
T cd06649         234 RPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIK  305 (331)
T ss_pred             ccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHh
Confidence                                    000000000001112456799999999999999999999999987643

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=2.3e-44  Score=351.01  Aligned_cols=259  Identities=19%  Similarity=0.270  Sum_probs=211.0

Q ss_pred             HHHhcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeC----
Q 016594           62 SIATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDN----  136 (386)
Q Consensus        62 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~----  136 (386)
                      ....++|.+.+.||+|+||+||+|... +++.||||++............+.+|+.++..++|+||+++++.+...    
T Consensus        28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~  107 (496)
T PTZ00283         28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN  107 (496)
T ss_pred             cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence            345679999999999999999999965 689999999976555556667788999999999999999998877432    


Q ss_pred             -----ceEEEEEeccCCCHhhhhhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEE
Q 016594          137 -----GLYLIFQFSSRGSVASLFHDVN--SPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQI  209 (386)
Q Consensus       137 -----~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl  209 (386)
                           ..++||||+.+|+|.+++....  ...+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||
T Consensus       108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~---~~IiHrDLKP~NILl~~~~~vkL  184 (496)
T PTZ00283        108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHS---KHMIHRDIKSANILLCSNGLVKL  184 (496)
T ss_pred             cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEeCCCCEEE
Confidence                 1579999999999999886532  3458999999999999999999999   99999999999999999999999


Q ss_pred             eecCccccCCCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccc
Q 016594          210 SDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGE  289 (386)
Q Consensus       210 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~  289 (386)
                      +|||+++.+.............||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.....  ......    
T Consensus       185 ~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~--~~~~~~----  258 (496)
T PTZ00283        185 GDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEE--VMHKTL----  258 (496)
T ss_pred             EecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHh----
Confidence            99999987654333333445679999999999999999999999999999999999999998653211  111110    


Q ss_pred             cccccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 016594          290 IEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVM  335 (386)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l  335 (386)
                           .. .....+...+..+.+++..||+.||.+||++.+++++.
T Consensus       259 -----~~-~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p  298 (496)
T PTZ00283        259 -----AG-RYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMP  298 (496)
T ss_pred             -----cC-CCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCH
Confidence                 00 01112233457799999999999999999999999763

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=2.2e-44  Score=340.44  Aligned_cols=262  Identities=23%  Similarity=0.389  Sum_probs=204.5

Q ss_pred             HHHhcCCCCCCeecccCCcEEEEEEEC------CCcEEEEEEeccccCChHhHHHHHHHHHHHhcc-CCCceeeecceEE
Q 016594           62 SIATNAFSSENLVGRGGYAEVYKGVLQ------DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHV-CHPNVLSLLGCCV  134 (386)
Q Consensus        62 ~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~  134 (386)
                      ....++|++.+.||+|+||.||+|.+.      ++..||+|++.... .......+.+|+.+++.+ .|+||+++++++.
T Consensus        34 ~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~  112 (374)
T cd05106          34 EFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA-HTDEREALMSELKILSHLGQHKNIVNLLGACT  112 (374)
T ss_pred             cccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC-CHHHHHHHHHHHHHHHhhccCCceeeEeeEec
Confidence            345568999999999999999999852      23579999997533 233456788999999999 7999999999997


Q ss_pred             eCc-eEEEEEeccCCCHhhhhhhcC-------------------------------------------------------
Q 016594          135 DNG-LYLIFQFSSRGSVASLFHDVN-------------------------------------------------------  158 (386)
Q Consensus       135 ~~~-~~lv~e~~~~~~L~~~~~~~~-------------------------------------------------------  158 (386)
                      +.+ .+++|||+.+|+|.+++....                                                       
T Consensus       113 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (374)
T cd05106         113 HGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSS  192 (374)
T ss_pred             CCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccc
Confidence            755 899999999999998875421                                                       


Q ss_pred             -------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCccc
Q 016594          159 -------------SPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHH  225 (386)
Q Consensus       159 -------------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  225 (386)
                                   ...+++..++.++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||++..........
T Consensus       193 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~---~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~  269 (374)
T cd05106         193 QSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLAS---KNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYV  269 (374)
T ss_pred             ccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCEEeccCchheEEEeCCCeEEEeeceeeeeccCCccee
Confidence                         1237888899999999999999999   999999999999999999999999999998654332221


Q ss_pred             cccccccccCccChhhhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCchhhhhhhhhhhcccccccccCCccCCCCCH
Q 016594          226 SIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDV  304 (386)
Q Consensus       226 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (386)
                      ......++..|+|||++.+..++.++|||||||++|+|++ |+.||......... .          ...........+.
T Consensus       270 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~-~----------~~~~~~~~~~~~~  338 (374)
T cd05106         270 VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKF-Y----------KMVKRGYQMSRPD  338 (374)
T ss_pred             eccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHH-H----------HHHHcccCccCCC
Confidence            2222335677999999999999999999999999999997 99999764321110 0          0001111111112


Q ss_pred             HHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          305 TQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       305 ~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                      ..+..+.+++.+||+.||++||++.+|++.|++.
T Consensus       339 ~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~  372 (374)
T cd05106         339 FAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ  372 (374)
T ss_pred             CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            2346799999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=2e-44  Score=335.45  Aligned_cols=250  Identities=22%  Similarity=0.300  Sum_probs=204.8

Q ss_pred             cCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEecccc-CChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEE
Q 016594           66 NAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVV-TDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIF  142 (386)
Q Consensus        66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~  142 (386)
                      ++|.+.+.||+|+||.||+|.++ +++.||+|++.... ........+.+|+.++++++||||+++++++.+++ .+++|
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   97 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL   97 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence            57888999999999999999986 68899999987532 12234456889999999999999999999997765 89999


Q ss_pred             EeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCC
Q 016594          143 QFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQW  222 (386)
Q Consensus       143 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  222 (386)
                      ||+.+++|.+++....  .+++..+..++.|++.||+|||+   ++|+||||||+|||++.++.+||+|||++...... 
T Consensus        98 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~-  171 (329)
T PTZ00263         98 EFVVGGELFTHLRKAG--RFPNDVAKFYHAELVLAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR-  171 (329)
T ss_pred             cCCCCChHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC-
Confidence            9999999999887543  48899999999999999999999   99999999999999999999999999999876432 


Q ss_pred             ccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCCCC
Q 016594          223 THHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAY  302 (386)
Q Consensus       223 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (386)
                          .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+......  ..         .+.....  ..
T Consensus       172 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~--~~---------~i~~~~~--~~  234 (329)
T PTZ00263        172 ----TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRI--YE---------KILAGRL--KF  234 (329)
T ss_pred             ----cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHH--HH---------HHhcCCc--CC
Confidence                1235699999999999999999999999999999999999999976532110  00         0111111  11


Q ss_pred             CHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHHHhcC
Q 016594          303 DVTQLNRLAFAASLCIRASPTWRPT-----MSEVLEVMLEG  338 (386)
Q Consensus       303 ~~~~~~~l~~li~~cl~~dP~~Rpt-----~~~il~~l~~~  338 (386)
                      +...+..+.+++.+||+.||.+||+     +.+++.|.+..
T Consensus       235 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~  275 (329)
T PTZ00263        235 PNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFH  275 (329)
T ss_pred             CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccC
Confidence            2223466899999999999999996     78999886544

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=4.3e-44  Score=331.61  Aligned_cols=258  Identities=26%  Similarity=0.422  Sum_probs=206.5

Q ss_pred             HhcCCCCCCeecccCCcEEEEEEEC-CCc----EEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCce
Q 016594           64 ATNAFSSENLVGRGGYAEVYKGVLQ-DGE----EIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNGL  138 (386)
Q Consensus        64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  138 (386)
                      ...+|++.+.||+|+||.||+|.+. ++.    .||+|.+... ........+.+|+.+++.++||||+++++++.....
T Consensus         5 ~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~~~   83 (316)
T cd05108           5 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTV   83 (316)
T ss_pred             chhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCCCc
Confidence            3467999999999999999999864 333    3899998642 334455678899999999999999999999988888


Q ss_pred             EEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccC
Q 016594          139 YLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWL  218 (386)
Q Consensus       139 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~  218 (386)
                      +++++|+.+|+|.+++.... ..+++..++.++.|++.||+|||+   ++|+||||||+|||++.++.+||+|||++..+
T Consensus        84 ~~v~e~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~---~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~  159 (316)
T cd05108          84 QLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEE---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLL  159 (316)
T ss_pred             eeeeecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEecCCCcEEEccccccccc
Confidence            99999999999999887543 348889999999999999999999   99999999999999999999999999999876


Q ss_pred             CCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCchhhhhhhhhhhcccccccccCCc
Q 016594          219 PSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGEIEKLVDPR  297 (386)
Q Consensus       219 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (386)
                      .............++..|+|||++.+..++.++|||||||++|||++ |..||.+......   ..         +....
T Consensus       160 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~---~~---------~~~~~  227 (316)
T cd05108         160 GADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI---SS---------ILEKG  227 (316)
T ss_pred             cCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH---HH---------HHhCC
Confidence            54322222222334678999999999999999999999999999998 9999986533211   00         11111


Q ss_pred             cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          298 LQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       298 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                      .....+..++..+.+++.+||..+|.+||++.+++..+...
T Consensus       228 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~  268 (316)
T cd05108         228 ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM  268 (316)
T ss_pred             CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            11111222345689999999999999999999999987655

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=2.9e-44  Score=333.62  Aligned_cols=247  Identities=22%  Similarity=0.260  Sum_probs=200.4

Q ss_pred             CeecccCCcEEEEEEEC-CCcEEEEEEeccccC-ChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEEEeccCC
Q 016594           72 NLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVT-DDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQFSSRG  148 (386)
Q Consensus        72 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~~~~~  148 (386)
                      +.||+|+||.||+|..+ +|+.||+|++.+... .......+.+|+.+++.++||||+++++++..++ .++||||+.++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999976 689999999875322 2334456788999999999999999999987765 89999999999


Q ss_pred             CHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCcccccc
Q 016594          149 SVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIA  228 (386)
Q Consensus       149 ~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  228 (386)
                      +|.+++...  ..+++..+..++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||++......  .....
T Consensus        81 ~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~--~~~~~  153 (323)
T cd05571          81 ELFFHLSRE--RVFSEDRARFYGAEIVSALGYLHS---CDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISD--GATMK  153 (323)
T ss_pred             cHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccC--CCccc
Confidence            999888653  348999999999999999999999   99999999999999999999999999998753221  11233


Q ss_pred             ccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCCCCCHHHHH
Q 016594          229 PIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQLN  308 (386)
Q Consensus       229 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (386)
                      ..+||+.|+|||++.+..++.++|||||||++|||++|..||.........  ..+.         ...  ..++...+.
T Consensus       154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~--~~~~---------~~~--~~~p~~~~~  220 (323)
T cd05571         154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF--ELIL---------MEE--IRFPRTLSP  220 (323)
T ss_pred             ceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHH--HHHH---------cCC--CCCCCCCCH
Confidence            457999999999999999999999999999999999999999765432110  0000         000  112233457


Q ss_pred             HHHHHHHHccccCCCCCC-----CHHHHHHHHhcC
Q 016594          309 RLAFAASLCIRASPTWRP-----TMSEVLEVMLEG  338 (386)
Q Consensus       309 ~l~~li~~cl~~dP~~Rp-----t~~~il~~l~~~  338 (386)
                      .+.+++.+||..||++||     ++.+++++-+..
T Consensus       221 ~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~  255 (323)
T cd05571         221 EAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFA  255 (323)
T ss_pred             HHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcC
Confidence            799999999999999999     899999875543

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=7.7e-44  Score=324.61  Aligned_cols=256  Identities=24%  Similarity=0.412  Sum_probs=205.7

Q ss_pred             cCCCCCCeecccCCcEEEEEEECC-C-----cEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-e
Q 016594           66 NAFSSENLVGRGGYAEVYKGVLQD-G-----EEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-L  138 (386)
Q Consensus        66 ~~~~~~~~lg~G~~g~V~~~~~~~-~-----~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~  138 (386)
                      ++|++.+.||+|+||.||+|.... +     ..||+|.+... ........+.+|+.++..++||||+++++++.+.. .
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~-~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~   83 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKEN-AEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPT   83 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccC-CCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCce
Confidence            468889999999999999998642 2     57999988643 23344567889999999999999999999987655 8


Q ss_pred             EEEEEeccCCCHhhhhhhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCC
Q 016594          139 YLIFQFSSRGSVASLFHDVNS--------------PGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTAD  204 (386)
Q Consensus       139 ~lv~e~~~~~~L~~~~~~~~~--------------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~  204 (386)
                      ++++||+.+++|.+++.....              ..+++..++.++.|++.||.|||+   ++++|+||||+||+++.+
T Consensus        84 ~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nil~~~~  160 (283)
T cd05048          84 CMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSS---HHFVHRDLAARNCLVGEG  160 (283)
T ss_pred             EEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccccceEEEcCC
Confidence            999999999999998865422              447889999999999999999999   999999999999999999


Q ss_pred             CCeEEeecCccccCCCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCchhhhhhhhh
Q 016594          205 FEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKP  283 (386)
Q Consensus       205 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~  283 (386)
                      +.++|+|||++................+++.|+|||.+.+..++.++|||||||++|||++ |..||.+......  .  
T Consensus       161 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~--~--  236 (283)
T cd05048         161 LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEV--I--  236 (283)
T ss_pred             CcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHH--H--
Confidence            9999999999976543322222233456788999999998899999999999999999998 9999976433211  0  


Q ss_pred             hhcccccccccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 016594          284 ILNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLE  337 (386)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~  337 (386)
                              ..+........+..++..+.+++.+||+.||.+||++.+|+++|..
T Consensus       237 --------~~i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         237 --------EMIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             --------HHHHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence                    1111111112233456789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=3.4e-44  Score=316.21  Aligned_cols=264  Identities=21%  Similarity=0.313  Sum_probs=206.1

Q ss_pred             cCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCc-eeeecceEEeC-------
Q 016594           66 NAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPN-VLSLLGCCVDN-------  136 (386)
Q Consensus        66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~-------  136 (386)
                      ..|...++||+|+||+||+|+.+ +|+.||+|++......+.......+|+.+|+.++|+| |+++++++...       
T Consensus        11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~   90 (323)
T KOG0594|consen   11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG   90 (323)
T ss_pred             HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence            34666778999999999999976 7899999999875544445667889999999999999 99999999653       


Q ss_pred             ceEEEEEeccCCCHhhhhhhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCc
Q 016594          137 GLYLIFQFSSRGSVASLFHDVNS--PGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGL  214 (386)
Q Consensus       137 ~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~  214 (386)
                      .+++|+||+.. +|..++.....  .+++...+..++.||+.||+|||+   ++|+||||||+|||++.+|.+||+|||+
T Consensus        91 ~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~---~~IlHRDLKPQNlLi~~~G~lKlaDFGl  166 (323)
T KOG0594|consen   91 KLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHS---HGILHRDLKPQNLLISSSGVLKLADFGL  166 (323)
T ss_pred             eEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCcceEEECCCCcEeeeccch
Confidence            37899999977 89888887654  367888999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCCccccccccccccCccChhhhccC-CCCcccchHHHHHHHHHHHhCCCCCCCCchhhhh-hhhhhhccc----
Q 016594          215 AKWLPSQWTHHSIAPIEGTFGHLAPEYFMHG-IVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHS-WAKPILNQG----  288 (386)
Q Consensus       215 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~-~~~~~~~~~----  288 (386)
                      |+.+....  ......++|.+|.|||++.+. .|+...||||+|||++||++++..|.+....... .+...+...    
T Consensus       167 Ara~~ip~--~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~  244 (323)
T KOG0594|consen  167 ARAFSIPM--RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKD  244 (323)
T ss_pred             HHHhcCCc--ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccC
Confidence            99665332  235566799999999999987 7999999999999999999999999987542111 111111110    


Q ss_pred             --ccccccCCc--cCCCC-CHHH-------HHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 016594          289 --EIEKLVDPR--LQGAY-DVTQ-------LNRLAFAASLCIRASPTWRPTMSEVLEVM  335 (386)
Q Consensus       289 --~~~~~~~~~--~~~~~-~~~~-------~~~l~~li~~cl~~dP~~Rpt~~~il~~l  335 (386)
                        .+..+.+-.  ..... +...       .....+++.+||+.+|.+|.|+..+++|-
T Consensus       245 Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~  303 (323)
T KOG0594|consen  245 WPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHP  303 (323)
T ss_pred             CCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcCh
Confidence              001111100  00011 1111       13788999999999999999999999984

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.4e-44  Score=333.89  Aligned_cols=258  Identities=21%  Similarity=0.270  Sum_probs=207.1

Q ss_pred             cCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCC-hHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEE
Q 016594           66 NAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTD-DRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIF  142 (386)
Q Consensus        66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~  142 (386)
                      ++|++.+.||+|+||.||+|.+. +++.||+|++.+.... ......+.+|+.++..++||||+++++++.+.. .++||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            46899999999999999999987 5889999999754222 234456889999999999999999999998765 89999


Q ss_pred             EeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCC
Q 016594          143 QFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQW  222 (386)
Q Consensus       143 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  222 (386)
                      ||+.+++|.+++....  .+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||++.....  
T Consensus        81 e~~~g~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~--  153 (333)
T cd05600          81 EYVPGGDFRTLLNNLG--VLSEDHARFYMAEMFEAVDALHE---LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--  153 (333)
T ss_pred             eCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEEEeCcCCccccc--
Confidence            9999999999987543  48899999999999999999999   9999999999999999999999999999976543  


Q ss_pred             ccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCCCC
Q 016594          223 THHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAY  302 (386)
Q Consensus       223 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (386)
                         ......||+.|+|||++.+..++.++|||||||++|+|++|..||.........  .......   ...........
T Consensus       154 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~--~~i~~~~---~~~~~~~~~~~  225 (333)
T cd05600         154 ---YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETW--ENLKYWK---ETLQRPVYDDP  225 (333)
T ss_pred             ---ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHH--HHHHhcc---ccccCCCCCcc
Confidence               223456999999999999999999999999999999999999999865432110  0000000   00000000000


Q ss_pred             CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          303 DVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       303 ~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                      ....+..+.+++.+||..+|.+||++.+++++.+..
T Consensus       226 ~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~  261 (333)
T cd05600         226 RFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFK  261 (333)
T ss_pred             ccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccC
Confidence            123457789999999999999999999999986544

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-44  Score=348.17  Aligned_cols=261  Identities=23%  Similarity=0.311  Sum_probs=216.3

Q ss_pred             HHHhcCCCCCCeecccCCcEEEEEEECCC-cEEEEEEeccccCChHhHHHHHHHHHHHhccC-CCceeeecce-EEe---
Q 016594           62 SIATNAFSSENLVGRGGYAEVYKGVLQDG-EEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVC-HPNVLSLLGC-CVD---  135 (386)
Q Consensus        62 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~-~~~---  135 (386)
                      .+..-++++.++|.+|||+.||+|.+..+ ..||+|++...  +......+.+|+++|+.|. |+|||.+++. ...   
T Consensus        33 ~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~--de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~  110 (738)
T KOG1989|consen   33 TVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN--DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSS  110 (738)
T ss_pred             EECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC--CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccC
Confidence            35566788999999999999999998755 99999998743  6777888999999999998 9999999993 321   


Q ss_pred             -C---ceEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEee
Q 016594          136 -N---GLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISD  211 (386)
Q Consensus       136 -~---~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~D  211 (386)
                       +   .++++||||.||.|.+++..+....|++.++++|+.++++|+++||. ++..|||||||-+||||+.+|+.||||
T Consensus       111 ~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~-~~pPiIHRDLKiENvLls~~g~~KLCD  189 (738)
T KOG1989|consen  111 NNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHY-LKPPIIHRDLKIENVLLSADGNYKLCD  189 (738)
T ss_pred             CCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhc-CCCccchhhhhhhheEEcCCCCEEeCc
Confidence             2   26899999999999999988777779999999999999999999997 335699999999999999999999999


Q ss_pred             cCccccCCCCCc-cccc------cccccccCccChhhh---ccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhh
Q 016594          212 FGLAKWLPSQWT-HHSI------APIEGTFGHLAPEYF---MHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWA  281 (386)
Q Consensus       212 fg~a~~~~~~~~-~~~~------~~~~gt~~y~aPE~~---~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~  281 (386)
                      ||.|.-.-.... ....      -...-|+.|+|||++   .+.+.++|+|||+|||+||-|+....||+...       
T Consensus       190 FGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg-------  262 (738)
T KOG1989|consen  190 FGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESG-------  262 (738)
T ss_pred             ccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCc-------
Confidence            999875432221 1110      122368999999987   47789999999999999999999999998742       


Q ss_pred             hhhhcccccccccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCCc
Q 016594          282 KPILNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEGDQ  340 (386)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~~~  340 (386)
                              ...|+......+....++..+.+||..||+.||.+||++.+++..+.+...
T Consensus       263 --------~laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~  313 (738)
T KOG1989|consen  263 --------KLAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELAN  313 (738)
T ss_pred             --------ceeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhc
Confidence                    234555555555556788999999999999999999999999998766543

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-44  Score=338.30  Aligned_cols=258  Identities=22%  Similarity=0.249  Sum_probs=207.6

Q ss_pred             cCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccC-ChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEE
Q 016594           66 NAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVT-DDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIF  142 (386)
Q Consensus        66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~  142 (386)
                      ++|.+.+.||+|+||+||+|... +++.||+|++..... .......+.+|+.++..++||||+++++++.+++ .++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            46889999999999999999976 689999999975322 2234567889999999999999999999997765 89999


Q ss_pred             EeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCC
Q 016594          143 QFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQW  222 (386)
Q Consensus       143 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  222 (386)
                      ||+.+++|.+++...  ..+++..+..++.|++.||+|||+   ++|+||||||+|||++.++.+||+|||++..+....
T Consensus        81 e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~---~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~  155 (350)
T cd05573          81 EYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHK---LGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAK  155 (350)
T ss_pred             cCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEeecCCCCccCcccC
Confidence            999999999998765  458999999999999999999999   999999999999999999999999999998765432


Q ss_pred             ---------------------------ccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCch
Q 016594          223 ---------------------------THHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQ  275 (386)
Q Consensus       223 ---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~  275 (386)
                                                 .........||+.|+|||++.+..++.++|||||||++|+|++|+.||.....
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~  235 (350)
T cd05573         156 DREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTL  235 (350)
T ss_pred             cccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCH
Confidence                                       00122345689999999999999999999999999999999999999987542


Q ss_pred             hhhhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCC-HHHHHHHHhcC
Q 016594          276 SLHSWAKPILNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPT-MSEVLEVMLEG  338 (386)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt-~~~il~~l~~~  338 (386)
                      ...  ...+...      . ...........+..+.++|..||. ||.+||+ +.+++++.+..
T Consensus       236 ~~~--~~~i~~~------~-~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~  289 (350)
T cd05573         236 QET--YNKIINW------K-ESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFK  289 (350)
T ss_pred             HHH--HHHHhcc------C-CcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcC
Confidence            211  0111110      0 001111111145779999999997 9999999 99999986543

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=8.7e-44  Score=334.70  Aligned_cols=272  Identities=20%  Similarity=0.259  Sum_probs=210.3

Q ss_pred             HhcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccC-C-----CceeeecceEEeC
Q 016594           64 ATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVC-H-----PNVLSLLGCCVDN  136 (386)
Q Consensus        64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h-----~niv~l~~~~~~~  136 (386)
                      ...+|.+.+.||+|+||.|.+|.+. +++.||||++++.   ..-..+...|+.+|..|+ |     -|+|+++++|...
T Consensus       184 i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~---k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr  260 (586)
T KOG0667|consen  184 IAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK---KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFR  260 (586)
T ss_pred             eEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccC---hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccc
Confidence            3447899999999999999999965 7999999999852   444556778999999987 3     3899999999876


Q ss_pred             c-eEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCC--CCeEEeecC
Q 016594          137 G-LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTAD--FEPQISDFG  213 (386)
Q Consensus       137 ~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~--~~~kl~Dfg  213 (386)
                      + .|+|+|.+.. +|.+++..++-.+++...++.++.||+.||.+||.   .+|||+||||+||||...  ..+||+|||
T Consensus       261 ~HlciVfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~---l~IIHcDLKPENILL~~~~r~~vKVIDFG  336 (586)
T KOG0667|consen  261 NHLCIVFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHE---LGIIHCDLKPENILLKDPKRSRIKVIDFG  336 (586)
T ss_pred             cceeeeehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCChhheeeccCCcCceeEEecc
Confidence            5 8999998866 99999999998999999999999999999999999   999999999999999743  479999999


Q ss_pred             ccccCCCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhh-hhhhhh--------
Q 016594          214 LAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLH-SWAKPI--------  284 (386)
Q Consensus       214 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~-~~~~~~--------  284 (386)
                      +|......     ..+.+.+..|+|||++.|.+|+.+.|+||||||++||++|.+.|.|.+.... ..+.+.        
T Consensus       337 SSc~~~q~-----vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~m  411 (586)
T KOG0667|consen  337 SSCFESQR-----VYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKM  411 (586)
T ss_pred             cccccCCc-----ceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHH
Confidence            99876443     2256688899999999999999999999999999999999999988753211 100000        


Q ss_pred             ----------hcc-ccccc-----c-----------------cCC-ccC-C------CCCHHHHHHHHHHHHHccccCCC
Q 016594          285 ----------LNQ-GEIEK-----L-----------------VDP-RLQ-G------AYDVTQLNRLAFAASLCIRASPT  323 (386)
Q Consensus       285 ----------~~~-~~~~~-----~-----------------~~~-~~~-~------~~~~~~~~~l~~li~~cl~~dP~  323 (386)
                                ... .....     .                 .+. ... .      .........+.+++.+||.+||.
T Consensus       412 L~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~  491 (586)
T KOG0667|consen  412 LDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPA  491 (586)
T ss_pred             HHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCch
Confidence                      000 00000     0                 000 000 0      00112235689999999999999


Q ss_pred             CCCCHHHHHHHHhcCCcccccccC
Q 016594          324 WRPTMSEVLEVMLEGDQIDKERWK  347 (386)
Q Consensus       324 ~Rpt~~~il~~l~~~~~~~~~~~~  347 (386)
                      +|+|..+.|+|-+-........+.
T Consensus       492 ~R~tp~qal~Hpfl~~~~~~~~~~  515 (586)
T KOG0667|consen  492 ERITPAQALNHPFLTGTSLERRNQ  515 (586)
T ss_pred             hcCCHHHHhcCcccccccccccCC
Confidence            999999999997665444333333

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.2e-43  Score=331.58  Aligned_cols=266  Identities=19%  Similarity=0.305  Sum_probs=201.1

Q ss_pred             CCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeC------ceE
Q 016594           67 AFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDN------GLY  139 (386)
Q Consensus        67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~  139 (386)
                      +|++.+.||+|+||.||+|... ++..||||.+............+.+|+.+++.++||||+++++++...      ..+
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            5888999999999999999976 689999999875433344456788999999999999999999988542      279


Q ss_pred             EEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCC
Q 016594          140 LIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLP  219 (386)
Q Consensus       140 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~  219 (386)
                      ++|||+. ++|.+++....  .+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||++....
T Consensus        81 lv~e~~~-~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~  154 (338)
T cd07859          81 VVFELME-SDLHQVIKAND--DLTPEHHQFFLYQLLRALKYIHT---ANVFHRDLKPKNILANADCKLKICDFGLARVAF  154 (338)
T ss_pred             EEEecCC-CCHHHHHHhcc--cCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEccCccccccc
Confidence            9999995 58888876543  48999999999999999999999   999999999999999999999999999997653


Q ss_pred             CCCc-cccccccccccCccChhhhcc--CCCCcccchHHHHHHHHHHHhCCCCCCCCchhhh-hhhhhhhc---------
Q 016594          220 SQWT-HHSIAPIEGTFGHLAPEYFMH--GIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLH-SWAKPILN---------  286 (386)
Q Consensus       220 ~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~-~~~~~~~~---------  286 (386)
                      .... ........||+.|+|||++.+  ..++.++|||||||++|+|++|+.||.+...... ........         
T Consensus       155 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (338)
T cd07859         155 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISR  234 (338)
T ss_pred             cccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence            2211 122234568999999999876  6789999999999999999999999976542110 00000000         


Q ss_pred             --cccccc---ccCCccCCCCC---HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          287 --QGEIEK---LVDPRLQGAYD---VTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       287 --~~~~~~---~~~~~~~~~~~---~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                        ......   .+.+.......   ...+..+.+++.+||+.||++||++.+++++-+..
T Consensus       235 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~  294 (338)
T cd07859         235 VRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFK  294 (338)
T ss_pred             hhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhh
Confidence              000000   00000000000   01235688999999999999999999999985543

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=8.6e-44  Score=321.49  Aligned_cols=256  Identities=20%  Similarity=0.314  Sum_probs=203.5

Q ss_pred             HhcCCCCCCeecccCCcEEEEEEEC----CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-e
Q 016594           64 ATNAFSSENLVGRGGYAEVYKGVLQ----DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-L  138 (386)
Q Consensus        64 ~~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~  138 (386)
                      ..++|++.+.||+|+||.||+|.++    .+..||+|.+.... .......+.+|+.++.+++||||+++++++..+. .
T Consensus         3 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   81 (266)
T cd05064           3 DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC-SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTM   81 (266)
T ss_pred             chHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCc
Confidence            4567899999999999999999853    35689999987532 2334567889999999999999999999987654 8


Q ss_pred             EEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccC
Q 016594          139 YLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWL  218 (386)
Q Consensus       139 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~  218 (386)
                      ++||||+.+|+|.+++.... ..+++..++.++.|++.||+|||+   ++++||||||+||+++.++.++++|||.+...
T Consensus        82 ~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~i~~al~~lH~---~~iiH~dikp~nili~~~~~~~l~dfg~~~~~  157 (266)
T cd05064          82 MIVTEYMSNGALDSFLRKHE-GQLVAGQLMGMLPGLASGMKYLSE---MGYVHKGLAAHKVLVNSDLVCKISGFRRLQED  157 (266)
T ss_pred             EEEEEeCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHH---CCEeeccccHhhEEEcCCCcEEECCCcccccc
Confidence            99999999999999887543 358999999999999999999999   99999999999999999999999999987654


Q ss_pred             CCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCchhhhhhhhhhhcccccccccCCc
Q 016594          219 PSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGEIEKLVDPR  297 (386)
Q Consensus       219 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (386)
                      ..... .......++..|+|||.+.+..++.++|||||||++||+++ |..||........  ... ...         .
T Consensus       158 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~--~~~-~~~---------~  224 (266)
T cd05064         158 KSEAI-YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDV--IKA-VED---------G  224 (266)
T ss_pred             cccch-hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHH--HHH-HHC---------C
Confidence            32211 11112335678999999999999999999999999999875 9999976533210  000 000         1


Q ss_pred             cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 016594          298 LQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLE  337 (386)
Q Consensus       298 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~  337 (386)
                      .....+..++..+.+++.+||+.+|.+||++.+|++.|..
T Consensus       225 ~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~  264 (266)
T cd05064         225 FRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSK  264 (266)
T ss_pred             CCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHh
Confidence            1111223355679999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=2.1e-43  Score=335.15  Aligned_cols=258  Identities=20%  Similarity=0.236  Sum_probs=201.4

Q ss_pred             CCCCCCeecccCCcEEEEEEEC-CCcEEEEEEecccc-CChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEEE
Q 016594           67 AFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVV-TDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQ  143 (386)
Q Consensus        67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~e  143 (386)
                      .|.+.+.||+|+||+||+|... +++.||+|++.+.. ........+.+|+.+++.++||||+++++++.+.. .++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            5888999999999999999976 68899999997532 23344567889999999999999999999998765 899999


Q ss_pred             eccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCc
Q 016594          144 FSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWT  223 (386)
Q Consensus       144 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~  223 (386)
                      |+.+|+|.+++....  .+++..+..++.|++.||.|||+   ++|+||||||+|||++.++++||+|||++..+.....
T Consensus        82 ~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~aL~~LH~---~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~  156 (381)
T cd05626          82 YIPGGDMMSLLIRME--VFPEVLARFYIAELTLAIESVHK---MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHN  156 (381)
T ss_pred             cCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccc
Confidence            999999999887543  48899999999999999999999   9999999999999999999999999999764321100


Q ss_pred             c---------------------------------------------ccccccccccCccChhhhccCCCCcccchHHHHH
Q 016594          224 H---------------------------------------------HSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGV  258 (386)
Q Consensus       224 ~---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~  258 (386)
                      .                                             ......+||+.|+|||++.+..++.++|||||||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~  236 (381)
T cd05626         157 SKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGV  236 (381)
T ss_pred             cccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhh
Confidence            0                                             0012357999999999999999999999999999


Q ss_pred             HHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHH--ccccCCCCCCCHHHHHHHHh
Q 016594          259 FLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQLNRLAFAASL--CIRASPTWRPTMSEVLEVML  336 (386)
Q Consensus       259 il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~--cl~~dP~~Rpt~~~il~~l~  336 (386)
                      ++|||++|..||..........  .+...       ............+..+.+++.+  |+..+|..||++.+++.|-+
T Consensus       237 il~elltG~~Pf~~~~~~~~~~--~i~~~-------~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~  307 (381)
T cd05626         237 ILFEMLVGQPPFLAPTPTETQL--KVINW-------ENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPF  307 (381)
T ss_pred             HHHHHHhCCCCCcCCCHHHHHH--HHHcc-------ccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcc
Confidence            9999999999998654321111  00000       0001111111234668888887  55666667999999999865


Q ss_pred             cC
Q 016594          337 EG  338 (386)
Q Consensus       337 ~~  338 (386)
                      ..
T Consensus       308 f~  309 (381)
T cd05626         308 FS  309 (381)
T ss_pred             cC
Confidence            43

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.1e-44  Score=319.01  Aligned_cols=259  Identities=21%  Similarity=0.266  Sum_probs=197.4

Q ss_pred             CCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc------eE
Q 016594           67 AFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG------LY  139 (386)
Q Consensus        67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------~~  139 (386)
                      .|...+++|.|+||.||.|... +++.||||++-....      .--+|+.+|+.+.|||||++..+|....      ..
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r------~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ln   98 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR------YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLN   98 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC------cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHH
Confidence            4666789999999999999976 578999998764322      1137999999999999999999885421      56


Q ss_pred             EEEEeccCCCHhhhhhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCC-CCeEEeecCccc
Q 016594          140 LIFQFSSRGSVASLFHDV--NSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTAD-FEPQISDFGLAK  216 (386)
Q Consensus       140 lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~-~~~kl~Dfg~a~  216 (386)
                      +||||++. +|.+.++..  ....++...+.-+.+||++||.|||+   .+|+||||||.|+|+|.+ |.+||||||.|+
T Consensus        99 lVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~---~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK  174 (364)
T KOG0658|consen   99 LVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHS---HGICHRDIKPQNLLVDPDTGVLKICDFGSAK  174 (364)
T ss_pred             HHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHh---cCcccCCCChheEEEcCCCCeEEeccCCcce
Confidence            89999987 788877642  23457888888899999999999999   999999999999999966 899999999999


Q ss_pred             cCCCCCccccccccccccCccChhhhccC-CCCcccchHHHHHHHHHHHhCCCCCCCCchhhhh-hhhhhhccc------
Q 016594          217 WLPSQWTHHSIAPIEGTFGHLAPEYFMHG-IVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHS-WAKPILNQG------  288 (386)
Q Consensus       217 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~-~~~~~~~~~------  288 (386)
                      .+......   .+...|..|+|||.+.+. .|+.+.||||.||++.||+-|++.|.|.+....- ....++...      
T Consensus       175 ~L~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~  251 (364)
T KOG0658|consen  175 VLVKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIK  251 (364)
T ss_pred             eeccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHh
Confidence            88655332   345578899999999874 6999999999999999999999999986532111 111111100      


Q ss_pred             ---------ccccccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          289 ---------EIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       289 ---------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                               ...++.............+.++.+|+.++|..+|.+|.++.+++.+-...
T Consensus       252 ~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFd  310 (364)
T KOG0658|consen  252 SMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFD  310 (364)
T ss_pred             hcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhH
Confidence                     00111111111112234467899999999999999999999999875443

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=1.7e-43  Score=323.29  Aligned_cols=262  Identities=20%  Similarity=0.271  Sum_probs=199.7

Q ss_pred             cCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEEE
Q 016594           66 NAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQ  143 (386)
Q Consensus        66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~e  143 (386)
                      ++|++.+.||.|+||.||+|..+ +++.||+|++..... ......+.+|+.++++++||||+++++++.+.. .+++||
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE-EGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFE   83 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEeccccc-CCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEe
Confidence            46899999999999999999976 688999999875322 223456778999999999999999999997765 889999


Q ss_pred             eccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCc
Q 016594          144 FSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWT  223 (386)
Q Consensus       144 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~  223 (386)
                      |+.+ +|.+++.... ..+++..+..++.|++.||+|||+   ++|+||||||+|||++.++.+||+|||++....... 
T Consensus        84 ~~~~-~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~-  157 (288)
T cd07871          84 YLDS-DLKQYLDNCG-NLMSMHNVKIFMFQLLRGLSYCHK---RKILHRDLKPQNLLINEKGELKLADFGLARAKSVPT-  157 (288)
T ss_pred             CCCc-CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEECcCcceeeccCCC-
Confidence            9985 8888776433 347899999999999999999999   999999999999999999999999999987653321 


Q ss_pred             cccccccccccCccChhhhcc-CCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhh-hhhhhh------------cccc
Q 016594          224 HHSIAPIEGTFGHLAPEYFMH-GIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHS-WAKPIL------------NQGE  289 (386)
Q Consensus       224 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~-~~~~~~------------~~~~  289 (386)
                       .......+++.|+|||++.+ ..++.++|||||||++|+|++|+.||.+....... ......            ....
T Consensus       158 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (288)
T cd07871         158 -KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEE  236 (288)
T ss_pred             -ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchh
Confidence             12234468999999999875 56899999999999999999999999875432110 000000            0000


Q ss_pred             cccccCCccCCC----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 016594          290 IEKLVDPRLQGA----YDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVM  335 (386)
Q Consensus       290 ~~~~~~~~~~~~----~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l  335 (386)
                      ......+.....    .....+..+.+++.+||+.||.+|||+.++++|-
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp  286 (288)
T cd07871         237 FRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHS  286 (288)
T ss_pred             hhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCC
Confidence            001111110000    0012245688999999999999999999999764

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=1.9e-43  Score=325.29  Aligned_cols=266  Identities=21%  Similarity=0.304  Sum_probs=200.5

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEE
Q 016594           65 TNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIF  142 (386)
Q Consensus        65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~  142 (386)
                      .++|++.+.||+|+||.||+|..+ +++.||+|++..... ......+.+|+.+++.++||||+++++++.+.. .++||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~   82 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE-EGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVF   82 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccc-cccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEE
Confidence            367999999999999999999986 688999999875322 223345778999999999999999999997765 89999


Q ss_pred             EeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCC
Q 016594          143 QFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQW  222 (386)
Q Consensus       143 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  222 (386)
                      ||+. ++|.+++... ...+++..+..++.|++.||+|||+   ++|+||||||+|||++.++.+||+|||++.......
T Consensus        83 e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  157 (303)
T cd07869          83 EYVH-TDLCQYMDKH-PGGLHPENVKLFLFQLLRGLSYIHQ---RYILHRDLKPQNLLISDTGELKLADFGLARAKSVPS  157 (303)
T ss_pred             ECCC-cCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECCCCcceeccCCC
Confidence            9996 5777776543 3448889999999999999999999   999999999999999999999999999987543221


Q ss_pred             ccccccccccccCccChhhhcc-CCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhh--cccc---------c
Q 016594          223 THHSIAPIEGTFGHLAPEYFMH-GIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPIL--NQGE---------I  290 (386)
Q Consensus       223 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~--~~~~---------~  290 (386)
                        .......+++.|+|||++.+ ..++.++|||||||++|+|++|..||.+.............  ....         .
T Consensus       158 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (303)
T cd07869         158 --HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSL  235 (303)
T ss_pred             --ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhc
Confidence              12234568999999999875 45889999999999999999999999875432111111000  0000         0


Q ss_pred             ccccCCccCCCCC---------HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          291 EKLVDPRLQGAYD---------VTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       291 ~~~~~~~~~~~~~---------~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                      ............+         ...+..+.+++.+||+.||++|||+.++++|-+..
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~  292 (303)
T cd07869         236 PHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFS  292 (303)
T ss_pred             cccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccc
Confidence            0000000000000         01135688999999999999999999999986653

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=3.7e-43  Score=327.43  Aligned_cols=265  Identities=18%  Similarity=0.312  Sum_probs=205.9

Q ss_pred             HhcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEE
Q 016594           64 ATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLI  141 (386)
Q Consensus        64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv  141 (386)
                      ..++|++.+.||.|+||.||+|.+. ++..+|+|.+.... .......+.+|+++++.++||||+++++++.+++ .+++
T Consensus         3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   81 (333)
T cd06650           3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC   81 (333)
T ss_pred             chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEE
Confidence            4578999999999999999999987 68889999887532 3344567899999999999999999999998765 8999


Q ss_pred             EEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCC
Q 016594          142 FQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQ  221 (386)
Q Consensus       142 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  221 (386)
                      |||+.+++|.+++....  .+++..+..++.|++.||.|||+  ..+++|+||||+|||++.++.+||+|||++..+...
T Consensus        82 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~l~~~l~~lH~--~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~  157 (333)
T cd06650          82 MEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS  157 (333)
T ss_pred             EecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh
Confidence            99999999999987543  48899999999999999999997  147999999999999999999999999998765332


Q ss_pred             CccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccc----------
Q 016594          222 WTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIE----------  291 (386)
Q Consensus       222 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~----------  291 (386)
                          ......|+..|+|||++.+..++.++|||||||++|+|++|+.||.....................          
T Consensus       158 ----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (333)
T cd06650         158 ----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRP  233 (333)
T ss_pred             ----ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCC
Confidence                123346899999999999989999999999999999999999999764332111100000000000          


Q ss_pred             -----------------------cccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 016594          292 -----------------------KLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLE  337 (386)
Q Consensus       292 -----------------------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~  337 (386)
                                             .+.............+..+.+++.+||+.||++|||+.+++++-+.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~  302 (333)
T cd06650         234 PGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFI  302 (333)
T ss_pred             ccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHH
Confidence                                   0000000000001134668999999999999999999999988654

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=8.7e-44  Score=331.53  Aligned_cols=257  Identities=22%  Similarity=0.256  Sum_probs=204.5

Q ss_pred             cCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccC-ChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEE
Q 016594           66 NAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVT-DDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIF  142 (386)
Q Consensus        66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~  142 (386)
                      ++|.+.+.||+|+||+||+|... +++.||+|++..... .......+.+|+.+++.++|+||+++++++.+.. .++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            46889999999999999999976 689999999986432 2334566788999999999999999999987755 89999


Q ss_pred             EeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCC
Q 016594          143 QFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQW  222 (386)
Q Consensus       143 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  222 (386)
                      ||+.+++|.+++.... ..+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||++..+....
T Consensus        81 e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~lH~---~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~  156 (330)
T cd05601          81 EYQPGGDLLSLLNRYE-DQFDEDMAQFYLAELVLAIHSVHQ---MGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANK  156 (330)
T ss_pred             CCCCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeEcccCchHheEECCCCCEEeccCCCCeECCCCC
Confidence            9999999999987642 358999999999999999999999   999999999999999999999999999998765432


Q ss_pred             ccccccccccccCccChhhhc------cCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCC
Q 016594          223 THHSIAPIEGTFGHLAPEYFM------HGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDP  296 (386)
Q Consensus       223 ~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (386)
                      .. ......||+.|+|||++.      +..++.++|||||||++|+|++|..||.......  ....+.....       
T Consensus       157 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~--~~~~i~~~~~-------  226 (330)
T cd05601         157 MV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAK--TYNNIMNFQR-------  226 (330)
T ss_pred             ce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHH--HHHHHHcCCC-------
Confidence            21 223346899999999987      4567899999999999999999999997643211  1111111100       


Q ss_pred             ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 016594          297 RLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLE  337 (386)
Q Consensus       297 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~  337 (386)
                      ..........+..+.+++..||. +|.+||++.+++.+-+.
T Consensus       227 ~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~  266 (330)
T cd05601         227 FLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFF  266 (330)
T ss_pred             ccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCc
Confidence            01111112245678999999998 99999999999987544

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-44  Score=326.15  Aligned_cols=252  Identities=21%  Similarity=0.363  Sum_probs=220.8

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeC-ceEEEE
Q 016594           65 TNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDN-GLYLIF  142 (386)
Q Consensus        65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~  142 (386)
                      .+-|.+.+.||+|.|+.|-+|++- +|..||||++.+...+......+.+|+..|+-++|||||++|.+.... .+|+|+
T Consensus        17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL   96 (864)
T KOG4717|consen   17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL   96 (864)
T ss_pred             eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence            456888999999999999999965 899999999999888888888999999999999999999999998664 499999


Q ss_pred             EeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEc-CCCCeEEeecCccccCCCC
Q 016594          143 QFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLT-ADFEPQISDFGLAKWLPSQ  221 (386)
Q Consensus       143 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~-~~~~~kl~Dfg~a~~~~~~  221 (386)
                      |.-.+|+|.+++.+.. .++.+..+.+++.||+.|+.|||+   ..+|||||||+||.+- +-|-|||+|||++..+...
T Consensus        97 ELGD~GDl~DyImKHe-~Gl~E~La~kYF~QI~~AI~YCHq---LHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG  172 (864)
T KOG4717|consen   97 ELGDGGDLFDYIMKHE-EGLNEDLAKKYFAQIVHAISYCHQ---LHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG  172 (864)
T ss_pred             EecCCchHHHHHHhhh-ccccHHHHHHHHHHHHHHHHHHhh---hhhhcccCCcceeEEeeecCceEeeeccccccCCCc
Confidence            9999999999987644 459999999999999999999999   9999999999998875 5688999999999877654


Q ss_pred             CccccccccccccCccChhhhccCCCC-cccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCC
Q 016594          222 WTHHSIAPIEGTFGHLAPEYFMHGIVD-EKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQG  300 (386)
Q Consensus       222 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (386)
                         ....+.||.+.|.|||++.|..|+ +++||||||||||-|++|++||+..++.           ..+..+++...  
T Consensus       173 ---~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDS-----------ETLTmImDCKY--  236 (864)
T KOG4717|consen  173 ---KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDS-----------ETLTMIMDCKY--  236 (864)
T ss_pred             ---chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccch-----------hhhhhhhcccc--
Confidence               346678999999999999999887 8899999999999999999999875443           23445555443  


Q ss_pred             CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 016594          301 AYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVML  336 (386)
Q Consensus       301 ~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~  336 (386)
                      ..+...+.++++||..||..||.+|.+.++|..+-|
T Consensus       237 tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~W  272 (864)
T KOG4717|consen  237 TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSW  272 (864)
T ss_pred             cCchhhhHHHHHHHHHHHhcCchhhccHHHHhcccc
Confidence            456678899999999999999999999999998654

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=1.1e-43  Score=331.29  Aligned_cols=261  Identities=25%  Similarity=0.398  Sum_probs=204.5

Q ss_pred             HHhcCCCCCCeecccCCcEEEEEEEC------CCcEEEEEEeccccCChHhHHHHHHHHHHHhcc-CCCceeeecceEEe
Q 016594           63 IATNAFSSENLVGRGGYAEVYKGVLQ------DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHV-CHPNVLSLLGCCVD  135 (386)
Q Consensus        63 ~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~  135 (386)
                      +..++|++.+.||.|+||.||+|...      +++.||+|++.... .......+.+|+.++.++ +|+||+++++++..
T Consensus         4 ~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~   82 (337)
T cd05054           4 FPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA-TASEYKALMTELKILIHIGHHLNVVNLLGACTK   82 (337)
T ss_pred             cCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC-CHHHHHHHHHHHHHHHhhccCcchhheeeeEec
Confidence            45568999999999999999999742      34789999987532 233456678899999999 79999999998865


Q ss_pred             C--ceEEEEEeccCCCHhhhhhhcCC------------------------------------------------------
Q 016594          136 N--GLYLIFQFSSRGSVASLFHDVNS------------------------------------------------------  159 (386)
Q Consensus       136 ~--~~~lv~e~~~~~~L~~~~~~~~~------------------------------------------------------  159 (386)
                      .  ..+++++|+.+++|.+++.....                                                      
T Consensus        83 ~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (337)
T cd05054          83 PGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEG  162 (337)
T ss_pred             CCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhh
Confidence            3  37899999999999988754221                                                      


Q ss_pred             -----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCcccccccccccc
Q 016594          160 -----PGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTF  234 (386)
Q Consensus       160 -----~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~  234 (386)
                           ..+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.++|+|||++..+.............++.
T Consensus       163 ~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~  239 (337)
T cd05054         163 DELYKEPLTLEDLISYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL  239 (337)
T ss_pred             hHHhhcCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCc
Confidence                 257899999999999999999999   999999999999999999999999999998764332222222344677


Q ss_pred             CccChhhhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCchhhhhhhhhhhcccccccccCCccCCCCCHHHHHHHHHH
Q 016594          235 GHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQLNRLAFA  313 (386)
Q Consensus       235 ~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  313 (386)
                      .|+|||++.+..++.++|||||||++|+|++ |..||.+...... .. ......         .....+...+..+.++
T Consensus       240 ~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~-~~-~~~~~~---------~~~~~~~~~~~~~~~l  308 (337)
T cd05054         240 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE-FC-RRLKEG---------TRMRAPEYATPEIYSI  308 (337)
T ss_pred             cccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH-HH-HHHhcc---------CCCCCCccCCHHHHHH
Confidence            8999999999999999999999999999998 9999976432110 00 001111         1111122334679999


Q ss_pred             HHHccccCCCCCCCHHHHHHHHhcC
Q 016594          314 ASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       314 i~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                      +.+||+.+|++||++.+++++|...
T Consensus       309 ~~~cl~~~p~~RPs~~ell~~l~~~  333 (337)
T cd05054         309 MLDCWHNNPEDRPTFSELVEILGDL  333 (337)
T ss_pred             HHHHccCChhhCcCHHHHHHHHHHH
Confidence            9999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.9e-43  Score=318.34  Aligned_cols=256  Identities=23%  Similarity=0.372  Sum_probs=207.2

Q ss_pred             HHhcCCCCCCeecccCCcEEEEEEECCCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEE
Q 016594           63 IATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLI  141 (386)
Q Consensus        63 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv  141 (386)
                      +..++|++.+.||.|++|.||+|.+.+++.||+|.+....   .....+.+|+.++++++||||+++++++...+ .+++
T Consensus         3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   79 (261)
T cd05068           3 IDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT---MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIV   79 (261)
T ss_pred             cchhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc---ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeee
Confidence            4567799999999999999999998777889999987532   23456889999999999999999999987655 8999


Q ss_pred             EEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCC
Q 016594          142 FQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQ  221 (386)
Q Consensus       142 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  221 (386)
                      ||++.+++|.+++.......+++..+..++.|++.||.|||+   ++++||||||+||+++.++.++|+|||++..+...
T Consensus        80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~  156 (261)
T cd05068          80 TELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEA---QNYIHRDLAARNVLVGENNICKVADFGLARVIKED  156 (261)
T ss_pred             eecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCcceEEEcCCCCEEECCcceEEEccCC
Confidence            999999999999876655568999999999999999999999   99999999999999999999999999999876532


Q ss_pred             CccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCchhhhhhhhhhhcccccccccCCccCC
Q 016594          222 WTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQG  300 (386)
Q Consensus       222 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (386)
                      ... .......+..|+|||++.+..++.++||||||+++|+|++ |+.||.+.......  ... .         .....
T Consensus       157 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~--~~~-~---------~~~~~  223 (261)
T cd05068         157 IYE-AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVL--QQV-D---------QGYRM  223 (261)
T ss_pred             ccc-ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHH--HHH-H---------cCCCC
Confidence            111 1111223457999999998899999999999999999999 99999765322100  000 0         01111


Q ss_pred             CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 016594          301 AYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLE  337 (386)
Q Consensus       301 ~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~  337 (386)
                      ..+...+..+.+++.+||+.+|.+||++.++++.|++
T Consensus       224 ~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~  260 (261)
T cd05068         224 PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED  260 (261)
T ss_pred             CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence            1222345779999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-43  Score=334.48  Aligned_cols=258  Identities=24%  Similarity=0.291  Sum_probs=204.2

Q ss_pred             cCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEecccc-CChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEE
Q 016594           66 NAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVV-TDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIF  142 (386)
Q Consensus        66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~  142 (386)
                      ++|++.+.||.|+||+||+|... +++.||||++.... ........+.+|+.+++.++||||+++++++.++. .++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            47889999999999999999976 68999999997532 22334456788999999999999999999998766 89999


Q ss_pred             EeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCC
Q 016594          143 QFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQW  222 (386)
Q Consensus       143 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  222 (386)
                      ||+.+|+|.+++....  .+++..+..++.|++.||+|||+   ++|+||||||+|||++.++.+||+|||++..+....
T Consensus        81 E~~~~g~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~  155 (364)
T cd05599          81 EYLPGGDMMTLLMKKD--TFTEEETRFYIAETILAIDSIHK---LGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSH  155 (364)
T ss_pred             CCCCCcHHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEeecccceeccccc
Confidence            9999999999887543  48999999999999999999999   999999999999999999999999999987653221


Q ss_pred             ccc------------------------------------cccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhC
Q 016594          223 THH------------------------------------SIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISG  266 (386)
Q Consensus       223 ~~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g  266 (386)
                      ...                                    .....+||+.|+|||++.+..++.++|||||||++|+|++|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G  235 (364)
T cd05599         156 RTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG  235 (364)
T ss_pred             cccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcC
Confidence            100                                    11134699999999999999999999999999999999999


Q ss_pred             CCCCCCCchhhhhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCC---HHHHHHHHhcC
Q 016594          267 RKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPT---MSEVLEVMLEG  338 (386)
Q Consensus       267 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt---~~~il~~l~~~  338 (386)
                      ..||.+......  ...+....       ...........+..+.++|.+|+. +|.+|++   +.+++++-+..
T Consensus       236 ~~Pf~~~~~~~~--~~~i~~~~-------~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~  300 (364)
T cd05599         236 YPPFCSDNPQET--YRKIINWK-------ETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFK  300 (364)
T ss_pred             CCCCCCCCHHHH--HHHHHcCC-------CccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcC
Confidence            999987543211  11111100       001111111235678899999996 9999998   99999886543

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=1.3e-43  Score=319.19  Aligned_cols=256  Identities=23%  Similarity=0.386  Sum_probs=207.6

Q ss_pred             HHhcCCCCCCeecccCCcEEEEEEECCCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEE
Q 016594           63 IATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLI  141 (386)
Q Consensus        63 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv  141 (386)
                      +..++|++.++||+|+||.||+|...++..||+|.+...   ......+.+|+.+++.++|+||+++++++.+.. .+++
T Consensus         3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   79 (261)
T cd05072           3 IPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPG---TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYII   79 (261)
T ss_pred             CchHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCC---chhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEE
Confidence            445789999999999999999999887888999987642   223567889999999999999999999887655 8999


Q ss_pred             EEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCC
Q 016594          142 FQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQ  221 (386)
Q Consensus       142 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  221 (386)
                      +||+.+++|.+++.......+++..++.++.|++.||+|||+   ++++||||||+||+++.++.++|+|||++......
T Consensus        80 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~  156 (261)
T cd05072          80 TEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIER---KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDN  156 (261)
T ss_pred             EecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEecCCCcEEECCCccceecCCC
Confidence            999999999999877655668999999999999999999999   99999999999999999999999999999876543


Q ss_pred             CccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCchhhhhhhhhhhcccccccccCCccCC
Q 016594          222 WTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQG  300 (386)
Q Consensus       222 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (386)
                      ... ......++..|+|||++.+..++.++|||||||++|+|++ |..||.........  ... ...         ...
T Consensus       157 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~--~~~-~~~---------~~~  223 (261)
T cd05072         157 EYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVM--SAL-QRG---------YRM  223 (261)
T ss_pred             cee-ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHH--HHH-HcC---------CCC
Confidence            211 1222345678999999998889999999999999999998 99999764332111  000 000         011


Q ss_pred             CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 016594          301 AYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLE  337 (386)
Q Consensus       301 ~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~  337 (386)
                      ......+..+.+++.+||..+|++||+++++++.|+.
T Consensus       224 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  260 (261)
T cd05072         224 PRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD  260 (261)
T ss_pred             CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence            1112244678999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-44  Score=300.39  Aligned_cols=263  Identities=27%  Similarity=0.363  Sum_probs=214.1

Q ss_pred             HHHHhcCCCCCCeecccCCcEEEEEE-ECCCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEe----
Q 016594           61 ISIATNAFSSENLVGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVD----  135 (386)
Q Consensus        61 ~~~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----  135 (386)
                      +.++.++|++.+.||+|||+-||++. ..++..||+|++....  .+.....++|++..++++|||+++++++...    
T Consensus        16 v~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~--~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D   93 (302)
T KOG2345|consen   16 VIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS--QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKD   93 (302)
T ss_pred             EEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc--hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhcc
Confidence            34788999999999999999999999 4478999999987543  5667889999999999999999999998742    


Q ss_pred             --CceEEEEEeccCCCHhhhhhhcCCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEEeCCCCCCeeEcCCCCeEE
Q 016594          136 --NGLYLIFQFSSRGSVASLFHDVNSP--GVEWKVRHKIAVGTARGLHYLHKGCQRR--IIHRDIKSSNILLTADFEPQI  209 (386)
Q Consensus       136 --~~~~lv~e~~~~~~L~~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~~~~--ivH~dlkp~Nill~~~~~~kl  209 (386)
                        ...|+++.|...|+|.+.+.....+  -+++..++.|+.++++||++||.   ..  +.||||||.|||+.+.+.++|
T Consensus        94 ~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~---~~~~yAH~DiKP~NILls~~~~~vl  170 (302)
T KOG2345|consen   94 GKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHE---KEPPYAHRDIKPANILLSDSGLPVL  170 (302)
T ss_pred             CceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhc---cCCcccccCCCcceeEecCCCceEE
Confidence              1289999999999999988766544  48999999999999999999998   56  999999999999999999999


Q ss_pred             eecCccccCCCCCccc-------cccccccccCccChhhhc---cCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhh
Q 016594          210 SDFGLAKWLPSQWTHH-------SIAPIEGTFGHLAPEYFM---HGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHS  279 (386)
Q Consensus       210 ~Dfg~a~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~  279 (386)
                      .|||.+...+......       ....-..|..|.|||.+.   +...+.++|||||||+||+|+.|..||+...+.   
T Consensus       171 ~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~---  247 (302)
T KOG2345|consen  171 MDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQ---  247 (302)
T ss_pred             EeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhc---
Confidence            9999998764332111       112334688899999986   456789999999999999999999999753221   


Q ss_pred             hhhhhhccccc-ccccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          280 WAKPILNQGEI-EKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       280 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                             .+.+ ..+.......+.....++.+.++|.+||+.||.+||++.+++.++...
T Consensus       248 -------GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L  300 (302)
T KOG2345|consen  248 -------GGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL  300 (302)
T ss_pred             -------CCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence                   1112 223333444444455788999999999999999999999999987643

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=2.5e-43  Score=317.31  Aligned_cols=256  Identities=23%  Similarity=0.390  Sum_probs=208.0

Q ss_pred             HHhcCCCCCCeecccCCcEEEEEEECCCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCceEEEE
Q 016594           63 IATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNGLYLIF  142 (386)
Q Consensus        63 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~lv~  142 (386)
                      +..++|++.+.||+|+||.||+|.+.++..||+|.+.....   ....+.+|+.++++++|+||+++++++.....+++|
T Consensus         3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~---~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~lv~   79 (260)
T cd05070           3 IPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM---SPESFLEEAQIMKKLRHDKLVQLYAVVSEEPIYIVT   79 (260)
T ss_pred             CchHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC---CHHHHHHHHHHHHhcCCCceEEEEeEECCCCcEEEE
Confidence            34567899999999999999999988788899999875332   235688999999999999999999998777789999


Q ss_pred             EeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCC
Q 016594          143 QFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQW  222 (386)
Q Consensus       143 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  222 (386)
                      +|+.+++|.+++.......+++..++.++.|++.||.|||+   ++++|+||||+||+++.++.++|+|||++..+....
T Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~  156 (260)
T cd05070          80 EYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIER---MNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNE  156 (260)
T ss_pred             EecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEEeCCceEEeCCceeeeeccCcc
Confidence            99999999999876555568999999999999999999999   999999999999999999999999999998764332


Q ss_pred             ccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCchhhhhhhhhhhcccccccccCCccCCC
Q 016594          223 THHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGA  301 (386)
Q Consensus       223 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (386)
                      .. ......++..|+|||.+.+..++.++||||||+++|+|++ |..||.+.....  .....          .......
T Consensus       157 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~--~~~~~----------~~~~~~~  223 (260)
T cd05070         157 YT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNRE--VLEQV----------ERGYRMP  223 (260)
T ss_pred             cc-cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHH--HHHHH----------HcCCCCC
Confidence            11 1122235667999999988889999999999999999999 999997643221  11110          1111112


Q ss_pred             CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 016594          302 YDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLE  337 (386)
Q Consensus       302 ~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~  337 (386)
                      .+...+..+.+++.+||..+|++|||+.++++.|++
T Consensus       224 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         224 CPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             CCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            233445679999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=2.6e-43  Score=317.20  Aligned_cols=257  Identities=23%  Similarity=0.401  Sum_probs=209.3

Q ss_pred             HHHhcCCCCCCeecccCCcEEEEEEECCCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCceEEE
Q 016594           62 SIATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNGLYLI  141 (386)
Q Consensus        62 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~lv  141 (386)
                      ++..+.|++.++||+|+||.||+|..++++.||+|.+.....   ....+.+|+.+++.++|+||+++++++.++..+++
T Consensus         2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v   78 (260)
T cd05067           2 EVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM---SPEAFLAEANLMKQLQHPRLVRLYAVVTQEPIYII   78 (260)
T ss_pred             ccchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC---cHHHHHHHHHHHHhcCCcCeeeEEEEEccCCcEEE
Confidence            356678999999999999999999988889999999875332   34578899999999999999999999877779999


Q ss_pred             EEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCC
Q 016594          142 FQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQ  221 (386)
Q Consensus       142 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  221 (386)
                      +|++.+++|.+++.......+++..+..++.|++.||+|||+   .+++|+||||+||+++.++.++|+|||++......
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~  155 (260)
T cd05067          79 TEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIER---KNYIHRDLRAANILVSETLCCKIADFGLARLIEDN  155 (260)
T ss_pred             EEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHHhEEEcCCCCEEEccCcceeecCCC
Confidence            999999999998876666668999999999999999999999   99999999999999999999999999999776532


Q ss_pred             CccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCchhhhhhhhhhhcccccccccCCccCC
Q 016594          222 WTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQG  300 (386)
Q Consensus       222 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (386)
                      .. .......++..|+|||++.+..++.++||||||+++|+|++ |..||.+......  ... ..         .....
T Consensus       156 ~~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~--~~~-~~---------~~~~~  222 (260)
T cd05067         156 EY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEV--IQN-LE---------RGYRM  222 (260)
T ss_pred             Cc-ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHH--HHH-HH---------cCCCC
Confidence            11 11122335678999999998889999999999999999999 9999976532211  000 00         01111


Q ss_pred             CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 016594          301 AYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLE  337 (386)
Q Consensus       301 ~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~  337 (386)
                      ..+...+..+.+++.+||+.+|++||+++++++.|+.
T Consensus       223 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         223 PRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence            1122234679999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=5.4e-44  Score=321.51  Aligned_cols=250  Identities=28%  Similarity=0.497  Sum_probs=196.4

Q ss_pred             CCCeecccCCcEEEEEEEC-----CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEEE
Q 016594           70 SENLVGRGGYAEVYKGVLQ-----DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQ  143 (386)
Q Consensus        70 ~~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~e  143 (386)
                      +.+.||.|.||.||+|.+.     .+..|+||.++. .........+.+|++.+++++||||++++|++...+ .++|+|
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~-~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e   81 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKP-SSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVME   81 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEEST-TSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecc-ccccccceeeeeccccccccccccccccccccccccccccccc
Confidence            4578999999999999976     256899999954 334445788999999999999999999999999544 899999


Q ss_pred             eccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCc
Q 016594          144 FSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWT  223 (386)
Q Consensus       144 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~  223 (386)
                      |+.+|+|.+++.......+++..++.++.|++.||.|||+   ++++|+||+++||+++.++.+||+|||++........
T Consensus        82 ~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~---~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~  158 (259)
T PF07714_consen   82 YCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHS---NNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK  158 (259)
T ss_dssp             --TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHH---TTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred             cccccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccc
Confidence            9999999999988756669999999999999999999999   9999999999999999999999999999987733322


Q ss_pred             cccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCchhhhhhhhhhhcccccccccCCccCCCC
Q 016594          224 HHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAY  302 (386)
Q Consensus       224 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (386)
                      ............|+|||.+.+..++.++||||||+++|||++ |+.||.......  ..... ..         ......
T Consensus       159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~--~~~~~-~~---------~~~~~~  226 (259)
T PF07714_consen  159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEE--IIEKL-KQ---------GQRLPI  226 (259)
T ss_dssp             EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHH--HHHHH-HT---------TEETTS
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccccc--ccccc-cc---------ccccee
Confidence            222333446778999999999999999999999999999999 789987653221  11111 11         111122


Q ss_pred             CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 016594          303 DVTQLNRLAFAASLCIRASPTWRPTMSEVLEVM  335 (386)
Q Consensus       303 ~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l  335 (386)
                      +..++..+.+++..||+.+|++||++.+|++.|
T Consensus       227 ~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  227 PDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             BTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             ccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence            233457799999999999999999999999875

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=4.7e-43  Score=333.02  Aligned_cols=261  Identities=22%  Similarity=0.387  Sum_probs=205.3

Q ss_pred             HHhcCCCCCCeecccCCcEEEEEEEC------CCcEEEEEEeccccCChHhHHHHHHHHHHHhccC-CCceeeecceEEe
Q 016594           63 IATNAFSSENLVGRGGYAEVYKGVLQ------DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVC-HPNVLSLLGCCVD  135 (386)
Q Consensus        63 ~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~  135 (386)
                      ...++|.++++||+|+||.||+|.+.      .+..||||++.... .......+.+|+.+++++. ||||+++++++.+
T Consensus        34 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~  112 (400)
T cd05105          34 FPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA-RSSEKQALMSELKIMTHLGPHLNIVNLLGACTK  112 (400)
T ss_pred             ccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEcc
Confidence            45678999999999999999999853      13469999987532 2334567899999999996 9999999999977


Q ss_pred             Cc-eEEEEEeccCCCHhhhhhhcC--------------------------------------------------------
Q 016594          136 NG-LYLIFQFSSRGSVASLFHDVN--------------------------------------------------------  158 (386)
Q Consensus       136 ~~-~~lv~e~~~~~~L~~~~~~~~--------------------------------------------------------  158 (386)
                      .+ .++||||+.+|+|.+++....                                                        
T Consensus       113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (400)
T cd05105         113 SGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPML  192 (400)
T ss_pred             CCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhh
Confidence            55 899999999999998775421                                                        


Q ss_pred             --------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCee
Q 016594          159 --------------------------------------SPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNIL  200 (386)
Q Consensus       159 --------------------------------------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nil  200 (386)
                                                            ...+++..+..++.|++.||.|||+   ++++||||||+|||
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dikp~Nil  269 (400)
T cd05105         193 EIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLAS---KNCVHRDLAARNVL  269 (400)
T ss_pred             hhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHhEE
Confidence                                                  1247788889999999999999999   99999999999999


Q ss_pred             EcCCCCeEEeecCccccCCCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCchhhhh
Q 016594          201 LTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHS  279 (386)
Q Consensus       201 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~  279 (386)
                      ++.++.+||+|||++..+.............++..|+|||.+.+..++.++|||||||++|+|++ |..||.........
T Consensus       270 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~  349 (400)
T cd05105         270 LAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTF  349 (400)
T ss_pred             EeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHH
Confidence            99999999999999986643322222233446788999999999999999999999999999997 99999764221111


Q ss_pred             hhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          280 WAKPILNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                      +  .....         ......+...+..+.+++.+||+.||++||++.+|.+.|...
T Consensus       350 ~--~~~~~---------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l  397 (400)
T cd05105         350 Y--NKIKS---------GYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESL  397 (400)
T ss_pred             H--HHHhc---------CCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHH
Confidence            0  00010         111112233456799999999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=1.9e-43  Score=321.13  Aligned_cols=258  Identities=22%  Similarity=0.396  Sum_probs=203.0

Q ss_pred             HHhcCCCCCCeecccCCcEEEEEEEC------CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeC
Q 016594           63 IATNAFSSENLVGRGGYAEVYKGVLQ------DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDN  136 (386)
Q Consensus        63 ~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~  136 (386)
                      +..++|++.+.||+|+||.||+|.++      ++..||+|.+... ........+.+|+.+++.++||||+++++++.++
T Consensus         3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~-~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~   81 (277)
T cd05062           3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG   81 (277)
T ss_pred             ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence            46788999999999999999999853      2467999988642 2233455688999999999999999999998765


Q ss_pred             c-eEEEEEeccCCCHhhhhhhcCC--------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCe
Q 016594          137 G-LYLIFQFSSRGSVASLFHDVNS--------PGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEP  207 (386)
Q Consensus       137 ~-~~lv~e~~~~~~L~~~~~~~~~--------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~  207 (386)
                      . .+++|||+.+++|.+++.....        ..+++..+..++.|++.||.|||+   ++++|+||||+||+++.++.+
T Consensus        82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~vH~dlkp~Nil~~~~~~~  158 (277)
T cd05062          82 QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTV  158 (277)
T ss_pred             CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCcchheEEEcCCCCE
Confidence            5 8999999999999998865321        235778889999999999999999   999999999999999999999


Q ss_pred             EEeecCccccCCCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCchhhhhhhhhhhc
Q 016594          208 QISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILN  286 (386)
Q Consensus       208 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~  286 (386)
                      +|+|||++................+++.|+|||.+.+..++.++|||||||++|+|++ |..||.+.....  ...... 
T Consensus       159 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~--~~~~~~-  235 (277)
T cd05062         159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQ--VLRFVM-  235 (277)
T ss_pred             EECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH--HHHHHH-
Confidence            9999999876543322111222345778999999999999999999999999999999 789997643221  000000 


Q ss_pred             ccccccccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 016594          287 QGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVML  336 (386)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~  336 (386)
                      ....         ...+...+..+.+++.+||+.+|++|||+.++++.|+
T Consensus       236 ~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  276 (277)
T cd05062         236 EGGL---------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK  276 (277)
T ss_pred             cCCc---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence            0000         0112233467999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=4.4e-43  Score=315.24  Aligned_cols=248  Identities=23%  Similarity=0.349  Sum_probs=201.1

Q ss_pred             eecccCCcEEEEEEEC---CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCceEEEEEeccCCC
Q 016594           73 LVGRGGYAEVYKGVLQ---DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNGLYLIFQFSSRGS  149 (386)
Q Consensus        73 ~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~lv~e~~~~~~  149 (386)
                      .||+|+||.||+|.++   ++..+|+|++............+.+|+.+++.+.||||+++++++..+..+++|||+.+++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~e~~~~~~   81 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEAESWMLVMELAELGP   81 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCcEEEEecCCCCc
Confidence            5899999999999753   5788999998765555556678899999999999999999999988777999999999999


Q ss_pred             HhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCcccc-cc
Q 016594          150 VASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHS-IA  228 (386)
Q Consensus       150 L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~-~~  228 (386)
                      |.+++....  .+++..+..++.|++.||.|||+   ++++||||||.||+++.++.+||+|||++..+........ ..
T Consensus        82 L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  156 (257)
T cd05116          82 LNKFLQKNK--HVTEKNITELVHQVSMGMKYLEE---TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKT  156 (257)
T ss_pred             HHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecC
Confidence            999886533  48999999999999999999999   9999999999999999999999999999987654322111 11


Q ss_pred             ccccccCccChhhhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCchhhhhhhhhhhcccccccccCCccCCCCCHHHH
Q 016594          229 PIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQL  307 (386)
Q Consensus       229 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (386)
                      ...++..|+|||.+....++.++|||||||++|||++ |..||.......  ....          +........+...+
T Consensus       157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--~~~~----------i~~~~~~~~~~~~~  224 (257)
T cd05116         157 HGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNE--VTQM----------IESGERMECPQRCP  224 (257)
T ss_pred             CCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHH----------HHCCCCCCCCCCCC
Confidence            2234578999999988889999999999999999998 999997653321  1111          11111112223345


Q ss_pred             HHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 016594          308 NRLAFAASLCIRASPTWRPTMSEVLEVMLE  337 (386)
Q Consensus       308 ~~l~~li~~cl~~dP~~Rpt~~~il~~l~~  337 (386)
                      ..+.++|.+||+.||++||++.+|.+.|..
T Consensus       225 ~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~  254 (257)
T cd05116         225 PEMYDLMKLCWTYGVDERPGFAVVELRLRN  254 (257)
T ss_pred             HHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence            779999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=2.2e-43  Score=343.66  Aligned_cols=251  Identities=20%  Similarity=0.307  Sum_probs=202.7

Q ss_pred             CCCCCCeecccCCcEEEEEEEC-C-CcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEEE
Q 016594           67 AFSSENLVGRGGYAEVYKGVLQ-D-GEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQ  143 (386)
Q Consensus        67 ~~~~~~~lg~G~~g~V~~~~~~-~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~e  143 (386)
                      .|.+.+.||+|+||.||+|... + +..||+|.+..  ........+.+|+.+++.++||||+++++++..++ .++|||
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~--~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E  145 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVML--NDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIME  145 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEccc--CCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEE
Confidence            4889999999999999999865 3 67788887643  23344456788999999999999999999998765 899999


Q ss_pred             eccCCCHhhhhhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCC
Q 016594          144 FSSRGSVASLFHDV--NSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQ  221 (386)
Q Consensus       144 ~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  221 (386)
                      |+.+|+|.+++...  ....+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||++..+...
T Consensus       146 ~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~  222 (478)
T PTZ00267        146 YGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHS---RKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDS  222 (478)
T ss_pred             CCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCcCHHhEEECCCCcEEEEeCcCceecCCc
Confidence            99999999877543  23458899999999999999999999   99999999999999999999999999999876544


Q ss_pred             CccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCCC
Q 016594          222 WTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGA  301 (386)
Q Consensus       222 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (386)
                      .........+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.....  .....         .... ...
T Consensus       223 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~--~~~~~---------~~~~-~~~  290 (478)
T PTZ00267        223 VSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQRE--IMQQV---------LYGK-YDP  290 (478)
T ss_pred             cccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHH---------HhCC-CCC
Confidence            33223445679999999999999999999999999999999999999997653321  00100         0000 011


Q ss_pred             CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 016594          302 YDVTQLNRLAFAASLCIRASPTWRPTMSEVLEV  334 (386)
Q Consensus       302 ~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~  334 (386)
                      .+...+..+.+++..||..||++||++.+++.+
T Consensus       291 ~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~  323 (478)
T PTZ00267        291 FPCPVSSGMKALLDPLLSKNPALRPTTQQLLHT  323 (478)
T ss_pred             CCccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence            122345679999999999999999999999864

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=6.7e-44  Score=332.92  Aligned_cols=252  Identities=22%  Similarity=0.294  Sum_probs=205.5

Q ss_pred             HhcCCCCCCeecccCCcEEEEEEECC--CcEEEEEEecccc-CChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eE
Q 016594           64 ATNAFSSENLVGRGGYAEVYKGVLQD--GEEIAVKRLTKVV-TDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LY  139 (386)
Q Consensus        64 ~~~~~~~~~~lg~G~~g~V~~~~~~~--~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~  139 (386)
                      ..++|++.+.||+|+||.||+|.++.  +..||+|.+.... ........+.+|+.+++.++||||+++++++.+.+ .+
T Consensus        28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~  107 (340)
T PTZ00426         28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLY  107 (340)
T ss_pred             ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEE
Confidence            34578999999999999999998653  3689999986532 22334556889999999999999999999998766 89


Q ss_pred             EEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCC
Q 016594          140 LIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLP  219 (386)
Q Consensus       140 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~  219 (386)
                      ++|||+.+|+|.+++....  .+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||++....
T Consensus       108 lv~Ey~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~  182 (340)
T PTZ00426        108 LVLEFVIGGEFFTFLRRNK--RFPNDVGCFYAAQIVLIFEYLQS---LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD  182 (340)
T ss_pred             EEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence            9999999999999987643  48999999999999999999999   999999999999999999999999999998764


Q ss_pred             CCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccC
Q 016594          220 SQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQ  299 (386)
Q Consensus       220 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (386)
                      ..     .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.......  ..         +....  
T Consensus       183 ~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~--~~---------i~~~~--  244 (340)
T PTZ00426        183 TR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIY--QK---------ILEGI--  244 (340)
T ss_pred             CC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHH--HH---------HhcCC--
Confidence            32     23456999999999999999999999999999999999999999875432110  00         01110  


Q ss_pred             CCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHHhcC
Q 016594          300 GAYDVTQLNRLAFAASLCIRASPTWRP-----TMSEVLEVMLEG  338 (386)
Q Consensus       300 ~~~~~~~~~~l~~li~~cl~~dP~~Rp-----t~~~il~~l~~~  338 (386)
                      ..++...+..+.+++.+||+.||++|+     ++++++++.+..
T Consensus       245 ~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~  288 (340)
T PTZ00426        245 IYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFG  288 (340)
T ss_pred             CCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcC
Confidence            011222346689999999999999995     899999986543

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=2.7e-43  Score=317.71  Aligned_cols=255  Identities=26%  Similarity=0.421  Sum_probs=206.3

Q ss_pred             HhcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEE
Q 016594           64 ATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLI  141 (386)
Q Consensus        64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv  141 (386)
                      ....|.+.+.||.|+||.||+|.++ ++..||+|.+...   ......+.+|+.+++.+.|+||+++++++..+. .+++
T Consensus         4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (263)
T cd05052           4 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII   80 (263)
T ss_pred             chHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC---chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEE
Confidence            3456888899999999999999976 5889999988642   334567889999999999999999999987655 8899


Q ss_pred             EEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCC
Q 016594          142 FQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQ  221 (386)
Q Consensus       142 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  221 (386)
                      |||+.+++|.+++.......+++..++.++.|++.||+|||+   ++++||||||+||+++.++.+||+|||++......
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~  157 (263)
T cd05052          81 TEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD  157 (263)
T ss_pred             EEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCcEEeCCCccccccccc
Confidence            999999999999876665668999999999999999999999   99999999999999999999999999999876543


Q ss_pred             CccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCchhhhhhhhhhhcccccccccCCccCC
Q 016594          222 WTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQG  300 (386)
Q Consensus       222 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (386)
                      ... ......++..|+|||.+.+..++.++|||||||++|+|++ |..||.+......  ....          ......
T Consensus       158 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~--~~~~----------~~~~~~  224 (263)
T cd05052         158 TYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV--YELL----------EKGYRM  224 (263)
T ss_pred             eee-ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH--HHHH----------HCCCCC
Confidence            211 1112234567999999999999999999999999999998 9999976433211  0100          011111


Q ss_pred             CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 016594          301 AYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLE  337 (386)
Q Consensus       301 ~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~  337 (386)
                      ..+...+..+.+++.+||+.+|++||++.++++.|..
T Consensus       225 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~  261 (263)
T cd05052         225 ERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFET  261 (263)
T ss_pred             CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHh
Confidence            2223345779999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=1.7e-43  Score=329.03  Aligned_cols=246  Identities=22%  Similarity=0.256  Sum_probs=199.3

Q ss_pred             CeecccCCcEEEEEEEC-CCcEEEEEEecccc-CChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEEEeccCC
Q 016594           72 NLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVV-TDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQFSSRG  148 (386)
Q Consensus        72 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~~~~~  148 (386)
                      +.||+|+||.||+|..+ +++.||+|++.+.. ........+.+|+.+++.++||||+++++++..+. .++||||+.++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999976 68999999997532 22334567889999999999999999999987765 89999999999


Q ss_pred             CHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCcccccc
Q 016594          149 SVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIA  228 (386)
Q Consensus       149 ~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  228 (386)
                      +|...+...  ..+++..+..++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||++......  .....
T Consensus        81 ~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~--~~~~~  153 (328)
T cd05593          81 ELFFHLSRE--RVFSEDRTRFYGAEIVSALDYLHS---GKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD--AATMK  153 (328)
T ss_pred             CHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeEECCCCcEEEecCcCCccCCCc--ccccc
Confidence            998887653  348999999999999999999999   99999999999999999999999999998754321  11233


Q ss_pred             ccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCCCCCHHHHH
Q 016594          229 PIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQLN  308 (386)
Q Consensus       229 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (386)
                      ..+||+.|+|||++.+..++.++|||||||++|+|++|..||.+......  ....         ....  ...+...+.
T Consensus       154 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~--~~~~---------~~~~--~~~p~~~~~  220 (328)
T cd05593         154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL--FELI---------LMED--IKFPRTLSA  220 (328)
T ss_pred             cccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHH--HHHh---------ccCC--ccCCCCCCH
Confidence            45699999999999999999999999999999999999999976432210  0000         0000  112223456


Q ss_pred             HHHHHHHHccccCCCCCC-----CHHHHHHHHhc
Q 016594          309 RLAFAASLCIRASPTWRP-----TMSEVLEVMLE  337 (386)
Q Consensus       309 ~l~~li~~cl~~dP~~Rp-----t~~~il~~l~~  337 (386)
                      .+.+++.+||..||++||     ++.+++++.+.
T Consensus       221 ~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~  254 (328)
T cd05593         221 DAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFF  254 (328)
T ss_pred             HHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCc
Confidence            789999999999999997     89999988554

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=2.6e-43  Score=317.66  Aligned_cols=256  Identities=22%  Similarity=0.367  Sum_probs=207.6

Q ss_pred             HHhcCCCCCCeecccCCcEEEEEEECCCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCceEEEE
Q 016594           63 IATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNGLYLIF  142 (386)
Q Consensus        63 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~lv~  142 (386)
                      +..++|++.++||+|+||.||+|.+.++..||+|.+.....   ....+.+|+.+++.++||||+++++.+.+...+++|
T Consensus         3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~---~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~lv~   79 (262)
T cd05071           3 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVT   79 (262)
T ss_pred             CChHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc---CHHHHHHHHHHHHhCCCCCcceEEEEECCCCcEEEE
Confidence            34567999999999999999999987667899999875322   235688999999999999999999988777789999


Q ss_pred             EeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCC
Q 016594          143 QFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQW  222 (386)
Q Consensus       143 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  222 (386)
                      ||+.+++|.+++.......+++..+..++.|++.||.|||+   .+++|+||||+||+++.++.++|+|||.+..+....
T Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~  156 (262)
T cd05071          80 EYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE  156 (262)
T ss_pred             EcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcccEEEcCCCcEEeccCCceeeccccc
Confidence            99999999999976555568999999999999999999999   999999999999999999999999999998664332


Q ss_pred             ccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCchhhhhhhhhhhcccccccccCCccCCC
Q 016594          223 THHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGA  301 (386)
Q Consensus       223 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (386)
                      .. ......++..|+|||+..+..++.++|||||||++|+|++ |..||.+.......  ....          ......
T Consensus       157 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~--~~~~----------~~~~~~  223 (262)
T cd05071         157 YT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL--DQVE----------RGYRMP  223 (262)
T ss_pred             cc-cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHH--HHHh----------cCCCCC
Confidence            11 1122335678999999988899999999999999999999 88899765322110  0000          001111


Q ss_pred             CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 016594          302 YDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLE  337 (386)
Q Consensus       302 ~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~  337 (386)
                      .+...+..+.+++.+||+.+|++||++.++++.|++
T Consensus       224 ~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~  259 (262)
T cd05071         224 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED  259 (262)
T ss_pred             CccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHH
Confidence            223456779999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=3.3e-43  Score=319.91  Aligned_cols=256  Identities=22%  Similarity=0.344  Sum_probs=204.2

Q ss_pred             hcCCCCCCeecccCCcEEEEEEECC------CcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-
Q 016594           65 TNAFSSENLVGRGGYAEVYKGVLQD------GEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-  137 (386)
Q Consensus        65 ~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-  137 (386)
                      ..+|.+.+.||+|+||.||+|.+.+      +..||+|.+.... .......+.+|+++++.+.|+||+++++++.... 
T Consensus         4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   82 (280)
T cd05049           4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA-SNDARKDFEREAELLTNFQHENIVKFYGVCTEGDP   82 (280)
T ss_pred             hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC-CHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCC
Confidence            4568889999999999999998642      4789999987532 2334578899999999999999999999997755 


Q ss_pred             eEEEEEeccCCCHhhhhhhcC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCC
Q 016594          138 LYLIFQFSSRGSVASLFHDVN------------SPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADF  205 (386)
Q Consensus       138 ~~lv~e~~~~~~L~~~~~~~~------------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~  205 (386)
                      .+++|||+.+++|.+++....            ...+++..+..++.|++.||.|||+   ++++||||||+||+++.++
T Consensus        83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~  159 (280)
T cd05049          83 PIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS---QHFVHRDLATRNCLVGYDL  159 (280)
T ss_pred             eEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeeccccccceEEEcCCC
Confidence            899999999999999986542            2347888999999999999999999   9999999999999999999


Q ss_pred             CeEEeecCccccCCCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCchhhhhhhhhh
Q 016594          206 EPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPI  284 (386)
Q Consensus       206 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~  284 (386)
                      .+||+|||++................+++.|+|||++.+..++.++|||||||++|+|++ |..||........  ....
T Consensus       160 ~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~--~~~~  237 (280)
T cd05049         160 VVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEV--IECI  237 (280)
T ss_pred             eEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHH--HHHH
Confidence            999999999876533222112223345778999999999999999999999999999998 9999976433211  0100


Q ss_pred             hcccccccccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 016594          285 LNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVML  336 (386)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~  336 (386)
                       ..         ......+...+..+.+++.+||+.||++||++.+|++.|.
T Consensus       238 -~~---------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~  279 (280)
T cd05049         238 -TQ---------GRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ  279 (280)
T ss_pred             -Hc---------CCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence             00         0111112234567999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=1.6e-43  Score=328.53  Aligned_cols=247  Identities=23%  Similarity=0.262  Sum_probs=199.1

Q ss_pred             CeecccCCcEEEEEEEC-CCcEEEEEEeccccC-ChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEEEeccCC
Q 016594           72 NLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVT-DDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQFSSRG  148 (386)
Q Consensus        72 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~~~~~  148 (386)
                      +.||+|+||.||+|..+ +|+.||+|++..... .......+.+|+.+++.++||||+++++++..++ .++||||+.++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            46999999999999976 689999999875322 2334556788999999999999999999997765 89999999999


Q ss_pred             CHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCcccccc
Q 016594          149 SVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIA  228 (386)
Q Consensus       149 ~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  228 (386)
                      +|..++....  .+++..++.++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||++......  .....
T Consensus        81 ~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~--~~~~~  153 (323)
T cd05595          81 ELFFHLSRER--VFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMK  153 (323)
T ss_pred             cHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEEcCCCCEEecccHHhccccCC--CCccc
Confidence            9988876543  48999999999999999999999   99999999999999999999999999998753221  11223


Q ss_pred             ccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCCCCCHHHHH
Q 016594          229 PIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQLN  308 (386)
Q Consensus       229 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (386)
                      ...||+.|+|||++.+..++.++|||||||++|+|++|..||.........  ...         ....  ...+...+.
T Consensus       154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~--~~~---------~~~~--~~~p~~~~~  220 (323)
T cd05595         154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLF--ELI---------LMEE--IRFPRTLSP  220 (323)
T ss_pred             cccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHH--HHH---------hcCC--CCCCCCCCH
Confidence            456999999999999999999999999999999999999999765322110  000         0000  011223456


Q ss_pred             HHHHHHHHccccCCCCCC-----CHHHHHHHHhcC
Q 016594          309 RLAFAASLCIRASPTWRP-----TMSEVLEVMLEG  338 (386)
Q Consensus       309 ~l~~li~~cl~~dP~~Rp-----t~~~il~~l~~~  338 (386)
                      .+.+++.+||+.||++||     ++.+++++-+..
T Consensus       221 ~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~  255 (323)
T cd05595         221 EAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFL  255 (323)
T ss_pred             HHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcC
Confidence            789999999999999998     899999875443

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=2.2e-43  Score=334.65  Aligned_cols=257  Identities=20%  Similarity=0.220  Sum_probs=200.7

Q ss_pred             cCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccC-ChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEE
Q 016594           66 NAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVT-DDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIF  142 (386)
Q Consensus        66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~  142 (386)
                      +.|++.+.||+|+||.||+|... +++.||||++.+... .......+.+|+.+++.++|+||+++++.+.+++ .++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence            46899999999999999999976 689999999865321 2233456788999999999999999999998766 89999


Q ss_pred             EeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCC
Q 016594          143 QFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQW  222 (386)
Q Consensus       143 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  222 (386)
                      ||+.+|+|.+++....  .+++..+..++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||++..+....
T Consensus        81 E~~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~  155 (376)
T cd05598          81 DYIPGGDMMSLLIRLG--IFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH  155 (376)
T ss_pred             eCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccc
Confidence            9999999999987543  48899999999999999999999   999999999999999999999999999975332100


Q ss_pred             c-----------------------------------------cccccccccccCccChhhhccCCCCcccchHHHHHHHH
Q 016594          223 T-----------------------------------------HHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLL  261 (386)
Q Consensus       223 ~-----------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~  261 (386)
                      .                                         .......+||+.|+|||++.+..++.++|||||||++|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvily  235 (376)
T cd05598         156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY  235 (376)
T ss_pred             cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceee
Confidence            0                                         00112357999999999999999999999999999999


Q ss_pred             HHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHccccCCCCCC---CHHHHHHHHhc
Q 016594          262 EIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRP---TMSEVLEVMLE  337 (386)
Q Consensus       262 ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp---t~~~il~~l~~  337 (386)
                      +|++|+.||.+.......  ..+...       ............+..+.+++.+|+ .+|.+|+   ++.+++++-+.
T Consensus       236 ell~G~~Pf~~~~~~~~~--~~i~~~-------~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~  304 (376)
T cd05598         236 EMLVGQPPFLADTPAETQ--LKVINW-------ETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFF  304 (376)
T ss_pred             ehhhCCCCCCCCCHHHHH--HHHhcc-------CccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCc
Confidence            999999999875432111  000000       000111111223456788888876 5999999   89999988554

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.2e-43  Score=324.29  Aligned_cols=245  Identities=20%  Similarity=0.227  Sum_probs=197.6

Q ss_pred             ecccCCcEEEEEEEC-CCcEEEEEEecccc-CChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEEEeccCCCH
Q 016594           74 VGRGGYAEVYKGVLQ-DGEEIAVKRLTKVV-TDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQFSSRGSV  150 (386)
Q Consensus        74 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~~~~~~L  150 (386)
                      ||+|+||.||+|... +++.||+|++.... ........+.+|+.++.+++||||+++++++.+.+ .++||||+.+|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            799999999999976 68899999987532 22344567789999999999999999999987755 8999999999999


Q ss_pred             hhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCcccccccc
Q 016594          151 ASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPI  230 (386)
Q Consensus       151 ~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~  230 (386)
                      .+++...  ..+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||++.......  ......
T Consensus        81 ~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~~  153 (312)
T cd05585          81 FHHLQRE--GRFDLSRARFYTAELLCALENLHK---FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--DKTNTF  153 (312)
T ss_pred             HHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHeEECCCCcEEEEECcccccCccCC--Cccccc
Confidence            9988753  348999999999999999999999   999999999999999999999999999987543221  123345


Q ss_pred             ccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCCCCCHHHHHHH
Q 016594          231 EGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQLNRL  310 (386)
Q Consensus       231 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  310 (386)
                      .||+.|+|||++.+..++.++|||||||++|+|++|..||.+.....  ....         +....  ...+...+..+
T Consensus       154 ~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~--~~~~---------~~~~~--~~~~~~~~~~~  220 (312)
T cd05585         154 CGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNE--MYRK---------ILQEP--LRFPDGFDRDA  220 (312)
T ss_pred             cCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHH--HHHH---------HHcCC--CCCCCcCCHHH
Confidence            69999999999999999999999999999999999999997653221  1111         11111  11222345678


Q ss_pred             HHHHHHccccCCCCCC---CHHHHHHHHhcC
Q 016594          311 AFAASLCIRASPTWRP---TMSEVLEVMLEG  338 (386)
Q Consensus       311 ~~li~~cl~~dP~~Rp---t~~~il~~l~~~  338 (386)
                      .+++.+||+.||.+||   ++.+++.+.+..
T Consensus       221 ~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~  251 (312)
T cd05585         221 KDLLIGLLSRDPTRRLGYNGAQEIKNHPFFS  251 (312)
T ss_pred             HHHHHHHcCCCHHHcCCCCCHHHHHcCCCcC
Confidence            9999999999999997   467888775443

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=7.3e-43  Score=317.64  Aligned_cols=256  Identities=24%  Similarity=0.380  Sum_probs=202.2

Q ss_pred             cCCCCCCeecccCCcEEEEEEEC-CCc----EEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCceEE
Q 016594           66 NAFSSENLVGRGGYAEVYKGVLQ-DGE----EIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNGLYL  140 (386)
Q Consensus        66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~l  140 (386)
                      .+|++.+.||+|+||+||+|.+. ++.    .+++|.+... ........+..|+.+++++.||||+++++++.....++
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~~~~~~   85 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR-SGRQTFQEITDHMLAMGSLDHAYIVRLLGICPGASLQL   85 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc-cchHHHHHHHHHHHHHhcCCCCCcceEEEEECCCccEE
Confidence            56888999999999999999975 344    4777776532 22334456778888999999999999999987777889


Q ss_pred             EEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCC
Q 016594          141 IFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPS  220 (386)
Q Consensus       141 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~  220 (386)
                      ++||+.+|+|.+++.... ..+++..+..++.|++.||.|||+   ++++||||||+||+++.++.+||+|||++..+..
T Consensus        86 i~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~  161 (279)
T cd05111          86 VTQLSPLGSLLDHVRQHR-DSLDPQRLLNWCVQIAKGMYYLEE---HRMVHRNLAARNILLKSDSIVQIADFGVADLLYP  161 (279)
T ss_pred             EEEeCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence            999999999999987533 348999999999999999999999   9999999999999999999999999999987644


Q ss_pred             CCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCchhhhhhhhhhhcccccccccCCccC
Q 016594          221 QWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQ  299 (386)
Q Consensus       221 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (386)
                      ...........++..|+|||.+.+..++.++|||||||++|||++ |..||.+.......   .....+         ..
T Consensus       162 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~---~~~~~~---------~~  229 (279)
T cd05111         162 DDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVP---DLLEKG---------ER  229 (279)
T ss_pred             CCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH---HHHHCC---------Cc
Confidence            322222334457778999999998899999999999999999998 99999775432111   001111         01


Q ss_pred             CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          300 GAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       300 ~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                      ...+..+...+.+++.+||..||++||++.++++.|...
T Consensus       230 ~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~  268 (279)
T cd05111         230 LAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRM  268 (279)
T ss_pred             CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence            111112345678899999999999999999999987653

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=4.8e-43  Score=318.79  Aligned_cols=259  Identities=25%  Similarity=0.392  Sum_probs=206.4

Q ss_pred             HhcCCCCCCeecccCCcEEEEEEEC-CCc----EEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCce
Q 016594           64 ATNAFSSENLVGRGGYAEVYKGVLQ-DGE----EIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNGL  138 (386)
Q Consensus        64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  138 (386)
                      ...+|++.+.||.|+||+||+|.+. ++.    .||+|++... ........+.+|+.++..+.||||+++++++.....
T Consensus         5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~   83 (279)
T cd05109           5 KETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLREN-TSPKANKEILDEAYVMAGVGSPYVCRLLGICLTSTV   83 (279)
T ss_pred             chhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCC-CCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCCCc
Confidence            4567889999999999999999864 444    4899988653 234445678899999999999999999999988788


Q ss_pred             EEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccC
Q 016594          139 YLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWL  218 (386)
Q Consensus       139 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~  218 (386)
                      +++++++.+|+|.+++.... ..+++..++.++.|++.||.|||+   ++++||||||+|||++.++.+||+|||++..+
T Consensus        84 ~l~~~~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~lH~---~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~  159 (279)
T cd05109          84 QLVTQLMPYGCLLDYVRENK-DRIGSQDLLNWCVQIAKGMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLL  159 (279)
T ss_pred             EEEEEcCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEEEcCCCcEEECCCCceeec
Confidence            99999999999999886533 348999999999999999999999   99999999999999999999999999999877


Q ss_pred             CCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCchhhhhhhhhhhcccccccccCCc
Q 016594          219 PSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGEIEKLVDPR  297 (386)
Q Consensus       219 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (386)
                      .............++..|+|||.+.+..++.++|||||||++|||++ |..||.........            ..+...
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~------------~~~~~~  227 (279)
T cd05109         160 DIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIP------------DLLEKG  227 (279)
T ss_pred             ccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHH------------HHHHCC
Confidence            54322222222335678999999999999999999999999999998 99999764332110            000011


Q ss_pred             cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCC
Q 016594          298 LQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEGD  339 (386)
Q Consensus       298 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~~  339 (386)
                      .....+...+..+.+++.+||..||+.||++.++++.|....
T Consensus       228 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~  269 (279)
T cd05109         228 ERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMA  269 (279)
T ss_pred             CcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence            111112234567899999999999999999999999886653

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=5.5e-43  Score=332.23  Aligned_cols=261  Identities=19%  Similarity=0.239  Sum_probs=198.2

Q ss_pred             HHhcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEE
Q 016594           63 IATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYL  140 (386)
Q Consensus        63 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~l  140 (386)
                      +..++|.+.+.||+|+||.||+|... +++.||+|....        ..+.+|+.++++++||||+++++++..+. .++
T Consensus        89 ~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~--------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~l  160 (391)
T PHA03212         89 IEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR--------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCL  160 (391)
T ss_pred             cccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh--------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEE
Confidence            34578999999999999999999976 688999996532        34678999999999999999999997765 788


Q ss_pred             EEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCC
Q 016594          141 IFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPS  220 (386)
Q Consensus       141 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~  220 (386)
                      +++++. ++|..++...  ..+++..++.++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||++.....
T Consensus       161 v~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~ylH~---~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~  234 (391)
T PHA03212        161 ILPRYK-TDLYCYLAAK--RNIAICDILAIERSVLRAIQYLHE---NRIIHRDIKAENIFINHPGDVCLGDFGAACFPVD  234 (391)
T ss_pred             EEecCC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHhEEEcCCCCEEEEeCCccccccc
Confidence            888885 5787777543  348899999999999999999999   9999999999999999999999999999975432


Q ss_pred             CCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchh------hhhhhhhh--hc------
Q 016594          221 QWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQS------LHSWAKPI--LN------  286 (386)
Q Consensus       221 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~------~~~~~~~~--~~------  286 (386)
                      . .........||+.|+|||++.+..++.++|||||||++|+|++|..||......      ........  ..      
T Consensus       235 ~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~  313 (391)
T PHA03212        235 I-NANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEF  313 (391)
T ss_pred             c-cccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhc
Confidence            2 112233457999999999999999999999999999999999999887542210      00000000  00      


Q ss_pred             ----ccccccc---------cCCccCCCC--CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          287 ----QGEIEKL---------VDPRLQGAY--DVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       287 ----~~~~~~~---------~~~~~~~~~--~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                          ...+...         ..+......  ....+..+.+++.+||+.||.+|||+.++|++-+..
T Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~  380 (391)
T PHA03212        314 PIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQ  380 (391)
T ss_pred             CcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhc
Confidence                0000000         000000000  012356789999999999999999999999986654

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=7.4e-43  Score=324.20  Aligned_cols=246  Identities=22%  Similarity=0.312  Sum_probs=197.7

Q ss_pred             CeecccCCcEEEEEEE----CCCcEEEEEEecccc--CChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEEEe
Q 016594           72 NLVGRGGYAEVYKGVL----QDGEEIAVKRLTKVV--TDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQF  144 (386)
Q Consensus        72 ~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~  144 (386)
                      +.||+|+||.||++..    .+++.||+|++.+..  ........+.+|+.+++.++||||+++++++..++ .+++|||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            6799999999999985    257899999987532  12233456788999999999999999999997765 8999999


Q ss_pred             ccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCcc
Q 016594          145 SSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTH  224 (386)
Q Consensus       145 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  224 (386)
                      +.+++|.+.+....  .+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||++.......  
T Consensus        82 ~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--  154 (323)
T cd05584          82 LSGGELFMHLEREG--IFMEDTACFYLSEISLALEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG--  154 (323)
T ss_pred             CCCchHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC--
Confidence            99999999886543  47888999999999999999999   999999999999999999999999999987543221  


Q ss_pred             ccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCCCCCH
Q 016594          225 HSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDV  304 (386)
Q Consensus       225 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (386)
                      .......||+.|+|||++.+..++.++|||||||++|+|++|+.||........  ..         .+....  ...+.
T Consensus       155 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~--~~---------~~~~~~--~~~~~  221 (323)
T cd05584         155 TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKT--ID---------KILKGK--LNLPP  221 (323)
T ss_pred             CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHH--HH---------HHHcCC--CCCCC
Confidence            122345699999999999998899999999999999999999999987543211  11         111111  11122


Q ss_pred             HHHHHHHHHHHHccccCCCCCC-----CHHHHHHHHhc
Q 016594          305 TQLNRLAFAASLCIRASPTWRP-----TMSEVLEVMLE  337 (386)
Q Consensus       305 ~~~~~l~~li~~cl~~dP~~Rp-----t~~~il~~l~~  337 (386)
                      ..+..+.+++.+||+.+|++||     ++.+++++.+.
T Consensus       222 ~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~  259 (323)
T cd05584         222 YLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFF  259 (323)
T ss_pred             CCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCc
Confidence            3356789999999999999999     89999987554

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=5.9e-43  Score=330.00  Aligned_cols=259  Identities=22%  Similarity=0.251  Sum_probs=199.1

Q ss_pred             cCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccC-ChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEE
Q 016594           66 NAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVT-DDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIF  142 (386)
Q Consensus        66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~  142 (386)
                      ++|++.+.||+|+||+||+|... +++.||+|++.+... .......+.+|+.++..++|+||+++++++.+.. .++||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            46889999999999999999976 688999999975322 2233456788999999999999999999998765 89999


Q ss_pred             EeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCC
Q 016594          143 QFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQW  222 (386)
Q Consensus       143 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  222 (386)
                      ||+.+|+|.+++...  ..+++..+..++.|++.||+|||+   ++|+||||||+|||++.++.+||+|||++..+....
T Consensus        81 E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~---~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~  155 (363)
T cd05628          81 EFLPGGDMMTLLMKK--DTLTEEETQFYIAETVLAIDSIHQ---LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAH  155 (363)
T ss_pred             cCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCCEEEeeccCcccccccc
Confidence            999999999998754  348999999999999999999999   999999999999999999999999999987653211


Q ss_pred             cc---------------------------------ccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCC
Q 016594          223 TH---------------------------------HSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKP  269 (386)
Q Consensus       223 ~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~p  269 (386)
                      ..                                 ......+||+.|+|||++.+..++.++|||||||++|||++|..|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~P  235 (363)
T cd05628         156 RTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP  235 (363)
T ss_pred             cccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCC
Confidence            00                                 001245799999999999999999999999999999999999999


Q ss_pred             CCCCchhhhhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHccc--cCCCCCCCHHHHHHHHhcC
Q 016594          270 VDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIR--ASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       270 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~--~dP~~Rpt~~~il~~l~~~  338 (386)
                      |.+......  ...+....       ..+........+..+.+++.+++.  .++..||++.+|+++-+..
T Consensus       236 f~~~~~~~~--~~~i~~~~-------~~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~hp~f~  297 (363)
T cd05628         236 FCSETPQET--YKKVMNWK-------ETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTNPFFE  297 (363)
T ss_pred             CCCCCHHHH--HHHHHcCc-------CcccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCCCCCC
Confidence            986543211  01111100       000001111234567777777543  2344568999999985443

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=6.8e-43  Score=325.06  Aligned_cols=258  Identities=22%  Similarity=0.306  Sum_probs=215.2

Q ss_pred             HHhcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccC-ChHhHHHHHHHHHHHhccC-CCceeeecceEEeCc-e
Q 016594           63 IATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVT-DDRKEKEFLTEIGTIGHVC-HPNVLSLLGCCVDNG-L  138 (386)
Q Consensus        63 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~-~  138 (386)
                      .....|.+.+.||.|.||.||+++.+ +|+.+|+|.+.+... .......+.+|+.+|+++. |||||.++++|++.. .
T Consensus        32 ~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~  111 (382)
T KOG0032|consen   32 DIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSV  111 (382)
T ss_pred             cccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeE
Confidence            34567999999999999999999987 599999999987433 2335578899999999999 999999999998866 8


Q ss_pred             EEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCC----CCeEEeecCc
Q 016594          139 YLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTAD----FEPQISDFGL  214 (386)
Q Consensus       139 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~----~~~kl~Dfg~  214 (386)
                      ++|||++.||.|.+.+...  . +++..+..++.|++.++.|||+   .||+||||||+|+|+...    +.+|++|||+
T Consensus       112 ~lvmEL~~GGeLfd~i~~~--~-~sE~da~~~~~~il~av~~lH~---~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGl  185 (382)
T KOG0032|consen  112 YLVMELCEGGELFDRIVKK--H-YSERDAAGIIRQILEAVKYLHS---LGVVHRDLKPENLLLASKDEGSGRIKLIDFGL  185 (382)
T ss_pred             EEEEEecCCchHHHHHHHc--c-CCHHHHHHHHHHHHHHHHHHHh---CCceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence            9999999999999988766  2 9999999999999999999999   999999999999999633    4799999999


Q ss_pred             cccCCCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhccccccccc
Q 016594          215 AKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLV  294 (386)
Q Consensus       215 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  294 (386)
                      +.....   .......+||+.|+|||++....|+..+||||+|+++|.|++|.+||.+........   ....+..    
T Consensus       186 a~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~---~i~~~~~----  255 (382)
T KOG0032|consen  186 AKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL---AILRGDF----  255 (382)
T ss_pred             ceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH---HHHcCCC----
Confidence            998765   345667889999999999999999999999999999999999999998865432211   0111111    


Q ss_pred             CCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          295 DPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       295 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                        .....+-...+..+.+++..||..||..|+|+.++|+|.|-.
T Consensus       256 --~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~  297 (382)
T KOG0032|consen  256 --DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIK  297 (382)
T ss_pred             --CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCcccc
Confidence              111122234478899999999999999999999999986643

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=7.4e-43  Score=318.24  Aligned_cols=256  Identities=23%  Similarity=0.394  Sum_probs=202.7

Q ss_pred             cCCCCCCeecccCCcEEEEEEE-----CCCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eE
Q 016594           66 NAFSSENLVGRGGYAEVYKGVL-----QDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LY  139 (386)
Q Consensus        66 ~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~  139 (386)
                      ..|++.+.||+|+||+||+|.+     .++..||+|.+... ........+.+|+.+++.++||||+++++++..+. .+
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~   83 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDI-NNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVC   83 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCC-CCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceE
Confidence            4678889999999999999985     24578999998753 23344567889999999999999999999987655 89


Q ss_pred             EEEEeccCCCHhhhhhhcC---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCC
Q 016594          140 LIFQFSSRGSVASLFHDVN---------------SPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTAD  204 (386)
Q Consensus       140 lv~e~~~~~~L~~~~~~~~---------------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~  204 (386)
                      ++|||+.+++|.+++....               ...+++..+..++.|++.||.|||+   ++++||||||+|||++.+
T Consensus        84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~nili~~~  160 (283)
T cd05090          84 MLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSS---HFFVHKDLAARNILIGEQ  160 (283)
T ss_pred             EEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---cCeehhccccceEEEcCC
Confidence            9999999999999875322               1237888899999999999999999   999999999999999999


Q ss_pred             CCeEEeecCccccCCCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCchhhhhhhhh
Q 016594          205 FEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKP  283 (386)
Q Consensus       205 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~  283 (386)
                      +.+||+|||++................++..|+|||++.+..++.++|||||||++|+|++ |..||.+......   ..
T Consensus       161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~---~~  237 (283)
T cd05090         161 LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEV---IE  237 (283)
T ss_pred             CcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH---HH
Confidence            9999999999987643322222233446778999999998889999999999999999998 9999976432110   00


Q ss_pred             hhcccccccccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 016594          284 ILNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLE  337 (386)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~  337 (386)
                      ....         ......+...+..+.+++.+||+.||++||++.+|+++|..
T Consensus       238 ~~~~---------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         238 MVRK---------RQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             HHHc---------CCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence            0111         10111222345679999999999999999999999998853

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=8.6e-43  Score=314.87  Aligned_cols=256  Identities=23%  Similarity=0.382  Sum_probs=204.7

Q ss_pred             hcCCCCCCeecccCCcEEEEEEECC----CcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eE
Q 016594           65 TNAFSSENLVGRGGYAEVYKGVLQD----GEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LY  139 (386)
Q Consensus        65 ~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~  139 (386)
                      .++|++.+.||+|+||+||+|.+..    ...||+|.+.... .......+.+|+.+++.++||||+++++++.+++ .+
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   81 (266)
T cd05033           3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS-SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVM   81 (266)
T ss_pred             hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceE
Confidence            4578999999999999999999752    3579999886532 3444567889999999999999999999987655 89


Q ss_pred             EEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCC
Q 016594          140 LIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLP  219 (386)
Q Consensus       140 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~  219 (386)
                      ++|||+.+++|.+++..... .+++..++.++.|++.||.|||+   ++|+|+||||+||+++.++.++|+|||++..+.
T Consensus        82 iv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~  157 (266)
T cd05033          82 IITEYMENGSLDKFLRENDG-KFTVGQLVGMLRGIASGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRRLE  157 (266)
T ss_pred             EEEEcCCCCCHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCCEEECccchhhccc
Confidence            99999999999999876433 58999999999999999999999   999999999999999999999999999998775


Q ss_pred             CCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCchhhhhhhhhhhcccccccccCCcc
Q 016594          220 SQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRL  298 (386)
Q Consensus       220 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (386)
                      ............++..|+|||.+.+..++.++||||||+++|+|++ |..||.......  .....          ....
T Consensus       158 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~--~~~~~----------~~~~  225 (266)
T cd05033         158 DSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD--VIKAV----------EDGY  225 (266)
T ss_pred             ccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHH--HHHHH----------HcCC
Confidence            2222112222335678999999998899999999999999999998 999996543211  00000          0000


Q ss_pred             CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 016594          299 QGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLE  337 (386)
Q Consensus       299 ~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~  337 (386)
                      ....+...+..+.+++.+||+.+|++||++.+|+++|..
T Consensus       226 ~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~  264 (266)
T cd05033         226 RLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDK  264 (266)
T ss_pred             CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence            111122345679999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.5e-43  Score=318.53  Aligned_cols=257  Identities=25%  Similarity=0.328  Sum_probs=206.5

Q ss_pred             CCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCC-hHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEEE
Q 016594           67 AFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTD-DRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQ  143 (386)
Q Consensus        67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~e  143 (386)
                      +|++.++||+|+||+||++.+. +++.||+|++...... ......+.+|+.+++.++||||+++++++.++. .+++||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            4788899999999999999975 6889999998753222 223455778999999999999999999987654 899999


Q ss_pred             eccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCc
Q 016594          144 FSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWT  223 (386)
Q Consensus       144 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~  223 (386)
                      |+.+++|.+++.......+++..+..++.|++.||.|||+   .+++||||||+||+++.++.++|+|||++....... 
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-  156 (285)
T cd05605          81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHR---ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE-  156 (285)
T ss_pred             ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC-
Confidence            9999999988866555569999999999999999999999   999999999999999999999999999998754321 


Q ss_pred             cccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCCCCC
Q 016594          224 HHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYD  303 (386)
Q Consensus       224 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (386)
                        ......|++.|+|||++.+..++.++|||||||++|+|++|..||.+........  .      +...+.. ....++
T Consensus       157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~--~------~~~~~~~-~~~~~~  225 (285)
T cd05605         157 --TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKRE--E------VERRVKE-DQEEYS  225 (285)
T ss_pred             --ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHH--H------HHHHhhh-cccccC
Confidence              1233468999999999999999999999999999999999999998653321100  0      0000110 111223


Q ss_pred             HHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHHhcC
Q 016594          304 VTQLNRLAFAASLCIRASPTWRP-----TMSEVLEVMLEG  338 (386)
Q Consensus       304 ~~~~~~l~~li~~cl~~dP~~Rp-----t~~~il~~l~~~  338 (386)
                      ...+..+.+++.+||+.||++||     ++.+++++.+..
T Consensus       226 ~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~  265 (285)
T cd05605         226 EKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFR  265 (285)
T ss_pred             cccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCcc
Confidence            34567789999999999999999     899999885544

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=3.2e-43  Score=316.69  Aligned_cols=255  Identities=24%  Similarity=0.409  Sum_probs=208.8

Q ss_pred             HhcCCCCCCeecccCCcEEEEEEECCCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEE
Q 016594           64 ATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIF  142 (386)
Q Consensus        64 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~  142 (386)
                      ...+|++.+.||.|+||.||+|.+.++..+|+|.+....  ......+..|+.+++.++|+||+++++++.+.. .+++|
T Consensus         4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   81 (261)
T cd05148           4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDD--LLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIIT   81 (261)
T ss_pred             cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccc--hhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEE
Confidence            345788999999999999999998888999999987532  333556889999999999999999999987765 89999


Q ss_pred             EeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCC
Q 016594          143 QFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQW  222 (386)
Q Consensus       143 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  222 (386)
                      ||+.+++|.+++.......+++..++.++.|++.||.|||+   ++++|+||||+||+++.++.+||+|||.+.......
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~  158 (261)
T cd05148          82 ELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEE---QNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDV  158 (261)
T ss_pred             eecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccCcceEEEcCCceEEEccccchhhcCCcc
Confidence            99999999999987666668999999999999999999999   999999999999999999999999999998764332


Q ss_pred             ccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCchhhhhhhhhhhcccccccccCCccCCC
Q 016594          223 THHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGA  301 (386)
Q Consensus       223 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (386)
                      .  ......++..|+|||.+.+..++.++||||||+++|+|++ |..||.......  .....          .......
T Consensus       159 ~--~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~--~~~~~----------~~~~~~~  224 (261)
T cd05148         159 Y--LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHE--VYDQI----------TAGYRMP  224 (261)
T ss_pred             c--cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHH--HHHHH----------HhCCcCC
Confidence            1  1123345678999999998899999999999999999998 899997654211  00000          0111112


Q ss_pred             CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 016594          302 YDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLE  337 (386)
Q Consensus       302 ~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~  337 (386)
                      .+...+..+.+++.+||+.||.+|||+.++++.|+.
T Consensus       225 ~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~  260 (261)
T cd05148         225 CPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN  260 (261)
T ss_pred             CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence            223445779999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=7.4e-43  Score=317.26  Aligned_cols=257  Identities=26%  Similarity=0.394  Sum_probs=202.0

Q ss_pred             HhcCCCCCCeecccCCcEEEEEEECC------CcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc
Q 016594           64 ATNAFSSENLVGRGGYAEVYKGVLQD------GEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG  137 (386)
Q Consensus        64 ~~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  137 (386)
                      .+++|.+.+.||+|+||.||+|.+..      +..||+|.+... ........+.+|+.+++.++|+||+++++++.+..
T Consensus         4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   82 (277)
T cd05036           4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPES-CSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERL   82 (277)
T ss_pred             CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence            45679999999999999999999753      567899987642 23344567899999999999999999999887654


Q ss_pred             -eEEEEEeccCCCHhhhhhhcCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCC---CeE
Q 016594          138 -LYLIFQFSSRGSVASLFHDVNS-----PGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADF---EPQ  208 (386)
Q Consensus       138 -~~lv~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~---~~k  208 (386)
                       .+++|||+.+++|.+++.....     ..+++..+..++.||+.||+|||+   ++++||||||+||+++.++   .+|
T Consensus        83 ~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~nil~~~~~~~~~~k  159 (277)
T cd05036          83 PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEE---NHFIHRDIAARNCLLTCKGPGRVAK  159 (277)
T ss_pred             CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchheEEEeccCCCcceE
Confidence             8999999999999998865432     248899999999999999999999   9999999999999998654   599


Q ss_pred             EeecCccccCCCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCchhhhhhhhhhhcc
Q 016594          209 ISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQ  287 (386)
Q Consensus       209 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~  287 (386)
                      |+|||++..+..............+..|+|||++.+..++.++|||||||++|+|++ |..||.+.....  ....    
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~--~~~~----  233 (277)
T cd05036         160 IADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE--VMEF----  233 (277)
T ss_pred             eccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH--HHHH----
Confidence            999999987633221111112233567999999999999999999999999999997 999997643221  1111    


Q ss_pred             cccccccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 016594          288 GEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVML  336 (386)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~  336 (386)
                            +........+...+..+.+++.+||+.+|++||++.+|+++|.
T Consensus       234 ------~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         234 ------VTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             ------HHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence                  1111111222334567999999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.9e-44  Score=354.88  Aligned_cols=259  Identities=25%  Similarity=0.458  Sum_probs=212.3

Q ss_pred             HHhcCCCCCCeecccCCcEEEEEEEC--CCc----EEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeC
Q 016594           63 IATNAFSSENLVGRGGYAEVYKGVLQ--DGE----EIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDN  136 (386)
Q Consensus        63 ~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~  136 (386)
                      +...+.++...||+|.||.||.|...  .|.    .||||.+.+ ..+.....+|++|+.+|++++|||||+++|++.+.
T Consensus       689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~-~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~  767 (1025)
T KOG1095|consen  689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKR-LSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDS  767 (1025)
T ss_pred             CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccc-cCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCC
Confidence            34567778899999999999999965  343    489999886 44567788999999999999999999999999886


Q ss_pred             c-eEEEEEeccCCCHhhhhhhc-----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEe
Q 016594          137 G-LYLIFQFSSRGSVASLFHDV-----NSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQIS  210 (386)
Q Consensus       137 ~-~~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~  210 (386)
                      + .++++|||.+|+|..++++.     ....++....+.++.+||+|+.||++   +++|||||..+|+||+.+..|||+
T Consensus       768 ~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~---~~fvHRDLAaRNCLL~~~r~VKIa  844 (1025)
T KOG1095|consen  768 GPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLES---KHFVHRDLAARNCLLDERRVVKIA  844 (1025)
T ss_pred             CCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHh---CCCcCcchhhhheeecccCcEEEc
Confidence            6 88999999999999999875     23458999999999999999999999   999999999999999999999999


Q ss_pred             ecCccccCCCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCchhhhhhhhhhhcccc
Q 016594          211 DFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGE  289 (386)
Q Consensus       211 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~  289 (386)
                      |||+|+.+-............-...|||||.+..+.++.|+|||||||++||+++ |..||.+.+..            +
T Consensus       845 DFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~------------~  912 (1025)
T KOG1095|consen  845 DFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNF------------E  912 (1025)
T ss_pred             ccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchH------------H
Confidence            9999994432211111111122357999999999999999999999999999999 99999875432            1


Q ss_pred             ccc-ccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          290 IEK-LVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       290 ~~~-~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                      +.. ..... +...+..++..+.+++.+||+.+|++||++..|++.+...
T Consensus       913 v~~~~~~gg-RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i  961 (1025)
T KOG1095|consen  913 VLLDVLEGG-RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAI  961 (1025)
T ss_pred             HHHHHHhCC-ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhh
Confidence            111 11122 4556667888999999999999999999999999966443

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=3.1e-43  Score=330.72  Aligned_cols=253  Identities=25%  Similarity=0.373  Sum_probs=196.9

Q ss_pred             cCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEEE
Q 016594           66 NAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQ  143 (386)
Q Consensus        66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~e  143 (386)
                      .+|+..+.||+|+||.||+|.+. +++.||||++.... .......+.+|+.+++.++|+||+++++++.+++ .+++||
T Consensus        74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  152 (353)
T PLN00034         74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH-EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLE  152 (353)
T ss_pred             HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC-cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEe
Confidence            45677899999999999999976 68999999986432 3344567889999999999999999999997655 899999


Q ss_pred             eccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCc
Q 016594          144 FSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWT  223 (386)
Q Consensus       144 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~  223 (386)
                      |+.+++|....      ...+..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||++..+.... 
T Consensus       153 ~~~~~~L~~~~------~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~-  222 (353)
T PLN00034        153 FMDGGSLEGTH------IADEQFLADVARQILSGIAYLHR---RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM-  222 (353)
T ss_pred             cCCCCcccccc------cCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEcccccceeccccc-
Confidence            99999886532      25677888999999999999999   999999999999999999999999999998764321 


Q ss_pred             cccccccccccCccChhhhcc-----CCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCcc
Q 016594          224 HHSIAPIEGTFGHLAPEYFMH-----GIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRL  298 (386)
Q Consensus       224 ~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (386)
                       .......||..|+|||++..     ...+.++|||||||++|||++|+.||.......  +......      + ....
T Consensus       223 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~--~~~~~~~------~-~~~~  292 (353)
T PLN00034        223 -DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD--WASLMCA------I-CMSQ  292 (353)
T ss_pred             -ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc--HHHHHHH------H-hccC
Confidence             12234568999999998743     334578999999999999999999997432211  1000000      0 0000


Q ss_pred             CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCC
Q 016594          299 QGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEGD  339 (386)
Q Consensus       299 ~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~~  339 (386)
                      ........+..+.++|.+||+.||++||++.+++++-+...
T Consensus       293 ~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~  333 (353)
T PLN00034        293 PPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILR  333 (353)
T ss_pred             CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCccccc
Confidence            11122234567999999999999999999999999865443

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-44  Score=334.04  Aligned_cols=264  Identities=28%  Similarity=0.409  Sum_probs=214.7

Q ss_pred             HHHHHHHhcCCCCCCeecccCCcEEEEEEECC--C--cE-EEEEEecc-ccCChHhHHHHHHHHHHHhccCCCceeeecc
Q 016594           58 FEEISIATNAFSSENLVGRGGYAEVYKGVLQD--G--EE-IAVKRLTK-VVTDDRKEKEFLTEIGTIGHVCHPNVLSLLG  131 (386)
Q Consensus        58 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~--~--~~-vavK~~~~-~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~  131 (386)
                      .+.|++.-++..+.++||+|+||.||+|.++.  +  .. ||||..+. .........++++|+++|++++|||||++||
T Consensus       149 r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yG  228 (474)
T KOG0194|consen  149 RQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYG  228 (474)
T ss_pred             ccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEE
Confidence            34466777788888999999999999999652  2  23 89998875 3355677889999999999999999999999


Q ss_pred             eEEeCc-eEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEe
Q 016594          132 CCVDNG-LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQIS  210 (386)
Q Consensus       132 ~~~~~~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~  210 (386)
                      ++.... +++|||++.||+|.++++.... .++..+...++.+.+.||+|||+   ++++||||-.+|+|++.++.+||+
T Consensus       229 Va~~~~Pl~ivmEl~~gGsL~~~L~k~~~-~v~~~ek~~~~~~AA~Gl~YLh~---k~~IHRDIAARNcL~~~~~~vKIS  304 (474)
T KOG0194|consen  229 VAVLEEPLMLVMELCNGGSLDDYLKKNKK-SLPTLEKLRFCYDAARGLEYLHS---KNCIHRDIAARNCLYSKKGVVKIS  304 (474)
T ss_pred             EEcCCCccEEEEEecCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHhHHHHHHH---CCCcchhHhHHHheecCCCeEEeC
Confidence            998766 8999999999999999987654 59999999999999999999999   999999999999999999999999


Q ss_pred             ecCccccCCCCCcccccc-ccccccCccChhhhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCchhhhhhhhhhhccc
Q 016594          211 DFGLAKWLPSQWTHHSIA-PIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQG  288 (386)
Q Consensus       211 Dfg~a~~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~  288 (386)
                      |||++.....-.   ... ...-...|+|||.+....|+.++|||||||++||+++ |..||.+.....           
T Consensus       305 DFGLs~~~~~~~---~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~-----------  370 (474)
T KOG0194|consen  305 DFGLSRAGSQYV---MKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYE-----------  370 (474)
T ss_pred             ccccccCCccee---eccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHH-----------
Confidence            999987653111   111 1124567999999999999999999999999999999 899998854321           


Q ss_pred             ccccccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCC
Q 016594          289 EIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEGD  339 (386)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~~  339 (386)
                      ....+.....+...+...+..+..++.+||..+|++||+|.++.+.+....
T Consensus       371 v~~kI~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~  421 (474)
T KOG0194|consen  371 VKAKIVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALE  421 (474)
T ss_pred             HHHHHHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHH
Confidence            011111222223333355678999999999999999999999999886654

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=1.3e-42  Score=311.71  Aligned_cols=251  Identities=25%  Similarity=0.375  Sum_probs=208.1

Q ss_pred             CCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEEEe
Q 016594           67 AFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQF  144 (386)
Q Consensus        67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~  144 (386)
                      +|.+.+.||+|++|.||+|.++ +++.|++|.+............+.+|+.+++.++||||+++++++.+.+ .++++||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            4778899999999999999976 6899999998765455566778899999999999999999999997755 8999999


Q ss_pred             ccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCcc
Q 016594          145 SSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTH  224 (386)
Q Consensus       145 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  224 (386)
                      +.+++|.+++.......+++..++.++.|++.||.|||+   ++++|+||||+||+++.++.++|+|||++..+..... 
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~---~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~-  156 (256)
T cd08529          81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHS---KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN-  156 (256)
T ss_pred             CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEeCCCCEEEcccccceeccCccc-
Confidence            999999999887655668999999999999999999999   9999999999999999999999999999887654321 


Q ss_pred             ccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCCCCCH
Q 016594          225 HSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDV  304 (386)
Q Consensus       225 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (386)
                       ......|++.|+|||++.+..++.++|+|||||++|+|++|+.||........  ...         +.. ......+.
T Consensus       157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~~---------~~~-~~~~~~~~  223 (256)
T cd08529         157 -FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGAL--ILK---------IIR-GVFPPVSQ  223 (256)
T ss_pred             -hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH--HHH---------HHc-CCCCCCcc
Confidence             22334688899999999999999999999999999999999999976542211  000         000 01111222


Q ss_pred             HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 016594          305 TQLNRLAFAASLCIRASPTWRPTMSEVLEV  334 (386)
Q Consensus       305 ~~~~~l~~li~~cl~~dP~~Rpt~~~il~~  334 (386)
                      ..+..+.+++.+||+.+|++||++.+++++
T Consensus       224 ~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         224 MYSQQLAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             ccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence            345679999999999999999999999975

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.9e-44  Score=328.87  Aligned_cols=260  Identities=20%  Similarity=0.369  Sum_probs=214.4

Q ss_pred             HHHHhcCCCCCCeecccCCcEEEEEEECCCcEEEEEEeccccCChHhHHHHHHHHHHHhccC-CCceeeecceEEeCc-e
Q 016594           61 ISIATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVC-HPNVLSLLGCCVDNG-L  138 (386)
Q Consensus        61 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~-~  138 (386)
                      +.+.+..|++.++||+||-+.||++...+.+.||+|.+.....+.....-+..|+..|.+|+ |.+||+|++|-..++ +
T Consensus       356 i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~l  435 (677)
T KOG0596|consen  356 IKVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYL  435 (677)
T ss_pred             EEECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceE
Confidence            45677889999999999999999999877888999988877777788888999999999997 999999999987766 7


Q ss_pred             EEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccC
Q 016594          139 YLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWL  218 (386)
Q Consensus       139 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~  218 (386)
                      |+|||+-+. +|..++.........+ .+..++.|++.|+.++|.   +||||.||||.|+|+- +|.+||+|||+|..+
T Consensus       436 YmvmE~Gd~-DL~kiL~k~~~~~~~~-~lk~ywkqML~aV~~IH~---~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI  509 (677)
T KOG0596|consen  436 YMVMECGDI-DLNKILKKKKSIDPDW-FLKFYWKQMLLAVKTIHQ---HGIVHSDLKPANFLLV-KGRLKLIDFGIANAI  509 (677)
T ss_pred             EEEeecccc-cHHHHHHhccCCCchH-HHHHHHHHHHHHHHHHHH---hceeecCCCcccEEEE-eeeEEeeeechhccc
Confidence            888887654 8999988765543333 788999999999999999   9999999999999996 468999999999999


Q ss_pred             CCCCccccccccccccCccChhhhccC-----------CCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcc
Q 016594          219 PSQWTHHSIAPIEGTFGHLAPEYFMHG-----------IVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQ  287 (386)
Q Consensus       219 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~  287 (386)
                      ....+.......+||+.||+||.+...           +.++++||||||||||+|+.|++||......          .
T Consensus       510 ~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~----------~  579 (677)
T KOG0596|consen  510 QPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQ----------I  579 (677)
T ss_pred             CccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHH----------H
Confidence            888777777889999999999998532           2568999999999999999999999763211          1


Q ss_pred             cccccccCCccCCCCCHHH-HHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 016594          288 GEIEKLVDPRLQGAYDVTQ-LNRLAFAASLCIRASPTWRPTMSEVLEVML  336 (386)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~-~~~l~~li~~cl~~dP~~Rpt~~~il~~l~  336 (386)
                      ..+..+.++.....++..- ..++.++++.||+.||++||++.++|++-.
T Consensus       580 aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpF  629 (677)
T KOG0596|consen  580 AKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHPF  629 (677)
T ss_pred             HHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCcc
Confidence            2344555554433333222 233999999999999999999999999843

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-42  Score=314.15  Aligned_cols=255  Identities=27%  Similarity=0.405  Sum_probs=202.2

Q ss_pred             CCCCCeecccCCcEEEEEEEC-C---CcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc------
Q 016594           68 FSSENLVGRGGYAEVYKGVLQ-D---GEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG------  137 (386)
Q Consensus        68 ~~~~~~lg~G~~g~V~~~~~~-~---~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------  137 (386)
                      |++.+.||+|+||.||+|.+. +   +..||+|.+............+.+|+..++.++||||+++++++....      
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            578899999999999999864 2   367999998765444555678899999999999999999999875432      


Q ss_pred             -eEEEEEeccCCCHhhhhhhc----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeec
Q 016594          138 -LYLIFQFSSRGSVASLFHDV----NSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDF  212 (386)
Q Consensus       138 -~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Df  212 (386)
                       .+++++|+.+++|..++...    ....+++..+..++.|++.||.|||+   ++++||||||+||++++++.+||+||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~df  157 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSN---RNFIHRDLAARNCMLREDMTVCVADF  157 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchheEEECCCCeEEECCc
Confidence             68999999999999887543    22358999999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCchhhhhhhhhhhcccccc
Q 016594          213 GLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGEIE  291 (386)
Q Consensus       213 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~  291 (386)
                      |++................++..|+|||.+.+..++.++|||||||++|||++ |..||.+.....  ...... ..   
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~--~~~~~~-~~---  231 (273)
T cd05035         158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE--IYDYLR-HG---  231 (273)
T ss_pred             cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHH-cC---
Confidence            99987644322111122235678999999988889999999999999999999 999997643221  111110 00   


Q ss_pred             cccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 016594          292 KLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLE  337 (386)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~  337 (386)
                            .....+...+..+.+++.+||+.||++||++.++++.|.+
T Consensus       232 ------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~  271 (273)
T cd05035         232 ------NRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLEN  271 (273)
T ss_pred             ------CCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence                  0111222345679999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=9.2e-43  Score=313.65  Aligned_cols=255  Identities=22%  Similarity=0.385  Sum_probs=206.3

Q ss_pred             HhcCCCCCCeecccCCcEEEEEEECCCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCceEEEEE
Q 016594           64 ATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNGLYLIFQ  143 (386)
Q Consensus        64 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~lv~e  143 (386)
                      ..++|.+...||+|++|.||+|.+..+..+|+|.+....   .....+.+|+.+++.+.|+|++++++++..+..+++||
T Consensus         4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e   80 (260)
T cd05069           4 PRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT---MMPEAFLQEAQIMKKLRHDKLVPLYAVVSEEPIYIVTE   80 (260)
T ss_pred             ChHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC---ccHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCcEEEEE
Confidence            446789999999999999999998776789999876432   23456788999999999999999999987777899999


Q ss_pred             eccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCc
Q 016594          144 FSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWT  223 (386)
Q Consensus       144 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~  223 (386)
                      |+.+++|.+++.......+++..+..++.|++.||.|||+   .+++|+||||+||+++.++.++|+|||++........
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~  157 (260)
T cd05069          81 FMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIER---MNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY  157 (260)
T ss_pred             cCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCeEEECCCccceEccCCcc
Confidence            9999999999876555568999999999999999999999   9999999999999999999999999999976643221


Q ss_pred             cccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCchhhhhhhhhhhcccccccccCCccCCCC
Q 016594          224 HHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAY  302 (386)
Q Consensus       224 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (386)
                       .......++..|+|||...+..++.++||||||+++|+|++ |..||.+.......  .....          ......
T Consensus       158 -~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~--~~~~~----------~~~~~~  224 (260)
T cd05069         158 -TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVL--EQVER----------GYRMPC  224 (260)
T ss_pred             -cccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH--HHHHc----------CCCCCC
Confidence             11122335678999999988889999999999999999999 99999765332110  00000          001112


Q ss_pred             CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 016594          303 DVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLE  337 (386)
Q Consensus       303 ~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~  337 (386)
                      +...+..+.+++.+||..||++||++.+|++.|++
T Consensus       225 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         225 PQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             CcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence            22345779999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5e-43  Score=332.24  Aligned_cols=258  Identities=22%  Similarity=0.259  Sum_probs=201.2

Q ss_pred             cCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEecccc-CChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEE
Q 016594           66 NAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVV-TDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIF  142 (386)
Q Consensus        66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~  142 (386)
                      ++|.+.+.||.|+||+||+|... +++.||||++.+.. ........+.+|+.+++.++||||+++++++.++. .|+||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            46889999999999999999976 68999999986532 12334566788999999999999999999998766 89999


Q ss_pred             EeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCC
Q 016594          143 QFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQW  222 (386)
Q Consensus       143 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  222 (386)
                      ||+.+|+|.+++...  ..+++..+..++.|++.||+|||+   ++|+||||||+|||++.++.+||+|||++..+....
T Consensus        81 E~~~gg~L~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH~---~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~  155 (377)
T cd05629          81 EFLPGGDLMTMLIKY--DTFSEDVTRFYMAECVLAIEAVHK---LGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQH  155 (377)
T ss_pred             eCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEEeeccccccccccc
Confidence            999999999988754  348899999999999999999999   999999999999999999999999999986432110


Q ss_pred             cc---------------------------------------------ccccccccccCccChhhhccCCCCcccchHHHH
Q 016594          223 TH---------------------------------------------HSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFG  257 (386)
Q Consensus       223 ~~---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG  257 (386)
                      ..                                             ......+||+.|+|||++.+..++.++||||||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG  235 (377)
T cd05629         156 DSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLG  235 (377)
T ss_pred             ccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecc
Confidence            00                                             000124699999999999999999999999999


Q ss_pred             HHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHccccCCCCC---CCHHHHHHH
Q 016594          258 VFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWR---PTMSEVLEV  334 (386)
Q Consensus       258 ~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R---pt~~~il~~  334 (386)
                      |++|||++|..||.+......  ...+....       ..+........+..+.+++.+||. +|.+|   +++.+++++
T Consensus       236 vil~elltG~~Pf~~~~~~~~--~~~i~~~~-------~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~h  305 (377)
T cd05629         236 AIMFECLIGWPPFCSENSHET--YRKIINWR-------ETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSH  305 (377)
T ss_pred             hhhhhhhcCCCCCCCCCHHHH--HHHHHccC-------CccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcC
Confidence            999999999999976543211  11111100       000101111234678999999997 67765   599999998


Q ss_pred             HhcC
Q 016594          335 MLEG  338 (386)
Q Consensus       335 l~~~  338 (386)
                      .+..
T Consensus       306 p~~~  309 (377)
T cd05629         306 PFFR  309 (377)
T ss_pred             CCcC
Confidence            6554

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=1.4e-42  Score=314.49  Aligned_cols=255  Identities=24%  Similarity=0.372  Sum_probs=200.4

Q ss_pred             CCCCCeecccCCcEEEEEEECC-Cc--EEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeC-------c
Q 016594           68 FSSENLVGRGGYAEVYKGVLQD-GE--EIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDN-------G  137 (386)
Q Consensus        68 ~~~~~~lg~G~~g~V~~~~~~~-~~--~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-------~  137 (386)
                      |.+++.||+|+||.||+|.+.. +.  .||+|.+............+.+|+.+++.++|+||+++++++...       .
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            4577899999999999999763 33  689998876544555667889999999999999999999987431       2


Q ss_pred             eEEEEEeccCCCHhhhhhhc----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecC
Q 016594          138 LYLIFQFSSRGSVASLFHDV----NSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFG  213 (386)
Q Consensus       138 ~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg  213 (386)
                      .+++++|+.+|+|.+++...    ....+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg  157 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSS---KSFIHRDLAARNCMLNENMNVCVADFG  157 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhheEEcCCCCEEECCCC
Confidence            68999999999998876422    22348899999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCchhhhhhhhhhhccccccc
Q 016594          214 LAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGEIEK  292 (386)
Q Consensus       214 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~  292 (386)
                      ++..+.............+++.|+|||.+.+..++.++|||||||++|+|++ |..||.+.....  .... ...+..  
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--~~~~-~~~~~~--  232 (272)
T cd05075         158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE--IYDY-LRQGNR--  232 (272)
T ss_pred             cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHH--HHHH-HHcCCC--
Confidence            9987644322111222345678999999999999999999999999999999 899997643321  1111 111110  


Q ss_pred             ccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 016594          293 LVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLE  337 (386)
Q Consensus       293 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~  337 (386)
                             ...+...+..+.+++.+||+.+|++|||+.+|++.|..
T Consensus       233 -------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~  270 (272)
T cd05075         233 -------LKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEK  270 (272)
T ss_pred             -------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence                   01122345678999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=1.7e-43  Score=334.19  Aligned_cols=260  Identities=19%  Similarity=0.263  Sum_probs=205.4

Q ss_pred             HHhcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEecccc-CChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eE
Q 016594           63 IATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVV-TDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LY  139 (386)
Q Consensus        63 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~  139 (386)
                      ...++|++.+.||+|+||.||+|... +++.||+|++.+.. ........+.+|+.+++.++||||+++++++.++. .+
T Consensus        40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~  119 (370)
T cd05596          40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLY  119 (370)
T ss_pred             CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence            34568999999999999999999976 68899999987532 22233455778999999999999999999988766 89


Q ss_pred             EEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCC
Q 016594          140 LIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLP  219 (386)
Q Consensus       140 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~  219 (386)
                      +||||+.+|+|.+++...   .+++..+..++.|++.||+|||+   ++|+||||||+|||++.++.+||+|||++....
T Consensus       120 lv~Ey~~gg~L~~~l~~~---~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~  193 (370)
T cd05596         120 MVMEYMPGGDLVNLMSNY---DIPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMD  193 (370)
T ss_pred             EEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence            999999999999988643   37889999999999999999999   999999999999999999999999999998664


Q ss_pred             CCCccccccccccccCccChhhhccC----CCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccC
Q 016594          220 SQWTHHSIAPIEGTFGHLAPEYFMHG----IVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVD  295 (386)
Q Consensus       220 ~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  295 (386)
                      .... .......||+.|+|||++.+.    .++.++|||||||++|+|++|..||.+..... . ...+....       
T Consensus       194 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~-~-~~~i~~~~-------  263 (370)
T cd05596         194 ANGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG-T-YSKIMDHK-------  263 (370)
T ss_pred             CCCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHH-H-HHHHHcCC-------
Confidence            3211 122345699999999998753    47899999999999999999999998754321 0 01111000       


Q ss_pred             CccCCCCCHHHHHHHHHHHHHccccCCCC--CCCHHHHHHHHhcC
Q 016594          296 PRLQGAYDVTQLNRLAFAASLCIRASPTW--RPTMSEVLEVMLEG  338 (386)
Q Consensus       296 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~--Rpt~~~il~~l~~~  338 (386)
                      ...........+..+.+++.+||+.+|.+  ||++.+++++.+..
T Consensus       264 ~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~  308 (370)
T cd05596         264 NSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFK  308 (370)
T ss_pred             CcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccC
Confidence            00111111234577999999999999988  99999999986543

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=9e-43  Score=318.39  Aligned_cols=262  Identities=21%  Similarity=0.344  Sum_probs=197.8

Q ss_pred             CCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhcc---CCCceeeecceEEeC------
Q 016594           67 AFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHV---CHPNVLSLLGCCVDN------  136 (386)
Q Consensus        67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~------  136 (386)
                      +|++.+.||+|+||+||+|..+ +++.||+|.+............+.+|+.+++.+   +||||+++++++...      
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            4888999999999999999976 688999999875433333333455677666655   699999999988642      


Q ss_pred             ceEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccc
Q 016594          137 GLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAK  216 (386)
Q Consensus       137 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~  216 (386)
                      ..++++|++.+ +|.+++.......+++..+..++.|++.||.|||+   ++++||||||+|||++.++.+||+|||++.
T Consensus        81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~kl~dfg~~~  156 (288)
T cd07863          81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGQVKLADFGLAR  156 (288)
T ss_pred             eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccCccc
Confidence            27899999985 88888877666669999999999999999999999   999999999999999999999999999998


Q ss_pred             cCCCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhh-hhhhhhc---ccccc-
Q 016594          217 WLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHS-WAKPILN---QGEIE-  291 (386)
Q Consensus       217 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~-~~~~~~~---~~~~~-  291 (386)
                      ......   ......|+..|+|||++.+..++.++|||||||++|+|++|.+||.+....... .......   ..... 
T Consensus       157 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (288)
T cd07863         157 IYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPR  233 (288)
T ss_pred             cccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcc
Confidence            664321   223446889999999999999999999999999999999999999765432110 0000000   00000 


Q ss_pred             ------cccCCccCC---CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 016594          292 ------KLVDPRLQG---AYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVM  335 (386)
Q Consensus       292 ------~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l  335 (386)
                            ....+....   ......+..+.+++.+||+.||++|||+.+++.+-
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp  286 (288)
T cd07863         234 DVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHP  286 (288)
T ss_pred             cccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCC
Confidence                  000000000   01112356789999999999999999999999763

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=9.5e-43  Score=316.56  Aligned_cols=250  Identities=24%  Similarity=0.299  Sum_probs=196.3

Q ss_pred             ecccCCcEEEEEEEC-CCcEEEEEEeccccCC-hHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEEEeccCCCH
Q 016594           74 VGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTD-DRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQFSSRGSV  150 (386)
Q Consensus        74 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~~~~~~L  150 (386)
                      ||+|+||.||++..+ +|+.||+|.+...... ......+..|++++++++||||+++++++.++. .+++|||+.+++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            799999999999976 6899999998753222 223345667999999999999999999987655 8999999999999


Q ss_pred             hhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCcccccccc
Q 016594          151 ASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPI  230 (386)
Q Consensus       151 ~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~  230 (386)
                      .+++.......+++..+..++.|++.||.|||+   .+++||||||+||+++.++.++|+|||++.......   .....
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---~~~~~  154 (277)
T cd05607          81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHS---MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TITQR  154 (277)
T ss_pred             HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHH---CCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---eeecc
Confidence            988876666668999999999999999999999   999999999999999999999999999988764332   12234


Q ss_pred             ccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCCCCCHHHHHHH
Q 016594          231 EGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQLNRL  310 (386)
Q Consensus       231 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  310 (386)
                      .|+..|+|||++.+..++.++|||||||++|+|++|..||...........   ..    .......... .....+..+
T Consensus       155 ~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~---~~----~~~~~~~~~~-~~~~~~~~~  226 (277)
T cd05607         155 AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEE---LK----RRTLEDEVKF-EHQNFTEES  226 (277)
T ss_pred             CCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHH---HH----HHhhcccccc-ccccCCHHH
Confidence            589999999999998899999999999999999999999976432111000   00    0011111110 011245678


Q ss_pred             HHHHHHccccCCCCCCCHHHHHHHHhc
Q 016594          311 AFAASLCIRASPTWRPTMSEVLEVMLE  337 (386)
Q Consensus       311 ~~li~~cl~~dP~~Rpt~~~il~~l~~  337 (386)
                      .+++..||+.||++||++.++++.+..
T Consensus       227 ~~li~~~L~~~P~~R~~~~~~~~~~~~  253 (277)
T cd05607         227 KDICRLFLAKKPEDRLGSREKNDDPRK  253 (277)
T ss_pred             HHHHHHHhccCHhhCCCCccchhhhhc
Confidence            999999999999999999666654443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=1.2e-42  Score=311.31  Aligned_cols=248  Identities=24%  Similarity=0.410  Sum_probs=196.4

Q ss_pred             CeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEEEeccCCC
Q 016594           72 NLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQFSSRGS  149 (386)
Q Consensus        72 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~~~~~~  149 (386)
                      +.||+|+||.||+|.+. +++.||+|.+... ........+.+|+++++.+.||||+++++++.... .++||||+.+++
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   79 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGD   79 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCcc-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCc
Confidence            46899999999999975 6889999987643 23445567899999999999999999999997655 899999999999


Q ss_pred             HhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCccccccc
Q 016594          150 VASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAP  229 (386)
Q Consensus       150 L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  229 (386)
                      |.+++... ...+++..++.++.|++.||.|||+   ++++||||||+||+++.++.+||+|||++..............
T Consensus        80 L~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  155 (252)
T cd05084          80 FLTFLRTE-GPRLKVKELIQMVENAAAGMEYLES---KHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM  155 (252)
T ss_pred             HHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEEcCCCcEEECccccCcccccccccccCCC
Confidence            99988653 3358899999999999999999999   9999999999999999999999999999876543211111111


Q ss_pred             cccccCccChhhhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCchhhhhhhhhhhcccccccccCCccCCCCCHHHHH
Q 016594          230 IEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQLN  308 (386)
Q Consensus       230 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (386)
                      ...+..|+|||.+.+..++.++|||||||++|+|++ |..||.........            ..+........+...+.
T Consensus       156 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~------------~~~~~~~~~~~~~~~~~  223 (252)
T cd05084         156 KQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTR------------EAIEQGVRLPCPELCPD  223 (252)
T ss_pred             CCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHH------------HHHHcCCCCCCcccCCH
Confidence            123456999999998889999999999999999998 99998654321100            00001111122233456


Q ss_pred             HHHHHHHHccccCCCCCCCHHHHHHHHh
Q 016594          309 RLAFAASLCIRASPTWRPTMSEVLEVML  336 (386)
Q Consensus       309 ~l~~li~~cl~~dP~~Rpt~~~il~~l~  336 (386)
                      .+.+++.+||+.+|++||++.++++.|.
T Consensus       224 ~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         224 AVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence            7999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=7.2e-43  Score=313.58  Aligned_cols=250  Identities=21%  Similarity=0.382  Sum_probs=200.1

Q ss_pred             cCCCCCCeecccCCcEEEEEEECCCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEEEe
Q 016594           66 NAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQF  144 (386)
Q Consensus        66 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~  144 (386)
                      +.|++.+.||+|+||.||+|.++++..+|+|.+....   .....+.+|+.+++.++||||+++++++.+.. .+++|||
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~   80 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA---MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEF   80 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC---ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEc
Confidence            4688889999999999999998877889999876432   23457889999999999999999999987655 8999999


Q ss_pred             ccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCcc
Q 016594          145 SSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTH  224 (386)
Q Consensus       145 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  224 (386)
                      +.+|+|.+++.... ..+++..+..++.|++.||.|||+   ++++|+||||+||+++.++.+||+|||.+.........
T Consensus        81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~  156 (256)
T cd05114          81 MENGCLLNYLRQRQ-GKLSKDMLLSMCQDVCEGMEYLER---NSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT  156 (256)
T ss_pred             CCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcceEEEcCCCeEEECCCCCccccCCCcee
Confidence            99999999886543 248899999999999999999999   99999999999999999999999999998765432211


Q ss_pred             ccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCchhhhhhhhhhhcccccccccCCccCCCCC
Q 016594          225 HSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYD  303 (386)
Q Consensus       225 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (386)
                       ......++..|+|||++.+..++.++||||||+++|+|++ |+.||.......  ....... +.         ....+
T Consensus       157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~--~~~~i~~-~~---------~~~~~  223 (256)
T cd05114         157 -SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYE--VVEMISR-GF---------RLYRP  223 (256)
T ss_pred             -ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHH--HHHHHHC-CC---------CCCCC
Confidence             1122235567999999998889999999999999999999 999997643211  1111100 00         00111


Q ss_pred             HHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 016594          304 VTQLNRLAFAASLCIRASPTWRPTMSEVLEVM  335 (386)
Q Consensus       304 ~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l  335 (386)
                      ...+..+.+++.+||+.+|++||++.++++.|
T Consensus       224 ~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l  255 (256)
T cd05114         224 KLASMTVYEVMYSCWHEKPEGRPTFAELLRAI  255 (256)
T ss_pred             CCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence            12346789999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=5.5e-43  Score=326.44  Aligned_cols=255  Identities=22%  Similarity=0.253  Sum_probs=200.5

Q ss_pred             CCCCCCeecccCCcEEEEEEEC----CCcEEEEEEeccccC--ChHhHHHHHHHHHHHhccC-CCceeeecceEEeCc-e
Q 016594           67 AFSSENLVGRGGYAEVYKGVLQ----DGEEIAVKRLTKVVT--DDRKEKEFLTEIGTIGHVC-HPNVLSLLGCCVDNG-L  138 (386)
Q Consensus        67 ~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~-~  138 (386)
                      +|++.+.||+|+||.||+|+..    +++.||+|++.+...  .......+..|+.+++.+. |+||+++++++..++ .
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            4788999999999999999852    578999999875321  2233456788999999995 999999999987655 8


Q ss_pred             EEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccC
Q 016594          139 YLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWL  218 (386)
Q Consensus       139 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~  218 (386)
                      +++|||+.+|+|.+++....  .+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||++..+
T Consensus        81 ~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~  155 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQRD--NFSEDEVRFYSGEIILALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEF  155 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHeEECCCCCEEEeeCcCCccc
Confidence            99999999999999886543  48999999999999999999999   99999999999999999999999999999865


Q ss_pred             CCCCccccccccccccCccChhhhccC-CCCcccchHHHHHHHHHHHhCCCCCCCCchhh--hhhhhhhhcccccccccC
Q 016594          219 PSQWTHHSIAPIEGTFGHLAPEYFMHG-IVDEKTDVFAFGVFLLEIISGRKPVDGSHQSL--HSWAKPILNQGEIEKLVD  295 (386)
Q Consensus       219 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~  295 (386)
                      ..... .......||+.|+|||++.+. .++.++|||||||++|+|++|..||.......  ......         +..
T Consensus       156 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~---------~~~  225 (332)
T cd05614         156 LSEEK-ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRR---------ILK  225 (332)
T ss_pred             cccCC-CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHH---------Hhc
Confidence            33221 122345699999999999865 47899999999999999999999997532211  011000         000


Q ss_pred             CccCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHHhcC
Q 016594          296 PRLQGAYDVTQLNRLAFAASLCIRASPTWRP-----TMSEVLEVMLEG  338 (386)
Q Consensus       296 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----t~~~il~~l~~~  338 (386)
                        .....+...+..+.+++.+||+.||++||     ++.+++++.+..
T Consensus       226 --~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~  271 (332)
T cd05614         226 --CDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFK  271 (332)
T ss_pred             --CCCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcC
Confidence              01112223456789999999999999999     788999886543

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=4e-43  Score=333.49  Aligned_cols=256  Identities=20%  Similarity=0.207  Sum_probs=199.3

Q ss_pred             CCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccC-ChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEEE
Q 016594           67 AFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVT-DDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQ  143 (386)
Q Consensus        67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~e  143 (386)
                      .|.+.+.||+|+||+||+|... +++.||+|++.+... .......+.+|+.++++++||||+++++++.++. .++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            5888999999999999999976 688999999875321 2334557889999999999999999999998765 899999


Q ss_pred             eccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCc
Q 016594          144 FSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWT  223 (386)
Q Consensus       144 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~  223 (386)
                      |+.+|+|.+++....  .+++..+..++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||++..+.....
T Consensus        82 ~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~al~~lH~---~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~  156 (382)
T cd05625          82 YIPGGDMMSLLIRMG--IFPEDLARFYIAELTCAVESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD  156 (382)
T ss_pred             CCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEEeECCCCcccccccc
Confidence            999999999886543  48899999999999999999999   9999999999999999999999999999754321000


Q ss_pred             ---------------------------------------------cccccccccccCccChhhhccCCCCcccchHHHHH
Q 016594          224 ---------------------------------------------HHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGV  258 (386)
Q Consensus       224 ---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~  258 (386)
                                                                   .......+||+.|+|||++.+..++.++|||||||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGv  236 (382)
T cd05625         157 SKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV  236 (382)
T ss_pred             ccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechH
Confidence                                                         00012356999999999999999999999999999


Q ss_pred             HHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCC---HHHHHHHH
Q 016594          259 FLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPT---MSEVLEVM  335 (386)
Q Consensus       259 il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt---~~~il~~l  335 (386)
                      ++|||++|..||.+.......  ......       ............+..+.+++.+|+ .+|.+|++   +.++++|-
T Consensus       237 il~elltG~~Pf~~~~~~~~~--~~i~~~-------~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp  306 (382)
T cd05625         237 ILYEMLVGQPPFLAQTPLETQ--MKVINW-------QTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHP  306 (382)
T ss_pred             HHHHHHhCCCCCCCCCHHHHH--HHHHcc-------CCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCC
Confidence            999999999999875432111  000000       011111111223466788888766 59999997   99999875


Q ss_pred             hc
Q 016594          336 LE  337 (386)
Q Consensus       336 ~~  337 (386)
                      +.
T Consensus       307 ~f  308 (382)
T cd05625         307 FF  308 (382)
T ss_pred             Cc
Confidence            43

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=1.1e-42  Score=327.83  Aligned_cols=263  Identities=23%  Similarity=0.327  Sum_probs=202.4

Q ss_pred             HhcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeC------
Q 016594           64 ATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDN------  136 (386)
Q Consensus        64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------  136 (386)
                      ..++|++.+.||+|+||.||+|... +|..||+|++............+.+|+.+++.++||||+++++++...      
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   98 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF   98 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence            4578999999999999999999976 689999999976555555667788999999999999999999998543      


Q ss_pred             -ceEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCcc
Q 016594          137 -GLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLA  215 (386)
Q Consensus       137 -~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a  215 (386)
                       ..+++|||+.+ +|...+..    .+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||++
T Consensus        99 ~~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~---~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a  170 (359)
T cd07876          99 QDVYLVMELMDA-NLCQVIHM----ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLA  170 (359)
T ss_pred             ceeEEEEeCCCc-CHHHHHhc----cCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEecCCCc
Confidence             26899999976 45555432    37888999999999999999999   99999999999999999999999999999


Q ss_pred             ccCCCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhh-----------
Q 016594          216 KWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPI-----------  284 (386)
Q Consensus       216 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~-----------  284 (386)
                      ......   .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+... .+....           
T Consensus       171 ~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~-~~~~~~~~~~~~~~~~~  246 (359)
T cd07876         171 RTACTN---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHID-QWNKVIEQLGTPSAEFM  246 (359)
T ss_pred             cccccC---ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCCcHHHH
Confidence            754322   12234568999999999999999999999999999999999999998654311 110000           


Q ss_pred             ----------hcc-cc-----cccccCCcc---CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          285 ----------LNQ-GE-----IEKLVDPRL---QGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       285 ----------~~~-~~-----~~~~~~~~~---~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                                ... ..     ..+......   ...........+.+++.+||..||++|||+.+++++.+..
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~  319 (359)
T cd07876         247 NRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYIT  319 (359)
T ss_pred             HHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhh
Confidence                      000 00     000000000   0000111245689999999999999999999999986543

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=2.9e-43  Score=332.25  Aligned_cols=259  Identities=20%  Similarity=0.281  Sum_probs=204.6

Q ss_pred             HHHhcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEecccc-CChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-e
Q 016594           62 SIATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVV-TDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-L  138 (386)
Q Consensus        62 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~  138 (386)
                      ....++|++.+.||+|+||.||+|.+. +++.||+|++.+.. ........+.+|+.+++.++||||+++++++.++. .
T Consensus        39 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~  118 (370)
T cd05621          39 QMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYL  118 (370)
T ss_pred             CCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEE
Confidence            345578999999999999999999986 68899999987522 22233456788999999999999999999998766 8


Q ss_pred             EEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccC
Q 016594          139 YLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWL  218 (386)
Q Consensus       139 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~  218 (386)
                      ++||||+.+|+|.+++...   .+++..+..++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||++..+
T Consensus       119 ~lv~Ey~~gg~L~~~l~~~---~~~~~~~~~~~~qil~aL~~LH~---~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~  192 (370)
T cd05621         119 YMVMEYMPGGDLVNLMSNY---DVPEKWAKFYTAEVVLALDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKM  192 (370)
T ss_pred             EEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEEecccceec
Confidence            9999999999999988643   38899999999999999999999   99999999999999999999999999999876


Q ss_pred             CCCCccccccccccccCccChhhhccC----CCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhccccccccc
Q 016594          219 PSQWTHHSIAPIEGTFGHLAPEYFMHG----IVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLV  294 (386)
Q Consensus       219 ~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  294 (386)
                      .... ........||+.|+|||++.+.    .++.++|||||||++|+|++|..||.+.....  ...         .+.
T Consensus       193 ~~~~-~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~--~~~---------~i~  260 (370)
T cd05621         193 DETG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVG--TYS---------KIM  260 (370)
T ss_pred             ccCC-ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHH--HHH---------HHH
Confidence            4321 1122356799999999999764    37899999999999999999999998654311  111         111


Q ss_pred             CCc--cCCCCCHHHHHHHHHHHHHccccCCCC--CCCHHHHHHHHhcC
Q 016594          295 DPR--LQGAYDVTQLNRLAFAASLCIRASPTW--RPTMSEVLEVMLEG  338 (386)
Q Consensus       295 ~~~--~~~~~~~~~~~~l~~li~~cl~~dP~~--Rpt~~~il~~l~~~  338 (386)
                      ...  .........+..+.+++..||..++.+  |+++.++++|.+..
T Consensus       261 ~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~  308 (370)
T cd05621         261 DHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFK  308 (370)
T ss_pred             hCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccC
Confidence            111  111111234567889999999865544  89999999986554

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=5.4e-43  Score=325.31  Aligned_cols=249  Identities=23%  Similarity=0.326  Sum_probs=197.1

Q ss_pred             CCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccC-ChHhHHHHHHHHHHH---hccCCCceeeecceEEeCc-eEEE
Q 016594           68 FSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVT-DDRKEKEFLTEIGTI---GHVCHPNVLSLLGCCVDNG-LYLI  141 (386)
Q Consensus        68 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l---~~l~h~niv~l~~~~~~~~-~~lv  141 (386)
                      |++.+.||+|+||.||+|.++ +++.||||++.+... .......+.+|+.++   +.+.||||+++++++.+.+ .|+|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            677899999999999999976 689999999975321 222334566665554   5677999999999998765 8999


Q ss_pred             EEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCC
Q 016594          142 FQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQ  221 (386)
Q Consensus       142 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  221 (386)
                      |||+.+++|...+..   ..+++..+..++.|++.||.|||+   ++++||||||+||+++.++.+||+|||++......
T Consensus        81 ~E~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~  154 (324)
T cd05589          81 MEYAAGGDLMMHIHT---DVFSEPRAVFYAACVVLGLQYLHE---NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF  154 (324)
T ss_pred             EcCCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCcEEeCcccCCccCCCC
Confidence            999999999887753   348999999999999999999999   99999999999999999999999999998753221


Q ss_pred             CccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCCC
Q 016594          222 WTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGA  301 (386)
Q Consensus       222 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (386)
                        ........|++.|+|||++.+..++.++|||||||++|+|++|+.||.+......  ...+         ....  ..
T Consensus       155 --~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~--~~~i---------~~~~--~~  219 (324)
T cd05589         155 --GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEV--FDSI---------VNDE--VR  219 (324)
T ss_pred             --CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHH--HHHH---------HhCC--CC
Confidence              1223356799999999999999999999999999999999999999987543211  0111         1100  01


Q ss_pred             CCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHHhc
Q 016594          302 YDVTQLNRLAFAASLCIRASPTWRP-----TMSEVLEVMLE  337 (386)
Q Consensus       302 ~~~~~~~~l~~li~~cl~~dP~~Rp-----t~~~il~~l~~  337 (386)
                      ++...+..+.+++.+||+.||.+||     ++.+++++.+.
T Consensus       220 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f  260 (324)
T cd05589         220 YPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFF  260 (324)
T ss_pred             CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCc
Confidence            2223456789999999999999999     68888887544

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=1.2e-42  Score=316.33  Aligned_cols=260  Identities=21%  Similarity=0.368  Sum_probs=208.3

Q ss_pred             HHhcCCCCCCeecccCCcEEEEEEECC-----CcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEe--
Q 016594           63 IATNAFSSENLVGRGGYAEVYKGVLQD-----GEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVD--  135 (386)
Q Consensus        63 ~~~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--  135 (386)
                      +..++|++.+.||+|+||.||+|.+..     +..|++|.+.. .........+.+|+.+++.+.|+||+++++++..  
T Consensus         3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~-~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~   81 (280)
T cd05043           3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKD-HASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDG   81 (280)
T ss_pred             cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccC-CCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence            456789999999999999999999764     67899998864 2344556778899999999999999999998876  


Q ss_pred             CceEEEEEeccCCCHhhhhhhcCC------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEE
Q 016594          136 NGLYLIFQFSSRGSVASLFHDVNS------PGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQI  209 (386)
Q Consensus       136 ~~~~lv~e~~~~~~L~~~~~~~~~------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl  209 (386)
                      ...+++++|+.+++|.+++.....      ..+++..++.++.|++.||+|||+   ++++|+||||+||+++.++.+||
T Consensus        82 ~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kl  158 (280)
T cd05043          82 EPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK---RGVIHKDIAARNCVIDEELQVKI  158 (280)
T ss_pred             CCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCHhhEEEcCCCcEEE
Confidence            348899999999999998865432      458999999999999999999999   99999999999999999999999


Q ss_pred             eecCccccCCCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCchhhhhhhhhhhccc
Q 016594          210 SDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQG  288 (386)
Q Consensus       210 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~  288 (386)
                      +|||+++.+.............++..|+|||++.+..++.++|||||||++|++++ |..||.......  +......  
T Consensus       159 ~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~~~~~--  234 (280)
T cd05043         159 TDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE--MAAYLKD--  234 (280)
T ss_pred             CCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH--HHHHHHc--
Confidence            99999986643322222223346778999999998899999999999999999999 999997643211  1111100  


Q ss_pred             ccccccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          289 EIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                              .........++..+.+++.+||..+|++|||+.++++.|...
T Consensus       235 --------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~  276 (280)
T cd05043         235 --------GYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDF  276 (280)
T ss_pred             --------CCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence                    011111122356789999999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=1.2e-42  Score=312.26  Aligned_cols=250  Identities=22%  Similarity=0.374  Sum_probs=200.5

Q ss_pred             cCCCCCCeecccCCcEEEEEEECCCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEEEe
Q 016594           66 NAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQF  144 (386)
Q Consensus        66 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~  144 (386)
                      ++|.+.+.||+|+||+||+|.+.++..+|+|.+....   .....+.+|+.++++++||||+++++++.+.. .+++|||
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS---MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEY   80 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc---ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEc
Confidence            4678889999999999999998777779999886432   23456889999999999999999999987655 8999999


Q ss_pred             ccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCcc
Q 016594          145 SSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTH  224 (386)
Q Consensus       145 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  224 (386)
                      +.+++|.+++..... .+++..++.++.|++.||.|||+   ++++|+||||+||+++.++.+||+|||++........ 
T Consensus        81 ~~~~~l~~~i~~~~~-~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~-  155 (256)
T cd05113          81 MSNGCLLNYLREHGK-RFQPSQLLEMCKDVCEGMAYLES---KQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY-  155 (256)
T ss_pred             CCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCCEEECCCccceecCCCce-
Confidence            999999998876433 58999999999999999999999   9999999999999999999999999999876543321 


Q ss_pred             ccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCchhhhhhhhhhhcccccccccCCccCCCCC
Q 016594          225 HSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYD  303 (386)
Q Consensus       225 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (386)
                      .......++..|+|||++.+..++.++|||||||++|+|++ |..||........  ..... ..         .....+
T Consensus       156 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~--~~~~~-~~---------~~~~~~  223 (256)
T cd05113         156 TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSET--VEKVS-QG---------LRLYRP  223 (256)
T ss_pred             eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHH--HHHHh-cC---------CCCCCC
Confidence            11112235677999999998889999999999999999998 9999976432210  00000 00         001111


Q ss_pred             HHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 016594          304 VTQLNRLAFAASLCIRASPTWRPTMSEVLEVM  335 (386)
Q Consensus       304 ~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l  335 (386)
                      ...+..+.+++.+||+.+|.+||++.+|++.|
T Consensus       224 ~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~  255 (256)
T cd05113         224 HLASEKVYAIMYSCWHEKAEERPTFQQLLSSI  255 (256)
T ss_pred             CCCCHHHHHHHHHHcCCCcccCCCHHHHHHhh
Confidence            12356799999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=9.3e-43  Score=319.15  Aligned_cols=261  Identities=24%  Similarity=0.411  Sum_probs=207.0

Q ss_pred             HHHhcCCCCCCeecccCCcEEEEEEEC------CCcEEEEEEeccccCChHhHHHHHHHHHHHhcc-CCCceeeecceEE
Q 016594           62 SIATNAFSSENLVGRGGYAEVYKGVLQ------DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHV-CHPNVLSLLGCCV  134 (386)
Q Consensus        62 ~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~  134 (386)
                      .+..++|++.+.||+|+||.||+|.+.      ....+|+|.+.... .......+.+|+.++.++ +|+||+++++++.
T Consensus         8 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~   86 (293)
T cd05053           8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT   86 (293)
T ss_pred             ccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc
Confidence            455678999999999999999999864      23679999887532 233456788999999999 7999999999987


Q ss_pred             eCc-eEEEEEeccCCCHhhhhhhc--------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCe
Q 016594          135 DNG-LYLIFQFSSRGSVASLFHDV--------------NSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNI  199 (386)
Q Consensus       135 ~~~-~~lv~e~~~~~~L~~~~~~~--------------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Ni  199 (386)
                      .++ .+++|||+.+++|..++...              ....+++..++.++.|++.||.|||+   ++|+||||||+||
T Consensus        87 ~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~Ni  163 (293)
T cd05053          87 QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLAS---KKCIHRDLAARNV  163 (293)
T ss_pred             CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCccccccceeeE
Confidence            655 89999999999999988643              23458899999999999999999999   9999999999999


Q ss_pred             eEcCCCCeEEeecCccccCCCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCchhhh
Q 016594          200 LLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLH  278 (386)
Q Consensus       200 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~  278 (386)
                      +++.++.+||+|||++..+.............++..|+|||++.+..++.++|||||||++|+|++ |..||.+......
T Consensus       164 l~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~  243 (293)
T cd05053         164 LVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL  243 (293)
T ss_pred             EEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHH
Confidence            999999999999999987654322222222335678999999999999999999999999999998 9999976432110


Q ss_pred             hhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          279 SWAKPILNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                      .            ...........+...+..+.+++.+||..||++|||+.++++.|...
T Consensus       244 ~------------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~  291 (293)
T cd05053         244 F------------KLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM  291 (293)
T ss_pred             H------------HHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence            0            00111111122233456799999999999999999999999998653

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=1.7e-42  Score=316.69  Aligned_cols=259  Identities=21%  Similarity=0.336  Sum_probs=204.7

Q ss_pred             HhcCCCCCCeecccCCcEEEEEEEC------CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc
Q 016594           64 ATNAFSSENLVGRGGYAEVYKGVLQ------DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG  137 (386)
Q Consensus        64 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  137 (386)
                      ...+|.+.+.||+|+||+||++...      ++..+|+|.+...  .......+.+|+.+++++.||||+++++++...+
T Consensus         3 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   80 (288)
T cd05093           3 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGD   80 (288)
T ss_pred             chHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence            3567889999999999999999842      3456899988642  2344567899999999999999999999997655


Q ss_pred             -eEEEEEeccCCCHhhhhhhcC-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCC
Q 016594          138 -LYLIFQFSSRGSVASLFHDVN-----------SPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADF  205 (386)
Q Consensus       138 -~~lv~e~~~~~~L~~~~~~~~-----------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~  205 (386)
                       .++++||+.+++|.+++....           ...+++..++.++.|++.||+|||+   ++++||||||+||+++.++
T Consensus        81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~---~~i~H~dlkp~Nili~~~~  157 (288)
T cd05093          81 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENL  157 (288)
T ss_pred             ccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCC
Confidence             899999999999999886432           1348999999999999999999999   9999999999999999999


Q ss_pred             CeEEeecCccccCCCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCchhhhhhhhhh
Q 016594          206 EPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPI  284 (386)
Q Consensus       206 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~  284 (386)
                      .+||+|||++................++..|+|||.+.+..++.++|||||||++|+|++ |..||........  ....
T Consensus       158 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~--~~~i  235 (288)
T cd05093         158 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEV--IECI  235 (288)
T ss_pred             cEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH--HHHH
Confidence            999999999986543322122223345778999999998999999999999999999998 9999976543211  0111


Q ss_pred             hcccccccccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCC
Q 016594          285 LNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEGD  339 (386)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~~  339 (386)
                       ..+..         ...+...+..+.+++.+||+.||.+|||+.+++..|+...
T Consensus       236 -~~~~~---------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~  280 (288)
T cd05093         236 -TQGRV---------LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLA  280 (288)
T ss_pred             -HcCCc---------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence             11110         0011123467999999999999999999999999887654

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=1.2e-42  Score=322.72  Aligned_cols=245  Identities=23%  Similarity=0.297  Sum_probs=192.4

Q ss_pred             CeecccCCcEEEEEEEC-CCcEEEEEEeccccC-ChHhHHHHHHHHH-HHhccCCCceeeecceEEeCc-eEEEEEeccC
Q 016594           72 NLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVT-DDRKEKEFLTEIG-TIGHVCHPNVLSLLGCCVDNG-LYLIFQFSSR  147 (386)
Q Consensus        72 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~-~~lv~e~~~~  147 (386)
                      +.||+|+||+||+|.+. +|+.||+|++.+... .......+..|.. +++.++||||+++++++.+.. .++||||+.+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            46999999999999986 689999999875322 2223345555555 457899999999999987755 8999999999


Q ss_pred             CCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCccccc
Q 016594          148 GSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSI  227 (386)
Q Consensus       148 ~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  227 (386)
                      ++|..++...  ..+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||++......  ....
T Consensus        81 g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~~  153 (323)
T cd05575          81 GELFFHLQRE--RSFPEPRARFYAAEIASALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH--SKTT  153 (323)
T ss_pred             CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeccCCCcccccC--CCcc
Confidence            9999888753  348899999999999999999999   99999999999999999999999999998754221  1223


Q ss_pred             cccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCCCCCHHHH
Q 016594          228 APIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQL  307 (386)
Q Consensus       228 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (386)
                      ....||+.|+|||++.+..++.++|||||||++|+|++|..||.......  .....         .....  ......+
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~--~~~~i---------~~~~~--~~~~~~~  220 (323)
T cd05575         154 STFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAE--MYDNI---------LNKPL--RLKPNIS  220 (323)
T ss_pred             ccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHH--HHHHH---------HcCCC--CCCCCCC
Confidence            34569999999999999999999999999999999999999998653221  11111         11110  1112235


Q ss_pred             HHHHHHHHHccccCCCCCCCH----HHHHHHHh
Q 016594          308 NRLAFAASLCIRASPTWRPTM----SEVLEVML  336 (386)
Q Consensus       308 ~~l~~li~~cl~~dP~~Rpt~----~~il~~l~  336 (386)
                      ..+.+++.+||+.||.+||++    .+++++.+
T Consensus       221 ~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~  253 (323)
T cd05575         221 VSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVF  253 (323)
T ss_pred             HHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCC
Confidence            678999999999999999988    46666543

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=2e-42  Score=320.29  Aligned_cols=244  Identities=24%  Similarity=0.333  Sum_probs=192.8

Q ss_pred             CeecccCCcEEEEEEEC-CCcEEEEEEeccccC-ChHhHHHHHHHHHHHhcc-CCCceeeecceEEeCc-eEEEEEeccC
Q 016594           72 NLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVT-DDRKEKEFLTEIGTIGHV-CHPNVLSLLGCCVDNG-LYLIFQFSSR  147 (386)
Q Consensus        72 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~-~~lv~e~~~~  147 (386)
                      +.||+|+||.||+|.+. +++.||+|++..... .......+..|..++..+ +||||+++++++..+. .++||||+.+
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999976 588999999975322 223344456677777654 7999999999987655 8999999999


Q ss_pred             CCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCccccc
Q 016594          148 GSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSI  227 (386)
Q Consensus       148 ~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  227 (386)
                      |+|..++....  .+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||++.......  ...
T Consensus        81 g~L~~~~~~~~--~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~~  153 (316)
T cd05592          81 GDLMFHIQSSG--RFDEARARFYAAEIICGLQFLHK---KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GKA  153 (316)
T ss_pred             CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Ccc
Confidence            99998886543  48999999999999999999999   999999999999999999999999999997653321  223


Q ss_pred             cccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCCCCCHHHH
Q 016594          228 APIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQL  307 (386)
Q Consensus       228 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (386)
                      ...+||+.|+|||++.+..++.++|||||||++|+|++|..||.+......  ...+.         ..  ....+...+
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~--~~~i~---------~~--~~~~~~~~~  220 (316)
T cd05592         154 STFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDEL--FDSIL---------ND--RPHFPRWIS  220 (316)
T ss_pred             ccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHH--HHHHH---------cC--CCCCCCCCC
Confidence            345699999999999999999999999999999999999999987543211  11110         00  111222345


Q ss_pred             HHHHHHHHHccccCCCCCCCHH-HHHHHH
Q 016594          308 NRLAFAASLCIRASPTWRPTMS-EVLEVM  335 (386)
Q Consensus       308 ~~l~~li~~cl~~dP~~Rpt~~-~il~~l  335 (386)
                      ..+.+++.+||+.||++||++. +++++.
T Consensus       221 ~~~~~ll~~~l~~~P~~R~~~~~~l~~h~  249 (316)
T cd05592         221 KEAKDCLSKLFERDPTKRLGVDGDIRQHP  249 (316)
T ss_pred             HHHHHHHHHHccCCHHHcCCChHHHHcCc
Confidence            6789999999999999999875 666653

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=3.3e-42  Score=309.56  Aligned_cols=248  Identities=21%  Similarity=0.338  Sum_probs=198.1

Q ss_pred             eecccCCcEEEEEEEC---CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCceEEEEEeccCCC
Q 016594           73 LVGRGGYAEVYKGVLQ---DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNGLYLIFQFSSRGS  149 (386)
Q Consensus        73 ~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~lv~e~~~~~~  149 (386)
                      .||+|+||.||+|.+.   ++..||+|++... ........+.+|+.++++++||||+++++++.....++||||+.+++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~-~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~lv~e~~~~~~   80 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNE-NEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEAEALMLVMEMASGGP   80 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccc-cChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcCCCeEEEEEeCCCCC
Confidence            3899999999999864   3557999988753 23444567899999999999999999999987777999999999999


Q ss_pred             HhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCcccc-cc
Q 016594          150 VASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHS-IA  228 (386)
Q Consensus       150 L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~-~~  228 (386)
                      |.+++... ...+++..++.++.|++.||.|||+   ++++||||||+||+++.++.+||+|||++..+........ ..
T Consensus        81 L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  156 (257)
T cd05115          81 LNKFLSGK-KDEITVSNVVELMHQVSMGMKYLEG---KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARS  156 (257)
T ss_pred             HHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHh---cCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccC
Confidence            99988643 3358999999999999999999999   9999999999999999999999999999986543322111 11


Q ss_pred             ccccccCccChhhhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCchhhhhhhhhhhcccccccccCCccCCCCCHHHH
Q 016594          229 PIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQL  307 (386)
Q Consensus       229 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (386)
                      ...++..|+|||.+.+..++.++|||||||++|+|++ |..||.......  .          ...+........+...+
T Consensus       157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~----------~~~~~~~~~~~~~~~~~  224 (257)
T cd05115         157 AGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE--V----------MSFIEQGKRLDCPAECP  224 (257)
T ss_pred             CCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH--H----------HHHHHCCCCCCCCCCCC
Confidence            1223578999999988889999999999999999996 999997653221  0          01111111122233446


Q ss_pred             HHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 016594          308 NRLAFAASLCIRASPTWRPTMSEVLEVMLE  337 (386)
Q Consensus       308 ~~l~~li~~cl~~dP~~Rpt~~~il~~l~~  337 (386)
                      ..+.+++.+||..+|++||++.+|++.|+.
T Consensus       225 ~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~  254 (257)
T cd05115         225 PEMYALMKDCWIYKWEDRPNFAKVEERMRT  254 (257)
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHHHHHhh
Confidence            789999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=7.3e-42  Score=308.87  Aligned_cols=259  Identities=24%  Similarity=0.414  Sum_probs=208.2

Q ss_pred             cCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEecccc-CChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEE
Q 016594           66 NAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVV-TDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIF  142 (386)
Q Consensus        66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~  142 (386)
                      ++|++.+.||+|+||.||+|+.. +++.||||.+.... ........+.+|+.+++.++||||+++++++.+.+ .++++
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            57899999999999999999976 68999999886522 33445567889999999999999999999987655 89999


Q ss_pred             EeccCCCHhhhhhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCC
Q 016594          143 QFSSRGSVASLFHDV--NSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPS  220 (386)
Q Consensus       143 e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~  220 (386)
                      ||+.+++|.+++...  ....+++..+..++.|++.||.|||+   ++++|+||||+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~  158 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence            999999999887543  23447899999999999999999999   9999999999999999999999999999887654


Q ss_pred             CCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCC
Q 016594          221 QWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQG  300 (386)
Q Consensus       221 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (386)
                      ...  ......|++.|+|||.+.+..++.++|+||||+++|+|++|..||.........+......         .....
T Consensus       159 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~---------~~~~~  227 (267)
T cd08228         159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQ---------CDYPP  227 (267)
T ss_pred             hhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhc---------CCCCC
Confidence            321  1223458889999999998889999999999999999999999997643322222111100         00111


Q ss_pred             CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          301 AYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       301 ~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                      ......+..+.+++.+||..+|++||++.++++.++..
T Consensus       228 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~  265 (267)
T cd08228         228 LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM  265 (267)
T ss_pred             CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence            11223457799999999999999999999999988653

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=1.5e-42  Score=334.23  Aligned_cols=262  Identities=19%  Similarity=0.254  Sum_probs=195.8

Q ss_pred             HhcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeC------
Q 016594           64 ATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDN------  136 (386)
Q Consensus        64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------  136 (386)
                      ...+|++.+.||+|+||.||+|... +++.||||++....      ....+|+.+++.++||||+++++++...      
T Consensus        64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~  137 (440)
T PTZ00036         64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNE  137 (440)
T ss_pred             cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc------chHHHHHHHHHhcCCCCCcceeeeEeecccccCC
Confidence            4568999999999999999999975 68899999885421      1234799999999999999999887431      


Q ss_pred             ---ceEEEEEeccCCCHhhhhhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCC-CeEEe
Q 016594          137 ---GLYLIFQFSSRGSVASLFHDV--NSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADF-EPQIS  210 (386)
Q Consensus       137 ---~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~-~~kl~  210 (386)
                         .++++|||+.+ +|.+++...  ....+++..+..++.||+.||.|||+   ++|+||||||+|||++.++ .+||+
T Consensus       138 ~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~---~~IiHrDLKp~NILl~~~~~~vkL~  213 (440)
T PTZ00036        138 KNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHS---KFICHRDLKPQNLLIDPNTHTLKLC  213 (440)
T ss_pred             CceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCcCHHHEEEcCCCCceeee
Confidence               15689999986 676665432  33458999999999999999999999   9999999999999999665 69999


Q ss_pred             ecCccccCCCCCccccccccccccCccChhhhccC-CCCcccchHHHHHHHHHHHhCCCCCCCCchhhhh-hhhhhhccc
Q 016594          211 DFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHG-IVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHS-WAKPILNQG  288 (386)
Q Consensus       211 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~-~~~~~~~~~  288 (386)
                      |||++..+....   ......||+.|+|||++.+. .++.++|||||||++|||++|.+||.+....... .........
T Consensus       214 DFGla~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p  290 (440)
T PTZ00036        214 DFGSAKNLLAGQ---RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTP  290 (440)
T ss_pred             ccccchhccCCC---CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence            999998764322   22345689999999998764 6899999999999999999999999875432110 000000000


Q ss_pred             c----------ccc-----ccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          289 E----------IEK-----LVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       289 ~----------~~~-----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                      .          ...     .....+...++...+..+.+|+.+||..||.+|||+.++++|-+..
T Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~  355 (440)
T PTZ00036        291 TEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFD  355 (440)
T ss_pred             CHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHH
Confidence            0          000     0000011111222346799999999999999999999999986643

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=8.7e-43  Score=317.72  Aligned_cols=256  Identities=21%  Similarity=0.322  Sum_probs=202.1

Q ss_pred             cCCCCCCeecccCCcEEEEEEEC------CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-e
Q 016594           66 NAFSSENLVGRGGYAEVYKGVLQ------DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-L  138 (386)
Q Consensus        66 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~  138 (386)
                      ..|.+.+.||+|+||.||+|.+.      .+..||+|++.... .......+.+|+.++..++||||+++++++.+.. .
T Consensus         5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~   83 (283)
T cd05091           5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA-EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPL   83 (283)
T ss_pred             HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCce
Confidence            35777889999999999999863      24789999987532 2333456889999999999999999999997655 8


Q ss_pred             EEEEEeccCCCHhhhhhhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCC
Q 016594          139 YLIFQFSSRGSVASLFHDVN--------------SPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTAD  204 (386)
Q Consensus       139 ~lv~e~~~~~~L~~~~~~~~--------------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~  204 (386)
                      +++++|+.+++|.+++....              ...+++..+..++.|++.||.|||+   ++++||||||+||+++.+
T Consensus        84 ~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~---~gi~H~dlkp~Nil~~~~  160 (283)
T cd05091          84 SMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSS---HHVVHKDLATRNVLVFDK  160 (283)
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---cCccccccchhheEecCC
Confidence            89999999999999875321              1247888899999999999999999   999999999999999999


Q ss_pred             CCeEEeecCccccCCCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCchhhhhhhhh
Q 016594          205 FEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKP  283 (386)
Q Consensus       205 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~  283 (386)
                      +.+||+|||++................+++.|+|||.+.+..++.++|||||||++|||++ |..||.+....  .....
T Consensus       161 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~--~~~~~  238 (283)
T cd05091         161 LNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ--DVIEM  238 (283)
T ss_pred             CceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHH
Confidence            9999999999886643322222233446778999999998889999999999999999998 88898764332  11111


Q ss_pred             hhcccccccccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 016594          284 ILNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLE  337 (386)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~  337 (386)
                      .         ... .....+..++..+.+++..||+.+|.+||++.+|+..|+.
T Consensus       239 i---------~~~-~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         239 I---------RNR-QVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             H---------HcC-CcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence            1         111 1112233456779999999999999999999999998853

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=8.3e-43  Score=329.40  Aligned_cols=264  Identities=20%  Similarity=0.265  Sum_probs=206.0

Q ss_pred             HHHHHHhcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEecccc-CChHhHHHHHHHHHHHhccCCCceeeecceEEeC
Q 016594           59 EEISIATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVV-TDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDN  136 (386)
Q Consensus        59 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~  136 (386)
                      ..+....++|++.+.||+|+||.||+|.++ +++.||+|++.+.. ........+.+|+.+++.++||||+++++++.++
T Consensus        36 ~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~  115 (371)
T cd05622          36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD  115 (371)
T ss_pred             hhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC
Confidence            344566789999999999999999999987 68899999987522 2223345577899999999999999999999776


Q ss_pred             c-eEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCcc
Q 016594          137 G-LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLA  215 (386)
Q Consensus       137 ~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a  215 (386)
                      . .++||||+.+|+|.+++...   .+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||++
T Consensus       116 ~~~~lv~Ey~~gg~L~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NIll~~~~~ikL~DfG~a  189 (371)
T cd05622         116 RYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTC  189 (371)
T ss_pred             CEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHEEECCCCCEEEEeCCce
Confidence            5 89999999999999988643   38889999999999999999999   99999999999999999999999999999


Q ss_pred             ccCCCCCccccccccccccCccChhhhccCC----CCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccc
Q 016594          216 KWLPSQWTHHSIAPIEGTFGHLAPEYFMHGI----VDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIE  291 (386)
Q Consensus       216 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  291 (386)
                      ..+..... .......||+.|+|||++.+..    ++.++|||||||++|+|++|..||.......  ....+.....  
T Consensus       190 ~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~--~~~~i~~~~~--  264 (371)
T cd05622         190 MKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG--TYSKIMNHKN--  264 (371)
T ss_pred             eEcCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHH--HHHHHHcCCC--
Confidence            87643211 1223567999999999997543    7899999999999999999999998754321  1111111000  


Q ss_pred             cccCCccCCCCCHHHHHHHHHHHHHccccCCCC--CCCHHHHHHHHhcC
Q 016594          292 KLVDPRLQGAYDVTQLNRLAFAASLCIRASPTW--RPTMSEVLEVMLEG  338 (386)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--Rpt~~~il~~l~~~  338 (386)
                           ..........+..+.++|..||..++.+  ||++.+++++.+..
T Consensus       265 -----~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~  308 (371)
T cd05622         265 -----SLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFK  308 (371)
T ss_pred             -----cccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccC
Confidence                 0111111234567899999999844433  78999999987654

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=3e-42  Score=319.94  Aligned_cols=245  Identities=21%  Similarity=0.262  Sum_probs=191.3

Q ss_pred             CeecccCCcEEEEEEEC-CCcEEEEEEeccccC-ChHhHHHHHHHHH-HHhccCCCceeeecceEEeCc-eEEEEEeccC
Q 016594           72 NLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVT-DDRKEKEFLTEIG-TIGHVCHPNVLSLLGCCVDNG-LYLIFQFSSR  147 (386)
Q Consensus        72 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~-~~lv~e~~~~  147 (386)
                      ++||+|+||.||+|... +++.||+|++.+... .......+.+|.. +++.++||||+++++++.+.+ .++||||+.+
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999986 688999999875322 2223344555554 578899999999999987755 8999999999


Q ss_pred             CCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCccccc
Q 016594          148 GSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSI  227 (386)
Q Consensus       148 ~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  227 (386)
                      ++|...+...  ..+++..+..++.||+.||.|||+   ++|+||||||+||+++.++.+||+|||++......  ....
T Consensus        81 ~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~~  153 (321)
T cd05603          81 GELFFHLQRE--RCFLEPRARFYAAEVASAIGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP--EETT  153 (321)
T ss_pred             CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEccCCCCccCCCC--CCcc
Confidence            9998877643  348889999999999999999999   99999999999999999999999999998753221  1123


Q ss_pred             cccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCCCCCHHHH
Q 016594          228 APIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQL  307 (386)
Q Consensus       228 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (386)
                      ....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+....  ...         +....  ...+...+
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~---------i~~~~--~~~~~~~~  220 (321)
T cd05603         154 STFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQM--YDN---------ILHKP--LQLPGGKT  220 (321)
T ss_pred             ccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHH--HHH---------HhcCC--CCCCCCCC
Confidence            345689999999999999999999999999999999999999987543211  111         11111  11122335


Q ss_pred             HHHHHHHHHccccCCCCCCCHH----HHHHHHh
Q 016594          308 NRLAFAASLCIRASPTWRPTMS----EVLEVML  336 (386)
Q Consensus       308 ~~l~~li~~cl~~dP~~Rpt~~----~il~~l~  336 (386)
                      ..+.+++.+||+.||.+||++.    +++++.+
T Consensus       221 ~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~  253 (321)
T cd05603         221 VAACDLLVGLLHKDQRRRLGAKADFLEIKNHVF  253 (321)
T ss_pred             HHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCC
Confidence            6789999999999999999764    5555443

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=2e-42  Score=321.48  Aligned_cols=249  Identities=24%  Similarity=0.326  Sum_probs=198.4

Q ss_pred             CCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccC-ChHhHHHHHHHHHHHhccCC-CceeeecceEEeCc-eEEEE
Q 016594           67 AFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVT-DDRKEKEFLTEIGTIGHVCH-PNVLSLLGCCVDNG-LYLIF  142 (386)
Q Consensus        67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~-~~lv~  142 (386)
                      +|++.+.||+|+||.||+|... +++.||+|++.+... .......+..|+.++..+.| ++|+++++++.+.+ .++||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            4788999999999999999976 578999999875322 23345667889999999976 56888888887655 89999


Q ss_pred             EeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCC
Q 016594          143 QFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQW  222 (386)
Q Consensus       143 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  222 (386)
                      ||+.+|+|.+++....  .+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||++...... 
T Consensus        81 E~~~~g~L~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~-  154 (324)
T cd05587          81 EYVNGGDLMYHIQQVG--KFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG-  154 (324)
T ss_pred             cCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEEcCCCCEEEeecCcceecCCC-
Confidence            9999999998886543  48899999999999999999999   99999999999999999999999999998753221 


Q ss_pred             ccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCCCC
Q 016594          223 THHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAY  302 (386)
Q Consensus       223 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (386)
                       ........||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.......  ..+         ...  ...+
T Consensus       155 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~--~~i---------~~~--~~~~  220 (324)
T cd05587         155 -GKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELF--QSI---------MEH--NVSY  220 (324)
T ss_pred             -CCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHH--HHH---------HcC--CCCC
Confidence             11233456999999999999999999999999999999999999999865432111  000         000  0112


Q ss_pred             CHHHHHHHHHHHHHccccCCCCCCCH-----HHHHHHH
Q 016594          303 DVTQLNRLAFAASLCIRASPTWRPTM-----SEVLEVM  335 (386)
Q Consensus       303 ~~~~~~~l~~li~~cl~~dP~~Rpt~-----~~il~~l  335 (386)
                      +...+..+.+++.+||..||.+|++.     .+++++.
T Consensus       221 ~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp  258 (324)
T cd05587         221 PKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHA  258 (324)
T ss_pred             CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCC
Confidence            22345678999999999999999976     6777664

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=4.9e-43  Score=325.71  Aligned_cols=248  Identities=21%  Similarity=0.259  Sum_probs=198.4

Q ss_pred             CeecccCCcEEEEEEEC-CCcEEEEEEeccccC-ChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEEEeccCC
Q 016594           72 NLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVT-DDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQFSSRG  148 (386)
Q Consensus        72 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~~~~~  148 (386)
                      +.||+|+||.||+|... +++.||+|++.+... .......+..|+.++..++||||+++++++..+. .++||||+.+|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999975 689999999976322 2334556788999999999999999999987765 89999999999


Q ss_pred             CHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCcccccc
Q 016594          149 SVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIA  228 (386)
Q Consensus       149 ~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  228 (386)
                      +|..++...  ..+++..+..++.||+.||.|||+  .++|+||||||+|||++.++.+||+|||++.......  ....
T Consensus        81 ~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~--~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~~~  154 (325)
T cd05594          81 ELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG--ATMK  154 (325)
T ss_pred             cHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCC--cccc
Confidence            998887653  348999999999999999999996  1599999999999999999999999999987543221  1223


Q ss_pred             ccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCCCCCHHHHH
Q 016594          229 PIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQLN  308 (386)
Q Consensus       229 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (386)
                      ...||+.|+|||++.+..++.++|||||||++|+|++|..||.+......  ....         ....  ...+...+.
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~--~~~i---------~~~~--~~~p~~~~~  221 (325)
T cd05594         155 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL--FELI---------LMEE--IRFPRTLSP  221 (325)
T ss_pred             cccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHH--HHHH---------hcCC--CCCCCCCCH
Confidence            45699999999999999999999999999999999999999976543211  0000         0000  011223456


Q ss_pred             HHHHHHHHccccCCCCCC-----CHHHHHHHHhcC
Q 016594          309 RLAFAASLCIRASPTWRP-----TMSEVLEVMLEG  338 (386)
Q Consensus       309 ~l~~li~~cl~~dP~~Rp-----t~~~il~~l~~~  338 (386)
                      .+.+++.+||+.||++|+     ++.+++++.+..
T Consensus       222 ~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~  256 (325)
T cd05594         222 EAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFA  256 (325)
T ss_pred             HHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcC
Confidence            789999999999999996     899999885543

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=2.2e-42  Score=321.70  Aligned_cols=249  Identities=22%  Similarity=0.312  Sum_probs=195.8

Q ss_pred             CeecccCCcEEEEEEEC-CCcEEEEEEeccccC-ChHhHHHHHHHHHHHhcc-CCCceeeecceEEeCc-eEEEEEeccC
Q 016594           72 NLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVT-DDRKEKEFLTEIGTIGHV-CHPNVLSLLGCCVDNG-LYLIFQFSSR  147 (386)
Q Consensus        72 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~-~~lv~e~~~~  147 (386)
                      +.||+|+||+||+|..+ +++.||+|++.+... .......+.+|+.++.++ +||||+++++++.+++ .++||||+.+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            46999999999999976 688999999986432 233455677888888776 6999999999997755 8999999999


Q ss_pred             CCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCccccc
Q 016594          148 GSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSI  227 (386)
Q Consensus       148 ~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  227 (386)
                      ++|..++...  ..+++..+..++.|++.||.|||+   ++|+||||||+||+++.++.+||+|||++......  ....
T Consensus        81 ~~L~~~~~~~--~~l~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~--~~~~  153 (329)
T cd05618          81 GDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP--GDTT  153 (329)
T ss_pred             CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCCEEEeeCCccccccCC--CCcc
Confidence            9998887653  348999999999999999999999   99999999999999999999999999998753221  1122


Q ss_pred             cccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchh------hhhhhhhhhcccccccccCCccCCC
Q 016594          228 APIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQS------LHSWAKPILNQGEIEKLVDPRLQGA  301 (386)
Q Consensus       228 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~  301 (386)
                      ....||+.|+|||++.+..++.++|||||||++|+|++|..||......      ...+....        +....  ..
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~--------i~~~~--~~  223 (329)
T cd05618         154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQV--------ILEKQ--IR  223 (329)
T ss_pred             ccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHH--------HhcCC--CC
Confidence            3457999999999999999999999999999999999999999532110      00111100        11111  11


Q ss_pred             CCHHHHHHHHHHHHHccccCCCCCCC------HHHHHHHHhc
Q 016594          302 YDVTQLNRLAFAASLCIRASPTWRPT------MSEVLEVMLE  337 (386)
Q Consensus       302 ~~~~~~~~l~~li~~cl~~dP~~Rpt------~~~il~~l~~  337 (386)
                      .+...+..+.+++.+||+.||++||+      +.++++|-+.
T Consensus       224 ~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f  265 (329)
T cd05618         224 IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFF  265 (329)
T ss_pred             CCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCC
Confidence            22334567899999999999999998      5788877543

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.6e-42  Score=314.92  Aligned_cols=258  Identities=21%  Similarity=0.371  Sum_probs=204.7

Q ss_pred             HHhcCCCCCCeecccCCcEEEEEEECC------CcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeC
Q 016594           63 IATNAFSSENLVGRGGYAEVYKGVLQD------GEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDN  136 (386)
Q Consensus        63 ~~~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~  136 (386)
                      +..++|++.+.||+|+||.||+|.++.      +..||+|.+.... .......+.+|+.+++.++||||+++++++...
T Consensus         3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~   81 (277)
T cd05032           3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSTG   81 (277)
T ss_pred             cchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc-CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCC
Confidence            456789999999999999999998642      3689999986432 233456788999999999999999999998765


Q ss_pred             c-eEEEEEeccCCCHhhhhhhcC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCe
Q 016594          137 G-LYLIFQFSSRGSVASLFHDVN--------SPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEP  207 (386)
Q Consensus       137 ~-~~lv~e~~~~~~L~~~~~~~~--------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~  207 (386)
                      . .+++|||+.+++|.+++....        ...+++..++.++.|++.||.|||+   ++++||||||+||+++.++.+
T Consensus        82 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~di~p~nill~~~~~~  158 (277)
T cd05032          82 QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAA---KKFVHRDLAARNCMVAEDLTV  158 (277)
T ss_pred             CCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccChheEEEcCCCCE
Confidence            5 899999999999999886532        1236888999999999999999999   999999999999999999999


Q ss_pred             EEeecCccccCCCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCchhhhhhhhhhhc
Q 016594          208 QISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILN  286 (386)
Q Consensus       208 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~  286 (386)
                      ||+|||++..+.............++..|+|||.+.+..++.++|||||||++|+|++ |..||........  ..... 
T Consensus       159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~--~~~~~-  235 (277)
T cd05032         159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEV--LKFVI-  235 (277)
T ss_pred             EECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHH--HHHHh-
Confidence            9999999876543322122233446788999999988889999999999999999998 9999976432211  11000 


Q ss_pred             ccccccccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 016594          287 QGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVML  336 (386)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~  336 (386)
                      ..         .....+...+..+.+++.+||+.+|++|||+.++++.|+
T Consensus       236 ~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  276 (277)
T cd05032         236 DG---------GHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK  276 (277)
T ss_pred             cC---------CCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence            10         011112223577999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=4.1e-42  Score=314.46  Aligned_cols=256  Identities=23%  Similarity=0.388  Sum_probs=201.7

Q ss_pred             CCCCCCeecccCCcEEEEEEEC------CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eE
Q 016594           67 AFSSENLVGRGGYAEVYKGVLQ------DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LY  139 (386)
Q Consensus        67 ~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~  139 (386)
                      +|++.+.||+|+||.||+|...      ....+|+|.+.... .......+.+|+.+++.+.||||+++++.+..++ .+
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   79 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA-SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLL   79 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcE
Confidence            4788899999999999999853      23568888886532 2334567889999999999999999999987655 89


Q ss_pred             EEEEeccCCCHhhhhhhcC----------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCC
Q 016594          140 LIFQFSSRGSVASLFHDVN----------------------SPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSS  197 (386)
Q Consensus       140 lv~e~~~~~~L~~~~~~~~----------------------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~  197 (386)
                      +++||+.+++|.+++....                      ...+++..++.++.|++.||.|||+   ++++||||||+
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~ivH~dikp~  156 (290)
T cd05045          80 LIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAE---MKLVHRDLAAR  156 (290)
T ss_pred             EEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHH---CCeehhhhhhh
Confidence            9999999999999876421                      1347889999999999999999999   99999999999


Q ss_pred             CeeEcCCCCeEEeecCccccCCCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCchh
Q 016594          198 NILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQS  276 (386)
Q Consensus       198 Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~  276 (386)
                      |||++.++.+||+|||++................++..|+|||.+.+..++.++||||||+++|+|++ |..||.+....
T Consensus       157 nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~  236 (290)
T cd05045         157 NVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE  236 (290)
T ss_pred             eEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH
Confidence            99999999999999999976543322111222345678999999998899999999999999999998 99999764322


Q ss_pred             hhhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          277 LHSWAKPILNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                      ..   .         +..........+...+..+.+++.+||+.+|++||++.++++.|+..
T Consensus       237 ~~---~---------~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~  286 (290)
T cd05045         237 RL---F---------NLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKM  286 (290)
T ss_pred             HH---H---------HHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHH
Confidence            10   0         01111111112223456799999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.3e-42  Score=310.30  Aligned_cols=250  Identities=20%  Similarity=0.370  Sum_probs=200.1

Q ss_pred             cCCCCCCeecccCCcEEEEEEECCCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEEEe
Q 016594           66 NAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQF  144 (386)
Q Consensus        66 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~  144 (386)
                      .+|++.+.||+|+||.||+|.++++..+|+|.+.....   ....+.+|+.++++++||||+++++++.+.+ .++++||
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM---SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEY   80 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC---CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEec
Confidence            45888999999999999999988777899998864322   2346788999999999999999999987655 8999999


Q ss_pred             ccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCcc
Q 016594          145 SSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTH  224 (386)
Q Consensus       145 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  224 (386)
                      +.+++|.+++..... .+++..++.++.|++.||+|||+   ++++||||||+||+++.++.+||+|||++.........
T Consensus        81 ~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~  156 (256)
T cd05059          81 MANGCLLNYLRERKG-KLGTEWLLDMCSDVCEAMEYLES---NGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT  156 (256)
T ss_pred             CCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHhhEEECCCCcEEECCcccceeccccccc
Confidence            999999998875433 58999999999999999999999   99999999999999999999999999998765432111


Q ss_pred             ccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCchhhhhhhhhhhcccccccccCCccCCCCC
Q 016594          225 HSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYD  303 (386)
Q Consensus       225 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (386)
                       ......++..|+|||.+.+..++.++||||||+++|+|++ |..||.........  ... .         .......+
T Consensus       157 -~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~--~~~-~---------~~~~~~~~  223 (256)
T cd05059         157 -SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVV--ESV-S---------AGYRLYRP  223 (256)
T ss_pred             -ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHH--HHH-H---------cCCcCCCC
Confidence             1111123457999999999999999999999999999999 89999764332111  110 0         00111112


Q ss_pred             HHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 016594          304 VTQLNRLAFAASLCIRASPTWRPTMSEVLEVM  335 (386)
Q Consensus       304 ~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l  335 (386)
                      ...+..+.+++.+||..+|++|||+.++++.|
T Consensus       224 ~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         224 KLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence            23456799999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=3.6e-42  Score=325.81  Aligned_cols=265  Identities=19%  Similarity=0.275  Sum_probs=201.4

Q ss_pred             CCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeC------ceE
Q 016594           67 AFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDN------GLY  139 (386)
Q Consensus        67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~  139 (386)
                      +|++.+.||+|+||.||+|... +++.||+|.+............+.+|+.+++.++|+||+++++++...      ..+
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            4788999999999999999975 789999999876444445567788999999999999999999998754      378


Q ss_pred             EEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCC
Q 016594          140 LIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLP  219 (386)
Q Consensus       140 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~  219 (386)
                      +++||+. ++|...+...  ..+++..+..++.|++.||.|||+   ++++||||||+|||++.++.+||+|||++....
T Consensus        81 lv~e~~~-~~l~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~  154 (372)
T cd07853          81 VVTELMQ-SDLHKIIVSP--QPLSSDHVKVFLYQILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEE  154 (372)
T ss_pred             EEeeccc-cCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHHEEECCCCCEEeccccceeecc
Confidence            9999986 4777766543  348999999999999999999999   999999999999999999999999999998654


Q ss_pred             CCCccccccccccccCccChhhhccC-CCCcccchHHHHHHHHHHHhCCCCCCCCchhhh-hhhhhhhcccccc------
Q 016594          220 SQWTHHSIAPIEGTFGHLAPEYFMHG-IVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLH-SWAKPILNQGEIE------  291 (386)
Q Consensus       220 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~-~~~~~~~~~~~~~------  291 (386)
                      .... .......+++.|+|||++.+. .++.++|||||||++|+|++|+.||.+...... .............      
T Consensus       155 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~  233 (372)
T cd07853         155 PDES-KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSAC  233 (372)
T ss_pred             cCcc-ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhh
Confidence            3211 122334578999999999874 478999999999999999999999987543211 0000000000000      


Q ss_pred             -----cccCCccCC-------CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          292 -----KLVDPRLQG-------AYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       292 -----~~~~~~~~~-------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                           .+.......       ......+..+.+++.+||+.||++|||+.+++++.+..
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~  292 (372)
T cd07853         234 EGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLD  292 (372)
T ss_pred             HHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhC
Confidence                 000000000       01112256789999999999999999999999986543

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=2.4e-42  Score=317.77  Aligned_cols=261  Identities=23%  Similarity=0.379  Sum_probs=207.0

Q ss_pred             HHHhcCCCCCCeecccCCcEEEEEEEC------CCcEEEEEEeccccCChHhHHHHHHHHHHHhcc-CCCceeeecceEE
Q 016594           62 SIATNAFSSENLVGRGGYAEVYKGVLQ------DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHV-CHPNVLSLLGCCV  134 (386)
Q Consensus        62 ~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~  134 (386)
                      ....++|.+.+.||+|+||.||+|.+.      ++..||+|.+.... .......+.+|+.+++++ +||||+++++++.
T Consensus        31 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~  109 (302)
T cd05055          31 EFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA-HSSEREALMSELKIMSHLGNHENIVNLLGACT  109 (302)
T ss_pred             cccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC-ChHHHHHHHHHHHHHHhccCCCCcceEEEEEe
Confidence            345567999999999999999999742      34579999887532 233456788999999999 7999999999987


Q ss_pred             eCc-eEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecC
Q 016594          135 DNG-LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFG  213 (386)
Q Consensus       135 ~~~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg  213 (386)
                      ..+ .+++|||+.+++|.+++.......+++..+..++.|++.||.|||+   ++++|+||||+|||++.++.++|+|||
T Consensus       110 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~dfg  186 (302)
T cd05055         110 IGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNVLLTHGKIVKICDFG  186 (302)
T ss_pred             cCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeehhhhccceEEEcCCCeEEECCCc
Confidence            655 8999999999999999876554458999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCchhhhhhhhhhhccccccc
Q 016594          214 LAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGEIEK  292 (386)
Q Consensus       214 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~  292 (386)
                      ++..+.............++..|+|||.+.+..++.++|||||||++|+|++ |..||.........  .         +
T Consensus       187 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~--~---------~  255 (302)
T cd05055         187 LARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKF--Y---------K  255 (302)
T ss_pred             ccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHH--H---------H
Confidence            9986644322112223346778999999999999999999999999999998 99999764322110  0         0


Q ss_pred             ccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 016594          293 LVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLE  337 (386)
Q Consensus       293 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~  337 (386)
                      ..........+...+..+.+++.+||+.+|++||++.++++.|..
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~  300 (302)
T cd05055         256 LIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGK  300 (302)
T ss_pred             HHHcCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHh
Confidence            011111111112234679999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=2.5e-42  Score=320.13  Aligned_cols=246  Identities=23%  Similarity=0.328  Sum_probs=196.6

Q ss_pred             CeecccCCcEEEEEEEC-CCcEEEEEEecccc-CChHhHHHHHHHHHHHhcc-CCCceeeecceEEeCc-eEEEEEeccC
Q 016594           72 NLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVV-TDDRKEKEFLTEIGTIGHV-CHPNVLSLLGCCVDNG-LYLIFQFSSR  147 (386)
Q Consensus        72 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~-~~lv~e~~~~  147 (386)
                      +.||+|+||+||+|.++ +++.||+|++.+.. ........+..|..++..+ +||||+++++++.+.+ .++||||+.+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999976 68899999987532 1223445677888888776 5999999999997765 8999999999


Q ss_pred             CCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCccccc
Q 016594          148 GSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSI  227 (386)
Q Consensus       148 ~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  227 (386)
                      |+|..++....  .+++..+..++.|++.||.|||+   ++++||||||+|||++.++.+||+|||++......  ....
T Consensus        81 g~L~~~i~~~~--~l~~~~~~~~~~ql~~~L~~lH~---~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~--~~~~  153 (320)
T cd05590          81 GDLMFHIQKSR--RFDEARARFYAAEITSALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN--GKTT  153 (320)
T ss_pred             chHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC--CCcc
Confidence            99998886543  48999999999999999999999   99999999999999999999999999998754221  1123


Q ss_pred             cccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCCCCCHHHH
Q 016594          228 APIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQL  307 (386)
Q Consensus       228 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (386)
                      ....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+......  ...+.         ...  ...+...+
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~--~~~i~---------~~~--~~~~~~~~  220 (320)
T cd05590         154 STFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDL--FEAIL---------NDE--VVYPTWLS  220 (320)
T ss_pred             cccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHH--HHHHh---------cCC--CCCCCCCC
Confidence            345699999999999999999999999999999999999999987543211  11111         000  01122245


Q ss_pred             HHHHHHHHHccccCCCCCCCH------HHHHHHHhc
Q 016594          308 NRLAFAASLCIRASPTWRPTM------SEVLEVMLE  337 (386)
Q Consensus       308 ~~l~~li~~cl~~dP~~Rpt~------~~il~~l~~  337 (386)
                      ..+.+++.+||+.||++||++      .+++++-+.
T Consensus       221 ~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f  256 (320)
T cd05590         221 QDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFF  256 (320)
T ss_pred             HHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCc
Confidence            678999999999999999998      788877544

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=2.6e-42  Score=315.47  Aligned_cols=261  Identities=22%  Similarity=0.393  Sum_probs=204.0

Q ss_pred             HHHhcCCCCCCeecccCCcEEEEEEEC------CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEe
Q 016594           62 SIATNAFSSENLVGRGGYAEVYKGVLQ------DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVD  135 (386)
Q Consensus        62 ~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~  135 (386)
                      ++..++|++.+.||+|+||.||+|..+      .+..||+|.+.... .......+.+|+.+++.++||||+++++++.+
T Consensus         2 ~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   80 (288)
T cd05061           2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA-SLRERIEFLNEASVMKGFTCHHVVRLLGVVSK   80 (288)
T ss_pred             cccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence            356778999999999999999999753      24579999876432 23334567889999999999999999999876


Q ss_pred             Cc-eEEEEEeccCCCHhhhhhhcC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCC
Q 016594          136 NG-LYLIFQFSSRGSVASLFHDVN--------SPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFE  206 (386)
Q Consensus       136 ~~-~~lv~e~~~~~~L~~~~~~~~--------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~  206 (386)
                      .. .+++|||+.+|+|.+++....        ...++...+..++.|++.||.|||+   ++++||||||+||+++.++.
T Consensus        81 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dikp~nili~~~~~  157 (288)
T cd05061          81 GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA---KKFVHRDLAARNCMVAHDFT  157 (288)
T ss_pred             CCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCCChheEEEcCCCc
Confidence            55 899999999999999986532        2335677889999999999999999   99999999999999999999


Q ss_pred             eEEeecCccccCCCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCchhhhhhhhhhh
Q 016594          207 PQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPIL  285 (386)
Q Consensus       207 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~  285 (386)
                      ++|+|||++................++..|+|||.+.+..++.++|||||||++|||++ |..||.+.....  ......
T Consensus       158 ~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~--~~~~~~  235 (288)
T cd05061         158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ--VLKFVM  235 (288)
T ss_pred             EEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHH
Confidence            99999999886543322112222335678999999999899999999999999999998 888997643221  111111


Q ss_pred             cccccccccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          286 NQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                      ...          ....+...+..+.+++.+||+.+|++||++.++++.|.+.
T Consensus       236 ~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~  278 (288)
T cd05061         236 DGG----------YLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD  278 (288)
T ss_pred             cCC----------CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence            100          0011122346799999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-44  Score=309.25  Aligned_cols=248  Identities=25%  Similarity=0.377  Sum_probs=210.9

Q ss_pred             CCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeC-ceEEEEEec
Q 016594           68 FSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDN-GLYLIFQFS  145 (386)
Q Consensus        68 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~  145 (386)
                      |.+..+||+|+||.||+|.++ +|+.+|+|.+..    .....++.+|+.++++...|++|++||.+... ++++|||||
T Consensus        35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV----~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYC  110 (502)
T KOG0574|consen   35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV----DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYC  110 (502)
T ss_pred             HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc----cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhc
Confidence            667889999999999999987 699999999874    34577889999999999999999999988764 599999999


Q ss_pred             cCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCccc
Q 016594          146 SRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHH  225 (386)
Q Consensus       146 ~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  225 (386)
                      -.|++.++++.++ +.+++.++..+++..++||+|||.   ..-+|||||..||||+.+|..||+|||.|..+.+..  .
T Consensus       111 GAGSiSDI~R~R~-K~L~E~EIs~iL~~TLKGL~YLH~---~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM--A  184 (502)
T KOG0574|consen  111 GAGSISDIMRARR-KPLSEQEISAVLRDTLKGLQYLHD---LKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM--A  184 (502)
T ss_pred             CCCcHHHHHHHhc-CCccHHHHHHHHHHHHhHHHHHHH---HHHHHhhcccccEEEcccchhhhhhccccchhhhhH--H
Confidence            9999999987644 459999999999999999999999   899999999999999999999999999998876543  2


Q ss_pred             cccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhccccccccc-CCccCCCCCH
Q 016594          226 SIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLV-DPRLQGAYDV  304 (386)
Q Consensus       226 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~  304 (386)
                      ...+..||+.|||||++..-.|+.++||||||++..||..|++||..-+.-           ..+.-+. .+......+.
T Consensus       185 KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPM-----------RAIFMIPT~PPPTF~KPE  253 (502)
T KOG0574|consen  185 KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPM-----------RAIFMIPTKPPPTFKKPE  253 (502)
T ss_pred             hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccc-----------ceeEeccCCCCCCCCChH
Confidence            345678999999999999999999999999999999999999999764321           1111111 1222233445


Q ss_pred             HHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 016594          305 TQLNRLAFAASLCIRASPTWRPTMSEVLEVML  336 (386)
Q Consensus       305 ~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~  336 (386)
                      .++.++.+++++||-++|++|.|+.++++|-.
T Consensus       254 ~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~F  285 (502)
T KOG0574|consen  254 EWSSEFNDFIRSCLIKKPEERKTALRLCEHTF  285 (502)
T ss_pred             hhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhh
Confidence            67889999999999999999999999998743

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=2.6e-42  Score=324.87  Aligned_cols=265  Identities=20%  Similarity=0.264  Sum_probs=203.5

Q ss_pred             HHhcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeC-----
Q 016594           63 IATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDN-----  136 (386)
Q Consensus        63 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----  136 (386)
                      ...++|++.+.||+|+||.||+|... +++.||||.+............+.+|+.+++.++||||+++++++...     
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   93 (355)
T cd07874          14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE   93 (355)
T ss_pred             hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence            34578999999999999999999975 688999999986555555667788999999999999999999988542     


Q ss_pred             --ceEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCc
Q 016594          137 --GLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGL  214 (386)
Q Consensus       137 --~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~  214 (386)
                        ..+++|||+.+ +|...+..    .+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+
T Consensus        94 ~~~~~lv~e~~~~-~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~---~givHrDikp~Nill~~~~~~kl~Dfg~  165 (355)
T cd07874          94 FQDVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGL  165 (355)
T ss_pred             cceeEEEhhhhcc-cHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEECCCCCEEEeeCcc
Confidence              26899999976 56555542    37888999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhh--hhhhh---------
Q 016594          215 AKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLH--SWAKP---------  283 (386)
Q Consensus       215 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~--~~~~~---------  283 (386)
                      +.......   ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+....  .....         
T Consensus       166 ~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  242 (355)
T cd07874         166 ARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM  242 (355)
T ss_pred             cccCCCcc---ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            98654321   22345689999999999999999999999999999999999999987542110  00000         


Q ss_pred             ---------hhcc-cccccc-----cCCccC---CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          284 ---------ILNQ-GEIEKL-----VDPRLQ---GAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       284 ---------~~~~-~~~~~~-----~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                               .... .....+     ......   ..........+.+++.+||+.||++|||+.+++++.+..
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~  315 (355)
T cd07874         243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYIN  315 (355)
T ss_pred             HhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchh
Confidence                     0000 000000     000000   001112245689999999999999999999999986543

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=7.2e-42  Score=311.71  Aligned_cols=264  Identities=22%  Similarity=0.368  Sum_probs=203.2

Q ss_pred             CCCCCeecccCCcEEEEEEE-----CCCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeC---ceE
Q 016594           68 FSSENLVGRGGYAEVYKGVL-----QDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDN---GLY  139 (386)
Q Consensus        68 ~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~---~~~  139 (386)
                      |++.+.||+|+||+||++..     .++..||+|.+.... .......+.+|+.+++.++||||+++++++...   ..+
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC-GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQ   84 (283)
T ss_pred             ceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEE
Confidence            48899999999999988753     257789999987532 233456788999999999999999999988653   378


Q ss_pred             EEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCC
Q 016594          140 LIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLP  219 (386)
Q Consensus       140 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~  219 (386)
                      ++|||+.+++|.+++...   .+++..++.++.|++.||.|||+   ++++||||||+||+++.++.++|+|||++..+.
T Consensus        85 lv~e~~~~~~l~~~~~~~---~l~~~~~~~i~~~l~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~  158 (283)
T cd05080          85 LIMEYVPLGSLRDYLPKH---KLNLAQLLLFAQQICEGMAYLHS---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP  158 (283)
T ss_pred             EEecCCCCCCHHHHHHHc---CCCHHHHHHHHHHHHHHHHHHHH---CCeeccccChheEEEcCCCcEEEeecccccccC
Confidence            999999999999988653   38999999999999999999999   999999999999999999999999999998765


Q ss_pred             CCCcccc-ccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhh---cccccccccC
Q 016594          220 SQWTHHS-IAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPIL---NQGEIEKLVD  295 (386)
Q Consensus       220 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~---~~~~~~~~~~  295 (386)
                      ....... .....++..|+|||.+.+..++.++||||||+++|+|++|..||...............   ....+.....
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (283)
T cd05080         159 EGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLE  238 (283)
T ss_pred             CcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhh
Confidence            4322111 12223566799999998888999999999999999999999998754332211111100   0001111111


Q ss_pred             CccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          296 PRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       296 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                      .......+...+..+.+++.+||+.+|++|||++++++.|+..
T Consensus       239 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~  281 (283)
T cd05080         239 RGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM  281 (283)
T ss_pred             cCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence            1222222334567899999999999999999999999988753

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6e-42  Score=308.67  Aligned_cols=255  Identities=22%  Similarity=0.338  Sum_probs=204.1

Q ss_pred             cCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCCh---HhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEE
Q 016594           66 NAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDD---RKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYL  140 (386)
Q Consensus        66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~l  140 (386)
                      ++|.+.+.||.|++|.||+|... +++.||+|.+.......   .....+.+|+.++++++||||+++++++.++. .++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            57899999999999999999965 68999999987533222   23456788999999999999999999997755 899


Q ss_pred             EEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCC
Q 016594          141 IFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPS  220 (386)
Q Consensus       141 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~  220 (386)
                      ++|++.+++|.+++....  .+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||++.....
T Consensus        82 v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~  156 (263)
T cd06625          82 FMEYMPGGSVKDQLKAYG--ALTETVTRKYTRQILEGVEYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQT  156 (263)
T ss_pred             EEEECCCCcHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceeccc
Confidence            999999999999887543  48889999999999999999999   9999999999999999999999999999876543


Q ss_pred             CCcccc-ccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccC
Q 016594          221 QWTHHS-IAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQ  299 (386)
Q Consensus       221 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (386)
                      ...... .....++..|+|||++.+..++.++||||||+++|+|++|+.||.......... .          .......
T Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~-~----------~~~~~~~  225 (263)
T cd06625         157 ICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIF-K----------IATQPTN  225 (263)
T ss_pred             cccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHH-H----------HhccCCC
Confidence            211111 123457889999999999889999999999999999999999997643221110 0          0011111


Q ss_pred             CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 016594          300 GAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVML  336 (386)
Q Consensus       300 ~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~  336 (386)
                      ...+...+..+.+++.+||..+|.+|||+.+++++.+
T Consensus       226 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~  262 (263)
T cd06625         226 PQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFF  262 (263)
T ss_pred             CCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCC
Confidence            1222334567899999999999999999999998753

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=3.2e-42  Score=313.60  Aligned_cols=251  Identities=25%  Similarity=0.306  Sum_probs=198.0

Q ss_pred             ecccCCcEEEEEEEC-CCcEEEEEEeccccCC-hHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEEEeccCCCH
Q 016594           74 VGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTD-DRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQFSSRGSV  150 (386)
Q Consensus        74 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~~~~~~L  150 (386)
                      ||+|+||+||+|.+. +++.||+|.+...... ......+..|+.+++.++|+||+++.+++..+. .+++|||+.+|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            699999999999976 6889999998753222 223356778999999999999999999887655 8999999999999


Q ss_pred             hhhhhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCcccccc
Q 016594          151 ASLFHDV--NSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIA  228 (386)
Q Consensus       151 ~~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  228 (386)
                      ...+...  ....+++..+..++.|++.||.|||+   ++|+||||||+||+++.++.++|+|||++..+.....  ...
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~~  155 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ---RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTK  155 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--ccc
Confidence            8876432  23458999999999999999999999   9999999999999999999999999999976644321  223


Q ss_pred             ccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCCCCCHHHHH
Q 016594          229 PIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQLN  308 (386)
Q Consensus       229 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (386)
                      ...||+.|+|||++.+..++.++|||||||++|+|++|+.||..........  .     ....+....  ...+...+.
T Consensus       156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~--~-----~~~~~~~~~--~~~~~~~~~  226 (280)
T cd05608         156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENK--E-----LKQRILNDS--VTYPDKFSP  226 (280)
T ss_pred             ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHH--H-----HHHhhcccC--CCCcccCCH
Confidence            4568999999999999999999999999999999999999997643211000  0     000011111  112233457


Q ss_pred             HHHHHHHHccccCCCCCC-----CHHHHHHHHhcC
Q 016594          309 RLAFAASLCIRASPTWRP-----TMSEVLEVMLEG  338 (386)
Q Consensus       309 ~l~~li~~cl~~dP~~Rp-----t~~~il~~l~~~  338 (386)
                      .+.+++.+||+.||++||     ++++++++-+..
T Consensus       227 ~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~  261 (280)
T cd05608         227 ASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFR  261 (280)
T ss_pred             HHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhh
Confidence            799999999999999999     778888875543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.3e-42  Score=322.00  Aligned_cols=244  Identities=23%  Similarity=0.284  Sum_probs=196.0

Q ss_pred             CeecccCCcEEEEEEE----CCCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEEEecc
Q 016594           72 NLVGRGGYAEVYKGVL----QDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQFSS  146 (386)
Q Consensus        72 ~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~~~  146 (386)
                      +.||+|+||.||++..    .+|+.||+|++............+..|+.++++++||||+++++++.+++ .|+||||+.
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            6799999999999875    25789999999864433334456778999999999999999999997765 899999999


Q ss_pred             CCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCcccc
Q 016594          147 RGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHS  226 (386)
Q Consensus       147 ~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  226 (386)
                      +++|.+++...  ..+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||++.......  ..
T Consensus        82 ~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--~~  154 (318)
T cd05582          82 GGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--KK  154 (318)
T ss_pred             CCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC--Cc
Confidence            99999988653  348999999999999999999999   999999999999999999999999999987654321  12


Q ss_pred             ccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCCCCCHHH
Q 016594          227 IAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQ  306 (386)
Q Consensus       227 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (386)
                      .....|++.|+|||.+.+..++.++|||||||++|+|++|+.||.........  ..+         ....  ...+...
T Consensus       155 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~--~~i---------~~~~--~~~p~~~  221 (318)
T cd05582         155 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETM--TMI---------LKAK--LGMPQFL  221 (318)
T ss_pred             eecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHH--HHH---------HcCC--CCCCCCC
Confidence            23456899999999999988999999999999999999999999865432111  100         0000  0112234


Q ss_pred             HHHHHHHHHHccccCCCCCCC-----HHHHHHHH
Q 016594          307 LNRLAFAASLCIRASPTWRPT-----MSEVLEVM  335 (386)
Q Consensus       307 ~~~l~~li~~cl~~dP~~Rpt-----~~~il~~l  335 (386)
                      +..+.+++.+||+.||++||+     +.+++.+.
T Consensus       222 ~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~  255 (318)
T cd05582         222 SPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHP  255 (318)
T ss_pred             CHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCC
Confidence            567899999999999999999     45566553

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.4e-42  Score=310.00  Aligned_cols=256  Identities=24%  Similarity=0.396  Sum_probs=207.3

Q ss_pred             HHhcCCCCCCeecccCCcEEEEEEECCCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeC-ceEEE
Q 016594           63 IATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDN-GLYLI  141 (386)
Q Consensus        63 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv  141 (386)
                      +..++|.+.+.||.|+||.||+|.++++..||||.+....   .....+.+|+.+++.++|+||+++++++... ..+++
T Consensus         3 ~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v   79 (261)
T cd05034           3 IPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT---MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIV   79 (261)
T ss_pred             cchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc---cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEE
Confidence            5567899999999999999999998878889999987532   2345788999999999999999999998774 48999


Q ss_pred             EEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCC
Q 016594          142 FQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQ  221 (386)
Q Consensus       142 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  221 (386)
                      ||++.+++|.+++.......+++..+..++.|++.||.|||+   ++++|+||||+||+++.++.++|+|||++..+...
T Consensus        80 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~  156 (261)
T cd05034          80 TEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLES---RNYIHRDLAARNILVGENLVCKIADFGLARLIEDD  156 (261)
T ss_pred             EeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcchheEEEcCCCCEEECccccceeccch
Confidence            999999999999977665668999999999999999999999   99999999999999999999999999998876532


Q ss_pred             CccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCchhhhhhhhhhhcccccccccCCccCC
Q 016594          222 WTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQG  300 (386)
Q Consensus       222 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (386)
                      .. .......++..|+|||.+.+..++.++||||||+++|+|++ |+.||.+......  ....          ......
T Consensus       157 ~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~--~~~~----------~~~~~~  223 (261)
T cd05034         157 EY-TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREV--LEQV----------ERGYRM  223 (261)
T ss_pred             hh-hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH--HHHH----------HcCCCC
Confidence            11 11112234567999999998889999999999999999998 9999976432210  0000          000111


Q ss_pred             CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 016594          301 AYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLE  337 (386)
Q Consensus       301 ~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~  337 (386)
                      ..+...+..+.+++.+||+.+|++||++.++++.|+.
T Consensus       224 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         224 PRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence            1112235679999999999999999999999988753

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=2.9e-42  Score=319.95  Aligned_cols=246  Identities=22%  Similarity=0.305  Sum_probs=196.9

Q ss_pred             CeecccCCcEEEEEEEC-CCcEEEEEEeccccC-ChHhHHHHHHHHHHHhcc-CCCceeeecceEEeCc-eEEEEEeccC
Q 016594           72 NLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVT-DDRKEKEFLTEIGTIGHV-CHPNVLSLLGCCVDNG-LYLIFQFSSR  147 (386)
Q Consensus        72 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~-~~lv~e~~~~  147 (386)
                      +.||+|+||.||+|..+ +++.||+|++.+... .......+..|..++..+ +||||+++++++.+++ .++||||+.+
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            46999999999999976 578999999875322 233445677888888866 6999999999998765 8999999999


Q ss_pred             CCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCccccc
Q 016594          148 GSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSI  227 (386)
Q Consensus       148 ~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  227 (386)
                      ++|...+...  ..+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||++.......  ...
T Consensus        81 ~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~--~~~  153 (321)
T cd05591          81 GDLMFQIQRS--RKFDEPRSRFYAAEVTLALMFLHR---HGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG--VTT  153 (321)
T ss_pred             CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeecccceecccCC--ccc
Confidence            9999888654  348899999999999999999999   999999999999999999999999999987543221  123


Q ss_pred             cccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCCCCCHHHH
Q 016594          228 APIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQL  307 (386)
Q Consensus       228 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (386)
                      ....||+.|+|||++.+..++.++|||||||++|+|++|+.||........  ...+..         ...  ..+...+
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~--~~~i~~---------~~~--~~p~~~~  220 (321)
T cd05591         154 TTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDL--FESILH---------DDV--LYPVWLS  220 (321)
T ss_pred             cccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHH--HHHHHc---------CCC--CCCCCCC
Confidence            345689999999999999999999999999999999999999987543211  111111         000  1112234


Q ss_pred             HHHHHHHHHccccCCCCCC-------CHHHHHHHHhc
Q 016594          308 NRLAFAASLCIRASPTWRP-------TMSEVLEVMLE  337 (386)
Q Consensus       308 ~~l~~li~~cl~~dP~~Rp-------t~~~il~~l~~  337 (386)
                      ..+.+++..||+.||++||       ++.+++++.+.
T Consensus       221 ~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~  257 (321)
T cd05591         221 KEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFF  257 (321)
T ss_pred             HHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCcc
Confidence            6789999999999999999       88899887543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=3.3e-42  Score=320.58  Aligned_cols=250  Identities=22%  Similarity=0.313  Sum_probs=197.4

Q ss_pred             CeecccCCcEEEEEEEC-CCcEEEEEEeccccC-ChHhHHHHHHHHHHHhcc-CCCceeeecceEEeCc-eEEEEEeccC
Q 016594           72 NLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVT-DDRKEKEFLTEIGTIGHV-CHPNVLSLLGCCVDNG-LYLIFQFSSR  147 (386)
Q Consensus        72 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~-~~lv~e~~~~  147 (386)
                      +.||+|+||.||+|.++ +++.||+|++.+... .......+.+|..++..+ +||||+++++++.+.. .++||||+.+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            46999999999999976 688999999986432 233445678899999888 6999999999997765 8999999999


Q ss_pred             CCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCccccc
Q 016594          148 GSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSI  227 (386)
Q Consensus       148 ~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  227 (386)
                      |+|..++...  ..+++..+..++.|++.||.|||+   ++++||||||+|||++.++.+||+|||++......  ....
T Consensus        81 g~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--~~~~  153 (329)
T cd05588          81 GDLMFHMQRQ--RKLPEEHARFYSAEISLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP--GDTT  153 (329)
T ss_pred             CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEECcCccccccccC--CCcc
Confidence            9998887654  348999999999999999999999   99999999999999999999999999998743211  1123


Q ss_pred             cccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchh------hhhhhhhhhcccccccccCCccCCC
Q 016594          228 APIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQS------LHSWAKPILNQGEIEKLVDPRLQGA  301 (386)
Q Consensus       228 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~  301 (386)
                      ...+||+.|+|||++.+..++.++|||||||++|+|++|+.||......      ...+....        +.....  .
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~--------~~~~~~--~  223 (329)
T cd05588         154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQV--------ILEKQI--R  223 (329)
T ss_pred             ccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHH--------HHcCCC--C
Confidence            3457999999999999999999999999999999999999999642110      00011100        111111  1


Q ss_pred             CCHHHHHHHHHHHHHccccCCCCCCC------HHHHHHHHhcC
Q 016594          302 YDVTQLNRLAFAASLCIRASPTWRPT------MSEVLEVMLEG  338 (386)
Q Consensus       302 ~~~~~~~~l~~li~~cl~~dP~~Rpt------~~~il~~l~~~  338 (386)
                      .+...+..+.+++.+||+.||.+||+      +.++++|-+..
T Consensus       224 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~  266 (329)
T cd05588         224 IPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFR  266 (329)
T ss_pred             CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCC
Confidence            22234567899999999999999997      78888875543

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=4.2e-42  Score=314.55  Aligned_cols=258  Identities=21%  Similarity=0.329  Sum_probs=204.6

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEC------CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-
Q 016594           65 TNAFSSENLVGRGGYAEVYKGVLQ------DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-  137 (386)
Q Consensus        65 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-  137 (386)
                      ..+|.+.+.||+|+||.||+|.+.      ++..+++|.+..  ........+.+|+.+++.++|+||+++++++.... 
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   81 (291)
T cd05094           4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKD--PTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDP   81 (291)
T ss_pred             hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCC--ccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCc
Confidence            356888899999999999999843      345688888764  22344567889999999999999999999997655 


Q ss_pred             eEEEEEeccCCCHhhhhhhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcC
Q 016594          138 LYLIFQFSSRGSVASLFHDVN--------------SPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTA  203 (386)
Q Consensus       138 ~~lv~e~~~~~~L~~~~~~~~--------------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~  203 (386)
                      .++||||+.+++|.+++....              ...+++..++.++.|++.||+|||+   ++++||||||+||+++.
T Consensus        82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Nil~~~  158 (291)
T cd05094          82 LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS---QHFVHRDLATRNCLVGA  158 (291)
T ss_pred             eEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEcc
Confidence            899999999999999986532              1347899999999999999999999   99999999999999999


Q ss_pred             CCCeEEeecCccccCCCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCchhhhhhhh
Q 016594          204 DFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAK  282 (386)
Q Consensus       204 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~  282 (386)
                      ++.++|+|||++................++..|+|||.+.+..++.++|||||||++|+|++ |..||........  ..
T Consensus       159 ~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~--~~  236 (291)
T cd05094         159 NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEV--IE  236 (291)
T ss_pred             CCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH--HH
Confidence            99999999999976544322222233446788999999999999999999999999999999 9999866433210  00


Q ss_pred             hhhcccccccccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCC
Q 016594          283 PILNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEGD  339 (386)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~~  339 (386)
                       .......         ...+...+..+.+++.+||+.+|++||++.+|++.|....
T Consensus       237 -~~~~~~~---------~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~  283 (291)
T cd05094         237 -CITQGRV---------LERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALG  283 (291)
T ss_pred             -HHhCCCC---------CCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHH
Confidence             0111110         1111223567999999999999999999999999987653

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=9.7e-43  Score=323.26  Aligned_cols=264  Identities=23%  Similarity=0.423  Sum_probs=221.2

Q ss_pred             HHHHHHHhcCCCCCCeecccCCcEEEEEEEC---CC--cEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecce
Q 016594           58 FEEISIATNAFSSENLVGRGGYAEVYKGVLQ---DG--EEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC  132 (386)
Q Consensus        58 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~---~~--~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~  132 (386)
                      ....++......+.+.||.|.||.||+|.+-   .|  -.||||..+.. ........|+.|+.+|+++.|||||+++|+
T Consensus       381 ~rnyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d-~t~d~tekflqEa~iMrnfdHphIikLIGv  459 (974)
T KOG4257|consen  381 VRNYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTD-CTPDDTEKFLQEASIMRNFDHPHIIKLIGV  459 (974)
T ss_pred             CCcceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccC-CChhhHHHHHHHHHHHHhCCCcchhheeee
Confidence            3344556667778899999999999999953   23  35889987753 334557889999999999999999999999


Q ss_pred             EEeCceEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeec
Q 016594          133 CVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDF  212 (386)
Q Consensus       133 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Df  212 (386)
                      |.+...++|||.+.-|.|..+++.++. .++......+..||+.||+|||+   .++|||||-.+|||+.....|||+||
T Consensus       460 ~~e~P~WivmEL~~~GELr~yLq~nk~-sL~l~tL~ly~~Qi~talaYLeS---krfVHRDIAaRNiLVsSp~CVKLaDF  535 (974)
T KOG4257|consen  460 CVEQPMWIVMELAPLGELREYLQQNKD-SLPLRTLTLYCYQICTALAYLES---KRFVHRDIAARNILVSSPQCVKLADF  535 (974)
T ss_pred             eeccceeEEEecccchhHHHHHHhccc-cchHHHHHHHHHHHHHHHHHHHh---hchhhhhhhhhheeecCcceeeeccc
Confidence            999999999999999999999987554 48888999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCchhhhhhhhhhhcccccc
Q 016594          213 GLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGEIE  291 (386)
Q Consensus       213 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~  291 (386)
                      |+++.+...... ......-..-|||||.+.-..++.++|||.|||++||++. |..||.+.            .+..+.
T Consensus       536 GLSR~~ed~~yY-kaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgv------------kNsDVI  602 (974)
T KOG4257|consen  536 GLSRYLEDDAYY-KASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGV------------KNSDVI  602 (974)
T ss_pred             chhhhccccchh-hccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccc------------cccceE
Confidence            999998765322 2222223456999999999999999999999999999998 99999884            333444


Q ss_pred             cccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCC
Q 016594          292 KLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEGD  339 (386)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~~  339 (386)
                      -.+...-+.+.+..++..+..|+.+||+++|.+||.+.+|...|.+..
T Consensus       603 ~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~  650 (974)
T KOG4257|consen  603 GHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVL  650 (974)
T ss_pred             EEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHH
Confidence            445556667778888999999999999999999999999987765443

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=3.7e-42  Score=319.54  Aligned_cols=248  Identities=23%  Similarity=0.320  Sum_probs=198.0

Q ss_pred             CCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccC-ChHhHHHHHHHHHHHhccC-CCceeeecceEEeCc-eEEEE
Q 016594           67 AFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVT-DDRKEKEFLTEIGTIGHVC-HPNVLSLLGCCVDNG-LYLIF  142 (386)
Q Consensus        67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~-~~lv~  142 (386)
                      +|.+.+.||+|+||.||+|... +++.||+|++.+... .......+..|..++..+. |++|+++++++.+.+ .++||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            4788999999999999999976 578999999876322 2233445677888887774 899999999987755 89999


Q ss_pred             EeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCC
Q 016594          143 QFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQW  222 (386)
Q Consensus       143 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  222 (386)
                      ||+.+|+|...+....  .+++..+..++.|++.||+|||+   ++|+||||||+|||++.++.+||+|||++.......
T Consensus        81 E~~~~g~L~~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~  155 (323)
T cd05616          81 EYVNGGDLMYQIQQVG--RFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG  155 (323)
T ss_pred             cCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCEEecCCCHHHeEECCCCcEEEccCCCceecCCCC
Confidence            9999999998886543  48899999999999999999999   999999999999999999999999999987543211


Q ss_pred             ccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCCCC
Q 016594          223 THHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAY  302 (386)
Q Consensus       223 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (386)
                        .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+......  ...+         ....  ..+
T Consensus       156 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~--~~~i---------~~~~--~~~  220 (323)
T cd05616         156 --VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL--FQSI---------MEHN--VAY  220 (323)
T ss_pred             --CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHH--HHHH---------HhCC--CCC
Confidence              123345699999999999999999999999999999999999999987543211  1111         1111  112


Q ss_pred             CHHHHHHHHHHHHHccccCCCCCCCH-----HHHHHH
Q 016594          303 DVTQLNRLAFAASLCIRASPTWRPTM-----SEVLEV  334 (386)
Q Consensus       303 ~~~~~~~l~~li~~cl~~dP~~Rpt~-----~~il~~  334 (386)
                      +...+..+.+++.+||+.+|.+|++.     .+++++
T Consensus       221 p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h  257 (323)
T cd05616         221 PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH  257 (323)
T ss_pred             CCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcC
Confidence            22345678999999999999999984     677665

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=9.3e-44  Score=300.61  Aligned_cols=257  Identities=26%  Similarity=0.353  Sum_probs=208.8

Q ss_pred             HHhcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCCh------HhHHHHHHHHHHHhccC-CCceeeecceEE
Q 016594           63 IATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDD------RKEKEFLTEIGTIGHVC-HPNVLSLLGCCV  134 (386)
Q Consensus        63 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~------~~~~~~~~e~~~l~~l~-h~niv~l~~~~~  134 (386)
                      -..+.|.-.+.||.|..+.|.++.++ +|+.+|+|++.......      .-...-.+|+.+|+++. ||+|+++.++++
T Consensus        14 ~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ye   93 (411)
T KOG0599|consen   14 GFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYE   93 (411)
T ss_pred             hHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeecc
Confidence            34567788899999999999999876 78999999887532211      12234567999999986 999999999998


Q ss_pred             eCc-eEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecC
Q 016594          135 DNG-LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFG  213 (386)
Q Consensus       135 ~~~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg  213 (386)
                      .+. .++|++.++.|.|.+++.+.-.  +++.....|+.|+.+|++|||.   ++||||||||+|||++++.++||+|||
T Consensus        94 s~sF~FlVFdl~prGELFDyLts~Vt--lSEK~tR~iMrqlfegVeylHa---~~IVHRDLKpENILlddn~~i~isDFG  168 (411)
T KOG0599|consen   94 SDAFVFLVFDLMPRGELFDYLTSKVT--LSEKETRRIMRQLFEGVEYLHA---RNIVHRDLKPENILLDDNMNIKISDFG  168 (411)
T ss_pred             CcchhhhhhhhcccchHHHHhhhhee--ecHHHHHHHHHHHHHHHHHHHH---hhhhhcccChhheeeccccceEEeccc
Confidence            877 8899999999999999976544  8999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCCccccccccccccCccChhhhcc------CCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcc
Q 016594          214 LAKWLPSQWTHHSIAPIEGTFGHLAPEYFMH------GIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQ  287 (386)
Q Consensus       214 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~  287 (386)
                      +|+.+...   ......||||+|+|||.+..      ..|+..+|+|++|+|+|.|+.|.+||....+-.+-        
T Consensus       169 Fa~~l~~G---ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlML--------  237 (411)
T KOG0599|consen  169 FACQLEPG---EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLML--------  237 (411)
T ss_pred             eeeccCCc---hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHH--------
Confidence            99988654   34567889999999998853      45889999999999999999999999764332111        


Q ss_pred             cccccccCCccCC--CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          288 GEIEKLVDPRLQG--AYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       288 ~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                         ..+.....+.  +.-.+.+....+||.+||+.||.+|.|++++|.|.+..
T Consensus       238 ---R~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~  287 (411)
T KOG0599|consen  238 ---RMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFI  287 (411)
T ss_pred             ---HHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHH
Confidence               1111111111  11123467799999999999999999999999987664

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=3.4e-42  Score=314.19  Aligned_cols=256  Identities=27%  Similarity=0.340  Sum_probs=204.7

Q ss_pred             CCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCC-hHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEEEe
Q 016594           68 FSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTD-DRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQF  144 (386)
Q Consensus        68 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~  144 (386)
                      |+..+.||+|+||.||+|.+. +++.||+|.+...... ......+.+|+.++++++|+||+++++.+.++. .+++|||
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence            677889999999999999976 6889999998753322 233456778999999999999999999987655 8999999


Q ss_pred             ccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCcc
Q 016594          145 SSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTH  224 (386)
Q Consensus       145 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  224 (386)
                      +.+++|.+++.......+++..+..++.|++.||.|||+   ++|+||||||+||+++.++.++|+|||++.......  
T Consensus        82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~--  156 (285)
T cd05630          82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQ---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ--  156 (285)
T ss_pred             cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc--
Confidence            999999998866555569999999999999999999999   999999999999999999999999999987654322  


Q ss_pred             ccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCCCCCH
Q 016594          225 HSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDV  304 (386)
Q Consensus       225 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (386)
                       ......|+..|+|||++.+..++.++|||||||++|+|++|..||............        ..... ......+.
T Consensus       157 -~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~--------~~~~~-~~~~~~~~  226 (285)
T cd05630         157 -TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEV--------ERLVK-EVQEEYSE  226 (285)
T ss_pred             -cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHH--------Hhhhh-hhhhhcCc
Confidence             122346899999999999999999999999999999999999999864321110000        00000 00111222


Q ss_pred             HHHHHHHHHHHHccccCCCCCCC-----HHHHHHHHhcC
Q 016594          305 TQLNRLAFAASLCIRASPTWRPT-----MSEVLEVMLEG  338 (386)
Q Consensus       305 ~~~~~l~~li~~cl~~dP~~Rpt-----~~~il~~l~~~  338 (386)
                      ..+..+.+++.+||+.||++|||     +.+++++-+..
T Consensus       227 ~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~  265 (285)
T cd05630         227 KFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFK  265 (285)
T ss_pred             cCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhh
Confidence            34567899999999999999999     89999876543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=8.1e-42  Score=316.19  Aligned_cols=246  Identities=24%  Similarity=0.301  Sum_probs=193.8

Q ss_pred             CeecccCCcEEEEEEEC-CCcEEEEEEeccccC-ChHhHHHHHHHHHHHhcc-CCCceeeecceEEeCc-eEEEEEeccC
Q 016594           72 NLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVT-DDRKEKEFLTEIGTIGHV-CHPNVLSLLGCCVDNG-LYLIFQFSSR  147 (386)
Q Consensus        72 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~-~~lv~e~~~~  147 (386)
                      +.||+|+||.||+|.++ +|..||+|++..... .......+..|..++..+ +||||+++++++.+++ .++||||+.+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            46999999999999987 688999999975321 122344566777777654 7999999999998765 8999999999


Q ss_pred             CCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCccccc
Q 016594          148 GSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSI  227 (386)
Q Consensus       148 ~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  227 (386)
                      ++|..++...  ..+++..+..++.|++.||+|||+   ++|+||||||+|||++.++.+||+|||++......  ....
T Consensus        81 g~L~~~i~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~  153 (316)
T cd05620          81 GDLMFHIQDK--GRFDLYRATFYAAEIVCGLQFLHS---KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG--DNRA  153 (316)
T ss_pred             CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEeCccCCCeecccC--CCce
Confidence            9999888653  348899999999999999999999   99999999999999999999999999998743221  1223


Q ss_pred             cccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCCCCCHHHH
Q 016594          228 APIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQL  307 (386)
Q Consensus       228 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (386)
                      ....||+.|+|||++.+..++.++|||||||++|+|++|..||.+......  ......       ..+    ..+...+
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~--~~~~~~-------~~~----~~~~~~~  220 (316)
T cd05620         154 STFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDEL--FESIRV-------DTP----HYPRWIT  220 (316)
T ss_pred             eccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH--HHHHHh-------CCC----CCCCCCC
Confidence            446699999999999999999999999999999999999999976543211  110000       011    1112235


Q ss_pred             HHHHHHHHHccccCCCCCCCH-HHHHHHHhc
Q 016594          308 NRLAFAASLCIRASPTWRPTM-SEVLEVMLE  337 (386)
Q Consensus       308 ~~l~~li~~cl~~dP~~Rpt~-~~il~~l~~  337 (386)
                      ..+.+++.+||+.||++||++ +++++|.+.
T Consensus       221 ~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f  251 (316)
T cd05620         221 KESKDILEKLFERDPTRRLGVVGNIRGHPFF  251 (316)
T ss_pred             HHHHHHHHHHccCCHHHcCCChHHHHcCCCc
Confidence            678999999999999999998 467766433

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=2.5e-42  Score=310.43  Aligned_cols=255  Identities=25%  Similarity=0.434  Sum_probs=202.0

Q ss_pred             CCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEEEec
Q 016594           68 FSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQFS  145 (386)
Q Consensus        68 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~~  145 (386)
                      |++.+.||+|+||+||+|... +++.||+|++..............+|+.++++++||||+++++++.+.. .+++|+++
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            567889999999999999987 5678999999875444444445567999999999999999999998755 89999999


Q ss_pred             cCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCccc
Q 016594          146 SRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHH  225 (386)
Q Consensus       146 ~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  225 (386)
                      .+++|.+++...  ..+++..++.++.|++.||.+||+   ++++|+||||+||+++.++.++|+|||.+.....  ...
T Consensus        81 ~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~Lh~---~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~--~~~  153 (260)
T PF00069_consen   81 PGGSLQDYLQKN--KPLSEEEILKIAYQILEALAYLHS---KGIVHRDIKPENILLDENGEVKLIDFGSSVKLSE--NNE  153 (260)
T ss_dssp             TTEBHHHHHHHH--SSBBHHHHHHHHHHHHHHHHHHHH---TTEEESSBSGGGEEESTTSEEEESSGTTTEESTS--TTS
T ss_pred             cccccccccccc--cccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc--ccc
Confidence            999999998833  348999999999999999999999   9999999999999999999999999999986521  222


Q ss_pred             cccccccccCccChhhhc-cCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCCCCCH
Q 016594          226 SIAPIEGTFGHLAPEYFM-HGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDV  304 (386)
Q Consensus       226 ~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (386)
                      ......++..|+|||++. +..++.++||||||+++|+|++|..||.........................      ...
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~  227 (260)
T PF00069_consen  154 NFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQ------QSR  227 (260)
T ss_dssp             EBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTT------SHT
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccccccccccc------ccc
Confidence            344566899999999998 8889999999999999999999999998762111111100000000000000      000


Q ss_pred             HHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 016594          305 TQLNRLAFAASLCIRASPTWRPTMSEVLEVM  335 (386)
Q Consensus       305 ~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l  335 (386)
                      .....+.+++.+||+.||++||++.+++++-
T Consensus       228 ~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~  258 (260)
T PF00069_consen  228 EKSEELRDLIKKMLSKDPEQRPSAEELLKHP  258 (260)
T ss_dssp             TSHHHHHHHHHHHSSSSGGGSTTHHHHHTSG
T ss_pred             hhHHHHHHHHHHHccCChhHCcCHHHHhcCC
Confidence            1127799999999999999999999999764

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=2.3e-42  Score=318.76  Aligned_cols=261  Identities=26%  Similarity=0.409  Sum_probs=204.7

Q ss_pred             HHhcCCCCCCeecccCCcEEEEEEEC--------CCcEEEEEEeccccCChHhHHHHHHHHHHHhcc-CCCceeeecceE
Q 016594           63 IATNAFSSENLVGRGGYAEVYKGVLQ--------DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHV-CHPNVLSLLGCC  133 (386)
Q Consensus        63 ~~~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~  133 (386)
                      +..++|.+.+.||+|+||.||+|.+.        +...+|+|.+.... .......+..|+.+++.+ +||||+++++++
T Consensus        15 ~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~   93 (307)
T cd05098          15 VPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGAC   93 (307)
T ss_pred             eehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC-ChHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence            44567999999999999999999853        23469999987532 234456788899999999 699999999999


Q ss_pred             EeCc-eEEEEEeccCCCHhhhhhhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCC
Q 016594          134 VDNG-LYLIFQFSSRGSVASLFHDVNS--------------PGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSN  198 (386)
Q Consensus       134 ~~~~-~~lv~e~~~~~~L~~~~~~~~~--------------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~N  198 (386)
                      ...+ .+++|||+.+++|.+++.....              ..+++..++.++.|++.||+|||+   ++++||||||+|
T Consensus        94 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~N  170 (307)
T cd05098          94 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS---KKCIHRDLAARN  170 (307)
T ss_pred             ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHHh
Confidence            7755 8999999999999999876432              247889999999999999999999   999999999999


Q ss_pred             eeEcCCCCeEEeecCccccCCCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCchhh
Q 016594          199 ILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSL  277 (386)
Q Consensus       199 ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~  277 (386)
                      |+++.++.+||+|||++................++..|+|||.+.+..++.++|||||||++|+|++ |..||.......
T Consensus       171 ill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~  250 (307)
T cd05098         171 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE  250 (307)
T ss_pred             eEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHH
Confidence            9999999999999999876543211111122234568999999999889999999999999999998 899997643221


Q ss_pred             hhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCC
Q 016594          278 HSWAKPILNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEGD  339 (386)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~~  339 (386)
                        .... ...         ......+...+..+.+++.+||..+|.+||++.++++.|....
T Consensus       251 --~~~~-~~~---------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~  300 (307)
T cd05098         251 --LFKL-LKE---------GHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL  300 (307)
T ss_pred             --HHHH-HHc---------CCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHH
Confidence              1110 111         1111122234567899999999999999999999999987643

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-43  Score=330.84  Aligned_cols=257  Identities=25%  Similarity=0.394  Sum_probs=220.9

Q ss_pred             HHhcCCCCCCeecccCCcEEEEEEEC--CCc--EEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCce
Q 016594           63 IATNAFSSENLVGRGGYAEVYKGVLQ--DGE--EIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNGL  138 (386)
Q Consensus        63 ~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~--~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  138 (386)
                      |..+...+.++||+|+||.|++|.|.  +|+  .||||.+....... ....|++|+.+|.+|.|+|+++|||+..+...
T Consensus       107 Ipee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~-~mddflrEas~M~~L~H~hliRLyGvVl~qp~  185 (1039)
T KOG0199|consen  107 IPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA-IMDDFLREASHMLKLQHPHLIRLYGVVLDQPA  185 (1039)
T ss_pred             ccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch-hHHHHHHHHHHHHhccCcceeEEeeeeccchh
Confidence            34455667889999999999999986  344  58999998644333 56789999999999999999999999999889


Q ss_pred             EEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccC
Q 016594          139 YLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWL  218 (386)
Q Consensus       139 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~  218 (386)
                      .+|+|.+..|+|.+.+++.....|.......++.||+.|+.||.+   +++|||||-..|+||.....|||+|||+.+.+
T Consensus       186 mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLes---krlvHRDLAARNlllasprtVKI~DFGLmRaL  262 (1039)
T KOG0199|consen  186 MMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLES---KRLVHRDLAARNLLLASPRTVKICDFGLMRAL  262 (1039)
T ss_pred             hHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhhhheecccceeeeecccceecc
Confidence            999999999999999988667779999999999999999999999   99999999999999999989999999999998


Q ss_pred             CCCCccccccccc-cccCccChhhhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCchhhhhhhhhhhcccccccccCC
Q 016594          219 PSQWTHHSIAPIE-GTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGEIEKLVDP  296 (386)
Q Consensus       219 ~~~~~~~~~~~~~-gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (386)
                      ......+.+.... -...|+|||.+....++.++|||+|||+||||++ |..||.+...            ..+.+.++.
T Consensus       263 g~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g------------~qIL~~iD~  330 (1039)
T KOG0199|consen  263 GENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG------------IQILKNIDA  330 (1039)
T ss_pred             CCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH------------HHHHHhccc
Confidence            8766555444322 3557999999999999999999999999999999 9999988533            234455566


Q ss_pred             ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 016594          297 RLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVM  335 (386)
Q Consensus       297 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l  335 (386)
                      ..+...+..+++.+.+++..||..+|.+||||..|.+.+
T Consensus       331 ~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~  369 (1039)
T KOG0199|consen  331 GERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL  369 (1039)
T ss_pred             cccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence            666667778899999999999999999999999997543

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=4e-42  Score=321.88  Aligned_cols=261  Identities=25%  Similarity=0.386  Sum_probs=201.7

Q ss_pred             HHhcCCCCCCeecccCCcEEEEEEE------CCCcEEEEEEeccccCChHhHHHHHHHHHHHhcc-CCCceeeecceEEe
Q 016594           63 IATNAFSSENLVGRGGYAEVYKGVL------QDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHV-CHPNVLSLLGCCVD  135 (386)
Q Consensus        63 ~~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~  135 (386)
                      ...++|++.+.||.|+||.||+|.+      .+++.||||++.... .......+.+|+.++.++ +||||+++++++..
T Consensus         4 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~   82 (343)
T cd05103           4 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTK   82 (343)
T ss_pred             cchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC-ChHHHHHHHHHHHHHHhccCCccHhhhcceeec
Confidence            3456899999999999999999974      246789999987532 233456788999999999 58999999998865


Q ss_pred             C--ceEEEEEeccCCCHhhhhhhcC-------------------------------------------------------
Q 016594          136 N--GLYLIFQFSSRGSVASLFHDVN-------------------------------------------------------  158 (386)
Q Consensus       136 ~--~~~lv~e~~~~~~L~~~~~~~~-------------------------------------------------------  158 (386)
                      .  ..+++|||+.+|+|.+++....                                                       
T Consensus        83 ~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (343)
T cd05103          83 PGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVE  162 (343)
T ss_pred             CCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccch
Confidence            3  3789999999999999876421                                                       


Q ss_pred             ----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCcccccc
Q 016594          159 ----------SPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIA  228 (386)
Q Consensus       159 ----------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  228 (386)
                                ...+++..+..++.|++.||+|||+   ++|+||||||+||+++.++.+||+|||++..+..........
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  239 (343)
T cd05103         163 EEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKG  239 (343)
T ss_pred             hhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcC
Confidence                      1236788889999999999999999   999999999999999999999999999998653322211122


Q ss_pred             ccccccCccChhhhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCchhhhhhhhhhhcccccccccCCccCCCCCHHHH
Q 016594          229 PIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQL  307 (386)
Q Consensus       229 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (386)
                      ...++..|+|||.+.+..++.++|||||||++|+|++ |..||......... .. ....+.         ....+...+
T Consensus       240 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~-~~-~~~~~~---------~~~~~~~~~  308 (343)
T cd05103         240 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF-CR-RLKEGT---------RMRAPDYTT  308 (343)
T ss_pred             CCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHH-HH-HHhccC---------CCCCCCCCC
Confidence            2335677999999999999999999999999999997 99999764321110 00 011110         001111123


Q ss_pred             HHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          308 NRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       308 ~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                      ..+.+++..||+.+|++||++.+|+++|...
T Consensus       309 ~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~  339 (343)
T cd05103         309 PEMYQTMLDCWHGEPSQRPTFSELVEHLGNL  339 (343)
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            5689999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=5.2e-42  Score=308.01  Aligned_cols=249  Identities=23%  Similarity=0.371  Sum_probs=202.0

Q ss_pred             HhcCCCCCCeecccCCcEEEEEEECCCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeC--ceEEE
Q 016594           64 ATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDN--GLYLI  141 (386)
Q Consensus        64 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~lv  141 (386)
                      ...+|++.+.||+|+||.||+|... +..||+|.+...    .....+.+|+.+++.++|+|++++++++...  ..+++
T Consensus         4 ~~~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv   78 (256)
T cd05082           4 NMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV   78 (256)
T ss_pred             cHHhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCC----chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEE
Confidence            3457899999999999999999876 788999988642    2345788999999999999999999987543  38999


Q ss_pred             EEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCC
Q 016594          142 FQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQ  221 (386)
Q Consensus       142 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  221 (386)
                      +||+.+++|.+++.......+++..++.++.|++.||+|||+   ++++||||||+||+++.++.+||+|||++......
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~  155 (256)
T cd05082          79 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEA---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST  155 (256)
T ss_pred             EECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeccccchheEEEcCCCcEEecCCccceecccc
Confidence            999999999999887666568999999999999999999999   99999999999999999999999999998765332


Q ss_pred             CccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCchhhhhhhhhhhcccccccccCCccCC
Q 016594          222 WTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQG  300 (386)
Q Consensus       222 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (386)
                      .     ....++..|+|||++.+..++.++|||||||++|+|++ |+.||.......  ..... .         .....
T Consensus       156 ~-----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~--~~~~~-~---------~~~~~  218 (256)
T cd05082         156 Q-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--VVPRV-E---------KGYKM  218 (256)
T ss_pred             C-----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHH-h---------cCCCC
Confidence            1     12234567999999998889999999999999999998 999997543211  11100 0         01111


Q ss_pred             CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 016594          301 AYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLE  337 (386)
Q Consensus       301 ~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~  337 (386)
                      ..+...+..+.+++.+||+.+|++|||+.++++.|..
T Consensus       219 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  255 (256)
T cd05082         219 DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH  255 (256)
T ss_pred             CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence            1222345679999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=3.8e-42  Score=326.69  Aligned_cols=262  Identities=20%  Similarity=0.380  Sum_probs=205.6

Q ss_pred             HHHHhcCCCCCCeecccCCcEEEEEEEC------CCcEEEEEEeccccCChHhHHHHHHHHHHHhccC-CCceeeecceE
Q 016594           61 ISIATNAFSSENLVGRGGYAEVYKGVLQ------DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVC-HPNVLSLLGCC  133 (386)
Q Consensus        61 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~  133 (386)
                      +.+..++|.+.+.||+|+||.||+|++.      .+..||+|++..... ......+.+|+.++..+. ||||+++++++
T Consensus        32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~~H~niv~~~~~~  110 (401)
T cd05107          32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTAR-SSEKQALMSELKIMSHLGPHLNIVNLLGAC  110 (401)
T ss_pred             ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCC-hhHHHHHHHHHHHHHhcCCCCCeEEEEEEE
Confidence            4456677889999999999999999863      246899999975432 223456889999999998 99999999999


Q ss_pred             EeCc-eEEEEEeccCCCHhhhhhhcCC-----------------------------------------------------
Q 016594          134 VDNG-LYLIFQFSSRGSVASLFHDVNS-----------------------------------------------------  159 (386)
Q Consensus       134 ~~~~-~~lv~e~~~~~~L~~~~~~~~~-----------------------------------------------------  159 (386)
                      ...+ .++|+||+.+|+|.+++.....                                                     
T Consensus       111 ~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  190 (401)
T cd05107         111 TKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYV  190 (401)
T ss_pred             ccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCcc
Confidence            7755 8999999999999998864321                                                     


Q ss_pred             -------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCC
Q 016594          160 -------------------------------------------PGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKS  196 (386)
Q Consensus       160 -------------------------------------------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp  196 (386)
                                                                 ..+++..++.++.|++.||.|||+   ++++||||||
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrdlkp  267 (401)
T cd05107         191 PMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLAS---KNCVHRDLAA  267 (401)
T ss_pred             chhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhc---CCcCcccCCc
Confidence                                                       236777888999999999999999   9999999999


Q ss_pred             CCeeEcCCCCeEEeecCccccCCCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCch
Q 016594          197 SNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQ  275 (386)
Q Consensus       197 ~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~  275 (386)
                      +|||++.++.+||+|||++..+.............++..|+|||.+.+..++.++|||||||++|||++ |..||.....
T Consensus       268 ~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~  347 (401)
T cd05107         268 RNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPM  347 (401)
T ss_pred             ceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc
Confidence            999999999999999999986533222112223356788999999998889999999999999999998 8999976432


Q ss_pred             hhhhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 016594          276 SLHSWAKPILNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLE  337 (386)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~  337 (386)
                      ....  ..         .+........+...+..+.+++.+||..+|.+||++.+|++.|+.
T Consensus       348 ~~~~--~~---------~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~  398 (401)
T cd05107         348 NEQF--YN---------AIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGD  398 (401)
T ss_pred             hHHH--HH---------HHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence            1110  00         001111111222345779999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=5.9e-42  Score=311.83  Aligned_cols=255  Identities=18%  Similarity=0.306  Sum_probs=201.7

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEC------CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-
Q 016594           65 TNAFSSENLVGRGGYAEVYKGVLQ------DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-  137 (386)
Q Consensus        65 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-  137 (386)
                      ..+|.+.++||+|+||.||+|...      ++..+|+|.+...  .......+.+|+.+++.+.|+||+++++++.+.. 
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   81 (280)
T cd05092           4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTVLQHQHIVRFYGVCTEGRP   81 (280)
T ss_pred             hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC--CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCc
Confidence            457888999999999999999742      3567899987642  3445567899999999999999999999987755 


Q ss_pred             eEEEEEeccCCCHhhhhhhcCC-------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCC
Q 016594          138 LYLIFQFSSRGSVASLFHDVNS-------------PGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTAD  204 (386)
Q Consensus       138 ~~lv~e~~~~~~L~~~~~~~~~-------------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~  204 (386)
                      .++++||+.+++|.+++.....             ..+++..++.++.|++.||+|||+   ++++||||||+|||++.+
T Consensus        82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~nil~~~~  158 (280)
T cd05092          82 LLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS---LHFVHRDLATRNCLVGQG  158 (280)
T ss_pred             eEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHH---CCeecccccHhhEEEcCC
Confidence            8999999999999998875432             247899999999999999999999   999999999999999999


Q ss_pred             CCeEEeecCccccCCCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCchhhhhhhhh
Q 016594          205 FEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKP  283 (386)
Q Consensus       205 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~  283 (386)
                      +.+||+|||++................+++.|+|||.+.+..++.++|||||||++|+|++ |..||.........  ..
T Consensus       159 ~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~--~~  236 (280)
T cd05092         159 LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAI--EC  236 (280)
T ss_pred             CCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHH--HH
Confidence            9999999999876543222111222335678999999999999999999999999999998 99999654322110  00


Q ss_pred             hhcccccccccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 016594          284 ILNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVML  336 (386)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~  336 (386)
                               ... ......+...+..+.+++.+||+.||.+||++.+|++.|+
T Consensus       237 ---------~~~-~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~  279 (280)
T cd05092         237 ---------ITQ-GRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ  279 (280)
T ss_pred             ---------HHc-CccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence                     000 0011111234567899999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=6.6e-42  Score=307.09  Aligned_cols=250  Identities=20%  Similarity=0.303  Sum_probs=204.1

Q ss_pred             CCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEEEe
Q 016594           67 AFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQF  144 (386)
Q Consensus        67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~  144 (386)
                      +|++.+.||.|+||.||++.+. +++.||+|.+.... .......+.+|+.+++.++|+||+++++++.+++ .+++++|
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   79 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK-SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEY   79 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc-chHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEee
Confidence            4788899999999999999976 68899999986432 2334567788999999999999999999998765 8999999


Q ss_pred             ccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCcc
Q 016594          145 SSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTH  224 (386)
Q Consensus       145 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  224 (386)
                      +.+++|.+++.......+++..++.++.|++.||.|||+   ++++|+||||+||+++.++.++|+|||++..+..... 
T Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-  155 (255)
T cd08219          80 CDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHE---KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA-  155 (255)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEECCCCcEEEcccCcceeeccccc-
Confidence            999999998876555668999999999999999999999   9999999999999999999999999999876643211 


Q ss_pred             ccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCCCCCH
Q 016594          225 HSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDV  304 (386)
Q Consensus       225 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (386)
                       ......|++.|+|||++.+..++.++|+||||+++|+|++|..||.........  ... ..+.         ....+.
T Consensus       156 -~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~--~~~-~~~~---------~~~~~~  222 (255)
T cd08219         156 -YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLI--LKV-CQGS---------YKPLPS  222 (255)
T ss_pred             -ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHH--HHH-hcCC---------CCCCCc
Confidence             223456888999999999888999999999999999999999999864322110  000 0111         111122


Q ss_pred             HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 016594          305 TQLNRLAFAASLCIRASPTWRPTMSEVLEV  334 (386)
Q Consensus       305 ~~~~~l~~li~~cl~~dP~~Rpt~~~il~~  334 (386)
                      ..+..+.+++.+||+.||++||++.+|+..
T Consensus       223 ~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         223 HYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             ccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence            345678999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=7.6e-42  Score=306.92  Aligned_cols=251  Identities=23%  Similarity=0.348  Sum_probs=205.9

Q ss_pred             CCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeC--ceEEEEE
Q 016594           67 AFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDN--GLYLIFQ  143 (386)
Q Consensus        67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~lv~e  143 (386)
                      .|++.+.||+|++|.||++..+ +++.||+|.+............+.+|+.+++.++|+|++++++.+...  ..++++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            4888999999999999999976 578999999876544455566788999999999999999999987643  3789999


Q ss_pred             eccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCc
Q 016594          144 FSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWT  223 (386)
Q Consensus       144 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~  223 (386)
                      |+.+++|.+++.......+++..+..++.|++.||.+||+   ++++|+||||+||+++.++.++|+|||++....... 
T Consensus        81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~---~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~-  156 (257)
T cd08223          81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHE---KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC-  156 (257)
T ss_pred             ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCchhEEEecCCcEEEecccceEEecccC-
Confidence            9999999998877655668999999999999999999999   999999999999999999999999999998764322 


Q ss_pred             cccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCCCCC
Q 016594          224 HHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYD  303 (386)
Q Consensus       224 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (386)
                       .......+++.|+|||++.+..++.++|||||||++|+|++|..||...+....  .... ..+.         ....+
T Consensus       157 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~--~~~~-~~~~---------~~~~~  223 (257)
T cd08223         157 -DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSL--VYRI-IEGK---------LPPMP  223 (257)
T ss_pred             -CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHH--HHHH-HhcC---------CCCCc
Confidence             122345688999999999999999999999999999999999999976442211  1111 0110         01122


Q ss_pred             HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 016594          304 VTQLNRLAFAASLCIRASPTWRPTMSEVLEV  334 (386)
Q Consensus       304 ~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~  334 (386)
                      ...+..+.+++.+||+.+|++||++.+++++
T Consensus       224 ~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  254 (257)
T cd08223         224 KDYSPELGELIATMLSKRPEKRPSVKSILRQ  254 (257)
T ss_pred             cccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence            3355779999999999999999999999976

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=5.8e-42  Score=320.98  Aligned_cols=262  Identities=21%  Similarity=0.274  Sum_probs=199.4

Q ss_pred             HhcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeC------
Q 016594           64 ATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDN------  136 (386)
Q Consensus        64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------  136 (386)
                      ..++|++.+.||.|+||+||+|... +++.||||.+............+.+|+.+++.++||||+++++++...      
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07878          13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF   92 (343)
T ss_pred             hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence            4578999999999999999999975 688999999876444444456678999999999999999999988532      


Q ss_pred             -ceEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCcc
Q 016594          137 -GLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLA  215 (386)
Q Consensus       137 -~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a  215 (386)
                       ..+++++++ +++|..++..   ..+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||++
T Consensus        93 ~~~~~~~~~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~~  165 (343)
T cd07878          93 NEVYLVTNLM-GADLNNIVKC---QKLSDEHVQFLIYQLLRGLKYIHS---AGIIHRDLKPSNVAVNEDCELRILDFGLA  165 (343)
T ss_pred             CcEEEEeecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeecccCChhhEEECCCCCEEEcCCccc
Confidence             257777776 6788877653   348999999999999999999999   99999999999999999999999999999


Q ss_pred             ccCCCCCccccccccccccCccChhhhcc-CCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhh-hhhhhhcc------
Q 016594          216 KWLPSQWTHHSIAPIEGTFGHLAPEYFMH-GIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHS-WAKPILNQ------  287 (386)
Q Consensus       216 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~-~~~~~~~~------  287 (386)
                      ......     .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+....... ........      
T Consensus       166 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  240 (343)
T cd07878         166 RQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVL  240 (343)
T ss_pred             eecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            865432     234568999999999877 56899999999999999999999999765421100 00000000      


Q ss_pred             -----cccccccCCccCCCCC-------HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          288 -----GEIEKLVDPRLQGAYD-------VTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       288 -----~~~~~~~~~~~~~~~~-------~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                           ......... +.....       ......+.+++.+||..||.+|||+.+++++-+..
T Consensus       241 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~  302 (343)
T cd07878         241 KKISSEHARKYIQS-LPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFS  302 (343)
T ss_pred             HhcchhhHHHHhhc-cccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchh
Confidence                 000000000 000000       01124578999999999999999999999986554

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=1.5e-41  Score=316.10  Aligned_cols=262  Identities=21%  Similarity=0.300  Sum_probs=199.8

Q ss_pred             CCCeeccc--CCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEEEec
Q 016594           70 SENLVGRG--GYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQFS  145 (386)
Q Consensus        70 ~~~~lg~G--~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~~  145 (386)
                      +.++||+|  +|++||++..+ +|+.||+|.+............+.+|+.+++.++||||+++++++..++ .++|+||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            46789999  78899999976 7899999999765444455567788999999999999999999997765 89999999


Q ss_pred             cCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCcc-
Q 016594          146 SRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTH-  224 (386)
Q Consensus       146 ~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~-  224 (386)
                      .+++|.+++.......+++..++.++.|++.||.|||+   ++|+||||||+|||++.++.++++||+.+......... 
T Consensus        82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~  158 (327)
T cd08227          82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL  158 (327)
T ss_pred             CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence            99999999876555568999999999999999999999   99999999999999999999999999875443211100 


Q ss_pred             ----ccccccccccCccChhhhcc--CCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccC---
Q 016594          225 ----HSIAPIEGTFGHLAPEYFMH--GIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVD---  295 (386)
Q Consensus       225 ----~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~---  295 (386)
                          .......++..|+|||++.+  ..++.++|||||||++|+|++|..||............  . ...+....+   
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~--~-~~~~~~~~~~~~  235 (327)
T cd08227         159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEK--L-NGTVPCLLDTTT  235 (327)
T ss_pred             cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHH--h-cCCccccccccc
Confidence                01122346778999999976  46899999999999999999999999754321111000  0 000000000   


Q ss_pred             ---------------------------------CccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 016594          296 ---------------------------------PRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLE  337 (386)
Q Consensus       296 ---------------------------------~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~  337 (386)
                                                       ...........+..+.+++.+||+.||++|||+.+++++.+.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f  310 (327)
T cd08227         236 IPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFF  310 (327)
T ss_pred             hhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhh
Confidence                                             000001122335679999999999999999999999997654

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-41  Score=306.10  Aligned_cols=249  Identities=26%  Similarity=0.397  Sum_probs=199.2

Q ss_pred             CeecccCCcEEEEEEEC-C---CcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCceEEEEEeccC
Q 016594           72 NLVGRGGYAEVYKGVLQ-D---GEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNGLYLIFQFSSR  147 (386)
Q Consensus        72 ~~lg~G~~g~V~~~~~~-~---~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~lv~e~~~~  147 (386)
                      +.||+|+||.||+|.+. .   +..||+|.+...... .....+.+|+.+++.+.|+||+++++++..+..+++|+|+.+
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-AGKKEFLREASVMAQLDHPCIVRLIGVCKGEPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEcCCceEEEEEeCCC
Confidence            46999999999999854 2   268999998764333 456678999999999999999999999887779999999999


Q ss_pred             CCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCcccc-
Q 016594          148 GSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHS-  226 (386)
Q Consensus       148 ~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~-  226 (386)
                      ++|.+++....  .+++..+..++.|++.||.|||.   ++++|+||||+|||++.++.+||+|||++..+........ 
T Consensus        80 ~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~  154 (257)
T cd05060          80 GPLLKYLKKRR--EIPVSDLKELAHQVAMGMAYLES---KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRA  154 (257)
T ss_pred             CcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhh---cCeeccCcccceEEEcCCCcEEeccccccceeecCCccccc
Confidence            99999987654  58999999999999999999999   9999999999999999999999999999986643322111 


Q ss_pred             ccccccccCccChhhhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCchhhhhhhhhhhcccccccccCCccCCCCCHH
Q 016594          227 IAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVT  305 (386)
Q Consensus       227 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (386)
                      .....++..|+|||.+.+..++.++|||||||++|+|++ |..||.......  ..... ...         .....+..
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~--~~~~~-~~~---------~~~~~~~~  222 (257)
T cd05060         155 TTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAE--VIAML-ESG---------ERLPRPEE  222 (257)
T ss_pred             ccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHH--HHHHH-HcC---------CcCCCCCC
Confidence            111223567999999998899999999999999999998 999997643311  11111 110         01112223


Q ss_pred             HHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          306 QLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       306 ~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                      .+..+.+++.+||..+|++||++.++++.|...
T Consensus       223 ~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~  255 (257)
T cd05060         223 CPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD  255 (257)
T ss_pred             CCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence            456789999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-41  Score=317.14  Aligned_cols=260  Identities=20%  Similarity=0.225  Sum_probs=199.5

Q ss_pred             cCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEecccc-CChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEE
Q 016594           66 NAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVV-TDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIF  142 (386)
Q Consensus        66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~  142 (386)
                      ++|++.+.||+|+||+||++... +++.||+|++.+.. ........+.+|+.++..++|+||+++++++.+++ .++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            46899999999999999999976 68899999987522 22334456788999999999999999999997765 89999


Q ss_pred             EeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCC
Q 016594          143 QFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQW  222 (386)
Q Consensus       143 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  222 (386)
                      ||+.+++|.+++... ...+++..+..++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||++..+....
T Consensus        81 e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  156 (331)
T cd05597          81 DYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVLAIDSVHQ---LGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG  156 (331)
T ss_pred             ecCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEECCCCHHHEEECCCCCEEEEECCceeecCCCC
Confidence            999999999998653 3348999999999999999999999   999999999999999999999999999987654322


Q ss_pred             ccccccccccccCccChhhhcc-----CCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCc
Q 016594          223 THHSIAPIEGTFGHLAPEYFMH-----GIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPR  297 (386)
Q Consensus       223 ~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (386)
                      . .......||+.|+|||++.+     ..++.++|||||||++|+|++|+.||.......  ....+........+    
T Consensus       157 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~--~~~~i~~~~~~~~~----  229 (331)
T cd05597         157 T-VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE--TYGKIMNHKEHFQF----  229 (331)
T ss_pred             C-ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHH--HHHHHHcCCCcccC----
Confidence            1 11223458999999999873     457889999999999999999999997643211  11111111000000    


Q ss_pred             cCCCCCHHHHHHHHHHHHHccccCCC--CCCCHHHHHHHHhcC
Q 016594          298 LQGAYDVTQLNRLAFAASLCIRASPT--WRPTMSEVLEVMLEG  338 (386)
Q Consensus       298 ~~~~~~~~~~~~l~~li~~cl~~dP~--~Rpt~~~il~~l~~~  338 (386)
                       . ......+..+.+++.+||..++.  .||++.+++++-+..
T Consensus       230 -~-~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~  270 (331)
T cd05597         230 -P-PDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFE  270 (331)
T ss_pred             -C-CccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCC
Confidence             0 01112456788899987765443  378999999986543

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=1.9e-41  Score=306.17  Aligned_cols=258  Identities=25%  Similarity=0.438  Sum_probs=207.3

Q ss_pred             cCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEecccc-CChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEE
Q 016594           66 NAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVV-TDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIF  142 (386)
Q Consensus        66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~  142 (386)
                      ++|++.+.||.|+||.||+|.+. ++..||||.+.... .+......+.+|+.+++.+.|+||+++++++.+++ .+++|
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            46888899999999999999965 78999999886532 23344567889999999999999999999997755 89999


Q ss_pred             EeccCCCHhhhhhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCC
Q 016594          143 QFSSRGSVASLFHDV--NSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPS  220 (386)
Q Consensus       143 e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~  220 (386)
                      +|+.+++|.+++...  ....+++..++.++.|++.||.|||+   ++++|+||||+||+++.++.++|+|||++..+..
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence            999999999988643  23458999999999999999999999   9999999999999999999999999999876643


Q ss_pred             CCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCC
Q 016594          221 QWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQG  300 (386)
Q Consensus       221 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (386)
                      ...  ......++..|+|||++.+..++.++|+||||+++|+|++|..||.+............      ...   ....
T Consensus       159 ~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~------~~~---~~~~  227 (267)
T cd08229         159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKI------EQC---DYPP  227 (267)
T ss_pred             CCc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhh------hcC---CCCC
Confidence            321  12334688899999999988899999999999999999999999976433221111111      000   0111


Q ss_pred             CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 016594          301 AYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLE  337 (386)
Q Consensus       301 ~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~  337 (386)
                      ......+..+.+++.+||..+|.+|||+.+|++.+.+
T Consensus       228 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~  264 (267)
T cd08229         228 LPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKR  264 (267)
T ss_pred             CCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhh
Confidence            1112356789999999999999999999999988765

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=2.9e-42  Score=319.52  Aligned_cols=246  Identities=24%  Similarity=0.323  Sum_probs=197.3

Q ss_pred             CeecccCCcEEEEEEEC-CCcEEEEEEeccccC-ChHhHHHHHHHHHHHhcc-CCCceeeecceEEeCc-eEEEEEeccC
Q 016594           72 NLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVT-DDRKEKEFLTEIGTIGHV-CHPNVLSLLGCCVDNG-LYLIFQFSSR  147 (386)
Q Consensus        72 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~-~~lv~e~~~~  147 (386)
                      +.||+|+||+||+|.++ +++.||+|++.+... .......+..|..++..+ +||||+++++++.+.+ .++||||+.+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999976 578999999986322 223445667888888887 5999999999997765 8999999999


Q ss_pred             CCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCccccc
Q 016594          148 GSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSI  227 (386)
Q Consensus       148 ~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  227 (386)
                      ++|...+....  .+++..+..++.|++.||.|||+   ++++||||||+||+++.++.+||+|||++.......  ...
T Consensus        81 ~~L~~~~~~~~--~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~~  153 (318)
T cd05570          81 GDLMFHIQRSG--RFDEPRARFYAAEIVLGLQFLHE---RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG--VTT  153 (318)
T ss_pred             CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHh---CCeEccCCCHHHeEECCCCcEEecccCCCeecCcCC--Ccc
Confidence            99998876543  48999999999999999999999   999999999999999999999999999987532211  122


Q ss_pred             cccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCCCCCHHHH
Q 016594          228 APIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQL  307 (386)
Q Consensus       228 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (386)
                      ...+|++.|+|||++.+..++.++|||||||++|+|++|+.||.+......  .....         ...  ...+...+
T Consensus       154 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~--~~~i~---------~~~--~~~~~~~~  220 (318)
T cd05570         154 STFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDEL--FQSIL---------EDE--VRYPRWLS  220 (318)
T ss_pred             cceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHH--HHHHH---------cCC--CCCCCcCC
Confidence            345689999999999999999999999999999999999999976543211  11110         100  11122345


Q ss_pred             HHHHHHHHHccccCCCCCCCH-----HHHHHHHhc
Q 016594          308 NRLAFAASLCIRASPTWRPTM-----SEVLEVMLE  337 (386)
Q Consensus       308 ~~l~~li~~cl~~dP~~Rpt~-----~~il~~l~~  337 (386)
                      ..+.+++.+||..||.+||++     .+++++-+.
T Consensus       221 ~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~  255 (318)
T cd05570         221 KEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFF  255 (318)
T ss_pred             HHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCc
Confidence            678999999999999999999     999887544

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.3e-42  Score=306.65  Aligned_cols=250  Identities=24%  Similarity=0.407  Sum_probs=205.5

Q ss_pred             HhcCCCCCCeecccCCcEEEEEEECCCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeC-ceEEEE
Q 016594           64 ATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDN-GLYLIF  142 (386)
Q Consensus        64 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~  142 (386)
                      ..++|++.+.||.|+||.||+|... |+.||+|.+.....   ....+.+|+.+++.++|+||+++++++.+. ..+++|
T Consensus         4 ~~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~   79 (256)
T cd05039           4 NSKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST---AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVT   79 (256)
T ss_pred             ChhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh---HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEE
Confidence            4568899999999999999999876 78999999875422   456789999999999999999999999754 489999


Q ss_pred             EeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCC
Q 016594          143 QFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQW  222 (386)
Q Consensus       143 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  222 (386)
                      ||+.+++|.+++.......+++..+..++.|++.||.|||+   ++++|+||||+||+++.++.++|+|||.+.......
T Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~  156 (256)
T cd05039          80 EYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEE---KNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ  156 (256)
T ss_pred             EecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccchhcccceEEEeCCCCEEEccccccccccccc
Confidence            99999999999987665568999999999999999999999   999999999999999999999999999998763321


Q ss_pred             ccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCchhhhhhhhhhhcccccccccCCccCCC
Q 016594          223 THHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGA  301 (386)
Q Consensus       223 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (386)
                      .     ....+..|+|||.+.+..++.++||||||+++|+|++ |..||.........  .. ..         ......
T Consensus       157 ~-----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~--~~-~~---------~~~~~~  219 (256)
T cd05039         157 D-----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV--PH-VE---------KGYRME  219 (256)
T ss_pred             c-----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHH--HH-Hh---------cCCCCC
Confidence            1     2234567999999988889999999999999999998 99999765322110  00 00         001111


Q ss_pred             CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 016594          302 YDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLE  337 (386)
Q Consensus       302 ~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~  337 (386)
                      .+...+..+.+++.+||..+|++||++.++++.|..
T Consensus       220 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  255 (256)
T cd05039         220 APEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL  255 (256)
T ss_pred             CccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence            122345779999999999999999999999998854

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=8e-42  Score=316.14  Aligned_cols=244  Identities=22%  Similarity=0.306  Sum_probs=192.8

Q ss_pred             CeecccCCcEEEEEEEC-CCcEEEEEEeccccC-ChHhHHHHHHHHHHHhc-cCCCceeeecceEEeCc-eEEEEEeccC
Q 016594           72 NLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVT-DDRKEKEFLTEIGTIGH-VCHPNVLSLLGCCVDNG-LYLIFQFSSR  147 (386)
Q Consensus        72 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~~~-~~lv~e~~~~  147 (386)
                      +.||+|+||+||+|.+. +++.||+|++..... .......+..|..++.. ++||||+++++++.+++ .++||||+.+
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999976 578999999975321 12233456677777775 48999999999997765 8999999999


Q ss_pred             CCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCccccc
Q 016594          148 GSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSI  227 (386)
Q Consensus       148 ~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  227 (386)
                      |+|..++...  ..+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||++.......  ...
T Consensus        81 g~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~  153 (316)
T cd05619          81 GDLMFHIQSC--HKFDLPRATFYAAEIICGLQFLHS---KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD--AKT  153 (316)
T ss_pred             CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC--Cce
Confidence            9999988753  348899999999999999999999   999999999999999999999999999987532211  122


Q ss_pred             cccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCCCCCHHHH
Q 016594          228 APIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQL  307 (386)
Q Consensus       228 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (386)
                      ....||+.|+|||++.+..++.++|||||||++|+|++|..||.+......  .....       ...    ..++...+
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~--~~~i~-------~~~----~~~~~~~~  220 (316)
T cd05619         154 CTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEEL--FQSIR-------MDN----PCYPRWLT  220 (316)
T ss_pred             eeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHH--HHHHH-------hCC----CCCCccCC
Confidence            345689999999999999999999999999999999999999976543211  00000       000    11122245


Q ss_pred             HHHHHHHHHccccCCCCCCCHH-HHHHHH
Q 016594          308 NRLAFAASLCIRASPTWRPTMS-EVLEVM  335 (386)
Q Consensus       308 ~~l~~li~~cl~~dP~~Rpt~~-~il~~l  335 (386)
                      ..+.+++.+||+.||++||++. +++++-
T Consensus       221 ~~~~~li~~~l~~~P~~R~~~~~~l~~h~  249 (316)
T cd05619         221 REAKDILVKLFVREPERRLGVKGDIRQHP  249 (316)
T ss_pred             HHHHHHHHHHhccCHhhcCCChHHHHcCc
Confidence            6789999999999999999997 776653

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=5.7e-42  Score=315.69  Aligned_cols=261  Identities=24%  Similarity=0.416  Sum_probs=206.1

Q ss_pred             HHhcCCCCCCeecccCCcEEEEEEEC--------CCcEEEEEEeccccCChHhHHHHHHHHHHHhcc-CCCceeeecceE
Q 016594           63 IATNAFSSENLVGRGGYAEVYKGVLQ--------DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHV-CHPNVLSLLGCC  133 (386)
Q Consensus        63 ~~~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~  133 (386)
                      +...+|.+.+.||+|+||.||+|.+.        ++..||+|.+... ........+.+|+.+++.+ .||||+++++++
T Consensus        12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~   90 (304)
T cd05101          12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC   90 (304)
T ss_pred             ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccc-cchHHHHHHHHHHHHHHhhccCCCchheeEEE
Confidence            55678899999999999999999741        2347999988643 2234456788999999999 799999999999


Q ss_pred             EeCc-eEEEEEeccCCCHhhhhhhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCC
Q 016594          134 VDNG-LYLIFQFSSRGSVASLFHDVNS--------------PGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSN  198 (386)
Q Consensus       134 ~~~~-~~lv~e~~~~~~L~~~~~~~~~--------------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~N  198 (386)
                      .... .+++|||+.+++|.+++.....              ..+++..+..++.|++.||.|||+   ++++||||||+|
T Consensus        91 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~N  167 (304)
T cd05101          91 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLAS---QKCIHRDLAARN  167 (304)
T ss_pred             ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHH---CCeeecccccce
Confidence            7755 8999999999999998876422              247888899999999999999999   999999999999


Q ss_pred             eeEcCCCCeEEeecCccccCCCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCchhh
Q 016594          199 ILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSL  277 (386)
Q Consensus       199 ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~  277 (386)
                      |+++.++.+||+|||++..+.............++..|+|||++.+..++.++||||||+++|+|++ |..||.+.....
T Consensus       168 ili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~  247 (304)
T cd05101         168 VLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE  247 (304)
T ss_pred             EEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH
Confidence            9999999999999999987654322222233345678999999998889999999999999999998 888887643211


Q ss_pred             hhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCC
Q 016594          278 HSWAKPILNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEGD  339 (386)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~~  339 (386)
                        ..... ...         .....+...+..+.+++.+||+.+|.+||++.++++.|....
T Consensus       248 --~~~~~-~~~---------~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~  297 (304)
T cd05101         248 --LFKLL-KEG---------HRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRIL  297 (304)
T ss_pred             --HHHHH-HcC---------CcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHH
Confidence              11111 110         111112234577999999999999999999999999987643

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=1e-41  Score=318.15  Aligned_cols=263  Identities=24%  Similarity=0.401  Sum_probs=205.6

Q ss_pred             HHHHhcCCCCCCeecccCCcEEEEEEEC--------CCcEEEEEEeccccCChHhHHHHHHHHHHHhcc-CCCceeeecc
Q 016594           61 ISIATNAFSSENLVGRGGYAEVYKGVLQ--------DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHV-CHPNVLSLLG  131 (386)
Q Consensus        61 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~  131 (386)
                      +++...+|++.+.||+|+||.||+|.+.        .+..||+|.+... ........+.+|+.+++++ .||||+++++
T Consensus         7 ~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~   85 (334)
T cd05100           7 WELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD-ATDKDLSDLVSEMEMMKMIGKHKNIINLLG   85 (334)
T ss_pred             cccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc-cCHHHHHHHHHHHHHHHhhcCCCCeeeeeE
Confidence            3455668999999999999999999742        1236899987643 2334456789999999999 7999999999


Q ss_pred             eEEeCc-eEEEEEeccCCCHhhhhhhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCC
Q 016594          132 CCVDNG-LYLIFQFSSRGSVASLFHDVN--------------SPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKS  196 (386)
Q Consensus       132 ~~~~~~-~~lv~e~~~~~~L~~~~~~~~--------------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp  196 (386)
                      ++...+ .++++||+.+++|.+++....              ...+++..+..++.|++.||.|||+   ++++||||||
T Consensus        86 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~givH~dlkp  162 (334)
T cd05100          86 ACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS---QKCIHRDLAA  162 (334)
T ss_pred             EEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCeecccccc
Confidence            997655 899999999999999887532              1247888899999999999999999   9999999999


Q ss_pred             CCeeEcCCCCeEEeecCccccCCCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCch
Q 016594          197 SNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQ  275 (386)
Q Consensus       197 ~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~  275 (386)
                      +||+++.++.+||+|||++................++..|+|||++.+..++.++|||||||++|+|++ |..||.+...
T Consensus       163 ~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~  242 (334)
T cd05100         163 RNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV  242 (334)
T ss_pred             ceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH
Confidence            999999999999999999986643322111222234567999999999999999999999999999998 8999976532


Q ss_pred             hhhhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCC
Q 016594          276 SLHSWAKPILNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEGD  339 (386)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~~  339 (386)
                      ..  ..... ..         ......+...+..+.+++.+||+.+|.+||++.++++.|....
T Consensus       243 ~~--~~~~~-~~---------~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~  294 (334)
T cd05100         243 EE--LFKLL-KE---------GHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVL  294 (334)
T ss_pred             HH--HHHHH-Hc---------CCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHh
Confidence            21  11111 00         0111112233567999999999999999999999999997664

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=1.4e-41  Score=307.08  Aligned_cols=254  Identities=24%  Similarity=0.344  Sum_probs=200.4

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEE
Q 016594           65 TNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIF  142 (386)
Q Consensus        65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~  142 (386)
                      .++|++.+.||+|+||.||+|... +++.||+|++....  ......+.+|+.++++++||||+++++++..+. .++++
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~--~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~   85 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP--GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICM   85 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc--cchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEE
Confidence            457999999999999999999975 68899999987432  223456788999999999999999999997765 88999


Q ss_pred             EeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCC
Q 016594          143 QFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQW  222 (386)
Q Consensus       143 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  222 (386)
                      ||+.+++|.+++...  ..+++..+..++.|++.||.|||+   ++|+||||+|+||+++.++.++|+|||++..+....
T Consensus        86 e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd06646          86 EYCGGGSLQDIYHVT--GPLSELQIAYVCRETLQGLAYLHS---KGKMHRDIKGANILLTDNGDVKLADFGVAAKITATI  160 (267)
T ss_pred             eCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEECcCccceeecccc
Confidence            999999999988653  348999999999999999999999   999999999999999999999999999998764321


Q ss_pred             ccccccccccccCccChhhhc---cCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccC
Q 016594          223 THHSIAPIEGTFGHLAPEYFM---HGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQ  299 (386)
Q Consensus       223 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (386)
                      .  ......|+..|+|||.+.   ...++.++|||||||++|+|++|..||..........      .........+...
T Consensus       161 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~------~~~~~~~~~~~~~  232 (267)
T cd06646         161 A--KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF------LMSKSNFQPPKLK  232 (267)
T ss_pred             c--ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe------eeecCCCCCCCCc
Confidence            1  123345888999999884   3457889999999999999999999986532211000      0000000111111


Q ss_pred             CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 016594          300 GAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVM  335 (386)
Q Consensus       300 ~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l  335 (386)
                        .....+..+.+++.+||+.+|++||++++|++++
T Consensus       233 --~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         233 --DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             --cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence              1123456799999999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=4.7e-41  Score=303.41  Aligned_cols=258  Identities=27%  Similarity=0.432  Sum_probs=208.9

Q ss_pred             cCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEecccc-CChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEE
Q 016594           66 NAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVV-TDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIF  142 (386)
Q Consensus        66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~  142 (386)
                      ++|++.+.||.|+||.||+|... +++.||+|.++... .+......+.+|+.++++++|+||+++++++.+++ .+++|
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            57899999999999999999987 78999999887432 23334667889999999999999999999997755 89999


Q ss_pred             EeccCCCHhhhhhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCC
Q 016594          143 QFSSRGSVASLFHDV--NSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPS  220 (386)
Q Consensus       143 e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~  220 (386)
                      ||+.+++|..++...  ....+++..++.++.+++.||.|||+   .+++|+||+|+||+++.++.++|+|||++..+..
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~  158 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence            999999999988653  23448999999999999999999999   9999999999999999999999999999876643


Q ss_pred             CCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCC
Q 016594          221 QWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQG  300 (386)
Q Consensus       221 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (386)
                      ...  ......++..|+|||.+.+..++.++|||||||++|+|++|..||...............         . ....
T Consensus       159 ~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~---------~-~~~~  226 (267)
T cd08224         159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIE---------K-CDYP  226 (267)
T ss_pred             CCc--ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhh---------c-CCCC
Confidence            321  122345888999999999888999999999999999999999999765432221111110         0 0111


Q ss_pred             CCCH-HHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          301 AYDV-TQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       301 ~~~~-~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                      ..+. ..+..+.+++.+||..+|++||++.+|++.|...
T Consensus       227 ~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~  265 (267)
T cd08224         227 PLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM  265 (267)
T ss_pred             CCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence            1112 3456799999999999999999999999988754

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=9.7e-42  Score=321.99  Aligned_cols=263  Identities=21%  Similarity=0.298  Sum_probs=202.7

Q ss_pred             HhcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeC------
Q 016594           64 ATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDN------  136 (386)
Q Consensus        64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------  136 (386)
                      ..++|++.+.||+|+||.||+|... .++.||||++............+.+|+.+++.++||||+++++++...      
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~  101 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  101 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence            4578999999999999999999976 688999999986555555567788999999999999999999987532      


Q ss_pred             -ceEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCcc
Q 016594          137 -GLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLA  215 (386)
Q Consensus       137 -~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a  215 (386)
                       ..++||||+.+ +|...+..    .+++..+..++.|++.||+|||+   ++|+||||||+|||++.++.+||+|||++
T Consensus       102 ~~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a  173 (364)
T cd07875         102 QDVYIVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLA  173 (364)
T ss_pred             CeEEEEEeCCCC-CHHHHHHh----cCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEECCCCcEEEEeCCCc
Confidence             26899999976 66666542    37888999999999999999999   99999999999999999999999999999


Q ss_pred             ccCCCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhh----------
Q 016594          216 KWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPIL----------  285 (386)
Q Consensus       216 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~----------  285 (386)
                      .......   ......||..|+|||++.+..++.++|||||||++|+|++|+.||.+.+... .+.....          
T Consensus       174 ~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~  249 (364)
T cd07875         174 RTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHID-QWNKVIEQLGTPCPEFM  249 (364)
T ss_pred             cccCCCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCCCHHHH
Confidence            8654321   2234568999999999999999999999999999999999999998654311 1000000          


Q ss_pred             -----------cc-cc-----cccccCCccC---CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          286 -----------NQ-GE-----IEKLVDPRLQ---GAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       286 -----------~~-~~-----~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                                 .. ..     ..........   ..........+.+++.+||+.||.+|||+.+++++-+..
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~  322 (364)
T cd07875         250 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYIN  322 (364)
T ss_pred             HhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccc
Confidence                       00 00     0000000000   000111235689999999999999999999999986543

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=9.3e-42  Score=315.67  Aligned_cols=260  Identities=26%  Similarity=0.443  Sum_probs=203.7

Q ss_pred             HHhcCCCCCCeecccCCcEEEEEEEC--------CCcEEEEEEeccccCChHhHHHHHHHHHHHhcc-CCCceeeecceE
Q 016594           63 IATNAFSSENLVGRGGYAEVYKGVLQ--------DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHV-CHPNVLSLLGCC  133 (386)
Q Consensus        63 ~~~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~  133 (386)
                      ....+|.+.+.||+|+||.||+|...        ....||+|.+.... .......+..|+.+++.+ .||||+++++++
T Consensus         9 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~   87 (314)
T cd05099           9 FPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA-TDKDLADLISEMELMKLIGKHKNIINLLGVC   87 (314)
T ss_pred             ccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC-ChHHHHHHHHHHHHHHhccCCCCeeeEEEEE
Confidence            44567889999999999999999742        24578999887532 334456788999999999 599999999999


Q ss_pred             EeCc-eEEEEEeccCCCHhhhhhhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCC
Q 016594          134 VDNG-LYLIFQFSSRGSVASLFHDVN--------------SPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSN  198 (386)
Q Consensus       134 ~~~~-~~lv~e~~~~~~L~~~~~~~~--------------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~N  198 (386)
                      .+.+ .++++||+.+++|.+++....              ...+++..+..++.|++.||.|||+   ++++||||||+|
T Consensus        88 ~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~N  164 (314)
T cd05099          88 TQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES---RRCIHRDLAARN  164 (314)
T ss_pred             ccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHH---CCeeecccccee
Confidence            7755 899999999999999886542              1347889999999999999999999   999999999999


Q ss_pred             eeEcCCCCeEEeecCccccCCCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCchhh
Q 016594          199 ILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSL  277 (386)
Q Consensus       199 ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~  277 (386)
                      ||++.++.+||+|||++................++..|+|||.+.+..++.++|||||||++|+|++ |..||.+.....
T Consensus       165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~  244 (314)
T cd05099         165 VLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE  244 (314)
T ss_pred             EEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHH
Confidence            9999999999999999986643222111122234567999999999899999999999999999999 899997653221


Q ss_pred             hhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          278 HSWAKPILNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                      .  .. .....         .....+...+..+.+++.+||+.+|++||++.++++.|...
T Consensus       245 ~--~~-~~~~~---------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~  293 (314)
T cd05099         245 L--FK-LLREG---------HRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKV  293 (314)
T ss_pred             H--HH-HHHcC---------CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence            1  00 00110         01111223456788999999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=2e-41  Score=310.70  Aligned_cols=262  Identities=23%  Similarity=0.333  Sum_probs=204.2

Q ss_pred             hcCCCCCCeecccCCcEEEEEEECC-----------------CcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCcee
Q 016594           65 TNAFSSENLVGRGGYAEVYKGVLQD-----------------GEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVL  127 (386)
Q Consensus        65 ~~~~~~~~~lg~G~~g~V~~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv  127 (386)
                      .++|++.+.||+|+||.||+|.+..                 +..||+|.+.... .......+.+|+.++++++||||+
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~   82 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA-SDNAREDFLKEVKILSRLSDPNIA   82 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhcCCCCEe
Confidence            4678999999999999999998642                 2458999887532 234566788999999999999999


Q ss_pred             eecceEEeCc-eEEEEEeccCCCHhhhhhhcC---------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCC
Q 016594          128 SLLGCCVDNG-LYLIFQFSSRGSVASLFHDVN---------SPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSS  197 (386)
Q Consensus       128 ~l~~~~~~~~-~~lv~e~~~~~~L~~~~~~~~---------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~  197 (386)
                      ++++++..+. .++++|++.+++|.+++....         ...+++..++.++.|++.||.|||+   ++++|+||||+
T Consensus        83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~---~~i~H~dlkp~  159 (296)
T cd05051          83 RLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES---LNFVHRDLATR  159 (296)
T ss_pred             EEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHH---cCccccccchh
Confidence            9999997755 899999999999999887644         1258999999999999999999999   99999999999


Q ss_pred             CeeEcCCCCeEEeecCccccCCCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHh--CCCCCCCCch
Q 016594          198 NILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS--GRKPVDGSHQ  275 (386)
Q Consensus       198 Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~--g~~pf~~~~~  275 (386)
                      ||+++.++.++|+|||++..+.............++..|+|||++.+..++.++|||||||++|+|++  |..||.....
T Consensus       160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~  239 (296)
T cd05051         160 NCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD  239 (296)
T ss_pred             ceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh
Confidence            99999999999999999886544322222334456778999999998889999999999999999998  7788865432


Q ss_pred             hh-hhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 016594          276 SL-HSWAKPILNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVML  336 (386)
Q Consensus       276 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~  336 (386)
                      .. ...........      ........+...+..+.+++.+||+.||++|||+.+|++.|.
T Consensus       240 ~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~  295 (296)
T cd05051         240 QQVIENAGHFFRDD------GRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ  295 (296)
T ss_pred             HHHHHHHHhccccc------cccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence            11 11111100000      011111112234467999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=9.8e-42  Score=306.99  Aligned_cols=257  Identities=24%  Similarity=0.397  Sum_probs=207.8

Q ss_pred             HHHhcCCCCCCeecccCCcEEEEEEECCCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCceEEE
Q 016594           62 SIATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNGLYLI  141 (386)
Q Consensus        62 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~lv  141 (386)
                      ++..++|++.+.||+|+||.||+|.+..+..+|+|.+...   ......+.+|+.+++.++|+||+++++++.+...+++
T Consensus         2 ~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~v   78 (260)
T cd05073           2 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG---SMSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPIYII   78 (260)
T ss_pred             cccccceeEEeEecCccceEEEEEEecCCccEEEEecCCC---hhHHHHHHHHHHHHHhcCCCCcceEEEEEcCCCeEEE
Confidence            3566789999999999999999999877788999988642   2345678899999999999999999999988778999


Q ss_pred             EEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCC
Q 016594          142 FQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQ  221 (386)
Q Consensus       142 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  221 (386)
                      |||+.+++|.+++.......+++..+..++.|++.||.|||+   .+++|+||||+||+++.++.+||+|||.+..+...
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  155 (260)
T cd05073          79 TEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDN  155 (260)
T ss_pred             EEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCCcceeeccCC
Confidence            999999999999977555568889999999999999999999   99999999999999999999999999999766432


Q ss_pred             CccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCchhhhhhhhhhhcccccccccCCccCC
Q 016594          222 WTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQG  300 (386)
Q Consensus       222 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (386)
                      .. .......++..|+|||++.+..++.++|+|||||++|++++ |..||.+........   .....         ...
T Consensus       156 ~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~---~~~~~---------~~~  222 (260)
T cd05073         156 EY-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIR---ALERG---------YRM  222 (260)
T ss_pred             Cc-ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHH---HHhCC---------CCC
Confidence            11 11122335677999999998889999999999999999999 999997653321110   00010         011


Q ss_pred             CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 016594          301 AYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLE  337 (386)
Q Consensus       301 ~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~  337 (386)
                      ......+..+.+++.+||+.+|++||++.++++.|..
T Consensus       223 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         223 PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             CCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            1112345679999999999999999999999988753

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=1.6e-42  Score=326.78  Aligned_cols=258  Identities=22%  Similarity=0.265  Sum_probs=201.3

Q ss_pred             cCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEecccc-CChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEE
Q 016594           66 NAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVV-TDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIF  142 (386)
Q Consensus        66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~  142 (386)
                      ++|++.+.||+|+||+||+|..+ +++.||+|++.... ........+.+|+.++..++||||+++++.+.++. .++||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            36888999999999999999976 68999999997532 22334566788999999999999999999998765 89999


Q ss_pred             EeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCC
Q 016594          143 QFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQW  222 (386)
Q Consensus       143 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  222 (386)
                      ||+.+|+|.+++...  ..+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||++..+....
T Consensus        81 E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~~L~~lH~---~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~  155 (360)
T cd05627          81 EFLPGGDMMTLLMKK--DTLSEEATQFYIAETVLAIDAIHQ---LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAH  155 (360)
T ss_pred             eCCCCccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEeeccCCccccccc
Confidence            999999999988754  348999999999999999999999   999999999999999999999999999987553211


Q ss_pred             cc---------------------------------ccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCC
Q 016594          223 TH---------------------------------HSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKP  269 (386)
Q Consensus       223 ~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~p  269 (386)
                      ..                                 ......+||+.|+|||++.+..++.++|||||||++|||++|..|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~P  235 (360)
T cd05627         156 RTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP  235 (360)
T ss_pred             ccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCC
Confidence            00                                 001235699999999999999999999999999999999999999


Q ss_pred             CCCCchhhhhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCC---HHHHHHHHhcC
Q 016594          270 VDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPT---MSEVLEVMLEG  338 (386)
Q Consensus       270 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt---~~~il~~l~~~  338 (386)
                      |.+......  ...+....       ...........+..+.++|.+|+ .||.+|++   +.++++|-+..
T Consensus       236 f~~~~~~~~--~~~i~~~~-------~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~  297 (360)
T cd05627         236 FCSETPQET--YRKVMNWK-------ETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSHPFFE  297 (360)
T ss_pred             CCCCCHHHH--HHHHHcCC-------CceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcCCCCC
Confidence            986543211  11111100       00000111123467888888876 49999984   78888886543

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=7.8e-42  Score=314.58  Aligned_cols=255  Identities=24%  Similarity=0.447  Sum_probs=199.1

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEC-CCc--EEEEEEeccccCChHhHHHHHHHHHHHhcc-CCCceeeecceEEeCc-eE
Q 016594           65 TNAFSSENLVGRGGYAEVYKGVLQ-DGE--EIAVKRLTKVVTDDRKEKEFLTEIGTIGHV-CHPNVLSLLGCCVDNG-LY  139 (386)
Q Consensus        65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~-~~  139 (386)
                      -++|++.+.||+|+||.||+|.++ ++.  .+|+|.+... ........+.+|+.++.++ +|+||+++++++.+++ .+
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~   84 (303)
T cd05088           6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY   84 (303)
T ss_pred             hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc-CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCce
Confidence            457889999999999999999975 454  4577776532 2334556788999999999 7999999999997655 89


Q ss_pred             EEEEeccCCCHhhhhhhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCC
Q 016594          140 LIFQFSSRGSVASLFHDVN--------------SPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADF  205 (386)
Q Consensus       140 lv~e~~~~~~L~~~~~~~~--------------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~  205 (386)
                      +++||+.+++|.+++....              ...+++..++.++.|++.||+|||+   ++++||||||+|||++.++
T Consensus        85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dlkp~Nili~~~~  161 (303)
T cd05088          85 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENY  161 (303)
T ss_pred             EEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEecCCC
Confidence            9999999999999886542              2347899999999999999999999   9999999999999999999


Q ss_pred             CeEEeecCccccCCCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCchhhhhhhhhh
Q 016594          206 EPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPI  284 (386)
Q Consensus       206 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~  284 (386)
                      .+||+|||++......   .......++..|+|||.+.+..++.++|||||||++|+|++ |..||........  ....
T Consensus       162 ~~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~--~~~~  236 (303)
T cd05088         162 VAKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL--YEKL  236 (303)
T ss_pred             cEEeCccccCcccchh---hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHH--HHHH
Confidence            9999999998643211   01111224567999999988889999999999999999998 9999976432210  0000


Q ss_pred             hcccccccccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          285 LNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                                ........+...+..+.+++.+||+.+|++||++.+++..|...
T Consensus       237 ----------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~  280 (303)
T cd05088         237 ----------PQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM  280 (303)
T ss_pred             ----------hcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence                      00111111222346789999999999999999999999988654

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=1.9e-41  Score=304.25  Aligned_cols=252  Identities=22%  Similarity=0.332  Sum_probs=208.0

Q ss_pred             CCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEEEe
Q 016594           67 AFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQF  144 (386)
Q Consensus        67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~  144 (386)
                      +|++.+.||.|+||.||.+... +++.+++|.+............+.+|+.++++++|+||+++++++.+.. .+++|||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            5888999999999999999865 6889999998765555566677899999999999999999999998765 8899999


Q ss_pred             ccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCcc
Q 016594          145 SSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTH  224 (386)
Q Consensus       145 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  224 (386)
                      +.+++|.+++.......+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.+||+|||++........ 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~-  156 (256)
T cd08221          81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHK---AGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS-  156 (256)
T ss_pred             cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChHhEEEeCCCCEEECcCcceEEcccccc-
Confidence            999999999887655668999999999999999999999   9999999999999999999999999999987644321 


Q ss_pred             ccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCCCCCH
Q 016594          225 HSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDV  304 (386)
Q Consensus       225 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (386)
                       ......+++.|+|||++.+..++.++||||||+++|+|++|..||........  ..... .+        .. .....
T Consensus       157 -~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~--~~~~~-~~--------~~-~~~~~  223 (256)
T cd08221         157 -MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNL--VVKIV-QG--------NY-TPVVS  223 (256)
T ss_pred             -cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHH--HHHHH-cC--------CC-CCCcc
Confidence             22345689999999999888899999999999999999999999976432211  11110 00        00 11112


Q ss_pred             HHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 016594          305 TQLNRLAFAASLCIRASPTWRPTMSEVLEVM  335 (386)
Q Consensus       305 ~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l  335 (386)
                      ..+..+.+++.+||..+|.+||++.++++++
T Consensus       224 ~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~  254 (256)
T cd08221         224 VYSSELISLVHSLLQQDPEKRPTADEVLDQP  254 (256)
T ss_pred             ccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence            3456789999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=1.8e-41  Score=304.81  Aligned_cols=249  Identities=29%  Similarity=0.491  Sum_probs=203.1

Q ss_pred             CeecccCCcEEEEEEECC----CcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEEEecc
Q 016594           72 NLVGRGGYAEVYKGVLQD----GEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQFSS  146 (386)
Q Consensus        72 ~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~~~  146 (386)
                      +.||+|+||.||+|.+..    +..|++|.+....... ....+.+|+..+..+.|+||+++++++.++. .+++|||+.
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYME   79 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEecc
Confidence            468999999999999763    7889999988643333 4678889999999999999999999997754 899999999


Q ss_pred             CCCHhhhhhhcC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCC
Q 016594          147 RGSVASLFHDVN-------SPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLP  219 (386)
Q Consensus       147 ~~~L~~~~~~~~-------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~  219 (386)
                      +++|.+++....       ...+++..++.++.|++.||+|||+   ++++|+||+|+||+++.++.+||+|||.+....
T Consensus        80 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~  156 (262)
T cd00192          80 GGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVY  156 (262)
T ss_pred             CCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHc---CCcccCccCcceEEECCCCcEEEcccccccccc
Confidence            999999987652       3558999999999999999999999   999999999999999999999999999998776


Q ss_pred             CCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCchhhhhhhhhhhcccccccccCCcc
Q 016594          220 SQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRL  298 (386)
Q Consensus       220 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (386)
                      ............++..|+|||.+.+..++.++|||||||++|+|++ |..||.......  ..... ..         ..
T Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--~~~~~-~~---------~~  224 (262)
T cd00192         157 DDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE--VLEYL-RK---------GY  224 (262)
T ss_pred             cccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHH--HHHHH-Hc---------CC
Confidence            5432222334557889999999988899999999999999999999 699998753221  11110 00         11


Q ss_pred             CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 016594          299 QGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVML  336 (386)
Q Consensus       299 ~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~  336 (386)
                      ....+...+..+.+++.+||..+|++||++.+++++|+
T Consensus       225 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         225 RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             CCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence            11222334678999999999999999999999998873

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=7.6e-42  Score=317.74  Aligned_cols=242  Identities=22%  Similarity=0.285  Sum_probs=189.4

Q ss_pred             CeecccCCcEEEEEEEC-CCcEEEEEEeccccC-ChHhHHHHHHHHH-HHhccCCCceeeecceEEeCc-eEEEEEeccC
Q 016594           72 NLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVT-DDRKEKEFLTEIG-TIGHVCHPNVLSLLGCCVDNG-LYLIFQFSSR  147 (386)
Q Consensus        72 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~-~~lv~e~~~~  147 (386)
                      +.||+|+||+||+|.+. +++.||+|++.+... .......+..|.. +++.+.||||+++++++.+.+ .+++|||+.+
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            46999999999999976 578899999875321 1222334455544 567889999999999987755 8999999999


Q ss_pred             CCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCccccc
Q 016594          148 GSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSI  227 (386)
Q Consensus       148 ~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  227 (386)
                      ++|..++...  ..+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||++......  ....
T Consensus        81 ~~L~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~---~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~--~~~~  153 (325)
T cd05602          81 GELFYHLQRE--RCFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH--NGTT  153 (325)
T ss_pred             CcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEEccCCCCcccccC--CCCc
Confidence            9999988753  347888999999999999999999   99999999999999999999999999998754321  1123


Q ss_pred             cccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCCCCCHHHH
Q 016594          228 APIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQL  307 (386)
Q Consensus       228 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (386)
                      ....||+.|+|||++.+..++.++|||||||++|+|++|..||.+......  ...         +.....  ......+
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~---------i~~~~~--~~~~~~~  220 (325)
T cd05602         154 STFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM--YDN---------ILNKPL--QLKPNIT  220 (325)
T ss_pred             ccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHH--HHH---------HHhCCc--CCCCCCC
Confidence            355699999999999999999999999999999999999999986543211  010         001100  1112345


Q ss_pred             HHHHHHHHHccccCCCCCCCHHHHHH
Q 016594          308 NRLAFAASLCIRASPTWRPTMSEVLE  333 (386)
Q Consensus       308 ~~l~~li~~cl~~dP~~Rpt~~~il~  333 (386)
                      ..+.+++.+||+.||.+||++.+.+.
T Consensus       221 ~~~~~li~~~l~~~p~~R~~~~~~~~  246 (325)
T cd05602         221 NSARHLLEGLLQKDRTKRLGAKDDFM  246 (325)
T ss_pred             HHHHHHHHHHcccCHHHCCCCCCCHH
Confidence            67899999999999999998874433

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=1.2e-41  Score=312.44  Aligned_cols=256  Identities=23%  Similarity=0.424  Sum_probs=199.9

Q ss_pred             cCCCCCCeecccCCcEEEEEEEC-CCc--EEEEEEeccccCChHhHHHHHHHHHHHhcc-CCCceeeecceEEeCc-eEE
Q 016594           66 NAFSSENLVGRGGYAEVYKGVLQ-DGE--EIAVKRLTKVVTDDRKEKEFLTEIGTIGHV-CHPNVLSLLGCCVDNG-LYL  140 (386)
Q Consensus        66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~-~~l  140 (386)
                      ++|++.+.||+|+||.||+|..+ ++.  .+++|.++.. ........+.+|+.++.++ +||||+++++++...+ .++
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l   80 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF-ASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYI   80 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc-CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceE
Confidence            47889999999999999999975 333  4788877632 2334456788999999999 6999999999997655 899


Q ss_pred             EEEeccCCCHhhhhhhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCC
Q 016594          141 IFQFSSRGSVASLFHDVN--------------SPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFE  206 (386)
Q Consensus       141 v~e~~~~~~L~~~~~~~~--------------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~  206 (386)
                      ++||+.+++|.+++....              ...+++..++.++.|++.||+|||+   ++++||||||+|||++.++.
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~  157 (297)
T cd05089          81 AIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSE---KQFIHRDLAARNVLVGENLA  157 (297)
T ss_pred             EEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCcCCcceEEECCCCe
Confidence            999999999999886532              1248889999999999999999999   99999999999999999999


Q ss_pred             eEEeecCccccCCCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCchhhhhhhhhhh
Q 016594          207 PQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPIL  285 (386)
Q Consensus       207 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~  285 (386)
                      +||+|||++.......   .......+..|+|||++.+..++.++|||||||++|+|++ |..||.......  ....  
T Consensus       158 ~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~--~~~~--  230 (297)
T cd05089         158 SKIADFGLSRGEEVYV---KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE--LYEK--  230 (297)
T ss_pred             EEECCcCCCcccccee---ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH--HHHH--
Confidence            9999999986432110   1111123457999999998899999999999999999997 999997653321  0000  


Q ss_pred             cccccccccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCCc
Q 016594          286 NQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEGDQ  340 (386)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~~~  340 (386)
                              .........+...+..+.+++.+||+.+|.+||++.++++.|.....
T Consensus       231 --------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~  277 (297)
T cd05089         231 --------LPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLE  277 (297)
T ss_pred             --------HhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence                    01111111222345678999999999999999999999998876543

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=1.4e-41  Score=309.21  Aligned_cols=255  Identities=22%  Similarity=0.322  Sum_probs=200.0

Q ss_pred             cCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEEE
Q 016594           66 NAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQ  143 (386)
Q Consensus        66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~e  143 (386)
                      ++|++.++||+|+||.||+|.+. +++.||+|.+.... .......+.+|+.++++++||||+++++++...+ .++++|
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   79 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI-TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTE   79 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC-ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEe
Confidence            36788899999999999999965 68899999986532 2344567889999999999999999999997755 899999


Q ss_pred             eccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCc
Q 016594          144 FSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWT  223 (386)
Q Consensus       144 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~  223 (386)
                      |+.+++|..+.      .+++..+..++.|++.||.|||+   ++|+|+||||+||+++.++.++|+|||++..+...  
T Consensus        80 ~~~~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~--  148 (279)
T cd06619          80 FMDGGSLDVYR------KIPEHVLGRIAVAVVKGLTYLWS---LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS--  148 (279)
T ss_pred             cCCCCChHHhh------cCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc--
Confidence            99999886542      27888999999999999999999   99999999999999999999999999999765432  


Q ss_pred             cccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCCCCC
Q 016594          224 HHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYD  303 (386)
Q Consensus       224 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (386)
                        ......|+..|+|||++.+..++.++|||||||++|+|++|+.||.............    .....+..........
T Consensus       149 --~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~  222 (279)
T cd06619         149 --IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPL----QLLQCIVDEDPPVLPV  222 (279)
T ss_pred             --cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchH----HHHHHHhccCCCCCCC
Confidence              2234568999999999999899999999999999999999999997532211000000    0000000010011111


Q ss_pred             HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          304 VTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       304 ~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                      ...+..+.+++.+||+.+|++||++.+++++.+..
T Consensus       223 ~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~  257 (279)
T cd06619         223 GQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIV  257 (279)
T ss_pred             CcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcccc
Confidence            12345789999999999999999999999886543

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=6.7e-42  Score=318.08  Aligned_cols=243  Identities=24%  Similarity=0.298  Sum_probs=190.5

Q ss_pred             CeecccCCcEEEEEEEC-CCcEEEEEEeccccC-ChHhHHHHHHHHH-HHhccCCCceeeecceEEeCc-eEEEEEeccC
Q 016594           72 NLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVT-DDRKEKEFLTEIG-TIGHVCHPNVLSLLGCCVDNG-LYLIFQFSSR  147 (386)
Q Consensus        72 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~-~~lv~e~~~~  147 (386)
                      +.||+|+||+||+|... +|+.||+|++.+... .......+..|.. +++.++||||+++++++..++ .+++|||+.+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            46999999999999976 689999999875322 2233445566655 467789999999999987655 8999999999


Q ss_pred             CCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCccccc
Q 016594          148 GSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSI  227 (386)
Q Consensus       148 ~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  227 (386)
                      ++|...+...  ..+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||++......  ....
T Consensus        81 ~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~---~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~--~~~~  153 (325)
T cd05604          81 GELFFHLQRE--RSFPEPRARFYAAEIASALGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ--SDTT  153 (325)
T ss_pred             CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEeecCCcccCCCC--CCCc
Confidence            9998887643  348999999999999999999999   99999999999999999999999999998754221  1123


Q ss_pred             cccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCCCCCHHHH
Q 016594          228 APIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQL  307 (386)
Q Consensus       228 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (386)
                      ....||+.|+|||++.+..++.++|||||||++|+|++|..||........  .....         ....  ......+
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~--~~~~~---------~~~~--~~~~~~~  220 (325)
T cd05604         154 TTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEM--YDNIL---------HKPL--VLRPGAS  220 (325)
T ss_pred             ccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHH--HHHHH---------cCCc--cCCCCCC
Confidence            345699999999999999999999999999999999999999986542211  11110         1000  0111234


Q ss_pred             HHHHHHHHHccccCCCCCCCHH----HHHHH
Q 016594          308 NRLAFAASLCIRASPTWRPTMS----EVLEV  334 (386)
Q Consensus       308 ~~l~~li~~cl~~dP~~Rpt~~----~il~~  334 (386)
                      ..+.+++.+||..+|.+||++.    +++++
T Consensus       221 ~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h  251 (325)
T cd05604         221 LTAWSILEELLEKDRQRRLGAKEDFLEIQEH  251 (325)
T ss_pred             HHHHHHHHHHhccCHHhcCCCCCCHHHHhcC
Confidence            6688999999999999999875    55554

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=1.1e-41  Score=311.37  Aligned_cols=257  Identities=23%  Similarity=0.372  Sum_probs=202.2

Q ss_pred             HhcCCCCCCeecccCCcEEEEEEEC------CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc
Q 016594           64 ATNAFSSENLVGRGGYAEVYKGVLQ------DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG  137 (386)
Q Consensus        64 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  137 (386)
                      ..++|++.+.||.|+||.||+|.++      ++..||+|.+.... .......+.+|+.+++.+.||||+++++++.++.
T Consensus         3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~   81 (288)
T cd05050           3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDHPNIVKLLGVCAVGK   81 (288)
T ss_pred             ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc-CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCC
Confidence            3567999999999999999999863      46789999887532 2344567889999999999999999999987654


Q ss_pred             -eEEEEEeccCCCHhhhhhhcC--------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCC
Q 016594          138 -LYLIFQFSSRGSVASLFHDVN--------------------SPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKS  196 (386)
Q Consensus       138 -~~lv~e~~~~~~L~~~~~~~~--------------------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp  196 (386)
                       .++++||+.+++|.+++....                    ...+++..++.++.|++.||.|||+   ++++||||||
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~---~~i~H~dl~p  158 (288)
T cd05050          82 PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSE---RKFVHRDLAT  158 (288)
T ss_pred             ccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCeecccccH
Confidence             899999999999999886432                    1347888999999999999999999   9999999999


Q ss_pred             CCeeEcCCCCeEEeecCccccCCCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCch
Q 016594          197 SNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQ  275 (386)
Q Consensus       197 ~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~  275 (386)
                      +||+++.++.++|+|||++..+..............+..|+|||.+.+..++.++|||||||++|+|++ |..||.+...
T Consensus       159 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~  238 (288)
T cd05050         159 RNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH  238 (288)
T ss_pred             hheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence            999999999999999999876533221111222234667999999998999999999999999999998 8889865432


Q ss_pred             hhhhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 016594          276 SLHSWAKPILNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVML  336 (386)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~  336 (386)
                      ..  ..... .....         ...+...+..+.+++.+||+.+|++||++.++++.|+
T Consensus       239 ~~--~~~~~-~~~~~---------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~  287 (288)
T cd05050         239 EE--VIYYV-RDGNV---------LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ  287 (288)
T ss_pred             HH--HHHHH-hcCCC---------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence            11  11100 11110         0112234567999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=2.5e-41  Score=308.54  Aligned_cols=254  Identities=25%  Similarity=0.329  Sum_probs=202.9

Q ss_pred             CCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCC-hHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEEEe
Q 016594           68 FSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTD-DRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQF  144 (386)
Q Consensus        68 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~  144 (386)
                      |+..+.||.|+||+||+|.+. +++.||+|.+...... ......+.+|+.+++.++|+||+++++++..++ .+++|||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            667789999999999999976 6889999998653222 223455788999999999999999999887655 8999999


Q ss_pred             ccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCcc
Q 016594          145 SSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTH  224 (386)
Q Consensus       145 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  224 (386)
                      +.+++|.+++.......+++..+..++.|++.||.|||+   ++|+||||||+||+++.++.++|+|||++.......  
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~---~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~--  156 (285)
T cd05632          82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHR---ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE--  156 (285)
T ss_pred             ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEECCCCCEEEecCCcceecCCCC--
Confidence            999999988876555569999999999999999999999   999999999999999999999999999987654321  


Q ss_pred             ccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhh-hhhhhhcccccccccCCccCCCCC
Q 016594          225 HSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHS-WAKPILNQGEIEKLVDPRLQGAYD  303 (386)
Q Consensus       225 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  303 (386)
                       ......|+..|+|||++.+..++.++|+|||||++|+|++|..||......... .....     +...     ...+.
T Consensus       157 -~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~-----~~~~-----~~~~~  225 (285)
T cd05632         157 -SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRR-----VLET-----EEVYS  225 (285)
T ss_pred             -cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh-----hhcc-----ccccC
Confidence             123446899999999999999999999999999999999999999865432111 00000     0000     01122


Q ss_pred             HHHHHHHHHHHHHccccCCCCCCC-----HHHHHHHHhc
Q 016594          304 VTQLNRLAFAASLCIRASPTWRPT-----MSEVLEVMLE  337 (386)
Q Consensus       304 ~~~~~~l~~li~~cl~~dP~~Rpt-----~~~il~~l~~  337 (386)
                      ...+..+.+++..||+.||++||+     +.+++.+-+.
T Consensus       226 ~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~  264 (285)
T cd05632         226 AKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFF  264 (285)
T ss_pred             ccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhh
Confidence            234567899999999999999999     7788877443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=1.2e-41  Score=314.19  Aligned_cols=265  Identities=19%  Similarity=0.275  Sum_probs=200.4

Q ss_pred             cCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEEE
Q 016594           66 NAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQ  143 (386)
Q Consensus        66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~e  143 (386)
                      ++|.+.+.||+|+||.||+|+.+ +++.||+|.+..... ......+.+|+.+++.++||||+++++++..++ .+++||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   84 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFE   84 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeecccc-CCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEe
Confidence            56889999999999999999976 688899999875332 223345778999999999999999999997655 899999


Q ss_pred             eccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCc
Q 016594          144 FSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWT  223 (386)
Q Consensus       144 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~  223 (386)
                      |+.+ +|.+.+.... ..+++..+..++.|++.||.|||+   ++|+||||||+||+++.++.+||+|||++....... 
T Consensus        85 ~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-  158 (309)
T cd07872          85 YLDK-DLKQYMDDCG-NIMSMHNVKIFLYQILRGLAYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSVPT-  158 (309)
T ss_pred             CCCC-CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECccccceecCCCc-
Confidence            9986 7777765433 347899999999999999999999   999999999999999999999999999987653321 


Q ss_pred             cccccccccccCccChhhhcc-CCCCcccchHHHHHHHHHHHhCCCCCCCCchhhh-hhhhhhhcc------------cc
Q 016594          224 HHSIAPIEGTFGHLAPEYFMH-GIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLH-SWAKPILNQ------------GE  289 (386)
Q Consensus       224 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~-~~~~~~~~~------------~~  289 (386)
                       .......+++.|+|||.+.+ ..++.++|||||||++|+|++|+.||.+...... .........            ..
T Consensus       159 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (309)
T cd07872         159 -KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDE  237 (309)
T ss_pred             -cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhh
Confidence             12223457899999999865 5688999999999999999999999986543211 000000000            00


Q ss_pred             cccccCCccCC----CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          290 IEKLVDPRLQG----AYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       290 ~~~~~~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                      ......+....    ......+..+.+++.+||+.||.+|||+.+++++.+..
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~  290 (309)
T cd07872         238 FKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFR  290 (309)
T ss_pred             hhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhh
Confidence            00000000000    00112356788999999999999999999999987654

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=6.5e-42  Score=318.35  Aligned_cols=249  Identities=22%  Similarity=0.316  Sum_probs=195.9

Q ss_pred             CeecccCCcEEEEEEEC-CCcEEEEEEeccccC-ChHhHHHHHHHHHHHhcc-CCCceeeecceEEeCc-eEEEEEeccC
Q 016594           72 NLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVT-DDRKEKEFLTEIGTIGHV-CHPNVLSLLGCCVDNG-LYLIFQFSSR  147 (386)
Q Consensus        72 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~-~~lv~e~~~~  147 (386)
                      +.||+|+||+||+|... +++.||+|++.+... .......+.+|+.++.++ +||||+++++++.+.+ .++||||+.+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999976 678999999986432 233455678899999888 5999999999997755 8999999999


Q ss_pred             CCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCccccc
Q 016594          148 GSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSI  227 (386)
Q Consensus       148 ~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  227 (386)
                      ++|..++....  .+++..+..++.|++.||+|||+   ++|+||||||+|||++.++.+||+|||++......  ....
T Consensus        81 ~~L~~~~~~~~--~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~--~~~~  153 (327)
T cd05617          81 GDLMFHMQRQR--KLPEEHARFYAAEICIALNFLHE---RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP--GDTT  153 (327)
T ss_pred             CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEeCCCCEEEeccccceeccCC--CCce
Confidence            99998876543  48999999999999999999999   99999999999999999999999999998753221  1123


Q ss_pred             cccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchh----hhhhhhhhhcccccccccCCccCCCCC
Q 016594          228 APIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQS----LHSWAKPILNQGEIEKLVDPRLQGAYD  303 (386)
Q Consensus       228 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (386)
                      ...+||+.|+|||++.+..++.++|||||||++|+|++|..||......    ...+....        +....  ...+
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~--------~~~~~--~~~p  223 (327)
T cd05617         154 STFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQV--------ILEKP--IRIP  223 (327)
T ss_pred             ecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHH--------HHhCC--CCCC
Confidence            3467999999999999999999999999999999999999999642211    00011100        01111  1122


Q ss_pred             HHHHHHHHHHHHHccccCCCCCCC------HHHHHHHHhc
Q 016594          304 VTQLNRLAFAASLCIRASPTWRPT------MSEVLEVMLE  337 (386)
Q Consensus       304 ~~~~~~l~~li~~cl~~dP~~Rpt------~~~il~~l~~  337 (386)
                      ...+..+.+++.+||+.||++|++      +.++++|-+.
T Consensus       224 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f  263 (327)
T cd05617         224 RFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFF  263 (327)
T ss_pred             CCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCC
Confidence            234567899999999999999998      4688877543

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-42  Score=323.94  Aligned_cols=245  Identities=25%  Similarity=0.396  Sum_probs=201.8

Q ss_pred             eecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEEEeccCCCH
Q 016594           73 LVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQFSSRGSV  150 (386)
Q Consensus        73 ~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~~~~~~L  150 (386)
                      +||+|.||+||-|++. +...+|||.+..  .+.....-+..|+.+.+.|+|.|||+++|++.+++ .-+.||.++||+|
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpe--kdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSL  659 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPE--KDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSL  659 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeeccc--ccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcH
Confidence            7999999999999977 456789998874  23444566889999999999999999999998877 5677899999999


Q ss_pred             hhhhhhcCCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEc-CCCCeEEeecCccccCCCCCcccccc
Q 016594          151 ASLFHDVNSP-GVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLT-ADFEPQISDFGLAKWLPSQWTHHSIA  228 (386)
Q Consensus       151 ~~~~~~~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~-~~~~~kl~Dfg~a~~~~~~~~~~~~~  228 (386)
                      .++++..-++ .-++..+-.+..||++||.|||.   +.|||||||.+|||++ -.|.+||+|||.++.+..-  .....
T Consensus       660 SsLLrskWGPlKDNEstm~fYtkQILeGLkYLHe---n~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi--nP~TE  734 (1226)
T KOG4279|consen  660 SSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHE---NKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI--NPCTE  734 (1226)
T ss_pred             HHHHHhccCCCccchhHHHHHHHHHHHHhhhhhh---cceeeccccCCcEEEeeccceEEecccccchhhccC--Ccccc
Confidence            9999765433 13888899999999999999999   9999999999999997 6789999999999887532  23455


Q ss_pred             ccccccCccChhhhccC--CCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCCCCCHHH
Q 016594          229 PIEGTFGHLAPEYFMHG--IVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQ  306 (386)
Q Consensus       229 ~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (386)
                      ++.||+.|||||++..+  .|+.++|||||||++.||.||++||........          .+.+.---+..++.+.+.
T Consensus       735 TFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA----------AMFkVGmyKvHP~iPeel  804 (1226)
T KOG4279|consen  735 TFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA----------AMFKVGMYKVHPPIPEEL  804 (1226)
T ss_pred             ccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH----------hhhhhcceecCCCCcHHH
Confidence            77899999999999764  589999999999999999999999975322111          111111123345677788


Q ss_pred             HHHHHHHHHHccccCCCCCCCHHHHHHH
Q 016594          307 LNRLAFAASLCIRASPTWRPTMSEVLEV  334 (386)
Q Consensus       307 ~~~l~~li~~cl~~dP~~Rpt~~~il~~  334 (386)
                      +.+.+.+|.+|+.++|.+||++.++|+-
T Consensus       805 saeak~FilrcFepd~~~R~sA~~LL~D  832 (1226)
T KOG4279|consen  805 SAEAKNFILRCFEPDPCDRPSAKDLLQD  832 (1226)
T ss_pred             HHHHHHHHHHHcCCCcccCccHHHhccC
Confidence            9999999999999999999999999975

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-42  Score=323.01  Aligned_cols=262  Identities=26%  Similarity=0.420  Sum_probs=223.7

Q ss_pred             HHHHHHHhcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeC
Q 016594           58 FEEISIATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDN  136 (386)
Q Consensus        58 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~  136 (386)
                      .++|+....+....++||-|.||.||.|.|+ ..-.||||.++..   .....+|++|+.+|+.++|||+|+|+|+|..+
T Consensus       259 ~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED---tMeveEFLkEAAvMKeikHpNLVqLLGVCT~E  335 (1157)
T KOG4278|consen  259 ADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHE  335 (1157)
T ss_pred             cchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc---chhHHHHHHHHHHHHhhcCccHHHHhhhhccC
Confidence            4677777888888999999999999999998 3567999999753   44567899999999999999999999999765


Q ss_pred             c-eEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCcc
Q 016594          137 G-LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLA  215 (386)
Q Consensus       137 ~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a  215 (386)
                      . +|+|.|||..|+|.+++++.+...++.-.++.++.||..|++||..   +++|||||-..|.|+.++..|||+|||++
T Consensus       336 pPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEk---knFIHRDLAARNCLVgEnhiVKvADFGLs  412 (1157)
T KOG4278|consen  336 PPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHIVKVADFGLS  412 (1157)
T ss_pred             CCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHH---hhhhhhhhhhhhccccccceEEeeccchh
Confidence            5 8999999999999999999888889999999999999999999999   99999999999999999999999999999


Q ss_pred             ccCCCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCchhhhhhhhhhhccccccccc
Q 016594          216 KWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGEIEKLV  294 (386)
Q Consensus       216 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  294 (386)
                      +++........ ....-..-|.|||-+....++.|+|||+|||+|||+.| |..||.+.+.+            .+..++
T Consensus       413 RlMtgDTYTAH-AGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlS------------qVY~LL  479 (1157)
T KOG4278|consen  413 RLMTGDTYTAH-AGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS------------QVYGLL  479 (1157)
T ss_pred             hhhcCCceecc-cCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHH------------HHHHHH
Confidence            98865422111 11123456999999999999999999999999999999 99999986432            233444


Q ss_pred             CCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          295 DPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       295 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                      ....+-..+..|++.+.+|++.||+++|.+||++.+|-+.++..
T Consensus       480 EkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtm  523 (1157)
T KOG4278|consen  480 EKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETM  523 (1157)
T ss_pred             hccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHH
Confidence            55555556667788899999999999999999999998877554

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=2.2e-41  Score=339.89  Aligned_cols=260  Identities=23%  Similarity=0.310  Sum_probs=201.5

Q ss_pred             cCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccC-ChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEE
Q 016594           66 NAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVT-DDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIF  142 (386)
Q Consensus        66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~  142 (386)
                      ++|++.++||+|+||.||+|.+. +++.||+|++..... .......+.+|+.+++.++||||+++++++.+++ .+++|
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            57899999999999999999976 689999999875432 2334567899999999999999999999997765 89999


Q ss_pred             EeccCCCHhhhhhhcC---------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecC
Q 016594          143 QFSSRGSVASLFHDVN---------SPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFG  213 (386)
Q Consensus       143 e~~~~~~L~~~~~~~~---------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg  213 (386)
                      ||+.+++|.+++....         ...+++..++.++.|++.||+|||+   ++|+||||||+||+++.++.+||+|||
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs---~GIIHRDLKPeNILLd~dg~vKLiDFG  158 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWG  158 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHH---CCccccCCchheEEEcCCCCEEEEecC
Confidence            9999999999886421         1235667788999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCCc----------------cccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhh
Q 016594          214 LAKWLPSQWT----------------HHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSL  277 (386)
Q Consensus       214 ~a~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~  277 (386)
                      ++........                .......+||+.|+|||++.+..++.++|||||||++|||++|..||.......
T Consensus       159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k  238 (932)
T PRK13184        159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK  238 (932)
T ss_pred             cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence            9986621100                001123569999999999999999999999999999999999999997643211


Q ss_pred             hhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHhcC
Q 016594          278 HSWAKPILNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRP-TMSEVLEVMLEG  338 (386)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-t~~~il~~l~~~  338 (386)
                      ....         ..+..+.. .......+..+.+++.+||+.||++|| +++++++.|...
T Consensus       239 i~~~---------~~i~~P~~-~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~  290 (932)
T PRK13184        239 ISYR---------DVILSPIE-VAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPH  290 (932)
T ss_pred             hhhh---------hhccChhh-ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            1000         00011100 000123356789999999999999997 555666655543

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.7e-41  Score=311.23  Aligned_cols=262  Identities=22%  Similarity=0.311  Sum_probs=200.6

Q ss_pred             hcCCCCCCeecccCCcEEEEEEECC---------------CcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeee
Q 016594           65 TNAFSSENLVGRGGYAEVYKGVLQD---------------GEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSL  129 (386)
Q Consensus        65 ~~~~~~~~~lg~G~~g~V~~~~~~~---------------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l  129 (386)
                      .++|++.+.||+|+||.||+|....               ...||+|.+... ........+.+|++++++++|+||+++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~ei~~l~~l~h~~i~~~   82 (295)
T cd05097           4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRAD-VTKTARNDFLKEIKIMSRLKNPNIIRL   82 (295)
T ss_pred             hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCC-CCHHHHHHHHHHHHHHHhCCCCCcCeE
Confidence            4689999999999999999987542               225899988753 233445678899999999999999999


Q ss_pred             cceEEeCc-eEEEEEeccCCCHhhhhhhcC----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCC
Q 016594          130 LGCCVDNG-LYLIFQFSSRGSVASLFHDVN----------SPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSN  198 (386)
Q Consensus       130 ~~~~~~~~-~~lv~e~~~~~~L~~~~~~~~----------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~N  198 (386)
                      ++++.... .+++|||+.+++|.+++....          ...+++..++.++.|++.||.|||+   ++++|+||||+|
T Consensus        83 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~N  159 (295)
T cd05097          83 LGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS---LNFVHRDLATRN  159 (295)
T ss_pred             EEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHh---cCeeccccChhh
Confidence            99997655 899999999999999885432          1236888999999999999999999   999999999999


Q ss_pred             eeEcCCCCeEEeecCccccCCCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHh--CCCCCCCCchh
Q 016594          199 ILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS--GRKPVDGSHQS  276 (386)
Q Consensus       199 ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~--g~~pf~~~~~~  276 (386)
                      |+++.++.+||+|||++..+.............++..|+|||++.+..++.++|||||||++|+|++  |..||......
T Consensus       160 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~  239 (295)
T cd05097         160 CLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE  239 (295)
T ss_pred             EEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChH
Confidence            9999999999999999976543322122223345678999999998899999999999999999998  66788654321


Q ss_pred             h-hhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 016594          277 L-HSWAKPILNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVML  336 (386)
Q Consensus       277 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~  336 (386)
                      . ...........      ........+...+..+.+++.+||+.+|++||++.+|++.|.
T Consensus       240 ~~~~~~~~~~~~~------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~  294 (295)
T cd05097         240 QVIENTGEFFRNQ------GRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR  294 (295)
T ss_pred             HHHHHHHHhhhhc------cccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence            1 00000000000      000001111223467999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=1.3e-41  Score=313.13  Aligned_cols=257  Identities=23%  Similarity=0.410  Sum_probs=203.6

Q ss_pred             HhcCCCCCCeecccCCcEEEEEEEC-CCc----EEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCce
Q 016594           64 ATNAFSSENLVGRGGYAEVYKGVLQ-DGE----EIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNGL  138 (386)
Q Consensus        64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  138 (386)
                      ..++|+..+.||+|+||.||+|.+. ++.    .||+|.+.... .......+.+|+.+++.+.||||+++++++.....
T Consensus         5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~   83 (303)
T cd05110           5 KETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT-GPKANVEFMDEALIMASMDHPHLVRLLGVCLSPTI   83 (303)
T ss_pred             chhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCCCc
Confidence            3467888999999999999999865 444    47888876432 23344568899999999999999999999987778


Q ss_pred             EEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccC
Q 016594          139 YLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWL  218 (386)
Q Consensus       139 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~  218 (386)
                      +++++|+.+|+|.+++.... ..+++..++.++.|++.||.|||+   ++|+|+||||+||+++.++.+||+|||++..+
T Consensus        84 ~~v~e~~~~g~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~  159 (303)
T cd05110          84 QLVTQLMPHGCLLDYVHEHK-DNIGSQLLLNWCVQIAKGMMYLEE---RRLVHRDLAARNVLVKSPNHVKITDFGLARLL  159 (303)
T ss_pred             eeeehhcCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHhh---cCeeccccccceeeecCCCceEEccccccccc
Confidence            89999999999999886543 348899999999999999999999   99999999999999999999999999999876


Q ss_pred             CCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCchhh-hhhhhhhhcccccccccCC
Q 016594          219 PSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSL-HSWAKPILNQGEIEKLVDP  296 (386)
Q Consensus       219 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~  296 (386)
                      .............++..|+|||++.+..++.++|||||||++|||++ |..||.+..... ..+.    ...        
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~----~~~--------  227 (303)
T cd05110         160 EGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLL----EKG--------  227 (303)
T ss_pred             cCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH----HCC--------
Confidence            54322222223345678999999999999999999999999999998 999997643221 1111    110        


Q ss_pred             ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          297 RLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       297 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                       .....+...+..+.+++..||..+|++||++.++++.|...
T Consensus       228 -~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~  268 (303)
T cd05110         228 -ERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRM  268 (303)
T ss_pred             -CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence             00111112345689999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=2e-41  Score=329.74  Aligned_cols=267  Identities=18%  Similarity=0.182  Sum_probs=193.0

Q ss_pred             HHHHHhcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccC------CCceeeecce
Q 016594           60 EISIATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVC------HPNVLSLLGC  132 (386)
Q Consensus        60 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~------h~niv~l~~~  132 (386)
                      ++....++|++.++||+|+||+||+|.+. +++.||||++....   .....+..|+.+++.+.      |.++++++++
T Consensus       123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~  199 (467)
T PTZ00284        123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP---KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRY  199 (467)
T ss_pred             ccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch---hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEE
Confidence            34456788999999999999999999975 57889999986421   22233445666665554      4568999998


Q ss_pred             EEeCc--eEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCC-----
Q 016594          133 CVDNG--LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADF-----  205 (386)
Q Consensus       133 ~~~~~--~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~-----  205 (386)
                      +....  .++||+++ +++|.+++...  ..+++..+..++.||+.||.|||+  ..+|+||||||+|||++.++     
T Consensus       200 ~~~~~~~~~iv~~~~-g~~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~--~~gIiHrDlKP~NILl~~~~~~~~~  274 (467)
T PTZ00284        200 FQNETGHMCIVMPKY-GPCLLDWIMKH--GPFSHRHLAQIIFQTGVALDYFHT--ELHLMHTDLKPENILMETSDTVVDP  274 (467)
T ss_pred             EEcCCceEEEEEecc-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHh--cCCeecCCCCHHHEEEecCCccccc
Confidence            87543  67777766 67888877654  348999999999999999999997  14999999999999998765     


Q ss_pred             -----------CeEEeecCccccCCCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCc
Q 016594          206 -----------EPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSH  274 (386)
Q Consensus       206 -----------~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~  274 (386)
                                 .+||+|||.+.....     .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+..
T Consensus       275 ~~~~~~~~~~~~vkl~DfG~~~~~~~-----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~  349 (467)
T PTZ00284        275 VTNRALPPDPCRVRICDLGGCCDERH-----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHD  349 (467)
T ss_pred             ccccccCCCCceEEECCCCccccCcc-----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence                       499999998754321     2235679999999999999999999999999999999999999998754


Q ss_pred             hhhhh-hhhhhhc-----------ccccccccCC--ccCCCC---------------CHHHHHHHHHHHHHccccCCCCC
Q 016594          275 QSLHS-WAKPILN-----------QGEIEKLVDP--RLQGAY---------------DVTQLNRLAFAASLCIRASPTWR  325 (386)
Q Consensus       275 ~~~~~-~~~~~~~-----------~~~~~~~~~~--~~~~~~---------------~~~~~~~l~~li~~cl~~dP~~R  325 (386)
                      ..... .......           ......+...  .+....               .......+.+||.+||..||++|
T Consensus       350 ~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R  429 (467)
T PTZ00284        350 NLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKR  429 (467)
T ss_pred             hHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhC
Confidence            32110 0000000           0000000000  000000               00113457899999999999999


Q ss_pred             CCHHHHHHHHhcCC
Q 016594          326 PTMSEVLEVMLEGD  339 (386)
Q Consensus       326 pt~~~il~~l~~~~  339 (386)
                      ||+.++|+|-+...
T Consensus       430 ~ta~e~L~Hp~~~~  443 (467)
T PTZ00284        430 LNARQMTTHPYVLK  443 (467)
T ss_pred             CCHHHHhcCccccc
Confidence            99999999866543

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=3.9e-41  Score=308.93  Aligned_cols=262  Identities=21%  Similarity=0.331  Sum_probs=200.7

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEC-----------------CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCcee
Q 016594           65 TNAFSSENLVGRGGYAEVYKGVLQ-----------------DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVL  127 (386)
Q Consensus        65 ~~~~~~~~~lg~G~~g~V~~~~~~-----------------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv  127 (386)
                      .++|++.+.||+|+||.||++.+.                 ++..||+|++... ........+.+|+.+++.++|+||+
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~-~~~~~~~~~~~E~~~l~~l~~~~i~   82 (296)
T cd05095           4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLRED-ANKNARNDFLKEIKIMSRLKDPNII   82 (296)
T ss_pred             hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCcc
Confidence            457999999999999999998642                 2346899988753 2344456789999999999999999


Q ss_pred             eecceEEeCc-eEEEEEeccCCCHhhhhhhcCC---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCC
Q 016594          128 SLLGCCVDNG-LYLIFQFSSRGSVASLFHDVNS---------PGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSS  197 (386)
Q Consensus       128 ~l~~~~~~~~-~~lv~e~~~~~~L~~~~~~~~~---------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~  197 (386)
                      ++++++..+. .+++|||+.+++|.+++.....         ..+++..++.++.|++.||+|||+   ++++|+||||+
T Consensus        83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dlkp~  159 (296)
T cd05095          83 RLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS---LNFVHRDLATR  159 (296)
T ss_pred             eEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCeecccCChh
Confidence            9999997655 8999999999999998865432         236778899999999999999999   99999999999


Q ss_pred             CeeEcCCCCeEEeecCccccCCCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHh--CCCCCCCCch
Q 016594          198 NILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS--GRKPVDGSHQ  275 (386)
Q Consensus       198 Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~--g~~pf~~~~~  275 (386)
                      |||++.++.++|+|||++..+.............++..|+|||...++.++.++|||||||++|||++  |..||.....
T Consensus       160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~  239 (296)
T cd05095         160 NCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSD  239 (296)
T ss_pred             eEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccCh
Confidence            99999999999999999986543322112222334678999999988899999999999999999998  7788865432


Q ss_pred             hhhh-hhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 016594          276 SLHS-WAKPILNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVML  336 (386)
Q Consensus       276 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~  336 (386)
                      .... .........      ........+..++..+.+++.+||+.||.+||++.+|++.|+
T Consensus       240 ~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~  295 (296)
T cd05095         240 EQVIENTGEFFRDQ------GRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL  295 (296)
T ss_pred             HHHHHHHHHHHhhc------cccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence            1110 000000000      000001111224467999999999999999999999999885

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=5.2e-41  Score=309.83  Aligned_cols=263  Identities=20%  Similarity=0.331  Sum_probs=203.4

Q ss_pred             cCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEEE
Q 016594           66 NAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQ  143 (386)
Q Consensus        66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~e  143 (386)
                      ++|++.+.||+|+||.||+|.+. ++..+|+|.+.... .......+.+|++++++++||||+++++++.+++ .++++|
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   79 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI-KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICME   79 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEee
Confidence            36889999999999999999976 68889999886432 2334567889999999999999999999997755 899999


Q ss_pred             eccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCc
Q 016594          144 FSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWT  223 (386)
Q Consensus       144 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~  223 (386)
                      |+.+++|.+++...  ..+++..+..++.|++.||.|||+  ..+++|+||||+||+++.++.+||+|||++......  
T Consensus        80 y~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--  153 (308)
T cd06615          80 HMDGGSLDQVLKKA--GRIPENILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--  153 (308)
T ss_pred             ccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh--hCCEEECCCChHHEEEecCCcEEEccCCCccccccc--
Confidence            99999999998754  348999999999999999999996  148999999999999999999999999998765332  


Q ss_pred             cccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhh-hhhhhccccc------------
Q 016594          224 HHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSW-AKPILNQGEI------------  290 (386)
Q Consensus       224 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~-~~~~~~~~~~------------  290 (386)
                        ......++..|+|||++.+..++.++|||||||++|+|++|..||.......... ..........            
T Consensus       154 --~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (308)
T cd06615         154 --MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPP  231 (308)
T ss_pred             --ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCC
Confidence              1234568899999999988889999999999999999999999997543211110 0000000000            


Q ss_pred             ------------ccccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 016594          291 ------------EKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLE  337 (386)
Q Consensus       291 ------------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~  337 (386)
                                  ..+.............+..+.+++.+||..+|++||++.+++++.+.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~  290 (308)
T cd06615         232 DSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFI  290 (308)
T ss_pred             CccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhh
Confidence                        00000000000001135579999999999999999999999998665

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=1.5e-41  Score=316.37  Aligned_cols=259  Identities=19%  Similarity=0.237  Sum_probs=200.2

Q ss_pred             cCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEecccc-CChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEE
Q 016594           66 NAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVV-TDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIF  142 (386)
Q Consensus        66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~  142 (386)
                      ++|++.+.||+|+||.||+++.. +++.||+|++.+.. ........+..|+.++..+.|+||+++++++.+++ .++||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            47899999999999999999976 68899999987522 22233455778999999999999999999998765 89999


Q ss_pred             EeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCC
Q 016594          143 QFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQW  222 (386)
Q Consensus       143 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  222 (386)
                      ||+.+|+|.+++.... ..+++..+..++.|++.||+|||+   ++|+||||||+|||++.++.+||+|||++.......
T Consensus        81 Ey~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~~L~~lH~---~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  156 (331)
T cd05624          81 DYYVGGDLLTLLSKFE-DRLPEDMARFYIAEMVLAIHSIHQ---LHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG  156 (331)
T ss_pred             eCCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCchHHEEEcCCCCEEEEeccceeeccCCC
Confidence            9999999999987633 348899999999999999999999   999999999999999999999999999998664332


Q ss_pred             ccccccccccccCccChhhhcc-----CCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCc
Q 016594          223 THHSIAPIEGTFGHLAPEYFMH-----GIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPR  297 (386)
Q Consensus       223 ~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (386)
                      . .......||+.|+|||++.+     +.++.++|||||||++|+|++|+.||........  ...+.....  ..   .
T Consensus       157 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~--~~~i~~~~~--~~---~  228 (331)
T cd05624         157 T-VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVET--YGKIMNHEE--RF---Q  228 (331)
T ss_pred             c-eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHH--HHHHHcCCC--cc---c
Confidence            1 11223569999999999875     5678999999999999999999999976543210  111111000  00   0


Q ss_pred             cCCCCCHHHHHHHHHHHHHccccCCCC--CCCHHHHHHHHhc
Q 016594          298 LQGAYDVTQLNRLAFAASLCIRASPTW--RPTMSEVLEVMLE  337 (386)
Q Consensus       298 ~~~~~~~~~~~~l~~li~~cl~~dP~~--Rpt~~~il~~l~~  337 (386)
                      . .......+..+.+++.+||...+.+  |+++.+++++.+.
T Consensus       229 ~-p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f  269 (331)
T cd05624         229 F-PSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFF  269 (331)
T ss_pred             C-CCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCc
Confidence            0 0011123577999999999876554  4689999987543

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.6e-41  Score=323.90  Aligned_cols=261  Identities=19%  Similarity=0.239  Sum_probs=195.8

Q ss_pred             HhcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEE
Q 016594           64 ATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLI  141 (386)
Q Consensus        64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv  141 (386)
                      ....|.+.+.||+|+||.||+|.+. +++.||||....        ..+.+|+.++++++|+||+++++++..++ .+++
T Consensus       167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~--------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv  238 (461)
T PHA03211        167 AGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY--------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLV  238 (461)
T ss_pred             ccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc--------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence            4568999999999999999999976 578899996431        23568999999999999999999987765 7889


Q ss_pred             EEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCC
Q 016594          142 FQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQ  221 (386)
Q Consensus       142 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  221 (386)
                      |+++. ++|..++.... ..+++..++.++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||++..+...
T Consensus       239 ~e~~~-~~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~  313 (461)
T PHA03211        239 LPKYR-SDLYTYLGARL-RPLGLAQVTAVARQLLSAIDYIHG---EGIIHRDIKTENVLVNGPEDICLGDFGAACFARGS  313 (461)
T ss_pred             EEccC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCEEECcCCHHHEEECCCCCEEEcccCCceecccc
Confidence            99885 58887775432 358999999999999999999999   99999999999999999999999999999876443


Q ss_pred             CccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCch---------hhhhhhhhhh-cccccc
Q 016594          222 WTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQ---------SLHSWAKPIL-NQGEIE  291 (386)
Q Consensus       222 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~---------~~~~~~~~~~-~~~~~~  291 (386)
                      ..........||..|+|||++.+..++.++|||||||++|||++|..|+.....         .+........ ......
T Consensus       314 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~  393 (461)
T PHA03211        314 WSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFP  393 (461)
T ss_pred             cccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCC
Confidence            222222345699999999999999999999999999999999998765532211         0111110000 000000


Q ss_pred             cc-----------------cCCccCCCCC--HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 016594          292 KL-----------------VDPRLQGAYD--VTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLE  337 (386)
Q Consensus       292 ~~-----------------~~~~~~~~~~--~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~  337 (386)
                      ..                 ........+.  ......+.+||.+||+.||.+|||+.|+|++-+.
T Consensus       394 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f  458 (461)
T PHA03211        394 QHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLF  458 (461)
T ss_pred             CCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCccc
Confidence            00                 0000000000  0123468899999999999999999999998543

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.2e-41  Score=306.81  Aligned_cols=257  Identities=26%  Similarity=0.410  Sum_probs=205.2

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEC-CCc----EEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCceE
Q 016594           65 TNAFSSENLVGRGGYAEVYKGVLQ-DGE----EIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNGLY  139 (386)
Q Consensus        65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  139 (386)
                      ..+|++.+.||+|+||.||+|.++ ++.    .||+|.+.... .......+.+|+.+++.+.||||+++++++.....+
T Consensus         6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   84 (279)
T cd05057           6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET-SPKANKEILDEAYVMASVDHPHVVRLLGICLSSQVQ   84 (279)
T ss_pred             HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCceE
Confidence            467889999999999999999965 333    58999876532 244556788999999999999999999999887799


Q ss_pred             EEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCC
Q 016594          140 LIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLP  219 (386)
Q Consensus       140 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~  219 (386)
                      +++||+.+|+|.+++..... .+++..++.++.|++.||+|||+   ++++|+||||+||+++.++.+||+|||++..+.
T Consensus        85 ~v~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~  160 (279)
T cd05057          85 LITQLMPLGCLLDYVRNHKD-NIGSQYLLNWCVQIAKGMSYLEE---KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLD  160 (279)
T ss_pred             EEEecCCCCcHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHh---CCEEecccCcceEEEcCCCeEEECCCccccccc
Confidence            99999999999998875433 38999999999999999999999   999999999999999999999999999998765


Q ss_pred             CCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCchhhhhhhhhhhcccccccccCCcc
Q 016594          220 SQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRL  298 (386)
Q Consensus       220 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (386)
                      ............++..|+|||.+....++.++|+|||||++||+++ |..||.+.....  ....+.          ...
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~~~~----------~~~  228 (279)
T cd05057         161 VDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE--IPDLLE----------KGE  228 (279)
T ss_pred             CcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHH--HHHHHh----------CCC
Confidence            3322111122224567999999988899999999999999999998 999998754321  111111          111


Q ss_pred             CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          299 QGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       299 ~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                      ....+...+..+.+++.+||..+|..||++.++++.|...
T Consensus       229 ~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~  268 (279)
T cd05057         229 RLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKM  268 (279)
T ss_pred             CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence            1111222345688999999999999999999999988765

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=2e-41  Score=314.54  Aligned_cols=248  Identities=23%  Similarity=0.329  Sum_probs=196.7

Q ss_pred             CCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccC-ChHhHHHHHHHHHHHhccC-CCceeeecceEEeCc-eEEEE
Q 016594           67 AFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVT-DDRKEKEFLTEIGTIGHVC-HPNVLSLLGCCVDNG-LYLIF  142 (386)
Q Consensus        67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~-~~lv~  142 (386)
                      +|+..+.||+|+||+||+|..+ +++.||+|++.+... .......+..|..++..+. |++|+++++++.+.+ .++||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            3677899999999999999976 688999999875322 2234456778888888886 577888998887655 89999


Q ss_pred             EeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCC
Q 016594          143 QFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQW  222 (386)
Q Consensus       143 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  222 (386)
                      ||+.+|+|..++....  .+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||++.......
T Consensus        81 Ey~~~g~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~lH~---~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~  155 (323)
T cd05615          81 EYVNGGDLMYHIQQVG--KFKEPQAVFYAAEISVGLFFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG  155 (323)
T ss_pred             cCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeccccccccCCCC
Confidence            9999999998886543  48999999999999999999999   999999999999999999999999999987543221


Q ss_pred             ccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCCCC
Q 016594          223 THHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAY  302 (386)
Q Consensus       223 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (386)
                        .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+......  ...+.         ...  ..+
T Consensus       156 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~--~~~i~---------~~~--~~~  220 (323)
T cd05615         156 --VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDEL--FQSIM---------EHN--VSY  220 (323)
T ss_pred             --ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHH--HHHHH---------hCC--CCC
Confidence              122345689999999999999999999999999999999999999987543211  11111         100  112


Q ss_pred             CHHHHHHHHHHHHHccccCCCCCCCH-----HHHHHH
Q 016594          303 DVTQLNRLAFAASLCIRASPTWRPTM-----SEVLEV  334 (386)
Q Consensus       303 ~~~~~~~l~~li~~cl~~dP~~Rpt~-----~~il~~  334 (386)
                      +...+..+.+++.+||+.+|.+|++.     .+++++
T Consensus       221 p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h  257 (323)
T cd05615         221 PKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREH  257 (323)
T ss_pred             CccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcC
Confidence            22345678999999999999999974     566655

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=1.9e-41  Score=309.10  Aligned_cols=262  Identities=19%  Similarity=0.278  Sum_probs=199.2

Q ss_pred             CCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEEEe
Q 016594           67 AFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQF  144 (386)
Q Consensus        67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~  144 (386)
                      +|++.+.||.|++|.||+|..+ ++..||+|.+............+.+|+.+++.+.||||+++++++.++. .++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            4788899999999999999976 6899999998754434444567788999999999999999999997755 8999999


Q ss_pred             ccCCCHhhhhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCc
Q 016594          145 SSRGSVASLFHDVNS-PGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWT  223 (386)
Q Consensus       145 ~~~~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~  223 (386)
                      +. ++|.+++..... ..+++..+..++.|++.||.|||+   ++++|+||||+||+++.++.++|+|||++....... 
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-  155 (285)
T cd07861          81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHS---RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV-  155 (285)
T ss_pred             CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc-
Confidence            97 578887765433 458999999999999999999999   999999999999999999999999999987654321 


Q ss_pred             cccccccccccCccChhhhcc-CCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhh--hhhcc-----------cc
Q 016594          224 HHSIAPIEGTFGHLAPEYFMH-GIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAK--PILNQ-----------GE  289 (386)
Q Consensus       224 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~--~~~~~-----------~~  289 (386)
                       .......+++.|+|||++.+ ..++.++|||||||++|+|++|+.||.+..........  .....           ..
T Consensus       156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (285)
T cd07861         156 -RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPD  234 (285)
T ss_pred             -ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHH
Confidence             11223357889999998875 45789999999999999999999999865432111100  00000           00


Q ss_pred             cccccCCccC---CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 016594          290 IEKLVDPRLQ---GAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEV  334 (386)
Q Consensus       290 ~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~  334 (386)
                      ..........   .......+.++.+++.+||..||++|||+.+|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~  282 (285)
T cd07861         235 YKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH  282 (285)
T ss_pred             HHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence            0000000000   00011235678899999999999999999999976

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=1.5e-41  Score=304.75  Aligned_cols=248  Identities=24%  Similarity=0.423  Sum_probs=202.7

Q ss_pred             hcCCCCCCeecccCCcEEEEEEECCCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCceEEEEEe
Q 016594           65 TNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNGLYLIFQF  144 (386)
Q Consensus        65 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~lv~e~  144 (386)
                      .+.|++.+.||+|+||.||++.. +++.||+|.+...    .....+.+|+.+++.++||||+++++++..++.+++|||
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~----~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~v~e~   79 (254)
T cd05083           5 LQKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCD----VTAQAFLEETAVMTKLHHKNLVRLLGVILHNGLYIVMEL   79 (254)
T ss_pred             HHHceeeeeeccCCCCceEeccc-CCCceEEEeecCc----chHHHHHHHHHHHHhCCCCCcCeEEEEEcCCCcEEEEEC
Confidence            35689999999999999999975 5788999988642    234568899999999999999999999988889999999


Q ss_pred             ccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCcc
Q 016594          145 SSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTH  224 (386)
Q Consensus       145 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  224 (386)
                      +.+++|.+++.......+++..++.++.|++.||.|||+   ++++||||||+||+++.++.+||+|||++.......  
T Consensus        80 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~--  154 (254)
T cd05083          80 MSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLES---KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV--  154 (254)
T ss_pred             CCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCcEEECCCccceeccccC--
Confidence            999999999877655568999999999999999999999   999999999999999999999999999987643221  


Q ss_pred             ccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCchhhhhhhhhhhcccccccccCCccCCCCC
Q 016594          225 HSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYD  303 (386)
Q Consensus       225 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (386)
                         .....+..|+|||.+.+..++.++|+|||||++|+|++ |..||........  ... ...         ......+
T Consensus       155 ---~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~--~~~-~~~---------~~~~~~~  219 (254)
T cd05083         155 ---DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEV--KEC-VEK---------GYRMEPP  219 (254)
T ss_pred             ---CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHH--HHH-HhC---------CCCCCCC
Confidence               12234567999999998899999999999999999998 9999976543211  110 011         1111112


Q ss_pred             HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 016594          304 VTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLE  337 (386)
Q Consensus       304 ~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~  337 (386)
                      ...+..+.+++.+||+.+|+.||++.++++.|.+
T Consensus       220 ~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         220 EGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             CcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence            2345678999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=6.1e-42  Score=345.21  Aligned_cols=259  Identities=22%  Similarity=0.346  Sum_probs=203.5

Q ss_pred             HHHhcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeC---c
Q 016594           62 SIATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDN---G  137 (386)
Q Consensus        62 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~---~  137 (386)
                      ....++|.+.+.||.|+||+||+|.+. ++..||+|++............+..|+.+++.+.||||++++++|.+.   .
T Consensus         9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~   88 (1021)
T PTZ00266          9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK   88 (1021)
T ss_pred             ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence            455678999999999999999999976 578899999876555555667889999999999999999999998653   3


Q ss_pred             eEEEEEeccCCCHhhhhhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC----CCCeEEeCCCCCCeeEcC--------
Q 016594          138 LYLIFQFSSRGSVASLFHDVN--SPGVEWKVRHKIAVGTARGLHYLHKGC----QRRIIHRDIKSSNILLTA--------  203 (386)
Q Consensus       138 ~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~----~~~ivH~dlkp~Nill~~--------  203 (386)
                      +++||||+.+++|.+++....  ...+++..++.|+.||+.||.|||+..    ..+|+||||||+||||+.        
T Consensus        89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i  168 (1021)
T PTZ00266         89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI  168 (1021)
T ss_pred             EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence            899999999999999886532  245899999999999999999999822    135999999999999964        


Q ss_pred             ---------CCCeEEeecCccccCCCCCccccccccccccCccChhhhcc--CCCCcccchHHHHHHHHHHHhCCCCCCC
Q 016594          204 ---------DFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMH--GIVDEKTDVFAFGVFLLEIISGRKPVDG  272 (386)
Q Consensus       204 ---------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~ell~g~~pf~~  272 (386)
                               .+.+||+|||++..+....   ......||+.|+|||++.+  ..++.++|||||||+||+|++|..||..
T Consensus       169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~  245 (1021)
T PTZ00266        169 TAQANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK  245 (1021)
T ss_pred             cccccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence                     3358999999998764332   1234569999999999864  4588999999999999999999999975


Q ss_pred             CchhhhhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 016594          273 SHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVM  335 (386)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l  335 (386)
                      ..... ...... ...       +.+.   ....+..+.+||..||..+|.+||++.++|.+-
T Consensus       246 ~~~~~-qli~~l-k~~-------p~lp---i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~  296 (1021)
T PTZ00266        246 ANNFS-QLISEL-KRG-------PDLP---IKGKSKELNILIKNLLNLSAKERPSALQCLGYQ  296 (1021)
T ss_pred             CCcHH-HHHHHH-hcC-------CCCC---cCCCCHHHHHHHHHHhcCChhHCcCHHHHhccH
Confidence            43211 111110 000       0000   012346799999999999999999999999653

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.7e-41  Score=300.82  Aligned_cols=248  Identities=25%  Similarity=0.430  Sum_probs=198.3

Q ss_pred             CeecccCCcEEEEEEECCCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEEEeccCCCH
Q 016594           72 NLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQFSSRGSV  150 (386)
Q Consensus        72 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~~~~~~L  150 (386)
                      ++||.|+||.||+|.+.+++.||+|.+...... .....+.+|+++++++.|+||+++++++.+.. .++++||+.+++|
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l   79 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPP-DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL   79 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence            468999999999999877899999988754332 45567899999999999999999999987755 8999999999999


Q ss_pred             hhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCcccccccc
Q 016594          151 ASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPI  230 (386)
Q Consensus       151 ~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~  230 (386)
                      .+++.... ..+++..+..++.+++.||.|||+   ++++||||||+||+++.++.++|+|||++...............
T Consensus        80 ~~~l~~~~-~~~~~~~~~~~~~~~~~~l~~lH~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~  155 (251)
T cd05041          80 LTFLRKKK-NRLTVKKLLQMSLDAAAGMEYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK  155 (251)
T ss_pred             HHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHh---CCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence            99886543 347889999999999999999999   99999999999999999999999999999865432111111122


Q ss_pred             ccccCccChhhhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCchhhhhhhhhhhcccccccccCCccCCCCCHHHHHH
Q 016594          231 EGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQLNR  309 (386)
Q Consensus       231 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (386)
                      .++..|+|||.+.+..++.++|+|||||++|+|++ |..||..........            .+........+...+..
T Consensus       156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~------------~~~~~~~~~~~~~~~~~  223 (251)
T cd05041         156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRE------------RIESGYRMPAPQLCPEE  223 (251)
T ss_pred             cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHH------------HHhcCCCCCCCccCCHH
Confidence            34567999999998899999999999999999999 899997654321110            00001111122234567


Q ss_pred             HHHHHHHccccCCCCCCCHHHHHHHHh
Q 016594          310 LAFAASLCIRASPTWRPTMSEVLEVML  336 (386)
Q Consensus       310 l~~li~~cl~~dP~~Rpt~~~il~~l~  336 (386)
                      +.+++.+||..+|.+||++.++++.|.
T Consensus       224 ~~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         224 IYRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             HHHHHHHHhccChhhCcCHHHHHHHhh
Confidence            999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=2.1e-41  Score=313.74  Aligned_cols=257  Identities=21%  Similarity=0.333  Sum_probs=187.1

Q ss_pred             CCeecccCCcEEEEEEEC---CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeC---ceEEEEEe
Q 016594           71 ENLVGRGGYAEVYKGVLQ---DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDN---GLYLIFQF  144 (386)
Q Consensus        71 ~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~---~~~lv~e~  144 (386)
                      +++||+|+||+||+|..+   +++.||+|.+....    ....+.+|+.++++++||||+++++++...   ..+++++|
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~   81 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG----ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDY   81 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC----CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEec
Confidence            568999999999999964   46789999986432    223467899999999999999999998642   27888998


Q ss_pred             ccCCCHhhhhhhcC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeE----cCCCCeEEeecC
Q 016594          145 SSRGSVASLFHDVN-------SPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILL----TADFEPQISDFG  213 (386)
Q Consensus       145 ~~~~~L~~~~~~~~-------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill----~~~~~~kl~Dfg  213 (386)
                      +.+ +|..++....       ...+++..+..++.|++.||.|||+   ++|+||||||+|||+    +.++.+||+|||
T Consensus        82 ~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG  157 (317)
T cd07868          82 AEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMG  157 (317)
T ss_pred             cCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEecCCCCcCcEEEeecC
Confidence            765 7777664321       2248899999999999999999999   999999999999999    456789999999


Q ss_pred             ccccCCCCCcc-ccccccccccCccChhhhcc-CCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhh--------h--h
Q 016594          214 LAKWLPSQWTH-HSIAPIEGTFGHLAPEYFMH-GIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHS--------W--A  281 (386)
Q Consensus       214 ~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~--------~--~  281 (386)
                      ++..+...... .......||+.|+|||++.+ ..++.++|||||||++|+|++|++||.........        .  .
T Consensus       158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~  237 (317)
T cd07868         158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRI  237 (317)
T ss_pred             ceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHH
Confidence            99876543211 22334678999999999987 45899999999999999999999999754321100        0  0


Q ss_pred             hhhhcc------cccc---------cccCCccCCCC---------CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 016594          282 KPILNQ------GEIE---------KLVDPRLQGAY---------DVTQLNRLAFAASLCIRASPTWRPTMSEVLEVM  335 (386)
Q Consensus       282 ~~~~~~------~~~~---------~~~~~~~~~~~---------~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l  335 (386)
                      ......      ..+.         ...........         .......+.+++.+||+.||.+|||+.+++++-
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp  315 (317)
T cd07868         238 FNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDP  315 (317)
T ss_pred             HHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCC
Confidence            000000      0000         00000000000         001124578999999999999999999999863

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=2e-41  Score=306.91  Aligned_cols=253  Identities=26%  Similarity=0.395  Sum_probs=201.7

Q ss_pred             HhcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhcc-CCCceeeecceEEeC-----
Q 016594           64 ATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHV-CHPNVLSLLGCCVDN-----  136 (386)
Q Consensus        64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~-----  136 (386)
                      +++.|.+.+.||+|+||.||+|.+. +++.||+|.+....   .....+.+|+.++..+ +|+||+++++++...     
T Consensus         4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~   80 (272)
T cd06637           4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG---DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM   80 (272)
T ss_pred             hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC---ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCC
Confidence            4567888999999999999999976 68899999986532   2345678899999998 699999999998642     


Q ss_pred             --ceEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCc
Q 016594          137 --GLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGL  214 (386)
Q Consensus       137 --~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~  214 (386)
                        ..+++|||+.+++|.+++.......+++..+..++.|++.||+|||+   ++++|+||||+||+++.++.++|+|||+
T Consensus        81 ~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~---~~ivh~dl~~~nili~~~~~~~l~Dfg~  157 (272)
T cd06637          81 DDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGV  157 (272)
T ss_pred             CcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHEEECCCCCEEEccCCC
Confidence              37899999999999999887555568999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCCccccccccccccCccChhhhc-----cCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccc
Q 016594          215 AKWLPSQWTHHSIAPIEGTFGHLAPEYFM-----HGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGE  289 (386)
Q Consensus       215 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~  289 (386)
                      +.......  .......|+..|+|||++.     +..++.++|||||||++|+|++|..||............   ..  
T Consensus       158 ~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~---~~--  230 (272)
T cd06637         158 SAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI---PR--  230 (272)
T ss_pred             ceeccccc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHH---hc--
Confidence            88654321  1233456899999999986     345788999999999999999999999754322111100   00  


Q ss_pred             cccccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 016594          290 IEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVM  335 (386)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l  335 (386)
                            ...........+..+.+++.+||..+|.+|||+.+++++-
T Consensus       231 ------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~  270 (272)
T cd06637         231 ------NPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHP  270 (272)
T ss_pred             ------CCCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCC
Confidence                  0001111122346789999999999999999999999763

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=3e-41  Score=305.08  Aligned_cols=257  Identities=21%  Similarity=0.395  Sum_probs=202.7

Q ss_pred             HhcCCCCCCeecccCCcEEEEEEEC-CCc---EEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-e
Q 016594           64 ATNAFSSENLVGRGGYAEVYKGVLQ-DGE---EIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-L  138 (386)
Q Consensus        64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~---~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~  138 (386)
                      ..++|+..+.||+|+||.||+|... ++.   .+|+|.+.... .......+..|+.+++.+.|+||+++++++.+.+ .
T Consensus         3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   81 (268)
T cd05063           3 HPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY-TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPA   81 (268)
T ss_pred             ChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCc
Confidence            3457888999999999999999975 333   68999886532 2334567889999999999999999999997655 8


Q ss_pred             EEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccC
Q 016594          139 YLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWL  218 (386)
Q Consensus       139 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~  218 (386)
                      +++|||+.+++|.+++.... ..+++..+..++.|++.||+|||+   .+++|+||||+||+++.++.+||+|||++...
T Consensus        82 ~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~  157 (268)
T cd05063          82 MIITEYMENGALDKYLRDHD-GEFSSYQLVGMLRGIAAGMKYLSD---MNYVHRDLAARNILVNSNLECKVSDFGLSRVL  157 (268)
T ss_pred             EEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEEcCCCcEEECCCccceec
Confidence            99999999999999886533 458999999999999999999999   99999999999999999999999999998866


Q ss_pred             CCCCccccc-cccccccCccChhhhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCchhhhhhhhhhhcccccccccCC
Q 016594          219 PSQWTHHSI-APIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGEIEKLVDP  296 (386)
Q Consensus       219 ~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (386)
                      ......... .....+..|+|||++.+..++.++|||||||++|+|++ |..||.......  ....+..          
T Consensus       158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~--~~~~i~~----------  225 (268)
T cd05063         158 EDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE--VMKAIND----------  225 (268)
T ss_pred             ccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHH--HHHHHhc----------
Confidence            433221111 11223457999999998889999999999999999998 999996543211  1111110          


Q ss_pred             ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 016594          297 RLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLE  337 (386)
Q Consensus       297 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~  337 (386)
                      ..........+..+.+++.+||+.+|++||++.+|++.|.+
T Consensus       226 ~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~  266 (268)
T cd05063         226 GFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDK  266 (268)
T ss_pred             CCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence            01111222345678999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=2e-41  Score=306.63  Aligned_cols=258  Identities=22%  Similarity=0.369  Sum_probs=205.4

Q ss_pred             HHhcCCCCCCeecccCCcEEEEEEECC----CcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCce
Q 016594           63 IATNAFSSENLVGRGGYAEVYKGVLQD----GEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNGL  138 (386)
Q Consensus        63 ~~~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  138 (386)
                      +..++|.+.+.||.|+||.||+|.+.+    ...||+|...... .......+.+|+.+++.+.||||+++++++.+...
T Consensus         3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~   81 (270)
T cd05056           3 IQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT-SPSVREKFLQEAYIMRQFDHPHIVKLIGVITENPV   81 (270)
T ss_pred             echhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCchhceeEEEcCCCc
Confidence            345678899999999999999998643    2468999876432 23445678899999999999999999999988888


Q ss_pred             EEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccC
Q 016594          139 YLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWL  218 (386)
Q Consensus       139 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~  218 (386)
                      +++|||+.+++|.+++.... ..+++..++.++.|++.||.|||+   ++++|+||||+||+++.++.++|+|||++...
T Consensus        82 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~  157 (270)
T cd05056          82 WIVMELAPLGELRSYLQVNK-YSLDLASLILYSYQLSTALAYLES---KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYL  157 (270)
T ss_pred             EEEEEcCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccChheEEEecCCCeEEccCceeeec
Confidence            99999999999999987543 358999999999999999999999   99999999999999999999999999998866


Q ss_pred             CCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCchhhhhhhhhhhcccccccccCCc
Q 016594          219 PSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGEIEKLVDPR  297 (386)
Q Consensus       219 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (386)
                      ..... .......++..|+|||.+....++.++||||||+++|+|++ |..||.........  ... ...         
T Consensus       158 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~--~~~-~~~---------  224 (270)
T cd05056         158 EDESY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVI--GRI-ENG---------  224 (270)
T ss_pred             ccccc-eecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHH--HHH-HcC---------
Confidence            44311 11122234567999999988889999999999999999996 99999765432111  000 000         


Q ss_pred             cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          298 LQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       298 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                      .....+...+..+.+++.+||..+|.+|||+.++++.|.+.
T Consensus       225 ~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~  265 (270)
T cd05056         225 ERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDI  265 (270)
T ss_pred             CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            01111223456799999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=5.5e-41  Score=300.15  Aligned_cols=247  Identities=25%  Similarity=0.432  Sum_probs=197.1

Q ss_pred             CeecccCCcEEEEEEECCCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEEEeccCCCH
Q 016594           72 NLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQFSSRGSV  150 (386)
Q Consensus        72 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~~~~~~L  150 (386)
                      ++||.|+||.||+|...++..||+|.+.... .......+.+|+.+++.+.||||+++++++.... .+++|||+.+++|
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   79 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDL-PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF   79 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence            3689999999999998888999999887533 2334456889999999999999999999987655 8999999999999


Q ss_pred             hhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCcccccccc
Q 016594          151 ASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPI  230 (386)
Q Consensus       151 ~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~  230 (386)
                      .+++.... ..+++..+..++.|++.||.|||+   ++++||||||+||+++.++.+||+|||++......... .....
T Consensus        80 ~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-~~~~~  154 (250)
T cd05085          80 LSFLRKKK-DELKTKQLVKFALDAAAGMAYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS-SSGLK  154 (250)
T ss_pred             HHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccChheEEEcCCCeEEECCCccceeccccccc-cCCCC
Confidence            99886543 347899999999999999999999   99999999999999999999999999998754332111 11122


Q ss_pred             ccccCccChhhhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCchhhhhhhhhhhcccccccccCCccCCCCCHHHHHH
Q 016594          231 EGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQLNR  309 (386)
Q Consensus       231 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (386)
                      .++..|+|||++.+..++.++||||||+++|++++ |..||.........  ... ..         ......+...+..
T Consensus       155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~--~~~-~~---------~~~~~~~~~~~~~  222 (250)
T cd05085         155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAR--EQV-EK---------GYRMSCPQKCPDD  222 (250)
T ss_pred             CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHH--HHH-Hc---------CCCCCCCCCCCHH
Confidence            34567999999998889999999999999999998 99999765332110  000 00         0111112234577


Q ss_pred             HHHHHHHccccCCCCCCCHHHHHHHHh
Q 016594          310 LAFAASLCIRASPTWRPTMSEVLEVML  336 (386)
Q Consensus       310 l~~li~~cl~~dP~~Rpt~~~il~~l~  336 (386)
                      +.+++.+||+.+|++||++.++++.|.
T Consensus       223 ~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         223 VYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             HHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.9e-41  Score=321.48  Aligned_cols=261  Identities=20%  Similarity=0.257  Sum_probs=199.4

Q ss_pred             HHhcCCCCCCeecccCCcEEEEEEEC---CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-e
Q 016594           63 IATNAFSSENLVGRGGYAEVYKGVLQ---DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-L  138 (386)
Q Consensus        63 ~~~~~~~~~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~  138 (386)
                      +...+|.+.+.||.|+||.||+|...   .+..||+|.+...       ....+|+.+++.++||||+++++++.... .
T Consensus        89 ~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~  161 (392)
T PHA03207         89 VVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-------KTPGREIDILKTISHRAIINLIHAYRWKSTV  161 (392)
T ss_pred             hccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-------ccHHHHHHHHHhcCCCCccceeeeEeeCCEE
Confidence            45568999999999999999999853   3578999987642       23457999999999999999999987655 8


Q ss_pred             EEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccC
Q 016594          139 YLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWL  218 (386)
Q Consensus       139 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~  218 (386)
                      +++|+++. ++|.+++..  ...+++..++.++.||+.||.|||+   ++|+||||||+|||++.++.++|+|||++..+
T Consensus       162 ~lv~e~~~-~~l~~~l~~--~~~l~~~~~~~i~~ql~~aL~~LH~---~givHrDlkp~Nill~~~~~~~l~DfG~a~~~  235 (392)
T PHA03207        162 CMVMPKYK-CDLFTYVDR--SGPLPLEQAITIQRRLLEALAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAACKL  235 (392)
T ss_pred             EEEehhcC-CCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEccCcccccc
Confidence            88999886 578777743  3458999999999999999999999   99999999999999999999999999999876


Q ss_pred             CCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchh-----hhhhhhhhhcccccc--
Q 016594          219 PSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQS-----LHSWAKPILNQGEIE--  291 (386)
Q Consensus       219 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~-----~~~~~~~~~~~~~~~--  291 (386)
                      .............||+.|+|||++.+..++.++|||||||++|+|++|+.||.+....     +...... .......  
T Consensus       236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~-~~~~~~~~~  314 (392)
T PHA03207        236 DAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRC-MQVHPLEFP  314 (392)
T ss_pred             CcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHH-hccCccccC
Confidence            5443333334567999999999999999999999999999999999999999764321     0000000 0000000  


Q ss_pred             --------c---ccCCccCCCCC-------HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 016594          292 --------K---LVDPRLQGAYD-------VTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLE  337 (386)
Q Consensus       292 --------~---~~~~~~~~~~~-------~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~  337 (386)
                              .   ......+..+.       ......+.++|.+||..||++||++.+++.+-+.
T Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f  378 (392)
T PHA03207        315 QNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLF  378 (392)
T ss_pred             CccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchh
Confidence                    0   00000000000       1124568899999999999999999999998554

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.9e-43  Score=322.15  Aligned_cols=247  Identities=26%  Similarity=0.409  Sum_probs=203.6

Q ss_pred             CCCCCCeecccCCcEEEEEEEC-CCcEEEEEEecccc-CChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEEE
Q 016594           67 AFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVV-TDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQ  143 (386)
Q Consensus        67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~e  143 (386)
                      .|.-++.||.|+||.||.|++. +...||||++.... ........+++|+..|+++.|||+|.+-|||..+. .++|||
T Consensus        27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME  106 (948)
T KOG0577|consen   27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME  106 (948)
T ss_pred             HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence            3555678999999999999965 78899999998632 22345678999999999999999999999997655 899999


Q ss_pred             eccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCc
Q 016594          144 FSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWT  223 (386)
Q Consensus       144 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~  223 (386)
                      ||.| +-.+++.- ..+++.+..+..|..+.+.||+|||+   ++.||||||..||||++.|.|||+|||.|....+   
T Consensus       107 YClG-SAsDlleV-hkKplqEvEIAAi~~gaL~gLaYLHS---~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P---  178 (948)
T KOG0577|consen  107 YCLG-SASDLLEV-HKKPLQEVEIAAITHGALQGLAYLHS---HNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP---  178 (948)
T ss_pred             HHhc-cHHHHHHH-HhccchHHHHHHHHHHHHHHHHHHHH---hhHHhhhccccceEecCCCeeeeccccchhhcCc---
Confidence            9987 66777654 34558899999999999999999999   9999999999999999999999999999986543   


Q ss_pred             cccccccccccCccChhhhc---cCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCC
Q 016594          224 HHSIAPIEGTFGHLAPEYFM---HGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQG  300 (386)
Q Consensus       224 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (386)
                         ..+++|||.|||||++.   .+.|+-++||||||++..||...++|+-+.+.-..-+        .+...-.|   .
T Consensus       179 ---AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALY--------HIAQNesP---t  244 (948)
T KOG0577|consen  179 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY--------HIAQNESP---T  244 (948)
T ss_pred             ---hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHH--------HHHhcCCC---C
Confidence               45788999999999996   4789999999999999999999999987643211110        11111122   2


Q ss_pred             CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 016594          301 AYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVM  335 (386)
Q Consensus       301 ~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l  335 (386)
                      ....+++..+++++..||++-|.+|||..++++|.
T Consensus       245 Lqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~  279 (948)
T KOG0577|consen  245 LQSNEWSDYFRNFVDSCLQKIPQERPTSEELLKHR  279 (948)
T ss_pred             CCCchhHHHHHHHHHHHHhhCcccCCcHHHHhhcc
Confidence            23567889999999999999999999999998764

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=4.9e-41  Score=303.46  Aligned_cols=251  Identities=26%  Similarity=0.409  Sum_probs=201.3

Q ss_pred             CCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCCh-------HhHHHHHHHHHHHhccCCCceeeecceEEeCc-
Q 016594           67 AFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDD-------RKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-  137 (386)
Q Consensus        67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-  137 (386)
                      +|.+...||.|+||.||+|... +++.||+|.+.......       .....+.+|+.++++++||||+++++++.+.. 
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            4788999999999999999975 58899999887533221       12356788999999999999999999987755 


Q ss_pred             eEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCcccc
Q 016594          138 LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKW  217 (386)
Q Consensus       138 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~  217 (386)
                      .++++||+.+++|.+++...  ..+++..+..++.|++.||.|||+   ++++||||+|+||+++.++.++|+|||.+..
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lH~---~~ivH~di~p~nil~~~~~~~~l~dfg~~~~  155 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNNY--GAFEETLVRNFVRQILKGLNYLHN---RGIIHRDIKGANILVDNKGGIKISDFGISKK  155 (267)
T ss_pred             cEEEEEecCCCCHHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHh---cCcccccCCHHHEEEcCCCCEEecccCCCcc
Confidence            89999999999999998754  348889999999999999999999   9999999999999999999999999999987


Q ss_pred             CCCCCcc----ccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccc
Q 016594          218 LPSQWTH----HSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKL  293 (386)
Q Consensus       218 ~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  293 (386)
                      +......    .......|+..|+|||.+.+..++.++|+|||||++|+|++|+.||.........  .         ..
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~--~---------~~  224 (267)
T cd06628         156 LEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAI--F---------KI  224 (267)
T ss_pred             cccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHH--H---------HH
Confidence            7532111    1112345888999999999888999999999999999999999999764321100  0         00


Q ss_pred             cCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 016594          294 VDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEV  334 (386)
Q Consensus       294 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~  334 (386)
                      .. ......+...+..+.+++.+||+.||.+||++.+|+++
T Consensus       225 ~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  264 (267)
T cd06628         225 GE-NASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH  264 (267)
T ss_pred             hc-cCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence            00 11111223345779999999999999999999999975

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=8.5e-42  Score=318.31  Aligned_cols=258  Identities=22%  Similarity=0.372  Sum_probs=219.7

Q ss_pred             HHhcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEe-CceEE
Q 016594           63 IATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVD-NGLYL  140 (386)
Q Consensus        63 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~l  140 (386)
                      ...+.|.+.+.||+|.|++|.+|++. ++..||+|.+.+...+......+.+|+++|..|+|||||+++.+... ..+|+
T Consensus        53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lyl  132 (596)
T KOG0586|consen   53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYL  132 (596)
T ss_pred             ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEE
Confidence            45678999999999999999999976 79999999999887777777779999999999999999999999986 45999


Q ss_pred             EEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCC
Q 016594          141 IFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPS  220 (386)
Q Consensus       141 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~  220 (386)
                      ||||+.+|.+.+++.....  ..+..+..++.|++.|++|||+   ++|+|||||++||||+.+-++||+|||++..+..
T Consensus       133 V~eya~~ge~~~yl~~~gr--~~e~~ar~~F~q~vsaveYcH~---k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~  207 (596)
T KOG0586|consen  133 VMEYASGGELFDYLVKHGR--MKEKEARAKFRQIVSAVEYCHS---KNIVHRDLKAENILLDENMNIKIADFGFSTFFDY  207 (596)
T ss_pred             EEEeccCchhHHHHHhccc--chhhhhhhhhHHHHHHHHHHhh---cceeccccchhhcccccccceeeeccccceeecc
Confidence            9999999999999987554  6668899999999999999999   9999999999999999999999999999998874


Q ss_pred             CCccccccccccccCccChhhhccCCCC-cccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccC
Q 016594          221 QWTHHSIAPIEGTFGHLAPEYFMHGIVD-EKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQ  299 (386)
Q Consensus       221 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (386)
                      .   ....+.+|++.|.|||++.+..|. +.+|+||+|+++|.|+.|..||++..-               ..+-...+.
T Consensus       208 ~---~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~l---------------k~Lr~rvl~  269 (596)
T KOG0586|consen  208 G---LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNL---------------KELRPRVLR  269 (596)
T ss_pred             c---ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccc---------------ccccchhee
Confidence            3   345678899999999999998775 899999999999999999999997432               111122222


Q ss_pred             CC--CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCCcccc
Q 016594          300 GA--YDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEGDQIDK  343 (386)
Q Consensus       300 ~~--~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~~~~~~  343 (386)
                      ..  .+...+.++.++|+++|-++|.+|++.++|.++-|...-...
T Consensus       270 gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~~~~  315 (596)
T KOG0586|consen  270 GKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDLLEA  315 (596)
T ss_pred             eeecccceeechhHHHHHHhhccCccccCCHHHhhhhcccchhhhh
Confidence            21  222335678999999999999999999999998776654433

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=4.4e-41  Score=302.07  Aligned_cols=250  Identities=26%  Similarity=0.369  Sum_probs=200.2

Q ss_pred             CeecccCCcEEEEEEECC--C--cEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCceEEEEEeccC
Q 016594           72 NLVGRGGYAEVYKGVLQD--G--EEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNGLYLIFQFSSR  147 (386)
Q Consensus        72 ~~lg~G~~g~V~~~~~~~--~--~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~lv~e~~~~  147 (386)
                      +.||+|++|.||+|.+.+  +  ..||+|.+...... .....+.+|+.++++++||||+++++.+.+...++++||+.+
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIRLYGVVLTHPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-HHHHHHHHHHHHHhhcCCCCccceeEEEcCCeEEEEEEecCC
Confidence            468999999999999753  3  36899998764433 556788999999999999999999999988668999999999


Q ss_pred             CCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCcccc-
Q 016594          148 GSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHS-  226 (386)
Q Consensus       148 ~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~-  226 (386)
                      ++|.+.+.......+++..++.++.|++.||.|||+   ++++|+||||+||+++.++.+||+|||++..+........ 
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  156 (257)
T cd05040          80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLES---KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM  156 (257)
T ss_pred             CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHh---CCccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence            999999876543558999999999999999999999   9999999999999999999999999999987754322111 


Q ss_pred             ccccccccCccChhhhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCchhhhhhhhhhhcccccccccCCccCCCCCHH
Q 016594          227 IAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVT  305 (386)
Q Consensus       227 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (386)
                      .....++..|+|||.+.+..++.++|||||||++|+|++ |..||........  ......         .......+..
T Consensus       157 ~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~--~~~~~~---------~~~~~~~~~~  225 (257)
T cd05040         157 EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQI--LKKIDK---------EGERLERPEA  225 (257)
T ss_pred             ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHH--HHHHHh---------cCCcCCCCcc
Confidence            123446788999999998899999999999999999999 9999965432211  110000         0001111223


Q ss_pred             HHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 016594          306 QLNRLAFAASLCIRASPTWRPTMSEVLEVML  336 (386)
Q Consensus       306 ~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~  336 (386)
                      .+..+.+++.+||+.+|++||++.++++.|.
T Consensus       226 ~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         226 CPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             CCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence            4567999999999999999999999998774

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=7.6e-41  Score=305.11  Aligned_cols=267  Identities=22%  Similarity=0.334  Sum_probs=201.7

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEC-----CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEe---C
Q 016594           65 TNAFSSENLVGRGGYAEVYKGVLQ-----DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVD---N  136 (386)
Q Consensus        65 ~~~~~~~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~---~  136 (386)
                      ..+|++.+.||+|+||.||+|..+     ++..||+|.+...  .......+.+|+.+++.+.||||+++++++..   .
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   80 (284)
T cd05081           3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS--TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR   80 (284)
T ss_pred             cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCC
Confidence            357888999999999999999742     5788999998743  34445678899999999999999999998754   2


Q ss_pred             ceEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccc
Q 016594          137 GLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAK  216 (386)
Q Consensus       137 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~  216 (386)
                      ..++++||+.+++|.+++.... ..+++..++.++.|++.||.|||+   ++++||||||+||+++.++.+||+|||++.
T Consensus        81 ~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~aL~~LH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~  156 (284)
T cd05081          81 NLRLVMEYLPYGSLRDYLQKHR-ERLDHRKLLLYASQICKGMEYLGS---KRYVHRDLATRNILVESENRVKIGDFGLTK  156 (284)
T ss_pred             ceEEEEEecCCCCHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHhhEEECCCCeEEECCCcccc
Confidence            3889999999999999986532 348899999999999999999999   999999999999999999999999999998


Q ss_pred             cCCCCCccccc-cccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhc-c---cccc
Q 016594          217 WLPSQWTHHSI-APIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILN-Q---GEIE  291 (386)
Q Consensus       217 ~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~-~---~~~~  291 (386)
                      .+......... ....++..|+|||++.+..++.++|||||||++|||++|..|+................ .   ..+.
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (284)
T cd05081         157 VLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLI  236 (284)
T ss_pred             cccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHH
Confidence            76543221111 11223456999999998899999999999999999999887765432211100000000 0   0000


Q ss_pred             cccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 016594          292 KLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLE  337 (386)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~  337 (386)
                      ..+........+...+..+.+++.+||+.+|++|||+.+|++.|..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~  282 (284)
T cd05081         237 ELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEA  282 (284)
T ss_pred             HHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHh
Confidence            1111111111222345679999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=8.6e-41  Score=304.88  Aligned_cols=263  Identities=24%  Similarity=0.332  Sum_probs=201.7

Q ss_pred             cCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEEE
Q 016594           66 NAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQ  143 (386)
Q Consensus        66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~e  143 (386)
                      ++|++.+.||+|+||.||+|.++ +++.||+|++............+.+|+.+++++.|+||+++++++.... .++++|
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            46889999999999999999987 6899999998754333334456789999999999999999999998765 899999


Q ss_pred             eccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCc
Q 016594          144 FSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWT  223 (386)
Q Consensus       144 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~  223 (386)
                      |+.++.|..++...  ..+++..++.++.|++.||.|||+   ++++|+||||+||+++.++.++|+|||++........
T Consensus        81 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~ql~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~  155 (286)
T cd07847          81 YCDHTVLNELEKNP--RGVPEHLIKKIIWQTLQAVNFCHK---HNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD  155 (286)
T ss_pred             ccCccHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCChhhEEEcCCCcEEECccccceecCCCcc
Confidence            99998888776543  348999999999999999999999   9999999999999999999999999999987654321


Q ss_pred             cccccccccccCccChhhhcc-CCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhh------------hcccc-
Q 016594          224 HHSIAPIEGTFGHLAPEYFMH-GIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPI------------LNQGE-  289 (386)
Q Consensus       224 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~------------~~~~~-  289 (386)
                        ......++..|+|||.+.+ ..++.++||||||+++|+|++|..||.+............            ..... 
T Consensus       156 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (286)
T cd07847         156 --DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQF  233 (286)
T ss_pred             --cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccc
Confidence              1223457888999999876 5578999999999999999999999986543211110000            00000 


Q ss_pred             cccccCCccCCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 016594          290 IEKLVDPRLQGAYD-----VTQLNRLAFAASLCIRASPTWRPTMSEVLEVM  335 (386)
Q Consensus       290 ~~~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l  335 (386)
                      ......+......+     ...+..+.+++.+||+.+|++||++.+++.+-
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~  284 (286)
T cd07847         234 FKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHP  284 (286)
T ss_pred             cccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCC
Confidence            00000000000000     12246789999999999999999999999763

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=9.6e-41  Score=301.56  Aligned_cols=253  Identities=23%  Similarity=0.333  Sum_probs=199.6

Q ss_pred             cCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCC---hHhHHHHHHHHHHHhccCCCceeeecceEEeC---ce
Q 016594           66 NAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTD---DRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDN---GL  138 (386)
Q Consensus        66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~---~~  138 (386)
                      .+|++.+.||+|+||.||+|... ++..||+|.+......   ......+.+|+.+++.++||||+++++++.+.   ..
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            47899999999999999999975 6889999988653222   23345688899999999999999999998653   37


Q ss_pred             EEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccC
Q 016594          139 YLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWL  218 (386)
Q Consensus       139 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~  218 (386)
                      ++++||+.+++|.+++....  .+++...+.++.|++.||.|||+   ++++||||+|+||+++.++.++|+|||++..+
T Consensus        82 ~l~~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~LH~---~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~  156 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKAYG--ALTESVTRKYTRQILEGMSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRL  156 (266)
T ss_pred             EEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCCCcccc
Confidence            89999999999999887543  38889999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCCc-cccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCc
Q 016594          219 PSQWT-HHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPR  297 (386)
Q Consensus       219 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (386)
                      ..... ........++..|+|||.+.+..++.++|||||||++|+|++|+.||.........           .......
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~-----------~~~~~~~  225 (266)
T cd06651         157 QTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAI-----------FKIATQP  225 (266)
T ss_pred             ccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHH-----------HHHhcCC
Confidence            43211 11122345888999999999988999999999999999999999999764321110           0011111


Q ss_pred             cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 016594          298 LQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVM  335 (386)
Q Consensus       298 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l  335 (386)
                      .....+......+.+++ +||..+|++||++.+|+++-
T Consensus       226 ~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp  262 (266)
T cd06651         226 TNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRHP  262 (266)
T ss_pred             CCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCc
Confidence            11222333456677787 68888999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=5e-41  Score=303.59  Aligned_cols=256  Identities=21%  Similarity=0.362  Sum_probs=202.4

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEC-C---CcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eE
Q 016594           65 TNAFSSENLVGRGGYAEVYKGVLQ-D---GEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LY  139 (386)
Q Consensus        65 ~~~~~~~~~lg~G~~g~V~~~~~~-~---~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~  139 (386)
                      ..+|++.+.||+|+||.||+|.+. +   +..+|+|.+.... .......+.+|+.++++++||||+++++++..++ .+
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   81 (267)
T cd05066           3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVM   81 (267)
T ss_pred             HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence            457889999999999999999864 2   3379999886532 2344567899999999999999999999987655 89


Q ss_pred             EEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCC
Q 016594          140 LIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLP  219 (386)
Q Consensus       140 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~  219 (386)
                      ++|||+.+++|.+++.... ..+++..++.++.|++.||.|||+   ++++||||||+||+++.++.++|+|||++..+.
T Consensus        82 lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~  157 (267)
T cd05066          82 IVTEYMENGSLDAFLRKHD-GQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLE  157 (267)
T ss_pred             EEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCEeehhhchhcEEECCCCeEEeCCCCcccccc
Confidence            9999999999999987543 348899999999999999999999   999999999999999999999999999998765


Q ss_pred             CCCcccc-ccccccccCccChhhhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCchhhhhhhhhhhcccccccccCCc
Q 016594          220 SQWTHHS-IAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGEIEKLVDPR  297 (386)
Q Consensus       220 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (386)
                      ....... .....++..|+|||.+.+..++.++|+|||||++|++++ |..||.......  .......          .
T Consensus       158 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~--~~~~~~~----------~  225 (267)
T cd05066         158 DDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD--VIKAIEE----------G  225 (267)
T ss_pred             cccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH--HHHHHhC----------C
Confidence            4322111 111223567999999998899999999999999999887 999997643211  0010000          0


Q ss_pred             cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 016594          298 LQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLE  337 (386)
Q Consensus       298 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~  337 (386)
                      .....+...+..+.+++.+||+.+|.+||++.++++.|..
T Consensus       226 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  265 (267)
T cd05066         226 YRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDK  265 (267)
T ss_pred             CcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHh
Confidence            0111122345678999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=3.2e-41  Score=305.15  Aligned_cols=255  Identities=22%  Similarity=0.389  Sum_probs=200.7

Q ss_pred             cCCCCCCeecccCCcEEEEEEEC-CC---cEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEE
Q 016594           66 NAFSSENLVGRGGYAEVYKGVLQ-DG---EEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYL  140 (386)
Q Consensus        66 ~~~~~~~~lg~G~~g~V~~~~~~-~~---~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~l  140 (386)
                      +.|++.+.||+|+||.||+|.+. ++   ..||||.+.... .......+..|+.+++.+.||||+++++++.++. .++
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l   82 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMI   82 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEE
Confidence            45788999999999999999975 33   369999987532 3445677999999999999999999999987655 899


Q ss_pred             EEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCC
Q 016594          141 IFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPS  220 (386)
Q Consensus       141 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~  220 (386)
                      ++||+.+++|.+++... ...+++..++.++.|++.||.|||+   ++++|+||||+||+++.++.+||+|||++.....
T Consensus        83 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~l~~al~~lH~---~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~  158 (269)
T cd05065          83 ITEFMENGALDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED  158 (269)
T ss_pred             EEecCCCCcHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccChheEEEcCCCcEEECCCcccccccc
Confidence            99999999999988654 3458999999999999999999999   9999999999999999999999999999876643


Q ss_pred             CCccccccccc---cccCccChhhhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCchhhhhhhhhhhcccccccccCC
Q 016594          221 QWTHHSIAPIE---GTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGEIEKLVDP  296 (386)
Q Consensus       221 ~~~~~~~~~~~---gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (386)
                      ...........   .+..|+|||.+.+..++.++|||||||++|||++ |..||.......  ....+.          .
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~--~~~~i~----------~  226 (269)
T cd05065         159 DTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD--VINAIE----------Q  226 (269)
T ss_pred             CccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHH--HHHHHH----------c
Confidence            32211111111   2457999999999999999999999999999887 999997643211  000000          0


Q ss_pred             ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 016594          297 RLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLE  337 (386)
Q Consensus       297 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~  337 (386)
                      ......+...+..+.+++.+||+.+|.+||++.+|+..|..
T Consensus       227 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  267 (269)
T cd05065         227 DYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDK  267 (269)
T ss_pred             CCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence            00111122345678999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=4.7e-41  Score=301.66  Aligned_cols=251  Identities=22%  Similarity=0.331  Sum_probs=205.8

Q ss_pred             CCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEEEe
Q 016594           67 AFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQF  144 (386)
Q Consensus        67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~  144 (386)
                      +|++.+.||.|+||.||++... +++.||+|.+............+.+|+.++++++||||+++++++.+.+ .++++||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            4788999999999999999975 6889999998764444455668899999999999999999999997765 8999999


Q ss_pred             ccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCcc
Q 016594          145 SSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTH  224 (386)
Q Consensus       145 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  224 (386)
                      +.+++|.+.+.......+++..++.++.|++.||.|||+   ++++|+||+|+||+++.++.++|+|||++........ 
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~-  156 (256)
T cd08218          81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE-  156 (256)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh-
Confidence            999999998876555568999999999999999999999   9999999999999999999999999999986644321 


Q ss_pred             ccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCCCCCH
Q 016594          225 HSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDV  304 (386)
Q Consensus       225 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (386)
                       ......|++.|+|||++.+..++.++|+|||||++|+|++|..||.......  .......         .. ....+.
T Consensus       157 -~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~--~~~~~~~---------~~-~~~~~~  223 (256)
T cd08218         157 -LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKN--LVLKIIR---------GS-YPPVSS  223 (256)
T ss_pred             -hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHH--HHHHHhc---------CC-CCCCcc
Confidence             1223457889999999998889999999999999999999999997543211  1111110         00 011222


Q ss_pred             HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 016594          305 TQLNRLAFAASLCIRASPTWRPTMSEVLEV  334 (386)
Q Consensus       305 ~~~~~l~~li~~cl~~dP~~Rpt~~~il~~  334 (386)
                      ..+..+.+++.+||+.+|++||++.+|+++
T Consensus       224 ~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~  253 (256)
T cd08218         224 HYSYDLRNLVSQLFKRNPRDRPSVNSILEK  253 (256)
T ss_pred             cCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence            345679999999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.4e-42  Score=318.17  Aligned_cols=245  Identities=21%  Similarity=0.241  Sum_probs=190.0

Q ss_pred             ecccCCcEEEEEEEC-CCcEEEEEEeccccC-ChHhHHHHHHHHHHHhcc---CCCceeeecceEEeCc-eEEEEEeccC
Q 016594           74 VGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVT-DDRKEKEFLTEIGTIGHV---CHPNVLSLLGCCVDNG-LYLIFQFSSR  147 (386)
Q Consensus        74 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~~-~~lv~e~~~~  147 (386)
                      ||+|+||+||+|... +++.||+|++.+... ..........|..++..+   .||||+++++++.+.. .++||||+.+
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            799999999999976 689999999865321 222334456677777655   6999999999997755 8999999999


Q ss_pred             CCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCccccc
Q 016594          148 GSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSI  227 (386)
Q Consensus       148 ~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  227 (386)
                      ++|..++...  ..+++..+..++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||++.......  ...
T Consensus        81 g~L~~~l~~~--~~~~~~~~~~~~~qil~al~~LH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~--~~~  153 (330)
T cd05586          81 GELFWHLQKE--GRFSEDRAKFYIAELVLALEHLHK---YDIVYRDLKPENILLDATGHIALCDFGLSKANLTDN--KTT  153 (330)
T ss_pred             ChHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC--CCc
Confidence            9999888653  348999999999999999999999   999999999999999999999999999987543221  123


Q ss_pred             cccccccCccChhhhccC-CCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCCCCCHHH
Q 016594          228 APIEGTFGHLAPEYFMHG-IVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQ  306 (386)
Q Consensus       228 ~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (386)
                      ...+||+.|+|||++.+. .++.++|||||||++|+|++|..||.+......  ...+. ..        .... .....
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~--~~~i~-~~--------~~~~-~~~~~  221 (330)
T cd05586         154 NTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQM--YRNIA-FG--------KVRF-PKNVL  221 (330)
T ss_pred             cCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHH--HHHHH-cC--------CCCC-CCccC
Confidence            345699999999998764 489999999999999999999999977543211  01000 00        0000 01123


Q ss_pred             HHHHHHHHHHccccCCCCCC----CHHHHHHHHhc
Q 016594          307 LNRLAFAASLCIRASPTWRP----TMSEVLEVMLE  337 (386)
Q Consensus       307 ~~~l~~li~~cl~~dP~~Rp----t~~~il~~l~~  337 (386)
                      +..+.+++.+||+.||.+||    ++.+++++.+.
T Consensus       222 ~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~  256 (330)
T cd05586         222 SDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFF  256 (330)
T ss_pred             CHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccc
Confidence            46788999999999999998    67888877544

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.5e-41  Score=304.44  Aligned_cols=253  Identities=25%  Similarity=0.404  Sum_probs=205.7

Q ss_pred             cCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEEE
Q 016594           66 NAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQ  143 (386)
Q Consensus        66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~e  143 (386)
                      ++|++.+.||.|++|.||+|.+. +++.||+|.+.... .......+.+|+.+++.++|+||+++++++.++. .++++|
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   79 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE-AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIME   79 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc-cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEE
Confidence            46888999999999999999976 68899999987532 2334566889999999999999999999987765 899999


Q ss_pred             eccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCc
Q 016594          144 FSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWT  223 (386)
Q Consensus       144 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~  223 (386)
                      |+.+++|.+++...   .+++..++.++.|++.||.|||+   ++++|+||+|+||+++.++.++|+|||++..+.... 
T Consensus        80 ~~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-  152 (274)
T cd06609          80 YCGGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLHE---EGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM-  152 (274)
T ss_pred             eeCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEcccccceeecccc-
Confidence            99999999988754   58999999999999999999999   999999999999999999999999999998775432 


Q ss_pred             cccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCCCCC
Q 016594          224 HHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYD  303 (386)
Q Consensus       224 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (386)
                       .......++..|+|||.+.+..++.++|||||||++|+|++|..||..........  .      +.....+.    ..
T Consensus       153 -~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~--~------~~~~~~~~----~~  219 (274)
T cd06609         153 -SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLF--L------IPKNNPPS----LE  219 (274)
T ss_pred             -cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHH--H------hhhcCCCC----Cc
Confidence             12234468889999999998889999999999999999999999997643211100  0      00001111    11


Q ss_pred             HH-HHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCC
Q 016594          304 VT-QLNRLAFAASLCIRASPTWRPTMSEVLEVMLEGD  339 (386)
Q Consensus       304 ~~-~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~~  339 (386)
                      .. .+..+.+++.+||..+|++||++.+++++-+...
T Consensus       220 ~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~  256 (274)
T cd06609         220 GNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKK  256 (274)
T ss_pred             ccccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcC
Confidence            11 4567899999999999999999999998755443

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-43  Score=325.35  Aligned_cols=253  Identities=23%  Similarity=0.368  Sum_probs=205.4

Q ss_pred             CCCCCCeecccCCcEEEEEEECC-CcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEE-eCceEEEEEe
Q 016594           67 AFSSENLVGRGGYAEVYKGVLQD-GEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCV-DNGLYLIFQF  144 (386)
Q Consensus        67 ~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~-~~~~~lv~e~  144 (386)
                      .|.++..||.|+||+||+|..++ +-..|.|++.-  ........++-|++||....||+||+|++.|. ++.+++++||
T Consensus        33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIet--kseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEF  110 (1187)
T KOG0579|consen   33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIET--KSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEF  110 (1187)
T ss_pred             HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcc--cchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEee
Confidence            45667789999999999999874 44456676652  34566778999999999999999999999775 5669999999


Q ss_pred             ccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCcc
Q 016594          145 SSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTH  224 (386)
Q Consensus       145 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  224 (386)
                      |.||-++.++-... +.+++.++..+.+|++.||.|||+   ++|||||||..|||++.+|.++|+|||.+.....  +.
T Consensus       111 C~GGAVDaimlEL~-r~LtE~QIqvvc~q~ldALn~LHs---~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~--t~  184 (1187)
T KOG0579|consen  111 CGGGAVDAIMLELG-RVLTEDQIQVVCYQVLDALNWLHS---QNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS--TR  184 (1187)
T ss_pred             cCCchHhHHHHHhc-cccchHHHHHHHHHHHHHHHHHhh---cchhhhhccccceEEEecCcEeeecccccccchh--HH
Confidence            99999998876644 459999999999999999999999   9999999999999999999999999999875433  23


Q ss_pred             ccccccccccCccChhhhc-----cCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCc-c
Q 016594          225 HSIAPIEGTFGHLAPEYFM-----HGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPR-L  298 (386)
Q Consensus       225 ~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-~  298 (386)
                      ....++.|||+|||||+..     ..+|++++||||||++|.||..+.+|-.....-           ..+.++.... .
T Consensus       185 qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpM-----------RVllKiaKSePP  253 (1187)
T KOG0579|consen  185 QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPM-----------RVLLKIAKSEPP  253 (1187)
T ss_pred             hhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchH-----------HHHHHHhhcCCC
Confidence            3456788999999999875     468999999999999999999999997653211           0111111111 1


Q ss_pred             CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          299 QGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       299 ~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                      ....+..++..+.+++..||.+||..||+++++++|-+-.
T Consensus       254 TLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~  293 (1187)
T KOG0579|consen  254 TLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQ  293 (1187)
T ss_pred             cccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccc
Confidence            1234456788899999999999999999999999987654

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=8e-41  Score=301.79  Aligned_cols=253  Identities=22%  Similarity=0.392  Sum_probs=201.8

Q ss_pred             CCCCCCeecccCCcEEEEEEECCCcEEEEEEeccccCC----hHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEE
Q 016594           67 AFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTD----DRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLI  141 (386)
Q Consensus        67 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv  141 (386)
                      +|++.+.||.|+||.||+|...+++.+|+|.+......    ......+.+|+.+++.++|+||+++++++.+.. .+++
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            47889999999999999999878899999988743221    223456888999999999999999999997765 8999


Q ss_pred             EEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCC
Q 016594          142 FQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQ  221 (386)
Q Consensus       142 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  221 (386)
                      +||+.+++|.+++.+..  .+++..+..++.|++.||+|||+   .+++|+||+|+||+++.++.++|+|||++......
T Consensus        81 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  155 (265)
T cd06631          81 MEFVPGGSISSILNRFG--PLPEPVFCKYTKQILDGVAYLHN---NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWV  155 (265)
T ss_pred             EecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHhEEECCCCeEEeccchhhHhhhhc
Confidence            99999999999987543  47899999999999999999999   99999999999999999999999999998765321


Q ss_pred             Cc----cccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCc
Q 016594          222 WT----HHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPR  297 (386)
Q Consensus       222 ~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (386)
                      ..    ........|+..|+|||++.+..++.++|||||||++|+|++|..||............  ....        .
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~--~~~~--------~  225 (265)
T cd06631         156 GLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYI--GAHR--------G  225 (265)
T ss_pred             cccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHh--hhcc--------C
Confidence            11    11123346889999999999988999999999999999999999999764322111000  0000        0


Q ss_pred             cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 016594          298 LQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEV  334 (386)
Q Consensus       298 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~  334 (386)
                      .....+...+..+.+++.+||+.+|.+||++.+++.+
T Consensus       226 ~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  262 (265)
T cd06631         226 LMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRH  262 (265)
T ss_pred             CCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            0011122345678999999999999999999999875

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=5.3e-41  Score=306.20  Aligned_cols=264  Identities=23%  Similarity=0.315  Sum_probs=204.6

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEE
Q 016594           65 TNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIF  142 (386)
Q Consensus        65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~  142 (386)
                      .++|++.+.||+|+||+||+|.+. +++.||+|++.... .......+.+|+++++.++||||+++++++.... .++++
T Consensus         4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   82 (284)
T cd06620           4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA-KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCM   82 (284)
T ss_pred             HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC-cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEE
Confidence            467888999999999999999976 68899999886532 2344677899999999999999999999997755 89999


Q ss_pred             EeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCC
Q 016594          143 QFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQW  222 (386)
Q Consensus       143 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  222 (386)
                      ||+.+++|.+++...  ..+++..+..++.+++.||.|||+.  ++++|+||+|+||+++.++.++|+|||++...... 
T Consensus        83 e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~-  157 (284)
T cd06620          83 EFMDCGSLDRIYKKG--GPIPVEILGKIAVAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS-  157 (284)
T ss_pred             ecCCCCCHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHh--cCeeccCCCHHHEEECCCCcEEEccCCcccchhhh-
Confidence            999999999988653  3489999999999999999999961  58999999999999999999999999998654322 


Q ss_pred             ccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCCCC
Q 016594          223 THHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAY  302 (386)
Q Consensus       223 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (386)
                         ......|+..|+|||++.+..++.++|||||||++|+|++|..||......................+.........
T Consensus       158 ---~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (284)
T cd06620         158 ---IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLP  234 (284)
T ss_pred             ---ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCC
Confidence               12245689999999999888999999999999999999999999986432100000000000001111111111111


Q ss_pred             CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 016594          303 DVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLE  337 (386)
Q Consensus       303 ~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~  337 (386)
                      ....+..+.+++.+||+.||++||++.+++++...
T Consensus       235 ~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~  269 (284)
T cd06620         235 SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPF  269 (284)
T ss_pred             chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccc
Confidence            11245679999999999999999999999987544

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=1.8e-40  Score=299.59  Aligned_cols=257  Identities=26%  Similarity=0.404  Sum_probs=205.7

Q ss_pred             cCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEEE
Q 016594           66 NAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQ  143 (386)
Q Consensus        66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~e  143 (386)
                      ++|++.+.||.|+||+||+|.+. ++..+|+|++....... ....+.+|+.+++.+.|+||+++++.+..+. .+++++
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   79 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMP   79 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch-HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEe
Confidence            47899999999999999999975 68899999987543333 5677899999999999999999999887655 899999


Q ss_pred             eccCCCHhhhhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCC
Q 016594          144 FSSRGSVASLFHDVNS-PGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQW  222 (386)
Q Consensus       144 ~~~~~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  222 (386)
                      ++.+++|.+++..... ..+++..+..++.|++.||.|||+   ++++|+||+|+||+++.++.++|+|||++..+....
T Consensus        80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~---~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~  156 (267)
T cd06610          80 YLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHS---NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGG  156 (267)
T ss_pred             ccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence            9999999999876433 468999999999999999999999   999999999999999999999999999998765443


Q ss_pred             ccc--cccccccccCccChhhhccC-CCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccC
Q 016594          223 THH--SIAPIEGTFGHLAPEYFMHG-IVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQ  299 (386)
Q Consensus       223 ~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (386)
                      ...  ......|+..|+|||++... .++.++|+|||||++|+|++|+.||........ ... ....      ..+...
T Consensus       157 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~-~~~-~~~~------~~~~~~  228 (267)
T cd06610         157 DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV-LML-TLQN------DPPSLE  228 (267)
T ss_pred             cccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhh-HHH-HhcC------CCCCcC
Confidence            221  22344688999999998876 789999999999999999999999976432110 000 0000      001111


Q ss_pred             CCC-CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 016594          300 GAY-DVTQLNRLAFAASLCIRASPTWRPTMSEVLEV  334 (386)
Q Consensus       300 ~~~-~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~  334 (386)
                      ... ....+..+.+++.+||..||++||++.+|+++
T Consensus       229 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~  264 (267)
T cd06610         229 TGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH  264 (267)
T ss_pred             CccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence            111 12345778999999999999999999999986

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=8e-41  Score=301.23  Aligned_cols=251  Identities=22%  Similarity=0.369  Sum_probs=205.7

Q ss_pred             CCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeC---ceEEEE
Q 016594           67 AFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDN---GLYLIF  142 (386)
Q Consensus        67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~---~~~lv~  142 (386)
                      +|++.+.||.|+||.||+|... ++..||+|.+............+..|+.+++.++|+||+++++++...   ..++++
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            4788899999999999999965 688999999876555556667788999999999999999999988642   278999


Q ss_pred             EeccCCCHhhhhhhc--CCCCCCHHHHHHHHHHHHHHHHHHH-----hCCCCCeEEeCCCCCCeeEcCCCCeEEeecCcc
Q 016594          143 QFSSRGSVASLFHDV--NSPGVEWKVRHKIAVGTARGLHYLH-----KGCQRRIIHRDIKSSNILLTADFEPQISDFGLA  215 (386)
Q Consensus       143 e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH-----~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a  215 (386)
                      ||+.+++|.+++...  ....+++..++.++.|++.||.|||     +   .+++|+||+|+||+++.++.+||+|||++
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~---~~i~h~dl~p~nili~~~~~~kl~d~g~~  157 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPG---NTVLHRDLKPANIFLDANNNVKLGDFGLA  157 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCcccc---CcceecCCCHHHEEEecCCCEEEeccccc
Confidence            999999999988654  2345899999999999999999999     6   89999999999999999999999999999


Q ss_pred             ccCCCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccC
Q 016594          216 KWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVD  295 (386)
Q Consensus       216 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  295 (386)
                      ........  ......++..|+|||.+.+..++.++|+||||+++|+|++|..||.......  .... .         .
T Consensus       158 ~~~~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~~~~-~---------~  223 (265)
T cd08217         158 KILGHDSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQ--LASK-I---------K  223 (265)
T ss_pred             ccccCCcc--cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHH--HHHH-H---------h
Confidence            87654321  1233468999999999998889999999999999999999999998754211  1111 0         1


Q ss_pred             CccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 016594          296 PRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEV  334 (386)
Q Consensus       296 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~  334 (386)
                      .......+...+..+.+++.+||+.+|++||++.+|+++
T Consensus       224 ~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         224 EGKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             cCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence            111112233445779999999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=3.7e-41  Score=307.13  Aligned_cols=262  Identities=19%  Similarity=0.289  Sum_probs=197.3

Q ss_pred             CCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEEEe
Q 016594           67 AFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQF  144 (386)
Q Consensus        67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~  144 (386)
                      +|++.+.||.|+||.||+|.+. +|..||+|.+............+.+|+.++++++||||+++++++.+.. .++++||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            4788899999999999999986 6899999998754433334456788999999999999999999997765 8999999


Q ss_pred             ccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCcc
Q 016594          145 SSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTH  224 (386)
Q Consensus       145 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  224 (386)
                      +.+ +|.+++.... ..+++..++.++.||+.||.|||+   ++++||||||+||+++.++.+||+|||++..+....  
T Consensus        81 ~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~--  153 (284)
T cd07839          81 CDQ-DLKKYFDSCN-GDIDPEIVKSFMFQLLKGLAFCHS---HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV--  153 (284)
T ss_pred             CCC-CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEcCCCcEEECccchhhccCCCC--
Confidence            975 7777765433 348999999999999999999999   999999999999999999999999999998654322  


Q ss_pred             ccccccccccCccChhhhccC-CCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhh--hccc------ccccccC
Q 016594          225 HSIAPIEGTFGHLAPEYFMHG-IVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPI--LNQG------EIEKLVD  295 (386)
Q Consensus       225 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~--~~~~------~~~~~~~  295 (386)
                      .......++..|+|||++.+. .++.++|||||||++|+|++|..||..............  ....      .+....+
T Consensus       154 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (284)
T cd07839         154 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPD  233 (284)
T ss_pred             CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhccc
Confidence            122334578899999998764 478999999999999999999888643322111110000  0000      0000000


Q ss_pred             C----ccCC-----CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 016594          296 P----RLQG-----AYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVM  335 (386)
Q Consensus       296 ~----~~~~-----~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l  335 (386)
                      .    ....     ......+..+.+++.+||+.||.+|||+.+++++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~  282 (284)
T cd07839         234 YKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHP  282 (284)
T ss_pred             ccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCC
Confidence            0    0000     01112356789999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=3.5e-41  Score=314.12  Aligned_cols=259  Identities=19%  Similarity=0.230  Sum_probs=198.9

Q ss_pred             cCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEecccc-CChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEE
Q 016594           66 NAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVV-TDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIF  142 (386)
Q Consensus        66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~  142 (386)
                      ++|++.+.||+|+||.||++.++ +++.||+|++.+.. ........+..|+.++..++|+||+++++++.+.. .++||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            46889999999999999999976 57889999986522 12223445778999999999999999999997765 89999


Q ss_pred             EeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCC
Q 016594          143 QFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQW  222 (386)
Q Consensus       143 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  222 (386)
                      ||+.+|+|.+++.... ..+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||++..+....
T Consensus        81 ey~~~g~L~~~l~~~~-~~l~~~~~~~~~~qi~~al~~lH~---~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~  156 (332)
T cd05623          81 DYYVGGDLLTLLSKFE-DRLPEDMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG  156 (332)
T ss_pred             eccCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEeecchheecccCC
Confidence            9999999999987533 348999999999999999999999   999999999999999999999999999987653321


Q ss_pred             ccccccccccccCccChhhhc-----cCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCc
Q 016594          223 THHSIAPIEGTFGHLAPEYFM-----HGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPR  297 (386)
Q Consensus       223 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (386)
                      . .......||+.|+|||++.     ...++.++|||||||++|||++|+.||........  ...+.....  ..   .
T Consensus       157 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~--~~~i~~~~~--~~---~  228 (332)
T cd05623         157 T-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVET--YGKIMNHKE--RF---Q  228 (332)
T ss_pred             c-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHH--HHHHhCCCc--cc---c
Confidence            1 1223356999999999986     34688999999999999999999999986532111  111111000  00   0


Q ss_pred             cCCCCCHHHHHHHHHHHHHccccCCCC--CCCHHHHHHHHhc
Q 016594          298 LQGAYDVTQLNRLAFAASLCIRASPTW--RPTMSEVLEVMLE  337 (386)
Q Consensus       298 ~~~~~~~~~~~~l~~li~~cl~~dP~~--Rpt~~~il~~l~~  337 (386)
                       ........+..+.+++.+|+..++..  |+++.+++++-+.
T Consensus       229 -~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f  269 (332)
T cd05623         229 -FPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFF  269 (332)
T ss_pred             -CCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCc
Confidence             00111234567899999988665444  6899999998543

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=1e-40  Score=302.37  Aligned_cols=256  Identities=23%  Similarity=0.364  Sum_probs=201.0

Q ss_pred             CCCCCeecccCCcEEEEEEEC----CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc------
Q 016594           68 FSSENLVGRGGYAEVYKGVLQ----DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG------  137 (386)
Q Consensus        68 ~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------  137 (386)
                      |.+.+.||+|+||.||+|.+.    ++..||||++............+.+|+.+++.++||||+++++++....      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            567889999999999999853    3678999999765555556777899999999999999999999886421      


Q ss_pred             -eEEEEEeccCCCHhhhhhhcC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeec
Q 016594          138 -LYLIFQFSSRGSVASLFHDVN----SPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDF  212 (386)
Q Consensus       138 -~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Df  212 (386)
                       .+++++|+.+++|..++....    ...+++..++.++.|++.||+|||+   ++|+||||||+||+++.++.+||+||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~nili~~~~~~kl~df  157 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSS---KNFIHRDLAARNCMLNENMTVCVADF  157 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccchhhEEEcCCCCEEECcc
Confidence             368889999999988764321    1247889999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCchhhhhhhhhhhcccccc
Q 016594          213 GLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGEIE  291 (386)
Q Consensus       213 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~  291 (386)
                      |++..+.............+++.|++||.+.+..++.++|||||||++|+|++ |..||.+.....  .........   
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~--~~~~~~~~~---  232 (273)
T cd05074         158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE--IYNYLIKGN---  232 (273)
T ss_pred             cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHH--HHHHHHcCC---
Confidence            99986643322222223345678999999998889999999999999999999 899997653311  000000000   


Q ss_pred             cccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          292 KLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                             ....+...+..+.+++.+||+.+|++||++.++++.|+..
T Consensus       233 -------~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         233 -------RLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             -------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                   0011122346799999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=7.7e-41  Score=300.11  Aligned_cols=250  Identities=20%  Similarity=0.317  Sum_probs=204.8

Q ss_pred             CCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEEEe
Q 016594           67 AFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQF  144 (386)
Q Consensus        67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~  144 (386)
                      +|++.+.||+|+||.||+|... +++.+|+|.+............+.+|+.+++.++||||+++++.+..++ .++++||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            5788999999999999999975 6889999998765545556678899999999999999999999887655 8999999


Q ss_pred             ccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCC-CeEEeecCccccCCCCCc
Q 016594          145 SSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADF-EPQISDFGLAKWLPSQWT  223 (386)
Q Consensus       145 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~-~~kl~Dfg~a~~~~~~~~  223 (386)
                      +.+++|.+++.......+++..+..++.|++.||.|||+   ++++|+||+|+||+++.++ .++|+|||.+........
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~  157 (256)
T cd08220          81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHT---KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK  157 (256)
T ss_pred             CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc
Confidence            999999999987655668999999999999999999999   9999999999999998554 589999999987654321


Q ss_pred             cccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCCCCC
Q 016594          224 HHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYD  303 (386)
Q Consensus       224 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (386)
                         .....++..|+|||.+.+..++.++||||||+++|+|++|..||........  .....         .. .....+
T Consensus       158 ---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~--~~~~~---------~~-~~~~~~  222 (256)
T cd08220         158 ---AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPAL--VLKIM---------SG-TFAPIS  222 (256)
T ss_pred             ---ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHH--HHHHH---------hc-CCCCCC
Confidence               2234588899999999988899999999999999999999999976543211  11100         00 011112


Q ss_pred             HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 016594          304 VTQLNRLAFAASLCIRASPTWRPTMSEVLEV  334 (386)
Q Consensus       304 ~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~  334 (386)
                      ...+..+.+++.+||+.+|++|||+.+++++
T Consensus       223 ~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~  253 (256)
T cd08220         223 DRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ  253 (256)
T ss_pred             CCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence            2345679999999999999999999999976

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-42  Score=311.10  Aligned_cols=260  Identities=27%  Similarity=0.373  Sum_probs=215.9

Q ss_pred             HHHhcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCC-hHhHHHHHHHHHHHhccCCCceeeecceEEeCc-e
Q 016594           62 SIATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTD-DRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-L  138 (386)
Q Consensus        62 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~  138 (386)
                      .+..+.|..-++||+|+||.||-+..+ +|+.||.|.+.+.... ...+...+.|-.+|.+++.+.||.+--.|+..+ +
T Consensus       181 pvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~L  260 (591)
T KOG0986|consen  181 PVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDAL  260 (591)
T ss_pred             hccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCce
Confidence            456678999999999999999999976 7999999998764333 334556788999999999999999988887755 9


Q ss_pred             EEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccC
Q 016594          139 YLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWL  218 (386)
Q Consensus       139 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~  218 (386)
                      |+|+..|.||+|.-.+.....++|++..+..++.+|+.||++||+   .+||+|||||+|||||++|+++|+|.|+|..+
T Consensus       261 ClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~---~~iVYRDLKPeNILLDd~GhvRISDLGLAvei  337 (591)
T KOG0986|consen  261 CLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHR---RRIVYRDLKPENILLDDHGHVRISDLGLAVEI  337 (591)
T ss_pred             EEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHh---cceeeccCChhheeeccCCCeEeeccceEEec
Confidence            999999999999998888888899999999999999999999999   99999999999999999999999999999988


Q ss_pred             CCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCcc
Q 016594          219 PSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRL  298 (386)
Q Consensus       219 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (386)
                      .....   ....+||.+|||||++.++.|+...|+|||||+||||+.|+.||.......        ...++...+.. -
T Consensus       338 ~~g~~---~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKv--------k~eEvdrr~~~-~  405 (591)
T KOG0986|consen  338 PEGKP---IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKV--------KREEVDRRTLE-D  405 (591)
T ss_pred             CCCCc---cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhh--------hHHHHHHHHhc-c
Confidence            76533   344479999999999999999999999999999999999999997643221        11122211111 1


Q ss_pred             CCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHHh
Q 016594          299 QGAYDVTQLNRLAFAASLCIRASPTWRP-----TMSEVLEVML  336 (386)
Q Consensus       299 ~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----t~~~il~~l~  336 (386)
                      ...++...++++.++....|..||++|.     ++.++.+|..
T Consensus       406 ~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~Hpf  448 (591)
T KOG0986|consen  406 PEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPF  448 (591)
T ss_pred             hhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcc
Confidence            2345566778899999999999999996     4567777643

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.2e-40  Score=303.97  Aligned_cols=267  Identities=21%  Similarity=0.344  Sum_probs=202.3

Q ss_pred             cCCCCCCeecccCCcEEEEEEE-----CCCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeC---c
Q 016594           66 NAFSSENLVGRGGYAEVYKGVL-----QDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDN---G  137 (386)
Q Consensus        66 ~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~---~  137 (386)
                      ..|++.+.||+|+||.||+|.+     .++..||+|.+.... .......+.+|+.+++.+.||||+++++++.+.   .
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG   82 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCc
Confidence            4578899999999999999984     257889999986532 334456789999999999999999999998764   3


Q ss_pred             eEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCcccc
Q 016594          138 LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKW  217 (386)
Q Consensus       138 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~  217 (386)
                      .+++|||+.+++|.+++.... ..+++..++.++.|++.||+|||+   ++++||||||+||+++.++.++|+|||++..
T Consensus        83 ~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~~i~~aL~~lH~---~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~  158 (284)
T cd05079          83 IKLIMEFLPSGSLKEYLPRNK-NKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKA  158 (284)
T ss_pred             eEEEEEccCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccchheEEEcCCCCEEECCCccccc
Confidence            789999999999999886543 348999999999999999999999   9999999999999999999999999999987


Q ss_pred             CCCCCccc-cccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccc---cccc
Q 016594          218 LPSQWTHH-SIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGE---IEKL  293 (386)
Q Consensus       218 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~---~~~~  293 (386)
                      +....... ......++..|+|||++.+..++.++|||||||++|+|+++..|+...................   ....
T Consensus       159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T cd05079         159 IETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRV  238 (284)
T ss_pred             cccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHH
Confidence            65432211 1223456778999999998889999999999999999999877653321110000000000000   0000


Q ss_pred             cCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 016594          294 VDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLE  337 (386)
Q Consensus       294 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~  337 (386)
                      .........+...+..+.+++.+||+.+|++||++.++++.|..
T Consensus       239 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~  282 (284)
T cd05079         239 LEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEA  282 (284)
T ss_pred             HHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHh
Confidence            00111111122345789999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=7.1e-41  Score=304.97  Aligned_cols=256  Identities=25%  Similarity=0.383  Sum_probs=202.5

Q ss_pred             HHHHHhcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhcc-CCCceeeecceEEe--
Q 016594           60 EISIATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHV-CHPNVLSLLGCCVD--  135 (386)
Q Consensus        60 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~--  135 (386)
                      +.....+.|++.+.||.|+||.||+|.+. +++.||+|++...   ......+..|+.+++++ +|+||+++++++..  
T Consensus        10 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~---~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~   86 (282)
T cd06636          10 ALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT---EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKS   86 (282)
T ss_pred             hhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC---hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhccc
Confidence            33445678999999999999999999975 6889999988642   23345678899999888 69999999999853  


Q ss_pred             -----CceEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEe
Q 016594          136 -----NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQIS  210 (386)
Q Consensus       136 -----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~  210 (386)
                           ...+++|||+.+++|.+++.......+++..++.++.|++.||.|||+   ++++|+||+|+||+++.++.++|+
T Consensus        87 ~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dl~~~nili~~~~~~~l~  163 (282)
T cd06636          87 PPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHA---HKVIHRDIKGQNVLLTENAEVKLV  163 (282)
T ss_pred             ccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEe
Confidence                 237999999999999999877655668899999999999999999999   999999999999999999999999


Q ss_pred             ecCccccCCCCCccccccccccccCccChhhhc-----cCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhh
Q 016594          211 DFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFM-----HGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPIL  285 (386)
Q Consensus       211 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~  285 (386)
                      |||++.......  .......|+..|+|||.+.     +..++.++|||||||++|+|++|..||..........     
T Consensus       164 dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~-----  236 (282)
T cd06636         164 DFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALF-----  236 (282)
T ss_pred             eCcchhhhhccc--cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhh-----
Confidence            999987654321  1223456889999999986     3567889999999999999999999997543211110     


Q ss_pred             cccccccccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 016594          286 NQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEV  334 (386)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~  334 (386)
                            .+.............+..+.+++.+||+.||.+||++.+|+++
T Consensus       237 ------~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~  279 (282)
T cd06636         237 ------LIPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH  279 (282)
T ss_pred             ------hHhhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence                  0001111111112345679999999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=6.5e-41  Score=302.99  Aligned_cols=249  Identities=28%  Similarity=0.462  Sum_probs=195.8

Q ss_pred             CeecccCCcEEEEEEECC-------CcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEEE
Q 016594           72 NLVGRGGYAEVYKGVLQD-------GEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQ  143 (386)
Q Consensus        72 ~~lg~G~~g~V~~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~e  143 (386)
                      +.||.|+||.||+|.+.+       +..+|+|.+.... .......+.+|+.+++.++||||+++++++.+.. .+++||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   79 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA-TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIME   79 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhccc-chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEe
Confidence            368999999999998642       2579999876432 2234567889999999999999999999987655 899999


Q ss_pred             eccCCCHhhhhhhcC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCC-----CeEEeecC
Q 016594          144 FSSRGSVASLFHDVN-----SPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADF-----EPQISDFG  213 (386)
Q Consensus       144 ~~~~~~L~~~~~~~~-----~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~-----~~kl~Dfg  213 (386)
                      |+.+++|.+++....     ...+++..++.++.|++.||.|||+   .+++|+||||+||+++.++     .++|+|||
T Consensus        80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg  156 (269)
T cd05044          80 LMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFG  156 (269)
T ss_pred             ccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHh---CCcccCCCChheEEEecCCCCCCcceEECCcc
Confidence            999999999886532     2347889999999999999999999   9999999999999999877     89999999


Q ss_pred             ccccCCCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCchhhhhhhhhhhccccccc
Q 016594          214 LAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGEIEK  292 (386)
Q Consensus       214 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~  292 (386)
                      ++................++..|+|||++.+..++.++|||||||++|+|++ |..||.......  .....        
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~--~~~~~--------  226 (269)
T cd05044         157 LARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE--VLQHV--------  226 (269)
T ss_pred             cccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHH--HHHHH--------
Confidence            9876543322122223345678999999999999999999999999999998 999997543211  00000        


Q ss_pred             ccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 016594          293 LVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVML  336 (386)
Q Consensus       293 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~  336 (386)
                        ........+...+..+.+++.+||..+|.+||++.+|++.|.
T Consensus       227 --~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  268 (269)
T cd05044         227 --TAGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ  268 (269)
T ss_pred             --hcCCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence              001111122334677999999999999999999999999875

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=2.4e-40  Score=299.46  Aligned_cols=253  Identities=24%  Similarity=0.344  Sum_probs=190.6

Q ss_pred             CeecccCCcEEEEEEEC---CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEEEeccC
Q 016594           72 NLVGRGGYAEVYKGVLQ---DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQFSSR  147 (386)
Q Consensus        72 ~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~~~~  147 (386)
                      +.||+|+||.||+|.+.   ++..+|+|.+.... .......+.+|+.++++++||||+++++++.+.. .+++|||+.+
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~   79 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSA-SVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPL   79 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCC
Confidence            36899999999999864   34579999886533 2334457889999999999999999999987655 8999999999


Q ss_pred             CCHhhhhhhcCC---CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCcc
Q 016594          148 GSVASLFHDVNS---PGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTH  224 (386)
Q Consensus       148 ~~L~~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  224 (386)
                      |+|.+++.....   ...++..+..++.|++.||+|||+   ++++|+||||+||+++.++.+||+|||++.........
T Consensus        80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~  156 (269)
T cd05087          80 GDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK---NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYY  156 (269)
T ss_pred             CcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEECCccccccccCccee
Confidence            999998865322   235677888999999999999999   99999999999999999999999999998754332221


Q ss_pred             ccccccccccCccChhhhccC-------CCCcccchHHHHHHHHHHHh-CCCCCCCCchhhhhhhhhhhcccccccccCC
Q 016594          225 HSIAPIEGTFGHLAPEYFMHG-------IVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGEIEKLVDP  296 (386)
Q Consensus       225 ~~~~~~~gt~~y~aPE~~~~~-------~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (386)
                      .......++..|+|||++.+.       .++.++|||||||++|+|++ |..||......... ..  ...........+
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~-~~--~~~~~~~~~~~~  233 (269)
T cd05087         157 VTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVL-TY--TVREQQLKLPKP  233 (269)
T ss_pred             ecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHH-HH--HhhcccCCCCCC
Confidence            122234577889999998642       35789999999999999997 99999764322110 00  001111111112


Q ss_pred             ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 016594          297 RLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVML  336 (386)
Q Consensus       297 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~  336 (386)
                      ..    ....+..+.+++..|| .+|++|||+.+|++.|.
T Consensus       234 ~~----~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         234 RL----KLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             cc----CCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            11    1123456888999999 68999999999998764

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=1.4e-40  Score=305.24  Aligned_cols=251  Identities=20%  Similarity=0.347  Sum_probs=202.0

Q ss_pred             cCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEEE
Q 016594           66 NAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQ  143 (386)
Q Consensus        66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~e  143 (386)
                      .+|++.+.||.|+||.||+|... +++.||+|.+.....  .....+.+|+.+++.+.|+||+++++.+..+. .++|||
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~--~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e   97 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ--PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME   97 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCc--chHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeec
Confidence            57888999999999999999975 688999998875332  23456889999999999999999999987654 899999


Q ss_pred             eccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCc
Q 016594          144 FSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWT  223 (386)
Q Consensus       144 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~  223 (386)
                      |+.+++|.+++..   ..+++..+..++.|++.||.|||+   .+++||||||+||+++.++.++|+|||++........
T Consensus        98 ~~~~~~L~~~~~~---~~~~~~~~~~i~~ql~~aL~~LH~---~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~  171 (296)
T cd06654          98 YLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  171 (296)
T ss_pred             ccCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCEEECccccchhcccccc
Confidence            9999999998854   237889999999999999999999   9999999999999999999999999999876543211


Q ss_pred             cccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCCCCC
Q 016594          224 HHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYD  303 (386)
Q Consensus       224 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (386)
                        ......+++.|+|||.+.+..++.++|||||||++|+|++|+.||...........  ..        .........+
T Consensus       172 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~--~~--------~~~~~~~~~~  239 (296)
T cd06654         172 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYL--IA--------TNGTPELQNP  239 (296)
T ss_pred             --ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHH--Hh--------cCCCCCCCCc
Confidence              12234688999999999988899999999999999999999999976543211100  00        0000011112


Q ss_pred             HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 016594          304 VTQLNRLAFAASLCIRASPTWRPTMSEVLEVML  336 (386)
Q Consensus       304 ~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~  336 (386)
                      ...+..+.+++.+||..+|++||++.+++++-+
T Consensus       240 ~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~  272 (296)
T cd06654         240 EKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQF  272 (296)
T ss_pred             cccCHHHHHHHHHHCcCCcccCcCHHHHhhChh
Confidence            234567899999999999999999999998643

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=2.6e-40  Score=300.49  Aligned_cols=252  Identities=23%  Similarity=0.385  Sum_probs=205.8

Q ss_pred             cCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEEE
Q 016594           66 NAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQ  143 (386)
Q Consensus        66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~e  143 (386)
                      ..|+..+.||.|+||.||+|.+. ++..||+|.+.... .......+.+|+.+++.+.||||+++++++.++. .++|||
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIME   82 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccc-cHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEe
Confidence            45778899999999999999976 58899999887532 2344567889999999999999999999998766 899999


Q ss_pred             eccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCc
Q 016594          144 FSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWT  223 (386)
Q Consensus       144 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~  223 (386)
                      |+.+++|.+++..   ..+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||++..+.....
T Consensus        83 ~~~~~~L~~~i~~---~~l~~~~~~~~~~~l~~~l~~lh~---~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06640          83 YLGGGSALDLLRA---GPFDEFQIATMLKEILKGLDYLHS---EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI  156 (277)
T ss_pred             cCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh---CCccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence            9999999998864   348889999999999999999999   9999999999999999999999999999976643321


Q ss_pred             cccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCCCCC
Q 016594          224 HHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYD  303 (386)
Q Consensus       224 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (386)
                        ......++..|+|||++.+..++.++|+|||||++|+|++|..||.........            ............
T Consensus       157 --~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~------------~~~~~~~~~~~~  222 (277)
T cd06640         157 --KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVL------------FLIPKNNPPTLT  222 (277)
T ss_pred             --ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHh------------hhhhcCCCCCCc
Confidence              122345788899999999888999999999999999999999999764322100            011111122233


Q ss_pred             HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          304 VTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       304 ~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                      ...+..+.+++.+||+.+|++||++.+++.+.+..
T Consensus       223 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~  257 (277)
T cd06640         223 GEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIV  257 (277)
T ss_pred             hhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhh
Confidence            45667899999999999999999999999885543

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-40  Score=307.20  Aligned_cols=256  Identities=23%  Similarity=0.269  Sum_probs=205.9

Q ss_pred             cCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCCh-HhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEE
Q 016594           66 NAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDD-RKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIF  142 (386)
Q Consensus        66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~  142 (386)
                      ++|++.+.||.|+||.||+|... +++.||+|.+....... .....+..|+++++.+.|+||+++++.+.++. .+++|
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            36888999999999999999976 58999999997643332 34567889999999999999999999997765 89999


Q ss_pred             EeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCC
Q 016594          143 QFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQW  222 (386)
Q Consensus       143 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  222 (386)
                      ||+.+++|.+++.......+++..+..++.|++.||+|||+   .+++|+||||+||+++.++.++|+|||++.......
T Consensus        81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~  157 (316)
T cd05574          81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHL---LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP  157 (316)
T ss_pred             EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence            99999999999876655679999999999999999999999   999999999999999999999999999987653221


Q ss_pred             cc---------------------------ccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCch
Q 016594          223 TH---------------------------HSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQ  275 (386)
Q Consensus       223 ~~---------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~  275 (386)
                      ..                           .......|+..|+|||++.+..++.++||||||+++|+|++|..||.+...
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~  237 (316)
T cd05574         158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR  237 (316)
T ss_pred             cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence            10                           011234678899999999998899999999999999999999999976543


Q ss_pred             hhhhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCC----HHHHHHHH
Q 016594          276 SLHSWAKPILNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPT----MSEVLEVM  335 (386)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt----~~~il~~l  335 (386)
                      ....           ..+.............+..+.+++.+||..+|++||+    +.+++.+-
T Consensus       238 ~~~~-----------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~  290 (316)
T cd05574         238 DETF-----------SNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHP  290 (316)
T ss_pred             HHHH-----------HHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCc
Confidence            2111           0111111111111124678999999999999999999    78888763

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=8.7e-41  Score=299.94  Aligned_cols=250  Identities=22%  Similarity=0.420  Sum_probs=199.2

Q ss_pred             cCCCCCCeecccCCcEEEEEEECCCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEEEe
Q 016594           66 NAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQF  144 (386)
Q Consensus        66 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~  144 (386)
                      .+|++.+.||.|+||.||+|.+.++..+|+|.+.....   ....+.+|+++++++.||||+++++++.... .+++++|
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM---SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEF   80 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC---CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEc
Confidence            46788899999999999999987788999998864322   2356889999999999999999999987655 8999999


Q ss_pred             ccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCcc
Q 016594          145 SSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTH  224 (386)
Q Consensus       145 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  224 (386)
                      +.+++|.+++.... ..+++..++.++.|++.||+|||+   ++++|+||||+||+++.++.++|+|||++........ 
T Consensus        81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-  155 (256)
T cd05112          81 MEHGCLSDYLRAQR-GKFSQETLLGMCLDVCEGMAYLES---SNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY-  155 (256)
T ss_pred             CCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHH---CCccccccccceEEEcCCCeEEECCCcceeecccCcc-
Confidence            99999999886533 347899999999999999999999   9999999999999999999999999999876543211 


Q ss_pred             ccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCchhhhhhhhhhhcccccccccCCccCCCCC
Q 016594          225 HSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYD  303 (386)
Q Consensus       225 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (386)
                      .......++..|+|||.+.+..++.++||||||+++|+|++ |..||........  .... ..         ......+
T Consensus       156 ~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~--~~~~-~~---------~~~~~~~  223 (256)
T cd05112         156 TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEV--VETI-NA---------GFRLYKP  223 (256)
T ss_pred             cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHH--HHHH-hC---------CCCCCCC
Confidence            11112234578999999998889999999999999999998 9999976432211  1100 00         0000011


Q ss_pred             HHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 016594          304 VTQLNRLAFAASLCIRASPTWRPTMSEVLEVM  335 (386)
Q Consensus       304 ~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l  335 (386)
                      ...+..+.+++.+||+.+|++||++.++++.|
T Consensus       224 ~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l  255 (256)
T cd05112         224 RLASQSVYELMQHCWKERPEDRPSFSLLLHQL  255 (256)
T ss_pred             CCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence            11346799999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-40  Score=298.76  Aligned_cols=253  Identities=24%  Similarity=0.363  Sum_probs=203.8

Q ss_pred             cCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEEE
Q 016594           66 NAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQ  143 (386)
Q Consensus        66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~e  143 (386)
                      ++|++.+.||.|+||.||+|... +++.+++|.+....  ......+.+|+.+++.++||||+++++++.++. .+++||
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e   80 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP--GDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVME   80 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCc--hhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEe
Confidence            57889999999999999999975 57889999987532  235577889999999999999999999987765 899999


Q ss_pred             eccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCc
Q 016594          144 FSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWT  223 (386)
Q Consensus       144 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~  223 (386)
                      |+.+++|.+++.... ..+++..+..++.|++.||.|||+   ++++|+||+|+||+++.++.+||+|||++..+.... 
T Consensus        81 ~~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-  155 (262)
T cd06613          81 YCGGGSLQDIYQVTR-GPLSELQIAYVCRETLKGLAYLHE---TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI-  155 (262)
T ss_pred             CCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHh---CCceecCCChhhEEECCCCCEEECccccchhhhhhh-
Confidence            999999999887642 348999999999999999999999   999999999999999999999999999988664321 


Q ss_pred             cccccccccccCccChhhhccC---CCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCC
Q 016594          224 HHSIAPIEGTFGHLAPEYFMHG---IVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQG  300 (386)
Q Consensus       224 ~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (386)
                       .......++..|+|||.+.+.   .++.++|||||||++|+|++|..||............   ...   .....  ..
T Consensus       156 -~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~---~~~---~~~~~--~~  226 (262)
T cd06613         156 -AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLI---SKS---NFPPP--KL  226 (262)
T ss_pred             -hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---Hhc---cCCCc--cc
Confidence             122345688899999999876   7899999999999999999999999765432111100   000   00001  11


Q ss_pred             CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 016594          301 AYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEV  334 (386)
Q Consensus       301 ~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~  334 (386)
                      ......+..+.+++.+||..+|.+||++.+|+.+
T Consensus       227 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  260 (262)
T cd06613         227 KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH  260 (262)
T ss_pred             cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            1223446779999999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.2e-40  Score=313.37  Aligned_cols=259  Identities=20%  Similarity=0.288  Sum_probs=192.3

Q ss_pred             HHhcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEE
Q 016594           63 IATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYL  140 (386)
Q Consensus        63 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~l  140 (386)
                      ....+|.+.+.||+|+||.||+|... ++..||+|+....        ....|+.++++++|+||+++++++.... .++
T Consensus        63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~--------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  134 (357)
T PHA03209         63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG--------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCM  134 (357)
T ss_pred             hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc--------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEE
Confidence            45568999999999999999999976 5778999975432        2346899999999999999999998766 788


Q ss_pred             EEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCC
Q 016594          141 IFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPS  220 (386)
Q Consensus       141 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~  220 (386)
                      |++++. ++|.+++... ...+++..++.++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||++.....
T Consensus       135 v~e~~~-~~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  209 (357)
T PHA03209        135 VLPHYS-SDLYTYLTKR-SRPLPIDQALIIEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVV  209 (357)
T ss_pred             EEEccC-CcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEecCcccccccc
Confidence            999885 4787777543 3458999999999999999999999   9999999999999999999999999999875432


Q ss_pred             CCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCC-CCCCCCchhhhh--------hhhhhhc----c
Q 016594          221 QWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGR-KPVDGSHQSLHS--------WAKPILN----Q  287 (386)
Q Consensus       221 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~-~pf~~~~~~~~~--------~~~~~~~----~  287 (386)
                      .   .......||+.|+|||++.+..++.++|||||||++|||+++. .+|.........        .......    .
T Consensus       210 ~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~  286 (357)
T PHA03209        210 A---PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHP  286 (357)
T ss_pred             C---cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccCh
Confidence            2   1223456899999999999999999999999999999999854 444432211000        0000000    0


Q ss_pred             cccc---------cccC--CccCCCC-------CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 016594          288 GEIE---------KLVD--PRLQGAY-------DVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLE  337 (386)
Q Consensus       288 ~~~~---------~~~~--~~~~~~~-------~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~  337 (386)
                      ....         ..+.  ...+..+       ....+..+.++|.+||+.||.+|||+.++++|-+.
T Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f  354 (357)
T PHA03209        287 EEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMF  354 (357)
T ss_pred             hhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchh
Confidence            0000         0000  0000000       01123456779999999999999999999988543

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=1.7e-40  Score=300.65  Aligned_cols=247  Identities=24%  Similarity=0.467  Sum_probs=192.2

Q ss_pred             CeecccCCcEEEEEEEC-CCc--EEEEEEeccccCChHhHHHHHHHHHHHhcc-CCCceeeecceEEeCc-eEEEEEecc
Q 016594           72 NLVGRGGYAEVYKGVLQ-DGE--EIAVKRLTKVVTDDRKEKEFLTEIGTIGHV-CHPNVLSLLGCCVDNG-LYLIFQFSS  146 (386)
Q Consensus        72 ~~lg~G~~g~V~~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~-~~lv~e~~~  146 (386)
                      +.||+|+||.||+|.++ ++.  .+++|.+... ........+.+|+.++.++ +||||+++++++...+ .+++|||+.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~   79 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP   79 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEcccc-CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCC
Confidence            36899999999999976 343  4688887642 2334456788999999999 6999999999997765 899999999


Q ss_pred             CCCHhhhhhhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeec
Q 016594          147 RGSVASLFHDVN--------------SPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDF  212 (386)
Q Consensus       147 ~~~L~~~~~~~~--------------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Df  212 (386)
                      +++|.+++....              ...+++..+..++.|++.||+|||+   ++++||||||+||+++.++.+||+||
T Consensus        80 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nili~~~~~~kl~df  156 (270)
T cd05047          80 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADF  156 (270)
T ss_pred             CCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccccceEEEcCCCeEEECCC
Confidence            999999886532              1247899999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCchhhhhhhhhhhcccccc
Q 016594          213 GLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGEIE  291 (386)
Q Consensus       213 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~  291 (386)
                      |++......   ........+..|+|||++.+..++.++|||||||++|+|++ |..||.+.....  .....       
T Consensus       157 gl~~~~~~~---~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~--~~~~~-------  224 (270)
T cd05047         157 GLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE--LYEKL-------  224 (270)
T ss_pred             CCccccchh---hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHH--HHHHH-------
Confidence            998532211   01111223567999999988899999999999999999997 999997643211  11111       


Q ss_pred             cccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 016594          292 KLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLE  337 (386)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~  337 (386)
                         ........+...+..+.+++.+||+.+|.+||++.+++..|..
T Consensus       225 ---~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~  267 (270)
T cd05047         225 ---PQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR  267 (270)
T ss_pred             ---hCCCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHH
Confidence               0001111112234678999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=7.8e-41  Score=302.22  Aligned_cols=252  Identities=24%  Similarity=0.373  Sum_probs=198.9

Q ss_pred             cCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEEE
Q 016594           66 NAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQ  143 (386)
Q Consensus        66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~e  143 (386)
                      ++|.+.+.||+|+||.||+|... +++.||+|.+....  ......+.+|+.+++.++||||+++++++...+ .++++|
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e   86 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP--GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICME   86 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc--hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEe
Confidence            46788899999999999999975 68899999987432  233455778999999999999999999987755 899999


Q ss_pred             eccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCc
Q 016594          144 FSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWT  223 (386)
Q Consensus       144 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~  223 (386)
                      |+.+++|.+++....  .+++..++.++.|++.||.|||+   ++++|+||||+||+++.++.++|+|||++..+.... 
T Consensus        87 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~-  160 (267)
T cd06645          87 FCGGGSLQDIYHVTG--PLSESQIAYVSRETLQGLYYLHS---KGKMHRDIKGANILLTDNGHVKLADFGVSAQITATI-  160 (267)
T ss_pred             ccCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECcceeeeEccCcc-
Confidence            999999999886543  48999999999999999999999   999999999999999999999999999987664321 


Q ss_pred             cccccccccccCccChhhhc---cCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCC
Q 016594          224 HHSIAPIEGTFGHLAPEYFM---HGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQG  300 (386)
Q Consensus       224 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (386)
                       .......|+..|+|||++.   ...++.++|||||||++|+|++|..||............   ..   .....+... 
T Consensus       161 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~---~~---~~~~~~~~~-  232 (267)
T cd06645         161 -AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM---TK---SNFQPPKLK-  232 (267)
T ss_pred             -cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhh---hc---cCCCCCccc-
Confidence             1223456899999999974   456889999999999999999999998654321111000   00   000011111 


Q ss_pred             CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 016594          301 AYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEV  334 (386)
Q Consensus       301 ~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~  334 (386)
                       .....+..+.+++.+||+.+|++||++.+|+++
T Consensus       233 -~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~  265 (267)
T cd06645         233 -DKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH  265 (267)
T ss_pred             -ccCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence             011234678999999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-41  Score=313.03  Aligned_cols=267  Identities=23%  Similarity=0.340  Sum_probs=216.1

Q ss_pred             HHHhcCCCCCCeecccCCcEEEEEEECCCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEE
Q 016594           62 SIATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYL  140 (386)
Q Consensus        62 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~l  140 (386)
                      +.......++++||+|.||.|.++....+..||||.++.. ........|.+|+++|.+|+|||||.++|+|..++ +++
T Consensus       534 EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~-a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicm  612 (807)
T KOG1094|consen  534 EFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPD-ATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCM  612 (807)
T ss_pred             hcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcc-cchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHH
Confidence            4566778889999999999999999887799999999863 23444688999999999999999999999997655 999


Q ss_pred             EEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCC
Q 016594          141 IFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPS  220 (386)
Q Consensus       141 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~  220 (386)
                      ++||+..|+|.+++.....+.+.-.....|+.||+.|++||.+   .++|||||.+.|+|++.++++||+|||+++-+-.
T Consensus       613 I~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes---~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lys  689 (807)
T KOG1094|consen  613 ITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLES---LNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYS  689 (807)
T ss_pred             HHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHh---hchhhccccccceeecCcccEEecCccccccccc
Confidence            9999999999999988766555556667899999999999999   9999999999999999999999999999997755


Q ss_pred             CCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHh--CCCCCCCCchhhh-hhhhhhhcccccccccCCc
Q 016594          221 QWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS--GRKPVDGSHQSLH-SWAKPILNQGEIEKLVDPR  297 (386)
Q Consensus       221 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~--g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~  297 (386)
                      ..........+-..+|||||.+.-++++.++|||+||+++||+++  ...||....+... .-...+...+      ...
T Consensus       690 g~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~------~~~  763 (807)
T KOG1094|consen  690 GDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQ------GRQ  763 (807)
T ss_pred             CCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCC------Ccc
Confidence            544433344456788999999999999999999999999999876  8889976543221 1111111111      111


Q ss_pred             cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          298 LQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       298 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                      .....+.-++..+.+++..||..+-++||+++++..+|.+.
T Consensus       764 ~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  764 VVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             eeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence            12223445667888999999999999999999999888653

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=1.1e-40  Score=306.66  Aligned_cols=265  Identities=20%  Similarity=0.289  Sum_probs=200.1

Q ss_pred             cCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEEE
Q 016594           66 NAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQ  143 (386)
Q Consensus        66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~e  143 (386)
                      ++|.+.+.||.|+||.||+|..+ +++.||+|.+..... ......+.+|+.+++.++||||+++++++...+ .++++|
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e   84 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE   84 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccc-cCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEe
Confidence            56889999999999999999976 688999999875322 223445778999999999999999999997755 899999


Q ss_pred             eccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCc
Q 016594          144 FSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWT  223 (386)
Q Consensus       144 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~  223 (386)
                      |+.+ +|.+++.... ..+++..+..++.|++.||.|||+   ++++|+||||+||+++.++.++|+|||++....... 
T Consensus        85 ~~~~-~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~-  158 (301)
T cd07873          85 YLDK-DLKQYLDDCG-NSINMHNVKLFLFQLLRGLNYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT-  158 (301)
T ss_pred             cccc-CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC-
Confidence            9974 8888776543 358899999999999999999999   999999999999999999999999999987653321 


Q ss_pred             cccccccccccCccChhhhcc-CCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhh-hhhhhhc---cccccccc----
Q 016594          224 HHSIAPIEGTFGHLAPEYFMH-GIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHS-WAKPILN---QGEIEKLV----  294 (386)
Q Consensus       224 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~-~~~~~~~---~~~~~~~~----  294 (386)
                       .......+++.|+|||++.+ ..++.++|||||||++|+|++|++||......... .......   ......+.    
T Consensus       159 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (301)
T cd07873         159 -KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEE  237 (301)
T ss_pred             -CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccc
Confidence             11223457889999999875 45789999999999999999999999865432110 0000000   00000000    


Q ss_pred             -----CCccCC----CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          295 -----DPRLQG----AYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       295 -----~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                           .+....    ......+..+.++|.+||+.||.+|||+.+++++-+..
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~  290 (301)
T cd07873         238 FKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFH  290 (301)
T ss_pred             ccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccc
Confidence                 000000    00112345789999999999999999999999976553

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=1.7e-40  Score=302.48  Aligned_cols=252  Identities=23%  Similarity=0.347  Sum_probs=199.8

Q ss_pred             CCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEEEec
Q 016594           68 FSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQFS  145 (386)
Q Consensus        68 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~~  145 (386)
                      |++.+.||.|+||.||+|.+. ++..+++|.+...  .......+.+|+.+++.+.||||+++++++...+ .++++||+
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~   84 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC   84 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC--CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEec
Confidence            677889999999999999976 5778899988642  2345567889999999999999999999987655 89999999


Q ss_pred             cCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCccc
Q 016594          146 SRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHH  225 (386)
Q Consensus       146 ~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  225 (386)
                      .+++|..++... ...+++..+..++.|++.||.|||+   .+++||||||+||+++.++.+||+|||++.......  .
T Consensus        85 ~~~~l~~~~~~~-~~~l~~~~~~~~~~qi~~~L~~LH~---~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~--~  158 (282)
T cd06643          85 AGGAVDAVMLEL-ERPLTEPQIRVVCKQTLEALNYLHE---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--Q  158 (282)
T ss_pred             CCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEccCCCEEEccccccccccccc--c
Confidence            999998877543 3458999999999999999999999   999999999999999999999999999987654321  1


Q ss_pred             cccccccccCccChhhhc-----cCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCC
Q 016594          226 SIAPIEGTFGHLAPEYFM-----HGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQG  300 (386)
Q Consensus       226 ~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (386)
                      ......++..|+|||++.     +..++.++|||||||++|+|++|..||.........  ..... .     ..+  ..
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~--~~~~~-~-----~~~--~~  228 (282)
T cd06643         159 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVL--LKIAK-S-----EPP--TL  228 (282)
T ss_pred             ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHH--HHHhh-c-----CCC--CC
Confidence            223456889999999984     455788999999999999999999999764321110  00000 0     000  01


Q ss_pred             CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 016594          301 AYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLE  337 (386)
Q Consensus       301 ~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~  337 (386)
                      ..+...+..+.+++.+||+.+|.+||++.+++++.+.
T Consensus       229 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  265 (282)
T cd06643         229 AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFV  265 (282)
T ss_pred             CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCE
Confidence            1122345679999999999999999999999987553

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=2.7e-40  Score=298.45  Aligned_cols=253  Identities=21%  Similarity=0.312  Sum_probs=201.1

Q ss_pred             cCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccC---ChHhHHHHHHHHHHHhccCCCceeeecceEEeC---ce
Q 016594           66 NAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVT---DDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDN---GL  138 (386)
Q Consensus        66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~---~~  138 (386)
                      .+|++.+.||+|+||.||.|... ++..||+|.+.....   .......+.+|+.+++++.||||+++++++.+.   ..
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            47889999999999999999976 689999998864221   123346788899999999999999999998653   37


Q ss_pred             EEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccC
Q 016594          139 YLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWL  218 (386)
Q Consensus       139 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~  218 (386)
                      ++++||+.+++|.+++....  .+++..++.++.|++.||.|||+   ++++|+||||+||+++.++.++|+|||++..+
T Consensus        82 ~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~  156 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSYG--ALTENVTRKYTRQILEGVSYLHS---NMIVHRDIKGANILRDSVGNVKLGDFGASKRL  156 (265)
T ss_pred             EEEEEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEecCCCCEEECcCcccccc
Confidence            89999999999999887543  37888999999999999999999   99999999999999999999999999998865


Q ss_pred             CCCCc-cccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCc
Q 016594          219 PSQWT-HHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPR  297 (386)
Q Consensus       219 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (386)
                      ..... ........|+..|+|||++.+..++.++|||||||++|+|++|+.||.........           .......
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~-----------~~~~~~~  225 (265)
T cd06652         157 QTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAI-----------FKIATQP  225 (265)
T ss_pred             ccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHH-----------HHHhcCC
Confidence            42211 11223356889999999999888999999999999999999999999764322110           0111111


Q ss_pred             cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 016594          298 LQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVM  335 (386)
Q Consensus       298 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l  335 (386)
                      .....+......+.+++.+||. +|++||++++|+++.
T Consensus       226 ~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~  262 (265)
T cd06652         226 TNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHT  262 (265)
T ss_pred             CCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCc
Confidence            1222334456778899999994 999999999999764

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=2.6e-40  Score=296.68  Aligned_cols=249  Identities=24%  Similarity=0.410  Sum_probs=203.1

Q ss_pred             cCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEEE
Q 016594           66 NAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQ  143 (386)
Q Consensus        66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~e  143 (386)
                      ++|++.+.||.|+||.||+|.+. +++.|++|.+....    ....+.+|+.+++.++|+||+++++++.++. .++++|
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e   78 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE----DLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVME   78 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH----HHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEe
Confidence            57899999999999999999987 47899999986432    2668899999999999999999999997765 899999


Q ss_pred             eccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCc
Q 016594          144 FSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWT  223 (386)
Q Consensus       144 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~  223 (386)
                      ++.+++|.+++.... ..+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||++........
T Consensus        79 ~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~  154 (256)
T cd06612          79 YCGAGSVSDIMKITN-KTLTEEEIAAILYQTLKGLEYLHS---NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA  154 (256)
T ss_pred             cCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEECCCCcEEEcccccchhcccCcc
Confidence            999999999886533 458999999999999999999999   9999999999999999999999999999987654321


Q ss_pred             cccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCCCCC
Q 016594          224 HHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYD  303 (386)
Q Consensus       224 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (386)
                        ......++..|+|||++.+..++.++||||||+++|+|++|+.||...........        +.....+  ....+
T Consensus       155 --~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~--------~~~~~~~--~~~~~  222 (256)
T cd06612         155 --KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFM--------IPNKPPP--TLSDP  222 (256)
T ss_pred             --ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhh--------hccCCCC--CCCch
Confidence              22234578899999999998999999999999999999999999976432211000        0000000  11112


Q ss_pred             HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 016594          304 VTQLNRLAFAASLCIRASPTWRPTMSEVLEV  334 (386)
Q Consensus       304 ~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~  334 (386)
                      ......+.+++.+||+.+|++||++.+++++
T Consensus       223 ~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~  253 (256)
T cd06612         223 EKWSPEFNDFVKKCLVKDPEERPSAIQLLQH  253 (256)
T ss_pred             hhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence            2345679999999999999999999999975

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=1e-40  Score=303.17  Aligned_cols=249  Identities=25%  Similarity=0.409  Sum_probs=201.0

Q ss_pred             CCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEEEe
Q 016594           67 AFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQF  144 (386)
Q Consensus        67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~  144 (386)
                      .|+..+.||.|+||.||+|.+. ++..||+|.+.... .......+.+|+.+++.+.||||+++++++..+. .++|+||
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEecccc-chHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence            4556778999999999999975 57889999887432 2334567889999999999999999999997765 8999999


Q ss_pred             ccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCcc
Q 016594          145 SSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTH  224 (386)
Q Consensus       145 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  224 (386)
                      +.+++|.+++..   ..+++..+..++.|++.||.|||+   ++++|+||+|+||+++.++.++|+|||++..+....  
T Consensus        84 ~~~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~---~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~--  155 (277)
T cd06642          84 LGGGSALDLLKP---GPLEETYIATILREILKGLDYLHS---ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ--  155 (277)
T ss_pred             cCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhc---CCeeccCCChheEEEeCCCCEEEccccccccccCcc--
Confidence            999999988753   348899999999999999999999   999999999999999999999999999987664321  


Q ss_pred             ccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCCCCCH
Q 016594          225 HSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDV  304 (386)
Q Consensus       225 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (386)
                      .......++..|+|||++.+..++.++|||||||++|+|++|..||.........            .............
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~------------~~~~~~~~~~~~~  223 (277)
T cd06642         156 IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVL------------FLIPKNSPPTLEG  223 (277)
T ss_pred             hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHH------------hhhhcCCCCCCCc
Confidence            1223345788999999999989999999999999999999999998753221100            0011111111222


Q ss_pred             HHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 016594          305 TQLNRLAFAASLCIRASPTWRPTMSEVLEVML  336 (386)
Q Consensus       305 ~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~  336 (386)
                      ..+..+.+++.+||+.+|++||++.+++++.+
T Consensus       224 ~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~  255 (277)
T cd06642         224 QYSKPFKEFVEACLNKDPRFRPTAKELLKHKF  255 (277)
T ss_pred             ccCHHHHHHHHHHccCCcccCcCHHHHHHhHH
Confidence            34567899999999999999999999999754

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=2e-40  Score=298.64  Aligned_cols=250  Identities=26%  Similarity=0.419  Sum_probs=191.4

Q ss_pred             CeecccCCcEEEEEEEC----CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEe-C-ceEEEEEec
Q 016594           72 NLVGRGGYAEVYKGVLQ----DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVD-N-GLYLIFQFS  145 (386)
Q Consensus        72 ~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~-~~~lv~e~~  145 (386)
                      +.||+|+||.||+|.+.    .+..||+|.+... ........+.+|+.+++.++||||+++++++.. + ..+++++|+
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~   79 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI-TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYM   79 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCcc-CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecC
Confidence            46899999999999853    2457999987542 233445678899999999999999999997753 3 378999999


Q ss_pred             cCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCcc-
Q 016594          146 SRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTH-  224 (386)
Q Consensus       146 ~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~-  224 (386)
                      .+++|.+++.... ..+++..+..++.|++.||.|||+   .+++||||||+|||++.++.+||+|||++..+...... 
T Consensus        80 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~  155 (262)
T cd05058          80 KHGDLRNFIRSET-HNPTVKDLIGFGLQVAKGMEYLAS---KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS  155 (262)
T ss_pred             CCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence            9999999987543 236777888999999999999999   99999999999999999999999999998765432111 


Q ss_pred             -ccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCchhhhhhhhhhhcccccccccCCccCCCC
Q 016594          225 -HSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAY  302 (386)
Q Consensus       225 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (386)
                       .......++..|+|||.+.+..++.++|||||||++|||++ |.+||......  ....... ..         .....
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~--~~~~~~~-~~---------~~~~~  223 (262)
T cd05058         156 VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSF--DITVYLL-QG---------RRLLQ  223 (262)
T ss_pred             ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHh-cC---------CCCCC
Confidence             11122345678999999988899999999999999999999 56666543221  1111110 00         00111


Q ss_pred             CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          303 DVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       303 ~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                      +...+..+.+++.+||..+|++||++.+|++.|...
T Consensus       224 ~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~  259 (262)
T cd05058         224 PEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQI  259 (262)
T ss_pred             CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence            112346799999999999999999999999988653

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=2.4e-40  Score=303.08  Aligned_cols=255  Identities=24%  Similarity=0.373  Sum_probs=201.7

Q ss_pred             HhcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEE
Q 016594           64 ATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLI  141 (386)
Q Consensus        64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv  141 (386)
                      ..+.|++.+.||.|+||.||+|... ++..||+|.+...  .......+.+|+.+++.++|+||+++++++..++ .+++
T Consensus        10 ~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   87 (292)
T cd06644          10 PNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIM   87 (292)
T ss_pred             cchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEE
Confidence            3467999999999999999999976 5889999998742  3445677889999999999999999999987655 8999


Q ss_pred             EEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCC
Q 016594          142 FQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQ  221 (386)
Q Consensus       142 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  221 (386)
                      |||+.+++|..++.... ..+++..+..++.|++.||.|||+   ++++||||||+||+++.++.++|+|||++......
T Consensus        88 ~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~  163 (292)
T cd06644          88 IEFCPGGAVDAIMLELD-RGLTEPQIQVICRQMLEALQYLHS---MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT  163 (292)
T ss_pred             EecCCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhc---CCeeecCCCcceEEEcCCCCEEEccCccceecccc
Confidence            99999999988775433 358999999999999999999999   99999999999999999999999999998754322


Q ss_pred             CccccccccccccCccChhhhc-----cCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCC
Q 016594          222 WTHHSIAPIEGTFGHLAPEYFM-----HGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDP  296 (386)
Q Consensus       222 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (386)
                      .  .......+++.|+|||++.     ...++.++|||||||++|+|++|..||........  ..... .     ...+
T Consensus       164 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~--~~~~~-~-----~~~~  233 (292)
T cd06644         164 L--QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV--LLKIA-K-----SEPP  233 (292)
T ss_pred             c--cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHH--HHHHh-c-----CCCc
Confidence            1  1123345788999999985     34578899999999999999999999976432110  00000 0     0000


Q ss_pred             ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 016594          297 RLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVML  336 (386)
Q Consensus       297 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~  336 (386)
                        ....+...+..+.+++.+||..+|++||++.+++++-+
T Consensus       234 --~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~  271 (292)
T cd06644         234 --TLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPF  271 (292)
T ss_pred             --cCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCcc
Confidence              01112234567899999999999999999999998744

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=1.7e-40  Score=307.60  Aligned_cols=257  Identities=22%  Similarity=0.342  Sum_probs=186.3

Q ss_pred             CCeecccCCcEEEEEEEC---CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeC---ceEEEEEe
Q 016594           71 ENLVGRGGYAEVYKGVLQ---DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDN---GLYLIFQF  144 (386)
Q Consensus        71 ~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~---~~~lv~e~  144 (386)
                      +.+||+|+||+||+|..+   ++..||+|.+....    ....+.+|+.+++.++||||+++++++...   ..+++++|
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~   81 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG----ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDY   81 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC----CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEee
Confidence            468999999999999965   35789999886432    223567899999999999999999998542   37899999


Q ss_pred             ccCCCHhhhhhhc-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeE----cCCCCeEEeecC
Q 016594          145 SSRGSVASLFHDV-------NSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILL----TADFEPQISDFG  213 (386)
Q Consensus       145 ~~~~~L~~~~~~~-------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill----~~~~~~kl~Dfg  213 (386)
                      +.+ +|.+++...       ....+++..++.++.|++.||.|||+   ++|+||||||+|||+    +.++.+||+|||
T Consensus        82 ~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG  157 (317)
T cd07867          82 AEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMG  157 (317)
T ss_pred             eCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEccCCCCCCcEEEeecc
Confidence            875 666665421       12248899999999999999999999   999999999999999    466789999999


Q ss_pred             ccccCCCCCcc-ccccccccccCccChhhhcc-CCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhh--------hh--
Q 016594          214 LAKWLPSQWTH-HSIAPIEGTFGHLAPEYFMH-GIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHS--------WA--  281 (386)
Q Consensus       214 ~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~--------~~--  281 (386)
                      ++......... .......||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.........        ..  
T Consensus       158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~  237 (317)
T cd07867         158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRI  237 (317)
T ss_pred             ceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHH
Confidence            99876543221 12234568999999999876 45899999999999999999999999754321100        00  


Q ss_pred             hhhhcc------------cccccccCCccCC------------CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 016594          282 KPILNQ------------GEIEKLVDPRLQG------------AYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVM  335 (386)
Q Consensus       282 ~~~~~~------------~~~~~~~~~~~~~------------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l  335 (386)
                      ......            .............            .........+.+++.+||..||.+|||+.+++++-
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp  315 (317)
T cd07867         238 FSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDP  315 (317)
T ss_pred             HHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCC
Confidence            000000            0000000000000            00011134588899999999999999999999763

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=3.1e-40  Score=303.05  Aligned_cols=253  Identities=20%  Similarity=0.328  Sum_probs=203.5

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEE
Q 016594           65 TNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIF  142 (386)
Q Consensus        65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~  142 (386)
                      .++|++.+.||.|+||.||+|... +++.||+|.+....  ......+.+|+.+++.++|+||+++++++..+. .++||
T Consensus        18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~   95 (297)
T cd06656          18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQ--QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM   95 (297)
T ss_pred             hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCc--cchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEee
Confidence            367999999999999999999975 78999999987532  233456788999999999999999999997655 89999


Q ss_pred             EeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCC
Q 016594          143 QFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQW  222 (386)
Q Consensus       143 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  222 (386)
                      ||+.+++|.+++..   ..+++..+..++.|++.||.|||+   .+++||||||+|||++.++.++|+|||++.......
T Consensus        96 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~l~~~L~~LH~---~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~  169 (297)
T cd06656          96 EYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALDFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ  169 (297)
T ss_pred             cccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEECcCccceEccCCc
Confidence            99999999998864   337889999999999999999999   999999999999999999999999999987654332


Q ss_pred             ccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCCCC
Q 016594          223 THHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAY  302 (386)
Q Consensus       223 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (386)
                      .  ......+++.|+|||.+.+..++.++|+|||||++|+|++|..||.........          .............
T Consensus       170 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~----------~~~~~~~~~~~~~  237 (297)
T cd06656         170 S--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL----------YLIATNGTPELQN  237 (297)
T ss_pred             c--CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhe----------eeeccCCCCCCCC
Confidence            1  123345888999999999988999999999999999999999999764321100          0000001111112


Q ss_pred             CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 016594          303 DVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLE  337 (386)
Q Consensus       303 ~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~  337 (386)
                      +...+..+.+++.+||..+|++||++.+++++-+.
T Consensus       238 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~  272 (297)
T cd06656         238 PERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFL  272 (297)
T ss_pred             ccccCHHHHHHHHHHccCChhhCcCHHHHhcCchh
Confidence            22345668999999999999999999999987543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=3.4e-40  Score=310.16  Aligned_cols=262  Identities=21%  Similarity=0.316  Sum_probs=203.0

Q ss_pred             HhcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeC------
Q 016594           64 ATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDN------  136 (386)
Q Consensus        64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------  136 (386)
                      ..++|++.+.||+|+||.||+|... +++.||+|.+.+..........+.+|+.+++.++||||+++++++...      
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   93 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF   93 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence            4578999999999999999999976 789999999876544455556788999999999999999999988532      


Q ss_pred             -ceEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCcc
Q 016594          137 -GLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLA  215 (386)
Q Consensus       137 -~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a  215 (386)
                       ..++|+||+.+ +|.+.+...    ++...+..++.|++.||+|||+   ++++||||||+||+++.++.+||+|||++
T Consensus        94 ~~~~lv~e~~~~-~l~~~~~~~----l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~  165 (353)
T cd07850          94 QDVYLVMELMDA-NLCQVIQMD----LDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLA  165 (353)
T ss_pred             CcEEEEEeccCC-CHHHHHhhc----CCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCccc
Confidence             26899999965 777766432    7888999999999999999999   99999999999999999999999999999


Q ss_pred             ccCCCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhh-----------
Q 016594          216 KWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPI-----------  284 (386)
Q Consensus       216 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~-----------  284 (386)
                      .......   ......++..|+|||.+.+..++.++|||||||++|+|++|+.||...+.. ..+....           
T Consensus       166 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~  241 (353)
T cd07850         166 RTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHI-DQWNKIIEQLGTPSDEFM  241 (353)
T ss_pred             eeCCCCC---CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHH-HHHHHHHHhcCCCCHHHH
Confidence            8764332   123345788999999999999999999999999999999999999765421 1110000           


Q ss_pred             ----------hccc------ccccccCCc----cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 016594          285 ----------LNQG------EIEKLVDPR----LQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLE  337 (386)
Q Consensus       285 ----------~~~~------~~~~~~~~~----~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~  337 (386)
                                ....      .........    .........+..+.+++.+||+.||++|||+.++|.+-+.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~  314 (353)
T cd07850         242 SRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYI  314 (353)
T ss_pred             HHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhH
Confidence                      0000      000000000    0000111235678999999999999999999999988544

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=2.9e-40  Score=296.49  Aligned_cols=251  Identities=28%  Similarity=0.481  Sum_probs=200.3

Q ss_pred             CCCCCeecccCCcEEEEEEECC-C----cEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEE
Q 016594           68 FSSENLVGRGGYAEVYKGVLQD-G----EEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLI  141 (386)
Q Consensus        68 ~~~~~~lg~G~~g~V~~~~~~~-~----~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv  141 (386)
                      +++.+.||.|+||.||+|.+.. +    ..||+|.+.... .......+..|+.++..++|+||+++++++.+.+ .+++
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i   79 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDA-DEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIV   79 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCC-ChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEE
Confidence            4577899999999999999763 3    789999986532 2225678889999999999999999999997755 8999


Q ss_pred             EEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCC
Q 016594          142 FQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQ  221 (386)
Q Consensus       142 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  221 (386)
                      |+++.+++|.+++.......+++..+..++.|++.||+|||+   .+++|+||||+||+++.++.++|+|||++......
T Consensus        80 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~---~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~  156 (258)
T smart00219       80 MEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLES---KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDD  156 (258)
T ss_pred             EeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhc---CCeeecccccceEEEccCCeEEEcccCCceecccc
Confidence            999999999999876554448999999999999999999999   99999999999999999999999999999876543


Q ss_pred             CccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCchhhhhhhhhhhcccccccccCCccCC
Q 016594          222 WTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQG  300 (386)
Q Consensus       222 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (386)
                      ..... ....+++.|+|||.+.+..++.++|||||||++|+|++ |..||........  .... ...         ...
T Consensus       157 ~~~~~-~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~--~~~~-~~~---------~~~  223 (258)
T smart00219      157 DYYKK-KGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEV--LEYL-KKG---------YRL  223 (258)
T ss_pred             ccccc-ccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHH--HHHH-hcC---------CCC
Confidence            21111 12236788999999988889999999999999999998 8899876432111  0000 000         011


Q ss_pred             CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 016594          301 AYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVM  335 (386)
Q Consensus       301 ~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l  335 (386)
                      ..+...+..+.+++.+||..+|++|||+.++++.|
T Consensus       224 ~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      224 PKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             CCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence            11222456799999999999999999999999754

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=3.5e-40  Score=298.31  Aligned_cols=252  Identities=25%  Similarity=0.386  Sum_probs=188.3

Q ss_pred             CeecccCCcEEEEEEECC---CcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEEEeccC
Q 016594           72 NLVGRGGYAEVYKGVLQD---GEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQFSSR  147 (386)
Q Consensus        72 ~~lg~G~~g~V~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~~~~  147 (386)
                      +.||+|+||.||+|....   ...+|+|.+... ........+.+|+.+++.++|+||+++++.+.+.. .+++|||+.+
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~   79 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRAS-ATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPL   79 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCcc-CChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCC
Confidence            358999999999997542   356888877542 23444567889999999999999999999987655 8999999999


Q ss_pred             CCHhhhhhhcCC---CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCcc
Q 016594          148 GSVASLFHDVNS---PGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTH  224 (386)
Q Consensus       148 ~~L~~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  224 (386)
                      |+|.+++.....   ...++..+..++.|++.||+|||+   ++|+||||||+|||++.++.+||+|||++.........
T Consensus        80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~  156 (269)
T cd05042          80 GDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ---ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYY  156 (269)
T ss_pred             CcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHh---cCEecccccHhheEecCCCcEEEeccccccccccchhe
Confidence            999999876432   235677888999999999999999   99999999999999999999999999998654322111


Q ss_pred             ccccccccccCccChhhhcc-------CCCCcccchHHHHHHHHHHHh-CCCCCCCCchhhhhhhhhhhcccccccccCC
Q 016594          225 HSIAPIEGTFGHLAPEYFMH-------GIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGEIEKLVDP  296 (386)
Q Consensus       225 ~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (386)
                      .......++..|+|||++..       ..++.++|||||||++|+|++ |..||........  ....... .......+
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~--~~~~~~~-~~~~~~~~  233 (269)
T cd05042         157 ITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQV--LKQVVRE-QDIKLPKP  233 (269)
T ss_pred             eccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHH--HHHHhhc-cCccCCCC
Confidence            11223345678999998743       456889999999999999999 8889876432110  0000010 11111111


Q ss_pred             ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 016594          297 RLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVM  335 (386)
Q Consensus       297 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l  335 (386)
                          ..+...+..+.+++..|| .||++||++++|++.|
T Consensus       234 ----~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l  267 (269)
T cd05042         234 ----QLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL  267 (269)
T ss_pred             ----cccccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence                122234566788888898 5999999999999876

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.3e-40  Score=302.20  Aligned_cols=255  Identities=23%  Similarity=0.411  Sum_probs=201.9

Q ss_pred             cCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEEE
Q 016594           66 NAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQ  143 (386)
Q Consensus        66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~e  143 (386)
                      ++|++.+.||+|+||.||+|.++ ++..||+|.+... ........+.+|+.++++++|+||+++++++..++ .++++|
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   79 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLE-LDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCME   79 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecc-cCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEe
Confidence            36888999999999999999987 7899999988653 23344567889999999999999999999987655 899999


Q ss_pred             eccCCCHhhhhhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCC
Q 016594          144 FSSRGSVASLFHDVN-SPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQW  222 (386)
Q Consensus       144 ~~~~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  222 (386)
                      |+.+++|..++.... ...+++..+..++.|++.||.|||+  ..+++|+||||+||+++.++.+||+|||++..+....
T Consensus        80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  157 (286)
T cd06622          80 YMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL  157 (286)
T ss_pred             ecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh--cCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc
Confidence            999999998886532 2358999999999999999999996  1589999999999999999999999999987654321


Q ss_pred             ccccccccccccCccChhhhccC------CCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCC
Q 016594          223 THHSIAPIEGTFGHLAPEYFMHG------IVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDP  296 (386)
Q Consensus       223 ~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (386)
                          .....+++.|+|||.+.+.      .++.++|+|||||++|+|++|..||...........        +..+...
T Consensus       158 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~--------~~~~~~~  225 (286)
T cd06622         158 ----AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQ--------LSAIVDG  225 (286)
T ss_pred             ----cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHH--------HHHHhhc
Confidence                2234578899999998554      358899999999999999999999975432111000        0011111


Q ss_pred             ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 016594          297 RLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVML  336 (386)
Q Consensus       297 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~  336 (386)
                       .....+...+..+.+++.+||+.+|++||++.+++.+.+
T Consensus       226 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~  264 (286)
T cd06622         226 -DPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPW  264 (286)
T ss_pred             -CCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChh
Confidence             111223335677999999999999999999999998754

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-41  Score=286.79  Aligned_cols=254  Identities=24%  Similarity=0.414  Sum_probs=200.7

Q ss_pred             cCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccC-CCceeeecceEEeCc-eEEEE
Q 016594           66 NAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVC-HPNVLSLLGCCVDNG-LYLIF  142 (386)
Q Consensus        66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~-~~lv~  142 (386)
                      +..+....||.|+.|+||+++.+ +|...|||.+.+. .+.+..++++..+.++...+ +|.||+.+|+|..+. ..+.|
T Consensus        92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt-~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcM  170 (391)
T KOG0983|consen   92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRT-GNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICM  170 (391)
T ss_pred             HHhhhHHhhcCCCccceEEEEEcccceEEEEEeeccc-CCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHH
Confidence            34556778999999999999977 6899999999873 45566778888888876665 899999999997765 66667


Q ss_pred             EeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCC
Q 016594          143 QFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQW  222 (386)
Q Consensus       143 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  222 (386)
                      |.+.. .+..++.+.. .++++..+-++...+++||.||-.  .++|+|||+||+|||+|..|++||||||++..+.+..
T Consensus       171 elMs~-C~ekLlkrik-~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk  246 (391)
T KOG0983|consen  171 ELMST-CAEKLLKRIK-GPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK  246 (391)
T ss_pred             HHHHH-HHHHHHHHhc-CCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccccceeeccc
Confidence            76643 4555655544 459999999999999999999998  4899999999999999999999999999999887665


Q ss_pred             ccccccccccccCccChhhhcc---CCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccC
Q 016594          223 THHSIAPIEGTFGHLAPEYFMH---GIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQ  299 (386)
Q Consensus       223 ~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (386)
                      .+.   ...|.+.|||||-+..   ..|+..+||||||++++||.||+.||.+.........+. .+ .     ..+.+.
T Consensus       247 Aht---rsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkv-ln-~-----ePP~L~  316 (391)
T KOG0983|consen  247 AHT---RSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKV-LN-E-----EPPLLP  316 (391)
T ss_pred             ccc---cccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHH-Hh-c-----CCCCCC
Confidence            433   3359999999999864   468999999999999999999999999865443222221 11 0     112222


Q ss_pred             CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 016594          300 GAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVML  336 (386)
Q Consensus       300 ~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~  336 (386)
                      .  ....+..+.+++..||.+|+.+||.+.++|+|-.
T Consensus       317 ~--~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~F  351 (391)
T KOG0983|consen  317 G--HMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPF  351 (391)
T ss_pred             c--ccCcCHHHHHHHHHHhhcCcccCcchHHHhcCcc
Confidence            1  1225678999999999999999999999998753

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-40  Score=302.37  Aligned_cols=256  Identities=23%  Similarity=0.362  Sum_probs=203.8

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEE
Q 016594           65 TNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIF  142 (386)
Q Consensus        65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~  142 (386)
                      .++|++.+.||.|+||.||+|.+. ++..||+|.+...  .......+.+|+.++++++||||+++++.+..+. .+++|
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE--SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILI   81 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEe
Confidence            356888999999999999999976 6889999998642  3445567889999999999999999999997655 89999


Q ss_pred             EeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCC
Q 016594          143 QFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQW  222 (386)
Q Consensus       143 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  222 (386)
                      ||+.+++|.+++.... ..+++..+..++.|++.||.|||+   ++++|+||||+||+++.++.++|+|||++.......
T Consensus        82 e~~~~~~L~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~  157 (280)
T cd06611          82 EFCDGGALDSIMLELE-RGLTEPQIRYVCRQMLEALNFLHS---HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL  157 (280)
T ss_pred             eccCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEECCCCCEEEccCccchhhcccc
Confidence            9999999999887543 358999999999999999999999   999999999999999999999999999987654321


Q ss_pred             ccccccccccccCccChhhhc-----cCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCc
Q 016594          223 THHSIAPIEGTFGHLAPEYFM-----HGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPR  297 (386)
Q Consensus       223 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (386)
                      .  ......++..|+|||++.     ...++.++|||||||++|+|++|..||.........  ... ...     ..+ 
T Consensus       158 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~--~~~-~~~-----~~~-  226 (280)
T cd06611         158 Q--KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVL--LKI-LKS-----EPP-  226 (280)
T ss_pred             c--ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHH--HHH-hcC-----CCC-
Confidence            1  223345889999999985     345778999999999999999999999765321100  000 000     000 


Q ss_pred             cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          298 LQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       298 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                       ....+...+..+.+++..||+.+|.+||++.+++++-+..
T Consensus       227 -~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~  266 (280)
T cd06611         227 -TLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVS  266 (280)
T ss_pred             -CcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhc
Confidence             1111223456789999999999999999999999985543

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=4.3e-40  Score=298.20  Aligned_cols=257  Identities=26%  Similarity=0.396  Sum_probs=200.5

Q ss_pred             CCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCC--------hHhHHHHHHHHHHHhccCCCceeeecceEEeCc
Q 016594           67 AFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTD--------DRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG  137 (386)
Q Consensus        67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  137 (386)
                      +|.+.+.||.|+||.||+|... +++.||+|.+......        ......+.+|+.+++.++||||+++++++....
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            5778899999999999999865 6889999987642111        112345778999999999999999999987755


Q ss_pred             -eEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccc
Q 016594          138 -LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAK  216 (386)
Q Consensus       138 -~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~  216 (386)
                       .++|+||+.+++|.+++...  ..+++..+..++.|++.||.|||+   ++++||||+|+||+++.++.++|+|||++.
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~~~nil~~~~~~~~l~d~~~~~  156 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTY--GRFEEQLVRFFTEQVLEGLAYLHS---KGILHRDLKADNLLVDADGICKISDFGISK  156 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhh---CCeeecCCChhhEEEcCCCeEEEeeccccc
Confidence             89999999999999988765  348899999999999999999999   999999999999999999999999999997


Q ss_pred             cCCCCCccccccccccccCccChhhhccCC--CCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhccccccccc
Q 016594          217 WLPSQWTHHSIAPIEGTFGHLAPEYFMHGI--VDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLV  294 (386)
Q Consensus       217 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  294 (386)
                      ...............|+..|+|||.+....  ++.++|+||||+++|+|++|..||..........  .... ...    
T Consensus       157 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~--~~~~-~~~----  229 (272)
T cd06629         157 KSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMF--KLGN-KRS----  229 (272)
T ss_pred             cccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHH--Hhhc-ccc----
Confidence            654332222233456888999999987654  8899999999999999999999996543221100  0000 000    


Q ss_pred             CCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 016594          295 DPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVM  335 (386)
Q Consensus       295 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l  335 (386)
                      ............+..+.+++.+||..+|++||++.+|+++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~  270 (272)
T cd06629         230 APPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHP  270 (272)
T ss_pred             CCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCC
Confidence            01111111123457799999999999999999999999874

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=2.5e-40  Score=300.26  Aligned_cols=256  Identities=25%  Similarity=0.393  Sum_probs=202.2

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEC------CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-
Q 016594           65 TNAFSSENLVGRGGYAEVYKGVLQ------DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-  137 (386)
Q Consensus        65 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-  137 (386)
                      .++|++...||.|+||.||+|+.+      +.+.|++|.+... ........+.+|+.++++++|+||+++++++.+.. 
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   82 (275)
T cd05046           4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKT-KDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEP   82 (275)
T ss_pred             hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCc-cchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCc
Confidence            367889999999999999999964      2457999987642 22334567899999999999999999999987654 


Q ss_pred             eEEEEEeccCCCHhhhhhhcCC-------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEe
Q 016594          138 LYLIFQFSSRGSVASLFHDVNS-------PGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQIS  210 (386)
Q Consensus       138 ~~lv~e~~~~~~L~~~~~~~~~-------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~  210 (386)
                      .+++|||+.+++|.+++.....       ..+++..+..++.|++.||.|||+   ++++||||||+||+++.++.++++
T Consensus        83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~  159 (275)
T cd05046          83 HYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSN---ARFVHRDLAARNCLVSSQREVKVS  159 (275)
T ss_pred             ceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhh---cCcccCcCccceEEEeCCCcEEEc
Confidence            8999999999999999876542       258999999999999999999999   999999999999999999999999


Q ss_pred             ecCccccCCCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCchhhhhhhhhhhcccc
Q 016594          211 DFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGE  289 (386)
Q Consensus       211 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~  289 (386)
                      |||++...... .........++..|+|||.+.+..++.++||||||+++|+|++ |..||........  ...      
T Consensus       160 ~~~~~~~~~~~-~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~--~~~------  230 (275)
T cd05046         160 LLSLSKDVYNS-EYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEV--LNR------  230 (275)
T ss_pred             ccccccccCcc-cccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHH--HHH------
Confidence            99998754322 1112233346778999999988888999999999999999999 8889965432111  110      


Q ss_pred             cccccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 016594          290 IEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVML  336 (386)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~  336 (386)
                         ..........+...+..+.+++.+||+.+|.+||++.+++..|.
T Consensus       231 ---~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         231 ---LQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             ---HHcCCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence               00011111112234567999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-41  Score=291.26  Aligned_cols=255  Identities=21%  Similarity=0.265  Sum_probs=206.2

Q ss_pred             HhcCCCCC-CeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccC-CCceeeecceEEeC----
Q 016594           64 ATNAFSSE-NLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVC-HPNVLSLLGCCVDN----  136 (386)
Q Consensus        64 ~~~~~~~~-~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~----  136 (386)
                      .+++|.+. .+||-|-.|+|..+..+ +++.+|+|++..       ....++|+++.-... |||||.++++|...    
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D-------s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~r  131 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD-------SPKARREVELHWMASGHPHIVSIIDVYENSYQGR  131 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc-------CHHHHhHhhhhhhhcCCCceEEeehhhhhhccCc
Confidence            34556554 58999999999999977 799999999863       234568888876655 99999999999642    


Q ss_pred             -ceEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcC---CCCeEEeec
Q 016594          137 -GLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTA---DFEPQISDF  212 (386)
Q Consensus       137 -~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~---~~~~kl~Df  212 (386)
                       .+.+|||.+.||.|...+++.....|++.++..|+.||..|+.|||+   .+|.||||||+|+|...   +..+||+||
T Consensus       132 kcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~---~nIAHRDlKpENLLyt~t~~na~lKLtDf  208 (400)
T KOG0604|consen  132 KCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHS---MNIAHRDLKPENLLYTTTSPNAPLKLTDF  208 (400)
T ss_pred             eeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHh---cchhhccCChhheeeecCCCCcceEeccc
Confidence             27889999999999999999998899999999999999999999999   99999999999999964   457999999


Q ss_pred             CccccCCCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhccccccc
Q 016594          213 GLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEK  292 (386)
Q Consensus       213 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  292 (386)
                      |+|+....   .....+.+-|+.|.|||++...+|+..+|+||+||++|-|++|.+||...+...       +..+-..+
T Consensus       209 GFAK~t~~---~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a-------ispgMk~r  278 (400)
T KOG0604|consen  209 GFAKETQE---PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA-------ISPGMKRR  278 (400)
T ss_pred             ccccccCC---CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCcc-------CChhHHhH
Confidence            99987543   344567789999999999999999999999999999999999999998765321       11111112


Q ss_pred             ccCCccCCC--CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          293 LVDPRLQGA--YDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       293 ~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                      +.......+  .-...++...++|+.+|..+|++|.|+.+++.+-|-.
T Consensus       279 I~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~  326 (400)
T KOG0604|consen  279 IRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWIN  326 (400)
T ss_pred             hhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhc
Confidence            222111111  1124578899999999999999999999999986654

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=2.2e-40  Score=301.94  Aligned_cols=261  Identities=20%  Similarity=0.314  Sum_probs=199.6

Q ss_pred             CCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEEEe
Q 016594           67 AFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQF  144 (386)
Q Consensus        67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~  144 (386)
                      +|++.+.||.|++|.||+|... +++.||||.+............+.+|++++++++||||+++++++.++. .+++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            4788999999999999999976 6889999988754434444467889999999999999999999987655 8999999


Q ss_pred             ccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCcc
Q 016594          145 SSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTH  224 (386)
Q Consensus       145 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  224 (386)
                      +. ++|..++.......+++..+..++.|++.||+|||+   ++++|+||+|+||+++.++.+||+|||++..+..... 
T Consensus        81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~---~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~-  155 (284)
T cd07860          81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR-  155 (284)
T ss_pred             cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc-
Confidence            96 588888876655668999999999999999999999   9999999999999999999999999999876543221 


Q ss_pred             ccccccccccCccChhhhccCC-CCcccchHHHHHHHHHHHhCCCCCCCCchhhhh--hhhhhhccc-------------
Q 016594          225 HSIAPIEGTFGHLAPEYFMHGI-VDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHS--WAKPILNQG-------------  288 (386)
Q Consensus       225 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~--~~~~~~~~~-------------  288 (386)
                       ......++..|+|||++.+.. ++.++|||||||++|+|++|+.||.+.......  .........             
T Consensus       156 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (284)
T cd07860         156 -TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDY  234 (284)
T ss_pred             -ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHH
Confidence             122334688899999887644 688999999999999999999999765432110  000000000             


Q ss_pred             --ccccccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 016594          289 --EIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEV  334 (386)
Q Consensus       289 --~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~  334 (386)
                        ........... .........+.++|.+||+.||++|||+.+++.+
T Consensus       235 ~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~  281 (284)
T cd07860         235 KPSFPKWARQDFS-KVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH  281 (284)
T ss_pred             HhhcccccccCHH-HHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence              00000000000 0011234568899999999999999999999976

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=1.5e-40  Score=303.42  Aligned_cols=261  Identities=24%  Similarity=0.356  Sum_probs=200.8

Q ss_pred             cCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEEE
Q 016594           66 NAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQ  143 (386)
Q Consensus        66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~e  143 (386)
                      ++|++.+.||.|+||.||+|.++ +++.||+|.+............+.+|+++++.++||||+++++++.++. .++++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            46888999999999999999986 5899999998764444444567889999999999999999999997755 899999


Q ss_pred             eccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCc
Q 016594          144 FSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWT  223 (386)
Q Consensus       144 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~  223 (386)
                      |+.++.|..+....  ..+++..++.++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||++..+.... 
T Consensus        81 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~---~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~-  154 (286)
T cd07846          81 FVDHTVLDDLEKYP--NGLDESRVRKYLFQILRGIEFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-  154 (286)
T ss_pred             cCCccHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc-
Confidence            99998888776533  338999999999999999999999   999999999999999999999999999988654332 


Q ss_pred             cccccccccccCccChhhhcc-CCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhh-------------hcccc
Q 016594          224 HHSIAPIEGTFGHLAPEYFMH-GIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPI-------------LNQGE  289 (386)
Q Consensus       224 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~-------------~~~~~  289 (386)
                       .......++..|+|||++.+ ..++.++||||||+++|+|++|.+||....... .+....             .....
T Consensus       155 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  232 (286)
T cd07846         155 -EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDID-QLYHIIKCLGNLIPRHQEIFQKNP  232 (286)
T ss_pred             -cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHH-HHHHHHHHhCCCchhhHHHhccch
Confidence             12233457889999999875 457889999999999999999999997543211 000000             00000


Q ss_pred             c-ccccCCccCC-----CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 016594          290 I-EKLVDPRLQG-----AYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEV  334 (386)
Q Consensus       290 ~-~~~~~~~~~~-----~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~  334 (386)
                      + .....+....     ......+..+.+++.+||..+|++||++.+++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  283 (286)
T cd07846         233 LFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH  283 (286)
T ss_pred             HhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence            0 0000000000     0011235679999999999999999999999976

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=2.6e-40  Score=301.35  Aligned_cols=267  Identities=24%  Similarity=0.354  Sum_probs=205.0

Q ss_pred             cCCCCCCeecccCCcEEEEEEEC-----CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEe--C-c
Q 016594           66 NAFSSENLVGRGGYAEVYKGVLQ-----DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVD--N-G  137 (386)
Q Consensus        66 ~~~~~~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~-~  137 (386)
                      ..|++.+.||+|+||.||+|.+.     ++..||||.+...... .....+.+|+++++.+.|+||+++++++..  . .
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~   82 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRS   82 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCc
Confidence            46778899999999999999854     3678999998764332 456788999999999999999999998876  2 3


Q ss_pred             eEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCcccc
Q 016594          138 LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKW  217 (386)
Q Consensus       138 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~  217 (386)
                      .+++|||+.+++|.+++.... ..+++..++.++.|++.||+|||+   ++++|+||||+||+++.++.++|+|||++..
T Consensus        83 ~~lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~  158 (284)
T cd05038          83 LRLIMEYLPSGSLRDYLQRHR-DQINLKRLLLFSSQICKGMDYLGS---QRYIHRDLAARNILVESEDLVKISDFGLAKV  158 (284)
T ss_pred             eEEEEecCCCCCHHHHHHhCc-cccCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEcccccccc
Confidence            899999999999999987543 248999999999999999999999   9999999999999999999999999999987


Q ss_pred             CCCCCccc-cccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhc---ccccccc
Q 016594          218 LPSQWTHH-SIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILN---QGEIEKL  293 (386)
Q Consensus       218 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~---~~~~~~~  293 (386)
                      ........ ......++..|+|||.+.+..++.++|||||||++|+|++|..||.........+......   ...+...
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T cd05038         159 LPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLEL  238 (284)
T ss_pred             cccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHH
Confidence            75332211 1112335567999999998899999999999999999999999986543221110000000   0000111


Q ss_pred             cCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 016594          294 VDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLE  337 (386)
Q Consensus       294 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~  337 (386)
                      +........+..++..+.+++.+||+.+|++||++.+|++.|..
T Consensus       239 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~  282 (284)
T cd05038         239 LKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDR  282 (284)
T ss_pred             HHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhh
Confidence            11111112222345679999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-41  Score=293.76  Aligned_cols=253  Identities=23%  Similarity=0.281  Sum_probs=208.9

Q ss_pred             HHhcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEecccc-CChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eE
Q 016594           63 IATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVV-TDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LY  139 (386)
Q Consensus        63 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~  139 (386)
                      +.-++|..+++||+|.||+|.+++-+ +++.||+|++++.. ........-+.|-.+|+..+||.+..+--.|...+ +|
T Consensus       165 vTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlC  244 (516)
T KOG0690|consen  165 VTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLC  244 (516)
T ss_pred             eccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEE
Confidence            45578889999999999999999976 79999999998743 34455667788999999999999999987776654 99


Q ss_pred             EEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCC
Q 016594          140 LIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLP  219 (386)
Q Consensus       140 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~  219 (386)
                      +||||+.||.|.-.+.+  .+.|++.....+-..|+.||.|||+   ++||.||||.+|+|+|.+|++||+|||+++.--
T Consensus       245 FVMeyanGGeLf~HLsr--er~FsE~RtRFYGaEIvsAL~YLHs---~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I  319 (516)
T KOG0690|consen  245 FVMEYANGGELFFHLSR--ERVFSEDRTRFYGAEIVSALGYLHS---RNIVYRDLKLENLLLDKDGHIKITDFGLCKEEI  319 (516)
T ss_pred             EEEEEccCceEeeehhh--hhcccchhhhhhhHHHHHHhhhhhh---CCeeeeechhhhheeccCCceEeeecccchhcc
Confidence            99999999999877765  4459999999999999999999999   999999999999999999999999999998532


Q ss_pred             CCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccC
Q 016594          220 SQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQ  299 (386)
Q Consensus       220 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (386)
                      .  ......++||||.|+|||++....|+.++|+|.+|+++|||++|+.||...+....           ..-++-..+ 
T Consensus       320 ~--~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kL-----------FeLIl~ed~-  385 (516)
T KOG0690|consen  320 K--YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKL-----------FELILMEDL-  385 (516)
T ss_pred             c--ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHH-----------HHHHHhhhc-
Confidence            2  23456789999999999999999999999999999999999999999987543211           011111111 


Q ss_pred             CCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHH
Q 016594          300 GAYDVTQLNRLAFAASLCIRASPTWRP-----TMSEVLEVM  335 (386)
Q Consensus       300 ~~~~~~~~~~l~~li~~cl~~dP~~Rp-----t~~~il~~l  335 (386)
                       .++...+.+...|+..+|.+||.+|.     .+.+|.++-
T Consensus       386 -kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~  425 (516)
T KOG0690|consen  386 -KFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHR  425 (516)
T ss_pred             -cCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhh
Confidence             23445567789999999999999995     456666653

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=3.1e-40  Score=301.23  Aligned_cols=263  Identities=21%  Similarity=0.278  Sum_probs=203.6

Q ss_pred             CCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEEEe
Q 016594           67 AFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQF  144 (386)
Q Consensus        67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~  144 (386)
                      +|++.+.||.|+||.||+|.+. +|+.||+|++............+.+|+.+++.++||||+++++++.++. .++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            4788999999999999999976 6899999998865444455677899999999999999999999997755 8999999


Q ss_pred             ccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCcc
Q 016594          145 SSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTH  224 (386)
Q Consensus       145 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  224 (386)
                      + +++|.+++.... ..+++..++.++.|++.||.|||+   ++++|+||||+||+++.++.++|+|||++........ 
T Consensus        81 ~-~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-  154 (286)
T cd07832          81 M-PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHA---NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP-  154 (286)
T ss_pred             c-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-
Confidence            9 999999886544 458999999999999999999999   9999999999999999999999999999987654321 


Q ss_pred             ccccccccccCccChhhhccC-CCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhh--hcc------------cc
Q 016594          225 HSIAPIEGTFGHLAPEYFMHG-IVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPI--LNQ------------GE  289 (386)
Q Consensus       225 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~--~~~------------~~  289 (386)
                      .......++..|+|||.+.+. .++.++|||||||++|+|++|.+||.+..... .+....  ...            ..
T Consensus       155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  233 (286)
T cd07832         155 RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIE-QLAIVFRTLGTPNEETWPGLTSLPD  233 (286)
T ss_pred             CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHH-HHHHHHHHcCCCChHHHhhccCcch
Confidence            122344688999999998754 46899999999999999999988887654211 110000  000            00


Q ss_pred             cccccCCccC----CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 016594          290 IEKLVDPRLQ----GAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVML  336 (386)
Q Consensus       290 ~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~  336 (386)
                      ...+..+...    ..........+.+++.+||+.+|.+||++++++++.+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~  284 (286)
T cd07832         234 YNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPY  284 (286)
T ss_pred             hhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcC
Confidence            0000000000    0000123478999999999999999999999998743

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=4.7e-40  Score=297.13  Aligned_cols=256  Identities=25%  Similarity=0.391  Sum_probs=202.5

Q ss_pred             CCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCC----hHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEE
Q 016594           67 AFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTD----DRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYL  140 (386)
Q Consensus        67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~l  140 (386)
                      +|+..+.||+|+||.||+|... +++.||+|++......    ......+.+|+.+++.++|+||+++++++.+.+ .++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            4788899999999999999964 6899999998753321    123467889999999999999999999997755 899


Q ss_pred             EEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCC-CeEEeecCccccCC
Q 016594          141 IFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADF-EPQISDFGLAKWLP  219 (386)
Q Consensus       141 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~-~~kl~Dfg~a~~~~  219 (386)
                      +++|+.+++|.+++....  .+++..+..++.|++.||.|||+   ++++|+||+|+||+++.++ .+||+|||.+..+.
T Consensus        81 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~ql~~al~~LH~---~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~  155 (268)
T cd06630          81 FVEWMAGGSVSHLLSKYG--AFKEAVIINYTEQLLRGLSYLHE---NQIIHRDVKGANLLIDSTGQRLRIADFGAAARLA  155 (268)
T ss_pred             EEeccCCCcHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEcccccccccc
Confidence            999999999999887543  48899999999999999999999   9999999999999998776 59999999988765


Q ss_pred             CCCcc--ccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCc
Q 016594          220 SQWTH--HSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPR  297 (386)
Q Consensus       220 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (386)
                      .....  .......++..|+|||.+.+..++.++|||||||++|+|++|..||...........        +.......
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~--------~~~~~~~~  227 (268)
T cd06630         156 AKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLAL--------IFKIASAT  227 (268)
T ss_pred             cccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHH--------HHHHhccC
Confidence            43211  111234578899999999888899999999999999999999999965332110000        00111111


Q ss_pred             cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 016594          298 LQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVM  335 (386)
Q Consensus       298 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l  335 (386)
                      .....+...+..+.+++.+||..+|++||++.+++.+-
T Consensus       228 ~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~  265 (268)
T cd06630         228 TAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHP  265 (268)
T ss_pred             CCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCc
Confidence            11223334567899999999999999999999999763

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=4.3e-40  Score=295.50  Aligned_cols=249  Identities=26%  Similarity=0.400  Sum_probs=201.9

Q ss_pred             CCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccC---ChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEE
Q 016594           67 AFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVT---DDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLI  141 (386)
Q Consensus        67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv  141 (386)
                      +|+..+.||+|+||+||+|... ++..|++|.+.....   .......+.+|+.+++.++|+||+++++++.++. .+++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            4778899999999999999987 789999999865332   2335567889999999999999999999987755 8999


Q ss_pred             EEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCC
Q 016594          142 FQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQ  221 (386)
Q Consensus       142 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  221 (386)
                      +||+.+++|.+++....  .+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.+||+|||++......
T Consensus        81 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~  155 (258)
T cd06632          81 LELVPGGSLAKLLKKYG--SFPEPVIRLYTRQILLGLEYLHD---RNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEF  155 (258)
T ss_pred             EEecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccceecccc
Confidence            99999999999987543  48899999999999999999999   99999999999999999999999999998765433


Q ss_pred             CccccccccccccCccChhhhccCC-CCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCC
Q 016594          222 WTHHSIAPIEGTFGHLAPEYFMHGI-VDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQG  300 (386)
Q Consensus       222 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (386)
                      .   ......++..|+|||.+.... ++.++|+|||||++|+|++|..||.........+.  .....         ...
T Consensus       156 ~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~--~~~~~---------~~~  221 (258)
T cd06632         156 S---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFK--IGRSK---------ELP  221 (258)
T ss_pred             c---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHH--HHhcc---------cCC
Confidence            2   223455888999999988766 89999999999999999999999976542111110  00000         011


Q ss_pred             CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 016594          301 AYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEV  334 (386)
Q Consensus       301 ~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~  334 (386)
                      ..+......+.+++.+||+.+|.+||++.+++.+
T Consensus       222 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  255 (258)
T cd06632         222 PIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH  255 (258)
T ss_pred             CcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence            1222345778999999999999999999999975

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=5.7e-40  Score=295.86  Aligned_cols=238  Identities=21%  Similarity=0.340  Sum_probs=185.4

Q ss_pred             CeecccCCcEEEEEEECC-------------CcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-
Q 016594           72 NLVGRGGYAEVYKGVLQD-------------GEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-  137 (386)
Q Consensus        72 ~~lg~G~~g~V~~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-  137 (386)
                      +.||+|+||.||+|++.+             ...|++|.+...  .......+..|+.++..++||||+++++++.++. 
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~   78 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS--HRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVE   78 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh--hhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence            368999999999998532             225888887642  2334457788999999999999999999987655 


Q ss_pred             eEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCC-------eEEe
Q 016594          138 LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFE-------PQIS  210 (386)
Q Consensus       138 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~-------~kl~  210 (386)
                      .+++|||+.+++|..++.... ..+++..++.++.|++.||+|||+   ++|+||||||+|||++.++.       ++++
T Consensus        79 ~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~  154 (262)
T cd05077          79 NIMVEEFVEFGPLDLFMHRKS-DVLTTPWKFKVAKQLASALSYLED---KDLVHGNVCTKNILLAREGIDGECGPFIKLS  154 (262)
T ss_pred             CEEEEecccCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhh---CCeECCCCCcccEEEecCCccCCCCceeEeC
Confidence            899999999999988876433 348999999999999999999999   99999999999999986654       8999


Q ss_pred             ecCccccCCCCCccccccccccccCccChhhhc-cCCCCcccchHHHHHHHHHHH-hCCCCCCCCchhhhhhhhhhhccc
Q 016594          211 DFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFM-HGIVDEKTDVFAFGVFLLEII-SGRKPVDGSHQSLHSWAKPILNQG  288 (386)
Q Consensus       211 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~ell-~g~~pf~~~~~~~~~~~~~~~~~~  288 (386)
                      |||++......      ....++..|+|||++. +..++.++|||||||++|+|+ +|..||..........        
T Consensus       155 d~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~--------  220 (262)
T cd05077         155 DPGIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER--------  220 (262)
T ss_pred             CCCCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHH--------
Confidence            99998755321      2334788899999887 467899999999999999998 5888887543211100        


Q ss_pred             ccccccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 016594          289 EIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVM  335 (386)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l  335 (386)
                          .......  ........+.+++.+||+.||.+||++.+|++.+
T Consensus       221 ----~~~~~~~--~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~  261 (262)
T cd05077         221 ----FYEGQCM--LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI  261 (262)
T ss_pred             ----HHhcCcc--CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence                0000000  0111245689999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=6.2e-40  Score=299.62  Aligned_cols=261  Identities=28%  Similarity=0.361  Sum_probs=203.9

Q ss_pred             cCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeC---ceEEE
Q 016594           66 NAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDN---GLYLI  141 (386)
Q Consensus        66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~---~~~lv  141 (386)
                      ++|...+.||.|++|.||+|... +++.||+|.+..... ......+.+|+++++.++||||+++++++.+.   ..+++
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   79 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN-PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIA   79 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc-hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEE
Confidence            35778899999999999999985 688999999875322 34556789999999999999999999998643   38999


Q ss_pred             EEeccCCCHhhhhhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCC
Q 016594          142 FQFSSRGSVASLFHDV--NSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLP  219 (386)
Q Consensus       142 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~  219 (386)
                      |||+.+++|.+++...  ....+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||++....
T Consensus        80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~  156 (287)
T cd06621          80 MEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELV  156 (287)
T ss_pred             EEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEecCCeEEEeecccccccc
Confidence            9999999999876542  23458899999999999999999999   999999999999999999999999999987654


Q ss_pred             CCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCch---hhhhhhhhhhcccccccccCC
Q 016594          220 SQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQ---SLHSWAKPILNQGEIEKLVDP  296 (386)
Q Consensus       220 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~---~~~~~~~~~~~~~~~~~~~~~  296 (386)
                      ...    .....++..|+|||.+.+..++.++|||||||++|+|++|..||.....   ........... .....+...
T Consensus       157 ~~~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~  231 (287)
T cd06621         157 NSL----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVN-MPNPELKDE  231 (287)
T ss_pred             ccc----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhc-CCchhhccC
Confidence            321    1234578889999999999999999999999999999999999986522   00111110000 000000000


Q ss_pred             ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          297 RLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       297 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                         .......+..+.+++.+||..+|++|||+.+++++-+..
T Consensus       232 ---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~  270 (287)
T cd06621         232 ---PGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIK  270 (287)
T ss_pred             ---CCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcccc
Confidence               011122457799999999999999999999999986653

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=3.8e-40  Score=300.88  Aligned_cols=263  Identities=25%  Similarity=0.367  Sum_probs=203.5

Q ss_pred             cCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEEE
Q 016594           66 NAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQ  143 (386)
Q Consensus        66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~e  143 (386)
                      ++|++.+.||+|+||.||+|.++ +++.||+|.+............+.+|+.+++.+.|+||+++++++.+++ .++++|
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   80 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE   80 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence            46889999999999999999976 6889999998764444445577899999999999999999999998765 899999


Q ss_pred             eccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCc
Q 016594          144 FSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWT  223 (386)
Q Consensus       144 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~  223 (386)
                      |+.++.+..+...  ...+++..+..++.|++.||.|||+   ++++|+||+|+||+++.++.+||+|||++........
T Consensus        81 ~~~~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~  155 (288)
T cd07833          81 YVERTLLELLEAS--PGGLPPDAVRSYIWQLLQAIAYCHS---HNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA  155 (288)
T ss_pred             cCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc
Confidence            9998777665543  2348999999999999999999999   9999999999999999999999999999887654422


Q ss_pred             cccccccccccCccChhhhccC-CCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhh-h------------cccc
Q 016594          224 HHSIAPIEGTFGHLAPEYFMHG-IVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPI-L------------NQGE  289 (386)
Q Consensus       224 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~-~------------~~~~  289 (386)
                       .......++..|+|||++.+. .++.++||||||+++|+|++|..||.+.......+.... .            ....
T Consensus       156 -~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (288)
T cd07833         156 -SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPR  234 (288)
T ss_pred             -ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcc
Confidence             122345678899999999887 889999999999999999999999976533211110000 0            0000


Q ss_pred             cc--cccCCc----cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 016594          290 IE--KLVDPR----LQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEV  334 (386)
Q Consensus       290 ~~--~~~~~~----~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~  334 (386)
                      ..  ......    ....++...+..+.+++.+||..+|++||++++++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  285 (288)
T cd07833         235 FAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH  285 (288)
T ss_pred             ccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence            00  000000    0001122236779999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=3e-40  Score=303.02  Aligned_cols=253  Identities=20%  Similarity=0.356  Sum_probs=203.8

Q ss_pred             cCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEEE
Q 016594           66 NAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQ  143 (386)
Q Consensus        66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~e  143 (386)
                      .+|++.+.||.|+||.||+|... +++.||+|.+....  ......+.+|+.+++.++||||+++++++.... .++++|
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   96 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK--QPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVME   96 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEeccc--CchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEE
Confidence            46889999999999999999965 68999999887532  233456789999999999999999999987655 899999


Q ss_pred             eccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCc
Q 016594          144 FSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWT  223 (386)
Q Consensus       144 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~  223 (386)
                      |+.+++|..++...   .+++..+..++.|++.||.|||+   ++++|+||||+||+++.++.+||+|||++..+.....
T Consensus        97 ~~~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~---~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~  170 (296)
T cd06655          97 YLAGGSLTDVVTET---CMDEAQIAAVCRECLQALEFLHA---NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS  170 (296)
T ss_pred             ecCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccchhcccccc
Confidence            99999999987642   48999999999999999999999   9999999999999999999999999999876543321


Q ss_pred             cccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCCCCC
Q 016594          224 HHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYD  303 (386)
Q Consensus       224 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (386)
                        ......++..|+|||.+.+..++.++|||||||++|+|++|..||...........  ... ..     .+.  ...+
T Consensus       171 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~--~~~-~~-----~~~--~~~~  238 (296)
T cd06655         171 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL--IAT-NG-----TPE--LQNP  238 (296)
T ss_pred             --cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH--HHh-cC-----Ccc--cCCc
Confidence              12234688899999999988899999999999999999999999987543211100  000 00     000  1112


Q ss_pred             HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          304 VTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       304 ~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                      ...+..+.+++.+||..||.+||++.+++.+-+..
T Consensus       239 ~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~  273 (296)
T cd06655         239 EKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLK  273 (296)
T ss_pred             ccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhh
Confidence            23346789999999999999999999999875544

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=3e-40  Score=301.43  Aligned_cols=260  Identities=26%  Similarity=0.381  Sum_probs=201.1

Q ss_pred             HHHHHHhcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhcc-CCCceeeecceEEe-
Q 016594           59 EEISIATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHV-CHPNVLSLLGCCVD-  135 (386)
Q Consensus        59 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~-  135 (386)
                      +.+....++|++.+.||+|+||.||+|... +++.+|+|++....   .....+.+|+.+++.+ +||||+++++++.. 
T Consensus        11 ~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~---~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   87 (286)
T cd06638          11 DSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH---DIDEEIEAEYNILKALSDHPNVVKFYGMYYKK   87 (286)
T ss_pred             ecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc---chHHHHHHHHHHHHHHhcCCCeeeeeeeeeec
Confidence            334456788999999999999999999976 58899999876421   2234677899999999 69999999998742 


Q ss_pred             -----CceEEEEEeccCCCHhhhhhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeE
Q 016594          136 -----NGLYLIFQFSSRGSVASLFHDV--NSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQ  208 (386)
Q Consensus       136 -----~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~k  208 (386)
                           +..+++|||+.+++|.+++...  ....+++..+..++.|++.||.|||+   ++++||||||+||+++.++.++
T Consensus        88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~k  164 (286)
T cd06638          88 DVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHV---NKTIHRDVKGNNILLTTEGGVK  164 (286)
T ss_pred             ccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHh---CCccccCCCHHhEEECCCCCEE
Confidence                 2379999999999999887532  23458899999999999999999999   9999999999999999999999


Q ss_pred             EeecCccccCCCCCccccccccccccCccChhhhcc-----CCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhh
Q 016594          209 ISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMH-----GIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKP  283 (386)
Q Consensus       209 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~  283 (386)
                      |+|||++..+....  .......|++.|+|||++..     ..++.++|||||||++|+|++|+.||........ ... 
T Consensus       165 l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~-~~~-  240 (286)
T cd06638         165 LVDFGVSAQLTSTR--LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA-LFK-  240 (286)
T ss_pred             EccCCceeecccCC--CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHH-Hhh-
Confidence            99999988664321  12233458999999998753     4578999999999999999999999976432110 000 


Q ss_pred             hhcccccccccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 016594          284 ILNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVML  336 (386)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~  336 (386)
                            ......+.  ...+...+..+.+++.+||+.+|++||++.+++++++
T Consensus       241 ------~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~  285 (286)
T cd06638         241 ------IPRNPPPT--LHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVF  285 (286)
T ss_pred             ------ccccCCCc--ccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhccc
Confidence                  00000000  0111123456999999999999999999999998764

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=3.7e-40  Score=300.32  Aligned_cols=255  Identities=24%  Similarity=0.389  Sum_probs=195.5

Q ss_pred             cCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHH-HhccCCCceeeecceEEeCc-eEEEE
Q 016594           66 NAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGT-IGHVCHPNVLSLLGCCVDNG-LYLIF  142 (386)
Q Consensus        66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~-l~~l~h~niv~l~~~~~~~~-~~lv~  142 (386)
                      ++|++.+.||+|+||.||+|.++ +|+.||+|.+...... .....+..|+.+ ++.++||||+++++++..++ .++++
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~   79 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNS-QEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICM   79 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCc-HHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEh
Confidence            46888999999999999999976 6899999998764322 234456666665 56678999999999997655 89999


Q ss_pred             EeccCCCHhhhhhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCC-CeEEeCCCCCCeeEcCCCCeEEeecCccccCC
Q 016594          143 QFSSRGSVASLFHDV--NSPGVEWKVRHKIAVGTARGLHYLHKGCQR-RIIHRDIKSSNILLTADFEPQISDFGLAKWLP  219 (386)
Q Consensus       143 e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~-~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~  219 (386)
                      ||+. ++|.+++...  ....+++..++.++.|++.||.|||+   + +++||||||+||+++.++.+||+|||++..+.
T Consensus        80 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~  155 (283)
T cd06617          80 EVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS---KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLV  155 (283)
T ss_pred             hhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhh---cCCeecCCCCHHHEEECCCCCEEEeecccccccc
Confidence            9997 5787777543  23458999999999999999999998   6 99999999999999999999999999988654


Q ss_pred             CCCccccccccccccCccChhhhcc----CCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccC
Q 016594          220 SQWTHHSIAPIEGTFGHLAPEYFMH----GIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVD  295 (386)
Q Consensus       220 ~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  295 (386)
                      ...   ......++..|+|||.+.+    ..++.++|+|||||++|+|++|..||............          ...
T Consensus       156 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~----------~~~  222 (283)
T cd06617         156 DSV---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQ----------VVE  222 (283)
T ss_pred             ccc---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHH----------HHh
Confidence            321   1122457889999998865    45689999999999999999999999653221111100          000


Q ss_pred             CccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          296 PRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       296 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                      ...........+..+.+++.+||..+|++||++.+++++-+..
T Consensus       223 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~  265 (283)
T cd06617         223 EPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFE  265 (283)
T ss_pred             cCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhh
Confidence            0000001112456799999999999999999999999875443

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.7e-40  Score=297.96  Aligned_cols=253  Identities=28%  Similarity=0.436  Sum_probs=201.3

Q ss_pred             HhcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhcc-CCCceeeecceEEeCc----
Q 016594           64 ATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHV-CHPNVLSLLGCCVDNG----  137 (386)
Q Consensus        64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~----  137 (386)
                      ..++|++.+.||.|++|.||+|..+ +++.+++|++....   .....+.+|+.+++++ .|+||+++++++.+..    
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~   80 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE---DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN   80 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc---hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence            4578999999999999999999986 57899999987532   2346788999999999 6999999999997533    


Q ss_pred             ---eEEEEEeccCCCHhhhhhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeec
Q 016594          138 ---LYLIFQFSSRGSVASLFHDVN--SPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDF  212 (386)
Q Consensus       138 ---~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Df  212 (386)
                         .+++|||+.+++|.+++....  ...+++..+..++.|++.||.|||+   ++++|+||+|+||+++.++.++|+||
T Consensus        81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~~l~p~ni~~~~~~~~~l~d~  157 (275)
T cd06608          81 DDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHE---NKVIHRDIKGQNILLTKNAEVKLVDF  157 (275)
T ss_pred             ceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEEccCCeEEECCC
Confidence               799999999999999886543  4558999999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCCCccccccccccccCccChhhhcc-----CCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcc
Q 016594          213 GLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMH-----GIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQ  287 (386)
Q Consensus       213 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~  287 (386)
                      |++.......  .......|+..|+|||++..     ..++.++|||||||++|+|++|..||.........  ...   
T Consensus       158 ~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~--~~~---  230 (275)
T cd06608         158 GVSAQLDSTL--GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRAL--FKI---  230 (275)
T ss_pred             ccceecccch--hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHH--HHh---
Confidence            9987654322  12234458899999998754     34678999999999999999999999754321100  000   


Q ss_pred             cccccccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 016594          288 GEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEV  334 (386)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~  334 (386)
                         .....+  ....+...+..+.+++.+||..||++|||+.+++++
T Consensus       231 ---~~~~~~--~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~  272 (275)
T cd06608         231 ---PRNPPP--TLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEH  272 (275)
T ss_pred             ---hccCCC--CCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence               000001  111122345679999999999999999999999975

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-41  Score=334.69  Aligned_cols=262  Identities=19%  Similarity=0.237  Sum_probs=214.9

Q ss_pred             HHHHHHhcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCC-hHhHHHHHHHHHHHhccCCCceeeecceEEeC
Q 016594           59 EEISIATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTD-DRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDN  136 (386)
Q Consensus        59 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~  136 (386)
                      .+......+|.+.++||+|+||.|.+++.+ +++.||+|++++...- .....-|..|-.+|..-+.+-|+.++-.|.++
T Consensus        68 ~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~  147 (1317)
T KOG0612|consen   68 KELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDE  147 (1317)
T ss_pred             HHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCc
Confidence            334556789999999999999999999986 6889999999873322 44556788899999998999999999999886


Q ss_pred             c-eEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCcc
Q 016594          137 G-LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLA  215 (386)
Q Consensus       137 ~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a  215 (386)
                      . +|+||+|++||+|..++.+..  .+++..+..++..|+.||.-||+   .|+|||||||+|||||..|++||+|||.+
T Consensus       148 ~~LYlVMdY~pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH~---mgyVHRDiKPDNvLld~~GHikLADFGsC  222 (1317)
T KOG0612|consen  148 RYLYLVMDYMPGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLHS---MGYVHRDIKPDNVLLDKSGHIKLADFGSC  222 (1317)
T ss_pred             cceEEEEecccCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHHh---ccceeccCCcceeEecccCcEeeccchhH
Confidence            5 999999999999999998776  59999999999999999999999   99999999999999999999999999999


Q ss_pred             ccCCCCCccccccccccccCccChhhhc----c-CCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhccccc
Q 016594          216 KWLPSQWTHHSIAPIEGTFGHLAPEYFM----H-GIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEI  290 (386)
Q Consensus       216 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  290 (386)
                      -.+..... ......+|||.|++||++.    + +.|++.+|+||+||++|||+.|..||....-  ..         ..
T Consensus       223 lkm~~dG~-V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadsl--ve---------TY  290 (1317)
T KOG0612|consen  223 LKMDADGT-VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSL--VE---------TY  290 (1317)
T ss_pred             HhcCCCCc-EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHH--HH---------HH
Confidence            88865432 3345567999999999986    3 5689999999999999999999999976421  11         12


Q ss_pred             ccccCCc--cCCCCCHHHHHHHHHHHHHccccCCCCCCC---HHHHHHHHhcC
Q 016594          291 EKLVDPR--LQGAYDVTQLNRLAFAASLCIRASPTWRPT---MSEVLEVMLEG  338 (386)
Q Consensus       291 ~~~~~~~--~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt---~~~il~~l~~~  338 (386)
                      .++++..  +..+.....++...+||...+. +|+.|..   +.++-.|....
T Consensus       291 ~KIm~hk~~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~  342 (1317)
T KOG0612|consen  291 GKIMNHKESLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFE  342 (1317)
T ss_pred             HHHhchhhhcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCcccc
Confidence            2233322  2222224467889999998774 8889988   99999985443

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=4e-40  Score=301.35  Aligned_cols=248  Identities=23%  Similarity=0.320  Sum_probs=203.4

Q ss_pred             cCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccC-ChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEE
Q 016594           66 NAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVT-DDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIF  142 (386)
Q Consensus        66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~  142 (386)
                      ++|++.+.||+|+||.||+|.+. +++.||+|++..... .......+.+|+++++++.||||+++++++.++. .+++|
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            46889999999999999999976 689999999875322 2334567889999999999999999999997765 89999


Q ss_pred             EeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCC
Q 016594          143 QFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQW  222 (386)
Q Consensus       143 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  222 (386)
                      ||+.+++|.+++...  ..+++..+..++.|++.||.|||+   ++++|+||+|.||+++.++.+||+|||++...... 
T Consensus        81 e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-  154 (290)
T cd05580          81 EYVPGGELFSHLRKS--GRFPEPVARFYAAQVVLALEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-  154 (290)
T ss_pred             ecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC-
Confidence            999999999998765  348999999999999999999999   99999999999999999999999999998876443 


Q ss_pred             ccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCCCC
Q 016594          223 THHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAY  302 (386)
Q Consensus       223 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (386)
                          .....+++.|+|||.+.+..++.++||||||+++|+|++|..||....... ....          +....  ...
T Consensus       155 ----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~----------~~~~~--~~~  217 (290)
T cd05580         155 ----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQ-IYEK----------ILEGK--VRF  217 (290)
T ss_pred             ----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH-HHHH----------HhcCC--ccC
Confidence                234468899999999988889999999999999999999999997654211 0000          00100  111


Q ss_pred             CHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHHh
Q 016594          303 DVTQLNRLAFAASLCIRASPTWRP-----TMSEVLEVML  336 (386)
Q Consensus       303 ~~~~~~~l~~li~~cl~~dP~~Rp-----t~~~il~~l~  336 (386)
                      +...+..+.+++.+||..||.+|+     ++.+++++-+
T Consensus       218 ~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~  256 (290)
T cd05580         218 PSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPW  256 (290)
T ss_pred             CccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcc
Confidence            222356789999999999999999     8888887754

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=1.1e-39  Score=303.57  Aligned_cols=263  Identities=23%  Similarity=0.316  Sum_probs=198.3

Q ss_pred             Ceeccc--CCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEEEeccC
Q 016594           72 NLVGRG--GYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQFSSR  147 (386)
Q Consensus        72 ~~lg~G--~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~~~~  147 (386)
                      ..||.|  +||+||+|.+. +++.||+|++............+.+|+.+++.++||||+++++++..+. .+++++|+.+
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~   83 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY   83 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence            346666  99999999975 7999999998765444555677889999999999999999999997765 8999999999


Q ss_pred             CCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCcccc-
Q 016594          148 GSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHS-  226 (386)
Q Consensus       148 ~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~-  226 (386)
                      ++|.+++.......+++..+..++.|++.||+|||+   ++++||||||+||+++.++.++++||+.+........... 
T Consensus        84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (328)
T cd08226          84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQ---NGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV  160 (328)
T ss_pred             CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence            999999887665668999999999999999999999   9999999999999999999999999986543321111000 


Q ss_pred             ----ccccccccCccChhhhccC--CCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhh---------------
Q 016594          227 ----IAPIEGTFGHLAPEYFMHG--IVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPIL---------------  285 (386)
Q Consensus       227 ----~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~---------------  285 (386)
                          .....++..|+|||++.+.  .++.++|||||||++|+|++|..||...............               
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (328)
T cd08226         161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEE  240 (328)
T ss_pred             cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhh
Confidence                0112345679999999764  4789999999999999999999999765422111000000               


Q ss_pred             -------------------cccccccccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 016594          286 -------------------NQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLE  337 (386)
Q Consensus       286 -------------------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~  337 (386)
                                         ....................++..+.+++.+||+.||++|||+.+++++.+.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~  311 (328)
T cd08226         241 SRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFF  311 (328)
T ss_pred             hhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHH
Confidence                               0000000111111222233456789999999999999999999999988654

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=3.3e-40  Score=296.17  Aligned_cols=252  Identities=22%  Similarity=0.368  Sum_probs=203.9

Q ss_pred             CCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEEEe
Q 016594           67 AFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQF  144 (386)
Q Consensus        67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~  144 (386)
                      +|.+.+.||.|+||.||+|..+ +|..||+|.+............+.+|+.+++.++|+||+++++.+.+.. .++++||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            4788899999999999999976 5889999998764333445567889999999999999999999987765 8999999


Q ss_pred             ccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCC-CeEEeecCccccCCCCCc
Q 016594          145 SSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADF-EPQISDFGLAKWLPSQWT  223 (386)
Q Consensus       145 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~-~~kl~Dfg~a~~~~~~~~  223 (386)
                      +.+++|.+++.......+++..+..++.|++.||.|||+   ++++|+||||+||+++.++ .+||+|||.+........
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~  157 (257)
T cd08225          81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHD---RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME  157 (257)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence            999999999877655568999999999999999999999   9999999999999999876 469999999987654321


Q ss_pred             cccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCCCCC
Q 016594          224 HHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYD  303 (386)
Q Consensus       224 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (386)
                        ......|++.|+|||++.+..++.++|+||||+++|+|++|..||.......  ....... ..    ..     ...
T Consensus       158 --~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~-~~----~~-----~~~  223 (257)
T cd08225         158 --LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQ--LVLKICQ-GY----FA-----PIS  223 (257)
T ss_pred             --cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH--HHHHHhc-cc----CC-----CCC
Confidence              1223458889999999988889999999999999999999999997643221  1111111 00    01     111


Q ss_pred             HHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 016594          304 VTQLNRLAFAASLCIRASPTWRPTMSEVLEVM  335 (386)
Q Consensus       304 ~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l  335 (386)
                      ...+..+.+++.+||..+|++|||+.+++++-
T Consensus       224 ~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~  255 (257)
T cd08225         224 PNFSRDLRSLISQLFKVSPRDRPSITSILKRP  255 (257)
T ss_pred             CCCCHHHHHHHHHHhccChhhCcCHHHHhhCC
Confidence            22346799999999999999999999999763

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=1.1e-39  Score=294.98  Aligned_cols=256  Identities=23%  Similarity=0.327  Sum_probs=198.5

Q ss_pred             HHhcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEE
Q 016594           63 IATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYL  140 (386)
Q Consensus        63 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~l  140 (386)
                      ...+++.....||+|+||.||+|.+. ++..||+|.+...  .......+.+|+.+++.++|+||+++++++..++ .++
T Consensus         5 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   82 (268)
T cd06624           5 YEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPER--DSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI   82 (268)
T ss_pred             cccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCC--CHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence            34455556678999999999999966 5788999988643  2344567889999999999999999999997765 899


Q ss_pred             EEEeccCCCHhhhhhhcCCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcC-CCCeEEeecCccccC
Q 016594          141 IFQFSSRGSVASLFHDVNSP-GVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTA-DFEPQISDFGLAKWL  218 (386)
Q Consensus       141 v~e~~~~~~L~~~~~~~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~-~~~~kl~Dfg~a~~~  218 (386)
                      ++||+.+++|.+++...... ..++..+..++.|++.||.|||+   ++|+||||||+||+++. ++.++|+|||++...
T Consensus        83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~  159 (268)
T cd06624          83 FMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHD---NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL  159 (268)
T ss_pred             EEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCeEEEecchhheec
Confidence            99999999999988754222 12788888999999999999999   99999999999999986 679999999998765


Q ss_pred             CCCCccccccccccccCccChhhhccCC--CCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCC
Q 016594          219 PSQWTHHSIAPIEGTFGHLAPEYFMHGI--VDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDP  296 (386)
Q Consensus       219 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (386)
                      ....  .......+++.|+|||++.+..  ++.++||||||+++|+|++|..||............          ....
T Consensus       160 ~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~----------~~~~  227 (268)
T cd06624         160 AGIN--PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFK----------VGMF  227 (268)
T ss_pred             ccCC--CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhh----------hhhh
Confidence            4321  1122345788999999987643  789999999999999999999999754321111000          0000


Q ss_pred             ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 016594          297 RLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVM  335 (386)
Q Consensus       297 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l  335 (386)
                      ......+......+.+++.+||+.+|.+|||+.+++++-
T Consensus       228 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~  266 (268)
T cd06624         228 KIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDP  266 (268)
T ss_pred             ccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCC
Confidence            011122333456799999999999999999999999863

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=4.2e-40  Score=295.90  Aligned_cols=250  Identities=21%  Similarity=0.280  Sum_probs=203.9

Q ss_pred             CCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCC-hHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEEE
Q 016594           67 AFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTD-DRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQ  143 (386)
Q Consensus        67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~e  143 (386)
                      +|++.+.||.|+||.||+|.+. +++.||+|.+.+.... ......+.+|+.++++++||||+++++++.++. .+++++
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            5788999999999999999976 6899999999764322 245678899999999999999999999987655 899999


Q ss_pred             eccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCc
Q 016594          144 FSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWT  223 (386)
Q Consensus       144 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~  223 (386)
                      |+.+++|.+++...  ..+++..+..++.|+++||.|||+   ++++|+||+|+||+++.++.++|+|||++....... 
T Consensus        81 ~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-  154 (258)
T cd05578          81 LLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHS---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT-  154 (258)
T ss_pred             CCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc-
Confidence            99999999988764  458899999999999999999999   999999999999999999999999999988764432 


Q ss_pred             cccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCCCCC
Q 016594          224 HHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYD  303 (386)
Q Consensus       224 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (386)
                        ......|+..|+|||.+.+..++.++|+||||+++|+|++|..||.................          .....+
T Consensus       155 --~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~----------~~~~~~  222 (258)
T cd05578         155 --LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET----------ADVLYP  222 (258)
T ss_pred             --cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc----------ccccCc
Confidence              22334588899999999988899999999999999999999999986543211111110000          111222


Q ss_pred             HHHHHHHHHHHHHccccCCCCCCCH--HHHHHH
Q 016594          304 VTQLNRLAFAASLCIRASPTWRPTM--SEVLEV  334 (386)
Q Consensus       304 ~~~~~~l~~li~~cl~~dP~~Rpt~--~~il~~  334 (386)
                      ...+..+.+++.+||+.||.+||++  .+++++
T Consensus       223 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~  255 (258)
T cd05578         223 ATWSTEAIDAINKLLERDPQKRLGDNLKDLKNH  255 (258)
T ss_pred             ccCcHHHHHHHHHHccCChhHcCCccHHHHhcC
Confidence            3345789999999999999999999  776653

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=3.8e-40  Score=297.23  Aligned_cols=254  Identities=25%  Similarity=0.420  Sum_probs=204.7

Q ss_pred             cCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEEE
Q 016594           66 NAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQ  143 (386)
Q Consensus        66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~e  143 (386)
                      ++|+..+.||.|+||.||+|.++ +++.||+|.+..... ......+.+|+++++.+.||||+++++++..++ .++++|
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   79 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN-EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICME   79 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC-hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEE
Confidence            35778899999999999999987 688999999876432 355677889999999999999999999987655 899999


Q ss_pred             eccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCc
Q 016594          144 FSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWT  223 (386)
Q Consensus       144 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~  223 (386)
                      |+.+++|.+++.... ..+++..+..++.|++.||+|||+  ..+++|+||||+||+++.++.++|+|||.+........
T Consensus        80 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~--~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~  156 (265)
T cd06605          80 YMDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHE--KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA  156 (265)
T ss_pred             ecCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcC--CCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh
Confidence            999999999987653 458999999999999999999997  36999999999999999999999999999876533211


Q ss_pred             cccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCch---hhhhhhhhhhcccccccccCCccCC
Q 016594          224 HHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQ---SLHSWAKPILNQGEIEKLVDPRLQG  300 (386)
Q Consensus       224 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~  300 (386)
                          ....++..|+|||.+.+..++.++||||||+++|+|++|..||.....   ........         +.... ..
T Consensus       157 ----~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~---------~~~~~-~~  222 (265)
T cd06605         157 ----KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQY---------IVNEP-PP  222 (265)
T ss_pred             ----hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHH---------HhcCC-CC
Confidence                125688899999999999999999999999999999999999976431   11111111         11111 11


Q ss_pred             CCCHH-HHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 016594          301 AYDVT-QLNRLAFAASLCIRASPTWRPTMSEVLEVMLE  337 (386)
Q Consensus       301 ~~~~~-~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~  337 (386)
                      ..+.. .+..+.++|.+||..+|++|||+.+++.+-+.
T Consensus       223 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~  260 (265)
T cd06605         223 RLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFI  260 (265)
T ss_pred             CCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchh
Confidence            11111 56679999999999999999999999987543

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=6.5e-42  Score=325.11  Aligned_cols=259  Identities=22%  Similarity=0.418  Sum_probs=221.7

Q ss_pred             HHHhcCCCCCCeecccCCcEEEEEEEC-CC---cEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc
Q 016594           62 SIATNAFSSENLVGRGGYAEVYKGVLQ-DG---EEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG  137 (386)
Q Consensus        62 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~---~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  137 (386)
                      ++..+...+.++||.|.||.|++|+++ .|   ..||||.++... ......+|+.|+.||-++.||||++|.|+.....
T Consensus       625 EId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy-tekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~  703 (996)
T KOG0196|consen  625 EIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY-TEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSK  703 (996)
T ss_pred             hcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCc-cHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCc
Confidence            456677888999999999999999976 23   469999998643 3445678999999999999999999999998866


Q ss_pred             -eEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccc
Q 016594          138 -LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAK  216 (386)
Q Consensus       138 -~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~  216 (386)
                       .++|.|||++|+|+.+++.+.++ |++.++..+++.|+.|+.||-+   .++|||||..+|||++.+...|++|||+++
T Consensus       704 PvMIiTEyMENGsLDsFLR~~DGq-ftviQLVgMLrGIAsGMkYLsd---m~YVHRDLAARNILVNsnLvCKVsDFGLSR  779 (996)
T KOG0196|consen  704 PVMIITEYMENGSLDSFLRQNDGQ-FTVIQLVGMLRGIASGMKYLSD---MNYVHRDLAARNILVNSNLVCKVSDFGLSR  779 (996)
T ss_pred             eeEEEhhhhhCCcHHHHHhhcCCc-eEeehHHHHHHHHHHHhHHHhh---cCchhhhhhhhheeeccceEEEecccccee
Confidence             78899999999999999887654 9999999999999999999999   999999999999999999999999999999


Q ss_pred             cCCCCCcccccccccc--ccCccChhhhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCchhhhhhhhhhhcccccccc
Q 016594          217 WLPSQWTHHSIAPIEG--TFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGEIEKL  293 (386)
Q Consensus       217 ~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  293 (386)
                      .+.+.. .....+.-|  ..+|.|||.+...+++.++||||+|+++||.++ |..||-..            .+.++.+.
T Consensus       780 vledd~-~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdm------------SNQdVIka  846 (996)
T KOG0196|consen  780 VLEDDP-EAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDM------------SNQDVIKA  846 (996)
T ss_pred             ecccCC-CccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCccccc------------chHHHHHH
Confidence            886553 222222222  467999999999999999999999999999988 99998653            33445555


Q ss_pred             cCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          294 VDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       294 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                      +....+.+.+.+++..|.+|+..||++|-..||.+.+|+..|.+.
T Consensus       847 Ie~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDkl  891 (996)
T KOG0196|consen  847 IEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKL  891 (996)
T ss_pred             HHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHH
Confidence            666677777888999999999999999999999999999988554

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=1.4e-39  Score=293.37  Aligned_cols=254  Identities=26%  Similarity=0.409  Sum_probs=203.5

Q ss_pred             CCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEEEe
Q 016594           67 AFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQF  144 (386)
Q Consensus        67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~  144 (386)
                      +|++.+.||+|+||.||+|... +++.||+|.+............+..|+.+++.++|+||+++++++.... .++++||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            5888999999999999999975 6889999998865544456778999999999999999999999987655 8999999


Q ss_pred             ccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCcc
Q 016594          145 SSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTH  224 (386)
Q Consensus       145 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  224 (386)
                      +.+++|.+++...  ..+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.+||+|||++.........
T Consensus        81 ~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~  155 (264)
T cd06626          81 CSGGTLEELLEHG--RILDEHVIRVYTLQLLEGLAYLHS---HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTT  155 (264)
T ss_pred             CCCCcHHHHHhhc--CCCChHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCc
Confidence            9999999988753  337889999999999999999999   99999999999999999999999999999876543221


Q ss_pred             cc--ccccccccCccChhhhccCC---CCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccC
Q 016594          225 HS--IAPIEGTFGHLAPEYFMHGI---VDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQ  299 (386)
Q Consensus       225 ~~--~~~~~gt~~y~aPE~~~~~~---~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (386)
                      ..  .....++..|+|||++.+..   ++.++||||||+++|+|++|..||............ . ..       .....
T Consensus       156 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~-~-~~-------~~~~~  226 (264)
T cd06626         156 MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFH-V-GA-------GHKPP  226 (264)
T ss_pred             ccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHH-H-hc-------CCCCC
Confidence            11  12345788999999998766   889999999999999999999999764322111000 0 00       00001


Q ss_pred             CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 016594          300 GAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEV  334 (386)
Q Consensus       300 ~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~  334 (386)
                      .......+..+.+++.+||+.+|.+||++.+++.+
T Consensus       227 ~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~  261 (264)
T cd06626         227 IPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQH  261 (264)
T ss_pred             CCcccccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence            11111235678899999999999999999999865

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=1.1e-39  Score=298.78  Aligned_cols=262  Identities=20%  Similarity=0.287  Sum_probs=200.1

Q ss_pred             cCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeC---ceEEE
Q 016594           66 NAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDN---GLYLI  141 (386)
Q Consensus        66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~---~~~lv  141 (386)
                      ++|++.+.||.|+||.||+|.++ +++.+|+|.+............+.+|+.+++++.||||+++++++...   ..+++
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv   84 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV   84 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence            47888999999999999999987 688999999975443333445677899999999999999999998764   48999


Q ss_pred             EEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCC
Q 016594          142 FQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQ  221 (386)
Q Consensus       142 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  221 (386)
                      +||+.+ +|.+++.... ..+++..++.++.|++.||+|||+   ++++|+||||+||+++.++.++|+|||++..+...
T Consensus        85 ~e~~~~-~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~  159 (293)
T cd07843          85 MEYVEH-DLKSLMETMK-QPFLQSEVKCLMLQLLSGVAHLHD---NWILHRDLKTSNLLLNNRGILKICDFGLAREYGSP  159 (293)
T ss_pred             ehhcCc-CHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCcEEEeecCceeeccCC
Confidence            999975 8888876543 358999999999999999999999   99999999999999999999999999999876543


Q ss_pred             CccccccccccccCccChhhhccC-CCCcccchHHHHHHHHHHHhCCCCCCCCchhhhh-hhhhhhc-----------c-
Q 016594          222 WTHHSIAPIEGTFGHLAPEYFMHG-IVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHS-WAKPILN-----------Q-  287 (386)
Q Consensus       222 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~-~~~~~~~-----------~-  287 (386)
                      .  .......+++.|+|||.+.+. .++.++|+||||+++|+|++|..||......... .......           . 
T Consensus       160 ~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (293)
T cd07843         160 L--KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSEL  237 (293)
T ss_pred             c--cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhcc
Confidence            2  122334578899999998764 4689999999999999999999999765421100 0000000           0 


Q ss_pred             -----cccccccCCccCCCCCHH-HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 016594          288 -----GEIEKLVDPRLQGAYDVT-QLNRLAFAASLCIRASPTWRPTMSEVLEV  334 (386)
Q Consensus       288 -----~~~~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~dP~~Rpt~~~il~~  334 (386)
                           ..........+...++.. .+..+.+++.+||+.+|++|||+.+++.+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~  290 (293)
T cd07843         238 PGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH  290 (293)
T ss_pred             chhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence                 000000000111111111 35678999999999999999999999976

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=2.3e-39  Score=297.36  Aligned_cols=263  Identities=23%  Similarity=0.277  Sum_probs=200.9

Q ss_pred             CCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCC---hHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEE
Q 016594           67 AFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTD---DRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLI  141 (386)
Q Consensus        67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv  141 (386)
                      +|++.+.||.|+||.||+|... +++.||+|.+......   ......+..|+.+++.++|+||+++++++.+.. .++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            4788899999999999999976 6899999999764333   233456778999999999999999999998755 8999


Q ss_pred             EEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCC
Q 016594          142 FQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQ  221 (386)
Q Consensus       142 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  221 (386)
                      |||+ +++|.+++.... ..+++..+..++.|+++||.|||+   ++++|+||+|+||+++.++.++|+|||++......
T Consensus        81 ~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~  155 (298)
T cd07841          81 FEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHS---NWILHRDLKPNNLLIASDGVLKLADFGLARSFGSP  155 (298)
T ss_pred             Eccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCChhhEEEcCCCCEEEccceeeeeccCC
Confidence            9999 889999987544 358999999999999999999999   99999999999999999999999999999876543


Q ss_pred             CccccccccccccCccChhhhcc-CCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhh--hcc---------cc
Q 016594          222 WTHHSIAPIEGTFGHLAPEYFMH-GIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPI--LNQ---------GE  289 (386)
Q Consensus       222 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~--~~~---------~~  289 (386)
                      ..  ......+++.|+|||.+.+ ..++.++|||||||++|+|++|.+||.+..... ......  ...         ..
T Consensus       156 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  232 (298)
T cd07841         156 NR--KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDID-QLGKIFEALGTPTEENWPGVTS  232 (298)
T ss_pred             Cc--cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHH-HHHHHHHHcCCCchhhhhhccc
Confidence            21  1223346788999998865 467899999999999999999988887644211 000000  000         00


Q ss_pred             cccccCCccCCCC-----CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 016594          290 IEKLVDPRLQGAY-----DVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLE  337 (386)
Q Consensus       290 ~~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~  337 (386)
                      .............     ....+..+.+++.+||+.+|++|||+.+++++-+.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~  285 (298)
T cd07841         233 LPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYF  285 (298)
T ss_pred             ccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccc
Confidence            0000000000011     11235678999999999999999999999997443

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.9e-39  Score=291.66  Aligned_cols=237  Identities=24%  Similarity=0.395  Sum_probs=188.1

Q ss_pred             CeecccCCcEEEEEEECC-C----------cEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCceEE
Q 016594           72 NLVGRGGYAEVYKGVLQD-G----------EEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNGLYL  140 (386)
Q Consensus        72 ~~lg~G~~g~V~~~~~~~-~----------~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~l  140 (386)
                      +.||+|+||.||+|.+.. +          ..+++|.+....   .....+.+|+.+++.++||||+++++++.....++
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~l   77 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH---RDSLAFFETASLMSQLSHKHLVKLYGVCVRDENIM   77 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccch---hhHHHHHHHHHHHHcCCCcchhheeeEEecCCcEE
Confidence            468999999999999763 3          247777765422   11577889999999999999999999987766899


Q ss_pred             EEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCC-------CeEEeecC
Q 016594          141 IFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADF-------EPQISDFG  213 (386)
Q Consensus       141 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~-------~~kl~Dfg  213 (386)
                      ++||+.+++|.+++..... .+++..+..++.|++.||.|||+   ++|+||||||+|||++.++       .+||+|||
T Consensus        78 v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg  153 (259)
T cd05037          78 VEEYVKFGPLDVFLHREKN-NVSLHWKLDVAKQLASALHYLED---KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPG  153 (259)
T ss_pred             EEEcCCCCcHHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHhh---CCeecccCccceEEEecCccccCCceeEEeCCCC
Confidence            9999999999998876443 58899999999999999999999   9999999999999999887       79999999


Q ss_pred             ccccCCCCCccccccccccccCccChhhhccC--CCCcccchHHHHHHHHHHHh-CCCCCCCCchhhhhhhhhhhccccc
Q 016594          214 LAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHG--IVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGEI  290 (386)
Q Consensus       214 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~  290 (386)
                      ++.....      .....++..|+|||++.+.  .++.++|||||||++|+|++ |..||.......  +.....     
T Consensus       154 ~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~--~~~~~~-----  220 (259)
T cd05037         154 IPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE--KERFYQ-----  220 (259)
T ss_pred             ccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchh--HHHHHh-----
Confidence            9886543      1223467789999999876  78999999999999999999 678886543111  000000     


Q ss_pred             ccccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 016594          291 EKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVM  335 (386)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l  335 (386)
                          ...   ..+......+.+++.+||..+|.+||++.++++.|
T Consensus       221 ----~~~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l  258 (259)
T cd05037         221 ----DQH---RLPMPDCAELANLINQCWTYDPTKRPSFRAILRDL  258 (259)
T ss_pred             ----cCC---CCCCCCchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence                000   00011126789999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=5.8e-40  Score=299.90  Aligned_cols=257  Identities=24%  Similarity=0.394  Sum_probs=196.1

Q ss_pred             CCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccC-CCceeeecceEEeCc-eEEEEE
Q 016594           67 AFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVC-HPNVLSLLGCCVDNG-LYLIFQ  143 (386)
Q Consensus        67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~-~~lv~e  143 (386)
                      +|...+.||+|+||.||++.+. +++.||+|.+...... .....+.+|+.++.++. |+||+++++++..++ .+++|+
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e   83 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME   83 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh-HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence            4556788999999999999976 6899999998753322 45567889999999997 999999999887655 788888


Q ss_pred             eccCCCHhhhh---hhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCC
Q 016594          144 FSSRGSVASLF---HDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPS  220 (386)
Q Consensus       144 ~~~~~~L~~~~---~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~  220 (386)
                      ++.. ++.++.   .......+++..+..++.|++.||+|||+  ..+++||||||+||+++.++.+||+|||++..+..
T Consensus        84 ~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  160 (288)
T cd06616          84 LMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD  160 (288)
T ss_pred             cccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh--cCCeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence            8764 554433   22233558999999999999999999997  14999999999999999999999999999876543


Q ss_pred             CCccccccccccccCccChhhhccC---CCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCc
Q 016594          221 QWTHHSIAPIEGTFGHLAPEYFMHG---IVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPR  297 (386)
Q Consensus       221 ~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (386)
                      ...   .....|+..|+|||++.+.   .++.++|||||||++|+|++|+.||......... ......      ...+.
T Consensus       161 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-~~~~~~------~~~~~  230 (288)
T cd06616         161 SIA---KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQ-LTQVVK------GDPPI  230 (288)
T ss_pred             CCc---cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHH-HhhhcC------CCCCc
Confidence            221   1223578899999999766   6899999999999999999999999764321111 010000      00111


Q ss_pred             cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 016594          298 LQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLE  337 (386)
Q Consensus       298 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~  337 (386)
                      .........+..+.+++.+||+.+|++|||+.+|+.+-+.
T Consensus       231 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~  270 (288)
T cd06616         231 LSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFI  270 (288)
T ss_pred             CCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhh
Confidence            1111222356779999999999999999999999998554

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=1.8e-39  Score=293.70  Aligned_cols=254  Identities=24%  Similarity=0.384  Sum_probs=200.1

Q ss_pred             CCCCCCeecccCCcEEEEEEECC--CcEEEEEEecccc--------CChHhHHHHHHHHHHHhc-cCCCceeeecceEEe
Q 016594           67 AFSSENLVGRGGYAEVYKGVLQD--GEEIAVKRLTKVV--------TDDRKEKEFLTEIGTIGH-VCHPNVLSLLGCCVD  135 (386)
Q Consensus        67 ~~~~~~~lg~G~~g~V~~~~~~~--~~~vavK~~~~~~--------~~~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~  135 (386)
                      .|++.+.||+|+||.||+|.+..  ++.+|+|.+....        ........+..|+.++.+ ++||||+++++++.+
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            47888999999999999999764  6889999876421        122344567788888865 789999999999877


Q ss_pred             Cc-eEEEEEeccCCCHhhhhhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeec
Q 016594          136 NG-LYLIFQFSSRGSVASLFHDV--NSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDF  212 (386)
Q Consensus       136 ~~-~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Df  212 (386)
                      ++ .+++|||+.+++|.+++...  ....+++..++.++.|++.||.|||+  ..+++|+||+|+||+++.++.++|+||
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~--~~~i~H~dl~~~nil~~~~~~~~l~df  158 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDF  158 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhcc--CCceeecCCCHHHEEECCCCcEEEecc
Confidence            55 89999999999999887542  33458999999999999999999995  167999999999999999999999999


Q ss_pred             CccccCCCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhccccccc
Q 016594          213 GLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEK  292 (386)
Q Consensus       213 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  292 (386)
                      |++.......   ......|+..|+|||.+.+..++.++||||||+++|+|++|..||........  ....        
T Consensus       159 g~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~--~~~~--------  225 (269)
T cd08528         159 GLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSL--ATKI--------  225 (269)
T ss_pred             cceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHH--HHHH--------
Confidence            9998764432   23345688999999999988899999999999999999999999976432211  1100        


Q ss_pred             ccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 016594          293 LVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVML  336 (386)
Q Consensus       293 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~  336 (386)
                       .............+..+.+++.+||+.||++||++.++..++.
T Consensus       226 -~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         226 -VEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             -hhccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence             0111011011123467999999999999999999999998875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=1.4e-39  Score=298.24  Aligned_cols=265  Identities=20%  Similarity=0.274  Sum_probs=198.9

Q ss_pred             cCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEEE
Q 016594           66 NAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQ  143 (386)
Q Consensus        66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~e  143 (386)
                      ++|++.+.||.|++|.||+|.++ +++.||+|.+............+.+|+.+++.++||||+++++++.++. .++|||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            46889999999999999999976 6889999998754433344466888999999999999999999998755 899999


Q ss_pred             eccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcC-CCCeEEeecCccccCCCCC
Q 016594          144 FSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTA-DFEPQISDFGLAKWLPSQW  222 (386)
Q Consensus       144 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~-~~~~kl~Dfg~a~~~~~~~  222 (386)
                      |+.+ +|.+.+.......+++..+..++.||+.||+|||+   ++++|+||+|+||+++. ++.+||+|||++.......
T Consensus        82 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~  157 (294)
T PLN00009         82 YLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHS---HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV  157 (294)
T ss_pred             cccc-cHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence            9964 78777765555557888999999999999999999   99999999999999985 5579999999997654321


Q ss_pred             ccccccccccccCccChhhhcc-CCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhccccccccc-------
Q 016594          223 THHSIAPIEGTFGHLAPEYFMH-GIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLV-------  294 (386)
Q Consensus       223 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-------  294 (386)
                        .......+++.|+|||++.+ ..++.++|||||||++|+|++|..||........................       
T Consensus       158 --~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (294)
T PLN00009        158 --RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLP  235 (294)
T ss_pred             --cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccch
Confidence              11223457889999999876 45789999999999999999999999765432110000000000000000       


Q ss_pred             ---C--CccCCC----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 016594          295 ---D--PRLQGA----YDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVML  336 (386)
Q Consensus       295 ---~--~~~~~~----~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~  336 (386)
                         .  +.....    .....+..+.+++.+||+.+|++||++.+++++-+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~  286 (294)
T PLN00009        236 DYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEY  286 (294)
T ss_pred             hhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCch
Confidence               0  000000    01123466899999999999999999999998643

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=2.1e-39  Score=293.22  Aligned_cols=252  Identities=23%  Similarity=0.356  Sum_probs=187.1

Q ss_pred             eecccCCcEEEEEEECCC---cEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEEEeccCC
Q 016594           73 LVGRGGYAEVYKGVLQDG---EEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQFSSRG  148 (386)
Q Consensus        73 ~lg~G~~g~V~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~~~~~  148 (386)
                      .||+|+||.||+|...++   ..+++|.+.... .......+.+|+.+++.++||||+++++.+.+.. .+++|||+.+|
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~   80 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANA-SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG   80 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCC-ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence            589999999999985433   345666665422 2344668899999999999999999999997655 89999999999


Q ss_pred             CHhhhhhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCcccc
Q 016594          149 SVASLFHDVN--SPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHS  226 (386)
Q Consensus       149 ~L~~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  226 (386)
                      +|.+++....  ...+++..+..++.|++.||+|||+   .+++||||||+|||++.++.++|+|||++...........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~  157 (268)
T cd05086          81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHK---HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET  157 (268)
T ss_pred             cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCeeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence            9999887542  2346777888999999999999999   9999999999999999999999999999864322211112


Q ss_pred             ccccccccCccChhhhcc-------CCCCcccchHHHHHHHHHHHh-CCCCCCCCchhhhhhhhhhhcccccccccCCcc
Q 016594          227 IAPIEGTFGHLAPEYFMH-------GIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRL  298 (386)
Q Consensus       227 ~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (386)
                      .....++..|+|||++..       ..++.++|||||||++|||++ |..||.......  ....... ........+..
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~--~~~~~~~-~~~~~~~~~~~  234 (268)
T cd05086         158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDRE--VLNHVIK-DQQVKLFKPQL  234 (268)
T ss_pred             ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHh-hcccccCCCcc
Confidence            234557889999998743       345789999999999999997 677886543211  1111111 11112222222


Q ss_pred             CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 016594          299 QGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVML  336 (386)
Q Consensus       299 ~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~  336 (386)
                      ..    .....+.+++..|| .+|++||++.+|++.|.
T Consensus       235 ~~----~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         235 EL----PYSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             CC----CCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            22    23466888999999 68999999999998763

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-39  Score=294.38  Aligned_cols=251  Identities=26%  Similarity=0.407  Sum_probs=200.5

Q ss_pred             CCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccC---CCceeeecceEEeCc-eEEE
Q 016594           67 AFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVC---HPNVLSLLGCCVDNG-LYLI  141 (386)
Q Consensus        67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~-~~lv  141 (386)
                      .|++.+.||.|+||.||+|.+. +++.||+|.+.... .......+.+|+.+++.+.   |||++++++++.++. .+++
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv   80 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT-PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWII   80 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC-CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEE
Confidence            4778899999999999999975 68999999987532 2334556788999999886   999999999987765 8999


Q ss_pred             EEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCC
Q 016594          142 FQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQ  221 (386)
Q Consensus       142 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  221 (386)
                      |||+.+++|.+++...   .+++..++.++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||++..+...
T Consensus        81 ~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~  154 (277)
T cd06917          81 MEYAEGGSVRTLMKAG---PIAEKYISVIIREVLVALKYIHK---VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQN  154 (277)
T ss_pred             EecCCCCcHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence            9999999999988643   58899999999999999999999   99999999999999999999999999999876543


Q ss_pred             CccccccccccccCccChhhhcc-CCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCC
Q 016594          222 WTHHSIAPIEGTFGHLAPEYFMH-GIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQG  300 (386)
Q Consensus       222 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (386)
                      .  .......|+..|+|||.+.+ ..++.++|+|||||++|+|++|..||.........  .      .+.....+.+..
T Consensus       155 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~--~------~~~~~~~~~~~~  224 (277)
T cd06917         155 S--SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAM--M------LIPKSKPPRLED  224 (277)
T ss_pred             c--cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhh--h------ccccCCCCCCCc
Confidence            2  12233468889999999875 45789999999999999999999999765321100  0      000000111111


Q ss_pred             CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 016594          301 AYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLE  337 (386)
Q Consensus       301 ~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~  337 (386)
                         ...+..+.+++.+||+.||++||++.+++.+-+.
T Consensus       225 ---~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~  258 (277)
T cd06917         225 ---NGYSKLLREFVAACLDEEPKERLSAEELLKSKWI  258 (277)
T ss_pred             ---ccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHh
Confidence               1145679999999999999999999999987544

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=2.1e-39  Score=294.52  Aligned_cols=252  Identities=24%  Similarity=0.390  Sum_probs=202.8

Q ss_pred             cCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEEE
Q 016594           66 NAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQ  143 (386)
Q Consensus        66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~e  143 (386)
                      +-|++.+.||.|+||.||+|.+. ++..||+|.+.... .......+.+|+.+++++.||||+++++++.++. .++|+|
T Consensus         4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   82 (277)
T cd06641           4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME   82 (277)
T ss_pred             HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEecccc-chHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEE
Confidence            34778899999999999999875 68899999876432 2334567889999999999999999999998766 899999


Q ss_pred             eccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCc
Q 016594          144 FSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWT  223 (386)
Q Consensus       144 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~  223 (386)
                      |+.+++|.+++..   ..+++..+..++.|++.|+.|||+   .+++|+||+|+||+++.++.++|+|||++..+.... 
T Consensus        83 ~~~~~~l~~~i~~---~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~-  155 (277)
T cd06641          83 YLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-  155 (277)
T ss_pred             eCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHcc---CCeecCCCCHHhEEECCCCCEEEeecccceecccch-
Confidence            9999999988764   348899999999999999999999   999999999999999999999999999987664321 


Q ss_pred             cccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCCCCC
Q 016594          224 HHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYD  303 (386)
Q Consensus       224 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (386)
                       .......++..|+|||.+.+..++.++|+|||||++|+|++|..||.........  .. .         .........
T Consensus       156 -~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~--~~-~---------~~~~~~~~~  222 (277)
T cd06641         156 -IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVL--FL-I---------PKNNPPTLE  222 (277)
T ss_pred             -hhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHH--HH-H---------hcCCCCCCC
Confidence             1123345788999999998888999999999999999999999999754321100  00 0         000111122


Q ss_pred             HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          304 VTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       304 ~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                      ...+..+.+++.+||+.+|.+||++.+++++-...
T Consensus       223 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~  257 (277)
T cd06641         223 GNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIV  257 (277)
T ss_pred             cccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHh
Confidence            23456789999999999999999999999974443

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-39  Score=297.19  Aligned_cols=261  Identities=20%  Similarity=0.302  Sum_probs=199.0

Q ss_pred             CCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEEEec
Q 016594           68 FSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQFS  145 (386)
Q Consensus        68 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~~  145 (386)
                      |++.+.||.|++|.||+|.+. +|..||+|++............+.+|+.+++.++||||+++++++.++. .++++||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            677899999999999999976 6899999998764433334456788999999999999999999997755 89999998


Q ss_pred             cCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCccc
Q 016594          146 SRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHH  225 (386)
Q Consensus       146 ~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  225 (386)
                      . ++|.+++.......+++..++.++.|++.||.|||+   ++++||||+|+||+++.++.++|+|||++..+.....  
T Consensus        81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~---~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~--  154 (283)
T cd07835          81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHS---HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR--  154 (283)
T ss_pred             C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc--
Confidence            5 589988876554568999999999999999999999   9999999999999999999999999999976543211  


Q ss_pred             cccccccccCccChhhhccC-CCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhh--hhhhhccc--------ccccc-
Q 016594          226 SIAPIEGTFGHLAPEYFMHG-IVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSW--AKPILNQG--------EIEKL-  293 (386)
Q Consensus       226 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~--~~~~~~~~--------~~~~~-  293 (386)
                      ......++..|+|||++.+. .++.++||||||+++|+|++|+.||..........  ........        .+... 
T Consensus       155 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (283)
T cd07835         155 TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYK  234 (283)
T ss_pred             ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhh
Confidence            11223468889999988764 57899999999999999999999997654321100  00000000        00000 


Q ss_pred             --cCCc---cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 016594          294 --VDPR---LQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEV  334 (386)
Q Consensus       294 --~~~~---~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~  334 (386)
                        ....   .........+..+.+++.+||+.+|++|||+.+++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  280 (283)
T cd07835         235 PTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH  280 (283)
T ss_pred             hhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence              0000   0001112234678999999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.2e-39  Score=295.79  Aligned_cols=237  Identities=22%  Similarity=0.319  Sum_probs=183.7

Q ss_pred             eecccCCcEEEEEEECC-------------------------CcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCcee
Q 016594           73 LVGRGGYAEVYKGVLQD-------------------------GEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVL  127 (386)
Q Consensus        73 ~lg~G~~g~V~~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv  127 (386)
                      .||+|+||.||+|.+..                         ...||+|++...  .......+.+|+.+++.++||||+
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~~~~~~~l~h~niv   79 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPS--HRDIALAFFETASLMSQVSHIHLA   79 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChH--HHHHHHHHHHHHHHHhcCCCCCee
Confidence            69999999999997521                         135888888642  223345688899999999999999


Q ss_pred             eecceEEeCc-eEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCC-
Q 016594          128 SLLGCCVDNG-LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADF-  205 (386)
Q Consensus       128 ~l~~~~~~~~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~-  205 (386)
                      ++++++.++. .++||||+.+++|..++... ...+++..+..++.|++.||+|||+   ++|+||||||+|||++..+ 
T Consensus        80 ~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~Nill~~~~~  155 (274)
T cd05076          80 FVHGVCVRGSENIMVEEFVEHGPLDVCLRKE-KGRVPVAWKITVAQQLASALSYLED---KNLVHGNVCAKNILLARLGL  155 (274)
T ss_pred             eEEEEEEeCCceEEEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHc---CCccCCCCCcccEEEeccCc
Confidence            9999998765 89999999999999888653 3358899999999999999999999   9999999999999997643 


Q ss_pred             ------CeEEeecCccccCCCCCccccccccccccCccChhhhcc-CCCCcccchHHHHHHHHHHH-hCCCCCCCCchhh
Q 016594          206 ------EPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMH-GIVDEKTDVFAFGVFLLEII-SGRKPVDGSHQSL  277 (386)
Q Consensus       206 ------~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell-~g~~pf~~~~~~~  277 (386)
                            .+|++|||++......      ....++..|+|||.+.+ ..++.++|||||||++|||+ +|..||.......
T Consensus       156 ~~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~  229 (274)
T cd05076         156 AEGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE  229 (274)
T ss_pred             ccCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH
Confidence                  3799999987643221      12346788999998875 56899999999999999995 6999997643321


Q ss_pred             hhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 016594          278 HSWAKPILNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVM  335 (386)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l  335 (386)
                      ....            ......  .+......+.+++.+||+.+|++||++.+|++.|
T Consensus       230 ~~~~------------~~~~~~--~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L  273 (274)
T cd05076         230 KERF------------YEKKHR--LPEPSCKELATLISQCLTYEPTQRPSFRTILRDL  273 (274)
T ss_pred             HHHH------------HHhccC--CCCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence            1100            000000  0111224689999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=1.2e-39  Score=298.23  Aligned_cols=258  Identities=28%  Similarity=0.412  Sum_probs=200.5

Q ss_pred             HHHHHhcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhcc-CCCceeeecceEEeC-
Q 016594           60 EISIATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHV-CHPNVLSLLGCCVDN-  136 (386)
Q Consensus        60 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~-  136 (386)
                      .+....++|.+.+.||.|+||.||+|... +++.+|+|++...   ......+.+|+.+++++ +||||+++++++... 
T Consensus        16 ~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~---~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~   92 (291)
T cd06639          16 SLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPI---SDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKAD   92 (291)
T ss_pred             cCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccc---ccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEecc
Confidence            33345678999999999999999999975 6889999998642   12345667899999998 799999999998642 


Q ss_pred             -----ceEEEEEeccCCCHhhhhhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEE
Q 016594          137 -----GLYLIFQFSSRGSVASLFHDV--NSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQI  209 (386)
Q Consensus       137 -----~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl  209 (386)
                           ..++++||+.+++|.+++...  ....+++..++.++.|++.||.|||+   ++++|+||||+||+++.++.+||
T Consensus        93 ~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~nili~~~~~~kl  169 (291)
T cd06639          93 KLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHN---NRIIHRDVKGNNILLTTEGGVKL  169 (291)
T ss_pred             ccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCEEE
Confidence                 379999999999999987642  23458999999999999999999999   99999999999999999999999


Q ss_pred             eecCccccCCCCCccccccccccccCccChhhhccC-----CCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhh
Q 016594          210 SDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHG-----IVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPI  284 (386)
Q Consensus       210 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~  284 (386)
                      +|||++........  ......|+..|+|||++...     .++.++|||||||++|+|++|+.||.......... . .
T Consensus       170 ~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~-~-~  245 (291)
T cd06639         170 VDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLF-K-I  245 (291)
T ss_pred             eecccchhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHH-H-H
Confidence            99999886543211  11234588899999998643     36899999999999999999999997643211100 0 0


Q ss_pred             hcccccccccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 016594          285 LNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVM  335 (386)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l  335 (386)
                       ....     .+..  ..+......+.+++.+||+.+|++||++.+++++-
T Consensus       246 -~~~~-----~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~  288 (291)
T cd06639         246 -PRNP-----PPTL--LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHP  288 (291)
T ss_pred             -hcCC-----CCCC--CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCc
Confidence             0000     0000  11122345799999999999999999999999863

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=1.5e-39  Score=300.34  Aligned_cols=267  Identities=25%  Similarity=0.324  Sum_probs=200.9

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeC---ceEE
Q 016594           65 TNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDN---GLYL  140 (386)
Q Consensus        65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~---~~~l  140 (386)
                      .++|++.+.||.|+||.||+|.++ +|+.||+|.+............+.+|+.++++++|+||+++++++.+.   ..++
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL   85 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence            467999999999999999999976 689999999875433333334567899999999999999999998754   3799


Q ss_pred             EEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCC
Q 016594          141 IFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPS  220 (386)
Q Consensus       141 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~  220 (386)
                      ||||+.+ +|.+++.... ..+++..++.++.|++.||.|||+   ++++||||||+||+++.++.+||+|||++.....
T Consensus        86 v~e~~~~-~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~  160 (309)
T cd07845          86 VMEYCEQ-DLASLLDNMP-TPFSESQVKCLMLQLLRGLQYLHE---NFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGL  160 (309)
T ss_pred             EEecCCC-CHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccceeeecCC
Confidence            9999975 7888776533 458999999999999999999999   9999999999999999999999999999987654


Q ss_pred             CCccccccccccccCccChhhhcc-CCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhh-hhhhhhcc--ccc------
Q 016594          221 QWTHHSIAPIEGTFGHLAPEYFMH-GIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHS-WAKPILNQ--GEI------  290 (386)
Q Consensus       221 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~-~~~~~~~~--~~~------  290 (386)
                      ..  .......++..|+|||.+.+ ..++.++|||||||++|+|++|..||......... ........  ...      
T Consensus       161 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (309)
T cd07845         161 PA--KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSD  238 (309)
T ss_pred             cc--CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhc
Confidence            32  11222345788999999875 55789999999999999999999999765432110 00000000  000      


Q ss_pred             ----ccc-cCCccCCCC---CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          291 ----EKL-VDPRLQGAY---DVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       291 ----~~~-~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                          ... .........   ....+..+.++|.+||+.||++|||+.+++++-+..
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~  294 (309)
T cd07845         239 LPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFK  294 (309)
T ss_pred             ccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhc
Confidence                000 000000000   011256688999999999999999999999986553

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.8e-42  Score=340.39  Aligned_cols=257  Identities=26%  Similarity=0.351  Sum_probs=211.2

Q ss_pred             HhcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEE
Q 016594           64 ATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLI  141 (386)
Q Consensus        64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv  141 (386)
                      .+-+|+.+..||.|.||.||.|... +|...|+|-+............+.+|+.++..++|||+|++||+-.+.. .++.
T Consensus      1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IF 1312 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIF 1312 (1509)
T ss_pred             ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHH
Confidence            3446888999999999999999955 7889999988765444555667889999999999999999999998765 8999


Q ss_pred             EEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCC
Q 016594          142 FQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQ  221 (386)
Q Consensus       142 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  221 (386)
                      ||||.+|+|.++++...  ..++.....+..|++.|++|||+   +|||||||||.||+|+.+|.+|++|||.|..+...
T Consensus      1313 MEyC~~GsLa~ll~~gr--i~dE~vt~vyt~qll~gla~LH~---~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~ 1387 (1509)
T KOG4645|consen 1313 MEYCEGGSLASLLEHGR--IEDEMVTRVYTKQLLEGLAYLHE---HGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNN 1387 (1509)
T ss_pred             HHHhccCcHHHHHHhcc--hhhhhHHHHHHHHHHHHHHHHHh---cCceecCCCccceeeecCCcEEeecccceeEecCc
Confidence            99999999999987543  36677777889999999999999   99999999999999999999999999999987654


Q ss_pred             Cc--cccccccccccCccChhhhccC---CCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCC
Q 016594          222 WT--HHSIAPIEGTFGHLAPEYFMHG---IVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDP  296 (386)
Q Consensus       222 ~~--~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (386)
                      ..  ........||+.|||||++.+.   ....++|||||||++.||+||+.||...+....           +...+..
T Consensus      1388 ~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~a-----------IMy~V~~ 1456 (1509)
T KOG4645|consen 1388 AQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWA-----------IMYHVAA 1456 (1509)
T ss_pred             hhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhH-----------HHhHHhc
Confidence            21  1223456799999999999864   456899999999999999999999987543321           2222233


Q ss_pred             ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 016594          297 RLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVML  336 (386)
Q Consensus       297 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~  336 (386)
                      ...+..+...+..-.+++..||..||+.|.++.+++++-.
T Consensus      1457 gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f 1496 (1509)
T KOG4645|consen 1457 GHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAF 1496 (1509)
T ss_pred             cCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhc
Confidence            3334455557788999999999999999999999998743

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=6.7e-40  Score=320.47  Aligned_cols=273  Identities=21%  Similarity=0.258  Sum_probs=189.3

Q ss_pred             HHhcCCCCCCeecccCCcEEEEEEECC--CcEEEEEEec--------------c-ccCChHhHHHHHHHHHHHhccCCCc
Q 016594           63 IATNAFSSENLVGRGGYAEVYKGVLQD--GEEIAVKRLT--------------K-VVTDDRKEKEFLTEIGTIGHVCHPN  125 (386)
Q Consensus        63 ~~~~~~~~~~~lg~G~~g~V~~~~~~~--~~~vavK~~~--------------~-~~~~~~~~~~~~~e~~~l~~l~h~n  125 (386)
                      ...++|++.+.||+|+||+||+|.++.  +..+++|.+.              + ..........+.+|+.+++.++|||
T Consensus       145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hpn  224 (501)
T PHA03210        145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHEN  224 (501)
T ss_pred             hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCC
Confidence            446789999999999999999987642  2222222111              1 1112223456789999999999999


Q ss_pred             eeeecceEEeCc-eEEEEEeccCCCHhhhhhhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeE
Q 016594          126 VLSLLGCCVDNG-LYLIFQFSSRGSVASLFHDVN---SPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILL  201 (386)
Q Consensus       126 iv~l~~~~~~~~-~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill  201 (386)
                      |+++++++.+.. .+++++++.+ +|..++....   ........+..++.|++.||.|||+   ++|+||||||+|||+
T Consensus       225 Iv~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~---~gIiHrDLKP~NILl  300 (501)
T PHA03210        225 ILKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHD---KKLIHRDIKLENIFL  300 (501)
T ss_pred             cCcEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEE
Confidence            999999998766 7788887754 6666554321   1123456778899999999999999   999999999999999


Q ss_pred             cCCCCeEEeecCccccCCCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCC-CCCCCchhh-hh
Q 016594          202 TADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRK-PVDGSHQSL-HS  279 (386)
Q Consensus       202 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~-pf~~~~~~~-~~  279 (386)
                      +.++.+||+|||++..+..... .......||..|+|||++.+..++.++|||||||++|||++|.. ||....... ..
T Consensus       301 ~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~  379 (501)
T PHA03210        301 NCDGKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQ  379 (501)
T ss_pred             CCCCCEEEEeCCCceecCcccc-cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHH
Confidence            9999999999999987654321 12234569999999999999999999999999999999999875 444322111 11


Q ss_pred             hhhhhhc----cccc-------ccccCC-cc---CCCC-----CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCC
Q 016594          280 WAKPILN----QGEI-------EKLVDP-RL---QGAY-----DVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEGD  339 (386)
Q Consensus       280 ~~~~~~~----~~~~-------~~~~~~-~~---~~~~-----~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~~  339 (386)
                      ....+..    ....       ...+.. ..   ....     ....+..+.+++.+||+.||.+|||+.++|.+-+...
T Consensus       380 ~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~  459 (501)
T PHA03210        380 LLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSA  459 (501)
T ss_pred             HHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhc
Confidence            1000000    0000       000000 00   0000     0012345778899999999999999999999866544


Q ss_pred             c
Q 016594          340 Q  340 (386)
Q Consensus       340 ~  340 (386)
                      .
T Consensus       460 ~  460 (501)
T PHA03210        460 E  460 (501)
T ss_pred             C
Confidence            3

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=3.3e-39  Score=289.49  Aligned_cols=254  Identities=26%  Similarity=0.400  Sum_probs=209.1

Q ss_pred             CCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeC--c-eEEEE
Q 016594           67 AFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDN--G-LYLIF  142 (386)
Q Consensus        67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~-~~lv~  142 (386)
                      +|++.+.||+|++|.||+|..+ +++.|++|++............+.+|+.++++++|+||+++++.+.+.  . .++++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            4778899999999999999987 689999999876554455677889999999999999999999999876  4 89999


Q ss_pred             EeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCC
Q 016594          143 QFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQW  222 (386)
Q Consensus       143 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  222 (386)
                      |++.+++|.+++....  .+++..++.++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||.+.......
T Consensus        81 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~---~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  155 (260)
T cd06606          81 EYVSGGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLHS---NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIE  155 (260)
T ss_pred             EecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEcccccEEeccccc
Confidence            9999999999987654  58999999999999999999999   999999999999999999999999999998776543


Q ss_pred             ccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCCCC
Q 016594          223 THHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAY  302 (386)
Q Consensus       223 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (386)
                      .........++..|+|||.+.+..++.++||||||+++|+|++|..||.......... .         .+.........
T Consensus       156 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~-~---------~~~~~~~~~~~  225 (260)
T cd06606         156 TGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAAL-Y---------KIGSSGEPPEI  225 (260)
T ss_pred             ccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHH-H---------hccccCCCcCC
Confidence            2112334568889999999988889999999999999999999999998765211111 0         11111111122


Q ss_pred             CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 016594          303 DVTQLNRLAFAASLCIRASPTWRPTMSEVLEVM  335 (386)
Q Consensus       303 ~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l  335 (386)
                      +...+..+.+++.+||..+|.+||++.+++.+-
T Consensus       226 ~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~  258 (260)
T cd06606         226 PEHLSEEAKDFLRKCLRRDPKKRPTADELLQHP  258 (260)
T ss_pred             CcccCHHHHHHHHHhCcCChhhCCCHHHHhhCC
Confidence            333467899999999999999999999999863

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=1.5e-39  Score=291.64  Aligned_cols=249  Identities=24%  Similarity=0.358  Sum_probs=205.6

Q ss_pred             CCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEEEe
Q 016594           67 AFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQF  144 (386)
Q Consensus        67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~  144 (386)
                      +|++.+.||.|+||.||++..+ +++.+|+|.+............+.+|+.+++.++|+||+++++++.+.. .++++||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            4788899999999999999866 6889999998765545555677889999999999999999999987655 8999999


Q ss_pred             ccCCCHhhhhhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCC
Q 016594          145 SSRGSVASLFHDVN--SPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQW  222 (386)
Q Consensus       145 ~~~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  222 (386)
                      +.+++|.+++....  ...+++..++.++.|++.||.|||+   .+++|+||+|+||+++.++.+||+|||++...... 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~---~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-  156 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVLKKN-  156 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence            99999999886532  2458999999999999999999999   99999999999999999999999999999876543 


Q ss_pred             ccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCCCC
Q 016594          223 THHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAY  302 (386)
Q Consensus       223 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (386)
                         ......++..|+|||.+.+..++.++|+||||+++|+|++|+.||...+......  .          .........
T Consensus       157 ---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~--~----------~~~~~~~~~  221 (256)
T cd08530         157 ---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRY--K----------VQRGKYPPI  221 (256)
T ss_pred             ---CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH--H----------HhcCCCCCC
Confidence               1223457889999999999999999999999999999999999997654321100  0          001111122


Q ss_pred             CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 016594          303 DVTQLNRLAFAASLCIRASPTWRPTMSEVLEV  334 (386)
Q Consensus       303 ~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~  334 (386)
                      +...+..+.+++.+||+.+|++||++.+++++
T Consensus       222 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  253 (256)
T cd08530         222 PPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS  253 (256)
T ss_pred             chhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            23456779999999999999999999999976

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=3.3e-39  Score=297.44  Aligned_cols=254  Identities=22%  Similarity=0.307  Sum_probs=197.5

Q ss_pred             cCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccC-ChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEE
Q 016594           66 NAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVT-DDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIF  142 (386)
Q Consensus        66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~  142 (386)
                      ++|++.+.||+|+||.||++... +++.||+|.+..... .......+.+|+.+++.++||||+++++.+..++ .+++|
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            46888999999999999999976 578999999875432 1233456789999999999999999999987765 89999


Q ss_pred             EeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCC
Q 016594          143 QFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQW  222 (386)
Q Consensus       143 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  222 (386)
                      ||+.+++|.+++....  .+++..+..++.|++.||.|||+   ++++||||||+||+++.++.++|+|||++.......
T Consensus        81 e~~~g~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~  155 (305)
T cd05609          81 EYVEGGDCATLLKNIG--ALPVDMARMYFAETVLALEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSL  155 (305)
T ss_pred             ecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHEEECCCCCEEEeeCCCccccCcCc
Confidence            9999999999986543  48999999999999999999999   999999999999999999999999999986421110


Q ss_pred             c-------------cccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccc
Q 016594          223 T-------------HHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGE  289 (386)
Q Consensus       223 ~-------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~  289 (386)
                      .             ........++..|+|||.+.+..++.++|+|||||++|+|++|..||.+.....  ....... . 
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~--~~~~~~~-~-  231 (305)
T cd05609         156 TTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE--LFGQVIS-D-  231 (305)
T ss_pred             cccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHh-c-
Confidence            0             001122457888999999998889999999999999999999999997643221  1111000 0 


Q ss_pred             cccccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCH---HHHHHH
Q 016594          290 IEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTM---SEVLEV  334 (386)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~---~~il~~  334 (386)
                        ....+.    .....+..+.+++.+||+.+|++||++   .+++++
T Consensus       232 --~~~~~~----~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~  273 (305)
T cd05609         232 --DIEWPE----GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH  273 (305)
T ss_pred             --ccCCCC----ccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence              000011    111245678999999999999999985   455554

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=3.4e-39  Score=295.61  Aligned_cols=252  Identities=20%  Similarity=0.343  Sum_probs=202.9

Q ss_pred             cCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEEE
Q 016594           66 NAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQ  143 (386)
Q Consensus        66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~e  143 (386)
                      ++|.+.+.||.|+||.||+|... ++..||+|.+...  .......+.+|+.+++.+.||||+++++++.... .++|+|
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e   96 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQ--QQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVME   96 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccc--cchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEe
Confidence            67899999999999999999865 6889999998642  2233466889999999999999999999997655 899999


Q ss_pred             eccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCc
Q 016594          144 FSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWT  223 (386)
Q Consensus       144 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~  223 (386)
                      |+.+++|.+++...   .+++..+..++.|++.||.|||+   ++++|+||+|+||+++.++.++|+|||++..+.....
T Consensus        97 ~~~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~---~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~  170 (293)
T cd06647          97 YLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  170 (293)
T ss_pred             cCCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHh---CCEeeccCCHHHEEEcCCCCEEEccCcceeccccccc
Confidence            99999999988643   37889999999999999999999   9999999999999999999999999999876543321


Q ss_pred             cccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCCCCC
Q 016594          224 HHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYD  303 (386)
Q Consensus       224 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (386)
                        ......+++.|+|||.+.+..++.++|+|||||++|++++|..||..........  .        ...........+
T Consensus       171 --~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~--~--------~~~~~~~~~~~~  238 (293)
T cd06647         171 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY--L--------IATNGTPELQNP  238 (293)
T ss_pred             --ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhee--e--------hhcCCCCCCCCc
Confidence              2233458889999999988889999999999999999999999997643211000  0        000111111112


Q ss_pred             HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 016594          304 VTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLE  337 (386)
Q Consensus       304 ~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~  337 (386)
                      ...+..+.+++.+||..+|++||++.+++.+-+.
T Consensus       239 ~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~  272 (293)
T cd06647         239 EKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFL  272 (293)
T ss_pred             cccCHHHHHHHHHHccCChhhCcCHHHHhcCHHH
Confidence            2345679999999999999999999999998544

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-39  Score=296.29  Aligned_cols=262  Identities=21%  Similarity=0.319  Sum_probs=196.3

Q ss_pred             cCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEEE
Q 016594           66 NAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQ  143 (386)
Q Consensus        66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~e  143 (386)
                      ++|++.+.||.|++|.||+|..+ +++.||+|.+...... .....+.+|+.++++++|+||+++++++.++. .++|||
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   83 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE-GAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE   83 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc-CCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence            57889999999999999999976 6889999998753322 22345678999999999999999999997765 899999


Q ss_pred             eccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCc
Q 016594          144 FSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWT  223 (386)
Q Consensus       144 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~  223 (386)
                      |+.+ +|.+++..... .+++..+..++.|++.||.|||+   ++++||||||+||+++.++.+||+|||++........
T Consensus        84 ~~~~-~L~~~~~~~~~-~~~~~~~~~~~~ql~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~  158 (291)
T cd07844          84 YLDT-DLKQYMDDCGG-GLSMHNVRLFLFQLLRGLAYCHQ---RRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK  158 (291)
T ss_pred             cCCC-CHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCHHHEEEcCCCCEEECccccccccCCCCc
Confidence            9985 89888765433 58899999999999999999999   9999999999999999999999999999875432211


Q ss_pred             cccccccccccCccChhhhcc-CCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhh--hhcc---cc--------
Q 016594          224 HHSIAPIEGTFGHLAPEYFMH-GIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKP--ILNQ---GE--------  289 (386)
Q Consensus       224 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~--~~~~---~~--------  289 (386)
                        ......++..|+|||++.+ ..++.++||||||+++|+|++|..||.............  ....   ..        
T Consensus       159 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (291)
T cd07844         159 --TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNP  236 (291)
T ss_pred             --cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcc
Confidence              1122346788999999875 558899999999999999999999997654211111000  0000   00        


Q ss_pred             -cccccC-----CccCCCC-CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 016594          290 -IEKLVD-----PRLQGAY-DVTQLNRLAFAASLCIRASPTWRPTMSEVLEVM  335 (386)
Q Consensus       290 -~~~~~~-----~~~~~~~-~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l  335 (386)
                       ......     ....... .......+.+++.+||+.+|++||++.+++++-
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~  289 (291)
T cd07844         237 EFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHP  289 (291)
T ss_pred             ccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCC
Confidence             000000     0000000 001125678999999999999999999998753

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=4.1e-39  Score=297.06  Aligned_cols=251  Identities=24%  Similarity=0.382  Sum_probs=199.3

Q ss_pred             cCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEecccc-CChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEE
Q 016594           66 NAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVV-TDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIF  142 (386)
Q Consensus        66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~  142 (386)
                      ..|.+.+.||.|+||.||+|... +++.||+|.+.... ........+.+|+.+++.++||||+++++++.++. .++|+
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   94 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM   94 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence            45888899999999999999976 68999999986532 22344467889999999999999999999998755 88999


Q ss_pred             EeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCC
Q 016594          143 QFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQW  222 (386)
Q Consensus       143 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  222 (386)
                      ||+.+ ++.+++.... ..+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||++...... 
T Consensus        95 e~~~g-~l~~~~~~~~-~~l~~~~~~~~~~ql~~~L~~LH~---~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~-  168 (307)
T cd06607          95 EYCLG-SASDILEVHK-KPLQEVEIAAICHGALQGLAYLHS---HERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA-  168 (307)
T ss_pred             HhhCC-CHHHHHHHcc-cCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEECCCCCEEEeecCcceecCCC-
Confidence            99874 6766665432 348999999999999999999999   99999999999999999999999999998765332 


Q ss_pred             ccccccccccccCccChhhhc---cCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccC
Q 016594          223 THHSIAPIEGTFGHLAPEYFM---HGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQ  299 (386)
Q Consensus       223 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (386)
                           ....++..|+|||++.   ...++.++||||||+++|+|++|..||.+.........  .. ..        ...
T Consensus       169 -----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~--~~-~~--------~~~  232 (307)
T cd06607         169 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH--IA-QN--------DSP  232 (307)
T ss_pred             -----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHH--Hh-cC--------CCC
Confidence                 2345788999999874   45688999999999999999999999976543211110  00 00        001


Q ss_pred             CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          300 GAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       300 ~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                      .......+..+.+++.+||+.+|++||++.+|+.+.+..
T Consensus       233 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~  271 (307)
T cd06607         233 TLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVL  271 (307)
T ss_pred             CCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhc
Confidence            111223456799999999999999999999999876544

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=2.1e-39  Score=297.19  Aligned_cols=264  Identities=19%  Similarity=0.253  Sum_probs=196.9

Q ss_pred             cCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccC-CCceeeecceEEeCc------
Q 016594           66 NAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVC-HPNVLSLLGCCVDNG------  137 (386)
Q Consensus        66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~------  137 (386)
                      ++|++.+.||.|+||.||+|.+. +++.||+|.+............+.+|+.+++.+. ||||+++++++....      
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            46889999999999999999976 6899999998764433334457788999999996 699999999886532      


Q ss_pred             eEEEEEeccCCCHhhhhhhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcC-CCCeEEeecC
Q 016594          138 LYLIFQFSSRGSVASLFHDVN---SPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTA-DFEPQISDFG  213 (386)
Q Consensus       138 ~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~-~~~~kl~Dfg  213 (386)
                      .+++|||+.+ +|.+++....   ...+++..++.++.||+.||.|||+   ++++||||+|+||+++. ++.+||+|||
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~~~nil~~~~~~~~kl~dfg  156 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK---HGVMHRDLKPQNLLVDKQKGLLKIADLG  156 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEecCCCeEEEeecc
Confidence            6899999986 7888775432   2358999999999999999999999   99999999999999998 8899999999


Q ss_pred             ccccCCCCCccccccccccccCccChhhhcc-CCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhh-hhhhcc--cc
Q 016594          214 LAKWLPSQWTHHSIAPIEGTFGHLAPEYFMH-GIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWA-KPILNQ--GE  289 (386)
Q Consensus       214 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~-~~~~~~--~~  289 (386)
                      ++..+.....  ......+++.|+|||++.+ ..++.++||||||+++|+|++|..||.+......... ......  ..
T Consensus       157 ~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (295)
T cd07837         157 LGRAFSIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQ  234 (295)
T ss_pred             cceecCCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence            9876533211  1122346888999998865 4578999999999999999999999976543211100 000000  00


Q ss_pred             ----cccccC----CccCC----CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 016594          290 ----IEKLVD----PRLQG----AYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVM  335 (386)
Q Consensus       290 ----~~~~~~----~~~~~----~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l  335 (386)
                          ......    +....    ......+..+.++|.+||..||.+||++.+++.+-
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~  292 (295)
T cd07837         235 VWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHP  292 (295)
T ss_pred             hCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCC
Confidence                000000    00000    00012356789999999999999999999999763

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=2.8e-39  Score=296.01  Aligned_cols=251  Identities=23%  Similarity=0.366  Sum_probs=199.3

Q ss_pred             CCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEEEec
Q 016594           68 FSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQFS  145 (386)
Q Consensus        68 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~~  145 (386)
                      |.....||.|+||.||++... ++..||||.+...  .......+.+|+.+++.++|+||+++++.+..++ .+++|||+
T Consensus        24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~  101 (292)
T cd06658          24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLR--KQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFL  101 (292)
T ss_pred             HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecc--hHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCC
Confidence            444567999999999999975 6889999988642  2334556889999999999999999999987655 89999999


Q ss_pred             cCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCccc
Q 016594          146 SRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHH  225 (386)
Q Consensus       146 ~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  225 (386)
                      .+++|.+++..   ..+++..+..++.|++.||.|||+   ++++||||||+||+++.++.++|+|||++........  
T Consensus       102 ~~~~L~~~~~~---~~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~--  173 (292)
T cd06658         102 EGGALTDIVTH---TRMNEEQIATVCLSVLRALSYLHN---QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP--  173 (292)
T ss_pred             CCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc--
Confidence            99999988753   238899999999999999999999   9999999999999999999999999999876543221  


Q ss_pred             cccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCCCCCHH
Q 016594          226 SIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVT  305 (386)
Q Consensus       226 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (386)
                      ......|+..|+|||.+.+..++.++||||||+++|+|++|..||.........  ..      +.....+....  ...
T Consensus       174 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~--~~------~~~~~~~~~~~--~~~  243 (292)
T cd06658         174 KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAM--RR------IRDNLPPRVKD--SHK  243 (292)
T ss_pred             cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH--HH------HHhcCCCcccc--ccc
Confidence            123345889999999998888999999999999999999999999764332110  00      00111111111  112


Q ss_pred             HHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          306 QLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       306 ~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                      .+..+.+++.+||..||.+|||+.+++++-+..
T Consensus       244 ~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~  276 (292)
T cd06658         244 VSSVLRGFLDLMLVREPSQRATAQELLQHPFLK  276 (292)
T ss_pred             cCHHHHHHHHHHccCChhHCcCHHHHhhChhhh
Confidence            345688999999999999999999999885443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=8.9e-40  Score=293.90  Aligned_cols=238  Identities=19%  Similarity=0.387  Sum_probs=185.6

Q ss_pred             CeecccCCcEEEEEEECC-C-------cEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeC-ceEEEE
Q 016594           72 NLVGRGGYAEVYKGVLQD-G-------EEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDN-GLYLIF  142 (386)
Q Consensus        72 ~~lg~G~~g~V~~~~~~~-~-------~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~  142 (386)
                      +.||.|+||.||+|..+. +       ..||+|.+...  .......+..|+.+++.+.||||+++++++..+ ..++||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   78 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS--HRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQ   78 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcch--hHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEE
Confidence            468999999999998642 2       24788876532  233445678899999999999999999999774 489999


Q ss_pred             EeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCC--------eEEeecCc
Q 016594          143 QFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFE--------PQISDFGL  214 (386)
Q Consensus       143 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~--------~kl~Dfg~  214 (386)
                      ||+.+|+|..++..... .+++..+..++.|++.||.|||+   ++|+||||||+||+++.++.        ++++|||+
T Consensus        79 e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~  154 (258)
T cd05078          79 EYVKFGSLDTYLKKNKN-LINISWKLEVAKQLAWALHFLED---KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGI  154 (258)
T ss_pred             ecCCCCcHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEEEecccccccCCCceEEeccccc
Confidence            99999999999875433 58899999999999999999999   99999999999999987765        69999998


Q ss_pred             cccCCCCCccccccccccccCccChhhhcc-CCCCcccchHHHHHHHHHHHhC-CCCCCCCchhhhhhhhhhhccccccc
Q 016594          215 AKWLPSQWTHHSIAPIEGTFGHLAPEYFMH-GIVDEKTDVFAFGVFLLEIISG-RKPVDGSHQSLHSWAKPILNQGEIEK  292 (386)
Q Consensus       215 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g-~~pf~~~~~~~~~~~~~~~~~~~~~~  292 (386)
                      +......      ....++..|+|||++.+ ..++.++|||||||++|+|++| ..||..........   ...      
T Consensus       155 ~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~---~~~------  219 (258)
T cd05078         155 SITVLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ---FYE------  219 (258)
T ss_pred             ccccCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHH---HHH------
Confidence            8654321      23457889999999986 4579999999999999999998 46665433221110   000      


Q ss_pred             ccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 016594          293 LVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVM  335 (386)
Q Consensus       293 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l  335 (386)
                         .  ....+......+.+++.+||+.+|++|||+.+|++.|
T Consensus       220 ---~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l  257 (258)
T cd05078         220 ---D--RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL  257 (258)
T ss_pred             ---c--cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence               0  0111222335689999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=2.6e-39  Score=290.13  Aligned_cols=251  Identities=24%  Similarity=0.398  Sum_probs=207.3

Q ss_pred             CCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEEEe
Q 016594           67 AFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQF  144 (386)
Q Consensus        67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~  144 (386)
                      +|.+.+.||.|+||.||++.+. ++..||+|++............+.+|+++++.++|+|++++++.+.... .++++|+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            5788899999999999999976 6889999999865555566778899999999999999999999987755 8999999


Q ss_pred             ccCCCHhhhhhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCC
Q 016594          145 SSRGSVASLFHDVN--SPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQW  222 (386)
Q Consensus       145 ~~~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  222 (386)
                      +.+++|.+++....  ...+++..+..++.+++.||.|||+   ++++|+||+|+||+++.++.++|+|||.+.......
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~---~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  157 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS---RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV  157 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence            99999999887653  3568999999999999999999999   999999999999999999999999999998765432


Q ss_pred             ccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCCCC
Q 016594          223 THHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAY  302 (386)
Q Consensus       223 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (386)
                        .......|++.|+|||.+.+..++.++|+||||+++|+|++|..||.......  ...... ..    .     ....
T Consensus       158 --~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~--~~~~~~-~~----~-----~~~~  223 (258)
T cd08215         158 --DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLE--LALKIL-KG----Q-----YPPI  223 (258)
T ss_pred             --ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHH--HHHHHh-cC----C-----CCCC
Confidence              12233468889999999988889999999999999999999999997653211  111000 00    0     1111


Q ss_pred             CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 016594          303 DVTQLNRLAFAASLCIRASPTWRPTMSEVLEV  334 (386)
Q Consensus       303 ~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~  334 (386)
                      +...+..+.+++.+||..+|++||++.+++++
T Consensus       224 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  255 (258)
T cd08215         224 PSQYSSELRNLVSSLLQKDPEERPSIAQILQS  255 (258)
T ss_pred             CCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            22345679999999999999999999999976

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=2.6e-39  Score=296.09  Aligned_cols=262  Identities=19%  Similarity=0.276  Sum_probs=195.7

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEE
Q 016594           65 TNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIF  142 (386)
Q Consensus        65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~  142 (386)
                      .++|.+.+.||+|+||.||+|... ++..||+|.+..... ......+.+|+.+++.++|+||+++++++.++. .++++
T Consensus         4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   82 (291)
T cd07870           4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE-EGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF   82 (291)
T ss_pred             cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc-CCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence            467999999999999999999975 688999999875332 223346678999999999999999999997765 88999


Q ss_pred             EeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCC
Q 016594          143 QFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQW  222 (386)
Q Consensus       143 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  222 (386)
                      ||+. +++.+.+.... ..+++..+..++.|++.||.|||+   ++++|+||||+||+++.++.++|+|||++.......
T Consensus        83 e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~  157 (291)
T cd07870          83 EYMH-TDLAQYMIQHP-GGLHPYNVRLFMFQLLRGLAYIHG---QHILHRDLKPQNLLISYLGELKLADFGLARAKSIPS  157 (291)
T ss_pred             eccc-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEEcCCCcEEEeccccccccCCCC
Confidence            9996 57766654432 347888899999999999999999   999999999999999999999999999987643321


Q ss_pred             ccccccccccccCccChhhhccC-CCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhh--c--c----------
Q 016594          223 THHSIAPIEGTFGHLAPEYFMHG-IVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPIL--N--Q----------  287 (386)
Q Consensus       223 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~--~--~----------  287 (386)
                        .......+++.|+|||++.+. .++.++|||||||++|+|++|..||...............  .  .          
T Consensus       158 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (291)
T cd07870         158 --QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKL  235 (291)
T ss_pred             --CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhc
Confidence              112234578899999998764 5788999999999999999999999865432111111000  0  0          


Q ss_pred             -cccccccCCccCCC-----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 016594          288 -GEIEKLVDPRLQGA-----YDVTQLNRLAFAASLCIRASPTWRPTMSEVLEV  334 (386)
Q Consensus       288 -~~~~~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~  334 (386)
                       ..............     ........+.+++.+|+..||++|||+.+++.+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h  288 (291)
T cd07870         236 PNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH  288 (291)
T ss_pred             ccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence             00000000000000     000124578899999999999999999999875

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=1e-39  Score=304.63  Aligned_cols=268  Identities=20%  Similarity=0.298  Sum_probs=203.6

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEe-----Cce
Q 016594           65 TNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVD-----NGL  138 (386)
Q Consensus        65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-----~~~  138 (386)
                      ..+|++.+.||.|+||.||+|... +++.||+|++............+.+|+.+++.++||||+++++++..     ...
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV   83 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence            368999999999999999999976 68999999987644444455677889999999999999999998753     237


Q ss_pred             EEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccC
Q 016594          139 YLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWL  218 (386)
Q Consensus       139 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~  218 (386)
                      +++++|+. ++|.+++...  ..+++..+..++.|++.||.|||+   ++++||||||+||+++.++.+||+|||++...
T Consensus        84 ~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~  157 (334)
T cd07855          84 YVVMDLME-SDLHHIIHSD--QPLTEEHIRYFLYQLLRGLKYIHS---ANVIHRDLKPSNLLVNEDCELRIGDFGMARGL  157 (334)
T ss_pred             EEEEehhh-hhHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEecccccceee
Confidence            89999996 5888887643  338999999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCCcc--ccccccccccCccChhhhcc-CCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhh-hhhhc--------
Q 016594          219 PSQWTH--HSIAPIEGTFGHLAPEYFMH-GIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWA-KPILN--------  286 (386)
Q Consensus       219 ~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~-~~~~~--------  286 (386)
                      ......  .......|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+......... .....        
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~  237 (334)
T cd07855         158 SSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLN  237 (334)
T ss_pred             cccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhh
Confidence            432211  11234468899999999865 5688999999999999999999999976543211000 00000        


Q ss_pred             ---ccccccccCC-ccCCCC-----CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          287 ---QGEIEKLVDP-RLQGAY-----DVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       287 ---~~~~~~~~~~-~~~~~~-----~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                         ...+...... ......     ....+..+.+++.+||+.+|++||++.+++.+.+..
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~  298 (334)
T cd07855         238 RIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLA  298 (334)
T ss_pred             hhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhh
Confidence               0000000000 000011     112357799999999999999999999999987654

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.3e-39  Score=290.45  Aligned_cols=253  Identities=22%  Similarity=0.311  Sum_probs=202.2

Q ss_pred             cCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEecccc---CChHhHHHHHHHHHHHhccCCCceeeecceEEeC---ce
Q 016594           66 NAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVV---TDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDN---GL  138 (386)
Q Consensus        66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~---~~  138 (386)
                      .+|++.+.||+|+||.||+|.+. ++..||+|.+....   ........+.+|+.++++++|+||+++++++.+.   ..
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            47899999999999999999975 68999999875421   1233456788999999999999999999998763   27


Q ss_pred             EEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccC
Q 016594          139 YLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWL  218 (386)
Q Consensus       139 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~  218 (386)
                      ++++||+.+++|.+++....  .+++..+..++.|++.||.|||+   ++++|+||||+||+++.++.++|+|||++...
T Consensus        82 ~~v~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~  156 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAYG--ALTENVTRRYTRQILQGVSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRI  156 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECcccccccc
Confidence            89999999999999887543  37889999999999999999999   99999999999999999999999999999865


Q ss_pred             CCCCc-cccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCc
Q 016594          219 PSQWT-HHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPR  297 (386)
Q Consensus       219 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (386)
                      ..... ........++..|+|||++.+..++.++|+|||||++|+|++|..||.......           .+.......
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-----------~~~~~~~~~  225 (264)
T cd06653         157 QTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMA-----------AIFKIATQP  225 (264)
T ss_pred             ccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHH-----------HHHHHHcCC
Confidence            43211 111223568899999999998889999999999999999999999997643211           011111111


Q ss_pred             cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 016594          298 LQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVM  335 (386)
Q Consensus       298 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l  335 (386)
                      .....+......+.+++.+||. +|..||++.+++.|.
T Consensus       226 ~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~  262 (264)
T cd06653         226 TKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHP  262 (264)
T ss_pred             CCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCC
Confidence            2223344556789999999999 579999999998763

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=4e-39  Score=295.26  Aligned_cols=262  Identities=16%  Similarity=0.213  Sum_probs=185.9

Q ss_pred             HHhcCCCCCCeecccCCcEEEEEEECC----CcEEEEEEeccccCChHhH---------HHHHHHHHHHhccCCCceeee
Q 016594           63 IATNAFSSENLVGRGGYAEVYKGVLQD----GEEIAVKRLTKVVTDDRKE---------KEFLTEIGTIGHVCHPNVLSL  129 (386)
Q Consensus        63 ~~~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~---------~~~~~e~~~l~~l~h~niv~l  129 (386)
                      +..++|++.+.||+|+||+||+|.+.+    +..+|+|+...........         .....+...+..+.|+||+++
T Consensus         9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~   88 (294)
T PHA02882          9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKY   88 (294)
T ss_pred             cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcE
Confidence            556789999999999999999999763    3456776543221111111         112234455667789999999


Q ss_pred             cceEEeCc-----eEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCC
Q 016594          130 LGCCVDNG-----LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTAD  204 (386)
Q Consensus       130 ~~~~~~~~-----~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~  204 (386)
                      ++++....     .+++++++.. ++.+++....  ..++..+..++.|++.||+|||+   ++|+||||||+|||++.+
T Consensus        89 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~---~~iiHrDiKp~Nill~~~  162 (294)
T PHA02882         89 YGCGSFKRCRMYYRFILLEKLVE-NTKEIFKRIK--CKNKKLIKNIMKDMLTTLEYIHE---HGISHGDIKPENIMVDGN  162 (294)
T ss_pred             EEeeeEecCCceEEEEEEehhcc-CHHHHHHhhc--cCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCC
Confidence            99875533     3455565543 5666655432  25788889999999999999999   999999999999999999


Q ss_pred             CCeEEeecCccccCCCCCcc-----ccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhh
Q 016594          205 FEPQISDFGLAKWLPSQWTH-----HSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHS  279 (386)
Q Consensus       205 ~~~kl~Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~  279 (386)
                      +.++|+|||+|..+......     .......||+.|+|||++.+..++.++|||||||++|||++|..||.+.......
T Consensus       163 ~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~  242 (294)
T PHA02882        163 NRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNL  242 (294)
T ss_pred             CcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHH
Confidence            99999999999876432111     1122346999999999999999999999999999999999999999865321110


Q ss_pred             hhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 016594          280 WAKPILNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVM  335 (386)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l  335 (386)
                      . ... ....+..+.......   ...+..+.+++..||+.+|++||++.+|++.+
T Consensus       243 ~-~~~-~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~  293 (294)
T PHA02882        243 I-HAA-KCDFIKRLHEGKIKI---KNANKFIYDFIECVTKLSYEEKPDYDALIKIF  293 (294)
T ss_pred             H-HHh-HHHHHHHhhhhhhcc---CCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence            0 000 000011111111111   12246799999999999999999999999865

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=2.4e-39  Score=294.17  Aligned_cols=249  Identities=28%  Similarity=0.344  Sum_probs=196.8

Q ss_pred             ecccCCcEEEEEEEC-CCcEEEEEEeccccCC-hHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEEEeccCCCH
Q 016594           74 VGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTD-DRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQFSSRGSV  150 (386)
Q Consensus        74 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~~~~~~L  150 (386)
                      ||+|+||+||+|..+ +|+.||+|.+...... ......+..|+.+++.++||||+++++++...+ .|+++||+.+++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            699999999999876 6889999998753222 223445678999999999999999999987655 8999999999999


Q ss_pred             hhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCcccccccc
Q 016594          151 ASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPI  230 (386)
Q Consensus       151 ~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~  230 (386)
                      .+++.......+++..+..++.|++.||.|||+   .+++||||+|+||+++.++.++|+|||++......   ......
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~---~~~~~~  154 (277)
T cd05577          81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQ---RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG---KKIKGR  154 (277)
T ss_pred             HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEccCcchhhhccC---Cccccc
Confidence            999877665669999999999999999999999   99999999999999999999999999998765432   112234


Q ss_pred             ccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCCCCCHHHHHHH
Q 016594          231 EGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQLNRL  310 (386)
Q Consensus       231 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  310 (386)
                      .++..|+|||++.+..++.++|||||||++|+|++|+.||..........        .+...... .....+...+..+
T Consensus       155 ~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~--------~~~~~~~~-~~~~~~~~~~~~~  225 (277)
T cd05577         155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKE--------ELKRRTLE-MAVEYPDKFSPEA  225 (277)
T ss_pred             cCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHH--------HHHhcccc-ccccCCccCCHHH
Confidence            57889999999988889999999999999999999999997643211000        00000000 0111222335678


Q ss_pred             HHHHHHccccCCCCCC-----CHHHHHHHHhc
Q 016594          311 AFAASLCIRASPTWRP-----TMSEVLEVMLE  337 (386)
Q Consensus       311 ~~li~~cl~~dP~~Rp-----t~~~il~~l~~  337 (386)
                      .+++.+||+.+|.+||     ++.+++.+.+.
T Consensus       226 ~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~  257 (277)
T cd05577         226 KDLCEALLQKDPEKRLGCRGGSADEVREHPLF  257 (277)
T ss_pred             HHHHHHHccCChhHccCCCcccHHHHHhChhh
Confidence            9999999999999999     77778876443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=4.2e-39  Score=295.50  Aligned_cols=251  Identities=21%  Similarity=0.313  Sum_probs=198.6

Q ss_pred             CCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEEEec
Q 016594           68 FSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQFS  145 (386)
Q Consensus        68 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~~  145 (386)
                      |.....||.|+||.||+|... +++.||+|.+....  ......+.+|+.++..+.||||+++++++..++ .++++||+
T Consensus        23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~  100 (297)
T cd06659          23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRK--QQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFL  100 (297)
T ss_pred             HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecc--cchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecC
Confidence            334557999999999999976 68999999986432  233456789999999999999999999987655 89999999


Q ss_pred             cCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCccc
Q 016594          146 SRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHH  225 (386)
Q Consensus       146 ~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  225 (386)
                      .+++|..++..   ..+++..++.++.|++.||.|||+   ++++|+||||+||+++.++.+||+|||++..+.....  
T Consensus       101 ~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~--  172 (297)
T cd06659         101 QGGALTDIVSQ---TRLNEEQIATVCESVLQALCYLHS---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--  172 (297)
T ss_pred             CCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHeEEccCCcEEEeechhHhhcccccc--
Confidence            99999987754   348899999999999999999999   9999999999999999999999999999876543321  


Q ss_pred             cccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCCCCCHH
Q 016594          226 SIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVT  305 (386)
Q Consensus       226 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (386)
                      ......|+..|+|||++.+..++.++|||||||++|+|++|+.||...........  . ...     .....  .....
T Consensus       173 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~--~-~~~-----~~~~~--~~~~~  242 (297)
T cd06659         173 KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKR--L-RDS-----PPPKL--KNAHK  242 (297)
T ss_pred             cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH--H-hcc-----CCCCc--cccCC
Confidence            22345688999999999988899999999999999999999999976432211100  0 000     00000  01112


Q ss_pred             HHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          306 QLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       306 ~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                      .+..+.+++.+||+.+|++||++.+++++-+..
T Consensus       243 ~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~  275 (297)
T cd06659         243 ISPVLRDFLERMLTREPQERATAQELLDHPFLL  275 (297)
T ss_pred             CCHHHHHHHHHHhcCCcccCcCHHHHhhChhhc
Confidence            345689999999999999999999999975443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-40  Score=286.80  Aligned_cols=262  Identities=23%  Similarity=0.326  Sum_probs=206.6

Q ss_pred             CeecccCCcEEEEEE-ECCCcEEEEEEeccccCChHhHHHHHHHHHHHhccC-CCceeeecceEEeCc-eEEEEEeccCC
Q 016594           72 NLVGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVC-HPNVLSLLGCCVDNG-LYLIFQFSSRG  148 (386)
Q Consensus        72 ~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~-~~lv~e~~~~~  148 (386)
                      +.||+|+|+.|--+. +.+|..||||++.+.  .........+|++++.+.+ |+||+.++++|+++. .|+|||-+.||
T Consensus        84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq--~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GG  161 (463)
T KOG0607|consen   84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ--PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGG  161 (463)
T ss_pred             HHhcCccceeeeeeeeeccchhhhhhhhhcC--CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCc
Confidence            579999999999988 568999999999874  3456678899999999887 999999999998866 99999999999


Q ss_pred             CHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCC---eEEeecCccccCCCC----
Q 016594          149 SVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFE---PQISDFGLAKWLPSQ----  221 (386)
Q Consensus       149 ~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~---~kl~Dfg~a~~~~~~----  221 (386)
                      +|...++....  |++.++..+..+|+.||.|||.   +||.||||||+|||.....+   +|||||.+..-....    
T Consensus       162 plLshI~~~~~--F~E~EAs~vvkdia~aLdFlH~---kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~s  236 (463)
T KOG0607|consen  162 PLLSHIQKRKH--FNEREASRVVKDIASALDFLHT---KGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCS  236 (463)
T ss_pred             hHHHHHHHhhh--ccHHHHHHHHHHHHHHHHHHhh---cCcccccCCccceeecCCCCcCceeeeccccccccccCCCCC
Confidence            99998887655  9999999999999999999999   99999999999999976654   799999886543221    


Q ss_pred             -CccccccccccccCccChhhhc-----cCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcc---ccccc
Q 016594          222 -WTHHSIAPIEGTFGHLAPEYFM-----HGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQ---GEIEK  292 (386)
Q Consensus       222 -~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~---~~~~~  292 (386)
                       .+.....+.+|+..|||||+..     ...|+.++|.||||+|+|-|++|.+||.+.-.....|..-..-.   ..+.+
T Consensus       237 pastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFe  316 (463)
T KOG0607|consen  237 PASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFE  316 (463)
T ss_pred             CCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHH
Confidence             1122334567899999999863     34689999999999999999999999988765544553322111   11112


Q ss_pred             ccCCccCCCCCH---HHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCCc
Q 016594          293 LVDPRLQGAYDV---TQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEGDQ  340 (386)
Q Consensus       293 ~~~~~~~~~~~~---~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~~~  340 (386)
                      -+..........   ..+....++++.+|..++.+|.++.+++.+.+....
T Consensus       317 sIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~  367 (463)
T KOG0607|consen  317 SIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRC  367 (463)
T ss_pred             HHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCcccccc
Confidence            222222222222   336778999999999999999999999997665543

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=4e-39  Score=290.21  Aligned_cols=247  Identities=20%  Similarity=0.294  Sum_probs=200.1

Q ss_pred             ecccCCcEEEEEEEC-CCcEEEEEEeccccC-ChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEEEeccCCCH
Q 016594           74 VGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVT-DDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQFSSRGSV  150 (386)
Q Consensus        74 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~~~~~~L  150 (386)
                      ||.|+||.||+|... +++.||+|++.+... .......+.+|+.+++.++||||+++++.+.++. .++++||+.+++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            699999999999976 588999999875332 2344567899999999999999999999987665 8999999999999


Q ss_pred             hhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCcccccccc
Q 016594          151 ASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPI  230 (386)
Q Consensus       151 ~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~  230 (386)
                      .+++.+..  .+++..+..++.|++.||.|||+   ++++|+||+|+||+++.++.++|+|||++.......   .....
T Consensus        81 ~~~l~~~~--~l~~~~~~~~~~~i~~~l~~lH~---~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~~  152 (262)
T cd05572          81 WTILRDRG--LFDEYTARFYIACVVLAFEYLHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTF  152 (262)
T ss_pred             HHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---ccccc
Confidence            99987543  38899999999999999999999   999999999999999999999999999998765432   12234


Q ss_pred             ccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCCCCCHHHHHHH
Q 016594          231 EGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQLNRL  310 (386)
Q Consensus       231 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  310 (386)
                      .++..|+|||.+.+..++.++|+||||+++|+|++|..||.............         +........++...+..+
T Consensus       153 ~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~  223 (262)
T cd05572         153 CGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYND---------ILKGNGKLEFPNYIDKAA  223 (262)
T ss_pred             cCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHH---------HhccCCCCCCCcccCHHH
Confidence            58889999999988889999999999999999999999998754211111111         111111122223336789


Q ss_pred             HHHHHHccccCCCCCCC-----HHHHHHHHhc
Q 016594          311 AFAASLCIRASPTWRPT-----MSEVLEVMLE  337 (386)
Q Consensus       311 ~~li~~cl~~dP~~Rpt-----~~~il~~l~~  337 (386)
                      .+++.+||+.+|++||+     +.+++++-+.
T Consensus       224 ~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~  255 (262)
T cd05572         224 KDLIKQLLRRNPEERLGNLKGGIKDIKKHKWF  255 (262)
T ss_pred             HHHHHHHccCChhhCcCCcccCHHHHhcChhh
Confidence            99999999999999999     8888887654

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=5.3e-39  Score=293.25  Aligned_cols=256  Identities=23%  Similarity=0.347  Sum_probs=206.3

Q ss_pred             HhcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEE
Q 016594           64 ATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLI  141 (386)
Q Consensus        64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv  141 (386)
                      ..+.|++.+.||.|++|.||+|.++ ++..|++|++.....   ....+.+|+.+++.++|+||+++++++.... .+++
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   93 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVV   93 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch---hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEE
Confidence            3456888899999999999999987 688999999875322   4567889999999999999999999997755 8999


Q ss_pred             EEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCC
Q 016594          142 FQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQ  221 (386)
Q Consensus       142 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  221 (386)
                      +||+.+++|.+++.... ..+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||++......
T Consensus        94 ~e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~---~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  169 (286)
T cd06614          94 MEYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE  169 (286)
T ss_pred             EeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCChhhEEEcCCCCEEECccchhhhhccc
Confidence            99999999999998654 358999999999999999999999   99999999999999999999999999998765432


Q ss_pred             CccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCCC
Q 016594          222 WTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGA  301 (386)
Q Consensus       222 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (386)
                      ..  ......++..|+|||.+.+..++.++|+||||+++|+|++|..||..........  .... ..       .....
T Consensus       170 ~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~--~~~~-~~-------~~~~~  237 (286)
T cd06614         170 KS--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALF--LITT-KG-------IPPLK  237 (286)
T ss_pred             hh--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHH--HHHh-cC-------CCCCc
Confidence            11  2233457889999999998889999999999999999999999997653321111  0000 00       00011


Q ss_pred             CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          302 YDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       302 ~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                      .....+..+.+++.+||+.+|.+||++.+++++....
T Consensus       238 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~  274 (286)
T cd06614         238 NPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLK  274 (286)
T ss_pred             chhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhh
Confidence            1112456799999999999999999999999875544

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=8.2e-39  Score=295.96  Aligned_cols=263  Identities=21%  Similarity=0.267  Sum_probs=195.8

Q ss_pred             CCeecccCCcEEEEEEECCCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEEEeccCCC
Q 016594           71 ENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQFSSRGS  149 (386)
Q Consensus        71 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~~~~~~  149 (386)
                      ++.+|.|+++.|+++.. +++.||||++............+.+|+.+++.++|+||+++++++.+.. .+++|||+.+++
T Consensus         7 ~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~   85 (314)
T cd08216           7 GKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS   85 (314)
T ss_pred             hHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCC
Confidence            34444444444444433 5899999999865445556778999999999999999999999997755 899999999999


Q ss_pred             HhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCc-----c
Q 016594          150 VASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWT-----H  224 (386)
Q Consensus       150 L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~-----~  224 (386)
                      |.+++.......+++..+..++.|++.||.|||+   ++|+||||||+||+++.++.+||+|||.+..+.....     .
T Consensus        86 l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~---~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~  162 (314)
T cd08216          86 CEDLLKTHFPEGLPELAIAFILKDVLNALDYIHS---KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVH  162 (314)
T ss_pred             HHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCcceEEEecCCceEEecCccceeeccccccccccc
Confidence            9999987655668999999999999999999999   9999999999999999999999999998875532211     1


Q ss_pred             ccccccccccCccChhhhcc--CCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhh------hcccc-------
Q 016594          225 HSIAPIEGTFGHLAPEYFMH--GIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPI------LNQGE-------  289 (386)
Q Consensus       225 ~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~------~~~~~-------  289 (386)
                      .......++..|+|||++.+  ..++.++|+|||||++|+|++|..||..............      .....       
T Consensus       163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (314)
T cd08216         163 DFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDS  242 (314)
T ss_pred             cccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCC
Confidence            11223457788999999876  4588999999999999999999999986543211110000      00000       


Q ss_pred             ccc----ccC----CccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 016594          290 IEK----LVD----PRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLE  337 (386)
Q Consensus       290 ~~~----~~~----~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~  337 (386)
                      ...    ...    ..............+.+++.+||..||++|||+.+++++.+.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~  298 (314)
T cd08216         243 MSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFF  298 (314)
T ss_pred             cCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchH
Confidence            000    000    001112223345678999999999999999999999998654

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=5.9e-39  Score=296.16  Aligned_cols=266  Identities=20%  Similarity=0.293  Sum_probs=196.7

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc------
Q 016594           65 TNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG------  137 (386)
Q Consensus        65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------  137 (386)
                      .++|++.+.||+|+||.||+|... +++.||||.+............+.+|+.+++++.||||+++++++....      
T Consensus        11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   90 (310)
T cd07865          11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY   90 (310)
T ss_pred             hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence            357999999999999999999976 6899999988754333333445678999999999999999999886532      


Q ss_pred             ---eEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCc
Q 016594          138 ---LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGL  214 (386)
Q Consensus       138 ---~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~  214 (386)
                         .+++|||+.+ +|.+.+.... ..+++..++.++.|++.||.|||+   ++++|+||||+||+++.++.+||+|||+
T Consensus        91 ~~~~~lv~e~~~~-~l~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~  165 (310)
T cd07865          91 KGSFYLVFEFCEH-DLAGLLSNKN-VKFTLSEIKKVMKMLLNGLYYIHR---NKILHRDMKAANILITKDGILKLADFGL  165 (310)
T ss_pred             CceEEEEEcCCCc-CHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEECCCCcEEECcCCC
Confidence               5899999875 7777765432 348999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCCcc--ccccccccccCccChhhhccC-CCCcccchHHHHHHHHHHHhCCCCCCCCchhhh-hhhhhhhc----
Q 016594          215 AKWLPSQWTH--HSIAPIEGTFGHLAPEYFMHG-IVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLH-SWAKPILN----  286 (386)
Q Consensus       215 a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~-~~~~~~~~----  286 (386)
                      +..+......  .......++..|+|||.+.+. .++.++||||||+++|+|++|..||.+...... ........    
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (310)
T cd07865         166 ARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITP  245 (310)
T ss_pred             cccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence            9876433221  112234578889999988764 478899999999999999999999976543211 00000000    


Q ss_pred             ----ccccccccCC-ccCCCC---------CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 016594          287 ----QGEIEKLVDP-RLQGAY---------DVTQLNRLAFAASLCIRASPTWRPTMSEVLEVM  335 (386)
Q Consensus       287 ----~~~~~~~~~~-~~~~~~---------~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l  335 (386)
                          ........+. ......         .......+.++|.+||..||.+|||+++++++-
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~  308 (310)
T cd07865         246 EVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHD  308 (310)
T ss_pred             hhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCC
Confidence                0000000000 000000         001134578999999999999999999999763

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=9.3e-39  Score=296.00  Aligned_cols=251  Identities=24%  Similarity=0.391  Sum_probs=198.4

Q ss_pred             CCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccC-ChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEEE
Q 016594           67 AFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVT-DDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQ  143 (386)
Q Consensus        67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~e  143 (386)
                      .|...+.||+|+||.||+|.+. ++..||+|.+..... .......+.+|+.+++.++|||++++++++.++. .+++||
T Consensus        26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  105 (317)
T cd06635          26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME  105 (317)
T ss_pred             hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence            3777889999999999999975 688999999875322 2334567889999999999999999999997765 889999


Q ss_pred             eccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCc
Q 016594          144 FSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWT  223 (386)
Q Consensus       144 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~  223 (386)
                      |+.+ +|.+++... ...+++..+..++.|++.||.|||+   ++++||||+|+||+++.++.++|+|||++......  
T Consensus       106 ~~~g-~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~---~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~--  178 (317)
T cd06635         106 YCLG-SASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA--  178 (317)
T ss_pred             CCCC-CHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcccEEECCCCCEEEecCCCccccCCc--
Confidence            9975 777766543 3348999999999999999999999   99999999999999999999999999998754322  


Q ss_pred             cccccccccccCccChhhhc---cCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCC
Q 016594          224 HHSIAPIEGTFGHLAPEYFM---HGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQG  300 (386)
Q Consensus       224 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (386)
                          ....|+..|+|||++.   ++.++.++|||||||++|+|++|..||..........           .+.......
T Consensus       179 ----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~-----------~~~~~~~~~  243 (317)
T cd06635         179 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY-----------HIAQNESPT  243 (317)
T ss_pred             ----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHH-----------HHHhccCCC
Confidence                2345888999999974   4568899999999999999999999987643211100           000001111


Q ss_pred             CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCC
Q 016594          301 AYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEGD  339 (386)
Q Consensus       301 ~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~~  339 (386)
                      ......+..+.+++.+||+.+|.+||++.+++++++...
T Consensus       244 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~  282 (317)
T cd06635         244 LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR  282 (317)
T ss_pred             CCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence            112234567999999999999999999999999876543

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=5.9e-39  Score=289.15  Aligned_cols=253  Identities=27%  Similarity=0.406  Sum_probs=205.9

Q ss_pred             cCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEEE
Q 016594           66 NAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQ  143 (386)
Q Consensus        66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~e  143 (386)
                      ++|++.+.||.|++|.||+|... +++.|++|++...... .....+.+|+..+..++|+||+++++++.... .++++|
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLE   79 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEE
Confidence            46888999999999999999987 5899999998764322 45677899999999999999999999997755 899999


Q ss_pred             eccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCc
Q 016594          144 FSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWT  223 (386)
Q Consensus       144 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~  223 (386)
                      |+.+++|.+++...  ..+++..++.++.|++.||.|||+.  .+++|+||+|+||+++.++.++|+|||.+........
T Consensus        80 ~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh~~--~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~  155 (264)
T cd06623          80 YMDGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLHTK--RHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD  155 (264)
T ss_pred             ecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhcc--CCCccCCCCHHHEEECCCCCEEEccCccceecccCCC
Confidence            99999999998764  4589999999999999999999962  6999999999999999999999999999887644322


Q ss_pred             cccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCch-hhhhhhhhhhcccccccccCCccCCCC
Q 016594          224 HHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQ-SLHSWAKPILNQGEIEKLVDPRLQGAY  302 (386)
Q Consensus       224 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (386)
                        ......++..|+|||.+.+..++.++|+||||+++|+|++|..||..... ........+.         .. .....
T Consensus       156 --~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~---------~~-~~~~~  223 (264)
T cd06623         156 --QCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAIC---------DG-PPPSL  223 (264)
T ss_pred             --cccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHh---------cC-CCCCC
Confidence              11234578899999999999999999999999999999999999976542 1111111111         11 11112


Q ss_pred             CHH-HHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 016594          303 DVT-QLNRLAFAASLCIRASPTWRPTMSEVLEVM  335 (386)
Q Consensus       303 ~~~-~~~~l~~li~~cl~~dP~~Rpt~~~il~~l  335 (386)
                      +.. .+..+.+++.+||..+|++||++.+++++-
T Consensus       224 ~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~  257 (264)
T cd06623         224 PAEEFSPEFRDFISACLQKDPKKRPSAAELLQHP  257 (264)
T ss_pred             CcccCCHHHHHHHHHHccCChhhCCCHHHHHhCH
Confidence            222 457899999999999999999999999863

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=3.4e-39  Score=301.48  Aligned_cols=266  Identities=20%  Similarity=0.286  Sum_probs=201.5

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeC------c
Q 016594           65 TNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDN------G  137 (386)
Q Consensus        65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~  137 (386)
                      .++|.+.+.||+|+||+||+|... ++..||||.+............+.+|+.+++.++|+||+++++++...      .
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            457899999999999999999975 689999999876443444456678899999999999999999988643      2


Q ss_pred             eEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCcccc
Q 016594          138 LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKW  217 (386)
Q Consensus       138 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~  217 (386)
                      .+++++|+. ++|.+++...  ..+++..+..++.|++.||.|||+   ++++||||||+||+++.++.+||+|||++..
T Consensus        84 ~~lv~e~~~-~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~  157 (337)
T cd07858          84 VYIVYELMD-TDLHQIIRSS--QTLSDDHCQYFLYQLLRGLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLART  157 (337)
T ss_pred             EEEEEeCCC-CCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECcCccccc
Confidence            789999986 5788877643  348999999999999999999999   9999999999999999999999999999986


Q ss_pred             CCCCCccccccccccccCccChhhhcc-CCCCcccchHHHHHHHHHHHhCCCCCCCCchhhh-hhhhhhh----------
Q 016594          218 LPSQWTHHSIAPIEGTFGHLAPEYFMH-GIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLH-SWAKPIL----------  285 (386)
Q Consensus       218 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~-~~~~~~~----------  285 (386)
                      .....  .......++..|+|||.+.+ ..++.++|||||||++|+|++|..||.+.+.... .......          
T Consensus       158 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (337)
T cd07858         158 TSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGF  235 (337)
T ss_pred             cCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhh
Confidence            64321  22234457889999998875 5688999999999999999999999976532100 0000000          


Q ss_pred             -ccccccccc---CCccCC---CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          286 -NQGEIEKLV---DPRLQG---AYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       286 -~~~~~~~~~---~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                       .........   ......   ......+..+.+++.+||+.+|++|||+.+++++-+..
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~  295 (337)
T cd07858         236 IRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLA  295 (337)
T ss_pred             cCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchh
Confidence             000000000   000000   00112356789999999999999999999999985443

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-39  Score=301.25  Aligned_cols=266  Identities=20%  Similarity=0.310  Sum_probs=198.7

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeC------c
Q 016594           65 TNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDN------G  137 (386)
Q Consensus        65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~  137 (386)
                      +++|++.+.||+|+||.||+|.+. +|+.||+|.+... ........+.+|+.+++.++|+||+++++++...      .
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   82 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPF-EHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND   82 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEeccc-ccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence            468999999999999999999976 6899999998642 2233455678899999999999999999987543      2


Q ss_pred             eEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCcccc
Q 016594          138 LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKW  217 (386)
Q Consensus       138 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~  217 (386)
                      .+++++++.+ +|.+++..   ..+++..+..++.|++.||.|||+   ++|+||||||+||+++.++.+||+|||++..
T Consensus        83 ~~lv~e~~~~-~l~~~~~~---~~l~~~~~~~i~~ql~~aL~~LH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~  155 (336)
T cd07849          83 VYIVQELMET-DLYKLIKT---QHLSNDHIQYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARI  155 (336)
T ss_pred             EEEEehhccc-CHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEECcccceee
Confidence            6889999875 77766643   348999999999999999999999   9999999999999999999999999999876


Q ss_pred             CCCCCccc-cccccccccCccChhhhcc-CCCCcccchHHHHHHHHHHHhCCCCCCCCchhhh-hhhhhhhccc---ccc
Q 016594          218 LPSQWTHH-SIAPIEGTFGHLAPEYFMH-GIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLH-SWAKPILNQG---EIE  291 (386)
Q Consensus       218 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~-~~~~~~~~~~---~~~  291 (386)
                      ........ ......|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+.... ..........   ...
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~  235 (336)
T cd07849         156 ADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLN  235 (336)
T ss_pred             ccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHH
Confidence            54322111 1233568899999998765 5689999999999999999999999976532110 0000000000   000


Q ss_pred             cccCCc---------cCCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          292 KLVDPR---------LQGAYD-----VTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       292 ~~~~~~---------~~~~~~-----~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                      .+....         .....+     ...+..+.+++.+||+.+|++|||+.+++++-+..
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~  296 (336)
T cd07849         236 CIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLE  296 (336)
T ss_pred             HhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCcccc
Confidence            000000         000000     11246689999999999999999999999985443

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.5e-40  Score=307.90  Aligned_cols=249  Identities=24%  Similarity=0.382  Sum_probs=198.4

Q ss_pred             CCCeecccCCcEEEEEEEC-CCcEEEEEEec--cccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc---eEEEEE
Q 016594           70 SENLVGRGGYAEVYKGVLQ-DGEEIAVKRLT--KVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG---LYLIFQ  143 (386)
Q Consensus        70 ~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~--~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~---~~lv~e  143 (386)
                      ...+||+|+|-+||+|.+. +|-.||.-.++  ...........|..|+.+|+.|+||||+++|+++.+..   ..+|.|
T Consensus        44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE  123 (632)
T KOG0584|consen   44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE  123 (632)
T ss_pred             hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence            3467999999999999976 68888755443  23344556688999999999999999999999998643   789999


Q ss_pred             eccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcC-CCCeEEeecCccccCCCCC
Q 016594          144 FSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTA-DFEPQISDFGLAKWLPSQW  222 (386)
Q Consensus       144 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~-~~~~kl~Dfg~a~~~~~~~  222 (386)
                      .+..|+|..++.+...  ++...+..|++||++||.|||+.. .+|||||||.+||+++. -|.|||+|+|+|.......
T Consensus       124 L~TSGtLr~Y~kk~~~--vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~  200 (632)
T KOG0584|consen  124 LFTSGTLREYRKKHRR--VNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH  200 (632)
T ss_pred             cccCCcHHHHHHHhcc--CCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhccc
Confidence            9999999999987665  788899999999999999999843 58999999999999984 5899999999999876543


Q ss_pred             ccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCCCC
Q 016594          223 THHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAY  302 (386)
Q Consensus       223 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (386)
                          .....|||.|||||++. ..|+..+||||||++++||+|+..||..-......+.+          ......+..+
T Consensus       201 ----aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKK----------V~SGiKP~sl  265 (632)
T KOG0584|consen  201 ----AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKK----------VTSGIKPAAL  265 (632)
T ss_pred             ----cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHH----------HHcCCCHHHh
Confidence                34467999999999987 78999999999999999999999999754332222211          1111111111


Q ss_pred             CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 016594          303 DVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLE  337 (386)
Q Consensus       303 ~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~  337 (386)
                      ..-...+++++|.+||.. .++|||+.|+|.+-..
T Consensus       266 ~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff  299 (632)
T KOG0584|consen  266 SKVKDPEVREFIEKCLAT-KSERLSAKELLKDPFF  299 (632)
T ss_pred             hccCCHHHHHHHHHHhcC-chhccCHHHHhhChhh
Confidence            111135699999999999 9999999999986433

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=4.7e-39  Score=297.70  Aligned_cols=264  Identities=23%  Similarity=0.348  Sum_probs=195.6

Q ss_pred             CCCCCCeecccCCcEEEEEEEC---CCcEEEEEEecccc-CChHhHHHHHHHHHHHhccCCCceeeecceEEeC--c-eE
Q 016594           67 AFSSENLVGRGGYAEVYKGVLQ---DGEEIAVKRLTKVV-TDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDN--G-LY  139 (386)
Q Consensus        67 ~~~~~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~-~~  139 (386)
                      .|.+.+.||+|+||.||+|..+   +++.||+|.+.... ........+.+|+.+++.++||||+++++++.+.  . .+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            4788899999999999999975   37899999988632 1122335678899999999999999999999766  3 89


Q ss_pred             EEEEeccCCCHhhhhhhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcC----CCCeEEeec
Q 016594          140 LIFQFSSRGSVASLFHDVN---SPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTA----DFEPQISDF  212 (386)
Q Consensus       140 lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~----~~~~kl~Df  212 (386)
                      +||||+.+ +|.+++....   ...+++..++.++.|++.||.|||+   ++++||||||+||+++.    ++.+||+||
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~h~dlkp~Nil~~~~~~~~~~~kl~Df  156 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHS---NWVLHRDLKPANILVMGEGPERGVVKIGDL  156 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence            99999876 6666554322   2358999999999999999999999   99999999999999999    899999999


Q ss_pred             CccccCCCCCc-cccccccccccCccChhhhcc-CCCCcccchHHHHHHHHHHHhCCCCCCCCchhhh--------hhh-
Q 016594          213 GLAKWLPSQWT-HHSIAPIEGTFGHLAPEYFMH-GIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLH--------SWA-  281 (386)
Q Consensus       213 g~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~--------~~~-  281 (386)
                      |++..+..... ........++..|+|||++.+ ..++.++|||||||++|+|++|..||.+......        ... 
T Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (316)
T cd07842         157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER  236 (316)
T ss_pred             ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence            99987644322 112234467889999998876 4578999999999999999999999986543220        000 


Q ss_pred             -hhhhc------------ccccccccCCccCCCCC---------H--HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 016594          282 -KPILN------------QGEIEKLVDPRLQGAYD---------V--TQLNRLAFAASLCIRASPTWRPTMSEVLEV  334 (386)
Q Consensus       282 -~~~~~------------~~~~~~~~~~~~~~~~~---------~--~~~~~l~~li~~cl~~dP~~Rpt~~~il~~  334 (386)
                       ...+.            ...............++         .  .....+.+++.+||+.||++|||+.+++++
T Consensus       237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~  313 (316)
T cd07842         237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH  313 (316)
T ss_pred             HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence             00000            00000000000000011         0  223568899999999999999999999976

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=9.8e-39  Score=285.21  Aligned_cols=249  Identities=27%  Similarity=0.436  Sum_probs=202.9

Q ss_pred             CCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEEEe
Q 016594           67 AFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQF  144 (386)
Q Consensus        67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~  144 (386)
                      .|.+.+.||.|++|.||+|... +++.+++|++.....  .....+.+|+.+++.+.|+||+++++++..+. .+++++|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~   78 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEF   78 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch--hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEec
Confidence            3778899999999999999986 688999999975432  35567889999999999999999999987655 8999999


Q ss_pred             ccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCcc
Q 016594          145 SSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTH  224 (386)
Q Consensus       145 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  224 (386)
                      +.+++|.+++.... ..+++..+..++.|++.||.+||+   ++++||||+|+||+++.++.++|+|||.+........ 
T Consensus        79 ~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-  153 (253)
T cd05122          79 CSGGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHS---NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-  153 (253)
T ss_pred             CCCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhc---CCEecCCCCHHHEEEccCCeEEEeecccccccccccc-
Confidence            99999999887643 458999999999999999999999   9999999999999999999999999999887654321 


Q ss_pred             ccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCCCCCH
Q 016594          225 HSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDV  304 (386)
Q Consensus       225 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (386)
                        .....++..|+|||.+.+..++.++|+||||+++|+|++|..||............   .......       .....
T Consensus       154 --~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~---~~~~~~~-------~~~~~  221 (253)
T cd05122         154 --RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKI---ATNGPPG-------LRNPE  221 (253)
T ss_pred             --ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHH---HhcCCCC-------cCccc
Confidence              23456888999999999888999999999999999999999999765321111000   0000000       01111


Q ss_pred             HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 016594          305 TQLNRLAFAASLCIRASPTWRPTMSEVLEV  334 (386)
Q Consensus       305 ~~~~~l~~li~~cl~~dP~~Rpt~~~il~~  334 (386)
                      ..+..+.+++.+||+.||++|||+.+++++
T Consensus       222 ~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~  251 (253)
T cd05122         222 KWSDEFKDFLKKCLQKNPEKRPTAEQLLKH  251 (253)
T ss_pred             ccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            125679999999999999999999999976

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=8.2e-39  Score=290.99  Aligned_cols=248  Identities=23%  Similarity=0.249  Sum_probs=190.1

Q ss_pred             eecccCCcEEEEEEEC-CCcEEEEEEeccccCC-hHhHHHHHHHHHH---HhccCCCceeeecceEEeCc-eEEEEEecc
Q 016594           73 LVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTD-DRKEKEFLTEIGT---IGHVCHPNVLSLLGCCVDNG-LYLIFQFSS  146 (386)
Q Consensus        73 ~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~---l~~l~h~niv~l~~~~~~~~-~~lv~e~~~  146 (386)
                      .||+|+||.||+|... +++.||+|.+.+.... ......+.+|..+   +....||||+.+++++..++ .++||||+.
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            4899999999999975 6889999988754322 2222333444433   33446999999999987654 899999999


Q ss_pred             CCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCcccc
Q 016594          147 RGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHS  226 (386)
Q Consensus       147 ~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  226 (386)
                      +++|.+++....  .+++..+..++.|++.||.|||+   ++++|+||||+||+++.++.++|+|||++.......    
T Consensus        81 ~~~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~----  151 (279)
T cd05633          81 GGDLHYHLSQHG--VFSEKEMRFYATEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----  151 (279)
T ss_pred             CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC----
Confidence            999998886543  48999999999999999999999   999999999999999999999999999987554321    


Q ss_pred             ccccccccCccChhhhc-cCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCCCCCHH
Q 016594          227 IAPIEGTFGHLAPEYFM-HGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVT  305 (386)
Q Consensus       227 ~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (386)
                      .....|+..|+|||.+. +..++.++|||||||++|+|++|..||...............          .......+..
T Consensus       152 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~----------~~~~~~~~~~  221 (279)
T cd05633         152 PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT----------LTVNVELPDS  221 (279)
T ss_pred             ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHh----------hcCCcCCccc
Confidence            12345899999999986 456899999999999999999999999754322111111000          0011112233


Q ss_pred             HHHHHHHHHHHccccCCCCCC-----CHHHHHHHHhcCC
Q 016594          306 QLNRLAFAASLCIRASPTWRP-----TMSEVLEVMLEGD  339 (386)
Q Consensus       306 ~~~~l~~li~~cl~~dP~~Rp-----t~~~il~~l~~~~  339 (386)
                      .+..+.+++.+||..||++||     ++++++++.+...
T Consensus       222 ~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~  260 (279)
T cd05633         222 FSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKG  260 (279)
T ss_pred             cCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccC
Confidence            457799999999999999999     6999999866544

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-38  Score=290.21  Aligned_cols=260  Identities=23%  Similarity=0.352  Sum_probs=197.1

Q ss_pred             CCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhcc---CCCceeeecceEEeCc------
Q 016594           68 FSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHV---CHPNVLSLLGCCVDNG------  137 (386)
Q Consensus        68 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~~------  137 (386)
                      |++.+.||.|+||.||+|.++ +++.||+|.+............+.+|+.+++++   .|+||+++++++....      
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            677899999999999999987 589999999975444333345566777777665   5999999999997533      


Q ss_pred             eEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCcccc
Q 016594          138 LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKW  217 (386)
Q Consensus       138 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~  217 (386)
                      .+++||++.+ +|.+++.......+++..++.++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||++..
T Consensus        81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~---~~i~h~~l~~~nili~~~~~~~l~dfg~~~~  156 (287)
T cd07838          81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHS---HRIVHRDLKPQNILVTSDGQVKIADFGLARI  156 (287)
T ss_pred             eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhEEEccCCCEEEeccCccee
Confidence            7899999875 78888876555568999999999999999999999   9999999999999999999999999999987


Q ss_pred             CCCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhh--hhhhhhhccccc-----
Q 016594          218 LPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLH--SWAKPILNQGEI-----  290 (386)
Q Consensus       218 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~--~~~~~~~~~~~~-----  290 (386)
                      +....   ......++..|+|||++.+..++.++|+|||||++|+|++|.+||........  ............     
T Consensus       157 ~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (287)
T cd07838         157 YSFEM---ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRN  233 (287)
T ss_pred             ccCCc---ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCC
Confidence            64332   12233478889999999999999999999999999999999999976542211  000000000000     


Q ss_pred             ----ccccCCccCC---CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 016594          291 ----EKLVDPRLQG---AYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEV  334 (386)
Q Consensus       291 ----~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~  334 (386)
                          ..........   .........+.+++.+||+.||++||++.+++.+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~  284 (287)
T cd07838         234 VSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH  284 (287)
T ss_pred             cccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence                0000000000   1111335678899999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=2.4e-40  Score=284.67  Aligned_cols=268  Identities=22%  Similarity=0.336  Sum_probs=199.3

Q ss_pred             cCCCCCCeecccCCcEEEEEEEC---C--CcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEe--Cce
Q 016594           66 NAFSSENLVGRGGYAEVYKGVLQ---D--GEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVD--NGL  138 (386)
Q Consensus        66 ~~~~~~~~lg~G~~g~V~~~~~~---~--~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~  138 (386)
                      ..|+....||+|+||.||+|.-+   +  ++.+|+|.++........-....+|+.+++.++||||+.+..++..  ...
T Consensus        24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v  103 (438)
T KOG0666|consen   24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV  103 (438)
T ss_pred             HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence            46889999999999999999633   2  3378999987643333334567899999999999999999999865  448


Q ss_pred             EEEEEeccCCCHhhhhhhc---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCC----CCeEEee
Q 016594          139 YLIFQFSSRGSVASLFHDV---NSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTAD----FEPQISD  211 (386)
Q Consensus       139 ~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~----~~~kl~D  211 (386)
                      +++++|++. +|..+++-.   ..+.++...+..|++||+.|+.|||+   +.|+||||||.|||+..+    |.|||+|
T Consensus       104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~---NWvlHRDLKPaNIlvmgdgperG~VKIaD  179 (438)
T KOG0666|consen  104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHS---NWVLHRDLKPANILVMGDGPERGRVKIAD  179 (438)
T ss_pred             EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhh---hheeeccCCcceEEEeccCCccCeeEeec
Confidence            999999998 676665422   33568999999999999999999999   999999999999999876    8999999


Q ss_pred             cCccccCCCCCcc-ccccccccccCccChhhhccC-CCCcccchHHHHHHHHHHHhCCCCCCCCchhhhh--------hh
Q 016594          212 FGLAKWLPSQWTH-HSIAPIEGTFGHLAPEYFMHG-IVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHS--------WA  281 (386)
Q Consensus       212 fg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~--------~~  281 (386)
                      ||+++.+...-.. ......+-|.+|.|||.+.|. -|+.+.|||+.|||+.||++-.+.|.+....+..        ..
T Consensus       180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~  259 (438)
T KOG0666|consen  180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLD  259 (438)
T ss_pred             ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHH
Confidence            9999987654322 234456789999999999985 5899999999999999999999999875432111        11


Q ss_pred             hh--hhcccccccccC------------Cc---cCCCCCH-H-------HHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 016594          282 KP--ILNQGEIEKLVD------------PR---LQGAYDV-T-------QLNRLAFAASLCIRASPTWRPTMSEVLEVML  336 (386)
Q Consensus       282 ~~--~~~~~~~~~~~~------------~~---~~~~~~~-~-------~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~  336 (386)
                      +.  ++.........+            ..   ....... .       .+....+|+.++|..||.+|.|+++.+++..
T Consensus       260 rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~y  339 (438)
T KOG0666|consen  260 RIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPY  339 (438)
T ss_pred             HHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcccc
Confidence            10  000000000000            00   0000000 0       0224788999999999999999999999854


Q ss_pred             c
Q 016594          337 E  337 (386)
Q Consensus       337 ~  337 (386)
                      .
T Consensus       340 F  340 (438)
T KOG0666|consen  340 F  340 (438)
T ss_pred             c
Confidence            3

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=5.9e-39  Score=298.51  Aligned_cols=262  Identities=22%  Similarity=0.308  Sum_probs=200.5

Q ss_pred             HHhcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeC--ceE
Q 016594           63 IATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDN--GLY  139 (386)
Q Consensus        63 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~  139 (386)
                      ..+++|++.+.||.|+||.||+|... +++.||+|.+.+..........+.+|+.+++.+.||||+++++++...  ..+
T Consensus         7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~   86 (328)
T cd07856           7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY   86 (328)
T ss_pred             ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence            45788999999999999999999976 789999998875444444556788999999999999999999998653  488


Q ss_pred             EEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCC
Q 016594          140 LIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLP  219 (386)
Q Consensus       140 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~  219 (386)
                      ++++|+ +++|..++..   ..+++..+..++.|++.||.|||+   ++++||||+|+||+++.++.++|+|||++....
T Consensus        87 lv~e~~-~~~L~~~~~~---~~~~~~~~~~~~~ql~~aL~~LH~---~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~  159 (328)
T cd07856          87 FVTELL-GTDLHRLLTS---RPLEKQFIQYFLYQILRGLKYVHS---AGVVHRDLKPSNILINENCDLKICDFGLARIQD  159 (328)
T ss_pred             EEeehh-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEeECCCCCEEeCccccccccC
Confidence            999987 5588877753   347888889999999999999999   999999999999999999999999999987543


Q ss_pred             CCCccccccccccccCccChhhhcc-CCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhh--h-----------hhhhh
Q 016594          220 SQWTHHSIAPIEGTFGHLAPEYFMH-GIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHS--W-----------AKPIL  285 (386)
Q Consensus       220 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~--~-----------~~~~~  285 (386)
                      ..     .....++..|+|||.+.+ ..++.++|||||||++|+|++|..||.........  .           .....
T Consensus       160 ~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (328)
T cd07856         160 PQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTIC  234 (328)
T ss_pred             CC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcc
Confidence            22     223457888999998766 56899999999999999999999999765431100  0           00000


Q ss_pred             cccccccccCC-ccCCCCCH-----HHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 016594          286 NQGEIEKLVDP-RLQGAYDV-----TQLNRLAFAASLCIRASPTWRPTMSEVLEVMLE  337 (386)
Q Consensus       286 ~~~~~~~~~~~-~~~~~~~~-----~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~  337 (386)
                      ... ....... ......+.     ..+..+.++|.+||+.+|++||++.+++.+-+.
T Consensus       235 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~  291 (328)
T cd07856         235 SEN-TLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYL  291 (328)
T ss_pred             chh-hHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCcc
Confidence            000 0000000 00011111     134679999999999999999999999987544

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=8.4e-39  Score=291.83  Aligned_cols=251  Identities=22%  Similarity=0.352  Sum_probs=199.5

Q ss_pred             CCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEEEe
Q 016594           67 AFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQF  144 (386)
Q Consensus        67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~  144 (386)
                      .|...+.||.|++|.||+|... +++.+++|.+...  .......+.+|+.+++.+.||||+++++++...+ .+++++|
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~   97 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLR--KQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEF   97 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEecc--chhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEec
Confidence            3455679999999999999975 6889999988632  2334556889999999999999999999987654 8999999


Q ss_pred             ccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCcc
Q 016594          145 SSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTH  224 (386)
Q Consensus       145 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  224 (386)
                      +.+++|.+++..   ..+++..+..++.|++.||+|||+   ++++||||+|+||+++.++.++|+|||.+........ 
T Consensus        98 ~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-  170 (285)
T cd06648          98 LEGGALTDIVTH---TRMNEEQIATVCLAVLKALSFLHA---QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-  170 (285)
T ss_pred             cCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChhhEEEcCCCcEEEcccccchhhccCCc-
Confidence            999999998875   348899999999999999999999   9999999999999999999999999998876543211 


Q ss_pred             ccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCCCCCH
Q 016594          225 HSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDV  304 (386)
Q Consensus       225 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (386)
                       ......|+..|+|||.+.+..++.++|||||||++|+|++|..||........  .....      ....+...  ...
T Consensus       171 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~--~~~~~------~~~~~~~~--~~~  239 (285)
T cd06648         171 -RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQA--MKRIR------DNLPPKLK--NLH  239 (285)
T ss_pred             -ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHH--HHHHH------hcCCCCCc--ccc
Confidence             12234588999999999988899999999999999999999999976432110  01000      00011111  111


Q ss_pred             HHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 016594          305 TQLNRLAFAASLCIRASPTWRPTMSEVLEVMLE  337 (386)
Q Consensus       305 ~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~  337 (386)
                      ..+..+.+++.+||+.+|++||++.+++++-+.
T Consensus       240 ~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~  272 (285)
T cd06648         240 KVSPRLRSFLDRMLVRDPAQRATAAELLNHPFL  272 (285)
T ss_pred             cCCHHHHHHHHHHcccChhhCcCHHHHccCccc
Confidence            234679999999999999999999999987443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-38  Score=290.26  Aligned_cols=261  Identities=24%  Similarity=0.321  Sum_probs=201.6

Q ss_pred             CCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEEEec
Q 016594           68 FSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQFS  145 (386)
Q Consensus        68 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~~  145 (386)
                      |.+.+.||.|++|.||+|... +++.+++|.+............+.+|+.+++.++|+||+++++++.++. .++++||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            567889999999999999976 6889999998765544455677889999999999999999999987655 89999999


Q ss_pred             cCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCccc
Q 016594          146 SRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHH  225 (386)
Q Consensus       146 ~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  225 (386)
                      .+ +|.+++.... ..+++..+..++.|++.||.|||+   ++++|+||||+||+++.++.++|+|||.+.......  .
T Consensus        81 ~~-~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--~  153 (283)
T cd05118          81 DT-DLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHS---HGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--R  153 (283)
T ss_pred             CC-CHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHHH---CCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--c
Confidence            76 7887776543 458999999999999999999999   999999999999999999999999999998775442  1


Q ss_pred             cccccccccCccChhhhccC-CCCcccchHHHHHHHHHHHhCCCCCCCCchhhhh-hhhhhhcc---cccccccC-----
Q 016594          226 SIAPIEGTFGHLAPEYFMHG-IVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHS-WAKPILNQ---GEIEKLVD-----  295 (386)
Q Consensus       226 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~-~~~~~~~~---~~~~~~~~-----  295 (386)
                      ......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...+..... ........   ........     
T Consensus       154 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (283)
T cd05118         154 PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNY  233 (283)
T ss_pred             cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhh
Confidence            22234578889999998876 7899999999999999999999999765431100 00000000   00000000     


Q ss_pred             ----Cc--c--CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 016594          296 ----PR--L--QGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVM  335 (386)
Q Consensus       296 ----~~--~--~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l  335 (386)
                          +.  .  ........+..+.++|.+||+.||.+||++.+++.+-
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~  281 (283)
T cd05118         234 KFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHP  281 (283)
T ss_pred             hhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCC
Confidence                00  0  0001123467899999999999999999999999763

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-38  Score=285.75  Aligned_cols=249  Identities=25%  Similarity=0.419  Sum_probs=205.0

Q ss_pred             CCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEEEe
Q 016594           67 AFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQF  144 (386)
Q Consensus        67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~  144 (386)
                      +|++.+.||.|++|.||+|... +++.|++|.+............+.+|+++++++.|+|++++++++.+.+ .++++++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            4788999999999999999976 5789999999875544456678899999999999999999999987755 8999999


Q ss_pred             ccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCcc
Q 016594          145 SSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTH  224 (386)
Q Consensus       145 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  224 (386)
                      +.+++|.+++...  ..+++..+..++.|++.||.|||+   .+++||||+|+||+++.++.++|+|||++........ 
T Consensus        81 ~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-  154 (254)
T cd06627          81 AENGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLHE---QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK-  154 (254)
T ss_pred             CCCCcHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEECCCCCEEEeccccceecCCCcc-
Confidence            9999999988765  458999999999999999999999   9999999999999999999999999999987754322 


Q ss_pred             ccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCCCCCH
Q 016594          225 HSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDV  304 (386)
Q Consensus       225 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (386)
                       ......++..|+|||...+..++.++||||||+++|+|++|..||.........+...   .         ......+.
T Consensus       155 -~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~---~---------~~~~~~~~  221 (254)
T cd06627         155 -DDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIV---Q---------DDHPPLPE  221 (254)
T ss_pred             -cccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHh---c---------cCCCCCCC
Confidence             1233458889999999988888999999999999999999999997644221111110   0         00111222


Q ss_pred             HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 016594          305 TQLNRLAFAASLCIRASPTWRPTMSEVLEV  334 (386)
Q Consensus       305 ~~~~~l~~li~~cl~~dP~~Rpt~~~il~~  334 (386)
                      ..+..+.+++.+||..+|++||++.+++.+
T Consensus       222 ~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~  251 (254)
T cd06627         222 GISPELKDFLMQCFQKDPNLRPTAKQLLKH  251 (254)
T ss_pred             CCCHHHHHHHHHHHhCChhhCcCHHHHhcC
Confidence            335679999999999999999999999864

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=1.1e-38  Score=293.27  Aligned_cols=266  Identities=22%  Similarity=0.305  Sum_probs=199.8

Q ss_pred             HHHhcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeC----
Q 016594           62 SIATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDN----  136 (386)
Q Consensus        62 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~----  136 (386)
                      +...++|++.+.||.|+||.||+|.++ +++.||+|.+............+.+|+.+++.++||||+++++++.+.    
T Consensus         3 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~   82 (302)
T cd07864           3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDAL   82 (302)
T ss_pred             hhhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhh
Confidence            356678999999999999999999986 588999999876443334445678899999999999999999988643    


Q ss_pred             -------ceEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEE
Q 016594          137 -------GLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQI  209 (386)
Q Consensus       137 -------~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl  209 (386)
                             ..++++||+.+ ++...+... ...+++..+..++.|++.||+|||+   .+|+|+||||+||+++.++.+||
T Consensus        83 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~kl  157 (302)
T cd07864          83 DFKKDKGAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCHK---KNFLHRDIKCSNILLNNKGQIKL  157 (302)
T ss_pred             hccccCCcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCcEEe
Confidence                   37899999986 666666543 3358999999999999999999999   99999999999999999999999


Q ss_pred             eecCccccCCCCCccccccccccccCccChhhhcc-CCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhh-hhhhhhcc
Q 016594          210 SDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMH-GIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHS-WAKPILNQ  287 (386)
Q Consensus       210 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~-~~~~~~~~  287 (386)
                      +|||++..+..... .......++..|+|||.+.+ ..++.++|||||||++|+|++|++||......... ........
T Consensus       158 ~dfg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~  236 (302)
T cd07864         158 ADFGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGS  236 (302)
T ss_pred             CcccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Confidence            99999987644321 11122346778999998865 45789999999999999999999999764321110 00000000


Q ss_pred             cc---cccc--------cCC------ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 016594          288 GE---IEKL--------VDP------RLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEV  334 (386)
Q Consensus       288 ~~---~~~~--------~~~------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~  334 (386)
                      ..   ...+        .+.      ...... ...+..+.+++.+||+.+|.+||++.+++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  299 (302)
T cd07864         237 PCPAVWPDVIKLPYFNTMKPKKQYRRRLREEF-SFIPTPALDLLDHMLTLDPSKRCTAEEALNS  299 (302)
T ss_pred             CChhhcccccccccccccccccccccchhhhc-CCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            00   0000        000      000000 1125679999999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=6.8e-39  Score=299.47  Aligned_cols=265  Identities=22%  Similarity=0.308  Sum_probs=200.5

Q ss_pred             HhcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhcc-CCCceeeecceEEeC---ce
Q 016594           64 ATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHV-CHPNVLSLLGCCVDN---GL  138 (386)
Q Consensus        64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~---~~  138 (386)
                      ..++|++.+.||.|+||.||+|.+. ++..||+|.+............+.+|+.+++++ +||||+++++++...   ..
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~   84 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI   84 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence            4567899999999999999999976 688999998865434444455677899999999 999999999998643   37


Q ss_pred             EEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccC
Q 016594          139 YLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWL  218 (386)
Q Consensus       139 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~  218 (386)
                      ++|+||+.+ +|..++...   .+++..+..++.|++.||.|||+   ++|+|+||||+||+++.++.+||+|||++..+
T Consensus        85 ~lv~e~~~~-~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~---~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~  157 (337)
T cd07852          85 YLVFEYMET-DLHAVIRAN---ILEDVHKRYIMYQLLKALKYIHS---GNVIHRDLKPSNILLNSDCRVKLADFGLARSL  157 (337)
T ss_pred             EEEeccccc-CHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccchhcc
Confidence            999999975 888877643   57888999999999999999999   99999999999999999999999999999876


Q ss_pred             CCCCcc---ccccccccccCccChhhhcc-CCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhh-hhhhhh--------
Q 016594          219 PSQWTH---HSIAPIEGTFGHLAPEYFMH-GIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHS-WAKPIL--------  285 (386)
Q Consensus       219 ~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~-~~~~~~--------  285 (386)
                      ......   .......|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||.+....... ......        
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  237 (337)
T cd07852         158 SELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDI  237 (337)
T ss_pred             ccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence            443221   12234568899999998765 55789999999999999999999999764322110 000000        


Q ss_pred             ---cccccccccC----CccC--CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 016594          286 ---NQGEIEKLVD----PRLQ--GAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVM  335 (386)
Q Consensus       286 ---~~~~~~~~~~----~~~~--~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l  335 (386)
                         .......+..    ....  .......+..+.+++.+||+.+|++|||+.+++++-
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~  296 (337)
T cd07852         238 ESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHP  296 (337)
T ss_pred             HHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhCh
Confidence               0000000000    0000  000111356789999999999999999999999873

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.6e-38  Score=297.77  Aligned_cols=270  Identities=20%  Similarity=0.284  Sum_probs=202.2

Q ss_pred             HHHHHHhcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeC-
Q 016594           59 EEISIATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDN-  136 (386)
Q Consensus        59 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-  136 (386)
                      ..+....++|.+.+.||+|+||.||+|... +++.||+|++............+.+|+.++++++||||+++++++... 
T Consensus        10 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~   89 (345)
T cd07877          10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR   89 (345)
T ss_pred             HHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecc
Confidence            445567789999999999999999999865 688999999876443444456788999999999999999999988542 


Q ss_pred             -----c-eEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEe
Q 016594          137 -----G-LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQIS  210 (386)
Q Consensus       137 -----~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~  210 (386)
                           . .++++++ .+++|.+++..   ..+++..+..++.|++.||+|||+   ++++||||||+||+++.++.+||+
T Consensus        90 ~~~~~~~~~lv~~~-~~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kl~  162 (345)
T cd07877          90 SLEEFNDVYLVTHL-MGADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKIL  162 (345)
T ss_pred             cccccccEEEEehh-cccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEcCCCCEEEe
Confidence                 1 4556655 47788887753   248999999999999999999999   999999999999999999999999


Q ss_pred             ecCccccCCCCCccccccccccccCccChhhhcc-CCCCcccchHHHHHHHHHHHhCCCCCCCCchhhh--hhhhhh---
Q 016594          211 DFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMH-GIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLH--SWAKPI---  284 (386)
Q Consensus       211 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~--~~~~~~---  284 (386)
                      |||++......     .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||........  ......   
T Consensus       163 dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  237 (345)
T cd07877         163 DFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP  237 (345)
T ss_pred             ccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence            99998764322     223457889999999876 5688999999999999999999999975432110  000000   


Q ss_pred             -------hcccccc---cccCCccCCCC---CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCCc
Q 016594          285 -------LNQGEIE---KLVDPRLQGAY---DVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEGDQ  340 (386)
Q Consensus       285 -------~~~~~~~---~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~~~  340 (386)
                             .......   ..........+   ....+..+.+++.+||+.||.+||++.+++++-+....
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~  306 (345)
T cd07877         238 GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY  306 (345)
T ss_pred             CHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhc
Confidence                   0000000   00000000000   01124568999999999999999999999998765543

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=1.8e-38  Score=288.98  Aligned_cols=258  Identities=22%  Similarity=0.266  Sum_probs=193.5

Q ss_pred             CCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccC-CCceeeecceEEeC--c-eEEEE
Q 016594           68 FSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVC-HPNVLSLLGCCVDN--G-LYLIF  142 (386)
Q Consensus        68 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~--~-~~lv~  142 (386)
                      |++.+.||+|+||.||+|... +++.||+|.+....... ......+|+.++.++. |+||+++++++.++  + .++++
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~   79 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSL-EQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVF   79 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCc-hhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEE
Confidence            677889999999999999975 68899999987643322 2334567899998886 99999999999765  4 89999


Q ss_pred             EeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCC
Q 016594          143 QFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQW  222 (386)
Q Consensus       143 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  222 (386)
                      ||+.+ +|.+.+.... ..+++..++.++.|++.||.|||+   .+++||||+|+||+++. +.+||+|||++..+....
T Consensus        80 e~~~~-~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~  153 (282)
T cd07831          80 ELMDM-NLYELIKGRK-RPLPEKRVKSYMYQLLKSLDHMHR---NGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKP  153 (282)
T ss_pred             ecCCc-cHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence            99975 7777765433 358999999999999999999999   99999999999999999 999999999998764332


Q ss_pred             ccccccccccccCccChhhhcc-CCCCcccchHHHHHHHHHHHhCCCCCCCCchhhh-hhhhhhh-----------cccc
Q 016594          223 THHSIAPIEGTFGHLAPEYFMH-GIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLH-SWAKPIL-----------NQGE  289 (386)
Q Consensus       223 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~-~~~~~~~-----------~~~~  289 (386)
                      .   .....++..|+|||++.. ..++.++|||||||++|+|++|..||.+.+.... .......           ....
T Consensus       154 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (282)
T cd07831         154 P---YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSR  230 (282)
T ss_pred             C---cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccc
Confidence            1   223457889999997654 5578999999999999999999999976543110 0000000           0000


Q ss_pred             cccccCCc-cC---CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 016594          290 IEKLVDPR-LQ---GAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVM  335 (386)
Q Consensus       290 ~~~~~~~~-~~---~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l  335 (386)
                      ......+. ..   .......+..+.+++.+||+.+|++||++.+++++-
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~  280 (282)
T cd07831         231 HMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHP  280 (282)
T ss_pred             cccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCC
Confidence            00000000 00   000113467899999999999999999999999863

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-39  Score=257.28  Aligned_cols=264  Identities=20%  Similarity=0.300  Sum_probs=207.8

Q ss_pred             CCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEEEe
Q 016594           67 AFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQF  144 (386)
Q Consensus        67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~  144 (386)
                      +|...++||+|.||+||+|+.+ +++-||+|.+.....++......++|+.+++.++|.|||+++++...+. +.+|+||
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~   82 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence            4556788999999999999965 6889999999887777777788999999999999999999999986654 8999999


Q ss_pred             ccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCcc
Q 016594          145 SSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTH  224 (386)
Q Consensus       145 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  224 (386)
                      |.. +|..++...++ .+....+..++.|++.||.++|+   +++.||||||+|+|++.+|.+||+|||+++.++.... 
T Consensus        83 cdq-dlkkyfdslng-~~d~~~~rsfmlqllrgl~fchs---hnvlhrdlkpqnllin~ngelkladfglarafgipvr-  156 (292)
T KOG0662|consen   83 CDQ-DLKKYFDSLNG-DLDPEIVRSFMLQLLRGLGFCHS---HNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR-  156 (292)
T ss_pred             hhH-HHHHHHHhcCC-cCCHHHHHHHHHHHHhhhhhhhh---hhhhhccCCcceEEeccCCcEEecccchhhhcCCceE-
Confidence            977 78888876554 48889999999999999999999   9999999999999999999999999999998765421 


Q ss_pred             ccccccccccCccChhhhccCC-CCcccchHHHHHHHHHHHh-CCCCCCCCchhhhhhhhhhhcc--------ccccccc
Q 016594          225 HSIAPIEGTFGHLAPEYFMHGI-VDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQ--------GEIEKLV  294 (386)
Q Consensus       225 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~--------~~~~~~~  294 (386)
                       .....+-|.+|.+|.++.+.+ |+...|+||.|||+.|+.. |.+.|.+.+.... ..+.+...        ..+.++.
T Consensus       157 -cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddq-lkrif~~lg~p~ed~wps~t~lp  234 (292)
T KOG0662|consen  157 -CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ-LKRIFRLLGTPTEDQWPSMTKLP  234 (292)
T ss_pred             -eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHH-HHHHHHHhCCCccccCCccccCC
Confidence             223345789999999998855 8999999999999999997 8888988754321 11111111        1122233


Q ss_pred             CCccCCCCCHH---------HHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          295 DPRLQGAYDVT---------QLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       295 ~~~~~~~~~~~---------~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                      +-...+.++..         ....-++++...|.-+|.+|.+++..+++....
T Consensus       235 dyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~  287 (292)
T KOG0662|consen  235 DYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFS  287 (292)
T ss_pred             CCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCcccc
Confidence            32222222221         122357889999999999999999999875443

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=1.8e-38  Score=288.50  Aligned_cols=252  Identities=24%  Similarity=0.399  Sum_probs=204.5

Q ss_pred             cCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEecccc-CChHhHHHHHHHHHHHhccC-CCceeeecceEEeCc-eEEE
Q 016594           66 NAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVV-TDDRKEKEFLTEIGTIGHVC-HPNVLSLLGCCVDNG-LYLI  141 (386)
Q Consensus        66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~-~~lv  141 (386)
                      ++|.+.+.||.|+||.||+|... +++.||+|++.+.. ........+.+|+.+++++. ||||+++++++.+++ .+++
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            47889999999999999999976 68999999987532 22344567889999999999 999999999987655 8999


Q ss_pred             EEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCC
Q 016594          142 FQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQ  221 (386)
Q Consensus       142 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  221 (386)
                      ||++.+++|.+++....  .+++..++.++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||++......
T Consensus        81 ~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~ql~~~l~~Lh~---~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~  155 (280)
T cd05581          81 LEYAPNGELLQYIRKYG--SLDEKCTRFYAAEILLALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPN  155 (280)
T ss_pred             EcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEecCCccccccCCc
Confidence            99999999999987643  49999999999999999999999   99999999999999999999999999998876543


Q ss_pred             Ccc------------------ccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhh
Q 016594          222 WTH------------------HSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKP  283 (386)
Q Consensus       222 ~~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~  283 (386)
                      ...                  .......++..|+|||.+.+..++.++||||||++++++++|..||........ . . 
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-~-~-  232 (280)
T cd05581         156 SSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLT-F-Q-  232 (280)
T ss_pred             cccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHH-H-H-
Confidence            211                  122334578899999999888899999999999999999999999986542110 0 0 


Q ss_pred             hhcccccccccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCH----HHHHHHH
Q 016594          284 ILNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTM----SEVLEVM  335 (386)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~----~~il~~l  335 (386)
                              ....  .....+...+..+.+++.+||+.+|.+||++    .+++++.
T Consensus       233 --------~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~  278 (280)
T cd05581         233 --------KILK--LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHP  278 (280)
T ss_pred             --------HHHh--cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCC
Confidence                    0000  1111222335679999999999999999999    8888753

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-38  Score=289.40  Aligned_cols=262  Identities=22%  Similarity=0.328  Sum_probs=198.9

Q ss_pred             CCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeC---ceEEEEE
Q 016594           68 FSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDN---GLYLIFQ  143 (386)
Q Consensus        68 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~---~~~lv~e  143 (386)
                      |++.+.||.|+||.||+|.+. +++.+|+|.+............+.+|+.+++.+.|+|++++++++.+.   ..+++++
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            667889999999999999987 588999999986543344456788999999999999999999999766   4899999


Q ss_pred             eccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCc
Q 016594          144 FSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWT  223 (386)
Q Consensus       144 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~  223 (386)
                      |+.+ +|.+++.... ..+++..++.++.|++.||+|||+   .+++|+||+|+||+++.++.++|+|||++........
T Consensus        81 ~~~~-~l~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~---~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~  155 (287)
T cd07840          81 YMDH-DLTGLLDSPE-VKFTESQIKCYMKQLLEGLQYLHS---NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS  155 (287)
T ss_pred             cccc-cHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc
Confidence            9975 8888776542 358999999999999999999999   9999999999999999999999999999987654321


Q ss_pred             cccccccccccCccChhhhcc-CCCCcccchHHHHHHHHHHHhCCCCCCCCchhhh-hhhhhhhc---ccc---cccc--
Q 016594          224 HHSIAPIEGTFGHLAPEYFMH-GIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLH-SWAKPILN---QGE---IEKL--  293 (386)
Q Consensus       224 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~-~~~~~~~~---~~~---~~~~--  293 (386)
                       .......++..|+|||.+.+ ..++.++||||||+++|+|++|..||........ ........   ...   ...+  
T Consensus       156 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (287)
T cd07840         156 -ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPW  234 (287)
T ss_pred             -ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchh
Confidence             11223346788999998765 4578999999999999999999999976543211 00000000   000   0000  


Q ss_pred             ---cCC------ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 016594          294 ---VDP------RLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVM  335 (386)
Q Consensus       294 ---~~~------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l  335 (386)
                         ..+      .+.......++..+.+++.+||+.+|.+||++.+++++-
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~  285 (287)
T cd07840         235 FENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHE  285 (287)
T ss_pred             hhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCc
Confidence               000      000000111256789999999999999999999999763

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=2.4e-38  Score=288.55  Aligned_cols=261  Identities=19%  Similarity=0.303  Sum_probs=197.3

Q ss_pred             CCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEEEe
Q 016594           67 AFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQF  144 (386)
Q Consensus        67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~  144 (386)
                      +|++.+.||.|++|.||+|++. +|..||+|.+..... ......+.+|+.++++++|+||+++++++.+.+ .++++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   79 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE-EGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEY   79 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc-ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEec
Confidence            5888999999999999999986 688999999875432 223456778999999999999999999998765 8999999


Q ss_pred             ccCCCHhhhhhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCc
Q 016594          145 SSRGSVASLFHDVN-SPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWT  223 (386)
Q Consensus       145 ~~~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~  223 (386)
                      +.+ +|.+++.... ...+++..+..++.|++.||.|||+   .+++||||||+||+++.++.++|+|||++........
T Consensus        80 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~  155 (284)
T cd07836          80 MDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE---NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN  155 (284)
T ss_pred             CCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc
Confidence            986 7888776543 2458999999999999999999999   9999999999999999999999999999976543211


Q ss_pred             cccccccccccCccChhhhcc-CCCCcccchHHHHHHHHHHHhCCCCCCCCchhhh-hhhhhhhc---cc------cccc
Q 016594          224 HHSIAPIEGTFGHLAPEYFMH-GIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLH-SWAKPILN---QG------EIEK  292 (386)
Q Consensus       224 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~-~~~~~~~~---~~------~~~~  292 (386)
                        ......++..|+|||++.+ ..++.++|||||||++|+|++|..||.+...... ........   ..      ....
T Consensus       156 --~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (284)
T cd07836         156 --TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPE  233 (284)
T ss_pred             --ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCch
Confidence              1223457889999999866 4578999999999999999999999976542110 00000000   00      0000


Q ss_pred             ccCCccC------CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 016594          293 LVDPRLQ------GAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEV  334 (386)
Q Consensus       293 ~~~~~~~------~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~  334 (386)
                      .......      .......+..+.+++.+||+.||.+||++.+++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~  281 (284)
T cd07836         234 YKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH  281 (284)
T ss_pred             hcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            0000000      00111234678899999999999999999999975

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.1e-38  Score=296.65  Aligned_cols=261  Identities=21%  Similarity=0.298  Sum_probs=199.4

Q ss_pred             HhcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-----
Q 016594           64 ATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-----  137 (386)
Q Consensus        64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----  137 (386)
                      ..++|++.+.||.|+||.||+|... ++..||||++............+.+|+.+++.++||||+++++++..+.     
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07880          13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF   92 (343)
T ss_pred             cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence            5678999999999999999999965 6899999998754444444567889999999999999999999986532     


Q ss_pred             --eEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCcc
Q 016594          138 --LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLA  215 (386)
Q Consensus       138 --~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a  215 (386)
                        .+++++++ +++|.+++..   ..+++..++.++.|++.||.|||+   .+|+||||||+||+++.++.++|+|||++
T Consensus        93 ~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~al~~LH~---~gi~H~dlkp~Nill~~~~~~kl~dfg~~  165 (343)
T cd07880          93 HDFYLVMPFM-GTDLGKLMKH---EKLSEDRIQFLVYQMLKGLKYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLA  165 (343)
T ss_pred             ceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccc
Confidence              48899988 6788887753   348999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCCccccccccccccCccChhhhcc-CCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhh---------
Q 016594          216 KWLPSQWTHHSIAPIEGTFGHLAPEYFMH-GIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPIL---------  285 (386)
Q Consensus       216 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~---------  285 (386)
                      ......     .....+++.|+|||.+.+ ..++.++|+|||||++|+|++|..||.+...... ......         
T Consensus       166 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~  239 (343)
T cd07880         166 RQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQ-LMEIMKVTGTPSKEF  239 (343)
T ss_pred             cccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhcCCCCHHH
Confidence            765432     223457889999999876 4588999999999999999999999986542110 000000         


Q ss_pred             ----cccccccccC---CccCC---CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 016594          286 ----NQGEIEKLVD---PRLQG---AYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLE  337 (386)
Q Consensus       286 ----~~~~~~~~~~---~~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~  337 (386)
                          ..........   .....   ......+..+.+++.+||+.||++|||+.+++.+-+.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~  301 (343)
T cd07880         240 VQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYF  301 (343)
T ss_pred             HHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccH
Confidence                0000000000   00000   0011234568899999999999999999999987443

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-39  Score=304.38  Aligned_cols=202  Identities=26%  Similarity=0.401  Sum_probs=174.7

Q ss_pred             CCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeC-------ce
Q 016594           67 AFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDN-------GL  138 (386)
Q Consensus        67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-------~~  138 (386)
                      .|...+.||+|+||.||+|+++ +|+.||||.++... .........+|+++|++++|+|||+++++-.+.       ..
T Consensus        14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~-~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~   92 (732)
T KOG4250|consen   14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES-SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLP   92 (732)
T ss_pred             ceeehhhhcCCccceeeeecccccccchhHHhhhhhc-ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccc
Confidence            3455678999999999999976 79999999998643 344556778999999999999999999987543       26


Q ss_pred             EEEEEeccCCCHhhhhhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEc--CCC--CeEEeecC
Q 016594          139 YLIFQFSSRGSVASLFHDV-NSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLT--ADF--EPQISDFG  213 (386)
Q Consensus       139 ~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~--~~~--~~kl~Dfg  213 (386)
                      .++||||.+|+|...+++- +..++++.+.+.+..+++.||.|||.   ++|+||||||.||++-  .+|  ..||+|||
T Consensus        93 vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrE---n~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG  169 (732)
T KOG4250|consen   93 VLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRE---NGIVHRDLKPGNIVLQIGEDGQSIYKLTDFG  169 (732)
T ss_pred             eEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHH---cCceeccCCCCcEEEeecCCCceEEeeeccc
Confidence            8999999999999998754 44679999999999999999999999   9999999999999984  334  37999999


Q ss_pred             ccccCCCCCccccccccccccCccChhhhcc-CCCCcccchHHHHHHHHHHHhCCCCCCCCch
Q 016594          214 LAKWLPSQWTHHSIAPIEGTFGHLAPEYFMH-GIVDEKTDVFAFGVFLLEIISGRKPVDGSHQ  275 (386)
Q Consensus       214 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~  275 (386)
                      .|+.+++..   ...+++||..|.+||++.. +.|+..+|.|||||++|+.+||..||-....
T Consensus       170 ~Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~  229 (732)
T KOG4250|consen  170 AARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGG  229 (732)
T ss_pred             ccccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCC
Confidence            999987653   6678889999999999984 8899999999999999999999999975443

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.4e-38  Score=296.58  Aligned_cols=266  Identities=21%  Similarity=0.287  Sum_probs=204.2

Q ss_pred             CCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeC------ceE
Q 016594           67 AFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDN------GLY  139 (386)
Q Consensus        67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~  139 (386)
                      +|++.+.||.|+||.||+|... +++.||+|.+............+.+|+.+++.++|+||+++++++...      ..+
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            5888999999999999999976 589999999886544455567789999999999999999999998664      378


Q ss_pred             EEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCC
Q 016594          140 LIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLP  219 (386)
Q Consensus       140 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~  219 (386)
                      ++|+|+.+ +|.+++....  .+++..++.++.|++.||.|||+   ++++||||||+|||++.++.++|+|||++....
T Consensus        81 lv~e~~~~-~l~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~---~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~  154 (330)
T cd07834          81 IVTELMET-DLHKVIKSPQ--PLTDDHIQYFLYQILRGLKYLHS---ANVIHRDLKPSNILVNSNCDLKICDFGLARGVD  154 (330)
T ss_pred             EEecchhh-hHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccCceEeec
Confidence            99999884 7888876533  58999999999999999999999   999999999999999999999999999998765


Q ss_pred             CCCcc-ccccccccccCccChhhhccC-CCCcccchHHHHHHHHHHHhCCCCCCCCchhhhh-hhhhhh-----------
Q 016594          220 SQWTH-HSIAPIEGTFGHLAPEYFMHG-IVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHS-WAKPIL-----------  285 (386)
Q Consensus       220 ~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~-~~~~~~-----------  285 (386)
                      ..... .......++..|+|||.+.+. .++.++|+||||+++|+|++|.+||.+....... ......           
T Consensus       155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  234 (330)
T cd07834         155 PDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFI  234 (330)
T ss_pred             ccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhc
Confidence            43210 112334578899999999887 7899999999999999999999999775431100 000000           


Q ss_pred             cccccccccCC-ccCCC-----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          286 NQGEIEKLVDP-RLQGA-----YDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       286 ~~~~~~~~~~~-~~~~~-----~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                      ........+.. .....     .....+..+.+++.+||+.+|.+||++.+++.+.+..
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~  293 (330)
T cd07834         235 TSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLA  293 (330)
T ss_pred             cccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHH
Confidence            00000000000 00000     0111356789999999999999999999999985443

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=6e-38  Score=283.46  Aligned_cols=247  Identities=18%  Similarity=0.190  Sum_probs=190.9

Q ss_pred             HHHhcCCCCCCee--cccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhcc-CCCceeeecceEEeCc
Q 016594           62 SIATNAFSSENLV--GRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHV-CHPNVLSLLGCCVDNG  137 (386)
Q Consensus        62 ~~~~~~~~~~~~l--g~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~  137 (386)
                      ....++|.+.+.+  |.|+||.||++..+ ++..+|+|.+........       |+.....+ +||||+++++++...+
T Consensus        10 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-------e~~~~~~~~~h~~iv~~~~~~~~~~   82 (267)
T PHA03390         10 VQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-------EPMVHQLMKDNPNFIKLYYSVTTLK   82 (267)
T ss_pred             HHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-------hHHHHHHhhcCCCEEEEEEEEecCC
Confidence            3345677777776  99999999999975 688899999875321111       22222212 6999999999997655


Q ss_pred             -eEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCC-CeEEeecCcc
Q 016594          138 -LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADF-EPQISDFGLA  215 (386)
Q Consensus       138 -~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~-~~kl~Dfg~a  215 (386)
                       .++||||+.+++|.+++....  .+++..+..++.|++.||.|||+   .+++||||||+||+++.++ .++|+|||++
T Consensus        83 ~~~iv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~l~dfg~~  157 (267)
T PHA03390         83 GHVLIMDYIKDGDLFDLLKKEG--KLSEAEVKKIIRQLVEALNDLHK---HNIIHNDIKLENVLYDRAKDRIYLCDYGLC  157 (267)
T ss_pred             eeEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEeCCCCeEEEecCccc
Confidence             899999999999999987643  58999999999999999999999   9999999999999999988 9999999998


Q ss_pred             ccCCCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccC
Q 016594          216 KWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVD  295 (386)
Q Consensus       216 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  295 (386)
                      ......      ....++..|+|||++.+..++.++||||||+++|+|++|..||............       +.....
T Consensus       158 ~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~-------~~~~~~  224 (267)
T PHA03390        158 KIIGTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLES-------LLKRQQ  224 (267)
T ss_pred             eecCCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHH-------HHHhhc
Confidence            765432      2235888999999999989999999999999999999999999754322111000       000001


Q ss_pred             CccCCCCCHHHHHHHHHHHHHccccCCCCCCC-HHHHHHHH
Q 016594          296 PRLQGAYDVTQLNRLAFAASLCIRASPTWRPT-MSEVLEVM  335 (386)
Q Consensus       296 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt-~~~il~~l  335 (386)
                      ..  .......+..+.+++.+||+.+|.+||+ +++++++-
T Consensus       225 ~~--~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~  263 (267)
T PHA03390        225 KK--LPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHP  263 (267)
T ss_pred             cc--CCcccccCHHHHHHHHHHhccChhhCCchHHHHhcCC
Confidence            00  1111235677999999999999999995 69999764

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.8e-38  Score=295.77  Aligned_cols=257  Identities=21%  Similarity=0.331  Sum_probs=194.8

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeC-------
Q 016594           65 TNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDN-------  136 (386)
Q Consensus        65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-------  136 (386)
                      .++|.+.+.||+|+||.||+|.+. +|+.||+|++.+..........+.+|+.+++.+.||||+++++++...       
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence            468999999999999999999975 689999999876443344445688999999999999999999998643       


Q ss_pred             ceEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccc
Q 016594          137 GLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAK  216 (386)
Q Consensus       137 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~  216 (386)
                      ..+++++|+.. +|..+.    ...+++..+..++.|++.||+|||+   ++++||||||+||+++.++.+||+|||++.
T Consensus        94 ~~~lv~e~~~~-~l~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dlkp~NIll~~~~~~kL~dfg~~~  165 (342)
T cd07879          94 DFYLVMPYMQT-DLQKIM----GHPLSEDKVQYLVYQMLCGLKYIHS---AGIIHRDLKPGNLAVNEDCELKILDFGLAR  165 (342)
T ss_pred             eEEEEeccccc-CHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCCCCc
Confidence            25899998864 666554    2348899999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCCccccccccccccCccChhhhcc-CCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhh-hhhhh---------
Q 016594          217 WLPSQWTHHSIAPIEGTFGHLAPEYFMH-GIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSW-AKPIL---------  285 (386)
Q Consensus       217 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~-~~~~~---------  285 (386)
                      .....     .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+........ .....         
T Consensus       166 ~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  240 (342)
T cd07879         166 HADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQ  240 (342)
T ss_pred             CCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence            65322     223457888999999876 468899999999999999999999998754211000 00000         


Q ss_pred             --ccccccccc---CCccCCCCC---HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 016594          286 --NQGEIEKLV---DPRLQGAYD---VTQLNRLAFAASLCIRASPTWRPTMSEVLEV  334 (386)
Q Consensus       286 --~~~~~~~~~---~~~~~~~~~---~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~  334 (386)
                        .........   .........   ...+..+.+++.+||+.||++||++.+++.+
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h  297 (342)
T cd07879         241 KLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEH  297 (342)
T ss_pred             HhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence              000000000   000000000   1124568899999999999999999999987

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=4.9e-38  Score=288.35  Aligned_cols=259  Identities=23%  Similarity=0.384  Sum_probs=197.5

Q ss_pred             HHhcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccC-CCceeeecceEEeCc-eE
Q 016594           63 IATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVC-HPNVLSLLGCCVDNG-LY  139 (386)
Q Consensus        63 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~-~~  139 (386)
                      +..++|++.+.||.|+||.||+|.++ +++.||||.+..... ......+.+|+.++.+.. ||||+++++++.+.. .+
T Consensus        12 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~   90 (296)
T cd06618          12 ADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGN-KEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVF   90 (296)
T ss_pred             CCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCC-hHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEE
Confidence            34567899999999999999999987 489999999875432 233456677777676665 999999999997755 88


Q ss_pred             EEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCC
Q 016594          140 LIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLP  219 (386)
Q Consensus       140 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~  219 (386)
                      ++|||+.+ ++..++.... ..+++..+..++.|++.||.|||+.  .+++||||+|+||+++.++.+||+|||++..+.
T Consensus        91 ~v~e~~~~-~l~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~--~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~  166 (296)
T cd06618          91 ICMELMST-CLDKLLKRIQ-GPIPEDILGKMTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCDFGISGRLV  166 (296)
T ss_pred             EEeeccCc-CHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhh--CCEecCCCcHHHEEEcCCCCEEECccccchhcc
Confidence            99999754 7777765533 3589999999999999999999961  489999999999999999999999999987664


Q ss_pred             CCCccccccccccccCccChhhhccCC----CCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccC
Q 016594          220 SQWTHHSIAPIEGTFGHLAPEYFMHGI----VDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVD  295 (386)
Q Consensus       220 ~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  295 (386)
                      ....   .....++..|+|||.+.+..    ++.++||||||+++|+|++|+.||............ .....      .
T Consensus       167 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~-~~~~~------~  236 (296)
T cd06618         167 DSKA---KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTK-ILQEE------P  236 (296)
T ss_pred             CCCc---ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHH-HhcCC------C
Confidence            3221   12234778899999987553    789999999999999999999999764322111111 11100      0


Q ss_pred             CccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          296 PRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       296 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                      +.  .......+..+.+++.+||+.||.+||++.+++++.+..
T Consensus       237 ~~--~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~  277 (296)
T cd06618         237 PS--LPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIR  277 (296)
T ss_pred             CC--CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhh
Confidence            00  011112356799999999999999999999999886543

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=8.8e-41  Score=281.57  Aligned_cols=257  Identities=23%  Similarity=0.360  Sum_probs=199.0

Q ss_pred             cCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhcc-CCCceeeecceEEeCc-eEEEE
Q 016594           66 NAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHV-CHPNVLSLLGCCVDNG-LYLIF  142 (386)
Q Consensus        66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~-~~lv~  142 (386)
                      .+.+-...||.|+||+|++-.++ .|+..|||.+..... ....++++.|.+...+- +.||||++||.+..++ .++.|
T Consensus        64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~-~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCM  142 (361)
T KOG1006|consen   64 DNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI-EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICM  142 (361)
T ss_pred             chHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc-hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeH
Confidence            34455678999999999999877 799999999986443 55678889999876655 5999999999987665 66777


Q ss_pred             EeccCCCHhhhhh---hcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCC
Q 016594          143 QFSSRGSVASLFH---DVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLP  219 (386)
Q Consensus       143 e~~~~~~L~~~~~---~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~  219 (386)
                      |.|.- +|..+..   ......+++..+..|+..++.||.||-.  ...|||||+||+|||++..|.+||||||++..+.
T Consensus       143 ELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv  219 (361)
T KOG1006|consen  143 ELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLV  219 (361)
T ss_pred             HHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCCEeeecccchHhHH
Confidence            77754 6665543   3345569999999999999999999998  3789999999999999999999999999998776


Q ss_pred             CCCccccccccccccCccChhhhcc--CCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCc
Q 016594          220 SQWTHHSIAPIEGTFGHLAPEYFMH--GIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPR  297 (386)
Q Consensus       220 ~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (386)
                      .+....   .-.|...|||||-+..  ..|+.++||||||++|||+.||..|+.+.+....+...  +..+....+..+.
T Consensus       220 ~SiAkT---~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~--Vv~gdpp~l~~~~  294 (361)
T KOG1006|consen  220 DSIAKT---VDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQ--VVIGDPPILLFDK  294 (361)
T ss_pred             HHHHhh---hccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHH--HHcCCCCeecCcc
Confidence            543322   2348889999999863  45899999999999999999999999886543322221  1112221221111


Q ss_pred             cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 016594          298 LQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVM  335 (386)
Q Consensus       298 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l  335 (386)
                          ...+.+..+..+|..||.+|-..||.+.+++++-
T Consensus       295 ----~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~  328 (361)
T KOG1006|consen  295 ----ECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFP  328 (361)
T ss_pred             ----cccccCHHHHHHHHHHhhcccccCcchhhhhcCc
Confidence                1134567899999999999999999999998763

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=2.4e-39  Score=320.79  Aligned_cols=254  Identities=25%  Similarity=0.395  Sum_probs=193.2

Q ss_pred             HHhcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEe------
Q 016594           63 IATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVD------  135 (386)
Q Consensus        63 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------  135 (386)
                      .-.++|+...+||+||||.||+++.+ +|+.||||++.... .......+.+|+..|++|+|||||++|..+.+      
T Consensus       476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~  554 (1351)
T KOG1035|consen  476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT  554 (1351)
T ss_pred             hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence            34567888899999999999999988 89999999998755 56667788999999999999999998544110      


Q ss_pred             --------------------------------------------------------------------------------
Q 016594          136 --------------------------------------------------------------------------------  135 (386)
Q Consensus       136 --------------------------------------------------------------------------------  135 (386)
                                                                                                      
T Consensus       555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS  634 (1351)
T KOG1035|consen  555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS  634 (1351)
T ss_pred             cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence                                                                                            


Q ss_pred             ----------------------------------CceEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHH
Q 016594          136 ----------------------------------NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYL  181 (386)
Q Consensus       136 ----------------------------------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~L  181 (386)
                                                        ..+|+-||||....+.+++.++.... ....+|+++++|++||.|+
T Consensus       635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~-~~d~~wrLFreIlEGLaYI  713 (1351)
T KOG1035|consen  635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS-QRDEAWRLFREILEGLAYI  713 (1351)
T ss_pred             ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch-hhHHHHHHHHHHHHHHHHH
Confidence                                              00356688888877777776544321 3678899999999999999


Q ss_pred             HhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCC----------------CCCccccccccccccCccChhhhccC
Q 016594          182 HKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLP----------------SQWTHHSIAPIEGTFGHLAPEYFMHG  245 (386)
Q Consensus       182 H~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~----------------~~~~~~~~~~~~gt~~y~aPE~~~~~  245 (386)
                      |+   +|||||||||.||+|+.++.|||+|||+|....                ........+..+||.-|+|||++.+.
T Consensus       714 H~---~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~  790 (1351)
T KOG1035|consen  714 HD---QGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDT  790 (1351)
T ss_pred             Hh---CceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccc
Confidence            99   999999999999999999999999999998721                00111134567899999999999764


Q ss_pred             ---CCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCCC--CCHHHHHHHHHHHHHcccc
Q 016594          246 ---IVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGA--YDVTQLNRLAFAASLCIRA  320 (386)
Q Consensus       246 ---~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~  320 (386)
                         .|+.|+|+||||++++||+.   ||...-.....          +..+-+..+..+  +.......-+.+|.+|++.
T Consensus       791 ~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~i----------L~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~h  857 (1351)
T KOG1035|consen  791 SSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASI----------LTNLRKGSIPEPADFFDPEHPEEASLIRWLLSH  857 (1351)
T ss_pred             ccccccchhhhHHHHHHHHHHhc---cCCchHHHHHH----------HHhcccCCCCCCcccccccchHHHHHHHHHhcC
Confidence               49999999999999999986   46553221111          111112222111  2223334567899999999


Q ss_pred             CCCCCCCHHHHHHH
Q 016594          321 SPTWRPTMSEVLEV  334 (386)
Q Consensus       321 dP~~Rpt~~~il~~  334 (386)
                      ||.+|||+.++|..
T Consensus       858 dP~kRPtA~eLL~s  871 (1351)
T KOG1035|consen  858 DPSKRPTATELLNS  871 (1351)
T ss_pred             CCccCCCHHHHhhc
Confidence            99999999999974

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=3.6e-38  Score=290.88  Aligned_cols=252  Identities=23%  Similarity=0.383  Sum_probs=198.2

Q ss_pred             cCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEecccc-CChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEE
Q 016594           66 NAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVV-TDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIF  142 (386)
Q Consensus        66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~  142 (386)
                      +.|...+.||.|+||.||+|+.. ++..||+|.+.... ........+.+|+.+++.++|+|++++++++.... .++|+
T Consensus        15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   94 (308)
T cd06634          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (308)
T ss_pred             HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence            34667788999999999999976 57889999886432 23344567889999999999999999999987765 88999


Q ss_pred             EeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCC
Q 016594          143 QFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQW  222 (386)
Q Consensus       143 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  222 (386)
                      ||+. +++.+++.... ..+++..+..++.|++.||.|||+   ++++||||+|+||+++.++.++|+|||++...... 
T Consensus        95 e~~~-~~l~~~~~~~~-~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~-  168 (308)
T cd06634          95 EYCL-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-  168 (308)
T ss_pred             EccC-CCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHhEEECCCCcEEECCcccceeecCc-
Confidence            9997 57777665433 348899999999999999999999   99999999999999999999999999998765432 


Q ss_pred             ccccccccccccCccChhhhc---cCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccC
Q 016594          223 THHSIAPIEGTFGHLAPEYFM---HGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQ  299 (386)
Q Consensus       223 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (386)
                           ....++..|+|||.+.   ...++.++|||||||++|+|++|..||...........           .......
T Consensus       169 -----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~-----------~~~~~~~  232 (308)
T cd06634         169 -----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH-----------IAQNESP  232 (308)
T ss_pred             -----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHH-----------HhhcCCC
Confidence                 2345788999999975   35678899999999999999999999876432111100           0000001


Q ss_pred             CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCC
Q 016594          300 GAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEGD  339 (386)
Q Consensus       300 ~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~~  339 (386)
                      .......+..+.++|.+||+.+|.+||++.+++++.+...
T Consensus       233 ~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~  272 (308)
T cd06634         233 ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR  272 (308)
T ss_pred             CcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccc
Confidence            1112234567899999999999999999999999876554

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=4.5e-38  Score=285.99  Aligned_cols=247  Identities=23%  Similarity=0.254  Sum_probs=189.3

Q ss_pred             eecccCCcEEEEEEEC-CCcEEEEEEeccccCCh-HhHHHHHHHH---HHHhccCCCceeeecceEEeCc-eEEEEEecc
Q 016594           73 LVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDD-RKEKEFLTEI---GTIGHVCHPNVLSLLGCCVDNG-LYLIFQFSS  146 (386)
Q Consensus        73 ~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~e~---~~l~~l~h~niv~l~~~~~~~~-~~lv~e~~~  146 (386)
                      .||+|+||.||+|... +++.||+|.+.+..... .....+..|.   ..++...||||+++++++.+.. .++|+||+.
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            4899999999999965 68899999987543221 1122233333   3445567999999999997755 899999999


Q ss_pred             CCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCcccc
Q 016594          147 RGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHS  226 (386)
Q Consensus       147 ~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  226 (386)
                      +++|..++...  ..+++..+..++.|++.||.|||+   ++++||||||+||+++.++.++|+|||++..+....    
T Consensus        81 g~~L~~~l~~~--~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~----  151 (278)
T cd05606          81 GGDLHYHLSQH--GVFSEAEMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----  151 (278)
T ss_pred             CCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC----
Confidence            99999887643  348999999999999999999999   999999999999999999999999999987654321    


Q ss_pred             ccccccccCccChhhhccC-CCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCCCCCHH
Q 016594          227 IAPIEGTFGHLAPEYFMHG-IVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVT  305 (386)
Q Consensus       227 ~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (386)
                      .....|+..|+|||++.++ .++.++||||+||++|+|++|..||............         .... ......+..
T Consensus       152 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~---------~~~~-~~~~~~~~~  221 (278)
T cd05606         152 PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID---------RMTL-TMAVELPDS  221 (278)
T ss_pred             CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHH---------HHhh-ccCCCCCCc
Confidence            2234689999999998754 6899999999999999999999999765321111000         0000 001112223


Q ss_pred             HHHHHHHHHHHccccCCCCCC-----CHHHHHHHHhcC
Q 016594          306 QLNRLAFAASLCIRASPTWRP-----TMSEVLEVMLEG  338 (386)
Q Consensus       306 ~~~~l~~li~~cl~~dP~~Rp-----t~~~il~~l~~~  338 (386)
                      .+..+.+++.+||..+|.+||     ++.+++++-+..
T Consensus       222 ~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~  259 (278)
T cd05606         222 FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFR  259 (278)
T ss_pred             CCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCcccc
Confidence            357799999999999999999     999999875543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.4e-38  Score=297.92  Aligned_cols=263  Identities=21%  Similarity=0.322  Sum_probs=200.4

Q ss_pred             HhcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-----
Q 016594           64 ATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-----  137 (386)
Q Consensus        64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----  137 (386)
                      ..++|++.+.||.|++|.||+|.+. +++.||+|++............+.+|+.+++.+.||||+++++++....     
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF   92 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence            4678999999999999999999986 6889999998754434445566788999999999999999999875432     


Q ss_pred             --eEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCcc
Q 016594          138 --LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLA  215 (386)
Q Consensus       138 --~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a  215 (386)
                        .+++++++ +++|.+++..   ..+++..++.++.|++.||.|||+   .+++||||||+||+++.++.++|+|||++
T Consensus        93 ~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nill~~~~~~kL~dfg~~  165 (343)
T cd07851          93 QDVYLVTHLM-GADLNNIVKC---QKLSDDHIQFLVYQILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLA  165 (343)
T ss_pred             ccEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEcccccc
Confidence              78888887 5689888764   348999999999999999999999   99999999999999999999999999999


Q ss_pred             ccCCCCCccccccccccccCccChhhhcc-CCCCcccchHHHHHHHHHHHhCCCCCCCCchhhh-hhhhhhhcc------
Q 016594          216 KWLPSQWTHHSIAPIEGTFGHLAPEYFMH-GIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLH-SWAKPILNQ------  287 (386)
Q Consensus       216 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~-~~~~~~~~~------  287 (386)
                      ......     .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+...... .........      
T Consensus       166 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~  240 (343)
T cd07851         166 RHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELL  240 (343)
T ss_pred             cccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHH
Confidence            866432     233457888999999865 4678999999999999999999999976543110 000000000      


Q ss_pred             -----cccccccC---CccCCCCC---HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          288 -----GEIEKLVD---PRLQGAYD---VTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       288 -----~~~~~~~~---~~~~~~~~---~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                           ......+.   ...+..+.   ...+..+.+++.+||+.+|++|||+.+|+++-+..
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~  302 (343)
T cd07851         241 QKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLA  302 (343)
T ss_pred             hhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCcc
Confidence                 00000000   00000000   11256799999999999999999999999885544

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=5.6e-38  Score=285.95  Aligned_cols=259  Identities=23%  Similarity=0.315  Sum_probs=197.0

Q ss_pred             CCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccC-CCceeeecceEEeCc-eEEEEEe
Q 016594           68 FSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVC-HPNVLSLLGCCVDNG-LYLIFQF  144 (386)
Q Consensus        68 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~-~~lv~e~  144 (386)
                      |++.+.||.|++|+||+|... +++.||+|.+...... .......+|+..++++. |+||+++++++.+++ .+++|||
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~   79 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEY   79 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc-hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEec
Confidence            677899999999999999986 5788999998754322 23344567999999999 999999999997755 8999999


Q ss_pred             ccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCcc
Q 016594          145 SSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTH  224 (386)
Q Consensus       145 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  224 (386)
                      + +++|.+.+.......+++..+..++.|++.+|.|||+   ++++|+||+|+||+++.++.++|+|||++.......  
T Consensus        80 ~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~--  153 (283)
T cd07830          80 M-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHK---HGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP--  153 (283)
T ss_pred             C-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCCEEEeecccceeccCCC--
Confidence            9 7799888876654568999999999999999999999   999999999999999999999999999998664322  


Q ss_pred             ccccccccccCccChhhhcc-CCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhh--------------hhhhcccc
Q 016594          225 HSIAPIEGTFGHLAPEYFMH-GIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWA--------------KPILNQGE  289 (386)
Q Consensus       225 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~--------------~~~~~~~~  289 (386)
                       ......++..|+|||++.+ ..++.++|+||||+++++|++|.+||...........              ........
T Consensus       154 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (283)
T cd07830         154 -PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASK  232 (283)
T ss_pred             -CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcc
Confidence             1223457889999998754 5578999999999999999999999976543211100              00000000


Q ss_pred             cccccCCccCC---CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 016594          290 IEKLVDPRLQG---AYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEV  334 (386)
Q Consensus       290 ~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~  334 (386)
                      ....+......   ......+..+.+++.+||+.+|++||++.+++.+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~  280 (283)
T cd07830         233 LGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH  280 (283)
T ss_pred             ccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence            00000000000   0000114679999999999999999999999876

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=2.5e-38  Score=284.96  Aligned_cols=245  Identities=24%  Similarity=0.355  Sum_probs=194.3

Q ss_pred             ecccCCcEEEEEEEC-CCcEEEEEEeccccC-ChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEEEeccCCCH
Q 016594           74 VGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVT-DDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQFSSRGSV  150 (386)
Q Consensus        74 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~~~~~~L  150 (386)
                      ||.|+||.||+|.+. +++.||+|.+..... .......+.+|+.+++++.||||+++++.+..+. .++++|++.+++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            689999999999987 589999999875322 2344567889999999999999999999987655 8999999999999


Q ss_pred             hhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCc------c
Q 016594          151 ASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWT------H  224 (386)
Q Consensus       151 ~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~------~  224 (386)
                      .+++.+..  .+++..+..++.|++.||.|||+   ++++|+||+|+||+++.++.++|+|||++........      .
T Consensus        81 ~~~l~~~~--~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~  155 (265)
T cd05579          81 ASLLENVG--SLDEDVARIYIAEIVLALEYLHS---NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDE  155 (265)
T ss_pred             HHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---cCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccc
Confidence            99987644  58999999999999999999999   9999999999999999999999999999876533211      1


Q ss_pred             ccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCCCCCH
Q 016594          225 HSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDV  304 (386)
Q Consensus       225 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (386)
                      .......++..|+|||...+..++.++||||||+++|+|++|..||.........  ..         +...........
T Consensus       156 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~--~~---------~~~~~~~~~~~~  224 (265)
T cd05579         156 KEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIF--QN---------ILNGKIEWPEDV  224 (265)
T ss_pred             ccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHH--HH---------HhcCCcCCCccc
Confidence            1223345788999999998888999999999999999999999999765432111  00         000000000111


Q ss_pred             HHHHHHHHHHHHccccCCCCCCCH---HHHHHH
Q 016594          305 TQLNRLAFAASLCIRASPTWRPTM---SEVLEV  334 (386)
Q Consensus       305 ~~~~~l~~li~~cl~~dP~~Rpt~---~~il~~  334 (386)
                      ..+..+.+++.+||+.+|++|||+   .+++++
T Consensus       225 ~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~  257 (265)
T cd05579         225 EVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNH  257 (265)
T ss_pred             cCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcC
Confidence            125778999999999999999999   666654

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=9.7e-38  Score=288.62  Aligned_cols=248  Identities=25%  Similarity=0.401  Sum_probs=195.2

Q ss_pred             CCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccC-ChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEEEe
Q 016594           68 FSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVT-DDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQF  144 (386)
Q Consensus        68 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~  144 (386)
                      |...+.||+|+||+||+|+.. ++..|++|.+..... .......+.+|+.+++.++|||++++++++.+.. .+++|||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            666788999999999999975 688999999875332 2334467889999999999999999999998765 8899999


Q ss_pred             ccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCcc
Q 016594          145 SSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTH  224 (386)
Q Consensus       145 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  224 (386)
                      +.+ ++.+++.... ..+++..+..++.|++.||.|||+   ++++|+||+|+||+++.++.+||+|||++.....    
T Consensus       103 ~~~-~l~~~l~~~~-~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~----  173 (313)
T cd06633         103 CLG-SASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP----  173 (313)
T ss_pred             CCC-CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChhhEEECCCCCEEEeecCCCcccCC----
Confidence            964 7777665433 348999999999999999999999   9999999999999999999999999999864322    


Q ss_pred             ccccccccccCccChhhhc---cCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCCC
Q 016594          225 HSIAPIEGTFGHLAPEYFM---HGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGA  301 (386)
Q Consensus       225 ~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (386)
                        .....|+..|+|||++.   ...++.++|||||||++|+|++|..||...........  ... ..        ....
T Consensus       174 --~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~--~~~-~~--------~~~~  240 (313)
T cd06633         174 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH--IAQ-ND--------SPTL  240 (313)
T ss_pred             --CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHH--HHh-cC--------CCCC
Confidence              22446888999999984   45688999999999999999999999976532211110  000 00        0011


Q ss_pred             CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 016594          302 YDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLE  337 (386)
Q Consensus       302 ~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~  337 (386)
                      .....+..+.+++.+||+.+|.+||++.+++.+-+.
T Consensus       241 ~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~  276 (313)
T cd06633         241 QSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFV  276 (313)
T ss_pred             CccccCHHHHHHHHHHccCChhhCcCHHHHhcCccc
Confidence            111234568999999999999999999999987543

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=1.1e-37  Score=329.24  Aligned_cols=258  Identities=26%  Similarity=0.526  Sum_probs=202.7

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEE
Q 016594           65 TNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIF  142 (386)
Q Consensus        65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~  142 (386)
                      ...|...+.||+|+||.||+|.+. ++..||||.+......      ...|+..+++++|||||++++++.+.. .++||
T Consensus       689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~  762 (968)
T PLN00113        689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI------PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIH  762 (968)
T ss_pred             HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc------cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEE
Confidence            356778889999999999999975 7899999988643211      124578899999999999999997755 89999


Q ss_pred             EeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCC
Q 016594          143 QFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQW  222 (386)
Q Consensus       143 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  222 (386)
                      ||+.+|+|.+++..     +++..+..++.|++.||+|||..+..+|+||||||+||+++.++..++. ||.+.....  
T Consensus       763 Ey~~~g~L~~~l~~-----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~--  834 (968)
T PLN00113        763 EYIEGKNLSEVLRN-----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT--  834 (968)
T ss_pred             eCCCCCcHHHHHhc-----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc--
Confidence            99999999999853     7899999999999999999996444899999999999999998888775 665543221  


Q ss_pred             ccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCc---hhhhhhhhhhhcccccccccCCccC
Q 016594          223 THHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSH---QSLHSWAKPILNQGEIEKLVDPRLQ  299 (386)
Q Consensus       223 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~  299 (386)
                          .....+++.|+|||++.+..++.++|||||||++|||++|+.||....   .....|.............+++...
T Consensus       835 ----~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  910 (968)
T PLN00113        835 ----DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIR  910 (968)
T ss_pred             ----CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCcccc
Confidence                112357899999999999999999999999999999999999995432   2233344333333333344444443


Q ss_pred             C--CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCCc
Q 016594          300 G--AYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEGDQ  340 (386)
Q Consensus       300 ~--~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~~~  340 (386)
                      .  ..+......+.+++.+||+.||++||+|.++++.|+....
T Consensus       911 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  953 (968)
T PLN00113        911 GDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR  953 (968)
T ss_pred             CCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence            2  2334556678899999999999999999999999976543

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=3.9e-38  Score=290.85  Aligned_cols=266  Identities=21%  Similarity=0.258  Sum_probs=195.8

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeC-------
Q 016594           65 TNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDN-------  136 (386)
Q Consensus        65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-------  136 (386)
                      .++|++.+.||.|+||.||+|.++ +++.||+|.+............+.+|+.+++.++||||+++++++.+.       
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            478999999999999999999976 688999999875433333344567899999999999999999987532       


Q ss_pred             --ceEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCc
Q 016594          137 --GLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGL  214 (386)
Q Consensus       137 --~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~  214 (386)
                        ..+++++|+.+ ++...+... ...+++..+..++.|+++||.|||+   ++++|+||||+||+++.++.++|+|||+
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~~~-~~~~~~~~~~~i~~~l~~al~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~  161 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLENP-SVKLTESQIKCYMLQLLEGINYLHE---NHILHRDIKAANILIDNQGILKIADFGL  161 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECcCcc
Confidence              26889999875 566655432 3359999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCCcc---------ccccccccccCccChhhhccC-CCCcccchHHHHHHHHHHHhCCCCCCCCchhhhh-hhhh
Q 016594          215 AKWLPSQWTH---------HSIAPIEGTFGHLAPEYFMHG-IVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHS-WAKP  283 (386)
Q Consensus       215 a~~~~~~~~~---------~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~-~~~~  283 (386)
                      +.........         .......+++.|+|||.+.+. .++.++|||||||++|+|++|++||.+....... ....
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~  241 (311)
T cd07866         162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFK  241 (311)
T ss_pred             chhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            9765432211         111234578889999988654 5789999999999999999999999765432110 0000


Q ss_pred             hhcc---------ccccccc----CCccCCCC---CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 016594          284 ILNQ---------GEIEKLV----DPRLQGAY---DVTQLNRLAFAASLCIRASPTWRPTMSEVLEVM  335 (386)
Q Consensus       284 ~~~~---------~~~~~~~----~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l  335 (386)
                      ....         ..+....    ........   .......+.+++.+||+.||++|||+.+++.+-
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~  309 (311)
T cd07866         242 LCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHP  309 (311)
T ss_pred             HhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCC
Confidence            0000         0000000    00000000   011235688999999999999999999998753

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-39  Score=285.15  Aligned_cols=269  Identities=19%  Similarity=0.239  Sum_probs=206.8

Q ss_pred             HHHHHHHhcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCC--C----ceeeec
Q 016594           58 FEEISIATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCH--P----NVLSLL  130 (386)
Q Consensus        58 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h--~----niv~l~  130 (386)
                      ++......++|.+...+|+|+||.|-.+.++ .+..||||+++..   .......+-|+++|.++.+  |    -+|.+.
T Consensus        81 ~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V---~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~  157 (415)
T KOG0671|consen   81 YQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV---DKYREAALIEIEVLQKINESDPNGKFRCVQMR  157 (415)
T ss_pred             EEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH---HHHhhHHHHHHHHHHHHHhcCCCCceEEEeee
Confidence            3444567899999999999999999999976 5789999998743   2334456779999999952  2    378888


Q ss_pred             ceEEeCc-eEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcC------
Q 016594          131 GCCVDNG-LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTA------  203 (386)
Q Consensus       131 ~~~~~~~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~------  203 (386)
                      ++|...+ .|+|+|.+ |-++.+++..++..+++...+..++.|+++++++||+   .+++|-||||+|||+..      
T Consensus       158 ~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~---~kl~HTDLKPENILfvss~~~~~  233 (415)
T KOG0671|consen  158 DWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHD---LKLTHTDLKPENILFVSSEYFKT  233 (415)
T ss_pred             hhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHh---cceeecCCChheEEEeccceEEE
Confidence            8887655 88999877 4489999999888899999999999999999999999   99999999999999832      


Q ss_pred             --------------CCCeEEeecCccccCCCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCC
Q 016594          204 --------------DFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKP  269 (386)
Q Consensus       204 --------------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~p  269 (386)
                                    ...++|+|||.|..-...     ....+.|..|.|||++.+-.|+.++||||+||||+||.+|...
T Consensus       234 ~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~-----hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~L  308 (415)
T KOG0671|consen  234 YNPKKKVCFIRPLKSTAIKVIDFGSATFDHEH-----HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETL  308 (415)
T ss_pred             eccCCccceeccCCCcceEEEecCCcceeccC-----cceeeeccccCCchheeccCcCCccCceeeeeEEEEeecccee
Confidence                          245899999999865433     2566789999999999999999999999999999999999999


Q ss_pred             CCCCchhhhhhhhhhhcccccccccCCc----------------------------cC-----CCCCHHHHHHHHHHHHH
Q 016594          270 VDGSHQSLHSWAKPILNQGEIEKLVDPR----------------------------LQ-----GAYDVTQLNRLAFAASL  316 (386)
Q Consensus       270 f~~~~~~~~~~~~~~~~~~~~~~~~~~~----------------------------~~-----~~~~~~~~~~l~~li~~  316 (386)
                      |++.+....-.+.+.........++...                            .+     ..........|.+|+..
T Consensus       309 FqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~  388 (415)
T KOG0671|consen  309 FQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRR  388 (415)
T ss_pred             cccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHH
Confidence            9876632211111111100000000000                            00     01112334579999999


Q ss_pred             ccccCCCCCCCHHHHHHHHhcC
Q 016594          317 CIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       317 cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                      ||.+||.+|+|+.|+|.|-...
T Consensus       389 mL~fDP~~RiTl~EAL~HpFF~  410 (415)
T KOG0671|consen  389 MLEFDPARRITLREALSHPFFA  410 (415)
T ss_pred             HHccCccccccHHHHhcCHHhh
Confidence            9999999999999999986543

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=1.6e-37  Score=284.26  Aligned_cols=246  Identities=21%  Similarity=0.340  Sum_probs=195.6

Q ss_pred             CCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEEEeccCC
Q 016594           71 ENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQFSSRG  148 (386)
Q Consensus        71 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~~~~~  148 (386)
                      ..+||+|+||.||+|..+ ++..||+|.+...  .......+.+|+.+++.++|+||+++++++..+. .+++|||+.++
T Consensus        25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~  102 (292)
T cd06657          25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR--KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGG  102 (292)
T ss_pred             HHHcCCCCCeEEEEEEEcCCCeEEEEEEeccc--chhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCC
Confidence            367999999999999975 6899999987532  2334566889999999999999999999997755 89999999999


Q ss_pred             CHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCcccccc
Q 016594          149 SVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIA  228 (386)
Q Consensus       149 ~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  228 (386)
                      +|.+++..   ..+++..+..++.|++.||+|||+   ++++|+||+|+||+++.++.++|+|||++........  ...
T Consensus       103 ~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~---~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~--~~~  174 (292)
T cd06657         103 ALTDIVTH---TRMNEEQIAAVCLAVLKALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRK  174 (292)
T ss_pred             cHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEcccccceecccccc--ccc
Confidence            99987753   247899999999999999999999   9999999999999999999999999999876543211  123


Q ss_pred             ccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCCCCCHHHHH
Q 016594          229 PIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQLN  308 (386)
Q Consensus       229 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (386)
                      ...|+..|+|||.+.+..++.++|+||||+++|+|++|..||.+.......  . ...     .........  ....+.
T Consensus       175 ~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~--~-~~~-----~~~~~~~~~--~~~~~~  244 (292)
T cd06657         175 SLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAM--K-MIR-----DNLPPKLKN--LHKVSP  244 (292)
T ss_pred             ccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH--H-HHH-----hhCCcccCC--cccCCH
Confidence            345889999999998888999999999999999999999999764321110  0 000     001111100  112345


Q ss_pred             HHHHHHHHccccCCCCCCCHHHHHHHHh
Q 016594          309 RLAFAASLCIRASPTWRPTMSEVLEVML  336 (386)
Q Consensus       309 ~l~~li~~cl~~dP~~Rpt~~~il~~l~  336 (386)
                      .+.+++.+||..+|.+||++.+++++-+
T Consensus       245 ~l~~li~~~l~~~P~~R~~~~~ll~~~~  272 (292)
T cd06657         245 SLKGFLDRLLVRDPAQRATAAELLKHPF  272 (292)
T ss_pred             HHHHHHHHHHhCCcccCcCHHHHhcChH
Confidence            6889999999999999999999998744

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-37  Score=280.75  Aligned_cols=244  Identities=22%  Similarity=0.270  Sum_probs=187.5

Q ss_pred             CeecccCCcEEEEEEEC-CCcEEEEEEeccccCC-hHhHHHHHHHHHHH-hccCCCceeeecceEEeCc-eEEEEEeccC
Q 016594           72 NLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTD-DRKEKEFLTEIGTI-GHVCHPNVLSLLGCCVDNG-LYLIFQFSSR  147 (386)
Q Consensus        72 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l-~~l~h~niv~l~~~~~~~~-~~lv~e~~~~  147 (386)
                      +.||.|+||.||+|... +++.||+|.+.+.... ......+..|..++ ....|+||+++++++..++ .++++||+.+
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            56899999999999975 6889999998753221 22223344554444 4557999999999997755 8999999999


Q ss_pred             CCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCccccc
Q 016594          148 GSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSI  227 (386)
Q Consensus       148 ~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  227 (386)
                      ++|.+++....  .+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||++.....      .
T Consensus        82 ~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------~  150 (260)
T cd05611          82 GDCASLIKTLG--GLPEDWAKQYIAEVVLGVEDLHQ---RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------N  150 (260)
T ss_pred             CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEeecccceeccc------c
Confidence            99999987543  48899999999999999999999   9999999999999999999999999999875432      2


Q ss_pred             cccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCCCCCHHHH
Q 016594          228 APIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQL  307 (386)
Q Consensus       228 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (386)
                      ....++..|+|||.+.+..++.++||||||+++|+|++|..||........  .... .....      ..........+
T Consensus       151 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~~~~-~~~~~------~~~~~~~~~~~  221 (260)
T cd05611         151 KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAV--FDNI-LSRRI------NWPEEVKEFCS  221 (260)
T ss_pred             ccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHH--HHHH-Hhccc------CCCCcccccCC
Confidence            234588899999999888899999999999999999999999976543211  0100 00000      00011111245


Q ss_pred             HHHHHHHHHccccCCCCCCCH---HHHHHHH
Q 016594          308 NRLAFAASLCIRASPTWRPTM---SEVLEVM  335 (386)
Q Consensus       308 ~~l~~li~~cl~~dP~~Rpt~---~~il~~l  335 (386)
                      ..+.+++.+||+.+|++||++   .+++.+-
T Consensus       222 ~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~  252 (260)
T cd05611         222 PEAVDLINRLLCMDPAKRLGANGYQEIKSHP  252 (260)
T ss_pred             HHHHHHHHHHccCCHHHccCCCcHHHHHcCh
Confidence            679999999999999999966   5665553

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=2.2e-37  Score=288.65  Aligned_cols=264  Identities=21%  Similarity=0.254  Sum_probs=194.3

Q ss_pred             CCCCCCeecccCCcEEEEEEEC-C--CcEEEEEEeccccCChHhHHHHHHHHHHHhccC-CCceeeecceEEeC-----c
Q 016594           67 AFSSENLVGRGGYAEVYKGVLQ-D--GEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVC-HPNVLSLLGCCVDN-----G  137 (386)
Q Consensus        67 ~~~~~~~lg~G~~g~V~~~~~~-~--~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~-----~  137 (386)
                      +|++.+.||+|+||.||+|... .  +..||+|.+............+.+|+.+++++. ||||+++++.+...     .
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            4778899999999999999976 4  778999998754334444567889999999995 99999999875421     2


Q ss_pred             eEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCcccc
Q 016594          138 LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKW  217 (386)
Q Consensus       138 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~  217 (386)
                      .+++++++. ++|.+++...  ..+++..+..++.|++.||.|||+   ++++||||||+|||++.++.+||+|||++..
T Consensus        81 ~~~~~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~---~givH~dlkp~Nili~~~~~~kl~Dfg~a~~  154 (332)
T cd07857          81 LYLYEELME-ADLHQIIRSG--QPLTDAHFQSFIYQILCGLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLARG  154 (332)
T ss_pred             EEEEEeccc-CCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHeEEcCCCCEEeCcCCCcee
Confidence            567777765 5888887543  348999999999999999999999   9999999999999999999999999999986


Q ss_pred             CCCCCcc--ccccccccccCccChhhhcc-CCCCcccchHHHHHHHHHHHhCCCCCCCCchhh-hhhhhhhhc---cccc
Q 016594          218 LPSQWTH--HSIAPIEGTFGHLAPEYFMH-GIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSL-HSWAKPILN---QGEI  290 (386)
Q Consensus       218 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~-~~~~~~~~~---~~~~  290 (386)
                      +......  .......|+..|+|||++.+ ..++.++|||||||++|+|++|.+||....... .........   ....
T Consensus       155 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  234 (332)
T cd07857         155 FSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETL  234 (332)
T ss_pred             cccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            6432211  11233568999999998765 568999999999999999999999997643210 000000000   0000


Q ss_pred             cc-----------ccCCccCCC---CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 016594          291 EK-----------LVDPRLQGA---YDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVML  336 (386)
Q Consensus       291 ~~-----------~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~  336 (386)
                      ..           .........   .....+..+.+++.+||+.||++|||+.+++.+-+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~  294 (332)
T cd07857         235 SRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPY  294 (332)
T ss_pred             HhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChh
Confidence            00           000000000   00112467999999999999999999999998743

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=8.4e-38  Score=291.87  Aligned_cols=267  Identities=18%  Similarity=0.251  Sum_probs=196.9

Q ss_pred             cCCC-CCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChH------------hHHHHHHHHHHHhccCCCceeeecc
Q 016594           66 NAFS-SENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDR------------KEKEFLTEIGTIGHVCHPNVLSLLG  131 (386)
Q Consensus        66 ~~~~-~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~------------~~~~~~~e~~~l~~l~h~niv~l~~  131 (386)
                      ++|. +.+.||.|+||+||+|.+. +++.||||.+........            ....+.+|+.+++.++|+||+++++
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   87 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD   87 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence            4554 5678999999999999976 689999999875322210            0124678999999999999999999


Q ss_pred             eEEeCc-eEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEe
Q 016594          132 CCVDNG-LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQIS  210 (386)
Q Consensus       132 ~~~~~~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~  210 (386)
                      ++..+. .+++||++. ++|.+++...  ..+++..+..++.|++.||.|||+   ++++|+||+|+||+++.++.++|+
T Consensus        88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH~---~~i~H~dl~~~nill~~~~~~kl~  161 (335)
T PTZ00024         88 VYVEGDFINLVMDIMA-SDLKKVVDRK--IRLTESQVKCILLQILNGLNVLHK---WYFMHRDLSPANIFINSKGICKIA  161 (335)
T ss_pred             EEecCCcEEEEEeccc-cCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHeEECCCCCEEEC
Confidence            987655 889999997 5888887643  348999999999999999999999   999999999999999999999999


Q ss_pred             ecCccccCCCCC------------ccccccccccccCccChhhhccC-CCCcccchHHHHHHHHHHHhCCCCCCCCchhh
Q 016594          211 DFGLAKWLPSQW------------THHSIAPIEGTFGHLAPEYFMHG-IVDEKTDVFAFGVFLLEIISGRKPVDGSHQSL  277 (386)
Q Consensus       211 Dfg~a~~~~~~~------------~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~  277 (386)
                      |||++.......            .........++..|+|||.+.+. .++.++|||||||++|+|++|..||.+.....
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~  241 (335)
T PTZ00024        162 DFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEID  241 (335)
T ss_pred             CccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            999997664110            01112233468889999998764 46899999999999999999999998764321


Q ss_pred             h-hhhhhhhcccc---cccc--------cCCccCC---CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          278 H-SWAKPILNQGE---IEKL--------VDPRLQG---AYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       278 ~-~~~~~~~~~~~---~~~~--------~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                      . ...........   ....        .......   ......+..+.+++.+||+.+|++||++.+++.+.+..
T Consensus       242 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~  317 (335)
T PTZ00024        242 QLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFK  317 (335)
T ss_pred             HHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccC
Confidence            1 00000000000   0000        0000000   00012246789999999999999999999999986654

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=7.9e-38  Score=281.45  Aligned_cols=250  Identities=20%  Similarity=0.337  Sum_probs=196.0

Q ss_pred             CCCCCCeecccCCcEEEEEEEC-CCcEEEEEEecccc---CChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEE
Q 016594           67 AFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVV---TDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLI  141 (386)
Q Consensus        67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv  141 (386)
                      +|.+.+.||+|+||.||++.+. .+..+++|+++...   ........+..|+.+++.++||||+++++++.+.. .+++
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            5888999999999999999976 34556666665321   22334456778999999999999999999987654 8999


Q ss_pred             EEeccCCCHhhhhhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCC
Q 016594          142 FQFSSRGSVASLFHDV--NSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLP  219 (386)
Q Consensus       142 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~  219 (386)
                      +||+.+++|.+++...  ....+++..++.++.|++.||.|||+   ++++|+||+|+||+++. +.++|+|||++....
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~  156 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ---RRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM  156 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHH---cCccccCCChhheEeec-CCEeecccCceeecC
Confidence            9999999999887642  33458999999999999999999999   99999999999999975 569999999987664


Q ss_pred             CCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccC
Q 016594          220 SQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQ  299 (386)
Q Consensus       220 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (386)
                      ...  .......|++.|+|||.+.+..++.++|+||||+++|+|++|..||......  .....         ... ...
T Consensus       157 ~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~--~~~~~---------~~~-~~~  222 (260)
T cd08222         157 GSC--DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFL--SVVLR---------IVE-GPT  222 (260)
T ss_pred             CCc--ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH--HHHHH---------HHc-CCC
Confidence            321  1223445788999999998888999999999999999999999999754321  11110         000 011


Q ss_pred             CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 016594          300 GAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEV  334 (386)
Q Consensus       300 ~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~  334 (386)
                      ...+...+..+.+++.+||..+|++||++.+++++
T Consensus       223 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  257 (260)
T cd08222         223 PSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN  257 (260)
T ss_pred             CCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence            11233456789999999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=5.4e-38  Score=293.90  Aligned_cols=264  Identities=19%  Similarity=0.274  Sum_probs=195.3

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeC-------
Q 016594           65 TNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDN-------  136 (386)
Q Consensus        65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-------  136 (386)
                      .++|.+.+.||.|+||.||+|... +++.||+|.+....  ......+.+|+.+++.++||||+++++++...       
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~--~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~   81 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTD--PQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTED   81 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCC--CchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccc
Confidence            468999999999999999999976 68899999986532  23456688899999999999999999877543       


Q ss_pred             --------ceEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcC-CCCe
Q 016594          137 --------GLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTA-DFEP  207 (386)
Q Consensus       137 --------~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~-~~~~  207 (386)
                              ..++++||+. ++|.+++..   ..+++..+..++.|++.||.|||+   ++++||||||+||+++. ++.+
T Consensus        82 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~---~givH~dikp~Nili~~~~~~~  154 (342)
T cd07854          82 VGSLTELNSVYIVQEYME-TDLANVLEQ---GPLSEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANVFINTEDLVL  154 (342)
T ss_pred             cccccccceEEEEeeccc-ccHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCceE
Confidence                    2689999997 488877753   248899999999999999999999   99999999999999984 5678


Q ss_pred             EEeecCccccCCCCCccc-cccccccccCccChhhhcc-CCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhh--hhhh
Q 016594          208 QISDFGLAKWLPSQWTHH-SIAPIEGTFGHLAPEYFMH-GIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHS--WAKP  283 (386)
Q Consensus       208 kl~Dfg~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~--~~~~  283 (386)
                      ||+|||++..+....... ......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.......  ....
T Consensus       155 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~  234 (342)
T cd07854         155 KIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILES  234 (342)
T ss_pred             EECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence            999999997654322111 1122357889999998754 56889999999999999999999999765431110  0000


Q ss_pred             h--hcc---c----ccccccC-CccCCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 016594          284 I--LNQ---G----EIEKLVD-PRLQGAYD-----VTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLE  337 (386)
Q Consensus       284 ~--~~~---~----~~~~~~~-~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~  337 (386)
                      .  ...   .    ....... .......+     ...+..+.+++.+||+.||.+|||+.+++.+-+.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~  303 (342)
T cd07854         235 VPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYM  303 (342)
T ss_pred             cCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCcc
Confidence            0  000   0    0000000 00000000     1234678899999999999999999999987554

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-37  Score=282.85  Aligned_cols=261  Identities=23%  Similarity=0.303  Sum_probs=199.7

Q ss_pred             CCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEEEec
Q 016594           68 FSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQFS  145 (386)
Q Consensus        68 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~~  145 (386)
                      |++.+.||+|++|.||+|... +++.||+|.+............+..|+.+++.++|+||+++++++.+.. .++++|++
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            566788999999999999976 5899999999865433444567788999999999999999999987754 89999999


Q ss_pred             cCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCccc
Q 016594          146 SRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHH  225 (386)
Q Consensus       146 ~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  225 (386)
                      .+ +|.+++.... ..+++..+..++.|++.||.|||+   ++++||||+|+||+++.++.++|+|||++........  
T Consensus        81 ~~-~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~--  153 (282)
T cd07829          81 DM-DLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHS---HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR--  153 (282)
T ss_pred             Cc-CHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc--
Confidence            85 8999887653 348999999999999999999999   9999999999999999999999999999987644321  


Q ss_pred             cccccccccCccChhhhccC-CCCcccchHHHHHHHHHHHhCCCCCCCCchhhh-hhhhhhhc---c------cc---cc
Q 016594          226 SIAPIEGTFGHLAPEYFMHG-IVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLH-SWAKPILN---Q------GE---IE  291 (386)
Q Consensus       226 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~-~~~~~~~~---~------~~---~~  291 (386)
                      ......++..|+|||.+.+. .++.++|||||||++|+|++|..||.+...... ........   .      ..   ..
T Consensus       154 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (282)
T cd07829         154 TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYK  233 (282)
T ss_pred             ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccc
Confidence            22233467789999998776 789999999999999999999999976542110 00000000   0      00   00


Q ss_pred             cccCCccCCCC---CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 016594          292 KLVDPRLQGAY---DVTQLNRLAFAASLCIRASPTWRPTMSEVLEVM  335 (386)
Q Consensus       292 ~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l  335 (386)
                      ...........   ....+..+.+++.+||..+|++||++.+++.+-
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p  280 (282)
T cd07829         234 PTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHP  280 (282)
T ss_pred             ccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCc
Confidence            00000000000   011256799999999999999999999999763

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-39  Score=286.41  Aligned_cols=246  Identities=23%  Similarity=0.333  Sum_probs=201.2

Q ss_pred             HHHhcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCCh-HhHHHHHHHHHHHhccC-CCceeeecceEEe-Cc
Q 016594           62 SIATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDD-RKEKEFLTEIGTIGHVC-HPNVLSLLGCCVD-NG  137 (386)
Q Consensus        62 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~-~~  137 (386)
                      .+...+|..+.+||+|+||+|.+|..+ +.+.||||++++...-+ ....--+.|-.+|.... -|.+++++.+|.. +.
T Consensus       345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR  424 (683)
T KOG0696|consen  345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR  424 (683)
T ss_pred             ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence            355668899999999999999999877 46789999998754322 22233355667776655 6789999999976 45


Q ss_pred             eEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCcccc
Q 016594          138 LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKW  217 (386)
Q Consensus       138 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~  217 (386)
                      +|+||||+.||+|.-.++....  +.+..+..++.+|+-||-+||+   +||++||||.+||||+.+|++||+|||+++.
T Consensus       425 LyFVMEyvnGGDLMyhiQQ~Gk--FKEp~AvFYAaEiaigLFFLh~---kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKE  499 (683)
T KOG0696|consen  425 LYFVMEYVNGGDLMYHIQQVGK--FKEPVAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKE  499 (683)
T ss_pred             eeeEEEEecCchhhhHHHHhcc--cCCchhhhhhHHHHHHhhhhhc---CCeeeeeccccceEeccCCceEeeecccccc
Confidence            9999999999999888876554  8888999999999999999999   9999999999999999999999999999985


Q ss_pred             CCCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCc
Q 016594          218 LPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPR  297 (386)
Q Consensus       218 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (386)
                      --.  ......+++||+.|+|||++..++|+.++|+||+|++||||+.|++||++.+....           ...+.+. 
T Consensus       500 ni~--~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~el-----------F~aI~eh-  565 (683)
T KOG0696|consen  500 NIF--DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL-----------FQAIMEH-  565 (683)
T ss_pred             ccc--CCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHH-----------HHHHHHc-
Confidence            422  23456789999999999999999999999999999999999999999998764321           1112222 


Q ss_pred             cCCCCCHHHHHHHHHHHHHccccCCCCCCC
Q 016594          298 LQGAYDVTQLNRLAFAASLCIRASPTWRPT  327 (386)
Q Consensus       298 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt  327 (386)
                       .-.++...+.+...++...|.+.|.+|..
T Consensus       566 -nvsyPKslSkEAv~ickg~ltK~P~kRLG  594 (683)
T KOG0696|consen  566 -NVSYPKSLSKEAVAICKGLLTKHPGKRLG  594 (683)
T ss_pred             -cCcCcccccHHHHHHHHHHhhcCCccccC
Confidence             23466677888999999999999999964

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=1e-37  Score=285.29  Aligned_cols=253  Identities=22%  Similarity=0.285  Sum_probs=196.7

Q ss_pred             CCCCCCeecccCCcEEEEEEE----CCCcEEEEEEeccccC--ChHhHHHHHHHHHHHhccC-CCceeeecceEEeCc-e
Q 016594           67 AFSSENLVGRGGYAEVYKGVL----QDGEEIAVKRLTKVVT--DDRKEKEFLTEIGTIGHVC-HPNVLSLLGCCVDNG-L  138 (386)
Q Consensus        67 ~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~-~  138 (386)
                      +|++.+.||.|+||.||+|..    .+|..||+|++.....  .......+.+|+.+++.+. |+||+++++++..+. .
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            478889999999999999986    3688999999875321  2233456788999999994 999999999987765 7


Q ss_pred             EEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccC
Q 016594          139 YLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWL  218 (386)
Q Consensus       139 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~  218 (386)
                      ++++||+.+++|.+++...  ..+++..+..++.|++.||.|||+   .+++||||+|+|||++.++.+||+|||++...
T Consensus        81 ~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~  155 (290)
T cd05613          81 HLILDYINGGELFTHLSQR--ERFKEQEVQIYSGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEF  155 (290)
T ss_pred             EEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEECCCCCEEEeeCccceec
Confidence            8999999999999988754  348899999999999999999999   99999999999999999999999999999866


Q ss_pred             CCCCccccccccccccCccChhhhcc--CCCCcccchHHHHHHHHHHHhCCCCCCCCchh--hhhhhhhhhccccccccc
Q 016594          219 PSQWTHHSIAPIEGTFGHLAPEYFMH--GIVDEKTDVFAFGVFLLEIISGRKPVDGSHQS--LHSWAKPILNQGEIEKLV  294 (386)
Q Consensus       219 ~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~ell~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~  294 (386)
                      ..... .......|+..|+|||.+.+  ..++.++||||||+++|+|++|..||......  ..........        
T Consensus       156 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~--------  226 (290)
T cd05613         156 HEDEV-ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILK--------  226 (290)
T ss_pred             ccccc-cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhc--------
Confidence            43221 12223558899999999875  34678999999999999999999999643211  1111111000        


Q ss_pred             CCccCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHHh
Q 016594          295 DPRLQGAYDVTQLNRLAFAASLCIRASPTWRP-----TMSEVLEVML  336 (386)
Q Consensus       295 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----t~~~il~~l~  336 (386)
                       .  ...++......+.+++.+||+.+|++||     ++.+++.+-+
T Consensus       227 -~--~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~  270 (290)
T cd05613         227 -S--EPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPF  270 (290)
T ss_pred             -c--CCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcc
Confidence             0  0112223456789999999999999997     7777777643

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-38  Score=302.45  Aligned_cols=254  Identities=26%  Similarity=0.414  Sum_probs=218.2

Q ss_pred             CCCCCeecccCCcEEEEEEEC-CC----cEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCceEEEE
Q 016594           68 FSSENLVGRGGYAEVYKGVLQ-DG----EEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNGLYLIF  142 (386)
Q Consensus        68 ~~~~~~lg~G~~g~V~~~~~~-~~----~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~lv~  142 (386)
                      .+..++||.|+||+||+|.|- .|    -+||+|++... .....-.+++.|+-+|.++.|||++++++++....+.+|.
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~-t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~~qlvt  776 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEF-TSPKASIELLDEALRMASLDHPNLLRLLGVCMLSTLQLVT  776 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecCCceecceeEEEEeecc-CCchhhHHHHHHHHHHhcCCCchHHHHhhhcccchHHHHH
Confidence            345689999999999999964 33    46899988753 3455567899999999999999999999999998899999


Q ss_pred             EeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCC
Q 016594          143 QFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQW  222 (386)
Q Consensus       143 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  222 (386)
                      +|++.|.|.++++... ..+.....+.|..||++||.|||.   ++++||||-.+|||+....++||.|||+++.+....
T Consensus       777 q~mP~G~LlDyvr~hr-~~igsq~lLnw~~QIAkgM~YLe~---qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~  852 (1177)
T KOG1025|consen  777 QLMPLGCLLDYVREHR-DNIGSQDLLNWCYQIAKGMKYLEE---QRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDE  852 (1177)
T ss_pred             HhcccchHHHHHHHhh-ccccHHHHHHHHHHHHHHHHHHHh---cchhhhhhhhhheeecCCCeEEEEecchhhccCccc
Confidence            9999999999998744 448889999999999999999999   999999999999999999999999999999987665


Q ss_pred             ccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCchhhhhhhhhhhcccccccccCCccCCC
Q 016594          223 THHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGA  301 (386)
Q Consensus       223 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (386)
                      .........-.+-|||-|.+....|+.++|||||||++||++| |..|+.+..            ..++.+++....+..
T Consensus       853 ~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~------------~~eI~dlle~geRLs  920 (1177)
T KOG1025|consen  853 KEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIP------------AEEIPDLLEKGERLS  920 (1177)
T ss_pred             ccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCC------------HHHhhHHHhccccCC
Confidence            5444444444567999999999999999999999999999999 999998843            345666666666677


Q ss_pred             CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          302 YDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       302 ~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                      .+..++..+..++.+||..|+..||+|+++...+.+.
T Consensus       921 qPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~  957 (1177)
T KOG1025|consen  921 QPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRM  957 (1177)
T ss_pred             CCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHH
Confidence            7788889999999999999999999999999876543

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=3.6e-37  Score=281.46  Aligned_cols=252  Identities=22%  Similarity=0.266  Sum_probs=194.5

Q ss_pred             CCCCCCeecccCCcEEEEEEEC----CCcEEEEEEeccccC--ChHhHHHHHHHHHHHhcc-CCCceeeecceEEeCc-e
Q 016594           67 AFSSENLVGRGGYAEVYKGVLQ----DGEEIAVKRLTKVVT--DDRKEKEFLTEIGTIGHV-CHPNVLSLLGCCVDNG-L  138 (386)
Q Consensus        67 ~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~-~  138 (386)
                      +|++.+.||+|+||.||+|...    ++..||||.+.+...  .......+.+|+.++.++ +||||+++++++..+. .
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            4778899999999999999842    467899999875321  123345678899999999 5999999999987655 8


Q ss_pred             EEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccC
Q 016594          139 YLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWL  218 (386)
Q Consensus       139 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~  218 (386)
                      ++||||+.+++|.+.+...  ..+++..+..++.|++.||.|||+   .+++||||+|+||+++.++.++|+|||++..+
T Consensus        81 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~---~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~  155 (288)
T cd05583          81 HLILDYVNGGELFTHLYQR--EHFTESEVRVYIAEIVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEF  155 (288)
T ss_pred             EEEEecCCCCcHHHHHhhc--CCcCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEEECcccccc
Confidence            8999999999999888653  348899999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCCccccccccccccCccChhhhccCC--CCcccchHHHHHHHHHHHhCCCCCCCCchh--hhhhhhhhhccccccccc
Q 016594          219 PSQWTHHSIAPIEGTFGHLAPEYFMHGI--VDEKTDVFAFGVFLLEIISGRKPVDGSHQS--LHSWAKPILNQGEIEKLV  294 (386)
Q Consensus       219 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~il~ell~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~  294 (386)
                      ..... .......|+..|+|||.+.+..  .+.++||||||+++|+|++|..||......  ........         .
T Consensus       156 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~---------~  225 (288)
T cd05583         156 LAEEE-ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRI---------L  225 (288)
T ss_pred             ccccc-cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHH---------H
Confidence            43321 1122345888999999987655  788999999999999999999999643211  11111110         0


Q ss_pred             CCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 016594          295 DPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVM  335 (386)
Q Consensus       295 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l  335 (386)
                      ..  ....+...+..+.+++.+||+.+|++|||+.++.+.|
T Consensus       226 ~~--~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l  264 (288)
T cd05583         226 KS--KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIK  264 (288)
T ss_pred             cc--CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHh
Confidence            00  0111222346789999999999999999977665543

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3e-38  Score=296.14  Aligned_cols=242  Identities=21%  Similarity=0.262  Sum_probs=196.7

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhcc-CCCceeeecceEEeCc-eEEE
Q 016594           65 TNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHV-CHPNVLSLLGCCVDNG-LYLI  141 (386)
Q Consensus        65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~-~~lv  141 (386)
                      ...|.+...+|.|+|+.|-.+... +++.+++|++.+...+      ..+|+.++... +||||+++.+.+.++. .++|
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~------~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v  394 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADD------NQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLV  394 (612)
T ss_pred             chhhccccccCCCCccceeeeeccccccchhheeccccccc------cccccchhhhhcCCCcceeecceecCCceeeee
Confidence            457888889999999999999866 6889999999864222      22455444444 5999999999998865 8999


Q ss_pred             EEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeE-cCCCCeEEeecCccccCCC
Q 016594          142 FQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILL-TADFEPQISDFGLAKWLPS  220 (386)
Q Consensus       142 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill-~~~~~~kl~Dfg~a~~~~~  220 (386)
                      ||.+.++-+.+.+.....  +. ..+..|+.+|+.|+.|||+   +|+|||||||+|||+ +..++++|+|||.+..+..
T Consensus       395 ~e~l~g~ell~ri~~~~~--~~-~e~~~w~~~lv~Av~~LH~---~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~  468 (612)
T KOG0603|consen  395 MELLDGGELLRRIRSKPE--FC-SEASQWAAELVSAVDYLHE---QGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELER  468 (612)
T ss_pred             ehhccccHHHHHHHhcch--hH-HHHHHHHHHHHHHHHHHHh---cCeeecCCChhheeecCCCCcEEEEEechhhhCch
Confidence            999999988776654332  33 6777899999999999999   999999999999999 6999999999999988765


Q ss_pred             CCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCC
Q 016594          221 QWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQG  300 (386)
Q Consensus       221 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (386)
                      .     ..+.+-|..|.|||+.....|++++||||||++||+||+|+.||.....+.              ++......+
T Consensus       469 ~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~--------------ei~~~i~~~  529 (612)
T KOG0603|consen  469 S-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGI--------------EIHTRIQMP  529 (612)
T ss_pred             h-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchH--------------HHHHhhcCC
Confidence            4     334457888999999999999999999999999999999999998754431              111112222


Q ss_pred             CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 016594          301 AYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLE  337 (386)
Q Consensus       301 ~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~  337 (386)
                      .+....+...++|+.+||+.||.+||++.+++.+-+.
T Consensus       530 ~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~  566 (612)
T KOG0603|consen  530 KFSECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF  566 (612)
T ss_pred             ccccccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence            3335567889999999999999999999999998765

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3e-39  Score=293.83  Aligned_cols=256  Identities=20%  Similarity=0.275  Sum_probs=213.4

Q ss_pred             HhcCCCCCCeecccCCcEEEEEEECCCc-EEEEEEecccc-CChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEE
Q 016594           64 ATNAFSSENLVGRGGYAEVYKGVLQDGE-EIAVKRLTKVV-TDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYL  140 (386)
Q Consensus        64 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~-~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~l  140 (386)
                      .-.++++...||-|+||.|=++..+... .+|+|++++.. .+...+..+..|-.+|...+.|.||++|..|.++. .|+
T Consensus       418 ~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYm  497 (732)
T KOG0614|consen  418 KLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYM  497 (732)
T ss_pred             chhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhh
Confidence            3456777889999999999999976433 48999988643 33445667889999999999999999999998866 899


Q ss_pred             EEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCC
Q 016594          141 IFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPS  220 (386)
Q Consensus       141 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~  220 (386)
                      +||-|.||.|...++++..  |....+..++..+++|++|||+   ++||+|||||+|++|+.+|-+||.|||+|+.+..
T Consensus       498 LmEaClGGElWTiLrdRg~--Fdd~tarF~~acv~EAfeYLH~---k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~  572 (732)
T KOG0614|consen  498 LMEACLGGELWTILRDRGS--FDDYTARFYVACVLEAFEYLHR---KGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS  572 (732)
T ss_pred             hHHhhcCchhhhhhhhcCC--cccchhhhhHHHHHHHHHHHHh---cCceeccCChhheeeccCCceEEeehhhHHHhcc
Confidence            9999999999999987655  8899999999999999999999   9999999999999999999999999999998865


Q ss_pred             CCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCC
Q 016594          221 QWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQG  300 (386)
Q Consensus       221 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (386)
                      .   ....++|||+.|.|||++.+...+.++|.||||+++|||++|.+||.+.++-. .+          ..++...-..
T Consensus       573 g---~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmk-tY----------n~ILkGid~i  638 (732)
T KOG0614|consen  573 G---RKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMK-TY----------NLILKGIDKI  638 (732)
T ss_pred             C---CceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHH-HH----------HHHHhhhhhh
Confidence            4   34568899999999999999999999999999999999999999999865421 11          1111111122


Q ss_pred             CCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHHHhcC
Q 016594          301 AYDVTQLNRLAFAASLCIRASPTWRPT-----MSEVLEVMLEG  338 (386)
Q Consensus       301 ~~~~~~~~~l~~li~~cl~~dP~~Rpt-----~~~il~~l~~~  338 (386)
                      .++........+||+++...+|.+|..     +.+|-+|-|..
T Consensus       639 ~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~  681 (732)
T KOG0614|consen  639 EFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFE  681 (732)
T ss_pred             hcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhh
Confidence            344555677889999999999999976     78898887654

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=2e-38  Score=289.58  Aligned_cols=251  Identities=18%  Similarity=0.282  Sum_probs=204.9

Q ss_pred             CCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEEEeccCC
Q 016594           71 ENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQFSSRG  148 (386)
Q Consensus        71 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~~~~~  148 (386)
                      .++||.|.||+||-|+++ +|+.||||++.+.......+..+.+|+.||++++||.||.+.-.|+..+ .+.|||-+.| 
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G-  647 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG-  647 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc-
Confidence            578999999999999976 7999999999987777777788999999999999999999998888766 6777777765 


Q ss_pred             CHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCC---CCeEEeecCccccCCCCCccc
Q 016594          149 SVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTAD---FEPQISDFGLAKWLPSQWTHH  225 (386)
Q Consensus       149 ~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~---~~~kl~Dfg~a~~~~~~~~~~  225 (386)
                      ++.+.+-......+++.....++.||+.||.|||-   ++|+|+||||+|||+...   .++||||||.|+..+...   
T Consensus       648 DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~---knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks---  721 (888)
T KOG4236|consen  648 DMLEMILSSEKGRLPERITKFLVTQILVALRYLHF---KNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS---  721 (888)
T ss_pred             hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhh---cceeeccCCchheeeccCCCCCceeeccccceeecchhh---
Confidence            66665555555669999999999999999999999   999999999999999743   479999999999887542   


Q ss_pred             cccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCCCCCHH
Q 016594          226 SIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVT  305 (386)
Q Consensus       226 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (386)
                      ...+.+||+.|+|||++.++.|...-|+||.|+|+|--++|..||....+--.+...        ..++-   ....-.+
T Consensus       722 FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQN--------AaFMy---Pp~PW~e  790 (888)
T KOG4236|consen  722 FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQN--------AAFMY---PPNPWSE  790 (888)
T ss_pred             hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHhhc--------ccccc---CCCchhh
Confidence            345678999999999999999999999999999999999999999765432111000        00111   1111234


Q ss_pred             HHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCC
Q 016594          306 QLNRLAFAASLCIRASPTWRPTMSEVLEVMLEGD  339 (386)
Q Consensus       306 ~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~~  339 (386)
                      .+....+||...|+..-.+|-+.+.-+.+.|-.+
T Consensus       791 is~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~  824 (888)
T KOG4236|consen  791 ISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQD  824 (888)
T ss_pred             cCHHHHHHHHHHHHHHHHHhcchHhhccchhhhc
Confidence            5677899999999999999999999988766554

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=1.1e-36  Score=306.67  Aligned_cols=146  Identities=27%  Similarity=0.424  Sum_probs=129.4

Q ss_pred             cCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEecccc-CChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEE
Q 016594           66 NAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVV-TDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIF  142 (386)
Q Consensus        66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~  142 (386)
                      ++|.+.++||+|+||+||+|.+. +++.||||++.... ........+.+|+.++..++||||+++++++.... .|+||
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm   83 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM   83 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence            57889999999999999999987 68999999987532 23344567889999999999999999999887655 89999


Q ss_pred             EeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccc
Q 016594          143 QFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAK  216 (386)
Q Consensus       143 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~  216 (386)
                      ||+.+++|.+++....  .+++..++.++.||+.||.|||.   ++|+||||||+|||++.++.+||+|||+++
T Consensus        84 Ey~~g~~L~~li~~~~--~l~~~~~~~i~~qil~aL~yLH~---~gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          84 EYLIGGDVKSLLHIYG--YFDEEMAVKYISEVALALDYLHR---HGIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             eCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            9999999999987543  37889999999999999999999   899999999999999999999999999975

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.7e-37  Score=274.04  Aligned_cols=241  Identities=25%  Similarity=0.309  Sum_probs=195.0

Q ss_pred             ecccCCcEEEEEEEC-CCcEEEEEEeccccCC-hHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEEEeccCCCH
Q 016594           74 VGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTD-DRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQFSSRGSV  150 (386)
Q Consensus        74 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~~~~~~L  150 (386)
                      ||.|+||.||++... +++.||+|.+...... ......+..|+.+++.+.|+||+++++.+..+. .+++|+++.+++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            699999999999976 5889999998764322 234567889999999999999999999987655 8999999999999


Q ss_pred             hhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCcccccccc
Q 016594          151 ASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPI  230 (386)
Q Consensus       151 ~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~  230 (386)
                      .+++....  .+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||++.......  ......
T Consensus        81 ~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lh~---~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~  153 (250)
T cd05123          81 FSHLSKEG--RFSEERARFYAAEIVLALEYLHS---LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNTF  153 (250)
T ss_pred             HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccCC
Confidence            99987543  48999999999999999999999   999999999999999999999999999987764331  122345


Q ss_pred             ccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCCCCCHHHHHHH
Q 016594          231 EGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQLNRL  310 (386)
Q Consensus       231 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  310 (386)
                      .++..|+|||.+.+..++.++|+||||+++|+|++|..||...+...  ....         +..  .....+...+..+
T Consensus       154 ~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~--~~~~---------~~~--~~~~~~~~~~~~l  220 (250)
T cd05123         154 CGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKE--IYEK---------ILK--DPLRFPEFLSPEA  220 (250)
T ss_pred             cCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH--HHHH---------Hhc--CCCCCCCCCCHHH
Confidence            57889999999988888999999999999999999999997654311  0000         000  0111222235778


Q ss_pred             HHHHHHccccCCCCCCCH---HHHHHH
Q 016594          311 AFAASLCIRASPTWRPTM---SEVLEV  334 (386)
Q Consensus       311 ~~li~~cl~~dP~~Rpt~---~~il~~  334 (386)
                      .+++.+||..||++||++   .+++.+
T Consensus       221 ~~~i~~~l~~~p~~R~~~~~~~~l~~~  247 (250)
T cd05123         221 RDLISGLLQKDPTKRLGSGGAEEIKAH  247 (250)
T ss_pred             HHHHHHHhcCCHhhCCCcccHHHHHhC
Confidence            999999999999999999   666654

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-37  Score=297.79  Aligned_cols=254  Identities=26%  Similarity=0.410  Sum_probs=212.0

Q ss_pred             HhcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccC-CCceeeecceEEe------
Q 016594           64 ATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVC-HPNVLSLLGCCVD------  135 (386)
Q Consensus        64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~------  135 (386)
                      .+.-|++...||.|.+|.||+++.+ +++..|+|++....   ....++..|.++|+.+. |||++.+++++..      
T Consensus        17 p~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~---d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~   93 (953)
T KOG0587|consen   17 PADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE---DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNG   93 (953)
T ss_pred             CCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc---cccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCC
Confidence            3456788999999999999999965 68899999887533   33445667889998886 9999999999853      


Q ss_pred             CceEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCcc
Q 016594          136 NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLA  215 (386)
Q Consensus       136 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a  215 (386)
                      +.++||||||.+|+..+++....+..+.|..+..|.+.++.||.+||.   +.++|||||-.|||++.++.|||+|||++
T Consensus        94 DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~---nkviHRDikG~NiLLT~e~~VKLvDFGvS  170 (953)
T KOG0587|consen   94 DQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHN---NKVIHRDIKGQNVLLTENAEVKLVDFGVS  170 (953)
T ss_pred             CeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhh---cceeeecccCceEEEeccCcEEEeeeeee
Confidence            339999999999999999998888889999999999999999999999   99999999999999999999999999999


Q ss_pred             ccCCCCCccccccccccccCccChhhhccC-----CCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhccccc
Q 016594          216 KWLPSQWTHHSIAPIEGTFGHLAPEYFMHG-----IVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEI  290 (386)
Q Consensus       216 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  290 (386)
                      ..+...  .....+.+||+.|||||++...     .|+..+|+||||++..||..|.+|+...+...           .+
T Consensus       171 aQldsT--~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmr-----------aL  237 (953)
T KOG0587|consen  171 AQLDST--VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMR-----------AL  237 (953)
T ss_pred             eeeecc--cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhh-----------hh
Confidence            887653  3345567899999999999743     47789999999999999999999997754321           11


Q ss_pred             ccc-cCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 016594          291 EKL-VDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVML  336 (386)
Q Consensus       291 ~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~  336 (386)
                      ..+ ..|.+....+..++..+.++|..||.+|..+||++.++++|-.
T Consensus       238 F~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpF  284 (953)
T KOG0587|consen  238 FLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPF  284 (953)
T ss_pred             ccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCc
Confidence            111 1233333445677899999999999999999999999998743

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-37  Score=305.87  Aligned_cols=262  Identities=26%  Similarity=0.447  Sum_probs=213.3

Q ss_pred             HHHHHhcCCCCCCeecccCCcEEEEEEEC----C----CcEEEEEEeccccCChHhHHHHHHHHHHHhccC-CCceeeec
Q 016594           60 EISIATNAFSSENLVGRGGYAEVYKGVLQ----D----GEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVC-HPNVLSLL  130 (386)
Q Consensus        60 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~----~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~  130 (386)
                      .+++..++..+.+.||+|.||.|++|...    .    ...||||.++..... .....+..|+++|+.+. |+||+.++
T Consensus       290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-~~~~~~~~El~~m~~~g~H~niv~ll  368 (609)
T KOG0200|consen  290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-SEKKDLMSELNVLKELGKHPNIVNLL  368 (609)
T ss_pred             ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc-HHHHHHHHHHHHHHHhcCCcchhhhe
Confidence            45667777788889999999999999832    1    346999999875555 67788999999999997 99999999


Q ss_pred             ceEEeCc-eEEEEEeccCCCHhhhhhhcC------C--------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCC
Q 016594          131 GCCVDNG-LYLIFQFSSRGSVASLFHDVN------S--------PGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIK  195 (386)
Q Consensus       131 ~~~~~~~-~~lv~e~~~~~~L~~~~~~~~------~--------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk  195 (386)
                      |++..++ .++++||+..|+|..+++...      .        ..++....+.++.||+.|++||++   .++|||||-
T Consensus       369 G~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~---~~~vHRDLA  445 (609)
T KOG0200|consen  369 GACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLAS---VPCVHRDLA  445 (609)
T ss_pred             eeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhh---CCccchhhh
Confidence            9998855 899999999999999987655      0        128889999999999999999999   999999999


Q ss_pred             CCCeeEcCCCCeEEeecCccccCCCCCcccccccccc--ccCccChhhhccCCCCcccchHHHHHHHHHHHh-CCCCCCC
Q 016594          196 SSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEG--TFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDG  272 (386)
Q Consensus       196 p~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~  272 (386)
                      .+|||+..+..+||+|||+|+........ ....-.|  ...|||||.+....|+.++||||||++|||+++ |..||.+
T Consensus       446 aRNVLi~~~~~~kIaDFGlar~~~~~~~y-~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~  524 (609)
T KOG0200|consen  446 ARNVLITKNKVIKIADFGLARDHYNKDYY-RTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPG  524 (609)
T ss_pred             hhhEEecCCCEEEEccccceeccCCCCce-EecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCC
Confidence            99999999999999999999865433211 1111122  234999999999999999999999999999999 9999987


Q ss_pred             CchhhhhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 016594          273 SHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLE  337 (386)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~  337 (386)
                      ....           ..+.+.+.+..+...+..+..++.++++.||+.+|++||++.++.+.+..
T Consensus       525 ~~~~-----------~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~  578 (609)
T KOG0200|consen  525 IPPT-----------EELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEK  578 (609)
T ss_pred             CCcH-----------HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHH
Confidence            3211           11122333444445566677889999999999999999999999998876

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-37  Score=278.79  Aligned_cols=269  Identities=26%  Similarity=0.385  Sum_probs=203.1

Q ss_pred             cCCCCCCeecccCCcEEEEEEECCCcEEEEEEeccccCChHhHHHHHHHHHHHhc--cCCCceeeecceEEeC-----ce
Q 016594           66 NAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGH--VCHPNVLSLLGCCVDN-----GL  138 (386)
Q Consensus        66 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~~-----~~  138 (386)
                      ...++..+||+|.||.||+|.+. ++.||||++.     ......+..|-+|.+.  +.|+||++++++-...     ++
T Consensus       210 ~pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp-----~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~ey  283 (534)
T KOG3653|consen  210 DPLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFP-----EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEY  283 (534)
T ss_pred             CchhhHHHhhcCccceeehhhcc-CceeEEEecC-----HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccce
Confidence            34566788999999999999986 6999999987     4456677788777765  4699999999987542     48


Q ss_pred             EEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHh------CCCCCeEEeCCCCCCeeEcCCCCeEEeec
Q 016594          139 YLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHK------GCQRRIIHRDIKSSNILLTADFEPQISDF  212 (386)
Q Consensus       139 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~------~~~~~ivH~dlkp~Nill~~~~~~kl~Df  212 (386)
                      .+|++|.+.|+|.+++...   .++|....+++..++.||+|||.      .++..|+|||||.+|||+..|++..|+||
T Consensus       284 wLVt~fh~kGsL~dyL~~n---tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDF  360 (534)
T KOG3653|consen  284 WLVTEFHPKGSLCDYLKAN---TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADF  360 (534)
T ss_pred             eEEeeeccCCcHHHHHHhc---cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecc
Confidence            9999999999999999754   38999999999999999999997      33467999999999999999999999999


Q ss_pred             CccccCCCCCccccccccccccCccChhhhccCC-CC-----cccchHHHHHHHHHHHhCCCCCC-CCchhhh-hhhhhh
Q 016594          213 GLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGI-VD-----EKTDVFAFGVFLLEIISGRKPVD-GSHQSLH-SWAKPI  284 (386)
Q Consensus       213 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-----~~~DvwslG~il~ell~g~~pf~-~~~~~~~-~~~~~~  284 (386)
                      |+|..+............+||.+|||||++.+.. +.     .+.||||+|.+||||++...-+. +...... .+..++
T Consensus       361 GLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~ev  440 (534)
T KOG3653|consen  361 GLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEV  440 (534)
T ss_pred             ceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHh
Confidence            9999988766555556688999999999997643 22     46899999999999999655442 1111000 000000


Q ss_pred             hccccc---cc-ccCCccCCCCCH-----HHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCCcccc
Q 016594          285 LNQGEI---EK-LVDPRLQGAYDV-----TQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEGDQIDK  343 (386)
Q Consensus       285 ~~~~~~---~~-~~~~~~~~~~~~-----~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~~~~~~  343 (386)
                      -....+   .. .+.++.++.++.     .....+.+.+..||..||+.|.|+.=+-+++.+......
T Consensus       441 G~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~  508 (534)
T KOG3653|consen  441 GNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWE  508 (534)
T ss_pred             cCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCC
Confidence            000011   11 111222222222     235679999999999999999999999988887765444

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.5e-39  Score=270.86  Aligned_cols=270  Identities=21%  Similarity=0.327  Sum_probs=203.4

Q ss_pred             HhcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEe-----C-
Q 016594           64 ATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVD-----N-  136 (386)
Q Consensus        64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-----~-  136 (386)
                      ..+.|....+||+|.||.||+|+.+ +|+.||+|++-.......-....++|+++|..|.|+|++.+++.|..     . 
T Consensus        15 ~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r   94 (376)
T KOG0669|consen   15 EVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNR   94 (376)
T ss_pred             cchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccc
Confidence            3456777789999999999999976 68889998765433334445677899999999999999999998842     1 


Q ss_pred             ---ceEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecC
Q 016594          137 ---GLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFG  213 (386)
Q Consensus       137 ---~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg  213 (386)
                         .+|+||.+|.. +|.-++.... ..++...+..++.+++.||.|+|.   ..|+|||+||.|+|++.+|.+||+|||
T Consensus        95 ~r~t~ylVf~~ceh-DLaGlLsn~~-vr~sls~Ikk~Mk~Lm~GL~~iHr---~kilHRDmKaaNvLIt~dgilklADFG  169 (376)
T KOG0669|consen   95 DRATFYLVFDFCEH-DLAGLLSNRK-VRFSLSEIKKVMKGLMNGLYYIHR---NKILHRDMKAANVLITKDGILKLADFG  169 (376)
T ss_pred             ccceeeeeHHHhhh-hHHHHhcCcc-ccccHHHHHHHHHHHHHHHHHHHH---hhHHhhcccHhhEEEcCCceEEeeccc
Confidence               27999999987 7777776543 238999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCC--ccccccccccccCccChhhhcc-CCCCcccchHHHHHHHHHHHhCCCCCCCCchhh-hhhhhh------
Q 016594          214 LAKWLPSQW--THHSIAPIEGTFGHLAPEYFMH-GIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSL-HSWAKP------  283 (386)
Q Consensus       214 ~a~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~-~~~~~~------  283 (386)
                      +++.+....  .....+..+-|++|.+||.+.| ..|+++.|||+.|||+.||++|.+-+.+..... ...+..      
T Consensus       170 lar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~t  249 (376)
T KOG0669|consen  170 LARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSIT  249 (376)
T ss_pred             cccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCC
Confidence            998765432  2223445567999999999987 569999999999999999999999998765321 111111      


Q ss_pred             -----hhccccccccc--CCccCCCCCH--H------HHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          284 -----ILNQGEIEKLV--DPRLQGAYDV--T------QLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       284 -----~~~~~~~~~~~--~~~~~~~~~~--~------~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                           .+..-.+.+.+  .|.....+..  +      ......+|+.++|..||.+|+++++++.+....
T Consensus       250 kevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~  319 (376)
T KOG0669|consen  250 KEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFW  319 (376)
T ss_pred             cccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhh
Confidence                 11111111111  1111111100  0      023678999999999999999999999986543

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=2.1e-36  Score=268.54  Aligned_cols=224  Identities=20%  Similarity=0.184  Sum_probs=177.6

Q ss_pred             cCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEEEeccCCCHhhhh
Q 016594           77 GGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQFSSRGSVASLF  154 (386)
Q Consensus        77 G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~~~~~~L~~~~  154 (386)
                      |.+|.||++.+. +++.||+|.+....       ...+|...+....||||+++++++.+.. .+++|||+.+++|.+++
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l   76 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHI   76 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHH
Confidence            899999999976 68999999987532       1223444455567999999999987755 89999999999999988


Q ss_pred             hhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCcccccccccccc
Q 016594          155 HDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTF  234 (386)
Q Consensus       155 ~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~  234 (386)
                      ....  .+++..+..++.|++.||.|||+   ++++||||||+||+++.++.++++|||.+..+...     .....++.
T Consensus        77 ~~~~--~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~  146 (237)
T cd05576          77 SKFL--NIPEECVKRWAAEMVVALDALHR---EGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CDGEAVEN  146 (237)
T ss_pred             HHhc--CCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCEEEecccchhccccc-----cccCCcCc
Confidence            6543  48999999999999999999999   99999999999999999999999999987665432     12234567


Q ss_pred             CccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHH
Q 016594          235 GHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQLNRLAFAA  314 (386)
Q Consensus       235 ~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  314 (386)
                      .|+|||.+.+..++.++||||+||++|+|++|..||.......             ..    ......+...+..+.+++
T Consensus       147 ~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~-------------~~----~~~~~~~~~~~~~~~~li  209 (237)
T cd05576         147 MYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI-------------NT----HTTLNIPEWVSEEARSLL  209 (237)
T ss_pred             cccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc-------------cc----ccccCCcccCCHHHHHHH
Confidence            7999999988889999999999999999999998876432110             00    000112223456789999


Q ss_pred             HHccccCCCCCCCH-----HHHHHH
Q 016594          315 SLCIRASPTWRPTM-----SEVLEV  334 (386)
Q Consensus       315 ~~cl~~dP~~Rpt~-----~~il~~  334 (386)
                      .+||+.||++||++     .+++.|
T Consensus       210 ~~~l~~dp~~R~~~~~~~~~~~~~h  234 (237)
T cd05576         210 QQLLQFNPTERLGAGVAGVEDIKSH  234 (237)
T ss_pred             HHHccCCHHHhcCCCccchHHHHcC
Confidence            99999999999996     555543

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=8.1e-37  Score=284.39  Aligned_cols=207  Identities=23%  Similarity=0.307  Sum_probs=175.5

Q ss_pred             HHHhcCCCCCCeecccCCcEEEEEEE-CCCcEEEEEEeccc-cCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-e
Q 016594           62 SIATNAFSSENLVGRGGYAEVYKGVL-QDGEEIAVKRLTKV-VTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-L  138 (386)
Q Consensus        62 ~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~-~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~  138 (386)
                      +....-|..++.||-|+||.|.+++- ++...||+|.+.+. ............|-+||.....+-||+||-.|.++. +
T Consensus       625 KMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnL  704 (1034)
T KOG0608|consen  625 KMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNL  704 (1034)
T ss_pred             hccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCce
Confidence            34456678889999999999999984 46778999998863 233444566788999999999999999999998765 9


Q ss_pred             EEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccC
Q 016594          139 YLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWL  218 (386)
Q Consensus       139 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~  218 (386)
                      |+||+|++||++..+|-+..-  |++..++.++.++..|+++.|.   .|+|||||||+|||||.+|++||+|||++.-+
T Consensus       705 YFVMdYIPGGDmMSLLIrmgI--FeE~LARFYIAEltcAiesVHk---mGFIHRDiKPDNILIDrdGHIKLTDFGLCTGf  779 (1034)
T KOG0608|consen  705 YFVMDYIPGGDMMSLLIRMGI--FEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGF  779 (1034)
T ss_pred             EEEEeccCCccHHHHHHHhcc--CHHHHHHHHHHHHHHHHHHHHh---ccceecccCccceEEccCCceeeeeccccccc
Confidence            999999999999998876544  8999999999999999999999   99999999999999999999999999998654


Q ss_pred             CCCCc----------------------------------------cccccccccccCccChhhhccCCCCcccchHHHHH
Q 016594          219 PSQWT----------------------------------------HHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGV  258 (386)
Q Consensus       219 ~~~~~----------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~  258 (386)
                      .....                                        .......+||+.|+|||++....|+..+|+||.||
T Consensus       780 RWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gv  859 (1034)
T KOG0608|consen  780 RWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGV  859 (1034)
T ss_pred             eeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhH
Confidence            21100                                        00112456999999999999999999999999999


Q ss_pred             HHHHHHhCCCCCCCC
Q 016594          259 FLLEIISGRKPVDGS  273 (386)
Q Consensus       259 il~ell~g~~pf~~~  273 (386)
                      |||||+.|++||...
T Consensus       860 il~em~~g~~pf~~~  874 (1034)
T KOG0608|consen  860 ILYEMLVGQPPFLAD  874 (1034)
T ss_pred             HHHHHhhCCCCccCC
Confidence            999999999999754

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-36  Score=269.71  Aligned_cols=267  Identities=26%  Similarity=0.360  Sum_probs=203.1

Q ss_pred             HHHhcCCCCCCeecccCCcEEEEEEECCCcEEEEEEeccccCChHhHHHHHHHHHHHhc--cCCCceeeecceEEeCc--
Q 016594           62 SIATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGH--VCHPNVLSLLGCCVDNG--  137 (386)
Q Consensus        62 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~~~--  137 (386)
                      .....+..+.+.||+|.||.||+|.|+ |..||||++..     .++....+|.++.+.  |+|+||+.+++....++  
T Consensus       207 RTiarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~s-----rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs  280 (513)
T KOG2052|consen  207 RTIARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSS-----RDERSWFRETEIYQTVMLRHENILGFIAADNKDNGS  280 (513)
T ss_pred             HhhhheeEEEEEecCccccceeecccc-CCceEEEEecc-----cchhhhhhHHHHHHHHHhccchhhhhhhccccCCCc
Confidence            345678889999999999999999998 89999999973     345667788888765  58999999999875432  


Q ss_pred             ---eEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHh-----CCCCCeEEeCCCCCCeeEcCCCCeEE
Q 016594          138 ---LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHK-----GCQRRIIHRDIKSSNILLTADFEPQI  209 (386)
Q Consensus       138 ---~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-----~~~~~ivH~dlkp~Nill~~~~~~kl  209 (386)
                         ++||.+|.+.|+|.|++.+   ..++....++++..++.||+|||.     ..+..|.|||||..|||+.+++...|
T Consensus       281 ~TQLwLvTdYHe~GSL~DyL~r---~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~I  357 (513)
T KOG2052|consen  281 WTQLWLVTDYHEHGSLYDYLNR---NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCI  357 (513)
T ss_pred             eEEEEEeeecccCCcHHHHHhh---ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEE
Confidence               8999999999999999986   338999999999999999999996     22367999999999999999999999


Q ss_pred             eecCccccCCCCCc--cccccccccccCccChhhhccCC----CC--cccchHHHHHHHHHHHhC----------CCCCC
Q 016594          210 SDFGLAKWLPSQWT--HHSIAPIEGTFGHLAPEYFMHGI----VD--EKTDVFAFGVFLLEIISG----------RKPVD  271 (386)
Q Consensus       210 ~Dfg~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~----~~--~~~DvwslG~il~ell~g----------~~pf~  271 (386)
                      +|+|+|........  .......+||.+|||||++...-    +.  ..+||||||.++||++..          ++||.
T Consensus       358 ADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyy  437 (513)
T KOG2052|consen  358 ADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYY  437 (513)
T ss_pred             eeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcc
Confidence            99999987654421  12335678999999999986432    21  468999999999998752          35665


Q ss_pred             CCchhhhh--hhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCCc
Q 016594          272 GSHQSLHS--WAKPILNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEGDQ  340 (386)
Q Consensus       272 ~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~~~  340 (386)
                      +.-+....  .+..++-   +.++.........+.+....+.++++.||..||..|.|+--|-+.|.+..+
T Consensus       438 d~Vp~DPs~eeMrkVVC---v~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~  505 (513)
T KOG2052|consen  438 DVVPSDPSFEEMRKVVC---VQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN  505 (513)
T ss_pred             cCCCCCCCHHHHhccee---ecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence            43221111  0111100   111111122223344567889999999999999999999888888876654

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-35  Score=268.48  Aligned_cols=267  Identities=20%  Similarity=0.308  Sum_probs=200.4

Q ss_pred             HHHh-cCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccC--------CCceeeecc
Q 016594           62 SIAT-NAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVC--------HPNVLSLLG  131 (386)
Q Consensus        62 ~~~~-~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~--------h~niv~l~~  131 (386)
                      .... ++|.+.++||.|.|++||+|.+. +.+.||+|+.+.   ........+.|+++|+++.        ..+||+|++
T Consensus        73 D~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKS---AqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD  149 (590)
T KOG1290|consen   73 DVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKS---AQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLD  149 (590)
T ss_pred             ccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEeh---hhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeec
Confidence            3444 89999999999999999999965 678899999873   2444566789999999884        247999999


Q ss_pred             eEEeCc-----eEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCC--
Q 016594          132 CCVDNG-----LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTAD--  204 (386)
Q Consensus       132 ~~~~~~-----~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~--  204 (386)
                      .|...+     +|+|+|++ |.+|..++.....++++...+..|++|++.||.|||..  .||||-||||+|||+...  
T Consensus       150 ~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~e--cgIIHTDlKPENvLl~~~e~  226 (590)
T KOG1290|consen  150 HFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRE--CGIIHTDLKPENVLLCSTEI  226 (590)
T ss_pred             cceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHh--cCccccCCCcceeeeecccc
Confidence            997532     78898887 45899999999999999999999999999999999994  699999999999999321  


Q ss_pred             --------------------------------------------------------------------------------
Q 016594          205 --------------------------------------------------------------------------------  204 (386)
Q Consensus       205 --------------------------------------------------------------------------------  204 (386)
                                                                                                      
T Consensus       227 ~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~  306 (590)
T KOG1290|consen  227 DPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNE  306 (590)
T ss_pred             chhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccc
Confidence                                                                                            


Q ss_pred             --------------------------------------------------------------------------------
Q 016594          205 --------------------------------------------------------------------------------  204 (386)
Q Consensus       205 --------------------------------------------------------------------------------  204 (386)
                                                                                                      
T Consensus       307 ~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~  386 (590)
T KOG1290|consen  307 PRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPL  386 (590)
T ss_pred             cCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCC
Confidence                                                                                            


Q ss_pred             ----CCeEEeecCccccCCCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCch-----
Q 016594          205 ----FEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQ-----  275 (386)
Q Consensus       205 ----~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~-----  275 (386)
                          -.+||+|||-|+....     .++.-..|..|+|||++.+..|++.+||||++|++|||+||...|+....     
T Consensus       387 ~~~di~vKIaDlGNACW~~k-----hFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~r  461 (590)
T KOG1290|consen  387 PECDIRVKIADLGNACWVHK-----HFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSR  461 (590)
T ss_pred             CccceeEEEeeccchhhhhh-----hhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCc
Confidence                0145666666554322     23333468889999999999999999999999999999999999964321     


Q ss_pred             ---hhhhhh-----------------hhhhc-ccccccccCCc-------c--CCCCCHHHHHHHHHHHHHccccCCCCC
Q 016594          276 ---SLHSWA-----------------KPILN-QGEIEKLVDPR-------L--QGAYDVTQLNRLAFAASLCIRASPTWR  325 (386)
Q Consensus       276 ---~~~~~~-----------------~~~~~-~~~~~~~~~~~-------~--~~~~~~~~~~~l~~li~~cl~~dP~~R  325 (386)
                         .+...+                 +.+.+ .+.+..+-.-+       +  .-.++.+...++.+++.-||+.+|++|
T Consensus       462 DEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR  541 (590)
T KOG1290|consen  462 DEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKR  541 (590)
T ss_pred             cHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCcccc
Confidence               111100                 00111 11111111000       0  012345556789999999999999999


Q ss_pred             CCHHHHHHHHhcCC
Q 016594          326 PTMSEVLEVMLEGD  339 (386)
Q Consensus       326 pt~~~il~~l~~~~  339 (386)
                      |||.+.|+|.+-..
T Consensus       542 ~tA~~cl~hPwLn~  555 (590)
T KOG1290|consen  542 PTAAQCLKHPWLNP  555 (590)
T ss_pred             ccHHHHhcCccccC
Confidence            99999999977664

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=3e-36  Score=266.66  Aligned_cols=264  Identities=20%  Similarity=0.322  Sum_probs=218.4

Q ss_pred             HHHHHHHhcCCCCCCeecccCCcEEEEEEECC------CcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecc
Q 016594           58 FEEISIATNAFSSENLVGRGGYAEVYKGVLQD------GEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLG  131 (386)
Q Consensus        58 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~  131 (386)
                      ..++.+...++++..++-+|.||.||.|.|++      .+.|-+|.++. ...+.....++.|...+..+.|||+..+.+
T Consensus       276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~-~AS~iQv~~~L~es~lly~~sH~nll~V~~  354 (563)
T KOG1024|consen  276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQ-HASQIQVNLLLQESMLLYGASHPNLLSVLG  354 (563)
T ss_pred             HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHh-cccHHHHHHHHHHHHHHhcCcCCCccceeE
Confidence            45667778889999999999999999998653      34566776654 233445567889999999999999999999


Q ss_pred             eEEeCc--eEEEEEeccCCCHhhhhhhc------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcC
Q 016594          132 CCVDNG--LYLIFQFSSRGSVASLFHDV------NSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTA  203 (386)
Q Consensus       132 ~~~~~~--~~lv~e~~~~~~L~~~~~~~------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~  203 (386)
                      ++.++.  .+.++.+..-|+|..++...      ..+.++..+...++.|++.|++|||+   +++||.||..+|.++|+
T Consensus       355 V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~---~~ViHkDiAaRNCvIdd  431 (563)
T KOG1024|consen  355 VSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHN---HGVIHKDIAARNCVIDD  431 (563)
T ss_pred             EEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHh---cCcccchhhhhcceehh
Confidence            987654  77888888899999988722      22346777888999999999999999   99999999999999999


Q ss_pred             CCCeEEeecCccccCCCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCchhhhhhhh
Q 016594          204 DFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAK  282 (386)
Q Consensus       204 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~  282 (386)
                      ..+|||+|-.+++.+...+.+.....-.....||+||.+.+..|+.++||||||+++|||+| |+.|+..-+.       
T Consensus       432 ~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDP-------  504 (563)
T KOG1024|consen  432 QLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDP-------  504 (563)
T ss_pred             heeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCH-------
Confidence            99999999999998766655544444456778999999999999999999999999999999 9999976433       


Q ss_pred             hhhcccccccccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 016594          283 PILNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLE  337 (386)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~  337 (386)
                           .++...+....+...+.+++.++..++..||...|++||+++++..-|.+
T Consensus       505 -----fEm~~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLse  554 (563)
T KOG1024|consen  505 -----FEMEHYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSE  554 (563)
T ss_pred             -----HHHHHHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence                 23444455556666777889999999999999999999999999988754

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-36  Score=272.85  Aligned_cols=261  Identities=23%  Similarity=0.305  Sum_probs=200.6

Q ss_pred             HhcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCCh-----HhHHHHHHHHHHHhccCCCceeeecceEEe--
Q 016594           64 ATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDD-----RKEKEFLTEIGTIGHVCHPNVLSLLGCCVD--  135 (386)
Q Consensus        64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--  135 (386)
                      ..++|-++.+||+|+|+.||+|.+- ..+.||||+-.......     ...+...+|..|.+.|.||.||++|++|.-  
T Consensus       461 Ln~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDt  540 (775)
T KOG1151|consen  461 LNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDT  540 (775)
T ss_pred             hHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecc
Confidence            4567888999999999999999954 57889999755322222     223457899999999999999999999954  


Q ss_pred             CceEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcC---CCCeEEeec
Q 016594          136 NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTA---DFEPQISDF  212 (386)
Q Consensus       136 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~---~~~~kl~Df  212 (386)
                      +.+|-|+|||+|.+|+-++....  .+++.++..|+.||+.||.||..- ..+|||-||||.||||..   -|.+||+||
T Consensus       541 dsFCTVLEYceGNDLDFYLKQhk--lmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDF  617 (775)
T KOG1151|consen  541 DSFCTVLEYCEGNDLDFYLKQHK--LMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDF  617 (775)
T ss_pred             ccceeeeeecCCCchhHHHHhhh--hhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeec
Confidence            33899999999999998887544  489999999999999999999973 267999999999999953   478999999


Q ss_pred             CccccCCCCCccc-----cccccccccCccChhhhccC----CCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhh
Q 016594          213 GLAKWLPSQWTHH-----SIAPIEGTFGHLAPEYFMHG----IVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKP  283 (386)
Q Consensus       213 g~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~  283 (386)
                      |+++.+.......     ......||.+|++||.+.-+    +.+.++||||+|||+|..+.|+.||........     
T Consensus       618 GLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQd-----  692 (775)
T KOG1151|consen  618 GLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQD-----  692 (775)
T ss_pred             chhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHH-----
Confidence            9999886553321     22346799999999998633    467899999999999999999999986532211     


Q ss_pred             hhcccccccccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 016594          284 ILNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEV  334 (386)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~  334 (386)
                      ++....+.+..  ....+..+..+.+...+|++||++--++|....++...
T Consensus       693 ILqeNTIlkAt--EVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~d  741 (775)
T KOG1151|consen  693 ILQENTILKAT--EVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACD  741 (775)
T ss_pred             HHhhhchhcce--eccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccC
Confidence            11112222211  11222223346778999999999999999988877754

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-36  Score=261.84  Aligned_cols=255  Identities=20%  Similarity=0.316  Sum_probs=198.7

Q ss_pred             HHhcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCCh-HhHHHHHHHHHHHhcc-CCCceeeecceEEeCc-e
Q 016594           63 IATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDD-RKEKEFLTEIGTIGHV-CHPNVLSLLGCCVDNG-L  138 (386)
Q Consensus        63 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~-~  138 (386)
                      ..-++|.+..+||+|+|++|.+++++ +.+-||+|++++...+. +...=...|-.+..+. +||.+|.++.||..+. +
T Consensus       247 l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrl  326 (593)
T KOG0695|consen  247 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRL  326 (593)
T ss_pred             cccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceE
Confidence            45578999999999999999999976 67889999998754333 3333344566666555 5999999999997655 9


Q ss_pred             EEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccC
Q 016594          139 YLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWL  218 (386)
Q Consensus       139 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~  218 (386)
                      ++|.||++||+|.-.+++.  +.++++.+..+...|+.||.|||+   +|||.||||.+|+|+|..|++||+|+|+++.-
T Consensus       327 ffvieyv~ggdlmfhmqrq--rklpeeharfys~ei~lal~flh~---rgiiyrdlkldnvlldaeghikltdygmcke~  401 (593)
T KOG0695|consen  327 FFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEICLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEG  401 (593)
T ss_pred             EEEEEEecCcceeeehhhh--hcCcHHHhhhhhHHHHHHHHHHhh---cCeeeeeccccceEEccCCceeecccchhhcC
Confidence            9999999999997766643  449999999999999999999999   99999999999999999999999999999864


Q ss_pred             CCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCch-----hhhhhhhhhhcccccccc
Q 016594          219 PSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQ-----SLHSWAKPILNQGEIEKL  293 (386)
Q Consensus       219 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~-----~~~~~~~~~~~~~~~~~~  293 (386)
                      -.  ......+++||+.|+|||.+.+..|...+|+|+||++++||+.|+.||+-...     .-.++..        .-+
T Consensus       402 l~--~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylf--------qvi  471 (593)
T KOG0695|consen  402 LG--PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLF--------QVI  471 (593)
T ss_pred             CC--CCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHH--------HHH
Confidence            22  22345678999999999999999999999999999999999999999973221     1111111        112


Q ss_pred             cCCccCCCCCHHHHHHHHHHHHHccccCCCCCC------CHHHHHHH
Q 016594          294 VDPRLQGAYDVTQLNRLAFAASLCIRASPTWRP------TMSEVLEV  334 (386)
Q Consensus       294 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp------t~~~il~~  334 (386)
                      +.+.++  .+...+-....+++..|++||.+|.      .+.++..|
T Consensus       472 lekqir--iprslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h  516 (593)
T KOG0695|consen  472 LEKQIR--IPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSH  516 (593)
T ss_pred             hhhccc--ccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcc
Confidence            223222  2233344566788889999999985      34555544

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=3e-35  Score=289.53  Aligned_cols=262  Identities=18%  Similarity=0.243  Sum_probs=172.2

Q ss_pred             HhcCCCCCCeecccCCcEEEEEEEC-C----CcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceE-----
Q 016594           64 ATNAFSSENLVGRGGYAEVYKGVLQ-D----GEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCC-----  133 (386)
Q Consensus        64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~-----  133 (386)
                      ..++|.+.+.||+|+||.||+|++. +    +..||+|.+......    .....+  .+....+.+++.+...+     
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~----e~~~~e--~l~~~~~~~~~~~~~~~~~~~~  203 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV----EIWMNE--RVRRACPNSCADFVYGFLEPVS  203 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh----HHHHHH--HHHhhchhhHHHHHHhhhcccc
Confidence            5578999999999999999999976 4    689999987642211    111111  12222233333332221     


Q ss_pred             --EeCceEEEEEeccCCCHhhhhhhcCCC------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeC
Q 016594          134 --VDNGLYLIFQFSSRGSVASLFHDVNSP------------------GVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRD  193 (386)
Q Consensus       134 --~~~~~~lv~e~~~~~~L~~~~~~~~~~------------------~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~d  193 (386)
                        .+...+++++|+.+++|.+++......                  ......+..++.|++.||.|||+   ++|+|||
T Consensus       204 ~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~---~gIiHRD  280 (566)
T PLN03225        204 SKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHS---TGIVHRD  280 (566)
T ss_pred             cccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHH---CCEEeCc
Confidence              223489999999999999988653211                  01234466899999999999999   9999999


Q ss_pred             CCCCCeeEcC-CCCeEEeecCccccCCCCCccccccccccccCccChhhhccC----------------------CCCcc
Q 016594          194 IKSSNILLTA-DFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHG----------------------IVDEK  250 (386)
Q Consensus       194 lkp~Nill~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~  250 (386)
                      |||+|||++. ++.+||+|||+|..+..... .......+++.|+|||.+...                      .++.+
T Consensus       281 LKP~NILl~~~~~~~KL~DFGlA~~l~~~~~-~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k  359 (566)
T PLN03225        281 VKPQNIIFSEGSGSFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDR  359 (566)
T ss_pred             CCHHHEEEeCCCCcEEEEeCCCccccccccc-cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCC
Confidence            9999999985 57999999999986643321 223456789999999976432                      23456


Q ss_pred             cchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccc----cccccCCccCCC----CC--HHHHHHHHHHHHHcccc
Q 016594          251 TDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGE----IEKLVDPRLQGA----YD--VTQLNRLAFAASLCIRA  320 (386)
Q Consensus       251 ~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~----~~--~~~~~~l~~li~~cl~~  320 (386)
                      +|||||||++|||+++..|+........   ..+...+.    ......+.....    +.  ........+|+.+||+.
T Consensus       360 ~DVwSlGviL~el~~~~~~~~~~~~~~~---~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~  436 (566)
T PLN03225        360 FDIYSAGLIFLQMAFPNLRSDSNLIQFN---RQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRF  436 (566)
T ss_pred             cccHHHHHHHHHHHhCcCCCchHHHHHH---HHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccC
Confidence            7999999999999998777544221111   11000000    000111110000    00  00123456899999999


Q ss_pred             CCCCCCCHHHHHHHHhcC
Q 016594          321 SPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       321 dP~~Rpt~~~il~~l~~~  338 (386)
                      ||++|||+.++++|-+..
T Consensus       437 dP~kR~ta~e~L~Hpff~  454 (566)
T PLN03225        437 KGRQRISAKAALAHPYFD  454 (566)
T ss_pred             CcccCCCHHHHhCCcCcC
Confidence            999999999999986554

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=8.8e-36  Score=242.70  Aligned_cols=207  Identities=26%  Similarity=0.409  Sum_probs=170.1

Q ss_pred             HHHHhcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhcc-CCCceeeecceEEeC-c
Q 016594           61 ISIATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHV-CHPNVLSLLGCCVDN-G  137 (386)
Q Consensus        61 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~-~  137 (386)
                      +++..+....+..||+|++|.|-+-++. +|...|+|.+.... +....+++++|+++..+. .+|.+|.+||...+. +
T Consensus        41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tv-n~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regd  119 (282)
T KOG0984|consen   41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATV-NSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGD  119 (282)
T ss_pred             cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhc-ChHHHHHHHHhhhhhccCCCCCeEEEeehhhhcccc
Confidence            3455556666788999999999888865 79999999998643 355677888999887654 599999999987664 4


Q ss_pred             eEEEEEeccCCCHhhhhhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCcc
Q 016594          138 LYLIFQFSSRGSVASLFHDV--NSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLA  215 (386)
Q Consensus       138 ~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a  215 (386)
                      .++.||.+.. +|..+....  .+..+++..+-+|+..+++||.|||+  +..++|||+||.|||++.+|+||+||||++
T Consensus       120 vwIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIs  196 (282)
T KOG0984|consen  120 VWICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGIS  196 (282)
T ss_pred             EEEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEcccccc
Confidence            8888888865 777765543  33458999999999999999999999  478999999999999999999999999999


Q ss_pred             ccCCCCCccccccccccccCccChhhhcc----CCCCcccchHHHHHHHHHHHhCCCCCCCCc
Q 016594          216 KWLPSQWTHHSIAPIEGTFGHLAPEYFMH----GIVDEKTDVFAFGVFLLEIISGRKPVDGSH  274 (386)
Q Consensus       216 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwslG~il~ell~g~~pf~~~~  274 (386)
                      ..+.++.....   -.|...|||||.+..    ..|+.++||||||+++.||.+++.||+...
T Consensus       197 G~L~dSiAkt~---daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~  256 (282)
T KOG0984|consen  197 GYLVDSIAKTM---DAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG  256 (282)
T ss_pred             eeehhhhHHHH---hcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC
Confidence            98866543221   348889999998853    479999999999999999999999998654

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-36  Score=289.12  Aligned_cols=250  Identities=27%  Similarity=0.364  Sum_probs=190.7

Q ss_pred             CCCCCCeecccCCcE-EEEEEECCCcEEEEEEeccccCChHhHHHHHHHHHHHhccC-CCceeeecceEEeCc-eEEEEE
Q 016594           67 AFSSENLVGRGGYAE-VYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVC-HPNVLSLLGCCVDNG-LYLIFQ  143 (386)
Q Consensus        67 ~~~~~~~lg~G~~g~-V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~-~~lv~e  143 (386)
                      -|.-.+++|.|+-|+ ||+|... |+.||||++-.     ....-+.+|+..|+.-. |||||++|+.-.+.. .|+..|
T Consensus       510 ~~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~-----e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalE  583 (903)
T KOG1027|consen  510 FFSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLE-----EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALE  583 (903)
T ss_pred             eeccHHHcccCCCCcEEEEEeeC-CceehHHHHhh-----HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEeh
Confidence            345567899999986 7999986 89999998863     34445679999998886 999999998877776 788888


Q ss_pred             eccCCCHhhhhhhc-CCCC-CCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcC---C--CCeEEeecCccc
Q 016594          144 FSSRGSVASLFHDV-NSPG-VEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTA---D--FEPQISDFGLAK  216 (386)
Q Consensus       144 ~~~~~~L~~~~~~~-~~~~-~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~---~--~~~kl~Dfg~a~  216 (386)
                      .|.. +|.+++... .... ......+.+..|+++||++||+   .+||||||||+||||+.   +  ..++|+|||+++
T Consensus       584 LC~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHs---l~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsK  659 (903)
T KOG1027|consen  584 LCAC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHS---LKIVHRDLKPQNILISVPSADGTLRAKISDFGLSK  659 (903)
T ss_pred             Hhhh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHh---cccccccCCCceEEEEccCCCcceeEEeccccccc
Confidence            8876 999998763 1111 1113456788999999999999   99999999999999975   3  468999999999


Q ss_pred             cCCCCCcc-ccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCchhhhhhhhhhhccccccccc
Q 016594          217 WLPSQWTH-HSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGEIEKLV  294 (386)
Q Consensus       217 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  294 (386)
                      .+...... .......||-+|+|||++....-+.++||+||||++|+.++ |.+||...-....+...   ....+..+.
T Consensus       660 kl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~---~~~~L~~L~  736 (903)
T KOG1027|consen  660 KLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILT---GNYTLVHLE  736 (903)
T ss_pred             ccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhc---Cccceeeec
Confidence            98765432 22455679999999999999888899999999999999999 69999875433222111   111111110


Q ss_pred             CCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          295 DPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       295 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                             ...++  ...+||.+|++++|..||++.+||.|...+
T Consensus       737 -------~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW  771 (903)
T KOG1027|consen  737 -------PLPDC--EAKDLISRMLNPDPQLRPSATDVLNHPLFW  771 (903)
T ss_pred             -------cCchH--HHHHHHHHhcCCCcccCCCHHHHhCCCccC
Confidence                   01111  689999999999999999999999875443

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=2.8e-34  Score=254.65  Aligned_cols=238  Identities=27%  Similarity=0.407  Sum_probs=191.2

Q ss_pred             CCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEEEeccCCCHhhhhh
Q 016594           78 GYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQFSSRGSVASLFH  155 (386)
Q Consensus        78 ~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~~~~~~L~~~~~  155 (386)
                      +||.||+|.+. +++.+|+|++........ ...+.+|+..+++++|+||+++++++.... .++++|++.+++|.+++.
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~   79 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK-RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLK   79 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccH-HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHH
Confidence            58999999987 589999999876433222 578899999999999999999999997754 899999999999999887


Q ss_pred             hcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCccccccccccccC
Q 016594          156 DVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFG  235 (386)
Q Consensus       156 ~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~  235 (386)
                      ....  ++...++.++.+++.++.|||+   .+++|+||+|.||+++.++.++|+|||.+.......   ......++..
T Consensus        80 ~~~~--~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~  151 (244)
T smart00220       80 KRGR--LSEDEARFYARQILSALEYLHS---NGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPE  151 (244)
T ss_pred             hccC--CCHHHHHHHHHHHHHHHHHHHH---cCeecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcC
Confidence            6443  8899999999999999999999   999999999999999999999999999998765432   2334558889


Q ss_pred             ccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCCCCCH-HHHHHHHHHH
Q 016594          236 HLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDV-TQLNRLAFAA  314 (386)
Q Consensus       236 y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~l~~li  314 (386)
                      |+|||.+.+..++.++||||||+++++|++|..||.......... . ...        .......... ..+..+.+++
T Consensus       152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~-~-~~~--------~~~~~~~~~~~~~~~~~~~~i  221 (244)
T smart00220      152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELF-K-KIG--------KPKPPFPPPEWKISPEAKDLI  221 (244)
T ss_pred             CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHH-H-HHh--------ccCCCCccccccCCHHHHHHH
Confidence            999999998889999999999999999999999997632111000 0 000        0000000000 0446799999


Q ss_pred             HHccccCCCCCCCHHHHHHH
Q 016594          315 SLCIRASPTWRPTMSEVLEV  334 (386)
Q Consensus       315 ~~cl~~dP~~Rpt~~~il~~  334 (386)
                      .+||..+|++||++.+++++
T Consensus       222 ~~~l~~~p~~Rp~~~~~~~~  241 (244)
T smart00220      222 RKLLVKDPEKRLTAEEALQH  241 (244)
T ss_pred             HHHccCCchhccCHHHHhhC
Confidence            99999999999999999974

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=5.1e-34  Score=274.32  Aligned_cols=270  Identities=17%  Similarity=0.166  Sum_probs=181.7

Q ss_pred             HhcCCCCCCeecccCCcEEEEEEE-----------------CCCcEEEEEEeccccCChH------------hHHHHHHH
Q 016594           64 ATNAFSSENLVGRGGYAEVYKGVL-----------------QDGEEIAVKRLTKVVTDDR------------KEKEFLTE  114 (386)
Q Consensus        64 ~~~~~~~~~~lg~G~~g~V~~~~~-----------------~~~~~vavK~~~~~~~~~~------------~~~~~~~e  114 (386)
                      ..++|.+.++||+|+||+||+|.+                 ..++.||||.+........            .......|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            467899999999999999999964                 2356799999864221100            01123346


Q ss_pred             HHHHhccCCCc-----eeeecceEEe---------CceEEEEEeccCCCHhhhhhhcCC---------------------
Q 016594          115 IGTIGHVCHPN-----VLSLLGCCVD---------NGLYLIFQFSSRGSVASLFHDVNS---------------------  159 (386)
Q Consensus       115 ~~~l~~l~h~n-----iv~l~~~~~~---------~~~~lv~e~~~~~~L~~~~~~~~~---------------------  159 (386)
                      +.++.++.|.+     +++++++|..         +..++||||+.+++|.+++.....                     
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            66777776554     4677777642         347999999999999998864211                     


Q ss_pred             -CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCccccccccccccCccC
Q 016594          160 -PGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLA  238 (386)
Q Consensus       160 -~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a  238 (386)
                       ..+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||++......... ......+++.|+|
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH~---~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~g~~tp~Y~a  378 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLHR---IGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-NPLYGMLDPRYSP  378 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCchHhEEECCCCcEEEEeCcCccccccCCcc-CccccCCCcceeC
Confidence             124567888999999999999999   99999999999999999999999999999765432111 1112234789999


Q ss_pred             hhhhccCC--------------------C--CcccchHHHHHHHHHHHhCCC-CCCCCchhhhhhhhhhhcccccccccC
Q 016594          239 PEYFMHGI--------------------V--DEKTDVFAFGVFLLEIISGRK-PVDGSHQSLHSWAKPILNQGEIEKLVD  295 (386)
Q Consensus       239 PE~~~~~~--------------------~--~~~~DvwslG~il~ell~g~~-pf~~~~~~~~~~~~~~~~~~~~~~~~~  295 (386)
                      ||.+....                    +  ..+.||||+||++|+|++|.. ||.+.......................
T Consensus       379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~  458 (507)
T PLN03224        379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKG  458 (507)
T ss_pred             hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcc
Confidence            99875422                    1  134799999999999999875 775421100000000000000000001


Q ss_pred             CccCCCCCHHHHHHHHHHHHHccccCC---CCCCCHHHHHHHHhc
Q 016594          296 PRLQGAYDVTQLNRLAFAASLCIRASP---TWRPTMSEVLEVMLE  337 (386)
Q Consensus       296 ~~~~~~~~~~~~~~l~~li~~cl~~dP---~~Rpt~~~il~~l~~  337 (386)
                      ...........+....+++.+||..+|   .+|+|+.++|+|-+.
T Consensus       459 ~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f  503 (507)
T PLN03224        459 QKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFF  503 (507)
T ss_pred             cCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCc
Confidence            111111112345778999999999766   689999999998654

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=100.00  E-value=1.2e-35  Score=271.11  Aligned_cols=272  Identities=20%  Similarity=0.242  Sum_probs=209.1

Q ss_pred             cccCHHHHHHHhcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccC------CCce
Q 016594           54 RCFSFEEISIATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVC------HPNV  126 (386)
Q Consensus        54 ~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~------h~ni  126 (386)
                      .+|.+...+...++|.+....|+|-|++|.+|.+. .|+.||||++...   ....+.=++|+++|++|+      --|+
T Consensus       420 GYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN---E~M~KtGl~EleiLkKL~~AD~Edk~Hc  496 (752)
T KOG0670|consen  420 GYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN---EVMHKTGLKELEILKKLNDADPEDKFHC  496 (752)
T ss_pred             ceEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc---hHHhhhhhHHHHHHHHhhccCchhhhHH
Confidence            56667777889999999999999999999999976 4889999999752   334455678999999996      3489


Q ss_pred             eeecceEEeC-ceEEEEEeccCCCHhhhhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCC
Q 016594          127 LSLLGCCVDN-GLYLIFQFSSRGSVASLFHDVNS-PGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTAD  204 (386)
Q Consensus       127 v~l~~~~~~~-~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~  204 (386)
                      ++++-.|... .+|+|+|.+.- +|.+++...+. -++....+..++.|+..||..|-.   .+|+|.||||+|||+++.
T Consensus       497 lrl~r~F~hknHLClVFE~Lsl-NLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~---c~vlHaDIKPDNiLVNE~  572 (752)
T KOG0670|consen  497 LRLFRHFKHKNHLCLVFEPLSL-NLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKK---CGVLHADIKPDNILVNES  572 (752)
T ss_pred             HHHHHHhhhcceeEEEehhhhc-hHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHh---cCeeecccCccceEeccC
Confidence            9999888664 49999998865 89998887654 358889999999999999999999   899999999999999854


Q ss_pred             -CCeEEeecCccccCCCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhh-hhhhh
Q 016594          205 -FEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSL-HSWAK  282 (386)
Q Consensus       205 -~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~-~~~~~  282 (386)
                       ..+||||||.|......    ..+++.-+..|.|||++.|-+|+...|+||+||+||||.||+..|.+..... ..+..
T Consensus       573 k~iLKLCDfGSA~~~~en----eitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~m  648 (752)
T KOG0670|consen  573 KNILKLCDFGSASFASEN----EITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFM  648 (752)
T ss_pred             cceeeeccCccccccccc----cccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHH
Confidence             56899999999876543    2333445667999999999999999999999999999999999998764211 11100


Q ss_pred             hh--------hc-cccccccc--------------------------CC------ccC-----CCCCHHHHHHHHHHHHH
Q 016594          283 PI--------LN-QGEIEKLV--------------------------DP------RLQ-----GAYDVTQLNRLAFAASL  316 (386)
Q Consensus       283 ~~--------~~-~~~~~~~~--------------------------~~------~~~-----~~~~~~~~~~l~~li~~  316 (386)
                      ..        +. ...+...+                          .|      .+.     ..-.......|.+|+..
T Consensus       649 e~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdk  728 (752)
T KOG0670|consen  649 ELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDK  728 (752)
T ss_pred             HhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHH
Confidence            00        00 00000000                          01      000     11112335679999999


Q ss_pred             ccccCCCCCCCHHHHHHHHh
Q 016594          317 CIRASPTWRPTMSEVLEVML  336 (386)
Q Consensus       317 cl~~dP~~Rpt~~~il~~l~  336 (386)
                      ||..||++|.|..+.|.|..
T Consensus       729 ml~LdP~KRit~nqAL~HpF  748 (752)
T KOG0670|consen  729 MLILDPEKRITVNQALKHPF  748 (752)
T ss_pred             HhccChhhcCCHHHHhcCCc
Confidence            99999999999999998754

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=100.00  E-value=3.4e-35  Score=242.87  Aligned_cols=258  Identities=20%  Similarity=0.288  Sum_probs=200.4

Q ss_pred             HhcCCCCCCeecccCCcEEEEEEE-CCCcEEEEEEeccccCChHhHHHHHHHHHHHhccC-CCceeeecceEEeCc---e
Q 016594           64 ATNAFSSENLVGRGGYAEVYKGVL-QDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVC-HPNVLSLLGCCVDNG---L  138 (386)
Q Consensus        64 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~---~  138 (386)
                      ..++|++.+++|+|.++.||.|.. .+++.++||+++     +-..+.+.+|+.+|..|. ||||++++++..+..   .
T Consensus        36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLK-----PVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktp  110 (338)
T KOG0668|consen   36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILK-----PVKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTP  110 (338)
T ss_pred             ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeec-----hHHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCc
Confidence            446899999999999999999994 468899999997     345677899999999998 999999999997643   7


Q ss_pred             EEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCC-CCeEEeecCcccc
Q 016594          139 YLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTAD-FEPQISDFGLAKW  217 (386)
Q Consensus       139 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~-~~~kl~Dfg~a~~  217 (386)
                      .+++|++.+.+...+...     ++...+..++.+++.||.|||+   .||+|||+||.|+++|.. -.++|+|+|+|.+
T Consensus       111 aLiFE~v~n~Dfk~ly~t-----l~d~dIryY~~elLkALdyCHS---~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEF  182 (338)
T KOG0668|consen  111 SLIFEYVNNTDFKQLYPT-----LTDYDIRYYIYELLKALDYCHS---MGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF  182 (338)
T ss_pred             hhHhhhhccccHHHHhhh-----hchhhHHHHHHHHHHHHhHHHh---cCcccccCCcceeeechhhceeeeeecchHhh
Confidence            899999999888777643     7777889999999999999999   999999999999999954 4699999999998


Q ss_pred             CCCCCccccccccccccCccChhhhcc-CCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcc---------
Q 016594          218 LPSQWTHHSIAPIEGTFGHLAPEYFMH-GIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQ---------  287 (386)
Q Consensus       218 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~---------  287 (386)
                      +.....   ....+.+..|--||.+.. +.|+.+-|+|||||++..|+..+.||-..++...+.++.....         
T Consensus       183 YHp~~e---YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl  259 (338)
T KOG0668|consen  183 YHPGKE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYL  259 (338)
T ss_pred             cCCCce---eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHH
Confidence            765432   233456777899999875 5689999999999999999999999864443333332221111         


Q ss_pred             --------cccccccCCccCCCCC--------HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 016594          288 --------GEIEKLVDPRLQGAYD--------VTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLE  337 (386)
Q Consensus       288 --------~~~~~~~~~~~~~~~~--------~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~  337 (386)
                              .....++....+..+.        .-...+..+++.+.|..|-.+|||+.|.+.|...
T Consensus       260 ~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF  325 (338)
T KOG0668|consen  260 NKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYF  325 (338)
T ss_pred             HHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchH
Confidence                    1111122222111111        1124678999999999999999999999988544

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-35  Score=251.96  Aligned_cols=265  Identities=20%  Similarity=0.280  Sum_probs=197.7

Q ss_pred             CCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc------eE
Q 016594           67 AFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG------LY  139 (386)
Q Consensus        67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------~~  139 (386)
                      +.+-.+.||.|+||.||.+++. +|+.||+|++......-...+.+.+|+++|..++|.|++..+++..-..      .|
T Consensus        54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY  133 (449)
T KOG0664|consen   54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY  133 (449)
T ss_pred             cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence            3455789999999999999975 7999999999876666667788999999999999999999999875433      45


Q ss_pred             EEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCC
Q 016594          140 LIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLP  219 (386)
Q Consensus       140 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~  219 (386)
                      .+.|.+.. +|..++..  ...++...+.-+..||+.||.|||+   .+|.||||||.|+|++.+-.+||||||+++.-.
T Consensus       134 V~TELmQS-DLHKIIVS--PQ~Ls~DHvKVFlYQILRGLKYLHs---A~ILHRDIKPGNLLVNSNCvLKICDFGLARvee  207 (449)
T KOG0664|consen  134 VLTELMQS-DLHKIIVS--PQALTPDHVKVFVYQILRGLKYLHT---ANILHRDIKPGNLLVNSNCILKICDFGLARTWD  207 (449)
T ss_pred             HHHHHHHh-hhhheecc--CCCCCcchhhhhHHHHHhhhHHHhh---cchhhccCCCccEEeccCceEEecccccccccc
Confidence            55555544 67766653  3448888888999999999999999   999999999999999999999999999998654


Q ss_pred             CCCccccccccccccCccChhhhccC-CCCcccchHHHHHHHHHHHhCCCCCCCCchh-hhhhhhhhhcccc--------
Q 016594          220 SQWTHHSIAPIEGTFGHLAPEYFMHG-IVDEKTDVFAFGVFLLEIISGRKPVDGSHQS-LHSWAKPILNQGE--------  289 (386)
Q Consensus       220 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~-~~~~~~~~~~~~~--------  289 (386)
                      .. ....++..+-|..|.|||.+.|. .|+.+.||||.|||+.||+..+..|.....- ....+...+....        
T Consensus       208 ~d-~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~AC  286 (449)
T KOG0664|consen  208 QR-DRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYAC  286 (449)
T ss_pred             hh-hhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHh
Confidence            43 22334444568899999999875 5899999999999999999999999754321 1111111111111        


Q ss_pred             ---cccccCCccC-CCCC--------HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          290 ---IEKLVDPRLQ-GAYD--------VTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       290 ---~~~~~~~~~~-~~~~--------~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                         ...++....+ +..+        ..-......++.+++.+||+.|.+..+.+.++...
T Consensus       287 EGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~  347 (449)
T KOG0664|consen  287 EGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLE  347 (449)
T ss_pred             hhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccccc
Confidence               1111111111 1111        11123567788889999999999999999876443

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-34  Score=249.92  Aligned_cols=260  Identities=23%  Similarity=0.309  Sum_probs=201.9

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEe-------C
Q 016594           65 TNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVD-------N  136 (386)
Q Consensus        65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-------~  136 (386)
                      ..+|.-...+|.|.- .|..|.+. .+++||+|.+.....+....+...+|..++..+.|+||++++.+|.-       .
T Consensus        16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~   94 (369)
T KOG0665|consen   16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ   94 (369)
T ss_pred             eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence            346777788999988 67777654 68999999988776666777888999999999999999999999853       2


Q ss_pred             ceEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccc
Q 016594          137 GLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAK  216 (386)
Q Consensus       137 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~  216 (386)
                      +.|+|||++.. +|...+...    +.-..+..++.|++.|+.|||+   .+|+||||||+||++..+..+||.|||+|.
T Consensus        95 e~y~v~e~m~~-nl~~vi~~e----lDH~tis~i~yq~~~~ik~lhs---~~IihRdLkPsnivv~~~~~lKi~dfg~ar  166 (369)
T KOG0665|consen   95 EVYLVMELMDA-NLCQVILME----LDHETISYILYQMLCGIKHLHS---AGIIHRDLKPSNIVVNSDCTLKILDFGLAR  166 (369)
T ss_pred             hHHHHHHhhhh-HHHHHHHHh----cchHHHHHHHHHHHHHHHHHHh---cceeecccCcccceecchhheeeccchhhc
Confidence            37999999987 788776522    5566788999999999999999   999999999999999999999999999997


Q ss_pred             cCCCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhccccc------
Q 016594          217 WLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEI------  290 (386)
Q Consensus       217 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~------  290 (386)
                      .-...   -..+..+.|..|.|||++.+..|.+.+||||+||++.||++|...|.+.+ .+.+|.+..-..+..      
T Consensus       167 ~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d-~idQ~~ki~~~lgtpd~~F~~  242 (369)
T KOG0665|consen  167 TEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKD-HIDQWNKIIEQLGTPDPSFMK  242 (369)
T ss_pred             ccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCch-HHHHHHHHHHHhcCCCHHHHH
Confidence            54322   34567788999999999999889999999999999999999999998653 233333321111110      


Q ss_pred             ---------------------cccc-CCccCCC--CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 016594          291 ---------------------EKLV-DPRLQGA--YDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLE  337 (386)
Q Consensus       291 ---------------------~~~~-~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~  337 (386)
                                           .+.+ |......  .+......+++++.+||..||++|.++.++|+|..-
T Consensus       243 qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~  313 (369)
T KOG0665|consen  243 QLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYI  313 (369)
T ss_pred             HhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCee
Confidence                                 0000 0000000  011224568999999999999999999999998644

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.98  E-value=6.6e-33  Score=256.15  Aligned_cols=200  Identities=23%  Similarity=0.333  Sum_probs=166.0

Q ss_pred             HhcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChH------hHHHHHHHHHHHhccC---CCceeeecceE
Q 016594           64 ATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDR------KEKEFLTEIGTIGHVC---HPNVLSLLGCC  133 (386)
Q Consensus        64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~------~~~~~~~e~~~l~~l~---h~niv~l~~~~  133 (386)
                      ....|...+.+|.|+||.|++|.++ +...|+||.+.+...-..      ..-..-.|+.||..|+   |+||++++++|
T Consensus       559 k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfF  638 (772)
T KOG1152|consen  559 KFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFF  638 (772)
T ss_pred             ccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhee
Confidence            3456899999999999999999987 567899998876322111      1122446999999997   99999999999


Q ss_pred             EeCc-eEEEEEec-cCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEee
Q 016594          134 VDNG-LYLIFQFS-SRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISD  211 (386)
Q Consensus       134 ~~~~-~~lv~e~~-~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~D  211 (386)
                      ++++ +|+++|-- ++.+|.+++...  +.+.+.++..|+.|++.|+++||+   ++|||||||-+|+.++.+|-+||+|
T Consensus       639 Eddd~yyl~te~hg~gIDLFd~IE~k--p~m~E~eAk~IFkQV~agi~hlh~---~~ivhrdikdenvivd~~g~~klid  713 (772)
T KOG1152|consen  639 EDDDYYYLETEVHGEGIDLFDFIEFK--PRMDEPEAKLIFKQVVAGIKHLHD---QGIVHRDIKDENVIVDSNGFVKLID  713 (772)
T ss_pred             ecCCeeEEEecCCCCCcchhhhhhcc--CccchHHHHHHHHHHHhccccccc---cCceecccccccEEEecCCeEEEee
Confidence            9988 55555543 345677777643  449999999999999999999999   9999999999999999999999999


Q ss_pred             cCccccCCCCCccccccccccccCccChhhhccCCC-CcccchHHHHHHHHHHHhCCCCCCC
Q 016594          212 FGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIV-DEKTDVFAFGVFLLEIISGRKPVDG  272 (386)
Q Consensus       212 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~ell~g~~pf~~  272 (386)
                      ||.|......    ....++||..|.|||++.|.+| +..-|||+||++||.++....||.+
T Consensus       714 fgsaa~~ksg----pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn  771 (772)
T KOG1152|consen  714 FGSAAYTKSG----PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN  771 (772)
T ss_pred             ccchhhhcCC----CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence            9999876443    4567889999999999998877 5778999999999999999999864

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.98  E-value=1.3e-30  Score=225.74  Aligned_cols=211  Identities=32%  Similarity=0.553  Sum_probs=181.5

Q ss_pred             ecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEEEeccCCCHh
Q 016594           74 VGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQFSSRGSVA  151 (386)
Q Consensus        74 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~~~~~~L~  151 (386)
                      ||.|++|.||++... +++.+++|++....... ....+.+|+..++.+.|++|+++++++.... .+++++++.+++|.
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~   79 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLK   79 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchh-HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHH
Confidence            689999999999976 48999999987533221 3567889999999999999999999998744 89999999999999


Q ss_pred             hhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcC-CCCeEEeecCccccCCCCCcccccccc
Q 016594          152 SLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTA-DFEPQISDFGLAKWLPSQWTHHSIAPI  230 (386)
Q Consensus       152 ~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~  230 (386)
                      +++.... ..++...+..++.+++.++.+||+   .+++|+||+|.||+++. ++.++|+|||.+........  .....
T Consensus        80 ~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~---~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~  153 (215)
T cd00180          80 DLLKENE-GKLSEDEILRILLQILEGLEYLHS---NGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTI  153 (215)
T ss_pred             HHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcc
Confidence            9987643 348899999999999999999999   89999999999999999 89999999999987654321  12334


Q ss_pred             ccccCccChhhhccC-CCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCCCCCHHHHHH
Q 016594          231 EGTFGHLAPEYFMHG-IVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQLNR  309 (386)
Q Consensus       231 ~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (386)
                      .+...|++||.+... .++.++|+|++|+++++|                                            ..
T Consensus       154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l--------------------------------------------~~  189 (215)
T cd00180         154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL--------------------------------------------PE  189 (215)
T ss_pred             cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH--------------------------------------------HH
Confidence            578889999999877 888999999999999998                                            45


Q ss_pred             HHHHHHHccccCCCCCCCHHHHHHHH
Q 016594          310 LAFAASLCIRASPTWRPTMSEVLEVM  335 (386)
Q Consensus       310 l~~li~~cl~~dP~~Rpt~~~il~~l  335 (386)
                      +.+++..|++.+|++||++.++++++
T Consensus       190 ~~~~l~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         190 LKDLIRKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             HHHHHHHHhhCCcccCcCHHHHhhCC
Confidence            88999999999999999999998753

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.97  E-value=1.5e-32  Score=257.56  Aligned_cols=253  Identities=24%  Similarity=0.352  Sum_probs=201.6

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEe-CceEEEE
Q 016594           65 TNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVD-NGLYLIF  142 (386)
Q Consensus        65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~lv~  142 (386)
                      ..+|.+...+|.|+||.||+|+++ +++..|+|+++...  .....-+.+|+-+++..+|||||.+++.+.. ...++.|
T Consensus        14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep--~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicM   91 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEP--GDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICM   91 (829)
T ss_pred             ccchhheeeecCCcccchhhhcccccCchhhheeeeccC--CccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEE
Confidence            357888999999999999999976 78999999998543  3334556789999999999999999999865 5599999


Q ss_pred             EeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCC
Q 016594          143 QFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQW  222 (386)
Q Consensus       143 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  222 (386)
                      ||+.+|+|.+..+-  ..++++.++..+.+..++||+|||+   .+-+|||||-.||++++.|.+|++|||.+..+... 
T Consensus        92 EycgggslQdiy~~--TgplselqiayvcRetl~gl~ylhs---~gk~hRdiKGanilltd~gDvklaDfgvsaqitat-  165 (829)
T KOG0576|consen   92 EYCGGGSLQDIYHV--TGPLSELQIAYVCRETLQGLKYLHS---QGKIHRDIKGANILLTDEGDVKLADFGVSAQITAT-  165 (829)
T ss_pred             EecCCCcccceeee--cccchhHHHHHHHhhhhccchhhhc---CCcccccccccceeecccCceeecccCchhhhhhh-
Confidence            99999999998763  4458999999999999999999999   99999999999999999999999999998776542 


Q ss_pred             ccccccccccccCccChhhhc---cCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccC
Q 016594          223 THHSIAPIEGTFGHLAPEYFM---HGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQ  299 (386)
Q Consensus       223 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (386)
                       -.....+.||+.|||||+..   .+.|...+|||++|++..|+-.-++|....++.......   ..    ..+++ ..
T Consensus       166 -i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~Lm---Tk----S~~qp-p~  236 (829)
T KOG0576|consen  166 -IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLM---TK----SGFQP-PT  236 (829)
T ss_pred             -hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHh---hc----cCCCC-Cc
Confidence             23445788999999999874   567899999999999999998888886543321111000   00    00111 11


Q ss_pred             CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 016594          300 GAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEV  334 (386)
Q Consensus       300 ~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~  334 (386)
                      ........+.+-++++.||..+|++||+++.+|.|
T Consensus       237 lkDk~kws~~fh~fvK~altknpKkRptaeklL~h  271 (829)
T KOG0576|consen  237 LKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQH  271 (829)
T ss_pred             ccCCccchHHHHHHHHHHhcCCCccCCChhhheec
Confidence            11223456789999999999999999999988864

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.97  E-value=4.1e-31  Score=223.85  Aligned_cols=248  Identities=16%  Similarity=0.293  Sum_probs=182.8

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccC-CCceeeecceEEe-Cc-eEE
Q 016594           65 TNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVC-HPNVLSLLGCCVD-NG-LYL  140 (386)
Q Consensus        65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~-~~-~~l  140 (386)
                      .+.|.+.+.||+|.||.+-++.++ +++.+++|.+.+.   .....+|.+|...--.|. |.||+.-|++..+ .+ +++
T Consensus        23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p---~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF   99 (378)
T KOG1345|consen   23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP---QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVF   99 (378)
T ss_pred             hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc---hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEE
Confidence            457889999999999999999988 5788999998764   456778999988776776 9999999887543 33 788


Q ss_pred             EEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEc--CCCCeEEeecCccccC
Q 016594          141 IFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLT--ADFEPQISDFGLAKWL  218 (386)
Q Consensus       141 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~--~~~~~kl~Dfg~a~~~  218 (386)
                      ++||++.|+|.+-+..   .++.+.....++.|+++|+.|+|+   .++||||||.+|||+-  +..++||||||..+..
T Consensus       100 ~qE~aP~gdL~snv~~---~GigE~~~K~v~~ql~SAi~fMHs---knlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~  173 (378)
T KOG1345|consen  100 VQEFAPRGDLRSNVEA---AGIGEANTKKVFAQLLSAIEFMHS---KNLVHRDLKAENILIFDADFYRVKLCDFGLTRKV  173 (378)
T ss_pred             eeccCccchhhhhcCc---ccccHHHHHHHHHHHHHHHHHhhc---cchhhcccccceEEEecCCccEEEeeeccccccc
Confidence            9999999999887654   458888889999999999999999   9999999999999994  3347999999998765


Q ss_pred             CCCCccccccccccccCccChhhhccC-----CCCcccchHHHHHHHHHHHhCCCCCCCCchhhhh-hhhhhhccccccc
Q 016594          219 PSQWTHHSIAPIEGTFGHLAPEYFMHG-----IVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHS-WAKPILNQGEIEK  292 (386)
Q Consensus       219 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~-~~~~~~~~~~~~~  292 (386)
                      +..     .....-+..|.+||+....     ...+.+|||.||+++|..+||..||+........ |.......+....
T Consensus       174 g~t-----V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~  248 (378)
T KOG1345|consen  174 GTT-----VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPA  248 (378)
T ss_pred             Cce-----ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCcc
Confidence            432     1122345679999987532     2467899999999999999999999843221111 1111111111111


Q ss_pred             ccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 016594          293 LVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVL  332 (386)
Q Consensus       293 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il  332 (386)
                           ++..+ ...++.+..+.++-|..+|++|--..++.
T Consensus       249 -----~P~~F-~~fs~~a~r~Fkk~lt~~~~drcki~~~k  282 (378)
T KOG1345|consen  249 -----LPKKF-NPFSEKALRLFKKSLTPRFKDRCKIWTAK  282 (378)
T ss_pred             -----Cchhh-cccCHHHHHHHHHhcCCcccccchhHHHH
Confidence                 11111 12346678888899999999994333333

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.97  E-value=1.8e-29  Score=221.51  Aligned_cols=199  Identities=31%  Similarity=0.511  Sum_probs=170.2

Q ss_pred             CCCCCeecccCCcEEEEEEECC-CcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEEEec
Q 016594           68 FSSENLVGRGGYAEVYKGVLQD-GEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQFS  145 (386)
Q Consensus        68 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~~  145 (386)
                      |.+.+.||.|++|.||+|.... ++.+|+|.+...... .....+.+|+..++.++|+|++++++++.... .++++|++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~   79 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYC   79 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEecc
Confidence            5677899999999999999874 889999998764322 24667889999999999999999999987654 89999999


Q ss_pred             cCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCccc
Q 016594          146 SRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHH  225 (386)
Q Consensus       146 ~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  225 (386)
                      .+++|.+++...... +++..+..++.+++.++.+||+   .+++|+||+|.||+++.++.++|+|||.+........ .
T Consensus        80 ~~~~L~~~~~~~~~~-~~~~~~~~~~~~l~~~l~~lh~---~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~-~  154 (225)
T smart00221       80 EGGDLFDYLRKKGGK-LSEEEARFYLRQILEALEYLHS---LGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA-A  154 (225)
T ss_pred             CCCCHHHHHHhcccC-CCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc-c
Confidence            999999998764332 7889999999999999999999   8999999999999999999999999999987754321 1


Q ss_pred             cccccccccCccChhhh-ccCCCCcccchHHHHHHHHHHHhCCCCCCC
Q 016594          226 SIAPIEGTFGHLAPEYF-MHGIVDEKTDVFAFGVFLLEIISGRKPVDG  272 (386)
Q Consensus       226 ~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwslG~il~ell~g~~pf~~  272 (386)
                      ......++..|++||.+ ....++.++|+|+||+++++|++|+.||..
T Consensus       155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            22344578889999998 667788899999999999999999999966

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.97  E-value=2e-30  Score=232.44  Aligned_cols=266  Identities=23%  Similarity=0.327  Sum_probs=196.9

Q ss_pred             HHHHhcCCCCCCeecccCCcEEEEEEEC----CCcEEEEEEeccccCChHhHHHHHHHHHHHhccC-CCceeeecceEEe
Q 016594           61 ISIATNAFSSENLVGRGGYAEVYKGVLQ----DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVC-HPNVLSLLGCCVD  135 (386)
Q Consensus        61 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~  135 (386)
                      +.-..+.|.+.++||+|+|++||++.+.    ..+.||+|.+....    ....+..|+++|..+. +.||+++.+++..
T Consensus        31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts----~p~ri~~El~~L~~~gG~~ni~~~~~~~rn  106 (418)
T KOG1167|consen   31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS----SPSRILNELEMLYRLGGSDNIIKLNGCFRN  106 (418)
T ss_pred             hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc----CchHHHHHHHHHHHhccchhhhcchhhhcc
Confidence            3456678999999999999999999854    36789999987532    3446889999999997 9999999999976


Q ss_pred             Cc-eEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCC-CCeEEeecC
Q 016594          136 NG-LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTAD-FEPQISDFG  213 (386)
Q Consensus       136 ~~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~-~~~kl~Dfg  213 (386)
                      ++ ..+|++|+.+....+++..     ++...+..+++.++.||.++|.   +|||||||||.|+|.+.. +.-.|+|||
T Consensus       107 nd~v~ivlp~~~H~~f~~l~~~-----l~~~~i~~Yl~~ll~Al~~~h~---~GIvHRDiKpsNFL~n~~t~rg~LvDFg  178 (418)
T KOG1167|consen  107 NDQVAIVLPYFEHDRFRDLYRS-----LSLAEIRWYLRNLLKALAHLHK---NGIVHRDIKPSNFLYNRRTQRGVLVDFG  178 (418)
T ss_pred             CCeeEEEecccCccCHHHHHhc-----CCHHHHHHHHHHHHHHhhhhhc---cCccccCCCccccccccccCCceEEech
Confidence            55 8999999999998888765     6788999999999999999999   999999999999999854 567899999


Q ss_pred             ccccCC-----------------C-C------------------------CccccccccccccCccChhhhcc-CCCCcc
Q 016594          214 LAKWLP-----------------S-Q------------------------WTHHSIAPIEGTFGHLAPEYFMH-GIVDEK  250 (386)
Q Consensus       214 ~a~~~~-----------------~-~------------------------~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~  250 (386)
                      +|....                 . .                        ..........||++|.|||++.. ...+++
T Consensus       179 LA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qtta  258 (418)
T KOG1167|consen  179 LAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTA  258 (418)
T ss_pred             hHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCc
Confidence            997210                 0 0                        00000113459999999999875 456899


Q ss_pred             cchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhh--h----------cccc-----------ccccc---CCc----cCC
Q 016594          251 TDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPI--L----------NQGE-----------IEKLV---DPR----LQG  300 (386)
Q Consensus       251 ~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~--~----------~~~~-----------~~~~~---~~~----~~~  300 (386)
                      +||||.|+|+..++++..||-...++....+...  .          ..+.           +.+..   ...    +..
T Consensus       259 iDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~  338 (418)
T KOG1167|consen  259 IDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYK  338 (418)
T ss_pred             cceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccc
Confidence            9999999999999999999965543221111100  0          0000           00000   000    000


Q ss_pred             -CC--------CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          301 -AY--------DVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       301 -~~--------~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                       ..        ....+..+.+++.+|+..||.+|.|+++.|+|....
T Consensus       339 ~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~  385 (418)
T KOG1167|consen  339 SRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFD  385 (418)
T ss_pred             ccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCc
Confidence             00        011133689999999999999999999999986543

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.96  E-value=1.9e-29  Score=260.15  Aligned_cols=199  Identities=16%  Similarity=0.193  Sum_probs=139.7

Q ss_pred             cCC-CceeeecceEE-------e-CceEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEE
Q 016594          121 VCH-PNVLSLLGCCV-------D-NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIH  191 (386)
Q Consensus       121 l~h-~niv~l~~~~~-------~-~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH  191 (386)
                      +.| .||++++++|.       . ..+++++|++ +++|.+++... ...+++..++.++.||+.||.|||+   ++|+|
T Consensus        29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~---~gIvH  103 (793)
T PLN00181         29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP-DRSVDAFECFHVFRQIVEIVNAAHS---QGIVV  103 (793)
T ss_pred             hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc-cccccHHHHHHHHHHHHHHHHHHHh---CCeee
Confidence            445 57888888762       2 2356667765 56999998643 3458999999999999999999999   99999


Q ss_pred             eCCCCCCeeEcCCC-------------------CeEEeecCccccCCCCCc--------------cccccccccccCccC
Q 016594          192 RDIKSSNILLTADF-------------------EPQISDFGLAKWLPSQWT--------------HHSIAPIEGTFGHLA  238 (386)
Q Consensus       192 ~dlkp~Nill~~~~-------------------~~kl~Dfg~a~~~~~~~~--------------~~~~~~~~gt~~y~a  238 (386)
                      |||||+||||+..+                   .+|++|||+++.......              ........||+.|||
T Consensus       104 rDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A  183 (793)
T PLN00181        104 HNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTS  183 (793)
T ss_pred             ccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEC
Confidence            99999999996544                   455666666543211000              000112357889999


Q ss_pred             hhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHcc
Q 016594          239 PEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCI  318 (386)
Q Consensus       239 PE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl  318 (386)
                      ||++.+..++.++|||||||+||||++|.+|+............         ....+..     .........++.+||
T Consensus       184 PE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~~~~~~~---------~~~~~~~-----~~~~~~~~~~~~~~L  249 (793)
T PLN00181        184 PEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSRTMSSLRH---------RVLPPQI-----LLNWPKEASFCLWLL  249 (793)
T ss_pred             hhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHHHHHHHHH---------hhcChhh-----hhcCHHHHHHHHHhC
Confidence            99999999999999999999999999999887643211111100         0011100     111234567888999


Q ss_pred             ccCCCCCCCHHHHHHHHhcC
Q 016594          319 RASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       319 ~~dP~~Rpt~~~il~~l~~~  338 (386)
                      +++|.+||++.+++++.+..
T Consensus       250 ~~~P~~Rps~~eil~h~~~~  269 (793)
T PLN00181        250 HPEPSCRPSMSELLQSEFIN  269 (793)
T ss_pred             CCChhhCcChHHHhhchhhh
Confidence            99999999999999876543

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.96  E-value=1.9e-28  Score=207.23  Aligned_cols=167  Identities=21%  Similarity=0.201  Sum_probs=126.0

Q ss_pred             CCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCccccc
Q 016594          148 GSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSI  227 (386)
Q Consensus       148 ~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  227 (386)
                      |+|.+++... ...+++..++.++.|++.||.|||+   ++      ||+|||++.++.+|+  ||++.......     
T Consensus         1 GsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~lH~---~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~-----   63 (176)
T smart00750        1 VSLADILEVR-GRPLNEEEIWAVCLQCLRALRELHR---QA------KSGNILLTWDGLLKL--DGSVAFKTPEQ-----   63 (176)
T ss_pred             CcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHh---cC------CcccEeEcCccceee--ccceEeecccc-----
Confidence            6888888754 3459999999999999999999999   66      999999999999999  99987654321     


Q ss_pred             cccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCCCCCHHHH
Q 016594          228 APIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQL  307 (386)
Q Consensus       228 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (386)
                        ..||+.|+|||++.+..++.++|||||||++|||++|..||.......... ......  .... .+. .........
T Consensus        64 --~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~-~~~~~~--~~~~-~~~-~~~~~~~~~  136 (176)
T smart00750       64 --SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAIL-EILLNG--MPAD-DPR-DRSNLESVS  136 (176)
T ss_pred             --CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHH-HHHHHH--hccC-Ccc-ccccHHHHH
Confidence              258899999999999999999999999999999999999997543211110 000000  0000 000 001112223


Q ss_pred             H--HHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          308 N--RLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       308 ~--~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                      .  .+.+++.+||..+|.+||++.++++++...
T Consensus       137 ~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~  169 (176)
T smart00750      137 AARSFADFMRVCASRLPQRREAANHYLAHCRAL  169 (176)
T ss_pred             hhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence            3  699999999999999999999999998654

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.95  E-value=3e-26  Score=212.08  Aligned_cols=259  Identities=18%  Similarity=0.180  Sum_probs=189.1

Q ss_pred             CCCCCCeecccCCcEEEEEEECCC--cEEEEEEeccccCChHhHHHHHHHHHHHhccC----CCceeeecceEE-eCceE
Q 016594           67 AFSSENLVGRGGYAEVYKGVLQDG--EEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVC----HPNVLSLLGCCV-DNGLY  139 (386)
Q Consensus        67 ~~~~~~~lg~G~~g~V~~~~~~~~--~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~----h~niv~l~~~~~-~~~~~  139 (386)
                      +|.+.+.||+|+||.||.|.....  ..+|+|...........  .+..|..++..+.    .+++..+++... .+...
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~--~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~   96 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPS--VLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFN   96 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCc--cchhHHHHHHHHhhhcCCCCCCEEEEeccCCCcee
Confidence            899999999999999999997643  47899987653222211  5667788777776    258888888883 55544


Q ss_pred             EEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCC-----CCeEEeecCc
Q 016594          140 LIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTAD-----FEPQISDFGL  214 (386)
Q Consensus       140 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~-----~~~kl~Dfg~  214 (386)
                      ++++-+.|.+|.++........++...++.|+.|++.+|++||+   .|++||||||.|+++...     ..+.|.|||+
T Consensus        97 ~iVM~l~G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~---~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl  173 (322)
T KOG1164|consen   97 FIVMSLLGPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHS---KGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGL  173 (322)
T ss_pred             EEEEeccCccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHh---cCcccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence            44455567799998877666779999999999999999999999   999999999999999865     3589999999


Q ss_pred             cc--cCCCCCcc----c-c-ccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhc
Q 016594          215 AK--WLPSQWTH----H-S-IAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILN  286 (386)
Q Consensus       215 a~--~~~~~~~~----~-~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~  286 (386)
                      ++  .+......    . . ...+.||..|+++..+.+...+.+.|+||++.++.+++.|..||.+........   ...
T Consensus       174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~---~~~  250 (322)
T KOG1164|consen  174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKS---KFE  250 (322)
T ss_pred             CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHH---HHH
Confidence            98  33222111    1 1 234569999999999999999999999999999999999999997644221100   000


Q ss_pred             ccccccccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          287 QGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                      ..........     .....+..+..+...+-..+...+|....+...+...
T Consensus       251 ~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~  297 (322)
T KOG1164|consen  251 KDPRKLLTDR-----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDV  297 (322)
T ss_pred             HHhhhhcccc-----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHH
Confidence            0000001110     1112235566666666668999999999999886554

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.94  E-value=6.9e-27  Score=195.15  Aligned_cols=256  Identities=20%  Similarity=0.265  Sum_probs=195.5

Q ss_pred             HHhcCCCCCCeecccCCcEEEEEEE-CCCcEEEEEEeccccCChHhHHHHHHHHHHHhccC-CCceeeecceEEeCc-eE
Q 016594           63 IATNAFSSENLVGRGGYAEVYKGVL-QDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVC-HPNVLSLLGCCVDNG-LY  139 (386)
Q Consensus        63 ~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~-~~  139 (386)
                      +..+.|.+.++||.|+||.+|.|.. .+|..||||+-....    ...++..|..+.+.|. ...|..+..+..+.. ..
T Consensus        12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a----~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynv   87 (341)
T KOG1163|consen   12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA----KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNV   87 (341)
T ss_pred             eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC----CCcchhHHHHHHHHhccCCCCchhhhhccccccce
Confidence            5678899999999999999999994 479999999876533    2335778999998887 467778877776655 56


Q ss_pred             EEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcC---CCCeEEeecCccc
Q 016594          140 LIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTA---DFEPQISDFGLAK  216 (386)
Q Consensus       140 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~---~~~~kl~Dfg~a~  216 (386)
                      +||+.+ |.+|.+++.-.. +.++...++.++-|++.-++|+|.   ++++||||||+|+|..-   ...+.|+|||+|+
T Consensus        88 lVMdLL-GPsLEdLfnfC~-R~ftmkTvLMLaDQml~RiEyvH~---r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaK  162 (341)
T KOG1163|consen   88 LVMDLL-GPSLEDLFNFCS-RRFTMKTVLMLADQMLSRIEYVHL---RNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAK  162 (341)
T ss_pred             eeeecc-CccHHHHHHHHh-hhhhHHhHHHHHHHHHHHHHHHHh---hccccccCCccceeeccccccceEEEEeccchh
Confidence            777765 669999886543 459999999999999999999999   99999999999999863   3468999999999


Q ss_pred             cCCCCCcccc-----ccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccc
Q 016594          217 WLPSQWTHHS-----IAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIE  291 (386)
Q Consensus       217 ~~~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  291 (386)
                      .+.+..+...     .....||.+|.+--.+.+...+...|+-|+|.+|.++.-|..||++......        ....+
T Consensus       163 ky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk--------~QKyE  234 (341)
T KOG1163|consen  163 KYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATK--------KQKYE  234 (341)
T ss_pred             hhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhH--------HHHHH
Confidence            8865543322     3456799999998888888889999999999999999999999998644322        12222


Q ss_pred             cccCCccCCCCCH---HHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 016594          292 KLVDPRLQGAYDV---TQLNRLAFAASLCIRASPTWRPTMSEVLEVM  335 (386)
Q Consensus       292 ~~~~~~~~~~~~~---~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l  335 (386)
                      ++...........   ..+.++...+.-|-..--++-|...-+-+.+
T Consensus       235 kI~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlF  281 (341)
T KOG1163|consen  235 KISEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLF  281 (341)
T ss_pred             HHHHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHH
Confidence            2323222222211   1256677788888888888888876665543

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.94  E-value=1.7e-26  Score=213.49  Aligned_cols=178  Identities=19%  Similarity=0.196  Sum_probs=136.8

Q ss_pred             HHHhcCCCCCCeecccCCcEEEEEEEC--CCcEEEEEEeccccC---ChHhHHHHHHHHHHHhccCCCceee-ecceEEe
Q 016594           62 SIATNAFSSENLVGRGGYAEVYKGVLQ--DGEEIAVKRLTKVVT---DDRKEKEFLTEIGTIGHVCHPNVLS-LLGCCVD  135 (386)
Q Consensus        62 ~~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~-l~~~~~~  135 (386)
                      ....++|.+.+.||+|+||+||+|.++  +++.||||++.....   .......+.+|+.+|+++.|+|+++ +++   .
T Consensus        14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~   90 (365)
T PRK09188         14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---T   90 (365)
T ss_pred             ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---c
Confidence            456778999999999999999999875  477789998753211   2334567899999999999999985 443   2


Q ss_pred             CceEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCC-CCCCeeEcCCCCeEEeecCc
Q 016594          136 NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDI-KSSNILLTADFEPQISDFGL  214 (386)
Q Consensus       136 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dl-kp~Nill~~~~~~kl~Dfg~  214 (386)
                      +..++||||+.+++|... .   .  ..   ...++.|++.||.|||+   +||+|||| ||+|||++.++.+||+|||+
T Consensus        91 ~~~~LVmE~~~G~~L~~~-~---~--~~---~~~~~~~i~~aL~~lH~---~gIiHrDL~KP~NILv~~~~~ikLiDFGl  158 (365)
T PRK09188         91 GKDGLVRGWTEGVPLHLA-R---P--HG---DPAWFRSAHRALRDLHR---AGITHNDLAKPQNWLMGPDGEAAVIDFQL  158 (365)
T ss_pred             CCcEEEEEccCCCCHHHh-C---c--cc---hHHHHHHHHHHHHHHHH---CCCeeCCCCCcceEEEcCCCCEEEEECcc
Confidence            458999999999998632 1   1  11   14678899999999999   99999999 99999999999999999999


Q ss_pred             cccCCCCCcccc------ccccccccCccChhhhccCC------CCcccchH
Q 016594          215 AKWLPSQWTHHS------IAPIEGTFGHLAPEYFMHGI------VDEKTDVF  254 (386)
Q Consensus       215 a~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~------~~~~~Dvw  254 (386)
                      |..+........      .....+++.|+|||.+....      .+..+|-|
T Consensus       159 A~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW  210 (365)
T PRK09188        159 ASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW  210 (365)
T ss_pred             ceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence            998755432222      23566888999999986432      23446665

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.94  E-value=4.7e-26  Score=198.42  Aligned_cols=256  Identities=18%  Similarity=0.221  Sum_probs=194.3

Q ss_pred             HHhcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccC-CCceeeecceEEeCc-eE
Q 016594           63 IATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVC-HPNVLSLLGCCVDNG-LY  139 (386)
Q Consensus        63 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~-~~  139 (386)
                      +.+-.|+++++||+|+||.++.|..- +++.||||.-....    ...++..|....+.|. .++|..+|-+-.++- -.
T Consensus        25 ~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS----~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~Ni  100 (449)
T KOG1165|consen   25 MVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS----EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNI  100 (449)
T ss_pred             EecccceeccccccCcceeeecccccccCceEEEEeccccC----CcchHHHHHHHHHHHcCCCCCCceeeeccccchhh
Confidence            45668999999999999999999943 79999999766433    2345667888777776 788888886665554 45


Q ss_pred             EEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCC-----CeEEeecCc
Q 016594          140 LIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADF-----EPQISDFGL  214 (386)
Q Consensus       140 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~-----~~kl~Dfg~  214 (386)
                      +|++.+ |.+|.+++.-.. +.|+...+..+|.|++.-++|+|+   +.+|.|||||+|+||...+     .+.++|||+
T Consensus       101 LVidLL-GPSLEDLFD~Cg-R~FSvKTV~miA~Qmi~rie~vH~---k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGm  175 (449)
T KOG1165|consen  101 LVIDLL-GPSLEDLFDLCG-RRFSVKTVAMIAKQMITRIEYVHE---KDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGM  175 (449)
T ss_pred             hhhhhh-CcCHHHHHHHhc-CcccHHhHHHHHHHHHHHHHHHHh---cceeecccCccceeecCCCCCCCceEEEEeccc
Confidence            666654 679999887544 459999999999999999999999   9999999999999997543     488999999


Q ss_pred             cccCCCCCcccc-----ccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccc
Q 016594          215 AKWLPSQWTHHS-----IAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGE  289 (386)
Q Consensus       215 a~~~~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~  289 (386)
                      |+.+.+..+...     .....||.+||+--.+.+...+...|+-|||-+++++|-|..||++....-        ....
T Consensus       176 AK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~t--------nK~k  247 (449)
T KOG1165|consen  176 AKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADT--------NKEK  247 (449)
T ss_pred             hhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcc--------hHHH
Confidence            999877654433     345679999999999999999999999999999999999999999854321        1122


Q ss_pred             cccccCCccCCCCCH---HHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 016594          290 IEKLVDPRLQGAYDV---TQLNRLAFAASLCIRASPTWRPTMSEVLEVM  335 (386)
Q Consensus       290 ~~~~~~~~~~~~~~~---~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l  335 (386)
                      .+++-+..-......   ..++++...+.-.-..+-.+-|..+-+...+
T Consensus       248 YeKIGe~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf  296 (449)
T KOG1165|consen  248 YEKIGETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLF  296 (449)
T ss_pred             HHHhccccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHH
Confidence            233333222221111   2356677777777777888888886655544

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.93  E-value=8.7e-27  Score=229.08  Aligned_cols=259  Identities=21%  Similarity=0.248  Sum_probs=190.8

Q ss_pred             CCCCeecccCCcEEEEEEEC-CCcEEEEEEec----cccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEE
Q 016594           69 SSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLT----KVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIF  142 (386)
Q Consensus        69 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~----~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~  142 (386)
                      ....++|.|++|.|+.+... ....++.|...    ...........+..|+.+-..+.|+|++..+..+.+.. ..-.|
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m  400 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM  400 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence            45788999999988877643 34445555433    11111222223667888888899999988887775533 44449


Q ss_pred             EeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCC
Q 016594          143 QFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQW  222 (386)
Q Consensus       143 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  222 (386)
                      ||++. +|..++.+.  ..+....+..++.|++.|+.|+|+   .||.|||||++|+++..+|.+||+|||.+..+...+
T Consensus       401 E~~~~-Dlf~~~~~~--~~~~~~e~~c~fKqL~~Gv~y~h~---~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~  474 (601)
T KOG0590|consen  401 EYCPY-DLFSLVMSN--GKLTPLEADCFFKQLLRGVKYLHS---MGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPW  474 (601)
T ss_pred             hcccH-HHHHHHhcc--cccchhhhhHHHHHHHHHHHHHHh---cCceeccCccccEEEecCCceEEeecCcceeeccCc
Confidence            99999 999888764  237888899999999999999999   999999999999999999999999999998876655


Q ss_pred             cc--ccccccccccCccChhhhccCCCC-cccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccC
Q 016594          223 TH--HSIAPIEGTFGHLAPEYFMHGIVD-EKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQ  299 (386)
Q Consensus       223 ~~--~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (386)
                      ..  ......+|+..|+|||++.+..|+ ...||||.|+++..|.+|+.||.......... .  ...... ..-...-.
T Consensus       475 e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~-~--~~~~~~-~~~~~~~~  550 (601)
T KOG0590|consen  475 EKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF-K--TNNYSD-QRNIFEGP  550 (601)
T ss_pred             chhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch-h--hhcccc-ccccccCh
Confidence            44  455678899999999999999987 56899999999999999999997654332211 0  000000 00000001


Q ss_pred             CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 016594          300 GAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLE  337 (386)
Q Consensus       300 ~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~  337 (386)
                      .......+...+.++.+||+.||.+|.|+.+|++.-|.
T Consensus       551 ~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~  588 (601)
T KOG0590|consen  551 NRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWI  588 (601)
T ss_pred             HHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHh
Confidence            11122346778899999999999999999999986443

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.93  E-value=3.2e-24  Score=198.40  Aligned_cols=260  Identities=28%  Similarity=0.408  Sum_probs=199.1

Q ss_pred             CCCCCeecccCCcEEEEEEECCCcEEEEEEeccccCChH-hHHHHHHHHHHHhccCCC-ceeeecceEEeCc-eEEEEEe
Q 016594           68 FSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDR-KEKEFLTEIGTIGHVCHP-NVLSLLGCCVDNG-LYLIFQF  144 (386)
Q Consensus        68 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~e~~~l~~l~h~-niv~l~~~~~~~~-~~lv~e~  144 (386)
                      |.+...||.|+||.||++...  ..+++|.+........ ....+.+|+.++..+.|+ +|+++++.+.... .++++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~   79 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY   79 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence            677889999999999999986  7899999987554443 577889999999999988 7999999996666 6999999


Q ss_pred             ccCCCHhhhhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCC-CeEEeecCccccCCCCC
Q 016594          145 SSRGSVASLFHDVNS-PGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADF-EPQISDFGLAKWLPSQW  222 (386)
Q Consensus       145 ~~~~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~-~~kl~Dfg~a~~~~~~~  222 (386)
                      +.++++.+++..... ..++......++.|++.++.|+|+   .+++|||+||+||+++..+ .++++|||.+..+....
T Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~---~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~  156 (384)
T COG0515          80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS---KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG  156 (384)
T ss_pred             CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence            999999976654432 258899999999999999999999   8999999999999999988 79999999998665443


Q ss_pred             ccc----cccccccccCccChhhhcc---CCCCcccchHHHHHHHHHHHhCCCCCCCCchh--hhhhhhhhhcccccccc
Q 016594          223 THH----SIAPIEGTFGHLAPEYFMH---GIVDEKTDVFAFGVFLLEIISGRKPVDGSHQS--LHSWAKPILNQGEIEKL  293 (386)
Q Consensus       223 ~~~----~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~ell~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~  293 (386)
                      ...    ......|+..|+|||.+.+   ..++...|+|++|++++++++|..||......  ............ .. .
T Consensus       157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~-~~-~  234 (384)
T COG0515         157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELP-TP-S  234 (384)
T ss_pred             ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcC-Cc-c
Confidence            221    3456779999999999987   57889999999999999999999998765421  001000000000 00 0


Q ss_pred             cCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 016594          294 VDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEV  334 (386)
Q Consensus       294 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~  334 (386)
                      ................+.+++..|+..+|..|.+.......
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         235 LASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             cccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence            00000000001223568899999999999999999887765

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.91  E-value=3.4e-25  Score=218.72  Aligned_cols=248  Identities=23%  Similarity=0.224  Sum_probs=175.8

Q ss_pred             CCCCCCeecccCCcEEEEEEECCCcEEEEEEecccc--CChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEEE
Q 016594           67 AFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVV--TDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQ  143 (386)
Q Consensus        67 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~e  143 (386)
                      +|...+.||.+.|=+|.+|+++.|. |+||++-+..  ..-....+.+.|++ ...+++||++++.-+-..+. .|+|=+
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq  101 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ  101 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence            6777899999999999999998776 9999987632  22233344445555 55667999999987765544 566666


Q ss_pred             eccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCc
Q 016594          144 FSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWT  223 (386)
Q Consensus       144 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~  223 (386)
                      |..+ +|.|.+..  ++-+...+...|+.|++.||..+|.   .||+|||||.+|||++.-+.+.|+||...+..--...
T Consensus       102 yvkh-nLyDRlST--RPFL~~iEKkWiaFQLL~al~qcH~---~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD  175 (1431)
T KOG1240|consen  102 YVKH-NLYDRLST--RPFLVLIEKKWIAFQLLKALSQCHK---LGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPED  175 (1431)
T ss_pred             HHhh-hhhhhhcc--chHHHHHHHHHHHHHHHHHHHHHHH---cCccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence            6666 77777653  2336777788899999999999999   9999999999999999999999999988754321111


Q ss_pred             c-----ccccccccccCccChhhhccC----------C-CCcccchHHHHHHHHHHHh-CCCCCCCCchhhhhhhhhhhc
Q 016594          224 H-----HSIAPIEGTFGHLAPEYFMHG----------I-VDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILN  286 (386)
Q Consensus       224 ~-----~~~~~~~gt~~y~aPE~~~~~----------~-~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~  286 (386)
                      .     ....+...-.+|+|||-+...          . .+++-||||+||+++||++ |++||.-..  +..+..  ..
T Consensus       176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQ--L~aYr~--~~  251 (1431)
T KOG1240|consen  176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQ--LLAYRS--GN  251 (1431)
T ss_pred             CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHH--HHhHhc--cC
Confidence            1     111222344569999987431          2 5788999999999999999 899996421  100000  00


Q ss_pred             ccccccccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 016594          287 QGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEV  334 (386)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~  334 (386)
                      ....+..+...        ....+++++..|++.||++|.++++.|+.
T Consensus       252 ~~~~e~~Le~I--------ed~~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  252 ADDPEQLLEKI--------EDVSLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             ccCHHHHHHhC--------cCccHHHHHHHHHccCchhccCHHHHHHh
Confidence            00111111110        01258999999999999999999999986

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.91  E-value=6.4e-25  Score=186.54  Aligned_cols=249  Identities=20%  Similarity=0.330  Sum_probs=192.3

Q ss_pred             cCCCCCCeecccCCcEEEEEEECCCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeC-ceEEEEEe
Q 016594           66 NAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDN-GLYLIFQF  144 (386)
Q Consensus        66 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~  144 (386)
                      +...+..+|.+...|..|+|+|+ |..+++|+++........-..|..|.-.|+-+.||||..+++.|... ++.++..|
T Consensus       190 ~~lnl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~  268 (448)
T KOG0195|consen  190 SSLNLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQY  268 (448)
T ss_pred             hhhhhhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeee
Confidence            34455678899999999999998 66788888875444444556788888889999999999999999775 48899999


Q ss_pred             ccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeE-EeCCCCCCeeEcCCCCeEEe--ecCccccCCCC
Q 016594          145 SSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRII-HRDIKSSNILLTADFEPQIS--DFGLAKWLPSQ  221 (386)
Q Consensus       145 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iv-H~dlkp~Nill~~~~~~kl~--Dfg~a~~~~~~  221 (386)
                      ++.|+|..+++....-...-.++.+++.+++.|++|||+.  ..++ ---|....+++|++.+.+|.  |--++..    
T Consensus       269 mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhsl--ep~ipr~~lns~hvmidedltarismad~kfsfq----  342 (448)
T KOG0195|consen  269 MPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSL--EPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ----  342 (448)
T ss_pred             ccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhc--chhhhhhhcccceEEecchhhhheecccceeeee----
Confidence            9999999999887766677788999999999999999983  2333 33588899999998876653  3222221    


Q ss_pred             CccccccccccccCccChhhhccCCCC---cccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCcc
Q 016594          222 WTHHSIAPIEGTFGHLAPEYFMHGIVD---EKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRL  298 (386)
Q Consensus       222 ~~~~~~~~~~gt~~y~aPE~~~~~~~~---~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (386)
                           .....-.+.||+||.+...+-+   .++|+|||++++|||.|...||.....-           ..-.++.-..+
T Consensus       343 -----e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspm-----------ecgmkialegl  406 (448)
T KOG0195|consen  343 -----EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPM-----------ECGMKIALEGL  406 (448)
T ss_pred             -----ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCch-----------hhhhhhhhccc
Confidence                 1112246789999999876543   6899999999999999999999764321           11123334455


Q ss_pred             CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 016594          299 QGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLE  337 (386)
Q Consensus       299 ~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~  337 (386)
                      +...++..+..+..|+.-|++.||.+||.+..|+-.|+.
T Consensus       407 rv~ippgis~hm~klm~icmnedpgkrpkfdmivpilek  445 (448)
T KOG0195|consen  407 RVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEK  445 (448)
T ss_pred             cccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHH
Confidence            566666777889999999999999999999998877754

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.91  E-value=4.6e-25  Score=207.69  Aligned_cols=226  Identities=23%  Similarity=0.268  Sum_probs=182.3

Q ss_pred             eecccCCcEEEEEE----ECCCcEEEEEEeccccCChHhHHHHHHHHHHHhccC-CCceeeecceEEeCc-eEEEEEecc
Q 016594           73 LVGRGGYAEVYKGV----LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVC-HPNVLSLLGCCVDNG-LYLIFQFSS  146 (386)
Q Consensus        73 ~lg~G~~g~V~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~-~~lv~e~~~  146 (386)
                      .+|.|+||.|++++    .+.|..+|+|++++.............|..++...+ ||.++++...+..++ .++++++..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            47999999999876    235788999998875433333335567888888888 999999999887655 899999999


Q ss_pred             CCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCcccc
Q 016594          147 RGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHS  226 (386)
Q Consensus       147 ~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  226 (386)
                      +|.|...+...  ..+.+.....+...++.+++++|+   .+++|||+|++||+++.+|++++.|||+++..-....   
T Consensus        81 gg~lft~l~~~--~~f~~~~~~~~~aelaLald~lh~---l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~---  152 (612)
T KOG0603|consen   81 GGDLFTRLSKE--VMFDELDVAFYLAELALALDHLHK---LGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI---  152 (612)
T ss_pred             cchhhhccccC--CchHHHHHHHHHHHHHHHHhhcch---hHHHHhcccccceeecccCccccCCchhhhHhHhhhh---
Confidence            99887665533  347788888888999999999999   9999999999999999999999999999987643321   


Q ss_pred             ccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCCCCCHHH
Q 016594          227 IAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQ  306 (386)
Q Consensus       227 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (386)
                         .|||..|||||++.  ....++|.||||+++++|++|..||.+..      .         ..+..  .....+...
T Consensus       153 ---~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~~~------~---------~~Il~--~~~~~p~~l  210 (612)
T KOG0603|consen  153 ---ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGGDT------M---------KRILK--AELEMPREL  210 (612)
T ss_pred             ---cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCchHH------H---------HHHhh--hccCCchhh
Confidence               18999999999988  66789999999999999999999998710      1         11111  123455667


Q ss_pred             HHHHHHHHHHccccCCCCCCCH
Q 016594          307 LNRLAFAASLCIRASPTWRPTM  328 (386)
Q Consensus       307 ~~~l~~li~~cl~~dP~~Rpt~  328 (386)
                      +..+++++..++..+|..|...
T Consensus       211 ~~~a~~~~~~l~~r~p~nrLg~  232 (612)
T KOG0603|consen  211 SAEARSLFRQLFKRNPENRLGA  232 (612)
T ss_pred             hHHHHHHHHHHHhhCHHHHhcc
Confidence            7889999999999999999865

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.90  E-value=8.7e-24  Score=182.10  Aligned_cols=174  Identities=11%  Similarity=0.085  Sum_probs=135.9

Q ss_pred             HHHhcCCCCCCeecccCCcEEEEEEECCCcEEEEEEeccccCChH-hHHH------HHHHHHHHhccCCCceeeecceEE
Q 016594           62 SIATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDR-KEKE------FLTEIGTIGHVCHPNVLSLLGCCV  134 (386)
Q Consensus        62 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~-~~~~------~~~e~~~l~~l~h~niv~l~~~~~  134 (386)
                      .+..++|++.++||.|+||.||++.. ++..+|+|++........ ....      +.+|+..+.++.|++|..+.+++.
T Consensus        27 ~~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~  105 (232)
T PRK10359         27 DFLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYL  105 (232)
T ss_pred             HHhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeee
Confidence            46789999999999999999999765 577899999975433222 1222      578999999999999999998865


Q ss_pred             eC---------ceEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCC
Q 016594          135 DN---------GLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADF  205 (386)
Q Consensus       135 ~~---------~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~  205 (386)
                      ..         ..+++|||++|.+|.++..      ++.    ....+++.+|..||.   .|++|||+||.||+++.+|
T Consensus       106 ~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~------~~~----~~~~~i~~~l~~lH~---~gi~H~Dikp~Nili~~~g  172 (232)
T PRK10359        106 LAERKTLRYAHTYIMLIEYIEGVELNDMPE------ISE----DVKAKIKASIESLHQ---HGMVSGDPHKGNFIVSKNG  172 (232)
T ss_pred             ecccccccccCCeEEEEEEECCccHHHhhh------ccH----HHHHHHHHHHHHHHH---cCCccCCCChHHEEEeCCC
Confidence            32         3789999999999987632      332    245689999999999   9999999999999999988


Q ss_pred             CeEEeecCccccCCCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHH
Q 016594          206 EPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEII  264 (386)
Q Consensus       206 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell  264 (386)
                       ++|+|||...........              ..+.....|..++|+|+||+++..+.
T Consensus       173 -i~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        173 -LRIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             -EEEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHH
Confidence             999999987655322111              11344555778999999999987654

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.90  E-value=1.5e-23  Score=178.50  Aligned_cols=141  Identities=16%  Similarity=0.157  Sum_probs=109.6

Q ss_pred             CCeecccCCcEEEEEEECCCcEEEEEEeccccCChHh------------------------HHHHHHHHHHHhccCCCce
Q 016594           71 ENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRK------------------------EKEFLTEIGTIGHVCHPNV  126 (386)
Q Consensus        71 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~------------------------~~~~~~e~~~l~~l~h~ni  126 (386)
                      ...||+|+||.||+|...+|+.||||+++........                        .....+|+..+.++.++++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            4689999999999999878999999999753221111                        1122459999999988776


Q ss_pred             eeecceEEeCceEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCeEEeCCCCCCeeEcCCC
Q 016594          127 LSLLGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYL-HKGCQRRIIHRDIKSSNILLTADF  205 (386)
Q Consensus       127 v~l~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~L-H~~~~~~ivH~dlkp~Nill~~~~  205 (386)
                      .....+ .....++||||+.++++......  ...++...+..++.|++.+|.+| |+   .||+||||||+|||++ ++
T Consensus        82 ~~p~~~-~~~~~~iVmE~i~g~~l~~~~~~--~~~~~~~~~~~i~~qi~~~L~~l~H~---~giiHrDlkP~NIli~-~~  154 (190)
T cd05147          82 PCPEPI-LLKSHVLVMEFIGDDGWAAPRLK--DAPLSESKARELYLQVIQIMRILYQD---CRLVHADLSEYNLLYH-DG  154 (190)
T ss_pred             CCCcEE-EecCCEEEEEEeCCCCCcchhhh--cCCCCHHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEE-CC
Confidence            443332 22345899999999876654322  23588999999999999999999 68   8999999999999998 47


Q ss_pred             CeEEeecCccccC
Q 016594          206 EPQISDFGLAKWL  218 (386)
Q Consensus       206 ~~kl~Dfg~a~~~  218 (386)
                      .++|+|||+|...
T Consensus       155 ~v~LiDFG~a~~~  167 (190)
T cd05147         155 KLYIIDVSQSVEH  167 (190)
T ss_pred             cEEEEEccccccC
Confidence            8999999999754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.89  E-value=2e-22  Score=178.80  Aligned_cols=232  Identities=20%  Similarity=0.240  Sum_probs=146.8

Q ss_pred             CCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCC-hHhHHHHHHHHHHHhccCC----------CceeeecceEE-
Q 016594           68 FSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTD-DRKEKEFLTEIGTIGHVCH----------PNVLSLLGCCV-  134 (386)
Q Consensus        68 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h----------~niv~l~~~~~-  134 (386)
                      +..+..||.|+++.||.+++. +++.+|||+....... ....+.+.+|.-....+.+          -.++..++... 
T Consensus        14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i   93 (288)
T PF14531_consen   14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI   93 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred             EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence            345788999999999999987 6899999988754322 2345566666544443221          12222222211 


Q ss_pred             --------eC---------ceEEEEEeccCCCHhhhhh---hcCCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEe
Q 016594          135 --------DN---------GLYLIFQFSSRGSVASLFH---DVNSP--GVEWKVRHKIAVGTARGLHYLHKGCQRRIIHR  192 (386)
Q Consensus       135 --------~~---------~~~lv~e~~~~~~L~~~~~---~~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~  192 (386)
                              ..         +.+++|.-+ .++|.+++.   .....  .+.....+.+..|+++.+++||+   .|++|+
T Consensus        94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~---~GlVHg  169 (288)
T PF14531_consen   94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHS---YGLVHG  169 (288)
T ss_dssp             TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---TTEEES
T ss_pred             cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhh---cceEec
Confidence                    11         235566655 447877643   22221  23444556777999999999999   999999


Q ss_pred             CCCCCCeeEcCCCCeEEeecCccccCCCCCccccccccccccCccChhhhccC--------CCCcccchHHHHHHHHHHH
Q 016594          193 DIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHG--------IVDEKTDVFAFGVFLLEII  264 (386)
Q Consensus       193 dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--------~~~~~~DvwslG~il~ell  264 (386)
                      ||+|+|++++.+|.++|+||+.....+....     ....+..|.+||.....        .++.+.|.|+||+++|.|+
T Consensus       170 di~~~nfll~~~G~v~Lg~F~~~~r~g~~~~-----~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lW  244 (288)
T PF14531_consen  170 DIKPENFLLDQDGGVFLGDFSSLVRAGTRYR-----CSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLW  244 (288)
T ss_dssp             T-SGGGEEE-TTS-EEE--GGGEEETTEEEE-----GGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHH
T ss_pred             ccceeeEEEcCCCCEEEcChHHHeecCceee-----ccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHH
Confidence            9999999999999999999988775543211     12345779999977542        4788999999999999999


Q ss_pred             hCCCCCCCCchhhhhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHccccCCCCC
Q 016594          265 SGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWR  325 (386)
Q Consensus       265 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R  325 (386)
                      +|..||........           ...    .. ..+. ..++.++.||..+|+.||.+|
T Consensus       245 C~~lPf~~~~~~~~-----------~~~----~f-~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  245 CGRLPFGLSSPEAD-----------PEW----DF-SRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             HSS-STCCCGGGST-----------SGG----GG-TTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             HccCCCCCCCcccc-----------ccc----cc-hhcC-CcCHHHHHHHHHHccCCcccC
Confidence            99999986432110           000    11 1233 678889999999999999987

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.88  E-value=8.7e-22  Score=168.27  Aligned_cols=144  Identities=20%  Similarity=0.195  Sum_probs=111.6

Q ss_pred             CCCeecccCCcEEEEEEECCCcEEEEEEeccccCChH------------------------hHHHHHHHHHHHhccCCCc
Q 016594           70 SENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDR------------------------KEKEFLTEIGTIGHVCHPN  125 (386)
Q Consensus        70 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~------------------------~~~~~~~e~~~l~~l~h~n  125 (386)
                      +...||+|+||+||+|...+|+.||||++........                        ....+.+|...+.++.|++
T Consensus         1 ~~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05145           1 INGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG   80 (190)
T ss_pred             CCceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence            3578999999999999987899999999886422110                        0122357889999999988


Q ss_pred             eeeecceEEeCceEEEEEeccCCCHhhh-hhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCC
Q 016594          126 VLSLLGCCVDNGLYLIFQFSSRGSVASL-FHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTAD  204 (386)
Q Consensus       126 iv~l~~~~~~~~~~lv~e~~~~~~L~~~-~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~  204 (386)
                      +.....+... ..++||||+.++++... +..   ..++...+..++.|++.++.++|+  ..||+||||||+|||++ +
T Consensus        81 i~~p~~~~~~-~~~lVmE~~~g~~~~~~~l~~---~~~~~~~~~~i~~~l~~~l~~lH~--~~givHrDlkP~NIll~-~  153 (190)
T cd05145          81 VPVPEPILLK-KNVLVMEFIGDDGSPAPRLKD---VPLEEEEAEELYEQVVEQMRRLYQ--EAGLVHGDLSEYNILYH-D  153 (190)
T ss_pred             CCCceEEEec-CCEEEEEEecCCCchhhhhhh---ccCCHHHHHHHHHHHHHHHHHHHH--hCCEecCCCChhhEEEE-C
Confidence            7554443333 35899999998855433 322   347788899999999999999996  26999999999999999 7


Q ss_pred             CCeEEeecCccccCCC
Q 016594          205 FEPQISDFGLAKWLPS  220 (386)
Q Consensus       205 ~~~kl~Dfg~a~~~~~  220 (386)
                      +.++|+|||++..+..
T Consensus       154 ~~~~liDFG~a~~~~~  169 (190)
T cd05145         154 GKPYIIDVSQAVELDH  169 (190)
T ss_pred             CCEEEEEcccceecCC
Confidence            8999999999987643

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.88  E-value=1.5e-21  Score=164.71  Aligned_cols=188  Identities=15%  Similarity=0.017  Sum_probs=140.0

Q ss_pred             CCCCeecccCCcEEEEEEECCCcEEEEEEeccccCC--hHhHHHHHHHHHHHhccC-CCceeeecceEEeCceEEEEEec
Q 016594           69 SSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTD--DRKEKEFLTEIGTIGHVC-HPNVLSLLGCCVDNGLYLIFQFS  145 (386)
Q Consensus        69 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~lv~e~~  145 (386)
                      .+...|++|+||+|+.+.. .+.+++.+.+......  ......+.+|+++|++|. |++|++++++   ++.+++|+|+
T Consensus         5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~---~~~~lvmeyI   80 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW---DGRHLDRSYL   80 (218)
T ss_pred             ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE---cCEEEEEeee
Confidence            4567899999999997766 5778887777643221  111225789999999996 5889999875   4579999999


Q ss_pred             cCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCC-CCCCeeEcCCCCeEEeecCccccCCCCCcc
Q 016594          146 SRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDI-KSSNILLTADFEPQISDFGLAKWLPSQWTH  224 (386)
Q Consensus       146 ~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dl-kp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  224 (386)
                      .|.+|......         ....++.|++.+|.++|+   +||+|||| ||+|||++.++.++|+|||+|.........
T Consensus        81 ~G~~L~~~~~~---------~~~~~~~qi~~~L~~lH~---~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~  148 (218)
T PRK12274         81 AGAAMYQRPPR---------GDLAYFRAARRLLQQLHR---CGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARW  148 (218)
T ss_pred             cCccHHhhhhh---------hhHHHHHHHHHHHHHHHH---CcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchH
Confidence            99988654321         113577899999999999   99999999 799999999999999999999865433210


Q ss_pred             ----c-c------ccccccccCccChhhhccC-CCC-cccchHHHHHHHHHHHhCCCCCCC
Q 016594          225 ----H-S------IAPIEGTFGHLAPEYFMHG-IVD-EKTDVFAFGVFLLEIISGRKPVDG  272 (386)
Q Consensus       225 ----~-~------~~~~~gt~~y~aPE~~~~~-~~~-~~~DvwslG~il~ell~g~~pf~~  272 (386)
                          . .      ......++.|++|+...-- ..+ ...++++.|+-+|.++|+..++-+
T Consensus       149 ~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~  209 (218)
T PRK12274        149 MRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE  209 (218)
T ss_pred             HHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence                0 0      0012257788888764422 233 678999999999999999888654

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.87  E-value=4.6e-22  Score=177.51  Aligned_cols=194  Identities=21%  Similarity=0.236  Sum_probs=135.4

Q ss_pred             CCCceeeecceEEeC----------------------------ceEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHH
Q 016594          122 CHPNVLSLLGCCVDN----------------------------GLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVG  173 (386)
Q Consensus       122 ~h~niv~l~~~~~~~----------------------------~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~q  173 (386)
                      .|||||+++++|.+.                            .+|+||..+.. +|..++-.+.   .+.....-++.|
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~---~s~r~~~~~laQ  349 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH---RSYRTGRVILAQ  349 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC---CchHHHHHHHHH
Confidence            499999998887531                            26777777665 7888775433   556667788999


Q ss_pred             HHHHHHHHHhCCCCCeEEeCCCCCCeeEc--CCC--CeEEeecCccccCCCCCc----cccccccccccCccChhhhccC
Q 016594          174 TARGLHYLHKGCQRRIIHRDIKSSNILLT--ADF--EPQISDFGLAKWLPSQWT----HHSIAPIEGTFGHLAPEYFMHG  245 (386)
Q Consensus       174 i~~~l~~LH~~~~~~ivH~dlkp~Nill~--~~~--~~kl~Dfg~a~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~  245 (386)
                      +++|+.|||.   +||.|||+|.+|||+.  +++  .+.|+|||++-......-    .......-|....||||+....
T Consensus       350 lLEav~hL~~---hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~  426 (598)
T KOG4158|consen  350 LLEAVTHLHK---HGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAV  426 (598)
T ss_pred             HHHHHHHHHH---ccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcC
Confidence            9999999999   9999999999999984  443  578999999754332110    0111233467778999998643


Q ss_pred             C------CCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHccc
Q 016594          246 I------VDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIR  319 (386)
Q Consensus       246 ~------~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~  319 (386)
                      +      --.++|.|+.|.+.||+++...||.+...-...       .....+--    -+..+..++..+++++...|+
T Consensus       427 PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~-------~r~Yqe~q----LPalp~~vpp~~rqlV~~lL~  495 (598)
T KOG4158|consen  427 PGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLD-------TRTYQESQ----LPALPSRVPPVARQLVFDLLK  495 (598)
T ss_pred             CCCceeeccchhhhhhhhhhHHHHhccCCcccccchheec-------hhhhhhhh----CCCCcccCChHHHHHHHHHhc
Confidence            2      125899999999999999999999873321110       00111111    112233455678999999999


Q ss_pred             cCCCCCCCHHHHHH
Q 016594          320 ASPTWRPTMSEVLE  333 (386)
Q Consensus       320 ~dP~~Rpt~~~il~  333 (386)
                      .||++|++..-...
T Consensus       496 r~pskRvsp~iAAN  509 (598)
T KOG4158|consen  496 RDPSKRVSPNIAAN  509 (598)
T ss_pred             CCccccCCccHHHh
Confidence            99999998754443

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.86  E-value=1.1e-21  Score=197.16  Aligned_cols=200  Identities=19%  Similarity=0.178  Sum_probs=159.7

Q ss_pred             HHHHHHhcCCCCCCeecccCCcEEEEEEECCCcEEEEEEeccccCChHhHHHHHHHHHHHhccC---CCceeeecceEEe
Q 016594           59 EEISIATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVC---HPNVLSLLGCCVD  135 (386)
Q Consensus        59 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~  135 (386)
                      .+.++.+..|.+.+.||+|+||+||+|...+|+.||+|+-+.....+..+     -.+++.+|+   -+.|..+..++..
T Consensus       691 ~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEfYI-----~~q~~~RLk~~~~~~~~~~~~a~~~  765 (974)
T KOG1166|consen  691 TEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEFYI-----CLQVMERLKPQMLPSIMHISSAHVF  765 (974)
T ss_pred             ceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceeeee-----hHHHHHhhchhhhcchHHHHHHHcc
Confidence            34456677899999999999999999998889999999877543332221     122233333   2345555555544


Q ss_pred             -CceEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcC-------CCCe
Q 016594          136 -NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTA-------DFEP  207 (386)
Q Consensus       136 -~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~-------~~~~  207 (386)
                       +..++|++|.+.|+|.+++.  ..+.+++..+..++.|++..+++||.   .+||||||||+|.||..       ...+
T Consensus       766 ~~~S~lv~ey~~~Gtlld~~N--~~~~m~e~lv~~~~~qml~ive~lH~---~~IIHgDiKPDNfll~~~~~~~~~~~~l  840 (974)
T KOG1166|consen  766 QNASVLVSEYSPYGTLLDLIN--TNKVMDEYLVMFFSCQMLRIVEHLHA---MGIIHGDIKPDNFLLRREICADSDSKGL  840 (974)
T ss_pred             CCcceeeeeccccccHHHhhc--cCCCCCchhhhHHHHHHHHHHHHHHh---cceecccCCcceeEeecccCCCCcccce
Confidence             55899999999999999998  55569999999999999999999999   99999999999999942       2358


Q ss_pred             EEeecCccccCCCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCC
Q 016594          208 QISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRK  268 (386)
Q Consensus       208 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~  268 (386)
                      +|+|||.+..+..-.........++|-.+-.+|+..|.+|++.+|.|.|+.+++.||.|+.
T Consensus       841 ~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  841 YLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             EEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence            9999999976644333345666778999999999999999999999999999999999874

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.84  E-value=8.4e-21  Score=178.90  Aligned_cols=213  Identities=22%  Similarity=0.393  Sum_probs=157.8

Q ss_pred             HhccCCCceeeecceEEeCc-eEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCe-EEeCCC
Q 016594          118 IGHVCHPNVLSLLGCCVDNG-LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRI-IHRDIK  195 (386)
Q Consensus       118 l~~l~h~niv~l~~~~~~~~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i-vH~dlk  195 (386)
                      |+.+.|.|+.+++|.+.++. .+.|.+|+..|+|.+.+.. ....+++.....++++++.||.|||.   ..| .|+.|+
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~-~~~~~d~~F~~s~~rdi~~Gl~ylh~---s~i~~hg~l~   76 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN-EDIKLDYFFILSFIRDISKGLAYLHN---SPIGYHGALK   76 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc-cccCccHHHHHHHHHHHHHHHHHHhc---Ccceeeeeec
Confidence            45788999999999998766 8889999999999999876 33447888888999999999999998   444 999999


Q ss_pred             CCCeeEcCCCCeEEeecCccccCCCCCccccccccccccCccChhhhccCC-------CCcccchHHHHHHHHHHHhCCC
Q 016594          196 SSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGI-------VDEKTDVFAFGVFLLEIISGRK  268 (386)
Q Consensus       196 p~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~DvwslG~il~ell~g~~  268 (386)
                      +.|.+++..+.+||+|||+.................-..-|.|||.+.+..       .+.+.||||||++++|+++...
T Consensus        77 s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~  156 (484)
T KOG1023|consen   77 SSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG  156 (484)
T ss_pred             cccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence            999999999999999999988764311111111222445689999987631       4677999999999999999999


Q ss_pred             CCCCCchhhh--hhhhhhhcccccccccCCccCCCCC-H-HHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCCc
Q 016594          269 PVDGSHQSLH--SWAKPILNQGEIEKLVDPRLQGAYD-V-TQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEGDQ  340 (386)
Q Consensus       269 pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~-~-~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~~~  340 (386)
                      ||........  ..+..+..      .-.+..++... . +..+.+..++..||..+|..||++.+|-..+.....
T Consensus       157 ~~~~~~~~~~~~eii~~~~~------~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~  226 (484)
T KOG1023|consen  157 PFDLRNLVEDPDEIILRVKK------GGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK  226 (484)
T ss_pred             ccccccccCChHHHHHHHHh------cCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence            9986433221  11111111      01111111111 1 334479999999999999999999999988766554

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.84  E-value=3e-21  Score=190.79  Aligned_cols=216  Identities=24%  Similarity=0.353  Sum_probs=147.6

Q ss_pred             HhcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCceEEEE
Q 016594           64 ATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNGLYLIF  142 (386)
Q Consensus        64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~lv~  142 (386)
                      ...+|..++.|..|+||.||.++++ +.+++|+| +++..       .+++-  ++.....|.+|               
T Consensus        81 ~e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~-------lilRn--ilt~a~npfvv---------------  135 (1205)
T KOG0606|consen   81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQN-------LILRN--ILTFAGNPFVV---------------  135 (1205)
T ss_pred             CccccceeEeeccCCCCceeeeeccccccchhhc-ccccc-------hhhhc--cccccCCccee---------------
Confidence            4568999999999999999999987 57789984 43311       11111  33333344333               


Q ss_pred             EeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCC
Q 016594          143 QFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQW  222 (386)
Q Consensus       143 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  222 (386)
                           |+-..++.....  ++...        +.+++|||+   .+|+|||+||+|+++..-|++|++|||+++..-...
T Consensus       136 -----gDc~tllk~~g~--lPvdm--------vla~Eylh~---ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~  197 (1205)
T KOG0606|consen  136 -----GDCATLLKNIGP--LPVDM--------VLAVEYLHS---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSL  197 (1205)
T ss_pred             -----chhhhhcccCCC--Ccchh--------hHHhHhhcc---CCeecCCCCCCcceeeecccccccchhhhhhhhhhc
Confidence                 333344443222  33332        679999999   999999999999999999999999999987532111


Q ss_pred             c------------cc-cccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccc
Q 016594          223 T------------HH-SIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGE  289 (386)
Q Consensus       223 ~------------~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~  289 (386)
                      .            +. .....+||+.|+|||++..+.|+..+|+|++|+|+||++.|..||.+......  ...++.. .
T Consensus       198 atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeel--fg~visd-~  274 (1205)
T KOG0606|consen  198 ATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEEL--FGQVISD-D  274 (1205)
T ss_pred             cchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHH--Hhhhhhh-h
Confidence            1            11 12345899999999999999999999999999999999999999988632110  0000000 0


Q ss_pred             cccccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 016594          290 IEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVL  332 (386)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il  332 (386)
                      + ..      ..-......++++++.++|+.+|..|--....+
T Consensus       275 i-~w------pE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~  310 (1205)
T KOG0606|consen  275 I-EW------PEEDEALPPEAQDLIEQLLRQNPLCRLGTGGAL  310 (1205)
T ss_pred             c-cc------cccCcCCCHHHHHHHHHHHHhChHhhcccchhh
Confidence            0 00      001122346799999999999999997444444

>smart00090 RIO RIO-like kinase

Probab=99.83  E-value=3.2e-20  Score=163.41  Aligned_cols=149  Identities=17%  Similarity=0.096  Sum_probs=113.1

Q ss_pred             HhcCCCCCCeecccCCcEEEEEE--ECCCcEEEEEEeccccCCh--------------------H--hHHHHHHHHHHHh
Q 016594           64 ATNAFSSENLVGRGGYAEVYKGV--LQDGEEIAVKRLTKVVTDD--------------------R--KEKEFLTEIGTIG  119 (386)
Q Consensus        64 ~~~~~~~~~~lg~G~~g~V~~~~--~~~~~~vavK~~~~~~~~~--------------------~--~~~~~~~e~~~l~  119 (386)
                      .+.-|.+.+.||+|+||.||+|.  ..+|+.||+|++.......                    .  ....+.+|+..+.
T Consensus        26 ~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~  105 (237)
T smart00090       26 RGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQ  105 (237)
T ss_pred             cCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHH
Confidence            33458899999999999999998  4579999999987532110                    0  1123568999999


Q ss_pred             ccCCCceeeecceEEeCceEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC-eEEeCCCCCC
Q 016594          120 HVCHPNVLSLLGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRR-IIHRDIKSSN  198 (386)
Q Consensus       120 ~l~h~niv~l~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~-ivH~dlkp~N  198 (386)
                      ++.+. .+.+...+.....++||||+.+++|......  ...+....+..++.|++.+|.+||+   ++ ++||||||+|
T Consensus       106 ~L~~~-~i~~p~~~~~~~~~lV~E~~~g~~L~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~---~g~iiH~Dikp~N  179 (237)
T smart00090      106 RLYEA-GVPVPKPIAWRRNVLVMEFIGGDGLPAPRLK--DVEPEEEEEFELYDDILEEMRKLYK---EGELVHGDLSEYN  179 (237)
T ss_pred             HHHhc-CCCCCeeeEecCceEEEEEecCCcccccccc--cCCcchHHHHHHHHHHHHHHHHHHh---cCCEEeCCCChhh
Confidence            99753 2222233333456899999999888665422  2235566678999999999999999   89 9999999999


Q ss_pred             eeEcCCCCeEEeecCccccCC
Q 016594          199 ILLTADFEPQISDFGLAKWLP  219 (386)
Q Consensus       199 ill~~~~~~kl~Dfg~a~~~~  219 (386)
                      |+++ ++.++|+|||.+....
T Consensus       180 Ili~-~~~i~LiDFg~a~~~~  199 (237)
T smart00090      180 ILVH-DGKVVIIDVSQSVELD  199 (237)
T ss_pred             EEEE-CCCEEEEEChhhhccC
Confidence            9999 8899999999987553

>PRK10345 hypothetical protein; Provisional

Probab=99.83  E-value=5.4e-20  Score=158.15  Aligned_cols=134  Identities=19%  Similarity=0.284  Sum_probs=103.1

Q ss_pred             CCCeecccCCcEEEEEEECCCcEEEEEEeccccCChHhHHHHHHHHHHHhcc-----CCCceeeecceEEeCc----eE-
Q 016594           70 SENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHV-----CHPNVLSLLGCCVDNG----LY-  139 (386)
Q Consensus        70 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~niv~l~~~~~~~~----~~-  139 (386)
                      -...||+|+||.||.  +......+||++....  ......+.+|+.+++.+     .||||+++++++.++.    .+ 
T Consensus         6 ~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~--~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~   81 (210)
T PRK10345          6 EQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRG--DGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD   81 (210)
T ss_pred             CcceecCCCceEEEE--CCCCcCeEEEEEeccc--cchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence            357899999999996  4433334789886532  22446789999999999     5799999999998753    23 


Q ss_pred             EEEEe--ccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHH-HHHHhCCCCCeEEeCCCCCCeeEcC----CCCeEEeec
Q 016594          140 LIFQF--SSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGL-HYLHKGCQRRIIHRDIKSSNILLTA----DFEPQISDF  212 (386)
Q Consensus       140 lv~e~--~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l-~~LH~~~~~~ivH~dlkp~Nill~~----~~~~kl~Df  212 (386)
                      +|++|  +.+++|.+++.+.   .+++.  ..++.+++.++ +|||+   ++|+||||||+|||++.    ++.++|+||
T Consensus        82 ~I~e~~G~~~~tL~~~l~~~---~~~e~--~~~~~~~L~~l~~yLh~---~~IvhrDlKp~NILl~~~~~~~~~~~LiDg  153 (210)
T PRK10345         82 VIADFDGKPSITLTEFAEQC---RYEED--VAQLRQLLKKLKRYLLD---NRIVTMELKPQNILCQRISESEVIPVVCDN  153 (210)
T ss_pred             EEecCCCCcchhHHHHHHcc---cccHh--HHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence            67899  5578999999652   25555  35677888887 99999   99999999999999974    347999994


Q ss_pred             -Ccc
Q 016594          213 -GLA  215 (386)
Q Consensus       213 -g~a  215 (386)
                       |..
T Consensus       154 ~G~~  157 (210)
T PRK10345        154 IGES  157 (210)
T ss_pred             CCCc
Confidence             543

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.82  E-value=1.8e-19  Score=155.22  Aligned_cols=148  Identities=17%  Similarity=0.094  Sum_probs=114.1

Q ss_pred             HHHHHHhcCCCCCCeecccCCcEEEEEEECCCcEEEEEEeccccCCh--------------------HhHHHHHHHHHHH
Q 016594           59 EEISIATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDD--------------------RKEKEFLTEIGTI  118 (386)
Q Consensus        59 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~--------------------~~~~~~~~e~~~l  118 (386)
                      .++......|.+.+.||.|+||.||+|...+|+.||||++.......                    .......+|+.++
T Consensus         8 ~~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l   87 (198)
T cd05144           8 HTLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAAL   87 (198)
T ss_pred             HHHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHH
Confidence            44444555588999999999999999998889999999876422110                    0112356788888


Q ss_pred             hccCCCc--eeeecceEEeCceEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCC
Q 016594          119 GHVCHPN--VLSLLGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKS  196 (386)
Q Consensus       119 ~~l~h~n--iv~l~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp  196 (386)
                      ..+.|++  +...++   ....+++|||+.+++|..+...        .....++.+++.++.++|.   .+++||||||
T Consensus        88 ~~l~~~~i~v~~~~~---~~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~---~gi~H~Dl~p  153 (198)
T cd05144          88 KALYEEGFPVPKPID---WNRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYK---HGIIHGDLSE  153 (198)
T ss_pred             HHHHHcCCCCCceee---cCCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHH---CCCCcCCCCc
Confidence            8888774  333332   3457899999999998765431        2356788999999999999   9999999999


Q ss_pred             CCeeEcCCCCeEEeecCccccCCC
Q 016594          197 SNILLTADFEPQISDFGLAKWLPS  220 (386)
Q Consensus       197 ~Nill~~~~~~kl~Dfg~a~~~~~  220 (386)
                      +||+++.++.++|+|||.+..+..
T Consensus       154 ~Nill~~~~~~~liDfg~~~~~~~  177 (198)
T cd05144         154 FNILVDDDEKIYIIDWPQMVSTDH  177 (198)
T ss_pred             ccEEEcCCCcEEEEECCccccCCC
Confidence            999999999999999999976544

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.79  E-value=1.9e-18  Score=150.41  Aligned_cols=135  Identities=21%  Similarity=0.299  Sum_probs=110.4

Q ss_pred             CeecccCCcEEEEEEECCCcEEEEEEeccccCCh------HhHHHHHHHHHHHhccCCCceeeecceEEe-CceEEEEEe
Q 016594           72 NLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDD------RKEKEFLTEIGTIGHVCHPNVLSLLGCCVD-NGLYLIFQF  144 (386)
Q Consensus        72 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~lv~e~  144 (386)
                      +.||+|++|.||+|.+ .|..|++|+........      .....+.+|+.++..+.|++|.....++.+ ...+++|||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            5799999999999988 57789999765422211      122457789999999999988777666644 448899999


Q ss_pred             ccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCcccc
Q 016594          145 SSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKW  217 (386)
Q Consensus       145 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~  217 (386)
                      +.|++|.+++....     . ....++.+++.+|.++|+   .+++|+|++|.|||++ ++.++|+|||++..
T Consensus        81 ~~G~~L~~~~~~~~-----~-~~~~i~~~i~~~l~~lH~---~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         81 IEGEPLKDLINSNG-----M-EELELSREIGRLVGKLHS---AGIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             eCCcCHHHHHHhcc-----H-HHHHHHHHHHHHHHHHHh---CCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            99999999886422     2 778899999999999999   9999999999999999 78999999998764

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.78  E-value=2.5e-18  Score=148.18  Aligned_cols=132  Identities=21%  Similarity=0.318  Sum_probs=104.2

Q ss_pred             eecccCCcEEEEEEECCCcEEEEEEeccccC-Ch-----HhHHHHHHHHHHHhccCCCceeeecceEEe-CceEEEEEec
Q 016594           73 LVGRGGYAEVYKGVLQDGEEIAVKRLTKVVT-DD-----RKEKEFLTEIGTIGHVCHPNVLSLLGCCVD-NGLYLIFQFS  145 (386)
Q Consensus        73 ~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~-----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~lv~e~~  145 (386)
                      .||+|+||.||+|.+. +..|++|....... ..     .....+.+|+.++..+.|+++.....++.+ +..+++|||+
T Consensus         1 ~ig~G~~~~vy~~~~~-~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDFL-GLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeecC-CccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            4899999999999964 78899998654221 11     123567789999999998765544444433 4478999999


Q ss_pred             cCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccC
Q 016594          146 SRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWL  218 (386)
Q Consensus       146 ~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~  218 (386)
                      .|++|.+++.....         .++.+++.+|.+||+   .+++|+|++|.||+++ ++.++++|||++...
T Consensus        80 ~g~~l~~~~~~~~~---------~~~~~i~~~l~~lH~---~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~  139 (199)
T TIGR03724        80 EGKPLKDVIEEGND---------ELLREIGRLVGKLHK---AGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS  139 (199)
T ss_pred             CCccHHHHHhhcHH---------HHHHHHHHHHHHHHH---CCeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence            99999987754210         788999999999999   9999999999999999 789999999998753

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.77  E-value=1.7e-19  Score=167.21  Aligned_cols=173  Identities=22%  Similarity=0.308  Sum_probs=128.5

Q ss_pred             eEEEEEeccCCCHhhhhhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccc
Q 016594          138 LYLIFQFSSRGSVASLFHDV-NSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAK  216 (386)
Q Consensus       138 ~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~  216 (386)
                      +|+.|+++...+|.+++... .....++...+.++.|++.|++|      ++.+|+|+||.||++..+..+||.|||+..
T Consensus       331 lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl~t  404 (516)
T KOG1033|consen  331 LYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGLVT  404 (516)
T ss_pred             hhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhhee
Confidence            68899999999999999643 33346788899999999999999      489999999999999999999999999988


Q ss_pred             cCCCCC----ccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCchhhhhhhhhhhcccccc
Q 016594          217 WLPSQW----THHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGEIE  291 (386)
Q Consensus       217 ~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~  291 (386)
                      ......    .....+...||..||+||.+.+..|+.++||||||++|+||+. =..+|...              ....
T Consensus       405 s~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~--------------~t~~  470 (516)
T KOG1033|consen  405 SQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERI--------------ATLT  470 (516)
T ss_pred             ecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHH--------------Hhhh
Confidence            765443    1223445679999999999999999999999999999999998 33343221              0111


Q ss_pred             cccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHH
Q 016594          292 KLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEV  331 (386)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~i  331 (386)
                      .+-+..+.+..-.+ ...-..|+.+++.+.|.+||++.+.
T Consensus       471 d~r~g~ip~~~~~d-~p~e~~ll~~lls~~p~~RP~~~~~  509 (516)
T KOG1033|consen  471 DIRDGIIPPEFLQD-YPEEYTLLQQLLSPSPEERPSAIEV  509 (516)
T ss_pred             hhhcCCCChHHhhc-CcHHHHHHHHhcCCCcccCchHHHH
Confidence            11111111001011 1224578899999999999954443

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.76  E-value=5.4e-18  Score=167.41  Aligned_cols=140  Identities=19%  Similarity=0.279  Sum_probs=110.4

Q ss_pred             HhcCCCCCCeecccCCcEEEEEEECCCcEEEEEEe-ccccCC-----hHhHHHHHHHHHHHhccCCCceeeecceEEe-C
Q 016594           64 ATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRL-TKVVTD-----DRKEKEFLTEIGTIGHVCHPNVLSLLGCCVD-N  136 (386)
Q Consensus        64 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~-~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~  136 (386)
                      ....|...+.||+|+||+||+|.+.. ..+++|+. .+....     ......+.+|+.+++.+.|++++....++.+ .
T Consensus       331 ~~~~~~~~~~iG~G~~g~Vy~~~~~~-~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~  409 (535)
T PRK09605        331 VKRRKIPDHLIGKGAEADIKKGEYLG-RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPE  409 (535)
T ss_pred             cccccCccceeccCCcEEEEEEeecC-ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCC
Confidence            34455778999999999999998764 34444433 221111     1223567899999999999999887766655 3


Q ss_pred             ceEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccc
Q 016594          137 GLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAK  216 (386)
Q Consensus       137 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~  216 (386)
                      ..+++|||+.+++|.+++.          ....++.+++.+|.+||+   ++++||||||+|||+ .++.++|+|||++.
T Consensus       410 ~~~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~---~giiHrDlkp~NILl-~~~~~~liDFGla~  475 (535)
T PRK09605        410 EKTIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHK---AGIVHGDLTTSNFIV-RDDRLYLIDFGLGK  475 (535)
T ss_pred             CCEEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHh---CCCccCCCChHHEEE-ECCcEEEEeCcccc
Confidence            4789999999999998775          346789999999999999   999999999999999 57799999999987


Q ss_pred             cC
Q 016594          217 WL  218 (386)
Q Consensus       217 ~~  218 (386)
                      ..
T Consensus       476 ~~  477 (535)
T PRK09605        476 YS  477 (535)
T ss_pred             cC
Confidence            53

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.76  E-value=8.8e-20  Score=179.75  Aligned_cols=258  Identities=19%  Similarity=0.228  Sum_probs=195.1

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEC--CCcEEEEEEeccccCChHhHHHHHHHHHHHhccC-CCceeeecceEEeCc-eEE
Q 016594           65 TNAFSSENLVGRGGYAEVYKGVLQ--DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVC-HPNVLSLLGCCVDNG-LYL  140 (386)
Q Consensus        65 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~-~~l  140 (386)
                      ...|.+.+.||+|+|+.|-.+...  ....+|+|.+...............|..+-..+. |.|++.+++...+.. .++
T Consensus        19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~   98 (601)
T KOG0590|consen   19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL   98 (601)
T ss_pred             cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence            345777888999999999988754  3455677766654433444555666888888887 999999999998766 788


Q ss_pred             EEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCCeEEeCCCCCCeeEcCCC-CeEEeecCccccC
Q 016594          141 IFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLH-KGCQRRIIHRDIKSSNILLTADF-EPQISDFGLAKWL  218 (386)
Q Consensus       141 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH-~~~~~~ivH~dlkp~Nill~~~~-~~kl~Dfg~a~~~  218 (386)
                      ..++..++++.+.+........+...+..++.|+..++.|+| .   .++.|+||||+|.+++..+ .++++|||+|..+
T Consensus        99 ~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~---~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~  175 (601)
T KOG0590|consen   99 SLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPE---NGVTHRDIKPSNSLLDESGSALKIADFGLATAY  175 (601)
T ss_pred             ccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcc---cccccCCCCCccchhccCCCcccCCCchhhccc
Confidence            889999998887763223224667778889999999999999 7   8999999999999999999 9999999999988


Q ss_pred             CC-CCcccccccccc-ccCccChhhhccC-CCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccC
Q 016594          219 PS-QWTHHSIAPIEG-TFGHLAPEYFMHG-IVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVD  295 (386)
Q Consensus       219 ~~-~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  295 (386)
                      .. ..........+| ++.|+|||...+. ...+..|+||.|+++..+++|..|+.........+          .....
T Consensus       176 ~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~----------~~~~~  245 (601)
T KOG0590|consen  176 RNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRY----------SSWKS  245 (601)
T ss_pred             cccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccc----------eeecc
Confidence            76 444455556678 9999999999884 55688999999999999999999997654332111          11111


Q ss_pred             Ccc--CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 016594          296 PRL--QGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVM  335 (386)
Q Consensus       296 ~~~--~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l  335 (386)
                      ...  .............+++.+++..+|..|.+.+++-..-
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~  287 (601)
T KOG0590|consen  246 NKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDN  287 (601)
T ss_pred             cccccccCccccCChhhhhcccccccCCchhccccccccccc
Confidence            110  0111122345577888889999999999998877543

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.73  E-value=4.6e-17  Score=138.84  Aligned_cols=140  Identities=22%  Similarity=0.262  Sum_probs=98.1

Q ss_pred             CCCeecccCCcEEEEEEECCCcEEEEEEeccccCChHhHHHH----------------------HHHHHHHhccCCCc--
Q 016594           70 SENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEF----------------------LTEIGTIGHVCHPN--  125 (386)
Q Consensus        70 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~----------------------~~e~~~l~~l~h~n--  125 (386)
                      +.+.||+|+||+||+|...+++.||||++.............                      ..|...+..+.+..  
T Consensus         1 ~~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~   80 (187)
T cd05119           1 VGGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP   80 (187)
T ss_pred             CCcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence            357899999999999998789999999987532221111111                      24555555554332  


Q ss_pred             eeeecceEEeCceEEEEEeccCCCHhh-hhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCC
Q 016594          126 VLSLLGCCVDNGLYLIFQFSSRGSVAS-LFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTAD  204 (386)
Q Consensus       126 iv~l~~~~~~~~~~lv~e~~~~~~L~~-~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~  204 (386)
                      +.+.++   ....+++|||+.++.+.. .+....   .. ..+..++.+++.++.++|.  .++++|+||||+||+++ +
T Consensus        81 ~~~~~~---~~~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh~--~~~ivH~Dl~p~Nili~-~  150 (187)
T cd05119          81 VPKPID---LNRHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLYR--EAGLVHGDLSEYNILVD-D  150 (187)
T ss_pred             CCceEe---cCCCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHhh--ccCcCcCCCChhhEEEE-C
Confidence            333332   234689999999954321 121111   11 5677899999999999997  36899999999999999 8


Q ss_pred             CCeEEeecCccccCC
Q 016594          205 FEPQISDFGLAKWLP  219 (386)
Q Consensus       205 ~~~kl~Dfg~a~~~~  219 (386)
                      +.++|+|||.+....
T Consensus       151 ~~~~liDfg~a~~~~  165 (187)
T cd05119         151 GKVYIIDVPQAVEID  165 (187)
T ss_pred             CcEEEEECccccccc
Confidence            899999999987553

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.68  E-value=5.2e-16  Score=127.15  Aligned_cols=134  Identities=19%  Similarity=0.167  Sum_probs=109.5

Q ss_pred             CCCeecccCCcEEEEEEECCCcEEEEEEeccccCChHhHHHHHHHHHHHhccCC--CceeeecceEEeC-ceEEEEEecc
Q 016594           70 SENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCH--PNVLSLLGCCVDN-GLYLIFQFSS  146 (386)
Q Consensus        70 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~-~~~lv~e~~~  146 (386)
                      +.+.||.|.++.||++... +..+++|.......    ...+.+|+.+++.+.|  .++++++.+.... ..+++++|+.
T Consensus         2 ~~~~i~~g~~~~v~~~~~~-~~~~~iK~~~~~~~----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~   76 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTK-DEDYVLKINPSREK----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIE   76 (155)
T ss_pred             cceecccccccceEEEEec-CCeEEEEecCCCCc----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecC
Confidence            4578999999999999986 47899998865322    4568889999999976  5888888777553 4899999999


Q ss_pred             CCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCcccc
Q 016594          147 RGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKW  217 (386)
Q Consensus       147 ~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~  217 (386)
                      ++.+..+         +......++.+++.+|.+||.....+++|+|++|+||+++..+.++++|||.+..
T Consensus        77 g~~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          77 GETLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             CeecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            8876544         4456677889999999999984334799999999999999989999999998864

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.68  E-value=7.1e-16  Score=136.09  Aligned_cols=137  Identities=13%  Similarity=0.180  Sum_probs=104.8

Q ss_pred             CCeec-ccCCcEEEEEEECCCcEEEEEEecccc------C-----ChHhHHHHHHHHHHHhccCCCce--eeecceEEeC
Q 016594           71 ENLVG-RGGYAEVYKGVLQDGEEIAVKRLTKVV------T-----DDRKEKEFLTEIGTIGHVCHPNV--LSLLGCCVDN  136 (386)
Q Consensus        71 ~~~lg-~G~~g~V~~~~~~~~~~vavK~~~~~~------~-----~~~~~~~~~~e~~~l~~l~h~ni--v~l~~~~~~~  136 (386)
                      ...|| .|+.|+||.+... +..++||.+....      .     .......+.+|+.++..|.|++|  +..+++....
T Consensus        36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            35687 8899999998875 7789999875321      0     11234567889999999998775  6666664332


Q ss_pred             -c----eEEEEEeccC-CCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEe
Q 016594          137 -G----LYLIFQFSSR-GSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQIS  210 (386)
Q Consensus       137 -~----~~lv~e~~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~  210 (386)
                       .    .++|+|++.+ .+|.+++...   .++..    .+.+++.+|.+||+   +||+||||||.|||++.++.++|+
T Consensus       115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~---~l~~~----~~~~i~~~l~~lH~---~GI~HrDlkp~NILv~~~~~v~LI  184 (239)
T PRK01723        115 HGLFYRADILIERIEGARDLVALLQEA---PLSEE----QWQAIGQLIARFHD---AGVYHADLNAHNILLDPDGKFWLI  184 (239)
T ss_pred             cCcceeeeEEEEecCCCCCHHHHHhcC---CCCHH----HHHHHHHHHHHHHH---CCCCCCCCCchhEEEcCCCCEEEE
Confidence             2    3599999997 6888887542   24443    35688999999999   999999999999999998899999


Q ss_pred             ecCccccC
Q 016594          211 DFGLAKWL  218 (386)
Q Consensus       211 Dfg~a~~~  218 (386)
                      |||.+...
T Consensus       185 Dfg~~~~~  192 (239)
T PRK01723        185 DFDRGELR  192 (239)
T ss_pred             ECCCcccC
Confidence            99988753

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.62  E-value=6.5e-16  Score=146.12  Aligned_cols=254  Identities=21%  Similarity=0.227  Sum_probs=187.3

Q ss_pred             HhcCCCCCCeecc--cCCcEEEEEEE--C-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccC-CCceeeecceEEeCc
Q 016594           64 ATNAFSSENLVGR--GGYAEVYKGVL--Q-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVC-HPNVLSLLGCCVDNG  137 (386)
Q Consensus        64 ~~~~~~~~~~lg~--G~~g~V~~~~~--~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~  137 (386)
                      ....+.+...+|.  |.+|.||.+..  + ++..+|+|.-+...........-++|+...++++ |+|.++.+..+.+.+
T Consensus       112 ~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~  191 (524)
T KOG0601|consen  112 FDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSG  191 (524)
T ss_pred             hhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCC
Confidence            4456778889999  99999999986  4 6888999986655554455555567888888887 999999888888888


Q ss_pred             eEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHH----HHHHHHhCCCCCeEEeCCCCCCeeEcCC-CCeEEeec
Q 016594          138 LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTAR----GLHYLHKGCQRRIIHRDIKSSNILLTAD-FEPQISDF  212 (386)
Q Consensus       138 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~----~l~~LH~~~~~~ivH~dlkp~Nill~~~-~~~kl~Df  212 (386)
                      ..+++....+.+|..+..... ..++...++.++.+...    ||.++|+   .+++|-|+||.||+...+ ...+++||
T Consensus       192 ~lfiqtE~~~~sl~~~~~~~~-~~~p~~~l~~~~~~~~~~~~~al~~~hs---~~~~~~~~kp~~i~~~~~~~s~~~~df  267 (524)
T KOG0601|consen  192 ILFIQTELCGESLQSYCHTPC-NFLPDNLLWNSLRDWLSRDVTALSHLHS---NNIVHDDLKPANIFTTSDWTSCKLTDF  267 (524)
T ss_pred             cceeeeccccchhHHhhhccc-ccCCchhhhhHHhhhhhcccccccccCC---CcccccccchhheecccccceeecCCc
Confidence            666666666678888776433 33778888999999999    9999999   999999999999999998 78999999


Q ss_pred             CccccCCCCCcccc---ccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccc
Q 016594          213 GLAKWLPSQWTHHS---IAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGE  289 (386)
Q Consensus       213 g~a~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~  289 (386)
                      |+...+....-...   .....|...|++||.. ..-++.+.|++++|.++.+..+|..+.......  .|       ..
T Consensus       268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~--~W-------~~  337 (524)
T KOG0601|consen  268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVGKNS--SW-------SQ  337 (524)
T ss_pred             ceeEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCCCCC--Cc-------cc
Confidence            99988866532211   1223577889999976 445688999999999999999987765432100  00       01


Q ss_pred             cccccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 016594          290 IEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEV  334 (386)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~  334 (386)
                      +....   ++..+-..-+..+...+.+|++.+|-.|++...+..+
T Consensus       338 ~r~~~---ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l  379 (524)
T KOG0601|consen  338 LRQGY---IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTAL  379 (524)
T ss_pred             ccccc---CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhcc
Confidence            11111   1111111123456668999999999999999887754

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.56  E-value=2.9e-14  Score=136.59  Aligned_cols=143  Identities=20%  Similarity=0.255  Sum_probs=99.5

Q ss_pred             CCeecccCCcEEEEEEECCCcEEEEEEeccccCChH--------------------------------------hHHHHH
Q 016594           71 ENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDR--------------------------------------KEKEFL  112 (386)
Q Consensus        71 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~--------------------------------------~~~~~~  112 (386)
                      .+.||.|++|+||+|++++|+.||||+.+.......                                      .+.++.
T Consensus       122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            468999999999999999999999999864321100                                      011234


Q ss_pred             HHHHHHhccC----CCceeeecceEE--eCceEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHH-HHHHHHhCC
Q 016594          113 TEIGTIGHVC----HPNVLSLLGCCV--DNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTAR-GLHYLHKGC  185 (386)
Q Consensus       113 ~e~~~l~~l~----h~niv~l~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~-~l~~LH~~~  185 (386)
                      +|+..+.++.    |.+-+.+-.++.  ....+++|||+.|++|.++...... +..   ...++..++. .+..+|.  
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~-~~~---~~~ia~~~~~~~l~ql~~--  275 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA-GLD---RKALAENLARSFLNQVLR--  275 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc-CCC---HHHHHHHHHHHHHHHHHh--
Confidence            4555554442    333333333332  2347999999999999887643211 122   2345555555 4678898  


Q ss_pred             CCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCC
Q 016594          186 QRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPS  220 (386)
Q Consensus       186 ~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~  220 (386)
                       .|++|+|++|.||+++.++.++++|||++..+..
T Consensus       276 -~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       276 -DGFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE  309 (437)
T ss_pred             -CCceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence             9999999999999999999999999999987754

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.50  E-value=3.4e-14  Score=124.71  Aligned_cols=203  Identities=17%  Similarity=0.216  Sum_probs=138.5

Q ss_pred             HHHhccCCCceeeecceEEeCc------eEEEEEeccCCCHhhhhhhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 016594          116 GTIGHVCHPNVLSLLGCCVDNG------LYLIFQFSSRGSVASLFHDVNS--PGVEWKVRHKIAVGTARGLHYLHKGCQR  187 (386)
Q Consensus       116 ~~l~~l~h~niv~l~~~~~~~~------~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~~  187 (386)
                      .-|-++-|.|||+++.++.+..      ..++.+|+..|++..++++...  ..+......++..||+.||.|||+ |..
T Consensus       119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~~P  197 (458)
T KOG1266|consen  119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-CDP  197 (458)
T ss_pred             HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-cCC
Confidence            3445567999999999987632      6899999999999999976543  447777888999999999999997 457


Q ss_pred             CeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCc---cccccccccccCccChhhhccCCCCcccchHHHHHHHHHHH
Q 016594          188 RIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWT---HHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEII  264 (386)
Q Consensus       188 ~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell  264 (386)
                      .|+|+++..+-|++..+|-+|+.--.-.. ......   ........+.++|.|||.=.....+.++|||+||+...+|.
T Consensus       198 piihgnlTc~tifiq~ngLIkig~~ap~s-~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema  276 (458)
T KOG1266|consen  198 PIIHGNLTCDTIFIQHNGLIKIGSVAPDS-THPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA  276 (458)
T ss_pred             ccccCCcchhheeecCCceEEecccCccc-cchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence            89999999999999988877764321111 100000   00011223678899999866667788999999999999999


Q ss_pred             hCCCCCCCCchhhhhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 016594          265 SGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVM  335 (386)
Q Consensus       265 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l  335 (386)
                      .|..--.......       ..+..+...+-...        -..-+.++..|++..|..||+|.+++.|.
T Consensus       277 ilEiq~tnseS~~-------~~ee~ia~~i~~le--------n~lqr~~i~kcl~~eP~~rp~ar~llfHp  332 (458)
T KOG1266|consen  277 ILEIQSTNSESKV-------EVEENIANVIIGLE--------NGLQRGSITKCLEGEPNGRPDARLLLFHP  332 (458)
T ss_pred             HheeccCCCccee-------ehhhhhhhheeecc--------CccccCcCcccccCCCCCCcchhhhhcCc
Confidence            8765422221110       00111111000000        00123467789999999999999998764

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.49  E-value=5.6e-14  Score=136.22  Aligned_cols=145  Identities=17%  Similarity=0.209  Sum_probs=94.9

Q ss_pred             cCCCCCCeecccCCcEEEEEEECC-CcEEEEEEeccccCCh--------------------------------HhHH---
Q 016594           66 NAFSSENLVGRGGYAEVYKGVLQD-GEEIAVKRLTKVVTDD--------------------------------RKEK---  109 (386)
Q Consensus        66 ~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~--------------------------------~~~~---  109 (386)
                      ..|.. +.||.|++|+||+|++++ |+.||||+........                                +-..   
T Consensus       120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~  198 (537)
T PRK04750        120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH  198 (537)
T ss_pred             HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence            45666 799999999999999986 9999999997532100                                0011   


Q ss_pred             ---HHHHHHHHHhccC----CCceeeecceEEe--CceEEEEEeccCCCHhhhh--hhcCC--CCCCHHHHHHHHHHHHH
Q 016594          110 ---EFLTEIGTIGHVC----HPNVLSLLGCCVD--NGLYLIFQFSSRGSVASLF--HDVNS--PGVEWKVRHKIAVGTAR  176 (386)
Q Consensus       110 ---~~~~e~~~l~~l~----h~niv~l~~~~~~--~~~~lv~e~~~~~~L~~~~--~~~~~--~~~~~~~~~~i~~qi~~  176 (386)
                         ++.+|+..+.++.    +.+.+.+-.++.+  ...++||||+.|+.+.++-  ...+.  ..+....+..++.|+  
T Consensus       199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi--  276 (537)
T PRK04750        199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV--  276 (537)
T ss_pred             HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH--
Confidence               2334444443332    3333444444433  3478999999999998742  21110  012233333333443  


Q ss_pred             HHHHHHhCCCCCeEEeCCCCCCeeEcCCC----CeEEeecCccccCCCC
Q 016594          177 GLHYLHKGCQRRIIHRDIKSSNILLTADF----EPQISDFGLAKWLPSQ  221 (386)
Q Consensus       177 ~l~~LH~~~~~~ivH~dlkp~Nill~~~~----~~kl~Dfg~a~~~~~~  221 (386)
                           ..   .|++|+|+||.||+++.++    .++++|||++..++..
T Consensus       277 -----f~---~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~  317 (537)
T PRK04750        277 -----FR---DGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKE  317 (537)
T ss_pred             -----Hh---CCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCHH
Confidence                 34   7999999999999999887    9999999999877543

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.46  E-value=2.7e-13  Score=113.62  Aligned_cols=128  Identities=16%  Similarity=0.041  Sum_probs=94.4

Q ss_pred             CCeecccCCcEEEEEEECCCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCcee-eecceEEeCceEEEEEeccCCC
Q 016594           71 ENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVL-SLLGCCVDNGLYLIFQFSSRGS  149 (386)
Q Consensus        71 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~l~~~~~~~~~~lv~e~~~~~~  149 (386)
                      .+.|+.|.++.||++... +..|++|.......   ....+.+|+.+++.+.+.+++ +++.+ .....++|||++.+.+
T Consensus         3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~P~~~~~-~~~~~~lv~e~i~G~~   77 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE---LLINRENEAENSKLAAEAGIGPKLYYF-DPETGVLITEFIEGSE   77 (170)
T ss_pred             eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc---cccCHHHHHHHHHHHHHhCCCCceEEE-eCCCCeEEEEecCCCc
Confidence            357899999999999876 77899998754321   123456788888888655544 44433 3334689999999987


Q ss_pred             HhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC-----eEEeCCCCCCeeEcCCCCeEEeecCcccc
Q 016594          150 VASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRR-----IIHRDIKSSNILLTADFEPQISDFGLAKW  217 (386)
Q Consensus       150 L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~-----ivH~dlkp~Nill~~~~~~kl~Dfg~a~~  217 (386)
                      +....       .   ....++.+++.+|..||+   .+     ++|+|++|.||+++ ++.++++|||.+..
T Consensus        78 l~~~~-------~---~~~~~~~~l~~~l~~LH~---~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          78 LLTED-------F---SDPENLEKIAKLLKKLHS---SPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             ccccc-------c---cCHHHHHHHHHHHHHHhC---CCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            75430       1   112456789999999998   55     59999999999999 66899999998763

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.44  E-value=1.7e-12  Score=109.72  Aligned_cols=139  Identities=14%  Similarity=0.111  Sum_probs=99.6

Q ss_pred             CCeecccCCcEEEEEEECC-------CcEEEEEEeccccC-----------C---------hHhHHHH----HHHHHHHh
Q 016594           71 ENLVGRGGYAEVYKGVLQD-------GEEIAVKRLTKVVT-----------D---------DRKEKEF----LTEIGTIG  119 (386)
Q Consensus        71 ~~~lg~G~~g~V~~~~~~~-------~~~vavK~~~~~~~-----------~---------~~~~~~~----~~e~~~l~  119 (386)
                      ...||.|--+.||.|...+       +..+|||+.+-...           +         ......+    .+|+..|+
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            4578999999999998542       47899998763111           0         0112222    37899998


Q ss_pred             ccCC--CceeeecceEEeCceEEEEEeccCCCHhh-hhhhcCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCeEEeCCC
Q 016594          120 HVCH--PNVLSLLGCCVDNGLYLIFQFSSRGSVAS-LFHDVNSPGVEWKVRHKIAVGTARGLHYL-HKGCQRRIIHRDIK  195 (386)
Q Consensus       120 ~l~h--~niv~l~~~~~~~~~~lv~e~~~~~~L~~-~~~~~~~~~~~~~~~~~i~~qi~~~l~~L-H~~~~~~ivH~dlk  195 (386)
                      ++..  -++..++++   ...++||||+.++.+.. .+.+   ..++......+..+++.+|..| |.   .+++|+||+
T Consensus        82 rl~~~Gv~vP~pi~~---~~~~lvME~Ig~~~~~~~~Lkd---~~~~~~~~~~i~~~i~~~l~~l~H~---~glVHGDLs  152 (197)
T cd05146          82 RMQKAGIPCPEVVVL---KKHVLVMSFIGDDQVPAPKLKD---AKLNDEEMKNAYYQVLSMMKQLYKE---CNLVHADLS  152 (197)
T ss_pred             HHHHcCCCCCeEEEe---cCCEEEEEEcCCCCccchhhhc---cccCHHHHHHHHHHHHHHHHHHHHh---CCeecCCCC
Confidence            8863  455566643   55789999998754422 2222   1245556677889999999998 88   899999999


Q ss_pred             CCCeeEcCCCCeEEeecCccccCC
Q 016594          196 SSNILLTADFEPQISDFGLAKWLP  219 (386)
Q Consensus       196 p~Nill~~~~~~kl~Dfg~a~~~~  219 (386)
                      +.|||+. ++.+.|+|||.+....
T Consensus       153 ~~NIL~~-~~~v~iIDF~qav~~~  175 (197)
T cd05146         153 EYNMLWH-DGKVWFIDVSQSVEPT  175 (197)
T ss_pred             HHHEEEE-CCcEEEEECCCceeCC
Confidence            9999997 4689999999887654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.42  E-value=2.5e-12  Score=123.35  Aligned_cols=163  Identities=15%  Similarity=0.208  Sum_probs=121.0

Q ss_pred             CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEEEeccCCCHhhhhhhcCCCCCCHHHH
Q 016594           89 DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQFSSRGSVASLFHDVNSPGVEWKVR  167 (386)
Q Consensus        89 ~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~  167 (386)
                      ++.+|.|+.......  .......+-++.|+.++||||+++++.++.++ .|+|.|-+.  .|...+...     ....+
T Consensus        36 ~~~~vsVF~~~~~~~--~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l-----~~~~v  106 (690)
T KOG1243|consen   36 DGGPVSVFVYKRSNG--EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL-----GKEEV  106 (690)
T ss_pred             cCCceEEEEEeCCCc--hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh-----HHHHH
Confidence            688888888875433  44556778888999999999999999997655 899999876  455555542     24556


Q ss_pred             HHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCccccccccccccCccChhhhccCCC
Q 016594          168 HKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIV  247 (386)
Q Consensus       168 ~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  247 (386)
                      ...+.||+.||.|||.  +.+++|++|....|+++..|..||++|-++........  ......--..|..|+.+.... 
T Consensus       107 ~~Gl~qIl~AL~FL~~--d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s~-  181 (690)
T KOG1243|consen  107 CLGLFQILAALSFLND--DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPSE-  181 (690)
T ss_pred             HHHHHHHHHHHHHHhc--cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCccc-
Confidence            6678999999999986  37899999999999999999999999988764432211  011111122356666543332 


Q ss_pred             CcccchHHHHHHHHHHHhC
Q 016594          248 DEKTDVFAFGVFLLEIISG  266 (386)
Q Consensus       248 ~~~~DvwslG~il~ell~g  266 (386)
                       ...|.|.|||++++++.|
T Consensus       182 -~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  182 -WSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             -cchhhhhHHHHHHHHhCc
Confidence             457999999999999999

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.38  E-value=4.3e-13  Score=127.16  Aligned_cols=249  Identities=18%  Similarity=0.144  Sum_probs=175.5

Q ss_pred             HHhcCCCCCCeecccCCcEEEEEEEC--CCcEEEEEEeccccCChHhHHHHHHHHHHHhccC-CCceeeecceEEe-Cce
Q 016594           63 IATNAFSSENLVGRGGYAEVYKGVLQ--DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVC-HPNVLSLLGCCVD-NGL  138 (386)
Q Consensus        63 ~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~-~~~  138 (386)
                      ....+|..+..||.|.|+.|+.+..+  ++..|++|.+.+..........-+.|+-+...+. |.++++.+..+.. .+.
T Consensus       262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~  341 (524)
T KOG0601|consen  262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG  341 (524)
T ss_pred             eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence            44567888999999999999998754  5778999988776555555555567777777665 8888888776654 557


Q ss_pred             EEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCC-CCeEEeecCcccc
Q 016594          139 YLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTAD-FEPQISDFGLAKW  217 (386)
Q Consensus       139 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~-~~~kl~Dfg~a~~  217 (386)
                      |+--||+.++++.....  -...+.+...+.+..|++.++.++|+   ..++|+|+||+||++..+ +..++.|||+...
T Consensus       342 ~ip~e~~~~~s~~l~~~--~~~~~d~~~~~~~~~q~~~~l~~i~s---~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~  416 (524)
T KOG0601|consen  342 YIPLEFCEGGSSSLRSV--TSQMLDEDPRLRLTAQILTALNVIHS---KLFVHLDVKPSNILISNDGFFSKLGDFGCWTR  416 (524)
T ss_pred             cCchhhhcCcchhhhhH--HHHhcCcchhhhhHHHHHhccccccc---hhhhcccccccceeeccchhhhhccccccccc
Confidence            78889999988765442  22236777888999999999999999   999999999999999886 7889999999864


Q ss_pred             CCCCCccccccccccccCc-cChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCC
Q 016594          218 LPSQWTHHSIAPIEGTFGH-LAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDP  296 (386)
Q Consensus       218 ~~~~~~~~~~~~~~gt~~y-~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (386)
                      +...    .......+..| .+|.......+..++|++|||..+.+.++|...-....+              ...+...
T Consensus       417 ~~~~----~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~--------------~~~i~~~  478 (524)
T KOG0601|consen  417 LAFS----SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ--------------SLTIRSG  478 (524)
T ss_pred             ccee----cccccccccccccchhhccccccccccccccccccccccccCcccCccccc--------------ceeeecc
Confidence            3221    11111123334 245555566788999999999999999998754322111              0011111


Q ss_pred             ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 016594          297 RLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVML  336 (386)
Q Consensus       297 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~  336 (386)
                       .....+. ....+..+...++..++..||.+.++..+..
T Consensus       479 -~~p~~~~-~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~  516 (524)
T KOG0601|consen  479 -DTPNLPG-LKLQLQVLLKVMINPDRKRRPSAVELSLHSE  516 (524)
T ss_pred             -cccCCCc-hHHhhhhhhhhhcCCccccchhhhhhcccch
Confidence             0111111 2256777888899999999999988776543

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.37  E-value=2.7e-13  Score=135.18  Aligned_cols=250  Identities=16%  Similarity=0.173  Sum_probs=171.3

Q ss_pred             HhcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccC-ChHhHHHHHHHHHHHhccCCCceeeecceEEe-CceEE
Q 016594           64 ATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVT-DDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVD-NGLYL  140 (386)
Q Consensus        64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~l  140 (386)
                      ....+.+.+.+-.|+++.++.+.-. .|...+.|+...... ..........+-.++-...+|-+++..-.+.. ...++
T Consensus       802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L  881 (1205)
T KOG0606|consen  802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL  881 (1205)
T ss_pred             CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence            4456677788999999999988743 354555554433111 11112223333333333345666665555433 44899


Q ss_pred             EEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCC
Q 016594          141 IFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPS  220 (386)
Q Consensus       141 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~  220 (386)
                      +++|+.+++|...++...  ..+...+...+..+..+++|||+   ..+.|+|++|.|++...+++.+++|||.......
T Consensus       882 ~~~~~~~~~~~Skl~~~~--~~saepaRs~i~~~vqs~e~L~s---~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~  956 (1205)
T KOG0606|consen  882 VGHYLNGGDLPSKLHNSG--CLSAEPARSPILERVQSLESLHS---SLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGL  956 (1205)
T ss_pred             hhHHhccCCchhhhhcCC--CcccccccchhHHHHhhhhcccc---chhhcccccccchhhcccCCcccCcccccccccc
Confidence            999999999988887654  35566667777888999999998   7799999999999999999999999985432210


Q ss_pred             C---------------------C--------ccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCC
Q 016594          221 Q---------------------W--------THHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVD  271 (386)
Q Consensus       221 ~---------------------~--------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~  271 (386)
                      .                     .        .........||+.|.+||...+.....++|+|++|++++|.++|.+||.
T Consensus       957 ~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~n 1036 (1205)
T KOG0606|consen  957 IPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFN 1036 (1205)
T ss_pred             ccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCC
Confidence            0                     0        0011223468999999999999999999999999999999999999997


Q ss_pred             CCchhhhhhhhhhhcccccccccCCccCCC-CCHHHHHHHHHHHHHccccCCCCCCCHH
Q 016594          272 GSHQSLHSWAKPILNQGEIEKLVDPRLQGA-YDVTQLNRLAFAASLCIRASPTWRPTMS  329 (386)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~Rpt~~  329 (386)
                      ....+           .....+......+. -+...+....+++...+..+|.+|..+.
T Consensus      1037 a~tpq-----------~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1037 AETPQ-----------QIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             Ccchh-----------hhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence            65322           11122222222211 1223356788899999999999999887

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.27  E-value=6.6e-11  Score=96.42  Aligned_cols=144  Identities=24%  Similarity=0.285  Sum_probs=104.2

Q ss_pred             CCCeecccCCcEEEEEEECCCcEEEEEE-eccccCCh-----HhHHHHHHHHHHHhccCCCceeeecceEEe-CceEEEE
Q 016594           70 SENLVGRGGYAEVYKGVLQDGEEIAVKR-LTKVVTDD-----RKEKEFLTEIGTIGHVCHPNVLSLLGCCVD-NGLYLIF  142 (386)
Q Consensus        70 ~~~~lg~G~~g~V~~~~~~~~~~vavK~-~~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~lv~  142 (386)
                      ...+|-+|+-+.|+++.+. |+.+.||. +.+....+     -......+|+.+|.++.--.|.-..-++.+ .+-+++|
T Consensus        11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M   89 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM   89 (229)
T ss_pred             cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence            5678899999999999986 77777763 33322222     234566789999988764344333333444 3478999


Q ss_pred             EeccC-CCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCC---CeEEeecCcccc
Q 016594          143 QFSSR-GSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADF---EPQISDFGLAKW  217 (386)
Q Consensus       143 e~~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~---~~kl~Dfg~a~~  217 (386)
                      ||+.| .++.+++...............++..|-+.+.-||.   ++|+|+||..+||++..++   .+.++|||++..
T Consensus        90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~---ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHD---NDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhh---CCeecccccccceEEecCCCcCceEEEeecchhc
Confidence            99988 467777766554444444447888999999999999   9999999999999997655   358999999763

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.27  E-value=1.5e-10  Score=108.09  Aligned_cols=214  Identities=16%  Similarity=0.232  Sum_probs=149.7

Q ss_pred             CcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEe-----CceEEEEEeccC-CCHh
Q 016594           79 YAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVD-----NGLYLIFQFSSR-GSVA  151 (386)
Q Consensus        79 ~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-----~~~~lv~e~~~~-~~L~  151 (386)
                      -.+.|++... +|..|++|+++....  ........-+++++++.|+|||++.++|..     ..+++|++|.++ ++|.
T Consensus       289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~--~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~  366 (655)
T KOG3741|consen  289 SITTYKATSNVDGNAYVLKRLHGDRD--QSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLY  366 (655)
T ss_pred             cceeEeeeeccCCceeeeeeeccccc--cCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHH
Confidence            3567899865 899999999953211  111122356788999999999999988862     338999999876 4677


Q ss_pred             hhhhhc-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccC
Q 016594          152 SLFHDV-------------NSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWL  218 (386)
Q Consensus       152 ~~~~~~-------------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~  218 (386)
                      ++.-..             .....++..+|.++.|+..||.++|+   .|+.-+-|.|.+|+++.+.+++|...|....+
T Consensus       367 d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHs---sGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl  443 (655)
T KOG3741|consen  367 DLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHS---SGLACKTLDLKKILVTGKMRIRISGCGIMDVL  443 (655)
T ss_pred             HHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHh---cCceeecccHhHeEeeCcceEEEecccceeee
Confidence            754221             22347899999999999999999999   99999999999999999999999998887765


Q ss_pred             CCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCcc
Q 016594          219 PSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRL  298 (386)
Q Consensus       219 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (386)
                      .....                +.+.+   -.+-|.=.||.+++.|.||..--...+..                  ....
T Consensus       444 ~~d~~----------------~~le~---~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~------------------~~s~  486 (655)
T KOG3741|consen  444 QEDPT----------------EPLES---QQQNDLRDLGLLLLALATGTENSNRTDST------------------QSSH  486 (655)
T ss_pred             cCCCC----------------cchhH---HhhhhHHHHHHHHHHHhhcccccccccch------------------HHHH
Confidence            44320                11111   13568889999999999986431111000                  0000


Q ss_pred             CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 016594          299 QGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVM  335 (386)
Q Consensus       299 ~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l  335 (386)
                      .......++.++++++.-....++.+ -++.+++.++
T Consensus       487 ~~~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~~  522 (655)
T KOG3741|consen  487 LTRITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPMI  522 (655)
T ss_pred             HHHhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHHH
Confidence            11122345667778888888888876 6777777654

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.25  E-value=1.5e-10  Score=94.82  Aligned_cols=132  Identities=21%  Similarity=0.305  Sum_probs=96.2

Q ss_pred             CeecccCCcEEEEEEECCCcEEEEEE-eccccCChH-----hHHHHHHHHHHHhccCCCceeeecceEEeC-ceEEEEEe
Q 016594           72 NLVGRGGYAEVYKGVLQDGEEIAVKR-LTKVVTDDR-----KEKEFLTEIGTIGHVCHPNVLSLLGCCVDN-GLYLIFQF  144 (386)
Q Consensus        72 ~~lg~G~~g~V~~~~~~~~~~vavK~-~~~~~~~~~-----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~  144 (386)
                      ..+++|+-+.+|.+.+. |..+++|. +.+....+.     ....-.+|+.++.++.--.|....=++.+. ...++|||
T Consensus         2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~   80 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY   80 (204)
T ss_pred             chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence            46789999999999875 44566664 333333332     223456799999888744444433344443 36799999


Q ss_pred             ccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCcccc
Q 016594          145 SSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKW  217 (386)
Q Consensus       145 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~  217 (386)
                      ..|..|.+.+...         ...++..+-..+.-||.   .||+|+||.++||++..++ +.++|||++..
T Consensus        81 I~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~---~givHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          81 IEGELLKDALEEA---------RPDLLREVGRLVGKLHK---AGIVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             eCChhHHHHHHhc---------chHHHHHHHHHHHHHHh---cCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence            9999999888654         13466667777888999   9999999999999998775 99999999874

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.24  E-value=9.1e-11  Score=102.62  Aligned_cols=142  Identities=16%  Similarity=0.193  Sum_probs=107.0

Q ss_pred             CeecccCCcEEEEEEECCCcEEEEEEeccccCChHhHHHHHHHHHHHhccCC--CceeeecceEEeC----ceEEEEEec
Q 016594           72 NLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCH--PNVLSLLGCCVDN----GLYLIFQFS  145 (386)
Q Consensus        72 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~----~~~lv~e~~  145 (386)
                      +.|+.|..+.||++...+|..+++|........ .....+.+|+.+++.+.+  .++.+++.+....    ..+++|+++
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~-~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i   82 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALL-PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV   82 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccC-cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence            568999999999998876689999987643221 234467889999999875  3456666666542    468999999


Q ss_pred             cCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC----------------------------------------
Q 016594          146 SRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGC----------------------------------------  185 (386)
Q Consensus       146 ~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~----------------------------------------  185 (386)
                      .|.++...+..   ..++......++.+++.+|..||+..                                        
T Consensus        83 ~G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (223)
T cd05154          83 DGRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER  159 (223)
T ss_pred             CCEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence            99888765431   23667777788888888888888521                                        


Q ss_pred             -------------CCCeEEeCCCCCCeeEcC--CCCeEEeecCcccc
Q 016594          186 -------------QRRIIHRDIKSSNILLTA--DFEPQISDFGLAKW  217 (386)
Q Consensus       186 -------------~~~ivH~dlkp~Nill~~--~~~~kl~Dfg~a~~  217 (386)
                                   ...++|+|++|.||+++.  ++.+.|+||+.+..
T Consensus       160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                         245799999999999998  56689999998763

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.11  E-value=1.7e-09  Score=96.59  Aligned_cols=142  Identities=14%  Similarity=0.069  Sum_probs=98.7

Q ss_pred             CeecccCCcEEEEEEECCCcEEEEEEeccccCCh---------HhHHHHHHHHHHHhccCCCce--eeecceEEe-----
Q 016594           72 NLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDD---------RKEKEFLTEIGTIGHVCHPNV--LSLLGCCVD-----  135 (386)
Q Consensus        72 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---------~~~~~~~~e~~~l~~l~h~ni--v~l~~~~~~-----  135 (386)
                      +.+-......|.++.+. |+.|.||.........         .....+.+|...+..+...+|  +.++++...     
T Consensus        28 e~v~~~~~rrvvr~~~~-g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~  106 (268)
T PRK15123         28 EVFRELEGRRTLRFELA-GKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA  106 (268)
T ss_pred             cEEecCCCceEEEEEEC-CEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence            34444444556677664 7889999764322110         011136788888877753332  333444432     


Q ss_pred             -CceEEEEEeccCC-CHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcC-------CCC
Q 016594          136 -NGLYLIFQFSSRG-SVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTA-------DFE  206 (386)
Q Consensus       136 -~~~~lv~e~~~~~-~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~-------~~~  206 (386)
                       ...++|+|++.+. +|.+++........+......++.+++..+..||.   .||+|+||++.|||++.       ++.
T Consensus       107 ~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~---~Gi~HgDL~~~NiLl~~~~~~~~~~~~  183 (268)
T PRK15123        107 TRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHA---AGINHRDCYICHFLLHLPFPGREEDLK  183 (268)
T ss_pred             cceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHH---CcCccCCCChhhEEEeccccCCCCCce
Confidence             2378999999986 78888764333445667778999999999999999   99999999999999975       467


Q ss_pred             eEEeecCcccc
Q 016594          207 PQISDFGLAKW  217 (386)
Q Consensus       207 ~kl~Dfg~a~~  217 (386)
                      +.|+||+.+..
T Consensus       184 ~~LIDl~r~~~  194 (268)
T PRK15123        184 LSVIDLHRAQI  194 (268)
T ss_pred             EEEEECCcccc
Confidence            99999998753

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.07  E-value=2.1e-09  Score=90.65  Aligned_cols=128  Identities=22%  Similarity=0.212  Sum_probs=82.6

Q ss_pred             EEEEEEECCCcEEEEEEeccccCCh------------------------HhHHHHHHHHHHHhccCCC--ceeeecceEE
Q 016594           81 EVYKGVLQDGEEIAVKRLTKVVTDD------------------------RKEKEFLTEIGTIGHVCHP--NVLSLLGCCV  134 (386)
Q Consensus        81 ~V~~~~~~~~~~vavK~~~~~~~~~------------------------~~~~~~~~e~~~l~~l~h~--niv~l~~~~~  134 (386)
                      .||.|...+|..+|||+.......-                        .......+|+..|.++...  ++.+++++  
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~--   78 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY--   78 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence            4899998889999999876321110                        0123456899999999855  45666533  


Q ss_pred             eCceEEEEEecc--CCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHH-HHhCCCCCeEEeCCCCCCeeEcCCCCeEEee
Q 016594          135 DNGLYLIFQFSS--RGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHY-LHKGCQRRIIHRDIKSSNILLTADFEPQISD  211 (386)
Q Consensus       135 ~~~~~lv~e~~~--~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~-LH~~~~~~ivH~dlkp~Nill~~~~~~kl~D  211 (386)
                       ...++||||+.  |..+..+....    ++......++.+++..+.. +|.   .|++|+||.+.||+++.+ .+.|+|
T Consensus        79 -~~~~ivME~I~~~G~~~~~l~~~~----~~~~~~~~~~~~il~~~~~~~~~---~givHGDLs~~NIlv~~~-~~~iID  149 (188)
T PF01163_consen   79 -NRNVIVMEYIGEDGVPLPRLKDVD----LSPEEPKELLEEILEEIIKMLHK---AGIVHGDLSEYNILVDDG-KVYIID  149 (188)
T ss_dssp             -ETTEEEEE--EETTEEGGCHHHCG----GGGSTHHHHHHHHHHHHHHHHHC---TTEEESS-STTSEEEETT-CEEE--
T ss_pred             -eCCEEEEEecCCCccchhhHHhcc----ccchhHHHHHHHHHHHHHHHHHh---cCceecCCChhhEEeecc-eEEEEe
Confidence             34679999999  65555443321    1122345667777775555 578   899999999999999987 999999


Q ss_pred             cCccccCC
Q 016594          212 FGLAKWLP  219 (386)
Q Consensus       212 fg~a~~~~  219 (386)
                      ||.+....
T Consensus       150 f~qav~~~  157 (188)
T PF01163_consen  150 FGQAVDSS  157 (188)
T ss_dssp             GTTEEETT
T ss_pred             cCcceecC
Confidence            99887553

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.05  E-value=1.8e-08  Score=92.21  Aligned_cols=258  Identities=14%  Similarity=0.147  Sum_probs=156.4

Q ss_pred             CCCCCeecccCCcEEEEEEECCCcEEEEEEeccccCChHhHHHHHHHHHHHhcc-CCCceee--------ecceEEeCce
Q 016594           68 FSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHV-CHPNVLS--------LLGCCVDNGL  138 (386)
Q Consensus        68 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~--------l~~~~~~~~~  138 (386)
                      ...+..||+|+-+.+|-.--  -...+-|+.....  .....+   .+..|... .||-+..        ++|--...-.
T Consensus        13 i~~gr~LgqGgea~ly~l~e--~~d~VAKIYh~Pp--pa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~i   85 (637)
T COG4248          13 IPPGRPLGQGGEADLYTLGE--VRDQVAKIYHAPP--PAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVI   85 (637)
T ss_pred             cCCCccccCCccceeeecch--hhchhheeecCCC--chHHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCcccee
Confidence            34578899999999996432  1223447766432  222222   22233333 2553332        1111111114


Q ss_pred             EEEEEeccCC-CHhhhhh----hcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecC
Q 016594          139 YLIFQFSSRG-SVASLFH----DVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFG  213 (386)
Q Consensus       139 ~lv~e~~~~~-~L~~~~~----~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg  213 (386)
                      -++|..+.+- .+..++.    +...+...|..++++++.++.+.+.||.   .|.+-+|+.++|+|+.+++.|.|.|-.
T Consensus        86 GflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~---~Gh~vGDVn~~~~lVsd~~~V~LVdsD  162 (637)
T COG4248          86 GFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHE---HGHVVGDVNQNSFLVSDDSKVVLVDSD  162 (637)
T ss_pred             EEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHh---cCCcccccCccceeeecCceEEEEccc
Confidence            5666666553 2333332    2233457899999999999999999999   999999999999999999999999976


Q ss_pred             ccccCCCCCccccccccccccCccChhhhc-----cCCCCcccchHHHHHHHHHHHhC-CCCCCCCchhhhh---hhhhh
Q 016594          214 LAKWLPSQWTHHSIAPIEGTFGHLAPEYFM-----HGIVDEKTDVFAFGVFLLEIISG-RKPVDGSHQSLHS---WAKPI  284 (386)
Q Consensus       214 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~ell~g-~~pf~~~~~~~~~---~~~~~  284 (386)
                      ......   ........+|...|.+||.-.     +-.-+...|.|.||+++++++.| ++||.+.......   .... 
T Consensus       163 sfqi~~---ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~-  238 (637)
T COG4248         163 SFQINA---NGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETD-  238 (637)
T ss_pred             ceeecc---CCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhh-
Confidence            544332   122334456889999999754     33456789999999999999985 9999875321100   0000 


Q ss_pred             hcccccccccC--Cc---cCCCCCHH-HHHHHHHHHHHcccc--CCCCCCCHHHHHHHHhcCC
Q 016594          285 LNQGEIEKLVD--PR---LQGAYDVT-QLNRLAFAASLCIRA--SPTWRPTMSEVLEVMLEGD  339 (386)
Q Consensus       285 ~~~~~~~~~~~--~~---~~~~~~~~-~~~~l~~li~~cl~~--dP~~Rpt~~~il~~l~~~~  339 (386)
                      +..+......+  ..   ....++.. .+..+..+..+|+..  ++.-|||++..+.-|-...
T Consensus       239 Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~  301 (637)
T COG4248         239 IAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALR  301 (637)
T ss_pred             hhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHH
Confidence            00000000000  00   11122222 345677888888875  3668999998887665443

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.05  E-value=5.1e-11  Score=114.86  Aligned_cols=156  Identities=19%  Similarity=0.289  Sum_probs=109.8

Q ss_pred             HHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCc-------cccccccccccCccChhhhcc
Q 016594          172 VGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWT-------HHSIAPIEGTFGHLAPEYFMH  244 (386)
Q Consensus       172 ~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~-------~~~~~~~~gt~~y~aPE~~~~  244 (386)
                      .+++.|+.|+|.  +.++||++|.|++|.++..+..||+.|+.+........       ............|.|||++.+
T Consensus       106 ~~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~  183 (700)
T KOG2137|consen  106 GNVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG  183 (700)
T ss_pred             hcccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence            344589999998  47899999999999999999999999998765433211       111111224567999999999


Q ss_pred             CCCCcccchHHHHHHHHHHHh-CCCCCCCCchhhhhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHccccCCC
Q 016594          245 GIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPT  323 (386)
Q Consensus       245 ~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~  323 (386)
                      ...+.++|++|+||++|.+.. |+.-+.........         ......+......++...+.++++-+.+++..++.
T Consensus       184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~---------~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~  254 (700)
T KOG2137|consen  184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSY---------SFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSA  254 (700)
T ss_pred             ccccccccceeeeeEEEEEecCCcchhhccCCcchh---------hhhhcccccccccccccCcHHHHHHHHHHhcCCcc
Confidence            888999999999999999994 66666543322111         11111111222233455677889999999999999


Q ss_pred             CCCCHHHHHHHHhcC
Q 016594          324 WRPTMSEVLEVMLEG  338 (386)
Q Consensus       324 ~Rpt~~~il~~l~~~  338 (386)
                      -||++..++......
T Consensus       255 ~rp~~~~l~~~~ff~  269 (700)
T KOG2137|consen  255 VRPTLDLLLSIPFFS  269 (700)
T ss_pred             cCcchhhhhcccccC
Confidence            999887777654333

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.93  E-value=9.9e-09  Score=89.21  Aligned_cols=144  Identities=17%  Similarity=0.134  Sum_probs=99.8

Q ss_pred             HHHhcCCCCCCeecccCCcEEEEEEECCCcEEEEEEeccccCC--------------------hHhHHHHHHHHHHHhcc
Q 016594           62 SIATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTD--------------------DRKEKEFLTEIGTIGHV  121 (386)
Q Consensus        62 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--------------------~~~~~~~~~e~~~l~~l  121 (386)
                      .....-..++..||-|--+.||.|....|.++|||.=......                    ........+|.++|.+|
T Consensus        87 ~~r~~ve~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L  166 (304)
T COG0478          87 VKRGIVEAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRL  166 (304)
T ss_pred             HHcChHHhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHh
Confidence            3334456778999999999999999988999999954421111                    11233456899999988


Q ss_pred             CCC--ceeeecceEEeCceEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCe
Q 016594          122 CHP--NVLSLLGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNI  199 (386)
Q Consensus       122 ~h~--niv~l~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Ni  199 (386)
                      ...  .+.+.+++   +...+|||++.|..|...--       .......++..|+.-+..+-.   .|+||+|+.+-||
T Consensus       167 ~~~G~~VP~P~~~---nRHaVvMe~ieG~eL~~~r~-------~~en~~~il~~il~~~~~~~~---~GiVHGDlSefNI  233 (304)
T COG0478         167 YPEGVKVPKPIAW---NRHAVVMEYIEGVELYRLRL-------DVENPDEILDKILEEVRKAYR---RGIVHGDLSEFNI  233 (304)
T ss_pred             hhcCCCCCCcccc---ccceeeeehcccceeecccC-------cccCHHHHHHHHHHHHHHHHH---cCccccCCchheE
Confidence            743  55555543   34689999999987765431       111222333334444443334   7999999999999


Q ss_pred             eEcCCCCeEEeecCccccC
Q 016594          200 LLTADFEPQISDFGLAKWL  218 (386)
Q Consensus       200 ll~~~~~~kl~Dfg~a~~~  218 (386)
                      +++.+|.+.++||-.+...
T Consensus       234 lV~~dg~~~vIDwPQ~v~~  252 (304)
T COG0478         234 LVTEDGDIVVIDWPQAVPI  252 (304)
T ss_pred             EEecCCCEEEEeCcccccC
Confidence            9999999999999876644

>PRK09902 hypothetical protein; Provisional

Probab=98.88  E-value=5.4e-08  Score=82.66  Aligned_cols=140  Identities=15%  Similarity=0.095  Sum_probs=102.9

Q ss_pred             ecccCCcEEEEEEECCCcEEEEEEecc-cc---CChHhHHHHHHHHHHHhccCC--CceeeecceEEe-Cc----eEEEE
Q 016594           74 VGRGGYAEVYKGVLQDGEEIAVKRLTK-VV---TDDRKEKEFLTEIGTIGHVCH--PNVLSLLGCCVD-NG----LYLIF  142 (386)
Q Consensus        74 lg~G~~g~V~~~~~~~~~~vavK~~~~-~~---~~~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~-~~----~~lv~  142 (386)
                      -|+||.+.|+..... |+.+-+|.-.. ..   .-+.....|.+|+..+..|..  -.+.++..+-.. .+    .++|+
T Consensus        26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT  104 (216)
T PRK09902         26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT  104 (216)
T ss_pred             cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence            367899999997775 55788887652 11   114456789999999998863  224444422111 11    57888


Q ss_pred             EeccC-CCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCC--eEEeecCcccc
Q 016594          143 QFSSR-GSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFE--PQISDFGLAKW  217 (386)
Q Consensus       143 e~~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~--~kl~Dfg~a~~  217 (386)
                      |.+.+ -+|.+++........+......++.+++..+.-||.   .|+.|+|+-+.||+++.++.  ++++||.-++.
T Consensus       105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~---~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHS---VNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            87764 478888766544456777788999999999999999   99999999999999986667  99999976653

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.85  E-value=1.7e-08  Score=97.75  Aligned_cols=144  Identities=19%  Similarity=0.246  Sum_probs=93.4

Q ss_pred             CeecccCCcEEEEEEECCCcEEEEEEeccccCChHh--------------------------------------HHHHHH
Q 016594           72 NLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRK--------------------------------------EKEFLT  113 (386)
Q Consensus        72 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~--------------------------------------~~~~~~  113 (386)
                      ..|+.++-|+||+|++++|+.||||+.+........                                      +-++.+
T Consensus       131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~  210 (517)
T COG0661         131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR  210 (517)
T ss_pred             CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence            789999999999999999999999988743221100                                      112334


Q ss_pred             HHHHHhccC----CCceeeecceEE--eCceEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 016594          114 EIGTIGHVC----HPNVLSLLGCCV--DNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQR  187 (386)
Q Consensus       114 e~~~l~~l~----h~niv~l~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~  187 (386)
                      |+.-+.++.    ...=+++=.++.  .+...++|||+.|..+.+...-.. .+++...+.....++.  +..+=.   .
T Consensus       211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~f--~~q~~~---d  284 (517)
T COG0661         211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRAF--LRQLLR---D  284 (517)
T ss_pred             HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHHH--HHHHHh---c
Confidence            555444442    222222333332  245789999999999988743222 3354333322222211  122222   6


Q ss_pred             CeEEeCCCCCCeeEcCCCCeEEeecCccccCCCC
Q 016594          188 RIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQ  221 (386)
Q Consensus       188 ~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  221 (386)
                      |++|.|.+|.||+++.+|++.+.|||+...+...
T Consensus       285 gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~  318 (517)
T COG0661         285 GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK  318 (517)
T ss_pred             CccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence            9999999999999999999999999999877544

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.81  E-value=3.8e-08  Score=85.03  Aligned_cols=106  Identities=18%  Similarity=0.186  Sum_probs=81.4

Q ss_pred             HHHHHHHHHHHhccCC--CceeeecceEEeC-----ceEEEEEeccCC-CHhhhhhhcCCCCCCHHHHHHHHHHHHHHHH
Q 016594          108 EKEFLTEIGTIGHVCH--PNVLSLLGCCVDN-----GLYLIFQFSSRG-SVASLFHDVNSPGVEWKVRHKIAVGTARGLH  179 (386)
Q Consensus       108 ~~~~~~e~~~l~~l~h--~niv~l~~~~~~~-----~~~lv~e~~~~~-~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~  179 (386)
                      .....+|...+..|..  -.+...+++....     ..++|+|++++. +|.+++.....  .+......++.+++..+.
T Consensus        55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~--~~~~~~~~ll~~l~~~i~  132 (206)
T PF06293_consen   55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ--LDPSQRRELLRALARLIA  132 (206)
T ss_pred             chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc--cchhhHHHHHHHHHHHHH
Confidence            3456778887777752  2344455555442     258999999884 78888876433  556677889999999999


Q ss_pred             HHHhCCCCCeEEeCCCCCCeeEcCCC---CeEEeecCccccC
Q 016594          180 YLHKGCQRRIIHRDIKSSNILLTADF---EPQISDFGLAKWL  218 (386)
Q Consensus       180 ~LH~~~~~~ivH~dlkp~Nill~~~~---~~kl~Dfg~a~~~  218 (386)
                      -||.   +||+|+|+++.|||++.++   .+.++||+-+...
T Consensus       133 ~lH~---~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  133 KLHD---AGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             HHHH---CcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            9999   9999999999999999887   8999999987643

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.69  E-value=4.4e-07  Score=77.43  Aligned_cols=138  Identities=14%  Similarity=0.167  Sum_probs=93.5

Q ss_pred             HHHhcCCCCCCeecccCCcEEEEEEECCCcEEEEEEeccccCChHhHHHH---------HHHHHHHhcc---CCCceeee
Q 016594           62 SIATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEF---------LTEIGTIGHV---CHPNVLSL  129 (386)
Q Consensus        62 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~---------~~e~~~l~~l---~h~niv~l  129 (386)
                      .+..++|...+++-......|.+-..+ |..+++|.......  ..+..+         .+.+..+..+   .-...+.+
T Consensus        27 ~i~~~~~~~~kv~k~~~r~~ValIei~-~~kyIlK~pr~~~~--r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~  103 (229)
T PF06176_consen   27 KILDNNYKIIKVFKNTKRNYVALIEID-GKKYILKEPREENR--RPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADP  103 (229)
T ss_pred             HHHhCCceEEEeecCCCccEEEEEEEC-CcEEEEeccchhhh--hHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccc
Confidence            467789999999999888888877765 78999998764321  111111         2333333333   23333343


Q ss_pred             cceEEe------CceEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcC
Q 016594          130 LGCCVD------NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTA  203 (386)
Q Consensus       130 ~~~~~~------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~  203 (386)
                      +.+...      ...+++|||++|..|.++..      +++    .++..+++++.-||.   .|++|+|..|.|++++.
T Consensus       104 yl~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~------i~e----~~~~ki~~~ikqlH~---~G~~HGD~hpgNFlv~~  170 (229)
T PF06176_consen  104 YLAAEKKIFRYTSSYVLLMEYIEGVELNDIED------IDE----DLAEKIVEAIKQLHK---HGFYHGDPHPGNFLVSN  170 (229)
T ss_pred             eeeeeeeeccceeEEEEEEEEecCeecccchh------cCH----HHHHHHHHHHHHHHH---cCCccCCCCcCcEEEEC
Confidence            333322      23568999999988776532      222    244567788999999   99999999999999986


Q ss_pred             CCCeEEeecCccc
Q 016594          204 DFEPQISDFGLAK  216 (386)
Q Consensus       204 ~~~~kl~Dfg~a~  216 (386)
                      + .++++||+..+
T Consensus       171 ~-~i~iID~~~k~  182 (229)
T PF06176_consen  171 N-GIRIIDTQGKR  182 (229)
T ss_pred             C-cEEEEECcccc
Confidence            5 49999997654

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.55  E-value=1.6e-06  Score=76.00  Aligned_cols=137  Identities=15%  Similarity=0.190  Sum_probs=80.5

Q ss_pred             CeecccCCcEEEEEEECCCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCc--eeeecceEEeCc-eEEEEEeccCC
Q 016594           72 NLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPN--VLSLLGCCVDNG-LYLIFQFSSRG  148 (386)
Q Consensus        72 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~~~~~~~~-~~lv~e~~~~~  148 (386)
                      ..||.|..+.||+.   .+..+++|......    ......+|.++++.+..-.  +.+.+++..+.+ ..++|+++.|.
T Consensus         7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~   79 (226)
T TIGR02172         7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF----DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGK   79 (226)
T ss_pred             eeecCCCCcceeEe---cCCCEEEEeCCCCC----CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCc
Confidence            57899999999984   25567888776422    2334678998888876333  456666665544 67899999996


Q ss_pred             C-Hhhhh---------------------hhcCCCCCCHHHHH-HHHHH----------HHH-HHHHHHh-CCCCCeEEeC
Q 016594          149 S-VASLF---------------------HDVNSPGVEWKVRH-KIAVG----------TAR-GLHYLHK-GCQRRIIHRD  193 (386)
Q Consensus       149 ~-L~~~~---------------------~~~~~~~~~~~~~~-~i~~q----------i~~-~l~~LH~-~~~~~ivH~d  193 (386)
                      . +...+                     +.......+..... .+..+          +.. ...+|.. .....++|+|
T Consensus        80 ~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD  159 (226)
T TIGR02172        80 RSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGD  159 (226)
T ss_pred             cchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecC
Confidence            3 21111                     11000111111111 01000          001 1122221 1124578999


Q ss_pred             CCCCCeeEcCCCCeEEeecCccc
Q 016594          194 IKSSNILLTADFEPQISDFGLAK  216 (386)
Q Consensus       194 lkp~Nill~~~~~~kl~Dfg~a~  216 (386)
                      +.|.||+++.++ +.|+||+.+.
T Consensus       160 ~~~~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       160 FQIGNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             CCCCcEEEcCCC-cEEEechhcC
Confidence            999999999888 9999999775

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.54  E-value=1.2e-06  Score=75.74  Aligned_cols=153  Identities=20%  Similarity=0.232  Sum_probs=96.9

Q ss_pred             HHHHHHHhcCCCCCCe---ecccCCcEEEEEEECCCcEEEEEEeccccCChHhHH-----------------H-----HH
Q 016594           58 FEEISIATNAFSSENL---VGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEK-----------------E-----FL  112 (386)
Q Consensus        58 ~~~~~~~~~~~~~~~~---lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~-----------------~-----~~  112 (386)
                      ...+....++..+...   |..|--+.||+|...++..+|||+............                 .     ..
T Consensus        37 ~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~  116 (268)
T COG1718          37 LETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWAR  116 (268)
T ss_pred             HHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHH
Confidence            3444445555555555   445666789999887799999999875322221111                 0     12


Q ss_pred             HHHHHHhccC--CCceeeecceEEeCceEEEEEeccCCCHhh-hhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 016594          113 TEIGTIGHVC--HPNVLSLLGCCVDNGLYLIFQFSSRGSVAS-LFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRI  189 (386)
Q Consensus       113 ~e~~~l~~l~--h~niv~l~~~~~~~~~~lv~e~~~~~~L~~-~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i  189 (386)
                      +|+.-|+++.  +-.+.+.+++   ....++|||+.....-. .+.+   -++....+..+..++++.+.-|-.  ..++
T Consensus       117 kEf~NL~R~~eAGVrvP~Pi~~---~~nVLvMEfIg~~g~pAP~LkD---v~~e~~e~~~~~~~~v~~~~~l~~--~a~L  188 (268)
T COG1718         117 KEFRNLKRAYEAGVRVPEPIAF---RNNVLVMEFIGDDGLPAPRLKD---VPLELEEAEGLYEDVVEYMRRLYK--EAGL  188 (268)
T ss_pred             HHHHHHHHHHHcCCCCCCceee---cCCeEEEEeccCCCCCCCCccc---CCcCchhHHHHHHHHHHHHHHHHH--hcCc
Confidence            4555565554  2222233322   23579999986642111 2222   123333677778888888887765  2799


Q ss_pred             EEeCCCCCCeeEcCCCCeEEeecCccccCC
Q 016594          190 IHRDIKSSNILLTADFEPQISDFGLAKWLP  219 (386)
Q Consensus       190 vH~dlkp~Nill~~~~~~kl~Dfg~a~~~~  219 (386)
                      ||+||+.=|||+. ++.+.++|||.|....
T Consensus       189 VHgDLSEyNiL~~-~~~p~iID~~QaV~~~  217 (268)
T COG1718         189 VHGDLSEYNILVH-DGEPYIIDVSQAVTID  217 (268)
T ss_pred             ccccchhhheEEE-CCeEEEEECccccccC
Confidence            9999999999999 8899999999887654

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.51  E-value=2e-06  Score=75.59  Aligned_cols=141  Identities=18%  Similarity=0.162  Sum_probs=82.1

Q ss_pred             CCeecccCCcEEEEEEECCCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCC--ceeeecceEEeC---c-eEEEEEe
Q 016594           71 ENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHP--NVLSLLGCCVDN---G-LYLIFQF  144 (386)
Q Consensus        71 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~--niv~l~~~~~~~---~-~~lv~e~  144 (386)
                      .+.|+.|..+.||++...+ ..+++|.....    .....+.+|+.+++.+...  .+.+++......   . .+++|++
T Consensus         2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~   76 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEY   76 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT-SEEEEEEESSH----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEE
T ss_pred             CccCCCCCeeeEEEEEECC-cEEEEEEeCCC----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEE
Confidence            3578999999999999876 68999987532    4456677888888887633  355666644332   2 6899999


Q ss_pred             ccCCCHhh----------------hhh---hc--CCCCCCHHH---------HHHH------------HHHHHH-HHHHH
Q 016594          145 SSRGSVAS----------------LFH---DV--NSPGVEWKV---------RHKI------------AVGTAR-GLHYL  181 (386)
Q Consensus       145 ~~~~~L~~----------------~~~---~~--~~~~~~~~~---------~~~i------------~~qi~~-~l~~L  181 (386)
                      +.+..+..                .+.   ..  ...++....         ....            ...+.. .+..+
T Consensus        77 i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (239)
T PF01636_consen   77 IPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQEL  156 (239)
T ss_dssp             ESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHH
T ss_pred             eccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHH
Confidence            99987776                111   11  001111000         0000            011111 22333


Q ss_pred             Hh----CCCCCeEEeCCCCCCeeEc-CCCCeEEeecCccc
Q 016594          182 HK----GCQRRIIHRDIKSSNILLT-ADFEPQISDFGLAK  216 (386)
Q Consensus       182 H~----~~~~~ivH~dlkp~Nill~-~~~~~kl~Dfg~a~  216 (386)
                      +.    .....++|+|+.|.|||++ .++.+-|+||+.+.
T Consensus       157 ~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~  196 (239)
T PF01636_consen  157 EALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG  196 (239)
T ss_dssp             HHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred             HhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence            32    1236799999999999999 56666799998765

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.46  E-value=1.1e-06  Score=85.00  Aligned_cols=144  Identities=19%  Similarity=0.162  Sum_probs=91.1

Q ss_pred             CCeecccCCcEEEEEEECCCcEEEEEEeccccCChH--h---------------------------------HHHHHHHH
Q 016594           71 ENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDR--K---------------------------------EKEFLTEI  115 (386)
Q Consensus        71 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~--~---------------------------------~~~~~~e~  115 (386)
                      .+.||..+.|+|++|+.++|+.||||+-+.......  +                                 +-+|.+|+
T Consensus       166 ~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA  245 (538)
T KOG1235|consen  166 EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA  245 (538)
T ss_pred             cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence            468999999999999999999999998775322110  0                                 11233344


Q ss_pred             HHHhc----cCCCc------eeeecceEEeCceEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 016594          116 GTIGH----VCHPN------VLSLLGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGC  185 (386)
Q Consensus       116 ~~l~~----l~h~n------iv~l~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~  185 (386)
                      +-..+    +.|-+      |.++|..+ .....++|||+.|..+.++-.- ...+++...+...+.+...-+ -++   
T Consensus       246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~-st~RVLtME~~~G~~i~Dl~~i-~~~gi~~~~i~~~l~~~~~~q-If~---  319 (538)
T KOG1235|consen  246 KNAERFRENFKDFSLLTYVLVPKVYWDL-STKRVLTMEYVDGIKINDLDAI-DKRGISPHDILNKLVEAYLEQ-IFK---  319 (538)
T ss_pred             HhHHHHHHHHHhcccccceeCCeehhhc-CcceEEEEEecCCccCCCHHHH-HHcCCCHHHHHHHHHHHHHHH-HHh---
Confidence            33322    23444      33333222 2347899999999988775322 223355554443333322111 122   


Q ss_pred             CCCeEEeCCCCCCeeEcC----CCCeEEeecCccccCCCC
Q 016594          186 QRRIIHRDIKSSNILLTA----DFEPQISDFGLAKWLPSQ  221 (386)
Q Consensus       186 ~~~ivH~dlkp~Nill~~----~~~~kl~Dfg~a~~~~~~  221 (386)
                       .|++|+|=+|.||++..    ++.+.+.|||+...+...
T Consensus       320 -~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~  358 (538)
T KOG1235|consen  320 -TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK  358 (538)
T ss_pred             -cCCccCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence             68999999999999983    678999999998876543

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.42  E-value=1.2e-05  Score=68.06  Aligned_cols=103  Identities=19%  Similarity=0.232  Sum_probs=81.0

Q ss_pred             HHHHHHhccCC-CceeeecceEEeCceEEEEEeccCCCHhhhhhh-cCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeE
Q 016594          113 TEIGTIGHVCH-PNVLSLLGCCVDNGLYLIFQFSSRGSVASLFHD-VNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRII  190 (386)
Q Consensus       113 ~e~~~l~~l~h-~niv~l~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iv  190 (386)
                      .|.-+++.+.+ +++++++|+|   +.+++.|+...+++...... ..-...+|..+.+|+.++++.+.+|+......+.
T Consensus         8 ~E~lll~~l~~~~~~pk~lG~C---G~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~~   84 (188)
T PF12260_consen    8 NEPLLLQLLQGSEPFPKLLGSC---GRFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFFY   84 (188)
T ss_pred             cHHHHHHHcCCCCCCCCeeeEC---CCEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcEE
Confidence            47777888875 6999999998   55789999988765422100 0111268999999999999999999975555688


Q ss_pred             EeCCCCCCeeEcCCCCeEEeecCccccC
Q 016594          191 HRDIKSSNILLTADFEPQISDFGLAKWL  218 (386)
Q Consensus       191 H~dlkp~Nill~~~~~~kl~Dfg~a~~~  218 (386)
                      -.|++++|+-++.++++|++|...+...
T Consensus        85 lcDv~~~nfgv~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   85 LCDVSPDNFGVNDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             EeecchHHeEEeCCCcEEEEechhcchh
Confidence            9999999999999999999999876543

Proteins in this uncharacterised family are described as transmembrane proteins.

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.33  E-value=1.3e-07  Score=91.05  Aligned_cols=183  Identities=21%  Similarity=0.182  Sum_probs=127.3

Q ss_pred             CCeecccCCcEEEEEEECCCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCc-eeeecceEEeCc-eEEEEEeccCC
Q 016594           71 ENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPN-VLSLLGCCVDNG-LYLIFQFSSRG  148 (386)
Q Consensus        71 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~-~~lv~e~~~~~  148 (386)
                      .+.+++|+++++++.+---.+....+.+...       ....-++++|.+++||| .++.++-+..+. ..+.++++.++
T Consensus       247 fh~fvK~altknpKkRptaeklL~h~fvs~~-------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~  319 (829)
T KOG0576|consen  247 FHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTG  319 (829)
T ss_pred             HHHHHHHHhcCCCccCCChhhheeceeeccc-------hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCC
Confidence            4458899999999877432333335544321       34456888999999999 555555554333 67778888776


Q ss_pred             -CHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCccccc
Q 016594          149 -SVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSI  227 (386)
Q Consensus       149 -~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  227 (386)
                       +....... ..-.+...+...+.+.-.++++++|+   ..-+|+|    ||+... +..+..||+....+....   ..
T Consensus       320 rs~~~~~~~-se~~~~~~~~~~~~r~et~~l~~l~~---~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~---~~  387 (829)
T KOG0576|consen  320 RSSALEMTV-SEIALEQYQFAYPLRKETRPLAELHS---SYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM---KP  387 (829)
T ss_pred             ccccccCCh-hhHhhhhhhhhhhhhhhccccccccc---ccccCcc----cccccc-cccccccccCCcccCccc---cc
Confidence             22211111 11113334445556666788999998   5558888    777765 679999999988776543   34


Q ss_pred             cccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCC
Q 016594          228 APIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDG  272 (386)
Q Consensus       228 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~  272 (386)
                      .+..+++.++|||+.....+..+.|+|++|.-..++.-|.+|-..
T Consensus       388 ~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~  432 (829)
T KOG0576|consen  388 RTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSS  432 (829)
T ss_pred             ccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCC
Confidence            456799999999999999999999999999988888888887644

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.26  E-value=1.3e-05  Score=71.24  Aligned_cols=138  Identities=16%  Similarity=0.101  Sum_probs=80.6

Q ss_pred             eecccCC-cEEEEEEECCCcEEEEEEeccccCChHhHHHHHHHHHHHhccC-CCceeeecceEEeC-ceEEEEEeccCCC
Q 016594           73 LVGRGGY-AEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVC-HPNVLSLLGCCVDN-GLYLIFQFSSRGS  149 (386)
Q Consensus        73 ~lg~G~~-g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~-~~~lv~e~~~~~~  149 (386)
                      .|..|.. ..||+.... +..+.||......     ...+.+|+.+++.+. +--+.+++++...+ ..++||+++.|.+
T Consensus         5 ~~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~-----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~   78 (244)
T cd05150           5 RVTEGQSGATVYRLDGK-NPGLYLKIAPSGP-----TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVP   78 (244)
T ss_pred             ecCCCCCcCeEEEEcCC-CCcEEEEecCCCc-----ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCcc
Confidence            3445555 789998765 4678888775421     234567888887775 34455667666544 3789999999987


Q ss_pred             Hhhhhh-------------------hcCCC--CCCHH--HHHHHHH--------------------HHHHHHHHHHh---
Q 016594          150 VASLFH-------------------DVNSP--GVEWK--VRHKIAV--------------------GTARGLHYLHK---  183 (386)
Q Consensus       150 L~~~~~-------------------~~~~~--~~~~~--~~~~i~~--------------------qi~~~l~~LH~---  183 (386)
                      +.....                   .....  .+...  .......                    .+...+..|-.   
T Consensus        79 l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  158 (244)
T cd05150          79 AAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRP  158 (244)
T ss_pred             HhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCC
Confidence            764321                   10100  11100  0000000                    01111112211   


Q ss_pred             -CCCCCeEEeCCCCCCeeEcCCCCeEEeecCccc
Q 016594          184 -GCQRRIIHRDIKSSNILLTADFEPQISDFGLAK  216 (386)
Q Consensus       184 -~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~  216 (386)
                       .....++|+|+.|.|||++.++.+.|+||+.+.
T Consensus       159 ~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~  192 (244)
T cd05150         159 AEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG  192 (244)
T ss_pred             CcCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence             112458999999999999998778899998765

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.25  E-value=6.3e-06  Score=67.44  Aligned_cols=130  Identities=18%  Similarity=0.206  Sum_probs=88.7

Q ss_pred             CCCCeecccCCcEEEEEEECCCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceee-ecceEEeCceEEEEEeccC
Q 016594           69 SSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLS-LLGCCVDNGLYLIFQFSSR  147 (386)
Q Consensus        69 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~-l~~~~~~~~~~lv~e~~~~  147 (386)
                      ...+.|++|++|.||+|.|. |..+|+|+-..    +.....+..|+++|..+.-.++.+ +|.+   +..++.|||+.|
T Consensus        25 ~v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~----ds~r~~l~kEakiLeil~g~~~~p~vy~y---g~~~i~me~i~G   96 (201)
T COG2112          25 RVEKELAKGTTSVVYLGEWR-GGEVALKVRRR----DSPRRNLEKEAKILEILAGEGVTPEVYFY---GEDFIRMEYIDG   96 (201)
T ss_pred             hhhhhhhcccccEEEEeecc-CceEEEEEecC----CcchhhHHHHHHHHHHhhhcCCCceEEEe---chhhhhhhhhcC
Confidence            44678999999999999997 66899997653    334567888999998887554433 3322   223455999999


Q ss_pred             CCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCC-CCCeeEcCCCCeEEeecCccccC
Q 016594          148 GSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIK-SSNILLTADFEPQISDFGLAKWL  218 (386)
Q Consensus       148 ~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk-p~Nill~~~~~~kl~Dfg~a~~~  218 (386)
                      -.|.++....     .-    +-...++++---|-.   .||-|+.|. |...++..++.+.|+||..|+.-
T Consensus        97 ~~L~~~~~~~-----~r----k~l~~vlE~a~~LD~---~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k  156 (201)
T COG2112          97 RPLGKLEIGG-----DR----KHLLRVLEKAYKLDR---LGIEHGELSRPWKNVLVNDRDVYIIDFDSATFK  156 (201)
T ss_pred             cchhhhhhcc-----cH----HHHHHHHHHHHHHHH---hccchhhhcCCceeEEecCCcEEEEEccchhhc
Confidence            8887765421     11    223344555444555   789999886 44444545558999999988743

>PLN02876 acyl-CoA dehydrogenase

Probab=98.20  E-value=2.7e-05  Score=81.24  Aligned_cols=79  Identities=11%  Similarity=0.190  Sum_probs=56.1

Q ss_pred             CCeecccCCcEEEEEEECCC---cEEEEEEeccccCChHhHHHHHHHHHHHhccC-CCce--eeecceEEeC----ceEE
Q 016594           71 ENLVGRGGYAEVYKGVLQDG---EEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVC-HPNV--LSLLGCCVDN----GLYL  140 (386)
Q Consensus        71 ~~~lg~G~~g~V~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~ni--v~l~~~~~~~----~~~l  140 (386)
                      ...|+.|.++.+|+....++   ..+++|+...... ......+.+|+.+++.+. |.++  .+++.++.+.    ..|+
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~-~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~fl  121 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKL-LQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFY  121 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCcc-CccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceE
Confidence            56789999999999887643   4677777543211 122346789999999986 6654  7777777653    4789


Q ss_pred             EEEeccCCCH
Q 016594          141 IFQFSSRGSV  150 (386)
Q Consensus       141 v~e~~~~~~L  150 (386)
                      |||++.|..+
T Consensus       122 VME~v~G~~~  131 (822)
T PLN02876        122 IMEYLEGRIF  131 (822)
T ss_pred             EEEecCCccc
Confidence            9999988643

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.13  E-value=8.1e-05  Score=63.41  Aligned_cols=134  Identities=16%  Similarity=0.295  Sum_probs=89.0

Q ss_pred             CCeecccCCcEEEEEEECCCcEEEEEEecccc--------------CChHhHHHHHHHHHHHhccC------CCceeeec
Q 016594           71 ENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVV--------------TDDRKEKEFLTEIGTIGHVC------HPNVLSLL  130 (386)
Q Consensus        71 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--------------~~~~~~~~~~~e~~~l~~l~------h~niv~l~  130 (386)
                      ...||.|+.-.||.  +.+.....||++....              .......+..+|+.....+.      +.+|.+++
T Consensus         6 ~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~   83 (199)
T PF10707_consen    6 SDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY   83 (199)
T ss_pred             CcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence            46799999999996  4556677889887644              01112345566666555554      88999999


Q ss_pred             ceEEeC-ceEEEEEeccCC------CHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcC
Q 016594          131 GCCVDN-GLYLIFQFSSRG------SVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTA  203 (386)
Q Consensus       131 ~~~~~~-~~~lv~e~~~~~------~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~  203 (386)
                      |+..++ +.-+|+|.+.+.      +|.+++..   ..++. .   +...+-.-..||-.   ++|+.+||+|.||++..
T Consensus        84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~---~~~~~-~---~~~~L~~f~~~l~~---~~Iv~~dl~~~NIv~~~  153 (199)
T PF10707_consen   84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKE---GGLTE-E---LRQALDEFKRYLLD---HHIVIRDLNPHNIVVQR  153 (199)
T ss_pred             EEEecCCceEEEEEEEECCCCCcCccHHHHHHc---CCccH-H---HHHHHHHHHHHHHH---cCCeecCCCcccEEEEe
Confidence            999765 488888876432      56666633   22444 2   22333344567777   89999999999999963


Q ss_pred             C--C--CeEEee-cCccc
Q 016594          204 D--F--EPQISD-FGLAK  216 (386)
Q Consensus       204 ~--~--~~kl~D-fg~a~  216 (386)
                      .  +  .+.|+| ||...
T Consensus       154 ~~~~~~~lvlIDG~G~~~  171 (199)
T PF10707_consen  154 RDSGEFRLVLIDGLGEKE  171 (199)
T ss_pred             cCCCceEEEEEeCCCCcc
Confidence            3  2  477777 45433

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.09  E-value=1.4e-05  Score=82.21  Aligned_cols=201  Identities=20%  Similarity=0.192  Sum_probs=134.1

Q ss_pred             HHHHHHHHHhccCCCceeeecceEEeCc-----eEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 016594          110 EFLTEIGTIGHVCHPNVLSLLGCCVDNG-----LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKG  184 (386)
Q Consensus       110 ~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~  184 (386)
                      ....|...+.++.|+|++.++.+-....     .....+++...++...++....  ++....+.+..++.+||.|+|+ 
T Consensus       228 ~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~--i~~~~~r~~~~~~~~GL~~~h~-  304 (1351)
T KOG1035|consen  228 TTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGS--IPLETLRILHQKLLEGLAYLHS-  304 (1351)
T ss_pred             HHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccc--cCHHHHHHHHHHHhhhHHHHHH-
Confidence            3445777788889999999998875432     2344567777777777765444  7888999999999999999999 


Q ss_pred             CCCCeEEeCCCCC---CeeEcCCCCeEEe--ecCccccCCCCCccccccccccccCccChhhhccCCCCc--ccchHHHH
Q 016594          185 CQRRIIHRDIKSS---NILLTADFEPQIS--DFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDE--KTDVFAFG  257 (386)
Q Consensus       185 ~~~~ivH~dlkp~---Nill~~~~~~kl~--Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~--~~DvwslG  257 (386)
                        ....|.-|...   +.-.+..+.+..+  ||+.+..+.....   .....-+..+.+||......++.  ..|+|.+|
T Consensus       305 --~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~---~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lg  379 (1351)
T KOG1035|consen  305 --LSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEK---SFSDLLAEIRNADEDLKENTAKKSRLTDLWCLG  379 (1351)
T ss_pred             --hccceeEEecccccccccCccceeecchhhhcccccCCCccc---chhhcCccccccccccccccchhhhhhHHHHHH
Confidence              55444444433   3334455666666  8888877654321   11222344577888776665554  47999999


Q ss_pred             HHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 016594          258 VFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLE  337 (386)
Q Consensus       258 ~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~  337 (386)
                      ..+..+..|..+-....              ....+.+.        .....+.+....|+..++++|+++.+++.+...
T Consensus       380 ll~~~~~~~~~i~~~~~--------------~~~~~l~~--------~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~  437 (1351)
T KOG1035|consen  380 LLLLQLSQGEDISEKSA--------------VPVSLLDV--------LSTSELLDALPKCLDEDSEERLSALELLTHPFL  437 (1351)
T ss_pred             HHHhhhhhcCccccccc--------------chhhhhcc--------ccchhhhhhhhhhcchhhhhccchhhhhhchhc
Confidence            99999998776532110              00111111        011147778889999999999999999988654


Q ss_pred             CCc
Q 016594          338 GDQ  340 (386)
Q Consensus       338 ~~~  340 (386)
                      ..+
T Consensus       438 ~~~  440 (1351)
T KOG1035|consen  438 RFP  440 (1351)
T ss_pred             ccc
Confidence            433

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.93  E-value=8.1e-05  Score=65.70  Aligned_cols=31  Identities=23%  Similarity=0.311  Sum_probs=26.0

Q ss_pred             CCeEEeCCCCCCeeEcCCCCeEEeecCcccc
Q 016594          187 RRIIHRDIKSSNILLTADFEPQISDFGLAKW  217 (386)
Q Consensus       187 ~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~  217 (386)
                      ..++|+|+.+.||+++.++..-|+||+.+..
T Consensus       164 ~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~  194 (235)
T cd05155         164 PVWFHGDLAPGNLLVQDGRLSAVIDFGCLGV  194 (235)
T ss_pred             ceEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence            4589999999999998765567999998753

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.89  E-value=0.00017  Score=63.55  Aligned_cols=73  Identities=11%  Similarity=0.056  Sum_probs=46.2

Q ss_pred             CeecccCCcEEEEEEECC--CcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCc-eeeecceEEeCceEEEEEeccCC
Q 016594           72 NLVGRGGYAEVYKGVLQD--GEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPN-VLSLLGCCVDNGLYLIFQFSSRG  148 (386)
Q Consensus        72 ~~lg~G~~g~V~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~~~lv~e~~~~~  148 (386)
                      +.|..|-...+|++...+  +..|++|+......   ......+|+.+++.+...+ .+++++.+ +  ..++|||+.|.
T Consensus         4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~---~~~d~~~E~~~~~~l~~~gl~P~v~~~~-~--~~~l~e~i~G~   77 (235)
T cd05157           4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE---LIIDRERELRIHKLLSKHGLAPKLYATF-Q--NGLIYEFIPGR   77 (235)
T ss_pred             EEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc---ceecHHHHHHHHHHHHhCCCCCeEEEEe-C--CcEEEEeeCCC
Confidence            567888899999998664  67899997653211   1122346777777775333 33443332 2  24799999887


Q ss_pred             CH
Q 016594          149 SV  150 (386)
Q Consensus       149 ~L  150 (386)
                      ++
T Consensus        78 ~l   79 (235)
T cd05157          78 TL   79 (235)
T ss_pred             cC
Confidence            65

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>PRK10593 hypothetical protein; Provisional

Probab=97.82  E-value=0.0004  Score=63.51  Aligned_cols=77  Identities=12%  Similarity=0.021  Sum_probs=53.9

Q ss_pred             CCCCeecccCCcEEEEEEECCCcEEEEEEeccccCChHhHHHHHHHHHHHhccCC---CceeeecceEEe----CceEEE
Q 016594           69 SSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCH---PNVLSLLGCCVD----NGLYLI  141 (386)
Q Consensus        69 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h---~niv~l~~~~~~----~~~~lv  141 (386)
                      .-.+.||.|..+.||.....++ .+.+|..+.    ......+..|+..|+.|.-   -.+.++++++.+    +..++|
T Consensus        17 ~~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~----~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LV   91 (297)
T PRK10593         17 SRVECISEQPYAALWALYDSQG-NPMPLMARS----FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLL   91 (297)
T ss_pred             heeeecCCccceeEEEEEcCCC-CEEEEEecc----cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEE
Confidence            3356799999999999876555 466676432    1122467788888888752   357778877643    338999


Q ss_pred             EEeccCCCH
Q 016594          142 FQFSSRGSV  150 (386)
Q Consensus       142 ~e~~~~~~L  150 (386)
                      ||++.+.++
T Consensus        92 mE~i~G~~~  100 (297)
T PRK10593         92 LERLRGVSV  100 (297)
T ss_pred             EeccCCEec
Confidence            999998754

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.82  E-value=1.8e-05  Score=70.92  Aligned_cols=143  Identities=15%  Similarity=0.104  Sum_probs=96.1

Q ss_pred             HHHHhcCCCCCCeecccCCcEEEEEEECCCcEEEEEEeccccCCh--------------------HhHHHHHHHHHHHhc
Q 016594           61 ISIATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDD--------------------RKEKEFLTEIGTIGH  120 (386)
Q Consensus        61 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~--------------------~~~~~~~~e~~~l~~  120 (386)
                      +.....-+.+++.||-|--+.||.+....|++.++|.-......-                    -......+|...|+.
T Consensus        87 L~~R~~v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmka  166 (465)
T KOG2268|consen   87 LSNRGSVESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKA  166 (465)
T ss_pred             HHhcchhhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHH
Confidence            333334578899999999999999999889999988533211110                    012234578888877


Q ss_pred             cC-CC-ceeeecceEEeCceEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCC
Q 016594          121 VC-HP-NVLSLLGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSN  198 (386)
Q Consensus       121 l~-h~-niv~l~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~N  198 (386)
                      |. |. -+.+.+++   +..+.||+++.+..|...-+-..     ..   .+...+..-+.-|-.   +|+||+|..-=|
T Consensus       167 L~e~gfpVPkpiD~---~RH~Vvmelv~g~Pl~~v~~v~d-----~~---~ly~~lm~~Iv~la~---~GlIHgDFNEFN  232 (465)
T KOG2268|consen  167 LYERGFPVPKPIDH---NRHCVVMELVDGYPLRQVRHVED-----PP---TLYDDLMGLIVRLAN---HGLIHGDFNEFN  232 (465)
T ss_pred             HHHcCCCCCCcccc---cceeeHHHhhcccceeeeeecCC-----hH---HHHHHHHHHHHHHHH---cCceecccchhe
Confidence            75 32 23333332   34689999999988876543211     12   233333444455666   899999999999


Q ss_pred             eeEcCCCCeEEeecCcccc
Q 016594          199 ILLTADFEPQISDFGLAKW  217 (386)
Q Consensus       199 ill~~~~~~kl~Dfg~a~~  217 (386)
                      |++++++.++++||-....
T Consensus       233 imv~dd~~i~vIDFPQmvS  251 (465)
T KOG2268|consen  233 IMVKDDDKIVVIDFPQMVS  251 (465)
T ss_pred             eEEecCCCEEEeechHhhc
Confidence            9999999999999976543

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.82  E-value=0.00032  Score=59.39  Aligned_cols=126  Identities=19%  Similarity=0.251  Sum_probs=86.3

Q ss_pred             cCCCCCCeecccCC-cEEEEEEECCCcEEEEEEecc---ccC-------Ch---------HhHHHHHHHHHHHhccC---
Q 016594           66 NAFSSENLVGRGGY-AEVYKGVLQDGEEIAVKRLTK---VVT-------DD---------RKEKEFLTEIGTIGHVC---  122 (386)
Q Consensus        66 ~~~~~~~~lg~G~~-g~V~~~~~~~~~~vavK~~~~---~~~-------~~---------~~~~~~~~e~~~l~~l~---  122 (386)
                      ..++..+.||.|.- |.||++.+. |+.||+|++..   ...       ..         ....-|..|-....+|+   
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I~-g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~  115 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEID-GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG  115 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEEC-CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence            78888999999999 999999996 78999999332   110       00         11123556766666654   


Q ss_pred             CCce--eeecceEEeC---------------c----eEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHH
Q 016594          123 HPNV--LSLLGCCVDN---------------G----LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYL  181 (386)
Q Consensus       123 h~ni--v~l~~~~~~~---------------~----~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~L  181 (386)
                      +.++  |+++|+..-.               .    ..+|.+|.....           .+..    .-+.+|.+-+..+
T Consensus       116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------~~~~----~~~~~~~~dl~~~  180 (207)
T PF13095_consen  116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------PLQI----RDIPQMLRDLKIL  180 (207)
T ss_pred             ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------ccch----hHHHHHHHHHHHH
Confidence            5566  9999987311               0    245556554432           1222    3345667778889


Q ss_pred             HhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCcc
Q 016594          182 HKGCQRRIIHRDIKSSNILLTADFEPQISDFGLA  215 (386)
Q Consensus       182 H~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a  215 (386)
                      |.   .||+-+|+++.|..     .-||+|||.+
T Consensus       181 ~k---~gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  181 HK---LGIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HH---CCeeeccCcccccc-----CCEEEecccC
Confidence            99   99999999999987     3489999864

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.80  E-value=0.00017  Score=64.58  Aligned_cols=138  Identities=11%  Similarity=0.057  Sum_probs=75.6

Q ss_pred             eecccCCcEEEEEEECCCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCce-eeecceEEeCceEEEEEeccCCCHh
Q 016594           73 LVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNV-LSLLGCCVDNGLYLIFQFSSRGSVA  151 (386)
Q Consensus        73 ~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~lv~e~~~~~~L~  151 (386)
                      .+..|-.+.+|+... ++..+++|.........  .....+|..+++.+....+ .+++...   .-.+|++|+.|..+.
T Consensus         3 ~~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~--~~~r~~E~~~l~~l~~~g~~P~~i~~~---~~~~v~e~i~G~~~~   76 (256)
T TIGR02721         3 TLSGGLTNRSWRIEH-PGISFVWRPQSPVCKAL--GVDRQREYQILQALSALGLAPKPILVN---EHWLLVEWLEGEVIT   76 (256)
T ss_pred             cCCCcCcCCeEEEEe-CCccEEEeeCCcccccc--cCcHHHHHHHHHHHHhcCCCCceEEEe---CCEEEEEeccCcccc
Confidence            356788889998874 46788888754321111  0124567777777753322 2333222   236899999886653


Q ss_pred             hh--------------hhhcCC-----CCCCHH-HHHHHHHHH---------HHHHHHHHh-----CCCCCeEEeCCCCC
Q 016594          152 SL--------------FHDVNS-----PGVEWK-VRHKIAVGT---------ARGLHYLHK-----GCQRRIIHRDIKSS  197 (386)
Q Consensus       152 ~~--------------~~~~~~-----~~~~~~-~~~~i~~qi---------~~~l~~LH~-----~~~~~ivH~dlkp~  197 (386)
                      ..              +.+...     ..++.. .+..+..++         ...+..+-.     .....++|+|+.|.
T Consensus        77 ~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~  156 (256)
T TIGR02721        77 LDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAY  156 (256)
T ss_pred             cccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcC
Confidence            21              111111     111211 111221111         111222211     11246899999999


Q ss_pred             CeeEcCCCCeEEeecCcccc
Q 016594          198 NILLTADFEPQISDFGLAKW  217 (386)
Q Consensus       198 Nill~~~~~~kl~Dfg~a~~  217 (386)
                      ||+++.++ +.|+||..+..
T Consensus       157 Nil~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       157 NLVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             cEEEeCCC-CEEEeccccCc
Confidence            99999876 78999988763

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.68  E-value=0.00065  Score=64.21  Aligned_cols=77  Identities=13%  Similarity=0.056  Sum_probs=52.6

Q ss_pred             CeecccCCcEEEEEEECCC-cEEEEEEeccccC---C--hHhHHHHHHHHHHHhccC---CCceeeecceEEeCceEEEE
Q 016594           72 NLVGRGGYAEVYKGVLQDG-EEIAVKRLTKVVT---D--DRKEKEFLTEIGTIGHVC---HPNVLSLLGCCVDNGLYLIF  142 (386)
Q Consensus        72 ~~lg~G~~g~V~~~~~~~~-~~vavK~~~~~~~---~--~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~lv~  142 (386)
                      +.||.|.+..||++...+| +.|+||.-.....   .  +........|.+.|..+.   ..++.+++.+.. +..++||
T Consensus        32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D~-~~~~lVM  110 (401)
T PRK09550         32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYDE-ELAVTVM  110 (401)
T ss_pred             eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEECC-CCCEEEE
Confidence            5789999999999998766 5899997432110   1  223456677888887763   345666776633 3478999


Q ss_pred             EeccCCC
Q 016594          143 QFSSRGS  149 (386)
Q Consensus       143 e~~~~~~  149 (386)
                      |++.+..
T Consensus       111 E~L~~~~  117 (401)
T PRK09550        111 EDLSDHK  117 (401)
T ss_pred             ecCCCcc
Confidence            9987643

>PRK05231 homoserine kinase; Provisional

Probab=97.66  E-value=0.0011  Score=61.29  Aligned_cols=31  Identities=32%  Similarity=0.435  Sum_probs=26.5

Q ss_pred             CCCeEEeCCCCCCeeEcCCCCeEEeecCccc
Q 016594          186 QRRIIHRDIKSSNILLTADFEPQISDFGLAK  216 (386)
Q Consensus       186 ~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~  216 (386)
                      +.+++|+|+.|.||+++.+...-|+||+.+.
T Consensus       186 p~~liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        186 PRGVIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             CcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence            3689999999999999976556899999775

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.65  E-value=0.0008  Score=60.83  Aligned_cols=31  Identities=26%  Similarity=0.430  Sum_probs=25.8

Q ss_pred             CCeEEeCCCCCCeeEcCCCC-eEEeecCcccc
Q 016594          187 RRIIHRDIKSSNILLTADFE-PQISDFGLAKW  217 (386)
Q Consensus       187 ~~ivH~dlkp~Nill~~~~~-~kl~Dfg~a~~  217 (386)
                      ..++|+|++|.|||++.++. .-|+||+.+..
T Consensus       185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            35899999999999997555 46999998764

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.62  E-value=0.00035  Score=64.12  Aligned_cols=74  Identities=19%  Similarity=0.189  Sum_probs=45.5

Q ss_pred             CeecccCCcEEEEEEECC-------CcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCce-eeecceEEeCceEEEEE
Q 016594           72 NLVGRGGYAEVYKGVLQD-------GEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNV-LSLLGCCVDNGLYLIFQ  143 (386)
Q Consensus        72 ~~lg~G~~g~V~~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~lv~e  143 (386)
                      +.|..|-...+|+....+       ++.+++|+.....   .......+|+.++..+...++ .++++++. +  ..|++
T Consensus         4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~---~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~-~--~~v~e   77 (302)
T cd05156           4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV---ELLIDRERELVVFARLSERNLGPKLYGIFP-N--GRIEE   77 (302)
T ss_pred             EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC---cceechHHHHHHHHHHHhCCCCCceEEEeC-C--Cchhh
Confidence            456677788999988654       4789999865422   122345677777777753222 34444443 2  25788


Q ss_pred             eccCCCHh
Q 016594          144 FSSRGSVA  151 (386)
Q Consensus       144 ~~~~~~L~  151 (386)
                      |+.|..+.
T Consensus        78 ~i~G~~l~   85 (302)
T cd05156          78 FIPSRTLT   85 (302)
T ss_pred             eeCCCcCC
Confidence            88876653

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.60  E-value=0.0011  Score=60.56  Aligned_cols=140  Identities=16%  Similarity=0.144  Sum_probs=79.9

Q ss_pred             CCeecccCCcEEEEEEECCCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCC--ceeeecceE-------EeCceEEE
Q 016594           71 ENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHP--NVLSLLGCC-------VDNGLYLI  141 (386)
Q Consensus        71 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~--niv~l~~~~-------~~~~~~lv  141 (386)
                      .+.|..|....+|+.... +..+++|+...     .....+..|+.++..+.+.  .+.+++...       ..+..+++
T Consensus        19 i~~i~~G~~n~~y~v~~~-~~~~vLr~~~~-----~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l   92 (296)
T cd05153          19 FEGISAGIENTNYFVTTD-SGRYVLTLFEK-----VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAAL   92 (296)
T ss_pred             eecccCccccceEEEEeC-CCcEEEEEcCC-----CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEE
Confidence            456778888899998765 45788898753     1223455677777666422  244443321       12336889


Q ss_pred             EEeccCCCHhh----h----------hhhcC----CC-----CCCHHHHH----------HHHHHHHHHHHHHHh----C
Q 016594          142 FQFSSRGSVAS----L----------FHDVN----SP-----GVEWKVRH----------KIAVGTARGLHYLHK----G  184 (386)
Q Consensus       142 ~e~~~~~~L~~----~----------~~~~~----~~-----~~~~~~~~----------~i~~qi~~~l~~LH~----~  184 (386)
                      +++++|..+..    .          ++...    ..     ...+....          .....+..++.++..    .
T Consensus        93 ~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~  172 (296)
T cd05153          93 VEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSD  172 (296)
T ss_pred             EEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhc
Confidence            99998876532    0          11100    00     00111100          011112233344332    1


Q ss_pred             CCCCeEEeCCCCCCeeEcCCCCeEEeecCccc
Q 016594          185 CQRRIIHRDIKSSNILLTADFEPQISDFGLAK  216 (386)
Q Consensus       185 ~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~  216 (386)
                      ...+++|+|+.|.||+++.++.+.|+||+.+.
T Consensus       173 ~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~  204 (296)
T cd05153         173 LPRGVIHADLFRDNVLFDGDELSGVIDFYFAC  204 (296)
T ss_pred             CCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence            23579999999999999988777899998765

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=97.49  E-value=0.0022  Score=58.58  Aligned_cols=140  Identities=14%  Similarity=0.168  Sum_probs=84.3

Q ss_pred             CCeecccCCcEEEEEEECCCcEEEEEEeccccCChHhHHHHHHHHHHHhccCC--CceeeecceEEeC---ceEEEEEec
Q 016594           71 ENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCH--PNVLSLLGCCVDN---GLYLIFQFS  145 (386)
Q Consensus        71 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~---~~~lv~e~~  145 (386)
                      .+.+..|.-..+|..... ++.+++. ...............+|..+++.+.-  .-+...+++|.++   ..++||+++
T Consensus        30 v~~~~~G~sn~t~~~~~~-~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~v  107 (321)
T COG3173          30 VEEISGGWSNDTFRLGDT-GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWV  107 (321)
T ss_pred             eeeccCCcccceEEEecC-CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEe
Confidence            334433433445554443 7788888 33222223344556678888777752  2344556666443   369999999


Q ss_pred             cCCCHhhhhhhcCCCCCCHHHHHHHHH-HHHHHHHHHHh-----------------------------------------
Q 016594          146 SRGSVASLFHDVNSPGVEWKVRHKIAV-GTARGLHYLHK-----------------------------------------  183 (386)
Q Consensus       146 ~~~~L~~~~~~~~~~~~~~~~~~~i~~-qi~~~l~~LH~-----------------------------------------  183 (386)
                      .|..+.+....       ......++. .++..|.-||+                                         
T Consensus       108 eGe~~~~~~~~-------~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~  180 (321)
T COG3173         108 EGEVVWSALPP-------ESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLA  180 (321)
T ss_pred             cceeccCcCCc-------ccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchH
Confidence            98543322211       111112222 55666666665                                         


Q ss_pred             --------------CCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCC
Q 016594          184 --------------GCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLP  219 (386)
Q Consensus       184 --------------~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~  219 (386)
                                    .....++|+|+.+.||+++..+-+-|.||+++..-+
T Consensus       181 ~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGD  230 (321)
T COG3173         181 DRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGD  230 (321)
T ss_pred             HHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCC
Confidence                          113468999999999999988889999999987643

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.48  E-value=0.0013  Score=60.50  Aligned_cols=140  Identities=20%  Similarity=0.236  Sum_probs=77.9

Q ss_pred             CCeecccCCcEEEEEEECCCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCC--ceeeecceE-------EeCceEEE
Q 016594           71 ENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHP--NVLSLLGCC-------VDNGLYLI  141 (386)
Q Consensus        71 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~--niv~l~~~~-------~~~~~~lv  141 (386)
                      ...++.|....+|+....++ .+++|+.....    ....+..|+.++..|...  .+.+++...       ..+..+++
T Consensus        27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~----~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l  101 (307)
T TIGR00938        27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRV----KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACL  101 (307)
T ss_pred             ccccCCccccceEEEEeCCC-cEEEEEecCCC----CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEE
Confidence            45677787789999876544 67788765411    122344566666666321  233433321       12336889


Q ss_pred             EEeccCCCHhh-----------h---hhhcCCCCC-----------CHHHHH------------HHHHHHHHHHHHHHh-
Q 016594          142 FQFSSRGSVAS-----------L---FHDVNSPGV-----------EWKVRH------------KIAVGTARGLHYLHK-  183 (386)
Q Consensus       142 ~e~~~~~~L~~-----------~---~~~~~~~~~-----------~~~~~~------------~i~~qi~~~l~~LH~-  183 (386)
                      +++++|..+..           .   ++... .++           .|....            .....+...++++.. 
T Consensus       102 ~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~-~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~  180 (307)
T TIGR00938       102 VEFLQGLSVGRPTAMHCRPVGEVLAWMHLAG-AHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKF  180 (307)
T ss_pred             EEeCCCCCCCCCCHHHHHHHHHHHHHHHhhh-ccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhh
Confidence            99998854321           1   11100 001           000000            001112234444432 


Q ss_pred             ---CCCCCeEEeCCCCCCeeEcCCCCeEEeecCccc
Q 016594          184 ---GCQRRIIHRDIKSSNILLTADFEPQISDFGLAK  216 (386)
Q Consensus       184 ---~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~  216 (386)
                         ....+++|+|+.+.||+++.++.+.|+||+.+.
T Consensus       181 ~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       181 WPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             hhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence               224789999999999999988777899998764

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=97.38  E-value=0.0015  Score=59.99  Aligned_cols=144  Identities=18%  Similarity=0.211  Sum_probs=95.1

Q ss_pred             CCCeecccCCcEEEEEEECCCcEEEEEEeccccC----------------------ChHhHHH--HHHHHHHHhccCCCc
Q 016594           70 SENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVT----------------------DDRKEKE--FLTEIGTIGHVCHPN  125 (386)
Q Consensus        70 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~----------------------~~~~~~~--~~~e~~~l~~l~h~n  125 (386)
                      +..-|..|--+.||.|...+|..+|||+++-...                      ++.....  ...|+.-|.+++...
T Consensus       148 inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG  227 (520)
T KOG2270|consen  148 INGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG  227 (520)
T ss_pred             cccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence            3456778888999999988899999998763111                      0111111  234666677776544


Q ss_pred             eeeecceEEeCceEEEEEeccCCCHhh-hhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCC
Q 016594          126 VLSLLGCCVDNGLYLIFQFSSRGSVAS-LFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTAD  204 (386)
Q Consensus       126 iv~l~~~~~~~~~~lv~e~~~~~~L~~-~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~  204 (386)
                      |... .-..-.+..|||+|+....-.. .|.   .-.++...+..+-.+++.-+.-|...  .++||.||.-=|+|+- +
T Consensus       228 IP~P-ePIlLk~hVLVM~FlGrdgw~aPkLK---d~~ls~~ka~~~Y~~~v~~MR~lY~~--c~LVHADLSEfN~Lyh-d  300 (520)
T KOG2270|consen  228 IPCP-EPILLKNHVLVMEFLGRDGWAAPKLK---DASLSTSKARELYQQCVRIMRRLYQK--CRLVHADLSEFNLLYH-D  300 (520)
T ss_pred             CCCC-CceeeecceEeeeeccCCCCcCcccc---cccCChHHHHHHHHHHHHHHHHHHHH--hceeccchhhhhheEE-C
Confidence            3222 2222344679999986533221 222   22366677888888888888887763  6899999999999985 5


Q ss_pred             CCeEEeecCccccCCC
Q 016594          205 FEPQISDFGLAKWLPS  220 (386)
Q Consensus       205 ~~~kl~Dfg~a~~~~~  220 (386)
                      |.+.++|-+.+.....
T Consensus       301 G~lyiIDVSQSVE~DH  316 (520)
T KOG2270|consen  301 GKLYIIDVSQSVEHDH  316 (520)
T ss_pred             CEEEEEEccccccCCC
Confidence            6899999988765543

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=97.24  E-value=0.0038  Score=57.91  Aligned_cols=75  Identities=16%  Similarity=0.034  Sum_probs=47.5

Q ss_pred             eecccCCcEEEEEEECCC-cEEEEEEeccc-----cCChHhHHHHHHHHHHHhccC--CC-ceeeecceEEeCceEEEEE
Q 016594           73 LVGRGGYAEVYKGVLQDG-EEIAVKRLTKV-----VTDDRKEKEFLTEIGTIGHVC--HP-NVLSLLGCCVDNGLYLIFQ  143 (386)
Q Consensus        73 ~lg~G~~g~V~~~~~~~~-~~vavK~~~~~-----~~~~~~~~~~~~e~~~l~~l~--h~-niv~l~~~~~~~~~~lv~e  143 (386)
                      .||.|...-||++...+| +.|+||.-...     ...+....+...|...|+...  -| .+.++|. +......++||
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~-~D~e~~~~vME   80 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH-FDTEMAVTVME   80 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE-EccccceehHh
Confidence            479999999999997644 68999964321     112334455667777776664  34 3444443 33344568899


Q ss_pred             eccCC
Q 016594          144 FSSRG  148 (386)
Q Consensus       144 ~~~~~  148 (386)
                      ++...
T Consensus        81 dL~~~   85 (370)
T TIGR01767        81 DLSHH   85 (370)
T ss_pred             hCccc
Confidence            88553

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=97.18  E-value=3.9e-05  Score=81.05  Aligned_cols=159  Identities=9%  Similarity=-0.032  Sum_probs=115.1

Q ss_pred             HHHHHHHHhccCCCceeeecceEEeC---ceEEEEEeccCCCHhhhhhhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 016594          111 FLTEIGTIGHVCHPNVLSLLGCCVDN---GLYLIFQFSSRGSVASLFHDVNS--PGVEWKVRHKIAVGTARGLHYLHKGC  185 (386)
Q Consensus       111 ~~~e~~~l~~l~h~niv~l~~~~~~~---~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~  185 (386)
                      .+.|.+.++...|+++...+.-....   ..+..++++.+|.+...+-+...  +.+....+.....+.+.+..-+|+..
T Consensus      1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred             hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence            34555566667899888877655432   26888999999999987765433  22334444444444466666666522


Q ss_pred             --CCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHH
Q 016594          186 --QRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEI  263 (386)
Q Consensus       186 --~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el  263 (386)
                        .+-.+|++||+-|.++..+..+|++++|+.+.....  ........+++.|++|+....-.++.++|+|..|+.+|+.
T Consensus      1356 nlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~--~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~r 1433 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPV--LSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLR 1433 (2724)
T ss_pred             cCCccchhhhhhhhccceecCCcccccccccccccCch--HhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHH
Confidence              234799999999999999999999999999833221  1223445678889999998888899889999999999999


Q ss_pred             HhCCCCCC
Q 016594          264 ISGRKPVD  271 (386)
Q Consensus       264 l~g~~pf~  271 (386)
                      ..|..+|-
T Consensus      1434 s~~n~~fi 1441 (2724)
T KOG1826|consen 1434 SDGNAYFI 1441 (2724)
T ss_pred             hcccHHHH
Confidence            88988874

>PLN02236 choline kinase

Probab=97.16  E-value=0.0029  Score=59.12  Aligned_cols=140  Identities=18%  Similarity=0.206  Sum_probs=77.5

Q ss_pred             CCeecccCCcEEEEEEECC-----CcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCcee-eecceEEeCceEEEEEe
Q 016594           71 ENLVGRGGYAEVYKGVLQD-----GEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVL-SLLGCCVDNGLYLIFQF  144 (386)
Q Consensus        71 ~~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~l~~~~~~~~~~lv~e~  144 (386)
                      ...|..|-...+|++.+.+     ++.|++|+......   ....-.+|..+++.+...++. ++++.+.. +  .+.+|
T Consensus        41 i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~---~~idR~~E~~~~~~l~~~gl~P~~~~~~~~-g--~v~ef  114 (344)
T PLN02236         41 VIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVE---LFFDRDDEIRTFECMSRHGQGPRLLGRFPN-G--RVEEF  114 (344)
T ss_pred             EEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCC---eeechHHHHHHHHHHHHcCCCCceEEEECC-c--eEEEe
Confidence            3456668888999987542     36789997764321   112225677777777633333 44454432 2  57888


Q ss_pred             ccCCCHhhh-----------------hhhcCCC----CCCHHHHHHHHHHH-----------------HHHHHHH----H
Q 016594          145 SSRGSVASL-----------------FHDVNSP----GVEWKVRHKIAVGT-----------------ARGLHYL----H  182 (386)
Q Consensus       145 ~~~~~L~~~-----------------~~~~~~~----~~~~~~~~~i~~qi-----------------~~~l~~L----H  182 (386)
                      +.+.++...                 ++....+    ...+..+..+..++                 ...+..|    .
T Consensus       115 i~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~  194 (344)
T PLN02236        115 IHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELS  194 (344)
T ss_pred             eCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhc
Confidence            877665311                 1111100    11122222322111                 1111112    2


Q ss_pred             h-CCCCCeEEeCCCCCCeeEcC-CCCeEEeecCccc
Q 016594          183 K-GCQRRIIHRDIKSSNILLTA-DFEPQISDFGLAK  216 (386)
Q Consensus       183 ~-~~~~~ivH~dlkp~Nill~~-~~~~kl~Dfg~a~  216 (386)
                      . .....++|+|+++.|||++. ++.+.++||..+.
T Consensus       195 ~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~  230 (344)
T PLN02236        195 GDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS  230 (344)
T ss_pred             ccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence            1 12346899999999999986 4689999998775

>PLN02756 S-methyl-5-thioribose kinase

Probab=97.09  E-value=0.0077  Score=56.92  Aligned_cols=75  Identities=12%  Similarity=0.038  Sum_probs=49.7

Q ss_pred             CCeecccCCcEEEEEEECCCcEEEEEEeccccC-----ChHhHHHHHHHHHHHhccC---CCceeeecceEEeCceEEEE
Q 016594           71 ENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVT-----DDRKEKEFLTEIGTIGHVC---HPNVLSLLGCCVDNGLYLIF  142 (386)
Q Consensus        71 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~lv~  142 (386)
                      .+.||.|....||+.... +..++||.-.....     .+....+...|+..|+.+.   ..++.+++.++.+ ..+++|
T Consensus        37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded-~~vlvM  114 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT-MALIGM  114 (418)
T ss_pred             EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC-CCEEEE
Confidence            467899999999998875 55688997552111     1113344455666666554   3477788887764 357789


Q ss_pred             EeccC
Q 016594          143 QFSSR  147 (386)
Q Consensus       143 e~~~~  147 (386)
                      |++.+
T Consensus       115 E~L~~  119 (418)
T PLN02756        115 RYLEP  119 (418)
T ss_pred             eecCC
Confidence            99977

>PRK12396 5-methylribose kinase; Reviewed

Probab=96.86  E-value=0.0046  Score=58.13  Aligned_cols=76  Identities=12%  Similarity=-0.019  Sum_probs=49.1

Q ss_pred             CCeecccCCcEEEEEEECC-CcEEEEEEecc----ccCChHhHHHHHHHHHHHhccC--CC-ceeeecceEEeCceEEEE
Q 016594           71 ENLVGRGGYAEVYKGVLQD-GEEIAVKRLTK----VVTDDRKEKEFLTEIGTIGHVC--HP-NVLSLLGCCVDNGLYLIF  142 (386)
Q Consensus        71 ~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~----~~~~~~~~~~~~~e~~~l~~l~--h~-niv~l~~~~~~~~~~lv~  142 (386)
                      .+.||.|.-.-||++.+.+ ++.|+||.-..    ....+-...+...|..+|+...  -| ++.++|.+ ......+||
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~-D~e~~~~vM  112 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF-DSVMNCCVM  112 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE-CcHHhhHHH
Confidence            4578999999999999753 56799986432    1122344566677888887664  34 44445543 333456788


Q ss_pred             EeccC
Q 016594          143 QFSSR  147 (386)
Q Consensus       143 e~~~~  147 (386)
                      |++..
T Consensus       113 EdL~~  117 (409)
T PRK12396        113 EDLSD  117 (409)
T ss_pred             HhCcc
Confidence            88754

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=96.68  E-value=0.013  Score=53.09  Aligned_cols=72  Identities=19%  Similarity=0.233  Sum_probs=43.7

Q ss_pred             CCeecccCCcEEEEEEECCCcEEEEEEeccccCChHhHHHHHHHHHHHhccC---CCceeeecceEEeC-ceEEEEEecc
Q 016594           71 ENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVC---HPNVLSLLGCCVDN-GLYLIFQFSS  146 (386)
Q Consensus        71 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~-~~~lv~e~~~  146 (386)
                      .+.++.|....+|+.. .+++.+.||+-..     .....|..|+.-|+.|.   --.+.+++++.... ..++++||++
T Consensus        22 ~~~v~GG~i~~a~~~~-~~~~~~FvK~~~~-----~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~   95 (288)
T PF03881_consen   22 IEPVSGGDINEAYRLD-TDGGSYFVKVNSE-----SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLE   95 (288)
T ss_dssp             EEEE--SSSSEEEEEE-TTS-EEEEEEEEG-----GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE---
T ss_pred             eEecCCCChhheEEEE-CCCccEEEEecCh-----hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeec
Confidence            4578999999999987 4578899997652     22335667777777773   44577777777543 4799999987


Q ss_pred             CC
Q 016594          147 RG  148 (386)
Q Consensus       147 ~~  148 (386)
                      .+
T Consensus        96 ~~   97 (288)
T PF03881_consen   96 MG   97 (288)
T ss_dssp             --
T ss_pred             CC
Confidence            76

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=96.42  E-value=0.019  Score=53.41  Aligned_cols=140  Identities=16%  Similarity=0.191  Sum_probs=75.7

Q ss_pred             CeecccCCcEEEEEEECC----CcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCcee-eecceEEeCceEEEEEecc
Q 016594           72 NLVGRGGYAEVYKGVLQD----GEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVL-SLLGCCVDNGLYLIFQFSS  146 (386)
Q Consensus        72 ~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~l~~~~~~~~~~lv~e~~~  146 (386)
                      +.|..|-...+|+....+    +..|++|+......   ....-.+|..+++.+...++. ++++++ .++  ++.+|+.
T Consensus        20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~---~~IdR~~E~~il~~l~~~gl~P~~l~~~-~~G--~i~~fi~   93 (330)
T PLN02421         20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD---YVIDRERELQAIKYLSAAGFGAKLLGVF-GNG--MIQSFIN   93 (330)
T ss_pred             EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcC---eEechHHHHHHHHHHHhcCCCCceeEEe-CCc--Eeehhhc
Confidence            456668888899887542    23788997764221   122234677777777644443 444444 333  4788887


Q ss_pred             CCCHhh--------------hhhhcCCCC------C-CHHHHHHHHHHH----------------------H---HHHHH
Q 016594          147 RGSVAS--------------LFHDVNSPG------V-EWKVRHKIAVGT----------------------A---RGLHY  180 (386)
Q Consensus       147 ~~~L~~--------------~~~~~~~~~------~-~~~~~~~i~~qi----------------------~---~~l~~  180 (386)
                      +..+..              .+.+.....      + .+..+..+..++                      .   ..+..
T Consensus        94 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~  173 (330)
T PLN02421         94 ARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKE  173 (330)
T ss_pred             CCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHH
Confidence            655421              111111111      1 122222222221                      1   11111


Q ss_pred             HH-h-CCCCCeEEeCCCCCCeeEcC-CCCeEEeecCcccc
Q 016594          181 LH-K-GCQRRIIHRDIKSSNILLTA-DFEPQISDFGLAKW  217 (386)
Q Consensus       181 LH-~-~~~~~ivH~dlkp~Nill~~-~~~~kl~Dfg~a~~  217 (386)
                      +. . ..+.-.+|+|+.+.|||++. ++.++++||..|..
T Consensus       174 ~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        174 ITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             HhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence            11 1 11234799999999999974 57899999988753

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=96.33  E-value=0.006  Score=58.44  Aligned_cols=164  Identities=16%  Similarity=0.189  Sum_probs=90.2

Q ss_pred             HHHHHHHHHHHhccCCCceeeecceEEeCc--eEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 016594          108 EKEFLTEIGTIGHVCHPNVLSLLGCCVDNG--LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGC  185 (386)
Q Consensus       108 ~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~  185 (386)
                      ..+++-...+++.+.|+|...++++.....  ..+|+|++ +.+|.+++..+....         .    +++    .  
T Consensus        26 s~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~l~~---------~----s~~----~--   85 (725)
T KOG1093|consen   26 SIQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGNLKD---------E----SLL----A--   85 (725)
T ss_pred             HHHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcccch---------h----hhc----c--
Confidence            346677888999999999999998876533  55666665 448888776543111         0    000    1  


Q ss_pred             CCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHh
Q 016594          186 QRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS  265 (386)
Q Consensus       186 ~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~  265 (386)
                       +++.|-++            .+.+| .++..                  |  |-     ...+|+||||+|.++.++.-
T Consensus        86 -~~~~~~~~------------~~~td-~~~t~------------------~--~~-----~~~pKsdVwsl~~i~~el~L  126 (725)
T KOG1093|consen   86 -HGVLHLNI------------IYITD-HFLTK------------------Y--PS-----PIGPKSDVWSLGFIILELYL  126 (725)
T ss_pred             -cccceehh------------hhccc-ccccc------------------C--CC-----CCCcchhhhhHHHHHHHHHH
Confidence             34444322            22233 00000                  0  10     01149999999999999999


Q ss_pred             CCCCCCCCchhhh--hhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 016594          266 GRKPVDGSHQSLH--SWAKPILNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLE  333 (386)
Q Consensus       266 g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~  333 (386)
                      |...+........  ...+....+.....+....   .....+...+..+...|+-..|..||...+..+
T Consensus       127 ~~~l~~~~~~s~~l~~i~k~~~~d~~~~~~a~e~---~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k  193 (725)
T KOG1093|consen  127 GISLEAELTESEYLEILLKYYTDDQELLSTAMEH---LIQLLADKKRLPLLKKCLWLEPIIRPLPMELSK  193 (725)
T ss_pred             hhHHHHHHHHHHHHHHHHHhccCchhHHHHHHHH---HHHHhhhHhHHHHhccCCccccccccchhHHhc
Confidence            8877654322111  0111111111111000000   112234556788899999999999987665553

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=96.22  E-value=0.01  Score=51.27  Aligned_cols=30  Identities=33%  Similarity=0.465  Sum_probs=21.3

Q ss_pred             CCeEEeCCCCCCeeE-cCCCCeEEeecCccc
Q 016594          187 RRIIHRDIKSSNILL-TADFEPQISDFGLAK  216 (386)
Q Consensus       187 ~~ivH~dlkp~Nill-~~~~~~kl~Dfg~a~  216 (386)
                      ..++|+||.|.|||+ +.++.++++||..|.
T Consensus       143 ~v~cHnDl~~~Nil~~~~~~~~~lIDfEya~  173 (211)
T PF01633_consen  143 LVFCHNDLNPGNILINNKDGEVKLIDFEYAG  173 (211)
T ss_dssp             EEEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred             ceEeeccCccccEEeccCCCeEEEecHHHHh
Confidence            468999999999999 888999999998775

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=95.98  E-value=0.023  Score=52.30  Aligned_cols=53  Identities=21%  Similarity=0.214  Sum_probs=46.5

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCcccc
Q 016594          162 VEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKW  217 (386)
Q Consensus       162 ~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~  217 (386)
                      ..+.++..++++.+..++-+..  .-..-|||+...|||++ .|++.|+||-+++.
T Consensus       318 ~~~~e~lsff~s~~sil~~lek--kf~fehrnlt~~niLId-~GnvtLIDfklsRl  370 (488)
T COG5072         318 DRSEEELSFFWSCISILDILEK--KFPFEHRNLTLDNILID-EGNVTLIDFKLSRL  370 (488)
T ss_pred             ccHHHHHHHHHHHHHHHhhhhh--cCCcccccccccceeee-cCceEEEEeeeeec
Confidence            4577889999999888888887  35789999999999999 99999999999984

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=95.93  E-value=0.03  Score=52.38  Aligned_cols=60  Identities=18%  Similarity=0.170  Sum_probs=41.4

Q ss_pred             eEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEc
Q 016594          138 LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLT  202 (386)
Q Consensus       138 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~  202 (386)
                      ..++-+|..|-++..++....   .++.....++.-.+.|+-.+--.  .+.+|.|+.|.||++-
T Consensus       320 ~vl~E~~~~Gl~v~~~v~~~~---~pe~l~kkva~lg~~AllkMl~v--DNFvHaDlHPGNVlir  379 (565)
T KOG1236|consen  320 LVLVETYERGLSVLRFVKWKS---QPEALVKKVAKLGVNALLKMLIV--DNFVHADLHPGNVLIR  379 (565)
T ss_pred             ceeeeeccccccHHhhhhccc---ChHHHHHHHHHHHHHHHHHHHHh--hcceecccCCCcEEEE
Confidence            456667788888887776433   45556666666666665543321  6899999999999995

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=95.81  E-value=0.047  Score=46.88  Aligned_cols=121  Identities=13%  Similarity=0.115  Sum_probs=73.7

Q ss_pred             HHHHHHHHHHHhccCCCceeeecceEEeCc--eEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 016594          108 EKEFLTEIGTIGHVCHPNVLSLLGCCVDNG--LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGC  185 (386)
Q Consensus       108 ~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~  185 (386)
                      ...+..+..++++++  .|+++..   +++  +-++.|.|.....           .+    ..++..=+.+|.-.|+.+
T Consensus       102 ~~~y~nky~v~Armh--GilrL~N---Dn~~~yGvIlE~Cy~~~i-----------~~----~N~i~agi~~L~~fH~~~  161 (308)
T PF07387_consen  102 DALYFNKYRVFARMH--GILRLKN---DNNYKYGVILERCYKIKI-----------NF----SNFITAGIKDLMDFHSEN  161 (308)
T ss_pred             hhhhhhhhhHHHHhh--heeEeec---CCCceeEEEEeeccCccc-----------ch----hHHHHHhHHHHHHhhccC
Confidence            344567777777764  3566652   222  6677888765321           11    112222246788889643


Q ss_pred             CCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHh
Q 016594          186 QRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS  265 (386)
Q Consensus       186 ~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~  265 (386)
                       .+.+|||..|+|||-|..|.+||.|-+..-.-              +..|.--|   ....+.++.+-+|=.-++++..
T Consensus       162 -~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll~~--------------~V~~vN~~---Y~~lT~~aE~~~fv~s~l~~v~  223 (308)
T PF07387_consen  162 -QHCLHGDCNPDNIMCDKFGYLKLVDPVCLLEN--------------QVNMVNIE---YESLTQEAEVKVFVKSCLKLVE  223 (308)
T ss_pred             -CCeecCCCChhheeecCCCCEEecChhhhhhh--------------eeeEEeee---ccccChHHHHHHHHHHHHHHHH
Confidence             68999999999999999999999998754311              11121111   1223566667666666666665


Q ss_pred             C
Q 016594          266 G  266 (386)
Q Consensus       266 g  266 (386)
                      .
T Consensus       224 ~  224 (308)
T PF07387_consen  224 K  224 (308)
T ss_pred             H
Confidence            3

The function of this family is unknown.

>PRK06148 hypothetical protein; Provisional

Probab=95.52  E-value=0.3  Score=52.46  Aligned_cols=32  Identities=38%  Similarity=0.488  Sum_probs=26.7

Q ss_pred             CCCeEEeCCCCCCeeEcCCC--CeE-EeecCcccc
Q 016594          186 QRRIIHRDIKSSNILLTADF--EPQ-ISDFGLAKW  217 (386)
Q Consensus       186 ~~~ivH~dlkp~Nill~~~~--~~k-l~Dfg~a~~  217 (386)
                      ..++||+|+.+.|||++.++  .+. |+|||-+..
T Consensus       202 p~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        202 PAQVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             CcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence            36799999999999999775  555 999998753

>PF03109 ABC1: ABC1 family; InterPro: IPR004147 This entry includes ABC1 from yeast [] and AarF from Escherichia coli []

Probab=95.43  E-value=0.008  Score=46.76  Aligned_cols=45  Identities=24%  Similarity=0.350  Sum_probs=34.1

Q ss_pred             CCeecccCCcEEEEEEECCCcEEEEEEeccccCChHhHHHHHHHHHHHhc
Q 016594           71 ENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGH  120 (386)
Q Consensus        71 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~  120 (386)
                      ...||.|+.|+||+|++++|+.||||+.+.     .....+...+.+++.
T Consensus        16 ~~PlasASiaQVh~a~l~~g~~VaVKV~rP-----~i~~~i~~Dl~~l~~   60 (119)
T PF03109_consen   16 PEPLASASIAQVHRARLKDGEEVAVKVQRP-----GIEEQIEADLRILRR   60 (119)
T ss_pred             cchhhheehhhheeeeecccchhhhhhcch-----HHHHHHHHHHHHHHH
Confidence            468999999999999999999999998874     334444455555443

These proteins have a nuclear or mitochondrial subcellular location in eukaryotes. The exact molecular functions of these proteins is not clear, however yeast ABC1 suppresses a cytochrome b mRNA translation defect and is essential for the electron transfer in the bc 1 complex [] and E. coli AarF is required for ubiquinone production []. It has been suggested that members of the ABC1 family are novel chaperonins []. These proteins are unrelated to the ABC transporter proteins.

>PRK11768 serine/threonine protein kinase; Provisional

Probab=95.07  E-value=1.2  Score=41.21  Aligned_cols=29  Identities=31%  Similarity=0.449  Sum_probs=24.5

Q ss_pred             CCCeEEeCCCCCCeeEcCCCCeEEeecCccc
Q 016594          186 QRRIIHRDIKSSNILLTADFEPQISDFGLAK  216 (386)
Q Consensus       186 ~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~  216 (386)
                      ..+++|+|+.+.|||++ + .+.|+||+-+.
T Consensus       195 ~~~liHgD~h~~NvL~~-d-~~~iIDFDd~~  223 (325)
T PRK11768        195 RLLRLHGDCHPGNILWR-D-GPHFVDLDDAR  223 (325)
T ss_pred             CccceecCCCchhcccc-C-CcEEEeCCCCC
Confidence            35789999999999995 4 57899999765

>COG4499 Predicted membrane protein [Function unknown]

Probab=94.71  E-value=0.3  Score=44.87  Aligned_cols=124  Identities=15%  Similarity=0.213  Sum_probs=76.1

Q ss_pred             HHHHHhccCCCceeeecceEEeCceEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeC
Q 016594          114 EIGTIGHVCHPNVLSLLGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRD  193 (386)
Q Consensus       114 e~~~l~~l~h~niv~l~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~d  193 (386)
                      ++.++.. ..|+++.-+...  ++ -+++-|-.......+-..   +.+.....++++.|.+..|.-+-    +--.|-=
T Consensus        41 ~~~lld~-~~~f~~~eit~~--~D-s~vIsy~i~~~~~~F~~~---k~~~k~~Klr~a~~~I~~l~e~~----~tr~~~~  109 (434)
T COG4499          41 LAELLDK-SPPFIVAEITED--ND-SFVISYPIPEAAKSFASA---KRKEKTRKLRLALQNIATLSELN----NTRYTFF  109 (434)
T ss_pred             HHHHhcc-CCCccceeeccc--Cc-eeEEEecCccccchHHHH---HHHHHHHHHHHHHHHHHHHHHhh----ccceeEE
Confidence            5566666 455555544322  22 233333333333322111   11455667777888888877654    3456667


Q ss_pred             CCCCCeeEcCCCCeEEeecCccccCCCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCC
Q 016594          194 IKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDG  272 (386)
Q Consensus       194 lkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~  272 (386)
                      |.|+||+++.++.+.+..+|+-..+++              .=+.||.+..          .+-+++..++.|+.+|..
T Consensus       110 laPeNilf~~~l~p~~vH~Glk~~lpP--------------ye~tee~f~~----------~ykA~~~~~fn~k~~Fe~  164 (434)
T COG4499         110 LAPENILFDGGLTPFFVHRGLKNSLPP--------------YEMTEERFLK----------EYKALAIYAFNGKFSFES  164 (434)
T ss_pred             ecchheEEcCCCceEEEecchhccCCC--------------CCCCHHHHHH----------HHHHHHHHHHcCCccHHH
Confidence            889999999999999999998654432              1245554432          566788889999999964

>PF04655 APH_6_hur: Aminoglycoside/hydroxyurea antibiotic resistance kinase; InterPro: IPR006748 The aminoglycosides are a large group of biologically active bacterial secondary metabolites, best known for their antibiotic properties []

Probab=94.43  E-value=0.24  Score=43.95  Aligned_cols=80  Identities=18%  Similarity=0.127  Sum_probs=52.1

Q ss_pred             CCCeecccCCcEEEEEEECCCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCceEEEEEec-cCC
Q 016594           70 SENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNGLYLIFQFS-SRG  148 (386)
Q Consensus        70 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~lv~e~~-~~~  148 (386)
                      ....+..|..+.|+.++..+|.++++|+........   .+ ......|+..+-...|++++.-.+.+ .+++|.+ .+.
T Consensus         6 ~~~~~~~g~~s~V~pv~~~dG~~avLKl~~p~~~~~---~E-~~g~~~L~~w~G~GaVrll~~d~~~~-AlLLErl~~g~   80 (253)
T PF04655_consen    6 PDGPPAHGSSSLVVPVRRADGTPAVLKLAPPHAEAE---HE-ARGEAALRWWNGRGAVRLLAADPERG-ALLLERLDPGR   80 (253)
T ss_pred             cCCCCCCCcceEEEEEEcCCCCeEEEEecCCcccch---hh-hhHHhHhheeCCCCceeeeccccccc-hhhhhhccCCC
Confidence            345567899999999998889999999876321111   11 11224577777778899998774443 4566777 444


Q ss_pred             CHhhhh
Q 016594          149 SVASLF  154 (386)
Q Consensus       149 ~L~~~~  154 (386)
                      +|.++.
T Consensus        81 ~L~~~~   86 (253)
T PF04655_consen   81 SLASLP   86 (253)
T ss_pred             chhhcc
Confidence            665443

Aminoglycoside phosphotransferases achieve inactivation of these enzymes by phosphorylation, utilising ATP. Likewise, hydroxyurea is inactivated by phosphorylation of the hydroxy group in the hydroxylamine moiety.; GO: 0016773 phosphotransferase activity, alcohol group as acceptor, 0006468 protein phosphorylation, 0019748 secondary metabolic process

>PTZ00384 choline kinase; Provisional

Probab=94.17  E-value=0.24  Score=46.93  Aligned_cols=75  Identities=15%  Similarity=0.218  Sum_probs=43.0

Q ss_pred             CCeecccCCcEEEEEEECCC--cE-----EEEEEeccccCChHhHHHHHHHHHHHhccCCCcee-eecceEEeCceEEEE
Q 016594           71 ENLVGRGGYAEVYKGVLQDG--EE-----IAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVL-SLLGCCVDNGLYLIF  142 (386)
Q Consensus        71 ~~~lg~G~~g~V~~~~~~~~--~~-----vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~l~~~~~~~~~~lv~  142 (386)
                      .+.|..|-...+|++...++  ..     |.++....   .......-.+|+.+++.+...++. ++++.+..   .++.
T Consensus        55 i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~---~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~---g~l~  128 (383)
T PTZ00384         55 IKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSST---YNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD---FTIQ  128 (383)
T ss_pred             EEEeCCcccceEEEEEecCCCCCccccceEEEEeccC---CCceEeccHHHHHHHHHHHhCCCCCeEEEecCC---EEEE
Confidence            34566788899999976432  22     33333211   111112234688888888754443 44444432   5888


Q ss_pred             EeccCCCHh
Q 016594          143 QFSSRGSVA  151 (386)
Q Consensus       143 e~~~~~~L~  151 (386)
                      +|+.|..|.
T Consensus       129 efIeGr~l~  137 (383)
T PTZ00384        129 EWVEGNTMG  137 (383)
T ss_pred             EEeccccCC
Confidence            999887653

>PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly

Probab=94.15  E-value=0.051  Score=49.66  Aligned_cols=53  Identities=21%  Similarity=0.261  Sum_probs=33.2

Q ss_pred             HHHHHHHHHHHHHHHHHh-CCCCCeEEeCCCCCCeeEcCC------------------CCeEEeecCccccC
Q 016594          166 VRHKIAVGTARGLHYLHK-GCQRRIIHRDIKSSNILLTAD------------------FEPQISDFGLAKWL  218 (386)
Q Consensus       166 ~~~~i~~qi~~~l~~LH~-~~~~~ivH~dlkp~Nill~~~------------------~~~kl~Dfg~a~~~  218 (386)
                      -+..++.|++.-.--+-. .|..+.+|-||||+|||+-+.                  -..+|.||.+++.-
T Consensus       276 YvkfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~~~vF~Epi~~~LnDFDfSqv~  347 (434)
T PF05445_consen  276 YVKFIFLQIALLYIKIYELPCCTNFLHVDLKPDNILIFDSKEPIRIKFGNRNYVFKEPIRCCLNDFDFSQVA  347 (434)
T ss_pred             HHHHHHHHHHHHHeeeecCCCcceeeecccCcCcEEEecCCCceEEEECCeEEEecccceeeecccCHHHhc
Confidence            345667777543322322 233689999999999998432                  23567777776643

; GO: 0004672 protein kinase activity, 0005524 ATP binding

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	386
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		4e-61
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		1e-60
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		4e-44
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		7e-44
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		2e-32
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		4e-32
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		8e-32
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		4e-30
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		3e-22
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		3e-22
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		3e-21
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		7e-21
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		3e-20
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		5e-20
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		8e-20
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		9e-20
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		1e-19
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		1e-19
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-19
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		1e-19
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		2e-19
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		2e-19
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		2e-19
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		2e-19
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		2e-19
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		2e-19
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-19
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		2e-19
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		2e-19
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		2e-19
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-19
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		2e-19
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		3e-19
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-19
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		6e-19
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		6e-19
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		6e-19
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		6e-19
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		7e-19
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		7e-19
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		7e-19
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		7e-19
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		7e-19
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		7e-19
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		7e-19
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		8e-19
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		8e-19
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		8e-19
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		8e-19
4h58_A	275	Braf In Complex With Compound 3 Length = 275		8e-19
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		9e-19
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		9e-19
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		9e-19
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		9e-19
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		1e-18
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		1e-18
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		1e-18
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		1e-18
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		1e-18
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		1e-18
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-18
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-18
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		1e-18
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		2e-18
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-18
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		2e-18
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		2e-18
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		2e-18
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		2e-18
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		2e-18
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		2e-18
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		2e-18
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		3e-18
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		3e-18
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		3e-18
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		3e-18
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		4e-18
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		4e-18
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-18
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		4e-18
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		4e-18
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		4e-18
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		4e-18
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		4e-18
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		4e-18
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		4e-18
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		5e-18
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		7e-18
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		7e-18
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		8e-18
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		8e-18
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		8e-18
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		8e-18
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		8e-18
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-17
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-17
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-17
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		1e-17
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-17
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-17
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		2e-17
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		2e-17
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-17
3a7f_A	303	Human Mst3 Kinase Length = 303		2e-17
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		2e-17
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		3e-17
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-17
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-17
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		3e-17
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		3e-17
3b2t_A	311	Structure Of Phosphotransferase Length = 311		3e-17
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		3e-17
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		3e-17
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-17
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-17
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		5e-17
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		5e-17
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		6e-17
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		1e-16
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		2e-16
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		2e-16
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		2e-16
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		3e-16
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		3e-16
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		4e-16
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		4e-16
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		4e-16
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		4e-16
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		5e-16
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		5e-16
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		5e-16
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		5e-16
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		5e-16
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		5e-16
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		5e-16
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		5e-16
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		5e-16
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		5e-16
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		5e-16
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		5e-16
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		6e-16
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		6e-16
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		6e-16
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		6e-16
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		6e-16
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		7e-16
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		7e-16
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		7e-16
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		7e-16
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		8e-16
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		8e-16
2pl0_A	289	Lck Bound To Imatinib Length = 289		8e-16
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		9e-16
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		9e-16
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		9e-16
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		9e-16
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		9e-16
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		1e-15
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		1e-15
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		1e-15
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		1e-15
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		1e-15
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		1e-15
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		1e-15
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		1e-15
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		1e-15
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		1e-15
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		2e-15
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		2e-15
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		2e-15
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		2e-15
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		2e-15
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		2e-15
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		2e-15
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		2e-15
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		2e-15
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		2e-15
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		2e-15
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		2e-15
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		3e-15
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		3e-15
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		3e-15
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		3e-15
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		3e-15
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		3e-15
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		3e-15
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		3e-15
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		3e-15
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		3e-15
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		3e-15
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		4e-15
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		4e-15
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		4e-15
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-15
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		4e-15
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		4e-15
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		4e-15
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		4e-15
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		4e-15
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-15
1fvr_A	327	Tie2 Kinase Domain Length = 327		4e-15
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		4e-15
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		4e-15
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		4e-15
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		5e-15
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		5e-15
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		6e-15
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		6e-15
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		6e-15
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		7e-15
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		7e-15
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		8e-15
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		8e-15
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		8e-15
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		9e-15
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		9e-15
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		1e-14
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-14
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		1e-14
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-14
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-14
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		1e-14
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		1e-14
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		1e-14
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		1e-14
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		1e-14
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		1e-14
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		1e-14
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		1e-14
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		1e-14
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		1e-14
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		1e-14
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-14
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		2e-14
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		2e-14
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		2e-14
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		2e-14
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-14
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		2e-14
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		2e-14
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-14
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		2e-14
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		2e-14
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		3e-14
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		3e-14
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		3e-14
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		3e-14
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		3e-14
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		3e-14
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		3e-14
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		4e-14
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		4e-14
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		4e-14
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		4e-14
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		5e-14
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		5e-14
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		5e-14
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		5e-14
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		5e-14
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		5e-14
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		6e-14
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		6e-14
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		6e-14
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		6e-14
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		6e-14
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		7e-14
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		7e-14
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		8e-14
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		8e-14
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		8e-14
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		8e-14
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		9e-14
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		9e-14
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		1e-13
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		1e-13
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-13
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-13
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		1e-13
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		1e-13
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		1e-13
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		2e-13
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-13
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		2e-13
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		2e-13
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		2e-13
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		2e-13
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		2e-13
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		2e-13
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		2e-13
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-13
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		2e-13
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-13
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		3e-13
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		3e-13
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		3e-13
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		3e-13
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		3e-13
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		3e-13
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		3e-13
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		3e-13
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		4e-13
3a4o_X	286	Lyn Kinase Domain Length = 286		4e-13
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-13
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-13
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		5e-13
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		6e-13
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		6e-13
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		6e-13
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-13
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		8e-13
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		8e-13
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		8e-13
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		8e-13
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		9e-13
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		9e-13
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		1e-12
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		1e-12
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		1e-12
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		1e-12
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-12
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		1e-12
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		1e-12
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		1e-12
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		1e-12
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		1e-12
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		1e-12
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		1e-12
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		2e-12
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		2e-12
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		2e-12
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		2e-12
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		2e-12
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-12
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		2e-12
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		2e-12
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		2e-12
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		2e-12
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		2e-12
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		2e-12
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		2e-12
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		2e-12
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		3e-12
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		3e-12
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		3e-12
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		3e-12
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		3e-12
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-12
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		4e-12
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		4e-12
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		4e-12
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		4e-12
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		5e-12
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		5e-12
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		5e-12
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		5e-12
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		5e-12
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		5e-12
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		5e-12
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		5e-12
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		5e-12
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		6e-12
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		6e-12
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		6e-12
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		6e-12
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		6e-12
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		7e-12
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		7e-12
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		7e-12
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		8e-12
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		8e-12
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		8e-12
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		8e-12
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		8e-12
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		8e-12
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		8e-12
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		9e-12
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		9e-12
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		9e-12
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		9e-12
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		9e-12
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		1e-11
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		1e-11
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		1e-11
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-11
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-11
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		1e-11
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		1e-11
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		1e-11
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-11
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-11
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-11
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-11
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		1e-11
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		1e-11
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		1e-11
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		1e-11
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		1e-11
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		1e-11
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		1e-11
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		1e-11
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		2e-11
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-11
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-11
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		2e-11
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		2e-11
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		2e-11
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		2e-11
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		2e-11
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		2e-11
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-11
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		2e-11
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		2e-11
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		2e-11
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		2e-11
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		2e-11
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-11
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		2e-11
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		2e-11
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		2e-11
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		2e-11
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		2e-11
4exu_A	371	Mapk13, Inactive Form Length = 371		3e-11
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		3e-11
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		3e-11
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		3e-11
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		3e-11
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		3e-11
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		3e-11
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		3e-11
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		3e-11
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		3e-11
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		3e-11
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		3e-11
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		3e-11
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		3e-11
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		3e-11
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		3e-11
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		3e-11
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-11
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		3e-11
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		3e-11
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		3e-11
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		3e-11
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		3e-11
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		3e-11
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		3e-11
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		3e-11
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		4e-11
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		4e-11
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		4e-11
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		4e-11
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		4e-11
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		4e-11
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		4e-11
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		4e-11
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		4e-11
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		4e-11
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		4e-11
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		4e-11
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		4e-11
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		5e-11
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		5e-11
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		5e-11
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		5e-11
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		5e-11
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		5e-11
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		6e-11
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		6e-11
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		6e-11
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		7e-11
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		7e-11
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		7e-11
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		7e-11
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		7e-11
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		8e-11
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		8e-11
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		8e-11
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		8e-11
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		9e-11
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		9e-11
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		9e-11
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		1e-10
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		1e-10
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-10
2oza_B	366	Structure Of P38alpha Complex Length = 366		1e-10
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		1e-10
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		1e-10
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		1e-10
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		1e-10
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		1e-10
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		1e-10
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		1e-10
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		1e-10
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		1e-10
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		1e-10
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		1e-10
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		1e-10
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		1e-10
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		1e-10
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		1e-10
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		1e-10
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		1e-10
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		1e-10
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		1e-10
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		1e-10
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		1e-10
3hec_A	348	P38 In Complex With Imatinib Length = 348		1e-10
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		1e-10
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		1e-10
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		1e-10
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-10
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		1e-10
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		1e-10
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		1e-10
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		1e-10
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		1e-10
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		1e-10
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		2e-10
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		2e-10
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-10
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		2e-10
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		2e-10
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		2e-10
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		2e-10
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		2e-10
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		2e-10
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		2e-10
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		2e-10
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		2e-10
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		2e-10
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		2e-10
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		2e-10
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		2e-10
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		2e-10
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		2e-10
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-10
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		2e-10
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-10
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		2e-10
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		2e-10
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		2e-10
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		2e-10
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		2e-10
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		2e-10
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		2e-10
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		2e-10
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		2e-10
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		2e-10
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		2e-10
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		2e-10
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		2e-10
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		2e-10
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		2e-10
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		2e-10
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		2e-10
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		2e-10
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		2e-10
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		2e-10
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		2e-10
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		2e-10
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		2e-10
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		2e-10
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		3e-10
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-10
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		3e-10
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		3e-10
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		3e-10
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		3e-10
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		3e-10
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		3e-10
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		3e-10
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		3e-10
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		3e-10
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		3e-10
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		3e-10
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		3e-10
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		3e-10
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		3e-10
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		3e-10
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		3e-10
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		3e-10
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		3e-10
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		3e-10
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		3e-10
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		3e-10
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		3e-10
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		3e-10
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		3e-10
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		4e-10
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		4e-10
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		4e-10
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		4e-10
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		4e-10
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		5e-10
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		5e-10
4fl3_A	635	Structural And Biophysical Characterization Of The		5e-10
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		5e-10
4fl2_A	636	Structural And Biophysical Characterization Of The		6e-10
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		6e-10
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		6e-10
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-10
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		7e-10
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		7e-10
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		7e-10
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		8e-10
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		8e-10
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		1e-09
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		1e-09
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		1e-09
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		1e-09
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		1e-09
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		1e-09
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		1e-09
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		1e-09
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-09
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		1e-09
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		1e-09
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		1e-09
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-09
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		2e-09
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		2e-09
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		2e-09
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		2e-09
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		2e-09
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		2e-09
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		2e-09
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		2e-09
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		2e-09
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		3e-09
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		3e-09
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		3e-09
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-09
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		3e-09
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		3e-09
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		3e-09
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		3e-09
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		3e-09
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		3e-09
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		3e-09
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		3e-09
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		3e-09
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		3e-09
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		3e-09
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-09
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		3e-09
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		3e-09
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		3e-09
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		3e-09
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		3e-09
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		3e-09
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		3e-09
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		3e-09
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		3e-09
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-09
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		4e-09
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		4e-09
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		4e-09
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		4e-09
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		5e-09
4fie_A	423	Full-Length Human Pak4 Length = 423		5e-09
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		5e-09
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		5e-09
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		5e-09
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		5e-09
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		6e-09
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		6e-09
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		6e-09
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		6e-09
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		6e-09
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		6e-09
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		7e-09
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		7e-09
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		8e-09
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		8e-09
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		9e-09
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		9e-09
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		9e-09
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		1e-08
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		1e-08
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		1e-08
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		1e-08
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		1e-08
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		1e-08
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		1e-08
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		1e-08
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		1e-08
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-08
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		2e-08
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		2e-08
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-08
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		2e-08
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		2e-08
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		2e-08
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-08
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		2e-08
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		2e-08
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		2e-08
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		2e-08
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		3e-08
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		3e-08
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		3e-08
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		3e-08
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		3e-08
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		3e-08
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		3e-08
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		3e-08
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		3e-08
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		3e-08
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		3e-08
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		3e-08
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		3e-08
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		3e-08
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		3e-08
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		3e-08
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		3e-08
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		3e-08
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		3e-08
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		3e-08
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		3e-08
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		3e-08
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		3e-08
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		3e-08
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		3e-08
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		4e-08
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		4e-08
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		4e-08
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		4e-08
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		4e-08
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		5e-08
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		6e-08
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		6e-08
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		6e-08
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		7e-08
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		7e-08
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		7e-08
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		8e-08
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		8e-08
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		9e-08
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		9e-08
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		9e-08
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		9e-08
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		1e-07
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		1e-07
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		1e-07
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		1e-07
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		1e-07
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		1e-07
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		1e-07
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		2e-07
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		2e-07
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		2e-07
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-07
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		2e-07
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		2e-07
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		2e-07
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		2e-07
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		2e-07
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-07
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		2e-07
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		2e-07
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		2e-07
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		2e-07
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-07
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-07
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-07
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		2e-07
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-07
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		2e-07
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		2e-07
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		2e-07
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		2e-07
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		2e-07
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		2e-07
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		2e-07
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		3e-07
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		3e-07
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		3e-07
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		3e-07
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		3e-07
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		3e-07
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		3e-07
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		3e-07
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		3e-07
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		4e-07
3g51_A	325	Structural Diversity Of The Active Conformation Of		4e-07
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		4e-07
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		4e-07
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		4e-07
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		4e-07
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		5e-07
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		5e-07
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		5e-07
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		5e-07
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		5e-07
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		5e-07
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		5e-07
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		5e-07
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		6e-07
3kk8_A	284	Camkii Substrate Complex A Length = 284		6e-07
3kk9_A	282	Camkii Substrate Complex B Length = 282		6e-07
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		6e-07
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		6e-07
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		6e-07
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		6e-07
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		6e-07
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		6e-07
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		7e-07
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		7e-07
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		7e-07
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		7e-07
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		7e-07
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		8e-07
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		8e-07
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		8e-07
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		8e-07
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		8e-07
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		8e-07
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		8e-07
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		8e-07
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		9e-07
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		1e-06
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		1e-06
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		1e-06
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		1e-06
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		1e-06
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		1e-06
3soa_A	444	Full-Length Human Camkii Length = 444		1e-06
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		1e-06
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		2e-06
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		2e-06
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		2e-06
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		2e-06
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		2e-06
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		2e-06
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		2e-06
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		2e-06
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		2e-06
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		2e-06
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		2e-06
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		2e-06
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		2e-06
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-06
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-06
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		2e-06
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		2e-06
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		2e-06
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		2e-06
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		2e-06
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		2e-06
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		2e-06
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		2e-06
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		2e-06
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		2e-06
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		2e-06
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		2e-06
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		2e-06
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		2e-06
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		2e-06
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		2e-06
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		2e-06
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		2e-06
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-06
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		2e-06
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		3e-06
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		3e-06
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		3e-06
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		3e-06
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		3e-06
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		4e-06
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		4e-06
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		4e-06
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		4e-06
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		5e-06
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		6e-06
3kmu_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		6e-06
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		6e-06
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		7e-06
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		7e-06
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		7e-06
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		8e-06
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		9e-06
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		9e-06
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		9e-06
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		1e-05
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-05
4ae6_A	343	Structure And Function Of The Human Sperm-specific		1e-05
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-05
4ae9_A	343	Structure And Function Of The Human Sperm-specific		2e-05
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		2e-05
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		2e-05
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		3e-05
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		3e-05
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		3e-05
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		4e-05
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		4e-05
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		4e-05
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		4e-05
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		4e-05
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		4e-05
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		4e-05
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		5e-05
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		5e-05
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		5e-05
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		7e-05
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		7e-05
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		7e-05
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		7e-05
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		8e-05
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		8e-05
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		8e-05
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		8e-05
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		8e-05
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		8e-05
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		8e-05
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		9e-05
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		9e-05
2oza_A	356	Structure Of P38alpha Complex Length = 356		9e-05
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		1e-04
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-04
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		1e-04
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-04
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		1e-04
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		1e-04
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		2e-04
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-04
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		2e-04
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		2e-04
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		2e-04
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		2e-04
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		2e-04
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		2e-04
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		2e-04
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		2e-04
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		2e-04
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		2e-04
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		2e-04
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		2e-04
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		2e-04
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		2e-04
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		2e-04
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		2e-04
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		3e-04
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		3e-04
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		3e-04
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		3e-04
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		3e-04
1how_A	373	The X-Ray Crystal Structure Of Sky1p, An Sr Protein		3e-04
1q8y_A	373	The Structure Of The Yeast Sr Protein Kinase, Sky1p		3e-04
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		3e-04
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		5e-04
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		5e-04
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		5e-04
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		6e-04

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  231 bits (590), Expect = 4e-61,   Method: Compositional matrix adjust.
 Identities = 130/301 (43%), Positives = 184/301 (61%), Gaps = 13/301 (4%)
Query: 56  FSFEEISIATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEI 115
           FS  E+ +A++ FS++N++GRGG+ +VYKG L DG  +AVKRL K       E +F TE+
Sbjct: 28  FSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRL-KEERXQGGELQFQTEV 86
Query: 116 GTIGHVCHPNVLSLLG-CCVDNGLYLIFQFSSRGSVASLFHDV--NSPGVEWKVRHKIAV 172
             I    H N+L L G C       L++ + + GSVAS   +   + P ++W  R +IA+
Sbjct: 87  EMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIAL 146
Query: 173 GTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEG 232
           G+ARGL YLH  C  +IIHRD+K++NILL  +FE  + DFGLAK +  +  H   A + G
Sbjct: 147 GSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXA-VRG 205
Query: 233 TFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQS------LHSWAKPILN 286
           T GH+APEY   G   EKTDVF +GV LLE+I+G++  D +  +      L  W K +L 
Sbjct: 206 TIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK 265
Query: 287 QGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEGDQIDKERW 346
           + ++E LVD  LQG Y   ++ +L   A LC ++SP  RP MSEV+  MLEGD +  ERW
Sbjct: 266 EKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVR-MLEGDGL-AERW 323
Query: 347 K 347
           +
Sbjct: 324 E 324

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  230 bits (586), Expect = 1e-60,   Method: Compositional matrix adjust.
 Identities = 128/301 (42%), Positives = 184/301 (61%), Gaps = 13/301 (4%)
Query: 56  FSFEEISIATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEI 115
           FS  E+ +A++ F ++N++GRGG+ +VYKG L DG  +AVKRL +  T    E +F TE+
Sbjct: 20  FSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQG-GELQFQTEV 78
Query: 116 GTIGHVCHPNVLSLLGCCVD-NGLYLIFQFSSRGSVASLFHDV--NSPGVEWKVRHKIAV 172
             I    H N+L L G C+      L++ + + GSVAS   +   + P ++W  R +IA+
Sbjct: 79  EMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIAL 138
Query: 173 GTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEG 232
           G+ARGL YLH  C  +IIHRD+K++NILL  +FE  + DFGLAK +  +  H   A + G
Sbjct: 139 GSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXA-VRG 197
Query: 233 TFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQS------LHSWAKPILN 286
             GH+APEY   G   EKTDVF +GV LLE+I+G++  D +  +      L  W K +L 
Sbjct: 198 XIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK 257
Query: 287 QGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEGDQIDKERW 346
           + ++E LVD  LQG Y   ++ +L   A LC ++SP  RP MSEV+  MLEGD +  ERW
Sbjct: 258 EKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVR-MLEGDGL-AERW 315
Query: 347 K 347
           +
Sbjct: 316 E 316

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  175 bits (443), Expect = 4e-44,   Method: Compositional matrix adjust.
 Identities = 106/276 (38%), Positives = 162/276 (58%), Gaps = 12/276 (4%)
Query: 64  ATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCH 123
           ATN F  + L+G G + +VYKGVL+DG ++A+KR T      +  +EF TEI T+    H
Sbjct: 37  ATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTP--ESSQGIEEFETEIETLSFCRH 94
Query: 124 PNVLSLLGCCVD-NGLYLIFQFSSRGSVASLFH--DVNSPGVEWKVRHKIAVGTARGLHY 180
           P+++SL+G C + N + LI+++   G++    +  D+ +  + W+ R +I +G ARGLHY
Sbjct: 95  PHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHY 154
Query: 181 LHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPE 240
           LH    R IIHRD+KS NILL  +F P+I+DFG++K        H    ++GT G++ PE
Sbjct: 155 LH---TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXVVKGTLGYIDPE 211
Query: 241 YFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGS----HQSLHSWAKPILNQGEIEKLVDP 296
           YF+ G + EK+DV++FGV L E++  R  +  S      +L  WA    N G++E++VDP
Sbjct: 212 YFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDP 271
Query: 297 RLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVL 332
            L        L +    A  C+  S   RP+M +VL
Sbjct: 272 NLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVL 307

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  174 bits (441), Expect = 7e-44,   Method: Compositional matrix adjust.
 Identities = 106/276 (38%), Positives = 162/276 (58%), Gaps = 12/276 (4%)
Query: 64  ATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCH 123
           ATN F  + L+G G + +VYKGVL+DG ++A+KR T      +  +EF TEI T+    H
Sbjct: 37  ATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTP--ESSQGIEEFETEIETLSFCRH 94
Query: 124 PNVLSLLGCCVD-NGLYLIFQFSSRGSVASLFH--DVNSPGVEWKVRHKIAVGTARGLHY 180
           P+++SL+G C + N + LI+++   G++    +  D+ +  + W+ R +I +G ARGLHY
Sbjct: 95  PHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHY 154
Query: 181 LHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPE 240
           LH    R IIHRD+KS NILL  +F P+I+DFG++K        H    ++GT G++ PE
Sbjct: 155 LH---TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVVKGTLGYIDPE 211
Query: 241 YFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGS----HQSLHSWAKPILNQGEIEKLVDP 296
           YF+ G + EK+DV++FGV L E++  R  +  S      +L  WA    N G++E++VDP
Sbjct: 212 YFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDP 271
Query: 297 RLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVL 332
            L        L +    A  C+  S   RP+M +VL
Sbjct: 272 NLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVL 307

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  136 bits (342), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 99/304 (32%), Positives = 157/304 (51%), Gaps = 19/304 (6%)
Query: 47  ETTKPTWRCFSFEEISIATNAFSSE------NLVGRGGYAEVYKGVLQDGEEIAVKRLTK 100
           E +   +  FSF E+   TN F         N +G GG+  VYKG + +   +AVK+L  
Sbjct: 6   EVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKLAA 64
Query: 101 VV--TDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVD-NGLYLIFQFSSRGSVASLFHDV 157
           +V  T +  +++F  EI  +    H N++ LLG   D + L L++ +   GS+      +
Sbjct: 65  MVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL 124
Query: 158 N-SPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAK 216
           + +P + W +R KIA G A G+++LH   +   IHRDIKS+NILL   F  +ISDFGLA+
Sbjct: 125 DGTPPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLAR 181
Query: 217 WLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQS 276
                      + I GT  ++APE  + G +  K+D+++FGV LLEII+G   VD   + 
Sbjct: 182 ASEKFAQTVMXSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDEHREP 240
Query: 277 ---LHSWAKPILNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLE 333
              L    +    +  IE  +D ++  A D T +  +   AS C+      RP + +V +
Sbjct: 241 QLLLDIKEEIEDEEKTIEDYIDKKMNDA-DSTSVEAMYSVASQCLHEKKNKRPDIKKVQQ 299
Query: 334 VMLE 337
           ++ E
Sbjct: 300 LLQE 303

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  135 bits (340), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 99/304 (32%), Positives = 156/304 (51%), Gaps = 19/304 (6%)
Query: 47  ETTKPTWRCFSFEEISIATNAFSSE------NLVGRGGYAEVYKGVLQDGEEIAVKRLTK 100
           E +   +  FSF E+   TN F         N +G GG+  VYKG + +   +AVK+L  
Sbjct: 6   EVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKLAA 64
Query: 101 VV--TDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVD-NGLYLIFQFSSRGSVASLFHDV 157
           +V  T +  +++F  EI  +    H N++ LLG   D + L L++ +   GS+      +
Sbjct: 65  MVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL 124
Query: 158 N-SPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAK 216
           + +P + W +R KIA G A G+++LH+      IHRDIKS+NILL   F  +ISDFGLA+
Sbjct: 125 DGTPPLSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLAR 181
Query: 217 WLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQS 276
                        I GT  ++APE  + G +  K+D+++FGV LLEII+G   VD   + 
Sbjct: 182 ASEKFAQTVMXXRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDEHREP 240
Query: 277 ---LHSWAKPILNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLE 333
              L    +    +  IE  +D ++  A D T +  +   AS C+      RP + +V +
Sbjct: 241 QLLLDIKEEIEDEEKTIEDYIDKKMNDA-DSTSVEAMYSVASQCLHEKKNKRPDIKKVQQ 299
Query: 334 VMLE 337
           ++ E
Sbjct: 300 LLQE 303

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  134 bits (337), Expect = 8e-32,   Method: Compositional matrix adjust.
 Identities = 98/298 (32%), Positives = 154/298 (51%), Gaps = 19/298 (6%)
Query: 53  WRCFSFEEISIATNAFSSE------NLVGRGGYAEVYKGVLQDGEEIAVKRLTKVV--TD 104
           +  FSF E+   TN F         N +G GG+  VYKG + +   +AVK+L  +V  T 
Sbjct: 6   FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITT 64
Query: 105 DRKEKEFLTEIGTIGHVCHPNVLSLLGCCVD-NGLYLIFQFSSRGSVASLFHDVN-SPGV 162
           +  +++F  EI  +    H N++ LLG   D + L L++ +   GS+      ++ +P +
Sbjct: 65  EELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPL 124
Query: 163 EWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQW 222
            W +R KIA G A G+++LH   +   IHRDIKS+NILL   F  +ISDFGLA+      
Sbjct: 125 SWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFA 181
Query: 223 THHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQS---LHS 279
                  I GT  ++APE  + G +  K+D+++FGV LLEII+G   VD   +    L  
Sbjct: 182 QXVMXXRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDI 240
Query: 280 WAKPILNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLE 337
             +    +  IE  +D ++  A D T +  +   AS C+      RP + +V +++ E
Sbjct: 241 KEEIEDEEKTIEDYIDKKMNDA-DSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQE 297

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  128 bits (322), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 98/298 (32%), Positives = 149/298 (50%), Gaps = 19/298 (6%)
Query: 53  WRCFSFEEISIATNAFSSE------NLVGRGGYAEVYKGVLQDGEEIAVKRLTKVV--TD 104
           +  FSF E+   TN F         N  G GG+  VYKG + +   +AVK+L  +V  T 
Sbjct: 3   FHSFSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITT 61
Query: 105 DRKEKEFLTEIGTIGHVCHPNVLSLLGCCVD-NGLYLIFQFSSRGSVASLFHDVN-SPGV 162
           +  +++F  EI       H N++ LLG   D + L L++ +   GS+      ++ +P +
Sbjct: 62  EELKQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPL 121
Query: 163 EWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQW 222
            W  R KIA G A G+++LH   +   IHRDIKS+NILL   F  +ISDFGLA+      
Sbjct: 122 SWHXRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFA 178
Query: 223 THHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQS---LHS 279
                + I GT  + APE  + G +  K+D+++FGV LLEII+G   VD   +    L  
Sbjct: 179 QXVXXSRIVGTTAYXAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDI 237
Query: 280 WAKPILNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLE 337
             +    +  IE  +D +   A D T +      AS C+      RP + +V +++ E
Sbjct: 238 KEEIEDEEKTIEDYIDKKXNDA-DSTSVEAXYSVASQCLHEKKNKRPDIKKVQQLLQE 294

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 77/275 (28%), Positives = 139/275 (50%), Gaps = 39/275 (14%)
Query: 71  ENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLL 130
           E +VGRG +  V K   +  +++A+K+    +  + + K F+ E+  +  V HPN++ L 
Sbjct: 14  EEVVGRGAFGVVCKAKWR-AKDVAIKQ----IESESERKAFIVELRQLSRVNHPNIVKLY 68
Query: 131 GCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIA--VGTARGLHYLHKGCQRR 188
           G C+ N + L+ +++  GS+ ++ H    P   +   H ++  +  ++G+ YLH    + 
Sbjct: 69  GACL-NPVCLVMEYAEGGSLYNVLHGAE-PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA 126
Query: 189 IIHRDIKSSNILLTADFEP-QISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIV 247
           +IHRD+K  N+LL A     +I DFG A  + +  T++     +G+   +APE F     
Sbjct: 127 LIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNN-----KGSAAWMAPEVFEGSNY 181
Query: 248 DEKTDVFAFGVFLLEIISGRKPVD--GSHQ-----SLHSWAKPILNQGEIEKLVDPRLQG 300
            EK DVF++G+ L E+I+ RKP D  G        ++H+  +P L    I+ L  P    
Sbjct: 182 SEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPL----IKNLPKP---- 233
Query: 301 AYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVM 335
                    +    + C    P+ RP+M E++++M
Sbjct: 234 ---------IESLMTRCWSKDPSQRPSMEEIVKIM 259

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 76/275 (27%), Positives = 138/275 (50%), Gaps = 39/275 (14%)
Query: 71  ENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLL 130
           E +VGRG +  V K   +  +++A+K+    +  + + K F+ E+  +  V HPN++ L 
Sbjct: 13  EEVVGRGAFGVVCKAKWR-AKDVAIKQ----IESESERKAFIVELRQLSRVNHPNIVKLY 67
Query: 131 GCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIA--VGTARGLHYLHKGCQRR 188
           G C+ N + L+ +++  GS+ ++ H    P   +   H ++  +  ++G+ YLH    + 
Sbjct: 68  GACL-NPVCLVMEYAEGGSLYNVLHGAE-PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA 125
Query: 189 IIHRDIKSSNILLTADFEP-QISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIV 247
           +IHRD+K  N+LL A     +I DFG A  + +  T++     +G+   +APE F     
Sbjct: 126 LIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNN-----KGSAAWMAPEVFEGSNY 180
Query: 248 DEKTDVFAFGVFLLEIISGRKPVD-------GSHQSLHSWAKPILNQGEIEKLVDPRLQG 300
            EK DVF++G+ L E+I+ RKP D           ++H+  +P L    I+ L  P    
Sbjct: 181 SEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPL----IKNLPKP---- 232
Query: 301 AYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVM 335
                    +    + C    P+ RP+M E++++M
Sbjct: 233 ---------IESLMTRCWSKDPSQRPSMEEIVKIM 258

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 72/273 (26%), Positives = 133/273 (48%), Gaps = 21/273 (7%)
Query: 68  FSSENLVGRGGYAEVYKGV-LQDGEEIAVKRLTKV-VTDDRKEKEFLTEIGTIGHVCHPN 125
           F  E  +GRG ++EVY+   L DG  +A+K++    + D +   + + EI  +  + HPN
Sbjct: 34  FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 93
Query: 126 VLSLLGCCV-DNGLYLIFQFSSRGSVASLFHDVNSPG--VEWKVRHKIAVGTARGLHYLH 182
           V+      + DN L ++ + +  G ++ +          +  +   K  V     L ++H
Sbjct: 94  VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH 153
Query: 183 KGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWT-HHSIAPIEGTFGHLAPEY 241
               RR++HRDIK +N+ +TA    ++ D GL ++  S+ T  HS+    GT  +++PE 
Sbjct: 154 ---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV---GTPYYMSPER 207
Query: 242 FMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGA 301
                 + K+D+++ G  L E+ + + P  G   +L+S  K      +IE+   P L   
Sbjct: 208 IHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCK------KIEQCDYPPLPSD 261
Query: 302 YDVTQLNRLAFAASLCIRASPTWRPTMSEVLEV 334
           +   +L +L    ++CI   P  RP ++ V +V
Sbjct: 262 HYSEELRQL---VNMCINPDPEKRPDVTYVYDV 291

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 98.2 bits (243), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 66/225 (29%), Positives = 112/225 (49%), Gaps = 37/225 (16%)
Query: 68  FSSENLVGRGGYAEVYKGVLQDGEEIAVKR--------LTKVVTDDRKEKEFLTEIGTIG 119
            + E ++G GG+ +VY+     G+E+AVK         +++ + + R+E +    +    
Sbjct: 9   LTLEEIIGIGGFGKVYRA-FWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLK--- 64
Query: 120 HVCHPNVLSLLGCCV-DNGLYLIFQFSSRGSVASLFHDVNSPG---VEWKVRHKIAVGTA 175
              HPN+++L G C+ +  L L+ +F+  G +  +      P    V W      AV  A
Sbjct: 65  ---HPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNW------AVQIA 115
Query: 176 RGLHYLHKGCQRRIIHRDIKSSNILLTADFEP--------QISDFGLAKWLPSQWTHHSI 227
           RG++YLH      IIHRD+KSSNIL+    E         +I+DFGLA+    +W   + 
Sbjct: 116 RGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR----EWHRTTK 171
Query: 228 APIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDG 272
               G +  +APE     +  + +DV+++GV L E+++G  P  G
Sbjct: 172 MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRG 216

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 66/202 (32%), Positives = 109/202 (53%), Gaps = 15/202 (7%)
Query: 74  VGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCC 133
           +G G +  VYKG      ++AVK L       ++ + F  E+G +    H N+L  +G  
Sbjct: 20  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 77
Query: 134 VDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRH--KIAVGTARGLHYLHKGCQRRIIH 191
               L ++ Q+   GS  SL+H +++   +++++    IA  TARG+ YLH    + IIH
Sbjct: 78  TKPQLAIVTQWCE-GS--SLYHHLHASETKFEMKKLIDIARQTARGMDYLHA---KSIIH 131
Query: 192 RDIKSSNILLTADFEPQISDFGLAKWLPSQWT-HHSIAPIEGTFGHLAPEYFMHGIVDE- 249
           RD+KS+NI L  D   +I DFGLA  + S+W+  H    + G+   +APE       +  
Sbjct: 132 RDLKSNNIFLHEDNTVKIGDFGLAT-VKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPY 190
Query: 250 --KTDVFAFGVFLLEIISGRKP 269
             ++DV+AFG+ L E+++G+ P
Sbjct: 191 SFQSDVYAFGIVLYELMTGQLP 212

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 95.1 bits (235), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 59/198 (29%), Positives = 105/198 (53%), Gaps = 6/198 (3%)
Query: 74  VGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCC 133
           +G G +  V++     G ++AVK L +      +  EFL E+  +  + HPN++  +G  
Sbjct: 45  IGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 134 VDN-GLYLIFQFSSRGSVASLFHDVNS-PGVEWKVRHKIAVGTARGLHYLHKGCQRRIIH 191
                L ++ ++ SRGS+  L H   +   ++ + R  +A   A+G++YLH      I+H
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR-NPPIVH 162
Query: 192 RDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKT 251
           RD+KS N+L+   +  ++ DFGL++   S +     A   GT   +APE       +EK+
Sbjct: 163 RDLKSPNLLVDKKYTVKVCDFGLSRLKASXFLXSKXA--AGTPEWMAPEVLRDEPSNEKS 220
Query: 252 DVFAFGVFLLEIISGRKP 269
           DV++FGV L E+ + ++P
Sbjct: 221 DVYSFGVILWELATLQQP 238

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 94.7 bits (234), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 66/202 (32%), Positives = 108/202 (53%), Gaps = 15/202 (7%)
Query: 74  VGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCC 133
           +G G +  VYKG      ++AVK L       ++ + F  E+G +    H N+L  +G  
Sbjct: 32  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 134 VDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRH--KIAVGTARGLHYLHKGCQRRIIH 191
               L ++ Q+   GS  SL+H +++   +++++    IA  TARG+ YLH    + IIH
Sbjct: 90  TKPQLAIVTQWCE-GS--SLYHHLHASETKFEMKKLIDIARQTARGMDYLHA---KSIIH 143
Query: 192 RDIKSSNILLTADFEPQISDFGLAKWLPSQWT-HHSIAPIEGTFGHLAPEYFMHGIVDE- 249
           RD+KS+NI L  D   +I DFGLA    S+W+  H    + G+   +APE       +  
Sbjct: 144 RDLKSNNIFLHEDNTVKIGDFGLAT-EKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPY 202
Query: 250 --KTDVFAFGVFLLEIISGRKP 269
             ++DV+AFG+ L E+++G+ P
Sbjct: 203 SFQSDVYAFGIVLYELMTGQLP 224

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 94.4 bits (233), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 106/205 (51%), Gaps = 16/205 (7%)
Query: 74  VGRGGYAEVYKGVLQDGE-EIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC 132
           +G G Y EVY+GV +     +AVK L +   D  + +EFL E   +  + HPN++ LLG 
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKE---DTMEVEEFLKEAAVMKEIKHPNLVQLLGV 82
Query: 133 CV-DNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIH 191
           C  +   Y+I +F + G++     + N   V   V   +A   +  + YL K   +  IH
Sbjct: 83  CTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK---KNFIH 139
Query: 192 RDIKSSNILLTADFEPQISDFGLAKWLPSQ-WTHHSIA--PIEGTFGHLAPEYFMHGIVD 248
           RD+ + N L+  +   +++DFGL++ +    +T H+ A  PI+ T    APE   +    
Sbjct: 140 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT----APESLAYNKFS 195
Query: 249 EKTDVFAFGVFLLEIIS-GRKPVDG 272
            K+DV+AFGV L EI + G  P  G
Sbjct: 196 IKSDVWAFGVLLWEIATYGMSPYPG 220

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 78/284 (27%), Positives = 137/284 (48%), Gaps = 35/284 (12%)
Query: 74  VGRGGYAEVYKGVLQDGE-EIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC 132
           +G G Y EVY+GV +     +AVK L +   D  + +EFL E   +  + HPN++ LLG 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKE---DTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 133 CV-DNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIH 191
           C  +   Y+I +F + G++     + N   V   V   +A   +  + YL K   +  IH
Sbjct: 78  CTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIH 134
Query: 192 RDIKSSNILLTADFEPQISDFGLAKWLPSQ-WTHHSIA--PIEGTFGHLAPEYFMHGIVD 248
           RD+ + N L+  +   +++DFGL++ +    +T H+ A  PI+ T    APE   +    
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT----APESLAYNKFS 190
Query: 249 EKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQL 307
            K+DV+AFGV L EI + G  P  G            ++  ++ +L++   +        
Sbjct: 191 IKSDVWAFGVLLWEIATYGMSPYPG------------IDLSQVYELLEKDYRMERPEGCP 238
Query: 308 NRLAFAASLCIRASPTWRPTMSEV---LEVMLE----GDQIDKE 344
            ++      C + +P+ RP+ +E+    E M +     D+++KE
Sbjct: 239 EKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKE 282

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 78/284 (27%), Positives = 137/284 (48%), Gaps = 35/284 (12%)
Query: 74  VGRGGYAEVYKGVLQDGE-EIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC 132
           +G G Y EVY+GV +     +AVK L +   D  + +EFL E   +  + HPN++ LLG 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKE---DTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 133 CV-DNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIH 191
           C  +   Y+I +F + G++     + N   V   V   +A   +  + YL K   +  IH
Sbjct: 78  CTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIH 134
Query: 192 RDIKSSNILLTADFEPQISDFGLAKWLPSQ-WTHHSIA--PIEGTFGHLAPEYFMHGIVD 248
           RD+ + N L+  +   +++DFGL++ +    +T H+ A  PI+ T    APE   +    
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT----APESLAYNKFS 190
Query: 249 EKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQL 307
            K+DV+AFGV L EI + G  P  G            ++  ++ +L++   +        
Sbjct: 191 IKSDVWAFGVLLWEIATYGMSPYPG------------IDLSQVYELLEKDYRMERPEGCP 238
Query: 308 NRLAFAASLCIRASPTWRPTMSEV---LEVMLE----GDQIDKE 344
            ++      C + +P+ RP+ +E+    E M +     D+++KE
Sbjct: 239 EKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKE 282

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 66/202 (32%), Positives = 108/202 (53%), Gaps = 15/202 (7%)
Query: 74  VGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCC 133
           +G G +  VYKG      ++AVK L       ++ + F  E+G +    H N+L  +G  
Sbjct: 32  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 134 VDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRH--KIAVGTARGLHYLHKGCQRRIIH 191
               L ++ Q+   GS  SL+H +++   +++++    IA  TARG+ YLH    + IIH
Sbjct: 90  TAPQLAIVTQWCE-GS--SLYHHLHASETKFEMKKLIDIARQTARGMDYLHA---KSIIH 143
Query: 192 RDIKSSNILLTADFEPQISDFGLAKWLPSQWT-HHSIAPIEGTFGHLAPEYFMHGIVDE- 249
           RD+KS+NI L  D   +I DFGLA    S+W+  H    + G+   +APE       +  
Sbjct: 144 RDLKSNNIFLHEDNTVKIGDFGLAT-EKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPY 202
Query: 250 --KTDVFAFGVFLLEIISGRKP 269
             ++DV+AFG+ L E+++G+ P
Sbjct: 203 SFQSDVYAFGIVLYELMTGQLP 224

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 78/284 (27%), Positives = 137/284 (48%), Gaps = 35/284 (12%)
Query: 74  VGRGGYAEVYKGVLQDGE-EIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC 132
           +G G Y EVY+GV +     +AVK L +   D  + +EFL E   +  + HPN++ LLG 
Sbjct: 34  LGGGQYGEVYEGVWKKYSLTVAVKTLKE---DTMEVEEFLKEAAVMKEIKHPNLVQLLGV 90
Query: 133 CV-DNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIH 191
           C  +   Y+I +F + G++     + N   V   V   +A   +  + YL K   +  IH
Sbjct: 91  CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK---KNFIH 147
Query: 192 RDIKSSNILLTADFEPQISDFGLAKWLPSQ-WTHHSIA--PIEGTFGHLAPEYFMHGIVD 248
           RD+ + N L+  +   +++DFGL++ +    +T H+ A  PI+ T    APE   +    
Sbjct: 148 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT----APESLAYNKFS 203
Query: 249 EKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQL 307
            K+DV+AFGV L EI + G  P  G            ++  ++ +L++   +        
Sbjct: 204 IKSDVWAFGVLLWEIATYGMSPYPG------------IDLSQVYELLEKDYRMERPEGCP 251
Query: 308 NRLAFAASLCIRASPTWRPTMSEV---LEVMLE----GDQIDKE 344
            ++      C + +P+ RP+ +E+    E M +     D+++KE
Sbjct: 252 EKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKE 295

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 78/284 (27%), Positives = 137/284 (48%), Gaps = 35/284 (12%)
Query: 74  VGRGGYAEVYKGVLQDGE-EIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC 132
           +G G Y EVY+GV +     +AVK L +   D  + +EFL E   +  + HPN++ LLG 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKE---DTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 133 CV-DNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIH 191
           C  +   Y+I +F + G++     + N   V   V   +A   +  + YL K   +  IH
Sbjct: 78  CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIH 134
Query: 192 RDIKSSNILLTADFEPQISDFGLAKWLPSQ-WTHHSIA--PIEGTFGHLAPEYFMHGIVD 248
           RD+ + N L+  +   +++DFGL++ +    +T H+ A  PI+ T    APE   +    
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT----APESLAYNKFS 190
Query: 249 EKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQL 307
            K+DV+AFGV L EI + G  P  G            ++  ++ +L++   +        
Sbjct: 191 IKSDVWAFGVLLWEIATYGMSPYPG------------IDLSQVYELLEKDYRMERPEGCP 238
Query: 308 NRLAFAASLCIRASPTWRPTMSEV---LEVMLE----GDQIDKE 344
            ++      C + +P+ RP+ +E+    E M +     D+++KE
Sbjct: 239 EKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKE 282

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 106/205 (51%), Gaps = 16/205 (7%)
Query: 74  VGRGGYAEVYKGVLQDGE-EIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC 132
           +G G Y EVY+GV +     +AVK L +   D  + +EFL E   +  + HPN++ LLG 
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKE---DTMEVEEFLKEAAVMKEIKHPNLVQLLGV 82
Query: 133 CV-DNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIH 191
           C  +   Y+I +F + G++     + N   V   V   +A   +  + YL K   +  IH
Sbjct: 83  CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK---KNFIH 139
Query: 192 RDIKSSNILLTADFEPQISDFGLAKWLPSQ-WTHHSIA--PIEGTFGHLAPEYFMHGIVD 248
           RD+ + N L+  +   +++DFGL++ +    +T H+ A  PI+ T    APE   +    
Sbjct: 140 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT----APESLAYNKFS 195
Query: 249 EKTDVFAFGVFLLEIIS-GRKPVDG 272
            K+DV+AFGV L EI + G  P  G
Sbjct: 196 IKSDVWAFGVLLWEIATYGMSPYPG 220

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 78/284 (27%), Positives = 137/284 (48%), Gaps = 35/284 (12%)
Query: 74  VGRGGYAEVYKGVLQDGE-EIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC 132
           +G G Y EVY+GV +     +AVK L +   D  + +EFL E   +  + HPN++ LLG 
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKE---DTMEVEEFLKEAAVMKEIKHPNLVQLLGV 82
Query: 133 CV-DNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIH 191
           C  +   Y+I +F + G++     + N   V   V   +A   +  + YL K   +  IH
Sbjct: 83  CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIH 139
Query: 192 RDIKSSNILLTADFEPQISDFGLAKWLPSQ-WTHHSIA--PIEGTFGHLAPEYFMHGIVD 248
           RD+ + N L+  +   +++DFGL++ +    +T H+ A  PI+ T    APE   +    
Sbjct: 140 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT----APESLAYNKFS 195
Query: 249 EKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQL 307
            K+DV+AFGV L EI + G  P  G            ++  ++ +L++   +        
Sbjct: 196 IKSDVWAFGVLLWEIATYGMSPYPG------------IDLSQVYELLEKDYRMERPEGCP 243
Query: 308 NRLAFAASLCIRASPTWRPTMSEV---LEVMLE----GDQIDKE 344
            ++      C + +P+ RP+ +E+    E M +     D+++KE
Sbjct: 244 EKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKE 287

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 78/284 (27%), Positives = 137/284 (48%), Gaps = 35/284 (12%)
Query: 74  VGRGGYAEVYKGVLQDGE-EIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC 132
           +G G Y EVY+GV +     +AVK L +   D  + +EFL E   +  + HPN++ LLG 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKE---DTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 133 CV-DNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIH 191
           C  +   Y+I +F + G++     + N   V   V   +A   +  + YL K   +  IH
Sbjct: 78  CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIH 134
Query: 192 RDIKSSNILLTADFEPQISDFGLAKWLPSQ-WTHHSIA--PIEGTFGHLAPEYFMHGIVD 248
           RD+ + N L+  +   +++DFGL++ +    +T H+ A  PI+ T    APE   +    
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT----APESLAYNKFS 190
Query: 249 EKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQL 307
            K+DV+AFGV L EI + G  P  G            ++  ++ +L++   +        
Sbjct: 191 IKSDVWAFGVLLWEIATYGMSPYPG------------IDLSQVYELLEKDYRMERPEGCP 238
Query: 308 NRLAFAASLCIRASPTWRPTMSEV---LEVMLE----GDQIDKE 344
            ++      C + +P+ RP+ +E+    E M +     D+++KE
Sbjct: 239 EKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKE 282

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 78/284 (27%), Positives = 137/284 (48%), Gaps = 35/284 (12%)
Query: 74  VGRGGYAEVYKGVLQDGE-EIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC 132
           +G G Y EVY+GV +     +AVK L +   D  + +EFL E   +  + HPN++ LLG 
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKE---DTMEVEEFLKEAAVMKEIKHPNLVQLLGV 82
Query: 133 CV-DNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIH 191
           C  +   Y+I +F + G++     + N   V   V   +A   +  + YL K   +  IH
Sbjct: 83  CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK---KNFIH 139
Query: 192 RDIKSSNILLTADFEPQISDFGLAKWLPSQ-WTHHSIA--PIEGTFGHLAPEYFMHGIVD 248
           RD+ + N L+  +   +++DFGL++ +    +T H+ A  PI+ T    APE   +    
Sbjct: 140 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT----APESLAYNKFS 195
Query: 249 EKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQL 307
            K+DV+AFGV L EI + G  P  G            ++  ++ +L++   +        
Sbjct: 196 IKSDVWAFGVLLWEIATYGMSPYPG------------IDLSQVYELLEKDYRMERPEGCP 243
Query: 308 NRLAFAASLCIRASPTWRPTMSEV---LEVMLE----GDQIDKE 344
            ++      C + +P+ RP+ +E+    E M +     D+++KE
Sbjct: 244 EKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKE 287

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 106/205 (51%), Gaps = 16/205 (7%)
Query: 74  VGRGGYAEVYKGVLQDGE-EIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC 132
           +G G Y EVY+GV +     +AVK L +   D  + +EFL E   +  + HPN++ LLG 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKE---DTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 133 CV-DNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIH 191
           C  +   Y+I +F + G++     + N   V   V   +A   +  + YL K   +  IH
Sbjct: 78  CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK---KNFIH 134
Query: 192 RDIKSSNILLTADFEPQISDFGLAKWLPSQ-WTHHSIA--PIEGTFGHLAPEYFMHGIVD 248
           RD+ + N L+  +   +++DFGL++ +    +T H+ A  PI+ T    APE   +    
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT----APESLAYNKFS 190
Query: 249 EKTDVFAFGVFLLEIIS-GRKPVDG 272
            K+DV+AFGV L EI + G  P  G
Sbjct: 191 IKSDVWAFGVLLWEIATYGMSPYPG 215

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 78/284 (27%), Positives = 137/284 (48%), Gaps = 35/284 (12%)
Query: 74  VGRGGYAEVYKGVLQDGE-EIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC 132
           +G G Y EVY+GV +     +AVK L +   D  + +EFL E   +  + HPN++ LLG 
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKE---DTMEVEEFLKEAAVMKEIKHPNLVQLLGV 79
Query: 133 CV-DNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIH 191
           C  +   Y+I +F + G++     + N   V   V   +A   +  + YL K   +  IH
Sbjct: 80  CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK---KNFIH 136
Query: 192 RDIKSSNILLTADFEPQISDFGLAKWLPSQ-WTHHSIA--PIEGTFGHLAPEYFMHGIVD 248
           RD+ + N L+  +   +++DFGL++ +    +T H+ A  PI+ T    APE   +    
Sbjct: 137 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT----APESLAYNKFS 192
Query: 249 EKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQL 307
            K+DV+AFGV L EI + G  P  G            ++  ++ +L++   +        
Sbjct: 193 IKSDVWAFGVLLWEIATYGMSPYPG------------IDLSQVYELLEKDYRMERPEGCP 240
Query: 308 NRLAFAASLCIRASPTWRPTMSEV---LEVMLE----GDQIDKE 344
            ++      C + +P+ RP+ +E+    E M +     D+++KE
Sbjct: 241 EKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKE 284

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 106/205 (51%), Gaps = 16/205 (7%)
Query: 74  VGRGGYAEVYKGVLQDGE-EIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC 132
           +G G Y EVY+GV +     +AVK L +   D  + +EFL E   +  + HPN++ LLG 
Sbjct: 25  LGGGQYGEVYEGVWKKYSLTVAVKTLKE---DTMEVEEFLKEAAVMKEIKHPNLVQLLGV 81
Query: 133 CV-DNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIH 191
           C  +   Y+I +F + G++     + N   V   V   +A   +  + YL K   +  IH
Sbjct: 82  CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK---KNFIH 138
Query: 192 RDIKSSNILLTADFEPQISDFGLAKWLPSQ-WTHHSIA--PIEGTFGHLAPEYFMHGIVD 248
           RD+ + N L+  +   +++DFGL++ +    +T H+ A  PI+ T    APE   +    
Sbjct: 139 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT----APESLAYNKFS 194
Query: 249 EKTDVFAFGVFLLEIIS-GRKPVDG 272
            K+DV+AFGV L EI + G  P  G
Sbjct: 195 IKSDVWAFGVLLWEIATYGMSPYPG 219

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 78/284 (27%), Positives = 137/284 (48%), Gaps = 35/284 (12%)
Query: 74  VGRGGYAEVYKGVLQDGE-EIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC 132
           +G G Y EVY+GV +     +AVK L +   D  + +EFL E   +  + HPN++ LLG 
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKE---DTMEVEEFLKEAAVMKEIKHPNLVQLLGV 79
Query: 133 CV-DNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIH 191
           C  +   Y+I +F + G++     + N   V   V   +A   +  + YL K   +  IH
Sbjct: 80  CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK---KNFIH 136
Query: 192 RDIKSSNILLTADFEPQISDFGLAKWLPSQ-WTHHSIA--PIEGTFGHLAPEYFMHGIVD 248
           RD+ + N L+  +   +++DFGL++ +    +T H+ A  PI+ T    APE   +    
Sbjct: 137 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT----APESLAYNKFS 192
Query: 249 EKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQL 307
            K+DV+AFGV L EI + G  P  G            ++  ++ +L++   +        
Sbjct: 193 IKSDVWAFGVLLWEIATYGMSPYPG------------IDLSQVYELLEKDYRMERPEGCP 240
Query: 308 NRLAFAASLCIRASPTWRPTMSEV---LEVMLE----GDQIDKE 344
            ++      C + +P+ RP+ +E+    E M +     D+++KE
Sbjct: 241 EKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKE 284

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 105/198 (53%), Gaps = 6/198 (3%)
Query: 74  VGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCC 133
           +G G +  V++     G ++AVK L +      +  EFL E+  +  + HPN++  +G  
Sbjct: 45  IGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 134 VDN-GLYLIFQFSSRGSVASLFHDVNS-PGVEWKVRHKIAVGTARGLHYLHKGCQRRIIH 191
                L ++ ++ SRGS+  L H   +   ++ + R  +A   A+G++YLH      I+H
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR-NPPIVH 162
Query: 192 RDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKT 251
           R++KS N+L+   +  ++ DFGL++   S +     A   GT   +APE       +EK+
Sbjct: 163 RNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSA--AGTPEWMAPEVLRDEPSNEKS 220
Query: 252 DVFAFGVFLLEIISGRKP 269
           DV++FGV L E+ + ++P
Sbjct: 221 DVYSFGVILWELATLQQP 238

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 79/302 (26%), Positives = 144/302 (47%), Gaps = 35/302 (11%)
Query: 56  FSFEEISIATNAFSSENLVGRGGYAEVYKGVLQDGE-EIAVKRLTKVVTDDRKEKEFLTE 114
            S ++  +     + ++ +G G Y EVY+GV +     +AVK L +   D  + +EFL E
Sbjct: 1   MSLDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE---DTMEVEEFLKE 57
Query: 115 IGTIGHVCHPNVLSLLGCCV-DNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVG 173
              +  + HPN++ LLG C  +   Y+I +F + G++     + N   V   V   +A  
Sbjct: 58  AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQ 117
Query: 174 TARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQ-WTHHSIA--PI 230
            +  + YL K   +  IHRD+ + N L+  +   +++DFGL++ +    +T H+ A  PI
Sbjct: 118 ISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKFPI 174
Query: 231 EGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGE 289
           + T    APE   +     K+DV+AFGV L EI + G  P  G            ++  +
Sbjct: 175 KWT----APESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG------------IDPSQ 218
Query: 290 IEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEV---LEVMLE----GDQID 342
           + +L++   +         ++      C + +P+ RP+ +E+    E M +     D+++
Sbjct: 219 VYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVE 278
Query: 343 KE 344
           KE
Sbjct: 279 KE 280

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 106/205 (51%), Gaps = 16/205 (7%)
Query: 74  VGRGGYAEVYKGVLQDGE-EIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC 132
           +G G Y EVY+GV +     +AVK L +   D  + +EFL E   +  + HPN++ LLG 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKE---DTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 133 CV-DNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIH 191
           C  +   Y+I +F + G++     + N   V   V   +A   +  + YL K   +  IH
Sbjct: 78  CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK---KNFIH 134
Query: 192 RDIKSSNILLTADFEPQISDFGLAKWLPSQ-WTHHSIA--PIEGTFGHLAPEYFMHGIVD 248
           RD+ + N L+  +   +++DFGL++ +    +T H+ A  PI+ T    APE   +    
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT----APESLAYNKFS 190
Query: 249 EKTDVFAFGVFLLEIIS-GRKPVDG 272
            K+DV+AFGV L EI + G  P  G
Sbjct: 191 IKSDVWAFGVLLWEIATYGMSPYPG 215

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 78/284 (27%), Positives = 136/284 (47%), Gaps = 35/284 (12%)
Query: 74  VGRGGYAEVYKGVLQDGE-EIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC 132
           +G G Y EVY+GV +     +AVK L +   D  + +EFL E   +  + HPN++ LLG 
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLKE---DTMEVEEFLKEAAVMKEIKHPNLVQLLGV 78
Query: 133 CV-DNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIH 191
           C  +   Y+I +F + G++     + N   V   V   +A   +  + YL K   +  IH
Sbjct: 79  CTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK---KNFIH 135
Query: 192 RDIKSSNILLTADFEPQISDFGLAKWLPSQ-WTHHSIA--PIEGTFGHLAPEYFMHGIVD 248
           RD+ + N L+  +   +++DFGL++ +     T H+ A  PI+ T    APE   +    
Sbjct: 136 RDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWT----APESLAYNKFS 191
Query: 249 EKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQL 307
            K+DV+AFGV L EI + G  P  G            ++  ++ +L++   +        
Sbjct: 192 IKSDVWAFGVLLWEIATYGMSPYPG------------IDLSQVYELLEKDYRMERPEGCP 239
Query: 308 NRLAFAASLCIRASPTWRPTMSEV---LEVMLE----GDQIDKE 344
            ++      C + +P+ RP+ +E+    E M +     D+++KE
Sbjct: 240 EKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKE 283

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 105/205 (51%), Gaps = 16/205 (7%)
Query: 74  VGRGGYAEVYKGVLQDGE-EIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC 132
           +G G Y EVY+GV +     +AVK L +   D  + +EFL E   +  + HPN++ LLG 
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLKE---DTMEVEEFLKEAAVMKEIKHPNLVQLLGV 75
Query: 133 CV-DNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIH 191
           C  +   Y+I +F + G++     + N   V   V   +A   +  + YL K   +  IH
Sbjct: 76  CTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIH 132
Query: 192 RDIKSSNILLTADFEPQISDFGLAKWLPSQ-WTHHSIA--PIEGTFGHLAPEYFMHGIVD 248
           RD+ + N L+  +   +++DFGL++ +     T H+ A  PI+ T    APE   +    
Sbjct: 133 RDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWT----APESLAYNKFS 188
Query: 249 EKTDVFAFGVFLLEIIS-GRKPVDG 272
            K+DV+AFGV L EI + G  P  G
Sbjct: 189 IKSDVWAFGVLLWEIATYGMSPYPG 213

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 77/294 (26%), Positives = 136/294 (46%), Gaps = 40/294 (13%)
Query: 62  SIATNAFSSENLVGRGGYAEVYKG-VLQDGEEIAVKRLTKVVTDDRKE-------KEFLT 113
           ++A N    E  +G+GG+  V+KG +++D   +A+K L  ++ D   E       +EF  
Sbjct: 15  TLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSL--ILGDSEGETEMIEKFQEFQR 72
Query: 114 EIGTIGHVCHPNVLSLLGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVG 173
           E+  + ++ HPN++ L G  + N   ++ +F   G +     D   P ++W V+ ++ + 
Sbjct: 73  EVFIMSNLNHPNIVKLYG-LMHNPPRMVMEFVPCGDLYHRLLDKAHP-IKWSVKLRLMLD 130
Query: 174 TARGLHYLHKGCQRRIIHRDIKSSNILL-----TADFEPQISDFGLAKWLPSQWTHHSIA 228
            A G+ Y+ +     I+HRD++S NI L      A    +++DFGL     SQ + HS++
Sbjct: 131 IALGIEYM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGL-----SQQSVHSVS 184
Query: 229 PIEGTFGHLAPEYF--MHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILN 286
            + G F  +APE          EK D ++F + L  I++G  P D        +   I  
Sbjct: 185 GLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIRE 244
Query: 287 QG---EIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLE 337
           +G    I +   PRL+   +            LC    P  RP  S +++ + E
Sbjct: 245 EGLRPTIPEDCPPRLRNVIE------------LCWSGDPKKRPHFSYIVKELSE 286

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 105/205 (51%), Gaps = 16/205 (7%)
Query: 74  VGRGGYAEVYKGVLQDGE-EIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC 132
           +G G Y EVY+GV +     +AVK L +   D  + +EFL E   +  + HPN++ LLG 
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKE---DTMEVEEFLKEAAVMKEIKHPNLVQLLGV 82
Query: 133 CV-DNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIH 191
           C  +   Y+I +F + G++     + N   V   V   +A   +  + YL K   +  IH
Sbjct: 83  CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK---KNFIH 139
Query: 192 RDIKSSNILLTADFEPQISDFGLAKWLPSQ-WTHHSIA--PIEGTFGHLAPEYFMHGIVD 248
           RD+ + N L+  +   +++DFGL++ +     T H+ A  PI+ T    APE   +    
Sbjct: 140 RDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWT----APESLAYNKFS 195
Query: 249 EKTDVFAFGVFLLEIIS-GRKPVDG 272
            K+DV+AFGV L EI + G  P  G
Sbjct: 196 IKSDVWAFGVLLWEIATYGMSPYPG 220

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 74/281 (26%), Positives = 133/281 (47%), Gaps = 29/281 (10%)
Query: 74  VGRGGYAEVYKGVLQDGE-EIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC 132
           +G G Y EVY+GV +     +AVK L +   D  + +EFL E   +  + HPN++ LLG 
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLKE---DTMEVEEFLKEAAVMKEIKHPNLVQLLGV 78
Query: 133 CV-DNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIH 191
           C  +   Y+I +F + G++     + N   V   V   +A   +  + YL K   +  IH
Sbjct: 79  CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK---KNFIH 135
Query: 192 RDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKT 251
           RD+ + N L+  +   +++DFGL++ +    T+ + A  +      APE   +     K+
Sbjct: 136 RDLAARNCLVGENHLVKVADFGLSRLMTGD-TYTAPAGAKFPIKWTAPESLAYNKFSIKS 194
Query: 252 DVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQLNRL 310
           DV+AFGV L EI + G  P  G            ++  ++ +L++   +         ++
Sbjct: 195 DVWAFGVLLWEIATYGMSPYPG------------IDLSQVYELLEKDYRMERPEGCPEKV 242
Query: 311 AFAASLCIRASPTWRPTMSEV---LEVMLE----GDQIDKE 344
                 C + +P+ RP+ +E+    E M +     D+++KE
Sbjct: 243 YELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKE 283

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 77/284 (27%), Positives = 137/284 (48%), Gaps = 35/284 (12%)
Query: 74  VGRGGYAEVYKGVLQDGE-EIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC 132
           +G G Y EVY+GV +     +AVK L +   D  + +EFL E   +  + HPN++ LLG 
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTLKE---DTMEVEEFLKEAAVMKEIKHPNLVQLLGV 284
Query: 133 CV-DNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIH 191
           C  +   Y+I +F + G++     + N   V   V   +A   +  + YL K   +  IH
Sbjct: 285 CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIH 341
Query: 192 RDIKSSNILLTADFEPQISDFGLAKWLPSQ-WTHHSIA--PIEGTFGHLAPEYFMHGIVD 248
           R++ + N L+  +   +++DFGL++ +    +T H+ A  PI+ T    APE   +    
Sbjct: 342 RNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT----APESLAYNKFS 397
Query: 249 EKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQL 307
            K+DV+AFGV L EI + G  P  G            ++  ++ +L++   +        
Sbjct: 398 IKSDVWAFGVLLWEIATYGMSPYPG------------IDLSQVYELLEKDYRMERPEGCP 445
Query: 308 NRLAFAASLCIRASPTWRPTMSEV---LEVMLE----GDQIDKE 344
            ++      C + +P+ RP+ +E+    E M +     D+++KE
Sbjct: 446 EKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKE 489

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 68/228 (29%), Positives = 117/228 (51%), Gaps = 14/228 (6%)
Query: 68  FSSENLVGRGGYAEVYKGV-LQDGEEI----AVKRLTKVVTDDRKEKEFLTEIGTIGHVC 122
           F    ++G G +  VYKG+ + +GE++    A+K L +  T  +  KE L E   +  V 
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVD 77
Query: 123 HPNVLSLLGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLH 182
           +P+V  LLG C+ + + LI Q    G +     + +   +  +      V  A+G++YL 
Sbjct: 78  NPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLE 136
Query: 183 KGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYF 242
               RR++HRD+ + N+L+      +I+DFGLAK L ++   +     +     +A E  
Sbjct: 137 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 193
Query: 243 MHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGE 289
           +H I   ++DV+++GV + E+++ G KP DG   S  S    IL +GE
Sbjct: 194 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS---SILEKGE 238

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 74/281 (26%), Positives = 133/281 (47%), Gaps = 29/281 (10%)
Query: 74  VGRGGYAEVYKGVLQDGE-EIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC 132
           +G G Y EVY+GV +     +AVK L +   D  + +EFL E   +  + HPN++ LLG 
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKE---DTMEVEEFLKEAAVMKEIKHPNLVQLLGV 79
Query: 133 CV-DNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIH 191
           C  +   Y+I +F + G++     + N   V   V   +A   +  + YL K   +  IH
Sbjct: 80  CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK---KNFIH 136
Query: 192 RDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKT 251
           RD+ + N L+  +   +++DFGL++ +    T+ + A  +      APE   +     K+
Sbjct: 137 RDLAARNCLVGENHLVKVADFGLSRLMTGD-TYTAPAGAKFPIKWTAPESLAYNKFSIKS 195
Query: 252 DVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQLNRL 310
           DV+AFGV L EI + G  P  G            ++  ++ +L++   +         ++
Sbjct: 196 DVWAFGVLLWEIATYGMSPYPG------------IDLSQVYELLEKDYRMERPEGCPEKV 243
Query: 311 AFAASLCIRASPTWRPTMSEV---LEVMLE----GDQIDKE 344
                 C + +P+ RP+ +E+    E M +     D+++KE
Sbjct: 244 YELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKE 284

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 69/229 (30%), Positives = 120/229 (52%), Gaps = 16/229 (6%)
Query: 68  FSSENLVGRGGYAEVYKGV-LQDGEEI----AVKRLTKVVTDDRKEKEFLTEIGTIGHVC 122
           F    ++G G +  VYKG+ + +GE++    A+K L +  T  +  KE L E   +  V 
Sbjct: 18  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVD 76
Query: 123 HPNVLSLLGCCVDNGLYLIFQFSSRGSVASLFHD-VNSPGVEWKVRHKIAVGTARGLHYL 181
           +P+V  LLG C+ + + LI Q    G +     +  ++ G ++ +     V  A+G++YL
Sbjct: 77  NPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNW--CVQIAKGMNYL 134
Query: 182 HKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEY 241
                RR++HRD+ + N+L+      +I+DFGLAK L ++   +     +     +A E 
Sbjct: 135 E---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 191
Query: 242 FMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGE 289
            +H I   ++DV+++GV + E+++ G KP DG   S  S    IL +GE
Sbjct: 192 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS---SILEKGE 237

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 68/228 (29%), Positives = 117/228 (51%), Gaps = 14/228 (6%)
Query: 68  FSSENLVGRGGYAEVYKGV-LQDGEEI----AVKRLTKVVTDDRKEKEFLTEIGTIGHVC 122
           F    ++G G +  VYKG+ + +GE++    A+K L +  T  +  KE L E   +  V 
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVD 78
Query: 123 HPNVLSLLGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLH 182
           +P+V  LLG C+ + + LI Q    G +     + +   +  +      V  A+G++YL 
Sbjct: 79  NPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLE 137
Query: 183 KGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYF 242
               RR++HRD+ + N+L+      +I+DFGLAK L ++   +     +     +A E  
Sbjct: 138 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 194
Query: 243 MHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGE 289
           +H I   ++DV+++GV + E+++ G KP DG   S  S    IL +GE
Sbjct: 195 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS---SILEKGE 239

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 69/229 (30%), Positives = 120/229 (52%), Gaps = 16/229 (6%)
Query: 68  FSSENLVGRGGYAEVYKGV-LQDGEEI----AVKRLTKVVTDDRKEKEFLTEIGTIGHVC 122
           F    ++G G +  VYKG+ + +GE++    A+K L +  T  +  KE L E   +  V 
Sbjct: 18  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVD 76
Query: 123 HPNVLSLLGCCVDNGLYLIFQFSSRGSVASLFHD-VNSPGVEWKVRHKIAVGTARGLHYL 181
           +P+V  LLG C+ + + LI Q    G +     +  ++ G ++ +     V  A+G++YL
Sbjct: 77  NPHVCRLLGICLTSTVQLIMQLMPFGXLLDYVREHKDNIGSQYLLNW--CVQIAKGMNYL 134
Query: 182 HKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEY 241
                RR++HRD+ + N+L+      +I+DFGLAK L ++   +     +     +A E 
Sbjct: 135 E---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 191
Query: 242 FMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGE 289
            +H I   ++DV+++GV + E+++ G KP DG   S  S    IL +GE
Sbjct: 192 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS---SILEKGE 237

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 91.3 bits (225), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 102/200 (51%), Gaps = 11/200 (5%)
Query: 74  VGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCC 133
           +G G +  VYKG      ++AVK L       ++ + F  E+G +    H N+L  +G  
Sbjct: 21  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 78
Query: 134 VDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRD 193
               L ++ Q+    S+    H + +     K+   IA  TA+G+ YLH    + IIHRD
Sbjct: 79  TKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLI-DIARQTAQGMDYLHA---KSIIHRD 134
Query: 194 IKSSNILLTADFEPQISDFGLAKWLPSQWT-HHSIAPIEGTFGHLAPEYFMHGIVDE--- 249
           +KS+NI L  D   +I DFGLA  + S+W+  H    + G+   +APE       +    
Sbjct: 135 LKSNNIFLHEDLTVKIGDFGLAT-VKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 193
Query: 250 KTDVFAFGVFLLEIISGRKP 269
           ++DV+AFG+ L E+++G+ P
Sbjct: 194 QSDVYAFGIVLYELMTGQLP 213

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 91.3 bits (225), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 69/229 (30%), Positives = 120/229 (52%), Gaps = 16/229 (6%)
Query: 68  FSSENLVGRGGYAEVYKGV-LQDGEEI----AVKRLTKVVTDDRKEKEFLTEIGTIGHVC 122
           F    ++G G +  VYKG+ + +GE++    A+K L +  T  +  KE L E   +  V 
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVD 75
Query: 123 HPNVLSLLGCCVDNGLYLIFQFSSRGSVASLFHD-VNSPGVEWKVRHKIAVGTARGLHYL 181
           +P+V  LLG C+ + + LI Q    G +     +  ++ G ++ +     V  A+G++YL
Sbjct: 76  NPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNW--CVQIAKGMNYL 133
Query: 182 HKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEY 241
                RR++HRD+ + N+L+      +I+DFGLAK L ++   +     +     +A E 
Sbjct: 134 E---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 190
Query: 242 FMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGE 289
            +H I   ++DV+++GV + E+++ G KP DG   S  S    IL +GE
Sbjct: 191 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS---SILEKGE 236

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 91.3 bits (225), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 102/200 (51%), Gaps = 11/200 (5%)
Query: 74  VGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCC 133
           +G G +  VYKG      ++AVK L       ++ + F  E+G +    H N+L  +G  
Sbjct: 43  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 100
Query: 134 VDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRD 193
               L ++ Q+    S+    H + +     K+   IA  TA+G+ YLH    + IIHRD
Sbjct: 101 TKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLI-DIARQTAQGMDYLHA---KSIIHRD 156
Query: 194 IKSSNILLTADFEPQISDFGLAKWLPSQWT-HHSIAPIEGTFGHLAPEYFMHGIVDE--- 249
           +KS+NI L  D   +I DFGLA  + S+W+  H    + G+   +APE       +    
Sbjct: 157 LKSNNIFLHEDLTVKIGDFGLAT-VKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 215
Query: 250 KTDVFAFGVFLLEIISGRKP 269
           ++DV+AFG+ L E+++G+ P
Sbjct: 216 QSDVYAFGIVLYELMTGQLP 235

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 91.3 bits (225), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 102/200 (51%), Gaps = 11/200 (5%)
Query: 74  VGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCC 133
           +G G +  VYKG      ++AVK L       ++ + F  E+G +    H N+L  +G  
Sbjct: 18  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 75
Query: 134 VDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRD 193
               L ++ Q+    S+    H + +     K+   IA  TA+G+ YLH    + IIHRD
Sbjct: 76  TKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLI-DIARQTAQGMDYLHA---KSIIHRD 131
Query: 194 IKSSNILLTADFEPQISDFGLAKWLPSQWT-HHSIAPIEGTFGHLAPEYFMHGIVDE--- 249
           +KS+NI L  D   +I DFGLA  + S+W+  H    + G+   +APE       +    
Sbjct: 132 LKSNNIFLHEDLTVKIGDFGLAT-VKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 190
Query: 250 KTDVFAFGVFLLEIISGRKP 269
           ++DV+AFG+ L E+++G+ P
Sbjct: 191 QSDVYAFGIVLYELMTGQLP 210

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 91.3 bits (225), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 69/229 (30%), Positives = 120/229 (52%), Gaps = 16/229 (6%)
Query: 68  FSSENLVGRGGYAEVYKGV-LQDGEEI----AVKRLTKVVTDDRKEKEFLTEIGTIGHVC 122
           F    ++G G +  VYKG+ + +GE++    A+K L +  T  +  KE L E   +  V 
Sbjct: 21  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVD 79
Query: 123 HPNVLSLLGCCVDNGLYLIFQFSSRGSVASLFHD-VNSPGVEWKVRHKIAVGTARGLHYL 181
           +P+V  LLG C+ + + LI Q    G +     +  ++ G ++ +     V  A+G++YL
Sbjct: 80  NPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNW--CVQIAKGMNYL 137
Query: 182 HKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEY 241
                RR++HRD+ + N+L+      +I+DFGLAK L ++   +     +     +A E 
Sbjct: 138 E---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 194
Query: 242 FMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGE 289
            +H I   ++DV+++GV + E+++ G KP DG   S  S    IL +GE
Sbjct: 195 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS---SILEKGE 240

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 91.3 bits (225), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 102/200 (51%), Gaps = 11/200 (5%)
Query: 74  VGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCC 133
           +G G +  VYKG      ++AVK L       ++ + F  E+G +    H N+L  +G  
Sbjct: 44  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 101
Query: 134 VDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRD 193
               L ++ Q+    S+    H + +     K+   IA  TA+G+ YLH    + IIHRD
Sbjct: 102 TKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLI-DIARQTAQGMDYLHA---KSIIHRD 157
Query: 194 IKSSNILLTADFEPQISDFGLAKWLPSQWT-HHSIAPIEGTFGHLAPEYFMHGIVDE--- 249
           +KS+NI L  D   +I DFGLA  + S+W+  H    + G+   +APE       +    
Sbjct: 158 LKSNNIFLHEDLTVKIGDFGLAT-VKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 216
Query: 250 KTDVFAFGVFLLEIISGRKP 269
           ++DV+AFG+ L E+++G+ P
Sbjct: 217 QSDVYAFGIVLYELMTGQLP 236

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 91.3 bits (225), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 102/200 (51%), Gaps = 11/200 (5%)
Query: 74  VGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCC 133
           +G G +  VYKG      ++AVK L       ++ + F  E+G +    H N+L  +G  
Sbjct: 16  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 134 VDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRD 193
               L ++ Q+    S+    H + +     K+   IA  TA+G+ YLH    + IIHRD
Sbjct: 74  TKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLI-DIARQTAQGMDYLHA---KSIIHRD 129
Query: 194 IKSSNILLTADFEPQISDFGLAKWLPSQWT-HHSIAPIEGTFGHLAPEYFMHGIVDE--- 249
           +KS+NI L  D   +I DFGLA  + S+W+  H    + G+   +APE       +    
Sbjct: 130 LKSNNIFLHEDLTVKIGDFGLAT-VKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 188
Query: 250 KTDVFAFGVFLLEIISGRKP 269
           ++DV+AFG+ L E+++G+ P
Sbjct: 189 QSDVYAFGIVLYELMTGQLP 208

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 102/200 (51%), Gaps = 11/200 (5%)
Query: 74  VGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCC 133
           +G G +  VYKG      ++AVK L       ++ + F  E+G +    H N+L  +G  
Sbjct: 21  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 78
Query: 134 VDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRD 193
               L ++ Q+    S+    H + +     K+   IA  TA+G+ YLH    + IIHRD
Sbjct: 79  TKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLI-DIARQTAQGMDYLHA---KSIIHRD 134
Query: 194 IKSSNILLTADFEPQISDFGLAKWLPSQWT-HHSIAPIEGTFGHLAPEYFMHGIVDE--- 249
           +KS+NI L  D   +I DFGLA  + S+W+  H    + G+   +APE       +    
Sbjct: 135 LKSNNIFLHEDLTVKIGDFGLAT-VKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 193
Query: 250 KTDVFAFGVFLLEIISGRKP 269
           ++DV+AFG+ L E+++G+ P
Sbjct: 194 QSDVYAFGIVLYELMTGQLP 213

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 102/200 (51%), Gaps = 11/200 (5%)
Query: 74  VGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCC 133
           +G G +  VYKG      ++AVK L       ++ + F  E+G +    H N+L  +G  
Sbjct: 16  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 134 VDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRD 193
               L ++ Q+    S+    H + +     K+   IA  TA+G+ YLH    + IIHRD
Sbjct: 74  TAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLI-DIARQTAQGMDYLHA---KSIIHRD 129
Query: 194 IKSSNILLTADFEPQISDFGLAKWLPSQWT-HHSIAPIEGTFGHLAPEYFMHGIVDE--- 249
           +KS+NI L  D   +I DFGLA  + S+W+  H    + G+   +APE       +    
Sbjct: 130 LKSNNIFLHEDLTVKIGDFGLAT-VKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 188
Query: 250 KTDVFAFGVFLLEIISGRKP 269
           ++DV+AFG+ L E+++G+ P
Sbjct: 189 QSDVYAFGIVLYELMTGQLP 208

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 77/284 (27%), Positives = 137/284 (48%), Gaps = 35/284 (12%)
Query: 74  VGRGGYAEVYKGVLQDGE-EIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC 132
           +G G Y EVY+GV +     +AVK L +   D  + +EFL E   +  + HPN++ LLG 
Sbjct: 267 LGGGQYGEVYEGVWKKYSLTVAVKTLKE---DTMEVEEFLKEAAVMKEIKHPNLVQLLGV 323
Query: 133 CV-DNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIH 191
           C  +   Y+I +F + G++     + N   V   V   +A   +  + YL K   +  IH
Sbjct: 324 CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK---KNFIH 380
Query: 192 RDIKSSNILLTADFEPQISDFGLAKWLPSQ-WTHHSIA--PIEGTFGHLAPEYFMHGIVD 248
           R++ + N L+  +   +++DFGL++ +    +T H+ A  PI+ T    APE   +    
Sbjct: 381 RNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT----APESLAYNKFS 436
Query: 249 EKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQL 307
            K+DV+AFGV L EI + G  P  G            ++  ++ +L++   +        
Sbjct: 437 IKSDVWAFGVLLWEIATYGMSPYPG------------IDLSQVYELLEKDYRMERPEGCP 484
Query: 308 NRLAFAASLCIRASPTWRPTMSEV---LEVMLE----GDQIDKE 344
            ++      C + +P+ RP+ +E+    E M +     D+++KE
Sbjct: 485 EKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKE 528

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 68/228 (29%), Positives = 117/228 (51%), Gaps = 14/228 (6%)
Query: 68  FSSENLVGRGGYAEVYKGV-LQDGEEI----AVKRLTKVVTDDRKEKEFLTEIGTIGHVC 122
           F    ++G G +  VYKG+ + +GE++    A+K L +  T  +  KE L E   +  V 
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVD 75
Query: 123 HPNVLSLLGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLH 182
           +P+V  LLG C+ + + LI Q    G +     + +   +  +      V  A+G++YL 
Sbjct: 76  NPHVCRLLGICLTSTVQLITQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLE 134
Query: 183 KGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYF 242
               RR++HRD+ + N+L+      +I+DFGLAK L ++   +     +     +A E  
Sbjct: 135 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 191
Query: 243 MHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGE 289
           +H I   ++DV+++GV + E+++ G KP DG   S  S    IL +GE
Sbjct: 192 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS---SILEKGE 236

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 69/229 (30%), Positives = 120/229 (52%), Gaps = 16/229 (6%)
Query: 68  FSSENLVGRGGYAEVYKGV-LQDGEEI----AVKRLTKVVTDDRKEKEFLTEIGTIGHVC 122
           F    ++G G +  VYKG+ + +GE++    A+K L +  T  +  KE L E   +  V 
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVD 78
Query: 123 HPNVLSLLGCCVDNGLYLIFQFSSRGSVASLFHD-VNSPGVEWKVRHKIAVGTARGLHYL 181
           +P+V  LLG C+ + + LI Q    G +     +  ++ G ++ +     V  A+G++YL
Sbjct: 79  NPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW--CVQIAKGMNYL 136
Query: 182 HKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEY 241
                RR++HRD+ + N+L+      +I+DFGLAK L ++   +     +     +A E 
Sbjct: 137 E---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 193
Query: 242 FMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGE 289
            +H I   ++DV+++GV + E+++ G KP DG   S  S    IL +GE
Sbjct: 194 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS---SILEKGE 239

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 69/229 (30%), Positives = 120/229 (52%), Gaps = 16/229 (6%)
Query: 68  FSSENLVGRGGYAEVYKGV-LQDGEEI----AVKRLTKVVTDDRKEKEFLTEIGTIGHVC 122
           F    ++G G +  VYKG+ + +GE++    A+K L +  T  +  KE L E   +  V 
Sbjct: 27  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVD 85
Query: 123 HPNVLSLLGCCVDNGLYLIFQFSSRGSVASLFHD-VNSPGVEWKVRHKIAVGTARGLHYL 181
           +P+V  LLG C+ + + LI Q    G +     +  ++ G ++ +     V  A+G++YL
Sbjct: 86  NPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW--CVQIAKGMNYL 143
Query: 182 HKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEY 241
                RR++HRD+ + N+L+      +I+DFGLAK L ++   +     +     +A E 
Sbjct: 144 E---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 200
Query: 242 FMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGE 289
            +H I   ++DV+++GV + E+++ G KP DG   S  S    IL +GE
Sbjct: 201 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS---SILEKGE 246

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 68/228 (29%), Positives = 117/228 (51%), Gaps = 14/228 (6%)
Query: 68  FSSENLVGRGGYAEVYKGV-LQDGEEI----AVKRLTKVVTDDRKEKEFLTEIGTIGHVC 122
           F    ++G G +  VYKG+ + +GE++    A+K L +  T  +  KE L E   +  V 
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVD 69
Query: 123 HPNVLSLLGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLH 182
           +P+V  LLG C+ + + LI Q    G +     + +   +  +      V  A+G++YL 
Sbjct: 70  NPHVCRLLGICLTSTVQLITQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLE 128
Query: 183 KGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYF 242
               RR++HRD+ + N+L+      +I+DFGLAK L ++   +     +     +A E  
Sbjct: 129 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 185
Query: 243 MHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGE 289
           +H I   ++DV+++GV + E+++ G KP DG   S  S    IL +GE
Sbjct: 186 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS---SILEKGE 230

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 68/228 (29%), Positives = 117/228 (51%), Gaps = 14/228 (6%)
Query: 68  FSSENLVGRGGYAEVYKGV-LQDGEEI----AVKRLTKVVTDDRKEKEFLTEIGTIGHVC 122
           F    ++G G +  VYKG+ + +GE++    A+K L +  T  +  KE L E   +  V 
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVD 78
Query: 123 HPNVLSLLGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLH 182
           +P+V  LLG C+ + + LI Q    G +     + +   +  +      V  A+G++YL 
Sbjct: 79  NPHVCRLLGICLTSTVQLITQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLE 137
Query: 183 KGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYF 242
               RR++HRD+ + N+L+      +I+DFGLAK L ++   +     +     +A E  
Sbjct: 138 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 194
Query: 243 MHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGE 289
           +H I   ++DV+++GV + E+++ G KP DG   S  S    IL +GE
Sbjct: 195 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS---SILEKGE 239

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 69/229 (30%), Positives = 120/229 (52%), Gaps = 16/229 (6%)
Query: 68  FSSENLVGRGGYAEVYKGV-LQDGEEI----AVKRLTKVVTDDRKEKEFLTEIGTIGHVC 122
           F    ++G G +  VYKG+ + +GE++    A+K L +  T  +  KE L E   +  V 
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVD 78
Query: 123 HPNVLSLLGCCVDNGLYLIFQFSSRGSVASLFHD-VNSPGVEWKVRHKIAVGTARGLHYL 181
           +P+V  LLG C+ + + LI Q    G +     +  ++ G ++ +     V  A+G++YL
Sbjct: 79  NPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW--CVQIAKGMNYL 136
Query: 182 HKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEY 241
                RR++HRD+ + N+L+      +I+DFGLAK L ++   +     +     +A E 
Sbjct: 137 E---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 193
Query: 242 FMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGE 289
            +H I   ++DV+++GV + E+++ G KP DG   S  S    IL +GE
Sbjct: 194 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS---SILEKGE 239

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 68/228 (29%), Positives = 117/228 (51%), Gaps = 14/228 (6%)
Query: 68  FSSENLVGRGGYAEVYKGV-LQDGEEI----AVKRLTKVVTDDRKEKEFLTEIGTIGHVC 122
           F    ++G G +  VYKG+ + +GE++    A+K L +  T  +  KE L E   +  V 
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVD 75
Query: 123 HPNVLSLLGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLH 182
           +P+V  LLG C+ + + LI Q    G +     + +   +  +      V  A+G++YL 
Sbjct: 76  NPHVCRLLGICLTSTVQLITQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLE 134
Query: 183 KGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYF 242
               RR++HRD+ + N+L+      +I+DFGLAK L ++   +     +     +A E  
Sbjct: 135 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 191
Query: 243 MHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGE 289
           +H I   ++DV+++GV + E+++ G KP DG   S  S    IL +GE
Sbjct: 192 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS---SILEKGE 236

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 68/228 (29%), Positives = 117/228 (51%), Gaps = 14/228 (6%)
Query: 68  FSSENLVGRGGYAEVYKGV-LQDGEEI----AVKRLTKVVTDDRKEKEFLTEIGTIGHVC 122
           F    ++G G +  VYKG+ + +GE++    A+K L +  T  +  KE L E   +  V 
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVD 75
Query: 123 HPNVLSLLGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLH 182
           +P+V  LLG C+ + + LI Q    G +     + +   +  +      V  A+G++YL 
Sbjct: 76  NPHVCRLLGICLTSTVQLITQLMPFGXLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLE 134
Query: 183 KGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYF 242
               RR++HRD+ + N+L+      +I+DFGLAK L ++   +     +     +A E  
Sbjct: 135 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 191
Query: 243 MHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGE 289
           +H I   ++DV+++GV + E+++ G KP DG   S  S    IL +GE
Sbjct: 192 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS---SILEKGE 236

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 68/228 (29%), Positives = 117/228 (51%), Gaps = 14/228 (6%)
Query: 68  FSSENLVGRGGYAEVYKGV-LQDGEEI----AVKRLTKVVTDDRKEKEFLTEIGTIGHVC 122
           F    ++G G +  VYKG+ + +GE++    A+K L +  T  +  KE L E   +  V 
Sbjct: 24  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVD 82
Query: 123 HPNVLSLLGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLH 182
           +P+V  LLG C+ + + LI Q    G +     + +   +  +      V  A+G++YL 
Sbjct: 83  NPHVCRLLGICLTSTVQLITQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLE 141
Query: 183 KGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYF 242
               RR++HRD+ + N+L+      +I+DFGLAK L ++   +     +     +A E  
Sbjct: 142 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 198
Query: 243 MHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGE 289
           +H I   ++DV+++GV + E+++ G KP DG   S  S    IL +GE
Sbjct: 199 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS---SILEKGE 243

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 68/228 (29%), Positives = 117/228 (51%), Gaps = 14/228 (6%)
Query: 68  FSSENLVGRGGYAEVYKGV-LQDGEEI----AVKRLTKVVTDDRKEKEFLTEIGTIGHVC 122
           F    ++G G +  VYKG+ + +GE++    A+K L +  T  +  KE L E   +  V 
Sbjct: 42  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVD 100
Query: 123 HPNVLSLLGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLH 182
           +P+V  LLG C+ + + LI Q    G +     + +   +  +      V  A+G++YL 
Sbjct: 101 NPHVCRLLGICLTSTVQLITQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLE 159
Query: 183 KGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYF 242
               RR++HRD+ + N+L+      +I+DFGLAK L ++   +     +     +A E  
Sbjct: 160 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 216
Query: 243 MHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGE 289
           +H I   ++DV+++GV + E+++ G KP DG   S  S    IL +GE
Sbjct: 217 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS---SILEKGE 261

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 78/302 (25%), Positives = 143/302 (47%), Gaps = 35/302 (11%)
Query: 56  FSFEEISIATNAFSSENLVGRGGYAEVYKGVLQDGE-EIAVKRLTKVVTDDRKEKEFLTE 114
            S ++  +     + ++ +G G + EVY+GV +     +AVK L +   D  + +EFL E
Sbjct: 1   MSLDKWEMERTDITMKHKLGGGQFGEVYEGVWKKYSLTVAVKTLKE---DTMEVEEFLKE 57
Query: 115 IGTIGHVCHPNVLSLLGCCV-DNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVG 173
              +  + HPN++ LLG C  +   Y+I +F + G++     + N   V   V   +A  
Sbjct: 58  AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQ 117
Query: 174 TARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQ-WTHHSIA--PI 230
            +  + YL K   +  IHRD+ + N L+  +   +++DFGL++ +     T H+ A  PI
Sbjct: 118 ISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPI 174
Query: 231 EGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGE 289
           + T    APE   +     K+DV+AFGV L EI + G  P  G            ++  +
Sbjct: 175 KWT----APESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG------------IDPSQ 218
Query: 290 IEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEV---LEVMLE----GDQID 342
           + +L++   +         ++      C + +P+ RP+ +E+    E M +     D+++
Sbjct: 219 VYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVE 278
Query: 343 KE 344
           KE
Sbjct: 279 KE 280

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 68/228 (29%), Positives = 117/228 (51%), Gaps = 14/228 (6%)
Query: 68  FSSENLVGRGGYAEVYKGV-LQDGEEI----AVKRLTKVVTDDRKEKEFLTEIGTIGHVC 122
           F    ++G G +  VYKG+ + +GE++    A+K L +  T  +  KE L E   +  V 
Sbjct: 23  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVD 81
Query: 123 HPNVLSLLGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLH 182
           +P+V  LLG C+ + + LI Q    G +     + +   +  +      V  A+G++YL 
Sbjct: 82  NPHVCRLLGICLTSTVQLITQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLE 140
Query: 183 KGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYF 242
               RR++HRD+ + N+L+      +I+DFGLAK L ++   +     +     +A E  
Sbjct: 141 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 197
Query: 243 MHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGE 289
           +H I   ++DV+++GV + E+++ G KP DG   S  S    IL +GE
Sbjct: 198 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS---SILEKGE 242

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 105/205 (51%), Gaps = 16/205 (7%)
Query: 74  VGRGGYAEVYKGVLQDGE-EIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC 132
           +G G Y EVY GV +     +AVK L +   D  + +EFL E   +  + HPN++ LLG 
Sbjct: 40  LGGGQYGEVYVGVWKKYSLTVAVKTLKE---DTMEVEEFLKEAAVMKEIKHPNLVQLLGV 96
Query: 133 C-VDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIH 191
           C ++   Y++ ++   G++     + N   V   V   +A   +  + YL K   +  IH
Sbjct: 97  CTLEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQISSAMEYLEK---KNFIH 153
Query: 192 RDIKSSNILLTADFEPQISDFGLAKWLPSQ-WTHHSIA--PIEGTFGHLAPEYFMHGIVD 248
           RD+ + N L+  +   +++DFGL++ +    +T H+ A  PI+ T    APE   +    
Sbjct: 154 RDLAARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAKFPIKWT----APESLAYNTFS 209
Query: 249 EKTDVFAFGVFLLEIIS-GRKPVDG 272
            K+DV+AFGV L EI + G  P  G
Sbjct: 210 IKSDVWAFGVLLWEIATYGMSPYPG 234

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 68/228 (29%), Positives = 117/228 (51%), Gaps = 14/228 (6%)
Query: 68  FSSENLVGRGGYAEVYKGV-LQDGEEI----AVKRLTKVVTDDRKEKEFLTEIGTIGHVC 122
           F    ++G G +  VYKG+ + +GE++    A+K L +  T  +  KE L E   +  V 
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVD 77
Query: 123 HPNVLSLLGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLH 182
           +P+V  LLG C+ + + LI Q    G +     + +   +  +      V  A+G++YL 
Sbjct: 78  NPHVCRLLGICLTSTVQLITQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLE 136
Query: 183 KGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYF 242
               RR++HRD+ + N+L+      +I+DFGLAK L ++   +     +     +A E  
Sbjct: 137 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 193
Query: 243 MHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGE 289
           +H I   ++DV+++GV + E+++ G KP DG   S  S    IL +GE
Sbjct: 194 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS---SILEKGE 238

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 101/200 (50%), Gaps = 11/200 (5%)
Query: 74  VGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCC 133
           +G G +  VYKG      ++AVK L       ++ + F  E+G +    H N+L  +G  
Sbjct: 36  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 93
Query: 134 VDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRD 193
               L ++ Q+    S+    H + +     K+   IA  TA+G+ YLH    + IIHRD
Sbjct: 94  TKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLI-DIARQTAQGMDYLHA---KSIIHRD 149
Query: 194 IKSSNILLTADFEPQISDFGLAKWLPSQWT-HHSIAPIEGTFGHLAPEYFMHGIVDE--- 249
           +KS+NI L  D   +I DFGLA    S+W+  H    + G+   +APE       +    
Sbjct: 150 LKSNNIFLHEDLTVKIGDFGLATE-KSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 208
Query: 250 KTDVFAFGVFLLEIISGRKP 269
           ++DV+AFG+ L E+++G+ P
Sbjct: 209 QSDVYAFGIVLYELMTGQLP 228

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 101/200 (50%), Gaps = 11/200 (5%)
Query: 74  VGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCC 133
           +G G +  VYKG      ++AVK L       ++ + F  E+G +    H N+L  +G  
Sbjct: 16  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 134 VDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRD 193
               L ++ Q+    S+    H + +     K+   IA  TA+G+ YLH    + IIHRD
Sbjct: 74  TKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLI-DIARQTAQGMDYLHA---KSIIHRD 129
Query: 194 IKSSNILLTADFEPQISDFGLAKWLPSQWT-HHSIAPIEGTFGHLAPEYFMHGIVDE--- 249
           +KS+NI L  D   +I DFGLA    S+W+  H    + G+   +APE       +    
Sbjct: 130 LKSNNIFLHEDLTVKIGDFGLATE-KSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 188
Query: 250 KTDVFAFGVFLLEIISGRKP 269
           ++DV+AFG+ L E+++G+ P
Sbjct: 189 QSDVYAFGIVLYELMTGQLP 208

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 101/200 (50%), Gaps = 11/200 (5%)
Query: 74  VGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCC 133
           +G G +  VYKG      ++AVK L       ++ + F  E+G +    H N+L  +G  
Sbjct: 44  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 101
Query: 134 VDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRD 193
               L ++ Q+    S+    H + +     K+   IA  TA+G+ YLH    + IIHRD
Sbjct: 102 TKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLI-DIARQTAQGMDYLHA---KSIIHRD 157
Query: 194 IKSSNILLTADFEPQISDFGLAKWLPSQWT-HHSIAPIEGTFGHLAPEYFMHGIVDE--- 249
           +KS+NI L  D   +I DFGLA    S+W+  H    + G+   +APE       +    
Sbjct: 158 LKSNNIFLHEDLTVKIGDFGLATE-KSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 216
Query: 250 KTDVFAFGVFLLEIISGRKP 269
           ++DV+AFG+ L E+++G+ P
Sbjct: 217 QSDVYAFGIVLYELMTGQLP 236

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 76/294 (25%), Positives = 135/294 (45%), Gaps = 40/294 (13%)
Query: 62  SIATNAFSSENLVGRGGYAEVYKG-VLQDGEEIAVKRLTKVVTDDRKE-------KEFLT 113
           ++A N    E  +G+GG+  V+KG +++D   +A+K L  ++ D   E       +EF  
Sbjct: 15  TLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSL--ILGDSEGETEMIEKFQEFQR 72
Query: 114 EIGTIGHVCHPNVLSLLGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVG 173
           E+  + ++ HPN++ L G  + N   ++ +F   G +     D   P ++W V+ ++ + 
Sbjct: 73  EVFIMSNLNHPNIVKLYG-LMHNPPRMVMEFVPCGDLYHRLLDKAHP-IKWSVKLRLMLD 130
Query: 174 TARGLHYLHKGCQRRIIHRDIKSSNILL-----TADFEPQISDFGLAKWLPSQWTHHSIA 228
            A G+ Y+ +     I+HRD++S NI L      A    +++DFG      SQ + HS++
Sbjct: 131 IALGIEYM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGT-----SQQSVHSVS 184
Query: 229 PIEGTFGHLAPEYF--MHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILN 286
            + G F  +APE          EK D ++F + L  I++G  P D        +   I  
Sbjct: 185 GLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIRE 244
Query: 287 QG---EIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLE 337
           +G    I +   PRL+   +            LC    P  RP  S +++ + E
Sbjct: 245 EGLRPTIPEDCPPRLRNVIE------------LCWSGDPKKRPHFSYIVKELSE 286

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 76/294 (25%), Positives = 135/294 (45%), Gaps = 40/294 (13%)
Query: 62  SIATNAFSSENLVGRGGYAEVYKG-VLQDGEEIAVKRLTKVVTDDRKE-------KEFLT 113
           ++A N    E  +G+GG+  V+KG +++D   +A+K L  ++ D   E       +EF  
Sbjct: 15  TLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSL--ILGDSEGETEMIEKFQEFQR 72
Query: 114 EIGTIGHVCHPNVLSLLGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVG 173
           E+  + ++ HPN++ L G  + N   ++ +F   G +     D   P ++W V+ ++ + 
Sbjct: 73  EVFIMSNLNHPNIVKLYG-LMHNPPRMVMEFVPCGDLYHRLLDKAHP-IKWSVKLRLMLD 130
Query: 174 TARGLHYLHKGCQRRIIHRDIKSSNILL-----TADFEPQISDFGLAKWLPSQWTHHSIA 228
            A G+ Y+ +     I+HRD++S NI L      A    +++DF L     SQ + HS++
Sbjct: 131 IALGIEYM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSL-----SQQSVHSVS 184
Query: 229 PIEGTFGHLAPEYF--MHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILN 286
            + G F  +APE          EK D ++F + L  I++G  P D        +   I  
Sbjct: 185 GLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIRE 244
Query: 287 QG---EIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLE 337
           +G    I +   PRL+   +            LC    P  RP  S +++ + E
Sbjct: 245 EGLRPTIPEDCPPRLRNVIE------------LCWSGDPKKRPHFSYIVKELSE 286

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 68/228 (29%), Positives = 116/228 (50%), Gaps = 14/228 (6%)
Query: 68  FSSENLVGRGGYAEVYKGV-LQDGEEI----AVKRLTKVVTDDRKEKEFLTEIGTIGHVC 122
           F    ++G G +  VYKG+ + +GE++    A+K L +  T  +  KE L E   +  V 
Sbjct: 14  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVD 72
Query: 123 HPNVLSLLGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLH 182
           +P+V  LLG C+ + + LI Q    G +     + +   +  +      V  A G++YL 
Sbjct: 73  NPHVCRLLGICLTSTVQLITQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAEGMNYLE 131
Query: 183 KGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYF 242
               RR++HRD+ + N+L+      +I+DFGLAK L ++   +     +     +A E  
Sbjct: 132 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 188
Query: 243 MHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGE 289
           +H I   ++DV+++GV + E+++ G KP DG   S  S    IL +GE
Sbjct: 189 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS---SILEKGE 233

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 81/289 (28%), Positives = 133/289 (46%), Gaps = 49/289 (16%)
Query: 74  VGRGGYAEVYK----GVLQDGEEIAVKRLTKVVTDDRKEKEF---LTEIGTIGHVC-HPN 125
           +G G + +V      G+ +D      K   K++  D  EK+    ++E+  +  +  H N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 126 VLSLLGCCVDNG-LYLIFQFSSRGSVASLFHDVNSPGVEW--------------KVRHKI 170
           +++LLG C  +G LY+I +++S+G++         PG+E+              K     
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLVSC 155
Query: 171 AVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPI 230
           A   ARG+ YL     ++ IHRD+ + N+L+T D   +I+DFGLA+ +     HH     
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI-----HHIDXXK 207
Query: 231 EGTFGHL-----APEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPI 284
           + T G L     APE     I   ++DV++FGV L EI + G  P  G    +    K +
Sbjct: 208 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV--PVEELFK-L 264
Query: 285 LNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLE 333
           L +G        R+    + T  N L      C  A P+ RPT  +++E
Sbjct: 265 LKEGH-------RMDKPSNCT--NELYMMMRDCWHAVPSQRPTFKQLVE 304

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 81/289 (28%), Positives = 133/289 (46%), Gaps = 49/289 (16%)
Query: 74  VGRGGYAEVYK----GVLQDGEEIAVKRLTKVVTDDRKEKEF---LTEIGTIGHVC-HPN 125
           +G G + +V      G+ +D      K   K++  D  EK+    ++E+  +  +  H N
Sbjct: 21  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 80
Query: 126 VLSLLGCCVDNG-LYLIFQFSSRGSVASLFHDVNSPGVEW--------------KVRHKI 170
           +++LLG C  +G LY+I +++S+G++         PG+E+              K     
Sbjct: 81  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 140
Query: 171 AVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPI 230
           A   ARG+ YL     ++ IHRD+ + N+L+T D   +I+DFGLA+ +     HH     
Sbjct: 141 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI-----HHIDYYK 192
Query: 231 EGTFGHL-----APEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPI 284
           + T G L     APE     I   ++DV++FGV L EI + G  P  G    +    K +
Sbjct: 193 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV--PVEELFK-L 249
Query: 285 LNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLE 333
           L +G        R+    + T  N L      C  A P+ RPT  +++E
Sbjct: 250 LKEGH-------RMDKPSNCT--NELYMMMRDCWHAVPSQRPTFKQLVE 289

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 82/291 (28%), Positives = 134/291 (46%), Gaps = 53/291 (18%)
Query: 74  VGRGGYAEVYK----GVLQDGEEIAVKRLTKVVTDDRKEKEF---LTEIGTIGHVC-HPN 125
           +G G + +V      G+ +D      K   K++  D  EK+    ++E+  +  +  H N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 126 VLSLLGCCVDNG-LYLIFQFSSRGSVASLFHDVNSPGVEW--------------KVRHKI 170
           +++LLG C  +G LY+I +++S+G++         PG+E+              K     
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 171 AVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPI 230
           A   ARG+ YL     ++ IHRD+ + N+L+T D   +I+DFGLA+ +     HH     
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI-----HHIDYYK 207
Query: 231 EGTFGHL-----APEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPI 284
           + T G L     APE     I   ++DV++FGV L EI + G  P  G          P+
Sbjct: 208 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV---------PV 258
Query: 285 LNQGEIEKLVDP--RLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLE 333
               E+ KL+    R+    + T  N L      C  A P+ RPT  +++E
Sbjct: 259 ---EELFKLLKEGHRMDKPSNCT--NELYMMMRDCWHAVPSQRPTFKQLVE 304

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 81/289 (28%), Positives = 133/289 (46%), Gaps = 49/289 (16%)
Query: 74  VGRGGYAEVYK----GVLQDGEEIAVKRLTKVVTDDRKEKEF---LTEIGTIGHVC-HPN 125
           +G G + +V      G+ +D      K   K++  D  EK+    ++E+  +  +  H N
Sbjct: 25  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 84
Query: 126 VLSLLGCCVDNG-LYLIFQFSSRGSVASLFHDVNSPGVEW--------------KVRHKI 170
           +++LLG C  +G LY+I +++S+G++         PG+E+              K     
Sbjct: 85  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 144
Query: 171 AVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPI 230
           A   ARG+ YL     ++ IHRD+ + N+L+T D   +I+DFGLA+ +     HH     
Sbjct: 145 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI-----HHIDYYK 196
Query: 231 EGTFGHL-----APEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPI 284
           + T G L     APE     I   ++DV++FGV L EI + G  P  G    +    K +
Sbjct: 197 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV--PVEELFK-L 253
Query: 285 LNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLE 333
           L +G        R+    + T  N L      C  A P+ RPT  +++E
Sbjct: 254 LKEGH-------RMDKPSNCT--NELYMMMRDCWHAVPSQRPTFKQLVE 293

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 81/289 (28%), Positives = 133/289 (46%), Gaps = 49/289 (16%)
Query: 74  VGRGGYAEVYK----GVLQDGEEIAVKRLTKVVTDDRKEKEF---LTEIGTIGHVC-HPN 125
           +G G + +V      G+ +D      K   K++  D  EK+    ++E+  +  +  H N
Sbjct: 29  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 88
Query: 126 VLSLLGCCVDNG-LYLIFQFSSRGSVASLFHDVNSPGVEW--------------KVRHKI 170
           +++LLG C  +G LY+I +++S+G++         PG+E+              K     
Sbjct: 89  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 148
Query: 171 AVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPI 230
           A   ARG+ YL     ++ IHRD+ + N+L+T D   +I+DFGLA+ +     HH     
Sbjct: 149 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI-----HHIDYYK 200
Query: 231 EGTFGHL-----APEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPI 284
           + T G L     APE     I   ++DV++FGV L EI + G  P  G    +    K +
Sbjct: 201 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV--PVEELFK-L 257
Query: 285 LNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLE 333
           L +G        R+    + T  N L      C  A P+ RPT  +++E
Sbjct: 258 LKEGH-------RMDKPSNCT--NELYMMMRDCWHAVPSQRPTFKQLVE 297

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 68/229 (29%), Positives = 119/229 (51%), Gaps = 16/229 (6%)
Query: 68  FSSENLVGRGGYAEVYKGV-LQDGEEI----AVKRLTKVVTDDRKEKEFLTEIGTIGHVC 122
           F    ++  G +  VYKG+ + +GE++    A+K L +  T  +  KE L E   +  V 
Sbjct: 24  FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVD 82
Query: 123 HPNVLSLLGCCVDNGLYLIFQFSSRGSVASLFHD-VNSPGVEWKVRHKIAVGTARGLHYL 181
           +P+V  LLG C+ + + LI Q    G +     +  ++ G ++ +     V  A+G++YL
Sbjct: 83  NPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNW--CVQIAKGMNYL 140
Query: 182 HKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEY 241
                RR++HRD+ + N+L+      +I+DFGLAK L ++   +     +     +A E 
Sbjct: 141 E---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 197
Query: 242 FMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGE 289
            +H I   ++DV+++GV + E+++ G KP DG   S  S    IL +GE
Sbjct: 198 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS---SILEKGE 243

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 68/229 (29%), Positives = 119/229 (51%), Gaps = 16/229 (6%)
Query: 68  FSSENLVGRGGYAEVYKGV-LQDGEEI----AVKRLTKVVTDDRKEKEFLTEIGTIGHVC 122
           F    ++G G +  VYKG+ + +GE++    A+K L +  T  +  KE L E   +  V 
Sbjct: 21  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVD 79
Query: 123 HPNVLSLLGCCVDNGLYLIFQFSSRGSVASLFHD-VNSPGVEWKVRHKIAVGTARGLHYL 181
           +P+V  LLG C+ + + LI Q    G +     +  ++ G ++ +     V  A+G++YL
Sbjct: 80  NPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNW--CVQIAKGMNYL 137
Query: 182 HKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEY 241
                RR++HRD+ + N+L+      +I+DFG AK L ++   +     +     +A E 
Sbjct: 138 E---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALES 194
Query: 242 FMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGE 289
            +H I   ++DV+++GV + E+++ G KP DG   S  S    IL +GE
Sbjct: 195 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS---SILEKGE 240

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 82/291 (28%), Positives = 134/291 (46%), Gaps = 53/291 (18%)
Query: 74  VGRGGYAEVYK----GVLQDGEEIAVKRLTKVVTDDRKEKEF---LTEIGTIGHVC-HPN 125
           +G G + +V      G+ +D      K   K++  D  EK+    ++E+  +  +  H N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 126 VLSLLGCCVDNG-LYLIFQFSSRGSVASLFHDVNSPGVEW--------------KVRHKI 170
           +++LLG C  +G LY+I +++S+G++         PG+E+              K     
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 171 AVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPI 230
           A   ARG+ YL     ++ IHRD+ + N+L+T D   +I+DFGLA+ +     HH     
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI-----HHIDYYK 207
Query: 231 EGTFGHL-----APEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPI 284
           + T G L     APE     I   ++DV++FGV L EI + G  P  G          P+
Sbjct: 208 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV---------PV 258
Query: 285 LNQGEIEKLVDP--RLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLE 333
               E+ KL+    R+    + T  N L      C  A P+ RPT  +++E
Sbjct: 259 ---EELFKLLKEGHRMDKPSNCT--NELYMMMRDCWHAVPSQRPTFKQLVE 304

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 81/289 (28%), Positives = 133/289 (46%), Gaps = 49/289 (16%)
Query: 74  VGRGGYAEVYK----GVLQDGEEIAVKRLTKVVTDDRKEKEF---LTEIGTIGHVC-HPN 125
           +G G + +V      G+ +D      K   K++  D  EK+    ++E+  +  +  H N
Sbjct: 28  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 87
Query: 126 VLSLLGCCVDNG-LYLIFQFSSRGSVASLFHDVNSPGVEW--------------KVRHKI 170
           +++LLG C  +G LY+I +++S+G++         PG+E+              K     
Sbjct: 88  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 147
Query: 171 AVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPI 230
           A   ARG+ YL     ++ IHRD+ + N+L+T D   +I+DFGLA+ +     HH     
Sbjct: 148 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI-----HHIDYYK 199
Query: 231 EGTFGHL-----APEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPI 284
           + T G L     APE     I   ++DV++FGV L EI + G  P  G    +    K +
Sbjct: 200 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV--PVEELFK-L 256
Query: 285 LNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLE 333
           L +G        R+    + T  N L      C  A P+ RPT  +++E
Sbjct: 257 LKEGH-------RMDKPSNCT--NELYMMMRDCWHAVPSQRPTFKQLVE 296

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 81/289 (28%), Positives = 133/289 (46%), Gaps = 49/289 (16%)
Query: 74  VGRGGYAEVYK----GVLQDGEEIAVKRLTKVVTDDRKEKEF---LTEIGTIGHVC-HPN 125
           +G G + +V      G+ +D      K   K++  D  EK+    ++E+  +  +  H N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 126 VLSLLGCCVDNG-LYLIFQFSSRGSVASLFHDVNSPGVEW--------------KVRHKI 170
           +++LLG C  +G LY+I +++S+G++         PG+E+              K     
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 155
Query: 171 AVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPI 230
           A   ARG+ YL     ++ IHRD+ + N+L+T D   +I+DFGLA+ +     HH     
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI-----HHIDYYK 207
Query: 231 EGTFGHL-----APEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPI 284
           + T G L     APE     I   ++DV++FGV L EI + G  P  G    +    K +
Sbjct: 208 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV--PVEELFK-L 264
Query: 285 LNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLE 333
           L +G        R+    + T  N L      C  A P+ RPT  +++E
Sbjct: 265 LKEGH-------RMDKPSNCT--NELYMMMRDCWHAVPSQRPTFKQLVE 304

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 116/228 (50%), Gaps = 14/228 (6%)
Query: 68  FSSENLVGRGGYAEVYKGV-LQDGEEI----AVKRLTKVVTDDRKEKEFLTEIGTIGHVC 122
           F    ++G G +  VYKG+ + +GE++    A+K L +  T  +  KE L E   +  V 
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVD 77
Query: 123 HPNVLSLLGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLH 182
           +P+V  LLG C+ + + LI Q    G +     + +   +  +      V  A+G++YL 
Sbjct: 78  NPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLE 136
Query: 183 KGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYF 242
               RR++HRD+ + N+L+      +I+DFG AK L ++   +     +     +A E  
Sbjct: 137 ---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESI 193
Query: 243 MHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGE 289
           +H I   ++DV+++GV + E+++ G KP DG   S  S    IL +GE
Sbjct: 194 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS---SILEKGE 238

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 81/289 (28%), Positives = 133/289 (46%), Gaps = 49/289 (16%)
Query: 74  VGRGGYAEVYK----GVLQDGEEIAVKRLTKVVTDDRKEKEF---LTEIGTIGHVC-HPN 125
           +G G + +V      G+ +D      K   K++  D  EK+    ++E+  +  +  H N
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 126 VLSLLGCCVDNG-LYLIFQFSSRGSVASLFHDVNSPGVEW--------------KVRHKI 170
           +++LLG C  +G LY+I +++S+G++         PG+E+              K     
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 171 AVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPI 230
           A   ARG+ YL     ++ IHRD+ + N+L+T D   +I+DFGLA+ +     HH     
Sbjct: 197 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI-----HHIDYYK 248
Query: 231 EGTFGHL-----APEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPI 284
           + T G L     APE     I   ++DV++FGV L EI + G  P  G    +    K +
Sbjct: 249 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV--PVEELFK-L 305
Query: 285 LNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLE 333
           L +G        R+    + T  N L      C  A P+ RPT  +++E
Sbjct: 306 LKEGH-------RMDKPSNCT--NELYMMMRDCWHAVPSQRPTFKQLVE 345

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 116/228 (50%), Gaps = 14/228 (6%)
Query: 68  FSSENLVGRGGYAEVYKGV-LQDGEEI----AVKRLTKVVTDDRKEKEFLTEIGTIGHVC 122
           F    ++G G +  VYKG+ + +GE++    A+K L +  T  +  KE L E   +  V 
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVD 77
Query: 123 HPNVLSLLGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLH 182
           +P+V  LLG C+ + + LI Q    G +     + +   +  +      V  A+G++YL 
Sbjct: 78  NPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLE 136
Query: 183 KGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYF 242
               RR++HRD+ + N+L+      +I+DFG AK L ++   +     +     +A E  
Sbjct: 137 ---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESI 193
Query: 243 MHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGE 289
           +H I   ++DV+++GV + E+++ G KP DG   S  S    IL +GE
Sbjct: 194 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS---SILEKGE 238

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 68/229 (29%), Positives = 119/229 (51%), Gaps = 16/229 (6%)
Query: 68  FSSENLVGRGGYAEVYKGV-LQDGEEI----AVKRLTKVVTDDRKEKEFLTEIGTIGHVC 122
           F    ++G G +  VYKG+ + +GE++    A+  L +  T  +  KE L E   +  V 
Sbjct: 51  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREA-TSPKANKEILDEAYVMASVD 109
Query: 123 HPNVLSLLGCCVDNGLYLIFQFSSRGSVASLFHD-VNSPGVEWKVRHKIAVGTARGLHYL 181
           +P+V  LLG C+ + + LI Q    G +     +  ++ G ++ +     V  A+G++YL
Sbjct: 110 NPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW--CVQIAKGMNYL 167
Query: 182 HKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEY 241
                RR++HRD+ + N+L+      +I+DFGLAK L ++   +     +     +A E 
Sbjct: 168 E---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 224
Query: 242 FMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGE 289
            +H I   ++DV+++GV + E+++ G KP DG   S  S    IL +GE
Sbjct: 225 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS---SILEKGE 270

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 116/228 (50%), Gaps = 14/228 (6%)
Query: 68  FSSENLVGRGGYAEVYKGV-LQDGEEI----AVKRLTKVVTDDRKEKEFLTEIGTIGHVC 122
           F    ++  G +  VYKG+ + +GE++    A+K L +  T  +  KE L E   +  V 
Sbjct: 17  FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVD 75
Query: 123 HPNVLSLLGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLH 182
           +P+V  LLG C+ + + LI Q    G +     + +   +  +      V  A+G++YL 
Sbjct: 76  NPHVCRLLGICLTSTVQLITQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLE 134
Query: 183 KGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYF 242
               RR++HRD+ + N+L+      +I+DFGLAK L ++   +     +     +A E  
Sbjct: 135 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 191
Query: 243 MHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGE 289
           +H I   ++DV+++GV + E+++ G KP DG   S  S    IL +GE
Sbjct: 192 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS---SILEKGE 236

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 78/276 (28%), Positives = 140/276 (50%), Gaps = 34/276 (12%)
Query: 62  SIATNAFSSENLVGRGGYAEVYKGVLQD---GEEIAVKRLTKVVTDDRKEKE-FLTEIGT 117
           +I ++ +  + ++G+G + EV   + +D   G+E AVK ++K     + +KE  L E+  
Sbjct: 28  AIFSDRYKGQRVLGKGSFGEVI--LCKDKITGQECAVKVISKRQVKQKTDKESLLREVQL 85
Query: 118 IGHVCHPNVLSLLGCCVDNG-LYLIFQFSSRGSVASLFHDVNSPGVEWKV-RHKIAVGTA 175
           +  + HPN++ L     D G  YL+ +  + G    LF ++ S     +V   +I     
Sbjct: 86  LKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGE---LFDEIISRKRFSEVDAARIIRQVL 142
Query: 176 RGLHYLHKGCQRRIIHRDIKSSNILL---TADFEPQISDFGLAKWLPSQWTHHSIAPIEG 232
            G+ Y+HK    +I+HRD+K  N+LL   + D   +I DFGL+    +      +    G
Sbjct: 143 SGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS---KKMKDKIG 196
Query: 233 TFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEK 292
           T  ++APE  +HG  DEK DV++ GV L  ++SG  P +G+            N+ +I K
Sbjct: 197 TAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGCPPFNGA------------NEYDILK 243
Query: 293 LVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTM 328
            V+ + +  +++ Q  +++ +A   IR   T+ P+M
Sbjct: 244 KVE-KGKYTFELPQWKKVSESAKDLIRKMLTYVPSM 278

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 116/228 (50%), Gaps = 14/228 (6%)
Query: 68  FSSENLVGRGGYAEVYKGV-LQDGEEI----AVKRLTKVVTDDRKEKEFLTEIGTIGHVC 122
           F    ++  G +  VYKG+ + +GE++    A+K L +  T  +  KE L E   +  V 
Sbjct: 24  FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVD 82
Query: 123 HPNVLSLLGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLH 182
           +P+V  LLG C+ + + LI Q    G +     + +   +  +      V  A+G++YL 
Sbjct: 83  NPHVCRLLGICLTSTVQLITQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLE 141
Query: 183 KGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYF 242
               RR++HRD+ + N+L+      +I+DFGLAK L ++   +     +     +A E  
Sbjct: 142 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 198
Query: 243 MHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGE 289
           +H I   ++DV+++GV + E+++ G KP DG   S  S    IL +GE
Sbjct: 199 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS---SILEKGE 243

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 116/228 (50%), Gaps = 14/228 (6%)
Query: 68  FSSENLVGRGGYAEVYKGV-LQDGEEI----AVKRLTKVVTDDRKEKEFLTEIGTIGHVC 122
           F    ++G G +  VYKG+ + +GE++    A+K L +  T  +  KE L E   +  V 
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVD 77
Query: 123 HPNVLSLLGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLH 182
           +P+V  LLG C+ + + LI Q    G +     + +   +  +      V  A+G++YL 
Sbjct: 78  NPHVCRLLGICLTSTVQLITQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLE 136
Query: 183 KGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYF 242
               RR++HRD+ + N+L+      +I+DFG AK L ++   +     +     +A E  
Sbjct: 137 ---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESI 193
Query: 243 MHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGE 289
           +H I   ++DV+++GV + E+++ G KP DG   S  S    IL +GE
Sbjct: 194 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS---SILEKGE 238

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 87.8 bits (216), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 116/228 (50%), Gaps = 14/228 (6%)
Query: 68  FSSENLVGRGGYAEVYKGV-LQDGEEI----AVKRLTKVVTDDRKEKEFLTEIGTIGHVC 122
           F    ++G G +  VYKG+ + +GE++    A+K L +  T  +  KE L E   +  V 
Sbjct: 24  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVD 82
Query: 123 HPNVLSLLGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLH 182
           +P+V  LLG C+ + + LI Q    G +     + +   +  +      V  A+G++YL 
Sbjct: 83  NPHVCRLLGICLTSTVQLITQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLE 141
Query: 183 KGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYF 242
               RR++HRD+ + N+L+      +I+DFG AK L ++   +     +     +A E  
Sbjct: 142 ---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESI 198
Query: 243 MHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGE 289
           +H I   ++DV+++GV + E+++ G KP DG   S  S    IL +GE
Sbjct: 199 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS---SILEKGE 243

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 87.8 bits (216), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 116/228 (50%), Gaps = 14/228 (6%)
Query: 68  FSSENLVGRGGYAEVYKGV-LQDGEEI----AVKRLTKVVTDDRKEKEFLTEIGTIGHVC 122
           F    ++G G +  VYKG+ + +GE++    A+K L +  T  +  KE L E   +  V 
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVD 75
Query: 123 HPNVLSLLGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLH 182
           +P+V  LLG C+ + + LI Q    G +     + +   +  +      V  A+G++YL 
Sbjct: 76  NPHVCRLLGICLTSTVQLITQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLE 134
Query: 183 KGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYF 242
               RR++HRD+ + N+L+      +I+DFG AK L ++   +     +     +A E  
Sbjct: 135 ---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESI 191
Query: 243 MHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGE 289
           +H I   ++DV+++GV + E+++ G KP DG   S  S    IL +GE
Sbjct: 192 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS---SILEKGE 236

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 78/276 (28%), Positives = 140/276 (50%), Gaps = 34/276 (12%)
Query: 62  SIATNAFSSENLVGRGGYAEVYKGVLQD---GEEIAVKRLTKVVTDDRKEKE-FLTEIGT 117
           +I ++ +  + ++G+G + EV   + +D   G+E AVK ++K     + +KE  L E+  
Sbjct: 22  AIFSDRYKGQRVLGKGSFGEVI--LCKDKITGQECAVKVISKRQVKQKTDKESLLREVQL 79
Query: 118 IGHVCHPNVLSLLGCCVDNG-LYLIFQFSSRGSVASLFHDVNSPGVEWKV-RHKIAVGTA 175
           +  + HPN++ L     D G  YL+ +  + G    LF ++ S     +V   +I     
Sbjct: 80  LKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGE---LFDEIISRKRFSEVDAARIIRQVL 136
Query: 176 RGLHYLHKGCQRRIIHRDIKSSNILL---TADFEPQISDFGLAKWLPSQWTHHSIAPIEG 232
            G+ Y+HK    +I+HRD+K  N+LL   + D   +I DFGL+    +      +    G
Sbjct: 137 SGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS---KKMKDKIG 190
Query: 233 TFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEK 292
           T  ++APE  +HG  DEK DV++ GV L  ++SG  P +G+            N+ +I K
Sbjct: 191 TAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGCPPFNGA------------NEYDILK 237
Query: 293 LVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTM 328
            V+ + +  +++ Q  +++ +A   IR   T+ P+M
Sbjct: 238 KVE-KGKYTFELPQWKKVSESAKDLIRKMLTYVPSM 272

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 75/285 (26%), Positives = 136/285 (47%), Gaps = 41/285 (14%)
Query: 74  VGRGGYAEVYK----GVLQDGEEIAVKRLTKVVTDDRKEKEF---LTEIGTIGHVC-HPN 125
           +G G + +V      G+ +D  + AV    K++ DD  EK+    ++E+  +  +  H N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 126 VLSLLGCCVDNG-LYLIFQFSSRGSVASLFHDVNSPGVEW----------KVRHKIAVGT 174
           +++LLG C  +G LY+I +++S+G++         PG+E+          ++  K  V  
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 175 ----ARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPI 230
               ARG+ YL     ++ IHRD+ + N+L+T +   +I+DFGLA+ + +   + +    
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKNTTNG 219
Query: 231 EGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDG-SHQSLHSWAKPILNQG 288
                 +APE     +   ++DV++FGV + EI + G  P  G   + L      +L +G
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK----LLKEG 275
Query: 289 EIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLE 333
                   R+    + T  N L      C  A P+ RPT  +++E
Sbjct: 276 H-------RMDKPANCT--NELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 75/285 (26%), Positives = 135/285 (47%), Gaps = 41/285 (14%)
Query: 74  VGRGGYAEVYK----GVLQDGEEIAVKRLTKVVTDDRKEKEF---LTEIGTIGHVC-HPN 125
           +G G + +V      G+ +D  + AV    K++ DD  EK+    ++E+  +  +  H N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 126 VLSLLGCCVDNG-LYLIFQFSSRGSVASLFHDVNSPGVEW----------KVRHKIAVGT 174
           +++LLG C  +G LY+I +++S+G++         PG+E+          ++  K  V  
Sbjct: 103 IITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 175 ----ARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPI 230
               ARG+ YL     ++ IHRD+ + N+L+T +   +I+DFGLA+ + +   +      
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 231 EGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDG-SHQSLHSWAKPILNQG 288
                 +APE     +   ++DV++FGV + EI + G  P  G   + L      +L +G
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK----LLKEG 275
Query: 289 EIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLE 333
                   R+    + T  N L      C  A P+ RPT  +++E
Sbjct: 276 H-------RMDKPANCT--NELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 72/268 (26%), Positives = 122/268 (45%), Gaps = 23/268 (8%)
Query: 68  FSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVL 127
           F+    +G+G + EV+KG+    +++   ++  +   + + ++   EI  +     P V 
Sbjct: 29  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 88
Query: 128 SLLGCCV-DNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQ 186
              G  + D  L++I ++   GS   L      P  E ++   I     +GL YLH    
Sbjct: 89  KYYGSYLKDTKLWIIMEYLGGGSALDLLEP--GPLDETQIA-TILREILKGLDYLH---S 142
Query: 187 RRIIHRDIKSSNILLTADFEPQISDFGLAKWLP-SQWTHHSIAPIEGTFGHLAPEYFMHG 245
            + IHRDIK++N+LL+   E +++DFG+A  L  +Q   ++     GT   +APE     
Sbjct: 143 EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV---GTPFWMAPEVIKQS 199
Query: 246 IVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVT 305
             D K D+++ G+  +E+  G  P    H  LH      L    I K   P L+G Y   
Sbjct: 200 AYDSKADIWSLGITAIELARGEPP----HSELHPMKVLFL----IPKNNPPTLEGNYS-- 249
Query: 306 QLNRLAFAASLCIRASPTWRPTMSEVLE 333
               L      C+   P++RPT  E+L+
Sbjct: 250 --KPLKEFVEACLNKEPSFRPTAKELLK 275

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 72/268 (26%), Positives = 122/268 (45%), Gaps = 23/268 (8%)
Query: 68  FSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVL 127
           F+    +G+G + EV+KG+    +++   ++  +   + + ++   EI  +     P V 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 128 SLLGCCV-DNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQ 186
              G  + D  L++I ++   GS   L      P  E ++   I     +GL YLH    
Sbjct: 69  KYYGSYLKDTKLWIIMEYLGGGSALDLLEP--GPLDETQIA-TILREILKGLDYLH---S 122
Query: 187 RRIIHRDIKSSNILLTADFEPQISDFGLAKWLP-SQWTHHSIAPIEGTFGHLAPEYFMHG 245
            + IHRDIK++N+LL+   E +++DFG+A  L  +Q   ++     GT   +APE     
Sbjct: 123 EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV---GTPFWMAPEVIKQS 179
Query: 246 IVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVT 305
             D K D+++ G+  +E+  G  P    H  LH      L    I K   P L+G Y   
Sbjct: 180 AYDSKADIWSLGITAIELARGEPP----HSELHPMKVLFL----IPKNNPPTLEGNYS-- 229
Query: 306 QLNRLAFAASLCIRASPTWRPTMSEVLE 333
               L      C+   P++RPT  E+L+
Sbjct: 230 --KPLKEFVEACLNKEPSFRPTAKELLK 255

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 75/285 (26%), Positives = 135/285 (47%), Gaps = 41/285 (14%)
Query: 74  VGRGGYAEVYK----GVLQDGEEIAVKRLTKVVTDDRKEKEF---LTEIGTIGHVC-HPN 125
           +G G + +V      G+ +D  + AV    K++ DD  EK+    ++E+  +  +  H N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 126 VLSLLGCCVDNG-LYLIFQFSSRGSVASLFHDVNSPGVEW----------KVRHKIAVGT 174
           +++LLG C  +G LY+I +++S+G++         PG+E+          ++  K  V  
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 175 ----ARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPI 230
               ARG+ YL     ++ IHRD+ + N+L+T +   +I+DFGLA+ + +   +      
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKKTTNG 219
Query: 231 EGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDG-SHQSLHSWAKPILNQG 288
                 +APE     +   ++DV++FGV + EI + G  P  G   + L      +L +G
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK----LLKEG 275
Query: 289 EIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLE 333
                   R+    + T  N L      C  A P+ RPT  +++E
Sbjct: 276 H-------RMDKPANCT--NELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 78/276 (28%), Positives = 140/276 (50%), Gaps = 34/276 (12%)
Query: 62  SIATNAFSSENLVGRGGYAEVYKGVLQD---GEEIAVKRLTKVVTDDRKEKE-FLTEIGT 117
           +I ++ +  + ++G+G + EV   + +D   G+E AVK ++K     + +KE  L E+  
Sbjct: 45  AIFSDRYKGQRVLGKGSFGEVI--LCKDKITGQECAVKVISKRQVKQKTDKESLLREVQL 102
Query: 118 IGHVCHPNVLSLLGCCVDNG-LYLIFQFSSRGSVASLFHDVNSPGVEWKV-RHKIAVGTA 175
           +  + HPN++ L     D G  YL+ +  + G    LF ++ S     +V   +I     
Sbjct: 103 LKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGE---LFDEIISRKRFSEVDAARIIRQVL 159
Query: 176 RGLHYLHKGCQRRIIHRDIKSSNILL---TADFEPQISDFGLAKWLPSQWTHHSIAPIEG 232
            G+ Y+HK    +I+HRD+K  N+LL   + D   +I DFGL+    +      +    G
Sbjct: 160 SGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS---KKMKDKIG 213
Query: 233 TFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEK 292
           T  ++APE  +HG  DEK DV++ GV L  ++SG  P +G+            N+ +I K
Sbjct: 214 TAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGCPPFNGA------------NEYDILK 260
Query: 293 LVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTM 328
            V+ + +  +++ Q  +++ +A   IR   T+ P+M
Sbjct: 261 KVE-KGKYTFELPQWKKVSESAKDLIRKMLTYVPSM 295

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 77/289 (26%), Positives = 140/289 (48%), Gaps = 49/289 (16%)
Query: 74  VGRGGYAEVYK----GVLQDGEEIAVKRLTKVVTDDRKEKEF---LTEIGTIGHVC-HPN 125
           +G G + +V      G+ +D  + AV    K++ DD  EK+    ++E+  +  +  H N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 126 VLSLLGCCVDNG-LYLIFQFSSRGSVASLFHDVNSPGVEW----------KVRHKIAVGT 174
           +++LLG C  +G LY+I +++S+G++         PG+E+          ++  K  V  
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 175 ----ARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPS----QWTHHS 226
               ARG+ YL     ++ IHRD+ + N+L+T +   +I+DFGLA+ + +    + T + 
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNG 219
Query: 227 IAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDG-SHQSLHSWAKPI 284
             P++     +APE     +   ++DV++FGV + EI + G  P  G   + L      +
Sbjct: 220 RLPVK----WMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK----L 271
Query: 285 LNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLE 333
           L +G        R+    + T  N L      C  A P+ RPT  +++E
Sbjct: 272 LKEGH-------RMDKPANCT--NELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 71/267 (26%), Positives = 119/267 (44%), Gaps = 21/267 (7%)
Query: 68  FSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVL 127
           F+    +G+G + EV+KG+    +++   ++  +   + + ++   EI  +     P V 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 128 SLLGCCV-DNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQ 186
              G  + D  L++I ++   GS   L      P  E ++   I     +GL YLH    
Sbjct: 69  KYYGSYLKDTKLWIIMEYLGGGSALDLLEP--GPLDETQIA-TILREILKGLDYLH---S 122
Query: 187 RRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGI 246
            + IHRDIK++N+LL+   E +++DFG+A  L       +     GT   +APE      
Sbjct: 123 EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNX--FVGTPFWMAPEVIKQSA 180
Query: 247 VDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQ 306
            D K D+++ G+  +E+  G  P    H  LH      L    I K   P L+G Y    
Sbjct: 181 YDSKADIWSLGITAIELARGEPP----HSELHPMKVLFL----IPKNNPPTLEGNYS--- 229
Query: 307 LNRLAFAASLCIRASPTWRPTMSEVLE 333
              L      C+   P++RPT  E+L+
Sbjct: 230 -KPLKEFVEACLNKEPSFRPTAKELLK 255

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 71/267 (26%), Positives = 119/267 (44%), Gaps = 21/267 (7%)
Query: 68  FSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVL 127
           F+    +G+G + EV+KG+    +++   ++  +   + + ++   EI  +     P V 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 128 SLLGCCV-DNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQ 186
              G  + D  L++I ++   GS   L      P  E ++   I     +GL YLH    
Sbjct: 84  KYYGSYLKDTKLWIIMEYLGGGSALDLLEP--GPLDETQIA-TILREILKGLDYLH---S 137
Query: 187 RRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGI 246
            + IHRDIK++N+LL+   E +++DFG+A  L       +     GT   +APE      
Sbjct: 138 EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNX--FVGTPFWMAPEVIKQSA 195
Query: 247 VDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQ 306
            D K D+++ G+  +E+  G  P    H  LH      L    I K   P L+G Y    
Sbjct: 196 YDSKADIWSLGITAIELARGEPP----HSELHPMKVLFL----IPKNNPPTLEGNYS--- 244
Query: 307 LNRLAFAASLCIRASPTWRPTMSEVLE 333
              L      C+   P++RPT  E+L+
Sbjct: 245 -KPLKEFVEACLNKEPSFRPTAKELLK 270

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 78/276 (28%), Positives = 140/276 (50%), Gaps = 34/276 (12%)
Query: 62  SIATNAFSSENLVGRGGYAEVYKGVLQD---GEEIAVKRLTKVVTDDRKEKE-FLTEIGT 117
           +I ++ +  + ++G+G + EV   + +D   G+E AVK ++K     + +KE  L E+  
Sbjct: 46  AIFSDRYKGQRVLGKGSFGEVI--LCKDKITGQECAVKVISKRQVKQKTDKESLLREVQL 103
Query: 118 IGHVCHPNVLSLLGCCVDNG-LYLIFQFSSRGSVASLFHDVNSPGVEWKV-RHKIAVGTA 175
           +  + HPN++ L     D G  YL+ +  + G    LF ++ S     +V   +I     
Sbjct: 104 LKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGE---LFDEIISRKRFSEVDAARIIRQVL 160
Query: 176 RGLHYLHKGCQRRIIHRDIKSSNILL---TADFEPQISDFGLAKWLPSQWTHHSIAPIEG 232
            G+ Y+HK    +I+HRD+K  N+LL   + D   +I DFGL+    +      +    G
Sbjct: 161 SGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS---KKMKDKIG 214
Query: 233 TFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEK 292
           T  ++APE  +HG  DEK DV++ GV L  ++SG  P +G+            N+ +I K
Sbjct: 215 TAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGCPPFNGA------------NEYDILK 261
Query: 293 LVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTM 328
            V+ + +  +++ Q  +++ +A   IR   T+ P+M
Sbjct: 262 KVE-KGKYTFELPQWKKVSESAKDLIRKMLTYVPSM 296

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 75/285 (26%), Positives = 135/285 (47%), Gaps = 41/285 (14%)
Query: 74  VGRGGYAEVYK----GVLQDGEEIAVKRLTKVVTDDRKEKEF---LTEIGTIGHVC-HPN 125
           +G G + +V      G+ +D  + AV    K++ DD  EK+    ++E+  +  +  H N
Sbjct: 35  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 94
Query: 126 VLSLLGCCVDNG-LYLIFQFSSRGSVASLFHDVNSPGVEW----------KVRHKIAVGT 174
           +++LLG C  +G LY+I +++S+G++         PG+E+          ++  K  V  
Sbjct: 95  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 154
Query: 175 ----ARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPI 230
               ARG+ YL     ++ IHRD+ + N+L+T +   +I+DFGLA+ + +   +      
Sbjct: 155 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 211
Query: 231 EGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDG-SHQSLHSWAKPILNQG 288
                 +APE     +   ++DV++FGV + EI + G  P  G   + L      +L +G
Sbjct: 212 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK----LLKEG 267
Query: 289 EIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLE 333
                   R+    + T  N L      C  A P+ RPT  +++E
Sbjct: 268 H-------RMDKPANCT--NELYMMMRDCWHAVPSQRPTFKQLVE 303

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 75/285 (26%), Positives = 134/285 (47%), Gaps = 41/285 (14%)
Query: 74  VGRGGYAEVYK----GVLQDGEEIAVKRLTKVVTDDRKEKEF---LTEIGTIGHVC-HPN 125
           +G G + +V      G+ +D  + AV    K++ DD  EK+    ++E+  +  +  H N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 126 VLSLLGCCVDNG-LYLIFQFSSRGSVASLFHDVNSPGVEW----------KVRHKIAVGT 174
           ++ LLG C  +G LY+I +++S+G++         PG+E+          ++  K  V  
Sbjct: 103 IIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 175 ----ARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPI 230
               ARG+ YL     ++ IHRD+ + N+L+T +   +I+DFGLA+ + +   +      
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 231 EGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDG-SHQSLHSWAKPILNQG 288
                 +APE     +   ++DV++FGV + EI + G  P  G   + L      +L +G
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK----LLKEG 275
Query: 289 EIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLE 333
                   R+    + T  N L      C  A P+ RPT  +++E
Sbjct: 276 H-------RMDKPANCT--NELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 75/285 (26%), Positives = 134/285 (47%), Gaps = 41/285 (14%)
Query: 74  VGRGGYAEVYK----GVLQDGEEIAVKRLTKVVTDDRKEKEF---LTEIGTIGHVC-HPN 125
           +G G + +V      G+ +D  + AV    K++ DD  EK+    ++E+  +  +  H N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 126 VLSLLGCCVDNG-LYLIFQFSSRGSVASLFHDVNSPGVEW----------KVRHKIAVGT 174
           +++LLG C  +G LY+I  ++S+G++         PG+E+          ++  K  V  
Sbjct: 103 IINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 175 ----ARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPI 230
               ARG+ YL     ++ IHRD+ + N+L+T +   +I+DFGLA+ + +   +      
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 231 EGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDG-SHQSLHSWAKPILNQG 288
                 +APE     +   ++DV++FGV + EI + G  P  G   + L      +L +G
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK----LLKEG 275
Query: 289 EIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLE 333
                   R+    + T  N L      C  A P+ RPT  +++E
Sbjct: 276 H-------RMDKPANCT--NELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 73/264 (27%), Positives = 121/264 (45%), Gaps = 27/264 (10%)
Query: 74  VGRGGYAEVYKGVLQDGEEI-AVKRLTKVVTDDRK-EKEFLTEIGTIGHVCHPNVLSLLG 131
           +G+G +  VY    +  + I A+K L K   +    E +   E+    H+ HPN+L L G
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 132 CCVD-NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRII 190
              D   +YLI +++ RG V      ++    +    +   +  A  L Y H    +R+I
Sbjct: 81  YFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELANA--LSYCH---SKRVI 135
Query: 191 HRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEK 250
           HRDIK  N+LL +  E +I+DFG +   PS         + GT  +L PE     + DEK
Sbjct: 136 HRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----XXLXGTLDYLPPEMIEGRMHDEK 191
Query: 251 TDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIE-KLVDPRLQGAYDVTQLNR 309
            D+++ GV   E + G+ P + +     ++ +       +E    D   +GA D+     
Sbjct: 192 VDLWSLGVLCYEFLVGKPPFEAN-----TYQETYKRISRVEFTFPDFVTEGARDLI---- 242
Query: 310 LAFAASLCIRASPTWRPTMSEVLE 333
                S  ++ +P+ RP + EVLE
Sbjct: 243 -----SRLLKHNPSQRPMLREVLE 261

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 75/285 (26%), Positives = 135/285 (47%), Gaps = 41/285 (14%)
Query: 74  VGRGGYAEVYK----GVLQDGEEIAVKRLTKVVTDDRKEKEF---LTEIGTIGHVC-HPN 125
           +G G + +V      G+ +D  + AV    K++ DD  EK+    ++E+  +  +  H N
Sbjct: 32  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 91
Query: 126 VLSLLGCCVDNG-LYLIFQFSSRGSVASLFHDVNSPGVEW----------KVRHKIAVGT 174
           +++LLG C  +G LY+I +++S+G++         PG+E+          ++  K  V  
Sbjct: 92  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 151
Query: 175 ----ARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPI 230
               ARG+ YL     ++ IHRD+ + N+L+T +   +I+DFGLA+ + +   +      
Sbjct: 152 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 208
Query: 231 EGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDG-SHQSLHSWAKPILNQG 288
                 +APE     +   ++DV++FGV + EI + G  P  G   + L      +L +G
Sbjct: 209 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK----LLKEG 264
Query: 289 EIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLE 333
                   R+    + T  N L      C  A P+ RPT  +++E
Sbjct: 265 H-------RMDKPANCT--NELYMMMRDCWHAVPSQRPTFKQLVE 300

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 75/285 (26%), Positives = 135/285 (47%), Gaps = 41/285 (14%)
Query: 74  VGRGGYAEVYK----GVLQDGEEIAVKRLTKVVTDDRKEKEF---LTEIGTIGHVC-HPN 125
           +G G + +V      G+ +D  + AV    K++ DD  EK+    ++E+  +  +  H N
Sbjct: 30  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 89
Query: 126 VLSLLGCCVDNG-LYLIFQFSSRGSVASLFHDVNSPGVEW----------KVRHKIAVGT 174
           +++LLG C  +G LY+I +++S+G++         PG+E+          ++  K  V  
Sbjct: 90  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 149
Query: 175 ----ARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPI 230
               ARG+ YL     ++ IHRD+ + N+L+T +   +I+DFGLA+ + +   +      
Sbjct: 150 TYQLARGMEYL---ASQKCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 206
Query: 231 EGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDG-SHQSLHSWAKPILNQG 288
                 +APE     +   ++DV++FGV + EI + G  P  G   + L      +L +G
Sbjct: 207 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK----LLKEG 262
Query: 289 EIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLE 333
                   R+    + T  N L      C  A P+ RPT  +++E
Sbjct: 263 H-------RMDKPANCT--NELYMMMRDCWHAVPSQRPTFKQLVE 298

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 76/289 (26%), Positives = 137/289 (47%), Gaps = 49/289 (16%)
Query: 74  VGRGGYAEVYK----GVLQDGEEIAVKRLTKVVTDDRKEKEF---LTEIGTIGHVC-HPN 125
           +G G + +V      G+ +D  + AV    K++ DD  EK+    ++E+  +  +  H N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 126 VLSLLGCCVDNG-LYLIFQFSSRGSVASLFHDVNSPGVE--------------WKVRHKI 170
           +++LLG C  +G LY+I +++S+G++         PG+E              +K     
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDLVSC 162
Query: 171 AVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPS----QWTHHS 226
               ARG+ YL     ++ IHRD+ + N+L+T +   +I+DFGLA+ + +    + T + 
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNG 219
Query: 227 IAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDG-SHQSLHSWAKPI 284
             P++     +APE     +   ++DV++FGV + EI + G  P  G   + L      +
Sbjct: 220 RLPVK----WMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK----L 271
Query: 285 LNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLE 333
           L +G        R+    + T  N L      C  A P+ RPT  +++E
Sbjct: 272 LKEGH-------RMDKPANCT--NELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 75/285 (26%), Positives = 135/285 (47%), Gaps = 41/285 (14%)
Query: 74  VGRGGYAEVYK----GVLQDGEEIAVKRLTKVVTDDRKEKEF---LTEIGTIGHVC-HPN 125
           +G G + +V      G+ +D  + AV    K++ DD  EK+    ++E+  +  +  H N
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 126 VLSLLGCCVDNG-LYLIFQFSSRGSVASLFHDVNSPGVEW----------KVRHKIAVGT 174
           +++LLG C  +G LY+I +++S+G++         PG+E+          ++  K  V  
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 208
Query: 175 ----ARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPI 230
               ARG+ YL     ++ IHRD+ + N+L+T +   +I+DFGLA+ + +   +      
Sbjct: 209 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 265
Query: 231 EGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDG-SHQSLHSWAKPILNQG 288
                 +APE     +   ++DV++FGV + EI + G  P  G   + L      +L +G
Sbjct: 266 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK----LLKEG 321
Query: 289 EIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLE 333
                   R+    + T  N L      C  A P+ RPT  +++E
Sbjct: 322 H-------RMDKPANCT--NELYMMMRDCWHAVPSQRPTFKQLVE 357

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 75/285 (26%), Positives = 134/285 (47%), Gaps = 41/285 (14%)
Query: 74  VGRGGYAEVYK----GVLQDGEEIAVKRLTKVVTDDRKEKEF---LTEIGTIGHVC-HPN 125
           +G G + +V      G+ +D  + AV    K++ DD  EK+    ++E+  +  +  H N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 126 VLSLLGCCVDNG-LYLIFQFSSRGSVASLFHDVNSPGVEW----------KVRHKIAVGT 174
           +++LLG C  +G LY+I  ++S+G++         PG+E+          ++  K  V  
Sbjct: 103 IINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 175 ----ARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPI 230
               ARG+ YL     ++ IHRD+ + N+L+T +   +I+DFGLA+ + +   +      
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 231 EGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDG-SHQSLHSWAKPILNQG 288
                 +APE     +   ++DV++FGV + EI + G  P  G   + L      +L +G
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK----LLKEG 275
Query: 289 EIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLE 333
                   R+    + T  N L      C  A P+ RPT  +++E
Sbjct: 276 H-------RMDKPANCT--NELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 74/285 (25%), Positives = 135/285 (47%), Gaps = 41/285 (14%)
Query: 74  VGRGGYAEVYK----GVLQDGEEIAVKRLTKVVTDDRKEKEF---LTEIGTIGHVC-HPN 125
           +G G + +V      G+ +D  + AV    K++ DD  E++    ++E+  +  +  H N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKHKN 102
Query: 126 VLSLLGCCVDNG-LYLIFQFSSRGSVASLFHDVNSPGVEW----------KVRHKIAVGT 174
           +++LLG C  +G LY+I +++S+G++         PG+E+          ++  K  V  
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 175 ----ARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPI 230
               ARG+ YL     ++ IHRD+ + N+L+T +   +I+DFGLA+ + +   +      
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 231 EGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDG-SHQSLHSWAKPILNQG 288
                 +APE     +   ++DV++FGV + EI + G  P  G   + L      +L +G
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK----LLKEG 275
Query: 289 EIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLE 333
                   R+    + T  N L      C  A P+ RPT  +++E
Sbjct: 276 H-------RMDKPANCT--NELYMMMRDCWHAVPSQRPTFKQLVE 311

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 107/206 (51%), Gaps = 9/206 (4%)
Query: 72  NLVGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEK---EFLTEIGTIGHVCHPNVL 127
            ++G G +  VYKG+ + +GE + +    K++ +    K   EF+ E   +  + HP+++
Sbjct: 21  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 80
Query: 128 SLLGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQR 187
            LLG C+   + L+ Q    G +    H+ +   +  ++     V  A+G+ YL    +R
Sbjct: 81  RLLGVCLSPTIQLVTQLMPHGCLLEYVHE-HKDNIGSQLLLNWCVQIAKGMMYLE---ER 136
Query: 188 RIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIV 247
           R++HRD+ + N+L+ +    +I+DFGLA+ L      ++    +     +A E   +   
Sbjct: 137 RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKF 196
Query: 248 DEKTDVFAFGVFLLEIIS-GRKPVDG 272
             ++DV+++GV + E+++ G KP DG
Sbjct: 197 THQSDVWSYGVTIWELMTFGGKPYDG 222

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 74/264 (28%), Positives = 124/264 (46%), Gaps = 27/264 (10%)
Query: 74  VGRGGYAEVYKGVLQDGEEI-AVKRLTKVVTDDRK-EKEFLTEIGTIGHVCHPNVLSLLG 131
           +G+G +  VY    +  + I A+K L K   +    E +   E+    H+ HPN+L L G
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 132 CCVD-NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRII 190
              D   +YLI +++ RG V      ++    +    +   +  A  L Y H    +R+I
Sbjct: 81  YFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELANA--LSYCH---SKRVI 135
Query: 191 HRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEK 250
           HRDIK  N+LL +  E +I+DFG +   PS         + GT  +L PE     + DEK
Sbjct: 136 HRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGTLDYLPPEMIEGRMHDEK 191
Query: 251 TDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIE-KLVDPRLQGAYDVTQLNR 309
            D+++ GV   E + G+ P + +     ++ +       +E    D   +GA D+  ++R
Sbjct: 192 VDLWSLGVLCYEFLVGKPPFEAN-----TYQETYKRISRVEFTFPDFVTEGARDL--ISR 244
Query: 310 LAFAASLCIRASPTWRPTMSEVLE 333
           L       ++ +P+ RP + EVLE
Sbjct: 245 L-------LKHNPSQRPMLREVLE 261

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 107/206 (51%), Gaps = 9/206 (4%)
Query: 72  NLVGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEK---EFLTEIGTIGHVCHPNVL 127
            ++G G +  VYKG+ + +GE + +    K++ +    K   EF+ E   +  + HP+++
Sbjct: 44  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 103
Query: 128 SLLGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQR 187
            LLG C+   + L+ Q    G +    H+ +   +  ++     V  A+G+ YL    +R
Sbjct: 104 RLLGVCLSPTIQLVTQLMPHGCLLEYVHE-HKDNIGSQLLLNWCVQIAKGMMYLE---ER 159
Query: 188 RIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIV 247
           R++HRD+ + N+L+ +    +I+DFGLA+ L      ++    +     +A E   +   
Sbjct: 160 RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKF 219
Query: 248 DEKTDVFAFGVFLLEIIS-GRKPVDG 272
             ++DV+++GV + E+++ G KP DG
Sbjct: 220 THQSDVWSYGVTIWELMTFGGKPYDG 245

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 74/264 (28%), Positives = 125/264 (47%), Gaps = 27/264 (10%)
Query: 74  VGRGGYAEVYKGVLQDGEEI-AVKRLTKVVTDDRK-EKEFLTEIGTIGHVCHPNVLSLLG 131
           +G+G +  VY    +  + I A+K L K   +    E +   E+    H+ HPN+L L G
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 132 CCVD-NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRII 190
              D   +YLI +++  G+V      ++    +    +   +  A  L Y H    +R+I
Sbjct: 79  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA--LSYCH---SKRVI 133
Query: 191 HRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEK 250
           HRDIK  N+LL +  E +I+DFG +   PS       A + GT  +L PE     + DEK
Sbjct: 134 HRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----AALCGTLDYLPPEMIEGRMHDEK 189
Query: 251 TDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIE-KLVDPRLQGAYDVTQLNR 309
            D+++ GV   E + G+ P + +     ++ +       +E    D   +GA D+  ++R
Sbjct: 190 VDLWSLGVLCYEFLVGKPPFEAN-----TYQETYKRISRVEFTFPDFVTEGARDL--ISR 242
Query: 310 LAFAASLCIRASPTWRPTMSEVLE 333
           L       ++ +P+ RP + EVLE
Sbjct: 243 L-------LKHNPSQRPMLREVLE 259

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 73/264 (27%), Positives = 122/264 (46%), Gaps = 27/264 (10%)
Query: 74  VGRGGYAEVYKGVLQDGEEI-AVKRLTKVVTDDRK-EKEFLTEIGTIGHVCHPNVLSLLG 131
           +G+G +  VY    +  + I A+K L K   +    E +   E+    H+ HPN+L L G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 132 CCVD-NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRII 190
              D   +YLI +++  G+V      ++    +    +   +  A  L Y H    +R+I
Sbjct: 76  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA--LSYCH---SKRVI 130
Query: 191 HRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEK 250
           HRDIK  N+LL +  E +I+DFG +   PS       A + GT  +L PE     + DEK
Sbjct: 131 HRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRAALCGTLDYLPPEMIEGRMHDEK 186
Query: 251 TDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIE-KLVDPRLQGAYDVTQLNR 309
            D+++ GV   E + G+ P + +     ++ +       +E    D   +GA D+     
Sbjct: 187 VDLWSLGVLCYEFLVGKPPFEAN-----TYQETYKRISRVEFTFPDFVTEGARDLI---- 237
Query: 310 LAFAASLCIRASPTWRPTMSEVLE 333
                S  ++ +P+ RP + EVLE
Sbjct: 238 -----SRLLKHNPSQRPMLREVLE 256

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 72/264 (27%), Positives = 121/264 (45%), Gaps = 27/264 (10%)
Query: 74  VGRGGYAEVYKGVLQDGEEI-AVKRLTKVVTDDRK-EKEFLTEIGTIGHVCHPNVLSLLG 131
           +G+G +  VY    +  + I A+K L K   +    E +   E+    H+ HPN+L L G
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 132 CCVD-NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRII 190
              D   +YLI +++  G+V      ++    +    +   +  A  L Y H    +R+I
Sbjct: 77  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA--LSYCH---SKRVI 131
Query: 191 HRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEK 250
           HRDIK  N+LL +  E +I+DFG +   PS         + GT  +L PE     + DEK
Sbjct: 132 HRDIKPENLLLGSAGELKIADFGWSCHAPSSRR----TTLSGTLDYLPPEMIEGRMHDEK 187
Query: 251 TDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIE-KLVDPRLQGAYDVTQLNR 309
            D+++ GV   E + G+ P + +     ++ +       +E    D   +GA D+     
Sbjct: 188 VDLWSLGVLCYEFLVGKPPFEAN-----TYQETYKRISRVEFTFPDFVTEGARDLI---- 238
Query: 310 LAFAASLCIRASPTWRPTMSEVLE 333
                S  ++ +P+ RP + EVLE
Sbjct: 239 -----SRLLKHNPSQRPMLREVLE 257

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 61/239 (25%), Positives = 105/239 (43%), Gaps = 27/239 (11%)
Query: 38  ENVVVACESETTKPTWRCFSFEEISIATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKR 97
           + + V C S   +  W   ++E   I   +   E  +G G + EV+        ++AVK 
Sbjct: 157 QKLSVPCMSSKPQKPWEKDAWE---IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKT 213
Query: 98  LTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNGLYLIFQFSSRGSVASLFHDV 157
           +          + FL E   +  + H  ++ L        +Y+I +F ++GS+       
Sbjct: 214 MK---PGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPIYIITEFMAKGSLLDFLKSD 270
Query: 158 NSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKW 217
                        +   A G+ ++    QR  IHRD++++NIL++A    +I+DFGLA+ 
Sbjct: 271 EGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARV 327
Query: 218 ---LPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDG 272
               P +WT              APE    G    K+DV++FG+ L+EI++ GR P  G
Sbjct: 328 GAKFPIKWT--------------APEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPG 372

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 72/264 (27%), Positives = 121/264 (45%), Gaps = 27/264 (10%)
Query: 74  VGRGGYAEVYKGVLQDGEEI-AVKRLTKVVTDDRK-EKEFLTEIGTIGHVCHPNVLSLLG 131
           +G+G +  VY    +  + I A+K L K   +    E +   E+    H+ HPN+L L G
Sbjct: 33  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 92
Query: 132 CCVD-NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRII 190
              D   +YLI +++  G+V      ++    +    +   +  A  L Y H    +R+I
Sbjct: 93  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA--LSYCH---SKRVI 147
Query: 191 HRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEK 250
           HRDIK  N+LL +  E +I+DFG +   PS         + GT  +L PE     + DEK
Sbjct: 148 HRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGTLDYLPPEMIEGRMHDEK 203
Query: 251 TDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIE-KLVDPRLQGAYDVTQLNR 309
            D+++ GV   E + G+ P + +     ++ +       +E    D   +GA D+     
Sbjct: 204 VDLWSLGVLCYEFLVGKPPFEAN-----TYQETYKRISRVEFTFPDFVTEGARDLI---- 254
Query: 310 LAFAASLCIRASPTWRPTMSEVLE 333
                S  ++ +P+ RP + EVLE
Sbjct: 255 -----SRLLKHNPSQRPMLREVLE 273

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/239 (26%), Positives = 111/239 (46%), Gaps = 17/239 (7%)
Query: 38  ENVVVACESETTKPTWRCFSFEEISIATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKR 97
           + + V C S   +  W   ++E   I   +   E  +G G + EV+        ++AVK 
Sbjct: 163 QKLSVPCMSSKPQKPWEKDAWE---IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKT 219
Query: 98  LTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNGLYLIFQFSSRGSVASLFHDV 157
           +          + FL E   +  + H  ++ L        +Y+I +F ++GS+       
Sbjct: 220 MK---PGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPIYIITEFMAKGSLLDFLKSD 276
Query: 158 NSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKW 217
                        +   A G+ ++    QR  IHRD++++NIL++A    +I+DFGLA+ 
Sbjct: 277 EGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARV 333
Query: 218 LP-SQWTHHSIA--PIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDG 272
           +  +++T    A  PI+ T    APE    G    K+DV++FG+ L+EI++ GR P  G
Sbjct: 334 IEDNEYTAREGAKFPIKWT----APEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPG 388

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 72/264 (27%), Positives = 123/264 (46%), Gaps = 27/264 (10%)
Query: 74  VGRGGYAEVYKGVLQDGEEI-AVKRLTKVVTDDRK-EKEFLTEIGTIGHVCHPNVLSLLG 131
           +G+G +  VY    ++ + I A+K L K   +    E +   E+    H+ HPN+L L G
Sbjct: 16  LGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 132 CCVDNG-LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRII 190
              D+  +YLI +++  G+V      ++    +    +   +  A  L Y H    +++I
Sbjct: 76  YFHDSTRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA--LSYCH---SKKVI 130
Query: 191 HRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEK 250
           HRDIK  N+LL +  E +I+DFG +   PS       A + GT  +L PE     + DEK
Sbjct: 131 HRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRAALCGTLDYLPPEMIEGRMHDEK 186
Query: 251 TDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIE-KLVDPRLQGAYDVTQLNR 309
            D+++ GV   E + G+ P + +     ++         +E    D   +GA D+     
Sbjct: 187 VDLWSLGVLCYEFLVGKPPFEAN-----TYQDTYKRISRVEFTFPDFVTEGARDLI---- 237
Query: 310 LAFAASLCIRASPTWRPTMSEVLE 333
                S  ++ +P+ RP + EVLE
Sbjct: 238 -----SRLLKHNPSQRPMLREVLE 256

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 73/264 (27%), Positives = 124/264 (46%), Gaps = 27/264 (10%)
Query: 74  VGRGGYAEVYKGVLQDGEEI-AVKRLTKVVTDDRK-EKEFLTEIGTIGHVCHPNVLSLLG 131
           +G+G +  VY    +  + I A+K L K   +    E +   E+    H+ HPN+L L G
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 132 CCVD-NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRII 190
              D   +YLI +++  G+V      ++    +    +   +  A  L Y H    +R+I
Sbjct: 81  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA--LSYCH---SKRVI 135
Query: 191 HRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEK 250
           HRDIK  N+LL +  E +I+DFG +   PS         + GT  +L PE     + DEK
Sbjct: 136 HRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGTLDYLPPEMIEGRMHDEK 191
Query: 251 TDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIE-KLVDPRLQGAYDVTQLNR 309
            D+++ GV   E + G+ P + +     ++ +       +E    D   +GA D+  ++R
Sbjct: 192 VDLWSLGVLCYEFLVGKPPFEAN-----TYQETYKRISRVEFTFPDFVTEGARDL--ISR 244
Query: 310 LAFAASLCIRASPTWRPTMSEVLE 333
           L       ++ +P+ RP + EVLE
Sbjct: 245 L-------LKHNPSQRPMLREVLE 261

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 73/264 (27%), Positives = 124/264 (46%), Gaps = 27/264 (10%)
Query: 74  VGRGGYAEVYKGVLQDGEEI-AVKRLTKVVTDDRK-EKEFLTEIGTIGHVCHPNVLSLLG 131
           +G+G +  VY    +  + I A+K L K   +    E +   E+    H+ HPN+L L G
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 132 CCVD-NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRII 190
              D   +YLI +++  G+V      ++    +    +   +  A  L Y H    +R+I
Sbjct: 79  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA--LSYCH---SKRVI 133
Query: 191 HRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEK 250
           HRDIK  N+LL +  E +I+DFG +   PS         + GT  +L PE     + DEK
Sbjct: 134 HRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRTTLCGTLDYLPPEMIEGRMHDEK 189
Query: 251 TDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIE-KLVDPRLQGAYDVTQLNR 309
            D+++ GV   E + G+ P + +     ++ +       +E    D   +GA D+  ++R
Sbjct: 190 VDLWSLGVLCYEFLVGKPPFEAN-----TYQETYKRISRVEFTFPDFVTEGARDL--ISR 242
Query: 310 LAFAASLCIRASPTWRPTMSEVLE 333
           L       ++ +P+ RP + EVLE
Sbjct: 243 L-------LKHNPSQRPMLREVLE 259

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 73/264 (27%), Positives = 124/264 (46%), Gaps = 27/264 (10%)
Query: 74  VGRGGYAEVYKGVLQDGEEI-AVKRLTKVVTDDRK-EKEFLTEIGTIGHVCHPNVLSLLG 131
           +G+G +  VY    +  + I A+K L K   +    E +   E+    H+ HPN+L L G
Sbjct: 42  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 101
Query: 132 CCVD-NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRII 190
              D   +YLI +++  G+V      ++    +    +   +  A  L Y H    +R+I
Sbjct: 102 YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA--LSYCH---SKRVI 156
Query: 191 HRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEK 250
           HRDIK  N+LL +  E +I+DFG +   PS         + GT  +L PE     + DEK
Sbjct: 157 HRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGTLDYLPPEMIEGRMHDEK 212
Query: 251 TDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIE-KLVDPRLQGAYDVTQLNR 309
            D+++ GV   E + G+ P + +     ++ +       +E    D   +GA D+  ++R
Sbjct: 213 VDLWSLGVLCYEFLVGKPPFEAN-----TYQETYKRISRVEFTFPDFVTEGARDL--ISR 265
Query: 310 LAFAASLCIRASPTWRPTMSEVLE 333
           L       ++ +P+ RP + EVLE
Sbjct: 266 L-------LKHNPSQRPMLREVLE 282

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 72/264 (27%), Positives = 121/264 (45%), Gaps = 27/264 (10%)
Query: 74  VGRGGYAEVYKGVLQDGEEI-AVKRLTKVVTDDRK-EKEFLTEIGTIGHVCHPNVLSLLG 131
           +G+G +  VY    +  + I A+K L K   +    E +   E+    H+ HPN+L L G
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 132 CCVD-NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRII 190
              D   +YLI +++  G+V      ++    +    +   +  A  L Y H    +R+I
Sbjct: 77  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA--LSYCH---SKRVI 131
Query: 191 HRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEK 250
           HRDIK  N+LL +  E +I+DFG +   PS         + GT  +L PE     + DEK
Sbjct: 132 HRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRTDLCGTLDYLPPEMIEGRMHDEK 187
Query: 251 TDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIE-KLVDPRLQGAYDVTQLNR 309
            D+++ GV   E + G+ P + +     ++ +       +E    D   +GA D+     
Sbjct: 188 VDLWSLGVLCYEFLVGKPPFEAN-----TYQETYKRISRVEFTFPDFVTEGARDLI---- 238
Query: 310 LAFAASLCIRASPTWRPTMSEVLE 333
                S  ++ +P+ RP + EVLE
Sbjct: 239 -----SRLLKHNPSQRPMLREVLE 257

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 72/264 (27%), Positives = 121/264 (45%), Gaps = 27/264 (10%)
Query: 74  VGRGGYAEVYKGVLQDGEEI-AVKRLTKVVTDDRK-EKEFLTEIGTIGHVCHPNVLSLLG 131
           +G+G +  VY    +  + I A+K L K   +    E +   E+    H+ HPN+L L G
Sbjct: 18  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 77
Query: 132 CCVD-NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRII 190
              D   +YLI +++  G+V      ++    +    +   +  A  L Y H    +R+I
Sbjct: 78  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA--LSYCH---SKRVI 132
Query: 191 HRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEK 250
           HRDIK  N+LL +  E +I+DFG +   PS         + GT  +L PE     + DEK
Sbjct: 133 HRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----XXLCGTLDYLPPEMIEGRMHDEK 188
Query: 251 TDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIE-KLVDPRLQGAYDVTQLNR 309
            D+++ GV   E + G+ P + +     ++ +       +E    D   +GA D+     
Sbjct: 189 VDLWSLGVLCYEFLVGKPPFEAN-----TYQETYKRISRVEFTFPDFVTEGARDLI---- 239
Query: 310 LAFAASLCIRASPTWRPTMSEVLE 333
                S  ++ +P+ RP + EVLE
Sbjct: 240 -----SRLLKHNPSQRPMLREVLE 258

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 72/264 (27%), Positives = 121/264 (45%), Gaps = 27/264 (10%)
Query: 74  VGRGGYAEVYKGVLQDGEEI-AVKRLTKVVTDDRK-EKEFLTEIGTIGHVCHPNVLSLLG 131
           +G+G +  VY    +  + I A+K L K   +    E +   E+    H+ HPN+L L G
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 132 CCVD-NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRII 190
              D   +YLI +++  G+V      ++    +    +   +  A  L Y H    +R+I
Sbjct: 81  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA--LSYCH---SKRVI 135
Query: 191 HRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEK 250
           HRDIK  N+LL +  E +I+DFG +   PS         + GT  +L PE     + DEK
Sbjct: 136 HRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TDLCGTLDYLPPEMIEGRMHDEK 191
Query: 251 TDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIE-KLVDPRLQGAYDVTQLNR 309
            D+++ GV   E + G+ P + +     ++ +       +E    D   +GA D+     
Sbjct: 192 VDLWSLGVLCYEFLVGKPPFEAN-----TYQETYKRISRVEFTFPDFVTEGARDLI---- 242
Query: 310 LAFAASLCIRASPTWRPTMSEVLE 333
                S  ++ +P+ RP + EVLE
Sbjct: 243 -----SRLLKHNPSQRPMLREVLE 261

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 79/276 (28%), Positives = 139/276 (50%), Gaps = 36/276 (13%)
Query: 62  SIATNAFSSENLVGRGGYAEVYKGVLQD---GEEIAVKRLTKVVTDDRKEKE-FLTEIGT 117
           +I ++ +  + ++G+G + EV   + +D   G+E AVK ++K     + +KE  L E+  
Sbjct: 22  AIFSDRYKGQRVLGKGSFGEVI--LCKDKITGQECAVKVISKRQVKQKTDKESLLREVQL 79
Query: 118 IGHVCHPNVLSLLGCCVDNG-LYLIFQFSSRGSVASLFHDVNSPGVEWKV-RHKIAVGTA 175
           +  + HPN+  L     D G  YL+ +  + G    LF ++ S     +V   +I     
Sbjct: 80  LKQLDHPNIXKLYEFFEDKGYFYLVGEVYTGGE---LFDEIISRKRFSEVDAARIIRQVL 136
Query: 176 RGLHYLHKGCQRRIIHRDIKSSNILL---TADFEPQISDFGLAK-WLPSQWTHHSIAPIE 231
            G+ Y HK    +I+HRD+K  N+LL   + D   +I DFGL+  +  S+     I    
Sbjct: 137 SGITYXHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKXKDKI---- 189
Query: 232 GTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIE 291
           GT  ++APE  +HG  DEK DV++ GV L  ++SG  P +G+            N+ +I 
Sbjct: 190 GTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGCPPFNGA------------NEYDIL 236
Query: 292 KLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPT 327
           K V+ + +  +++ Q  +++ +A   IR   T+ P+
Sbjct: 237 KKVE-KGKYTFELPQWKKVSESAKDLIRKXLTYVPS 271

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 104/202 (51%), Gaps = 13/202 (6%)
Query: 74  VGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC- 132
           +G G + +VYK   ++   +A  ++    +++  E +++ EI  +    HPN++ LL   
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELE-DYMVEIDILASCDHPNIVKLLDAF 103
Query: 133 CVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHR 192
             +N L+++ +F + G+V ++  ++  P  E +++  +   T   L+YLH     +IIHR
Sbjct: 104 YYENNLWILIEFCAGGAVDAVMLELERPLTESQIQ-VVCKQTLDALNYLHDN---KIIHR 159
Query: 193 DIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGI-----V 247
           D+K+ NIL T D + +++DFG++    +  T        GT   +APE  M         
Sbjct: 160 DLKAGNILFTLDGDIKLADFGVSA--KNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPY 217
Query: 248 DEKTDVFAFGVFLLEIISGRKP 269
           D K DV++ G+ L+E+     P
Sbjct: 218 DYKADVWSLGITLIEMAEIEPP 239

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 73/264 (27%), Positives = 124/264 (46%), Gaps = 27/264 (10%)
Query: 74  VGRGGYAEVYKGVLQDGEEI-AVKRLTKVVTDDRK-EKEFLTEIGTIGHVCHPNVLSLLG 131
           +G+G +  VY    +  + I A+K L K   +    E +   E+    H+ HPN+L L G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 132 CCVD-NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRII 190
              D   +YLI +++  G+V      ++    +    +   +  A  L Y H    +R+I
Sbjct: 76  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA--LSYCH---SKRVI 130
Query: 191 HRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEK 250
           HRDIK  N+LL +  E +I+DFG +   PS         + GT  +L PE     + DEK
Sbjct: 131 HRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRTTLCGTLDYLPPEMIEGRMHDEK 186
Query: 251 TDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIE-KLVDPRLQGAYDVTQLNR 309
            D+++ GV   E + G+ P + +     ++ +       +E    D   +GA D+  ++R
Sbjct: 187 VDLWSLGVLCYEFLVGKPPFEAN-----TYQETYKRISRVEFTFPDFVTEGARDL--ISR 239
Query: 310 LAFAASLCIRASPTWRPTMSEVLE 333
           L       ++ +P+ RP + EVLE
Sbjct: 240 L-------LKHNPSQRPMLREVLE 256

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 72/264 (27%), Positives = 121/264 (45%), Gaps = 27/264 (10%)
Query: 74  VGRGGYAEVYKGVLQDGEEI-AVKRLTKVVTDDRK-EKEFLTEIGTIGHVCHPNVLSLLG 131
           +G+G +  VY    +  + I A+K L K   +    E +   E+    H+ HPN+L L G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 132 CCVD-NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRII 190
              D   +YLI +++  G+V      ++    +    +   +  A  L Y H    +R+I
Sbjct: 76  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA--LSYCH---SKRVI 130
Query: 191 HRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEK 250
           HRDIK  N+LL +  E +I+DFG +   PS         + GT  +L PE     + DEK
Sbjct: 131 HRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TELCGTLDYLPPEMIEGRMHDEK 186
Query: 251 TDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIE-KLVDPRLQGAYDVTQLNR 309
            D+++ GV   E + G+ P + +     ++ +       +E    D   +GA D+     
Sbjct: 187 VDLWSLGVLCYEFLVGKPPFEAN-----TYQETYKRISRVEFTFPDFVTEGARDLI---- 237
Query: 310 LAFAASLCIRASPTWRPTMSEVLE 333
                S  ++ +P+ RP + EVLE
Sbjct: 238 -----SRLLKHNPSQRPMLREVLE 256

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 72/264 (27%), Positives = 121/264 (45%), Gaps = 27/264 (10%)
Query: 74  VGRGGYAEVYKGVLQDGEEI-AVKRLTKVVTDDRK-EKEFLTEIGTIGHVCHPNVLSLLG 131
           +G+G +  VY    +  + I A+K L K   +    E +   E+    H+ HPN+L L G
Sbjct: 42  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 101
Query: 132 CCVD-NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRII 190
              D   +YLI +++  G+V      ++    +    +   +  A  L Y H    +R+I
Sbjct: 102 YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA--LSYCH---SKRVI 156
Query: 191 HRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEK 250
           HRDIK  N+LL +  E +I+DFG +   PS         + GT  +L PE     + DEK
Sbjct: 157 HRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDD----LCGTLDYLPPEMIEGRMHDEK 212
Query: 251 TDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIE-KLVDPRLQGAYDVTQLNR 309
            D+++ GV   E + G+ P + +     ++ +       +E    D   +GA D+     
Sbjct: 213 VDLWSLGVLCYEFLVGKPPFEAN-----TYQETYKRISRVEFTFPDFVTEGARDLI---- 263
Query: 310 LAFAASLCIRASPTWRPTMSEVLE 333
                S  ++ +P+ RP + EVLE
Sbjct: 264 -----SRLLKHNPSQRPMLREVLE 282

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 72/264 (27%), Positives = 121/264 (45%), Gaps = 27/264 (10%)
Query: 74  VGRGGYAEVYKGVLQDGEEI-AVKRLTKVVTDDRK-EKEFLTEIGTIGHVCHPNVLSLLG 131
           +G+G +  VY    +  + I A+K L K   +    E +   E+    H+ HPN+L L G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 132 CCVD-NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRII 190
              D   +YLI +++  G+V      ++    +    +   +  A  L Y H    +R+I
Sbjct: 76  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA--LSYCH---SKRVI 130
Query: 191 HRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEK 250
           HRDIK  N+LL +  E +I+DFG +   PS         + GT  +L PE     + DEK
Sbjct: 131 HRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRTDLCGTLDYLPPEMIEGRMHDEK 186
Query: 251 TDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIE-KLVDPRLQGAYDVTQLNR 309
            D+++ GV   E + G+ P + +     ++ +       +E    D   +GA D+     
Sbjct: 187 VDLWSLGVLCYEFLVGKPPFEAN-----TYQETYKRISRVEFTFPDFVTEGARDLI---- 237
Query: 310 LAFAASLCIRASPTWRPTMSEVLE 333
                S  ++ +P+ RP + EVLE
Sbjct: 238 -----SRLLKHNPSQRPMLREVLE 256

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 68/268 (25%), Positives = 117/268 (43%), Gaps = 23/268 (8%)
Query: 68  FSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVL 127
           F+  + +G+G + EVYKG+    +E+   ++  +   + + ++   EI  +     P + 
Sbjct: 21  FTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 80
Query: 128 SLLGCCVDN-GLYLIFQFSSRGSVASLFHDVNSPG-VEWKVRHKIAVGTARGLHYLHKGC 185
              G  + +  L++I ++   GS   L      PG +E      I     +GL YLH   
Sbjct: 81  RYFGSYLKSTKLWIIMEYLGGGSALDLL----KPGPLEETYIATILREILKGLDYLH--- 133
Query: 186 QRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHG 245
             R IHRDIK++N+LL+   + +++DFG+A  L       +     GT   +APE     
Sbjct: 134 SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNX--FVGTPFWMAPEVIKQS 191
Query: 246 IVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVT 305
             D K D+++ G+  +E+  G  P    H        P+     I K   P L+G +   
Sbjct: 192 AYDFKADIWSLGITAIELAKGEPPNSDLH--------PMRVLFLIPKNSPPTLEGQHS-- 241
Query: 306 QLNRLAFAASLCIRASPTWRPTMSEVLE 333
                      C+   P +RPT  E+L+
Sbjct: 242 --KPFKEFVEACLNKDPRFRPTAKELLK 267

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 74/290 (25%), Positives = 127/290 (43%), Gaps = 30/290 (10%)
Query: 50  KPTWRCFSFEEISIATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEK 109
           KP W     +E  +          +G G + EV+ G      ++AVK L +         
Sbjct: 1   KPWWE----DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQ---GSMSPD 53
Query: 110 EFLTEIGTIGHVCHPNVLSLLGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHK 169
            FL E   +  + H  ++ L        +Y+I ++   GS+       +   +       
Sbjct: 54  AFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLD 113
Query: 170 IAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLP-SQWTHHSIA 228
           +A   A G+ ++    +R  IHRD++++NIL++     +I+DFGLA+ +  +++T    A
Sbjct: 114 MAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGA 170
Query: 229 --PIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPIL 285
             PI+ T    APE   +G    K+DV++FG+ L EI++ GR P  G         + I 
Sbjct: 171 KFPIKWT----APEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP-----EVIQ 221
Query: 286 NQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVM 335
           N     ++V P      ++ QL R      LC +  P  RPT   +  V+
Sbjct: 222 NLERGYRMVRPD-NCPEELYQLMR------LCWKERPEDRPTFDYLRSVL 264

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 72/264 (27%), Positives = 121/264 (45%), Gaps = 27/264 (10%)
Query: 74  VGRGGYAEVYKGVLQDGEEI-AVKRLTKVVTDDRK-EKEFLTEIGTIGHVCHPNVLSLLG 131
           +G+G +  VY    +  + I A+K L K   +    E +   E+    H+ HPN+L L G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 132 CCVD-NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRII 190
              D   +YLI +++  G+V      ++    +    +   +  A  L Y H    +R+I
Sbjct: 76  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA--LSYCH---SKRVI 130
Query: 191 HRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEK 250
           HRDIK  N+LL +  E +I+DFG +   PS         + GT  +L PE     + DEK
Sbjct: 131 HRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TDLCGTLDYLPPEMIEGRMHDEK 186
Query: 251 TDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIE-KLVDPRLQGAYDVTQLNR 309
            D+++ GV   E + G+ P + +     ++ +       +E    D   +GA D+     
Sbjct: 187 VDLWSLGVLCYEFLVGKPPFEAN-----TYQETYKRISRVEFTFPDFVTEGARDLI---- 237
Query: 310 LAFAASLCIRASPTWRPTMSEVLE 333
                S  ++ +P+ RP + EVLE
Sbjct: 238 -----SRLLKHNPSQRPMLREVLE 256

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 72/264 (27%), Positives = 121/264 (45%), Gaps = 27/264 (10%)
Query: 74  VGRGGYAEVYKGVLQDGEEI-AVKRLTKVVTDDRK-EKEFLTEIGTIGHVCHPNVLSLLG 131
           +G+G +  VY    +  + I A+K L K   +    E +   E+    H+ HPN+L L G
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 132 CCVD-NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRII 190
              D   +YLI +++  G+V      ++    +    +   +  A  L Y H    +R+I
Sbjct: 79  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA--LSYCH---SKRVI 133
Query: 191 HRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEK 250
           HRDIK  N+LL +  E +I+DFG +   PS         + GT  +L PE     + DEK
Sbjct: 134 HRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRTTLCGTLDYLPPEMIEGRMHDEK 189
Query: 251 TDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIE-KLVDPRLQGAYDVTQLNR 309
            D+++ GV   E + G+ P + +     ++ +       +E    D   +GA D+     
Sbjct: 190 VDLWSLGVLCYEFLVGKPPFEAN-----TYQETYKRISRVEFTFPDFVTEGARDLI---- 240
Query: 310 LAFAASLCIRASPTWRPTMSEVLE 333
                S  ++ +P+ RP + EVLE
Sbjct: 241 -----SRLLKHNPSQRPMLREVLE 259

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 72/264 (27%), Positives = 121/264 (45%), Gaps = 27/264 (10%)
Query: 74  VGRGGYAEVYKGVLQDGEEI-AVKRLTKVVTDDRK-EKEFLTEIGTIGHVCHPNVLSLLG 131
           +G+G +  VY    +  + I A+K L K   +    E +   E+    H+ HPN+L L G
Sbjct: 15  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 74
Query: 132 CCVD-NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRII 190
              D   +YLI +++  G+V      ++    +    +   +  A  L Y H    +R+I
Sbjct: 75  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA--LSYCH---SKRVI 129
Query: 191 HRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEK 250
           HRDIK  N+LL +  E +I+DFG +   PS         + GT  +L PE     + DEK
Sbjct: 130 HRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRTTLCGTLDYLPPEMIEGRMHDEK 185
Query: 251 TDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIE-KLVDPRLQGAYDVTQLNR 309
            D+++ GV   E + G+ P + +     ++ +       +E    D   +GA D+     
Sbjct: 186 VDLWSLGVLCYEFLVGKPPFEAN-----TYQETYKRISRVEFTFPDFVTEGARDLI---- 236
Query: 310 LAFAASLCIRASPTWRPTMSEVLE 333
                S  ++ +P+ RP + EVLE
Sbjct: 237 -----SRLLKHNPSQRPMLREVLE 255

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 72/264 (27%), Positives = 121/264 (45%), Gaps = 27/264 (10%)
Query: 74  VGRGGYAEVYKGVLQDGEEI-AVKRLTKVVTDDRK-EKEFLTEIGTIGHVCHPNVLSLLG 131
           +G+G +  VY    +  + I A+K L K   +    E +   E+    H+ HPN+L L G
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 132 CCVD-NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRII 190
              D   +YLI +++  G+V      ++    +    +   +  A  L Y H    +R+I
Sbjct: 77  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA--LSYCH---SKRVI 131
Query: 191 HRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEK 250
           HRDIK  N+LL +  E +I+DFG +   PS         + GT  +L PE     + DEK
Sbjct: 132 HRDIKPENLLLGSAGELKIADFGWSVHAPSSRRD----TLCGTLDYLPPEMIEGRMHDEK 187
Query: 251 TDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIE-KLVDPRLQGAYDVTQLNR 309
            D+++ GV   E + G+ P + +     ++ +       +E    D   +GA D+     
Sbjct: 188 VDLWSLGVLCYEFLVGKPPFEAN-----TYQETYKRISRVEFTFPDFVTEGARDLI---- 238
Query: 310 LAFAASLCIRASPTWRPTMSEVLE 333
                S  ++ +P+ RP + EVLE
Sbjct: 239 -----SRLLKHNPSQRPMLREVLE 257

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 74/290 (25%), Positives = 127/290 (43%), Gaps = 30/290 (10%)
Query: 50  KPTWRCFSFEEISIATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEK 109
           KP W     +E  +          +G G + EV+ G      ++AVK L +         
Sbjct: 7   KPWWE----DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQ---GSMSPD 59
Query: 110 EFLTEIGTIGHVCHPNVLSLLGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHK 169
            FL E   +  + H  ++ L        +Y+I ++   GS+       +   +       
Sbjct: 60  AFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLD 119
Query: 170 IAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLP-SQWTHHSIA 228
           +A   A G+ ++    +R  IHRD++++NIL++     +I+DFGLA+ +  +++T    A
Sbjct: 120 MAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGA 176
Query: 229 --PIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPIL 285
             PI+ T    APE   +G    K+DV++FG+ L EI++ GR P  G         + I 
Sbjct: 177 KFPIKWT----APEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP-----EVIQ 227
Query: 286 NQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVM 335
           N     ++V P      ++ QL R      LC +  P  RPT   +  V+
Sbjct: 228 NLERGYRMVRPD-NCPEELYQLMR------LCWKERPEDRPTFDYLRSVL 270

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 74/290 (25%), Positives = 127/290 (43%), Gaps = 30/290 (10%)
Query: 50  KPTWRCFSFEEISIATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEK 109
           KP W     +E  +          +G G + EV+ G      ++AVK L +         
Sbjct: 6   KPWWE----DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQ---GSMSPD 58
Query: 110 EFLTEIGTIGHVCHPNVLSLLGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHK 169
            FL E   +  + H  ++ L        +Y+I ++   GS+       +   +       
Sbjct: 59  AFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLD 118
Query: 170 IAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLP-SQWTHHSIA 228
           +A   A G+ ++    +R  IHRD++++NIL++     +I+DFGLA+ +  +++T    A
Sbjct: 119 MAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGA 175
Query: 229 --PIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPIL 285
             PI+ T    APE   +G    K+DV++FG+ L EI++ GR P  G         + I 
Sbjct: 176 KFPIKWT----APEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP-----EVIQ 226
Query: 286 NQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVM 335
           N     ++V P      ++ QL R      LC +  P  RPT   +  V+
Sbjct: 227 NLERGYRMVRPD-NCPEELYQLMR------LCWKERPEDRPTFDYLRSVL 269

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 72/264 (27%), Positives = 121/264 (45%), Gaps = 27/264 (10%)
Query: 74  VGRGGYAEVYKGVLQDGEEI-AVKRLTKVVTDDRK-EKEFLTEIGTIGHVCHPNVLSLLG 131
           +G+G +  VY    +  + I A+K L K   +    E +   E+    H+ HPN+L L G
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 132 CCVD-NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRII 190
              D   +YLI +++  G+V      ++    +    +   +  A  L Y H    +R+I
Sbjct: 79  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA--LSYCH---SKRVI 133
Query: 191 HRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEK 250
           HRDIK  N+LL +  E +I+DFG +   PS         + GT  +L PE     + DEK
Sbjct: 134 HRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRXXLCGTLDYLPPEMIEGRMHDEK 189
Query: 251 TDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIE-KLVDPRLQGAYDVTQLNR 309
            D+++ GV   E + G+ P + +     ++ +       +E    D   +GA D+     
Sbjct: 190 VDLWSLGVLCYEFLVGKPPFEAN-----TYQETYKRISRVEFTFPDFVTEGARDLI---- 240
Query: 310 LAFAASLCIRASPTWRPTMSEVLE 333
                S  ++ +P+ RP + EVLE
Sbjct: 241 -----SRLLKHNPSQRPMLREVLE 259

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 72/264 (27%), Positives = 121/264 (45%), Gaps = 27/264 (10%)
Query: 74  VGRGGYAEVYKGVLQDGEEI-AVKRLTKVVTDDRK-EKEFLTEIGTIGHVCHPNVLSLLG 131
           +G+G +  VY    +  + I A+K L K   +    E +   E+    H+ HPN+L L G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 132 CCVD-NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRII 190
              D   +YLI +++  G+V      ++    +    +   +  A  L Y H    +R+I
Sbjct: 76  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA--LSYCH---SKRVI 130
Query: 191 HRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEK 250
           HRDIK  N+LL +  E +I+DFG +   PS         + GT  +L PE     + DEK
Sbjct: 131 HRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRTXLCGTLDYLPPEMIEGRMHDEK 186
Query: 251 TDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIE-KLVDPRLQGAYDVTQLNR 309
            D+++ GV   E + G+ P + +     ++ +       +E    D   +GA D+     
Sbjct: 187 VDLWSLGVLCYEFLVGKPPFEAN-----TYQETYKRISRVEFTFPDFVTEGARDLI---- 237
Query: 310 LAFAASLCIRASPTWRPTMSEVLE 333
                S  ++ +P+ RP + EVLE
Sbjct: 238 -----SRLLKHNPSQRPMLREVLE 256

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 72/264 (27%), Positives = 121/264 (45%), Gaps = 27/264 (10%)
Query: 74  VGRGGYAEVYKGVLQDGEEI-AVKRLTKVVTDDRK-EKEFLTEIGTIGHVCHPNVLSLLG 131
           +G+G +  VY    +  + I A+K L K   +    E +   E+    H+ HPN+L L G
Sbjct: 20  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 132 CCVD-NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRII 190
              D   +YLI +++  G+V      ++    +    +   +  A  L Y H    +R+I
Sbjct: 80  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA--LSYCH---SKRVI 134
Query: 191 HRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEK 250
           HRDIK  N+LL +  E +I+DFG +   PS         + GT  +L PE     + DEK
Sbjct: 135 HRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRTTLCGTLDYLPPEMIEGRMHDEK 190
Query: 251 TDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIE-KLVDPRLQGAYDVTQLNR 309
            D+++ GV   E + G+ P + +     ++ +       +E    D   +GA D+     
Sbjct: 191 VDLWSLGVLCYEFLVGKPPFEAN-----TYQETYKRISRVEFTFPDFVTEGARDLI---- 241
Query: 310 LAFAASLCIRASPTWRPTMSEVLE 333
                S  ++ +P+ RP + EVLE
Sbjct: 242 -----SRLLKHNPSQRPMLREVLE 260

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 83/291 (28%), Positives = 131/291 (45%), Gaps = 35/291 (12%)
Query: 62  SIATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKR--LTKVVTDDRKEKEFLTEIGTI 118
           SI  + +  + ++G G  A V         E++A+KR  L K  T      E L EI  +
Sbjct: 11  SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTS---MDELLKEIQAM 67
Query: 119 GHVCHPNVLSLLGC-CVDNGLYLIFQFSSRGSVASLFHDVNSPG------VEWKVRHKIA 171
               HPN++S      V + L+L+ +  S GSV  +   + + G      ++      I 
Sbjct: 68  SQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATIL 127
Query: 172 VGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPS--QWTHHSI-A 228
                GL YLHK  Q   IHRD+K+ NILL  D   QI+DFG++ +L +    T + +  
Sbjct: 128 REVLEGLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRK 184
Query: 229 PIEGTFGHLAPEYFMHGI--VDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILN 286
              GT   +APE  M  +   D K D+++FG+  +E+ +G  P    +  +      + N
Sbjct: 185 TFVGTPCWMAPE-VMEQVRGYDFKADIWSFGITAIELATGAAPYH-KYPPMKVLMLTLQN 242
Query: 287 QGEIEKLVDPRLQ-GAYDVTQLNRLAFA----ASLCIRASPTWRPTMSEVL 332
                    P L+ G  D   L +   +     SLC++  P  RPT +E+L
Sbjct: 243 D-------PPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELL 286

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 110/206 (53%), Gaps = 15/206 (7%)
Query: 73  LVGRGGYAEVYKGVL--QDGEEI--AVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLS 128
           ++GRG +  VY G L   DG++I  AVK L ++ TD  +  +FLTE   +    HPNVLS
Sbjct: 55  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLS 113
Query: 129 LLGCCV--DNGLYLIFQFSSRGSVASLF-HDVNSPGVEWKVRHKIAVGTARGLHYLHKGC 185
           LLG C+  +    ++  +   G + +   ++ ++P V+  +   + V  A+G+ YL    
Sbjct: 114 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV--AKGMKYL---A 168
Query: 186 QRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQ--WTHHSIAPIEGTFGHLAPEYFM 243
            ++ +HRD+ + N +L   F  +++DFGLA+ +  +  ++ H+    +     +A E   
Sbjct: 169 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ 228
Query: 244 HGIVDEKTDVFAFGVFLLEIISGRKP 269
                 K+DV++FGV L E+++   P
Sbjct: 229 TQKFTTKSDVWSFGVLLWELMTRGAP 254

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 110/206 (53%), Gaps = 15/206 (7%)
Query: 73  LVGRGGYAEVYKGVL--QDGEEI--AVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLS 128
           ++GRG +  VY G L   DG++I  AVK L ++ TD  +  +FLTE   +    HPNVLS
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLS 95
Query: 129 LLGCCV--DNGLYLIFQFSSRGSVASLF-HDVNSPGVEWKVRHKIAVGTARGLHYLHKGC 185
           LLG C+  +    ++  +   G + +   ++ ++P V+  +   + V  A+G+ YL    
Sbjct: 96  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV--AKGMKYL---A 150
Query: 186 QRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQ--WTHHSIAPIEGTFGHLAPEYFM 243
            ++ +HRD+ + N +L   F  +++DFGLA+ +  +  ++ H+    +     +A E   
Sbjct: 151 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ 210
Query: 244 HGIVDEKTDVFAFGVFLLEIISGRKP 269
                 K+DV++FGV L E+++   P
Sbjct: 211 TQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 74/290 (25%), Positives = 127/290 (43%), Gaps = 30/290 (10%)
Query: 50  KPTWRCFSFEEISIATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEK 109
           KP W     +E  +          +G G + EV+ G      ++AVK L +         
Sbjct: 11  KPWWE----DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQ---GSMSPD 63
Query: 110 EFLTEIGTIGHVCHPNVLSLLGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHK 169
            FL E   +  + H  ++ L        +Y+I ++   GS+       +   +       
Sbjct: 64  AFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLD 123
Query: 170 IAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLP-SQWTHHSIA 228
           +A   A G+ ++    +R  IHRD++++NIL++     +I+DFGLA+ +  +++T    A
Sbjct: 124 MAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGA 180
Query: 229 --PIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPIL 285
             PI+ T    APE   +G    K+DV++FG+ L EI++ GR P  G         + I 
Sbjct: 181 KFPIKWT----APEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP-----EVIQ 231
Query: 286 NQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVM 335
           N     ++V P      ++ QL R      LC +  P  RPT   +  V+
Sbjct: 232 NLERGYRMVRPD-NCPEELYQLMR------LCWKERPEDRPTFDYLRSVL 274

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 110/206 (53%), Gaps = 15/206 (7%)
Query: 73  LVGRGGYAEVYKGVL--QDGEEI--AVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLS 128
           ++GRG +  VY G L   DG++I  AVK L ++ TD  +  +FLTE   +    HPNVLS
Sbjct: 56  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLS 114
Query: 129 LLGCCV--DNGLYLIFQFSSRGSVASLF-HDVNSPGVEWKVRHKIAVGTARGLHYLHKGC 185
           LLG C+  +    ++  +   G + +   ++ ++P V+  +   + V  A+G+ YL    
Sbjct: 115 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV--AKGMKYL---A 169
Query: 186 QRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQ--WTHHSIAPIEGTFGHLAPEYFM 243
            ++ +HRD+ + N +L   F  +++DFGLA+ +  +  ++ H+    +     +A E   
Sbjct: 170 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ 229
Query: 244 HGIVDEKTDVFAFGVFLLEIISGRKP 269
                 K+DV++FGV L E+++   P
Sbjct: 230 TQKFTTKSDVWSFGVLLWELMTRGAP 255

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 73/264 (27%), Positives = 123/264 (46%), Gaps = 27/264 (10%)
Query: 74  VGRGGYAEVYKGVLQDGEEI-AVKRLTKVVTDDRK-EKEFLTEIGTIGHVCHPNVLSLLG 131
           +G+G +  VY    +  + I A+K L K   +    E +   E+    H+ HPN+L L G
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 132 CCVD-NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRII 190
              D   +YLI +++  G+V      ++    +    +   +  A  L Y H    +R+I
Sbjct: 81  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA--LSYCH---SKRVI 135
Query: 191 HRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEK 250
           HRDIK  N+LL +  E +I+DFG +   PS         + GT  +L PE       DEK
Sbjct: 136 HRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGTLDYLPPEXIEGRXHDEK 191
Query: 251 TDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIE-KLVDPRLQGAYDVTQLNR 309
            D+++ GV   E + G+ P + +     ++ +       +E    D   +GA D+  ++R
Sbjct: 192 VDLWSLGVLCYEFLVGKPPFEAN-----TYQETYKRISRVEFTFPDFVTEGARDL--ISR 244
Query: 310 LAFAASLCIRASPTWRPTMSEVLE 333
           L       ++ +P+ RP + EVLE
Sbjct: 245 L-------LKHNPSQRPXLREVLE 261

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 110/206 (53%), Gaps = 15/206 (7%)
Query: 73  LVGRGGYAEVYKGVL--QDGEEI--AVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLS 128
           ++GRG +  VY G L   DG++I  AVK L ++ TD  +  +FLTE   +    HPNVLS
Sbjct: 29  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLS 87
Query: 129 LLGCCV--DNGLYLIFQFSSRGSVASLF-HDVNSPGVEWKVRHKIAVGTARGLHYLHKGC 185
           LLG C+  +    ++  +   G + +   ++ ++P V+  +   + V  A+G+ YL    
Sbjct: 88  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV--AKGMKYL---A 142
Query: 186 QRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQ--WTHHSIAPIEGTFGHLAPEYFM 243
            ++ +HRD+ + N +L   F  +++DFGLA+ +  +  ++ H+    +     +A E   
Sbjct: 143 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ 202
Query: 244 HGIVDEKTDVFAFGVFLLEIISGRKP 269
                 K+DV++FGV L E+++   P
Sbjct: 203 TQKFTTKSDVWSFGVLLWELMTRGAP 228

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 70/266 (26%), Positives = 121/266 (45%), Gaps = 26/266 (9%)
Query: 74  VGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCC 133
           +G G + EV+ G      ++AVK L +          FL E   +  + H  ++ L    
Sbjct: 16  LGAGQFGEVWMGYYNGHTKVAVKSLKQ---GSMSPDAFLAEANLMKQLQHQRLVRLYAVV 72
Query: 134 VDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRD 193
               +Y+I ++   GS+       +   +       +A   A G+ ++    +R  IHRD
Sbjct: 73  TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRD 129
Query: 194 IKSSNILLTADFEPQISDFGLAKWLP-SQWTHHSIA--PIEGTFGHLAPEYFMHGIVDEK 250
           ++++NIL++     +I+DFGLA+ +  +++T    A  PI+ T    APE   +G    K
Sbjct: 130 LRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWT----APEAINYGTFTIK 185
Query: 251 TDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQLNR 309
           +DV++FG+ L EI++ GR P  G         + I N     ++V P      ++ QL R
Sbjct: 186 SDVWSFGILLTEIVTHGRIPYPGMTNP-----EVIQNLERGYRMVRPD-NCPEELYQLMR 239
Query: 310 LAFAASLCIRASPTWRPTMSEVLEVM 335
                 LC +  P  RPT   +  V+
Sbjct: 240 ------LCWKERPEDRPTFDYLRSVL 259

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 72/264 (27%), Positives = 121/264 (45%), Gaps = 27/264 (10%)
Query: 74  VGRGGYAEVYKGVLQDGEEI-AVKRLTKVVTDDRK-EKEFLTEIGTIGHVCHPNVLSLLG 131
           +G+G +  VY    +  + I A+K L K   +    E +   E+    H+ HPN+L L G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 132 CCVD-NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRII 190
              D   +YLI +++  G+V      ++    +    +   +  A  L Y H    +R+I
Sbjct: 76  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA--LSYCH---SKRVI 130
Query: 191 HRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEK 250
           HRDIK  N+LL +  E +I+DFG +   PS         + GT  +L PE     + DEK
Sbjct: 131 HRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRXXLCGTLDYLPPEMIEGRMHDEK 186
Query: 251 TDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIE-KLVDPRLQGAYDVTQLNR 309
            D+++ GV   E + G+ P + +     ++ +       +E    D   +GA D+     
Sbjct: 187 VDLWSLGVLCYEFLVGKPPFEAN-----TYQETYKRISRVEFTFPDFVTEGARDLI---- 237
Query: 310 LAFAASLCIRASPTWRPTMSEVLE 333
                S  ++ +P+ RP + EVLE
Sbjct: 238 -----SRLLKHNPSQRPMLREVLE 256

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 110/206 (53%), Gaps = 15/206 (7%)
Query: 73  LVGRGGYAEVYKGVL--QDGEEI--AVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLS 128
           ++GRG +  VY G L   DG++I  AVK L ++ TD  +  +FLTE   +    HPNVLS
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLS 95
Query: 129 LLGCCV--DNGLYLIFQFSSRGSVASLF-HDVNSPGVEWKVRHKIAVGTARGLHYLHKGC 185
           LLG C+  +    ++  +   G + +   ++ ++P V+  +   + V  A+G+ YL    
Sbjct: 96  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV--AKGMKYL---A 150
Query: 186 QRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQ--WTHHSIAPIEGTFGHLAPEYFM 243
            ++ +HRD+ + N +L   F  +++DFGLA+ +  +  ++ H+    +     +A E   
Sbjct: 151 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ 210
Query: 244 HGIVDEKTDVFAFGVFLLEIISGRKP 269
                 K+DV++FGV L E+++   P
Sbjct: 211 TQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 74/274 (27%), Positives = 123/274 (44%), Gaps = 27/274 (9%)
Query: 64  ATNAFSSENLVGRGGYAEVYKGVLQDGEEI-AVKRLTKVVTDDRK-EKEFLTEIGTIGHV 121
           A   F     +G+G +  VY    +  + I A+K L K   +    E +   E+    H+
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 122 CHPNVLSLLGCCVD-NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHY 180
            HPN+L L G   D   +YLI +++  G+V      ++    +    +   +  A  L Y
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA--LSY 126
Query: 181 LHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPE 240
            H    +R+IHRDIK  N+LL +  E +I+DFG +   PS         + GT  +L PE
Sbjct: 127 CH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDD----LCGTLDYLPPE 179
Query: 241 YFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIE-KLVDPRLQ 299
                + DEK D+++ GV   E + G+ P + +     ++ +       +E    D   +
Sbjct: 180 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN-----TYQETYKRISRVEFTFPDFVTE 234
Query: 300 GAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLE 333
           GA D+          S  ++ +P+ RP + EVLE
Sbjct: 235 GARDLI---------SRLLKHNPSQRPMLREVLE 259

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 110/206 (53%), Gaps = 15/206 (7%)
Query: 73  LVGRGGYAEVYKGVL--QDGEEI--AVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLS 128
           ++GRG +  VY G L   DG++I  AVK L ++ TD  +  +FLTE   +    HPNVLS
Sbjct: 36  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLS 94
Query: 129 LLGCCV--DNGLYLIFQFSSRGSVASLF-HDVNSPGVEWKVRHKIAVGTARGLHYLHKGC 185
           LLG C+  +    ++  +   G + +   ++ ++P V+  +   + V  A+G+ YL    
Sbjct: 95  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV--AKGMKYL---A 149
Query: 186 QRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQ--WTHHSIAPIEGTFGHLAPEYFM 243
            ++ +HRD+ + N +L   F  +++DFGLA+ +  +  ++ H+    +     +A E   
Sbjct: 150 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ 209
Query: 244 HGIVDEKTDVFAFGVFLLEIISGRKP 269
                 K+DV++FGV L E+++   P
Sbjct: 210 TQKFTTKSDVWSFGVLLWELMTRGAP 235

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 110/206 (53%), Gaps = 15/206 (7%)
Query: 73  LVGRGGYAEVYKGVL--QDGEEI--AVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLS 128
           ++GRG +  VY G L   DG++I  AVK L ++ TD  +  +FLTE   +    HPNVLS
Sbjct: 34  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLS 92
Query: 129 LLGCCV--DNGLYLIFQFSSRGSVASLF-HDVNSPGVEWKVRHKIAVGTARGLHYLHKGC 185
           LLG C+  +    ++  +   G + +   ++ ++P V+  +   + V  A+G+ YL    
Sbjct: 93  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV--AKGMKYL---A 147
Query: 186 QRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQ--WTHHSIAPIEGTFGHLAPEYFM 243
            ++ +HRD+ + N +L   F  +++DFGLA+ +  +  ++ H+    +     +A E   
Sbjct: 148 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ 207
Query: 244 HGIVDEKTDVFAFGVFLLEIISGRKP 269
                 K+DV++FGV L E+++   P
Sbjct: 208 TQKFTTKSDVWSFGVLLWELMTRGAP 233

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 110/206 (53%), Gaps = 15/206 (7%)
Query: 73  LVGRGGYAEVYKGVL--QDGEEI--AVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLS 128
           ++GRG +  VY G L   DG++I  AVK L ++ TD  +  +FLTE   +    HPNVLS
Sbjct: 35  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLS 93
Query: 129 LLGCCV--DNGLYLIFQFSSRGSVASLF-HDVNSPGVEWKVRHKIAVGTARGLHYLHKGC 185
           LLG C+  +    ++  +   G + +   ++ ++P V+  +   + V  A+G+ YL    
Sbjct: 94  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV--AKGMKYL---A 148
Query: 186 QRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQ--WTHHSIAPIEGTFGHLAPEYFM 243
            ++ +HRD+ + N +L   F  +++DFGLA+ +  +  ++ H+    +     +A E   
Sbjct: 149 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ 208
Query: 244 HGIVDEKTDVFAFGVFLLEIISGRKP 269
                 K+DV++FGV L E+++   P
Sbjct: 209 TQKFTTKSDVWSFGVLLWELMTRGAP 234

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 110/206 (53%), Gaps = 15/206 (7%)
Query: 73  LVGRGGYAEVYKGVL--QDGEEI--AVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLS 128
           ++GRG +  VY G L   DG++I  AVK L ++ TD  +  +FLTE   +    HPNVLS
Sbjct: 32  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 129 LLGCCV--DNGLYLIFQFSSRGSVASLF-HDVNSPGVEWKVRHKIAVGTARGLHYLHKGC 185
           LLG C+  +    ++  +   G + +   ++ ++P V+  +   + V  A+G+ YL    
Sbjct: 91  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV--AKGMKYL---A 145
Query: 186 QRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQ--WTHHSIAPIEGTFGHLAPEYFM 243
            ++ +HRD+ + N +L   F  +++DFGLA+ +  +  ++ H+    +     +A E   
Sbjct: 146 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ 205
Query: 244 HGIVDEKTDVFAFGVFLLEIISGRKP 269
                 K+DV++FGV L E+++   P
Sbjct: 206 TQKFTTKSDVWSFGVLLWELMTRGAP 231

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 72/264 (27%), Positives = 121/264 (45%), Gaps = 27/264 (10%)
Query: 74  VGRGGYAEVYKGVLQDGEEI-AVKRLTKVVTDDRK-EKEFLTEIGTIGHVCHPNVLSLLG 131
           +G+G +  VY    +  + I A+K L K   +    E +   E+    H+ HPN+L L G
Sbjct: 13  LGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 72
Query: 132 CCVD-NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRII 190
              D   +YLI +++  G+V      ++    +    +   +  A  L Y H    +R+I
Sbjct: 73  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA--LSYCH---SKRVI 127
Query: 191 HRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEK 250
           HRDIK  N+LL +  E +I+DFG +   PS         + GT  +L PE     + DEK
Sbjct: 128 HRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRTTLCGTLDYLPPEMIEGRMHDEK 183
Query: 251 TDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIE-KLVDPRLQGAYDVTQLNR 309
            D+++ GV   E + G+ P + +     ++ +       +E    D   +GA D+     
Sbjct: 184 VDLWSLGVLCYEFLVGKPPFEAN-----TYQETYKRISRVEFTFPDFVTEGARDLI---- 234
Query: 310 LAFAASLCIRASPTWRPTMSEVLE 333
                S  ++ +P+ RP + EVLE
Sbjct: 235 -----SRLLKHNPSQRPMLREVLE 253

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 80/289 (27%), Positives = 130/289 (44%), Gaps = 31/289 (10%)
Query: 62  SIATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGH 120
           SI  + +  + ++G G  A V         E++A+KR+         + E L EI  +  
Sbjct: 6   SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMD-ELLKEIQAMSQ 64
Query: 121 VCHPNVLSLLGC-CVDNGLYLIFQFSSRGSVASLFHDVNSPG------VEWKVRHKIAVG 173
             HPN++S      V + L+L+ +  S GSV  +   + + G      ++      I   
Sbjct: 65  CHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILRE 124
Query: 174 TARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPS--QWTHHSI-API 230
              GL YLHK  Q   IHRD+K+ NILL  D   QI+DFG++ +L +    T + +    
Sbjct: 125 VLEGLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTF 181
Query: 231 EGTFGHLAPEYFMHGI--VDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQG 288
            GT   +APE  M  +   D K D+++FG+  +E+ +G  P    +  +      + N  
Sbjct: 182 VGTPCWMAPE-VMEQVRGYDFKADIWSFGITAIELATGAAPYH-KYPPMKVLMLTLQND- 238
Query: 289 EIEKLVDPRLQ-GAYDVTQLNRLAFA----ASLCIRASPTWRPTMSEVL 332
                  P L+ G  D   L +   +     SLC++  P  RPT +E+L
Sbjct: 239 ------PPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELL 281

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 72/264 (27%), Positives = 124/264 (46%), Gaps = 27/264 (10%)
Query: 74  VGRGGYAEVYKGVLQDGEEI-AVKRLTKVVTDDRK-EKEFLTEIGTIGHVCHPNVLSLLG 131
           +G+G +  VY    +  + I A+K L K   +    E +   E+    H+ HPN+L L G
Sbjct: 18  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 77
Query: 132 CCVD-NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRII 190
              D   +YLI +++  G+V      ++    +    +   +  A  L Y H    +R+I
Sbjct: 78  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA--LSYCH---SKRVI 132
Query: 191 HRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEK 250
           HRDIK  N+LL +  E +I++FG +   PS         + GT  +L PE     + DEK
Sbjct: 133 HRDIKPENLLLGSAGELKIANFGWSVHAPSSRR----TTLCGTLDYLPPEMIEGRMHDEK 188
Query: 251 TDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIE-KLVDPRLQGAYDVTQLNR 309
            D+++ GV   E + G+ P + +     ++ +       +E    D   +GA D+  ++R
Sbjct: 189 VDLWSLGVLCYEFLVGKPPFEAN-----TYQETYKRISRVEFTFPDFVTEGARDL--ISR 241
Query: 310 LAFAASLCIRASPTWRPTMSEVLE 333
           L       ++ +P+ RP + EVLE
Sbjct: 242 L-------LKHNPSQRPMLREVLE 258

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 104/203 (51%), Gaps = 15/203 (7%)
Query: 74  VGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC- 132
           +G G + +VYK   ++   +A  ++    +++  E +++ EI  +    HPN++ LL   
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELE-DYMVEIDILASCDHPNIVKLLDAF 103
Query: 133 CVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHR 192
             +N L+++ +F + G+V ++  ++  P  E +++  +   T   L+YLH     +IIHR
Sbjct: 104 YYENNLWILIEFCAGGAVDAVMLELERPLTESQIQ-VVCKQTLDALNYLHDN---KIIHR 159
Query: 193 DIKSSNILLTADFEPQISDFGL-AKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGI----- 246
           D+K+ NIL T D + +++DFG+ AK         S     GT   +APE  M        
Sbjct: 160 DLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDSFI---GTPYWMAPEVVMCETSKDRP 216
Query: 247 VDEKTDVFAFGVFLLEIISGRKP 269
            D K DV++ G+ L+E+     P
Sbjct: 217 YDYKADVWSLGITLIEMAEIEPP 239

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 69/238 (28%), Positives = 108/238 (45%), Gaps = 29/238 (12%)
Query: 57  SFEEISIAT-----NAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEF 111
           S +EI ++        F    LVG G Y +VYKG      ++A  ++  V  D+  E+E 
Sbjct: 10  SLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE--EEEI 67
Query: 112 LTEIGTIGHVCH-PNVLSLLGCCV-------DNGLYLIFQFSSRGSVASLFHDV--NSPG 161
             EI  +    H  N+ +  G  +       D+ L+L+ +F   GSV  L  +   N+  
Sbjct: 68  KQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLK 127
Query: 162 VEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQ 221
            EW     I     RGL +LH   Q ++IHRDIK  N+LLT + E ++ DFG++  L   
Sbjct: 128 EEWIAY--ICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT 182
Query: 222 WTHHSIAPIEGTFGHLAPEYFM-----HGIVDEKTDVFAFGVFLLEIISGRKPVDGSH 274
               +     GT   +APE            D K+D+++ G+  +E+  G  P+   H
Sbjct: 183 VGRRNT--FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH 238

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 71/264 (26%), Positives = 121/264 (45%), Gaps = 27/264 (10%)
Query: 74  VGRGGYAEVYKGVLQDGEEI-AVKRLTKVVTDDRK-EKEFLTEIGTIGHVCHPNVLSLLG 131
           +G+G +  VY    +  + I A+K L K   +    E +   E+    H+ HPN+L L G
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 132 CCVD-NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRII 190
              D   +YLI +++  G+V      ++    +    +   +  A  L Y H    +R+I
Sbjct: 79  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA--LSYCH---SKRVI 133
Query: 191 HRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEK 250
           HRDIK  N+LL +  E +I++FG +   PS         + GT  +L PE     + DEK
Sbjct: 134 HRDIKPENLLLGSAGELKIANFGWSVHAPSS----RRTTLCGTLDYLPPEMIEGRMHDEK 189
Query: 251 TDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIE-KLVDPRLQGAYDVTQLNR 309
            D+++ GV   E + G+ P + +     ++ +       +E    D   +GA D+     
Sbjct: 190 VDLWSLGVLCYEFLVGKPPFEAN-----TYQETYKRISRVEFTFPDFVTEGARDLI---- 240
Query: 310 LAFAASLCIRASPTWRPTMSEVLE 333
                S  ++ +P+ RP + EVLE
Sbjct: 241 -----SRLLKHNPSQRPMLREVLE 259

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 97/200 (48%), Gaps = 11/200 (5%)
Query: 74  VGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCC 133
           +G G +  VYKG      ++AVK L  V     + + F  E+  +    H N+L  +G  
Sbjct: 44  IGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYM 101
Query: 134 VDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRD 193
             + L ++ Q+    S+    H V     +      IA  TA+G+ YLH    + IIHRD
Sbjct: 102 TKDNLAIVTQWCEGSSLYKHLH-VQETKFQMFQLIDIARQTAQGMDYLHA---KNIIHRD 157
Query: 194 IKSSNILLTADFEPQISDFGLAKWLPSQWT-HHSIAPIEGTFGHLAPEYFM---HGIVDE 249
           +KS+NI L      +I DFGLA  + S+W+    +    G+   +APE      +     
Sbjct: 158 MKSNNIFLHEGLTVKIGDFGLAT-VKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSF 216
Query: 250 KTDVFAFGVFLLEIISGRKP 269
           ++DV+++G+ L E+++G  P
Sbjct: 217 QSDVYSYGIVLYELMTGELP 236

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 83/295 (28%), Positives = 130/295 (44%), Gaps = 31/295 (10%)
Query: 58  FEEISIATNAFSSENLVGRGGYAEVYKGVL--QDGE--EIAVKRLTKVVTDDRKEKEFLT 113
            E++ I  N      ++G G +  V +G L  +DG   ++AVK +    +  R+ +EFL+
Sbjct: 26  LEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLS 85
Query: 114 EIGTIGHVCHPNVLSLLGCCVD---NGL---YLIFQFSSRGSVAS-LFHDVNSPG---VE 163
           E   +    HPNV+ LLG C++    G+    +I  F   G + + L +     G   + 
Sbjct: 86  EAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIP 145
Query: 164 WKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWT 223
            +   K  V  A G+ YL     R  +HRD+ + N +L  D    ++DFGL+K + S   
Sbjct: 146 LQTLLKFMVDIALGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDY 202
Query: 224 HHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAK 282
           +      +     +A E     +   K+DV+AFGV + EI + G  P  G     H    
Sbjct: 203 YRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQN--HEMYD 260
Query: 283 PILNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLE 337
            +L+          RL+   D   L+ L      C R  P  RPT S VL + LE
Sbjct: 261 YLLHGH--------RLKQPEDC--LDELYEIMYSCWRTDPLDRPTFS-VLRLQLE 304

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 101/216 (46%), Gaps = 21/216 (9%)
Query: 73  LVGRGGYAEVYKGVLQD-GEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLG 131
           ++G+G + +  K   ++ GE + +K L +   D+  ++ FL E+  +  + HPNVL  +G
Sbjct: 17  VLGKGCFGQAIKVTHRETGEVMVMKELIRF--DEETQRTFLKEVKVMRCLEHPNVLKFIG 74
Query: 132 CCV-DNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRII 190
               D  L  I ++   G++  +   ++S    W  R   A   A G+ YLH      II
Sbjct: 75  VLYKDKRLNFITEYIKGGTLRGIIKSMDS-QYPWSQRVSFAKDIASGMAYLH---SMNII 130
Query: 191 HRDIKSSNILLTADFEPQISDFGLAKWLPSQWTH------------HSIAPIEGTFGHLA 238
           HRD+ S N L+  +    ++DFGLA+ +  + T                  + G    +A
Sbjct: 131 HRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMA 190
Query: 239 PEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSH 274
           PE       DEK DVF+FG+ L EII GR   D  +
Sbjct: 191 PEMINGRSYDEKVDVFSFGIVLCEII-GRVNADPDY 225

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 74/290 (25%), Positives = 126/290 (43%), Gaps = 30/290 (10%)
Query: 50  KPTWRCFSFEEISIATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEK 109
           KP W     +E  +          +G G + EV+ G      ++AVK L +         
Sbjct: 2   KPWWE----DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQ---GSMSPD 54
Query: 110 EFLTEIGTIGHVCHPNVLSLLGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHK 169
            FL E   +  + H  ++ L        +Y+I ++   GS+       +   +       
Sbjct: 55  AFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLD 114
Query: 170 IAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLP-SQWTHHSIA 228
           +A   A G+ ++    +R  IHRD++++NIL++     +I+DFGLA+ +  ++ T    A
Sbjct: 115 MAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGA 171
Query: 229 --PIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPIL 285
             PI+ T    APE   +G    K+DV++FG+ L EI++ GR P  G         + I 
Sbjct: 172 KFPIKWT----APEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP-----EVIQ 222
Query: 286 NQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVM 335
           N     ++V P      ++ QL R      LC +  P  RPT   +  V+
Sbjct: 223 NLERGYRMVRPD-NCPEELYQLMR------LCWKERPEDRPTFDYLRSVL 265

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 74/290 (25%), Positives = 126/290 (43%), Gaps = 30/290 (10%)
Query: 50  KPTWRCFSFEEISIATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEK 109
           KP W     +E  +          +G G + EV+ G      ++AVK L +         
Sbjct: 1   KPWWE----DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQ---GSMSPD 53
Query: 110 EFLTEIGTIGHVCHPNVLSLLGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHK 169
            FL E   +  + H  ++ L        +Y+I ++   GS+       +   +       
Sbjct: 54  AFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLD 113
Query: 170 IAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLP-SQWTHHSIA 228
           +A   A G+ ++    +R  IHRD++++NIL++     +I+DFGLA+ +  ++ T    A
Sbjct: 114 MAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGA 170
Query: 229 --PIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPIL 285
             PI+ T    APE   +G    K+DV++FG+ L EI++ GR P  G         + I 
Sbjct: 171 KFPIKWT----APEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP-----EVIQ 221
Query: 286 NQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVM 335
           N     ++V P      ++ QL R      LC +  P  RPT   +  V+
Sbjct: 222 NLERGYRMVRPD-NCPEELYQLMR------LCWKERPEDRPTFDYLRSVL 264

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 74/290 (25%), Positives = 126/290 (43%), Gaps = 30/290 (10%)
Query: 50  KPTWRCFSFEEISIATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEK 109
           KP W     +E  +          +G G + EV+ G      ++AVK L +         
Sbjct: 3   KPWWE----DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQ---GSMSPD 55
Query: 110 EFLTEIGTIGHVCHPNVLSLLGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHK 169
            FL E   +  + H  ++ L        +Y+I ++   GS+       +   +       
Sbjct: 56  AFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLD 115
Query: 170 IAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLP-SQWTHHSIA 228
           +A   A G+ ++    +R  IHRD++++NIL++     +I+DFGLA+ +  ++ T    A
Sbjct: 116 MAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGA 172
Query: 229 --PIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPIL 285
             PI+ T    APE   +G    K+DV++FG+ L EI++ GR P  G         + I 
Sbjct: 173 KFPIKWT----APEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP-----EVIQ 223
Query: 286 NQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVM 335
           N     ++V P      ++ QL R      LC +  P  RPT   +  V+
Sbjct: 224 NLERGYRMVRPD-NCPEELYQLMR------LCWKERPEDRPTFDYLRSVL 266

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 103/205 (50%), Gaps = 19/205 (9%)
Query: 74  VGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKE---FLTEIGTIGHVCHPNVLSLL 130
           +G G + +VYK      +E +V    KV+ D + E+E   ++ EI  +    HPN++ LL
Sbjct: 45  LGDGAFGKVYKA---QNKETSVLAAAKVI-DTKSEEELEDYMVEIDILASCDHPNIVKLL 100
Query: 131 GC-CVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRI 189
                +N L+++ +F + G+V ++  ++  P  E +++  +   T   L+YLH     +I
Sbjct: 101 DAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQ-VVCKQTLDALNYLHDN---KI 156
Query: 190 IHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGI--- 246
           IHRD+K+ NIL T D + +++DFG++                GT   +APE  M      
Sbjct: 157 IHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDX--FIGTPYWMAPEVVMCETSKD 214
Query: 247 --VDEKTDVFAFGVFLLEIISGRKP 269
              D K DV++ G+ L+E+     P
Sbjct: 215 RPYDYKADVWSLGITLIEMAEIEPP 239

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 75/294 (25%), Positives = 130/294 (44%), Gaps = 27/294 (9%)
Query: 46  SETTKPTWRCFSFEEISIATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDD 105
           S+T KP  + +  +E  +          +G G + EV+ G      ++AVK L +     
Sbjct: 2   SQTQKPQ-KPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQ---GS 57
Query: 106 RKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWK 165
                FL E   +  + H  ++ L        +Y+I ++   GS+       +   +   
Sbjct: 58  MSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTIN 117
Query: 166 VRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLP-SQWTH 224
               +A   A G+ ++    +R  IHRD++++NIL++     +I+DFGLA+ +  ++ T 
Sbjct: 118 KLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTA 174
Query: 225 HSIA--PIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWA 281
              A  PI+ T    APE   +G    K+DV++FG+ L EI++ GR P  G         
Sbjct: 175 REGAKFPIKWT----APEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP----- 225
Query: 282 KPILNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVM 335
           + I N     ++V P      ++ QL R      LC +  P  RPT   +  V+
Sbjct: 226 EVIQNLERGYRMVRPD-NCPEELYQLMR------LCWKERPEDRPTFDYLRSVL 272

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 74/290 (25%), Positives = 126/290 (43%), Gaps = 30/290 (10%)
Query: 50  KPTWRCFSFEEISIATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEK 109
           KP W     +E  +          +G G + EV+ G      ++AVK L +         
Sbjct: 1   KPWWE----DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQ---GSMSPD 53
Query: 110 EFLTEIGTIGHVCHPNVLSLLGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHK 169
            FL E   +  + H  ++ L        +Y+I ++   GS+       +   +       
Sbjct: 54  AFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLD 113
Query: 170 IAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLP-SQWTHHSIA 228
           +A   A G+ ++    +R  IHRD++++NIL++     +I+DFGLA+ +  ++ T    A
Sbjct: 114 MAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGA 170
Query: 229 --PIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPIL 285
             PI+ T    APE   +G    K+DV++FG+ L EI++ GR P  G         + I 
Sbjct: 171 KFPIKWT----APEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP-----EVIQ 221
Query: 286 NQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVM 335
           N     ++V P      ++ QL R      LC +  P  RPT   +  V+
Sbjct: 222 NLERGYRMVRPD-NCPEELYQLMR------LCWKERPEDRPTFDYLRSVL 264

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 74/290 (25%), Positives = 126/290 (43%), Gaps = 30/290 (10%)
Query: 50  KPTWRCFSFEEISIATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEK 109
           KP W     +E  +          +G G + EV+ G      ++AVK L +         
Sbjct: 10  KPWWE----DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQ---GSMSPD 62
Query: 110 EFLTEIGTIGHVCHPNVLSLLGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHK 169
            FL E   +  + H  ++ L        +Y+I ++   GS+       +   +       
Sbjct: 63  AFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLD 122
Query: 170 IAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLP-SQWTHHSIA 228
           +A   A G+ ++    +R  IHRD++++NIL++     +I+DFGLA+ +  ++ T    A
Sbjct: 123 MAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGA 179
Query: 229 --PIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPIL 285
             PI+ T    APE   +G    K+DV++FG+ L EI++ GR P  G         + I 
Sbjct: 180 KFPIKWT----APEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP-----EVIQ 230
Query: 286 NQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVM 335
           N     ++V P      ++ QL R      LC +  P  RPT   +  V+
Sbjct: 231 NLERGYRMVRPD-NCPEELYQLMR------LCWKERPEDRPTFDYLRSVL 273

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 96/210 (45%), Gaps = 39/210 (18%)
Query: 74  VGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC 132
           +GRG + EV+ G L+ D   +AVK   + +  D K K FL E   +    HPN++ L+G 
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAK-FLQEARILKQYSHPNIVRLIGV 180
Query: 133 CVD-NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAV--GTARGLHYLHKGCQRRI 189
           C     +Y++ +    G   +    + + G   +V+  + +    A G+ YL   C    
Sbjct: 181 CTQKQPIYIVMELVQGGDFLTF---LRTEGARLRVKTLLQMVGDAAAGMEYLESKC---C 234
Query: 190 IHRDIKSSNILLTADFEPQISDFGLA--------------KWLPSQWTHHSIAPIEGTFG 235
           IHRD+ + N L+T     +ISDFG++              + +P +WT            
Sbjct: 235 IHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWT------------ 282
Query: 236 HLAPEYFMHGIVDEKTDVFAFGVFLLEIIS 265
             APE   +G    ++DV++FG+ L E  S
Sbjct: 283 --APEALNYGRYSSESDVWSFGILLWETFS 310

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 108/206 (52%), Gaps = 15/206 (7%)
Query: 73  LVGRGGYAEVYKGVL--QDGEEI--AVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLS 128
           ++GRG +  VY G L   DG++I  AVK L ++ TD  +  +FLTE   +    HPNVLS
Sbjct: 36  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLS 94
Query: 129 LLGCCV--DNGLYLIFQFSSRGSVASLF-HDVNSPGVEWKVRHKIAVGTARGLHYLHKGC 185
           LLG C+  +    ++  +   G + +   ++ ++P V+  +   + V  A+G+ YL    
Sbjct: 95  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV--AKGMKYL---A 149
Query: 186 QRRIIHRDIKSSNILLTADFEPQISDFGLAK--WLPSQWTHHSIAPIEGTFGHLAPEYFM 243
            ++ +HRD+ + N +L   F  +++DFGLA+  +     + H+    +     +A E   
Sbjct: 150 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALESLQ 209
Query: 244 HGIVDEKTDVFAFGVFLLEIISGRKP 269
                 K+DV++FGV L E+++   P
Sbjct: 210 TQKFTTKSDVWSFGVLLWELMTRGAP 235

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 67/269 (24%), Positives = 111/269 (41%), Gaps = 32/269 (11%)
Query: 92  EIAVKRLTKVVTDDRKEKEFLTEIGTIGHVC-HPNVLSLLGCCVDNGLYLIF-QFSSRGS 149
           ++AVK L      D KE   ++E+  + H+  H N+++LLG C   G  L+  ++   G 
Sbjct: 78  KVAVKMLKSTAHADEKEA-LMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGD 136
Query: 150 VASLFHDVNSPGVEWKVRHK--------------IAVGTARGLHYLHKGCQRRIIHRDIK 195
           + +       PG+E+                    +   A+G+ +L     +  IHRD+ 
Sbjct: 137 LLNFLRRKRPPGLEYSYNPSHNPEEQLSSRDLLHFSSQVAQGMAFL---ASKNCIHRDVA 193
Query: 196 SSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFA 255
           + N+LLT     +I DFGLA+ + +   +            +APE     +   ++DV++
Sbjct: 194 ARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWS 253
Query: 256 FGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQLNRLAFAA 314
           +G+ L EI S G  P  G           IL   +  KLV    Q A        +    
Sbjct: 254 YGILLWEIFSLGLNPYPG-----------ILVNSKFYKLVKDGYQMAQPAFAPKNIYSIM 302
Query: 315 SLCIRASPTWRPTMSEVLEVMLEGDQIDK 343
             C    PT RPT  ++   + E  Q D+
Sbjct: 303 QACWALEPTHRPTFQQICSFLQEQAQEDR 331

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 74/290 (25%), Positives = 126/290 (43%), Gaps = 30/290 (10%)
Query: 50  KPTWRCFSFEEISIATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEK 109
           KP W     +E  +          +G G + EV+ G      ++AVK L +         
Sbjct: 7   KPWWE----DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQ---GSMSPD 59
Query: 110 EFLTEIGTIGHVCHPNVLSLLGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHK 169
            FL E   +  + H  ++ L        +Y+I ++   GS+       +   +       
Sbjct: 60  AFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLD 119
Query: 170 IAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLP-SQWTHHSIA 228
           +A   A G+ ++    +R  IHRD++++NIL++     +I+DFGLA+ +  ++ T    A
Sbjct: 120 MAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGA 176
Query: 229 --PIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPIL 285
             PI+ T    APE   +G    K+DV++FG+ L EI++ GR P  G         + I 
Sbjct: 177 KFPIKWT----APEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP-----EVIQ 227
Query: 286 NQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVM 335
           N     ++V P      ++ QL R      LC +  P  RPT   +  V+
Sbjct: 228 NLERGYRMVRPD-NCPEELYQLMR------LCWKERPEDRPTFDYLRSVL 270

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 96/210 (45%), Gaps = 39/210 (18%)
Query: 74  VGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC 132
           +GRG + EV+ G L+ D   +AVK   + +  D K K FL E   +    HPN++ L+G 
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAK-FLQEARILKQYSHPNIVRLIGV 180
Query: 133 CVD-NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAV--GTARGLHYLHKGCQRRI 189
           C     +Y++ +    G   +    + + G   +V+  + +    A G+ YL   C    
Sbjct: 181 CTQKQPIYIVMELVQGGDFLTF---LRTEGARLRVKTLLQMVGDAAAGMEYLESKC---C 234
Query: 190 IHRDIKSSNILLTADFEPQISDFGLA--------------KWLPSQWTHHSIAPIEGTFG 235
           IHRD+ + N L+T     +ISDFG++              + +P +WT            
Sbjct: 235 IHRDLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPVKWT------------ 282
Query: 236 HLAPEYFMHGIVDEKTDVFAFGVFLLEIIS 265
             APE   +G    ++DV++FG+ L E  S
Sbjct: 283 --APEALNYGRYSSESDVWSFGILLWETFS 310

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 69/266 (25%), Positives = 121/266 (45%), Gaps = 26/266 (9%)
Query: 74  VGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCC 133
           +G G + EV+ G      ++AVK L +          FL E   +  + H  ++ L    
Sbjct: 17  LGAGQFGEVWMGYYNGHTKVAVKSLKQ---GSMSPDAFLAEANLMKQLQHQRLVRLYAVV 73
Query: 134 VDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRD 193
               +Y+I ++   GS+       +   +       +A   A G+ ++    +R  IHR+
Sbjct: 74  TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRN 130
Query: 194 IKSSNILLTADFEPQISDFGLAKWLP-SQWTHHSIA--PIEGTFGHLAPEYFMHGIVDEK 250
           ++++NIL++     +I+DFGLA+ +  +++T    A  PI+ T    APE   +G    K
Sbjct: 131 LRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWT----APEAINYGTFTIK 186
Query: 251 TDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQLNR 309
           +DV++FG+ L EI++ GR P  G         + I N     ++V P      ++ QL R
Sbjct: 187 SDVWSFGILLTEIVTHGRIPYPGMTNP-----EVIQNLERGYRMVRPD-NCPEELYQLMR 240
Query: 310 LAFAASLCIRASPTWRPTMSEVLEVM 335
                 LC +  P  RPT   +  V+
Sbjct: 241 ------LCWKERPEDRPTFDYLRSVL 260

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 96/208 (46%), Gaps = 34/208 (16%)
Query: 74  VGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCC 133
           +G+G + +V  G  + G ++AVK     + +D   + FL E   +  + H N++ LLG  
Sbjct: 20  IGKGEFGDVMLGDYR-GNKVAVK----CIKNDATAQAFLAEASVMTQLRHSNLVQLLGVI 74
Query: 134 VD--NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIH 191
           V+   GLY++ ++ ++GS+           +      K ++     + YL        +H
Sbjct: 75  VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVH 131
Query: 192 RDIKSSNILLTADFEPQISDFGLAK---------WLPSQWTHHSIAPIEGTFGHLAPEYF 242
           RD+ + N+L++ D   ++SDFGL K          LP +WT              APE  
Sbjct: 132 RDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT--------------APEAL 177
Query: 243 MHGIVDEKTDVFAFGVFLLEIIS-GRKP 269
                  K+DV++FG+ L EI S GR P
Sbjct: 178 REAAFSTKSDVWSFGILLWEIYSFGRVP 205

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 98/207 (47%), Gaps = 9/207 (4%)
Query: 68  FSSENLVGRGGYAEVYKG-VLQDGEEIAVKRL-TKVVTDDRKEKEFLTEIGTIGHVCHPN 125
           F   NL+G+G +A VY+   +  G E+A+K +  K +      +    E+     + HP+
Sbjct: 13  FKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPS 72
Query: 126 VLSLLGCCVD-NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKG 184
           +L L     D N +YL+ +    G +     +   P  E + RH +      G+ YLH  
Sbjct: 73  ILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMH-QIITGMLYLH-- 129
Query: 185 CQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMH 244
               I+HRD+  SN+LLT +   +I+DFGLA  L  +  H     + GT  +++PE    
Sbjct: 130 -SHGILHRDLTLSNLLLTRNMNIKIADFGLATQL--KMPHEKHYTLCGTPNYISPEIATR 186
Query: 245 GIVDEKTDVFAFGVFLLEIISGRKPVD 271
                ++DV++ G     ++ GR P D
Sbjct: 187 SAHGLESDVWSLGCMFYTLLIGRPPFD 213

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 101/214 (47%), Gaps = 14/214 (6%)
Query: 63  IATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVC 122
           I   +   E  +G G + EV+        ++AVK +          + FL E   +  + 
Sbjct: 12  IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMK---PGSMSVEAFLAEANVMKTLQ 68
Query: 123 HPNVLSLLGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLH 182
           H  ++ L        +Y+I +F ++GS+                    +   A G+ ++ 
Sbjct: 69  HDKLVKLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE 128
Query: 183 KGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLP-SQWTHHSIA--PIEGTFGHLAP 239
              QR  IHRD++++NIL++A    +I+DFGLA+ +  +++T    A  PI+ T    AP
Sbjct: 129 ---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWT----AP 181
Query: 240 EYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDG 272
           E    G    K+DV++FG+ L+EI++ GR P  G
Sbjct: 182 EAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPG 215

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 57/229 (24%), Positives = 110/229 (48%), Gaps = 14/229 (6%)
Query: 48  TTKPTWRCFSFEEISIATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRK 107
           T+KP  +  + +   I   +   E  +G+G + EV+ G       +A+K L         
Sbjct: 166 TSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-- 223
Query: 108 EKEFLTEIGTIGHVCHPNVLSLLGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVR 167
            + FL E   +  + H  ++ L     +  +Y++ ++ S+GS+           +     
Sbjct: 224 -EAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQL 282
Query: 168 HKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLP-SQWTHHS 226
             +A   A G+ Y+ +      +HRD++++NIL+  +   +++DFGLA+ +  +++T   
Sbjct: 283 VDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ 339
Query: 227 IA--PIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDG 272
            A  PI+ T    APE  ++G    K+DV++FG+ L E+ + GR P  G
Sbjct: 340 GAKFPIKWT----APEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG 384

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 57/229 (24%), Positives = 110/229 (48%), Gaps = 14/229 (6%)
Query: 48  TTKPTWRCFSFEEISIATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRK 107
           T+KP  +  + +   I   +   E  +G+G + EV+ G       +A+K L         
Sbjct: 166 TSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-- 223
Query: 108 EKEFLTEIGTIGHVCHPNVLSLLGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVR 167
            + FL E   +  + H  ++ L     +  +Y++ ++ S+GS+           +     
Sbjct: 224 -EAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQL 282
Query: 168 HKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLP-SQWTHHS 226
             +A   A G+ Y+ +      +HRD++++NIL+  +   +++DFGLA+ +  +++T   
Sbjct: 283 VDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ 339
Query: 227 IA--PIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDG 272
            A  PI+ T    APE  ++G    K+DV++FG+ L E+ + GR P  G
Sbjct: 340 GAKFPIKWT----APEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG 384

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 57/229 (24%), Positives = 110/229 (48%), Gaps = 14/229 (6%)
Query: 48  TTKPTWRCFSFEEISIATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRK 107
           T+KP  +  + +   I   +   E  +G+G + EV+ G       +A+K L         
Sbjct: 249 TSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-- 306
Query: 108 EKEFLTEIGTIGHVCHPNVLSLLGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVR 167
            + FL E   +  + H  ++ L     +  +Y++ ++ S+GS+           +     
Sbjct: 307 -EAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQL 365
Query: 168 HKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLP-SQWTHHS 226
             +A   A G+ Y+ +      +HRD++++NIL+  +   +++DFGLA+ +  +++T   
Sbjct: 366 VDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ 422
Query: 227 IA--PIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDG 272
            A  PI+ T    APE  ++G    K+DV++FG+ L E+ + GR P  G
Sbjct: 423 GAKFPIKWT----APEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG 467

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 102/204 (50%), Gaps = 11/204 (5%)
Query: 74  VGRGGYAEVYKGVLQDGEE----IAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSL 129
           +G G + +V++G+    E     +A+K      +D  +EK FL E  T+    HP+++ L
Sbjct: 15  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREK-FLQEALTMRQFDHPHIVKL 73
Query: 130 LGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRI 189
           +G   +N +++I +  + G + S F  V    ++       A   +  L YL     +R 
Sbjct: 74  IGVITENPVWIIMELCTLGELRS-FLQVRKYSLDLASLILYAYQLSTALAYLE---SKRF 129
Query: 190 IHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDE 249
           +HRDI + N+L++++   ++ DFGL++++    T++  +  +     +APE         
Sbjct: 130 VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS-TYYKASKGKLPIKWMAPESINFRRFTS 188
Query: 250 KTDVFAFGVFLLEII-SGRKPVDG 272
            +DV+ FGV + EI+  G KP  G
Sbjct: 189 ASDVWMFGVCMWEILMHGVKPFQG 212

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 102/204 (50%), Gaps = 11/204 (5%)
Query: 74  VGRGGYAEVYKGVLQDGEE----IAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSL 129
           +G G + +V++G+    E     +A+K      +D  +EK FL E  T+    HP+++ L
Sbjct: 20  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREK-FLQEALTMRQFDHPHIVKL 78
Query: 130 LGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRI 189
           +G   +N +++I +  + G + S F  V    ++       A   +  L YL     +R 
Sbjct: 79  IGVITENPVWIIMELCTLGELRS-FLQVRKYSLDLASLILYAYQLSTALAYLE---SKRF 134
Query: 190 IHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDE 249
           +HRDI + N+L++++   ++ DFGL++++    T++  +  +     +APE         
Sbjct: 135 VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS-TYYKASKGKLPIKWMAPESINFRRFTS 193
Query: 250 KTDVFAFGVFLLEIIS-GRKPVDG 272
            +DV+ FGV + EI+  G KP  G
Sbjct: 194 ASDVWMFGVCMWEILMHGVKPFQG 217

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 102/204 (50%), Gaps = 11/204 (5%)
Query: 74  VGRGGYAEVYKGVLQDGEE----IAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSL 129
           +G G + +V++G+    E     +A+K      +D  +EK FL E  T+    HP+++ L
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREK-FLQEALTMRQFDHPHIVKL 76
Query: 130 LGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRI 189
           +G   +N +++I +  + G + S F  V    ++       A   +  L YL     +R 
Sbjct: 77  IGVITENPVWIIMELCTLGELRS-FLQVRKYSLDLASLILYAYQLSTALAYLE---SKRF 132
Query: 190 IHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDE 249
           +HRDI + N+L++++   ++ DFGL++++    T++  +  +     +APE         
Sbjct: 133 VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS-TYYKASKGKLPIKWMAPESINFRRFTS 191
Query: 250 KTDVFAFGVFLLEIIS-GRKPVDG 272
            +DV+ FGV + EI+  G KP  G
Sbjct: 192 ASDVWMFGVCMWEILMHGVKPFQG 215

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 72/264 (27%), Positives = 121/264 (45%), Gaps = 27/264 (10%)
Query: 74  VGRGGYAEVYKGVLQDGEEI-AVKRLTKVVTDDRK-EKEFLTEIGTIGHVCHPNVLSLLG 131
           +G+G +  VY    +  + I A+K L K   +    E +   E+    H+ HPN+L L G
Sbjct: 20  LGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 132 CCVD-NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRII 190
              D   +YLI +++  G+V      ++    +    +   +  A  L Y H    +R+I
Sbjct: 80  YFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANA--LSYCH---SKRVI 134
Query: 191 HRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEK 250
           HRDIK  N+LL ++ E +I+DFG +   PS         + GT  +L PE     + DEK
Sbjct: 135 HRDIKPENLLLGSNGELKIADFGWSVHAPSS----RRTTLCGTLDYLPPEMIEGRMHDEK 190
Query: 251 TDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIE-KLVDPRLQGAYDVTQLNR 309
            D+++ GV   E + G  P +      H++ +       +E    D   +GA D+     
Sbjct: 191 VDLWSLGVLCYEFLVGMPPFEA-----HTYQETYRRISRVEFTFPDFVTEGARDLI---- 241
Query: 310 LAFAASLCIRASPTWRPTMSEVLE 333
                S  ++ + + R T++EVLE
Sbjct: 242 -----SRLLKHNASQRLTLAEVLE 260

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 102/204 (50%), Gaps = 11/204 (5%)
Query: 74  VGRGGYAEVYKGVLQDGEE----IAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSL 129
           +G G + +V++G+    E     +A+K      +D  +EK FL E  T+    HP+++ L
Sbjct: 18  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREK-FLQEALTMRQFDHPHIVKL 76
Query: 130 LGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRI 189
           +G   +N +++I +  + G + S F  V    ++       A   +  L YL     +R 
Sbjct: 77  IGVITENPVWIIMELCTLGELRS-FLQVRKYSLDLASLILYAYQLSTALAYLE---SKRF 132
Query: 190 IHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDE 249
           +HRDI + N+L++++   ++ DFGL++++    T++  +  +     +APE         
Sbjct: 133 VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS-TYYKASKGKLPIKWMAPESINFRRFTS 191
Query: 250 KTDVFAFGVFLLEIIS-GRKPVDG 272
            +DV+ FGV + EI+  G KP  G
Sbjct: 192 ASDVWMFGVCMWEILMHGVKPFQG 215

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 102/204 (50%), Gaps = 11/204 (5%)
Query: 74  VGRGGYAEVYKGVLQDGEE----IAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSL 129
           +G G + +V++G+    E     +A+K      +D  +EK FL E  T+    HP+++ L
Sbjct: 46  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREK-FLQEALTMRQFDHPHIVKL 104
Query: 130 LGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRI 189
           +G   +N +++I +  + G + S F  V    ++       A   +  L YL     +R 
Sbjct: 105 IGVITENPVWIIMELCTLGELRS-FLQVRKYSLDLASLILYAYQLSTALAYLE---SKRF 160
Query: 190 IHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDE 249
           +HRDI + N+L++++   ++ DFGL++++    T++  +  +     +APE         
Sbjct: 161 VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS-TYYKASKGKLPIKWMAPESINFRRFTS 219
Query: 250 KTDVFAFGVFLLEIIS-GRKPVDG 272
            +DV+ FGV + EI+  G KP  G
Sbjct: 220 ASDVWMFGVCMWEILMHGVKPFQG 243

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 57/229 (24%), Positives = 110/229 (48%), Gaps = 14/229 (6%)
Query: 48  TTKPTWRCFSFEEISIATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRK 107
           T+KP  +  + +   I   +   E  +G+G + EV+ G       +A+K L         
Sbjct: 166 TSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-- 223
Query: 108 EKEFLTEIGTIGHVCHPNVLSLLGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVR 167
            + FL E   +  + H  ++ L     +  +Y++ ++ S+GS+           +     
Sbjct: 224 -EAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVGEYMSKGSLLDFLKGETGKYLRLPQL 282
Query: 168 HKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLP-SQWTHHS 226
             +A   A G+ Y+ +      +HRD++++NIL+  +   +++DFGLA+ +  +++T   
Sbjct: 283 VDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ 339
Query: 227 IA--PIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDG 272
            A  PI+ T    APE  ++G    K+DV++FG+ L E+ + GR P  G
Sbjct: 340 GAKFPIKWT----APEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG 384

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 82/294 (27%), Positives = 138/294 (46%), Gaps = 53/294 (18%)
Query: 66  NAFSSENLVGRGGYAEVYKG-VLQDGEEI--AVKRLTKVVTDDRKEKEFLTEIGTI---G 119
           N    ++++G G + +V K  + +DG  +  A+KR+ +  + D   ++F  E+  +   G
Sbjct: 15  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKD-DHRDFAGELEVLCKLG 73
Query: 120 HVCHPNVLSLLGCCVDNG-LYLIFQFSSRGSVASL------------FHDVNSPGVEWKV 166
           H  HPN+++LLG C   G LYL  +++  G++               F   NS       
Sbjct: 74  H--HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS 131
Query: 167 RHKI--AVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTH 224
           +  +  A   ARG+ YL    Q++ IHRD+ + NIL+  ++  +I+DFGL++    Q  +
Sbjct: 132 QQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVY 185
Query: 225 HSIAPIEGTFGHL-----APEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLH 278
                ++ T G L     A E   + +    +DV+++GV L EI+S G  P  G      
Sbjct: 186 -----VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM-TCAE 239
Query: 279 SWAKPILNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVL 332
            + K  L QG   +L  P L    +V  L R       C R  P  RP+ +++L
Sbjct: 240 LYEK--LPQG--YRLEKP-LNCDDEVYDLMR------QCWREKPYERPSFAQIL 282

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 101/204 (49%), Gaps = 11/204 (5%)
Query: 74  VGRGGYAEVYKGVLQDGEE----IAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSL 129
           +G G + +V++G+    E     +A+K      +D  +EK FL E  T+    HP+++ L
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREK-FLQEALTMRQFDHPHIVKL 76
Query: 130 LGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRI 189
           +G   +N +++I +  + G + S F  V    ++       A   +  L YL     +R 
Sbjct: 77  IGVITENPVWIIMELCTLGELRS-FLQVRKFSLDLASLILYAYQLSTALAYLE---SKRF 132
Query: 190 IHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDE 249
           +HRDI + N+L++A    ++ DFGL++++    T++  +  +     +APE         
Sbjct: 133 VHRDIAARNVLVSATDCVKLGDFGLSRYMEDS-TYYKASKGKLPIKWMAPESINFRRFTS 191
Query: 250 KTDVFAFGVFLLEIIS-GRKPVDG 272
            +DV+ FGV + EI+  G KP  G
Sbjct: 192 ASDVWMFGVCMWEILMHGVKPFQG 215

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 78/302 (25%), Positives = 138/302 (45%), Gaps = 69/302 (22%)
Query: 66  NAFSSENLVGRGGYAEVYKG-VLQDGEEI--AVKRLTKVVTDDRKEKEFLTEIGTI---G 119
           N    ++++G G + +V K  + +DG  +  A+KR+ +  + D   ++F  E+  +   G
Sbjct: 25  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKD-DHRDFAGELEVLCKLG 83
Query: 120 HVCHPNVLSLLGCCVDNG-LYLIFQFSSRGSVASL------------FHDVNSPGVEWKV 166
           H  HPN+++LLG C   G LYL  +++  G++               F   NS       
Sbjct: 84  H--HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS 141
Query: 167 RHKI--AVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTH 224
           +  +  A   ARG+ YL    Q++ IHRD+ + NIL+  ++  +I+DFGL++    Q  +
Sbjct: 142 QQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVY 195
Query: 225 HSIAPIEGTFGHL-----APEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGS----- 273
                ++ T G L     A E   + +    +DV+++GV L EI+S G  P  G      
Sbjct: 196 -----VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL 250
Query: 274 HQSL---HSWAKPILNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSE 330
           ++ L   +   KP+    E+           YD+ +          C R  P  RP+ ++
Sbjct: 251 YEKLPQGYRLEKPLNCDDEV-----------YDLMR---------QCWREKPYERPSFAQ 290
Query: 331 VL 332
           +L
Sbjct: 291 IL 292

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 102/204 (50%), Gaps = 11/204 (5%)
Query: 74  VGRGGYAEVYKGVLQDGEE----IAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSL 129
           +G G + +V++G+    E     +A+K      +D  +EK FL E  T+    HP+++ L
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREK-FLQEALTMRQFDHPHIVKL 81
Query: 130 LGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRI 189
           +G   +N +++I +  + G + S F  V    ++       A   +  L YL     +R 
Sbjct: 82  IGVITENPVWIIMELCTLGELRS-FLQVRKYSLDLASLILYAYQLSTALAYLE---SKRF 137
Query: 190 IHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDE 249
           +HRDI + N+L++++   ++ DFGL++++    T++  +  +     +APE         
Sbjct: 138 VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS-TYYKASKGKLPIKWMAPESINFRRFTS 196
Query: 250 KTDVFAFGVFLLEIIS-GRKPVDG 272
            +DV+ FGV + EI+  G KP  G
Sbjct: 197 ASDVWMFGVCMWEILMHGVKPFQG 220

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 103/205 (50%), Gaps = 13/205 (6%)
Query: 74  VGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC 132
           +G+G +A+V     +  G E+A+K + K   +    ++   E+  +  + HPN++ L   
Sbjct: 20  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 79
Query: 133 C-VDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGC-QRRII 190
              +  LYLI +++S G V   F  + + G   +++ K A    R +    + C Q+RI+
Sbjct: 80  IETEKTLYLIMEYASGGEV---FDYLVAHG---RMKEKEARSKFRQIVSAVQYCHQKRIV 133
Query: 191 HRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVD-E 249
           HRD+K+ N+LL AD   +I+DFG +          +     G+  + APE F     D  
Sbjct: 134 HRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDTFC---GSPPYAAPELFQGKKYDGP 190
Query: 250 KTDVFAFGVFLLEIISGRKPVDGSH 274
           + DV++ GV L  ++SG  P DG +
Sbjct: 191 EVDVWSLGVILYTLVSGSLPFDGQN 215

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 62/240 (25%), Positives = 107/240 (44%), Gaps = 42/240 (17%)
Query: 42  VACESETTKPTWRCFSFEEISIATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKV 101
           VA + E  +  W   + +E+ +          +G+G + +V  G  + G ++AVK     
Sbjct: 5   VAAQDEFYRSGW-ALNMKELKLLQT-------IGKGEFGDVMLGDYR-GNKVAVK----C 51
Query: 102 VTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVD--NGLYLIFQFSSRGSVASLFHDVNS 159
           + +D   + FL E   +  + H N++ LLG  V+   GLY++ ++ ++GS+         
Sbjct: 52  IKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR 111
Query: 160 PGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAK--- 216
             +      K ++     + YL        +HRD+ + N+L++ D   ++SDFGL K   
Sbjct: 112 SVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 168
Query: 217 ------WLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKP 269
                  LP +WT              APE         K+DV++FG+ L EI S GR P
Sbjct: 169 STQDTGKLPVKWT--------------APEALREKKFSTKSDVWSFGILLWEIYSFGRVP 214

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 102/204 (50%), Gaps = 11/204 (5%)
Query: 74  VGRGGYAEVYKGVLQDGEE----IAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSL 129
           +G G + +V++G+    E     +A+K      +D  +EK FL E  T+    HP+++ L
Sbjct: 21  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREK-FLQEALTMRQFDHPHIVKL 79
Query: 130 LGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRI 189
           +G   +N +++I +  + G + S F  V    ++       A   +  L YL     +R 
Sbjct: 80  IGVITENPVWIIMELCTLGELRS-FLQVRKYSLDLASLILYAYQLSTALAYLE---SKRF 135
Query: 190 IHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDE 249
           +HRDI + N+L++++   ++ DFGL++++    T++  +  +     +APE         
Sbjct: 136 VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS-TYYKASKGKLPIKWMAPESINFRRFTS 194
Query: 250 KTDVFAFGVFLLEII-SGRKPVDG 272
            +DV+ FGV + EI+  G KP  G
Sbjct: 195 ASDVWMFGVCMWEILMHGVKPFQG 218

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 102/205 (49%), Gaps = 14/205 (6%)
Query: 74  VGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCC 133
           +G G + EV+ G      ++A+K L          + FL E   +  + H  ++ L    
Sbjct: 17  LGNGQFGEVWMGTWNGNTKVAIKTLKPGTMSP---ESFLEEAQIMKKLKHDKLVQLYAVV 73
Query: 134 VDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRD 193
            +  +Y++ ++ ++GS+     D     ++      +A   A G+ Y+ +      IHRD
Sbjct: 74  SEEPIYIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIER---MNYIHRD 130
Query: 194 IKSSNILLTADFEPQISDFGLAKWLP-SQWTHHSIA--PIEGTFGHLAPEYFMHGIVDEK 250
           ++S+NIL+      +I+DFGLA+ +  ++ T    A  PI+ T    APE  ++G    K
Sbjct: 131 LRSANILVGNGLICKIADFGLARLIEDNEXTARQGAKFPIKWT----APEAALYGRFTIK 186
Query: 251 TDVFAFGVFLLEIIS-GRKPVDGSH 274
           +DV++FG+ L E+++ GR P  G +
Sbjct: 187 SDVWSFGILLTELVTKGRVPYPGMN 211

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 72/264 (27%), Positives = 121/264 (45%), Gaps = 27/264 (10%)
Query: 74  VGRGGYAEVYKGVLQDGEEI-AVKRLTKVVTDDRK-EKEFLTEIGTIGHVCHPNVLSLLG 131
           +G+G +  VY    +  + I A+K L K   +    E +   E+    H+ HPN+L L G
Sbjct: 20  LGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 132 CCVD-NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRII 190
              D   +YLI +++  G+V      ++    +    +   +  A  L Y H    +R+I
Sbjct: 80  YFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANA--LSYCH---SKRVI 134
Query: 191 HRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEK 250
           HRDIK  N+LL ++ E +I+DFG +   PS         + GT  +L PE     + DEK
Sbjct: 135 HRDIKPENLLLGSNGELKIADFGWSVHAPSS----RRDTLCGTLDYLPPEMIEGRMHDEK 190
Query: 251 TDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIE-KLVDPRLQGAYDVTQLNR 309
            D+++ GV   E + G  P +      H++ +       +E    D   +GA D+     
Sbjct: 191 VDLWSLGVLCYEFLVGMPPFEA-----HTYQETYRRISRVEFTFPDFVTEGARDLI---- 241
Query: 310 LAFAASLCIRASPTWRPTMSEVLE 333
                S  ++ + + R T++EVLE
Sbjct: 242 -----SRLLKHNASQRLTLAEVLE 260

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 102/208 (49%), Gaps = 19/208 (9%)
Query: 74  VGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC 132
           +G+G +A+V     +  G E+A+K + K   +    ++   E+  +  + HPN++ L   
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 133 C-VDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTAR----GLHYLHKGCQR 187
              +  LYLI +++S G V   F  + + G   +++ K A    R     + Y H   Q+
Sbjct: 83  IETEKTLYLIMEYASGGEV---FDYLVAHG---RMKEKEARSKFRQIVSAVQYCH---QK 133
Query: 188 RIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIV 247
           RI+HRD+K+ N+LL AD   +I+DFG +          +     G   + APE F     
Sbjct: 134 RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFC---GAPPYAAPELFQGKKY 190
Query: 248 D-EKTDVFAFGVFLLEIISGRKPVDGSH 274
           D  + DV++ GV L  ++SG  P DG +
Sbjct: 191 DGPEVDVWSLGVILYTLVSGSLPFDGQN 218

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 96/208 (46%), Gaps = 34/208 (16%)
Query: 74  VGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCC 133
           +G+G + +V  G  + G ++AVK     + +D   + FL E   +  + H N++ LLG  
Sbjct: 14  IGKGEFGDVMLGDYR-GNKVAVK----CIKNDATAQAFLAEASVMTQLRHSNLVQLLGVI 68
Query: 134 VD--NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIH 191
           V+   GLY++ ++ ++GS+           +      K ++     + YL        +H
Sbjct: 69  VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVH 125
Query: 192 RDIKSSNILLTADFEPQISDFGLAK---------WLPSQWTHHSIAPIEGTFGHLAPEYF 242
           RD+ + N+L++ D   ++SDFGL K          LP +WT              APE  
Sbjct: 126 RDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT--------------APEAL 171
Query: 243 MHGIVDEKTDVFAFGVFLLEIIS-GRKP 269
                  K+DV++FG+ L EI S GR P
Sbjct: 172 REKKFSTKSDVWSFGILLWEIYSFGRVP 199

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 101/204 (49%), Gaps = 11/204 (5%)
Query: 74  VGRGGYAEVYKGVLQDGEE----IAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSL 129
           +G G + +V++G+    E     +A+K      +D  +EK FL E  T+    HP+++ L
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREK-FLQEALTMRQFDHPHIVKL 456
Query: 130 LGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRI 189
           +G   +N +++I +  + G + S F  V    ++       A   +  L YL     +R 
Sbjct: 457 IGVITENPVWIIMELCTLGELRS-FLQVRKFSLDLASLILYAYQLSTALAYLE---SKRF 512
Query: 190 IHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDE 249
           +HRDI + N+L++A    ++ DFGL++++    T++  +  +     +APE         
Sbjct: 513 VHRDIAARNVLVSATDCVKLGDFGLSRYMEDS-TYYKASKGKLPIKWMAPESINFRRFTS 571
Query: 250 KTDVFAFGVFLLEII-SGRKPVDG 272
            +DV+ FGV + EI+  G KP  G
Sbjct: 572 ASDVWMFGVCMWEILMHGVKPFQG 595

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 96/208 (46%), Gaps = 34/208 (16%)
Query: 74  VGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCC 133
           +G+G + +V  G  + G ++AVK     + +D   + FL E   +  + H N++ LLG  
Sbjct: 201 IGKGEFGDVMLGDYR-GNKVAVK----CIKNDATAQAFLAEASVMTQLRHSNLVQLLGVI 255
Query: 134 VD--NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIH 191
           V+   GLY++ ++ ++GS+           +      K ++     + YL        +H
Sbjct: 256 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVH 312
Query: 192 RDIKSSNILLTADFEPQISDFGLAK---------WLPSQWTHHSIAPIEGTFGHLAPEYF 242
           RD+ + N+L++ D   ++SDFGL K          LP +WT              APE  
Sbjct: 313 RDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT--------------APEAL 358
Query: 243 MHGIVDEKTDVFAFGVFLLEIIS-GRKP 269
                  K+DV++FG+ L EI S GR P
Sbjct: 359 REKKFSTKSDVWSFGILLWEIYSFGRVP 386

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 102/204 (50%), Gaps = 11/204 (5%)
Query: 74  VGRGGYAEVYKGVLQDGEE----IAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSL 129
           +G G + +V++G+    E     +A+K      +D  +EK FL E  T+    HP+++ L
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREK-FLQEALTMRQFDHPHIVKL 456
Query: 130 LGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRI 189
           +G   +N +++I +  + G + S F  V    ++       A   +  L YL     +R 
Sbjct: 457 IGVITENPVWIIMELCTLGELRS-FLQVRKFSLDLASLILYAYQLSTALAYLE---SKRF 512
Query: 190 IHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDE 249
           +HRDI + N+L++++   ++ DFGL++++    T++  +  +     +APE         
Sbjct: 513 VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS-TYYKASKGKLPIKWMAPESINFRRFTS 571
Query: 250 KTDVFAFGVFLLEII-SGRKPVDG 272
            +DV+ FGV + EI+  G KP  G
Sbjct: 572 ASDVWMFGVCMWEILMHGVKPFQG 595

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 108/206 (52%), Gaps = 15/206 (7%)
Query: 74  VGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC 132
           +G+G +A+V     +  G+E+AVK + K   +    ++   E+  +  + HPN++ L   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 133 C-VDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGC-QRRII 190
              +  LYL+ +++S G V   F  + + G   +++ K A    R +    + C Q+ I+
Sbjct: 82  IETEKTLYLVMEYASGGEV---FDYLVAHG---RMKEKEARAKFRQIVSAVQYCHQKFIV 135
Query: 191 HRDIKSSNILLTADFEPQISDFGLAKWLPSQWTH-HSIAPIEGTFGHLAPEYFMHGIVD- 248
           HRD+K+ N+LL AD   +I+DFG +    +++T  + +    G+  + APE F     D 
Sbjct: 136 HRDLKAENLLLDADMNIKIADFGFS----NEFTFGNKLDTFCGSPPYAAPELFQGKKYDG 191
Query: 249 EKTDVFAFGVFLLEIISGRKPVDGSH 274
            + DV++ GV L  ++SG  P DG +
Sbjct: 192 PEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 108/206 (52%), Gaps = 15/206 (7%)
Query: 74  VGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC 132
           +G+G +A+V     +  G+E+AVK + K   +    ++   E+  +  + HPN++ L   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 133 C-VDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGC-QRRII 190
              +  LYL+ +++S G V   F  + + G   +++ K A    R +    + C Q+ I+
Sbjct: 82  IETEKTLYLVMEYASGGEV---FDYLVAHG---RMKEKEARAKFRQIVSAVQYCHQKFIV 135
Query: 191 HRDIKSSNILLTADFEPQISDFGLAKWLPSQWTH-HSIAPIEGTFGHLAPEYFMHGIVD- 248
           HRD+K+ N+LL AD   +I+DFG +    +++T  + +    G+  + APE F     D 
Sbjct: 136 HRDLKAENLLLDADMNIKIADFGFS----NEFTFGNKLDTFCGSPPYAAPELFQGKKYDG 191
Query: 249 EKTDVFAFGVFLLEIISGRKPVDGSH 274
            + DV++ GV L  ++SG  P DG +
Sbjct: 192 PEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 56/229 (24%), Positives = 110/229 (48%), Gaps = 14/229 (6%)
Query: 48  TTKPTWRCFSFEEISIATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRK 107
           T+KP  +  + +   I   +   E  +G+G + EV+ G       +A+K L      +  
Sbjct: 167 TSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP---GNMS 223
Query: 108 EKEFLTEIGTIGHVCHPNVLSLLGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVR 167
            + FL E   +  + H  ++ L     +  +Y++ ++ S+GS+           +     
Sbjct: 224 PEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQL 283
Query: 168 HKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLP-SQWTHHS 226
             +A   A G+ Y+ +      +HRD++++NIL+  +   +++DFGL + +  +++T   
Sbjct: 284 VDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLGRLIEDNEYTARQ 340
Query: 227 IA--PIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDG 272
            A  PI+ T    APE  ++G    K+DV++FG+ L E+ + GR P  G
Sbjct: 341 GAKFPIKWT----APEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG 385

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 70/278 (25%), Positives = 126/278 (45%), Gaps = 31/278 (11%)
Query: 74  VGRGGYAE-VYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC 132
           +G G + + +     +DG +  +K +       ++ +E   E+  + ++ HPN++     
Sbjct: 32  IGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRES 91
Query: 133 CVDNG-LYLIFQFSSRGSVASLFHDVNS-PGVEWKVRHKIA--VGTARGLHYLHKGCQRR 188
             +NG LY++  +   G    LF  +N+  GV ++    +   V     L ++H    R+
Sbjct: 92  FEENGSLYIVMDYCEGGD---LFKRINAQKGVLFQEDQILDWFVQICLALKHVH---DRK 145
Query: 189 IIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVD 248
           I+HRDIKS NI LT D   Q+ DFG+A+ L S  T        GT  +L+PE   +   +
Sbjct: 146 ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS--TVELARACIGTPYYLSPEICENKPYN 203
Query: 249 EKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQLN 308
            K+D++A G  L E+ +                K     G ++ LV   + G++    L+
Sbjct: 204 NKSDIWALGCVLYELCT---------------LKHAFEAGSMKNLVLKIISGSFPPVSLH 248
Query: 309 R---LAFAASLCIRASPTWRPTMSEVLEVMLEGDQIDK 343
               L    S   + +P  RP+++ +LE      +I+K
Sbjct: 249 YSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKRIEK 286

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 109/206 (52%), Gaps = 15/206 (7%)
Query: 73  LVGRGGYAEVYKGVL--QDGEEI--AVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLS 128
           ++GRG +  VY G L   DG++I  AVK L ++ TD  +  +FLTE   +    HPNVLS
Sbjct: 96  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLS 154
Query: 129 LLGCCV--DNGLYLIFQFSSRGSVASLF-HDVNSPGVEWKVRHKIAVGTARGLHYLHKGC 185
           LLG C+  +    ++  +   G + +   ++ ++P V+  +   + V  A+G+ +L    
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV--AKGMKFL---A 209
Query: 186 QRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQW--THHSIAPIEGTFGHLAPEYFM 243
            ++ +HRD+ + N +L   F  +++DFGLA+ +  +   + H+    +     +A E   
Sbjct: 210 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 269
Query: 244 HGIVDEKTDVFAFGVFLLEIISGRKP 269
                 K+DV++FGV L E+++   P
Sbjct: 270 TQKFTTKSDVWSFGVLLWELMTRGAP 295

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 101/206 (49%), Gaps = 9/206 (4%)
Query: 72  NLVGRGGYAEVYKGV-LQDGEEIAVKRLTKVV---TDDRKEKEFLTEIGTIGHVCHPNVL 127
            ++G G +  VYKG+ + DGE + +    KV+   T  +  KE L E   +  V  P V 
Sbjct: 23  KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVS 82
Query: 128 SLLGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQR 187
            LLG C+ + + L+ Q    G +     + N   +  +      +  A+G+ YL      
Sbjct: 83  RLLGICLTSTVQLVTQLMPYGCLLDHVRE-NRGRLGSQDLLNWCMQIAKGMSYLE---DV 138
Query: 188 RIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIV 247
           R++HRD+ + N+L+ +    +I+DFGLA+ L    T +     +     +A E  +    
Sbjct: 139 RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILRRRF 198
Query: 248 DEKTDVFAFGVFLLEIIS-GRKPVDG 272
             ++DV+++GV + E+++ G KP DG
Sbjct: 199 THQSDVWSYGVTVWELMTFGAKPYDG 224

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 107/206 (51%), Gaps = 15/206 (7%)
Query: 74  VGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC 132
           +G+G +A+V     +  G+E+AVK + K   +    ++   E+  +  + HPN++ L   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 133 C-VDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGC-QRRII 190
              +  LYL+ +++S G V   F  + + G   +++ K A    R +    + C Q+ I+
Sbjct: 82  IETEKTLYLVMEYASGGEV---FDYLVAHG---RMKEKEARAKFRQIVSAVQYCHQKFIV 135
Query: 191 HRDIKSSNILLTADFEPQISDFGLAKWLPSQWTH-HSIAPIEGTFGHLAPEYFMHGIVD- 248
           HRD+K+ N+LL AD   +I+DFG +    +++T  + +    G   + APE F     D 
Sbjct: 136 HRDLKAENLLLDADMNIKIADFGFS----NEFTFGNKLDAFCGAPPYAAPELFQGKKYDG 191
Query: 249 EKTDVFAFGVFLLEIISGRKPVDGSH 274
            + DV++ GV L  ++SG  P DG +
Sbjct: 192 PEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 109/206 (52%), Gaps = 15/206 (7%)
Query: 73  LVGRGGYAEVYKGVL--QDGEEI--AVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLS 128
           ++GRG +  VY G L   DG++I  AVK L ++ TD  +  +FLTE   +    HPNVLS
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLS 95
Query: 129 LLGCCV--DNGLYLIFQFSSRGSVASLF-HDVNSPGVEWKVRHKIAVGTARGLHYLHKGC 185
           LLG C+  +    ++  +   G + +   ++ ++P V+  +   + V  A+G+ +L    
Sbjct: 96  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV--AKGMKFL---A 150
Query: 186 QRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQW--THHSIAPIEGTFGHLAPEYFM 243
            ++ +HRD+ + N +L   F  +++DFGLA+ +  +   + H+    +     +A E   
Sbjct: 151 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 210
Query: 244 HGIVDEKTDVFAFGVFLLEIISGRKP 269
                 K+DV++FGV L E+++   P
Sbjct: 211 TQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 110/206 (53%), Gaps = 15/206 (7%)
Query: 73  LVGRGGYAEVYKGVL--QDGEEI--AVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLS 128
           ++GRG +  VY G L   DG++I  AVK L ++ TD  +  +FLTE   +    HPNVLS
Sbjct: 38  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLS 96
Query: 129 LLGCCV--DNGLYLIFQFSSRGSVASLF-HDVNSPGVEWKVRHKIAVGTARGLHYLHKGC 185
           LLG C+  +    ++  +   G + +   ++ ++P V+  +   + V  A+G+ +L    
Sbjct: 97  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV--AKGMKFL---A 151
Query: 186 QRRIIHRDIKSSNILLTADFEPQISDFGLAK-WLPSQW-THHSIAPIEGTFGHLAPEYFM 243
            ++ +HRD+ + N +L   F  +++DFGLA+  L  ++ + H+    +     +A E   
Sbjct: 152 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMALESLQ 211
Query: 244 HGIVDEKTDVFAFGVFLLEIISGRKP 269
                 K+DV++FGV L E+++   P
Sbjct: 212 TQKFTTKSDVWSFGVLLWELMTRGAP 237

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 70/266 (26%), Positives = 119/266 (44%), Gaps = 26/266 (9%)
Query: 74  VGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCC 133
           +G G   EV+ G      ++AVK L +          FL E   +  + H  ++ L    
Sbjct: 21  LGAGQAGEVWMGYYNGHTKVAVKSLKQ---GSMSPDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 134 VDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRD 193
               +Y+I ++   GS+       +   +       +A   A G+ ++    +R  IHRD
Sbjct: 78  TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRD 134
Query: 194 IKSSNILLTADFEPQISDFGLAKWLP-SQWTHHSIA--PIEGTFGHLAPEYFMHGIVDEK 250
           ++++NIL++     +I+DFGLA+ +  ++ T    A  PI+ T    APE   +G    K
Sbjct: 135 LRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKFPIKWT----APEAINYGTFTIK 190
Query: 251 TDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQLNR 309
           +DV++FG+ L EI++ GR P  G         + I N     ++V P      ++ QL R
Sbjct: 191 SDVWSFGILLTEIVTHGRIPYPGMTNP-----EVIQNLERGYRMVRPD-NCPEELYQLMR 244
Query: 310 LAFAASLCIRASPTWRPTMSEVLEVM 335
                 LC +  P  RPT   +  V+
Sbjct: 245 ------LCWKERPEDRPTFDYLRSVL 264

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 53/214 (24%), Positives = 103/214 (48%), Gaps = 14/214 (6%)
Query: 63  IATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVC 122
           I   +   E  +G+G + EV+ G       +A+K L          + FL E   +  + 
Sbjct: 12  IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP---EAFLQEAQVMKKLR 68
Query: 123 HPNVLSLLGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLH 182
           H  ++ L     +  +Y++ ++ ++GS+           +       ++   A G+ Y+ 
Sbjct: 69  HEKLVQLYAVVSEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVE 128
Query: 183 KGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLP-SQWTHHSIA--PIEGTFGHLAP 239
           +      +HRD++++NIL+  +   +++DFGLA+ +  ++WT    A  PI+ T    AP
Sbjct: 129 R---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEWTARQGAKFPIKWT----AP 181
Query: 240 EYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDG 272
           E  ++G    K+DV++FG+ L E+ + GR P  G
Sbjct: 182 EAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG 215

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 109/206 (52%), Gaps = 15/206 (7%)
Query: 73  LVGRGGYAEVYKGVL--QDGEEI--AVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLS 128
           ++GRG +  VY G L   DG++I  AVK L ++ TD  +  +FLTE   +    HPNVLS
Sbjct: 38  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLS 96
Query: 129 LLGCCV--DNGLYLIFQFSSRGSVASLF-HDVNSPGVEWKVRHKIAVGTARGLHYLHKGC 185
           LLG C+  +    ++  +   G + +   ++ ++P V+  +   + V  A+G+ +L    
Sbjct: 97  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV--AKGMKFL---A 151
Query: 186 QRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQW--THHSIAPIEGTFGHLAPEYFM 243
            ++ +HRD+ + N +L   F  +++DFGLA+ +  +   + H+    +     +A E   
Sbjct: 152 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 211
Query: 244 HGIVDEKTDVFAFGVFLLEIISGRKP 269
                 K+DV++FGV L E+++   P
Sbjct: 212 TQKFTTKSDVWSFGVLLWELMTRGAP 237

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 77/302 (25%), Positives = 138/302 (45%), Gaps = 69/302 (22%)
Query: 66  NAFSSENLVGRGGYAEVYKG-VLQDGEEI--AVKRLTKVVTDDRKEKEFLTEIGTI---G 119
           N    ++++G G + +V K  + +DG  +  A+KR+ +  + D   ++F  E+  +   G
Sbjct: 22  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKD-DHRDFAGELEVLCKLG 80
Query: 120 HVCHPNVLSLLGCCVDNG-LYLIFQFSSRGSVASL------------FHDVNSPGVEWKV 166
           H  HPN+++LLG C   G LYL  +++  G++               F   NS       
Sbjct: 81  H--HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS 138
Query: 167 RHKI--AVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTH 224
           +  +  A   ARG+ YL    Q++ IHR++ + NIL+  ++  +I+DFGL++    Q  +
Sbjct: 139 QQLLHFAADVARGMDYL---SQKQFIHRNLAARNILVGENYVAKIADFGLSR---GQEVY 192
Query: 225 HSIAPIEGTFGHL-----APEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGS----- 273
                ++ T G L     A E   + +    +DV+++GV L EI+S G  P  G      
Sbjct: 193 -----VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL 247
Query: 274 HQSL---HSWAKPILNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSE 330
           ++ L   +   KP+    E+           YD+ +          C R  P  RP+ ++
Sbjct: 248 YEKLPQGYRLEKPLNCDDEV-----------YDLMR---------QCWREKPYERPSFAQ 287
Query: 331 VL 332
           +L
Sbjct: 288 IL 289

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 98/210 (46%), Gaps = 15/210 (7%)
Query: 74  VGRGGYAEVYKGVLQDGEEI-AVKRLTKV-VTDDRKEKEFLTEIGTIGHVCHPNVLSLLG 131
           +G+G +  VY    +  + I A+K L K  +  +  E +   EI    H+ HPN+L +  
Sbjct: 23  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 82
Query: 132 CCVDNG-LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGT-ARGLHYLHKGCQRRI 189
              D   +YL+ +F+ RG    L+ ++   G   + R    +   A  LHY H   +R++
Sbjct: 83  YFHDRKRIYLMLEFAPRGE---LYKELQKHGRFDEQRSATFMEELADALHYCH---ERKV 136
Query: 190 IHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDE 249
           IHRDIK  N+L+    E +I+DFG +   PS           GT  +L PE       DE
Sbjct: 137 IHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRXMC----GTLDYLPPEMIEGKTHDE 192
Query: 250 KTDVFAFGVFLLEIISGRKPVDG-SHQSLH 278
           K D++  GV   E + G  P D  SH   H
Sbjct: 193 KVDLWCAGVLCYEFLVGMPPFDSPSHTETH 222

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 98/210 (46%), Gaps = 15/210 (7%)
Query: 74  VGRGGYAEVYKGVLQDGEEI-AVKRLTKV-VTDDRKEKEFLTEIGTIGHVCHPNVLSLLG 131
           +G+G +  VY    +  + I A+K L K  +  +  E +   EI    H+ HPN+L +  
Sbjct: 22  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81
Query: 132 CCVDNG-LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGT-ARGLHYLHKGCQRRI 189
              D   +YL+ +F+ RG    L+ ++   G   + R    +   A  LHY H   +R++
Sbjct: 82  YFHDRKRIYLMLEFAPRGE---LYKELQKHGRFDEQRSATFMEELADALHYCH---ERKV 135
Query: 190 IHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDE 249
           IHRDIK  N+L+    E +I+DFG +   PS           GT  +L PE       DE
Sbjct: 136 IHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRXMC----GTLDYLPPEMIEGKTHDE 191
Query: 250 KTDVFAFGVFLLEIISGRKPVDG-SHQSLH 278
           K D++  GV   E + G  P D  SH   H
Sbjct: 192 KVDLWCAGVLCYEFLVGMPPFDSPSHTETH 221

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 69/264 (26%), Positives = 111/264 (42%), Gaps = 28/264 (10%)
Query: 92  EIAVKRLTKVVTDDRKEKEFLTEIGTIGHVC-HPNVLSLLGCCVDNGLYLI--------- 141
           ++AVK L      D KE   ++E+  + H+  H N+++LLG C   G  L+         
Sbjct: 78  KVAVKMLKSTAHADEKEA-LMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGD 136
Query: 142 -FQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNIL 200
              F  R + A L  +   P +E +     +   A+G+ +L     +  IHRD+ + N+L
Sbjct: 137 LLNFLRRKAEADLDKEDGRP-LELRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVL 192
Query: 201 LTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFL 260
           LT     +I DFGLA+ + +   +            +APE     +   ++DV+++G+ L
Sbjct: 193 LTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILL 252
Query: 261 LEIIS-GRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIR 319
            EI S G  P  G           IL   +  KLV    Q A        +      C  
Sbjct: 253 WEIFSLGLNPYPG-----------ILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWA 301
Query: 320 ASPTWRPTMSEVLEVMLEGDQIDK 343
             PT RPT  ++   + E  Q D+
Sbjct: 302 LEPTHRPTFQQICSFLQEQAQEDR 325

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 109/206 (52%), Gaps = 15/206 (7%)
Query: 73  LVGRGGYAEVYKGVL--QDGEEI--AVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLS 128
           ++GRG +  VY G L   DG++I  AVK L ++ TD  +  +FLTE   +    HPNVLS
Sbjct: 42  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLS 100
Query: 129 LLGCCV--DNGLYLIFQFSSRGSVASLF-HDVNSPGVEWKVRHKIAVGTARGLHYLHKGC 185
           LLG C+  +    ++  +   G + +   ++ ++P V+  +   + V  A+G+ +L    
Sbjct: 101 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV--AKGMKFL---A 155
Query: 186 QRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQW--THHSIAPIEGTFGHLAPEYFM 243
            ++ +HRD+ + N +L   F  +++DFGLA+ +  +   + H+    +     +A E   
Sbjct: 156 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 215
Query: 244 HGIVDEKTDVFAFGVFLLEIISGRKP 269
                 K+DV++FGV L E+++   P
Sbjct: 216 TQKFTTKSDVWSFGVLLWELMTRGAP 241

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 108/206 (52%), Gaps = 15/206 (7%)
Query: 74  VGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC 132
           +G+G +A+V     +  G+E+AVK + K   +    ++   E+  +  + HPN++ L   
Sbjct: 15  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 74
Query: 133 C-VDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGC-QRRII 190
              +  LYL+ +++S G V   F  + + G  W ++ K A    R +    + C Q+ I+
Sbjct: 75  IETEKTLYLVMEYASGGEV---FDYLVAHG--W-MKEKEARAKFRQIVSAVQYCHQKFIV 128
Query: 191 HRDIKSSNILLTADFEPQISDFGLAKWLPSQWTH-HSIAPIEGTFGHLAPEYFMHGIVD- 248
           HRD+K+ N+LL AD   +I+DFG +    +++T  + +    G+  + APE F     D 
Sbjct: 129 HRDLKAENLLLDADMNIKIADFGFS----NEFTFGNKLDTFCGSPPYAAPELFQGKKYDG 184
Query: 249 EKTDVFAFGVFLLEIISGRKPVDGSH 274
            + DV++ GV L  ++SG  P DG +
Sbjct: 185 PEVDVWSLGVILYTLVSGSLPFDGQN 210

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 109/206 (52%), Gaps = 15/206 (7%)
Query: 73  LVGRGGYAEVYKGVL--QDGEEI--AVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLS 128
           ++GRG +  VY G L   DG++I  AVK L ++ TD  +  +FLTE   +    HPNVLS
Sbjct: 35  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLS 93
Query: 129 LLGCCV--DNGLYLIFQFSSRGSVASLF-HDVNSPGVEWKVRHKIAVGTARGLHYLHKGC 185
           LLG C+  +    ++  +   G + +   ++ ++P V+  +   + V  A+G+ +L    
Sbjct: 94  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV--AKGMKFL---A 148
Query: 186 QRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQW--THHSIAPIEGTFGHLAPEYFM 243
            ++ +HRD+ + N +L   F  +++DFGLA+ +  +   + H+    +     +A E   
Sbjct: 149 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 208
Query: 244 HGIVDEKTDVFAFGVFLLEIISGRKP 269
                 K+DV++FGV L E+++   P
Sbjct: 209 TQKFTTKSDVWSFGVLLWELMTRGAP 234

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/267 (23%), Positives = 120/267 (44%), Gaps = 24/267 (8%)
Query: 74  VGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCC 133
           +G G +  V+ G   + +++A+K + +       E++F+ E   +  + HP ++ L G C
Sbjct: 18  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQLYGVC 74
Query: 134 VDNG-LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHR 192
           ++   + L+F+F   G ++             +    + +    G+ YL + C   +IHR
Sbjct: 75  LEQAPICLVFEFMEHGCLSDYLRTQRGLFAA-ETLLGMCLDVCEGMAYLEEAC---VIHR 130
Query: 193 DIKSSNILLTADFEPQISDFGLAKW-LPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKT 251
           D+ + N L+  +   ++SDFG+ ++ L  Q+T  +       +   +PE F       K+
Sbjct: 131 DLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWA--SPEVFSFSRYSSKS 188
Query: 252 DVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQLNRL 310
           DV++FGV + E+ S G+ P +    S     + + +     +L  PRL   +    +N  
Sbjct: 189 DVWSFGVLMWEVFSEGKIPYENRSNS-----EVVEDISTGFRLYKPRLASTHVYQIMNH- 242
Query: 311 AFAASLCIRASPTWRPTMSEVLEVMLE 337
                 C R  P  RP  S +L  + E
Sbjct: 243 ------CWRERPEDRPAFSRLLRQLAE 263

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 109/206 (52%), Gaps = 15/206 (7%)
Query: 73  LVGRGGYAEVYKGVL--QDGEEI--AVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLS 128
           ++GRG +  VY G L   DG++I  AVK L ++ TD  +  +FLTE   +    HPNVLS
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLS 95
Query: 129 LLGCCV--DNGLYLIFQFSSRGSVASLF-HDVNSPGVEWKVRHKIAVGTARGLHYLHKGC 185
           LLG C+  +    ++  +   G + +   ++ ++P V+  +   + V  A+G+ +L    
Sbjct: 96  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV--AKGMKFL---A 150
Query: 186 QRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQW--THHSIAPIEGTFGHLAPEYFM 243
            ++ +HRD+ + N +L   F  +++DFGLA+ +  +   + H+    +     +A E   
Sbjct: 151 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 210
Query: 244 HGIVDEKTDVFAFGVFLLEIISGRKP 269
                 K+DV++FGV L E+++   P
Sbjct: 211 TQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 69/264 (26%), Positives = 111/264 (42%), Gaps = 28/264 (10%)
Query: 92  EIAVKRLTKVVTDDRKEKEFLTEIGTIGHVC-HPNVLSLLGCCVDNGLYLI--------- 141
           ++AVK L      D KE   ++E+  + H+  H N+++LLG C   G  L+         
Sbjct: 70  KVAVKMLKSTAHADEKEA-LMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGD 128
Query: 142 -FQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNIL 200
              F  R + A L  +   P +E +     +   A+G+ +L     +  IHRD+ + N+L
Sbjct: 129 LLNFLRRKAEADLDKEDGRP-LELRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVL 184
Query: 201 LTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFL 260
           LT     +I DFGLA+ + +   +            +APE     +   ++DV+++G+ L
Sbjct: 185 LTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILL 244
Query: 261 LEIIS-GRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIR 319
            EI S G  P  G           IL   +  KLV    Q A        +      C  
Sbjct: 245 WEIFSLGLNPYPG-----------ILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWA 293
Query: 320 ASPTWRPTMSEVLEVMLEGDQIDK 343
             PT RPT  ++   + E  Q D+
Sbjct: 294 LEPTHRPTFQQICSFLQEQAQEDR 317

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 108/206 (52%), Gaps = 15/206 (7%)
Query: 74  VGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC 132
           +G+G +A+V     +  G+E+AV+ + K   +    ++   E+  +  + HPN++ L   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 133 C-VDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGC-QRRII 190
              +  LYL+ +++S G V   F  + + G   +++ K A    R +    + C Q+ I+
Sbjct: 82  IETEKTLYLVMEYASGGEV---FDYLVAHG---RMKEKEARAKFRQIVSAVQYCHQKFIV 135
Query: 191 HRDIKSSNILLTADFEPQISDFGLAKWLPSQWTH-HSIAPIEGTFGHLAPEYFMHGIVD- 248
           HRD+K+ N+LL AD   +I+DFG +    +++T  + +    G+  + APE F     D 
Sbjct: 136 HRDLKAENLLLDADMNIKIADFGFS----NEFTFGNKLDEFCGSPPYAAPELFQGKKYDG 191
Query: 249 EKTDVFAFGVFLLEIISGRKPVDGSH 274
            + DV++ GV L  ++SG  P DG +
Sbjct: 192 PEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 108/206 (52%), Gaps = 15/206 (7%)
Query: 74  VGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC 132
           +G+G +A+V     +  G+E+AV+ + K   +    ++   E+  +  + HPN++ L   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 133 C-VDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGC-QRRII 190
              +  LYL+ +++S G V   F  + + G   +++ K A    R +    + C Q+ I+
Sbjct: 82  IETEKTLYLVMEYASGGEV---FDYLVAHG---RMKEKEARAKFRQIVSAVQYCHQKFIV 135
Query: 191 HRDIKSSNILLTADFEPQISDFGLAKWLPSQWTH-HSIAPIEGTFGHLAPEYFMHGIVD- 248
           HRD+K+ N+LL AD   +I+DFG +    +++T  + +    G+  + APE F     D 
Sbjct: 136 HRDLKAENLLLDADMNIKIADFGFS----NEFTFGNKLDTFCGSPPYAAPELFQGKKYDG 191
Query: 249 EKTDVFAFGVFLLEIISGRKPVDGSH 274
            + DV++ GV L  ++SG  P DG +
Sbjct: 192 PEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 67/268 (25%), Positives = 122/268 (45%), Gaps = 23/268 (8%)
Query: 68  FSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVL 127
           F+    +G+G + EV+KG+    +++   ++  +   + + ++   EI  +       V 
Sbjct: 25  FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVT 84
Query: 128 SLLGCCVDNG-LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQ 186
              G  +    L++I ++   GS   L      P  E+++   +     +GL YLH    
Sbjct: 85  KYYGSYLKGSKLWIIMEYLGGGSALDLLR--AGPFDEFQIATMLK-EILKGLDYLH---S 138
Query: 187 RRIIHRDIKSSNILLTADFEPQISDFGLAKWLP-SQWTHHSIAPIEGTFGHLAPEYFMHG 245
            + IHRDIK++N+LL+   + +++DFG+A  L  +Q   ++     GT   +APE     
Sbjct: 139 EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV---GTPFWMAPEVIQQS 195
Query: 246 IVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVT 305
             D K D+++ G+  +E+  G  P    H        P+     I K   P L G  D T
Sbjct: 196 AYDSKADIWSLGITAIELAKGEPPNSDMH--------PMRVLFLIPKNNPPTLVG--DFT 245
Query: 306 QLNRLAFAASLCIRASPTWRPTMSEVLE 333
           +  +    A  C+   P++RPT  E+L+
Sbjct: 246 KSFKEFIDA--CLNKDPSFRPTAKELLK 271

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 95/202 (47%), Gaps = 10/202 (4%)
Query: 74  VGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCC 133
           +G G Y  VYK + ++  +I   +   V +D    +E + EI  +     P+V+   G  
Sbjct: 37  LGEGSYGSVYKAIHKETGQIVAIKQVPVESD---LQEIIKEISIMQQCDSPHVVKYYGSY 93
Query: 134 VDN-GLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHR 192
             N  L+++ ++   GSV+ +    N    E ++   I   T +GL YLH     R IHR
Sbjct: 94  FKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEI-ATILQSTLKGLEYLHF---MRKIHR 149
Query: 193 DIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTD 252
           DIK+ NILL  +   +++DFG+A  L       +   + GT   +APE       +   D
Sbjct: 150 DIKAGNILLNTEGHAKLADFGVAGQLTDXMAKRNX--VIGTPFWMAPEVIQEIGYNCVAD 207
Query: 253 VFAFGVFLLEIISGRKPVDGSH 274
           +++ G+  +E+  G+ P    H
Sbjct: 208 IWSLGITAIEMAEGKPPYADIH 229

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 70/270 (25%), Positives = 126/270 (46%), Gaps = 37/270 (13%)
Query: 73  LVGRGGYAEVYKGVLQDGEEI-AVKRLTKVVTDDRKEKEFL-TEIGTIGHVCHPNVLSLL 130
            +G+GG+A+ Y+    D +E+ A K + K +     +KE + TEI     + +P+V+   
Sbjct: 33  FLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFH 92
Query: 131 GCCVDNG-LYLIFQFSSRGSVASLFHD---VNSPGVEWKVRHKIAVGTARGLHYLHKGCQ 186
           G   D+  +Y++ +   R S+  L      V  P   + +R      T +G+ YLH    
Sbjct: 93  GFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQ-----TIQGVQYLHNN-- 145
Query: 187 RRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGI 246
            R+IHRD+K  N+ L  D + +I DFGLA  +  ++       + GT  ++APE      
Sbjct: 146 -RVIHRDLKLGNLFLNDDMDVKIGDFGLATKI--EFDGERKKDLCGTPNYIAPEVLCKKG 202
Query: 247 VDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQ 306
              + D+++ G  L  ++ G+ P + S     ++ +   N+  + + ++P          
Sbjct: 203 HSFEVDIWSLGCILYTLLVGKPPFETSCLK-ETYIRIKKNEYSVPRHINP---------- 251
Query: 307 LNRLAFAASLCIR----ASPTWRPTMSEVL 332
                  AS  IR    A PT RP+++E+L
Sbjct: 252 ------VASALIRRMLHADPTLRPSVAELL 275

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 70/270 (25%), Positives = 126/270 (46%), Gaps = 37/270 (13%)
Query: 73  LVGRGGYAEVYKGVLQDGEEI-AVKRLTKVVTDDRKEKEFL-TEIGTIGHVCHPNVLSLL 130
            +G+GG+A+ Y+    D +E+ A K + K +     +KE + TEI     + +P+V+   
Sbjct: 49  FLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFH 108
Query: 131 GCCVDNG-LYLIFQFSSRGSVASLFHD---VNSPGVEWKVRHKIAVGTARGLHYLHKGCQ 186
           G   D+  +Y++ +   R S+  L      V  P   + +R      T +G+ YLH    
Sbjct: 109 GFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQ-----TIQGVQYLHNN-- 161
Query: 187 RRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGI 246
            R+IHRD+K  N+ L  D + +I DFGLA  +  ++       + GT  ++APE      
Sbjct: 162 -RVIHRDLKLGNLFLNDDMDVKIGDFGLATKI--EFDGERKKTLCGTPNYIAPEVLCKKG 218
Query: 247 VDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQ 306
              + D+++ G  L  ++ G+ P + S     ++ +   N+  + + ++P          
Sbjct: 219 HSFEVDIWSLGCILYTLLVGKPPFETSCLK-ETYIRIKKNEYSVPRHINP---------- 267
Query: 307 LNRLAFAASLCIR----ASPTWRPTMSEVL 332
                  AS  IR    A PT RP+++E+L
Sbjct: 268 ------VASALIRRMLHADPTLRPSVAELL 291

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 103/214 (48%), Gaps = 14/214 (6%)
Query: 63  IATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVC 122
           I   +   E  +G+G + EV+ G       +A+K L          + FL E   +  + 
Sbjct: 8   IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP---EAFLQEAQVMKKLR 64
Query: 123 HPNVLSLLGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLH 182
           H  ++ L     +  +Y++ ++ S+GS+           +       +A   A G+ Y+ 
Sbjct: 65  HEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE 124
Query: 183 KGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLP-SQWTHHSIA--PIEGTFGHLAP 239
           +      +HRD++++NIL+  +   +++DFGLA+ +  +++T    A  PI+ T    AP
Sbjct: 125 R---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT----AP 177
Query: 240 EYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDG 272
           E  ++G    K+DV++FG+ L E+ + GR P  G
Sbjct: 178 EAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG 211

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 70/270 (25%), Positives = 126/270 (46%), Gaps = 37/270 (13%)
Query: 73  LVGRGGYAEVYKGVLQDGEEI-AVKRLTKVVTDDRKEKEFL-TEIGTIGHVCHPNVLSLL 130
            +G+GG+A+ Y+    D +E+ A K + K +     +KE + TEI     + +P+V+   
Sbjct: 49  FLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFH 108
Query: 131 GCCVDNG-LYLIFQFSSRGSVASLFHD---VNSPGVEWKVRHKIAVGTARGLHYLHKGCQ 186
           G   D+  +Y++ +   R S+  L      V  P   + +R      T +G+ YLH    
Sbjct: 109 GFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQ-----TIQGVQYLHNN-- 161
Query: 187 RRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGI 246
            R+IHRD+K  N+ L  D + +I DFGLA  +  ++       + GT  ++APE      
Sbjct: 162 -RVIHRDLKLGNLFLNDDMDVKIGDFGLATKI--EFDGERKKXLCGTPNYIAPEVLCKKG 218
Query: 247 VDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQ 306
              + D+++ G  L  ++ G+ P + S     ++ +   N+  + + ++P          
Sbjct: 219 HSFEVDIWSLGCILYTLLVGKPPFETSCLK-ETYIRIKKNEYSVPRHINP---------- 267
Query: 307 LNRLAFAASLCIR----ASPTWRPTMSEVL 332
                  AS  IR    A PT RP+++E+L
Sbjct: 268 ------VASALIRRMLHADPTLRPSVAELL 291

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 70/270 (25%), Positives = 126/270 (46%), Gaps = 37/270 (13%)
Query: 73  LVGRGGYAEVYKGVLQDGEEI-AVKRLTKVVTDDRKEKEFL-TEIGTIGHVCHPNVLSLL 130
            +G+GG+A+ Y+    D +E+ A K + K +     +KE + TEI     + +P+V+   
Sbjct: 49  FLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFH 108
Query: 131 GCCVDNG-LYLIFQFSSRGSVASLFHD---VNSPGVEWKVRHKIAVGTARGLHYLHKGCQ 186
           G   D+  +Y++ +   R S+  L      V  P   + +R      T +G+ YLH    
Sbjct: 109 GFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQ-----TIQGVQYLHNN-- 161
Query: 187 RRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGI 246
            R+IHRD+K  N+ L  D + +I DFGLA  +  ++       + GT  ++APE      
Sbjct: 162 -RVIHRDLKLGNLFLNDDMDVKIGDFGLATKI--EFDGERKKDLCGTPNYIAPEVLCKKG 218
Query: 247 VDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQ 306
              + D+++ G  L  ++ G+ P + S     ++ +   N+  + + ++P          
Sbjct: 219 HSFEVDIWSLGCILYTLLVGKPPFETSCLK-ETYIRIKKNEYSVPRHINP---------- 267
Query: 307 LNRLAFAASLCIR----ASPTWRPTMSEVL 332
                  AS  IR    A PT RP+++E+L
Sbjct: 268 ------VASALIRRMLHADPTLRPSVAELL 291

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 100/204 (49%), Gaps = 11/204 (5%)
Query: 74  VGRGGYAEVYKGVLQDGEE----IAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSL 129
           +G G + +V++G+    E     +A+K      +D  +EK FL E  T+    HP+++ L
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREK-FLQEALTMRQFDHPHIVKL 76
Query: 130 LGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRI 189
           +G   +N +++I +  + G + S F  V    ++       A   +  L YL     +R 
Sbjct: 77  IGVITENPVWIIMELCTLGELRS-FLQVRKFSLDLASLILYAYQLSTALAYLE---SKRF 132
Query: 190 IHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDE 249
           +HRDI + N+L++++   ++ DFGL++++    T    +  +     +APE         
Sbjct: 133 VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS-TXXKASKGKLPIKWMAPESINFRRFTS 191
Query: 250 KTDVFAFGVFLLEIIS-GRKPVDG 272
            +DV+ FGV + EI+  G KP  G
Sbjct: 192 ASDVWMFGVCMWEILMHGVKPFQG 215

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 103/214 (48%), Gaps = 14/214 (6%)
Query: 63  IATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVC 122
           I   +   E  +G+G + EV+ G       +A+K L          + FL E   +  + 
Sbjct: 15  IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP---EAFLQEAQVMKKLR 71
Query: 123 HPNVLSLLGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLH 182
           H  ++ L     +  +Y++ ++ S+GS+           +       +A   A G+ Y+ 
Sbjct: 72  HEKLVQLYAVVSEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE 131
Query: 183 KGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLP-SQWTHHSIA--PIEGTFGHLAP 239
           +      +HRD++++NIL+  +   +++DFGLA+ +  +++T    A  PI+ T    AP
Sbjct: 132 R---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT----AP 184
Query: 240 EYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDG 272
           E  ++G    K+DV++FG+ L E+ + GR P  G
Sbjct: 185 EAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG 218

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 103/214 (48%), Gaps = 14/214 (6%)
Query: 63  IATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVC 122
           I   +   E  +G+G + EV+ G       +A+K L          + FL E   +  + 
Sbjct: 15  IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP---EAFLQEAQVMKKIR 71
Query: 123 HPNVLSLLGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLH 182
           H  ++ L     +  +Y++ ++ S+GS+           +       +A   A G+ Y+ 
Sbjct: 72  HEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE 131
Query: 183 KGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLP-SQWTHHSIA--PIEGTFGHLAP 239
           +      +HRD++++NIL+  +   +++DFGLA+ +  +++T    A  PI+ T    AP
Sbjct: 132 R---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT----AP 184
Query: 240 EYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDG 272
           E  ++G    K+DV++FG+ L E+ + GR P  G
Sbjct: 185 EAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG 218

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 106/212 (50%), Gaps = 15/212 (7%)
Query: 68  FSSENLVGRGGYAEVY--KGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPN 125
           +  +  +G+G +A+V   + VL  G E+AVK + K   +    ++   E+  +  + HPN
Sbjct: 17  YRLQKTIGKGNFAKVKLARHVLT-GREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHPN 75
Query: 126 VLSLLGCC-VDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKG 184
           ++ L      +  LYL+ +++S G V   F  + + G   +++ K A    R +    + 
Sbjct: 76  IVKLFEVIETEKTLYLVMEYASGGEV---FDYLVAHG---RMKEKEARAKFRQIVSAVQY 129
Query: 185 C-QRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFM 243
           C Q+ I+HRD+K+ N+LL  D   +I+DFG +         + +    G+  + APE F 
Sbjct: 130 CHQKYIVHRDLKAENLLLDGDMNIKIADFGFSNEFT---VGNKLDTFCGSPPYAAPELFQ 186
Query: 244 HGIVD-EKTDVFAFGVFLLEIISGRKPVDGSH 274
               D  + DV++ GV L  ++SG  P DG +
Sbjct: 187 GKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 218

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 71/265 (26%), Positives = 111/265 (41%), Gaps = 26/265 (9%)
Query: 92  EIAVKRLTKVVTDDRKEKEFLTEIGTIGHVC-HPNVLSLLGCCVDNG-LYLIFQFSSRGS 149
           ++AVK L      D KE   ++E+  + H+  H N+++LLG C   G + +I ++   G 
Sbjct: 78  KVAVKMLKSTAHADEKEA-LMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGD 136
Query: 150 VASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQ----------RRIIHRDIKSSNI 199
           + + F    S  +E      IA  TA     LH   Q          +  IHRD+ + N+
Sbjct: 137 LLN-FLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNV 195
Query: 200 LLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVF 259
           LLT     +I DFGLA+ + +   +            +APE     +   ++DV+++G+ 
Sbjct: 196 LLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGIL 255
Query: 260 LLEIIS-GRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCI 318
           L EI S G  P  G           IL   +  KLV    Q A        +      C 
Sbjct: 256 LWEIFSLGLNPYPG-----------ILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACW 304
Query: 319 RASPTWRPTMSEVLEVMLEGDQIDK 343
              PT RPT  ++   + E  Q D+
Sbjct: 305 ALEPTHRPTFQQICSFLQEQAQEDR 329

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 72/264 (27%), Positives = 121/264 (45%), Gaps = 33/264 (12%)
Query: 73  LVGRGGYAEVYK---GVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSL 129
           ++G+G + EV K    + Q  +E AVK + K    ++     L E+  +  + HPN++ L
Sbjct: 29  MLGKGSFGEVLKCKDRITQ--QEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKL 86
Query: 130 LGCCVDNG-LYLIFQFSSRGSVASLFHDV-NSPGVEWKVRHKIAVGTARGLHYLHKGCQR 187
                D+   Y++ +  + G    LF ++            +I      G+ Y+HK    
Sbjct: 87  FEILEDSSSFYIVGELYTGGE---LFDEIIKRKRFSEHDAARIIKQVFSGITYMHK---H 140
Query: 188 RIIHRDIKSSNILLTA---DFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMH 244
            I+HRD+K  NILL +   D + +I DFGL+        +  +    GT  ++APE  + 
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ---NTKMKDRIGTAYYIAPE-VLR 196
Query: 245 GIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDV 304
           G  DEK DV++ GV L  ++SG  P  G ++        IL + E  K        A+D+
Sbjct: 197 GTYDEKCDVWSAGVILYILLSGTPPFYGKNEY------DILKRVETGKY-------AFDL 243
Query: 305 TQLNRLAFAASLCIRASPTWRPTM 328
            Q   ++  A   IR   T+ P++
Sbjct: 244 PQWRTISDDAKDLIRKMLTFHPSL 267

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 103/214 (48%), Gaps = 14/214 (6%)
Query: 63  IATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVC 122
           I   +   E  +G+G + EV+ G       +A+K L          + FL E   +  + 
Sbjct: 4   IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP---EAFLQEAQVMKKLR 60
Query: 123 HPNVLSLLGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLH 182
           H  ++ L     +  +Y++ ++ S+GS+           +       +A   A G+ Y+ 
Sbjct: 61  HEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE 120
Query: 183 KGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLP-SQWTHHSIA--PIEGTFGHLAP 239
           +      +HRD++++NIL+  +   +++DFGLA+ +  +++T    A  PI+ T    AP
Sbjct: 121 R---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT----AP 173
Query: 240 EYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDG 272
           E  ++G    K+DV++FG+ L E+ + GR P  G
Sbjct: 174 EAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG 207

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 103/214 (48%), Gaps = 14/214 (6%)
Query: 63  IATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVC 122
           I   +   E  +G+G + EV+ G       +A+K L          + FL E   +  + 
Sbjct: 6   IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP---EAFLQEAQVMKKLR 62
Query: 123 HPNVLSLLGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLH 182
           H  ++ L     +  +Y++ ++ S+GS+           +       +A   A G+ Y+ 
Sbjct: 63  HEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE 122
Query: 183 KGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLP-SQWTHHSIA--PIEGTFGHLAP 239
           +      +HRD++++NIL+  +   +++DFGLA+ +  +++T    A  PI+ T    AP
Sbjct: 123 R---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT----AP 175
Query: 240 EYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDG 272
           E  ++G    K+DV++FG+ L E+ + GR P  G
Sbjct: 176 EAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG 209

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 61/267 (22%), Positives = 120/267 (44%), Gaps = 24/267 (8%)
Query: 74  VGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCC 133
           +G G +  V+ G   + +++A+K + +       E++F+ E   +  + HP ++ L G C
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQLYGVC 71
Query: 134 VDNG-LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHR 192
           ++   + L+F+F   G ++             +    + +    G+ YL + C   +IHR
Sbjct: 72  LEQAPICLVFEFMEHGCLSDYLRTQRGLFAA-ETLLGMCLDVCEGMAYLEEAC---VIHR 127
Query: 193 DIKSSNILLTADFEPQISDFGLAKW-LPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKT 251
           D+ + N L+  +   ++SDFG+ ++ L  Q+T  +       +   +PE F       K+
Sbjct: 128 DLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWA--SPEVFSFSRYSSKS 185
Query: 252 DVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQLNRL 310
           DV++FGV + E+ S G+ P +    S     + + +     +L  PRL   +    +N  
Sbjct: 186 DVWSFGVLMWEVFSEGKIPYENRSNS-----EVVEDISTGFRLYKPRLASTHVYQIMNH- 239
Query: 311 AFAASLCIRASPTWRPTMSEVLEVMLE 337
                 C +  P  RP  S +L  + E
Sbjct: 240 ------CWKERPEDRPAFSRLLRQLAE 260

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 96/208 (46%), Gaps = 19/208 (9%)
Query: 74  VGRGGYAEVYKG--VLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVC---HPNVLS 128
           +G G Y +V+K   +   G  +A+KR+     ++      + E+  + H+    HPNV+ 
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 129 LLGCCV------DNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLH 182
           L   C       +  L L+F+   +  + +    V  PGV  +    +     RGL +LH
Sbjct: 79  LFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 137
Query: 183 KGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYF 242
                R++HRD+K  NIL+T+  + +++DFGLA+    Q    S+     T  + APE  
Sbjct: 138 S---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVV---VTLWYRAPEVL 191
Query: 243 MHGIVDEKTDVFAFGVFLLEIISGRKPV 270
           +        D+++ G    E+   RKP+
Sbjct: 192 LQSSYATPVDLWSVGCIFAEMFR-RKPL 218

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 61/267 (22%), Positives = 120/267 (44%), Gaps = 24/267 (8%)
Query: 74  VGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCC 133
           +G G +  V+ G   + +++A+K + +       E++F+ E   +  + HP ++ L G C
Sbjct: 13  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQLYGVC 69
Query: 134 VDNG-LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHR 192
           ++   + L+F+F   G ++             +    + +    G+ YL + C   +IHR
Sbjct: 70  LEQAPICLVFEFMEHGCLSDYLRTQRGLFAA-ETLLGMCLDVCEGMAYLEEAC---VIHR 125
Query: 193 DIKSSNILLTADFEPQISDFGLAKW-LPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKT 251
           D+ + N L+  +   ++SDFG+ ++ L  Q+T  +       +   +PE F       K+
Sbjct: 126 DLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWA--SPEVFSFSRYSSKS 183
Query: 252 DVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQLNRL 310
           DV++FGV + E+ S G+ P +    S     + + +     +L  PRL   +    +N  
Sbjct: 184 DVWSFGVLMWEVFSEGKIPYENRSNS-----EVVEDISTGFRLYKPRLASTHVYQIMNH- 237
Query: 311 AFAASLCIRASPTWRPTMSEVLEVMLE 337
                 C +  P  RP  S +L  + E
Sbjct: 238 ------CWKERPEDRPAFSRLLRQLAE 258

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 108/203 (53%), Gaps = 15/203 (7%)
Query: 74  VGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCC 133
           +G G + +VYK   ++   +A  ++ +  +++  E +++ EI  +    HP ++ LLG  
Sbjct: 27  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELE-DYIVEIEILATCDHPYIVKLLGAY 85
Query: 134 VDNG-LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHR 192
             +G L+++ +F   G+V ++  +++    E +++  +       L++LH    +RIIHR
Sbjct: 86  YHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQ-VVCRQMLEALNFLH---SKRIIHR 141
Query: 193 DIKSSNILLTADFEPQISDFGL-AKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIV---- 247
           D+K+ N+L+T + + +++DFG+ AK L +     S     GT   +APE  M   +    
Sbjct: 142 DLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI---GTPYWMAPEVVMCETMKDTP 198
Query: 248 -DEKTDVFAFGVFLLEIISGRKP 269
            D K D+++ G+ L+E+     P
Sbjct: 199 YDYKADIWSLGITLIEMAQIEPP 221

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 103/214 (48%), Gaps = 14/214 (6%)
Query: 63  IATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVC 122
           I   +   E  +G+G + EV+ G       +A+K L          + FL E   +  + 
Sbjct: 15  IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP---EAFLQEAQVMKKLR 71
Query: 123 HPNVLSLLGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLH 182
           H  ++ L     +  +Y++ ++ S+GS+           +       +A   A G+ Y+ 
Sbjct: 72  HEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE 131
Query: 183 KGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLP-SQWTHHSIA--PIEGTFGHLAP 239
           +      +HRD++++NIL+  +   +++DFGLA+ +  +++T    A  PI+ T    AP
Sbjct: 132 R---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT----AP 184
Query: 240 EYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDG 272
           E  ++G    K+DV++FG+ L E+ + GR P  G
Sbjct: 185 EAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG 218

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 108/203 (53%), Gaps = 15/203 (7%)
Query: 74  VGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCC 133
           +G G + +VYK   ++   +A  ++ +  +++  E +++ EI  +    HP ++ LLG  
Sbjct: 19  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELE-DYIVEIEILATCDHPYIVKLLGAY 77
Query: 134 VDNG-LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHR 192
             +G L+++ +F   G+V ++  +++    E +++  +       L++LH    +RIIHR
Sbjct: 78  YHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQ-VVCRQMLEALNFLH---SKRIIHR 133
Query: 193 DIKSSNILLTADFEPQISDFGL-AKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIV---- 247
           D+K+ N+L+T + + +++DFG+ AK L +     S     GT   +APE  M   +    
Sbjct: 134 DLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI---GTPYWMAPEVVMCETMKDTP 190
Query: 248 -DEKTDVFAFGVFLLEIISGRKP 269
            D K D+++ G+ L+E+     P
Sbjct: 191 YDYKADIWSLGITLIEMAQIEPP 213

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 103/214 (48%), Gaps = 14/214 (6%)
Query: 63  IATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVC 122
           I   +   E  +G+G + EV+ G       +A+K L          + FL E   +  + 
Sbjct: 15  IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP---EAFLQEAQVMKKLR 71
Query: 123 HPNVLSLLGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLH 182
           H  ++ L     +  +Y++ ++ S+GS+           +       +A   A G+ Y+ 
Sbjct: 72  HEKLVQLYAVVSEEPIYIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE 131
Query: 183 KGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLP-SQWTHHSIA--PIEGTFGHLAP 239
           +      +HRD++++NIL+  +   +++DFGLA+ +  +++T    A  PI+ T    AP
Sbjct: 132 R---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT----AP 184
Query: 240 EYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDG 272
           E  ++G    K+DV++FG+ L E+ + GR P  G
Sbjct: 185 EAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG 218

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 94/198 (47%), Gaps = 13/198 (6%)
Query: 74  VGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCC 133
           VG G Y  VYK     G  +A+KR+     D+      + EI  +  + HPN++SL+   
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI 88
Query: 134 -VDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHR 192
             +  L L+F+F  +     L  D N  G++            RG+ + H   Q RI+HR
Sbjct: 89  HSERCLTLVFEFMEKDLKKVL--DENKTGLQDSQIKIYLYQLLRGVAHCH---QHRILHR 143
Query: 193 DIKSSNILLTADFEPQISDFGLAKW--LPSQWTHHSIAPIEGTFGHLAPEYFM-HGIVDE 249
           D+K  N+L+ +D   +++DFGLA+   +P +   H +     T  + AP+  M       
Sbjct: 144 DLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV----TLWYRAPDVLMGSKKYST 199
Query: 250 KTDVFAFGVFLLEIISGR 267
             D+++ G    E+I+G+
Sbjct: 200 SVDIWSIGCIFAEMITGK 217

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 110/214 (51%), Gaps = 25/214 (11%)
Query: 70  SENLVGRGGYAEVYKGVL----QDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPN 125
           S+ ++G+G +  VY G      Q+  + A+K L+++ T+ ++ + FL E   +  + HPN
Sbjct: 25  SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI-TEMQQVEAFLREGLLMRGLNHPN 83
Query: 126 VLSLLGCCVD-NGL-YLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVG--TARGLHYL 181
           VL+L+G  +   GL +++  +   G    L   + SP     V+  I+ G   ARG+ YL
Sbjct: 84  VLALIGIMLPPEGLPHVLLPYMCHGD---LLQFIRSPQRNPTVKDLISFGLQVARGMEYL 140
Query: 182 HKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAK------WLPSQWTHHSIAPIEGTFG 235
               +++ +HRD+ + N +L   F  +++DFGLA+      +   Q   H+  P++ T  
Sbjct: 141 ---AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWT-- 195
Query: 236 HLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKP 269
             A E         K+DV++FGV L E+++   P
Sbjct: 196 --ALESLQTYRFTTKSDVWSFGVLLWELLTRGAP 227

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 94/198 (47%), Gaps = 13/198 (6%)
Query: 74  VGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCC 133
           VG G Y  VYK     G  +A+KR+     D+      + EI  +  + HPN++SL+   
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI 88
Query: 134 -VDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHR 192
             +  L L+F+F  +     L  D N  G++            RG+ + H   Q RI+HR
Sbjct: 89  HSERCLTLVFEFMEKDLKKVL--DENKTGLQDSQIKIYLYQLLRGVAHCH---QHRILHR 143
Query: 193 DIKSSNILLTADFEPQISDFGLAKW--LPSQWTHHSIAPIEGTFGHLAPEYFM-HGIVDE 249
           D+K  N+L+ +D   +++DFGLA+   +P +   H +     T  + AP+  M       
Sbjct: 144 DLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV----TLWYRAPDVLMGSKKYST 199
Query: 250 KTDVFAFGVFLLEIISGR 267
             D+++ G    E+I+G+
Sbjct: 200 SVDIWSIGCIFAEMITGK 217

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 96/208 (46%), Gaps = 19/208 (9%)
Query: 74  VGRGGYAEVYKG--VLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVC---HPNVLS 128
           +G G Y +V+K   +   G  +A+KR+     ++      + E+  + H+    HPNV+ 
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 129 LLGCCV------DNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLH 182
           L   C       +  L L+F+   +  + +    V  PGV  +    +     RGL +LH
Sbjct: 79  LFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 137
Query: 183 KGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYF 242
                R++HRD+K  NIL+T+  + +++DFGLA+    Q    S+     T  + APE  
Sbjct: 138 ---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVV---VTLWYRAPEVL 191
Query: 243 MHGIVDEKTDVFAFGVFLLEIISGRKPV 270
           +        D+++ G    E+   RKP+
Sbjct: 192 LQSSYATPVDLWSVGCIFAEMFR-RKPL 218

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 96/208 (46%), Gaps = 19/208 (9%)
Query: 74  VGRGGYAEVYKG--VLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVC---HPNVLS 128
           +G G Y +V+K   +   G  +A+KR+     ++      + E+  + H+    HPNV+ 
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 129 LLGCCV------DNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLH 182
           L   C       +  L L+F+   +  + +    V  PGV  +    +     RGL +LH
Sbjct: 79  LFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 137
Query: 183 KGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYF 242
                R++HRD+K  NIL+T+  + +++DFGLA+    Q    S+     T  + APE  
Sbjct: 138 ---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVV---VTLWYRAPEVL 191
Query: 243 MHGIVDEKTDVFAFGVFLLEIISGRKPV 270
           +        D+++ G    E+   RKP+
Sbjct: 192 LQSSYATPVDLWSVGCIFAEMFR-RKPL 218

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 63/234 (26%), Positives = 116/234 (49%), Gaps = 27/234 (11%)
Query: 56  FSFEEISIATNAFSSE---------NLVGRGGYAEVYKGVLQ-DGEE---IAVKRLTKVV 102
           F+FE+ + A   F+ E          ++G G + EV  G L+  G+    +A+K L    
Sbjct: 14  FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 73
Query: 103 TDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQFSSRGSVASLFHDVNSPG 161
           T+ ++ ++FL+E   +G   HPNV+ L G    +  + +I +F   GS+ S     +   
Sbjct: 74  TE-KQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDG-- 130
Query: 162 VEWKVRHKIAV--GTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWL- 218
            ++ V   + +  G A G+ YL        +HRD+ + NIL+ ++   ++SDFGL+++L 
Sbjct: 131 -QFTVIQLVGMLRGIAAGMKYL---ADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 186
Query: 219 --PSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKP 269
              S  T+ S    +      APE   +      +DV+++G+ + E++S G +P
Sbjct: 187 DDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERP 240

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 66/233 (28%), Positives = 114/233 (48%), Gaps = 27/233 (11%)
Query: 51  PTWRCFSFEEISIATNAFSSENLVGRGGYAEVYKGVLQ--DGEEIAVK-RLTKVVTDDRK 107
           PT     F +   ATN  S + +VG G + EV  G L+    +EI+V  +  KV   +++
Sbjct: 31  PTQTVHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ 89
Query: 108 EKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQFSSRGSVASLF--HDVNSPGVEW 164
            ++FL E   +G   HPN++ L G    +  + ++ ++   GS+ S    HD      ++
Sbjct: 90  RRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA-----QF 144
Query: 165 KVRHKIAV--GTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWL---- 218
            V   + +  G A G+ YL        +HRD+ + NIL+ ++   ++SDFGLA+ L    
Sbjct: 145 TVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLARVLEDDP 201
Query: 219 -PSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKP 269
             +  T     PI  T    +PE   +      +DV+++G+ L E++S G +P
Sbjct: 202 EAAYTTRGGKIPIRWT----SPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 61/267 (22%), Positives = 119/267 (44%), Gaps = 24/267 (8%)
Query: 74  VGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCC 133
           +G G +  V+ G   + +++A+K + +       E +F+ E   +  + HP ++ L G C
Sbjct: 35  IGSGQFGLVHLGYWLNKDKVAIKTIKE---GSMSEDDFIEEAEVMMKLSHPKLVQLYGVC 91
Query: 134 VDNG-LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHR 192
           ++   + L+F+F   G ++             +    + +    G+ YL + C   +IHR
Sbjct: 92  LEQAPICLVFEFMEHGCLSDYLRTQRGLFAA-ETLLGMCLDVCEGMAYLEEAC---VIHR 147
Query: 193 DIKSSNILLTADFEPQISDFGLAKW-LPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKT 251
           D+ + N L+  +   ++SDFG+ ++ L  Q+T  +       +   +PE F       K+
Sbjct: 148 DLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWA--SPEVFSFSRYSSKS 205
Query: 252 DVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQLNRL 310
           DV++FGV + E+ S G+ P +    S     + + +     +L  PRL   +    +N  
Sbjct: 206 DVWSFGVLMWEVFSEGKIPYENRSNS-----EVVEDISTGFRLYKPRLASTHVYQIMNH- 259
Query: 311 AFAASLCIRASPTWRPTMSEVLEVMLE 337
                 C +  P  RP  S +L  + E
Sbjct: 260 ------CWKERPEDRPAFSRLLRQLAE 280

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 62/264 (23%), Positives = 122/264 (46%), Gaps = 28/264 (10%)
Query: 74  VGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCC 133
           +G G +  V  G  +   ++AVK + +       E EF  E  T+  + HP ++   G C
Sbjct: 16  LGSGQFGVVKLGKWKGQYDVAVKMIKE---GSMSEDEFFQEAQTMMKLSHPKLVKFYGVC 72
Query: 134 V-DNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHR 192
             +  +Y++ ++ S G + +     +  G+E     ++      G+ +L      + IHR
Sbjct: 73  SKEYPIYIVTEYISNGCLLNYLRS-HGKGLEPSQLLEMCYDVCEGMAFLE---SHQFIHR 128
Query: 193 DIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIA---PIEGTFGHLAPEYFMHGIVDE 249
           D+ + N L+  D   ++SDFG+ +++       S+    P++ +    APE F +     
Sbjct: 129 DLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWS----APEVFHYFKYSS 184
Query: 250 KTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQLN 308
           K+DV+AFG+ + E+ S G+ P D     L++ ++ +L   +  +L  P L        + 
Sbjct: 185 KSDVWAFGILMWEVFSLGKMPYD-----LYTNSEVVLKVSQGHRLYRPHLAS----DTIY 235
Query: 309 RLAFAASLCIRASPTWRPTMSEVL 332
           ++ ++   C    P  RPT  ++L
Sbjct: 236 QIMYS---CWHELPEKRPTFQQLL 256

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 72/264 (27%), Positives = 121/264 (45%), Gaps = 33/264 (12%)
Query: 73  LVGRGGYAEVYK---GVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSL 129
           ++G+G + EV K    + Q  +E AVK + K    ++     L E+  +  + HPN++ L
Sbjct: 29  MLGKGSFGEVLKCKDRITQ--QEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKL 86
Query: 130 LGCCVDNG-LYLIFQFSSRGSVASLFHDV-NSPGVEWKVRHKIAVGTARGLHYLHKGCQR 187
                D+   Y++ +  + G    LF ++            +I      G+ Y+HK    
Sbjct: 87  FEILEDSSSFYIVGELYTGGE---LFDEIIKRKRFSEHDAARIIKQVFSGITYMHK---H 140
Query: 188 RIIHRDIKSSNILLTA---DFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMH 244
            I+HRD+K  NILL +   D + +I DFGL+        +  +    GT  ++APE  + 
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ---NTKMKDRIGTAYYIAPE-VLR 196
Query: 245 GIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDV 304
           G  DEK DV++ GV L  ++SG  P  G ++        IL + E  K        A+D+
Sbjct: 197 GTYDEKCDVWSAGVILYILLSGTPPFYGKNEY------DILKRVETGKY-------AFDL 243
Query: 305 TQLNRLAFAASLCIRASPTWRPTM 328
            Q   ++  A   IR   T+ P++
Sbjct: 244 PQWRTISDDAKDLIRKMLTFHPSL 267

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 53/214 (24%), Positives = 102/214 (47%), Gaps = 14/214 (6%)
Query: 63  IATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVC 122
           I   +   E  +G+G + EV+ G       +A+K L          + FL E   +  + 
Sbjct: 15  IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP---EAFLQEAQVMKKLR 71
Query: 123 HPNVLSLLGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLH 182
           H  ++ L     +  +Y++ ++ S+G +           +       +A   A G+ Y+ 
Sbjct: 72  HEKLVQLYAVVSEEPIYIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE 131
Query: 183 KGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLP-SQWTHHSIA--PIEGTFGHLAP 239
           +      +HRD++++NIL+  +   +++DFGLA+ +  +++T    A  PI+ T    AP
Sbjct: 132 R---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT----AP 184
Query: 240 EYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDG 272
           E  ++G    K+DV++FG+ L E+ + GR P  G
Sbjct: 185 EAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG 218

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 71/262 (27%), Positives = 120/262 (45%), Gaps = 29/262 (11%)
Query: 73  LVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLG 131
           ++G+G + EV K   +   +E AVK + K    ++     L E+  +  + HPN++ L  
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 132 CCVDNG-LYLIFQFSSRGSVASLFHDV-NSPGVEWKVRHKIAVGTARGLHYLHKGCQRRI 189
              D+   Y++ +  + G    LF ++            +I      G+ Y+HK     I
Sbjct: 89  ILEDSSSFYIVGELYTGGE---LFDEIIKRKRFSEHDAARIIKQVFSGITYMHK---HNI 142
Query: 190 IHRDIKSSNILLTA---DFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGI 246
           +HRD+K  NILL +   D + +I DFGL+        +  +    GT  ++APE  + G 
Sbjct: 143 VHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ---NTKMKDRIGTAYYIAPE-VLRGT 198
Query: 247 VDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQ 306
            DEK DV++ GV L  ++SG  P  G ++        IL + E  K        A+D+ Q
Sbjct: 199 YDEKCDVWSAGVILYILLSGTPPFYGKNEY------DILKRVETGKY-------AFDLPQ 245
Query: 307 LNRLAFAASLCIRASPTWRPTM 328
              ++  A   IR   T+ P++
Sbjct: 246 WRTISDDAKDLIRKMLTFHPSL 267

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 102/214 (47%), Gaps = 14/214 (6%)
Query: 63  IATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVC 122
           I   +   E  +G+G + EV+ G       +A+K L          + FL E   +  + 
Sbjct: 15  IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP---EAFLQEAQVMKKLR 71
Query: 123 HPNVLSLLGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLH 182
           H  ++ L     +  +Y++ ++ S+GS+           +       +A   A G+ Y+ 
Sbjct: 72  HEKLVQLYAVVSEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE 131
Query: 183 KGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLP-SQWTHHSIA--PIEGTFGHLAP 239
           +      +HRD++++NIL+  +   +++DFGLA+ +  ++ T    A  PI+ T    AP
Sbjct: 132 R---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWT----AP 184
Query: 240 EYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDG 272
           E  ++G    K+DV++FG+ L E+ + GR P  G
Sbjct: 185 EAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG 218

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 107/221 (48%), Gaps = 25/221 (11%)
Query: 63  IATNAFSSENLVGRGGYAEVYKGVLQDGE-----EIAVKRLTKVVTDDRKEKEFLTEIGT 117
           I  +  + + ++G G + EVYKG+L+         +A+K L    T+ ++  +FL E G 
Sbjct: 41  IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTE-KQRVDFLGEAGI 99
Query: 118 IGHVCHPNVLSLLGCCVD-NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAV--GT 174
           +G   H N++ L G       + +I ++   G++     + +    E+ V   + +  G 
Sbjct: 100 MGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDG---EFSVLQLVGMLRGI 156
Query: 175 ARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWL-----PSQWTHHSIAP 229
           A G+ YL        +HRD+ + NIL+ ++   ++SDFGL++ L      +  T     P
Sbjct: 157 AAGMKYL---ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIP 213
Query: 230 IEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKP 269
           I  T    APE   +      +DV++FG+ + E+++ G +P
Sbjct: 214 IRWT----APEAISYRKFTSASDVWSFGIVMWEVMTYGERP 250

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 102/214 (47%), Gaps = 14/214 (6%)
Query: 63  IATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVC 122
           I   +   E  +G+G + EV+ G       +A+K L          + FL E   +  + 
Sbjct: 15  IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP---EAFLQEAQVMKKLR 71
Query: 123 HPNVLSLLGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLH 182
           H  ++ L     +  +Y++ ++ S+GS+           +       +A   A G+ Y+ 
Sbjct: 72  HEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE 131
Query: 183 KGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLP-SQWTHHSIA--PIEGTFGHLAP 239
           +      +HRD+ ++NIL+  +   +++DFGLA+ +  +++T    A  PI+ T    AP
Sbjct: 132 R---MNYVHRDLAAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT----AP 184
Query: 240 EYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDG 272
           E  ++G    K+DV++FG+ L E+ + GR P  G
Sbjct: 185 EAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG 218

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/233 (27%), Positives = 114/233 (48%), Gaps = 27/233 (11%)
Query: 51  PTWRCFSFEEISIATNAFSSENLVGRGGYAEVYKGVLQ--DGEEIAVK-RLTKVVTDDRK 107
           PT     F +   ATN  S + +VG G + EV  G L+    +EI+V  +  KV   +++
Sbjct: 31  PTQTVHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ 89
Query: 108 EKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQFSSRGSVASLF--HDVNSPGVEW 164
            ++FL E   +G   HPN++ L G    +  + ++ ++   GS+ S    HD      ++
Sbjct: 90  RRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA-----QF 144
Query: 165 KVRHKIAV--GTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWL---- 218
            V   + +  G A G+ YL        +HRD+ + NIL+ ++   ++SDFGL++ L    
Sbjct: 145 TVIQLVGMLRGIASGMKYL---SDMGFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDP 201
Query: 219 -PSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKP 269
             +  T     PI  T    +PE   +      +DV+++G+ L E++S G +P
Sbjct: 202 EAAYTTRGGKIPIRWT----SPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 102/205 (49%), Gaps = 13/205 (6%)
Query: 74  VGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC 132
           +G+G +A+V     +  G+E+AVK + K   +    ++   E+     + HPN++ L   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPNIVKLFEV 81
Query: 133 C-VDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIH 191
              +  LYL+ +++S G V   +   +    E + R K        + Y H   Q+ I+H
Sbjct: 82  IETEKTLYLVXEYASGGEVFD-YLVAHGRXKEKEARAKFR-QIVSAVQYCH---QKFIVH 136
Query: 192 RDIKSSNILLTADFEPQISDFGLAKWLPSQWTH-HSIAPIEGTFGHLAPEYFMHGIVD-E 249
           RD+K+ N+LL AD   +I+DFG +    +++T  + +    G   + APE F     D  
Sbjct: 137 RDLKAENLLLDADXNIKIADFGFS----NEFTFGNKLDAFCGAPPYAAPELFQGKKYDGP 192
Query: 250 KTDVFAFGVFLLEIISGRKPVDGSH 274
           + DV++ GV L  ++SG  P DG +
Sbjct: 193 EVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 70/265 (26%), Positives = 110/265 (41%), Gaps = 26/265 (9%)
Query: 92  EIAVKRLTKVVTDDRKEKEFLTEIGTIGHVC-HPNVLSLLGCCVDNG-LYLIFQFSSRGS 149
           ++AVK L      D KE   ++E+  + H+  H N+++LLG C   G + +I ++   G 
Sbjct: 78  KVAVKMLKSTAHADEKEA-LMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGD 136
Query: 150 VASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQ----------RRIIHRDIKSSNI 199
           + + F    S  +E      IA  T      LH   Q          +  IHRD+ + N+
Sbjct: 137 LLN-FLRRKSRVLETDPAFAIANSTLSTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNV 195
Query: 200 LLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVF 259
           LLT     +I DFGLA+ + +   +            +APE     +   ++DV+++G+ 
Sbjct: 196 LLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGIL 255
Query: 260 LLEIIS-GRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCI 318
           L EI S G  P  G           IL   +  KLV    Q A        +      C 
Sbjct: 256 LWEIFSLGLNPYPG-----------ILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACW 304
Query: 319 RASPTWRPTMSEVLEVMLEGDQIDK 343
              PT RPT  ++   + E  Q D+
Sbjct: 305 ALEPTHRPTFQQICSFLQEQAQEDR 329

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 52/214 (24%), Positives = 103/214 (48%), Gaps = 14/214 (6%)
Query: 63  IATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVC 122
           I   +   E  +G+G + EV+ G       +A+K L          + FL E   +  + 
Sbjct: 12  IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP---EAFLQEAQVMKKLR 68
Query: 123 HPNVLSLLGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLH 182
           H  ++ L     +  +Y++ ++ ++GS+           +       ++   A G+ Y+ 
Sbjct: 69  HEKLVQLYAVVSEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVE 128
Query: 183 KGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLP-SQWTHHSIA--PIEGTFGHLAP 239
           +      +HRD++++NIL+  +   +++DFGLA+ +  +++T    A  PI+ T    AP
Sbjct: 129 R---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT----AP 181
Query: 240 EYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDG 272
           E  ++G    K+DV++FG+ L E+ + GR P  G
Sbjct: 182 EAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG 215

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/233 (27%), Positives = 114/233 (48%), Gaps = 27/233 (11%)
Query: 51  PTWRCFSFEEISIATNAFSSENLVGRGGYAEVYKGVLQ--DGEEIAVK-RLTKVVTDDRK 107
           PT     F +   ATN  S + +VG G + EV  G L+    +EI+V  +  KV   +++
Sbjct: 31  PTQTVHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ 89
Query: 108 EKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQFSSRGSVASLF--HDVNSPGVEW 164
            ++FL E   +G   HPN++ L G    +  + ++ ++   GS+ S    HD      ++
Sbjct: 90  RRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA-----QF 144
Query: 165 KVRHKIAV--GTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWL---- 218
            V   + +  G A G+ YL        +HRD+ + NIL+ ++   ++SDFGL++ L    
Sbjct: 145 TVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDP 201
Query: 219 -PSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKP 269
             +  T     PI  T    +PE   +      +DV+++G+ L E++S G +P
Sbjct: 202 EAAYTTRGGKIPIRWT----SPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/233 (27%), Positives = 114/233 (48%), Gaps = 27/233 (11%)
Query: 51  PTWRCFSFEEISIATNAFSSENLVGRGGYAEVYKGVLQ--DGEEIAVK-RLTKVVTDDRK 107
           PT     F +   ATN  S + +VG G + EV  G L+    +EI+V  +  KV   +++
Sbjct: 29  PTQTVHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ 87
Query: 108 EKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQFSSRGSVASLF--HDVNSPGVEW 164
            ++FL E   +G   HPN++ L G    +  + ++ ++   GS+ S    HD      ++
Sbjct: 88  RRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA-----QF 142
Query: 165 KVRHKIAV--GTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWL---- 218
            V   + +  G A G+ YL        +HRD+ + NIL+ ++   ++SDFGL++ L    
Sbjct: 143 TVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDP 199
Query: 219 -PSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKP 269
             +  T     PI  T    +PE   +      +DV+++G+ L E++S G +P
Sbjct: 200 EAAYTTRGGKIPIRWT----SPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 248

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/233 (27%), Positives = 114/233 (48%), Gaps = 27/233 (11%)
Query: 51  PTWRCFSFEEISIATNAFSSENLVGRGGYAEVYKGVLQ--DGEEIAVK-RLTKVVTDDRK 107
           PT     F +   ATN  S + +VG G + EV  G L+    +EI+V  +  KV   +++
Sbjct: 31  PTQTVHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ 89
Query: 108 EKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQFSSRGSVASLF--HDVNSPGVEW 164
            ++FL E   +G   HPN++ L G    +  + ++ ++   GS+ S    HD      ++
Sbjct: 90  RRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA-----QF 144
Query: 165 KVRHKIAV--GTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWL---- 218
            V   + +  G A G+ YL        +HRD+ + NIL+ ++   ++SDFGL++ L    
Sbjct: 145 TVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDP 201
Query: 219 -PSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKP 269
             +  T     PI  T    +PE   +      +DV+++G+ L E++S G +P
Sbjct: 202 EAAYTTRGGKIPIRWT----SPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/233 (27%), Positives = 114/233 (48%), Gaps = 27/233 (11%)
Query: 51  PTWRCFSFEEISIATNAFSSENLVGRGGYAEVYKGVLQ--DGEEIAVK-RLTKVVTDDRK 107
           PT     F +   ATN  S + +VG G + EV  G L+    +EI+V  +  KV   +++
Sbjct: 31  PTQTVHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ 89
Query: 108 EKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQFSSRGSVASLF--HDVNSPGVEW 164
            ++FL E   +G   HPN++ L G    +  + ++ ++   GS+ S    HD      ++
Sbjct: 90  RRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA-----QF 144
Query: 165 KVRHKIAV--GTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWL---- 218
            V   + +  G A G+ YL        +HRD+ + NIL+ ++   ++SDFGL++ L    
Sbjct: 145 TVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDP 201
Query: 219 -PSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKP 269
             +  T     PI  T    +PE   +      +DV+++G+ L E++S G +P
Sbjct: 202 EAAYTTRGGKIPIRWT----SPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/233 (27%), Positives = 114/233 (48%), Gaps = 27/233 (11%)
Query: 51  PTWRCFSFEEISIATNAFSSENLVGRGGYAEVYKGVLQ--DGEEIAVK-RLTKVVTDDRK 107
           PT     F +   ATN  S + +VG G + EV  G L+    +EI+V  +  KV   +++
Sbjct: 31  PTQTVHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ 89
Query: 108 EKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQFSSRGSVASLF--HDVNSPGVEW 164
            ++FL E   +G   HPN++ L G    +  + ++ ++   GS+ S    HD      ++
Sbjct: 90  RRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA-----QF 144
Query: 165 KVRHKIAV--GTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWL---- 218
            V   + +  G A G+ YL        +HRD+ + NIL+ ++   ++SDFGL++ L    
Sbjct: 145 TVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDP 201
Query: 219 -PSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKP 269
             +  T     PI  T    +PE   +      +DV+++G+ L E++S G +P
Sbjct: 202 EAAYTTRGGKIPIRWT----SPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/214 (24%), Positives = 102/214 (47%), Gaps = 14/214 (6%)
Query: 63  IATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVC 122
           I   +   E  +G+G + EV+ G       +A+K L          + FL E   +  + 
Sbjct: 15  IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP---EAFLQEAQVMKKLR 71
Query: 123 HPNVLSLLGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLH 182
           H  ++ L     +  +Y++ ++ S+G +           +       +A   A G+ Y+ 
Sbjct: 72  HEKLVQLYAVVSEEPIYIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE 131
Query: 183 KGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLP-SQWTHHSIA--PIEGTFGHLAP 239
           +      +HRD++++NIL+  +   +++DFGLA+ +  +++T    A  PI+ T    AP
Sbjct: 132 R---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT----AP 184
Query: 240 EYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDG 272
           E  ++G    K+DV++FG+ L E+ + GR P  G
Sbjct: 185 EAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG 218

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 113/223 (50%), Gaps = 27/223 (12%)
Query: 71  ENLVGRGGYAEVYKGVLQ-DGEE---IAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNV 126
           E ++G G + EV +G L+  G++   +A+K L    T+ R+ +EFL+E   +G   HPN+
Sbjct: 19  EEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTE-RQRREFLSEASIMGQFEHPNI 77
Query: 127 LSLLGCCVDNGLYLIF-QFSSRGSVASLFHDVNSPGVEWKVRHKIAV--GTARGLHYLHK 183
           + L G   ++   +I  +F   G++ S     +    ++ V   + +  G A G+ YL  
Sbjct: 78  IRLEGVVTNSMPVMILTEFMENGALDSFLRLNDG---QFTVIQLVGMLRGIASGMRYL-- 132
Query: 184 GCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIA-------PIEGTFGH 236
             +   +HRD+ + NIL+ ++   ++SDFGL+++L    +  +         PI  T   
Sbjct: 133 -AEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWT--- 188
Query: 237 LAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPV-DGSHQSL 277
            APE          +D +++G+ + E++S G +P  D S+Q +
Sbjct: 189 -APEAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSNQDV 230

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/267 (22%), Positives = 119/267 (44%), Gaps = 24/267 (8%)
Query: 74  VGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCC 133
           +G G +  V+ G   + +++A+K + +       E++F+ E   +  + HP ++ L G C
Sbjct: 16  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQLYGVC 72
Query: 134 VDNG-LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHR 192
           ++   + L+ +F   G ++             +    + +    G+ YL + C   +IHR
Sbjct: 73  LEQAPICLVTEFMEHGCLSDYLRTQRGLFAA-ETLLGMCLDVCEGMAYLEEAC---VIHR 128
Query: 193 DIKSSNILLTADFEPQISDFGLAKW-LPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKT 251
           D+ + N L+  +   ++SDFG+ ++ L  Q+T  +       +   +PE F       K+
Sbjct: 129 DLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWA--SPEVFSFSRYSSKS 186
Query: 252 DVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQLNRL 310
           DV++FGV + E+ S G+ P +    S     + + +     +L  PRL   +    +N  
Sbjct: 187 DVWSFGVLMWEVFSEGKIPYENRSNS-----EVVEDISTGFRLYKPRLASTHVYQIMNH- 240
Query: 311 AFAASLCIRASPTWRPTMSEVLEVMLE 337
                 C R  P  RP  S +L  + E
Sbjct: 241 ------CWRERPEDRPAFSRLLRQLAE 261

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/233 (27%), Positives = 113/233 (48%), Gaps = 27/233 (11%)
Query: 51  PTWRCFSFEEISIATNAFSSENLVGRGGYAEVYKGVLQ--DGEEIAVK-RLTKVVTDDRK 107
           PT     F +   ATN  S + +VG G + EV  G L+    +EI+V  +  KV   +++
Sbjct: 31  PTQTVHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ 89
Query: 108 EKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQFSSRGSVASLF--HDVNSPGVEW 164
            ++FL E   +G   HPN++ L G    +  + ++ ++   GS+ S    HD      ++
Sbjct: 90  RRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA-----QF 144
Query: 165 KVRHKIAV--GTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWL---- 218
            V   + +  G A G+ YL        +HRD+ + NIL+ ++   ++SDFGL + L    
Sbjct: 145 TVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDP 201
Query: 219 -PSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKP 269
             +  T     PI  T    +PE   +      +DV+++G+ L E++S G +P
Sbjct: 202 EAAYTTRGGKIPIRWT----SPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 105/207 (50%), Gaps = 11/207 (5%)
Query: 72  NLVGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLT---EIGTIGHVCHPNVL 127
            ++G G +  V+KGV + +GE I +    KV+ D    + F      +  IG + H +++
Sbjct: 37  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 96
Query: 128 SLLGCCVDNGLYLIFQFSSRGSVASLFHDVNSPG-VEWKVRHKIAVGTARGLHYLHKGCQ 186
            LLG C  + L L+ Q+   GS+  L H     G +  ++     V  A+G++YL    +
Sbjct: 97  RLLGLCPGSSLQLVTQYLPLGSL--LDHVRQHRGALGPQLLLNWGVQIAKGMYYLE---E 151
Query: 187 RRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGI 246
             ++HR++ + N+LL +  + Q++DFG+A  LP        +  +     +A E    G 
Sbjct: 152 HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGK 211
Query: 247 VDEKTDVFAFGVFLLEIIS-GRKPVDG 272
              ++DV+++GV + E+++ G +P  G
Sbjct: 212 YTHQSDVWSYGVTVWELMTFGAEPYAG 238

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/266 (24%), Positives = 122/266 (45%), Gaps = 29/266 (10%)
Query: 73  LVGRGGYAEVYKGVLQDGEEIAVKRLT--KVVTDDRKEKEFLTEIGTIGHVCHPNVLSLL 130
            +G+GG+A+ ++    D +E+   ++    ++    + ++   EI     + H +V+   
Sbjct: 24  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 83
Query: 131 GCCVDNG-LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRI 189
           G   DN  ++++ +   R S+  L H       E + R+ +      G  YLH+    R+
Sbjct: 84  GFFEDNDFVFVVLELCRRRSLLEL-HKRRKALTEPEARYYLR-QIVLGCQYLHRN---RV 138
Query: 190 IHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDE 249
           IHRD+K  N+ L  D E +I DFGLA  +  ++       + GT  ++APE         
Sbjct: 139 IHRDLKLGNLFLNEDLEVKIGDFGLATKV--EYDGERKKTLCGTPNYIAPEVLSKKGHSF 196
Query: 250 KTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQLNR 309
           + DV++ G  +  ++ G+ P + S     ++ +   N+  I K ++P             
Sbjct: 197 EVDVWSIGCIMYTLLVGKPPFETSCLK-ETYLRIKKNEYSIPKHINP------------- 242
Query: 310 LAFAASLC---IRASPTWRPTMSEVL 332
              AASL    ++  PT RPT++E+L
Sbjct: 243 --VAASLIQKMLQTDPTARPTINELL 266

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/266 (24%), Positives = 121/266 (45%), Gaps = 29/266 (10%)
Query: 73  LVGRGGYAEVYKGVLQDGEEIAVKRLT--KVVTDDRKEKEFLTEIGTIGHVCHPNVLSLL 130
            +G+GG+A+ ++    D +E+   ++    ++    + ++   EI     + H +V+   
Sbjct: 22  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81
Query: 131 GCCVDNG-LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRI 189
           G   DN  ++++ +   R S+  L H       E + R+ +      G  YLH+    R+
Sbjct: 82  GFFEDNDFVFVVLELCRRRSLLEL-HKRRKALTEPEARYYLR-QIVLGCQYLHRN---RV 136
Query: 190 IHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDE 249
           IHRD+K  N+ L  D E +I DFGLA  +        +  + GT  ++APE         
Sbjct: 137 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCGTPNYIAPEVLSKKGHSF 194
Query: 250 KTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQLNR 309
           + DV++ G  +  ++ G+ P + S     ++ +   N+  I K ++P             
Sbjct: 195 EVDVWSIGCIMYTLLVGKPPFETSCLK-ETYLRIKKNEYSIPKHINP------------- 240
Query: 310 LAFAASLC---IRASPTWRPTMSEVL 332
              AASL    ++  PT RPT++E+L
Sbjct: 241 --VAASLIQKMLQTDPTARPTINELL 264

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/266 (24%), Positives = 122/266 (45%), Gaps = 29/266 (10%)
Query: 73  LVGRGGYAEVYKGVLQDGEEIAVKRLT--KVVTDDRKEKEFLTEIGTIGHVCHPNVLSLL 130
            +G+GG+A+ ++    D +E+   ++    ++    + ++   EI     + H +V+   
Sbjct: 24  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 83
Query: 131 GCCVDNG-LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRI 189
           G   DN  ++++ +   R S+  L H       E + R+ +      G  YLH+    R+
Sbjct: 84  GFFEDNDFVFVVLELCRRRSLLEL-HKRRKALTEPEARYYLR-QIVLGCQYLHRN---RV 138
Query: 190 IHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDE 249
           IHRD+K  N+ L  D E +I DFGLA  +  ++       + GT  ++APE         
Sbjct: 139 IHRDLKLGNLFLNEDLEVKIGDFGLATKV--EYDGERKKTLCGTPNYIAPEVLSKKGHSF 196
Query: 250 KTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQLNR 309
           + DV++ G  +  ++ G+ P + S     ++ +   N+  I K ++P             
Sbjct: 197 EVDVWSIGCIMYTLLVGKPPFETSCLK-ETYLRIKKNEYSIPKHINP------------- 242
Query: 310 LAFAASLC---IRASPTWRPTMSEVL 332
              AASL    ++  PT RPT++E+L
Sbjct: 243 --VAASLIQKMLQTDPTARPTINELL 266

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/266 (24%), Positives = 122/266 (45%), Gaps = 29/266 (10%)
Query: 73  LVGRGGYAEVYKGVLQDGEEIAVKRLT--KVVTDDRKEKEFLTEIGTIGHVCHPNVLSLL 130
            +G+GG+A+ ++    D +E+   ++    ++    + ++   EI     + H +V+   
Sbjct: 28  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 87
Query: 131 GCCVDNG-LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRI 189
           G   DN  ++++ +   R S+  L H       E + R+ +      G  YLH+    R+
Sbjct: 88  GFFEDNDFVFVVLELCRRRSLLEL-HKRRKALTEPEARYYLR-QIVLGCQYLHRN---RV 142
Query: 190 IHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDE 249
           IHRD+K  N+ L  D E +I DFGLA  +  ++       + GT  ++APE         
Sbjct: 143 IHRDLKLGNLFLNEDLEVKIGDFGLATKV--EYDGERKKTLCGTPNYIAPEVLSKKGHSF 200
Query: 250 KTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQLNR 309
           + DV++ G  +  ++ G+ P + S     ++ +   N+  I K ++P             
Sbjct: 201 EVDVWSIGCIMYTLLVGKPPFETSCLK-ETYLRIKKNEYSIPKHINP------------- 246
Query: 310 LAFAASLC---IRASPTWRPTMSEVL 332
              AASL    ++  PT RPT++E+L
Sbjct: 247 --VAASLIQKMLQTDPTARPTINELL 270

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/266 (24%), Positives = 121/266 (45%), Gaps = 29/266 (10%)
Query: 73  LVGRGGYAEVYKGVLQDGEEIAVKRLT--KVVTDDRKEKEFLTEIGTIGHVCHPNVLSLL 130
            +G+GG+A+ ++    D +E+   ++    ++    + ++   EI     + H +V+   
Sbjct: 46  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 105
Query: 131 GCCVDNG-LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRI 189
           G   DN  ++++ +   R S+  L H       E + R+ +      G  YLH+    R+
Sbjct: 106 GFFEDNDFVFVVLELCRRRSLLEL-HKRRKALTEPEARYYLR-QIVLGCQYLHRN---RV 160
Query: 190 IHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDE 249
           IHRD+K  N+ L  D E +I DFGLA  +        +  + GT  ++APE         
Sbjct: 161 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCGTPNYIAPEVLSKKGHSF 218
Query: 250 KTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQLNR 309
           + DV++ G  +  ++ G+ P + S     ++ +   N+  I K ++P             
Sbjct: 219 EVDVWSIGCIMYTLLVGKPPFETSCLK-ETYLRIKKNEYSIPKHINP------------- 264
Query: 310 LAFAASLC---IRASPTWRPTMSEVL 332
              AASL    ++  PT RPT++E+L
Sbjct: 265 --VAASLIQKMLQTDPTARPTINELL 288

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 105/207 (50%), Gaps = 11/207 (5%)
Query: 72  NLVGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLT---EIGTIGHVCHPNVL 127
            ++G G +  V+KGV + +GE I +    KV+ D    + F      +  IG + H +++
Sbjct: 19  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78
Query: 128 SLLGCCVDNGLYLIFQFSSRGSVASLFHDVNSPG-VEWKVRHKIAVGTARGLHYLHKGCQ 186
            LLG C  + L L+ Q+   GS+  L H     G +  ++     V  A+G++YL    +
Sbjct: 79  RLLGLCPGSSLQLVTQYLPLGSL--LDHVRQHRGALGPQLLLNWGVQIAKGMYYLE---E 133
Query: 187 RRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGI 246
             ++HR++ + N+LL +  + Q++DFG+A  LP        +  +     +A E    G 
Sbjct: 134 HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGK 193
Query: 247 VDEKTDVFAFGVFLLEIIS-GRKPVDG 272
              ++DV+++GV + E+++ G +P  G
Sbjct: 194 YTHQSDVWSYGVTVWELMTFGAEPYAG 220

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 74/280 (26%), Positives = 125/280 (44%), Gaps = 35/280 (12%)
Query: 74  VGRGGYAEVYK----GVLQDG--EEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHP-NV 126
           +GRG + +V +    G+ +      +AVK L +  T   + +  ++E+  + H+ H  NV
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHS-EHRALMSELKILIHIGHHLNV 93
Query: 127 LSLLGCCVDNG--LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHK----------IAVGT 174
           ++LLG C   G  L +I +F   G++++      +  V +K  +K           +   
Sbjct: 94  VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXYSFQV 153
Query: 175 ARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTF 234
           A+G+ +L     R+ IHRD+ + NILL+     +I DFGLA+ +     +          
Sbjct: 154 AKGMEFL---ASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDARLPL 210
Query: 235 GHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGEIEKL 293
             +APE     +   ++DV++FGV L EI S G  P  G         +  L +G   + 
Sbjct: 211 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFXRR--LKEGTRMRA 268
Query: 294 VDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLE 333
            D      Y  T L+        C    P+ RPT SE++E
Sbjct: 269 PDYTTPEMYQ-TMLD--------CWHGEPSQRPTFSELVE 299

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 110/220 (50%), Gaps = 27/220 (12%)
Query: 64  ATNAFSSENLVGRGGYAEVYKGVLQ--DGEEIAVK-RLTKVVTDDRKEKEFLTEIGTIGH 120
           ATN  S + +VG G + EV  G L+    +EI+V  +  KV   +++ ++FL E   +G 
Sbjct: 15  ATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQ 73
Query: 121 VCHPNVLSLLGCCVDNG-LYLIFQFSSRGSVASLF--HDVNSPGVEWKVRHKIAV--GTA 175
             HPN++ L G    +  + ++ ++   GS+ S    HD      ++ V   + +  G A
Sbjct: 74  FDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA-----QFTVIQLVGMLRGIA 128
Query: 176 RGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWL-----PSQWTHHSIAPI 230
            G+ YL        +HRD+ + NIL+ ++   ++SDFGL++ L      +  T     PI
Sbjct: 129 SGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPI 185
Query: 231 EGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKP 269
             T    +PE   +      +DV+++G+ L E++S G +P
Sbjct: 186 RWT----SPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 221

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/266 (24%), Positives = 121/266 (45%), Gaps = 29/266 (10%)
Query: 73  LVGRGGYAEVYKGVLQDGEEIAVKRLTK--VVTDDRKEKEFLTEIGTIGHVCHPNVLSLL 130
            +G+GG+A+ ++    D +E+   ++    ++    + ++   EI     + H +V+   
Sbjct: 48  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 107
Query: 131 GCCVDNG-LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRI 189
           G   DN  ++++ +   R S+  L H       E + R+ +      G  YLH+    R+
Sbjct: 108 GFFEDNDFVFVVLELCRRRSLLEL-HKRRKALTEPEARYYLR-QIVLGCQYLHRN---RV 162
Query: 190 IHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDE 249
           IHRD+K  N+ L  D E +I DFGLA  +        +  + GT  ++APE         
Sbjct: 163 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCGTPNYIAPEVLSKKGHSF 220
Query: 250 KTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQLNR 309
           + DV++ G  +  ++ G+ P + S     ++ +   N+  I K ++P             
Sbjct: 221 EVDVWSIGCIMYTLLVGKPPFETSCLK-ETYLRIKKNEYSIPKHINP------------- 266
Query: 310 LAFAASLC---IRASPTWRPTMSEVL 332
              AASL    ++  PT RPT++E+L
Sbjct: 267 --VAASLIQKMLQTDPTARPTINELL 290

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 113/223 (50%), Gaps = 27/223 (12%)
Query: 71  ENLVGRGGYAEVYKGVLQ-DGEE---IAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNV 126
           E ++G G + EV +G L+  G++   +A+K L    T+ R+ +EFL+E   +G   HPN+
Sbjct: 21  EEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTE-RQRREFLSEASIMGQFEHPNI 79
Query: 127 LSLLGCCVDNGLYLIF-QFSSRGSVASLFHDVNSPGVEWKVRHKIAV--GTARGLHYLHK 183
           + L G   ++   +I  +F   G++ S     +    ++ V   + +  G A G+ YL  
Sbjct: 80  IRLEGVVTNSMPVMILTEFMENGALDSFLRLNDG---QFTVIQLVGMLRGIASGMRYL-- 134
Query: 184 GCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGT-------FGH 236
             +   +HRD+ + NIL+ ++   ++SDFGL+++L      +S  P E +          
Sbjct: 135 -AEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFL----EENSSDPTETSSLGGKIPIRW 189
Query: 237 LAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPV-DGSHQSL 277
            APE          +D +++G+ + E++S G +P  D S+Q +
Sbjct: 190 TAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSNQDV 232

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 110/220 (50%), Gaps = 27/220 (12%)
Query: 64  ATNAFSSENLVGRGGYAEVYKGVLQ--DGEEIAVK-RLTKVVTDDRKEKEFLTEIGTIGH 120
           ATN  S + +VG G + EV  G L+    +EI+V  +  KV   +++ ++FL E   +G 
Sbjct: 32  ATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQ 90
Query: 121 VCHPNVLSLLGCCVDNG-LYLIFQFSSRGSVASLF--HDVNSPGVEWKVRHKIAV--GTA 175
             HPN++ L G    +  + ++ ++   GS+ S    HD      ++ V   + +  G A
Sbjct: 91  FDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA-----QFTVIQLVGMLRGIA 145
Query: 176 RGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWL-----PSQWTHHSIAPI 230
            G+ YL        +HRD+ + NIL+ ++   ++SDFGL++ L      +  T     PI
Sbjct: 146 SGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPI 202
Query: 231 EGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKP 269
             T    +PE   +      +DV+++G+ L E++S G +P
Sbjct: 203 RWT----SPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 238

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 74/280 (26%), Positives = 125/280 (44%), Gaps = 35/280 (12%)
Query: 74  VGRGGYAEVYK----GVLQDG--EEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHP-NV 126
           +GRG + +V +    G+ +      +AVK L +  T   + +  ++E+  + H+ H  NV
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHS-EHRALMSELKILIHIGHHLNV 93
Query: 127 LSLLGCCVDNG--LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHK----------IAVGT 174
           ++LLG C   G  L +I +F   G++++      +  V +K  +K           +   
Sbjct: 94  VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICYSFQV 153
Query: 175 ARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTF 234
           A+G+ +L     R+ IHRD+ + NILL+     +I DFGLA+ +     +          
Sbjct: 154 AKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 210
Query: 235 GHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGEIEKL 293
             +APE     +   ++DV++FGV L EI S G  P  G         +  L +G   + 
Sbjct: 211 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR--LKEGTRMRA 268
Query: 294 VDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLE 333
            D      Y  T L+        C    P+ RPT SE++E
Sbjct: 269 PDYTTPEMYQ-TMLD--------CWHGEPSQRPTFSELVE 299

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 100/204 (49%), Gaps = 15/204 (7%)
Query: 74  VGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCC 133
           +G G + EV+ G   +  ++AVK L          + FL E   +  + H  ++ L    
Sbjct: 21  LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMS---VQAFLEEANLMKTLQHDKLVRLYAVV 77
Query: 134 V-DNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHR 192
             +  +Y+I ++ ++GS+           V        +   A G+ Y+ +   +  IHR
Sbjct: 78  TREEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIER---KNYIHR 134
Query: 193 DIKSSNILLTADFEPQISDFGLAKWLP-SQWTHHSIA--PIEGTFGHLAPEYFMHGIVDE 249
           D++++N+L++     +I+DFGLA+ +  +++T    A  PI+ T    APE    G    
Sbjct: 135 DLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWT----APEAINFGCFTI 190
Query: 250 KTDVFAFGVFLLEIIS-GRKPVDG 272
           K+DV++FG+ L EI++ G+ P  G
Sbjct: 191 KSDVWSFGILLYEIVTYGKIPYPG 214

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 76/284 (26%), Positives = 125/284 (44%), Gaps = 39/284 (13%)
Query: 74  VGRGGYAEVYK----GVLQDG--EEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHP-NV 126
           +GRG + +V +    G+ +      +AVK L +  T   + +  ++E+  + H+ H  NV
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS-EHRALMSELKILIHIGHHLNV 93
Query: 127 LSLLGCCVDNG--LYLIFQFSSRGSVASLFHDVNSPGVEWKV------------RHKIAV 172
           ++LLG C   G  L +I +F   G++++      +  V +KV             H I  
Sbjct: 94  VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 153
Query: 173 G--TARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPI 230
               A+G+ +L     R+ IHRD+ + NILL+     +I DFGLA+ +     +      
Sbjct: 154 SFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 210
Query: 231 EGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGE 289
                 +APE     +   ++DV++FGV L EI S G  P  G         +  L +G 
Sbjct: 211 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR--LKEGT 268
Query: 290 IEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLE 333
             +  D      Y  T L+        C    P+ RPT SE++E
Sbjct: 269 RMRAPDYTTPEMYQ-TMLD--------CWHGEPSQRPTFSELVE 303

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 65/233 (27%), Positives = 113/233 (48%), Gaps = 27/233 (11%)
Query: 51  PTWRCFSFEEISIATNAFSSENLVGRGGYAEVYKGVLQ--DGEEIAVK-RLTKVVTDDRK 107
           PT     F +   ATN  S + +VG G + EV  G L+    +EI+V  +  KV   +++
Sbjct: 31  PTQTVHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ 89
Query: 108 EKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQFSSRGSVASLF--HDVNSPGVEW 164
            ++FL E   +G   HPN++ L G    +  + ++ +    GS+ S    HD      ++
Sbjct: 90  RRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDA-----QF 144
Query: 165 KVRHKIAV--GTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWL---- 218
            V   + +  G A G+ YL        +HRD+ + NIL+ ++   ++SDFGL++ L    
Sbjct: 145 TVIQLVGMLRGIASGMKYL---SDMGAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDP 201
Query: 219 -PSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKP 269
             +  T     PI  T    +PE   +      +DV+++G+ L E++S G +P
Sbjct: 202 EAAYTTRGGKIPIRWT----SPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 76/284 (26%), Positives = 125/284 (44%), Gaps = 39/284 (13%)
Query: 74  VGRGGYAEVYK----GVLQDG--EEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHP-NV 126
           +GRG + +V +    G+ +      +AVK L +  T   + +  ++E+  + H+ H  NV
Sbjct: 72  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS-EHRALMSELKILIHIGHHLNV 130
Query: 127 LSLLGCCVDNG--LYLIFQFSSRGSVASLFHDVNSPGVEWKV------------RHKIAV 172
           ++LLG C   G  L +I +F   G++++      +  V +KV             H I  
Sbjct: 131 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 190
Query: 173 G--TARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPI 230
               A+G+ +L     R+ IHRD+ + NILL+     +I DFGLA+ +     +      
Sbjct: 191 SFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 247
Query: 231 EGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGE 289
                 +APE     +   ++DV++FGV L EI S G  P  G         +  L +G 
Sbjct: 248 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR--LKEGT 305
Query: 290 IEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLE 333
             +  D      Y  T L+        C    P+ RPT SE++E
Sbjct: 306 RMRAPDYTTPEMYQ-TMLD--------CWHGEPSQRPTFSELVE 340

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 65/233 (27%), Positives = 113/233 (48%), Gaps = 27/233 (11%)
Query: 51  PTWRCFSFEEISIATNAFSSENLVGRGGYAEVYKGVLQ--DGEEIAVK-RLTKVVTDDRK 107
           PT     F +   ATN  S + +VG G + EV  G L+    +EI+V  +  KV   +++
Sbjct: 31  PTQTVHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ 89
Query: 108 EKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQFSSRGSVASLF--HDVNSPGVEW 164
            ++FL E   +G   HPN++ L G    +  + ++ +    GS+ S    HD      ++
Sbjct: 90  RRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDA-----QF 144
Query: 165 KVRHKIAV--GTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWL---- 218
            V   + +  G A G+ YL        +HRD+ + NIL+ ++   ++SDFGL++ L    
Sbjct: 145 TVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDP 201
Query: 219 -PSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKP 269
             +  T     PI  T    +PE   +      +DV+++G+ L E++S G +P
Sbjct: 202 EAAYTTRGGKIPIRWT----SPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 100/204 (49%), Gaps = 15/204 (7%)
Query: 74  VGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCC 133
           +G G + EV+ G   +  ++AVK L          + FL E   +  + H  ++ L    
Sbjct: 20  LGAGQFGEVWMGYYNNSTKVAVKTLK---PGTMSVQAFLEEANLMKTLQHDKLVRLYAVV 76
Query: 134 V-DNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHR 192
             +  +Y+I +F ++GS+           V        +   A G+ Y+ +   +  IHR
Sbjct: 77  TKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIER---KNYIHR 133
Query: 193 DIKSSNILLTADFEPQISDFGLAKWLP-SQWTHHSIA--PIEGTFGHLAPEYFMHGIVDE 249
           D++++N+L++     +I+DFGLA+ +  +++T    A  PI+ T    APE    G    
Sbjct: 134 DLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWT----APEAINFGCFTI 189
Query: 250 KTDVFAFGVFLLEIIS-GRKPVDG 272
           K++V++FG+ L EI++ G+ P  G
Sbjct: 190 KSNVWSFGILLYEIVTYGKIPYPG 213

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 99/215 (46%), Gaps = 24/215 (11%)
Query: 75  GRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC-- 132
            RG +  V+K  L + E +AVK        D++  +   E+ ++  + H N+L  +G   
Sbjct: 33  ARGRFGCVWKAQLLN-EYVAVKIFP---IQDKQSWQNEYEVYSLPGMKHENILQFIGAEK 88
Query: 133 ---CVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHK------ 183
               VD  L+LI  F  +GS++     + +  V W     IA   ARGL YLH+      
Sbjct: 89  RGTSVDVDLWLITAFHEKGSLSDF---LKANVVSWNELCHIAETMARGLAYLHEDIPGLK 145
Query: 184 -GCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYF 242
            G +  I HRDIKS N+LL  +    I+DFGLA    +  +        GT  ++APE  
Sbjct: 146 DGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVL 205
Query: 243 MHGIVDE-----KTDVFAFGVFLLEIISGRKPVDG 272
              I  +     + D++A G+ L E+ S     DG
Sbjct: 206 EGAINFQRDAFLRIDMYAMGLVLWELASRCTAADG 240

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 76/284 (26%), Positives = 125/284 (44%), Gaps = 39/284 (13%)
Query: 74  VGRGGYAEVYK----GVLQDG--EEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHP-NV 126
           +GRG + +V +    G+ +      +AVK L +  T   + +  ++E+  + H+ H  NV
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS-EHRALMSELKILIHIGHHLNV 84
Query: 127 LSLLGCCVDNG--LYLIFQFSSRGSVASLFHDVNSPGVEWKV------------RHKIAV 172
           ++LLG C   G  L +I +F   G++++      +  V +KV             H I  
Sbjct: 85  VNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 144
Query: 173 G--TARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPI 230
               A+G+ +L     R+ IHRD+ + NILL+     +I DFGLA+ +     +      
Sbjct: 145 SFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 201
Query: 231 EGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGE 289
                 +APE     +   ++DV++FGV L EI S G  P  G         +  L +G 
Sbjct: 202 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR--LKEGT 259
Query: 290 IEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLE 333
             +  D      Y  T L+        C    P+ RPT SE++E
Sbjct: 260 RMRAPDYTTPEMYQ-TMLD--------CWHGEPSQRPTFSELVE 294

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 76/284 (26%), Positives = 125/284 (44%), Gaps = 39/284 (13%)
Query: 74  VGRGGYAEVYK----GVLQDG--EEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHP-NV 126
           +GRG + +V +    G+ +      +AVK L +  T   + +  ++E+  + H+ H  NV
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS-EHRALMSELKILIHIGHHLNV 84
Query: 127 LSLLGCCVDNG--LYLIFQFSSRGSVASLFHDVNSPGVEWKV------------RHKIAV 172
           ++LLG C   G  L +I +F   G++++      +  V +KV             H I  
Sbjct: 85  VNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 144
Query: 173 G--TARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPI 230
               A+G+ +L     R+ IHRD+ + NILL+     +I DFGLA+ +     +      
Sbjct: 145 SFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 201
Query: 231 EGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGE 289
                 +APE     +   ++DV++FGV L EI S G  P  G         +  L +G 
Sbjct: 202 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR--LKEGT 259
Query: 290 IEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLE 333
             +  D      Y  T L+        C    P+ RPT SE++E
Sbjct: 260 RMRAPDYTTPEMYQ-TMLD--------CWHGEPSQRPTFSELVE 294

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 76/284 (26%), Positives = 124/284 (43%), Gaps = 39/284 (13%)
Query: 74  VGRGGYAEVYK----GVLQDG--EEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHP-NV 126
           +GRG + +V +    G+ +      +AVK L +  T   + +  ++E+  + H+ H  NV
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS-EHRALMSELKILIHIGHHLNV 93
Query: 127 LSLLGCCVDNG--LYLIFQFSSRGSVASLFHDVNSPGVEWKV------------RHKIAV 172
           ++LLG C   G  L +I +F   G++++      +  V +KV             H I  
Sbjct: 94  VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 153
Query: 173 G--TARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPI 230
               A+G+ +L     R+ IHRD+ + NILL+     +I DFGLA+ +            
Sbjct: 154 SFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDA 210
Query: 231 EGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGE 289
                 +APE     +   ++DV++FGV L EI S G  P  G         +  L +G 
Sbjct: 211 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR--LKEGT 268
Query: 290 IEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLE 333
             +  D      Y  T L+        C    P+ RPT SE++E
Sbjct: 269 RMRAPDYTTPEMYQ-TMLD--------CWHGEPSQRPTFSELVE 303

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 53/214 (24%), Positives = 101/214 (47%), Gaps = 14/214 (6%)
Query: 63  IATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVC 122
           I   +   E  +G+G + EV+ G       +A+K L          + FL E   +  + 
Sbjct: 5   IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP---EAFLQEAQVMKKLR 61
Query: 123 HPNVLSLLGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLH 182
           H  ++ L     +  + ++ ++ S+GS+           +       +A   A G+ Y+ 
Sbjct: 62  HEKLVQLYAVVSEEPIXIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE 121
Query: 183 KGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLP-SQWTHHSIA--PIEGTFGHLAP 239
           +      +HRD++++NIL+  +   +++DFGLA+ +  ++ T    A  PI+ T    AP
Sbjct: 122 R---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWT----AP 174
Query: 240 EYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDG 272
           E  ++G    K+DV++FG+ L E+ + GR P  G
Sbjct: 175 EAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG 208

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 76/284 (26%), Positives = 124/284 (43%), Gaps = 39/284 (13%)
Query: 74  VGRGGYAEVYK----GVLQDG--EEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHP-NV 126
           +GRG + +V +    G+ +      +AVK L +  T   + +  ++E+  + H+ H  NV
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS-EHRALMSELKILIHIGHHLNV 84
Query: 127 LSLLGCCVDNG--LYLIFQFSSRGSVASLFHDVNSPGVEWKV------------RHKIAV 172
           ++LLG C   G  L +I +F   G++++      +  V +KV             H I  
Sbjct: 85  VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 144
Query: 173 G--TARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPI 230
               A+G+ +L     R+ IHRD+ + NILL+     +I DFGLA+ +            
Sbjct: 145 SFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDA 201
Query: 231 EGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGE 289
                 +APE     +   ++DV++FGV L EI S G  P  G         +  L +G 
Sbjct: 202 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR--LKEGT 259
Query: 290 IEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLE 333
             +  D      Y  T L+        C    P+ RPT SE++E
Sbjct: 260 RMRAPDYTTPEMYQ-TMLD--------CWHGEPSQRPTFSELVE 294

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 70/277 (25%), Positives = 113/277 (40%), Gaps = 41/277 (14%)
Query: 92  EIAVKRLTKVVTDDRKEKEFLTEIGTIGHVC-HPNVLSLLGCCVDNGLYLI--------- 141
           ++AVK L      D KE   ++E+  + H+  H N+++LLG C   G  L+         
Sbjct: 63  KVAVKMLKSTAHADEKEA-LMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGD 121
Query: 142 -FQFSSRGSVASLFHDVNSPG-------------VEWKVRHKIAVGTARGLHYLHKGCQR 187
              F  R + A L   + +PG             +E +     +   A+G+ +L     +
Sbjct: 122 LLNFLRRKAEAMLGPSL-APGQDPEGLDKEDGRPLELRDLLHFSSQVAQGMAFL---ASK 177
Query: 188 RIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIV 247
             IHRD+ + N+LLT     +I DFGLA+ + +   +            +APE     + 
Sbjct: 178 NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVY 237
Query: 248 DEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQ 306
             ++DV+++G+ L EI S G  P  G           IL   +  KLV    Q A     
Sbjct: 238 TVQSDVWSYGILLWEIFSLGLNPYPG-----------ILVNSKFYKLVKDGYQMAQPAFA 286
Query: 307 LNRLAFAASLCIRASPTWRPTMSEVLEVMLEGDQIDK 343
              +      C    PT RPT  ++   + E  Q D+
Sbjct: 287 PKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQEDR 323

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 51/199 (25%), Positives = 99/199 (49%), Gaps = 14/199 (7%)
Query: 74  VGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC 132
           +G+G    VY  + +  G+E+A++++   +    K++  + EI  +    +PN+++ L  
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMN--LQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 133 -CVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIH 191
             V + L+++ ++ + GS+  +   V    ++      +     + L +LH     ++IH
Sbjct: 86  YLVGDELWVVMEYLAGGSLTDV---VTETCMDEGQIAAVCRECLQALEFLHSN---QVIH 139
Query: 192 RDIKSSNILLTADFEPQISDFGL-AKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEK 250
           RDIKS NILL  D   +++DFG  A+  P Q    ++    GT   +APE         K
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV---GTPYWMAPEVVTRKAYGPK 196
Query: 251 TDVFAFGVFLLEIISGRKP 269
            D+++ G+  +E+I G  P
Sbjct: 197 VDIWSLGIMAIEMIEGEPP 215

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 66/243 (27%), Positives = 108/243 (44%), Gaps = 35/243 (14%)
Query: 74  VGRGG--YAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLG 131
           +G GG  Y ++ +G L DG   A+KR+      DR+E +   ++  + +  HPN+L L+ 
Sbjct: 37  LGEGGFSYVDLVEG-LHDGHFYALKRILCHEQQDREEAQREADMHRLFN--HPNILRLVA 93
Query: 132 CCV-----DNGLYLIFQFSSRGSVASLFHDVNSPG-------VEWKVRHKIAVGTARGLH 179
            C+      +  +L+  F  RG++ +    +   G       + W     + +G  RGL 
Sbjct: 94  YCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILW-----LLLGICRGLE 148
Query: 180 YLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWL-------PSQWTHHSIAPIEG 232
            +H    +   HRD+K +NILL  + +P + D G                T    A    
Sbjct: 149 AIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRC 205
Query: 233 TFGHLAPEYFM---HGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGE 289
           T  + APE F    H ++DE+TDV++ G  L  ++ G  P D   Q   S A  + NQ  
Sbjct: 206 TISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLS 265
Query: 290 IEK 292
           I +
Sbjct: 266 IPQ 268

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/240 (25%), Positives = 107/240 (44%), Gaps = 39/240 (16%)
Query: 68  FSSENL-----VGRGGYAEVYK----GVLQDGEEIAVK-RLTKVVTDDRKEKEFLTEIGT 117
           F  ENL     +G G + +V      G+ + G  I V  ++ K   D  + +  ++E+  
Sbjct: 42  FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKM 101
Query: 118 IGHV-CHPNVLSLLGCCVDNG-LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHK------ 169
           +  +  H N+++LLG C  +G +YLIF++   G + +          E ++ ++      
Sbjct: 102 MTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLE 161
Query: 170 ---------------IAVGTARGLHYLH-KGCQRRIIHRDIKSSNILLTADFEPQISDFG 213
                           A   A+G+ +L  K C    +HRD+ + N+L+T     +I DFG
Sbjct: 162 EEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSC----VHRDLAARNVLVTHGKVVKICDFG 217
Query: 214 LAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDG 272
           LA+ + S   +            +APE    GI   K+DV+++G+ L EI S G  P  G
Sbjct: 218 LARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG 277

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 93/208 (44%), Gaps = 29/208 (13%)
Query: 74  VGRGGYAEV---YKGVLQD--GEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLS 128
           +G+G +  V       LQD  GE +AVK+L    + +   ++F  EI  +  + H N++ 
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH--STEEHLRDFEREIEILKSLQHDNIVK 78
Query: 129 LLGCCVDNG---LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGC 185
             G C   G   L LI +F   GS+            E+  +HK  +   + L Y  + C
Sbjct: 79  YKGVCYSAGRRNLKLIMEFLPYGSLR-----------EYLQKHKERIDHIKLLQYTSQIC 127
Query: 186 Q-------RRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIA-PIEGTFGHL 237
           +       +R IHRD+ + NIL+  +   +I DFGL K LP       +  P E      
Sbjct: 128 KGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY 187
Query: 238 APEYFMHGIVDEKTDVFAFGVFLLEIIS 265
           APE          +DV++FGV L E+ +
Sbjct: 188 APESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/245 (25%), Positives = 117/245 (47%), Gaps = 34/245 (13%)
Query: 56  FSFEEISIATNAFSSE---------NLVGRGGYAEVYKGVLQ-DGEE---IAVKRLTKVV 102
           F+FE+ + A   F+ E          ++G G + EV  G L+  G+    +A+K L    
Sbjct: 10  FTFEDPNQAVREFAKEIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGY 69
Query: 103 TDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVD-NGLYLIFQFSSRGSVASLFHDVNSPG 161
           TD ++ ++FL+E   +G   HPN++ L G       + +I ++   GS+ +     +   
Sbjct: 70  TD-KQRRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDG-- 126
Query: 162 VEWKVRHKIAV--GTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWL- 218
             + V   + +  G   G+ YL        +HRD+ + NIL+ ++   ++SDFG+++ L 
Sbjct: 127 -RFTVIQLVGMLRGIGSGMKYLS---DMSAVHRDLAARNILVNSNLVCKVSDFGMSRVLE 182
Query: 219 ----PSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPV-DG 272
                +  T     PI  T    APE   +      +DV+++G+ + E++S G +P  D 
Sbjct: 183 DDPEAAYTTRGGKIPIRWT----APEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDM 238
Query: 273 SHQSL 277
           S+Q +
Sbjct: 239 SNQDV 243

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 76/284 (26%), Positives = 124/284 (43%), Gaps = 39/284 (13%)
Query: 74  VGRGGYAEVYK----GVLQDG--EEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHP-NV 126
           +GRG + +V +    G+ +      +AVK L +  T   + +  ++E+  + H+ H  NV
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS-EHRALMSELKILIHIGHHLNV 84
Query: 127 LSLLGCCVDNG--LYLIFQFSSRGSVASLFHDVNSPGVEWKV------------RHKIAV 172
           ++LLG C   G  L +I +F   G++++      +  V +KV             H I  
Sbjct: 85  VNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 144
Query: 173 G--TARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPI 230
               A+G+ +L     R+ IHRD+ + NILL+     +I DFGLA+ +            
Sbjct: 145 SFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDA 201
Query: 231 EGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGE 289
                 +APE     +   ++DV++FGV L EI S G  P  G         +  L +G 
Sbjct: 202 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR--LKEGT 259
Query: 290 IEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLE 333
             +  D      Y  T L+        C    P+ RPT SE++E
Sbjct: 260 RMRAPDYTTPEMYQ-TMLD--------CWHGEPSQRPTFSELVE 294

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 76/284 (26%), Positives = 124/284 (43%), Gaps = 39/284 (13%)
Query: 74  VGRGGYAEVYK----GVLQDG--EEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHP-NV 126
           +GRG + +V +    G+ +      +AVK L +  T   + +  ++E+  + H+ H  NV
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS-EHRALMSELKILIHIGHHLNV 93
Query: 127 LSLLGCCVDNG--LYLIFQFSSRGSVASLFHDVNSPGVEWKV------------RHKIAV 172
           ++LLG C   G  L +I +F   G++++      +  V +KV             H I  
Sbjct: 94  VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 153
Query: 173 G--TARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPI 230
               A+G+ +L     R+ IHRD+ + NILL+     +I DFGLA+ +            
Sbjct: 154 SFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRKGDA 210
Query: 231 EGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGE 289
                 +APE     +   ++DV++FGV L EI S G  P  G         +  L +G 
Sbjct: 211 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR--LKEGT 268
Query: 290 IEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLE 333
             +  D      Y  T L+        C    P+ RPT SE++E
Sbjct: 269 RMRAPDYTTPEMYQ-TMLD--------CWHGEPSQRPTFSELVE 303

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 75/284 (26%), Positives = 125/284 (44%), Gaps = 39/284 (13%)
Query: 74  VGRGGYAEVYK----GVLQDG--EEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHP-NV 126
           +GRG + +V +    G+ +      +AVK L +  T   + +  ++E+  + H+ H  NV
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS-EHRALMSELKILIHIGHHLNV 95
Query: 127 LSLLGCCVDNG--LYLIFQFSSRGSVASLFHDVNSPGVEWK------------VRHKIAV 172
           ++LLG C   G  L +I +F   G++++      +  V +K            + H I  
Sbjct: 96  VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHLICY 155
Query: 173 G--TARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPI 230
               A+G+ +L     R+ IHRD+ + NILL+     +I DFGLA+ +     +      
Sbjct: 156 SFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 212
Query: 231 EGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGE 289
                 +APE     +   ++DV++FGV L EI S G  P  G         +  L +G 
Sbjct: 213 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR--LKEGT 270
Query: 290 IEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLE 333
             +  D      Y  T L+        C    P+ RPT SE++E
Sbjct: 271 RMRAPDYTTPEMYQ-TMLD--------CWHGEPSQRPTFSELVE 305

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/224 (25%), Positives = 95/224 (42%), Gaps = 25/224 (11%)
Query: 62  SIATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHV 121
           S+AT+ +     +G G Y  VYK   +D        L  V   +         I T+  V
Sbjct: 5   SMATSRYEPVAEIGVGAYGTVYKA--RDPHSGHFVALKSVRVPNGGGGGGGLPISTVREV 62
Query: 122 C---------HPNVLSLLGCCVDN------GLYLIFQFSSRGSVASLFHDVNSPGVEWKV 166
                     HPNV+ L+  C  +       + L+F+   +  + +       PG+  + 
Sbjct: 63  ALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAET 121
Query: 167 RHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHS 226
              +     RGL +LH  C   I+HRD+K  NIL+T+    +++DFGLA+    Q    +
Sbjct: 122 IKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQM---A 175
Query: 227 IAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPV 270
           + P+  T  + APE  +        D+++ G    E+   RKP+
Sbjct: 176 LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 218

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 109/220 (49%), Gaps = 27/220 (12%)
Query: 64  ATNAFSSENLVGRGGYAEVYKGVLQ--DGEEIAVK-RLTKVVTDDRKEKEFLTEIGTIGH 120
           ATN  S + +VG G + EV  G L+    +EI+V  +  KV   +++ ++FL E   +G 
Sbjct: 15  ATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQ 73
Query: 121 VCHPNVLSLLGCCVDNG-LYLIFQFSSRGSVASLF--HDVNSPGVEWKVRHKIAV--GTA 175
             HPN++ L G    +  + ++ +    GS+ S    HD      ++ V   + +  G A
Sbjct: 74  FDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDA-----QFTVIQLVGMLRGIA 128
Query: 176 RGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWL-----PSQWTHHSIAPI 230
            G+ YL        +HRD+ + NIL+ ++   ++SDFGL++ L      +  T     PI
Sbjct: 129 SGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPI 185
Query: 231 EGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKP 269
             T    +PE   +      +DV+++G+ L E++S G +P
Sbjct: 186 RWT----SPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 221

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 75/282 (26%), Positives = 125/282 (44%), Gaps = 37/282 (13%)
Query: 74  VGRGGYAEVYK----GVLQDG--EEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHP-NV 126
           +GRG + +V +    G+ +      +AVK L +  T   + +  ++E+  + H+ H  NV
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHS-EHRALMSELKILIHIGHHLNV 95
Query: 127 LSLLGCCVDNG--LYLIFQFSSRGSVASLFHDVNSPGVEWK----------VRHKI--AV 172
           ++LLG C   G  L +I +F   G++++      +  V +K          + H I  + 
Sbjct: 96  VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIXYSF 155
Query: 173 GTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEG 232
             A+G+ +L     R+ IHRD+ + NILL+     +I DFGLA+ +              
Sbjct: 156 QVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARL 212
Query: 233 TFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGEIE 291
               +APE     +   ++DV++FGV L EI S G  P  G         +  L +G   
Sbjct: 213 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR--LKEGTRM 270
Query: 292 KLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLE 333
           +  D      Y  T L+        C    P+ RPT SE++E
Sbjct: 271 RAPDYTTPEMYQ-TMLD--------CWHGEPSQRPTFSELVE 303

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 72/284 (25%), Positives = 126/284 (44%), Gaps = 35/284 (12%)
Query: 68  FSSENL-----VGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHV 121
           F++E+L     +GRG Y  V K V +  G+ +AVKR+   V D++++K+ L ++  +   
Sbjct: 19  FTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV-DEKEQKQLLMDLDVVMRS 77
Query: 122 CH-PNVLSLLGCCVDNG-LYLIFQFSSRG------SVASLFHDVNSPGVEWKVRHKIAVG 173
              P ++   G     G  ++  +  S         V S+  DV    +  ++  KI + 
Sbjct: 78  SDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDV----IPEEILGKITLA 133
Query: 174 TARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGT 233
           T + L++L +    +IIHRDIK SNILL      ++ DFG++  L         A   G 
Sbjct: 134 TVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDA---GC 188
Query: 234 FGHLAPEYFMHGI----VDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGE 289
             ++APE           D ++DV++ G+ L E+ +GR P          W        +
Sbjct: 189 RPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFP-------YPKWNSVFDQLTQ 241
Query: 290 IEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLE 333
           + K   P+L  + +           +LC+    + RP   E+L+
Sbjct: 242 VVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 75/283 (26%), Positives = 124/283 (43%), Gaps = 38/283 (13%)
Query: 74  VGRGGYAEVYK----GVLQDG--EEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHP-NV 126
           +GRG + +V +    G+ +      +AVK L +  T   + +  ++E+  + H+ H  NV
Sbjct: 36  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS-EHRALMSELKILIHIGHHLNV 94
Query: 127 LSLLGCCVDNG--LYLIFQFSSRGSVASLFHDVNSPGVEWK-----------VRHKIAVG 173
           ++LLG C   G  L +I +F   G++++      +  V +K           + H I   
Sbjct: 95  VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHLICYS 154
Query: 174 --TARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIE 231
              A+G+ +L     R+ IHRD+ + NILL+     +I DFGLA+ +             
Sbjct: 155 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDAR 211
Query: 232 GTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGEI 290
                +APE     +   ++DV++FGV L EI S G  P  G         +  L +G  
Sbjct: 212 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR--LKEGTR 269
Query: 291 EKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLE 333
            +  D      Y  T L+        C    P+ RPT SE++E
Sbjct: 270 MRAPDYTTPEMYQ-TMLD--------CWHGEPSQRPTFSELVE 303

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 98/198 (49%), Gaps = 12/198 (6%)
Query: 74  VGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC 132
           +G+G    VY  + +  G+E+A++++   +    K++  + EI  +    +PN+++ L  
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMN--LQQQPKKELIINEILVMRENKNPNIVNYLDS 86
Query: 133 -CVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIH 191
             V + L+++ ++ + GS+  +   V    ++      +     + L +LH     ++IH
Sbjct: 87  YLVGDELWVVMEYLAGGSLTDV---VTETCMDEGQIAAVCRECLQALEFLHSN---QVIH 140
Query: 192 RDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKT 251
           RDIKS NILL  D   +++DFG    +  + +  S   + GT   +APE         K 
Sbjct: 141 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSX--MVGTPYWMAPEVVTRKAYGPKV 198
Query: 252 DVFAFGVFLLEIISGRKP 269
           D+++ G+  +E+I G  P
Sbjct: 199 DIWSLGIMAIEMIEGEPP 216

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 98/198 (49%), Gaps = 12/198 (6%)
Query: 74  VGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC 132
           +G+G    VY  + +  G+E+A++++   +    K++  + EI  +    +PN+++ L  
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMN--LQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 133 -CVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIH 191
             V + L+++ ++ + GS+  +   V    ++      +     + L +LH     ++IH
Sbjct: 86  YLVGDELWVVMEYLAGGSLTDV---VTETCMDEGQIAAVCRECLQALEFLHSN---QVIH 139
Query: 192 RDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKT 251
           RDIKS NILL  D   +++DFG    +  + +  S   + GT   +APE         K 
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSX--MVGTPYWMAPEVVTRKAYGPKV 197
Query: 252 DVFAFGVFLLEIISGRKP 269
           D+++ G+  +E+I G  P
Sbjct: 198 DIWSLGIMAIEMIEGEPP 215

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/199 (25%), Positives = 98/199 (49%), Gaps = 14/199 (7%)
Query: 74  VGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC 132
           +G+G    VY  + +  G+E+A++++   +    K++  + EI  +    +PN+++ L  
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMN--LQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 133 -CVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIH 191
             V + L+++ ++ + GS+  +   V    ++      +     + L +LH     ++IH
Sbjct: 86  YLVGDELWVVMEYLAGGSLTDV---VTETCMDEGQIAAVCRECLQALEFLHSN---QVIH 139
Query: 192 RDIKSSNILLTADFEPQISDFGL-AKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEK 250
           RDIKS NILL  D   +++DFG  A+  P Q     +    GT   +APE         K
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSEMV---GTPYWMAPEVVTRKAYGPK 196
Query: 251 TDVFAFGVFLLEIISGRKP 269
            D+++ G+  +E+I G  P
Sbjct: 197 VDIWSLGIMAIEMIEGEPP 215

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 71/222 (31%), Positives = 108/222 (48%), Gaps = 30/222 (13%)
Query: 74  VGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFL--TEIGTIGHVCHPNVLSLLG 131
           +G+G + EV++G  + GEE+AVK     +   R+E+ +    EI     + H N+L  + 
Sbjct: 12  IGKGRFGEVWRGKWR-GEEVAVK-----IFSSREERSWFREAEIYQTVMLRHENILGFIA 65
Query: 132 C-CVDNG----LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHK--- 183
               DNG    L+L+  +   GS   LF  +N   V  +   K+A+ TA GL +LH    
Sbjct: 66  ADNKDNGTWTQLWLVSDYHEHGS---LFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIV 122
Query: 184 GCQRR--IIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIE--GTFGHLAP 239
           G Q +  I HRD+KS NIL+  +    I+D GLA    S      IAP    GT  ++AP
Sbjct: 123 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 182
Query: 240 EYF------MHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQ 275
           E         H    ++ D++A G+   E I+ R  + G H+
Sbjct: 183 EVLDDSINMKHFESFKRADIYAMGLVFWE-IARRCSIGGIHE 223

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/262 (22%), Positives = 117/262 (44%), Gaps = 24/262 (9%)
Query: 74  VGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCC 133
           +G G +  V+ G   + +++A+K + +       E++F+ E   +  + HP ++ L G C
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIRE---GAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 71
Query: 134 VDNG-LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHR 192
           ++   + L+F+F   G ++             +    + +    G+ YL +     +IHR
Sbjct: 72  LEQAPICLVFEFMEHGCLSDYLRTQRGLFAA-ETLLGMCLDVCEGMAYLEEA---SVIHR 127
Query: 193 DIKSSNILLTADFEPQISDFGLAKW-LPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKT 251
           D+ + N L+  +   ++SDFG+ ++ L  Q+T  +       +   +PE F       K+
Sbjct: 128 DLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWA--SPEVFSFSRYSSKS 185
Query: 252 DVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQLNRL 310
           DV++FGV + E+ S G+ P +    S     + + +     +L  PRL   +    +N  
Sbjct: 186 DVWSFGVLMWEVFSEGKIPYENRSNS-----EVVEDISTGFRLYKPRLASTHVYQIMNH- 239
Query: 311 AFAASLCIRASPTWRPTMSEVL 332
                 C +  P  RP  S +L
Sbjct: 240 ------CWKERPEDRPAFSRLL 255

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 99/218 (45%), Gaps = 18/218 (8%)
Query: 63  IATNAFSSENLVGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHV 121
           +AT+ +     +G G Y  VYK      G  +A+K +     ++      + E+  +  +
Sbjct: 1   MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRL 60
Query: 122 C---HPNVLSLLGCCVDN------GLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAV 172
               HPNV+ L+  C  +       + L+F+   +  + +       PG+  +    +  
Sbjct: 61  EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMR 119
Query: 173 GTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEG 232
              RGL +LH  C   I+HRD+K  NIL+T+    +++DFGLA+    Q    ++AP+  
Sbjct: 120 QFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQM---ALAPVVV 173
Query: 233 TFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPV 270
           T  + APE  +        D+++ G    E+   RKP+
Sbjct: 174 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 210

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 106/210 (50%), Gaps = 18/210 (8%)
Query: 71  ENLVGRGGYAEVYKGVLQ-DGEE---IAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNV 126
           E ++G G + EV  G L+  G+    +A+K L    T+ ++ ++FL+E   +G   HPNV
Sbjct: 12  EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTE-KQRRDFLSEASIMGQFDHPNV 70
Query: 127 LSLLGCCVDNG-LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAV--GTARGLHYLHK 183
           + L G    +  + +I +F   GS+ S     +    ++ V   + +  G A G+ YL  
Sbjct: 71  IHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDG---QFTVIQLVGMLRGIAAGMKYL-- 125
Query: 184 GCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWL---PSQWTHHSIAPIEGTFGHLAPE 240
                 +HR + + NIL+ ++   ++SDFGL+++L    S  T+ S    +      APE
Sbjct: 126 -ADMNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPE 184
Query: 241 YFMHGIVDEKTDVFAFGVFLLEIIS-GRKP 269
              +      +DV+++G+ + E++S G +P
Sbjct: 185 AIQYRKFTSASDVWSYGIVMWEVMSYGERP 214

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 71/222 (31%), Positives = 108/222 (48%), Gaps = 30/222 (13%)
Query: 74  VGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFL--TEIGTIGHVCHPNVLSLLG 131
           +G+G + EV++G  + GEE+AVK     +   R+E+ +    EI     + H N+L  + 
Sbjct: 17  IGKGRFGEVWRGKWR-GEEVAVK-----IFSSREERSWFREAEIYQTVMLRHENILGFIA 70
Query: 132 C-CVDNG----LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHK--- 183
               DNG    L+L+  +   GS   LF  +N   V  +   K+A+ TA GL +LH    
Sbjct: 71  ADNKDNGTWTQLWLVSDYHEHGS---LFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIV 127
Query: 184 GCQRR--IIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIE--GTFGHLAP 239
           G Q +  I HRD+KS NIL+  +    I+D GLA    S      IAP    GT  ++AP
Sbjct: 128 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 187
Query: 240 EYF------MHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQ 275
           E         H    ++ D++A G+   E I+ R  + G H+
Sbjct: 188 EVLDDSINMKHFESFKRADIYAMGLVFWE-IARRCSIGGIHE 228

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 71/222 (31%), Positives = 108/222 (48%), Gaps = 30/222 (13%)
Query: 74  VGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFL--TEIGTIGHVCHPNVLSLLG 131
           +G+G + EV++G  + GEE+AVK     +   R+E+ +    EI     + H N+L  + 
Sbjct: 37  IGKGRFGEVWRGKWR-GEEVAVK-----IFSSREERSWFREAEIYQTVMLRHENILGFIA 90
Query: 132 C-CVDNG----LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHK--- 183
               DNG    L+L+  +   GS   LF  +N   V  +   K+A+ TA GL +LH    
Sbjct: 91  ADNKDNGTWTQLWLVSDYHEHGS---LFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIV 147
Query: 184 GCQRR--IIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIE--GTFGHLAP 239
           G Q +  I HRD+KS NIL+  +    I+D GLA    S      IAP    GT  ++AP
Sbjct: 148 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 207
Query: 240 EYF------MHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQ 275
           E         H    ++ D++A G+   E I+ R  + G H+
Sbjct: 208 EVLDDSINMKHFESFKRADIYAMGLVFWE-IARRCSIGGIHE 248

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 71/222 (31%), Positives = 108/222 (48%), Gaps = 30/222 (13%)
Query: 74  VGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFL--TEIGTIGHVCHPNVLSLLG 131
           +G+G + EV++G  + GEE+AVK     +   R+E+ +    EI     + H N+L  + 
Sbjct: 50  IGKGRFGEVWRGKWR-GEEVAVK-----IFSSREERSWFREAEIYQTVMLRHENILGFIA 103
Query: 132 C-CVDNG----LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHK--- 183
               DNG    L+L+  +   GS   LF  +N   V  +   K+A+ TA GL +LH    
Sbjct: 104 ADNKDNGTWTQLWLVSDYHEHGS---LFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIV 160
Query: 184 GCQRR--IIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIE--GTFGHLAP 239
           G Q +  I HRD+KS NIL+  +    I+D GLA    S      IAP    GT  ++AP
Sbjct: 161 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 220
Query: 240 EYFMHGIVD------EKTDVFAFGVFLLEIISGRKPVDGSHQ 275
           E     I        ++ D++A G+   E I+ R  + G H+
Sbjct: 221 EVLDDSINMKHFESFKRADIYAMGLVFWE-IARRCSIGGIHE 261

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 71/222 (31%), Positives = 108/222 (48%), Gaps = 30/222 (13%)
Query: 74  VGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFL--TEIGTIGHVCHPNVLSLLG 131
           +G+G + EV++G  + GEE+AVK     +   R+E+ +    EI     + H N+L  + 
Sbjct: 11  IGKGRFGEVWRGKWR-GEEVAVK-----IFSSREERSWFREAEIYQTVMLRHENILGFIA 64
Query: 132 C-CVDNG----LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHK--- 183
               DNG    L+L+  +   GS   LF  +N   V  +   K+A+ TA GL +LH    
Sbjct: 65  ADNKDNGTWTQLWLVSDYHEHGS---LFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIV 121
Query: 184 GCQRR--IIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIE--GTFGHLAP 239
           G Q +  I HRD+KS NIL+  +    I+D GLA    S      IAP    GT  ++AP
Sbjct: 122 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 181
Query: 240 EYF------MHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQ 275
           E         H    ++ D++A G+   E I+ R  + G H+
Sbjct: 182 EVLDDSINMKHFESFKRADIYAMGLVFWE-IARRCSIGGIHE 222

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 71/222 (31%), Positives = 108/222 (48%), Gaps = 30/222 (13%)
Query: 74  VGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFL--TEIGTIGHVCHPNVLSLLG 131
           +G+G + EV++G  + GEE+AVK     +   R+E+ +    EI     + H N+L  + 
Sbjct: 14  IGKGRFGEVWRGKWR-GEEVAVK-----IFSSREERSWFREAEIYQTVMLRHENILGFIA 67
Query: 132 C-CVDNG----LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHK--- 183
               DNG    L+L+  +   GS   LF  +N   V  +   K+A+ TA GL +LH    
Sbjct: 68  ADNKDNGTWTQLWLVSDYHEHGS---LFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIV 124
Query: 184 GCQRR--IIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIE--GTFGHLAP 239
           G Q +  I HRD+KS NIL+  +    I+D GLA    S      IAP    GT  ++AP
Sbjct: 125 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 184
Query: 240 EYF------MHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQ 275
           E         H    ++ D++A G+   E I+ R  + G H+
Sbjct: 185 EVLDDSINMKHFESFKRADIYAMGLVFWE-IARRCSIGGIHE 225

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/180 (28%), Positives = 90/180 (50%), Gaps = 9/180 (5%)
Query: 90  GEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVD---NGLYLIFQFSS 146
           GE++AVK L K  +      +   EI  + ++ H N++   G C +   NG+ LI +F  
Sbjct: 50  GEQVAVKSL-KPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLP 108
Query: 147 RGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFE 206
            GS+   +   N   +  K + K AV   +G+ YL     R+ +HRD+ + N+L+ ++ +
Sbjct: 109 SGSLKE-YLPKNKNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQ 164
Query: 207 PQISDFGLAKWLPSQWTHHSIA-PIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS 265
            +I DFGL K + +     ++    +      APE  M       +DV++FGV L E+++
Sbjct: 165 VKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLT 224

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 75/297 (25%), Positives = 129/297 (43%), Gaps = 70/297 (23%)
Query: 74  VGRGGYAEVYKGVLQD---GE---EIAVKRLTKVVTDDRKEKEFLTEIGTI-GHVCHPNV 126
           +G+G +  VY+G  +D   GE    +AVK + +  +  R+  EFL E   + G  CH +V
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASL-RERIEFLNEASVMKGFTCH-HV 82
Query: 127 LSLLGCCVDNG--LYLIFQFSSRGSVASLFHDV-----NSPGVEWKVRH---KIAVGTAR 176
           + LLG  V  G    ++ +  + G + S    +     N+PG          ++A   A 
Sbjct: 83  VRLLGV-VSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIAD 141
Query: 177 GLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAK--------------WLPSQW 222
           G+ YL+    ++ +HRD+ + N ++  DF  +I DFG+ +               LP +W
Sbjct: 142 GMAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRW 198
Query: 223 THHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWA 281
                         +APE    G+    +D+++FGV L EI S   +P  G         
Sbjct: 199 --------------MAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQG--------- 235
Query: 282 KPILNQGEIEKLVDPRLQGAYDVTQLN---RLAFAASLCIRASPTWRPTMSEVLEVM 335
              L+  ++ K V   + G Y     N   R+     +C + +P  RPT  E++ ++
Sbjct: 236 ---LSNEQVLKFV---MDGGYLDQPDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLL 286

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 51/180 (28%), Positives = 90/180 (50%), Gaps = 9/180 (5%)
Query: 90  GEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVD---NGLYLIFQFSS 146
           GE++AVK L K  +      +   EI  + ++ H N++   G C +   NG+ LI +F  
Sbjct: 38  GEQVAVKSL-KPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLP 96
Query: 147 RGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFE 206
            GS+   +   N   +  K + K AV   +G+ YL     R+ +HRD+ + N+L+ ++ +
Sbjct: 97  SGSLKE-YLPKNKNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQ 152
Query: 207 PQISDFGLAKWLPSQWTHHSIA-PIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS 265
            +I DFGL K + +     ++    +      APE  M       +DV++FGV L E+++
Sbjct: 153 VKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLT 212

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 74/296 (25%), Positives = 127/296 (42%), Gaps = 68/296 (22%)
Query: 74  VGRGGYAEVYKGVLQD---GE---EIAVKRLTKVVTDDRKEKEFLTEIGTI-GHVCHPNV 126
           +G+G +  VY+G  +D   GE    +AVK + +  +  R+  EFL E   + G  CH +V
Sbjct: 22  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASL-RERIEFLNEASVMKGFTCH-HV 79
Query: 127 LSLLGCCVDNGLYLI-FQFSSRGSVASLFHDV-----NSPGVEWKVRH---KIAVGTARG 177
           + LLG        L+  +  + G + S    +     N+PG          ++A   A G
Sbjct: 80  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 139
Query: 178 LHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAK--------------WLPSQWT 223
           + YL+    ++ +HRD+ + N ++  DF  +I DFG+ +               LP +W 
Sbjct: 140 MAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRW- 195
Query: 224 HHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAK 282
                        +APE    G+    +D+++FGV L EI S   +P  G          
Sbjct: 196 -------------MAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQG---------- 232
Query: 283 PILNQGEIEKLVDPRLQGAYDVTQLN---RLAFAASLCIRASPTWRPTMSEVLEVM 335
             L+  ++ K V   + G Y     N   R+     +C + +P  RPT  E++ ++
Sbjct: 233 --LSNEQVLKFV---MDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLL 283

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 75/297 (25%), Positives = 129/297 (43%), Gaps = 70/297 (23%)
Query: 74  VGRGGYAEVYKGVLQD---GE---EIAVKRLTKVVTDDRKEKEFLTEIGTI-GHVCHPNV 126
           +G+G +  VY+G  +D   GE    +AVK + +  +  R+  EFL E   + G  CH +V
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASL-RERIEFLNEASVMKGFTCH-HV 82
Query: 127 LSLLGCCVDNG--LYLIFQFSSRGSVASLFHDV-----NSPGVEWKVRH---KIAVGTAR 176
           + LLG  V  G    ++ +  + G + S    +     N+PG          ++A   A 
Sbjct: 83  VRLLGV-VSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIAD 141
Query: 177 GLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAK--------------WLPSQW 222
           G+ YL+    ++ +HRD+ + N ++  DF  +I DFG+ +               LP +W
Sbjct: 142 GMAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRW 198
Query: 223 THHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWA 281
                         +APE    G+    +D+++FGV L EI S   +P  G         
Sbjct: 199 --------------MAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQG--------- 235
Query: 282 KPILNQGEIEKLVDPRLQGAYDVTQLN---RLAFAASLCIRASPTWRPTMSEVLEVM 335
              L+  ++ K V   + G Y     N   R+     +C + +P  RPT  E++ ++
Sbjct: 236 ---LSNEQVLKFV---MDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLL 286

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 99/199 (49%), Gaps = 14/199 (7%)
Query: 74  VGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC 132
           +G+G    VY  + +  G+E+A++++   +    K++  + EI  +    +PN+++ L  
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMN--LQQQPKKELIINEILVMRENKNPNIVNYLDS 86
Query: 133 -CVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIH 191
             V + L+++ ++ + GS+  +   V    ++      +     + L +LH     ++IH
Sbjct: 87  YLVGDELWVVMEYLAGGSLTDV---VTETCMDEGQIAAVCRECLQALEFLHSN---QVIH 140
Query: 192 RDIKSSNILLTADFEPQISDFGL-AKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEK 250
           R+IKS NILL  D   +++DFG  A+  P Q    ++    GT   +APE         K
Sbjct: 141 RNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV---GTPYWMAPEVVTRKAYGPK 197
Query: 251 TDVFAFGVFLLEIISGRKP 269
            D+++ G+  +E+I G  P
Sbjct: 198 VDIWSLGIMAIEMIEGEPP 216

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 93/208 (44%), Gaps = 29/208 (13%)
Query: 74  VGRGGYAEV---YKGVLQD--GEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLS 128
           +G+G +  V       LQD  GE +AVK+L    + +   ++F  EI  +  + H N++ 
Sbjct: 19  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH--STEEHLRDFEREIEILKSLQHDNIVK 76
Query: 129 LLGCCVDNG---LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGC 185
             G C   G   L LI ++   GS+                +HK  +   + L Y  + C
Sbjct: 77  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ-----------KHKERIDHIKLLQYTSQIC 125
Query: 186 Q-------RRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIA-PIEGTFGHL 237
           +       +R IHR++ + NIL+  +   +I DFGL K LP    ++ +  P E      
Sbjct: 126 KGMEYLGTKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWY 185
Query: 238 APEYFMHGIVDEKTDVFAFGVFLLEIIS 265
           APE          +DV++FGV L E+ +
Sbjct: 186 APESLTESKFSVASDVWSFGVVLYELFT 213

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 74/296 (25%), Positives = 127/296 (42%), Gaps = 68/296 (22%)
Query: 74  VGRGGYAEVYKGVLQD---GE---EIAVKRLTKVVTDDRKEKEFLTEIGTI-GHVCHPNV 126
           +G+G +  VY+G  +D   GE    +AVK + +  +  R+  EFL E   + G  CH +V
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASL-RERIEFLNEASVMKGFTCH-HV 82
Query: 127 LSLLGCCVDNGLYLI-FQFSSRGSVASLFHDV-----NSPGVEWKVRH---KIAVGTARG 177
           + LLG        L+  +  + G + S    +     N+PG          ++A   A G
Sbjct: 83  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 142
Query: 178 LHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAK--------------WLPSQWT 223
           + YL+    ++ +HRD+ + N ++  DF  +I DFG+ +               LP +W 
Sbjct: 143 MAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW- 198
Query: 224 HHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAK 282
                        +APE    G+    +D+++FGV L EI S   +P  G          
Sbjct: 199 -------------MAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQG---------- 235
Query: 283 PILNQGEIEKLVDPRLQGAYDVTQLN---RLAFAASLCIRASPTWRPTMSEVLEVM 335
             L+  ++ K V   + G Y     N   R+     +C + +P  RPT  E++ ++
Sbjct: 236 --LSNEQVLKFV---MDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLL 286

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 98/212 (46%), Gaps = 29/212 (13%)
Query: 74  VGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKE-----FLTEIGTIGHVCHPNVLS 128
           +G GG + VY   L +   + +K   K +    +EKE     F  E+     + H N++S
Sbjct: 19  LGGGGMSTVY---LAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVS 75
Query: 129 LLGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTA--------RGLHY 180
           ++    ++  Y +      G   S + + + P         ++V TA         G+ +
Sbjct: 76  MIDVDEEDDCYYLVMEYIEGPTLSEYIESHGP---------LSVDTAINFTNQILDGIKH 126
Query: 181 LHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPE 240
            H     RI+HRDIK  NIL+ ++   +I DFG+AK L S+ +      + GT  + +PE
Sbjct: 127 AH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKAL-SETSLTQTNHVLGTVQYFSPE 182
Query: 241 YFMHGIVDEKTDVFAFGVFLLEIISGRKPVDG 272
                  DE TD+++ G+ L E++ G  P +G
Sbjct: 183 QAKGEATDECTDIYSIGIVLYEMLVGEPPFNG 214

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 75/297 (25%), Positives = 129/297 (43%), Gaps = 70/297 (23%)
Query: 74  VGRGGYAEVYKGVLQD---GE---EIAVKRLTKVVTDDRKEKEFLTEIGTI-GHVCHPNV 126
           +G+G +  VY+G  +D   GE    +AVK + +  +  R+  EFL E   + G  CH +V
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASL-RERIEFLNEASVMKGFTCH-HV 82
Query: 127 LSLLGCCVDNG--LYLIFQFSSRGSVASLFHDV-----NSPGVEWKVRH---KIAVGTAR 176
           + LLG  V  G    ++ +  + G + S    +     N+PG          ++A   A 
Sbjct: 83  VRLLGV-VSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIAD 141
Query: 177 GLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAK--------------WLPSQW 222
           G+ YL+    ++ +HRD+ + N ++  DF  +I DFG+ +               LP +W
Sbjct: 142 GMAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRKGGKGLLPVRW 198
Query: 223 THHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWA 281
                         +APE    G+    +D+++FGV L EI S   +P  G         
Sbjct: 199 --------------MAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQG--------- 235
Query: 282 KPILNQGEIEKLVDPRLQGAYDVTQLN---RLAFAASLCIRASPTWRPTMSEVLEVM 335
              L+  ++ K V   + G Y     N   R+     +C + +P  RPT  E++ ++
Sbjct: 236 ---LSNEQVLKFV---MDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLL 286

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 75/297 (25%), Positives = 129/297 (43%), Gaps = 70/297 (23%)
Query: 74  VGRGGYAEVYKGVLQD---GE---EIAVKRLTKVVTDDRKEKEFLTEIGTI-GHVCHPNV 126
           +G+G +  VY+G  +D   GE    +AVK + +  +  R+  EFL E   + G  CH +V
Sbjct: 24  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASL-RERIEFLNEASVMKGFTCH-HV 81
Query: 127 LSLLGCCVDNG--LYLIFQFSSRGSVASLFHDV-----NSPGVEWKVRH---KIAVGTAR 176
           + LLG  V  G    ++ +  + G + S    +     N+PG          ++A   A 
Sbjct: 82  VRLLGV-VSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIAD 140
Query: 177 GLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAK--------------WLPSQW 222
           G+ YL+    ++ +HRD+ + N ++  DF  +I DFG+ +               LP +W
Sbjct: 141 GMAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 197
Query: 223 THHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWA 281
                         +APE    G+    +D+++FGV L EI S   +P  G         
Sbjct: 198 --------------MAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQG--------- 234
Query: 282 KPILNQGEIEKLVDPRLQGAYDVTQLN---RLAFAASLCIRASPTWRPTMSEVLEVM 335
              L+  ++ K V   + G Y     N   R+     +C + +P  RPT  E++ ++
Sbjct: 235 ---LSNEQVLKFV---MDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLL 285

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 91/208 (43%), Gaps = 29/208 (13%)
Query: 74  VGRGGYAEV---YKGVLQD--GEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLS 128
           +G+G +  V       LQD  GE +AVK+L    + +   ++F  EI  +  + H N++ 
Sbjct: 22  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH--STEEHLRDFEREIEILKSLQHDNIVK 79
Query: 129 LLGCCVDNG---LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGC 185
             G C   G   L LI ++   GS+                +HK  +   + L Y  + C
Sbjct: 80  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ-----------KHKERIDHIKLLQYTSQIC 128
Query: 186 Q-------RRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIA-PIEGTFGHL 237
           +       +R IHRD+ + NIL+  +   +I DFGL K LP       +  P E      
Sbjct: 129 KGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY 188
Query: 238 APEYFMHGIVDEKTDVFAFGVFLLEIIS 265
           APE          +DV++FGV L E+ +
Sbjct: 189 APESLTESKFSVASDVWSFGVVLYELFT 216

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 91/208 (43%), Gaps = 29/208 (13%)
Query: 74  VGRGGYAEV---YKGVLQD--GEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLS 128
           +G+G +  V       LQD  GE +AVK+L    + +   ++F  EI  +  + H N++ 
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH--STEEHLRDFEREIEILKSLQHDNIVK 78
Query: 129 LLGCCVDNG---LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGC 185
             G C   G   L LI ++   GS+                +HK  +   + L Y  + C
Sbjct: 79  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ-----------KHKERIDHIKLLQYTSQIC 127
Query: 186 Q-------RRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIA-PIEGTFGHL 237
           +       +R IHRD+ + NIL+  +   +I DFGL K LP       +  P E      
Sbjct: 128 KGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY 187
Query: 238 APEYFMHGIVDEKTDVFAFGVFLLEIIS 265
           APE          +DV++FGV L E+ +
Sbjct: 188 APESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 91/208 (43%), Gaps = 29/208 (13%)
Query: 74  VGRGGYAEV---YKGVLQD--GEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLS 128
           +G+G +  V       LQD  GE +AVK+L    + +   ++F  EI  +  + H N++ 
Sbjct: 23  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH--STEEHLRDFEREIEILKSLQHDNIVK 80
Query: 129 LLGCCVDNG---LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGC 185
             G C   G   L LI ++   GS+                +HK  +   + L Y  + C
Sbjct: 81  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ-----------KHKERIDHIKLLQYTSQIC 129
Query: 186 Q-------RRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIA-PIEGTFGHL 237
           +       +R IHRD+ + NIL+  +   +I DFGL K LP       +  P E      
Sbjct: 130 KGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY 189
Query: 238 APEYFMHGIVDEKTDVFAFGVFLLEIIS 265
           APE          +DV++FGV L E+ +
Sbjct: 190 APESLTESKFSVASDVWSFGVVLYELFT 217

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 70/224 (31%), Positives = 108/224 (48%), Gaps = 40/224 (17%)
Query: 74  VGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFL--TEIGTIGHVCHPNVLSLLG 131
           VG+G Y EV++G L  GE +AVK     +   R E+ +   TEI     + H N+L  + 
Sbjct: 16  VGKGRYGEVWRG-LWHGESVAVK-----IFSSRDEQSWFRETEIYNTVLLRHDNILGFIA 69
Query: 132 CCV-----DNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHK--- 183
             +        L+LI  +   GS   L+  +    +E  +  ++AV  A GL +LH    
Sbjct: 70  SDMTSRNSSTQLWLITHYHEHGS---LYDFLQRQTLEPHLALRLAVSAACGLAHLHVEIF 126
Query: 184 GCQRR--IIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIA--PIEGTFGHLAP 239
           G Q +  I HRD KS N+L+ ++ +  I+D GLA        +  I   P  GT  ++AP
Sbjct: 127 GTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRVGTKRYMAP 186
Query: 240 EYFMHGIVDEK-----------TDVFAFGVFLLEIISGRKPVDG 272
           E     ++DE+           TD++AFG+ L E I+ R  V+G
Sbjct: 187 E-----VLDEQIRTDCFESYKWTDIWAFGLVLWE-IARRTIVNG 224

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 91/208 (43%), Gaps = 29/208 (13%)
Query: 74  VGRGGYAEV---YKGVLQD--GEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLS 128
           +G+G +  V       LQD  GE +AVK+L    + +   ++F  EI  +  + H N++ 
Sbjct: 49  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH--STEEHLRDFEREIEILKSLQHDNIVK 106
Query: 129 LLGCCVDNG---LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGC 185
             G C   G   L LI ++   GS+                +HK  +   + L Y  + C
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ-----------KHKERIDHIKLLQYTSQIC 155
Query: 186 Q-------RRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIA-PIEGTFGHL 237
           +       +R IHRD+ + NIL+  +   +I DFGL K LP       +  P E      
Sbjct: 156 KGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY 215
Query: 238 APEYFMHGIVDEKTDVFAFGVFLLEIIS 265
           APE          +DV++FGV L E+ +
Sbjct: 216 APESLTESKFSVASDVWSFGVVLYELFT 243

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 91/208 (43%), Gaps = 29/208 (13%)
Query: 74  VGRGGYAEV---YKGVLQD--GEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLS 128
           +G+G +  V       LQD  GE +AVK+L    + +   ++F  EI  +  + H N++ 
Sbjct: 25  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH--STEEHLRDFEREIEILKSLQHDNIVK 82
Query: 129 LLGCCVDNG---LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGC 185
             G C   G   L LI ++   GS+                +HK  +   + L Y  + C
Sbjct: 83  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ-----------KHKERIDHIKLLQYTSQIC 131
Query: 186 Q-------RRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIA-PIEGTFGHL 237
           +       +R IHRD+ + NIL+  +   +I DFGL K LP       +  P E      
Sbjct: 132 KGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY 191
Query: 238 APEYFMHGIVDEKTDVFAFGVFLLEIIS 265
           APE          +DV++FGV L E+ +
Sbjct: 192 APESLTESKFSVASDVWSFGVVLYELFT 219

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 59/229 (25%), Positives = 110/229 (48%), Gaps = 25/229 (10%)
Query: 63  IATNAFSSENLVGRGGYAEVYKGVLQ-DGEE---IAVKRLTKVVTDDRKEKEFLTEIGTI 118
           I  +    E ++G G + EV  G L+  G+    +A+K L    TD ++ ++FL+E   +
Sbjct: 11  IDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTD-KQRRDFLSEASIM 69
Query: 119 GHVCHPNVLSLLGCCVD-NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAV--GTA 175
           G   HPN++ L G       + +I ++   GS+ +     +     + V   + +  G  
Sbjct: 70  GQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDG---RFTVIQLVGMLRGIG 126
Query: 176 RGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWL-----PSQWTHHSIAPI 230
            G+ YL        +HRD+ + NIL+ ++   ++SDFG+++ L      +  T     PI
Sbjct: 127 SGMKYLS---DMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPI 183
Query: 231 EGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPV-DGSHQSL 277
             T    APE   +      +DV+++G+ + E++S G +P  D S+Q +
Sbjct: 184 RWT----APEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDV 228

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 91/208 (43%), Gaps = 29/208 (13%)
Query: 74  VGRGGYAEV---YKGVLQD--GEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLS 128
           +G+G +  V       LQD  GE +AVK+L    + +   ++F  EI  +  + H N++ 
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH--STEEHLRDFEREIEILKSLQHDNIVK 75
Query: 129 LLGCCVDNG---LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGC 185
             G C   G   L LI ++   GS+                +HK  +   + L Y  + C
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ-----------KHKERIDHIKLLQYTSQIC 124
Query: 186 Q-------RRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIA-PIEGTFGHL 237
           +       +R IHRD+ + NIL+  +   +I DFGL K LP       +  P E      
Sbjct: 125 KGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY 184
Query: 238 APEYFMHGIVDEKTDVFAFGVFLLEIIS 265
           APE          +DV++FGV L E+ +
Sbjct: 185 APESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 91/208 (43%), Gaps = 29/208 (13%)
Query: 74  VGRGGYAEV---YKGVLQD--GEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLS 128
           +G+G +  V       LQD  GE +AVK+L    + +   ++F  EI  +  + H N++ 
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH--STEEHLRDFEREIEILKSLQHDNIVK 75
Query: 129 LLGCCVDNG---LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGC 185
             G C   G   L LI ++   GS+                +HK  +   + L Y  + C
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ-----------KHKERIDHIKLLQYTSQIC 124
Query: 186 Q-------RRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIA-PIEGTFGHL 237
           +       +R IHRD+ + NIL+  +   +I DFGL K LP       +  P E      
Sbjct: 125 KGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY 184
Query: 238 APEYFMHGIVDEKTDVFAFGVFLLEIIS 265
           APE          +DV++FGV L E+ +
Sbjct: 185 APESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 91/208 (43%), Gaps = 29/208 (13%)
Query: 74  VGRGGYAEV---YKGVLQD--GEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLS 128
           +G+G +  V       LQD  GE +AVK+L    + +   ++F  EI  +  + H N++ 
Sbjct: 17  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH--STEEHLRDFEREIEILKSLQHDNIVK 74
Query: 129 LLGCCVDNG---LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGC 185
             G C   G   L LI ++   GS+                +HK  +   + L Y  + C
Sbjct: 75  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ-----------KHKERIDHIKLLQYTSQIC 123
Query: 186 Q-------RRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIA-PIEGTFGHL 237
           +       +R IHRD+ + NIL+  +   +I DFGL K LP       +  P E      
Sbjct: 124 KGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY 183
Query: 238 APEYFMHGIVDEKTDVFAFGVFLLEIIS 265
           APE          +DV++FGV L E+ +
Sbjct: 184 APESLTESKFSVASDVWSFGVVLYELFT 211

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 91/208 (43%), Gaps = 29/208 (13%)
Query: 74  VGRGGYAEV---YKGVLQD--GEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLS 128
           +G+G +  V       LQD  GE +AVK+L    + +   ++F  EI  +  + H N++ 
Sbjct: 24  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH--STEEHLRDFEREIEILKSLQHDNIVK 81
Query: 129 LLGCCVDNG---LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGC 185
             G C   G   L LI ++   GS+                +HK  +   + L Y  + C
Sbjct: 82  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ-----------KHKERIDHIKLLQYTSQIC 130
Query: 186 Q-------RRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIA-PIEGTFGHL 237
           +       +R IHRD+ + NIL+  +   +I DFGL K LP       +  P E      
Sbjct: 131 KGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY 190
Query: 238 APEYFMHGIVDEKTDVFAFGVFLLEIIS 265
           APE          +DV++FGV L E+ +
Sbjct: 191 APESLTESKFSVASDVWSFGVVLYELFT 218

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 59/229 (25%), Positives = 110/229 (48%), Gaps = 25/229 (10%)
Query: 63  IATNAFSSENLVGRGGYAEVYKGVLQ-DGEE---IAVKRLTKVVTDDRKEKEFLTEIGTI 118
           I  +    E ++G G + EV  G L+  G+    +A+K L    TD ++ ++FL+E   +
Sbjct: 5   IDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTD-KQRRDFLSEASIM 63
Query: 119 GHVCHPNVLSLLGCCVD-NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAV--GTA 175
           G   HPN++ L G       + +I ++   GS+ +     +     + V   + +  G  
Sbjct: 64  GQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDG---RFTVIQLVGMLRGIG 120
Query: 176 RGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWL-----PSQWTHHSIAPI 230
            G+ YL        +HRD+ + NIL+ ++   ++SDFG+++ L      +  T     PI
Sbjct: 121 SGMKYLS---DMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPI 177
Query: 231 EGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPV-DGSHQSL 277
             T    APE   +      +DV+++G+ + E++S G +P  D S+Q +
Sbjct: 178 RWT----APEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDV 222

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 91/208 (43%), Gaps = 29/208 (13%)
Query: 74  VGRGGYAEV---YKGVLQD--GEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLS 128
           +G+G +  V       LQD  GE +AVK+L    + +   ++F  EI  +  + H N++ 
Sbjct: 16  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH--STEEHLRDFEREIEILKSLQHDNIVK 73
Query: 129 LLGCCVDNG---LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGC 185
             G C   G   L LI ++   GS+                +HK  +   + L Y  + C
Sbjct: 74  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ-----------KHKERIDHIKLLQYTSQIC 122
Query: 186 Q-------RRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIA-PIEGTFGHL 237
           +       +R IHRD+ + NIL+  +   +I DFGL K LP       +  P E      
Sbjct: 123 KGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY 182
Query: 238 APEYFMHGIVDEKTDVFAFGVFLLEIIS 265
           APE          +DV++FGV L E+ +
Sbjct: 183 APESLTESKFSVASDVWSFGVVLYELFT 210

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 65/241 (26%), Positives = 108/241 (44%), Gaps = 36/241 (14%)
Query: 58  FEEISIATNAFSSENLVGRGGYAEVYKGVL------QDGEEIAVKRLTKVVTDDRKEKEF 111
            +EIS++   F  E  +G   + +VYKG L      +  + +A+K L        +E EF
Sbjct: 20  LKEISLSAVRFMEE--LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLRE-EF 76
Query: 112 LTEIGTIGHVCHPNVLSLLGCCV-DNGLYLIFQFSSRGSVASLF------HDVNSPGVEW 164
             E      + HPNV+ LLG    D  L +IF + S G +           DV S   + 
Sbjct: 77  RHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDR 136
Query: 165 KVRHKI--------AVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAK 216
            V+  +            A G+ YL       ++H+D+ + N+L+      +ISD GL +
Sbjct: 137 TVKSALEPPDFVHLVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFR 193
Query: 217 WLPS----QWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVD 271
            + +    +   +S+ PI      +APE  M+G     +D++++GV L E+ S G +P  
Sbjct: 194 EVYAADYYKLLGNSLLPIRW----MAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYC 249
Query: 272 G 272
           G
Sbjct: 250 G 250

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 60/229 (26%), Positives = 106/229 (46%), Gaps = 27/229 (11%)
Query: 54  RCFSFEEISIATNAFSSENLVGRGGYAEVYKGVL----QDGEEIAVKRLTKVVTDDRKEK 109
           R F+ E   I  +    E ++G G   EV  G L    Q    +A+K L    T+ R+ +
Sbjct: 40  RSFTRE---IEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTE-RQRR 95
Query: 110 EFLTEIGTIGHVCHPNVLSLLGCCVDNGLYLIF-QFSSRGSVASLFHDVNSPGVEWKVRH 168
           +FL+E   +G   HPN++ L G      L +I  ++   GS+ +     +    ++ +  
Sbjct: 96  DFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDG---QFTIMQ 152
Query: 169 KIAV--GTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWL-----PSQ 221
            + +  G   G+ YL        +HRD+ + N+L+ ++   ++SDFGL++ L      + 
Sbjct: 153 LVGMLRGVGAGMRYL---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAX 209
Query: 222 WTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKP 269
            T     PI  T    APE          +DV++FGV + E+++ G +P
Sbjct: 210 TTTGGKIPIRWT----APEAIAFRTFSSASDVWSFGVVMWEVLAYGERP 254

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 98/210 (46%), Gaps = 25/210 (11%)
Query: 74  VGRGGYAEVYKGVLQDGE------EIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVL 127
           +G G + EVY+G +          ++AVK L +V ++ + E +FL E   I  + H N++
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE-QDELDFLMEALIISKLNHQNIV 97
Query: 128 SLLGCCVDN-GLYLIFQFSSRGSVASLFHDVN------SPGVEWKVRHKIAVGTARGLHY 180
             +G  + +   +++ +  + G + S   +        S      + H +A   A G  Y
Sbjct: 98  RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH-VARDIACGCQY 156
Query: 181 LHKGCQRRIIHRDIKSSNILLTADFE---PQISDFGLAK--WLPSQWTHHSIAPIEGTFG 235
           L    +   IHRDI + N LLT        +I DFG+A+  +  S +     A +   + 
Sbjct: 157 LE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW- 212
Query: 236 HLAPEYFMHGIVDEKTDVFAFGVFLLEIIS 265
            + PE FM GI   KTD ++FGV L EI S
Sbjct: 213 -MPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 91/208 (43%), Gaps = 29/208 (13%)
Query: 74  VGRGGYAEV---YKGVLQD--GEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLS 128
           +G+G +  V       LQD  GE +AVK+L    + +   ++F  EI  +  + H N++ 
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH--STEEHLRDFEREIEILKSLQHDNIVK 75
Query: 129 LLGCCVDNG---LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGC 185
             G C   G   L LI ++   GS+                +HK  +   + L Y  + C
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ-----------KHKERIDHIKLLQYTSQIC 124
Query: 186 Q-------RRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIA-PIEGTFGHL 237
           +       +R IHRD+ + NIL+  +   +I DFGL K LP       +  P E      
Sbjct: 125 KGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWY 184
Query: 238 APEYFMHGIVDEKTDVFAFGVFLLEIIS 265
           APE          +DV++FGV L E+ +
Sbjct: 185 APESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 91/208 (43%), Gaps = 29/208 (13%)
Query: 74  VGRGGYAEV---YKGVLQD--GEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLS 128
           +G+G +  V       LQD  GE +AVK+L    + +   ++F  EI  +  + H N++ 
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH--STEEHLRDFEREIEILKSLQHDNIVK 93
Query: 129 LLGCCVDNG---LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGC 185
             G C   G   L LI ++   GS+                +HK  +   + L Y  + C
Sbjct: 94  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ-----------KHKERIDHIKLLQYTSQIC 142
Query: 186 Q-------RRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIA-PIEGTFGHL 237
           +       +R IHRD+ + NIL+  +   +I DFGL K LP       +  P E      
Sbjct: 143 KGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY 202
Query: 238 APEYFMHGIVDEKTDVFAFGVFLLEIIS 265
           APE          +DV++FGV L E+ +
Sbjct: 203 APESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 98/210 (46%), Gaps = 25/210 (11%)
Query: 74  VGRGGYAEVYKGVLQDGE------EIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVL 127
           +G G + EVY+G +          ++AVK L +V ++ + E +FL E   I  + H N++
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE-QDELDFLMEALIISKLNHQNIV 111
Query: 128 SLLGCCVDN-GLYLIFQFSSRGSVASLFHDVN------SPGVEWKVRHKIAVGTARGLHY 180
             +G  + +   +++ +  + G + S   +        S      + H +A   A G  Y
Sbjct: 112 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH-VARDIACGCQY 170
Query: 181 LHKGCQRRIIHRDIKSSNILLTADFE---PQISDFGLAK--WLPSQWTHHSIAPIEGTFG 235
           L    +   IHRDI + N LLT        +I DFG+A+  +  S +     A +   + 
Sbjct: 171 LE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW- 226
Query: 236 HLAPEYFMHGIVDEKTDVFAFGVFLLEIIS 265
            + PE FM GI   KTD ++FGV L EI S
Sbjct: 227 -MPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 91/208 (43%), Gaps = 29/208 (13%)
Query: 74  VGRGGYAEV---YKGVLQD--GEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLS 128
           +G+G +  V       LQD  GE +AVK+L    + +   ++F  EI  +  + H N++ 
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH--STEEHLRDFEREIEILKSLQHDNIVK 93
Query: 129 LLGCCVDNG---LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGC 185
             G C   G   L LI ++   GS+                +HK  +   + L Y  + C
Sbjct: 94  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ-----------KHKERIDHIKLLQYTSQIC 142
Query: 186 Q-------RRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIA-PIEGTFGHL 237
           +       +R IHRD+ + NIL+  +   +I DFGL K LP       +  P E      
Sbjct: 143 KGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY 202
Query: 238 APEYFMHGIVDEKTDVFAFGVFLLEIIS 265
           APE          +DV++FGV L E+ +
Sbjct: 203 APESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 106/216 (49%), Gaps = 13/216 (6%)
Query: 60  EISIATNAFSSENLVGRGGYAEVYKGVLQD--GEEI--AVKRLTKVVTDDRKEKEFLTEI 115
           +  IA        ++G G + EVY+GV  +  GE+I  AVK   K  T D KEK F++E 
Sbjct: 18  QYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEK-FMSEA 76
Query: 116 GTIGHVCHPNVLSLLGCCVDNGLYLIFQFSSRGSVAS-LFHDVNSPGVEWKVRHKIAVGT 174
             + ++ HP+++ L+G   +   ++I +    G +   L  + NS  V   V + + +  
Sbjct: 77  VIMKNLDHPHIVKLIGIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQI-- 134
Query: 175 ARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTF 234
            + + YL        +HRDI   NIL+ +    ++ DFGL++++  +  ++  +      
Sbjct: 135 CKAMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDE-DYYKASVTRLPI 190
Query: 235 GHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKP 269
             ++PE          +DV+ F V + EI+S G++P
Sbjct: 191 KWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQP 226

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 106/216 (49%), Gaps = 13/216 (6%)
Query: 60  EISIATNAFSSENLVGRGGYAEVYKGVLQD--GEEI--AVKRLTKVVTDDRKEKEFLTEI 115
           +  IA        ++G G + EVY+GV  +  GE+I  AVK   K  T D KEK F++E 
Sbjct: 2   QYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEK-FMSEA 60
Query: 116 GTIGHVCHPNVLSLLGCCVDNGLYLIFQFSSRGSVAS-LFHDVNSPGVEWKVRHKIAVGT 174
             + ++ HP+++ L+G   +   ++I +    G +   L  + NS  V   V + + +  
Sbjct: 61  VIMKNLDHPHIVKLIGIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQI-- 118
Query: 175 ARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTF 234
            + + YL        +HRDI   NIL+ +    ++ DFGL++++  +  ++  +      
Sbjct: 119 CKAMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDE-DYYKASVTRLPI 174
Query: 235 GHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKP 269
             ++PE          +DV+ F V + EI+S G++P
Sbjct: 175 KWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQP 210

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 106/216 (49%), Gaps = 13/216 (6%)
Query: 60  EISIATNAFSSENLVGRGGYAEVYKGVLQD--GEEI--AVKRLTKVVTDDRKEKEFLTEI 115
           +  IA        ++G G + EVY+GV  +  GE+I  AVK   K  T D KEK F++E 
Sbjct: 6   QYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEK-FMSEA 64
Query: 116 GTIGHVCHPNVLSLLGCCVDNGLYLIFQFSSRGSVAS-LFHDVNSPGVEWKVRHKIAVGT 174
             + ++ HP+++ L+G   +   ++I +    G +   L  + NS  V   V + + +  
Sbjct: 65  VIMKNLDHPHIVKLIGIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQI-- 122
Query: 175 ARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTF 234
            + + YL        +HRDI   NIL+ +    ++ DFGL++++  +  ++  +      
Sbjct: 123 CKAMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDE-DYYKASVTRLPI 178
Query: 235 GHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKP 269
             ++PE          +DV+ F V + EI+S G++P
Sbjct: 179 KWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQP 214

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 98/205 (47%), Gaps = 17/205 (8%)
Query: 73  LVGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLG 131
           ++G+G Y  VY G  L +   IA+K + +   D R  +    EI    H+ H N++  LG
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIPE--RDSRYSQPLHEEIALHKHLKHKNIVQYLG 86
Query: 132 CCVDNGLYLIF-QFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTAR---GLHYLHKGCQR 187
              +NG   IF +    GS+++L      P  + +    I   T +   GL YLH     
Sbjct: 87  SFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNE--QTIGFYTKQILEGLKYLH---DN 141
Query: 188 RIIHRDIKSSNILL-TADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGI 246
           +I+HRDIK  N+L+ T     +ISDFG +K L     +       GT  ++APE    G 
Sbjct: 142 QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG--INPCTETFTGTLQYMAPEIIDKGP 199
Query: 247 --VDEKTDVFAFGVFLLEIISGRKP 269
               +  D+++ G  ++E+ +G+ P
Sbjct: 200 RGYGKAADIWSLGCTIIEMATGKPP 224

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 60/229 (26%), Positives = 106/229 (46%), Gaps = 27/229 (11%)
Query: 54  RCFSFEEISIATNAFSSENLVGRGGYAEVYKGVL----QDGEEIAVKRLTKVVTDDRKEK 109
           R F+ E   I  +    E ++G G   EV  G L    Q    +A+K L    T+ R+ +
Sbjct: 40  RSFTRE---IEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTE-RQRR 95
Query: 110 EFLTEIGTIGHVCHPNVLSLLGCCVDNGLYLIF-QFSSRGSVASLFHDVNSPGVEWKVRH 168
           +FL+E   +G   HPN++ L G      L +I  ++   GS+ +     +    ++ +  
Sbjct: 96  DFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDG---QFTIMQ 152
Query: 169 KIAV--GTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWL-----PSQ 221
            + +  G   G+ YL        +HRD+ + N+L+ ++   ++SDFGL++ L      + 
Sbjct: 153 LVGMLRGVGAGMRYL---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAY 209
Query: 222 WTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKP 269
            T     PI  T    APE          +DV++FGV + E+++ G +P
Sbjct: 210 TTTGGKIPIRWT----APEAIAFRTFSSASDVWSFGVVMWEVLAYGERP 254

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 98/218 (44%), Gaps = 18/218 (8%)
Query: 63  IATNAFSSENLVGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHV 121
           +AT+ +     +G G Y  VYK      G  +A+K +     ++      + E+  +  +
Sbjct: 1   MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRL 60
Query: 122 C---HPNVLSLLGCCVDN------GLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAV 172
               HPNV+ L+  C  +       + L+F+   +  + +       PG+  +    +  
Sbjct: 61  EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMR 119
Query: 173 GTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEG 232
              RGL +LH  C   I+HRD+K  NIL+T+    +++DFGLA+    Q    ++ P+  
Sbjct: 120 QFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQM---ALDPVVV 173
Query: 233 TFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPV 270
           T  + APE  +        D+++ G    E+   RKP+
Sbjct: 174 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 210

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 74/297 (24%), Positives = 129/297 (43%), Gaps = 70/297 (23%)
Query: 74  VGRGGYAEVYKGVLQD---GE---EIAVKRLTKVVTDDRKEKEFLTEIGTI-GHVCHPNV 126
           +G+G +  VY+G  +D   GE    +AVK + +  +  R+  EFL E   + G  CH +V
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASL-RERIEFLNEASVMKGFTCH-HV 82
Query: 127 LSLLGCCVDNG--LYLIFQFSSRGSVASLFHDV-----NSPGVEWKVRH---KIAVGTAR 176
           + LLG  V  G    ++ +  + G + S    +     N+PG          ++A   A 
Sbjct: 83  VRLLGV-VSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIAD 141
Query: 177 GLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAK--------------WLPSQW 222
           G+ YL+    ++ +HR++ + N ++  DF  +I DFG+ +               LP +W
Sbjct: 142 GMAYLNA---KKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 198
Query: 223 THHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWA 281
                         +APE    G+    +D+++FGV L EI S   +P  G         
Sbjct: 199 --------------MAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQG--------- 235
Query: 282 KPILNQGEIEKLVDPRLQGAYDVTQLN---RLAFAASLCIRASPTWRPTMSEVLEVM 335
              L+  ++ K V   + G Y     N   R+     +C + +P  RPT  E++ ++
Sbjct: 236 ---LSNEQVLKFV---MDGGYLDQPDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLL 286

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 74/297 (24%), Positives = 129/297 (43%), Gaps = 70/297 (23%)
Query: 74  VGRGGYAEVYKGVLQD---GE---EIAVKRLTKVVTDDRKEKEFLTEIGTI-GHVCHPNV 126
           +G+G +  VY+G  +D   GE    +AVK + +  +  R+  EFL E   + G  CH +V
Sbjct: 26  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASL-RERIEFLNEASVMKGFTCH-HV 83
Query: 127 LSLLGCCVDNG--LYLIFQFSSRGSVASLFHDV-----NSPGVEWKVRH---KIAVGTAR 176
           + LLG  V  G    ++ +  + G + S    +     N+PG          ++A   A 
Sbjct: 84  VRLLGV-VSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIAD 142
Query: 177 GLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAK--------------WLPSQW 222
           G+ YL+    ++ +HR++ + N ++  DF  +I DFG+ +               LP +W
Sbjct: 143 GMAYLNA---KKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 199
Query: 223 THHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWA 281
                         +APE    G+    +D+++FGV L EI S   +P  G         
Sbjct: 200 --------------MAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQG--------- 236
Query: 282 KPILNQGEIEKLVDPRLQGAYDVTQLN---RLAFAASLCIRASPTWRPTMSEVLEVM 335
              L+  ++ K V   + G Y     N   R+     +C + +P  RPT  E++ ++
Sbjct: 237 ---LSNEQVLKFV---MDGGYLDQPDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLL 287

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 114/240 (47%), Gaps = 35/240 (14%)
Query: 74  VGRGGYAEVYK----GVL--QDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVL 127
           +G G +  V++    G+L  +    +AVK L +  + D  + +F  E   +    +PN++
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASAD-MQADFQREAALMAEFDNPNIV 113
Query: 128 SLLG-CCVDNGLYLIFQFSSRG------------SVASLFHD-------VNSPG---VEW 164
            LLG C V   + L+F++ + G            +V SL H        V+SPG   +  
Sbjct: 114 KLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSC 173
Query: 165 KVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTH 224
             +  IA   A G+ YL    +R+ +HRD+ + N L+  +   +I+DFGL++ + S   +
Sbjct: 174 AEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY 230
Query: 225 HSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDG-SHQSLHSWAK 282
            +          + PE   +     ++DV+A+GV L EI S G +P  G +H+ +  + +
Sbjct: 231 KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVR 290

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 97/208 (46%), Gaps = 14/208 (6%)
Query: 64  ATNAFSSENLVGRGGYAEVYKGVLQD-GEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVC 122
           +   + +  LVG G Y  V K   +D G  +A+K+  +   D   +K  + EI  +  + 
Sbjct: 23  SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLR 82
Query: 123 HPNVLSLLGCCVDNGL-YLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYL 181
           H N+++LL  C      YL+F+F     +  L  ++   G++++V  K       G+ + 
Sbjct: 83  HENLVNLLEVCKKKKRWYLVFEFVDHTILDDL--ELFPNGLDYQVVQKYLFQIINGIGFC 140
Query: 182 HKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWL--PSQWTHHSIAPIEGTFGHLAP 239
           H      IIHRDIK  NIL++     ++ DFG A+ L  P +     +A    T  + AP
Sbjct: 141 H---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVA----TRWYRAP 193
Query: 240 EYFMHGI-VDEKTDVFAFGVFLLEIISG 266
           E  +  +   +  DV+A G  + E+  G
Sbjct: 194 ELLVGDVKYGKAVDVWAIGCLVTEMFMG 221

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/241 (26%), Positives = 108/241 (44%), Gaps = 36/241 (14%)
Query: 58  FEEISIATNAFSSENLVGRGGYAEVYKGVL------QDGEEIAVKRLTKVVTDDRKEKEF 111
            +EIS++   F  E  +G   + +VYKG L      +  + +A+K L        +E EF
Sbjct: 3   LKEISLSAVRFMEE--LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLRE-EF 59
Query: 112 LTEIGTIGHVCHPNVLSLLGCCV-DNGLYLIFQFSSRGSVASLF------HDVNSPGVEW 164
             E      + HPNV+ LLG    D  L +IF + S G +           DV S   + 
Sbjct: 60  RHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDR 119
Query: 165 KVRHKI--------AVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAK 216
            V+  +            A G+ YL       ++H+D+ + N+L+      +ISD GL +
Sbjct: 120 TVKSALEPPDFVHLVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFR 176
Query: 217 WLPS----QWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVD 271
            + +    +   +S+ PI      +APE  M+G     +D++++GV L E+ S G +P  
Sbjct: 177 EVYAADYYKLLGNSLLPIRW----MAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYC 232
Query: 272 G 272
           G
Sbjct: 233 G 233

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 101/212 (47%), Gaps = 21/212 (9%)
Query: 73  LVGRGGYAEVYKGV-LQDGEEIAVKRL-TKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLL 130
           ++G GG +EV+    L+D  ++AVK L   +  D      F  E      + HP ++++ 
Sbjct: 19  ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 131 GCCVDNG---------LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYL 181
               D G          Y++ ++    ++  + H    P    +    IA    + L++ 
Sbjct: 79  ----DTGEAETPAGPLPYIVMEYVDGVTLRDIVH-TEGPMTPKRAIEVIA-DACQALNFS 132
Query: 182 HKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLP-SQWTHHSIAPIEGTFGHLAPE 240
           H   Q  IIHRD+K +NIL++A    ++ DFG+A+ +  S  +    A + GT  +L+PE
Sbjct: 133 H---QNGIIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSPE 189
Query: 241 YFMHGIVDEKTDVFAFGVFLLEIISGRKPVDG 272
                 VD ++DV++ G  L E+++G  P  G
Sbjct: 190 QARGDSVDARSDVYSLGCVLYEVLTGEPPFTG 221

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/247 (24%), Positives = 114/247 (46%), Gaps = 27/247 (10%)
Query: 90  GEEIAVKRLTKVVTDDRKEKE---FLTEIGTIGHVCHPNVLSLLGC-CVDNGLYLIFQFS 145
           G+++AVK++     D RK++       E+  +    H NV+ +     V + L+++ +F 
Sbjct: 70  GKQVAVKKM-----DLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSYLVGDELWVVMEFL 124
Query: 146 SRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADF 205
             G++  +   V    +  +    + +   R L YLH    + +IHRDIKS +ILLT+D 
Sbjct: 125 EGGALTDI---VTHTRMNEEQIATVCLSVLRALSYLHN---QGVIHRDIKSDSILLTSDG 178
Query: 206 EPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS 265
             ++SDFG    +  +        + GT   +APE         + D+++ G+ ++E+I 
Sbjct: 179 RIKLSDFGFCAQVSKEVPKRKX--LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMID 236
Query: 266 GRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWR 325
           G  P        +    P+     I   + PR++  + V+ + R  F   + +R  P+ R
Sbjct: 237 GEPP--------YFNEPPLQAMRRIRDSLPPRVKDLHKVSSVLR-GFLDLMLVR-EPSQR 286
Query: 326 PTMSEVL 332
            T  E+L
Sbjct: 287 ATAQELL 293

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 98/218 (44%), Gaps = 18/218 (8%)
Query: 63  IATNAFSSENLVGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHV 121
           +AT+ +     +G G Y  VYK      G  +A+K +     ++      + E+  +  +
Sbjct: 1   MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRL 60
Query: 122 C---HPNVLSLLGCCVDN------GLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAV 172
               HPNV+ L+  C  +       + L+F+   +  + +       PG+  +    +  
Sbjct: 61  EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMR 119
Query: 173 GTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEG 232
              RGL +LH  C   I+HRD+K  NIL+T+    +++DFGLA+    Q    ++ P+  
Sbjct: 120 QFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQM---ALFPVVV 173
Query: 233 TFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPV 270
           T  + APE  +        D+++ G    E+   RKP+
Sbjct: 174 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 210

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 97/210 (46%), Gaps = 25/210 (11%)
Query: 74  VGRGGYAEVYKGVLQDGE------EIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVL 127
           +G G + EVY+G +          ++AVK L +V ++ + E +FL E   I    H N++
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE-QDELDFLMEALIISKFNHQNIV 97
Query: 128 SLLGCCVDN-GLYLIFQFSSRGSVASLFHDVN------SPGVEWKVRHKIAVGTARGLHY 180
             +G  + +   +++ +  + G + S   +        S      + H +A   A G  Y
Sbjct: 98  RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH-VARDIACGCQY 156
Query: 181 LHKGCQRRIIHRDIKSSNILLTADFE---PQISDFGLAK--WLPSQWTHHSIAPIEGTFG 235
           L    +   IHRDI + N LLT        +I DFG+A+  +  S +     A +   + 
Sbjct: 157 LE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW- 212
Query: 236 HLAPEYFMHGIVDEKTDVFAFGVFLLEIIS 265
            + PE FM GI   KTD ++FGV L EI S
Sbjct: 213 -MPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 97/210 (46%), Gaps = 25/210 (11%)
Query: 74  VGRGGYAEVYKGVLQDGE------EIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVL 127
           +G G + EVY+G +          ++AVK L +V ++ + E +FL E   I    H N++
Sbjct: 55  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE-QDELDFLMEALIISKFNHQNIV 113
Query: 128 SLLGCCVDN-GLYLIFQFSSRGSVASLFHDVN------SPGVEWKVRHKIAVGTARGLHY 180
             +G  + +   +++ +  + G + S   +        S      + H +A   A G  Y
Sbjct: 114 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH-VARDIACGCQY 172
Query: 181 LHKGCQRRIIHRDIKSSNILLTADFE---PQISDFGLAK--WLPSQWTHHSIAPIEGTFG 235
           L    +   IHRDI + N LLT        +I DFG+A+  +  S +     A +   + 
Sbjct: 173 LE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW- 228
Query: 236 HLAPEYFMHGIVDEKTDVFAFGVFLLEIIS 265
            + PE FM GI   KTD ++FGV L EI S
Sbjct: 229 -MPPEAFMEGIFTSKTDTWSFGVLLWEIFS 257

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 108/220 (49%), Gaps = 24/220 (10%)
Query: 63  IATNAFSSENLVGRGGYAEVYKGVLQ-DGEE---IAVKRLTKVVTDDRKEKEFLTEIGTI 118
           I  +  + E ++G G + EV  G L+  G+    +A+K L KV   +++ ++FL E   +
Sbjct: 19  IEASCITIERVIGAGEFGEVCSGRLKLPGKRELPVAIKTL-KVGYTEKQRRDFLGEASIM 77
Query: 119 GHVCHPNVLSLLGCCVDNG-LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAV--GTA 175
           G   HPN++ L G    +  + ++ ++   GS+ +     +    ++ V   + +  G +
Sbjct: 78  GQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDTFLKKNDG---QFTVIQLVGMLRGIS 134
Query: 176 RGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWL-----PSQWTHHSIAPI 230
            G+ YL        +HRD+ + NIL+ ++   ++SDFGL++ L      +  T     PI
Sbjct: 135 AGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPI 191
Query: 231 EGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKP 269
             T    APE          +DV+++G+ + E++S G +P
Sbjct: 192 RWT----APEAIAFRKFTSASDVWSYGIVMWEVVSYGERP 227

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/267 (24%), Positives = 118/267 (44%), Gaps = 22/267 (8%)
Query: 74  VGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC 132
           +GRG Y  V K   +  G+ +AVKR+   V    +++  +    ++  V  P  ++  G 
Sbjct: 59  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 118
Query: 133 CVDNGLYLIFQFSSRGSVASLFHDVNSPG--VEWKVRHKIAVGTARGLHYLHKGCQRRII 190
               G   I       S+   +  V   G  +   +  KIAV   + L +LH   +  +I
Sbjct: 119 LFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH--SKLSVI 176
Query: 191 HRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDE- 249
           HRD+K SN+L+ A  + ++ DFG++ +L         A   G   ++APE     +  + 
Sbjct: 177 HRDVKPSNVLINALGQVKMCDFGISGYLVDSVAKTIDA---GCKPYMAPERINPELNQKG 233
Query: 250 ---KTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQ 306
              K+D+++ G+ ++E+   R P D       SW  P     ++ +   P+L    D   
Sbjct: 234 YSVKSDIWSLGITMIELAILRFPYD-------SWGTPFQQLKQVVEEPSPQLPA--DKFS 284
Query: 307 LNRLAFAASLCIRASPTWRPTMSEVLE 333
              + F  S C++ +   RPT  E+++
Sbjct: 285 AEFVDF-TSQCLKKNSKERPTYPELMQ 310

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 97/214 (45%), Gaps = 15/214 (7%)
Query: 68  FSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNV 126
           F     +G G Y  VYK   +  GE +A+K++      +      + EI  +  + HPN+
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 127 LSLLGCC-VDNGLYLIFQFSSRGSVASLFHDVNS-PGVEWKVRHKIAVGTARGLHYLHKG 184
           + LL     +N LYL+F+F S       F D ++  G+   +         +GL + H  
Sbjct: 68  VKLLDVIHTENKLYLVFEFLSMD--LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH-- 123
Query: 185 CQRRIIHRDIKSSNILLTADFEPQISDFGLAKW--LPSQWTHHSIAPIEGTFGHLAPEYF 242
              R++HRD+K  N+L+  +   +++DFGLA+   +P +   H +     T  + APE  
Sbjct: 124 -SHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAPEIL 178
Query: 243 MH-GIVDEKTDVFAFGVFLLEIISGRKPVDGSHQ 275
           +         D+++ G    E+++ R    G  +
Sbjct: 179 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE 212

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 97/214 (45%), Gaps = 15/214 (7%)
Query: 68  FSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNV 126
           F     +G G Y  VYK   +  GE +A+K++      +      + EI  +  + HPN+
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 127 LSLLGCC-VDNGLYLIFQFSSRGSVASLFHDVNS-PGVEWKVRHKIAVGTARGLHYLHKG 184
           + LL     +N LYL+F+F S       F D ++  G+   +         +GL + H  
Sbjct: 66  VKLLDVIHTENKLYLVFEFLSMD--LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH-- 121
Query: 185 CQRRIIHRDIKSSNILLTADFEPQISDFGLAKW--LPSQWTHHSIAPIEGTFGHLAPEYF 242
              R++HRD+K  N+L+  +   +++DFGLA+   +P +   H +     T  + APE  
Sbjct: 122 -SHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAPEIL 176
Query: 243 MH-GIVDEKTDVFAFGVFLLEIISGRKPVDGSHQ 275
           +         D+++ G    E+++ R    G  +
Sbjct: 177 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE 210

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 97/210 (46%), Gaps = 25/210 (11%)
Query: 74  VGRGGYAEVYKGVLQDGE------EIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVL 127
           +G G + EVY+G +          ++AVK L +V ++ + E +FL E   I    H N++
Sbjct: 65  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE-QDELDFLMEALIISKFNHQNIV 123
Query: 128 SLLGCCVDN-GLYLIFQFSSRGSVASLFHDVN------SPGVEWKVRHKIAVGTARGLHY 180
             +G  + +   +++ +  + G + S   +        S      + H +A   A G  Y
Sbjct: 124 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH-VARDIACGCQY 182
Query: 181 LHKGCQRRIIHRDIKSSNILLTADFE---PQISDFGLAK--WLPSQWTHHSIAPIEGTFG 235
           L    +   IHRDI + N LLT        +I DFG+A+  +  S +     A +   + 
Sbjct: 183 LE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW- 238
Query: 236 HLAPEYFMHGIVDEKTDVFAFGVFLLEIIS 265
            + PE FM GI   KTD ++FGV L EI S
Sbjct: 239 -MPPEAFMEGIFTSKTDTWSFGVLLWEIFS 267

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 97/210 (46%), Gaps = 25/210 (11%)
Query: 74  VGRGGYAEVYKGVLQDGE------EIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVL 127
           +G G + EVY+G +          ++AVK L +V ++ + E +FL E   I    H N++
Sbjct: 45  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE-QDELDFLMEALIISKFNHQNIV 103
Query: 128 SLLGCCVDN-GLYLIFQFSSRGSVASLFHDVN------SPGVEWKVRHKIAVGTARGLHY 180
             +G  + +   +++ +  + G + S   +        S      + H +A   A G  Y
Sbjct: 104 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH-VARDIACGCQY 162
Query: 181 LHKGCQRRIIHRDIKSSNILLTADFE---PQISDFGLAK--WLPSQWTHHSIAPIEGTFG 235
           L    +   IHRDI + N LLT        +I DFG+A+  +  S +     A +   + 
Sbjct: 163 LE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW- 218
Query: 236 HLAPEYFMHGIVDEKTDVFAFGVFLLEIIS 265
            + PE FM GI   KTD ++FGV L EI S
Sbjct: 219 -MPPEAFMEGIFTSKTDTWSFGVLLWEIFS 247

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 97/210 (46%), Gaps = 25/210 (11%)
Query: 74  VGRGGYAEVYKGVLQDGE------EIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVL 127
           +G G + EVY+G +          ++AVK L +V ++ + E +FL E   I    H N++
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE-QDELDFLMEALIISKFNHQNIV 96
Query: 128 SLLGCCVDN-GLYLIFQFSSRGSVASLFHDVN------SPGVEWKVRHKIAVGTARGLHY 180
             +G  + +   +++ +  + G + S   +        S      + H +A   A G  Y
Sbjct: 97  RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH-VARDIACGCQY 155
Query: 181 LHKGCQRRIIHRDIKSSNILLTADFE---PQISDFGLAK--WLPSQWTHHSIAPIEGTFG 235
           L    +   IHRDI + N LLT        +I DFG+A+  +  S +     A +   + 
Sbjct: 156 LE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW- 211
Query: 236 HLAPEYFMHGIVDEKTDVFAFGVFLLEIIS 265
            + PE FM GI   KTD ++FGV L EI S
Sbjct: 212 -MPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 97/210 (46%), Gaps = 25/210 (11%)
Query: 74  VGRGGYAEVYKGVLQDGE------EIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVL 127
           +G G + EVY+G +          ++AVK L +V ++ + E +FL E   I    H N++
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE-QDELDFLMEALIISKFNHQNIV 96
Query: 128 SLLGCCVDN-GLYLIFQFSSRGSVASLFHDVN------SPGVEWKVRHKIAVGTARGLHY 180
             +G  + +   +++ +  + G + S   +        S      + H +A   A G  Y
Sbjct: 97  RCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH-VARDIACGCQY 155
Query: 181 LHKGCQRRIIHRDIKSSNILLTADFE---PQISDFGLAK--WLPSQWTHHSIAPIEGTFG 235
           L    +   IHRDI + N LLT        +I DFG+A+  +  S +     A +   + 
Sbjct: 156 LE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW- 211
Query: 236 HLAPEYFMHGIVDEKTDVFAFGVFLLEIIS 265
            + PE FM GI   KTD ++FGV L EI S
Sbjct: 212 -MPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 97/210 (46%), Gaps = 25/210 (11%)
Query: 74  VGRGGYAEVYKGVLQDGE------EIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVL 127
           +G G + EVY+G +          ++AVK L +V ++ + E +FL E   I    H N++
Sbjct: 30  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE-QDELDFLMEALIISKFNHQNIV 88
Query: 128 SLLGCCVDN-GLYLIFQFSSRGSVASLFHDVN------SPGVEWKVRHKIAVGTARGLHY 180
             +G  + +   +++ +  + G + S   +        S      + H +A   A G  Y
Sbjct: 89  RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH-VARDIACGCQY 147
Query: 181 LHKGCQRRIIHRDIKSSNILLTADFE---PQISDFGLAK--WLPSQWTHHSIAPIEGTFG 235
           L    +   IHRDI + N LLT        +I DFG+A+  +  S +     A +   + 
Sbjct: 148 LE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW- 203
Query: 236 HLAPEYFMHGIVDEKTDVFAFGVFLLEIIS 265
            + PE FM GI   KTD ++FGV L EI S
Sbjct: 204 -MPPEAFMEGIFTSKTDTWSFGVLLWEIFS 232

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/267 (24%), Positives = 118/267 (44%), Gaps = 22/267 (8%)
Query: 74  VGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC 132
           +GRG Y  V K   +  G+ +AVKR+   V    +++  +    ++  V  P  ++  G 
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74
Query: 133 CVDNGLYLIFQFSSRGSVASLFHDVNSPG--VEWKVRHKIAVGTARGLHYLHKGCQRRII 190
               G   I       S+   +  V   G  +   +  KIAV   + L +LH   +  +I
Sbjct: 75  LFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS--KLSVI 132
Query: 191 HRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDE- 249
           HRD+K SN+L+ A  + ++ DFG++ +L         A   G   ++APE     +  + 
Sbjct: 133 HRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDA---GCKPYMAPERINPELNQKG 189
Query: 250 ---KTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQ 306
              K+D+++ G+ ++E+   R P D       SW  P     ++ +   P+L    D   
Sbjct: 190 YSVKSDIWSLGITMIELAILRFPYD-------SWGTPFQQLKQVVEEPSPQLPA--DKFS 240
Query: 307 LNRLAFAASLCIRASPTWRPTMSEVLE 333
              + F  S C++ +   RPT  E+++
Sbjct: 241 AEFVDF-TSQCLKKNSKERPTYPELMQ 266

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 98/205 (47%), Gaps = 17/205 (8%)
Query: 73  LVGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLG 131
           ++G+G Y  VY G  L +   IA+K + +   D R  +    EI    H+ H N++  LG
Sbjct: 15  VLGKGTYGIVYAGRDLSNQVRIAIKEIPE--RDSRYSQPLHEEIALHKHLKHKNIVQYLG 72
Query: 132 CCVDNGLYLIF-QFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTAR---GLHYLHKGCQR 187
              +NG   IF +    GS+++L      P  + +    I   T +   GL YLH     
Sbjct: 73  SFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNE--QTIGFYTKQILEGLKYLH---DN 127
Query: 188 RIIHRDIKSSNILL-TADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGI 246
           +I+HRDIK  N+L+ T     +ISDFG +K L     +       GT  ++APE    G 
Sbjct: 128 QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG--INPCTETFTGTLQYMAPEIIDKGP 185
Query: 247 --VDEKTDVFAFGVFLLEIISGRKP 269
               +  D+++ G  ++E+ +G+ P
Sbjct: 186 RGYGKAADIWSLGCTIIEMATGKPP 210

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 97/210 (46%), Gaps = 25/210 (11%)
Query: 74  VGRGGYAEVYKGVLQDGE------EIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVL 127
           +G G + EVY+G +          ++AVK L +V ++ + E +FL E   I    H N++
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE-QDELDFLMEALIISKFNHQNIV 111
Query: 128 SLLGCCVDN-GLYLIFQFSSRGSVASLFHDVN------SPGVEWKVRHKIAVGTARGLHY 180
             +G  + +   +++ +  + G + S   +        S      + H +A   A G  Y
Sbjct: 112 RCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH-VARDIACGCQY 170
Query: 181 LHKGCQRRIIHRDIKSSNILLTADFE---PQISDFGLAK--WLPSQWTHHSIAPIEGTFG 235
           L    +   IHRDI + N LLT        +I DFG+A+  +  S +     A +   + 
Sbjct: 171 LE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW- 226
Query: 236 HLAPEYFMHGIVDEKTDVFAFGVFLLEIIS 265
            + PE FM GI   KTD ++FGV L EI S
Sbjct: 227 -MPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 88/213 (41%), Gaps = 8/213 (3%)
Query: 68  FSSENLVGRGGYAEVYKGV-LQDGEEIAVKRLTKV-VTDDRKEKEFLTEIGTIGHVCHPN 125
           F    ++G G ++ V     L    E A+K L K  +  + K      E   +  + HP 
Sbjct: 39  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 98
Query: 126 VLSLLGCCVDN-GLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKG 184
            + L  C  D+  LY    ++  G +      + S   +              L YLH  
Sbjct: 99  FVKLYFCFQDDEKLYFGLSYAKNGELLKYIRKIGS--FDETCTRFYTAEIVSALEYLHG- 155
Query: 185 CQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMH 244
             + IIHRD+K  NILL  D   QI+DFG AK L  +          GT  +++PE    
Sbjct: 156 --KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 213
Query: 245 GIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSL 277
               + +D++A G  + ++++G  P    ++ L
Sbjct: 214 KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL 246

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 104/220 (47%), Gaps = 15/220 (6%)
Query: 63  IATNAFSSENLVGRGGYAEVYKGVLQDGEEI-AVKRLTK-VVTDDRKEKEFLTEIGTIGH 120
           +    F+   ++G+G + +V     +  EE+ A+K L K VV  D   +  + E   +  
Sbjct: 16  VKLTDFNFLMVLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLAL 75
Query: 121 VCHPNVLSLLGCCVD--NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGL 178
           +  P  L+ L  C    + LY + ++ + G +      V        V +  A   + GL
Sbjct: 76  LDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFY--AAEISIGL 133
Query: 179 HYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIE--GTFGH 236
            +LHK   R II+RD+K  N++L ++   +I+DFG+ K    +     +   E  GT  +
Sbjct: 134 FFLHK---RGIIYRDLKLDNVMLDSEGHIKIADFGMCK----EHMMDGVTTREFCGTPDY 186
Query: 237 LAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQS 276
           +APE   +    +  D +A+GV L E+++G+ P DG  + 
Sbjct: 187 IAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED 226

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 97/210 (46%), Gaps = 25/210 (11%)
Query: 74  VGRGGYAEVYKGVLQDGE------EIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVL 127
           +G G + EVY+G +          ++AVK L +V ++ + E +FL E   I    H N++
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE-QDELDFLMEALIISKFNHQNIV 97
Query: 128 SLLGCCVDN-GLYLIFQFSSRGSVASLFHDVN------SPGVEWKVRHKIAVGTARGLHY 180
             +G  + +   +++ +  + G + S   +        S      + H +A   A G  Y
Sbjct: 98  RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH-VARDIACGCQY 156
Query: 181 LHKGCQRRIIHRDIKSSNILLTADFE---PQISDFGLAK--WLPSQWTHHSIAPIEGTFG 235
           L    +   IHRDI + N LLT        +I DFG+A+  +  S +     A +   + 
Sbjct: 157 LE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRKGGCAMLPVKW- 212
Query: 236 HLAPEYFMHGIVDEKTDVFAFGVFLLEIIS 265
            + PE FM GI   KTD ++FGV L EI S
Sbjct: 213 -MPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 93/208 (44%), Gaps = 21/208 (10%)
Query: 74  VGRGGYAEVYKGVLQDGE------EIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVL 127
           +G G + EVY+G +          ++AVK L +V ++ + E +FL E   I    H N++
Sbjct: 56  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE-QDELDFLMEALIISKFNHQNIV 114
Query: 128 SLLGCCVDN-GLYLIFQFSSRGSVASLFHDVN------SPGVEWKVRHKIAVGTARGLHY 180
             +G  + +   +++ +  + G + S   +        S      + H +A   A G  Y
Sbjct: 115 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH-VARDIACGCQY 173
Query: 181 LHKGCQRRIIHRDIKSSNILLTADFE---PQISDFGLAKWLPSQWTHHSIAPIEGTFGHL 237
           L    +   IHRDI + N LLT        +I DFG+A+ +     +            +
Sbjct: 174 LE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWM 230
Query: 238 APEYFMHGIVDEKTDVFAFGVFLLEIIS 265
            PE FM GI   KTD ++FGV L EI S
Sbjct: 231 PPEAFMEGIFTSKTDTWSFGVLLWEIFS 258

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 93/208 (44%), Gaps = 21/208 (10%)
Query: 74  VGRGGYAEVYKGVLQDGE------EIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVL 127
           +G G + EVY+G +          ++AVK L +V ++ + E +FL E   I    H N++
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE-QDELDFLMEALIISKFNHQNIV 137
Query: 128 SLLGCCVDN-GLYLIFQFSSRGSVASLFHDVN------SPGVEWKVRHKIAVGTARGLHY 180
             +G  + +   +++ +  + G + S   +        S      + H +A   A G  Y
Sbjct: 138 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH-VARDIACGCQY 196
Query: 181 LHKGCQRRIIHRDIKSSNILLTADFE---PQISDFGLAKWLPSQWTHHSIAPIEGTFGHL 237
           L    +   IHRDI + N LLT        +I DFG+A+ +     +            +
Sbjct: 197 LE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWM 253
Query: 238 APEYFMHGIVDEKTDVFAFGVFLLEIIS 265
            PE FM GI   KTD ++FGV L EI S
Sbjct: 254 PPEAFMEGIFTSKTDTWSFGVLLWEIFS 281

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/176 (29%), Positives = 82/176 (46%), Gaps = 28/176 (15%)
Query: 60  EISIATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKE---------KE 110
           E+    + ++ +  +  G Y  V  GV  +G  +A+KR+   V+D R           K 
Sbjct: 16  ELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKR 75
Query: 111 FLTEIGTIGHVCHPNVLSLLGCCVD------NGLYLIFQFSSRGSVASLFHD---VNSPG 161
            L EI  + H  HPN+L L    V       + LYL+ +   R  +A + HD   V SP 
Sbjct: 76  VLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTEL-MRTDLAQVIHDQRIVISPQ 134
Query: 162 -VEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAK 216
            +++ + H +      GLH LH+     ++HRD+   NILL  + +  I DF LA+
Sbjct: 135 HIQYFMYHILL-----GLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAR 182

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 73/280 (26%), Positives = 124/280 (44%), Gaps = 47/280 (16%)
Query: 68  FSSENLVGRGGYAEVYKGV-LQDGEEIAVKRLTKV-VTDDRKEKEFLTEIGTIGHVCHPN 125
           FS    +G G +  VY    +++ E +A+K+++      + K ++ + E+  +  + HPN
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 126 VLSLLGCCV-DNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKG 184
            +   GC + ++  +L+ ++   GS + L      P  E ++   +  G  +GL YLH  
Sbjct: 116 TIQYRGCYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIA-AVTHGALQGLAYLHS- 172
Query: 185 CQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIE---GTFGHLAPEY 241
               +IHRD+K+ NILL+     ++ DFG A  +         AP     GT   +APE 
Sbjct: 173 --HNMIHRDVKAGNILLSEPGLVKLGDFGSASIM---------APANXFVGTPYWMAPEV 221
Query: 242 FM---HGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLV---- 294
            +    G  D K DV++ G+  +E ++ RKP             P+ N   +  L     
Sbjct: 222 ILAMDEGQYDGKVDVWSLGITCIE-LAERKP-------------PLFNMNAMSALYHIAQ 267
Query: 295 --DPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVL 332
              P LQ  +          +   C++  P  RPT SEVL
Sbjct: 268 NESPALQSGHWSEYFRNFVDS---CLQKIPQDRPT-SEVL 303

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 73/280 (26%), Positives = 124/280 (44%), Gaps = 47/280 (16%)
Query: 68  FSSENLVGRGGYAEVYKGV-LQDGEEIAVKRLTKV-VTDDRKEKEFLTEIGTIGHVCHPN 125
           FS    +G G +  VY    +++ E +A+K+++      + K ++ + E+  +  + HPN
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 126 VLSLLGCCV-DNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKG 184
            +   GC + ++  +L+ ++   GS + L      P  E ++   +  G  +GL YLH  
Sbjct: 77  TIQYRGCYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIA-AVTHGALQGLAYLHS- 133
Query: 185 CQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIE---GTFGHLAPEY 241
               +IHRD+K+ NILL+     ++ DFG A  +         AP     GT   +APE 
Sbjct: 134 --HNMIHRDVKAGNILLSEPGLVKLGDFGSASIM---------APANXFVGTPYWMAPEV 182
Query: 242 FM---HGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLV---- 294
            +    G  D K DV++ G+  +E ++ RKP             P+ N   +  L     
Sbjct: 183 ILAMDEGQYDGKVDVWSLGITCIE-LAERKP-------------PLFNMNAMSALYHIAQ 228
Query: 295 --DPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVL 332
              P LQ  +          +   C++  P  RPT SEVL
Sbjct: 229 NESPALQSGHWSEYFRNFVDS---CLQKIPQDRPT-SEVL 264

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 100/216 (46%), Gaps = 15/216 (6%)
Query: 62  SIATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTK--VVTDDRKEKEFLTEIGTIG 119
           S+    F    ++GRG YA+V    L+  + I   R+ K  +V DD       TE     
Sbjct: 48  SLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFE 107
Query: 120 HVC-HPNVLSLLGCC-VDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARG 177
               HP ++ L  C   ++ L+ + ++ + G +  +FH      +  +     +   +  
Sbjct: 108 QASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSAEISLA 165
Query: 178 LHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAK--WLPSQWTHHSIAPIEGTFG 235
           L+YLH   +R II+RD+K  N+LL ++   +++D+G+ K    P   T    +   GT  
Sbjct: 166 LNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT----STFCGTPN 218
Query: 236 HLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVD 271
           ++APE           D +A GV + E+++GR P D
Sbjct: 219 YIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 254

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 97/210 (46%), Gaps = 25/210 (11%)
Query: 74  VGRGGYAEVYKGVLQDGE------EIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVL 127
           +G G + EVY+G +          ++AVK L +V ++ + E +FL E   I    H N++
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSE-QDELDFLMEALIISKFNHQNIV 111
Query: 128 SLLGCCVDN-GLYLIFQFSSRGSVASLFHDVN------SPGVEWKVRHKIAVGTARGLHY 180
             +G  + +   +++ +  + G + S   +        S      + H +A   A G  Y
Sbjct: 112 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH-VARDIACGCQY 170
Query: 181 LHKGCQRRIIHRDIKSSNILLTADFE---PQISDFGLAK--WLPSQWTHHSIAPIEGTFG 235
           L    +   IHRDI + N LLT        +I DFG+A+  +  S +     A +   + 
Sbjct: 171 LE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW- 226
Query: 236 HLAPEYFMHGIVDEKTDVFAFGVFLLEIIS 265
            + PE FM GI   KTD ++FGV L EI S
Sbjct: 227 -MPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 101/212 (47%), Gaps = 21/212 (9%)
Query: 73  LVGRGGYAEVYKGV-LQDGEEIAVKRL-TKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLL 130
           ++G GG +EV+    L+D  ++AVK L   +  D      F  E      + HP ++++ 
Sbjct: 19  ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 131 GCCVDNG---------LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYL 181
               D G          Y++ ++    ++  + H    P    +    IA    + L++ 
Sbjct: 79  ----DTGEAETPAGPLPYIVMEYVDGVTLRDIVH-TEGPMTPKRAIEVIA-DACQALNFS 132
Query: 182 HKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLP-SQWTHHSIAPIEGTFGHLAPE 240
           H   Q  IIHRD+K +NI+++A    ++ DFG+A+ +  S  +    A + GT  +L+PE
Sbjct: 133 H---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 189
Query: 241 YFMHGIVDEKTDVFAFGVFLLEIISGRKPVDG 272
                 VD ++DV++ G  L E+++G  P  G
Sbjct: 190 QARGDSVDARSDVYSLGCVLYEVLTGEPPFTG 221

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 97/214 (45%), Gaps = 15/214 (7%)
Query: 68  FSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNV 126
           F     +G G Y  VYK   +  GE +A+K++      +      + EI  +  + HPN+
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 66
Query: 127 LSLLGCC-VDNGLYLIFQFSSRGSVASLFHDVNS-PGVEWKVRHKIAVGTARGLHYLHKG 184
           + LL     +N LYL+F+F S       F D ++  G+   +         +GL + H  
Sbjct: 67  VKLLDVIHTENKLYLVFEFLSMD--LKDFMDASALTGIPLPLIKSYLFQLLQGLAFCH-- 122
Query: 185 CQRRIIHRDIKSSNILLTADFEPQISDFGLAKW--LPSQWTHHSIAPIEGTFGHLAPEYF 242
              R++HRD+K  N+L+  +   +++DFGLA+   +P +   H +     T  + APE  
Sbjct: 123 -SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAPEIL 177
Query: 243 MH-GIVDEKTDVFAFGVFLLEIISGRKPVDGSHQ 275
           +         D+++ G    E+++ R    G  +
Sbjct: 178 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE 211

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/176 (29%), Positives = 82/176 (46%), Gaps = 28/176 (15%)
Query: 60  EISIATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKE---------KE 110
           E+    + ++ +  +  G Y  V  GV  +G  +A+KR+   V+D R           K 
Sbjct: 16  ELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKR 75
Query: 111 FLTEIGTIGHVCHPNVLSLLGCCVD------NGLYLIFQFSSRGSVASLFHD---VNSPG 161
            L EI  + H  HPN+L L    V       + LYL+ +   R  +A + HD   V SP 
Sbjct: 76  VLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTEL-MRTDLAQVIHDQRIVISPQ 134
Query: 162 -VEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAK 216
            +++ + H +      GLH LH+     ++HRD+   NILL  + +  I DF LA+
Sbjct: 135 HIQYFMYHILL-----GLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAR 182

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/227 (28%), Positives = 101/227 (44%), Gaps = 38/227 (16%)
Query: 61  ISIATNAFSSENLVGRGGYAEVYKGVLQD-GEEIAVKRLTKVVTDDRK-------EKEFL 112
           I +  N FS   ++GRGG+ EVY     D G+  A+K L K     ++       E+  L
Sbjct: 184 IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIML 243
Query: 113 TEIGT--------IGHVCH-PNVLSLLGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVE 163
           + + T        + +  H P+ LS +   + NG  L +  S  G  +           E
Sbjct: 244 SLVSTGDCPFIVCMSYAFHTPDKLSFI-LDLMNGGDLHYHLSQHGVFS-----------E 291
Query: 164 WKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWT 223
             +R   A     GL ++H    R +++RD+K +NILL      +ISD GLA     +  
Sbjct: 292 ADMRF-YAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP 347
Query: 224 HHSIAPIEGTFGHLAPEYFMHGIV-DEKTDVFAFGVFLLEIISGRKP 269
           H S+    GT G++APE    G+  D   D F+ G  L +++ G  P
Sbjct: 348 HASV----GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 101/212 (47%), Gaps = 21/212 (9%)
Query: 73  LVGRGGYAEVYKGV-LQDGEEIAVKRL-TKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLL 130
           ++G GG +EV+    L+D  ++AVK L   +  D      F  E      + HP ++++ 
Sbjct: 19  ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 131 GCCVDNG---------LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYL 181
               D G          Y++ ++    ++  + H    P    +    IA    + L++ 
Sbjct: 79  ----DTGEAETPAGPLPYIVMEYVDGVTLRDIVH-TEGPMTPKRAIEVIA-DACQALNFS 132
Query: 182 HKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLP-SQWTHHSIAPIEGTFGHLAPE 240
           H   Q  IIHRD+K +NI+++A    ++ DFG+A+ +  S  +    A + GT  +L+PE
Sbjct: 133 H---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 189
Query: 241 YFMHGIVDEKTDVFAFGVFLLEIISGRKPVDG 272
                 VD ++DV++ G  L E+++G  P  G
Sbjct: 190 QARGDSVDARSDVYSLGCVLYEVLTGEPPFTG 221

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/227 (28%), Positives = 101/227 (44%), Gaps = 38/227 (16%)
Query: 61  ISIATNAFSSENLVGRGGYAEVYKGVLQD-GEEIAVKRLTKVVTDDRK-------EKEFL 112
           I +  N FS   ++GRGG+ EVY     D G+  A+K L K     ++       E+  L
Sbjct: 183 IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIML 242
Query: 113 TEIGT--------IGHVCH-PNVLSLLGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVE 163
           + + T        + +  H P+ LS +   + NG  L +  S  G  +           E
Sbjct: 243 SLVSTGDCPFIVCMSYAFHTPDKLSFI-LDLMNGGDLHYHLSQHGVFS-----------E 290
Query: 164 WKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWT 223
             +R   A     GL ++H    R +++RD+K +NILL      +ISD GLA     +  
Sbjct: 291 ADMRF-YAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP 346
Query: 224 HHSIAPIEGTFGHLAPEYFMHGIV-DEKTDVFAFGVFLLEIISGRKP 269
           H S+    GT G++APE    G+  D   D F+ G  L +++ G  P
Sbjct: 347 HASV----GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 389

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 94/210 (44%), Gaps = 23/210 (10%)
Query: 74  VGRGGYAEVYKGVLQD-GEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSL--- 129
           +G GG+  V + + QD GE++A+K+  + ++   +E+ +  EI  +  + HPNV+S    
Sbjct: 23  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRER-WCLEIQIMKKLNHPNVVSAREV 81
Query: 130 ---LGCCVDNGLYLI-FQFSSRGSVASLFHDV-NSPGVEWKVRHKIAVGTARGLHYLHKG 184
              L     N L L+  ++   G +    +   N  G++      +    +  L YLH+ 
Sbjct: 82  PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN 141
Query: 185 CQRRIIHRDIKSSNILLTADFEPQ-----ISDFGLAKWLPSQWTHHSIAPIEGTFGHLAP 239
              RIIHRD+K  NI+L     PQ     I D G AK L             GT  +LAP
Sbjct: 142 ---RIIHRDLKPENIVLQPG--PQRLIHKIIDLGYAKELDQ---GELCTEFVGTLQYLAP 193
Query: 240 EYFMHGIVDEKTDVFAFGVFLLEIISGRKP 269
           E           D ++FG    E I+G +P
Sbjct: 194 ELLEQKKYTVTVDYWSFGTLAFECITGFRP 223

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 97/214 (45%), Gaps = 15/214 (7%)
Query: 68  FSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNV 126
           F     +G G Y  VYK   +  GE +A+K++      +      + EI  +  + HPN+
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 127 LSLLGCC-VDNGLYLIFQFSSRGSVASLFHDVNS-PGVEWKVRHKIAVGTARGLHYLHKG 184
           + LL     +N LYL+F+F S       F D ++  G+   +         +GL + H  
Sbjct: 68  VKLLDVIHTENKLYLVFEFLSMD--LKDFMDASALTGIPLPLIKSYLFQLLQGLAFCH-- 123
Query: 185 CQRRIIHRDIKSSNILLTADFEPQISDFGLAKW--LPSQWTHHSIAPIEGTFGHLAPEYF 242
              R++HRD+K  N+L+  +   +++DFGLA+   +P +   H +     T  + APE  
Sbjct: 124 -SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAPEIL 178
Query: 243 MH-GIVDEKTDVFAFGVFLLEIISGRKPVDGSHQ 275
           +         D+++ G    E+++ R    G  +
Sbjct: 179 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE 212

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 94/210 (44%), Gaps = 23/210 (10%)
Query: 74  VGRGGYAEVYKGVLQD-GEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSL--- 129
           +G GG+  V + + QD GE++A+K+  + ++   +E+ +  EI  +  + HPNV+S    
Sbjct: 22  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRER-WCLEIQIMKKLNHPNVVSAREV 80
Query: 130 ---LGCCVDNGLYLI-FQFSSRGSVASLFHDV-NSPGVEWKVRHKIAVGTARGLHYLHKG 184
              L     N L L+  ++   G +    +   N  G++      +    +  L YLH+ 
Sbjct: 81  PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN 140
Query: 185 CQRRIIHRDIKSSNILLTADFEPQ-----ISDFGLAKWLPSQWTHHSIAPIEGTFGHLAP 239
              RIIHRD+K  NI+L     PQ     I D G AK L             GT  +LAP
Sbjct: 141 ---RIIHRDLKPENIVLQPG--PQRLIHKIIDLGYAKELDQ---GELCTEFVGTLQYLAP 192
Query: 240 EYFMHGIVDEKTDVFAFGVFLLEIISGRKP 269
           E           D ++FG    E I+G +P
Sbjct: 193 ELLEQKKYTVTVDYWSFGTLAFECITGFRP 222

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 109/221 (49%), Gaps = 25/221 (11%)
Query: 71  ENLVGRGGYAEVYKGVLQ-DGEE---IAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNV 126
           E ++G G + EV  G L+  G+    +A+K L KV   +++ ++FL E   +G   HPNV
Sbjct: 48  ERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTL-KVGYTEKQRRDFLCEASIMGQFDHPNV 106
Query: 127 LSLLGCCV-DNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAV--GTARGLHYLHK 183
           + L G       + ++ +F   G++ +     +    ++ V   + +  G A G+ YL  
Sbjct: 107 VHLEGVVTRGKPVMIVIEFMENGALDAFLRKHDG---QFTVIQLVGMLRGIAAGMRYL-- 161
Query: 184 GCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQ-----WTHHSIAPIEGTFGHLA 238
                 +HRD+ + NIL+ ++   ++SDFGL++ +         T     P+  T    A
Sbjct: 162 -ADMGYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTTGGKIPVRWT----A 216
Query: 239 PEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPV-DGSHQSL 277
           PE   +      +DV+++G+ + E++S G +P  D S+Q +
Sbjct: 217 PEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDV 257

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/227 (28%), Positives = 101/227 (44%), Gaps = 38/227 (16%)
Query: 61  ISIATNAFSSENLVGRGGYAEVYKGVLQD-GEEIAVKRLTKVVTDDRK-------EKEFL 112
           I +  N FS   ++GRGG+ EVY     D G+  A+K L K     ++       E+  L
Sbjct: 184 IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIML 243
Query: 113 TEIGT--------IGHVCH-PNVLSLLGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVE 163
           + + T        + +  H P+ LS +   + NG  L +  S  G  +           E
Sbjct: 244 SLVSTGDCPFIVCMSYAFHTPDKLSFI-LDLMNGGDLHYHLSQHGVFS-----------E 291
Query: 164 WKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWT 223
             +R   A     GL ++H    R +++RD+K +NILL      +ISD GLA     +  
Sbjct: 292 ADMRF-YAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP 347
Query: 224 HHSIAPIEGTFGHLAPEYFMHGIV-DEKTDVFAFGVFLLEIISGRKP 269
           H S+    GT G++APE    G+  D   D F+ G  L +++ G  P
Sbjct: 348 HASV----GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/227 (28%), Positives = 101/227 (44%), Gaps = 38/227 (16%)
Query: 61  ISIATNAFSSENLVGRGGYAEVYKGVLQD-GEEIAVKRLTKVVTDDRK-------EKEFL 112
           I +  N FS   ++GRGG+ EVY     D G+  A+K L K     ++       E+  L
Sbjct: 184 IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIML 243
Query: 113 TEIGT--------IGHVCH-PNVLSLLGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVE 163
           + + T        + +  H P+ LS +   + NG  L +  S  G  +           E
Sbjct: 244 SLVSTGDCPFIVCMSYAFHTPDKLSFI-LDLMNGGDLHYHLSQHGVFS-----------E 291
Query: 164 WKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWT 223
             +R   A     GL ++H    R +++RD+K +NILL      +ISD GLA     +  
Sbjct: 292 ADMRF-YAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP 347
Query: 224 HHSIAPIEGTFGHLAPEYFMHGIV-DEKTDVFAFGVFLLEIISGRKP 269
           H S+    GT G++APE    G+  D   D F+ G  L +++ G  P
Sbjct: 348 HASV----GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 95/206 (46%), Gaps = 15/206 (7%)
Query: 68  FSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNV 126
           F     +G G Y  VYK   +  GE +A+K++      +      + EI  +  + HPN+
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 127 LSLLGCC-VDNGLYLIFQFSSRGSVASLFHDVNS-PGVEWKVRHKIAVGTARGLHYLHKG 184
           + LL     +N LYL+F+F  +      F D ++  G+   +         +GL + H  
Sbjct: 68  VKLLDVIHTENKLYLVFEFLHQD--LKTFMDASALTGIPLPLIKSYLFQLLQGLAFCH-- 123
Query: 185 CQRRIIHRDIKSSNILLTADFEPQISDFGLAKW--LPSQWTHHSIAPIEGTFGHLAPEYF 242
              R++HRD+K  N+L+  +   +++DFGLA+   +P +   H +     T  + APE  
Sbjct: 124 -SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAPEIL 178
Query: 243 MH-GIVDEKTDVFAFGVFLLEIISGR 267
           +         D+++ G    E+++ R
Sbjct: 179 LGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 72/294 (24%), Positives = 128/294 (43%), Gaps = 37/294 (12%)
Query: 66  NAFSSENLVGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHP 124
             + S   VG G Y  V   +  + GE++A+K+L++    +   K    E+  + H+ H 
Sbjct: 42  KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHE 101
Query: 125 NVLSLLGCCVDNG-------LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARG 177
           NV+ LL               YL+  F        +  + +   +++ V   +     +G
Sbjct: 102 NVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGMEFSEEKIQYLVYQML-----KG 156
Query: 178 LHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHL 237
           L Y+H      ++HRD+K  N+ +  D E +I DFGLA+   ++ T + +     T  + 
Sbjct: 157 LKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVV-----TRWYR 208
Query: 238 APEYFMHGI-VDEKTDVFAFGVFLLEIISGRKPVDGSH------QSLHSWAKPILNQGEI 290
           APE  +  +  ++  D+++ G  + E+++G+    G        Q L     P      +
Sbjct: 209 APEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVP--GTEFV 266
Query: 291 EKLVDPRLQGAYD-VTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEGDQIDK 343
           +KL D   +     + Q  R  F   L  RAS    P  +++LE MLE D +DK
Sbjct: 267 QKLNDKAAKSYIQSLPQTPRKDF-TQLFPRAS----PQAADLLEKMLELD-VDK 314

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 67/211 (31%), Positives = 100/211 (47%), Gaps = 31/211 (14%)
Query: 74  VGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFL--TEIGTIGHVCHPNVLSLLG 131
           VG+G Y EV++G  Q GE +AVK     +   R EK +   TE+     + H N+L  + 
Sbjct: 16  VGKGRYGEVWRGSWQ-GENVAVK-----IFSSRDEKSWFRETELYNTVMLRHENILGFIA 69
Query: 132 CCV-----DNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHK--- 183
             +        L+LI  +   GS+           V      +I +  A GL +LH    
Sbjct: 70  SDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCL---RIVLSIASGLAHLHIEIF 126
Query: 184 GCQRR--IIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHH---SIAPIEGTFGHLA 238
           G Q +  I HRD+KS NIL+  + +  I+D GLA  + SQ T+       P  GT  ++A
Sbjct: 127 GTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAV-MHSQSTNQLDVGNNPRVGTKRYMA 185
Query: 239 PEYFMHGI-VD-----EKTDVFAFGVFLLEI 263
           PE     I VD     ++ D++AFG+ L E+
Sbjct: 186 PEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 95/206 (46%), Gaps = 15/206 (7%)
Query: 68  FSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNV 126
           F     +G G Y  VYK   +  GE +A+K++      +      + EI  +  + HPN+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 127 LSLLGCC-VDNGLYLIFQFSSRGSVASLFHDVNS-PGVEWKVRHKIAVGTARGLHYLHKG 184
           + LL     +N LYL+F+F  +      F D ++  G+   +         +GL + H  
Sbjct: 65  VKLLDVIHTENKLYLVFEFLHQD--LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH-- 120
Query: 185 CQRRIIHRDIKSSNILLTADFEPQISDFGLAKW--LPSQWTHHSIAPIEGTFGHLAPEYF 242
              R++HRD+K  N+L+  +   +++DFGLA+   +P +   H +     T  + APE  
Sbjct: 121 -SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV----TLWYRAPEIL 175
Query: 243 M-HGIVDEKTDVFAFGVFLLEIISGR 267
           +         D+++ G    E+++ R
Sbjct: 176 LGXKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 95/206 (46%), Gaps = 15/206 (7%)
Query: 68  FSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNV 126
           F     +G G Y  VYK   +  GE +A+K++      +      + EI  +  + HPN+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 127 LSLLGCC-VDNGLYLIFQFSSRGSVASLFHDVNS-PGVEWKVRHKIAVGTARGLHYLHKG 184
           + LL     +N LYL+F+F  +      F D ++  G+   +         +GL + H  
Sbjct: 65  VKLLDVIHTENKLYLVFEFLHQD--LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH-- 120
Query: 185 CQRRIIHRDIKSSNILLTADFEPQISDFGLAKW--LPSQWTHHSIAPIEGTFGHLAPEYF 242
              R++HRD+K  N+L+  +   +++DFGLA+   +P +   H +     T  + APE  
Sbjct: 121 -SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAPEIL 175
Query: 243 MH-GIVDEKTDVFAFGVFLLEIISGR 267
           +         D+++ G    E+++ R
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 53/214 (24%), Positives = 97/214 (45%), Gaps = 15/214 (7%)
Query: 68  FSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNV 126
           F     +G G Y  VYK   +  GE +A+K++      +      + EI  +  + HPN+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 127 LSLLGCC-VDNGLYLIFQFSSRGSVASLFHDVNS-PGVEWKVRHKIAVGTARGLHYLHKG 184
           + LL     +N LYL+F+F  +      F D ++  G+   +         +GL + H  
Sbjct: 65  VKLLDVIHTENKLYLVFEFLHQD--LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH-- 120
Query: 185 CQRRIIHRDIKSSNILLTADFEPQISDFGLAKW--LPSQWTHHSIAPIEGTFGHLAPEYF 242
              R++HRD+K  N+L+  +   +++DFGLA+   +P +   H +     T  + APE  
Sbjct: 121 -SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAPEIL 175
Query: 243 MH-GIVDEKTDVFAFGVFLLEIISGRKPVDGSHQ 275
           +         D+++ G    E+++ R    G  +
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE 209

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 95/206 (46%), Gaps = 15/206 (7%)
Query: 68  FSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNV 126
           F     +G G Y  VYK   +  GE +A+K++      +      + EI  +  + HPN+
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 66
Query: 127 LSLLGCC-VDNGLYLIFQFSSRGSVASLFHDVNS-PGVEWKVRHKIAVGTARGLHYLHKG 184
           + LL     +N LYL+F+F  +      F D ++  G+   +         +GL + H  
Sbjct: 67  VKLLDVIHTENKLYLVFEFLHQD--LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH-- 122
Query: 185 CQRRIIHRDIKSSNILLTADFEPQISDFGLAKW--LPSQWTHHSIAPIEGTFGHLAPEYF 242
              R++HRD+K  N+L+  +   +++DFGLA+   +P +   H +     T  + APE  
Sbjct: 123 -SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAPEIL 177
Query: 243 MH-GIVDEKTDVFAFGVFLLEIISGR 267
           +         D+++ G    E+++ R
Sbjct: 178 LGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 95/206 (46%), Gaps = 15/206 (7%)
Query: 68  FSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNV 126
           F     +G G Y  VYK   +  GE +A+K++      +      + EI  +  + HPN+
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 127 LSLLGCC-VDNGLYLIFQFSSRGSVASLFHDVNS-PGVEWKVRHKIAVGTARGLHYLHKG 184
           + LL     +N LYL+F+F  +      F D ++  G+   +         +GL + H  
Sbjct: 68  VKLLDVIHTENKLYLVFEFLHQD--LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH-- 123
Query: 185 CQRRIIHRDIKSSNILLTADFEPQISDFGLAKW--LPSQWTHHSIAPIEGTFGHLAPEYF 242
              R++HRD+K  N+L+  +   +++DFGLA+   +P +   H +     T  + APE  
Sbjct: 124 -SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAPEIL 178
Query: 243 MH-GIVDEKTDVFAFGVFLLEIISGR 267
           +         D+++ G    E+++ R
Sbjct: 179 LGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 95/206 (46%), Gaps = 15/206 (7%)
Query: 68  FSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNV 126
           F     +G G Y  VYK   +  GE +A+K++      +      + EI  +  + HPN+
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 66
Query: 127 LSLLGCC-VDNGLYLIFQFSSRGSVASLFHDVNS-PGVEWKVRHKIAVGTARGLHYLHKG 184
           + LL     +N LYL+F+F  +      F D ++  G+   +         +GL + H  
Sbjct: 67  VKLLDVIHTENKLYLVFEFLHQD--LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH-- 122
Query: 185 CQRRIIHRDIKSSNILLTADFEPQISDFGLAKW--LPSQWTHHSIAPIEGTFGHLAPEYF 242
              R++HRD+K  N+L+  +   +++DFGLA+   +P +   H +     T  + APE  
Sbjct: 123 -SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAPEIL 177
Query: 243 MH-GIVDEKTDVFAFGVFLLEIISGR 267
           +         D+++ G    E+++ R
Sbjct: 178 LGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 95/206 (46%), Gaps = 15/206 (7%)
Query: 68  FSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNV 126
           F     +G G Y  VYK   +  GE +A+K++      +      + EI  +  + HPN+
Sbjct: 12  FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 71
Query: 127 LSLLGCC-VDNGLYLIFQFSSRGSVASLFHDVNS-PGVEWKVRHKIAVGTARGLHYLHKG 184
           + LL     +N LYL+F+F  +      F D ++  G+   +         +GL + H  
Sbjct: 72  VKLLDVIHTENKLYLVFEFLHQD--LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH-- 127
Query: 185 CQRRIIHRDIKSSNILLTADFEPQISDFGLAKW--LPSQWTHHSIAPIEGTFGHLAPEYF 242
              R++HRD+K  N+L+  +   +++DFGLA+   +P +   H +     T  + APE  
Sbjct: 128 -SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV----TLWYRAPEIL 182
Query: 243 M-HGIVDEKTDVFAFGVFLLEIISGR 267
           +         D+++ G    E+++ R
Sbjct: 183 LGXKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 95/206 (46%), Gaps = 15/206 (7%)
Query: 68  FSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNV 126
           F     +G G Y  VYK   +  GE +A+K++      +      + EI  +  + HPN+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 127 LSLLGCC-VDNGLYLIFQFSSRGSVASLFHDVNS-PGVEWKVRHKIAVGTARGLHYLHKG 184
           + LL     +N LYL+F+F  +      F D ++  G+   +         +GL + H  
Sbjct: 65  VKLLDVIHTENKLYLVFEFLHQD--LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH-- 120
Query: 185 CQRRIIHRDIKSSNILLTADFEPQISDFGLAKW--LPSQWTHHSIAPIEGTFGHLAPEYF 242
              R++HRD+K  N+L+  +   +++DFGLA+   +P +   H +     T  + APE  
Sbjct: 121 -SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAPEIL 175
Query: 243 MH-GIVDEKTDVFAFGVFLLEIISGR 267
           +         D+++ G    E+++ R
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 95/206 (46%), Gaps = 15/206 (7%)
Query: 68  FSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNV 126
           F     +G G Y  VYK   +  GE +A+K++      +      + EI  +  + HPN+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 127 LSLLGCC-VDNGLYLIFQFSSRGSVASLFHDVNS-PGVEWKVRHKIAVGTARGLHYLHKG 184
           + LL     +N LYL+F+F  +      F D ++  G+   +         +GL + H  
Sbjct: 64  VKLLDVIHTENKLYLVFEFLHQD--LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH-- 119
Query: 185 CQRRIIHRDIKSSNILLTADFEPQISDFGLAKW--LPSQWTHHSIAPIEGTFGHLAPEYF 242
              R++HRD+K  N+L+  +   +++DFGLA+   +P +   H +     T  + APE  
Sbjct: 120 -SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAPEIL 174
Query: 243 MH-GIVDEKTDVFAFGVFLLEIISGR 267
           +         D+++ G    E+++ R
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 89/197 (45%), Gaps = 13/197 (6%)
Query: 74  VGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCC 133
           +G G Y  VYK     GE  A+K++     D+      + EI  +  + H N++ L    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 134 -VDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHR 192
                L L+F+   +     L  DV   G+E        +    G+ Y H    RR++HR
Sbjct: 70  HTKKRLVLVFEHLDQDLKKLL--DVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHR 124
Query: 193 DIKSSNILLTADFEPQISDFGLAKW--LPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEK 250
           D+K  N+L+  + E +I+DFGLA+   +P +   H I     T  + AP+  M       
Sbjct: 125 DLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV----TLWYRAPDVLMGSKKYST 180
Query: 251 T-DVFAFGVFLLEIISG 266
           T D+++ G    E+++G
Sbjct: 181 TIDIWSVGCIFAEMVNG 197

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 95/206 (46%), Gaps = 15/206 (7%)
Query: 68  FSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNV 126
           F     +G G Y  VYK   +  GE +A+K++      +      + EI  +  + HPN+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 127 LSLLGCC-VDNGLYLIFQFSSRGSVASLFHDVNS-PGVEWKVRHKIAVGTARGLHYLHKG 184
           + LL     +N LYL+F+F  +      F D ++  G+   +         +GL + H  
Sbjct: 64  VKLLDVIHTENKLYLVFEFLHQD--LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH-- 119
Query: 185 CQRRIIHRDIKSSNILLTADFEPQISDFGLAKW--LPSQWTHHSIAPIEGTFGHLAPEYF 242
              R++HRD+K  N+L+  +   +++DFGLA+   +P +   H +     T  + APE  
Sbjct: 120 -SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAPEIL 174
Query: 243 MH-GIVDEKTDVFAFGVFLLEIISGR 267
           +         D+++ G    E+++ R
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 95/206 (46%), Gaps = 15/206 (7%)
Query: 68  FSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNV 126
           F     +G G Y  VYK   +  GE +A+K++      +      + EI  +  + HPN+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 127 LSLLGCC-VDNGLYLIFQFSSRGSVASLFHDVNS-PGVEWKVRHKIAVGTARGLHYLHKG 184
           + LL     +N LYL+F+F  +      F D ++  G+   +         +GL + H  
Sbjct: 65  VKLLDVIHTENKLYLVFEFLHQD--LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH-- 120
Query: 185 CQRRIIHRDIKSSNILLTADFEPQISDFGLAKW--LPSQWTHHSIAPIEGTFGHLAPEYF 242
              R++HRD+K  N+L+  +   +++DFGLA+   +P +   H +     T  + APE  
Sbjct: 121 -SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAPEIL 175
Query: 243 MH-GIVDEKTDVFAFGVFLLEIISGR 267
           +         D+++ G    E+++ R
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 100/220 (45%), Gaps = 33/220 (15%)
Query: 75  GRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLL---- 130
            RG +  V+K  L + + +AVK        D++  +   EI +   + H N+L  +    
Sbjct: 24  ARGRFGCVWKAQLMN-DFVAVKIFP---LQDKQSWQSEREIFSTPGMKHENLLQFIAAEK 79
Query: 131 -GCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHK------ 183
            G  ++  L+LI  F  +GS+      +    + W     +A   +RGL YLH+      
Sbjct: 80  RGSNLEVELWLITAFHDKGSLTDY---LKGNIITWNELCHVAETMSRGLSYLHEDVPWCR 136
Query: 184 --GCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWL----PSQWTHHSIAPIEGTFGHL 237
             G +  I HRD KS N+LL +D    ++DFGLA       P   TH  +    GT  ++
Sbjct: 137 GEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQV----GTRRYM 192
Query: 238 APEYFMHGIVDE-----KTDVFAFGVFLLEIISGRKPVDG 272
           APE     I  +     + D++A G+ L E++S  K  DG
Sbjct: 193 APEVLEGAINFQRDAFLRIDMYAMGLVLWELVSRCKAADG 232

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 67/211 (31%), Positives = 100/211 (47%), Gaps = 31/211 (14%)
Query: 74  VGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFL--TEIGTIGHVCHPNVLSLLG 131
           VG+G Y EV++G  Q GE +AVK     +   R EK +   TE+     + H N+L  + 
Sbjct: 16  VGKGRYGEVWRGSWQ-GENVAVK-----IFSSRDEKSWFRETELYNTVMLRHENILGFIA 69
Query: 132 CCV-----DNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHK--- 183
             +        L+LI  +   GS+           V      +I +  A GL +LH    
Sbjct: 70  SDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCL---RIVLSIASGLAHLHIEIF 126
Query: 184 GCQRR--IIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHH---SIAPIEGTFGHLA 238
           G Q +  I HRD+KS NIL+  + +  I+D GLA  + SQ T+       P  GT  ++A
Sbjct: 127 GTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAV-MHSQSTNQLDVGNNPRVGTKRYMA 185
Query: 239 PEYFMHGI-VD-----EKTDVFAFGVFLLEI 263
           PE     I VD     ++ D++AFG+ L E+
Sbjct: 186 PEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 91/201 (45%), Gaps = 15/201 (7%)
Query: 74  VGRGGYAEV---YKGVLQD--GEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLS 128
           +G+G +  V       LQD  GE +AVK+L    + +   ++F  EI  +  + H N++ 
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH--STEEHLRDFEREIEILKSLQHDNIVK 78
Query: 129 LLGCCVDNG---LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGC 185
             G C   G   L LI ++   GS+       ++  ++     +      +G+ YL    
Sbjct: 79  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ-AHAERIDHIKLLQYTSQICKGMEYL---G 134
Query: 186 QRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIA-PIEGTFGHLAPEYFMH 244
            +R IHRD+ + NIL+  +   +I DFGL K LP       +  P E      APE    
Sbjct: 135 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 194
Query: 245 GIVDEKTDVFAFGVFLLEIIS 265
                 +DV++FGV L E+ +
Sbjct: 195 SKFSVASDVWSFGVVLYELFT 215

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 95/206 (46%), Gaps = 15/206 (7%)
Query: 68  FSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNV 126
           F     +G G Y  VYK   +  GE +A+K++      +      + EI  +  + HPN+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 127 LSLLGCC-VDNGLYLIFQFSSRGSVASLFHDVNS-PGVEWKVRHKIAVGTARGLHYLHKG 184
           + LL     +N LYL+F+F  +      F D ++  G+   +         +GL + H  
Sbjct: 65  VKLLDVIHTENKLYLVFEFLHQD--LKKFMDASALTGIPLPLIKSYLFQLLQGLSFCH-- 120
Query: 185 CQRRIIHRDIKSSNILLTADFEPQISDFGLAKW--LPSQWTHHSIAPIEGTFGHLAPEYF 242
              R++HRD+K  N+L+  +   +++DFGLA+   +P +   H +     T  + APE  
Sbjct: 121 -SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV----TLWYRAPEIL 175
Query: 243 MH-GIVDEKTDVFAFGVFLLEIISGR 267
           +         D+++ G    E+++ R
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 95/206 (46%), Gaps = 15/206 (7%)
Query: 68  FSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNV 126
           F     +G G Y  VYK   +  GE +A+K++      +      + EI  +  + HPN+
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 66
Query: 127 LSLLGCC-VDNGLYLIFQFSSRGSVASLFHDVNS-PGVEWKVRHKIAVGTARGLHYLHKG 184
           + LL     +N LYL+F+F  +      F D ++  G+   +         +GL + H  
Sbjct: 67  VKLLDVIHTENKLYLVFEFLHQD--LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH-- 122
Query: 185 CQRRIIHRDIKSSNILLTADFEPQISDFGLAKW--LPSQWTHHSIAPIEGTFGHLAPEYF 242
              R++HRD+K  N+L+  +   +++DFGLA+   +P +   H +     T  + APE  
Sbjct: 123 -SHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAPEIL 177
Query: 243 MH-GIVDEKTDVFAFGVFLLEIISGR 267
           +         D+++ G    E+++ R
Sbjct: 178 LGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 95/206 (46%), Gaps = 15/206 (7%)
Query: 68  FSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNV 126
           F     +G G Y  VYK   +  GE +A+K++      +      + EI  +  + HPN+
Sbjct: 9   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 68
Query: 127 LSLLGCC-VDNGLYLIFQFSSRGSVASLFHDVNS-PGVEWKVRHKIAVGTARGLHYLHKG 184
           + LL     +N LYL+F+F  +      F D ++  G+   +         +GL + H  
Sbjct: 69  VKLLDVIHTENKLYLVFEFLHQD--LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH-- 124
Query: 185 CQRRIIHRDIKSSNILLTADFEPQISDFGLAKW--LPSQWTHHSIAPIEGTFGHLAPEYF 242
              R++HRD+K  N+L+  +   +++DFGLA+   +P +   H +     T  + APE  
Sbjct: 125 -SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAPEIL 179
Query: 243 MH-GIVDEKTDVFAFGVFLLEIISGR 267
           +         D+++ G    E+++ R
Sbjct: 180 LGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 67/211 (31%), Positives = 100/211 (47%), Gaps = 31/211 (14%)
Query: 74  VGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFL--TEIGTIGHVCHPNVLSLLG 131
           VG+G Y EV++G  Q GE +AVK     +   R EK +   TE+     + H N+L  + 
Sbjct: 45  VGKGRYGEVWRGSWQ-GENVAVK-----IFSSRDEKSWFRETELYNTVMLRHENILGFIA 98
Query: 132 CCV-----DNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHK--- 183
             +        L+LI  +   GS+           V      +I +  A GL +LH    
Sbjct: 99  SDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCL---RIVLSIASGLAHLHIEIF 155
Query: 184 GCQRR--IIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHH---SIAPIEGTFGHLA 238
           G Q +  I HRD+KS NIL+  + +  I+D GLA  + SQ T+       P  GT  ++A
Sbjct: 156 GTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAV-MHSQSTNQLDVGNNPRVGTKRYMA 214
Query: 239 PEYFMHGI-VD-----EKTDVFAFGVFLLEI 263
           PE     I VD     ++ D++AFG+ L E+
Sbjct: 215 PEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 245

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 102/210 (48%), Gaps = 15/210 (7%)
Query: 73  LVGRGGYAEVYKGVLQDGEEI-AVKRLTK-VVTDDRKEKEFLTEIGTIGHVCHPNVLSLL 130
           ++G+G + +V     +  +E+ AVK L K VV  D   +  + E   +     P  L+ L
Sbjct: 27  VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQL 86
Query: 131 GCCVD--NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKI--AVGTARGLHYLHKGCQ 186
             C    + LY + ++ + G    L + +   G  +K  H +  A   A GL +L     
Sbjct: 87  HSCFQTMDRLYFVMEYVNGGD---LMYHIQQVG-RFKEPHAVFYAAEIAIGLFFLQ---S 139
Query: 187 RRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGI 246
           + II+RD+K  N++L ++   +I+DFG+ K   + W   +     GT  ++APE   +  
Sbjct: 140 KGIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENIWDGVTTKXFCGTPDYIAPEIIAYQP 197
Query: 247 VDEKTDVFAFGVFLLEIISGRKPVDGSHQS 276
             +  D +AFGV L E+++G+ P +G  + 
Sbjct: 198 YGKSVDWWAFGVLLYEMLAGQAPFEGEDED 227

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 95/206 (46%), Gaps = 15/206 (7%)
Query: 68  FSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNV 126
           F     +G G Y  VYK   +  GE +A+K++      +      + EI  +  + HPN+
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 127 LSLLGCC-VDNGLYLIFQFSSRGSVASLFHDVNS-PGVEWKVRHKIAVGTARGLHYLHKG 184
           + LL     +N LYL+F+F  +      F D ++  G+   +         +GL + H  
Sbjct: 68  VKLLDVIHTENKLYLVFEFLHQD--LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH-- 123
Query: 185 CQRRIIHRDIKSSNILLTADFEPQISDFGLAKW--LPSQWTHHSIAPIEGTFGHLAPEYF 242
              R++HRD+K  N+L+  +   +++DFGLA+   +P +   H +     T  + APE  
Sbjct: 124 -SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAPEIL 178
Query: 243 MH-GIVDEKTDVFAFGVFLLEIISGR 267
           +         D+++ G    E+++ R
Sbjct: 179 LGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 53/214 (24%), Positives = 97/214 (45%), Gaps = 15/214 (7%)
Query: 68  FSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNV 126
           F     +G G Y  VYK   +  GE +A+K++      +      + EI  +  + HPN+
Sbjct: 12  FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 71
Query: 127 LSLLGCC-VDNGLYLIFQFSSRGSVASLFHDVNS-PGVEWKVRHKIAVGTARGLHYLHKG 184
           + LL     +N LYL+F+F  +      F D ++  G+   +         +GL + H  
Sbjct: 72  VKLLDVIHTENKLYLVFEFLHQD--LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH-- 127
Query: 185 CQRRIIHRDIKSSNILLTADFEPQISDFGLAKW--LPSQWTHHSIAPIEGTFGHLAPEYF 242
              R++HRD+K  N+L+  +   +++DFGLA+   +P +   H +     T  + APE  
Sbjct: 128 -SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV----TLWYRAPEIL 182
Query: 243 MH-GIVDEKTDVFAFGVFLLEIISGRKPVDGSHQ 275
           +         D+++ G    E+++ R    G  +
Sbjct: 183 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE 216

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 95/206 (46%), Gaps = 15/206 (7%)
Query: 68  FSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNV 126
           F     +G G Y  VYK   +  GE +A+K++      +      + EI  +  + HPN+
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 127 LSLLGCC-VDNGLYLIFQFSSRGSVASLFHDVNS-PGVEWKVRHKIAVGTARGLHYLHKG 184
           + LL     +N LYL+F+F  +      F D ++  G+   +         +GL + H  
Sbjct: 66  VKLLDVIHTENKLYLVFEFLHQD--LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH-- 121
Query: 185 CQRRIIHRDIKSSNILLTADFEPQISDFGLAKW--LPSQWTHHSIAPIEGTFGHLAPEYF 242
              R++HRD+K  N+L+  +   +++DFGLA+   +P +   H +     T  + APE  
Sbjct: 122 -SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAPEIL 176
Query: 243 MH-GIVDEKTDVFAFGVFLLEIISGR 267
           +         D+++ G    E+++ R
Sbjct: 177 LGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 53/214 (24%), Positives = 97/214 (45%), Gaps = 15/214 (7%)
Query: 68  FSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNV 126
           F     +G G Y  VYK   +  GE +A+K++      +      + EI  +  + HPN+
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 127 LSLLGCC-VDNGLYLIFQFSSRGSVASLFHDVNS-PGVEWKVRHKIAVGTARGLHYLHKG 184
           + LL     +N LYL+F+F  +      F D ++  G+   +         +GL + H  
Sbjct: 66  VKLLDVIHTENKLYLVFEFLHQD--LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH-- 121
Query: 185 CQRRIIHRDIKSSNILLTADFEPQISDFGLAKW--LPSQWTHHSIAPIEGTFGHLAPEYF 242
              R++HRD+K  N+L+  +   +++DFGLA+   +P +   H +     T  + APE  
Sbjct: 122 -SHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAPEIL 176
Query: 243 MH-GIVDEKTDVFAFGVFLLEIISGRKPVDGSHQ 275
           +         D+++ G    E+++ R    G  +
Sbjct: 177 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE 210

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 95/206 (46%), Gaps = 15/206 (7%)
Query: 68  FSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNV 126
           F     +G G Y  VYK   +  GE +A+K++      +      + EI  +  + HPN+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 127 LSLLGCC-VDNGLYLIFQFSSRGSVASLFHDVNS-PGVEWKVRHKIAVGTARGLHYLHKG 184
           + LL     +N LYL+F+F  +      F D ++  G+   +         +GL + H  
Sbjct: 65  VKLLDVIHTENKLYLVFEFLHQD--LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH-- 120
Query: 185 CQRRIIHRDIKSSNILLTADFEPQISDFGLAKW--LPSQWTHHSIAPIEGTFGHLAPEYF 242
              R++HRD+K  N+L+  +   +++DFGLA+   +P +   H +     T  + APE  
Sbjct: 121 -SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV----TLWYRAPEIL 175
Query: 243 MH-GIVDEKTDVFAFGVFLLEIISGR 267
           +         D+++ G    E+++ R
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 95/206 (46%), Gaps = 15/206 (7%)
Query: 68  FSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNV 126
           F     +G G Y  VYK   +  GE +A+K++      +      + EI  +  + HPN+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 127 LSLLGCC-VDNGLYLIFQFSSRGSVASLFHDVNS-PGVEWKVRHKIAVGTARGLHYLHKG 184
           + LL     +N LYL+F+F  +      F D ++  G+   +         +GL + H  
Sbjct: 64  VKLLDVIHTENKLYLVFEFLHQD--LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH-- 119
Query: 185 CQRRIIHRDIKSSNILLTADFEPQISDFGLAKW--LPSQWTHHSIAPIEGTFGHLAPEYF 242
              R++HRD+K  N+L+  +   +++DFGLA+   +P +   H +     T  + APE  
Sbjct: 120 -SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV----TLWYRAPEIL 174
Query: 243 MH-GIVDEKTDVFAFGVFLLEIISGR 267
           +         D+++ G    E+++ R
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 100/209 (47%), Gaps = 15/209 (7%)
Query: 73  LVGRGGYAEVYKGVLQDGEEI-AVKRLTK-VVTDDRKEKEFLTEIGTIGHVCHPNVLSLL 130
           ++G+G + +V     +  +E+ AVK L K VV  D   +  + E   +     P  L+ L
Sbjct: 348 VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQL 407
Query: 131 GCCVD--NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKI--AVGTARGLHYLHKGCQ 186
             C    + LY + ++ + G +      V      +K  H +  A   A GL +L     
Sbjct: 408 HSCFQTMDRLYFVMEYVNGGDLMYHIQQVG----RFKEPHAVFYAAEIAIGLFFLQ---S 460
Query: 187 RRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGI 246
           + II+RD+K  N++L ++   +I+DFG+ K   + W   +     GT  ++APE   +  
Sbjct: 461 KGIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENIWDGVTTKXFCGTPDYIAPEIIAYQP 518
Query: 247 VDEKTDVFAFGVFLLEIISGRKPVDGSHQ 275
             +  D +AFGV L E+++G+ P +G  +
Sbjct: 519 YGKSVDWWAFGVLLYEMLAGQAPFEGEDE 547

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 92/209 (44%), Gaps = 21/209 (10%)
Query: 74  VGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC 132
           VG G Y  V      + G  +AVK+L++        K    E+  + H+ H NV+ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 133 CVD-------NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGC 185
                     N +YL+         A L + V    +       +     RGL Y+H   
Sbjct: 90  FTPARSLEEFNDVYLVTHLMG----ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 144
Query: 186 QRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHG 245
              IIHRD+K SN+ +  D E +I DFGLA+      T   +A    T  + APE  ++ 
Sbjct: 145 --DIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMAGFVATRWYRAPEIMLNW 197
Query: 246 I-VDEKTDVFAFGVFLLEIISGRKPVDGS 273
           +  ++  D+++ G  + E+++GR    G+
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGT 226

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 92/209 (44%), Gaps = 21/209 (10%)
Query: 74  VGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC 132
           VG G Y  V      + G  +AVK+L++        K    E+  + H+ H NV+ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 133 CVD-------NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGC 185
                     N +YL+         A L + V    +       +     RGL Y+H   
Sbjct: 90  FTPARSLEEFNDVYLVTHLMG----ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 144
Query: 186 QRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHG 245
              IIHRD+K SN+ +  D E +I DFGLA+      T   +A    T  + APE  ++ 
Sbjct: 145 --DIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMAGFVATRWYRAPEIMLNW 197
Query: 246 I-VDEKTDVFAFGVFLLEIISGRKPVDGS 273
           +  ++  D+++ G  + E+++GR    G+
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGT 226

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 95/206 (46%), Gaps = 15/206 (7%)
Query: 68  FSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNV 126
           F     +G G Y  VYK   +  GE +A+K++      +      + EI  +  + HPN+
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 127 LSLLGCC-VDNGLYLIFQFSSRGSVASLFHDVNS-PGVEWKVRHKIAVGTARGLHYLHKG 184
           + LL     +N LYL+F+F  +      F D ++  G+   +         +GL + H  
Sbjct: 66  VKLLDVIHTENKLYLVFEFLHQD--LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH-- 121
Query: 185 CQRRIIHRDIKSSNILLTADFEPQISDFGLAKW--LPSQWTHHSIAPIEGTFGHLAPEYF 242
              R++HRD+K  N+L+  +   +++DFGLA+   +P +   H +     T  + APE  
Sbjct: 122 -SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV----TLWYRAPEIL 176
Query: 243 MH-GIVDEKTDVFAFGVFLLEIISGR 267
           +         D+++ G    E+++ R
Sbjct: 177 LGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 95/206 (46%), Gaps = 15/206 (7%)
Query: 68  FSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNV 126
           F     +G G Y  VYK   +  GE +A+K++      +      + EI  +  + HPN+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 127 LSLLGCC-VDNGLYLIFQFSSRGSVASLFHDVNS-PGVEWKVRHKIAVGTARGLHYLHKG 184
           + LL     +N LYL+F+F  +      F D ++  G+   +         +GL + H  
Sbjct: 65  VKLLDVIHTENKLYLVFEFLHQD--LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH-- 120
Query: 185 CQRRIIHRDIKSSNILLTADFEPQISDFGLAKW--LPSQWTHHSIAPIEGTFGHLAPEYF 242
              R++HRD+K  N+L+  +   +++DFGLA+   +P +   H +     T  + APE  
Sbjct: 121 -SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV----TLWYRAPEIL 175
Query: 243 MH-GIVDEKTDVFAFGVFLLEIISGR 267
           +         D+++ G    E+++ R
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 95/206 (46%), Gaps = 15/206 (7%)
Query: 68  FSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNV 126
           F     +G G Y  VYK   +  GE +A+K++      +      + EI  +  + HPN+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 127 LSLLGCC-VDNGLYLIFQFSSRGSVASLFHDVNS-PGVEWKVRHKIAVGTARGLHYLHKG 184
           + LL     +N LYL+F+F  +      F D ++  G+   +         +GL + H  
Sbjct: 64  VKLLDVIHTENKLYLVFEFLHQD--LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH-- 119
Query: 185 CQRRIIHRDIKSSNILLTADFEPQISDFGLAKW--LPSQWTHHSIAPIEGTFGHLAPEYF 242
              R++HRD+K  N+L+  +   +++DFGLA+   +P +   H +     T  + APE  
Sbjct: 120 -SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV----TLWYRAPEIL 174
Query: 243 MH-GIVDEKTDVFAFGVFLLEIISGR 267
           +         D+++ G    E+++ R
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 95/206 (46%), Gaps = 15/206 (7%)
Query: 68  FSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNV 126
           F     +G G Y  VYK   +  GE +A+K++      +      + EI  +  + HPN+
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 127 LSLLGCC-VDNGLYLIFQFSSRGSVASLFHDVNS-PGVEWKVRHKIAVGTARGLHYLHKG 184
           + LL     +N LYL+F+F  +      F D ++  G+   +         +GL + H  
Sbjct: 66  VKLLDVIHTENKLYLVFEFLHQD--LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH-- 121
Query: 185 CQRRIIHRDIKSSNILLTADFEPQISDFGLAKW--LPSQWTHHSIAPIEGTFGHLAPEYF 242
              R++HRD+K  N+L+  +   +++DFGLA+   +P +   H +     T  + APE  
Sbjct: 122 -SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAPEIL 176
Query: 243 MH-GIVDEKTDVFAFGVFLLEIISGR 267
           +         D+++ G    E+++ R
Sbjct: 177 LGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 104/220 (47%), Gaps = 23/220 (10%)
Query: 62  SIATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTK--VVTDDRKEKEFLTEIGTIG 119
           S+    F    ++GRG YA+V    L+  + I   ++ K  +V DD    E +  + T  
Sbjct: 16  SLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDD----EDIDWVQTEK 71
Query: 120 HVC-----HPNVLSLLGCC-VDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVG 173
           HV      HP ++ L  C   ++ L+ + ++ + G +  +FH      +  +     +  
Sbjct: 72  HVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSAE 129
Query: 174 TARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAK--WLPSQWTHHSIAPIE 231
            +  L+YLH   +R II+RD+K  N+LL ++   +++D+G+ K    P   T    +   
Sbjct: 130 ISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT----SXFC 182
Query: 232 GTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVD 271
           GT  ++APE           D +A GV + E+++GR P D
Sbjct: 183 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 222

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 95/206 (46%), Gaps = 15/206 (7%)
Query: 68  FSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNV 126
           F     +G G Y  VYK   +  GE +A+K++      +      + EI  +  + HPN+
Sbjct: 9   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 68
Query: 127 LSLLGCC-VDNGLYLIFQFSSRGSVASLFHDVNS-PGVEWKVRHKIAVGTARGLHYLHKG 184
           + LL     +N LYL+F+F  +      F D ++  G+   +         +GL + H  
Sbjct: 69  VKLLDVIHTENKLYLVFEFLHQD--LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH-- 124
Query: 185 CQRRIIHRDIKSSNILLTADFEPQISDFGLAKW--LPSQWTHHSIAPIEGTFGHLAPEYF 242
              R++HRD+K  N+L+  +   +++DFGLA+   +P +   H +     T  + APE  
Sbjct: 125 -SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV----TLWYRAPEIL 179
Query: 243 MH-GIVDEKTDVFAFGVFLLEIISGR 267
           +         D+++ G    E+++ R
Sbjct: 180 LGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 92/209 (44%), Gaps = 21/209 (10%)
Query: 74  VGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC 132
           VG G Y  V      + G  +AVK+L++        K    E+  + H+ H NV+ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 133 CVD-------NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGC 185
                     N +YL+         A L + V    +       +     RGL Y+H   
Sbjct: 90  FTPARSLEEFNDVYLVTHLMG----ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 144
Query: 186 QRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHG 245
              IIHRD+K SN+ +  D E +I DFGLA+    + T +       T  + APE  ++ 
Sbjct: 145 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYRAPEIMLNA 197
Query: 246 I-VDEKTDVFAFGVFLLEIISGRKPVDGS 273
           +  ++  D+++ G  + E+++GR    G+
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGT 226

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 92/209 (44%), Gaps = 21/209 (10%)
Query: 74  VGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC 132
           VG G Y  V      + G  +AVK+L++        K    E+  + H+ H NV+ LL  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 133 CVD-------NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGC 185
                     N +YL+         A L + V    +       +     RGL Y+H   
Sbjct: 86  FTPARSLEEFNDVYLVTHLMG----ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 140
Query: 186 QRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHG 245
              IIHRD+K SN+ +  D E +I DFGLA+      T   +A    T  + APE  ++ 
Sbjct: 141 --DIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMAGFVATRWYRAPEIMLNW 193
Query: 246 I-VDEKTDVFAFGVFLLEIISGRKPVDGS 273
           +  ++  D+++ G  + E+++GR    G+
Sbjct: 194 MHYNQTVDIWSVGCIMAELLTGRTLFPGT 222

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 95/206 (46%), Gaps = 15/206 (7%)
Query: 68  FSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNV 126
           F     +G G Y  VYK   +  GE +A+K++      +      + EI  +  + HPN+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 127 LSLLGCC-VDNGLYLIFQFSSRGSVASLFHDVNS-PGVEWKVRHKIAVGTARGLHYLHKG 184
           + LL     +N LYL+F+F  +      F D ++  G+   +         +GL + H  
Sbjct: 65  VKLLDVIHTENKLYLVFEFLHQD--LKDFMDASALTGIPLPLIKSYLFQLLQGLAFCH-- 120
Query: 185 CQRRIIHRDIKSSNILLTADFEPQISDFGLAKW--LPSQWTHHSIAPIEGTFGHLAPEYF 242
              R++HRD+K  N+L+  +   +++DFGLA+   +P +   H +     T  + APE  
Sbjct: 121 -SHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAPEIL 175
Query: 243 MH-GIVDEKTDVFAFGVFLLEIISGR 267
           +         D+++ G    E+++ R
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 94/198 (47%), Gaps = 14/198 (7%)
Query: 74  VGRGGYAEVYKGVLQD-GEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC 132
           +G G Y  V+K   +D G+ +A+K+  +   D   +K  L EI  +  + HPN+++LL  
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70
Query: 133 CV-DNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIH 191
                 L+L+F++     +  L  D    GV   +   I   T + +++ HK      IH
Sbjct: 71  FRRKRRLHLVFEYCDHTVLHEL--DRYQRGVPEHLVKSITWQTLQAVNFCHK---HNCIH 125
Query: 192 RDIKSSNILLTADFEPQISDFGLAKWL--PSQWTHHSIAPIEGTFGHLAPEYFMHGI-VD 248
           RD+K  NIL+T     ++ DFG A+ L  PS +    +A    T  + +PE  +      
Sbjct: 126 RDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVA----TRWYRSPELLVGDTQYG 181
Query: 249 EKTDVFAFGVFLLEIISG 266
              DV+A G    E++SG
Sbjct: 182 PPVDVWAIGCVFAELLSG 199

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 89/197 (45%), Gaps = 13/197 (6%)
Query: 74  VGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCC 133
           +G G Y  VYK     GE  A+K++     D+      + EI  +  + H N++ L    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 134 -VDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHR 192
                L L+F+   +     L  DV   G+E        +    G+ Y H    RR++HR
Sbjct: 70  HTKKRLVLVFEHLDQDLKKLL--DVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHR 124
Query: 193 DIKSSNILLTADFEPQISDFGLAKW--LPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEK 250
           D+K  N+L+  + E +I+DFGLA+   +P +   H +     T  + AP+  M       
Sbjct: 125 DLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVV----TLWYRAPDVLMGSKKYST 180
Query: 251 T-DVFAFGVFLLEIISG 266
           T D+++ G    E+++G
Sbjct: 181 TIDIWSVGCIFAEMVNG 197

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 89/197 (45%), Gaps = 13/197 (6%)
Query: 74  VGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCC 133
           +G G Y  VYK     GE  A+K++     D+      + EI  +  + H N++ L    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 134 -VDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHR 192
                L L+F+   +     L  DV   G+E        +    G+ Y H    RR++HR
Sbjct: 70  HTKKRLVLVFEHLDQDLKKLL--DVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHR 124
Query: 193 DIKSSNILLTADFEPQISDFGLAKW--LPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEK 250
           D+K  N+L+  + E +I+DFGLA+   +P +   H +     T  + AP+  M       
Sbjct: 125 DLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVV----TLWYRAPDVLMGSKKYST 180
Query: 251 T-DVFAFGVFLLEIISG 266
           T D+++ G    E+++G
Sbjct: 181 TIDIWSVGCIFAEMVNG 197

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 100/216 (46%), Gaps = 15/216 (6%)
Query: 62  SIATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTK--VVTDDRKEKEFLTEIGTIG 119
           S+    F    ++GRG YA+V    L+  + I   ++ K  +V DD       TE     
Sbjct: 1   SLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFE 60
Query: 120 HVC-HPNVLSLLGCC-VDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARG 177
               HP ++ L  C   ++ L+ + ++ + G +  +FH      +  +     +   +  
Sbjct: 61  QASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSAEISLA 118
Query: 178 LHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAK--WLPSQWTHHSIAPIEGTFG 235
           L+YLH   +R II+RD+K  N+LL ++   +++D+G+ K    P   T    +   GT  
Sbjct: 119 LNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT----SXFCGTPN 171
Query: 236 HLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVD 271
           ++APE           D +A GV + E+++GR P D
Sbjct: 172 YIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 207

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 93/203 (45%), Gaps = 12/203 (5%)
Query: 74  VGRGGYAEVYKGVLQDGEEI-AVKRLTKV-VTDDRKEKEFLTEIGTIGHVCHPNVLSLLG 131
           +G+G +  VY    +    I A+K L K  +  +  E +   EI    H+ HPN+L L  
Sbjct: 31  LGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHHPNILRLYN 90
Query: 132 CCVDNG-LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRII 190
              D   +YLI +++ RG +        S   + +    I    A  L Y H    +++I
Sbjct: 91  YFYDRRRIYLILEYAPRGELYKELQ--KSCTFDEQRTATIMEELADALMYCHG---KKVI 145
Query: 191 HRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEK 250
           HRDIK  N+LL    E +I+DFG +   PS         + GT  +L PE     + +EK
Sbjct: 146 HRDIKPENLLLGLKGELKIADFGWSVHAPSLRR----KTMCGTLDYLPPEMIEGRMHNEK 201
Query: 251 TDVFAFGVFLLEIISGRKPVDGS 273
            D++  GV   E++ G  P + +
Sbjct: 202 VDLWCIGVLCYELLVGNPPFESA 224

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 92/209 (44%), Gaps = 21/209 (10%)
Query: 74  VGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC 132
           VG G Y  V      + G  +AVK+L+K        K    E+  + H+ H NV+ LL  
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 101
Query: 133 CVD-------NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGC 185
                     N +YL+         A L + V    +       +     RGL Y+H   
Sbjct: 102 FTPARSLEEFNDVYLVTHLMG----ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 156
Query: 186 QRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHG 245
              IIHRD+K SN+ +  D E +I DFGLA+    + T +       T  + APE  ++ 
Sbjct: 157 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYRAPEIMLNW 209
Query: 246 I-VDEKTDVFAFGVFLLEIISGRKPVDGS 273
           +  ++  D+++ G  + E+++GR    G+
Sbjct: 210 MHYNQTVDIWSVGCIMAELLTGRTLFPGT 238

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 92/209 (44%), Gaps = 21/209 (10%)
Query: 74  VGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC 132
           VG G Y  V      + G  +AVK+L++        K    E+  + H+ H NV+ LL  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 133 CVD-------NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGC 185
                     N +YL+         A L + V    +       +     RGL Y+H   
Sbjct: 86  FTPARSLEEFNDVYLVTHLMG----ADLNNIVKCAKLTDDHVQFLIYQILRGLKYIHSA- 140
Query: 186 QRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHG 245
              IIHRD+K SN+ +  D E +I DFGLA+    + T +       T  + APE  ++ 
Sbjct: 141 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYRAPEIMLNW 193
Query: 246 I-VDEKTDVFAFGVFLLEIISGRKPVDGS 273
           +  ++  D+++ G  + E+++GR    G+
Sbjct: 194 MHYNQTVDIWSVGCIMAELLTGRTLFPGT 222

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 72/294 (24%), Positives = 127/294 (43%), Gaps = 37/294 (12%)
Query: 66  NAFSSENLVGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHP 124
             + S   VG G Y  V   +  + GE++A+K+L++    +   K    E+  + H+ H 
Sbjct: 24  KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHE 83
Query: 125 NVLSLLGCCVDNG-------LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARG 177
           NV+ LL               YL+  F        +    +   +++ V   +     +G
Sbjct: 84  NVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQML-----KG 138
Query: 178 LHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHL 237
           L Y+H      ++HRD+K  N+ +  D E +I DFGLA+   ++ T + +     T  + 
Sbjct: 139 LKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVV-----TRWYR 190
Query: 238 APEYFMHGI-VDEKTDVFAFGVFLLEIISGRKPVDGSH------QSLHSWAKPILNQGEI 290
           APE  +  +  ++  D+++ G  + E+++G+    G        Q L     P      +
Sbjct: 191 APEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVP--GTEFV 248
Query: 291 EKLVDPRLQGAYD-VTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEGDQIDK 343
           +KL D   +     + Q  R  F   L  RAS    P  +++LE MLE D +DK
Sbjct: 249 QKLNDKAAKSYIQSLPQTPRKDF-TQLFPRAS----PQAADLLEKMLELD-VDK 296

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 92/209 (44%), Gaps = 21/209 (10%)
Query: 74  VGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC 132
           VG G Y  V      + G  +AVK+L++        K    E+  + H+ H NV+ LL  
Sbjct: 40  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 99
Query: 133 CVD-------NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGC 185
                     N +YL+         A L + V    +       +     RGL Y+H   
Sbjct: 100 FTPARSLEEFNDVYLVTHLMG----ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 154
Query: 186 QRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHG 245
              IIHRD+K SN+ +  D E +I DFGLA+    + T +       T  + APE  ++ 
Sbjct: 155 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYRAPEIMLNW 207
Query: 246 I-VDEKTDVFAFGVFLLEIISGRKPVDGS 273
           +  ++  D+++ G  + E+++GR    G+
Sbjct: 208 MHYNQTVDIWSVGCIMAELLTGRTLFPGT 236

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 94/207 (45%), Gaps = 20/207 (9%)
Query: 74  VGRGGYAEVYKGVLQDGE---EIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLL 130
           +G G Y EV   + +D     E A+K + K         + L E+  +  + HPN++ L 
Sbjct: 45  LGSGAYGEVL--LCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLY 102
Query: 131 GCCVDN-GLYLIFQFSSRGSV-ASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRR 188
               D    YL+ +    G +   + H +    V+  V   I      G+ YLHK     
Sbjct: 103 DFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAV---IIKQVLSGVTYLHK---HN 156
Query: 189 IIHRDIKSSNILLTA---DFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHG 245
           I+HRD+K  N+LL +   D   +I DFGL+    +Q     +    GT  ++APE  +  
Sbjct: 157 IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ---KKMKERLGTAYYIAPE-VLRK 212
Query: 246 IVDEKTDVFAFGVFLLEIISGRKPVDG 272
             DEK DV++ GV L  +++G  P  G
Sbjct: 213 KYDEKCDVWSIGVILFILLAGYPPFGG 239

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 93/209 (44%), Gaps = 21/209 (10%)
Query: 74  VGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC 132
           VG G Y  V     ++ G +IAVK+L++        K    E+  + H+ H NV+ LL  
Sbjct: 59  VGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 118
Query: 133 CVD-------NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGC 185
                     N +YL+         A L + V    +       +     RGL Y+H   
Sbjct: 119 FTPATSLEEFNDVYLVTHLMG----ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 173
Query: 186 QRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHG 245
              IIHRD+K SN+ +  D E +I DFGLA+    + T +       T  + APE  ++ 
Sbjct: 174 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYRAPEIMLNW 226
Query: 246 I-VDEKTDVFAFGVFLLEIISGRKPVDGS 273
           +  +   D+++ G  + E+++GR    G+
Sbjct: 227 MHYNMTVDIWSVGCIMAELLTGRTLFPGT 255

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 92/209 (44%), Gaps = 21/209 (10%)
Query: 74  VGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC 132
           VG G Y  V      + G  +AVK+L++        K    E+  + H+ H NV+ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 133 CVD-------NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGC 185
                     N +YL+         A L + V    +       +     RGL Y+H   
Sbjct: 90  FTPARSLEEFNDVYLVTHLMG----ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 144
Query: 186 QRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHG 245
              IIHRD+K SN+ +  D E +I DFGLA+    + T +       T  + APE  ++ 
Sbjct: 145 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYRAPEIMLNW 197
Query: 246 I-VDEKTDVFAFGVFLLEIISGRKPVDGS 273
           +  ++  D+++ G  + E+++GR    G+
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGT 226

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 92/209 (44%), Gaps = 21/209 (10%)
Query: 74  VGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC 132
           VG G Y  V      + G  +AVK+L++        K    E+  + H+ H NV+ LL  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 133 CVD-------NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGC 185
                     N +YL+         A L + V    +       +     RGL Y+H   
Sbjct: 86  FTPARSLEEFNDVYLVTHLMG----ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 140
Query: 186 QRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHG 245
              IIHRD+K SN+ +  D E +I DFGLA+    + T +       T  + APE  ++ 
Sbjct: 141 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYRAPEIMLNW 193
Query: 246 I-VDEKTDVFAFGVFLLEIISGRKPVDGS 273
           +  ++  D+++ G  + E+++GR    G+
Sbjct: 194 MHYNQTVDIWSVGCIMAELLTGRTLFPGT 222

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 92/209 (44%), Gaps = 21/209 (10%)
Query: 74  VGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC 132
           VG G Y  V      + G  +AVK+L++        K    E+  + H+ H NV+ LL  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 133 CVD-------NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGC 185
                     N +YL+         A L + V    +       +     RGL Y+H   
Sbjct: 97  FTPARSLEEFNDVYLVTHLMG----ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 151
Query: 186 QRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHG 245
              IIHRD+K SN+ +  D E +I DFGLA+    + T +       T  + APE  ++ 
Sbjct: 152 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYV-----ATRWYRAPEIMLNW 204
Query: 246 I-VDEKTDVFAFGVFLLEIISGRKPVDGS 273
           +  ++  D+++ G  + E+++GR    G+
Sbjct: 205 MHYNQTVDIWSVGCIMAELLTGRTLFPGT 233

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 92/209 (44%), Gaps = 21/209 (10%)
Query: 74  VGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC 132
           VG G Y  V      + G  +AVK+L++        K    E+  + H+ H NV+ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 133 CVD-------NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGC 185
                     N +YL+         A L + V    +       +     RGL Y+H   
Sbjct: 90  FTPARSLEEFNDVYLVTHLMG----ADLNNIVKXQKLTDDHVQFLIYQILRGLKYIHSA- 144
Query: 186 QRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHG 245
              IIHRD+K SN+ +  D E +I DFGLA+    + T +       T  + APE  ++ 
Sbjct: 145 --DIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYV-----ATRWYRAPEIMLNW 197
Query: 246 I-VDEKTDVFAFGVFLLEIISGRKPVDGS 273
           +  ++  D+++ G  + E+++GR    G+
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGT 226

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 92/209 (44%), Gaps = 21/209 (10%)
Query: 74  VGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC 132
           VG G Y  V      + G  +AVK+L++        K    E+  + H+ H NV+ LL  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 133 CVD-------NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGC 185
                     N +YL+         A L + V    +       +     RGL Y+H   
Sbjct: 97  FTPARSLEEFNDVYLVTHLMG----ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 151
Query: 186 QRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHG 245
              IIHRD+K SN+ +  D E +I DFGLA+    + T +       T  + APE  ++ 
Sbjct: 152 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYV-----ATRWYRAPEIMLNW 204
Query: 246 I-VDEKTDVFAFGVFLLEIISGRKPVDGS 273
           +  ++  D+++ G  + E+++GR    G+
Sbjct: 205 MHYNQTVDIWSVGCIMAELLTGRTLFPGT 233

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 92/209 (44%), Gaps = 21/209 (10%)
Query: 74  VGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC 132
           VG G Y  V      + G  +AVK+L++        K    E+  + H+ H NV+ LL  
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 109
Query: 133 CVD-------NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGC 185
                     N +YL+         A L + V    +       +     RGL Y+H   
Sbjct: 110 FTPARSLEEFNDVYLVTHLMG----ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 164
Query: 186 QRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHG 245
              IIHRD+K SN+ +  D E +I DFGLA+    + T +       T  + APE  ++ 
Sbjct: 165 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYRAPEIMLNW 217
Query: 246 I-VDEKTDVFAFGVFLLEIISGRKPVDGS 273
           +  ++  D+++ G  + E+++GR    G+
Sbjct: 218 MHYNQTVDIWSVGCIMAELLTGRTLFPGT 246

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 56/225 (24%), Positives = 102/225 (45%), Gaps = 39/225 (17%)
Query: 72  NLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLG 131
           +L GR GY  V           AVK L +  +   + ++ L+E   +  V HP+V+ L G
Sbjct: 46  HLKGRAGYTTV-----------AVKMLKENASPS-ELRDLLSEFNVLKQVNHPHVIKLYG 93
Query: 132 CCVDNG-LYLIFQFSSRGSVASLFHDVNSPG--------------VEWKVRHKIAVG--- 173
            C  +G L LI +++  GS+     +    G              ++      + +G   
Sbjct: 94  ACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLI 153
Query: 174 -----TARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIA 228
                 ++G+ YL    + +++HRD+ + NIL+    + +ISDFGL++ +  + ++   +
Sbjct: 154 SFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRS 210
Query: 229 PIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDG 272
                   +A E     I   ++DV++FGV L EI++ G  P  G
Sbjct: 211 QGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG 255

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 92/209 (44%), Gaps = 21/209 (10%)
Query: 74  VGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC 132
           VG G Y  V      + G  +AVK+L++        K    E+  + H+ H NV+ LL  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 133 CVD-------NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGC 185
                     N +YL+         A L + V    +       +     RGL Y+H   
Sbjct: 97  FTPARSLEEFNDVYLVTHLMG----ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 151
Query: 186 QRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHG 245
              IIHRD+K SN+ +  D E +I DFGLA+    + T +       T  + APE  ++ 
Sbjct: 152 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYV-----ATRWYRAPEIMLNW 204
Query: 246 I-VDEKTDVFAFGVFLLEIISGRKPVDGS 273
           +  ++  D+++ G  + E+++GR    G+
Sbjct: 205 MHYNQTVDIWSVGCIMAELLTGRTLFPGT 233

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 92/209 (44%), Gaps = 21/209 (10%)
Query: 74  VGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC 132
           VG G Y  V      + G  +AVK+L++        K    E+  + H+ H NV+ LL  
Sbjct: 49  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 108
Query: 133 CVD-------NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGC 185
                     N +YL+         A L + V    +       +     RGL Y+H   
Sbjct: 109 FTPARSLEEFNDVYLVTHLMG----ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 163
Query: 186 QRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHG 245
              IIHRD+K SN+ +  D E +I DFGLA+    + T +       T  + APE  ++ 
Sbjct: 164 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYRAPEIMLNW 216
Query: 246 I-VDEKTDVFAFGVFLLEIISGRKPVDGS 273
           +  ++  D+++ G  + E+++GR    G+
Sbjct: 217 MHYNQTVDIWSVGCIMAELLTGRTLFPGT 245

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 92/209 (44%), Gaps = 21/209 (10%)
Query: 74  VGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC 132
           VG G Y  V      + G  +AVK+L++        K    E+  + H+ H NV+ LL  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 133 CVD-------NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGC 185
                     N +YL+         A L + V    +       +     RGL Y+H   
Sbjct: 95  FTPARSLEEFNDVYLVTHLMG----ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 149
Query: 186 QRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHG 245
              IIHRD+K SN+ +  D E +I DFGLA+    + T +       T  + APE  ++ 
Sbjct: 150 --DIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYV-----ATRWYRAPEIMLNW 202
Query: 246 I-VDEKTDVFAFGVFLLEIISGRKPVDGS 273
           +  ++  D+++ G  + E+++GR    G+
Sbjct: 203 MHYNQTVDIWSVGCIMAELLTGRTLFPGT 231

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 92/209 (44%), Gaps = 21/209 (10%)
Query: 74  VGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC 132
           VG G Y  V      + G  +AVK+L++        K    E+  + H+ H NV+ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 133 CVD-------NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGC 185
                     N +YL+         A L + V    +       +     RGL Y+H   
Sbjct: 90  FTPARSLEEFNDVYLVTHLMG----ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 144
Query: 186 QRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHG 245
              IIHRD+K SN+ +  D E +I DFGLA+    + T +       T  + APE  ++ 
Sbjct: 145 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYRAPEIMLNW 197
Query: 246 I-VDEKTDVFAFGVFLLEIISGRKPVDGS 273
           +  ++  D+++ G  + E+++GR    G+
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGT 226

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 92/209 (44%), Gaps = 21/209 (10%)
Query: 74  VGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC 132
           VG G Y  V      + G  +AVK+L++        K    E+  + H+ H NV+ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 133 CVD-------NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGC 185
                     N +YL+         A L + V    +       +     RGL Y+H   
Sbjct: 90  FTPARSLEEFNDVYLVTHLMG----ADLNNIVKXQKLTDDHVQFLIYQILRGLKYIHSA- 144
Query: 186 QRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHG 245
              IIHRD+K SN+ +  D E +I DFGLA+    + T +       T  + APE  ++ 
Sbjct: 145 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYRAPEIMLNW 197
Query: 246 I-VDEKTDVFAFGVFLLEIISGRKPVDGS 273
           +  ++  D+++ G  + E+++GR    G+
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGT 226

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 92/209 (44%), Gaps = 21/209 (10%)
Query: 74  VGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC 132
           VG G Y  V      + G  +AVK+L++        K    E+  + H+ H NV+ LL  
Sbjct: 36  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 133 CVD-------NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGC 185
                     N +YL+         A L + V    +       +     RGL Y+H   
Sbjct: 96  FTPARSLEEFNDVYLVTHLMG----ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 150
Query: 186 QRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHG 245
              IIHRD+K SN+ +  D E +I DFGLA+    + T +       T  + APE  ++ 
Sbjct: 151 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYRAPEIMLNW 203
Query: 246 I-VDEKTDVFAFGVFLLEIISGRKPVDGS 273
           +  ++  D+++ G  + E+++GR    G+
Sbjct: 204 MHYNQTVDIWSVGCIMAELLTGRTLFPGT 232

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 43/114 (37%), Positives = 56/114 (49%), Gaps = 5/114 (4%)
Query: 156 DVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLA 215
           D ++PG +             GL +LH   QR II+RD+K  N+LL  D   +ISD GLA
Sbjct: 280 DEDNPGFQEPRAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLA 336
Query: 216 KWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKP 269
             L +  T        GT G +APE  +    D   D FA GV L E+I+ R P
Sbjct: 337 VELKAGQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 92/209 (44%), Gaps = 21/209 (10%)
Query: 74  VGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC 132
           VG G Y  V      + G  +AVK+L++        K    E+  + H+ H NV+ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 133 CVD-------NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGC 185
                     N +YL+         A L + V    +       +     RGL Y+H   
Sbjct: 90  FTPARSLEEFNDVYLVTHLMG----ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 144
Query: 186 QRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHG 245
              IIHRD+K SN+ +  D E +I DFGLA+    + T +       T  + APE  ++ 
Sbjct: 145 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYRAPEIMLNW 197
Query: 246 I-VDEKTDVFAFGVFLLEIISGRKPVDGS 273
           +  ++  D+++ G  + E+++GR    G+
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGT 226

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 92/209 (44%), Gaps = 21/209 (10%)
Query: 74  VGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC 132
           VG G Y  V      + G  +AVK+L++        K    E+  + H+ H NV+ LL  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 133 CVD-------NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGC 185
                     N +YL+         A L + V    +       +     RGL Y+H   
Sbjct: 97  FTPARSLEEFNDVYLVTHLMG----ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 151
Query: 186 QRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHG 245
              IIHRD+K SN+ +  D E +I DFGLA+    + T +       T  + APE  ++ 
Sbjct: 152 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYRAPEIMLNW 204
Query: 246 I-VDEKTDVFAFGVFLLEIISGRKPVDGS 273
           +  ++  D+++ G  + E+++GR    G+
Sbjct: 205 MHYNQTVDIWSVGCIMAELLTGRTLFPGT 233

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 43/114 (37%), Positives = 56/114 (49%), Gaps = 5/114 (4%)
Query: 156 DVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLA 215
           D ++PG +             GL +LH   QR II+RD+K  N+LL  D   +ISD GLA
Sbjct: 280 DEDNPGFQEPRAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLA 336
Query: 216 KWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKP 269
             L +  T        GT G +APE  +    D   D FA GV L E+I+ R P
Sbjct: 337 VELKAGQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 92/209 (44%), Gaps = 21/209 (10%)
Query: 74  VGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC 132
           VG G Y  V      + G  +AVK+L++        K    E+  + H+ H NV+ LL  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 91
Query: 133 CVD-------NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGC 185
                     N +YL+         A L + V    +       +     RGL Y+H   
Sbjct: 92  FTPARSLEEFNDVYLVTHLMG----ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 146
Query: 186 QRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHG 245
              IIHRD+K SN+ +  D E +I DFGLA+    + T +       T  + APE  ++ 
Sbjct: 147 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYRAPEIMLNW 199
Query: 246 I-VDEKTDVFAFGVFLLEIISGRKPVDGS 273
           +  ++  D+++ G  + E+++GR    G+
Sbjct: 200 MHYNQTVDIWSVGCIMAELLTGRTLFPGT 228

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 92/209 (44%), Gaps = 21/209 (10%)
Query: 74  VGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC 132
           VG G Y  V      + G  +AVK+L++        K    E+  + H+ H NV+ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 133 CVD-------NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGC 185
                     N +YL+         A L + V    +       +     RGL Y+H   
Sbjct: 90  FTPARSLEEFNDVYLVTHLMG----ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 144
Query: 186 QRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHG 245
              IIHRD+K SN+ +  D E +I DFGLA+    + T +       T  + APE  ++ 
Sbjct: 145 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYRAPEIMLNW 197
Query: 246 I-VDEKTDVFAFGVFLLEIISGRKPVDGS 273
           +  ++  D+++ G  + E+++GR    G+
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGT 226

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 92/209 (44%), Gaps = 21/209 (10%)
Query: 74  VGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC 132
           VG G Y  V      + G  +AVK+L++        K    E+  + H+ H NV+ LL  
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 100
Query: 133 CVD-------NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGC 185
                     N +YL+         A L + V    +       +     RGL Y+H   
Sbjct: 101 FTPARSLEEFNDVYLVTHLMG----ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 155
Query: 186 QRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHG 245
              IIHRD+K SN+ +  D E +I DFGLA+    + T +       T  + APE  ++ 
Sbjct: 156 --DIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYV-----ATRWYRAPEIMLNW 208
Query: 246 I-VDEKTDVFAFGVFLLEIISGRKPVDGS 273
           +  ++  D+++ G  + E+++GR    G+
Sbjct: 209 MHYNQTVDIWSVGCIMAELLTGRTLFPGT 237

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 92/209 (44%), Gaps = 21/209 (10%)
Query: 74  VGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC 132
           VG G Y  V      + G  +AVK+L++        K    E+  + H+ H NV+ LL  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 133 CVD-------NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGC 185
                     N +YL+         A L + V    +       +     RGL Y+H   
Sbjct: 95  FTPARSLEEFNDVYLVTHLMG----ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 149
Query: 186 QRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHG 245
              IIHRD+K SN+ +  D E +I DFGLA+    + T +       T  + APE  ++ 
Sbjct: 150 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYRAPEIMLNW 202
Query: 246 I-VDEKTDVFAFGVFLLEIISGRKPVDGS 273
           +  ++  D+++ G  + E+++GR    G+
Sbjct: 203 MHYNQTVDIWSVGCIMAELLTGRTLFPGT 231

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 92/209 (44%), Gaps = 21/209 (10%)
Query: 74  VGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC 132
           VG G Y  V      + G  +AVK+L++        K    E+  + H+ H NV+ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 133 CVD-------NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGC 185
                     N +YL+         A L + V    +       +     RGL Y+H   
Sbjct: 90  FTPARSLEEFNDVYLVTHLMG----ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 144
Query: 186 QRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHG 245
              IIHRD+K SN+ +  D E +I DFGLA+    + T +       T  + APE  ++ 
Sbjct: 145 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYRAPEIMLNW 197
Query: 246 I-VDEKTDVFAFGVFLLEIISGRKPVDGS 273
           +  ++  D+++ G  + E+++GR    G+
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGT 226

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 92/209 (44%), Gaps = 21/209 (10%)
Query: 74  VGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC 132
           VG G Y  V      + G  +AVK+L++        K    E+  + H+ H NV+ LL  
Sbjct: 29  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 88
Query: 133 CVD-------NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGC 185
                     N +YL+         A L + V    +       +     RGL Y+H   
Sbjct: 89  FTPARSLEEFNDVYLVTHLMG----ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 143
Query: 186 QRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHG 245
              IIHRD+K SN+ +  D E +I DFGLA+    + T +       T  + APE  ++ 
Sbjct: 144 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYRAPEIMLNW 196
Query: 246 I-VDEKTDVFAFGVFLLEIISGRKPVDGS 273
           +  ++  D+++ G  + E+++GR    G+
Sbjct: 197 MHYNQTVDIWSVGCIMAELLTGRTLFPGT 225

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 92/209 (44%), Gaps = 21/209 (10%)
Query: 74  VGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC 132
           VG G Y  V      + G  +AVK+L++        K    E+  + H+ H NV+ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 133 CVD-------NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGC 185
                     N +YL+         A L + V    +       +     RGL Y+H   
Sbjct: 90  FTPARSLEEFNDVYLVTHLMG----ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 144
Query: 186 QRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHG 245
              IIHRD+K SN+ +  D E +I DFGLA+    + T +       T  + APE  ++ 
Sbjct: 145 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYRAPEIMLNW 197
Query: 246 I-VDEKTDVFAFGVFLLEIISGRKPVDGS 273
           +  ++  D+++ G  + E+++GR    G+
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGT 226

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 43/114 (37%), Positives = 56/114 (49%), Gaps = 5/114 (4%)
Query: 156 DVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLA 215
           D ++PG +             GL +LH   QR II+RD+K  N+LL  D   +ISD GLA
Sbjct: 280 DEDNPGFQEPRAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLA 336
Query: 216 KWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKP 269
             L +  T        GT G +APE  +    D   D FA GV L E+I+ R P
Sbjct: 337 VELKAGQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 92/209 (44%), Gaps = 21/209 (10%)
Query: 74  VGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC 132
           VG G Y  V      + G  +AVK+L++        K    E+  + H+ H NV+ LL  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 91
Query: 133 CVD-------NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGC 185
                     N +YL+         A L + V    +       +     RGL Y+H   
Sbjct: 92  FTPARSLEEFNDVYLVTHLMG----ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 146
Query: 186 QRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHG 245
              IIHRD+K SN+ +  D E +I DFGLA+    + T +       T  + APE  ++ 
Sbjct: 147 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYRAPEIMLNW 199
Query: 246 I-VDEKTDVFAFGVFLLEIISGRKPVDGS 273
           +  ++  D+++ G  + E+++GR    G+
Sbjct: 200 MHYNQTVDIWSVGCIMAELLTGRTLFPGT 228

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 92/209 (44%), Gaps = 21/209 (10%)
Query: 74  VGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC 132
           VG G Y  V      + G  +AVK+L++        K    E+  + H+ H NV+ LL  
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 101
Query: 133 CVD-------NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGC 185
                     N +YL+         A L + V    +       +     RGL Y+H   
Sbjct: 102 FTPARSLEEFNDVYLVTHLMG----ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 156
Query: 186 QRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHG 245
              IIHRD+K SN+ +  D E +I DFGLA+    + T +       T  + APE  ++ 
Sbjct: 157 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYRAPEIMLNW 209
Query: 246 I-VDEKTDVFAFGVFLLEIISGRKPVDGS 273
           +  ++  D+++ G  + E+++GR    G+
Sbjct: 210 MHYNQTVDIWSVGCIMAELLTGRTLFPGT 238

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 92/209 (44%), Gaps = 21/209 (10%)
Query: 74  VGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC 132
           VG G Y  V      + G  +AVK+L++        K    E+  + H+ H NV+ LL  
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 101
Query: 133 CVD-------NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGC 185
                     N +YL+         A L + V    +       +     RGL Y+H   
Sbjct: 102 FTPARSLEEFNDVYLVTHLMG----ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 156
Query: 186 QRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHG 245
              IIHRD+K SN+ +  D E +I DFGLA+    + T +       T  + APE  ++ 
Sbjct: 157 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYRAPEIMLNW 209
Query: 246 I-VDEKTDVFAFGVFLLEIISGRKPVDGS 273
           +  ++  D+++ G  + E+++GR    G+
Sbjct: 210 MHYNQTVDIWSVGCIMAELLTGRTLFPGT 238

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 43/114 (37%), Positives = 56/114 (49%), Gaps = 5/114 (4%)
Query: 156 DVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLA 215
           D ++PG +             GL +LH   QR II+RD+K  N+LL  D   +ISD GLA
Sbjct: 280 DEDNPGFQEPRAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLA 336
Query: 216 KWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKP 269
             L +  T        GT G +APE  +    D   D FA GV L E+I+ R P
Sbjct: 337 VELKAGQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 87/213 (40%), Gaps = 8/213 (3%)
Query: 68  FSSENLVGRGGYAEVYKGV-LQDGEEIAVKRLTKV-VTDDRKEKEFLTEIGTIGHVCHPN 125
           F    ++G G ++ V     L    E A+K L K  +  + K      E   +  + HP 
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 126 VLSLLGCCVDN-GLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKG 184
            + L     D+  LY    ++  G +      + S   +              L YLH  
Sbjct: 94  FVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGS--FDETCTRFYTAEIVSALEYLHG- 150
Query: 185 CQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMH 244
             + IIHRD+K  NILL  D   QI+DFG AK L  +          GT  +++PE    
Sbjct: 151 --KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 208
Query: 245 GIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSL 277
               + +D++A G  + ++++G  P    ++ L
Sbjct: 209 KSASKSSDLWALGCIIYQLVAGLPPFRAGNEYL 241

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 92/209 (44%), Gaps = 21/209 (10%)
Query: 74  VGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC 132
           VG G Y  V      + G  +AVK+L++        K    E+  + H+ H NV+ LL  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 91
Query: 133 CVD-------NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGC 185
                     N +YL+         A L + V    +       +     RGL Y+H   
Sbjct: 92  FTPARSLEEFNDVYLVTHLMG----ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 146
Query: 186 QRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHG 245
              IIHRD+K SN+ +  D E +I DFGLA+    + T +       T  + APE  ++ 
Sbjct: 147 --DIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMTGYV-----ATRWYRAPEIMLNW 199
Query: 246 I-VDEKTDVFAFGVFLLEIISGRKPVDGS 273
           +  ++  D+++ G  + E+++GR    G+
Sbjct: 200 MHYNQTVDIWSVGCIMAELLTGRTLFPGT 228

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 92/209 (44%), Gaps = 21/209 (10%)
Query: 74  VGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC 132
           VG G Y  V      + G  +AVK+L++        K    E+  + H+ H NV+ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 133 CVD-------NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGC 185
                     N +YL+         A L + V    +       +     RGL Y+H   
Sbjct: 90  FTPARSLEEFNDVYLVTHLMG----ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 144
Query: 186 QRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHG 245
              IIHRD+K SN+ +  D E +I DFGLA+    + T +       T  + APE  ++ 
Sbjct: 145 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYRAPEIMLNW 197
Query: 246 I-VDEKTDVFAFGVFLLEIISGRKPVDGS 273
           +  ++  D+++ G  + E+++GR    G+
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGT 226

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 92/209 (44%), Gaps = 21/209 (10%)
Query: 74  VGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC 132
           VG G Y  V      + G  +AVK+L++        K    E+  + H+ H NV+ LL  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 133 CVD-------NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGC 185
                     N +YL+         A L + V    +       +     RGL Y+H   
Sbjct: 96  FTPARSLEEFNDVYLVTHLMG----ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 150
Query: 186 QRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHG 245
              IIHRD+K SN+ +  D E +I DFGLA+    + T +       T  + APE  ++ 
Sbjct: 151 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYRAPEIMLNW 203
Query: 246 I-VDEKTDVFAFGVFLLEIISGRKPVDGS 273
           +  ++  D+++ G  + E+++GR    G+
Sbjct: 204 MHYNQTVDIWSVGCIMAELLTGRTLFPGT 232

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 92/209 (44%), Gaps = 21/209 (10%)
Query: 74  VGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC 132
           VG G Y  V      + G  +AVK+L++        K    E+  + H+ H NV+ LL  
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 86
Query: 133 CVD-------NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGC 185
                     N +YL+         A L + V    +       +     RGL Y+H   
Sbjct: 87  FTPARSLEEFNDVYLVTHLMG----ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 141
Query: 186 QRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHG 245
              IIHRD+K SN+ +  D E +I DFGLA+    + T +       T  + APE  ++ 
Sbjct: 142 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYRAPEIMLNW 194
Query: 246 I-VDEKTDVFAFGVFLLEIISGRKPVDGS 273
           +  ++  D+++ G  + E+++GR    G+
Sbjct: 195 MHYNQTVDIWSVGCIMAELLTGRTLFPGT 223

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 92/209 (44%), Gaps = 21/209 (10%)
Query: 74  VGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC 132
           VG G Y  V      + G  +AVK+L++        K    E+  + H+ H NV+ LL  
Sbjct: 26  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 133 CVD-------NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGC 185
                     N +YL+         A L + V    +       +     RGL Y+H   
Sbjct: 86  FTPARSLEEFNDVYLVTHLMG----ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 140
Query: 186 QRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHG 245
              IIHRD+K SN+ +  D E +I DFGLA+    + T +       T  + APE  ++ 
Sbjct: 141 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYRAPEIMLNW 193
Query: 246 I-VDEKTDVFAFGVFLLEIISGRKPVDGS 273
           +  ++  D+++ G  + E+++GR    G+
Sbjct: 194 MHYNQTVDIWSVGCIMAELLTGRTLFPGT 222

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 92/209 (44%), Gaps = 21/209 (10%)
Query: 74  VGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC 132
           VG G Y  V      + G  +AVK+L++        K    E+  + H+ H NV+ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 133 CVD-------NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGC 185
                     N +YL+         A L + V S  +       +     RGL Y+H   
Sbjct: 90  FTPARSLEEFNDVYLVTHLMG----ADLNNIVKSQKLTDDHVQFLIYQILRGLKYIHSA- 144
Query: 186 QRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHG 245
              IIHRD+K SN+ +  D E +I DFGL +    + T +       T  + APE  ++ 
Sbjct: 145 --DIIHRDLKPSNLAVNEDSELKILDFGLCRHTDDEMTGYV-----ATRWYRAPEIMLNW 197
Query: 246 I-VDEKTDVFAFGVFLLEIISGRKPVDGS 273
           +  ++  D+++ G  + E+++GR    G+
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGT 226

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 90/213 (42%), Gaps = 8/213 (3%)
Query: 68  FSSENLVGRGGYAEVYKGV-LQDGEEIAVKRLTKV-VTDDRKEKEFLTEIGTIGHVCHPN 125
           F    ++G G ++ V     L    E A+K L K  +  + K      E   +  + HP 
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 126 VLSLLGCCVDN-GLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKG 184
            + L     D+  LY    ++  G +      + S        +   + +A  L YLH  
Sbjct: 94  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA--LEYLH-- 149
Query: 185 CQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMH 244
             + IIHRD+K  NILL  D   QI+DFG AK L  +          GT  +++PE    
Sbjct: 150 -GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 208
Query: 245 GIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSL 277
               + +D++A G  + ++++G  P    ++ L
Sbjct: 209 KSAXKSSDLWALGCIIYQLVAGLPPFRAGNEGL 241

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 92/209 (44%), Gaps = 21/209 (10%)
Query: 74  VGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC 132
           VG G Y  V      + G  +AVK+L++        K    E+  + H+ H NV+ LL  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 133 CVD-------NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGC 185
                     N +YL+         A L + V    +       +     RGL Y+H   
Sbjct: 95  FTPARSLEEFNDVYLVTHLMG----ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 149
Query: 186 QRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHG 245
              IIHRD+K SN+ +  D E +I DFGLA+    + T +       T  + APE  ++ 
Sbjct: 150 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYRAPEIMLNW 202
Query: 246 I-VDEKTDVFAFGVFLLEIISGRKPVDGS 273
           +  ++  D+++ G  + E+++GR    G+
Sbjct: 203 MHYNQTVDIWSVGCIMAELLTGRTLFPGT 231

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 94/203 (46%), Gaps = 20/203 (9%)
Query: 74  VGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC 132
           VGRG + EV++    Q G + AVK++       R E   + E+     +  P ++ L G 
Sbjct: 66  VGRGSFGEVHRMKDKQTGFQCAVKKV-------RLEVFRVEELVACAGLSSPRIVPLYGA 118
Query: 133 CVDNGLYLIF-QFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTA-RGLHYLHKGCQRRII 190
             +     IF +    GS+  L   +   G   + R    +G A  GL YLH    RRI+
Sbjct: 119 VREGPWVNIFMELLEGGSLGQLIKQM---GCLPEDRALYYLGQALEGLEYLHT---RRIL 172
Query: 191 HRDIKSSNILLTAD-FEPQISDFGLAKWLPSQWTHHSIAP---IEGTFGHLAPEYFMHGI 246
           H D+K+ N+LL++D     + DFG A  L       S+     I GT  H+APE  M   
Sbjct: 173 HGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKP 232
Query: 247 VDEKTDVFAFGVFLLEIISGRKP 269
            D K D+++    +L +++G  P
Sbjct: 233 CDAKVDIWSSCCMMLHMLNGCHP 255

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 92/209 (44%), Gaps = 21/209 (10%)
Query: 74  VGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC 132
           VG G Y  V      + G  +AVK+L++        K    E+  + H+ H NV+ LL  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 91
Query: 133 CVD-------NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGC 185
                     N +YL+         A L + V    +       +     RGL Y+H   
Sbjct: 92  FTPARSLEEFNDVYLVTHLMG----ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 146
Query: 186 QRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHG 245
              IIHRD+K SN+ +  D E +I DFGLA+    + T +       T  + APE  ++ 
Sbjct: 147 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYRAPEIMLNW 199
Query: 246 I-VDEKTDVFAFGVFLLEIISGRKPVDGS 273
           +  ++  D+++ G  + E+++GR    G+
Sbjct: 200 MHYNQTVDIWSVGCIMAELLTGRTLFPGT 228

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 92/209 (44%), Gaps = 21/209 (10%)
Query: 74  VGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC 132
           VG G Y  V      + G  +AVK+L++        K    E+  + H+ H NV+ LL  
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 86
Query: 133 CVD-------NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGC 185
                     N +YL+         A L + V    +       +     RGL Y+H   
Sbjct: 87  FTPARSLEEFNDVYLVTHLMG----ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 141
Query: 186 QRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHG 245
              IIHRD+K SN+ +  D E +I DFGLA+    + T +       T  + APE  ++ 
Sbjct: 142 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYRAPEIMLNW 194
Query: 246 I-VDEKTDVFAFGVFLLEIISGRKPVDGS 273
           +  ++  D+++ G  + E+++GR    G+
Sbjct: 195 MHYNQTVDIWSVGCIMAELLTGRTLFPGT 223

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 92/209 (44%), Gaps = 21/209 (10%)
Query: 74  VGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC 132
           VG G Y  V      + G  +AVK+L++        K    E+  + H+ H NV+ LL  
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 100
Query: 133 CVD-------NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGC 185
                     N +YL+         A L + V    +       +     RGL Y+H   
Sbjct: 101 FTPARSLEEFNDVYLVTHLMG----ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 155
Query: 186 QRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHG 245
              IIHRD+K SN+ +  D E +I DFGLA+    + T +       T  + APE  ++ 
Sbjct: 156 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYRAPEIMLNW 208
Query: 246 I-VDEKTDVFAFGVFLLEIISGRKPVDGS 273
           +  ++  D+++ G  + E+++GR    G+
Sbjct: 209 MHYNQTVDIWSVGCIMAELLTGRTLFPGT 237

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 92/209 (44%), Gaps = 21/209 (10%)
Query: 74  VGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC 132
           VG G Y  V      + G  +AVK+L++        K    E+  + H+ H NV+ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 133 CVD-------NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGC 185
                     N +YL+         A L + V    +       +     RGL Y+H   
Sbjct: 90  FTPARSLEEFNDVYLVTHLMG----ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 144
Query: 186 QRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHG 245
              IIHRD+K SN+ +  D E +I DFGLA+    + T +       T  + APE  ++ 
Sbjct: 145 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYRAPEIMLNW 197
Query: 246 I-VDEKTDVFAFGVFLLEIISGRKPVDGS 273
           +  ++  D+++ G  + E+++GR    G+
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGT 226

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/231 (25%), Positives = 100/231 (43%), Gaps = 19/231 (8%)
Query: 58  FEEISIATNAFSSENLVGRGGYAEVYKGVL--QDGE--EIAVKRLTKVVTDDRKEKEFLT 113
            E++ I    F+   ++G+G +  V +  L  +DG   ++AVK L   +      +EFL 
Sbjct: 15  LEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLR 74
Query: 114 EIGTIGHVCHPNVLSLLGCCVDNGL-------YLIFQFSSRGSVASLFHDV----NSPGV 162
           E   +    HP+V  L+G  + +          +I  F   G + +         N   +
Sbjct: 75  EAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNL 134
Query: 163 EWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQW 222
             +   +  V  A G+ YL     R  IHRD+ + N +L  D    ++DFGL++ + S  
Sbjct: 135 PLQTLVRFMVDIACGMEYLSS---RNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGD 191
Query: 223 THHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDG 272
            +      +     LA E     +    +DV+AFGV + EI++ G+ P  G
Sbjct: 192 YYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAG 242

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 92/209 (44%), Gaps = 21/209 (10%)
Query: 74  VGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC 132
           VG G Y  V      + G  +AVK+L++        K    E+  + H+ H NV+ LL  
Sbjct: 28  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 87
Query: 133 CVD-------NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGC 185
                     N +YL+         A L + V    +       +     RGL Y+H   
Sbjct: 88  FTPARSLEEFNDVYLVTHLMG----ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 142
Query: 186 QRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHG 245
              IIHRD+K SN+ +  D E +I DFGLA+    + T +       T  + APE  ++ 
Sbjct: 143 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYRAPEIMLNW 195
Query: 246 I-VDEKTDVFAFGVFLLEIISGRKPVDGS 273
           +  ++  D+++ G  + E+++GR    G+
Sbjct: 196 MHYNQTVDIWSVGCIMAELLTGRTLFPGT 224

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 92/209 (44%), Gaps = 21/209 (10%)
Query: 74  VGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC 132
           +G G Y  V      + G  +AVK+L++        K    E+  + H+ H NV+ LL  
Sbjct: 35  IGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 133 CVD-------NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGC 185
                     N +YL+         A L + V    +       +     RGL Y+H   
Sbjct: 95  FTPARSLEEFNDVYLVTHLMG----ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 149
Query: 186 QRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHG 245
              IIHRD+K SN+ +  D E +I DFGLA+    + T +       T  + APE  ++ 
Sbjct: 150 --DIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYV-----ATRWYRAPEIMLNW 202
Query: 246 I-VDEKTDVFAFGVFLLEIISGRKPVDGS 273
           +  ++  D+++ G  + E+++GR    G+
Sbjct: 203 MHYNQTVDIWSVGCIMAELLTGRTLFPGT 231

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 92/209 (44%), Gaps = 21/209 (10%)
Query: 74  VGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC 132
           VG G Y  V      + G  +AVK+L++        K    E+  + H+ H NV+ LL  
Sbjct: 50  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 109
Query: 133 CVD-------NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGC 185
                     N +YL+         A L + V    +       +     RGL Y+H   
Sbjct: 110 FTPARSLEEFNDVYLVTHLMG----ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 164
Query: 186 QRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHG 245
              IIHRD+K SN+ +  D E +I DFGLA+    + T +       T  + APE  ++ 
Sbjct: 165 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYRAPEIMLNW 217
Query: 246 I-VDEKTDVFAFGVFLLEIISGRKPVDGS 273
           +  ++  D+++ G  + E+++GR    G+
Sbjct: 218 MHYNQTVDIWSVGCIMAELLTGRTLFPGT 246

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/214 (24%), Positives = 96/214 (44%), Gaps = 15/214 (7%)
Query: 68  FSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNV 126
           F     +G G Y  VYK   +  GE +A+ ++      +      + EI  +  + HPN+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 127 LSLLGCC-VDNGLYLIFQFSSRGSVASLFHDVNS-PGVEWKVRHKIAVGTARGLHYLHKG 184
           + LL     +N LYL+F+F  +      F D ++  G+   +         +GL + H  
Sbjct: 65  VKLLDVIHTENKLYLVFEFLHQD--LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH-- 120
Query: 185 CQRRIIHRDIKSSNILLTADFEPQISDFGLAKW--LPSQWTHHSIAPIEGTFGHLAPEYF 242
              R++HRD+K  N+L+  +   +++DFGLA+   +P +   H +     T  + APE  
Sbjct: 121 -SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV----TLWYRAPEIL 175
Query: 243 MH-GIVDEKTDVFAFGVFLLEIISGRKPVDGSHQ 275
           +         D+++ G    E+++ R    G  +
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE 209

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/214 (24%), Positives = 96/214 (44%), Gaps = 15/214 (7%)
Query: 68  FSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNV 126
           F     +G G Y  VYK   +  GE +A+ ++      +      + EI  +  + HPN+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 127 LSLLGCC-VDNGLYLIFQFSSRGSVASLFHDVNS-PGVEWKVRHKIAVGTARGLHYLHKG 184
           + LL     +N LYL+F+F  +      F D ++  G+   +         +GL + H  
Sbjct: 64  VKLLDVIHTENKLYLVFEFLHQD--LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH-- 119
Query: 185 CQRRIIHRDIKSSNILLTADFEPQISDFGLAKW--LPSQWTHHSIAPIEGTFGHLAPEYF 242
              R++HRD+K  N+L+  +   +++DFGLA+   +P +   H +     T  + APE  
Sbjct: 120 -SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV----TLWYRAPEIL 174
Query: 243 MH-GIVDEKTDVFAFGVFLLEIISGRKPVDGSHQ 275
           +         D+++ G    E+++ R    G  +
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE 208

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 92/209 (44%), Gaps = 21/209 (10%)
Query: 74  VGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC 132
           VG G Y  V      + G  +AVK+L++        K    E+  + H+ H NV+ LL  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 133 CVD-------NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGC 185
                     N +YL+         A L + V    +       +     RGL Y+H   
Sbjct: 96  FTPARSLEEFNDVYLVTHLMG----ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 150
Query: 186 QRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHG 245
              IIHRD+K SN+ +  D E +I DFGLA+    + T +       T  + APE  ++ 
Sbjct: 151 --DIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMTGYV-----ATRWYRAPEIMLNW 203
Query: 246 I-VDEKTDVFAFGVFLLEIISGRKPVDGS 273
           +  ++  D+++ G  + E+++GR    G+
Sbjct: 204 MHYNQTVDIWSVGCIMAELLTGRTLFPGT 232

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/206 (24%), Positives = 94/206 (45%), Gaps = 15/206 (7%)
Query: 68  FSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNV 126
           F     +G G Y  VYK   +  GE +A+K++      +      + EI  +  + HPN+
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 127 LSLLGCC-VDNGLYLIFQFSSRGSVASLFHDVNS-PGVEWKVRHKIAVGTARGLHYLHKG 184
           + LL     +N LYL+F+   +      F D ++  G+   +         +GL + H  
Sbjct: 68  VKLLDVIHTENKLYLVFEHVDQD--LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH-- 123
Query: 185 CQRRIIHRDIKSSNILLTADFEPQISDFGLAKW--LPSQWTHHSIAPIEGTFGHLAPEYF 242
              R++HRD+K  N+L+  +   +++DFGLA+   +P +   H +     T  + APE  
Sbjct: 124 -SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAPEIL 178
Query: 243 MH-GIVDEKTDVFAFGVFLLEIISGR 267
           +         D+++ G    E+++ R
Sbjct: 179 LGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/250 (26%), Positives = 110/250 (44%), Gaps = 52/250 (20%)
Query: 55  CFSFEEISIATNAFSSENLVGRGGYAEVY----KGVLQDGEE--IAVKRLTKVVTDDRKE 108
            F  +E  +A    +    +G+G +  VY    KGV++D  E  +A+K + +  +  R+ 
Sbjct: 5   VFVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASM-RER 63
Query: 109 KEFLTEIGTIGHV-CHPNVLSLLGCCVDNG--LYLIFQFSSRGSVASLFHDV-----NSP 160
            EFL E   +    CH +V+ LLG  V  G    +I +  +RG + S    +     N+P
Sbjct: 64  IEFLNEASVMKEFNCH-HVVRLLGV-VSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNP 121
Query: 161 GVEWKVRHKI---AVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAK- 216
            +      K+   A   A G+ YL+     + +HRD+ + N ++  DF  +I DFG+ + 
Sbjct: 122 VLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRD 178
Query: 217 -------------WLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEI 263
                         LP +W              ++PE    G+    +DV++FGV L EI
Sbjct: 179 IYETDYYRKGGKGLLPVRW--------------MSPESLKDGVFTTYSDVWSFGVVLWEI 224
Query: 264 IS-GRKPVDG 272
            +   +P  G
Sbjct: 225 ATLAEQPYQG 234

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 94/203 (46%), Gaps = 20/203 (9%)
Query: 74  VGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC 132
           VGRG + EV++    Q G + AVK++       R E   + E+     +  P ++ L G 
Sbjct: 82  VGRGSFGEVHRMKDKQTGFQCAVKKV-------RLEVFRVEELVACAGLSSPRIVPLYGA 134
Query: 133 CVDNGLYLIF-QFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTA-RGLHYLHKGCQRRII 190
             +     IF +    GS+  L   +   G   + R    +G A  GL YLH    RRI+
Sbjct: 135 VREGPWVNIFMELLEGGSLGQLIKQM---GCLPEDRALYYLGQALEGLEYLHT---RRIL 188
Query: 191 HRDIKSSNILLTAD-FEPQISDFGLAKWLPSQWTHHSIAP---IEGTFGHLAPEYFMHGI 246
           H D+K+ N+LL++D     + DFG A  L       S+     I GT  H+APE  M   
Sbjct: 189 HGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKP 248
Query: 247 VDEKTDVFAFGVFLLEIISGRKP 269
            D K D+++    +L +++G  P
Sbjct: 249 CDAKVDIWSSCCMMLHMLNGCHP 271

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 92/209 (44%), Gaps = 21/209 (10%)
Query: 74  VGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC 132
           VG G Y  V      + G  +AVK+L++        K    E+  + H+ H NV+ LL  
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 112
Query: 133 CVD-------NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGC 185
                     N +YL+         A L + V    +       +     RGL Y+H   
Sbjct: 113 FTPARSLEEFNDVYLVTHLMG----ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 167
Query: 186 QRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHG 245
              IIHRD+K SN+ +  D E +I DFGLA+    + T +       T  + APE  ++ 
Sbjct: 168 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYRAPEIMLNW 220
Query: 246 I-VDEKTDVFAFGVFLLEIISGRKPVDGS 273
           +  ++  D+++ G  + E+++GR    G+
Sbjct: 221 MHYNQTVDIWSVGCIMAELLTGRTLFPGT 249

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/245 (25%), Positives = 107/245 (43%), Gaps = 50/245 (20%)
Query: 59  EEISIATNAFSSENLVGRGGYAEVY----KGVLQDGEE--IAVKRLTKVVTDDRKEKEFL 112
           +E  +A    +    +G+G +  VY    KGV++D  E  +A+K + +  +  R+  EFL
Sbjct: 18  DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASM-RERIEFL 76
Query: 113 TEIGTIGHV-CHPNVLSLLGCCVDNGLYL-IFQFSSRGSVASLFHDV-----NSPGVEWK 165
            E   +    CH +V+ LLG        L I +  +RG + S    +     N+P +   
Sbjct: 77  NEASVMKEFNCH-HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPP 135
Query: 166 VRHKI---AVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAK------ 216
              K+   A   A G+ YL+     + +HRD+ + N ++  DF  +I DFG+ +      
Sbjct: 136 SLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD 192
Query: 217 --------WLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GR 267
                    LP +W              ++PE    G+    +DV++FGV L EI +   
Sbjct: 193 YYRKGGKGLLPVRW--------------MSPESLKDGVFTTYSDVWSFGVVLWEIATLAE 238
Query: 268 KPVDG 272
           +P  G
Sbjct: 239 QPYQG 243

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 88/214 (41%), Gaps = 10/214 (4%)
Query: 68  FSSENLVGRGGYAEVYKGV-LQDGEEIAVKRLTKV-VTDDRKEKEFLTEIGTIGHVCHPN 125
           F    ++G G ++ V     L    E A+K L K  +  + K      E   +  + HP 
Sbjct: 12  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 71
Query: 126 VLSLLGCCVDN-GLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLH-K 183
            + L     D+  LY    ++  G +      + S   +              L YLH K
Sbjct: 72  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS--FDETCTRFYTAEIVSALEYLHGK 129
Query: 184 GCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFM 243
           G    IIHRD+K  NILL  D   QI+DFG AK L  +          GT  +++PE   
Sbjct: 130 G----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 185
Query: 244 HGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSL 277
                + +D++A G  + ++++G  P    ++ L
Sbjct: 186 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL 219

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 92/209 (44%), Gaps = 21/209 (10%)
Query: 74  VGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC 132
           VG G Y  V      + G  +AVK+L++        K    E+  + H+ H NV+ LL  
Sbjct: 49  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 108
Query: 133 CVD-------NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGC 185
                     N +YL+         A L + V    +       +     RGL Y+H   
Sbjct: 109 FTPARSLEEFNDVYLVTHLMG----ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 163
Query: 186 QRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHG 245
              IIHRD+K SN+ +  D E +I DFGLA+    + T +       T  + APE  ++ 
Sbjct: 164 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYRAPEIMLNW 216
Query: 246 I-VDEKTDVFAFGVFLLEIISGRKPVDGS 273
           +  ++  D+++ G  + E+++GR    G+
Sbjct: 217 MHYNQTVDIWSVGCIMAELLTGRTLFPGT 245

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/156 (28%), Positives = 85/156 (54%), Gaps = 21/156 (13%)
Query: 74  VGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEK---EFLTEIGTIGHVCHPNVLSL 129
           +G+G + EV+K    + G+++A+K   KV+ ++ KE      L EI  +  + H NV++L
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALK---KVLMENEKEGFPITALREIKILQLLKHENVVNL 82
Query: 130 LGCC---------VDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHY 180
           +  C             +YL+F F     +A L  +V       +++ ++      GL+Y
Sbjct: 83  IEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIK-RVMQMLLNGLYY 140
Query: 181 LHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAK 216
           +H+    +I+HRD+K++N+L+T D   +++DFGLA+
Sbjct: 141 IHRN---KILHRDMKAANVLITRDGVLKLADFGLAR 173

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 92/209 (44%), Gaps = 12/209 (5%)
Query: 74  VGRGGYAEVYKGVLQDGEEIAVKR---LTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLL 130
           +G G +  V KG  Q  + +       L     D   + E L E   +  + +P ++ ++
Sbjct: 35  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 94
Query: 131 GCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRII 190
           G C      L+ + +  G +        +  V+ K   ++    + G+ YL    +   +
Sbjct: 95  GICEAESWMLVMEMAELGPLNKYLQ--QNRHVKDKNIIELVHQVSMGMKYLE---ESNFV 149
Query: 191 HRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTF--GHLAPEYFMHGIVD 248
           HRD+ + N+LL      +ISDFGL+K L +   ++  A   G +     APE   +    
Sbjct: 150 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK-AQTHGKWPVKWYAPECINYYKFS 208
Query: 249 EKTDVFAFGVFLLEIIS-GRKPVDGSHQS 276
            K+DV++FGV + E  S G+KP  G   S
Sbjct: 209 SKSDVWSFGVLMWEAFSYGQKPYRGMKGS 237

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 92/209 (44%), Gaps = 12/209 (5%)
Query: 74  VGRGGYAEVYKGVLQDGEEIAVKR---LTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLL 130
           +G G +  V KG  Q  + +       L     D   + E L E   +  + +P ++ ++
Sbjct: 35  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 94
Query: 131 GCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRII 190
           G C      L+ + +  G +        +  V+ K   ++    + G+ YL    +   +
Sbjct: 95  GICEAESWMLVMEMAELGPLNKYLQ--QNRHVKDKNIIELVHQVSMGMKYLE---ESNFV 149
Query: 191 HRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTF--GHLAPEYFMHGIVD 248
           HRD+ + N+LL      +ISDFGL+K L +   ++  A   G +     APE   +    
Sbjct: 150 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK-AQTHGKWPVKWYAPECINYYKFS 208
Query: 249 EKTDVFAFGVFLLEIIS-GRKPVDGSHQS 276
            K+DV++FGV + E  S G+KP  G   S
Sbjct: 209 SKSDVWSFGVLMWEAFSYGQKPYRGMKGS 237

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 99/215 (46%), Gaps = 15/215 (6%)
Query: 63  IATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTK--VVTDDRKEKEFLTEIGTIGH 120
           +    F    ++GRG YA+V    L+  + I   ++ K  +V DD       TE      
Sbjct: 6   LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQ 65
Query: 121 VC-HPNVLSLLGCC-VDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGL 178
              HP ++ L  C   ++ L+ + ++ + G +  +FH      +  +     +   +  L
Sbjct: 66  ASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSAEISLAL 123
Query: 179 HYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAK--WLPSQWTHHSIAPIEGTFGH 236
           +YLH   +R II+RD+K  N+LL ++   +++D+G+ K    P   T    +   GT  +
Sbjct: 124 NYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT----SXFCGTPNY 176
Query: 237 LAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVD 271
           +APE           D +A GV + E+++GR P D
Sbjct: 177 IAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 211

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/245 (25%), Positives = 107/245 (43%), Gaps = 50/245 (20%)
Query: 59  EEISIATNAFSSENLVGRGGYAEVY----KGVLQDGEE--IAVKRLTKVVTDDRKEKEFL 112
           +E  +A    +    +G+G +  VY    KGV++D  E  +A+K + +  +  R+  EFL
Sbjct: 18  DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASM-RERIEFL 76
Query: 113 TEIGTIGHV-CHPNVLSLLGCCVDNGLYL-IFQFSSRGSVASLFHDV-----NSPGVEWK 165
            E   +    CH +V+ LLG        L I +  +RG + S    +     N+P +   
Sbjct: 77  NEASVMKEFNCH-HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPP 135
Query: 166 VRHKI---AVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAK------ 216
              K+   A   A G+ YL+     + +HRD+ + N ++  DF  +I DFG+ +      
Sbjct: 136 SLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD 192
Query: 217 --------WLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GR 267
                    LP +W              ++PE    G+    +DV++FGV L EI +   
Sbjct: 193 YYRKGGKGLLPVRW--------------MSPESLKDGVFTTYSDVWSFGVVLWEIATLAE 238
Query: 268 KPVDG 272
           +P  G
Sbjct: 239 QPYQG 243

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 91/214 (42%), Gaps = 10/214 (4%)
Query: 68  FSSENLVGRGGYAEVYKGV-LQDGEEIAVKRLTKV-VTDDRKEKEFLTEIGTIGHVCHPN 125
           F    ++G G ++ V     L    E A+K L K  +  + K      E   +  + HP 
Sbjct: 9   FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 68
Query: 126 VLSLLGCCVDN-GLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLH-K 183
            + L     D+  LY    ++  G +      + S        +   + +A  L YLH K
Sbjct: 69  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA--LEYLHGK 126
Query: 184 GCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFM 243
           G    IIHRD+K  NILL  D   QI+DFG AK L  +          GT  +++PE   
Sbjct: 127 G----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 182
Query: 244 HGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSL 277
                + +D++A G  + ++++G  P    ++ L
Sbjct: 183 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL 216

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/239 (25%), Positives = 102/239 (42%), Gaps = 67/239 (28%)
Query: 72  NLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLG 131
           +L GR GY  V           AVK L +  +   + ++ L+E   +  V HP+V+ L G
Sbjct: 46  HLKGRAGYTTV-----------AVKMLKENASPS-ELRDLLSEFNVLKQVNHPHVIKLYG 93
Query: 132 CCVDNG-LYLIFQFSSRGSVASLFHDVNSPG--------------VEWKVRHKIAVG--- 173
            C  +G L LI +++  GS+     +    G              ++      + +G   
Sbjct: 94  ACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLI 153
Query: 174 -----TARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAK------------ 216
                 ++G+ YL    + +++HRD+ + NIL+    + +ISDFGL++            
Sbjct: 154 SFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXVKRS 210
Query: 217 --WLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDG 272
              +P +W       IE  F H         I   ++DV++FGV L EI++ G  P  G
Sbjct: 211 QGRIPVKWM-----AIESLFDH---------IYTTQSDVWSFGVLLWEIVTLGGNPYPG 255

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/206 (24%), Positives = 94/206 (45%), Gaps = 15/206 (7%)
Query: 68  FSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNV 126
           F     +G G Y  VYK   +  GE +A+K++      +      + EI  +  + HPN+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 127 LSLLGCC-VDNGLYLIFQFSSRGSVASLFHDVNS-PGVEWKVRHKIAVGTARGLHYLHKG 184
           + LL     +N LYL+F+   +      F D ++  G+   +         +GL + H  
Sbjct: 64  VKLLDVIHTENKLYLVFEHVHQD--LKTFMDASALTGIPLPLIKSYLFQLLQGLAFCH-- 119
Query: 185 CQRRIIHRDIKSSNILLTADFEPQISDFGLAKW--LPSQWTHHSIAPIEGTFGHLAPEYF 242
              R++HRD+K  N+L+  +   +++DFGLA+   +P +   H +     T  + APE  
Sbjct: 120 -SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV----TLWYRAPEIL 174
Query: 243 MH-GIVDEKTDVFAFGVFLLEIISGR 267
           +         D+++ G    E+++ R
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 88/214 (41%), Gaps = 10/214 (4%)
Query: 68  FSSENLVGRGGYAEVYKGV-LQDGEEIAVKRLTKV-VTDDRKEKEFLTEIGTIGHVCHPN 125
           F    ++G G ++ V     L    E A+K L K  +  + K      E   +  + HP 
Sbjct: 11  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 70
Query: 126 VLSLLGCCVDN-GLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLH-K 183
            + L     D+  LY    ++  G +      + S   +              L YLH K
Sbjct: 71  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS--FDETCTRFYTAEIVSALEYLHGK 128
Query: 184 GCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFM 243
           G    IIHRD+K  NILL  D   QI+DFG AK L  +          GT  +++PE   
Sbjct: 129 G----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 184
Query: 244 HGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSL 277
                + +D++A G  + ++++G  P    ++ L
Sbjct: 185 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL 218

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 94/201 (46%), Gaps = 14/201 (6%)
Query: 88  QDGEEIAVKRLTKVVTDDRKEKEFLT-EIGTIGHVCHPNVLSLLGCCVD-NGLYLIFQFS 145
            +G   A+K L K +    K+ E    E   +  V HP ++ + G   D   +++I  + 
Sbjct: 29  HNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYI 88
Query: 146 SRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADF 205
             G + SL     S      V    A      L YLH    + II+RD+K  NILL  + 
Sbjct: 89  EGGELFSLLR--KSQRFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNG 143
Query: 206 EPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS 265
             +I+DFG AK++P          + GT  ++APE       ++  D ++FG+ + E+++
Sbjct: 144 HIKITDFGFAKYVPD-----VTYXLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLA 198
Query: 266 GRKPVDGSHQSLHSWAKPILN 286
           G  P   S+ ++ ++ K ILN
Sbjct: 199 GYTPFYDSN-TMKTYEK-ILN 217

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 91/214 (42%), Gaps = 10/214 (4%)
Query: 68  FSSENLVGRGGYAEVYKGV-LQDGEEIAVKRLTKV-VTDDRKEKEFLTEIGTIGHVCHPN 125
           F    ++G G ++ V     L    E A+K L K  +  + K      E   +  + HP 
Sbjct: 10  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 69
Query: 126 VLSLLGCCVDN-GLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLH-K 183
            + L     D+  LY    ++  G +      + S        +   + +A  L YLH K
Sbjct: 70  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA--LEYLHGK 127
Query: 184 GCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFM 243
           G    IIHRD+K  NILL  D   QI+DFG AK L  +          GT  +++PE   
Sbjct: 128 G----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 183
Query: 244 HGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSL 277
                + +D++A G  + ++++G  P    ++ L
Sbjct: 184 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL 217

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/246 (26%), Positives = 109/246 (44%), Gaps = 52/246 (21%)
Query: 59  EEISIATNAFSSENLVGRGGYAEVY----KGVLQDGEE--IAVKRLTKVVTDDRKEKEFL 112
           +E  +A    +    +G+G +  VY    KGV++D  E  +A+K + +  +  R+  EFL
Sbjct: 11  DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASM-RERIEFL 69
Query: 113 TEIGTIGHV-CHPNVLSLLGCCVDNG--LYLIFQFSSRGSVASLFHDV-----NSPGVEW 164
            E   +    CH +V+ LLG  V  G    +I +  +RG + S    +     N+P +  
Sbjct: 70  NEASVMKEFNCH-HVVRLLGV-VSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAP 127
Query: 165 KVRHKI---AVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAK----- 216
               K+   A   A G+ YL+     + +HRD+ + N ++  DF  +I DFG+ +     
Sbjct: 128 PSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET 184
Query: 217 ---------WLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-G 266
                     LP +W              ++PE    G+    +DV++FGV L EI +  
Sbjct: 185 DYYRKGGKGLLPVRW--------------MSPESLKDGVFTTYSDVWSFGVVLWEIATLA 230
Query: 267 RKPVDG 272
            +P  G
Sbjct: 231 EQPYQG 236

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/246 (26%), Positives = 109/246 (44%), Gaps = 52/246 (21%)
Query: 59  EEISIATNAFSSENLVGRGGYAEVY----KGVLQDGEE--IAVKRLTKVVTDDRKEKEFL 112
           +E  +A    +    +G+G +  VY    KGV++D  E  +A+K + +  +  R+  EFL
Sbjct: 12  DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASM-RERIEFL 70
Query: 113 TEIGTIGHV-CHPNVLSLLGCCVDNG--LYLIFQFSSRGSVASLFHDV-----NSPGVEW 164
            E   +    CH +V+ LLG  V  G    +I +  +RG + S    +     N+P +  
Sbjct: 71  NEASVMKEFNCH-HVVRLLGV-VSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAP 128
Query: 165 KVRHKI---AVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAK----- 216
               K+   A   A G+ YL+     + +HRD+ + N ++  DF  +I DFG+ +     
Sbjct: 129 PSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXET 185
Query: 217 ---------WLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-G 266
                     LP +W              ++PE    G+    +DV++FGV L EI +  
Sbjct: 186 DXXRKGGKGLLPVRW--------------MSPESLKDGVFTTYSDVWSFGVVLWEIATLA 231
Query: 267 RKPVDG 272
            +P  G
Sbjct: 232 EQPYQG 237

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/246 (26%), Positives = 109/246 (44%), Gaps = 52/246 (21%)
Query: 59  EEISIATNAFSSENLVGRGGYAEVY----KGVLQDGEE--IAVKRLTKVVTDDRKEKEFL 112
           +E  +A    +    +G+G +  VY    KGV++D  E  +A+K + +  +  R+  EFL
Sbjct: 3   DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASM-RERIEFL 61
Query: 113 TEIGTIGHV-CHPNVLSLLGCCVDNG--LYLIFQFSSRGSVASLFHDV-----NSPGVEW 164
            E   +    CH +V+ LLG  V  G    +I +  +RG + S    +     N+P +  
Sbjct: 62  NEASVMKEFNCH-HVVRLLGV-VSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAP 119
Query: 165 KVRHKI---AVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAK----- 216
               K+   A   A G+ YL+     + +HRD+ + N ++  DF  +I DFG+ +     
Sbjct: 120 PSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXET 176
Query: 217 ---------WLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-G 266
                     LP +W              ++PE    G+    +DV++FGV L EI +  
Sbjct: 177 DXXRKGGKGLLPVRW--------------MSPESLKDGVFTTYSDVWSFGVVLWEIATLA 222
Query: 267 RKPVDG 272
            +P  G
Sbjct: 223 EQPYQG 228

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/156 (28%), Positives = 85/156 (54%), Gaps = 21/156 (13%)
Query: 74  VGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEK---EFLTEIGTIGHVCHPNVLSL 129
           +G+G + EV+K    + G+++A+K   KV+ ++ KE      L EI  +  + H NV++L
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALK---KVLMENEKEGFPITALREIKILQLLKHENVVNL 81
Query: 130 LGCC---------VDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHY 180
           +  C             +YL+F F     +A L  +V       +++ ++      GL+Y
Sbjct: 82  IEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIK-RVMQMLLNGLYY 139
Query: 181 LHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAK 216
           +H+    +I+HRD+K++N+L+T D   +++DFGLA+
Sbjct: 140 IHRN---KILHRDMKAANVLITRDGVLKLADFGLAR 172

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 72/275 (26%), Positives = 116/275 (42%), Gaps = 37/275 (13%)
Query: 85  GVLQDGE---------EIAVKRLT-KVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCV 134
           GV++ GE          +AVK L   V++      +F+ E+  +  + H N++ L G  +
Sbjct: 26  GVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL 85
Query: 135 DNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDI 194
              + ++ + +  GS+           +   +  + AV  A G+ YL     +R IHRD+
Sbjct: 86  TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTL-SRYAVQVAEGMGYLES---KRFIHRDL 141
Query: 195 KSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGT-FGHLAPEYFMHGIVDEKTDV 253
            + N+LL      +I DFGL + LP    H+ +       F   APE          +D 
Sbjct: 142 AARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDT 201
Query: 254 FAFGVFLLEIIS-GRKP---VDGSHQSLHSWAKPILNQGEIEKLVDPR--LQGAYDVTQL 307
           + FGV L E+ + G++P   ++GS Q LH   K      E E+L  P    Q  Y+V   
Sbjct: 202 WMFGVTLWEMFTYGQEPWIGLNGS-QILHKIDK------EGERLPRPEDCPQDIYNVM-- 252
Query: 308 NRLAFAASLCIRASPTWRPTMSEVLEVMLEGDQID 342
                    C    P  RPT   + + +LE    D
Sbjct: 253 -------VQCWAHKPEDRPTFVALRDFLLEAQPTD 280

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 92/209 (44%), Gaps = 21/209 (10%)
Query: 74  VGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC 132
           VG G Y  V      + G  +AVK+L++        K    E+  + H+ H NV+ LL  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 133 CVD-------NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGC 185
                     N +YL+         A L + V    +       +     RGL Y+H   
Sbjct: 96  FTPARSLEEFNDVYLVTHLMG----ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 150
Query: 186 QRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHG 245
              IIHRD+K SN+ +  D E +I DFGLA+    + T +       T  + APE  ++ 
Sbjct: 151 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYRAPEIMLNW 203
Query: 246 I-VDEKTDVFAFGVFLLEIISGRKPVDGS 273
           +  ++  D+++ G  + E+++GR    G+
Sbjct: 204 MHYNQTVDIWSVGCIMAELLTGRTLFPGT 232

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/245 (25%), Positives = 107/245 (43%), Gaps = 50/245 (20%)
Query: 59  EEISIATNAFSSENLVGRGGYAEVY----KGVLQDGEE--IAVKRLTKVVTDDRKEKEFL 112
           +E  +A    +    +G+G +  VY    KGV++D  E  +A+K + +  +  R+  EFL
Sbjct: 5   DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASM-RERIEFL 63
Query: 113 TEIGTIGHV-CHPNVLSLLGCCVDNGLYL-IFQFSSRGSVASLFHDV-----NSPGVEWK 165
            E   +    CH +V+ LLG        L I +  +RG + S    +     N+P +   
Sbjct: 64  NEASVMKEFNCH-HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPP 122
Query: 166 VRHKI---AVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAK------ 216
              K+   A   A G+ YL+     + +HRD+ + N ++  DF  +I DFG+ +      
Sbjct: 123 SLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD 179
Query: 217 --------WLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GR 267
                    LP +W              ++PE    G+    +DV++FGV L EI +   
Sbjct: 180 YYRKGGKGLLPVRW--------------MSPESLKDGVFTTYSDVWSFGVVLWEIATLAE 225
Query: 268 KPVDG 272
           +P  G
Sbjct: 226 QPYQG 230

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/246 (26%), Positives = 109/246 (44%), Gaps = 52/246 (21%)
Query: 59  EEISIATNAFSSENLVGRGGYAEVY----KGVLQDGEE--IAVKRLTKVVTDDRKEKEFL 112
           +E  +A    +    +G+G +  VY    KGV++D  E  +A+K + +  +  R+  EFL
Sbjct: 12  DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASM-RERIEFL 70
Query: 113 TEIGTIGHV-CHPNVLSLLGCCVDNG--LYLIFQFSSRGSVASLFHDV-----NSPGVEW 164
            E   +    CH +V+ LLG  V  G    +I +  +RG + S    +     N+P +  
Sbjct: 71  NEASVMKEFNCH-HVVRLLGV-VSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAP 128
Query: 165 KVRHKI---AVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAK----- 216
               K+   A   A G+ YL+     + +HRD+ + N ++  DF  +I DFG+ +     
Sbjct: 129 PSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET 185
Query: 217 ---------WLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-G 266
                     LP +W              ++PE    G+    +DV++FGV L EI +  
Sbjct: 186 DYYRKGGKGLLPVRW--------------MSPESLKDGVFTTYSDVWSFGVVLWEIATLA 231
Query: 267 RKPVDG 272
            +P  G
Sbjct: 232 EQPYQG 237

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 90/213 (42%), Gaps = 8/213 (3%)
Query: 68  FSSENLVGRGGYAEVYKGV-LQDGEEIAVKRLTKV-VTDDRKEKEFLTEIGTIGHVCHPN 125
           F    ++G G ++ V     L    E A+K L K  +  + K      E   +  + HP 
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 126 VLSLLGCCVDN-GLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKG 184
            + L     D+  LY    ++  G +      + S        +   + +A  L YLH  
Sbjct: 94  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA--LEYLHG- 150
Query: 185 CQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMH 244
             + IIHRD+K  NILL  D   QI+DFG AK L  +          GT  +++PE    
Sbjct: 151 --KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 208
Query: 245 GIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSL 277
               + +D++A G  + ++++G  P    ++ L
Sbjct: 209 KSACKSSDLWALGCIIYQLVAGLPPFRAGNEGL 241

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/246 (26%), Positives = 109/246 (44%), Gaps = 52/246 (21%)
Query: 59  EEISIATNAFSSENLVGRGGYAEVY----KGVLQDGEE--IAVKRLTKVVTDDRKEKEFL 112
           +E  +A    +    +G+G +  VY    KGV++D  E  +A+K + +  +  R+  EFL
Sbjct: 8   DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASM-RERIEFL 66
Query: 113 TEIGTIGHV-CHPNVLSLLGCCVDNG--LYLIFQFSSRGSVASLFHDV-----NSPGVEW 164
            E   +    CH +V+ LLG  V  G    +I +  +RG + S    +     N+P +  
Sbjct: 67  NEASVMKEFNCH-HVVRLLGV-VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAP 124
Query: 165 KVRHKI---AVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAK----- 216
               K+   A   A G+ YL+     + +HRD+ + N ++  DF  +I DFG+ +     
Sbjct: 125 PSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET 181
Query: 217 ---------WLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-G 266
                     LP +W              ++PE    G+    +DV++FGV L EI +  
Sbjct: 182 DYYRKGGKGLLPVRW--------------MSPESLKDGVFTTYSDVWSFGVVLWEIATLA 227
Query: 267 RKPVDG 272
            +P  G
Sbjct: 228 EQPYQG 233

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 91/205 (44%), Gaps = 12/205 (5%)
Query: 74  VGRGGYAEVYKGVLQDGEEIAVKR---LTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLL 130
           +G G +  V KG  Q  + +       L     D   + E L E   +  + +P ++ ++
Sbjct: 33  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 92
Query: 131 GCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRII 190
           G C      L+ + +  G +        +  V+ K   ++    + G+ YL    +   +
Sbjct: 93  GICEAESWMLVMEMAELGPLNKYLQ--QNRHVKDKNIIELVHQVSMGMKYLE---ESNFV 147
Query: 191 HRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTF--GHLAPEYFMHGIVD 248
           HRD+ + N+LL      +ISDFGL+K L +   ++  A   G +     APE   +    
Sbjct: 148 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK-AQTHGKWPVKWYAPECINYYKFS 206
Query: 249 EKTDVFAFGVFLLEIIS-GRKPVDG 272
            K+DV++FGV + E  S G+KP  G
Sbjct: 207 SKSDVWSFGVLMWEAFSYGQKPYRG 231

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 91/214 (42%), Gaps = 10/214 (4%)
Query: 68  FSSENLVGRGGYAEVYKGV-LQDGEEIAVKRLTKV-VTDDRKEKEFLTEIGTIGHVCHPN 125
           F    ++G G ++ V     L    E A+K L K  +  + K      E   +  + HP 
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 126 VLSLLGCCVDN-GLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLH-K 183
            + L     D+  LY    ++  G +      + S        +   + +A  L YLH K
Sbjct: 92  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA--LEYLHGK 149
Query: 184 GCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFM 243
           G    IIHRD+K  NILL  D   QI+DFG AK L  +          GT  +++PE   
Sbjct: 150 G----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPELLT 205
Query: 244 HGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSL 277
                + +D++A G  + ++++G  P    ++ L
Sbjct: 206 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL 239

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 92/209 (44%), Gaps = 12/209 (5%)
Query: 74  VGRGGYAEVYKGVLQDGEEIAVKR---LTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLL 130
           +G G +  V KG  Q  + +       L     D   + E L E   +  + +P ++ ++
Sbjct: 15  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 74
Query: 131 GCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRII 190
           G C      L+ + +  G +        +  V+ K   ++    + G+ YL    +   +
Sbjct: 75  GICEAESWMLVMEMAELGPLNKYLQ--QNRHVKDKNIIELVHQVSMGMKYLE---ESNFV 129
Query: 191 HRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTF--GHLAPEYFMHGIVD 248
           HRD+ + N+LL      +ISDFGL+K L +   ++  A   G +     APE   +    
Sbjct: 130 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK-AQTHGKWPVKWYAPECINYYKFS 188
Query: 249 EKTDVFAFGVFLLEIIS-GRKPVDGSHQS 276
            K+DV++FGV + E  S G+KP  G   S
Sbjct: 189 SKSDVWSFGVLMWEAFSYGQKPYRGMKGS 217

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 92/209 (44%), Gaps = 12/209 (5%)
Query: 74  VGRGGYAEVYKGVLQDGEEIAVKR---LTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLL 130
           +G G +  V KG  Q  + +       L     D   + E L E   +  + +P ++ ++
Sbjct: 19  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 78
Query: 131 GCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRII 190
           G C      L+ + +  G +        +  V+ K   ++    + G+ YL    +   +
Sbjct: 79  GICEAESWMLVMEMAELGPLNKYLQ--QNRHVKDKNIIELVHQVSMGMKYLE---ESNFV 133
Query: 191 HRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTF--GHLAPEYFMHGIVD 248
           HRD+ + N+LL      +ISDFGL+K L +   ++  A   G +     APE   +    
Sbjct: 134 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK-AQTHGKWPVKWYAPECINYYKFS 192
Query: 249 EKTDVFAFGVFLLEIIS-GRKPVDGSHQS 276
            K+DV++FGV + E  S G+KP  G   S
Sbjct: 193 SKSDVWSFGVLMWEAFSYGQKPYRGMKGS 221

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 92/209 (44%), Gaps = 12/209 (5%)
Query: 74  VGRGGYAEVYKGVLQDGEEIAVKR---LTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLL 130
           +G G +  V KG  Q  + +       L     D   + E L E   +  + +P ++ ++
Sbjct: 25  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 131 GCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRII 190
           G C      L+ + +  G +        +  V+ K   ++    + G+ YL    +   +
Sbjct: 85  GICEAESWMLVMEMAELGPLNKYLQ--QNRHVKDKNIIELVHQVSMGMKYLE---ESNFV 139
Query: 191 HRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTF--GHLAPEYFMHGIVD 248
           HRD+ + N+LL      +ISDFGL+K L +   ++  A   G +     APE   +    
Sbjct: 140 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK-AQTHGKWPVKWYAPECINYYKFS 198
Query: 249 EKTDVFAFGVFLLEIIS-GRKPVDGSHQS 276
            K+DV++FGV + E  S G+KP  G   S
Sbjct: 199 SKSDVWSFGVLMWEAFSYGQKPYRGMKGS 227

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 91/209 (43%), Gaps = 21/209 (10%)
Query: 74  VGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC 132
           VG G Y  V      + G  +AVK+L++        K    E+  + H+ H NV+ LL  
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 109
Query: 133 CVD-------NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGC 185
                     N +YL+         A L + V    +       +     RGL Y+H   
Sbjct: 110 FTPARSLEEFNDVYLVTHLMG----ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 164
Query: 186 QRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHG 245
              IIHRD+K SN+ +  D E +I DFGLA+      T   +     T  + APE  ++ 
Sbjct: 165 --DIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMXGXVATRWYRAPEIMLNW 217
Query: 246 I-VDEKTDVFAFGVFLLEIISGRKPVDGS 273
           +  ++  D+++ G  + E+++GR    G+
Sbjct: 218 MHYNQTVDIWSVGCIMAELLTGRTLFPGT 246

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/246 (26%), Positives = 109/246 (44%), Gaps = 52/246 (21%)
Query: 59  EEISIATNAFSSENLVGRGGYAEVY----KGVLQDGEE--IAVKRLTKVVTDDRKEKEFL 112
           +E  +A    +    +G+G +  VY    KGV++D  E  +A+K + +  +  R+  EFL
Sbjct: 11  DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASM-RERIEFL 69
Query: 113 TEIGTIGHV-CHPNVLSLLGCCVDNG--LYLIFQFSSRGSVASLFHDV-----NSPGVEW 164
            E   +    CH +V+ LLG  V  G    +I +  +RG + S    +     N+P +  
Sbjct: 70  NEASVMKEFNCH-HVVRLLGV-VSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAP 127
Query: 165 KVRHKI---AVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAK----- 216
               K+   A   A G+ YL+     + +HRD+ + N ++  DF  +I DFG+ +     
Sbjct: 128 PSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET 184
Query: 217 ---------WLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-G 266
                     LP +W              ++PE    G+    +DV++FGV L EI +  
Sbjct: 185 DYYRKGGKGLLPVRW--------------MSPESLKDGVFTTYSDVWSFGVVLWEIATLA 230
Query: 267 RKPVDG 272
            +P  G
Sbjct: 231 EQPYQG 236

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/246 (25%), Positives = 105/246 (42%), Gaps = 22/246 (8%)
Query: 38  ENVVVACESETTKPT-WRCFSFEEISIATNAFSSENLVGRGGYAEVYKGV-LQDGEEIAV 95
           EN+     +   +PT +R    + I      + + + VG G Y  V      + G  +AV
Sbjct: 16  ENLYFQSNASQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAV 75
Query: 96  KRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVD-------NGLYLIFQFSSRG 148
           K+L++        K    E+  + H+ H NV+ LL            N +YL+       
Sbjct: 76  KKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-- 133
Query: 149 SVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQ 208
             A L + V    +       +     RGL Y+H      IIHRD+K SN+ +  D E +
Sbjct: 134 --ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELK 188
Query: 209 ISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGI-VDEKTDVFAFGVFLLEIISGR 267
           I DFGLA+      T   +     T  + APE  ++ +  ++  D+++ G  + E+++GR
Sbjct: 189 ILDFGLAR-----HTDDEMXGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243
Query: 268 KPVDGS 273
               G+
Sbjct: 244 TLFPGT 249

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 92/209 (44%), Gaps = 12/209 (5%)
Query: 74  VGRGGYAEVYKGVLQDGEEIAVKR---LTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLL 130
           +G G +  V KG  Q  + +       L     D   + E L E   +  + +P ++ ++
Sbjct: 13  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 72
Query: 131 GCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRII 190
           G C      L+ + +  G +        +  V+ K   ++    + G+ YL    +   +
Sbjct: 73  GICEAESWMLVMEMAELGPLNKYLQQ--NRHVKDKNIIELVHQVSMGMKYLE---ESNFV 127
Query: 191 HRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTF--GHLAPEYFMHGIVD 248
           HRD+ + N+LL      +ISDFGL+K L +   ++  A   G +     APE   +    
Sbjct: 128 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK-AQTHGKWPVKWYAPECINYYKFS 186
Query: 249 EKTDVFAFGVFLLEIIS-GRKPVDGSHQS 276
            K+DV++FGV + E  S G+KP  G   S
Sbjct: 187 SKSDVWSFGVLMWEAFSYGQKPYRGMKGS 215

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 87/213 (40%), Gaps = 8/213 (3%)
Query: 68  FSSENLVGRGGYAEVYKGV-LQDGEEIAVKRLTKV-VTDDRKEKEFLTEIGTIGHVCHPN 125
           F    ++G G ++ V     L    E A+K L K  +  + K      E   +  + HP 
Sbjct: 35  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 94
Query: 126 VLSLLGCCVDN-GLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKG 184
            + L     D+  LY    ++  G +      + S   +              L YLH  
Sbjct: 95  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS--FDETCTRFYTAEIVSALEYLHG- 151
Query: 185 CQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMH 244
             + IIHRD+K  NILL  D   QI+DFG AK L  +          GT  +++PE    
Sbjct: 152 --KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 209
Query: 245 GIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSL 277
               + +D++A G  + ++++G  P    ++ L
Sbjct: 210 KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL 242

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 96/210 (45%), Gaps = 23/210 (10%)
Query: 74  VGRGGYAEVYKGVL-QDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC 132
           VG G Y  V   V  + G ++A+K+L +    +   K    E+  + H+ H NV+ LL  
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDV 92
Query: 133 CVDN-------GLYLIFQFSSRGSVASLFHD-VNSPGVEWKVRHKIAVGTARGLHYLHKG 184
              +         YL+  F        + H+ +    +++ V   +     +GL Y+H  
Sbjct: 93  FTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQML-----KGLRYIHAA 147
Query: 185 CQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMH 244
               IIHRD+K  N+ +  D E +I DFGLA+   S+     +     T  + APE  ++
Sbjct: 148 G---IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMXGXVV-----TRWYRAPEVILN 199
Query: 245 GIVDEKT-DVFAFGVFLLEIISGRKPVDGS 273
            +   +T D+++ G  + E+I+G+    GS
Sbjct: 200 WMRYTQTVDIWSVGCIMAEMITGKTLFKGS 229

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 72/275 (26%), Positives = 116/275 (42%), Gaps = 37/275 (13%)
Query: 85  GVLQDGE---------EIAVKRLTK-VVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCV 134
           GV++ GE          +AVK L   V++      +F+ E+  +  + H N++ L G  +
Sbjct: 32  GVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL 91
Query: 135 DNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDI 194
              + ++ + +  GS+           +   +  + AV  A G+ YL     +R IHRD+
Sbjct: 92  TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTL-SRYAVQVAEGMGYLES---KRFIHRDL 147
Query: 195 KSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGT-FGHLAPEYFMHGIVDEKTDV 253
            + N+LL      +I DFGL + LP    H+ +       F   APE          +D 
Sbjct: 148 AARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDT 207
Query: 254 FAFGVFLLEIIS-GRKP---VDGSHQSLHSWAKPILNQGEIEKLVDPR--LQGAYDVTQL 307
           + FGV L E+ + G++P   ++GS Q LH   K      E E+L  P    Q  Y+V   
Sbjct: 208 WMFGVTLWEMFTYGQEPWIGLNGS-QILHKIDK------EGERLPRPEDCPQDIYNVM-- 258
Query: 308 NRLAFAASLCIRASPTWRPTMSEVLEVMLEGDQID 342
                    C    P  RPT   + + +LE    D
Sbjct: 259 -------VQCWAHKPEDRPTFVALRDFLLEAQPTD 286

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 96/211 (45%), Gaps = 25/211 (11%)
Query: 74  VGRGGYAEV---YKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLL 130
           VG G Y  V   Y   L+  +++AVK+L++        +    E+  + H+ H NV+ LL
Sbjct: 36  VGSGAYGSVCSAYDARLR--QKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 131 GCCVD-------NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHK 183
                       + +YL+         A L + V S  +  +    +     RGL Y+H 
Sbjct: 94  DVFTPATSIEDFSEVYLVTTLMG----ADLNNIVKSQALSDEHVQFLVYQLLRGLKYIHS 149
Query: 184 GCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFM 243
                IIHRD+K SN+ +  D E +I DFGLA+    + T +       T  + APE  +
Sbjct: 150 AG---IIHRDLKPSNVAVNEDSELRILDFGLARQADEEMTGYV-----ATRWYRAPEIML 201
Query: 244 HGI-VDEKTDVFAFGVFLLEIISGRKPVDGS 273
           + +  ++  D+++ G  + E++ G+    GS
Sbjct: 202 NWMHYNQTVDIWSVGCIMAELLQGKALFPGS 232

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 92/209 (44%), Gaps = 21/209 (10%)
Query: 74  VGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC 132
           VG G Y  V      + G  +AVK+L++        K    E+  + H+ H NV+ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 133 CVD-------NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGC 185
                     N +YL+         A L + V    +       +     RGL Y+H   
Sbjct: 90  FTPARSLEEFNDVYLVTHLMG----ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 144
Query: 186 QRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHG 245
              IIHRD+K SN+ +  D E +I D+GLA+    + T +       T  + APE  ++ 
Sbjct: 145 --DIIHRDLKPSNLAVNEDCELKILDYGLARHTDDEMTGYV-----ATRWYRAPEIMLNW 197
Query: 246 I-VDEKTDVFAFGVFLLEIISGRKPVDGS 273
           +  ++  D+++ G  + E+++GR    G+
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGT 226

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 87/213 (40%), Gaps = 8/213 (3%)
Query: 68  FSSENLVGRGGYAEVYKGV-LQDGEEIAVKRLTKV-VTDDRKEKEFLTEIGTIGHVCHPN 125
           F    ++G G ++ V     L    E A+K L K  +  + K      E   +  + HP 
Sbjct: 35  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 94
Query: 126 VLSLLGCCVDN-GLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKG 184
            + L     D+  LY    ++  G +      + S   +              L YLH  
Sbjct: 95  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS--FDETCTRFYTAEIVSALEYLHG- 151
Query: 185 CQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMH 244
             + IIHRD+K  NILL  D   QI+DFG AK L  +          GT  +++PE    
Sbjct: 152 --KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 209
Query: 245 GIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSL 277
               + +D++A G  + ++++G  P    ++ L
Sbjct: 210 KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL 242

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 91/214 (42%), Gaps = 10/214 (4%)
Query: 68  FSSENLVGRGGYAEVYKGV-LQDGEEIAVKRLTKV-VTDDRKEKEFLTEIGTIGHVCHPN 125
           F    ++G G ++ V     L    E A+K L K  +  + K      E   +  + HP 
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 126 VLSLLGCCVDN-GLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLH-K 183
            + L     D+  LY    ++  G +      + S        +   + +A  L YLH K
Sbjct: 92  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA--LEYLHGK 149
Query: 184 GCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFM 243
           G    IIHRD+K  NILL  D   QI+DFG AK L  +          GT  +++PE   
Sbjct: 150 G----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 205
Query: 244 HGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSL 277
                + +D++A G  + ++++G  P    ++ L
Sbjct: 206 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL 239

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 45/156 (28%), Positives = 85/156 (54%), Gaps = 21/156 (13%)
Query: 74  VGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEK---EFLTEIGTIGHVCHPNVLSL 129
           +G+G + EV+K    + G+++A+K   KV+ ++ KE      L EI  +  + H NV++L
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALK---KVLMENEKEGFPITALREIKILQLLKHENVVNL 82
Query: 130 LGCC---------VDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHY 180
           +  C             +YL+F F     +A L  +V       +++ ++      GL+Y
Sbjct: 83  IEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIK-RVMQMLLNGLYY 140
Query: 181 LHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAK 216
           +H+    +I+HRD+K++N+L+T D   +++DFGLA+
Sbjct: 141 IHRN---KILHRDMKAANVLITRDGVLKLADFGLAR 173

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 49/187 (26%), Positives = 86/187 (45%), Gaps = 24/187 (12%)
Query: 90  GEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG---LYLIFQFSS 146
           G  +AVK+L     D  ++++F  EI  +  +    ++   G     G   L L+ ++  
Sbjct: 39  GALVAVKQLQHSGPD--QQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLP 96
Query: 147 RGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQ-------RRIIHRDIKSSNI 199
            G +                RH+  +  +R L Y  + C+       RR +HRD+ + NI
Sbjct: 97  SGCLRDFLQ-----------RHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNI 145
Query: 200 LLTADFEPQISDFGLAKWLPSQWTHHSI-APIEGTFGHLAPEYFMHGIVDEKTDVFAFGV 258
           L+ ++   +I+DFGLAK LP    ++ +  P +      APE     I   ++DV++FGV
Sbjct: 146 LVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGV 205
Query: 259 FLLEIIS 265
            L E+ +
Sbjct: 206 VLYELFT 212

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 90/213 (42%), Gaps = 8/213 (3%)
Query: 68  FSSENLVGRGGYAEVYKGV-LQDGEEIAVKRLTKV-VTDDRKEKEFLTEIGTIGHVCHPN 125
           F    ++G G ++ V     L    E A+K L K  +  + K      E   +  + HP 
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 126 VLSLLGCCVDN-GLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKG 184
            + L     D+  LY    ++  G +      + S        +   + +A  L YLH  
Sbjct: 94  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA--LEYLHG- 150
Query: 185 CQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMH 244
             + IIHRD+K  NILL  D   QI+DFG AK L  +          GT  +++PE    
Sbjct: 151 --KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 208
Query: 245 GIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSL 277
               + +D++A G  + ++++G  P    ++ L
Sbjct: 209 KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL 241

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 87/213 (40%), Gaps = 8/213 (3%)
Query: 68  FSSENLVGRGGYAEVYKGV-LQDGEEIAVKRLTKV-VTDDRKEKEFLTEIGTIGHVCHPN 125
           F    ++G G ++ V     L    E A+K L K  +  + K      E   +  + HP 
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 126 VLSLLGCCVDN-GLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKG 184
            + L     D+  LY    ++  G +      + S   +              L YLH  
Sbjct: 94  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS--FDETCTRFYTAEIVSALEYLHG- 150
Query: 185 CQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMH 244
             + IIHRD+K  NILL  D   QI+DFG AK L  +          GT  +++PE    
Sbjct: 151 --KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 208
Query: 245 GIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSL 277
               + +D++A G  + ++++G  P    ++ L
Sbjct: 209 KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL 241

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 91/214 (42%), Gaps = 10/214 (4%)
Query: 68  FSSENLVGRGGYAEVYKGV-LQDGEEIAVKRLTKV-VTDDRKEKEFLTEIGTIGHVCHPN 125
           F    ++G G ++ V     L    E A+K L K  +  + K      E   +  + HP 
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 126 VLSLLGCCVDN-GLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLH-K 183
            + L     D+  LY    ++  G +      + S        +   + +A  L YLH K
Sbjct: 92  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA--LEYLHGK 149
Query: 184 GCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFM 243
           G    IIHRD+K  NILL  D   QI+DFG AK L  +          GT  +++PE   
Sbjct: 150 G----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 205
Query: 244 HGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSL 277
                + +D++A G  + ++++G  P    ++ L
Sbjct: 206 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL 239

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 91/214 (42%), Gaps = 10/214 (4%)
Query: 68  FSSENLVGRGGYAEVYKGV-LQDGEEIAVKRLTKV-VTDDRKEKEFLTEIGTIGHVCHPN 125
           F    ++G G ++ V     L    E A+K L K  +  + K      E   +  + HP 
Sbjct: 16  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 75
Query: 126 VLSLLGCCVDN-GLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLH-K 183
            + L     D+  LY    ++  G +      + S        +   + +A  L YLH K
Sbjct: 76  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA--LEYLHGK 133
Query: 184 GCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFM 243
           G    IIHRD+K  NILL  D   QI+DFG AK L  +          GT  +++PE   
Sbjct: 134 G----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 189
Query: 244 HGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSL 277
                + +D++A G  + ++++G  P    ++ L
Sbjct: 190 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL 223

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 91/209 (43%), Gaps = 21/209 (10%)
Query: 74  VGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC 132
           VG G Y  V      + G  +AVK+L++        K    E+  + H+ H NV+ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 133 CVD-------NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGC 185
                     N +YL+         A L + V    +       +     RGL Y+H   
Sbjct: 90  FTPARSLEEFNDVYLVTHLMG----ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 144
Query: 186 QRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHG 245
              IIHRD+K SN+ +  D E +I DFGLA+      T   +     T  + APE  ++ 
Sbjct: 145 --DIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGXVATRWYRAPEIMLNW 197
Query: 246 I-VDEKTDVFAFGVFLLEIISGRKPVDGS 273
           +  ++  D+++ G  + E+++GR    G+
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGT 226

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 87/213 (40%), Gaps = 8/213 (3%)
Query: 68  FSSENLVGRGGYAEVYKGV-LQDGEEIAVKRLTKV-VTDDRKEKEFLTEIGTIGHVCHPN 125
           F    ++G G ++ V     L    E A+K L K  +  + K      E   +  + HP 
Sbjct: 37  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 96
Query: 126 VLSLLGCCVDN-GLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKG 184
            + L     D+  LY    ++  G +      + S   +              L YLH  
Sbjct: 97  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS--FDETCTRFYTAEIVSALEYLHG- 153
Query: 185 CQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMH 244
             + IIHRD+K  NILL  D   QI+DFG AK L  +          GT  +++PE    
Sbjct: 154 --KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 211
Query: 245 GIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSL 277
               + +D++A G  + ++++G  P    ++ L
Sbjct: 212 KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL 244

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 91/214 (42%), Gaps = 10/214 (4%)
Query: 68  FSSENLVGRGGYAEVYKGV-LQDGEEIAVKRLTKV-VTDDRKEKEFLTEIGTIGHVCHPN 125
           F    ++G G ++ V     L    E A+K L K  +  + K      E   +  + HP 
Sbjct: 31  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 90
Query: 126 VLSLLGCCVDN-GLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLH-K 183
            + L     D+  LY    ++  G +      + S        +   + +A  L YLH K
Sbjct: 91  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA--LEYLHGK 148
Query: 184 GCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFM 243
           G    IIHRD+K  NILL  D   QI+DFG AK L  +          GT  +++PE   
Sbjct: 149 G----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 204
Query: 244 HGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSL 277
                + +D++A G  + ++++G  P    ++ L
Sbjct: 205 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL 238

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 91/214 (42%), Gaps = 10/214 (4%)
Query: 68  FSSENLVGRGGYAE-VYKGVLQDGEEIAVKRLTKV-VTDDRKEKEFLTEIGTIGHVCHPN 125
           F    ++G G ++  V    L    E A+K L K  +  + K      E   +  + HP 
Sbjct: 32  FKFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 126 VLSLLGCCVDN-GLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLH-K 183
            + L     D+  LY    ++  G +      + S        +   + +A  L YLH K
Sbjct: 92  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA--LEYLHGK 149
Query: 184 GCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFM 243
           G    IIHRD+K  NILL  D   QI+DFG AK L  +          GT  +++PE   
Sbjct: 150 G----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 205
Query: 244 HGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSL 277
                + +D++A G  + ++++G  P    ++ L
Sbjct: 206 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL 239

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 100/212 (47%), Gaps = 21/212 (9%)
Query: 73  LVGRGGYAEVYKGV-LQDGEEIAVKRL-TKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLL 130
           ++G GG +EV+    L+   ++AVK L   +  D      F  E      + HP ++++ 
Sbjct: 19  ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 131 GCCVDNG---------LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYL 181
               D G          Y++ ++    ++  + H    P    +    IA    + L++ 
Sbjct: 79  ----DTGEAETPAGPLPYIVMEYVDGVTLRDIVH-TEGPMTPKRAIEVIA-DACQALNFS 132
Query: 182 HKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLP-SQWTHHSIAPIEGTFGHLAPE 240
           H   Q  IIHRD+K +NI+++A    ++ DFG+A+ +  S  +    A + GT  +L+PE
Sbjct: 133 H---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 189
Query: 241 YFMHGIVDEKTDVFAFGVFLLEIISGRKPVDG 272
                 VD ++DV++ G  L E+++G  P  G
Sbjct: 190 QARGDSVDARSDVYSLGCVLYEVLTGEPPFTG 221

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 49/187 (26%), Positives = 86/187 (45%), Gaps = 24/187 (12%)
Query: 90  GEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG---LYLIFQFSS 146
           G  +AVK+L     D  ++++F  EI  +  +    ++   G     G   L L+ ++  
Sbjct: 52  GALVAVKQLQHSGPD--QQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLP 109
Query: 147 RGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQ-------RRIIHRDIKSSNI 199
            G +                RH+  +  +R L Y  + C+       RR +HRD+ + NI
Sbjct: 110 SGCLRDFLQ-----------RHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNI 158
Query: 200 LLTADFEPQISDFGLAKWLPSQWTHHSI-APIEGTFGHLAPEYFMHGIVDEKTDVFAFGV 258
           L+ ++   +I+DFGLAK LP    ++ +  P +      APE     I   ++DV++FGV
Sbjct: 159 LVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGV 218
Query: 259 FLLEIIS 265
            L E+ +
Sbjct: 219 VLYELFT 225

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 101/224 (45%), Gaps = 18/224 (8%)
Query: 62  SIATNAFSSENLVGRGGYAEVYK----GVLQDGEEIAVKRLTK--VVTDDRKEKEFLTEI 115
            I    F    ++G+GGY +V++         G+  A+K L K  +V + +       E 
Sbjct: 13  KIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAER 72
Query: 116 GTIGHVCHPNVLSLLGCCVDNG-LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVG- 173
             +  V HP ++ L+      G LYLI ++ S G    LF  +   G+  +      +  
Sbjct: 73  NILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGE---LFMQLEREGIFMEDTACFYLAE 129
Query: 174 TARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWT-HHSIAPIEG 232
            +  L +LH   Q+ II+RD+K  NI+L      +++DFGL K      T  H+     G
Sbjct: 130 ISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFC---G 183
Query: 233 TFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQS 276
           T  ++APE  M    +   D ++ G  + ++++G  P  G ++ 
Sbjct: 184 TIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRK 227

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 45/156 (28%), Positives = 85/156 (54%), Gaps = 21/156 (13%)
Query: 74  VGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEK---EFLTEIGTIGHVCHPNVLSL 129
           +G+G + EV+K    + G+++A+K   KV+ ++ KE      L EI  +  + H NV++L
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALK---KVLMENEKEGFPITALREIKILQLLKHENVVNL 82
Query: 130 LGCC---------VDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHY 180
           +  C             +YL+F F     +A L  +V       +++ ++      GL+Y
Sbjct: 83  IEICRTKASPYNRCKASIYLVFDFCEH-DLAGLLSNVLVKFTLSEIK-RVMQMLLNGLYY 140
Query: 181 LHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAK 216
           +H+    +I+HRD+K++N+L+T D   +++DFGLA+
Sbjct: 141 IHRN---KILHRDMKAANVLITRDGVLKLADFGLAR 173

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 94/203 (46%), Gaps = 20/203 (9%)
Query: 74  VGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC 132
           +GRG + EV++    Q G + AVK++       R E   + E+     +  P ++ L G 
Sbjct: 80  LGRGSFGEVHRMKDKQTGFQCAVKKV-------RLEVFRVEELVACAGLSSPRIVPLYGA 132
Query: 133 CVDNGLYLIF-QFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTA-RGLHYLHKGCQRRII 190
             +     IF +    GS+  L   +   G   + R    +G A  GL YLH    RRI+
Sbjct: 133 VREGPWVNIFMELLEGGSLGQLIKQM---GCLPEDRALYYLGQALEGLEYLHT---RRIL 186
Query: 191 HRDIKSSNILLTAD-FEPQISDFGLAKWLPSQWTHHSIAP---IEGTFGHLAPEYFMHGI 246
           H D+K+ N+LL++D     + DFG A  L       S+     I GT  H+APE  M   
Sbjct: 187 HGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKP 246
Query: 247 VDEKTDVFAFGVFLLEIISGRKP 269
            D K D+++    +L +++G  P
Sbjct: 247 CDAKVDIWSSCCMMLHMLNGCHP 269

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 98/225 (43%), Gaps = 41/225 (18%)
Query: 74  VGRGGYAEVYKGVLQDGE-EIAVKRLTKV------VTDDRKE-----KEFLTEIGTIGHV 121
           +G G Y EV     ++G  E A+K + K        +DD K      +E   EI  +  +
Sbjct: 44  LGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL 103
Query: 122 CHPNVLSLLGCCVDNG-LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHK--------IAV 172
            HPN++ L     D    YL+ +F   G    LF  + +       RHK        I  
Sbjct: 104 DHPNIIKLFDVFEDKKYFYLVTEFYEGGE---LFEQIIN-------RHKFDECDAANIMK 153
Query: 173 GTARGLHYLHKGCQRRIIHRDIKSSNILL---TADFEPQISDFGLAKWLPSQWTHHSIAP 229
               G+ YLHK     I+HRDIK  NILL    +    +I DFGL+ +    +    +  
Sbjct: 154 QILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDY---KLRD 207
Query: 230 IEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSH 274
             GT  ++APE  +    +EK DV++ GV +  ++ G  P  G +
Sbjct: 208 RLGTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCGYPPFGGQN 251

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 72/275 (26%), Positives = 116/275 (42%), Gaps = 37/275 (13%)
Query: 85  GVLQDGE---------EIAVKRLT-KVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCV 134
           GV++ GE          +AVK L   V++      +F+ E+  +  + H N++ L G  +
Sbjct: 22  GVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL 81
Query: 135 DNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDI 194
              + ++ + +  GS+           +   +  + AV  A G+ YL     +R IHRD+
Sbjct: 82  TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTL-SRYAVQVAEGMGYLE---SKRFIHRDL 137
Query: 195 KSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGT-FGHLAPEYFMHGIVDEKTDV 253
            + N+LL      +I DFGL + LP    H+ +       F   APE          +D 
Sbjct: 138 AARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDT 197
Query: 254 FAFGVFLLEIIS-GRKP---VDGSHQSLHSWAKPILNQGEIEKLVDPR--LQGAYDVTQL 307
           + FGV L E+ + G++P   ++GS Q LH   K      E E+L  P    Q  Y+V   
Sbjct: 198 WMFGVTLWEMFTYGQEPWIGLNGS-QILHKIDK------EGERLPRPEDCPQDIYNVM-- 248
Query: 308 NRLAFAASLCIRASPTWRPTMSEVLEVMLEGDQID 342
                    C    P  RPT   + + +LE    D
Sbjct: 249 -------VQCWAHKPEDRPTFVALRDFLLEAQPTD 276

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 91/214 (42%), Gaps = 10/214 (4%)
Query: 68  FSSENLVGRGGYAEVYKGV-LQDGEEIAVKRLTKV-VTDDRKEKEFLTEIGTIGHVCHPN 125
           F    ++G G ++ V     L    E A+K L K  +  + K      E   +  + HP 
Sbjct: 31  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 90
Query: 126 VLSLLGCCVDN-GLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLH-K 183
            + L     D+  LY    ++  G +      + S        +   + +A  L YLH K
Sbjct: 91  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA--LEYLHGK 148
Query: 184 GCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFM 243
           G    IIHRD+K  NILL  D   QI+DFG AK L  +          GT  +++PE   
Sbjct: 149 G----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 204
Query: 244 HGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSL 277
                + +D++A G  + ++++G  P    ++ L
Sbjct: 205 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL 238

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 91/214 (42%), Gaps = 10/214 (4%)
Query: 68  FSSENLVGRGGYAEVYKGV-LQDGEEIAVKRLTKV-VTDDRKEKEFLTEIGTIGHVCHPN 125
           F    ++G G ++ V     L    E A+K L K  +  + K      E   +  + HP 
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 126 VLSLLGCCVDN-GLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLH-K 183
            + L     D+  LY    ++  G +      + S        +   + +A  L YLH K
Sbjct: 94  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA--LEYLHGK 151
Query: 184 GCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFM 243
           G    IIHRD+K  NILL  D   QI+DFG AK L  +          GT  +++PE   
Sbjct: 152 G----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 207
Query: 244 HGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSL 277
                + +D++A G  + ++++G  P    ++ L
Sbjct: 208 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL 241

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 49/187 (26%), Positives = 86/187 (45%), Gaps = 24/187 (12%)
Query: 90  GEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG---LYLIFQFSS 146
           G  +AVK+L     D  ++++F  EI  +  +    ++   G     G   L L+ ++  
Sbjct: 40  GALVAVKQLQHSGPD--QQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLP 97
Query: 147 RGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQ-------RRIIHRDIKSSNI 199
            G +                RH+  +  +R L Y  + C+       RR +HRD+ + NI
Sbjct: 98  SGCLRDFLQ-----------RHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNI 146
Query: 200 LLTADFEPQISDFGLAKWLPSQWTHHSI-APIEGTFGHLAPEYFMHGIVDEKTDVFAFGV 258
           L+ ++   +I+DFGLAK LP    ++ +  P +      APE     I   ++DV++FGV
Sbjct: 147 LVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGV 206
Query: 259 FLLEIIS 265
            L E+ +
Sbjct: 207 VLYELFT 213

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 64/246 (26%), Positives = 109/246 (44%), Gaps = 52/246 (21%)
Query: 59  EEISIATNAFSSENLVGRGGYAEVY----KGVLQDGEE--IAVKRLTKVVTDDRKEKEFL 112
           +E  +A    +    +G+G +  VY    KGV++D  E  +A+K + +  +  R+  EFL
Sbjct: 40  DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASM-RERIEFL 98
Query: 113 TEIGTIGHV-CHPNVLSLLGCCVDNG--LYLIFQFSSRGSVASLFHDV-----NSPGVEW 164
            E   +    CH +V+ LLG  V  G    +I +  +RG + S    +     N+P +  
Sbjct: 99  NEASVMKEFNCH-HVVRLLGV-VSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAP 156
Query: 165 KVRHKI---AVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAK----- 216
               K+   A   A G+ YL+     + +HRD+ + N ++  DF  +I DFG+ +     
Sbjct: 157 PSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET 213
Query: 217 ---------WLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-G 266
                     LP +W              ++PE    G+    +DV++FGV L EI +  
Sbjct: 214 DYYRKGGKGLLPVRW--------------MSPESLKDGVFTTYSDVWSFGVVLWEIATLA 259
Query: 267 RKPVDG 272
            +P  G
Sbjct: 260 EQPYQG 265

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 99/217 (45%), Gaps = 22/217 (10%)
Query: 59  EEISIATNAFSSENLVGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGT 117
           EE+  AT+       +GRG + EV++    Q G + AVK   KV  +  + +E +   G 
Sbjct: 90  EEVHWATHQLR----LGRGSFGEVHRMEDKQTGFQCAVK---KVRLEVFRAEELMACAG- 141
Query: 118 IGHVCHPNVLSLLGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTA-R 176
              +  P ++ L G   +     IF     G   SL   V   G   + R    +G A  
Sbjct: 142 ---LTSPRIVPLYGAVREGPWVNIFMELLEG--GSLGQLVKEQGCLPEDRALYYLGQALE 196
Query: 177 GLHYLHKGCQRRIIHRDIKSSNILLTAD-FEPQISDFGLAKWLPSQWTHHSIAP---IEG 232
           GL YLH    RRI+H D+K+ N+LL++D     + DFG A  L       S+     I G
Sbjct: 197 GLEYLHS---RRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPG 253
Query: 233 TFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKP 269
           T  H+APE  +    D K DV++    +L +++G  P
Sbjct: 254 TETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHP 290

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 100/212 (47%), Gaps = 21/212 (9%)
Query: 73  LVGRGGYAEVYKGV-LQDGEEIAVKRL-TKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLL 130
           ++G GG +EV+    L+   ++AVK L   +  D      F  E      + HP ++++ 
Sbjct: 36  ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 95
Query: 131 GCCVDNG---------LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYL 181
               D G          Y++ ++    ++  + H    P    +    IA    + L++ 
Sbjct: 96  ----DTGEAETPAGPLPYIVMEYVDGVTLRDIVH-TEGPMTPKRAIEVIA-DACQALNFS 149
Query: 182 HKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLP-SQWTHHSIAPIEGTFGHLAPE 240
           H   Q  IIHRD+K +NI+++A    ++ DFG+A+ +  S  +    A + GT  +L+PE
Sbjct: 150 H---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 206
Query: 241 YFMHGIVDEKTDVFAFGVFLLEIISGRKPVDG 272
                 VD ++DV++ G  L E+++G  P  G
Sbjct: 207 QARGDSVDARSDVYSLGCVLYEVLTGEPPFTG 238

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/245 (23%), Positives = 109/245 (44%), Gaps = 21/245 (8%)
Query: 90  GEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC-CVDNGLYLIFQFSSRG 148
           G ++AVK +  +    R+E  F  E+  +    H NV+ +     V   L+++ +F   G
Sbjct: 70  GRQVAVK-MMDLRKQQRRELLF-NEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGG 127
Query: 149 SVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQ 208
           ++  +   V    +  +    +     + L YLH    + +IHRDIKS +ILLT D   +
Sbjct: 128 ALTDIVSQVR---LNEEQIATVCEAVLQALAYLHA---QGVIHRDIKSDSILLTLDGRVK 181
Query: 209 ISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRK 268
           +SDFG    +           + GT   +APE     +   + D+++ G+ ++E++ G  
Sbjct: 182 LSDFGFCAQISKDVPKRKX--LVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEP 239
Query: 269 PVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTM 328
           P        +    P+     +     P+L+ ++ V+ + R  F   + +R  P  R T 
Sbjct: 240 P--------YFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLR-DFLERMLVR-DPQERATA 289
Query: 329 SEVLE 333
            E+L+
Sbjct: 290 QELLD 294

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 74/279 (26%), Positives = 116/279 (41%), Gaps = 45/279 (16%)
Query: 85  GVLQDGE---------EIAVKRLTK-VVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCV 134
           GV++ GE          +AVK L   V++      +F+ E+  +  + H N++ L G  +
Sbjct: 32  GVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL 91
Query: 135 DNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDI 194
              + ++ + +  GS+           +   +  + AV  A G+ YL     +R IHRD+
Sbjct: 92  TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTL-SRYAVQVAEGMGYLES---KRFIHRDL 147
Query: 195 KSSNILLTADFEPQISDFGLAKWLPSQWTH-----HSIAPIEGTFGHLAPEYFMHGIVDE 249
            + N+LL      +I DFGL + LP    H     H   P    F   APE         
Sbjct: 148 AARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVP----FAWCAPESLKTRTFSH 203
Query: 250 KTDVFAFGVFLLEIIS-GRKP---VDGSHQSLHSWAKPILNQGEIEKLVDPR--LQGAYD 303
            +D + FGV L E+ + G++P   ++GS Q LH   K      E E+L  P    Q  Y+
Sbjct: 204 ASDTWMFGVTLWEMFTYGQEPWIGLNGS-QILHKIDK------EGERLPRPEDCPQDIYN 256
Query: 304 VTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEGDQID 342
           V            C    P  RPT   + + +LE    D
Sbjct: 257 VM---------VQCWAHKPEDRPTFVALRDFLLEAQPTD 286

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 98/208 (47%), Gaps = 13/208 (6%)
Query: 73  LVGRGGYAEVYKGV-LQDGEEIAVKRL-TKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLL 130
           ++G GG +EV+    L+   ++AVK L   +  D      F  E      + HP ++++ 
Sbjct: 19  ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 131 GCCVDNGL-----YLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGC 185
                        Y++ ++    ++  + H    P    +    IA    + L++ H   
Sbjct: 79  ATGEAETPAGPLPYIVMEYVDGVTLRDIVH-TEGPMTPKRAIEVIA-DACQALNFSH--- 133
Query: 186 QRRIIHRDIKSSNILLTADFEPQISDFGLAKWLP-SQWTHHSIAPIEGTFGHLAPEYFMH 244
           Q  IIHRD+K +NI+++A    ++ DFG+A+ +  S  +    A + GT  +L+PE    
Sbjct: 134 QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 193
Query: 245 GIVDEKTDVFAFGVFLLEIISGRKPVDG 272
             VD ++DV++ G  L E+++G  P  G
Sbjct: 194 DSVDARSDVYSLGCVLYEVLTGEPPFTG 221

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 60/239 (25%), Positives = 101/239 (42%), Gaps = 67/239 (28%)
Query: 72  NLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLG 131
           +L GR GY  V           AVK L +  +   + ++ L+E   +  V HP+V+ L G
Sbjct: 46  HLKGRAGYTTV-----------AVKMLKENASPS-ELRDLLSEFNVLKQVNHPHVIKLYG 93
Query: 132 CCVDNG-LYLIFQFSSRGSVASLFHDVNSPG--------------VEWKVRHKIAVG--- 173
            C  +G L LI +++  GS+     +    G              ++      + +G   
Sbjct: 94  ACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLI 153
Query: 174 -----TARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAK------------ 216
                 ++G+ YL    +  ++HRD+ + NIL+    + +ISDFGL++            
Sbjct: 154 SFAWQISQGMQYL---AEMSLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXVKRS 210
Query: 217 --WLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDG 272
              +P +W       IE  F H         I   ++DV++FGV L EI++ G  P  G
Sbjct: 211 QGRIPVKWM-----AIESLFDH---------IYTTQSDVWSFGVLLWEIVTLGGNPYPG 255

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 100/224 (44%), Gaps = 18/224 (8%)
Query: 62  SIATNAFSSENLVGRGGYAEVYK----GVLQDGEEIAVKRLTK--VVTDDRKEKEFLTEI 115
            I    F    ++G+GGY +V++         G+  A+K L K  +V + +       E 
Sbjct: 13  KIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAER 72
Query: 116 GTIGHVCHPNVLSLLGCCVDNG-LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVG- 173
             +  V HP ++ L+      G LYLI ++ S G    LF  +   G+  +      +  
Sbjct: 73  NILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGE---LFMQLEREGIFMEDTACFYLAE 129
Query: 174 TARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWT-HHSIAPIEG 232
            +  L +LH   Q+ II+RD+K  NI+L      +++DFGL K      T  H      G
Sbjct: 130 ISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHXFC---G 183
Query: 233 TFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQS 276
           T  ++APE  M    +   D ++ G  + ++++G  P  G ++ 
Sbjct: 184 TIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRK 227

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 91/209 (43%), Gaps = 12/209 (5%)
Query: 74  VGRGGYAEVYKGVLQDGEEIAVKR---LTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLL 130
           +G G +  V KG  Q  + +       L     D   + E L E   +  + +P ++ ++
Sbjct: 19  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 78
Query: 131 GCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRII 190
           G C      L+ + +  G +        +  V+ K   ++    + G+ YL    +   +
Sbjct: 79  GICEAESWMLVMEMAELGPLNKYLQ--QNRHVKDKNIIELVHQVSMGMKYLE---ESNFV 133
Query: 191 HRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTF--GHLAPEYFMHGIVD 248
           HRD+ + N+LL      +ISDFGL+K L +    +  A   G +     APE   +    
Sbjct: 134 HRDLAARNVLLVTQHYAKISDFGLSKALRADENXYK-AQTHGKWPVKWYAPECINYYKFS 192
Query: 249 EKTDVFAFGVFLLEIIS-GRKPVDGSHQS 276
            K+DV++FGV + E  S G+KP  G   S
Sbjct: 193 SKSDVWSFGVLMWEAFSYGQKPYRGMKGS 221

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 90/205 (43%), Gaps = 12/205 (5%)
Query: 74  VGRGGYAEVYKGVLQDGEEIAVKR---LTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLL 130
           +G G +  V KG  Q  + +       L     D   + E L E   +  + +P ++ ++
Sbjct: 377 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 436
Query: 131 GCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRII 190
           G C      L+ + +  G +           V+ K   ++    + G+ YL    +   +
Sbjct: 437 GICEAESWMLVMEMAELGPLNKYLQQNRH--VKDKNIIELVHQVSMGMKYLE---ESNFV 491
Query: 191 HRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTF--GHLAPEYFMHGIVD 248
           HRD+ + N+LL      +ISDFGL+K L +   ++  A   G +     APE   +    
Sbjct: 492 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK-AQTHGKWPVKWYAPECINYYKFS 550
Query: 249 EKTDVFAFGVFLLEIIS-GRKPVDG 272
            K+DV++FGV + E  S G+KP  G
Sbjct: 551 SKSDVWSFGVLMWEAFSYGQKPYRG 575

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 60/286 (20%), Positives = 121/286 (42%), Gaps = 47/286 (16%)
Query: 68  FSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNV 126
           F    L+G GG+ +V+K   + DG+   +KR+     +++ E+E    +  +  + H N+
Sbjct: 13  FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVK--YNNEKAERE----VKALAKLDHVNI 66
Query: 127 LSLLGC-----------------CVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHK 169
           +   GC                      L++  +F  +G++           ++  +  +
Sbjct: 67  VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALE 126
Query: 170 IAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAP 229
           +     +G+ Y+H    +++I+RD+K SNI L    + +I DFGL   L +         
Sbjct: 127 LFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR---XR 180
Query: 230 IEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGE 289
            +GT  +++PE        ++ D++A G+ L E++      D + ++   +    L  G 
Sbjct: 181 SKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLH---VCDTAFETSKFFTD--LRDGI 235
Query: 290 IEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVM 335
           I  + D +     + T L +L       +   P  RP  SE+L  +
Sbjct: 236 ISDIFDKK-----EKTLLQKL-------LSKKPEDRPNTSEILRTL 269

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 90/205 (43%), Gaps = 12/205 (5%)
Query: 74  VGRGGYAEVYKGVLQDGEEIAVKR---LTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLL 130
           +G G +  V KG  Q  + +       L     D   + E L E   +  + +P ++ ++
Sbjct: 378 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 437
Query: 131 GCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRII 190
           G C      L+ + +  G +           V+ K   ++    + G+ YL    +   +
Sbjct: 438 GICEAESWMLVMEMAELGPLNKYLQQNRH--VKDKNIIELVHQVSMGMKYLE---ESNFV 492
Query: 191 HRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTF--GHLAPEYFMHGIVD 248
           HRD+ + N+LL      +ISDFGL+K L +   ++  A   G +     APE   +    
Sbjct: 493 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK-AQTHGKWPVKWYAPECINYYKFS 551
Query: 249 EKTDVFAFGVFLLEIIS-GRKPVDG 272
            K+DV++FGV + E  S G+KP  G
Sbjct: 552 SKSDVWSFGVLMWEAFSYGQKPYRG 576

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 91/209 (43%), Gaps = 21/209 (10%)
Query: 74  VGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC 132
           VG G Y  V      + G  +AVK+L++        K    E+  + H+ H NV+ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 133 CVD-------NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGC 185
                     N +YL+         A L + V    +       +     RGL Y+H   
Sbjct: 90  FTPARSLEEFNDVYLVTHLMG----ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 144
Query: 186 QRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHG 245
              IIHRD+K SN+ +  D E +I DF LA+    + T +       T  + APE  ++ 
Sbjct: 145 --DIIHRDLKPSNLAVNEDCELKILDFYLARHTDDEMTGYV-----ATRWYRAPEIMLNW 197
Query: 246 I-VDEKTDVFAFGVFLLEIISGRKPVDGS 273
           +  ++  D+++ G  + E+++GR    G+
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGT 226

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 64/246 (26%), Positives = 108/246 (43%), Gaps = 52/246 (21%)
Query: 59  EEISIATNAFSSENLVGRGGYAEVY----KGVLQDGEE--IAVKRLTKVVTDDRKEKEFL 112
           +E  +A    +    +G+G +  VY    KGV++D  E  +A+K + +  +  R+  EFL
Sbjct: 5   DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASM-RERIEFL 63
Query: 113 TEIGTIGHV-CHPNVLSLLGCCVDNG--LYLIFQFSSRGSVASLFHDV-----NSPGVEW 164
            E   +    CH +V+ LLG  V  G    +I +  +RG + S    +     N+P +  
Sbjct: 64  NEASVMKEFNCH-HVVRLLGV-VSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAP 121
Query: 165 KVRHKI---AVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAK----- 216
               K+   A   A G+ YL+     + +HRD+ + N  +  DF  +I DFG+ +     
Sbjct: 122 PSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYET 178
Query: 217 ---------WLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-G 266
                     LP +W              ++PE    G+    +DV++FGV L EI +  
Sbjct: 179 DYYRKGGKGLLPVRW--------------MSPESLKDGVFTTYSDVWSFGVVLWEIATLA 224
Query: 267 RKPVDG 272
            +P  G
Sbjct: 225 EQPYQG 230

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 40/179 (22%), Positives = 86/179 (48%), Gaps = 9/179 (5%)
Query: 93  IAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQFSSRGSVA 151
           I  ++L  +        + + E+  +     P ++   G    +G + +  +    GS+ 
Sbjct: 43  IMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLD 102
Query: 152 SLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISD 211
            +  +     +  ++  K+++   RGL YL +  + +I+HRD+K SNIL+ +  E ++ D
Sbjct: 103 QVLKEAKR--IPEEILGKVSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCD 158
Query: 212 FGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPV 270
           FG++  L     +  +    GT  ++APE         ++D+++ G+ L+E+  GR P+
Sbjct: 159 FGVSGQLIDSMANSFV----GTRSYMAPERLQGTHYSVQSDIWSMGLSLVELAVGRYPI 213

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 98/218 (44%), Gaps = 11/218 (5%)
Query: 63  IATNAFSSENLVGRGGYAEVYKG-VLQDGEEIAVKRLTK-VVTDDRKEKEFLTEIGTIGH 120
           +  + F    ++G+G + +V    V + G+  AVK L K V+  D   +  +TE   +  
Sbjct: 20  LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSL 79
Query: 121 VCHPNVLSLLGCCVD--NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGL 178
             +   L+ L CC    + L+ + +F + G +  +FH   S   +       A      L
Sbjct: 80  ARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDL--MFHIQKSRRFDEARARFYAAEIISAL 137
Query: 179 HYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLA 238
            +LH    + II+RD+K  N+LL  +   +++DFG+ K         + A   GT  ++A
Sbjct: 138 MFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCK--EGICNGVTTATFCGTPDYIA 192
Query: 239 PEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQS 276
           PE     +     D +A GV L E++ G  P +  ++ 
Sbjct: 193 PEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENED 230

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 71/271 (26%), Positives = 115/271 (42%), Gaps = 37/271 (13%)
Query: 85  GVLQDGE---------EIAVKRLT-KVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCV 134
           GV++ GE          +AVK L   V++      +F+ E+  +  + H N++ L G  +
Sbjct: 22  GVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL 81
Query: 135 DNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDI 194
              + ++ + +  GS+           +   +  + AV  A G+ YL     +R IHRD+
Sbjct: 82  TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLS-RYAVQVAEGMGYLE---SKRFIHRDL 137
Query: 195 KSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGT-FGHLAPEYFMHGIVDEKTDV 253
            + N+LL      +I DFGL + LP    H+ +       F   APE          +D 
Sbjct: 138 AARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDT 197
Query: 254 FAFGVFLLEIIS-GRKP---VDGSHQSLHSWAKPILNQGEIEKLVDPR--LQGAYDVTQL 307
           + FGV L E+ + G++P   ++GS Q LH   K      E E+L  P    Q  Y+V   
Sbjct: 198 WMFGVTLWEMFTYGQEPWIGLNGS-QILHKIDK------EGERLPRPEDCPQDIYNVM-- 248
Query: 308 NRLAFAASLCIRASPTWRPTMSEVLEVMLEG 338
                    C    P  RPT   + + +LE 
Sbjct: 249 -------VQCWAHKPEDRPTFVALRDFLLEA 272

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 71/271 (26%), Positives = 115/271 (42%), Gaps = 37/271 (13%)
Query: 85  GVLQDGE---------EIAVKRLT-KVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCV 134
           GV++ GE          +AVK L   V++      +F+ E+  +  + H N++ L G  +
Sbjct: 26  GVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL 85
Query: 135 DNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDI 194
              + ++ + +  GS+           +   +  + AV  A G+ YL     +R IHRD+
Sbjct: 86  TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTL-SRYAVQVAEGMGYLES---KRFIHRDL 141
Query: 195 KSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGT-FGHLAPEYFMHGIVDEKTDV 253
            + N+LL      +I DFGL + LP    H+ +       F   APE          +D 
Sbjct: 142 AARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDT 201
Query: 254 FAFGVFLLEIIS-GRKP---VDGSHQSLHSWAKPILNQGEIEKLVDPR--LQGAYDVTQL 307
           + FGV L E+ + G++P   ++GS Q LH   K      E E+L  P    Q  Y+V   
Sbjct: 202 WMFGVTLWEMFTYGQEPWIGLNGS-QILHKIDK------EGERLPRPEDCPQDIYNVM-- 252
Query: 308 NRLAFAASLCIRASPTWRPTMSEVLEVMLEG 338
                    C    P  RPT   + + +LE 
Sbjct: 253 -------VQCWAHKPEDRPTFVALRDFLLEA 276

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 95/211 (45%), Gaps = 25/211 (11%)
Query: 74  VGRGGYAEV---YKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLL 130
           VG G Y  V   Y   L+  +++AVK+L++        +    E+  + H+ H NV+ LL
Sbjct: 28  VGSGAYGSVCSAYDARLR--QKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 85
Query: 131 GCCVD-------NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHK 183
                       + +YL+         A L + V    +  +    +     RGL Y+H 
Sbjct: 86  DVFTPATSIEDFSEVYLVTTLMG----ADLNNIVKCQALSDEHVQFLVYQLLRGLKYIHS 141
Query: 184 GCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFM 243
                IIHRD+K SN+ +  D E +I DFGLA+    + T +       T  + APE  +
Sbjct: 142 AG---IIHRDLKPSNVAVNEDCELRILDFGLARQADEEMTGYV-----ATRWYRAPEIML 193
Query: 244 HGI-VDEKTDVFAFGVFLLEIISGRKPVDGS 273
           + +  ++  D+++ G  + E++ G+    GS
Sbjct: 194 NWMHYNQTVDIWSVGCIMAELLQGKALFPGS 224

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 97/220 (44%), Gaps = 40/220 (18%)
Query: 73  LVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTE--IGTIGHVCHPNVLSLL 130
           L+GRG Y  VYKG L D   +AVK     V      + F+ E  I  +  + H N+   +
Sbjct: 20  LIGRGRYGAVYKGSL-DERPVAVK-----VFSFANRQNFINEKNIYRVPLMEHDNIARFI 73
Query: 131 ----GCCVDNGL--YLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKG 184
                   D  +   L+ ++   GS+        S   +W    ++A    RGL YLH  
Sbjct: 74  VGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTS---DWVSSCRLAHSVTRGLAYLHTE 130
Query: 185 CQR------RIIHRDIKSSNILLTADFEPQISDFGLAKWL-------PSQWTHHSIAPIE 231
             R       I HRD+ S N+L+  D    ISDFGL+  L       P +  + +I+ + 
Sbjct: 131 LPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEV- 189
Query: 232 GTFGHLAPEYFMHGIVD--------EKTDVFAFGVFLLEI 263
           GT  ++APE  + G V+        ++ D++A G+   EI
Sbjct: 190 GTIRYMAPE-VLEGAVNLRDXESALKQVDMYALGLIYWEI 228

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/213 (23%), Positives = 105/213 (49%), Gaps = 18/213 (8%)
Query: 66  NAFSSENLVGRGGYAEVYKGVLQDGE---EIAVKRLTKVVTDDRKEKEFLTEIGTIGHVC 122
           N   ++  +G G +  V +GV +  +   ++A+K L K  T+    +E + E   +  + 
Sbjct: 10  NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVL-KQGTEKADTEEMMREAQIMHQLD 68
Query: 123 HPNVLSLLGCCVDNGLYLIFQFSSRGSVASLF----HDVNSPGVEWKVRHKIAVGTARGL 178
           +P ++ L+G C    L L+ + +  G +         ++    V  ++ H++++G    +
Sbjct: 69  NPYIVRLIGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVA-ELLHQVSMG----M 123
Query: 179 HYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPI-EGTFGHL 237
            YL    ++  +HRD+ + N+LL      +ISDFGL+K L +  ++++     +      
Sbjct: 124 KYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY 180
Query: 238 APEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKP 269
           APE         ++DV+++GV + E +S G+KP
Sbjct: 181 APECINFRKFSSRSDVWSYGVTMWEALSYGQKP 213

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 91/209 (43%), Gaps = 21/209 (10%)
Query: 74  VGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC 132
           VG G Y  V      + G  +AVK+L++        K    E+  + H+ H NV+ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 133 CVD-------NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGC 185
                     N +YL+         A L + V    +       +     RGL Y+H   
Sbjct: 90  FTPARSLEEFNDVYLVTHLMG----ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 144
Query: 186 QRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHG 245
              IIHRD+K SN+ +  D E +I  FGLA+    + T +       T  + APE  ++ 
Sbjct: 145 --DIIHRDLKPSNLAVNEDCELKILGFGLARHTDDEMTGYV-----ATRWYRAPEIMLNW 197
Query: 246 I-VDEKTDVFAFGVFLLEIISGRKPVDGS 273
           +  ++  D+++ G  + E+++GR    G+
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGT 226

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 49/187 (26%), Positives = 84/187 (44%), Gaps = 24/187 (12%)
Query: 90  GEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG---LYLIFQFSS 146
           G  +AVK+L     D  ++++F  EI  +  +    ++   G     G   L L+ ++  
Sbjct: 36  GALVAVKQLQHSGPD--QQRDFQREIQILKALHSDFIVKYRGVSYGPGRPELRLVMEYLP 93
Query: 147 RGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQ-------RRIIHRDIKSSNI 199
            G +                RH+  +  +R L Y  + C+       RR +HRD+ + NI
Sbjct: 94  SGCLRDFLQ-----------RHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNI 142
Query: 200 LLTADFEPQISDFGLAKWLPSQWTHHSI-APIEGTFGHLAPEYFMHGIVDEKTDVFAFGV 258
           L+ ++   +I+DFGLAK LP       +  P +      APE     I   ++DV++FGV
Sbjct: 143 LVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGV 202
Query: 259 FLLEIIS 265
            L E+ +
Sbjct: 203 VLYELFT 209

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 95/211 (45%), Gaps = 25/211 (11%)
Query: 74  VGRGGYAEV---YKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLL 130
           VG G Y  V   Y   L+  +++AVK+L++        +    E+  + H+ H NV+ LL
Sbjct: 36  VGSGAYGSVCSAYDARLR--QKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 131 GCCVD-------NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHK 183
                       + +YL+         A L + V    +  +    +     RGL Y+H 
Sbjct: 94  DVFTPATSIEDFSEVYLVTTLMG----ADLNNIVKCQALSDEHVQFLVYQLLRGLKYIHS 149
Query: 184 GCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFM 243
                IIHRD+K SN+ +  D E +I DFGLA+    + T +       T  + APE  +
Sbjct: 150 AG---IIHRDLKPSNVAVNEDSELRILDFGLARQADEEMTGYV-----ATRWYRAPEIML 201
Query: 244 HGI-VDEKTDVFAFGVFLLEIISGRKPVDGS 273
           + +  ++  D+++ G  + E++ G+    GS
Sbjct: 202 NWMHYNQTVDIWSVGCIMAELLQGKALFPGS 232

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 98/217 (45%), Gaps = 22/217 (10%)
Query: 59  EEISIATNAFSSENLVGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGT 117
           EE+  AT+       +GRG + EV++    Q G + AVK   KV  +  + +E +   G 
Sbjct: 71  EEVHWATHQLR----LGRGSFGEVHRMEDKQTGFQCAVK---KVRLEVFRAEELMACAG- 122
Query: 118 IGHVCHPNVLSLLGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTA-R 176
              +  P ++ L G   +     IF     G   SL   V   G   + R    +G A  
Sbjct: 123 ---LTSPRIVPLYGAVREGPWVNIFMELLEG--GSLGQLVKEQGCLPEDRALYYLGQALE 177
Query: 177 GLHYLHKGCQRRIIHRDIKSSNILLTAD-FEPQISDFGLAKWLPSQWTHHSIAP---IEG 232
           GL YLH    RRI+H D+K+ N+LL++D     + DFG A  L        +     I G
Sbjct: 178 GLEYLHS---RRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPG 234
Query: 233 TFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKP 269
           T  H+APE  +    D K DV++    +L +++G  P
Sbjct: 235 TETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHP 271

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 91/209 (43%), Gaps = 21/209 (10%)
Query: 74  VGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC 132
           VG G Y  V      + G  +AVK+L++        K    E+  + H+ H NV+ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 133 CVD-------NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGC 185
                     N +YL+         A L + V    +       +     RGL Y+H   
Sbjct: 90  FTPARSLEEFNDVYLVTHLMG----ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 144
Query: 186 QRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHG 245
              IIHRD+K SN+ +  D E +I D GLA+    + T +       T  + APE  ++ 
Sbjct: 145 --DIIHRDLKPSNLAVNEDCELKILDAGLARHTDDEMTGYV-----ATRWYRAPEIMLNW 197
Query: 246 I-VDEKTDVFAFGVFLLEIISGRKPVDGS 273
           +  ++  D+++ G  + E+++GR    G+
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGT 226

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 67/268 (25%), Positives = 116/268 (43%), Gaps = 24/268 (8%)
Query: 74  VGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIG-TIGHVCHPNVLSLLG 131
           +GRG Y  V K   +  G+  AVKR+   V + +++K  L ++  +   V  P  ++  G
Sbjct: 42  LGRGAYGVVEKXRHVPSGQIXAVKRIRATV-NSQEQKRLLXDLDISXRTVDCPFTVTFYG 100
Query: 132 CCVDNGLYLIFQFSSRGSVASLFHDVNSPG--VEWKVRHKIAVGTARGLHYLHKGCQRRI 189
                G   I       S+   +  V   G  +   +  KIAV   + L +LH   +  +
Sbjct: 101 ALFREGDVWICXELXDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH--SKLSV 158
Query: 190 IHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDE 249
           IHRD+K SN+L+ A  + +  DFG++ +L         A   G   + APE     +  +
Sbjct: 159 IHRDVKPSNVLINALGQVKXCDFGISGYLVDDVAKDIDA---GCKPYXAPERINPELNQK 215
Query: 250 ----KTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVT 305
               K+D+++ G+  +E+   R P D       SW  P     ++ +   P+L    D  
Sbjct: 216 GYSVKSDIWSLGITXIELAILRFPYD-------SWGTPFQQLKQVVEEPSPQLPA--DKF 266
Query: 306 QLNRLAFAASLCIRASPTWRPTMSEVLE 333
               + F  S C++ +   RPT  E+ +
Sbjct: 267 SAEFVDF-TSQCLKKNSKERPTYPELXQ 293

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/206 (24%), Positives = 91/206 (44%), Gaps = 19/206 (9%)
Query: 90  GEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDN-------GLYLIF 142
           G  +AVK+L++   +    K    E+  +  V H N++SLL              +YL+ 
Sbjct: 47  GINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVM 106
Query: 143 QFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLT 202
           +         +  +++   + + +   +      G+ +LH      IIHRD+K SNI++ 
Sbjct: 107 ELMDANLCQVIHMELDHERMSYLLYQMLC-----GIKHLHSAG---IIHRDLKPSNIVVK 158
Query: 203 ADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLE 262
           +D   +I DFGLA+   +  T+  + P   T  + APE  +     E  D+++ G  + E
Sbjct: 159 SDCTLKILDFGLAR---TASTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 215
Query: 263 IISGRKPVDGSHQSLHSWAKPILNQG 288
           ++ G     G+   +  W K I   G
Sbjct: 216 LVKGSVIFQGTDH-IDQWNKVIEQLG 240

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 91/209 (43%), Gaps = 21/209 (10%)
Query: 74  VGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC 132
           VG G Y  V      + G  +AVK+L++        K    E+  + H+ H NV+ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 133 CVD-------NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGC 185
                     N +YL+         A L + V    +       +     RGL Y+H   
Sbjct: 90  FTPARSLEEFNDVYLVTHLMG----ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 144
Query: 186 QRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHG 245
              IIHRD+K SN+ +  D E +I D GLA+    + T +       T  + APE  ++ 
Sbjct: 145 --DIIHRDLKPSNLAVNEDCELKILDRGLARHTDDEMTGYV-----ATRWYRAPEIMLNW 197
Query: 246 I-VDEKTDVFAFGVFLLEIISGRKPVDGS 273
           +  ++  D+++ G  + E+++GR    G+
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGT 226

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/181 (30%), Positives = 88/181 (48%), Gaps = 15/181 (8%)
Query: 109 KEFLTEIGTIGHVCHPNVLSLLGCCVD---NGLYLIFQFSSRGSVASLFHDVNSPGVEWK 165
           ++   EI  +  + HPNV+ L+    D   + LY++F+  ++G V  +      P  E +
Sbjct: 81  EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEV--PTLKPLSEDQ 138
Query: 166 VRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHH 225
            R        +G+ YLH    ++IIHRDIK SN+L+  D   +I+DFG++     + +  
Sbjct: 139 ARFYFQ-DLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEF--KGSDA 192
Query: 226 SIAPIEGTFGHLAPEYF--MHGIVDEKT-DVFAFGVFLLEIISGRKP-VDGSHQSLHSWA 281
            ++   GT   +APE       I   K  DV+A GV L   + G+ P +D     LHS  
Sbjct: 193 LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKI 252
Query: 282 K 282
           K
Sbjct: 253 K 253

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 73/275 (26%), Positives = 115/275 (41%), Gaps = 45/275 (16%)
Query: 85  GVLQDGE---------EIAVKRLTK-VVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCV 134
           GV++ GE          +AVK L   V++      +F+ E+  +  + H N++ L G  +
Sbjct: 22  GVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL 81
Query: 135 DNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDI 194
              + ++ + +  GS+           +   +  + AV  A G+ YL     +R IHRD+
Sbjct: 82  TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTL-SRYAVQVAEGMGYLE---SKRFIHRDL 137
Query: 195 KSSNILLTADFEPQISDFGLAKWLPSQWTH-----HSIAPIEGTFGHLAPEYFMHGIVDE 249
            + N+LL      +I DFGL + LP    H     H   P    F   APE         
Sbjct: 138 AARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVP----FAWCAPESLKTRTFSH 193
Query: 250 KTDVFAFGVFLLEIIS-GRKP---VDGSHQSLHSWAKPILNQGEIEKLVDPR--LQGAYD 303
            +D + FGV L E+ + G++P   ++GS Q LH   K      E E+L  P    Q  Y+
Sbjct: 194 ASDTWMFGVTLWEMFTYGQEPWIGLNGS-QILHKIDK------EGERLPRPEDCPQDIYN 246
Query: 304 VTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG 338
           V            C    P  RPT   + + +LE 
Sbjct: 247 VM---------VQCWAHKPEDRPTFVALRDFLLEA 272

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/222 (23%), Positives = 98/222 (44%), Gaps = 13/222 (5%)
Query: 60  EISIATNAFSSENLVGRGGYAEVYKGVLQDGEEI-AVKRLTK--VVTDDRKEKEFLTEIG 116
           +I +    F    ++G+G + +V+    +   +  A+K L K  V+ DD  E   + +  
Sbjct: 12  QIKLKIEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRV 71
Query: 117 TIGHVCHPNVLSLLGCCVDN--GLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGT 174
                 HP  L+ + C       L+ + ++ + G +  ++H  +    +       A   
Sbjct: 72  LSLAWEHP-FLTHMFCTFQTKENLFFVMEYLNGGDL--MYHIQSCHKFDLSRATFYAAEI 128
Query: 175 ARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTF 234
             GL +LH    + I++RD+K  NILL  D   +I+DFG+ K   +           GT 
Sbjct: 129 ILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCK--ENMLGDAKTNEFCGTP 183
Query: 235 GHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQS 276
            ++APE  +    +   D ++FGV L E++ G+ P  G  + 
Sbjct: 184 DYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE 225

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 91/209 (43%), Gaps = 21/209 (10%)
Query: 74  VGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC 132
           VG G Y  V      + G  +AVK+L++        K    E+  + H+ H NV+ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 133 CVD-------NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGC 185
                     N +YL+         A L + V    +       +     RGL Y+H   
Sbjct: 90  FTPARSLEEFNDVYLVTHLMG----ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 144
Query: 186 QRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHG 245
              IIHRD+K SN+ +  D E +I D GLA+    + T +       T  + APE  ++ 
Sbjct: 145 --DIIHRDLKPSNLAVNEDCELKILDGGLARHTDDEMTGYV-----ATRWYRAPEIMLNW 197
Query: 246 I-VDEKTDVFAFGVFLLEIISGRKPVDGS 273
           +  ++  D+++ G  + E+++GR    G+
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGRTLFPGT 226

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/215 (23%), Positives = 99/215 (46%), Gaps = 18/215 (8%)
Query: 74  VGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC 132
           +G G Y    K   + DG+ +  K L      + +++  ++E+  +  + HPN++     
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 133 CVD---NGLYLIFQFSSRGSVASLFHDVNSPGVEWK--VRHKIAVGTARGLHYLHKGCQR 187
            +D     LY++ ++   G +AS    V + G + +  +  +  +     L    K C R
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLAS----VITKGTKERQYLDEEFVLRVMTQLTLALKECHR 129
Query: 188 R------IIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEY 241
           R      ++HRD+K +N+ L      ++ DFGLA+ L +  T  + A + GT  +++PE 
Sbjct: 130 RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL-NHDTSFAKAFV-GTPYYMSPEQ 187
Query: 242 FMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQS 276
                 +EK+D+++ G  L E+ +   P     Q 
Sbjct: 188 MNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK 222

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/296 (21%), Positives = 125/296 (42%), Gaps = 42/296 (14%)
Query: 66  NAFSSENLVGRGGYAEV-----YKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGH 120
           N  S    +G G + +V     Y  +  D       ++ K      + +  ++E+  + +
Sbjct: 46  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 105
Query: 121 V-CHPNVLSLLGCCVDNGLYLIF-QFSSRGSVASLFH--------DVNSPGV-------- 162
           +  H N+++LLG C   G  L+  ++   G + +              SP +        
Sbjct: 106 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 165
Query: 163 EWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQW 222
           + +     +   A+G+ +L     +  IHRD+ + NILLT     +I DFGLA+ + +  
Sbjct: 166 DLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARHIKNDS 222
Query: 223 THHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWA 281
            +            +APE   + +   ++DV+++G+FL E+ S G  P  G    + S  
Sbjct: 223 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPG--MPVDSKF 280
Query: 282 KPILNQGEIEKLVDPRLQGA--YDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVM 335
             ++ +G   +++ P    A  YD+ +          C  A P  RPT  ++++++
Sbjct: 281 YKMIKEG--FRMLSPEHAPAEMYDIMK---------TCWDADPLKRPTFKQIVQLI 325

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 42/148 (28%), Positives = 77/148 (52%), Gaps = 12/148 (8%)
Query: 74  VGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTI----GHVCHPNVLS 128
           +G+G Y  V+K +  + GE +AVK++     +    +    EI  +    GH    N+L+
Sbjct: 17  LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLN 76
Query: 129 LLGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRR 188
           +L    D  +YL+F +      A +  ++  P  +  V +++     + + YLH G    
Sbjct: 77  VLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQYVVYQLI----KVIKYLHSGG--- 129
Query: 189 IIHRDIKSSNILLTADFEPQISDFGLAK 216
           ++HRD+K SNILL A+   +++DFGL++
Sbjct: 130 LLHRDMKPSNILLNAECHVKVADFGLSR 157

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 100/208 (48%), Gaps = 23/208 (11%)
Query: 68  FSSENLVGRGGYAEVYKGVLQDGEEI-AVKRLT---KVVTDDRKEKEFLTEIGTIGHVCH 123
           +   + +G G +A VYK   ++  +I A+K++    +    D   +  L EI  +  + H
Sbjct: 12  YEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSH 71
Query: 124 PNVLSLLGCCV-DNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLH 182
           PN++ LL      + + L+F F     +  +  D NS  +         + T +GL YLH
Sbjct: 72  PNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKD-NSLVLTPSHIKAYMLMTLQGLEYLH 129
Query: 183 KGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWL--PSQWTHHSIAPIEGTFGHLAPE 240
              Q  I+HRD+K +N+LL  +   +++DFGLAK    P++   H +     T  + APE
Sbjct: 130 ---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVV----TRWYRAPE 182
Query: 241 YF----MHGIVDEKTDVFAFGVFLLEII 264
                 M+G+     D++A G  L E++
Sbjct: 183 LLFGARMYGV---GVDMWAVGCILAELL 207

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 46/203 (22%), Positives = 97/203 (47%), Gaps = 16/203 (7%)
Query: 74  VGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCC 133
           +G G +  V  G  +   ++A+K + +       E EF+ E   + ++ H  ++ L G C
Sbjct: 16  LGTGQFGVVKYGKWRGQYDVAIKMIKE---GSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 72
Query: 134 VDNG-LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHR 192
                +++I ++ + G + +   ++     + +   ++       + YL     ++ +HR
Sbjct: 73  TKQRPIFIITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVCEAMEYLE---SKQFLHR 128
Query: 193 DIKSSNILLTADFEPQISDFGLAKW-LPSQWTHH--SIAPIEGTFGHLAPEYFMHGIVDE 249
           D+ + N L+      ++SDFGL+++ L  ++T    S  P+  +     PE  M+     
Sbjct: 129 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWS----PPEVLMYSKFSS 184
Query: 250 KTDVFAFGVFLLEIIS-GRKPVD 271
           K+D++AFGV + EI S G+ P +
Sbjct: 185 KSDIWAFGVLMWEIYSLGKMPYE 207

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/296 (21%), Positives = 125/296 (42%), Gaps = 42/296 (14%)
Query: 66  NAFSSENLVGRGGYAEV-----YKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGH 120
           N  S    +G G + +V     Y  +  D       ++ K      + +  ++E+  + +
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 121 V-CHPNVLSLLGCCVDNGLYLIF-QFSSRGSVASLFH--------DVNSPGV-------- 162
           +  H N+++LLG C   G  L+  ++   G + +              SP +        
Sbjct: 83  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 163 EWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQW 222
           + +     +   A+G+ +L     +  IHRD+ + NILLT     +I DFGLA+ + +  
Sbjct: 143 DLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 223 THHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWA 281
            +            +APE   + +   ++DV+++G+FL E+ S G  P  G    + S  
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPG--MPVDSKF 257
Query: 282 KPILNQGEIEKLVDPRLQGA--YDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVM 335
             ++ +G   +++ P    A  YD+ +          C  A P  RPT  ++++++
Sbjct: 258 YKMIKEG--FRMLSPEHAPAEMYDIMK---------TCWDADPLKRPTFKQIVQLI 302

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/252 (23%), Positives = 112/252 (44%), Gaps = 27/252 (10%)
Query: 86  VLQDGEEIAVKRLTKVVTDDRKEKE---FLTEIGTIGHVCHPNVLSLLGC-CVDNGLYLI 141
           V   G+ +AVK++     D RK++       E+  +    H NV+ +     V + L+++
Sbjct: 41  VRSSGKLVAVKKM-----DLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVV 95
Query: 142 FQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILL 201
            +F   G++  +   V    +  +    + +   + L  LH    + +IHRDIKS +ILL
Sbjct: 96  MEFLEGGALTDI---VTHTRMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILL 149
Query: 202 TADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLL 261
           T D   ++SDFG    +  +        + GT   +APE         + D+++ G+ ++
Sbjct: 150 THDGRVKLSDFGFCAQVSKEVPRRKX--LVGTPYWMAPELISRLPYGPEVDIWSLGIMVI 207
Query: 262 EIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRAS 321
           E++ G  P        +    P+     I   + PRL+  + V+   +  F   L +R  
Sbjct: 208 EMVDGEPP--------YFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLK-GFLDRLLVR-D 257
Query: 322 PTWRPTMSEVLE 333
           P  R T +E+L+
Sbjct: 258 PAQRATAAELLK 269

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/296 (21%), Positives = 125/296 (42%), Gaps = 42/296 (14%)
Query: 66  NAFSSENLVGRGGYAEV-----YKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGH 120
           N  S    +G G + +V     Y  +  D       ++ K      + +  ++E+  + +
Sbjct: 39  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 98
Query: 121 V-CHPNVLSLLGCCVDNGLYLIF-QFSSRGSVASLFH--------DVNSPGV-------- 162
           +  H N+++LLG C   G  L+  ++   G + +              SP +        
Sbjct: 99  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 158
Query: 163 EWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQW 222
           + +     +   A+G+ +L     +  IHRD+ + NILLT     +I DFGLA+ + +  
Sbjct: 159 DLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 215
Query: 223 THHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWA 281
            +            +APE   + +   ++DV+++G+FL E+ S G  P  G    + S  
Sbjct: 216 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPG--MPVDSKF 273
Query: 282 KPILNQGEIEKLVDPRLQGA--YDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVM 335
             ++ +G   +++ P    A  YD+ +          C  A P  RPT  ++++++
Sbjct: 274 YKMIKEG--FRMLSPEHAPAEMYDIMK---------TCWDADPLKRPTFKQIVQLI 318

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 46/203 (22%), Positives = 97/203 (47%), Gaps = 16/203 (7%)
Query: 74  VGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCC 133
           +G G +  V  G  +   ++A+K + +       E EF+ E   + ++ H  ++ L G C
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIKE---GSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 88
Query: 134 VDN-GLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHR 192
                +++I ++ + G + +   ++     + +   ++       + YL     ++ +HR
Sbjct: 89  TKQRPIFIITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVCEAMEYLE---SKQFLHR 144
Query: 193 DIKSSNILLTADFEPQISDFGLAKW-LPSQWTHH--SIAPIEGTFGHLAPEYFMHGIVDE 249
           D+ + N L+      ++SDFGL+++ L  ++T    S  P+  +     PE  M+     
Sbjct: 145 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWS----PPEVLMYSKFSS 200
Query: 250 KTDVFAFGVFLLEIIS-GRKPVD 271
           K+D++AFGV + EI S G+ P +
Sbjct: 201 KSDIWAFGVLMWEIYSLGKMPYE 223

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 101/220 (45%), Gaps = 29/220 (13%)
Query: 68  FSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIG----HVC 122
           +  ++++GRG  + V + V +  G E AVK +   VT +R   E L E+        H+ 
Sbjct: 96  YDPKDVIGRGVSSVVRRCVHRATGHEFAVKIME--VTAERLSPEQLEEVREATRRETHIL 153
Query: 123 -----HPNVLSLLGCCVDNG-LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTAR 176
                HP++++L+     +  ++L+F    +G +           +  K    I      
Sbjct: 154 RQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYL--TEKVALSEKETRSIMRSLLE 211
Query: 177 GLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWL-PSQWTHHSIAPIEGTFG 235
            + +LH      I+HRD+K  NILL  + + ++SDFG +  L P +     +  + GT G
Sbjct: 212 AVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGE----KLRELCGTPG 264
Query: 236 HLAPEYF------MHGIVDEKTDVFAFGVFLLEIISGRKP 269
           +LAPE         H    ++ D++A GV L  +++G  P
Sbjct: 265 YLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPP 304

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 41/198 (20%), Positives = 92/198 (46%), Gaps = 9/198 (4%)
Query: 74  VGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCC 133
           +G G    V+K   +    +  ++L  +        + + E+  +     P ++   G  
Sbjct: 76  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 135
Query: 134 VDNG-LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHR 192
             +G + +  +    GS+  +        +  ++  K+++   +GL YL +  + +I+HR
Sbjct: 136 YSDGEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLTYLRE--KHKIMHR 191
Query: 193 DIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTD 252
           D+K SNIL+ +  E ++ DFG++  L     +  +    GT  +++PE         ++D
Sbjct: 192 DVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV----GTRSYMSPERLQGTHYSVQSD 247
Query: 253 VFAFGVFLLEIISGRKPV 270
           +++ G+ L+E+  GR P+
Sbjct: 248 IWSMGLSLVEMAVGRYPI 265

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 44/203 (21%), Positives = 95/203 (46%), Gaps = 16/203 (7%)
Query: 74  VGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCC 133
           +G G +  V  G  +   ++A+K + +       E EF+ E   + ++ H  ++ L G C
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIKE---GSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 88
Query: 134 VDN-GLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHR 192
                +++I ++ + G + +   ++     + +   ++       + YL     ++ +HR
Sbjct: 89  TKQRPIFIITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVCEAMEYLE---SKQFLHR 144
Query: 193 DIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIA---PIEGTFGHLAPEYFMHGIVDE 249
           D+ + N L+      ++SDFGL++++       S+    P+  +     PE  M+     
Sbjct: 145 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGSKFPVRWS----PPEVLMYSKFSS 200
Query: 250 KTDVFAFGVFLLEIIS-GRKPVD 271
           K+D++AFGV + EI S G+ P +
Sbjct: 201 KSDIWAFGVLMWEIYSLGKMPYE 223

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 42/211 (19%), Positives = 97/211 (45%), Gaps = 9/211 (4%)
Query: 61  ISIATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGH 120
           + +  + F   + +G G    V+K   +    +  ++L  +        + + E+  +  
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 121 VCHPNVLSLLGCCVDNG-LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLH 179
              P ++   G    +G + +  +    GS+  +        +  ++  K+++   +GL 
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLT 118
Query: 180 YLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAP 239
           YL +  + +I+HRD+K SNIL+ +  E ++ DFG++  L     +  +    GT  +++P
Sbjct: 119 YLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV----GTRSYMSP 172
Query: 240 EYFMHGIVDEKTDVFAFGVFLLEIISGRKPV 270
           E         ++D+++ G+ L+E+  GR P+
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/252 (23%), Positives = 112/252 (44%), Gaps = 27/252 (10%)
Query: 86  VLQDGEEIAVKRLTKVVTDDRKEKE---FLTEIGTIGHVCHPNVLSLLGC-CVDNGLYLI 141
           V   G+ +AVK++     D RK++       E+  +    H NV+ +     V + L+++
Sbjct: 45  VRSSGKLVAVKKM-----DLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVV 99
Query: 142 FQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILL 201
            +F   G++  +   V    +  +    + +   + L  LH    + +IHRDIKS +ILL
Sbjct: 100 MEFLEGGALTDI---VTHTRMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILL 153
Query: 202 TADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLL 261
           T D   ++SDFG    +  +        + GT   +APE         + D+++ G+ ++
Sbjct: 154 THDGRVKLSDFGFCAQVSKEVPRRKX--LVGTPYWMAPELISRLPYGPEVDIWSLGIMVI 211
Query: 262 EIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRAS 321
           E++ G  P        +    P+     I   + PRL+  + V+   +  F   L +R  
Sbjct: 212 EMVDGEPP--------YFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLK-GFLDRLLVR-D 261
Query: 322 PTWRPTMSEVLE 333
           P  R T +E+L+
Sbjct: 262 PAQRATAAELLK 273

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 102/217 (47%), Gaps = 12/217 (5%)
Query: 64  ATNAFSSENLVGRGGYAEVYKGVLQD-GEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVC 122
           +++ F     +G G YA VYKG+ +  G  +A+K + K+ +++      + EI  +  + 
Sbjct: 3   SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEV-KLDSEEGTPSTAIREISLMKELK 61
Query: 123 HPNVLSLLGCC-VDNGLYLIFQFSSRGSVASLFHDV--NSP-GVEWKVRHKIAVGTARGL 178
           H N++ L      +N L L+F+F        +      N+P G+E  +         +GL
Sbjct: 62  HENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGL 121
Query: 179 HYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLA 238
            + H   + +I+HRD+K  N+L+    + ++ DFGLA+         S   +  T  + A
Sbjct: 122 AFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV--TLWYRA 176
Query: 239 PEYFMHG-IVDEKTDVFAFGVFLLEIISGRKPVDGSH 274
           P+  M         D+++ G  L E+I+G+    G++
Sbjct: 177 PDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTN 213

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 46/203 (22%), Positives = 97/203 (47%), Gaps = 16/203 (7%)
Query: 74  VGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCC 133
           +G G +  V  G  +   ++A+K + +       E EF+ E   + ++ H  ++ L G C
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIKE---GSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 73
Query: 134 VDNG-LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHR 192
                +++I ++ + G + +   ++     + +   ++       + YL     ++ +HR
Sbjct: 74  TKQRPIFIITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVCEAMEYLE---SKQFLHR 129
Query: 193 DIKSSNILLTADFEPQISDFGLAKW-LPSQWTHH--SIAPIEGTFGHLAPEYFMHGIVDE 249
           D+ + N L+      ++SDFGL+++ L  ++T    S  P+  +     PE  M+     
Sbjct: 130 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSKFPVRWS----PPEVLMYSKFSS 185
Query: 250 KTDVFAFGVFLLEIIS-GRKPVD 271
           K+D++AFGV + EI S G+ P +
Sbjct: 186 KSDIWAFGVLMWEIYSLGKMPYE 208

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 42/211 (19%), Positives = 97/211 (45%), Gaps = 9/211 (4%)
Query: 61  ISIATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGH 120
           + +  + F   + +G G    V+K   +    +  ++L  +        + + E+  +  
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 121 VCHPNVLSLLGCCVDNG-LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLH 179
              P ++   G    +G + +  +    GS+  +        +  ++  K+++   +GL 
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLT 118
Query: 180 YLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAP 239
           YL +  + +I+HRD+K SNIL+ +  E ++ DFG++  L     +  +    GT  +++P
Sbjct: 119 YLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV----GTRSYMSP 172
Query: 240 EYFMHGIVDEKTDVFAFGVFLLEIISGRKPV 270
           E         ++D+++ G+ L+E+  GR P+
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 42/211 (19%), Positives = 97/211 (45%), Gaps = 9/211 (4%)
Query: 61  ISIATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGH 120
           + +  + F   + +G G    V+K   +    +  ++L  +        + + E+  +  
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 121 VCHPNVLSLLGCCVDNG-LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLH 179
              P ++   G    +G + +  +    GS+  +        +  ++  K+++   +GL 
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLT 118
Query: 180 YLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAP 239
           YL +  + +I+HRD+K SNIL+ +  E ++ DFG++  L     +  +    GT  +++P
Sbjct: 119 YLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV----GTRSYMSP 172
Query: 240 EYFMHGIVDEKTDVFAFGVFLLEIISGRKPV 270
           E         ++D+++ G+ L+E+  GR P+
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/222 (23%), Positives = 97/222 (43%), Gaps = 13/222 (5%)
Query: 60  EISIATNAFSSENLVGRGGYAEVYKGVLQDGEEI-AVKRLTK--VVTDDRKEKEFLTEIG 116
           +I +    F    ++G+G + +V+    +   +  A+K L K  V+ DD  E   + E  
Sbjct: 11  QIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECT-MVEKR 69
Query: 117 TIGHVCHPNVLSLLGCCVDN--GLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGT 174
            +        L+ + C       L+ + ++ + G +  ++H  +    +       A   
Sbjct: 70  VLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDL--MYHIQSCHKFDLSRATFYAAEI 127
Query: 175 ARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTF 234
             GL +LH    + I++RD+K  NILL  D   +I+DFG+ K   +           GT 
Sbjct: 128 ILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCK--ENMLGDAKTNXFCGTP 182
Query: 235 GHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQS 276
            ++APE  +    +   D ++FGV L E++ G+ P  G  + 
Sbjct: 183 DYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE 224

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 42/211 (19%), Positives = 97/211 (45%), Gaps = 9/211 (4%)
Query: 61  ISIATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGH 120
           + +  + F   + +G G    V+K   +    +  ++L  +        + + E+  +  
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 121 VCHPNVLSLLGCCVDNG-LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLH 179
              P ++   G    +G + +  +    GS+  +        +  ++  K+++   +GL 
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLT 118
Query: 180 YLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAP 239
           YL +  + +I+HRD+K SNIL+ +  E ++ DFG++  L     +  +    GT  +++P
Sbjct: 119 YLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV----GTRSYMSP 172
Query: 240 EYFMHGIVDEKTDVFAFGVFLLEIISGRKPV 270
           E         ++D+++ G+ L+E+  GR P+
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 49/215 (22%), Positives = 95/215 (44%), Gaps = 18/215 (8%)
Query: 74  VGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC 132
           +G G Y    K   + DG+ +  K L      + +++  ++E+  +  + HPN++     
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 133 CVD---NGLYLIFQFSSRGSVASLFHDVNSPGVEWK--VRHKIAVGTARGLHYLHKGCQR 187
            +D     LY++ ++   G +AS    V + G + +  +  +  +     L    K C R
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLAS----VITKGTKERQYLDEEFVLRVMTQLTLALKECHR 129
Query: 188 R------IIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEY 241
           R      ++HRD+K +N+ L      ++ DFGLA+ L    +        GT  +++PE 
Sbjct: 130 RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT--FVGTPYYMSPEQ 187
Query: 242 FMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQS 276
                 +EK+D+++ G  L E+ +   P     Q 
Sbjct: 188 MNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK 222

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 46/203 (22%), Positives = 97/203 (47%), Gaps = 16/203 (7%)
Query: 74  VGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCC 133
           +G G +  V  G  +   ++A+K + +       E EF+ E   + ++ H  ++ L G C
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIKE---GSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 73
Query: 134 VDNG-LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHR 192
                +++I ++ + G + +   ++     + +   ++       + YL     ++ +HR
Sbjct: 74  TKQRPIFIITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVCEAMEYLE---SKQFLHR 129
Query: 193 DIKSSNILLTADFEPQISDFGLAKW-LPSQWTHH--SIAPIEGTFGHLAPEYFMHGIVDE 249
           D+ + N L+      ++SDFGL+++ L  ++T    S  P+  +     PE  M+     
Sbjct: 130 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWS----PPEVLMYSKFSS 185
Query: 250 KTDVFAFGVFLLEIIS-GRKPVD 271
           K+D++AFGV + EI S G+ P +
Sbjct: 186 KSDIWAFGVLMWEIYSLGKMPYE 208

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/252 (23%), Positives = 112/252 (44%), Gaps = 27/252 (10%)
Query: 86  VLQDGEEIAVKRLTKVVTDDRKEKE---FLTEIGTIGHVCHPNVLSLLGC-CVDNGLYLI 141
           V   G+ +AVK++     D RK++       E+  +    H NV+ +     V + L+++
Sbjct: 52  VRSSGKLVAVKKM-----DLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVV 106
Query: 142 FQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILL 201
            +F   G++  +   V    +  +    + +   + L  LH    + +IHRDIKS +ILL
Sbjct: 107 MEFLEGGALTDI---VTHTRMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILL 160
Query: 202 TADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLL 261
           T D   ++SDFG    +  +        + GT   +APE         + D+++ G+ ++
Sbjct: 161 THDGRVKLSDFGFCAQVSKEVPRRKX--LVGTPYWMAPELISRLPYGPEVDIWSLGIMVI 218
Query: 262 EIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRAS 321
           E++ G  P        +    P+     I   + PRL+  + V+   +  F   L +R  
Sbjct: 219 EMVDGEPP--------YFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLK-GFLDRLLVR-D 268
Query: 322 PTWRPTMSEVLE 333
           P  R T +E+L+
Sbjct: 269 PAQRATAAELLK 280

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 63/296 (21%), Positives = 125/296 (42%), Gaps = 42/296 (14%)
Query: 66  NAFSSENLVGRGGYAEV-----YKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGH 120
           N  S    +G G + +V     Y  +  D       ++ K      + +  ++E+  + +
Sbjct: 46  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 105
Query: 121 V-CHPNVLSLLGCCVDNGLYLIF-QFSSRGSVASLFH--------DVNSPGV-------- 162
           +  H N+++LLG C   G  L+  ++   G + +              SP +        
Sbjct: 106 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 165
Query: 163 EWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQW 222
           + +     +   A+G+ +L     +  IHRD+ + NILLT     +I DFGLA+ + +  
Sbjct: 166 DLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 222
Query: 223 THHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWA 281
            +            +APE   + +   ++DV+++G+FL E+ S G  P  G    + S  
Sbjct: 223 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPG--MPVDSKF 280
Query: 282 KPILNQGEIEKLVDPRLQGA--YDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVM 335
             ++ +G   +++ P    A  YD+ +          C  A P  RPT  ++++++
Sbjct: 281 YKMIKEG--FRMLSPEHAPAEMYDIMK---------TCWDADPLKRPTFKQIVQLI 325

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 42/211 (19%), Positives = 97/211 (45%), Gaps = 9/211 (4%)
Query: 61  ISIATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGH 120
           + +  + F   + +G G    V+K   +    +  ++L  +        + + E+  +  
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 121 VCHPNVLSLLGCCVDNG-LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLH 179
              P ++   G    +G + +  +    GS+  +        +  ++  K+++   +GL 
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLT 118
Query: 180 YLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAP 239
           YL +  + +I+HRD+K SNIL+ +  E ++ DFG++  L     +  +    GT  +++P
Sbjct: 119 YLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV----GTRSYMSP 172
Query: 240 EYFMHGIVDEKTDVFAFGVFLLEIISGRKPV 270
           E         ++D+++ G+ L+E+  GR P+
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 98/222 (44%), Gaps = 37/222 (16%)
Query: 74  VGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCC 133
           +G+G Y EV+ G  + GE++AVK      T +       TEI     + H N+L  +   
Sbjct: 45  IGKGRYGEVWMGKWR-GEKVAVKVF---FTTEEASWFRETEIYQTVLMRHENILGFIAAD 100
Query: 134 VD-----NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGC--- 185
           +        LYLI  +   GS   L+  + S  ++ K   K+A  +  GL +LH      
Sbjct: 101 IKGTGSWTQLYLITDYHENGS---LYDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFST 157
Query: 186 --QRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIE--GTFGHLAPEY 241
             +  I HRD+KS NIL+  +    I+D GLA    S      I P    GT  ++ PE 
Sbjct: 158 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPE- 216
Query: 242 FMHGIVDEK-----------TDVFAFGVFLLEIISGRKPVDG 272
               ++DE             D+++FG+ L E+   R+ V G
Sbjct: 217 ----VLDESLNRNHFQSYIMADMYSFGLILWEV--ARRCVSG 252

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/252 (23%), Positives = 112/252 (44%), Gaps = 27/252 (10%)
Query: 86  VLQDGEEIAVKRLTKVVTDDRKEKE---FLTEIGTIGHVCHPNVLSLLGC-CVDNGLYLI 141
           V   G+ +AVK++     D RK++       E+  +    H NV+ +     V + L+++
Sbjct: 50  VRSSGKLVAVKKM-----DLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVV 104
Query: 142 FQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILL 201
            +F   G++  +   V    +  +    + +   + L  LH    + +IHRDIKS +ILL
Sbjct: 105 MEFLEGGALTDI---VTHTRMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILL 158
Query: 202 TADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLL 261
           T D   ++SDFG    +  +        + GT   +APE         + D+++ G+ ++
Sbjct: 159 THDGRVKLSDFGFCAQVSKEVPRRKX--LVGTPYWMAPELISRLPYGPEVDIWSLGIMVI 216
Query: 262 EIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRAS 321
           E++ G  P        +    P+     I   + PRL+  + V+   +  F   L +R  
Sbjct: 217 EMVDGEPP--------YFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLK-GFLDRLLVR-D 266
Query: 322 PTWRPTMSEVLE 333
           P  R T +E+L+
Sbjct: 267 PAQRATAAELLK 278

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 63/296 (21%), Positives = 125/296 (42%), Gaps = 42/296 (14%)
Query: 66  NAFSSENLVGRGGYAEV-----YKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGH 120
           N  S    +G G + +V     Y  +  D       ++ K      + +  ++E+  + +
Sbjct: 41  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 100
Query: 121 V-CHPNVLSLLGCCVDNGLYLIF-QFSSRGSVASLFH--------DVNSPGV-------- 162
           +  H N+++LLG C   G  L+  ++   G + +              SP +        
Sbjct: 101 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 160
Query: 163 EWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQW 222
           + +     +   A+G+ +L     +  IHRD+ + NILLT     +I DFGLA+ + +  
Sbjct: 161 DLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 217
Query: 223 THHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWA 281
            +            +APE   + +   ++DV+++G+FL E+ S G  P  G    + S  
Sbjct: 218 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPG--MPVDSKF 275
Query: 282 KPILNQGEIEKLVDPRLQGA--YDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVM 335
             ++ +G   +++ P    A  YD+ +          C  A P  RPT  ++++++
Sbjct: 276 YKMIKEG--FRMLSPEHAPAEMYDIMK---------TCWDADPLKRPTFKQIVQLI 320

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/299 (20%), Positives = 123/299 (41%), Gaps = 60/299 (20%)
Query: 68  FSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNV 126
           F    L+G GG+ +V+K   + DG+   ++R+     +++ E+E    +  +  + H N+
Sbjct: 14  FKEIELIGSGGFGQVFKAKHRIDGKTYVIRRVK--YNNEKAERE----VKALAKLDHVNI 67
Query: 127 LSLLGC---------CVDNGL---------------------YLIFQFSSRGSVASLFHD 156
           +   GC           D+ L                     ++  +F  +G++      
Sbjct: 68  VHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEK 127
Query: 157 VNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAK 216
                ++  +  ++     +G+ Y+H    +++IHRD+K SNI L    + +I DFGL  
Sbjct: 128 RRGEKLDKVLALELFEQITKGVDYIH---SKKLIHRDLKPSNIFLVDTKQVKIGDFGLVT 184
Query: 217 WLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQS 276
            L +          +GT  +++PE        ++ D++A G+ L E++      D + ++
Sbjct: 185 SLKNDGKR---TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLH---VCDTAFET 238
Query: 277 LHSWAKPILNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVM 335
              +    L  G I  + D +     + T L +L       +   P  RP  SE+L  +
Sbjct: 239 SKFFTD--LRDGIISDIFDKK-----EKTLLQKL-------LSKKPEDRPNTSEILRTL 283

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 46/203 (22%), Positives = 97/203 (47%), Gaps = 16/203 (7%)
Query: 74  VGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCC 133
           +G G +  V  G  +   ++A+K + +       E EF+ E   + ++ H  ++ L G C
Sbjct: 23  LGTGQFGVVKYGKWRGQYDVAIKMIKE---GSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 79
Query: 134 VDNG-LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHR 192
                +++I ++ + G + +   ++     + +   ++       + YL     ++ +HR
Sbjct: 80  TKQRPIFIITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVCEAMEYLE---SKQFLHR 135
Query: 193 DIKSSNILLTADFEPQISDFGLAKW-LPSQWTHH--SIAPIEGTFGHLAPEYFMHGIVDE 249
           D+ + N L+      ++SDFGL+++ L  ++T    S  P+  +     PE  M+     
Sbjct: 136 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWS----PPEVLMYSKFSS 191
Query: 250 KTDVFAFGVFLLEIIS-GRKPVD 271
           K+D++AFGV + EI S G+ P +
Sbjct: 192 KSDIWAFGVLMWEIYSLGKMPYE 214

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 46/203 (22%), Positives = 97/203 (47%), Gaps = 16/203 (7%)
Query: 74  VGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCC 133
           +G G +  V  G  +   ++A+K + +       E EF+ E   + ++ H  ++ L G C
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIKE---GSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 68
Query: 134 VDNG-LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHR 192
                +++I ++ + G + +   ++     + +   ++       + YL     ++ +HR
Sbjct: 69  TKQRPIFIITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVCEAMEYLE---SKQFLHR 124
Query: 193 DIKSSNILLTADFEPQISDFGLAKW-LPSQWTHH--SIAPIEGTFGHLAPEYFMHGIVDE 249
           D+ + N L+      ++SDFGL+++ L  ++T    S  P+  +     PE  M+     
Sbjct: 125 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWS----PPEVLMYSKFSS 180
Query: 250 KTDVFAFGVFLLEIIS-GRKPVD 271
           K+D++AFGV + EI S G+ P +
Sbjct: 181 KSDIWAFGVLMWEIYSLGKMPYE 203

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 68/273 (24%), Positives = 115/273 (42%), Gaps = 24/273 (8%)
Query: 54  RCFSFEEISIATNAFSS----ENL--VGRGGYAEV---YKGVLQDGEEIAVKRLTKVVTD 104
           R  +F  + I  + F+     +NL  +G G    V   Y  +L+    +A+K+L++   +
Sbjct: 6   RDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQN 63
Query: 105 DRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEW 164
               K    E+  +  V H N++ LL          + +F     V  L     S  ++ 
Sbjct: 64  QTHAKRAYRELVLMKVVNHKNIIGLLNVFTPQKS--LEEFQDVYIVMELMDANLSQVIQM 121
Query: 165 KVRHK----IAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPS 220
           ++ H+    +      G+ +LH      IIHRD+K SNI++ +D   +I DFGLA+   +
Sbjct: 122 ELDHERMSYLLYQMLVGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLAR---T 175
Query: 221 QWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSW 280
             T   + P   T  + APE  +     E  D+++ GV + E+I G     G+   +  W
Sbjct: 176 AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGVIMGEMIKGGVLFPGTDH-IDQW 234
Query: 281 AKPILNQGEIEKLVDPRLQGAYDVTQLNRLAFA 313
            K I   G        +LQ        NR  +A
Sbjct: 235 NKVIEQLGTPSPEFMKKLQPTVRTYVENRPKYA 267

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 68/261 (26%), Positives = 118/261 (45%), Gaps = 23/261 (8%)
Query: 74  VGRGGYAEVYKGVLQD-GEEIAVKRLTKVVTDDRKEKEFLTEIGTI--GHVCHPNVLSLL 130
           +GRG +A V + + +  G+E A K L K         E L EI  +     C P V++L 
Sbjct: 37  LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSC-PRVINLH 95
Query: 131 GCCVDNG-LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRI 189
               +   + LI ++++ G + SL     +  V      ++      G++YLH   Q  I
Sbjct: 96  EVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLH---QNNI 152
Query: 190 IHRDIKSSNILLTADF---EPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGI 246
           +H D+K  NILL++ +   + +I DFG+++ +        +  I GT  +LAPE   +  
Sbjct: 153 VHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHAC---ELREIMGTPEYLAPEILNYDP 209
Query: 247 VDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQ 306
           +   TD++  G+    +++   P  G         +  LN  ++   VD   +    V+Q
Sbjct: 210 ITTATDMWNIGIIAYMLLTHTSPFVGEDNQ-----ETYLNISQVN--VDYSEETFSSVSQ 262
Query: 307 LNRLAFAASLCIRASPTWRPT 327
           L    F  SL ++ +P  RPT
Sbjct: 263 L-ATDFIQSLLVK-NPEKRPT 281

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 68/273 (24%), Positives = 115/273 (42%), Gaps = 24/273 (8%)
Query: 54  RCFSFEEISIATNAFSS----ENL--VGRGGYAEV---YKGVLQDGEEIAVKRLTKVVTD 104
           R  +F  + I  + F+     +NL  +G G    V   Y  +L+    +A+K+L++   +
Sbjct: 6   RDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVVAAYDAILE--RNVAIKKLSRPFQN 63
Query: 105 DRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEW 164
               K    E+  +  V H N++ LL          + +F     V  L     S  ++ 
Sbjct: 64  QTHAKRAYRELVLMKVVNHKNIIGLLNVFTPQKS--LEEFQDVYIVMELMDANLSQVIQM 121
Query: 165 KVRHK----IAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPS 220
           ++ H+    +      G+ +LH      IIHRD+K SNI++ +D   +I DFGLA+   +
Sbjct: 122 ELDHERMSYLLYQMLVGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLAR---T 175
Query: 221 QWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSW 280
             T   + P   T  + APE  +     E  D+++ GV + E+I G     G+   +  W
Sbjct: 176 AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGVIMGEMIKGGVLFPGTDH-IDQW 234
Query: 281 AKPILNQGEIEKLVDPRLQGAYDVTQLNRLAFA 313
            K I   G        +LQ        NR  +A
Sbjct: 235 NKVIEQLGTPSPEFMKKLQPTVRTYVENRPKYA 267

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 42/209 (20%), Positives = 96/209 (45%), Gaps = 9/209 (4%)
Query: 63  IATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVC 122
           +  + F   + +G G    V+K   +    +  ++L  +        + + E+  +    
Sbjct: 30  LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECN 89
Query: 123 HPNVLSLLGCCVDNG-LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYL 181
            P ++   G    +G + +  +    GS+  +        +  ++  K+++   +GL YL
Sbjct: 90  SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLTYL 147
Query: 182 HKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEY 241
            +  + +I+HRD+K SNIL+ +  E ++ DFG++  L     +  +    GT  +++PE 
Sbjct: 148 RE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV----GTRSYMSPER 201
Query: 242 FMHGIVDEKTDVFAFGVFLLEIISGRKPV 270
                   ++D+++ G+ L+E+  GR P+
Sbjct: 202 LQGTHYSVQSDIWSMGLSLVEMAVGRYPI 230

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/252 (23%), Positives = 112/252 (44%), Gaps = 27/252 (10%)
Query: 86  VLQDGEEIAVKRLTKVVTDDRKEKE---FLTEIGTIGHVCHPNVLSLLGC-CVDNGLYLI 141
           V   G+ +AVK++     D RK++       E+  +    H NV+ +     V + L+++
Sbjct: 95  VRSSGKLVAVKKM-----DLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVV 149
Query: 142 FQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILL 201
            +F   G++  +   V    +  +    + +   + L  LH    + +IHRDIKS +ILL
Sbjct: 150 MEFLEGGALTDI---VTHTRMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILL 203
Query: 202 TADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLL 261
           T D   ++SDFG    +  +        + GT   +APE         + D+++ G+ ++
Sbjct: 204 THDGRVKLSDFGFCAQVSKEVPRRKX--LVGTPYWMAPELISRLPYGPEVDIWSLGIMVI 261
Query: 262 EIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRAS 321
           E++ G  P        +    P+     I   + PRL+  + V+   +  F   L +R  
Sbjct: 262 EMVDGEPP--------YFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLK-GFLDRLLVR-D 311
Query: 322 PTWRPTMSEVLE 333
           P  R T +E+L+
Sbjct: 312 PAQRATAAELLK 323

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/192 (28%), Positives = 87/192 (45%), Gaps = 35/192 (18%)
Query: 90  GEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG---LYLIFQFSS 146
           GE +AVK L K     +    +  EI  +  + H +++   GCC D G   L L+ ++  
Sbjct: 60  GEMVAVKAL-KADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVP 118
Query: 147 RGSVASLFHDVNSPGVEWKVRHKIAVG--------TARGLHYLHKGCQRRIIHRDIKSSN 198
            GS+            ++  RH I +            G+ YLH    +  IHRD+ + N
Sbjct: 119 LGSLR-----------DYLPRHSIGLAQLLLFAQQICEGMAYLHA---QHYIHRDLAARN 164
Query: 199 ILLTADFEPQISDFGLAKWLPSQWTHHSI-----APIEGTFGHLAPEYFMHGIVDEKTDV 253
           +LL  D   +I DFGLAK +P     + +     +P+   F + APE          +DV
Sbjct: 165 VLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPV---FWY-APECLKEYKFYYASDV 220
Query: 254 FAFGVFLLEIIS 265
           ++FGV L E+++
Sbjct: 221 WSFGVTLYELLT 232

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 53/192 (27%), Positives = 88/192 (45%), Gaps = 35/192 (18%)
Query: 90  GEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG---LYLIFQFSS 146
           GE +AVK L K     +    +  EI  +  + H +++   GCC D G   L L+ ++  
Sbjct: 43  GEMVAVKAL-KADCGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVP 101
Query: 147 RGSVASLFHDVNSPGVEWKVRHKIAVGT--------ARGLHYLHKGCQRRIIHRDIKSSN 198
            GS+            ++  RH I +            G+ YLH    +  IHR++ + N
Sbjct: 102 LGSLR-----------DYLPRHSIGLAQLLLFAQQICEGMAYLH---SQHYIHRNLAARN 147
Query: 199 ILLTADFEPQISDFGLAKWLPSQWTHHSI-----APIEGTFGHLAPEYFMHGIVDEKTDV 253
           +LL  D   +I DFGLAK +P    ++ +     +P+   F + APE          +DV
Sbjct: 148 VLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPV---FWY-APECLKEYKFYYASDV 203
Query: 254 FAFGVFLLEIIS 265
           ++FGV L E+++
Sbjct: 204 WSFGVTLYELLT 215

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 51/217 (23%), Positives = 96/217 (44%), Gaps = 22/217 (10%)
Query: 74  VGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC 132
           +G G Y    K   + DG+ +  K L      + +++  ++E+  +  + HPN++     
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 133 CVD---NGLYLIFQFSSRGSVASLFHDVNSPGVEWK--VRHKIAVGTARGLHYLHKGCQR 187
            +D     LY++ ++   G +AS    V + G + +  +  +  +     L    K C R
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLAS----VITKGTKERQYLDEEFVLRVMTQLTLALKECHR 129
Query: 188 R------IIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIE--GTFGHLAP 239
           R      ++HRD+K +N+ L      ++ DFGLA+ L     H      E  GT  +++P
Sbjct: 130 RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL----NHDEDFAKEFVGTPYYMSP 185
Query: 240 EYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQS 276
           E       +EK+D+++ G  L E+ +   P     Q 
Sbjct: 186 EQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK 222

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 41/197 (20%), Positives = 92/197 (46%), Gaps = 9/197 (4%)
Query: 74  VGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCC 133
           +G G    V+K   +    +  ++L  +        + + E+  +     P ++   G  
Sbjct: 17  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 76
Query: 134 VDNG-LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHR 192
             +G + +  +    GS+  +        +  ++  K+++   +GL YL +  + +I+HR
Sbjct: 77  YSDGEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLTYLRE--KHKIMHR 132
Query: 193 DIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTD 252
           D+K SNIL+ +  E ++ DFG++  L  +  +  +    GT  +++PE         ++D
Sbjct: 133 DVKPSNILVNSRGEIKLCDFGVSGQLIDEMANEFV----GTRSYMSPERLQGTHYSVQSD 188
Query: 253 VFAFGVFLLEIISGRKP 269
           +++ G+ L+E+  GR P
Sbjct: 189 IWSMGLSLVEMAVGRYP 205

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 60/252 (23%), Positives = 112/252 (44%), Gaps = 27/252 (10%)
Query: 86  VLQDGEEIAVKRLTKVVTDDRKEKE---FLTEIGTIGHVCHPNVLSLLGC-CVDNGLYLI 141
           V   G+ +AVK++     D RK++       E+  +    H NV+ +     V + L+++
Sbjct: 172 VRSSGKLVAVKKM-----DLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVV 226
Query: 142 FQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILL 201
            +F   G++  +   V    +  +    + +   + L  LH    + +IHRDIKS +ILL
Sbjct: 227 MEFLEGGALTDI---VTHTRMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILL 280
Query: 202 TADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLL 261
           T D   ++SDFG    +  +        + GT   +APE         + D+++ G+ ++
Sbjct: 281 THDGRVKLSDFGFCAQVSKEVPRRKX--LVGTPYWMAPELISRLPYGPEVDIWSLGIMVI 338
Query: 262 EIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRAS 321
           E++ G  P        +    P+     I   + PRL+  + V+   +  F   L +R  
Sbjct: 339 EMVDGEPP--------YFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLK-GFLDRLLVR-D 388
Query: 322 PTWRPTMSEVLE 333
           P  R T +E+L+
Sbjct: 389 PAQRATAAELLK 400

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 53/192 (27%), Positives = 88/192 (45%), Gaps = 35/192 (18%)
Query: 90  GEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG---LYLIFQFSS 146
           GE +AVK L K     +    +  EI  +  + H +++   GCC D G   L L+ ++  
Sbjct: 43  GEMVAVKAL-KADCGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVP 101
Query: 147 RGSVASLFHDVNSPGVEWKVRHKIAVGT--------ARGLHYLHKGCQRRIIHRDIKSSN 198
            GS+            ++  RH I +            G+ YLH    +  IHR++ + N
Sbjct: 102 LGSLR-----------DYLPRHSIGLAQLLLFAQQICEGMAYLHA---QHYIHRNLAARN 147
Query: 199 ILLTADFEPQISDFGLAKWLPSQWTHHSI-----APIEGTFGHLAPEYFMHGIVDEKTDV 253
           +LL  D   +I DFGLAK +P    ++ +     +P+   F + APE          +DV
Sbjct: 148 VLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPV---FWY-APECLKEYKFYYASDV 203
Query: 254 FAFGVFLLEIIS 265
           ++FGV L E+++
Sbjct: 204 WSFGVTLYELLT 215

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 61/245 (24%), Positives = 110/245 (44%), Gaps = 17/245 (6%)
Query: 65  TNAFSSENLVGRGGYAEVYKGVLQD-GEEIAVK--RLTKVVTD----DRKEKEFLTEIGT 117
           +  +S+ + +G G +  V+  V ++  +E+ VK  +  KV+ D    D K  +   EI  
Sbjct: 23  SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAI 82
Query: 118 IGHVCHPNVLSLLGCCVDNGLYLIFQFSSRGSVASLFHDVNS-PGVEWKVRHKIAVGTAR 176
           +  V H N++ +L    + G + +      GS   LF  ++  P ++  +   I      
Sbjct: 83  LSRVEHANIIKVLDIFENQGFFQLV-MEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVS 141
Query: 177 GLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGH 236
            + YL     + IIHRDIK  NI++  DF  ++ DFG A +L      ++     GT  +
Sbjct: 142 AVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFC---GTIEY 195
Query: 237 LAPEYFM-HGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWA-KPILNQGEIEKLV 294
            APE  M +     + ++++ GV L  ++    P     +++ +    P L   E+  LV
Sbjct: 196 CAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVEAAIHPPYLVSKELMSLV 255
Query: 295 DPRLQ 299
              LQ
Sbjct: 256 SGLLQ 260

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 103/220 (46%), Gaps = 34/220 (15%)
Query: 74  VGRGGYAEVYKGVL------QDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVL 127
           +G G + +V+          QD   +AVK L      D   K+F  E   + ++ H +++
Sbjct: 21  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKD--ASDNARKDFHREAELLTNLQHEHIV 78
Query: 128 SLLGCCVD-NGLYLIFQFSSRGSV----------ASLFHDVNSPG--VEWKVRHKIAVGT 174
              G CV+ + L ++F++   G +          A L  + N P    + ++ H IA   
Sbjct: 79  KFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLH-IAQQI 137
Query: 175 ARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTH----HSIAPI 230
           A G+ YL     +  +HRD+ + N L+  +   +I DFG+++ + S   +    H++ PI
Sbjct: 138 AAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 194
Query: 231 EGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKP 269
                 + PE  M+     ++DV++ GV L EI + G++P
Sbjct: 195 RW----MPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 230

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 42/205 (20%), Positives = 94/205 (45%), Gaps = 9/205 (4%)
Query: 74  VGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCC 133
           +G G    V+K   +    +  ++L  +        + + E+  +     P ++   G  
Sbjct: 33  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 92
Query: 134 VDNG-LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHR 192
             +G + +  +    GS+  +        +  ++  K+++   +GL YL +  + +I+HR
Sbjct: 93  YSDGEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLTYLRE--KHKIMHR 148
Query: 193 DIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTD 252
           D+K SNIL+ +  E ++ DFG++  L     +  +    GT  +++PE         ++D
Sbjct: 149 DVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV----GTRSYMSPERLQGTHYSVQSD 204
Query: 253 VFAFGVFLLEIISGRKPVDGSHQSL 277
           +++ G+ L+E+  GR P+     S+
Sbjct: 205 IWSMGLSLVEMAVGRYPIGSGSGSM 229

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 101/225 (44%), Gaps = 21/225 (9%)
Query: 51  PTWRCFSFEEISIATNAFSSENLVGRGGYAEVYKGVLQDGEE-IAVKRLTKVVTDDRKEK 109
           P W+    E+I    + +   +++G G ++EV     +  ++ +A+K + K   +  KE 
Sbjct: 8   PRWK--QAEDIR---DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEG-KEG 61
Query: 110 EFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQFSSRGSVASLFHDVNSPGV-EWKVR 167
               EI  +  + HPN+++L       G LYLI Q  S G    LF  +   G    +  
Sbjct: 62  SMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGE---LFDRIVEKGFYTERDA 118
Query: 168 HKIAVGTARGLHYLHKGCQRRIIHRDIKSSNIL---LTADFEPQISDFGLAKWLPSQWTH 224
            ++       + YLH      I+HRD+K  N+L   L  D +  ISDFGL+K    +   
Sbjct: 119 SRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPG 172
Query: 225 HSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKP 269
             ++   GT G++APE        +  D ++ GV    ++ G  P
Sbjct: 173 SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 217

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 101/225 (44%), Gaps = 21/225 (9%)
Query: 51  PTWRCFSFEEISIATNAFSSENLVGRGGYAEVYKGVLQDGEE-IAVKRLTKVVTDDRKEK 109
           P W+    E+I    + +   +++G G ++EV     +  ++ +A+K + K   +  KE 
Sbjct: 8   PRWK--QAEDIR---DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEG-KEG 61
Query: 110 EFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQFSSRGSVASLFHDVNSPGV-EWKVR 167
               EI  +  + HPN+++L       G LYLI Q  S G    LF  +   G    +  
Sbjct: 62  SMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGE---LFDRIVEKGFYTERDA 118
Query: 168 HKIAVGTARGLHYLHKGCQRRIIHRDIKSSNIL---LTADFEPQISDFGLAKWLPSQWTH 224
            ++       + YLH      I+HRD+K  N+L   L  D +  ISDFGL+K    +   
Sbjct: 119 SRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPG 172
Query: 225 HSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKP 269
             ++   GT G++APE        +  D ++ GV    ++ G  P
Sbjct: 173 SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 217

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 101/225 (44%), Gaps = 21/225 (9%)
Query: 51  PTWRCFSFEEISIATNAFSSENLVGRGGYAEVYKGVLQDGEE-IAVKRLTKVVTDDRKEK 109
           P W+    E+I    + +   +++G G ++EV     +  ++ +A+K + K   +  KE 
Sbjct: 8   PRWK--QAEDIR---DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG-KEG 61
Query: 110 EFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQFSSRGSVASLFHDVNSPGV-EWKVR 167
               EI  +  + HPN+++L       G LYLI Q  S G    LF  +   G    +  
Sbjct: 62  SMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGE---LFDRIVEKGFYTERDA 118
Query: 168 HKIAVGTARGLHYLHKGCQRRIIHRDIKSSNIL---LTADFEPQISDFGLAKWLPSQWTH 224
            ++       + YLH      I+HRD+K  N+L   L  D +  ISDFGL+K    +   
Sbjct: 119 SRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPG 172
Query: 225 HSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKP 269
             ++   GT G++APE        +  D ++ GV    ++ G  P
Sbjct: 173 SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 217

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 50/213 (23%), Positives = 105/213 (49%), Gaps = 18/213 (8%)
Query: 66  NAFSSENLVGRGGYAEVYKGVLQDGE---EIAVKRLTKVVTDDRKEKEFLTEIGTIGHVC 122
           N   ++  +G G +  V +GV +  +   ++A+K L K  T+    +E + E   +  + 
Sbjct: 336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVL-KQGTEKADTEEMMREAQIMHQLD 394
Query: 123 HPNVLSLLGCCVDNGLYLIFQFSSRGSVASLF----HDVNSPGVEWKVRHKIAVGTARGL 178
           +P ++ L+G C    L L+ + +  G +         ++    V  ++ H++++G    +
Sbjct: 395 NPYIVRLIGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVA-ELLHQVSMG----M 449
Query: 179 HYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPI-EGTFGHL 237
            YL    ++  +HR++ + N+LL      +ISDFGL+K L +  ++++     +      
Sbjct: 450 KYLE---EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY 506
Query: 238 APEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKP 269
           APE         ++DV+++GV + E +S G+KP
Sbjct: 507 APECINFRKFSSRSDVWSYGVTMWEALSYGQKP 539

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 66/248 (26%), Positives = 107/248 (43%), Gaps = 33/248 (13%)
Query: 58  FEEISIATNAFSSENLVGRGGYAEVYK-GVLQDGEEIAVKRLTKVVTDDRK-EKEFLTEI 115
            E   +  N F    ++G+GG+ EV    V   G+  A K+L K     RK E   L E 
Sbjct: 176 LERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEK 235
Query: 116 GTIGHVCHPNVLSLLGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVG-- 173
             +  V    V+SL            + + ++ ++  +   +N   +++ + H    G  
Sbjct: 236 QILEKVNSRFVVSL-----------AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFP 284
Query: 174 TARGLHYLHKGC-------QRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHS 226
            AR + Y  + C       + RI++RD+K  NILL      +ISD GLA  +P   T   
Sbjct: 285 EARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--- 341
Query: 227 IAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILN 286
           I    GT G++APE   +       D +A G  L E+I+G+ P     +         + 
Sbjct: 342 IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKK--------IK 393
Query: 287 QGEIEKLV 294
           + E+E+LV
Sbjct: 394 REEVERLV 401

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 66/248 (26%), Positives = 107/248 (43%), Gaps = 33/248 (13%)
Query: 58  FEEISIATNAFSSENLVGRGGYAEVYK-GVLQDGEEIAVKRLTKVVTDDRK-EKEFLTEI 115
            E   +  N F    ++G+GG+ EV    V   G+  A K+L K     RK E   L E 
Sbjct: 176 LERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEK 235
Query: 116 GTIGHVCHPNVLSLLGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVG-- 173
             +  V    V+SL            + + ++ ++  +   +N   +++ + H    G  
Sbjct: 236 QILEKVNSRFVVSL-----------AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFP 284
Query: 174 TARGLHYLHKGC-------QRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHS 226
            AR + Y  + C       + RI++RD+K  NILL      +ISD GLA  +P   T   
Sbjct: 285 EARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--- 341
Query: 227 IAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILN 286
           I    GT G++APE   +       D +A G  L E+I+G+ P     +         + 
Sbjct: 342 IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKK--------IK 393
Query: 287 QGEIEKLV 294
           + E+E+LV
Sbjct: 394 REEVERLV 401

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 101/225 (44%), Gaps = 21/225 (9%)
Query: 51  PTWRCFSFEEISIATNAFSSENLVGRGGYAEVYKGVLQDGEE-IAVKRLTKVVTDDRKEK 109
           P W+    E+I    + +   +++G G ++EV     +  ++ +A+K + K   +  KE 
Sbjct: 8   PRWK--QAEDIR---DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEG-KEG 61
Query: 110 EFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQFSSRGSVASLFHDVNSPGV-EWKVR 167
               EI  +  + HPN+++L       G LYLI Q  S G    LF  +   G    +  
Sbjct: 62  SMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGE---LFDRIVEKGFYTERDA 118
Query: 168 HKIAVGTARGLHYLHKGCQRRIIHRDIKSSNIL---LTADFEPQISDFGLAKWLPSQWTH 224
            ++       + YLH      I+HRD+K  N+L   L  D +  ISDFGL+K    +   
Sbjct: 119 SRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPG 172
Query: 225 HSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKP 269
             ++   GT G++APE        +  D ++ GV    ++ G  P
Sbjct: 173 SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 217

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 90/206 (43%), Gaps = 19/206 (9%)
Query: 90  GEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDN-------GLYLIF 142
           G  +AVK+L++   +    K    E+  +  V H N++SLL              +YL+ 
Sbjct: 49  GINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVM 108
Query: 143 QFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLT 202
           +         +  +++   + + +   +      G+ +LH      IIHRD+K SNI++ 
Sbjct: 109 ELMDANLCQVIHMELDHERMSYLLYQMLC-----GIKHLHSA---GIIHRDLKPSNIVVK 160
Query: 203 ADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLE 262
           +D   +I DFGLA+   +  T+  + P   T  + APE  +        D+++ G  + E
Sbjct: 161 SDCTLKILDFGLAR---TACTNFMMTPYVVTRYYRAPEVILGMGYAANVDIWSVGCIMGE 217
Query: 263 IISGRKPVDGSHQSLHSWAKPILNQG 288
           ++ G     G+   +  W K I   G
Sbjct: 218 LVKGCVIFQGTDH-IDQWNKVIEQLG 242

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 91/208 (43%), Gaps = 19/208 (9%)
Query: 74  VGRGGYAEVYKGVLQD---GEEIAVKRLTKV-VTDDRKEKEFLTEIGTIGHVCHPNVLSL 129
           +G G Y EV   + +D   G E A+K + K  VT        L E+  +  + HPN++ L
Sbjct: 29  LGSGAYGEVL--LCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKL 86
Query: 130 LGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTA-RGLHYLHKGCQRR 188
                D   Y +     RG    LF ++       +V   + +     G  YLHK     
Sbjct: 87  YEFFEDKRNYYLVMEVYRG--GELFDEIILRQKFSEVDAAVIMKQVLSGTTYLHK---HN 141
Query: 189 IIHRDIKSSNILLTA---DFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHG 245
           I+HRD+K  N+LL +   D   +I DFGL+           +    GT  ++APE  +  
Sbjct: 142 IVHRDLKPENLLLESKSRDALIKIVDFGLSAHFE---VGGKMKERLGTAYYIAPE-VLRK 197
Query: 246 IVDEKTDVFAFGVFLLEIISGRKPVDGS 273
             DEK DV++ GV L  ++ G  P  G 
Sbjct: 198 KYDEKCDVWSCGVILYILLCGYPPFGGQ 225

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 99/215 (46%), Gaps = 32/215 (14%)
Query: 68  FSSENLVGRGGYAEVYKGVLQDGEEI--AVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPN 125
           ++ EN +GRG + EV K  +Q G  I  A K++ K   +D     F  EI  +  + HPN
Sbjct: 28  YTLENTIGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVED--VDRFKQEIEIMKSLDHPN 84
Query: 126 VLSLLGCCVDN-GLYLIFQFSSRGSV------ASLFHDVNSPGVEWKVRHKIAVGTARGL 178
           ++ L     DN  +YL+ +  + G +        +F + ++  +   V   +A       
Sbjct: 85  IIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVA------- 137
Query: 179 HYLHKGCQRRIIHRDIKSSNILL---TADFEPQISDFGL-AKWLPSQWTHHSIAPIEGTF 234
            Y HK     + HRD+K  N L    + D   ++ DFGL A++ P +     +    GT 
Sbjct: 138 -YCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKV----GTP 189
Query: 235 GHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKP 269
            +++P+  + G+   + D ++ GV +  ++ G  P
Sbjct: 190 YYVSPQ-VLEGLYGPECDEWSAGVMMYVLLCGYPP 223

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 91/208 (43%), Gaps = 19/208 (9%)
Query: 74  VGRGGYAEVYKGVLQD---GEEIAVKRLTKV-VTDDRKEKEFLTEIGTIGHVCHPNVLSL 129
           +G G Y EV   + +D   G E A+K + K  VT        L E+  +  + HPN++ L
Sbjct: 12  LGSGAYGEVL--LCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKL 69
Query: 130 LGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTA-RGLHYLHKGCQRR 188
                D   Y +     RG    LF ++       +V   + +     G  YLHK     
Sbjct: 70  YEFFEDKRNYYLVMEVYRG--GELFDEIILRQKFSEVDAAVIMKQVLSGTTYLHK---HN 124
Query: 189 IIHRDIKSSNILLTA---DFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHG 245
           I+HRD+K  N+LL +   D   +I DFGL+           +    GT  ++APE  +  
Sbjct: 125 IVHRDLKPENLLLESKSRDALIKIVDFGLSAHFE---VGGKMKERLGTAYYIAPE-VLRK 180
Query: 246 IVDEKTDVFAFGVFLLEIISGRKPVDGS 273
             DEK DV++ GV L  ++ G  P  G 
Sbjct: 181 KYDEKCDVWSCGVILYILLCGYPPFGGQ 208

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 68/249 (27%), Positives = 111/249 (44%), Gaps = 36/249 (14%)
Query: 70  SENLVGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVC--HPNV 126
           +  L+G G YA+V   V LQ+G+E AVK + K     R       E+ T+ + C  + N+
Sbjct: 17  TSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSR--VFREVETL-YQCQGNKNI 73
Query: 127 LSLLGCCVDNG-LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGC 185
           L L+    D+   YL+F+    GS+  L H         +   ++    A  L +LH   
Sbjct: 74  LELIEFFEDDTRFYLVFEKLQGGSI--LAHIQKQKHFNEREASRVVRDVAAALDFLHT-- 129
Query: 186 QRRIIHRDIKSSNILLTA--DFEP-QISDFGLAKWLPSQWTHHSIAPIE--------GTF 234
            + I HRD+K  NIL  +     P +I DF L   +     ++S  PI         G+ 
Sbjct: 130 -KGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMK---LNNSCTPITTPELTTPCGSA 185
Query: 235 GHLAPEYF-----MHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGE 289
            ++APE            D++ D+++ GV L  ++SG  P  G     H  A    ++GE
Sbjct: 186 EYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVG-----HCGADCGWDRGE 240
Query: 290 IEKLVDPRL 298
           + ++   +L
Sbjct: 241 VCRVCQNKL 249

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 99/215 (46%), Gaps = 32/215 (14%)
Query: 68  FSSENLVGRGGYAEVYKGVLQDGEEI--AVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPN 125
           ++ EN +GRG + EV K  +Q G  I  A K++ K   +D     F  EI  +  + HPN
Sbjct: 11  YTLENTIGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVED--VDRFKQEIEIMKSLDHPN 67
Query: 126 VLSLLGCCVDN-GLYLIFQFSSRGSV------ASLFHDVNSPGVEWKVRHKIAVGTARGL 178
           ++ L     DN  +YL+ +  + G +        +F + ++  +   V   +A       
Sbjct: 68  IIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVA------- 120
Query: 179 HYLHKGCQRRIIHRDIKSSNILL---TADFEPQISDFGL-AKWLPSQWTHHSIAPIEGTF 234
            Y HK     + HRD+K  N L    + D   ++ DFGL A++ P +     +    GT 
Sbjct: 121 -YCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKV----GTP 172
Query: 235 GHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKP 269
            +++P+  + G+   + D ++ GV +  ++ G  P
Sbjct: 173 YYVSPQ-VLEGLYGPECDEWSAGVMMYVLLCGYPP 206

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 89/215 (41%), Gaps = 17/215 (7%)
Query: 74  VGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCC 133
           +G G Y EV   V +  EE    ++  +       +    EI     + H NV+   G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHR 73
Query: 134 VDNGL-YLIFQFSSRGSVASLFH-DVNSPGVE-WKVRHKIAVGTARGLHYLHKGCQRRII 190
            +  + YL  ++ S G +      D+  P  +  +  H++  G      YLH G    I 
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV----YLH-GIG--IT 126
Query: 191 HRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYF----MHGI 246
           HRDIK  N+LL      +ISDFGLA           +  + GT  ++APE       H  
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHA- 185
Query: 247 VDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWA 281
             E  DV++ G+ L  +++G  P D    S   ++
Sbjct: 186 --EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS 218

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/266 (22%), Positives = 115/266 (43%), Gaps = 20/266 (7%)
Query: 21  DGDNAAVSPNGFTEESLENVVVACESETTKPTWRCFSFEEISIATNAFSSENLVGRGGYA 80
           DG++ +  P G  +    +   +  ++      +  SF+      + +     +G G Y 
Sbjct: 11  DGEDGSAEPPGPVKAEPAHTAASVAAKNLA-LLKARSFDVTFDVGDEYEIIETIGNGAYG 69
Query: 81  EVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSL---LGCCVDN 136
            V     +  G+++A+K++          K  L E+  + H  H N++++   L   V  
Sbjct: 70  VVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPY 129
Query: 137 G----LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHR 192
           G    +Y++        +  + H  + P     VR+ +     RGL Y+H     ++IHR
Sbjct: 130 GEFKSVYVVLDLME-SDLHQIIHS-SQPLTLEHVRYFL-YQLLRGLKYMHSA---QVIHR 183
Query: 193 DIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIE--GTFGHLAPEYF--MHGIVD 248
           D+K SN+L+  + E +I DFG+A+ L +    H     E   T  + APE    +H    
Sbjct: 184 DLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYT- 242
Query: 249 EKTDVFAFGVFLLEIISGRKPVDGSH 274
           +  D+++ G    E+++ R+   G +
Sbjct: 243 QAIDLWSVGCIFGEMLARRQLFPGKN 268

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 97/212 (45%), Gaps = 21/212 (9%)
Query: 65  TNAFSSENLVGRGGYAEVYKGVLQDGEE--IAVKRLTKVVTDDRKEKEFLTEIGTIGHVC 122
           ++ F  E+ +GRG  + VY+   Q G +   A+K L K V     +K   TEIG +  + 
Sbjct: 52  SDFFEVESELGRGATSIVYR-CKQKGTQKPYALKVLKKTV----DKKIVRTEIGVLLRLS 106
Query: 123 HPNVLSLLGCC-VDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVG-TARGLHY 180
           HPN++ L         + L+ +  + G    LF  +   G   +     AV      + Y
Sbjct: 107 HPNIIKLKEIFETPTEISLVLELVTGG---ELFDRIVEKGYYSERDAADAVKQILEAVAY 163
Query: 181 LHKGCQRRIIHRDIKSSNILLTA---DFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHL 237
           LH   +  I+HRD+K  N+L      D   +I+DFGL+K +  Q    ++    GT G+ 
Sbjct: 164 LH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVC---GTPGYC 217
Query: 238 APEYFMHGIVDEKTDVFAFGVFLLEIISGRKP 269
           APE         + D+++ G+    ++ G +P
Sbjct: 218 APEILRGCAYGPEVDMWSVGIITYILLCGFEP 249

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 89/215 (41%), Gaps = 17/215 (7%)
Query: 74  VGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCC 133
           +G G Y EV   V +  EE    ++  +       +    EI     + H NV+   G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 134 VDNGL-YLIFQFSSRGSVASLFH-DVNSPGVE-WKVRHKIAVGTARGLHYLHKGCQRRII 190
            +  + YL  ++ S G +      D+  P  +  +  H++  G      YLH G    I 
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV----YLH-GIG--IT 126
Query: 191 HRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYF----MHGI 246
           HRDIK  N+LL      +ISDFGLA           +  + GT  ++APE       H  
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHA- 185
Query: 247 VDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWA 281
             E  DV++ G+ L  +++G  P D    S   ++
Sbjct: 186 --EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS 218

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/266 (22%), Positives = 115/266 (43%), Gaps = 20/266 (7%)
Query: 21  DGDNAAVSPNGFTEESLENVVVACESETTKPTWRCFSFEEISIATNAFSSENLVGRGGYA 80
           DG++ +  P G  +    +   +  ++      +  SF+      + +     +G G Y 
Sbjct: 10  DGEDGSAEPPGPVKAEPAHTAASVAAKNLA-LLKARSFDVTFDVGDEYEIIETIGNGAYG 68
Query: 81  EVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSL---LGCCVDN 136
            V     +  G+++A+K++          K  L E+  + H  H N++++   L   V  
Sbjct: 69  VVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPY 128
Query: 137 G----LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHR 192
           G    +Y++        +  + H  + P     VR+ +     RGL Y+H     ++IHR
Sbjct: 129 GEFKSVYVVLDLME-SDLHQIIHS-SQPLTLEHVRYFL-YQLLRGLKYMHSA---QVIHR 182
Query: 193 DIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIE--GTFGHLAPEYF--MHGIVD 248
           D+K SN+L+  + E +I DFG+A+ L +    H     E   T  + APE    +H    
Sbjct: 183 DLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYT- 241
Query: 249 EKTDVFAFGVFLLEIISGRKPVDGSH 274
           +  D+++ G    E+++ R+   G +
Sbjct: 242 QAIDLWSVGCIFGEMLARRQLFPGKN 267

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 88/215 (40%), Gaps = 17/215 (7%)
Query: 74  VGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCC 133
           +G G Y EV   V +  EE    ++  +       +    EI     + H NV+   G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHR 74
Query: 134 VDNGL-YLIFQFSSRGSVASLFH-DVNSPGVE-WKVRHKIAVGTARGLHYLHKGCQRRII 190
            +  + YL  ++ S G +      D+  P  +  +  H++  G      YLH      I 
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV----YLHGIG---IT 127
Query: 191 HRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYF----MHGI 246
           HRDIK  N+LL      +ISDFGLA           +  + GT  ++APE       H  
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHA- 186
Query: 247 VDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWA 281
             E  DV++ G+ L  +++G  P D    S   ++
Sbjct: 187 --EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS 219

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 67/273 (24%), Positives = 114/273 (41%), Gaps = 24/273 (8%)
Query: 54  RCFSFEEISIATNAFSS----ENL--VGRGGYAEV---YKGVLQDGEEIAVKRLTKVVTD 104
           R  +F  + I  + F+     +NL  +G G    V   Y  +L+    +A+K+L++   +
Sbjct: 6   RDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQN 63
Query: 105 DRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEW 164
               K    E+  +  V H N++ LL          + +F     V  L     S  ++ 
Sbjct: 64  QTHAKRAYRELVLMKVVNHKNIIGLLNVFTPQKS--LEEFQDVYIVMELMDANLSQVIQM 121
Query: 165 KVRHK----IAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPS 220
           ++ H+    +      G+ +LH      IIHRD+K SNI++ +D   +I DFGLA+   +
Sbjct: 122 ELDHERMSYLLYQMLVGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLAR---T 175
Query: 221 QWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSW 280
             T   + P   T  + APE  +     E  D+++ G  + E+I G     G+   +  W
Sbjct: 176 AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDH-IDQW 234
Query: 281 AKPILNQGEIEKLVDPRLQGAYDVTQLNRLAFA 313
            K I   G        +LQ        NR  +A
Sbjct: 235 NKVIEQLGTPSPEFMKKLQPTVRTYVENRPKYA 267

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 89/215 (41%), Gaps = 17/215 (7%)
Query: 74  VGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCC 133
           +G G Y EV   V +  EE    ++  +       +    EI     + H NV+   G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 134 VDNGL-YLIFQFSSRGSVASLFH-DVNSPGVE-WKVRHKIAVGTARGLHYLHKGCQRRII 190
            +  + YL  ++ S G +      D+  P  +  +  H++  G      YLH G    I 
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV----YLH-GIG--IT 126
Query: 191 HRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYF----MHGI 246
           HRDIK  N+LL      +ISDFGLA           +  + GT  ++APE       H  
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHA- 185
Query: 247 VDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWA 281
             E  DV++ G+ L  +++G  P D    S   ++
Sbjct: 186 --EPVDVWSCGIVLTAMLAGELPWDQPSDSXQEYS 218

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 88/215 (40%), Gaps = 17/215 (7%)
Query: 74  VGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCC 133
           +G G Y EV   V +  EE    ++  +       +    EI     + H NV+   G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 134 VDNGL-YLIFQFSSRGSVASLFH-DVNSPGVE-WKVRHKIAVGTARGLHYLHKGCQRRII 190
            +  + YL  ++ S G +      D+  P  +  +  H++  G      YLH      I 
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV----YLHGIG---IT 126
Query: 191 HRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYF----MHGI 246
           HRDIK  N+LL      +ISDFGLA           +  + GT  ++APE       H  
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHA- 185
Query: 247 VDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWA 281
             E  DV++ G+ L  +++G  P D    S   ++
Sbjct: 186 --EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS 218

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/244 (24%), Positives = 101/244 (41%), Gaps = 15/244 (6%)
Query: 75  GRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCV 134
            +G     Y  +L+    +A+K+L++   +    K    E+  +  V H N++ LL    
Sbjct: 36  AQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFT 93
Query: 135 DNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHK----IAVGTARGLHYLHKGCQRRII 190
                 + +F     V  L     S  ++ ++ H+    +      G+ +LH      II
Sbjct: 94  PQKS--LEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLCGIKHLHSAG---II 148
Query: 191 HRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEK 250
           HRD+K SNI++ +D   +I DFGLA+   +  T   + P   T  + APE  +     E 
Sbjct: 149 HRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMGYKEN 205
Query: 251 TDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQLNRL 310
            D+++ G  + E+I G     G+   +  W K I   G        +LQ        NR 
Sbjct: 206 VDIWSVGCIMGEMIKGGVLFPGTDH-IDQWNKVIEQLGTPSPEFMKKLQPTVRTYVENRP 264
Query: 311 AFAA 314
            +A 
Sbjct: 265 KYAG 268

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/222 (22%), Positives = 94/222 (42%), Gaps = 26/222 (11%)
Query: 75  GRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCV 134
            +G     Y  VL     +A+K+L++   +    K    E+  +  V H N++SLL    
Sbjct: 36  AQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNVFT 93
Query: 135 DN-------GLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQR 187
                     +YL+ +         +  +++   + + +   +      G+ +LH     
Sbjct: 94  PQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLC-----GIKHLHSAG-- 146
Query: 188 RIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIV 247
            IIHRD+K SNI++ +D   +I DFGLA+   +  T   + P   T  + APE  +    
Sbjct: 147 -IIHRDLKPSNIVVKSDXTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMGY 202
Query: 248 DEKTDVFAFGVFLLEII------SGRKPVDGSHQSLHSWAKP 283
            E  D+++ G  + E++       GR  +D  ++ +     P
Sbjct: 203 KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP 244

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/244 (24%), Positives = 101/244 (41%), Gaps = 15/244 (6%)
Query: 75  GRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCV 134
            +G     Y  +L+    +A+K+L++   +    K    E+  +  V H N++ LL    
Sbjct: 36  AQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFT 93
Query: 135 DNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHK----IAVGTARGLHYLHKGCQRRII 190
                 + +F     V  L     S  ++ ++ H+    +      G+ +LH      II
Sbjct: 94  PQKS--LEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLCGIKHLHSAG---II 148
Query: 191 HRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEK 250
           HRD+K SNI++ +D   +I DFGLA+   +  T   + P   T  + APE  +     E 
Sbjct: 149 HRDLKPSNIVVKSDATLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMGYKEN 205
Query: 251 TDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQLNRL 310
            D+++ G  + E+I G     G+   +  W K I   G        +LQ        NR 
Sbjct: 206 VDIWSVGCIMGEMIKGGVLFPGTDH-IDQWNKVIEQLGTPSPEFMKKLQPTVRTYVENRP 264
Query: 311 AFAA 314
            +A 
Sbjct: 265 KYAG 268

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/247 (22%), Positives = 101/247 (40%), Gaps = 21/247 (8%)
Query: 75  GRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCV 134
            +G     Y  +L+    +A+K+L++   +    K    E+  +  V H N++ LL    
Sbjct: 36  AQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFT 93
Query: 135 DN-------GLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQR 187
                     +Y++ +         +  +++   + + +   +      G+ +LH     
Sbjct: 94  PQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLC-----GIKHLHSAG-- 146
Query: 188 RIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIV 247
            IIHRD+K SNI++ +D   +I DFGLA+   +  T   + P   T  + APE  +    
Sbjct: 147 -IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMGY 202
Query: 248 DEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQL 307
            E  D+++ G  + E+I G     G+   +  W K I   G        +LQ        
Sbjct: 203 KENVDIWSVGCIMGEMIKGGVLFPGTDH-IDQWNKVIEQLGTPSPEFMKKLQPTVRTYVE 261
Query: 308 NRLAFAA 314
           NR  +A 
Sbjct: 262 NRPKYAG 268

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/222 (22%), Positives = 94/222 (42%), Gaps = 26/222 (11%)
Query: 75  GRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCV 134
            +G     Y  VL     +A+K+L++   +    K    E+  +  V H N++SLL    
Sbjct: 36  AQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNVFT 93
Query: 135 DN-------GLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQR 187
                     +YL+ +         +  +++   + + +   +      G+ +LH     
Sbjct: 94  PQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLC-----GIKHLHSAG-- 146
Query: 188 RIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIV 247
            IIHRD+K SNI++ +D   +I DFGLA+   +  T   + P   T  + APE  +    
Sbjct: 147 -IIHRDLKPSNIVVKSDXTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMGY 202
Query: 248 DEKTDVFAFGVFLLEII------SGRKPVDGSHQSLHSWAKP 283
            E  D+++ G  + E++       GR  +D  ++ +     P
Sbjct: 203 KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP 244

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/222 (22%), Positives = 94/222 (42%), Gaps = 26/222 (11%)
Query: 75  GRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCV 134
            +G     Y  VL     +A+K+L++   +    K    E+  +  V H N++SLL    
Sbjct: 36  AQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNVFT 93
Query: 135 DN-------GLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQR 187
                     +YL+ +         +  +++   + + +   +      G+ +LH     
Sbjct: 94  PQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLX-----GIKHLHSAG-- 146
Query: 188 RIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIV 247
            IIHRD+K SNI++ +D   +I DFGLA+   +  T   + P   T  + APE  +    
Sbjct: 147 -IIHRDLKPSNIVVKSDXTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMGY 202
Query: 248 DEKTDVFAFGVFLLEII------SGRKPVDGSHQSLHSWAKP 283
            E  D+++ G  + E++       GR  +D  ++ +     P
Sbjct: 203 KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP 244

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 88/215 (40%), Gaps = 17/215 (7%)
Query: 74  VGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCC 133
           +G G Y EV   V +  EE    ++  +       +    EI     + H NV+   G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHENVVKFYGHR 74
Query: 134 VDNGL-YLIFQFSSRGSVASLFH-DVNSPGVE-WKVRHKIAVGTARGLHYLHKGCQRRII 190
            +  + YL  ++ S G +      D+  P  +  +  H++  G      YLH      I 
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV----YLHG---IGIT 127
Query: 191 HRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYF----MHGI 246
           HRDIK  N+LL      +ISDFGLA           +  + GT  ++APE       H  
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA- 186
Query: 247 VDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWA 281
             E  DV++ G+ L  +++G  P D    S   ++
Sbjct: 187 --EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS 219

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 67/274 (24%), Positives = 114/274 (41%), Gaps = 24/274 (8%)
Query: 54  RCFSFEEISIATNAFS----SENL--VGRGGYAEV---YKGVLQDGEEIAVKRLTKVVTD 104
           R  +F  + I  + F+     +NL  +G G    V   Y  +L+    +A+K+L++   +
Sbjct: 6   RDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQN 63
Query: 105 DRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEW 164
               K    E+  +  V H N++ LL          + +F     V  L     S  ++ 
Sbjct: 64  QTHAKRAYRELVLMKVVNHKNIIGLLNVFTPQKS--LEEFQDVYIVMELMDANLSQVIQM 121
Query: 165 KVRHK----IAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPS 220
           ++ H+    +      G+ +LH      IIHRD+K SNI++ +D   +I DFGLA+   +
Sbjct: 122 ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLAR---T 175
Query: 221 QWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSW 280
             T   + P   T  + APE  +     E  D+++ G  + E+I G     G+   +  W
Sbjct: 176 AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDH-IDQW 234
Query: 281 AKPILNQGEIEKLVDPRLQGAYDVTQLNRLAFAA 314
            K I   G        +LQ        NR  +A 
Sbjct: 235 NKVIEQLGTPSPEFMKKLQPTVRTYVENRPKYAG 268

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 89/215 (41%), Gaps = 17/215 (7%)
Query: 74  VGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCC 133
           +G G Y EV   V +  EE    ++  +       +    EI     + H NV+   G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHR 73
Query: 134 VDNGL-YLIFQFSSRGSVASLFH-DVNSPGVE-WKVRHKIAVGTARGLHYLHKGCQRRII 190
            +  + YL  ++ S G +      D+  P  +  +  H++  G      YLH G    I 
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV----YLH-GIG--IT 126
Query: 191 HRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYF----MHGI 246
           HRDIK  N+LL      +ISDFGLA           +  + GT  ++APE       H  
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA- 185
Query: 247 VDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWA 281
             E  DV++ G+ L  +++G  P D    S   ++
Sbjct: 186 --EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS 218

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 72/290 (24%), Positives = 122/290 (42%), Gaps = 58/290 (20%)
Query: 73  LVGRGGYAEVYKGVLQD---GEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVC-HPNVLS 128
           ++  GG+A VY+   QD   G E A+KRL  +  ++ K +  + E+  +  +  HPN++ 
Sbjct: 35  VLAEGGFAFVYEA--QDVGSGREYALKRL--LSNEEEKNRAIIQEVCFMKKLSGHPNIVQ 90
Query: 129 LLGCCV------DNGL--YLIFQFSSRGSVASLFHDVNSPG-VEWKVRHKIAVGTARGLH 179
                       D G   +L+     +G +      + S G +      KI   T R + 
Sbjct: 91  FCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQ 150
Query: 180 YLHKGCQRRIIHRDIKSSNILLTADFEPQISDFG----LAKWLPSQWTHHSIAPIEGTFG 235
           ++H+  +  IIHRD+K  N+LL+     ++ DFG    ++ +    W+    A +E    
Sbjct: 151 HMHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEIT 209
Query: 236 -HLAPEYFMHGIVD--------EKTDVFAFGVFL---------------LEIISGR---K 268
            +  P Y    I+D        EK D++A G  L               L I++G+    
Sbjct: 210 RNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNGKYSIP 269
Query: 269 PVDGSHQSLHSWAKPILNQGEIEKLVDP--RLQGAYDVTQLNRLAFAASL 316
           P D  +   HS  + +L        V+P  RL  A  V QL  +A A ++
Sbjct: 270 PHDTQYTVFHSLIRAMLQ-------VNPEERLSIAEVVHQLQEIAAARNV 312

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 89/196 (45%), Gaps = 16/196 (8%)
Query: 43  ACESETTKPTWRCFSFEEISIATNAFSSENLVGRGGYAEVYKGV-LQDGEEIAVKRLTKV 101
             E++T  P     S    + + + +     +G G Y EVYK +     E +A+KR+   
Sbjct: 11  TLEAQTQGPGSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLE 70
Query: 102 VTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQFSSRGSVASLFHDVNSP 160
             ++      + E+  +  + H N++ L      N  L+LIF+++        + D N P
Sbjct: 71  HEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEND--LKKYMDKN-P 127
Query: 161 GVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLT---ADFEP--QISDFGLA 215
            V  +V          G+++ H    RR +HRD+K  N+LL+   A   P  +I DFGLA
Sbjct: 128 DVSMRVIKSFLYQLINGVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA 184
Query: 216 KW--LP-SQWTHHSIA 228
           +   +P  Q+TH  I 
Sbjct: 185 RAFGIPIRQFTHEIIT 200

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/221 (22%), Positives = 94/221 (42%), Gaps = 21/221 (9%)
Query: 75  GRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCV 134
            +G     Y  +L+    +A+K+L++   +    K    E+  +  V H N++ LL    
Sbjct: 38  AQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFT 95
Query: 135 DN-------GLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQR 187
                     +Y++ +         +  +++   + + +   +      G+ +LH     
Sbjct: 96  PQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLC-----GIKHLHSAG-- 148
Query: 188 RIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIV 247
            IIHRD+K SNI++ +D   +I DFGLA+   +  T   + P   T  + APE  +    
Sbjct: 149 -IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMVPFVVTRYYRAPEVILGMGY 204
Query: 248 DEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQG 288
            E  D+++ G  + E+I G     G+   +  W K I   G
Sbjct: 205 KENVDIWSVGCIMGEMIKGGVLFPGTDH-IDQWNKVIEQLG 244

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 87/212 (41%), Gaps = 11/212 (5%)
Query: 74  VGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCC 133
           +G G Y EV   V +  EE    ++  +       +    EI     + H NV+   G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 134 VDNGL-YLIFQFSSRGSVASLFH-DVNSPGVE-WKVRHKIAVGTARGLHYLHKGCQRRII 190
            +  + YL  ++ S G +      D+  P  +  +  H++  G      YLH      I 
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV----YLHGIG---IT 127
Query: 191 HRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFM-HGIVDE 249
           HRDIK  N+LL      +ISDFGLA           +  + GT  ++APE         E
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 187
Query: 250 KTDVFAFGVFLLEIISGRKPVDGSHQSLHSWA 281
             DV++ G+ L  +++G  P D    S   ++
Sbjct: 188 PVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS 219

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/222 (22%), Positives = 94/222 (42%), Gaps = 26/222 (11%)
Query: 75  GRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCV 134
            +G     Y  VL     +A+K+L++   +    K    E+  +  V H N++SLL    
Sbjct: 74  AQGIVCAAYDAVLD--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFT 131
Query: 135 DN-------GLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQR 187
                     +YL+ +         +  +++   + + +   +      G+ +LH     
Sbjct: 132 PQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLC-----GIKHLHSA--- 183
Query: 188 RIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIV 247
            IIHRD+K SNI++ +D   +I DFGLA+   +  T   + P   T  + APE  +    
Sbjct: 184 GIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMGY 240
Query: 248 DEKTDVFAFGVFLLEII------SGRKPVDGSHQSLHSWAKP 283
            E  D+++ G  + E++       GR  +D  ++ +     P
Sbjct: 241 KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP 282

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 87/212 (41%), Gaps = 11/212 (5%)
Query: 74  VGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCC 133
           +G G Y EV   V +  EE    ++  +       +    EI     + H NV+   G  
Sbjct: 13  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 72
Query: 134 VDNGL-YLIFQFSSRGSVASLFH-DVNSPGVE-WKVRHKIAVGTARGLHYLHKGCQRRII 190
            +  + YL  ++ S G +      D+  P  +  +  H++  G      YLH      I 
Sbjct: 73  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV----YLHGIG---IT 125
Query: 191 HRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHG-IVDE 249
           HRDIK  N+LL      +ISDFGLA           +  + GT  ++APE         E
Sbjct: 126 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 185
Query: 250 KTDVFAFGVFLLEIISGRKPVDGSHQSLHSWA 281
             DV++ G+ L  +++G  P D    S   ++
Sbjct: 186 PVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS 217

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 88/215 (40%), Gaps = 17/215 (7%)
Query: 74  VGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCC 133
           +G G Y EV   V +  EE    ++  +       +    EI     + H NV+   G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 134 VDNGL-YLIFQFSSRGSVASLFH-DVNSPGVE-WKVRHKIAVGTARGLHYLHKGCQRRII 190
            +  + YL  ++ S G +      D+  P  +  +  H++  G      YLH      I 
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV----YLHGIG---IT 126
Query: 191 HRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYF----MHGI 246
           HRDIK  N+LL      +ISDFGLA           +  + GT  ++APE       H  
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA- 185
Query: 247 VDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWA 281
             E  DV++ G+ L  +++G  P D    S   ++
Sbjct: 186 --EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS 218

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 88/215 (40%), Gaps = 17/215 (7%)
Query: 74  VGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCC 133
           +G G Y EV   V +  EE    ++  +       +    EI     + H NV+   G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 134 VDNGL-YLIFQFSSRGSVASLFH-DVNSPGVE-WKVRHKIAVGTARGLHYLHKGCQRRII 190
            +  + YL  ++ S G +      D+  P  +  +  H++  G      YLH      I 
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV----YLHGIG---IT 126
Query: 191 HRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYF----MHGI 246
           HRDIK  N+LL      +ISDFGLA           +  + GT  ++APE       H  
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA- 185
Query: 247 VDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWA 281
             E  DV++ G+ L  +++G  P D    S   ++
Sbjct: 186 --EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS 218

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 88/215 (40%), Gaps = 17/215 (7%)
Query: 74  VGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCC 133
           +G G Y EV   V +  EE    ++  +       +    EI     + H NV+   G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 134 VDNGL-YLIFQFSSRGSVASLFH-DVNSPGVE-WKVRHKIAVGTARGLHYLHKGCQRRII 190
            +  + YL  ++ S G +      D+  P  +  +  H++  G      YLH      I 
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV----YLHGIG---IT 126
Query: 191 HRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYF----MHGI 246
           HRDIK  N+LL      +ISDFGLA           +  + GT  ++APE       H  
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA- 185
Query: 247 VDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWA 281
             E  DV++ G+ L  +++G  P D    S   ++
Sbjct: 186 --EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS 218

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 88/215 (40%), Gaps = 17/215 (7%)
Query: 74  VGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCC 133
           +G G Y EV   V +  EE    ++  +       +    EI     + H NV+   G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 134 VDNGL-YLIFQFSSRGSVASLFH-DVNSPGVE-WKVRHKIAVGTARGLHYLHKGCQRRII 190
            +  + YL  ++ S G +      D+  P  +  +  H++  G      YLH      I 
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV----YLHGIG---IT 127
Query: 191 HRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYF----MHGI 246
           HRDIK  N+LL      +ISDFGLA           +  + GT  ++APE       H  
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA- 186
Query: 247 VDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWA 281
             E  DV++ G+ L  +++G  P D    S   ++
Sbjct: 187 --EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS 219

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 88/215 (40%), Gaps = 17/215 (7%)
Query: 74  VGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCC 133
           +G G Y EV   V +  EE    ++  +       +    EI     + H NV+   G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 134 VDNGL-YLIFQFSSRGSVASLFH-DVNSPGVE-WKVRHKIAVGTARGLHYLHKGCQRRII 190
            +  + YL  ++ S G +      D+  P  +  +  H++  G      YLH      I 
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV----YLHGIG---IT 127
Query: 191 HRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYF----MHGI 246
           HRDIK  N+LL      +ISDFGLA           +  + GT  ++APE       H  
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA- 186
Query: 247 VDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWA 281
             E  DV++ G+ L  +++G  P D    S   ++
Sbjct: 187 --EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS 219

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/221 (22%), Positives = 94/221 (42%), Gaps = 21/221 (9%)
Query: 75  GRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCV 134
            +G     Y  +L+    +A+K+L++   +    K    E+  +  V H N++ LL    
Sbjct: 36  AQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFT 93
Query: 135 DN-------GLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQR 187
                     +Y++ +         +  +++   + + +   +      G+ +LH     
Sbjct: 94  PQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLC-----GIKHLHSAG-- 146
Query: 188 RIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIV 247
            IIHRD+K SNI++ +D   +I DFGLA+   +  T   + P   T  + APE  +    
Sbjct: 147 -IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMGY 202
Query: 248 DEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQG 288
            E  D+++ G  + E+I G     G+   +  W K I   G
Sbjct: 203 KENVDIWSVGCIMGEMIKGGVLFPGTDH-IDQWNKVIEQLG 242

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 87/212 (41%), Gaps = 11/212 (5%)
Query: 74  VGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCC 133
           +G G Y EV   V +  EE    ++  +       +    EI     + H NV+   G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 134 VDNGL-YLIFQFSSRGSVASLFH-DVNSPGVE-WKVRHKIAVGTARGLHYLHKGCQRRII 190
            +  + YL  ++ S G +      D+  P  +  +  H++  G      YLH      I 
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV----YLHGIG---IT 126
Query: 191 HRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFM-HGIVDE 249
           HRDIK  N+LL      +ISDFGLA           +  + GT  ++APE         E
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 186
Query: 250 KTDVFAFGVFLLEIISGRKPVDGSHQSLHSWA 281
             DV++ G+ L  +++G  P D    S   ++
Sbjct: 187 PVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS 218

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/222 (22%), Positives = 94/222 (42%), Gaps = 26/222 (11%)
Query: 75  GRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCV 134
            +G     Y  VL     +A+K+L++   +    K    E+  +  V H N++SLL    
Sbjct: 36  AQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFT 93
Query: 135 DN-------GLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQR 187
                     +YL+ +         +  +++   + + +   +      G+ +LH     
Sbjct: 94  PQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLX-----GIKHLHSAG-- 146
Query: 188 RIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIV 247
            IIHRD+K SNI++ +D   +I DFGLA+   +  T   + P   T  + APE  +    
Sbjct: 147 -IIHRDLKPSNIVVKSDXTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMGY 202
Query: 248 DEKTDVFAFGVFLLEII------SGRKPVDGSHQSLHSWAKP 283
            E  D+++ G  + E++       GR  +D  ++ +     P
Sbjct: 203 KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP 244

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 87/212 (41%), Gaps = 11/212 (5%)
Query: 74  VGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCC 133
           +G G Y EV   V +  EE    ++  +       +    EI     + H NV+   G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 134 VDNGL-YLIFQFSSRGSVASLFH-DVNSPGVE-WKVRHKIAVGTARGLHYLHKGCQRRII 190
            +  + YL  ++ S G +      D+  P  +  +  H++  G      YLH      I 
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV----YLHGIG---IT 127
Query: 191 HRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHG-IVDE 249
           HRDIK  N+LL      +ISDFGLA           +  + GT  ++APE         E
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 187
Query: 250 KTDVFAFGVFLLEIISGRKPVDGSHQSLHSWA 281
             DV++ G+ L  +++G  P D    S   ++
Sbjct: 188 PVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS 219

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 87/212 (41%), Gaps = 11/212 (5%)
Query: 74  VGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCC 133
           +G G Y EV   V +  EE    ++  +       +    EI     + H NV+   G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 134 VDNGL-YLIFQFSSRGSVASLFH-DVNSPGVE-WKVRHKIAVGTARGLHYLHKGCQRRII 190
            +  + YL  ++ S G +      D+  P  +  +  H++  G      YLH      I 
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV----YLHGIG---IT 127
Query: 191 HRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHG-IVDE 249
           HRDIK  N+LL      +ISDFGLA           +  + GT  ++APE         E
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 187
Query: 250 KTDVFAFGVFLLEIISGRKPVDGSHQSLHSWA 281
             DV++ G+ L  +++G  P D    S   ++
Sbjct: 188 PVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS 219

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 88/215 (40%), Gaps = 17/215 (7%)
Query: 74  VGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCC 133
           +G G Y EV   V +  EE    ++  +       +    EI     + H NV+   G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 134 VDNGL-YLIFQFSSRGSVASLFH-DVNSPGVE-WKVRHKIAVGTARGLHYLHKGCQRRII 190
            +  + YL  ++ S G +      D+  P  +  +  H++  G      YLH      I 
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV----YLHGIG---IT 126
Query: 191 HRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYF----MHGI 246
           HRDIK  N+LL      +ISDFGLA           +  + GT  ++APE       H  
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA- 185
Query: 247 VDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWA 281
             E  DV++ G+ L  +++G  P D    S   ++
Sbjct: 186 --EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS 218

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/222 (22%), Positives = 94/222 (42%), Gaps = 26/222 (11%)
Query: 75  GRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCV 134
            +G     Y  VL     +A+K+L++   +    K    E+  +  V H N++SLL    
Sbjct: 36  AQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFT 93
Query: 135 DN-------GLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQR 187
                     +YL+ +         +  +++   + + +   +      G+ +LH     
Sbjct: 94  PQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLC-----GIKHLHSAG-- 146
Query: 188 RIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIV 247
            IIHRD+K SNI++ +D   +I DFGLA+   +  T   + P   T  + APE  +    
Sbjct: 147 -IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMGY 202
Query: 248 DEKTDVFAFGVFLLEII------SGRKPVDGSHQSLHSWAKP 283
            E  D+++ G  + E++       GR  +D  ++ +     P
Sbjct: 203 KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP 244

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 87/212 (41%), Gaps = 11/212 (5%)
Query: 74  VGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCC 133
           +G G Y EV   V +  EE    ++  +       +    EI     + H NV+   G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 134 VDNGL-YLIFQFSSRGSVASLFH-DVNSPGVE-WKVRHKIAVGTARGLHYLHKGCQRRII 190
            +  + YL  ++ S G +      D+  P  +  +  H++  G      YLH      I 
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV----YLHGIG---IT 127
Query: 191 HRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHG-IVDE 249
           HRDIK  N+LL      +ISDFGLA           +  + GT  ++APE         E
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 187
Query: 250 KTDVFAFGVFLLEIISGRKPVDGSHQSLHSWA 281
             DV++ G+ L  +++G  P D    S   ++
Sbjct: 188 PVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS 219

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/221 (22%), Positives = 94/221 (42%), Gaps = 21/221 (9%)
Query: 75  GRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCV 134
            +G     Y  +L+    +A+K+L++   +    K    E+  +  V H N++ LL    
Sbjct: 37  AQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFT 94
Query: 135 DN-------GLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQR 187
                     +Y++ +         +  +++   + + +   +      G+ +LH     
Sbjct: 95  PQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLC-----GIKHLHSAG-- 147
Query: 188 RIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIV 247
            IIHRD+K SNI++ +D   +I DFGLA+   +  T   + P   T  + APE  +    
Sbjct: 148 -IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMGY 203
Query: 248 DEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQG 288
            E  D+++ G  + E+I G     G+   +  W K I   G
Sbjct: 204 KENVDIWSVGCIMGEMIKGGVLFPGTDH-IDQWNKVIEQLG 243

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/222 (22%), Positives = 94/222 (42%), Gaps = 26/222 (11%)
Query: 75  GRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCV 134
            +G     Y  VL     +A+K+L++   +    K    E+  +  V H N++SLL    
Sbjct: 35  AQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFT 92
Query: 135 DN-------GLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQR 187
                     +YL+ +         +  +++   + + +   +      G+ +LH     
Sbjct: 93  PQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLC-----GIKHLHSAG-- 145
Query: 188 RIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIV 247
            IIHRD+K SNI++ +D   +I DFGLA+   +  T   + P   T  + APE  +    
Sbjct: 146 -IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMGY 201
Query: 248 DEKTDVFAFGVFLLEII------SGRKPVDGSHQSLHSWAKP 283
            E  D+++ G  + E++       GR  +D  ++ +     P
Sbjct: 202 KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP 243

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 88/215 (40%), Gaps = 17/215 (7%)
Query: 74  VGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCC 133
           +G G Y EV   V +  EE    ++  +       +    EI     + H NV+   G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 134 VDNGL-YLIFQFSSRGSVASLFH-DVNSPGVE-WKVRHKIAVGTARGLHYLHKGCQRRII 190
            +  + YL  ++ S G +      D+  P  +  +  H++  G      YLH      I 
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV----YLHGIG---IT 126
Query: 191 HRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYF----MHGI 246
           HRDIK  N+LL      +ISDFGLA           +  + GT  ++APE       H  
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA- 185
Query: 247 VDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWA 281
             E  DV++ G+ L  +++G  P D    S   ++
Sbjct: 186 --EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS 218

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/222 (22%), Positives = 94/222 (42%), Gaps = 26/222 (11%)
Query: 75  GRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCV 134
            +G     Y  VL     +A+K+L++   +    K    E+  +  V H N++SLL    
Sbjct: 37  AQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFT 94
Query: 135 DN-------GLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQR 187
                     +YL+ +         +  +++   + + +   +      G+ +LH     
Sbjct: 95  PQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLC-----GIKHLHSAG-- 147
Query: 188 RIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIV 247
            IIHRD+K SNI++ +D   +I DFGLA+   +  T   + P   T  + APE  +    
Sbjct: 148 -IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMGY 203
Query: 248 DEKTDVFAFGVFLLEII------SGRKPVDGSHQSLHSWAKP 283
            E  D+++ G  + E++       GR  +D  ++ +     P
Sbjct: 204 KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP 245

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/222 (22%), Positives = 94/222 (42%), Gaps = 26/222 (11%)
Query: 75  GRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCV 134
            +G     Y  VL     +A+K+L++   +    K    E+  +  V H N++SLL    
Sbjct: 29  AQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFT 86
Query: 135 DN-------GLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQR 187
                     +YL+ +         +  +++   + + +   +      G+ +LH     
Sbjct: 87  PQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLC-----GIKHLHSAG-- 139
Query: 188 RIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIV 247
            IIHRD+K SNI++ +D   +I DFGLA+   +  T   + P   T  + APE  +    
Sbjct: 140 -IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMGY 195
Query: 248 DEKTDVFAFGVFLLEII------SGRKPVDGSHQSLHSWAKP 283
            E  D+++ G  + E++       GR  +D  ++ +     P
Sbjct: 196 KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP 237

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/222 (22%), Positives = 94/222 (42%), Gaps = 26/222 (11%)
Query: 75  GRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCV 134
            +G     Y  VL     +A+K+L++   +    K    E+  +  V H N++SLL    
Sbjct: 30  AQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFT 87
Query: 135 DN-------GLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQR 187
                     +YL+ +         +  +++   + + +   +      G+ +LH     
Sbjct: 88  PQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLC-----GIKHLHSAG-- 140
Query: 188 RIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIV 247
            IIHRD+K SNI++ +D   +I DFGLA+   +  T   + P   T  + APE  +    
Sbjct: 141 -IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMGY 196
Query: 248 DEKTDVFAFGVFLLEII------SGRKPVDGSHQSLHSWAKP 283
            E  D+++ G  + E++       GR  +D  ++ +     P
Sbjct: 197 KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP 238

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/222 (22%), Positives = 94/222 (42%), Gaps = 26/222 (11%)
Query: 75  GRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCV 134
            +G     Y  VL     +A+K+L++   +    K    E+  +  V H N++SLL    
Sbjct: 36  AQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFT 93
Query: 135 DN-------GLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQR 187
                     +YL+ +         +  +++   + + +   +      G+ +LH     
Sbjct: 94  PQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLC-----GIKHLHSAG-- 146
Query: 188 RIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIV 247
            IIHRD+K SNI++ +D   +I DFGLA+   +  T   + P   T  + APE  +    
Sbjct: 147 -IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMGY 202
Query: 248 DEKTDVFAFGVFLLEII------SGRKPVDGSHQSLHSWAKP 283
            E  D+++ G  + E++       GR  +D  ++ +     P
Sbjct: 203 KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP 244

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/222 (22%), Positives = 94/222 (42%), Gaps = 26/222 (11%)
Query: 75  GRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCV 134
            +G     Y  VL     +A+K+L++   +    K    E+  +  V H N++SLL    
Sbjct: 37  AQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFT 94
Query: 135 DN-------GLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQR 187
                     +YL+ +         +  +++   + + +   +      G+ +LH     
Sbjct: 95  PQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLC-----GIKHLHSAG-- 147
Query: 188 RIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIV 247
            IIHRD+K SNI++ +D   +I DFGLA+   +  T   + P   T  + APE  +    
Sbjct: 148 -IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMGY 203
Query: 248 DEKTDVFAFGVFLLEII------SGRKPVDGSHQSLHSWAKP 283
            E  D+++ G  + E++       GR  +D  ++ +     P
Sbjct: 204 KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP 245

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/222 (22%), Positives = 94/222 (42%), Gaps = 26/222 (11%)
Query: 75  GRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCV 134
            +G     Y  VL     +A+K+L++   +    K    E+  +  V H N++SLL    
Sbjct: 30  AQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFT 87
Query: 135 DN-------GLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQR 187
                     +YL+ +         +  +++   + + +   +      G+ +LH     
Sbjct: 88  PQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLC-----GIKHLHSAG-- 140
Query: 188 RIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIV 247
            IIHRD+K SNI++ +D   +I DFGLA+   +  T   + P   T  + APE  +    
Sbjct: 141 -IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMGY 196
Query: 248 DEKTDVFAFGVFLLEII------SGRKPVDGSHQSLHSWAKP 283
            E  D+++ G  + E++       GR  +D  ++ +     P
Sbjct: 197 KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP 238

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/222 (22%), Positives = 94/222 (42%), Gaps = 26/222 (11%)
Query: 75  GRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCV 134
            +G     Y  VL     +A+K+L++   +    K    E+  +  V H N++SLL    
Sbjct: 29  AQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFT 86
Query: 135 DN-------GLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQR 187
                     +YL+ +         +  +++   + + +   +      G+ +LH     
Sbjct: 87  PQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLX-----GIKHLHSAG-- 139
Query: 188 RIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIV 247
            IIHRD+K SNI++ +D   +I DFGLA+   +  T   + P   T  + APE  +    
Sbjct: 140 -IIHRDLKPSNIVVKSDXTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMGY 195
Query: 248 DEKTDVFAFGVFLLEII------SGRKPVDGSHQSLHSWAKP 283
            E  D+++ G  + E++       GR  +D  ++ +     P
Sbjct: 196 KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP 237

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 96/216 (44%), Gaps = 24/216 (11%)
Query: 63  IATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHV 121
           + ++ +  +  +G G Y+E  + V +    E AVK + K   D  +E E L   G     
Sbjct: 24  VFSDGYVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSEEIEILLRYGQ---- 79
Query: 122 CHPNVLSLLGCCVDNG--LYLIFQFSSRGSVAS--LFHDVNSPGVEWKVRHKIAVGTARG 177
            HPN+++L     D+G  +YL+ +    G +    L     S      V H I     + 
Sbjct: 80  -HPNIITLKDV-YDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIG----KT 133
Query: 178 LHYLHKGCQRRIIHRDIKSSNILLTADF-EPQ---ISDFGLAKWLPSQWTHHSIAPIEGT 233
           + YLH    + ++HRD+K SNIL   +   P+   I DFG AK L ++            
Sbjct: 134 VEYLH---SQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTAN 190
Query: 234 FGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKP 269
           F  +APE       DE  D+++ G+ L  +++G  P
Sbjct: 191 F--VAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTP 224

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 95/209 (45%), Gaps = 18/209 (8%)
Query: 71  ENL--VGRGGYAEVYKGVLQD-GEEIAVKRLTKVVTDDRKEKEFLTEIGTI--GHVCHPN 125
           ENL  +G G   +V+K   +  G  IAVK++ +   +  + K  L ++  +   H C P 
Sbjct: 28  ENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRS-GNKEENKRILMDLDVVLKSHDC-PY 85
Query: 126 VLSLLGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGC 185
           ++   G  + N    I      G+ A          +  ++  K+ V   + L+YL +  
Sbjct: 86  IVQCFGTFITNTDVFI-AMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKE-- 142
Query: 186 QRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYF--- 242
           +  +IHRD+K SNILL    + ++ DFG++  L         A   G   ++APE     
Sbjct: 143 KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSA---GCAAYMAPERIDPP 199
Query: 243 --MHGIVDEKTDVFAFGVFLLEIISGRKP 269
                  D + DV++ G+ L+E+ +G+ P
Sbjct: 200 DPTKPDYDIRADVWSLGISLVELATGQFP 228

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/222 (22%), Positives = 94/222 (42%), Gaps = 26/222 (11%)
Query: 75  GRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCV 134
            +G     Y  VL     +A+K+L++   +    K    E+  +  V H N++SLL    
Sbjct: 74  AQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFT 131
Query: 135 DN-------GLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQR 187
                     +YL+ +         +  +++   + + +   +      G+ +LH     
Sbjct: 132 PQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLC-----GIKHLHSA--- 183
Query: 188 RIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIV 247
            IIHRD+K SNI++ +D   +I DFGLA+   +  T   + P   T  + APE  +    
Sbjct: 184 GIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMGY 240
Query: 248 DEKTDVFAFGVFLLEII------SGRKPVDGSHQSLHSWAKP 283
            E  D+++ G  + E++       GR  +D  ++ +     P
Sbjct: 241 KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP 282

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 96/216 (44%), Gaps = 24/216 (11%)
Query: 63  IATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHV 121
           + ++ +  +  +G G Y+E  + V +    E AVK + K   D  +E E L   G     
Sbjct: 24  VFSDGYVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSEEIEILLRYGQ---- 79
Query: 122 CHPNVLSLLGCCVDNG--LYLIFQFSSRGSVAS--LFHDVNSPGVEWKVRHKIAVGTARG 177
            HPN+++L     D+G  +YL+ +    G +    L     S      V H I     + 
Sbjct: 80  -HPNIITLKDV-YDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIG----KT 133
Query: 178 LHYLHKGCQRRIIHRDIKSSNILLTADF-EPQ---ISDFGLAKWLPSQWTHHSIAPIEGT 233
           + YLH    + ++HRD+K SNIL   +   P+   I DFG AK L ++            
Sbjct: 134 VEYLH---SQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTAN 190
Query: 234 FGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKP 269
           F  +APE       DE  D+++ G+ L  +++G  P
Sbjct: 191 F--VAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTP 224

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 50/221 (22%), Positives = 94/221 (42%), Gaps = 21/221 (9%)
Query: 75  GRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCV 134
            +G     Y  +L+    +A+K+L++   +    K    E+  +  V H N++ LL    
Sbjct: 36  AQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFT 93
Query: 135 DN-------GLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQR 187
                     +Y++ +         +  +++   + + +   +      G+ +LH     
Sbjct: 94  PQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLC-----GIKHLHSAG-- 146
Query: 188 RIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIV 247
            IIHRD+K SNI++ +D   +I DFGLA+   +  T   + P   T  + APE  +    
Sbjct: 147 -IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPEVVTRYYRAPEVILGMGY 202
Query: 248 DEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQG 288
            E  D+++ G  + E+I G     G+   +  W K I   G
Sbjct: 203 KENVDIWSVGCIMGEMIKGGVLFPGTDH-IDQWNKVIEQLG 242

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 65/260 (25%), Positives = 109/260 (41%), Gaps = 38/260 (14%)
Query: 24  NAAVSPNGFTEESLENVVVACESETTKP-------TWRCFSFEEI-SIATNAFSSENLVG 75
           NAA +  G  +ES++  +   + +  K        T     FE I ++ T +F    LV 
Sbjct: 2   NAAAAKKGSEQESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVK 61
Query: 76  RGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEF-LTEIGTIGHVCHPNVLSLLGCCV 134
                      ++ G   A+K L K      KE E  L E   +  V  P ++ L     
Sbjct: 62  H----------METGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPFLVKLEFSFK 111
Query: 135 DN-GLYLIFQFSSRGSVASLFHDV---NSPGVEWKVRHKIAVGTARGLHYLHKGCQRRII 190
           DN  LY++ +++  G + S    +   + P   +      A        YLH      +I
Sbjct: 112 DNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-----YAAQIVLTFEYLH---SLDLI 163
Query: 191 HRDIKSSNILLTADFEPQISDFGLAKWLPSQ-WTHHSIAPIEGTFGHLAPEYFMHGIVDE 249
           +RD+K  N+++      Q++DFGLAK +  + W       + GT  +LAPE  +    ++
Sbjct: 164 YRDLKPENLMIDQQGYIQVTDFGLAKRVKGRTWX------LCGTPEYLAPEIILSKGYNK 217
Query: 250 KTDVFAFGVFLLEIISGRKP 269
             D +A GV + E+ +G  P
Sbjct: 218 AVDWWALGVLIYEMAAGYPP 237

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 35/100 (35%), Positives = 51/100 (51%), Gaps = 4/100 (4%)
Query: 174 TARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGT 233
            ARG+ +L     R+ IHRD+ + NILL+ +   +I DFGLA+ +     +         
Sbjct: 208 VARGMEFLS---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDTRLP 264
Query: 234 FGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDG 272
              +APE     I   K+DV+++GV L EI S G  P  G
Sbjct: 265 LKWMAPESIFDKIYSTKSDVWSYGVLLWEIFSLGGSPYPG 304

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 101/221 (45%), Gaps = 32/221 (14%)
Query: 71  ENLVGRGGYAEVYK-GVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSL 129
           E   G+   AE Y     +D   +AVK L       RK+  F  E   + ++ H +++  
Sbjct: 25  EGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKD--FQREAELLTNLQHEHIVKF 82
Query: 130 LGCCVD-NGLYLIFQFSSRGSVASLFHDVNSPG----VEWKVRHK-----------IAVG 173
            G C D + L ++F++   G +   F   + P     V+ + R             IA  
Sbjct: 83  YGVCGDGDPLIMVFEYMKHGDLNK-FLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 141
Query: 174 TARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTH----HSIAP 229
            A G+ YL     +  +HRD+ + N L+ A+   +I DFG+++ + S   +    H++ P
Sbjct: 142 IASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 198
Query: 230 IEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKP 269
           I      + PE  M+     ++DV++FGV L EI + G++P
Sbjct: 199 IRW----MPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 235

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 63/253 (24%), Positives = 109/253 (43%), Gaps = 24/253 (9%)
Query: 24  NAAVSPNGFTEESLENVVVACESETTKPTWRCFSFEEISIATNAFSSENLVGRGGYAEVY 83
           NAA +  G  +ES++  +   + +  K  W   S  + +   + F     +G G +  V 
Sbjct: 23  NAAAAKKGSEQESVKEFLAKAKEDFLK-KWETPS--QNTAQLDQFDRIKTLGTGSFGRVM 79
Query: 84  KGVLQD-GEEIAVKRLTKVVTDDRKEKEF-LTEIGTIGHVCHPNVLSLLGCCVDN-GLYL 140
               ++ G   A+K L K      K+ E  L E   +  V  P ++ L     DN  LY+
Sbjct: 80  LVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM 139
Query: 141 IFQFSSRGSVASLFHDV---NSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSS 197
           + ++ + G + S    +   + P   +      A        YLH      +I+RD+K  
Sbjct: 140 VMEYVAGGEMFSHLRRIGRFSEPHARF-----YAAQIVLTFEYLH---SLDLIYRDLKPE 191
Query: 198 NILLTADFEPQISDFGLAKWLP-SQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAF 256
           N+L+      Q++DFG AK +  + WT      + GT  +LAPE  +    ++  D +A 
Sbjct: 192 NLLIDQQGYIQVTDFGFAKRVKGATWT------LCGTPEYLAPEIILSKGYNKAVDWWAL 245
Query: 257 GVFLLEIISGRKP 269
           GV + E+ +G  P
Sbjct: 246 GVLIYEMAAGYPP 258

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 92/211 (43%), Gaps = 22/211 (10%)
Query: 68  FSSENLVGRGGYAEVYKGVLQD----GEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCH 123
           F  +  +G G ++EV   VL +    G+  AVK + K      KE     EI  +  + H
Sbjct: 24  FEFKETLGTGAFSEV---VLAEEKATGKLFAVKCIPKKALKG-KESSIENEIAVLRKIKH 79
Query: 124 PNVLSLLGCCVD-NGLYLIFQFSSRGSVASLFHDVNSPGV-EWKVRHKIAVGTARGLHYL 181
            N+++L       N LYL+ Q  S G    LF  +   G    K    +       ++YL
Sbjct: 80  ENIVALEDIYESPNHLYLVMQLVSGGE---LFDRIVEKGFYTEKDASTLIRQVLDAVYYL 136
Query: 182 HKGCQRRIIHRDIKSSNILLTADFEP---QISDFGLAKWLPSQWTHHSIAPIEGTFGHLA 238
           H+     I+HRD+K  N+L  +  E     ISDFGL+K    +     ++   GT G++A
Sbjct: 137 HR---MGIVHRDLKPENLLYYSQDEESKIMISDFGLSKM---EGKGDVMSTACGTPGYVA 190
Query: 239 PEYFMHGIVDEKTDVFAFGVFLLEIISGRKP 269
           PE        +  D ++ GV    ++ G  P
Sbjct: 191 PEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 221

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 92/204 (45%), Gaps = 17/204 (8%)
Query: 73  LVGRGGYAEVYKGVLQDGEEI--AVKRL-TKVVTDDRKEKEFLTEIGTI-GHVCHPNVLS 128
           ++G+G + +V        EE+  AVK L  K +   ++EK  ++E   +  +V HP ++ 
Sbjct: 45  VIGKGSFGKVLLAR-HKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 103
Query: 129 L-LGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKI-AVGTARGLHYLHKGCQ 186
           L       + LY +  + + G    LF+ +       + R +  A   A  L YLH    
Sbjct: 104 LHFSFQTADKLYFVLDYINGGE---LFYHLQRERCFLEPRARFYAAEIASALGYLH---S 157
Query: 187 RRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHS-IAPIEGTFGHLAPEYFMHG 245
             I++RD+K  NILL +     ++DFGL K       H+S  +   GT  +LAPE     
Sbjct: 158 LNIVYRDLKPENILLDSQGHIVLTDFGLCK---ENIEHNSTTSTFCGTPEYLAPEVLHKQ 214
Query: 246 IVDEKTDVFAFGVFLLEIISGRKP 269
             D   D +  G  L E++ G  P
Sbjct: 215 PYDRTVDWWCLGAVLYEMLYGLPP 238

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 50/209 (23%), Positives = 96/209 (45%), Gaps = 19/209 (9%)
Query: 74  VGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKE---KEFLTEIGTIGHVCHPNVLSLL 130
           +G G + +V+   L +     ++R+ K +  DR +   ++   EI  +  + HPN++ + 
Sbjct: 30  LGSGAFGDVH---LVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIF 86
Query: 131 GCCVD-NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRH--KIAVGTARGLHYLHKGCQR 187
               D + +Y++ +    G +        + G      +  ++       L Y H    +
Sbjct: 87  EVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS---Q 143
Query: 188 RIIHRDIKSSNILL--TADFEP-QISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMH 244
            ++H+D+K  NIL   T+   P +I DFGLA+   S     + A   GT  ++APE F  
Sbjct: 144 HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAA---GTALYMAPEVFKR 200
Query: 245 GIVDEKTDVFAFGVFLLEIISGRKPVDGS 273
             V  K D+++ GV +  +++G  P  G+
Sbjct: 201 D-VTFKCDIWSAGVVMYFLLTGCLPFTGT 228

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 40/145 (27%), Positives = 71/145 (48%), Gaps = 7/145 (4%)
Query: 74  VGRGGYAEVYKGVLQDGEEI-AVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC 132
           +G G Y  V+K   ++  EI A+KR+     D+      L EI  +  + H N++ L   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 133 C-VDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIH 191
              D  L L+F+F  +  +   F   N   ++ ++         +GL + H    R ++H
Sbjct: 70  LHSDKKLTLVFEFCDQ-DLKKYFDSCNG-DLDPEIVKSFLFQLLKGLGFCH---SRNVLH 124
Query: 192 RDIKSSNILLTADFEPQISDFGLAK 216
           RD+K  N+L+  + E +++DFGLA+
Sbjct: 125 RDLKPQNLLINRNGELKLADFGLAR 149

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 91/212 (42%), Gaps = 16/212 (7%)
Query: 65  TNAFSSENLVGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCH 123
           T+ +     +G+G ++ V + V L  G E A K +       R  ++   E      + H
Sbjct: 3   TDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 124 PNVLSLLGCCVDNGL-YLIFQFSSRGSVASLFHDVNSPGV--EWKVRHKIAVGTARGLHY 180
            N++ L     + G  YL+F   + G    LF D+ +     E    H I       LH 
Sbjct: 63  SNIVRLHDSISEEGFHYLVFDLVTGGE---LFEDIVAREYYSEADASHCIQQILEAVLHC 119
Query: 181 LHKGCQRRIIHRDIKSSNILLTADFEP---QISDFGLAKWLPSQWTHHSIAPIEGTFGHL 237
              G    ++HRD+K  N+LL +  +    +++DFGLA  +  Q    +     GT G+L
Sbjct: 120 HQMG----VVHRDLKPENLLLASKCKGAAVKLADFGLA--IEVQGDQQAWFGFAGTPGYL 173
Query: 238 APEYFMHGIVDEKTDVFAFGVFLLEIISGRKP 269
           +PE        +  D++A GV L  ++ G  P
Sbjct: 174 SPEVLRKEAYGKPVDIWACGVILYILLVGYPP 205

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 62/253 (24%), Positives = 108/253 (42%), Gaps = 24/253 (9%)
Query: 24  NAAVSPNGFTEESLENVVVACESETTKPTWRCFSFEEISIATNAFSSENLVGRGGYAEVY 83
           NAA +  G  +ES++  +   + +  K  W   S  + +   + F     +G G +  V 
Sbjct: 2   NAAAAKKGSEQESVKEFLAKAKEDFLK-KWETPS--QNTAQLDQFDRIKTLGTGSFGRVM 58
Query: 84  KGVLQD-GEEIAVKRLTKVVTDDRKEKEF-LTEIGTIGHVCHPNVLSLLGCCVDN-GLYL 140
               ++ G   A+K L K      K+ E  L E   +  V  P ++ L     DN  LY+
Sbjct: 59  LVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM 118
Query: 141 IFQFSSRGSVASLFHDV---NSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSS 197
           + ++ + G + S    +   + P   +      A        YLH      +I+RD+K  
Sbjct: 119 VMEYVAGGEMFSHLRRIGRFSEPHARF-----YAAQIVLTFEYLH---SLDLIYRDLKPE 170
Query: 198 NILLTADFEPQISDFGLAKWLPSQ-WTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAF 256
           N+L+      Q++DFG AK +  + W       + GT  +LAPE  +    ++  D +A 
Sbjct: 171 NLLIDQQGYIQVTDFGFAKRVKGRTWX------LAGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 257 GVFLLEIISGRKP 269
           GV + E+ +G  P
Sbjct: 225 GVLIYEMAAGYPP 237

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 62/253 (24%), Positives = 108/253 (42%), Gaps = 24/253 (9%)
Query: 24  NAAVSPNGFTEESLENVVVACESETTKPTWRCFSFEEISIATNAFSSENLVGRGGYAEVY 83
           NAA +  G  +ES++  +   + +  K  W   S  + +   + F     +G G +  V 
Sbjct: 2   NAAAAKKGSEQESVKEFLAKAKEDFLK-KWETPS--QNTAQLDQFDRIKTLGTGSFGRVM 58
Query: 84  KGVLQD-GEEIAVKRLTKVVTDDRKEKEF-LTEIGTIGHVCHPNVLSLLGCCVDN-GLYL 140
               ++ G   A+K L K      K+ E  L E   +  V  P ++ L     DN  LY+
Sbjct: 59  LVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM 118
Query: 141 IFQFSSRGSVASLFHDV---NSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSS 197
           + ++ + G + S    +   + P   +      A        YLH      +I+RD+K  
Sbjct: 119 VMEYVAGGEMFSHLRRIGRFSEPHARF-----YAAQIVLTFEYLH---SLDLIYRDLKPE 170
Query: 198 NILLTADFEPQISDFGLAKWLPSQ-WTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAF 256
           N+L+      Q++DFG AK +  + W       + GT  +LAPE  +    ++  D +A 
Sbjct: 171 NLLIDQQGYIQVTDFGFAKRVKGRTWX------LXGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 257 GVFLLEIISGRKP 269
           GV + E+ +G  P
Sbjct: 225 GVLIYEMAAGYPP 237

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 94/214 (43%), Gaps = 18/214 (8%)
Query: 68  FSSENLVGRGGYAEVY---KGVLQD-GEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCH 123
           F    ++G+G + +V+   K    D G   A+K L K     R       E   +  V H
Sbjct: 30  FELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDILADVNH 89
Query: 124 PNVLSL-LGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGV--EWKVRHKIAVGTARGLHY 180
           P V+ L      +  LYLI  F   G    LF  ++   +  E  V+  +A   A GL +
Sbjct: 90  PFVVKLHYAFQTEGKLYLILDFLRGGD---LFTRLSKEVMFTEEDVKFYLA-ELALGLDH 145
Query: 181 LHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIA-PIEGTFGHLAP 239
           LH      II+RD+K  NILL  +   +++DFGL+K       H   A    GT  ++AP
Sbjct: 146 LHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSK---EAIDHEKKAYSFCGTVEYMAP 199
Query: 240 EYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGS 273
           E           D +++GV + E+++G  P  G 
Sbjct: 200 EVVNRQGHSHSADWWSYGVLMFEMLTGSLPFQGK 233

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 66/278 (23%), Positives = 108/278 (38%), Gaps = 49/278 (17%)
Query: 74  VGRGGYAEVYKGVLQDGE--------EIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPN 125
           +GRG +  VYKG+  D E        E+  ++LTK      + + F  E   +  + HPN
Sbjct: 34  IGRGSFKTVYKGL--DTETTVEVAWCELQDRKLTK-----SERQRFKEEAEXLKGLQHPN 86
Query: 126 VLSLLG----------CCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTA 175
           ++              C V     L+ +  + G++ +         +  KV         
Sbjct: 87  IVRFYDSWESTVKGKKCIV-----LVTELXTSGTLKTYLKRFKVXKI--KVLRSWCRQIL 139
Query: 176 RGLHYLHKGCQRRIIHRDIKSSNILLTADF-EPQISDFGLAKWLPSQWTHHSIAPIEGTF 234
           +GL +LH      IIHRD+K  NI +T      +I D GLA    + +    I    GT 
Sbjct: 140 KGLQFLHTRTPP-IIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVI----GTP 194
Query: 235 GHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLV 294
              APE +     DE  DV+AFG   LE  +   P      +   + +       +   V
Sbjct: 195 EFXAPEXYEEK-YDESVDVYAFGXCXLEXATSEYPYSECQNAAQIYRR-------VTSGV 246
Query: 295 DPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVL 332
            P    ++D   +  +      CIR +   R ++ ++L
Sbjct: 247 KP---ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLL 281

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 92/203 (45%), Gaps = 16/203 (7%)
Query: 74  VGRGGYAEVYKGVLQD-GEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC 132
           +G+G ++ V + V +   +E A K +       R  ++   E      + HPN++ L   
Sbjct: 39  LGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 98
Query: 133 CVDNGL-YLIFQFSSRGSVASLFHDVNSPGV--EWKVRHKIAVGTARGLHYLHKGCQRRI 189
             + G  YL+F   + G    LF D+ +     E    H I       ++++H   Q  I
Sbjct: 99  ISEEGFHYLVFDLVTGGE---LFEDIVAREYYSEADASHCIH-QILESVNHIH---QHDI 151
Query: 190 IHRDIKSSNILLTADFE---PQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGI 246
           +HRD+K  N+LL +  +    +++DFGLA  +  Q    +     GT G+L+PE      
Sbjct: 152 VHRDLKPENLLLASKCKGAAVKLADFGLA--IEVQGEQQAWFGFAGTPGYLSPEVLRKDP 209
Query: 247 VDEKTDVFAFGVFLLEIISGRKP 269
             +  D++A GV L  ++ G  P
Sbjct: 210 YGKPVDIWACGVILYILLVGYPP 232

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 90/203 (44%), Gaps = 16/203 (7%)
Query: 74  VGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC 132
           +G+G ++ V + V +  G+E A K +       R  ++   E      + HPN++ L   
Sbjct: 30  LGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 89
Query: 133 CVDNGL-YLIFQFSSRGSVASLFHDVNSPGV--EWKVRHKIAVGTARGLHYLHKGCQRRI 189
             + G  YLIF   + G    LF D+ +     E    H I       LH    G    +
Sbjct: 90  ISEEGHHYLIFDLVTGGE---LFEDIVAREYYSEADASHCIQQILEAVLHCHQMG----V 142
Query: 190 IHRDIKSSNILLTADFEP---QISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGI 246
           +HRD+K  N+LL +  +    +++DFGLA  +  +    +     GT G+L+PE      
Sbjct: 143 VHRDLKPENLLLASKLKGAAVKLADFGLA--IEVEGEQQAWFGFAGTPGYLSPEVLRKDP 200
Query: 247 VDEKTDVFAFGVFLLEIISGRKP 269
             +  D++A GV L  ++ G  P
Sbjct: 201 YGKPVDLWACGVILYILLVGYPP 223

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 65/260 (25%), Positives = 108/260 (41%), Gaps = 38/260 (14%)
Query: 24  NAAVSPNGFTEESLENVVVACESETTKP-------TWRCFSFEEI-SIATNAFSSENLVG 75
           NAA +  G  +ES++  +   + +  K        T     FE I ++ T +F    LV 
Sbjct: 3   NAAAAKKGSEQESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVK 62
Query: 76  RGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEF-LTEIGTIGHVCHPNVLSLLGCCV 134
                      ++ G   A+K L K      K+ E  L E   +  V  P ++ L     
Sbjct: 63  H----------METGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 112
Query: 135 DN-GLYLIFQFSSRGSVASLFHDV---NSPGVEWKVRHKIAVGTARGLHYLHKGCQRRII 190
           DN  LY++ ++   G + S    +   + P   +      A        YLH      +I
Sbjct: 113 DNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-----YAAQIVLTFEYLH---SLDLI 164
Query: 191 HRDIKSSNILLTADFEPQISDFGLAKWLPSQ-WTHHSIAPIEGTFGHLAPEYFMHGIVDE 249
           +RD+K  N+L+      Q++DFG AK +  + WT      + GT  +LAPE  +    ++
Sbjct: 165 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT------LCGTPEYLAPEIILSKGYNK 218
Query: 250 KTDVFAFGVFLLEIISGRKP 269
             D +A GV + E+ +G  P
Sbjct: 219 AVDWWALGVLIYEMAAGYPP 238

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/224 (25%), Positives = 99/224 (44%), Gaps = 34/224 (15%)
Query: 74  VGRGGYAEVYKGVLQDGEE-IAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC 132
           +G GG   V+  V  D ++ +A+K++  V+TD +  K  L EI  I  + H N++ +   
Sbjct: 19  LGCGGNGLVFSAVDNDCDKRVAIKKI--VLTDPQSVKHALREIKIIRRLDHDNIVKVFEI 76
Query: 133 CVDNGLYLIFQFSSRGSVASLF-------HDV-----NSPGVEWKVRHKIAVGTARGLHY 180
              +G  L     S   + S++        D+       P +E   R        RGL Y
Sbjct: 77  LGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHAR-LFMYQLLRGLKY 135
Query: 181 LHKGCQRRIIHRDIKSSNILL-TADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGH--- 236
           +H      ++HRD+K +N+ + T D   +I DFGLA+ +   ++H      EG       
Sbjct: 136 IHSA---NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLS-EGLVTKWYR 191
Query: 237 -----LAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQ 275
                L+P  +   I     D++A G    E+++G+    G+H+
Sbjct: 192 SPRLLLSPNNYTKAI-----DMWAAGCIFAEMLTGKTLFAGAHE 230

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 62/243 (25%), Positives = 99/243 (40%), Gaps = 34/243 (13%)
Query: 41  VVACESETTKPTWRCFSFEEISIATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTK 100
           +++  S   K +      +E  I         L+G+G + +VY G      E+A+ RL  
Sbjct: 8   LLSARSFPRKASQTSIFLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAI-RLID 64
Query: 101 VVTDDRKE-KEFLTEIGTIGHVCHPNVLSLLGCCVDNGLYLIFQFSSRGSV-------AS 152
           +  D+  + K F  E+       H NV+  +G C+      I     +G         A 
Sbjct: 65  IERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAK 124
Query: 153 LFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDF 212
           +  DVN      K R +IA    +G+ YLH    + I+H+D+KS N+    + +  I+DF
Sbjct: 125 IVLDVN------KTR-QIAQEIVKGMGYLHA---KGILHKDLKSKNVFYD-NGKVVITDF 173
Query: 213 GL---AKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVD---------EKTDVFAFGVFL 260
           GL   +  L +      +    G   HLAPE       D         + +DVFA G   
Sbjct: 174 GLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIW 233
Query: 261 LEI 263
            E+
Sbjct: 234 YEL 236

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 62/253 (24%), Positives = 108/253 (42%), Gaps = 24/253 (9%)
Query: 24  NAAVSPNGFTEESLENVVVACESETTKPTWRCFSFEEISIATNAFSSENLVGRGGYAEVY 83
           NAA +  G  +ES++  +   + +  K  W   S  + +   + F     +G G +  V 
Sbjct: 2   NAAAAKKGXEQESVKEFLAKAKEDFLK-KWETPS--QNTAQLDQFDRIKTLGTGSFGRVM 58
Query: 84  KGVLQD-GEEIAVKRLTKVVTDDRKEKEF-LTEIGTIGHVCHPNVLSLLGCCVDN-GLYL 140
               ++ G   A+K L K      K+ E  L E   +  V  P ++ L     DN  LY+
Sbjct: 59  LVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM 118
Query: 141 IFQFSSRGSVASLFHDV---NSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSS 197
           + ++ + G + S    +   + P   +      A        YLH      +I+RD+K  
Sbjct: 119 VMEYVAGGEMFSHLRRIGRFSEPHARF-----YAAQIVLTFEYLH---SLDLIYRDLKPE 170
Query: 198 NILLTADFEPQISDFGLAKWLPSQ-WTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAF 256
           N+L+      Q++DFG AK +  + W       + GT  +LAPE  +    ++  D +A 
Sbjct: 171 NLLIDQQGYIQVTDFGFAKRVKGRTWX------LCGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 257 GVFLLEIISGRKP 269
           GV + E+ +G  P
Sbjct: 225 GVLIYEMAAGYPP 237

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/201 (24%), Positives = 91/201 (45%), Gaps = 12/201 (5%)
Query: 74  VGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC 132
           +G+G ++ V + + +  G+E A K +       R  ++   E      + HPN++ L   
Sbjct: 12  LGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 71
Query: 133 CVDNGL-YLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIH 191
             + G  YL+F   + G    LF D+ +   E+      +    + L  ++      I+H
Sbjct: 72  ISEEGFHYLVFDLVTGGE---LFEDIVA--REYYSEADASHCIQQILESVNHCHLNGIVH 126
Query: 192 RDIKSSNILLTADFEP---QISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVD 248
           RD+K  N+LL +  +    +++DFGLA  +  Q    +     GT G+L+PE        
Sbjct: 127 RDLKPENLLLASKSKGAAVKLADFGLA--IEVQGDQQAWFGFAGTPGYLSPEVLRKDPYG 184
Query: 249 EKTDVFAFGVFLLEIISGRKP 269
           +  D++A GV L  ++ G  P
Sbjct: 185 KPVDMWACGVILYILLVGYPP 205

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 62/253 (24%), Positives = 108/253 (42%), Gaps = 24/253 (9%)
Query: 24  NAAVSPNGFTEESLENVVVACESETTKPTWRCFSFEEISIATNAFSSENLVGRGGYAEVY 83
           NAA +  G  +ES++  +   + +  K  W   S  + +   + F     +G G +  V 
Sbjct: 2   NAAAAKKGXEQESVKEFLAKAKEDFLK-KWETPS--QNTAQLDQFDRIKTLGTGSFGRVM 58
Query: 84  KGVLQD-GEEIAVKRLTKVVTDDRKEKEF-LTEIGTIGHVCHPNVLSLLGCCVDN-GLYL 140
               ++ G   A+K L K      K+ E  L E   +  V  P ++ L     DN  LY+
Sbjct: 59  LVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM 118
Query: 141 IFQFSSRGSVASLFHDV---NSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSS 197
           + ++ + G + S    +   + P   +      A        YLH      +I+RD+K  
Sbjct: 119 VMEYVAGGEMFSHLRRIGRFSEPHARF-----YAAQIVLTFEYLH---SLDLIYRDLKPE 170
Query: 198 NILLTADFEPQISDFGLAKWLPSQ-WTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAF 256
           N+L+      Q++DFG AK +  + W       + GT  +LAPE  +    ++  D +A 
Sbjct: 171 NLLIDQQGYIQVTDFGFAKRVKGRTWX------LCGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 257 GVFLLEIISGRKP 269
           GV + E+ +G  P
Sbjct: 225 GVLIYEMAAGYPP 237

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 98/224 (43%), Gaps = 19/224 (8%)
Query: 62  SIATNAFSSENLVGRGGYAEVYKGVL----QDGEEIAVKRLTKVVTDDRKE-KEFLTEIG 116
            +  N F    L+G+G + +V   +L      G   A+K L K V   + E    +TE  
Sbjct: 4   KVTMNDFDYLKLLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESR 60
Query: 117 TIGHVCHPNVLSL-LGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKI-AVGT 174
            + +  HP + +L       + L  + ++++ G    LF  ++   V  + R +      
Sbjct: 61  VLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGE---LFFHLSRERVFTEERARFYGAEI 117
Query: 175 ARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTF 234
              L YLH    R +++RDIK  N++L  D   +I+DFGL K   S     ++    GT 
Sbjct: 118 VSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTFCGTP 172
Query: 235 GHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPV-DGSHQSL 277
            +LAPE           D +  GV + E++ GR P  +  H+ L
Sbjct: 173 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL 216

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 64/260 (24%), Positives = 109/260 (41%), Gaps = 38/260 (14%)
Query: 24  NAAVSPNGFTEESLENVVVACESETTKP-------TWRCFSFEEI-SIATNAFSSENLVG 75
           NAA +  G  +ES++  +   + +  K        T     FE I ++ T +F    LV 
Sbjct: 2   NAAAAKKGSEQESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVK 61
Query: 76  RGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEF-LTEIGTIGHVCHPNVLSLLGCCV 134
                      ++ G   A+K L K      KE E  L E   +  V  P ++ L     
Sbjct: 62  H----------METGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPFLVKLEFSFK 111
Query: 135 DN-GLYLIFQFSSRGSVASLFHDV---NSPGVEWKVRHKIAVGTARGLHYLHKGCQRRII 190
           DN  LY++ +++  G + S    +   + P   +      A        YLH      +I
Sbjct: 112 DNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-----YAAQIVLTFEYLH---SLDLI 163
Query: 191 HRDIKSSNILLTADFEPQISDFGLAKWLPSQ-WTHHSIAPIEGTFGHLAPEYFMHGIVDE 249
           +RD+K  N+++      +++DFGLAK +  + W       + GT  +LAPE  +    ++
Sbjct: 164 YRDLKPENLMIDQQGYIKVTDFGLAKRVKGRTWX------LCGTPEYLAPEIILSKGYNK 217
Query: 250 KTDVFAFGVFLLEIISGRKP 269
             D +A GV + E+ +G  P
Sbjct: 218 AVDWWALGVLIYEMAAGYPP 237

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 98/224 (43%), Gaps = 19/224 (8%)
Query: 62  SIATNAFSSENLVGRGGYAEVYKGVL----QDGEEIAVKRLTKVVTDDRKE-KEFLTEIG 116
            +  N F    L+G+G + +V   +L      G   A+K L K V   + E    +TE  
Sbjct: 6   KVTMNDFDYLKLLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESR 62
Query: 117 TIGHVCHPNVLSL-LGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKI-AVGT 174
            + +  HP + +L       + L  + ++++ G    LF  ++   V  + R +      
Sbjct: 63  VLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGE---LFFHLSRERVFTEERARFYGAEI 119
Query: 175 ARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTF 234
              L YLH    R +++RDIK  N++L  D   +I+DFGL K   S     ++    GT 
Sbjct: 120 VSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKXFCGTP 174
Query: 235 GHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPV-DGSHQSL 277
            +LAPE           D +  GV + E++ GR P  +  H+ L
Sbjct: 175 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL 218

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/216 (22%), Positives = 90/216 (41%), Gaps = 14/216 (6%)
Query: 61  ISIATNAFSSENLVGRGGYAEVYKGVLQDGEEI-AVKRLTKVVTDDRKEKEFLTEIGTIG 119
           + +    +    ++GRG + EV     +  +++ A+K L+K     R +  F  E   I 
Sbjct: 70  LQMKAEDYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIM 129
Query: 120 HVCHPNVLSLLGCCV--DNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARG 177
              +   +  L C    D  LY++ ++   G + +L  + + P    K      V     
Sbjct: 130 AFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDA 189
Query: 178 LHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHL 237
           +H +       +IHRD+K  N+LL      +++DFG    +      H    + GT  ++
Sbjct: 190 IHSMG------LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTAV-GTPDYI 242
Query: 238 APEYFM----HGIVDEKTDVFAFGVFLLEIISGRKP 269
           +PE        G    + D ++ GVFL E++ G  P
Sbjct: 243 SPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTP 278

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 98/224 (43%), Gaps = 19/224 (8%)
Query: 62  SIATNAFSSENLVGRGGYAEVYKGVL----QDGEEIAVKRLTKVVTDDRKE-KEFLTEIG 116
            +  N F    L+G+G + +V   +L      G   A+K L K V   + E    +TE  
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESR 57
Query: 117 TIGHVCHPNVLSL-LGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKI-AVGT 174
            + +  HP + +L       + L  + ++++ G    LF  ++   V  + R +      
Sbjct: 58  VLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGE---LFFHLSRERVFTEERARFYGAEI 114
Query: 175 ARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTF 234
              L YLH    R +++RDIK  N++L  D   +I+DFGL K   S     ++    GT 
Sbjct: 115 VSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTFCGTP 169
Query: 235 GHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPV-DGSHQSL 277
            +LAPE           D +  GV + E++ GR P  +  H+ L
Sbjct: 170 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL 213

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 98/224 (43%), Gaps = 19/224 (8%)
Query: 62  SIATNAFSSENLVGRGGYAEVYKGVL----QDGEEIAVKRLTKVVTDDRKE-KEFLTEIG 116
            +  N F    L+G+G + +V   +L      G   A+K L K V   + E    +TE  
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESR 57
Query: 117 TIGHVCHPNVLSL-LGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKI-AVGT 174
            + +  HP + +L       + L  + ++++ G    LF  ++   V  + R +      
Sbjct: 58  VLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGE---LFFHLSRERVFTEERARFYGAEI 114
Query: 175 ARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTF 234
              L YLH    R +++RDIK  N++L  D   +I+DFGL K   S     ++    GT 
Sbjct: 115 VSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKXFCGTP 169
Query: 235 GHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPV-DGSHQSL 277
            +LAPE           D +  GV + E++ GR P  +  H+ L
Sbjct: 170 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL 213

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 63/250 (25%), Positives = 107/250 (42%), Gaps = 18/250 (7%)
Query: 24  NAAVSPNGFTEESLENVVVACESETTKPTWRCFSFEEISIATNAFSSENLVGRGGYAEVY 83
           NAA +  G  +ES++  +   + +  K  W   S  + +   + F     +G G +  V 
Sbjct: 2   NAAAAKKGXEQESVKEFLAKAKEDFLK-KWETPS--QNTAQLDQFDRIKTLGTGSFGRVM 58
Query: 84  KGVLQD-GEEIAVKRLTKVVTDDRKEKEF-LTEIGTIGHVCHPNVLSLLGCCVDN-GLYL 140
               ++ G   A+K L K      K+ E  L E   +  V  P ++ L     DN  LY+
Sbjct: 59  LVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM 118
Query: 141 IFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNIL 200
           + ++ + G + S    +     E   R   A        YLH      +I+RD+K  N+L
Sbjct: 119 VMEYVAGGEMFSHLRRIGR-FAEPHARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLL 173
Query: 201 LTADFEPQISDFGLAKWLPSQ-WTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVF 259
           +      Q++DFG AK +  + W       + GT  +LAPE  +    ++  D +A GV 
Sbjct: 174 IDQQGYIQVTDFGFAKRVKGRTWX------LCGTPEYLAPEIILSKGYNKAVDWWALGVL 227
Query: 260 LLEIISGRKP 269
           + E+ +G  P
Sbjct: 228 IYEMAAGYPP 237

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 71/161 (44%), Gaps = 15/161 (9%)
Query: 174 TARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGT 233
            A+G+ +L     R+ IHRD+ + NILL+     +I DFGLA+ +     +         
Sbjct: 200 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 256
Query: 234 FGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGEIEK 292
              +APE     +   ++DV++FGV L EI S G  P  G         +  L +G   +
Sbjct: 257 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR--LKEGTRMR 314
Query: 293 LVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLE 333
             D      Y  T L+        C    P+ RPT SE++E
Sbjct: 315 APDYTTPEMYQ-TMLD--------CWHGEPSQRPTFSELVE 346

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 62/253 (24%), Positives = 107/253 (42%), Gaps = 24/253 (9%)
Query: 24  NAAVSPNGFTEESLENVVVACESETTKPTWRCFSFEEISIATNAFSSENLVGRGGYAEVY 83
           NAA +  G  +ES++  +   + +  K  W   S  + +   + F     +G G +  V 
Sbjct: 2   NAAAAKKGXEQESVKEFLAKAKEDFLK-KWETPS--QNTAQLDQFDRIKTLGTGSFGRVM 58
Query: 84  KGVLQD-GEEIAVKRLTKVVTDDRKEKEF-LTEIGTIGHVCHPNVLSLLGCCVDN-GLYL 140
               ++ G   A+K L K      K+ E  L E   +  V  P ++ L     DN  LY+
Sbjct: 59  LVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM 118
Query: 141 IFQFSSRGSVASLFHDVN---SPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSS 197
           + ++ + G + S    +     P   +      A        YLH      +I+RD+K  
Sbjct: 119 VMEYVAGGEMFSHLRRIGRFXEPHARF-----YAAQIVLTFEYLH---SLDLIYRDLKPE 170
Query: 198 NILLTADFEPQISDFGLAKWLPSQ-WTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAF 256
           N+L+      Q++DFG AK +  + W       + GT  +LAPE  +    ++  D +A 
Sbjct: 171 NLLIDQQGYIQVTDFGFAKRVKGRTWX------LCGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 257 GVFLLEIISGRKP 269
           GV + E+ +G  P
Sbjct: 225 GVLIYEMAAGYPP 237

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/209 (23%), Positives = 96/209 (45%), Gaps = 23/209 (11%)
Query: 74  VGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCC 133
           +G G YA VYKG  +  + +   +  ++  ++      + E+  +  + H N+++L    
Sbjct: 10  LGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 69
Query: 134 -VDNGLYLIFQFSSRGSVASLFHD----VNSPGVEWKVRHKIAVGTARGLHYLHKGCQRR 188
             +  L L+F++  +  +     D    +N   V+            RGL Y H+   ++
Sbjct: 70  HTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKL-----FLFQLLRGLAYCHR---QK 120
Query: 189 IIHRDIKSSNILLTADFEPQISDFGL--AKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGI 246
           ++HRD+K  N+L+    E +++DFGL  AK +P++   + +     T  +  P+  + G 
Sbjct: 121 VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV----TLWYRPPDILL-GS 175
Query: 247 VDEKT--DVFAFGVFLLEIISGRKPVDGS 273
            D  T  D++  G    E+ +GR    GS
Sbjct: 176 TDYSTQIDMWGVGCIFYEMATGRPLFPGS 204

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 71/161 (44%), Gaps = 15/161 (9%)
Query: 174 TARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGT 233
            A+G+ +L     R+ IHRD+ + NILL+     +I DFGLA+ +     +         
Sbjct: 207 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 263
Query: 234 FGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGEIEK 292
              +APE     +   ++DV++FGV L EI S G  P  G         +  L +G   +
Sbjct: 264 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR--LKEGTRMR 321
Query: 293 LVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLE 333
             D      Y  T L+        C    P+ RPT SE++E
Sbjct: 322 APDYTTPEMYQ-TMLD--------CWHGEPSQRPTFSELVE 353

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 98/224 (43%), Gaps = 19/224 (8%)
Query: 62  SIATNAFSSENLVGRGGYAEVYKGVL----QDGEEIAVKRLTKVVTDDRKE-KEFLTEIG 116
            +  N F    L+G+G + +V   +L      G   A+K L K V   + E    +TE  
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESR 57
Query: 117 TIGHVCHPNVLSL-LGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKI-AVGT 174
            + +  HP + +L       + L  + ++++ G    LF  ++   V  + R +      
Sbjct: 58  VLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGE---LFFHLSRERVFTEERARFYGAEI 114
Query: 175 ARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTF 234
              L YLH    R +++RDIK  N++L  D   +I+DFGL K   S     ++    GT 
Sbjct: 115 VSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTFCGTP 169
Query: 235 GHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPV-DGSHQSL 277
            +LAPE           D +  GV + E++ GR P  +  H+ L
Sbjct: 170 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL 213

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 71/161 (44%), Gaps = 15/161 (9%)
Query: 174 TARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGT 233
            A+G+ +L     R+ IHRD+ + NILL+     +I DFGLA+ +     +         
Sbjct: 202 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 258
Query: 234 FGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGEIEK 292
              +APE     +   ++DV++FGV L EI S G  P  G         +  L +G   +
Sbjct: 259 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR--LKEGTRMR 316
Query: 293 LVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLE 333
             D      Y  T L+        C    P+ RPT SE++E
Sbjct: 317 APDYTTPEMYQ-TMLD--------CWHGEPSQRPTFSELVE 348

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 71/161 (44%), Gaps = 15/161 (9%)
Query: 174 TARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGT 233
            A+G+ +L     R+ IHRD+ + NILL+     +I DFGLA+ +     +         
Sbjct: 209 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 265
Query: 234 FGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGEIEK 292
              +APE     +   ++DV++FGV L EI S G  P  G         +  L +G   +
Sbjct: 266 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR--LKEGTRMR 323
Query: 293 LVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLE 333
             D      Y  T L+        C    P+ RPT SE++E
Sbjct: 324 APDYTTPEMYQ-TMLD--------CWHGEPSQRPTFSELVE 355

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/192 (26%), Positives = 87/192 (45%), Gaps = 35/192 (18%)
Query: 90  GEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG---LYLIFQFSS 146
           GE +AVK L +      +   +  EI  +  + H +++   GCC D G   + L+ ++  
Sbjct: 38  GEMVAVKALKEGCGPQLRSG-WQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVP 96
Query: 147 RGSVASLFHDVNSPGVEWKVRHKIAVGT--------ARGLHYLHKGCQRRIIHRDIKSSN 198
            GS+            ++  RH + +            G+ YLH    +  IHR + + N
Sbjct: 97  LGSLR-----------DYLPRHCVGLAQLLLFAQQICEGMAYLHA---QHYIHRALAARN 142
Query: 199 ILLTADFEPQISDFGLAKWLPSQWTHHSI-----APIEGTFGHLAPEYFMHGIVDEKTDV 253
           +LL  D   +I DFGLAK +P    ++ +     +P+   F + APE          +DV
Sbjct: 143 VLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPV---FWY-APECLKECKFYYASDV 198
Query: 254 FAFGVFLLEIIS 265
           ++FGV L E+++
Sbjct: 199 WSFGVTLYELLT 210

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 98/224 (43%), Gaps = 19/224 (8%)
Query: 62  SIATNAFSSENLVGRGGYAEVYKGVL----QDGEEIAVKRLTKVVTDDRKE-KEFLTEIG 116
            +  N F    L+G+G + +V   +L      G   A+K L K V   + E    +TE  
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESR 57
Query: 117 TIGHVCHPNVLSL-LGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKI-AVGT 174
            + +  HP + +L       + L  + ++++ G    LF  ++   V  + R +      
Sbjct: 58  VLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGE---LFFHLSRERVFTEERARFYGAEI 114
Query: 175 ARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTF 234
              L YLH    R +++RDIK  N++L  D   +I+DFGL K   S     ++    GT 
Sbjct: 115 VSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKXFCGTP 169
Query: 235 GHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPV-DGSHQSL 277
            +LAPE           D +  GV + E++ GR P  +  H+ L
Sbjct: 170 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL 213

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/192 (26%), Positives = 87/192 (45%), Gaps = 35/192 (18%)
Query: 90  GEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG---LYLIFQFSS 146
           GE +AVK L +      +   +  EI  +  + H +++   GCC D G   + L+ ++  
Sbjct: 37  GEMVAVKALKEGCGPQLRSG-WQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVP 95
Query: 147 RGSVASLFHDVNSPGVEWKVRHKIAVGT--------ARGLHYLHKGCQRRIIHRDIKSSN 198
            GS+            ++  RH + +            G+ YLH    +  IHR + + N
Sbjct: 96  LGSLR-----------DYLPRHCVGLAQLLLFAQQICEGMAYLHA---QHYIHRALAARN 141
Query: 199 ILLTADFEPQISDFGLAKWLPSQWTHHSI-----APIEGTFGHLAPEYFMHGIVDEKTDV 253
           +LL  D   +I DFGLAK +P    ++ +     +P+   F + APE          +DV
Sbjct: 142 VLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPV---FWY-APECLKECKFYYASDV 197
Query: 254 FAFGVFLLEIIS 265
           ++FGV L E+++
Sbjct: 198 WSFGVTLYELLT 209

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 62/253 (24%), Positives = 108/253 (42%), Gaps = 24/253 (9%)
Query: 24  NAAVSPNGFTEESLENVVVACESETTKPTWRCFSFEEISIATNAFSSENLVGRGGYAEVY 83
           NAA +  G  +ES++  +   + +  K  W   S  + +   + F     +G G +  V 
Sbjct: 2   NAAAAKKGSEQESVKEFLAKAKEDFLK-KWETPS--QNTAQLDQFDRIKTLGTGSFGRVM 58
Query: 84  KGVLQD-GEEIAVKRLTKVVTDDRKEKEF-LTEIGTIGHVCHPNVLSLLGCCVDN-GLYL 140
               ++ G   A+K L K      K+ E  L E   +  V  P ++ L     DN  LY+
Sbjct: 59  LVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM 118
Query: 141 IFQFSSRGSVASLFHDV---NSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSS 197
           + ++ + G + S    +   + P   +      A        YLH      +I+RD+K  
Sbjct: 119 VMEYVAGGEMFSHLRRIGRFSEPHARF-----YAAQIVLTFEYLH---SLDLIYRDLKPE 170
Query: 198 NILLTADFEPQISDFGLAKWLPSQ-WTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAF 256
           N+L+      Q++DFG AK +  + W       + GT  +LAPE  +    ++  D +A 
Sbjct: 171 NLLIDQQGYIQVTDFGFAKRVKGRTWX------LCGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 257 GVFLLEIISGRKP 269
           GV + E+ +G  P
Sbjct: 225 GVLIYEMAAGYPP 237

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/201 (24%), Positives = 91/201 (45%), Gaps = 12/201 (5%)
Query: 74  VGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC 132
           +G+G ++ V + + +  G+E A K +       R  ++   E      + HPN++ L   
Sbjct: 12  LGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 71
Query: 133 CVDNGL-YLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIH 191
             + G  YL+F   + G    LF D+ +   E+      +    + L  ++      I+H
Sbjct: 72  ISEEGFHYLVFDLVTGGE---LFEDIVAR--EYYSEADASHCIQQILESVNHCHLNGIVH 126
Query: 192 RDIKSSNILLTADFE---PQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVD 248
           RD+K  N+LL +  +    +++DFGLA  +  Q    +     GT G+L+PE        
Sbjct: 127 RDLKPENLLLASKSKGAAVKLADFGLA--IEVQGDQQAWFGFAGTPGYLSPEVLRKDPYG 184
Query: 249 EKTDVFAFGVFLLEIISGRKP 269
           +  D++A GV L  ++ G  P
Sbjct: 185 KPVDMWACGVILYILLVGYPP 205

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 98/224 (43%), Gaps = 19/224 (8%)
Query: 62  SIATNAFSSENLVGRGGYAEVYKGVL----QDGEEIAVKRLTKVVTDDRKE-KEFLTEIG 116
            +  N F    L+G+G + +V   +L      G   A+K L K V   + E    +TE  
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESR 57
Query: 117 TIGHVCHPNVLSL-LGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKI-AVGT 174
            + +  HP + +L       + L  + ++++ G    LF  ++   V  + R +      
Sbjct: 58  VLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGE---LFFHLSRERVFTEERARFYGAEI 114
Query: 175 ARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTF 234
              L YLH    R +++RDIK  N++L  D   +I+DFGL K   S     ++    GT 
Sbjct: 115 VSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKXFCGTP 169
Query: 235 GHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPV-DGSHQSL 277
            +LAPE           D +  GV + E++ GR P  +  H+ L
Sbjct: 170 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL 213

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 62/253 (24%), Positives = 108/253 (42%), Gaps = 24/253 (9%)
Query: 24  NAAVSPNGFTEESLENVVVACESETTKPTWRCFSFEEISIATNAFSSENLVGRGGYAEVY 83
           NAA +  G  +ES++  +   + +  K  W   S  + +   + F     +G G +  V 
Sbjct: 2   NAAAAKKGSEQESVKEFLAKAKEDFLK-KWETPS--QNTAQLDQFDRIKTLGTGSFGRVM 58
Query: 84  KGVLQD-GEEIAVKRLTKVVTDDRKEKEF-LTEIGTIGHVCHPNVLSLLGCCVDN-GLYL 140
               ++ G   A+K L K      K+ E  L E   +  V  P ++ L     DN  LY+
Sbjct: 59  LVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM 118
Query: 141 IFQFSSRGSVASLFHDV---NSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSS 197
           + ++ + G + S    +   + P   +      A        YLH      +I+RD+K  
Sbjct: 119 VMEYVAGGEMFSHLRRIGRFSEPHARF-----YAAQIVLTFEYLH---SLDLIYRDLKPE 170
Query: 198 NILLTADFEPQISDFGLAKWLPSQ-WTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAF 256
           N+L+      Q++DFG AK +  + W       + GT  +LAPE  +    ++  D +A 
Sbjct: 171 NLLIDQQGYIQVTDFGFAKRVKGRTWX------LCGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 257 GVFLLEIISGRKP 269
           GV + E+ +G  P
Sbjct: 225 GVLIYEMAAGYPP 237

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 62/253 (24%), Positives = 108/253 (42%), Gaps = 24/253 (9%)
Query: 24  NAAVSPNGFTEESLENVVVACESETTKPTWRCFSFEEISIATNAFSSENLVGRGGYAEVY 83
           NAA +  G  +ES++  +   + +  K  W   S  + +   + F     +G G +  V 
Sbjct: 2   NAAAAKKGSEQESVKEFLAKAKEDFLK-KWETPS--QNTAQLDQFDRIKTLGTGSFGRVM 58
Query: 84  KGVLQD-GEEIAVKRLTKVVTDDRKEKEF-LTEIGTIGHVCHPNVLSLLGCCVDN-GLYL 140
               ++ G   A+K L K      K+ E  L E   +  V  P ++ L     DN  LY+
Sbjct: 59  LVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM 118
Query: 141 IFQFSSRGSVASLFHDV---NSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSS 197
           + ++ + G + S    +   + P   +      A        YLH      +I+RD+K  
Sbjct: 119 VMEYVAGGEMFSHLRRIGRFSEPHARF-----YAAQIVLTFEYLH---SLDLIYRDLKPE 170
Query: 198 NILLTADFEPQISDFGLAKWLPSQ-WTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAF 256
           N+L+      Q++DFG AK +  + W       + GT  +LAPE  +    ++  D +A 
Sbjct: 171 NLLIDQQGYIQVTDFGFAKRVKGRTWX------LCGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 257 GVFLLEIISGRKP 269
           GV + E+ +G  P
Sbjct: 225 GVLIYEMAAGYPP 237

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 62/253 (24%), Positives = 108/253 (42%), Gaps = 24/253 (9%)
Query: 24  NAAVSPNGFTEESLENVVVACESETTKPTWRCFSFEEISIATNAFSSENLVGRGGYAEVY 83
           NAA +  G  +ES++  +   + +  K  W   S  + +   + F     +G G +  V 
Sbjct: 3   NAAAAKKGSEQESVKEFLAKAKEDFLK-KWETPS--QNTAQLDQFDRIKTLGTGSFGRVM 59
Query: 84  KGVLQD-GEEIAVKRLTKVVTDDRKEKEF-LTEIGTIGHVCHPNVLSLLGCCVDN-GLYL 140
               ++ G   A+K L K      K+ E  L E   +  V  P ++ L     DN  LY+
Sbjct: 60  LVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM 119
Query: 141 IFQFSSRGSVASLFHDV---NSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSS 197
           + ++ + G + S    +   + P   +      A        YLH      +I+RD+K  
Sbjct: 120 VMEYVAGGEMFSHLRRIGRFSEPHARF-----YAAQIVLTFEYLH---SLDLIYRDLKPE 171
Query: 198 NILLTADFEPQISDFGLAKWLPSQ-WTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAF 256
           N+L+      Q++DFG AK +  + W       + GT  +LAPE  +    ++  D +A 
Sbjct: 172 NLLIDQQGYIQVTDFGFAKRVKGRTWX------LCGTPEYLAPEIILSKGYNKAVDWWAL 225
Query: 257 GVFLLEIISGRKP 269
           GV + E+ +G  P
Sbjct: 226 GVLIYEMAAGYPP 238

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 64/260 (24%), Positives = 108/260 (41%), Gaps = 38/260 (14%)
Query: 24  NAAVSPNGFTEESLENVVVACESETTKP-------TWRCFSFEEI-SIATNAFSSENLVG 75
           NAA +  G  +ES++  +   + +  K        T     FE I ++ T +F    LV 
Sbjct: 2   NAAAAKKGSEQESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVK 61
Query: 76  RGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEF-LTEIGTIGHVCHPNVLSLLGCCV 134
                      ++ G   A+K L K      K+ E  L E   +  V  P ++ L     
Sbjct: 62  H----------METGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 111
Query: 135 DN-GLYLIFQFSSRGSVASLFHDV---NSPGVEWKVRHKIAVGTARGLHYLHKGCQRRII 190
           DN  LY++ ++ + G + S    +   + P   +      A        YLH      +I
Sbjct: 112 DNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-----YAAQIVLTFEYLH---SLDLI 163
Query: 191 HRDIKSSNILLTADFEPQISDFGLAKWLPSQ-WTHHSIAPIEGTFGHLAPEYFMHGIVDE 249
           +RD+K  N+L+      Q++DFG AK +  + W       + GT  +LAPE  +    ++
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWX------LCGTPEYLAPEIILSKGYNK 217
Query: 250 KTDVFAFGVFLLEIISGRKP 269
             D +A GV + E+ +G  P
Sbjct: 218 AVDWWALGVLIYEMAAGYPP 237

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 97/217 (44%), Gaps = 19/217 (8%)
Query: 73  LVGRGGYAEVYKGVLQD-GEEIAVK--RLTKVVTDDRKEKEFLTEIGTIGHVC-HPNVLS 128
           ++G+G ++ V + + ++ G++ AVK   + K  +      E L    +I H+  HP+++ 
Sbjct: 31  VIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 129 LLGCCVDNG-LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTAR----GLHYLHK 183
           LL     +G LY++F+F     +   F  V      +     +A    R     L Y H 
Sbjct: 91  LLETYSSDGMLYMVFEFMDGADLC--FEIVKRADAGFVYSEAVASHYMRQILEALRYCH- 147
Query: 184 GCQRRIIHRDIKSSNILLTA--DFEP-QISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPE 240
                IIHRD+K  N+LL +  +  P ++ DFG+A  L             GT   +APE
Sbjct: 148 --DNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGL--VAGGRVGTPHFMAPE 203
Query: 241 YFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSL 277
                   +  DV+  GV L  ++SG  P  G+ + L
Sbjct: 204 VVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERL 240

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/222 (21%), Positives = 94/222 (42%), Gaps = 26/222 (11%)
Query: 75  GRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCV 134
            +G     Y  +L+    +A+K+L++   +    K    E+  +  V H N++ LL    
Sbjct: 41  AQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFT 98
Query: 135 DN-------GLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQR 187
                     +Y++ +         +  +++   + + +   +      G+ +LH     
Sbjct: 99  PQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLC-----GIKHLHSAG-- 151
Query: 188 RIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIV 247
            IIHRD+K SNI++ +D   +I DFGLA+   +  T   + P   T  + APE  +    
Sbjct: 152 -IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMGY 207
Query: 248 DEKTDVFAFGVFLLEII------SGRKPVDGSHQSLHSWAKP 283
            E  D+++ G  + E++       GR  +D  ++ +     P
Sbjct: 208 KENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTP 249

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/222 (21%), Positives = 94/222 (42%), Gaps = 26/222 (11%)
Query: 75  GRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCV 134
            +G     Y  +L+    +A+K+L++   +    K    E+  +  V H N++ LL    
Sbjct: 30  AQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFT 87
Query: 135 DN-------GLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQR 187
                     +Y++ +         +  +++   + + +   +      G+ +LH     
Sbjct: 88  PQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLC-----GIKHLHSA--- 139
Query: 188 RIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIV 247
            IIHRD+K SNI++ +D   +I DFGLA+   +  T   + P   T  + APE  +    
Sbjct: 140 GIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMGY 196
Query: 248 DEKTDVFAFGVFLLEII------SGRKPVDGSHQSLHSWAKP 283
            E  D+++ G  + E++       GR  +D  ++ +     P
Sbjct: 197 KENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTP 238

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 39/145 (26%), Positives = 71/145 (48%), Gaps = 7/145 (4%)
Query: 74  VGRGGYAEVYKGVLQDGEEI-AVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC 132
           +G G Y  V+K   ++  EI A+KR+     D+      L EI  +  + H N++ L   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 133 C-VDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIH 191
              D  L L+F+F  +  +   F   N   ++ ++         +GL + H    R ++H
Sbjct: 70  LHSDKKLTLVFEFCDQ-DLKKYFDSCNG-DLDPEIVKSFLFQLLKGLGFCH---SRNVLH 124
Query: 192 RDIKSSNILLTADFEPQISDFGLAK 216
           RD+K  N+L+  + E ++++FGLA+
Sbjct: 125 RDLKPQNLLINRNGELKLANFGLAR 149

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 87/215 (40%), Gaps = 17/215 (7%)
Query: 74  VGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCC 133
           +G G   EV   V +  EE    ++  +       +    EI     + H NV+   G  
Sbjct: 14  LGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 134 VDNGL-YLIFQFSSRGSVASLFH-DVNSPGVE-WKVRHKIAVGTARGLHYLHKGCQRRII 190
            +  + YL  ++ S G +      D+  P  +  +  H++  G      YLH      I 
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV----YLHGIG---IT 126
Query: 191 HRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYF----MHGI 246
           HRDIK  N+LL      +ISDFGLA           +  + GT  ++APE       H  
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA- 185
Query: 247 VDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWA 281
             E  DV++ G+ L  +++G  P D    S   ++
Sbjct: 186 --EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS 218

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 62/253 (24%), Positives = 107/253 (42%), Gaps = 24/253 (9%)
Query: 24  NAAVSPNGFTEESLENVVVACESETTKPTWRCFSFEEISIATNAFSSENLVGRGGYAEVY 83
           NAA +  G  +ES++  +   + +  K  W   S  + +   + F     +G G +  V 
Sbjct: 2   NAAAAKKGSEQESVKEFLAKAKEDFLK-KWETPS--QNTAQLDQFDRIKTLGTGSFGRVM 58
Query: 84  KGVLQD-GEEIAVKRLTKVVTDDRKEKEF-LTEIGTIGHVCHPNVLSLLGCCVDN-GLYL 140
               ++ G   A+K L K      K+ E  L E   +  V  P ++ L     DN  LY+
Sbjct: 59  LVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM 118
Query: 141 IFQFSSRGSVASLFHDVN---SPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSS 197
           + ++ + G + S    +     P   +      A        YLH      +I+RD+K  
Sbjct: 119 VMEYVAGGEMFSHLRRIGRFXEPHARF-----YAAQIVLTFEYLH---SLDLIYRDLKPE 170
Query: 198 NILLTADFEPQISDFGLAKWLPSQ-WTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAF 256
           N+L+      Q++DFG AK +  + W       + GT  +LAPE  +    ++  D +A 
Sbjct: 171 NLLIDQQGYIQVTDFGFAKRVKGRTWX------LCGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 257 GVFLLEIISGRKP 269
           GV + E+ +G  P
Sbjct: 225 GVLIYEMAAGYPP 237

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 62/253 (24%), Positives = 107/253 (42%), Gaps = 24/253 (9%)
Query: 24  NAAVSPNGFTEESLENVVVACESETTKPTWRCFSFEEISIATNAFSSENLVGRGGYAEVY 83
           NAA +  G  +ES++  +   + +  K  W   S  + +   + F     +G G +  V 
Sbjct: 23  NAAAAKKGSEQESVKEFLAKAKEDFLK-KWETPS--QNTAQLDQFDRIKTLGTGSFGRVM 79
Query: 84  KGVLQD-GEEIAVKRLTKVVTDDRKEKEF-LTEIGTIGHVCHPNVLSLLGCCVDN-GLYL 140
               ++ G   A+K L K      K+ E  L E   +  V  P ++ L     DN  LY+
Sbjct: 80  LVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM 139
Query: 141 IFQFSSRGSVASLFHDVN---SPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSS 197
           + ++ + G + S    +     P   +      A        YLH      +I+RD+K  
Sbjct: 140 VMEYVAGGEMFSHLRRIGRFXEPHARF-----YAAQIVLTFEYLH---SLDLIYRDLKPE 191
Query: 198 NILLTADFEPQISDFGLAKWLPSQ-WTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAF 256
           N+L+      Q++DFG AK +  + W       + GT  +LAPE  +    ++  D +A 
Sbjct: 192 NLLIDQQGYIQVTDFGFAKRVKGRTWX------LCGTPEYLAPEIILSKGYNKAVDWWAL 245
Query: 257 GVFLLEIISGRKP 269
           GV + E+ +G  P
Sbjct: 246 GVLIYEMAAGYPP 258

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 64/260 (24%), Positives = 107/260 (41%), Gaps = 38/260 (14%)
Query: 24  NAAVSPNGFTEESLENVVVACESETTKP-------TWRCFSFEEI-SIATNAFSSENLVG 75
           NAA +  G  +ES++  +   + +  K        T     FE I ++ T +F    LV 
Sbjct: 2   NAAAAKKGXEQESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVK 61
Query: 76  RGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEF-LTEIGTIGHVCHPNVLSLLGCCV 134
                      ++ G   A+K L K      K+ E  L E   +  V  P ++ L     
Sbjct: 62  H----------METGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 111
Query: 135 DN-GLYLIFQFSSRGSVASLFHDV---NSPGVEWKVRHKIAVGTARGLHYLHKGCQRRII 190
           DN  LY++ ++   G + S    +   + P   +      A        YLH      +I
Sbjct: 112 DNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-----YAAQIVLTFEYLH---SLDLI 163
Query: 191 HRDIKSSNILLTADFEPQISDFGLAKWLPSQ-WTHHSIAPIEGTFGHLAPEYFMHGIVDE 249
           +RD+K  N+L+      Q++DFG AK +  + W       + GT  +LAPE  +    ++
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWX------LCGTPEYLAPEIILSKGYNK 217
Query: 250 KTDVFAFGVFLLEIISGRKP 269
             D +A GV + E+ +G  P
Sbjct: 218 AVDWWALGVLIYEMAAGYPP 237

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 63/260 (24%), Positives = 108/260 (41%), Gaps = 38/260 (14%)
Query: 24  NAAVSPNGFTEESLENVVVACESETTKP-------TWRCFSFEEI-SIATNAFSSENLVG 75
           NAA +  G  +ES++  +   + +  K        T     FE I ++ T +F    LV 
Sbjct: 2   NAAAAKKGSEQESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVK 61
Query: 76  RGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEF-LTEIGTIGHVCHPNVLSLLGCCV 134
                      ++ G   A+K L K      K+ E  L E   +  V  P ++ L     
Sbjct: 62  H----------METGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 111
Query: 135 DN-GLYLIFQFSSRGSVASLFHDV---NSPGVEWKVRHKIAVGTARGLHYLHKGCQRRII 190
           DN  LY++ +++  G + S    +   + P   +      A        YLH      +I
Sbjct: 112 DNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-----YAAQIVLTFEYLH---SLDLI 163
Query: 191 HRDIKSSNILLTADFEPQISDFGLAKWLPSQ-WTHHSIAPIEGTFGHLAPEYFMHGIVDE 249
           +RD+K  N+++      Q++DFG AK +  + W       + GT  +LAPE  +    ++
Sbjct: 164 YRDLKPENLMIDQQGYIQVTDFGFAKRVKGRTWX------LCGTPEYLAPEIILSKGYNK 217
Query: 250 KTDVFAFGVFLLEIISGRKP 269
             D +A GV + E+ +G  P
Sbjct: 218 AVDWWALGVLIYEMAAGYPP 237

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 47/222 (21%), Positives = 94/222 (42%), Gaps = 26/222 (11%)
Query: 75  GRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCV 134
            +G     Y  +L+    +A+K+L++   +    K    E+  +  V H N++ LL    
Sbjct: 36  AQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFT 93
Query: 135 DN-------GLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQR 187
                     +Y++ +         +  +++   + + +   +      G+ +LH     
Sbjct: 94  PQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLC-----GIKHLHSAG-- 146
Query: 188 RIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIV 247
            IIHRD+K SNI++ +D   +I DFGLA+   +  T   + P   T  + APE  +    
Sbjct: 147 -IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMEPEVVTRYYRAPEVILGMGY 202
Query: 248 DEKTDVFAFGVFLLEII------SGRKPVDGSHQSLHSWAKP 283
            E  D+++ G  + E++       GR  +D  ++ +     P
Sbjct: 203 KENVDIWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTP 244

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 96/216 (44%), Gaps = 18/216 (8%)
Query: 66  NAFSSENLVGRGGYAEVY---KGVLQDGEEI-AVKRLTKVVTDDRKEKEFLTEIGTIGHV 121
           + F    ++G+G + +V+   K    D  ++ A+K L K     R       E   +  V
Sbjct: 24  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV 83
Query: 122 CHPNVLSL-LGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGV--EWKVRHKIAVGTARGL 178
            HP ++ L      +  LYLI  F   G    LF  ++   +  E  V+  +A   A  L
Sbjct: 84  NHPFIVKLHYAFQTEGKLYLILDFLRGGD---LFTRLSKEVMFTEEDVKFYLA-ELALAL 139
Query: 179 HYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIA-PIEGTFGHL 237
            +LH      II+RD+K  NILL  +   +++DFGL+K       H   A    GT  ++
Sbjct: 140 DHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSK---ESIDHEKKAYSFCGTVEYM 193
Query: 238 APEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGS 273
           APE        +  D ++FGV + E+++G  P  G 
Sbjct: 194 APEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGK 229

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 64/260 (24%), Positives = 106/260 (40%), Gaps = 38/260 (14%)
Query: 24  NAAVSPNGFTEESLENVVVACESETTKP-------TWRCFSFEEI-SIATNAFSSENLVG 75
           NAA +  G  +ES++  +   + +  K        T     FE I ++ T +F    LV 
Sbjct: 2   NAAAAKKGXEQESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVK 61
Query: 76  RGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEF-LTEIGTIGHVCHPNVLSLLGCCV 134
                      ++ G   A+K L K      K+ E  L E   +  V  P ++ L     
Sbjct: 62  H----------METGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 111
Query: 135 DN-GLYLIFQFSSRGSVASLFHDVN---SPGVEWKVRHKIAVGTARGLHYLHKGCQRRII 190
           DN  LY++ ++   G + S    +     P   +      A        YLH      +I
Sbjct: 112 DNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARF-----YAAQIVLTFEYLH---SLDLI 163
Query: 191 HRDIKSSNILLTADFEPQISDFGLAKWLPSQ-WTHHSIAPIEGTFGHLAPEYFMHGIVDE 249
           +RD+K  N+L+      Q++DFG AK +  + W       + GT  +LAPE  +    ++
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWX------LCGTPEYLAPEIILSKGYNK 217
Query: 250 KTDVFAFGVFLLEIISGRKP 269
             D +A GV + E+ +G  P
Sbjct: 218 AVDWWALGVLIYEMAAGYPP 237

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 100/222 (45%), Gaps = 16/222 (7%)
Query: 63  IATNAFSSENLVGRGGYAEVYKGVLQD---GEEIAVKRLTKVVTDDRKE-KEFLTEIGTI 118
           +  N F    L+G+G + +V   ++++   G   A+K L K V   + E    LTE   +
Sbjct: 148 VTMNEFEYLKLLGKGTFGKVI--LVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVL 205
Query: 119 GHVCHPNVLSL-LGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKI-AVGTAR 176
            +  HP + +L       + L  + ++++ G    LF  ++   V  + R +        
Sbjct: 206 QNSRHPFLTALKYSFQTHDRLCFVMEYANGGE---LFFHLSRERVFSEDRARFYGAEIVS 262
Query: 177 GLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGH 236
            L YLH   ++ +++RD+K  N++L  D   +I+DFGL K         ++    GT  +
Sbjct: 263 ALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGTPEY 318
Query: 237 LAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPV-DGSHQSL 277
           LAPE           D +  GV + E++ GR P  +  H+ L
Sbjct: 319 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL 360

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 64/260 (24%), Positives = 107/260 (41%), Gaps = 38/260 (14%)
Query: 24  NAAVSPNGFTEESLENVVVACESETTKP-------TWRCFSFEEI-SIATNAFSSENLVG 75
           NAA +  G  +ES++  +   + +  K        T     FE I ++ T +F    LV 
Sbjct: 2   NAAAAKKGSEQESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVK 61
Query: 76  RGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEF-LTEIGTIGHVCHPNVLSLLGCCV 134
                      ++ G   A+K L K      K+ E  L E   +  V  P ++ L     
Sbjct: 62  H----------METGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 111
Query: 135 DN-GLYLIFQFSSRGSVASLFHDV---NSPGVEWKVRHKIAVGTARGLHYLHKGCQRRII 190
           DN  LY++ ++   G + S    +   + P   +      A        YLH      +I
Sbjct: 112 DNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-----YAAQIVLTFEYLH---SLDLI 163
Query: 191 HRDIKSSNILLTADFEPQISDFGLAKWLPSQ-WTHHSIAPIEGTFGHLAPEYFMHGIVDE 249
           +RD+K  N+L+      Q++DFG AK +  + W       + GT  +LAPE  +    ++
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWX------LCGTPEYLAPEIILSKGYNK 217
Query: 250 KTDVFAFGVFLLEIISGRKP 269
             D +A GV + E+ +G  P
Sbjct: 218 AVDWWALGVLIYEMAAGYPP 237

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 64/260 (24%), Positives = 107/260 (41%), Gaps = 38/260 (14%)
Query: 24  NAAVSPNGFTEESLENVVVACESETTKP-------TWRCFSFEEI-SIATNAFSSENLVG 75
           NAA +  G  +ES++  +   + +  K        T     FE I ++ T +F    LV 
Sbjct: 2   NAAAAKKGSEQESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVK 61
Query: 76  RGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEF-LTEIGTIGHVCHPNVLSLLGCCV 134
                      ++ G   A+K L K      K+ E  L E   +  V  P ++ L     
Sbjct: 62  H----------METGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 111
Query: 135 DN-GLYLIFQFSSRGSVASLFHDV---NSPGVEWKVRHKIAVGTARGLHYLHKGCQRRII 190
           DN  LY++ ++   G + S    +   + P   +      A        YLH      +I
Sbjct: 112 DNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-----YAAQIVLTFEYLH---SLDLI 163
Query: 191 HRDIKSSNILLTADFEPQISDFGLAKWLPSQ-WTHHSIAPIEGTFGHLAPEYFMHGIVDE 249
           +RD+K  N+L+      Q++DFG AK +  + W       + GT  +LAPE  +    ++
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWX------LCGTPEYLAPEIILSKGYNK 217
Query: 250 KTDVFAFGVFLLEIISGRKP 269
             D +A GV + E+ +G  P
Sbjct: 218 AVDWWALGVLIYEMAAGYPP 237

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 100/222 (45%), Gaps = 16/222 (7%)
Query: 63  IATNAFSSENLVGRGGYAEVYKGVLQD---GEEIAVKRLTKVVTDDRKE-KEFLTEIGTI 118
           +  N F    L+G+G + +V   ++++   G   A+K L K V   + E    LTE   +
Sbjct: 145 VTMNEFEYLKLLGKGTFGKVI--LVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVL 202
Query: 119 GHVCHPNVLSL-LGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKI-AVGTAR 176
            +  HP + +L       + L  + ++++ G    LF  ++   V  + R +        
Sbjct: 203 QNSRHPFLTALKYSFQTHDRLCFVMEYANGGE---LFFHLSRERVFSEDRARFYGAEIVS 259
Query: 177 GLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGH 236
            L YLH   ++ +++RD+K  N++L  D   +I+DFGL K         ++    GT  +
Sbjct: 260 ALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGTPEY 315
Query: 237 LAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPV-DGSHQSL 277
           LAPE           D +  GV + E++ GR P  +  H+ L
Sbjct: 316 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL 357

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 64/260 (24%), Positives = 107/260 (41%), Gaps = 38/260 (14%)
Query: 24  NAAVSPNGFTEESLENVVVACESETTKP-------TWRCFSFEEI-SIATNAFSSENLVG 75
           NAA +  G  +ES++  +   + +  K        T     FE I +I T +F    LV 
Sbjct: 2   NAAAAKKGXEQESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTIGTGSFGRVMLVK 61
Query: 76  RGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEF-LTEIGTIGHVCHPNVLSLLGCCV 134
                      ++ G   A+K L K      K+ E  L E   +  V  P ++ L     
Sbjct: 62  H----------METGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 111
Query: 135 DN-GLYLIFQFSSRGSVASLFHDV---NSPGVEWKVRHKIAVGTARGLHYLHKGCQRRII 190
           DN  LY++ ++   G + S    +   + P   +      A        YLH      +I
Sbjct: 112 DNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARF-----YAAQIVLTFEYLH---SLDLI 163
Query: 191 HRDIKSSNILLTADFEPQISDFGLAKWLPSQ-WTHHSIAPIEGTFGHLAPEYFMHGIVDE 249
           +RD+K  N+L+      +++DFG AK +  + W       + GT  +LAPE  +    ++
Sbjct: 164 YRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWX------LCGTPEYLAPEIILSKGYNK 217
Query: 250 KTDVFAFGVFLLEIISGRKP 269
             D +A GV + E+ +G  P
Sbjct: 218 AVDWWALGVLIYEMAAGYPP 237

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 96/216 (44%), Gaps = 18/216 (8%)
Query: 66  NAFSSENLVGRGGYAEVY---KGVLQDGEEI-AVKRLTKVVTDDRKEKEFLTEIGTIGHV 121
           + F    ++G+G + +V+   K    D  ++ A+K L K     R       E   +  V
Sbjct: 24  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV 83
Query: 122 CHPNVLSL-LGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGV--EWKVRHKIAVGTARGL 178
            HP ++ L      +  LYLI  F   G    LF  ++   +  E  V+  +A   A  L
Sbjct: 84  NHPFIVKLHYAFQTEGKLYLILDFLRGGD---LFTRLSKEVMFTEEDVKFYLA-ELALAL 139
Query: 179 HYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIA-PIEGTFGHL 237
            +LH      II+RD+K  NILL  +   +++DFGL+K       H   A    GT  ++
Sbjct: 140 DHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSK---ESIDHEKKAYSFCGTVEYM 193
Query: 238 APEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGS 273
           APE        +  D ++FGV + E+++G  P  G 
Sbjct: 194 APEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGK 229

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 62/253 (24%), Positives = 107/253 (42%), Gaps = 24/253 (9%)
Query: 24  NAAVSPNGFTEESLENVVVACESETTKPTWRCFSFEEISIATNAFSSENLVGRGGYAEVY 83
           NAA +  G  +ES++  +   + +  K  W   S  + +   + F     +G G +  V 
Sbjct: 3   NAAAAKKGXEQESVKEFLAKAKEDFLK-KWE--SPAQNTAHLDQFERIKTLGTGSFGRVM 59
Query: 84  KGVLQD-GEEIAVKRLTKVVTDDRKEKEF-LTEIGTIGHVCHPNVLSLLGCCVDN-GLYL 140
               ++ G   A+K L K      K+ E  L E   +  V  P ++ L     DN  LY+
Sbjct: 60  LVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM 119
Query: 141 IFQFSSRGSVASLFHDV---NSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSS 197
           + ++   G + S    +   + P   +      A        YLH      +I+RD+K  
Sbjct: 120 VMEYVPGGEMFSHLRRIGRFSEPHARF-----YAAQIVLTFEYLH---SLDLIYRDLKPE 171
Query: 198 NILLTADFEPQISDFGLAKWLPSQ-WTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAF 256
           N+L+      Q++DFG AK +  + W       + GT  +LAPE  +    ++  D +A 
Sbjct: 172 NLLIDQQGYIQVTDFGFAKRVKGRTWX------LCGTPEYLAPEIILSKGYNKAVDWWAL 225
Query: 257 GVFLLEIISGRKP 269
           GV + E+ +G  P
Sbjct: 226 GVLIYEMAAGYPP 238

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 64/260 (24%), Positives = 107/260 (41%), Gaps = 38/260 (14%)
Query: 24  NAAVSPNGFTEESLENVVVACESETTKP-------TWRCFSFEEI-SIATNAFSSENLVG 75
           NAA +  G  +ES++  +   + +  K        T     FE I ++ T +F    LV 
Sbjct: 3   NAAAAKKGSEQESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVK 62
Query: 76  RGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEF-LTEIGTIGHVCHPNVLSLLGCCV 134
                      ++ G   A+K L K      K+ E  L E   +  V  P ++ L     
Sbjct: 63  H----------METGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 112
Query: 135 DN-GLYLIFQFSSRGSVASLFHDV---NSPGVEWKVRHKIAVGTARGLHYLHKGCQRRII 190
           DN  LY++ ++   G + S    +   + P   +      A        YLH      +I
Sbjct: 113 DNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-----YAAQIVLTFEYLH---SLDLI 164
Query: 191 HRDIKSSNILLTADFEPQISDFGLAKWLPSQ-WTHHSIAPIEGTFGHLAPEYFMHGIVDE 249
           +RD+K  N+L+      Q++DFG AK +  + W       + GT  +LAPE  +    ++
Sbjct: 165 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWX------LCGTPEYLAPEIILSKGYNK 218
Query: 250 KTDVFAFGVFLLEIISGRKP 269
             D +A GV + E+ +G  P
Sbjct: 219 AVDWWALGVLIYEMAAGYPP 238

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 61/253 (24%), Positives = 108/253 (42%), Gaps = 24/253 (9%)
Query: 24  NAAVSPNGFTEESLENVVVACESETTKPTWRCFSFEEISIATNAFSSENLVGRGGYAEVY 83
           NAA +  G  +ES++  +   + +  K  W   S  + +   + F     +G G +  V 
Sbjct: 2   NAAAAKKGSEQESVKEFLAKAKEDFLK-KWETPS--QNTAQLDQFDRIKTLGTGSFGRVM 58
Query: 84  KGVLQD-GEEIAVKRLTKVVTDDRKEKEF-LTEIGTIGHVCHPNVLSLLGCCVDN-GLYL 140
               ++ G   A+K L K      K+ E  L E   +  V  P ++ L     DN  LY+
Sbjct: 59  LVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM 118
Query: 141 IFQFSSRGSVASLFHDV---NSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSS 197
           + ++ + G + S    +   + P   +      A        YLH      +I+RD+K  
Sbjct: 119 VMEYVAGGEMFSHLRRIGRFSEPHARF-----YAAQIVLTFEYLH---SLDLIYRDLKPE 170
Query: 198 NILLTADFEPQISDFGLAKWLPSQ-WTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAF 256
           N+L+      Q++DFG AK +  + W       + GT  +LAPE  +    ++  D +A 
Sbjct: 171 NLLIDQQGYIQVTDFGFAKRVKGRTWX------LCGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 257 GVFLLEIISGRKP 269
           GV + ++ +G  P
Sbjct: 225 GVLIYQMAAGYPP 237

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 89/202 (44%), Gaps = 14/202 (6%)
Query: 74  VGRGGYAEVYKGVLQDGEEI-AVKRLTKVVTDDRKE-KEFLTEIGTIGHVCHPNVLSLLG 131
           +G+G + +V      D +++ A+K + K    +R E +    E+  +  + HP +++L  
Sbjct: 23  IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWY 82
Query: 132 CCVDN-GLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRII 190
              D   ++++      G +   +H   +   + +            L YL     +RII
Sbjct: 83  SFQDEEDMFMVVDLLLGGDLR--YHLQQNVHFKEETVKLFICELVMALDYLQN---QRII 137
Query: 191 HRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMH---GIV 247
           HRD+K  NILL       I+DF +A  LP +     I  + GT  ++APE F        
Sbjct: 138 HRDMKPDNILLDEHGHVHITDFNIAAMLPRE---TQITTMAGTKPYMAPEMFSSRKGAGY 194
Query: 248 DEKTDVFAFGVFLLEIISGRKP 269
               D ++ GV   E++ GR+P
Sbjct: 195 SFAVDWWSLGVTAYELLRGRRP 216

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 96/216 (44%), Gaps = 18/216 (8%)
Query: 66  NAFSSENLVGRGGYAEVY---KGVLQDGEEI-AVKRLTKVVTDDRKEKEFLTEIGTIGHV 121
           + F    ++G+G + +V+   K    D  ++ A+K L K     R       E   +  V
Sbjct: 25  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV 84
Query: 122 CHPNVLSL-LGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGV--EWKVRHKIAVGTARGL 178
            HP ++ L      +  LYLI  F   G    LF  ++   +  E  V+  +A   A  L
Sbjct: 85  NHPFIVKLHYAFQTEGKLYLILDFLRGGD---LFTRLSKEVMFTEEDVKFYLA-ELALAL 140
Query: 179 HYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIA-PIEGTFGHL 237
            +LH      II+RD+K  NILL  +   +++DFGL+K       H   A    GT  ++
Sbjct: 141 DHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSK---ESIDHEKKAYSFCGTVEYM 194
Query: 238 APEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGS 273
           APE        +  D ++FGV + E+++G  P  G 
Sbjct: 195 APEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGK 230

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 47/222 (21%), Positives = 94/222 (42%), Gaps = 26/222 (11%)
Query: 75  GRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCV 134
            +G     Y  +L+    +A+K+L++   +    K    E+  +  V H N++ LL    
Sbjct: 36  AQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFT 93
Query: 135 DN-------GLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQR 187
                     +Y++ +         +  +++   + + +   +      G+ +LH     
Sbjct: 94  PQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLC-----GIKHLHSAG-- 146
Query: 188 RIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIV 247
            IIHRD+K SNI++ +D   +I DFGLA+   +  T   + P   T  + APE  +    
Sbjct: 147 -IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMEPEVVTRYYRAPEVILGMGY 202
Query: 248 DEKTDVFAFGVFLLEII------SGRKPVDGSHQSLHSWAKP 283
            E  D+++ G  + E++       GR  +D  ++ +     P
Sbjct: 203 KENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTP 244

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 92/212 (43%), Gaps = 17/212 (8%)
Query: 65  TNAFSSENLVGRGGYAEVYKGVLQD-GEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCH 123
           ++ +  +  +G+G ++ V + V +  G E A K +       R  ++   E      + H
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 124 PNVLSLLGCCVDNGL-YLIFQFSSRGSVASLFHDVNSPGV--EWKVRHKIAVGTARGLHY 180
           PN++ L     +    YL+F   + G    LF D+ +     E    H I       + Y
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGE---LFEDIVAREFYSEADASHCIQ-QILESIAY 120
Query: 181 LHKGCQRRIIHRDIKSSNILLTADFE---PQISDFGLAKWLPSQWTHHSIAPIEGTFGHL 237
            H      I+HR++K  N+LL +  +    +++DFGLA  +      H  A   GT G+L
Sbjct: 121 CHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA---GTPGYL 174
Query: 238 APEYFMHGIVDEKTDVFAFGVFLLEIISGRKP 269
           +PE        +  D++A GV L  ++ G  P
Sbjct: 175 SPEVLKKDPYSKPVDIWACGVILYILLVGYPP 206

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 92/212 (43%), Gaps = 17/212 (8%)
Query: 65  TNAFSSENLVGRGGYAEVYKGVLQD-GEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCH 123
           ++ +  +  +G+G ++ V + V +  G E A K +       R  ++   E      + H
Sbjct: 4   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 63
Query: 124 PNVLSLLGCCVDNGL-YLIFQFSSRGSVASLFHDVNSPGV--EWKVRHKIAVGTARGLHY 180
           PN++ L     +    YL+F   + G    LF D+ +     E    H I       + Y
Sbjct: 64  PNIVRLHDSIQEESFHYLVFDLVTGGE---LFEDIVAREFYSEADASHCIQ-QILESIAY 119
Query: 181 LHKGCQRRIIHRDIKSSNILLTADFE---PQISDFGLAKWLPSQWTHHSIAPIEGTFGHL 237
            H      I+HR++K  N+LL +  +    +++DFGLA  +      H  A   GT G+L
Sbjct: 120 CHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA---GTPGYL 173
Query: 238 APEYFMHGIVDEKTDVFAFGVFLLEIISGRKP 269
           +PE        +  D++A GV L  ++ G  P
Sbjct: 174 SPEVLKKDPYSKPVDIWACGVILYILLVGYPP 205

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 62/253 (24%), Positives = 107/253 (42%), Gaps = 24/253 (9%)
Query: 24  NAAVSPNGFTEESLENVVVACESETTKPTWRCFSFEEISIATNAFSSENLVGRGGYAEVY 83
           NAA +  G  +ES++  +   + +  K  W   S  + +   + F     +G G +  V 
Sbjct: 2   NAAAACKGSEQESVKEFLAKAKEDFLK-KWETPS--QNTAQLDQFDRIKTLGTGSFGRVM 58
Query: 84  KGVLQD-GEEIAVKRLTKVVTDDRKEKEF-LTEIGTIGHVCHPNVLSLLGCCVDN-GLYL 140
               ++ G   A+K L K      K+ E  L E   +  V  P ++ L     DN  LY+
Sbjct: 59  LVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM 118
Query: 141 IFQFSSRGSVASLFHDVN---SPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSS 197
           + ++ + G + S    +     P   +      A        YLH      +I+RD+K  
Sbjct: 119 VMEYVAGGEMFSHLRRIGRFXEPHARF-----YAAQIVLTFEYLH---SLDLIYRDLKPE 170
Query: 198 NILLTADFEPQISDFGLAKWLPSQ-WTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAF 256
           N+L+      Q++DFG AK +  + W       + GT  +LAPE  +    ++  D +A 
Sbjct: 171 NLLIDQQGYIQVTDFGFAKRVKGRTWX------LCGTPEYLAPEIILSKGYNKAVDWWAL 224
Query: 257 GVFLLEIISGRKP 269
           GV + E+ +G  P
Sbjct: 225 GVLIYEMAAGYPP 237

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 61/253 (24%), Positives = 108/253 (42%), Gaps = 24/253 (9%)
Query: 24  NAAVSPNGFTEESLENVVVACESETTKPTWRCFSFEEISIATNAFSSENLVGRGGYAEVY 83
           NAA +  G  +ES++  +   + +  K  W   S  + +   + F     +G G +  V 
Sbjct: 2   NAAAAKKGSEQESVKEFLAKAKEDFLK-KWETPS--QNTAQLDQFDRIKTLGTGSFGRVM 58
Query: 84  KGVLQD-GEEIAVKRLTKVVTDDRKEKEF-LTEIGTIGHVCHPNVLSLLGCCVDN-GLYL 140
               ++ G   A+K L K      K+ E  L E   +  V  P ++ L     DN  LY+
Sbjct: 59  LVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM 118
Query: 141 IFQFSSRGSVASLFHDV---NSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSS 197
           + ++ + G + S    +   + P   +      A        YLH      +I+RD+K  
Sbjct: 119 VMEYVAGGEMFSHLRRIGRFSEPHARF-----YAAQIVLTFEYLH---SLDLIYRDLKPE 170
Query: 198 NILLTADFEPQISDFGLAKWLPSQ-WTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAF 256
           N+++      Q++DFG AK +  + W       + GT  +LAPE  +    ++  D +A 
Sbjct: 171 NLIIDQQGYIQVTDFGFAKRVKGRTWX------LCGTPEYLAPEIIISKGYNKAVDWWAL 224
Query: 257 GVFLLEIISGRKP 269
           GV + E+ +G  P
Sbjct: 225 GVLIYEMAAGYPP 237

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 62/253 (24%), Positives = 107/253 (42%), Gaps = 24/253 (9%)
Query: 24  NAAVSPNGFTEESLENVVVACESETTKPTWRCFSFEEISIATNAFSSENLVGRGGYAEVY 83
           NAA +  G  +ES++  +   + +  K  W   S  + +   + F     +G G +  V 
Sbjct: 2   NAAAAKKGSEQESVKEFLAKAKEDFLK-KWETPS--QNTAQLDQFDRIKTLGTGSFGRVM 58
Query: 84  KGVLQD-GEEIAVKRLTKVVTDDRKEKEF-LTEIGTIGHVCHPNVLSLLGCCVDN-GLYL 140
               ++ G   A+K L K      K+ E  L E   +  V  P ++ L     DN  LY+
Sbjct: 59  LVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM 118
Query: 141 IFQFSSRGSVASLFHDV---NSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSS 197
           + ++ + G + S    +   + P   +      A        YLH      +I+RD+K  
Sbjct: 119 VMEYVAGGEMFSHLRRIGRFSEPHARF-----YAAQIVLTFEYLH---SLDLIYRDLKPE 170
Query: 198 NILLTADFEPQISDFGLAKWLPSQ-WTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAF 256
           N+L+      Q++DFG AK +  + W       + GT   LAPE  +    ++  D +A 
Sbjct: 171 NLLIDQQGYIQVTDFGFAKRVKGRTWX------LCGTPEALAPEIILSKGYNKAVDWWAL 224
Query: 257 GVFLLEIISGRKP 269
           GV + E+ +G  P
Sbjct: 225 GVLIYEMAAGYPP 237

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 64/260 (24%), Positives = 106/260 (40%), Gaps = 38/260 (14%)
Query: 24  NAAVSPNGFTEESLENVVVACESETTKP-------TWRCFSFEEI-SIATNAFSSENLVG 75
           NAA +  G  +ES++  +   + +  K        T     FE I ++ T +F    LV 
Sbjct: 2   NAAAAKKGSEQESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVK 61
Query: 76  RGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEF-LTEIGTIGHVCHPNVLSLLGCCV 134
                      ++ G   A+K L K      K+ E  L E   +  V  P ++ L     
Sbjct: 62  H----------METGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 111
Query: 135 DN-GLYLIFQFSSRGSVASLFHDVN---SPGVEWKVRHKIAVGTARGLHYLHKGCQRRII 190
           DN  LY++ ++   G + S    +     P   +      A        YLH      +I
Sbjct: 112 DNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARF-----YAAQIVLTFEYLH---SLDLI 163
Query: 191 HRDIKSSNILLTADFEPQISDFGLAKWLPSQ-WTHHSIAPIEGTFGHLAPEYFMHGIVDE 249
           +RD+K  N+L+      Q++DFG AK +  + W       + GT  +LAPE  +    ++
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWX------LCGTPEYLAPEIILSKGYNK 217
Query: 250 KTDVFAFGVFLLEIISGRKP 269
             D +A GV + E+ +G  P
Sbjct: 218 AVDWWALGVLIYEMAAGYPP 237

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 88/203 (43%), Gaps = 17/203 (8%)
Query: 74  VGRGGYAEVYKGVLQD-GEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC 132
           +G+G ++ V + V +  G E A K +       R  ++   E      + HPN++ L   
Sbjct: 37  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 96
Query: 133 CVDNGL-YLIFQFSSRGSVASLFHDVNSPGV--EWKVRHKIAVGTARGLHYLHKGCQRRI 189
             +    YL+F   + G    LF D+ +     E    H I       + Y H      I
Sbjct: 97  IQEESFHYLVFDLVTGGE---LFEDIVAREFYSEADASHCIQ-QILESIAYCHSNG---I 149
Query: 190 IHRDIKSSNILLTADFEP---QISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGI 246
           +HR++K  N+LL +  +    +++DFGLA  +      H  A   GT G+L+PE      
Sbjct: 150 VHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA---GTPGYLSPEVLKKDP 206
Query: 247 VDEKTDVFAFGVFLLEIISGRKP 269
             +  D++A GV L  ++ G  P
Sbjct: 207 YSKPVDIWACGVILYILLVGYPP 229

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 64/260 (24%), Positives = 106/260 (40%), Gaps = 38/260 (14%)
Query: 24  NAAVSPNGFTEESLENVVVACESETTKP-------TWRCFSFEEI-SIATNAFSSENLVG 75
           NAA +  G  +ES++  +   + +  K        T     FE I ++ T +F    LV 
Sbjct: 3   NAAAAKKGSEQESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVK 62
Query: 76  RGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEF-LTEIGTIGHVCHPNVLSLLGCCV 134
                      ++ G   A+K L K      K+ E  L E   +  V  P ++ L     
Sbjct: 63  H----------METGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 112
Query: 135 DN-GLYLIFQFSSRGSVASLFHDVN---SPGVEWKVRHKIAVGTARGLHYLHKGCQRRII 190
           DN  LY++ ++   G + S    +     P   +      A        YLH      +I
Sbjct: 113 DNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARF-----YAAQIVLTFEYLH---SLDLI 164
Query: 191 HRDIKSSNILLTADFEPQISDFGLAKWLPSQ-WTHHSIAPIEGTFGHLAPEYFMHGIVDE 249
           +RD+K  N+L+      Q++DFG AK +  + W       + GT  +LAPE  +    ++
Sbjct: 165 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWX------LCGTPEYLAPEIILSKGYNK 218
Query: 250 KTDVFAFGVFLLEIISGRKP 269
             D +A GV + E+ +G  P
Sbjct: 219 AVDWWALGVLIYEMAAGYPP 238

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 64/260 (24%), Positives = 107/260 (41%), Gaps = 38/260 (14%)
Query: 24  NAAVSPNGFTEESLENVVVACESETTKP-------TWRCFSFEEI-SIATNAFSSENLVG 75
           NAA +  G  +ES++  +   + +  K        T     FE I +I T +F    LV 
Sbjct: 2   NAAAAKKGSEQESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTIGTGSFGRVMLVK 61
Query: 76  RGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEF-LTEIGTIGHVCHPNVLSLLGCCV 134
                      ++ G   A+K L K      K+ E  L E   +  V  P ++ L     
Sbjct: 62  H----------METGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 111
Query: 135 DN-GLYLIFQFSSRGSVASLFHDV---NSPGVEWKVRHKIAVGTARGLHYLHKGCQRRII 190
           DN  LY++ ++   G + S    +   + P   +      A        YLH      +I
Sbjct: 112 DNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARF-----YAAQIVLTFEYLH---SLDLI 163
Query: 191 HRDIKSSNILLTADFEPQISDFGLAKWLPSQ-WTHHSIAPIEGTFGHLAPEYFMHGIVDE 249
           +RD+K  N+L+      +++DFG AK +  + W       + GT  +LAPE  +    ++
Sbjct: 164 YRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWX------LCGTPEYLAPEIILSKGYNK 217
Query: 250 KTDVFAFGVFLLEIISGRKP 269
             D +A GV + E+ +G  P
Sbjct: 218 AVDWWALGVLIYEMAAGYPP 237

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 92/212 (43%), Gaps = 17/212 (8%)
Query: 65  TNAFSSENLVGRGGYAEVYKGVLQD-GEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCH 123
           ++ +  +  +G+G ++ V + V +  G E A K +       R  ++   E      + H
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 124 PNVLSLLGCCVDNGL-YLIFQFSSRGSVASLFHDVNSPGV--EWKVRHKIAVGTARGLHY 180
           PN++ L     +    YL+F   + G    LF D+ +     E    H I       + Y
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGE---LFEDIVAREFYSEADASHCIQ-QILESIAY 120
Query: 181 LHKGCQRRIIHRDIKSSNILLTADFE---PQISDFGLAKWLPSQWTHHSIAPIEGTFGHL 237
            H      I+HR++K  N+LL +  +    +++DFGLA  +      H  A   GT G+L
Sbjct: 121 CHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA---GTPGYL 174
Query: 238 APEYFMHGIVDEKTDVFAFGVFLLEIISGRKP 269
           +PE        +  D++A GV L  ++ G  P
Sbjct: 175 SPEVLKKDPYSKPVDIWACGVILYILLVGYPP 206

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 46/222 (20%), Positives = 92/222 (41%), Gaps = 29/222 (13%)
Query: 68  FSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNV 126
           F     +GRGG+  V++   + D    A+KR+ ++   +   ++ + E+  +  + HP +
Sbjct: 7   FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRI-RLPNRELAREKVMREVKALAKLEHPGI 65
Query: 127 LSLLGCCVDNG-------------LYLIFQFSSRGSVASLFH-DVNSPGVEWKVRHKIAV 172
           +      ++               LY+  Q   + ++    +        E  V   I +
Sbjct: 66  VRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFL 125
Query: 173 GTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSI-APIE 231
             A  + +LH    + ++HRD+K SNI  T D   ++ DFGL   +       ++  P+ 
Sbjct: 126 QIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMP 182
Query: 232 ---------GTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEII 264
                    GT  +++PE         K D+F+ G+ L E++
Sbjct: 183 AYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 86/197 (43%), Gaps = 19/197 (9%)
Query: 81  EVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNGL-- 138
           E++KG  Q G +I VK L       RK ++F  E   +    HPNVL +LG C       
Sbjct: 25  ELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPH 83
Query: 139 -YLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSS 197
             LI  +   GS+ ++ H+  +  V+     K A+  ARG+ +LH   +  I    + S 
Sbjct: 84  PTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHT-LEPLIPRHALNSR 142
Query: 198 NILLTADFEPQIS--DFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVD---EKTD 252
           ++++  D   +IS  D   +   P +      AP       +APE       D      D
Sbjct: 143 SVMIDEDMTARISMADVKFSFQSPGR----MYAP-----AWVAPEALQKKPEDTNRRSAD 193
Query: 253 VFAFGVFLLEIISGRKP 269
           +++F V L E+++   P
Sbjct: 194 MWSFAVLLWELVTREVP 210

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 62/253 (24%), Positives = 107/253 (42%), Gaps = 24/253 (9%)
Query: 24  NAAVSPNGFTEESLENVVVACESETTKPTWRCFSFEEISIATNAFSSENLVGRGGYAEVY 83
           NAA +  G  +ES++  +   + +  K  W   S  + +   + F     +G G +  V 
Sbjct: 3   NAAAAKKGSEQESVKEFLAKAKEDFLK-KWE--SPAQNTAHLDQFERIKTLGTGSFGRVM 59
Query: 84  KGVLQD-GEEIAVKRLTKVVTDDRKEKEF-LTEIGTIGHVCHPNVLSLLGCCVDN-GLYL 140
               ++ G   A+K L K      K+ E  L E   +  V  P ++ L     DN  LY+
Sbjct: 60  LVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM 119
Query: 141 IFQFSSRGSVASLFHDV---NSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSS 197
           + ++   G + S    +   + P   +      A        YLH      +I+RD+K  
Sbjct: 120 VMEYVPGGEMFSHLRRIGRFSEPHARF-----YAAQIVLTFEYLH---SLDLIYRDLKPE 171
Query: 198 NILLTADFEPQISDFGLAKWLPSQ-WTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAF 256
           N+L+      Q++DFG AK +  + W       + GT  +LAPE  +    ++  D +A 
Sbjct: 172 NLLIDQQGYIQVTDFGFAKRVKGRTWX------LCGTPEYLAPEIILSKGYNKAVDWWAL 225
Query: 257 GVFLLEIISGRKP 269
           GV + E+ +G  P
Sbjct: 226 GVLIYEMAAGYPP 238

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 100/222 (45%), Gaps = 16/222 (7%)
Query: 63  IATNAFSSENLVGRGGYAEVYKGVLQD---GEEIAVKRLTKVVTDDRKE-KEFLTEIGTI 118
           +  N F    L+G+G + +V   ++++   G   A+K L K V   + E    LTE   +
Sbjct: 5   VTMNEFEYLKLLGKGTFGKVI--LVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVL 62
Query: 119 GHVCHPNVLSL-LGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKI-AVGTAR 176
            +  HP + +L       + L  + ++++ G    LF  ++   V  + R +        
Sbjct: 63  QNSRHPFLTALKYSFQTHDRLCFVMEYANGGE---LFFHLSRERVFSEDRARFYGAEIVS 119
Query: 177 GLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGH 236
            L YLH   ++ +++RD+K  N++L  D   +I+DFGL K         ++    GT  +
Sbjct: 120 ALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--TMKXFCGTPEY 175
Query: 237 LAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPV-DGSHQSL 277
           LAPE           D +  GV + E++ GR P  +  H+ L
Sbjct: 176 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL 217

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 64/260 (24%), Positives = 106/260 (40%), Gaps = 38/260 (14%)
Query: 24  NAAVSPNGFTEESLENVVVACESETTKP-------TWRCFSFEEI-SIATNAFSSENLVG 75
           NAA +  G  +ES++  +   + +  K        T     FE I ++ T +F    LV 
Sbjct: 2   NAAAAKKGSEQESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVK 61
Query: 76  RGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEF-LTEIGTIGHVCHPNVLSLLGCCV 134
                       + G   A+K L K      K+ E  L E   +  V  P ++ L     
Sbjct: 62  HK----------ETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEYSFK 111
Query: 135 DN-GLYLIFQFSSRGSVASLFHDV---NSPGVEWKVRHKIAVGTARGLHYLHKGCQRRII 190
           DN  LY++ ++   G + S    +   + P   +      A        YLH      +I
Sbjct: 112 DNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-----YAAQIVLTFEYLH---SLDLI 163
Query: 191 HRDIKSSNILLTADFEPQISDFGLAKWLPSQ-WTHHSIAPIEGTFGHLAPEYFMHGIVDE 249
           +RD+K  N+L+      Q++DFG AK +  + W       + GT  +LAPE  +    ++
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWX------LCGTPEYLAPEIILSKGYNK 217
Query: 250 KTDVFAFGVFLLEIISGRKP 269
             D +A GV + E+ +G  P
Sbjct: 218 AVDWWALGVLIYEMAAGYPP 237

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 100/222 (45%), Gaps = 16/222 (7%)
Query: 63  IATNAFSSENLVGRGGYAEVYKGVLQD---GEEIAVKRLTKVVTDDRKE-KEFLTEIGTI 118
           +  N F    L+G+G + +V   ++++   G   A+K L K V   + E    LTE   +
Sbjct: 6   VTMNEFEYLKLLGKGTFGKVI--LVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVL 63
Query: 119 GHVCHPNVLSL-LGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKI-AVGTAR 176
            +  HP + +L       + L  + ++++ G    LF  ++   V  + R +        
Sbjct: 64  QNSRHPFLTALKYSFQTHDRLCFVMEYANGGE---LFFHLSRERVFSEDRARFYGAEIVS 120
Query: 177 GLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGH 236
            L YLH   ++ +++RD+K  N++L  D   +I+DFGL K         ++    GT  +
Sbjct: 121 ALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--TMKXFCGTPEY 176
Query: 237 LAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPV-DGSHQSL 277
           LAPE           D +  GV + E++ GR P  +  H+ L
Sbjct: 177 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL 218

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 62/253 (24%), Positives = 107/253 (42%), Gaps = 24/253 (9%)
Query: 24  NAAVSPNGFTEESLENVVVACESETTKPTWRCFSFEEISIATNAFSSENLVGRGGYAEVY 83
           NAA +  G  +ES++  +   + +  K  W   S  + +   + F     +G G +  V 
Sbjct: 3   NAAAAKKGSEQESVKEFLAKAKEDFLK-KWE--SPAQNTAHLDQFERIKTLGTGSFGRVM 59
Query: 84  KGVLQD-GEEIAVKRLTKVVTDDRKEKEF-LTEIGTIGHVCHPNVLSLLGCCVDN-GLYL 140
               ++ G   A+K L K      K+ E  L E   +  V  P ++ L     DN  LY+
Sbjct: 60  LVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM 119
Query: 141 IFQFSSRGSVASLFHDV---NSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSS 197
           + ++   G + S    +   + P   +      A        YLH      +I+RD+K  
Sbjct: 120 VMEYVPGGEMFSHLRRIGRFSEPHARF-----YAAQIVLTFEYLH---SLDLIYRDLKPE 171
Query: 198 NILLTADFEPQISDFGLAKWLPSQ-WTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAF 256
           N+L+      Q++DFG AK +  + W       + GT  +LAPE  +    ++  D +A 
Sbjct: 172 NLLIDQQGYIQVTDFGFAKRVKGRTWX------LCGTPEYLAPEIILSKGYNKAVDWWAL 225
Query: 257 GVFLLEIISGRKP 269
           GV + E+ +G  P
Sbjct: 226 GVLIYEMAAGYPP 238

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 100/222 (45%), Gaps = 16/222 (7%)
Query: 63  IATNAFSSENLVGRGGYAEVYKGVLQD---GEEIAVKRLTKVVTDDRKE-KEFLTEIGTI 118
           +  N F    L+G+G + +V   ++++   G   A+K L K V   + E    LTE   +
Sbjct: 7   VTMNEFEYLKLLGKGTFGKVI--LVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVL 64
Query: 119 GHVCHPNVLSL-LGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKI-AVGTAR 176
            +  HP + +L       + L  + ++++ G    LF  ++   V  + R +        
Sbjct: 65  QNSRHPFLTALKYSFQTHDRLCFVMEYANGGE---LFFHLSRERVFSEDRARFYGAEIVS 121
Query: 177 GLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGH 236
            L YLH   ++ +++RD+K  N++L  D   +I+DFGL K         ++    GT  +
Sbjct: 122 ALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--TMKXFCGTPEY 177
Query: 237 LAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPV-DGSHQSL 277
           LAPE           D +  GV + E++ GR P  +  H+ L
Sbjct: 178 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL 219

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 64/260 (24%), Positives = 106/260 (40%), Gaps = 38/260 (14%)
Query: 24  NAAVSPNGFTEESLENVVVACESETTKP-------TWRCFSFEEI-SIATNAFSSENLVG 75
           NAA +  G  +ES++  +   + +  K        T     FE I ++ T +F    LV 
Sbjct: 2   NAAAAKKGSEQESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVK 61
Query: 76  RGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEF-LTEIGTIGHVCHPNVLSLLGCCV 134
                       + G   A+K L K      K+ E  L E   +  V  P ++ L     
Sbjct: 62  HK----------ETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEYSFK 111
Query: 135 DN-GLYLIFQFSSRGSVASLFHDV---NSPGVEWKVRHKIAVGTARGLHYLHKGCQRRII 190
           DN  LY++ ++   G + S    +   + P   +      A        YLH      +I
Sbjct: 112 DNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-----YAAQIVLTFEYLH---SLDLI 163
Query: 191 HRDIKSSNILLTADFEPQISDFGLAKWLPSQ-WTHHSIAPIEGTFGHLAPEYFMHGIVDE 249
           +RD+K  N+L+      Q++DFG AK +  + W       + GT  +LAPE  +    ++
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWX------LCGTPEYLAPEIILSKGYNK 217
Query: 250 KTDVFAFGVFLLEIISGRKP 269
             D +A GV + E+ +G  P
Sbjct: 218 AVDWWALGVLIYEMAAGYPP 237

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 64/260 (24%), Positives = 107/260 (41%), Gaps = 38/260 (14%)
Query: 24  NAAVSPNGFTEESLENVVVACESETTKP-------TWRCFSFEEI-SIATNAFSSENLVG 75
           NAA +  G  +ES++  +   + +  K        T     FE I +I T +F    LV 
Sbjct: 2   NAAAAKKGSEQESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTIGTGSFGRVMLVK 61
Query: 76  RGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEF-LTEIGTIGHVCHPNVLSLLGCCV 134
                      ++ G   A+K L K      K+ E  L E   +  V  P ++ L     
Sbjct: 62  H----------METGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 111
Query: 135 DN-GLYLIFQFSSRGSVASLFHDV---NSPGVEWKVRHKIAVGTARGLHYLHKGCQRRII 190
           DN  LY++ ++   G + S    +   + P   +      A        YLH      +I
Sbjct: 112 DNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-----YAAQIVLTFEYLH---SLDLI 163
Query: 191 HRDIKSSNILLTADFEPQISDFGLAKWLPSQ-WTHHSIAPIEGTFGHLAPEYFMHGIVDE 249
           +RD+K  N+L+      +++DFG AK +  + W       + GT  +LAPE  +    ++
Sbjct: 164 YRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWX------LCGTPEYLAPEIILSKGYNK 217
Query: 250 KTDVFAFGVFLLEIISGRKP 269
             D +A GV + E+ +G  P
Sbjct: 218 AVDWWALGVLIYEMAAGYPP 237

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 62/253 (24%), Positives = 107/253 (42%), Gaps = 24/253 (9%)
Query: 24  NAAVSPNGFTEESLENVVVACESETTKPTWRCFSFEEISIATNAFSSENLVGRGGYAEVY 83
           NAA +  G  +ES++  +   + +  K  W   S  + +   + F     +G G +  V 
Sbjct: 23  NAAAAKKGSEQESVKEFLAKAKEDFLK-KWE--SPAQNTAHLDQFERIKTLGTGSFGRVM 79
Query: 84  KGVLQD-GEEIAVKRLTKVVTDDRKEKEF-LTEIGTIGHVCHPNVLSLLGCCVDN-GLYL 140
               ++ G   A+K L K      K+ E  L E   +  V  P ++ L     DN  LY+
Sbjct: 80  LVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM 139
Query: 141 IFQFSSRGSVASLFHDV---NSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSS 197
           + ++   G + S    +   + P   +      A        YLH      +I+RD+K  
Sbjct: 140 VMEYVPGGEMFSHLRRIGRFSEPHARF-----YAAQIVLTFEYLH---SLDLIYRDLKPE 191
Query: 198 NILLTADFEPQISDFGLAKWLPSQ-WTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAF 256
           N+L+      Q++DFG AK +  + W       + GT  +LAPE  +    ++  D +A 
Sbjct: 192 NLLIDQQGYIQVTDFGFAKRVKGRTWX------LCGTPEYLAPEIILSKGYNKAVDWWAL 245
Query: 257 GVFLLEIISGRKP 269
           GV + E+ +G  P
Sbjct: 246 GVLIYEMAAGYPP 258

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 64/260 (24%), Positives = 106/260 (40%), Gaps = 38/260 (14%)
Query: 24  NAAVSPNGFTEESLENVVVACESETTKP-------TWRCFSFEEI-SIATNAFSSENLVG 75
           NAA +  G  +ES++  +   + +  K        T     FE I ++ T +F    LV 
Sbjct: 2   NAAAAKKGSEQESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVK 61
Query: 76  RGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEF-LTEIGTIGHVCHPNVLSLLGCCV 134
                       + G   A+K L K      K+ E  L E   +  V  P ++ L     
Sbjct: 62  HK----------ETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEYSFK 111
Query: 135 DN-GLYLIFQFSSRGSVASLFHDV---NSPGVEWKVRHKIAVGTARGLHYLHKGCQRRII 190
           DN  LY++ ++   G + S    +   + P   +      A        YLH      +I
Sbjct: 112 DNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-----YAAQIVLTFEYLH---SLDLI 163
Query: 191 HRDIKSSNILLTADFEPQISDFGLAKWLPSQ-WTHHSIAPIEGTFGHLAPEYFMHGIVDE 249
           +RD+K  N+L+      Q++DFG AK +  + W       + GT  +LAPE  +    ++
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWX------LCGTPEYLAPEIILSKGYNK 217
Query: 250 KTDVFAFGVFLLEIISGRKP 269
             D +A GV + E+ +G  P
Sbjct: 218 AVDWWALGVLIYEMAAGYPP 237

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 70/307 (22%), Positives = 119/307 (38%), Gaps = 41/307 (13%)
Query: 11  RLFSLKRRSFDGDNAAVSPNGFTEESLENVVVACESETTKPTWR---------------C 55
           RL  L++   DG  A  +   F+ E+L ++++    E      R                
Sbjct: 5   RLRQLEQFILDGP-AQTNGQCFSVETLLDILICLYDECNNSPLRREKNILEYLEWAKPFT 63
Query: 56  FSFEEISIATNAFSSENLVGRGGYAEVYKGVLQDGEEI-AVKRLTKVVTDDRKEKEFLTE 114
              +++ +    F    ++GRG + EV    L++ +++ A+K L K     R E     E
Sbjct: 64  SKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFRE 123
Query: 115 IGTIGHVCHPNVLSLLGCCV--DNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHK--- 169
              +        ++ L      DN LYL+  +   G + +L         E   R     
Sbjct: 124 ERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAE 183
Query: 170 --IAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSI 227
             IA+ +   LHY         +HRDIK  NIL+  +   +++DFG    L    T  S 
Sbjct: 184 MVIAIDSVHQLHY---------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSS 234
Query: 228 APIEGTFGHLAPEYFM-----HGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAK 282
             + GT  +++PE         G    + D ++ GV + E++ G  P     +SL     
Sbjct: 235 VAV-GTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYA--ESLVETYG 291
Query: 283 PILNQGE 289
            I+N  E
Sbjct: 292 KIMNHKE 298

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 62/260 (23%), Positives = 108/260 (41%), Gaps = 38/260 (14%)
Query: 24  NAAVSPNGFTEESLENVVVACESETTKP-------TWRCFSFEEI-SIATNAFSSENLVG 75
           NAA +  G  +ES++  +   + +  K        T     FE I ++ T +F    LV 
Sbjct: 2   NAAAAKKGSEQESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVK 61
Query: 76  RGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEF-LTEIGTIGHVCHPNVLSLLGCCV 134
                      ++ G   A+K L K      K+ E  L E   +  V  P ++ L     
Sbjct: 62  H----------METGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 111
Query: 135 DN-GLYLIFQFSSRGSVASLFHDV---NSPGVEWKVRHKIAVGTARGLHYLHKGCQRRII 190
           DN  LY++ +++  G + S    +   + P   +      A        YLH      +I
Sbjct: 112 DNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-----YAAQIVLTFEYLH---SLDLI 163
Query: 191 HRDIKSSNILLTADFEPQISDFGLAKWLPSQ-WTHHSIAPIEGTFGHLAPEYFMHGIVDE 249
           +RD+K  N+++      +++DFG AK +  + W       + GT  +LAPE  +    ++
Sbjct: 164 YRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWX------LCGTPEYLAPEIILSKGYNK 217
Query: 250 KTDVFAFGVFLLEIISGRKP 269
             D +A GV + E+ +G  P
Sbjct: 218 AVDWWALGVLIYEMAAGYPP 237

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 61/253 (24%), Positives = 107/253 (42%), Gaps = 24/253 (9%)
Query: 24  NAAVSPNGFTEESLENVVVACESETTKPTWRCFSFEEISIATNAFSSENLVGRGGYAEVY 83
           NAA +  G  +ES++  +   + +  K  W   S  + +   + F     +G G +  V 
Sbjct: 2   NAAAAKKGSEQESVKEFLAKAKEDFLK-KWETPS--QNTAQLDQFDRIKTLGTGSFGRVM 58
Query: 84  KGVLQD-GEEIAVKRLTKVVTDDRKEKEF-LTEIGTIGHVCHPNVLSLLGCCVDN-GLYL 140
               ++ G   A+K L K      K+ E  L E   +  V  P ++ L     DN  LY+
Sbjct: 59  LVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM 118
Query: 141 IFQFSSRGSVASLFHDV---NSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSS 197
           + ++ + G + S    +   + P   +      A        YLH      +I+RD+K  
Sbjct: 119 VMEYVAGGEMFSHLRRIGRFSEPHARF-----YAAQIVLTFEYLH---SLDLIYRDLKPE 170
Query: 198 NILLTADFEPQISDFGLAKWLPSQ-WTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAF 256
           N+L+      Q++DFG AK +  + W       + GT  +LAP   +    ++  D +A 
Sbjct: 171 NLLIDQQGYIQVTDFGFAKRVKGRTWX------LCGTPEYLAPAIILSKGYNKAVDWWAL 224
Query: 257 GVFLLEIISGRKP 269
           GV + E+ +G  P
Sbjct: 225 GVLIYEMAAGYPP 237

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 73/293 (24%), Positives = 121/293 (41%), Gaps = 48/293 (16%)
Query: 61  ISIATNAFSSENLVGRGGYAE-VYKGVLQDGEEIAVKR-LTKVVTDDRKEKEFLTEIGTI 118
           + +   +F  ++++G G     VY+G+  D  ++AVKR L +  +   +E + L E    
Sbjct: 19  VIVGKISFCPKDVLGHGAEGTIVYRGMF-DNRDVAVKRILPECFSFADREVQLLRESDE- 76
Query: 119 GHVCHPNVLSLLGCCVDNGLYLIFQFSSRGSVASLFH------DVNSPGVEWKVRHKIAV 172
               HPNV+       D      FQ+ +    A+         D    G+E      +  
Sbjct: 77  ----HPNVIRYFCTEKDRQ----FQYIAIELCAATLQEYVEQKDFAHLGLEPIT---LLQ 125
Query: 173 GTARGLHYLHKGCQRRIIHRDIKSSNILLT-----ADFEPQISDFGLAKWLP-SQWTHHS 226
            T  GL +LH      I+HRD+K  NIL++        +  ISDFGL K L   + +   
Sbjct: 126 QTTSGLAHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSR 182
Query: 227 IAPIEGTFGHLAPEYFMHGIVDEKT---DVFAFGVFLLEIISGRKPVDGSH---QSLHSW 280
            + + GT G +APE       +  T   D+F+ G     +IS     +GSH   +SL   
Sbjct: 183 RSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVIS-----EGSHPFGKSLQRQ 237
Query: 281 AKPILNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLE 333
           A  +L    ++ L   + +       + ++       I   P  RP+   VL+
Sbjct: 238 ANILLGACSLDCLHPEKHEDVIARELIEKM-------IAMDPQKRPSAKHVLK 283

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 62/260 (23%), Positives = 107/260 (41%), Gaps = 38/260 (14%)
Query: 24  NAAVSPNGFTEESLENVVVACESETTKP-------TWRCFSFEEI-SIATNAFSSENLVG 75
           NAA +  G  +ES++  +   + +  K        T     FE I ++ T +F    LV 
Sbjct: 3   NAAAAKKGXEQESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVK 62
Query: 76  RGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEF-LTEIGTIGHVCHPNVLSLLGCCV 134
                      ++ G   A+K L K      K+ E  L E   +  V  P +  L     
Sbjct: 63  H----------METGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLEFSFK 112
Query: 135 DN-GLYLIFQFSSRGSVASLFHDV---NSPGVEWKVRHKIAVGTARGLHYLHKGCQRRII 190
           DN  LY++ +++  G + S    +   + P   +      A        YLH      +I
Sbjct: 113 DNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-----YAAQIVLTFEYLH---SLDLI 164
Query: 191 HRDIKSSNILLTADFEPQISDFGLAKWLPSQ-WTHHSIAPIEGTFGHLAPEYFMHGIVDE 249
           +RD+K  N+++      +++DFG AK +  + W       + GT  +LAPE  +    ++
Sbjct: 165 YRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWX------LCGTPEYLAPEIILSKGYNK 218
Query: 250 KTDVFAFGVFLLEIISGRKP 269
             D +A GV + E+ +G  P
Sbjct: 219 AVDWWALGVLIYEMAAGYPP 238

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 41/159 (25%), Positives = 77/159 (48%), Gaps = 15/159 (9%)
Query: 71  ENLVGRGGYAEVYKGVLQDGEE-IAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSL 129
           ++L+GRG Y  VY    ++ E+ +A+K++ ++  D    K  L EI  +  +    ++ L
Sbjct: 31  KHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRL 90
Query: 130 LGCCVDNGL------YLIFQFSSRGSVASLFHDVNSPGVEWKVRHK-IAVGTARGLHYLH 182
               + + L      Y++ + +    +  LF    +P    +   K I      G +++H
Sbjct: 91  YDLIIPDDLLKFDELYIVLEIAD-SDLKKLF---KTPIFLTEEHIKTILYNLLLGENFIH 146
Query: 183 KGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQ 221
           +     IIHRD+K +N LL  D   ++ DFGLA+ + S+
Sbjct: 147 ESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSE 182

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 89/203 (43%), Gaps = 16/203 (7%)
Query: 74  VGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC 132
           +G+G ++ V + V +  G+E A   +       R  ++   E      + HPN++ L   
Sbjct: 19  LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 78
Query: 133 CVDNGL-YLIFQFSSRGSVASLFHDVNSPGV--EWKVRHKIAVGTARGLHYLHKGCQRRI 189
             + G  YLIF   + G    LF D+ +     E    H I       LH    G    +
Sbjct: 79  ISEEGHHYLIFDLVTGGE---LFEDIVAREYYSEADASHCIQQILEAVLHCHQMG----V 131
Query: 190 IHRDIKSSNILLTADFE---PQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGI 246
           +HR++K  N+LL +  +    +++DFGLA  +  +    +     GT G+L+PE      
Sbjct: 132 VHRNLKPENLLLASKLKGAAVKLADFGLA--IEVEGEQQAWFGFAGTPGYLSPEVLRKDP 189
Query: 247 VDEKTDVFAFGVFLLEIISGRKP 269
             +  D++A GV L  ++ G  P
Sbjct: 190 YGKPVDLWACGVILYILLVGYPP 212

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 62/260 (23%), Positives = 107/260 (41%), Gaps = 38/260 (14%)
Query: 24  NAAVSPNGFTEESLENVVVACESETTKP-------TWRCFSFEEI-SIATNAFSSENLVG 75
           NAA +  G  +ES++  +   + +  K        T     FE I ++ T +F    LV 
Sbjct: 2   NAAAAKKGSEQESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVK 61
Query: 76  RGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEF-LTEIGTIGHVCHPNVLSLLGCCV 134
                      ++ G   A+K L K      K+ E  L E   +  V  P ++ L     
Sbjct: 62  H----------METGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 111
Query: 135 DN-GLYLIFQFSSRGSVASLFHDVN---SPGVEWKVRHKIAVGTARGLHYLHKGCQRRII 190
           DN  LY++ +++  G + S    +     P   +      A        YLH      +I
Sbjct: 112 DNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARF-----YAAQIVLTFEYLH---SLDLI 163
Query: 191 HRDIKSSNILLTADFEPQISDFGLAKWLPSQ-WTHHSIAPIEGTFGHLAPEYFMHGIVDE 249
           +RD+K  N+++      +++DFG AK +  + W       + GT  +LAPE  +    ++
Sbjct: 164 YRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWX------LCGTPEYLAPEIILSKGYNK 217
Query: 250 KTDVFAFGVFLLEIISGRKP 269
             D +A GV + E+ +G  P
Sbjct: 218 AVDWWALGVLIYEMAAGYPP 237

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 32/101 (31%), Positives = 52/101 (51%), Gaps = 5/101 (4%)
Query: 176 RGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHS-IAPIEGTF 234
           RGL Y+H      ++HRD+K SN+L+    + +I DFGLA+    +  H   +     T 
Sbjct: 155 RGLKYIHSA---NVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATR 211
Query: 235 GHLAPEYFMHGIVDEKT-DVFAFGVFLLEIISGRKPVDGSH 274
            + APE  ++     K+ D+++ G  L E++S R    G H
Sbjct: 212 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 252

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 81/294 (27%), Positives = 118/294 (40%), Gaps = 45/294 (15%)
Query: 66  NAFSSENLVGRGGYAEV-YKGVLQDGEEIAVKRLTKVVTD-DRKEKEFLTEIGTIGHVCH 123
           N   SE ++G G    V ++G  Q G  +AVKR+     D    E + LTE        H
Sbjct: 33  NLVVSEKILGYGSSGTVVFQGSFQ-GRPVAVKRMLIDFCDIALMEIKLLTESDD-----H 86
Query: 124 PNVLSLLGC-CVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHK-----IAVGTARG 177
           PNV+        D  LY+  +  +  ++  L    N      K++ +     +    A G
Sbjct: 87  PNVIRYYCSETTDRFLYIALELCNL-NLQDLVESKNVSDENLKLQKEYNPISLLRQIASG 145
Query: 178 LHYLHKGCQRRIIHRDIKSSNILL------TAD-------FEPQISDFGLAKWLPSQWT- 223
           + +LH     +IIHRD+K  NIL+      TAD           ISDFGL K L S    
Sbjct: 146 VAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXX 202
Query: 224 -HHSIAPIEGTFGHLAPEYFMHGI---VDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLH 278
              ++    GT G  APE         +    D+F+ G     I+S G+ P    +    
Sbjct: 203 FRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRES 262
Query: 279 SWAKPILNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVL 332
           +  + I +  E++ L D  L    + T L       S  I   P  RPT  +VL
Sbjct: 263 NIIRGIFSLDEMKCLHDRSLIA--EATDL------ISQMIDHDPLKRPTAMKVL 308

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 81/294 (27%), Positives = 118/294 (40%), Gaps = 45/294 (15%)
Query: 66  NAFSSENLVGRGGYAEV-YKGVLQDGEEIAVKRLTKVVTD-DRKEKEFLTEIGTIGHVCH 123
           N   SE ++G G    V ++G  Q G  +AVKR+     D    E + LTE        H
Sbjct: 33  NLVVSEKILGYGSSGTVVFQGSFQ-GRPVAVKRMLIDFCDIALMEIKLLTESDD-----H 86
Query: 124 PNVLSLLGC-CVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHK-----IAVGTARG 177
           PNV+        D  LY+  +  +  ++  L    N      K++ +     +    A G
Sbjct: 87  PNVIRYYCSETTDRFLYIALELCNL-NLQDLVESKNVSDENLKLQKEYNPISLLRQIASG 145
Query: 178 LHYLHKGCQRRIIHRDIKSSNILL------TAD-------FEPQISDFGLAKWLPSQWT- 223
           + +LH     +IIHRD+K  NIL+      TAD           ISDFGL K L S    
Sbjct: 146 VAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXX 202
Query: 224 -HHSIAPIEGTFGHLAPEYFMHGI---VDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLH 278
              ++    GT G  APE         +    D+F+ G     I+S G+ P    +    
Sbjct: 203 FRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRES 262
Query: 279 SWAKPILNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVL 332
           +  + I +  E++ L D  L    + T L       S  I   P  RPT  +VL
Sbjct: 263 NIIRGIFSLDEMKCLHDRSLIA--EATDL------ISQMIDHDPLKRPTAMKVL 308

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 65/238 (27%), Positives = 106/238 (44%), Gaps = 20/238 (8%)
Query: 62  SIATNAFSSENLVGRGGYAEVY---KGVLQD-GEEIAVKRLTK--VVTDDRKEKEFLTEI 115
            +    F    ++G G Y +V+   K    D G+  A+K L K  +V   +  +   TE 
Sbjct: 50  KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTER 109
Query: 116 GTIGHVCHPNVLSLLGCC--VDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVG 173
             + H+     L  L      +  L+LI  + + G    LF  ++      +   +I VG
Sbjct: 110 QVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGE---LFTHLSQRERFTEHEVQIYVG 166
Query: 174 -TARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEG 232
                L +LHK     II+RDIK  NILL ++    ++DFGL+K   +  T  +     G
Sbjct: 167 EIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAY-DFCG 222
Query: 233 TFGHLAPEYFMHGIV--DEKTDVFAFGVFLLEIISGRKP--VDGSHQSLHSWAKPILN 286
           T  ++AP+    G    D+  D ++ GV + E+++G  P  VDG   S    ++ IL 
Sbjct: 223 TIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILK 280

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 51/101 (50%), Gaps = 5/101 (4%)
Query: 176 RGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHS-IAPIEGTF 234
           RGL Y+H      ++HRD+K SN+LL    + +I DFGLA+       H   +     T 
Sbjct: 139 RGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 195
Query: 235 GHLAPEYFMHGIVDEKT-DVFAFGVFLLEIISGRKPVDGSH 274
            + APE  ++     K+ D+++ G  L E++S R    G H
Sbjct: 196 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 236

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 51/101 (50%), Gaps = 5/101 (4%)
Query: 176 RGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHS-IAPIEGTF 234
           RGL Y+H      ++HRD+K SN+LL    + +I DFGLA+       H   +     T 
Sbjct: 139 RGLKYIHSA---NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATR 195
Query: 235 GHLAPEYFMHGIVDEKT-DVFAFGVFLLEIISGRKPVDGSH 274
            + APE  ++     K+ D+++ G  L E++S R    G H
Sbjct: 196 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 236

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 51/101 (50%), Gaps = 5/101 (4%)
Query: 176 RGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHS-IAPIEGTF 234
           RGL Y+H      ++HRD+K SN+LL    + +I DFGLA+       H   +     T 
Sbjct: 135 RGLKYIHSA---NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATR 191
Query: 235 GHLAPEYFMHGIVDEKT-DVFAFGVFLLEIISGRKPVDGSH 274
            + APE  ++     K+ D+++ G  L E++S R    G H
Sbjct: 192 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 232

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 60/253 (23%), Positives = 108/253 (42%), Gaps = 24/253 (9%)
Query: 24  NAAVSPNGFTEESLENVVVACESETTKPTWRCFSFEEISIATNAFSSENLVGRGGYAEVY 83
           NAA +  G  +ES++  +   + +  K  W   S  + +   + F     +G G +  V 
Sbjct: 3   NAAAAKKGSEQESVKEFLAKAKEDFLK-KWE--SPAQNTAHLDQFERIKTLGTGSFGRVM 59
Query: 84  KGVLQD-GEEIAVKRLTKVVTDDRKEKEF-LTEIGTIGHVCHPNVLSLLGCCVDN-GLYL 140
               ++ G   A+K L K      K+ E  L E   +  V  P ++ L     DN  LY+
Sbjct: 60  LVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM 119
Query: 141 IFQFSSRGSVASLFHDV---NSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSS 197
           + +++  G + S    +   + P   +      A        YLH      +I+RD+K  
Sbjct: 120 VMEYAPGGEMFSHLRRIGRFSEPHARF-----YAAQIVLTFEYLH---SLDLIYRDLKPE 171
Query: 198 NILLTADFEPQISDFGLAKWLPSQ-WTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAF 256
           N+++      +++DFG AK +  + W       + GT  +LAPE  +    ++  D +A 
Sbjct: 172 NLMIDQQGYIKVTDFGFAKRVKGRTWX------LCGTPEYLAPEIILSKGYNKAVDWWAL 225
Query: 257 GVFLLEIISGRKP 269
           GV + E+ +G  P
Sbjct: 226 GVLIYEMAAGYPP 238

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 51/101 (50%), Gaps = 5/101 (4%)
Query: 176 RGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHS-IAPIEGTF 234
           RGL Y+H      ++HRD+K SN+LL    + +I DFGLA+       H   +     T 
Sbjct: 143 RGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 199
Query: 235 GHLAPEYFMHGIVDEKT-DVFAFGVFLLEIISGRKPVDGSH 274
            + APE  ++     K+ D+++ G  L E++S R    G H
Sbjct: 200 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 240

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 51/101 (50%), Gaps = 5/101 (4%)
Query: 176 RGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHS-IAPIEGTF 234
           RGL Y+H      ++HRD+K SN+LL    + +I DFGLA+       H   +     T 
Sbjct: 135 RGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 191
Query: 235 GHLAPEYFMHGIVDEKT-DVFAFGVFLLEIISGRKPVDGSH 274
            + APE  ++     K+ D+++ G  L E++S R    G H
Sbjct: 192 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 232

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 96/218 (44%), Gaps = 32/218 (14%)
Query: 65  TNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCH 123
           T+ +  +  +G G Y+   + + +    E AVK + K   D  +E E L   G      H
Sbjct: 21  TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQ-----H 75
Query: 124 PNVLSLLGCCVDNG--LYLIFQFSSRGSV------ASLFHDVNSPGVEWKVRHKIAVGTA 175
           PN+++L     D+G  +Y++ +    G +         F +  +  V + +         
Sbjct: 76  PNIITLKDV-YDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTI--------T 126
Query: 176 RGLHYLHKGCQRRIIHRDIKSSNILLTADF-EPQ---ISDFGLAKWLPSQWTHHSIAPIE 231
           + + YLH    + ++HRD+K SNIL   +   P+   I DFG AK L ++     + P  
Sbjct: 127 KTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE-NGLLMTPCY 182
Query: 232 GTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKP 269
            T   +APE       D   D+++ GV L  +++G  P
Sbjct: 183 -TANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTP 219

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 96/207 (46%), Gaps = 18/207 (8%)
Query: 74  VGRGGYAEVYKGVLQDGEEIAVKRLT--KVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLG 131
           VG  G  +V K  L  G ++AVK L   K+ + D   K    EI  +    HP+++ L  
Sbjct: 26  VGTFGKVKVGKHELT-GHKVAVKILNRQKIRSLDVVGK-IRREIQNLKLFRHPHIIKLYQ 83
Query: 132 CC-VDNGLYLIFQFSSRGSVASLFHDVNSPG-VEWKVRHKIAVGTARGLHYLHKGCQRRI 189
                + ++++ ++ S G    LF  +   G ++ K   ++      G+ Y H+     +
Sbjct: 84  VISTPSDIFMVMEYVSGGE---LFDYICKNGRLDEKESRRLFQQILSGVDYCHR---HMV 137
Query: 190 IHRDIKSSNILLTADFEPQISDFGLAKWLPS-QWTHHSIAPIEGTFGHLAPEYFMHGI-V 247
           +HRD+K  N+LL A    +I+DFGL+  +   ++   S     G+  + APE     +  
Sbjct: 138 VHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRXSC----GSPNYAAPEVISGRLYA 193
Query: 248 DEKTDVFAFGVFLLEIISGRKPVDGSH 274
             + D+++ GV L  ++ G  P D  H
Sbjct: 194 GPEVDIWSSGVILYALLCGTLPFDDDH 220

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 93/218 (42%), Gaps = 32/218 (14%)
Query: 65  TNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCH 123
           T+ +  +  +G G Y+   + + +    E AVK + K   D  +E E L   G      H
Sbjct: 21  TDGYEVKEDIGVGSYSVCKRCIHKATNXEFAVKIIDKSKRDPTEEIEILLRYGQ-----H 75
Query: 124 PNVLSLLGCCVDNG--LYLIFQFSSRGSV------ASLFHDVNSPGVEWKVRHKIAVGTA 175
           PN+++L     D+G  +Y++ +    G +         F +  +  V + +         
Sbjct: 76  PNIITLKDV-YDDGKYVYVVTELXKGGELLDKILRQKFFSEREASAVLFTI--------T 126
Query: 176 RGLHYLHKGCQRRIIHRDIKSSNILLTADF-EPQ---ISDFGLAKWLPSQWTHHSIAPIE 231
           + + YLH    + ++HRD+K SNIL   +   P+   I DFG AK L ++          
Sbjct: 127 KTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLXTPCYT 183
Query: 232 GTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKP 269
             F  +APE       D   D+++ GV L   ++G  P
Sbjct: 184 ANF--VAPEVLERQGYDAACDIWSLGVLLYTXLTGYTP 219

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 51/101 (50%), Gaps = 5/101 (4%)
Query: 176 RGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHS-IAPIEGTF 234
           RGL Y+H      ++HRD+K SN+LL    + +I DFGLA+       H   +     T 
Sbjct: 137 RGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 193
Query: 235 GHLAPEYFMHGIVDEKT-DVFAFGVFLLEIISGRKPVDGSH 274
            + APE  ++     K+ D+++ G  L E++S R    G H
Sbjct: 194 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 234

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 51/101 (50%), Gaps = 5/101 (4%)
Query: 176 RGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHS-IAPIEGTF 234
           RGL Y+H      ++HRD+K SN+LL    + +I DFGLA+       H   +     T 
Sbjct: 137 RGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 193
Query: 235 GHLAPEYFMHGIVDEKT-DVFAFGVFLLEIISGRKPVDGSH 274
            + APE  ++     K+ D+++ G  L E++S R    G H
Sbjct: 194 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 234

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/260 (22%), Positives = 109/260 (41%), Gaps = 38/260 (14%)
Query: 24  NAAVSPNGFTEESLENVVVACESETTKP-------TWRCFSFEEI-SIATNAFSSENLVG 75
           NAA +  G  +ES++  +   + +  K        T     FE I ++ T +F    LV 
Sbjct: 3   NAAAAKKGXEQESVKEFLAKAKEDFLKKWESPAQNTAHLDQFERIRTLGTGSFGRVMLVK 62
Query: 76  RGGYAEVYKGVLQDGEEIA-VKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCV 134
                  Y   + D +++  +K++   + + R ++           V  P ++ L     
Sbjct: 63  HKETGNHYAMKILDKQKVVKLKQIEHTLNEKRIQQA----------VNFPFLVKLEFSFK 112
Query: 135 DN-GLYLIFQFSSRGSVASLFHDV---NSPGVEWKVRHKIAVGTARGLHYLHKGCQRRII 190
           DN  LY++ +++  G + S    +   + P   +      A        YLH      +I
Sbjct: 113 DNSNLYMVLEYAPGGEMFSHLRRIGRFSEPHARF-----YAAQIVLTFEYLH---SLDLI 164
Query: 191 HRDIKSSNILLTADFEPQISDFGLAKWLPSQ-WTHHSIAPIEGTFGHLAPEYFMHGIVDE 249
           +RD+K  N+L+      +++DFG AK +  + W       + GT  +LAPE  +    ++
Sbjct: 165 YRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWX------LCGTPEYLAPEIILSKGYNK 218
Query: 250 KTDVFAFGVFLLEIISGRKP 269
             D +A GV + E+ +G  P
Sbjct: 219 AVDWWALGVLIYEMAAGYPP 238

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 51/101 (50%), Gaps = 5/101 (4%)
Query: 176 RGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHS-IAPIEGTF 234
           RGL Y+H      ++HRD+K SN+LL    + +I DFGLA+       H   +     T 
Sbjct: 139 RGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 195
Query: 235 GHLAPEYFMHGIVDEKT-DVFAFGVFLLEIISGRKPVDGSH 274
            + APE  ++     K+ D+++ G  L E++S R    G H
Sbjct: 196 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 236

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 51/101 (50%), Gaps = 5/101 (4%)
Query: 176 RGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHS-IAPIEGTF 234
           RGL Y+H      ++HRD+K SN+LL    + +I DFGLA+       H   +     T 
Sbjct: 140 RGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 196
Query: 235 GHLAPEYFMHGIVDEKT-DVFAFGVFLLEIISGRKPVDGSH 274
            + APE  ++     K+ D+++ G  L E++S R    G H
Sbjct: 197 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 237

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 51/101 (50%), Gaps = 5/101 (4%)
Query: 176 RGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHS-IAPIEGTF 234
           RGL Y+H      ++HRD+K SN+LL    + +I DFGLA+       H   +     T 
Sbjct: 141 RGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 197
Query: 235 GHLAPEYFMHGIVDEKT-DVFAFGVFLLEIISGRKPVDGSH 274
            + APE  ++     K+ D+++ G  L E++S R    G H
Sbjct: 198 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 238

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 51/101 (50%), Gaps = 5/101 (4%)
Query: 176 RGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHS-IAPIEGTF 234
           RGL Y+H      ++HRD+K SN+LL    + +I DFGLA+       H   +     T 
Sbjct: 132 RGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 188
Query: 235 GHLAPEYFMHGIVDEKT-DVFAFGVFLLEIISGRKPVDGSH 274
            + APE  ++     K+ D+++ G  L E++S R    G H
Sbjct: 189 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 229

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 51/101 (50%), Gaps = 5/101 (4%)
Query: 176 RGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHS-IAPIEGTF 234
           RGL Y+H      ++HRD+K SN+LL    + +I DFGLA+       H   +     T 
Sbjct: 139 RGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 195
Query: 235 GHLAPEYFMHGIVDEKT-DVFAFGVFLLEIISGRKPVDGSH 274
            + APE  ++     K+ D+++ G  L E++S R    G H
Sbjct: 196 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 236

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 51/101 (50%), Gaps = 5/101 (4%)
Query: 176 RGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHS-IAPIEGTF 234
           RGL Y+H      ++HRD+K SN+LL    + +I DFGLA+       H   +     T 
Sbjct: 135 RGLKYIHSA---NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATR 191
Query: 235 GHLAPEYFMHGIVDEKT-DVFAFGVFLLEIISGRKPVDGSH 274
            + APE  ++     K+ D+++ G  L E++S R    G H
Sbjct: 192 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 232

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 51/101 (50%), Gaps = 5/101 (4%)
Query: 176 RGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHS-IAPIEGTF 234
           RGL Y+H      ++HRD+K SN+LL    + +I DFGLA+       H   +     T 
Sbjct: 133 RGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 189
Query: 235 GHLAPEYFMHGIVDEKT-DVFAFGVFLLEIISGRKPVDGSH 274
            + APE  ++     K+ D+++ G  L E++S R    G H
Sbjct: 190 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 230

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 51/101 (50%), Gaps = 5/101 (4%)
Query: 176 RGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHS-IAPIEGTF 234
           RGL Y+H      ++HRD+K SN+LL    + +I DFGLA+       H   +     T 
Sbjct: 133 RGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 189
Query: 235 GHLAPEYFMHGIVDEKT-DVFAFGVFLLEIISGRKPVDGSH 274
            + APE  ++     K+ D+++ G  L E++S R    G H
Sbjct: 190 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 230

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 51/101 (50%), Gaps = 5/101 (4%)
Query: 176 RGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHS-IAPIEGTF 234
           RGL Y+H      ++HRD+K SN+LL    + +I DFGLA+       H   +     T 
Sbjct: 135 RGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 191
Query: 235 GHLAPEYFMHGIVDEKT-DVFAFGVFLLEIISGRKPVDGSH 274
            + APE  ++     K+ D+++ G  L E++S R    G H
Sbjct: 192 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 232

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 51/101 (50%), Gaps = 5/101 (4%)
Query: 176 RGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHS-IAPIEGTF 234
           RGL Y+H      ++HRD+K SN+LL    + +I DFGLA+       H   +     T 
Sbjct: 139 RGLKYIHSA---NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATR 195
Query: 235 GHLAPEYFMHGIVDEKT-DVFAFGVFLLEIISGRKPVDGSH 274
            + APE  ++     K+ D+++ G  L E++S R    G H
Sbjct: 196 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 236

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 51/101 (50%), Gaps = 5/101 (4%)
Query: 176 RGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHS-IAPIEGTF 234
           RGL Y+H      ++HRD+K SN+LL    + +I DFGLA+       H   +     T 
Sbjct: 135 RGLKYIHSA---NVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATR 191
Query: 235 GHLAPEYFMHGIVDEKT-DVFAFGVFLLEIISGRKPVDGSH 274
            + APE  ++     K+ D+++ G  L E++S R    G H
Sbjct: 192 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 232

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/189 (26%), Positives = 83/189 (43%), Gaps = 20/189 (10%)
Query: 87  LQDGEEIAVKRLTKVVTDDRKEKEF-LTEIGTIGHVCHPNVLSLLGCCVDN-GLYLIFQF 144
           ++ G   A+K L K      K+ E  L E   +  V  P ++ L     DN  LY++ ++
Sbjct: 49  METGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 108
Query: 145 SSRGSVASLFHDV---NSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILL 201
              G + S    +   + P   +      A        YLH      +I+RD+K  N+L+
Sbjct: 109 VPGGEMFSHLRRIGRFSEPHARF-----YAAQIVLTFEYLH---SLDLIYRDLKPENLLI 160
Query: 202 TADFEPQISDFGLAKWLPSQ-WTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFL 260
                 Q++DFG AK +  + WT      + GT  +LAPE  +    ++  D +A GV +
Sbjct: 161 DQQGYIQVTDFGFAKRVKGRTWT------LCGTPEYLAPEIILSKGYNKAVDWWALGVLI 214
Query: 261 LEIISGRKP 269
            E+ +G  P
Sbjct: 215 YEMAAGYPP 223

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 51/101 (50%), Gaps = 5/101 (4%)
Query: 176 RGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHS-IAPIEGTF 234
           RGL Y+H      ++HRD+K SN+LL    + +I DFGLA+       H   +     T 
Sbjct: 155 RGLKYIHSA---NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATR 211
Query: 235 GHLAPEYFMHGIVDEKT-DVFAFGVFLLEIISGRKPVDGSH 274
            + APE  ++     K+ D+++ G  L E++S R    G H
Sbjct: 212 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 252

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 51/101 (50%), Gaps = 5/101 (4%)
Query: 176 RGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHS-IAPIEGTF 234
           RGL Y+H      ++HRD+K SN+LL    + +I DFGLA+       H   +     T 
Sbjct: 155 RGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 211
Query: 235 GHLAPEYFMHGIVDEKT-DVFAFGVFLLEIISGRKPVDGSH 274
            + APE  ++     K+ D+++ G  L E++S R    G H
Sbjct: 212 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 252

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 51/101 (50%), Gaps = 5/101 (4%)
Query: 176 RGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHS-IAPIEGTF 234
           RGL Y+H      ++HRD+K SN+LL    + +I DFGLA+       H   +     T 
Sbjct: 139 RGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATR 195
Query: 235 GHLAPEYFMHGIVDEKT-DVFAFGVFLLEIISGRKPVDGSH 274
            + APE  ++     K+ D+++ G  L E++S R    G H
Sbjct: 196 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 236

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 51/101 (50%), Gaps = 5/101 (4%)
Query: 176 RGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHS-IAPIEGTF 234
           RGL Y+H      ++HRD+K SN+LL    + +I DFGLA+       H   +     T 
Sbjct: 140 RGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATR 196
Query: 235 GHLAPEYFMHGIVDEKT-DVFAFGVFLLEIISGRKPVDGSH 274
            + APE  ++     K+ D+++ G  L E++S R    G H
Sbjct: 197 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 237

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 62/260 (23%), Positives = 107/260 (41%), Gaps = 38/260 (14%)
Query: 24  NAAVSPNGFTEESLENVVVACESETTKP-------TWRCFSFEEI-SIATNAFSSENLVG 75
           NAA +  G  +ES++  +   + +  K        T     FE I ++ T +F    LV 
Sbjct: 3   NAAAAKKGSEQESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVK 62
Query: 76  RGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEF-LTEIGTIGHVCHPNVLSLLGCCV 134
                      ++ G   A+K L K      K+ E  L E   +  V  P +  L     
Sbjct: 63  H----------METGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLEFSFK 112
Query: 135 DN-GLYLIFQFSSRGSVASLFHDV---NSPGVEWKVRHKIAVGTARGLHYLHKGCQRRII 190
           DN  LY++ +++  G + S    +   + P   +      A        YLH      +I
Sbjct: 113 DNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-----YAAQIVLTFEYLH---SLDLI 164
Query: 191 HRDIKSSNILLTADFEPQISDFGLAKWLPSQ-WTHHSIAPIEGTFGHLAPEYFMHGIVDE 249
           +RD+K  N+++      +++DFG AK +  + W       + GT  +LAPE  +    ++
Sbjct: 165 YRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWX------LCGTPEYLAPEIILSKGYNK 218
Query: 250 KTDVFAFGVFLLEIISGRKP 269
             D +A GV + E+ +G  P
Sbjct: 219 AVDWWALGVLIYEMAAGYPP 238

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 51/101 (50%), Gaps = 5/101 (4%)
Query: 176 RGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHS-IAPIEGTF 234
           RGL Y+H      ++HRD+K SN+LL    + +I DFGLA+       H   +     T 
Sbjct: 137 RGLKYIHSA---NVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATR 193
Query: 235 GHLAPEYFMHGIVDEKT-DVFAFGVFLLEIISGRKPVDGSH 274
            + APE  ++     K+ D+++ G  L E++S R    G H
Sbjct: 194 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 234

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 74/166 (44%), Gaps = 16/166 (9%)
Query: 112 LTEIGTIGHVC-HPNVLSLLGCCVDNGLY-LIFQFSSRGSVASLFHDVNSPGVEWKVRHK 169
           L E+  +  V  HPN++ L      N  + L+F    +G +     +  +  +  K   K
Sbjct: 71  LKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT--LSEKETRK 128
Query: 170 IAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAP 229
           I       +  LHK     I+HRD+K  NILL  D   +++DFG +  L       S+  
Sbjct: 129 IMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRSVC- 184
Query: 230 IEGTFGHLAPEYFMHGIVD------EKTDVFAFGVFLLEIISGRKP 269
             GT  +LAPE     + D      ++ D+++ GV +  +++G  P
Sbjct: 185 --GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 62/260 (23%), Positives = 106/260 (40%), Gaps = 38/260 (14%)
Query: 24  NAAVSPNGFTEESLENVVVACESETTKP-------TWRCFSFEEI-SIATNAFSSENLVG 75
           NAA +  G  +ES++  +   + +  K        T     FE I ++ T +F    LV 
Sbjct: 3   NAAAAKKGSEQESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVK 62
Query: 76  RGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEF-LTEIGTIGHVCHPNVLSLLGCCV 134
                      ++ G   A+K L K      K+ E  L E   +  V  P +  L     
Sbjct: 63  H----------METGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLEFSFK 112
Query: 135 DN-GLYLIFQFSSRGSVASLFHDVN---SPGVEWKVRHKIAVGTARGLHYLHKGCQRRII 190
           DN  LY++ +++  G + S    +     P   +      A        YLH      +I
Sbjct: 113 DNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARF-----YAAQIVLTFEYLH---SLDLI 164
Query: 191 HRDIKSSNILLTADFEPQISDFGLAKWLPSQ-WTHHSIAPIEGTFGHLAPEYFMHGIVDE 249
           +RD+K  N+++      +++DFG AK +  + W       + GT  +LAPE  +    ++
Sbjct: 165 YRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWX------LCGTPEYLAPEIILSKGYNK 218
Query: 250 KTDVFAFGVFLLEIISGRKP 269
             D +A GV + E+ +G  P
Sbjct: 219 AVDWWALGVLIYEMAAGYPP 238

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 50/217 (23%), Positives = 93/217 (42%), Gaps = 14/217 (6%)
Query: 60  EISIATNAFSSENLVGRGGYAEVYKGVLQDGEEI-AVKRLTKVVTDDRKEKEFL-TEIGT 117
           ++ +    +    ++GRG + EV     +   ++ A+K L+K     R +  F   E   
Sbjct: 63  DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDI 122
Query: 118 IGHVCHPNVLSLLGCCVDNG-LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTAR 176
           +     P V+ L     D+  LY++ ++   G + +L  + + P  +W   +   V  A 
Sbjct: 123 MAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPE-KWARFYTAEVVLA- 180
Query: 177 GLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGH 236
            L  +H       IHRD+K  N+LL      +++DFG    +  +        + GT  +
Sbjct: 181 -LDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDY 235
Query: 237 LAPEYFM----HGIVDEKTDVFAFGVFLLEIISGRKP 269
           ++PE        G    + D ++ GVFL E++ G  P
Sbjct: 236 ISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 50/217 (23%), Positives = 93/217 (42%), Gaps = 14/217 (6%)
Query: 60  EISIATNAFSSENLVGRGGYAEVYKGVLQDGEEI-AVKRLTKVVTDDRKEKEFL-TEIGT 117
           ++ +    +    ++GRG + EV     +   ++ A+K L+K     R +  F   E   
Sbjct: 68  DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDI 127
Query: 118 IGHVCHPNVLSLLGCCVDNG-LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTAR 176
           +     P V+ L     D+  LY++ ++   G + +L  + + P  +W   +   V  A 
Sbjct: 128 MAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPE-KWARFYTAEVVLA- 185
Query: 177 GLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGH 236
            L  +H       IHRD+K  N+LL      +++DFG    +  +        + GT  +
Sbjct: 186 -LDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDY 240
Query: 237 LAPEYFM----HGIVDEKTDVFAFGVFLLEIISGRKP 269
           ++PE        G    + D ++ GVFL E++ G  P
Sbjct: 241 ISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 277

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 44/167 (26%), Positives = 76/167 (45%), Gaps = 18/167 (10%)
Query: 112 LTEIGTIGHVC-HPNVLSLLGCCVDNGLY-LIFQFSSRGSVASLFHDVNSPGVEWKVRHK 169
           L E+  +  V  HPN++ L      N  + L+F    +G +     +  +  +  K   K
Sbjct: 58  LKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT--LSEKETRK 115
Query: 170 IAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWL-PSQWTHHSIA 228
           I       +  LHK     I+HRD+K  NILL  D   +++DFG +  L P +     + 
Sbjct: 116 IMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE----KLR 168
Query: 229 PIEGTFGHLAPEYFMHGIVD------EKTDVFAFGVFLLEIISGRKP 269
            + GT  +LAPE     + D      ++ D+++ GV +  +++G  P
Sbjct: 169 EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 215

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 50/217 (23%), Positives = 93/217 (42%), Gaps = 14/217 (6%)
Query: 60  EISIATNAFSSENLVGRGGYAEVYKGVLQDGEEI-AVKRLTKVVTDDRKEKEFL-TEIGT 117
           ++ +    +    ++GRG + EV     +   ++ A+K L+K     R +  F   E   
Sbjct: 68  DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDI 127
Query: 118 IGHVCHPNVLSLLGCCVDNG-LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTAR 176
           +     P V+ L     D+  LY++ ++   G + +L  + + P  +W   +   V  A 
Sbjct: 128 MAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPE-KWARFYTAEVVLA- 185
Query: 177 GLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGH 236
            L  +H       IHRD+K  N+LL      +++DFG    +  +        + GT  +
Sbjct: 186 -LDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDY 240
Query: 237 LAPEYFM----HGIVDEKTDVFAFGVFLLEIISGRKP 269
           ++PE        G    + D ++ GVFL E++ G  P
Sbjct: 241 ISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 277

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 43/169 (25%), Positives = 78/169 (46%), Gaps = 17/169 (10%)
Query: 68  FSSENLVGRGGYAEVYKGVLQDGEE-IAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNV 126
           +  ++L+GRG Y  VY    ++  + +A+K++ ++  D    K  L EI  +  +    +
Sbjct: 30  YEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYI 89
Query: 127 LSLLGCCVD------NGLYLIFQFSSRGSVASLFHDVNSP--GVEWKVRHKIAVGTARGL 178
           + L    +       + LY++ + +    +  LF    +P    E  V+  I      G 
Sbjct: 90  IRLHDLIIPEDLLKFDELYIVLEIAD-SDLKKLF---KTPIFLTEQHVK-TILYNLLLGE 144
Query: 179 HYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSI 227
            ++H+     IIHRD+K +N LL  D   +I DFGLA+ + S    H +
Sbjct: 145 KFIHESG---IIHRDLKPANCLLNQDCSVKICDFGLARTINSDKDIHIV 190

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 41/155 (26%), Positives = 71/155 (45%), Gaps = 17/155 (10%)
Query: 123 HPNVLSLLGCCVDNGLY-LIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYL 181
           HPN++ L      N  + L+F    +G +     +  +  +  K   KI       +  L
Sbjct: 83  HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT--LSEKETRKIMRALLEVICAL 140
Query: 182 HKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWL-PSQWTHHSIAPIEGTFGHLAPE 240
           HK     I+HRD+K  NILL  D   +++DFG +  L P +     +  + GT  +LAPE
Sbjct: 141 HK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE----KLREVCGTPSYLAPE 193
Query: 241 YFMHGIVD------EKTDVFAFGVFLLEIISGRKP 269
                + D      ++ D+++ GV +  +++G  P
Sbjct: 194 IIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 69/275 (25%), Positives = 115/275 (41%), Gaps = 39/275 (14%)
Query: 16  KRRSFDGDNAA--VSPNGFTEESLENVVVACESETTKPTWRCFSFEEISI----ATNAFS 69
           +RR +D D     V   G    + +N V           W+ +  + + I      + + 
Sbjct: 109 RRRGYDVDEQGKIVRGKGTVSSNYDNYVFDI--------WKQYYPQPVEIKHDHVLDHYD 160
Query: 70  SENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFL-TEIGTIGHVCHPNVL 127
               +G G +  V++   +  G   A K    V+T    +KE +  EI T+  + HP ++
Sbjct: 161 IHEELGTGAFGVVHRVTERATGNNFAAKF---VMTPHESDKETVRKEIQTMSVLRHPTLV 217
Query: 128 SLLGCCVD-NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTAR----GLHYLH 182
           +L     D N + +I++F S G +     D ++     K+    AV   R    GL ++H
Sbjct: 218 NLHDAFEDDNEMVMIYEFMSGGELFEKVADEHN-----KMSEDEAVEYMRQVCKGLCHMH 272
Query: 183 KGCQRRIIHRDIKSSNILLTA--DFEPQISDFGLAKWL-PSQWTHHSIAPIEGTFGHLAP 239
              +   +H D+K  NI+ T     E ++ DFGL   L P Q    S+    GT    AP
Sbjct: 273 ---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ----SVKVTTGTAEFAAP 325
Query: 240 EYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSH 274
           E      V   TD+++ GV    ++SG  P  G +
Sbjct: 326 EVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN 360

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 69/275 (25%), Positives = 115/275 (41%), Gaps = 39/275 (14%)
Query: 16  KRRSFDGDNAA--VSPNGFTEESLENVVVACESETTKPTWRCFSFEEISI----ATNAFS 69
           +RR +D D     V   G    + +N V           W+ +  + + I      + + 
Sbjct: 3   RRRGYDVDEQGKIVRGKGTVSSNYDNYVFDI--------WKQYYPQPVEIKHDHVLDHYD 54
Query: 70  SENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFL-TEIGTIGHVCHPNVL 127
               +G G +  V++   +  G   A K    V+T    +KE +  EI T+  + HP ++
Sbjct: 55  IHEELGTGAFGVVHRVTERATGNNFAAKF---VMTPHESDKETVRKEIQTMSVLRHPTLV 111
Query: 128 SLLGCCVD-NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTAR----GLHYLH 182
           +L     D N + +I++F S G +     D ++     K+    AV   R    GL ++H
Sbjct: 112 NLHDAFEDDNEMVMIYEFMSGGELFEKVADEHN-----KMSEDEAVEYMRQVCKGLCHMH 166
Query: 183 KGCQRRIIHRDIKSSNILLTADF--EPQISDFGLAKWL-PSQWTHHSIAPIEGTFGHLAP 239
              +   +H D+K  NI+ T     E ++ DFGL   L P Q    S+    GT    AP
Sbjct: 167 ---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ----SVKVTTGTAEFAAP 219
Query: 240 EYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSH 274
           E      V   TD+++ GV    ++SG  P  G +
Sbjct: 220 EVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN 254

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 29/92 (31%), Positives = 46/92 (50%), Gaps = 5/92 (5%)
Query: 189 IIHRDIKSSNILLTA---DFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHG 245
           ++HRD+K  N+L T    + E +I DFG A+  P    +  +     T  + APE     
Sbjct: 127 VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD--NQPLKTPCFTLHYAAPELLNQN 184
Query: 246 IVDEKTDVFAFGVFLLEIISGRKPVDGSHQSL 277
             DE  D+++ GV L  ++SG+ P     +SL
Sbjct: 185 GYDESCDLWSLGVILYTMLSGQVPFQSHDRSL 216

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 99/224 (44%), Gaps = 24/224 (10%)
Query: 64  ATNAF---SSENLVGRGGYAEVYKGVLQDGEEIA--VKRLTKVV-TDDRKEKEFL-TEIG 116
           A N+F   S   ++G G + +V+K      EE A  +K   K++ T   K+KE +  EI 
Sbjct: 84  AVNSFYTVSKTEILGGGRFGQVHKC-----EETATGLKLAAKIIKTRGMKDKEEVKNEIS 138
Query: 117 TIGHVCHPNVLSLLGCC-VDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTA 175
            +  + H N++ L       N + L+ ++   G +     D +    E      +     
Sbjct: 139 VMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMK-QIC 197
Query: 176 RGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQIS--DFGLAK-WLPSQWTHHSIAPIEG 232
            G+ ++H   Q  I+H D+K  NIL       QI   DFGLA+ + P +    +     G
Sbjct: 198 EGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNF----G 250
Query: 233 TFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQS 276
           T   LAPE   +  V   TD+++ GV    ++SG  P  G + +
Sbjct: 251 TPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA 294

>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 81/195 (41%), Gaps = 15/195 (7%)
Query: 81  EVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNGL-- 138
           E++KG  Q G +I VK L       RK ++F  E   +    HPNVL +LG C       
Sbjct: 25  ELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPH 83
Query: 139 -YLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSS 197
             LI  +   GS+ ++ H+  +  V+     K A+  ARG  +LH   +  I    + S 
Sbjct: 84  PTLITHWXPYGSLYNVLHEGTNFVVDQSQAVKFALDXARGXAFLHT-LEPLIPRHALNSR 142
Query: 198 NILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVD---EKTDVF 254
           ++ +  D   +IS   +      Q      AP       +APE       D      D +
Sbjct: 143 SVXIDEDXTARISXADVK--FSFQSPGRXYAP-----AWVAPEALQKKPEDTNRRSADXW 195
Query: 255 AFGVFLLEIISGRKP 269
           +F V L E+++   P
Sbjct: 196 SFAVLLWELVTREVP 210

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 41/171 (23%), Positives = 78/171 (45%), Gaps = 15/171 (8%)
Query: 68  FSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNV 126
           +   +L+G G Y  V +   + +   +A+K++ +V  D    K  L EI  +  + H +V
Sbjct: 55  YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHV 114
Query: 127 LSLLGCCVD------NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHK-IAVGTARGLH 179
           + +L   +       + LY++ + +       LF    +P    ++  K +      G+ 
Sbjct: 115 VKVLDIVIPKDVEKFDELYVVLEIAD-SDFKKLF---RTPVYLTELHIKTLLYNLLVGVK 170
Query: 180 YLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPI 230
           Y+H      I+HRD+K +N L+  D   ++ DFGLA+ +      +S  PI
Sbjct: 171 YVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPI 218

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 30/90 (33%), Positives = 43/90 (47%), Gaps = 7/90 (7%)
Query: 191 HRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHL---APEYFMHGIV 247
           HRD+K  NIL++AD    + DFG+A    S  T   +  +  T G L   APE F     
Sbjct: 157 HRDVKPENILVSADDFAYLVDFGIA----SATTDEKLTQLGNTVGTLYYXAPERFSESHA 212
Query: 248 DEKTDVFAFGVFLLEIISGRKPVDGSHQSL 277
             + D++A    L E ++G  P  G   S+
Sbjct: 213 TYRADIYALTCVLYECLTGSPPYQGDQLSV 242

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 81/298 (27%), Positives = 119/298 (39%), Gaps = 49/298 (16%)
Query: 66  NAFSSENLVGRGGYAEV-YKGVLQDGEEIAVKRLTKVVTD-DRKEKEFLTEIGTIGHVCH 123
           N   SE ++G G    V ++G  Q G  +AVKR+     D    E + LTE        H
Sbjct: 15  NLVVSEKILGYGSSGTVVFQGSFQ-GRPVAVKRMLIDFCDIALMEIKLLTESDD-----H 68
Query: 124 PNVLSLLGC-CVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHK-----IAVGTARG 177
           PNV+        D  LY+  +  +  ++  L    N      K++ +     +    A G
Sbjct: 69  PNVIRYYCSETTDRFLYIALELCNL-NLQDLVESKNVSDENLKLQKEYNPISLLRQIASG 127
Query: 178 LHYLHKGCQRRIIHRDIKSSNILL------TAD-------FEPQISDFGLAKWLPSQWT- 223
           + +LH     +IIHRD+K  NIL+      TAD           ISDFGL K L S  + 
Sbjct: 128 VAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSS 184
Query: 224 -HHSIAPIEGTFGHLAPEYFMHG-------IVDEKTDVFAFGVFLLEIIS-GRKPVDGSH 274
              ++    GT G  APE             +    D+F+ G     I+S G+ P    +
Sbjct: 185 FRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKY 244
Query: 275 QSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVL 332
               +  + I +  E++ L D  L    + T L       S  I   P  RPT  +VL
Sbjct: 245 SRESNIIRGIFSLDEMKCLHDRSLIA--EATDL------ISQMIDHDPLKRPTAMKVL 294

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 54/224 (24%), Positives = 91/224 (40%), Gaps = 23/224 (10%)
Query: 59  EEISIATNAFSSENLVGRGGYAEVYKGVLQDGEEI-AVKRLTKVVTDDRKEKEFLTEIGT 117
           +E+ +    F    ++GRG + EV    +++ E I A+K L K     R E     E   
Sbjct: 67  KEMQLHREDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERD 126
Query: 118 IGHVCHPNVLSLLGCCV--DNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKI----- 170
           +        ++ L      +N LYL+  +   G + +L         E   R  I     
Sbjct: 127 VLVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVL 186
Query: 171 AVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPI 230
           A+ +   LHY         +HRDIK  N+LL  +   +++DFG    +    T  S   +
Sbjct: 187 AIDSIHQLHY---------VHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAV 237
Query: 231 EGTFGHLAPEYFM-----HGIVDEKTDVFAFGVFLLEIISGRKP 269
            GT  +++PE         G    + D ++ GV + E++ G  P
Sbjct: 238 -GTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 280

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 81/298 (27%), Positives = 118/298 (39%), Gaps = 49/298 (16%)
Query: 66  NAFSSENLVGRGGYAEV-YKGVLQDGEEIAVKRLTKVVTD-DRKEKEFLTEIGTIGHVCH 123
           N   SE ++G G    V ++G  Q G  +AVKR+     D    E + LTE        H
Sbjct: 15  NLVVSEKILGYGSSGTVVFQGSFQ-GRPVAVKRMLIDFCDIALMEIKLLTESDD-----H 68
Query: 124 PNVLSLLGC-CVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHK-----IAVGTARG 177
           PNV+        D  LY+  +  +  ++  L    N      K++ +     +    A G
Sbjct: 69  PNVIRYYCSETTDRFLYIALELCNL-NLQDLVESKNVSDENLKLQKEYNPISLLRQIASG 127
Query: 178 LHYLHKGCQRRIIHRDIKSSNILL------TAD-------FEPQISDFGLAKWLPSQWT- 223
           + +LH     +IIHRD+K  NIL+      TAD           ISDFGL K L S    
Sbjct: 128 VAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXX 184
Query: 224 -HHSIAPIEGTFGHLAPEYFMHG-------IVDEKTDVFAFGVFLLEIIS-GRKPVDGSH 274
              ++    GT G  APE             +    D+F+ G     I+S G+ P    +
Sbjct: 185 FRXNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKY 244
Query: 275 QSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVL 332
               +  + I +  E++ L D  L    + T L       S  I   P  RPT  +VL
Sbjct: 245 SRESNIIRGIFSLDEMKCLHDRSLIA--EATDL------ISQMIDHDPLKRPTAMKVL 294

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 49/188 (26%), Positives = 82/188 (43%), Gaps = 20/188 (10%)
Query: 88  QDGEEIAVKRLTKVVTDDRKEKEF-LTEIGTIGHVCHPNVLSLLGCCVDN-GLYLIFQFS 145
           + G   A+K L K      K+ E  L E   +  V  P ++ L     DN  LY++ ++ 
Sbjct: 51  ESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYV 110
Query: 146 SRGSVASLFHDV---NSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLT 202
           + G + S    +   + P   +      A        YLH      +I+RD+K  N+L+ 
Sbjct: 111 AGGEMFSHLRRIGRFSEPHARF-----YAAQIVLTFEYLH---SLDLIYRDLKPENLLID 162
Query: 203 ADFEPQISDFGLAKWLPSQ-WTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLL 261
                Q++DFG AK +  + W       + GT  +LAPE  +    ++  D +A GV + 
Sbjct: 163 EQGYIQVTDFGFAKRVKGRTWX------LCGTPEYLAPEIILSKGYNKAVDWWALGVLIY 216
Query: 262 EIISGRKP 269
           E+ +G  P
Sbjct: 217 EMAAGYPP 224

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 89/218 (40%), Gaps = 38/218 (17%)
Query: 62  SIATNAFSSENLVGRGGYAEVYK-GVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGH 120
           S    +F   + +G G Y EV+K    +DG   AVKR        +     L E+G+   
Sbjct: 53  SFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEK 112
Query: 121 VC-HPNVLSLLGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVG------ 173
           V  HP       CCV      + Q    G +  L  ++  P ++   +H  A G      
Sbjct: 113 VGQHP-------CCVR-----LEQAWEEGGILYLQTELCGPSLQ---QHCEAWGASLPEA 157
Query: 174 --------TARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHH 225
                   T   L +LH    + ++H D+K +NI L      ++ DFGL   L    T  
Sbjct: 158 QVWGYLRDTLLALAHLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVEL---GTAG 211
Query: 226 SIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEI 263
           +    EG   ++APE  + G      DVF+ G+ +LE+
Sbjct: 212 AGEVQEGDPRYMAPE-LLQGSYGTAADVFSLGLTILEV 248

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 54/224 (24%), Positives = 91/224 (40%), Gaps = 23/224 (10%)
Query: 59  EEISIATNAFSSENLVGRGGYAEVYKGVLQDGEEI-AVKRLTKVVTDDRKEKEFLTEIGT 117
           +E+ +    F    ++GRG + EV    +++ E I A+K L K     R E     E   
Sbjct: 83  KEMQLHREDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERD 142
Query: 118 IGHVCHPNVLSLLGCCV--DNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKI----- 170
           +        ++ L      +N LYL+  +   G + +L         E   R  I     
Sbjct: 143 VLVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVL 202
Query: 171 AVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPI 230
           A+ +   LHY         +HRDIK  N+LL  +   +++DFG    +    T  S   +
Sbjct: 203 AIDSIHQLHY---------VHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAV 253
Query: 231 EGTFGHLAPEYFM-----HGIVDEKTDVFAFGVFLLEIISGRKP 269
            GT  +++PE         G    + D ++ GV + E++ G  P
Sbjct: 254 -GTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 296

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/188 (26%), Positives = 81/188 (43%), Gaps = 20/188 (10%)
Query: 88  QDGEEIAVKRLTKVVTDDRKEKEF-LTEIGTIGHVCHPNVLSLLGCCVDN-GLYLIFQFS 145
           + G   A+K L K      K+ E  L E   +  V  P ++ L     DN  LY++ ++ 
Sbjct: 59  ESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYV 118
Query: 146 SRGSVASLFHDVN---SPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLT 202
           + G + S    +     P   +      A        YLH      +I+RD+K  N+L+ 
Sbjct: 119 AGGEMFSHLRRIGRFXEPHARF-----YAAQIVLTFEYLH---SLDLIYRDLKPENLLID 170
Query: 203 ADFEPQISDFGLAKWLPSQ-WTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLL 261
                Q++DFG AK +  + W       + GT  +LAPE  +    ++  D +A GV + 
Sbjct: 171 QQGYIQVTDFGFAKRVKGRTWX------LCGTPEYLAPEIILSKGYNKAVDWWALGVLIY 224
Query: 262 EIISGRKP 269
           E+ +G  P
Sbjct: 225 EMAAGYPP 232

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 90/204 (44%), Gaps = 20/204 (9%)
Query: 73  LVGRGGYAEVY--KGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLL 130
           ++G G ++EV+  K  L  G+  A+K + K  +   ++     EI  +  + H N+++L 
Sbjct: 16  VLGSGAFSEVFLVKQRLT-GKLFALKCIKK--SPAFRDSSLENEIAVLKKIKHENIVTLE 72
Query: 131 GCCVDNG-LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTA-RGLHYLHKGCQRR 188
                    YL+ Q  S G    LF  +   GV  +    + +      + YLH   +  
Sbjct: 73  DIYESTTHYYLVMQLVSGGE---LFDRILERGVYTEKDASLVIQQVLSAVKYLH---ENG 126
Query: 189 IIHRDIKSSNILLTADFEP---QISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHG 245
           I+HRD+K  N+L     E     I+DFGL+K       +  ++   GT G++APE     
Sbjct: 127 IVHRDLKPENLLYLTPEENSKIMITDFGLSK----MEQNGIMSTACGTPGYVAPEVLAQK 182
Query: 246 IVDEKTDVFAFGVFLLEIISGRKP 269
              +  D ++ GV    ++ G  P
Sbjct: 183 PYSKAVDCWSIGVITYILLCGYPP 206

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/188 (26%), Positives = 81/188 (43%), Gaps = 20/188 (10%)
Query: 88  QDGEEIAVKRLTKVVTDDRKEKEF-LTEIGTIGHVCHPNVLSLLGCCVDN-GLYLIFQFS 145
           + G   A+K L K      K+ E  L E   +  V  P ++ L     DN  LY++ ++ 
Sbjct: 57  ETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYV 116
Query: 146 SRGSVASLFHDV---NSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLT 202
             G + S    +   + P   +      A        YLH      +I+RD+K  N+L+ 
Sbjct: 117 PGGEMFSHLRRIGRFSEPHARF-----YAAQIVLTFEYLH---SLDLIYRDLKPENLLID 168
Query: 203 ADFEPQISDFGLAKWLPSQ-WTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLL 261
                Q++DFG AK +  + W       + GT  +LAPE  +    ++  D +A GV + 
Sbjct: 169 QQGYIQVTDFGFAKRVKGRTWX------LCGTPEYLAPEIILSKGYNKAVDWWALGVLIY 222
Query: 262 EIISGRKP 269
           E+ +G  P
Sbjct: 223 EMAAGYPP 230

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/238 (23%), Positives = 101/238 (42%), Gaps = 51/238 (21%)
Query: 58  FEEISIATNAFSSENLVGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIG 116
           FEEI++          +G+G + +V K     D    A+K   K+   + K    L+E+ 
Sbjct: 8   FEEIAV----------LGQGAFGQVVKARNALDSRYYAIK---KIRHTEEKLSTILSEVM 54
Query: 117 TIGHVCHPNVLSLLGCCVD--------------NGLYLIFQFSSRGSVASLFH--DVNSP 160
            +  + H  V+      ++              + L++  ++   G++  L H  ++N  
Sbjct: 55  LLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQ 114
Query: 161 GVE-WKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAK--- 216
             E W++  +I       L Y+H    + IIHRD+K  NI +      +I DFGLAK   
Sbjct: 115 RDEYWRLFRQIL----EALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVH 167
Query: 217 ------WLPSQ---WTHHSIAPIEGTFGHLAPEYF-MHGIVDEKTDVFAFGVFLLEII 264
                  L SQ    +  ++    GT  ++A E     G  +EK D+++ G+   E+I
Sbjct: 168 RSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 49/188 (26%), Positives = 80/188 (42%), Gaps = 20/188 (10%)
Query: 88  QDGEEIAVKRLTKVVTDDRKEKEF-LTEIGTIGHVCHPNVLSLLGCCVDN-GLYLIFQFS 145
           + G   A+K L K      K+ E  L E   +  V  P ++ L     DN  LY++ ++ 
Sbjct: 57  ETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYV 116
Query: 146 SRGSVASLFHDVN---SPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLT 202
             G + S    +     P   +      A        YLH      +I+RD+K  N+L+ 
Sbjct: 117 PGGEMFSHLRRIGRFXEPHARF-----YAAQIVLTFEYLH---SLDLIYRDLKPENLLID 168
Query: 203 ADFEPQISDFGLAKWLPSQ-WTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLL 261
                Q++DFG AK +  + W       + GT  +LAPE  +    ++  D +A GV + 
Sbjct: 169 QQGYIQVTDFGFAKRVKGRTWX------LCGTPEYLAPEIILSKGYNKAVDWWALGVLIY 222
Query: 262 EIISGRKP 269
           E+ +G  P
Sbjct: 223 EMAAGYPP 230

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 95/209 (45%), Gaps = 18/209 (8%)
Query: 74  VGRGGYAEVYKGVLQ-DGEEIAVKRLTKV-VTDDRK---EKEFLTEIGTIGHVCHPNVLS 128
           +G G +A V K   +  G+E A K + K  ++  R+    +E   E+  +  + HPN+++
Sbjct: 20  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 79
Query: 129 LLGCCVDN-GLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQR 187
           L     +   + LI +  S G +     +  S   +   +    +    G+HYLH    +
Sbjct: 80  LHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQI--LDGVHYLH---SK 134
Query: 188 RIIHRDIKSSNILLTADFEP----QISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFM 243
           RI H D+K  NI+L     P    ++ DFG+A  + +    +    I GT   +APE   
Sbjct: 135 RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAG---NEFKNIFGTPEFVAPEIVN 191
Query: 244 HGIVDEKTDVFAFGVFLLEIISGRKPVDG 272
           +  +  + D+++ GV    ++SG  P  G
Sbjct: 192 YEPLGLEADMWSIGVITYILLSGASPFLG 220

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 95/209 (45%), Gaps = 18/209 (8%)
Query: 74  VGRGGYAEVYKGVLQ-DGEEIAVKRLTKV-VTDDRK---EKEFLTEIGTIGHVCHPNVLS 128
           +G G +A V K   +  G+E A K + K  ++  R+    +E   E+  +  + HPN+++
Sbjct: 13  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 129 LLGCCVDN-GLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQR 187
           L     +   + LI +  S G +     +  S   +   +    +    G+HYLH    +
Sbjct: 73  LHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQI--LDGVHYLH---SK 127
Query: 188 RIIHRDIKSSNILLTADFEP----QISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFM 243
           RI H D+K  NI+L     P    ++ DFG+A  + +    +    I GT   +APE   
Sbjct: 128 RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAG---NEFKNIFGTPEFVAPEIVN 184
Query: 244 HGIVDEKTDVFAFGVFLLEIISGRKPVDG 272
           +  +  + D+++ GV    ++SG  P  G
Sbjct: 185 YEPLGLEADMWSIGVITYILLSGASPFLG 213

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 30/108 (27%), Positives = 49/108 (45%), Gaps = 19/108 (17%)
Query: 170 IAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKW------------ 217
           I +  A  + +LH    + ++HRD+K SNI  T D   ++ DFGL               
Sbjct: 169 IFIQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLT 225
Query: 218 -LPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEII 264
            +P+  TH       GT  +++PE         K D+F+ G+ L E++
Sbjct: 226 PMPAYATHXGQV---GTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL 270

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 95/217 (43%), Gaps = 19/217 (8%)
Query: 73  LVGRGGYAEVYKGVLQD-GEEIAVK--RLTKVVTDDRKEKEFLTEIGTIGHVC-HPNVLS 128
           ++G+G ++ V + + ++ G++ AVK   + K  +      E L    +I H+  HP+++ 
Sbjct: 33  VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 92
Query: 129 LLGCCVDNG-LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTAR----GLHYLHK 183
           LL     +G LY++F+F     +   F  V      +     +A    R     L Y H 
Sbjct: 93  LLETYSSDGMLYMVFEFMDGADLC--FEIVKRADAGFVYSEAVASHYMRQILEALRYCH- 149
Query: 184 GCQRRIIHRDIKSSNILLTA--DFEP-QISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPE 240
                IIHRD+K   +LL +  +  P ++  FG+A  L             GT   +APE
Sbjct: 150 --DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGL--VAGGRVGTPHFMAPE 205
Query: 241 YFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSL 277
                   +  DV+  GV L  ++SG  P  G+ + L
Sbjct: 206 VVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERL 242

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 46/201 (22%), Positives = 88/201 (43%), Gaps = 28/201 (13%)
Query: 88  QDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDN-GLYLIFQFSS 146
           QD   +AVK L +     R++ +   E+ T+  + H +++   G C +   L ++F++  
Sbjct: 69  QDKMLVAVKALKEASESARQDFQREAELLTM--LQHQHIVRFFGVCTEGRPLLMVFEYMR 126
Query: 147 RGSVASLFH-------------DVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRD 193
            G +                  DV    +       +A   A G+ YL        +HRD
Sbjct: 127 HGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYL---AGLHFVHRD 183
Query: 194 IKSSNILLTADFEPQISDFGLAKWLPSQWTH----HSIAPIEGTFGHLAPEYFMHGIVDE 249
           + + N L+      +I DFG+++ + S   +     ++ PI      + PE  ++     
Sbjct: 184 LATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR----WMPPESILYRKFTT 239
Query: 250 KTDVFAFGVFLLEIIS-GRKP 269
           ++DV++FGV L EI + G++P
Sbjct: 240 ESDVWSFGVVLWEIFTYGKQP 260

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 47/217 (21%), Positives = 91/217 (41%), Gaps = 26/217 (11%)
Query: 74  VGRGGYAEVYKGVL------QDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVL 127
           +G G + +V+          QD   +AVK L +     R++ +   E+ T+  + H +++
Sbjct: 20  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTM--LQHQHIV 77
Query: 128 SLLGCCVDN-GLYLIFQFSSRGSVASLFH-------------DVNSPGVEWKVRHKIAVG 173
              G C +   L ++F++   G +                  DV    +       +A  
Sbjct: 78  RFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 137
Query: 174 TARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGT 233
            A G+ YL        +HRD+ + N L+      +I DFG+++ + S   +         
Sbjct: 138 VAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLP 194
Query: 234 FGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKP 269
              + PE  ++     ++DV++FGV L EI + G++P
Sbjct: 195 IRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 231

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 95/217 (43%), Gaps = 19/217 (8%)
Query: 73  LVGRGGYAEVYKGVLQD-GEEIAVK--RLTKVVTDDRKEKEFLTEIGTIGHVC-HPNVLS 128
           ++G+G ++ V + + ++ G++ AVK   + K  +      E L    +I H+  HP+++ 
Sbjct: 31  VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 129 LLGCCVDNG-LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTAR----GLHYLHK 183
           LL     +G LY++F+F     +   F  V      +     +A    R     L Y H 
Sbjct: 91  LLETYSSDGMLYMVFEFMDGADLC--FEIVKRADAGFVYSEAVASHYMRQILEALRYCH- 147
Query: 184 GCQRRIIHRDIKSSNILLTA--DFEP-QISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPE 240
                IIHRD+K   +LL +  +  P ++  FG+A  L             GT   +APE
Sbjct: 148 --DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGL--VAGGRVGTPHFMAPE 203
Query: 241 YFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSL 277
                   +  DV+  GV L  ++SG  P  G+ + L
Sbjct: 204 VVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERL 240

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 47/217 (21%), Positives = 91/217 (41%), Gaps = 26/217 (11%)
Query: 74  VGRGGYAEVYKGVL------QDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVL 127
           +G G + +V+          QD   +AVK L +     R++ +   E+ T+  + H +++
Sbjct: 26  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTM--LQHQHIV 83
Query: 128 SLLGCCVD-NGLYLIFQFSSRGSVASLFH-------------DVNSPGVEWKVRHKIAVG 173
              G C +   L ++F++   G +                  DV    +       +A  
Sbjct: 84  RFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 143
Query: 174 TARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGT 233
            A G+ YL        +HRD+ + N L+      +I DFG+++ + S   +         
Sbjct: 144 VAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLP 200
Query: 234 FGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKP 269
              + PE  ++     ++DV++FGV L EI + G++P
Sbjct: 201 IRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 237

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 66/238 (27%), Positives = 99/238 (41%), Gaps = 43/238 (18%)
Query: 71  ENLVGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDR----KEKEFLTEIGTIGHVCHPN 125
           E+++G G +A V   + L   +E AVK + K     R    +E E L +        H N
Sbjct: 18  EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQG-----HRN 72
Query: 126 VLSLLGCCVD-NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRH-------KIAVGTARG 177
           VL L+    + +  YL+F+    GS+ S  H         K RH        +    A  
Sbjct: 73  VLELIEFFEEEDRFYLVFEKMRGGSILSHIH---------KRRHFNELEASVVVQDVASA 123
Query: 178 LHYLHKGCQRRIIHRDIKSSNILL--TADFEP-QISDFGLAKWLPSQWTHHSIAPIE--- 231
           L +LH    + I HRD+K  NIL        P +I DFGL   +        I+  E   
Sbjct: 124 LDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLT 180
Query: 232 --GTFGHLAPEYFMH-----GIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAK 282
             G+  ++APE          I D++ D+++ GV L  ++SG  P  G   S   W +
Sbjct: 181 PCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDR 238

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 69/276 (25%), Positives = 115/276 (41%), Gaps = 58/276 (21%)
Query: 58  FEEISIATNAFSSENLVGRGGYAEVYKGV--LQDG--EEIAVKRLTKVVTDDR--KEKEF 111
           +E +   +N F  E+ +G G ++ VY     LQ G  E+IA+K L       R   E + 
Sbjct: 13  YEAVPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQC 72
Query: 112 LTEIGTIGHVCHPNVLSLLGCCVDNGLYLIFQFSSRGSVASLFHD-----VNSPGVEWKV 166
           LT  G        NV+ +  C   N   +I       ++  L H+     +NS  + ++ 
Sbjct: 73  LTVAGG-----QDNVMGVKYCFRKNDHVVI-------AMPYLEHESFLDILNS--LSFQE 118
Query: 167 RHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEP-QISDFGLA---------- 215
             +  +   + L  +H   Q  I+HRD+K SN L     +   + DFGLA          
Sbjct: 119 VREYMLNLFKALKRIH---QFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIEL 175
Query: 216 -KWLPSQWTH---------------HSIAPIEGTFGHLAPEYFMHGIVDEKT--DVFAFG 257
            K++ S+                    +AP  GT G  APE  +    ++ T  D+++ G
Sbjct: 176 LKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPE-VLTKCPNQTTAIDMWSAG 234
Query: 258 VFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKL 293
           V  L ++SGR P   +   L + A+ +  +G  E +
Sbjct: 235 VIFLSLLSGRYPFYKASDDLTALAQIMTIRGSRETI 270

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 93/208 (44%), Gaps = 18/208 (8%)
Query: 74  VGRGGYAEVYKGVLQ-DGEEIAVKRLT--KVVTDDRKEKEFLTEIGTIGHVCHPNVLSLL 130
           +G G + +V  G  Q  G ++AVK L   K+ + D   K    EI  +    HP+++ L 
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGK-IKREIQNLKLFRHPHIIKLY 77
Query: 131 GCC-VDNGLYLIFQFSSRGSVASLFHDVNSPG-VEWKVRHKIAVGTARGLHYLHKGCQRR 188
                    +++ ++ S G    LF  +   G VE     ++       + Y H+     
Sbjct: 78  QVISTPTDFFMVMEYVSGGE---LFDYICKHGRVEEMEARRLFQQILSAVDYCHR---HM 131
Query: 189 IIHRDIKSSNILLTADFEPQISDFGLAKWLP-SQWTHHSIAPIEGTFGHLAPEYFMHGI- 246
           ++HRD+K  N+LL A    +I+DFGL+  +   ++   S     G+  + APE     + 
Sbjct: 132 VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRDSC----GSPNYAAPEVISGRLY 187
Query: 247 VDEKTDVFAFGVFLLEIISGRKPVDGSH 274
              + D+++ GV L  ++ G  P D  H
Sbjct: 188 AGPEVDIWSCGVILYALLCGTLPFDDEH 215

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 94/209 (44%), Gaps = 18/209 (8%)
Query: 74  VGRGGYAEVYKGVLQ-DGEEIAVKRLTKV-VTDDRK---EKEFLTEIGTIGHVCHPNVLS 128
           +G G +A V K   +  G+E A K + K  +   R+    +E   E+  +  + HPN+++
Sbjct: 34  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNILREIRHPNIIT 93
Query: 129 LLGCCVDN-GLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQR 187
           L     +   + LI +  S G +     +  S   +   +    +    G+HYLH    +
Sbjct: 94  LHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQI--LDGVHYLH---SK 148
Query: 188 RIIHRDIKSSNILLTADFEP----QISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFM 243
           RI H D+K  NI+L     P    ++ DFG+A  + +    +    I GT   +APE   
Sbjct: 149 RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAG---NEFKNIFGTPEFVAPEIVN 205
Query: 244 HGIVDEKTDVFAFGVFLLEIISGRKPVDG 272
           +  +  + D+++ GV    ++SG  P  G
Sbjct: 206 YEPLGLEADMWSIGVITYILLSGASPFLG 234

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 92/207 (44%), Gaps = 19/207 (9%)
Query: 74  VGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCC 133
           VGRG Y  VYK   +DG++     L K +           EI  +  + HPNV+SL    
Sbjct: 29  VGRGTYGHVYKAKRKDGKDDKDYAL-KQIEGTGISMSACREIALLRELKHPNVISLQKVF 87
Query: 134 V---DNGLYLIFQFSSRGSVASL-FH---DVNSPGVEWK--VRHKIAVGTARGLHYLHKG 184
           +   D  ++L+F ++       + FH     N   V+    +   +      G+HYLH  
Sbjct: 88  LSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN 147
Query: 185 CQRRIIHRDIKSSNILLTADFEP----QISDFGLAKWLPSQWTHHS-IAPIEGTFGHLAP 239
               ++HRD+K +NIL+  +       +I+D G A+   S     + + P+  TF + AP
Sbjct: 148 W---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 204
Query: 240 EYFMHGIVDEKT-DVFAFGVFLLEIIS 265
           E  +      K  D++A G    E+++
Sbjct: 205 ELLLGARHYTKAIDIWAIGCIFAELLT 231

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 93/208 (44%), Gaps = 18/208 (8%)
Query: 74  VGRGGYAEVYKGVLQ-DGEEIAVKRLT--KVVTDDRKEKEFLTEIGTIGHVCHPNVLSLL 130
           +G G + +V  G  Q  G ++AVK L   K+ + D   K    EI  +    HP+++ L 
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGK-IKREIQNLKLFRHPHIIKLY 77
Query: 131 GCC-VDNGLYLIFQFSSRGSVASLFHDVNSPG-VEWKVRHKIAVGTARGLHYLHKGCQRR 188
                    +++ ++ S G    LF  +   G VE     ++       + Y H+     
Sbjct: 78  QVISTPTDFFMVMEYVSGGE---LFDYICKHGRVEEMEARRLFQQILSAVDYCHR---HM 131
Query: 189 IIHRDIKSSNILLTADFEPQISDFGLAKWLP-SQWTHHSIAPIEGTFGHLAPEYFMHGI- 246
           ++HRD+K  N+LL A    +I+DFGL+  +   ++   S     G+  + APE     + 
Sbjct: 132 VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC----GSPNYAAPEVISGRLY 187
Query: 247 VDEKTDVFAFGVFLLEIISGRKPVDGSH 274
              + D+++ GV L  ++ G  P D  H
Sbjct: 188 AGPEVDIWSCGVILYALLCGTLPFDDEH 215

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 38/163 (23%), Positives = 75/163 (46%), Gaps = 15/163 (9%)
Query: 107 KEKEFLTEIGTIGHVCHPNVLSLLGCCVD-NGLYLIFQFSSRGSVASL-----FHDVN-S 159
           K  +F  E+  I  + +   L+  G   + + +Y+I+++    S+          D N +
Sbjct: 86  KYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYT 145
Query: 160 PGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLP 219
             +  +V   I         Y+H   ++ I HRD+K SNIL+  +   ++SDFG ++++ 
Sbjct: 146 CFIPIQVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGESEYMV 203
Query: 220 SQWTHHSIAPIEGTFGHLAPEYFMH--GIVDEKTDVFAFGVFL 260
            +     I    GT+  + PE+F +       K D+++ G+ L
Sbjct: 204 DK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICL 242

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 87/209 (41%), Gaps = 18/209 (8%)
Query: 74  VGRGGYAEVYK-----GVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLS 128
           +G G +A V K       LQ   +   KR TK        ++   E+  +  + HPNV++
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 129 LLGCCVDN-GLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQR 187
           L     +   + LI +  + G +     +  S   E        +    G++YLH     
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI--LNGVYYLH---SL 133
Query: 188 RIIHRDIKSSNILLTADFEPQ----ISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFM 243
           +I H D+K  NI+L     P+    I DFGLA  +      +    I GT   +APE   
Sbjct: 134 QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID---FGNEFKNIFGTPAFVAPEIVN 190
Query: 244 HGIVDEKTDVFAFGVFLLEIISGRKPVDG 272
           +  +  + D+++ GV    ++SG  P  G
Sbjct: 191 YEPLGLEADMWSIGVITYILLSGASPFLG 219

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 36/141 (25%), Positives = 61/141 (43%), Gaps = 11/141 (7%)
Query: 138 LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSS 197
           L ++ +    G + S   D        +   +I       + YLH      I HRD+K  
Sbjct: 88  LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPE 144
Query: 198 NILLTADFEP----QISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDV 253
           N+L T+   P    +++DFG AK   S   H+S+     T  ++APE       D+  D+
Sbjct: 145 NLLYTSK-RPNAILKLTDFGFAKETTS---HNSLTTPCYTPYYVAPEVLGPEKYDKSCDM 200
Query: 254 FAFGVFLLEIISGRKPVDGSH 274
           ++ GV +  ++ G  P   +H
Sbjct: 201 WSLGVIMYILLCGYPPFYSNH 221

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 36/141 (25%), Positives = 61/141 (43%), Gaps = 11/141 (7%)
Query: 138 LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSS 197
           L ++ +    G + S   D        +   +I       + YLH      I HRD+K  
Sbjct: 88  LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPE 144
Query: 198 NILLTADFEP----QISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDV 253
           N+L T+   P    +++DFG AK   S   H+S+     T  ++APE       D+  D+
Sbjct: 145 NLLYTSK-RPNAILKLTDFGFAKETTS---HNSLTEPCYTPYYVAPEVLGPEKYDKSCDM 200
Query: 254 FAFGVFLLEIISGRKPVDGSH 274
           ++ GV +  ++ G  P   +H
Sbjct: 201 WSLGVIMYILLCGYPPFYSNH 221

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 36/141 (25%), Positives = 61/141 (43%), Gaps = 11/141 (7%)
Query: 138 LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSS 197
           L ++ +    G + S   D        +   +I       + YLH      I HRD+K  
Sbjct: 96  LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPE 152
Query: 198 NILLTADFEP----QISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDV 253
           N+L T+   P    +++DFG AK   S   H+S+     T  ++APE       D+  D+
Sbjct: 153 NLLYTSK-RPNAILKLTDFGFAKETTS---HNSLTTPCYTPYYVAPEVLGPEKYDKSCDM 208
Query: 254 FAFGVFLLEIISGRKPVDGSH 274
           ++ GV +  ++ G  P   +H
Sbjct: 209 WSLGVIMYILLCGYPPFYSNH 229

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 36/141 (25%), Positives = 61/141 (43%), Gaps = 11/141 (7%)
Query: 138 LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSS 197
           L ++ +    G + S   D        +   +I       + YLH      I HRD+K  
Sbjct: 89  LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPE 145
Query: 198 NILLTADFEP----QISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDV 253
           N+L T+   P    +++DFG AK   S   H+S+     T  ++APE       D+  D+
Sbjct: 146 NLLYTSK-RPNAILKLTDFGFAKETTS---HNSLTTPCYTPYYVAPEVLGPEKYDKSCDM 201
Query: 254 FAFGVFLLEIISGRKPVDGSH 274
           ++ GV +  ++ G  P   +H
Sbjct: 202 WSLGVIMYILLCGYPPFYSNH 222

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 36/141 (25%), Positives = 61/141 (43%), Gaps = 11/141 (7%)
Query: 138 LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSS 197
           L ++ +    G + S   D        +   +I       + YLH      I HRD+K  
Sbjct: 95  LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPE 151
Query: 198 NILLTADFEP----QISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDV 253
           N+L T+   P    +++DFG AK   S   H+S+     T  ++APE       D+  D+
Sbjct: 152 NLLYTSK-RPNAILKLTDFGFAKETTS---HNSLTTPCYTPYYVAPEVLGPEKYDKSCDM 207
Query: 254 FAFGVFLLEIISGRKPVDGSH 274
           ++ GV +  ++ G  P   +H
Sbjct: 208 WSLGVIMYILLCGYPPFYSNH 228

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 36/141 (25%), Positives = 61/141 (43%), Gaps = 11/141 (7%)
Query: 138 LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSS 197
           L ++ +    G + S   D        +   +I       + YLH      I HRD+K  
Sbjct: 94  LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPE 150
Query: 198 NILLTADFEP----QISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDV 253
           N+L T+   P    +++DFG AK   S   H+S+     T  ++APE       D+  D+
Sbjct: 151 NLLYTSK-RPNAILKLTDFGFAKETTS---HNSLTTPCYTPYYVAPEVLGPEKYDKSCDM 206
Query: 254 FAFGVFLLEIISGRKPVDGSH 274
           ++ GV +  ++ G  P   +H
Sbjct: 207 WSLGVIMYILLCGYPPFYSNH 227

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 36/141 (25%), Positives = 61/141 (43%), Gaps = 11/141 (7%)
Query: 138 LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSS 197
           L ++ +    G + S   D        +   +I       + YLH      I HRD+K  
Sbjct: 134 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPE 190
Query: 198 NILLTADFEP----QISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDV 253
           N+L T+   P    +++DFG AK   S   H+S+     T  ++APE       D+  D+
Sbjct: 191 NLLYTSK-RPNAILKLTDFGFAKETTS---HNSLTTPCYTPYYVAPEVLGPEKYDKSCDM 246
Query: 254 FAFGVFLLEIISGRKPVDGSH 274
           ++ GV +  ++ G  P   +H
Sbjct: 247 WSLGVIMYILLCGYPPFYSNH 267

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 88/213 (41%), Gaps = 16/213 (7%)
Query: 72  NLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTD-----DRKEKEFLTEIGTIGHVCHPNV 126
           +L+G G Y +V K VL D E +  + +  +           E     EI  +  + H NV
Sbjct: 11  DLLGEGSYGKV-KEVL-DSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNV 68
Query: 127 LSLLGCCVD---NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHK 183
           + L+    +     +Y++ ++   G +  +   V          H        GL YLH 
Sbjct: 69  IQLVDVLYNEEKQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLH- 126
Query: 184 GCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYF- 242
              + I+H+DIK  N+LLT     +IS  G+A+ L       +    +G+     PE   
Sbjct: 127 --SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIAN 184
Query: 243 -MHGIVDEKTDVFAFGVFLLEIISGRKPVDGSH 274
            +      K D+++ GV L  I +G  P +G +
Sbjct: 185 GLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN 217

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 36/141 (25%), Positives = 61/141 (43%), Gaps = 11/141 (7%)
Query: 138 LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSS 197
           L ++ +    G + S   D        +   +I       + YLH      I HRD+K  
Sbjct: 90  LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPE 146
Query: 198 NILLTADFEP----QISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDV 253
           N+L T+   P    +++DFG AK   S   H+S+     T  ++APE       D+  D+
Sbjct: 147 NLLYTSK-RPNAILKLTDFGFAKETTS---HNSLTTPCYTPYYVAPEVLGPEKYDKSCDM 202
Query: 254 FAFGVFLLEIISGRKPVDGSH 274
           ++ GV +  ++ G  P   +H
Sbjct: 203 WSLGVIMYILLCGYPPFYSNH 223

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 99/216 (45%), Gaps = 32/216 (14%)
Query: 67  AFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNV 126
           A+++  ++G G +  V++  L + +E+A+K   KV+ D R +     E+  +  V HPNV
Sbjct: 41  AYTNCKVIGNGSFGVVFQAKLVESDEVAIK---KVLQDKRFKNR---ELQIMRIVKHPNV 94
Query: 127 LSLLGCCVDNG-------LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAV-GTARGL 178
           + L      NG       L L+ ++       +  H          +  K+ +    R L
Sbjct: 95  VDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSL 154
Query: 179 HYLHKGCQRRIIHRDIKSSNILLTADFEP-----QISDFGLAKWLPSQWTHHSIAPIEGT 233
            Y+H      I HRDIK  N+LL    +P     ++ DFG AK L +     +++ I   
Sbjct: 155 AYIHSIG---ICHRDIKPQNLLL----DPPSGVLKLIDFGSAKILIA--GEPNVSXICSR 205
Query: 234 FGHLAPEYFMHGIVDEKT--DVFAFGVFLLEIISGR 267
           + + APE  + G  +  T  D+++ G  + E++ G+
Sbjct: 206 Y-YRAPE-LIFGATNYTTNIDIWSTGCVMAELMQGQ 239

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 36/141 (25%), Positives = 61/141 (43%), Gaps = 11/141 (7%)
Query: 138 LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSS 197
           L ++ +    G + S   D        +   +I       + YLH      I HRD+K  
Sbjct: 104 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPE 160
Query: 198 NILLTADFEP----QISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDV 253
           N+L T+   P    +++DFG AK   S   H+S+     T  ++APE       D+  D+
Sbjct: 161 NLLYTSK-RPNAILKLTDFGFAKETTS---HNSLTTPCYTPYYVAPEVLGPEKYDKSCDM 216
Query: 254 FAFGVFLLEIISGRKPVDGSH 274
           ++ GV +  ++ G  P   +H
Sbjct: 217 WSLGVIMYILLCGYPPFYSNH 237

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 36/141 (25%), Positives = 61/141 (43%), Gaps = 11/141 (7%)
Query: 138 LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSS 197
           L ++ +    G + S   D        +   +I       + YLH      I HRD+K  
Sbjct: 140 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPE 196
Query: 198 NILLTADFEP----QISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDV 253
           N+L T+   P    +++DFG AK   S   H+S+     T  ++APE       D+  D+
Sbjct: 197 NLLYTSK-RPNAILKLTDFGFAKETTS---HNSLTTPCYTPYYVAPEVLGPEKYDKSCDM 252
Query: 254 FAFGVFLLEIISGRKPVDGSH 274
           ++ GV +  ++ G  P   +H
Sbjct: 253 WSLGVIMYILLCGYPPFYSNH 273

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 36/141 (25%), Positives = 61/141 (43%), Gaps = 11/141 (7%)
Query: 138 LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSS 197
           L ++ +    G + S   D        +   +I       + YLH      I HRD+K  
Sbjct: 90  LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPE 146
Query: 198 NILLTADFEP----QISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDV 253
           N+L T+   P    +++DFG AK   S   H+S+     T  ++APE       D+  D+
Sbjct: 147 NLLYTSK-RPNAILKLTDFGFAKETTS---HNSLTTPCYTPYYVAPEVLGPEKYDKSCDM 202
Query: 254 FAFGVFLLEIISGRKPVDGSH 274
           ++ GV +  ++ G  P   +H
Sbjct: 203 WSLGVIMYILLCGYPPFYSNH 223

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 49/99 (49%), Gaps = 12/99 (12%)
Query: 177 GLHYLHKGCQRRIIHRDIKSSNILLTADFEP---QISDFGLAKWLPSQWTHHSIAPIEGT 233
            + YLH   +  IIHRD+K  N+LL++  E    +I+DFG +K L       ++    GT
Sbjct: 126 AVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC---GT 179
Query: 234 FGHLAPEYFMH---GIVDEKTDVFAFGVFLLEIISGRKP 269
             +LAPE  +       +   D ++ GV L   +SG  P
Sbjct: 180 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 218

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 49/99 (49%), Gaps = 12/99 (12%)
Query: 177 GLHYLHKGCQRRIIHRDIKSSNILLTADFEP---QISDFGLAKWLPSQWTHHSIAPIEGT 233
            + YLH   +  IIHRD+K  N+LL++  E    +I+DFG +K L       ++    GT
Sbjct: 126 AVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC---GT 179
Query: 234 FGHLAPEYFMH---GIVDEKTDVFAFGVFLLEIISGRKP 269
             +LAPE  +       +   D ++ GV L   +SG  P
Sbjct: 180 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 218

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 49/99 (49%), Gaps = 12/99 (12%)
Query: 177 GLHYLHKGCQRRIIHRDIKSSNILLTADFEP---QISDFGLAKWLPSQWTHHSIAPIEGT 233
            + YLH   +  IIHRD+K  N+LL++  E    +I+DFG +K L       ++    GT
Sbjct: 125 AVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC---GT 178
Query: 234 FGHLAPEYFMH---GIVDEKTDVFAFGVFLLEIISGRKP 269
             +LAPE  +       +   D ++ GV L   +SG  P
Sbjct: 179 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 217

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 49/99 (49%), Gaps = 12/99 (12%)
Query: 177 GLHYLHKGCQRRIIHRDIKSSNILLTADFEP---QISDFGLAKWLPSQWTHHSIAPIEGT 233
            + YLH   +  IIHRD+K  N+LL++  E    +I+DFG +K L       ++    GT
Sbjct: 126 AVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC---GT 179
Query: 234 FGHLAPEYFMH---GIVDEKTDVFAFGVFLLEIISGRKP 269
             +LAPE  +       +   D ++ GV L   +SG  P
Sbjct: 180 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 218

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 87/209 (41%), Gaps = 18/209 (8%)
Query: 74  VGRGGYAEVYK-----GVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLS 128
           +G G +A V K       LQ   +   KR TK        ++   E+  +  + HPNV++
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 129 LLGCCVDN-GLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQR 187
           L     +   + LI +  + G +     +  S   E        +    G++YLH     
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI--LNGVYYLH---SL 133
Query: 188 RIIHRDIKSSNILLTADFEP----QISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFM 243
           +I H D+K  NI+L     P    +I DFGLA  +      +    I GT   +APE   
Sbjct: 134 QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID---FGNEFKNIFGTPEFVAPEIVN 190
Query: 244 HGIVDEKTDVFAFGVFLLEIISGRKPVDG 272
           +  +  + D+++ GV    ++SG  P  G
Sbjct: 191 YEPLGLEADMWSIGVITYILLSGASPFLG 219

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 49/99 (49%), Gaps = 12/99 (12%)
Query: 177 GLHYLHKGCQRRIIHRDIKSSNILLTADFEP---QISDFGLAKWLPSQWTHHSIAPIEGT 233
            + YLH   +  IIHRD+K  N+LL++  E    +I+DFG +K L       ++    GT
Sbjct: 132 AVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC---GT 185
Query: 234 FGHLAPEYFMH---GIVDEKTDVFAFGVFLLEIISGRKP 269
             +LAPE  +       +   D ++ GV L   +SG  P
Sbjct: 186 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 224

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 43/164 (26%), Positives = 70/164 (42%), Gaps = 16/164 (9%)
Query: 113 TEIGTIGHVCHPNVLSLLGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAV 172
           TEI  +  + HP ++ +         Y++ +    G    LF  V       +   K+  
Sbjct: 189 TEIEILKKLNHPCIIKIKNFFDAEDYYIVLELMEGGE---LFDKVVGNKRLKEATCKLYF 245
Query: 173 -GTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEP---QISDFGLAKWLPSQWTHHSIA 228
                 + YLH   +  IIHRD+K  N+LL++  E    +I+DFG +K L       ++ 
Sbjct: 246 YQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC 302
Query: 229 PIEGTFGHLAPEYFMH---GIVDEKTDVFAFGVFLLEIISGRKP 269
              GT  +LAPE  +       +   D ++ GV L   +SG  P
Sbjct: 303 ---GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 343

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 56/238 (23%), Positives = 100/238 (42%), Gaps = 51/238 (21%)
Query: 58  FEEISIATNAFSSENLVGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIG 116
           FEEI++          +G+G + +V K     D    A+K   K+   + K    L+E+ 
Sbjct: 8   FEEIAV----------LGQGAFGQVVKARNALDSRYYAIK---KIRHTEEKLSTILSEVM 54
Query: 117 TIGHVCHPNVLSLLGCCVD--------------NGLYLIFQFSSRGSVASLFH--DVNSP 160
            +  + H  V+      ++              + L++  ++    ++  L H  ++N  
Sbjct: 55  LLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQ 114
Query: 161 GVE-WKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAK--- 216
             E W++  +I       L Y+H    + IIHRD+K  NI +      +I DFGLAK   
Sbjct: 115 RDEYWRLFRQIL----EALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVH 167
Query: 217 ------WLPSQ---WTHHSIAPIEGTFGHLAPEYF-MHGIVDEKTDVFAFGVFLLEII 264
                  L SQ    +  ++    GT  ++A E     G  +EK D+++ G+   E+I
Sbjct: 168 RSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 87/209 (41%), Gaps = 18/209 (8%)
Query: 74  VGRGGYAEVYK-----GVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLS 128
           +G G +A V K       LQ   +   KR TK        ++   E+  +  + HPNV++
Sbjct: 18  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 77
Query: 129 LLGCCVDN-GLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQR 187
           L     +   + LI +  + G +     +  S   E        +    G++YLH     
Sbjct: 78  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI--LNGVYYLH---SL 132
Query: 188 RIIHRDIKSSNILLTADFEP----QISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFM 243
           +I H D+K  NI+L     P    +I DFGLA  +      +    I GT   +APE   
Sbjct: 133 QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID---FGNEFKNIFGTPEFVAPEIVN 189
Query: 244 HGIVDEKTDVFAFGVFLLEIISGRKPVDG 272
           +  +  + D+++ GV    ++SG  P  G
Sbjct: 190 YEPLGLEADMWSIGVITYILLSGASPFLG 218

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 87/209 (41%), Gaps = 18/209 (8%)
Query: 74  VGRGGYAEVYK-----GVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLS 128
           +G G +A V K       LQ   +   KR TK        ++   E+  +  + HPNV++
Sbjct: 19  LGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 129 LLGCCVDN-GLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQR 187
           L     +   + LI +  + G +     +  S   E        +    G++YLH     
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI--LNGVYYLH---SL 133
Query: 188 RIIHRDIKSSNILLTADFEP----QISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFM 243
           +I H D+K  NI+L     P    +I DFGLA  +      +    I GT   +APE   
Sbjct: 134 QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID---FGNEFKNIFGTPEFVAPEIVN 190
Query: 244 HGIVDEKTDVFAFGVFLLEIISGRKPVDG 272
           +  +  + D+++ GV    ++SG  P  G
Sbjct: 191 YEPLGLEADMWSIGVITYILLSGASPFLG 219

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 87/209 (41%), Gaps = 18/209 (8%)
Query: 74  VGRGGYAEVYK-----GVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLS 128
           +G G +A V K       LQ   +   KR TK        ++   E+  +  + HPNV++
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 129 LLGCCVDN-GLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQR 187
           L     +   + LI +  + G +     +  S   E        +    G++YLH     
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI--LNGVYYLH---SL 133
Query: 188 RIIHRDIKSSNILLTADFEP----QISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFM 243
           +I H D+K  NI+L     P    +I DFGLA  +      +    I GT   +APE   
Sbjct: 134 QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID---FGNEFKNIFGTPEFVAPEIVN 190
Query: 244 HGIVDEKTDVFAFGVFLLEIISGRKPVDG 272
           +  +  + D+++ GV    ++SG  P  G
Sbjct: 191 YEPLGLEADMWSIGVITYILLSGASPFLG 219

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 87/209 (41%), Gaps = 18/209 (8%)
Query: 74  VGRGGYAEVYK-----GVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLS 128
           +G G +A V K       LQ   +   KR TK        ++   E+  +  + HPNV++
Sbjct: 18  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 77
Query: 129 LLGCCVDN-GLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQR 187
           L     +   + LI +  + G +     +  S   E        +    G++YLH     
Sbjct: 78  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI--LNGVYYLH---SL 132
Query: 188 RIIHRDIKSSNILLTADFEP----QISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFM 243
           +I H D+K  NI+L     P    +I DFGLA  +      +    I GT   +APE   
Sbjct: 133 QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID---FGNEFKNIFGTPEFVAPEIVN 189
Query: 244 HGIVDEKTDVFAFGVFLLEIISGRKPVDG 272
           +  +  + D+++ GV    ++SG  P  G
Sbjct: 190 YEPLGLEADMWSIGVITYILLSGASPFLG 218

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 87/209 (41%), Gaps = 18/209 (8%)
Query: 74  VGRGGYAEVYK-----GVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLS 128
           +G G +A V K       LQ   +   KR TK        ++   E+  +  + HPNV++
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 129 LLGCCVDN-GLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQR 187
           L     +   + LI +  + G +     +  S   E        +    G++YLH     
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI--LNGVYYLH---SL 133
Query: 188 RIIHRDIKSSNILLTADFEP----QISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFM 243
           +I H D+K  NI+L     P    +I DFGLA  +      +    I GT   +APE   
Sbjct: 134 QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID---FGNEFKNIFGTPEFVAPEIVN 190
Query: 244 HGIVDEKTDVFAFGVFLLEIISGRKPVDG 272
           +  +  + D+++ GV    ++SG  P  G
Sbjct: 191 YEPLGLEADMWSIGVITYILLSGASPFLG 219

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 43/164 (26%), Positives = 70/164 (42%), Gaps = 16/164 (9%)
Query: 113 TEIGTIGHVCHPNVLSLLGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAV 172
           TEI  +  + HP ++ +         Y++ +    G    LF  V       +   K+  
Sbjct: 203 TEIEILKKLNHPCIIKIKNFFDAEDYYIVLELMEGGE---LFDKVVGNKRLKEATCKLYF 259
Query: 173 -GTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEP---QISDFGLAKWLPSQWTHHSIA 228
                 + YLH   +  IIHRD+K  N+LL++  E    +I+DFG +K L       ++ 
Sbjct: 260 YQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC 316
Query: 229 PIEGTFGHLAPEYFMH---GIVDEKTDVFAFGVFLLEIISGRKP 269
              GT  +LAPE  +       +   D ++ GV L   +SG  P
Sbjct: 317 ---GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 357

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 43/169 (25%), Positives = 72/169 (42%), Gaps = 13/169 (7%)
Query: 109 KEFLTEIGTIGHVCHPNVLSLLGCCVD-NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVR 167
           +E   E+  +  V HPN+++L     +   + LI +  S G +        S   E    
Sbjct: 60  EEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEAT- 118
Query: 168 HKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEP----QISDFGLAKWLPSQWT 223
                    G++YLH    ++I H D+K  NI+L     P    ++ DFGLA  +     
Sbjct: 119 -SFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE 174
Query: 224 HHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDG 272
             +I    GT   +APE   +  +  + D+++ GV    ++SG  P  G
Sbjct: 175 FKNIF---GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG 220

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 33/102 (32%), Positives = 50/102 (49%), Gaps = 9/102 (8%)
Query: 177 GLHYLHKGCQRRIIHRDIKSSNILLTAD--FEPQISDFGLAK--WLPSQWTHHSIAPIEG 232
            LHYLH    + I HRDIK  N L + +  FE ++ DFGL+K  +  +   ++ +    G
Sbjct: 180 ALHYLH---NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAG 236
Query: 233 TFGHLAPEYF--MHGIVDEKTDVFAFGVFLLEIISGRKPVDG 272
           T   +APE     +     K D ++ GV L  ++ G  P  G
Sbjct: 237 TPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPG 278

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 54/232 (23%), Positives = 96/232 (41%), Gaps = 33/232 (14%)
Query: 68  FSSENLVGRGGYAEVYKGVLQD-GEEIAVKRLTKVVTDDRK--EKEFLTEIGTIGHVCHP 124
           F  ++L+G G Y  V     +  GE +A+K++      D+       L EI  + H  H 
Sbjct: 13  FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF---DKPLFALRTLREIKILKHFKHE 69
Query: 125 NVLSLLGCCVD------NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGL 178
           N++++            N +Y+I +         L   +++  +           T R +
Sbjct: 70  NIITIFNIQRPDSFENFNEVYIIQELMQ----TDLHRVISTQMLSDDHIQYFIYQTLRAV 125
Query: 179 HYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHS--------IAPI 230
             LH      +IHRD+K SN+L+ ++ + ++ DFGLA+ +      +S        +   
Sbjct: 126 KVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEF 182
Query: 231 EGTFGHLAPEYFM-HGIVDEKTDVFAFGVFLLEIISGRKPV----DGSHQSL 277
             T  + APE  +         DV++ G  L E+   R+P+    D  HQ L
Sbjct: 183 VATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRPIFPGRDYRHQLL 233

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 92/224 (41%), Gaps = 19/224 (8%)
Query: 58  FEEISIATNAFSSENLVGRGGYAEV-YKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIG 116
            +E+ +  + F    ++GRG ++EV    + Q G+  A+K + K     R E     E  
Sbjct: 53  LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREER 112
Query: 117 TIGHVCHPNVLSLLGCCV--DNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIA--V 172
            +        ++ L      +N LYL+ ++   G + +L             R  +A  V
Sbjct: 113 DVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIV 172
Query: 173 GTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEG 232
                +H L        +HRDIK  NILL      +++DFG    L +  T  S+  + G
Sbjct: 173 MAIDSVHRLG------YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAV-G 225
Query: 233 TFGHLAPEYFM-------HGIVDEKTDVFAFGVFLLEIISGRKP 269
           T  +L+PE           G    + D +A GVF  E+  G+ P
Sbjct: 226 TPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 87/209 (41%), Gaps = 18/209 (8%)
Query: 74  VGRGGYAEVYK-----GVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLS 128
           +G G +A V K       LQ   +   KR TK        ++   E+  +  + HPNV++
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 129 LLGCCVDN-GLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQR 187
           L     +   + LI +  + G +     +  S   E        +    G++YLH     
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI--LNGVYYLH---SL 133
Query: 188 RIIHRDIKSSNILLTADFEP----QISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFM 243
           +I H D+K  NI+L     P    +I DFGLA  +      +    I GT   +APE   
Sbjct: 134 QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID---FGNEFKNIFGTPEFVAPEIVN 190
Query: 244 HGIVDEKTDVFAFGVFLLEIISGRKPVDG 272
           +  +  + D+++ GV    ++SG  P  G
Sbjct: 191 YEPLGLEADMWSIGVITYILLSGASPFLG 219

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 87/209 (41%), Gaps = 18/209 (8%)
Query: 74  VGRGGYAEVYK-----GVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLS 128
           +G G +A V K       LQ   +   KR TK        ++   E+  +  + HPNV++
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 129 LLGCCVDN-GLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQR 187
           L     +   + LI +  + G +     +  S   E        +    G++YLH     
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI--LNGVYYLH---SL 133
Query: 188 RIIHRDIKSSNILLTADFEP----QISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFM 243
           +I H D+K  NI+L     P    +I DFGLA  +      +    I GT   +APE   
Sbjct: 134 QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID---FGNEFKNIFGTPEFVAPEIVN 190
Query: 244 HGIVDEKTDVFAFGVFLLEIISGRKPVDG 272
           +  +  + D+++ GV    ++SG  P  G
Sbjct: 191 YEPLGLEADMWSIGVITYILLSGASPFLG 219

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 65/238 (27%), Positives = 98/238 (41%), Gaps = 43/238 (18%)
Query: 71  ENLVGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDR----KEKEFLTEIGTIGHVCHPN 125
           E+++G G +A V   + L   +E AVK + K     R    +E E L +        H N
Sbjct: 18  EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQG-----HRN 72
Query: 126 VLSLLGCCVD-NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRH-------KIAVGTARG 177
           VL L+    + +  YL+F+    GS+ S  H         K RH        +    A  
Sbjct: 73  VLELIEFFEEEDRFYLVFEKMRGGSILSHIH---------KRRHFNELEASVVVQDVASA 123
Query: 178 LHYLHKGCQRRIIHRDIKSSNILL--TADFEP-QISDFGLAKWLPSQWTHHSIAPIE--- 231
           L +LH    + I HRD+K  NIL        P +I DF L   +        I+  E   
Sbjct: 124 LDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLT 180
Query: 232 --GTFGHLAPEYFMH-----GIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAK 282
             G+  ++APE          I D++ D+++ GV L  ++SG  P  G   S   W +
Sbjct: 181 PCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDR 238

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 87/209 (41%), Gaps = 18/209 (8%)
Query: 74  VGRGGYAEVYK-----GVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLS 128
           +G G +A V K       LQ   +   KR TK        ++   E+  +  + HPNV++
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 129 LLGCCVDN-GLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQR 187
           L     +   + LI +  + G +     +  S   E        +    G++YLH     
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI--LNGVYYLH---SL 133
Query: 188 RIIHRDIKSSNILLTADFEP----QISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFM 243
           +I H D+K  NI+L     P    +I DFGLA  +      +    I GT   +APE   
Sbjct: 134 QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID---FGNEFKNIFGTPEFVAPEIVN 190
Query: 244 HGIVDEKTDVFAFGVFLLEIISGRKPVDG 272
           +  +  + D+++ GV    ++SG  P  G
Sbjct: 191 YEPLGLEADMWSIGVITYILLSGASPFLG 219

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 47/210 (22%), Positives = 95/210 (45%), Gaps = 23/210 (10%)
Query: 74  VGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHV-CHPNVLSLLG 131
           +GRG Y+EV++ + + + E++ VK L  V     K+ +   EI  + ++   PN+++L  
Sbjct: 45  LGRGKYSEVFEAINITNNEKVVVKILKPV-----KKNKIKREIKILENLRGGPNIITLAD 99
Query: 132 CCVD---NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRR 188
              D       L+F+  +      L+  +    + + +         + L Y H      
Sbjct: 100 IVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYM-----YEILKALDYCHSMG--- 151
Query: 189 IIHRDIKSSNILLTADFEP-QISDFGLAKWL-PSQWTHHSIAPIEGTFGHLAPEYFMHGI 246
           I+HRD+K  N+++  +    ++ D+GLA++  P Q  +  +A        L  +Y M+  
Sbjct: 152 IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMY-- 209
Query: 247 VDEKTDVFAFGVFLLEIISGRKPVDGSHQS 276
            D   D+++ G  L  +I  ++P    H +
Sbjct: 210 -DYSLDMWSLGCMLASMIFRKEPFFHGHDN 238

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 87/209 (41%), Gaps = 18/209 (8%)
Query: 74  VGRGGYAEVYK-----GVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLS 128
           +G G +A V K       LQ   +   KR TK        ++   E+  +  + HPNV++
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 129 LLGCCVDN-GLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQR 187
           L     +   + LI +  + G +     +  S   E        +    G++YLH     
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI--LNGVYYLH---SL 133
Query: 188 RIIHRDIKSSNILLTADFEP----QISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFM 243
           +I H D+K  NI+L     P    +I DFGLA  +      +    I GT   +APE   
Sbjct: 134 QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID---FGNEFKNIFGTPEFVAPEIVN 190
Query: 244 HGIVDEKTDVFAFGVFLLEIISGRKPVDG 272
           +  +  + D+++ GV    ++SG  P  G
Sbjct: 191 YEPLGLEADMWSIGVITYILLSGASPFLG 219

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 87/209 (41%), Gaps = 18/209 (8%)
Query: 74  VGRGGYAEVYK-----GVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLS 128
           +G G +A V K       LQ   +   KR TK        ++   E+  +  + HPNV++
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 129 LLGCCVDN-GLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQR 187
           L     +   + LI +  + G +     +  S   E        +    G++YLH     
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI--LNGVYYLH---SL 133
Query: 188 RIIHRDIKSSNILLTADFEP----QISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFM 243
           +I H D+K  NI+L     P    +I DFGLA  +      +    I GT   +APE   
Sbjct: 134 QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID---FGNEFKNIFGTPEFVAPEIVN 190
Query: 244 HGIVDEKTDVFAFGVFLLEIISGRKPVDG 272
           +  +  + D+++ GV    ++SG  P  G
Sbjct: 191 YEPLGLEADMWSIGVITYILLSGASPFLG 219

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 54/232 (23%), Positives = 96/232 (41%), Gaps = 33/232 (14%)
Query: 68  FSSENLVGRGGYAEVYKGVLQD-GEEIAVKRLTKVVTDDRK--EKEFLTEIGTIGHVCHP 124
           F  ++L+G G Y  V     +  GE +A+K++      D+       L EI  + H  H 
Sbjct: 13  FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF---DKPLFALRTLREIKILKHFKHE 69
Query: 125 NVLSLLGCCVD------NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGL 178
           N++++            N +Y+I +         L   +++  +           T R +
Sbjct: 70  NIITIFNIQRPDSFENFNEVYIIQELMQ----TDLHRVISTQMLSDDHIQYFIYQTLRAV 125
Query: 179 HYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHS--------IAPI 230
             LH      +IHRD+K SN+L+ ++ + ++ DFGLA+ +      +S        +   
Sbjct: 126 KVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEX 182
Query: 231 EGTFGHLAPEYFM-HGIVDEKTDVFAFGVFLLEIISGRKPV----DGSHQSL 277
             T  + APE  +         DV++ G  L E+   R+P+    D  HQ L
Sbjct: 183 VATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRPIFPGRDYRHQLL 233

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 54/232 (23%), Positives = 96/232 (41%), Gaps = 33/232 (14%)
Query: 68  FSSENLVGRGGYAEVYKGVLQD-GEEIAVKRLTKVVTDDRK--EKEFLTEIGTIGHVCHP 124
           F  ++L+G G Y  V     +  GE +A+K++      D+       L EI  + H  H 
Sbjct: 13  FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF---DKPLFALRTLREIKILKHFKHE 69
Query: 125 NVLSLLGCCVD------NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGL 178
           N++++            N +Y+I +         L   +++  +           T R +
Sbjct: 70  NIITIFNIQRPDSFENFNEVYIIQELMQ----TDLHRVISTQMLSDDHIQYFIYQTLRAV 125
Query: 179 HYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHS--------IAPI 230
             LH      +IHRD+K SN+L+ ++ + ++ DFGLA+ +      +S        +   
Sbjct: 126 KVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEY 182
Query: 231 EGTFGHLAPEYFM-HGIVDEKTDVFAFGVFLLEIISGRKPV----DGSHQSL 277
             T  + APE  +         DV++ G  L E+   R+P+    D  HQ L
Sbjct: 183 VATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRPIFPGRDYRHQLL 233

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 87/209 (41%), Gaps = 18/209 (8%)
Query: 74  VGRGGYAEVYK-----GVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLS 128
           +G G +A V K       LQ   +   KR TK        ++   E+  +  + HPNV++
Sbjct: 19  LGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 129 LLGCCVDN-GLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQR 187
           L     +   + LI +  + G +     +  S   E        +    G++YLH     
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI--LNGVYYLH---SL 133
Query: 188 RIIHRDIKSSNILLTADFEP----QISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFM 243
           +I H D+K  NI+L     P    +I DFGLA  +      +    I GT   +APE   
Sbjct: 134 QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID---FGNEFKNIFGTPEFVAPEIVN 190
Query: 244 HGIVDEKTDVFAFGVFLLEIISGRKPVDG 272
           +  +  + D+++ GV    ++SG  P  G
Sbjct: 191 YEPLGLEADMWSIGVITYILLSGASPFLG 219

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 48/168 (28%), Positives = 73/168 (43%), Gaps = 20/168 (11%)
Query: 113 TEIGTIGHVCHPNVLSLLGCCVDN-GLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIA 171
            EI  +  + HP +++L     D   + LI +F S G    LF  + +   ++K+     
Sbjct: 97  NEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGE---LFDRIAAE--DYKMSEAEV 151
Query: 172 VGTAR----GLHYLHKGCQRRIIHRDIKSSNILLTADFEP--QISDFGLAKWL-PSQWTH 224
           +   R    GL ++H   +  I+H DIK  NI+         +I DFGLA  L P +   
Sbjct: 152 INYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVK 208
Query: 225 HSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDG 272
            + A  E      APE      V   TD++A GV    ++SG  P  G
Sbjct: 209 VTTATAEFA----APEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAG 252

>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 36/138 (26%), Positives = 63/138 (45%), Gaps = 14/138 (10%)
Query: 136 NGLYLIFQFSSRG-SVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDI 194
           NG++++  F   G ++ +L       G+      +I+     GL Y+H+ C   IIH DI
Sbjct: 101 NGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG--IIHTDI 158
Query: 195 KSSNILLTADFEPQ------ISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVD 248
           K  N+L+     P+      I+D G A W    +T +SI   E    + +PE  +     
Sbjct: 159 KPENVLMEIVDSPENLIQIKIADLGNACWYDEHYT-NSIQTRE----YRSPEVLLGAPWG 213
Query: 249 EKTDVFAFGVFLLEIISG 266
              D+++    + E+I+G
Sbjct: 214 CGADIWSTACLIFELITG 231

>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 36/138 (26%), Positives = 63/138 (45%), Gaps = 14/138 (10%)
Query: 136 NGLYLIFQFSSRG-SVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDI 194
           NG++++  F   G ++ +L       G+      +I+     GL Y+H+ C   IIH DI
Sbjct: 101 NGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG--IIHTDI 158
Query: 195 KSSNILLTADFEPQ------ISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVD 248
           K  N+L+     P+      I+D G A W    +T +SI   E    + +PE  +     
Sbjct: 159 KPENVLMEIVDSPENLIQIKIADLGNACWYDEHYT-NSIQTRE----YRSPEVLLGAPWG 213
Query: 249 EKTDVFAFGVFLLEIISG 266
              D+++    + E+I+G
Sbjct: 214 CGADIWSTACLIFELITG 231

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 62/275 (22%), Positives = 109/275 (39%), Gaps = 45/275 (16%)
Query: 74  VGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCC 133
           +GRG +  V++ V    ++  + +  KV   D+   +   EI  +    H N+L L    
Sbjct: 13  LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVK--KEISILNIARHRNILHLHESF 70
Query: 134 VD-NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQ------ 186
                L +IF+F S      +F  +N+   E   R  ++        Y+H+ C+      
Sbjct: 71  ESMEELVMIFEFISG---LDIFERINTSAFELNEREIVS--------YVHQVCEALQFLH 119
Query: 187 -RRIIHRDIKSSNILLTADFEP--QISDFGLAKWLP--SQWTHHSIAPIEGTFGHLAPEY 241
              I H DI+  NI+         +I +FG A+ L     +     AP      + APE 
Sbjct: 120 SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAP-----EYYAPEV 174
Query: 242 FMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRL--- 298
             H +V   TD+++ G  +  ++SG  P                NQ  IE +++      
Sbjct: 175 HQHDVVSTATDMWSLGTLVYVLLSGINPFLAE-----------TNQQIIENIMNAEYTFD 223
Query: 299 QGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLE 333
           + A+    +  + F   L ++   + R T SE L+
Sbjct: 224 EEAFKEISIEAMDFVDRLLVKERKS-RMTASEALQ 257

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 87/209 (41%), Gaps = 18/209 (8%)
Query: 74  VGRGGYAEVYK-----GVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLS 128
           +G G +A V K       LQ   +   KR TK        ++   E+  +  + HPNV++
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 129 LLGCCVDN-GLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQR 187
           L     +   + LI +  + G +     +  S   E        +    G++YLH     
Sbjct: 79  LHEVYENKTDVILIGELVAGGELFDFLAEKESLTEEEATEFLKQI--LNGVYYLH---SL 133
Query: 188 RIIHRDIKSSNILLTADFEP----QISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFM 243
           +I H D+K  NI+L     P    +I DFGLA  +      +    I GT   +APE   
Sbjct: 134 QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID---FGNEFKNIFGTPEFVAPEIVN 190
Query: 244 HGIVDEKTDVFAFGVFLLEIISGRKPVDG 272
           +  +  + D+++ GV    ++SG  P  G
Sbjct: 191 YEPLGLEADMWSIGVITYILLSGASPFLG 219

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 36/140 (25%), Positives = 57/140 (40%), Gaps = 9/140 (6%)
Query: 138 LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSS 197
           L ++ +    G + S   D        +   +I       + YLH      I HRD+K  
Sbjct: 134 LLIVXECLDGGELFSRIQDRGDQAFTEREASEIXKSIGEAIQYLHSI---NIAHRDVKPE 190
Query: 198 NILLTADFEPQI---SDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVF 254
           N+L T+     I   +DFG AK   S   H+S+     T  ++APE       D+  D +
Sbjct: 191 NLLYTSKRPNAILKLTDFGFAKETTS---HNSLTTPCYTPYYVAPEVLGPEKYDKSCDXW 247
Query: 255 AFGVFLLEIISGRKPVDGSH 274
           + GV    ++ G  P   +H
Sbjct: 248 SLGVIXYILLCGYPPFYSNH 267

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 33/102 (32%), Positives = 47/102 (46%), Gaps = 9/102 (8%)
Query: 177 GLHYLHKGCQRRIIHRDIKSSNILLTADFEP--QISDFGLAKWLPSQWTHHSIAPIEGTF 234
           G+ Y H     +I HRD+K  N LL     P  +I DFG +K   S   H       GT 
Sbjct: 128 GVSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTP 181
Query: 235 GHLAPEYFMHGIVDEK-TDVFAFGVFLLEIISGRKPVDGSHQ 275
            ++APE  +    D K  DV++ GV L  ++ G  P +   +
Sbjct: 182 AYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 223

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 27/89 (30%), Positives = 47/89 (52%), Gaps = 5/89 (5%)
Query: 185 CQR-RIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFM 243
           C R +I+HRD+K  N+LL  +   +I+DFGL+  +      + +    G+  + APE   
Sbjct: 124 CHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG---NFLKTSCGSPNYAAPEVIN 180
Query: 244 HGI-VDEKTDVFAFGVFLLEIISGRKPVD 271
             +    + DV++ G+ L  ++ GR P D
Sbjct: 181 GKLYAGPEVDVWSCGIVLYVMLVGRLPFD 209

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	386
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-135
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-119
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-118
3soc_A	322	Activin receptor type-2A; structural genomics cons	4e-74
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	2e-56
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	3e-56
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	4e-56
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	4e-54
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	1e-53
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	2e-52
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	4e-51
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	2e-50
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	4e-49
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	4e-48
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	5e-47
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	3e-46
3q4u_A	301	Activin receptor type-1; structural genomics conso	3e-45
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	1e-44
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	7e-35
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	1e-34
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	4e-34
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	7e-34
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	8e-34
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	2e-33
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	5e-33
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	7e-33
2a19_B	284	Interferon-induced, double-stranded RNA-activated	9e-33
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	1e-32
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	2e-32
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	2e-32
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	3e-32
3pls_A	298	Macrophage-stimulating protein receptor; protein k	4e-32
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	6e-32
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	7e-32
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	1e-31
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	1e-31
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	2e-31
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	3e-31
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	3e-31
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	6e-31
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	8e-31
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	8e-31
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	1e-30
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	2e-30
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	3e-30
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	4e-30
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	6e-30
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	6e-30
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	8e-30
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	1e-29
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	1e-29
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	1e-29
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	1e-29
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	1e-29
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	2e-29
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	2e-29
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	3e-29
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	4e-29
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	5e-29
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	9e-29
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	1e-28
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	1e-28
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	1e-28
4aoj_A	329	High affinity nerve growth factor receptor; transf	1e-28
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	2e-28
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	2e-28
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	2e-28
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	2e-28
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	3e-28
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	4e-28
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	4e-28
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	5e-28
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	5e-28
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	6e-28
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	6e-28
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	7e-28
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	7e-28
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	9e-28
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	1e-27
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	2e-27
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	3e-27
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	3e-27
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	4e-27
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	5e-27
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	5e-27
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	6e-27
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	6e-27
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	8e-27
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	9e-27
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	9e-27
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	1e-26
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	1e-26
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	1e-26
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	2e-26
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	3e-26
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	5e-26
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	5e-26
3aln_A	327	Dual specificity mitogen-activated protein kinase;	6e-26
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	6e-26
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	1e-25
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	1e-25
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	2e-25
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	4e-25
3fme_A	290	Dual specificity mitogen-activated protein kinase;	6e-25
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	6e-25
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	6e-25
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	6e-25
3an0_A	340	Dual specificity mitogen-activated protein kinase;	7e-25
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	1e-24
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	2e-24
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	4e-24
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	6e-24
2dyl_A	318	Dual specificity mitogen-activated protein kinase	7e-24
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	1e-23
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	3e-23
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	1e-22
3ork_A	311	Serine/threonine protein kinase; structural genomi	2e-22
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	5e-22
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	5e-22
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	6e-22
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	1e-21
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	3e-21
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	5e-21
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	1e-20
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	3e-20
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	3e-20
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	4e-20
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	7e-20
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	1e-19
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	1e-19
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	1e-19
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	3e-19
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	5e-19
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	5e-19
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	6e-19
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	7e-19
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	1e-18
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	2e-18
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	2e-18
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	2e-18
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	4e-18
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	4e-18
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	5e-18
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	5e-18
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	7e-18
3niz_A	311	Rhodanese family protein; structural genomics, str	9e-18
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	1e-17
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	1e-17
3o0g_A	292	Cell division protein kinase 5; kinase activator c	1e-17
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	1e-17
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	1e-17
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	1e-17
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	2e-17
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	2e-17
3bhy_A	283	Death-associated protein kinase 3; death associate	2e-17
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	2e-17
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	2e-17
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	2e-17
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	2e-17
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	3e-17
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	4e-17
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	4e-17
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	6e-17
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	8e-17
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	9e-17
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	9e-17
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	1e-16
3uqc_A	286	Probable conserved transmembrane protein; structur	1e-16
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	2e-16
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	2e-16
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	2e-16
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	2e-16
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	3e-16
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	4e-16
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	9e-16
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	2e-15
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	3e-15
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	3e-15
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	4e-15
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	6e-15
3rp9_A	458	Mitogen-activated protein kinase; structural genom	7e-15
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	1e-14
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	2e-14
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	2e-14
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	2e-14
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	2e-14
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	2e-14
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	3e-14
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	4e-14
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	5e-14
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	7e-14
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	8e-14
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	2e-13
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-13
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	6e-08
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	2e-13
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	3e-13
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	3e-13
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	1e-12
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	2e-12
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	2e-12
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	5e-12
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	9e-12
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	2e-11
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	3e-11
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	3e-11
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	4e-11
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	4e-11
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	5e-11
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	7e-11
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	9e-11
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	1e-10
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	8e-10
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	2e-09
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	3e-09
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	3e-09
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	4e-09
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	1e-08
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	2e-08
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	3e-08
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	4e-08
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	4e-08
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	7e-08
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	2e-06
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	6e-06
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	3e-05
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	3e-05
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	8e-05
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	9e-05
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	2e-04
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	4e-04
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	4e-04

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  389 bits (1002), Expect = e-135
 Identities = 133/310 (42%), Positives = 191/310 (61%), Gaps = 13/310 (4%)

Query: 53  WRCFSFEEISIATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFL 112
            + FS  E+ +A++ FS++N++GRGG+ +VYKG L DG  +AVKRL K       E +F 
Sbjct: 17  LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRL-KEERTQGGELQFQ 75

Query: 113 TEIGTIGHVCHPNVLSLLGCCVD-NGLYLIFQFSSRGSVASLFHDV--NSPGVEWKVRHK 169
           TE+  I    H N+L L G C+      L++ + + GSVAS   +   + P ++W  R +
Sbjct: 76  TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQR 135

Query: 170 IAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAP 229
           IA+G+ARGL YLH  C  +IIHRD+K++NILL  +FE  + DFGLAK +  + TH + A 
Sbjct: 136 IALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA- 194

Query: 230 IEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGS------HQSLHSWAKP 283
           + GT GH+APEY   G   EKTDVF +GV LLE+I+G++  D +         L  W K 
Sbjct: 195 VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 254

Query: 284 ILNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEGDQIDK 343
           +L + ++E LVD  LQG Y   ++ +L   A LC ++SP  RP MSEV+  MLEGD +  
Sbjct: 255 LLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVR-MLEGDGL-A 312

Query: 344 ERWKMPEEEE 353
           ERW+  ++EE
Sbjct: 313 ERWEEWQKEE 322

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  346 bits (890), Expect = e-119
 Identities = 108/294 (36%), Positives = 165/294 (56%), Gaps = 15/294 (5%)

Query: 54  RCFSFEEISIATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLT 113
                 ++  ATN F  + L+G G + +VYKGVL+DG ++A+KR T      +  +EF T
Sbjct: 27  YRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTP--ESSQGIEEFET 84

Query: 114 EIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQFSSRGSVASLFHDVNSPGV--EWKVRHKI 170
           EI T+    HP+++SL+G C +   + LI+++   G++    +  + P +   W+ R +I
Sbjct: 85  EIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEI 144

Query: 171 AVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQ-WTHHSIAP 229
            +G ARGLHYLH      IIHRD+KS NILL  +F P+I+DFG++K       TH S   
Sbjct: 145 CIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTV- 200

Query: 230 IEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGS----HQSLHSWAKPIL 285
           ++GT G++ PEYF+ G + EK+DV++FGV L E++  R  +  S      +L  WA    
Sbjct: 201 VKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESH 260

Query: 286 NQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEGD 339
           N G++E++VDP L        L +    A  C+  S   RP+M +VL   LE  
Sbjct: 261 NNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLW-KLEYA 313

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  344 bits (885), Expect = e-118
 Identities = 100/301 (33%), Positives = 152/301 (50%), Gaps = 22/301 (7%)

Query: 54  RCFSFEEISIATNAFSSE------NLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRK 107
             FSF E+   TN F         N +G GG+  VYKG + +   +AVK+L  +V    +
Sbjct: 13  HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTE 71

Query: 108 --EKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQFSSRGSVAS-LFHDVNSPGVE 163
             +++F  EI  +    H N++ LLG   D   L L++ +   GS+   L     +P + 
Sbjct: 72  ELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLS 131

Query: 164 WKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPS-QW 222
           W +R KIA G A G+++LH+      IHRDIKS+NILL   F  +ISDFGLA+       
Sbjct: 132 WHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQ 188

Query: 223 THHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGS--HQSLHSW 280
           T  +   I GT  ++APE  + G +  K+D+++FGV LLEII+G   VD     Q L   
Sbjct: 189 TVMTSR-IVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDI 246

Query: 281 AKPIL-NQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEGD 339
            + I   +  IE  +D ++    D T +  +   AS C+      RP + +V + +L+  
Sbjct: 247 KEEIEDEEKTIEDYIDKKMND-ADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQ-LLQEM 304

Query: 340 Q 340
            
Sbjct: 305 T 305

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  232 bits (593), Expect = 4e-74
 Identities = 77/309 (24%), Positives = 116/309 (37%), Gaps = 35/309 (11%)

Query: 56  FSFEEISIATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEI 115
              E +   +       +  RG +  V+K  L   E +AVK        D++  +   E+
Sbjct: 14  LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFP---IQDKQSWQNEYEV 69

Query: 116 GTIGHVCHPNVLSLLGCC-----VDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKI 170
            ++  + H N+L  +G       VD  L+LI  F  +GS   L   + +  V W     I
Sbjct: 70  YSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGS---LSDFLKANVVSWNELCHI 126

Query: 171 AVGTARGLHYLH-------KGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWT 223
           A   ARGL YLH        G +  I HRDIKS N+LL  +    I+DFGLA    +  +
Sbjct: 127 AETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKS 186

Query: 224 HHSIAPIEGTFGHLAPEYFMHGI-----VDEKTDVFAFGVFLLEIISGRKPVDGSHQSLH 278
                   GT  ++APE     I        + D++A G+ L E+ S     DG      
Sbjct: 187 AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYM 246

Query: 279 S------WAKPILNQGE---IEKLVDPRLQGAYDVTQ-LNRLAFAASLCIRASPTWRPTM 328
                     P L   +   + K   P L+  +     +  L      C       R + 
Sbjct: 247 LPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSA 306

Query: 329 SEVLEVMLE 337
             V E  + 
Sbjct: 307 GCVGE-RIT 314

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  186 bits (475), Expect = 2e-56
 Identities = 71/335 (21%), Positives = 114/335 (34%), Gaps = 50/335 (14%)

Query: 56  FSFEEISIATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTE- 114
            +  E S+  +      L+GRG Y  VYKG L D   +AVK            + F+ E 
Sbjct: 3   AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVF-----SFANRQNFINEK 56

Query: 115 -IGTIGHVCHPNVLSLLGCCV------DNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVR 167
            I  +  + H N+   +               L+ ++   GS   L   ++    +W   
Sbjct: 57  NIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGS---LXKYLSLHTSDWVSS 113

Query: 168 HKIAVGTARGLHYLH------KGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQ 221
            ++A    RGL YLH         +  I HRD+ S N+L+  D    ISDFGL+  L   
Sbjct: 114 CRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGN 173

Query: 222 WTHHSIAPIE------GTFGHLAPEYFMHGI-------VDEKTDVFAFGVFLLEIISGR- 267
                           GT  ++APE     +         ++ D++A G+   EI     
Sbjct: 174 RLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCT 233

Query: 268 -----KPVDGSHQSLHSWAKPILNQGEIEKLVD-----PRLQGAYDVTQLNRLAFA--AS 315
                + V     +  +         +++ LV      P+   A+    L   +      
Sbjct: 234 DLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIE 293

Query: 316 LCIRASPTWRPTMSEVLEVMLEGDQIDKERWKMPE 350
            C       R T     E  +    +  ER K   
Sbjct: 294 DCWDQDAEARLTAQXAEE-RMAELMMIWERNKSVS 327

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  185 bits (473), Expect = 3e-56
 Identities = 79/326 (24%), Positives = 142/326 (43%), Gaps = 46/326 (14%)

Query: 57  SFEEISIATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIG 116
           S   I         E +VGRG +  V K   +  +++A+K++      + + K F+ E+ 
Sbjct: 1   SLHMIDY--KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIE----SESERKAFIVELR 53

Query: 117 TIGHVCHPNVLSLLGCCVDNGLYLIFQFSSRGSVASLFHDV-NSPGVEWKVRHKIAVGTA 175
            +  V HPN++ L G C++  + L+ +++  GS+ ++ H     P           +  +
Sbjct: 54  QLSRVNHPNIVKLYGACLNP-VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCS 112

Query: 176 RGLHYLHKGCQRRIIHRDIKSSNILLTADFE-PQISDFGLAKWLPSQWTHHSIAPIEGTF 234
           +G+ YLH    + +IHRD+K  N+LL A     +I DFG A  + +  T++      G+ 
Sbjct: 113 QGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNK-----GSA 167

Query: 235 GHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQG---EIE 291
             +APE F      EK DVF++G+ L E+I+ RKP D             ++ G    + 
Sbjct: 168 AWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFR-IMWAVHNGTRPPLI 226

Query: 292 KLVDPRLQGAYDVTQLNRLAFAASL---CIRASPTWRPTMSEVLEVMLEGDQI----DKE 344
           K +   +                SL   C    P+ RP+M E++++M    +     D+ 
Sbjct: 227 KNLPKPI---------------ESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEP 271

Query: 345 RWK-----MPEEEEEDQEEFWGFDDL 365
                   +P  E+   E +  F + 
Sbjct: 272 LQYPCQHSLPPGEDGRVEPYVDFAEF 297

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  185 bits (472), Expect = 4e-56
 Identities = 69/289 (23%), Positives = 139/289 (48%), Gaps = 30/289 (10%)

Query: 57  SFEEISIATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIG 116
             +++ I     + +  +G G +  V++     G ++AVK L +      +  EFL E+ 
Sbjct: 28  DGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVA 86

Query: 117 TIGHVCHPNVLSLLGCCVDNG-LYLIFQFSSRGSVASLFHDVNSPG-VEWKVRHKIAVGT 174
            +  + HPN++  +G       L ++ ++ SRGS+  L H   +   ++ + R  +A   
Sbjct: 87  IMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDV 146

Query: 175 ARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTF 234
           A+G++YLH      I+HR++KS N+L+   +  ++ DFGL++ L +     S +   GT 
Sbjct: 147 AKGMNYLH-NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSR-LKASTFLSSKSAA-GTP 203

Query: 235 GHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQG---EIE 291
             +APE       +EK+DV++FGV L E+ + ++P    + +    A  +  +    EI 
Sbjct: 204 EWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAA--VGFKCKRLEIP 261

Query: 292 KLVDPRLQGAYDVTQLNRLAFAASL---CIRASPTWRPTMSEVLEVMLE 337
           + ++P++               A++   C    P  RP+ + +++ +L 
Sbjct: 262 RNLNPQV---------------AAIIEGCWTNEPWKRPSFATIMD-LLR 294

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  179 bits (456), Expect = 4e-54
 Identities = 59/292 (20%), Positives = 106/292 (36%), Gaps = 46/292 (15%)

Query: 58  FEEISIATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGT 117
           F++++           +      E++KG  Q G +I VK L       RK ++F  E   
Sbjct: 9   FKQLNF-------LTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPR 60

Query: 118 IGHVCHPNVLSLLGCCVD---NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGT 174
           +    HPNVL +LG C         LI  +   GS+ ++ H+  +  V+     K A+  
Sbjct: 61  LRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDM 120

Query: 175 ARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTF 234
           ARG+ +LH   +  I    + S ++++  D   +IS   +       +            
Sbjct: 121 ARGMAFLH-TLEPLIPRHALNSRSVMIDEDMTARISMADVKF----SFQSPGRM---YAP 172

Query: 235 GHLAPEYFMH---GIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQG--- 288
             +APE              D+++F V L E+++   P              +  +G   
Sbjct: 173 AWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNM--EIGMKVALEGLRP 230

Query: 289 EIEKLVDPRLQGAYDVTQLNRLAFAASL---CIRASPTWRPTMSEVLEVMLE 337
            I   + P +               + L   C+   P  RP    ++  +LE
Sbjct: 231 TIPPGISPHV---------------SKLMKICMNEDPAKRPKFDMIVP-ILE 266

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  178 bits (453), Expect = 1e-53
 Identities = 75/312 (24%), Positives = 126/312 (40%), Gaps = 50/312 (16%)

Query: 45  ESETTKPTWRCFSFEEISIATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVT 103
            SE  K      +  EI         E  +G+GG+  V+KG L  D   +A+K L    +
Sbjct: 5   GSEFPKSRLPTLADNEIEY-------EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDS 57

Query: 104 DDRKE-----KEFLTEIGTIGHVCHPNVLSLLGCCVDNGLYLIFQFSSRGSVASLFHDVN 158
           +   E     +EF  E+  + ++ HPN++ L G    N   ++ +F   G +     D  
Sbjct: 58  EGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMH-NPPRMVMEFVPCGDLYHRLLDKA 116

Query: 159 SPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQ-----ISDFG 213
            P ++W V+ ++ +  A G+ Y+       I+HRD++S NI L +  E       ++DFG
Sbjct: 117 HP-IKWSVKLRLMLDIALGIEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFG 174

Query: 214 LAKWLPSQWTHHSIAPIEGTFGHLAPEYFM--HGIVDEKTDVFAFGVFLLEIISGRKPVD 271
           L++      +        G F  +APE          EK D ++F + L  I++G  P D
Sbjct: 175 LSQQSVHSVSGLL-----GNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD 229

Query: 272 GSHQSLHSWAKPILNQG---EIEKLVDPRLQGAYDVTQLNRLAFAASL---CIRASPTWR 325
                   +   I  +G    I +   PRL                ++   C    P  R
Sbjct: 230 EYSYGKIKFINMIREEGLRPTIPEDCPPRL---------------RNVIELCWSGDPKKR 274

Query: 326 PTMSEVLEVMLE 337
           P  S +++  L 
Sbjct: 275 PHFSYIVK-ELS 285

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  174 bits (443), Expect = 2e-52
 Identities = 74/295 (25%), Positives = 125/295 (42%), Gaps = 49/295 (16%)

Query: 58  FEEISIATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKE--KEFLTEI 115
           F E+++       E ++G GG+ +VY+     G+E+AVK       +D  +  +    E 
Sbjct: 6   FAELTL-------EEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEA 57

Query: 116 GTIGHVCHPNVLSLLGCCVDNG-LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGT 174
                + HPN+++L G C+    L L+ +F+  G +  +        +   +    AV  
Sbjct: 58  KLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSG---KRIPPDILVNWAVQI 114

Query: 175 ARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQ--------ISDFGLAKWLPSQWTHHS 226
           ARG++YLH      IIHRD+KSSNIL+    E          I+DFGLA+    +W   +
Sbjct: 115 ARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR----EWHRTT 170

Query: 227 IAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILN 286
                G +  +APE     +  + +DV+++GV L E+++G  P  G      + A  +  
Sbjct: 171 KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGL--AVAYGVAM 228

Query: 287 QG---EIEKLVDPRLQGAYDVTQLNRLAFAASL---CIRASPTWRPTMSEVLEVM 335
                 I                       A L   C    P  RP+ + +L+ +
Sbjct: 229 NKLALPIPSTCPEPF---------------AKLMEDCWNPDPHSRPSFTNILDQL 268

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  169 bits (431), Expect = 2e-50
 Identities = 72/288 (25%), Positives = 121/288 (42%), Gaps = 34/288 (11%)

Query: 58  FEEISIATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGT 117
             +I++          +G G +  VYKG      ++AVK L       ++ + F  E+G 
Sbjct: 23  DGQITV-------GQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGV 73

Query: 118 IGHVCHPNVLSLLGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARG 177
           +    H N+L  +G      L ++ Q+    S+    H  +    E K    IA  TARG
Sbjct: 74  LRKTRHVNILLFMGYSTAPQLAIVTQWCEGSSLYHHLHA-SETKFEMKKLIDIARQTARG 132

Query: 178 LHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHL 237
           + YLH    + IIHRD+KS+NI L  D   +I DFGLA         H    + G+   +
Sbjct: 133 MDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWM 189

Query: 238 APE---YFMHGIVDEKTDVFAFGVFLLEIISGRKP---VDGSHQSLHSWAKPIL--NQGE 289
           APE            ++DV+AFG+ L E+++G+ P   ++   Q +    +  L  +  +
Sbjct: 190 APEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSK 249

Query: 290 IEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLE 337
           +      R+     +            C++     RP+   +L   +E
Sbjct: 250 VRSNCPKRM---KRLMA---------ECLKKKRDERPSFPRILA-EIE 284

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  167 bits (425), Expect = 4e-49
 Identities = 63/294 (21%), Positives = 114/294 (38%), Gaps = 41/294 (13%)

Query: 58  FEEISIATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGT 117
           FE++ I         L+G+G + +VY G      E+A++ +     ++ + K F  E+  
Sbjct: 32  FEQLEI-------GELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMA 82

Query: 118 IGHVCHPNVLSLLGCCVDNG-LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTAR 176
                H NV+  +G C+    L +I       ++ S+  D     ++     +IA    +
Sbjct: 83  YRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIV-LDVNKTRQIAQEIVK 141

Query: 177 GLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAK----WLPSQWTHHSIAPIEG 232
           G+ YLH    + I+H+D+KS N+    + +  I+DFGL          +          G
Sbjct: 142 GMGYLH---AKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQN-G 196

Query: 233 TFGHLAPEYFMHGIV---------DEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKP 283
              HLAPE                 + +DVFA G    E+ +   P          W   
Sbjct: 197 WLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQ-- 254

Query: 284 ILNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLE 337
            +  G   K    ++    +++ +         C       RPT +++++ MLE
Sbjct: 255 -MGTG--MKPNLSQIGMGKEISDI------LLFCWAFEQEERPTFTKLMD-MLE 298

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  164 bits (418), Expect = 4e-48
 Identities = 69/310 (22%), Positives = 117/310 (37%), Gaps = 42/310 (13%)

Query: 71  ENLVGRGGYAEVYKGVL-QDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSL 129
             ++G+G + +  K    + GE + +K L +   D+  ++ FL E+  +  + HPNVL  
Sbjct: 15  GEVLGKGCFGQAIKVTHRETGEVMVMKELIR--FDEETQRTFLKEVKVMRCLEHPNVLKF 72

Query: 130 LGCCVDNG-LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRR 188
           +G    +  L  I ++   G++  +   ++S    W  R   A   A G+ YLH      
Sbjct: 73  IGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQ-YPWSQRVSFAKDIASGMAYLH---SMN 128

Query: 189 IIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIA------------PIEGTFGH 236
           IIHRD+ S N L+  +    ++DFGLA+ +  + T                  + G    
Sbjct: 129 IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYW 188

Query: 237 LAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDP 296
           +APE       DEK DVF+FG+ L EII                   +    +    V  
Sbjct: 189 MAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNA----------DPDYLPRTMDFGLNVRG 238

Query: 297 --RLQGAYDV-TQLNRLAFAASLCIRASPTWRPTMSEV---LEVMLEGDQIDKERWKMPE 350
                   +       +      C    P  RP+  ++   LE +            +  
Sbjct: 239 FLDRYCPPNCPPSFFPITVR---CCDLDPEKRPSFVKLEHWLETLRMHLAGHLP---LGP 292

Query: 351 EEEEDQEEFW 360
           + E+    FW
Sbjct: 293 QLEQLDRGFW 302

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  162 bits (412), Expect = 5e-47
 Identities = 68/292 (23%), Positives = 113/292 (38%), Gaps = 34/292 (11%)

Query: 71  ENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLL 130
              +G+G Y EV+ G  + GE++AVK      T +       TEI     + H N+L  +
Sbjct: 42  VKQIGKGRYGEVWMGKWR-GEKVAVKVFF---TTEEASWFRETEIYQTVLMRHENILGFI 97

Query: 131 GCCVDNG-----LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLH--- 182
              +        LYLI  +   GS   L+  + S  ++ K   K+A  +  GL +LH   
Sbjct: 98  AADIKGTGSWTQLYLITDYHENGS---LYDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEI 154

Query: 183 --KGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIE--GTFGHLA 238
                +  I HRD+KS NIL+  +    I+D GLA    S      I P    GT  ++ 
Sbjct: 155 FSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMP 214

Query: 239 PE------YFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEK 292
           PE         H       D+++FG+ L E+           +    +   + +    E 
Sbjct: 215 PEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYED 274

Query: 293 LVD--------PRLQGAYDVTQ-LNRLAFAASLCIRASPTWRPTMSEVLEVM 335
           + +        P     +   + L ++    + C   +P  R T   V + +
Sbjct: 275 MREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTL 326

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  156 bits (397), Expect = 3e-45
 Identities = 69/301 (22%), Positives = 112/301 (37%), Gaps = 52/301 (17%)

Query: 71  ENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFL--TEIGTIGHVCHPNVLS 128
              VG+G Y EV++G  Q GE +AVK         R EK +   TE+     + H N+L 
Sbjct: 13  LECVGKGRYGEVWRGSWQ-GENVAVKIF-----SSRDEKSWFRETELYNTVMLRHENILG 66

Query: 129 LLGCCVDNG-----LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLH- 182
            +   + +      L+LI  +   GS   L+  +    ++     +I +  A GL +LH 
Sbjct: 67  FIASDMTSRHSSTQLWLITHYHEMGS---LYDYLQLTTLDTVSCLRIVLSIASGLAHLHI 123

Query: 183 ----KGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIE--GTFGH 236
                  +  I HRD+KS NIL+  + +  I+D GLA           +      GT  +
Sbjct: 124 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRY 183

Query: 237 LAPEYFMHGIV------DEKTDVFAFGVFLLEIISGRKPVD-------------GSHQSL 277
           +APE     I        ++ D++AFG+ L E+                      +  S 
Sbjct: 184 MAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSF 243

Query: 278 HSWAKPILNQGEIEKLVDPRLQGAYDVTQLNRLAFAASL---CIRASPTWRPTMSEVLEV 334
               K +    +       R            L   A L   C   +P+ R T   + + 
Sbjct: 244 EDMRKVVCVDQQ-------RPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKT 296

Query: 335 M 335
           +
Sbjct: 297 L 297

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  156 bits (397), Expect = 1e-44
 Identities = 77/315 (24%), Positives = 122/315 (38%), Gaps = 56/315 (17%)

Query: 71  ENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTE--IGTIGHVCHPNVLS 128
           +  +G+G + EV++G  + GEE+AVK         R+E+ +  E  I     + H N+L 
Sbjct: 47  QESIGKGRFGEVWRGKWR-GEEVAVKIF-----SSREERSWFREAEIYQTVMLRHENILG 100

Query: 129 LLGCCVDNG-----LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLH- 182
            +     +      L+L+  +   GS   LF  +N   V  +   K+A+ TA GL +LH 
Sbjct: 101 FIAADNKDNGTWTQLWLVSDYHEHGS---LFDYLNRYTVTVEGMIKLALSTASGLAHLHM 157

Query: 183 ----KGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIE--GTFGH 236
                  +  I HRD+KS NIL+  +    I+D GLA    S      IAP    GT  +
Sbjct: 158 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 217

Query: 237 LAPE------YFMHGIVDEKTDVFAFGVFLLEIISGRKPVD-------------GSHQSL 277
           +APE         H    ++ D++A G+   EI                      S  S+
Sbjct: 218 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 277

Query: 278 HSWAKPILNQGEIEKLVDPRLQGAYDVTQLNRLAFAASL---CIRASPTWRPTMSEVLEV 334
               K +  Q         R            L   A +   C  A+   R T   + + 
Sbjct: 278 EEMRKVVCEQKL-------RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 330

Query: 335 MLEGDQIDKE-RWKM 348
           +    Q+ ++   KM
Sbjct: 331 L---SQLSQQEGIKM 342

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  129 bits (327), Expect = 7e-35
 Identities = 71/293 (24%), Positives = 117/293 (39%), Gaps = 35/293 (11%)

Query: 60  EISIATNAFSSENLVGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTI 118
            + I    +     +G GG++ V     L DG   A+KR+  +  + +  +E   E    
Sbjct: 23  MVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRI--LCHEQQDREEAQREADMH 80

Query: 119 GHVCHPNVLSLLGCCVDNG-----LYLIFQFSSRGSVASLFHDVNSPGV---EWKVRHKI 170
               HPN+L L+  C+         +L+  F  RG++ +    +   G    E ++   +
Sbjct: 81  RLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQIL-WL 139

Query: 171 AVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPI 230
            +G  RGL  +H    +   HRD+K +NILL  + +P + D G              A  
Sbjct: 140 LLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALT 196

Query: 231 E-------GTFGHLAPEYF---MHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSW 280
                    T  + APE F    H ++DE+TDV++ G  L  ++ G  P D   Q   S 
Sbjct: 197 LQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSV 256

Query: 281 AKPILNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLE 333
           A  + NQ  I     P+         L +L    +  +   P  RP +  +L 
Sbjct: 257 ALAVQNQLSI-----PQSPRHSS--ALWQL---LNSMMTVDPHQRPHIPLLLS 299

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  128 bits (324), Expect = 1e-34
 Identities = 71/269 (26%), Positives = 127/269 (47%), Gaps = 23/269 (8%)

Query: 73  LVGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFL-TEIGTIGHVCHPNVLSLL 130
            +GRG ++EVY+   L DG  +A+K++      D K +     EI  +  + HPNV+   
Sbjct: 39  KIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYY 98

Query: 131 GCCVDNG-LYLIFQFSSRGSVASLFHDVNSPGV---EWKVRHKIAVGTARGLHYLHKGCQ 186
              +++  L ++ + +  G ++ +            E  V  K  V     L ++H    
Sbjct: 99  ASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVW-KYFVQLCSALEHMH---S 154

Query: 187 RRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTH-HSIAPIEGTFGHLAPEYFMHG 245
           RR++HRDIK +N+ +TA    ++ D GL ++  S+ T  HS+    GT  +++PE     
Sbjct: 155 RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV---GTPYYMSPERIHEN 211

Query: 246 IVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVT 305
             + K+D+++ G  L E+ + + P  G   +L+S  K I  Q +      P     Y   
Sbjct: 212 GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKI-EQCDY----PPLPSDHYS-E 265

Query: 306 QLNRLAFAASLCIRASPTWRPTMSEVLEV 334
           +L +L    ++CI   P  RP ++ V +V
Sbjct: 266 ELRQL---VNMCINPDPEKRPDVTYVYDV 291

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  127 bits (322), Expect = 4e-34
 Identities = 64/269 (23%), Positives = 101/269 (37%), Gaps = 26/269 (9%)

Query: 68  FSSENLVGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVC-HPN 125
           F   + +G G Y EV+K    +DG   AVKR        +     L E+G+   V  HP 
Sbjct: 59  FQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPC 118

Query: 126 VLSLLGCCVDNG-LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKG 184
            + L     + G LYL  +     S+        +   E +V       T   L +LH  
Sbjct: 119 CVRLEQAWEEGGILYLQTELCG-PSLQQHCEAWGASLPEAQVW-GYLRDTLLALAHLH-- 174

Query: 185 CQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMH 244
             + ++H D+K +NI L      ++ DFGL   L +          EG   ++APE    
Sbjct: 175 -SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQ---EGDPRYMAPELLQG 230

Query: 245 GIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDV 304
                  DVF+ G+ +LE+    +   G       W +  L QG +     P        
Sbjct: 231 SY-GTAADVFSLGLTILEVACNMELPHG----GEGWQQ--LRQGYL----PPEFTAGLS- 278

Query: 305 TQLNRLAFAASLCIRASPTWRPTMSEVLE 333
           ++L  +     + +   P  R T   +L 
Sbjct: 279 SELRSVL---VMMLEPDPKLRATAEALLA 304

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  128 bits (324), Expect = 7e-34
 Identities = 57/235 (24%), Positives = 99/235 (42%), Gaps = 24/235 (10%)

Query: 42  VACESETTKPTWRCFSFEEISIATNAFSSENLVGRGGYAEVYKGVLQDGE-EIAVKRLTK 100
           V       K  W   + E++ +          +GRG + EV+ G L+     +AVK   +
Sbjct: 98  VVLHRAVPKDKWV-LNHEDLVL-------GEQIGRGNFGEVFSGRLRADNTLVAVKSC-R 148

Query: 101 VVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQFSSRGSVASLFHDVNS 159
                  + +FL E   +    HPN++ L+G C     +Y++ +    G   +       
Sbjct: 149 ETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRT-EG 207

Query: 160 PGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLP 219
             +  K   ++    A G+ YL     +  IHRD+ + N L+T     +ISDFG+++   
Sbjct: 208 ARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEA 264

Query: 220 -SQWTHHSIA---PIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKP 269
              +         P++ T    APE   +G    ++DV++FG+ L E  S G  P
Sbjct: 265 DGVYAASGGLRQVPVKWT----APEALNYGRYSSESDVWSFGILLWETFSLGASP 315

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  127 bits (321), Expect = 8e-34
 Identities = 61/205 (29%), Positives = 101/205 (49%), Gaps = 19/205 (9%)

Query: 75  GRGGYAEVYKGVLQDGEE-----IAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSL 129
           G G +  VYKG+     E     +A+K L +  T  +  KE L E   +  V +P+V  L
Sbjct: 24  GSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEILDEAYVMASVDNPHVCRL 82

Query: 130 LGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRI 189
           LG C+ + + LI Q    G +     + +   +  +      V  A+G++YL     RR+
Sbjct: 83  LGICLTSTVQLITQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLE---DRRL 138

Query: 190 IHRDIKSSNILLTADFEPQISDFGLAKWLP--SQWTHHSIA--PIEGTFGHLAPEYFMHG 245
           +HRD+ + N+L+      +I+DFGLAK L    +  H      PI+      A E  +H 
Sbjct: 139 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM----ALESILHR 194

Query: 246 IVDEKTDVFAFGVFLLEIIS-GRKP 269
           I   ++DV+++GV + E+++ G KP
Sbjct: 195 IYTHQSDVWSYGVTVWELMTFGSKP 219

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  125 bits (316), Expect = 2e-33
 Identities = 62/233 (26%), Positives = 100/233 (42%), Gaps = 42/233 (18%)

Query: 60  EISIATNAFSSENLVGRGGYAEVYKGVLQDGEE----IAVKRLTKVVTDDRKEKEFLTEI 115
            I  ++       ++GRG +  VY G L D +      AVK L   +TD  +  +FLTE 
Sbjct: 19  VIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL-NRITDIGEVSQFLTEG 77

Query: 116 GTIGHVCHPNVLSLLGCCVDNG--LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVG 173
             +    HPNVLSLLG C+ +     ++  +   G + + F    +     K      + 
Sbjct: 78  IIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRN-FIRNETHNPTVKDLIGFGLQ 136

Query: 174 TARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKW---------------- 217
            A+G+ YL     ++ +HRD+ + N +L   F  +++DFGLA+                 
Sbjct: 137 VAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAK 193

Query: 218 LPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKP 269
           LP +W               A E         K+DV++FGV L E+++ G  P
Sbjct: 194 LPVKWM--------------ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 232

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  126 bits (317), Expect = 5e-33
 Identities = 59/222 (26%), Positives = 97/222 (43%), Gaps = 42/222 (18%)

Query: 71  ENLVGRGGYAEVYKGVLQDGEE----IAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNV 126
             ++GRG +  VY G L D +      AVK L   +TD  +  +FLTE   +    HPNV
Sbjct: 94  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL-NRITDIGEVSQFLTEGIIMKDFSHPNV 152

Query: 127 LSLLGCCVDNG--LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKG 184
           LSLLG C+ +     ++  +   G + +   +  +     K      +  A+G+ +L   
Sbjct: 153 LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN-ETHNPTVKDLIGFGLQVAKGMKFLA-- 209

Query: 185 CQRRIIHRDIKSSNILLTADFEPQISDFGLAKW----------------LPSQWTHHSIA 228
             ++ +HRD+ + N +L   F  +++DFGLA+                 LP +W      
Sbjct: 210 -SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM----- 263

Query: 229 PIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKP 269
                    A E         K+DV++FGV L E+++ G  P
Sbjct: 264 ---------ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 296

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  124 bits (313), Expect = 7e-33
 Identities = 58/228 (25%), Positives = 97/228 (42%), Gaps = 46/228 (20%)

Query: 71  ENLVGRGGYAEVYKGVLQDGEE----IAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNV 126
             ++G G +  V +G L+  +     +AVK +    +  R+ +EFL+E   +    HPNV
Sbjct: 39  GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98

Query: 127 LSLLGCCVDNG------LYLIFQFSSRGSVAS--LFHDVNSPGVEWKVRH--KIAVGTAR 176
           + LLG C++          +I  F   G + +  L+  + +      ++   K  V  A 
Sbjct: 99  IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158

Query: 177 GLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKW--------------LPSQW 222
           G+ YL     R  +HRD+ + N +L  D    ++DFGL+K               +P +W
Sbjct: 159 GMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKW 215

Query: 223 THHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKP 269
                          A E     +   K+DV+AFGV + EI + G  P
Sbjct: 216 I--------------AIESLADRVYTSKSDVWAFGVTMWEIATRGMTP 249

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  123 bits (310), Expect = 9e-33
 Identities = 55/285 (19%), Positives = 104/285 (36%), Gaps = 49/285 (17%)

Query: 68  FSSENLVGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNV 126
           F    L+G GG+ +V+K     DG+   +KR+          ++   E+  +  + H N+
Sbjct: 13  FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRV------KYNNEKAEREVKALAKLDHVNI 66

Query: 127 LSLLGCCVDNG-----------------LYLIFQFSSRGSVASLFHDVNSPGV-EWKVRH 168
           +   GC                      L++  +F  +G++           + +     
Sbjct: 67  VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALE 126

Query: 169 KIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIA 228
            +     +G+ Y+H    +++I+RD+K SNI L    + +I DFGL   L +        
Sbjct: 127 -LFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSK 182

Query: 229 PIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQG 288
              GT  +++PE        ++ D++A G+ L E++                        
Sbjct: 183 ---GTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT-------------AFETSK 226

Query: 289 EIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLE 333
               L D  +   +D  +   L       +   P  RP  SE+L 
Sbjct: 227 FFTDLRDGIISDIFD-KKEKTL---LQKLLSKKPEDRPNTSEILR 267

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  123 bits (312), Expect = 1e-32
 Identities = 52/212 (24%), Positives = 104/212 (49%), Gaps = 19/212 (8%)

Query: 71  ENLVGRGGYAEVYKGVLQDGEE-----IAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPN 125
             ++G G +  V+KGV     E     + +K + +  +  +  +     +  IG + H +
Sbjct: 18  LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVI-EDKSGRQSFQAVTDHMLAIGSLDHAH 76

Query: 126 VLSLLGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGC 185
           ++ LLG C  + L L+ Q+   GS+       +   +  ++     V  A+G++YL    
Sbjct: 77  IVRLLGLCPGSSLQLVTQYLPLGSLLDHVRQ-HRGALGPQLLLNWGVQIAKGMYYLE--- 132

Query: 186 QRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPS--QWTHHSIA--PIEGTFGHLAPEY 241
           +  ++HR++ + N+LL +  + Q++DFG+A  LP   +   +S A  PI+      A E 
Sbjct: 133 EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWM----ALES 188

Query: 242 FMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDG 272
              G    ++DV+++GV + E+++ G +P  G
Sbjct: 189 IHFGKYTHQSDVWSYGVTVWELMTFGAEPYAG 220

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  122 bits (309), Expect = 2e-32
 Identities = 61/272 (22%), Positives = 107/272 (39%), Gaps = 33/272 (12%)

Query: 73  LVGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLG 131
            +GRG +  VYKG+  +   E+A   L        + + F  E   +  + HPN++    
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92

Query: 132 CCVD-----NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQ 186
                      + L+ +  + G++ +         ++ KV         +GL +LH    
Sbjct: 93  SWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV--MKIKVLRSWCRQILKGLQFLH-TRT 149

Query: 187 RRIIHRDIKSSNILLTA-DFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHG 245
             IIHRD+K  NI +T      +I D GLA    + +    I    GT   +APE +   
Sbjct: 150 PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVI----GTPEFMAPEMYEEK 205

Query: 246 IVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGE----IEKLVDPRLQGA 301
             DE  DV+AFG+ +LE+ +   P      +     +  +  G      +K+  P ++  
Sbjct: 206 -YDESVDVYAFGMCMLEMATSEYPYSECQ-NAAQIYR-RVTSGVKPASFDKVAIPEVK-- 260

Query: 302 YDVTQLNRLAFAASLCIRASPTWRPTMSEVLE 333
                          CIR +   R ++ ++L 
Sbjct: 261 ---------EI-IEGCIRQNKDERYSIKDLLN 282

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  123 bits (310), Expect = 2e-32
 Identities = 63/208 (30%), Positives = 104/208 (50%), Gaps = 19/208 (9%)

Query: 75  GRGGYAEVYKGVLQDGEE-----IAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSL 129
           G G +  VYKG+     E     +A+K L +  T  +  KE L E   +  V +P+V  L
Sbjct: 24  GSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEILDEAYVMASVDNPHVCRL 82

Query: 130 LGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRI 189
           LG C+ + + LI Q    G +     + +   +  +      V  A+G++YL     RR+
Sbjct: 83  LGICLTSTVQLITQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLE---DRRL 138

Query: 190 IHRDIKSSNILLTADFEPQISDFGLAKWLPSQ--WTHHSIA--PIEGTFGHLAPEYFMHG 245
           +HRD+ + N+L+      +I+DFGLAK L ++    H      PI+      A E  +H 
Sbjct: 139 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM----ALESILHR 194

Query: 246 IVDEKTDVFAFGVFLLEIIS-GRKPVDG 272
           I   ++DV+++GV + E+++ G KP DG
Sbjct: 195 IYTHQSDVWSYGVTVWELMTFGSKPYDG 222

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  122 bits (307), Expect = 3e-32
 Identities = 53/291 (18%), Positives = 108/291 (37%), Gaps = 43/291 (14%)

Query: 68  FSSENLVGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNV 126
           F     +GRGG+  V++     D    A+KR+ ++   +   ++ + E+  +  + HP +
Sbjct: 7   FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRI-RLPNRELAREKVMREVKALAKLEHPGI 65

Query: 127 LSLLGCCVDNG-------------LYLIFQFSSRGSVASLFHDVNS-PGVEWKVRHKIAV 172
           +      ++               LY+  Q   + ++    +   +    E  V   I +
Sbjct: 66  VRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFL 125

Query: 173 GTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIE- 231
             A  + +LH    + ++HRD+K SNI  T D   ++ DFGL   +       ++     
Sbjct: 126 QIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMP 182

Query: 232 ---------GTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAK 282
                    GT  +++PE         K D+F+ G+ L E++    P     + + +   
Sbjct: 183 AYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLTD 239

Query: 283 PILNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLE 333
             +   +   L   +    Y +             +  SP  RP    ++E
Sbjct: 240 --VRNLKFPPLFTQKYPCEYVM---------VQDMLSPSPMERPEAINIIE 279

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  121 bits (306), Expect = 4e-32
 Identities = 57/223 (25%), Positives = 102/223 (45%), Gaps = 22/223 (9%)

Query: 60  EISIATNAFSSENLVGRGGYAEVYKGVLQDGEE----IAVKRLTKVVTDDRKEKEFLTEI 115
            I        S+ ++G+G +  VY G   D  +     A+K L   +T+ ++ + FL E 
Sbjct: 15  LIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSL-SRITEMQQVEAFLREG 73

Query: 116 GTIGHVCHPNVLSLLGCCVDNG--LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVG 173
             +  + HPNVL+L+G  +      +++  +   G +   F          K      + 
Sbjct: 74  LLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQ-FIRSPQRNPTVKDLISFGLQ 132

Query: 174 TARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWL------PSQWTHHSI 227
            ARG+ YL    +++ +HRD+ + N +L   F  +++DFGLA+ +        Q   H+ 
Sbjct: 133 VARGMEYLA---EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHAR 189

Query: 228 APIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKP 269
            P++ T    A E         K+DV++FGV L E+++ G  P
Sbjct: 190 LPVKWT----ALESLQTYRFTTKSDVWSFGVLLWELLTRGAPP 228

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  122 bits (307), Expect = 6e-32
 Identities = 53/225 (23%), Positives = 88/225 (39%), Gaps = 47/225 (20%)

Query: 75  GRGGYAEVYKGVLQDGEE----IAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLL 130
           G+G +  V +  L+  +     +AVK L   +      +EFL E   +    HP+V  L+
Sbjct: 32  GKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLV 91

Query: 131 GCCVDNG-------LYLIFQFSSRGSVAS----LFHDVNSPGVEWKVRHKIAVGTARGLH 179
           G  + +          +I  F   G + +         N   +  +   +  V  A G+ 
Sbjct: 92  GVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGME 151

Query: 180 YLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKW--------------LPSQWTHH 225
           YL     R  IHRD+ + N +L  D    ++DFGL++               LP +W   
Sbjct: 152 YLS---SRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWL-- 206

Query: 226 SIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKP 269
                       A E     +    +DV+AFGV + EI++ G+ P
Sbjct: 207 ------------ALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP 239

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  124 bits (313), Expect = 7e-32
 Identities = 59/241 (24%), Positives = 101/241 (41%), Gaps = 34/241 (14%)

Query: 41  VVACESETTKPTWRCFSFEEISIATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTK 100
           +     E T      F     ++          +G+G + +V  G  + G ++AVK +  
Sbjct: 168 IKPKVMEGTVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIK- 225

Query: 101 VVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG--LYLIFQFSSRGSVASLFHDVN 158
              +D   + FL E   +  + H N++ LLG  V+    LY++ ++ ++GS+        
Sbjct: 226 ---NDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRG 282

Query: 159 SPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKW- 217
              +      K ++     + YL        +HRD+ + N+L++ D   ++SDFGL K  
Sbjct: 283 RSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA 339

Query: 218 --------LPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRK 268
                   LP +WT              APE         K+DV++FG+ L EI S GR 
Sbjct: 340 SSTQDTGKLPVKWT--------------APEALREKKFSTKSDVWSFGILLWEIYSFGRV 385

Query: 269 P 269
           P
Sbjct: 386 P 386

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  124 bits (312), Expect = 1e-31
 Identities = 62/233 (26%), Positives = 108/233 (46%), Gaps = 17/233 (7%)

Query: 41  VVACESETTKPTWRCFSFEEISIATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTK 100
            V C S   +  W   ++E   I   +   E  +G G + EV+        ++AVK +  
Sbjct: 166 SVPCMSSKPQKPWEKDAWE---IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTM-- 220

Query: 101 VVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNGLYLIFQFSSRGSVASLFHDVNSP 160
                   + FL E   +  + H  ++ L        +Y+I +F ++GS+          
Sbjct: 221 -KPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGS 279

Query: 161 GVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLP- 219
                     +   A G+ ++    QR  IHRD++++NIL++A    +I+DFGLA+ +  
Sbjct: 280 KQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIED 336

Query: 220 SQWTHHSIA--PIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKP 269
           +++T    A  PI+ T    APE    G    K+DV++FG+ L+EI++ GR P
Sbjct: 337 NEYTAREGAKFPIKWT----APEAINFGSFTIKSDVWSFGILLMEIVTYGRIP 385

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  121 bits (306), Expect = 1e-31
 Identities = 66/289 (22%), Positives = 121/289 (41%), Gaps = 25/289 (8%)

Query: 73  LVGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLG 131
            +G G + +       +DG +  +K +       ++ +E   E+  + ++ HPN++    
Sbjct: 31  KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE 90

Query: 132 CCVDNG-LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRII 190
              +NG LY++  +   G +    +       +        V     L ++H    R+I+
Sbjct: 91  SFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH---DRKIL 147

Query: 191 HRDIKSSNILLTADFEPQISDFGLAKWLPSQWTH-HSIAPIEGTFGHLAPEYFMHGIVDE 249
           HRDIKS NI LT D   Q+ DFG+A+ L S      +     GT  +L+PE   +   + 
Sbjct: 148 HRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI---GTPYYLSPEICENKPYNN 204

Query: 250 KTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQLNR 309
           K+D++A G  L E+ + +   +    S+ +    I++ G       P +   Y    L  
Sbjct: 205 KSDIWALGCVLYELCTLKHAFEA--GSMKNLVLKIIS-GSF-----PPVSLHYS-YDLRS 255

Query: 310 LAFAASLCIRASPTWRPTMSEVLEVMLEGDQIDKERWKMPEEEEEDQEE 358
           L    S   + +P  RP+++ +LE       I K   K    +   +E 
Sbjct: 256 L---VSQLFKRNPRDRPSVNSILEK----GFIAKRIEKFLSPQLIAEEF 297

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  123 bits (310), Expect = 2e-31
 Identities = 52/203 (25%), Positives = 99/203 (48%), Gaps = 14/203 (6%)

Query: 71  ENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLL 130
           E  +G+G + EV+ G       +A+K L          + FL E   +  + H  ++ L 
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKP---GTMSPEAFLQEAQVMKKLRHEKLVQLY 245

Query: 131 GCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRII 190
               +  +Y++ ++ S+GS+           +       +A   A G+ Y+ +      +
Sbjct: 246 AVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYV 302

Query: 191 HRDIKSSNILLTADFEPQISDFGLAKWLPS-QWTHHSIA--PIEGTFGHLAPEYFMHGIV 247
           HRD++++NIL+  +   +++DFGLA+ +   ++T    A  PI+ T    APE  ++G  
Sbjct: 303 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT----APEAALYGRF 358

Query: 248 DEKTDVFAFGVFLLEIIS-GRKP 269
             K+DV++FG+ L E+ + GR P
Sbjct: 359 TIKSDVWSFGILLTELTTKGRVP 381

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  119 bits (300), Expect = 3e-31
 Identities = 58/292 (19%), Positives = 105/292 (35%), Gaps = 51/292 (17%)

Query: 68  FSSENLVGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVC-HPN 125
           F     +G G +  V+K V   DG   A+KR  K +     E+  L E+     +  H +
Sbjct: 13  FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSH 72

Query: 126 VLSLLGCCVDNG-LYLIFQFSSRGSVASL---FHDVNSPGVEWKVRHKIAVGTARGLHYL 181
           V+       ++  + +  ++ + GS+A      + + S   E +++  + +   RGL Y+
Sbjct: 73  VVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELK-DLLLQVGRGLRYI 131

Query: 182 HKGCQRRIIHRDIKSSNILLTADFEPQ-------------------ISDFGLAKWLPSQW 222
           H      ++H DIK SNI ++    P                    I D G    + S  
Sbjct: 132 H---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ 188

Query: 223 THHSIAPIEGTFGHLAPEYFMHGIV-DEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWA 281
                   EG    LA E          K D+FA  + ++             ++   W 
Sbjct: 189 V------EEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPL----PRNGDQWH 238

Query: 282 KPILNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLE 333
           +  + QG +     PR+       +   L     + I   P  RP+   +++
Sbjct: 239 E--IRQGRL-----PRIPQVLS-QEFTEL---LKVMIHPDPERRPSAMALVK 279

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  123 bits (310), Expect = 3e-31
 Identities = 52/203 (25%), Positives = 100/203 (49%), Gaps = 14/203 (6%)

Query: 71  ENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLL 130
           E  +G+G + EV+ G       +A+K L          + FL E   +  + H  ++ L 
Sbjct: 272 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKP---GTMSPEAFLQEAQVMKKLRHEKLVQLY 328

Query: 131 GCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRII 190
               +  +Y++ ++ S+GS+           +       +A   A G+ Y+ +      +
Sbjct: 329 AVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYV 385

Query: 191 HRDIKSSNILLTADFEPQISDFGLAKWLP-SQWTHHSIA--PIEGTFGHLAPEYFMHGIV 247
           HRD++++NIL+  +   +++DFGLA+ +  +++T    A  PI+ T    APE  ++G  
Sbjct: 386 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT----APEAALYGRF 441

Query: 248 DEKTDVFAFGVFLLEIIS-GRKP 269
             K+DV++FG+ L E+ + GR P
Sbjct: 442 TIKSDVWSFGILLTELTTKGRVP 464

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  119 bits (300), Expect = 6e-31
 Identities = 59/230 (25%), Positives = 102/230 (44%), Gaps = 49/230 (21%)

Query: 71  ENLVGRGGYAEVYKGVLQDGEE---IAVKRLTKVVTDDRKEKEFLTEIGTIGHV-CHPNV 126
           ++++G G + +V K  ++        A+KR+ K        ++F  E+  +  +  HPN+
Sbjct: 30  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRM-KEYASKDDHRDFAGELEVLCKLGHHPNI 88

Query: 127 LSLLGCCVDNG-LYLIFQFSSRGS------------VASLFHDVNSPGVEWKVRH--KIA 171
           ++LLG C   G LYL  +++  G+                F   NS       +     A
Sbjct: 89  INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 148

Query: 172 VGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAK-----------WLPS 220
              ARG+ YL    Q++ IHRD+ + NIL+  ++  +I+DFGL++            LP 
Sbjct: 149 ADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPV 205

Query: 221 QWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKP 269
           +W               A E   + +    +DV+++GV L EI+S G  P
Sbjct: 206 RWM--------------AIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 241

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  118 bits (299), Expect = 8e-31
 Identities = 51/225 (22%), Positives = 91/225 (40%), Gaps = 48/225 (21%)

Query: 75  GRGGYAEVYKGVLQDGEE------IAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLS 128
           G+G +  VY+GV +   +      +A+K +       R+  EFL E   +      +V+ 
Sbjct: 34  GQGSFGMVYEGVAKGVVKDEPETRVAIKTV-NEAASMRERIEFLNEASVMKEFNCHHVVR 92

Query: 129 LLGCCVDNG-LYLIFQFSSRGSVAS--------LFHDVNSPGVEWKVRHKIAVGTARGLH 179
           LLG         +I +  +RG + S        + ++            ++A   A G+ 
Sbjct: 93  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 152

Query: 180 YLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAK--------------WLPSQWTHH 225
           YL+     + +HRD+ + N ++  DF  +I DFG+ +               LP +W   
Sbjct: 153 YLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM-- 207

Query: 226 SIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKP 269
                       +PE    G+    +DV++FGV L EI +   +P
Sbjct: 208 ------------SPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 240

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  117 bits (296), Expect = 8e-31
 Identities = 55/203 (27%), Positives = 98/203 (48%), Gaps = 14/203 (6%)

Query: 71  ENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLL 130
              +G G + EV+ G      ++AVK L +          FL E   +  + H  ++ L 
Sbjct: 18  VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS---PDAFLAEANLMKQLQHQRLVRLY 74

Query: 131 GCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRII 190
                  +Y+I ++   GS+       +   +       +A   A G+ ++    +R  I
Sbjct: 75  AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYI 131

Query: 191 HRDIKSSNILLTADFEPQISDFGLAKWLP-SQWTHHSIA--PIEGTFGHLAPEYFMHGIV 247
           HRD++++NIL++     +I+DFGLA+ +  +++T    A  PI+ T    APE   +G  
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWT----APEAINYGTF 187

Query: 248 DEKTDVFAFGVFLLEIIS-GRKP 269
             K+DV++FG+ L EI++ GR P
Sbjct: 188 TIKSDVWSFGILLTEIVTHGRIP 210

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  117 bits (296), Expect = 1e-30
 Identities = 55/223 (24%), Positives = 96/223 (43%), Gaps = 23/223 (10%)

Query: 75  GRGGYAEVYKGVL-----QDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSL 129
           G G + +V            GE++AVK L K  +      +   EI  + ++ H N++  
Sbjct: 30  GEGHFGKVELCRYDPEGDNTGEQVAVKSL-KPESGGNHIADLKKEIEILRNLYHENIVKY 88

Query: 130 LGCCVDNG---LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQ 186
            G C ++G   + LI +F   GS+   +   N   +  K + K AV   +G+ YL     
Sbjct: 89  KGICTEDGGNGIKLIMEFLPSGSLKE-YLPKNKNKINLKQQLKYAVQICKGMDYLG---S 144

Query: 187 RRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQW-----THHSIAPIEGTFGHLAPEY 241
           R+ +HRD+ + N+L+ ++ + +I DFGL K + +            +P+       APE 
Sbjct: 145 RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWY----APEC 200

Query: 242 FMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKP 283
            M       +DV++FGV L E+++            L      
Sbjct: 201 LMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPT 243

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  116 bits (293), Expect = 2e-30
 Identities = 58/271 (21%), Positives = 110/271 (40%), Gaps = 26/271 (9%)

Query: 73  LVGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLG 131
            +G G Y    K     DG+ +  K L      + +++  ++E+  +  + HPN++    
Sbjct: 13  TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72

Query: 132 CCVD---NGLYLIFQFSSRGSVASLFHDVNSPGV---EWKVRHKIAVGTARGLHYLH--K 183
             +D     LY++ ++   G +AS+            E  V  ++       L   H   
Sbjct: 73  RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVL-RVMTQLTLALKECHRRS 131

Query: 184 GCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTH-HSIAPIEGTFGHLAPEYF 242
                ++HRD+K +N+ L      ++ DFGLA+ L    +   +     GT  +++PE  
Sbjct: 132 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV---GTPYYMSPEQM 188

Query: 243 MHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAY 302
                +EK+D+++ G  L E+ +   P      S    A  I   G+       R+   Y
Sbjct: 189 NRMSYNEKSDIWSLGCLLYELCALMPPFTA--FSQKELAGKIRE-GKF-----RRIPYRY 240

Query: 303 DVTQLNRLAFAASLCIRASPTWRPTMSEVLE 333
              +LN +    +  +      RP++ E+LE
Sbjct: 241 S-DELNEI---ITRMLNLKDYHRPSVEEILE 267

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  116 bits (293), Expect = 3e-30
 Identities = 58/235 (24%), Positives = 100/235 (42%), Gaps = 34/235 (14%)

Query: 47  ETTKPTWRCFSFEEISIATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDR 106
             +      F     ++          +G+G + +V  G  + G ++AVK + K   +D 
Sbjct: 2   GGSVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCI-K---NDA 56

Query: 107 KEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG--LYLIFQFSSRGSVASLFHDVNSPGVEW 164
             + FL E   +  + H N++ LLG  V+    LY++ ++ ++GS+           +  
Sbjct: 57  TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGG 116

Query: 165 KVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKW------- 217
               K ++     + YL        +HRD+ + N+L++ D   ++SDFGL K        
Sbjct: 117 DCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT 173

Query: 218 --LPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKP 269
             LP +WT              APE         K+DV++FG+ L EI S GR P
Sbjct: 174 GKLPVKWT--------------APEALREKKFSTKSDVWSFGILLWEIYSFGRVP 214

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  116 bits (292), Expect = 4e-30
 Identities = 46/225 (20%), Positives = 100/225 (44%), Gaps = 16/225 (7%)

Query: 50  KPTWRCFSFEEISIATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEK 109
            P+     +    I     +    +G G +  V  G  +   ++A+K + +       E 
Sbjct: 8   APSTAGLGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS---ED 64

Query: 110 EFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQFSSRGSVASLFHDVNSPGVEWKVRH 168
           EF+ E   + ++ H  ++ L G C     +++I ++ + G + +   +      + +   
Sbjct: 65  EFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLRE-MRHRFQTQQLL 123

Query: 169 KIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLP-SQWTHHSI 227
           ++       + YL     ++ +HRD+ + N L+      ++SDFGL++++   ++T    
Sbjct: 124 EMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVG 180

Query: 228 A--PIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKP 269
           +  P+  +     PE  M+     K+D++AFGV + EI S G+ P
Sbjct: 181 SKFPVRWS----PPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMP 221

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  116 bits (293), Expect = 6e-30
 Identities = 66/325 (20%), Positives = 125/325 (38%), Gaps = 44/325 (13%)

Query: 59  EEISIATNAFSSENLVGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGT 117
           + + +         ++  GG+A VY+   +  G E A+KRL  +  ++ K +  + E+  
Sbjct: 21  QTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRL--LSNEEEKNRAIIQEVCF 78

Query: 118 IGHVC-HPNVLSLLGCCV--------DNGLYLIFQFSSRGSVASLFHDVNSPGV--EWKV 166
           +  +  HPN++                   +L+     +G +      + S G      V
Sbjct: 79  MKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTV 138

Query: 167 RHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWL----PSQW 222
             KI   T R + ++H+  +  IIHRD+K  N+LL+     ++ DFG A  +       W
Sbjct: 139 L-KIFYQTCRAVQHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSW 196

Query: 223 THHSIAPIE------GTFGHLAPE---YFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGS 273
           +    A +E       T  +  PE    + +  + EK D++A G  L  +   + P +  
Sbjct: 197 SAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDG 256

Query: 274 HQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLE 333
            +        I+N G+               T  + L       ++ +P  R +++EV+ 
Sbjct: 257 AK------LRIVN-GKYSIPPHDT----QY-TVFHSL---IRAMLQVNPEERLSIAEVVH 301

Query: 334 VMLEGDQIDKERWKMPEEEEEDQEE 358
            + E         K P  E  +Q  
Sbjct: 302 QLQEIAAARNVNPKSPITELLEQNG 326

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  120 bits (302), Expect = 6e-30
 Identities = 54/203 (26%), Positives = 97/203 (47%), Gaps = 17/203 (8%)

Query: 75  GRGGYAEVYKGVLQDGEE----IAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLL 130
           G G + +V++G+    E     +A+K   K  T D   ++FL E  T+    HP+++ L+
Sbjct: 399 GEGQFGDVHQGIYMSPENPAMAVAIKTC-KNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457

Query: 131 GCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRII 190
           G   +N +++I +  + G + S F  V    ++       A   +  L YL     +R +
Sbjct: 458 GVITENPVWIIMELCTLGELRS-FLQVRKFSLDLASLILYAYQLSTALAYLE---SKRFV 513

Query: 191 HRDIKSSNILLTADFEPQISDFGLAKWLPSQ---WTHHSIAPIEGTFGHLAPEYFMHGIV 247
           HRDI + N+L++++   ++ DFGL++++             PI+      APE       
Sbjct: 514 HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM----APESINFRRF 569

Query: 248 DEKTDVFAFGVFLLEIIS-GRKP 269
              +DV+ FGV + EI+  G KP
Sbjct: 570 TSASDVWMFGVCMWEILMHGVKP 592

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  115 bits (291), Expect = 8e-30
 Identities = 59/294 (20%), Positives = 104/294 (35%), Gaps = 46/294 (15%)

Query: 68  FSSENLVGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNV 126
           F    ++G+G + +V K     D    A+K++      + K    L+E+  +  + H  V
Sbjct: 8   FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH---TEEKLSTILSEVMLLASLNHQYV 64

Query: 127 LSLLGCCVDNG--------------LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAV 172
           +      ++                L++  ++   G++  L H  N      +   ++  
Sbjct: 65  VRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYW-RLFR 123

Query: 173 GTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIE- 231
                L Y+H    + IIHRD+K  NI +      +I DFGLAK +        +     
Sbjct: 124 QILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNL 180

Query: 232 -----------GTFGHLAPEYFM-HGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHS 279
                      GT  ++A E     G  +EK D+++ G+   E+I       G  +  + 
Sbjct: 181 PGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP--FSTGMERV-NI 237

Query: 280 WAKPILNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLE 333
             K  L    IE    P         +   +     L I   P  RP    +L 
Sbjct: 238 LKK--LRSVSIE--FPPDFDDNKMKVEKKII----RLLIDHDPNKRPGARTLLN 283

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  115 bits (289), Expect = 1e-29
 Identities = 55/213 (25%), Positives = 97/213 (45%), Gaps = 37/213 (17%)

Query: 75  GRGGYAEVYKGVLQDGEE----IAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLL 130
           G G + +V++G+    E     +A+K   K  T D   ++FL E  T+    HP+++ L+
Sbjct: 24  GEGQFGDVHQGIYMSPENPALAVAIKTC-KNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82

Query: 131 GCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRII 190
           G   +N +++I +  + G + S F  V    ++       A   +  L YL     +R +
Sbjct: 83  GVITENPVWIIMELCTLGELRS-FLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFV 138

Query: 191 HRDIKSSNILLTADFEPQISDFGLAKW-------------LPSQWTHHSIAPIEGTFGHL 237
           HRDI + N+L++++   ++ DFGL+++             LP +W               
Sbjct: 139 HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM-------------- 184

Query: 238 APEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKP 269
           APE          +DV+ FGV + EI+  G KP
Sbjct: 185 APESINFRRFTSASDVWMFGVCMWEILMHGVKP 217

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  115 bits (291), Expect = 1e-29
 Identities = 56/223 (25%), Positives = 87/223 (39%), Gaps = 25/223 (11%)

Query: 75  GRGGYAEVYKGVLQD-----GEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSL 129
           G G + +V            GE +AVK L K     +    +  EI  +  + H +++  
Sbjct: 40  GEGHFGKVSLYCYDPTNDGTGEMVAVKAL-KADAGPQHRSGWKQEIDILRTLYHEHIIKY 98

Query: 130 LGCCVDNG---LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQ 186
            GCC D G   L L+ ++   GS   L   +    +        A     G+ YLH    
Sbjct: 99  KGCCEDAGAASLQLVMEYVPLGS---LRDYLPRHSIGLAQLLLFAQQICEGMAYLH---A 152

Query: 187 RRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQW-----THHSIAPIEGTFGHLAPEY 241
           +  IHRD+ + N+LL  D   +I DFGLAK +P             +P+       APE 
Sbjct: 153 QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY----APEC 208

Query: 242 FMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKP 283
                    +DV++FGV L E+++          + L      
Sbjct: 209 LKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIA 251

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  114 bits (287), Expect = 1e-29
 Identities = 50/200 (25%), Positives = 94/200 (47%), Gaps = 16/200 (8%)

Query: 75  GRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCV 134
           G G +  V  G  +   ++AVK + +       E EF  E  T+  + HP ++   G C 
Sbjct: 17  GSGQFGVVKLGKWKGQYDVAVKMIKEGSMS---EDEFFQEAQTMMKLSHPKLVKFYGVCS 73

Query: 135 DNG-LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRD 193
               +Y++ ++ S G + +     +  G+E     ++      G+ +L      + IHRD
Sbjct: 74  KEYPIYIVTEYISNGCLLNYLRS-HGKGLEPSQLLEMCYDVCEGMAFLE---SHQFIHRD 129

Query: 194 IKSSNILLTADFEPQISDFGLAKWLP-SQWTHHSIA--PIEGTFGHLAPEYFMHGIVDEK 250
           + + N L+  D   ++SDFG+ +++   Q+        P++ +    APE F +     K
Sbjct: 130 LAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWS----APEVFHYFKYSSK 185

Query: 251 TDVFAFGVFLLEIIS-GRKP 269
           +DV+AFG+ + E+ S G+ P
Sbjct: 186 SDVWAFGILMWEVFSLGKMP 205

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  114 bits (287), Expect = 1e-29
 Identities = 46/204 (22%), Positives = 97/204 (47%), Gaps = 16/204 (7%)

Query: 71  ENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLL 130
              +G G +  V+ G   + +++A+K + +       E++F+ E   +  + HP ++ L 
Sbjct: 13  VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQLY 69

Query: 131 GCCVDNG-LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRI 189
           G C++   + L+ +F   G ++             +    + +    G+ YL    +  +
Sbjct: 70  GVCLEQAPICLVTEFMEHGCLSDYLRT-QRGLFAAETLLGMCLDVCEGMAYL---EEACV 125

Query: 190 IHRDIKSSNILLTADFEPQISDFGLAKWLPS-QWTHHSIA--PIEGTFGHLAPEYFMHGI 246
           IHRD+ + N L+  +   ++SDFG+ +++   Q+T  +    P++      +PE F    
Sbjct: 126 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWA----SPEVFSFSR 181

Query: 247 VDEKTDVFAFGVFLLEIIS-GRKP 269
              K+DV++FGV + E+ S G+ P
Sbjct: 182 YSSKSDVWSFGVLMWEVFSEGKIP 205

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  114 bits (288), Expect = 1e-29
 Identities = 59/231 (25%), Positives = 93/231 (40%), Gaps = 54/231 (23%)

Query: 75  GRGGYAEVYKGVLQDGEE------IAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLS 128
           G   + +VYKG L           +A+K L K   +    +EF  E      + HPNV+ 
Sbjct: 18  GEDRFGKVYKGHLFGPAPGEQTQAVAIKTL-KDKAEGPLREEFRHEAMLRARLQHPNVVC 76

Query: 129 LLGCCVDNG-LYLIFQFSSRGS------VASLFHDVNSPGVEWKVRHK--------IAVG 173
           LLG    +  L +IF + S G       + S   DV S   +  V+          +   
Sbjct: 77  LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 136

Query: 174 TARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAK--------------WLP 219
            A G+ YL       ++H+D+ + N+L+      +ISD GL +               LP
Sbjct: 137 IAAGMEYLS---SHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLP 193

Query: 220 SQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKP 269
            +W               APE  M+G     +D++++GV L E+ S G +P
Sbjct: 194 IRWM--------------APEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 230

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  114 bits (287), Expect = 2e-29
 Identities = 52/206 (25%), Positives = 86/206 (41%), Gaps = 19/206 (9%)

Query: 75  GRGGYAEVYKGVLQ--DGEEI--AVKRLTKVVTDDRKE-KEFLTEIGTIGHVCHPNVLSL 129
           G G +  V +G      G+ +  AVK L   V    +   +F+ E+  +  + H N++ L
Sbjct: 27  GDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRL 86

Query: 130 LGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRI 189
            G  +   + ++ + +  GS+       +          + AV  A G+ YL     +R 
Sbjct: 87  YGVVLTPPMKMVTELAPLGSLLDRLRK-HQGHFLLGTLSRYAVQVAEGMGYLE---SKRF 142

Query: 190 IHRDIKSSNILLTADFEPQISDFGLAKWLPSQ-----WTHHSIAPIEGTFGHLAPEYFMH 244
           IHRD+ + N+LL      +I DFGL + LP          H   P        APE    
Sbjct: 143 IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC----APESLKT 198

Query: 245 GIVDEKTDVFAFGVFLLEIIS-GRKP 269
                 +D + FGV L E+ + G++P
Sbjct: 199 RTFSHASDTWMFGVTLWEMFTYGQEP 224

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  113 bits (286), Expect = 2e-29
 Identities = 50/213 (23%), Positives = 92/213 (43%), Gaps = 37/213 (17%)

Query: 75  GRGGYAEVYKGVLQ--DGEEI--AVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLL 130
           G G + EVY+GV     GE+I  AVK   K       +++F++E   + ++ HP+++ L+
Sbjct: 21  GEGFFGEVYEGVYTNHKGEKINVAVKTC-KKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79

Query: 131 GCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRII 190
           G   +   ++I +    G +       N   ++       ++   + + YL        +
Sbjct: 80  GIIEEEPTWIIMELYPYGELGHYLER-NKNSLKVLTLVLYSLQICKAMAYLE---SINCV 135

Query: 191 HRDIKSSNILLTADFEPQISDFGLAKW-------------LPSQWTHHSIAPIEGTFGHL 237
           HRDI   NIL+ +    ++ DFGL+++             LP +W               
Sbjct: 136 HRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWM-------------- 181

Query: 238 APEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKP 269
           +PE          +DV+ F V + EI+S G++P
Sbjct: 182 SPESINFRRFTTASDVWMFAVCMWEILSFGKQP 214

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  113 bits (286), Expect = 3e-29
 Identities = 64/201 (31%), Positives = 102/201 (50%), Gaps = 16/201 (7%)

Query: 75  GRGGYAEVYKGVLQDGE-EIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCC 133
           G G Y EVY+GV +     +AVK L +   +    +EFL E   +  + HPN++ LLG C
Sbjct: 22  GGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQLLGVC 78

Query: 134 VDNG-LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHR 192
                 Y+I +F + G++     + N   V   V   +A   +  + YL    ++  IHR
Sbjct: 79  TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHR 135

Query: 193 DIKSSNILLTADFEPQISDFGLAKWLPS-QWTHHSIA--PIEGTFGHLAPEYFMHGIVDE 249
           D+ + N L+  +   +++DFGL++ +    +T H+ A  PI+ T    APE   +     
Sbjct: 136 DLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT----APESLAYNKFSI 191

Query: 250 KTDVFAFGVFLLEIIS-GRKP 269
           K+DV+AFGV L EI + G  P
Sbjct: 192 KSDVWAFGVLLWEIATYGMSP 212

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  114 bits (287), Expect = 4e-29
 Identities = 66/294 (22%), Positives = 120/294 (40%), Gaps = 47/294 (15%)

Query: 75  GRGGYAEVYKGVL-----QDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSL 129
           G+G +  V            G  +AVK+L     D  ++++F  EI  +  +    ++  
Sbjct: 32  GKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPD--QQRDFQREIQILKALHSDFIVKY 89

Query: 130 LGCCVDNG---LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQ 186
            G     G   L L+ ++   G +   F   +   ++       +    +G+ YL     
Sbjct: 90  RGVSYGPGRQSLRLVMEYLPSGCLRD-FLQRHRARLDASRLLLYSSQICKGMEYLG---S 145

Query: 187 RRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQ-----WTHHSIAPIEGTFGHLAPEY 241
           RR +HRD+ + NIL+ ++   +I+DFGLAK LP             +PI       APE 
Sbjct: 146 RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWY----APES 201

Query: 242 FMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSW--AKPILNQGEIEKLVDP-- 296
               I   ++DV++FGV L E+ +   K    S + L      + +     + +L++   
Sbjct: 202 LSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQ 261

Query: 297 RL-------QGAYDVTQLNRLAFAASLCIRASPTWRPTMSEV---LEVMLEGDQ 340
           RL          +++ +         LC   SP  RP+ S +   L+++  G +
Sbjct: 262 RLPAPPACPAEVHELMK---------LCWAPSPQDRPSFSALGPQLDMLWSGSR 306

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  113 bits (286), Expect = 5e-29
 Identities = 60/233 (25%), Positives = 96/233 (41%), Gaps = 56/233 (24%)

Query: 75  GRGGYAEVYKGVLQDGEE------IAVKRLTKVVTDDRKEKEFLTEIGTIGHV-CHPNVL 127
           GRG + +V +      ++      +AVK L K      + +  ++E+  + H+  H NV+
Sbjct: 36  GRGAFGQVIEADAFGIDKTATCRTVAVKML-KEGATHSEHRALMSELKILIHIGHHLNVV 94

Query: 128 SLLGCCVDNG--LYLIFQFSSRGS------------VASLFHDVNSPGVEWKVRH--KIA 171
           +LLG C   G  L +I +F   G+            V       +       + H    +
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154

Query: 172 VGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKW-------------- 217
              A+G+ +L     R+ IHRD+ + NILL+     +I DFGLA+               
Sbjct: 155 FQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 211

Query: 218 LPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKP 269
           LP +W               APE     +   ++DV++FGV L EI S G  P
Sbjct: 212 LPLKWM--------------APETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  116 bits (291), Expect = 9e-29
 Identities = 64/205 (31%), Positives = 106/205 (51%), Gaps = 16/205 (7%)

Query: 71  ENLVGRGGYAEVYKGVLQDGE-EIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSL 129
           ++ +G G Y EVY+GV +     +AVK L +   D  + +EFL E   +  + HPN++ L
Sbjct: 225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE---DTMEVEEFLKEAAVMKEIKHPNLVQL 281

Query: 130 LGCCVDNG-LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRR 188
           LG C      Y+I +F + G++     + N   V   V   +A   +  + YL    ++ 
Sbjct: 282 LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKN 338

Query: 189 IIHRDIKSSNILLTADFEPQISDFGLAKWLP-SQWTHHSIA--PIEGTFGHLAPEYFMHG 245
            IHR++ + N L+  +   +++DFGL++ +    +T H+ A  PI+ T    APE   + 
Sbjct: 339 FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT----APESLAYN 394

Query: 246 IVDEKTDVFAFGVFLLEIIS-GRKP 269
               K+DV+AFGV L EI + G  P
Sbjct: 395 KFSIKSDVWAFGVLLWEIATYGMSP 419

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  113 bits (284), Expect = 1e-28
 Identities = 60/225 (26%), Positives = 90/225 (40%), Gaps = 48/225 (21%)

Query: 75  GRGGYAEVYKGVLQDGE------EIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLS 128
           G G + EVY+G +          ++AVK L   V  ++ E +FL E   I    H N++ 
Sbjct: 39  GHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVCSEQDELDFLMEALIISKFNHQNIVR 97

Query: 129 LLGCCVDNG-LYLIFQFSSRGSV-----ASLFHDVNSPGVEWKVRHKIAVGTARGLHYLH 182
            +G  + +   +++ +  + G +      +         +       +A   A G  YL 
Sbjct: 98  CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157

Query: 183 KGCQRRIIHRDIKSSNILLTADFEPQ---ISDFGLAK--------------WLPSQWTHH 225
              +   IHRDI + N LLT     +   I DFG+A+               LP +W   
Sbjct: 158 ---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWM-- 212

Query: 226 SIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKP 269
                        PE FM GI   KTD ++FGV L EI S G  P
Sbjct: 213 ------------PPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 245

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  114 bits (288), Expect = 1e-28
 Identities = 63/286 (22%), Positives = 103/286 (36%), Gaps = 48/286 (16%)

Query: 68  FSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTK-VVTDDRKEKEFLTEIGTIGHVCHPNV 126
           F  ++++G G    +    + D  ++AVKR+     +   +E + L E        HPNV
Sbjct: 26  FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADREVQLLRESDE-----HPNV 80

Query: 127 LSLLGCCVDNG-LYLIFQFSSRGSVASLFHDVNSPGVEW--KVRHKIAVGTARGLHYLHK 183
           +       D    Y+  +  +    A+L   V              +   T  GL +LH 
Sbjct: 81  IRYFCTEKDRQFQYIAIELCA----ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLH- 135

Query: 184 GCQRRIIHRDIKSSNILLT-----ADFEPQISDFGLAKWL-PSQWTHHSIAPIEGTFGHL 237
                I+HRD+K  NIL++        +  ISDFGL K L   + +    + + GT G +
Sbjct: 136 --SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWI 193

Query: 238 APEYF---MHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLV 294
           APE              D+F+ G     +IS                 P     + +  +
Sbjct: 194 APEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSH-------------PFGKSLQRQANI 240

Query: 295 DPRLQGAYDVTQLNRLAFAASL-------CIRASPTWRPTMSEVLE 333
              L GA  +  L+       +        I   P  RP+   VL+
Sbjct: 241 ---LLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  112 bits (282), Expect = 1e-28
 Identities = 49/204 (24%), Positives = 93/204 (45%), Gaps = 18/204 (8%)

Query: 75  GRGGYAEVYKGVLQDGEE---IAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLG 131
           G G +  V +GV +  ++   +A+K L K  T+    +E + E   +  + +P ++ L+G
Sbjct: 19  GCGNFGSVRQGVYRMRKKQIDVAIKVL-KQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77

Query: 132 CCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIH 191
            C    L L+ + +  G +           +      ++    + G+ YL    ++  +H
Sbjct: 78  VCQAEALMLVMEMAGGGPLHKFLVG-KREEIPVSNVAELLHQVSMGMKYL---EEKNFVH 133

Query: 192 RDIKSSNILLTADFEPQISDFGLAKWLPSQ-----WTHHSIAPIEGTFGHLAPEYFMHGI 246
           RD+ + N+LL      +ISDFGL+K L +             P++      APE      
Sbjct: 134 RDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY----APECINFRK 189

Query: 247 VDEKTDVFAFGVFLLEIIS-GRKP 269
              ++DV+++GV + E +S G+KP
Sbjct: 190 FSSRSDVWSYGVTMWEALSYGQKP 213

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  113 bits (284), Expect = 1e-28
 Identities = 47/230 (20%), Positives = 88/230 (38%), Gaps = 54/230 (23%)

Query: 75  GRGGYAEVYKGVLQDGEE------IAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLS 128
           G G + +V+     +         +AVK L +     R++  F  E   +  + H +++ 
Sbjct: 50  GEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQD--FQREAELLTMLQHQHIVR 107

Query: 129 LLGCCVDNG-LYLIFQFSSRGS-------------VASLFHDVNSPGVEWKVRHKIAVGT 174
             G C +   L ++F++   G              + +   DV    +       +A   
Sbjct: 108 FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 167

Query: 175 ARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAK--------------WLPS 220
           A G+ YL        +HRD+ + N L+      +I DFG+++               LP 
Sbjct: 168 AAGMVYLA---GLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 224

Query: 221 QWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKP 269
           +W                PE  ++     ++DV++FGV L EI + G++P
Sbjct: 225 RWM--------------PPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 260

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  113 bits (284), Expect = 2e-28
 Identities = 61/327 (18%), Positives = 125/327 (38%), Gaps = 42/327 (12%)

Query: 59  EEISIATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTI 118
           E IS+    +S    +G GG ++V++ + +  +  A+K +     D++    +  EI  +
Sbjct: 2   ECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYL 61

Query: 119 GHVCHPN--VLSLLGCCVDNG-LYLIFQFSSRGSVASLFHDVNSPGV--EWKVRHKIAVG 173
             +   +  ++ L    + +  +Y++ +  +      L   +        W+ +      
Sbjct: 62  NKLQQHSDKIIRLYDYEITDQYIYMVMECGNI----DLNSWLKKKKSIDPWERKS-YWKN 116

Query: 174 TARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGT 233
               +H +H   Q  I+H D+K +N L+  D   ++ DFG+A  +    T        GT
Sbjct: 117 MLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGT 172

Query: 234 FGHLAPEYFM-----------HGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAK 282
             ++ PE                 +  K+DV++ G  L  +  G+ P       +     
Sbjct: 173 VNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHA 232

Query: 283 PILNQGEIE--KLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLE---VMLE 337
            I    EIE   + +  LQ   DV  L         C++  P  R ++ E+L    V ++
Sbjct: 233 IIDPNHEIEFPDIPEKDLQ---DV--LKC-------CLKRDPKQRISIPELLAHPYVQIQ 280

Query: 338 GDQIDKERWKMPEEEEEDQEEFWGFDD 364
              +++      EE +    +  G + 
Sbjct: 281 THPVNQMAKGTTEEMKYVLGQLVGLNS 307

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  111 bits (281), Expect = 2e-28
 Identities = 53/231 (22%), Positives = 93/231 (40%), Gaps = 55/231 (23%)

Query: 75  GRGGYAEVYKGVLQDGEE------IAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLS 128
           G G + +V+     +         +AVK L K  T     K+F  E   + ++ H +++ 
Sbjct: 24  GEGAFGKVFLAECYNLSPTKDKMLVAVKAL-KDPTL-AARKDFQREAELLTNLQHEHIVK 81

Query: 129 LLGCCVDNG-LYLIFQFSSRGS----------VASLFHDVNSPGVEWKVRHK----IAVG 173
             G C D   L ++F++   G            A +  D      + ++       IA  
Sbjct: 82  FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 141

Query: 174 TARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAK--------------WLP 219
            A G+ YL     +  +HRD+ + N L+ A+   +I DFG+++               LP
Sbjct: 142 IASGMVYLA---SQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 198

Query: 220 SQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKP 269
            +W                PE  M+     ++DV++FGV L EI + G++P
Sbjct: 199 IRWM--------------PPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 235

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  112 bits (281), Expect = 2e-28
 Identities = 56/295 (18%), Positives = 114/295 (38%), Gaps = 39/295 (13%)

Query: 57  SFEEISIATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIG 116
            F+ +S+    +S    +G GG ++V++ + +  +  A+K +     D++    +  EI 
Sbjct: 19  YFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIA 78

Query: 117 TIGHVCHPN--VLSLLGCCVDNG-LYLIFQFSSRGSVASLFHDVNSPGV--EWKVRHKIA 171
            +  +   +  ++ L    + +  +Y++ +  +      L   +        W+ +    
Sbjct: 79  YLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNI----DLNSWLKKKKSIDPWERKS-YW 133

Query: 172 VGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIE 231
                 +H +H   Q  I+H D+K +N L+  D   ++ DFG+A  +    T        
Sbjct: 134 KNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQV 189

Query: 232 GTFGHLAPEYFM-----------HGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSW 280
           GT  ++ PE                 +  K+DV++ G  L  +  G+ P       +   
Sbjct: 190 GTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKL 249

Query: 281 AKPILNQGEIE--KLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLE 333
              I    EIE   + +  LQ   DV  L         C++  P  R ++ E+L 
Sbjct: 250 HAIIDPNHEIEFPDIPEKDLQ---DV--LKC-------CLKRDPKQRISIPELLA 292

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  111 bits (281), Expect = 2e-28
 Identities = 57/239 (23%), Positives = 95/239 (39%), Gaps = 62/239 (25%)

Query: 75  GRGGYAEVYKGVLQDGEE------IAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLS 128
           G G + +V K      +       +AVK L K      + ++ L+E   +  V HP+V+ 
Sbjct: 32  GEGEFGKVVKATAFHLKGRAGYTTVAVKML-KENASPSELRDLLSEFNVLKQVNHPHVIK 90

Query: 129 LLGCCVDNG-LYLIFQFSSRGS------------------VASLFHDVNSPGVEWKVRHK 169
           L G C  +G L LI +++  GS                    S          E  +   
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150

Query: 170 ----IAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKW-------- 217
                A   ++G+ YL    + +++HRD+ + NIL+    + +ISDFGL++         
Sbjct: 151 DLISFAWQISQGMQYLA---EMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYV 207

Query: 218 ------LPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKP 269
                 +P +W               A E     I   ++DV++FGV L EI++ G  P
Sbjct: 208 KRSQGRIPVKWM--------------AIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 252

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  113 bits (284), Expect = 3e-28
 Identities = 63/307 (20%), Positives = 118/307 (38%), Gaps = 58/307 (18%)

Query: 3   YIRTNSLKRLFSLKRRSFDGDNAAVSPNGFTEESL-ENVVVACESETTKPTWRCFSFEEI 61
           +   +    + + +   F+G       +    +      +           +        
Sbjct: 5   HHHHHHDYDIPTTENLYFNGMGYYHHHHHHDYDIPTTENLYFQGMLAGVSEYELPEDPRW 64

Query: 62  SIATNAFSSENLVGRGGYAEVYKGVLQDGE--------EIAVKRLTKVVTDDRKEKEFLT 113
            +  +       +G G + +V        +        ++AVK L K    ++   + ++
Sbjct: 65  ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML-KSDATEKDLSDLIS 123

Query: 114 EIGTIGHV-CHPNVLSLLGCCVDNG-LYLIFQFSSRGS----------VASLFHDVNSPG 161
           E+  +  +  H N+++LLG C  +G LY+I +++S+G+              +    S  
Sbjct: 124 EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHN 183

Query: 162 VEWKVRHK----IAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKW 217
            E ++  K     A   ARG+ YL     ++ IHRD+ + N+L+T D   +I+DFGLA+ 
Sbjct: 184 PEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARD 240

Query: 218 --------------LPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEI 263
                         LP +W               APE     I   ++DV++FGV L EI
Sbjct: 241 IHHIDYYKKTTNGRLPVKWM--------------APEALFDRIYTHQSDVWSFGVLLWEI 286

Query: 264 IS-GRKP 269
            + G  P
Sbjct: 287 FTLGGSP 293

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  112 bits (281), Expect = 4e-28
 Identities = 52/239 (21%), Positives = 90/239 (37%), Gaps = 62/239 (25%)

Query: 75  GRGGYAEVYKGVLQDGEE------IAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLS 128
           G G +  V++              +AVK L K       + +F  E   +    +PN++ 
Sbjct: 56  GEGAFGRVFQARAPGLLPYEPFTMVAVKML-KEEASADMQADFQREAALMAEFDNPNIVK 114

Query: 129 LLGCCVDNG-LYLIFQFSSRGS----------------------VASLFHDVNSPGVEWK 165
           LLG C     + L+F++ + G                         +       P +   
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174

Query: 166 VRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAK--------- 216
            +  IA   A G+ YL    +R+ +HRD+ + N L+  +   +I+DFGL++         
Sbjct: 175 EQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK 231

Query: 217 -----WLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKP 269
                 +P +W                PE   +     ++DV+A+GV L EI S G +P
Sbjct: 232 ADGNDAIPIRWM--------------PPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 276

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  111 bits (280), Expect = 4e-28
 Identities = 53/230 (23%), Positives = 91/230 (39%), Gaps = 53/230 (23%)

Query: 75  GRGGYAEVYKGVLQDGEE------IAVKRLTKVVTDDRKEKEFLTEIGTIGHV-CHPNVL 127
           G G + +V +       +      +AVK L K      +++  ++E+  + H+  H N++
Sbjct: 55  GAGAFGKVVEATAFGLGKEDAVLKVAVKML-KSTAHADEKEALMSELKIMSHLGQHENIV 113

Query: 128 SLLGCCVDNG-LYLIFQFSSRGS----------VASLFHDVNSPGVEWKVRH--KIAVGT 174
           +LLG C   G + +I ++   G           V                R     +   
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQV 173

Query: 175 ARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKW--------------LPS 220
           A+G+ +L     +  IHRD+ + N+LLT     +I DFGLA+               LP 
Sbjct: 174 AQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPV 230

Query: 221 QWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKP 269
           +W               APE     +   ++DV+++G+ L EI S G  P
Sbjct: 231 KWM--------------APESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 266

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  115 bits (288), Expect = 5e-28
 Identities = 52/210 (24%), Positives = 98/210 (46%), Gaps = 22/210 (10%)

Query: 71  ENLVGRGGYAEVYKGVLQ-DGEEI--AVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVL 127
           +  +G G +  V +GV +   ++I  A+K L K  T+    +E + E   +  + +P ++
Sbjct: 341 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVL-KQGTEKADTEEMMREAQIMHQLDNPYIV 399

Query: 128 SLLGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRH--KIAVGTARGLHYLHKGC 185
            L+G C    L L+ + +  G    L   +     E  V +  ++    + G+ YL    
Sbjct: 400 RLIGVCQAEALMLVMEMAGGGP---LHKFLVGKREEIPVSNVAELLHQVSMGMKYL---E 453

Query: 186 QRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQ-----WTHHSIAPIEGTFGHLAPE 240
           ++  +HR++ + N+LL      +ISDFGL+K L +             P++      APE
Sbjct: 454 EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY----APE 509

Query: 241 YFMHGIVDEKTDVFAFGVFLLEIIS-GRKP 269
                    ++DV+++GV + E +S G+KP
Sbjct: 510 CINFRKFSSRSDVWSYGVTMWEALSYGQKP 539

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  111 bits (279), Expect = 5e-28
 Identities = 56/309 (18%), Positives = 115/309 (37%), Gaps = 34/309 (11%)

Query: 62  SIATNAFSSENLVGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGH 120
           S + + +   +++G+G  A V++G   + G+  A+K    +      +   + E   +  
Sbjct: 5   STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDV-QMREFEVLKK 63

Query: 121 VCHPNVLSLLGC---CVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTAR- 176
           + H N++ L             LI +F   GS   L+  +  P   + +     +   R 
Sbjct: 64  LNHKNIVKLFAIEEETTTRHKVLIMEFCPCGS---LYTVLEEPSNAYGLPESEFLIVLRD 120

Query: 177 ---GLHYLHKGCQRRIIHRDIKSSNILLTADFEPQ----ISDFGLAKWLPSQWTHHSIAP 229
              G+++L +     I+HR+IK  NI+     + Q    ++DFG A+ L       S+  
Sbjct: 121 VVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY- 176

Query: 230 IEGTFGHLAPEYFMHGIV--------DEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWA 281
             GT  +L P+ +   ++            D+++ GV      +G  P         +  
Sbjct: 177 --GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN-- 232

Query: 282 KPILNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEGDQI 341
           K ++ +    K                  +    +    S   +  ++ VL  +LE DQ 
Sbjct: 233 KEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQ- 291

Query: 342 DKERWKMPE 350
            ++ W   +
Sbjct: 292 -EKCWGFDQ 299

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  110 bits (277), Expect = 6e-28
 Identities = 52/204 (25%), Positives = 89/204 (43%), Gaps = 18/204 (8%)

Query: 75  GRGGYAEVYKGVLQDGE---EIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLG 131
           G G +  V KG  Q  +    +AVK L     D   + E L E   +  + +P ++ ++G
Sbjct: 26  GSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIG 85

Query: 132 CCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIH 191
            C      L+ + +  G +            +  +  ++    + G+ YL    +   +H
Sbjct: 86  ICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNII--ELVHQVSMGMKYLE---ESNFVH 140

Query: 192 RDIKSSNILLTADFEPQISDFGLAKWLPSQ-----WTHHSIAPIEGTFGHLAPEYFMHGI 246
           RD+ + N+LL      +ISDFGL+K L +         H   P++      APE   +  
Sbjct: 141 RDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY----APECINYYK 196

Query: 247 VDEKTDVFAFGVFLLEIIS-GRKP 269
              K+DV++FGV + E  S G+KP
Sbjct: 197 FSSKSDVWSFGVLMWEAFSYGQKP 220

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  109 bits (276), Expect = 6e-28
 Identities = 60/210 (28%), Positives = 97/210 (46%), Gaps = 16/210 (7%)

Query: 72  NLVGRGGYAEVYKGV-LQDGEEIAVKRLTK-VVTDDRKEKEFLTEIGTIGHVCHPNVLSL 129
             +G+G +  VY     Q    +A+K L K  +     E +   E+    H+ HPN+L L
Sbjct: 15  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74

Query: 130 LGCCVDNG-LYLIFQFSSRGSVASLFHDVNSPG--VEWKVRHKIAVGTARGLHYLHKGCQ 186
            G   D   +YLI +++  G+   ++ ++       E +    I    A  L Y H    
Sbjct: 75  YGYFHDATRVYLILEYAPLGT---VYRELQKLSKFDEQRTATYIT-ELANALSYCHS--- 127

Query: 187 RRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGI 246
           +R+IHRDIK  N+LL +  E +I+DFG +   PS      +    GT  +L PE     +
Sbjct: 128 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-RRTDLC---GTLDYLPPEMIEGRM 183

Query: 247 VDEKTDVFAFGVFLLEIISGRKPVDGSHQS 276
            DEK D+++ GV   E + G+ P + +   
Sbjct: 184 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQ 213

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  111 bits (279), Expect = 7e-28
 Identities = 55/234 (23%), Positives = 101/234 (43%), Gaps = 57/234 (24%)

Query: 75  GRGGYAEVYKGVLQDGEE--------IAVKRLTKVVTDDRKEKEFLTEIGTIGHV-CHPN 125
           G G + +V        ++        +AVK L K    ++   + ++E+  +  +  H N
Sbjct: 44  GEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML-KDDATEKDLSDLVSEMEMMKMIGKHKN 102

Query: 126 VLSLLGCCVDNG-LYLIFQFSSRGS------------VASLFHDVNSPGVEWKVRH--KI 170
           +++LLG C  +G LY+I +++S+G+            +   +     P  +   +     
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162

Query: 171 AVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKW------------- 217
               ARG+ YL     ++ IHRD+ + N+L+T +   +I+DFGLA+              
Sbjct: 163 TYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219

Query: 218 -LPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKP 269
            LP +W               APE     +   ++DV++FGV + EI + G  P
Sbjct: 220 RLPVKWM--------------APEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  111 bits (280), Expect = 7e-28
 Identities = 55/234 (23%), Positives = 101/234 (43%), Gaps = 57/234 (24%)

Query: 75  GRGGYAEVYKGVLQDGEE--------IAVKRLTKVVTDDRKEKEFLTEIGTIGHV-CHPN 125
           G G + +V        ++        +AVK L K    ++   + ++E+  +  +  H N
Sbjct: 90  GEGCFGQVVMAEAVGIDKDKPKEAVTVAVKML-KDDATEKDLSDLVSEMEMMKMIGKHKN 148

Query: 126 VLSLLGCCVDNG-LYLIFQFSSRGS------------VASLFHDVNSPGVEWKVRH--KI 170
           +++LLG C  +G LY+I +++S+G+            +   +     P  +   +     
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 208

Query: 171 AVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKW------------- 217
               ARG+ YL     ++ IHRD+ + N+L+T +   +I+DFGLA+              
Sbjct: 209 TYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 265

Query: 218 -LPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKP 269
            LP +W               APE     +   ++DV++FGV + EI + G  P
Sbjct: 266 RLPVKWM--------------APEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 305

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  111 bits (279), Expect = 9e-28
 Identities = 60/225 (26%), Positives = 90/225 (40%), Gaps = 48/225 (21%)

Query: 75  GRGGYAEVYKGVLQDGE------EIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLS 128
           G G + EVY+G +          ++AVK L   V  ++ E +FL E   I    H N++ 
Sbjct: 80  GHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVCSEQDELDFLMEALIISKFNHQNIVR 138

Query: 129 LLGCCVDNG-LYLIFQFSSRGSV-----ASLFHDVNSPGVEWKVRHKIAVGTARGLHYLH 182
            +G  + +   +++ +  + G +      +         +       +A   A G  YL 
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 198

Query: 183 KGCQRRIIHRDIKSSNILLTADFEPQ---ISDFGLAK--------------WLPSQWTHH 225
              +   IHRDI + N LLT     +   I DFG+A+               LP +W   
Sbjct: 199 ---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWM-- 253

Query: 226 SIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKP 269
                        PE FM GI   KTD ++FGV L EI S G  P
Sbjct: 254 ------------PPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 286

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  110 bits (276), Expect = 1e-27
 Identities = 58/253 (22%), Positives = 107/253 (42%), Gaps = 48/253 (18%)

Query: 41  VVACESETTKPTWRCFSFEEISIATNAFSSENLVGRGGYAEVYKGVLQDGEE-----IAV 95
                          F+ E   I  +  + + ++G G + EVYKG+L+         +A+
Sbjct: 22  FQGAMGSDPNQAVLKFTTE---IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAI 78

Query: 96  KRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQFSSRGSVASLF 154
           K L K    +++  +FL E G +G   H N++ L G       + +I ++   G+   L 
Sbjct: 79  KTL-KAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGA---LD 134

Query: 155 HDVNSPGVEWKVRH--KIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDF 212
             +     E+ V     +  G A G+ YL        +HRD+ + NIL+ ++   ++SDF
Sbjct: 135 KFLREKDGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDF 191

Query: 213 GLAKW---------------LPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFG 257
           GL++                +P +WT              APE   +      +DV++FG
Sbjct: 192 GLSRVLEDDPEATYTTSGGKIPIRWT--------------APEAISYRKFTSASDVWSFG 237

Query: 258 VFLLEIIS-GRKP 269
           + + E+++ G +P
Sbjct: 238 IVMWEVMTYGERP 250

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  109 bits (274), Expect = 2e-27
 Identities = 53/234 (22%), Positives = 94/234 (40%), Gaps = 57/234 (24%)

Query: 75  GRGGYAEVYKGVLQDGEE------IAVKRLTKVVTDDRKEKEFLTEIGTIGHV-CHPNVL 127
           G G + +V +       +      +AVK L K      + +  ++E+  + ++  H N++
Sbjct: 32  GAGAFGKVVEATAYGLIKSDAAMTVAVKML-KPSAHLTEREALMSELKVLSYLGNHMNIV 90

Query: 128 SLLGCCVDNG-LYLIFQFSSRGS------------VASLFHDVNSPGVEWKVRHK----I 170
           +LLG C   G   +I ++   G             + S          E  +  +     
Sbjct: 91  NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150

Query: 171 AVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKW------------- 217
           +   A+G+ +L     +  IHRD+ + NILLT     +I DFGLA+              
Sbjct: 151 SYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA 207

Query: 218 -LPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKP 269
            LP +W               APE   + +   ++DV+++G+FL E+ S G  P
Sbjct: 208 RLPVKWM--------------APESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  108 bits (273), Expect = 3e-27
 Identities = 76/273 (27%), Positives = 119/273 (43%), Gaps = 33/273 (12%)

Query: 68  FSSENLVGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNV 126
           F+    +G+G + EV+KG+  +  + +A+K +     +D  E +   EI  +     P V
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIE-DIQQEITVLSQCDSPYV 82

Query: 127 LSLLGC-CVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAV---GTARGLHYLH 182
               G    D  L++I ++   GS   L      P  E     +IA       +GL YLH
Sbjct: 83  TKYYGSYLKDTKLWIIMEYLGGGSALDLLE--PGPLDE----TQIATILREILKGLDYLH 136

Query: 183 KGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYF 242
                + IHRDIK++N+LL+   E +++DFG+A  L    T        GT   +APE  
Sbjct: 137 S---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD--TQIKRNTFVGTPFWMAPEVI 191

Query: 243 MHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAY 302
                D K D+++ G+  +E+  G  P    H  LH    P+     I K   P L+G Y
Sbjct: 192 KQSAYDSKADIWSLGITAIELARGEPP----HSELH----PMKVLFLIPKNNPPTLEGNY 243

Query: 303 DVTQLNRLAFAA--SLCIRASPTWRPTMSEVLE 333
                           C+   P++RPT  E+L+
Sbjct: 244 SK------PLKEFVEACLNKEPSFRPTAKELLK 270

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  110 bits (276), Expect = 3e-27
 Identities = 56/309 (18%), Positives = 115/309 (37%), Gaps = 34/309 (11%)

Query: 62  SIATNAFSSENLVGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGH 120
           S + + +   +++G+G  A V++G   + G+  A+K    +      +   + E   +  
Sbjct: 5   STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDV-QMREFEVLKK 63

Query: 121 VCHPNVLSLLGC---CVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTAR- 176
           + H N++ L             LI +F   GS   L+  +  P   + +     +   R 
Sbjct: 64  LNHKNIVKLFAIEEETTTRHKVLIMEFCPCGS---LYTVLEEPSNAYGLPESEFLIVLRD 120

Query: 177 ---GLHYLHKGCQRRIIHRDIKSSNILLTADFEPQ----ISDFGLAKWLPSQWTHHSIAP 229
              G+++L +     I+HR+IK  NI+     + Q    ++DFG A+ L       S+  
Sbjct: 121 VVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY- 176

Query: 230 IEGTFGHLAPEYFMHGIV--------DEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWA 281
             GT  +L P+ +   ++            D+++ GV      +G  P         +  
Sbjct: 177 --GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN-- 232

Query: 282 KPILNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEGDQI 341
           K ++ +    K                  +    +    S   +  ++ VL  +LE DQ 
Sbjct: 233 KEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQ- 291

Query: 342 DKERWKMPE 350
            ++ W   +
Sbjct: 292 -EKCWGFDQ 299

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  108 bits (271), Expect = 4e-27
 Identities = 54/204 (26%), Positives = 88/204 (43%), Gaps = 23/204 (11%)

Query: 75  GRGGYAEVYKGVL-----QDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSL 129
           G+G +  V            GE +AVK+L +  T++   ++F  EI  +  + H N++  
Sbjct: 19  GKGNFGSVEMCRYDPLQDNTGEVVAVKKL-QHSTEE-HLRDFEREIEILKSLQHDNIVKY 76

Query: 130 LGCCVDNG---LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQ 186
            G C   G   L LI ++   GS+       +   ++     +      +G+ YL     
Sbjct: 77  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQK-HKERIDHIKLLQYTSQICKGMEYLG---T 132

Query: 187 RRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQW-----THHSIAPIEGTFGHLAPEY 241
           +R IHRD+ + NIL+  +   +I DFGL K LP             +PI       APE 
Sbjct: 133 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWY----APES 188

Query: 242 FMHGIVDEKTDVFAFGVFLLEIIS 265
                    +DV++FGV L E+ +
Sbjct: 189 LTESKFSVASDVWSFGVVLYELFT 212

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  108 bits (272), Expect = 5e-27
 Identities = 54/212 (25%), Positives = 98/212 (46%), Gaps = 24/212 (11%)

Query: 71  ENLVGRGGYAEVYKGVLQ--DGEEI--AVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNV 126
           E ++G G   EV  G L+     ++  A+K L K    +R+ ++FL+E   +G   HPN+
Sbjct: 54  EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKAL-KAGYTERQRRDFLSEASIMGQFDHPNI 112

Query: 127 LSLLGCCVDNG-LYLIFQFSSRGSVASLFHDVNSPGVEWKVRH--KIAVGTARGLHYLHK 183
           + L G         ++ ++   GS   L   + +   ++ +     +  G   G+ YL  
Sbjct: 113 IRLEGVVTRGRLAMIVTEYMENGS---LDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLS- 168

Query: 184 GCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQW-----THHSIAPIEGTFGHLA 238
                 +HRD+ + N+L+ ++   ++SDFGL++ L         T     PI  T    A
Sbjct: 169 --DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWT----A 222

Query: 239 PEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKP 269
           PE          +DV++FGV + E+++ G +P
Sbjct: 223 PEAIAFRTFSSASDVWSFGVVMWEVLAYGERP 254

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  108 bits (272), Expect = 5e-27
 Identities = 54/204 (26%), Positives = 88/204 (43%), Gaps = 23/204 (11%)

Query: 75  GRGGYAEVYKGVL-----QDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSL 129
           G+G +  V            GE +AVK+L +  T++    +F  EI  +  + H N++  
Sbjct: 50  GKGNFGSVEMCRYDPLQDNTGEVVAVKKL-QHSTEEHLR-DFEREIEILKSLQHDNIVKY 107

Query: 130 LGCCVDNG---LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQ 186
            G C   G   L LI ++   GS+   +   +   ++     +      +G+ YL     
Sbjct: 108 KGVCYSAGRRNLKLIMEYLPYGSLRD-YLQKHKERIDHIKLLQYTSQICKGMEYLG---T 163

Query: 187 RRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQW-----THHSIAPIEGTFGHLAPEY 241
           +R IHRD+ + NIL+  +   +I DFGL K LP             +PI       APE 
Sbjct: 164 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWY----APES 219

Query: 242 FMHGIVDEKTDVFAFGVFLLEIIS 265
                    +DV++FGV L E+ +
Sbjct: 220 LTESKFSVASDVWSFGVVLYELFT 243

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  109 bits (274), Expect = 6e-27
 Identities = 60/362 (16%), Positives = 131/362 (36%), Gaps = 42/362 (11%)

Query: 24  NAAVSPNGFTEESLENVVVACESETTKPTWRCFSFEEISIATNAFSSENLVGRGGYAEVY 83
            + +      +   +++                + E IS+    +S    +G GG ++V+
Sbjct: 14  GSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSILKQIGSGGSSKVF 73

Query: 84  KGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPN--VLSLLGCCVDNG-LYL 140
           + + +  +  A+K +     D++    +  EI  +  +   +  ++ L    + +  +Y+
Sbjct: 74  QVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 133

Query: 141 IFQFSSRGSVASLFHDVNSPGV--EWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSN 198
           + +  +      L   +        W+ +          +H +H   Q  I+H D+K +N
Sbjct: 134 VMECGNI----DLNSWLKKKKSIDPWERKS-YWKNMLEAVHTIH---QHGIVHSDLKPAN 185

Query: 199 ILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFM-----------HGIV 247
            L+  D   ++ DFG+A  +    T        G   ++ PE                 +
Sbjct: 186 FLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKI 244

Query: 248 DEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIE--KLVDPRLQGAYDVT 305
             K+DV++ G  L  +  G+ P       +      I    EIE   + +  LQ   DV 
Sbjct: 245 SPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQ---DV- 300

Query: 306 QLNRLAFAASLCIRASPTWRPTMSEVLE---VMLEGDQIDKERWKMPEEEEEDQEEFWGF 362
            L         C++  P  R ++ E+L    V ++   +++      EE +    +  G 
Sbjct: 301 -LKC-------CLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEMKYVLGQLVGL 352

Query: 363 DD 364
           + 
Sbjct: 353 NS 354

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  111 bits (279), Expect = 6e-27
 Identities = 65/294 (22%), Positives = 112/294 (38%), Gaps = 34/294 (11%)

Query: 75  GRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLL--- 130
           G GG+  V + +    GE++A+K+  + ++   +E+ +  EI  +  + HPNV+S     
Sbjct: 23  GTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRER-WCLEIQIMKKLNHPNVVSAREVP 81

Query: 131 ----GCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTAR----GLHYLH 182
                   ++   L  ++   G    L   +N       ++              L YLH
Sbjct: 82  DGLQKLAPNDLPLLAMEYCEGGD---LRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH 138

Query: 183 KGCQRRIIHRDIKSSNILLTADFEPQ---ISDFGLAKWLPSQWTHHSIAPIEGTFGHLAP 239
              + RIIHRD+K  NI+L    +     I D G AK L             GT  +LAP
Sbjct: 139 ---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFV---GTLQYLAP 192

Query: 240 EYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQ 299
           E           D ++FG    E I+G +P   + Q       P+   G++ +  +  + 
Sbjct: 193 ELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQ-------PVQWHGKVREKSNEHIV 245

Query: 300 GAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEGDQIDKERWKMPEEEE 353
              D+T   + +         S      +   L+ ML   Q  ++R   P+   
Sbjct: 246 VYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQ--RQRGTDPQNPN 297

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  108 bits (273), Expect = 8e-27
 Identities = 57/210 (27%), Positives = 100/210 (47%), Gaps = 20/210 (9%)

Query: 71  ENLVGRGGYAEVYKGVLQ--DGEEI--AVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNV 126
           + +VG G + EV  G L+    +EI  A+K L KV   +++ ++FL E   +G   HPN+
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL-KVGYTEKQRRDFLGEASIMGQFDHPNI 108

Query: 127 LSLLGCCVDNG-LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGC 185
           + L G    +  + ++ ++   GS+ S     +           +  G A G+ YL    
Sbjct: 109 IRLEGVVTKSKPVMIVTEYMENGSLDSFLRK-HDAQFTVIQLVGMLRGIASGMKYLS--- 164

Query: 186 QRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQW-----THHSIAPIEGTFGHLAPE 240
               +HRD+ + NIL+ ++   ++SDFGL + L         T     PI  T    +PE
Sbjct: 165 DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWT----SPE 220

Query: 241 YFMHGIVDEKTDVFAFGVFLLEIIS-GRKP 269
              +      +DV+++G+ L E++S G +P
Sbjct: 221 AIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  108 bits (271), Expect = 9e-27
 Identities = 58/239 (24%), Positives = 95/239 (39%), Gaps = 62/239 (25%)

Query: 75  GRGGYAEVYKGVLQDGEE------IAVKRLTKVVTDDRKEKEFLTEIGTIGHV-CHPNVL 127
           G G + +V         +      +AVK L K   D  + +  ++E+  +  +  H N++
Sbjct: 54  GSGAFGKVMNATAYGISKTGVSIQVAVKML-KEKADSSEREALMSELKMMTQLGSHENIV 112

Query: 128 SLLGCCVDNG-LYLIFQFSSRGS------------VASLFHDVNSPGVEWKVRHK----- 169
           +LLG C  +G +YLIF++   G                     N   +E +         
Sbjct: 113 NLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFE 172

Query: 170 ----IAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKW-------- 217
                A   A+G+ +L     +  +HRD+ + N+L+T     +I DFGLA+         
Sbjct: 173 DLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYV 229

Query: 218 ------LPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKP 269
                 LP +W               APE    GI   K+DV+++G+ L EI S G  P
Sbjct: 230 VRGNARLPVKWM--------------APESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 274

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  106 bits (268), Expect = 9e-27
 Identities = 65/236 (27%), Positives = 102/236 (43%), Gaps = 26/236 (11%)

Query: 46  SETTKPTWRCFSFEEISIATNAFSSENLVGRGGYAEVYKGV-LQDGEEIAVKRLTK-VVT 103
           +E  K  +    F+              +G+G +  VY     Q+   +A+K L K  + 
Sbjct: 4   AEMPKRKFTIDDFDIG----------RPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLE 53

Query: 104 DDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQFSSRGSVASLFHDVNSPG- 161
            +  E +   EI    H+ HPN+L +     D   +YL+ +F+ RG    L+ ++   G 
Sbjct: 54  KEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGE---LYKELQKHGR 110

Query: 162 -VEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPS 220
             E +    +    A  LHY H+   R++IHRDIK  N+L+    E +I+DFG +   PS
Sbjct: 111 FDEQRSATFME-ELADALHYCHE---RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPS 166

Query: 221 QWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQS 276
                      GT  +L PE       DEK D++  GV   E + G  P D    +
Sbjct: 167 LRRRTMC----GTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHT 218

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  107 bits (270), Expect = 1e-26
 Identities = 68/296 (22%), Positives = 112/296 (37%), Gaps = 35/296 (11%)

Query: 72  NLVGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLL 130
             VGRG + EV++    Q G + AVK   KV  +  + +E    +     +  P ++ L 
Sbjct: 64  PRVGRGSFGEVHRMKDKQTGFQCAVK---KVRLEVFRVEE----LVACAGLSSPRIVPLY 116

Query: 131 GCCVDNG-LYLIFQFSSRGSVASLFHDVNSPGV--EWKVRHKIAVGTARGLHYLHKGCQR 187
           G   +   + +  +    GS+  L   +   G   E +  +        GL YLH    R
Sbjct: 117 GAVREGPWVNIFMELLEGGSLGQL---IKQMGCLPEDRALY-YLGQALEGLEYLH---TR 169

Query: 188 RIIHRDIKSSNILLTAD-FEPQISDFGLAKWLPSQWTHHSIAPIE---GTFGHLAPEYFM 243
           RI+H D+K+ N+LL++D     + DFG A  L       S+   +   GT  H+APE  M
Sbjct: 170 RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVM 229

Query: 244 HGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYD 303
               D K D+++    +L +++G  P              +  +  I     P  +    
Sbjct: 230 GKPCDAKVDIWSSCCMMLHMLNGCHP----WTQYFRGP--LCLK--IASEPPPIREIPPS 281

Query: 304 VTQLNRLAFAASLCIRASPTWRPTMSEVLE---VMLEGDQIDKERWKMPEEEEEDQ 356
              L          +R  P  R +  E+       L+     K  WK   +E    
Sbjct: 282 CAPLTA-QA-IQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYKEPRGN 335

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  106 bits (267), Expect = 1e-26
 Identities = 49/223 (21%), Positives = 92/223 (41%), Gaps = 49/223 (21%)

Query: 75  GRGGYAEVYKGVLQDGE--------EIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNV 126
           G+G + +++KGV ++          E+ +K L K   +  +   F      +  + H ++
Sbjct: 17  GQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSES--FFEAASMMSKLSHKHL 74

Query: 127 LSLLGCCVDNG-LYLIFQFSSRGSVAS-LFHDVNSPGVEWKVRHKIAVGTARGLHYLHKG 184
           +   G CV      L+ +F   GS+ + L  + N   + WK+  ++A   A  +H+L   
Sbjct: 75  VLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKL--EVAKQLAAAMHFLE-- 130

Query: 185 CQRRIIHRDIKSSNILLTADFEPQ--------ISDFGLAKWL--------PSQWTHHSIA 228
            +  +IH ++ + NILL  + + +        +SD G++  +           W      
Sbjct: 131 -ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWV----- 184

Query: 229 PIEGTFGHLAPEYFMHGIV-DEKTDVFAFGVFLLEIIS-GRKP 269
                     PE   +    +  TD ++FG  L EI S G KP
Sbjct: 185 ---------PPECIENPKNLNLATDKWSFGTTLWEICSGGDKP 218

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  106 bits (267), Expect = 1e-26
 Identities = 77/290 (26%), Positives = 127/290 (43%), Gaps = 31/290 (10%)

Query: 62  SIATNAFSSENLVGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGH 120
           SI  + +  + ++G G  A V         E++A+KR+         + E L EI  +  
Sbjct: 11  SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMD-ELLKEIQAMSQ 69

Query: 121 VCHPNVLSLLGC-CVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVR---HKIAV---G 173
             HPN++S      V + L+L+ +  S GSV  +   + + G           IA     
Sbjct: 70  CHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILRE 129

Query: 174 TARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGT 233
              GL YLHK      IHRD+K+ NILL  D   QI+DFG++ +L +     +   +  T
Sbjct: 130 VLEGLEYLHK---NGQIHRDVKAGNILLGEDGSVQIADFGVSAFL-ATGGDITRNKVRKT 185

Query: 234 F-GH---LAPEYFMHGIV-DEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQG 288
           F G    +APE        D K D+++FG+  +E+ +G  P    +       K ++   
Sbjct: 186 FVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAP----YHKYPP-MKVLML-- 238

Query: 289 EIEKLVDPRLQGAYDVTQLNRL---AFAA--SLCIRASPTWRPTMSEVLE 333
              +   P L+      ++ +    +F    SLC++  P  RPT +E+L 
Sbjct: 239 -TLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  106 bits (266), Expect = 2e-26
 Identities = 75/308 (24%), Positives = 131/308 (42%), Gaps = 42/308 (13%)

Query: 68  FSSENLVGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNV 126
           F     +G G Y  VYK +  + G+ +A+K     V  +   +E + EI  +     P+V
Sbjct: 31  FDVLEKLGEGSYGSVYKAIHKETGQIVAIK----QVPVESDLQEIIKEISIMQQCDSPHV 86

Query: 127 LSLLGC-CVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAV---GTARGLHYLH 182
           +   G    +  L+++ ++   GSV+ +    N    E     +IA     T +GL YLH
Sbjct: 87  VKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTE----DEIATILQSTLKGLEYLH 142

Query: 183 KGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYF 242
                R IHRDIK+ NILL  +   +++DFG+A  L       +   + GT   +APE  
Sbjct: 143 F---MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT--VIGTPFWMAPEVI 197

Query: 243 MHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAY 302
                +   D+++ G+  +E+  G+ P    +  +H    P+     I     P  +   
Sbjct: 198 QEIGYNCVADIWSLGITAIEMAEGKPP----YADIH----PMRAIFMIPTNPPPTFRKPE 249

Query: 303 DVTQLNRLAFAA--SLCIRASPTWRPTMSEVLE---------VMLEGDQIDK-ERWKMPE 350
             +      F      C+  SP  R T +++L+         V +  D I++    K+  
Sbjct: 250 LWSD----NFTDFVKQCLVKSPEQRATATQLLQHPFVRSAKGVSILRDLINEAMDVKLKR 305

Query: 351 EEEEDQEE 358
           +E + +EE
Sbjct: 306 QESQQREE 313

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  106 bits (267), Expect = 3e-26
 Identities = 54/353 (15%), Positives = 126/353 (35%), Gaps = 53/353 (15%)

Query: 32  FTEESLENVVVACESETTKPTWRCFSFEEISIATNAFSSENLVGRGGYAEVYKGVL-QDG 90
             E  L+               +    ++     + F   + +G G    V+K      G
Sbjct: 4   LEELELDEQQRKRLEAFLTQKQKVGELKD-----DDFEKISELGAGNGGVVFKVSHKPSG 58

Query: 91  EEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVC-HPNVLSLLGCCVDNG-LYLIFQFSSRG 148
             +A K +  +        + + E+  + H C  P ++   G    +G + +  +    G
Sbjct: 59  LVMARKLIH-LEIKPAIRNQIIREL-QVLHECNSPYIVGFYGAFYSDGEISICMEHMDGG 116

Query: 149 SVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQ 208
           S+  +        +  ++  K+++   +GL YL +  + +I+HRD+K SNIL+ +  E +
Sbjct: 117 SLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIK 172

Query: 209 ISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRK 268
           + DFG++  L     +  +    GT  +++PE         ++D+++ G+ L+E+  GR 
Sbjct: 173 LCDFGVSGQLIDSMANSFV----GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRY 228

Query: 269 PVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQLNRLAFAA-------------- 314
           P+                +G+  +           + +    +                 
Sbjct: 229 PIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEP 288

Query: 315 -----------------SLCIRASPTWRPTMSEVLE----VMLEGDQIDKERW 346
                            + C+  +P  R  + +++        + +++D   W
Sbjct: 289 PPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEVDFAGW 341

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  105 bits (265), Expect = 5e-26
 Identities = 80/322 (24%), Positives = 139/322 (43%), Gaps = 54/322 (16%)

Query: 68  FSSENLVGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVC-HPN 125
           F    LVG G Y +VYKG  ++ G+  A+K +  V  D+  E+E   EI  +     H N
Sbjct: 26  FELVELVGNGTYGQVYKGRHVKTGQLAAIKVM-DVTGDE--EEEIKQEINMLKKYSHHRN 82

Query: 126 VLSLLGC-------CVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAV---GTA 175
           + +  G         +D+ L+L+ +F   GSV  L  +     ++      IA       
Sbjct: 83  IATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLK---EEWIAYICREIL 139

Query: 176 RGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWT-HHSIAPIEGTF 234
           RGL +LH+    ++IHRDIK  N+LLT + E ++ DFG++  L       ++     GT 
Sbjct: 140 RGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI---GTP 193

Query: 235 GHLAPE-----YFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGE 289
             +APE            D K+D+++ G+  +E+  G  P       +H   + +     
Sbjct: 194 YWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP----LCDMHP-MRALFL--- 245

Query: 290 IEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLE-------------VML 336
           I +   PRL+      +    +F    C+  + + RP   ++++              + 
Sbjct: 246 IPRNPAPRLKSKKWSKKFQ--SFIE-SCLVKNHSQRPATEQLMKHPFIRDQPNERQVRIQ 302

Query: 337 EGDQIDKERWKMPEEEEEDQEE 358
             D ID+ + K  E++E + E 
Sbjct: 303 LKDHIDRTKKKRGEKDETEYEY 324

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  105 bits (264), Expect = 5e-26
 Identities = 51/207 (24%), Positives = 87/207 (42%), Gaps = 13/207 (6%)

Query: 71  ENLVGRGGYAEVYKGVLQD---GEEIAVKRLTKVVTDDRKEKE-FLTEIGTIGHVCHPNV 126
             LVGRGG  +VY+   +D      +A+K +++ ++ D   +     E  T G +  P+V
Sbjct: 39  RRLVGRGGMGDVYEA--EDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHV 96

Query: 127 LSLLGCCVDNG-LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGC 185
           + +      +G LY+  +  +   +A++            V   I       L   H   
Sbjct: 97  VPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVA--IVRQIGSALDAAH--- 151

Query: 186 QRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHG 245
                HRD+K  NIL++AD    + DFG+A     +     +    GT  ++APE F   
Sbjct: 152 AAGATHRDVKPENILVSADDFAYLVDFGIASATTDE-KLTQLGNTVGTLYYMAPERFSES 210

Query: 246 IVDEKTDVFAFGVFLLEIISGRKPVDG 272
               + D++A    L E ++G  P  G
Sbjct: 211 HATYRADIYALTCVLYECLTGSPPYQG 237

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  105 bits (264), Expect = 6e-26
 Identities = 57/226 (25%), Positives = 100/226 (44%), Gaps = 17/226 (7%)

Query: 59  EEISIATNAFSSENLVGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGT 117
           +              +GRG Y  V K V    G+ +AVKR+ +   D++++K+ L ++  
Sbjct: 15  QHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRI-RSTVDEKEQKQLLMDLDV 73

Query: 118 IGHVC-HPNVLSLLGCCVDNG-LYLIFQFSSRGSVASLFHDVNSP---GVEWKVRHKIAV 172
           +      P ++   G     G  ++  +  S  S    +  V S     +  ++  KI +
Sbjct: 74  VMRSSDCPYIVQFYGALFREGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITL 132

Query: 173 GTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEG 232
            T + L++L +    +IIHRDIK SNILL      ++ DFG++  L         A   G
Sbjct: 133 ATVKALNHLKE--NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDA---G 187

Query: 233 TFGHLAPEYFMHGIV----DEKTDVFAFGVFLLEIISGRKPVDGSH 274
              ++APE           D ++DV++ G+ L E+ +GR P    +
Sbjct: 188 CRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWN 233

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  106 bits (266), Expect = 6e-26
 Identities = 45/219 (20%), Positives = 81/219 (36%), Gaps = 20/219 (9%)

Query: 65  TNAFSSENLVGRG--GYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHV 121
              +    ++G+G      V        GE + V+R+      +        E+      
Sbjct: 24  GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83

Query: 122 CHPNVLSLLGC-CVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAV---GTARG 177
            HPN++        DN L+++  F + GS   L       G+       IA    G  + 
Sbjct: 84  NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELA---IAYILQGVLKA 140

Query: 178 LHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWT-----HHSIAPIEG 232
           L Y+H       +HR +K+S+IL++ D +  +S       + S        H        
Sbjct: 141 LDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVK 197

Query: 233 TFGHLAPEYFMHGIV--DEKTDVFAFGVFLLEIISGRKP 269
               L+PE     +   D K+D+++ G+   E+ +G  P
Sbjct: 198 VLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVP 236

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  105 bits (264), Expect = 1e-25
 Identities = 28/299 (9%), Positives = 64/299 (21%), Gaps = 53/299 (17%)

Query: 73  LVGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKE-KEFLTEIGTIGHVCHPNVLSLL 130
            +  G  + V+    ++  E+ A+K  T    + R E +           +   +     
Sbjct: 69  PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128

Query: 131 GCCVDNGLYLIFQFSSRGSVASLFHDVNSPGV---------------------------- 162
                          S+   A L    +   V                            
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFR 188

Query: 163 ---EWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLP 219
                   H +     R    L     + ++H      N+ +  D    + D      + 
Sbjct: 189 GDEGILALHILTAQLIRLAANLQS---KGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVG 245

Query: 220 SQWTHHSIAPIEGTFGHLAPEYFMHG--IVDEKTDVFAFGVFLLEIISGRKPVDGSHQSL 277
           ++              +   E+            + +  G+ +  +     P       +
Sbjct: 246 TRGP-----ASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGI 300

Query: 278 HSWAKPILNQGEIEKLVDPRLQGAYDVTQLNRLAFAASL---CIRASPTWRPTMSEVLE 333
               K       +             +       F  +L    +      R    E +E
Sbjct: 301 KGSWKRPSL--RVPGTDSLAFGSCTPLPD-----FVKTLIGRFLNFDRRRRLLPLEAME 352

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  103 bits (260), Expect = 1e-25
 Identities = 64/272 (23%), Positives = 124/272 (45%), Gaps = 30/272 (11%)

Query: 68  FSSENLVGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNV 126
           ++    +G+G    VY  + +  G+E+A++++  +    +KE   + EI  +    +PN+
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQM-NLQQQPKKE-LIINEILVMRENKNPNI 79

Query: 127 LSLLGCC-VDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAV---GTARGLHYLH 182
           ++ L    V + L+++ ++ + GS+  +     +   E     +IA       + L +LH
Sbjct: 80  VNYLDSYLVGDELWVVMEYLAGGSLTDVVT--ETCMDE----GQIAAVCRECLQALEFLH 133

Query: 183 KGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWL-PSQWTHHSIAPIEGTFGHLAPEY 241
                ++IHRDIKS NILL  D   +++DFG    + P Q    ++    GT   +APE 
Sbjct: 134 S---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV---GTPYWMAPEV 187

Query: 242 FMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGA 301
                   K D+++ G+  +E+I G  P    + + +    P+     I     P LQ  
Sbjct: 188 VTRKAYGPKVDIWSLGIMAIEMIEGEPP----YLNEN----PLRALYLIATNGTPELQNP 239

Query: 302 YDVTQLNRLAFAASLCIRASPTWRPTMSEVLE 333
             ++ + R  F  + C+      R +  E+L+
Sbjct: 240 EKLSAIFR-DF-LNRCLEMDVEKRGSAKELLQ 269

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  104 bits (261), Expect = 2e-25
 Identities = 50/208 (24%), Positives = 91/208 (43%), Gaps = 16/208 (7%)

Query: 73  LVGRGGYAEVYKGV-LQDGEEIAVKRLTK-VVTDDRKEKEFLTEIGTIGHVCHPNVLSLL 130
            +G+GG+A+ ++       E  A K + K ++    + ++   EI     + H +V+   
Sbjct: 48  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 107

Query: 131 GCCVD-NGLYLIFQFSSRGSVASLFHDVNSPGV--EWKVRHKIAVGTARGLHYLHKGCQR 187
           G   D + ++++ +   R S   L           E + R+ +      G  YLH   + 
Sbjct: 108 GFFEDNDFVFVVLELCRRRS---LLELHKRRKALTEPEARYYL-RQIVLGCQYLH---RN 160

Query: 188 RIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWT-HHSIAPIEGTFGHLAPEYFMHGI 246
           R+IHRD+K  N+ L  D E +I DFGLA  +         +    GT  ++APE      
Sbjct: 161 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC---GTPNYIAPEVLSKKG 217

Query: 247 VDEKTDVFAFGVFLLEIISGRKPVDGSH 274
              + DV++ G  +  ++ G+ P + S 
Sbjct: 218 HSFEVDVWSIGCIMYTLLVGKPPFETSC 245

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  102 bits (257), Expect = 4e-25
 Identities = 59/205 (28%), Positives = 95/205 (46%), Gaps = 17/205 (8%)

Query: 73  LVGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLG 131
           ++G+G Y  VY G  L +   IA+K +     D R  +    EI    H+ H N++  LG
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIP--ERDSRYSQPLHEEIALHKHLKHKNIVQYLG 86

Query: 132 CCVDNG-LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTA---RGLHYLHKGCQR 187
              +NG + +  +    GS+++L      P  + +    I   T     GL YLH     
Sbjct: 87  SFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNE--QTIGFYTKQILEGLKYLH---DN 141

Query: 188 RIIHRDIKSSNILL-TADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGI 246
           +I+HRDIK  N+L+ T     +ISDFG +K L             GT  ++APE    G 
Sbjct: 142 QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCT--ETFTGTLQYMAPEIIDKGP 199

Query: 247 V--DEKTDVFAFGVFLLEIISGRKP 269
               +  D+++ G  ++E+ +G+ P
Sbjct: 200 RGYGKAADIWSLGCTIIEMATGKPP 224

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  101 bits (255), Expect = 6e-25
 Identities = 63/286 (22%), Positives = 120/286 (41%), Gaps = 30/286 (10%)

Query: 74  VGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVC-HPNVLSLLG 131
           +GRG Y  V K   +  G+ +AVKR+     + +++K  L ++         P  ++  G
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVKRIR-ATVNSQEQKRLLMDLDISMRTVDCPFTVTFYG 73

Query: 132 CCVDNG-LYLIFQFSSRGSVASLFHDVNSPGVEWKVRH--KIAVGTARGLHYLHKGCQRR 188
                G +++  +     S+   +  V   G         KIAV   + L +LH   +  
Sbjct: 74  ALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS--KLS 130

Query: 189 IIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIV- 247
           +IHRD+K SN+L+ A  + ++ DFG++ +L         A   G   ++APE     +  
Sbjct: 131 VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDA---GCKPYMAPERINPELNQ 187

Query: 248 ---DEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDV 304
                K+D+++ G+ ++E+   R P         SW  P     ++ +   P+L      
Sbjct: 188 KGYSVKSDIWSLGITMIELAILRFP-------YDSWGTPFQQLKQVVEEPSPQLPADKFS 240

Query: 305 TQLNRLAFAASLCIRASPTWRPTMSEVLE----VMLEGDQIDKERW 346
            +     F +  C++ +   RPT  E+++     + E    D   +
Sbjct: 241 AEFVD--FTSQ-CLKKNSKERPTYPELMQHPFFTLHESKGTDVASF 283

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  101 bits (255), Expect = 6e-25
 Identities = 56/209 (26%), Positives = 92/209 (44%), Gaps = 21/209 (10%)

Query: 75  GRGGYAEVYKGV-LQDGEEIAVKRLTK-VVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC 132
           G+G +A VY+   +  G E+A+K + K  +      +    E+     + HP++L L   
Sbjct: 20  GKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNY 79

Query: 133 CVD-NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIH 191
             D N +YL+ +    G +     +   P  E + RH +      G+ YLH      I+H
Sbjct: 80  FEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMH-QIITGMLYLH---SHGILH 135

Query: 192 RDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIE------GTFGHLAPEYFMHG 245
           RD+  SN+LLT +   +I+DFGLA             P E      GT  +++PE     
Sbjct: 136 RDLTLSNLLLTRNMNIKIADFGLA--------TQLKMPHEKHYTLCGTPNYISPEIATRS 187

Query: 246 IVDEKTDVFAFGVFLLEIISGRKPVDGSH 274
               ++DV++ G     ++ GR P D   
Sbjct: 188 AHGLESDVWSLGCMFYTLLIGRPPFDTDT 216

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  104 bits (261), Expect = 6e-25
 Identities = 71/308 (23%), Positives = 104/308 (33%), Gaps = 71/308 (23%)

Query: 68  FSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDD-RKEKEFLTEIGTIGHVCHPNV 126
             SE ++G G    V       G  +AVKR+     D    E + LTE        HPNV
Sbjct: 17  VVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTES-----DDHPNV 71

Query: 127 LSLLGCCVDNG-LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTAR--------G 177
           +        +  LY+  +  +     +L   V S  V  +                   G
Sbjct: 72  IRYYCSETTDRFLYIALELCN----LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASG 127

Query: 178 LHYLHKGCQRRIIHRDIKSSNILLTADFEPQ-------------ISDFGLAKWLPS--QW 222
           + +LH     +IIHRD+K  NIL++                   ISDFGL K L S    
Sbjct: 128 VAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSS 184

Query: 223 THHSIAPIEGTFGHLAPEYFMHGIV-------DEKTDVFAFGVFLLEIIS-GRKPVDGSH 274
              ++    GT G  APE                  D+F+ G     I+S G+ P    +
Sbjct: 185 FRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKY 244

Query: 275 QSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQLNRLAF------AASL---CIRASPTWR 325
                       +  I       ++G + + ++  L        A  L    I   P  R
Sbjct: 245 S----------RESNI-------IRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKR 287

Query: 326 PTMSEVLE 333
           PT  +VL 
Sbjct: 288 PTAMKVLR 295

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  102 bits (256), Expect = 6e-25
 Identities = 53/216 (24%), Positives = 103/216 (47%), Gaps = 29/216 (13%)

Query: 68  FSSENLVGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNV 126
           +     +G G + +VYK    + G   A K + +  +++  E +++ EI  +    HP +
Sbjct: 21  WEIVGELGDGAFGKVYKAKNKETGALAAAKVI-ETKSEEELE-DYIVEIEILATCDHPYI 78

Query: 127 LSLLGC-CVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAV---GTARGLHYLH 182
           + LLG    D  L+++ +F   G+V ++  +++    E     +I V        L++LH
Sbjct: 79  VKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTE----PQIQVVCRQMLEALNFLH 134

Query: 183 KGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTF-GH---LA 238
               +RIIHRD+K+ N+L+T + + +++DFG++                 +F G    +A
Sbjct: 135 ---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRD------SFIGTPYWMA 185

Query: 239 PEYFMHGIV-----DEKTDVFAFGVFLLEIISGRKP 269
           PE  M   +     D K D+++ G+ L+E+     P
Sbjct: 186 PEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 221

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  101 bits (253), Expect = 1e-24
 Identities = 49/203 (24%), Positives = 92/203 (45%), Gaps = 9/203 (4%)

Query: 73  LVGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRK-EKEFLTEIGTIGHVCHPNVLSLL 130
            +G GG + VY         ++A+K +     +  +  K F  E+     + H N++S++
Sbjct: 18  KLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMI 77

Query: 131 GCCVDNGL-YLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRI 189
               ++   YL+ ++    +++          V+  +          G+ + H     RI
Sbjct: 78  DVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAIN--FTNQILDGIKHAH---DMRI 132

Query: 190 IHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDE 249
           +HRDIK  NIL+ ++   +I DFG+AK L    +      + GT  + +PE       DE
Sbjct: 133 VHRDIKPQNILIDSNKTLKIFDFGIAKALSET-SLTQTNHVLGTVQYFSPEQAKGEATDE 191

Query: 250 KTDVFAFGVFLLEIISGRKPVDG 272
            TD+++ G+ L E++ G  P +G
Sbjct: 192 CTDIYSIGIVLYEMLVGEPPFNG 214

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  101 bits (253), Expect = 2e-24
 Identities = 50/208 (24%), Positives = 91/208 (43%), Gaps = 16/208 (7%)

Query: 73  LVGRGGYAEVYKGV-LQDGEEIAVKRLTK-VVTDDRKEKEFLTEIGTIGHVCHPNVLSLL 130
            +G+GG+A+ ++       E  A K + K ++    + ++   EI     + H +V+   
Sbjct: 22  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81

Query: 131 GCCVD-NGLYLIFQFSSRGSVASLFHDVNSPGV--EWKVRHKIAVGTARGLHYLHKGCQR 187
           G   D + ++++ +   R S   L           E + R+ +      G  YLH   + 
Sbjct: 82  GFFEDNDFVFVVLELCRRRS---LLELHKRRKALTEPEARYYL-RQIVLGCQYLH---RN 134

Query: 188 RIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWT-HHSIAPIEGTFGHLAPEYFMHGI 246
           R+IHRD+K  N+ L  D E +I DFGLA  +         +    GT  ++APE      
Sbjct: 135 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC---GTPNYIAPEVLSKKG 191

Query: 247 VDEKTDVFAFGVFLLEIISGRKPVDGSH 274
              + DV++ G  +  ++ G+ P + S 
Sbjct: 192 HSFEVDVWSIGCIMYTLLVGKPPFETSC 219

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  100 bits (251), Expect = 4e-24
 Identities = 64/272 (23%), Positives = 113/272 (41%), Gaps = 30/272 (11%)

Query: 68  FSSENLVGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNV 126
             S   +G G    V        G ++AVK +  +    R+E     E+  +    H NV
Sbjct: 47  LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMM-DLRKQQRRE-LLFNEVVIMRDYQHFNV 104

Query: 127 LSLLGCC-VDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAV---GTARGLHYLH 182
           + +     V   L+++ +F   G++  +         E     +IA       + L YLH
Sbjct: 105 VEMYKSYLVGEELWVLMEFLQGGALTDIVS--QVRLNE----EQIATVCEAVLQALAYLH 158

Query: 183 KGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWL-PSQWTHHSIAPIEGTFGHLAPEY 241
               + +IHRDIKS +ILLT D   ++SDFG    +        S+    GT   +APE 
Sbjct: 159 A---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV---GTPYWMAPEV 212

Query: 242 FMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGA 301
               +   + D+++ G+ ++E++ G  P    + S      P+     +     P+L+ +
Sbjct: 213 ISRSLYATEVDIWSLGIMVIEMVDGEPP----YFSDS----PVQAMKRLRDSPPPKLKNS 264

Query: 302 YDVTQLNRLAFAASLCIRASPTWRPTMSEVLE 333
           + V+ + R  F     +   P  R T  E+L+
Sbjct: 265 HKVSPVLR-DF-LERMLVRDPQERATAQELLD 294

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  102 bits (255), Expect = 6e-24
 Identities = 58/213 (27%), Positives = 86/213 (40%), Gaps = 18/213 (8%)

Query: 71  ENLVGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSL 129
              +G G Y EV          E A+K + K         + L E+  +  + HPN++ L
Sbjct: 42  VKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKL 101

Query: 130 LGCCVD-NGLYLIFQFSSRGSVASLFHDVNSPGV--EWKVRHKIAVGTARGLHYLHKGCQ 186
                D    YL+ +    G    LF ++       E      I      G+ YLH   +
Sbjct: 102 YDFFEDKRNYYLVMECYKGG---ELFDEIIHRMKFNEVDAAV-IIKQVLSGVTYLH---K 154

Query: 187 RRIIHRDIKSSNILLT---ADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFM 243
             I+HRD+K  N+LL     D   +I DFGL+    +Q          GT  ++APE   
Sbjct: 155 HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERL---GTAYYIAPEVL- 210

Query: 244 HGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQS 276
               DEK DV++ GV L  +++G  P  G    
Sbjct: 211 RKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQ 243

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 99.7 bits (249), Expect = 7e-24
 Identities = 47/224 (20%), Positives = 93/224 (41%), Gaps = 16/224 (7%)

Query: 59  EEISIATNAFSSENLVGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGT 117
           +      N   +   +G G   +V+K    + G  IAVK++     +  + K  L ++  
Sbjct: 18  QRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMR-RSGNKEENKRILMDLDV 76

Query: 118 IGHVC-HPNVLSLLGCCVDNG-LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTA 175
           +      P ++   G  + N  +++  +     +            +  ++  K+ V   
Sbjct: 77  VLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCA--EKLKKRMQGPIPERILGKMTVAIV 134

Query: 176 RGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFG 235
           + L+YL +  +  +IHRD+K SNILL    + ++ DFG++  L         A   G   
Sbjct: 135 KALYYLKE--KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSA---GCAA 189

Query: 236 HLAPEYFMHGIV-----DEKTDVFAFGVFLLEIISGRKPVDGSH 274
           ++APE            D + DV++ G+ L+E+ +G+ P     
Sbjct: 190 YMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCK 233

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score = 99.8 bits (249), Expect = 1e-23
 Identities = 42/227 (18%), Positives = 90/227 (39%), Gaps = 37/227 (16%)

Query: 75  GRGGYAEVYKGVLQDGEEIAVKRLTK---------------VVTDDRKEKEFLTEIGTIG 119
            +G + ++     +D +  A+K+  K                ++   K  +F  E+  I 
Sbjct: 40  NQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIIT 98

Query: 120 HVCHPNVLSLLGCCVDNG-LYLIFQFSSRGSVASLF-HDVNSPGVEWKVRHKIAVGTAR- 176
            + +   L+  G   +   +Y+I+++    S   +   D     ++      I +   + 
Sbjct: 99  DIKNEYCLTCEGIITNYDEVYIIYEYMENDS---ILKFDEYFFVLDKNYTCFIPIQVIKC 155

Query: 177 -------GLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAP 229
                     Y+H   ++ I HRD+K SNIL+  +   ++SDFG ++++  +    S   
Sbjct: 156 IIKSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGSR-- 211

Query: 230 IEGTFGHLAPEYFMH--GIVDEKTDVFAFGVFLLEIISGRKPVDGSH 274
             GT+  + PE+F +       K D+++ G+ L  +     P     
Sbjct: 212 --GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKI 256

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score = 98.9 bits (246), Expect = 3e-23
 Identities = 35/235 (14%), Positives = 72/235 (30%), Gaps = 32/235 (13%)

Query: 59  EEISIATNAFSSENLVGRGGYAEVYKGV------LQDGEEIAVKRLTKVVTDDRKEKEF- 111
            E  + +      +L+G G +A+VY+         ++ ++  +K             EF 
Sbjct: 58  TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKP-----ANPWEFY 112

Query: 112 --LTEIGTIGHVCHPNVLSLLGCCVD-NGLYLIFQFSSRGS---VASLFHDVNSPGVEWK 165
                +  +        +      +  NG  L+ +  S G+     +L+ +     +   
Sbjct: 113 IGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQG 172

Query: 166 VRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEP-----------QISDFGL 214
           +    A+     +  +H      IIH DIK  N +L   F              + D G 
Sbjct: 173 LVISFAMRMLYMIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQ 229

Query: 215 AKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKP 269
           +  +              T G    E   +   + + D F     +  ++ G   
Sbjct: 230 SIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYM 284

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 97.8 bits (244), Expect = 1e-22
 Identities = 75/273 (27%), Positives = 122/273 (44%), Gaps = 40/273 (14%)

Query: 75  GRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKE-FLTEIGTIGHVCHPNVLSLLGC 132
           G+G + EV        G+E AVK ++K     + +KE  L E+  +  + HPN++ L   
Sbjct: 35  GKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEF 94

Query: 133 CVD-NGLYLIFQFSSRGSVASLFHDVNSPGV--EWKVRHKIAVGTARGLHYLHKGCQRRI 189
             D    YL+ +  + G    LF ++ S     E      I      G+ Y+H   + +I
Sbjct: 95  FEDKGYFYLVGEVYTGGE---LFDEIISRKRFSEVDAAR-IIRQVLSGITYMH---KNKI 147

Query: 190 IHRDIKSSNILLTA---DFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGI 246
           +HRD+K  N+LL +   D   +I DFGL+    +           GT  ++APE   HG 
Sbjct: 148 VHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKI---GTAYYIAPEVL-HGT 203

Query: 247 VDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQ 306
            DEK DV++ GV L  ++SG  P +G+            N+ +I K V    +G Y    
Sbjct: 204 YDEKCDVWSTGVILYILLSGCPPFNGA------------NEYDILKKV---EKGKYTFEL 248

Query: 307 L--NRLAFAASLCIRA----SPTWRPTMSEVLE 333
               +++ +A   IR      P+ R +  + L+
Sbjct: 249 PQWKKVSESAKDLIRKMLTYVPSMRISARDALD 281

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 95.4 bits (238), Expect = 2e-22
 Identities = 51/208 (24%), Positives = 98/208 (47%), Gaps = 13/208 (6%)

Query: 73  LVGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRK-EKEFLTEIGTIGHVCHPNVLSLL 130
           ++G GG +EV+    L+D  ++AVK L   +  D      F  E      + HP ++++ 
Sbjct: 19  ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78

Query: 131 GCCVDNGL-----YLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGC 185
                        Y++ ++    ++  + H       +  +   +     + L++ H   
Sbjct: 79  DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIE--VIADACQALNFSH--- 133

Query: 186 QRRIIHRDIKSSNILLTADFEPQISDFGLAKWL-PSQWTHHSIAPIEGTFGHLAPEYFMH 244
           Q  IIHRD+K +NI+++A    ++ DFG+A+ +  S  +    A + GT  +L+PE    
Sbjct: 134 QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 193

Query: 245 GIVDEKTDVFAFGVFLLEIISGRKPVDG 272
             VD ++DV++ G  L E+++G  P  G
Sbjct: 194 DSVDARSDVYSLGCVLYEVLTGEPPFTG 221

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 96.3 bits (240), Expect = 5e-22
 Identities = 73/276 (26%), Positives = 114/276 (41%), Gaps = 39/276 (14%)

Query: 71  ENLVGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSL 129
             ++G+G + EV K       +E AVK + K    ++     L E+  +  + HPN++ L
Sbjct: 27  VCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKL 86

Query: 130 LGCCVD-NGLYLIFQFSSRGSVASLFHDVNSPGV--EWKVRHKIAVGTARGLHYLHKGCQ 186
                D +  Y++ +  + G    LF ++       E      I      G+ Y+H   +
Sbjct: 87  FEILEDSSSFYIVGELYTGG---ELFDEIIKRKRFSEHDAAR-IIKQVFSGITYMH---K 139

Query: 187 RRIIHRDIKSSNILLT---ADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFM 243
             I+HRD+K  NILL     D + +I DFGL+                GT  ++APE   
Sbjct: 140 HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI---GTAYYIAPEVL- 195

Query: 244 HGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYD 303
            G  DEK DV++ GV L  ++SG  P  G             N+ +I K V     G Y 
Sbjct: 196 RGTYDEKCDVWSAGVILYILLSGTPPFYGK------------NEYDILKRV---ETGKYA 240

Query: 304 VTQL--NRLAFAASLCIRA----SPTWRPTMSEVLE 333
                   ++  A   IR      P+ R T ++ LE
Sbjct: 241 FDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score = 95.5 bits (237), Expect = 5e-22
 Identities = 30/309 (9%), Positives = 75/309 (24%), Gaps = 77/309 (24%)

Query: 73  LVGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKE--------------------- 110
           ++G+       +    + GE   V              +                     
Sbjct: 80  VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139

Query: 111 -----FLTEIGTIGHVCHPNVLSLLGCCVDNGLYLIFQ--FSSRGSVASLF-----HDVN 158
                F+     +       ++ +     D  +   F      + ++ +       H   
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199

Query: 159 SPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWL 218
              +    R ++ +   R L  LH      ++H  ++  +I+L       ++ F      
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 256

Query: 219 PSQWTHHSIAPIEGTFGHLAPEYFMH-----------GIVDEKTDVFAFGVFLLEIISGR 267
            ++           + G   PE                ++    D +A G+ +  I    
Sbjct: 257 GARVV------SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310

Query: 268 KPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQLNRLAFAASL---CIRASPTW 324
            P+                        +   +   ++ Q        +L    +R     
Sbjct: 311 LPITKDAA---------------LGGSEWIFRSCKNIPQ-----PVRALLEGFLRYPKED 350

Query: 325 RPTMSEVLE 333
           R    + +E
Sbjct: 351 RLLPLQAME 359

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 96.3 bits (240), Expect = 6e-22
 Identities = 70/287 (24%), Positives = 105/287 (36%), Gaps = 50/287 (17%)

Query: 71  ENLVGRGGYAEVYKGV-LQDGEEIAVKRLTK-----------VVTDDRKEKEFLTEIGTI 118
              +G G Y EV          E A+K + K               ++  +E   EI  +
Sbjct: 41  VRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLL 100

Query: 119 GHVCHPNVLSLLGCCVD-NGLYLIFQFSSRGSVASLFHDVNSPGV--EWKVRHKIAVGTA 175
             + HPN++ L     D    YL+ +F   G    LF  + +     E      I     
Sbjct: 101 KSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGE---LFEQIINRHKFDECDAA-NIMKQIL 156

Query: 176 RGLHYLHKGCQRRIIHRDIKSSNILLT---ADFEPQISDFGLAKWLPSQWTHHSIAPIEG 232
            G+ YLH   +  I+HRDIK  NILL    +    +I DFGL+ +    +         G
Sbjct: 157 SGICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRL---G 210

Query: 233 TFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEK 292
           T  ++APE       +EK DV++ GV +  ++ G  P  G             N  +I K
Sbjct: 211 TAYYIAPEVL-KKKYNEKCDVWSCGVIMYILLCGYPPFGGQ------------NDQDIIK 257

Query: 293 LVDPRLQGAYD--VTQLNRLAFAASLCIRA----SPTWRPTMSEVLE 333
            V    +G Y         ++  A   I+         R T  E L 
Sbjct: 258 KV---EKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALN 301

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 93.6 bits (233), Expect = 1e-21
 Identities = 56/212 (26%), Positives = 97/212 (45%), Gaps = 25/212 (11%)

Query: 68  FSSENLVGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKE--KEFLTEIGTIGHVCHP 124
           FS    +G G +  VY    +++ E +A+K++         E  ++ + E+  +  + HP
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKM-SYSGKQSNEKWQDIIKEVRFLQKLRHP 114

Query: 125 NVLSLLGCCV-DNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAV---GTARGLHY 180
           N +   GC + ++  +L+ ++   GS + L      P  E     +IA    G  +GL Y
Sbjct: 115 NTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQE----VEIAAVTHGALQGLAY 169

Query: 181 LHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPE 240
           LH      +IHRD+K+ NILL+     ++ DFG A  +    +        GT   +APE
Sbjct: 170 LHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS------FVGTPYWMAPE 220

Query: 241 ---YFMHGIVDEKTDVFAFGVFLLEIISGRKP 269
                  G  D K DV++ G+  +E+   + P
Sbjct: 221 VILAMDEGQYDGKVDVWSLGITCIELAERKPP 252

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score = 93.6 bits (232), Expect = 3e-21
 Identities = 27/245 (11%), Positives = 60/245 (24%), Gaps = 53/245 (21%)

Query: 73  LVGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKE--------------------- 110
           ++G+       +    + GE   V              +                     
Sbjct: 85  VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144

Query: 111 -----FLTEIGTIGHVCHPNVLSLLGCCVDNG------LYLIFQFSSRGSVASLFHDVNS 159
                F+     +       ++ +     D        LY   Q + +     L    ++
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204

Query: 160 PG-VEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWL 218
              +    R ++ +   R L  LH      ++H  ++  +I+L       ++ F      
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV-- 259

Query: 219 PSQWTHHSIAPIEGTFGHLAPEYFM----------HGIVDEKTDVFAFGVFLLEIISGRK 268
                  + A      G   PE               ++    D +  G+ +  I     
Sbjct: 260 ----RDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADL 315

Query: 269 PVDGS 273
           P    
Sbjct: 316 PNTDD 320

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 93.2 bits (232), Expect = 5e-21
 Identities = 53/251 (21%), Positives = 99/251 (39%), Gaps = 38/251 (15%)

Query: 45  ESETTKPTWRCFSFEEISIATNAFSSENL---------VGRGGYAEVYKGV-LQDGEEIA 94
           E   +    + F F ++++   +   + L         +G G   EV      +  +++A
Sbjct: 105 EIALSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVA 164

Query: 95  VKRLTK--VVTDDRKEKE----FLTEIGTIGHVCHPNVLSLLGCCVDNGLYLIFQFSSRG 148
           ++ ++K        +E +      TEI  +  + HP ++ +         Y++ +    G
Sbjct: 165 IRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDYYIVLELMEGG 224

Query: 149 SVASLFHDVNSPGVEWKVRHKIAVGTAR----GLHYLHKGCQRRIIHRDIKSSNILLTAD 204
               LF  V       +++              + YLH+     IIHRD+K  N+LL++ 
Sbjct: 225 E---LFDKVVGNK---RLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQ 275

Query: 205 FEPQ---ISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIV---DEKTDVFAFGV 258
            E     I+DFG +K L       ++    GT  +LAPE  +       +   D ++ GV
Sbjct: 276 EEDCLIKITDFGHSKILGETSLMRTLC---GTPTYLAPEVLVSVGTAGYNRAVDCWSLGV 332

Query: 259 FLLEIISGRKP 269
            L   +SG  P
Sbjct: 333 ILFICLSGYPP 343

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score = 92.6 bits (230), Expect = 1e-20
 Identities = 38/210 (18%), Positives = 74/210 (35%), Gaps = 24/210 (11%)

Query: 73  LVGRGGYAEVYKGV--LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLL 130
            +  GG   +Y  +    +G  + +K L     D   +   + E   +  V HP+++ + 
Sbjct: 87  CIAHGGLGWIYLALDRNVNGRPVVLKGL-VHSGDAEAQAMAMAERQFLAEVVHPSIVQIF 145

Query: 131 ------GCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKG 184
                     D   Y++ ++    S+               +     +     L YLH  
Sbjct: 146 NFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKLPV--AEAIA--YLLEILPALSYLH-- 199

Query: 185 CQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMH 244
               +++ D+K  NI+LT + + ++ D G    +           + GT G  APE    
Sbjct: 200 -SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRI----NSFG--YLYGTPGFQAPEIVRT 251

Query: 245 GIVDEKTDVFAFGVFLLEIISGRKPVDGSH 274
           G     TD++  G  L  +       +G +
Sbjct: 252 GPTV-ATDIYTVGRTLAALTLDLPTRNGRY 280

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 89.9 bits (223), Expect = 3e-20
 Identities = 43/223 (19%), Positives = 80/223 (35%), Gaps = 28/223 (12%)

Query: 122 CHPNVLSLLGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGV-EWKVRHKIAVGTARGLHY 180
               V  L        LY+  Q   + ++    +   S    E  V   I +  A  + +
Sbjct: 120 TKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEF 179

Query: 181 LHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIE--------- 231
           LH    + ++HRD+K SNI  T D   ++ DFGL   +       ++             
Sbjct: 180 LH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQ 236

Query: 232 -GTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEI 290
            GT  +++PE         K D+F+ G+ L E++          + +       +   + 
Sbjct: 237 VGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLY---SFSTQMERVRIITD--VRNLKF 291

Query: 291 EKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLE 333
             L   +    + + Q           +  SPT RP  ++++E
Sbjct: 292 PLLFTQKYPQEHMMVQ---------DMLSPSPTERPEATDIIE 325

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 90.1 bits (224), Expect = 3e-20
 Identities = 55/212 (25%), Positives = 85/212 (40%), Gaps = 23/212 (10%)

Query: 75  GRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCC 133
           G+G ++ V + V    G E A K +       R  ++   E      + HPN++ L    
Sbjct: 38  GKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI 97

Query: 134 VDNG-LYLIFQFSSRGSVASLFHDVNSPGV--EWKVRHKIAVGTARGLHYLHKGCQRRII 190
            +    YL+F   + G    LF D+ +     E    H I       + Y H      I+
Sbjct: 98  QEESFHYLVFDLVTGG---ELFEDIVAREFYSEADASHCIQQ-ILESIAYCH---SNGIV 150

Query: 191 HRDIKSSNILLTADFEPQ---ISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIV 247
           HR++K  N+LL +  +     ++DFGLA  +      H  A   GT G+L+PE       
Sbjct: 151 HRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA---GTPGYLSPEVLKKDPY 207

Query: 248 DEKTDVFAFGV---FLLEIISGRKPVDGSHQS 276
            +  D++A GV    LL    G  P     Q 
Sbjct: 208 SKPVDIWACGVILYILL---VGYPPFWDEDQH 236

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 88.4 bits (220), Expect = 4e-20
 Identities = 65/236 (27%), Positives = 101/236 (42%), Gaps = 33/236 (13%)

Query: 75  GRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCC 133
           G+G + EV K       +E AVK + K    ++     L E+  +  + HPN++ L    
Sbjct: 31  GKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEIL 90

Query: 134 VD-NGLYLIFQFSSRGSVASLFHDVNSPGV--EWKVRHKIAVGTARGLHYLHKGCQRRII 190
            D +  Y++ +  + G    LF ++       E      I      G+ Y+H   +  I+
Sbjct: 91  EDSSSFYIVGELYTGG---ELFDEIIKRKRFSEHDAAR-IIKQVFSGITYMH---KHNIV 143

Query: 191 HRDIKSSNILLTA---DFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIV 247
           HRD+K  NILL +   D + +I DFGL+                GT  ++APE  + G  
Sbjct: 144 HRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI---GTAYYIAPE-VLRGTY 199

Query: 248 DEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYD 303
           DEK DV++ GV L  ++SG  P  G             N+ +I K V     G Y 
Sbjct: 200 DEKCDVWSAGVILYILLSGTPPFYGK------------NEYDILKRV---ETGKYA 240

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 88.1 bits (219), Expect = 7e-20
 Identities = 54/221 (24%), Positives = 87/221 (39%), Gaps = 34/221 (15%)

Query: 73  LVGRGGYAEVYKGV-LQDGEEIAVKRL--TKVVTDDRKEKEFLTEIGTIGHVCHPNVLSL 129
           L+G G Y +V + +  +     AVK L   K+      E     EI  +  + H NV+ L
Sbjct: 12  LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71

Query: 130 ---LGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTAR--------GL 178
              L       +Y++ ++     +  +   V           +  V  A         GL
Sbjct: 72  VDVLYNEEKQKMYMVMEYCV-CGMQEMLDSV--------PEKRFPVCQAHGYFCQLIDGL 122

Query: 179 HYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLA 238
            YLH    + I+H+DIK  N+LLT     +IS  G+A+ L       +    +G+     
Sbjct: 123 EYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQP 179

Query: 239 PEYFM-----HGIVDEKTDVFAFGVFLLEIISGRKPVDGSH 274
           PE         G    K D+++ GV L  I +G  P +G +
Sbjct: 180 PEIANGLDTFSG---FKVDIWSAGVTLYNITTGLYPFEGDN 217

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 87.6 bits (218), Expect = 1e-19
 Identities = 54/213 (25%), Positives = 87/213 (40%), Gaps = 28/213 (13%)

Query: 75  GRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCC 133
           G G ++EV+       G+  A+K + K      ++     EI  +  + H N+++L    
Sbjct: 18  GSGAFSEVFLVKQRLTGKLFALKCIKKSPA--FRDSSLENEIAVLKKIKHENIVTLEDIY 75

Query: 134 VD-NGLYLIFQFSSRGSVASLFHDVNSPGV--EWKVRHKIAVGTAR----GLHYLHKGCQ 186
                 YL+ Q  S G    LF  +   GV  E     K A    +     + YLH+   
Sbjct: 76  ESTTHYYLVMQLVSGGE---LFDRILERGVYTE-----KDASLVIQQVLSAVKYLHE--- 124

Query: 187 RRIIHRDIKSSNILLTADFEP---QISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFM 243
             I+HRD+K  N+L     E     I+DFGL+K   +     +     GT G++APE   
Sbjct: 125 NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTAC----GTPGYVAPEVLA 180

Query: 244 HGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQS 276
                +  D ++ GV    ++ G  P     +S
Sbjct: 181 QKPYSKAVDCWSIGVITYILLCGYPPFYEETES 213

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 86.8 bits (216), Expect = 1e-19
 Identities = 51/193 (26%), Positives = 81/193 (41%), Gaps = 17/193 (8%)

Query: 75  GRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCC 133
           G+G ++ V + V    G E A K +       R  ++   E      + HPN++ L    
Sbjct: 15  GKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI 74

Query: 134 VDNG-LYLIFQFSSRGSVASLFHDVNSPGV--EWKVRHKIAVGTARGLHYLHKGCQRRII 190
            +    YL+F   + G    LF D+ +     E    H I       + Y H      I+
Sbjct: 75  QEESFHYLVFDLVTGG---ELFEDIVAREFYSEADASHCIQQ-ILESIAYCHS---NGIV 127

Query: 191 HRDIKSSNILLTADFEPQ---ISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIV 247
           HR++K  N+LL +  +     ++DFGLA  +      H  A   GT G+L+PE       
Sbjct: 128 HRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA---GTPGYLSPEVLKKDPY 184

Query: 248 DEKTDVFAFGVFL 260
            +  D++A GV L
Sbjct: 185 SKPVDIWACGVIL 197

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 87.3 bits (217), Expect = 1e-19
 Identities = 60/252 (23%), Positives = 99/252 (39%), Gaps = 27/252 (10%)

Query: 70  SENLVGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVC-HPNVL 127
            E+++G G +A V   + L   +E AVK + K     R       E+  +     H NVL
Sbjct: 17  QEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSR--VFREVEMLYQCQGHRNVL 74

Query: 128 SLLGCCVDNG-LYLIFQFSSRGSVASLFHDVNSPGV--EWKVRHKIAVGTARGLHYLHKG 184
            L+    +    YL+F+    GS   +   ++      E +    +    A  L +LH  
Sbjct: 75  ELIEFFEEEDRFYLVFEKMRGGS---ILSHIHKRRHFNELEASVVVQD-VASALDFLH-- 128

Query: 185 CQRRIIHRDIKSSNILLTADFEP---QISDFGLAKWLPSQWTHHSIAPIE-----GTFGH 236
             + I HRD+K  NIL     +    +I DF L   +        I+  E     G+  +
Sbjct: 129 -NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEY 187

Query: 237 LAPEYFMHGIV-----DEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIE 291
           +APE            D++ D+++ GV L  ++SG  P  G   S   W +         
Sbjct: 188 MAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQN 247

Query: 292 KLVDPRLQGAYD 303
            L +   +G Y+
Sbjct: 248 MLFESIQEGKYE 259

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 86.6 bits (215), Expect = 3e-19
 Identities = 51/199 (25%), Positives = 85/199 (42%), Gaps = 29/199 (14%)

Query: 73  LVGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLG 131
            +GRG  + VY+       +  A+K L K       +K   TEIG +  + HPN++ L  
Sbjct: 60  ELGRGATSIVYRCKQKGTQKPYALKVLKK----TVDKKIVRTEIGVLLRLSHPNIIKLKE 115

Query: 132 CCVD-NGLYLIFQFSSRGSVASLFHDVNSPGV--EWKVRHKIAVGTAR----GLHYLHKG 184
                  + L+ +  + G    LF  +   G   E     + A    +     + YLH  
Sbjct: 116 IFETPTEISLVLELVTGGE---LFDRIVEKGYYSE-----RDAADAVKQILEAVAYLH-- 165

Query: 185 CQRRIIHRDIKSSNILLT---ADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEY 241
            +  I+HRD+K  N+L      D   +I+DFGL+K +  Q    ++    GT G+ APE 
Sbjct: 166 -ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVC---GTPGYCAPEI 221

Query: 242 FMHGIVDEKTDVFAFGVFL 260
                   + D+++ G+  
Sbjct: 222 LRGCAYGPEVDMWSVGIIT 240

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 85.4 bits (212), Expect = 5e-19
 Identities = 59/280 (21%), Positives = 107/280 (38%), Gaps = 51/280 (18%)

Query: 74  VGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC 132
           +G G + +V+       G E  +K + K  +    E+    EI  +  + HPN++ +   
Sbjct: 30  LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQ-IEAEIEVLKSLDHPNIIKIFEV 88

Query: 133 CVD-NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRH-KIAVGTAR----GLHYLHKGCQ 186
             D + +Y++ +    G    L   + S     K           +     L Y H    
Sbjct: 89  FEDYHNMYIVMETCEGGE---LLERIVSAQARGKALSEGYVAELMKQMMNALAYFH---S 142

Query: 187 RRIIHRDIKSSNILLT---ADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFM 243
           + ++H+D+K  NIL          +I DFGLA+   S     + A   GT  ++APE F 
Sbjct: 143 QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAA---GTALYMAPEVF- 198

Query: 244 HGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYD 303
              V  K D+++ GV +  +++G  P  G+            +  E+++          +
Sbjct: 199 KRDVTFKCDIWSAGVVMYFLLTGCLPFTGT------------SLEEVQQKA---TYKEPN 243

Query: 304 -------VTQLNRLAFAASL---CIRASPTWRPTMSEVLE 333
                  +T       A  L    +   P  RP+ ++VL 
Sbjct: 244 YAVECRPLTPQ-----AVDLLKQMLTKDPERRPSAAQVLH 278

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 86.0 bits (213), Expect = 5e-19
 Identities = 53/255 (20%), Positives = 87/255 (34%), Gaps = 58/255 (22%)

Query: 74  VGRGGYAEVYKGV-LQDGEEIAVKRLTK---VVTDDRKEKEFLTEIGTIGHVCHPNVLSL 129
           +G+G Y  V   +  Q     A+K + K      + +  +   TE+  +  + HPN+  L
Sbjct: 34  IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93

Query: 130 LGCCVDNG-LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTAR------------ 176
                D   + L+ +    G    L   +N    +   +  + V   +            
Sbjct: 94  YEVYEDEQYICLVMELCHGGH---LLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAI 150

Query: 177 -----------------------------GLHYLHKGCQRRIIHRDIKSSNILLTAD--F 205
                                         LHYLH    + I HRDIK  N L + +  F
Sbjct: 151 NGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH---NQGICHRDIKPENFLFSTNKSF 207

Query: 206 EPQISDFGLAKWLPSQWTHHSIAPIE--GTFGHLAPE--YFMHGIVDEKTDVFAFGVFLL 261
           E ++ DFGL+K                 GT   +APE     +     K D ++ GV L 
Sbjct: 208 EIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLH 267

Query: 262 EIISGRKPVDGSHQS 276
            ++ G  P  G + +
Sbjct: 268 LLLMGAVPFPGVNDA 282

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 85.8 bits (213), Expect = 6e-19
 Identities = 46/203 (22%), Positives = 80/203 (39%), Gaps = 29/203 (14%)

Query: 75  GRGGYAEVYKGV-LQDGEEIAVKRLTK------VVTDDRKEKEFLTEIGTIGHVCHPNVL 127
           G G   EV      +  +++A+K ++K         +        TEI  +  + HP ++
Sbjct: 19  GSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCII 78

Query: 128 SLLGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTAR----GLHYLHK 183
            +         Y++ +    G    LF  V       +++              + YLH+
Sbjct: 79  KIKNFFDAEDYYIVLELMEGG---ELFDKVVGNK---RLKEATCKLYFYQMLLAVQYLHE 132

Query: 184 GCQRRIIHRDIKSSNILLTADFEPQ---ISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPE 240
                IIHRD+K  N+LL++  E     I+DFG +K L       ++    GT  +LAPE
Sbjct: 133 ---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC---GTPTYLAPE 186

Query: 241 YFMHGIV---DEKTDVFAFGVFL 260
             +       +   D ++ GV L
Sbjct: 187 VLVSVGTAGYNRAVDCWSLGVIL 209

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 85.8 bits (213), Expect = 7e-19
 Identities = 55/220 (25%), Positives = 86/220 (39%), Gaps = 29/220 (13%)

Query: 75  GRGGYAEVYKGV-LQDGEEIAVK--RLTKVVTDDRKEKE-FLTEIGTIGHVCHPNVLSLL 130
           G+G ++ V + +  + G++ AVK   + K  +      E    E      + HP+++ LL
Sbjct: 33  GKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELL 92

Query: 131 GCCVDNG-LYLIFQFSSRGSVASLFHDVNSPGVEWKV-RHKIAVGTAR----GLHYLHKG 184
                +G LY++F+F        L  ++        V    +A    R     L Y H  
Sbjct: 93  ETYSSDGMLYMVFEFMDGAD---LCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH-- 147

Query: 185 CQRRIIHRDIKSSNILLTADFEPQ---ISDFGLAKWLP-SQWTHHSIAPIEGTFGHLAPE 240
               IIHRD+K   +LL +        +  FG+A  L  S           GT   +APE
Sbjct: 148 -DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV---GTPHFMAPE 203

Query: 241 YFMHGIVDEKTDVFAFGV---FLLEIISGRKPVDGSHQSL 277
                   +  DV+  GV    LL   SG  P  G+ + L
Sbjct: 204 VVKREPYGKPVDVWGCGVILFILL---SGCLPFYGTKERL 240

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 85.5 bits (212), Expect = 1e-18
 Identities = 49/224 (21%), Positives = 81/224 (36%), Gaps = 25/224 (11%)

Query: 47  ETTKPTWRCFSFEEISIATNAFSS----ENLVGRGGYAEVYKGV-LQDGEEIAVKRLTKV 101
           +  +  W+ +  + + +   +          +G G +  V++ V    G     K +   
Sbjct: 28  KFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP 87

Query: 102 VTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVD-NGLYLIFQFSSRGSVASLFHDVNSP 160
              D+       EI  +  + HP +++L     D   + LI +F S G    LF  + + 
Sbjct: 88  YPLDKYT--VKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGE---LFDRIAAE 142

Query: 161 GVEWKVRHKIAVGTAR----GLHYLHKGCQRRIIHRDIKSSNILLTADFEPQ--ISDFGL 214
             +        +   R    GL ++H   +  I+H DIK  NI+          I DFGL
Sbjct: 143 DYKMS--EAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGL 197

Query: 215 AKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGV 258
           A  L              T    APE      V   TD++A GV
Sbjct: 198 ATKLNPDEIVKVTT---ATAEFAAPEIVDREPVGFYTDMWAIGV 238

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 84.2 bits (209), Expect = 2e-18
 Identities = 41/169 (24%), Positives = 70/169 (41%), Gaps = 21/169 (12%)

Query: 72  NLVGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEF----LTEIGT---IGHVCH 123
             +G G Y  VYK      G  +A+K + +V              + E+     +    H
Sbjct: 15  AEIGVGAYGTVYKARDPHSGHFVALKSV-RVPNGGGGGGGLPISTVREVALLRRLEAFEH 73

Query: 124 PNVLSLLGCCVDNG------LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARG 177
           PNV+ L+  C  +       + L+F+   +  + +       PG+  +    +     RG
Sbjct: 74  PNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRG 132

Query: 178 LHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKW--LPSQWTH 224
           L +LH      I+HRD+K  NIL+T+    +++DFGLA+        T 
Sbjct: 133 LDFLH---ANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTP 178

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 85.4 bits (212), Expect = 2e-18
 Identities = 54/217 (24%), Positives = 89/217 (41%), Gaps = 32/217 (14%)

Query: 75  GRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCC 133
           G+G ++ V + V +  G+E A   +       R  ++   E      + HPN++ L    
Sbjct: 20  GKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSI 79

Query: 134 VDNG-LYLIFQFSSRGSVASLFHDVNSPGV--EWKVRHKIAVGTAR----GLHYLHKGCQ 186
            + G  YLIF   + G    LF D+ +     E       A    +     + + H   Q
Sbjct: 80  SEEGHHYLIFDLVTGG---ELFEDIVAREYYSE-----ADASHCIQQILEAVLHCH---Q 128

Query: 187 RRIIHRDIKSSNILLTADFEP---QISDFGLAKWL-PSQWTHHSIAPIEGTFGHLAPEYF 242
             ++HR++K  N+LL +  +    +++DFGLA  +   Q      A   GT G+L+PE  
Sbjct: 129 MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA---GTPGYLSPEVL 185

Query: 243 MHGIVDEKTDVFAFGV---FLLEIISGRKPVDGSHQS 276
                 +  D++A GV    LL    G  P     Q 
Sbjct: 186 RKDPYGKPVDLWACGVILYILL---VGYPPFWDEDQH 219

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 84.7 bits (210), Expect = 2e-18
 Identities = 49/202 (24%), Positives = 81/202 (40%), Gaps = 27/202 (13%)

Query: 68  FSSENLVGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNV 126
            S   ++G G + +V+K      G ++A K +      D++E     EI  +  + H N+
Sbjct: 91  VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEE--VKNEISVMNQLDHANL 148

Query: 127 LSLLGCCVD-NGLYLIFQFSSRGSVASLFHDVNSPGV---EWKVRHKIAVGTAR----GL 178
           + L       N + L+ ++   G    LF  +        E      +     +    G+
Sbjct: 149 IQLYDAFESKNDIVLVMEYVDGGE---LFDRIIDESYNLTELDTILFM-----KQICEGI 200

Query: 179 HYLHKGCQRRIIHRDIKSSNILLTADFEPQI--SDFGLAKWLPSQWTHHSIAPIEGTFGH 236
            ++H   Q  I+H D+K  NIL       QI   DFGLA+    +          GT   
Sbjct: 201 RHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNF---GTPEF 254

Query: 237 LAPEYFMHGIVDEKTDVFAFGV 258
           LAPE   +  V   TD+++ GV
Sbjct: 255 LAPEVVNYDFVSFPTDMWSVGV 276

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 82.6 bits (205), Expect = 4e-18
 Identities = 51/210 (24%), Positives = 82/210 (39%), Gaps = 20/210 (9%)

Query: 74  VGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC 132
           +GRG + EV   V        A K++ K   +D     F  EI  +  + HPN++ L   
Sbjct: 17  IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED--VDRFKQEIEIMKSLDHPNIIRLYET 74

Query: 133 CVD-NGLYLIFQFSSRGSVASLFHDVNSPGV--EWKVRHKIAVGTARGLHYLHKGCQRRI 189
             D   +YL+ +  + G    LF  V    V  E      I       + Y H   +  +
Sbjct: 75  FEDNTDIYLVMELCTGGE---LFERVVHKRVFRESDAAR-IMKDVLSAVAYCH---KLNV 127

Query: 190 IHRDIKSSNILLTA---DFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGI 246
            HRD+K  N L      D   ++ DFGLA          +     GT  +++P+    G+
Sbjct: 128 AHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKV---GTPYYVSPQVL-EGL 183

Query: 247 VDEKTDVFAFGVFLLEIISGRKPVDGSHQS 276
              + D ++ GV +  ++ G  P      S
Sbjct: 184 YGPECDEWSAGVMMYVLLCGYPPFSAPTDS 213

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 83.4 bits (207), Expect = 4e-18
 Identities = 43/155 (27%), Positives = 72/155 (46%), Gaps = 24/155 (15%)

Query: 74  VGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEF----LTEIGTIGHVCHPNVLS 128
           +G G +A VYK       + +A+K++ K+      +       L EI  +  + HPN++ 
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKI-KLGHRSEAKDGINRTALREIKLLQELSHPNIIG 76

Query: 129 LLGCCV-DNGLYLIFQFSSRGSVASLFHD----VNSPGVEWKVRH--KIAVGTARGLHYL 181
           LL      + + L+F F        +  D    +    +     H     + T +GL YL
Sbjct: 77  LLDAFGHKSNISLVFDF--------METDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYL 128

Query: 182 HKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAK 216
           H   Q  I+HRD+K +N+LL  +   +++DFGLAK
Sbjct: 129 H---QHWILHRDLKPNNLLLDENGVLKLADFGLAK 160

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299

 Score = 82.6 bits (205), Expect = 5e-18
 Identities = 44/154 (28%), Positives = 71/154 (46%), Gaps = 12/154 (7%)

Query: 68  FSSENLVGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLT---EIGTIGHVCH 123
           F     +G G Y  VYK      GE +A+K   K+  D   E    T   EI  +  + H
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALK---KIRLDTETEGVPSTAIREISLLKELNH 61

Query: 124 PNVLSLLGCCV-DNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLH 182
           PN++ LL     +N LYL+F+F  +  +          G+   +         +GL + H
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 120

Query: 183 KGCQRRIIHRDIKSSNILLTADFEPQISDFGLAK 216
                R++HRD+K  N+L+  +   +++DFGLA+
Sbjct: 121 ---SHRVLHRDLKPQNLLINTEGAIKLADFGLAR 151

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 83.1 bits (206), Expect = 5e-18
 Identities = 54/229 (23%), Positives = 95/229 (41%), Gaps = 26/229 (11%)

Query: 75  GRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVC-HPNVLSLLGC 132
           G G ++   K V  +  +  AVK ++K     R E     EI  +     HPN++ L   
Sbjct: 20  GEGSFSICRKCVHKKSNQAFAVKIISK-----RMEANTQKEITALKLCEGHPNIVKLHEV 74

Query: 133 CVD-NGLYLIFQFSSRGSVASLFHDVNSPGV--EWKVRHKIAVGTARGLHYLHKGCQRRI 189
             D    +L+ +  + G    LF  +       E +  + +       + ++H      +
Sbjct: 75  FHDQLHTFLVMELLNGGE---LFERIKKKKHFSETEASYIMRK-LVSAVSHMH---DVGV 127

Query: 190 IHRDIKSSNILLT---ADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGI 246
           +HRD+K  N+L T    + E +I DFG A+  P    +  +     T  + APE      
Sbjct: 128 VHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD--NQPLKTPCFTLHYAAPELLNQNG 185

Query: 247 VDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKP-ILNQ---GEIE 291
            DE  D+++ GV L  ++SG+ P     +SL   +   I+ +   G+  
Sbjct: 186 YDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFS 234

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 82.6 bits (205), Expect = 7e-18
 Identities = 45/192 (23%), Positives = 80/192 (41%), Gaps = 38/192 (19%)

Query: 53  WRCFSFEEISIATNAFSSENLVGRGGYAEVYKG--VLQDGEEIAVKRLTKVVTDDRKEKE 110
             C + ++       +     +G G Y +V+K   +   G  +A+KR+       R +  
Sbjct: 5   GLCRADQQ-------YECVAEIGEGAYGKVFKARDLKNGGRFVALKRV-------RVQTG 50

Query: 111 F-------LTEIGT---IGHVCHPNVLSLLGCCV------DNGLYLIFQFSSRGSVASLF 154
                   + E+     +    HPNV+ L   C       +  L L+F+   +  + +  
Sbjct: 51  EEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYL 109

Query: 155 HDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGL 214
             V  PGV  +    +     RGL +LH     R++HRD+K  NIL+T+  + +++DFGL
Sbjct: 110 DKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGL 166

Query: 215 AKW--LPSQWTH 224
           A+        T 
Sbjct: 167 ARIYSFQMALTS 178

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 82.2 bits (204), Expect = 9e-18
 Identities = 42/153 (27%), Positives = 75/153 (49%), Gaps = 12/153 (7%)

Query: 68  FSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLT---EIGTIGHVCHP 124
           +     VG G Y  VYK     G  +A+K   ++  D   E    T   EI  +  + HP
Sbjct: 23  YQKLEKVGEGTYGVVYKAKDSQGRIVALK---RIRLDAEDEGIPSTAIREISLLKELHHP 79

Query: 125 NVLSLLGCCV-DNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHK 183
           N++SL+     +  L L+F+F  +  +  +  +  +   + +++        RG+ + H 
Sbjct: 80  NIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIK-IYLYQLLRGVAHCH- 136

Query: 184 GCQRRIIHRDIKSSNILLTADFEPQISDFGLAK 216
             Q RI+HRD+K  N+L+ +D   +++DFGLA+
Sbjct: 137 --QHRILHRDLKPQNLLINSDGALKLADFGLAR 167

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 81.9 bits (203), Expect = 1e-17
 Identities = 50/204 (24%), Positives = 83/204 (40%), Gaps = 28/204 (13%)

Query: 75  GRGGYAEVYKGV-LQDGEEIAVKRLTK-----VVTDDRKEKE--FLTEIGTIGHVC-HPN 125
           GRG  + V + +     +E AVK +          ++ +E     L E+  +  V  HPN
Sbjct: 26  GRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPN 85

Query: 126 VLSLLGCCVD-NGLYLIFQFSSRGSVASLFHDVNSPGV--EWKVRHKIAVGTARGLHYLH 182
           ++ L          +L+F    +G    LF  +       E + R  I       +  LH
Sbjct: 86  IIQLKDTYETNTFFFLVFDLMKKGE---LFDYLTEKVTLSEKETRK-IMRALLEVICALH 141

Query: 183 KGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYF 242
           K     I+HRD+K  NILL  D   +++DFG +  L        +    GT  +LAPE  
Sbjct: 142 K---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVC---GTPSYLAPEII 195

Query: 243 MHGIV------DEKTDVFAFGVFL 260
              +        ++ D+++ GV +
Sbjct: 196 ECSMNDNHPGYGKEVDMWSTGVIM 219

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 83.7 bits (207), Expect = 1e-17
 Identities = 54/237 (22%), Positives = 91/237 (38%), Gaps = 25/237 (10%)

Query: 45  ESETTKPTWRCFSFEEISIATNAFSS----ENLVGRGGYAEVYKGV-LQDGEEIAVKRLT 99
                   W+ +  + + I  +           +G G +  V++      G   A K + 
Sbjct: 132 YDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVM 191

Query: 100 KVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVD-NGLYLIFQFSSRGSVASLFHDVN 158
                D++      EI T+  + HP +++L     D N + +I++F S G    LF  V 
Sbjct: 192 TPHESDKET--VRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGE---LFEKVA 246

Query: 159 SPGVEWKVRHKIAVGTAR----GLHYLHKGCQRRIIHRDIKSSNILLTADFEPQI--SDF 212
               +       AV   R    GL ++H   +   +H D+K  NI+ T     ++   DF
Sbjct: 247 DEHNKMS--EDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDF 301

Query: 213 GLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKP 269
           GL   L  + +        GT    APE      V   TD+++ GV    ++SG  P
Sbjct: 302 GLTAHLDPKQSVKVTT---GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSP 355

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 81.4 bits (202), Expect = 1e-17
 Identities = 50/215 (23%), Positives = 92/215 (42%), Gaps = 30/215 (13%)

Query: 68  FSSENLVGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLT---EIGTIGHVCH 123
           +     +G G Y  V+K    +  E +A+K   +V  DD  E    +   EI  +  + H
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHEIVALK---RVRLDDDDEGVPSSALREICLLKELKH 60

Query: 124 PNVLSLLGCCV-DNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLH 182
            N++ L      D  L L+F+F  +  +   F   N       V+        +GL + H
Sbjct: 61  KNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVK-SFLFQLLKGLGFCH 118

Query: 183 KGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKW--LPSQ-WTHHSI-----APIEGTF 234
               R ++HRD+K  N+L+  + E ++++FGLA+   +P + ++   +      P +  F
Sbjct: 119 ---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPP-DVLF 174

Query: 235 GHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKP 269
           G  A  Y          D+++ G    E+ +  +P
Sbjct: 175 G--AKLY------STSIDMWSAGCIFAELANAGRP 201

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 81.8 bits (203), Expect = 1e-17
 Identities = 39/147 (26%), Positives = 65/147 (44%), Gaps = 13/147 (8%)

Query: 74  VGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLT---EIGTIGHVCHPNVLSL 129
           +G G Y  V+K      G+ +A+K   K +  +           EI  +  + HPN+++L
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIK---KFLESEDDPVIKKIALREIRMLKQLKHPNLVNL 67

Query: 130 LGCCVDNG-LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRR 188
           L        L+L+F++    +V            E  V+  I   T + +++ HK     
Sbjct: 68  LEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVK-SITWQTLQAVNFCHK---HN 122

Query: 189 IIHRDIKSSNILLTADFEPQISDFGLA 215
            IHRD+K  NIL+T     ++ DFG A
Sbjct: 123 CIHRDVKPENILITKHSVIKLCDFGFA 149

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 81.4 bits (202), Expect = 1e-17
 Identities = 40/147 (27%), Positives = 64/147 (43%), Gaps = 12/147 (8%)

Query: 74  VGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLT---EIGTIGHVCHPNVLSLL 130
           +G G Y  VYK     GE  A+K   K+  +   E    T   EI  +  + H N++ L 
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALK---KIRLEKEDEGIPSTTIREISILKELKHSNIVKLY 66

Query: 131 GCCV-DNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRI 189
                   L L+F+   +  +  L             +    +    G+ Y H    RR+
Sbjct: 67  DVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAK-SFLLQLLNGIAYCH---DRRV 121

Query: 190 IHRDIKSSNILLTADFEPQISDFGLAK 216
           +HRD+K  N+L+  + E +I+DFGLA+
Sbjct: 122 LHRDLKPQNLLINREGELKIADFGLAR 148

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 81.5 bits (202), Expect = 1e-17
 Identities = 50/198 (25%), Positives = 81/198 (40%), Gaps = 26/198 (13%)

Query: 75  GRGGYAEVYKGV-LQDGEEIAVK----RLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSL 129
           G G +A V K      G E A K    R ++        +E   E+  +  V H NV++L
Sbjct: 21  GSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITL 80

Query: 130 LGCCVD-NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTAR----GLHYLHKG 184
                +   + LI +  S G    LF  +        +  + A    +    G++YLH  
Sbjct: 81  HDVYENRTDVVLILELVSGGE---LFDFLAQKE---SLSEEEATSFIKQILDGVNYLH-- 132

Query: 185 CQRRIIHRDIKSSNILLTADFEPQ----ISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPE 240
             ++I H D+K  NI+L     P     + DFGLA  +       +I    GT   +APE
Sbjct: 133 -TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF---GTPEFVAPE 188

Query: 241 YFMHGIVDEKTDVFAFGV 258
              +  +  + D+++ GV
Sbjct: 189 IVNYEPLGLEADMWSIGV 206

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 81.5 bits (202), Expect = 2e-17
 Identities = 49/197 (24%), Positives = 84/197 (42%), Gaps = 26/197 (13%)

Query: 75  GRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCH-PNVLSLLGC 132
           GRG +A V + +    G+E A K L K         E L EI  +      P V++L   
Sbjct: 38  GRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEV 97

Query: 133 CVD-NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRH---KIAVGTAR----GLHYLHKG 184
             + + + LI ++++ G    +F       +            +   +    G++YLH  
Sbjct: 98  YENTSEIILILEYAAGGE---IFSLC----LPELAEMVSENDVIRLIKQILEGVYYLH-- 148

Query: 185 CQRRIIHRDIKSSNILLTADFEPQ---ISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEY 241
            Q  I+H D+K  NILL++ +      I DFG+++ +        I    GT  +LAPE 
Sbjct: 149 -QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIM---GTPEYLAPEI 204

Query: 242 FMHGIVDEKTDVFAFGV 258
             +  +   TD++  G+
Sbjct: 205 LNYDPITTATDMWNIGI 221

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 81.6 bits (202), Expect = 2e-17
 Identities = 46/225 (20%), Positives = 83/225 (36%), Gaps = 40/225 (17%)

Query: 73  LVGRGGYAEVYKGV-LQDGEEIAVKRLTK----VVTDDRKEKEFLTEIGTI----GHVCH 123
           L+G+GG+  V+ G  L D  ++A+K + +      +          E+  +        H
Sbjct: 38  LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97

Query: 124 PNVLSLLGCCV---DNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTAR---- 176
           P V+ LL         G  L+ +         LF  +   G        +  G +R    
Sbjct: 98  PGVIRLLD--WFETQEGFMLVLERPLPA--QDLFDYITEKG-------PLGEGPSRCFFG 146

Query: 177 ----GLHYLHKGCQRRIIHRDIKSSNILLTAD-FEPQISDFGLAKWLPSQWTHHSIAPIE 231
                + + H    R ++HRDIK  NIL+       ++ DFG    L  +         +
Sbjct: 147 QVVAAIQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDF----D 199

Query: 232 GTFGHLAPEYFMHGIVD-EKTDVFAFGVFLLEIISGRKPVDGSHQ 275
           GT  +  PE+            V++ G+ L +++ G  P +   +
Sbjct: 200 GTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE 244

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 81.1 bits (201), Expect = 2e-17
 Identities = 51/200 (25%), Positives = 85/200 (42%), Gaps = 30/200 (15%)

Query: 75  GRGGYAEVYKGV-LQDGEEIAVK--RLTKVVTDDRKE--KEFLTEIGTIGHVCHPNVLSL 129
           G G +A V K      G+E A K  +  ++ +  R    +E   E+  +  + HPN+++L
Sbjct: 14  GSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITL 73

Query: 130 LGCCVD-NGLYLIFQFSSRGSVASLFHDVNSPGV--EWKVRHKIAVGTAR----GLHYLH 182
                +   + LI +  S G    LF  +       E       A    +    G+HYLH
Sbjct: 74  HDIFENKTDVVLILELVSGGE---LFDFLAEKESLTE-----DEATQFLKQILDGVHYLH 125

Query: 183 KGCQRRIIHRDIKSSNILLTADFEPQ----ISDFGLAKWLPSQWTHHSIAPIEGTFGHLA 238
               +RI H D+K  NI+L     P     + DFG+A  + +     +I    GT   +A
Sbjct: 126 ---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIF---GTPEFVA 179

Query: 239 PEYFMHGIVDEKTDVFAFGV 258
           PE   +  +  + D+++ GV
Sbjct: 180 PEIVNYEPLGLEADMWSIGV 199

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 83.4 bits (206), Expect = 2e-17
 Identities = 81/334 (24%), Positives = 135/334 (40%), Gaps = 50/334 (14%)

Query: 66  NAFSSENLVGRGGYAEVYKGVLQDGEEI-AVKRLTKVVTDDRKEKEF-LTE---IGTIGH 120
           N FS   ++GRGG+ EVY     D  ++ A+K L K     ++ +   L E   +  +  
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248

Query: 121 VCHPNVLSLLGCCVDNG-LYLIFQFSSRGSVASLFHDVNSPGV--EWKVRHKIAVGTARG 177
              P ++ +         L  I    + G    L + ++  GV  E  +R   A     G
Sbjct: 249 GDCPFIVCMSYAFHTPDKLSFILDLMNGGD---LHYHLSQHGVFSEADMRFYAA-EIILG 304

Query: 178 LHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHL 237
           L ++H    R +++RD+K +NILL      +ISD GLA     +  H S+    GT G++
Sbjct: 305 LEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GTHGYM 357

Query: 238 APEYFMHGIVDEKT-DVFAFGVFLLEIISGRKPVDGSH-------------------QSL 277
           APE    G+  + + D F+ G  L +++ G  P                         S 
Sbjct: 358 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSF 417

Query: 278 HSWAKPILNQGEIEKLVDPRL----QGAYDVTQ---LNRLAFAASLCIRASPTWRPTMSE 330
               + +L +G +++ V+ RL    +GA +V +      L +      +  P   P   E
Sbjct: 418 SPELRSLL-EGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPPRGE 476

Query: 331 VLEVMLEGD--QIDKERWKMPEEEEEDQEEFWGF 362
           V       D    D+E  K  +  + DQE +  F
Sbjct: 477 V-NAADAFDIGSFDEEDTKGIKLLDSDQELYRNF 509

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 81.6 bits (202), Expect = 2e-17
 Identities = 50/198 (25%), Positives = 82/198 (41%), Gaps = 26/198 (13%)

Query: 75  GRGGYAEVYKGV-LQDGEEIAVK--RLTKVVTDDRKE--KEFLTEIGTIGHVCHPNVLSL 129
           G G +A V K      G E A K  +  +     R    +E   E+  +  V HPN+++L
Sbjct: 21  GSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITL 80

Query: 130 LGCCVD-NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTAR----GLHYLHKG 184
                +   + LI +  S G    LF  +        +  + A    +    G++YLH  
Sbjct: 81  HDVYENRTDVVLILELVSGGE---LFDFLAQKE---SLSEEEATSFIKQILDGVNYLH-- 132

Query: 185 CQRRIIHRDIKSSNILLTADFEPQ----ISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPE 240
             ++I H D+K  NI+L     P     + DFGLA  +       +I    GT   +APE
Sbjct: 133 -TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF---GTPEFVAPE 188

Query: 241 YFMHGIVDEKTDVFAFGV 258
              +  +  + D+++ GV
Sbjct: 189 IVNYEPLGLEADMWSIGV 206

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 81.5 bits (202), Expect = 2e-17
 Identities = 47/163 (28%), Positives = 86/163 (52%), Gaps = 37/163 (22%)

Query: 74  VGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKE-F----LTEIGTIGHVCHPNVL 127
           +G+G + EV+K    + G+++A+K   KV+ +   EKE F    L EI  +  + H NV+
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALK---KVLME--NEKEGFPITALREIKILQLLKHENVV 79

Query: 128 SLLGCCVDNG---------LYLIFQFSSRGSVASLFHD----VNSPGVEWKVRH--KIAV 172
           +L+  C             +YL+F F          HD    +++  V++ +    ++  
Sbjct: 80  NLIEICRTKASPYNRCKGSIYLVFDF--------CEHDLAGLLSNVLVKFTLSEIKRVMQ 131

Query: 173 GTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLA 215
               GL+Y+H+    +I+HRD+K++N+L+T D   +++DFGLA
Sbjct: 132 MLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLA 171

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 82.2 bits (203), Expect = 2e-17
 Identities = 42/166 (25%), Positives = 68/166 (40%), Gaps = 39/166 (23%)

Query: 74  VGRGGYAEVYKGVLQD---GEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLL 130
           VGRG Y  VYK   +D    ++ A+K++               EI  +  + HPNV+SL 
Sbjct: 29  VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISM----SACREIALLRELKHPNVISLQ 84

Query: 131 GCCV---DNGLYLIFQFSSRGSVASLFHD------VNSPGVEWKVRHKIAVGTA------ 175
              +   D  ++L+F +          HD       +      K   ++  G        
Sbjct: 85  KVFLSHADRKVWLLFDY--------AEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQ 136

Query: 176 --RGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQ----ISDFGLA 215
              G+HYLH      ++HRD+K +NIL+  +   +    I+D G A
Sbjct: 137 ILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 179

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 80.7 bits (200), Expect = 3e-17
 Identities = 45/193 (23%), Positives = 71/193 (36%), Gaps = 22/193 (11%)

Query: 74  VGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC 132
           +GRG +  V++ V     +    K +    TD   +     EI  +    H N+L L   
Sbjct: 13  LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD---QVLVKKEISILNIARHRNILHLHES 69

Query: 133 CVD-NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTAR----GLHYLHKGCQR 187
                 L +IF+F S      +F  +N+   E     +  V         L +LH     
Sbjct: 70  FESMEELVMIFEFISGLD---IFERINTSAFELN--EREIVSYVHQVCEALQFLH---SH 121

Query: 188 RIIHRDIKSSNILLTADFEPQ--ISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHG 245
            I H DI+  NI+          I +FG A+ L        +        + APE   H 
Sbjct: 122 NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF---TAPEYYAPEVHQHD 178

Query: 246 IVDEKTDVFAFGV 258
           +V   TD+++ G 
Sbjct: 179 VVSTATDMWSLGT 191

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 80.8 bits (200), Expect = 4e-17
 Identities = 55/238 (23%), Positives = 87/238 (36%), Gaps = 36/238 (15%)

Query: 75  GRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCC 133
           G G Y+   + +      E AVK + K   D  +E E L   G      HPN+++L    
Sbjct: 31  GVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQ-----HPNIITLKDVY 85

Query: 134 VD-NGLYLIFQFSSRGSVASLFHDVNSPGV--EWKVRHKIAVGTARGLHYLHKGCQRRII 190
            D   +Y++ +    G    L   +       E +    +     + + YLH    + ++
Sbjct: 86  DDGKYVYVVTELMKGGE---LLDKILRQKFFSEREASAVLFT-ITKTVEYLHA---QGVV 138

Query: 191 HRDIKSSNILLTADFEPQ----ISDFGLAKWL-PSQWTHHSIAPIEGTFGHLAPEYFMHG 245
           HRD+K SNIL   +        I DFG AK L        +      T   +APE     
Sbjct: 139 HRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPC---YTANFVAPEVLERQ 195

Query: 246 IVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYD 303
             D   D+++ GV L  +++G  P             P     EI   +     G + 
Sbjct: 196 GYDAACDIWSLGVLLYTMLTGYTPF---------ANGPDDTPEEILARI---GSGKFS 241

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 80.0 bits (198), Expect = 4e-17
 Identities = 58/240 (24%), Positives = 91/240 (37%), Gaps = 57/240 (23%)

Query: 75  GRGGYAEVYKGV-LQDGEEIAVK-----RLTKVVTDDRKEKEFLT--------------- 113
           G+G Y  V       D    A+K     +L +     R+     T               
Sbjct: 22  GKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIE 81

Query: 114 ----EIGTIGHVCHPNVLSL---LGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKV 166
               EI  +  + HPNV+ L   L    ++ LY++F+  ++G    +             
Sbjct: 82  QVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGP---VMEVPT-------- 130

Query: 167 RHKIAVGTAR--------GLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWL 218
              ++   AR        G+ YLH    ++IIHRDIK SN+L+  D   +I+DFG++   
Sbjct: 131 LKPLSEDQARFYFQDLIKGIEYLHY---QKIIHRDIKPSNLLVGEDGHIKIADFGVSNEF 187

Query: 219 -PSQWTHHSIAPIEGTFGHLAPEYF--MHGIVD-EKTDVFAFGVFLLEIISGRKPVDGSH 274
             S     +     GT   +APE       I   +  DV+A GV L   + G+ P     
Sbjct: 188 KGSDALLSNTV---GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER 244

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 80.0 bits (198), Expect = 6e-17
 Identities = 41/149 (27%), Positives = 62/149 (41%), Gaps = 13/149 (8%)

Query: 72  NLVGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLT---EIGTIGHVCHPNVL 127
            LVG G Y  V K      G  +A+K   K +  D  +        EI  +  + H N++
Sbjct: 31  GLVGEGSYGMVMKCRNKDTGRIVAIK---KFLESDDDKMVKKIAMREIKLLKQLRHENLV 87

Query: 128 SLLGCCVDNG-LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQ 186
           +LL  C      YL+F+F    ++        +      V+ K       G+ + H    
Sbjct: 88  NLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQ-KYLFQIINGIGFCHS--- 142

Query: 187 RRIIHRDIKSSNILLTADFEPQISDFGLA 215
             IIHRDIK  NIL++     ++ DFG A
Sbjct: 143 HNIIHRDIKPENILVSQSGVVKLCDFGFA 171

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 79.6 bits (197), Expect = 8e-17
 Identities = 49/200 (24%), Positives = 83/200 (41%), Gaps = 30/200 (15%)

Query: 75  GRGGYAEVYKGV-LQDGEEIAVK--RLTKVVTDDRKE--KEFLTEIGTIGHVCHPNVLSL 129
           G G +A V K      G + A K  +  +  +  R    ++   E+  +  + HPNV++L
Sbjct: 20  GSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITL 79

Query: 130 LGCCVD-NGLYLIFQFSSRGSVASLFHDVNSPGV--EWKVRHKIAVGTAR----GLHYLH 182
                +   + LI +  + G    LF  +       E     + A    +    G++YLH
Sbjct: 80  HEVYENKTDVILILELVAGGE---LFDFLAEKESLTE-----EEATEFLKQILNGVYYLH 131

Query: 183 KGCQRRIIHRDIKSSNILLTADFEPQ----ISDFGLAKWLPSQWTHHSIAPIEGTFGHLA 238
                +I H D+K  NI+L     P+    I DFGLA  +       +I    GT   +A
Sbjct: 132 ---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF---GTPEFVA 185

Query: 239 PEYFMHGIVDEKTDVFAFGV 258
           PE   +  +  + D+++ GV
Sbjct: 186 PEIVNYEPLGLEADMWSIGV 205

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 79.3 bits (196), Expect = 9e-17
 Identities = 49/221 (22%), Positives = 83/221 (37%), Gaps = 34/221 (15%)

Query: 73  LVGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLT----EIGTIGHVCH--PN 125
           L+G GG+  VY G+ + D   +A+K + K    D  E    T    E+  +  V      
Sbjct: 50  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109

Query: 126 VLSLLGCC-VDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTAR-------- 176
           V+ LL      +   LI +         LF  +   G        +    AR        
Sbjct: 110 VIRLLDWFERPDSFVLILERPEPV--QDLFDFITERG-------ALQEELARSFFWQVLE 160

Query: 177 GLHYLHKGCQRRIIHRDIKSSNILLTAD-FEPQISDFGLAKWLPSQWTHHSIAPIEGTFG 235
            + + H      ++HRDIK  NIL+  +  E ++ DFG    L            +GT  
Sbjct: 161 AVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDF----DGTRV 213

Query: 236 HLAPEYFMHGIVD-EKTDVFAFGVFLLEIISGRKPVDGSHQ 275
           +  PE+  +         V++ G+ L +++ G  P +   +
Sbjct: 214 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE 254

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 79.6 bits (197), Expect = 9e-17
 Identities = 39/157 (24%), Positives = 72/157 (45%), Gaps = 20/157 (12%)

Query: 68  FSSENLVGRGGYAEVYKG-VLQDGEEIAVKRLTKVVTDDRKEKE------FLTEIGTIGH 120
           +   + +G G YA VYKG        +A+K +       R E E       + E+  +  
Sbjct: 4   YIKLDKLGEGTYATVYKGKSKLTDNLVALKEI-------RLEHEEGAPCTAIREVSLLKD 56

Query: 121 VCHPNVLSLLGCCV-DNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLH 179
           + H N+++L      +  L L+F++  +  +     D  +      V+        RGL 
Sbjct: 57  LKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVK-LFLFQLLRGLA 114

Query: 180 YLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAK 216
           Y H   +++++HRD+K  N+L+    E +++DFGLA+
Sbjct: 115 YCH---RQKVLHRDLKPQNLLINERGELKLADFGLAR 148

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 78.8 bits (195), Expect = 1e-16
 Identities = 47/191 (24%), Positives = 82/191 (42%), Gaps = 37/191 (19%)

Query: 45  ESETTKPTWRCFSFEEISIATNAFSSENLVGRGGYAEVYKGV-LQDGEEIAVKRLTKVVT 103
           E++T  P     S    + + + +     +G G Y EVYK +     E +A+KR+     
Sbjct: 13  EAQTQGPGSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRI----- 67

Query: 104 DDRKEKEF-------LTEIGTIGHVCHPNVLSLLGCCV-DNGLYLIFQFSSRGSVASLFH 155
             R E E        + E+  +  + H N++ L      ++ L+LIF++          +
Sbjct: 68  --RLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEY--------AEN 117

Query: 156 DV-----NSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQ-- 208
           D+      +P V  +V          G+++ H    RR +HRD+K  N+LL+     +  
Sbjct: 118 DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCH---SRRCLHRDLKPQNLLLSVSDASETP 174

Query: 209 ---ISDFGLAK 216
              I DFGLA+
Sbjct: 175 VLKIGDFGLAR 185

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 78.2 bits (193), Expect = 1e-16
 Identities = 30/275 (10%), Positives = 78/275 (28%), Gaps = 51/275 (18%)

Query: 73  LVGRGGYAEVYKGVLQD---GEEIAVKRL-TKVVTDDRKEKEFLTEIGTIGHVCHPNVLS 128
             G     + ++ +  D     ++A+  +  + V  D   +E L+    +  +  P V  
Sbjct: 38  FHGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95

Query: 129 LLGCCVDNGL-YLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQR 187
           +L          ++ ++   GS+  +     SP     +R       A      H   + 
Sbjct: 96  VLDVVHTRAGGLVVAEWIRGGSLQEVADT--SPSPVGAIR--AMQSLAAAADAAH---RA 148

Query: 188 RIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIV 247
            +       S + ++ D        G                       +          
Sbjct: 149 GVALSIDHPSRVRVSID--------GDVVL--------------AYPATMPD-------A 179

Query: 248 DEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQL 307
           + + D+   G  L  ++  R P+  +             +    + ++P         Q+
Sbjct: 180 NPQDDIRGIGASLYALLVNRWPLPEAG---VRSGLAPAERDTAGQPIEPADIDRDIPFQI 236

Query: 308 NRLAFAASLCIRASPTWRP--TMSEVLEVMLEGDQ 340
           + +A  +   ++     R   T+  +++       
Sbjct: 237 SAVAARS---VQGDGGIRSASTLLNLMQQATAVAD 268

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 78.9 bits (195), Expect = 2e-16
 Identities = 51/209 (24%), Positives = 96/209 (45%), Gaps = 22/209 (10%)

Query: 68  FSSENLVGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNV 126
           + S   VG G Y  V   +  + GE++A+K+L++    +   K    E+  + H+ H NV
Sbjct: 26  YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENV 85

Query: 127 LSLL-------GCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLH 179
           + LL               YL+  F        L   +     E K+++ +     +GL 
Sbjct: 86  IGLLDVFTPASSLRNFYDFYLVMPFMQ----TDLQKIMGLKFSEEKIQY-LVYQMLKGLK 140

Query: 180 YLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAP 239
           Y+H      ++HRD+K  N+ +  D E +I DFGLA+   ++ T + +     T  + AP
Sbjct: 141 YIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVV-----TRWYRAP 192

Query: 240 EYFM-HGIVDEKTDVFAFGVFLLEIISGR 267
           E  +     ++  D+++ G  + E+++G+
Sbjct: 193 EVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 78.5 bits (194), Expect = 2e-16
 Identities = 45/226 (19%), Positives = 84/226 (37%), Gaps = 39/226 (17%)

Query: 68  FSSENLVGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVC-HPN 125
            S + L G G   +V +    + G++ A+K L           +   E+         P+
Sbjct: 32  LSKQVL-GLGVNGKVLECFHRRTGQKCALKLL-------YDSPKARQEVDHHWQASGGPH 83

Query: 126 VLSLLGCCVD-----NGLYLIFQFSSRGSVASLFHDVNSPGVEW-------KVRHKIAVG 173
           ++ +L    +       L +I +    G    LF  +   G +        ++   I   
Sbjct: 84  IVCILDVYENMHHGKRCLLIIMECMEGGE---LFSRIQERGDQAFTEREAAEIMRDIG-- 138

Query: 174 TARGLHYLHKGCQRRIIHRDIKSSNILLT---ADFEPQISDFGLAKWLPSQWTHHSIAPI 230
               + +LH      I HRD+K  N+L T    D   +++DFG AK         ++   
Sbjct: 139 --TAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN----ALQTP 189

Query: 231 EGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQS 276
             T  ++APE       D+  D+++ GV +  ++ G  P   +   
Sbjct: 190 CYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQ 235

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 78.6 bits (194), Expect = 2e-16
 Identities = 52/204 (25%), Positives = 86/204 (42%), Gaps = 27/204 (13%)

Query: 74  VGRGGYAEVYKGV-LQDGEEIAVKRLTK------VVTDDRKEKEFLTEIGTIGHVC-HPN 125
           +GRG  + V + V    G E AVK +            +   +    E   +  V  HP+
Sbjct: 102 IGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPH 161

Query: 126 VLSLLGCCVD-NGLYLIFQFSSRGSVASLFHDVNSPGV--EWKVRHKIAVGTARGLHYLH 182
           +++L+      + ++L+F    +G    LF  +       E + R  I       + +LH
Sbjct: 162 IITLIDSYESSSFMFLVFDLMRKGE---LFDYLTEKVALSEKETRS-IMRSLLEAVSFLH 217

Query: 183 KGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPE-- 240
                 I+HRD+K  NILL  + + ++SDFG +  L        +    GT G+LAPE  
Sbjct: 218 ---ANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELC---GTPGYLAPEIL 271

Query: 241 ----YFMHGIVDEKTDVFAFGVFL 260
                  H    ++ D++A GV L
Sbjct: 272 KCSMDETHPGYGKEVDLWACGVIL 295

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 78.5 bits (194), Expect = 2e-16
 Identities = 44/165 (26%), Positives = 68/165 (41%), Gaps = 24/165 (14%)

Query: 68  FSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEF---------LTEIGTI 118
           ++ +  +  G Y  V  GV  +G  +A+KR+   V+D R              L EI  +
Sbjct: 24  YTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLL 83

Query: 119 GHVCHPNVLSLLGCCV------DNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHK--I 170
            H  HPN+L L    V       + LYL+ +         L   ++   +    +H    
Sbjct: 84  NHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMR----TDLAQVIHDQRIVISPQHIQYF 139

Query: 171 AVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLA 215
                 GLH LH+     ++HRD+   NILL  + +  I DF LA
Sbjct: 140 MYHILLGLHVLHEA---GVVHRDLHPGNILLADNNDITICDFNLA 181

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 79.1 bits (195), Expect = 3e-16
 Identities = 80/345 (23%), Positives = 126/345 (36%), Gaps = 60/345 (17%)

Query: 59  EEISIATNAFSSENLVGRGGYAEVYKGVLQDGEEI-AVKRLTKVVTDDRKEKEF-LTEIG 116
           E   +  N F    ++G+GG+ EV    ++   ++ A K+L K     RK +   L E  
Sbjct: 177 ERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQ 236

Query: 117 TIGHVCHPNVLSLLGCC-VDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTA 175
            +  V    V+SL       + L L+    + G    L   +   G     +       A
Sbjct: 237 ILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGD---LKFHIYHMG-----QAGFPEARA 288

Query: 176 R--------GLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSI 227
                    GL  LH+    RI++RD+K  NILL      +ISD GLA  +P   T    
Sbjct: 289 VFYAAEICCGLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR 345

Query: 228 APIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGS-------------- 273
               GT G++APE   +       D +A G  L E+I+G+ P                  
Sbjct: 346 V---GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVK 402

Query: 274 ------HQSLHSWAKPILNQGEIEKLVDPRL----QGAYDVTQ---LNRLAFAASLCIRA 320
                  +     A+ +     + K    RL      A +V +     +L F        
Sbjct: 403 EVPEEYSERFSPQARSLC-SQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFKRLGAGML 461

Query: 321 SPTWRPTMSEVLEVMLEGDQIDKERW---KMPEEEEEDQEEFWGF 362
            P ++P    +       D +D E++   K  E E  DQ+ +  F
Sbjct: 462 EPPFKPDPQAIYCK----DVLDIEQFSTVKGVELEPTDQDFYQKF 502

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 77.2 bits (191), Expect = 4e-16
 Identities = 41/161 (25%), Positives = 71/161 (44%), Gaps = 37/161 (22%)

Query: 74  VGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKE------FLTEIGTIGHVCHPNV 126
           +G G YA VYKG+    G  +A+K +       + + E       + EI  +  + H N+
Sbjct: 13  LGNGTYATVYKGLNKTTGVYVALKEV-------KLDSEEGTPSTAIREISLMKELKHENI 65

Query: 127 LSLLGCCV-DNGLYLIFQFSSRGSVASLFHD----VNSPGVEWKVRH-------KIAVGT 174
           + L      +N L L+F+F        + +D    ++S  V    R              
Sbjct: 66  VRLYDVIHTENKLTLVFEF--------MDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQL 117

Query: 175 ARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLA 215
            +GL + H   + +I+HRD+K  N+L+    + ++ DFGLA
Sbjct: 118 LQGLAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLA 155

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 76.6 bits (189), Expect = 9e-16
 Identities = 59/213 (27%), Positives = 100/213 (46%), Gaps = 31/213 (14%)

Query: 75  GRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCC 133
           G+G +A+V     +  G E+A+K + K   +    ++   E+  +  + HPN++ L    
Sbjct: 24  GKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVI 83

Query: 134 V-DNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRH-KIAVGTAR--------GLHYLHK 183
             +  LYLI +++S G    +F        ++ V H ++    AR         + Y H 
Sbjct: 84  ETEKTLYLIMEYASGGE---VF--------DYLVAHGRMKEKEARSKFRQIVSAVQYCH- 131

Query: 184 GCQRRIIHRDIKSSNILLTADFEPQISDFGL-AKWLPSQWTHHSIAPIEGTFGHLAPEYF 242
             Q+RI+HRD+K+ N+LL AD   +I+DFG   ++              G   + APE F
Sbjct: 132 --QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFC----GAPPYAAPELF 185

Query: 243 MHGIVD-EKTDVFAFGVFLLEIISGRKPVDGSH 274
                D  + DV++ GV L  ++SG  P DG +
Sbjct: 186 QGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 218

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 77.1 bits (190), Expect = 2e-15
 Identities = 62/229 (27%), Positives = 96/229 (41%), Gaps = 26/229 (11%)

Query: 53  WRCFSFEEISIATNAFSSENLVGRGGYAEVYKGVLQDGEEI-AVKRLTKVVTDDRKEKEF 111
           W+    + +    + F    ++GRGG+ EV+   ++   ++ A K+L K     RK  + 
Sbjct: 174 WKWLEAQPMGE--DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQG 231

Query: 112 -LTEIGTIGHVCHPNVLSLLGCC-VDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHK 169
            + E   +  V    ++SL         L L+    + G    + + + +     +    
Sbjct: 232 AMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGD---IRYHIYNVD---EDNPG 285

Query: 170 IAVGTAR--------GLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAK-WLPS 220
                A         GL +LH   QR II+RD+K  N+LL  D   +ISD GLA      
Sbjct: 286 FQEPRAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAG 342

Query: 221 QWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKP 269
           Q      A   GT G +APE  +    D   D FA GV L E+I+ R P
Sbjct: 343 QTKTKGYA---GTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 75.8 bits (187), Expect = 3e-15
 Identities = 44/176 (25%), Positives = 71/176 (40%), Gaps = 44/176 (25%)

Query: 65  TNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHP 124
             A+++  ++G G +  V++  L + +E+A+K+    V  D++ K    E+  +  V HP
Sbjct: 39  EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKK----VLQDKRFK--NRELQIMRIVKHP 92

Query: 125 NVLSLLGCCVDNG-------LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTA-- 175
           NV+ L      NG       L L+ ++     V    +           RH   +     
Sbjct: 93  NVVDLKAFFYSNGDKKDEVFLNLVLEY-----VPETVYRA--------SRHYAKLKQTMP 139

Query: 176 ------------RGLHYLHKGCQRRIIHRDIKSSNILLTAD-FEPQISDFGLAKWL 218
                       R L Y+H      I HRDIK  N+LL       ++ DFG AK L
Sbjct: 140 MLLIKLYMYQLLRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL 192

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 75.4 bits (186), Expect = 3e-15
 Identities = 75/335 (22%), Positives = 134/335 (40%), Gaps = 49/335 (14%)

Query: 73  LVGRGGYAEVYKGVLQDGEEI-AVKRLTKVVTDDRKEKEF-LTEIGTIGHVCHPNVLSLL 130
            +G+G + +V      D +++ A+K + K    +R E      E+  +  + HP +++L 
Sbjct: 22  AIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLW 81

Query: 131 GCCVDNG-LYLIFQFSSRGSVASLFHDVNSPGV--EWKVRHKIA-VGTARGLHYLHKGCQ 186
               D   ++++      G    L + +       E  V+  I  +  A  L YL     
Sbjct: 82  YSFQDEEDMFMVVDLLLGGD---LRYHLQQNVHFKEETVKLFICELVMA--LDYLQN--- 133

Query: 187 RRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGI 246
           +RIIHRD+K  NILL       I+DF +A  LP +    ++A   GT  ++APE F    
Sbjct: 134 QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMA---GTKPYMAPEMFSSRK 190

Query: 247 V---DEKTDVFAFGVFLLEIISGRKPVDG-SHQSLHSWAKPILN-------------QGE 289
                   D ++ GV   E++ GR+P    S  S                          
Sbjct: 191 GAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQEMVSL 250

Query: 290 IEKL--VDP--RLQGAYDVTQ---LNRLAFAASLCIRASPTWRPTMS--------EVLEV 334
           ++KL   +P  R     DV     +N + + A    R  P + P           E+ E+
Sbjct: 251 LKKLLEPNPDQRFSQLSDVQNFPYMNDINWDAVFQKRLIPGFIPNKGRLNCDPTFELEEM 310

Query: 335 MLEGDQIDKERWKMPEEEEEDQEEFWGFDDLEYEC 369
           +LE   + K++ ++ ++E++ ++       L  E 
Sbjct: 311 ILESKPLHKKKKRLAKKEKDMRKCDSSQTCLLQEH 345

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 75.1 bits (185), Expect = 4e-15
 Identities = 44/174 (25%), Positives = 68/174 (39%), Gaps = 45/174 (25%)

Query: 68  FSSENLVGRGGYAEVYKGVLQD-GEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNV 126
           ++   ++G G +  VY+  L D GE +A+K+    V  D++ K    E+  +  + H N+
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKK----VLQDKRFK--NRELQIMRKLDHCNI 109

Query: 127 LSLLGCCVDNG-------LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTA---- 175
           + L      +G       L L+  +     V    + V         RH           
Sbjct: 110 VRLRYFFYSSGEKKDEVYLNLVLDY-----VPETVYRV--------ARHYSRAKQTLPVI 156

Query: 176 ----------RGLHYLHKGCQRRIIHRDIKSSNILLTADFEP-QISDFGLAKWL 218
                     R L Y+H      I HRDIK  N+LL  D    ++ DFG AK L
Sbjct: 157 YVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 207

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 74.0 bits (182), Expect = 6e-15
 Identities = 50/210 (23%), Positives = 85/210 (40%), Gaps = 22/210 (10%)

Query: 75  GRGGYAEVYKGV-LQDGEEIAVKRLTK------VVTDDRKEKEFLTEIGTIGHVCHPNVL 127
           G G +  V+  V  +  +E+ VK + K         +D K  +   EI  +  V H N++
Sbjct: 33  GSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANII 92

Query: 128 SLLGCCV---DNGLYLIFQFSSRGSVASLF-HDVNSPGVEWKVRHKIAVGTARGLHYLHK 183
            +L   +        L+ +    G    LF      P ++  +   I       + YL  
Sbjct: 93  KVLD--IFENQGFFQLVMEKHGSG--LDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLR- 147

Query: 184 GCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFM 243
              + IIHRDIK  NI++  DF  ++ DFG A +L      ++     GT  + APE  M
Sbjct: 148 --LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFC---GTIEYCAPEVLM 202

Query: 244 HGIVD-EKTDVFAFGVFLLEIISGRKPVDG 272
                  + ++++ GV L  ++    P   
Sbjct: 203 GNPYRGPELEMWSLGVTLYTLVFEENPFCE 232

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 74.9 bits (184), Expect = 7e-15
 Identities = 38/157 (24%), Positives = 68/157 (43%), Gaps = 17/157 (10%)

Query: 68  FSSENLVGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNV 126
           +   +L+G G Y  V +     +   +A+K++ +V  D    K  L EI  +  + H +V
Sbjct: 55  YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHV 114

Query: 127 LSLLGCCV------DNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHK--IAVGTARGL 178
           + +L   +       + LY++ +        S F  +    V     H   +      G+
Sbjct: 115 VKVLDIVIPKDVEKFDELYVVLEI-----ADSDFKKLFRTPVYLTELHIKTLLYNLLVGV 169

Query: 179 HYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLA 215
            Y+H      I+HRD+K +N L+  D   ++ DFGLA
Sbjct: 170 KYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLA 203

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 74.0 bits (182), Expect = 1e-14
 Identities = 37/157 (23%), Positives = 66/157 (42%), Gaps = 17/157 (10%)

Query: 68  FSSENLVGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNV 126
           +  ++L+GRG Y  VY        + +A+K++ ++  D    K  L EI  +  +    +
Sbjct: 28  YIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYI 87

Query: 127 LSLL------GCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHK--IAVGTARGL 178
           + L            + LY++ +        S    +    +     H   I      G 
Sbjct: 88  IRLYDLIIPDDLLKFDELYIVLEI-----ADSDLKKLFKTPIFLTEEHIKTILYNLLLGE 142

Query: 179 HYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLA 215
           +++H+     IIHRD+K +N LL  D   ++ DFGLA
Sbjct: 143 NFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLA 176

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 73.2 bits (180), Expect = 2e-14
 Identities = 47/208 (22%), Positives = 86/208 (41%), Gaps = 19/208 (9%)

Query: 68  FSSENLVGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNV 126
           + +   +G G    V           +A+K+L++   +    K    E+  +  V H N+
Sbjct: 27  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 86

Query: 127 LSLL-------GCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLH 179
           + LL              +Y++ +       A+L   +       ++ + +      G+ 
Sbjct: 87  IGLLNVFTPQKSLEEFQDVYIVMELMD----ANLCQVIQMELDHERMSY-LLYQMLCGIK 141

Query: 180 YLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAP 239
           +LH      IIHRD+K SNI++ +D   +I DFGLA    +  T   + P   T  + AP
Sbjct: 142 HLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA---RTAGTSFMMTPYVVTRYYRAP 195

Query: 240 EYFMHGIVDEKTDVFAFGVFLLEIISGR 267
           E  +     E  D+++ G  + E+I G 
Sbjct: 196 EVILGMGYKENVDIWSVGCIMGEMIKGG 223

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 72.6 bits (179), Expect = 2e-14
 Identities = 57/213 (26%), Positives = 90/213 (42%), Gaps = 24/213 (11%)

Query: 68  FSSENLVGRGGYAEVYKGVLQDGEEI-AVKRLTK-VVTDDRKEKEFLTEIGTIGHVCHPN 125
           F    ++G G ++ V            A+K L K  +  + K      E   +  + HP 
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91

Query: 126 VLSLLGCCVDNG-LYLIFQFSSRGSVASLFHDVNSPGV--EWKVRHKIA-VGTARGLHYL 181
            + L     D+  LY    ++  G    L   +   G   E   R   A + +A  L YL
Sbjct: 92  FVKLYFTFQDDEKLYFGLSYAKNGE---LLKYIRKIGSFDETCTRFYTAEIVSA--LEYL 146

Query: 182 HKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEY 241
           H    + IIHRD+K  NILL  D   QI+DFG AK L  +          GT  +++PE 
Sbjct: 147 HG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE- 202

Query: 242 FMHGIVDEK-----TDVFAFGVFLLEIISGRKP 269
               ++ EK     +D++A G  + ++++G  P
Sbjct: 203 ----LLTEKSACKSSDLWALGCIIYQLVAGLPP 231

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 73.2 bits (180), Expect = 2e-14
 Identities = 42/212 (19%), Positives = 81/212 (38%), Gaps = 37/212 (17%)

Query: 75  GRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVC-HPNVLSLLGC 132
           G G   +V +    +  E+ A+K L       +   +   E+         P+++ ++  
Sbjct: 71  GLGINGKVLQIFNKRTQEKFALKML-------QDCPKARREVELHWRASQCPHIVRIVDV 123

Query: 133 CVD-----NGLYLIFQFSSRGSVASLFHDVNSPGVEW-------KVRHKIAVGTARGLHY 180
             +       L ++ +    G    LF  +   G +        ++   I       + Y
Sbjct: 124 YENLYAGRKCLLIVMECLDGGE---LFSRIQDRGDQAFTEREASEIMKSIG----EAIQY 176

Query: 181 LHKGCQRRIIHRDIKSSNILLTADFEP---QISDFGLAKWLPSQWTHHSIAPIEGTFGHL 237
           LH      I HRD+K  N+L T+       +++DFG AK   S  +  +      T  ++
Sbjct: 177 LH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPC---YTPYYV 230

Query: 238 APEYFMHGIVDEKTDVFAFGVFLLEIISGRKP 269
           APE       D+  D+++ GV +  ++ G  P
Sbjct: 231 APEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 262

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 72.7 bits (179), Expect = 2e-14
 Identities = 50/220 (22%), Positives = 97/220 (44%), Gaps = 41/220 (18%)

Query: 74  VGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVC-HPNVLSLLG 131
           +GRG Y+EV++ + + + E++ VK L  V     K+K+   EI  + ++   PN+++L  
Sbjct: 44  LGRGKYSEVFEAINITNNEKVVVKILKPV-----KKKKIKREIKILENLRGGPNIITLAD 98

Query: 132 CCVDNG---LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRR 188
              D       L+F+  +     + F  +     ++ +R  +     + L Y H      
Sbjct: 99  IVKDPVSRTPALVFEHVN----NTDFKQLYQTLTDYDIRFYM-YEILKALDYCH---SMG 150

Query: 189 IIHRDIKSSNILL-TADFEPQISDFGLAK-WLPSQWTHHSIAPIEGTFGHLAPE------ 240
           I+HRD+K  N+++     + ++ D+GLA+ + P Q  +  +A    +     PE      
Sbjct: 151 IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVA----SRYFKGPELLVDYQ 206

Query: 241 -YFMHGIVDEKTDVFAFGVFLLEIISGRKPV----DGSHQ 275
            Y      D   D+++ G  L  +I  ++P     D   Q
Sbjct: 207 MY------DYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ 240

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 73.3 bits (180), Expect = 2e-14
 Identities = 47/208 (22%), Positives = 88/208 (42%), Gaps = 19/208 (9%)

Query: 68  FSSENLVGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNV 126
           + +   +G G    V           +A+K+L++   +    K    E+  +  V H N+
Sbjct: 64  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 123

Query: 127 LSLL-------GCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLH 179
           +SLL              +YL+ +       A+L   +       ++ + +      G+ 
Sbjct: 124 ISLLNVFTPQKTLEEFQDVYLVMELMD----ANLCQVIQMELDHERMSY-LLYQMLCGIK 178

Query: 180 YLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAP 239
           +LH      IIHRD+K SNI++ +D   +I DFGLA+   +  T   + P   T  + AP
Sbjct: 179 HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAP 232

Query: 240 EYFMHGIVDEKTDVFAFGVFLLEIISGR 267
           E  +     E  D+++ G  + E++  +
Sbjct: 233 EVILGMGYKENVDIWSVGCIMGEMVRHK 260

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 72.3 bits (178), Expect = 3e-14
 Identities = 42/178 (23%), Positives = 66/178 (37%), Gaps = 41/178 (23%)

Query: 65  TNAFSSENLVGRGGYAEVYKGVLQD-GEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCH 123
            + F  E + G+G +  V  G  +  G  +A+K   KV+ D R     L  +  +  + H
Sbjct: 22  MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIK---KVIQDPRFRNRELQIMQDLAVLHH 78

Query: 124 PNVLSLLGCCVDNG--------LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTA 175
           PN++ L       G        L ++ ++     V    H           R+      A
Sbjct: 79  PNIVQLQSYFYTLGERDRRDIYLNVVMEY-----VPDTLHRC--------CRNYYRRQVA 125

Query: 176 --------------RGLHYLHKGCQRRIIHRDIKSSNILL-TADFEPQISDFGLAKWL 218
                         R +  LH      + HRDIK  N+L+  AD   ++ DFG AK L
Sbjct: 126 PPPILIKVFLFQLIRSIGCLHLPSVN-VCHRDIKPHNVLVNEADGTLKLCDFGSAKKL 182

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 70.7 bits (174), Expect = 4e-14
 Identities = 60/218 (27%), Positives = 83/218 (38%), Gaps = 29/218 (13%)

Query: 73  LVGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLG 131
            +G G Y EV   V     E +AVK +      D  E     EI     + H NV+   G
Sbjct: 14  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIK-KEICINKMLNHENVVKFYG 72

Query: 132 CCV---DNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTAR--------GLHY 180
                  N  YL  ++ S G    LF  +            +    A+        G+ Y
Sbjct: 73  --HRREGNIQYLFLEYCSGGE---LFDRIEPDI-------GMPEPDAQRFFHQLMAGVVY 120

Query: 181 LHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPE 240
           LH      I HRDIK  N+LL      +ISDFGLA           +  + GT  ++APE
Sbjct: 121 LH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177

Query: 241 YFMHGIVD-EKTDVFAFGVFLLEIISGRKPVDGSHQSL 277
                    E  DV++ G+ L  +++G  P D    S 
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC 215

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 72.0 bits (177), Expect = 5e-14
 Identities = 48/217 (22%), Positives = 87/217 (40%), Gaps = 30/217 (13%)

Query: 68  FSSENLVGRGGYAEVYKGVLQDGEEI-AVKRLTKVVTDDRKEKE-FLTEIGTIGHVCHPN 125
           +    ++GRG + EV     +   ++ A+K L+K     R +   F  E   +     P 
Sbjct: 71  YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 130

Query: 126 VLSLLGCCVDNG-LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTAR-------- 176
           V+ L     D+  LY++ ++   G    L + ++         + +    AR        
Sbjct: 131 VVQLFYAFQDDRYLYMVMEYMPGGD---LVNLMS--------NYDVPEKWARFYTAEVVL 179

Query: 177 GLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGH 236
            L  +H       IHRD+K  N+LL      +++DFG    +  +        + GT  +
Sbjct: 180 ALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDY 235

Query: 237 LAPEYFM----HGIVDEKTDVFAFGVFLLEIISGRKP 269
           ++PE        G    + D ++ GVFL E++ G  P
Sbjct: 236 ISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 71.2 bits (175), Expect = 7e-14
 Identities = 52/204 (25%), Positives = 90/204 (44%), Gaps = 23/204 (11%)

Query: 74  VGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLL-- 130
           VG G Y  V   V  + G ++A+K+L +    +   K    E+  + H+ H NV+ LL  
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDV 92

Query: 131 -----GCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHK-IAVGTARGLHYLHKG 184
                        YL+  F     + +    +       + R + +     +GL Y+H  
Sbjct: 93  FTPDETLDDFTDFYLVMPF-----MGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAA 147

Query: 185 CQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFM- 243
               IIHRD+K  N+ +  D E +I DFGLA+   S+ T + +     T  + APE  + 
Sbjct: 148 ---GIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVV-----TRWYRAPEVILN 199

Query: 244 HGIVDEKTDVFAFGVFLLEIISGR 267
                +  D+++ G  + E+I+G+
Sbjct: 200 WMRYTQTVDIWSVGCIMAEMITGK 223

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 71.3 bits (175), Expect = 8e-14
 Identities = 50/218 (22%), Positives = 89/218 (40%), Gaps = 29/218 (13%)

Query: 68  FSSENLVGRGGYAEVYKGVLQDGEEI-AVKRLTKVVTDDRKEKE-FLTEIGTIGHVCHPN 125
           F    ++GRG + EV    L++ +++ A+K L K     R E   F  E   + +     
Sbjct: 76  FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKW 135

Query: 126 VLSLLGCCVDNG-LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTAR-------- 176
           + +L     D+  LYL+  +   G    L   ++      K   ++    AR        
Sbjct: 136 ITTLHYAFQDDNNLYLVMDYYVGGD---LLTLLS------KFEDRLPEEMARFYLAEMVI 186

Query: 177 GLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGH 236
            +  +H+      +HRDIK  NIL+  +   +++DFG    L    T  S   + GT  +
Sbjct: 187 AIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-GTPDY 242

Query: 237 LAPEYFMHGIVDEKT-----DVFAFGVFLLEIISGRKP 269
           ++PE        +       D ++ GV + E++ G  P
Sbjct: 243 ISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 70.1 bits (172), Expect = 2e-13
 Identities = 59/274 (21%), Positives = 101/274 (36%), Gaps = 46/274 (16%)

Query: 29  PNGFTEESLENVVVACESETTKPTWR---------------CFSFEEISIATNAFSSENL 73
           P     E L ++++    E                          +E+ +  + F    +
Sbjct: 9   PGFLGLEPLLDLLLGVHQELGASELAQDKYVADFLQWAEPIVVRLKEVRLQRDDFEILKV 68

Query: 74  VGRGGYAEVYKGVLQDGEEI-AVKRLTKVVTDDRKEKE-FLTEIGTIGHVCHPNVLSLLG 131
           +GRG ++EV    ++   ++ A+K + K     R E   F  E   + +     +  L  
Sbjct: 69  IGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHF 128

Query: 132 CCVDNG-LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTAR--------GLHYLH 182
              D   LYL+ ++   G + +L           K   +I    AR         +  +H
Sbjct: 129 AFQDENYLYLVMEYYVGGDLLTLLS---------KFGERIPAEMARFYLAEIVMAIDSVH 179

Query: 183 KGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYF 242
              +   +HRDIK  NILL      +++DFG    L +  T  S+  + GT  +L+PE  
Sbjct: 180 ---RLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAV-GTPDYLSPEIL 235

Query: 243 M-HGIVDEKT------DVFAFGVFLLEIISGRKP 269
              G            D +A GVF  E+  G+ P
Sbjct: 236 QAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 70.0 bits (171), Expect = 2e-13
 Identities = 35/116 (30%), Positives = 51/116 (43%), Gaps = 32/116 (27%)

Query: 169 KIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKW----------- 217
             +   A+G+ +L     R+ IHRD+ + NILL+     +I DFGLA+            
Sbjct: 197 CYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 253

Query: 218 ---LPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKP 269
              LP +W               APE     +   ++DV++FGV L EI S G  P
Sbjct: 254 DARLPLKWM--------------APETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 295

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 53.0 bits (127), Expect = 6e-08
 Identities = 35/165 (21%), Positives = 62/165 (37%), Gaps = 24/165 (14%)

Query: 68  FSSENLV-----GRGGYAEVYKGVL------QDGEEIAVKRLTKVVTDDRKEKEFLTEIG 116
           F  + L      GRG + +V +              +AVK L K      + +  ++E+ 
Sbjct: 19  FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML-KEGATHSEHRALMSELK 77

Query: 117 TIGHV-CHPNVLSLLGCCVDNG--LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVG 173
            + H+  H NV++LLG C   G  L +I +F   G++++              R++    
Sbjct: 78  ILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLR---------SKRNEFVPY 128

Query: 174 TARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWL 218
             +G  +         I  D+K     +T+      S F   K L
Sbjct: 129 KTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSL 173

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 69.6 bits (171), Expect = 2e-13
 Identities = 65/263 (24%), Positives = 107/263 (40%), Gaps = 44/263 (16%)

Query: 24  NAAVSPNGFTEESLENVVVACESETTKPTWRCFSFEEISIATNAFSSENLVGRGGYAEVY 83
           NAA +  G  +ES++  +   + +  K  W   S     +  + F     +G G +  V 
Sbjct: 2   NAAAAKKGSEQESVKEFLAKAKEDFLK-KWETPSQNTAQL--DQFDRIKTLGTGSFGRVM 58

Query: 84  KGVLQDGEEI-AVKRLTKVVTDDRKEKE-FLTEIGTIGHVCHPNVLSLLGCCVDNG-LYL 140
               ++     A+K L K      K+ E  L E   +  V  P ++ L     DN  LY+
Sbjct: 59  LVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM 118

Query: 141 IFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTAR--------GLHYLHKGCQRRIIHR 192
           + ++ + G    +F  +   G       + +   AR           YLH      +I+R
Sbjct: 119 VMEYVAGGE---MFSHLRRIG-------RFSEPHARFYAAQIVLTFEYLHS---LDLIYR 165

Query: 193 DIKSSNILLTADFEPQISDFGLAKWLPSQ-WTHHSIAPIEGTFGHLAPEYFMHGIVDEK- 250
           D+K  N+L+      Q++DFG AK +  + WT      + GT   LAPE     I+  K 
Sbjct: 166 DLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT------LCGTPEALAPE-----IILSKG 214

Query: 251 ----TDVFAFGVFLLEIISGRKP 269
                D +A GV + E+ +G  P
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPP 237

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 69.3 bits (170), Expect = 3e-13
 Identities = 60/228 (26%), Positives = 86/228 (37%), Gaps = 29/228 (12%)

Query: 73  LVGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLG 131
            +G G Y EV   V     E +AVK +      D  E     EI     + H NV+   G
Sbjct: 14  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIK-KEICINKMLNHENVVKFYG 72

Query: 132 CCV---DNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTAR--------GLHY 180
                  N  YL  ++ S G    LF  +            +    A+        G+ Y
Sbjct: 73  --HRREGNIQYLFLEYCSGGE---LFDRIEPDI-------GMPEPDAQRFFHQLMAGVVY 120

Query: 181 LHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPE 240
           LH      I HRDIK  N+LL      +ISDFGLA           +  + GT  ++APE
Sbjct: 121 LH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177

Query: 241 YFMHGIVD-EKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQ 287
                    E  DV++ G+ L  +++G  P D    S   ++     +
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK 225

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 69.3 bits (170), Expect = 3e-13
 Identities = 55/203 (27%), Positives = 88/203 (43%), Gaps = 21/203 (10%)

Query: 74  VGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLL-- 130
           VG G Y  V      + G  +AVK+L++        K    E+  + H+ H NV+ LL  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96

Query: 131 -----GCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGC 185
                     N +YL+         A L + V    +       +     RGL Y+H   
Sbjct: 97  FTPARSLEEFNDVYLVTHLMG----ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 151

Query: 186 QRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFM-H 244
              IIHRD+K SN+ +  D E +I DFGLA+    + T +       T  + APE  +  
Sbjct: 152 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVA-----TRWYRAPEIMLNW 204

Query: 245 GIVDEKTDVFAFGVFLLEIISGR 267
              ++  D+++ G  + E+++GR
Sbjct: 205 MHYNQTVDIWSVGCIMAELLTGR 227

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 66.5 bits (163), Expect = 1e-12
 Identities = 53/224 (23%), Positives = 90/224 (40%), Gaps = 52/224 (23%)

Query: 75  GRGGYAEVYKGV-LQDGEEIAVKRL--TKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLG 131
           G G + +V  G     G ++AVK L   K+ + D   K    EI  +    HP+++ L  
Sbjct: 20  GVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIK-REIQNLKLFRHPHIIKLYQ 78

Query: 132 CCV---DNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRH-KIAVGTAR--------GLH 179
             V       +++ ++ S G    LF        ++  +H ++    AR         + 
Sbjct: 79  --VISTPTDFFMVMEYVSGGE---LF--------DYICKHGRVEEMEARRLFQQILSAVD 125

Query: 180 YLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHL-- 237
           Y H+     ++HRD+K  N+LL A    +I+DFGL+               +G F     
Sbjct: 126 YCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNM-----------MSDGEFLRTSC 171

Query: 238 ------APEYFMHGIVD-EKTDVFAFGVFLLEIISGRKPVDGSH 274
                 APE     +    + D+++ GV L  ++ G  P D  H
Sbjct: 172 GSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEH 215

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 67.1 bits (164), Expect = 2e-12
 Identities = 53/205 (25%), Positives = 90/205 (43%), Gaps = 13/205 (6%)

Query: 73  LVGRGGYAEVYKGVLQDGEEI-AVKRLTKVVTDDRKEKEF-LTEIGTIGHVCHPNVLSLL 130
           L+G+G + +V     +      A+K L K V   + E    LTE   + +  HP + +L 
Sbjct: 155 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 214

Query: 131 GCC-VDNGLYLIFQFSSRGSVASLFHDVNSPGV--EWKVRHKIAVGTARGLHYLHKGCQR 187
                 + L  + ++++ G    LF  ++   V  E + R   A      L YLH   ++
Sbjct: 215 YSFQTHDRLCFVMEYANGGE---LFFHLSRERVFSEDRARFYGA-EIVSALDYLHS--EK 268

Query: 188 RIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIV 247
            +++RD+K  N++L  D   +I+DFGL K         ++    GT  +LAPE       
Sbjct: 269 NVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGTPEYLAPEVLEDNDY 326

Query: 248 DEKTDVFAFGVFLLEIISGRKPVDG 272
               D +  GV + E++ GR P   
Sbjct: 327 GRAVDWWGLGVVMYEMMCGRLPFYN 351

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 66.6 bits (163), Expect = 2e-12
 Identities = 51/213 (23%), Positives = 83/213 (38%), Gaps = 32/213 (15%)

Query: 75  GRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCC 133
           G G +            E +AVK + +    D   +    EI     + HPN++      
Sbjct: 29  GSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQ---REIINHRSLRHPNIVRFKEVI 85

Query: 134 V-DNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTAR--------GLHYLHKG 184
           +    L +I +++S G    L+  + + G       + +   AR        G+ Y H  
Sbjct: 86  LTPTHLAIIMEYASGGE---LYERICNAG-------RFSEDEARFFFQQLLSGVSYCHS- 134

Query: 185 CQRRIIHRDIKSSNILLTADFEPQ--ISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYF 242
              +I HRD+K  N LL     P+  I DFG +K         S     GT  ++APE  
Sbjct: 135 --MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV---GTPAYIAPEVL 189

Query: 243 MHGIVD-EKTDVFAFGVFLLEIISGRKPVDGSH 274
           +    D +  DV++ GV L  ++ G  P +   
Sbjct: 190 LRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPE 222

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 65.9 bits (161), Expect = 5e-12
 Identities = 41/185 (22%), Positives = 80/185 (43%), Gaps = 26/185 (14%)

Query: 68  FSSENLVGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVC-HPN 125
           +     +G+G Y  V+K +  + GE +AVK++     +    +    EI  +  +  H N
Sbjct: 11  YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHEN 70

Query: 126 VLSLLGCCV---DNGLYLIFQFSS-------RGSVASLFHDVNSPGVEWKVRHKIAVGTA 175
           +++LL       D  +YL+F +         R ++    H           ++ +     
Sbjct: 71  IVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVH----------KQY-VVYQLI 119

Query: 176 RGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFG 235
           + + YLH G    ++HRD+K SNILL A+   +++DFGL++   +     +  P+     
Sbjct: 120 KVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINEN 176

Query: 236 HLAPE 240
               +
Sbjct: 177 TENFD 181

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 64.8 bits (158), Expect = 9e-12
 Identities = 37/193 (19%), Positives = 61/193 (31%), Gaps = 51/193 (26%)

Query: 68  FSSENLVGRGGYAEVYKGVLQD-GEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNV 126
           +S    +G G +  V +    + G+  A+K+    V  D + K    E+  +  + H N+
Sbjct: 9   YSLGKTLGTGSFGIVCEVFDIESGKRFALKK----VLQDPRYK--NRELDIMKVLDHVNI 62

Query: 127 LSLLGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVR------------------- 167
           + L+      G               L    N      K                     
Sbjct: 63  IKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD 122

Query: 168 --HKIAVGTA-------------------RGLHYLHKGCQRRIIHRDIKSSNILLTA-DF 205
             HK+                        R + ++H      I HRDIK  N+L+ + D 
Sbjct: 123 TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL---GICHRDIKPQNLLVNSKDN 179

Query: 206 EPQISDFGLAKWL 218
             ++ DFG AK L
Sbjct: 180 TLKLCDFGSAKKL 192

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 63.4 bits (155), Expect = 2e-11
 Identities = 49/217 (22%), Positives = 89/217 (41%), Gaps = 26/217 (11%)

Query: 68  FSSENLVGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNV 126
           F  ++L+G G Y  V        GE +A+K++ +           L EI  + H  H N+
Sbjct: 13  FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKI-EPFDKPLFALRTLREIKILKHFKHENI 71

Query: 127 LSLL------GCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHK-IAVGTARGLH 179
           +++            N +Y+I +      + +  H V S  +      +     T R + 
Sbjct: 72  ITIFNIQRPDSFENFNEVYIIQEL-----MQTDLHRVISTQMLSDDHIQYFIYQTLRAVK 126

Query: 180 YLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTF--GHL 237
            LH      +IHRD+K SN+L+ ++ + ++ DFGLA+ +      +S    + +     +
Sbjct: 127 VLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFV 183

Query: 238 ------APEYFM-HGIVDEKTDVFAFGVFLLEIISGR 267
                 APE  +         DV++ G  L E+   R
Sbjct: 184 ATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 63.7 bits (155), Expect = 3e-11
 Identities = 51/227 (22%), Positives = 92/227 (40%), Gaps = 58/227 (25%)

Query: 75  GRGGYAEVYKGV-LQDGEEIAVKRL--TKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLG 131
           G G + +V  G     G ++AVK L   K+ + D   K    EI  +    HP+++ L  
Sbjct: 25  GVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIR-REIQNLKLFRHPHIIKLYQ 83

Query: 132 CCV---DNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRH-KIAVGTAR--------GLH 179
             V    + ++++ ++ S G    LF        ++  ++ ++    +R        G+ 
Sbjct: 84  --VISTPSDIFMVMEYVSGGE---LF--------DYICKNGRLDEKESRRLFQQILSGVD 130

Query: 180 YLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHL-- 237
           Y H+     ++HRD+K  N+LL A    +I+DFGL+  +                G    
Sbjct: 131 YCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD--------------GEFLR 173

Query: 238 ---------APEYFMHGIVD-EKTDVFAFGVFLLEIISGRKPVDGSH 274
                    APE     +    + D+++ GV L  ++ G  P D  H
Sbjct: 174 TSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDH 220

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 62.9 bits (154), Expect = 3e-11
 Identities = 55/219 (25%), Positives = 93/219 (42%), Gaps = 41/219 (18%)

Query: 68  FSSENLVGRGGYAEVYKGVLQDGEEI-AVKRLTKVVTDDRKEKE-FLTEIGTIGHVCHPN 125
           F     +G G +  V+    +      A+K L K +    K+ E    E   +  V HP 
Sbjct: 8   FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 67

Query: 126 VLSLLGCCVDNG-LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTAR-------- 176
           ++ + G   D   +++I  +   G    LF  +           +     A+        
Sbjct: 68  IIRMWGTFQDAQQIFMIMDYIEGGE---LFSLLRKSQ-------RFPNPVAKFYAAEVCL 117

Query: 177 GLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQ-WTHHSIAPIEGTFG 235
            L YLH    + II+RD+K  NILL  +   +I+DFG AK++P   +T      + GT  
Sbjct: 118 ALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYT------LCGTPD 168

Query: 236 HLAPEYFMHGIVDEK-----TDVFAFGVFLLEIISGRKP 269
           ++APE     +V  K      D ++FG+ + E+++G  P
Sbjct: 169 YIAPE-----VVSTKPYNKSIDWWSFGILIYEMLAGYTP 202

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 62.3 bits (152), Expect = 4e-11
 Identities = 33/158 (20%), Positives = 59/158 (37%), Gaps = 32/158 (20%)

Query: 75  GRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCC 133
           G G   +V +    +  E+ A+K L       R+E E             P+++ ++   
Sbjct: 27  GLGINGKVLQIFNKRTQEKFALKMLQDCP-KARREVELHWRASQ-----CPHIVRIVDVY 80

Query: 134 VD-----NGLYLIFQFSSRGSVASLFHDVNSPGVEW-------KVRHKIAVGTARGLHYL 181
            +       L ++ +    G    LF  +   G +        ++   I       + YL
Sbjct: 81  ENLYAGRKCLLIVMECLDGGE---LFSRIQDRGDQAFTEREASEIMKSIG----EAIQYL 133

Query: 182 HKGCQRRIIHRDIKSSNILLTADFEP---QISDFGLAK 216
           H      I HRD+K  N+L T+       +++DFG AK
Sbjct: 134 H---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 62.3 bits (152), Expect = 5e-11
 Identities = 44/217 (20%), Positives = 90/217 (41%), Gaps = 39/217 (17%)

Query: 75  GRGGYAEVYKGV-LQDGEEIAVKRL--TKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLG 131
           G G + +V      +  +++A+K +    +   D   +    EI  +  + HP+++ L  
Sbjct: 18  GEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVE-REISYLKLLRHPHIIKLYD 76

Query: 132 CCV---DNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRH-KIAVGTAR--------GLH 179
             V      + ++ +++       LF        ++ V   ++     R         + 
Sbjct: 77  --VITTPTDIVMVIEYAG----GELF--------DYIVEKKRMTEDEGRRFFQQIICAIE 122

Query: 180 YLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWL-PSQWTHHSIAPIEGTFGHLA 238
           Y H+    +I+HRD+K  N+LL  +   +I+DFGL+  +    +   S     G+  + A
Sbjct: 123 YCHR---HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC----GSPNYAA 175

Query: 239 PEYFMHGIVD-EKTDVFAFGVFLLEIISGRKPVDGSH 274
           PE     +    + DV++ G+ L  ++ GR P D   
Sbjct: 176 PEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEF 212

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 61.9 bits (151), Expect = 7e-11
 Identities = 44/220 (20%), Positives = 81/220 (36%), Gaps = 39/220 (17%)

Query: 68  FSSENLVGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNV 126
           +++ + +G G Y  V       +   +A+K+++         +  L EI  +    H N+
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS-PFEHQTYCQRTLREIKILLRFRHENI 87

Query: 127 LSLL------GCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHY 180
           + +              +Y++           L+  + +  +             RGL Y
Sbjct: 88  IGINDIIRAPTIEQMKDVYIVQDLME----TDLYKLLKTQHLSNDHICYFLYQILRGLKY 143

Query: 181 LHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHL--- 237
           +H      ++HRD+K SN+LL    + +I DFGLA+            P     G L   
Sbjct: 144 IHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLAR---------VADPDHDHTGFLTEY 191

Query: 238 -------APE---YFMHGIVDEKTDVFAFGVFLLEIISGR 267
                  APE           +  D+++ G  L E++S R
Sbjct: 192 VATRWYRAPEIMLNSKG--YTKSIDIWSVGCILAEMLSNR 229

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 61.5 bits (150), Expect = 9e-11
 Identities = 55/216 (25%), Positives = 93/216 (43%), Gaps = 36/216 (16%)

Query: 73  LVGRGGYAEVYKGVLQDGEEI-AVKRLTKVVTDDRKEKEF-LTEIGTIGHVCHPNVLSLL 130
           L+G+G + +V     +      A+K L K V   + E    +TE   + +  HP + +L 
Sbjct: 12  LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 71

Query: 131 GCC-VDNGLYLIFQFSSRGSVASLFHDVNSPGV--EWKVRHKIAVGTARGLHYLHKGCQR 187
                 + L  + ++++ G    LF  ++   V  E + R   A      L YLH    R
Sbjct: 72  YAFQTHDRLCFVMEYANGGE---LFFHLSRERVFTEERARFYGA-EIVSALEYLHS---R 124

Query: 188 RIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIE------GTFGHLAPEY 241
            +++RDIK  N++L  D   +I+DFGL K          I+         GT  +LAPE 
Sbjct: 125 DVVYRDIKLENLMLDKDGHIKITDFGLCK--------EGISDGATMKTFCGTPEYLAPE- 175

Query: 242 FMHGIVDEKT-----DVFAFGVFLLEIISGRKPVDG 272
               ++++       D +  GV + E++ GR P   
Sbjct: 176 ----VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 207

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 61.4 bits (150), Expect = 1e-10
 Identities = 59/211 (27%), Positives = 99/211 (46%), Gaps = 30/211 (14%)

Query: 73  LVGRGGYAEVY---KGVLQDGEEI-AVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLS 128
           ++G+G + +V+   K    D  ++ A+K L K     R       E   +  V HP ++ 
Sbjct: 31  VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVK 90

Query: 129 LLGCCVDNG-LYLIFQFSSRGSVASLFHDVNSPGV--EWKVRHKIA-VGTARGLHYLHKG 184
           L       G LYLI  F   G    LF  ++   +  E  V+  +A +  A  L +LH  
Sbjct: 91  LHYAFQTEGKLYLILDFLRGGD---LFTRLSKEVMFTEEDVKFYLAELALA--LDHLHS- 144

Query: 185 CQRRIIHRDIKSSNILLTADFEPQISDFGLAK-WLPSQWTHHSIAPIEGTFGHLAPEYFM 243
               II+RD+K  NILL  +   +++DFGL+K  +  +   +S     GT  ++APE   
Sbjct: 145 --LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC---GTVEYMAPE--- 196

Query: 244 HGIVDEKT-----DVFAFGVFLLEIISGRKP 269
             +V+ +      D ++FGV + E+++G  P
Sbjct: 197 --VVNRRGHTQSADWWSFGVLMFEMLTGTLP 225

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 58.7 bits (141), Expect = 8e-10
 Identities = 26/209 (12%), Positives = 51/209 (24%), Gaps = 53/209 (25%)

Query: 56  FSFEEISIATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRL------------TKVVT 103
             F    + T        +G G + EV++ +  D   +A+K +             K   
Sbjct: 11  VPFSHC-LPTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFE 68

Query: 104 DDRKEKEFLTEIGTIGHV---CHPNVLSLLGCCV-------------------------- 134
           +   E     E+  +           + L                               
Sbjct: 69  EILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDR 128

Query: 135 -----DNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRI 189
                D+ L+++ +F   G        + +          I       L       +   
Sbjct: 129 PDFFKDDQLFIVLEFEFGGI---DLEQMRTKLSSLATAKSILHQLTASLAVAEASLR--F 183

Query: 190 IHRDIKSSNILLTADFEPQISDFGLAKWL 218
            HRD+   N+LL      ++      K  
Sbjct: 184 EHRDLHWGNVLLKKTSLKKLHYTLNGKSS 212

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 57.6 bits (140), Expect = 2e-09
 Identities = 55/222 (24%), Positives = 93/222 (41%), Gaps = 47/222 (21%)

Query: 73  LVGRGGYAEVYKGVLQDGEEI-AVKRLTK--VVTDD-----RKEKEFLTEIGTIGHVCHP 124
           ++G+G + +V    +++  ++ AVK L K  ++ DD       EK  L+         HP
Sbjct: 30  VLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARN-----HP 84

Query: 125 NVLSLLGCC-VDNGLYLIFQFSSRGSVASLFHDVNSPGV--EWKVRHKIAVGTARGLHYL 181
            +  L  C    + L+ + +F + G    L   +       E + R   A      L +L
Sbjct: 85  FLTQLFCCFQTPDRLFFVMEFVNGGD---LMFHIQKSRRFDEARARFYAA-EIISALMFL 140

Query: 182 HKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIE------GTFG 235
           H    + II+RD+K  N+LL  +   +++DFG+ K          I          GT  
Sbjct: 141 HD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCK--------EGICNGVTTATFCGTPD 189

Query: 236 HLAPEYFMHGIVDEKT-----DVFAFGVFLLEIISGRKPVDG 272
           ++APE     I+ E       D +A GV L E++ G  P + 
Sbjct: 190 YIAPE-----ILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEA 226

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 56.9 bits (138), Expect = 3e-09
 Identities = 48/232 (20%), Positives = 89/232 (38%), Gaps = 54/232 (23%)

Query: 68  FSSENLVGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKE-KEFLTEIGTIGHVCHPN 125
           +     +G GG   V+  V     + +A+K   K+V  D +  K  L EI  I  + H N
Sbjct: 13  YMDLKPLGCGGNGLVFSAVDNDCDKRVAIK---KIVLTDPQSVKHALREIKIIRRLDHDN 69

Query: 126 VLSLL---------------GCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHK- 169
           ++ +                     N +Y++ ++     + +   +V   G   +   + 
Sbjct: 70  IVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEY-----METDLANVLEQGPLLEEHARL 124

Query: 170 IAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTA-DFEPQISDFGLAKWLPSQWTHHSIA 228
                 RGL Y+H      ++HRD+K +N+ +   D   +I DFGLA+          + 
Sbjct: 125 FMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFGLAR---------IMD 172

Query: 229 PIEGTFGHL----------APE---YFMHGIVDEKTDVFAFGVFLLEIISGR 267
           P     GHL          +P       +    +  D++A G    E+++G+
Sbjct: 173 PHYSHKGHLSEGLVTKWYRSPRLLLSPNN--YTKAIDMWAAGCIFAEMLTGK 222

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 56.8 bits (138), Expect = 3e-09
 Identities = 58/216 (26%), Positives = 101/216 (46%), Gaps = 32/216 (14%)

Query: 73  LVGRGGYAEVY---KGVLQDGEEI-AVKRLTK-VVTDDRKEKEF-LTEIGTIGHVCHPNV 126
           ++G+GGY +V+   K    +  +I A+K L K ++  + K+      E   +  V HP +
Sbjct: 24  VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83

Query: 127 LSLLGCCVDNG-LYLIFQFSSRGSVASLFHDVNSPGV--EWKVRHKIA-VGTARGLHYLH 182
           + L+      G LYLI ++ S G    LF  +   G+  E      +A +  A  L +LH
Sbjct: 84  VDLIYAFQTGGKLYLILEYLSGGE---LFMQLEREGIFMEDTACFYLAEISMA--LGHLH 138

Query: 183 KGCQRRIIHRDIKSSNILLTADFEPQISDFGLAK-WLPSQWTHHSIAPIEGTFGHLAPEY 241
           +   + II+RD+K  NI+L      +++DFGL K  +      H+     GT  ++APE 
Sbjct: 139 Q---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFC---GTIEYMAPE- 191

Query: 242 FMHGIVDEKT-----DVFAFGVFLLEIISGRKPVDG 272
               I+         D ++ G  + ++++G  P  G
Sbjct: 192 ----ILMRSGHNRAVDWWSLGALMYDMLTGAPPFTG 223

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 57.3 bits (138), Expect = 4e-09
 Identities = 59/222 (26%), Positives = 98/222 (44%), Gaps = 47/222 (21%)

Query: 73  LVGRGGYAEVYKGVLQDGEEI-AVKRLTK--VVTDD-----RKEKEFLTEIGTIGHVCHP 124
           ++G+G + +V     +  +E+ AVK L K  V+ DD       EK  L   G       P
Sbjct: 348 VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK-----PP 402

Query: 125 NVLSLLGCC-VDNGLYLIFQFSSRGSVASLFHDVNSPGV--EWKVRHKIAVGTARGLHYL 181
            +  L  C    + LY + ++ + G    L + +   G   E       A   A GL +L
Sbjct: 403 FLTQLHSCFQTMDRLYFVMEYVNGGD---LMYHIQQVGRFKEPHAVFYAA-EIAIGLFFL 458

Query: 182 HKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIE------GTFG 235
                + II+RD+K  N++L ++   +I+DFG+ K         +I          GT  
Sbjct: 459 QS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCK--------ENIWDGVTTKTFCGTPD 507

Query: 236 HLAPEYFMHGIVDEKT-----DVFAFGVFLLEIISGRKPVDG 272
           ++APE     I+  +      D +AFGV L E+++G+ P +G
Sbjct: 508 YIAPE-----IIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG 544

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 55.3 bits (134), Expect = 1e-08
 Identities = 59/222 (26%), Positives = 98/222 (44%), Gaps = 47/222 (21%)

Query: 73  LVGRGGYAEVYKGVLQDGEEI-AVKRLTK--VVTDD-----RKEKEFLTEIGTIGHVCHP 124
           ++G+G + +V     +  +E+ AVK L K  V+ DD       EK  L   G       P
Sbjct: 27  VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK-----PP 81

Query: 125 NVLSLLGCC-VDNGLYLIFQFSSRGSVASLFHDVNSPGV--EWKVRHKIAVGTARGLHYL 181
            +  L  C    + LY + ++ + G    L + +   G   E       A   A GL +L
Sbjct: 82  FLTQLHSCFQTMDRLYFVMEYVNGGD---LMYHIQQVGRFKEPHAVFYAA-EIAIGLFFL 137

Query: 182 HKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIE------GTFG 235
                + II+RD+K  N++L ++   +I+DFG+ K         +I          GT  
Sbjct: 138 Q---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK--------ENIWDGVTTKTFCGTPD 186

Query: 236 HLAPEYFMHGIVDEKT-----DVFAFGVFLLEIISGRKPVDG 272
           ++APE     I+  +      D +AFGV L E+++G+ P +G
Sbjct: 187 YIAPE-----IIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG 223

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 54.5 bits (132), Expect = 2e-08
 Identities = 56/225 (24%), Positives = 100/225 (44%), Gaps = 59/225 (26%)

Query: 73  LVGRGGYAEVYKGVLQDGEEI-AVKRLTK--VVTDD-----RKEKEFLTEIGTIGHVCHP 124
           ++GRG YA+V    L+  + I A+K + K  V  D+     + EK    +        HP
Sbjct: 16  VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN-----HP 70

Query: 125 NVLSLLGCC-VDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTAR------- 176
            ++ L  C   ++ L+ + ++ + G    L   +           K+    AR       
Sbjct: 71  FLVGLHSCFQTESRLFFVIEYVNGGD---LMFHMQRQR-------KLPEEHARFYSAEIS 120

Query: 177 -GLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIE---- 231
             L+YLH   +R II+RD+K  N+LL ++   +++D+G+ K          + P +    
Sbjct: 121 LALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK--------EGLRPGDTTST 169

Query: 232 --GTFGHLAPEYFMHGIVDEKT-----DVFAFGVFLLEIISGRKP 269
             GT  ++APE     I+  +      D +A GV + E+++GR P
Sbjct: 170 FCGTPNYIAPE-----ILRGEDYGFSVDWWALGVLMFEMMAGRSP 209

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 53.9 bits (130), Expect = 3e-08
 Identities = 55/219 (25%), Positives = 100/219 (45%), Gaps = 47/219 (21%)

Query: 73  LVGRGGYAEVYKGVLQDGEEI-AVKRLTK--VVTDD-----RKEKEFLTEIGTIGHVCHP 124
           ++GRG YA+V    L+  + I A++ + K  V  D+     + EK    +        HP
Sbjct: 59  VIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASN-----HP 113

Query: 125 NVLSLLGCC-VDNGLYLIFQFSSRGSVASLFHDVNSPGV--EWKVRHKIAVGTARGLHYL 181
            ++ L  C   ++ L+ + ++ + G    L   +       E   R   A   +  L+YL
Sbjct: 114 FLVGLHSCFQTESRLFFVIEYVNGGD---LMFHMQRQRKLPEEHARFYSAE-ISLALNYL 169

Query: 182 HKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIE------GTFG 235
           H   +R II+RD+K  N+LL ++   +++D+G+ K          + P +      GT  
Sbjct: 170 H---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK--------EGLRPGDTTSTFCGTPN 218

Query: 236 HLAPEYFMHGIVDEKT-----DVFAFGVFLLEIISGRKP 269
           ++APE     I+  +      D +A GV + E+++GR P
Sbjct: 219 YIAPE-----ILRGEDYGFSVDWWALGVLMFEMMAGRSP 252

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 53.4 bits (129), Expect = 4e-08
 Identities = 56/220 (25%), Positives = 98/220 (44%), Gaps = 42/220 (19%)

Query: 73  LVGRGGYAEVY---KGVLQDGEEI-AVKRLTK--VVTDDRKEKEFLTE---IGTIGHVCH 123
           ++G G Y +V+   K    D  ++ A+K L K  +V   +  +   TE   +  I     
Sbjct: 61  VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQ--S 118

Query: 124 PNVLSLLGCCVDNG-LYLIFQFSSRGSVASLFHDVNSPGV--EWKVRHKIA-VGTARGLH 179
           P +++L         L+LI  + + G    LF  ++      E +V+  +  +  A  L 
Sbjct: 119 PFLVTLHYAFQTETKLHLILDYINGGE---LFTHLSQRERFTEHEVQIYVGEIVLA--LE 173

Query: 180 YLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAK---WLPSQWTHHSIAPIEGTFGH 236
           +LHK     II+RDIK  NILL ++    ++DFGL+K      ++   +      GT  +
Sbjct: 174 HLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERA-YDFC---GTIEY 226

Query: 237 LAPEYFMHGIVDEKT-------DVFAFGVFLLEIISGRKP 269
           +AP+     IV           D ++ GV + E+++G  P
Sbjct: 227 MAPD-----IVRGGDSGHDKAVDWWSLGVLMYELLTGASP 261

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 53.4 bits (129), Expect = 4e-08
 Identities = 54/222 (24%), Positives = 88/222 (39%), Gaps = 47/222 (21%)

Query: 73  LVGRGGYAEVYKGVLQDGEEI-AVKRLTK--VVTDD-----RKEKEFLTEIGTIGHVCHP 124
           ++G+G + +V     +  E   AVK L K  ++          E+  L +     +V HP
Sbjct: 45  VIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLK-----NVKHP 99

Query: 125 NVLSLLGCCVDNG-LYLIFQFSSRGSVASLFHDVNSPGV--EWKVRHKIAVGTARGLHYL 181
            ++ L         LY +  + + G    LF+ +       E + R   A   A  L YL
Sbjct: 100 FLVGLHFSFQTADKLYFVLDYINGGE---LFYHLQRERCFLEPRARFYAA-EIASALGYL 155

Query: 182 HKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIE------GTFG 235
           H      I++RD+K  NILL +     ++DFGL K         +I          GT  
Sbjct: 156 HS---LNIVYRDLKPENILLDSQGHIVLTDFGLCK--------ENIEHNSTTSTFCGTPE 204

Query: 236 HLAPEYFMHGIVDEKT-----DVFAFGVFLLEIISGRKPVDG 272
           +LAPE     ++ ++      D +  G  L E++ G  P   
Sbjct: 205 YLAPE-----VLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYS 241

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 52.6 bits (127), Expect = 7e-08
 Identities = 53/222 (23%), Positives = 93/222 (41%), Gaps = 47/222 (21%)

Query: 73  LVGRGGYAEVYKGVLQDGEEI-AVKRLTK--VVTDD-----RKEKEFLTEIGTIGHVCHP 124
           ++G+G + +V+    +   +  A+K L K  V+ DD       EK  L+         HP
Sbjct: 24  MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE-----HP 78

Query: 125 NVLSLLGC-CVDNGLYLIFQFSSRGSVASLFHDVNSPGV--EWKVRHKIAVGTARGLHYL 181
            +  +         L+ + ++ + G    L + + S       +     A     GL +L
Sbjct: 79  FLTHMFCTFQTKENLFFVMEYLNGGD---LMYHIQSCHKFDLSRATFYAA-EIILGLQFL 134

Query: 182 HKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIE------GTFG 235
           H    + I++RD+K  NILL  D   +I+DFG+ K         ++          GT  
Sbjct: 135 HS---KGIVYRDLKLDNILLDKDGHIKIADFGMCK--------ENMLGDAKTNTFCGTPD 183

Query: 236 HLAPEYFMHGIVDEKT-----DVFAFGVFLLEIISGRKPVDG 272
           ++APE     I+  +      D ++FGV L E++ G+ P  G
Sbjct: 184 YIAPE-----ILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG 220

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 48.1 bits (115), Expect = 2e-06
 Identities = 42/179 (23%), Positives = 62/179 (34%), Gaps = 41/179 (22%)

Query: 74  VGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDD---RKEKEFLTEIGTIGHVCHPN---- 125
           +G G + E+  G  L   E +A+K L  + +       E  F  ++G+   +        
Sbjct: 17  IGCGNFGELRLGKNLYTNEYVAIK-LEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGP 75

Query: 126 -------VLSLLGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGL 178
                  VL LLG      L  +F    R    SL           K    IA+     +
Sbjct: 76  CGKYNAMVLELLGPS----LEDLFDLCDR--TFSL-----------KTVLMIAIQLISRM 118

Query: 179 HYLHKGCQRRIIHRDIKSSNILLTADFEPQ-----ISDFGLAKWLPSQWTHHSIAPIEG 232
            Y+H    + +I+RD+K  N L+            I DF LAK      T   I   E 
Sbjct: 119 EYVH---SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREH 174

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 46.6 bits (111), Expect = 6e-06
 Identities = 26/97 (26%), Positives = 41/97 (42%), Gaps = 13/97 (13%)

Query: 177 GLHYLHKGCQRRIIHRDIKSSNILLTADFEPQ------ISDFGLAKWLPSQWTHHSIAPI 230
           GL Y+H+ C   IIH DIK  N+L+     P+      I+D G A      W        
Sbjct: 143 GLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA-----CWYDEHYTNS 195

Query: 231 EGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGR 267
             T  + +PE  +        D+++    + E+I+G 
Sbjct: 196 IQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 232

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 44.3 bits (105), Expect = 3e-05
 Identities = 32/179 (17%), Positives = 60/179 (33%), Gaps = 41/179 (22%)

Query: 74  VGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDD---RKEKEFLTEIGTIGHVCHPN---- 125
           +G G +  +++G  L + +++A+K      +D    R E      +     + +      
Sbjct: 18  IGEGSFGVIFEGTNLLNNQQVAIKF-EPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQ 76

Query: 126 -------VLSLLGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGL 178
                  V+ LLG      L  +     R    S+           K     A      +
Sbjct: 77  EGLHNVLVIDLLGPS----LEDLLDLCGR--KFSV-----------KTVAMAAKQMLARV 119

Query: 179 HYLHKGCQRRIIHRDIKSSNILLTADFEPQ-----ISDFGLAKWLPSQWTHHSIAPIEG 232
             +H   ++ +++RDIK  N L+            + DFG+ K+     T   I   E 
Sbjct: 120 QSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREK 175

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 44.7 bits (106), Expect = 3e-05
 Identities = 23/170 (13%), Positives = 55/170 (32%), Gaps = 31/170 (18%)

Query: 71  ENLVGRGGYAEVYKGV---------LQDGEEIAVK-------RLTKVVTDDRKEK----E 110
           ++   R     +Y+               ++ ++K          +     R  K     
Sbjct: 47  KSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVN 106

Query: 111 FLTEIGTIGHVCHPNVLSLLGCCVDNGLY--LIFQFSSRGSVASLFHDVNSPGVEWKVRH 168
              ++ +   +  P  +   G  V    Y  L+     R S+ S         +  +   
Sbjct: 107 KWKKLYSTPLLAIPTCM---GFGVHQDKYRFLVLPSLGR-SLQSALDVSPKHVLSERSVL 162

Query: 169 KIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQI--SDFGLAK 216
           ++A      L +LH   +   +H ++ + NI +  + + Q+  + +G A 
Sbjct: 163 QVACRLLDALEFLH---ENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 43.2 bits (102), Expect = 8e-05
 Identities = 14/41 (34%), Positives = 24/41 (58%), Gaps = 5/41 (12%)

Query: 178 LHYLHKGCQRRIIHRDIKSSNILLTADFEPQI--SDFGLAK 216
           L Y+H   +   +H DIK++N+LL      Q+  +D+GL+ 
Sbjct: 164 LEYIH---ENEYVHGDIKAANLLLGYKNPDQVYLADYGLSY 201

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 43.2 bits (102), Expect = 9e-05
 Identities = 30/172 (17%), Positives = 56/172 (32%), Gaps = 39/172 (22%)

Query: 73  LVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRK------EKEFLTEIGTIGHVCHPNV 126
            +G+GG+  +Y   +   E +       V  +         E +F         +     
Sbjct: 42  PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101

Query: 127 LSLLGC-----CVDNGLYLIFQFSSR-------G-SVASLFHDVNSPGVEWKVRH----- 168
              L          +GL+     S R       G  +  ++            +      
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANA--------KRFSRKT 153

Query: 169 --KIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQI--SDFGLAK 216
             ++++     L Y+H   +   +H DIK+SN+LL      Q+   D+GLA 
Sbjct: 154 VLQLSLRILDILEYIH---EHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 42.0 bits (99), Expect = 2e-04
 Identities = 38/167 (22%), Positives = 62/167 (37%), Gaps = 19/167 (11%)

Query: 74  VGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDD---RKEKEFLTEIGTIGHVCHPNVLSL 129
           +G G + ++Y G  +  GEE+A+K    V T       E +    +     +       +
Sbjct: 17  IGSGSFGDIYLGTDIAAGEEVAIKL-ECVKTKHPQLHIESKIYKMMQGGVGIPT-----I 70

Query: 130 LGCCVDNGL-YLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRR 188
             C  +     ++ +     S+  LF +  S     K    +A      + Y+H    + 
Sbjct: 71  RWCGAEGDYNVMVMELLGP-SLEDLF-NFCSRKFSLKTVLLLADQMISRIEYIH---SKN 125

Query: 189 IIHRDIKSSNILL-TADFEPQI--SDFGLAKWLPSQWTHHSIAPIEG 232
            IHRD+K  N L+        +   DFGLAK      TH  I   E 
Sbjct: 126 FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYREN 172

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 41.1 bits (96), Expect = 4e-04
 Identities = 45/177 (25%), Positives = 64/177 (36%), Gaps = 39/177 (22%)

Query: 74  VGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDD---RKEKEFLTEIGTIGHVCHPN---- 125
           +G G + E+Y G  +Q  EE+A+K    V T       E +    +     + +      
Sbjct: 15  IGSGSFGEIYLGTNIQTNEEVAIKL-ENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGV 73

Query: 126 -------VLSLLGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGL 178
                  V+ LLG      L  +F F SR    SL           K    +A      +
Sbjct: 74  EGDYNVLVMDLLG----PSLEDLFNFCSRK--LSL-----------KTVLMLADQMINRV 116

Query: 179 HYLHKGCQRRIIHRDIKSSNILLTADFEPQ---ISDFGLAKWLPSQWTHHSIAPIEG 232
            ++H    +  +HRDIK  N L+          I DFGLAK      TH  I   E 
Sbjct: 117 EFVH---SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYREN 170

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 41.0 bits (96), Expect = 4e-04
 Identities = 36/217 (16%), Positives = 64/217 (29%), Gaps = 74/217 (34%)

Query: 120 HVCHPNVLSLLGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLH 179
           H+C   V  +LG                  +       N  G+      KI     +GL 
Sbjct: 119 HICM--VFEVLGH----------------HLLKWIIKSNYQGLPLPCVKKIIQQVLQGLD 160

Query: 180 YLHKGCQRRIIHRDIKSSNILLTAD----------------------------------- 204
           YLH  C+  IIH DIK  NILL+ +                                   
Sbjct: 161 YLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAG 218

Query: 205 --------------FEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEK 250
                          + +I+D G A W+   +T   I   +    + + E  +    +  
Sbjct: 219 NFLVNPLEPKNAEKLKVKIADLGNACWVHKHFT-EDIQTRQ----YRSLEVLIGSGYNTP 273

Query: 251 TDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQ 287
            D+++      E+ +G    +      ++  +  +  
Sbjct: 274 ADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIAL 310

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	386
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.97
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.96
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.94
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.86
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.77
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.33
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.22
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.09
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.04
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.79
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.64
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.49
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.45
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.33
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.19
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.14
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.07
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.06
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.88
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.86
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.75
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.46
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.41
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.38
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.35
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.25
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.09
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.01
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.71
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.52
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.39
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	94.75
3mes_A	424	Choline kinase; malaria, structural genomics, stru	94.42
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	92.42
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	89.65
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	88.46

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=2.6e-61  Score=445.10  Aligned_cols=256  Identities=22%  Similarity=0.332  Sum_probs=212.2

Q ss_pred             cCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEEE
Q 016594           66 NAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQ  143 (386)
Q Consensus        66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~e  143 (386)
                      ++|++.+.||+|+||+||+|+++ +|+.||||++.+..........+.+|+.+|++++|||||++++++.+++ +|+|||
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE  103 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD  103 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence            57999999999999999999986 6999999999876666667788999999999999999999999998866 899999


Q ss_pred             eccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCc
Q 016594          144 FSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWT  223 (386)
Q Consensus       144 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~  223 (386)
                      |+.||+|.+++.......+++..++.|+.||+.||+|||+   ++|+||||||+||||+.+|.+||+|||+|+.+...  
T Consensus       104 y~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~--  178 (350)
T 4b9d_A          104 YCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST--  178 (350)
T ss_dssp             CCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTCEETTCCGGGEEECTTCCEEECSTTEESCCCHH--
T ss_pred             CCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCCEEEcccccceeecCC--
Confidence            9999999999987766678999999999999999999999   99999999999999999999999999999876432  


Q ss_pred             cccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCCCCC
Q 016594          224 HHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYD  303 (386)
Q Consensus       224 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (386)
                      .......+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.....  ....+... ..         ...+
T Consensus       179 ~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~--~~~~i~~~-~~---------~~~~  246 (350)
T 4b9d_A          179 VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKN--LVLKIISG-SF---------PPVS  246 (350)
T ss_dssp             HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHT-CC---------CCCC
T ss_pred             cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH--HHHHHHcC-CC---------CCCC
Confidence            122345679999999999999999999999999999999999999998754321  11111111 10         1122


Q ss_pred             HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          304 VTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       304 ~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                      ...+..+.+||.+||+.||++|||+.+++++-+..
T Consensus       247 ~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~  281 (350)
T 4b9d_A          247 LHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIA  281 (350)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHH
T ss_pred             ccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhh
Confidence            33467899999999999999999999999985543

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=6.4e-61  Score=436.44  Aligned_cols=264  Identities=24%  Similarity=0.382  Sum_probs=211.1

Q ss_pred             HHHhcCCCCCCeecccCCcEEEEEEECCCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCceEEE
Q 016594           62 SIATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNGLYLI  141 (386)
Q Consensus        62 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~lv  141 (386)
                      ++..+++.+.+.||+|+||+||+|+++  ..||||+++...........|.+|+.++++++|||||++++++.++..++|
T Consensus        32 ei~~~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~iV  109 (307)
T 3omv_A           32 EIEASEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIV  109 (307)
T ss_dssp             BCCTTSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEE
T ss_pred             EEcHHHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEECCeEEEE
Confidence            456678999999999999999999875  369999998665566677889999999999999999999999988889999


Q ss_pred             EEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCC
Q 016594          142 FQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQ  221 (386)
Q Consensus       142 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  221 (386)
                      |||+.+|+|.+++.... ..+++..+..|+.||+.||+|||+   ++||||||||+||||+.++.+||+|||+|+.....
T Consensus       110 mEy~~gGsL~~~l~~~~-~~l~~~~~~~i~~qia~gL~yLH~---~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~  185 (307)
T 3omv_A          110 TQWCEGSSLYKHLHVQE-TKFQMFQLIDIARQTAQGMDYLHA---KNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRW  185 (307)
T ss_dssp             EECCSSCBHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCSSSEEEETTEEEEECCCSSCBC----
T ss_pred             EEcCCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCccCCccCHHHEEECCCCcEEEeeccCceecccC
Confidence            99999999999987543 349999999999999999999999   99999999999999999999999999999876544


Q ss_pred             CccccccccccccCccChhhhcc---CCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCcc
Q 016594          222 WTHHSIAPIEGTFGHLAPEYFMH---GIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRL  298 (386)
Q Consensus       222 ~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (386)
                      .........+||+.|||||++.+   ..|+.++|||||||++|||+||+.||.+.......  ......+    ...+..
T Consensus       186 ~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~--~~~~~~~----~~~p~~  259 (307)
T 3omv_A          186 SGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQI--IFMVGRG----YASPDL  259 (307)
T ss_dssp             --------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHH--HHHHHTT----CCCCCS
T ss_pred             CcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHH--HHHHhcC----CCCCCc
Confidence            33344556789999999999964   46899999999999999999999999865432111  1111111    011111


Q ss_pred             CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          299 QGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       299 ~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                       ...+..++..+.+|+.+||+.||++|||+.+|++.|+..
T Consensus       260 -~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l  298 (307)
T 3omv_A          260 -SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELL  298 (307)
T ss_dssp             -TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHH
T ss_pred             -ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence             122334567899999999999999999999999988643

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=5.3e-60  Score=432.00  Aligned_cols=259  Identities=23%  Similarity=0.331  Sum_probs=212.7

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEC------CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-
Q 016594           65 TNAFSSENLVGRGGYAEVYKGVLQ------DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-  137 (386)
Q Consensus        65 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-  137 (386)
                      .+.+++.+.||+|+||+||+|.+.      +++.||||+++... .......|.+|+.++++++|||||+++|++.+++ 
T Consensus        25 ~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~-~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~  103 (308)
T 4gt4_A           25 LSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA-EGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQP  103 (308)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C-CC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc-ChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCE
Confidence            345667889999999999999963      46789999997533 3345678999999999999999999999998755 


Q ss_pred             eEEEEEeccCCCHhhhhhhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcC
Q 016594          138 LYLIFQFSSRGSVASLFHDVN--------------SPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTA  203 (386)
Q Consensus       138 ~~lv~e~~~~~~L~~~~~~~~--------------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~  203 (386)
                      .++||||+.+|+|.+++....              ...+++..++.|+.||+.||+|||+   ++||||||||+|||++.
T Consensus       104 ~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLK~~NILl~~  180 (308)
T 4gt4_A          104 LSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS---HHVVHKDLATRNVLVYD  180 (308)
T ss_dssp             CEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECG
T ss_pred             EEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCccccceEECC
Confidence            899999999999999986532              1348999999999999999999999   99999999999999999


Q ss_pred             CCCeEEeecCccccCCCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCchhhhhhhh
Q 016594          204 DFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAK  282 (386)
Q Consensus       204 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~  282 (386)
                      ++.+||+|||+|+.+.............||+.|||||++.++.|+.++|||||||++|||+| |..||.+.....  ...
T Consensus       181 ~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~--~~~  258 (308)
T 4gt4_A          181 KLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD--VVE  258 (308)
T ss_dssp             GGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHH--HHH
T ss_pred             CCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHH--HHH
Confidence            99999999999987654433334455679999999999999999999999999999999998 899998754321  111


Q ss_pred             hhhcccccccccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCC
Q 016594          283 PILNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEGD  339 (386)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~~  339 (386)
                      .+ .         .......+..++..+.+|+.+||+.||++||||.+|+++|+...
T Consensus       259 ~i-~---------~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~  305 (308)
T 4gt4_A          259 MI-R---------NRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWG  305 (308)
T ss_dssp             HH-H---------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred             HH-H---------cCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcc
Confidence            11 1         11112233455678999999999999999999999999998654

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=1.7e-60  Score=433.52  Aligned_cols=258  Identities=21%  Similarity=0.324  Sum_probs=211.9

Q ss_pred             HhcCCCCCCeecccCCcEEEEEEEC------CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc
Q 016594           64 ATNAFSSENLVGRGGYAEVYKGVLQ------DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG  137 (386)
Q Consensus        64 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  137 (386)
                      ..++|.+.+.||+|+||+||+|++.      ++..||||+++..  .......|.+|+.+|++++|||||++++++.+++
T Consensus        11 ~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~   88 (299)
T 4asz_A           11 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGD   88 (299)
T ss_dssp             CGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred             CHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC--ChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC
Confidence            3467888999999999999999864      4678999999753  3455678999999999999999999999998755


Q ss_pred             -eEEEEEeccCCCHhhhhhhcC-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCC
Q 016594          138 -LYLIFQFSSRGSVASLFHDVN-----------SPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADF  205 (386)
Q Consensus       138 -~~lv~e~~~~~~L~~~~~~~~-----------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~  205 (386)
                       .++||||+.+|+|.+++....           ...+++..++.++.||+.||+|||+   ++|+||||||+|||++.++
T Consensus        89 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDlKp~NILl~~~~  165 (299)
T 4asz_A           89 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENL  165 (299)
T ss_dssp             SEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGG
T ss_pred             EEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccCHhhEEECCCC
Confidence             899999999999999987532           3459999999999999999999999   9999999999999999999


Q ss_pred             CeEEeecCccccCCCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCchhhhhhhhhh
Q 016594          206 EPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPI  284 (386)
Q Consensus       206 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~  284 (386)
                      .+||+|||+|+...............||+.|||||++.+..|+.++|||||||++|||+| |+.||.+.....  ....+
T Consensus       166 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~--~~~~i  243 (299)
T 4asz_A          166 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE--VIECI  243 (299)
T ss_dssp             CEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH--HHHHH
T ss_pred             cEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH--HHHHH
Confidence            999999999987654433333344569999999999999999999999999999999999 999998754321  11111


Q ss_pred             hcccccccccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          285 LNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                       ..+         .....+..++..+.+|+.+||+.||++|||+.+|++.|+..
T Consensus       244 -~~~---------~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~  287 (299)
T 4asz_A          244 -TQG---------RVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNL  287 (299)
T ss_dssp             -HHT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -HcC---------CCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence             111         11122334567899999999999999999999999888754

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=1.4e-59  Score=433.23  Aligned_cols=259  Identities=19%  Similarity=0.307  Sum_probs=205.7

Q ss_pred             HhcCCCCCCeecccCCcEEEEEEEC------CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc
Q 016594           64 ATNAFSSENLVGRGGYAEVYKGVLQ------DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG  137 (386)
Q Consensus        64 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  137 (386)
                      ..++|.+.++||+|+||+||+|+++      ++..||||+++.  ........|.+|+.+|++++|||||+++++|.++.
T Consensus        39 ~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~--~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~  116 (329)
T 4aoj_A           39 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE--ASESARQDFQREAELLTMLQHQHIVRFFGVCTEGR  116 (329)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESC--CSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred             CHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECc--CCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence            3456778899999999999999864      478899999975  34555678999999999999999999999998755


Q ss_pred             -eEEEEEeccCCCHhhhhhhcC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcC
Q 016594          138 -LYLIFQFSSRGSVASLFHDVN-------------SPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTA  203 (386)
Q Consensus       138 -~~lv~e~~~~~~L~~~~~~~~-------------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~  203 (386)
                       .++||||+.+|+|.+++....             ...+++..++.|+.||+.||+|||+   ++|+||||||+||||+.
T Consensus       117 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLKp~NILl~~  193 (329)
T 4aoj_A          117 PLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG---LHFVHRDLATRNCLVGQ  193 (329)
T ss_dssp             SEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEET
T ss_pred             EEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHhhEEECC
Confidence             899999999999999987542             2358999999999999999999999   99999999999999999


Q ss_pred             CCCeEEeecCccccCCCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCchhhhhhhh
Q 016594          204 DFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAK  282 (386)
Q Consensus       204 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~  282 (386)
                      ++.+||+|||+|+.+.............||+.|||||++.+..|+.++|||||||++|||+| |+.||.+......  ..
T Consensus       194 ~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~--~~  271 (329)
T 4aoj_A          194 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEA--ID  271 (329)
T ss_dssp             TTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHH--HH
T ss_pred             CCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHH--HH
Confidence            99999999999987654433333445679999999999999999999999999999999999 9999987543211  11


Q ss_pred             hhhcccccccccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCC
Q 016594          283 PILNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEGD  339 (386)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~~  339 (386)
                      .+. .+         .+...+..++..+.+|+.+||+.||++|||+.+|+++|+...
T Consensus       272 ~i~-~g---------~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~  318 (329)
T 4aoj_A          272 CIT-QG---------RELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALA  318 (329)
T ss_dssp             HHH-HT---------CCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHH
T ss_pred             HHH-cC---------CCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHh
Confidence            111 11         112233345678999999999999999999999999987653

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=3e-59  Score=424.51  Aligned_cols=250  Identities=22%  Similarity=0.328  Sum_probs=211.4

Q ss_pred             cCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEecccc-CChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEE
Q 016594           66 NAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVV-TDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIF  142 (386)
Q Consensus        66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~  142 (386)
                      ++|++.+.||+|+||+||+|+++ +|+.||||++.+.. ........+.+|+++|++++|||||++++++.+++ .|+||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm  111 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL  111 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            56999999999999999999986 79999999997532 22334567899999999999999999999998866 89999


Q ss_pred             EeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCC
Q 016594          143 QFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQW  222 (386)
Q Consensus       143 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  222 (386)
                      ||+.||+|.+++.+..  .+++..+..++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+|+.+....
T Consensus       112 Ey~~gG~L~~~i~~~~--~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~  186 (311)
T 4aw0_A          112 SYAKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES  186 (311)
T ss_dssp             CCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTT
T ss_pred             ecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCC
Confidence            9999999999997654  49999999999999999999999   999999999999999999999999999999886554


Q ss_pred             ccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCCCC
Q 016594          223 THHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAY  302 (386)
Q Consensus       223 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (386)
                      ......+.+||+.|||||++.+..|+.++|||||||++|+|++|.+||.+.+....  ...+...         .  ..+
T Consensus       187 ~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~--~~~i~~~---------~--~~~  253 (311)
T 4aw0_A          187 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLI--FAKIIKL---------E--YDF  253 (311)
T ss_dssp             TCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHT---------C--CCC
T ss_pred             CcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHcC---------C--CCC
Confidence            44455678899999999999999999999999999999999999999987543211  1111110         0  112


Q ss_pred             CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 016594          303 DVTQLNRLAFAASLCIRASPTWRPTMSEVLE  333 (386)
Q Consensus       303 ~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~  333 (386)
                      +...+..+.+||.+||..||++|||+.|++.
T Consensus       254 p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~  284 (311)
T 4aw0_A          254 PEKFFPKARDLVEKLLVLDATKRLGCEEMEG  284 (311)
T ss_dssp             CTTCCHHHHHHHHHHSCSSGGGSTTSGGGTC
T ss_pred             CcccCHHHHHHHHHHccCCHhHCcChHHHcC
Confidence            2234567999999999999999999998643

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=7.8e-59  Score=419.69  Aligned_cols=251  Identities=24%  Similarity=0.389  Sum_probs=205.0

Q ss_pred             CCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEe-----CceEEE
Q 016594           68 FSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVD-----NGLYLI  141 (386)
Q Consensus        68 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-----~~~~lv  141 (386)
                      |++.+.||+|+||+||+|.+. ++..||+|++............+.+|+.+|++++|||||++++++.+     +.+|+|
T Consensus        28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv  107 (290)
T 3fpq_A           28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV  107 (290)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence            356678999999999999987 68899999998766666667889999999999999999999999865     227999


Q ss_pred             EEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEEeCCCCCCeeEcC-CCCeEEeecCccccC
Q 016594          142 FQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRR--IIHRDIKSSNILLTA-DFEPQISDFGLAKWL  218 (386)
Q Consensus       142 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~--ivH~dlkp~Nill~~-~~~~kl~Dfg~a~~~  218 (386)
                      |||+.+|+|.+++.+..  .+++..+..++.||+.||+|||+   ++  |+||||||+|||++. ++.+||+|||+|+..
T Consensus       108 mEy~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~ylH~---~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~  182 (290)
T 3fpq_A          108 TELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK  182 (290)
T ss_dssp             EECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred             EeCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCCCEEecccChhheeEECCCCCEEEEeCcCCEeC
Confidence            99999999999997654  48999999999999999999999   77  999999999999984 789999999999865


Q ss_pred             CCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCcc
Q 016594          219 PSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRL  298 (386)
Q Consensus       219 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (386)
                      ...    ...+.+||+.|||||++.+ .|+.++|||||||++|||+||+.||.+....... ...+ ..        ...
T Consensus       183 ~~~----~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~-~~~i-~~--------~~~  247 (290)
T 3fpq_A          183 RAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI-YRRV-TS--------GVK  247 (290)
T ss_dssp             CTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHH-HHHH-TT--------TCC
T ss_pred             CCC----ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHH-HHHH-Hc--------CCC
Confidence            432    2345689999999998865 6999999999999999999999999764322111 1111 00        000


Q ss_pred             CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          299 QGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       299 ~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                      ....+...+..+.+||.+||+.||++|||+.++++|-+..
T Consensus       248 ~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~  287 (290)
T 3fpq_A          248 PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ  287 (290)
T ss_dssp             CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred             CCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccc
Confidence            1111222345789999999999999999999999986543

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=1.6e-58  Score=425.88  Aligned_cols=253  Identities=21%  Similarity=0.304  Sum_probs=211.3

Q ss_pred             cCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEEE
Q 016594           66 NAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQ  143 (386)
Q Consensus        66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~e  143 (386)
                      ..|++.+.||+|+||+||+|+++ +|+.||||++......  ....+.+|+.+|+.++|||||++++++.+++ +|+|||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~--~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmE  151 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ--RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVME  151 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCS--SGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchh--HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence            56999999999999999999987 7999999999754322  2345789999999999999999999998866 899999


Q ss_pred             eccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCc
Q 016594          144 FSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWT  223 (386)
Q Consensus       144 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~  223 (386)
                      |+.+|+|.+++...   .+++..+..++.||+.||+|||+   ++|+||||||+||||+.+|.+||+|||+|+.+.... 
T Consensus       152 y~~gg~L~~~l~~~---~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~-  224 (346)
T 4fih_A          152 FLEGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-  224 (346)
T ss_dssp             CCTTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS-
T ss_pred             CCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEECCCCCEEEecCcCceecCCCC-
Confidence            99999999988753   49999999999999999999999   999999999999999999999999999998775432 


Q ss_pred             cccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCCCCC
Q 016594          224 HHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYD  303 (386)
Q Consensus       224 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (386)
                       ....+.+||+.|||||++.+..|+.++|||||||++|||++|.+||.+......  ...+..      ...+.  ....
T Consensus       225 -~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~--~~~i~~------~~~~~--~~~~  293 (346)
T 4fih_A          225 -PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA--MKMIRD------NLPPR--LKNL  293 (346)
T ss_dssp             -CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH--HHHHHH------SSCCC--CSCG
T ss_pred             -CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH--HHHHHc------CCCCC--CCcc
Confidence             234567899999999999999999999999999999999999999987543211  111110      01111  1122


Q ss_pred             HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          304 VTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       304 ~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                      ...+..+.+||.+||..||++|||+.|+++|-+..
T Consensus       294 ~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~  328 (346)
T 4fih_A          294 HKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLA  328 (346)
T ss_dssp             GGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGG
T ss_pred             ccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhc
Confidence            34467899999999999999999999999986553

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=3.6e-58  Score=422.33  Aligned_cols=251  Identities=24%  Similarity=0.318  Sum_probs=204.3

Q ss_pred             cCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEEE
Q 016594           66 NAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQ  143 (386)
Q Consensus        66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~e  143 (386)
                      +.|++.++||+|+||+||+|+++ +|+.||||+++....       ..+|+.+++.++|||||++++++.+++ +|+|||
T Consensus        58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmE  130 (336)
T 4g3f_A           58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-------RVEELVACAGLSSPRIVPLYGAVREGPWVNIFME  130 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence            46788899999999999999986 699999999975322       247999999999999999999998866 899999


Q ss_pred             eccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCC-CeEEeecCccccCCCCC
Q 016594          144 FSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADF-EPQISDFGLAKWLPSQW  222 (386)
Q Consensus       144 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~-~~kl~Dfg~a~~~~~~~  222 (386)
                      |+.||+|.+++....  .+++..+..++.||+.||+|||+   ++|+||||||+|||++.+| ++||+|||+|+.+....
T Consensus       131 y~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~  205 (336)
T 4g3f_A          131 LLEGGSLGQLIKQMG--CLPEDRALYYLGQALEGLEYLHT---RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG  205 (336)
T ss_dssp             CCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred             ccCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence            999999999998654  49999999999999999999999   9999999999999999987 69999999999875432


Q ss_pred             cc---ccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccC
Q 016594          223 TH---HSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQ  299 (386)
Q Consensus       223 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (386)
                      ..   ......+||+.|||||++.+..|+.++|||||||++|||++|+.||.+......  ...+...        +...
T Consensus       206 ~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~--~~~i~~~--------~~~~  275 (336)
T 4g3f_A          206 LGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPL--CLKIASE--------PPPI  275 (336)
T ss_dssp             --------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCC--HHHHHHS--------CCGG
T ss_pred             cccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH--HHHHHcC--------CCCc
Confidence            21   122346799999999999999999999999999999999999999986533210  0001110        0000


Q ss_pred             CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          300 GAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       300 ~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                      ...+..++..+.++|.+||+.||++|||+.|++++|...
T Consensus       276 ~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~  314 (336)
T 4g3f_A          276 REIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKA  314 (336)
T ss_dssp             GGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             hhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence            112334567899999999999999999999999987654

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=7.6e-58  Score=409.72  Aligned_cols=250  Identities=19%  Similarity=0.311  Sum_probs=194.6

Q ss_pred             cCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccC-ChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEE
Q 016594           66 NAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVT-DDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIF  142 (386)
Q Consensus        66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~  142 (386)
                      ++|++.+.||+|+||+||+|.++ +|+.||||++.+... .......+.+|+.+++.++|||||++++++.+++ .|+||
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm   92 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI   92 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence            68999999999999999999976 799999999976432 2344567899999999999999999999998766 89999


Q ss_pred             EeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCC
Q 016594          143 QFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQW  222 (386)
Q Consensus       143 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  222 (386)
                      ||+ +|+|.+++....  .+++..+..++.||+.||+|||+   ++|+||||||+|||++.++++||+|||+|+..... 
T Consensus        93 Ey~-~g~L~~~l~~~~--~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~-  165 (275)
T 3hyh_A           93 EYA-GNELFDYIVQRD--KMSEQEARRFFQQIISAVEYCHR---HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG-  165 (275)
T ss_dssp             ECC-CEEHHHHHHHSC--SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTCCEEECCSSCC-------
T ss_pred             eCC-CCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCcccccCChHHeEECCCCCEEEeecCCCeecCCC-
Confidence            998 679999887643  49999999999999999999999   99999999999999999999999999999876433 


Q ss_pred             ccccccccccccCccChhhhccCCC-CcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCCC
Q 016594          223 THHSIAPIEGTFGHLAPEYFMHGIV-DEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGA  301 (386)
Q Consensus       223 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (386)
                        ....+.+||+.|||||++.+..| +.++|||||||++|+|++|+.||.+.....  ....+.. .        .  ..
T Consensus       166 --~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~--~~~~i~~-~--------~--~~  230 (275)
T 3hyh_A          166 --NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPV--LFKNISN-G--------V--YT  230 (275)
T ss_dssp             -----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHH-T--------C--CC
T ss_pred             --CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHHc-C--------C--CC
Confidence              23345789999999999998876 589999999999999999999998754321  1111111 0        0  11


Q ss_pred             CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 016594          302 YDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLE  337 (386)
Q Consensus       302 ~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~  337 (386)
                      .+...+..+.+||.+||+.||++|||+.++++|-+.
T Consensus       231 ~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~  266 (275)
T 3hyh_A          231 LPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWF  266 (275)
T ss_dssp             CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHH
T ss_pred             CCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCccc
Confidence            222345779999999999999999999999998665

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=2.4e-57  Score=428.05  Aligned_cols=253  Identities=21%  Similarity=0.315  Sum_probs=211.1

Q ss_pred             cCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEEE
Q 016594           66 NAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQ  143 (386)
Q Consensus        66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~e  143 (386)
                      +.|++.+.||+|+||+||+|+++ +|+.||||++.....  .....+.+|+.+|+.++|||||++++++.+++ +|+|||
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~--~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmE  228 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ--QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVME  228 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTC--SSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccch--hHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEe
Confidence            56999999999999999999987 699999999975432  23456889999999999999999999998866 899999


Q ss_pred             eccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCc
Q 016594          144 FSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWT  223 (386)
Q Consensus       144 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~  223 (386)
                      |+.||+|.+++...   .+++..+..++.||+.||+|||+   ++||||||||+||||+.+|.+||+|||+|..+.... 
T Consensus       229 y~~gG~L~~~i~~~---~l~e~~~~~~~~qil~aL~ylH~---~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~-  301 (423)
T 4fie_A          229 FLEGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-  301 (423)
T ss_dssp             CCTTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC-
T ss_pred             CCCCCcHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEecCccceECCCCC-
Confidence            99999999988653   39999999999999999999999   999999999999999999999999999998775432 


Q ss_pred             cccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCCCCC
Q 016594          224 HHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYD  303 (386)
Q Consensus       224 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (386)
                       ......+||+.|||||++.+..|+.++|||||||++|||++|..||.+.......  ..+..      ...+.+  ...
T Consensus       302 -~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~--~~i~~------~~~~~~--~~~  370 (423)
T 4fie_A          302 -PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAM--KMIRD------NLPPRL--KNL  370 (423)
T ss_dssp             -CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH--HHHHH------SCCCCC--SCT
T ss_pred             -ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHH--HHHHc------CCCCCC--ccc
Confidence             2345678999999999999999999999999999999999999999875432111  11111      011111  112


Q ss_pred             HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          304 VTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       304 ~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                      ...+..+.+||.+||..||++|||+.|+|+|-+..
T Consensus       371 ~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~  405 (423)
T 4fie_A          371 HKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLA  405 (423)
T ss_dssp             TSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGG
T ss_pred             ccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhc
Confidence            23457799999999999999999999999986543

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=3.1e-58  Score=427.53  Aligned_cols=268  Identities=24%  Similarity=0.355  Sum_probs=219.6

Q ss_pred             cCHHHHHHHhcCCCCCCeecccCCcEEEEEEECC------CcEEEEEEeccccCChHhHHHHHHHHHHHhccCC-Cceee
Q 016594           56 FSFEEISIATNAFSSENLVGRGGYAEVYKGVLQD------GEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCH-PNVLS  128 (386)
Q Consensus        56 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~  128 (386)
                      +....|++..++|++.+.||+|+||+||+|.+..      ++.||||.+.... .......+.+|+.+|.++.| ||||+
T Consensus        54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~-~~~~~~~~~~E~~il~~l~hhpnIV~  132 (353)
T 4ase_A           54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVN  132 (353)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-ChHHHHHHHHHHHHHHHcCCCCcEEE
Confidence            4456778888999999999999999999999642      3579999997533 34456779999999999975 89999


Q ss_pred             ecceEEeC--ceEEEEEeccCCCHhhhhhhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEe
Q 016594          129 LLGCCVDN--GLYLIFQFSSRGSVASLFHDVN--------------SPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHR  192 (386)
Q Consensus       129 l~~~~~~~--~~~lv~e~~~~~~L~~~~~~~~--------------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~  192 (386)
                      ++++|.+.  .+++||||+.+|+|.+++....              ...+++..+..++.||+.||+|||+   ++||||
T Consensus       133 l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~---~~iiHR  209 (353)
T 4ase_A          133 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHR  209 (353)
T ss_dssp             EEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCS
T ss_pred             EEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhh---CCeecC
Confidence            99999653  3899999999999999987532              2348999999999999999999999   999999


Q ss_pred             CCCCCCeeEcCCCCeEEeecCccccCCCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHh-CCCCCC
Q 016594          193 DIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVD  271 (386)
Q Consensus       193 dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~  271 (386)
                      ||||+|||++.++.+||+|||+|+.+............+||+.|||||++.+..|+.++|||||||++|||+| |..||.
T Consensus       210 DLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~  289 (353)
T 4ase_A          210 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP  289 (353)
T ss_dssp             CCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred             ccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCC
Confidence            9999999999999999999999997765444344456679999999999999999999999999999999998 999998


Q ss_pred             CCchhhhhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          272 GSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                      +......  .......         ..+...+..++..+.+++.+||+.||++|||+.+|+++|...
T Consensus       290 ~~~~~~~--~~~~i~~---------g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~l  345 (353)
T 4ase_A          290 GVKIDEE--FCRRLKE---------GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL  345 (353)
T ss_dssp             TCCCSHH--HHHHHHH---------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCHHHH--HHHHHHc---------CCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence            7532211  0111111         112223334567899999999999999999999999998654

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=4.4e-58  Score=416.81  Aligned_cols=253  Identities=23%  Similarity=0.268  Sum_probs=203.3

Q ss_pred             cCCCCCCeecccCCcEEEEEEEC----CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEE
Q 016594           66 NAFSSENLVGRGGYAEVYKGVLQ----DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYL  140 (386)
Q Consensus        66 ~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~l  140 (386)
                      ++|++.+.||+|+||+||+|+..    +++.||||++.+..........+.+|+.+|++++|||||++++++.+++ .|+
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i  103 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL  103 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            57999999999999999999863    4788999999865433334456889999999999999999999998866 899


Q ss_pred             EEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCC
Q 016594          141 IFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPS  220 (386)
Q Consensus       141 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~  220 (386)
                      ||||+.||+|.+++.+..  .+++..+..++.||+.||+|||+   ++|+||||||+|||++.+|.+||+|||+|+....
T Consensus       104 vmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~  178 (304)
T 3ubd_A          104 ILDFLRGGDLFTRLSKEV--MFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESID  178 (304)
T ss_dssp             EECCCTTCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTSCEEEESSEEEEC---
T ss_pred             EEEcCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHeEEcCCCCEEecccccceeccC
Confidence            999999999999998654  49999999999999999999999   9999999999999999999999999999986543


Q ss_pred             CCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCC
Q 016594          221 QWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQG  300 (386)
Q Consensus       221 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (386)
                      ..  ....+.+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+....  ...+..         ..  .
T Consensus       179 ~~--~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~--~~~i~~---------~~--~  243 (304)
T 3ubd_A          179 HE--KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKET--MTMILK---------AK--L  243 (304)
T ss_dssp             ----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHH---------CC--C
T ss_pred             CC--ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHH--HHHHHc---------CC--C
Confidence            22  234467899999999999999999999999999999999999999987543211  111111         01  1


Q ss_pred             CCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHHHhcC
Q 016594          301 AYDVTQLNRLAFAASLCIRASPTWRPT-----MSEVLEVMLEG  338 (386)
Q Consensus       301 ~~~~~~~~~l~~li~~cl~~dP~~Rpt-----~~~il~~l~~~  338 (386)
                      ..+...+..+.+||.+||+.||++|||     ++++++|-+..
T Consensus       244 ~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~  286 (304)
T 3ubd_A          244 GMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFS  286 (304)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGT
T ss_pred             CCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCcccc
Confidence            122334577999999999999999998     47888876543

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=4.8e-56  Score=404.74  Aligned_cols=254  Identities=20%  Similarity=0.355  Sum_probs=193.2

Q ss_pred             cCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-------
Q 016594           66 NAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-------  137 (386)
Q Consensus        66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-------  137 (386)
                      ++|++.+.||+|+||+||+|+++ +|+.||||++.... .......+.+|+.+|++++|||||++++++.+.+       
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~   83 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP   83 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence            45889999999999999999986 78999999997533 3445567899999999999999999999986532       


Q ss_pred             ------eEEEEEeccCCCHhhhhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEe
Q 016594          138 ------LYLIFQFSSRGSVASLFHDVNS-PGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQIS  210 (386)
Q Consensus       138 ------~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~  210 (386)
                            .|++|||+.+|+|.+++..... ...++..++.++.||+.||+|||+   ++|+||||||+|||++.++.+||+
T Consensus        84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~---~~IiHRDlKp~NILl~~~~~vKl~  160 (299)
T 4g31_A           84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVG  160 (299)
T ss_dssp             ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEEC
T ss_pred             cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHH---CcCccccCcHHHeEECCCCcEEEc
Confidence                  5899999999999999976433 235667789999999999999999   999999999999999999999999


Q ss_pred             ecCccccCCCCCcc----------ccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhh
Q 016594          211 DFGLAKWLPSQWTH----------HSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSW  280 (386)
Q Consensus       211 Dfg~a~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~  280 (386)
                      |||+|+.+......          ......+||+.|||||++.+..|+.++|||||||++|||++   ||.+........
T Consensus       161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~  237 (299)
T 4g31_A          161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTL  237 (299)
T ss_dssp             CCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHH
T ss_pred             cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHHH
Confidence            99999877543211          12234679999999999999999999999999999999996   886532211111


Q ss_pred             hhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 016594          281 AKPILNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLE  337 (386)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~  337 (386)
                      ..          +..... +......+..+.+||.+||+.||++|||+.+++++-+.
T Consensus       238 ~~----------~~~~~~-p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~  283 (299)
T 4g31_A          238 TD----------VRNLKF-PPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVF  283 (299)
T ss_dssp             HH----------HHTTCC-CHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGG
T ss_pred             HH----------HhcCCC-CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhh
Confidence            00          001000 01112234567889999999999999999999987544

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=2.2e-55  Score=402.14  Aligned_cols=266  Identities=23%  Similarity=0.284  Sum_probs=197.9

Q ss_pred             cCCCCCCeecccCCcEEEEEEECCCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-----eEE
Q 016594           66 NAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-----LYL  140 (386)
Q Consensus        66 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~l  140 (386)
                      ++|.+.+.||+|+||+||+|+++ |+.||||++...   ......+..|+..+.+++|||||++++++.+++     +++
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~~-g~~VAvK~l~~~---~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~l   78 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL   78 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEET-TEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECcc---chhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEE
Confidence            45778899999999999999985 899999998642   222223345666777899999999999997642     699


Q ss_pred             EEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-----CCCCeEEeCCCCCCeeEcCCCCeEEeecCcc
Q 016594          141 IFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKG-----CQRRIIHRDIKSSNILLTADFEPQISDFGLA  215 (386)
Q Consensus       141 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~-----~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a  215 (386)
                      ||||+.+|+|.+++...   .+++..+..++.|++.||+|||+.     +..+|+||||||+|||++.++++||+|||+|
T Consensus        79 V~Ey~~~gsL~~~l~~~---~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla  155 (303)
T 3hmm_A           79 VSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA  155 (303)
T ss_dssp             EEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred             EecCCCCCcHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCC
Confidence            99999999999999753   489999999999999999999972     1138999999999999999999999999999


Q ss_pred             ccCCCCCccc--cccccccccCccChhhhccC------CCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcc
Q 016594          216 KWLPSQWTHH--SIAPIEGTFGHLAPEYFMHG------IVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQ  287 (386)
Q Consensus       216 ~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~  287 (386)
                      +.........  .....+||+.|||||++.+.      .++.++|||||||++|||+||.+||.........+.......
T Consensus       156 ~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~  235 (303)
T 3hmm_A          156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD  235 (303)
T ss_dssp             EEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred             ccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccccc
Confidence            8765432221  22345799999999999764      367899999999999999999888754322110000000000


Q ss_pred             ---cccc-cccCCccCCC-----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          288 ---GEIE-KLVDPRLQGA-----YDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       288 ---~~~~-~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                         ..+. .+.....++.     .+...+..+.+|+.+||+.||++||||.+|++.|...
T Consensus       236 ~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l  295 (303)
T 3hmm_A          236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL  295 (303)
T ss_dssp             CCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred             chHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence               0000 0111112211     1234567899999999999999999999999998754

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.5e-54  Score=407.91  Aligned_cols=269  Identities=18%  Similarity=0.289  Sum_probs=210.1

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEe-------C
Q 016594           65 TNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVD-------N  136 (386)
Q Consensus        65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-------~  136 (386)
                      +++|++.+.||+|+||+||+|+++ +|+.||||++.+..........+++|+.+|+.++|||||++++++..       +
T Consensus        53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~  132 (398)
T 4b99_A           53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK  132 (398)
T ss_dssp             CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred             CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence            357999999999999999999986 79999999998766666667788999999999999999999998753       3


Q ss_pred             ceEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccc
Q 016594          137 GLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAK  216 (386)
Q Consensus       137 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~  216 (386)
                      .+|+||||+. |+|.+++...  ..+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+|+
T Consensus       133 ~~~ivmE~~~-g~L~~~i~~~--~~l~~~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~  206 (398)
T 4b99_A          133 SVYVVLDLME-SDLHQIIHSS--QPLTLEHVRYFLYQLLRGLKYMHS---AQVIHRDLKPSNLLVNENCELKIGDFGMAR  206 (398)
T ss_dssp             CEEEEEECCS-EEHHHHHTSS--SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred             EEEEEEeCCC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CcCcCCCcCccccccCCCCCEEEeecceee
Confidence            4899999996 5798888653  459999999999999999999999   999999999999999999999999999998


Q ss_pred             cCCCCC--ccccccccccccCccChhhhccC-CCCcccchHHHHHHHHHHHhCCCCCCCCchhhhh-hhhhhhcccc---
Q 016594          217 WLPSQW--THHSIAPIEGTFGHLAPEYFMHG-IVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHS-WAKPILNQGE---  289 (386)
Q Consensus       217 ~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~-~~~~~~~~~~---  289 (386)
                      .+....  ......+.+||+.|||||++.+. .|+.++||||+||++|||++|++||.+.+..... .+........   
T Consensus       207 ~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~  286 (398)
T 4b99_A          207 GLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAV  286 (398)
T ss_dssp             CC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred             ecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHH
Confidence            765432  22334567899999999998875 5799999999999999999999999876532111 1100000000   


Q ss_pred             --------cccccCCc-cCCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCC
Q 016594          290 --------IEKLVDPR-LQGAYD-----VTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEGD  339 (386)
Q Consensus       290 --------~~~~~~~~-~~~~~~-----~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~~  339 (386)
                              ....+... .....+     ...+..+.+||.+||..||++|||+.++|+|-+...
T Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~  350 (398)
T 4b99_A          287 IQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAK  350 (398)
T ss_dssp             TC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTT
T ss_pred             hhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCc
Confidence                    00000000 000011     112467899999999999999999999999976654

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=3.1e-53  Score=396.29  Aligned_cols=263  Identities=24%  Similarity=0.344  Sum_probs=201.0

Q ss_pred             HhcCCCCCCeecccCCcEEEEEEEC----CCcEEEEEEeccccCChHhHHHHHHHHHHHhcc-CCCceeeecceEEeCc-
Q 016594           64 ATNAFSSENLVGRGGYAEVYKGVLQ----DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHV-CHPNVLSLLGCCVDNG-  137 (386)
Q Consensus        64 ~~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~-  137 (386)
                      ..++|++.+.||+|+||+||+|+.+    +++.||+|.+...    .....+.+|+++|+.+ +||||+++++++.+++ 
T Consensus        19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~----~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~   94 (361)
T 4f9c_A           19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT----SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDH   94 (361)
T ss_dssp             GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT----SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTE
T ss_pred             ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc----cCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCE
Confidence            4678999999999999999999863    4678999998653    2345678999999988 5999999999998766 


Q ss_pred             eEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCC-CCeEEeecCccc
Q 016594          138 LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTAD-FEPQISDFGLAK  216 (386)
Q Consensus       138 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~-~~~kl~Dfg~a~  216 (386)
                      .|+||||+.+|+|.+++.     .+++..+..++.||+.||+|||+   +||+||||||+|||++.+ +.+||+|||+|+
T Consensus        95 ~~lvmE~~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH~---~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~  166 (361)
T 4f9c_A           95 VVIAMPYLEHESFLDILN-----SLSFQEVREYMLNLFKALKRIHQ---FGIVHRDVKPSNFLYNRRLKKYALVDFGLAQ  166 (361)
T ss_dssp             EEEEEECCCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             EEEEEeCCCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCcCCHHHeEEeCCCCeEEECcCCCCc
Confidence            899999999999999884     38999999999999999999999   999999999999999876 799999999998


Q ss_pred             cCCCCCc--------------------------cccccccccccCccChhhhccC-CCCcccchHHHHHHHHHHHhCCCC
Q 016594          217 WLPSQWT--------------------------HHSIAPIEGTFGHLAPEYFMHG-IVDEKTDVFAFGVFLLEIISGRKP  269 (386)
Q Consensus       217 ~~~~~~~--------------------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~p  269 (386)
                      .......                          .....+.+||+.|+|||++.+. .|+.++||||+||++|||++|+.|
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~P  246 (361)
T 4f9c_A          167 GTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYP  246 (361)
T ss_dssp             ECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSS
T ss_pred             ccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCC
Confidence            6543211                          1122346799999999999875 589999999999999999999999


Q ss_pred             CCCCchhhhhhhhhhhccc------------------------ccccc------cC---Ccc---------CCCCCHHHH
Q 016594          270 VDGSHQSLHSWAKPILNQG------------------------EIEKL------VD---PRL---------QGAYDVTQL  307 (386)
Q Consensus       270 f~~~~~~~~~~~~~~~~~~------------------------~~~~~------~~---~~~---------~~~~~~~~~  307 (386)
                      |.................+                        .....      .+   +..         ........+
T Consensus       247 f~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is  326 (361)
T 4f9c_A          247 FYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVP  326 (361)
T ss_dssp             SSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCC
T ss_pred             CCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCC
Confidence            9655432221111000000                        00000      00   000         000011234


Q ss_pred             HHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          308 NRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       308 ~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                      ..+.+|+.+||..||++|||+.|+|+|-+..
T Consensus       327 ~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~  357 (361)
T 4f9c_A          327 DEAYDLLDKLLDLNPASRITAEEALLHPFFK  357 (361)
T ss_dssp             HHHHHHHHHHTCSCTTTSCCHHHHHTSGGGT
T ss_pred             HHHHHHHHHHCcCChhHCcCHHHHhcCcccC
Confidence            6789999999999999999999999986653

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=3e-52  Score=410.52  Aligned_cols=256  Identities=21%  Similarity=0.233  Sum_probs=206.3

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccC----ChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-e
Q 016594           65 TNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVT----DDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-L  138 (386)
Q Consensus        65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~  138 (386)
                      -++|++.++||+|+||+||+|+.+ +|+.||||++.+...    ..........++.+++.++|||||+++++|.+.+ +
T Consensus       188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l  267 (689)
T 3v5w_A          188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL  267 (689)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence            467999999999999999999987 699999999975321    1112223344567778889999999999998866 9


Q ss_pred             EEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccC
Q 016594          139 YLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWL  218 (386)
Q Consensus       139 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~  218 (386)
                      |+||||+.||+|..++....  .+++..+..++.||+.||+|||+   ++||||||||+||||+.+|++||+|||+|..+
T Consensus       268 ylVmEy~~GGdL~~~l~~~~--~l~E~~a~~y~~qIl~aL~yLH~---~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~  342 (689)
T 3v5w_A          268 SFILDLMNGGDLHYHLSQHG--VFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDF  342 (689)
T ss_dssp             EEEECCCCSCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHeEEeCCCCEEecccceeeec
Confidence            99999999999999998654  49999999999999999999999   99999999999999999999999999999877


Q ss_pred             CCCCccccccccccccCccChhhhcc-CCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCc
Q 016594          219 PSQWTHHSIAPIEGTFGHLAPEYFMH-GIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPR  297 (386)
Q Consensus       219 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (386)
                      ...    ...+.+||+.|||||++.+ ..|+.++|||||||++|||++|.+||.+...........        .+... 
T Consensus       343 ~~~----~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~--------~i~~~-  409 (689)
T 3v5w_A          343 SKK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR--------MTLTM-  409 (689)
T ss_dssp             SSC----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHH--------HHHHC-
T ss_pred             CCC----CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH--------hhcCC-
Confidence            543    2345789999999999974 579999999999999999999999997643211110000        00011 


Q ss_pred             cCCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHHHhcCC
Q 016594          298 LQGAYDVTQLNRLAFAASLCIRASPTWRPT-----MSEVLEVMLEGD  339 (386)
Q Consensus       298 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt-----~~~il~~l~~~~  339 (386)
                       ...++...+..+.+||.+||..||.+|++     +.+|++|-+...
T Consensus       410 -~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~  455 (689)
T 3v5w_A          410 -AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS  455 (689)
T ss_dssp             -CCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTT
T ss_pred             -CCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccC
Confidence             11223345678999999999999999998     799999876543

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=6.3e-51  Score=402.62  Aligned_cols=255  Identities=22%  Similarity=0.286  Sum_probs=210.7

Q ss_pred             cCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEEE
Q 016594           66 NAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQ  143 (386)
Q Consensus        66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~e  143 (386)
                      ++|++.+.||+|+||+||+|..+ +|+.||+|++...  .......+.+|+.+|+.++|||||++++++.+++ +|++||
T Consensus       157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~--~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E  234 (573)
T 3uto_A          157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP--HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE  234 (573)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEecc--chhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence            67999999999999999999987 7999999998753  2444567889999999999999999999998866 899999


Q ss_pred             eccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCC--CCeEEeecCccccCCCC
Q 016594          144 FSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTAD--FEPQISDFGLAKWLPSQ  221 (386)
Q Consensus       144 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~--~~~kl~Dfg~a~~~~~~  221 (386)
                      |+.||+|.+++.... ..+++..+..++.||+.||+|||+   ++|+||||||+|||++.+  +.+||+|||+|+.+...
T Consensus       235 ~~~gg~L~~~i~~~~-~~l~e~~~~~~~~qi~~al~ylH~---~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~  310 (573)
T 3uto_A          235 FMSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK  310 (573)
T ss_dssp             CCCCCBHHHHHTCTT-SCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT
T ss_pred             ecCCCcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhccccCCCCCCEEEeeccceeEccCC
Confidence            999999999886432 349999999999999999999999   999999999999999854  89999999999987644


Q ss_pred             CccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCCC
Q 016594          222 WTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGA  301 (386)
Q Consensus       222 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (386)
                      .   .....+||+.|||||++.+..|+.++|||||||++|+|++|..||.+.......  ..+...       .......
T Consensus       311 ~---~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~--~~i~~~-------~~~~~~~  378 (573)
T 3uto_A          311 Q---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETL--RNVKSC-------DWNMDDS  378 (573)
T ss_dssp             S---EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH--HHHHTT-------CCCCCSG
T ss_pred             C---ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHH--HHHHhC-------CCCCCcc
Confidence            2   334567999999999999999999999999999999999999999876542211  111000       0000111


Q ss_pred             CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          302 YDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       302 ~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                      .....+..+.+||.+||..||.+|||+.++|+|-+..
T Consensus       379 ~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~  415 (573)
T 3uto_A          379 AFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLT  415 (573)
T ss_dssp             GGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTS
T ss_pred             cccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcC
Confidence            1122356789999999999999999999999986544

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=3.2e-50  Score=372.78  Aligned_cols=288  Identities=42%  Similarity=0.749  Sum_probs=240.2

Q ss_pred             CCccccCHHHHHHHhcCCCCCCeecccCCcEEEEEEECCCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeec
Q 016594           51 PTWRCFSFEEISIATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLL  130 (386)
Q Consensus        51 ~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~  130 (386)
                      ...+.+++.++....++|++.+.||+|+||.||+|.+++++.||||++..... ......+.+|+.+++.++||||++++
T Consensus        15 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~   93 (326)
T 3uim_A           15 GQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLR   93 (326)
T ss_dssp             CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC------CCCHHHHHHHGGGTCCCTTBCCCC
T ss_pred             CccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccC-chHHHHHHHHHHHHHhccCCCccceE
Confidence            34567888999999999999999999999999999987899999999875322 22233688999999999999999999


Q ss_pred             ceEEeCc-eEEEEEeccCCCHhhhhhhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCe
Q 016594          131 GCCVDNG-LYLIFQFSSRGSVASLFHDVNS--PGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEP  207 (386)
Q Consensus       131 ~~~~~~~-~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~  207 (386)
                      +++.+.. .++||||+.+++|.+++.....  ..+++..++.++.|++.||.|||+.+..+|+||||||+|||++.++.+
T Consensus        94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~  173 (326)
T 3uim_A           94 GFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEA  173 (326)
T ss_dssp             EEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCE
T ss_pred             EEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCE
Confidence            9997655 8999999999999999876543  348999999999999999999999211299999999999999999999


Q ss_pred             EEeecCccccCCCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCC------Cchhhhhhh
Q 016594          208 QISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDG------SHQSLHSWA  281 (386)
Q Consensus       208 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~------~~~~~~~~~  281 (386)
                      ||+|||++........ .......||+.|+|||++.+..++.++|||||||++|+|++|..||..      .......+.
T Consensus       174 kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  252 (326)
T 3uim_A          174 VVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV  252 (326)
T ss_dssp             EECCCSSCEECCSSSS-CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHH
T ss_pred             EeccCccccccCcccc-cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHH
Confidence            9999999987754322 233445699999999999999999999999999999999999999952      122333445


Q ss_pred             hhhhcccccccccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCCc
Q 016594          282 KPILNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEGDQ  340 (386)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~~~  340 (386)
                      ...........+.+...........+..+.+++.+||+.||.+|||+.+|+++|+....
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~  311 (326)
T 3uim_A          253 KGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGL  311 (326)
T ss_dssp             TTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSC
T ss_pred             HHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcch
Confidence            55555556666777777777888889999999999999999999999999999987544

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=7.5e-50  Score=369.63  Aligned_cols=276  Identities=38%  Similarity=0.666  Sum_probs=230.4

Q ss_pred             HHHHHhcCCCCCCeecccCCcEEEEEEECCCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-e
Q 016594           60 EISIATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-L  138 (386)
Q Consensus        60 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~  138 (386)
                      ++....++|++.+.||+|+||.||+|.+++++.||||++...  .......+.+|+.+++.++||||+++++++.+.+ .
T Consensus        33 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  110 (321)
T 2qkw_B           33 DLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPE--SSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEM  110 (321)
T ss_dssp             CCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSC--CSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCC
T ss_pred             HHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEeccc--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeE
Confidence            344567899999999999999999999888999999988753  2334567899999999999999999999997655 8


Q ss_pred             EEEEEeccCCCHhhhhhhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccc
Q 016594          139 YLIFQFSSRGSVASLFHDVNS--PGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAK  216 (386)
Q Consensus       139 ~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~  216 (386)
                      ++||||+.+++|.+++.....  ..+++..++.++.|++.||.|||+   ++|+||||||+||+++.++.+||+|||++.
T Consensus       111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~  187 (321)
T 2qkw_B          111 ILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT---RAIIHRDVKSINILLDENFVPKITDFGISK  187 (321)
T ss_dssp             EEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCSTTEEECTTCCEEECCCTTCE
T ss_pred             EEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcC---CCeecCCCCHHHEEECCCCCEEEeeccccc
Confidence            999999999999998865433  348999999999999999999999   999999999999999999999999999998


Q ss_pred             cCCCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchh----hhhhhhhhhccccccc
Q 016594          217 WLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQS----LHSWAKPILNQGEIEK  292 (386)
Q Consensus       217 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~----~~~~~~~~~~~~~~~~  292 (386)
                      ...............||+.|+|||++.+..++.++|||||||++|+|++|+.||.+....    ...|.........+..
T Consensus       188 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  267 (321)
T 2qkw_B          188 KGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQ  267 (321)
T ss_dssp             ECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCS
T ss_pred             ccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHH
Confidence            755433333334456899999999999999999999999999999999999999764321    2223233333444556


Q ss_pred             ccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCCc
Q 016594          293 LVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEGDQ  340 (386)
Q Consensus       293 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~~~  340 (386)
                      .+++..........+..+.+++.+||+.||++|||+.+++++|+....
T Consensus       268 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~  315 (321)
T 2qkw_B          268 IVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR  315 (321)
T ss_dssp             SSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             hcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhh
Confidence            666666667778889999999999999999999999999999986543

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=1.1e-48  Score=362.40  Aligned_cols=255  Identities=23%  Similarity=0.368  Sum_probs=214.1

Q ss_pred             HhcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEE
Q 016594           64 ATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLI  141 (386)
Q Consensus        64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv  141 (386)
                      ..++|++.+.||+|+||.||+|.+. +|+.||||++............+.+|+.+++.++||||+++++++.+.+ .++|
T Consensus        13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv   92 (328)
T 3fe3_A           13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI   92 (328)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence            3467999999999999999999985 7999999999876666667778999999999999999999999998765 8999


Q ss_pred             EEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCC
Q 016594          142 FQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQ  221 (386)
Q Consensus       142 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  221 (386)
                      |||+.+++|.+++....  .+++..++.++.|++.||+|||+   ++|+||||||+|||++.++.+||+|||++......
T Consensus        93 ~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  167 (328)
T 3fe3_A           93 MEYASGGEVFDYLVAHG--RMKEKEARSKFRQIVSAVQYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG  167 (328)
T ss_dssp             ECCCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS
T ss_pred             EECCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCCHHHEEEcCCCCEEEeeccCceecCCC
Confidence            99999999999987654  38999999999999999999999   99999999999999999999999999999866543


Q ss_pred             CccccccccccccCccChhhhccCCCC-cccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCC
Q 016594          222 WTHHSIAPIEGTFGHLAPEYFMHGIVD-EKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQG  300 (386)
Q Consensus       222 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (386)
                         ......+||+.|+|||++.+..+. .++|||||||++|+|++|..||.+.......  ..+..         ..  .
T Consensus       168 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~--~~i~~---------~~--~  231 (328)
T 3fe3_A          168 ---GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELR--ERVLR---------GK--Y  231 (328)
T ss_dssp             ---CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH--HHHHH---------CC--C
T ss_pred             ---CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHH--HHHHh---------CC--C
Confidence               233456799999999999988775 8999999999999999999999876432111  11110         00  0


Q ss_pred             CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCC
Q 016594          301 AYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEGD  339 (386)
Q Consensus       301 ~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~~  339 (386)
                      ..+...+..+.+++.+||..||.+|||+.+++++-+...
T Consensus       232 ~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~  270 (328)
T 3fe3_A          232 RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINA  270 (328)
T ss_dssp             CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTT
T ss_pred             CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcC
Confidence            112234567899999999999999999999999866543

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=1.3e-48  Score=368.16  Aligned_cols=260  Identities=24%  Similarity=0.405  Sum_probs=212.9

Q ss_pred             HhcCCCCCCeecccCCcEEEEEEEC--------CCcEEEEEEeccccCChHhHHHHHHHHHHHhcc-CCCceeeecceEE
Q 016594           64 ATNAFSSENLVGRGGYAEVYKGVLQ--------DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHV-CHPNVLSLLGCCV  134 (386)
Q Consensus        64 ~~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~  134 (386)
                      ..++|++.+.||+|+||.||+|.+.        ++..||||++... ........+.+|+.+++.+ +||||+++++++.
T Consensus        79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~  157 (370)
T 2psq_A           79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT  157 (370)
T ss_dssp             CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTT-CBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEEC
T ss_pred             cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCC-cCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEc
Confidence            4578999999999999999999852        3457999999754 3345567899999999999 7999999999997


Q ss_pred             eCc-eEEEEEeccCCCHhhhhhhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCe
Q 016594          135 DNG-LYLIFQFSSRGSVASLFHDVNS--------------PGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNI  199 (386)
Q Consensus       135 ~~~-~~lv~e~~~~~~L~~~~~~~~~--------------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Ni  199 (386)
                      +.+ .++||||+.+|+|.+++.....              ..+++..++.++.||+.||.|||+   ++|+||||||+||
T Consensus       158 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NI  234 (370)
T 2psq_A          158 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNV  234 (370)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGE
T ss_pred             cCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchhhE
Confidence            655 8999999999999999876532              348899999999999999999999   9999999999999


Q ss_pred             eEcCCCCeEEeecCccccCCCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCchhhh
Q 016594          200 LLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLH  278 (386)
Q Consensus       200 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~  278 (386)
                      |++.++.+||+|||++..+.............+|+.|+|||++.+..++.++|||||||++|||++ |..||.+......
T Consensus       235 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~  314 (370)
T 2psq_A          235 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL  314 (370)
T ss_dssp             EECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH
T ss_pred             EECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence            999999999999999987654433233344557889999999999999999999999999999999 9999987543211


Q ss_pred             hhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCC
Q 016594          279 SWAKPILNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEGD  339 (386)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~~  339 (386)
                      .            ..+........+..++..+.+++.+||+.||.+||++.++++.|....
T Consensus       315 ~------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il  363 (370)
T 2psq_A          315 F------------KLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL  363 (370)
T ss_dssp             H------------HHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             H------------HHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            1            011111112223345577999999999999999999999999987653

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=4.9e-48  Score=353.56  Aligned_cols=254  Identities=20%  Similarity=0.340  Sum_probs=210.0

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEE
Q 016594           65 TNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIF  142 (386)
Q Consensus        65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~  142 (386)
                      .++|++.+.||+|+||+||+|.+. +++.||||++.....  .....+.+|+.+++.++||||+++++++..++ .++||
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   96 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ--PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM   96 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGC--SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccc--cHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEE
Confidence            468999999999999999999965 789999999875432  23456889999999999999999999998765 89999


Q ss_pred             EeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCC
Q 016594          143 QFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQW  222 (386)
Q Consensus       143 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  222 (386)
                      ||+.+++|.+++...   .+++..++.++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||++.......
T Consensus        97 e~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  170 (297)
T 3fxz_A           97 EYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ  170 (297)
T ss_dssp             ECCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred             ECCCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc
Confidence            999999999998754   48999999999999999999999   999999999999999999999999999998765432


Q ss_pred             ccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCCCC
Q 016594          223 THHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAY  302 (386)
Q Consensus       223 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (386)
                      .  ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+..........  ....        ......
T Consensus       171 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~--~~~~--------~~~~~~  238 (297)
T 3fxz_A          171 S--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI--ATNG--------TPELQN  238 (297)
T ss_dssp             C--CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH--HHHC--------SCCCSC
T ss_pred             c--ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--HhCC--------CCCCCC
Confidence            2  234567999999999999999999999999999999999999999875432211111  0000        001112


Q ss_pred             CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          303 DVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       303 ~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                      +...+..+.+++.+||+.||++|||+.+++++.+..
T Consensus       239 ~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~  274 (297)
T 3fxz_A          239 PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLK  274 (297)
T ss_dssp             GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGG
T ss_pred             ccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhc
Confidence            233457799999999999999999999999976543

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=5.5e-49  Score=361.80  Aligned_cols=262  Identities=25%  Similarity=0.426  Sum_probs=206.9

Q ss_pred             HHHHHhcCCCCCCeecccCCcEEEEEEECCCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-e
Q 016594           60 EISIATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-L  138 (386)
Q Consensus        60 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~  138 (386)
                      .+.+..++|++.+.||+|+||+||+|.+. ++.||||++............+.+|+.++++++||||+++++++.+.. .
T Consensus        31 ~~~i~~~~y~i~~~lG~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~  109 (309)
T 3p86_A           31 DMDIPWCDLNIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNL  109 (309)
T ss_dssp             -CBCCGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCC
T ss_pred             cccCChhHceeeeEeecCCCeEEEEEEEC-CCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCce
Confidence            33456678999999999999999999884 889999999876666666778999999999999999999999997755 8


Q ss_pred             EEEEEeccCCCHhhhhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEEeCCCCCCeeEcCCCCeEEeecCcc
Q 016594          139 YLIFQFSSRGSVASLFHDVNS-PGVEWKVRHKIAVGTARGLHYLHKGCQRR--IIHRDIKSSNILLTADFEPQISDFGLA  215 (386)
Q Consensus       139 ~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~--ivH~dlkp~Nill~~~~~~kl~Dfg~a  215 (386)
                      ++||||+.+++|.+++..... ..+++..++.++.|++.||+|||+   ++  |+||||||+|||++.++.+||+|||++
T Consensus       110 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a  186 (309)
T 3p86_A          110 SIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN---RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLS  186 (309)
T ss_dssp             EEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHT---SSSCCCCTTCCGGGEEECTTCCEEECCCC--
T ss_pred             EEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHc---CCCCEECCCCChhhEEEeCCCcEEECCCCCC
Confidence            999999999999999875432 238999999999999999999999   88  999999999999999999999999999


Q ss_pred             ccCCCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccC
Q 016594          216 KWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVD  295 (386)
Q Consensus       216 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  295 (386)
                      .......  .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+..........  ..         
T Consensus       187 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~--~~---------  253 (309)
T 3p86_A          187 RLKASTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAV--GF---------  253 (309)
T ss_dssp             -----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHH--HH---------
T ss_pred             ccccccc--cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--Hh---------
Confidence            7654321  1233456999999999999999999999999999999999999999875432211100  00         


Q ss_pred             CccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          296 PRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       296 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                      .......+...+..+.+++.+||+.||.+|||+.++++.|+..
T Consensus       254 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~  296 (309)
T 3p86_A          254 KCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPL  296 (309)
T ss_dssp             SCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             cCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            0011122233456799999999999999999999999988754

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=1.3e-48  Score=359.39  Aligned_cols=260  Identities=24%  Similarity=0.400  Sum_probs=209.8

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEE
Q 016594           65 TNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIF  142 (386)
Q Consensus        65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~  142 (386)
                      .++|.+.+.||+|+||+||+|.+. +++.||+|.+..  ........+.+|+.++++++||||+++++++.+++ .++||
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   86 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR--FDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFIT   86 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESC--CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEecc--CCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEE
Confidence            467889999999999999999986 689999998864  34566778999999999999999999999998766 89999


Q ss_pred             EeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCC
Q 016594          143 QFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQW  222 (386)
Q Consensus       143 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  222 (386)
                      ||+.+++|.+++... ...+++..++.++.|++.||+|||+   ++|+||||||+|||++.++.+||+|||++.......
T Consensus        87 e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  162 (310)
T 3s95_A           87 EYIKGGTLRGIIKSM-DSQYPWSQRVSFAKDIASGMAYLHS---MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEK  162 (310)
T ss_dssp             ECCTTCBHHHHHHHC-CTTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEECTTSCEEECCCTTCEECC---
T ss_pred             EecCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCcCeEEECCCCCEEEeecccceeccccc
Confidence            999999999999764 3458999999999999999999999   999999999999999999999999999998765432


Q ss_pred             ccc------------cccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhccccc
Q 016594          223 THH------------SIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEI  290 (386)
Q Consensus       223 ~~~------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  290 (386)
                      ...            ......||+.|+|||++.+..++.++|||||||++|+|++|..||............      ..
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~------~~  236 (310)
T 3s95_A          163 TQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGL------NV  236 (310)
T ss_dssp             -----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSB------CH
T ss_pred             ccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhh------hh
Confidence            211            112457999999999999999999999999999999999999998754221100000      00


Q ss_pred             ccccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCCc
Q 016594          291 EKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEGDQ  340 (386)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~~~  340 (386)
                      .....    ...+..++..+.+++.+||+.||++|||+.++++.|+....
T Consensus       237 ~~~~~----~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~  282 (310)
T 3s95_A          237 RGFLD----RYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRM  282 (310)
T ss_dssp             HHHHH----HTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             hcccc----ccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence            00000    11122234568999999999999999999999998876543

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=1.6e-48  Score=360.87  Aligned_cols=261  Identities=22%  Similarity=0.267  Sum_probs=209.6

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEE
Q 016594           65 TNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIF  142 (386)
Q Consensus        65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~  142 (386)
                      .++|++.+.||+|+||+||+|.+. +++.||||++..... ......+.+|+.+++.++||||+++++++.+++ .++||
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~   84 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL   84 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc-cchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence            468999999999999999999987 789999999865322 223456789999999999999999999998766 79999


Q ss_pred             EeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCC
Q 016594          143 QFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQW  222 (386)
Q Consensus       143 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  222 (386)
                      ||+.+++|.+++...  ..+++..++.++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||++..+....
T Consensus        85 e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  159 (323)
T 3tki_A           85 EYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN  159 (323)
T ss_dssp             ECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred             EcCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCccccccchHHEEEeCCCCEEEEEeeccceeccCC
Confidence            999999999988643  349999999999999999999999   999999999999999999999999999998765433


Q ss_pred             ccccccccccccCccChhhhccCCC-CcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCCC
Q 016594          223 THHSIAPIEGTFGHLAPEYFMHGIV-DEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGA  301 (386)
Q Consensus       223 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (386)
                      .........||+.|+|||++.+..+ +.++|||||||++|+|++|..||.........+....          .......
T Consensus       160 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~----------~~~~~~~  229 (323)
T 3tki_A          160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWK----------EKKTYLN  229 (323)
T ss_dssp             EECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHH----------TTCTTST
T ss_pred             cccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh----------cccccCC
Confidence            3333456679999999999988775 7899999999999999999999986543221111100          0000111


Q ss_pred             CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCCcc
Q 016594          302 YDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEGDQI  341 (386)
Q Consensus       302 ~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~~~~  341 (386)
                      .....+..+.+++.+||+.||++|||+.+++++.+.....
T Consensus       230 ~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~  269 (323)
T 3tki_A          230 PWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL  269 (323)
T ss_dssp             TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred             ccccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhcccc
Confidence            1123456788999999999999999999999987766543

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=2.3e-48  Score=360.64  Aligned_cols=258  Identities=26%  Similarity=0.424  Sum_probs=204.5

Q ss_pred             HhcCCCCCCeecccCCcEEEEEEEC-CCcE----EEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCce
Q 016594           64 ATNAFSSENLVGRGGYAEVYKGVLQ-DGEE----IAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNGL  138 (386)
Q Consensus        64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~----vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  138 (386)
                      ..++|++.+.||+|+||+||+|.+. +++.    ||+|.+... ........+.+|+.++++++||||+++++++.++..
T Consensus        13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   91 (327)
T 3poz_A           13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTV   91 (327)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC--------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSSE
T ss_pred             CHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccc-cCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCe
Confidence            3467899999999999999999975 4444    577777542 233455778999999999999999999999999889


Q ss_pred             EEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccC
Q 016594          139 YLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWL  218 (386)
Q Consensus       139 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~  218 (386)
                      +++++++.+|+|.+++.... ..+++..++.++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||++..+
T Consensus        92 ~~v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~  167 (327)
T 3poz_A           92 QLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLL  167 (327)
T ss_dssp             EEEEECCTTCBHHHHHHHST-TSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred             EEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCChheEEECCCCCEEEccCcceeEc
Confidence            99999999999999887643 458999999999999999999999   99999999999999999999999999999877


Q ss_pred             CCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCchhhhhhhhhhhcccccccccCCc
Q 016594          219 PSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGEIEKLVDPR  297 (386)
Q Consensus       219 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (386)
                      .............+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+......            ...+...
T Consensus       168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~------------~~~~~~~  235 (327)
T 3poz_A          168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI------------SSILEKG  235 (327)
T ss_dssp             TTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH------------HHHHHTT
T ss_pred             cCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHH------------HHHHHcC
Confidence            55433333344557889999999999999999999999999999999 9999987543211            1111111


Q ss_pred             cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          298 LQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       298 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                      .....+..++..+.+++.+||+.||.+||++.+++++|...
T Consensus       236 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~  276 (327)
T 3poz_A          236 ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM  276 (327)
T ss_dssp             CCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHH
T ss_pred             CCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence            12222333456799999999999999999999999998664

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=3e-47  Score=357.02  Aligned_cols=258  Identities=21%  Similarity=0.263  Sum_probs=210.1

Q ss_pred             HhcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCCh----HhHHHHHHHHHHHhccCCCceeeecceEEeCc-
Q 016594           64 ATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDD----RKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-  137 (386)
Q Consensus        64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-  137 (386)
                      ..+.|++.+.||+|+||+||+|..+ +|+.||+|++.+.....    .....+.+|+.+++.+.||||+++++++.+.. 
T Consensus        10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~   89 (361)
T 2yab_A           10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD   89 (361)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence            3567999999999999999999987 68999999998643222    23567899999999999999999999998765 


Q ss_pred             eEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCC----CeEEeecC
Q 016594          138 LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADF----EPQISDFG  213 (386)
Q Consensus       138 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~----~~kl~Dfg  213 (386)
                      .++||||+.+|+|.+++...  ..+++..+..++.||+.||.|||+   ++|+||||||+|||++.++    .+||+|||
T Consensus        90 ~~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~~~vkl~DFG  164 (361)
T 2yab_A           90 VVLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFG  164 (361)
T ss_dssp             EEEEEECCCSCBHHHHHTTC--SCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEECCCS
T ss_pred             EEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEeCCCCCccCEEEEecC
Confidence            89999999999999998653  359999999999999999999999   9999999999999998776    79999999


Q ss_pred             ccccCCCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccc
Q 016594          214 LAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKL  293 (386)
Q Consensus       214 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  293 (386)
                      ++..+....   .....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.......  ..+.. ...   
T Consensus       165 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~--~~i~~-~~~---  235 (361)
T 2yab_A          165 LAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL--ANITA-VSY---  235 (361)
T ss_dssp             SCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH--HHHHT-TCC---
T ss_pred             CceEcCCCC---ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHh-cCC---
Confidence            998765432   234567999999999999999999999999999999999999999875432111  00000 000   


Q ss_pred             cCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          294 VDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       294 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                         ..........+..+.++|.+||..||.+|||+.++++|.+..
T Consensus       236 ---~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~  277 (361)
T 2yab_A          236 ---DFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWIT  277 (361)
T ss_dssp             ---CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTS
T ss_pred             ---CCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcC
Confidence               000000012346799999999999999999999999986654

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=2.1e-47  Score=354.95  Aligned_cols=254  Identities=23%  Similarity=0.267  Sum_probs=210.1

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccC-ChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEE
Q 016594           65 TNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVT-DDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLI  141 (386)
Q Consensus        65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv  141 (386)
                      .++|++.+.||+|+||+||+|+.+ +|+.||+|++.+... .......+.+|+.+++.++||||+++++++.+.+ .++|
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv   83 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence            467899999999999999999987 689999999975321 2234567889999999999999999999998765 8999


Q ss_pred             EEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCC
Q 016594          142 FQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQ  221 (386)
Q Consensus       142 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  221 (386)
                      |||+.+|+|..++....  .+++..++.++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||++......
T Consensus        84 ~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~  158 (337)
T 1o6l_A           84 MEYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD  158 (337)
T ss_dssp             EECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred             EeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCCHHHEEECCCCCEEEeeccchhhcccC
Confidence            99999999999887643  48999999999999999999999   99999999999999999999999999999864322


Q ss_pred             CccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCCC
Q 016594          222 WTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGA  301 (386)
Q Consensus       222 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (386)
                        .......+||+.|+|||++.+..++.++|||||||++|||++|..||.+......  ...+..         ..  ..
T Consensus       159 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~--~~~i~~---------~~--~~  223 (337)
T 1o6l_A          159 --GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL--FELILM---------EE--IR  223 (337)
T ss_dssp             --TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHH---------CC--CC
T ss_pred             --CCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHH--HHHHHc---------CC--CC
Confidence              1233456799999999999999999999999999999999999999987543211  111111         00  11


Q ss_pred             CCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHHhcC
Q 016594          302 YDVTQLNRLAFAASLCIRASPTWRP-----TMSEVLEVMLEG  338 (386)
Q Consensus       302 ~~~~~~~~l~~li~~cl~~dP~~Rp-----t~~~il~~l~~~  338 (386)
                      ++...+..+.++|.+||+.||++||     ++.+|++|-+..
T Consensus       224 ~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~  265 (337)
T 1o6l_A          224 FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFL  265 (337)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGT
T ss_pred             CCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcC
Confidence            2223457799999999999999999     899999986554

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=1.7e-47  Score=352.31  Aligned_cols=268  Identities=21%  Similarity=0.288  Sum_probs=204.5

Q ss_pred             HhcCCCCCCeecccCCcEEEEEEECCCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEE
Q 016594           64 ATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIF  142 (386)
Q Consensus        64 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~  142 (386)
                      ..++|++.+.||+|+||+||+|.+.+++.||+|++............+.+|+.+++.++||||+++++++.++. .++||
T Consensus        19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   98 (311)
T 3niz_A           19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF   98 (311)
T ss_dssp             SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred             hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence            34679999999999999999999988999999999765444445677889999999999999999999997755 89999


Q ss_pred             EeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCC
Q 016594          143 QFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQW  222 (386)
Q Consensus       143 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  222 (386)
                      ||+.+ +|.+.+... ...+++..++.++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||++.......
T Consensus        99 e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~  173 (311)
T 3niz_A           99 EFMEK-DLKKVLDEN-KTGLQDSQIKIYLYQLLRGVAHCHQ---HRILHRDLKPQNLLINSDGALKLADFGLARAFGIPV  173 (311)
T ss_dssp             ECCSE-EHHHHHHTC-TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCC
T ss_pred             cCCCC-CHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCchHhEEECCCCCEEEccCcCceecCCCc
Confidence            99986 777777653 3458999999999999999999999   999999999999999999999999999998765332


Q ss_pred             ccccccccccccCccChhhhcc-CCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhh-hhhhhhccccc---c------
Q 016594          223 THHSIAPIEGTFGHLAPEYFMH-GIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHS-WAKPILNQGEI---E------  291 (386)
Q Consensus       223 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~-~~~~~~~~~~~---~------  291 (386)
                        .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+....... ...........   .      
T Consensus       174 --~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  251 (311)
T 3niz_A          174 --RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELP  251 (311)
T ss_dssp             --C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSH
T ss_pred             --ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccc
Confidence              22334568999999999876 56899999999999999999999999865432111 11100000000   0      


Q ss_pred             -------cccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          292 -------KLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       292 -------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                             ...............+..+.+++.+||+.||++|||+.+++++-+..
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~  305 (311)
T 3niz_A          252 LWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFK  305 (311)
T ss_dssp             HHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGT
T ss_pred             hhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccc
Confidence                   00000000000112246789999999999999999999999986553

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=9.3e-49  Score=378.97  Aligned_cols=262  Identities=23%  Similarity=0.374  Sum_probs=216.5

Q ss_pred             HHHHHHhcCCCCCCeecccCCcEEEEEEECCCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCce
Q 016594           59 EEISIATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNGL  138 (386)
Q Consensus        59 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  138 (386)
                      ..+.+..++|++.+.||+|+||+||+|.++++..||||++....   .....+.+|+.++++++||||+++++++..+..
T Consensus       181 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~  257 (454)
T 1qcf_A          181 DAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS---MSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPI  257 (454)
T ss_dssp             TCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS---BCHHHHHHHHHHHTTCCCTTBCCEEEEECSSSC
T ss_pred             cceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC---ccHHHHHHHHHHHhhCCCCCEeeEEEEEeCCcc
Confidence            33456778899999999999999999999888899999997532   245678999999999999999999999987779


Q ss_pred             EEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccC
Q 016594          139 YLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWL  218 (386)
Q Consensus       139 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~  218 (386)
                      ++||||+.+|+|.+++.......+++..++.++.|++.||+|||+   ++|+||||||+|||++.++.+||+|||++...
T Consensus       258 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~  334 (454)
T 1qcf_A          258 YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVI  334 (454)
T ss_dssp             EEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTCCEEECSTTGGGGB
T ss_pred             EEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHHHEEECCCCcEEEeeCCCceEc
Confidence            999999999999999976544458899999999999999999999   99999999999999999999999999999876


Q ss_pred             CCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCchhhhhhhhhhhcccccccccCCc
Q 016594          219 PSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGEIEKLVDPR  297 (386)
Q Consensus       219 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (386)
                      .... ........++..|+|||++.+..++.++|||||||++|||++ |..||.+.......  ..+ ..         .
T Consensus       335 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~--~~i-~~---------~  401 (454)
T 1qcf_A          335 EDNE-YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI--RAL-ER---------G  401 (454)
T ss_dssp             CCHH-HHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH--HHH-HH---------T
T ss_pred             CCCc-eeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHH--HHH-Hc---------C
Confidence            4321 111223346778999999999999999999999999999999 99999875432111  100 00         1


Q ss_pred             cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCC
Q 016594          298 LQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEGD  339 (386)
Q Consensus       298 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~~  339 (386)
                      .....+..++..+.+++.+||+.||++|||+.+|++.|+...
T Consensus       402 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~  443 (454)
T 1qcf_A          402 YRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFY  443 (454)
T ss_dssp             CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred             CCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence            111222344678999999999999999999999999998764

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=1.8e-48  Score=365.81  Aligned_cols=268  Identities=24%  Similarity=0.369  Sum_probs=216.4

Q ss_pred             cCHHHHHHHhcCCCCCCeecccCCcEEEEEEEC------CCcEEEEEEeccccCChHhHHHHHHHHHHHhcc-CCCceee
Q 016594           56 FSFEEISIATNAFSSENLVGRGGYAEVYKGVLQ------DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHV-CHPNVLS  128 (386)
Q Consensus        56 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~  128 (386)
                      +....+++..++|++.+.||+|+||.||+|.+.      +++.||||++... ........+.+|+.++.++ +||||++
T Consensus        12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpniv~   90 (359)
T 3vhe_A           12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-ATHSEHRALMSELKILIHIGHHLNVVN   90 (359)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCc-CCHHHHHHHHHHHHHHHhhcCCcceee
Confidence            445667788899999999999999999999842      4678999999753 3344556789999999999 6999999


Q ss_pred             ecceEEeCc--eEEEEEeccCCCHhhhhhhcCC-----------------------------------------------
Q 016594          129 LLGCCVDNG--LYLIFQFSSRGSVASLFHDVNS-----------------------------------------------  159 (386)
Q Consensus       129 l~~~~~~~~--~~lv~e~~~~~~L~~~~~~~~~-----------------------------------------------  159 (386)
                      +++++.+.+  .++||||+.+|+|.+++.....                                               
T Consensus        91 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  170 (359)
T 3vhe_A           91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE  170 (359)
T ss_dssp             EEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------
T ss_pred             eeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccc
Confidence            999997643  8999999999999999876432                                               


Q ss_pred             -----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCC
Q 016594          160 -----------------PGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQW  222 (386)
Q Consensus       160 -----------------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  222 (386)
                                       ..+++..++.++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||++..+....
T Consensus       171 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~  247 (359)
T 3vhe_A          171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP  247 (359)
T ss_dssp             -------------CTTTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCT
T ss_pred             cccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCcEEEEeccceeeecccc
Confidence                             128899999999999999999999   999999999999999999999999999998765443


Q ss_pred             ccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCchhhhhhhhhhhcccccccccCCccCCC
Q 016594          223 THHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGA  301 (386)
Q Consensus       223 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (386)
                      .........||+.|+|||++.+..++.++|||||||++|+|++ |..||.+.........  ....         .....
T Consensus       248 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~--~~~~---------~~~~~  316 (359)
T 3vhe_A          248 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR--RLKE---------GTRMR  316 (359)
T ss_dssp             TCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHH--HHHH---------TCCCC
T ss_pred             cchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHH--HHHc---------CCCCC
Confidence            3334445668999999999999999999999999999999998 9999987543211110  0000         01111


Q ss_pred             CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          302 YDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       302 ~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                      .+...+..+.+++..||+.||.+|||+.+++++|...
T Consensus       317 ~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~  353 (359)
T 3vhe_A          317 APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL  353 (359)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence            2223456799999999999999999999999999764

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=7.5e-48  Score=356.37  Aligned_cols=266  Identities=26%  Similarity=0.339  Sum_probs=208.2

Q ss_pred             HHhcCCCCCCeecccCCcEEEEEEECCCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-----
Q 016594           63 IATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-----  137 (386)
Q Consensus        63 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----  137 (386)
                      +..++|++.+.||+|+||+||+|.+. ++.||||++...   ........+|+.++++++||||+++++++.+..     
T Consensus        21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~   96 (322)
T 3soc_A           21 FQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQ---DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVD   96 (322)
T ss_dssp             ETTEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             cchhhchhhheecccCceEEEEEEEC-CCEEEEEEeecC---chHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCce
Confidence            34578999999999999999999986 899999998642   233445667999999999999999999997643     


Q ss_pred             eEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC----------CeEEeCCCCCCeeEcCCCCe
Q 016594          138 LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQR----------RIIHRDIKSSNILLTADFEP  207 (386)
Q Consensus       138 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~----------~ivH~dlkp~Nill~~~~~~  207 (386)
                      .++||||+.+|+|.+++...   .+++..++.++.|++.||.|||+   .          +|+||||||+|||++.++.+
T Consensus        97 ~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~al~~LH~---~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~  170 (322)
T 3soc_A           97 LWLITAFHEKGSLSDFLKAN---VVSWNELCHIAETMARGLAYLHE---DIPGLKDGHKPAISHRDIKSKNVLLKNNLTA  170 (322)
T ss_dssp             EEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHTC---CEEEETTEEECEEECSCCSGGGEEECTTCCE
T ss_pred             EEEEEecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHh---hccccccccCCCEEeCCCChHhEEECCCCeE
Confidence            69999999999999999753   38999999999999999999998   7          99999999999999999999


Q ss_pred             EEeecCccccCCCCCccccccccccccCccChhhhccC-----CCCcccchHHHHHHHHHHHhCCCCCCCCchhhhh-hh
Q 016594          208 QISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHG-----IVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHS-WA  281 (386)
Q Consensus       208 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~-~~  281 (386)
                      ||+|||++..+.............||+.|+|||++.+.     .++.++|||||||++|+|++|+.||.+....... +.
T Consensus       171 kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~  250 (322)
T 3soc_A          171 CIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFE  250 (322)
T ss_dssp             EECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTH
T ss_pred             EEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchh
Confidence            99999999877654433334456799999999999863     4567899999999999999999999765321110 00


Q ss_pred             hhhhc---cccc-----ccccCCccCCC-CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          282 KPILN---QGEI-----EKLVDPRLQGA-YDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       282 ~~~~~---~~~~-----~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                      .....   ...+     .....+..... .....+..+.+++.+||+.||++|||+.++++.|+..
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l  316 (322)
T 3soc_A          251 EEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQM  316 (322)
T ss_dssp             HHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             hhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            00000   0000     00111111111 1224567799999999999999999999999998764

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=2.2e-48  Score=367.68  Aligned_cols=261  Identities=23%  Similarity=0.366  Sum_probs=212.4

Q ss_pred             HHHHhcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-e
Q 016594           61 ISIATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-L  138 (386)
Q Consensus        61 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~  138 (386)
                      +.+..++|.+.+.||+|+||.||+|.+. +++.||||++... ........+.+|+.++++++||||+++++++.+.+ .
T Consensus       109 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~  187 (377)
T 3cbl_A          109 WVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPI  187 (377)
T ss_dssp             TBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTT-SCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred             cEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEcccc-CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCc
Confidence            3456678999999999999999999987 7899999998753 23444567889999999999999999999997755 8


Q ss_pred             EEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccC
Q 016594          139 YLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWL  218 (386)
Q Consensus       139 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~  218 (386)
                      ++||||+.+|+|.+++.... ..+++..++.++.|++.||+|||+   ++|+||||||+|||++.++.+||+|||++...
T Consensus       188 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~  263 (377)
T 3cbl_A          188 YIVMELVQGGDFLTFLRTEG-ARLRVKTLLQMVGDAAAGMEYLES---KCCIHRDLAARNCLVTEKNVLKISDFGMSREE  263 (377)
T ss_dssp             EEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred             EEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCcCCcccCHHHEEEcCCCcEEECcCCCceec
Confidence            99999999999999987543 348999999999999999999999   99999999999999999999999999999865


Q ss_pred             CCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCchhhhhhhhhhhcccccccccCCc
Q 016594          219 PSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGEIEKLVDPR  297 (386)
Q Consensus       219 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (386)
                      .............+++.|+|||++.+..++.++|||||||++|||++ |..||.+.......   .         .+...
T Consensus       264 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~---~---------~~~~~  331 (377)
T 3cbl_A          264 ADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTR---E---------FVEKG  331 (377)
T ss_dssp             TTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHH---H---------HHHTT
T ss_pred             CCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH---H---------HHHcC
Confidence            43322111122335778999999999999999999999999999998 99999875432111   0         11111


Q ss_pred             cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          298 LQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       298 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                      .....+..++..+.+++.+||+.||++|||+.+|++.|...
T Consensus       332 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  372 (377)
T 3cbl_A          332 GRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSI  372 (377)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence            11122333457799999999999999999999999998754

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=1.3e-47  Score=345.38  Aligned_cols=258  Identities=22%  Similarity=0.358  Sum_probs=211.9

Q ss_pred             HHhcCCCCCCeecccCCcEEEEEEECCCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEE
Q 016594           63 IATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLI  141 (386)
Q Consensus        63 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv  141 (386)
                      +..++|++.+.||+|+||.||+|.++++..||+|++.....   ....+.+|+.++++++||||+++++++.+.. .++|
T Consensus         5 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   81 (268)
T 3sxs_A            5 LKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM---SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIV   81 (268)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB---CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEE
T ss_pred             echhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC---cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEE
Confidence            34678999999999999999999998888999999975332   3456889999999999999999999997755 8999


Q ss_pred             EEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCC
Q 016594          142 FQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQ  221 (386)
Q Consensus       142 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  221 (386)
                      |||+.+++|.+++.... ..+++..++.++.|++.||.|||+   ++++||||||+||+++.++.+||+|||++......
T Consensus        82 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~  157 (268)
T 3sxs_A           82 TEYISNGCLLNYLRSHG-KGLEPSQLLEMCYDVCEGMAFLES---HQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD  157 (268)
T ss_dssp             EECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCSGGGEEECTTCCEEECCTTCEEECCTT
T ss_pred             EEccCCCcHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCcceEEECCCCCEEEccCccceecchh
Confidence            99999999999987643 348999999999999999999999   99999999999999999999999999999876544


Q ss_pred             CccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCchhhhhhhhhhhcccccccccCCccCC
Q 016594          222 WTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQG  300 (386)
Q Consensus       222 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (386)
                      .. .......+|+.|+|||.+.+..++.++||||||+++|+|++ |..||............   ..         ....
T Consensus       158 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~---~~---------~~~~  224 (268)
T 3sxs_A          158 QY-VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKV---SQ---------GHRL  224 (268)
T ss_dssp             CE-EECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH---HT---------TCCC
T ss_pred             hh-hcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHH---Hc---------CCCC
Confidence            22 22233446778999999999999999999999999999999 99999865433211100   00         0011


Q ss_pred             CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCCc
Q 016594          301 AYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEGDQ  340 (386)
Q Consensus       301 ~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~~~  340 (386)
                      ..+...+..+.+++.+||+.||++|||+.+++++|+....
T Consensus       225 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~  264 (268)
T 3sxs_A          225 YRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE  264 (268)
T ss_dssp             CCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred             CCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence            1122234679999999999999999999999999987654

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=4.7e-47  Score=364.75  Aligned_cols=259  Identities=21%  Similarity=0.255  Sum_probs=210.9

Q ss_pred             HHhcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEE
Q 016594           63 IATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYL  140 (386)
Q Consensus        63 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~l  140 (386)
                      ...++|++.+.||+|+||.||+|... +|+.||+|++............+.+|+.+++.++||||+++++++.+++ .++
T Consensus         8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l   87 (444)
T 3soa_A            8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL   87 (444)
T ss_dssp             HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred             cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence            35678999999999999999999976 7899999999875555556677899999999999999999999998766 899


Q ss_pred             EEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEc---CCCCeEEeecCcccc
Q 016594          141 IFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLT---ADFEPQISDFGLAKW  217 (386)
Q Consensus       141 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~---~~~~~kl~Dfg~a~~  217 (386)
                      ||||+.+|+|.+.+....  .+++..+..++.||+.||.|||+   ++|+||||||+|||++   .++.+||+|||++..
T Consensus        88 v~E~~~gg~L~~~i~~~~--~~~e~~~~~i~~qil~aL~~lH~---~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~  162 (444)
T 3soa_A           88 IFDLVTGGELFEDIVARE--YYSEADASHCIQQILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIE  162 (444)
T ss_dssp             EECCCBCCBHHHHHHHCS--CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBC
T ss_pred             EEEeCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEeccCCCCcEEEccCceeEE
Confidence            999999999999887643  49999999999999999999999   9999999999999998   467899999999987


Q ss_pred             CCCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCc
Q 016594          218 LPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPR  297 (386)
Q Consensus       218 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (386)
                      .....  .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.......  ..+ ..+..    .  
T Consensus       163 ~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~--~~i-~~~~~----~--  231 (444)
T 3soa_A          163 VEGEQ--QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLY--QQI-KAGAY----D--  231 (444)
T ss_dssp             CCTTC--CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH--HHH-HHTCC----C--
T ss_pred             ecCCC--ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHH--HHH-HhCCC----C--
Confidence            65432  2234567999999999999999999999999999999999999999875432111  100 00000    0  


Q ss_pred             cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 016594          298 LQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLE  337 (386)
Q Consensus       298 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~  337 (386)
                      .........+..+.+++.+||+.||++|||+.+++++.+.
T Consensus       232 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~  271 (444)
T 3soa_A          232 FPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWI  271 (444)
T ss_dssp             CCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTT
T ss_pred             CCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccc
Confidence            0001112335679999999999999999999999998553

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=1.1e-47  Score=355.73  Aligned_cols=259  Identities=22%  Similarity=0.357  Sum_probs=208.8

Q ss_pred             HHhcCCCCCCeecccCCcEEEEEEEC----CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-
Q 016594           63 IATNAFSSENLVGRGGYAEVYKGVLQ----DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-  137 (386)
Q Consensus        63 ~~~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-  137 (386)
                      +..++|++.+.||+|+||.||+|.+.    .+..||||++... ........+.+|+.+++.++||||+++++++.+++ 
T Consensus        46 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  124 (325)
T 3kul_A           46 IEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAG-YTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRL  124 (325)
T ss_dssp             CCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTT-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGC
T ss_pred             cChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCC-CCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCc
Confidence            34578999999999999999999975    3446999999753 23455678999999999999999999999997755 


Q ss_pred             eEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCcccc
Q 016594          138 LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKW  217 (386)
Q Consensus       138 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~  217 (386)
                      .++||||+.+++|.+++.... ..+++..++.++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||++..
T Consensus       125 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  200 (325)
T 3kul_A          125 AMIVTEYMENGSLDTFLRTHD-GQFTIMQLVGMLRGVGAGMRYLSD---LGYVHRDLAARNVLVDSNLVCKVSDFGLSRV  200 (325)
T ss_dssp             CEEEEECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred             cEEEeeCCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEECCCCCEEECCCCcccc
Confidence            899999999999999986543 359999999999999999999999   9999999999999999999999999999987


Q ss_pred             CCCCCcc-ccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCchhhhhhhhhhhcccccccccC
Q 016594          218 LPSQWTH-HSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGEIEKLVD  295 (386)
Q Consensus       218 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  295 (386)
                      ....... .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+.......  ..          +.
T Consensus       201 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~--~~----------~~  268 (325)
T 3kul_A          201 LEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVI--SS----------VE  268 (325)
T ss_dssp             CC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHH--HH----------HH
T ss_pred             cccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHH--HH----------HH
Confidence            7543221 12223346778999999999999999999999999999999 99999775432111  00          00


Q ss_pred             CccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          296 PRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       296 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                      .......+..++..+.+++..||..||.+|||+.+|++.|...
T Consensus       269 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l  311 (325)
T 3kul_A          269 EGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDAL  311 (325)
T ss_dssp             TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             cCCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            1111222334557899999999999999999999999998764

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=1.4e-48  Score=377.52  Aligned_cols=263  Identities=22%  Similarity=0.360  Sum_probs=212.0

Q ss_pred             HHHHHHhcCCCCCCeecccCCcEEEEEEECCCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCce
Q 016594           59 EEISIATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNGL  138 (386)
Q Consensus        59 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  138 (386)
                      ..+++..++|++.+.||+|+||.||+|.++.+..||||++.....   ....+.+|+.++++++||||+++++++.++..
T Consensus       177 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~  253 (452)
T 1fmk_A          177 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPI  253 (452)
T ss_dssp             TCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSC
T ss_pred             cccccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCC---CHHHHHHHHHHHHhCCCCCEeeEEEEEcCCce
Confidence            334567788999999999999999999998778899999975432   34578999999999999999999999988779


Q ss_pred             EEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccC
Q 016594          139 YLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWL  218 (386)
Q Consensus       139 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~  218 (386)
                      ++||||+.+|+|.+++.......+++..++.++.|++.||+|||+   ++|+||||||+|||++.++.+||+|||++...
T Consensus       254 ~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~  330 (452)
T 1fmk_A          254 YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLI  330 (452)
T ss_dssp             EEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC--
T ss_pred             EEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEECCCCCEEECCCccceec
Confidence            999999999999999976544568999999999999999999999   99999999999999999999999999999876


Q ss_pred             CCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCchhhhhhhhhhhcccccccccCCc
Q 016594          219 PSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGEIEKLVDPR  297 (386)
Q Consensus       219 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (386)
                      ..... .......++..|+|||++.+..++.++|||||||++|||++ |..||.+......  ...          +...
T Consensus       331 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~--~~~----------i~~~  397 (452)
T 1fmk_A          331 EDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV--LDQ----------VERG  397 (452)
T ss_dssp             -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH--HHH----------HHTT
T ss_pred             CCCce-ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHH--HHH----------HHcC
Confidence            43211 11223346788999999999999999999999999999999 9999987543211  000          0111


Q ss_pred             cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCCc
Q 016594          298 LQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEGDQ  340 (386)
Q Consensus       298 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~~~  340 (386)
                      .....+..++..+.+++.+||+.||++|||+.+|++.|.....
T Consensus       398 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~  440 (452)
T 1fmk_A          398 YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT  440 (452)
T ss_dssp             CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred             CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhc
Confidence            1122233456789999999999999999999999999987643

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=4e-48  Score=356.62  Aligned_cols=260  Identities=22%  Similarity=0.375  Sum_probs=213.4

Q ss_pred             HHhcCCCCCCeecccCCcEEEEEEE------CCCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeC
Q 016594           63 IATNAFSSENLVGRGGYAEVYKGVL------QDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDN  136 (386)
Q Consensus        63 ~~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~  136 (386)
                      +..++|.+.+.||+|+||.||+|.+      .++..||||++... ........+.+|+.+++.++||||+++++++.+.
T Consensus        20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~   98 (314)
T 2ivs_A           20 FPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKEN-ASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQD   98 (314)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTT-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred             cchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCC-CCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecC
Confidence            4567899999999999999999986      23578999998753 3345567889999999999999999999999765


Q ss_pred             c-eEEEEEeccCCCHhhhhhhcCC----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeC
Q 016594          137 G-LYLIFQFSSRGSVASLFHDVNS----------------------PGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRD  193 (386)
Q Consensus       137 ~-~~lv~e~~~~~~L~~~~~~~~~----------------------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~d  193 (386)
                      + .++||||+.+++|.+++.....                      ..+++..++.++.|++.||.|||+   ++|+|||
T Consensus        99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~d  175 (314)
T 2ivs_A           99 GPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE---MKLVHRD  175 (314)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHH---TTEECCC
T ss_pred             CceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHH---CCCcccc
Confidence            5 8999999999999999876533                      338899999999999999999999   9999999


Q ss_pred             CCCCCeeEcCCCCeEEeecCccccCCCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHh-CCCCCCC
Q 016594          194 IKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDG  272 (386)
Q Consensus       194 lkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~  272 (386)
                      |||+||+++.++.+||+|||++................+++.|+|||++.+..++.++|||||||++|+|++ |..||.+
T Consensus       176 ikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~  255 (314)
T 2ivs_A          176 LAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG  255 (314)
T ss_dssp             CSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             cchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            999999999999999999999987755433333344557889999999999999999999999999999999 9999987


Q ss_pred             CchhhhhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          273 SHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                      .......            ..+........+...+..+.+++.+||+.||.+||++.+++++|+..
T Consensus       256 ~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~  309 (314)
T 2ivs_A          256 IPPERLF------------NLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKM  309 (314)
T ss_dssp             CCGGGHH------------HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCHHHHH------------HHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            5432111            00111111122233457799999999999999999999999998754

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1e-47  Score=346.31  Aligned_cols=256  Identities=22%  Similarity=0.398  Sum_probs=210.5

Q ss_pred             HHhcCCCCCCeecccCCcEEEEEEECCCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEE
Q 016594           63 IATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLI  141 (386)
Q Consensus        63 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv  141 (386)
                      +..++|++.+.||+|+||.||+|.+.+++.||+|++.....   ....+.+|+.++++++||||+++++++.+.+ .++|
T Consensus         7 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (269)
T 4hcu_A            7 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM---SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLV   83 (269)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB---CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEE
T ss_pred             eChhhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc---CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEE
Confidence            44578999999999999999999998888999999975432   2356889999999999999999999997755 8999


Q ss_pred             EEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCC
Q 016594          142 FQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQ  221 (386)
Q Consensus       142 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  221 (386)
                      |||+.+++|.+++.... ..+++..++.++.|++.||.|||+   ++++||||||+||+++.++.+||+|||++......
T Consensus        84 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  159 (269)
T 4hcu_A           84 FEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD  159 (269)
T ss_dssp             EECCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred             EEeCCCCcHHHHHHhcC-cccCHHHHHHHHHHHHHHHHHHHh---CCeecCCcchheEEEcCCCCEEecccccccccccc
Confidence            99999999999986533 358999999999999999999999   99999999999999999999999999999876443


Q ss_pred             CccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCchhhhhhhhhhhcccccccccCCccCC
Q 016594          222 WTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQG  300 (386)
Q Consensus       222 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (386)
                      . ........+++.|+|||++.+..++.++||||||+++|+|++ |..||.........  .....          ....
T Consensus       160 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~--~~~~~----------~~~~  226 (269)
T 4hcu_A          160 Q-YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVV--EDIST----------GFRL  226 (269)
T ss_dssp             H-HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH--HHHHT----------TCCC
T ss_pred             c-cccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHH--HHHhc----------CccC
Confidence            1 122233456788999999999999999999999999999999 99999875432111  10000          0111


Q ss_pred             CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          301 AYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       301 ~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                      ..+...+..+.+++.+||+.||++||++.+++++|.+.
T Consensus       227 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l  264 (269)
T 4hcu_A          227 YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI  264 (269)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHH
Confidence            12223356799999999999999999999999998764

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=4.1e-48  Score=361.05  Aligned_cols=266  Identities=23%  Similarity=0.361  Sum_probs=215.0

Q ss_pred             HHHHHHhcCCCCCCeecccCCcEEEEEEEC------CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecce
Q 016594           59 EEISIATNAFSSENLVGRGGYAEVYKGVLQ------DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGC  132 (386)
Q Consensus        59 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~  132 (386)
                      ..+.+..++|++.+.||+|+||.||+|.+.      +++.||||++.... .......+.+|+.+++.++||||++++++
T Consensus        40 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~  118 (343)
T 1luf_A           40 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGV  118 (343)
T ss_dssp             HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             ceeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence            344556789999999999999999999974      34789999997532 34456778999999999999999999999


Q ss_pred             EEeCc-eEEEEEeccCCCHhhhhhhcCC----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 016594          133 CVDNG-LYLIFQFSSRGSVASLFHDVNS----------------------PGVEWKVRHKIAVGTARGLHYLHKGCQRRI  189 (386)
Q Consensus       133 ~~~~~-~~lv~e~~~~~~L~~~~~~~~~----------------------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i  189 (386)
                      +.+.+ .++||||+.+++|.+++.....                      ..+++..++.++.|++.||.|||+   ++|
T Consensus       119 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~---~~i  195 (343)
T 1luf_A          119 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKF  195 (343)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTC
T ss_pred             EccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCe
Confidence            97655 8999999999999999876431                      458999999999999999999999   999


Q ss_pred             EEeCCCCCCeeEcCCCCeEEeecCccccCCCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHh-CCC
Q 016594          190 IHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRK  268 (386)
Q Consensus       190 vH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~  268 (386)
                      +||||||+|||++.++.+||+|||++................+|+.|+|||++.+..++.++|||||||++|+|++ |..
T Consensus       196 vH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~  275 (343)
T 1luf_A          196 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ  275 (343)
T ss_dssp             CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             ecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCC
Confidence            9999999999999999999999999986643322223334568899999999999999999999999999999999 999


Q ss_pred             CCCCCchhhhhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCCc
Q 016594          269 PVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEGDQ  340 (386)
Q Consensus       269 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~~~  340 (386)
                      ||.+.......  .. ......         ...+..++..+.+++.+||+.||.+||++.++++.|.....
T Consensus       276 p~~~~~~~~~~--~~-~~~~~~---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~  335 (343)
T 1luf_A          276 PYYGMAHEEVI--YY-VRDGNI---------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE  335 (343)
T ss_dssp             TTTTSCHHHHH--HH-HHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             cCCCCChHHHH--HH-HhCCCc---------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHh
Confidence            99875432111  10 111111         11222345679999999999999999999999999987643

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=9.3e-48  Score=358.86  Aligned_cols=260  Identities=18%  Similarity=0.319  Sum_probs=206.0

Q ss_pred             HHhcCCCCCCeecccCCcEEEEEEECCCcEEEEEEeccccCChHhHHHHHHHHHHHhccCC--CceeeecceEEeCc-eE
Q 016594           63 IATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCH--PNVLSLLGCCVDNG-LY  139 (386)
Q Consensus        63 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~-~~  139 (386)
                      +.+++|++.+.||+|+||.||+|...+++.||||++............+.+|+.+++.+.|  |||+++++++.++. .+
T Consensus         6 ~~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~   85 (343)
T 3dbq_A            6 VKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY   85 (343)
T ss_dssp             SSSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             eecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEE
Confidence            3467799999999999999999998889999999998765566667789999999999986  99999999998766 78


Q ss_pred             EEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCC
Q 016594          140 LIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLP  219 (386)
Q Consensus       140 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~  219 (386)
                      +||| +.+++|.+++...  ..+++..+..++.|++.||.|||+   ++|+||||||+|||++ ++.+||+|||++..+.
T Consensus        86 lv~e-~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~---~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~  158 (343)
T 3dbq_A           86 MVME-CGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ  158 (343)
T ss_dssp             EEEC-CCSEEHHHHHHHS--CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC-
T ss_pred             EEEe-CCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEE-CCcEEEeecccccccC
Confidence            8888 6778999998764  348999999999999999999999   9999999999999997 5789999999998775


Q ss_pred             CCCccccccccccccCccChhhhcc-----------CCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhccc
Q 016594          220 SQWTHHSIAPIEGTFGHLAPEYFMH-----------GIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQG  288 (386)
Q Consensus       220 ~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~  288 (386)
                      ............||+.|+|||++.+           ..++.++|||||||++|+|++|..||..........        
T Consensus       159 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~--------  230 (343)
T 3dbq_A          159 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKL--------  230 (343)
T ss_dssp             -----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHH--------
T ss_pred             cccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHH--------
Confidence            5433333445679999999999875           678999999999999999999999997643322111        


Q ss_pred             ccccccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCC
Q 016594          289 EIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEGD  339 (386)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~~  339 (386)
                        ..++++......+...+..+.+++.+||+.||.+|||+.+++++.+...
T Consensus       231 --~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~  279 (343)
T 3dbq_A          231 --HAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI  279 (343)
T ss_dssp             --HHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHS
T ss_pred             --HHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccc
Confidence              1111222222222233467899999999999999999999999876543

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=1.7e-46  Score=342.83  Aligned_cols=262  Identities=20%  Similarity=0.312  Sum_probs=207.6

Q ss_pred             HhcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEecccc-CChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEE
Q 016594           64 ATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVV-TDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYL  140 (386)
Q Consensus        64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~l  140 (386)
                      ..++|++.+.||+|+||.||+|.+. ++..||+|++.... ........+.+|+.++++++||||+++++++.+++ .++
T Consensus         9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l   88 (294)
T 4eqm_A            9 INERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYL   88 (294)
T ss_dssp             EETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEE
T ss_pred             hhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEE
Confidence            4578999999999999999999976 68999999986533 33445678899999999999999999999998766 899


Q ss_pred             EEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCC
Q 016594          141 IFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPS  220 (386)
Q Consensus       141 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~  220 (386)
                      ||||+.+++|.+++....  .+++..++.++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||++..+..
T Consensus        89 v~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  163 (294)
T 4eqm_A           89 VMEYIEGPTLSEYIESHG--PLSVDTAINFTNQILDGIKHAHD---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSE  163 (294)
T ss_dssp             EEECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred             EEeCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence            999999999999987654  48999999999999999999999   9999999999999999999999999999987643


Q ss_pred             CCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCC
Q 016594          221 QWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQG  300 (386)
Q Consensus       221 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (386)
                      .. ........||+.|+|||++.+..++.++|||||||++|+|++|..||.+..........  ... ..     +....
T Consensus       164 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~--~~~-~~-----~~~~~  234 (294)
T 4eqm_A          164 TS-LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKH--IQD-SV-----PNVTT  234 (294)
T ss_dssp             ------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHH--HSS-CC-----CCHHH
T ss_pred             cc-ccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH--hhc-cC-----CCcch
Confidence            32 12233456999999999999999999999999999999999999999876432211100  000 00     00001


Q ss_pred             CCCHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHhcCC
Q 016594          301 AYDVTQLNRLAFAASLCIRASPTWRP-TMSEVLEVMLEGD  339 (386)
Q Consensus       301 ~~~~~~~~~l~~li~~cl~~dP~~Rp-t~~~il~~l~~~~  339 (386)
                      ......+..+.+++.+||+.||.+|| ++.++++.|....
T Consensus       235 ~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~  274 (294)
T 4eqm_A          235 DVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVL  274 (294)
T ss_dssp             HSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSS
T ss_pred             hcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHH
Confidence            11223457799999999999999999 8888888887653

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=4.2e-46  Score=342.16  Aligned_cols=281  Identities=34%  Similarity=0.578  Sum_probs=225.8

Q ss_pred             CccccCHHHHHHHhcCCCCC------CeecccCCcEEEEEEECCCcEEEEEEecccc--CChHhHHHHHHHHHHHhccCC
Q 016594           52 TWRCFSFEEISIATNAFSSE------NLVGRGGYAEVYKGVLQDGEEIAVKRLTKVV--TDDRKEKEFLTEIGTIGHVCH  123 (386)
Q Consensus        52 ~~~~~~~~~~~~~~~~~~~~------~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~e~~~l~~l~h  123 (386)
                      ....|++.++...+++|...      +.||+|+||.||+|.+ +++.||||++....  ........+.+|+.+++.++|
T Consensus        11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h   89 (307)
T 2nru_A           11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH   89 (307)
T ss_dssp             CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred             CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence            34668888888888888776      8999999999999987 48899999987532  233456778999999999999


Q ss_pred             CceeeecceEEeCc-eEEEEEeccCCCHhhhhhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeE
Q 016594          124 PNVLSLLGCCVDNG-LYLIFQFSSRGSVASLFHDVN-SPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILL  201 (386)
Q Consensus       124 ~niv~l~~~~~~~~-~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill  201 (386)
                      |||+++++++.+.+ .+++|||+.+++|.+++.... ...+++..++.++.|++.||.|||+   ++++||||||+||++
T Consensus        90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nili  166 (307)
T 2nru_A           90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHE---NHHIHRDIKSANILL  166 (307)
T ss_dssp             TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEE
T ss_pred             CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecCCCCHHHEEE
Confidence            99999999997654 899999999999999886433 3458999999999999999999999   999999999999999


Q ss_pred             cCCCCeEEeecCccccCCCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhh--hh
Q 016594          202 TADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSL--HS  279 (386)
Q Consensus       202 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~--~~  279 (386)
                      +.++.+||+|||++................||+.|+|||.+.+ .++.++|||||||++|+|++|..||.......  ..
T Consensus       167 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~  245 (307)
T 2nru_A          167 DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLD  245 (307)
T ss_dssp             CTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTH
T ss_pred             cCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHH
Confidence            9999999999999987654433333445679999999998865 47899999999999999999999998654321  11


Q ss_pred             hhhhhhc-ccccccccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          280 WAKPILN-QGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       280 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                      +...... ...+...+++.. ...+...+..+.+++.+||+.||.+|||+.+++++|+..
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l  304 (307)
T 2nru_A          246 IKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM  304 (307)
T ss_dssp             HHHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             HHHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence            1111111 111222333332 234567788999999999999999999999999999764

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=3.1e-48  Score=359.41  Aligned_cols=259  Identities=22%  Similarity=0.350  Sum_probs=205.9

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEC-CCcE----EEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCceE
Q 016594           65 TNAFSSENLVGRGGYAEVYKGVLQ-DGEE----IAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNGLY  139 (386)
Q Consensus        65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~----vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  139 (386)
                      .++|++.+.||+|+||+||+|.+. +++.    ||+|.+.... .......+.+|+.+++.++||||+++++++.++..+
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   90 (325)
T 3kex_A           12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS-GRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPGSSLQ   90 (325)
T ss_dssp             TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTT-SCSCBCSCCHHHHHHHTCCCTTBCCEEEEECBSSEE
T ss_pred             HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccc-cHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCccE
Confidence            467889999999999999999975 4554    7777775422 222334567899999999999999999999888899


Q ss_pred             EEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCC
Q 016594          140 LIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLP  219 (386)
Q Consensus       140 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~  219 (386)
                      +||+|+.+|+|.+++... ...+++..++.++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||++..+.
T Consensus        91 ~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~  166 (325)
T 3kex_A           91 LVTQYLPLGSLLDHVRQH-RGALGPQLLLNWGVQIAKGMYYLEE---HGMVHRNLAARNVLLKSPSQVQVADFGVADLLP  166 (325)
T ss_dssp             EEEECCTTCBSHHHHHSS-GGGSCTTHHHHHHHHHHHHHHHHHH---TTCCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred             EEEEeCCCCCHHHHHHHc-cccCCHHHHHHHHHHHHHHHHHHHh---CCCCCCccchheEEECCCCeEEECCCCcccccC
Confidence            999999999999988653 2348889999999999999999999   999999999999999999999999999999876


Q ss_pred             CCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCchhhhhhhhhhhcccccccccCCcc
Q 016594          220 SQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRL  298 (386)
Q Consensus       220 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (386)
                      ............|+..|+|||++.+..++.++|||||||++|+|++ |..||.+........            .+....
T Consensus       167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~------------~~~~~~  234 (325)
T 3kex_A          167 PDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPD------------LLEKGE  234 (325)
T ss_dssp             CCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHH------------HHHTTC
T ss_pred             cccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHH------------HHHcCC
Confidence            5544334455668889999999999999999999999999999999 999998754321110            000111


Q ss_pred             CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCCc
Q 016594          299 QGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEGDQ  340 (386)
Q Consensus       299 ~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~~~  340 (386)
                      ....+..++..+.+++.+||+.||.+||++.+++++|.....
T Consensus       235 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~  276 (325)
T 3kex_A          235 RLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR  276 (325)
T ss_dssp             BCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred             CCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence            111122234458899999999999999999999999977643

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=7.2e-48  Score=357.18  Aligned_cols=259  Identities=26%  Similarity=0.428  Sum_probs=204.2

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEC-CCcE----EEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCceE
Q 016594           65 TNAFSSENLVGRGGYAEVYKGVLQ-DGEE----IAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNGLY  139 (386)
Q Consensus        65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~----vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  139 (386)
                      .++|++.+.||+|+||.||+|.+. +++.    ||+|.+... ........+.+|+.+++.++||||+++++++..+..+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   92 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ   92 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCC-SSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSSEE
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccc-cCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCCce
Confidence            567999999999999999999975 4554    467766542 2334567889999999999999999999999998899


Q ss_pred             EEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCC
Q 016594          140 LIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLP  219 (386)
Q Consensus       140 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~  219 (386)
                      ++++++.+++|.+++.... ..+++..++.++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||++....
T Consensus        93 ~v~~~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~  168 (327)
T 3lzb_A           93 LITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG  168 (327)
T ss_dssp             EEECCCSSCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred             EEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhh---CCCcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence            9999999999999887643 348999999999999999999999   999999999999999999999999999998775


Q ss_pred             CCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCchhhhhhhhhhhcccccccccCCcc
Q 016594          220 SQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRL  298 (386)
Q Consensus       220 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (386)
                      ............+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+.......            ..+....
T Consensus       169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~------------~~~~~~~  236 (327)
T 3lzb_A          169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS------------SILEKGE  236 (327)
T ss_dssp             -----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH------------HHHHTTC
T ss_pred             CccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHH------------HHHHcCC
Confidence            4433333344557888999999999999999999999999999999 99999875432211            1111111


Q ss_pred             CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCCc
Q 016594          299 QGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEGDQ  340 (386)
Q Consensus       299 ~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~~~  340 (386)
                      ....+...+..+.+++.+||+.||.+||++.++++.|.....
T Consensus       237 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~  278 (327)
T 3lzb_A          237 RLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR  278 (327)
T ss_dssp             CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred             CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence            122233345679999999999999999999999999877644

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.8e-47  Score=362.03  Aligned_cols=263  Identities=25%  Similarity=0.394  Sum_probs=215.6

Q ss_pred             HHHhcCCCCCCeecccCCcEEEEEEEC--------CCcEEEEEEeccccCChHhHHHHHHHHHHHhcc-CCCceeeecce
Q 016594           62 SIATNAFSSENLVGRGGYAEVYKGVLQ--------DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHV-CHPNVLSLLGC  132 (386)
Q Consensus        62 ~~~~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~  132 (386)
                      .+..++|.+.+.||+|+||.||+|.+.        .+..||||++... ........+.+|+.+++.+ +||||++++++
T Consensus        65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~  143 (382)
T 3tt0_A           65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD-ATEKDLSDLISEMEMMKMIGKHKNIINLLGA  143 (382)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc-cCHHHHHHHHHHHHHHHHhcCCchhhhheee
Confidence            456688999999999999999999852        2357999999754 3445567889999999999 89999999999


Q ss_pred             EEeCc-eEEEEEeccCCCHhhhhhhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCC
Q 016594          133 CVDNG-LYLIFQFSSRGSVASLFHDVNS--------------PGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSS  197 (386)
Q Consensus       133 ~~~~~-~~lv~e~~~~~~L~~~~~~~~~--------------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~  197 (386)
                      +.+++ .++||||+.+++|.+++.....              ..+++..++.++.|++.||.|||+   ++|+||||||+
T Consensus       144 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~  220 (382)
T 3tt0_A          144 CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAAR  220 (382)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGG
T ss_pred             eccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCcc
Confidence            97755 8999999999999999976542              348999999999999999999999   99999999999


Q ss_pred             CeeEcCCCCeEEeecCccccCCCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCchh
Q 016594          198 NILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQS  276 (386)
Q Consensus       198 Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~  276 (386)
                      |||++.++.+||+|||++................+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+....
T Consensus       221 NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~  300 (382)
T 3tt0_A          221 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE  300 (382)
T ss_dssp             GEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred             eEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence            99999999999999999987754433333444567889999999999999999999999999999999 99999875432


Q ss_pred             hhhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCCc
Q 016594          277 LHSWAKPILNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEGDQ  340 (386)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~~~  340 (386)
                      ...  ..          +........+..++..+.+++.+||+.||++|||+.+|+++|.....
T Consensus       301 ~~~--~~----------~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~  352 (382)
T 3tt0_A          301 ELF--KL----------LKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA  352 (382)
T ss_dssp             HHH--HH----------HHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHH--HH----------HHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence            111  10          01111111223345779999999999999999999999999876643

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=5.9e-47  Score=345.47  Aligned_cols=266  Identities=19%  Similarity=0.272  Sum_probs=205.8

Q ss_pred             cCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEEE
Q 016594           66 NAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQ  143 (386)
Q Consensus        66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~e  143 (386)
                      ++|++.+.||+|+||+||+|.+. +++.||+|++............+.+|+.++++++||||+++++++.+++ .++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            47889999999999999999986 6899999999876655666678899999999999999999999998766 899999


Q ss_pred             eccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCc
Q 016594          144 FSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWT  223 (386)
Q Consensus       144 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~  223 (386)
                      |+.+ ++.+.+... ...+++..++.++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||++....... 
T Consensus        82 ~~~~-~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~---~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-  155 (292)
T 3o0g_A           82 FCDQ-DLKKYFDSC-NGDLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV-  155 (292)
T ss_dssp             CCSE-EHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCC-
T ss_pred             cCCC-CHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceecCCcc-
Confidence            9986 555555443 3459999999999999999999999   999999999999999999999999999998765332 


Q ss_pred             cccccccccccCccChhhhccCC-CCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhh--hccc------cccccc
Q 016594          224 HHSIAPIEGTFGHLAPEYFMHGI-VDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPI--LNQG------EIEKLV  294 (386)
Q Consensus       224 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~--~~~~------~~~~~~  294 (386)
                       .......||+.|+|||++.+.. ++.++|||||||++|+|++|..||..............  ....      ......
T Consensus       156 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  234 (292)
T 3o0g_A          156 -RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP  234 (292)
T ss_dssp             -SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGST
T ss_pred             -ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccc
Confidence             2234456899999999998765 89999999999999999998877543322111111100  0000      000000


Q ss_pred             C---------CccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          295 D---------PRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       295 ~---------~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                      +         ...........+..+.+++.+||+.||++|||+.++++|-+..
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~  287 (292)
T 3o0g_A          235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFS  287 (292)
T ss_dssp             TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGT
T ss_pred             cccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccc
Confidence            0         0000111123457789999999999999999999999986654

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=2.8e-48  Score=379.19  Aligned_cols=260  Identities=26%  Similarity=0.409  Sum_probs=216.0

Q ss_pred             HHHHhcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-e
Q 016594           61 ISIATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-L  138 (386)
Q Consensus        61 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~  138 (386)
                      +++...+|++.+.||+|+||.||+|.++ ++..||||++....   .....+.+|+.++++++||||+++++++.+.. .
T Consensus       215 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  291 (495)
T 1opk_A          215 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF  291 (495)
T ss_dssp             CBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             cccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc---cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcE
Confidence            4456678999999999999999999987 48899999997532   23567899999999999999999999997654 8


Q ss_pred             EEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccC
Q 016594          139 YLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWL  218 (386)
Q Consensus       139 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~  218 (386)
                      ++||||+.+|+|.+++.......+++..++.++.|++.||+|||+   ++|+||||||+|||++.++.+||+|||++...
T Consensus       292 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~  368 (495)
T 1opk_A          292 YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRNLAARNCLVGENHLVKVADFGLSRLM  368 (495)
T ss_dssp             EEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCEEECCTTCEECC
T ss_pred             EEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChhhEEECCCCcEEEeecccceec
Confidence            999999999999999987666679999999999999999999999   99999999999999999999999999999876


Q ss_pred             CCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCchhhhhhhhhhhcccccccccCCc
Q 016594          219 PSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGEIEKLVDPR  297 (386)
Q Consensus       219 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (386)
                      .... ........++..|+|||++.+..++.++|||||||++|||++ |..||.+......            ...+...
T Consensus       369 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~------------~~~~~~~  435 (495)
T 1opk_A          369 TGDT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV------------YELLEKD  435 (495)
T ss_dssp             TTCC-EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH------------HHHHHTT
T ss_pred             cCCc-eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHH------------HHHHHcC
Confidence            5432 112223446788999999999999999999999999999999 9999987543211            1111111


Q ss_pred             cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCC
Q 016594          298 LQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEGD  339 (386)
Q Consensus       298 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~~  339 (386)
                      .....+..++..+.+++.+||+.||++|||+.+|++.|+...
T Consensus       436 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~  477 (495)
T 1opk_A          436 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF  477 (495)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred             CCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence            222233345678999999999999999999999999998653

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=4e-47  Score=360.62  Aligned_cols=268  Identities=21%  Similarity=0.308  Sum_probs=211.9

Q ss_pred             HhcCCCCCCeeccc--CCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eE
Q 016594           64 ATNAFSSENLVGRG--GYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LY  139 (386)
Q Consensus        64 ~~~~~~~~~~lg~G--~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~  139 (386)
                      ..++|++.+.||+|  +||+||+|.++ +++.||||++............+.+|+.+++.++||||+++++++.+++ .+
T Consensus        23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  102 (389)
T 3gni_B           23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW  102 (389)
T ss_dssp             CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEE
Confidence            45789999999999  99999999987 7999999999876555666778889999999999999999999998766 89


Q ss_pred             EEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCC
Q 016594          140 LIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLP  219 (386)
Q Consensus       140 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~  219 (386)
                      +||||+.+++|.+++.......+++..++.++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||.+....
T Consensus       103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~  179 (389)
T 3gni_B          103 VVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMI  179 (389)
T ss_dssp             EEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred             EEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence            99999999999999987766679999999999999999999999   999999999999999999999999999986543


Q ss_pred             CCCc-----cccccccccccCccChhhhcc--CCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhccccccc
Q 016594          220 SQWT-----HHSIAPIEGTFGHLAPEYFMH--GIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEK  292 (386)
Q Consensus       220 ~~~~-----~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  292 (386)
                      ....     ........||+.|+|||++.+  ..++.++|||||||++|+|++|..||.+..........  .. .....
T Consensus       180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~--~~-~~~~~  256 (389)
T 3gni_B          180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEK--LN-GTVPC  256 (389)
T ss_dssp             ETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC----------
T ss_pred             cccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH--hc-CCCCc
Confidence            2211     111223468999999999987  67899999999999999999999999765432111100  00 00000


Q ss_pred             ccC------------------------------------CccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 016594          293 LVD------------------------------------PRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVML  336 (386)
Q Consensus       293 ~~~------------------------------------~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~  336 (386)
                      +.+                                    ...........+..+.+||.+||+.||++|||+.+++++-+
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~  336 (389)
T 3gni_B          257 LLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSF  336 (389)
T ss_dssp             -------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGG
T ss_pred             cccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHH
Confidence            000                                    00000112233567999999999999999999999998855


Q ss_pred             c
Q 016594          337 E  337 (386)
Q Consensus       337 ~  337 (386)
                      .
T Consensus       337 f  337 (389)
T 3gni_B          337 F  337 (389)
T ss_dssp             G
T ss_pred             H
Confidence            4

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=2.5e-48  Score=365.90  Aligned_cols=261  Identities=25%  Similarity=0.357  Sum_probs=210.2

Q ss_pred             HHhcCCCCCCeecccCCcEEEEEEEC------CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeC
Q 016594           63 IATNAFSSENLVGRGGYAEVYKGVLQ------DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDN  136 (386)
Q Consensus        63 ~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~  136 (386)
                      +..++|++.+.||+|+||+||+|.+.      ++..||||++... ........+.+|+.++++++||||+++++++.+.
T Consensus        68 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  146 (367)
T 3l9p_A           68 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS  146 (367)
T ss_dssp             CCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             cCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccc-cChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence            34578999999999999999999953      4668999998743 3445566789999999999999999999999775


Q ss_pred             c-eEEEEEeccCCCHhhhhhhcCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCC---Ce
Q 016594          137 G-LYLIFQFSSRGSVASLFHDVNS-----PGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADF---EP  207 (386)
Q Consensus       137 ~-~~lv~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~---~~  207 (386)
                      . .++||||+.+|+|.+++.....     ..+++..++.++.|++.||.|||+   ++|+||||||+|||++.++   .+
T Consensus       147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~~~~  223 (367)
T 3l9p_A          147 LPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVA  223 (367)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCE
T ss_pred             CCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEEecCCCCceE
Confidence            5 8999999999999999876542     348999999999999999999999   9999999999999999555   59


Q ss_pred             EEeecCccccCCCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCchhhhhhhhhhhc
Q 016594          208 QISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILN  286 (386)
Q Consensus       208 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~  286 (386)
                      ||+|||++..+.............||+.|+|||++.+..++.++|||||||++|||++ |..||.+.......  ...  
T Consensus       224 kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~--~~i--  299 (367)
T 3l9p_A          224 KIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVL--EFV--  299 (367)
T ss_dssp             EECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH--HHH--
T ss_pred             EECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH--HHH--
Confidence            9999999975432222222334557899999999999999999999999999999998 99999875432111  100  


Q ss_pred             ccccccccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCC
Q 016594          287 QGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEGD  339 (386)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~~  339 (386)
                              ........+..++..+.+++.+||+.||.+||++.+|+++|+...
T Consensus       300 --------~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~  344 (367)
T 3l9p_A          300 --------TSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT  344 (367)
T ss_dssp             --------HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             --------HcCCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence                    011111122334567999999999999999999999999997764

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=1.3e-47  Score=356.04  Aligned_cols=254  Identities=18%  Similarity=0.286  Sum_probs=206.9

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCC-hHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEE
Q 016594           65 TNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTD-DRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLI  141 (386)
Q Consensus        65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv  141 (386)
                      .++|.+.+.||+|+||+||+|.+. +++.||+|++...... ......+.+|+.+++.++||||+++++++.+.. .++|
T Consensus         8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv   87 (336)
T 3h4j_B            8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV   87 (336)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            368999999999999999999975 7899999998753211 122356889999999999999999999998766 8999


Q ss_pred             EEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCC
Q 016594          142 FQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQ  221 (386)
Q Consensus       142 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  221 (386)
                      |||+ +|+|.+++....  .+++..++.++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||++......
T Consensus        88 ~E~~-~g~l~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~  161 (336)
T 3h4j_B           88 IEYA-GGELFDYIVEKK--RMTEDEGRRFFQQIICAIEYCHR---HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG  161 (336)
T ss_dssp             ECCC-CEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHH---HTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS
T ss_pred             EECC-CCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCchhhEEEcCCCCEEEEEeccceeccCC
Confidence            9999 678888876644  49999999999999999999999   99999999999999999999999999999876543


Q ss_pred             CccccccccccccCccChhhhccCCC-CcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCC
Q 016594          222 WTHHSIAPIEGTFGHLAPEYFMHGIV-DEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQG  300 (386)
Q Consensus       222 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (386)
                         ......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+....            .+...+... ..
T Consensus       162 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~------------~~~~~i~~~-~~  225 (336)
T 3h4j_B          162 ---NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIP------------NLFKKVNSC-VY  225 (336)
T ss_dssp             ---BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSST------------TCBCCCCSS-CC
T ss_pred             ---cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHH------------HHHHHHHcC-CC
Confidence               22345679999999999988776 68999999999999999999999764221            111111110 11


Q ss_pred             CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCCc
Q 016594          301 AYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEGDQ  340 (386)
Q Consensus       301 ~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~~~  340 (386)
                      ..+...+..+.+++.+||+.||.+|||+.+++++.+....
T Consensus       226 ~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~  265 (336)
T 3h4j_B          226 VMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVN  265 (336)
T ss_dssp             CCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHTT
T ss_pred             CCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhccC
Confidence            1223345779999999999999999999999998765443

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=6.1e-47  Score=355.60  Aligned_cols=258  Identities=21%  Similarity=0.271  Sum_probs=211.4

Q ss_pred             HHhcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEE
Q 016594           63 IATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYL  140 (386)
Q Consensus        63 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~l  140 (386)
                      ...++|++.+.||+|+||.||+|.++ +++.||+|++............+.+|+.+++.++||||+++++++.+.+ .++
T Consensus        26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l  105 (362)
T 2bdw_A           26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL  105 (362)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence            34578999999999999999999986 6899999999876555666678899999999999999999999998766 899


Q ss_pred             EEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCC---CCeEEeecCcccc
Q 016594          141 IFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTAD---FEPQISDFGLAKW  217 (386)
Q Consensus       141 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~---~~~kl~Dfg~a~~  217 (386)
                      ||||+.+++|.+.+...  ..+++..++.++.||+.||.|||+   ++|+||||||+|||++.+   +.+||+|||++..
T Consensus       106 v~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~  180 (362)
T 2bdw_A          106 VFDLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE  180 (362)
T ss_dssp             EECCCCSCBHHHHHTTC--SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred             EEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence            99999999999888654  348999999999999999999999   999999999999999865   4599999999987


Q ss_pred             CCCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCc
Q 016594          218 LPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPR  297 (386)
Q Consensus       218 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (386)
                      .....   ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.......  ..+. .+..    .  
T Consensus       181 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~--~~i~-~~~~----~--  248 (362)
T 2bdw_A          181 VNDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLY--AQIK-AGAY----D--  248 (362)
T ss_dssp             CTTCC---SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH--HHHH-HTCC----C--
T ss_pred             ecCCc---ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHH--HHHH-hCCC----C--
Confidence            65432   233467999999999999999999999999999999999999999875432111  1000 0000    0  


Q ss_pred             cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 016594          298 LQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLE  337 (386)
Q Consensus       298 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~  337 (386)
                      .........+..+.++|.+||+.||++||++.+++++.+.
T Consensus       249 ~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~  288 (362)
T 2bdw_A          249 YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWI  288 (362)
T ss_dssp             CCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHH
T ss_pred             CCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCccc
Confidence            0000112335679999999999999999999999988654

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=1.4e-47  Score=358.28  Aligned_cols=256  Identities=23%  Similarity=0.324  Sum_probs=205.4

Q ss_pred             HHhcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEecccc-CChHhHHHHHHHHHHHhcc-CCCceeeecceEEeCc-e
Q 016594           63 IATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVV-TDDRKEKEFLTEIGTIGHV-CHPNVLSLLGCCVDNG-L  138 (386)
Q Consensus        63 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~-~  138 (386)
                      +..++|++.+.||+|+||+||+|+++ +++.||||++.+.. ........+.+|..+++.+ +||||+++++++.+.+ .
T Consensus        20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~   99 (353)
T 3txo_A           20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRL   99 (353)
T ss_dssp             ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred             CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEE
Confidence            45678999999999999999999987 68999999997532 1223455678899999988 6999999999998765 8


Q ss_pred             EEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccC
Q 016594          139 YLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWL  218 (386)
Q Consensus       139 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~  218 (386)
                      ++||||+.+|+|..++....  .+++..++.++.||+.||+|||+   ++|+||||||+|||++.++++||+|||++...
T Consensus       100 ~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NILl~~~g~ikL~DFG~a~~~  174 (353)
T 3txo_A          100 FFVMEFVNGGDLMFHIQKSR--RFDEARARFYAAEIISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEG  174 (353)
T ss_dssp             EEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred             EEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCCHHHEEECCCCCEEEccccceeec
Confidence            99999999999999987654  39999999999999999999999   99999999999999999999999999999864


Q ss_pred             CCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCcc
Q 016594          219 PSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRL  298 (386)
Q Consensus       219 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (386)
                      ...  .......+||+.|+|||++.+..++.++|||||||++|||++|..||.+......  ...+..         .. 
T Consensus       175 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~--~~~i~~---------~~-  240 (353)
T 3txo_A          175 ICN--GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDL--FEAILN---------DE-  240 (353)
T ss_dssp             CC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHH---------CC-
T ss_pred             ccC--CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHH--HHHHHc---------CC-
Confidence            332  2234456799999999999999999999999999999999999999987643211  111111         11 


Q ss_pred             CCCCCHHHHHHHHHHHHHccccCCCCCCCH------HHHHHHHhcC
Q 016594          299 QGAYDVTQLNRLAFAASLCIRASPTWRPTM------SEVLEVMLEG  338 (386)
Q Consensus       299 ~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~------~~il~~l~~~  338 (386)
                       ..++...+..+.+++.+||+.||.+||++      .++++|-+..
T Consensus       241 -~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~  285 (353)
T 3txo_A          241 -VVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFK  285 (353)
T ss_dssp             -CCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGT
T ss_pred             -CCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCccc
Confidence             11222345679999999999999999998      8899886654

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-46  Score=348.15  Aligned_cols=255  Identities=19%  Similarity=0.184  Sum_probs=209.3

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEE
Q 016594           65 TNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIF  142 (386)
Q Consensus        65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~  142 (386)
                      .++|++.+.||+|+||+||+|.+. +++.||+|.+...   ......+.+|+.+++.++||||+++++++.+.+ .++||
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~   80 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK---GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIF   80 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC---THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC---cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEE
Confidence            467999999999999999999987 6889999998642   344567889999999999999999999998765 89999


Q ss_pred             EeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcC--CCCeEEeecCccccCCC
Q 016594          143 QFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTA--DFEPQISDFGLAKWLPS  220 (386)
Q Consensus       143 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~--~~~~kl~Dfg~a~~~~~  220 (386)
                      ||+.+++|.+++.... ..+++..++.++.|++.||.|||+   ++|+||||||+|||++.  ++.+||+|||++..+..
T Consensus        81 e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~---~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~  156 (321)
T 1tki_A           81 EFISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP  156 (321)
T ss_dssp             CCCCCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred             EeCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCC
Confidence            9999999999886532 358999999999999999999999   99999999999999987  78999999999987754


Q ss_pred             CCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCC
Q 016594          221 QWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQG  300 (386)
Q Consensus       221 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (386)
                      ..   ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+......  ...+..         .....
T Consensus       157 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~--~~~i~~---------~~~~~  222 (321)
T 1tki_A          157 GD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQI--IENIMN---------AEYTF  222 (321)
T ss_dssp             TC---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH--HHHHHH---------TCCCC
T ss_pred             CC---ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHH--HHHHHc---------CCCCC
Confidence            32   23345689999999999998899999999999999999999999987543211  111110         00000


Q ss_pred             C--CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCCc
Q 016594          301 A--YDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEGDQ  340 (386)
Q Consensus       301 ~--~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~~~  340 (386)
                      .  .....+..+.+++.+||..||.+|||+.+++++.+....
T Consensus       223 ~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  264 (321)
T 1tki_A          223 DEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK  264 (321)
T ss_dssp             CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred             ChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccC
Confidence            0  001235679999999999999999999999998766544

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=1.7e-47  Score=354.12  Aligned_cols=261  Identities=23%  Similarity=0.347  Sum_probs=196.3

Q ss_pred             HHhcCCCCCCeecccCCcEEEEEEECC-Cc---EEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-
Q 016594           63 IATNAFSSENLVGRGGYAEVYKGVLQD-GE---EIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-  137 (386)
Q Consensus        63 ~~~~~~~~~~~lg~G~~g~V~~~~~~~-~~---~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-  137 (386)
                      +..++|++.+.||+|+||.||+|.+.. +.   .||||++............+.+|+.++++++||||+++++++.... 
T Consensus        20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   99 (323)
T 3qup_A           20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRA   99 (323)
T ss_dssp             CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC--
T ss_pred             cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccc
Confidence            456789999999999999999999653 32   7999999875555666788999999999999999999999997654 


Q ss_pred             ------eEEEEEeccCCCHhhhhhhcCC----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCe
Q 016594          138 ------LYLIFQFSSRGSVASLFHDVNS----PGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEP  207 (386)
Q Consensus       138 ------~~lv~e~~~~~~L~~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~  207 (386)
                            .+++|||+.+++|.+++.....    ..+++..++.++.|++.||.|||+   ++|+||||||+|||++.++.+
T Consensus       100 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~ivH~Dikp~NIli~~~~~~  176 (323)
T 3qup_A          100 KGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSS---RNFIHRDLAARNCMLAEDMTV  176 (323)
T ss_dssp             -----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCE
T ss_pred             ccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHc---CCcccCCCCcceEEEcCCCCE
Confidence                  2899999999999998864321    248999999999999999999999   999999999999999999999


Q ss_pred             EEeecCccccCCCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCchhhhhhhhhhhc
Q 016594          208 QISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILN  286 (386)
Q Consensus       208 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~  286 (386)
                      ||+|||++................+++.|+|||.+.+..++.++|||||||++|+|++ |..||.+.......  ..   
T Consensus       177 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~--~~---  251 (323)
T 3qup_A          177 CVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIY--NY---  251 (323)
T ss_dssp             EECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH--HH---
T ss_pred             EEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHH--HH---
Confidence            9999999987654433223334457788999999999999999999999999999999 99999875432111  00   


Q ss_pred             ccccccccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          287 QGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                            +.. ......+...+..+.+++.+||+.||++|||+.++++.|++.
T Consensus       252 ------~~~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~  296 (323)
T 3qup_A          252 ------LIG-GNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENI  296 (323)
T ss_dssp             ------HHT-TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ------Hhc-CCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence                  000 011122233457799999999999999999999999988764

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=2.6e-47  Score=361.63  Aligned_cols=258  Identities=18%  Similarity=0.320  Sum_probs=205.1

Q ss_pred             HhcCCCCCCeecccCCcEEEEEEECCCcEEEEEEeccccCChHhHHHHHHHHHHHhccC--CCceeeecceEEeCc-eEE
Q 016594           64 ATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVC--HPNVLSLLGCCVDNG-LYL  140 (386)
Q Consensus        64 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~-~~l  140 (386)
                      ...+|++.+.||+|+||+||+|...+++.||||++............+.+|+.+++.+.  ||||+++++++.... .++
T Consensus        54 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~l  133 (390)
T 2zmd_A           54 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM  133 (390)
T ss_dssp             TTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             cCCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEE
Confidence            34569999999999999999999888999999999876556666788999999999997  599999999998766 788


Q ss_pred             EEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCC
Q 016594          141 IFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPS  220 (386)
Q Consensus       141 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~  220 (386)
                      ||| +.+++|.+++....  .+++..+..++.||+.||.|||+   ++|+||||||+|||++ ++.+||+|||++..+..
T Consensus       134 v~E-~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~  206 (390)
T 2zmd_A          134 VME-CGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP  206 (390)
T ss_dssp             EEE-CCSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred             EEe-cCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence            888 67789999987654  58899999999999999999999   9999999999999995 57999999999987754


Q ss_pred             CCccccccccccccCccChhhhcc-----------CCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccc
Q 016594          221 QWTHHSIAPIEGTFGHLAPEYFMH-----------GIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGE  289 (386)
Q Consensus       221 ~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~  289 (386)
                      ..........+||+.|+|||++.+           ..++.++|||||||++|+|++|..||..........         
T Consensus       207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~---------  277 (390)
T 2zmd_A          207 DTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKL---------  277 (390)
T ss_dssp             -------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHH---------
T ss_pred             CCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHH---------
Confidence            433333445679999999999875           468999999999999999999999997643322111         


Q ss_pred             cccccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          290 IEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                       ..++++......+...+..+.++|.+||+.||.+|||+.+++++.+..
T Consensus       278 -~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~  325 (390)
T 2zmd_A          278 -HAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ  325 (390)
T ss_dssp             -HHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHH
T ss_pred             -HHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCcc
Confidence             111121111122222346789999999999999999999999986654

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=5.7e-47  Score=358.51  Aligned_cols=265  Identities=20%  Similarity=0.278  Sum_probs=207.4

Q ss_pred             HHhcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCC-hHhHHHHHHHHHHHhcc-CCCceeeecceEEeCc-e
Q 016594           63 IATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTD-DRKEKEFLTEIGTIGHV-CHPNVLSLLGCCVDNG-L  138 (386)
Q Consensus        63 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~-~  138 (386)
                      +..++|++.++||+|+||+||+|+++ +++.||+|++.+.... ......+.+|..++.++ +||||+++++++.+.. .
T Consensus        49 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~  128 (396)
T 4dc2_A           49 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL  128 (396)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred             CChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEE
Confidence            34568999999999999999999987 6889999999864322 23345578899999887 7999999999998766 8


Q ss_pred             EEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccC
Q 016594          139 YLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWL  218 (386)
Q Consensus       139 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~  218 (386)
                      ++||||+.+|+|..++....  .+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++..
T Consensus       129 ~lV~E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DFGla~~~  203 (396)
T 4dc2_A          129 FFVIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG  203 (396)
T ss_dssp             EEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred             EEEEEcCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEECCCCCEEEeecceeeec
Confidence            99999999999999887654  49999999999999999999999   99999999999999999999999999999863


Q ss_pred             CCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCcc
Q 016594          219 PSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRL  298 (386)
Q Consensus       219 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (386)
                      ...  .......+||+.|+|||++.+..++.++|||||||++|||++|..||.............  .......+.... 
T Consensus       204 ~~~--~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~--~~~~~~~i~~~~-  278 (396)
T 4dc2_A          204 LRP--GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNT--EDYLFQVILEKQ-  278 (396)
T ss_dssp             CCT--TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CC--HHHHHHHHHHCC-
T ss_pred             ccC--CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhh--HHHHHHHHhccc-
Confidence            322  123456789999999999999999999999999999999999999996532110000000  000000011111 


Q ss_pred             CCCCCHHHHHHHHHHHHHccccCCCCCCCH------HHHHHHHhcC
Q 016594          299 QGAYDVTQLNRLAFAASLCIRASPTWRPTM------SEVLEVMLEG  338 (386)
Q Consensus       299 ~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~------~~il~~l~~~  338 (386)
                       ..++...+..+.++|.+||+.||.+||++      .+|++|-+..
T Consensus       279 -~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~  323 (396)
T 4dc2_A          279 -IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFR  323 (396)
T ss_dssp             -CCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTT
T ss_pred             -cCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCcccc
Confidence             11223345779999999999999999985      7888886554

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=7.3e-48  Score=349.77  Aligned_cols=257  Identities=21%  Similarity=0.350  Sum_probs=208.0

Q ss_pred             HHHhcCCCCCCeecccCCcEEEEEEECCCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEE
Q 016594           62 SIATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYL  140 (386)
Q Consensus        62 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~l  140 (386)
                      .+..++|++.+.||+|+||.||+|.++++..||+|++.....   ....+.+|+.++++++||||+++++++.+.. .++
T Consensus        20 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l   96 (283)
T 3gen_A           20 EIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM---SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFI   96 (283)
T ss_dssp             BCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB---CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             cCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC---CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEE
Confidence            355678999999999999999999998888999999975432   2356889999999999999999999997755 899


Q ss_pred             EEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCC
Q 016594          141 IFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPS  220 (386)
Q Consensus       141 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~  220 (386)
                      ||||+.+++|.+++.... ..+++..++.++.|++.||.|||+   ++|+||||||+||+++.++.+||+|||++.....
T Consensus        97 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~  172 (283)
T 3gen_A           97 ITEYMANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD  172 (283)
T ss_dssp             EECCCTTCBHHHHHHCGG-GCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCC
T ss_pred             EEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCccceEEEcCCCCEEEccccccccccc
Confidence            999999999999987532 349999999999999999999999   9999999999999999999999999999987643


Q ss_pred             CCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCchhhhhhhhhhhcccccccccCCccC
Q 016594          221 QWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQ  299 (386)
Q Consensus       221 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (386)
                      .. ........+|+.|+|||++.+..++.++||||||+++|+|++ |..||..........  .. .         ....
T Consensus       173 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~--~~-~---------~~~~  239 (283)
T 3gen_A          173 DE-YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAE--HI-A---------QGLR  239 (283)
T ss_dssp             HH-HHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHH--HH-H---------TTCC
T ss_pred             cc-cccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHH--HH-h---------cccC
Confidence            31 112233446788999999999999999999999999999998 999998754321111  00 0         0111


Q ss_pred             CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          300 GAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       300 ~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                      ...+...+..+.+++.+||+.||.+|||+.+++++|...
T Consensus       240 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~  278 (283)
T 3gen_A          240 LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV  278 (283)
T ss_dssp             CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence            111222346799999999999999999999999998754

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=1.8e-47  Score=348.48  Aligned_cols=264  Identities=28%  Similarity=0.452  Sum_probs=203.4

Q ss_pred             HHHhcCCCCCCeecccCCcEEEEEEECCCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCceEEE
Q 016594           62 SIATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNGLYLI  141 (386)
Q Consensus        62 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~lv  141 (386)
                      ++..++|++.+.||+|+||+||+|.+.  ..||+|++............+.+|+.+++.++||||++++++......++|
T Consensus        20 ei~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~lv   97 (289)
T 3og7_A           20 EIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQLAIV   97 (289)
T ss_dssp             BCCTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEE
T ss_pred             ccCccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeeccCCccEEE
Confidence            466789999999999999999999865  359999998766666677889999999999999999999998777779999


Q ss_pred             EEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCC
Q 016594          142 FQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQ  221 (386)
Q Consensus       142 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  221 (386)
                      |||+.+++|.+++.... ..+++..++.++.|++.||.|||+   ++|+||||||+||+++.++.+||+|||++......
T Consensus        98 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  173 (289)
T 3og7_A           98 TQWCEGSSLYHHLHASE-TKFEMKKLIDIARQTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRW  173 (289)
T ss_dssp             EECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTEEEECCCC--------
T ss_pred             EEecCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHh---CCcccccCccceEEECCCCCEEEccceeccccccc
Confidence            99999999999886543 458999999999999999999999   99999999999999999999999999999866543


Q ss_pred             CccccccccccccCccChhhhc---cCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCcc
Q 016594          222 WTHHSIAPIEGTFGHLAPEYFM---HGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRL  298 (386)
Q Consensus       222 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (386)
                      ..........||+.|+|||++.   +..++.++|||||||++|+|++|..||.+.......  ..........    +..
T Consensus       174 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~--~~~~~~~~~~----~~~  247 (289)
T 3og7_A          174 SGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI--IEMVGRGSLS----PDL  247 (289)
T ss_dssp             ----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHH--HHHHHHTSCC----CCT
T ss_pred             cccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHH--HHHhcccccC----cch
Confidence            3333344567999999999987   667889999999999999999999999865432111  1111111111    100


Q ss_pred             CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          299 QGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       299 ~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                       ......++..+.+++.+||+.||.+|||+.++++.|++.
T Consensus       248 -~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l  286 (289)
T 3og7_A          248 -SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEEL  286 (289)
T ss_dssp             -TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred             -hhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence             111223457799999999999999999999999999765

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=5.2e-47  Score=345.20  Aligned_cols=265  Identities=22%  Similarity=0.323  Sum_probs=203.2

Q ss_pred             cCCCCCCeecccCCcEEEEEEECCCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEEEe
Q 016594           66 NAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQF  144 (386)
Q Consensus        66 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~  144 (386)
                      ++|++.+.||+|+||+||+|...+++.||+|++............+.+|+.+++.++||||+++++++.+.+ .++|||+
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence            478899999999999999999988999999999764433434567889999999999999999999998755 8999999


Q ss_pred             ccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCcc
Q 016594          145 SSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTH  224 (386)
Q Consensus       145 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  224 (386)
                      +.+ +|.+++.... ..+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||++.......  
T Consensus        82 ~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--  154 (288)
T 1ob3_A           82 LDQ-DLKKLLDVCE-GGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV--  154 (288)
T ss_dssp             CSE-EHHHHHHTST-TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred             cCC-CHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEeECccccccCccc--
Confidence            986 8888876533 458999999999999999999999   999999999999999999999999999998664321  


Q ss_pred             ccccccccccCccChhhhcc-CCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhh-hhhhhccc------cccc--cc
Q 016594          225 HSIAPIEGTFGHLAPEYFMH-GIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSW-AKPILNQG------EIEK--LV  294 (386)
Q Consensus       225 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~-~~~~~~~~------~~~~--~~  294 (386)
                      .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+........ ........      ....  ..
T Consensus       155 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (288)
T 1ob3_A          155 RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY  234 (288)
T ss_dssp             -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred             cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccccc
Confidence            12234468999999999976 458999999999999999999999998754321110 00000000      0000  00


Q ss_pred             CCccC-------CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 016594          295 DPRLQ-------GAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLE  337 (386)
Q Consensus       295 ~~~~~-------~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~  337 (386)
                      ++...       .......+..+.+++.+||+.||++|||+.+++++-+.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f  284 (288)
T 1ob3_A          235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYF  284 (288)
T ss_dssp             CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGG
T ss_pred             ccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcch
Confidence            00000       01112245678999999999999999999999987553

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.7e-46  Score=347.90  Aligned_cols=257  Identities=21%  Similarity=0.264  Sum_probs=208.8

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCCh----HhHHHHHHHHHHHhccCCCceeeecceEEeCc-e
Q 016594           65 TNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDD----RKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-L  138 (386)
Q Consensus        65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~  138 (386)
                      .++|.+.+.||+|+||.||+|... +++.||+|++.......    .....+.+|+.+++.++||||+++++++.+.. .
T Consensus        10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   89 (326)
T 2y0a_A           10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   89 (326)
T ss_dssp             HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            456899999999999999999987 68999999997643221    23567899999999999999999999998765 8


Q ss_pred             EEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCC----CeEEeecCc
Q 016594          139 YLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADF----EPQISDFGL  214 (386)
Q Consensus       139 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~----~~kl~Dfg~  214 (386)
                      ++||||+.+++|.+++...  ..+++..++.++.|++.||.|||+   ++|+||||||+|||++.++    .+||+|||+
T Consensus        90 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~  164 (326)
T 2y0a_A           90 ILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL  164 (326)
T ss_dssp             EEEEECCCSCBHHHHHTTS--SCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCSSSSSCCEEECCCTT
T ss_pred             EEEEEcCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHH---CCeEcCCCCHHHEEEecCCCCCCCEEEEECCC
Confidence            9999999999999998653  459999999999999999999999   9999999999999999877    799999999


Q ss_pred             cccCCCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhccccccccc
Q 016594          215 AKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLV  294 (386)
Q Consensus       215 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  294 (386)
                      +.......   ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.........  ... .      
T Consensus       165 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~--~~~-~------  232 (326)
T 2y0a_A          165 AHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLAN--VSA-V------  232 (326)
T ss_dssp             CEECCTTS---CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHH--HHH-T------
T ss_pred             CeECCCCC---ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHH--HHh-c------
Confidence            98775332   23345699999999999999999999999999999999999999987543211100  000 0      


Q ss_pred             CCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          295 DPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       295 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                      ............+..+.+++.+||..||++|||+.+++++.+..
T Consensus       233 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~  276 (326)
T 2y0a_A          233 NYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK  276 (326)
T ss_dssp             CCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTS
T ss_pred             CCCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCcc
Confidence            00000000012246789999999999999999999999986654

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=2.7e-46  Score=345.45  Aligned_cols=268  Identities=18%  Similarity=0.247  Sum_probs=211.6

Q ss_pred             HhcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeC---ceE
Q 016594           64 ATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDN---GLY  139 (386)
Q Consensus        64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~---~~~  139 (386)
                      ..++|++.+.||+|+||+||+|.+. +++.||||++..... ......+.+|+.++++++||||+++++++...   ..+
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   85 (319)
T 4euu_A            7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKV   85 (319)
T ss_dssp             SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEE
T ss_pred             CCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEE
Confidence            3567999999999999999999987 589999999975322 22356678999999999999999999999764   379


Q ss_pred             EEEEeccCCCHhhhhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeE----cCCCCeEEeecCc
Q 016594          140 LIFQFSSRGSVASLFHDVNS-PGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILL----TADFEPQISDFGL  214 (386)
Q Consensus       140 lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill----~~~~~~kl~Dfg~  214 (386)
                      +||||+.+++|.+++..... ..+++..++.++.|++.||.|||+   ++|+||||||+|||+    +.++.+||+|||+
T Consensus        86 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~  162 (319)
T 4euu_A           86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA  162 (319)
T ss_dssp             EEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEECTTSCEEEEECCCTT
T ss_pred             EEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEeccCCCCceEEEccCCC
Confidence            99999999999999876433 348999999999999999999999   999999999999999    7788899999999


Q ss_pred             cccCCCCCccccccccccccCccChhhhc--------cCCCCcccchHHHHHHHHHHHhCCCCCCCCchhh--hhhhhhh
Q 016594          215 AKWLPSQWTHHSIAPIEGTFGHLAPEYFM--------HGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSL--HSWAKPI  284 (386)
Q Consensus       215 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~--~~~~~~~  284 (386)
                      +.......   ......||+.|+|||++.        +..++.++|||||||++|+|++|..||.......  .......
T Consensus       163 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~  239 (319)
T 4euu_A          163 ARELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI  239 (319)
T ss_dssp             CEECCTTC---CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHH
T ss_pred             ceecCCCC---ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHH
Confidence            98775432   223456999999999986        5778999999999999999999999997533211  1111111


Q ss_pred             hccc---ccc---ccc--------CCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          285 LNQG---EIE---KLV--------DPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       285 ~~~~---~~~---~~~--------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                      ....   .+.   ...        ...............+.+++.+||+.||++|||+.+++++..+.
T Consensus       240 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~  307 (319)
T 4euu_A          240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI  307 (319)
T ss_dssp             HHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred             hcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence            1100   000   000        01112234567788899999999999999999999999998754

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=3.5e-47  Score=350.15  Aligned_cols=252  Identities=23%  Similarity=0.298  Sum_probs=201.3

Q ss_pred             HHhcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhcc-CCCceeeecceEEeCc-eE
Q 016594           63 IATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHV-CHPNVLSLLGCCVDNG-LY  139 (386)
Q Consensus        63 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~-~~  139 (386)
                      ...++|++.++||+|+||+||+|.+. +++.||||++...............|+..+..+ .||||+++++++.+++ .+
T Consensus        54 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~  133 (311)
T 3p1a_A           54 FFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILY  133 (311)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             hhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEE
Confidence            45578999999999999999999987 799999999876555555666677777777666 7999999999998766 88


Q ss_pred             EEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCC
Q 016594          140 LIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLP  219 (386)
Q Consensus       140 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~  219 (386)
                      +|||++ +++|.+++.... ..+++..++.++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||++....
T Consensus       134 lv~e~~-~~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~  208 (311)
T 3p1a_A          134 LQTELC-GPSLQQHCEAWG-ASLPEAQVWGYLRDTLLALAHLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELG  208 (311)
T ss_dssp             EEEECC-CCBHHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECGGGCEEECCCTTCEECC
T ss_pred             EEEecc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEccceeeeecc
Confidence            999999 668888876653 459999999999999999999999   999999999999999999999999999998765


Q ss_pred             CCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccC
Q 016594          220 SQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQ  299 (386)
Q Consensus       220 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (386)
                      ...   ......||+.|+|||++.+ .++.++|||||||++|+|++|..|+.+.... ..             +......
T Consensus       209 ~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~~-~~-------------~~~~~~~  270 (311)
T 3p1a_A          209 TAG---AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGW-QQ-------------LRQGYLP  270 (311)
T ss_dssp             ---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHH-HH-------------HTTTCCC
T ss_pred             cCC---CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHH-HH-------------HhccCCC
Confidence            432   2334569999999999876 7899999999999999999997766543211 00             0000011


Q ss_pred             CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 016594          300 GAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLE  337 (386)
Q Consensus       300 ~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~  337 (386)
                      .......+..+.+++.+||+.||++|||+.+++++.+.
T Consensus       271 ~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~  308 (311)
T 3p1a_A          271 PEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVL  308 (311)
T ss_dssp             HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGG
T ss_pred             cccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCccc
Confidence            11111235679999999999999999999999987654

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=3.3e-47  Score=345.18  Aligned_cols=258  Identities=22%  Similarity=0.363  Sum_probs=200.4

Q ss_pred             HHhcCCCCCCeecccCCcEEEEEEECC----CcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCce
Q 016594           63 IATNAFSSENLVGRGGYAEVYKGVLQD----GEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNGL  138 (386)
Q Consensus        63 ~~~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  138 (386)
                      +..++|++.+.||+|+||.||+|.+..    +..||+|.+... ........+.+|+.++++++||||+++++++.++..
T Consensus        12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   90 (281)
T 1mp8_A           12 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPV   90 (281)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT-TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSC
T ss_pred             EehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCccceEEEEEccCcc
Confidence            456789999999999999999999752    457999988753 334456778999999999999999999999977779


Q ss_pred             EEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccC
Q 016594          139 YLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWL  218 (386)
Q Consensus       139 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~  218 (386)
                      ++||||+.+++|.+++... ...+++..++.++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||++...
T Consensus        91 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  166 (281)
T 1mp8_A           91 WIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM  166 (281)
T ss_dssp             EEEEECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred             EEEEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHEEECCCCCEEECcccccccc
Confidence            9999999999999998754 3358999999999999999999999   99999999999999999999999999999876


Q ss_pred             CCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCchhhhhhhhhhhcccccccccCCc
Q 016594          219 PSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGEIEKLVDPR  297 (386)
Q Consensus       219 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (386)
                      ..... .......+++.|+|||++.+..++.++|||||||++|+|++ |..||.+.......  ..+ ..         .
T Consensus       167 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~--~~i-~~---------~  233 (281)
T 1mp8_A          167 EDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI--GRI-EN---------G  233 (281)
T ss_dssp             -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH--HHH-HT---------T
T ss_pred             Ccccc-cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHH--HHH-Hc---------C
Confidence            54321 12223346788999999999999999999999999999997 99999875432110  000 00         0


Q ss_pred             cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          298 LQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       298 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                      .....+...+..+.+++.+||+.||++|||+.++++.|...
T Consensus       234 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~  274 (281)
T 1mp8_A          234 ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI  274 (281)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            11112234457799999999999999999999999998764

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=3.3e-47  Score=358.81  Aligned_cols=259  Identities=22%  Similarity=0.360  Sum_probs=199.1

Q ss_pred             HHhcCCCCCCeecccCCcEEEEEEEC----CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-
Q 016594           63 IATNAFSSENLVGRGGYAEVYKGVLQ----DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-  137 (386)
Q Consensus        63 ~~~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-  137 (386)
                      +..++|.+.+.||+|+||.||+|+++    ++..||||++.... .......+.+|+.++++++||||+++++++.+.. 
T Consensus        42 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  120 (373)
T 2qol_A           42 LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY-TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKP  120 (373)
T ss_dssp             CCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred             cCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCc
Confidence            34568999999999999999999864    46789999997532 3455678999999999999999999999997755 


Q ss_pred             eEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCcccc
Q 016594          138 LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKW  217 (386)
Q Consensus       138 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~  217 (386)
                      .++||||+.+++|.+++... ...+++..++.++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||++..
T Consensus       121 ~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  196 (373)
T 2qol_A          121 VMIVTEYMENGSLDSFLRKH-DAQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLGRV  196 (373)
T ss_dssp             CEEEEECCTTCBHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred             eEEEEeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEEcCCCCEEECcCccccc
Confidence            89999999999999998754 3458999999999999999999999   9999999999999999999999999999987


Q ss_pred             CCCCCcc-ccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCchhhhhhhhhhhcccccccccC
Q 016594          218 LPSQWTH-HSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGEIEKLVD  295 (386)
Q Consensus       218 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  295 (386)
                      ....... .......+++.|+|||++.+..++.++|||||||++|||++ |..||.........  .          .+.
T Consensus       197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~--~----------~i~  264 (373)
T 2qol_A          197 LEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVI--K----------AVD  264 (373)
T ss_dssp             -----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHH--H----------HHH
T ss_pred             cccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHH--H----------HHH
Confidence            6543211 11122335778999999999999999999999999999998 99999765432111  0          011


Q ss_pred             CccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          296 PRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       296 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                      .......+..++..+.+++.+||+.||.+||++.+|++.|...
T Consensus       265 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~  307 (373)
T 2qol_A          265 EGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL  307 (373)
T ss_dssp             TTEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             cCCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHH
Confidence            1111122234457799999999999999999999999988665

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=1.4e-47  Score=347.24  Aligned_cols=259  Identities=23%  Similarity=0.384  Sum_probs=213.5

Q ss_pred             HHHHhcCCCCCCeecccCCcEEEEEEECCCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCceEE
Q 016594           61 ISIATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNGLYL  140 (386)
Q Consensus        61 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~l  140 (386)
                      +.+..++|++.+.||+|+||.||+|.+.++..||+|.+.....   ....+.+|+.+++.++||||+++++++.++..++
T Consensus         8 ~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   84 (279)
T 1qpc_A            8 WEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM---SPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYI   84 (279)
T ss_dssp             TBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEE
T ss_pred             cccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcc---cHHHHHHHHHHHHhCCCcCcceEEEEEcCCCcEE
Confidence            3456678999999999999999999998888999999875332   3457889999999999999999999998878999


Q ss_pred             EEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCC
Q 016594          141 IFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPS  220 (386)
Q Consensus       141 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~  220 (386)
                      +|||+.+++|.+++.......+++..++.++.|++.||.|||+   ++++||||||+||+++.++.+||+|||++.....
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  161 (279)
T 1qpc_A           85 ITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIED  161 (279)
T ss_dssp             EEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             EEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHhhEEEcCCCCEEECCCcccccccC
Confidence            9999999999999876543458999999999999999999999   9999999999999999999999999999987754


Q ss_pred             CCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCchhhhhhhhhhhcccccccccCCccC
Q 016594          221 QWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQ  299 (386)
Q Consensus       221 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (386)
                      ... .......++..|+|||++.+..++.++|||||||++|+|++ |..||.+.......  ... ..         ...
T Consensus       162 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~--~~~-~~---------~~~  228 (279)
T 1qpc_A          162 NEY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI--QNL-ER---------GYR  228 (279)
T ss_dssp             SCE-ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH--HHH-HT---------TCC
T ss_pred             ccc-ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHH--HHH-hc---------ccC
Confidence            321 22233456788999999998999999999999999999999 99999875432111  100 00         011


Q ss_pred             CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          300 GAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       300 ~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                      ...+...+..+.+++.+||+.||++|||+.++++.|...
T Consensus       229 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~  267 (279)
T 1qpc_A          229 MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF  267 (279)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence            112223457799999999999999999999999988764

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=9.8e-47  Score=346.64  Aligned_cols=269  Identities=22%  Similarity=0.320  Sum_probs=203.7

Q ss_pred             HHHhcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCC---hHhHHHHHHHHHHHhccC---CCceeeecceEE
Q 016594           62 SIATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTD---DRKEKEFLTEIGTIGHVC---HPNVLSLLGCCV  134 (386)
Q Consensus        62 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~  134 (386)
                      .+..++|++.+.||+|+||+||+|.+. +++.||||++......   ......+.+|+.+++.+.   ||||+++++++.
T Consensus         5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~   84 (308)
T 3g33_A            5 SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCA   84 (308)
T ss_dssp             -----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEE
T ss_pred             cccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeee
Confidence            356789999999999999999999975 6899999998753221   112345566777766664   999999999997


Q ss_pred             eCc------eEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeE
Q 016594          135 DNG------LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQ  208 (386)
Q Consensus       135 ~~~------~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~k  208 (386)
                      ...      .+++||++. ++|.+++.......+++..++.++.|++.||+|||+   ++|+||||||+|||++.++.+|
T Consensus        85 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~~k  160 (308)
T 3g33_A           85 TSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGTVK  160 (308)
T ss_dssp             ECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCTTTEEECTTSCEE
T ss_pred             ccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCEE
Confidence            643      688999997 499999987766679999999999999999999999   9999999999999999999999


Q ss_pred             EeecCccccCCCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhh-hhhhhcc
Q 016594          209 ISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSW-AKPILNQ  287 (386)
Q Consensus       209 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~-~~~~~~~  287 (386)
                      |+|||++.......   ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+........ .......
T Consensus       161 l~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~  237 (308)
T 3g33_A          161 LADFGLARIYSYQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGL  237 (308)
T ss_dssp             ECSCSCTTTSTTCC---CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred             EeeCccccccCCCc---ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence            99999998765332   2344568999999999999999999999999999999999999998765432111 1000000


Q ss_pred             ---ccccc-------ccCCccCC---CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 016594          288 ---GEIEK-------LVDPRLQG---AYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLE  337 (386)
Q Consensus       288 ---~~~~~-------~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~  337 (386)
                         .....       .+.+....   ......+..+.+++.+||+.||++|||+.++++|-+.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~  300 (308)
T 3g33_A          238 PPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYL  300 (308)
T ss_dssp             CCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC
T ss_pred             CChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccc
Confidence               00000       00000000   0011234678999999999999999999999987654

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=1e-46  Score=352.78  Aligned_cols=260  Identities=22%  Similarity=0.293  Sum_probs=207.8

Q ss_pred             HhcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEecccc---CChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-e
Q 016594           64 ATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVV---TDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-L  138 (386)
Q Consensus        64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~  138 (386)
                      ..+.|++.+.||+|+||+||+|.++ +++.||||++....   ........+.+|+.+++.++||||+++++++.+++ .
T Consensus        22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  101 (351)
T 3c0i_A           22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGML  101 (351)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred             cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            3567999999999999999999986 68999999986421   11224567899999999999999999999998766 8


Q ss_pred             EEEEEeccCCCHhhhhhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCC---eEEeecC
Q 016594          139 YLIFQFSSRGSVASLFHDV--NSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFE---PQISDFG  213 (386)
Q Consensus       139 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~---~kl~Dfg  213 (386)
                      ++||||+.+++|.+.+...  ....+++..++.++.||+.||.|||+   ++|+||||||+|||++.++.   +||+|||
T Consensus       102 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg  178 (351)
T 3c0i_A          102 YMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFG  178 (351)
T ss_dssp             EEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECSSSTTCCEEECCCT
T ss_pred             EEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChHHeEEecCCCCCcEEEecCc
Confidence            9999999999998877543  23458999999999999999999999   99999999999999986654   9999999


Q ss_pred             ccccCCCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccc
Q 016594          214 LAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKL  293 (386)
Q Consensus       214 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  293 (386)
                      ++.......  .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+..........   . ....  
T Consensus       179 ~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~i~---~-~~~~--  250 (351)
T 3c0i_A          179 VAIQLGESG--LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGII---K-GKYK--  250 (351)
T ss_dssp             TCEECCTTS--CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHHHHHHHH---H-TCCC--
T ss_pred             ceeEecCCC--eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHHHHHHHH---c-CCCC--
Confidence            998775432  1234457999999999999999999999999999999999999999875432211110   0 0000  


Q ss_pred             cCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          294 VDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       294 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                      ..+.    .....+..+.++|.+||+.||++|||+.+++++.+..
T Consensus       251 ~~~~----~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~  291 (351)
T 3c0i_A          251 MNPR----QWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLK  291 (351)
T ss_dssp             CCHH----HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHH
T ss_pred             CCcc----ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhc
Confidence            0000    0012346799999999999999999999999876543

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=6.7e-47  Score=356.82  Aligned_cols=257  Identities=20%  Similarity=0.297  Sum_probs=208.3

Q ss_pred             HhcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEecccc-CChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEE
Q 016594           64 ATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVV-TDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYL  140 (386)
Q Consensus        64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~l  140 (386)
                      ..++|++.+.||+|+||.||+|... +++.||+|++.+.. ........+.+|+.+++.++||||+++++++.+.. .++
T Consensus        13 ~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l   92 (384)
T 4fr4_A           13 NFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFM   92 (384)
T ss_dssp             CGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence            3467899999999999999999977 68899999987532 12234567889999999999999999999998765 899


Q ss_pred             EEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCC
Q 016594          141 IFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPS  220 (386)
Q Consensus       141 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~  220 (386)
                      ||||+.+|+|..++...  ..+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||++..+..
T Consensus        93 v~e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  167 (384)
T 4fr4_A           93 VVDLLLGGDLRYHLQQN--VHFKEETVKLFICELVMALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR  167 (384)
T ss_dssp             EECCCTTEEHHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence            99999999999998753  349999999999999999999999   9999999999999999999999999999987654


Q ss_pred             CCccccccccccccCccChhhhcc---CCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCc
Q 016594          221 QWTHHSIAPIEGTFGHLAPEYFMH---GIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPR  297 (386)
Q Consensus       221 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (386)
                      .   ......+||+.|+|||++.+   ..++.++|||||||++|+|++|..||.................          
T Consensus       168 ~---~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~----------  234 (384)
T 4fr4_A          168 E---TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFET----------  234 (384)
T ss_dssp             T---CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHH----------
T ss_pred             C---CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhh----------
Confidence            3   23345679999999999974   4589999999999999999999999975432211111100000          


Q ss_pred             cCCCCCHHHHHHHHHHHHHccccCCCCCCC-HHHHHHHHhcC
Q 016594          298 LQGAYDVTQLNRLAFAASLCIRASPTWRPT-MSEVLEVMLEG  338 (386)
Q Consensus       298 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt-~~~il~~l~~~  338 (386)
                      ....++...+..+.++|.+||+.||.+||+ +.+++++.+..
T Consensus       235 ~~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~  276 (384)
T 4fr4_A          235 TVVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMN  276 (384)
T ss_dssp             CCCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGT
T ss_pred             cccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhh
Confidence            011122334577999999999999999998 88888765544

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=8.3e-47  Score=350.11  Aligned_cols=265  Identities=22%  Similarity=0.271  Sum_probs=213.5

Q ss_pred             HHHHHHhcCCCCC-CeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccC-CCceeeecceEEe
Q 016594           59 EEISIATNAFSSE-NLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVC-HPNVLSLLGCCVD  135 (386)
Q Consensus        59 ~~~~~~~~~~~~~-~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~  135 (386)
                      +..+...++|.+. +.||+|+||.||+|... +++.||+|++............+.+|+.+++.+. ||||+++++++.+
T Consensus        21 ~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~  100 (327)
T 3lm5_A           21 QSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYEN  100 (327)
T ss_dssp             BCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred             HHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEe
Confidence            3345677788887 89999999999999987 6899999999876555556778999999999996 7999999999987


Q ss_pred             Cc-eEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcC---CCCeEEee
Q 016594          136 NG-LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTA---DFEPQISD  211 (386)
Q Consensus       136 ~~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~---~~~~kl~D  211 (386)
                      .. .++||||+.+++|.+++.......+++..++.++.|++.||+|||+   ++|+||||||+|||++.   ++.+||+|
T Consensus       101 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~---~givH~Dikp~NIl~~~~~~~~~~kL~D  177 (327)
T 3lm5_A          101 TSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDIKIVD  177 (327)
T ss_dssp             SSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESCBTTBCCEEECC
T ss_pred             CCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCChHHEEEecCCCCCcEEEee
Confidence            65 8999999999999999876656679999999999999999999999   99999999999999997   78999999


Q ss_pred             cCccccCCCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccc
Q 016594          212 FGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIE  291 (386)
Q Consensus       212 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  291 (386)
                      ||++.......   ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.............      
T Consensus       178 fg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~------  248 (327)
T 3lm5_A          178 FGMSRKIGHAC---ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQV------  248 (327)
T ss_dssp             GGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT------
T ss_pred             CccccccCCcc---ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhc------
Confidence            99998765332   223456999999999999999999999999999999999999999876543211110000      


Q ss_pred             cccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          292 KLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                         ............+..+.+++.+||+.||.+|||+.+++++.+..
T Consensus       249 ---~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~  292 (327)
T 3lm5_A          249 ---NVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQ  292 (327)
T ss_dssp             ---CCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGC
T ss_pred             ---ccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhc
Confidence               00111111123456799999999999999999999999986654

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=1.7e-46  Score=346.27  Aligned_cols=252  Identities=24%  Similarity=0.327  Sum_probs=209.4

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccC-ChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEE
Q 016594           65 TNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVT-DDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLI  141 (386)
Q Consensus        65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv  141 (386)
                      .++|++.+.||+|+||+||+|+.+ +|+.||+|++.+... .......+.+|+.+++.++||||+++++++.+.. .++|
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv   84 (318)
T 1fot_A            5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI   84 (318)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence            467899999999999999999986 689999999975321 1223456788999999999999999999998765 8999


Q ss_pred             EEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCC
Q 016594          142 FQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQ  221 (386)
Q Consensus       142 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  221 (386)
                      |||+.+|+|.+++....  .+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||++......
T Consensus        85 ~e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~  159 (318)
T 1fot_A           85 MDYIEGGELFSLLRKSQ--RFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV  159 (318)
T ss_dssp             ECCCCSCBHHHHHHHTS--SCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred             EeCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChheEEEcCCCCEEEeecCcceecCCc
Confidence            99999999999987643  48999999999999999999999   99999999999999999999999999999876432


Q ss_pred             CccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCCC
Q 016594          222 WTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGA  301 (386)
Q Consensus       222 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (386)
                           ....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+......  ...+..         ...  .
T Consensus       160 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--~~~i~~---------~~~--~  221 (318)
T 1fot_A          160 -----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT--YEKILN---------AEL--R  221 (318)
T ss_dssp             -----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH--HHHHHH---------CCC--C
T ss_pred             -----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH--HHHHHh---------CCC--C
Confidence                 2356799999999999999999999999999999999999999987543211  111111         111  1


Q ss_pred             CCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHHhcCC
Q 016594          302 YDVTQLNRLAFAASLCIRASPTWRP-----TMSEVLEVMLEGD  339 (386)
Q Consensus       302 ~~~~~~~~l~~li~~cl~~dP~~Rp-----t~~~il~~l~~~~  339 (386)
                      ++...+..+.+++.+||..||++||     ++.++++|-+...
T Consensus       222 ~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~  264 (318)
T 1fot_A          222 FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKE  264 (318)
T ss_dssp             CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSS
T ss_pred             CCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccC
Confidence            2223456799999999999999999     8999999876543

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=1.6e-47  Score=366.75  Aligned_cols=266  Identities=19%  Similarity=0.236  Sum_probs=210.5

Q ss_pred             HHHHHhcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccC-ChHhHHHHHHHHHHHhccCCCceeeecceEEeCc
Q 016594           60 EISIATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVT-DDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG  137 (386)
Q Consensus        60 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  137 (386)
                      .+.+..++|++.++||+|+||+||+|+++ +++.||+|++.+... .......+.+|+.++..++||||+++++++.+..
T Consensus        68 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~  147 (437)
T 4aw2_A           68 QMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDN  147 (437)
T ss_dssp             HHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSS
T ss_pred             cccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCC
Confidence            34455689999999999999999999987 588999999975211 1112234788999999999999999999998766


Q ss_pred             -eEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccc
Q 016594          138 -LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAK  216 (386)
Q Consensus       138 -~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~  216 (386)
                       .++||||+.+|+|.+++... ...+++..++.++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||++.
T Consensus       148 ~~~lV~Ey~~gg~L~~~l~~~-~~~l~e~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILl~~~g~vkL~DFGla~  223 (437)
T 4aw2_A          148 NLYLVMDYYVGGDLLTLLSKF-EDRLPEEMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCL  223 (437)
T ss_dssp             EEEEEECCCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             EEEEEEecCCCCcHHHHHHHc-cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeeEcCCCCEEEcchhhhh
Confidence             89999999999999999763 3459999999999999999999999   999999999999999999999999999998


Q ss_pred             cCCCCCccccccccccccCccChhhhc-----cCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccc
Q 016594          217 WLPSQWTHHSIAPIEGTFGHLAPEYFM-----HGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIE  291 (386)
Q Consensus       217 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  291 (386)
                      .+..... ......+||+.|+|||++.     ...++.++|||||||++|||++|+.||.+.......  ..+.....  
T Consensus       224 ~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~--~~i~~~~~--  298 (437)
T 4aw2_A          224 KLMEDGT-VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETY--GKIMNHKE--  298 (437)
T ss_dssp             ECCTTSC-EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH--HHHHTHHH--
T ss_pred             hcccCCC-cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHH--Hhhhhccc--
Confidence            7654322 2234467999999999997     467899999999999999999999999875432111  11111000  


Q ss_pred             cccCCccCCCCCHHHHHHHHHHHHHccccCCCC--CCCHHHHHHHHhcC
Q 016594          292 KLVDPRLQGAYDVTQLNRLAFAASLCIRASPTW--RPTMSEVLEVMLEG  338 (386)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--Rpt~~~il~~l~~~  338 (386)
                      ...-+    ......+..+.+||.+||..+|++  ||++.++++|-+..
T Consensus       299 ~~~~p----~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~  343 (437)
T 4aw2_A          299 RFQFP----TQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFS  343 (437)
T ss_dssp             HCCCC----SSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGT
T ss_pred             cccCC----cccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccC
Confidence            00000    011124567999999999888888  99999999987654

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=6.2e-46  Score=343.33  Aligned_cols=251  Identities=22%  Similarity=0.319  Sum_probs=206.1

Q ss_pred             CCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEEEec
Q 016594           68 FSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQFS  145 (386)
Q Consensus        68 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~~  145 (386)
                      |...+.||+|+||.||+|... +|+.||||++....  ......+.+|+.+++.++||||+++++++...+ .++||||+
T Consensus        47 ~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  124 (321)
T 2c30_A           47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK--QQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFL  124 (321)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT--CCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             hhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccc--hhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecC
Confidence            666789999999999999987 79999999987533  334567889999999999999999999998765 89999999


Q ss_pred             cCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCccc
Q 016594          146 SRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHH  225 (386)
Q Consensus       146 ~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  225 (386)
                      .+++|.+++..   ..+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||++........  
T Consensus       125 ~~~~L~~~l~~---~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~--  196 (321)
T 2c30_A          125 QGGALTDIVSQ---VRLNEEQIATVCEAVLQALAYLHA---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--  196 (321)
T ss_dssp             CSCBHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC--
T ss_pred             CCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCcc--
Confidence            99999998864   348999999999999999999999   9999999999999999999999999999987654322  


Q ss_pred             cccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCCCCCHH
Q 016594          226 SIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVT  305 (386)
Q Consensus       226 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (386)
                      ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+......  .....      ....+..  .....
T Consensus       197 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~--~~~~~------~~~~~~~--~~~~~  266 (321)
T 2c30_A          197 KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQA--MKRLR------DSPPPKL--KNSHK  266 (321)
T ss_dssp             CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH--HHHHH------HSSCCCC--TTGGG
T ss_pred             ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHh------cCCCCCc--Ccccc
Confidence            23455799999999999999999999999999999999999999986543211  01000      0011111  11123


Q ss_pred             HHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          306 QLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       306 ~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                      .+..+.+++.+||+.||++|||+.+++++.+..
T Consensus       267 ~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~  299 (321)
T 2c30_A          267 VSPVLRDFLERMLVRDPQERATAQELLDHPFLL  299 (321)
T ss_dssp             SCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGG
T ss_pred             CCHHHHHHHHHHccCChhhCcCHHHHhcChhhc
Confidence            456799999999999999999999999986553

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=3.1e-47  Score=347.74  Aligned_cols=270  Identities=21%  Similarity=0.315  Sum_probs=208.1

Q ss_pred             HHhcCCCCCCeecccCCcEEEEEEE-----CCCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEe--
Q 016594           63 IATNAFSSENLVGRGGYAEVYKGVL-----QDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVD--  135 (386)
Q Consensus        63 ~~~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--  135 (386)
                      +..++|++.+.||+|+||+||+|++     .+++.||||++...  .......+.+|+.++++++||||+++++++..  
T Consensus         7 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   84 (295)
T 3ugc_A            7 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG   84 (295)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHH
T ss_pred             CCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence            3457899999999999999999984     26889999998743  34556788999999999999999999999864  


Q ss_pred             -CceEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCc
Q 016594          136 -NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGL  214 (386)
Q Consensus       136 -~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~  214 (386)
                       ...++||||+.+++|.+++.... ..+++..++.++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+
T Consensus        85 ~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~  160 (295)
T 3ugc_A           85 RRNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGL  160 (295)
T ss_dssp             HTSCEEEEECCTTCBHHHHHHHCG-GGCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCS
T ss_pred             CCceEEEEEeCCCCCHHHHHHhcc-cccCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHhhEEEcCCCeEEEccCcc
Confidence             33899999999999999987643 348999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCCcc-ccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhc----ccc
Q 016594          215 AKWLPSQWTH-HSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILN----QGE  289 (386)
Q Consensus       215 a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~----~~~  289 (386)
                      +......... .......++..|+|||.+.+..++.++|||||||++|+|++|..||................    ...
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (295)
T 3ugc_A          161 TKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH  240 (295)
T ss_dssp             CC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHH
T ss_pred             cccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHH
Confidence            9876543221 12233457788999999999999999999999999999999999987643322111110000    000


Q ss_pred             cccccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          290 IEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                      ....+........+..++..+.+++.+||+.||++|||+.++++.|...
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l  289 (295)
T 3ugc_A          241 LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI  289 (295)
T ss_dssp             HHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence            1111111112223344567899999999999999999999999988754

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.6e-47  Score=357.40  Aligned_cols=263  Identities=22%  Similarity=0.395  Sum_probs=210.5

Q ss_pred             HHHhcCCCCCCeecccCCcEEEEEEE------CCCcEEEEEEeccccCChHhHHHHHHHHHHHhcc-CCCceeeecceEE
Q 016594           62 SIATNAFSSENLVGRGGYAEVYKGVL------QDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHV-CHPNVLSLLGCCV  134 (386)
Q Consensus        62 ~~~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~  134 (386)
                      ++..++|.+.+.||+|+||.||+|.+      .++..||||++.... .......+.+|+.+++++ .||||+++++++.
T Consensus        41 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~  119 (344)
T 1rjb_A           41 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACT  119 (344)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence            45568899999999999999999996      245689999997532 233456789999999999 8999999999997


Q ss_pred             eCc-eEEEEEeccCCCHhhhhhhcCC---------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEe
Q 016594          135 DNG-LYLIFQFSSRGSVASLFHDVNS---------------------PGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHR  192 (386)
Q Consensus       135 ~~~-~~lv~e~~~~~~L~~~~~~~~~---------------------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~  192 (386)
                      ..+ .++||||+.+|+|.+++.....                     ..+++..++.++.|++.||.|||+   ++|+||
T Consensus       120 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~  196 (344)
T 1rjb_A          120 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHR  196 (344)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEET
T ss_pred             eCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCcccC
Confidence            755 8999999999999999876432                     237899999999999999999999   999999


Q ss_pred             CCCCCCeeEcCCCCeEEeecCccccCCCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHh-CCCCCC
Q 016594          193 DIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVD  271 (386)
Q Consensus       193 dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~  271 (386)
                      ||||+|||++.++.+||+|||++................||+.|+|||++.+..++.++|||||||++|+|++ |..||.
T Consensus       197 Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~  276 (344)
T 1rjb_A          197 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP  276 (344)
T ss_dssp             TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred             CCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcc
Confidence            9999999999999999999999987654333233344557889999999999999999999999999999998 999998


Q ss_pred             CCchhhhhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCC
Q 016594          272 GSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEGD  339 (386)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~~  339 (386)
                      +........           ..+........+...+..+.+++.+||+.||.+|||+.+++++|....
T Consensus       277 ~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~  333 (344)
T 1rjb_A          277 GIPVDANFY-----------KLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQL  333 (344)
T ss_dssp             TCCCSHHHH-----------HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred             cCCcHHHHH-----------HHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence            754321110           001111111222334577999999999999999999999999997653

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=3.2e-47  Score=362.02  Aligned_cols=263  Identities=20%  Similarity=0.268  Sum_probs=210.6

Q ss_pred             HHHHhcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccC-ChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-
Q 016594           61 ISIATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVT-DDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-  137 (386)
Q Consensus        61 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-  137 (386)
                      +.+..++|++.+.||+|+||+||+|+++ +++.||+|++.+... .......+.+|+.+++.++||||+++++++.+.. 
T Consensus        64 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~  143 (410)
T 3v8s_A           64 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY  143 (410)
T ss_dssp             HSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             cccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCE
Confidence            3445678999999999999999999987 688999999975211 1112234778999999999999999999998766 


Q ss_pred             eEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCcccc
Q 016594          138 LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKW  217 (386)
Q Consensus       138 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~  217 (386)
                      .|+||||+.+|+|.+++...   .+++..+..++.||+.||+|||+   ++|+||||||+|||++.++++||+|||++..
T Consensus       144 ~~lV~E~~~gg~L~~~l~~~---~~~e~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DFG~a~~  217 (410)
T 3v8s_A          144 LYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMK  217 (410)
T ss_dssp             EEEEECCCTTEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEEEEeCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeeECCCCCEEEeccceeEe
Confidence            89999999999999988653   48999999999999999999999   9999999999999999999999999999987


Q ss_pred             CCCCCccccccccccccCccChhhhccCC----CCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccc
Q 016594          218 LPSQWTHHSIAPIEGTFGHLAPEYFMHGI----VDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKL  293 (386)
Q Consensus       218 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  293 (386)
                      ..... .......+||+.|+|||++.+..    ++.++|||||||++|||++|..||.+......  ...+.....    
T Consensus       218 ~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~--~~~i~~~~~----  290 (410)
T 3v8s_A          218 MNKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT--YSKIMNHKN----  290 (410)
T ss_dssp             CCTTS-EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHH--HHHHHTHHH----
T ss_pred             eccCC-cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhH--HHHHHhccc----
Confidence            65432 22334678999999999998765    78999999999999999999999987543211  111111000    


Q ss_pred             cCCccCCCCCHHHHHHHHHHHHHccccCCCC--CCCHHHHHHHHhcCC
Q 016594          294 VDPRLQGAYDVTQLNRLAFAASLCIRASPTW--RPTMSEVLEVMLEGD  339 (386)
Q Consensus       294 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--Rpt~~~il~~l~~~~  339 (386)
                         ..........+..+.+||.+||..+|.+  ||++.+|++|.+...
T Consensus       291 ---~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~  335 (410)
T 3v8s_A          291 ---SLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKN  335 (410)
T ss_dssp             ---HCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCC
T ss_pred             ---cccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccC
Confidence               0001111124577999999999999988  999999999977653

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=5.2e-47  Score=353.23  Aligned_cols=257  Identities=21%  Similarity=0.292  Sum_probs=208.7

Q ss_pred             HHHhcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccC-ChHhHHHHHHHHHHHhcc-CCCceeeecceEEeCc-
Q 016594           62 SIATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVT-DDRKEKEFLTEIGTIGHV-CHPNVLSLLGCCVDNG-  137 (386)
Q Consensus        62 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~-  137 (386)
                      .+..++|.+.+.||+|+||+||+|+++ +++.||+|++.+... .......+..|..++..+ +||||+++++++.+.. 
T Consensus        13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~   92 (345)
T 1xjd_A           13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN   92 (345)
T ss_dssp             ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred             CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence            456688999999999999999999987 689999999975321 122345677899999877 8999999999998765 


Q ss_pred             eEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCcccc
Q 016594          138 LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKW  217 (386)
Q Consensus       138 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~  217 (386)
                      .++||||+.+|+|.+++....  .+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||++..
T Consensus        93 ~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~  167 (345)
T 1xjd_A           93 LFFVMEYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKE  167 (345)
T ss_dssp             EEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             EEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCChhhEEECCCCCEEEeEChhhhh
Confidence            899999999999999987654  48999999999999999999999   9999999999999999999999999999986


Q ss_pred             CCCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCc
Q 016594          218 LPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPR  297 (386)
Q Consensus       218 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (386)
                      .....  ......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+......  ...+...       .  
T Consensus       168 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~--~~~i~~~-------~--  234 (345)
T 1xjd_A          168 NMLGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEEL--FHSIRMD-------N--  234 (345)
T ss_dssp             CCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHC-------C--
T ss_pred             cccCC--CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHH--HHHHHhC-------C--
Confidence            53321  224456799999999999999999999999999999999999999987543211  1111110       0  


Q ss_pred             cCCCCCHHHHHHHHHHHHHccccCCCCCCCHH-HHHHHHhcC
Q 016594          298 LQGAYDVTQLNRLAFAASLCIRASPTWRPTMS-EVLEVMLEG  338 (386)
Q Consensus       298 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~-~il~~l~~~  338 (386)
                        ..++...+..+.++|.+||..||++||++. +|++|-+..
T Consensus       235 --~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~  274 (345)
T 1xjd_A          235 --PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFR  274 (345)
T ss_dssp             --CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGT
T ss_pred             --CCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcCcccc
Confidence              112223457799999999999999999998 888776543

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=5.4e-47  Score=348.88  Aligned_cols=262  Identities=21%  Similarity=0.384  Sum_probs=213.7

Q ss_pred             HHHhcCCCCCCeecccCCcEEEEEEE------CCCcEEEEEEeccccCChHhHHHHHHHHHHHhcc-CCCceeeecceEE
Q 016594           62 SIATNAFSSENLVGRGGYAEVYKGVL------QDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHV-CHPNVLSLLGCCV  134 (386)
Q Consensus        62 ~~~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~  134 (386)
                      .+..++|++.+.||+|+||.||+|.+      .+++.||||++... ........+.+|+.+++++ +||||+++++++.
T Consensus        19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~   97 (313)
T 1t46_A           19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS-AHLTEREALMSELKVLSYLGNHMNIVNLLGACT   97 (313)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcc-hhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEe
Confidence            35567899999999999999999985      24678999999753 2334567789999999999 8999999999997


Q ss_pred             eCc-eEEEEEeccCCCHhhhhhhcCCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCC
Q 016594          135 DNG-LYLIFQFSSRGSVASLFHDVNSP----------------GVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSS  197 (386)
Q Consensus       135 ~~~-~~lv~e~~~~~~L~~~~~~~~~~----------------~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~  197 (386)
                      +.+ .++||||+.+++|.+++......                .+++..++.++.|++.||.|||+   ++|+||||||+
T Consensus        98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~  174 (313)
T 1t46_A           98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAAR  174 (313)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGG
T ss_pred             cCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccc
Confidence            655 89999999999999998765432                48999999999999999999999   99999999999


Q ss_pred             CeeEcCCCCeEEeecCccccCCCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCchh
Q 016594          198 NILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQS  276 (386)
Q Consensus       198 Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~  276 (386)
                      ||+++.++.+||+|||++................+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+....
T Consensus       175 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~  254 (313)
T 1t46_A          175 NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD  254 (313)
T ss_dssp             GEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS
T ss_pred             eEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccch
Confidence            99999999999999999987765433333344567889999999999999999999999999999999 99999875432


Q ss_pred             hhhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          277 LHSWAKPILNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                      .....  ....         ......+...+..+.+++.+||+.||.+|||+.++++.|...
T Consensus       255 ~~~~~--~~~~---------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~  305 (313)
T 1t46_A          255 SKFYK--MIKE---------GFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ  305 (313)
T ss_dssp             HHHHH--HHHH---------TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             hHHHH--Hhcc---------CCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence            11110  0000         011111223457799999999999999999999999998754

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=3.3e-46  Score=348.25  Aligned_cols=257  Identities=21%  Similarity=0.293  Sum_probs=208.2

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccC-ChHhHHHHHHHHHHHhcc-CCCceeeecceEEeCc-eEE
Q 016594           65 TNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVT-DDRKEKEFLTEIGTIGHV-CHPNVLSLLGCCVDNG-LYL  140 (386)
Q Consensus        65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~-~~l  140 (386)
                      .++|++.+.||+|+||.||+|+++ +++.||+|++.+... .......+.+|+.++.++ +||||+++++++.+.. .++
T Consensus         8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l   87 (345)
T 3a8x_A            8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF   87 (345)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence            357889999999999999999987 689999999986433 344556788999999988 7999999999998765 899


Q ss_pred             EEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCC
Q 016594          141 IFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPS  220 (386)
Q Consensus       141 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~  220 (386)
                      ||||+.+|+|..++....  .+++..++.++.||+.||.|||+   ++|+||||||+|||++.++++||+|||++.....
T Consensus        88 v~e~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~  162 (345)
T 3a8x_A           88 VIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR  162 (345)
T ss_dssp             EECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred             EEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence            999999999999887654  48999999999999999999999   9999999999999999999999999999986432


Q ss_pred             CCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhh------hhhhhhhhccccccccc
Q 016594          221 QWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSL------HSWAKPILNQGEIEKLV  294 (386)
Q Consensus       221 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~------~~~~~~~~~~~~~~~~~  294 (386)
                      .  .......+||+.|+|||++.+..++.++|||||||++|||++|..||.......      ......        .+.
T Consensus       163 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~--------~i~  232 (345)
T 3a8x_A          163 P--GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQ--------VIL  232 (345)
T ss_dssp             T--TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHH--------HHH
T ss_pred             C--CCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHH--------HHH
Confidence            2  123445679999999999999999999999999999999999999997532110      000000        011


Q ss_pred             CCccCCCCCHHHHHHHHHHHHHccccCCCCCCCH------HHHHHHHhcC
Q 016594          295 DPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTM------SEVLEVMLEG  338 (386)
Q Consensus       295 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~------~~il~~l~~~  338 (386)
                      ...  ...+...+..+.++|.+||+.||.+||++      .++++|-+..
T Consensus       233 ~~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~  280 (345)
T 3a8x_A          233 EKQ--IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFR  280 (345)
T ss_dssp             HCC--CCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGT
T ss_pred             cCC--CCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccC
Confidence            111  11223345679999999999999999995      7888886554

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=1.3e-46  Score=363.38  Aligned_cols=252  Identities=23%  Similarity=0.367  Sum_probs=209.1

Q ss_pred             HHHhcCCCCCCeecccCCcEEEEEEECCCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeC--ceE
Q 016594           62 SIATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDN--GLY  139 (386)
Q Consensus        62 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~  139 (386)
                      .+..++|++.+.||+|+||.||+|.++ ++.||||+++...    ....+.+|+.++++++||||+++++++.+.  ..+
T Consensus       189 ~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  263 (450)
T 1k9a_A          189 ALNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY  263 (450)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEE
T ss_pred             ccChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceE
Confidence            345678899999999999999999986 7899999997532    346789999999999999999999998764  489


Q ss_pred             EEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCC
Q 016594          140 LIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLP  219 (386)
Q Consensus       140 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~  219 (386)
                      +||||+.+|+|.+++.......+++..++.++.|++.||+|||+   ++|+||||||+|||++.++.+||+|||++....
T Consensus       264 iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~  340 (450)
T 1k9a_A          264 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS  340 (450)
T ss_dssp             EEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEECCCCCEEEeeCCCccccc
Confidence            99999999999999987766668999999999999999999999   999999999999999999999999999998653


Q ss_pred             CCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCchhhhhhhhhhhcccccccccCCcc
Q 016594          220 SQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRL  298 (386)
Q Consensus       220 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (386)
                      ..     .....++..|+|||++.+..++.++|||||||++|||++ |..||.+......            ...+....
T Consensus       341 ~~-----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~------------~~~i~~~~  403 (450)
T 1k9a_A          341 ST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV------------VPRVEKGY  403 (450)
T ss_dssp             -----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTH------------HHHHHTTC
T ss_pred             cc-----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH------------HHHHHcCC
Confidence            22     122357889999999999999999999999999999998 9999986532210            01111111


Q ss_pred             CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          299 QGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       299 ~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                      ....+..++..+.+++.+||+.||.+|||+.+|++.|+..
T Consensus       404 ~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i  443 (450)
T 1k9a_A          404 KMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHI  443 (450)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence            2223334567899999999999999999999999988654

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.5e-46  Score=356.58  Aligned_cols=269  Identities=20%  Similarity=0.322  Sum_probs=199.1

Q ss_pred             HHhcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccC-CCceeeecceEEeC---c
Q 016594           63 IATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVC-HPNVLSLLGCCVDN---G  137 (386)
Q Consensus        63 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~---~  137 (386)
                      ...++|++.+.||+|+||.||+|.+. +++.||||++............+.+|+.+++.+. ||||+++++++...   .
T Consensus         6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~   85 (388)
T 3oz6_A            6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD   85 (388)
T ss_dssp             HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred             cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence            45678999999999999999999976 6899999999776566667788899999999998 99999999999753   3


Q ss_pred             eEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCcccc
Q 016594          138 LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKW  217 (386)
Q Consensus       138 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~  217 (386)
                      .|+||||+.+ +|..++..   ..+++..+..++.|++.||+|||+   ++|+||||||+|||++.++.+||+|||+++.
T Consensus        86 ~~lv~e~~~~-~L~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~  158 (388)
T 3oz6_A           86 VYLVFDYMET-DLHAVIRA---NILEPVHKQYVVYQLIKVIKYLHS---GGLLHRDMKPSNILLNAECHVKVADFGLSRS  158 (388)
T ss_dssp             EEEEEECCSE-EHHHHHHH---TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEecccCc-CHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHeEEcCCCCEEecCCccccc
Confidence            8999999984 88888865   248999999999999999999999   9999999999999999999999999999986


Q ss_pred             CCCCC-------------------ccccccccccccCccChhhhcc-CCCCcccchHHHHHHHHHHHhCCCCCCCCchhh
Q 016594          218 LPSQW-------------------THHSIAPIEGTFGHLAPEYFMH-GIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSL  277 (386)
Q Consensus       218 ~~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~  277 (386)
                      +....                   ........+||+.|+|||++.+ ..++.++|||||||++|||++|++||.+.....
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~  238 (388)
T 3oz6_A          159 FVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMN  238 (388)
T ss_dssp             SSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred             ccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            53311                   1112344679999999999987 678999999999999999999999998765321


Q ss_pred             hhh-hhhhhcccc---ccccc------------------CCccCCCC------------CHHHHHHHHHHHHHccccCCC
Q 016594          278 HSW-AKPILNQGE---IEKLV------------------DPRLQGAY------------DVTQLNRLAFAASLCIRASPT  323 (386)
Q Consensus       278 ~~~-~~~~~~~~~---~~~~~------------------~~~~~~~~------------~~~~~~~l~~li~~cl~~dP~  323 (386)
                      ... .........   +..+.                  .......+            ....+..+.+|+.+||..||+
T Consensus       239 ~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~  318 (388)
T 3oz6_A          239 QLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPN  318 (388)
T ss_dssp             HHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGG
T ss_pred             HHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcc
Confidence            110 000000000   00000                  00000000            002245789999999999999


Q ss_pred             CCCCHHHHHHHHhcC
Q 016594          324 WRPTMSEVLEVMLEG  338 (386)
Q Consensus       324 ~Rpt~~~il~~l~~~  338 (386)
                      +|||+.++++|.+..
T Consensus       319 ~R~t~~e~l~Hp~~~  333 (388)
T 3oz6_A          319 KRISANDALKHPFVS  333 (388)
T ss_dssp             GSCCHHHHTTSTTTT
T ss_pred             cCCCHHHHhCCHHHH
Confidence            999999999986543

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=1.9e-47  Score=347.83  Aligned_cols=259  Identities=26%  Similarity=0.421  Sum_probs=216.0

Q ss_pred             HHHHhcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-e
Q 016594           61 ISIATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-L  138 (386)
Q Consensus        61 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~  138 (386)
                      +++..++|++.+.||+|+||.||+|.+. ++..||+|++...   ......+.+|+.+++.++||||+++++++.+.. .
T Consensus         8 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   84 (288)
T 3kfa_A            8 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF   84 (288)
T ss_dssp             TBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC---STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSE
T ss_pred             ccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC---HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCE
Confidence            3456788999999999999999999987 5889999998742   334567889999999999999999999997755 8


Q ss_pred             EEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccC
Q 016594          139 YLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWL  218 (386)
Q Consensus       139 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~  218 (386)
                      ++||||+.+++|.+++.......+++..++.++.|++.||.|||+   ++|+||||||+||+++.++.+||+|||++...
T Consensus        85 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~  161 (288)
T 3kfa_A           85 YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLM  161 (288)
T ss_dssp             EEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHH---HTCCCSCCSGGGEEECGGGCEEECCCCGGGTS
T ss_pred             EEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHH---CCccCCCCCcceEEEcCCCCEEEccCccceec
Confidence            999999999999999988777779999999999999999999999   99999999999999999999999999999876


Q ss_pred             CCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCchhhhhhhhhhhcccccccccCCc
Q 016594          219 PSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGEIEKLVDPR  297 (386)
Q Consensus       219 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (386)
                      ..... .......+++.|+|||.+.+..++.++||||||+++|+|++ |..||.+.......            ..+...
T Consensus       162 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~------------~~~~~~  228 (288)
T 3kfa_A          162 TGDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY------------ELLEKD  228 (288)
T ss_dssp             CSSSS-EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH------------HHHHTT
T ss_pred             cCCcc-ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH------------HHHhcc
Confidence            54322 22334457888999999999999999999999999999999 99999875432111            111111


Q ss_pred             cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          298 LQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       298 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                      .....+...+..+.+++.+||+.||.+|||+.++++.|...
T Consensus       229 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~  269 (288)
T 3kfa_A          229 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM  269 (288)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHH
Confidence            11222233457799999999999999999999999988764

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=7e-47  Score=345.98  Aligned_cols=254  Identities=24%  Similarity=0.301  Sum_probs=199.6

Q ss_pred             HhcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCCh------------------------HhHHHHHHHHHHH
Q 016594           64 ATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDD------------------------RKEKEFLTEIGTI  118 (386)
Q Consensus        64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~------------------------~~~~~~~~e~~~l  118 (386)
                      ..++|++.+.||+|+||.||+|... +++.||||++.......                        .....+.+|+.++
T Consensus        11 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l   90 (298)
T 2zv2_A           11 QLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAIL   90 (298)
T ss_dssp             EETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHH
T ss_pred             eecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHH
Confidence            3468999999999999999999976 68899999987532111                        1235688999999


Q ss_pred             hccCCCceeeecceEEeC---ceEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCC
Q 016594          119 GHVCHPNVLSLLGCCVDN---GLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIK  195 (386)
Q Consensus       119 ~~l~h~niv~l~~~~~~~---~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlk  195 (386)
                      +.++||||+++++++.+.   ..++||||+.+++|.+++.   ...+++..++.++.|++.||.|||+   ++|+|||||
T Consensus        91 ~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlk  164 (298)
T 2zv2_A           91 KKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT---LKPLSEDQARFYFQDLIKGIEYLHY---QKIIHRDIK  164 (298)
T ss_dssp             HTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC---SSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCC
T ss_pred             HhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCC
Confidence            999999999999999862   3899999999999988653   3459999999999999999999999   999999999


Q ss_pred             CCCeeEcCCCCeEEeecCccccCCCCCccccccccccccCccChhhhccCC---CCcccchHHHHHHHHHHHhCCCCCCC
Q 016594          196 SSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGI---VDEKTDVFAFGVFLLEIISGRKPVDG  272 (386)
Q Consensus       196 p~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwslG~il~ell~g~~pf~~  272 (386)
                      |+|||++.++.+||+|||++........  ......||+.|+|||++.+..   ++.++|||||||++|+|++|..||.+
T Consensus       165 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~  242 (298)
T 2zv2_A          165 PSNLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD  242 (298)
T ss_dssp             GGGEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             HHHEEECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence            9999999999999999999987654321  233457999999999998765   37889999999999999999999987


Q ss_pred             CchhhhhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 016594          273 SHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVML  336 (386)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~  336 (386)
                      ......  ...... .        ..........+..+.+++.+||+.||++|||+.+++++-+
T Consensus       243 ~~~~~~--~~~~~~-~--------~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~  295 (298)
T 2zv2_A          243 ERIMCL--HSKIKS-Q--------ALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPW  295 (298)
T ss_dssp             SSHHHH--HHHHHH-C--------CCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHH
T ss_pred             ccHHHH--HHHHhc-c--------cCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcc
Confidence            543211  111100 0        0011111223467999999999999999999999998754

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=8.3e-47  Score=340.25  Aligned_cols=253  Identities=22%  Similarity=0.311  Sum_probs=210.2

Q ss_pred             HhcCCCCCCeecccCCcEEEEEEECCCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeC---ceEE
Q 016594           64 ATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDN---GLYL  140 (386)
Q Consensus        64 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~---~~~l  140 (386)
                      ..++|++.+.||+|+||.||+|.++ ++.||||++............+.+|+.++++++||||+++++++.+.   ..++
T Consensus         8 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l   86 (271)
T 3kmu_A            8 DFKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTL   86 (271)
T ss_dssp             CGGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEE
T ss_pred             CHHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEe
Confidence            3567999999999999999999986 88999999987665666677899999999999999999999999764   3799


Q ss_pred             EEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEEeCCCCCCeeEcCCCCeEEeecCccccC
Q 016594          141 IFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRR--IIHRDIKSSNILLTADFEPQISDFGLAKWL  218 (386)
Q Consensus       141 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~--ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~  218 (386)
                      +|||+.+++|.+++.......+++..++.++.|++.||.|||+   ++  ++||||||+||+++.++.++|+|||++...
T Consensus        87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~  163 (271)
T 3kmu_A           87 ITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHT---LEPLIPRHALNSRSVMIDEDMTARISMADVKFSF  163 (271)
T ss_dssp             EEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTT---SSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTT
T ss_pred             eecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhc---CCCceecCCCccceEEEcCCcceeEEeccceeee
Confidence            9999999999999987665569999999999999999999999   88  999999999999999999999999887643


Q ss_pred             CCCCccccccccccccCccChhhhccCCCCc---ccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccC
Q 016594          219 PSQWTHHSIAPIEGTFGHLAPEYFMHGIVDE---KTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVD  295 (386)
Q Consensus       219 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  295 (386)
                      ..       ....||+.|+|||++.+..++.   ++|||||||++|+|++|..||.+........  .         ...
T Consensus       164 ~~-------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~--~---------~~~  225 (271)
T 3kmu_A          164 QS-------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGM--K---------VAL  225 (271)
T ss_dssp             SC-------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHH--H---------HHH
T ss_pred             cc-------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHH--H---------HHh
Confidence            22       2345899999999998765544   8999999999999999999998754322111  0         011


Q ss_pred             CccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          296 PRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       296 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                      .......+...+..+.+++..||+.||++|||+.++++.|...
T Consensus       226 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l  268 (271)
T 3kmu_A          226 EGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKM  268 (271)
T ss_dssp             SCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             cCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence            1111122333457799999999999999999999999998754

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=2.1e-46  Score=350.07  Aligned_cols=251  Identities=21%  Similarity=0.266  Sum_probs=209.5

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccC-ChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEE
Q 016594           65 TNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVT-DDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLI  141 (386)
Q Consensus        65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv  141 (386)
                      .++|++.+.||+|+||.||+|.++ +|+.||+|++.+... .......+.+|+.+++.++||||+++++++.+.. .++|
T Consensus        40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv  119 (350)
T 1rdq_E           40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV  119 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence            367899999999999999999986 689999999975321 1233567889999999999999999999998765 8999


Q ss_pred             EEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCC
Q 016594          142 FQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQ  221 (386)
Q Consensus       142 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  221 (386)
                      |||+.+|+|.+++....  .+++..++.++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||++......
T Consensus       120 ~e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~  194 (350)
T 1rdq_E          120 MEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR  194 (350)
T ss_dssp             EECCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred             EcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCcccccCccceEEECCCCCEEEcccccceeccCC
Confidence            99999999999987654  38999999999999999999999   99999999999999999999999999999876432


Q ss_pred             CccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCCC
Q 016594          222 WTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGA  301 (386)
Q Consensus       222 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (386)
                           ....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+......  ...+..         ..  ..
T Consensus       195 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~--~~~i~~---------~~--~~  256 (350)
T 1rdq_E          195 -----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI--YEKIVS---------GK--VR  256 (350)
T ss_dssp             -----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHH---------CC--CC
T ss_pred             -----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHH--HHHHHc---------CC--CC
Confidence                 2346799999999999999999999999999999999999999987543211  111111         00  11


Q ss_pred             CCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHHHhcC
Q 016594          302 YDVTQLNRLAFAASLCIRASPTWRPT-----MSEVLEVMLEG  338 (386)
Q Consensus       302 ~~~~~~~~l~~li~~cl~~dP~~Rpt-----~~~il~~l~~~  338 (386)
                      ++...+..+.++|.+||+.||.+||+     +.+|++|-+..
T Consensus       257 ~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~  298 (350)
T 1rdq_E          257 FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA  298 (350)
T ss_dssp             CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGT
T ss_pred             CCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcC
Confidence            22234577999999999999999998     99999986654

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=2.6e-47  Score=352.53  Aligned_cols=264  Identities=22%  Similarity=0.369  Sum_probs=213.6

Q ss_pred             HHHHHhcCCCCCCeecccCCcEEEEEEEC------CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceE
Q 016594           60 EISIATNAFSSENLVGRGGYAEVYKGVLQ------DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCC  133 (386)
Q Consensus        60 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~  133 (386)
                      ++.+..++|++.+.||+|+||.||+|.+.      +++.||+|.+... ........+.+|+.+++.++||||+++++++
T Consensus        19 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~   97 (322)
T 1p4o_A           19 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNEASVMKEFNCHHVVRLLGVV   97 (322)
T ss_dssp             TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT-SCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred             hhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccc-cCHHHHHHHHHHHHHHHhcCCCCEeeeEEEE
Confidence            34566788999999999999999999864      3678999998753 2344556789999999999999999999999


Q ss_pred             EeCc-eEEEEEeccCCCHhhhhhhcC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCC
Q 016594          134 VDNG-LYLIFQFSSRGSVASLFHDVN--------SPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTAD  204 (386)
Q Consensus       134 ~~~~-~~lv~e~~~~~~L~~~~~~~~--------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~  204 (386)
                      .+.. .++||||+.+++|.+++....        ...+++..++.++.|++.||.|||+   ++|+||||||+||+++.+
T Consensus        98 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~NIli~~~  174 (322)
T 1p4o_A           98 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAED  174 (322)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECTT
T ss_pred             ccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCCccCCCccceEEEcCC
Confidence            7755 899999999999999886532        1347899999999999999999999   999999999999999999


Q ss_pred             CCeEEeecCccccCCCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCchhhhhhhhh
Q 016594          205 FEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKP  283 (386)
Q Consensus       205 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~  283 (386)
                      +.+||+|||++................+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+.......  ..
T Consensus       175 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~--~~  252 (322)
T 1p4o_A          175 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL--RF  252 (322)
T ss_dssp             CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHH--HH
T ss_pred             CeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHH--HH
Confidence            9999999999986644322223334457889999999999999999999999999999999 89999875432111  10


Q ss_pred             hhcccccccccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCC
Q 016594          284 ILNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEGD  339 (386)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~~  339 (386)
                      . ....         ....+...+..+.+++.+||+.||.+|||+.+++++|+...
T Consensus       253 ~-~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~  298 (322)
T 1p4o_A          253 V-MEGG---------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM  298 (322)
T ss_dssp             H-HTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred             H-HcCC---------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhh
Confidence            0 0110         01112234567999999999999999999999999998753

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=2.1e-46  Score=345.92  Aligned_cols=267  Identities=22%  Similarity=0.340  Sum_probs=192.7

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEE
Q 016594           65 TNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIF  142 (386)
Q Consensus        65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~  142 (386)
                      .++|++.+.||+|+||.||+|.++ +++.||+|++.... .......+.+|+.+++.++||||+++++++.+++ .++||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   82 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS-EEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVF   82 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCS-TTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccc-ccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEE
Confidence            468999999999999999999976 68999999997543 2233456789999999999999999999998765 89999


Q ss_pred             EeccCCCHhhhhhhcC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccC
Q 016594          143 QFSSRGSVASLFHDVN----SPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWL  218 (386)
Q Consensus       143 e~~~~~~L~~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~  218 (386)
                      ||+.+ +|.+++....    ...+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||++...
T Consensus        83 e~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~  158 (317)
T 2pmi_A           83 EFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE---NKILHRDLKPQNLLINKRGQLKLGDFGLARAF  158 (317)
T ss_dssp             ECCCC-BHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCSSCEET
T ss_pred             EecCC-CHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCChHHeEEcCCCCEEECcCccceec
Confidence            99984 8988876542    2358999999999999999999999   99999999999999999999999999999876


Q ss_pred             CCCCccccccccccccCccChhhhcc-CCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhh-hhhhhccc------cc
Q 016594          219 PSQWTHHSIAPIEGTFGHLAPEYFMH-GIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSW-AKPILNQG------EI  290 (386)
Q Consensus       219 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~-~~~~~~~~------~~  290 (386)
                      ....  .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+........ ........      ..
T Consensus       159 ~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  236 (317)
T 2pmi_A          159 GIPV--NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSV  236 (317)
T ss_dssp             TSCC--CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGG
T ss_pred             CCCc--ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhh
Confidence            4322  12334568999999999976 468999999999999999999999998765422110 00000000      00


Q ss_pred             ccc--cCCcc------------CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          291 EKL--VDPRL------------QGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       291 ~~~--~~~~~------------~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                      ...  ..+..            ........+..+.+++.+||+.||++|||+.+++++-+..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~  298 (317)
T 2pmi_A          237 TKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFA  298 (317)
T ss_dssp             GGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGG
T ss_pred             hhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhh
Confidence            000  00000            0000112346799999999999999999999999886553

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=9e-47  Score=350.07  Aligned_cols=255  Identities=20%  Similarity=0.340  Sum_probs=202.0

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc------
Q 016594           65 TNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG------  137 (386)
Q Consensus        65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------  137 (386)
                      .++|++.+.||+|+||.||+|.++ +++.||||++.... .......+.+|+.++++++||||+++++++.+..      
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~   83 (332)
T 3qd2_B            5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE   83 (332)
T ss_dssp             HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS-TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred             hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC-chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence            467899999999999999999987 79999999997543 3445677899999999999999999999986532      


Q ss_pred             ----------------------------------------------------eEEEEEeccCCCHhhhhhhcCC-CCCCH
Q 016594          138 ----------------------------------------------------LYLIFQFSSRGSVASLFHDVNS-PGVEW  164 (386)
Q Consensus       138 ----------------------------------------------------~~lv~e~~~~~~L~~~~~~~~~-~~~~~  164 (386)
                                                                          .+++|||+.+++|.+++..... ...++
T Consensus        84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~  163 (332)
T 3qd2_B           84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREH  163 (332)
T ss_dssp             HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCH
T ss_pred             hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhh
Confidence                                                                6899999999999999876543 23567


Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCcc----------cccccccccc
Q 016594          165 KVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTH----------HSIAPIEGTF  234 (386)
Q Consensus       165 ~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~----------~~~~~~~gt~  234 (386)
                      ..++.++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||++.........          .......||+
T Consensus       164 ~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~  240 (332)
T 3qd2_B          164 GVCLHIFIQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK  240 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred             HHHHHHHHHHHHHHHHHHh---CCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence            7789999999999999999   99999999999999999999999999999877554211          1223456999


Q ss_pred             CccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHH
Q 016594          235 GHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQLNRLAFAA  314 (386)
Q Consensus       235 ~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  314 (386)
                      .|+|||++.+..++.++|||||||++|+|++|..|+.......    .         ...... ........+..+.+++
T Consensus       241 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~~~~----~---------~~~~~~-~~~~~~~~~~~~~~li  306 (332)
T 3qd2_B          241 LYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVRII----T---------DVRNLK-FPLLFTQKYPQEHMMV  306 (332)
T ss_dssp             GGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHHHHH----H---------HHHTTC-CCHHHHHHCHHHHHHH
T ss_pred             CccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHHHHH----H---------HhhccC-CCcccccCChhHHHHH
Confidence            9999999999999999999999999999999877753211100    0         000000 0011123346789999


Q ss_pred             HHccccCCCCCCCHHHHHHHHhc
Q 016594          315 SLCIRASPTWRPTMSEVLEVMLE  337 (386)
Q Consensus       315 ~~cl~~dP~~Rpt~~~il~~l~~  337 (386)
                      .+||+.||++|||+.+++++-+.
T Consensus       307 ~~~l~~~p~~Rps~~~~l~~~~f  329 (332)
T 3qd2_B          307 QDMLSPSPTERPEATDIIENAIF  329 (332)
T ss_dssp             HHHHCSSGGGSCCHHHHHHSTTC
T ss_pred             HHHccCCCCcCCCHHHHhhchhh
Confidence            99999999999999999987543

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=9.5e-47  Score=354.31  Aligned_cols=271  Identities=22%  Similarity=0.265  Sum_probs=211.7

Q ss_pred             cccCHHHHHHHhcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccC-----CCcee
Q 016594           54 RCFSFEEISIATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVC-----HPNVL  127 (386)
Q Consensus        54 ~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-----h~niv  127 (386)
                      ..+++....+..++|++.+.||+|+||+||+|.+. +++.||||++..   .......+..|+.+++.+.     ||||+
T Consensus        23 ~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~h~~iv   99 (360)
T 3llt_A           23 VHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN---IKKYTRSAKIEADILKKIQNDDINNNNIV   99 (360)
T ss_dssp             GSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS---CHHHHHHHHHHHHHHHHTCCCSTTGGGBC
T ss_pred             eeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc---chhhhhhhHHHHHHHHHhcccCCCCCCee
Confidence            44555556677889999999999999999999985 688999999864   2344556778999999886     99999


Q ss_pred             eecceEEeCc-eEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcC---
Q 016594          128 SLLGCCVDNG-LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTA---  203 (386)
Q Consensus       128 ~l~~~~~~~~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~---  203 (386)
                      ++++++...+ .++|||++ +++|.+++.......+++..+..++.||+.||+|||+   ++|+||||||+|||++.   
T Consensus       100 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~  175 (360)
T 3llt_A          100 KYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRK---MSLTHTDLKPENILLDDPYF  175 (360)
T ss_dssp             CEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCTTC
T ss_pred             cccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCcccEEEccccc
Confidence            9999998765 89999999 8899999988776679999999999999999999999   99999999999999975   


Q ss_pred             ----------------------CCCeEEeecCccccCCCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHH
Q 016594          204 ----------------------DFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLL  261 (386)
Q Consensus       204 ----------------------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~  261 (386)
                                            ++.+||+|||++......     .....||+.|+|||++.+..++.++|||||||++|
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~  250 (360)
T 3llt_A          176 EKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLA  250 (360)
T ss_dssp             CEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHH
T ss_pred             cccccchhcccccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHH
Confidence                                  789999999999865432     23456899999999999999999999999999999


Q ss_pred             HHHhCCCCCCCCchhhhhh-hhhhhcc-----------ccccccc-CCccCCCC-----C---------------HHHHH
Q 016594          262 EIISGRKPVDGSHQSLHSW-AKPILNQ-----------GEIEKLV-DPRLQGAY-----D---------------VTQLN  308 (386)
Q Consensus       262 ell~g~~pf~~~~~~~~~~-~~~~~~~-----------~~~~~~~-~~~~~~~~-----~---------------~~~~~  308 (386)
                      +|++|+.||.+........ .......           ....... .......+     .               .....
T Consensus       251 ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~  330 (360)
T 3llt_A          251 ELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHE  330 (360)
T ss_dssp             HHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCH
T ss_pred             HHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHH
Confidence            9999999998754321110 0000000           0000000 00000000     0               00125


Q ss_pred             HHHHHHHHccccCCCCCCCHHHHHHHHh
Q 016594          309 RLAFAASLCIRASPTWRPTMSEVLEVML  336 (386)
Q Consensus       309 ~l~~li~~cl~~dP~~Rpt~~~il~~l~  336 (386)
                      .+.+|+.+||+.||++|||+.++|++-+
T Consensus       331 ~l~~li~~~L~~dP~~Rpta~elL~hp~  358 (360)
T 3llt_A          331 LFCDFLYSILQIDPTLRPSPAELLKHKF  358 (360)
T ss_dssp             HHHHHHHHHCCSSGGGSCCHHHHTTSGG
T ss_pred             HHHHHHHHHhcCChhhCCCHHHHhcCcc
Confidence            6889999999999999999999998754

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=3.1e-46  Score=343.64  Aligned_cols=267  Identities=23%  Similarity=0.292  Sum_probs=205.3

Q ss_pred             cCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEEE
Q 016594           66 NAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQ  143 (386)
Q Consensus        66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~e  143 (386)
                      ++|++.+.||+|+||+||+|.+. +++.||+|++............+.+|+.++++++||||+++++++.+.+ .++|||
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE   82 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence            67899999999999999999986 5899999999776555566677889999999999999999999998766 899999


Q ss_pred             eccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCc
Q 016594          144 FSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWT  223 (386)
Q Consensus       144 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~  223 (386)
                      |+.+++|..++...  ..+++..+..++.|++.||.|||+   ++|+||||||+||+++.++.+||+|||++....... 
T Consensus        83 ~~~~~~l~~~~~~~--~~~~~~~~~~i~~~l~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-  156 (311)
T 4agu_A           83 YCDHTVLHELDRYQ--RGVPEHLVKSITWQTLQAVNFCHK---HNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPS-  156 (311)
T ss_dssp             CCSEEHHHHHHHTS--SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred             eCCCchHHHHHhhh--cCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc-
Confidence            99999998887643  348999999999999999999999   999999999999999999999999999998765332 


Q ss_pred             cccccccccccCccChhhhcc-CCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhh-hhhhc------------ccc
Q 016594          224 HHSIAPIEGTFGHLAPEYFMH-GIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWA-KPILN------------QGE  289 (386)
Q Consensus       224 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~-~~~~~------------~~~  289 (386)
                       .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+......... .....            ...
T Consensus       157 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (311)
T 4agu_A          157 -DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQY  235 (311)
T ss_dssp             ----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGG
T ss_pred             -cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccc
Confidence             12234568999999999986 6789999999999999999999999987654321110 00000            000


Q ss_pred             cccccCCccCCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCC
Q 016594          290 IEKLVDPRLQGAYD-----VTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEGD  339 (386)
Q Consensus       290 ~~~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~~  339 (386)
                      ......+......+     ...+..+.+++.+||+.||.+|||+.+++++-+...
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~  290 (311)
T 4agu_A          236 FSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFEN  290 (311)
T ss_dssp             GTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTT
T ss_pred             cccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHh
Confidence            00000000000000     123467899999999999999999999999866543

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=7.2e-48  Score=379.67  Aligned_cols=262  Identities=21%  Similarity=0.356  Sum_probs=216.1

Q ss_pred             HHHHHHhcCCCCCCeecccCCcEEEEEEECCCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCce
Q 016594           59 EEISIATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNGL  138 (386)
Q Consensus        59 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  138 (386)
                      ..+++..++|++.+.||+|+||.||+|.++.+..||||++.....   ....+.+|+.+|++++||||+++++++.++..
T Consensus       260 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  336 (535)
T 2h8h_A          260 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPI  336 (535)
T ss_dssp             TCSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSC
T ss_pred             cceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCC---CHHHHHHHHHHHHhCCCCCEeeEEEEEeeccc
Confidence            344567788999999999999999999998778899999975432   34578999999999999999999999988779


Q ss_pred             EEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccC
Q 016594          139 YLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWL  218 (386)
Q Consensus       139 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~  218 (386)
                      ++||||+.+|+|.+++.......+++..++.++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||++...
T Consensus       337 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~  413 (535)
T 2h8h_A          337 YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLI  413 (535)
T ss_dssp             EEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCTTSTTTC
T ss_pred             eEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEEcCCCcEEEcccccceec
Confidence            999999999999999976544558999999999999999999999   99999999999999999999999999999876


Q ss_pred             CCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCchhhhhhhhhhhcccccccccCCc
Q 016594          219 PSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGEIEKLVDPR  297 (386)
Q Consensus       219 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (386)
                      .... ........++..|+|||++.+..++.++|||||||++|||++ |..||.+......  ... ..         ..
T Consensus       414 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~--~~~-i~---------~~  480 (535)
T 2h8h_A          414 EDNE-YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV--LDQ-VE---------RG  480 (535)
T ss_dssp             CCHH-HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHH--HHH-HH---------TT
T ss_pred             CCCc-eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH--HHH-HH---------cC
Confidence            4321 111223346788999999999999999999999999999999 9999987543211  000 00         11


Q ss_pred             cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCC
Q 016594          298 LQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEGD  339 (386)
Q Consensus       298 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~~  339 (386)
                      .....+..++..+.+||.+||+.||++|||+.+|++.|+...
T Consensus       481 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~  522 (535)
T 2h8h_A          481 YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF  522 (535)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred             CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence            111223345677999999999999999999999999998764

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=1.2e-46  Score=353.53  Aligned_cols=254  Identities=20%  Similarity=0.255  Sum_probs=195.7

Q ss_pred             HhcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEE
Q 016594           64 ATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLI  141 (386)
Q Consensus        64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv  141 (386)
                      ..++|++.+.||+|+||+||+|+.. +++.||||++.....   ....+.+|+.+++.++||||+++++++.+.. .++|
T Consensus        18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv   94 (361)
T 3uc3_A           18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAII   94 (361)
T ss_dssp             CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT---SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc---ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEE
Confidence            3568999999999999999999987 789999999975332   2345789999999999999999999998765 8999


Q ss_pred             EEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCC--eEEeecCccccCC
Q 016594          142 FQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFE--PQISDFGLAKWLP  219 (386)
Q Consensus       142 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~--~kl~Dfg~a~~~~  219 (386)
                      |||+.+|+|.+++....  .+++..++.++.|++.||.|||+   ++|+||||||+|||++.++.  +||+|||++....
T Consensus        95 ~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~ql~~~L~~LH~---~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~  169 (361)
T 3uc3_A           95 MEYASGGELYERICNAG--RFSEDEARFFFQQLLSGVSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSV  169 (361)
T ss_dssp             EECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH---TTCCSCCCCGGGEEECSSSSCCEEECCCCCC----
T ss_pred             EEeCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCceEEEeecCcccccc
Confidence            99999999999887644  39999999999999999999999   99999999999999987765  9999999987433


Q ss_pred             CCCccccccccccccCccChhhhccCCCCcc-cchHHHHHHHHHHHhCCCCCCCCchhh--hhhhhhhhcccccccccCC
Q 016594          220 SQWTHHSIAPIEGTFGHLAPEYFMHGIVDEK-TDVFAFGVFLLEIISGRKPVDGSHQSL--HSWAKPILNQGEIEKLVDP  296 (386)
Q Consensus       220 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DvwslG~il~ell~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~  296 (386)
                      ..   .......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.....  .....         .+...
T Consensus       170 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~---------~~~~~  237 (361)
T 3uc3_A          170 LH---SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQ---------RILSV  237 (361)
T ss_dssp             --------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHH---------HHHTT
T ss_pred             cc---CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHH---------HHhcC
Confidence            22   22334569999999999988887655 899999999999999999998643211  11111         11111


Q ss_pred             ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 016594          297 RLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLE  337 (386)
Q Consensus       297 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~  337 (386)
                      ..........+..+.+||.+||+.||.+|||+.++++|.+.
T Consensus       238 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f  278 (361)
T 3uc3_A          238 KYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWF  278 (361)
T ss_dssp             CCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHH
T ss_pred             CCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcch
Confidence            11111112235678999999999999999999999998654

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=3.8e-46  Score=352.56  Aligned_cols=256  Identities=21%  Similarity=0.224  Sum_probs=208.4

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEE
Q 016594           65 TNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIF  142 (386)
Q Consensus        65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~  142 (386)
                      .++|++.+.||+|+||.||+|..+ +++.||+|++...  .......+.+|+.+++.++||||+++++++.+.. .++||
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~  127 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP--YPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLIL  127 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--SHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEeccc--chhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEE
Confidence            467999999999999999999986 6899999998753  2334567889999999999999999999998765 89999


Q ss_pred             EeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcC--CCCeEEeecCccccCCC
Q 016594          143 QFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTA--DFEPQISDFGLAKWLPS  220 (386)
Q Consensus       143 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~--~~~~kl~Dfg~a~~~~~  220 (386)
                      ||+.+++|.+++... ...+++..++.++.||+.||.|||+   ++|+||||||+|||++.  .+.+||+|||++..+..
T Consensus       128 E~~~gg~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~  203 (387)
T 1kob_A          128 EFLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP  203 (387)
T ss_dssp             ECCCCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred             EcCCCCcHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccchHHeEEecCCCCceEEEecccceecCC
Confidence            999999999988653 2358999999999999999999999   99999999999999974  57899999999987754


Q ss_pred             CCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCC
Q 016594          221 QWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQG  300 (386)
Q Consensus       221 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (386)
                      ...   .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.......  ..+.. ..      .....
T Consensus       204 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~--~~i~~-~~------~~~~~  271 (387)
T 1kob_A          204 DEI---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETL--QNVKR-CD------WEFDE  271 (387)
T ss_dssp             TSC---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH--HHHHH-CC------CCCCS
T ss_pred             Ccc---eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHH--HHHHh-CC------CCCCc
Confidence            322   23346999999999999999999999999999999999999999875432111  00000 00      00011


Q ss_pred             CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          301 AYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       301 ~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                      ......+..+.++|.+||+.||.+|||+.+++++.+..
T Consensus       272 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~  309 (387)
T 1kob_A          272 DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLK  309 (387)
T ss_dssp             STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTS
T ss_pred             cccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCcccc
Confidence            11123456799999999999999999999999986554

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=2.2e-46  Score=342.94  Aligned_cols=259  Identities=25%  Similarity=0.336  Sum_probs=200.7

Q ss_pred             HhcCCCCCCeecccCCcEEEEEEECCCcEEEEEEeccccCChHhHHHHHHHHHHHhc--cCCCceeeecceEEeC-----
Q 016594           64 ATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGH--VCHPNVLSLLGCCVDN-----  136 (386)
Q Consensus        64 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~~-----  136 (386)
                      ..++|++.+.||+|+||+||+|.+ +++.||||++...     ....+.+|.+++..  ++||||+++++++.+.     
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~   79 (301)
T 3q4u_A            6 VARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR-----DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSST   79 (301)
T ss_dssp             CGGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG-----GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEE
T ss_pred             ccCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc-----cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCc
Confidence            457899999999999999999998 5899999998642     34455666666665  7899999999987542     


Q ss_pred             ceEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCCeEEeCCCCCCeeEcCCCCeE
Q 016594          137 GLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLH--------KGCQRRIIHRDIKSSNILLTADFEPQ  208 (386)
Q Consensus       137 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH--------~~~~~~ivH~dlkp~Nill~~~~~~k  208 (386)
                      ..++||||+.+|+|.+++..   ..+++..++.++.|++.||.|||        +   ++|+||||||+|||++.++.+|
T Consensus        80 ~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~---~~ivH~Dlkp~Nill~~~~~~k  153 (301)
T 3q4u_A           80 QLWLITHYHEMGSLYDYLQL---TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGK---PAIAHRDLKSKNILVKKNGQCC  153 (301)
T ss_dssp             EEEEEECCCTTCBHHHHHTT---CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCB---CEEECSCCCGGGEEECTTSCEE
T ss_pred             eeEEehhhccCCCHHHHHhh---cccCHHHHHHHHHHHHHHHHHHHHhhhhccCC---CCeecCCCChHhEEEcCCCCEE
Confidence            27899999999999999854   35899999999999999999999        7   8999999999999999999999


Q ss_pred             EeecCccccCCCCCccc--cccccccccCccChhhhccC------CCCcccchHHHHHHHHHHHhC----------CCCC
Q 016594          209 ISDFGLAKWLPSQWTHH--SIAPIEGTFGHLAPEYFMHG------IVDEKTDVFAFGVFLLEIISG----------RKPV  270 (386)
Q Consensus       209 l~Dfg~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslG~il~ell~g----------~~pf  270 (386)
                      |+|||++..........  ......||+.|+|||++.+.      .++.++|||||||++|+|++|          ..||
T Consensus       154 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf  233 (301)
T 3q4u_A          154 IADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPF  233 (301)
T ss_dssp             ECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred             EeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccc
Confidence            99999997654432221  12345799999999999876      455799999999999999999          8888


Q ss_pred             CCCchhh---hhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          271 DGSHQSL---HSWAKPILNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       271 ~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                      .......   ...........    ..........+...+..+.+++.+||+.||++|||+.+|++.|...
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  300 (301)
T 3q4u_A          234 YDVVPNDPSFEDMRKVVCVDQ----QRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI  300 (301)
T ss_dssp             TTTSCSSCCHHHHHHHHTTSC----CCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             cccCCCCcchhhhhHHHhccC----CCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence            6532111   11111000000    0001111112234678899999999999999999999999998753

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=2.2e-46  Score=350.05  Aligned_cols=256  Identities=23%  Similarity=0.300  Sum_probs=208.5

Q ss_pred             HHhcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccC-ChHhHHHHHHHHHHHhcc-CCCceeeecceEEeCc-e
Q 016594           63 IATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVT-DDRKEKEFLTEIGTIGHV-CHPNVLSLLGCCVDNG-L  138 (386)
Q Consensus        63 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~-~  138 (386)
                      +..++|++.+.||+|+||+||+|..+ +++.||+|++.+... .......+..|..++..+ +||||+++++++.+.+ .
T Consensus        17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~   96 (353)
T 2i0e_A           17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL   96 (353)
T ss_dssp             --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEE
T ss_pred             CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEE
Confidence            45678999999999999999999987 578999999975321 123356678899999988 6999999999998765 8


Q ss_pred             EEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccC
Q 016594          139 YLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWL  218 (386)
Q Consensus       139 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~  218 (386)
                      |+||||+.+|+|.+++....  .+++..++.++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||++...
T Consensus        97 ~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~~  171 (353)
T 2i0e_A           97 YFVMEYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN  171 (353)
T ss_dssp             EEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred             EEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEEcCCCcEEEEeCCccccc
Confidence            99999999999999987654  38999999999999999999999   99999999999999999999999999999864


Q ss_pred             CCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCcc
Q 016594          219 PSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRL  298 (386)
Q Consensus       219 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (386)
                      ...  .......+||+.|+|||++.+..++.++|||||||++|||++|..||.+......  ...+..         .. 
T Consensus       172 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~--~~~i~~---------~~-  237 (353)
T 2i0e_A          172 IWD--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL--FQSIME---------HN-  237 (353)
T ss_dssp             CCT--TCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHH---------CC-
T ss_pred             ccC--CcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHH--HHHHHh---------CC-
Confidence            322  1234456799999999999999999999999999999999999999987543211  111111         11 


Q ss_pred             CCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHHHhcC
Q 016594          299 QGAYDVTQLNRLAFAASLCIRASPTWRPT-----MSEVLEVMLEG  338 (386)
Q Consensus       299 ~~~~~~~~~~~l~~li~~cl~~dP~~Rpt-----~~~il~~l~~~  338 (386)
                       ..++...+..+.++|.+||..||.+||+     +.+|++|.+..
T Consensus       238 -~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~  281 (353)
T 2i0e_A          238 -VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFR  281 (353)
T ss_dssp             -CCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGT
T ss_pred             -CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCcccc
Confidence             1122334577999999999999999995     68998876543

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=4.5e-46  Score=360.47  Aligned_cols=262  Identities=22%  Similarity=0.296  Sum_probs=202.0

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeC-------
Q 016594           65 TNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDN-------  136 (386)
Q Consensus        65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-------  136 (386)
                      .++|++.+.||+|+||+||+|.+. +++.||||++............+.+|+.+++.++||||+++++++...       
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            478999999999999999999976 689999999987655666778899999999999999999999999653       


Q ss_pred             ceEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccc
Q 016594          137 GLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAK  216 (386)
Q Consensus       137 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~  216 (386)
                      ..++||||+.++ |.+.+..    .+++..+..++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||++.
T Consensus       141 ~~~lv~E~~~~~-l~~~~~~----~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDlkp~NIll~~~~~~kl~DFG~a~  212 (464)
T 3ttj_A          141 DVYLVMELMDAN-LCQVIQM----ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR  212 (464)
T ss_dssp             EEEEEEECCSEE-HHHHHTS----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCCC-
T ss_pred             eEEEEEeCCCCC-HHHHHhh----cCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChHhEEEeCCCCEEEEEEEeee
Confidence            269999999875 5555532    38899999999999999999999   999999999999999999999999999998


Q ss_pred             cCCCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhccc--------
Q 016594          217 WLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQG--------  288 (386)
Q Consensus       217 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~--------  288 (386)
                      .....   ......+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.+.... +.......+        
T Consensus       213 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~-~~~i~~~lg~p~~~~~~  288 (464)
T 3ttj_A          213 TAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ-WNKVIEQLGTPCPEFMK  288 (464)
T ss_dssp             ----C---CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHHHCSCCHHHHT
T ss_pred             ecCCC---cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhcCCCCHHHHH
Confidence            76432   223456799999999999999999999999999999999999999987653211 100000000        


Q ss_pred             -------------------ccccccCCccCCCC---CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          289 -------------------EIEKLVDPRLQGAY---DVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       289 -------------------~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                                         .....+........   ....+..+.+|+.+||..||++|||+.++++|-+..
T Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~  360 (464)
T 3ttj_A          289 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYIN  360 (464)
T ss_dssp             TSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTG
T ss_pred             HcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhh
Confidence                               00000000000000   011256799999999999999999999999987654

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=8.7e-47  Score=351.01  Aligned_cols=262  Identities=24%  Similarity=0.413  Sum_probs=212.5

Q ss_pred             HHhcCCCCCCeecccCCcEEEEEEEC--------CCcEEEEEEeccccCChHhHHHHHHHHHHHhcc-CCCceeeecceE
Q 016594           63 IATNAFSSENLVGRGGYAEVYKGVLQ--------DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHV-CHPNVLSLLGCC  133 (386)
Q Consensus        63 ~~~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~  133 (386)
                      +..++|++.+.||+|+||.||+|.+.        ++..||||++... ........+.+|+.+++.+ +||||+++++++
T Consensus        32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~  110 (334)
T 2pvf_A           32 FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC  110 (334)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             CCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccC-CcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEE
Confidence            45678999999999999999999863        4678999998753 2345567789999999999 899999999999


Q ss_pred             EeCc-eEEEEEeccCCCHhhhhhhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCC
Q 016594          134 VDNG-LYLIFQFSSRGSVASLFHDVNS--------------PGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSN  198 (386)
Q Consensus       134 ~~~~-~~lv~e~~~~~~L~~~~~~~~~--------------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~N  198 (386)
                      .+.+ .++||||+.+++|.+++.....              ..+++..++.++.|++.||.|||+   ++|+||||||+|
T Consensus       111 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~N  187 (334)
T 2pvf_A          111 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARN  187 (334)
T ss_dssp             CSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGG
T ss_pred             ccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCccce
Confidence            7755 8999999999999999876532              248999999999999999999999   999999999999


Q ss_pred             eeEcCCCCeEEeecCccccCCCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCchhh
Q 016594          199 ILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSL  277 (386)
Q Consensus       199 ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~  277 (386)
                      |+++.++.+||+|||++................+++.|+|||++.+..++.++|||||||++|+|++ |..||.+.....
T Consensus       188 Ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~  267 (334)
T 2pvf_A          188 VLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE  267 (334)
T ss_dssp             EEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred             EEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHH
Confidence            9999999999999999987765433333344557889999999999999999999999999999999 999998754321


Q ss_pred             hhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCCc
Q 016594          278 HSWAKPILNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEGDQ  340 (386)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~~~  340 (386)
                      ..  ... ...         .....+..++..+.+++.+||+.||.+||++.++++.|.....
T Consensus       268 ~~--~~~-~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~  318 (334)
T 2pvf_A          268 LF--KLL-KEG---------HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT  318 (334)
T ss_dssp             HH--HHH-HHT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HH--HHH-hcC---------CCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            11  100 000         0111222345679999999999999999999999999876643

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=1.3e-45  Score=335.09  Aligned_cols=257  Identities=21%  Similarity=0.278  Sum_probs=210.9

Q ss_pred             HhcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEE
Q 016594           64 ATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLI  141 (386)
Q Consensus        64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv  141 (386)
                      ..++|++.+.||+|+||.||+|.+. +++.||+|++............+.+|+.++++++||||+++++++.+.+ .+++
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v   83 (284)
T 3kk8_A            4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV   83 (284)
T ss_dssp             TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence            3578999999999999999999986 6899999999876556666778899999999999999999999998766 7999


Q ss_pred             EEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCC---eEEeecCccccC
Q 016594          142 FQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFE---PQISDFGLAKWL  218 (386)
Q Consensus       142 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~---~kl~Dfg~a~~~  218 (386)
                      |||+.+++|.+.+....  .+++..+..++.|++.||.|||+   ++|+||||||+||+++.++.   +||+|||++...
T Consensus        84 ~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~  158 (284)
T 3kk8_A           84 FDLVTGGELFEDIVARE--FYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV  158 (284)
T ss_dssp             ECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred             EecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEc
Confidence            99999999988887653  48999999999999999999999   99999999999999986655   999999999876


Q ss_pred             CCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCcc
Q 016594          219 PSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRL  298 (386)
Q Consensus       219 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (386)
                      ....   ......||+.|+|||++.+..++.++||||||+++|+|++|..||.+........  .. .....    .  .
T Consensus       159 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~--~~-~~~~~----~--~  226 (284)
T 3kk8_A          159 NDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYA--QI-KAGAY----D--Y  226 (284)
T ss_dssp             CSSC---BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH--HH-HHTCC----C--C
T ss_pred             ccCc---cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHH--HH-Hhccc----c--C
Confidence            5432   2234569999999999999999999999999999999999999998754322111  00 00000    0  0


Q ss_pred             CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 016594          299 QGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLE  337 (386)
Q Consensus       299 ~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~  337 (386)
                      ........+..+.+++.+||+.||++|||+.+++++.+.
T Consensus       227 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~  265 (284)
T 3kk8_A          227 PSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWI  265 (284)
T ss_dssp             CTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHH
T ss_pred             CchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccc
Confidence            001112235679999999999999999999999997554

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=8.9e-47  Score=342.32  Aligned_cols=261  Identities=21%  Similarity=0.314  Sum_probs=208.6

Q ss_pred             HHhcCCCCCCeecccCCcEEEEEEECC----CcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCce
Q 016594           63 IATNAFSSENLVGRGGYAEVYKGVLQD----GEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNGL  138 (386)
Q Consensus        63 ~~~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  138 (386)
                      +..++|.+.+.||+|+||+||+|.+..    +..||+|.+... ........+.+|+.+++.++||||+++++++.++..
T Consensus         9 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   87 (281)
T 3cc6_A            9 IAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKD-CTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEEPT   87 (281)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTT-SCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSSSC
T ss_pred             ecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccc-cCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCC
Confidence            345789999999999999999998642    346999998753 234456788999999999999999999999988889


Q ss_pred             EEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccC
Q 016594          139 YLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWL  218 (386)
Q Consensus       139 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~  218 (386)
                      +++||++.+++|.+++.... ..+++..++.++.|++.||.|||+   ++++||||||+||+++.++.+||+|||++...
T Consensus        88 ~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  163 (281)
T 3cc6_A           88 WIIMELYPYGELGHYLERNK-NSLKVLTLVLYSLQICKAMAYLES---INCVHRDIAVRNILVASPECVKLGDFGLSRYI  163 (281)
T ss_dssp             EEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred             EEEEecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEECCCCcEEeCccCCCccc
Confidence            99999999999999987643 348999999999999999999999   99999999999999999999999999999876


Q ss_pred             CCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCchhhhhhhhhhhcccccccccCCc
Q 016594          219 PSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGEIEKLVDPR  297 (386)
Q Consensus       219 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (386)
                      ..... .......+++.|+|||++.+..++.++|||||||++|+|++ |..||.........  .. ....         
T Consensus       164 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~--~~-~~~~---------  230 (281)
T 3cc6_A          164 EDEDY-YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVI--GV-LEKG---------  230 (281)
T ss_dssp             ----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHH--HH-HHHT---------
T ss_pred             ccccc-cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHH--HH-HhcC---------
Confidence            54321 12233457888999999999999999999999999999998 99999754332111  00 0000         


Q ss_pred             cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCCcc
Q 016594          298 LQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEGDQI  341 (386)
Q Consensus       298 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~~~~  341 (386)
                      .....+...+..+.+++.+||+.||++||++.+++++|....+.
T Consensus       231 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~  274 (281)
T 3cc6_A          231 DRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM  274 (281)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHh
Confidence            01111223456799999999999999999999999999775443

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=2.1e-46  Score=345.20  Aligned_cols=262  Identities=26%  Similarity=0.378  Sum_probs=202.1

Q ss_pred             HHHhcCCCCCCeecccCCcEEEEEEEC----CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc
Q 016594           62 SIATNAFSSENLVGRGGYAEVYKGVLQ----DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG  137 (386)
Q Consensus        62 ~~~~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  137 (386)
                      .+..++|.+.+.||+|+||.||+|.+.    ++..||+|.+............+.+|+.++++++||||+++++++.+..
T Consensus        30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  109 (313)
T 3brb_A           30 VIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMS  109 (313)
T ss_dssp             BCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC--
T ss_pred             ccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecc
Confidence            356778999999999999999999864    3458999999866556666778999999999999999999999997633


Q ss_pred             ------eEEEEEeccCCCHhhhhhhc----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCe
Q 016594          138 ------LYLIFQFSSRGSVASLFHDV----NSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEP  207 (386)
Q Consensus       138 ------~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~  207 (386)
                            .+++|+|+.+++|.+++...    ....+++..++.++.|++.||.|||+   ++|+||||||+||+++.++.+
T Consensus       110 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~~~~  186 (313)
T 3brb_A          110 SQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSN---RNFLHRDLAARNCMLRDDMTV  186 (313)
T ss_dssp             -----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCSGGGEEECTTSCE
T ss_pred             ccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCcE
Confidence                  49999999999999988432    33459999999999999999999999   999999999999999999999


Q ss_pred             EEeecCccccCCCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCchhhhhhhhhhhc
Q 016594          208 QISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILN  286 (386)
Q Consensus       208 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~  286 (386)
                      ||+|||++................+++.|+|||.+.+..++.++|||||||++|+|++ |..||.+.......  .....
T Consensus       187 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~--~~~~~  264 (313)
T 3brb_A          187 CVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMY--DYLLH  264 (313)
T ss_dssp             EECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH--HHHHT
T ss_pred             EEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHH--HHHHc
Confidence            9999999987654322222334457889999999999999999999999999999999 99999875432111  00000


Q ss_pred             ccccccccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          287 QGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                                ......+...+..+.+++.+||+.||.+||++.+++++|...
T Consensus       265 ----------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l  306 (313)
T 3brb_A          265 ----------GHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKL  306 (313)
T ss_dssp             ----------TCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ----------CCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence                      001112223456799999999999999999999999998764

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=5.7e-46  Score=337.99  Aligned_cols=255  Identities=27%  Similarity=0.476  Sum_probs=205.3

Q ss_pred             HhcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhH-----HHHHHHHHHHhccCCCceeeecceEEeCc
Q 016594           64 ATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKE-----KEFLTEIGTIGHVCHPNVLSLLGCCVDNG  137 (386)
Q Consensus        64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~-----~~~~~e~~~l~~l~h~niv~l~~~~~~~~  137 (386)
                      ..++|++.+.||+|+||+||+|.+. +++.||+|++..........     ..+.+|+.++++++||||+++++++.+..
T Consensus        17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   96 (287)
T 4f0f_A           17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP   96 (287)
T ss_dssp             CSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT
T ss_pred             hhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC
Confidence            3568999999999999999999985 78999999987543322221     67889999999999999999999886554


Q ss_pred             eEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEEeCCCCCCeeEcCCCC-----eEEe
Q 016594          138 LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRR--IIHRDIKSSNILLTADFE-----PQIS  210 (386)
Q Consensus       138 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~--ivH~dlkp~Nill~~~~~-----~kl~  210 (386)
                       +++|||+.+++|.+.+... ...+++..++.++.|++.||.|||+   ++  |+||||||+|||++.++.     +||+
T Consensus        97 -~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~l~~~l~~lH~---~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~  171 (287)
T 4f0f_A           97 -RMVMEFVPCGDLYHRLLDK-AHPIKWSVKLRLMLDIALGIEYMQN---QNPPIVHRDLRSPNIFLQSLDENAPVCAKVA  171 (287)
T ss_dssp             -EEEEECCTTCBHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCSCCSGGGEEESCCCTTCSCCEEEC
T ss_pred             -eEEEEecCCCCHHHHHhcc-cCCccHHHHHHHHHHHHHHHHHHHh---CCCCeecCCCCcceEEEeccCCCCceeEEeC
Confidence             7999999999998887653 3459999999999999999999999   88  999999999999988776     9999


Q ss_pred             ecCccccCCCCCccccccccccccCccChhhhc--cCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhccc
Q 016594          211 DFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFM--HGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQG  288 (386)
Q Consensus       211 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~  288 (386)
                      |||++.....     ......||+.|+|||++.  ...++.++|||||||++|+|++|..||................  
T Consensus       172 Dfg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~--  244 (287)
T 4f0f_A          172 DFGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIRE--  244 (287)
T ss_dssp             CCTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHH--
T ss_pred             CCCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhc--
Confidence            9999975433     233456999999999984  4567899999999999999999999998654332211111111  


Q ss_pred             ccccccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 016594          289 EIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLE  337 (386)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~  337 (386)
                             .......+...+..+.+++.+||+.||.+|||+.++++.|.+
T Consensus       245 -------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~  286 (287)
T 4f0f_A          245 -------EGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE  286 (287)
T ss_dssp             -------SCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred             -------cCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence                   111122233445779999999999999999999999999865

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.1e-46  Score=341.00  Aligned_cols=259  Identities=21%  Similarity=0.316  Sum_probs=211.3

Q ss_pred             hcCCCCCC-eecccCCcEEEEEEEC---CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCceEE
Q 016594           65 TNAFSSEN-LVGRGGYAEVYKGVLQ---DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNGLYL  140 (386)
Q Consensus        65 ~~~~~~~~-~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~l  140 (386)
                      .++|.+.+ .||+|+||.||+|.+.   ++..||||++... ........+.+|+.+++.++||||+++++++..+..++
T Consensus         8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~l   86 (287)
T 1u59_A            8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALML   86 (287)
T ss_dssp             GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEE
T ss_pred             HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCc-cchhHHHHHHHHHHHHHhCCCCCEeEEEEEecCCCcEE
Confidence            45566666 9999999999999864   5778999999763 34456678899999999999999999999997777999


Q ss_pred             EEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCC
Q 016594          141 IFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPS  220 (386)
Q Consensus       141 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~  220 (386)
                      |||++.+++|.+++... ...+++..++.++.|++.||.|||+   ++|+||||||+||+++.++.+||+|||++.....
T Consensus        87 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~  162 (287)
T 1u59_A           87 VMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGA  162 (287)
T ss_dssp             EEECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred             EEEeCCCCCHHHHHHhC-CccCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence            99999999999988643 3458999999999999999999999   9999999999999999999999999999987754


Q ss_pred             CCcc-ccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCchhhhhhhhhhhcccccccccCCcc
Q 016594          221 QWTH-HSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRL  298 (386)
Q Consensus       221 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (386)
                      .... .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.........  .. ...         ..
T Consensus       163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~--~~-i~~---------~~  230 (287)
T 1u59_A          163 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM--AF-IEQ---------GK  230 (287)
T ss_dssp             CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHH--HH-HHT---------TC
T ss_pred             CcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHH--HH-Hhc---------CC
Confidence            3222 12233456889999999998999999999999999999998 99999875432111  00 001         11


Q ss_pred             CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCCc
Q 016594          299 QGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEGDQ  340 (386)
Q Consensus       299 ~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~~~  340 (386)
                      ....+...+..+.+++..||+.||.+||++.+++++|+....
T Consensus       231 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~  272 (287)
T 1u59_A          231 RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY  272 (287)
T ss_dssp             CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence            112233446789999999999999999999999999987644

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=5.7e-47  Score=349.17  Aligned_cols=267  Identities=24%  Similarity=0.380  Sum_probs=215.6

Q ss_pred             CHHHHHHHhcCCCCCCeecccCCcEEEEEEE------CCCcEEEEEEeccccCChHhHHHHHHHHHHHhcc-CCCceeee
Q 016594           57 SFEEISIATNAFSSENLVGRGGYAEVYKGVL------QDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHV-CHPNVLSL  129 (386)
Q Consensus        57 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l  129 (386)
                      ....+.+..++|++.+.||+|+||.||+|.+      .+++.||||++.... .......+.+|+.++.++ +||||+++
T Consensus        18 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~   96 (316)
T 2xir_A           18 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNL   96 (316)
T ss_dssp             CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             cccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC-CcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence            4455667788999999999999999999984      246889999997542 344556789999999999 69999999


Q ss_pred             cceEEeCc--eEEEEEeccCCCHhhhhhhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeC
Q 016594          130 LGCCVDNG--LYLIFQFSSRGSVASLFHDVNS--------------PGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRD  193 (386)
Q Consensus       130 ~~~~~~~~--~~lv~e~~~~~~L~~~~~~~~~--------------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~d  193 (386)
                      ++++...+  .+++|||+.+++|.+++.....              ..+++..++.++.|++.||.|||+   ++|+|||
T Consensus        97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~d  173 (316)
T 2xir_A           97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRD  173 (316)
T ss_dssp             EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHH---TTCCCSC
T ss_pred             EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHh---CCccccc
Confidence            99987643  8999999999999999876543              127899999999999999999999   9999999


Q ss_pred             CCCCCeeEcCCCCeEEeecCccccCCCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHh-CCCCCCC
Q 016594          194 IKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDG  272 (386)
Q Consensus       194 lkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~  272 (386)
                      |||+||+++.++.+||+|||++................||+.|+|||++.+..++.++|||||||++|+|++ |..||.+
T Consensus       174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~  253 (316)
T 2xir_A          174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG  253 (316)
T ss_dssp             CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             CccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcc
Confidence            999999999999999999999987655433333445568899999999999999999999999999999998 9999976


Q ss_pred             CchhhhhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          273 SHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                      ........ . .....         .....+...+..+.+++.+||+.||.+|||+.+++++|...
T Consensus       254 ~~~~~~~~-~-~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~  308 (316)
T 2xir_A          254 VKIDEEFC-R-RLKEG---------TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL  308 (316)
T ss_dssp             CCCSHHHH-H-HHHHT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             cchhHHHH-H-HhccC---------ccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            54221110 0 00100         01111222356799999999999999999999999998765

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=4.6e-46  Score=345.59  Aligned_cols=259  Identities=17%  Similarity=0.159  Sum_probs=205.2

Q ss_pred             HhcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhcc-CCCceeeecceEEeCc-eEE
Q 016594           64 ATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHV-CHPNVLSLLGCCVDNG-LYL  140 (386)
Q Consensus        64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~-~~l  140 (386)
                      .+++|++.+.||+|+||+||+|... +++.||||++.....    ...+.+|+.+++.+ +||||+++++++.++. .++
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l   82 (330)
T 2izr_A            7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR----APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAM   82 (330)
T ss_dssp             ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS----SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEE
T ss_pred             EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc----hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEE
Confidence            4578999999999999999999975 789999999875322    23577899999999 8999999999998866 799


Q ss_pred             EEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCC-----eEEeecCcc
Q 016594          141 IFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFE-----PQISDFGLA  215 (386)
Q Consensus       141 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~-----~kl~Dfg~a  215 (386)
                      ||||+ +++|.+++... ...+++..++.++.|++.||+|||+   ++|+||||||+|||++.++.     +||+|||++
T Consensus        83 v~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~---~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a  157 (330)
T 2izr_A           83 VLELL-GPSLEDLFDLC-DRTFSLKTVLMIAIQLISRMEYVHS---KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALA  157 (330)
T ss_dssp             EEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTCTTSEEECCCTTC
T ss_pred             EEEeC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeeccCCCCCCceEEEEEcccc
Confidence            99999 99999998764 3459999999999999999999999   99999999999999998887     999999999


Q ss_pred             ccCCCCCccc-----cccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhh-hhhhhhhcccc
Q 016594          216 KWLPSQWTHH-----SIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLH-SWAKPILNQGE  289 (386)
Q Consensus       216 ~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~-~~~~~~~~~~~  289 (386)
                      ..+.......     ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+...... .....+.. ..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~-~~  236 (330)
T 2izr_A          158 KEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGD-TK  236 (330)
T ss_dssp             EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHH-HH
T ss_pred             eeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHh-hh
Confidence            8764432211     12456799999999999999999999999999999999999999987532211 11110000 00


Q ss_pred             cccccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          290 IEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                      .   ..+.  .......+ .+.+++..||+.||.+||++.+|++.|...
T Consensus       237 ~---~~~~--~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~  279 (330)
T 2izr_A          237 R---ATPI--EVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDL  279 (330)
T ss_dssp             H---HSCH--HHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred             c---cCCH--HHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHH
Confidence            0   0000  00000123 799999999999999999999999988644

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=7e-46  Score=343.85  Aligned_cols=256  Identities=22%  Similarity=0.302  Sum_probs=200.0

Q ss_pred             HHhcCCCCCCeecccCCcEEEEEEE----CCCcEEEEEEeccccC--ChHhHHHHHHHHHHHhccCCCceeeecceEEeC
Q 016594           63 IATNAFSSENLVGRGGYAEVYKGVL----QDGEEIAVKRLTKVVT--DDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDN  136 (386)
Q Consensus        63 ~~~~~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~  136 (386)
                      +..++|++.+.||+|+||.||+|+.    .+++.||+|++.+...  .......+.+|+.+++.++||||+++++++.+.
T Consensus        14 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~   93 (327)
T 3a62_A           14 IRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTG   93 (327)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECS
T ss_pred             CCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcC
Confidence            3456899999999999999999997    4689999999986432  223445678899999999999999999999876


Q ss_pred             c-eEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCcc
Q 016594          137 G-LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLA  215 (386)
Q Consensus       137 ~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a  215 (386)
                      + .++||||+.+++|.+++....  .+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||++
T Consensus        94 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~  168 (327)
T 3a62_A           94 GKLYLILEYLSGGELFMQLEREG--IFMEDTACFYLAEISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLC  168 (327)
T ss_dssp             SCEEEEEECCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTSCEEECCCSCC
T ss_pred             CEEEEEEeCCCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHh---CCEEcccCCHHHeEECCCCcEEEEeCCcc
Confidence            5 899999999999999987644  38999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccC
Q 016594          216 KWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVD  295 (386)
Q Consensus       216 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  295 (386)
                      .......  ......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+......  ...+..         
T Consensus       169 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~i~~---------  235 (327)
T 3a62_A          169 KESIHDG--TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKT--IDKILK---------  235 (327)
T ss_dssp             ------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHH---------
T ss_pred             cccccCC--ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHH--HHHHHh---------
Confidence            7543221  223456799999999999999999999999999999999999999987543211  111110         


Q ss_pred             CccCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHHhcC
Q 016594          296 PRLQGAYDVTQLNRLAFAASLCIRASPTWRP-----TMSEVLEVMLEG  338 (386)
Q Consensus       296 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----t~~~il~~l~~~  338 (386)
                      ..  ...+...+..+.+++.+||..||.+||     ++.++++|.+..
T Consensus       236 ~~--~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~  281 (327)
T 3a62_A          236 CK--LNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFR  281 (327)
T ss_dssp             TC--CCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGS
T ss_pred             CC--CCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCccc
Confidence            00  111223457799999999999999999     888999987654

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=2.4e-46  Score=337.55  Aligned_cols=252  Identities=27%  Similarity=0.481  Sum_probs=197.5

Q ss_pred             HhcCCCCCCeecccCCcEEEEEEECCCcEEEEEEeccccCC--hHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEE
Q 016594           64 ATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTD--DRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYL  140 (386)
Q Consensus        64 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~l  140 (386)
                      ..++|++.+.||+|+||.||+|.+. ++.||||++......  ......+.+|+.+++.++||||+++++++.+++ .++
T Consensus         5 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (271)
T 3dtc_A            5 DFAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCL   83 (271)
T ss_dssp             CTTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEE
T ss_pred             chhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEE
Confidence            3467899999999999999999986 889999998753322  233467889999999999999999999997655 899


Q ss_pred             EEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC---eEEeCCCCCCeeEcC--------CCCeEE
Q 016594          141 IFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRR---IIHRDIKSSNILLTA--------DFEPQI  209 (386)
Q Consensus       141 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~---ivH~dlkp~Nill~~--------~~~~kl  209 (386)
                      ||||+.+++|.+++..   ..+++..++.++.|++.||.|||+   ++   |+||||||+||+++.        ++.+||
T Consensus        84 v~e~~~~~~L~~~~~~---~~~~~~~~~~i~~~l~~~l~~lH~---~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl  157 (271)
T 3dtc_A           84 VMEFARGGPLNRVLSG---KRIPPDILVNWAVQIARGMNYLHD---EAIVPIIHRDLKSSNILILQKVENGDLSNKILKI  157 (271)
T ss_dssp             EEECCTTEEHHHHHTS---SCCCHHHHHHHHHHHHHHHHHHHH---SSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEE
T ss_pred             EEEcCCCCCHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHh---CCCCceeecCCchHHEEEecccccccccCcceEE
Confidence            9999999999998853   358999999999999999999999   77   999999999999986        678999


Q ss_pred             eecCccccCCCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccc
Q 016594          210 SDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGE  289 (386)
Q Consensus       210 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~  289 (386)
                      +|||++.......    .....||+.|+|||.+.+..++.++||||||+++|+|++|..||.+..........       
T Consensus       158 ~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~-------  226 (271)
T 3dtc_A          158 TDFGLAREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGV-------  226 (271)
T ss_dssp             CCCCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHH-------
T ss_pred             ccCCccccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhh-------
Confidence            9999998664332    22446899999999999999999999999999999999999999875533221111       


Q ss_pred             cccccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 016594          290 IEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLE  337 (386)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~  337 (386)
                          .........+...+..+.+++.+||+.||.+|||+.+++++|..
T Consensus       227 ----~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~  270 (271)
T 3dtc_A          227 ----AMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT  270 (271)
T ss_dssp             ----HTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred             ----hcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence                11111122233445779999999999999999999999999864

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.2e-47  Score=361.43  Aligned_cols=266  Identities=21%  Similarity=0.242  Sum_probs=210.3

Q ss_pred             HHHHHHhcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccC-ChHhHHHHHHHHHHHhccCCCceeeecceEEeC
Q 016594           59 EEISIATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVT-DDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDN  136 (386)
Q Consensus        59 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~  136 (386)
                      .+..+..++|++.+.||+|+||+||+|+.+ +++.||+|++.+... .......+.+|..++..++||||+++++++.+.
T Consensus        54 ~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~  133 (412)
T 2vd5_A           54 KEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDE  133 (412)
T ss_dssp             HHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECS
T ss_pred             hhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC
Confidence            344556789999999999999999999986 799999999975221 122234578899999999999999999999876


Q ss_pred             c-eEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCcc
Q 016594          137 G-LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLA  215 (386)
Q Consensus       137 ~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a  215 (386)
                      + .|+||||+.+|+|.+++.... ..+++..++.++.||+.||+|||+   ++|+||||||+|||++.++++||+|||++
T Consensus       134 ~~~~lVmE~~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILld~~g~vkL~DFGla  209 (412)
T 2vd5_A          134 NYLYLVMEYYVGGDLLTLLSKFG-ERIPAEMARFYLAEIVMAIDSVHR---LGYVHRDIKPDNILLDRCGHIRLADFGSC  209 (412)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHHS-SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             CEEEEEEcCCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccCHHHeeecCCCCEEEeechhh
Confidence            6 899999999999999997643 349999999999999999999999   99999999999999999999999999999


Q ss_pred             ccCCCCCccccccccccccCccChhhhc-------cCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhccc
Q 016594          216 KWLPSQWTHHSIAPIEGTFGHLAPEYFM-------HGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQG  288 (386)
Q Consensus       216 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~  288 (386)
                      ..+..... ......+||+.|+|||++.       +..++.++|||||||++|||++|+.||.+......  ...+....
T Consensus       210 ~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~--~~~i~~~~  286 (412)
T 2vd5_A          210 LKLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAET--YGKIVHYK  286 (412)
T ss_dssp             EECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH--HHHHHTHH
T ss_pred             eeccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHH--HHHHHhcc
Confidence            87654322 2233467999999999997       35689999999999999999999999987543211  01111100


Q ss_pred             ccccccCCccCCCCCHHHHHHHHHHHHHccccCCCCC---CCHHHHHHHHhcC
Q 016594          289 EIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWR---PTMSEVLEVMLEG  338 (386)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R---pt~~~il~~l~~~  338 (386)
                      .  ....+    ......+..+.++|.+||. +|.+|   |++.+|++|-+..
T Consensus       287 ~--~~~~p----~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~  332 (412)
T 2vd5_A          287 E--HLSLP----LVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFF  332 (412)
T ss_dssp             H--HCCCC--------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGT
T ss_pred             c--CcCCC----ccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcC
Confidence            0  00001    0112345779999999999 99998   5999999986654

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-45  Score=347.80  Aligned_cols=262  Identities=23%  Similarity=0.308  Sum_probs=203.0

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeC-------
Q 016594           65 TNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDN-------  136 (386)
Q Consensus        65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-------  136 (386)
                      .++|++.+.||+|+||.||+|.+. +|+.||||++............+.+|+.+++.++||||+++++++...       
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  103 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT  103 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence            467999999999999999999986 799999999976555566677889999999999999999999999754       


Q ss_pred             ceEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccc
Q 016594          137 GLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAK  216 (386)
Q Consensus       137 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~  216 (386)
                      ..++|||++ +++|.+++..   ..+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||++.
T Consensus       104 ~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  176 (367)
T 1cm8_A          104 DFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLAR  176 (367)
T ss_dssp             CCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             eEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCHHHEEEcCCCCEEEEeeeccc
Confidence            259999999 7899998875   348999999999999999999999   999999999999999999999999999998


Q ss_pred             cCCCCCccccccccccccCccChhhhcc-CCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhh-hhhhhhccc--c---
Q 016594          217 WLPSQWTHHSIAPIEGTFGHLAPEYFMH-GIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHS-WAKPILNQG--E---  289 (386)
Q Consensus       217 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~-~~~~~~~~~--~---  289 (386)
                      .....     .....+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..... .........  .   
T Consensus       177 ~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~  251 (367)
T 1cm8_A          177 QADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQ  251 (367)
T ss_dssp             ECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred             ccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence            76432     234568999999999987 67999999999999999999999999876532110 000000000  0   


Q ss_pred             -------------cccccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCC
Q 016594          290 -------------IEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEGD  339 (386)
Q Consensus       290 -------------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~~  339 (386)
                                   +........ .......+..+.+|+.+||..||.+|||+.++++|-+...
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~  313 (367)
T 1cm8_A          252 RLQSDEAKNYMKGLPELEKKDF-ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFES  313 (367)
T ss_dssp             TCSCHHHHHHHHHSCCCCCCCG-GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTT
T ss_pred             HhhhHHHHHHHHhCCCCCCCCH-HHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHh
Confidence                         000000000 0111223567999999999999999999999999876554

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=2e-46  Score=341.77  Aligned_cols=259  Identities=24%  Similarity=0.341  Sum_probs=208.3

Q ss_pred             HHhcCCCCCC-eecccCCcEEEEEEEC---CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCce
Q 016594           63 IATNAFSSEN-LVGRGGYAEVYKGVLQ---DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNGL  138 (386)
Q Consensus        63 ~~~~~~~~~~-~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  138 (386)
                      +..++|.+.+ .||+|+||.||+|.+.   +++.||||++............+.+|+.+++.++||||+++++++..+..
T Consensus        13 ~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   92 (291)
T 1xbb_A           13 LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESW   92 (291)
T ss_dssp             CCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESSSE
T ss_pred             ecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEECCCCc
Confidence            3456788888 9999999999999642   46889999998755555567789999999999999999999999977779


Q ss_pred             EEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccC
Q 016594          139 YLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWL  218 (386)
Q Consensus       139 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~  218 (386)
                      ++|||++.+++|.+++...  ..+++..++.++.|++.||.|||+   ++++||||||+||+++.++.+||+|||++...
T Consensus        93 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~  167 (291)
T 1xbb_A           93 MLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKAL  167 (291)
T ss_dssp             EEEEECCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             EEEEEeCCCCCHHHHHHhC--cCCCHHHHHHHHHHHHHHHHHHHh---CCeEcCCCCcceEEEeCCCcEEEccCCcceee
Confidence            9999999999999999764  348999999999999999999999   99999999999999999999999999999877


Q ss_pred             CCCCccc-cccccccccCccChhhhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCchhhhhhhhhhhcccccccccCC
Q 016594          219 PSQWTHH-SIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGEIEKLVDP  296 (386)
Q Consensus       219 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (386)
                      ....... ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||.+........   ....         
T Consensus       168 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~---~~~~---------  235 (291)
T 1xbb_A          168 RADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTA---MLEK---------  235 (291)
T ss_dssp             CTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHH---HHHT---------
T ss_pred             ccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHH---HHHc---------
Confidence            5432211 1223346788999999999899999999999999999999 999998754322110   0011         


Q ss_pred             ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          297 RLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       297 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                      ......+...+..+.+++.+||+.||.+||++.++++.|...
T Consensus       236 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~  277 (291)
T 1xbb_A          236 GERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY  277 (291)
T ss_dssp             TCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            111122234457799999999999999999999999998764

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.1e-46  Score=339.03  Aligned_cols=256  Identities=22%  Similarity=0.396  Sum_probs=209.7

Q ss_pred             HHhcCCCCCCeecccCCcEEEEEEECCCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEE
Q 016594           63 IATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLI  141 (386)
Q Consensus        63 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv  141 (386)
                      +..++|++.+.||+|+||.||+|.+.+++.||+|++.....   ....+.+|+.+++.++||||+++++++.+.+ .+++
T Consensus         5 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   81 (267)
T 3t9t_A            5 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM---SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLV   81 (267)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB---CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             EchhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC---CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEE
Confidence            34578899999999999999999998888999999976432   2357889999999999999999999997754 8999


Q ss_pred             EEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCC
Q 016594          142 FQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQ  221 (386)
Q Consensus       142 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  221 (386)
                      ||++.+++|.+++.... ..+++..++.++.|++.||.|||+   ++++||||||+||+++.++.+||+|||++......
T Consensus        82 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~  157 (267)
T 3t9t_A           82 TEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD  157 (267)
T ss_dssp             ECCCTTCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred             EeCCCCCcHHHHHhhCc-ccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEECCCCCEEEcccccccccccc
Confidence            99999999999987643 458999999999999999999999   99999999999999999999999999999876432


Q ss_pred             CccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCchhhhhhhhhhhcccccccccCCccCC
Q 016594          222 WTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQG  300 (386)
Q Consensus       222 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (386)
                      . ........++..|+|||++.+..++.++||||||+++|+|++ |..||.........  ..... .         ...
T Consensus       158 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~--~~i~~-~---------~~~  224 (267)
T 3t9t_A          158 Q-YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVV--EDIST-G---------FRL  224 (267)
T ss_dssp             H-HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH--HHHHT-T---------CCC
T ss_pred             c-ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHH--HHHhc-C---------CcC
Confidence            1 112233457788999999999999999999999999999999 99999875432111  10000 0         011


Q ss_pred             CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          301 AYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       301 ~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                      ..+...+..+.+++.+||+.||++||++.+++++|...
T Consensus       225 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l  262 (267)
T 3t9t_A          225 YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI  262 (267)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            11223356799999999999999999999999998754

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=4.2e-46  Score=350.58  Aligned_cols=254  Identities=23%  Similarity=0.284  Sum_probs=197.4

Q ss_pred             HhcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccC-ChHhHHHHHHHHHH-HhccCCCceeeecceEEeCc-eE
Q 016594           64 ATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVT-DDRKEKEFLTEIGT-IGHVCHPNVLSLLGCCVDNG-LY  139 (386)
Q Consensus        64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~-l~~l~h~niv~l~~~~~~~~-~~  139 (386)
                      ..++|++.+.||+|+||+||+|+.+ +++.||+|++.+... .......+.+|..+ ++.++||||+++++++.+.+ .|
T Consensus        36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~  115 (373)
T 2r5t_A           36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLY  115 (373)
T ss_dssp             CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEE
T ss_pred             ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEE
Confidence            3467999999999999999999987 688999999986433 23344566778777 57789999999999998765 89


Q ss_pred             EEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCC
Q 016594          140 LIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLP  219 (386)
Q Consensus       140 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~  219 (386)
                      +||||+.+|+|.+++....  .+++..++.++.||+.||+|||+   ++|+||||||+|||++.+|++||+|||+++...
T Consensus       116 lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~  190 (373)
T 2r5t_A          116 FVLDYINGGELFYHLQRER--CFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENI  190 (373)
T ss_dssp             EEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred             EEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence            9999999999999987644  48999999999999999999999   999999999999999999999999999998643


Q ss_pred             CCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccC
Q 016594          220 SQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQ  299 (386)
Q Consensus       220 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (386)
                      ..  .......+||+.|+|||++.+..++.++|||||||++|||++|..||.+......  ...+..         ... 
T Consensus       191 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~--~~~i~~---------~~~-  256 (373)
T 2r5t_A          191 EH--NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM--YDNILN---------KPL-  256 (373)
T ss_dssp             CC--CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHH--HHHHHH---------SCC-
T ss_pred             cC--CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHH--HHHHHh---------ccc-
Confidence            22  1234456799999999999999999999999999999999999999987543211  111111         111 


Q ss_pred             CCCCHHHHHHHHHHHHHccccCCCCCCCHH----HHHHHHhc
Q 016594          300 GAYDVTQLNRLAFAASLCIRASPTWRPTMS----EVLEVMLE  337 (386)
Q Consensus       300 ~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~----~il~~l~~  337 (386)
                       .++...+..+.++|.+||+.||.+||++.    ++++|.+.
T Consensus       257 -~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f  297 (373)
T 2r5t_A          257 -QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFF  297 (373)
T ss_dssp             -CCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGG
T ss_pred             -CCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccc
Confidence             11223456799999999999999999874    66655443

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=4.7e-46  Score=342.63  Aligned_cols=259  Identities=21%  Similarity=0.343  Sum_probs=200.2

Q ss_pred             HhcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccC-ChHhHHHHHHHHHHHhccCCCceeeecceEEeCc----
Q 016594           64 ATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVT-DDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG----  137 (386)
Q Consensus        64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----  137 (386)
                      ..++|++.+.||+|+||.||+|.+. +++.||||++..... .......+.+|+.++++++||||+++++++....    
T Consensus        10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~   89 (311)
T 3ork_A           10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP   89 (311)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred             ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence            3568999999999999999999975 789999999986433 3345567899999999999999999999986543    


Q ss_pred             -eEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccc
Q 016594          138 -LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAK  216 (386)
Q Consensus       138 -~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~  216 (386)
                       .++||||+.+++|.+++....  .+++..++.++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||++.
T Consensus        90 ~~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~  164 (311)
T 3ork_A           90 LPYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIAR  164 (311)
T ss_dssp             EEEEEEECCCEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred             ccEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence             499999999999999987654  48999999999999999999999   999999999999999999999999999998


Q ss_pred             cCCCCCcc-ccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccC
Q 016594          217 WLPSQWTH-HSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVD  295 (386)
Q Consensus       217 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  295 (386)
                      .+...... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.......+..  ......    .
T Consensus       165 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~--~~~~~~----~  238 (311)
T 3ork_A          165 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQH--VREDPI----P  238 (311)
T ss_dssp             -----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH--HHCCCC----C
T ss_pred             cccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH--hcCCCC----C
Confidence            76543221 2233456899999999999999999999999999999999999999876543211111  010000    0


Q ss_pred             CccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 016594          296 PRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVML  336 (386)
Q Consensus       296 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~  336 (386)
                         ........+..+.+++.+||+.||.+||++.+++.+-+
T Consensus       239 ---~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l  276 (311)
T 3ork_A          239 ---PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADL  276 (311)
T ss_dssp             ---HHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHH
T ss_pred             ---cccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHH
Confidence               00001123567999999999999999998888777644

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=4.7e-46  Score=336.44  Aligned_cols=261  Identities=22%  Similarity=0.261  Sum_probs=210.5

Q ss_pred             HhcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEE
Q 016594           64 ATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLI  141 (386)
Q Consensus        64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv  141 (386)
                      ..++|++.+.||+|+||.||+|... +++.||||++..... ......+.+|+.+++.++||||+++++++.+++ .++|
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (276)
T 2yex_A            5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF   83 (276)
T ss_dssp             HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC-TTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc-hhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEE
Confidence            3467999999999999999999986 689999999875332 234567889999999999999999999998766 7999


Q ss_pred             EEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCC
Q 016594          142 FQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQ  221 (386)
Q Consensus       142 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  221 (386)
                      +||+.+++|.+++...  ..+++..++.++.|++.||.|||+   ++++||||||+||+++.++.+||+|||++......
T Consensus        84 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~  158 (276)
T 2yex_A           84 LEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYN  158 (276)
T ss_dssp             EECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred             EEecCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCChHHEEEccCCCEEEeeCCCccccCCC
Confidence            9999999999988643  348999999999999999999999   99999999999999999999999999999876433


Q ss_pred             CccccccccccccCccChhhhccCCC-CcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCC
Q 016594          222 WTHHSIAPIEGTFGHLAPEYFMHGIV-DEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQG  300 (386)
Q Consensus       222 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (386)
                      ..........|++.|+|||++.+..+ +.++|||||||++|+|++|..||.........+....          ......
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~----------~~~~~~  228 (276)
T 2yex_A          159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWK----------EKKTYL  228 (276)
T ss_dssp             TEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHH----------TTCTTS
T ss_pred             cchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhh----------hccccc
Confidence            22233445678999999999987665 7899999999999999999999987543221111100          000000


Q ss_pred             CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCCc
Q 016594          301 AYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEGDQ  340 (386)
Q Consensus       301 ~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~~~  340 (386)
                      ......+..+.+++.+||+.||.+|||+.+++++.+....
T Consensus       229 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~  268 (276)
T 2yex_A          229 NPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKP  268 (276)
T ss_dssp             TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred             CchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccCh
Confidence            1112345678999999999999999999999987665443

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=1.4e-45  Score=357.45  Aligned_cols=269  Identities=20%  Similarity=0.281  Sum_probs=192.9

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeC------c
Q 016594           65 TNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDN------G  137 (386)
Q Consensus        65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~  137 (386)
                      .++|++.+.||+|+||+||+|.+. +++.||||++............+.+|+.+|+.++||||+++++++...      .
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  131 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE  131 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence            468999999999999999999976 689999999987666666778899999999999999999999998532      3


Q ss_pred             eEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCcccc
Q 016594          138 LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKW  217 (386)
Q Consensus       138 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~  217 (386)
                      .|+|||++. ++|.+++...  ..+++..++.++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+++.
T Consensus       132 ~~lv~e~~~-~~L~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~---~~iiHrDlKp~NILl~~~~~~kl~DFGla~~  205 (458)
T 3rp9_A          132 LYVVLEIAD-SDFKKLFRTP--VYLTELHIKTLLYNLLVGVKYVHS---AGILHRDLKPANCLVNQDCSVKVCDFGLART  205 (458)
T ss_dssp             EEEEECCCS-EEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred             EEEEEeccc-cchhhhcccC--CCCCHHHHHHHHHHHHHHHHHHHh---CCcCCCCCChhhEEECCCCCEeecccccchh
Confidence            799999874 6888888653  349999999999999999999999   9999999999999999999999999999987


Q ss_pred             CCCCCcc-------------------------ccccccccccCccChhhhc-cCCCCcccchHHHHHHHHHHHh------
Q 016594          218 LPSQWTH-------------------------HSIAPIEGTFGHLAPEYFM-HGIVDEKTDVFAFGVFLLEIIS------  265 (386)
Q Consensus       218 ~~~~~~~-------------------------~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~ell~------  265 (386)
                      .......                         ......+||+.|+|||++. +..++.++|||||||++|||++      
T Consensus       206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~  285 (458)
T 3rp9_A          206 VDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENV  285 (458)
T ss_dssp             TTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTC
T ss_pred             ccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccc
Confidence            6432111                         1234567899999999874 5679999999999999999999      


Q ss_pred             -----CCCCCCCCchh-------------------hh--hhhhhhhcccc--------------cccccCCccCC---CC
Q 016594          266 -----GRKPVDGSHQS-------------------LH--SWAKPILNQGE--------------IEKLVDPRLQG---AY  302 (386)
Q Consensus       266 -----g~~pf~~~~~~-------------------~~--~~~~~~~~~~~--------------~~~~~~~~~~~---~~  302 (386)
                           |.++|.+....                   ..  ...........              ....+......   ..
T Consensus       286 ~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  365 (458)
T 3rp9_A          286 AYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAER  365 (458)
T ss_dssp             SSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGG
T ss_pred             cccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHH
Confidence                 67777654310                   00  00000000000              00000000000   00


Q ss_pred             CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCC
Q 016594          303 DVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEGD  339 (386)
Q Consensus       303 ~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~~  339 (386)
                      ....+..+.+||.+||..||++|||+.++|+|-+...
T Consensus       366 ~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~  402 (458)
T 3rp9_A          366 FPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKE  402 (458)
T ss_dssp             STTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTT
T ss_pred             CCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhh
Confidence            1122567899999999999999999999999976553

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=7.8e-47  Score=342.19  Aligned_cols=259  Identities=21%  Similarity=0.340  Sum_probs=210.0

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeC---ceEE
Q 016594           65 TNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDN---GLYL  140 (386)
Q Consensus        65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~---~~~l  140 (386)
                      .++|++.+.||+|+||.||+|... +++.||+|.+............+.+|+.++++++||||+++++++.+.   ..++
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   84 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   84 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence            467899999999999999999986 689999999987655566677899999999999999999999988652   3899


Q ss_pred             EEEeccCCCHhhhhhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCC-----eEEeCCCCCCeeEcCCCCeEEeecC
Q 016594          141 IFQFSSRGSVASLFHDVN--SPGVEWKVRHKIAVGTARGLHYLHKGCQRR-----IIHRDIKSSNILLTADFEPQISDFG  213 (386)
Q Consensus       141 v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~-----ivH~dlkp~Nill~~~~~~kl~Dfg  213 (386)
                      ||||+.+++|.+++....  ...+++..++.++.|++.||.|||+   ++     ++||||||+||+++.++.+||+|||
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg  161 (279)
T 2w5a_A           85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR---RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG  161 (279)
T ss_dssp             EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---HC------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred             EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhc---ccCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence            999999999999887542  3448999999999999999999999   78     9999999999999999999999999


Q ss_pred             ccccCCCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccc
Q 016594          214 LAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKL  293 (386)
Q Consensus       214 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  293 (386)
                      ++........  ......|++.|+|||++.+..++.++||||||+++|+|++|..||........  ... ...+..   
T Consensus       162 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~~-i~~~~~---  233 (279)
T 2w5a_A          162 LARILNHDTS--FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKEL--AGK-IREGKF---  233 (279)
T ss_dssp             HHHHC---CH--HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHH-HHHTCC---
T ss_pred             hheeeccccc--cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHH--HHH-Hhhccc---
Confidence            9987654321  12234689999999999999999999999999999999999999987543211  111 111111   


Q ss_pred             cCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCCc
Q 016594          294 VDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEGDQ  340 (386)
Q Consensus       294 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~~~  340 (386)
                            ...+...+..+.+++.+||+.||.+||++.+|+++++..++
T Consensus       234 ------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~  274 (279)
T 2w5a_A          234 ------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEH  274 (279)
T ss_dssp             ------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGG
T ss_pred             ------ccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhh
Confidence                  11222345779999999999999999999999998766543

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=1.1e-45  Score=345.50  Aligned_cols=255  Identities=24%  Similarity=0.302  Sum_probs=193.0

Q ss_pred             HhcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEE
Q 016594           64 ATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLI  141 (386)
Q Consensus        64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv  141 (386)
                      ..++|++.+.||+|+||.||+|.+. +++.||||++....    ....+.+|+.++++++||||+++++++.+.. .++|
T Consensus        51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  126 (349)
T 2w4o_A           51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLV  126 (349)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC--------------CHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEE
Confidence            4578999999999999999999987 58899999997532    3456788999999999999999999998765 8999


Q ss_pred             EEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcC---CCCeEEeecCccccC
Q 016594          142 FQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTA---DFEPQISDFGLAKWL  218 (386)
Q Consensus       142 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~---~~~~kl~Dfg~a~~~  218 (386)
                      |||+.+++|.+++...  ..+++..++.++.|++.||.|||+   ++|+||||||+|||++.   ++.+||+|||++...
T Consensus       127 ~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~  201 (349)
T 2w4o_A          127 LELVTGGELFDRIVEK--GYYSERDAADAVKQILEAVAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV  201 (349)
T ss_dssp             ECCCCSCBHHHHHTTC--SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESSSSTTCCEEECCCC-----
T ss_pred             EEeCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCcccEEEecCCCCCCEEEccCcccccc
Confidence            9999999999988753  348999999999999999999999   99999999999999975   889999999999866


Q ss_pred             CCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCcc
Q 016594          219 PSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRL  298 (386)
Q Consensus       219 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (386)
                      ....   ......||+.|+|||++.+..++.++|||||||++|+|++|..||............ +.. ...      ..
T Consensus       202 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~-i~~-~~~------~~  270 (349)
T 2w4o_A          202 EHQV---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRR-ILN-CEY------YF  270 (349)
T ss_dssp             --------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHH-HHT-TCC------CC
T ss_pred             Cccc---ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHH-HHh-CCC------cc
Confidence            4321   233456999999999999999999999999999999999999999765432211111 111 000      00


Q ss_pred             CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          299 QGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       299 ~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                      ........+..+.+++.+||+.||++|||+.+++++-+..
T Consensus       271 ~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~  310 (349)
T 2w4o_A          271 ISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVT  310 (349)
T ss_dssp             CTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTT
T ss_pred             CCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccC
Confidence            0111123456799999999999999999999999986554

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=1.3e-46  Score=349.59  Aligned_cols=262  Identities=23%  Similarity=0.408  Sum_probs=211.0

Q ss_pred             HHHhcCCCCCCeecccCCcEEEEEEECC-C-----cEEEEEEeccccCChHhHHHHHHHHHHHhcc-CCCceeeecceEE
Q 016594           62 SIATNAFSSENLVGRGGYAEVYKGVLQD-G-----EEIAVKRLTKVVTDDRKEKEFLTEIGTIGHV-CHPNVLSLLGCCV  134 (386)
Q Consensus        62 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~-~-----~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~  134 (386)
                      .+..++|++.+.||+|+||.||+|.+.. +     ..||+|.+.... .......+.+|+.+++.+ +||||+++++++.
T Consensus        42 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~  120 (333)
T 2i1m_A           42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA-HADEKEALMSELKIMSHLGQHENIVNLLGACT  120 (333)
T ss_dssp             BCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc-ChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence            4556889999999999999999999752 3     479999987532 344567789999999999 7999999999997


Q ss_pred             eCc-eEEEEEeccCCCHhhhhhhcC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeE
Q 016594          135 DNG-LYLIFQFSSRGSVASLFHDVN------------SPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILL  201 (386)
Q Consensus       135 ~~~-~~lv~e~~~~~~L~~~~~~~~------------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill  201 (386)
                      +.+ .++||||+.+|+|.+++....            ...+++..++.++.|++.||.|||+   ++|+||||||+|||+
T Consensus       121 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~  197 (333)
T 2i1m_A          121 HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS---KNCIHRDVAARNVLL  197 (333)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGCEE
T ss_pred             cCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhc---CCcccCCcccceEEE
Confidence            655 899999999999999887542            3358999999999999999999999   999999999999999


Q ss_pred             cCCCCeEEeecCccccCCCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCchhhhhh
Q 016594          202 TADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSW  280 (386)
Q Consensus       202 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~  280 (386)
                      +.++.+||+|||++................+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+........
T Consensus       198 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~  277 (333)
T 2i1m_A          198 TNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFY  277 (333)
T ss_dssp             EGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHH
T ss_pred             CCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHH
Confidence            9999999999999986644332223334557889999999999999999999999999999998 999998754321111


Q ss_pred             hhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          281 AKPILNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                        .....         ......+...+..+.+++.+||+.||.+|||+.++++.|+..
T Consensus       278 --~~~~~---------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~  324 (333)
T 2i1m_A          278 --KLVKD---------GYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQ  324 (333)
T ss_dssp             --HHHHH---------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             --HHHhc---------CCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHH
Confidence              00000         011111222356799999999999999999999999998765

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=4.2e-46  Score=346.35  Aligned_cols=250  Identities=22%  Similarity=0.319  Sum_probs=206.3

Q ss_pred             HhcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCCh------HhHHHHHHHHHHHhccCCCceeeecceEEeC
Q 016594           64 ATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDD------RKEKEFLTEIGTIGHVCHPNVLSLLGCCVDN  136 (386)
Q Consensus        64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~  136 (386)
                      ..++|++.+.||+|+||.||+|.+. +++.||||++.......      .....+.+|+.+++.++||||+++++++.+.
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~  101 (335)
T 3dls_A           22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ  101 (335)
T ss_dssp             HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence            4578999999999999999999976 68999999998643221      1334567899999999999999999999876


Q ss_pred             c-eEEEEEeccCC-CHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCc
Q 016594          137 G-LYLIFQFSSRG-SVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGL  214 (386)
Q Consensus       137 ~-~~lv~e~~~~~-~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~  214 (386)
                      + .++|||++.+| +|.+++....  .+++..++.++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+
T Consensus       102 ~~~~lv~e~~~~g~~l~~~~~~~~--~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~  176 (335)
T 3dls_A          102 GFFQLVMEKHGSGLDLFAFIDRHP--RLDEPLASYIFRQLVSAVGYLRL---KDIIHRDIKDENIVIAEDFTIKLIDFGS  176 (335)
T ss_dssp             SEEEEEEECCTTSCBHHHHHHTCC--CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred             CEEEEEEEeCCCCccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh---CCeEEeccCHHHEEEcCCCcEEEeeccc
Confidence            6 88999998776 9999887543  49999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCCccccccccccccCccChhhhccCCC-CcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccc
Q 016594          215 AKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIV-DEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKL  293 (386)
Q Consensus       215 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  293 (386)
                      +.......   ......||+.|+|||++.+..+ +.++|||||||++|+|++|..||......                 
T Consensus       177 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-----------------  236 (335)
T 3dls_A          177 AAYLERGK---LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET-----------------  236 (335)
T ss_dssp             CEECCTTC---CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG-----------------
T ss_pred             ceECCCCC---ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH-----------------
Confidence            98765432   2234569999999999988876 78999999999999999999999763211                 


Q ss_pred             cCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCCc
Q 016594          294 VDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEGDQ  340 (386)
Q Consensus       294 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~~~  340 (386)
                      .....  ..+...+..+.+++.+||+.||++|||+.+++++.+....
T Consensus       237 ~~~~~--~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~  281 (335)
T 3dls_A          237 VEAAI--HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQP  281 (335)
T ss_dssp             TTTCC--CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCC
T ss_pred             Hhhcc--CCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccccCC
Confidence            00000  0111235679999999999999999999999998765543

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=4.5e-46  Score=345.47  Aligned_cols=268  Identities=19%  Similarity=0.278  Sum_probs=197.4

Q ss_pred             HHhcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEE
Q 016594           63 IATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYL  140 (386)
Q Consensus        63 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~l  140 (386)
                      ...++|++.+.||+|+||+||+|.+. +++.||||++............+.+|+.+++.++||||+++++++.++. .++
T Consensus        31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  110 (329)
T 3gbz_A           31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL  110 (329)
T ss_dssp             -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred             cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence            45578999999999999999999976 7899999999865544555567889999999999999999999998766 899


Q ss_pred             EEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEc-----CCCCeEEeecCcc
Q 016594          141 IFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLT-----ADFEPQISDFGLA  215 (386)
Q Consensus       141 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~-----~~~~~kl~Dfg~a  215 (386)
                      ||||+.+ +|.+++....  .+++..++.++.|++.||.|||+   ++|+||||||+|||++     ..+.+||+|||++
T Consensus       111 v~e~~~~-~L~~~~~~~~--~~~~~~~~~i~~ql~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a  184 (329)
T 3gbz_A          111 IFEYAEN-DLKKYMDKNP--DVSMRVIKSFLYQLINGVNFCHS---RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA  184 (329)
T ss_dssp             EEECCSE-EHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEC-----CCEEEECCTTHH
T ss_pred             EEecCCC-CHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHh---CCEECCCCCHHHEEEecCCCCccceEEECcCCCc
Confidence            9999985 8999887644  48999999999999999999999   9999999999999994     4556999999999


Q ss_pred             ccCCCCCccccccccccccCccChhhhccC-CCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhh-hhhcc---ccc
Q 016594          216 KWLPSQWTHHSIAPIEGTFGHLAPEYFMHG-IVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAK-PILNQ---GEI  290 (386)
Q Consensus       216 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~-~~~~~---~~~  290 (386)
                      ..+....  .......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.......... .....   ...
T Consensus       185 ~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  262 (329)
T 3gbz_A          185 RAFGIPI--RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTW  262 (329)
T ss_dssp             HHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred             cccCCcc--cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhh
Confidence            8764321  123345689999999999874 4899999999999999999999999876532211100 00000   000


Q ss_pred             ---c----------cccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          291 ---E----------KLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       291 ---~----------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                         .          ...............+..+.+|+.+||+.||++|||+.+++++-+..
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~  323 (329)
T 3gbz_A          263 PGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFS  323 (329)
T ss_dssp             TTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGS
T ss_pred             hhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccC
Confidence               0          00000000000111346789999999999999999999999986654

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=1.1e-45  Score=337.81  Aligned_cols=262  Identities=13%  Similarity=0.157  Sum_probs=206.6

Q ss_pred             HHhcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhcc-CCCceeeecceEEeCc-eE
Q 016594           63 IATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHV-CHPNVLSLLGCCVDNG-LY  139 (386)
Q Consensus        63 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~-~~  139 (386)
                      +..++|++.+.||+|+||.||+|... +++.||||++....    ....+.+|+.+++.+ +|+|++++++++.+.. .+
T Consensus         7 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~   82 (298)
T 1csn_A            7 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS----DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNV   82 (298)
T ss_dssp             EETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT----TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEE
T ss_pred             ccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC----ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeE
Confidence            34678999999999999999999974 78999999986532    223467899999999 6999999999998766 88


Q ss_pred             EEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCC-----eEEeecCc
Q 016594          140 LIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFE-----PQISDFGL  214 (386)
Q Consensus       140 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~-----~kl~Dfg~  214 (386)
                      ++|||+ +++|.+++.... ..+++..++.++.|++.||.|||+   ++|+||||||+|||++.++.     +||+|||+
T Consensus        83 lv~e~~-~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~  157 (298)
T 1csn_A           83 LVIDLL-GPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGM  157 (298)
T ss_dssp             EEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCTT
T ss_pred             EEEEec-CCCHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEeccCCCCCCCeEEEEECcc
Confidence            999999 999999997643 349999999999999999999999   99999999999999987766     99999999


Q ss_pred             cccCCCCCcc-----ccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccc
Q 016594          215 AKWLPSQWTH-----HSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGE  289 (386)
Q Consensus       215 a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~  289 (386)
                      +.........     .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.................
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  237 (298)
T 1csn_A          158 VKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKK  237 (298)
T ss_dssp             CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHH
T ss_pred             ccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhc
Confidence            9877543221     12345679999999999999999999999999999999999999998743211110000000000


Q ss_pred             cccccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          290 IEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                      .   ..+.  .......+..+.+++.+||+.||++||++.+|++.|...
T Consensus       238 ~---~~~~--~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~  281 (298)
T 1csn_A          238 Q---STPL--RELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV  281 (298)
T ss_dssp             H---HSCH--HHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred             c---CccH--HHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHH
Confidence            0   0000  000112346799999999999999999999999998765

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=1.2e-45  Score=334.53  Aligned_cols=252  Identities=27%  Similarity=0.409  Sum_probs=204.7

Q ss_pred             HhcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccC-ChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEE
Q 016594           64 ATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVT-DDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYL  140 (386)
Q Consensus        64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~l  140 (386)
                      ..++|++.+.||+|+||.||+|.+. ++..||+|++..... .......+.+|+.+++.++||||+++++++.+.. .++
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   86 (279)
T 3fdn_A            7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL   86 (279)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence            3467999999999999999999977 578999999865321 1223466889999999999999999999998766 899


Q ss_pred             EEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCC
Q 016594          141 IFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPS  220 (386)
Q Consensus       141 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~  220 (386)
                      +|||+.+++|.+++....  .+++..++.++.|++.||.|||+   ++|+||||||+||+++.++.+||+|||++.....
T Consensus        87 v~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~  161 (279)
T 3fdn_A           87 ILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS  161 (279)
T ss_dssp             EECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHT---TTCEECCCCGGGEEECTTSCEEECSCCEESCC--
T ss_pred             EEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHhEEEcCCCCEEEEeccccccCCc
Confidence            999999999999887654  38999999999999999999999   9999999999999999999999999999865543


Q ss_pred             CCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCC
Q 016594          221 QWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQG  300 (386)
Q Consensus       221 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (386)
                      .    ......|++.|+|||.+.+..++.++||||||+++|+|++|..||..........  .. ..          ...
T Consensus       162 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~--~~-~~----------~~~  224 (279)
T 3fdn_A          162 S----RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYK--RI-SR----------VEF  224 (279)
T ss_dssp             ----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH--HH-HH----------TCC
T ss_pred             c----cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHH--HH-Hh----------CCC
Confidence            2    2234568999999999999999999999999999999999999998754321110  00 00          011


Q ss_pred             CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 016594          301 AYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLE  337 (386)
Q Consensus       301 ~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~  337 (386)
                      ..+...+..+.+++.+||+.||.+|||+.+++++.+.
T Consensus       225 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~  261 (279)
T 3fdn_A          225 TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI  261 (279)
T ss_dssp             CCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHH
T ss_pred             CCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCccc
Confidence            1222345678999999999999999999999998664

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=1.2e-45  Score=336.52  Aligned_cols=254  Identities=23%  Similarity=0.387  Sum_probs=206.0

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeC-----ce
Q 016594           65 TNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDN-----GL  138 (386)
Q Consensus        65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~  138 (386)
                      +..|.+.+.||+|+||.||+|.+. ++..||+|.+............+.+|+.+++.++||||+++++++...     ..
T Consensus        25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  104 (290)
T 1t4h_A           25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI  104 (290)
T ss_dssp             SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred             ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceE
Confidence            445788889999999999999976 688999999987666666778899999999999999999999998652     27


Q ss_pred             EEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEEeCCCCCCeeEc-CCCCeEEeecCcc
Q 016594          139 YLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRR--IIHRDIKSSNILLT-ADFEPQISDFGLA  215 (386)
Q Consensus       139 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~--ivH~dlkp~Nill~-~~~~~kl~Dfg~a  215 (386)
                      ++||||+.+++|.+++....  .+++..++.++.|++.||.|||+   ++  |+||||||+|||++ .++.+||+|||++
T Consensus       105 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~  179 (290)
T 1t4h_A          105 VLVTELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA  179 (290)
T ss_dssp             EEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCTTGG
T ss_pred             EEEEEecCCCCHHHHHHHcc--CCCHHHHHHHHHHHHHHHHHHHc---CCCCEEECCCCHHHEEEECCCCCEEEeeCCCc
Confidence            99999999999999997653  48999999999999999999999   88  99999999999998 7889999999999


Q ss_pred             ccCCCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccC
Q 016594          216 KWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVD  295 (386)
Q Consensus       216 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  295 (386)
                      ......    ......||+.|+|||++. ..++.++|||||||++|+|++|..||............ . .        .
T Consensus       180 ~~~~~~----~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~-~-~--------~  244 (290)
T 1t4h_A          180 TLKRAS----FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRR-V-T--------S  244 (290)
T ss_dssp             GGCCTT----SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHH-H-T--------T
T ss_pred             cccccc----ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHH-H-h--------c
Confidence            765433    223456899999999876 45899999999999999999999999764432211111 0 0        0


Q ss_pred             CccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          296 PRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       296 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                      .......+...+..+.+++.+||+.||.+|||+.+++++.+..
T Consensus       245 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~  287 (290)
T 1t4h_A          245 GVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ  287 (290)
T ss_dssp             TCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred             cCCccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCcccc
Confidence            0001111112235799999999999999999999999886543

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=4.7e-46  Score=347.66  Aligned_cols=252  Identities=24%  Similarity=0.402  Sum_probs=204.1

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCC-hHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEE
Q 016594           65 TNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTD-DRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLI  141 (386)
Q Consensus        65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv  141 (386)
                      .+.|.+.+.||+|+||+||+|... +++.||||++...... ......+.+|+.++++++||||+++++++.+++ .++|
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  132 (348)
T 1u5q_A           53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV  132 (348)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence            345888999999999999999975 7899999999754322 334567899999999999999999999998766 8999


Q ss_pred             EEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCC
Q 016594          142 FQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQ  221 (386)
Q Consensus       142 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  221 (386)
                      |||+. |+|.+++.... ..+++..++.++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||++......
T Consensus       133 ~e~~~-g~l~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~  207 (348)
T 1u5q_A          133 MEYCL-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA  207 (348)
T ss_dssp             EECCS-EEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred             EecCC-CCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC
Confidence            99998 57877775433 458999999999999999999999   99999999999999999999999999999866432


Q ss_pred             CccccccccccccCccChhhhc---cCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCcc
Q 016594          222 WTHHSIAPIEGTFGHLAPEYFM---HGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRL  298 (386)
Q Consensus       222 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (386)
                            ....||+.|+|||++.   +..++.++|||||||++|+|++|..||.+........  ..... .     .+  
T Consensus       208 ------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~--~~~~~-~-----~~--  271 (348)
T 1u5q_A          208 ------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY--HIAQN-E-----SP--  271 (348)
T ss_dssp             ------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH--HHHHS-C-----CC--
T ss_pred             ------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH--HHHhc-C-----CC--
Confidence                  3456999999999985   5678999999999999999999999997754321111  11110 0     01  


Q ss_pred             CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          299 QGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       299 ~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                       .......+..+.+++.+||+.||++|||+.+++++.+..
T Consensus       272 -~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~  310 (348)
T 1u5q_A          272 -ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVL  310 (348)
T ss_dssp             -CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHH
T ss_pred             -CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhh
Confidence             111123356789999999999999999999999986654

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=6e-46  Score=346.06  Aligned_cols=255  Identities=23%  Similarity=0.309  Sum_probs=202.5

Q ss_pred             HhcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhcc-CCCceeeecceEEeCc-eEE
Q 016594           64 ATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHV-CHPNVLSLLGCCVDNG-LYL  140 (386)
Q Consensus        64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~-~~l  140 (386)
                      ..++|++.+.||+|+||+||+|..+ +++.||||++.+....      ..+|+.++.++ +||||+++++++.++. .++
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~------~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~l   93 (342)
T 2qr7_A           20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD------PTEEIEILLRYGQHPNIITLKDVYDDGKYVYV   93 (342)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC------CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEE
T ss_pred             ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC------hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEE
Confidence            4567999999999999999999987 6899999999764322      34678888887 6999999999998766 899


Q ss_pred             EEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCC----CCeEEeecCccc
Q 016594          141 IFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTAD----FEPQISDFGLAK  216 (386)
Q Consensus       141 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~----~~~kl~Dfg~a~  216 (386)
                      ||||+.+|+|.+.+...  ..+++..+..++.||+.||.|||+   ++|+||||||+|||+..+    +.+||+|||++.
T Consensus        94 v~E~~~gg~L~~~i~~~--~~~~~~~~~~~~~qi~~al~~lH~---~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~  168 (342)
T 2qr7_A           94 VTELMKGGELLDKILRQ--KFFSEREASAVLFTITKTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAK  168 (342)
T ss_dssp             EECCCCSCBHHHHHHTC--TTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSCSGGGEEECCCTTCE
T ss_pred             EEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCcEeccCCHHHEEEecCCCCcCeEEEEECCCcc
Confidence            99999999999988754  349999999999999999999999   999999999999998543    359999999998


Q ss_pred             cCCCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCC
Q 016594          217 WLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDP  296 (386)
Q Consensus       217 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (386)
                      ......  ......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+...............+..      
T Consensus       169 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~------  240 (342)
T 2qr7_A          169 QLRAEN--GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKF------  240 (342)
T ss_dssp             ECBCTT--CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCC------
T ss_pred             cCcCCC--CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCc------
Confidence            764432  223456789999999999988899999999999999999999999986432111111111111111      


Q ss_pred             ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 016594          297 RLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLE  337 (386)
Q Consensus       297 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~  337 (386)
                      ..........+..+.+++.+||..||++||++.+++++.+.
T Consensus       241 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~  281 (342)
T 2qr7_A          241 SLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWI  281 (342)
T ss_dssp             CCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHH
T ss_pred             ccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCee
Confidence            01111122345779999999999999999999999998655

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=5.5e-46  Score=345.17  Aligned_cols=267  Identities=24%  Similarity=0.334  Sum_probs=205.9

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEE
Q 016594           65 TNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIF  142 (386)
Q Consensus        65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~  142 (386)
                      .++|++.+.||+|+||.||+|.+. +++.||||++............+.+|+.+++.++||||+++++++.+.+ .++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  103 (331)
T 4aaa_A           24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF  103 (331)
T ss_dssp             GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence            357899999999999999999987 5899999999776555666677889999999999999999999998866 89999


Q ss_pred             EeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCC
Q 016594          143 QFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQW  222 (386)
Q Consensus       143 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  222 (386)
                      ||+.+++|..+....  ..+++..++.++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||++..+....
T Consensus       104 e~~~~~~l~~~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  178 (331)
T 4aaa_A          104 EFVDHTILDDLELFP--NGLDYQVVQKYLFQIINGIGFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG  178 (331)
T ss_dssp             ECCSEEHHHHHHHST--TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred             ecCCcchHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHH---CCEEccCcChheEEEcCCCcEEEEeCCCceeecCCc
Confidence            999999888876543  349999999999999999999999   999999999999999999999999999998664322


Q ss_pred             ccccccccccccCccChhhhccC-CCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhh-------------hccc
Q 016594          223 THHSIAPIEGTFGHLAPEYFMHG-IVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPI-------------LNQG  288 (386)
Q Consensus       223 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~-------------~~~~  288 (386)
                        .......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+............             ....
T Consensus       179 --~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (331)
T 4aaa_A          179 --EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNP  256 (331)
T ss_dssp             -------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCG
T ss_pred             --cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcc
Confidence              123345689999999999875 789999999999999999999999987653221110000             0000


Q ss_pred             ccccccCCccCCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          289 EIEKLVDPRLQGAYD-----VTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       289 ~~~~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                      .......+......+     ...+..+.+++.+||+.||++|||+.+++++-+..
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~  311 (331)
T 4aaa_A          257 VFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQ  311 (331)
T ss_dssp             GGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHH
T ss_pred             ccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhc
Confidence            000011111111111     12357799999999999999999999999986543

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=5e-45  Score=334.59  Aligned_cols=257  Identities=23%  Similarity=0.260  Sum_probs=207.4

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccC--ChHhHHHHHHHHHHHhccCCCceeeecceEEe---Cce
Q 016594           65 TNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVT--DDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVD---NGL  138 (386)
Q Consensus        65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~---~~~  138 (386)
                      .++|++.+.||+|+||.||+|... +++.||+|++.....  .......+.+|+.+++.++||||+++++++..   ...
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM   83 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence            478999999999999999999975 688999999975321  12345678999999999999999999999853   248


Q ss_pred             EEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccC
Q 016594          139 YLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWL  218 (386)
Q Consensus       139 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~  218 (386)
                      ++||||+.++ |.+++.......+++..++.++.|++.||.|||+   ++++||||||+||+++.++.+||+|||++...
T Consensus        84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~  159 (305)
T 2wtk_C           84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAEAL  159 (305)
T ss_dssp             EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEcCCCcEEeecccccccc
Confidence            9999999986 7777776666679999999999999999999999   99999999999999999999999999999877


Q ss_pred             CCCCccccccccccccCccChhhhccCC--CCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCC
Q 016594          219 PSQWTHHSIAPIEGTFGHLAPEYFMHGI--VDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDP  296 (386)
Q Consensus       219 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (386)
                      .............||+.|+|||++.+..  ++.++|||||||++|+|++|..||.+......  .... ....       
T Consensus       160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~~i-~~~~-------  229 (305)
T 2wtk_C          160 HPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKL--FENI-GKGS-------  229 (305)
T ss_dssp             CTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHH-HHCC-------
T ss_pred             CccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHH--HHHH-hcCC-------
Confidence            5443333444566999999999997654  37899999999999999999999987543211  1110 0000       


Q ss_pred             ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          297 RLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       297 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                         ...+...+..+.+++.+||+.||.+|||+.+++++.+..
T Consensus       230 ---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~  268 (305)
T 2wtk_C          230 ---YAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFR  268 (305)
T ss_dssp             ---CCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHH
T ss_pred             ---CCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccc
Confidence               011223356789999999999999999999999986544

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=4.4e-46  Score=365.53  Aligned_cols=259  Identities=26%  Similarity=0.331  Sum_probs=213.4

Q ss_pred             HHhcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccC-ChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eE
Q 016594           63 IATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVT-DDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LY  139 (386)
Q Consensus        63 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~  139 (386)
                      +..++|++.+.||+|+||.||+|..+ +|+.||+|++.+... .......+.+|+.+|+.++||||+++++++.+.. .+
T Consensus       181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~  260 (576)
T 2acx_A          181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALC  260 (576)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEE
Confidence            34567999999999999999999986 799999999975321 1233456889999999999999999999998765 89


Q ss_pred             EEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCC
Q 016594          140 LIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLP  219 (386)
Q Consensus       140 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~  219 (386)
                      +||||+.+|+|.+++.......+++..++.++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||++..+.
T Consensus       261 lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~---~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~  337 (576)
T 2acx_A          261 LVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVP  337 (576)
T ss_dssp             EEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCchheEEEeCCCCeEEEecccceecc
Confidence            99999999999999887666669999999999999999999999   999999999999999999999999999998775


Q ss_pred             CCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhh--hhhhhhhhcccccccccCCc
Q 016594          220 SQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSL--HSWAKPILNQGEIEKLVDPR  297 (386)
Q Consensus       220 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~  297 (386)
                      ...   .....+||+.|+|||++.+..++.++|||||||++|||++|..||.+.....  ......+..           
T Consensus       338 ~~~---~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~-----------  403 (576)
T 2acx_A          338 EGQ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE-----------  403 (576)
T ss_dssp             TTC---CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHH-----------
T ss_pred             cCc---cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhc-----------
Confidence            432   2234579999999999999999999999999999999999999998753211  000000000           


Q ss_pred             cCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHHhcC
Q 016594          298 LQGAYDVTQLNRLAFAASLCIRASPTWRP-----TMSEVLEVMLEG  338 (386)
Q Consensus       298 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----t~~~il~~l~~~  338 (386)
                      ....++...+..+.++|.+||+.||.+||     ++.+|++|-+..
T Consensus       404 ~~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~  449 (576)
T 2acx_A          404 VPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFK  449 (576)
T ss_dssp             CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGT
T ss_pred             ccccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhc
Confidence            01112233457899999999999999999     789999986654

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=2.7e-45  Score=339.02  Aligned_cols=257  Identities=21%  Similarity=0.257  Sum_probs=208.7

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCCh----HhHHHHHHHHHHHhccCCCceeeecceEEeCc-e
Q 016594           65 TNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDD----RKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-L  138 (386)
Q Consensus        65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~  138 (386)
                      .++|++.+.||+|+||.||+|... +|+.||+|++.......    .....+.+|+.+++.+.||||+++++++.+.. .
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   90 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV   90 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence            467999999999999999999987 68999999997643222    23567899999999999999999999998765 8


Q ss_pred             EEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCC----CeEEeecCc
Q 016594          139 YLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADF----EPQISDFGL  214 (386)
Q Consensus       139 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~----~~kl~Dfg~  214 (386)
                      ++||||+.+++|.+++...  ..+++..++.++.|++.||.|||+   ++|+||||||+||+++.++    .+||+|||+
T Consensus        91 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~---~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~  165 (321)
T 2a2a_A           91 VLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL  165 (321)
T ss_dssp             EEEECCCCSCBHHHHHHTC--SCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEECCCTT
T ss_pred             EEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChHHEEEecCCCCcCCEEEccCcc
Confidence            9999999999999998753  358999999999999999999999   9999999999999999887    799999999


Q ss_pred             cccCCCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhccccccccc
Q 016594          215 AKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLV  294 (386)
Q Consensus       215 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  294 (386)
                      +.......   ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.......  ...... .     
T Consensus       166 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~~i~~~-~-----  234 (321)
T 2a2a_A          166 AHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL--ANITSV-S-----  234 (321)
T ss_dssp             CEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH--HHHHTT-C-----
T ss_pred             ceecCccc---cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHH--HHHHhc-c-----
Confidence            98765432   223456999999999999999999999999999999999999999875432111  000000 0     


Q ss_pred             CCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          295 DPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       295 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                       ...........+..+.+++.+||+.||++|||+.+++++.+..
T Consensus       235 -~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~  277 (321)
T 2a2a_A          235 -YDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWIT  277 (321)
T ss_dssp             -CCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTS
T ss_pred             -cccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCcccc
Confidence             0000000012346789999999999999999999999986543

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=7.1e-46  Score=342.53  Aligned_cols=264  Identities=21%  Similarity=0.328  Sum_probs=209.7

Q ss_pred             CCCCCeecccCCcEEEEEEEC-----CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeC---ceE
Q 016594           68 FSSENLVGRGGYAEVYKGVLQ-----DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDN---GLY  139 (386)
Q Consensus        68 ~~~~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~---~~~  139 (386)
                      |++.+.||+|+||+||+|.++     +++.||||++... ........+.+|+.+++.++||||+++++++.+.   ..+
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  111 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD-AGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQ  111 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEE
T ss_pred             HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc-cChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEE
Confidence            488999999999999998753     5789999999764 3345567789999999999999999999999874   378


Q ss_pred             EEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCC
Q 016594          140 LIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLP  219 (386)
Q Consensus       140 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~  219 (386)
                      +||||+.+++|.+++...   .+++..++.++.|++.||.|||+   ++|+||||||+||+++.++.+||+|||++....
T Consensus       112 lv~e~~~~~~L~~~l~~~---~~~~~~~~~i~~~l~~~l~~LH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~  185 (318)
T 3lxp_A          112 LVMEYVPLGSLRDYLPRH---SIGLAQLLLFAQQICEGMAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP  185 (318)
T ss_dssp             EEECCCTTCBHHHHGGGS---CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred             EEEecccCCcHHHHHhhC---CCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEEcCCCCEEECCcccccccc
Confidence            999999999999998754   38999999999999999999999   999999999999999999999999999998876


Q ss_pred             CCCcc-ccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhh---hhhcccccccccC
Q 016594          220 SQWTH-HSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAK---PILNQGEIEKLVD  295 (386)
Q Consensus       220 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~---~~~~~~~~~~~~~  295 (386)
                      ..... .......++..|+|||++.+..++.++|||||||++|+|++|..||............   .......+...+.
T Consensus       186 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (318)
T 3lxp_A          186 EGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLE  265 (318)
T ss_dssp             TTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHH
T ss_pred             ccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHh
Confidence            54322 1233455788899999999999999999999999999999999999764322111100   0000011112222


Q ss_pred             CccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          296 PRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       296 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                      .......+..++..+.+++.+||+.||.+|||+.++++.|...
T Consensus       266 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l  308 (318)
T 3lxp_A          266 RGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTV  308 (318)
T ss_dssp             TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             cccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence            2222333444567899999999999999999999999988754

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=2.4e-45  Score=351.44  Aligned_cols=262  Identities=19%  Similarity=0.258  Sum_probs=199.7

Q ss_pred             HHHhcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCC------hHhHHHHHHHHHHHhccCCCceeeecceEE
Q 016594           62 SIATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTD------DRKEKEFLTEIGTIGHVCHPNVLSLLGCCV  134 (386)
Q Consensus        62 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~  134 (386)
                      ....++|.+.+.||+|+||+||+|... +++.||||++......      ......+.+|+.++++++||||+++++++.
T Consensus       131 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  210 (419)
T 3i6u_A          131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD  210 (419)
T ss_dssp             HHHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE
T ss_pred             hhhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence            356789999999999999999999976 6899999998753211      122235789999999999999999999998


Q ss_pred             eCceEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCC---CeEEee
Q 016594          135 DNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADF---EPQISD  211 (386)
Q Consensus       135 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~---~~kl~D  211 (386)
                      .+..++||||+.+++|.+++...  ..+++..++.++.|++.||.|||+   ++|+||||||+|||++.++   .+||+|
T Consensus       211 ~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~~~~kl~D  285 (419)
T 3i6u_A          211 AEDYYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITD  285 (419)
T ss_dssp             SSEEEEEEECCTTCBGGGGTSSS--CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSSSCCEEECC
T ss_pred             cCceEEEEEcCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCCCcceEEEee
Confidence            88899999999999999988653  349999999999999999999999   9999999999999997544   599999


Q ss_pred             cCccccCCCCCccccccccccccCccChhhhcc---CCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhccc
Q 016594          212 FGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMH---GIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQG  288 (386)
Q Consensus       212 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~  288 (386)
                      ||++......   ......+||+.|+|||++.+   ..++.++|||||||++|+|++|..||.......... . .....
T Consensus       286 FG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~-~-~i~~~  360 (419)
T 3i6u_A          286 FGHSKILGET---SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLK-D-QITSG  360 (419)
T ss_dssp             SSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHH-H-HHHTT
T ss_pred             cccceecCCC---ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHH-H-HHhcC
Confidence            9999876533   22345679999999999863   678899999999999999999999997643211000 0 00000


Q ss_pred             ccccccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCC
Q 016594          289 EIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEGD  339 (386)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~~  339 (386)
                      ...      .........+..+.+++.+||+.||++|||+.++++|-+..+
T Consensus       361 ~~~------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~  405 (419)
T 3i6u_A          361 KYN------FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD  405 (419)
T ss_dssp             CCC------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred             CCC------CCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCC
Confidence            000      000000123567999999999999999999999999876643

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=7.5e-46  Score=358.75  Aligned_cols=253  Identities=21%  Similarity=0.326  Sum_probs=208.1

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccC-ChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEE
Q 016594           65 TNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVT-DDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLI  141 (386)
Q Consensus        65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv  141 (386)
                      .++|.+.+.||+|+||.||+|.+. +|+.||||++..... .......+.+|+.+++.++||||+++++++.+.. .++|
T Consensus        15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv   94 (476)
T 2y94_A           15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV   94 (476)
T ss_dssp             ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            467999999999999999999987 799999999975321 1223457889999999999999999999998765 8999


Q ss_pred             EEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCC
Q 016594          142 FQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQ  221 (386)
Q Consensus       142 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  221 (386)
                      |||+.+++|.+++...  ..+++..++.++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||++......
T Consensus        95 ~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~  169 (476)
T 2y94_A           95 MEYVSGGELFDYICKN--GRLDEKESRRLFQQILSGVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG  169 (476)
T ss_dssp             EECCSSEEHHHHTTSS--SSCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEECTTCCEEECCCSSCEECCTT
T ss_pred             EeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCCCcccccHHHEEEecCCCeEEEeccchhhcccc
Confidence            9999999999998753  349999999999999999999999   99999999999999999999999999999876543


Q ss_pred             CccccccccccccCccChhhhccCCC-CcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCC
Q 016594          222 WTHHSIAPIEGTFGHLAPEYFMHGIV-DEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQG  300 (386)
Q Consensus       222 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (386)
                      .   .....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+......  ...+         .....  
T Consensus       170 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~--~~~i---------~~~~~--  233 (476)
T 2y94_A          170 E---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTL--FKKI---------CDGIF--  233 (476)
T ss_dssp             C---CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHH--HHHH---------HTTCC--
T ss_pred             c---cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHH--HHHH---------hcCCc--
Confidence            2   2345679999999999988765 6899999999999999999999987543211  1111         11100  


Q ss_pred             CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          301 AYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       301 ~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                      ..+...+..+.+++.+||+.||.+|||+.+++++-+..
T Consensus       234 ~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~  271 (476)
T 2y94_A          234 YTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFK  271 (476)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHH
T ss_pred             CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhh
Confidence            11122346789999999999999999999999975543

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=4.5e-46  Score=347.57  Aligned_cols=265  Identities=21%  Similarity=0.230  Sum_probs=204.7

Q ss_pred             HHHhcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEecccc---CChHhHHHHHHHHHHHhccCCCceeeecceEEeCc
Q 016594           62 SIATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVV---TDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG  137 (386)
Q Consensus        62 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  137 (386)
                      ....++|++.+.||+|+||.||+|.+. ++..||+|++....   ........+.+|+.+++.++||||+++++++.+.+
T Consensus        22 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  101 (345)
T 3hko_A           22 LELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQ  101 (345)
T ss_dssp             HHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             hhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCC
Confidence            456788999999999999999999986 68899999987532   13345678899999999999999999999998766


Q ss_pred             -eEEEEEeccCCCHhhhhhhcC--------------------------------------CCCCCHHHHHHHHHHHHHHH
Q 016594          138 -LYLIFQFSSRGSVASLFHDVN--------------------------------------SPGVEWKVRHKIAVGTARGL  178 (386)
Q Consensus       138 -~~lv~e~~~~~~L~~~~~~~~--------------------------------------~~~~~~~~~~~i~~qi~~~l  178 (386)
                       .++||||+.+|+|.+++....                                      ...+++..++.++.|++.||
T Consensus       102 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l  181 (345)
T 3hko_A          102 YICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSAL  181 (345)
T ss_dssp             EEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHH
T ss_pred             eEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHH
Confidence             899999999999999885211                                      11246778889999999999


Q ss_pred             HHHHhCCCCCeEEeCCCCCCeeEcCCC--CeEEeecCccccCCCCCc--cccccccccccCccChhhhcc--CCCCcccc
Q 016594          179 HYLHKGCQRRIIHRDIKSSNILLTADF--EPQISDFGLAKWLPSQWT--HHSIAPIEGTFGHLAPEYFMH--GIVDEKTD  252 (386)
Q Consensus       179 ~~LH~~~~~~ivH~dlkp~Nill~~~~--~~kl~Dfg~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~--~~~~~~~D  252 (386)
                      +|||+   ++|+||||||+|||++.++  .+||+|||++..+.....  ........||+.|+|||++.+  ..++.++|
T Consensus       182 ~~LH~---~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~D  258 (345)
T 3hko_A          182 HYLHN---QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCD  258 (345)
T ss_dssp             HHHHH---TTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHH
T ss_pred             HHHHH---CCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHH
Confidence            99999   9999999999999998766  899999999986533211  112345569999999999975  67899999


Q ss_pred             hHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 016594          253 VFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVL  332 (386)
Q Consensus       253 vwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il  332 (386)
                      ||||||++|+|++|..||.+........  .......       ..........+..+.+++.+||+.||.+||++.+++
T Consensus       259 iwslG~il~el~~g~~pf~~~~~~~~~~--~~~~~~~-------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l  329 (345)
T 3hko_A          259 AWSAGVLLHLLLMGAVPFPGVNDADTIS--QVLNKKL-------CFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRAL  329 (345)
T ss_dssp             HHHHHHHHHHHHHSSCSSCCSSHHHHHH--HHHHCCC-------CTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHH
T ss_pred             HHHHHHHHHHHHHCCCCCCCCChHHHHH--HHHhccc-------ccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHh
Confidence            9999999999999999998764432111  1111000       000011112356799999999999999999999999


Q ss_pred             HHHhcC
Q 016594          333 EVMLEG  338 (386)
Q Consensus       333 ~~l~~~  338 (386)
                      ++.+..
T Consensus       330 ~hp~~~  335 (345)
T 3hko_A          330 QHPWIS  335 (345)
T ss_dssp             HSHHHH
T ss_pred             cChhhc
Confidence            986543

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=9.3e-46  Score=357.33  Aligned_cols=257  Identities=22%  Similarity=0.263  Sum_probs=200.8

Q ss_pred             HhcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEecccc-CChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEE
Q 016594           64 ATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVV-TDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYL  140 (386)
Q Consensus        64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~l  140 (386)
                      ..++|++.+.||+|+||.||+|... +++.||||++.... ........+.+|+.+++.++||||+++++++.+.+ .++
T Consensus       146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l  225 (446)
T 4ejn_A          146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCF  225 (446)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEE
T ss_pred             ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEE
Confidence            3467999999999999999999976 68999999997532 22334566789999999999999999999998766 899


Q ss_pred             EEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCC
Q 016594          141 IFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPS  220 (386)
Q Consensus       141 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~  220 (386)
                      ||||+.+++|.+++....  .+++..+..++.|++.||+|||+  .++|+||||||+|||++.++.+||+|||++.....
T Consensus       226 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~--~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  301 (446)
T 4ejn_A          226 VMEYANGGELFFHLSRER--VFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK  301 (446)
T ss_dssp             EECCCSSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHH--HTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC
T ss_pred             EEeeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhh--cCCEEECCCCHHHEEECCCCCEEEccCCCceeccC
Confidence            999999999999887654  48999999999999999999995  16899999999999999999999999999986433


Q ss_pred             CCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCC
Q 016594          221 QWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQG  300 (386)
Q Consensus       221 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (386)
                      .  .......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.......  ..+..         ..  .
T Consensus       302 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~--~~i~~---------~~--~  366 (446)
T 4ejn_A          302 D--GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF--ELILM---------EE--I  366 (446)
T ss_dssp             -------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH--HHHHH---------CC--C
T ss_pred             C--CcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHH--HHHHh---------CC--C
Confidence            2  12334567999999999999999999999999999999999999999875432111  11110         00  0


Q ss_pred             CCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHHhcCC
Q 016594          301 AYDVTQLNRLAFAASLCIRASPTWRP-----TMSEVLEVMLEGD  339 (386)
Q Consensus       301 ~~~~~~~~~l~~li~~cl~~dP~~Rp-----t~~~il~~l~~~~  339 (386)
                      ..+...+..+.++|.+||+.||.+||     ++.++++|.+...
T Consensus       367 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~  410 (446)
T 4ejn_A          367 RFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAG  410 (446)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred             CCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccC
Confidence            11223456799999999999999999     9999999876654

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=3.4e-46  Score=351.11  Aligned_cols=267  Identities=17%  Similarity=0.205  Sum_probs=202.9

Q ss_pred             HHhcCCCCCCeecccCCcEEEEEEECC------CcEEEEEEeccccCChHhH---------HHHHHHHHHHhccCCCcee
Q 016594           63 IATNAFSSENLVGRGGYAEVYKGVLQD------GEEIAVKRLTKVVTDDRKE---------KEFLTEIGTIGHVCHPNVL  127 (386)
Q Consensus        63 ~~~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~~~~~~---------~~~~~e~~~l~~l~h~niv  127 (386)
                      +..++|++.+.||+|+||.||+|.++.      ++.||||++.........+         ..+..|+..+..+.||||+
T Consensus        32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv  111 (364)
T 3op5_A           32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP  111 (364)
T ss_dssp             TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSC
T ss_pred             cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCC
Confidence            345689999999999999999999764      4789999987532211111         1234566677888999999


Q ss_pred             eecceEEeC-----ceEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEc
Q 016594          128 SLLGCCVDN-----GLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLT  202 (386)
Q Consensus       128 ~l~~~~~~~-----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~  202 (386)
                      ++++++...     ..++||||+ +++|.+++... ...+++..++.++.||+.||.|||+   ++|+||||||+|||++
T Consensus       112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH~---~~iiHrDlkp~Nill~  186 (364)
T 3op5_A          112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN-AKRFSRKTVLQLSLRILDILEYIHE---HEYVHGDIKASNLLLN  186 (364)
T ss_dssp             CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEE
T ss_pred             eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEEecCCHHHEEEe
Confidence            999998653     279999999 99999998764 3459999999999999999999999   9999999999999999


Q ss_pred             --CCCCeEEeecCccccCCCCCcc-----ccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCch
Q 016594          203 --ADFEPQISDFGLAKWLPSQWTH-----HSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQ  275 (386)
Q Consensus       203 --~~~~~kl~Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~  275 (386)
                        .++.+||+|||++..+......     .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+...
T Consensus       187 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~  266 (364)
T 3op5_A          187 YKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLK  266 (364)
T ss_dssp             SSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred             cCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence              8899999999999876533211     112345699999999999999999999999999999999999999985322


Q ss_pred             hh--hhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          276 SL--HSWAKPILNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       276 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                      ..  ....... ....+..++++.+.   ....+..+.+++..||+.||.+||++.+|++.|...
T Consensus       267 ~~~~~~~~~~~-~~~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~  327 (364)
T 3op5_A          267 DPKYVRDSKIR-YRENIASLMDKCFP---AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQG  327 (364)
T ss_dssp             CHHHHHHHHHH-HHHCHHHHHHHHSC---TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred             CHHHHHHHHHH-hhhhHHHHHHHhcc---cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Confidence            11  1111110 01112222221111   012346799999999999999999999999988654

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=6.3e-46  Score=371.95  Aligned_cols=249  Identities=24%  Similarity=0.354  Sum_probs=203.5

Q ss_pred             CeecccCCcEEEEEEEC---CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCceEEEEEeccCC
Q 016594           72 NLVGRGGYAEVYKGVLQ---DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNGLYLIFQFSSRG  148 (386)
Q Consensus        72 ~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~lv~e~~~~~  148 (386)
                      +.||+|+||.||+|.+.   .++.||||+++...........+.+|+.++++++||||+++++++.++..++||||+.+|
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~lv~E~~~~g  454 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELG  454 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEEEECCTTE
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEEEccCCC
Confidence            47999999999999753   467899999987655566678899999999999999999999999888899999999999


Q ss_pred             CHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCcc-ccc
Q 016594          149 SVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTH-HSI  227 (386)
Q Consensus       149 ~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~-~~~  227 (386)
                      +|.+++...  ..+++..++.++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||++..+...... ...
T Consensus       455 ~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~yLH~---~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~  529 (635)
T 4fl3_A          455 PLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ  529 (635)
T ss_dssp             EHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC--------
T ss_pred             CHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHHHH---CCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccc
Confidence            999999754  348999999999999999999999   99999999999999999999999999999877543221 122


Q ss_pred             cccccccCccChhhhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCchhhhhhhhhhhcccccccccCCccCCCCCHHH
Q 016594          228 APIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQ  306 (386)
Q Consensus       228 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (386)
                      ....+|+.|+|||++.+..++.++|||||||++|||++ |..||.+.......            ..+........+..+
T Consensus       530 ~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~------------~~i~~~~~~~~p~~~  597 (635)
T 4fl3_A          530 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT------------AMLEKGERMGCPAGC  597 (635)
T ss_dssp             -----CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH------------HHHHTTCCCCCCTTC
T ss_pred             cCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH------------HHHHcCCCCCCCCCC
Confidence            23346788999999999999999999999999999998 99999876432111            111111122233345


Q ss_pred             HHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 016594          307 LNRLAFAASLCIRASPTWRPTMSEVLEVMLE  337 (386)
Q Consensus       307 ~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~  337 (386)
                      +..+.+++..||+.||++||++.+|++.|..
T Consensus       598 ~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~  628 (635)
T 4fl3_A          598 PREMYDLMNLCWTYDVENRPGFAAVELRLRN  628 (635)
T ss_dssp             CHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             CHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence            6789999999999999999999999998865

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=7.3e-46  Score=336.93  Aligned_cols=251  Identities=22%  Similarity=0.308  Sum_probs=205.4

Q ss_pred             HhcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhcc-CCCceeeecceEEeCc-eEE
Q 016594           64 ATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHV-CHPNVLSLLGCCVDNG-LYL  140 (386)
Q Consensus        64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~-~~l  140 (386)
                      ..++|++.+.||+|+||+||+|.+. +++.||+|++............+.+|+..+..+ +||||+++++++.+.+ .++
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l   88 (289)
T 1x8b_A            9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI   88 (289)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred             ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence            4577999999999999999999987 799999999987666666778889999999999 8999999999998766 899


Q ss_pred             EEEeccCCCHhhhhhhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCC--------------
Q 016594          141 IFQFSSRGSVASLFHDVNS--PGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTAD--------------  204 (386)
Q Consensus       141 v~e~~~~~~L~~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~--------------  204 (386)
                      ||||+.+++|.+++.....  ..+++..++.++.|++.||.|||+   ++|+||||||+|||++.+              
T Consensus        89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~  165 (289)
T 1x8b_A           89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDD  165 (289)
T ss_dssp             EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEC----------------
T ss_pred             EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHh---CCEeecCCCHHHEEEcCCCCCccccccccccc
Confidence            9999999999999876422  458999999999999999999999   999999999999999844              


Q ss_pred             -----CCeEEeecCccccCCCCCccccccccccccCccChhhhccC-CCCcccchHHHHHHHHHHHhCCCCCCCCchhhh
Q 016594          205 -----FEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHG-IVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLH  278 (386)
Q Consensus       205 -----~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~  278 (386)
                           ..+||+|||++.......      ...||+.|+|||++.+. .++.++|||||||++|+|++|.+|+...... .
T Consensus       166 ~~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~-~  238 (289)
T 1x8b_A          166 WASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQW-H  238 (289)
T ss_dssp             ----CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHH-H
T ss_pred             ccCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHH-H
Confidence                 479999999998765432      23489999999999876 5678999999999999999999877553221 1


Q ss_pred             hhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          279 SWAKPILNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                      .     ......         ...+...+..+.+++.+||+.||++|||+.+++++.+..
T Consensus       239 ~-----~~~~~~---------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~  284 (289)
T 1x8b_A          239 E-----IRQGRL---------PRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLL  284 (289)
T ss_dssp             H-----HHTTCC---------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC-
T ss_pred             H-----HHcCCC---------CCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhh
Confidence            0     011111         111223356799999999999999999999999886543

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=2.7e-45  Score=352.55  Aligned_cols=269  Identities=20%  Similarity=0.305  Sum_probs=201.9

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeC------c
Q 016594           65 TNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDN------G  137 (386)
Q Consensus        65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~  137 (386)
                      .++|++.+.||+|+||.||+|.+. +++.||||++............+.+|+.+|+.++||||+++++++...      .
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  104 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE  104 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence            568999999999999999999976 688999999987666666778899999999999999999999998654      3


Q ss_pred             eEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCcccc
Q 016594          138 LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKW  217 (386)
Q Consensus       138 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~  217 (386)
                      .|+|||++. ++|.+++...  ..+++..++.++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||++..
T Consensus       105 ~~lv~e~~~-~~L~~~~~~~--~~l~~~~~~~i~~qil~aL~~LH~---~givHrDlkp~NILl~~~~~~kL~DFGla~~  178 (432)
T 3n9x_A          105 LYIVLEIAD-SDLKKLFKTP--IFLTEEHIKTILYNLLLGENFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFGLART  178 (432)
T ss_dssp             EEEEEECCS-EEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEEecCC-cCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCHHHeEECCCCCEEEccCCCccc
Confidence            899999887 4999988753  349999999999999999999999   9999999999999999999999999999987


Q ss_pred             CCCCCcc--------------------ccccccccccCccChhhh-ccCCCCcccchHHHHHHHHHHHhCCCCC------
Q 016594          218 LPSQWTH--------------------HSIAPIEGTFGHLAPEYF-MHGIVDEKTDVFAFGVFLLEIISGRKPV------  270 (386)
Q Consensus       218 ~~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwslG~il~ell~g~~pf------  270 (386)
                      .......                    ......+||+.|+|||++ .+..++.++|||||||++|||++|..||      
T Consensus       179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~  258 (432)
T 3n9x_A          179 INSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTN  258 (432)
T ss_dssp             C-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGG
T ss_pred             ccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccccccc
Confidence            6543211                    123567799999999986 4567999999999999999999854444      


Q ss_pred             -----CCCch----------------hhhhh--hhhhhcc-----------cccccccCC-ccCCCCC-----HHHHHHH
Q 016594          271 -----DGSHQ----------------SLHSW--AKPILNQ-----------GEIEKLVDP-RLQGAYD-----VTQLNRL  310 (386)
Q Consensus       271 -----~~~~~----------------~~~~~--~~~~~~~-----------~~~~~~~~~-~~~~~~~-----~~~~~~l  310 (386)
                           .+...                .....  .......           ......+.. ......+     ...+..+
T Consensus       259 ~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  338 (432)
T 3n9x_A          259 RFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDG  338 (432)
T ss_dssp             CCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHH
T ss_pred             ccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHH
Confidence                 33210                00000  0000000           000000000 0000000     1235678


Q ss_pred             HHHHHHccccCCCCCCCHHHHHHHHhcCC
Q 016594          311 AFAASLCIRASPTWRPTMSEVLEVMLEGD  339 (386)
Q Consensus       311 ~~li~~cl~~dP~~Rpt~~~il~~l~~~~  339 (386)
                      .+||.+||..||++|||+.++|+|.+...
T Consensus       339 ~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~  367 (432)
T 3n9x_A          339 INLLESMLKFNPNKRITIDQALDHPYLKD  367 (432)
T ss_dssp             HHHHHHHSCSSTTTSCCHHHHHTCGGGTT
T ss_pred             HHHHHHHhcCCcccCCCHHHHhcChhhhh
Confidence            99999999999999999999999876553

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=5.5e-46  Score=340.48  Aligned_cols=268  Identities=21%  Similarity=0.335  Sum_probs=208.2

Q ss_pred             hcCCCCCCeecccCCcEEEEEEE-----CCCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeC---
Q 016594           65 TNAFSSENLVGRGGYAEVYKGVL-----QDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDN---  136 (386)
Q Consensus        65 ~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~---  136 (386)
                      ..+|++.+.||+|+||.||+|.+     .+++.||+|++.... .......+.+|+.+++.++||||+++++++.+.   
T Consensus        20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   98 (302)
T 4e5w_A           20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN   98 (302)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---C
T ss_pred             hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCc
Confidence            45688899999999999999984     268899999997533 233456789999999999999999999999764   


Q ss_pred             ceEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccc
Q 016594          137 GLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAK  216 (386)
Q Consensus       137 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~  216 (386)
                      ..+++|||+.+++|.+++.... ..+++..++.++.|++.||+|||+   ++|+||||||+||+++.++.+||+|||++.
T Consensus        99 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~  174 (302)
T 4e5w_A           99 GIKLIMEFLPSGSLKEYLPKNK-NKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTK  174 (302)
T ss_dssp             CEEEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred             eEEEEEEeCCCCcHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHhhc---CCcccCCCchheEEEcCCCCEEECcccccc
Confidence            3799999999999999986543 348999999999999999999999   999999999999999999999999999998


Q ss_pred             cCCCCCcc-ccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcc---ccccc
Q 016594          217 WLPSQWTH-HSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQ---GEIEK  292 (386)
Q Consensus       217 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~---~~~~~  292 (386)
                      ........ .......||..|+|||++.+..++.++|||||||++|+|++|..|+.................   ..+..
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (302)
T 4e5w_A          175 AIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVN  254 (302)
T ss_dssp             ECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHH
T ss_pred             cccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHH
Confidence            77554322 223345688889999999999999999999999999999999998754322111110000000   00111


Q ss_pred             ccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 016594          293 LVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLE  337 (386)
Q Consensus       293 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~  337 (386)
                      .+........+...+..+.+++.+||+.||.+|||+.++++.|..
T Consensus       255 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~  299 (302)
T 4e5w_A          255 TLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEA  299 (302)
T ss_dssp             HHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred             HHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHH
Confidence            111112222334456789999999999999999999999999864

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=1.6e-45  Score=336.78  Aligned_cols=257  Identities=25%  Similarity=0.375  Sum_probs=202.8

Q ss_pred             hcCCCCCCeecccCCcEEEEEEECC----CcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeC--ce
Q 016594           65 TNAFSSENLVGRGGYAEVYKGVLQD----GEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDN--GL  138 (386)
Q Consensus        65 ~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~  138 (386)
                      ..+|++.+.||+|+||+||+|.+..    ...||+|.+.. .........+.+|+.++++++||||+++++++.+.  ..
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~-~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  102 (298)
T 3f66_A           24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR-ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP  102 (298)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETT-CCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred             ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEeccc-CCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCce
Confidence            4568889999999999999999642    23589998875 33445567889999999999999999999987543  48


Q ss_pred             EEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccC
Q 016594          139 YLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWL  218 (386)
Q Consensus       139 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~  218 (386)
                      +++|||+.+++|.+++... ...+++..++.++.|++.||.|||+   ++|+||||||+||+++.++.+||+|||++...
T Consensus       103 ~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~ql~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~  178 (298)
T 3f66_A          103 LVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKYLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDM  178 (298)
T ss_dssp             EEEEECCTTCBHHHHHHCT-TCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred             EEEEeCCCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEECCCCCEEECcccccccc
Confidence            9999999999999998653 3458999999999999999999999   99999999999999999999999999999876


Q ss_pred             CCCCc--cccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCchhhhhhhhhhhcccccccccC
Q 016594          219 PSQWT--HHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGEIEKLVD  295 (386)
Q Consensus       219 ~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  295 (386)
                      .....  ........+|+.|+|||.+.+..++.++|||||||++|+|++ |.+||...........  .          .
T Consensus       179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~--~----------~  246 (298)
T 3f66_A          179 YDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY--L----------L  246 (298)
T ss_dssp             SCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHH--H----------H
T ss_pred             cccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHH--H----------h
Confidence            54321  112234457889999999999999999999999999999999 6667765432211100  0          0


Q ss_pred             CccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          296 PRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       296 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                      .......+...+..+.+++.+||+.||.+|||+.++++.|...
T Consensus       247 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~  289 (298)
T 3f66_A          247 QGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI  289 (298)
T ss_dssp             TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             cCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            0011111222356799999999999999999999999998764

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=1.1e-45  Score=347.02  Aligned_cols=265  Identities=18%  Similarity=0.318  Sum_probs=208.9

Q ss_pred             HhcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEE
Q 016594           64 ATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLI  141 (386)
Q Consensus        64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv  141 (386)
                      ..++|++.+.||+|+||.||+|.+. ++..||+|++... ........+.+|+.+++.++||||+++++++.+++ .++|
T Consensus        31 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  109 (360)
T 3eqc_A           31 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE-IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC  109 (360)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECC-CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred             ccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccc-cCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEE
Confidence            4568999999999999999999987 6899999998764 24455678899999999999999999999998766 8999


Q ss_pred             EEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC-CeEEeCCCCCCeeEcCCCCeEEeecCccccCCC
Q 016594          142 FQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQR-RIIHRDIKSSNILLTADFEPQISDFGLAKWLPS  220 (386)
Q Consensus       142 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~-~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~  220 (386)
                      |||+.+++|.+++....  .+++..+..++.|++.||.|||+   . +|+||||||+|||++.++.+||+|||++.....
T Consensus       110 ~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lh~---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  184 (360)
T 3eqc_A          110 MEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLRE---KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  184 (360)
T ss_dssp             ECCCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH---HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred             EECCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---hCCEEcCCccHHHEEECCCCCEEEEECCCCccccc
Confidence            99999999999997654  38999999999999999999998   6 899999999999999999999999999865422


Q ss_pred             CCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccc-----------
Q 016594          221 QWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGE-----------  289 (386)
Q Consensus       221 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~-----------  289 (386)
                          .......||+.|+|||++.+..++.++|||||||++|+|++|..||...................           
T Consensus       185 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (360)
T 3eqc_A          185 ----SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP  260 (360)
T ss_dssp             ----HC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-----------------
T ss_pred             ----ccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccC
Confidence                12234569999999999999999999999999999999999999998755432211110000000           


Q ss_pred             --------------------cccccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          290 --------------------IEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       290 --------------------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                                          +..+.............+..+.+++.+||+.||++|||+.++++|.+..
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~  329 (360)
T 3eqc_A          261 GRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIK  329 (360)
T ss_dssp             -------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHH
T ss_pred             CCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhh
Confidence                                0000000011111122356799999999999999999999999986543

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=1.4e-45  Score=350.85  Aligned_cols=254  Identities=20%  Similarity=0.266  Sum_probs=193.4

Q ss_pred             cCCCCC-CeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhc-cCCCceeeecceEEe-----Cc
Q 016594           66 NAFSSE-NLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGH-VCHPNVLSLLGCCVD-----NG  137 (386)
Q Consensus        66 ~~~~~~-~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~-----~~  137 (386)
                      ++|.+. +.||+|+||+||+|.++ +++.||||++...       ..+.+|+.++.+ .+||||+++++++..     ..
T Consensus        61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~  133 (400)
T 1nxk_A           61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC  133 (400)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred             ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcE
Confidence            455555 68999999999999986 6899999998631       346678888744 479999999999864     23


Q ss_pred             eEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcC---CCCeEEeecCc
Q 016594          138 LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTA---DFEPQISDFGL  214 (386)
Q Consensus       138 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~---~~~~kl~Dfg~  214 (386)
                      .++||||+.+|+|.+++.......+++..++.++.||+.||.|||+   ++|+||||||+|||++.   ++.+||+|||+
T Consensus       134 ~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~  210 (400)
T 1nxk_A          134 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGF  210 (400)
T ss_dssp             EEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred             EEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCcceEEEecCCCCccEEEEeccc
Confidence            8999999999999999987655669999999999999999999999   99999999999999997   78999999999


Q ss_pred             cccCCCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhh-hhhhhhcccccccc
Q 016594          215 AKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHS-WAKPILNQGEIEKL  293 (386)
Q Consensus       215 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~  293 (386)
                      +......   ......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+....... ........+..   
T Consensus       211 a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~---  284 (400)
T 1nxk_A          211 AKETTSH---NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY---  284 (400)
T ss_dssp             CEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCC---
T ss_pred             ccccCCC---CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcc---
Confidence            9876432   2234567899999999999999999999999999999999999999765321100 00000000000   


Q ss_pred             cCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          294 VDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       294 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                         ..........+..+.+||.+||+.||++|||+.+++++.+..
T Consensus       285 ---~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~  326 (400)
T 1nxk_A          285 ---EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIM  326 (400)
T ss_dssp             ---CCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHH
T ss_pred             ---cCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccc
Confidence               000011123457799999999999999999999999986654

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=5e-46  Score=343.07  Aligned_cols=265  Identities=22%  Similarity=0.300  Sum_probs=199.0

Q ss_pred             hcCCCCC-CeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhcc-CCCceeeecceEEeCc-eEE
Q 016594           65 TNAFSSE-NLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHV-CHPNVLSLLGCCVDNG-LYL  140 (386)
Q Consensus        65 ~~~~~~~-~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~-~~l  140 (386)
                      .+.|++. +.||+|+||+||+|... +++.||||++....  ......+.+|+.++.++ +||||+++++++.+++ .++
T Consensus        11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~l   88 (316)
T 2ac3_A           11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP--GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYL   88 (316)
T ss_dssp             TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS--SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc--chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEE
Confidence            4567774 78999999999999965 78999999997542  33456788999999885 6999999999998766 899


Q ss_pred             EEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCC---eEEeecCcccc
Q 016594          141 IFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFE---PQISDFGLAKW  217 (386)
Q Consensus       141 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~---~kl~Dfg~a~~  217 (386)
                      ||||+.+++|.+++....  .+++..++.++.|++.||+|||+   ++|+||||||+|||++.++.   +||+|||++..
T Consensus        89 v~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~  163 (316)
T 2ac3_A           89 VFEKMRGGSILSHIHKRR--HFNELEASVVVQDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSG  163 (316)
T ss_dssp             EEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-
T ss_pred             EEEcCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEEccCCCcCceEEEEccCccc
Confidence            999999999999987653  48999999999999999999999   99999999999999998776   99999999876


Q ss_pred             CCCCCc-----cccccccccccCccChhhhcc-----CCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhh--
Q 016594          218 LPSQWT-----HHSIAPIEGTFGHLAPEYFMH-----GIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPIL--  285 (386)
Q Consensus       218 ~~~~~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~--  285 (386)
                      ......     ........||+.|+|||++.+     ..++.++|||||||++|+|++|..||.+.......|.....  
T Consensus       164 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  243 (316)
T 2ac3_A          164 IKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACP  243 (316)
T ss_dssp             ------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCH
T ss_pred             cccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccch
Confidence            542211     112234569999999999975     56889999999999999999999999875422111100000  


Q ss_pred             --cccccccccCCccCCCCCH----HHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          286 --NQGEIEKLVDPRLQGAYDV----TQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       286 --~~~~~~~~~~~~~~~~~~~----~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                        .......+.....  ..+.    ..+..+.+++.+||+.||.+|||+.+++++.+..
T Consensus       244 ~~~~~~~~~i~~~~~--~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~  300 (316)
T 2ac3_A          244 ACQNMLFESIQEGKY--EFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQ  300 (316)
T ss_dssp             HHHHHHHHHHHHCCC--CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC
T ss_pred             hHHHHHHHHHhccCc--ccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhc
Confidence              0000000000000  1111    1346799999999999999999999999986654

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=1e-45  Score=369.38  Aligned_cols=254  Identities=21%  Similarity=0.326  Sum_probs=202.9

Q ss_pred             CCCCC-eecccCCcEEEEEEEC---CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCceEEEEE
Q 016594           68 FSSEN-LVGRGGYAEVYKGVLQ---DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNGLYLIFQ  143 (386)
Q Consensus        68 ~~~~~-~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~lv~e  143 (386)
                      +.+.+ .||+|+||.||+|.++   ++..||||+++.. ........+.+|+.+|++++||||+++++++.++..++|||
T Consensus       337 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~lv~E  415 (613)
T 2ozo_A          337 LLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALMLVME  415 (613)
T ss_dssp             EEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCC-CSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEESSSEEEEEE
T ss_pred             eeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCC-CChHHHHHHHHHHHHHHhCCCCCEeeEEEEeccCCeEEEEE
Confidence            33344 7999999999999864   4567999999764 23445678999999999999999999999998888999999


Q ss_pred             eccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCc
Q 016594          144 FSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWT  223 (386)
Q Consensus       144 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~  223 (386)
                      |+.+|+|.+++... ...+++..++.++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||++..+.....
T Consensus       416 ~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~---~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~  491 (613)
T 2ozo_A          416 MAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEE---KNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDS  491 (613)
T ss_dssp             CCTTCBHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC----
T ss_pred             eCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCc
Confidence            99999999988653 3458999999999999999999999   9999999999999999999999999999987654322


Q ss_pred             cc-cccccccccCccChhhhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCchhhhhhhhhhhcccccccccCCccCCC
Q 016594          224 HH-SIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGA  301 (386)
Q Consensus       224 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (386)
                      .. ......+++.|+|||++.+..++.++|||||||++|||++ |..||.+.......            ..+.......
T Consensus       492 ~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~------------~~i~~~~~~~  559 (613)
T 2ozo_A          492 YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM------------AFIEQGKRME  559 (613)
T ss_dssp             ----------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHH------------HHHHTTCCCC
T ss_pred             eeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHH------------HHHHcCCCCC
Confidence            11 1122335688999999999999999999999999999998 99999875432110            1111111222


Q ss_pred             CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          302 YDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       302 ~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                      .+..++..+.+++..||+.||++||++.+|++.|...
T Consensus       560 ~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~  596 (613)
T 2ozo_A          560 CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC  596 (613)
T ss_dssp             CCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHH
T ss_pred             CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence            3334567899999999999999999999999988654

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=1.3e-45  Score=341.75  Aligned_cols=253  Identities=22%  Similarity=0.272  Sum_probs=182.2

Q ss_pred             CCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccC-CCceeeecceEEeCc-eEEEEEeccC
Q 016594           71 ENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVC-HPNVLSLLGCCVDNG-LYLIFQFSSR  147 (386)
Q Consensus        71 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~-~~lv~e~~~~  147 (386)
                      .+.||+|+||+||+|.++ +++.||||++..     .....+.+|+.+++.+. ||||+++++++.++. .++||||+.+
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~   90 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISK-----RMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNG   90 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEG-----GGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEECh-----hhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCC
Confidence            478999999999999986 689999999864     23456788999999997 999999999998766 8999999999


Q ss_pred             CCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCC---CeEEeecCccccCCCCCcc
Q 016594          148 GSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADF---EPQISDFGLAKWLPSQWTH  224 (386)
Q Consensus       148 ~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~---~~kl~Dfg~a~~~~~~~~~  224 (386)
                      ++|.+++...  ..+++..++.++.|++.||.|||+   ++|+||||||+|||++.++   .+||+|||++.......  
T Consensus        91 ~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~--  163 (325)
T 3kn6_A           91 GELFERIKKK--KHFSETEASYIMRKLVSAVSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN--  163 (325)
T ss_dssp             CBHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC----
T ss_pred             CcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCC--
Confidence            9999998764  349999999999999999999999   9999999999999998765   79999999998664432  


Q ss_pred             ccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCCCC--
Q 016594          225 HSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAY--  302 (386)
Q Consensus       225 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--  302 (386)
                      ......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+..........    ......+.........  
T Consensus       164 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~----~~~~~~i~~~~~~~~~~~  239 (325)
T 3kn6_A          164 QPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSA----VEIMKKIKKGDFSFEGEA  239 (325)
T ss_dssp             --------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCH----HHHHHHHTTTCCCCCSHH
T ss_pred             CcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccH----HHHHHHHHcCCCCCCccc
Confidence            2234456899999999999999999999999999999999999999865432100000    0000011111111100  


Q ss_pred             CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCC
Q 016594          303 DVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEGD  339 (386)
Q Consensus       303 ~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~~  339 (386)
                      ....+..+.+++.+||+.||.+|||+.+++++-+...
T Consensus       240 ~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~  276 (325)
T 3kn6_A          240 WKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQD  276 (325)
T ss_dssp             HHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCT
T ss_pred             ccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhcc
Confidence            0123577999999999999999999999998866543

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.9e-46  Score=349.17  Aligned_cols=255  Identities=26%  Similarity=0.405  Sum_probs=194.2

Q ss_pred             CCCCCCeecccCCcEEEEEEEC--CC--cEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEe--CceEE
Q 016594           67 AFSSENLVGRGGYAEVYKGVLQ--DG--EEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVD--NGLYL  140 (386)
Q Consensus        67 ~~~~~~~lg~G~~g~V~~~~~~--~~--~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~l  140 (386)
                      .|.+.+.||+|+||+||+|.+.  ++  ..||+|.+.. .........+.+|+.++++++||||+++++++.+  +..++
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~-~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l  168 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR-ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV  168 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCS-CSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCC-CCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence            4667789999999999999964  22  3689998875 3344566789999999999999999999998754  34899


Q ss_pred             EEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCC
Q 016594          141 IFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPS  220 (386)
Q Consensus       141 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~  220 (386)
                      ||||+.+++|.+++... ...+++..++.++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||++..+..
T Consensus       169 v~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~  244 (373)
T 3c1x_A          169 VLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD  244 (373)
T ss_dssp             EEECCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             EEECCCCCCHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHH---CCEecCccchheEEECCCCCEEEeeccccccccc
Confidence            99999999999998653 3458899999999999999999999   9999999999999999999999999999986643


Q ss_pred             CCcc--ccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCchhhhhhhhhhhcccccccccCCc
Q 016594          221 QWTH--HSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGEIEKLVDPR  297 (386)
Q Consensus       221 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (386)
                      ....  .......+++.|+|||++.+..++.++|||||||++|+|++ |.+||.........  .. ...+         
T Consensus       245 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~--~~-~~~~---------  312 (373)
T 3c1x_A          245 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDIT--VY-LLQG---------  312 (373)
T ss_dssp             -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHH--HH-HHTT---------
T ss_pred             cccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHH--HH-HHcC---------
Confidence            3211  11233457788999999999999999999999999999999 78888764321110  00 0000         


Q ss_pred             cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          298 LQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       298 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                      .....+..++..+.+++.+||+.||++||++.++++.|...
T Consensus       313 ~~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i  353 (373)
T 3c1x_A          313 RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI  353 (373)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            01111223456799999999999999999999999998765

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.6e-45  Score=342.40  Aligned_cols=260  Identities=22%  Similarity=0.385  Sum_probs=202.7

Q ss_pred             HHhcCCCCCCeecccCCcEEEEEEECC-----CcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc
Q 016594           63 IATNAFSSENLVGRGGYAEVYKGVLQD-----GEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG  137 (386)
Q Consensus        63 ~~~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  137 (386)
                      +..++|.+.+.||+|+||.||+|.+..     +..||||.+.... .......+.+|+.+++.++||||+++++++.+.+
T Consensus        41 i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  119 (333)
T 1mqb_A           41 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYK  119 (333)
T ss_dssp             CCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred             CChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCC
Confidence            345678889999999999999998652     2359999987532 3445667899999999999999999999997755


Q ss_pred             -eEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccc
Q 016594          138 -LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAK  216 (386)
Q Consensus       138 -~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~  216 (386)
                       .++||||+.+++|.+++... ...+++..++.++.|++.||.|||+   ++|+||||||+||+++.++.+||+|||++.
T Consensus       120 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~  195 (333)
T 1mqb_A          120 PMMIITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSR  195 (333)
T ss_dssp             SEEEEEECCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred             CcEEEEeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChheEEECCCCcEEECCCCcch
Confidence             89999999999999998754 3458999999999999999999999   999999999999999999999999999998


Q ss_pred             cCCCCCcc-ccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCchhhhhhhhhhhccccccccc
Q 016594          217 WLPSQWTH-HSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGEIEKLV  294 (386)
Q Consensus       217 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  294 (386)
                      ........ .......+++.|+|||++.+..++.++|||||||++|+|++ |..||.+......  ...+ ..       
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~--~~~~-~~-------  265 (333)
T 1mqb_A          196 VLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV--MKAI-ND-------  265 (333)
T ss_dssp             ---------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH--HHHH-HT-------
T ss_pred             hhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHH--HHHH-HC-------
Confidence            76543211 11222346788999999999999999999999999999999 9999976543211  1100 00       


Q ss_pred             CCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCC
Q 016594          295 DPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEGD  339 (386)
Q Consensus       295 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~~  339 (386)
                        ......+...+..+.+++.+||+.||++||++.++++.|....
T Consensus       266 --~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~  308 (333)
T 1mqb_A          266 --GFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI  308 (333)
T ss_dssp             --TCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             --CCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence              1111122334577999999999999999999999999987653

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=1.9e-45  Score=359.96  Aligned_cols=258  Identities=26%  Similarity=0.323  Sum_probs=210.3

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccC-ChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEE
Q 016594           65 TNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVT-DDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLI  141 (386)
Q Consensus        65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv  141 (386)
                      .++|.+.+.||+|+||+||+|+.+ +|+.||+|++.+... .......+.+|+.+++.++||||+++++++.+.. .|+|
T Consensus       184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  263 (543)
T 3c4z_A          184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV  263 (543)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence            467899999999999999999986 699999999975321 1233467889999999999999999999998765 8999


Q ss_pred             EEeccCCCHhhhhhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCC
Q 016594          142 FQFSSRGSVASLFHDVN--SPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLP  219 (386)
Q Consensus       142 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~  219 (386)
                      |||+.+|+|..++....  ...+++..++.++.||+.||.|||+   ++|+||||||+|||++.+|++||+|||++..+.
T Consensus       264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~---~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~  340 (543)
T 3c4z_A          264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELK  340 (543)
T ss_dssp             ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHH---cCCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence            99999999999887643  4469999999999999999999999   999999999999999999999999999998765


Q ss_pred             CCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchh--hhhhhhhhhcccccccccCCc
Q 016594          220 SQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQS--LHSWAKPILNQGEIEKLVDPR  297 (386)
Q Consensus       220 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~  297 (386)
                      ....  .....+||+.|+|||++.+..++.++|||||||++|||++|..||.+....  .......+.         ...
T Consensus       341 ~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~---------~~~  409 (543)
T 3c4z_A          341 AGQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVL---------EQA  409 (543)
T ss_dssp             TTCC--CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHH---------HCC
T ss_pred             CCCc--ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHh---------hcc
Confidence            4322  233457999999999999999999999999999999999999999875321  111111111         110


Q ss_pred             cCCCCCHHHHHHHHHHHHHccccCCCCCCCH-----HHHHHHHhcC
Q 016594          298 LQGAYDVTQLNRLAFAASLCIRASPTWRPTM-----SEVLEVMLEG  338 (386)
Q Consensus       298 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~-----~~il~~l~~~  338 (386)
                        ..++...+..+.++|.+||+.||.+||++     .+|++|-+..
T Consensus       410 --~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~  453 (543)
T 3c4z_A          410 --VTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFR  453 (543)
T ss_dssp             --CCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGT
T ss_pred             --cCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCcccc
Confidence              11223345779999999999999999964     7888876554

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=5.3e-46  Score=344.67  Aligned_cols=261  Identities=25%  Similarity=0.370  Sum_probs=205.8

Q ss_pred             HHhcCCCCCCeecccCCcEEEEEEE------CCCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeC
Q 016594           63 IATNAFSSENLVGRGGYAEVYKGVL------QDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDN  136 (386)
Q Consensus        63 ~~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~  136 (386)
                      +..++|++.+.||+|+||.||+|.+      .++..||||.+... ........+.+|+.++++++||||+++++++.+.
T Consensus        27 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  105 (327)
T 2yfx_A           27 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS  105 (327)
T ss_dssp             CCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             CChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccc-cchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCC
Confidence            4567899999999999999999983      24778999999743 3345566889999999999999999999999875


Q ss_pred             c-eEEEEEeccCCCHhhhhhhcCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcC---CCCe
Q 016594          137 G-LYLIFQFSSRGSVASLFHDVNS-----PGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTA---DFEP  207 (386)
Q Consensus       137 ~-~~lv~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~---~~~~  207 (386)
                      . .++||||+.+++|.+++.....     ..+++..++.++.|++.||.|||+   ++|+||||||+|||++.   +..+
T Consensus       106 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~i~H~dlkp~NIli~~~~~~~~~  182 (327)
T 2yfx_A          106 LPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVA  182 (327)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCE
T ss_pred             CCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeecCcCCHhHEEEecCCCcceE
Confidence            5 8999999999999999976542     348999999999999999999999   99999999999999984   4469


Q ss_pred             EEeecCccccCCCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCchhhhhhhhhhhc
Q 016594          208 QISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILN  286 (386)
Q Consensus       208 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~  286 (386)
                      ||+|||++................|++.|+|||++.+..++.++|||||||++|+|++ |..||.........  ... .
T Consensus       183 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~--~~~-~  259 (327)
T 2yfx_A          183 KIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVL--EFV-T  259 (327)
T ss_dssp             EECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH--HHH-H
T ss_pred             EECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHH--HHH-h
Confidence            9999999876533322222334557889999999999999999999999999999998 99999875432111  000 0


Q ss_pred             ccccccccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCC
Q 016594          287 QGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEGD  339 (386)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~~  339 (386)
                      ..         .....+...+..+.+++.+||+.||.+||++.+++++|+...
T Consensus       260 ~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~  303 (327)
T 2yfx_A          260 SG---------GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT  303 (327)
T ss_dssp             TT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             cC---------CCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence            00         011122234567999999999999999999999999987654

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=6.4e-46  Score=344.15  Aligned_cols=270  Identities=20%  Similarity=0.289  Sum_probs=213.3

Q ss_pred             HhcCCCCCCeecccCCcEEEEEEE-----CCCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeC--
Q 016594           64 ATNAFSSENLVGRGGYAEVYKGVL-----QDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDN--  136 (386)
Q Consensus        64 ~~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--  136 (386)
                      ..++|++.+.||+|+||.||+|.+     .+++.||||++...  .......+.+|+.++++++||||+++++++...  
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   98 (327)
T 3lxl_A           21 EERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS--GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGR   98 (327)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSS
T ss_pred             chhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC--CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCC
Confidence            346889999999999999999984     36889999998753  345566789999999999999999999998642  


Q ss_pred             -ceEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCcc
Q 016594          137 -GLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLA  215 (386)
Q Consensus       137 -~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a  215 (386)
                       ..++||||+.+++|.+++..... .+++..++.++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||++
T Consensus        99 ~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~  174 (327)
T 3lxl_A           99 QSLRLVMEYLPSGCLRDFLQRHRA-RLDASRLLLYSSQICKGMEYLGS---RRCVHRDLAARNILVESEAHVKIADFGLA  174 (327)
T ss_dssp             CEEEEEEECCTTCBHHHHHHHHGG-GCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCGGGC
T ss_pred             ceEEEEEeecCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChhhEEECCCCCEEEcccccc
Confidence             28899999999999999876432 48999999999999999999999   99999999999999999999999999999


Q ss_pred             ccCCCCCcc-ccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhc---ccccc
Q 016594          216 KWLPSQWTH-HSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILN---QGEIE  291 (386)
Q Consensus       216 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~---~~~~~  291 (386)
                      ......... .......||+.|+|||++.+..++.++|||||||++|+|++|..||................   ...+.
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  254 (327)
T 3lxl_A          175 KLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLL  254 (327)
T ss_dssp             EECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHH
T ss_pred             eecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHH
Confidence            877544322 12234558888999999999999999999999999999999999997643322111000000   00111


Q ss_pred             cccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCC
Q 016594          292 KLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEGD  339 (386)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~~  339 (386)
                      ..+........+..++..+.+++.+||+.||.+|||+.+++++|+...
T Consensus       255 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~  302 (327)
T 3lxl_A          255 ELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLW  302 (327)
T ss_dssp             HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-
T ss_pred             HHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            111222222334455678999999999999999999999999997663

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=3.4e-45  Score=332.68  Aligned_cols=255  Identities=20%  Similarity=0.298  Sum_probs=200.1

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEE
Q 016594           65 TNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIF  142 (386)
Q Consensus        65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~  142 (386)
                      .++|.+.+.||+|+||.||+|... ++..||+|++.... .......+.+|+.+++.++||||+++++++.+.. .++||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   99 (285)
T 3is5_A           21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDR-SQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVM   99 (285)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGG-CCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccc-cchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEE
Confidence            457999999999999999999976 68899999987643 2334567889999999999999999999998765 89999


Q ss_pred             EeccCCCHhhhhhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeE---cCCCCeEEeecCcccc
Q 016594          143 QFSSRGSVASLFHDV--NSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILL---TADFEPQISDFGLAKW  217 (386)
Q Consensus       143 e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~a~~  217 (386)
                      ||+.+++|.+.+...  ....+++..++.++.|++.||.|||+   ++|+||||||+||++   +.++.+||+|||++..
T Consensus       100 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~  176 (285)
T 3is5_A          100 ETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAEL  176 (285)
T ss_dssp             CCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC
T ss_pred             EeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCCCHHHEEEecCCCCCCEEEEeeeccee
Confidence            999999999987543  23559999999999999999999999   999999999999999   4567899999999986


Q ss_pred             CCCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCc
Q 016594          218 LPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPR  297 (386)
Q Consensus       218 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (386)
                      +....   ......||+.|+|||++. ..++.++|||||||++|+|++|..||.+............ .        .+.
T Consensus       177 ~~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~-~--------~~~  243 (285)
T 3is5_A          177 FKSDE---HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATY-K--------EPN  243 (285)
T ss_dssp             -------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH-C--------CCC
T ss_pred             cCCcc---cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhcc-C--------Ccc
Confidence            64432   233456899999999875 5689999999999999999999999987643221111000 0        000


Q ss_pred             cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 016594          298 LQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLE  337 (386)
Q Consensus       298 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~  337 (386)
                      ... .....+..+.+++.+||+.||++|||+.+++++-+.
T Consensus       244 ~~~-~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f  282 (285)
T 3is5_A          244 YAV-ECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWF  282 (285)
T ss_dssp             CCC---CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGG
T ss_pred             ccc-ccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHh
Confidence            000 001124678899999999999999999999987543

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=2.7e-45  Score=343.29  Aligned_cols=269  Identities=20%  Similarity=0.281  Sum_probs=206.3

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeC-------
Q 016594           65 TNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDN-------  136 (386)
Q Consensus        65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-------  136 (386)
                      .++|++.+.||+|+||+||+|.+. +|+.||||++............+.+|+.+++.++||||+++++++...       
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   95 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   95 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred             ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence            367999999999999999999985 789999999876554454556788999999999999999999998753       


Q ss_pred             --ceEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCc
Q 016594          137 --GLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGL  214 (386)
Q Consensus       137 --~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~  214 (386)
                        ..++||||+.+ +|.+.+.... ..+++..++.++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+
T Consensus        96 ~~~~~lv~e~~~~-~l~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~  170 (351)
T 3mi9_A           96 KGSIYLVFDFCEH-DLAGLLSNVL-VKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGL  170 (351)
T ss_dssp             -CEEEEEEECCSE-EHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             CceEEEEEeccCC-CHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCCEEEccchh
Confidence              27899999986 6766665433 349999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCCc--cccccccccccCccChhhhcc-CCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhh-hhhhhcc---
Q 016594          215 AKWLPSQWT--HHSIAPIEGTFGHLAPEYFMH-GIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSW-AKPILNQ---  287 (386)
Q Consensus       215 a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~-~~~~~~~---  287 (386)
                      +..+.....  ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+........ .......   
T Consensus       171 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~  250 (351)
T 3mi9_A          171 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP  250 (351)
T ss_dssp             CEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred             cccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence            987653221  222345678999999999976 558999999999999999999999998765432111 1000000   


Q ss_pred             --------cccccccCCccCCCCCH--H-----HHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          288 --------GEIEKLVDPRLQGAYDV--T-----QLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       288 --------~~~~~~~~~~~~~~~~~--~-----~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                              .................  .     .+..+.+|+.+||+.||++|||+.+++++-+..
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~  316 (351)
T 3mi9_A          251 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFW  316 (351)
T ss_dssp             TTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGG
T ss_pred             hhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcC
Confidence                    00000000000000000  0     134688999999999999999999999986654

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=6.3e-45  Score=334.84  Aligned_cols=263  Identities=24%  Similarity=0.420  Sum_probs=200.5

Q ss_pred             HhcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccc-cCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEE
Q 016594           64 ATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKV-VTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYL  140 (386)
Q Consensus        64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~l  140 (386)
                      ..++|++.+.||+|+||.||+|... +++.||||++... .........+.+|+.+++.++||||+++++++.+.+ .++
T Consensus        30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l  109 (310)
T 2wqm_A           30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI  109 (310)
T ss_dssp             SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEE
Confidence            3457999999999999999999975 7899999999753 234455677899999999999999999999998765 899


Q ss_pred             EEEeccCCCHhhhhhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccC
Q 016594          141 IFQFSSRGSVASLFHDV--NSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWL  218 (386)
Q Consensus       141 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~  218 (386)
                      +||++.+++|.+++...  ....+++..++.++.|++.||.|||+   ++++||||||+||+++.++.+||+|||++...
T Consensus       110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~  186 (310)
T 2wqm_A          110 VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFF  186 (310)
T ss_dssp             EEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCC------
T ss_pred             EEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCcHHHEEEcCCCCEEEEeccceeee
Confidence            99999999999988653  34558999999999999999999999   99999999999999999999999999998866


Q ss_pred             CCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCcc
Q 016594          219 PSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRL  298 (386)
Q Consensus       219 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (386)
                      ....  .......|++.|+|||++.+..++.++||||||+++|+|++|..||.+.............. ..        .
T Consensus       187 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~--------~  255 (310)
T 2wqm_A          187 SSKT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQ-CD--------Y  255 (310)
T ss_dssp             --------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHT-TC--------S
T ss_pred             cCCC--ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhc-cc--------C
Confidence            4332  12234568999999999999999999999999999999999999997654322222111111 00        0


Q ss_pred             CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCCc
Q 016594          299 QGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEGDQ  340 (386)
Q Consensus       299 ~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~~~  340 (386)
                      ........+..+.+++.+||+.||.+||++.++++.|.....
T Consensus       256 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~  297 (310)
T 2wqm_A          256 PPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHA  297 (310)
T ss_dssp             CCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence            111112345679999999999999999999999999876543

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=2.3e-45  Score=358.42  Aligned_cols=256  Identities=25%  Similarity=0.351  Sum_probs=206.6

Q ss_pred             HhcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEE
Q 016594           64 ATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLI  141 (386)
Q Consensus        64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv  141 (386)
                      ..++|++.+.||+|+||+||+|..+ +++.||||++............+.+|+.++++++||||+++++++.+.. .++|
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv   99 (486)
T 3mwu_A           20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV   99 (486)
T ss_dssp             HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence            4567999999999999999999986 7899999999764433445677899999999999999999999998766 8999


Q ss_pred             EEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEc---CCCCeEEeecCccccC
Q 016594          142 FQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLT---ADFEPQISDFGLAKWL  218 (386)
Q Consensus       142 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~---~~~~~kl~Dfg~a~~~  218 (386)
                      |||+.+++|.+.+....  .+++..++.++.|++.||.|||+   ++|+||||||+|||++   .++.+||+|||++..+
T Consensus       100 ~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~  174 (486)
T 3mwu_A          100 GELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF  174 (486)
T ss_dssp             ECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTB
T ss_pred             EEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEEECCcCeEC
Confidence            99999999999887654  48999999999999999999999   9999999999999995   4567999999999876


Q ss_pred             CCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCcc
Q 016594          219 PSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRL  298 (386)
Q Consensus       219 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (386)
                      ....   ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.......  ..+.. ....      .
T Consensus       175 ~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~--~~i~~-~~~~------~  241 (486)
T 3mwu_A          175 QQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDIL--KRVET-GKYA------F  241 (486)
T ss_dssp             CCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH--HHHHH-TCCC------S
T ss_pred             CCCC---ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHh-CCCC------C
Confidence            5432   2344569999999999876 5899999999999999999999999875432111  11100 0000      0


Q ss_pred             CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 016594          299 QGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLE  337 (386)
Q Consensus       299 ~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~  337 (386)
                      ........+..+.++|.+||+.||.+|||+.+++++.+.
T Consensus       242 ~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~  280 (486)
T 3mwu_A          242 DLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWI  280 (486)
T ss_dssp             CSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHH
T ss_pred             CCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhh
Confidence            001112345779999999999999999999999998654

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=5.4e-45  Score=343.59  Aligned_cols=250  Identities=23%  Similarity=0.281  Sum_probs=197.7

Q ss_pred             CCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEEEeccCC
Q 016594           71 ENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQFSSRG  148 (386)
Q Consensus        71 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~~~~~  148 (386)
                      .+.||+|+||.||+|... +|+.||+|++...  .......+.+|+.++++++||||+++++++.+.+ .++||||+.++
T Consensus        94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~  171 (373)
T 2x4f_A           94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTR--GMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGG  171 (373)
T ss_dssp             EEECC-----CEEEEEETTTCCEEEEEEEECC--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred             ceEEecCcCEEEEEEEEcCCCcEEEEEEEccc--ccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCC
Confidence            568999999999999976 6899999999753  2345667899999999999999999999998765 89999999999


Q ss_pred             CHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeE--cCCCCeEEeecCccccCCCCCcccc
Q 016594          149 SVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILL--TADFEPQISDFGLAKWLPSQWTHHS  226 (386)
Q Consensus       149 ~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill--~~~~~~kl~Dfg~a~~~~~~~~~~~  226 (386)
                      +|.+++... ...+++..++.++.||+.||.|||+   ++|+||||||+|||+  +.++.+||+|||++..+....   .
T Consensus       172 ~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~---~  244 (373)
T 2x4f_A          172 ELFDRIIDE-SYNLTELDTILFMKQICEGIRHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE---K  244 (373)
T ss_dssp             EEHHHHHHT-GGGCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC---B
T ss_pred             cHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc---c
Confidence            999887653 2348999999999999999999999   999999999999999  567889999999998775432   2


Q ss_pred             ccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCCCCCHHH
Q 016594          227 IAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQ  306 (386)
Q Consensus       227 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (386)
                      .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.......  ..+....     ..  .........
T Consensus       245 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~--~~i~~~~-----~~--~~~~~~~~~  315 (373)
T 2x4f_A          245 LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETL--NNILACR-----WD--LEDEEFQDI  315 (373)
T ss_dssp             CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH--HHHHHTC-----CC--SCSGGGTTS
T ss_pred             cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHhcc-----CC--CChhhhccC
Confidence            23456999999999999999999999999999999999999999876432111  1111000     00  000001123


Q ss_pred             HHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          307 LNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       307 ~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                      +..+.++|.+||+.||.+|||+.+++++.+..
T Consensus       316 ~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~  347 (373)
T 2x4f_A          316 SEEAKEFISKLLIKEKSWRISASEALKHPWLS  347 (373)
T ss_dssp             CHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHH
T ss_pred             CHHHHHHHHHHcCCChhhCCCHHHHhcCcCcC
Confidence            56799999999999999999999999986544

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=3.1e-45  Score=336.54  Aligned_cols=254  Identities=28%  Similarity=0.492  Sum_probs=200.1

Q ss_pred             hcCCCCCCeecccCCcEEEEEEECCCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCceEEEEEe
Q 016594           65 TNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNGLYLIFQF  144 (386)
Q Consensus        65 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~lv~e~  144 (386)
                      .++|++.+.||+|+||+||+|.+. ++.||||.+..    ......+.+|+.++++++||||+++++++. +..++||||
T Consensus         7 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~----~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-~~~~lv~e~   80 (307)
T 2eva_A            7 YKEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIES----ESERKAFIVELRQLSRVNHPNIVKLYGACL-NPVCLVMEY   80 (307)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSS----TTHHHHHHHHHHHHHHCCCTTBCCEEEBCT-TTTEEEEEC
T ss_pred             HhHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecC----hhHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCcEEEEEc
Confidence            467889999999999999999986 78999999863    234567899999999999999999999886 448999999


Q ss_pred             ccCCCHhhhhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCC-eEEeecCccccCCCCC
Q 016594          145 SSRGSVASLFHDVNS-PGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFE-PQISDFGLAKWLPSQW  222 (386)
Q Consensus       145 ~~~~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~-~kl~Dfg~a~~~~~~~  222 (386)
                      +.+++|.+++..... ..+++..++.++.|++.||.|||+.+.++|+||||||+|||++.++. +||+|||++...... 
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~-  159 (307)
T 2eva_A           81 AEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH-  159 (307)
T ss_dssp             CTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC--------
T ss_pred             CCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc-
Confidence            999999999875443 24788999999999999999999854468999999999999998886 799999999765432 


Q ss_pred             ccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCCCC
Q 016594          223 THHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAY  302 (386)
Q Consensus       223 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (386)
                          .....||+.|+|||++.+..++.++|||||||++|+|++|+.||................ .         .....
T Consensus       160 ----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-~---------~~~~~  225 (307)
T 2eva_A          160 ----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHN-G---------TRPPL  225 (307)
T ss_dssp             ---------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHT-T---------CCCCC
T ss_pred             ----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhc-C---------CCCCc
Confidence                223458999999999999999999999999999999999999997643322111111100 0         01111


Q ss_pred             CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCC
Q 016594          303 DVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEGD  339 (386)
Q Consensus       303 ~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~~  339 (386)
                      ....+..+.+++.+||+.||++|||+.++++.|....
T Consensus       226 ~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~  262 (307)
T 2eva_A          226 IKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLM  262 (307)
T ss_dssp             BTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHG
T ss_pred             ccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence            1233567999999999999999999999999987654

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=4.7e-45  Score=344.18  Aligned_cols=263  Identities=22%  Similarity=0.302  Sum_probs=199.1

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeC-------
Q 016594           65 TNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDN-------  136 (386)
Q Consensus        65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-------  136 (386)
                      .++|++.+.||+|+||.||+|... +++.||||++............+.+|+.+++.++||||+++++++...       
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            467999999999999999999976 689999999987555566677889999999999999999999998653       


Q ss_pred             ceEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccc
Q 016594          137 GLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAK  216 (386)
Q Consensus       137 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~  216 (386)
                      ..++||||+.+ +|.+.+..    .+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||++.
T Consensus       104 ~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~  175 (371)
T 2xrw_A          104 DVYIVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR  175 (371)
T ss_dssp             EEEEEEECCSE-EHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCCCC--
T ss_pred             ceEEEEEcCCC-CHHHHHhh----ccCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEEEeeccc
Confidence            36999999986 67777652    38899999999999999999999   999999999999999999999999999998


Q ss_pred             cCCCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhccc--------
Q 016594          217 WLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQG--------  288 (386)
Q Consensus       217 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~--------  288 (386)
                      ......   ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+...... +.......+        
T Consensus       176 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~  251 (371)
T 2xrw_A          176 TAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQ-WNKVIEQLGTPCPEFMK  251 (371)
T ss_dssp             -----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHC-CCCCCHHHHT
T ss_pred             cccccc---ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCCHHHHH
Confidence            664321   23345699999999999999999999999999999999999999987653211 100000000        


Q ss_pred             -------------------ccccccCCccCCC---CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCC
Q 016594          289 -------------------EIEKLVDPRLQGA---YDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEGD  339 (386)
Q Consensus       289 -------------------~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~~  339 (386)
                                         .............   .....+..+.+|+.+||..||++|||+.+++++-+...
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~  324 (371)
T 2xrw_A          252 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV  324 (371)
T ss_dssp             TSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred             HhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhh
Confidence                               0000000000000   01123678999999999999999999999999876543

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=2.4e-45  Score=345.29  Aligned_cols=263  Identities=21%  Similarity=0.292  Sum_probs=190.2

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeC-------
Q 016594           65 TNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDN-------  136 (386)
Q Consensus        65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-------  136 (386)
                      .++|++.+.||+|+||.||+|.+. +|+.||||++............+.+|+.+++.++||||+++++++...       
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  107 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN  107 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence            478999999999999999999975 689999999987555566677889999999999999999999998642       


Q ss_pred             ceEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccc
Q 016594          137 GLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAK  216 (386)
Q Consensus       137 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~  216 (386)
                      ..+++++++ +++|.+++..   ..+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||++.
T Consensus       108 ~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kL~DFG~a~  180 (367)
T 2fst_X          108 DVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR  180 (367)
T ss_dssp             CCEEEEECC-CEECC--------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECC-----
T ss_pred             eEEEEeccc-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHhhEEECCCCCEEEeeccccc
Confidence            368888888 6788888764   359999999999999999999999   999999999999999999999999999998


Q ss_pred             cCCCCCccccccccccccCccChhhhcc-CCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhh-hhhhhhccc------
Q 016594          217 WLPSQWTHHSIAPIEGTFGHLAPEYFMH-GIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHS-WAKPILNQG------  288 (386)
Q Consensus       217 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~-~~~~~~~~~------  288 (386)
                      .....     .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..... .........      
T Consensus       181 ~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~  255 (367)
T 2fst_X          181 HTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK  255 (367)
T ss_dssp             ---------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHT
T ss_pred             ccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            65432     234569999999999987 67899999999999999999999999876532111 000000000      


Q ss_pred             -----ccccc---cCCccCCCC---CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCC
Q 016594          289 -----EIEKL---VDPRLQGAY---DVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEGD  339 (386)
Q Consensus       289 -----~~~~~---~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~~  339 (386)
                           .....   +........   ....+..+.+|+.+||..||.+|||+.++++|-+...
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~  317 (367)
T 2fst_X          256 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ  317 (367)
T ss_dssp             TCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred             HhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhh
Confidence                 00000   000000000   0112467899999999999999999999999876654

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=1.4e-45  Score=341.90  Aligned_cols=255  Identities=24%  Similarity=0.452  Sum_probs=202.9

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEC-CCcEE--EEEEeccccCChHhHHHHHHHHHHHhcc-CCCceeeecceEEeCc-eE
Q 016594           65 TNAFSSENLVGRGGYAEVYKGVLQ-DGEEI--AVKRLTKVVTDDRKEKEFLTEIGTIGHV-CHPNVLSLLGCCVDNG-LY  139 (386)
Q Consensus        65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~v--avK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~-~~  139 (386)
                      .++|++.+.||+|+||.||+|.+. ++..+  |+|.+... ........+.+|+.+++++ +||||+++++++.+.+ .+
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~  102 (327)
T 1fvr_A           24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY  102 (327)
T ss_dssp             GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEE
T ss_pred             HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccc-cchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceE
Confidence            467999999999999999999975 56644  99988742 2333456788999999999 8999999999998766 89


Q ss_pred             EEEEeccCCCHhhhhhhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCC
Q 016594          140 LIFQFSSRGSVASLFHDVN--------------SPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADF  205 (386)
Q Consensus       140 lv~e~~~~~~L~~~~~~~~--------------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~  205 (386)
                      +||||+.+++|.+++....              ...+++..++.++.|++.||.|||+   ++|+||||||+|||++.++
T Consensus       103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~  179 (327)
T 1fvr_A          103 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENY  179 (327)
T ss_dssp             EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGG
T ss_pred             EEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCccceEEEcCCC
Confidence            9999999999999987543              2458999999999999999999999   9999999999999999999


Q ss_pred             CeEEeecCccccCCCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCchhhhhhhhhh
Q 016594          206 EPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPI  284 (386)
Q Consensus       206 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~  284 (386)
                      .+||+|||++......   .......+++.|+|||++.+..++.++|||||||++|+|++ |..||.+.......  ...
T Consensus       180 ~~kL~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~--~~~  254 (327)
T 1fvr_A          180 VAKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY--EKL  254 (327)
T ss_dssp             CEEECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH--HHG
T ss_pred             eEEEcccCcCcccccc---ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHH--HHh
Confidence            9999999998744321   11223346889999999999999999999999999999998 99999875432111  000


Q ss_pred             hcccccccccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          285 LNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                       ..         ......+...+..+.+++.+||+.||.+|||+.+++++|...
T Consensus       255 -~~---------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~  298 (327)
T 1fvr_A          255 -PQ---------GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM  298 (327)
T ss_dssp             -GG---------TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -hc---------CCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence             00         111112233457799999999999999999999999998764

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=7.5e-46  Score=335.69  Aligned_cols=251  Identities=23%  Similarity=0.371  Sum_probs=200.9

Q ss_pred             HHhcCCCCCCeecccCCcEEEEEEECCCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeC--ceEE
Q 016594           63 IATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDN--GLYL  140 (386)
Q Consensus        63 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~l  140 (386)
                      +..++|++.+.||+|+||+||+|.+. ++.||||++...    .....+.+|+.+++.++||||+++++++.+.  ..++
T Consensus        18 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~l   92 (278)
T 1byg_A           18 LNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI   92 (278)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC----C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEE
T ss_pred             CChhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecch----hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEE
Confidence            34578999999999999999999986 889999998743    2456788999999999999999999987543  4899


Q ss_pred             EEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCC
Q 016594          141 IFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPS  220 (386)
Q Consensus       141 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~  220 (386)
                      +|||+.+++|.+++.......+++..++.++.|++.||.|||+   ++++||||||+||+++.++.+||+|||++.....
T Consensus        93 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~  169 (278)
T 1byg_A           93 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS  169 (278)
T ss_dssp             EECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred             EEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHh---CCccccCCCcceEEEeCCCcEEEeeccccccccc
Confidence            9999999999999876544448899999999999999999999   9999999999999999999999999999876543


Q ss_pred             CCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCchhhhhhhhhhhcccccccccCCccC
Q 016594          221 QWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQ  299 (386)
Q Consensus       221 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (386)
                      .     .....+++.|+|||.+.+..++.++||||||+++|+|++ |..||........  ..          .+.....
T Consensus       170 ~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~--~~----------~~~~~~~  232 (278)
T 1byg_A          170 T-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV--VP----------RVEKGYK  232 (278)
T ss_dssp             -----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGH--HH----------HHTTTCC
T ss_pred             c-----ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHH--HH----------HHhcCCC
Confidence            2     123357889999999999999999999999999999998 9999986533211  00          0111111


Q ss_pred             CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          300 GAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       300 ~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                      ...+...+..+.+++.+||+.||.+||++.++++.|...
T Consensus       233 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i  271 (278)
T 1byg_A          233 MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI  271 (278)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHH
Confidence            122234457799999999999999999999999988764

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=1.5e-44  Score=327.01  Aligned_cols=250  Identities=22%  Similarity=0.294  Sum_probs=205.3

Q ss_pred             HhcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEE
Q 016594           64 ATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLI  141 (386)
Q Consensus        64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv  141 (386)
                      ..++|++.+.||+|+||.||+|.+. ++..||+|++.....  .....+.+|+.+++.++||||+++++++.+.. .++|
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (277)
T 3f3z_A            7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV--EDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLV   84 (277)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC--SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc--chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEE
Confidence            3567999999999999999999987 577999999876432  23567889999999999999999999998766 8999


Q ss_pred             EEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeE---cCCCCeEEeecCccccC
Q 016594          142 FQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILL---TADFEPQISDFGLAKWL  218 (386)
Q Consensus       142 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~a~~~  218 (386)
                      |||+.+++|.+++....  .+++..++.++.|++.||.|||+   ++|+||||||+||++   +.++.+||+|||++...
T Consensus        85 ~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~  159 (277)
T 3f3z_A           85 MELCTGGELFERVVHKR--VFRESDAARIMKDVLSAVAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF  159 (277)
T ss_dssp             EECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred             EeccCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEecCCCCCcEEEEecccceec
Confidence            99999999999887644  38999999999999999999999   999999999999999   78889999999999876


Q ss_pred             CCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCcc
Q 016594          219 PSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRL  298 (386)
Q Consensus       219 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (386)
                      ....   ......||+.|+|||++.+. ++.++||||||+++|+|++|..||...........  ... .        . 
T Consensus       160 ~~~~---~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~--~~~-~--------~-  223 (277)
T 3f3z_A          160 KPGK---MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLK--IRE-G--------T-  223 (277)
T ss_dssp             CTTS---CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH--HHH-C--------C-
T ss_pred             cCcc---chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHH--HHh-C--------C-
Confidence            5432   23345699999999998654 89999999999999999999999987543221110  000 0        0 


Q ss_pred             CCCCCH----HHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 016594          299 QGAYDV----TQLNRLAFAASLCIRASPTWRPTMSEVLEVMLE  337 (386)
Q Consensus       299 ~~~~~~----~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~  337 (386)
                       ...+.    ..+..+.+++.+||+.||++|||+.+++++-+.
T Consensus       224 -~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~  265 (277)
T 3f3z_A          224 -FTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWF  265 (277)
T ss_dssp             -CCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHH
T ss_pred             -CCCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHH
Confidence             00111    235679999999999999999999999987554

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.3e-45  Score=341.57  Aligned_cols=265  Identities=18%  Similarity=0.271  Sum_probs=197.0

Q ss_pred             cCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEEE
Q 016594           66 NAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQ  143 (386)
Q Consensus        66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~e  143 (386)
                      ++|++.+.||+|+||+||+|... +++.||+|++..... ......+.+|+.+++.++||||+++++++.+.+ .++|||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE   80 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC-------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccc-cccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEec
Confidence            47889999999999999999987 789999999875321 111223557999999999999999999998765 899999


Q ss_pred             eccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCc
Q 016594          144 FSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWT  223 (386)
Q Consensus       144 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~  223 (386)
                      |+.+ +|.+++... ...+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||++....... 
T Consensus        81 ~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~-  154 (324)
T 3mtl_A           81 YLDK-DLKQYLDDC-GNIINMHNVKLFLFQLLRGLAYCHR---QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT-  154 (324)
T ss_dssp             CCSE-EHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred             cccc-CHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCcCHHHEEECCCCCEEEccCcccccccCCc-
Confidence            9985 888887654 3458999999999999999999999   999999999999999999999999999998654321 


Q ss_pred             cccccccccccCccChhhhcc-CCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhh-hhhhhhcccc---ccccc----
Q 016594          224 HHSIAPIEGTFGHLAPEYFMH-GIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHS-WAKPILNQGE---IEKLV----  294 (386)
Q Consensus       224 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~-~~~~~~~~~~---~~~~~----  294 (386)
                       .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+....... ..........   .....    
T Consensus       155 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  233 (324)
T 3mtl_A          155 -KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEE  233 (324)
T ss_dssp             ---------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHH
T ss_pred             -cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchh
Confidence             22334568999999999876 56899999999999999999999999876532211 1111000000   00000    


Q ss_pred             -----CCccCC----CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          295 -----DPRLQG----AYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       295 -----~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                           .+....    ......+..+.+|+.+||+.||++|||+.+++++-+..
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~  286 (324)
T 3mtl_A          234 FKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFL  286 (324)
T ss_dssp             HHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGG
T ss_pred             hcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhh
Confidence                 000000    00112346789999999999999999999999987654

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=4.9e-46  Score=342.77  Aligned_cols=268  Identities=18%  Similarity=0.322  Sum_probs=206.5

Q ss_pred             cccCHHHHHHHhcCCCCCCeecccCCcEEEEEEECCCcEEEEEEeccccCChHhHHHHHHHHHHHhccC--CCceeeecc
Q 016594           54 RCFSFEEISIATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVC--HPNVLSLLG  131 (386)
Q Consensus        54 ~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~--h~niv~l~~  131 (386)
                      ..+.++.+.+..++|++.+.||+|+||.||+|.+.+++.||||++............+.+|+.+++++.  |+||+++++
T Consensus        16 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~   95 (313)
T 3cek_A           16 ENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD   95 (313)
T ss_dssp             ----CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEE
T ss_pred             CCCCeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEE
Confidence            334444455677889999999999999999999888999999999865555666788999999999997  599999999


Q ss_pred             eEEeCc-eEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEe
Q 016594          132 CCVDNG-LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQIS  210 (386)
Q Consensus       132 ~~~~~~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~  210 (386)
                      ++.+.. .+++|| +.+++|.+++....  .+++..++.++.|++.||.|||+   ++|+||||||+|||++. +.+||+
T Consensus        96 ~~~~~~~~~lv~e-~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~-~~~kL~  168 (313)
T 3cek_A           96 YEITDQYIYMVME-CGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIVD-GMLKLI  168 (313)
T ss_dssp             EEECSSEEEEEEC-CCSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEET-TEEEEC
T ss_pred             EeecCCEEEEEEe-cCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEEEC-CeEEEe
Confidence            998766 778888 67789999987643  48999999999999999999999   99999999999999965 799999


Q ss_pred             ecCccccCCCCCccccccccccccCccChhhhcc-----------CCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhh
Q 016594          211 DFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMH-----------GIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHS  279 (386)
Q Consensus       211 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~  279 (386)
                      |||++..+.............|++.|+|||++.+           ..++.++|||||||++|+|++|..||.........
T Consensus       169 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~  248 (313)
T 3cek_A          169 DFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK  248 (313)
T ss_dssp             CCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHH
T ss_pred             eccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHH
Confidence            9999987654433223345568999999999875           47889999999999999999999999765332211


Q ss_pred             hhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          280 WAKPILNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                      ..          ....+......+...+..+.+++.+||+.||.+||++.+++++.+..
T Consensus       249 ~~----------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~  297 (313)
T 3cek_A          249 LH----------AIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ  297 (313)
T ss_dssp             HH----------HHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHH
T ss_pred             HH----------HHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCcccc
Confidence            11          11111111122222346799999999999999999999999986554

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=7.8e-45  Score=355.27  Aligned_cols=256  Identities=23%  Similarity=0.317  Sum_probs=201.6

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEE
Q 016594           65 TNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIF  142 (386)
Q Consensus        65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~  142 (386)
                      .++|++.+.||+|+||+||+|.++ ++..||+|++.+..........+.+|+.+++.++||||+++++++.+.. .++||
T Consensus        36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  115 (494)
T 3lij_A           36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM  115 (494)
T ss_dssp             HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            457999999999999999999987 6889999999865444444567899999999999999999999998765 89999


Q ss_pred             EeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCC---CCeEEeecCccccCC
Q 016594          143 QFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTAD---FEPQISDFGLAKWLP  219 (386)
Q Consensus       143 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~---~~~kl~Dfg~a~~~~  219 (386)
                      ||+.+|+|.+.+....  .+++..++.++.||+.||.|||+   ++|+||||||+|||++..   +.+||+|||++..+.
T Consensus       116 e~~~~g~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~  190 (494)
T 3lij_A          116 ECYKGGELFDEIIHRM--KFNEVDAAVIIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE  190 (494)
T ss_dssp             ECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECB
T ss_pred             ecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChhhEEEeCCCCCCcEEEEECCCCeECC
Confidence            9999999998886653  38999999999999999999999   999999999999999764   459999999998765


Q ss_pred             CCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccC
Q 016594          220 SQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQ  299 (386)
Q Consensus       220 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (386)
                      ..   .......||+.|+|||++. ..++.++|||||||++|+|++|..||.+.......  ..+.. ... .. .    
T Consensus       191 ~~---~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~--~~i~~-~~~-~~-~----  257 (494)
T 3lij_A          191 NQ---KKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEIL--RKVEK-GKY-TF-D----  257 (494)
T ss_dssp             TT---BCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH--HHHHH-TCC-CC-C----
T ss_pred             CC---ccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHh-CCC-CC-C----
Confidence            43   2234567999999999886 56899999999999999999999999876442111  11100 000 00 0    


Q ss_pred             CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          300 GAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       300 ~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                      .......+..+.++|.+||+.||.+|||+.+++++.+..
T Consensus       258 ~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~  296 (494)
T 3lij_A          258 SPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIK  296 (494)
T ss_dssp             SGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHH
T ss_pred             chhcccCCHHHHHHHHHHCCCChhhCccHHHHhcCcccc
Confidence            000112356799999999999999999999999875543

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4e-45  Score=334.03  Aligned_cols=255  Identities=22%  Similarity=0.332  Sum_probs=202.3

Q ss_pred             CCCCCCeecccCCcEEEEEEEC-CC---cEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc--eEE
Q 016594           67 AFSSENLVGRGGYAEVYKGVLQ-DG---EEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG--LYL  140 (386)
Q Consensus        67 ~~~~~~~lg~G~~g~V~~~~~~-~~---~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~l  140 (386)
                      .|.+.+.||+|+||+||+|.+. ++   ..||+|.+.. .........+.+|+.+++.++||||+++++++.+.+  .++
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~-~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  100 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSR-ITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHV  100 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETT-CCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccc-cccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEE
Confidence            4566789999999999999854 22   3799999875 334455678899999999999999999999997644  489


Q ss_pred             EEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCC
Q 016594          141 IFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPS  220 (386)
Q Consensus       141 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~  220 (386)
                      +++|+.+++|.+++... ...+++..++.++.|++.||.|||+   ++++||||||+||+++.++.+||+|||++.....
T Consensus       101 v~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~  176 (298)
T 3pls_A          101 LLPYMCHGDLLQFIRSP-QRNPTVKDLISFGLQVARGMEYLAE---QKFVHRDLAARNCMLDESFTVKVADFGLARDILD  176 (298)
T ss_dssp             EECCCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred             EEecccCCCHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence            99999999999998753 3458999999999999999999999   9999999999999999999999999999986644


Q ss_pred             CCc--cccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCC-CCCCchhhhhhhhhhhcccccccccCCc
Q 016594          221 QWT--HHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKP-VDGSHQSLHSWAKPILNQGEIEKLVDPR  297 (386)
Q Consensus       221 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~p-f~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (386)
                      ...  ........+++.|+|||.+.+..++.++|||||||++|+|++|..| |........            ...+...
T Consensus       177 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~------------~~~~~~~  244 (298)
T 3pls_A          177 REYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDL------------THFLAQG  244 (298)
T ss_dssp             GGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGH------------HHHHHTT
T ss_pred             CcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHH------------HHHhhcC
Confidence            321  1222345678899999999999999999999999999999995554 544322111            0111111


Q ss_pred             cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          298 LQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       298 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                      .....+...+..+.+++.+||+.||.+|||+.++++.|...
T Consensus       245 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~  285 (298)
T 3pls_A          245 RRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQI  285 (298)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            11122233456799999999999999999999999998765

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=2.4e-45  Score=332.36  Aligned_cols=255  Identities=24%  Similarity=0.364  Sum_probs=186.8

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccC-ChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEE
Q 016594           65 TNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVT-DDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLI  141 (386)
Q Consensus        65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv  141 (386)
                      .++|++.+.||+|+||.||+|... +++.||||++..... .......+.+|+.+++.++||||+++++++.+.+ .+++
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV   89 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence            357899999999999999999975 789999999875321 1223467889999999999999999999998766 8999


Q ss_pred             EEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCC
Q 016594          142 FQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQ  221 (386)
Q Consensus       142 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  221 (386)
                      |||+.+++|.+++... ...+++..++.++.|++.||.|||+   ++++||||||+||+++.++.+||+|||++......
T Consensus        90 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~  165 (278)
T 3cok_A           90 LEMCHNGEMNRYLKNR-VKPFSENEARHFMHQIITGMLYLHS---HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP  165 (278)
T ss_dssp             EECCTTEEHHHHHHTC-SSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSSCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred             EecCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEEeecceeeccCC
Confidence            9999999999988754 3458999999999999999999999   99999999999999999999999999999876533


Q ss_pred             CccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCCC
Q 016594          222 WTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGA  301 (386)
Q Consensus       222 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (386)
                      ..  ......||+.|+|||.+.+..++.++|||||||++|+|++|..||.......           .........  ..
T Consensus       166 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-----------~~~~~~~~~--~~  230 (278)
T 3cok_A          166 HE--KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKN-----------TLNKVVLAD--YE  230 (278)
T ss_dssp             ----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC----------------CCSSC--CC
T ss_pred             CC--cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHH-----------HHHHHhhcc--cC
Confidence            21  2234568999999999999999999999999999999999999997643210           011111111  11


Q ss_pred             CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          302 YDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       302 ~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                      .+...+..+.+++.+||+.||++|||+.+++++.+..
T Consensus       231 ~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~  267 (278)
T 3cok_A          231 MPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMS  267 (278)
T ss_dssp             CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC
T ss_pred             CccccCHHHHHHHHHHcccCHhhCCCHHHHhcCcccc
Confidence            2223456799999999999999999999999876543

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=9.5e-45  Score=329.15  Aligned_cols=257  Identities=22%  Similarity=0.298  Sum_probs=204.9

Q ss_pred             HhcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCCh----HhHHHHHHHHHHHhccCCCceeeecceEEeCc-
Q 016594           64 ATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDD----RKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-  137 (386)
Q Consensus        64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-  137 (386)
                      ..++|++.+.||+|+||.||+|... +++.||+|++.......    .....+.+|+.++++++||||+++++++.+.. 
T Consensus         3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   82 (283)
T 3bhy_A            3 VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTD   82 (283)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             hhhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCe
Confidence            3467999999999999999999987 68999999987643221    23677899999999999999999999998765 


Q ss_pred             eEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCC----CeEEeecC
Q 016594          138 LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADF----EPQISDFG  213 (386)
Q Consensus       138 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~----~~kl~Dfg  213 (386)
                      .+++|||+.+++|.+++....  .+++..++.++.|++.||.|||+   ++++||||||+||+++.++    .+||+|||
T Consensus        83 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg  157 (283)
T 3bhy_A           83 VVLILELVSGGELFDFLAEKE--SLTEDEATQFLKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFG  157 (283)
T ss_dssp             EEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred             EEEEEeecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChHHEEEecCCCCCCceEEEecc
Confidence            899999999999999987643  48999999999999999999999   9999999999999998877    89999999


Q ss_pred             ccccCCCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccc
Q 016594          214 LAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKL  293 (386)
Q Consensus       214 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  293 (386)
                      ++.......   ......|++.|+|||++.+..++.++||||||+++|+|++|..||.+........  .... .     
T Consensus       158 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~--~~~~-~-----  226 (283)
T 3bhy_A          158 IAHKIEAGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLT--NISA-V-----  226 (283)
T ss_dssp             TCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH--HHHT-T-----
T ss_pred             cceeccCCC---cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHH--HhHh-c-----
Confidence            998765432   2234568999999999999999999999999999999999999998754321110  0000 0     


Q ss_pred             cCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 016594          294 VDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLE  337 (386)
Q Consensus       294 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~  337 (386)
                       ............+..+.+++.+||..||.+||++.+++++.+.
T Consensus       227 -~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~  269 (283)
T 3bhy_A          227 -NYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWI  269 (283)
T ss_dssp             -CCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHH
T ss_pred             -ccCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHH
Confidence             0000000001224678999999999999999999999987543

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=1.2e-45  Score=336.19  Aligned_cols=258  Identities=21%  Similarity=0.325  Sum_probs=192.4

Q ss_pred             HHhcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEE
Q 016594           63 IATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYL  140 (386)
Q Consensus        63 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~l  140 (386)
                      +..++|++.+.||+|+||+||+|.+. +++.||+|++............+..+...++.+.||||+++++++.+++ .++
T Consensus         4 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~l   83 (290)
T 3fme_A            4 VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWI   83 (290)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEE
T ss_pred             ccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEE
Confidence            34678999999999999999999975 7899999999764433444444555666688889999999999998765 899


Q ss_pred             EEEeccCCCHhhhhhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCC-CeEEeCCCCCCeeEcCCCCeEEeecCcccc
Q 016594          141 IFQFSSRGSVASLFHDV--NSPGVEWKVRHKIAVGTARGLHYLHKGCQR-RIIHRDIKSSNILLTADFEPQISDFGLAKW  217 (386)
Q Consensus       141 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~-~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~  217 (386)
                      ||||+.+ +|.+++...  ....+++..++.++.|++.||.|||+   + +++||||||+||+++.++.+||+|||++..
T Consensus        84 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  159 (290)
T 3fme_A           84 CMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS---KLSVIHRDVKPSNVLINALGQVKMCDFGISGY  159 (290)
T ss_dssp             EEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---HSCCCCCCCSGGGCEECTTCCEEBCCC-----
T ss_pred             EEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh---cCCeecCCCCHHHEEECCCCCEEEeecCCccc
Confidence            9999985 887776542  34569999999999999999999999   8 999999999999999999999999999987


Q ss_pred             CCCCCccccccccccccCccChhhh----ccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccc
Q 016594          218 LPSQWTHHSIAPIEGTFGHLAPEYF----MHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKL  293 (386)
Q Consensus       218 ~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  293 (386)
                      ......   .....||+.|+|||++    .+..++.++|||||||++|+|++|..||...............        
T Consensus       160 ~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--------  228 (290)
T 3fme_A          160 LVDDVA---KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVE--------  228 (290)
T ss_dssp             -------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHH--------
T ss_pred             cccccc---ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhc--------
Confidence            654322   2234689999999996    4667899999999999999999999999864332222111110        


Q ss_pred             cCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 016594          294 VDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLE  337 (386)
Q Consensus       294 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~  337 (386)
                        ...........+..+.+++.+||+.||++|||+.+++++.+.
T Consensus       229 --~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f  270 (290)
T 3fme_A          229 --EPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFF  270 (290)
T ss_dssp             --SCCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHH
T ss_pred             --cCCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCccc
Confidence              001111112335679999999999999999999999997654

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=4.9e-45  Score=340.72  Aligned_cols=266  Identities=14%  Similarity=0.152  Sum_probs=199.2

Q ss_pred             HhcCCCCCCeecccCCcEEEEEEEC----CCcEEEEEEeccccCChHh---------HHHHHHHHHHHhccCCCceeeec
Q 016594           64 ATNAFSSENLVGRGGYAEVYKGVLQ----DGEEIAVKRLTKVVTDDRK---------EKEFLTEIGTIGHVCHPNVLSLL  130 (386)
Q Consensus        64 ~~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~---------~~~~~~e~~~l~~l~h~niv~l~  130 (386)
                      ..++|.+.+.||+|+||.||+|.+.    ++..||+|++.........         ...+.+|+..++.+.||||++++
T Consensus        35 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~  114 (345)
T 2v62_A           35 EGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFY  114 (345)
T ss_dssp             TSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEE
T ss_pred             cCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceee
Confidence            4578999999999999999999975    5678999998754321111         12356788899999999999999


Q ss_pred             ceEEe----Cc-eEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCC
Q 016594          131 GCCVD----NG-LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADF  205 (386)
Q Consensus       131 ~~~~~----~~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~  205 (386)
                      +++..    .. .++||||+ +++|.+++....  .+++..++.++.|++.||.|||+   ++|+||||||+|||++.++
T Consensus       115 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~  188 (345)
T 2v62_A          115 GSGLTEFKGRSYRFMVMERL-GIDLQKISGQNG--TFKKSTVLQLGIRMLDVLEYIHE---NEYVHGDIKAANLLLGYKN  188 (345)
T ss_dssp             EEEEEESSSCEEEEEEEECE-EEEHHHHCBGGG--BCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEESSS
T ss_pred             cccccccCCCcEEEEEEecc-CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCcCHHHEEEccCC
Confidence            99976    33 89999999 999999987654  59999999999999999999999   9999999999999999877


Q ss_pred             --CeEEeecCccccCCCCCc-----cccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhh
Q 016594          206 --EPQISDFGLAKWLPSQWT-----HHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLH  278 (386)
Q Consensus       206 --~~kl~Dfg~a~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~  278 (386)
                        .+||+|||++..+.....     ........||+.|+|||++.+..++.++|||||||++|+|++|..||.+......
T Consensus       189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~  268 (345)
T 2v62_A          189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPV  268 (345)
T ss_dssp             TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHH
T ss_pred             CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccH
Confidence              999999999987643211     1112455799999999999999999999999999999999999999964221111


Q ss_pred             --hhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCC
Q 016594          279 --SWAKPILNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEGD  339 (386)
Q Consensus       279 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~~  339 (386)
                        ......... .+.......   ......+..+.+++..||+.||++||++.+|++.|+...
T Consensus       269 ~~~~~~~~~~~-~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~  327 (345)
T 2v62_A          269 AVQTAKTNLLD-ELPQSVLKW---APSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG  327 (345)
T ss_dssp             HHHHHHHHHHH-TTTHHHHHH---SCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred             HHHHHHHhhcc-cccHHHHhh---ccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence              111100000 000000000   000123467999999999999999999999999997754

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=2.3e-44  Score=331.11  Aligned_cols=261  Identities=21%  Similarity=0.286  Sum_probs=201.2

Q ss_pred             HhcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccC-ChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEE
Q 016594           64 ATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVT-DDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYL  140 (386)
Q Consensus        64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~l  140 (386)
                      ..++|++.+.||+|+||.||+|.+. +++.||+|++..... .......+.+|+.+++.++||||+++++++.+++ .++
T Consensus        32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l  111 (309)
T 2h34_A           32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV  111 (309)
T ss_dssp             --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred             EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence            3578999999999999999999976 688999999976432 3344577899999999999999999999998765 899


Q ss_pred             EEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCC
Q 016594          141 IFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPS  220 (386)
Q Consensus       141 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~  220 (386)
                      ++|++.+++|.+++....  .+++..++.++.|++.||.|||+   ++|+||||||+||+++.++.+||+|||++.....
T Consensus       112 v~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  186 (309)
T 2h34_A          112 DMRLINGVDLAAMLRRQG--PLAPPRAVAIVRQIGSALDAAHA---AGATHRDVKPENILVSADDFAYLVDFGIASATTD  186 (309)
T ss_dssp             EEECCCCEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSCCC------
T ss_pred             EEEecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CcCCcCCCChHHEEEcCCCCEEEecCccCccccc
Confidence            999999999999987653  48999999999999999999999   9999999999999999999999999999986644


Q ss_pred             CCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCC
Q 016594          221 QWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQG  300 (386)
Q Consensus       221 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (386)
                      ... .......|++.|+|||++.+..++.++||||||+++|+|++|..||.+.......   ......     ...  ..
T Consensus       187 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~---~~~~~~-----~~~--~~  255 (309)
T 2h34_A          187 EKL-TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMG---AHINQA-----IPR--PS  255 (309)
T ss_dssp             -----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHH---HHHHSC-----CCC--GG
T ss_pred             ccc-ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHH---HHhccC-----CCC--cc
Confidence            321 2223456899999999999999999999999999999999999999876543111   101100     000  01


Q ss_pred             CCCHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHhcCCc
Q 016594          301 AYDVTQLNRLAFAASLCIRASPTWRP-TMSEVLEVMLEGDQ  340 (386)
Q Consensus       301 ~~~~~~~~~l~~li~~cl~~dP~~Rp-t~~~il~~l~~~~~  340 (386)
                      ......+..+.+++.+||+.||++|| ++.++++.|.....
T Consensus       256 ~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~  296 (309)
T 2h34_A          256 TVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALA  296 (309)
T ss_dssp             GTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC
T ss_pred             ccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHH
Confidence            11223346799999999999999999 99999999876543

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=4e-45  Score=335.09  Aligned_cols=253  Identities=25%  Similarity=0.414  Sum_probs=208.4

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEE
Q 016594           65 TNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIF  142 (386)
Q Consensus        65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~  142 (386)
                      ...|++.+.||+|+||.||+|... +++.||||++..... ......+.+|+.+++.+.||||+++++++.+.. .++||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   99 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM   99 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTC-STTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEeccccc-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEE
Confidence            356889999999999999999976 689999999975432 334677899999999999999999999998765 89999


Q ss_pred             EeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCC
Q 016594          143 QFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQW  222 (386)
Q Consensus       143 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  222 (386)
                      ||+.+++|.+++..   ..+++..++.++.|++.||.|||+   ++++||||||+||+++.++.+||+|||++.......
T Consensus       100 e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~  173 (303)
T 3a7i_A          100 EYLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ  173 (303)
T ss_dssp             ECCTTEEHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB
T ss_pred             EeCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChheEEECCCCCEEEeecccceecCccc
Confidence            99999999998864   358999999999999999999999   999999999999999999999999999998764432


Q ss_pred             ccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCCCC
Q 016594          223 THHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAY  302 (386)
Q Consensus       223 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (386)
                        .......|++.|+|||++.+..++.++|||||||++|+|++|..||...........   ....     ..+    ..
T Consensus       174 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~---~~~~-----~~~----~~  239 (303)
T 3a7i_A          174 --IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFL---IPKN-----NPP----TL  239 (303)
T ss_dssp             --CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH---HHHS-----CCC----CC
T ss_pred             --cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHH---hhcC-----CCC----CC
Confidence              123345689999999999999999999999999999999999999986543211110   0000     011    11


Q ss_pred             CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          303 DVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       303 ~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                      ....+..+.+++.+||+.||.+|||+.+++++.+..
T Consensus       240 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~  275 (303)
T 3a7i_A          240 EGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIL  275 (303)
T ss_dssp             CSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHH
T ss_pred             ccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhh
Confidence            223346799999999999999999999999976543

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=3.1e-45  Score=337.87  Aligned_cols=263  Identities=24%  Similarity=0.313  Sum_probs=205.8

Q ss_pred             HHhcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEe-----C
Q 016594           63 IATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVD-----N  136 (386)
Q Consensus        63 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-----~  136 (386)
                      +..++|++.+.||+|+||.||+|... +++.||||++..  ........+.+|+.+++.++||||+++++++..     .
T Consensus        26 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  103 (317)
T 2buj_A           26 IDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILC--HEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKH  103 (317)
T ss_dssp             ETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEE--SSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEE
T ss_pred             ECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEec--CCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCc
Confidence            45678999999999999999999975 789999999864  234556778999999999999999999999863     2


Q ss_pred             ceEEEEEeccCCCHhhhhhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCc
Q 016594          137 GLYLIFQFSSRGSVASLFHDV--NSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGL  214 (386)
Q Consensus       137 ~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~  214 (386)
                      ..++||||+.+++|.+++...  ....+++..++.++.|++.||.|||+   ++|+||||||+||+++.++.+||+|||+
T Consensus       104 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~dfg~  180 (317)
T 2buj_A          104 EAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGS  180 (317)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCSS
T ss_pred             eeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCCEEEEecCc
Confidence            378999999999999988763  33558999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCCcc-------ccccccccccCccChhhhccCC---CCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhh
Q 016594          215 AKWLPSQWTH-------HSIAPIEGTFGHLAPEYFMHGI---VDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPI  284 (386)
Q Consensus       215 a~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~  284 (386)
                      +.........       .......||+.|+|||++.+..   ++.++|||||||++|+|++|..||............  
T Consensus       181 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~--  258 (317)
T 2buj_A          181 MNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVAL--  258 (317)
T ss_dssp             CEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHH--
T ss_pred             chhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhH--
Confidence            8765422111       0112344799999999987654   689999999999999999999999542111000000  


Q ss_pred             hcccccccccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCCc
Q 016594          285 LNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEGDQ  340 (386)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~~~  340 (386)
                              ..............+..+.+++.+||+.||.+||++.+++++|....+
T Consensus       259 --------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~  306 (317)
T 2buj_A          259 --------AVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP  306 (317)
T ss_dssp             --------HHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCC
T ss_pred             --------HhhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCC
Confidence                    000011111122345679999999999999999999999999987643

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.3e-44  Score=334.77  Aligned_cols=266  Identities=24%  Similarity=0.335  Sum_probs=201.4

Q ss_pred             HHHHHHHhcCCCCCCeecccCCcEEEEEEECCCcEEEEEEeccccCChHhHHHHHHHHHHHhcc--CCCceeeecceEEe
Q 016594           58 FEEISIATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHV--CHPNVLSLLGCCVD  135 (386)
Q Consensus        58 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l--~h~niv~l~~~~~~  135 (386)
                      ........++|++.+.||+|+||.||+|.+. ++.||||++...     ......+|.+++..+  +||||+++++++.+
T Consensus        29 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~-----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~  102 (337)
T 3mdy_A           29 LLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT-----EEASWFRETEIYQTVLMRHENILGFIAADIK  102 (337)
T ss_dssp             HHHHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG-----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEE
T ss_pred             cccccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc-----ccchhhhHHHHHHHHhhcCCCeeeEEEEEcc
Confidence            3344556789999999999999999999986 899999998632     233445556655554  89999999999976


Q ss_pred             C-----ceEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC--------CeEEeCCCCCCeeEc
Q 016594          136 N-----GLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQR--------RIIHRDIKSSNILLT  202 (386)
Q Consensus       136 ~-----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~--------~ivH~dlkp~Nill~  202 (386)
                      .     ..++||||+.+|+|.+++...   .+++..++.++.|++.||.|||+   +        +|+||||||+|||++
T Consensus       103 ~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~---~~~~~~~~~~ivH~Dikp~Nill~  176 (337)
T 3mdy_A          103 GTGSWTQLYLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLHT---EIFSTQGKPAIAHRDLKSKNILVK  176 (337)
T ss_dssp             SCGGGCEEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHS---CBCSTTCBCCEECSCCCGGGEEEC
T ss_pred             CCCCCCceEEEEeccCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHH---hhhhhccCCCEEecccchHHEEEC
Confidence            5     379999999999999999653   48999999999999999999998   7        999999999999999


Q ss_pred             CCCCeEEeecCccccCCCCCccc--cccccccccCccChhhhccCCCCcc------cchHHHHHHHHHHHhC--------
Q 016594          203 ADFEPQISDFGLAKWLPSQWTHH--SIAPIEGTFGHLAPEYFMHGIVDEK------TDVFAFGVFLLEIISG--------  266 (386)
Q Consensus       203 ~~~~~kl~Dfg~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~------~DvwslG~il~ell~g--------  266 (386)
                      .++.+||+|||++..+.......  ......||+.|+|||++.+..++.+      +|||||||++|||++|        
T Consensus       177 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~  256 (337)
T 3mdy_A          177 KNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVE  256 (337)
T ss_dssp             TTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCC
T ss_pred             CCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccc
Confidence            99999999999998765432211  1234579999999999988776665      9999999999999999        


Q ss_pred             --CCCCCCCchhhh--hhhhhhhcccccccccCCccCC-CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCC
Q 016594          267 --RKPVDGSHQSLH--SWAKPILNQGEIEKLVDPRLQG-AYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEGD  339 (386)
Q Consensus       267 --~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~~  339 (386)
                        ..||........  ........    .....+.... .....++..+.+++.+||+.||.+|||+.+|+++|....
T Consensus       257 ~~~~p~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~  330 (337)
T 3mdy_A          257 EYQLPYHDLVPSDPSYEDMREIVC----IKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMS  330 (337)
T ss_dssp             CCCCTTTTTSCSSCCHHHHHHHHT----TSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred             cccccHhhhcCCCCchhhhHHHHh----hhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHH
Confidence              566644211100  00000000    0011111111 112356788999999999999999999999999997653

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=1.9e-44  Score=335.32  Aligned_cols=255  Identities=23%  Similarity=0.335  Sum_probs=210.4

Q ss_pred             HhcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEecccc-CChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEE
Q 016594           64 ATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVV-TDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYL  140 (386)
Q Consensus        64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~l  140 (386)
                      ..++|.+.+.||+|+||.||+|.+. +++.||+|++.... ........+.+|+.+++.+.||||+++++++.+.+ .++
T Consensus        39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  118 (335)
T 2owb_A           39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV  118 (335)
T ss_dssp             TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence            4568999999999999999999987 58899999987643 33455677889999999999999999999998766 899


Q ss_pred             EEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCC
Q 016594          141 IFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPS  220 (386)
Q Consensus       141 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~  220 (386)
                      +|||+.+++|.+++....  .+++..++.++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||++.....
T Consensus       119 v~e~~~~~~L~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  193 (335)
T 2owb_A          119 VLELCRRRSLLELHKRRK--ALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY  193 (335)
T ss_dssp             EECCCTTCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             EEecCCCCCHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHH---CCCEecCCCchhEEEcCCCCEEEeeccCceeccc
Confidence            999999999999887653  48999999999999999999999   9999999999999999999999999999987643


Q ss_pred             CCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCC
Q 016594          221 QWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQG  300 (386)
Q Consensus       221 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (386)
                      ..  .......||+.|+|||++.+..++.++|||||||++|+|++|..||.........  ..... ..          .
T Consensus       194 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~~~~~-~~----------~  258 (335)
T 2owb_A          194 DG--ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETY--LRIKK-NE----------Y  258 (335)
T ss_dssp             TT--CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH--HHHHH-TC----------C
T ss_pred             Cc--ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHH--HHHhc-CC----------C
Confidence            22  1233456999999999999999999999999999999999999999875432111  00000 00          0


Q ss_pred             CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          301 AYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       301 ~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                      ..+...+..+.+++.+||+.||++||++.+++++-+..
T Consensus       259 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~  296 (335)
T 2owb_A          259 SIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFT  296 (335)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHH
T ss_pred             CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccc
Confidence            11122346789999999999999999999999875543

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=1.3e-44  Score=330.29  Aligned_cols=255  Identities=23%  Similarity=0.331  Sum_probs=210.2

Q ss_pred             HhcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEecccc-CChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEE
Q 016594           64 ATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVV-TDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYL  140 (386)
Q Consensus        64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~l  140 (386)
                      ..++|.+.+.||+|+||.||+|.+. +++.||+|++.... ........+.+|+.+++.+.||||+++++++.+.+ .++
T Consensus        13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   92 (294)
T 2rku_A           13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV   92 (294)
T ss_dssp             TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEE
Confidence            3467889999999999999999987 58899999987643 23445677889999999999999999999998766 899


Q ss_pred             EEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCC
Q 016594          141 IFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPS  220 (386)
Q Consensus       141 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~  220 (386)
                      +|||+.+++|.+++....  .+++..++.++.|++.||.|||+   ++++||||||+||+++.++.+||+|||++.....
T Consensus        93 v~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~  167 (294)
T 2rku_A           93 VLELCRRRSLLELHKRRK--ALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY  167 (294)
T ss_dssp             EEECCTTCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             EEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEcCCCCEEEEeccCceeccc
Confidence            999999999999887644  48999999999999999999999   9999999999999999999999999999987643


Q ss_pred             CCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCC
Q 016594          221 QWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQG  300 (386)
Q Consensus       221 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (386)
                      ..  .......||+.|+|||++.+..++.++||||||+++|+|++|..||..........  ...         ...  .
T Consensus       168 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~--~~~---------~~~--~  232 (294)
T 2rku_A          168 DG--ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYL--RIK---------KNE--Y  232 (294)
T ss_dssp             TT--CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH--HHH---------TTC--C
T ss_pred             Cc--cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH--HHh---------hcc--C
Confidence            22  12334568999999999999999999999999999999999999998754321110  000         000  0


Q ss_pred             CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          301 AYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       301 ~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                      ..+...+..+.+++.+||+.||++|||+.+++++.+..
T Consensus       233 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~  270 (294)
T 2rku_A          233 SIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFT  270 (294)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHH
T ss_pred             CCccccCHHHHHHHHHHcccChhhCcCHHHHhhChhee
Confidence            11223346789999999999999999999999976543

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=2e-45  Score=358.71  Aligned_cols=257  Identities=24%  Similarity=0.360  Sum_probs=208.9

Q ss_pred             HhcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccC-ChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEE
Q 016594           64 ATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVT-DDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYL  140 (386)
Q Consensus        64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~l  140 (386)
                      ..++|++.+.||+|+||.||+|... +++.||||++..... .......+.+|+.++++++||||+++++++.+.+ .++
T Consensus        24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  103 (484)
T 3nyv_A           24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL  103 (484)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence            4567999999999999999999987 789999999975432 2345677899999999999999999999998766 899


Q ss_pred             EEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeE---cCCCCeEEeecCcccc
Q 016594          141 IFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILL---TADFEPQISDFGLAKW  217 (386)
Q Consensus       141 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~a~~  217 (386)
                      ||||+.+++|.+.+...  ..+++..++.++.|++.||.|||+   ++|+||||||+|||+   +.++.+||+|||++..
T Consensus       104 v~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~  178 (484)
T 3nyv_A          104 VGEVYTGGELFDEIISR--KRFSEVDAARIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTH  178 (484)
T ss_dssp             EECCCCSCBHHHHHHTC--SCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHH
T ss_pred             EEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEE
Confidence            99999999999988654  349999999999999999999999   999999999999999   5678999999999987


Q ss_pred             CCCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCc
Q 016594          218 LPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPR  297 (386)
Q Consensus       218 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (386)
                      +....   ......||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.......  ..+.. ....      
T Consensus       179 ~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~--~~i~~-~~~~------  245 (484)
T 3nyv_A          179 FEASK---KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDIL--KKVEK-GKYT------  245 (484)
T ss_dssp             BCCCC---SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH--HHHHH-CCCC------
T ss_pred             ccccc---ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHH--HHHHc-CCCC------
Confidence            65432   2234569999999999876 6899999999999999999999999876432111  11100 0000      


Q ss_pred             cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          298 LQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       298 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                      .........+..+.++|.+||+.||.+|||+.++++|.+..
T Consensus       246 ~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~  286 (484)
T 3nyv_A          246 FELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQ  286 (484)
T ss_dssp             CCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHH
T ss_pred             CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhc
Confidence            00011123457799999999999999999999999986653

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=7.8e-45  Score=348.77  Aligned_cols=265  Identities=20%  Similarity=0.259  Sum_probs=204.7

Q ss_pred             HhcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhcc------CCCceeeecceEEeC
Q 016594           64 ATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHV------CHPNVLSLLGCCVDN  136 (386)
Q Consensus        64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l------~h~niv~l~~~~~~~  136 (386)
                      ...+|++.+.||+|+||+||+|.+. +++.||||++...   ......+.+|+.+++.+      +|+||+++++++...
T Consensus        95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~  171 (429)
T 3kvw_A           95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE---KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFR  171 (429)
T ss_dssp             ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEET
T ss_pred             ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc---cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccC
Confidence            3567999999999999999999976 5899999999742   33445667788777776      578999999999876


Q ss_pred             c-eEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCC--eEEeecC
Q 016594          137 G-LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFE--PQISDFG  213 (386)
Q Consensus       137 ~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~--~kl~Dfg  213 (386)
                      . .+++||++. ++|.+++.......+++..++.++.||+.||+|||+   ++|+||||||+|||++.++.  +||+|||
T Consensus       172 ~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NILl~~~~~~~vkL~DFG  247 (429)
T 3kvw_A          172 NHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHK---NRIIHCDLKPENILLKQQGRSGIKVIDFG  247 (429)
T ss_dssp             TEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---HTEECSCCSGGGEEESSTTSCCEEECCCT
T ss_pred             CeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEccCCCcceEEeecc
Confidence            5 889999996 589999887776779999999999999999999999   99999999999999999887  9999999


Q ss_pred             ccccCCCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhh-hhhhhcc-----
Q 016594          214 LAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSW-AKPILNQ-----  287 (386)
Q Consensus       214 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~-~~~~~~~-----  287 (386)
                      ++......     .....||+.|+|||++.+..++.++|||||||++|+|++|.+||.+........ .......     
T Consensus       248 ~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~  322 (429)
T 3kvw_A          248 SSCYEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKL  322 (429)
T ss_dssp             TCEETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred             cceecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHH
Confidence            99765432     234578999999999999999999999999999999999999998765321110 0000000     


Q ss_pred             ----cccccccCC---------------------------cc---CCCC------CHHHHHHHHHHHHHccccCCCCCCC
Q 016594          288 ----GEIEKLVDP---------------------------RL---QGAY------DVTQLNRLAFAASLCIRASPTWRPT  327 (386)
Q Consensus       288 ----~~~~~~~~~---------------------------~~---~~~~------~~~~~~~l~~li~~cl~~dP~~Rpt  327 (386)
                          ......++.                           ..   ....      ....+..+.+||.+||+.||++|||
T Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpt  402 (429)
T 3kvw_A          323 LDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMT  402 (429)
T ss_dssp             HHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCC
T ss_pred             HHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCC
Confidence                000000000                           00   0000      0011456899999999999999999


Q ss_pred             HHHHHHHHhcCCc
Q 016594          328 MSEVLEVMLEGDQ  340 (386)
Q Consensus       328 ~~~il~~l~~~~~  340 (386)
                      +.++|+|-+....
T Consensus       403 a~e~L~Hpw~~~~  415 (429)
T 3kvw_A          403 PGQALRHPWLRRR  415 (429)
T ss_dssp             HHHHHTSTTTC--
T ss_pred             HHHHhCChhhccC
Confidence            9999998766543

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=5.6e-45  Score=346.53  Aligned_cols=268  Identities=18%  Similarity=0.245  Sum_probs=210.0

Q ss_pred             HhcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeC---ceE
Q 016594           64 ATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDN---GLY  139 (386)
Q Consensus        64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~---~~~  139 (386)
                      ..++|.+.+.||+|+||+||+|.+. +++.||||++..... ......+.+|+.++++++||||+++++++.+.   ..+
T Consensus         7 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~   85 (396)
T 4eut_A            7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKV   85 (396)
T ss_dssp             SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEE
T ss_pred             CCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeE
Confidence            3567999999999999999999987 589999999975322 22356678999999999999999999999764   379


Q ss_pred             EEEEeccCCCHhhhhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeE----cCCCCeEEeecCc
Q 016594          140 LIFQFSSRGSVASLFHDVNS-PGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILL----TADFEPQISDFGL  214 (386)
Q Consensus       140 lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill----~~~~~~kl~Dfg~  214 (386)
                      +||||+.+++|.+++..... ..+++..++.++.|++.||+|||+   ++|+||||||+|||+    +.++.+||+|||+
T Consensus        86 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~  162 (396)
T 4eut_A           86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA  162 (396)
T ss_dssp             EEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEECTTSCEEEEECCGGG
T ss_pred             EEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHH---CCEEECCcCHHHEEEeecCCCceeEEEecCCC
Confidence            99999999999999876433 348999999999999999999999   999999999999999    7778899999999


Q ss_pred             cccCCCCCccccccccccccCccChhhhcc--------CCCCcccchHHHHHHHHHHHhCCCCCCCCchh--hhhhhhhh
Q 016594          215 AKWLPSQWTHHSIAPIEGTFGHLAPEYFMH--------GIVDEKTDVFAFGVFLLEIISGRKPVDGSHQS--LHSWAKPI  284 (386)
Q Consensus       215 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwslG~il~ell~g~~pf~~~~~~--~~~~~~~~  284 (386)
                      +.......   ......||+.|+|||++.+        ..++.++|||||||++|+|++|..||......  ........
T Consensus       163 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~  239 (396)
T 4eut_A          163 ARELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI  239 (396)
T ss_dssp             CEECCCGG---GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHH
T ss_pred             ceEccCCC---ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHH
Confidence            98765432   2334569999999999875        56788999999999999999999999643221  11111111


Q ss_pred             hccc---ccc---ccc--------CCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          285 LNQG---EIE---KLV--------DPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       285 ~~~~---~~~---~~~--------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                      ....   .+.   ...        ...............+.+++.+||+.||++||++.++++.+...
T Consensus       240 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~i  307 (396)
T 4eut_A          240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI  307 (396)
T ss_dssp             HHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred             hcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHH
Confidence            1100   000   000        00111234466788899999999999999999999999887654

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=4.7e-46  Score=351.77  Aligned_cols=246  Identities=12%  Similarity=0.093  Sum_probs=191.9

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEecccc-CChHhHHHHHHHH---HHHhccCCCceeeec-------ce
Q 016594           65 TNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVV-TDDRKEKEFLTEI---GTIGHVCHPNVLSLL-------GC  132 (386)
Q Consensus        65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~e~---~~l~~l~h~niv~l~-------~~  132 (386)
                      .++|++.+.||+|+||+||+|.+. +|+.||||++.... ........+.+|+   .+++.++||||++++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            467888999999999999999964 69999999997542 2344567788999   455556799999998       55


Q ss_pred             EEeC------------------ceEEEEEeccCCCHhhhhhhcCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 016594          133 CVDN------------------GLYLIFQFSSRGSVASLFHDVNS-----PGVEWKVRHKIAVGTARGLHYLHKGCQRRI  189 (386)
Q Consensus       133 ~~~~------------------~~~lv~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i  189 (386)
                      +.+.                  ..+++|||+ +|+|.+++.....     ..+++..++.++.||+.||+|||+   ++|
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~i  227 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGL  227 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHH---TTE
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHh---CCe
Confidence            5433                  278999999 6799999876422     113357888999999999999999   999


Q ss_pred             EEeCCCCCCeeEcCCCCeEEeecCccccCCCCCccccccccccccCccChhhhccC-----------CCCcccchHHHHH
Q 016594          190 IHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHG-----------IVDEKTDVFAFGV  258 (386)
Q Consensus       190 vH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~DvwslG~  258 (386)
                      +||||||+|||++.++.+||+|||++.....     ......| +.|+|||++.+.           .++.++|||||||
T Consensus       228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~  301 (377)
T 3byv_A          228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL  301 (377)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred             ecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence            9999999999999999999999999986432     2334567 999999999887           8999999999999


Q ss_pred             HHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 016594          259 FLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLE  337 (386)
Q Consensus       259 il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~  337 (386)
                      ++|+|++|+.||.+.....           ....+....      ...+..+.+++.+||+.||++|||+.+++++.+.
T Consensus       302 il~elltg~~Pf~~~~~~~-----------~~~~~~~~~------~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f  363 (377)
T 3byv_A          302 VIYWIWCADLPITKDAALG-----------GSEWIFRSC------KNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEY  363 (377)
T ss_dssp             HHHHHHHSSCCC------C-----------CSGGGGSSC------CCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHH
T ss_pred             HHHHHHHCCCCCccccccc-----------chhhhhhhc------cCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHH
Confidence            9999999999997643210           111111110      1234679999999999999999999999987543

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.7e-45  Score=338.85  Aligned_cols=270  Identities=22%  Similarity=0.271  Sum_probs=200.0

Q ss_pred             HHhcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCCh---HhHHHHHHHHHHHhccCCCceeeecceEEeCc-
Q 016594           63 IATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDD---RKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-  137 (386)
Q Consensus        63 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-  137 (386)
                      ...++|++.+.||+|+||.||+|.+. +|+.||||++.......   .....+.+|+.+++.++||||+++++++.+.. 
T Consensus         7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (346)
T 1ua2_A            7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN   86 (346)
T ss_dssp             ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred             HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence            44678999999999999999999976 68999999987532221   11246789999999999999999999997654 


Q ss_pred             eEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCcccc
Q 016594          138 LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKW  217 (386)
Q Consensus       138 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~  217 (386)
                      .++||||+.+ +|..++... ...+++..++.++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||++..
T Consensus        87 ~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~  161 (346)
T 1ua2_A           87 ISLVFDFMET-DLEVIIKDN-SLVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKS  161 (346)
T ss_dssp             CEEEEECCSE-EHHHHHTTC-CSSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGGST
T ss_pred             eEEEEEcCCC-CHHHHHHhc-CcCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCCHHHEEEcCCCCEEEEeccccee
Confidence            8999999987 788877653 3458889999999999999999999   9999999999999999999999999999987


Q ss_pred             CCCCCccccccccccccCccChhhhccC-CCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhh-hhhhhcccccc----
Q 016594          218 LPSQWTHHSIAPIEGTFGHLAPEYFMHG-IVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSW-AKPILNQGEIE----  291 (386)
Q Consensus       218 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~-~~~~~~~~~~~----  291 (386)
                      +....  .......||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+........ ...........    
T Consensus       162 ~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~  239 (346)
T 1ua2_A          162 FGSPN--RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPD  239 (346)
T ss_dssp             TTSCC--CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSS
T ss_pred             ccCCc--ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhh
Confidence            64332  223445689999999999764 58999999999999999999999998765321110 00000000000    


Q ss_pred             -----cccCCccCCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCC
Q 016594          292 -----KLVDPRLQGAYD-----VTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEGD  339 (386)
Q Consensus       292 -----~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~~  339 (386)
                           ...........+     ...+..+.++|.+||+.||++|||+.+++++.+...
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~  297 (346)
T 1ua2_A          240 MCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN  297 (346)
T ss_dssp             TTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTS
T ss_pred             hccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhc
Confidence                 000000000011     123467999999999999999999999999876653

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=2.1e-44  Score=353.01  Aligned_cols=254  Identities=25%  Similarity=0.350  Sum_probs=203.6

Q ss_pred             HhcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCCh-----------HhHHHHHHHHHHHhccCCCceeeecc
Q 016594           64 ATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDD-----------RKEKEFLTEIGTIGHVCHPNVLSLLG  131 (386)
Q Consensus        64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-----------~~~~~~~~e~~~l~~l~h~niv~l~~  131 (386)
                      ..++|.+.+.||+|+||+||+|..+ +++.||+|++.......           .....+.+|+.+++.++||||+++++
T Consensus        34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~  113 (504)
T 3q5i_A           34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD  113 (504)
T ss_dssp             GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            4678999999999999999999986 68899999997643221           23567889999999999999999999


Q ss_pred             eEEeCc-eEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCC---Ce
Q 016594          132 CCVDNG-LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADF---EP  207 (386)
Q Consensus       132 ~~~~~~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~---~~  207 (386)
                      ++.+.. .++||||+.+|+|.+.+....  .+++..++.++.||+.||.|||+   ++|+||||||+|||++.++   .+
T Consensus       114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~  188 (504)
T 3q5i_A          114 VFEDKKYFYLVTEFYEGGELFEQIINRH--KFDECDAANIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNI  188 (504)
T ss_dssp             EEECSSEEEEEEECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESSTTCCSSE
T ss_pred             EEEcCCEEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCcHHHEEEecCCCCccE
Confidence            998866 899999999999999887653  49999999999999999999999   9999999999999998776   69


Q ss_pred             EEeecCccccCCCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcc
Q 016594          208 QISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQ  287 (386)
Q Consensus       208 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~  287 (386)
                      ||+|||++..+....   ......||+.|+|||++. ..++.++|||||||++|+|++|..||.+......  ...+.. 
T Consensus       189 kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~--~~~i~~-  261 (504)
T 3q5i_A          189 KIVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDI--IKKVEK-  261 (504)
T ss_dssp             EECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHH-
T ss_pred             EEEECCCCEEcCCCC---ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHc-
Confidence            999999998775432   234556999999999986 4689999999999999999999999987643211  111100 


Q ss_pred             cccccccCCccCCCC--CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 016594          288 GEIEKLVDPRLQGAY--DVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLE  337 (386)
Q Consensus       288 ~~~~~~~~~~~~~~~--~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~  337 (386)
                      +        ......  ....+..+.+++.+||+.||.+|||+.+++++.+.
T Consensus       262 ~--------~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~  305 (504)
T 3q5i_A          262 G--------KYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWI  305 (504)
T ss_dssp             C--------CCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred             C--------CCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhh
Confidence            0        000000  01234679999999999999999999999998654

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=1.3e-44  Score=340.21  Aligned_cols=268  Identities=19%  Similarity=0.251  Sum_probs=206.4

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeC------c
Q 016594           65 TNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDN------G  137 (386)
Q Consensus        65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~  137 (386)
                      .++|++.+.||+|+||.||+|.+. +++.||||++... ........+.+|+.++++++||||+++++++...      .
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  104 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPF-EHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD  104 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCT-TCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccc-cCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence            468999999999999999999976 6889999998752 3344557789999999999999999999998653      3


Q ss_pred             eEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCcccc
Q 016594          138 LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKW  217 (386)
Q Consensus       138 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~  217 (386)
                      .+++++++.+ +|.+++...   .+++..++.++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||++..
T Consensus       105 ~~iv~e~~~~-~L~~~l~~~---~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~  177 (364)
T 3qyz_A          105 VYIVQDLMET-DLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARV  177 (364)
T ss_dssp             EEEEEECCSE-EHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEEcccCc-CHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChHhEEECCCCCEEEEeCcceEe
Confidence            7899999885 888888653   48999999999999999999999   9999999999999999999999999999987


Q ss_pred             CCCCCccc-cccccccccCccChhhhcc-CCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhh-hhhhhhccccc---c
Q 016594          218 LPSQWTHH-SIAPIEGTFGHLAPEYFMH-GIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHS-WAKPILNQGEI---E  291 (386)
Q Consensus       218 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~-~~~~~~~~~~~---~  291 (386)
                      ........ ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+....... ...........   .
T Consensus       178 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  257 (364)
T 3qyz_A          178 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN  257 (364)
T ss_dssp             CCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHH
T ss_pred             cCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence            65432211 2344579999999998764 55899999999999999999999999876432111 00000000000   0


Q ss_pred             cc---------cCCccCCCC-----CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCCc
Q 016594          292 KL---------VDPRLQGAY-----DVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEGDQ  340 (386)
Q Consensus       292 ~~---------~~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~~~  340 (386)
                      ..         .........     ....+..+.+++.+||+.||++|||+.+++++-+....
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~  320 (364)
T 3qyz_A          258 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY  320 (364)
T ss_dssp             TCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTT
T ss_pred             HhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhc
Confidence            00         000000000     01224678999999999999999999999998776544

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=6.5e-45  Score=344.67  Aligned_cols=263  Identities=17%  Similarity=0.200  Sum_probs=198.8

Q ss_pred             HHHhcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeC----
Q 016594           62 SIATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDN----  136 (386)
Q Consensus        62 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~----  136 (386)
                      +...++|++.+.||+|+||+||+|.+. +|+.||||++......      ..+|+.+++.++||||+++++++...    
T Consensus         3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~------~~~E~~il~~l~hpnIv~l~~~~~~~~~~~   76 (383)
T 3eb0_A            3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY------KNRELDIMKVLDHVNIIKLVDYFYTTGDEE   76 (383)
T ss_dssp             ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS------CCHHHHHHTTCCCTTBCCEEEEEEEC----
T ss_pred             ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch------HHHHHHHHHHcCCCCccchhheeeecCccc
Confidence            456788999999999999999999975 7899999998753221      23799999999999999999998432    


Q ss_pred             ----------------------------------c-eEEEEEeccCCCHhhhhhh--cCCCCCCHHHHHHHHHHHHHHHH
Q 016594          137 ----------------------------------G-LYLIFQFSSRGSVASLFHD--VNSPGVEWKVRHKIAVGTARGLH  179 (386)
Q Consensus       137 ----------------------------------~-~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~i~~qi~~~l~  179 (386)
                                                        . .++||||+.+ +|.+.+..  .....+++..+..++.|++.||.
T Consensus        77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~  155 (383)
T 3eb0_A           77 PKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVG  155 (383)
T ss_dssp             ---------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHH
Confidence                                              1 7799999985 77776653  23456999999999999999999


Q ss_pred             HHHhCCCCCeEEeCCCCCCeeEc-CCCCeEEeecCccccCCCCCccccccccccccCccChhhhccC-CCCcccchHHHH
Q 016594          180 YLHKGCQRRIIHRDIKSSNILLT-ADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHG-IVDEKTDVFAFG  257 (386)
Q Consensus       180 ~LH~~~~~~ivH~dlkp~Nill~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG  257 (386)
                      |||+   ++|+||||||+|||++ .++.+||+|||++..+....   ......||+.|+|||++.+. .++.++||||||
T Consensus       156 ~LH~---~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG  229 (383)
T 3eb0_A          156 FIHS---LGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE---PSVAYICSRFYRAPELMLGATEYTPSIDLWSIG  229 (383)
T ss_dssp             HHHT---TTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS---CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHH
T ss_pred             HHHH---CcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC---CCcCcccCCCccCHHHhcCCCCCCcchhhhhHH
Confidence            9999   9999999999999998 68899999999998765432   22345689999999998875 489999999999


Q ss_pred             HHHHHHHhCCCCCCCCchhhhhh-hhhhhccc---------------ccccccCCccCCCCCHHHHHHHHHHHHHccccC
Q 016594          258 VFLLEIISGRKPVDGSHQSLHSW-AKPILNQG---------------EIEKLVDPRLQGAYDVTQLNRLAFAASLCIRAS  321 (386)
Q Consensus       258 ~il~ell~g~~pf~~~~~~~~~~-~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d  321 (386)
                      |++|+|++|+.||.+........ ........               ..............+...+..+.+|+.+||+.|
T Consensus       230 ~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d  309 (383)
T 3eb0_A          230 CVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYE  309 (383)
T ss_dssp             HHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSS
T ss_pred             HHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCC
Confidence            99999999999998764322111 00000000               000000000001112234567999999999999


Q ss_pred             CCCCCCHHHHHHHHhc
Q 016594          322 PTWRPTMSEVLEVMLE  337 (386)
Q Consensus       322 P~~Rpt~~~il~~l~~  337 (386)
                      |.+|||+.++++|-+.
T Consensus       310 P~~R~t~~e~l~hp~f  325 (383)
T 3eb0_A          310 PDLRINPYEAMAHPFF  325 (383)
T ss_dssp             GGGSCCHHHHHTSGGG
T ss_pred             hhhCCCHHHHhcCHHH
Confidence            9999999999987554

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=1.9e-45  Score=333.74  Aligned_cols=248  Identities=21%  Similarity=0.366  Sum_probs=206.3

Q ss_pred             HHhcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEe------
Q 016594           63 IATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVD------  135 (386)
Q Consensus        63 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------  135 (386)
                      ...++|++.+.||+|+||.||+|.+. +++.||+|.+....      ..+.+|+.+++.++||||+++++++..      
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (284)
T 2a19_B            8 RFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPE   81 (284)
T ss_dssp             HHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC--
T ss_pred             hhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcc
Confidence            45678999999999999999999987 79999999987532      245689999999999999999998853      


Q ss_pred             -----------CceEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCC
Q 016594          136 -----------NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTAD  204 (386)
Q Consensus       136 -----------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~  204 (386)
                                 ...+++|||+.+++|.+++.......+++..++.++.|++.||.|||+   ++|+||||||+||+++.+
T Consensus        82 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~  158 (284)
T 2a19_B           82 TSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDT  158 (284)
T ss_dssp             -------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEET
T ss_pred             cccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHEEEcCC
Confidence                       227899999999999999987655669999999999999999999999   999999999999999999


Q ss_pred             CCeEEeecCccccCCCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhh
Q 016594          205 FEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPI  284 (386)
Q Consensus       205 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~  284 (386)
                      +.+||+|||++.......   ......|++.|+|||++.+..++.++|||||||++|+|++|..||.......    .  
T Consensus       159 ~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~----~--  229 (284)
T 2a19_B          159 KQVKIGDFGLVTSLKNDG---KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFF----T--  229 (284)
T ss_dssp             TEEEECCCTTCEESSCCS---CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHHHH----H--
T ss_pred             CCEEECcchhheeccccc---cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHHHHH----H--
Confidence            999999999998765432   2234468999999999999999999999999999999999998874321110    0  


Q ss_pred             hcccccccccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCC
Q 016594          285 LNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEGD  339 (386)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~~  339 (386)
                             .+.....    +...+..+.+++.+||+.||.+|||+.+++++|+...
T Consensus       230 -------~~~~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~  273 (284)
T 2a19_B          230 -------DLRDGII----SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK  273 (284)
T ss_dssp             -------HHHTTCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred             -------Hhhcccc----cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence                   0011111    1123456899999999999999999999999987654

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=8.1e-45  Score=331.57  Aligned_cols=263  Identities=18%  Similarity=0.216  Sum_probs=199.6

Q ss_pred             HHhcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEE-eCc-eE
Q 016594           63 IATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCV-DNG-LY  139 (386)
Q Consensus        63 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~-~~~-~~  139 (386)
                      ...++|++.+.||+|+||+||+|.+. +++.||||++.....    ...+.+|+.+++.+.|++++..+..+. +.. .+
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~   81 (296)
T 4hgt_A            6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV   81 (296)
T ss_dssp             -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEE
T ss_pred             ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc----chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceE
Confidence            34678999999999999999999975 789999998764322    234778999999999888777777664 444 78


Q ss_pred             EEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeE---cCCCCeEEeecCccc
Q 016594          140 LIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILL---TADFEPQISDFGLAK  216 (386)
Q Consensus       140 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~a~  216 (386)
                      ++||++ +++|.+++.... ..+++..++.++.|++.||.|||+   ++|+||||||+|||+   +.++.+||+|||++.
T Consensus        82 lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~  156 (296)
T 4hgt_A           82 MVMELL-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK  156 (296)
T ss_dssp             EEEECC-CCBHHHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECCGGGTTCEEECCCTTCE
T ss_pred             EEEEcc-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeeeeccCCCCeEEEecCccce
Confidence            999999 899999987533 349999999999999999999999   999999999999999   788999999999998


Q ss_pred             cCCCCCcc-----ccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccc
Q 016594          217 WLPSQWTH-----HSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIE  291 (386)
Q Consensus       217 ~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  291 (386)
                      ........     .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.................. 
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-  235 (296)
T 4hgt_A          157 KYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM-  235 (296)
T ss_dssp             ECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHH-
T ss_pred             eccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccc-
Confidence            76543221     122355799999999999999999999999999999999999999986432110000000000000 


Q ss_pred             cccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCC
Q 016594          292 KLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEGD  339 (386)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~~  339 (386)
                        ..+.  .......+..+.+++..||+.||++|||+.++++.|....
T Consensus       236 --~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~  279 (296)
T 4hgt_A          236 --STPI--EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF  279 (296)
T ss_dssp             --HSCH--HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHH
T ss_pred             --cchh--hhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHH
Confidence              0000  0000112467999999999999999999999999987654

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=1.5e-45  Score=335.71  Aligned_cols=262  Identities=24%  Similarity=0.354  Sum_probs=202.3

Q ss_pred             HhcCCCCCCeecccCCcEEEEEEEC--CCc--EEEEEEecccc-CChHhHHHHHHHHHHHhccCCCceeeecceEEeCce
Q 016594           64 ATNAFSSENLVGRGGYAEVYKGVLQ--DGE--EIAVKRLTKVV-TDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNGL  138 (386)
Q Consensus        64 ~~~~~~~~~~lg~G~~g~V~~~~~~--~~~--~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  138 (386)
                      ..++|++.+.||+|+||+||+|.+.  +++  .||||++.... ........+.+|+.+++.++||||+++++++.+...
T Consensus        16 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   95 (291)
T 1u46_A           16 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPM   95 (291)
T ss_dssp             CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSC
T ss_pred             chhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCCc
Confidence            4568999999999999999999863  233  68999887543 234556788999999999999999999999988889


Q ss_pred             EEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccC
Q 016594          139 YLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWL  218 (386)
Q Consensus       139 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~  218 (386)
                      ++++|++.+++|.+++.... ..+++..++.++.|++.||.|||+   ++++||||||+||+++.++.+||+|||++...
T Consensus        96 ~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~  171 (291)
T 1u46_A           96 KMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRAL  171 (291)
T ss_dssp             EEEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred             eeeEecccCCCHHHHHHhcc-CCcCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEEcCCCCEEEccccccccc
Confidence            99999999999999887643 348999999999999999999999   99999999999999999999999999999877


Q ss_pred             CCCCccc-cccccccccCccChhhhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCchhhhhhhhhhhcccccccccCC
Q 016594          219 PSQWTHH-SIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGEIEKLVDP  296 (386)
Q Consensus       219 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (386)
                      ....... ......++..|+|||++.+..++.++||||||+++|+|++ |..||.+......  .....         ..
T Consensus       172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~--~~~~~---------~~  240 (291)
T 1u46_A          172 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI--LHKID---------KE  240 (291)
T ss_dssp             CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH--HHHHH---------TS
T ss_pred             cccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHH--HHHHH---------cc
Confidence            5443221 2233457888999999999999999999999999999999 9999987543211  11111         11


Q ss_pred             ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCCc
Q 016594          297 RLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEGDQ  340 (386)
Q Consensus       297 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~~~  340 (386)
                      ......+...+..+.+++.+||+.||.+|||+.++++.|.+..+
T Consensus       241 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~  284 (291)
T 1u46_A          241 GERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP  284 (291)
T ss_dssp             CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred             CCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence            11111223345779999999999999999999999999987644

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=9e-45  Score=329.64  Aligned_cols=252  Identities=26%  Similarity=0.383  Sum_probs=207.6

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccC-ChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEE
Q 016594           65 TNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVT-DDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLI  141 (386)
Q Consensus        65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv  141 (386)
                      .++|++.+.||+|+||.||+|... +++.||+|++..... .......+.+|+.+++.++||||+++++++.+.+ .+++
T Consensus        13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   92 (284)
T 2vgo_A           13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM   92 (284)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence            467899999999999999999986 578999999865321 1223467889999999999999999999998765 8999


Q ss_pred             EEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCC
Q 016594          142 FQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQ  221 (386)
Q Consensus       142 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  221 (386)
                      |||+.+++|.+++....  .+++..++.++.|++.||.|||+   ++++||||||+||+++.++.+||+|||++......
T Consensus        93 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~  167 (284)
T 2vgo_A           93 LEFAPRGELYKELQKHG--RFDEQRSATFMEELADALHYCHE---RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL  167 (284)
T ss_dssp             ECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS
T ss_pred             EEeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEEcCCCCEEEecccccccCccc
Confidence            99999999999887654  48999999999999999999999   99999999999999999999999999998765432


Q ss_pred             CccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCCC
Q 016594          222 WTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGA  301 (386)
Q Consensus       222 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (386)
                          ......|++.|+|||++.+..++.++||||||+++|+|++|..||.........  ..+.         ...  ..
T Consensus       168 ----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~~~~---------~~~--~~  230 (284)
T 2vgo_A          168 ----RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETH--RRIV---------NVD--LK  230 (284)
T ss_dssp             ----CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH--HHHH---------TTC--CC
T ss_pred             ----ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHH--HHHh---------ccc--cC
Confidence                223456899999999999999999999999999999999999999875432111  1110         000  11


Q ss_pred             CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          302 YDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       302 ~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                      .+...+..+.+++.+||+.||.+||++.+++++-+..
T Consensus       231 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~  267 (284)
T 2vgo_A          231 FPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVK  267 (284)
T ss_dssp             CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHH
T ss_pred             CCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHH
Confidence            2223456789999999999999999999999976543

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=4.8e-44  Score=336.41  Aligned_cols=261  Identities=23%  Similarity=0.365  Sum_probs=208.9

Q ss_pred             HHHHHHHhcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCC------hHhHHHHHHHHHHHhcc-CCCceeee
Q 016594           58 FEEISIATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTD------DRKEKEFLTEIGTIGHV-CHPNVLSL  129 (386)
Q Consensus        58 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~------~~~~~~~~~e~~~l~~l-~h~niv~l  129 (386)
                      +.......++|.+.+.||+|+||.||+|.+. +|+.||||++......      ......+.+|+.+++++ +||||+++
T Consensus        86 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~  165 (365)
T 2y7j_A           86 WAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITL  165 (365)
T ss_dssp             HHHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCE
T ss_pred             chhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence            3444556678999999999999999999986 7999999998754321      12245678999999999 79999999


Q ss_pred             cceEEeCc-eEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeE
Q 016594          130 LGCCVDNG-LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQ  208 (386)
Q Consensus       130 ~~~~~~~~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~k  208 (386)
                      ++++.... .++||||+.+++|.+++....  .+++..+..++.|++.||.|||+   .|++||||||+|||++.++.+|
T Consensus       166 ~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~---~gi~H~Dlkp~NIl~~~~~~ik  240 (365)
T 2y7j_A          166 IDSYESSSFMFLVFDLMRKGELFDYLTEKV--ALSEKETRSIMRSLLEAVSFLHA---NNIVHRDLKPENILLDDNMQIR  240 (365)
T ss_dssp             EEEEEBSSEEEEEECCCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEE
T ss_pred             EEEEeeCCEEEEEEEeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEE
Confidence            99998765 899999999999999987643  48999999999999999999999   9999999999999999999999


Q ss_pred             EeecCccccCCCCCccccccccccccCccChhhhcc------CCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhh
Q 016594          209 ISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMH------GIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAK  282 (386)
Q Consensus       209 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~  282 (386)
                      |+|||++..+....   ......||+.|+|||++.+      ..++.++|||||||++|+|++|..||.........  .
T Consensus       241 l~DfG~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~--~  315 (365)
T 2y7j_A          241 LSDFGFSCHLEPGE---KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILML--R  315 (365)
T ss_dssp             ECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH--H
T ss_pred             EEecCcccccCCCc---ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHH--H
Confidence            99999998775432   2344679999999999864      35889999999999999999999999775432111  0


Q ss_pred             hhhcccccccccCCccCCCCC--HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 016594          283 PILNQGEIEKLVDPRLQGAYD--VTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLE  337 (386)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~  337 (386)
                      .+. ..        ......+  ...+..+.+++.+||+.||++|||+.+++++-+.
T Consensus       316 ~i~-~~--------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f  363 (365)
T 2y7j_A          316 MIM-EG--------QYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFF  363 (365)
T ss_dssp             HHH-HT--------CCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGG
T ss_pred             HHH-hC--------CCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccc
Confidence            000 00        0000000  0124569999999999999999999999997653

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=2.1e-44  Score=334.19  Aligned_cols=258  Identities=19%  Similarity=0.286  Sum_probs=203.3

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccC-CCceeeecceEEeC---ceE
Q 016594           65 TNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVC-HPNVLSLLGCCVDN---GLY  139 (386)
Q Consensus        65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~---~~~  139 (386)
                      .++|++.+.||+|+||+||+|.+. +++.||||++...     ....+.+|+.+++.+. ||||+++++++.+.   ..+
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~  109 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-----KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA  109 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEE
T ss_pred             CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc-----chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceE
Confidence            467999999999999999999975 7899999998742     2456889999999997 99999999999863   389


Q ss_pred             EEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCC-CeEEeecCccccC
Q 016594          140 LIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADF-EPQISDFGLAKWL  218 (386)
Q Consensus       140 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~-~~kl~Dfg~a~~~  218 (386)
                      ++|||+.+++|.+++..     +++..+..++.|++.||.|||+   ++|+||||||+|||++.++ .+||+|||++...
T Consensus       110 lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~  181 (330)
T 3nsz_A          110 LVFEHVNNTDFKQLYQT-----LTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY  181 (330)
T ss_dssp             EEEECCCCCCHHHHGGG-----CCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred             EEEeccCchhHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEc
Confidence            99999999999998853     8899999999999999999999   9999999999999999776 8999999999876


Q ss_pred             CCCCccccccccccccCccChhhhcc-CCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhh--hhccccc-----
Q 016594          219 PSQWTHHSIAPIEGTFGHLAPEYFMH-GIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKP--ILNQGEI-----  290 (386)
Q Consensus       219 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~--~~~~~~~-----  290 (386)
                      ....   ......|+..|+|||++.+ ..++.++|||||||++|+|++|..||.............  .......     
T Consensus       182 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~  258 (330)
T 3nsz_A          182 HPGQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYID  258 (330)
T ss_dssp             CTTC---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHH
T ss_pred             CCCC---ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHH
Confidence            5432   2334568999999999987 678999999999999999999999996543221111100  0000000     


Q ss_pred             ----------cc--------ccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          291 ----------EK--------LVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       291 ----------~~--------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                                ..        ..............+..+.++|.+||+.||++|||+.++++|-+..
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~  324 (330)
T 3nsz_A          259 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFY  324 (330)
T ss_dssp             HTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGT
T ss_pred             HhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHh
Confidence                      00        0000111111222467899999999999999999999999987654

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=2.3e-44  Score=338.81  Aligned_cols=252  Identities=13%  Similarity=0.119  Sum_probs=201.1

Q ss_pred             HHHHhcCCCCCCeecccCCcEEEEEE------ECCCcEEEEEEeccccCChHhHHHHHHHHHHHhccC---CCceeeecc
Q 016594           61 ISIATNAFSSENLVGRGGYAEVYKGV------LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVC---HPNVLSLLG  131 (386)
Q Consensus        61 ~~~~~~~~~~~~~lg~G~~g~V~~~~------~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~  131 (386)
                      +.+..++|.+.+.||+|+||+||+|.      ..+++.||||++...     ....+.+|+.+++.+.   |+||+++++
T Consensus        60 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~~~~l~~~~~~~iv~~~~  134 (365)
T 3e7e_A           60 FQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA-----NPWEFYIGTQLMERLKPSMQHMFMKFYS  134 (365)
T ss_dssp             EECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC-----CHHHHHHHHHHHHHSCGGGGGGBCCEEE
T ss_pred             EEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC-----ChhHHHHHHHHHHHhhhhhhhhhhhhhe
Confidence            34566789999999999999999994      336889999998743     2345667777777776   999999999


Q ss_pred             eEEeCc-eEEEEEeccCCCHhhhhhhc---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcC----
Q 016594          132 CCVDNG-LYLIFQFSSRGSVASLFHDV---NSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTA----  203 (386)
Q Consensus       132 ~~~~~~-~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~----  203 (386)
                      ++...+ .++||||+.+|+|.+++...   ....+++..++.++.|++.||+|||+   ++|+||||||+|||++.    
T Consensus       135 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~---~~ivHrDiKp~NIll~~~~~~  211 (365)
T 3e7e_A          135 AHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD---CEIIHGDIKPDNFILGNGFLE  211 (365)
T ss_dssp             EEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECGGGTC
T ss_pred             eeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEecccccC
Confidence            997755 89999999999999998753   34559999999999999999999999   99999999999999998    


Q ss_pred             -------CCCeEEeecCccccCCCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchh
Q 016594          204 -------DFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQS  276 (386)
Q Consensus       204 -------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~  276 (386)
                             ++.+||+|||+|..+............+||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus       212 ~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~  291 (365)
T 3e7e_A          212 QDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGG  291 (365)
T ss_dssp             C------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETT
T ss_pred             ccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCC
Confidence                   8999999999997654333333455677999999999999999999999999999999999999999643221


Q ss_pred             hhhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHhc
Q 016594          277 LHSWAKPILNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRP-TMSEVLEVMLE  337 (386)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-t~~~il~~l~~  337 (386)
                                   ... ........   ...+.+.+++..||+.+|.+|+ ++.++.+.|+.
T Consensus       292 -------------~~~-~~~~~~~~---~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~  336 (365)
T 3e7e_A          292 -------------ECK-PEGLFRRL---PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKK  336 (365)
T ss_dssp             -------------EEE-ECSCCTTC---SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHH
T ss_pred             -------------cee-echhcccc---CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHH
Confidence                         000 11111111   1246688899999999999995 66666666654

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=1e-44  Score=365.46  Aligned_cols=256  Identities=22%  Similarity=0.296  Sum_probs=209.7

Q ss_pred             HHhcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEecccc-CChHhHHHHHHHHHHHhcc-CCCceeeecceEEeCc-e
Q 016594           63 IATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVV-TDDRKEKEFLTEIGTIGHV-CHPNVLSLLGCCVDNG-L  138 (386)
Q Consensus        63 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~-~  138 (386)
                      +..++|++.+.||+|+||+||+|.++ +++.||||++.+.. ........+..|..++..+ +||||+++++++.+.. .
T Consensus       338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~  417 (674)
T 3pfq_A          338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL  417 (674)
T ss_dssp             --CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEE
T ss_pred             ccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEE
Confidence            45578999999999999999999987 68899999997532 1223345678899999988 5999999999998755 8


Q ss_pred             EEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccC
Q 016594          139 YLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWL  218 (386)
Q Consensus       139 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~  218 (386)
                      |+||||+.+|+|..++....  .+++..++.++.||+.||+|||+   ++|+||||||+|||++.++++||+|||+++..
T Consensus       418 ~lV~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~---~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~  492 (674)
T 3pfq_A          418 YFVMEYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN  492 (674)
T ss_dssp             EEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH---TSEECCCCCSTTEEECSSSCEEECCCTTCEEC
T ss_pred             EEEEeCcCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh---CCeEeccCChhhEEEcCCCcEEEeecceeecc
Confidence            99999999999999998654  49999999999999999999999   99999999999999999999999999999864


Q ss_pred             CCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCcc
Q 016594          219 PSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRL  298 (386)
Q Consensus       219 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (386)
                      ....  ......+||+.|+|||++.+..|+.++|||||||++|||++|..||.+.+....  ..         .+.... 
T Consensus       493 ~~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~--~~---------~i~~~~-  558 (674)
T 3pfq_A          493 IWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL--FQ---------SIMEHN-  558 (674)
T ss_dssp             CCTT--CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HH---------HHHSSC-
T ss_pred             ccCC--cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHH--HH---------HHHhCC-
Confidence            3321  234567899999999999999999999999999999999999999987543211  11         111111 


Q ss_pred             CCCCCHHHHHHHHHHHHHccccCCCCCCCH-----HHHHHHHhcC
Q 016594          299 QGAYDVTQLNRLAFAASLCIRASPTWRPTM-----SEVLEVMLEG  338 (386)
Q Consensus       299 ~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~-----~~il~~l~~~  338 (386)
                       ..++...+..+.+||.+||+.||++||++     .+|++|-+..
T Consensus       559 -~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~  602 (674)
T 3pfq_A          559 -VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFR  602 (674)
T ss_dssp             -CCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGS
T ss_pred             -CCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCcccc
Confidence             12233456789999999999999999997     8888876543

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=1.1e-44  Score=335.45  Aligned_cols=268  Identities=22%  Similarity=0.344  Sum_probs=206.2

Q ss_pred             HhcCCCCCCeecccCCcEEEEEEEC--CCcEEEEEEeccccCChHhHHHHHHHHHHHhcc---CCCceeeecceEEe---
Q 016594           64 ATNAFSSENLVGRGGYAEVYKGVLQ--DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHV---CHPNVLSLLGCCVD---  135 (386)
Q Consensus        64 ~~~~~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~---  135 (386)
                      ..++|++.+.||+|+||.||+|.+.  +++.||+|++............+.+|+.+++.+   .||||+++++++..   
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~   88 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   88 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence            4578999999999999999999983  588999999875433332233456777777666   89999999999862   


Q ss_pred             ---CceEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeec
Q 016594          136 ---NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDF  212 (386)
Q Consensus       136 ---~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Df  212 (386)
                         ...++|||++. ++|.+++.......+++..++.++.|++.||.|||+   ++|+||||||+||+++.++.+||+||
T Consensus        89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~gi~H~dlkp~Nili~~~~~~kl~Df  164 (326)
T 1blx_A           89 DRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADF  164 (326)
T ss_dssp             SSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECSC
T ss_pred             CCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHHHeEEcCCCCEEEecC
Confidence               23789999998 599999987766679999999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhh-hhhhhhcc---c
Q 016594          213 GLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHS-WAKPILNQ---G  288 (386)
Q Consensus       213 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~-~~~~~~~~---~  288 (386)
                      |++......   .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+....... ........   .
T Consensus       165 g~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~  241 (326)
T 1blx_A          165 GLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE  241 (326)
T ss_dssp             CSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGG
T ss_pred             cccccccCC---CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcc
Confidence            999866432   2234556899999999999999999999999999999999999999876532111 00000000   0


Q ss_pred             ccc-------cccC---CccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          289 EIE-------KLVD---PRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       289 ~~~-------~~~~---~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                      ...       ....   ...........+..+.+++.+||+.||.+|||+.+++++-+..
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~  301 (326)
T 1blx_A          242 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ  301 (326)
T ss_dssp             GSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGT
T ss_pred             cCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCcccc
Confidence            000       0000   0000111123457789999999999999999999999875543

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=9.7e-45  Score=330.10  Aligned_cols=251  Identities=20%  Similarity=0.344  Sum_probs=201.2

Q ss_pred             HhcCCCCCCeecccCCcEEEEEEEC-CC-------cEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEe
Q 016594           64 ATNAFSSENLVGRGGYAEVYKGVLQ-DG-------EEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVD  135 (386)
Q Consensus        64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~-------~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~  135 (386)
                      ..++|.+.+.||+|+||+||+|.+. ++       ..||+|++...  .......+.+|+.++++++||||+++++++.+
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   83 (289)
T 4fvq_A            6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA--HRNYSESFFEAASMMSKLSHKHLVLNYGVCVC   83 (289)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGG--GGGGHHHHHHHHHHHHTSCCTTBCCEEEEECC
T ss_pred             chhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccc--cHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEe
Confidence            4568899999999999999999965 33       46999998653  23455678999999999999999999999977


Q ss_pred             Cc-eEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCC--------
Q 016594          136 NG-LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFE--------  206 (386)
Q Consensus       136 ~~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~--------  206 (386)
                      ++ .++||||+.+++|.+++.... ..+++..++.++.|++.||.|||+   ++|+||||||+|||++.++.        
T Consensus        84 ~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~~~  159 (289)
T 4fvq_A           84 GDENILVQEFVKFGSLDTYLKKNK-NCINILWKLEVAKQLAAAMHFLEE---NTLIHGNVCAKNILLIREEDRKTGNPPF  159 (289)
T ss_dssp             TTCCEEEEECCTTCBHHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEEECCBGGGTBCCE
T ss_pred             CCCCEEEEECCCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHhh---CCeECCCcCcceEEEecCCcccccccce
Confidence            55 899999999999999987643 348999999999999999999999   99999999999999998887        


Q ss_pred             eEEeecCccccCCCCCccccccccccccCccChhhhcc-CCCCcccchHHHHHHHHHHHhC-CCCCCCCchhhhhhhhhh
Q 016594          207 PQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMH-GIVDEKTDVFAFGVFLLEIISG-RKPVDGSHQSLHSWAKPI  284 (386)
Q Consensus       207 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g-~~pf~~~~~~~~~~~~~~  284 (386)
                      +||+|||++......      ....||+.|+|||++.+ ..++.++|||||||++|+|++| .+||............  
T Consensus       160 ~kl~Dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~--  231 (289)
T 4fvq_A          160 IKLSDPGISITVLPK------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFY--  231 (289)
T ss_dssp             EEECCCCSCTTTSCH------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH--
T ss_pred             eeeccCcccccccCc------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHh--
Confidence            999999998755322      23348889999999987 7799999999999999999995 5555543322111100  


Q ss_pred             hcccccccccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCCc
Q 016594          285 LNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEGDQ  340 (386)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~~~  340 (386)
                      ...        ..    .+...+..+.+++.+||+.||.+|||+.+++++|.....
T Consensus       232 ~~~--------~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~  275 (289)
T 4fvq_A          232 EDR--------HQ----LPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT  275 (289)
T ss_dssp             HTT--------CC----CCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred             hcc--------CC----CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence            000        00    011113458899999999999999999999999987654

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=1.3e-44  Score=334.60  Aligned_cols=261  Identities=21%  Similarity=0.275  Sum_probs=202.8

Q ss_pred             HHhcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccC------ChHhHHHHHHHHHHHhccCCCceeeecceEEe
Q 016594           63 IATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVT------DDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVD  135 (386)
Q Consensus        63 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~------~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~  135 (386)
                      ...++|.+.+.||+|+||.||+|.+. +++.||||++.....      .......+.+|+.+++.++||||+++++++..
T Consensus         7 ~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   86 (322)
T 2ycf_A            7 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA   86 (322)
T ss_dssp             HHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES
T ss_pred             hhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC
Confidence            34578999999999999999999986 688999999875321      11223457899999999999999999999988


Q ss_pred             CceEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCC---eEEeec
Q 016594          136 NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFE---PQISDF  212 (386)
Q Consensus       136 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~---~kl~Df  212 (386)
                      +..++||||+.+++|.+++...  ..+++..++.++.|++.||.|||+   ++|+||||||+|||++.++.   +||+||
T Consensus        87 ~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl~Df  161 (322)
T 2ycf_A           87 EDYYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDF  161 (322)
T ss_dssp             SSEEEEEECCTTEETHHHHSTT--CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSSSCCEEECCC
T ss_pred             CceEEEEecCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEecCCCCCeEEEccC
Confidence            8899999999999999988643  458999999999999999999999   99999999999999987654   999999


Q ss_pred             CccccCCCCCccccccccccccCccChhhhc---cCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccc
Q 016594          213 GLAKWLPSQWTHHSIAPIEGTFGHLAPEYFM---HGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGE  289 (386)
Q Consensus       213 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~  289 (386)
                      |++.......   ......||+.|+|||++.   +..++.++|||||||++|+|++|..||.......... . ......
T Consensus       162 g~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-~-~~~~~~  236 (322)
T 2ycf_A          162 GHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLK-D-QITSGK  236 (322)
T ss_dssp             TTCEECCCCH---HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHH-H-HHHHTC
T ss_pred             ccceeccccc---ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHH-H-HHHhCc
Confidence            9998765331   223456899999999974   4678999999999999999999999997643211000 0 000000


Q ss_pred             cccccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCC
Q 016594          290 IEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEGD  339 (386)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~~  339 (386)
                      ..  ..+.    .....+..+.+++.+||+.||++||++.+++++-+...
T Consensus       237 ~~--~~~~----~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~  280 (322)
T 2ycf_A          237 YN--FIPE----VWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD  280 (322)
T ss_dssp             CC--CCHH----HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCC
T ss_pred             cc--cCch----hhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCC
Confidence            00  0000    00123467999999999999999999999998866543

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=6.8e-45  Score=345.81  Aligned_cols=262  Identities=19%  Similarity=0.254  Sum_probs=204.5

Q ss_pred             HHhcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccC--------CCceeeecceE
Q 016594           63 IATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVC--------HPNVLSLLGCC  133 (386)
Q Consensus        63 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~--------h~niv~l~~~~  133 (386)
                      +..++|++.+.||+|+||+||+|+.. +++.||||++...   ......+.+|+.+++.+.        |+||+++++++
T Consensus        34 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~  110 (397)
T 1wak_A           34 LFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA---EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDF  110 (397)
T ss_dssp             EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEE
T ss_pred             hcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC---CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecce
Confidence            44678999999999999999999976 6889999999742   345567889999999885        78899999998


Q ss_pred             Ee-----CceEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC-CeEEeCCCCCCeeEcCCC--
Q 016594          134 VD-----NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQR-RIIHRDIKSSNILLTADF--  205 (386)
Q Consensus       134 ~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~-~ivH~dlkp~Nill~~~~--  205 (386)
                      ..     ...++|||++ +++|.+.+.......+++..++.++.||+.||.|||+   + +|+||||||+|||++.++  
T Consensus       111 ~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~---~~givHrDikp~NIll~~~~~~  186 (397)
T 1wak_A          111 KISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHT---KCRIIHTDIKPENILLSVNEQY  186 (397)
T ss_dssp             EEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH---TTCEECCCCSGGGEEECCCHHH
T ss_pred             eecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHeeEeccchh
Confidence            63     2388999999 5577776666555669999999999999999999999   8 999999999999999775  


Q ss_pred             -----------------------------------------------CeEEeecCccccCCCCCccccccccccccCccC
Q 016594          206 -----------------------------------------------EPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLA  238 (386)
Q Consensus       206 -----------------------------------------------~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a  238 (386)
                                                                     .+||+|||++......     .....||+.|+|
T Consensus       187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~a  261 (397)
T 1wak_A          187 IRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRS  261 (397)
T ss_dssp             HHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCC
T ss_pred             hhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccC
Confidence                                                           7999999999876432     234568999999


Q ss_pred             hhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhh-----hhh--hhhhhcc-------------------ccccc
Q 016594          239 PEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSL-----HSW--AKPILNQ-------------------GEIEK  292 (386)
Q Consensus       239 PE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~-----~~~--~~~~~~~-------------------~~~~~  292 (386)
                      ||++.+..++.++|||||||++|+|++|..||.+.....     ...  .......                   .....
T Consensus       262 PE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~  341 (397)
T 1wak_A          262 LEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKH  341 (397)
T ss_dssp             HHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSS
T ss_pred             ChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccc
Confidence            999999999999999999999999999999997643210     000  0000000                   00000


Q ss_pred             ccCCc---------cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 016594          293 LVDPR---------LQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVML  336 (386)
Q Consensus       293 ~~~~~---------~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~  336 (386)
                      +....         .....+...+..+.+||.+||+.||++|||+.++++|-+
T Consensus       342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~  394 (397)
T 1wak_A          342 ITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPW  394 (397)
T ss_dssp             CCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGG
T ss_pred             ccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCcc
Confidence            00000         011234566788999999999999999999999998754

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=2e-44  Score=329.10  Aligned_cols=260  Identities=18%  Similarity=0.228  Sum_probs=202.0

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEE-eCc-eEEE
Q 016594           65 TNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCV-DNG-LYLI  141 (386)
Q Consensus        65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~-~~~-~~lv  141 (386)
                      .++|++.+.||+|+||.||+|.+. +++.||||++......    ..+.+|+.+++.+.|++++..+..+. .+. .+++
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv   83 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV   83 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC----CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch----hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEE
Confidence            578999999999999999999974 7899999998753322    35789999999999888777776664 333 7899


Q ss_pred             EEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeE---cCCCCeEEeecCccccC
Q 016594          142 FQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILL---TADFEPQISDFGLAKWL  218 (386)
Q Consensus       142 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~a~~~  218 (386)
                      |||+ +++|.+++.... ..+++..++.++.|++.||.|||+   ++|+||||||+|||+   +.++.+||+|||++...
T Consensus        84 ~e~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~  158 (296)
T 3uzp_A           84 MELL-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY  158 (296)
T ss_dssp             EECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred             EEec-CCCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccc
Confidence            9999 889999987533 459999999999999999999999   999999999999999   48889999999999876


Q ss_pred             CCCCccc-----cccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccc
Q 016594          219 PSQWTHH-----SIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKL  293 (386)
Q Consensus       219 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  293 (386)
                      .......     ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+..................   
T Consensus       159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~---  235 (296)
T 3uzp_A          159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM---  235 (296)
T ss_dssp             BCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHH---
T ss_pred             cccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhccccc---
Confidence            5442211     12455799999999999999999999999999999999999999986432100000000000000   


Q ss_pred             cCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          294 VDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       294 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                      ..+.  .......+..+.+++.+||+.||++|||+.+|++.|...
T Consensus       236 ~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~  278 (296)
T 3uzp_A          236 STPI--EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL  278 (296)
T ss_dssp             HSCH--HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred             CCch--HHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHH
Confidence            0000  000112346799999999999999999999999998764

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.7e-45  Score=343.68  Aligned_cols=258  Identities=22%  Similarity=0.269  Sum_probs=205.0

Q ss_pred             hcCCCCCCeecccCCcEEEEEEE----CCCcEEEEEEeccccC--ChHhHHHHHHHHHHHhcc-CCCceeeecceEEeCc
Q 016594           65 TNAFSSENLVGRGGYAEVYKGVL----QDGEEIAVKRLTKVVT--DDRKEKEFLTEIGTIGHV-CHPNVLSLLGCCVDNG  137 (386)
Q Consensus        65 ~~~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~  137 (386)
                      .++|++.+.||+|+||.||+|+.    .+++.||||++.....  .......+.+|+.+++.+ +||||+++++++.+..
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  132 (355)
T 1vzo_A           53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  132 (355)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence            46899999999999999999997    3689999999875321  122334567899999999 5999999999998765


Q ss_pred             -eEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccc
Q 016594          138 -LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAK  216 (386)
Q Consensus       138 -~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~  216 (386)
                       .++||||+.+++|.+++....  .+++..++.++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||++.
T Consensus       133 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~  207 (355)
T 1vzo_A          133 KLHLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSK  207 (355)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred             eEEEEeecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCcEEEeeCCCCe
Confidence             899999999999999987654  48999999999999999999999   999999999999999999999999999998


Q ss_pred             cCCCCCccccccccccccCccChhhhcc--CCCCcccchHHHHHHHHHHHhCCCCCCCCchh--hhhhhhhhhccccccc
Q 016594          217 WLPSQWTHHSIAPIEGTFGHLAPEYFMH--GIVDEKTDVFAFGVFLLEIISGRKPVDGSHQS--LHSWAKPILNQGEIEK  292 (386)
Q Consensus       217 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~ell~g~~pf~~~~~~--~~~~~~~~~~~~~~~~  292 (386)
                      .+.... ........||+.|+|||++.+  ..++.++|||||||++|+|++|..||......  ..........      
T Consensus       208 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~------  280 (355)
T 1vzo_A          208 EFVADE-TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILK------  280 (355)
T ss_dssp             ECCGGG-GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHH------
T ss_pred             ecccCC-CCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhc------
Confidence            764332 122334679999999999986  34789999999999999999999999754321  1111111100      


Q ss_pred             ccCCccCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHHhcCC
Q 016594          293 LVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRP-----TMSEVLEVMLEGD  339 (386)
Q Consensus       293 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----t~~~il~~l~~~~  339 (386)
                         .  ...++...+..+.++|.+||..||.+||     ++.+++++.+...
T Consensus       281 ---~--~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~  327 (355)
T 1vzo_A          281 ---S--EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK  327 (355)
T ss_dssp             ---C--CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred             ---c--CCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhc
Confidence               0  1112233456789999999999999999     9999999877653

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=7.2e-45  Score=340.52  Aligned_cols=260  Identities=13%  Similarity=0.162  Sum_probs=202.8

Q ss_pred             hcCCCCCCeecccCCcEEEEEEECC---------CcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceee-------
Q 016594           65 TNAFSSENLVGRGGYAEVYKGVLQD---------GEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLS-------  128 (386)
Q Consensus        65 ~~~~~~~~~lg~G~~g~V~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~-------  128 (386)
                      .++|++.+.||+|+||.||+|.+..         ++.||+|++...       ..+.+|+.+++++.||||++       
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~  113 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------GRLFNEQNFFQRAAKPLQVNKWKKLYS  113 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-------STHHHHHHHHHHHCCHHHHHHHHHHTT
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-------chHHHHHHHHHHhcccchhhhhhhhcc
Confidence            5789999999999999999999763         789999998743       35778999999999999988       


Q ss_pred             --------ecceEEe--CceEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCC
Q 016594          129 --------LLGCCVD--NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSN  198 (386)
Q Consensus       129 --------l~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~N  198 (386)
                              +++++..  ...++||||+ +++|.+++.......+++..++.++.|++.||.|||+   ++|+||||||+|
T Consensus       114 ~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~N  189 (352)
T 2jii_A          114 TPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHE---NEYVHGNVTAEN  189 (352)
T ss_dssp             CTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCGGG
T ss_pred             CCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHHH
Confidence                    5666665  3389999999 9999999987644569999999999999999999999   999999999999


Q ss_pred             eeEcCCC--CeEEeecCccccCCCCCcc-----ccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCC
Q 016594          199 ILLTADF--EPQISDFGLAKWLPSQWTH-----HSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVD  271 (386)
Q Consensus       199 ill~~~~--~~kl~Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~  271 (386)
                      ||++.++  .+||+|||++..+......     .......||+.|+|||++.+..++.++|||||||++|+|++|..||.
T Consensus       190 Il~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~  269 (352)
T 2jii_A          190 IFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWT  269 (352)
T ss_dssp             EEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTG
T ss_pred             EEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence            9999998  8999999999876533211     11234579999999999999999999999999999999999999998


Q ss_pred             CCchhhhhhhhhhh-cccccccccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          272 GSHQSLHSWAKPIL-NQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       272 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                      .............. .......+......   ....+..+.+++.+||+.||.+||++.+|++.|...
T Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~  334 (352)
T 2jii_A          270 NCLPNTEDIMKQKQKFVDKPGPFVGPCGH---WIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEAL  334 (352)
T ss_dssp             GGTTCHHHHHHHHHHHHHSCCCEECTTSC---EECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred             cCCcCHHHHHHHHHhccCChhhhhhhccc---cCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHH
Confidence            64321111111000 00011111111100   012247799999999999999999999999998765

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=3.6e-44  Score=330.29  Aligned_cols=256  Identities=24%  Similarity=0.372  Sum_probs=203.0

Q ss_pred             HHhcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEE
Q 016594           63 IATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYL  140 (386)
Q Consensus        63 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~l  140 (386)
                      ...++|++.+.||+|+||.||+|.+. +|+.||+|.+....    ....+.+|+.+++.++||||+++++++.+.+ .++
T Consensus        26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l  101 (314)
T 3com_A           26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES----DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWI  101 (314)
T ss_dssp             ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS----CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH----HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEE
Confidence            45678999999999999999999987 58999999987532    2356889999999999999999999998765 899


Q ss_pred             EEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCC
Q 016594          141 IFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPS  220 (386)
Q Consensus       141 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~  220 (386)
                      +|||+.+++|.+++... ...+++..++.++.|++.||.|||+   ++++|+||||+||+++.++.+||+|||++.....
T Consensus       102 v~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~  177 (314)
T 3com_A          102 VMEYCGAGSVSDIIRLR-NKTLTEDEIATILQSTLKGLEYLHF---MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTD  177 (314)
T ss_dssp             EEECCTTEEHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECBT
T ss_pred             EeecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCcCHHHEEECCCCCEEEeecccchhhhh
Confidence            99999999999988643 3458999999999999999999999   9999999999999999999999999999987644


Q ss_pred             CCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCC
Q 016594          221 QWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQG  300 (386)
Q Consensus       221 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (386)
                      ..  .......|++.|+|||++.+..++.++|||||||++|+|++|..||............   ...       .....
T Consensus       178 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~---~~~-------~~~~~  245 (314)
T 3com_A          178 TM--AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMI---PTN-------PPPTF  245 (314)
T ss_dssp             TB--SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH---HHS-------CCCCC
T ss_pred             hc--cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHH---hcC-------CCccc
Confidence            32  1223456899999999999999999999999999999999999999875432211110   000       00011


Q ss_pred             CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          301 AYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       301 ~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                      ..+...+..+.+++.+||+.||.+|||+.+++++.+..
T Consensus       246 ~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~  283 (314)
T 3com_A          246 RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVR  283 (314)
T ss_dssp             SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHH
T ss_pred             CCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHh
Confidence            11223456799999999999999999999999875543

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=1.8e-44  Score=338.99  Aligned_cols=275  Identities=22%  Similarity=0.264  Sum_probs=204.4

Q ss_pred             HHHHHHHhcCCCCCCeecccCCcEEEEEEECCCcEEEEEEeccccCC---------hHhHHHHHHHHHHHhccCCCceee
Q 016594           58 FEEISIATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTD---------DRKEKEFLTEIGTIGHVCHPNVLS  128 (386)
Q Consensus        58 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~---------~~~~~~~~~e~~~l~~l~h~niv~  128 (386)
                      ..++....++|++.+.||+|+||.||+|...+|+.||||++......         ......+.+|+.++++++||||++
T Consensus        14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~   93 (362)
T 3pg1_A           14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILG   93 (362)
T ss_dssp             HHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             HHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccc
Confidence            45677888999999999999999999999888999999998753222         223477899999999999999999


Q ss_pred             ecceEEeC------ceEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEc
Q 016594          129 LLGCCVDN------GLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLT  202 (386)
Q Consensus       129 l~~~~~~~------~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~  202 (386)
                      +++++...      ..++||||+. |+|.+.+... ...+++..++.++.|++.||.|||+   ++|+||||||+|||++
T Consensus        94 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~  168 (362)
T 3pg1_A           94 LRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQ-RIVISPQHIQYFMYHILLGLHVLHE---AGVVHRDLHPGNILLA  168 (362)
T ss_dssp             CSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEC
T ss_pred             eeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHH---CcCEecCCChHHEEEc
Confidence            99998642      2689999998 4787777643 3458999999999999999999999   9999999999999999


Q ss_pred             CCCCeEEeecCccccCCCCCccccccccccccCccChhhhcc-CCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhh-h
Q 016594          203 ADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMH-GIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHS-W  280 (386)
Q Consensus       203 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~-~  280 (386)
                      .++.+||+|||++.......   ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+....... .
T Consensus       169 ~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~  245 (362)
T 3pg1_A          169 DNNDITICDFNLAREDTADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNK  245 (362)
T ss_dssp             TTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred             CCCCEEEEecCccccccccc---ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            99999999999997543322   2234568999999999987 67899999999999999999999999875432110 0


Q ss_pred             hhhhhcccc---------------cccccCCccCC---CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCCc
Q 016594          281 AKPILNQGE---------------IEKLVDPRLQG---AYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEGDQ  340 (386)
Q Consensus       281 ~~~~~~~~~---------------~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~~~  340 (386)
                      .........               +..........   ......+..+.+++.+||+.||.+|||+.+++++.+....
T Consensus       246 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  323 (362)
T 3pg1_A          246 IVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESL  323 (362)
T ss_dssp             HHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTT
T ss_pred             HHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhc
Confidence            000000000               00000000000   0011224678999999999999999999999998776544

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=3e-45  Score=335.53  Aligned_cols=270  Identities=27%  Similarity=0.374  Sum_probs=189.6

Q ss_pred             HHHHhcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-e
Q 016594           61 ISIATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-L  138 (386)
Q Consensus        61 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~  138 (386)
                      +.+..++|++.+.||+|+||.||+|.+. +++.||||++.... .......+.+|+.++++++||||+++++++...+ .
T Consensus        10 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   88 (303)
T 2vwi_A           10 WSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEK-CQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDEL   88 (303)
T ss_dssp             ---CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC-----------------CCCCCCCTTBCCEEEEEESSSCE
T ss_pred             cccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhh-cchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCc
Confidence            3466789999999999999999999965 68899999886532 1234567889999999999999999999998755 8


Q ss_pred             EEEEEeccCCCHhhhhhhc------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeec
Q 016594          139 YLIFQFSSRGSVASLFHDV------NSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDF  212 (386)
Q Consensus       139 ~lv~e~~~~~~L~~~~~~~------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Df  212 (386)
                      ++||||+.+++|.+++...      ....+++..++.++.|++.||.|||+   ++++||||||+||+++.++.+||+||
T Consensus        89 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~df  165 (303)
T 2vwi_A           89 WLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK---NGQIHRDVKAGNILLGEDGSVQIADF  165 (303)
T ss_dssp             EEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCEEECCC
T ss_pred             EEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCCChhhEEEcCCCCEEEEec
Confidence            9999999999999988642      23458999999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCCCc---cccccccccccCccChhhhcc-CCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhccc
Q 016594          213 GLAKWLPSQWT---HHSIAPIEGTFGHLAPEYFMH-GIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQG  288 (386)
Q Consensus       213 g~a~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~  288 (386)
                      |++........   ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||............  .. .
T Consensus       166 g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~--~~-~  242 (303)
T 2vwi_A          166 GVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLT--LQ-N  242 (303)
T ss_dssp             HHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHH--HT-S
T ss_pred             cchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHH--hc-c
Confidence            99987643311   112234568999999999876 56899999999999999999999999875432111100  00 0


Q ss_pred             ccccccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 016594          289 EIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLE  337 (386)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~  337 (386)
                      ..................+..+.+++.+||+.||.+||++.+++++-+.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~  291 (303)
T 2vwi_A          243 DPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFF  291 (303)
T ss_dssp             SCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC
T ss_pred             CCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhh
Confidence            0000000000011112234678999999999999999999999987554

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.1e-45  Score=339.20  Aligned_cols=257  Identities=25%  Similarity=0.394  Sum_probs=201.0

Q ss_pred             HHhcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhcc-CCCceeeecceEEe-----
Q 016594           63 IATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHV-CHPNVLSLLGCCVD-----  135 (386)
Q Consensus        63 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~-----  135 (386)
                      ...++|++.+.||+|+||.||+|.+. +++.||||++....   .....+.+|+.+++++ +||||+++++++..     
T Consensus        21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~   97 (326)
T 2x7f_A           21 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG---DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG   97 (326)
T ss_dssp             CCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--C
T ss_pred             CCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc---ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCcc
Confidence            35678999999999999999999985 68999999987532   2345688999999999 79999999999975     


Q ss_pred             --CceEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecC
Q 016594          136 --NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFG  213 (386)
Q Consensus       136 --~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg  213 (386)
                        ...++||||+.+++|.+++.......+++..++.++.|++.||.|||+   ++|+||||||+||+++.++.+||+|||
T Consensus        98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg  174 (326)
T 2x7f_A           98 MDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFG  174 (326)
T ss_dssp             CCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCEEECCCT
T ss_pred             ccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCcHHHEEEcCCCCEEEeeCc
Confidence              238999999999999999987655669999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCCccccccccccccCccChhhhc-----cCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhccc
Q 016594          214 LAKWLPSQWTHHSIAPIEGTFGHLAPEYFM-----HGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQG  288 (386)
Q Consensus       214 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~  288 (386)
                      ++.......  .......|++.|+|||++.     +..++.++|||||||++|+|++|..||............   ...
T Consensus       175 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~---~~~  249 (326)
T 2x7f_A          175 VSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI---PRN  249 (326)
T ss_dssp             TTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH---HHS
T ss_pred             CceecCcCc--cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHh---hcC
Confidence            998764321  1223456899999999987     567899999999999999999999999765432211110   000


Q ss_pred             ccccccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          289 EIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                      .     .+   .......+..+.++|.+||..||.+||++.+++++.+..
T Consensus       250 ~-----~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~  291 (326)
T 2x7f_A          250 P-----AP---RLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIR  291 (326)
T ss_dssp             C-----CC---CCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHH
T ss_pred             c-----cc---cCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHh
Confidence            0     00   011122346799999999999999999999999975543

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=1.3e-44  Score=331.90  Aligned_cols=255  Identities=21%  Similarity=0.294  Sum_probs=205.0

Q ss_pred             HhcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEE
Q 016594           64 ATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLI  141 (386)
Q Consensus        64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv  141 (386)
                      ..++|.+.+.||+|+||.||+|... +|+.||+|++....  ......+.+|+.+++.++||||+++++++.+.. .+++
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (304)
T 2jam_A            7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSP--AFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLV   84 (304)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC--------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccc--ccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEE
Confidence            4567999999999999999999986 78999999997532  223456889999999999999999999998766 8999


Q ss_pred             EEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeE---cCCCCeEEeecCccccC
Q 016594          142 FQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILL---TADFEPQISDFGLAKWL  218 (386)
Q Consensus       142 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~a~~~  218 (386)
                      |||+.+++|.+++....  .+++..++.++.|++.||.|||+   ++++||||||+||++   +.++.+||+|||++...
T Consensus        85 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~  159 (304)
T 2jam_A           85 MQLVSGGELFDRILERG--VYTEKDASLVIQQVLSAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKME  159 (304)
T ss_dssp             ECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCC
T ss_pred             EEcCCCccHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEecCCCCCCEEEccCCcceec
Confidence            99999999999887644  48999999999999999999999   999999999999999   78889999999998765


Q ss_pred             CCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCcc
Q 016594          219 PSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRL  298 (386)
Q Consensus       219 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (386)
                      ...    ......|++.|+|||++.+..++.++|||||||++|+|++|..||........  ...+ .....      ..
T Consensus       160 ~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~i-~~~~~------~~  226 (304)
T 2jam_A          160 QNG----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKL--FEKI-KEGYY------EF  226 (304)
T ss_dssp             CCB----TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHH--HHHH-HHCCC------CC
T ss_pred             CCC----ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHH--HHHH-HcCCC------CC
Confidence            432    22334589999999999999999999999999999999999999987543211  0000 00000      00


Q ss_pred             CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          299 QGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       299 ~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                      ........+..+.+++.+||..||.+|||+.+++++.+..
T Consensus       227 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~  266 (304)
T 2jam_A          227 ESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWID  266 (304)
T ss_dssp             CTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHH
T ss_pred             CccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccc
Confidence            1111123457799999999999999999999999976543

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=3.7e-44  Score=337.99  Aligned_cols=261  Identities=20%  Similarity=0.293  Sum_probs=202.3

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc------
Q 016594           65 TNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG------  137 (386)
Q Consensus        65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------  137 (386)
                      .++|.+.+.||+|+||.||+|.+. +|+.||||++............+.+|+.+++.++||||+++++++....      
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  120 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  120 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence            468999999999999999999976 6899999999876556666788899999999999999999999997644      


Q ss_pred             -eEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccc
Q 016594          138 -LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAK  216 (386)
Q Consensus       138 -~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~  216 (386)
                       .++||+|+. ++|.+++.    ..+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||++.
T Consensus       121 ~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~  192 (371)
T 4exu_A          121 DFYLVMPFMQ-TDLQKIMG----MEFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLAR  192 (371)
T ss_dssp             CCEEEEECCC-EEHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECSTTCC-
T ss_pred             eEEEEEcccc-ccHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCcCHHHeEECCCCCEEEEecCccc
Confidence             299999998 47777663    238999999999999999999999   999999999999999999999999999998


Q ss_pred             cCCCCCccccccccccccCccChhhhcc-CCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhh-hhhcc--cc---
Q 016594          217 WLPSQWTHHSIAPIEGTFGHLAPEYFMH-GIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAK-PILNQ--GE---  289 (386)
Q Consensus       217 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~-~~~~~--~~---  289 (386)
                      .....     .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.......... .....  ..   
T Consensus       193 ~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  267 (371)
T 4exu_A          193 HADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQ  267 (371)
T ss_dssp             ------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred             ccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHH
Confidence            65432     234568999999999987 78899999999999999999999999876432111000 00000  00   


Q ss_pred             ---------cccccCCccCCC---CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          290 ---------IEKLVDPRLQGA---YDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       290 ---------~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                               ............   .....+..+.+|+.+||+.||++|||+.+++++-+..
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~  328 (371)
T 4exu_A          268 KLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFE  328 (371)
T ss_dssp             TCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGT
T ss_pred             HhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccc
Confidence                     000000000000   0112356799999999999999999999999987654

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=5.8e-45  Score=343.58  Aligned_cols=258  Identities=10%  Similarity=0.026  Sum_probs=185.6

Q ss_pred             cCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccC-ChHhHHHHHHHHHHHhcc--CCCceeeec-------ceEE
Q 016594           66 NAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVT-DDRKEKEFLTEIGTIGHV--CHPNVLSLL-------GCCV  134 (386)
Q Consensus        66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l--~h~niv~l~-------~~~~  134 (386)
                      ..|.+.+.||+|+||.||+|.+. +++.||||++..... .......+.+|+.+++.+  +||||++++       +++.
T Consensus        62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~  141 (371)
T 3q60_A           62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA  141 (371)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred             eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence            45888999999999999999976 789999999987543 234455667775444444  699988755       3433


Q ss_pred             e------------------CceEEEEEeccCCCHhhhhhhcCCCCCCHHHH------HHHHHHHHHHHHHHHhCCCCCeE
Q 016594          135 D------------------NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVR------HKIAVGTARGLHYLHKGCQRRII  190 (386)
Q Consensus       135 ~------------------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~------~~i~~qi~~~l~~LH~~~~~~iv  190 (386)
                      .                  ...++||||+. ++|.+++..... .++...+      +.++.||+.||+|||+   ++|+
T Consensus       142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~~vk~~i~~qi~~aL~~LH~---~~iv  216 (371)
T 3q60_A          142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF-VYVFRGDEGILALHILTAQLIRLAANLQS---KGLV  216 (371)
T ss_dssp             ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH-SCCCCHHHHHHHHHHHHHHHHHHHHHHHH---TTEE
T ss_pred             cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc-ccchhhhhhhhhHHHHHHHHHHHHHHHHH---CCCc
Confidence            2                  22699999999 799999876432 2344455      6788999999999999   9999


Q ss_pred             EeCCCCCCeeEcCCCCeEEeecCccccCCCCCccccccccccccCccChhhhcc--CCCCcccchHHHHHHHHHHHhCCC
Q 016594          191 HRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMH--GIVDEKTDVFAFGVFLLEIISGRK  268 (386)
Q Consensus       191 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~ell~g~~  268 (386)
                      ||||||+|||++.++.+||+|||++......     .....+|+.|+|||++.+  ..++.++|||||||++|+|++|+.
T Consensus       217 HrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~  291 (371)
T 3q60_A          217 HGHFTPDNLFIMPDGRLMLGDVSALWKVGTR-----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFL  291 (371)
T ss_dssp             ETTCSGGGEEECTTSCEEECCGGGEEETTCE-----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSC
T ss_pred             cCcCCHHHEEECCCCCEEEEecceeeecCCC-----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCC
Confidence            9999999999999999999999999876432     113446799999999987  779999999999999999999999


Q ss_pred             CCCCCchhhhhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 016594          269 PVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLE  337 (386)
Q Consensus       269 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~  337 (386)
                      ||.+........    ......................+..+.+++.+||+.||++|||+.+++++-+.
T Consensus       292 Pf~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f  356 (371)
T 3q60_A          292 PFGLVTPGIKGS----WKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEF  356 (371)
T ss_dssp             STTBCCTTCTTC----CCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHH
T ss_pred             CCCCcCcccccc----hhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHH
Confidence            998753321110    00000001111111111112446789999999999999999999999987554

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=8.8e-44  Score=324.66  Aligned_cols=255  Identities=23%  Similarity=0.345  Sum_probs=201.1

Q ss_pred             CCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEEEe
Q 016594           67 AFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQF  144 (386)
Q Consensus        67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~  144 (386)
                      .|.....||+|+||.||+|.+. ++..||||.+...  .......+.+|+.+++.++||||+++++++.+.+ .+++||+
T Consensus        23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  100 (295)
T 2clq_A           23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPER--DSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQ  100 (295)
T ss_dssp             TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECC--CC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCC--chHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEe
Confidence            4555669999999999999975 6889999998753  2344567889999999999999999999998766 8999999


Q ss_pred             ccCCCHhhhhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcC-CCCeEEeecCccccCCCCC
Q 016594          145 SSRGSVASLFHDVNS-PGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTA-DFEPQISDFGLAKWLPSQW  222 (386)
Q Consensus       145 ~~~~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~-~~~~kl~Dfg~a~~~~~~~  222 (386)
                      +.+++|.+++..... ..+++..++.++.|++.||.|||+   ++++|+||||+||+++. ++.+||+|||++.......
T Consensus       101 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~  177 (295)
T 2clq_A          101 VPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHD---NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN  177 (295)
T ss_dssp             CSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC--
T ss_pred             CCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHh---CCEEccCCChhhEEEECCCCCEEEeecccccccCCCC
Confidence            999999999876532 346789999999999999999999   99999999999999987 8999999999998765321


Q ss_pred             ccccccccccccCccChhhhccCC--CCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCC
Q 016594          223 THHSIAPIEGTFGHLAPEYFMHGI--VDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQG  300 (386)
Q Consensus       223 ~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (386)
                        .......|++.|+|||++.+..  ++.++||||||+++|+|++|..||...............      .    ....
T Consensus       178 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~------~----~~~~  245 (295)
T 2clq_A          178 --PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGM------F----KVHP  245 (295)
T ss_dssp             -----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHH------H----CCCC
T ss_pred             --CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhcc------c----cccc
Confidence              1223456899999999997654  889999999999999999999999753322111111000      0    0011


Q ss_pred             CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          301 AYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       301 ~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                      ..+...+..+.+++.+||+.||++||++.+++++-+..
T Consensus       246 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~  283 (295)
T 2clq_A          246 EIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLK  283 (295)
T ss_dssp             CCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGC
T ss_pred             cccccCCHHHHHHHHHHccCChhhCCCHHHHhcChhhh
Confidence            12233456799999999999999999999999876554

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=8.1e-45  Score=336.59  Aligned_cols=269  Identities=21%  Similarity=0.304  Sum_probs=210.4

Q ss_pred             HhcCCCCCCeecccCCcEEEEEEE-----CCCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeC--
Q 016594           64 ATNAFSSENLVGRGGYAEVYKGVL-----QDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDN--  136 (386)
Q Consensus        64 ~~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--  136 (386)
                      ..++|++.+.||+|+||.||+|.+     .+++.||||++...  .......+.+|+.+++.++||||+++++++...  
T Consensus        39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  116 (326)
T 2w1i_A           39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR  116 (326)
T ss_dssp             CGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC--CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC---
T ss_pred             CHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCC
Confidence            356789999999999999999984     26889999998753  345567889999999999999999999988543  


Q ss_pred             -ceEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCcc
Q 016594          137 -GLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLA  215 (386)
Q Consensus       137 -~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a  215 (386)
                       ..++||||+.+++|.+++.... ..+++..++.++.|++.||.|||+   ++|+||||||+||+++.++.+||+|||++
T Consensus       117 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~~~~kL~Dfg~~  192 (326)
T 2w1i_A          117 RNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLT  192 (326)
T ss_dssp             -CCEEEECCCTTCBHHHHHHHST-TSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred             CceEEEEECCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEEcCCCcEEEecCcch
Confidence             4899999999999999987643 348999999999999999999999   99999999999999999999999999999


Q ss_pred             ccCCCCCccc-cccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhh----ccccc
Q 016594          216 KWLPSQWTHH-SIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPIL----NQGEI  290 (386)
Q Consensus       216 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~----~~~~~  290 (386)
                      .......... ......++..|+|||.+.+..++.++|||||||++|+|++|..||...............    ....+
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (326)
T 2w1i_A          193 KVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL  272 (326)
T ss_dssp             EECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHH
T ss_pred             hhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHH
Confidence            8775443221 123345778899999999999999999999999999999999998753222111100000    00001


Q ss_pred             ccccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          291 EKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                      ...+........+..++..+.+++.+||+.||++|||+.+|++.|...
T Consensus       273 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l  320 (326)
T 2w1i_A          273 IELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI  320 (326)
T ss_dssp             HHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            111111111222334567899999999999999999999999988754

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=2.8e-44  Score=342.82  Aligned_cols=266  Identities=20%  Similarity=0.324  Sum_probs=184.5

Q ss_pred             cCCCC-CCeecccCCcEEEEEEEC---CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeC---ce
Q 016594           66 NAFSS-ENLVGRGGYAEVYKGVLQ---DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDN---GL  138 (386)
Q Consensus        66 ~~~~~-~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~---~~  138 (386)
                      +.|.+ +++||+|+||+||+|.++   +++.||||++.....    ...+.+|+.+|+.++||||+++++++...   ..
T Consensus        20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~   95 (405)
T 3rgf_A           20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI----SMSACREIALLRELKHPNVISLQKVFLSHADRKV   95 (405)
T ss_dssp             HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC----CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEE
T ss_pred             hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC----CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeE
Confidence            44665 568999999999999975   578899999875322    23578999999999999999999999652   38


Q ss_pred             EEEEEeccCCCHhhhhhhc-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeE----cCCCCe
Q 016594          139 YLIFQFSSRGSVASLFHDV-------NSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILL----TADFEP  207 (386)
Q Consensus       139 ~lv~e~~~~~~L~~~~~~~-------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill----~~~~~~  207 (386)
                      ++||||+.+ +|.+++...       ....+++..++.++.||+.||.|||+   ++|+||||||+|||+    +.++.+
T Consensus        96 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~  171 (405)
T 3rgf_A           96 WLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRV  171 (405)
T ss_dssp             EEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECCSSTTTTCE
T ss_pred             EEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCEeCCCcCHHHeEEecCCCCCCcE
Confidence            999999875 777766422       12248999999999999999999999   999999999999999    677899


Q ss_pred             EEeecCccccCCCCCc-cccccccccccCccChhhhccC-CCCcccchHHHHHHHHHHHhCCCCCCCCchhhh-------
Q 016594          208 QISDFGLAKWLPSQWT-HHSIAPIEGTFGHLAPEYFMHG-IVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLH-------  278 (386)
Q Consensus       208 kl~Dfg~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~-------  278 (386)
                      ||+|||++..+..... .......+||+.|+|||++.+. .++.++|||||||++|+|++|..||.+......       
T Consensus       172 kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~  251 (405)
T 3rgf_A          172 KIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHH  251 (405)
T ss_dssp             EECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCH
T ss_pred             EEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchH
Confidence            9999999987654321 1223456799999999999874 589999999999999999999999976543210       


Q ss_pred             -hh--hhhhhcc---cccccc------------cCCccCCCCCH---------HHHHHHHHHHHHccccCCCCCCCHHHH
Q 016594          279 -SW--AKPILNQ---GEIEKL------------VDPRLQGAYDV---------TQLNRLAFAASLCIRASPTWRPTMSEV  331 (386)
Q Consensus       279 -~~--~~~~~~~---~~~~~~------------~~~~~~~~~~~---------~~~~~l~~li~~cl~~dP~~Rpt~~~i  331 (386)
                       ..  ....+..   .....+            +..........         ..+..+.+||.+||..||.+|||+.++
T Consensus       252 ~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~  331 (405)
T 3rgf_A          252 DQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQA  331 (405)
T ss_dssp             HHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred             HHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHH
Confidence             00  0000000   000000            00000000000         013568899999999999999999999


Q ss_pred             HHHHhcCC
Q 016594          332 LEVMLEGD  339 (386)
Q Consensus       332 l~~l~~~~  339 (386)
                      |+|-+...
T Consensus       332 L~hp~f~~  339 (405)
T 3rgf_A          332 MQDPYFLE  339 (405)
T ss_dssp             HTSGGGTS
T ss_pred             hcChhhcc
Confidence            99977654

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=5.9e-44  Score=332.74  Aligned_cols=267  Identities=25%  Similarity=0.344  Sum_probs=209.5

Q ss_pred             ccCHHHHHHHhcCCCCCCeecccCCcEEEEEEECCCcEEEEEEeccccCChHhHHHHHHHHHHHhc--cCCCceeeecce
Q 016594           55 CFSFEEISIATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGH--VCHPNVLSLLGC  132 (386)
Q Consensus        55 ~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~  132 (386)
                      ..++.......++|.+.+.||+|+||.||+|.+. ++.||||++..     .....+.+|++++..  ++||||++++++
T Consensus        31 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~-----~~~~~~~~e~~~~~~~~l~h~ni~~~~~~  104 (342)
T 1b6c_B           31 GLPLLVQRTIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSS-----REERSWFREAEIYQTVMLRHENILGFIAA  104 (342)
T ss_dssp             SSCHHHHHHHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEECG-----GGHHHHHHHHHHHHHSCCCCTTBCCEEEE
T ss_pred             CCceeecccccccEEEEeeecCCCCcEEEEEEEc-CccEEEEEeCc-----hhHHHHHHHHHHHHHhhcCCCcEEEEEee
Confidence            3444555677889999999999999999999985 89999999864     234567788888877  789999999999


Q ss_pred             EEeC-----ceEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCCeEEeCCCCCCe
Q 016594          133 CVDN-----GLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLH--------KGCQRRIIHRDIKSSNI  199 (386)
Q Consensus       133 ~~~~-----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH--------~~~~~~ivH~dlkp~Ni  199 (386)
                      +...     ..++||||+.+++|.+++...   .+++..++.++.|++.||.|||        +   ++|+||||||+||
T Consensus       105 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~---~~ivH~Dlkp~NI  178 (342)
T 1b6c_B          105 DNKDNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGK---PAIAHRDLKSKNI  178 (342)
T ss_dssp             EECCCSSCCCEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCB---CEEECSCCSGGGE
T ss_pred             ecccCCccceeEEEEeecCCCcHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHHHHhhhccc---CCeeeCCCCHHHE
Confidence            9764     479999999999999999753   4899999999999999999999        7   8999999999999


Q ss_pred             eEcCCCCeEEeecCccccCCCCCccc--cccccccccCccChhhhccCC------CCcccchHHHHHHHHHHHhC-----
Q 016594          200 LLTADFEPQISDFGLAKWLPSQWTHH--SIAPIEGTFGHLAPEYFMHGI------VDEKTDVFAFGVFLLEIISG-----  266 (386)
Q Consensus       200 ll~~~~~~kl~Dfg~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~------~~~~~DvwslG~il~ell~g-----  266 (386)
                      |++.++.+||+|||++..........  ......||+.|+|||++.+..      ++.++|||||||++|+|++|     
T Consensus       179 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~  258 (342)
T 1b6c_B          179 LVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG  258 (342)
T ss_dssp             EECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTT
T ss_pred             EECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCC
Confidence            99999999999999998764432211  224456999999999998753      34789999999999999999     


Q ss_pred             -----CCCCCCCchh---hhhhhhhhhcccccccccCCccCC-CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 016594          267 -----RKPVDGSHQS---LHSWAKPILNQGEIEKLVDPRLQG-AYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLE  337 (386)
Q Consensus       267 -----~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~  337 (386)
                           ..||......   ...+.....     .....+.... ......+..+.+++.+||+.||++|||+.+|+++|..
T Consensus       259 ~~~~~~~p~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~  333 (342)
T 1b6c_B          259 IHEDYQLPYYDLVPSDPSVEEMRKVVC-----EQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ  333 (342)
T ss_dssp             BCCCCCCTTTTTSCSSCCHHHHHHHHT-----TSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHH
T ss_pred             cccccccCccccCcCcccHHHHHHHHH-----HHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHH
Confidence                 7788654211   111111110     0111111111 1223567789999999999999999999999999876


Q ss_pred             C
Q 016594          338 G  338 (386)
Q Consensus       338 ~  338 (386)
                      .
T Consensus       334 i  334 (342)
T 1b6c_B          334 L  334 (342)
T ss_dssp             H
T ss_pred             H
Confidence            5

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=3e-44  Score=324.71  Aligned_cols=255  Identities=21%  Similarity=0.318  Sum_probs=200.1

Q ss_pred             HHhcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccC-ChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eE
Q 016594           63 IATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVT-DDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LY  139 (386)
Q Consensus        63 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~  139 (386)
                      +..++|++.+.||+|+||.||+|.+. +++.||||++..... .......+.+|+.+++.++||||+++++++.+.+ .+
T Consensus         8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   87 (276)
T 2h6d_A            8 VKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFF   87 (276)
T ss_dssp             CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             ceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEE
Confidence            34578999999999999999999987 789999999875321 1223457889999999999999999999998765 89


Q ss_pred             EEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCC
Q 016594          140 LIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLP  219 (386)
Q Consensus       140 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~  219 (386)
                      ++||++.+++|.+++....  .+++..++.++.|++.||.|||+   ++++|+||||+||+++.++.+||+|||++....
T Consensus        88 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~  162 (276)
T 2h6d_A           88 MVMEYVSGGELFDYICKHG--RVEEMEARRLFQQILSAVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS  162 (276)
T ss_dssp             EEEECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHH---HCSSCCCCCGGGEEECTTSCEEECCCCGGGCCC
T ss_pred             EEEeccCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChhhEEECCCCCEEEeecccccccC
Confidence            9999999999999987654  38999999999999999999999   999999999999999999999999999998765


Q ss_pred             CCCccccccccccccCccChhhhccCCC-CcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCcc
Q 016594          220 SQWTHHSIAPIEGTFGHLAPEYFMHGIV-DEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRL  298 (386)
Q Consensus       220 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (386)
                      ...   ......|++.|+|||.+.+..+ +.++||||||+++|+|++|..||........  ...... ..         
T Consensus       163 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~--~~~~~~-~~---------  227 (276)
T 2h6d_A          163 DGE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTL--FKKIRG-GV---------  227 (276)
T ss_dssp             C----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHH-CC---------
T ss_pred             CCc---ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHH--HHHhhc-Cc---------
Confidence            432   2234468999999999988765 6899999999999999999999987543211  111000 00         


Q ss_pred             CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          299 QGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       299 ~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                       ...+...+..+.+++.+||+.||.+|||+.+++++-+..
T Consensus       228 -~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~  266 (276)
T 2h6d_A          228 -FYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFK  266 (276)
T ss_dssp             -CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHH
T ss_pred             -ccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhc
Confidence             011122346789999999999999999999999986543

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=7.2e-44  Score=331.36  Aligned_cols=263  Identities=20%  Similarity=0.271  Sum_probs=206.7

Q ss_pred             HHhcCCCCCCeecccCCcEEEEEEE-C-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCC------ceeeecceEE
Q 016594           63 IATNAFSSENLVGRGGYAEVYKGVL-Q-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHP------NVLSLLGCCV  134 (386)
Q Consensus        63 ~~~~~~~~~~~lg~G~~g~V~~~~~-~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~------niv~l~~~~~  134 (386)
                      +..++|++.+.||+|+||+||+|.+ . +++.||||++...   ......+.+|+.+++.+.|+      +|+++++++.
T Consensus        11 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~   87 (339)
T 1z57_A           11 VLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV---DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFE   87 (339)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEE
T ss_pred             CccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC---CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccc
Confidence            3457899999999999999999997 3 6889999998642   34456788899999888765      4999999998


Q ss_pred             eCc-eEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcC----------
Q 016594          135 DNG-LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTA----------  203 (386)
Q Consensus       135 ~~~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~----------  203 (386)
                      +.+ .++||||+ +++|.+++.......+++..++.++.|++.||+|||+   ++|+||||||+|||++.          
T Consensus        88 ~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~~~  163 (339)
T 1z57_A           88 HHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYNPK  163 (339)
T ss_dssp             ETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCCCEEEEEC--
T ss_pred             cCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEEEeccccccccCCc
Confidence            766 89999999 8899999987766679999999999999999999999   99999999999999987          


Q ss_pred             ---------CCCeEEeecCccccCCCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCc
Q 016594          204 ---------DFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSH  274 (386)
Q Consensus       204 ---------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~  274 (386)
                               ++.+||+|||++......     .....||+.|+|||++.+..++.++|||||||++|+|++|..||....
T Consensus       164 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~  238 (339)
T 1z57_A          164 IKRDERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHD  238 (339)
T ss_dssp             --CEEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSC
T ss_pred             cccccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence                     668999999999865432     234568999999999999999999999999999999999999998765


Q ss_pred             hhhhhhh-hhhhcccc-----------------------------cccccCCc-cCCCCCHHHHHHHHHHHHHccccCCC
Q 016594          275 QSLHSWA-KPILNQGE-----------------------------IEKLVDPR-LQGAYDVTQLNRLAFAASLCIRASPT  323 (386)
Q Consensus       275 ~~~~~~~-~~~~~~~~-----------------------------~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~dP~  323 (386)
                      ....... ........                             ......+. .........+..+.+++.+||+.||.
T Consensus       239 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~  318 (339)
T 1z57_A          239 SKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPA  318 (339)
T ss_dssp             HHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTT
T ss_pred             hHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcc
Confidence            3221110 00000000                             00000000 00112234567899999999999999


Q ss_pred             CCCCHHHHHHHHhc
Q 016594          324 WRPTMSEVLEVMLE  337 (386)
Q Consensus       324 ~Rpt~~~il~~l~~  337 (386)
                      +|||+.+++++-+.
T Consensus       319 ~Rpt~~ell~hp~f  332 (339)
T 1z57_A          319 KRITLREALKHPFF  332 (339)
T ss_dssp             TSCCHHHHTTSGGG
T ss_pred             cccCHHHHhcCHHH
Confidence            99999999987544

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=6.8e-45  Score=338.11  Aligned_cols=257  Identities=21%  Similarity=0.328  Sum_probs=188.1

Q ss_pred             HHhcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccC-CCceeeecceEEe-----
Q 016594           63 IATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVC-HPNVLSLLGCCVD-----  135 (386)
Q Consensus        63 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~-----  135 (386)
                      +...+|++.+.||+|+||.||+|.+. +++.||||++...  .......+.+|+.++.++. ||||+++++++..     
T Consensus        25 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~  102 (337)
T 3ll6_A           25 LGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN--EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEES  102 (337)
T ss_dssp             ETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTS
T ss_pred             ccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC--chHHHHHHHHHHHHHHHhccCCChhhcccccccccccc
Confidence            45568999999999999999999976 6899999998642  3455667899999999996 9999999999852     


Q ss_pred             ---Cc-eEEEEEeccCCCHhhhhhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEEeCCCCCCeeEcCCCCeE
Q 016594          136 ---NG-LYLIFQFSSRGSVASLFHDV-NSPGVEWKVRHKIAVGTARGLHYLHKGCQRR--IIHRDIKSSNILLTADFEPQ  208 (386)
Q Consensus       136 ---~~-~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~--ivH~dlkp~Nill~~~~~~k  208 (386)
                         .. .++++||+. |+|.+++... ....+++..++.++.|++.||.|||+   ++  |+||||||+|||++.++.+|
T Consensus       103 ~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~~~ivH~Dikp~NIl~~~~~~~k  178 (337)
T 3ll6_A          103 DTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR---QKPPIIHRDLKVENLLLSNQGTIK  178 (337)
T ss_dssp             TTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCCCCCGGGCEECTTSCEE
T ss_pred             ccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHh---CCCCEEEccCCcccEEECCCCCEE
Confidence               11 688888886 6888877652 33459999999999999999999999   88  99999999999999999999


Q ss_pred             EeecCccccCCCCCccc----------cccccccccCccChhhh---ccCCCCcccchHHHHHHHHHHHhCCCCCCCCch
Q 016594          209 ISDFGLAKWLPSQWTHH----------SIAPIEGTFGHLAPEYF---MHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQ  275 (386)
Q Consensus       209 l~Dfg~a~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~  275 (386)
                      |+|||++..........          ......||+.|+|||++   .+..++.++|||||||++|+|++|..||.....
T Consensus       179 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~  258 (337)
T 3ll6_A          179 LCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAK  258 (337)
T ss_dssp             BCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred             EecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhH
Confidence            99999998765432111          11244589999999998   567789999999999999999999999975322


Q ss_pred             hhhhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCCc
Q 016594          276 SLHSWAKPILNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEGDQ  340 (386)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~~~  340 (386)
                      .               .+.............+..+.+++.+||+.||.+|||+.+++++|+....
T Consensus       259 ~---------------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~  308 (337)
T 3ll6_A          259 L---------------RIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAA  308 (337)
T ss_dssp             ----------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             H---------------HhhcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            1               0111111111111223458899999999999999999999999977643

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=7e-44  Score=333.80  Aligned_cols=267  Identities=21%  Similarity=0.269  Sum_probs=203.9

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEe------Cc
Q 016594           65 TNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVD------NG  137 (386)
Q Consensus        65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------~~  137 (386)
                      .++|++.+.||+|+||.||+|.+. +|+.||||++... ........+.+|+.+++.++||||+++++++..      ..
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   88 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF-DKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE   88 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeeccc-ccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence            468999999999999999999986 6899999999642 334456678899999999999999999998864      33


Q ss_pred             eEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCcccc
Q 016594          138 LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKW  217 (386)
Q Consensus       138 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~  217 (386)
                      .+++||++. ++|.+++..   ..+++..++.++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||++..
T Consensus        89 ~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~  161 (353)
T 2b9h_A           89 VYIIQELMQ-TDLHRVIST---QMLSDDHIQYFIYQTLRAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARI  161 (353)
T ss_dssp             EEEEECCCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEEeccC-ccHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEcCCCcEEEEecccccc
Confidence            799999997 489888865   348999999999999999999999   9999999999999999999999999999987


Q ss_pred             CCCCCccc--------cccccccccCccChhhhcc-CCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhh-hhhhhcc
Q 016594          218 LPSQWTHH--------SIAPIEGTFGHLAPEYFMH-GIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSW-AKPILNQ  287 (386)
Q Consensus       218 ~~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~-~~~~~~~  287 (386)
                      ........        ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+........ .......
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  241 (353)
T 2b9h_A          162 IDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGT  241 (353)
T ss_dssp             CC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred             cccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC
Confidence            65332111        1234568999999998765 778999999999999999999999998765321110 0000000


Q ss_pred             cc----c--------ccccCCccC-CC-----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCC
Q 016594          288 GE----I--------EKLVDPRLQ-GA-----YDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEGD  339 (386)
Q Consensus       288 ~~----~--------~~~~~~~~~-~~-----~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~~  339 (386)
                      ..    .        ......... ..     .....+..+.+++.+||+.||++|||+.+++++.+...
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~  311 (353)
T 2b9h_A          242 PHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQT  311 (353)
T ss_dssp             CCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred             CchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccc
Confidence            00    0        000000000 00     00123567899999999999999999999999866543

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=2.4e-44  Score=341.88  Aligned_cols=262  Identities=21%  Similarity=0.244  Sum_probs=197.7

Q ss_pred             hcCCCCCCeecccCCcEEEEEEECCCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-------
Q 016594           65 TNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-------  137 (386)
Q Consensus        65 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-------  137 (386)
                      ..+|++.+.||+|+||+||+|.+..+..||+|++......      ..+|+.+++.++||||+++++++...+       
T Consensus        39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~------~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~  112 (394)
T 4e7w_A           39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF------KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVF  112 (394)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS------CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEE
T ss_pred             cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch------HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceE
Confidence            4578999999999999999999987777999988643211      136999999999999999999986422       


Q ss_pred             eEEEEEeccCCCHhhhhh-hcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEc-CCCCeEEeecCcc
Q 016594          138 LYLIFQFSSRGSVASLFH-DVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLT-ADFEPQISDFGLA  215 (386)
Q Consensus       138 ~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~-~~~~~kl~Dfg~a  215 (386)
                      .++||||+.++.+..+.. ......+++..++.++.|++.||+|||+   ++|+||||||+|||++ .++.+||+|||++
T Consensus       113 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~kL~DFG~a  189 (394)
T 4e7w_A          113 LNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSA  189 (394)
T ss_dssp             EEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             EEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEcCCCCcEEEeeCCCc
Confidence            689999998865444332 1234459999999999999999999999   9999999999999999 7899999999999


Q ss_pred             ccCCCCCccccccccccccCccChhhhccC-CCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhh-hhhhh--------
Q 016594          216 KWLPSQWTHHSIAPIEGTFGHLAPEYFMHG-IVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSW-AKPIL--------  285 (386)
Q Consensus       216 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~-~~~~~--------  285 (386)
                      ..+....   ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+........ .....        
T Consensus       190 ~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~  266 (394)
T 4e7w_A          190 KILIAGE---PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQI  266 (394)
T ss_dssp             EECCTTC---CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             ccccCCC---CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            8764432   22345689999999999765 58999999999999999999999998765321111 00000        


Q ss_pred             ---cccccccccCC----ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          286 ---NQGEIEKLVDP----RLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       286 ---~~~~~~~~~~~----~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                         ........+..    .....+....+..+.+|+.+||..||.+|||+.++++|-+..
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~  326 (394)
T 4e7w_A          267 KTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFD  326 (394)
T ss_dssp             HHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGS
T ss_pred             HhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhh
Confidence               00000000000    000011122456799999999999999999999999986654

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=2.5e-44  Score=336.17  Aligned_cols=268  Identities=19%  Similarity=0.302  Sum_probs=208.3

Q ss_pred             HhcCCCCCCeecccCCcEEEEEEECCCcEEEEEEeccccCChH---------------hHHHHHHHHHHHhccCCCceee
Q 016594           64 ATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDR---------------KEKEFLTEIGTIGHVCHPNVLS  128 (386)
Q Consensus        64 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~---------------~~~~~~~e~~~l~~l~h~niv~  128 (386)
                      ..++|.+.+.||+|+||.||+|.+ +++.||||++........               ....+.+|+.+++.++||||++
T Consensus        29 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~  107 (348)
T 2pml_X           29 YINDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT  107 (348)
T ss_dssp             EETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred             ccCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence            356899999999999999999999 799999999875322111               1267899999999999999999


Q ss_pred             ecceEEeCc-eEEEEEeccCCCHhhh------hhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeE
Q 016594          129 LLGCCVDNG-LYLIFQFSSRGSVASL------FHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILL  201 (386)
Q Consensus       129 l~~~~~~~~-~~lv~e~~~~~~L~~~------~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill  201 (386)
                      +++++.+.+ .++||||+.+++|.++      +.......+++..++.++.|++.||.|||+  .++++||||||+||++
T Consensus       108 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~~i~H~dl~p~Nil~  185 (348)
T 2pml_X          108 CEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNILM  185 (348)
T ss_dssp             CSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHH--TSCEECCCCCGGGEEE
T ss_pred             EEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhc--cCCEeecCCChHhEEE
Confidence            999998765 8999999999999998      655445679999999999999999999996  2799999999999999


Q ss_pred             cCCCCeEEeecCccccCCCCCccccccccccccCccChhhhccC-CCCc-ccchHHHHHHHHHHHhCCCCCCCCchhhhh
Q 016594          202 TADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHG-IVDE-KTDVFAFGVFLLEIISGRKPVDGSHQSLHS  279 (386)
Q Consensus       202 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~DvwslG~il~ell~g~~pf~~~~~~~~~  279 (386)
                      +.++.+||+|||++......    ......|++.|+|||++.+. .++. ++|||||||++|+|++|..||.........
T Consensus       186 ~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~  261 (348)
T 2pml_X          186 DKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVEL  261 (348)
T ss_dssp             CTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHH
T ss_pred             cCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHH
Confidence            99999999999999876433    33455699999999999887 6666 999999999999999999999875431111


Q ss_pred             hhhhhhccccccc----ccCCc---cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          280 WAKPILNQGEIEK----LVDPR---LQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       280 ~~~~~~~~~~~~~----~~~~~---~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                      .............    ...+.   .........+..+.+++.+||+.||.+|||+.+++++-+..
T Consensus       262 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~  327 (348)
T 2pml_X          262 FNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLA  327 (348)
T ss_dssp             HHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGT
T ss_pred             HHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCcccc
Confidence            1110000000000    00000   00001123457799999999999999999999999986554

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=1e-43  Score=335.06  Aligned_cols=272  Identities=18%  Similarity=0.258  Sum_probs=208.4

Q ss_pred             HhcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccC-----------CCceeeecc
Q 016594           64 ATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVC-----------HPNVLSLLG  131 (386)
Q Consensus        64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~l~~  131 (386)
                      ..++|++.+.||+|+||+||+|.+. +++.||||++..   .......+.+|+.+++++.           ||||+++++
T Consensus        17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~   93 (373)
T 1q8y_A           17 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG---DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLD   93 (373)
T ss_dssp             TTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS---CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCE
T ss_pred             cCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecC---CccchhhhhHHHHHHHHhhcccccchhccccchHHHHHH
Confidence            3468999999999999999999975 689999999874   2344566788999988876           899999999


Q ss_pred             eEEeC-----ceEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC-CeEEeCCCCCCeeEc---
Q 016594          132 CCVDN-----GLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQR-RIIHRDIKSSNILLT---  202 (386)
Q Consensus       132 ~~~~~-----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~-~ivH~dlkp~Nill~---  202 (386)
                      ++...     ..+++||++ +++|.+++.......+++..++.++.||+.||.|||+   + +|+||||||+|||++   
T Consensus        94 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~---~~~ivH~Dikp~NIll~~~~  169 (373)
T 1q8y_A           94 HFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR---RCGIIHTDIKPENVLMEIVD  169 (373)
T ss_dssp             EEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH---TTCEECSCCSGGGEEEEEEE
T ss_pred             HhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHh---cCCEEecCCChHHeEEeccC
Confidence            99753     378888888 8899999987766679999999999999999999999   8 999999999999994   


Q ss_pred             ---CCCCeEEeecCccccCCCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhh-
Q 016594          203 ---ADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLH-  278 (386)
Q Consensus       203 ---~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~-  278 (386)
                         ..+.+||+|||++......     .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+...... 
T Consensus       170 ~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~  244 (373)
T 1q8y_A          170 SPENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYT  244 (373)
T ss_dssp             TTTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred             CCcCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccC
Confidence               4447999999999876432     2344689999999999999999999999999999999999999986532100 


Q ss_pred             ---hhhhhh---h------------------cccccccccCC----------ccCCCCCHHHHHHHHHHHHHccccCCCC
Q 016594          279 ---SWAKPI---L------------------NQGEIEKLVDP----------RLQGAYDVTQLNRLAFAASLCIRASPTW  324 (386)
Q Consensus       279 ---~~~~~~---~------------------~~~~~~~~~~~----------~~~~~~~~~~~~~l~~li~~cl~~dP~~  324 (386)
                         ......   .                  ........+..          ......+...+..+.+||.+||+.||++
T Consensus       245 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~  324 (373)
T 1q8y_A          245 KDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRK  324 (373)
T ss_dssp             CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTT
T ss_pred             ChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccc
Confidence               000000   0                  00000000000          0011244567888999999999999999


Q ss_pred             CCCHHHHHHHHhcCCcccccccC
Q 016594          325 RPTMSEVLEVMLEGDQIDKERWK  347 (386)
Q Consensus       325 Rpt~~~il~~l~~~~~~~~~~~~  347 (386)
                      |||+.+++++-+...........
T Consensus       325 Rpt~~ell~hp~f~~~~~~~~~~  347 (373)
T 1q8y_A          325 RADAGGLVNHPWLKDTLGMEEIR  347 (373)
T ss_dssp             CBCHHHHHTCGGGTTCTTCTTCC
T ss_pred             cCCHHHHhhChhhhcccCccccc
Confidence            99999999987776554444333

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=3.5e-44  Score=343.43  Aligned_cols=261  Identities=21%  Similarity=0.232  Sum_probs=196.9

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeC-----c-
Q 016594           65 TNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDN-----G-  137 (386)
Q Consensus        65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~-  137 (386)
                      ..+|++.+.||+|+||.||+|.+. +++.||||++.....      ...+|+.+++.++||||+++++++...     . 
T Consensus        53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~  126 (420)
T 1j1b_A           53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV  126 (420)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEE
T ss_pred             cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch------hHHHHHHHHHHcCCCCccceeeEEeccCCCCcce
Confidence            346888999999999999999986 689999999865321      123799999999999999999998542     1 


Q ss_pred             -eEEEEEeccCCCHhhhhhh--cCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCC-CCeEEeecC
Q 016594          138 -LYLIFQFSSRGSVASLFHD--VNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTAD-FEPQISDFG  213 (386)
Q Consensus       138 -~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~-~~~kl~Dfg  213 (386)
                       .++||||+.+ +|.+++..  .....+++..++.++.||+.||.|||+   ++|+||||||+|||++.+ +.+||+|||
T Consensus       127 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NILl~~~~~~~kl~DFG  202 (420)
T 1j1b_A          127 YLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFG  202 (420)
T ss_dssp             EEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred             eEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChhhEEEeCCCCeEEeccch
Confidence             5789999986 56555442  234569999999999999999999999   999999999999999965 568999999


Q ss_pred             ccccCCCCCccccccccccccCccChhhhccC-CCCcccchHHHHHHHHHHHhCCCCCCCCchhhh--hhhhhhhc----
Q 016594          214 LAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHG-IVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLH--SWAKPILN----  286 (386)
Q Consensus       214 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~--~~~~~~~~----  286 (386)
                      +++.+....   ......||+.|+|||++.+. .++.++|||||||++|||++|+.||.+......  ........    
T Consensus       203 ~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~  279 (420)
T 1j1b_A          203 SAKQLVRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTRE  279 (420)
T ss_dssp             TCEECCTTC---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHH
T ss_pred             hhhhcccCC---CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence            998764332   22345689999999999765 799999999999999999999999987653211  11110000    


Q ss_pred             -----ccccccccCCccCC-----CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          287 -----QGEIEKLVDPRLQG-----AYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       287 -----~~~~~~~~~~~~~~-----~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                           .........+....     .+....+..+.+||.+||..||.+|||+.++++|.+..
T Consensus       280 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~  341 (420)
T 1j1b_A          280 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFD  341 (420)
T ss_dssp             HHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGG
T ss_pred             HHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhc
Confidence                 00000000010000     01122356799999999999999999999999986653

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=1.1e-43  Score=332.67  Aligned_cols=261  Identities=20%  Similarity=0.288  Sum_probs=202.5

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc------
Q 016594           65 TNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG------  137 (386)
Q Consensus        65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------  137 (386)
                      .++|.+.+.||+|+||.||+|.+. +|+.||||++............+.+|+.+++.++||||+++++++....      
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  102 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  102 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence            467899999999999999999986 6899999999875555666778899999999999999999999997643      


Q ss_pred             -eEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccc
Q 016594          138 -LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAK  216 (386)
Q Consensus       138 -~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~  216 (386)
                       .+++||++. ++|.+++.    ..+++..++.++.|++.||.|||+   ++|+||||||+||+++.++.+||+|||++.
T Consensus       103 ~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~  174 (353)
T 3coi_A          103 DFYLVMPFMQ-TDLQKIMG----LKFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLAR  174 (353)
T ss_dssp             CCEEEEECCS-EEGGGTTT----SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTCCEEECSTTCTT
T ss_pred             eEEEEecccc-CCHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEeECCCCcEEEeeccccc
Confidence             499999998 47877764    238999999999999999999999   999999999999999999999999999998


Q ss_pred             cCCCCCccccccccccccCccChhhhcc-CCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhh-hhhhhcc-------
Q 016594          217 WLPSQWTHHSIAPIEGTFGHLAPEYFMH-GIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSW-AKPILNQ-------  287 (386)
Q Consensus       217 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~-~~~~~~~-------  287 (386)
                      .....     .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+........ .......       
T Consensus       175 ~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  249 (353)
T 3coi_A          175 HADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQ  249 (353)
T ss_dssp             C-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHT
T ss_pred             CCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            65432     234568999999999987 678999999999999999999999998765321100 0000000       


Q ss_pred             ----cc---cccccCCccC---CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          288 ----GE---IEKLVDPRLQ---GAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       288 ----~~---~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                          ..   ....+.....   .......+..+.+++.+||+.||++|||+.+++++-+..
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~  310 (353)
T 3coi_A          250 KLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFE  310 (353)
T ss_dssp             TCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGT
T ss_pred             HHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchh
Confidence                00   0000000000   011123467899999999999999999999999986654

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=4.5e-44  Score=332.85  Aligned_cols=265  Identities=24%  Similarity=0.344  Sum_probs=195.0

Q ss_pred             HHhcCCCCCCeecccCCcEEEEEEECCCcEEEEEEeccccCChHhHHHHH--HHHHHHhccCCCceeeecceEEe----C
Q 016594           63 IATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFL--TEIGTIGHVCHPNVLSLLGCCVD----N  136 (386)
Q Consensus        63 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~--~e~~~l~~l~h~niv~l~~~~~~----~  136 (386)
                      +..++|++.+.||+|+||.||+|.+ +++.||||++...     ....+.  .++..+..+.||||+++++.+..    +
T Consensus        10 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~   83 (336)
T 3g2f_A           10 LDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFA-----NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADG   83 (336)
T ss_dssp             CCTTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGG-----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTS
T ss_pred             cChHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeecc-----chhhHHHHHHHHHHHhccCcchhhheecccccccCC
Confidence            3457899999999999999999987 4899999998742     222333  34444556899999999986643    1


Q ss_pred             --ceEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC---------CeEEeCCCCCCeeEcCCC
Q 016594          137 --GLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQR---------RIIHRDIKSSNILLTADF  205 (386)
Q Consensus       137 --~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~---------~ivH~dlkp~Nill~~~~  205 (386)
                        ..++||||+.+|+|.+++....   .++..++.++.|++.||.|||+   +         +|+||||||+|||++.++
T Consensus        84 ~~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~i~~qi~~~L~~LH~---~~~~~~~~~~~ivH~Dikp~Nill~~~~  157 (336)
T 3g2f_A           84 RMEYLLVMEYYPNGSLXKYLSLHT---SDWVSSCRLAHSVTRGLAYLHT---ELPRGDHYKPAISHRDLNSRNVLVKNDG  157 (336)
T ss_dssp             CEEEEEEECCCTTCBHHHHHHHCC---BCHHHHHHHHHHHHHHHHHHHC---CBCCGGGCBCCEECSSCSGGGEEECTTS
T ss_pred             CceEEEEEecCCCCcHHHHHhhcc---cchhHHHHHHHHHHHHHHHHHh---hhccccccccceeecccccceEEEcCCC
Confidence              2689999999999999986543   5889999999999999999999   7         999999999999999999


Q ss_pred             CeEEeecCccccCCCCCc------cccccccccccCccChhhhcc-------CCCCcccchHHHHHHHHHHHhCCCCCCC
Q 016594          206 EPQISDFGLAKWLPSQWT------HHSIAPIEGTFGHLAPEYFMH-------GIVDEKTDVFAFGVFLLEIISGRKPVDG  272 (386)
Q Consensus       206 ~~kl~Dfg~a~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslG~il~ell~g~~pf~~  272 (386)
                      .+||+|||++..+.....      ........||+.|+|||++.+       ..++.++|||||||++|||++|..||..
T Consensus       158 ~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~  237 (336)
T 3g2f_A          158 TCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFP  237 (336)
T ss_dssp             CEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGST
T ss_pred             cEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCC
Confidence            999999999987654321      122234569999999999987       4566899999999999999999777643


Q ss_pred             Cch-hhhh--hhhhhhccc---c-----cccccCCccCC--CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCC
Q 016594          273 SHQ-SLHS--WAKPILNQG---E-----IEKLVDPRLQG--AYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEGD  339 (386)
Q Consensus       273 ~~~-~~~~--~~~~~~~~~---~-----~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~~  339 (386)
                      ... ....  +........   .     ......+....  ......+..+.++|.+||+.||++|||+.++++.|....
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll  317 (336)
T 3g2f_A          238 GESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELM  317 (336)
T ss_dssp             TSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHH
Confidence            221 0000  000000000   0     00000111111  112346678999999999999999999999999987754

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=2.9e-43  Score=333.20  Aligned_cols=267  Identities=21%  Similarity=0.236  Sum_probs=204.7

Q ss_pred             HHHhcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccC-CC-----ceeeecceEE
Q 016594           62 SIATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVC-HP-----NVLSLLGCCV  134 (386)
Q Consensus        62 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~-----niv~l~~~~~  134 (386)
                      ....++|++.+.||+|+||+||+|.+. +++.||||++...   ......+.+|+.+++.+. |+     +|+++++++.
T Consensus        50 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~  126 (382)
T 2vx3_A           50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK---KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFM  126 (382)
T ss_dssp             CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEE
T ss_pred             CEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc---HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeec
Confidence            345678999999999999999999976 6889999999742   334556777888888775 44     4999999998


Q ss_pred             eCc-eEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEc--CCCCeEEee
Q 016594          135 DNG-LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLT--ADFEPQISD  211 (386)
Q Consensus       135 ~~~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~--~~~~~kl~D  211 (386)
                      ..+ .++|||++.+ +|.+++.......+++..+..++.|++.||.|||+. ..+|+||||||+|||++  .++.+||+|
T Consensus       127 ~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~D  204 (382)
T 2vx3_A          127 FRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVD  204 (382)
T ss_dssp             ETTEEEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECC
T ss_pred             cCCceEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEe
Confidence            765 8999999965 999999877666799999999999999999999941 17899999999999995  577899999


Q ss_pred             cCccccCCCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhh-hhhhhhcc---
Q 016594          212 FGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHS-WAKPILNQ---  287 (386)
Q Consensus       212 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~-~~~~~~~~---  287 (386)
                      ||++......     .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+....... ........   
T Consensus       205 FG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~  279 (382)
T 2vx3_A          205 FGSSCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPA  279 (382)
T ss_dssp             CTTCEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCH
T ss_pred             ccCceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence            9999876432     23456899999999999999999999999999999999999999876432111 00000000   


Q ss_pred             ------c----ccccccCC-----------------c--------------------cCCCCCHHHHHHHHHHHHHcccc
Q 016594          288 ------G----EIEKLVDP-----------------R--------------------LQGAYDVTQLNRLAFAASLCIRA  320 (386)
Q Consensus       288 ------~----~~~~~~~~-----------------~--------------------~~~~~~~~~~~~l~~li~~cl~~  320 (386)
                            .    ....+.+.                 .                    -...........+.+||.+||+.
T Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~  359 (382)
T 2vx3_A          280 HILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDY  359 (382)
T ss_dssp             HHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCS
T ss_pred             HHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCC
Confidence                  0    00000000                 0                    00001123345799999999999


Q ss_pred             CCCCCCCHHHHHHHHhcC
Q 016594          321 SPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       321 dP~~Rpt~~~il~~l~~~  338 (386)
                      ||++|||+.++|++-+..
T Consensus       360 dP~~Rpta~e~L~hp~f~  377 (382)
T 2vx3_A          360 DPKTRIQPYYALQHSFFK  377 (382)
T ss_dssp             CTTTSCCHHHHTTSGGGC
T ss_pred             ChhhCCCHHHHhcCcccc
Confidence            999999999999986654

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=3.1e-44  Score=328.88  Aligned_cols=257  Identities=22%  Similarity=0.370  Sum_probs=202.0

Q ss_pred             HhcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEE
Q 016594           64 ATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLI  141 (386)
Q Consensus        64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv  141 (386)
                      ..++|++.+.||+|+||.||+|.+. +++.||+|++....  ......+.+|+.+++.++||||+++++++.+++ .++|
T Consensus        17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   94 (302)
T 2j7t_A           17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS--EEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIM   94 (302)
T ss_dssp             GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEE
T ss_pred             CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC--HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEE
Confidence            4568999999999999999999987 58999999987532  334567889999999999999999999998755 8999


Q ss_pred             EEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCC
Q 016594          142 FQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQ  221 (386)
Q Consensus       142 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  221 (386)
                      |||+.+++|.+++.... ..+++..++.++.|++.||.|||+   ++++||||||+||+++.++.+||+|||++......
T Consensus        95 ~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  170 (302)
T 2j7t_A           95 IEFCPGGAVDAIMLELD-RGLTEPQIQVVCRQMLEALNFLHS---KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT  170 (302)
T ss_dssp             EECCTTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH
T ss_pred             EEeCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEECCCCCEEEEECCCCcccccc
Confidence            99999999999886543 348999999999999999999999   99999999999999999999999999987532111


Q ss_pred             CccccccccccccCccChhhhc-----cCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCC
Q 016594          222 WTHHSIAPIEGTFGHLAPEYFM-----HGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDP  296 (386)
Q Consensus       222 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (386)
                        ........||+.|+|||++.     +..++.++|||||||++|+|++|..||..........  ..... .       
T Consensus       171 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~--~~~~~-~-------  238 (302)
T 2j7t_A          171 --LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLL--KIAKS-D-------  238 (302)
T ss_dssp             --HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH--HHHHS-C-------
T ss_pred             --ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHH--HHhcc-C-------
Confidence              11123346899999999984     6678999999999999999999999998754321110  00000 0       


Q ss_pred             ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          297 RLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       297 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                      ......+...+..+.+++.+||+.||.+|||+.+++++.+..
T Consensus       239 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~  280 (302)
T 2j7t_A          239 PPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVS  280 (302)
T ss_dssp             CCCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTT
T ss_pred             CcccCCccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHh
Confidence            001112233456799999999999999999999999876544

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=9.5e-44  Score=324.99  Aligned_cols=259  Identities=24%  Similarity=0.321  Sum_probs=207.5

Q ss_pred             HHhcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCC-------hHhHHHHHHHHHHHhccC-CCceeeecceE
Q 016594           63 IATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTD-------DRKEKEFLTEIGTIGHVC-HPNVLSLLGCC  133 (386)
Q Consensus        63 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-------~~~~~~~~~e~~~l~~l~-h~niv~l~~~~  133 (386)
                      ...++|++.+.||+|+||.||+|.++ +++.||||++......       ......+.+|+.+++++. ||||+++++++
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~   93 (298)
T 1phk_A           14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY   93 (298)
T ss_dssp             -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred             chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence            34578999999999999999999986 6899999999753211       123456789999999996 99999999999


Q ss_pred             EeCc-eEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeec
Q 016594          134 VDNG-LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDF  212 (386)
Q Consensus       134 ~~~~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Df  212 (386)
                      .++. .++||||+.+++|.+++....  .+++..++.++.|++.||.|||+   ++++||||||+||+++.++.+||+||
T Consensus        94 ~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~df  168 (298)
T 1phk_A           94 ETNTFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDF  168 (298)
T ss_dssp             ECSSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCC
T ss_pred             ccCCeEEEEEeccCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEcCCCcEEEecc
Confidence            8766 899999999999999987643  48999999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCCCccccccccccccCccChhhhc------cCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhc
Q 016594          213 GLAKWLPSQWTHHSIAPIEGTFGHLAPEYFM------HGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILN  286 (386)
Q Consensus       213 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~  286 (386)
                      |++.......   ......|++.|+|||++.      ...++.++||||||+++|+|++|..||.........  .....
T Consensus       169 g~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~--~~~~~  243 (298)
T 1phk_A          169 GFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLML--RMIMS  243 (298)
T ss_dssp             TTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH--HHHHH
T ss_pred             cchhhcCCCc---ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHH--HHHhc
Confidence            9998765432   233456899999999985      456889999999999999999999999775432111  10000


Q ss_pred             ccccccccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          287 QGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                       ...      ..........+..+.+++.+||+.||.+|||+.+++++-+..
T Consensus       244 -~~~------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~  288 (298)
T 1phk_A          244 -GNY------QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQ  288 (298)
T ss_dssp             -TCC------CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred             -CCc------ccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhh
Confidence             000      000011123457799999999999999999999999876544

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=1.4e-43  Score=343.36  Aligned_cols=261  Identities=19%  Similarity=0.234  Sum_probs=200.9

Q ss_pred             HhcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCC-ceeeecceEEeCc-eEE
Q 016594           64 ATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHP-NVLSLLGCCVDNG-LYL  140 (386)
Q Consensus        64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~-niv~l~~~~~~~~-~~l  140 (386)
                      ..++|++.+.||+|+||.||+|.+. +++.||||++......    ..+.+|+.+++.+.|+ +|..+..++.+.. .++
T Consensus         5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~l   80 (483)
T 3sv0_A            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVL   80 (483)
T ss_dssp             ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS----CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEE
T ss_pred             cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc----HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEE
Confidence            3578999999999999999999975 6899999988753322    2477899999999874 5555555555554 789


Q ss_pred             EEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeE---cCCCCeEEeecCcccc
Q 016594          141 IFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILL---TADFEPQISDFGLAKW  217 (386)
Q Consensus       141 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~a~~  217 (386)
                      ||||+ +++|.+++.... ..+++..++.++.||+.||.|||+   ++|+||||||+|||+   +.++.+||+|||++..
T Consensus        81 vme~~-g~sL~~ll~~~~-~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~  155 (483)
T 3sv0_A           81 VMDLL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHS---KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK  155 (483)
T ss_dssp             EEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred             EEECC-CCCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCcceEEEecCCCCCeEEEEeCCccee
Confidence            99999 899999987543 359999999999999999999999   999999999999999   5889999999999987


Q ss_pred             CCCCCccc-----cccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhccccccc
Q 016594          218 LPSQWTHH-----SIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEK  292 (386)
Q Consensus       218 ~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  292 (386)
                      +.......     ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+....................
T Consensus       156 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~  235 (483)
T 3sv0_A          156 YRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVAT  235 (483)
T ss_dssp             CBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHS
T ss_pred             ccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccc
Confidence            75443221     1235679999999999999999999999999999999999999998753311110000000000000


Q ss_pred             ccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          293 LVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       293 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                      .+.. +.    ..++..+.+++..||+.+|++||++.+|++.|+..
T Consensus       236 ~~~~-l~----~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l  276 (483)
T 3sv0_A          236 SIEA-LC----RGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDL  276 (483)
T ss_dssp             CHHH-HH----TTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred             cHHH-Hh----cCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence            0000 00    11246799999999999999999999999887654

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=3.7e-45  Score=337.63  Aligned_cols=264  Identities=22%  Similarity=0.386  Sum_probs=204.3

Q ss_pred             HHHHHHhcCCCCCCeecccCCcEEEEEEECCCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-
Q 016594           59 EEISIATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-  137 (386)
Q Consensus        59 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-  137 (386)
                      ..+.+..++|++.+.||+|+||.||+|.++.  .||+|++............+.+|+.++++++||||+++++++.+.. 
T Consensus        26 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  103 (319)
T 2y4i_B           26 QEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPH  103 (319)
T ss_dssp             GGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSC
T ss_pred             ccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCc
Confidence            4445667899999999999999999999863  5999998765444444456778999999999999999999998765 


Q ss_pred             eEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCcccc
Q 016594          138 LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKW  217 (386)
Q Consensus       138 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~  217 (386)
                      .+++|||+.+++|.+++.... ..+++..++.++.|++.||.|||+   ++++||||||+||+++ ++.+||+|||++..
T Consensus       104 ~~iv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~  178 (319)
T 2y4i_B          104 LAIITSLCKGRTLYSVVRDAK-IVLDVNKTRQIAQEIVKGMGYLHA---KGILHKDLKSKNVFYD-NGKVVITDFGLFSI  178 (319)
T ss_dssp             EEEECBCCCSEEHHHHTTSSC-CCCCSHHHHHHHHHHHHHHHHHHH---TTCCCCCCCSTTEEEC---CCEECCCSCCC-
T ss_pred             eEEEeecccCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChhhEEEe-CCCEEEeecCCccc
Confidence            899999999999999987543 358999999999999999999999   9999999999999998 67999999999876


Q ss_pred             CCCCC---ccccccccccccCccChhhhcc---------CCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhh
Q 016594          218 LPSQW---THHSIAPIEGTFGHLAPEYFMH---------GIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPIL  285 (386)
Q Consensus       218 ~~~~~---~~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~  285 (386)
                      .....   .........|++.|+|||++.+         ..++.++|||||||++|+|++|..||.........+..   
T Consensus       179 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~---  255 (319)
T 2y4i_B          179 SGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQM---  255 (319)
T ss_dssp             ---------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHH---
T ss_pred             cccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh---
Confidence            53221   1122234458999999999874         45789999999999999999999999875443211111   


Q ss_pred             cccccccccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCCc
Q 016594          286 NQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEGDQ  340 (386)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~~~  340 (386)
                      ....     .+.   ......+..+.+++.+||..||.+|||+.++++.|.....
T Consensus       256 ~~~~-----~~~---~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~  302 (319)
T 2y4i_B          256 GTGM-----KPN---LSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPK  302 (319)
T ss_dssp             HTTC-----CCC---CCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC--
T ss_pred             ccCC-----CCC---CCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence            0010     010   0111233568999999999999999999999999987644

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=5e-44  Score=325.28  Aligned_cols=257  Identities=25%  Similarity=0.351  Sum_probs=207.1

Q ss_pred             HHHhcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eE
Q 016594           62 SIATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LY  139 (386)
Q Consensus        62 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~  139 (386)
                      ....++|++.+.||+|+||.||+|... +++.||+|++............+.+|+.++++++||||+++++++.+.. .+
T Consensus        18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   97 (287)
T 2wei_A           18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY   97 (287)
T ss_dssp             HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEE
Confidence            345678999999999999999999986 6899999999865555556678899999999999999999999998765 89


Q ss_pred             EEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCC---CCeEEeecCccc
Q 016594          140 LIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTAD---FEPQISDFGLAK  216 (386)
Q Consensus       140 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~---~~~kl~Dfg~a~  216 (386)
                      +++|++.+++|.+.+....  .+++..++.++.|++.||.|||+   ++++||||||+||+++.+   +.+||+|||++.
T Consensus        98 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~  172 (287)
T 2wei_A           98 IVGELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLST  172 (287)
T ss_dssp             EEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEECSTTGGG
T ss_pred             EEEEccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChhhEEEecCCCcccEEEeccCcce
Confidence            9999999999998886544  48999999999999999999999   999999999999999754   469999999998


Q ss_pred             cCCCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCC
Q 016594          217 WLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDP  296 (386)
Q Consensus       217 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (386)
                      ......   ......|++.|+|||.+.+ .++.++||||||+++|+|++|..||.+......  ...... ....     
T Consensus       173 ~~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~--~~~~~~-~~~~-----  240 (287)
T 2wei_A          173 CFQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDI--LKRVET-GKYA-----  240 (287)
T ss_dssp             TBCCCS---SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHH-CCCC-----
T ss_pred             eecCCC---ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHH--HHHHHc-CCCC-----
Confidence            764432   1233458999999998875 489999999999999999999999987543211  111100 0000     


Q ss_pred             ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 016594          297 RLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVML  336 (386)
Q Consensus       297 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~  336 (386)
                       .........+..+.+++.+||+.||++|||+.+++++.+
T Consensus       241 -~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~  279 (287)
T 2wei_A          241 -FDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPW  279 (287)
T ss_dssp             -CCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHH
T ss_pred             -CCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHH
Confidence             000001123567999999999999999999999999754

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=1.6e-44  Score=363.00  Aligned_cols=260  Identities=23%  Similarity=0.369  Sum_probs=208.9

Q ss_pred             HHHHhcCCCCCCeecccCCcEEEEEEECC----CcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeC
Q 016594           61 ISIATNAFSSENLVGRGGYAEVYKGVLQD----GEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDN  136 (386)
Q Consensus        61 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~  136 (386)
                      ..+..++|++.+.||+|+||+||+|.+..    +..||+|.+... ........+.+|+.++++++||||+++++++.++
T Consensus       385 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~  463 (656)
T 2j0j_A          385 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVITEN  463 (656)
T ss_dssp             TBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSST-TCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             cccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence            34566789999999999999999999752    457999988753 3344557789999999999999999999999777


Q ss_pred             ceEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccc
Q 016594          137 GLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAK  216 (386)
Q Consensus       137 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~  216 (386)
                      ..++||||+.+|+|.+++... ...+++..++.++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||++.
T Consensus       464 ~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDikp~NILl~~~~~vkL~DFG~a~  539 (656)
T 2j0j_A          464 PVWIIMELCTLGELRSFLQVR-KFSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSR  539 (656)
T ss_dssp             SCEEEEECCTTCBHHHHHHHT-TTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCCCC
T ss_pred             ceEEEEEcCCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchHhEEEeCCCCEEEEecCCCe
Confidence            799999999999999998754 3348999999999999999999999   999999999999999999999999999998


Q ss_pred             cCCCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCchhhhhhhhhhhcccccccccC
Q 016594          217 WLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGEIEKLVD  295 (386)
Q Consensus       217 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  295 (386)
                      ....... .......+++.|+|||++.+..++.++|||||||++|||++ |..||.+.......  ..+.. .       
T Consensus       540 ~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~--~~i~~-~-------  608 (656)
T 2j0j_A          540 YMEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI--GRIEN-G-------  608 (656)
T ss_dssp             SCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH--HHHHH-T-------
T ss_pred             ecCCCcc-eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHH--HHHHc-C-------
Confidence            7654321 12223456789999999999999999999999999999997 99999875432111  11100 0       


Q ss_pred             CccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          296 PRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       296 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                        .....+..++..+.+++.+||+.||.+|||+.+|++.|...
T Consensus       609 --~~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~i  649 (656)
T 2j0j_A          609 --ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI  649 (656)
T ss_dssp             --CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             --CCCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence              01112233457799999999999999999999999988754

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=1e-43  Score=333.57  Aligned_cols=270  Identities=18%  Similarity=0.210  Sum_probs=192.9

Q ss_pred             HHHHHhcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-
Q 016594           60 EISIATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-  137 (386)
Q Consensus        60 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-  137 (386)
                      ......++|++.+.||+|+||+||+|.+. +++.||||++.....   ......+++..+..++||||+++++++...+ 
T Consensus        17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~   93 (360)
T 3e3p_A           17 RSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR---FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGE   93 (360)
T ss_dssp             HHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTT---CCCHHHHHHHHHHHHCCTTBCCEEEEEEEECS
T ss_pred             hchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc---ccHHHHHHHHHHHhcCCCCcccHHHhhhcccc
Confidence            34567789999999999999999999986 689999998865322   2234567788888899999999999986421 


Q ss_pred             -------eEEEEEeccCCCHhhhhhh--cCCCCCCHHHHHHHHHHHHHHHHHHH--hCCCCCeEEeCCCCCCeeEcC-CC
Q 016594          138 -------LYLIFQFSSRGSVASLFHD--VNSPGVEWKVRHKIAVGTARGLHYLH--KGCQRRIIHRDIKSSNILLTA-DF  205 (386)
Q Consensus       138 -------~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~i~~qi~~~l~~LH--~~~~~~ivH~dlkp~Nill~~-~~  205 (386)
                             .++||||+.+ +|...+..  .....+++..+..++.|++.||.|||  +   ++|+||||||+|||++. ++
T Consensus        94 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~ivH~Dlkp~NIll~~~~~  169 (360)
T 3e3p_A           94 RDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPS---VNVCHRDIKPHNVLVNEADG  169 (360)
T ss_dssp             SCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTT---TCCBCSCCCGGGEEEETTTT
T ss_pred             ccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCC---CCeecCcCCHHHEEEeCCCC
Confidence                   6889999987 44443332  23445899999999999999999999  7   99999999999999996 89


Q ss_pred             CeEEeecCccccCCCCCccccccccccccCccChhhhccCC-CCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhh-h
Q 016594          206 EPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGI-VDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAK-P  283 (386)
Q Consensus       206 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~-~  283 (386)
                      .+||+|||++..+....   ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.......... .
T Consensus       170 ~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~  246 (360)
T 3e3p_A          170 TLKLCDFGSAKKLSPSE---PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVR  246 (360)
T ss_dssp             EEEECCCTTCBCCCTTS---CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred             cEEEeeCCCceecCCCC---CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHH
Confidence            99999999998765432   223456899999999987654 899999999999999999999999876532211100 0


Q ss_pred             hhcc------------cccccccCC------ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCC
Q 016594          284 ILNQ------------GEIEKLVDP------RLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEGD  339 (386)
Q Consensus       284 ~~~~------------~~~~~~~~~------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~~  339 (386)
                      ....            .........      ..........+..+.+++.+||+.||.+|||+.++++|.+...
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~  320 (360)
T 3e3p_A          247 VLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDE  320 (360)
T ss_dssp             HHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGG
T ss_pred             HcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccc
Confidence            0000            000000000      0001111224678999999999999999999999999876654

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=1.2e-43  Score=328.70  Aligned_cols=260  Identities=25%  Similarity=0.400  Sum_probs=182.7

Q ss_pred             HHhcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHH-HHhccCCCceeeecceEEeCc-eE
Q 016594           63 IATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIG-TIGHVCHPNVLSLLGCCVDNG-LY  139 (386)
Q Consensus        63 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~-~~  139 (386)
                      +..++|++.+.||+|+||.||+|.+. +++.||||++.... .......+..|+. +++.++||||+++++++.+.+ .+
T Consensus        19 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~   97 (327)
T 3aln_A           19 FTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV-DEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCW   97 (327)
T ss_dssp             CCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCC-CHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEE
T ss_pred             cCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeeccc-CchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceE
Confidence            34578999999999999999999986 78999999997643 2334455666666 777889999999999998766 88


Q ss_pred             EEEEeccCCCHhhhhhh---cCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC-CeEEeCCCCCCeeEcCCCCeEEeecCcc
Q 016594          140 LIFQFSSRGSVASLFHD---VNSPGVEWKVRHKIAVGTARGLHYLHKGCQR-RIIHRDIKSSNILLTADFEPQISDFGLA  215 (386)
Q Consensus       140 lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~-~ivH~dlkp~Nill~~~~~~kl~Dfg~a  215 (386)
                      +||||+.+ +|.+++..   .....+++..+..++.|++.||.|||+   + +|+||||||+||+++.++.+||+|||++
T Consensus        98 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~  173 (327)
T 3aln_A           98 ICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE---NLKIIHRDIKPSNILLDRSGNIKLCDFGIS  173 (327)
T ss_dssp             EEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHH---HHSCCCSCCCGGGEEEETTTEEEECCCSSS
T ss_pred             EEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhc---cCCEeECCCCHHHEEEcCCCCEEEccCCCc
Confidence            99999986 77776653   234568999999999999999999999   8 9999999999999999999999999999


Q ss_pred             ccCCCCCccccccccccccCccChhhh----ccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccc
Q 016594          216 KWLPSQWTHHSIAPIEGTFGHLAPEYF----MHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIE  291 (386)
Q Consensus       216 ~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  291 (386)
                      .......   ......||+.|+|||++    .+..++.++|||||||++|+|++|..||.+.........       .+.
T Consensus       174 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~-------~~~  243 (327)
T 3aln_A          174 GQLVDSI---AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLT-------QVV  243 (327)
T ss_dssp             CC---------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------C-------CCC
T ss_pred             eeccccc---ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHH-------HHh
Confidence            8764332   12234689999999998    466789999999999999999999999976432111000       000


Q ss_pred             cccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 016594          292 KLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLE  337 (386)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~  337 (386)
                      ....+..........+..+.+++.+||+.||++||++.+++++.+.
T Consensus       244 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~  289 (327)
T 3aln_A          244 KGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFI  289 (327)
T ss_dssp             CSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHH
T ss_pred             cCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHH
Confidence            0001111111112345679999999999999999999999987544

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=4.4e-43  Score=328.22  Aligned_cols=263  Identities=18%  Similarity=0.241  Sum_probs=203.9

Q ss_pred             HhcCCCCCCeecccCCcEEEEEEEC-CC-cEEEEEEeccccCChHhHHHHHHHHHHHhccCCCc------eeeecceEEe
Q 016594           64 ATNAFSSENLVGRGGYAEVYKGVLQ-DG-EEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPN------VLSLLGCCVD  135 (386)
Q Consensus        64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~-~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~n------iv~l~~~~~~  135 (386)
                      ..++|++.+.||+|+||+||+|... ++ ..||+|++...   ......+.+|+.+++.+.|++      ++.+++++..
T Consensus        17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~   93 (355)
T 2eu9_A           17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV---GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNF   93 (355)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEE
T ss_pred             ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc---ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeee
Confidence            4578999999999999999999975 44 68999998642   344567788999999987665      8999998877


Q ss_pred             Cc-eEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeE-------------
Q 016594          136 NG-LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILL-------------  201 (386)
Q Consensus       136 ~~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill-------------  201 (386)
                      .+ .++|||++ ++++.+.+.......+++..++.++.||+.||.|||+   ++|+||||||+|||+             
T Consensus        94 ~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~~~~  169 (355)
T 2eu9_A           94 HGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHE---NQLTHTDLKPENILFVNSEFETLYNEHK  169 (355)
T ss_dssp             TTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEESCCCEEEEECCC-
T ss_pred             CCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEecccccccccccc
Confidence            65 89999999 6677777766655669999999999999999999999   999999999999999             


Q ss_pred             ------cCCCCeEEeecCccccCCCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCch
Q 016594          202 ------TADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQ  275 (386)
Q Consensus       202 ------~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~  275 (386)
                            +.++.+||+|||++......     .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+...
T Consensus       170 ~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~  244 (355)
T 2eu9_A          170 SCEEKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHEN  244 (355)
T ss_dssp             CCCEEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred             cccccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCH
Confidence                  56789999999999865432     2345699999999999999999999999999999999999999987653


Q ss_pred             hhhhh-hhhhhcc--------ccccc-c--------------------cCC-ccCCCCCHHHHHHHHHHHHHccccCCCC
Q 016594          276 SLHSW-AKPILNQ--------GEIEK-L--------------------VDP-RLQGAYDVTQLNRLAFAASLCIRASPTW  324 (386)
Q Consensus       276 ~~~~~-~~~~~~~--------~~~~~-~--------------------~~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~  324 (386)
                      ..... .......        ..... .                    ..+ ..........+..+.+|+.+||+.||++
T Consensus       245 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~  324 (355)
T 2eu9_A          245 REHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQ  324 (355)
T ss_dssp             HHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred             HHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhh
Confidence            22111 0000000        00000 0                    000 0001122344668999999999999999


Q ss_pred             CCCHHHHHHHHhcC
Q 016594          325 RPTMSEVLEVMLEG  338 (386)
Q Consensus       325 Rpt~~~il~~l~~~  338 (386)
                      |||+.+++++-+..
T Consensus       325 Rpt~~e~l~hp~f~  338 (355)
T 2eu9_A          325 RITLAEALLHPFFA  338 (355)
T ss_dssp             SCCHHHHTTSGGGG
T ss_pred             CcCHHHHhcChhhc
Confidence            99999999886554

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=2.5e-44  Score=332.47  Aligned_cols=255  Identities=20%  Similarity=0.315  Sum_probs=204.1

Q ss_pred             CHHHHHHHhcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCCh----HhHHHHHHHHHHHhccC--CCceeee
Q 016594           57 SFEEISIATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDD----RKEKEFLTEIGTIGHVC--HPNVLSL  129 (386)
Q Consensus        57 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~----~~~~~~~~e~~~l~~l~--h~niv~l  129 (386)
                      +........++|++.+.||+|+||.||+|.+. +++.||||++.......    .....+.+|+.+++++.  |+||+++
T Consensus        34 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~  113 (320)
T 3a99_A           34 PGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRL  113 (320)
T ss_dssp             ------CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCE
T ss_pred             cccccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEE
Confidence            33445567789999999999999999999975 68999999997643222    12244667999999996  5999999


Q ss_pred             cceEEeCc-eEEEEEeccC-CCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEc-CCCC
Q 016594          130 LGCCVDNG-LYLIFQFSSR-GSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLT-ADFE  206 (386)
Q Consensus       130 ~~~~~~~~-~~lv~e~~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~-~~~~  206 (386)
                      ++++.+.+ .++++|++.+ ++|.+++....  .+++..++.++.|++.||.|||+   ++|+||||||+|||++ .++.
T Consensus       114 ~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~  188 (320)
T 3a99_A          114 LDWFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGE  188 (320)
T ss_dssp             EEEEECSSEEEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTE
T ss_pred             EEEEecCCcEEEEEEcCCCCccHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHH---CCcEeCCCCHHHEEEeCCCCC
Confidence            99998765 8899999976 89999887643  48999999999999999999999   9999999999999999 7889


Q ss_pred             eEEeecCccccCCCCCccccccccccccCccChhhhccCCC-CcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhh
Q 016594          207 PQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIV-DEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPIL  285 (386)
Q Consensus       207 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~  285 (386)
                      +||+|||++......    ......||+.|+|||++.+..+ +.++|||||||++|+|++|..||.......        
T Consensus       189 ~kL~Dfg~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~--------  256 (320)
T 3a99_A          189 LKLIDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII--------  256 (320)
T ss_dssp             EEECCCTTCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHH--------
T ss_pred             EEEeeCccccccccc----cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhhhh--------
Confidence            999999999876543    2234569999999999987765 688999999999999999999997632110        


Q ss_pred             cccccccccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCC
Q 016594          286 NQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEGD  339 (386)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~~  339 (386)
                      .. .          ...+...+..+.+++.+||+.||++|||+.+++++.+..+
T Consensus       257 ~~-~----------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~  299 (320)
T 3a99_A          257 RG-Q----------VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD  299 (320)
T ss_dssp             HC-C----------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSS
T ss_pred             cc-c----------ccccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcC
Confidence            00 0          0011123467899999999999999999999999866543

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=2.3e-43  Score=322.80  Aligned_cols=257  Identities=21%  Similarity=0.359  Sum_probs=197.6

Q ss_pred             HhcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEe-------
Q 016594           64 ATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVD-------  135 (386)
Q Consensus        64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-------  135 (386)
                      ..++|++.+.||+|+||.||+|... +++.||||++..   .......+.+|+.+++.++||||+++++++.+       
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (303)
T 1zy4_A            4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH---TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKP   80 (303)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE---EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-
T ss_pred             ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec---cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhh
Confidence            3567899999999999999999976 789999999864   23455778999999999999999999998854       


Q ss_pred             -------CceEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeE
Q 016594          136 -------NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQ  208 (386)
Q Consensus       136 -------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~k  208 (386)
                             ...++||||+.+++|.+++... ...+++..++.++.|++.||.|||+   ++++||||||+||+++.++.+|
T Consensus        81 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dlkp~Nil~~~~~~~k  156 (303)
T 1zy4_A           81 MTAVKKKSTLFIQMEYCENGTLYDLIHSE-NLNQQRDEYWRLFRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVK  156 (303)
T ss_dssp             -----CEEEEEEEEECCCSCBHHHHHHHS-CGGGCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEE
T ss_pred             hcccccCCceEEEEecCCCCCHHHhhhcc-ccccchHHHHHHHHHHHHHHHHHHh---CCeecccCCHHhEEEcCCCCEE
Confidence                   2378999999999999999753 3347889999999999999999999   9999999999999999999999


Q ss_pred             EeecCccccCCCCCc------------cccccccccccCccChhhhccC-CCCcccchHHHHHHHHHHHhCCCCCCCCch
Q 016594          209 ISDFGLAKWLPSQWT------------HHSIAPIEGTFGHLAPEYFMHG-IVDEKTDVFAFGVFLLEIISGRKPVDGSHQ  275 (386)
Q Consensus       209 l~Dfg~a~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~  275 (386)
                      |+|||++........            ........|++.|+|||++.+. .++.++|||||||++|+|++   ||.....
T Consensus       157 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~  233 (303)
T 1zy4_A          157 IGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGME  233 (303)
T ss_dssp             ECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHH
T ss_pred             EeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchh
Confidence            999999987643211            1122345689999999999864 68999999999999999998   5543221


Q ss_pred             hhhhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          276 SLHSWAKPILNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                      ... .......       .........+...+..+.+++.+||+.||.+|||+.+++++.+..
T Consensus       234 ~~~-~~~~~~~-------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~  288 (303)
T 1zy4_A          234 RVN-ILKKLRS-------VSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLP  288 (303)
T ss_dssp             HHH-HHHHHHS-------TTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSC
T ss_pred             HHH-HHHhccc-------cccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcC
Confidence            111 1110000       011112223334456789999999999999999999999986553

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=1.6e-43  Score=329.29  Aligned_cols=256  Identities=19%  Similarity=0.240  Sum_probs=178.0

Q ss_pred             HhcCCCCCC-eecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEe----C-
Q 016594           64 ATNAFSSEN-LVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVD----N-  136 (386)
Q Consensus        64 ~~~~~~~~~-~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~-  136 (386)
                      ..++|.+.+ .||+|+||+||+|.++ +++.||||++...   ....   ......++.+.||||+++++++..    + 
T Consensus        26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~---~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~   99 (336)
T 3fhr_A           26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS---PKAR---QEVDHHWQASGGPHIVCILDVYENMHHGKR   99 (336)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS---HHHH---HHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred             ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc---HHHH---HHHHHHHHhcCCCChHHHHHHHhhccCCCc
Confidence            456788854 6999999999999987 6899999998642   1111   122233566789999999999865    2 


Q ss_pred             ceEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcC---CCCeEEeecC
Q 016594          137 GLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTA---DFEPQISDFG  213 (386)
Q Consensus       137 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~---~~~~kl~Dfg  213 (386)
                      ..++||||+.+|+|.+++.......+++..++.++.|++.||.|||+   ++|+||||||+|||++.   ++.+||+|||
T Consensus       100 ~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~---~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg  176 (336)
T 3fhr_A          100 CLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFG  176 (336)
T ss_dssp             EEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred             eEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEEecCCCceEEEeccc
Confidence            27899999999999999987766679999999999999999999999   99999999999999976   4559999999


Q ss_pred             ccccCCCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccc
Q 016594          214 LAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKL  293 (386)
Q Consensus       214 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  293 (386)
                      ++......    ......||+.|+|||++.+..++.++|||||||++|+|++|..||..........       .....+
T Consensus       177 ~~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-------~~~~~~  245 (336)
T 3fhr_A          177 FAKETTQN----ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISP-------GMKRRI  245 (336)
T ss_dssp             TCEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-----------------------
T ss_pred             cceecccc----ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhh-------hHHHhh
Confidence            99866432    2234568999999999988889999999999999999999999997643321100       000000


Q ss_pred             cC--CccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCC
Q 016594          294 VD--PRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEGD  339 (386)
Q Consensus       294 ~~--~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~~  339 (386)
                      ..  ...........+..+.+++.+||+.||.+|||+.+++++.+...
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~  293 (336)
T 3fhr_A          246 RLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQ  293 (336)
T ss_dssp             -----CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred             hccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccc
Confidence            00  00111111234577999999999999999999999999876543

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.2e-43  Score=326.62  Aligned_cols=253  Identities=19%  Similarity=0.298  Sum_probs=196.8

Q ss_pred             HHHHHhcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCCh----HhHHHHHHHHHHHhcc----CCCceeeec
Q 016594           60 EISIATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDD----RKEKEFLTEIGTIGHV----CHPNVLSLL  130 (386)
Q Consensus        60 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~----~~~~~~~~e~~~l~~l----~h~niv~l~  130 (386)
                      ..+...++|++.+.||+|+||.||+|.+. +++.||||++.......    .....+.+|+.++.++    .||||++++
T Consensus        25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~  104 (312)
T 2iwi_A           25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL  104 (312)
T ss_dssp             --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred             chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence            34566789999999999999999999975 68899999997543222    1223456788988888    899999999


Q ss_pred             ceEEeCc-eEEEEEe-ccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEc-CCCCe
Q 016594          131 GCCVDNG-LYLIFQF-SSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLT-ADFEP  207 (386)
Q Consensus       131 ~~~~~~~-~~lv~e~-~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~-~~~~~  207 (386)
                      +++.+.+ .++++++ +.+++|.+++....  .+++..++.++.|++.||.|||+   ++|+||||||+||+++ .++.+
T Consensus       105 ~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~  179 (312)
T 2iwi_A          105 DWFETQEGFMLVLERPLPAQDLFDYITEKG--PLGEGPSRCFFGQVVAAIQHCHS---RGVVHRDIKDENILIDLRRGCA  179 (312)
T ss_dssp             EEC-----CEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHH---HTEECCCCSGGGEEEETTTTEE
T ss_pred             EEEecCCeEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChhhEEEeCCCCeE
Confidence            9987654 8999999 78899999987644  48999999999999999999999   9999999999999999 88999


Q ss_pred             EEeecCccccCCCCCccccccccccccCccChhhhccCCCC-cccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhc
Q 016594          208 QISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVD-EKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILN  286 (386)
Q Consensus       208 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~  286 (386)
                      ||+|||++......    ......|+..|+|||++.+..+. .++|||||||++|+|++|+.||.......        .
T Consensus       180 kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--------~  247 (312)
T 2iwi_A          180 KLIDFGSGALLHDE----PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEIL--------E  247 (312)
T ss_dssp             EECCCSSCEECCSS----CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHH--------H
T ss_pred             EEEEcchhhhcccC----cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHHHh--------h
Confidence            99999999876543    23345689999999999877664 58999999999999999999997632110        0


Q ss_pred             ccccccccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCCc
Q 016594          287 QGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEGDQ  340 (386)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~~~  340 (386)
                       .        .  ...+...+..+.+++.+||+.||++|||+.+++++.+....
T Consensus       248 -~--------~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~  290 (312)
T 2iwi_A          248 -A--------E--LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTP  290 (312)
T ss_dssp             -T--------C--CCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC-
T ss_pred             -h--------c--cCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCc
Confidence             0        0  01112335678999999999999999999999998765543

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=5.3e-43  Score=336.66  Aligned_cols=256  Identities=27%  Similarity=0.316  Sum_probs=191.1

Q ss_pred             cCCCCCCeecccCCcEEEEEEECCCcEEEEEEeccccCChHhHHHHHHHHHHHhcc-CCCceeeecceEEeCc-eEEEEE
Q 016594           66 NAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHV-CHPNVLSLLGCCVDNG-LYLIFQ  143 (386)
Q Consensus        66 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~-~~lv~e  143 (386)
                      +.|.+.+.||+|+||+||.+...+|+.||||++...     ....+.+|+.+++++ +||||+++++++.++. .++|||
T Consensus        15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~-----~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E   89 (434)
T 2rio_A           15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID-----FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALE   89 (434)
T ss_dssp             SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG-----GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred             heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH-----HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEe
Confidence            455667899999999998776667999999998642     234578899999887 7999999999998766 889999


Q ss_pred             eccCCCHhhhhhhcCCCC-----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCC-------------C
Q 016594          144 FSSRGSVASLFHDVNSPG-----VEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTAD-------------F  205 (386)
Q Consensus       144 ~~~~~~L~~~~~~~~~~~-----~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~-------------~  205 (386)
                      |+. |+|.+++.......     .++..++.++.||+.||+|||+   ++|+||||||+|||++.+             +
T Consensus        90 ~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~  165 (434)
T 2rio_A           90 LCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENL  165 (434)
T ss_dssp             CCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEECCHHHHSCCTTCCCSC
T ss_pred             cCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCcccccccccCCCce
Confidence            996 59999987643321     1233457899999999999999   999999999999999754             4


Q ss_pred             CeEEeecCccccCCCCCccc--cccccccccCccChhhhcc-------CCCCcccchHHHHHHHHHHHh-CCCCCCCCch
Q 016594          206 EPQISDFGLAKWLPSQWTHH--SIAPIEGTFGHLAPEYFMH-------GIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQ  275 (386)
Q Consensus       206 ~~kl~Dfg~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslG~il~ell~-g~~pf~~~~~  275 (386)
                      .+||+|||++..+.......  ......||+.|+|||++.+       ..++.++|||||||++|+|++ |..||.....
T Consensus       166 ~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~  245 (434)
T 2rio_A          166 RILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS  245 (434)
T ss_dssp             EEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTT
T ss_pred             EEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchh
Confidence            79999999998875532211  2234579999999999976       678999999999999999999 9999976533


Q ss_pred             hhhhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          276 SLHSWAKPILNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                      ...........        .+..........+..+.+++.+||+.||.+|||+.+++++.+..
T Consensus       246 ~~~~i~~~~~~--------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~  300 (434)
T 2rio_A          246 RESNIIRGIFS--------LDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFW  300 (434)
T ss_dssp             HHHHHHHTCCC--------CCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGS
T ss_pred             hHHHHhcCCCC--------cccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccC
Confidence            22111111000        01112223446678899999999999999999999999876554

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=6.1e-43  Score=322.52  Aligned_cols=257  Identities=21%  Similarity=0.342  Sum_probs=184.2

Q ss_pred             HhcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEE
Q 016594           64 ATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLI  141 (386)
Q Consensus        64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv  141 (386)
                      ..++|++.+.||+|+||.||+|.+. +++.||||++............+..+..+++.++||||+++++++.+++ .++|
T Consensus        23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv  102 (318)
T 2dyl_A           23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIA  102 (318)
T ss_dssp             CGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEE
Confidence            3467888999999999999999986 6899999999865433333344455556788889999999999998765 8999


Q ss_pred             EEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC-CeEEeCCCCCCeeEcCCCCeEEeecCccccCCC
Q 016594          142 FQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQR-RIIHRDIKSSNILLTADFEPQISDFGLAKWLPS  220 (386)
Q Consensus       142 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~-~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~  220 (386)
                      |||+ ++.+..+.... ...+++..++.++.|++.||.|||+   + +++||||||+||+++.++.+||+|||++.....
T Consensus       103 ~e~~-~~~~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  177 (318)
T 2dyl_A          103 MELM-GTCAEKLKKRM-QGPIPERILGKMTVAIVKALYYLKE---KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVD  177 (318)
T ss_dssp             ECCC-SEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHH---HHCCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred             Eecc-CCcHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHh---hCCEEeCCCCHHHEEECCCCCEEEEECCCchhccC
Confidence            9998 55555555432 3458999999999999999999998   6 999999999999999999999999999976643


Q ss_pred             CCccccccccccccCccChhhhc-----cCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccC
Q 016594          221 QWTHHSIAPIEGTFGHLAPEYFM-----HGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVD  295 (386)
Q Consensus       221 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  295 (386)
                      ..   ......|++.|+|||++.     +..++.++|||||||++|+|++|..||.............. .. .     .
T Consensus       178 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~-~~-~-----~  247 (318)
T 2dyl_A          178 DK---AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVL-QE-E-----P  247 (318)
T ss_dssp             ------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHH-HS-C-----C
T ss_pred             Cc---cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHh-cc-C-----C
Confidence            32   223446899999999994     56688999999999999999999999986433221111111 10 0     0


Q ss_pred             CccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 016594          296 PRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLE  337 (386)
Q Consensus       296 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~  337 (386)
                      +..  ......+..+.+++.+||+.||.+||++.+++++.+.
T Consensus       248 ~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~  287 (318)
T 2dyl_A          248 PLL--PGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFI  287 (318)
T ss_dssp             CCC--CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHH
T ss_pred             CCC--CccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHH
Confidence            000  0111234679999999999999999999999987543

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=3.6e-43  Score=324.15  Aligned_cols=264  Identities=20%  Similarity=0.305  Sum_probs=195.2

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEe--------
Q 016594           65 TNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVD--------  135 (386)
Q Consensus        65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--------  135 (386)
                      .++|++.+.||+|+||.||+|.+. +++.||+|++...  .......+.+|+.+++.++||||+++++++..        
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   87 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT--DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDD   87 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC-
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC--ChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccc
Confidence            568999999999999999999987 5899999998743  34556788999999999999999999988732        


Q ss_pred             -------CceEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEc-CCCCe
Q 016594          136 -------NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLT-ADFEP  207 (386)
Q Consensus       136 -------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~-~~~~~  207 (386)
                             ...++||||+. ++|.+++..   ..+++..++.++.|++.||+|||+   ++|+||||||+||+++ .++.+
T Consensus        88 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~  160 (320)
T 2i6l_A           88 VGSLTELNSVYIVQEYME-TDLANVLEQ---GPLLEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANLFINTEDLVL  160 (320)
T ss_dssp             ---CCSCSEEEEEEECCS-EEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTTEE
T ss_pred             cccccccCceeEEeeccC-CCHHHHhhc---CCccHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCeE
Confidence                   23789999998 589988854   348999999999999999999999   9999999999999997 56799


Q ss_pred             EEeecCccccCCCCCcc-ccccccccccCccChhhhcc-CCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhh-hhhh
Q 016594          208 QISDFGLAKWLPSQWTH-HSIAPIEGTFGHLAPEYFMH-GIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSW-AKPI  284 (386)
Q Consensus       208 kl~Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~-~~~~  284 (386)
                      ||+|||++......... .......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+........ ....
T Consensus       161 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~  240 (320)
T 2i6l_A          161 KIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILES  240 (320)
T ss_dssp             EECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred             EEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence            99999999876433211 12234457899999998876 678999999999999999999999998765321100 0000


Q ss_pred             hc---ccccccc------------cCCccC-CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 016594          285 LN---QGEIEKL------------VDPRLQ-GAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLE  337 (386)
Q Consensus       285 ~~---~~~~~~~------------~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~  337 (386)
                      ..   ......+            ..+... .......+..+.+++.+||+.||++|||+.+++++-+.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~  309 (320)
T 2i6l_A          241 IPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYM  309 (320)
T ss_dssp             SCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHH
T ss_pred             cCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCccc
Confidence            00   0000000            000000 00011235679999999999999999999999998654

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=4.5e-42  Score=329.51  Aligned_cols=255  Identities=22%  Similarity=0.258  Sum_probs=189.4

Q ss_pred             HhcCCCCCCeecccCCcEEEEEEECCCcEEEEEEeccccCChHhHHHHHHHHHHHhcc-CCCceeeecceEEeCc-eEEE
Q 016594           64 ATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHV-CHPNVLSLLGCCVDNG-LYLI  141 (386)
Q Consensus        64 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~-~~lv  141 (386)
                      ...+|.+.+.||+|+||+|+.....+++.||||++.....     ..+.+|+.+++.+ +||||+++++++.+.. .++|
T Consensus        22 ~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~-----~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv   96 (432)
T 3p23_A           22 GKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF-----SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIA   96 (432)
T ss_dssp             TTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE-----EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEE
T ss_pred             ccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH-----HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEE
Confidence            4456888999999999997655556799999999865321     1245799999999 6999999999998866 7899


Q ss_pred             EEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcC-----CCCeEEeecCccc
Q 016594          142 FQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTA-----DFEPQISDFGLAK  216 (386)
Q Consensus       142 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~-----~~~~kl~Dfg~a~  216 (386)
                      ||++. |+|.+++..... .+....++.++.||+.||.|||+   ++|+||||||+|||++.     ...+||+|||++.
T Consensus        97 ~E~~~-g~L~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~  171 (432)
T 3p23_A           97 IELCA-ATLQEYVEQKDF-AHLGLEPITLLQQTTSGLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCK  171 (432)
T ss_dssp             EECCS-EEHHHHHHSSSC-CCCSSCHHHHHHHHHHHHHHHHH---TTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEE
T ss_pred             EECCC-CCHHHHHHhcCC-CccchhHHHHHHHHHHHHHHHHH---CcCEeCCCCHHHEEEecCCCCCceeEEEeccccee
Confidence            99997 499998875443 24445567899999999999999   99999999999999953     3358899999998


Q ss_pred             cCCCCCc-cccccccccccCccChhhhc---cCCCCcccchHHHHHHHHHHHh-CCCCCCCCchhhhhhhhhhhcccccc
Q 016594          217 WLPSQWT-HHSIAPIEGTFGHLAPEYFM---HGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGEIE  291 (386)
Q Consensus       217 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~  291 (386)
                      .+..... ........||+.|+|||++.   ...++.++|||||||++|+|++ |..||............   ....  
T Consensus       172 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~---~~~~--  246 (432)
T 3p23_A          172 KLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILL---GACS--  246 (432)
T ss_dssp             CC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHT---TCCC--
T ss_pred             eccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHh---ccCC--
Confidence            7754321 12234567999999999997   4567889999999999999999 99999764332211110   0000  


Q ss_pred             cccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          292 KLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                         ..  ...........+.++|.+||+.||.+|||+.++++|.+..
T Consensus       247 ---~~--~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~  288 (432)
T 3p23_A          247 ---LD--CLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFW  288 (432)
T ss_dssp             ---CT--TSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTC
T ss_pred             ---cc--ccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCcccc
Confidence               00  0111234456789999999999999999999999876543

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=1.7e-42  Score=343.44  Aligned_cols=261  Identities=22%  Similarity=0.311  Sum_probs=200.2

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEe-------C
Q 016594           65 TNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVD-------N  136 (386)
Q Consensus        65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-------~  136 (386)
                      .++|++.+.||+|+||.||+|.+. +|+.||||++... ........+.+|+.+++.++||||+++++++..       +
T Consensus        13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~-~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~   91 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPND   91 (676)
T ss_dssp             ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC-CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTS
T ss_pred             CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCC
Confidence            478999999999999999999975 6899999998753 345556778999999999999999999998643       2


Q ss_pred             ceEEEEEeccCCCHhhhhhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCC---eEEeec
Q 016594          137 GLYLIFQFSSRGSVASLFHDVN-SPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFE---PQISDF  212 (386)
Q Consensus       137 ~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~---~kl~Df  212 (386)
                      ..++||||+.+++|.+++.... ...+++..++.++.|++.||.|||+   ++|+||||||+||+++.++.   +||+||
T Consensus        92 ~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs---~gIVHrDLKP~NILl~~~g~~~~vKL~DF  168 (676)
T 3qa8_A           92 LPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDL  168 (676)
T ss_dssp             SCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHH---TTBCCCCCCSTTEEEECCSSSCEEEECSC
T ss_pred             eEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEeecCCCceeEEEccc
Confidence            3799999999999999987643 2358899999999999999999999   99999999999999997765   899999


Q ss_pred             CccccCCCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhccccc--
Q 016594          213 GLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEI--  290 (386)
Q Consensus       213 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~--  290 (386)
                      |++.......   ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+..... .|..........  
T Consensus       169 G~a~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~-~~~~~i~~~~~~~~  244 (676)
T 3qa8_A          169 GYAKELDQGE---LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPV-QWHGKVREKSNEHI  244 (676)
T ss_dssp             CCCCBTTSCC---CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHH-HSSTTCC------C
T ss_pred             cccccccccc---ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchh-hhhhhhhcccchhh
Confidence            9998765432   2344579999999999999999999999999999999999999997653221 111111000000  


Q ss_pred             --ccc------cCC--ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 016594          291 --EKL------VDP--RLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLE  333 (386)
Q Consensus       291 --~~~------~~~--~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~  333 (386)
                        ...      ...  ..........+..+.+++..||..||++|||+.++++
T Consensus       245 ~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~  297 (676)
T 3qa8_A          245 VVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPN  297 (676)
T ss_dssp             CSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCC
T ss_pred             hhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhc
Confidence              000      000  1112234456788999999999999999999987553

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=2.9e-41  Score=342.08  Aligned_cols=237  Identities=19%  Similarity=0.291  Sum_probs=192.5

Q ss_pred             HHhcCCCCCCeecccCCcEEEEEEEC--CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc---
Q 016594           63 IATNAFSSENLVGRGGYAEVYKGVLQ--DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG---  137 (386)
Q Consensus        63 ~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~---  137 (386)
                      +..++|++.+.||+|+||.||+|.+.  +++.||||++... ........+.+|+.++++++||||+++++++...+   
T Consensus        77 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~  155 (681)
T 2pzi_A           77 IVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHS-GDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHG  155 (681)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSS-CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTS
T ss_pred             EeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCcc-CCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCC
Confidence            44589999999999999999999975  5899999998753 33455667899999999999999999999997643   


Q ss_pred             ---eEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCc
Q 016594          138 ---LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGL  214 (386)
Q Consensus       138 ---~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~  214 (386)
                         .|+||||+.+++|.+++..    .+++..++.++.||+.||.|||+   ++|+||||||+|||++.+ .+||+|||+
T Consensus       156 ~~~~~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~---~giiHrDlkp~NIll~~~-~~kl~DFG~  227 (681)
T 2pzi_A          156 DPVGYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHS---IGLVYNDLKPENIMLTEE-QLKLIDLGA  227 (681)
T ss_dssp             CEEEEEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSS-CEEECCCTT
T ss_pred             CceeEEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHH---CCCeecccChHHeEEeCC-cEEEEeccc
Confidence               5999999999999887653    59999999999999999999999   999999999999999985 899999999


Q ss_pred             cccCCCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhccccccccc
Q 016594          215 AKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLV  294 (386)
Q Consensus       215 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  294 (386)
                      +......      ....||+.|+|||++.+.. +.++|||||||++|+|++|..||.+....               .+.
T Consensus       228 a~~~~~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~---------------~~~  285 (681)
T 2pzi_A          228 VSRINSF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVD---------------GLP  285 (681)
T ss_dssp             CEETTCC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECS---------------SCC
T ss_pred             chhcccC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccc---------------ccc
Confidence            9876432      3456999999999987764 89999999999999999999988652110               000


Q ss_pred             CCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 016594          295 DPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEV  334 (386)
Q Consensus       295 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~  334 (386)
                          ........+..+.++|.+||+.||.+||+..+.+.+
T Consensus       286 ----~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~  321 (681)
T 2pzi_A          286 ----EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSA  321 (681)
T ss_dssp             ----TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred             ----ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHH
Confidence                011112234679999999999999999965554443

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=1.3e-40  Score=302.53  Aligned_cols=233  Identities=12%  Similarity=0.091  Sum_probs=185.5

Q ss_pred             HHhcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCC-hHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eE
Q 016594           63 IATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTD-DRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LY  139 (386)
Q Consensus        63 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~  139 (386)
                      +..++|++.+.||+|+||.||+|.+. +++.||||++...... ......+.+|+.++.+++||||+++++++.+++ .|
T Consensus        28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~  107 (286)
T 3uqc_A           28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGL  107 (286)
T ss_dssp             ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred             EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEE
Confidence            34578999999999999999999986 5899999999864433 445578899999999999999999999998765 89


Q ss_pred             EEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCC
Q 016594          140 LIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLP  219 (386)
Q Consensus       140 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~  219 (386)
                      +||||+.+++|.+++...    .....+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+++|      
T Consensus       108 lv~e~~~g~~L~~~l~~~----~~~~~~~~i~~ql~~aL~~lH~---~givH~Dikp~NIll~~~g~~kl~~~~------  174 (286)
T 3uqc_A          108 VVAEWIRGGSLQEVADTS----PSPVGAIRAMQSLAAAADAAHR---AGVALSIDHPSRVRVSIDGDVVLAYPA------  174 (286)
T ss_dssp             EEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEETTSCEEECSCC------
T ss_pred             EEEEecCCCCHHHHHhcC----CChHHHHHHHHHHHHHHHHHHH---CCCccCCCCcccEEEcCCCCEEEEecc------
Confidence            999999999999998532    3556788899999999999999   999999999999999999999998543      


Q ss_pred             CCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccC
Q 016594          220 SQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQ  299 (386)
Q Consensus       220 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (386)
                                      |++|       ++.++|||||||++|+|++|+.||.+.......        ............
T Consensus       175 ----------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~--------~~~~~~~~~~~~  223 (286)
T 3uqc_A          175 ----------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGL--------APAERDTAGQPI  223 (286)
T ss_dssp             ----------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCS--------EECCBCTTSCBC
T ss_pred             ----------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhh--------HHHHHHhccCCC
Confidence                            3333       688999999999999999999999875321000        000000111000


Q ss_pred             C--CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCCc
Q 016594          300 G--AYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEGDQ  340 (386)
Q Consensus       300 ~--~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~~~  340 (386)
                      .  ......+..+.+++.+||+.||++| |+.++++.|.....
T Consensus       224 ~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~  265 (286)
T 3uqc_A          224 EPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATA  265 (286)
T ss_dssp             CHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC
T ss_pred             ChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhc
Confidence            0  1112345679999999999999999 99999999987644

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=1.7e-40  Score=303.74  Aligned_cols=231  Identities=19%  Similarity=0.285  Sum_probs=181.9

Q ss_pred             cCCCCC-CeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHH-hccCCCceeeecceEEe----C-c
Q 016594           66 NAFSSE-NLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTI-GHVCHPNVLSLLGCCVD----N-G  137 (386)
Q Consensus        66 ~~~~~~-~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l-~~l~h~niv~l~~~~~~----~-~  137 (386)
                      ++|.+. +.||+|+||.||+|... +++.||+|++..       ...+.+|+.++ +.++||||+++++++..    . .
T Consensus        17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-------~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~   89 (299)
T 3m2w_A           17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-------CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKC   89 (299)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred             cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-------cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCce
Confidence            456665 78999999999999985 689999999863       23466788887 55679999999999875    2 3


Q ss_pred             eEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcC---CCCeEEeecCc
Q 016594          138 LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTA---DFEPQISDFGL  214 (386)
Q Consensus       138 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~---~~~~kl~Dfg~  214 (386)
                      .++||||+.+++|.+++.......+++..++.++.|++.||.|||+   ++|+||||||+|||++.   ++.+||+|||+
T Consensus        90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~  166 (299)
T 3m2w_A           90 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGF  166 (299)
T ss_dssp             EEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred             EEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEecCCCCCcEEEecccc
Confidence            8999999999999999988766679999999999999999999999   99999999999999998   78899999999


Q ss_pred             cccCCCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhccccccccc
Q 016594          215 AKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLV  294 (386)
Q Consensus       215 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  294 (386)
                      +....                        +..++.++|||||||++|+|++|..||.+.......       ......+.
T Consensus       167 a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~-------~~~~~~~~  215 (299)
T 3m2w_A          167 AKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS-------PGMKTRIR  215 (299)
T ss_dssp             CEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC--------------CCSCCSSC
T ss_pred             ccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh-------HHHHHHHh
Confidence            86432                        234678999999999999999999999764321100       00000111


Q ss_pred             CCccCCCCC----HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCC
Q 016594          295 DPRLQGAYD----VTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEGD  339 (386)
Q Consensus       295 ~~~~~~~~~----~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~~  339 (386)
                      ...  ...+    ...+..+.+++.+||+.||.+|||+.+++++.+...
T Consensus       216 ~~~--~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~  262 (299)
T 3m2w_A          216 MGQ--YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ  262 (299)
T ss_dssp             TTC--CSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHT
T ss_pred             hcc--ccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcc
Confidence            111  1111    123577999999999999999999999999866543

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=3.9e-41  Score=321.57  Aligned_cols=243  Identities=13%  Similarity=0.074  Sum_probs=179.8

Q ss_pred             cCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEecccc-CChHhHHHHHHHHHHHhccCC-Cceeeec------------
Q 016594           66 NAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVV-TDDRKEKEFLTEIGTIGHVCH-PNVLSLL------------  130 (386)
Q Consensus        66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h-~niv~l~------------  130 (386)
                      ..|...+.||+|+||+||+|.+. +|+.||||++.... ........+.+|+.+++.+.| +|...+.            
T Consensus        78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  157 (413)
T 3dzo_A           78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV  157 (413)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred             eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence            34677889999999999999976 79999999987422 222335678899999999976 3221111            


Q ss_pred             ---------ceEEeC-----ceEEEEEeccCCCHhhhhhh-----cCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEE
Q 016594          131 ---------GCCVDN-----GLYLIFQFSSRGSVASLFHD-----VNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIH  191 (386)
Q Consensus       131 ---------~~~~~~-----~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH  191 (386)
                               .++...     ..+++++...+++|.+++..     .....+++..++.++.|++.||+|||+   ++|+|
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~iiH  234 (413)
T 3dzo_A          158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGLVH  234 (413)
T ss_dssp             ECCC---------------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---TTEEC
T ss_pred             ccCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHh---CCccc
Confidence                     111111     12334444556799988752     223347788999999999999999999   99999


Q ss_pred             eCCCCCCeeEcCCCCeEEeecCccccCCCCCccccccccccccCccChhhh----------ccCCCCcccchHHHHHHHH
Q 016594          192 RDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYF----------MHGIVDEKTDVFAFGVFLL  261 (386)
Q Consensus       192 ~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~DvwslG~il~  261 (386)
                      |||||+|||++.++.+||+|||++......     ....+| +.|+|||++          .+..++.++|||||||++|
T Consensus       235 rDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~  308 (413)
T 3dzo_A          235 TYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIY  308 (413)
T ss_dssp             SCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHH
T ss_pred             CCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHH
Confidence            999999999999999999999998865432     344567 999999999          5556888999999999999


Q ss_pred             HHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 016594          262 EIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEV  334 (386)
Q Consensus       262 ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~  334 (386)
                      +|++|+.||......           .....++...      ...+..+.+++.+||+.||++||++.+++++
T Consensus       309 elltg~~Pf~~~~~~-----------~~~~~~~~~~------~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~  364 (413)
T 3dzo_A          309 WIWCADLPNTDDAAL-----------GGSEWIFRSC------KNIPQPVRALLEGFLRYPKEDRLLPLQAMET  364 (413)
T ss_dssp             HHHHSSCCCCTTGGG-----------SCSGGGGSSC------CCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             HHHHCCCCCCCcchh-----------hhHHHHHhhc------ccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            999999999765321           1111111111      1224679999999999999999999998875

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=2.6e-41  Score=314.31  Aligned_cols=249  Identities=16%  Similarity=0.169  Sum_probs=186.1

Q ss_pred             HHhcCCCCCCeecccCCcEEEEEEECCCcEEEEEEeccccC------ChHhHHHHHHHHHHHhccC---------CCcee
Q 016594           63 IATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVT------DDRKEKEFLTEIGTIGHVC---------HPNVL  127 (386)
Q Consensus        63 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~~e~~~l~~l~---------h~niv  127 (386)
                      +..++|++.+.||+|+||+||+|++ +|+.||||++.....      .......+.+|+.+++.++         ||||+
T Consensus        17 ~~~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv   95 (336)
T 2vuw_A           17 LPTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFI   95 (336)
T ss_dssp             SCHHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBC
T ss_pred             cccccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchh
Confidence            3457799999999999999999998 589999999986432      2233467788888888775         55555


Q ss_pred             eecce-----------------EE--------------eCceEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHH
Q 016594          128 SLLGC-----------------CV--------------DNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTAR  176 (386)
Q Consensus       128 ~l~~~-----------------~~--------------~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~  176 (386)
                      ++.++                 +.              .+..++||||+.+|++.+.+..   ..+++..++.++.||+.
T Consensus        96 ~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~qi~~  172 (336)
T 2vuw_A           96 GLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILHQLTA  172 (336)
T ss_dssp             CEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHHHHHH
T ss_pred             hhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHHHHHH
Confidence            55544                 43              3449999999999976666543   44899999999999999


Q ss_pred             HHHHHH-hCCCCCeEEeCCCCCCeeEcCCC--------------------CeEEeecCccccCCCCCccccccccccccC
Q 016594          177 GLHYLH-KGCQRRIIHRDIKSSNILLTADF--------------------EPQISDFGLAKWLPSQWTHHSIAPIEGTFG  235 (386)
Q Consensus       177 ~l~~LH-~~~~~~ivH~dlkp~Nill~~~~--------------------~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~  235 (386)
                      ||.||| +   ++|+||||||+|||++.++                    .+||+|||+|+.....       ..+||+.
T Consensus       173 aL~~lH~~---~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt~~  242 (336)
T 2vuw_A          173 SLAVAEAS---LRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVFCDV  242 (336)
T ss_dssp             HHHHHHHH---HCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEECCCC
T ss_pred             HHHHHHHh---CCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEEeec
Confidence            999999 8   9999999999999999887                    8999999999866432       3469999


Q ss_pred             ccChhhhccCCCCcccchHHHHHH-HHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHH
Q 016594          236 HLAPEYFMHGIVDEKTDVFAFGVF-LLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQLNRLAFAA  314 (386)
Q Consensus       236 y~aPE~~~~~~~~~~~DvwslG~i-l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  314 (386)
                      |+|||++.+.. +.++||||||++ .+++++|..||.+.... ..........    ...............+..+.+||
T Consensus       243 y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~-~~~~~~~~~~----~~~~~~~~~~~~~~~s~~~~dli  316 (336)
T 2vuw_A          243 SMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWL-HYLTDKMLKQ----MTFKTKCNTPAMKQIKRKIQEFH  316 (336)
T ss_dssp             TTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHH-HHHHHHHHHT----CCCSSCCCSHHHHHHHHHHHHHH
T ss_pred             ccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhh-hHHHHhhhhh----hccCcccchhhhhhcCHHHHHHH
Confidence            99999998776 899999998777 77788899998541100 0000000000    00111111112335678899999


Q ss_pred             HHccccCCCCCCCHHHHH-HHHh
Q 016594          315 SLCIRASPTWRPTMSEVL-EVML  336 (386)
Q Consensus       315 ~~cl~~dP~~Rpt~~~il-~~l~  336 (386)
                      .+||+.|     |+.++| +|-+
T Consensus       317 ~~~L~~d-----sa~e~l~~Hp~  334 (336)
T 2vuw_A          317 RTMLNFS-----SATDLLCQHSL  334 (336)
T ss_dssp             HHGGGSS-----SHHHHHHHCGG
T ss_pred             HHHhccC-----CHHHHHhcCCC
Confidence            9999976     999999 7643

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.97  E-value=9.8e-34  Score=279.79  Aligned_cols=186  Identities=15%  Similarity=0.113  Sum_probs=129.3

Q ss_pred             eecccCCcEEEEEEEC-CCcEEEEEEeccccCC--------hHhHHHHHHHHHHHhcc-CCCceeeecceEEeCc-eEEE
Q 016594           73 LVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTD--------DRKEKEFLTEIGTIGHV-CHPNVLSLLGCCVDNG-LYLI  141 (386)
Q Consensus        73 ~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--------~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~-~~lv  141 (386)
                      .++.|++|.+..++.. .|+.||+|++.+....        .....++.+|+++|+++ .|+||+++++++++++ .|+|
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV  320 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV  320 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence            3566777766665532 5899999999753211        23345689999999999 5999999999998876 9999


Q ss_pred             EEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCC
Q 016594          142 FQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQ  221 (386)
Q Consensus       142 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  221 (386)
                      |||+.|++|.+++....  .++..   .|+.||+.||+|||+   +|||||||||+|||++.+|.+||+|||+|+.....
T Consensus       321 MEyv~G~~L~d~i~~~~--~l~~~---~I~~QIl~AL~ylH~---~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~  392 (569)
T 4azs_A          321 MEKLPGRLLSDMLAAGE--EIDRE---KILGSLLRSLAALEK---QGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD  392 (569)
T ss_dssp             EECCCSEEHHHHHHTTC--CCCHH---HHHHHHHHHHHHHHH---TTCEESCCCGGGEEECTTSCEEECCCTTEESCC--
T ss_pred             EecCCCCcHHHHHHhCC--CCCHH---HHHHHHHHHHHHHHH---CCceeccCchHhEEECCCCCEEEeecccCeeCCCC
Confidence            99999999999997643  36554   588999999999999   99999999999999999999999999999876543


Q ss_pred             CccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCC
Q 016594          222 WTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKP  269 (386)
Q Consensus       222 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~p  269 (386)
                      .  ....+.+||+.|||||++.+. +..++|+||+|++++++.++..+
T Consensus       393 ~--~~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          393 C--SWPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             ---CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred             C--ccccCceechhhccHHHhCCC-CCCcccccccccchhhhccccch
Confidence            2  223456799999999998764 57789999999998887665444

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.96  E-value=1.5e-29  Score=248.61  Aligned_cols=186  Identities=18%  Similarity=0.186  Sum_probs=144.6

Q ss_pred             CCCCeecccCCcEEEEEEECCCcEEEEEEeccccCCh------HhHHHHHHHHHHHhccCCCceeeecceEEe-CceEEE
Q 016594           69 SSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDD------RKEKEFLTEIGTIGHVCHPNVLSLLGCCVD-NGLYLI  141 (386)
Q Consensus        69 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~lv  141 (386)
                      ...+.||+|+||+||+|.. .+..+++|.........      .....+.+|+.++++++||||+++..++.+ +..++|
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV  417 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM  417 (540)
T ss_dssp             ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred             CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence            4467999999999999965 47889999865422221      123457999999999999999966555554 448999


Q ss_pred             EEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCC
Q 016594          142 FQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQ  221 (386)
Q Consensus       142 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  221 (386)
                      |||+.+++|.+++..          +..++.|++.||.|||+   ++|+||||||+|||++.  .+||+|||+++.....
T Consensus       418 mE~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~---~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~  482 (540)
T 3en9_A          418 MSYINGKLAKDVIED----------NLDIAYKIGEIVGKLHK---NDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLD  482 (540)
T ss_dssp             EECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHH---TTEECTTCCTTSEEESS--SEEECCCTTCEECCCH
T ss_pred             EECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHH---CcCccCCCCHHHEEECC--eEEEEECccCEECCCc
Confidence            999999999999875          45899999999999999   99999999999999998  9999999999987553


Q ss_pred             Cccc-----cccccccccCccChhhhcc--CCCCcccchHHHHHHHHHHHhCCCCC
Q 016594          222 WTHH-----SIAPIEGTFGHLAPEYFMH--GIVDEKTDVFAFGVFLLEIISGRKPV  270 (386)
Q Consensus       222 ~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~ell~g~~pf  270 (386)
                      ....     ......||+.|+|||++..  ..|+..+|+|+..+-..+-+.++.+|
T Consensus       483 ~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          483 EDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             HHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             cccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            2211     1235679999999999987  66888999999999988888777665

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.94  E-value=7.1e-27  Score=211.12  Aligned_cols=164  Identities=13%  Similarity=0.067  Sum_probs=130.4

Q ss_pred             HHHHhcCCCCCCeecccCCcEEEEEEECCCcEEEEEEeccccCCh----------------HhHHHHHHHHHHHhccCCC
Q 016594           61 ISIATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDD----------------RKEKEFLTEIGTIGHVCHP  124 (386)
Q Consensus        61 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~----------------~~~~~~~~e~~~l~~l~h~  124 (386)
                      .......|.+++.||+|+||.||+|.+.+|+.||+|++.......                .....+.+|+.++++++  
T Consensus        85 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--  162 (282)
T 1zar_A           85 LVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--  162 (282)
T ss_dssp             HHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--
T ss_pred             HHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--
Confidence            334556677889999999999999999779999999996432111                23567889999999999  


Q ss_pred             ceeeecceEEeCceEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCC
Q 016594          125 NVLSLLGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTAD  204 (386)
Q Consensus       125 niv~l~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~  204 (386)
                      | +++.+++..+..++||||+.+++|.+ +..        .....++.|++.||.|||+   ++|+||||||+|||++ +
T Consensus       163 ~-~~v~~~~~~~~~~lvmE~~~g~~L~~-l~~--------~~~~~i~~qi~~~l~~lH~---~giiHrDlkp~NILl~-~  228 (282)
T 1zar_A          163 G-LAVPKVYAWEGNAVLMELIDAKELYR-VRV--------ENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVLVS-E  228 (282)
T ss_dssp             T-SSSCCEEEEETTEEEEECCCCEEGGG-CCC--------SCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEE-T
T ss_pred             C-CCcCeEEeccceEEEEEecCCCcHHH-cch--------hhHHHHHHHHHHHHHHHHH---CCCEeCCCCHHHEEEE-C
Confidence            6 78888777777899999999999988 421        1245799999999999999   9999999999999999 9


Q ss_pred             CCeEEeecCccccCCCCCccccccccccccCccChhhhcc----------CCCCcccchHH
Q 016594          205 FEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMH----------GIVDEKTDVFA  255 (386)
Q Consensus       205 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----------~~~~~~~Dvws  255 (386)
                      +.+||+|||+|..               +..++|||++..          ..|...+|+|.
T Consensus       229 ~~vkl~DFG~a~~---------------~~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~  274 (282)
T 1zar_A          229 EGIWIIDFPQSVE---------------VGEEGWREILERDVRNIITYFSRTYRTEKDINS  274 (282)
T ss_dssp             TEEEECCCTTCEE---------------TTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHH
T ss_pred             CcEEEEECCCCeE---------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCChHH
Confidence            9999999999873               334789998753          33455566654

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.86  E-value=8.2e-22  Score=175.74  Aligned_cols=141  Identities=16%  Similarity=0.114  Sum_probs=107.2

Q ss_pred             CCCCCCeecccCCcEEEEEEE-CCCcE--EEEEEeccccCCh----------------------HhHHHHHHHHHHHhcc
Q 016594           67 AFSSENLVGRGGYAEVYKGVL-QDGEE--IAVKRLTKVVTDD----------------------RKEKEFLTEIGTIGHV  121 (386)
Q Consensus        67 ~~~~~~~lg~G~~g~V~~~~~-~~~~~--vavK~~~~~~~~~----------------------~~~~~~~~e~~~l~~l  121 (386)
                      -|.+.+.||+|+||.||+|.+ .+|+.  ||||++.......                      .....+.+|+.++..+
T Consensus        48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l  127 (258)
T 1zth_A           48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA  127 (258)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred             chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence            367889999999999999998 57888  9999875421110                      1123678899999999


Q ss_pred             CCCceeeecceEEeCceEEEEEeccC-C----CHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCCeEEeCCC
Q 016594          122 CHPNVLSLLGCCVDNGLYLIFQFSSR-G----SVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLH-KGCQRRIIHRDIK  195 (386)
Q Consensus       122 ~h~niv~l~~~~~~~~~~lv~e~~~~-~----~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH-~~~~~~ivH~dlk  195 (386)
                      .|+++.. ...+.....++||||+.+ |    +|.++...     .++..+..++.|++.||.||| +   ++|+|||||
T Consensus       128 ~~~~i~~-p~~~~~~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~---~givHrDlk  198 (258)
T 1zth_A          128 KEAGVSV-PQPYTYMKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQE---AELVHADLS  198 (258)
T ss_dssp             HHTTCCC-CCEEEEETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHHT---SCEECSSCS
T ss_pred             HhCCCCC-CeEEEcCCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHHH---CCEEeCCCC
Confidence            8876422 122223467899999942 3    66665432     224457789999999999999 8   999999999


Q ss_pred             CCCeeEcCCCCeEEeecCccccC
Q 016594          196 SSNILLTADFEPQISDFGLAKWL  218 (386)
Q Consensus       196 p~Nill~~~~~~kl~Dfg~a~~~  218 (386)
                      |+|||++.  .++|+|||+|...
T Consensus       199 p~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          199 EYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             TTSEEESS--SEEECCCTTCEET
T ss_pred             HHHEEEcC--cEEEEECcccccC
Confidence            99999998  9999999999765

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.77  E-value=6e-19  Score=163.66  Aligned_cols=143  Identities=13%  Similarity=0.137  Sum_probs=102.2

Q ss_pred             HhcCCCCCCeecccCCcEEEEEEECCCcEEEEEEeccccCC------------hHhHHH--------HHHHHHHHhccCC
Q 016594           64 ATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTD------------DRKEKE--------FLTEIGTIGHVCH  123 (386)
Q Consensus        64 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~------------~~~~~~--------~~~e~~~l~~l~h  123 (386)
                      .+.-|.+++.||.|+||.||+|...+|+.||||+++.....            ......        ..+|...|.++.+
T Consensus        93 rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~  172 (397)
T 4gyi_A           93 RKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYE  172 (397)
T ss_dssp             TTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             CCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHh
Confidence            34459999999999999999999888999999987632110            001111        2345555555543


Q ss_pred             CceeeecceEEeCceEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcC
Q 016594          124 PNVLSLLGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTA  203 (386)
Q Consensus       124 ~niv~l~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~  203 (386)
                      .++. ....+.....++||||+.|++|..+..      .  .....++.|++.+|.+||+   +|||||||||.|||++.
T Consensus       173 ~gv~-vp~p~~~~~~~LVME~i~G~~L~~l~~------~--~~~~~l~~qll~~l~~lH~---~gIVHrDLKp~NILl~~  240 (397)
T 4gyi_A          173 EGFP-VPEPIAQSRHTIVMSLVDALPMRQVSS------V--PDPASLYADLIALILRLAK---HGLIHGDFNEFNILIRE  240 (397)
T ss_dssp             TTCS-CCCEEEEETTEEEEECCSCEEGGGCCC------C--SCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEEE
T ss_pred             cCCC-CCeeeeccCceEEEEecCCccHhhhcc------c--HHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEEEeC
Confidence            3322 222222334579999999988876542      1  1345688999999999999   99999999999999987


Q ss_pred             CC----------CeEEeecCccccC
Q 016594          204 DF----------EPQISDFGLAKWL  218 (386)
Q Consensus       204 ~~----------~~kl~Dfg~a~~~  218 (386)
                      ++          .+.|+||+.+...
T Consensus       241 dgd~~d~~~~~~~~~iID~~Q~V~~  265 (397)
T 4gyi_A          241 EKDAEDPSSITLTPIIIXFPQMVSM  265 (397)
T ss_dssp             EECSSCTTSEEEEEEECCCTTCEET
T ss_pred             CCCcccccccccceEEEEeCCcccC
Confidence            76          3899999987654

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.33  E-value=7e-12  Score=111.49  Aligned_cols=142  Identities=17%  Similarity=0.102  Sum_probs=108.7

Q ss_pred             hcCCCCCCeecccCCcEEEEEEECCCcEEEEEEeccccCChHhHHHHHHHHHHHhccC-CCceeeecceEEeCc-eEEEE
Q 016594           65 TNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVC-HPNVLSLLGCCVDNG-LYLIF  142 (386)
Q Consensus        65 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~-~~lv~  142 (386)
                      -..|.+...++.|+.+.||++... +..+++|+.......  ....+.+|+.+++.+. +..+.++++++.+.+ .++||
T Consensus        13 l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~--~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~   89 (263)
T 3tm0_A           13 IEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKG--TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLM   89 (263)
T ss_dssp             HTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTT--STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEE
T ss_pred             hccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCC--CHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEE
Confidence            356888888999999999999764 688999998642211  1235778999998885 677888998887765 89999


Q ss_pred             EeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC--------------------------------------
Q 016594          143 QFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKG--------------------------------------  184 (386)
Q Consensus       143 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~--------------------------------------  184 (386)
                      +++.|.+|.+.+..       ......++.+++.+|..||+.                                      
T Consensus        90 e~i~G~~l~~~~~~-------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (263)
T 3tm0_A           90 SEADGVLCSEEYED-------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDT  162 (263)
T ss_dssp             ECCSSEEHHHHCCT-------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTC
T ss_pred             EecCCeehhhccCC-------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccc
Confidence            99999998875321       112346788999999999981                                      


Q ss_pred             ------------------CCCCeEEeCCCCCCeeEcCCCCeEEeecCccc
Q 016594          185 ------------------CQRRIIHRDIKSSNILLTADFEPQISDFGLAK  216 (386)
Q Consensus       185 ------------------~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~  216 (386)
                                        ....++|+|++|.|||++.++.+.|+||+.+.
T Consensus       163 ~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          163 PFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             SSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             cCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                              11458999999999999876556799998765

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.22  E-value=1.1e-11  Score=109.85  Aligned_cols=128  Identities=15%  Similarity=0.086  Sum_probs=93.0

Q ss_pred             ecccCCcEEEEEEECCCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCc--eeeecceEEeCc-eEEEEEeccCCCH
Q 016594           74 VGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPN--VLSLLGCCVDNG-LYLIFQFSSRGSV  150 (386)
Q Consensus        74 lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~~~~~~~~-~~lv~e~~~~~~L  150 (386)
                      .+.|..+.||++...+|..+++|+....     ....+.+|+.+++.+.+.+  +.+++++...++ .+++|+++.|.+|
T Consensus        28 ~~gg~~~~v~~~~~~~g~~~vlK~~~~~-----~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l  102 (264)
T 1nd4_A           28 TIGCSDAAVFRLSAQGRPVLFVKTDLSG-----ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL  102 (264)
T ss_dssp             SCTTSSCEEEEEECTTSCCEEEEEECSC-----TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred             ccCCCCceEEEEecCCCCeEEEEeCCcc-----cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCccc
Confidence            3466679999998767788999987642     1234678888888886444  556787776644 7999999999887


Q ss_pred             hhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---------------------------------------------
Q 016594          151 ASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGC---------------------------------------------  185 (386)
Q Consensus       151 ~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---------------------------------------------  185 (386)
                      .  ...     ..   ...++.+++..|..||+..                                             
T Consensus       103 ~--~~~-----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (264)
T 1nd4_A          103 L--SSH-----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFA  172 (264)
T ss_dssp             T--TSC-----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHH
T ss_pred             C--cCc-----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHH
Confidence            4  211     11   2256777888888888621                                             


Q ss_pred             ----------CCCeEEeCCCCCCeeEcCCCCeEEeecCccc
Q 016594          186 ----------QRRIIHRDIKSSNILLTADFEPQISDFGLAK  216 (386)
Q Consensus       186 ----------~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~  216 (386)
                                ...++|+|++|.||+++.++.+.|+||+.+.
T Consensus       173 ~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~  213 (264)
T 1nd4_A          173 RLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  213 (264)
T ss_dssp             HHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence                      1129999999999999877667799999875

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.09  E-value=3.7e-10  Score=105.09  Aligned_cols=142  Identities=18%  Similarity=0.199  Sum_probs=104.5

Q ss_pred             CCCeecccCCcEEEEEEECCCcEEEEEEec--cccCChHhHHHHHHHHHHHhccC--CCceeeecceEEeCc----eEEE
Q 016594           70 SENLVGRGGYAEVYKGVLQDGEEIAVKRLT--KVVTDDRKEKEFLTEIGTIGHVC--HPNVLSLLGCCVDNG----LYLI  141 (386)
Q Consensus        70 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~--~~~~~~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~----~~lv  141 (386)
                      ..+.|+.|.++.||++... +..+++|+..  ... .......+.+|+.+++.+.  +..+.+++.++.+..    .++|
T Consensus        42 ~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~-~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~v  119 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSK-LLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYI  119 (359)
T ss_dssp             EEEECCC-CCSCEEEEECS-SCEEEEECCCC-----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEE
T ss_pred             eEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCC-CCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEE
Confidence            3567899999999998876 4678888765  211 1122346778999999887  456788888876642    7899


Q ss_pred             EEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC------------------------------------
Q 016594          142 FQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGC------------------------------------  185 (386)
Q Consensus       142 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~------------------------------------  185 (386)
                      ||++.|..+.+..    ...++......++.+++.+|..||+..                                    
T Consensus       120 me~v~G~~l~~~~----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (359)
T 3dxp_A          120 MEFVSGRVLWDQS----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP  195 (359)
T ss_dssp             EECCCCBCCCCTT----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred             EEecCCeecCCCc----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence            9999998774321    123677888899999999999999721                                    


Q ss_pred             -------------------CCCeEEeCCCCCCeeEcCCCC--eEEeecCcccc
Q 016594          186 -------------------QRRIIHRDIKSSNILLTADFE--PQISDFGLAKW  217 (386)
Q Consensus       186 -------------------~~~ivH~dlkp~Nill~~~~~--~kl~Dfg~a~~  217 (386)
                                         ...++|+|++|.|||++.++.  +.|+||+.+..
T Consensus       196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                               257999999999999997653  68999998864

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.04  E-value=1.9e-10  Score=104.47  Aligned_cols=187  Identities=17%  Similarity=0.160  Sum_probs=120.6

Q ss_pred             CCeecccCCcEEEEEEECCCcEEEEEEeccccCChHhHHHHHHHHHHHhccC-CCc--eeeecceEEeCc----eEEEEE
Q 016594           71 ENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVC-HPN--VLSLLGCCVDNG----LYLIFQ  143 (386)
Q Consensus        71 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~n--iv~l~~~~~~~~----~~lv~e  143 (386)
                      .+.++.|....||++.    ..+++|+...    ......+.+|+.+++.+. +..  +.+++.......    .|+||+
T Consensus        25 i~~~~~G~~n~v~~v~----~~~vlR~~~~----~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~   96 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN----RDFIFKFPKH----SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFT   96 (304)
T ss_dssp             CCEEEECSSEEEEEST----TSEEEEEESS----HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEE
T ss_pred             eEecCCCCcceEEEEC----CEEEEEecCC----cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEc
Confidence            4568999999999863    5688898653    234567889999998874 322  334443332222    478999


Q ss_pred             eccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--------------------------------------
Q 016594          144 FSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGC--------------------------------------  185 (386)
Q Consensus       144 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--------------------------------------  185 (386)
                      ++.|.++.....    ..++......++.+++..|..||+..                                      
T Consensus        97 ~i~G~~l~~~~~----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (304)
T 3sg8_A           97 KIKGVPLTPLLL----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK  172 (304)
T ss_dssp             CCCCEECCHHHH----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred             ccCCeECCcccc----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence            999988765322    12667777888888888888888511                                      


Q ss_pred             -----------------CCCeEEeCCCCCCeeEcC--CCCeEEeecCccccCCCCCccccccc------------ccccc
Q 016594          186 -----------------QRRIIHRDIKSSNILLTA--DFEPQISDFGLAKWLPSQWTHHSIAP------------IEGTF  234 (386)
Q Consensus       186 -----------------~~~ivH~dlkp~Nill~~--~~~~kl~Dfg~a~~~~~~~~~~~~~~------------~~gt~  234 (386)
                                       ...++|+|++|.||+++.  ...+.|+||+.+........-.....            +....
T Consensus       173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y  252 (304)
T 3sg8_A          173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHY  252 (304)
T ss_dssp             HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHc
Confidence                             135899999999999998  45678999999875432211000000            00001


Q ss_pred             CccC-hhhhccCCCCcccchHHHHHHHHHHHhCCCCCC
Q 016594          235 GHLA-PEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVD  271 (386)
Q Consensus       235 ~y~a-PE~~~~~~~~~~~DvwslG~il~ell~g~~pf~  271 (386)
                      +... |+.....  ....+.|++|.++|.+.+|..+|.
T Consensus       253 ~~~~~~~~~~r~--~~~~~~~~l~~~~~~~~~g~~~~~  288 (304)
T 3sg8_A          253 KHKDIPTVLEKY--RMKEKYWSFEKIIYGKEYGYMDWY  288 (304)
T ss_dssp             TCSCHHHHHHHH--HHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred             CCCCcHHHHHHH--HHHHHHHHHHHHHHHHHcCCHHHH
Confidence            1111 2221111  122689999999999999998763

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.64  E-value=2.6e-07  Score=82.09  Aligned_cols=133  Identities=12%  Similarity=0.083  Sum_probs=94.6

Q ss_pred             eecccCCc-EEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccC-CCceeeecceEEeCc-eEEEEEeccCC
Q 016594           73 LVGRGGYA-EVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVC-HPNVLSLLGCCVDNG-LYLIFQFSSRG  148 (386)
Q Consensus        73 ~lg~G~~g-~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~-~~lv~e~~~~~  148 (386)
                      .+..|..+ .||+.... ++..+++|+-..     .....+.+|+..|+.+. +--+.++++++.+.+ .++||+++.|.
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~-----~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~  105 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG-----SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGK  105 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEET-----HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSE
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCC-----CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCc
Confidence            34455554 68988765 467889997653     23456788999988875 334677788877655 89999999998


Q ss_pred             CHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC--------------------------------------------
Q 016594          149 SVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKG--------------------------------------------  184 (386)
Q Consensus       149 ~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~--------------------------------------------  184 (386)
                      ++.+......      .....+..+++..|..||..                                            
T Consensus       106 ~~~~~~~~~~------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  179 (272)
T 4gkh_A          106 TAFQVLEEYP------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQV  179 (272)
T ss_dssp             EHHHHHHHCG------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHH
T ss_pred             cccccccCCH------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHH
Confidence            8877554311      12335666777777777751                                            


Q ss_pred             -----------CCCCeEEeCCCCCCeeEcCCCCeEEeecCccc
Q 016594          185 -----------CQRRIIHRDIKSSNILLTADFEPQISDFGLAK  216 (386)
Q Consensus       185 -----------~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~  216 (386)
                                 ....++|+|+.+.|||++.++.+-|+||+.+.
T Consensus       180 ~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~  222 (272)
T 4gkh_A          180 WKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG  222 (272)
T ss_dssp             HHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence                       01237999999999999987767799999875

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.45  E-value=1.5e-06  Score=78.64  Aligned_cols=135  Identities=14%  Similarity=0.076  Sum_probs=92.4

Q ss_pred             CCeecccCCcEEEEEEECCCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCC---ceeeecceEEe--CceEEEEEec
Q 016594           71 ENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHP---NVLSLLGCCVD--NGLYLIFQFS  145 (386)
Q Consensus        71 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~l~~~~~~--~~~~lv~e~~  145 (386)
                      ...++.|....||+.    +..+++|+...    ......+.+|+.+|+.+.+.   .+.+++.+...  +..+++|+++
T Consensus        24 v~~l~~G~~n~v~~v----g~~~VlR~~~~----~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i   95 (306)
T 3tdw_A           24 VESLGEGFRNYAILV----NGDWVFRFPKS----QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKV   95 (306)
T ss_dssp             EEEEEECSSEEEEEE----TTTEEEEEESS----HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECC
T ss_pred             eeecCCCcceeEEEE----CCEEEEEecCC----chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEecc
Confidence            456888999999987    56788887532    33456788999999998742   35555555542  2378999999


Q ss_pred             cCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-----------------------------------------
Q 016594          146 SRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKG-----------------------------------------  184 (386)
Q Consensus       146 ~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~-----------------------------------------  184 (386)
                      .|..+....-.    .++......++.++...|..||+.                                         
T Consensus        96 ~G~~l~~~~~~----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~  171 (306)
T 3tdw_A           96 QGQILGEDGMA----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY  171 (306)
T ss_dssp             CSEECHHHHHT----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred             CCeECchhhhh----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence            99887653111    134444555555555555555541                                         


Q ss_pred             ----------------CCCCeEEeCCCCCCeeEcC---CCCe-EEeecCcccc
Q 016594          185 ----------------CQRRIIHRDIKSSNILLTA---DFEP-QISDFGLAKW  217 (386)
Q Consensus       185 ----------------~~~~ivH~dlkp~Nill~~---~~~~-kl~Dfg~a~~  217 (386)
                                      ....++|+|++|.||+++.   ++.+ .|+||+.+..
T Consensus       172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                            1235799999999999987   4554 8999998764

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.19  E-value=2.2e-06  Score=79.35  Aligned_cols=80  Identities=8%  Similarity=-0.059  Sum_probs=51.8

Q ss_pred             Cee-cccCCcEEEEEEEC-------CCcEEEEEEeccccC-ChHhHHHHHHHHHHHhccC-C--CceeeecceEEeC---
Q 016594           72 NLV-GRGGYAEVYKGVLQ-------DGEEIAVKRLTKVVT-DDRKEKEFLTEIGTIGHVC-H--PNVLSLLGCCVDN---  136 (386)
Q Consensus        72 ~~l-g~G~~g~V~~~~~~-------~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h--~niv~l~~~~~~~---  136 (386)
                      +.| +.|....+|+....       ++..+++|+...... .......+.+|+.+++.+. +  -.+.+++.++.+.   
T Consensus        26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~  105 (357)
T 3ats_A           26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL  105 (357)
T ss_dssp             EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred             EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence            567 88888999998754       266788987653210 0001134567777777764 2  3466777776554   


Q ss_pred             -ceEEEEEeccCCCHh
Q 016594          137 -GLYLIFQFSSRGSVA  151 (386)
Q Consensus       137 -~~~lv~e~~~~~~L~  151 (386)
                       ..+++|+++.|..+.
T Consensus       106 g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A          106 GTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             SSCEEEEECCCCBCCC
T ss_pred             CCceEEEEecCCCChh
Confidence             268999999987654

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.14  E-value=8.9e-06  Score=76.40  Aligned_cols=77  Identities=12%  Similarity=0.011  Sum_probs=48.1

Q ss_pred             CCeecccCCcEEEEEEEC-CCcEEEEEEeccccC--C---hHhHHHHHHHHHHHhccCC--C-ceeeecceEEeCceEEE
Q 016594           71 ENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVT--D---DRKEKEFLTEIGTIGHVCH--P-NVLSLLGCCVDNGLYLI  141 (386)
Q Consensus        71 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~---~~~~~~~~~e~~~l~~l~h--~-niv~l~~~~~~~~~~lv  141 (386)
                      .+.||.|..+.||++... +++.++||.......  .   ......+..|+.+++.+..  + .+.+++.+ ..+..++|
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~-d~~~~~lv  113 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS-DTEMAVTV  113 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE-ETTTTEEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE-cCCccEEE
Confidence            467999999999999754 467899998653211  0   0122345678888877642  3 34455533 33447899


Q ss_pred             EEeccCC
Q 016594          142 FQFSSRG  148 (386)
Q Consensus       142 ~e~~~~~  148 (386)
                      ||++.+.
T Consensus       114 mE~l~g~  120 (397)
T 2olc_A          114 MEDLSHL  120 (397)
T ss_dssp             ECCCTTS
T ss_pred             EEeCCCc
Confidence            9999764

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=98.07  E-value=1.4e-05  Score=71.62  Aligned_cols=82  Identities=16%  Similarity=0.163  Sum_probs=56.2

Q ss_pred             HhcCCCCCCeecccCCcEEEEEEECCCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCC---ceeeecceEEeCceEE
Q 016594           64 ATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHP---NVLSLLGCCVDNGLYL  140 (386)
Q Consensus        64 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~l~~~~~~~~~~l  140 (386)
                      .+....-...+|.|..+.||+....+|+.|++|+.....  ......+..|+..|+.|.-.   -+.+++++   +..++
T Consensus        13 ~G~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~---~~~~l   87 (288)
T 3f7w_A           13 TGREVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDA--PALDGLFRAEALGLDWLGRSFGSPVPQVAGW---DDRTL   87 (288)
T ss_dssp             HCCCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTC--CCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE---ETTEE
T ss_pred             cCCCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCC--cchhhHHHHHHHHHHHHHhhCCCCcceEEec---cCceE
Confidence            445555677899999999999999999999999865422  11223467888888877522   23333332   34578


Q ss_pred             EEEeccCCCH
Q 016594          141 IFQFSSRGSV  150 (386)
Q Consensus       141 v~e~~~~~~L  150 (386)
                      +||++.++..
T Consensus        88 v~e~l~~~~~   97 (288)
T 3f7w_A           88 AMEWVDERPP   97 (288)
T ss_dssp             EEECCCCCCC
T ss_pred             EEEeecccCC
Confidence            9999887643

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.06  E-value=5.1e-05  Score=69.42  Aligned_cols=30  Identities=20%  Similarity=0.282  Sum_probs=27.5

Q ss_pred             CCeEEeCCCCCCeeEcCCCCeEEeecCccc
Q 016594          187 RRIIHRDIKSSNILLTADFEPQISDFGLAK  216 (386)
Q Consensus       187 ~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~  216 (386)
                      ..++|+|+++.|||++.++.+.|+||+.+.
T Consensus       222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             CCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             CceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence            789999999999999888899999999765

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.88  E-value=9.9e-05  Score=66.71  Aligned_cols=74  Identities=15%  Similarity=0.159  Sum_probs=56.2

Q ss_pred             CCeecccCCcEEEEEEECCCcEEEEEEeccccCChHhHHHHHHHHHHHhccC---CCceeeecceEEeCc-eEEEEEecc
Q 016594           71 ENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVC---HPNVLSLLGCCVDNG-LYLIFQFSS  146 (386)
Q Consensus        71 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~-~~lv~e~~~  146 (386)
                      .+.|+.|....+|+.... +..+++|+....     ....+..|+..|+.|.   ...+.+++.+....+ .+++|++++
T Consensus        41 ~~~l~gG~~n~~y~v~~~-~~~~vlK~~~~~-----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~  114 (312)
T 3jr1_A           41 KEKLYSGEMNEIWLINDE-VQTVFVKINERS-----YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALN  114 (312)
T ss_dssp             EEEECCSSSSEEEEEESS-SCEEEEEEEEGG-----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCC
T ss_pred             eEEeCCccceeeeEEEEC-CCeEEEEeCCcc-----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEecc
Confidence            457899999999998864 678889987532     2456788888888874   356777887776544 899999999


Q ss_pred             CCCH
Q 016594          147 RGSV  150 (386)
Q Consensus       147 ~~~L  150 (386)
                      +..+
T Consensus       115 G~~~  118 (312)
T 3jr1_A          115 KSKN  118 (312)
T ss_dssp             CCCC
T ss_pred             CCCC
Confidence            8764

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.86  E-value=6.6e-05  Score=63.10  Aligned_cols=141  Identities=10%  Similarity=0.038  Sum_probs=89.3

Q ss_pred             CHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCcccccc
Q 016594          149 SVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIA  228 (386)
Q Consensus       149 ~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  228 (386)
                      +|.+++...+. +++++++|.+..|.+.+|.-+-..  +.-..+=+.|..|++..+|.|.+.+ +.+.            
T Consensus        34 SL~eIL~~~~~-PlsEEqaWALc~Qc~~~L~~~~~~--~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~------------   97 (229)
T 2yle_A           34 SLEEILRLYNQ-PINEEQAWAVCYQCCGSLRAAARR--RQPRHRVRSAAQIRVWRDGAVTLAP-AADD------------   97 (229)
T ss_dssp             EHHHHHHHHTS-CCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCSGGGEEEETTSCEEECC-C---------------
T ss_pred             cHHHHHHHcCC-CcCHHHHHHHHHHHHHHHHhhhhc--ccCCceecCCcceEEecCCceeccc-cccc------------
Confidence            78888887655 499999999999999998776210  1111333457899999999888764 2111            


Q ss_pred             ccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCCCCCHHHHH
Q 016594          229 PIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQLN  308 (386)
Q Consensus       229 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (386)
                        .....+.|||... ...+.+.=|||||++||..+--..|=.                              .+...++
T Consensus        98 --~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~e~------------------------------eE~eLS~  144 (229)
T 2yle_A           98 --AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLKEN------------------------------EERELSP  144 (229)
T ss_dssp             -----------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCCTT------------------------------EEECCCH
T ss_pred             --ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCCcc------------------------------cchhhCH
Confidence              0222356888653 344678899999999999887333311                              1112235


Q ss_pred             HHHHHHHHcccc-------------------------CCCCCCCHHHHHHHHhcC
Q 016594          309 RLAFAASLCIRA-------------------------SPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       309 ~l~~li~~cl~~-------------------------dP~~Rpt~~~il~~l~~~  338 (386)
                      .|..||..|...                         .+..|+++.+|++.-...
T Consensus       145 ~LE~LL~~Mt~~~~d~~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~~C~~h  199 (229)
T 2yle_A          145 PLEQLIDHMANTVEADGSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMKLCAAH  199 (229)
T ss_dssp             HHHHHHHHHTTCCC--------------------CCSCCCCCCSHHHHHHHHHTT
T ss_pred             HHHHHHHHHHhcccccccccccccccccccccccccccccCcCCHHHHHHHHHhh
Confidence            566777776644                         356889999999876543

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.75  E-value=0.00015  Score=68.55  Aligned_cols=76  Identities=14%  Similarity=0.185  Sum_probs=45.6

Q ss_pred             CCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCcccccccccc--ccCccChhhhccCC---CCcccchHHHHHHHH
Q 016594          187 RRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEG--TFGHLAPEYFMHGI---VDEKTDVFAFGVFLL  261 (386)
Q Consensus       187 ~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~---~~~~~DvwslG~il~  261 (386)
                      ..++|+|++|.|||++.++ ++|+||+.+..-.....-   .....  ...|++|+......   .....++..+...+|
T Consensus       232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dl---a~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (420)
T 2pyw_A          232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDI---GAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTW  307 (420)
T ss_dssp             CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHH---HHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHH
T ss_pred             CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHH---HHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHH
Confidence            7899999999999998776 999999988753321110   00000  12355555443111   112344557777777


Q ss_pred             HHHhC
Q 016594          262 EIISG  266 (386)
Q Consensus       262 ell~g  266 (386)
                      +.+.+
T Consensus       308 ~~y~~  312 (420)
T 2pyw_A          308 NLFNK  312 (420)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            77664

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.46  E-value=0.00042  Score=62.23  Aligned_cols=71  Identities=8%  Similarity=0.001  Sum_probs=41.7

Q ss_pred             CCeecccCCcEEEEEEECCCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCce-eeecceEEeCceEEEEEec-cCC
Q 016594           71 ENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNV-LSLLGCCVDNGLYLIFQFS-SRG  148 (386)
Q Consensus        71 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~lv~e~~-~~~  148 (386)
                      .+.|+.|....+|++     ..+++|+.......   .....+|+.+++.+...++ .++++++ .+.-+++++|+ .+.
T Consensus        23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~---~~~r~~E~~~l~~l~~~g~~P~~~~~~-~~~~~~v~e~i~~g~   93 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE---YINRANEAVAAREAAKAGVSPEVLHVD-PATGVMVTRYIAGAQ   93 (301)
T ss_dssp             CEEEESCSSEEEEEE-----TTEEEEEECC-------CCCHHHHHHHHHHHHHTTSSCCEEEEC-TTTCCEEEECCTTCE
T ss_pred             eeEcCCcccccccee-----eeEEEECCCCCccc---eeCHHHHHHHHHHHHHcCCCCceEEEE-CCCCEEEEeecCCCc
Confidence            678999999999998     56888887642111   1112356666666542222 3444332 22356889999 554


Q ss_pred             CH
Q 016594          149 SV  150 (386)
Q Consensus       149 ~L  150 (386)
                      ++
T Consensus        94 ~l   95 (301)
T 3dxq_A           94 TM   95 (301)
T ss_dssp             EC
T ss_pred             cC
Confidence            44

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.41  E-value=0.00032  Score=63.98  Aligned_cols=33  Identities=27%  Similarity=0.355  Sum_probs=28.2

Q ss_pred             CCCeEEeCCCCCCeeEcCC----CCeEEeecCccccC
Q 016594          186 QRRIIHRDIKSSNILLTAD----FEPQISDFGLAKWL  218 (386)
Q Consensus       186 ~~~ivH~dlkp~Nill~~~----~~~kl~Dfg~a~~~  218 (386)
                      ...++|||+.+.|||++.+    +.+.|+||+.+..-
T Consensus       182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G  218 (333)
T 3csv_A          182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG  218 (333)
T ss_dssp             CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred             CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence            3689999999999999874    67899999988754

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.38  E-value=0.00046  Score=64.03  Aligned_cols=140  Identities=14%  Similarity=0.164  Sum_probs=80.2

Q ss_pred             CCeecccCCcEEEEEEEC--------CCcEEEEEEeccccCChHhHHHHHHHHHHHhccC-CCceeeecceEEeCceEEE
Q 016594           71 ENLVGRGGYAEVYKGVLQ--------DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVC-HPNVLSLLGCCVDNGLYLI  141 (386)
Q Consensus        71 ~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~lv  141 (386)
                      .+.|..|-...+|++...        +++.+++|+.....   .....+.+|..+++.|. +.-..++++++.+   .+|
T Consensus        55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~---~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~---g~v  128 (379)
T 3feg_A           55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL---QGVDSLVLESVMFAILAERSLGPQLYGVFPE---GRL  128 (379)
T ss_dssp             CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT---EEE
T ss_pred             EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc---chHHHHHHHHHHHHHHHhcCCCCeEEEEcCC---ccE
Confidence            456778888999999864        24789999863311   12345568888888775 3223555555432   289


Q ss_pred             EEeccCCCHhh--------------hh---hhcC---CCCCC--HHHHHHHHHHHHH-------------------HHHH
Q 016594          142 FQFSSRGSVAS--------------LF---HDVN---SPGVE--WKVRHKIAVGTAR-------------------GLHY  180 (386)
Q Consensus       142 ~e~~~~~~L~~--------------~~---~~~~---~~~~~--~~~~~~i~~qi~~-------------------~l~~  180 (386)
                      ++|+.|..|..              .+   +...   .+...  +..+..+..++..                   .+..
T Consensus       129 ~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  208 (379)
T 3feg_A          129 EQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGN  208 (379)
T ss_dssp             EECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHH
T ss_pred             EEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHH
Confidence            99998865431              01   1111   11122  3444445443321                   1222


Q ss_pred             HH----h-CCCCCeEEeCCCCCCeeEcCC----CCeEEeecCccc
Q 016594          181 LH----K-GCQRRIIHRDIKSSNILLTAD----FEPQISDFGLAK  216 (386)
Q Consensus       181 LH----~-~~~~~ivH~dlkp~Nill~~~----~~~kl~Dfg~a~  216 (386)
                      |.    . .....++|+|+.+.|||++.+    +.+.|+||..+.
T Consensus       209 L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~  253 (379)
T 3feg_A          209 LRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS  253 (379)
T ss_dssp             HHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred             HHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence            22    1 123469999999999999876    789999998775

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.35  E-value=0.00096  Score=60.36  Aligned_cols=140  Identities=15%  Similarity=0.167  Sum_probs=74.4

Q ss_pred             CeecccCCcEEEEEEECCCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCc--eeeecce------E-EeCceEEEE
Q 016594           72 NLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPN--VLSLLGC------C-VDNGLYLIF  142 (386)
Q Consensus        72 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~~~------~-~~~~~~lv~  142 (386)
                      +.|+.|....+|+....++ .+++|+.....    ....+..|+.+++.+...+  +.+++..      . ..+..++++
T Consensus        28 ~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~----~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~  102 (322)
T 2ppq_A           28 KGIAEGVENSNFLLHTTKD-PLILTLYEKRV----EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALI  102 (322)
T ss_dssp             EEECC---EEEEEEEESSC-CEEEEEECC-------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEE
T ss_pred             eccCCCcccceEEEEeCCc-cEEEEEeCCCC----CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEE
Confidence            3567788899999987655 68899876421    1123445666666554111  2333321      1 123468899


Q ss_pred             EeccCCCHhh--------------hhhhc----CCCC---CC---HHHHHH------------HHHHHHHHHHHHHh---
Q 016594          143 QFSSRGSVAS--------------LFHDV----NSPG---VE---WKVRHK------------IAVGTARGLHYLHK---  183 (386)
Q Consensus       143 e~~~~~~L~~--------------~~~~~----~~~~---~~---~~~~~~------------i~~qi~~~l~~LH~---  183 (386)
                      +++.|..+..              .++..    ..+.   ..   |.....            +...+...+..+..   
T Consensus       103 ~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~  182 (322)
T 2ppq_A          103 SFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWP  182 (322)
T ss_dssp             ECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCC
T ss_pred             EeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCc
Confidence            9998865321              01111    1110   11   111000            00113334455542   


Q ss_pred             -CCCCCeEEeCCCCCCeeEcCCCCeEEeecCccc
Q 016594          184 -GCQRRIIHRDIKSSNILLTADFEPQISDFGLAK  216 (386)
Q Consensus       184 -~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~  216 (386)
                       ....+++|+|+.+.|||++.++.+.|+||+.+.
T Consensus       183 ~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          183 KDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             CSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             ccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence             113579999999999999887656899998765

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.25  E-value=0.00042  Score=65.62  Aligned_cols=72  Identities=8%  Similarity=0.095  Sum_probs=47.1

Q ss_pred             CCeecccCCcEEEEEEECC--------CcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCce-eeecceEEeCceEEE
Q 016594           71 ENLVGRGGYAEVYKGVLQD--------GEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNV-LSLLGCCVDNGLYLI  141 (386)
Q Consensus        71 ~~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~lv  141 (386)
                      .+.|+.|....||++...+        +..+++|+....  .  ....+.+|+.+++.+...++ .++++.+. +  .++
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~-~--g~v  150 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--E--TESHLVAESVIFTLLSERHLGPKLYGIFS-G--GRL  150 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--C--CHHHHHHHHHHHHHHHHTTSSSCEEEEET-T--EEE
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--C--cHHHHHHHHHHHHHHHhCCCCCcEEEEeC-C--CEE
Confidence            4578889899999998753        478999987431  1  11345578888887763333 55555443 2  378


Q ss_pred             EEeccCCC
Q 016594          142 FQFSSRGS  149 (386)
Q Consensus       142 ~e~~~~~~  149 (386)
                      ++|+.|.+
T Consensus       151 ~e~l~G~~  158 (429)
T 1nw1_A          151 EEYIPSRP  158 (429)
T ss_dssp             ECCCCEEE
T ss_pred             EEEeCCcc
Confidence            89987643

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.09  E-value=0.0022  Score=61.05  Aligned_cols=74  Identities=9%  Similarity=-0.060  Sum_probs=45.7

Q ss_pred             CCeecccCCcEEEEEEECC-CcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCce-eeecceEEeCceEEEEEeccCC
Q 016594           71 ENLVGRGGYAEVYKGVLQD-GEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNV-LSLLGCCVDNGLYLIFQFSSRG  148 (386)
Q Consensus        71 ~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~lv~e~~~~~  148 (386)
                      .+.|+.|-...+|++...+ +..+++|+........   ....+|+.+++.|...++ .++++++ .+  .+|++|++|.
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~---idR~~E~~vl~~L~~~gl~P~ll~~~-~~--G~v~e~I~G~  186 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI---INREREKKISCILYNKNIAKKIYVFF-TN--GRIEEFMDGY  186 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC---SCHHHHHHHHHHHTTSSSBCCEEEEE-TT--EEEEECCCSE
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh---cCHHHHHHHHHHHHhcCCCCCEEEEe-CC--eEEEEeeCCc
Confidence            3468888889999998764 4788899875321111   112478888888764444 4566655 22  3599999875


Q ss_pred             CH
Q 016594          149 SV  150 (386)
Q Consensus       149 ~L  150 (386)
                      .|
T Consensus       187 ~l  188 (458)
T 2qg7_A          187 AL  188 (458)
T ss_dssp             EC
T ss_pred             cC
Confidence            44

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.01  E-value=0.011  Score=53.31  Aligned_cols=140  Identities=15%  Similarity=0.111  Sum_probs=77.5

Q ss_pred             CeecccCCcEEEEEEECCCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCC--ceeeecce-----EE-eCceEEEEE
Q 016594           72 NLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHP--NVLSLLGC-----CV-DNGLYLIFQ  143 (386)
Q Consensus        72 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~--niv~l~~~-----~~-~~~~~lv~e  143 (386)
                      ..|+ |....||++...+|+.+++|.......   ....+..|+.+++.+...  .+++++..     .. ++..+++++
T Consensus        32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~---~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~  107 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPERW---TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFP  107 (328)
T ss_dssp             EEEC-CSSSEEEEECCTTCCCEEEEEECTTTS---CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEE
T ss_pred             Eeec-CcccceEEEEcCCCCEEEEEEcCCCCC---CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEE
Confidence            3566 888899998776677899998863211   233455677777666421  23444432     11 223578899


Q ss_pred             eccCCCHh-----h------h---hhhc-C------CCCCCHHHH----------------------HHHHHHHHHHHHH
Q 016594          144 FSSRGSVA-----S------L---FHDV-N------SPGVEWKVR----------------------HKIAVGTARGLHY  180 (386)
Q Consensus       144 ~~~~~~L~-----~------~---~~~~-~------~~~~~~~~~----------------------~~i~~qi~~~l~~  180 (386)
                      ++.|..+.     .      .   ++.. .      .........                      ...+..++..+.-
T Consensus       108 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~  187 (328)
T 1zyl_A          108 SVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTA  187 (328)
T ss_dssp             CCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHH
T ss_pred             ecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHH
Confidence            99875432     0      0   1110 0      011222111                      0111112222222


Q ss_pred             HHh-CCCCCeEEeCCCCCCeeEcCCCCeEEeecCcccc
Q 016594          181 LHK-GCQRRIIHRDIKSSNILLTADFEPQISDFGLAKW  217 (386)
Q Consensus       181 LH~-~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~  217 (386)
                      +-. .....++|+|+++.|||++ + .+.|+||+.+..
T Consensus       188 ~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          188 HWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             HCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             HhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence            111 1235789999999999999 4 899999987653

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.71  E-value=0.0063  Score=56.17  Aligned_cols=74  Identities=12%  Similarity=0.065  Sum_probs=42.1

Q ss_pred             CCeecccCCcEEEEEEECC---------CcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCc-eeeecceEEeCceEE
Q 016594           71 ENLVGRGGYAEVYKGVLQD---------GEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPN-VLSLLGCCVDNGLYL  140 (386)
Q Consensus        71 ~~~lg~G~~g~V~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~~~l  140 (386)
                      ...|+.|....+|++...+         +..+++|+.....   ........|+.+++.+...+ +.++++.+  . -++
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~---~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~-~~~  111 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV---DELYNTISEFEVYKTMSKYKIAPQLLNTF--N-GGR  111 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG---GGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T-TEE
T ss_pred             EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc---cceecHHHHHHHHHHHHhcCCCCceEEec--C-CcE
Confidence            3567888889999998753         2688888765321   11112346777777665323 34555433  2 368


Q ss_pred             EEEeccCCCH
Q 016594          141 IFQFSSRGSV  150 (386)
Q Consensus       141 v~e~~~~~~L  150 (386)
                      +++++.|..+
T Consensus       112 v~e~i~G~~l  121 (369)
T 3c5i_A          112 IEEWLYGDPL  121 (369)
T ss_dssp             EEECCCSEEC
T ss_pred             EEEEecCCcC
Confidence            8999987543

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.39  E-value=0.026  Score=51.33  Aligned_cols=31  Identities=23%  Similarity=0.287  Sum_probs=27.7

Q ss_pred             CCeEEeCCCCCCeeEcCCCCeEEeecCcccc
Q 016594          187 RRIIHRDIKSSNILLTADFEPQISDFGLAKW  217 (386)
Q Consensus       187 ~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~  217 (386)
                      ..++|+|+.+.||+++.++.+.|+||+.+..
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            5799999999999999888899999987764

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=94.75  E-value=0.049  Score=50.79  Aligned_cols=30  Identities=27%  Similarity=0.448  Sum_probs=25.0

Q ss_pred             CeEEeCCCCCCeeE------cCCCCeEEeecCcccc
Q 016594          188 RIIHRDIKSSNILL------TADFEPQISDFGLAKW  217 (386)
Q Consensus       188 ~ivH~dlkp~Nill------~~~~~~kl~Dfg~a~~  217 (386)
                      .++|+|+.+.|||+      +.+..+.++||..|..
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            36799999999999      4567799999988753

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=94.42  E-value=0.27  Score=46.04  Aligned_cols=74  Identities=11%  Similarity=-0.017  Sum_probs=45.8

Q ss_pred             CCeecccCCcEEEEEEECC--------CcEEEEEEeccccCChHhHHHHHHHHHHHhccC-CCceeeecceEEeCceEEE
Q 016594           71 ENLVGRGGYAEVYKGVLQD--------GEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVC-HPNVLSLLGCCVDNGLYLI  141 (386)
Q Consensus        71 ~~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~lv  141 (386)
                      .+.|..|....+|++...+        +..+++++.....   .......+|..+++.+. +.-..++++.  .. -++|
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t---~~~idR~~E~~~l~~L~~~gi~P~l~~~--~~-~~~I  148 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV---GKFYDSKVELDVFRYLSNINIAPNIIAD--FP-EGRI  148 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC----CCCCHHHHHHHHHHHHHTTSSCCEEEE--ET-TEEE
T ss_pred             EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc---chhcCHHHHHHHHHHHHhcCCCCCEEEE--cC-CCEE
Confidence            4567788899999998753        5789999865321   11112346777776665 2223444432  22 3688


Q ss_pred             EEeccCCCH
Q 016594          142 FQFSSRGSV  150 (386)
Q Consensus       142 ~e~~~~~~L  150 (386)
                      ++|+.|..|
T Consensus       149 ~efI~G~~l  157 (424)
T 3mes_A          149 EEFIDGEPL  157 (424)
T ss_dssp             EECCCSEEC
T ss_pred             EEEeCCccC
Confidence            999998654

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=92.42  E-value=0.019  Score=54.75  Aligned_cols=64  Identities=8%  Similarity=0.032  Sum_probs=19.5

Q ss_pred             CCCCeecccCCcEEEEEEECC-CcEEEE------EEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEe
Q 016594           69 SSENLVGRGGYAEVYKGVLQD-GEEIAV------KRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVD  135 (386)
Q Consensus        69 ~~~~~lg~G~~g~V~~~~~~~-~~~vav------K~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~  135 (386)
                      .+.+.||   ||.||+|.+.. ..+|||      |..............+.+|..+++.+.|||+++.+++...
T Consensus       145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~  215 (463)
T 3cxl_A          145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVH  215 (463)
T ss_dssp             CSTTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEEE
T ss_pred             cccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEEe
Confidence            4566776   99999999863 457888      7665434444445678889999999999999999988653

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=89.65  E-value=0.71  Score=38.59  Aligned_cols=116  Identities=9%  Similarity=0.057  Sum_probs=73.8

Q ss_pred             CCCceeeecceEEeCceEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeE
Q 016594          122 CHPNVLSLLGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILL  201 (386)
Q Consensus       122 ~h~niv~l~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill  201 (386)
                      .||+.+.. .+-.+.+ -+.+.|-.......+-.-   +.++....++++.+|+....++++     -+|--|+|+||++
T Consensus        43 ~~~~Fl~~-~I~e~eD-~v~~~y~~~~~~~~f~~i---k~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~NL~f  112 (215)
T 4ann_A           43 HSPYFIDA-ELTELRD-SFQIHYDINDNHTPFDNI---KSFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPDELFF  112 (215)
T ss_dssp             CCTTBCCE-EEEECSS-EEEEEECCCTTSEEGGGG---GGSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGGGEEE
T ss_pred             cCCcccce-EEEEccc-EEEEEEEcCcccCCHHHH---HhcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecceEEE
Confidence            47877766 3444444 333334333322222211   127788999999999887765553     4788899999999


Q ss_pred             cCCCCeEEeecCccccCCCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCC
Q 016594          202 TADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVD  271 (386)
Q Consensus       202 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~  271 (386)
                      +.++.+++.-.|+-..+                   +|.     .++...=+-.+=|++..+++++..|.
T Consensus       113 ~~~~~p~i~~RGik~~l-------------------~P~-----~~~ee~fL~qyKAliiall~~K~~Fe  158 (215)
T 4ann_A          113 TRDGLPIAKTRGLQNVV-------------------DPL-----PVSEAEFLTRYKALVICAFNEKQSFD  158 (215)
T ss_dssp             CTTSCEEESCCEETTTB-------------------SCC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred             cCCCCEEEEEccCccCC-------------------CCC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence            99999999988864432                   221     11112223356788889999998885

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=88.46  E-value=0.78  Score=38.48  Aligned_cols=81  Identities=16%  Similarity=0.230  Sum_probs=57.6

Q ss_pred             CCHHHHHHHHHHHHHHHH-HHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCccccccccccccCccChh
Q 016594          162 VEWKVRHKIAVGTARGLH-YLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPE  240 (386)
Q Consensus       162 ~~~~~~~~i~~qi~~~l~-~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE  240 (386)
                      ++....++++.+|+.... +++     .-+|--|+|+||+++.++.+++.-.|+-..+                   +|.
T Consensus        82 ~~~~eKlrll~nl~~L~~~~~~-----~r~tf~l~P~NL~f~~~~~p~i~hRGi~~~l-------------------pP~  137 (219)
T 4ano_A           82 TTLLSRIRAAIHLVSKVKHHSA-----RRLIFIVCPENLMFNRALEPFFLHVGVKESL-------------------PPD  137 (219)
T ss_dssp             SCHHHHHHHHHHHHHHHSSCCS-----SSEECCCCGGGEEECTTCCEEESCCEETTTB-------------------SSC
T ss_pred             cCHHHHHHHHHHHHHHHHHhhh-----CceeEEEeCceEEEeCCCcEEEEEcCCcccC-------------------CCC
Confidence            778889999888877666 444     4678889999999999999999988864432                   222


Q ss_pred             hhccCCCCcccchHHHHHHHHHHHhCCCCCC
Q 016594          241 YFMHGIVDEKTDVFAFGVFLLEIISGRKPVD  271 (386)
Q Consensus       241 ~~~~~~~~~~~DvwslG~il~ell~g~~pf~  271 (386)
                      -+     +..-=+-.+=|++..++.++..|.
T Consensus       138 e~-----~ee~fl~qyKali~all~~K~~Fe  163 (219)
T 4ano_A          138 EW-----DDERLLREVKATVLALTEGEYRFD  163 (219)
T ss_dssp             SC-----CHHHHHHHHHHHHHHHTTCSSCHH
T ss_pred             CC-----CHHHHHHHHHHHHHHHHcCCCCHH
Confidence            11     111113356678888888888774

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	386
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	4e-66
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	2e-60
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	2e-59
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	8e-59
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	5e-58
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	5e-57
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	6e-57
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	3e-56
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	5e-56
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	6e-56
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	9e-56
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	1e-55
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	1e-55
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	3e-54
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	4e-54
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	1e-53
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	5e-53
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	5e-53
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	5e-52
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	6e-52
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	1e-51
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	4e-51
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	5e-51
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	1e-49
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	1e-49
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	7e-49
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	1e-48
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	2e-48
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	3e-46
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	3e-45
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	3e-44
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	9e-44
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	2e-43
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	2e-42
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	2e-41
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	3e-41
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	7e-41
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	2e-40
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	2e-39
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	3e-39
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	3e-39
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	1e-38
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	1e-38
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	1e-38
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	7e-38
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	8e-38
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	4e-37
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	6e-36
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	6e-36
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	9e-36
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	1e-35
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	2e-35
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	5e-35
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	9e-35
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	4e-34
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	5e-34
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	7e-32
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	1e-28
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	3e-28
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	3e-28
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	5e-28
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	7e-28
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	9e-20

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  209 bits (532), Expect = 4e-66
 Identities = 70/282 (24%), Positives = 120/282 (42%), Gaps = 17/282 (6%)

Query: 59  EEISIATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTI 118
           ++  I     +    +G G +  VYKG      ++AVK L       ++ + F  E+G +
Sbjct: 1   DDWEIPDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVL 58

Query: 119 GHVCHPNVLSLLGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGL 178
               H N+L  +G      L ++ Q+    S+    H + +   E      IA  TA+G+
Sbjct: 59  RKTRHVNILLFMGYSTAPQLAIVTQWCEGSSLYHHLHIIETK-FEMIKLIDIARQTAQGM 117

Query: 179 HYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLA 238
            YLH    + IIHRD+KS+NI L  D   +I DFGLA         H    + G+   +A
Sbjct: 118 DYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMA 174

Query: 239 PEYFMH---GIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVD 295
           PE            ++DV+AFG+ L E+++G+ P    +         ++ +G +   + 
Sbjct: 175 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN--RDQIIFMVGRGYLSPDLS 232

Query: 296 PRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLE 337
                      + RL    + C++     RP   ++L   +E
Sbjct: 233 KVRSNCPK--AMKRL---MAECLKKKRDERPLFPQILA-SIE 268

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (494), Expect = 2e-60
 Identities = 63/288 (21%), Positives = 115/288 (39%), Gaps = 23/288 (7%)

Query: 50  KPTWRCFSFEEISIATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEK 109
           KP W     +E  +          +G G + EV+ G      ++AVK L +         
Sbjct: 1   KPWWE----DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQ---GSMSPD 53

Query: 110 EFLTEIGTIGHVCHPNVLSLLGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHK 169
            FL E   +  + H  ++ L        +Y+I ++   GS+       +   +       
Sbjct: 54  AFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLD 113

Query: 170 IAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAP 229
           +A   A G+ ++    +R  IHRD++++NIL++     +I+DFGLA+ +     + +   
Sbjct: 114 MAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN-EYTAREG 169

Query: 230 IEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGE 289
            +      APE   +G    K+DV++FG+ L EI++  +       +        L +G 
Sbjct: 170 AKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQN--LERGY 227

Query: 290 IEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLE 337
                D   +  Y +           LC +  P  RPT   +   +LE
Sbjct: 228 RMVRPDNCPEELYQL---------MRLCWKERPEDRPTFDYLRS-VLE 265

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (488), Expect = 2e-59
 Identities = 59/288 (20%), Positives = 114/288 (39%), Gaps = 19/288 (6%)

Query: 50  KPTWRCFSFEEISIATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEK 109
           KP  +  + +   I   +   E  +G+G + EV+ G       +A+K L          +
Sbjct: 1   KPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP---GTMSPE 57

Query: 110 EFLTEIGTIGHVCHPNVLSLLGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHK 169
            FL E   +  + H  ++ L     +  +Y++ ++ S+GS+           +       
Sbjct: 58  AFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVD 117

Query: 170 IAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAP 229
           +A   A G+ Y+    +   +HRD++++NIL+  +   +++DFGLA+ +           
Sbjct: 118 MAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG- 173

Query: 230 IEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGE 289
            +      APE  ++G    K+DV++FG+ L E+ +  +              P +   E
Sbjct: 174 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY-----------PGMVNRE 222

Query: 290 IEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLE 337
           +   V+   +          L      C R  P  RPT   +    LE
Sbjct: 223 VLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQA-FLE 269

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (482), Expect = 8e-59
 Identities = 58/271 (21%), Positives = 116/271 (42%), Gaps = 21/271 (7%)

Query: 68  FSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVL 127
            +    +G G +  V+ G   + +++A+K + +       E++F+ E   +  + HP ++
Sbjct: 7   LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIRE---GAMSEEDFIEEAEVMMKLSHPKLV 63

Query: 128 SLLGCCVDNG-LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQ 186
            L G C++   + L+F+F   G ++             +    + +    G+ YL    +
Sbjct: 64  QLYGVCLEQAPICLVFEFMEHGCLSDYLRT-QRGLFAAETLLGMCLDVCEGMAYL---EE 119

Query: 187 RRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGI 246
             +IHRD+ + N L+  +   ++SDFG+ +++       S    +      +PE F    
Sbjct: 120 ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG-TKFPVKWASPEVFSFSR 178

Query: 247 VDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQ 306
              K+DV++FGV + E+ S  K    +     S ++ + +     +L  PRL     V Q
Sbjct: 179 YSSKSDVWSFGVLMWEVFSEGKIPYEN----RSNSEVVEDISTGFRLYKPRLAST-HVYQ 233

Query: 307 LNRLAFAASLCIRASPTWRPTMSEVLEVMLE 337
           +       + C +  P  RP  S +L   L 
Sbjct: 234 I------MNHCWKERPEDRPAFSRLLR-QLA 257

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  189 bits (480), Expect = 5e-58
 Identities = 67/300 (22%), Positives = 127/300 (42%), Gaps = 36/300 (12%)

Query: 56  FSFEEISIATNAFSSE---------NLVGRGGYAEVYKGVL----QDGEEIAVKRLTKVV 102
           F+FE+ + A   F+ E          ++G G + EV  G L    +    +A+K L    
Sbjct: 7   FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66

Query: 103 TDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQFSSRGSVASLFHDVNSPG 161
           T+  + ++FL+E   +G   HPNV+ L G    +  + +I +F   GS+ S     N   
Sbjct: 67  TEK-QRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQ-NDGQ 124

Query: 162 VEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLP-- 219
                   +  G A G+ YL        +HRD+ + NIL+ ++   ++SDFGL+++L   
Sbjct: 125 FTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181

Query: 220 -SQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSL 277
            S  T+ S    +      APE   +      +DV+++G+ + E++S G +P        
Sbjct: 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWD----- 236

Query: 278 HSWAKPILNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLE 337
                  +   ++   ++   +    +   + L      C +     RP   +++   L+
Sbjct: 237 -------MTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVN-TLD 288

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (469), Expect = 5e-57
 Identities = 51/272 (18%), Positives = 109/272 (40%), Gaps = 22/272 (8%)

Query: 68  FSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVL 127
            +    +G G +  V  G  +   ++A+K + +       E EF+ E   + ++ H  ++
Sbjct: 6   LTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKE---GSMSEDEFIEEAKVMMNLSHEKLV 62

Query: 128 SLLGCCVDNG-LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQ 186
            L G C     +++I ++ + G + +   ++     + +   ++       + YL     
Sbjct: 63  QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVCEAMEYLE---S 118

Query: 187 RRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGI 246
           ++ +HRD+ + N L+      ++SDFGL++++       S+           PE  M+  
Sbjct: 119 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSK-FPVRWSPPEVLMYSK 177

Query: 247 VDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVT 305
              K+D++AFGV + EI S G+ P +                 E  + +   L+      
Sbjct: 178 FSSKSDIWAFGVLMWEIYSLGKMPYER------------FTNSETAEHIAQGLRLYRPHL 225

Query: 306 QLNRLAFAASLCIRASPTWRPTMSEVLEVMLE 337
              ++      C       RPT   +L  +L+
Sbjct: 226 ASEKVYTIMYSCWHEKADERPTFKILLSNILD 257

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (473), Expect = 6e-57
 Identities = 70/294 (23%), Positives = 116/294 (39%), Gaps = 35/294 (11%)

Query: 71  ENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLL 130
           +  +G+G + EV++G    GEE+AVK  +     + +      EI     + H N+L  +
Sbjct: 8   QESIGKGRFGEVWRGKW-RGEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFI 63

Query: 131 GCCVDNG-----LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGC 185
                +      L+L+  +   GS   LF  +N   V  +   K+A+ TA GL +LH   
Sbjct: 64  AADNKDNGTWTQLWLVSDYHEHGS---LFDYLNRYTVTVEGMIKLALSTASGLAHLHMEI 120

Query: 186 -----QRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAP--IEGTFGHLA 238
                +  I HRD+KS NIL+  +    I+D GLA    S      IAP    GT  ++A
Sbjct: 121 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 180

Query: 239 PEYF------MHGIVDEKTDVFAFGVFLLEIISGRKPVDGS--------HQSLHSWAKPI 284
           PE         H    ++ D++A G+   EI                         +   
Sbjct: 181 PEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEE 240

Query: 285 LNQGEIEKLVDPRLQGAYDVTQ-LNRLAFAASLCIRASPTWRPTMSEVLEVMLE 337
           + +   E+ + P +   +   + L  +A     C  A+   R T   + +  L 
Sbjct: 241 MRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK-TLS 293

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  184 bits (467), Expect = 3e-56
 Identities = 69/298 (23%), Positives = 136/298 (45%), Gaps = 29/298 (9%)

Query: 57  SFEEISIATNAFSSENLVGRGGYAEVYKGVLQD-GEEIAVKRLTKVVTDDRKEKEFLTEI 115
           ++++  +     + ++ +G G Y EVY+GV +     +AVK L +   D  + +EFL E 
Sbjct: 8   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE---DTMEVEEFLKEA 64

Query: 116 GTIGHVCHPNVLSLLGCCVDNG-LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGT 174
             +  + HPN++ LLG C      Y+I +F + G++     + N   V   V   +A   
Sbjct: 65  AVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQI 124

Query: 175 ARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTF 234
           +  + YL    ++  IHRD+ + N L+  +   +++DFGL++ +    T+ + A  +   
Sbjct: 125 SSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD-TYTAHAGAKFPI 180

Query: 235 GHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLV 294
              APE   +     K+DV+AFGV L EI +                   ++  ++ +L+
Sbjct: 181 KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG-----------IDLSQVYELL 229

Query: 295 DPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG--------DQIDKE 344
           +   +         ++      C + +P+ RP+ +E+ +   E         D+++KE
Sbjct: 230 EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ-AFETMFQESSISDEVEKE 286

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (465), Expect = 5e-56
 Identities = 65/272 (23%), Positives = 111/272 (40%), Gaps = 23/272 (8%)

Query: 71  ENLVGRGGYAEVYKGVLQD---GEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVL 127
           +  +G G +  V KG  Q     + +AVK L     D   + E L E   +  + +P ++
Sbjct: 12  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 71

Query: 128 SLLGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQR 187
            ++G C      L+ + +  G +        +  V+ K   ++    + G+ YL    + 
Sbjct: 72  RMIGICEAESWMLVMEMAELGPLNKYLQ--QNRHVKDKNIIELVHQVSMGMKYLE---ES 126

Query: 188 RIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAP-IEGTFGHLAPEYFMHGI 246
             +HRD+ + N+LL      +ISDFGL+K L +   ++      +      APE   +  
Sbjct: 127 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 186

Query: 247 VDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVT 305
              K+DV++FGV + E  S G+KP  G      S    +L +GE         +  YD+ 
Sbjct: 187 FSSKSDVWSFGVLMWEAFSYGQKPYRGMK---GSEVTAMLEKGERMGCPAGCPREMYDL- 242

Query: 306 QLNRLAFAASLCIRASPTWRPTMSEVLEVMLE 337
                    +LC       RP  + V    L 
Sbjct: 243 --------MNLCWTYDVENRPGFAAVEL-RLR 265

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (468), Expect = 6e-56
 Identities = 50/323 (15%), Positives = 121/323 (37%), Gaps = 46/323 (14%)

Query: 61  ISIATNAFSSENLVGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIG 119
           + +  + F   + +G G    V+K      G  +A K +   +       + + E+  + 
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLH 59

Query: 120 HVCHPNVLSLLGCCVDNG-LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGL 178
               P ++   G    +G + +  +    GS+  +     +  +  ++  K+++   +GL
Sbjct: 60  ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK--KAGRIPEQILGKVSIAVIKGL 117

Query: 179 HYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLA 238
            YL +  + +I+HRD+K SNIL+ +  E ++ DFG++  L     +  +    GT  +++
Sbjct: 118 TYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV----GTRSYMS 171

Query: 239 PEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRL 298
           PE         ++D+++ G+ L+E+  GR P+                +G+  +      
Sbjct: 172 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPR 231

Query: 299 QGAYDVTQLNRLAFAA-------------------------------SLCIRASPTWRPT 327
                ++     +                                  + C+  +P  R  
Sbjct: 232 TPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERAD 291

Query: 328 MSEVLE----VMLEGDQIDKERW 346
           + +++        + +++D   W
Sbjct: 292 LKQLMVHAFIKRSDAEEVDFAGW 314

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (466), Expect = 9e-56
 Identities = 69/292 (23%), Positives = 130/292 (44%), Gaps = 22/292 (7%)

Query: 68  FSSENLVGRGGYAEVYKGV-LQDGEEIAVKRLTKVV---TDDRKEKEFLTEIGTIGHVCH 123
           F    ++G G +  VYKG+ + +GE++ +    K +   T  +  KE L E   +  V +
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70

Query: 124 PNVLSLLGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHK 183
           P+V  LLG C+ + + LI Q    G +     + +   +  +      V  A+G++YL  
Sbjct: 71  PHVCRLLGICLTSTVQLITQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYL-- 127

Query: 184 GCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFM 243
              RR++HRD+ + N+L+      +I+DFGLAK L ++   +     +     +A E  +
Sbjct: 128 -EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 186

Query: 244 HGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAY 302
           H I   ++DV+++GV + E+++ G KP DG            +   EI  +++   +   
Sbjct: 187 HRIYTHQSDVWSYGVTVWELMTFGSKPYDG------------IPASEISSILEKGERLPQ 234

Query: 303 DVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEGDQIDKERWKMPEEEEE 354
                  +      C       RP   E++         D +R+ + + +E 
Sbjct: 235 PPICTIDVYMIMVKCWMIDADSRPKFRELII-EFSKMARDPQRYLVIQGDER 285

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (463), Expect = 1e-55
 Identities = 56/283 (19%), Positives = 121/283 (42%), Gaps = 24/283 (8%)

Query: 63  IATNAFSSENLVGRGGYAEVYKGVLQDGEE-----IAVKRLTKVVTDDRKEKEFLTEIGT 117
           I  +  + + ++G G + EVYKG+L+         +A+K L K    +++  +FL E G 
Sbjct: 4   IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTL-KAGYTEKQRVDFLGEAGI 62

Query: 118 IGHVCHPNVLSLLGCCVDNG-LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTAR 176
           +G   H N++ L G       + +I ++   G++     +             +  G A 
Sbjct: 63  MGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE-KDGEFSVLQLVGMLRGIAA 121

Query: 177 GLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTH-HSIAPIEGTFG 235
           G+ YL        +HRD+ + NIL+ ++   ++SDFGL++ L       ++ +  +    
Sbjct: 122 GMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIR 178

Query: 236 HLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVD 295
             APE   +      +DV++FG+ + E+++  +                L+  E+ K ++
Sbjct: 179 WTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWE-----------LSNHEVMKAIN 227

Query: 296 PRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG 338
              +    +   + +      C +     RP  ++++  +L+ 
Sbjct: 228 DGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVS-ILDK 269

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (460), Expect = 1e-55
 Identities = 62/280 (22%), Positives = 109/280 (38%), Gaps = 29/280 (10%)

Query: 60  EISIATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIG 119
            +++          +G+G + +V  G    G ++AVK +      D   + FL E   + 
Sbjct: 3   ALNM--KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKN----DATAQAFLAEASVMT 55

Query: 120 HVCHPNVLSLLGCCVD--NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARG 177
            + H N++ LLG  V+   GLY++ ++ ++GS+           +      K ++     
Sbjct: 56  QLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEA 115

Query: 178 LHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHL 237
           + YL        +HRD+ + N+L++ D   ++SDFGL K   S          +      
Sbjct: 116 MEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG-----KLPVKWT 167

Query: 238 APEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPR 297
           APE         K+DV++FG+ L EI S  +              P + +G      D  
Sbjct: 168 APEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP--LKDVVPRVEKGYKMDAPDGC 225

Query: 298 LQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLE 337
               Y+V            C       RP+  ++ E  LE
Sbjct: 226 PPAVYEV---------MKNCWHLDAAMRPSFLQLRE-QLE 255

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (452), Expect = 3e-54
 Identities = 52/274 (18%), Positives = 109/274 (39%), Gaps = 22/274 (8%)

Query: 68  FSSENLVGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNV 126
           +     +G G Y    K     DG+ +  K L      + +++  ++E+  +  + HPN+
Sbjct: 6   YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 65

Query: 127 LSLLGCCVD---NGLYLIFQFSSRGSVASLFHDVNSPG--VEWKVRHKIAVGTARGLHYL 181
           +      +D     LY++ ++   G +AS+          ++ +   ++       L   
Sbjct: 66  VRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKEC 125

Query: 182 HK--GCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAP 239
           H+       ++HRD+K +N+ L      ++ DFGLA+ L    +        GT  +++P
Sbjct: 126 HRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAK--AFVGTPYYMSP 183

Query: 240 EYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQ 299
           E       +EK+D+++ G  L E+ +   P     Q     A  I   G+  ++      
Sbjct: 184 EQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ--KELAGKIRE-GKFRRIPYRYSD 240

Query: 300 GAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLE 333
              ++          +  +      RP++ E+LE
Sbjct: 241 ELNEI---------ITRMLNLKDYHRPSVEEILE 265

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (453), Expect = 4e-54
 Identities = 55/285 (19%), Positives = 116/285 (40%), Gaps = 24/285 (8%)

Query: 59  EEISIATNAFSSENLV-GRGGYAEVYKGVLQ---DGEEIAVKRLTKVVTDDRKEKEFLTE 114
           +++ +  +     ++  G G +  V +GV +      ++A+K L +  T+    +E + E
Sbjct: 1   KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMRE 59

Query: 115 IGTIGHVCHPNVLSLLGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGT 174
              +  + +P ++ L+G C    L L+ + +  G +           +      ++    
Sbjct: 60  AQIMHQLDNPYIVRLIGVCQAEALMLVMEMAGGGPLHKFLVGKREE-IPVSNVAELLHQV 118

Query: 175 ARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSI-APIEGT 233
           + G+ YL    ++  +HRD+ + N+LL      +ISDFGL+K L +  ++++  +  +  
Sbjct: 119 SMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWP 175

Query: 234 FGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGEIEK 292
               APE         ++DV+++GV + E +S G+KP               + QG+  +
Sbjct: 176 LKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK---GPEVMAFIEQGKRME 232

Query: 293 LVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLE 337
                    Y +          S C       RP    V +  + 
Sbjct: 233 CPPECPPELYAL---------MSDCWIYKWEDRPDFLTVEQ-RMR 267

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (451), Expect = 1e-53
 Identities = 66/275 (24%), Positives = 118/275 (42%), Gaps = 25/275 (9%)

Query: 71  ENLVGRGGYAEVYKGVLQD----GEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNV 126
             ++GRG +  VY G L D        AVK L ++ TD  +  +FLTE   +    HPNV
Sbjct: 32  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNV 90

Query: 127 LSLLGCCV--DNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKG 184
           LSLLG C+  +    ++  +   G + +   +  +     K      +  A+G+ +L   
Sbjct: 91  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN-ETHNPTVKDLIGFGLQVAKGMKFLA-- 147

Query: 185 CQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQW--THHSIAPIEGTFGHLAPEYF 242
             ++ +HRD+ + N +L   F  +++DFGLA+ +  +   + H+    +     +A E  
Sbjct: 148 -SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 206

Query: 243 MHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAY 302
                  K+DV++FGV L E+++   P      +       +L      +L+ P     Y
Sbjct: 207 QTQKFTTKSDVWSFGVLLWELMTRGAPPYP-DVNTFDITVYLLQG---RRLLQPE----Y 258

Query: 303 DVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLE 337
               L  +      C       RP+ SE++   + 
Sbjct: 259 CPDPLYEV---MLKCWHPKAEMRPSFSELVS-RIS 289

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (444), Expect = 5e-53
 Identities = 60/270 (22%), Positives = 108/270 (40%), Gaps = 25/270 (9%)

Query: 71  ENLVGRGGYAEVYKGVL-QDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSL 129
           +  +GRG +  VYKG+  +   E+A   L        + + F  E   +  + HPN++  
Sbjct: 14  DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73

Query: 130 LGCCVD-----NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKG 184
                        + L+ +  + G++ +         ++ KV         +GL +LH  
Sbjct: 74  YDSWESTVKGKKCIVLVTELMTSGTLKTYLK--RFKVMKIKVLRSWCRQILKGLQFLHTR 131

Query: 185 CQRRIIHRDIKSSNILLTA-DFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFM 243
               IIHRD+K  NI +T      +I D GLA    + +    I    GT   +APE + 
Sbjct: 132 T-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVI----GTPEFMAPEMYE 186

Query: 244 HGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYD 303
               DE  DV+AFG+ +LE+ +   P      +   + +       +   V P       
Sbjct: 187 EK-YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRR-------VTSGVKPASFDKVA 238

Query: 304 VTQLNRLAFAASLCIRASPTWRPTMSEVLE 333
           + ++  +      CIR +   R ++ ++L 
Sbjct: 239 IPEVKEI---IEGCIRQNKDERYSIKDLLN 265

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (443), Expect = 5e-53
 Identities = 72/269 (26%), Positives = 117/269 (43%), Gaps = 25/269 (9%)

Query: 68  FSSENLVGRGGYAEVYKGVL-QDGEEIAVKRLTKV-VTDDRKEKEFLTEIGTIGHVCHPN 125
           F     +G+G +  VY     Q    +A+K L K  +     E +   E+    H+ HPN
Sbjct: 8   FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 67

Query: 126 VLSLLGCCVDNG-LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKG 184
           +L L G   D   +YLI +++  G+V      ++    + +         A  L Y H  
Sbjct: 68  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCH-- 123

Query: 185 CQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMH 244
             +R+IHRDIK  N+LL +  E +I+DFG +   PS           GT  +L PE    
Sbjct: 124 -SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC----GTLDYLPPEMIEG 178

Query: 245 GIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDV 304
            + DEK D+++ GV   E + G+ P + +     ++ +    +      V     GA D+
Sbjct: 179 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ-ETYKRISRVEFTFPDFVTE---GARDL 234

Query: 305 TQLNRLAFAASLCIRASPTWRPTMSEVLE 333
                     S  ++ +P+ RP + EVLE
Sbjct: 235 ---------ISRLLKHNPSQRPMLREVLE 254

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (440), Expect = 5e-52
 Identities = 59/301 (19%), Positives = 119/301 (39%), Gaps = 39/301 (12%)

Query: 63  IATNAFSSENLVGRGGYAEVYKGVL------QDGEEIAVKRLTKVVTDDRKEKEFLTEIG 116
              N  S    +G G + +V +              +AVK L K      + +  ++E+ 
Sbjct: 20  FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML-KPSAHLTEREALMSELK 78

Query: 117 TIGHVC-HPNVLSLLGCCVDNG-LYLIFQFSSRGSVASLFH----------------DVN 158
            + ++  H N+++LLG C   G   +I ++   G + +                   + +
Sbjct: 79  VLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDD 138

Query: 159 SPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWL 218
              ++ +     +   A+G+ +L     +  IHRD+ + NILLT     +I DFGLA+ +
Sbjct: 139 ELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDI 195

Query: 219 PSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLH 278
            +   +            +APE   + +   ++DV+++G+FL E+ S           + 
Sbjct: 196 KNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY-PGMPVD 254

Query: 279 SWAKPILNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG 338
           S    ++ +G      +      YD+            C  A P  RPT  ++++ ++E 
Sbjct: 255 SKFYKMIKEGFRMLSPEHAPAEMYDI---------MKTCWDADPLKRPTFKQIVQ-LIEK 304

Query: 339 D 339
            
Sbjct: 305 Q 305

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  173 bits (440), Expect = 6e-52
 Identities = 62/272 (22%), Positives = 116/272 (42%), Gaps = 28/272 (10%)

Query: 68  FSSENLVGRGGYAEVYKGV-LQDGEEIAVKRLTK-VVTDDRKEKEFLTEIGTIGHVCHPN 125
           FS    +G G +  VY    +++ E +A+K+++      + K ++ + E+  +  + HPN
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 126 VLSLLGCCVDNG-LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKG 184
            +   GC +     +L+ ++    +  S   +V+   ++      +  G  +GL YLH  
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCLGSA--SDLLEVHKKPLQEVEIAAVTHGALQGLAYLH-- 132

Query: 185 CQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFM- 243
               +IHRD+K+ NILL+     ++ DFG A  +    +        GT   +APE  + 
Sbjct: 133 -SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV------GTPYWMAPEVILA 185

Query: 244 --HGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGA 301
              G  D K DV++ G+  +E+   + P+   +          L    I +   P LQ  
Sbjct: 186 MDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSALYH--IAQNESPALQSG 237

Query: 302 YDVTQLNRLAFAASLCIRASPTWRPTMSEVLE 333
           +              C++  P  RPT   +L+
Sbjct: 238 HWSEYFRNF---VDSCLQKIPQDRPTSEVLLK 266

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (435), Expect = 1e-51
 Identities = 65/271 (23%), Positives = 110/271 (40%), Gaps = 22/271 (8%)

Query: 74  VGRGGYAEVYKGVL----QDGEEIAVKRLTK-VVTDDRKEKEFLTEIGTIGHVCHPNVLS 128
           +G G +  V +G           +AVK L   V++      +F+ E+  +  + H N++ 
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75

Query: 129 LLGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRR 188
           L G  +   + ++ + +  GS+       +          + AV  A G+ YL     +R
Sbjct: 76  LYGVVLTPPMKMVTELAPLGSLLDRLRK-HQGHFLLGTLSRYAVQVAEGMGYLE---SKR 131

Query: 189 IIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIA-PIEGTFGHLAPEYFMHGIV 247
            IHRD+ + N+LL      +I DFGL + LP    H+ +    +  F   APE       
Sbjct: 132 FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTF 191

Query: 248 DEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQ 306
              +D + FGV L E+ + G++P  G   +       I  +GE     +   Q  Y+V  
Sbjct: 192 SHASDTWMFGVTLWEMFTYGQEPWIG--LNGSQILHKIDKEGERLPRPEDCPQDIYNV-- 247

Query: 307 LNRLAFAASLCIRASPTWRPTMSEVLEVMLE 337
                     C    P  RPT   + + +LE
Sbjct: 248 -------MVQCWAHKPEDRPTFVALRDFLLE 271

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (435), Expect = 4e-51
 Identities = 60/303 (19%), Positives = 110/303 (36%), Gaps = 45/303 (14%)

Query: 63  IATNAFSSENLVGRGGYAEVYKGVLQD------GEEIAVKRLTKVVTDDRKEKEFLTEIG 116
                     ++G G + +V               ++AVK L +   D  + +  ++E+ 
Sbjct: 34  FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEK-ADSSEREALMSELK 92

Query: 117 TIGHVC-HPNVLSLLGCCVDNG-LYLIFQFSSRGSVASLFHDVNSPGVE----------- 163
            +  +  H N+++LLG C  +G +YLIF++   G + +          E           
Sbjct: 93  MMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRL 152

Query: 164 ----------WKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFG 213
                     ++     A   A+G+ +L     +  +HRD+ + N+L+T     +I DFG
Sbjct: 153 EEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFG 209

Query: 214 LAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDG 272
           LA+ + S   +            +APE    GI   K+DV+++G+ L EI S G  P  G
Sbjct: 210 LARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG 269

Query: 273 SHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVL 332
                              KL+    +          +      C       RP+   + 
Sbjct: 270 IP-----------VDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLT 318

Query: 333 EVM 335
             +
Sbjct: 319 SFL 321

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  170 bits (432), Expect = 5e-51
 Identities = 59/310 (19%), Positives = 113/310 (36%), Gaps = 45/310 (14%)

Query: 57  SFEEISIATNAFSSENLVGRGGYAEVYKGVL------QDGEEIAVKRLTKVVTDDRKEKE 110
               +    N       +G G +  V++         +    +AVK L +  + D  + +
Sbjct: 4   KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASAD-MQAD 62

Query: 111 FLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQFSSRGSVASLFHDVN----------- 158
           F  E   +    +PN++ LLG C     + L+F++ + G +      ++           
Sbjct: 63  FQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSD 122

Query: 159 -----------SPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEP 207
                       P +    +  IA   A G+ YL    +R+ +HRD+ + N L+  +   
Sbjct: 123 LSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVV 179

Query: 208 QISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGR 267
           +I+DFGL++ + S   + +          + PE   +     ++DV+A+GV L EI S  
Sbjct: 180 KIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYG 239

Query: 268 KPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPT 327
                            +  G I    +      Y++           LC    P  RP+
Sbjct: 240 LQPYYGMAHEEVIYY--VRDGNILACPENCPLELYNL---------MRLCWSKLPADRPS 288

Query: 328 MSEVLEVMLE 337
              +   +L+
Sbjct: 289 FCSIHR-ILQ 297

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  167 bits (423), Expect = 1e-49
 Identities = 62/271 (22%), Positives = 111/271 (40%), Gaps = 29/271 (10%)

Query: 72  NLVGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLL 130
             +G G + +VYK    +     A K +      + + ++++ EI  +    HPN++ LL
Sbjct: 18  GELGDGAFGKVYKAQNKETSVLAAAKVIDT--KSEEELEDYMVEIDILASCDHPNIVKLL 75

Query: 131 GCCVDNG-LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRI 189
                   L+++ +F + G+V ++  ++  P +       +   T   L+YLH     +I
Sbjct: 76  DAFYYENNLWILIEFCAGGAVDAVMLELERP-LTESQIQVVCKQTLDALNYLH---DNKI 131

Query: 190 IHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFM-----H 244
           IHRD+K+ NIL T D + +++DFG++                GT   +APE  M      
Sbjct: 132 IHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRD--SFIGTPYWMAPEVVMCETSKD 189

Query: 245 GIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRL--QGAY 302
              D K DV++ G+ L+E+     P    +         I  + E   L  P        
Sbjct: 190 RPYDYKADVWSLGITLIEMAEIEPPHHELNP--MRVLLKIA-KSEPPTLAQPSRWSSNFK 246

Query: 303 DVTQLNRLAFAASLCIRASPTWRPTMSEVLE 333
           D             C+  +   R T S++L+
Sbjct: 247 DF---------LKKCLEKNVDARWTTSQLLQ 268

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  167 bits (423), Expect = 1e-49
 Identities = 58/268 (21%), Positives = 116/268 (43%), Gaps = 22/268 (8%)

Query: 68  FSSENLVGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNV 126
           ++    +G+G    VY  + +  G+E+A++++        K++  + EI  +    +PN+
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNL--QQQPKKELIINEILVMRENKNPNI 79

Query: 127 LSLLGCCVDNG-LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGC 185
           ++ L   +    L+++ ++ + GS   L   V    ++      +     + L +LH   
Sbjct: 80  VNYLDSYLVGDELWVVMEYLAGGS---LTDVVTETCMDEGQIAAVCRECLQALEFLH--- 133

Query: 186 QRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHG 245
             ++IHRDIKS NILL  D   +++DFG    +  + +  S   + GT   +APE     
Sbjct: 134 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS--TMVGTPYWMAPEVVTRK 191

Query: 246 IVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVT 305
               K D+++ G+  +E+I G  P    +        P+     I     P LQ    ++
Sbjct: 192 AYGPKVDIWSLGIMAIEMIEGEPPYLNEN--------PLRALYLIATNGTPELQNPEKLS 243

Query: 306 QLNRLAFAASLCIRASPTWRPTMSEVLE 333
            +       + C+      R +  E+L+
Sbjct: 244 AI--FRDFLNRCLDMDVEKRGSAKELLQ 269

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (416), Expect = 7e-49
 Identities = 62/269 (23%), Positives = 99/269 (36%), Gaps = 19/269 (7%)

Query: 68  FSSENLVGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNV 126
           +     +G G Y EV   V     E +AVK +      D  E     EI     + H NV
Sbjct: 7   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE-NIKKEICINKMLNHENV 65

Query: 127 LSLLGCCV-DNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGC 185
           +   G     N  YL  ++ S G +          G+      +       G+ YLH   
Sbjct: 66  VKFYGHRREGNIQYLFLEYCSGGELFDRIE--PDIGMPEPDAQRFFHQLMAGVVYLH--- 120

Query: 186 QRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHG 245
              I HRDIK  N+LL      +ISDFGLA           +  + GT  ++APE     
Sbjct: 121 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 180

Query: 246 -IVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDV 304
               E  DV++ G+ L  +++G  P D    S   ++     +                +
Sbjct: 181 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD-WKEKKTYLNPWKKIDSAPLAL 239

Query: 305 TQLNRLAFAASLCIRASPTWRPTMSEVLE 333
             L++        +  +P+ R T+ ++ +
Sbjct: 240 --LHK-------ILVENPSARITIPDIKK 259

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (417), Expect = 1e-48
 Identities = 66/316 (20%), Positives = 130/316 (41%), Gaps = 40/316 (12%)

Query: 58  FEEISIATNAFSSENLVGRGGYAEVYKGVLQDG---EEIAVKRLTKVVTDDRKEKEFLTE 114
           +  +    N    ++++G G + +V K  ++      + A+KR+ +  + D   ++F  E
Sbjct: 4   YPVLDW--NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKD-DHRDFAGE 60

Query: 115 IGTIGHVC-HPNVLSLLGCCVDNG-LYLIFQFSSRGSVASLFH--------------DVN 158
           +  +  +  HPN+++LLG C   G LYL  +++  G++                   +  
Sbjct: 61  LEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANST 120

Query: 159 SPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWL 218
           +  +  +     A   ARG+ YL    Q++ IHRD+ + NIL+  ++  +I+DFGL++  
Sbjct: 121 ASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQ 177

Query: 219 PSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLH 278
                             +A E   + +    +DV+++GV L EI+S             
Sbjct: 178 EVYVKKTMGR---LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE 234

Query: 279 SWAKPILNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG 338
            + K  L QG   +         YD+            C R  P  RP+ +++L   L  
Sbjct: 235 LYEK--LPQGYRLEKPLNCDDEVYDL---------MRQCWREKPYERPSFAQILV-SLNR 282

Query: 339 DQIDKERWKMPEEEEE 354
              +++ +      E+
Sbjct: 283 MLEERKTYVNTTLYEK 298

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (413), Expect = 2e-48
 Identities = 56/279 (20%), Positives = 118/279 (42%), Gaps = 23/279 (8%)

Query: 71  ENLVGRGGYAEVYKGVL----QDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNV 126
              +G G + +V++G+          +A+K   K  T D   ++FL E  T+    HP++
Sbjct: 12  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTC-KNCTSDSVREKFLQEALTMRQFDHPHI 70

Query: 127 LSLLGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQ 186
           + L+G   +N +++I +  + G + S         ++       A   +  L YL     
Sbjct: 71  VKLIGVITENPVWIIMELCTLGELRSFLQVRKYS-LDLASLILYAYQLSTALAYLES--- 126

Query: 187 RRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGI 246
           +R +HRDI + N+L++++   ++ DFGL++++     + + +  +     +APE      
Sbjct: 127 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKA-SKGKLPIKWMAPESINFRR 185

Query: 247 VDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQ 306
               +DV+ FGV + EI+          ++     +  +  GE   +        Y +  
Sbjct: 186 FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR--IENGERLPMPPNCPPTLYSL-- 241

Query: 307 LNRLAFAASLCIRASPTWRPTMSEVLEVMLEGDQIDKER 345
                   + C    P+ RP  +E+    L    +++E+
Sbjct: 242 -------MTKCWAYDPSRRPRFTELKA-QLS-TILEEEK 271

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (400), Expect = 3e-46
 Identities = 66/289 (22%), Positives = 106/289 (36%), Gaps = 36/289 (12%)

Query: 71  ENLVGRGGYAEVYKGV------LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHP 124
              +GRG + +V +              +AVK L +  T              I    H 
Sbjct: 18  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 77

Query: 125 NVLSLLGCCVDNG--LYLIFQFSSRGSVASLFHDVNSPGVE--------------WKVRH 168
           NV++LLG C   G  L +I +F   G++++      +  V                +   
Sbjct: 78  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 137

Query: 169 KIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIA 228
             +   A+G+ +L     R+ IHRD+ + NILL+     +I DFGLA+ +     +    
Sbjct: 138 CYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 194

Query: 229 PIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQG 288
                   +APE     +   ++DV++FGV L EI S           +       L +G
Sbjct: 195 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY-PGVKIDEEFCRRLKEG 253

Query: 289 EIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLE 337
              +  D      Y              C    P+ RPT SE++E  L 
Sbjct: 254 TRMRAPDYTTPEMYQT---------MLDCWHGEPSQRPTFSELVE-HLG 292

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (394), Expect = 3e-45
 Identities = 56/296 (18%), Positives = 115/296 (38%), Gaps = 31/296 (10%)

Query: 59  EEISIATNAFSSENLVGRGGYAEVYKGVL------QDGEEIAVKRLTKVVTDDRKEKEFL 112
           +E  +A    +    +G+G +  VY+GV       +    +A+K + +     R+  EFL
Sbjct: 13  DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA-ASMRERIEFL 71

Query: 113 TEIGTIGHVCHPNVLSLLGCCV-DNGLYLIFQFSSRGSVASLFHDVNSPGVE-------- 163
            E   +      +V+ LLG         +I +  +RG + S    +              
Sbjct: 72  NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPS 131

Query: 164 WKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWT 223
                ++A   A G+ YL      + +HRD+ + N ++  DF  +I DFG+ + +     
Sbjct: 132 LSKMIQMAGEIADGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY 188

Query: 224 HHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKP 283
           +            ++PE    G+    +DV++FGV L EI +  +       +       
Sbjct: 189 YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF- 247

Query: 284 ILNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEGD 339
            + +G +    D      +++           +C + +P  RP+  E++   ++ +
Sbjct: 248 -VMEGGLLDKPDNCPDMLFEL---------MRMCWQYNPKMRPSFLEIIS-SIKEE 292

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  154 bits (390), Expect = 3e-44
 Identities = 54/266 (20%), Positives = 101/266 (37%), Gaps = 24/266 (9%)

Query: 73  LVGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLG 131
            +G G +  V++      G   A K +      D++      EI T+  + HP +++L  
Sbjct: 33  ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKET--VRKEIQTMSVLRHPTLVNLHD 90

Query: 132 CCVDNG-LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRII 190
              D+  + +I++F S G +     D ++  +      +      +GL ++H+      +
Sbjct: 91  AFEDDNEMVMIYEFMSGGELFEKVADEHNK-MSEDEAVEYMRQVCKGLCHMHE---NNYV 146

Query: 191 HRDIKSSNILLTADFEPQI--SDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVD 248
           H D+K  NI+ T     ++   DFGL   L  + +        GT    APE      V 
Sbjct: 147 HLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT---TGTAEFAAPEVAEGKPVG 203

Query: 249 EKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRL-QGAYDVTQL 307
             TD+++ GV    ++SG  P  G +    +          ++      + +   D    
Sbjct: 204 YYTDMWSVGVLSYILLSGLSPFGGENDD-ETLRNVKSCDWNMDDSAFSGISEDGKDF--- 259

Query: 308 NRLAFAASLCIRASPTWRPTMSEVLE 333
                     + A P  R T+ + LE
Sbjct: 260 ------IRKLLLADPNTRMTIHQALE 279

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (383), Expect = 9e-44
 Identities = 68/291 (23%), Positives = 119/291 (40%), Gaps = 40/291 (13%)

Query: 71  ENLVGRGGYAEVYKGVL--------QDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVC 122
              +G G + +V                 ++AVK L K    ++   + ++E+  +  + 
Sbjct: 18  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML-KSDATEKDLSDLISEMEMMKMIG 76

Query: 123 -HPNVLSLLGCCVDNG-LYLIFQFSSRGSVASLFHDVNSPGVE--------------WKV 166
            H N+++LLG C  +G LY+I +++S+G++         PG+E               K 
Sbjct: 77  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 136

Query: 167 RHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHS 226
               A   ARG+ YL     ++ IHRD+ + N+L+T D   +I+DFGLA+ +     +  
Sbjct: 137 LVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 193

Query: 227 IAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILN 286
                     +APE     I   ++DV++FGV L EI +                  +L 
Sbjct: 194 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP--VEELFKLLK 251

Query: 287 QGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLE 337
           +G             Y +            C  A P+ RPT  +++E  L+
Sbjct: 252 EGHRMDKPSNCTNELYMM---------MRDCWHAVPSQRPTFKQLVE-DLD 292

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (380), Expect = 2e-43
 Identities = 59/269 (21%), Positives = 105/269 (39%), Gaps = 23/269 (8%)

Query: 68  FSSENLVGRGGYAEVYKGV-LQDGEEIAVKRLTK-VVTDDRKEKEFLTEIGTIGHVCHPN 125
           F    ++G G ++ V     L    E A+K L K  +  + K      E   +  + HP 
Sbjct: 10  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 69

Query: 126 VLSLLGCCVDNG-LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKG 184
            + L     D+  LY    ++  G +      + S   +              L YLH  
Sbjct: 70  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS--FDETCTRFYTAEIVSALEYLHG- 126

Query: 185 CQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMH 244
             + IIHRD+K  NILL  D   QI+DFG AK L  +          GT  +++PE    
Sbjct: 127 --KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 184

Query: 245 GIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILN-QGEIEKLVDPRLQGAYD 303
               + +D++A G  + ++++G  P    ++  +   + I+  + +  +   P+   A D
Sbjct: 185 KSACKSSDLWALGCIIYQLVAGLPPFRAGNE--YLIFQKIIKLEYDFPEKFFPK---ARD 239

Query: 304 VTQLNRLAFAASLCIRASPTWRPTMSEVL 332
           +  + +        +    T R    E+ 
Sbjct: 240 L--VEK-------LLVLDATKRLGCEEME 259

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  149 bits (378), Expect = 2e-42
 Identities = 57/266 (21%), Positives = 91/266 (34%), Gaps = 24/266 (9%)

Query: 73  LVGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLG 131
            +G G +  V++ V    G     K +      D+       EI  +  + HP +++L  
Sbjct: 36  ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYT--VKNEISIMNQLHHPKLINLHD 93

Query: 132 CCVDNG-LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRII 190
              D   + LI +F S G +           +              GL ++H   +  I+
Sbjct: 94  AFEDKYEMVLILEFLSGGELFDRIAA-EDYKMSEAEVINYMRQACEGLKHMH---EHSIV 149

Query: 191 HRDIKSSNILLTADFEPQI--SDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVD 248
           H DIK  NI+        +   DFGLA  L              T    APE      V 
Sbjct: 150 HLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT---ATAEFAAPEIVDREPVG 206

Query: 249 EKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRL-QGAYDVTQL 307
             TD++A GV    ++SG  P  G    L +         E ++     +   A D   +
Sbjct: 207 FYTDMWAIGVLGYVLLSGLSPFAGEDD-LETLQNVKRCDWEFDEDAFSSVSPEAKDF--I 263

Query: 308 NRLAFAASLCIRASPTWRPTMSEVLE 333
                     ++  P  R T+ + LE
Sbjct: 264 KN-------LLQKEPRKRLTVHDALE 282

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (367), Expect = 2e-41
 Identities = 55/286 (19%), Positives = 100/286 (34%), Gaps = 30/286 (10%)

Query: 72  NLVGRGGYAEVYKG--VLQDGEEIAVKRLTKVVTDDRKEKEFLTEIG---TIGHVCHPNV 126
             +G G Y +V+K   +   G  +A+KR+     ++      + E+     +    HPNV
Sbjct: 13  AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 72

Query: 127 LSLLGCCVD-----NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYL 181
           + L   C            +        + +    V  PGV  +    +     RGL +L
Sbjct: 73  VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 132

Query: 182 HKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEY 241
           H     R++HRD+K  NIL+T+  + +++DFGLA+    Q    S+     T  + APE 
Sbjct: 133 H---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVV---VTLWYRAPEV 186

Query: 242 FMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQ--------------SLHSWAKPILNQ 287
            +        D+++ G    E+   +    GS                    W + +   
Sbjct: 187 LLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALP 246

Query: 288 GEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLE 333
            +       +    +              C+  +P  R +    L 
Sbjct: 247 RQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  144 bits (364), Expect = 3e-41
 Identities = 59/278 (21%), Positives = 116/278 (41%), Gaps = 23/278 (8%)

Query: 65  TNAFSSENLVGRGGYAEVYKGV-LQDGEEIAVKRLTK-VVTDDRKEKEFLTEIGTIGHVC 122
           ++ +    ++G GG +EV+    L+   ++AVK L   +  D      F  E      + 
Sbjct: 6   SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65

Query: 123 HPNVLSLLGCCVDNG-----LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARG 177
           HP ++++              Y++ ++    ++  + H      +  K   ++     + 
Sbjct: 66  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQA 123

Query: 178 LHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTH-HSIAPIEGTFGH 236
           L++     Q  IIHRD+K +NI+++A    ++ DFG+A+ +          A + GT  +
Sbjct: 124 LNFS---HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQY 180

Query: 237 LAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDP 296
           L+PE      VD ++DV++ G  L E+++G  P  G   S  S A   + +  I     P
Sbjct: 181 LSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTG--DSPVSVAYQHVREDPI-----P 233

Query: 297 RLQGAYDVTQLNRLAFAASLCIRASPTWRP-TMSEVLE 333
                  ++    L       +  +P  R  T +E+  
Sbjct: 234 PSARHEGLSA--DLDAVVLKALAKNPENRYQTAAEMRA 269

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  146 bits (368), Expect = 7e-41
 Identities = 79/336 (23%), Positives = 129/336 (38%), Gaps = 44/336 (13%)

Query: 61  ISIATNAFSSENLVGRGGYAEVYKGV-LQDGEEIAVKRLTKV-VTDDRKEKEFLTE---I 115
           +++  N FS   ++GRGG+ EVY       G+  A+K L K  +   + E   L E   +
Sbjct: 1   LTM--NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIML 58

Query: 116 GTIGHVCHPNVLSLLGCCVDNG-LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGT 174
             +     P ++ +         L  I    + G +       +    E  +R   A   
Sbjct: 59  SLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQ-HGVFSEADMRF-YAAEI 116

Query: 175 ARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTF 234
             GL ++H    R +++RD+K +NILL      +ISD GLA     +  H S+    GT 
Sbjct: 117 ILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GTH 169

Query: 235 GHLAPEYFMHGI-VDEKTDVFAFGVFLLEIISGRKPVDGS-----HQSLHSWAKPILNQG 288
           G++APE    G+  D   D F+ G  L +++ G  P         H+         +   
Sbjct: 170 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELP 229

Query: 289 E---------IEKL--VDP--RL----QGAYDVTQ---LNRLAFAASLCIRASPTWRPTM 328
           +         +E L   D   RL    +GA +V +      L +      +  P   P  
Sbjct: 230 DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPPR 289

Query: 329 SEVLEV-MLEGDQIDKERWKMPEEEEEDQEEFWGFD 363
            EV      +    D+E  K  +  + DQE +  F 
Sbjct: 290 GEVNAADAFDIGSFDEEDTKGIKLLDSDQELYRNFP 325

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  143 bits (362), Expect = 2e-40
 Identities = 50/210 (23%), Positives = 86/210 (40%), Gaps = 11/210 (5%)

Query: 68  FSSENLVGRGGYAEVYKGV-LQDGEEIAVKRLTK-VVTDDRKEKEFLTEIGTIGHVCHPN 125
           F     +G G +  V+      +G   A+K L K +V   ++ +    E   +  V HP 
Sbjct: 6   FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 65

Query: 126 VLSLLGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGC 185
           ++ + G   D     +      G         +        +   A      L YLH   
Sbjct: 66  IIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKF-YAAEVCLALEYLHS-- 122

Query: 186 QRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHG 245
            + II+RD+K  NILL  +   +I+DFG AK++P            GT  ++APE     
Sbjct: 123 -KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLC-----GTPDYIAPEVVSTK 176

Query: 246 IVDEKTDVFAFGVFLLEIISGRKPVDGSHQ 275
             ++  D ++FG+ + E+++G  P   S+ 
Sbjct: 177 PYNKSIDWWSFGILIYEMLAGYTPFYDSNT 206

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (357), Expect = 2e-39
 Identities = 58/318 (18%), Positives = 118/318 (37%), Gaps = 43/318 (13%)

Query: 71  ENLVGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVC-HPNVLS 128
             ++G G   +V +    +  E+ A+K L       +   +   E+         P+++ 
Sbjct: 17  SQVLGLGINGKVLQIFNKRTQEKFALKML-------QDCPKARREVELHWRASQCPHIVR 69

Query: 129 LLGCCVD-----NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHK 183
           ++    +       L ++ +    G + S   D        +   +I       + YLH 
Sbjct: 70  IVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS 129

Query: 184 GCQRRIIHRDIKSSNILLTADFEP---QISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPE 240
                I HRD+K  N+L T+       +++DFG AK   S  +  +      T  ++APE
Sbjct: 130 ---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY---TPYYVAPE 183

Query: 241 YFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQG 300
                  D+  D+++ GV +  ++ G  P   +H    + +  +  +  + +   P  + 
Sbjct: 184 VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG--LAISPGMKTRIRMGQYEFPNPEW 241

Query: 301 AYDVTQLNRLAFAASLCIRASPTWRPTMSEVLE------------VMLEGDQI---DKER 345
           +    ++  L       ++  PT R T++E +               L   ++   DKER
Sbjct: 242 SEVSEEVKML---IRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKER 298

Query: 346 WKMPEEEEEDQEEFWGFD 363
           W+  +EE          D
Sbjct: 299 WEDVKEEMTSALATMRVD 316

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (354), Expect = 3e-39
 Identities = 50/266 (18%), Positives = 90/266 (33%), Gaps = 25/266 (9%)

Query: 73  LVGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLG 131
            +GRG +  V++ V     +    K +         +     EI  +    H N+L L  
Sbjct: 12  DLGRGEFGIVHRCVETSSKKTYMAKFVKV---KGTDQVLVKKEISILNIARHRNILHLHE 68

Query: 132 CCVDNG-LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRII 190
                  L +IF+F S   +    +  ++  +  +            L +LH      I 
Sbjct: 69  SFESMEELVMIFEFISGLDIFERINT-SAFELNEREIVSYVHQVCEALQFLH---SHNIG 124

Query: 191 HRDIKSSNILLTADFEPQ--ISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVD 248
           H DI+  NI+          I +FG A+ L        +        + APE   H +V 
Sbjct: 125 HFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLL---FTAPEYYAPEVHQHDVVS 181

Query: 249 EKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRL-QGAYDVTQL 307
             TD+++ G  +  ++SG  P              +  +   ++     +   A D   +
Sbjct: 182 TATDMWSLGTLVYVLLSGINPFLAETNQ-QIIENIMNAEYTFDEEAFKEISIEAMDF--V 238

Query: 308 NRLAFAASLCIRASPTWRPTMSEVLE 333
           +R        +      R T SE L+
Sbjct: 239 DR-------LLVKERKSRMTASEALQ 257

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  139 bits (351), Expect = 3e-39
 Identities = 63/282 (22%), Positives = 106/282 (37%), Gaps = 33/282 (11%)

Query: 68  FSSENLVGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKE-------FLTEIGTIG 119
           +  + ++GRG  + V + +     +E AVK +          +E        L E+  + 
Sbjct: 5   YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 64

Query: 120 HV-CHPNVLSLLGCCVDNG-LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARG 177
            V  HPN++ L      N   +L+F    +G +           +  K   KI       
Sbjct: 65  KVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT--EKVTLSEKETRKIMRALLEV 122

Query: 178 LHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHL 237
           +  LHK     I+HRD+K  NILL  D   +++DFG +  L        +    GT  +L
Sbjct: 123 ICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVC---GTPSYL 176

Query: 238 APEYFM------HGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIE 291
           APE         H    ++ D+++ GV +  +++G  P     Q      + I++     
Sbjct: 177 APEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ--MLMLRMIMSGN--Y 232

Query: 292 KLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLE 333
           +   P      D   +  L    S  +   P  R T  E L 
Sbjct: 233 QFGSPEWDDYSD--TVKDL---VSRFLVVQPQKRYTAEEALA 269

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (348), Expect = 1e-38
 Identities = 59/283 (20%), Positives = 108/283 (38%), Gaps = 28/283 (9%)

Query: 72  NLVGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKE---KEFLTEIGTIGHVCHPNVL 127
           + +G G +A VYK       + +A+K++      + K+   +  L EI  +  + HPN++
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 128 SLLGCCVDNG-LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQ 186
            LL        + L+F F    +   +    NS  +         + T +GL YLH+   
Sbjct: 64  GLLDAFGHKSNISLVFDFME--TDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW- 120

Query: 187 RRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFM-HG 245
             I+HRD+K +N+LL  +   +++DFGLAK   S    ++      T  + APE      
Sbjct: 121 --ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYT--HQVVTRWYRAPELLFGAR 176

Query: 246 IVDEKTDVFAFGVFLLEIISGRKPVDGSHQ--------------SLHSWAKPILNQGEIE 291
           +     D++A G  L E++     + G                 +   W         + 
Sbjct: 177 MYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVT 236

Query: 292 KLVDPRLQGAYDVTQLNRLAFA-ASLCIRASPTWRPTMSEVLE 333
               P +   +  +                +P  R T ++ L+
Sbjct: 237 FKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  138 bits (349), Expect = 1e-38
 Identities = 59/275 (21%), Positives = 107/275 (38%), Gaps = 25/275 (9%)

Query: 65  TNAFSSENLVGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCH 123
            + +   +++G G ++EV      +  + +A+K + K   +  KE     EI  +  + H
Sbjct: 8   RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG-KEGSMENEIAVLHKIKH 66

Query: 124 PNVLSLLGCCVDNG-LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLH 182
           PN+++L       G LYLI Q  S G +              +   ++       + YLH
Sbjct: 67  PNIVALDDIYESGGHLYLIMQLVSGGELFDRIV--EKGFYTERDASRLIFQVLDAVKYLH 124

Query: 183 KGCQRRIIHRDIKSSNILLT---ADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAP 239
                 I+HRD+K  N+L      D +  ISDFGL+K         +     GT G++AP
Sbjct: 125 DLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTAC---GTPGYVAP 178

Query: 240 EYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRL- 298
           E        +  D ++ GV    ++ G  P    + +   + + +  + E +      + 
Sbjct: 179 EVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA-KLFEQILKAEYEFDSPYWDDIS 237

Query: 299 QGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLE 333
             A D   +          +   P  R T  + L+
Sbjct: 238 DSAKDF--IRH-------LMEKDPEKRFTCEQALQ 263

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (348), Expect = 1e-38
 Identities = 47/283 (16%), Positives = 91/283 (32%), Gaps = 21/283 (7%)

Query: 68  FSSENLVGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNV 126
           F     +G G Y  VYK      GE +A+K++      +      + EI  +  + HPN+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63

Query: 127 LSLLGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQ 186
           + LL          +        +          G+   +         +GL + H    
Sbjct: 64  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS--- 120

Query: 187 RRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGI 246
            R++HRD+K  N+L+  +   +++DFGLA+        ++   +   +            
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHE-VVTLWYRAPEILLGCKY 179

Query: 247 VDEKTDVFAFGVFLLEIISGRKPVDGSHQ------------SLHSWAKPILNQGEIEKLV 294
                D+++ G    E+++ R    G  +            +      P +      K  
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 239

Query: 295 DPRLQGAYDVTQLNRLAFAA----SLCIRASPTWRPTMSEVLE 333
            P+         +  L        S  +   P  R +    L 
Sbjct: 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (344), Expect = 7e-38
 Identities = 49/213 (23%), Positives = 90/213 (42%), Gaps = 11/213 (5%)

Query: 68  FSSENLVGRGGYAEVYKGV-LQDGEEIAVKRLTK-VVTDDRKEKEFLTEIGTIGHVC-HP 124
           F    ++G+G + +V+     +  +  A+K L K VV  D   +  + E   +     HP
Sbjct: 4   FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63

Query: 125 NVLSLLGCCVDNG-LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHK 183
            +  +         L+ + ++ + G +       +    +       A     GL +LH 
Sbjct: 64  FLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ--SCHKFDLSRATFYAAEIILGLQFLHS 121

Query: 184 GCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFM 243
              + I++RD+K  NILL  D   +I+DFG+ K         +     GT  ++APE  +
Sbjct: 122 ---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTN--TFCGTPDYIAPEILL 176

Query: 244 HGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQS 276
               +   D ++FGV L E++ G+ P  G  + 
Sbjct: 177 GQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE 209

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  135 bits (341), Expect = 8e-38
 Identities = 54/278 (19%), Positives = 97/278 (34%), Gaps = 21/278 (7%)

Query: 72  NLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLG 131
             +G G Y  VYK     GE  A+K++     D+      + EI  +  + H N++ L  
Sbjct: 8   EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67

Query: 132 CCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIH 191
                   ++        +     DV   G+E        +    G+ Y H    RR++H
Sbjct: 68  VIHTKKRLVLVFEHLDQDLKK-LLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLH 123

Query: 192 RDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKT 251
           RD+K  N+L+  + E +I+DFGLA+             I   +                 
Sbjct: 124 RDLKPQNLLINREGELKIADFGLARAFGIP-VRKYTHEIVTLWYRAPDVLMGSKKYSTTI 182

Query: 252 DVFAFGVFLLEIISGRKPVDGSHQ------------SLHSWAKPILNQGEIEKLVDPRLQ 299
           D+++ G    E+++G     G  +            + +S   P + +           +
Sbjct: 183 DIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYE 242

Query: 300 GAYDVTQLNRLAFAA----SLCIRASPTWRPTMSEVLE 333
                + L  L  +     S  ++  P  R T  + LE
Sbjct: 243 PLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (340), Expect = 4e-37
 Identities = 66/345 (19%), Positives = 120/345 (34%), Gaps = 58/345 (16%)

Query: 65  TNAFSSENLVGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCH 123
              +++ + +G G Y  V       +   +A+K+++         +  L EI  +    H
Sbjct: 7   GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISP-FEHQTYCQRTLREIKILLRFRH 65

Query: 124 PNVLSLLGCCVDNG------LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARG 177
            N++ +              +YL+           L+  + +  +             RG
Sbjct: 66  ENIIGINDIIRAPTIEQMKDVYLVTHLMGA----DLYKLLKTQHLSNDHICYFLYQILRG 121

Query: 178 LHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWL-PSQWTHHSIAPIEGTFGH 236
           L Y+H      ++HRD+K SN+LL    + +I DFGLA+   P       +     T  +
Sbjct: 122 LKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 178

Query: 237 LAPEYFMHGIVD-EKTDVFAFGVFLLEIISGRKPVDGSHQS---------LHSWAKPILN 286
            APE  ++     +  D+++ G  L E++S R    G H           L S ++  LN
Sbjct: 179 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN 238

Query: 287 QGEIEKLVDPRLQGAYDVTQLNRLAF------AASL---CIRASPTWRPTMSEVL----- 332
                K  +  L   +         F      A  L    +  +P  R  + + L     
Sbjct: 239 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 298

Query: 333 ----------------EVMLEGDQIDKERWK--MPEEEEEDQEEF 359
                           +  +E D + KE+ K  + EE    Q  +
Sbjct: 299 EQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGY 343

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (332), Expect = 6e-36
 Identities = 57/293 (19%), Positives = 100/293 (34%), Gaps = 39/293 (13%)

Query: 68  FSSENLVGRGGYAEVYKGVL-QDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNV 126
           ++   ++G G +  VY+  L   GE +A+K++ +       ++    E+  +  + H N+
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ------DKRFKNRELQIMRKLDHCNI 75

Query: 127 LSLLGCCVDNG-------LYLIFQFSSRGSVASLFHDVNSPG-VEWKVRHKIAVGTARGL 178
           + L      +G       L L+  +          H   +   +             R L
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135

Query: 179 HYLHKGCQRRIIHRDIKSSNILLTADFEPQ-ISDFGLAKWLPSQWTHHSIAPIEGTFGHL 237
            Y+H      I HRDIK  N+LL  D     + DFG AK L     + S   I   +   
Sbjct: 136 AYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS--YICSRYYRA 190

Query: 238 APEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPR 297
               F         DV++ G  L E++ G+    G    +    + I   G   +     
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG-VDQLVEIIKVLGTPTREQIRE 249

Query: 298 LQGAYDVTQLNRLAF--------------AASL---CIRASPTWRPTMSEVLE 333
           +   Y   +  ++                A +L    +  +PT R T  E   
Sbjct: 250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  131 bits (329), Expect = 6e-36
 Identities = 54/285 (18%), Positives = 93/285 (32%), Gaps = 22/285 (7%)

Query: 60  EISIATNAFSSENLVGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTI 118
           E+ +  N +     +G G + ++Y G  +  GEE+A+K          K  +   E    
Sbjct: 2   ELRVG-NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECV----KTKHPQLHIESKIY 56

Query: 119 GHVCHPNVLSLLGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGL 178
             +     +  +  C   G Y +      G       +  S     K    +A      +
Sbjct: 57  KMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRI 116

Query: 179 HYLHKGCQRRIIHRDIKSSNILLT---ADFEPQISDFGLAKWLPSQWTHHSIAPIE---- 231
            Y+H    +  IHRD+K  N L+          I DFGLAK      TH  I   E    
Sbjct: 117 EYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNL 173

Query: 232 -GTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEI 290
            GT  + +    +      + D+ + G  L+    G  P  G      +  +    +   
Sbjct: 174 TGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLK---AATKRQKYERISE 230

Query: 291 EKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVM 335
           +K+  P              A   + C       +P  S + ++ 
Sbjct: 231 KKMSTPIEVLCKGYPS--EFATYLNFCRSLRFDDKPDYSYLRQLF 273

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  130 bits (327), Expect = 9e-36
 Identities = 39/276 (14%), Positives = 85/276 (30%), Gaps = 23/276 (8%)

Query: 71  ENLVGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSL 129
              +G G +  +++G  L + +++A+K   +         +   E  T   +     +  
Sbjct: 10  GRRIGEGSFGVIFEGTNLLNNQQVAIKFEPR----RSDAPQLRDEYRTYKLLAGCTGIPN 65

Query: 130 LGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRI 189
           +      GL+ +      G       D+       K     A      +  +H   ++ +
Sbjct: 66  VYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSL 122

Query: 190 IHRDIKSSNILLTADFEPQ-----ISDFGLAKWLPSQWTHHSIAPIE-----GTFGHLAP 239
           ++RDIK  N L+            + DFG+ K+     T   I   E     GT  +++ 
Sbjct: 123 VYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSI 182

Query: 240 EYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQ 299
              +      + D+ A G   +  + G  P  G   + +        +   +K   P  +
Sbjct: 183 NTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQ---KYERIGEKKQSTPLRE 239

Query: 300 GAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVM 335
                 +              +    P    +  + 
Sbjct: 240 LCAGFPE--EFYKYMHYARNLAFDATPDYDYLQGLF 273

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (325), Expect = 1e-35
 Identities = 51/270 (18%), Positives = 93/270 (34%), Gaps = 35/270 (12%)

Query: 73  LVGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKE----KEFLTEIGTIGHV--CHPN 125
           L+G GG+  VY G+ + D   +A+K + K    D  E         E+  +  V      
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70

Query: 126 VLSLLGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGC 185
           V+ LL        +++                    ++ ++           + + H   
Sbjct: 71  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHN-- 128

Query: 186 QRRIIHRDIKSSNILLTAD-FEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFM- 243
              ++HRDIK  NIL+  +  E ++ DFG    L            +GT  +  PE+   
Sbjct: 129 -CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD----FDGTRVYSPPEWIRY 183

Query: 244 HGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYD 303
           H        V++ G+ L +++ G  P +   + +         Q    + V    Q    
Sbjct: 184 HRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIR-------GQVFFRQRVSSECQ---H 233

Query: 304 VTQLNRLAFAASLCIRASPTWRPTMSEVLE 333
           +            C+   P+ RPT  E+  
Sbjct: 234 L---------IRWCLALRPSDRPTFEEIQN 254

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (325), Expect = 2e-35
 Identities = 49/280 (17%), Positives = 97/280 (34%), Gaps = 23/280 (8%)

Query: 72  NLVGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLL 130
             +G G Y  V+K    +  E +A+KR+     D+      L EI  +  + H N++ L 
Sbjct: 8   EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67

Query: 131 GCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRII 190
                +    +        +   F   N       V+        +GL + H    R ++
Sbjct: 68  DVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVK-SFLFQLLKGLGFCH---SRNVL 123

Query: 191 HRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEK 250
           HRD+K  N+L+  + E ++++FGLA+        +S   +   +       F   +    
Sbjct: 124 HRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA-EVVTLWYRPPDVLFGAKLYSTS 182

Query: 251 TDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQLNRL 310
            D+++ G    E+ +  +P+   +       +     G   +   P +    D       
Sbjct: 183 IDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMY 242

Query: 311 AFAASL-----------------CIRASPTWRPTMSEVLE 333
               SL                  ++ +P  R +  E L+
Sbjct: 243 PATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (322), Expect = 5e-35
 Identities = 63/286 (22%), Positives = 107/286 (37%), Gaps = 38/286 (13%)

Query: 68  FSSENL---------VGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKE----KEFLT 113
           F  EN+         +G G +A V K      G + A K + K  T   +     ++   
Sbjct: 3   FRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIER 62

Query: 114 EIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAV 172
           E+  +  + HPNV++L     +   + LI +  + G +           +  +   +   
Sbjct: 63  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLA--EKESLTEEEATEFLK 120

Query: 173 GTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQ----ISDFGLAKWLPSQWTHHSIA 228
               G++YLH     +I H D+K  NI+L     P+    I DFGLA  +          
Sbjct: 121 QILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK--- 174

Query: 229 PIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQG 288
            I GT   +APE   +  +  + D+++ GV    ++SG  P  G  +   + A       
Sbjct: 175 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ-ETLANVSAVNY 233

Query: 289 EIEKLVDPRL-QGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLE 333
           E E          A D   + R        +   P  R T+ + L+
Sbjct: 234 EFEDEYFSNTSALAKDF--IRR-------LLVKDPKKRMTIQDSLQ 270

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (322), Expect = 9e-35
 Identities = 54/294 (18%), Positives = 112/294 (38%), Gaps = 37/294 (12%)

Query: 72  NLVGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLL 130
             +G+G + EV+K    + G+++A+K++      +      L EI  +  + H NV++L+
Sbjct: 16  AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 75

Query: 131 GCCVD---------NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYL 181
             C             +YL+F F        L + +    +    R  +      GL+Y+
Sbjct: 76  EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKR--VMQMLLNGLYYI 133

Query: 182 HKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWL--PSQWTHHSIAPIEGTFGHLAP 239
           H+    +I+HRD+K++N+L+T D   +++DFGLA+          +       T  +  P
Sbjct: 134 HR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPP 190

Query: 240 EYFMHGI-VDEKTDVFAFGVFLLEIISGRKPVDGSHQ----------------SLHSWAK 282
           E  +         D++  G  + E+ +    + G+ +                 +     
Sbjct: 191 ELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVD 250

Query: 283 PILNQGEIEKLVDPRLQGAYDVTQLNRLAFAASL---CIRASPTWRPTMSEVLE 333
                 ++E +   + +    +    R  +A  L    +   P  R    + L 
Sbjct: 251 NYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  127 bits (319), Expect = 4e-34
 Identities = 57/254 (22%), Positives = 94/254 (37%), Gaps = 14/254 (5%)

Query: 24  NAAVSPNGFTEESLENVVVACESETTKPTWRCFSFEEISIATNAFSSENLVGRGGYAEVY 83
           NAA +  G  +ES++  +   + +  K  W   S     +  + F     +G G +  V 
Sbjct: 2   NAAAAKKGSEQESVKEFLAKAKEDFLK-KWETPSQNTAQL--DQFDRIKTLGTGSFGRVM 58

Query: 84  KGV-LQDGEEIAVKRLTK-VVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNGLYLI 141
                + G   A+K L K  V   ++ +  L E   +  V  P ++ L     DN    +
Sbjct: 59  LVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM 118

Query: 142 FQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILL 201
                 G      H               A        YLH      +I+RD+K  N+L+
Sbjct: 119 VMEYVAGGE-MFSHLRRIGRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLI 174

Query: 202 TADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLL 261
                 Q++DFG AK +  +        + GT   LAPE  +    ++  D +A GV + 
Sbjct: 175 DQQGYIQVTDFGFAKRVKGRTWT-----LCGTPEALAPEIILSKGYNKAVDWWALGVLIY 229

Query: 262 EIISGRKPVDGSHQ 275
           E+ +G  P      
Sbjct: 230 EMAAGYPPFFADQP 243

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (318), Expect = 5e-34
 Identities = 51/215 (23%), Positives = 79/215 (36%), Gaps = 8/215 (3%)

Query: 63  IATNAFSSENLVGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKE-KEFLTEIGTIGH 120
           +  N F    L+G+G + +V        G   A+K L K V   + E    +TE   + +
Sbjct: 2   VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61

Query: 121 VCHPNVLSLLGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHY 180
             HP + +L      +         + G              E + R   A      +  
Sbjct: 62  TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGA----EIVSA 117

Query: 181 LHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPE 240
           L     R +++RDIK  N++L  D   +I+DFGL K   S           GT  +LAPE
Sbjct: 118 LEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK--TFCGTPEYLAPE 175

Query: 241 YFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQ 275
                      D +  GV + E++ GR P      
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH 210

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (303), Expect = 7e-32
 Identities = 60/288 (20%), Positives = 104/288 (36%), Gaps = 39/288 (13%)

Query: 73  LVGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLG 131
            VG G Y  V   V  + G ++A+K+L +    +   K    E+  + H+ H NV+ LL 
Sbjct: 25  PVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLD 84

Query: 132 CCVDNG-------LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKG 184
               +         YL+  F            +    +       +     +GL Y+H  
Sbjct: 85  VFTPDETLDDFTDFYLVMPFMGTDL----GKLMKHEKLGEDRIQFLVYQMLKGLRYIHA- 139

Query: 185 CQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFM- 243
               IIHRD+K  N+ +  D E +I DFGLA+   S+ T + +        + APE  + 
Sbjct: 140 --AGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTR-----WYRAPEVILN 192

Query: 244 HGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQ--------------SLHSWAKPILNQGE 289
                +  D+++ G  + E+I+G+    GS                      +   ++ +
Sbjct: 193 WMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAK 252

Query: 290 IEKLVDPRLQGAYDVTQLNRLAFAA----SLCIRASPTWRPTMSEVLE 333
                 P L+     + L   +  A       +      R T  E L 
Sbjct: 253 NYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 300

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  111 bits (278), Expect = 1e-28
 Identities = 57/240 (23%), Positives = 101/240 (42%), Gaps = 20/240 (8%)

Query: 59  EEISIATNAFSSENLVGRGGYAEVYKGVL----QDGEEIAVKRLTK--VVTDDRKEKEFL 112
           E++ I    F    ++G G Y +V+          G+  A+K L K  +V   +  +   
Sbjct: 19  EKVGI--ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTR 76

Query: 113 TEIGTIGHVCH-PNVLSLLGCCVDNG-LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKI 170
           TE   + H+   P +++L         L+LI  + + G + +               +  
Sbjct: 77  TERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIY-- 134

Query: 171 AVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPI 230
                  +  L    +  II+RDIK  NILL ++    ++DFGL+K   +  T  +    
Sbjct: 135 ---VGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAY-DF 190

Query: 231 EGTFGHLAPEYFMHGI--VDEKTDVFAFGVFLLEIISGRKP--VDGSHQSLHSWAKPILN 286
            GT  ++AP+    G    D+  D ++ GV + E+++G  P  VDG   S    ++ IL 
Sbjct: 191 CGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILK 250

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  111 bits (278), Expect = 3e-28
 Identities = 48/232 (20%), Positives = 89/232 (38%), Gaps = 25/232 (10%)

Query: 58  FEEISIATNAFSSEN------LVGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKE 110
           F  + +  + F+          +G G    V           +A+K+L++   +    K 
Sbjct: 3   FYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKR 62

Query: 111 FLTEIGTIGHVCHPNVLSLLGCCVDNG-------LYLIFQFSSRGSVASLFHDVNSPGVE 163
              E+  +  V H N++SLL              +YL+ +             V    ++
Sbjct: 63  AYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-----LCQVIQMELD 117

Query: 164 WKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWT 223
            +    +      G+ +LH       IHRD+K SNI++ +D   +I DFGLA+   +  T
Sbjct: 118 HERMSYLLYQMLCGIKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLAR---TAGT 171

Query: 224 HHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQ 275
              + P   T  + APE  +     E  D+++ G  + E++  +    G   
Sbjct: 172 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY 223

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  111 bits (277), Expect = 3e-28
 Identities = 56/287 (19%), Positives = 103/287 (35%), Gaps = 35/287 (12%)

Query: 72  NLVGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLL 130
           + VG G Y  V      + G  +AVK+L++        K    E+  + H+ H NV+ LL
Sbjct: 24  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 83

Query: 131 GCCV------DNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKG 184
                     +     +        + ++        +       +     RGL Y+H  
Sbjct: 84  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIH-- 138

Query: 185 CQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMH 244
               IIHRD+K SN+ +  D E +I DFGLA+    + T +        +          
Sbjct: 139 -SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR----WYRAPEIMLNW 193

Query: 245 GIVDEKTDVFAFGVFLLEIISGRKPVDGSH---------QSLHSWAKPILNQGEIEKLVD 295
              ++  D+++ G  + E+++GR    G+          + + +    +L +   E   +
Sbjct: 194 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 253

Query: 296 --------PRLQGAYDVTQLNRLAFA-ASLCIRASPTWRPTMSEVLE 333
                   P++  A      N LA       +      R T ++ L 
Sbjct: 254 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  110 bits (275), Expect = 5e-28
 Identities = 45/218 (20%), Positives = 97/218 (44%), Gaps = 23/218 (10%)

Query: 72  NLVGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHV-CHPNVLSL 129
             +GRG Y+EV++ + + + E++ VK L  V     K+K+   EI  + ++   PN+++L
Sbjct: 41  RKLGRGKYSEVFEAINITNNEKVVVKILKPV-----KKKKIKREIKILENLRGGPNIITL 95

Query: 130 LGCCVD---NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQ 186
                D       L+F+  +      L+  +     ++ +R        + L Y H    
Sbjct: 96  ADIVKDPVSRTPALVFEHVNNTDFKQLYQTLT----DYDIR-FYMYEILKALDYCHS--- 147

Query: 187 RRIIHRDIKSSNILLTADF-EPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFM-H 244
             I+HRD+K  N+++  +  + ++ D+GLA++      ++       +     PE  + +
Sbjct: 148 MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRV---ASRYFKGPELLVDY 204

Query: 245 GIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAK 282
            + D   D+++ G  L  +I  ++P    H +     +
Sbjct: 205 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVR 242

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  110 bits (275), Expect = 7e-28
 Identities = 39/234 (16%), Positives = 81/234 (34%), Gaps = 22/234 (9%)

Query: 71  ENLVGRGGYAEVYKGV-LQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSL 129
              +G G ++ V+    + +   +A+K +     D    +    EI  +  V   +    
Sbjct: 18  VRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG---DKVYTEAAEDEIKLLQRVNDADNTKE 74

Query: 130 LGCCVDNGLYLIFQFSSRGS---------------VASLFHDVNSPGVEWKVRHKIAVGT 174
                ++ L L+  F+ +G                + +L       G+      +I+   
Sbjct: 75  DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQL 134

Query: 175 ARGLHYLHKGCQRRIIHRDIKSSNILLTA-DFEPQISDFGLAKWLPSQWTHHSIAPIEGT 233
             GL Y+H   +  IIH DIK  N+L+   D    +    +A    + W          T
Sbjct: 135 LLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQT 192

Query: 234 FGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQ 287
             + +PE  +        D+++    + E+I+G    +      ++     + Q
Sbjct: 193 REYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ 246

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 84.1 bits (207), Expect = 9e-20
 Identities = 24/153 (15%), Positives = 45/153 (29%), Gaps = 16/153 (10%)

Query: 72  NLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRK--------EKEFLTEIGTIGHVCH 123
            L+G G  + V+    +   E  VK      T  +K        +  F            
Sbjct: 6   KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65

Query: 124 PNVLSLLGCCVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHK 183
             +  L G  V         +     +  L        V  +   ++       +   + 
Sbjct: 66  RALQKLQGLAVPKVYA----WEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFY- 120

Query: 184 GCQRRIIHRDIKSSNILLTADFEPQISDFGLAK 216
              R I+H D+   N+L++ +    I DF  + 
Sbjct: 121 --HRGIVHGDLSQYNVLVS-EEGIWIIDFPQSV 150

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	386
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.93
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.62
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.12
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.73
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.3
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	97.21
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.79

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.4e-59  Score=417.50  Aligned_cols=264  Identities=26%  Similarity=0.426  Sum_probs=210.6

Q ss_pred             HHHhcCCCCCCeecccCCcEEEEEEECCCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCceEEE
Q 016594           62 SIATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNGLYLI  141 (386)
Q Consensus        62 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~lv  141 (386)
                      ++..++|++.+.||+|+||+||+|+++  ..||||+++...........+.+|+.++++++|||||++++++.++..++|
T Consensus         4 ei~~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~lv   81 (276)
T d1uwha_           4 EIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQLAIV   81 (276)
T ss_dssp             BCCTTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEE
T ss_pred             ccccccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEeccEEEEE
Confidence            355688999999999999999999875  369999998766666677889999999999999999999999887789999


Q ss_pred             EEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCC
Q 016594          142 FQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQ  221 (386)
Q Consensus       142 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  221 (386)
                      |||+.+|+|.+++.... ..+++..+..++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+|......
T Consensus        82 ~Ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~gl~yLH~---~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~  157 (276)
T d1uwha_          82 TQWCEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW  157 (276)
T ss_dssp             EECCCEEEHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTSSEEECCCCCSCC----
T ss_pred             EecCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHhc---CCEeccccCHHHEEEcCCCCEEEccccceeecccc
Confidence            99999999999987543 349999999999999999999999   99999999999999999999999999999877654


Q ss_pred             CccccccccccccCccChhhhcc---CCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCcc
Q 016594          222 WTHHSIAPIEGTFGHLAPEYFMH---GIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRL  298 (386)
Q Consensus       222 ~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (386)
                      ..........||+.|||||++.+   ..|+.++|||||||++|||+||+.||.+........  .....+.    ..+..
T Consensus       158 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~--~~~~~~~----~~p~~  231 (276)
T d1uwha_         158 SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQII--FMVGRGY----LSPDL  231 (276)
T ss_dssp             --------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHH--HHHHHTS----CCCCG
T ss_pred             CCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHH--HHHhcCC----CCCcc
Confidence            44444556779999999999964   358999999999999999999999998754321111  1111110    01110


Q ss_pred             CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          299 QGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       299 ~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                       ...+..++..+.+++.+||+.||++|||+.+|+++|+..
T Consensus       232 -~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l  270 (276)
T d1uwha_         232 -SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELL  270 (276)
T ss_dssp             -GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence             112233457899999999999999999999999998754

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.3e-59  Score=415.96  Aligned_cols=259  Identities=22%  Similarity=0.266  Sum_probs=210.1

Q ss_pred             cCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEEE
Q 016594           66 NAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQ  143 (386)
Q Consensus        66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~e  143 (386)
                      ++|++.+.||+|+||+||+|+++ +|+.||||++..... ......+.+|+.++++++|||||++++++.+++ .|+|||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE   83 (271)
T d1nvra_           5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   83 (271)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence            57899999999999999999986 689999999975432 233456889999999999999999999998876 889999


Q ss_pred             eccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCc
Q 016594          144 FSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWT  223 (386)
Q Consensus       144 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~  223 (386)
                      |+.+|+|.+++...  ..+++..+..++.|++.||+|||+   ++|+||||||+|||++.++.+||+|||+|+.+.....
T Consensus        84 y~~gg~L~~~l~~~--~~l~e~~~~~i~~qi~~al~ylH~---~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~  158 (271)
T d1nvra_          84 YCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR  158 (271)
T ss_dssp             CCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred             ccCCCcHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHH---cCCccCcccHHHEEECCCCCEEEccchhheeeccCCc
Confidence            99999999998643  359999999999999999999999   9999999999999999999999999999998754433


Q ss_pred             cccccccccccCccChhhhccCCC-CcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCCCC
Q 016594          224 HHSIAPIEGTFGHLAPEYFMHGIV-DEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAY  302 (386)
Q Consensus       224 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (386)
                      .......+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.............          .........
T Consensus       159 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~----------~~~~~~~~~  228 (271)
T d1nvra_         159 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW----------KEKKTYLNP  228 (271)
T ss_dssp             ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHH----------HTTCTTSTT
T ss_pred             cccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHH----------hcCCCCCCc
Confidence            344556789999999999988776 678999999999999999999997654332211111          011111111


Q ss_pred             CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCCc
Q 016594          303 DVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEGDQ  340 (386)
Q Consensus       303 ~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~~~  340 (386)
                      ....+..+.+|+.+||+.||++|||+.++++|-+...+
T Consensus       229 ~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~  266 (271)
T d1nvra_         229 WKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKP  266 (271)
T ss_dssp             GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred             cccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCcC
Confidence            12345778999999999999999999999988665443

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-58  Score=412.64  Aligned_cols=258  Identities=22%  Similarity=0.377  Sum_probs=212.9

Q ss_pred             HHHHhcCCCCCCeecccCCcEEEEEEECCCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCceEE
Q 016594           61 ISIATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNGLYL  140 (386)
Q Consensus        61 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~l  140 (386)
                      +++..++|++.+.||+|+||+||+|.+++++.||||++....   .....+.+|+.++++++|||||++++++.++..++
T Consensus         8 wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~i   84 (272)
T d1qpca_           8 WEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS---MSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYI   84 (272)
T ss_dssp             TBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEE
T ss_pred             eecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc---CCHHHHHHHHHHHHhCCCCCEeEEEeeeccCCeEE
Confidence            445667899999999999999999999888899999997533   23457899999999999999999999998888999


Q ss_pred             EEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCC
Q 016594          141 IFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPS  220 (386)
Q Consensus       141 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~  220 (386)
                      ||||+.+|+|.+++.......+++..++.++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+|+.+..
T Consensus        85 v~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~---~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~  161 (272)
T d1qpca_          85 ITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIED  161 (272)
T ss_dssp             EEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             EEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccchhheeeecccceeeccccceEEccC
Confidence            9999999999998766555569999999999999999999999   9999999999999999999999999999998754


Q ss_pred             CCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCC-CCCCCchhhhhhhhhhhcccccccccCCccC
Q 016594          221 QWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRK-PVDGSHQSLHSWAKPILNQGEIEKLVDPRLQ  299 (386)
Q Consensus       221 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~-pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (386)
                      .. ........||+.|+|||++.+..++.++|||||||++|||+||.. ||.......  ....          +.....
T Consensus       162 ~~-~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~--~~~~----------i~~~~~  228 (272)
T d1qpca_         162 NE-YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE--VIQN----------LERGYR  228 (272)
T ss_dssp             SC-EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HHHH----------HHTTCC
T ss_pred             Cc-cccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHH--HHHH----------HHhcCC
Confidence            42 223344568999999999999999999999999999999999554 554432211  0010          011112


Q ss_pred             CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 016594          300 GAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLE  337 (386)
Q Consensus       300 ~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~  337 (386)
                      ...+..++..+.+|+.+||+.||++|||+++|++.|+.
T Consensus       229 ~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~  266 (272)
T d1qpca_         229 MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLED  266 (272)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhh
Confidence            22233455779999999999999999999999998764

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-58  Score=410.86  Aligned_cols=256  Identities=21%  Similarity=0.337  Sum_probs=200.3

Q ss_pred             cCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEe---CceEEE
Q 016594           66 NAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVD---NGLYLI  141 (386)
Q Consensus        66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~---~~~~lv  141 (386)
                      ++|++.+.||+|+||+||+|+++ +|+.||||++............+.+|+.++++++|||||++++++.+   +..|+|
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv   83 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   83 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence            57899999999999999999986 68999999998766666667789999999999999999999999864   237999


Q ss_pred             EEeccCCCHhhhhhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeEEeCCCCCCeeEcCCCCeEEeecCcccc
Q 016594          142 FQFSSRGSVASLFHDV--NSPGVEWKVRHKIAVGTARGLHYLHKGC--QRRIIHRDIKSSNILLTADFEPQISDFGLAKW  217 (386)
Q Consensus       142 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~--~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~  217 (386)
                      |||+.+|+|.+++...  ....+++..++.++.|++.||.|||+..  .++|+||||||+|||++.++.+||+|||+|..
T Consensus        84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~  163 (269)
T d2java1          84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI  163 (269)
T ss_dssp             EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred             EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence            9999999999988643  2345999999999999999999999811  12399999999999999999999999999988


Q ss_pred             CCCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCc
Q 016594          218 LPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPR  297 (386)
Q Consensus       218 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (386)
                      +....  .......||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.....  ....+ .....       
T Consensus       164 ~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~--~~~~i-~~~~~-------  231 (269)
T d2java1         164 LNHDT--SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE--LAGKI-REGKF-------  231 (269)
T ss_dssp             C-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHH-HHTCC-------
T ss_pred             cccCC--CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHH--HHHHH-HcCCC-------
Confidence            75432  22345679999999999999999999999999999999999999998754321  11111 11111       


Q ss_pred             cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 016594          298 LQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVM  335 (386)
Q Consensus       298 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l  335 (386)
                        ...+...++.+.+|+.+||+.||.+|||+.++++|-
T Consensus       232 --~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp  267 (269)
T d2java1         232 --RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENP  267 (269)
T ss_dssp             --CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTST
T ss_pred             --CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCC
Confidence              112223457799999999999999999999999763

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-57  Score=403.37  Aligned_cols=249  Identities=28%  Similarity=0.416  Sum_probs=209.2

Q ss_pred             cCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEecccc-CChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEE
Q 016594           66 NAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVV-TDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIF  142 (386)
Q Consensus        66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~  142 (386)
                      ++|++.+.||+|+||+||+|+++ +++.||+|++.+.. ........+.+|+.++++++|||||++++++.+++ .++||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm   85 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   85 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence            46899999999999999999986 68999999987532 22334567889999999999999999999998866 89999


Q ss_pred             EeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCC
Q 016594          143 QFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQW  222 (386)
Q Consensus       143 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  222 (386)
                      ||+.+|+|.+++....  .+++..+..++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+|...... 
T Consensus        86 Ey~~~g~L~~~l~~~~--~l~e~~~~~i~~qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~-  159 (263)
T d2j4za1          86 EYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-  159 (263)
T ss_dssp             ECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC-
T ss_pred             eecCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeeeeeeccccceecCCCCEeecccceeeecCCC-
Confidence            9999999999987654  39999999999999999999999   99999999999999999999999999999876543 


Q ss_pred             ccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCCCC
Q 016594          223 THHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAY  302 (386)
Q Consensus       223 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (386)
                         ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+......  ...+         ....  ...
T Consensus       160 ---~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~--~~~i---------~~~~--~~~  223 (263)
T d2j4za1         160 ---RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET--YKRI---------SRVE--FTF  223 (263)
T ss_dssp             ---CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH--HHHH---------HTTC--CCC
T ss_pred             ---cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHH--HHHH---------HcCC--CCC
Confidence               23346799999999999999999999999999999999999999987543211  1111         0110  112


Q ss_pred             CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 016594          303 DVTQLNRLAFAASLCIRASPTWRPTMSEVLEVML  336 (386)
Q Consensus       303 ~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~  336 (386)
                      +...+..+.+|+.+||+.||++|||+.++++|-+
T Consensus       224 p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~  257 (263)
T d2j4za1         224 PDFVTEGARDLISRLLKHNPSQRPMLREVLEHPW  257 (263)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHH
T ss_pred             CccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcC
Confidence            2334577999999999999999999999998754

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-56  Score=404.63  Aligned_cols=252  Identities=21%  Similarity=0.349  Sum_probs=210.0

Q ss_pred             cCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEEE
Q 016594           66 NAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQ  143 (386)
Q Consensus        66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~e  143 (386)
                      ++|++.+.||+|+||+||+|.+. +|+.||||++.....  .....+.+|+.++++++|||||++++++.+++ .|+|||
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE   97 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ--PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME   97 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGC--SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccC--hHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEE
Confidence            46999999999999999999975 799999999875432  23467899999999999999999999998766 899999


Q ss_pred             eccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCc
Q 016594          144 FSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWT  223 (386)
Q Consensus       144 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~  223 (386)
                      |+.+|+|.+++...   .+++..+..++.||+.||+|||+   +||+||||||+|||++.++++||+|||+|..+.... 
T Consensus        98 y~~gg~L~~~~~~~---~l~~~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~-  170 (293)
T d1yhwa1          98 YLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-  170 (293)
T ss_dssp             CCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT-
T ss_pred             ecCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCcHHHeEECCCCcEeeccchhheeecccc-
Confidence            99999999987653   49999999999999999999999   999999999999999999999999999998775432 


Q ss_pred             cccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCCCCC
Q 016594          224 HHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYD  303 (386)
Q Consensus       224 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (386)
                       ......+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.........  .....        ......+
T Consensus       171 -~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~--~~~~~--------~~~~~~~  239 (293)
T d1yhwa1         171 -SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYL--IATNG--------TPELQNP  239 (293)
T ss_dssp             -CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH--HHHHC--------SCCCSSG
T ss_pred             -ccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHH--HHhCC--------CCCCCCc
Confidence             233456799999999999999999999999999999999999999987543221111  11110        0111122


Q ss_pred             HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 016594          304 VTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLE  337 (386)
Q Consensus       304 ~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~  337 (386)
                      ...+..+.+||.+||+.||++|||+.++++|-+.
T Consensus       240 ~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~  273 (293)
T d1yhwa1         240 EKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFL  273 (293)
T ss_dssp             GGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGG
T ss_pred             ccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhh
Confidence            3446789999999999999999999999987543

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=7e-58  Score=413.24  Aligned_cols=259  Identities=25%  Similarity=0.399  Sum_probs=214.6

Q ss_pred             HHHHhcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-e
Q 016594           61 ISIATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-L  138 (386)
Q Consensus        61 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~  138 (386)
                      +++..++|++.+.||+|+||+||+|.++ +++.||||+++...   ....++.+|+.+|++++|||||++++++.+++ .
T Consensus        12 wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~---~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   88 (287)
T d1opja_          12 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF   88 (287)
T ss_dssp             TBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC---SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             cEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc---chHHHHHHHHHHHHhCCCCCEecCCccEeeCCee
Confidence            3466778999999999999999999987 58899999987533   23457899999999999999999999998754 8


Q ss_pred             EEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccC
Q 016594          139 YLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWL  218 (386)
Q Consensus       139 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~  218 (386)
                      +++|||+.+|+|.+++.......+++..++.++.|++.||+|||+   ++|+||||||+|||++.++.+||+|||+|+..
T Consensus        89 ~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~  165 (287)
T d1opja_          89 YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLM  165 (287)
T ss_dssp             EEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCCTTTC
T ss_pred             EEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHH---CCcccCccccCeEEECCCCcEEEccccceeec
Confidence            999999999999999987777779999999999999999999999   99999999999999999999999999999877


Q ss_pred             CCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCC-CCchhhhhhhhhhhcccccccccCCc
Q 016594          219 PSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVD-GSHQSLHSWAKPILNQGEIEKLVDPR  297 (386)
Q Consensus       219 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~-~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (386)
                      ..... .......|++.|+|||++.+..|+.++|||||||++|||++|..||. +.....            +.+.+...
T Consensus       166 ~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~------------~~~~i~~~  232 (287)
T d1opja_         166 TGDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ------------VYELLEKD  232 (287)
T ss_dssp             CSSSS-EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH------------HHHHHHTT
T ss_pred             CCCCc-eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHH------------HHHHHhcC
Confidence            54422 22334458899999999999999999999999999999999766654 332211            11111112


Q ss_pred             cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          298 LQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       298 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                      .....+..++..+.+|+.+||+.||++|||+.+|++.|+..
T Consensus       233 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~  273 (287)
T d1opja_         233 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM  273 (287)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred             CCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            22233344567899999999999999999999999988654

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-56  Score=403.33  Aligned_cols=249  Identities=24%  Similarity=0.351  Sum_probs=203.3

Q ss_pred             CeecccCCcEEEEEEEC---CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCceEEEEEeccCC
Q 016594           72 NLVGRGGYAEVYKGVLQ---DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNGLYLIFQFSSRG  148 (386)
Q Consensus        72 ~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~lv~e~~~~~  148 (386)
                      ++||+|+||+||+|.++   .++.||||+++....+......+.+|+.+|++++|||||++++++.++..++||||+.+|
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~~~~lvmE~~~~g   92 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELG   92 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESSSEEEEEECCTTE
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccCCEEEEEEcCCCC
Confidence            46999999999999864   356899999986555566677899999999999999999999999888899999999999


Q ss_pred             CHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCccc-cc
Q 016594          149 SVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHH-SI  227 (386)
Q Consensus       149 ~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~-~~  227 (386)
                      +|.+++....  .+++..++.++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+++.+....... ..
T Consensus        93 ~L~~~l~~~~--~l~~~~~~~i~~qi~~gl~ylH~---~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~  167 (277)
T d1xbba_          93 PLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ  167 (277)
T ss_dssp             EHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC-
T ss_pred             cHHHHHhhcc--CCCHHHHHHHHHHHHHHHhhHHh---CCcccCCCcchhhcccccCcccccchhhhhhccccccccccc
Confidence            9999987643  49999999999999999999999   999999999999999999999999999998875543322 23


Q ss_pred             cccccccCccChhhhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCchhhhhhhhhhhcccccccccCCccCCCCCHHH
Q 016594          228 APIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQ  306 (386)
Q Consensus       228 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (386)
                      ....||+.|+|||++.+..++.++|||||||++|||++ |+.||.+......  ..          .+....+...+..+
T Consensus       168 ~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~--~~----------~i~~~~~~~~p~~~  235 (277)
T d1xbba_         168 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV--TA----------MLEKGERMGCPAGC  235 (277)
T ss_dssp             ---CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH--HH----------HHHTTCCCCCCTTC
T ss_pred             cccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHH--HH----------HHHcCCCCCCCccc
Confidence            34568999999999999999999999999999999998 9999987543211  11          11111122233445


Q ss_pred             HHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 016594          307 LNRLAFAASLCIRASPTWRPTMSEVLEVMLE  337 (386)
Q Consensus       307 ~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~  337 (386)
                      +..+.+|+.+||+.||++|||+++|++.|+.
T Consensus       236 ~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~  266 (277)
T d1xbba_         236 PREMYDLMNLCWTYDVENRPGFAAVELRLRN  266 (277)
T ss_dssp             CHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             CHHHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence            6789999999999999999999999887653

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-57  Score=414.87  Aligned_cols=265  Identities=18%  Similarity=0.326  Sum_probs=208.6

Q ss_pred             HHhcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEE
Q 016594           63 IATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYL  140 (386)
Q Consensus        63 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~l  140 (386)
                      +..++|++.+.||+|+||+||+|++. +|+.||+|+++... .......+.+|+.+|++++|||||+++++|.+++ .++
T Consensus         3 l~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~i   81 (322)
T d1s9ja_           3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI   81 (322)
T ss_dssp             CCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC-CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEE
T ss_pred             CCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            34678999999999999999999986 68999999997643 3444578899999999999999999999998866 899


Q ss_pred             EEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCC
Q 016594          141 IFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPS  220 (386)
Q Consensus       141 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~  220 (386)
                      ||||+.+|+|.+++.+..  .+++..+..++.|++.||.|||+  .++|+||||||+|||++.++.+||+|||+|..+..
T Consensus        82 VmEy~~gg~L~~~l~~~~--~l~~~~~~~~~~qil~aL~yLH~--~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~  157 (322)
T d1s9ja_          82 CMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  157 (322)
T ss_dssp             EEECCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH--HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred             EEEcCCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHH--hCCEEccccCHHHeeECCCCCEEEeeCCCccccCC
Confidence            999999999999997654  39999999999999999999996  04899999999999999999999999999986532


Q ss_pred             CCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhccccc----------
Q 016594          221 QWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEI----------  290 (386)
Q Consensus       221 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~----------  290 (386)
                          ....+.+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+...............+..          
T Consensus       158 ----~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (322)
T d1s9ja_         158 ----SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP  233 (322)
T ss_dssp             ----HTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------
T ss_pred             ----CccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccc
Confidence                223456899999999999999999999999999999999999999976543221111000000000          


Q ss_pred             ---------------------ccccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 016594          291 ---------------------EKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVML  336 (386)
Q Consensus       291 ---------------------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~  336 (386)
                                           ..+.............+..+.+++.+||..||.+|||++|+|+|-+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf  300 (322)
T d1s9ja_         234 GRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAF  300 (322)
T ss_dssp             ------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred             cccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHh
Confidence                                 0000000000011123467899999999999999999999999744

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.2e-57  Score=402.01  Aligned_cols=254  Identities=21%  Similarity=0.392  Sum_probs=198.7

Q ss_pred             hcCCCCCCeecccCCcEEEEEEECCCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEEE
Q 016594           65 TNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQ  143 (386)
Q Consensus        65 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~e  143 (386)
                      .++|++.+.||+|+||+||+|.+.+++.||||++....   ....++.+|+.++++++|||||++++++.+++ .++|||
T Consensus         4 p~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E   80 (263)
T d1sm2a_           4 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA---MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFE   80 (263)
T ss_dssp             CSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             hHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc---CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEE
Confidence            35788899999999999999999888899999997533   23457899999999999999999999997654 899999


Q ss_pred             eccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCc
Q 016594          144 FSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWT  223 (386)
Q Consensus       144 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~  223 (386)
                      |+.+|+|.+++... ...+++..++.++.|++.||+|||+   ++|+||||||+|||++.++.+||+|||+++.+.....
T Consensus        81 ~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qia~gl~~lH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~  156 (263)
T d1sm2a_          81 FMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY  156 (263)
T ss_dssp             CCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCTTCSGGGEEECGGGCEEECSCC----------
T ss_pred             ecCCCcHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHhhhc---cceeecccchhheeecCCCCeEecccchheeccCCCc
Confidence            99999999988654 3458999999999999999999999   9999999999999999999999999999987654322


Q ss_pred             cccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCchhhhhhhhhhhcccccccccCCccCCCC
Q 016594          224 HHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAY  302 (386)
Q Consensus       224 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (386)
                       .......||+.|+|||++.+..|+.++|||||||++|||+| |.+||.......  ....+..          ......
T Consensus       157 -~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~--~~~~i~~----------~~~~~~  223 (263)
T d1sm2a_         157 -TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE--VVEDIST----------GFRLYK  223 (263)
T ss_dssp             ---------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHH--HHHHHHH----------TCCCCC
T ss_pred             -eeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHH--HHHHHHh----------cCCCCC
Confidence             22234568999999999999999999999999999999999 566665533211  1111111          111122


Q ss_pred             CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          303 DVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       303 ~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                      +..++..+.+++.+||+.||++|||+++|+++|++.
T Consensus       224 p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i  259 (263)
T d1sm2a_         224 PRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI  259 (263)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence            233457799999999999999999999999998754

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-56  Score=395.64  Aligned_cols=253  Identities=21%  Similarity=0.362  Sum_probs=211.7

Q ss_pred             hcCCCCCCeecccCCcEEEEEEECCCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEEE
Q 016594           65 TNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQ  143 (386)
Q Consensus        65 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~e  143 (386)
                      .++|++.+.||+|+||+||+|++++++.||||++++...   ...++++|+.++++++||||+++++++.+++ .++|||
T Consensus         3 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~---~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~E   79 (258)
T d1k2pa_           3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM---SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITE   79 (258)
T ss_dssp             CCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS---CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEE
T ss_pred             hHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC---CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEE
Confidence            468999999999999999999998888999999986433   3457899999999999999999999997654 899999


Q ss_pred             eccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCc
Q 016594          144 FSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWT  223 (386)
Q Consensus       144 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~  223 (386)
                      |+.+|+|..++.... ..+++..++.++.|+++||.|||+   ++|+||||||+|||++.++.+||+|||+++.+.....
T Consensus        80 y~~~g~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~~LH~---~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~  155 (258)
T d1k2pa_          80 YMANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY  155 (258)
T ss_dssp             CCTTEEHHHHHHSGG-GCCCHHHHHHHHHHHHHHHHHHHH---TTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC
T ss_pred             ccCCCcHHHhhhccc-cCCcHHHHHHHHHHHHHHHHHHhh---cCcccccccceeEEEcCCCcEEECcchhheeccCCCc
Confidence            999999998865543 348899999999999999999999   9999999999999999999999999999987654322


Q ss_pred             cccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCchhhhhhhhhhhcccccccccCCccCCCC
Q 016594          224 HHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAY  302 (386)
Q Consensus       224 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (386)
                       .......||+.|+|||.+.+..++.++|||||||++|||+| |+.||.+.......  ..+ .         ...+...
T Consensus       156 -~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~--~~i-~---------~~~~~~~  222 (258)
T d1k2pa_         156 -TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETA--EHI-A---------QGLRLYR  222 (258)
T ss_dssp             -CCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHH--HHH-H---------TTCCCCC
T ss_pred             -eeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHH--HHH-H---------hCCCCCC
Confidence             23334568999999999999999999999999999999998 89999876433211  111 1         1112222


Q ss_pred             CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 016594          303 DVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLE  337 (386)
Q Consensus       303 ~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~  337 (386)
                      +...+..+.+++.+||+.||++|||+++|+++|.+
T Consensus       223 p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d  257 (258)
T d1k2pa_         223 PHLASEKVYTIMYSCWHEKADERPTFKILLSNILD  257 (258)
T ss_dssp             CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred             cccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence            33445789999999999999999999999999864

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-56  Score=399.06  Aligned_cols=249  Identities=24%  Similarity=0.407  Sum_probs=202.7

Q ss_pred             CCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeC-----ceEEE
Q 016594           68 FSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDN-----GLYLI  141 (386)
Q Consensus        68 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~lv  141 (386)
                      |++.+.||+|+||+||+|.+. ++..||+|.+............+.+|+++|++++|||||++++++.+.     .+++|
T Consensus        11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv   90 (270)
T d1t4ha_          11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV   90 (270)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence            356678999999999999986 688999999987655666677899999999999999999999998651     27899


Q ss_pred             EEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEEeCCCCCCeeEc-CCCCeEEeecCccccC
Q 016594          142 FQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRR--IIHRDIKSSNILLT-ADFEPQISDFGLAKWL  218 (386)
Q Consensus       142 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~--ivH~dlkp~Nill~-~~~~~kl~Dfg~a~~~  218 (386)
                      |||+.+|+|.+++.+..  .+++..+..++.||+.||+|||+   ++  |+||||||+|||++ .++.+||+|||+|+..
T Consensus        91 mE~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~gl~yLH~---~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~  165 (270)
T d1t4ha_          91 TELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK  165 (270)
T ss_dssp             EECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred             EeCCCCCcHHHHHhccc--cccHHHHHHHHHHHHHHHHHHHH---CCCCEEeCCcChhhceeeCCCCCEEEeecCcceec
Confidence            99999999999987654  48999999999999999999999   77  99999999999996 5789999999999865


Q ss_pred             CCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCcc
Q 016594          219 PSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRL  298 (386)
Q Consensus       219 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (386)
                      ...    .....+||+.|+|||++.+ .++.++|||||||++|||++|+.||.+........ ..+ .        ....
T Consensus       166 ~~~----~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~-~~i-~--------~~~~  230 (270)
T d1t4ha_         166 RAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIY-RRV-T--------SGVK  230 (270)
T ss_dssp             CTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHH-HHH-T--------TTCC
T ss_pred             cCC----ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHH-HHH-H--------cCCC
Confidence            433    2335679999999998865 59999999999999999999999997643321111 111 0        0000


Q ss_pred             CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 016594          299 QGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVML  336 (386)
Q Consensus       299 ~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~  336 (386)
                      ....+...++.+.+++.+||+.||++|||+.|+++|-+
T Consensus       231 ~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~  268 (270)
T d1t4ha_         231 PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAF  268 (270)
T ss_dssp             CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred             CcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcc
Confidence            11112223466899999999999999999999998754

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-56  Score=405.04  Aligned_cols=251  Identities=22%  Similarity=0.323  Sum_probs=205.3

Q ss_pred             cCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEecccc-CChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEE
Q 016594           66 NAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVV-TDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIF  142 (386)
Q Consensus        66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~  142 (386)
                      ++|++.+.||+|+||+||+|.++ +|+.||||++.+.. ........+.+|+.++++++||||+++++++.+++ .|+||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            56999999999999999999986 78999999997532 12334567899999999999999999999998766 89999


Q ss_pred             EeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCC
Q 016594          143 QFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQW  222 (386)
Q Consensus       143 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  222 (386)
                      ||+.+|+|.+++....  .+++..++.++.|++.||+|||+   ++|+||||||+|||++.++.+||+|||+|+.+....
T Consensus        88 Ey~~gg~L~~~~~~~~--~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~  162 (288)
T d1uu3a_          88 SYAKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES  162 (288)
T ss_dssp             CCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred             EccCCCCHHHhhhccC--CCCHHHHHHHHHHHHHHHHhhcc---ccEEcCcCCccccccCCCceEEecccccceecccCC
Confidence            9999999999887654  39999999999999999999999   999999999999999999999999999999876544


Q ss_pred             ccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCCCC
Q 016594          223 THHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAY  302 (386)
Q Consensus       223 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (386)
                      ........+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.+....  ...+         ....  ..+
T Consensus       163 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~--~~~i---------~~~~--~~~  229 (288)
T d1uu3a_         163 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLI--FQKI---------IKLE--YDF  229 (288)
T ss_dssp             -------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHH---------HTTC--CCC
T ss_pred             cccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHH--HHHH---------HcCC--CCC
Confidence            44444567899999999999999999999999999999999999999987543211  1111         1111  112


Q ss_pred             CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 016594          303 DVTQLNRLAFAASLCIRASPTWRPTMSEVLEV  334 (386)
Q Consensus       303 ~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~  334 (386)
                      +...+..+.+||.+||+.||++|||++|++.+
T Consensus       230 p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~  261 (288)
T d1uu3a_         230 PEKFFPKARDLVEKLLVLDATKRLGCEEMEGY  261 (288)
T ss_dssp             CTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred             CccCCHHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence            23345779999999999999999999987544

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-56  Score=402.19  Aligned_cols=257  Identities=21%  Similarity=0.328  Sum_probs=210.9

Q ss_pred             hcCCCCCCe-ecccCCcEEEEEEEC---CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCceEE
Q 016594           65 TNAFSSENL-VGRGGYAEVYKGVLQ---DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNGLYL  140 (386)
Q Consensus        65 ~~~~~~~~~-lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~l  140 (386)
                      .++|.+.+. ||+|+||+||+|.++   ++..||||+++.. ........+.+|+.+|++++|||||++++++.++..++
T Consensus         7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~-~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~l   85 (285)
T d1u59a_           7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALML   85 (285)
T ss_dssp             GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEE
T ss_pred             ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChh-cCHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccCeEEE
Confidence            345666674 999999999999865   3557999999753 34556678999999999999999999999998888999


Q ss_pred             EEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCC
Q 016594          141 IFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPS  220 (386)
Q Consensus       141 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~  220 (386)
                      ||||+.+|+|.+++... ...+++..++.++.|++.||+|||+   ++|+||||||+|||++.++.+||+|||+|+.+..
T Consensus        86 vmE~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~gL~ylH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~  161 (285)
T d1u59a_          86 VMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGA  161 (285)
T ss_dssp             EEECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred             EEEeCCCCcHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCcCchhheeeccCCceeeccchhhhcccc
Confidence            99999999999987543 3359999999999999999999999   9999999999999999999999999999998765


Q ss_pred             CCcc-ccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCchhhhhhhhhhhcccccccccCCcc
Q 016594          221 QWTH-HSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRL  298 (386)
Q Consensus       221 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (386)
                      .... .......||+.|+|||++.+..++.++|||||||++|||+| |..||.+......  ... ..         ...
T Consensus       162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~--~~~-i~---------~~~  229 (285)
T d1u59a_         162 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV--MAF-IE---------QGK  229 (285)
T ss_dssp             CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHH--HHH-HH---------TTC
T ss_pred             cccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHH--HHH-HH---------cCC
Confidence            4322 22334568999999999999999999999999999999998 9999987543211  111 11         111


Q ss_pred             CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          299 QGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       299 ~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                      +...+..++..+.+|+.+||+.||++|||+.+|++.|+..
T Consensus       230 ~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~  269 (285)
T d1u59a_         230 RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC  269 (285)
T ss_dssp             CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            2223344567899999999999999999999999887643

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-56  Score=402.58  Aligned_cols=254  Identities=23%  Similarity=0.326  Sum_probs=207.8

Q ss_pred             cCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEEE
Q 016594           66 NAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQ  143 (386)
Q Consensus        66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~e  143 (386)
                      +.|++.+.||+|+||+||+|+++ +++.||||++...  .......+.+|+++|++++|||||++++++.+++ .++|||
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmE   89 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIE   89 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--SSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEe
Confidence            46889999999999999999986 6899999998753  2344567889999999999999999999998766 899999


Q ss_pred             eccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCc
Q 016594          144 FSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWT  223 (386)
Q Consensus       144 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~  223 (386)
                      |+.+|+|.+++.+.. ..+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+|......  
T Consensus        90 y~~~g~L~~~~~~~~-~~l~e~~~~~i~~qi~~gL~ylH~---~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~--  163 (288)
T d2jfla1          90 FCAGGAVDAVMLELE-RPLTESQIQVVCKQTLDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT--  163 (288)
T ss_dssp             CCTTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECHHH--
T ss_pred             cCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCEEEeecChhheeECCCCCEEEEechhhhccCCC--
Confidence            999999999876543 349999999999999999999999   99999999999999999999999999999765322  


Q ss_pred             cccccccccccCccChhhhc-----cCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCcc
Q 016594          224 HHSIAPIEGTFGHLAPEYFM-----HGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRL  298 (386)
Q Consensus       224 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (386)
                      .......+||+.|+|||++.     +..|+.++|||||||++|+|++|+.||.+.......  ..+.. .       ...
T Consensus       164 ~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~--~~i~~-~-------~~~  233 (288)
T d2jfla1         164 IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVL--LKIAK-S-------EPP  233 (288)
T ss_dssp             HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHH--HHHHH-S-------CCC
T ss_pred             cccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHH--HHHHc-C-------CCC
Confidence            12234567999999999984     456899999999999999999999999875432110  00100 0       001


Q ss_pred             CCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 016594          299 QGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLE  337 (386)
Q Consensus       299 ~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~  337 (386)
                      ....+...+..+.+||.+||+.||++|||+.++++|-+.
T Consensus       234 ~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~  272 (288)
T d2jfla1         234 TLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFV  272 (288)
T ss_dssp             CCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGG
T ss_pred             CCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcCccc
Confidence            112223456789999999999999999999999987554

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=4e-56  Score=404.04  Aligned_cols=257  Identities=23%  Similarity=0.387  Sum_probs=198.3

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEC-CCc---EEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eE
Q 016594           65 TNAFSSENLVGRGGYAEVYKGVLQ-DGE---EIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LY  139 (386)
Q Consensus        65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~---~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~  139 (386)
                      .++|++.++||+|+||+||+|.++ +++   .||||.+... ........+.+|+.+|++++|||||++++++.+++ .+
T Consensus        25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~  103 (299)
T d1jpaa_          25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG-YTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVM  103 (299)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSS-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred             hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcc-cCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence            457888899999999999999976 332   5889988653 33445678999999999999999999999997654 89


Q ss_pred             EEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCC
Q 016594          140 LIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLP  219 (386)
Q Consensus       140 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~  219 (386)
                      +||||+.+|+|.+++... ...+++..++.++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+|+.+.
T Consensus       104 iv~Ey~~~g~L~~~~~~~-~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~  179 (299)
T d1jpaa_         104 IITEFMENGSLDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE  179 (299)
T ss_dssp             EEEECCTTEEHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred             EEEEecCCCcceeeeccc-cCCCCHHHHHHHHHHHHHHHHHHhh---CCCccCccccceEEECCCCcEEECCcccceEcc
Confidence            999999999999987653 3358999999999999999999999   999999999999999999999999999998775


Q ss_pred             CCCccc---cccccccccCccChhhhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCchhhhhhhhhhhcccccccccC
Q 016594          220 SQWTHH---SIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGEIEKLVD  295 (386)
Q Consensus       220 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  295 (386)
                      ......   ......||+.|+|||++.+..++.++|||||||++|||+| |..||.+.....  ...          .+.
T Consensus       180 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~--~~~----------~i~  247 (299)
T d1jpaa_         180 DDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD--VIN----------AIE  247 (299)
T ss_dssp             ----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHH----------HHH
T ss_pred             CCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHH--HHH----------HHH
Confidence            432221   1223457899999999999999999999999999999998 899998754321  111          111


Q ss_pred             CccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          296 PRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       296 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                      ...+...+..++..+.+|+.+||+.||++|||+.+|++.|+..
T Consensus       248 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~  290 (299)
T d1jpaa_         248 QDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM  290 (299)
T ss_dssp             TTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             cCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            1112223344567899999999999999999999999988654

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-56  Score=412.33  Aligned_cols=260  Identities=23%  Similarity=0.404  Sum_probs=210.2

Q ss_pred             HHHhcCCCCCCeecccCCcEEEEEEECC-C-----cEEEEEEeccccCChHhHHHHHHHHHHHhcc-CCCceeeecceEE
Q 016594           62 SIATNAFSSENLVGRGGYAEVYKGVLQD-G-----EEIAVKRLTKVVTDDRKEKEFLTEIGTIGHV-CHPNVLSLLGCCV  134 (386)
Q Consensus        62 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~-~-----~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~  134 (386)
                      ++..++|++.+.||+|+||+||+|++.. +     ..||+|.+.... .......+.+|+.++.++ +|||||++++++.
T Consensus        33 ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~  111 (325)
T d1rjba_          33 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACT  111 (325)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc-CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEe
Confidence            3556789999999999999999999652 2     369999887532 233456789999999998 7999999999998


Q ss_pred             eCc-eEEEEEeccCCCHhhhhhhcCC---------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEe
Q 016594          135 DNG-LYLIFQFSSRGSVASLFHDVNS---------------------PGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHR  192 (386)
Q Consensus       135 ~~~-~~lv~e~~~~~~L~~~~~~~~~---------------------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~  192 (386)
                      +.+ .++||||+.+|+|.+++.....                     ..+++..++.++.|++.||+|||+   ++|+||
T Consensus       112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~---~~IiHR  188 (325)
T d1rjba_         112 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHR  188 (325)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEET
T ss_pred             eCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeec
Confidence            765 8999999999999999875432                     348999999999999999999999   999999


Q ss_pred             CCCCCCeeEcCCCCeEEeecCccccCCCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHh-CCCCCC
Q 016594          193 DIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVD  271 (386)
Q Consensus       193 dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~  271 (386)
                      ||||+|||++.++.+||+|||+|+...............||+.|||||++.+..++.++|||||||++|||++ |..||.
T Consensus       189 DlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~  268 (325)
T d1rjba_         189 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP  268 (325)
T ss_dssp             TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred             cCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCC
Confidence            9999999999999999999999987655444334455678999999999999999999999999999999998 899998


Q ss_pred             CCchhhhhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 016594          272 GSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVML  336 (386)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~  336 (386)
                      +.......           .+++....+...+..++..+.+||.+||+.||++|||+++|+++|.
T Consensus       269 ~~~~~~~~-----------~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         269 GIPVDANF-----------YKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             TCCCSHHH-----------HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCCHHHHH-----------HHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence            75432111           1111111222333445678999999999999999999999999985

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-56  Score=403.13  Aligned_cols=259  Identities=21%  Similarity=0.339  Sum_probs=207.8

Q ss_pred             HHhcCCCCCCeecccCCcEEEEEEECCCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCceEEEE
Q 016594           63 IATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNGLYLIF  142 (386)
Q Consensus        63 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~lv~  142 (386)
                      +..++|++.+.||+|+||+||+|++++++.||||++.....   ....+.+|+.++++++|||||++++++.++..++||
T Consensus        14 i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~---~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~lv~   90 (285)
T d1fmka3          14 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVT   90 (285)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEE
T ss_pred             cCHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccC---CHHHHHHHHHHHHhcccCCEeEEEEEEecCCeEEEE
Confidence            45578999999999999999999998888899999975432   346789999999999999999999999887899999


Q ss_pred             EeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCC
Q 016594          143 QFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQW  222 (386)
Q Consensus       143 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  222 (386)
                      ||+.+|+|..++.......+++..++.++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+++.+....
T Consensus        91 Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~---~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~  167 (285)
T d1fmka3          91 EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE  167 (285)
T ss_dssp             CCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred             EecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhh---hheecccccceEEEECCCCcEEEcccchhhhccCCC
Confidence            99999999998876655669999999999999999999999   999999999999999999999999999998765432


Q ss_pred             ccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCC-CCCCchhhhhhhhhhhcccccccccCCccCCC
Q 016594          223 THHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKP-VDGSHQSLHSWAKPILNQGEIEKLVDPRLQGA  301 (386)
Q Consensus       223 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~p-f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (386)
                      . .......||+.|+|||++.++.++.++|||||||++|||++|..| +.+.....  ....          +.......
T Consensus       168 ~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~--~~~~----------i~~~~~~~  234 (285)
T d1fmka3         168 Y-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE--VLDQ----------VERGYRMP  234 (285)
T ss_dssp             ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HHHH----------HHTTCCCC
T ss_pred             c-eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHH--HHHH----------HHhcCCCC
Confidence            2 223345689999999999999999999999999999999996555 44432211  0000          11111222


Q ss_pred             CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCCc
Q 016594          302 YDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEGDQ  340 (386)
Q Consensus       302 ~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~~~  340 (386)
                      .+..+++.+.++|.+||+.||++||++++|++.|+....
T Consensus       235 ~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~  273 (285)
T d1fmka3         235 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT  273 (285)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred             CCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhc
Confidence            334456789999999999999999999999998876543

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=9.8e-56  Score=402.64  Aligned_cols=248  Identities=23%  Similarity=0.361  Sum_probs=204.1

Q ss_pred             CCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCC-hHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEEE
Q 016594           67 AFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTD-DRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQ  143 (386)
Q Consensus        67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~e  143 (386)
                      .|+..+.||+|+||+||+|++. +++.||||++...... ......+.+|+.+|++++|||||++++++.+++ .++|||
T Consensus        16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E   95 (309)
T d1u5ra_          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (309)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence            4888999999999999999976 6889999999764433 344567899999999999999999999998765 899999


Q ss_pred             eccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCc
Q 016594          144 FSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWT  223 (386)
Q Consensus       144 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~  223 (386)
                      |+.+|+|..++...  ..+++..++.++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+|......  
T Consensus        96 ~~~~g~l~~~~~~~--~~l~e~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~--  168 (309)
T d1u5ra_          96 YCLGSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--  168 (309)
T ss_dssp             CCSEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB--
T ss_pred             ecCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEECCCCCEEEeecccccccCCC--
Confidence            99999887665543  359999999999999999999999   99999999999999999999999999999865432  


Q ss_pred             cccccccccccCccChhhhcc---CCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCC
Q 016594          224 HHSIAPIEGTFGHLAPEYFMH---GIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQG  300 (386)
Q Consensus       224 ~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (386)
                          ....||+.|+|||++.+   ..|+.++|||||||++|||++|..||.+.......  .....         .....
T Consensus       169 ----~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~--~~i~~---------~~~~~  233 (309)
T d1u5ra_         169 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL--YHIAQ---------NESPA  233 (309)
T ss_dssp             ----CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH--HHHHH---------SCCCC
T ss_pred             ----CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHH--HHHHh---------CCCCC
Confidence                34579999999999864   46899999999999999999999999875432111  11111         01111


Q ss_pred             CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 016594          301 AYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVML  336 (386)
Q Consensus       301 ~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~  336 (386)
                      ..+...++.+.+||.+||+.||++|||+.++++|-+
T Consensus       234 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~  269 (309)
T d1u5ra_         234 LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF  269 (309)
T ss_dssp             CSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHH
T ss_pred             CCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHH
Confidence            112234578999999999999999999999998744

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.2e-55  Score=400.16  Aligned_cols=255  Identities=24%  Similarity=0.327  Sum_probs=193.9

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEE
Q 016594           65 TNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIF  142 (386)
Q Consensus        65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~  142 (386)
                      .+.|++.+.||+|+||+||+|+++ +++.||||++.+..... ....+.+|+.+|++++|||||++++++.+++ .|+||
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm   86 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG-KEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM   86 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh-HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            467999999999999999999986 68999999997643322 3456789999999999999999999998766 89999


Q ss_pred             EeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEc---CCCCeEEeecCccccCC
Q 016594          143 QFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLT---ADFEPQISDFGLAKWLP  219 (386)
Q Consensus       143 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~---~~~~~kl~Dfg~a~~~~  219 (386)
                      ||+.+|+|.+++...  ..+++..+..++.||+.||+|||+   ++|+||||||+|||+.   .++.+||+|||+|+...
T Consensus        87 E~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~  161 (307)
T d1a06a_          87 QLVSGGELFDRIVEK--GFYTERDASRLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED  161 (307)
T ss_dssp             CCCCSCBHHHHHHTC--SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred             eccCCCcHHHhhhcc--cCCCHHHHHHHHHHHHHHHHhhhh---ceeeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence            999999999998753  359999999999999999999999   9999999999999995   57899999999998664


Q ss_pred             CCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccC
Q 016594          220 SQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQ  299 (386)
Q Consensus       220 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (386)
                      ..   ......+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.......  ..+... .      ....
T Consensus       162 ~~---~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~--~~i~~~-~------~~~~  229 (307)
T d1a06a_         162 PG---SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLF--EQILKA-E------YEFD  229 (307)
T ss_dssp             --------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH--HHHHTT-C------CCCC
T ss_pred             CC---CeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHH--HHHhcc-C------CCCC
Confidence            33   2234567999999999999999999999999999999999999999875432111  111110 0      0111


Q ss_pred             CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 016594          300 GAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLE  337 (386)
Q Consensus       300 ~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~  337 (386)
                      .......++.+.+|+.+||+.||++|||+.|+++|-+.
T Consensus       230 ~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~  267 (307)
T d1a06a_         230 SPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWI  267 (307)
T ss_dssp             TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTT
T ss_pred             CccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhh
Confidence            11223345779999999999999999999999998554

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-55  Score=397.06  Aligned_cols=257  Identities=20%  Similarity=0.363  Sum_probs=199.7

Q ss_pred             hcCCCCCCeecccCCcEEEEEEECCC-----cEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-e
Q 016594           65 TNAFSSENLVGRGGYAEVYKGVLQDG-----EEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-L  138 (386)
Q Consensus        65 ~~~~~~~~~lg~G~~g~V~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~  138 (386)
                      .++|++.++||+|+||+||+|.++.+     ..||||++... ........+++|+.++++++|||||++++++.+.. .
T Consensus         6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~   84 (283)
T d1mqba_           6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG-YTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPM   84 (283)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred             HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcc-cChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCce
Confidence            45788899999999999999997632     36999998753 33445667999999999999999999999997654 8


Q ss_pred             EEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccC
Q 016594          139 YLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWL  218 (386)
Q Consensus       139 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~  218 (386)
                      +++|||+.++++.+++... ...+++..+..++.|++.||+|||+   ++|+||||||+|||++.++.+||+|||+++.+
T Consensus        85 ~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~~i~~gl~~lH~---~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~  160 (283)
T d1mqba_          85 MIITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVL  160 (283)
T ss_dssp             EEEEECCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred             EEEEEecccCcchhhhhcc-cccccHHHHHHHHHHHHHhhhhccc---cccccCccccceEEECCCCeEEEcccchhhcc
Confidence            9999999999999877654 3459999999999999999999999   99999999999999999999999999999876


Q ss_pred             CCCCcc-ccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCC-CCCchhhhhhhhhhhcccccccccCC
Q 016594          219 PSQWTH-HSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPV-DGSHQSLHSWAKPILNQGEIEKLVDP  296 (386)
Q Consensus       219 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (386)
                      ...... .......||+.|+|||++.+..++.++|||||||++|||++|..|+ ......  .          +...+..
T Consensus       161 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~--~----------~~~~i~~  228 (283)
T d1mqba_         161 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH--E----------VMKAIND  228 (283)
T ss_dssp             -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--H----------HHHHHHT
T ss_pred             cCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHH--H----------HHHHHhc
Confidence            543221 2223456899999999999999999999999999999999965554 432221  1          1111111


Q ss_pred             ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          297 RLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       297 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                      ..+...+..++..+.+|+.+||+.||++|||+.+|++.|...
T Consensus       229 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l  270 (283)
T d1mqba_         229 GFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL  270 (283)
T ss_dssp             TCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             cCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHH
Confidence            222333444567899999999999999999999999988653

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-55  Score=402.71  Aligned_cols=256  Identities=27%  Similarity=0.433  Sum_probs=206.3

Q ss_pred             cCCCCCCeecccCCcEEEEEEEC-CCc----EEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCceEE
Q 016594           66 NAFSSENLVGRGGYAEVYKGVLQ-DGE----EIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNGLYL  140 (386)
Q Consensus        66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~l  140 (386)
                      .+|++.++||+|+||+||+|.+. +|+    .||+|.+... ......+.+.+|+.++++++|||||++++++.++..++
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~   87 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQL   87 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeeE
Confidence            46899999999999999999975 444    5888888653 23345678999999999999999999999999988999


Q ss_pred             EEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCC
Q 016594          141 IFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPS  220 (386)
Q Consensus       141 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~  220 (386)
                      +++++.+++|.+.+... ...+++..++.++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+|+.+..
T Consensus        88 v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~yLH~---~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~  163 (317)
T d1xkka_          88 ITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  163 (317)
T ss_dssp             EEECCTTCBHHHHHHHT-SSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred             EEEeccCCccccccccc-ccCCCHHHHHHHHHHHHHHHHHHHH---cCcccCcchhhcceeCCCCCeEeeccccceeccc
Confidence            99999999999887654 4459999999999999999999999   9999999999999999999999999999998765


Q ss_pred             CCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCchhhhhhhhhhhcccccccccCCccC
Q 016594          221 QWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQ  299 (386)
Q Consensus       221 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (386)
                      ...........||+.|+|||++.++.++.++|||||||++|||+| |.+||.+.....            +...+....+
T Consensus       164 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~------------~~~~i~~~~~  231 (317)
T d1xkka_         164 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE------------ISSILEKGER  231 (317)
T ss_dssp             TCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG------------HHHHHHHTCC
T ss_pred             ccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH------------HHHHHHcCCC
Confidence            544444445568999999999999999999999999999999998 899998754321            1111111112


Q ss_pred             CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          300 GAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       300 ~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                      ...+..++..+.+++.+||+.||.+|||+.+|+++|...
T Consensus       232 ~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~  270 (317)
T d1xkka_         232 LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM  270 (317)
T ss_dssp             CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHH
Confidence            223344567899999999999999999999999987654

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-54  Score=391.11  Aligned_cols=257  Identities=21%  Similarity=0.267  Sum_probs=210.1

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCC----hHhHHHHHHHHHHHhccCCCceeeecceEEeCc-e
Q 016594           65 TNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTD----DRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-L  138 (386)
Q Consensus        65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~  138 (386)
                      .++|++++.||+|+||+||+|+++ +|+.||||++.+....    ......+.+|+.+|++++|||||++++++.+++ .
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   88 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   88 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            467999999999999999999986 7899999999764322    224678899999999999999999999998866 8


Q ss_pred             EEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCC----CeEEeecCc
Q 016594          139 YLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADF----EPQISDFGL  214 (386)
Q Consensus       139 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~----~~kl~Dfg~  214 (386)
                      ++||||+.+|+|.+++....  .+++..++.++.|++.||+|||+   ++|+||||||+|||++.++    .+||+|||+
T Consensus        89 ~iv~E~~~gg~L~~~i~~~~--~l~~~~~~~~~~qi~~al~yLH~---~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~  163 (293)
T d1jksa_          89 ILILELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL  163 (293)
T ss_dssp             EEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred             EEEEEcCCCccccchhcccc--ccchhHHHHHHHHHHHHHHhhhh---cceeecccccceEEEecCCCcccceEecchhh
Confidence            99999999999999987654  49999999999999999999999   9999999999999998776    599999999


Q ss_pred             cccCCCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhccccccccc
Q 016594          215 AKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLV  294 (386)
Q Consensus       215 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  294 (386)
                      |.......   ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.......  ..+.. ..     
T Consensus       164 a~~~~~~~---~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~--~~i~~-~~-----  232 (293)
T d1jksa_         164 AHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL--ANVSA-VN-----  232 (293)
T ss_dssp             CEECTTSC---BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH--HHHHT-TC-----
T ss_pred             hhhcCCCc---cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHH--HHHHh-cC-----
Confidence            98775432   234557999999999999999999999999999999999999999875432211  00000 00     


Q ss_pred             CCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          295 DPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       295 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                       ...........+..+.+||.+||+.||++|||++++++|-+..
T Consensus       233 -~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~  275 (293)
T d1jksa_         233 -YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK  275 (293)
T ss_dssp             -CCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTC
T ss_pred             -CCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccC
Confidence             0000001112356789999999999999999999999985543

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=3.5e-54  Score=399.13  Aligned_cols=255  Identities=21%  Similarity=0.227  Sum_probs=209.9

Q ss_pred             cCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEEE
Q 016594           66 NAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQ  143 (386)
Q Consensus        66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~e  143 (386)
                      ++|++.+.||+|+||+||+|+.. +|+.||||++...  .......+.+|+.+|++++|||||++++++.+++ .|+|||
T Consensus        29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~--~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE  106 (352)
T d1koba_          29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP--YPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE  106 (352)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--SHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCc--chhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            57999999999999999999986 7999999998753  2344567889999999999999999999998766 899999


Q ss_pred             eccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEc--CCCCeEEeecCccccCCCC
Q 016594          144 FSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLT--ADFEPQISDFGLAKWLPSQ  221 (386)
Q Consensus       144 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~--~~~~~kl~Dfg~a~~~~~~  221 (386)
                      |+.+|+|.+.+... ...+++..++.++.||+.||.|||+   +||+||||||+|||++  .++.+||+|||+|..+...
T Consensus       107 ~~~gg~L~~~~~~~-~~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~  182 (352)
T d1koba_         107 FLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD  182 (352)
T ss_dssp             CCCCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred             cCCCChHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccccccccccccCCCeEEEeecccceecCCC
Confidence            99999998877543 3349999999999999999999999   9999999999999998  6789999999999987653


Q ss_pred             CccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCCC
Q 016594          222 WTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGA  301 (386)
Q Consensus       222 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (386)
                      .   ......||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.......  ..+.. .      .......
T Consensus       183 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~--~~i~~-~------~~~~~~~  250 (352)
T d1koba_         183 E---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETL--QNVKR-C------DWEFDED  250 (352)
T ss_dssp             S---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH--HHHHH-C------CCCCCSS
T ss_pred             C---ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHh-C------CCCCCcc
Confidence            2   234456999999999999999999999999999999999999999875432211  11100 0      0011111


Q ss_pred             CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          302 YDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       302 ~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                      .....+..+.+||.+||+.||.+|||+.++++|-+..
T Consensus       251 ~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~  287 (352)
T d1koba_         251 AFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLK  287 (352)
T ss_dssp             TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTS
T ss_pred             cccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhC
Confidence            2223457799999999999999999999999985543

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=2.1e-54  Score=400.35  Aligned_cols=255  Identities=21%  Similarity=0.280  Sum_probs=209.6

Q ss_pred             cCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEEE
Q 016594           66 NAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQ  143 (386)
Q Consensus        66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~e  143 (386)
                      ++|++.+.||+|+||+||+|+++ +|+.||||++...  .......+.+|+.+|++++|||||++++++.+++ .|+|||
T Consensus        26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~--~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE  103 (350)
T d1koaa2          26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP--HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE  103 (350)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCC--SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEccc--chhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            57999999999999999999986 7899999999753  3445567899999999999999999999998866 899999


Q ss_pred             eccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEc--CCCCeEEeecCccccCCCC
Q 016594          144 FSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLT--ADFEPQISDFGLAKWLPSQ  221 (386)
Q Consensus       144 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~--~~~~~kl~Dfg~a~~~~~~  221 (386)
                      |+.+|+|.+++.... ..+++..+..++.||+.||.|||+   ++|+||||||+|||++  .++.+||+|||+|..+...
T Consensus       104 ~~~gg~L~~~l~~~~-~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~  179 (350)
T d1koaa2         104 FMSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK  179 (350)
T ss_dssp             CCCSCBHHHHHTCTT-SCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred             cCCCCCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHh---cCCeeeeechhHeeeccCCCCeEEEeecchheecccc
Confidence            999999999886433 349999999999999999999999   9999999999999996  4678999999999887544


Q ss_pred             CccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCCC
Q 016594          222 WTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGA  301 (386)
Q Consensus       222 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (386)
                      .   ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+......  ...+....       ......
T Consensus       180 ~---~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~--~~~i~~~~-------~~~~~~  247 (350)
T d1koaa2         180 Q---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET--LRNVKSCD-------WNMDDS  247 (350)
T ss_dssp             S---CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHTC-------CCSCCG
T ss_pred             c---ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHH--HHHHHhCC-------CCCCcc
Confidence            2   23446799999999999999999999999999999999999999987543211  11111100       000111


Q ss_pred             CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          302 YDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       302 ~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                      .....++.+.+||.+||+.||++|||+.++++|-+..
T Consensus       248 ~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~  284 (350)
T d1koaa2         248 AFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLT  284 (350)
T ss_dssp             GGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTS
T ss_pred             cccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccC
Confidence            1123457799999999999999999999999985443

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-55  Score=394.94  Aligned_cols=258  Identities=22%  Similarity=0.363  Sum_probs=201.4

Q ss_pred             HHhcCCCCCCeecccCCcEEEEEEECC----CcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCce
Q 016594           63 IATNAFSSENLVGRGGYAEVYKGVLQD----GEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNGL  138 (386)
Q Consensus        63 ~~~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  138 (386)
                      +..++|++++.||+|+||+||+|.+..    +..||||.+... ........+.+|+.++++++|||||++++++.++..
T Consensus         4 i~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~   82 (273)
T d1mp8a_           4 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPV   82 (273)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT-TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSC
T ss_pred             cCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCeE
Confidence            445789999999999999999999752    346889988643 345556789999999999999999999999987789


Q ss_pred             EEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccC
Q 016594          139 YLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWL  218 (386)
Q Consensus       139 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~  218 (386)
                      ++||||+.+|+|.+++... ...+++..++.++.||+.||.|||+   ++|+||||||+||+++.++.+||+|||+|+.+
T Consensus        83 ~iv~E~~~~g~l~~~~~~~-~~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~  158 (273)
T d1mp8a_          83 WIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM  158 (273)
T ss_dssp             EEEEECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred             EEEEEeccCCcHHhhhhcc-CCCCCHHHHHHHHHHHHHHhhhhcc---cCeeccccchhheeecCCCcEEEccchhheec
Confidence            9999999999999887653 3458999999999999999999999   99999999999999999999999999999876


Q ss_pred             CCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCchhhhhhhhhhhcccccccccCCc
Q 016594          219 PSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGEIEKLVDPR  297 (386)
Q Consensus       219 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (386)
                      ..... .......||+.|+|||++.+..++.++|||||||++|||++ |.+||.+.......  ..+ ..         .
T Consensus       159 ~~~~~-~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~--~~i-~~---------~  225 (273)
T d1mp8a_         159 EDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI--GRI-EN---------G  225 (273)
T ss_dssp             -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH--HHH-HT---------T
T ss_pred             cCCcc-eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHH--HHH-Hc---------C
Confidence            54322 22334568999999999999999999999999999999998 89999875432111  001 11         1


Q ss_pred             cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          298 LQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       298 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                      .....+..++..+.+||.+||+.||++|||+.+|+++|...
T Consensus       226 ~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i  266 (273)
T d1mp8a_         226 ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI  266 (273)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            11223344567899999999999999999999999998653

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-54  Score=397.13  Aligned_cols=254  Identities=23%  Similarity=0.265  Sum_probs=212.3

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccC-ChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEE
Q 016594           65 TNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVT-DDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLI  141 (386)
Q Consensus        65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv  141 (386)
                      -++|++.+.||+|+||+||+|+.+ +|+.||||++.+... .......+.+|+.+|+.++||||+++++++.++. +|+|
T Consensus         4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv   83 (337)
T d1o6la_           4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence            467999999999999999999986 799999999976321 2334567889999999999999999999998876 8999


Q ss_pred             EEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCC
Q 016594          142 FQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQ  221 (386)
Q Consensus       142 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  221 (386)
                      |||+.+|+|.+++.....  +++..++.++.||+.||+|||+   ++|+||||||+|||++.+|.+||+|||+|+.....
T Consensus        84 ~ey~~gg~L~~~~~~~~~--~~e~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~  158 (337)
T d1o6la_          84 MEYANGGELFFHLSRERV--FTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD  158 (337)
T ss_dssp             EECCTTCBHHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred             eeccCCCchhhhhhcccC--CcHHHHHHHHHHHhhhhhhhhh---cCccccccCHHHeEecCCCCEEEeecccccccccC
Confidence            999999999999876543  8999999999999999999999   99999999999999999999999999999876432


Q ss_pred             CccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCCC
Q 016594          222 WTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGA  301 (386)
Q Consensus       222 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (386)
                      .  ......+||+.|+|||++.+..|+.++|||||||++|||++|++||.+.+.....  .....         ..  ..
T Consensus       159 ~--~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~--~~i~~---------~~--~~  223 (337)
T d1o6la_         159 G--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLF--ELILM---------EE--IR  223 (337)
T ss_dssp             T--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH--HHHHH---------CC--CC
T ss_pred             C--cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHH--HHHhc---------CC--CC
Confidence            2  2345678999999999999999999999999999999999999999876542211  11100         00  11


Q ss_pred             CCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHHHhcC
Q 016594          302 YDVTQLNRLAFAASLCIRASPTWRPT-----MSEVLEVMLEG  338 (386)
Q Consensus       302 ~~~~~~~~l~~li~~cl~~dP~~Rpt-----~~~il~~l~~~  338 (386)
                      ++...+..+.+||.+||++||.+||+     +.++++|-+..
T Consensus       224 ~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~  265 (337)
T d1o6la_         224 FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFL  265 (337)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGT
T ss_pred             CCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCcccc
Confidence            22334577899999999999999994     89999986543

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.5e-53  Score=389.63  Aligned_cols=251  Identities=24%  Similarity=0.320  Sum_probs=209.5

Q ss_pred             cCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEecccc-CChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEE
Q 016594           66 NAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVV-TDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIF  142 (386)
Q Consensus        66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~  142 (386)
                      ++|++.+.||+|+||+||+|+++ +|+.||||++.+.. ........+.+|+.+++.++|||||++++++.+++ .|+||
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence            46899999999999999999986 69999999997532 12234567889999999999999999999998866 89999


Q ss_pred             EeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCC
Q 016594          143 QFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQW  222 (386)
Q Consensus       143 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  222 (386)
                      ||+.+|+|..++.....  +++..+..++.||+.||+|||+   ++|+||||||+|||++.+|.+||+|||+|+..... 
T Consensus        84 E~~~gg~l~~~~~~~~~--~~~~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~-  157 (316)
T d1fota_          84 DYIEGGELFSLLRKSQR--FPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-  157 (316)
T ss_dssp             CCCCSCBHHHHHHHTSS--CCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC-
T ss_pred             eecCCcccccccccccc--ccccHHHHHHHHHHHhhhhhcc---CcEEccccCchheeEcCCCCEEEecCccceEeccc-
Confidence            99999999998876543  8899999999999999999999   99999999999999999999999999999876543 


Q ss_pred             ccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCCCC
Q 016594          223 THHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAY  302 (386)
Q Consensus       223 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (386)
                          ....+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+......  ...+..         ..  ...
T Consensus       158 ----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~--~~~i~~---------~~--~~~  220 (316)
T d1fota_         158 ----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT--YEKILN---------AE--LRF  220 (316)
T ss_dssp             ----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH--HHHHHH---------CC--CCC
T ss_pred             ----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHH--HHHHHc---------CC--CCC
Confidence                2356799999999999999999999999999999999999999987543211  111111         00  112


Q ss_pred             CHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHHhcCC
Q 016594          303 DVTQLNRLAFAASLCIRASPTWRP-----TMSEVLEVMLEGD  339 (386)
Q Consensus       303 ~~~~~~~l~~li~~cl~~dP~~Rp-----t~~~il~~l~~~~  339 (386)
                      +...+..+.+++.+||..||.+||     |++++++|-+..+
T Consensus       221 p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~  262 (316)
T d1fota_         221 PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKE  262 (316)
T ss_dssp             CTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSS
T ss_pred             CCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCccccc
Confidence            223456799999999999999996     8999999865543

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.1e-55  Score=387.20  Aligned_cols=251  Identities=23%  Similarity=0.375  Sum_probs=202.2

Q ss_pred             HHhcCCCCCCeecccCCcEEEEEEECCCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEe--CceEE
Q 016594           63 IATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVD--NGLYL  140 (386)
Q Consensus        63 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~l  140 (386)
                      +.-++|++.+.||+|+||.||+|.++ |..||||+++..    ...+.+.+|++++++++||||+++++++.+  +..++
T Consensus         4 i~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~----~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~l   78 (262)
T d1byga_           4 LNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI   78 (262)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC----C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEE
T ss_pred             cCHHHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcH----HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEE
Confidence            34567888999999999999999996 789999999752    234678999999999999999999999864  34899


Q ss_pred             EEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCC
Q 016594          141 IFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPS  220 (386)
Q Consensus       141 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~  220 (386)
                      ||||+.+|+|.+++.......+++..++.++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++....
T Consensus        79 v~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~  155 (262)
T d1byga_          79 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS  155 (262)
T ss_dssp             EECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred             EEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhcccccc---CceeccccchHhheecCCCCEeecccccceecCC
Confidence            9999999999999876554558999999999999999999999   9999999999999999999999999999986543


Q ss_pred             CCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCchhhhhhhhhhhcccccccccCCccC
Q 016594          221 QWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQ  299 (386)
Q Consensus       221 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (386)
                      .     .....++..|+|||++.+..++.++|||||||++|||+| |++||.......            +...+....+
T Consensus       156 ~-----~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~------------~~~~i~~~~~  218 (262)
T d1byga_         156 T-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD------------VVPRVEKGYK  218 (262)
T ss_dssp             -----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG------------HHHHHTTTCC
T ss_pred             C-----CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHH------------HHHHHHcCCC
Confidence            2     223458899999999999999999999999999999998 788887653321            1111111222


Q ss_pred             CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          300 GAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       300 ~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                      ...+...+..+.+|+.+||+.||.+|||+.+|+++|+..
T Consensus       219 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i  257 (262)
T d1byga_         219 MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI  257 (262)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence            333444557899999999999999999999999998653

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-54  Score=388.70  Aligned_cols=259  Identities=24%  Similarity=0.353  Sum_probs=202.1

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEC--CC--cEEEEEEeccccC-ChHhHHHHHHHHHHHhccCCCceeeecceEEeCceE
Q 016594           65 TNAFSSENLVGRGGYAEVYKGVLQ--DG--EEIAVKRLTKVVT-DDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNGLY  139 (386)
Q Consensus        65 ~~~~~~~~~lg~G~~g~V~~~~~~--~~--~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  139 (386)
                      .++|++.+.||+|+||+||+|+++  ++  ..||||++.+... .......+.+|+.+|++++||||+++++++.++..+
T Consensus         7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~~~~   86 (273)
T d1u46a_           7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMK   86 (273)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCE
T ss_pred             hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeecchh
Confidence            467899999999999999999864  22  3689999876432 344567899999999999999999999999888899


Q ss_pred             EEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCC
Q 016594          140 LIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLP  219 (386)
Q Consensus       140 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~  219 (386)
                      +||||+.+|++.+.+.... ..+++..++.++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||++..+.
T Consensus        87 lv~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~  162 (273)
T d1u46a_          87 MVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALP  162 (273)
T ss_dssp             EEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred             eeeeeecCcchhhhhhccc-CCCCHHHHHHHHHHHHHHHHHhhh---CCEeeeeecHHHhccccccceeeccchhhhhcc
Confidence            9999999999998776543 349999999999999999999999   999999999999999999999999999999876


Q ss_pred             CCCcccc-ccccccccCccChhhhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCchhhhhhhhhhhcccccccccCCc
Q 016594          220 SQWTHHS-IAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSLHSWAKPILNQGEIEKLVDPR  297 (386)
Q Consensus       220 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (386)
                      ....... .....|+..|+|||++.+..++.++|||||||++|||+| |..||.+.......  .         .+....
T Consensus       163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~--~---------~i~~~~  231 (273)
T d1u46a_         163 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQIL--H---------KIDKEG  231 (273)
T ss_dssp             C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH--H---------HHHTSC
T ss_pred             cCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHH--H---------HHHhCC
Confidence            5533322 234457889999999999999999999999999999998 89999875443211  1         111111


Q ss_pred             cCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          298 LQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       298 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                      .....+...+..+.+|+.+||+.||++|||+.+|++.|++.
T Consensus       232 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         232 ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence            22223334457799999999999999999999999988753

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.6e-54  Score=392.22  Aligned_cols=263  Identities=22%  Similarity=0.346  Sum_probs=212.5

Q ss_pred             HHHHHhcCCCCCCeecccCCcEEEEEEEC------CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceE
Q 016594           60 EISIATNAFSSENLVGRGGYAEVYKGVLQ------DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCC  133 (386)
Q Consensus        60 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~  133 (386)
                      .++...++|++.+.||+|+||+||+|+++      +++.||||+++.. ........+.+|+.++++++||||+++++++
T Consensus         7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~-~~~~~~~~~~~E~~il~~l~h~niv~~~~~~   85 (301)
T d1lufa_           7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE-ASADMQADFQREAALMAEFDNPNIVKLLGVC   85 (301)
T ss_dssp             HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTT-CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             hccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChh-cChHHHHHHHHHHHHHHhcCCCCcccceeee
Confidence            34456678999999999999999999964      3578999998753 3344567899999999999999999999999


Q ss_pred             EeCc-eEEEEEeccCCCHhhhhhhcC----------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeE
Q 016594          134 VDNG-LYLIFQFSSRGSVASLFHDVN----------------------SPGVEWKVRHKIAVGTARGLHYLHKGCQRRII  190 (386)
Q Consensus       134 ~~~~-~~lv~e~~~~~~L~~~~~~~~----------------------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~iv  190 (386)
                      .+.+ .+++||++.+|+|.+++....                      ...+++..++.++.|++.||+|||+   ++|+
T Consensus        86 ~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~---~~iv  162 (301)
T d1lufa_          86 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFV  162 (301)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCC
T ss_pred             ccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhccc---CCeE
Confidence            7654 899999999999999886432                      2348899999999999999999999   9999


Q ss_pred             EeCCCCCCeeEcCCCCeEEeecCccccCCCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCC-CC
Q 016594          191 HRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGR-KP  269 (386)
Q Consensus       191 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~-~p  269 (386)
                      ||||||+|||++.++.+||+|||+|+.+.............|++.|+|||.+.+..|+.++|||||||++|||++|. +|
T Consensus       163 HrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p  242 (301)
T d1lufa_         163 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP  242 (301)
T ss_dssp             CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred             eeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCC
Confidence            99999999999999999999999998765443333444567899999999999999999999999999999999985 67


Q ss_pred             CCCCchhhhhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          270 VDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       270 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                      |.+.......  .. ...+         .....+...+..+.+|+.+||+.||++||||.+|++.|+..
T Consensus       243 ~~~~~~~e~~--~~-v~~~---------~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i  299 (301)
T d1lufa_         243 YYGMAHEEVI--YY-VRDG---------NILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM  299 (301)
T ss_dssp             TTTSCHHHHH--HH-HHTT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred             CCCCCHHHHH--HH-HHcC---------CCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence            8765432111  11 1111         11122334456799999999999999999999999998754

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=4.5e-53  Score=391.62  Aligned_cols=250  Identities=21%  Similarity=0.269  Sum_probs=209.5

Q ss_pred             cCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEecccc-CChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEE
Q 016594           66 NAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVV-TDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIF  142 (386)
Q Consensus        66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~  142 (386)
                      ++|++.+.||+|+||+||+|+++ +|+.||||++.+.. ........+++|+.+|+.++|||||++++++.+.. .++||
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            57999999999999999999986 79999999987532 22334567899999999999999999999998766 89999


Q ss_pred             EeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCC
Q 016594          143 QFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQW  222 (386)
Q Consensus       143 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  222 (386)
                      ||+.+|+|..++....  .+++..++.++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+|+.+... 
T Consensus       121 e~~~~g~l~~~l~~~~--~l~e~~~~~i~~qi~~aL~yLH~---~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~-  194 (350)
T d1rdqe_         121 EYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-  194 (350)
T ss_dssp             ECCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred             ccccccchhhhHhhcC--CCCHHHHHHHHHHHHHHHHHHHh---CCEecCcCCHHHcccCCCCCEEeeeceeeeecccc-
Confidence            9999999999887654  39999999999999999999999   99999999999999999999999999999877532 


Q ss_pred             ccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCCCC
Q 016594          223 THHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAY  302 (386)
Q Consensus       223 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (386)
                          .....||+.|||||++.+..++.++|||||||++|+|++|..||.+......  ...+..         ..  ...
T Consensus       195 ----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~--~~~i~~---------~~--~~~  257 (350)
T d1rdqe_         195 ----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI--YEKIVS---------GK--VRF  257 (350)
T ss_dssp             ----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHH---------CC--CCC
T ss_pred             ----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHH--HHHHhc---------CC--CCC
Confidence                2356799999999999999999999999999999999999999987543211  111111         00  111


Q ss_pred             CHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHHhcC
Q 016594          303 DVTQLNRLAFAASLCIRASPTWRP-----TMSEVLEVMLEG  338 (386)
Q Consensus       303 ~~~~~~~l~~li~~cl~~dP~~Rp-----t~~~il~~l~~~  338 (386)
                      +...+..+.++|.+||..||.+|+     |++++++|-+..
T Consensus       258 p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~  298 (350)
T d1rdqe_         258 PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA  298 (350)
T ss_dssp             CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGT
T ss_pred             CccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCcccc
Confidence            223457799999999999999994     899999986654

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-54  Score=391.87  Aligned_cols=267  Identities=23%  Similarity=0.336  Sum_probs=205.5

Q ss_pred             CHHHHHHHhcCCCCCCeecccCCcEEEEEEEC------CCcEEEEEEeccccCChHhHHHHHHHHHHHhcc-CCCceeee
Q 016594           57 SFEEISIATNAFSSENLVGRGGYAEVYKGVLQ------DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHV-CHPNVLSL  129 (386)
Q Consensus        57 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l  129 (386)
                      ....+++..++|++.+.||+|+||+||+|.+.      +++.||||++.... .......+.+|..++.++ +|+||+.+
T Consensus         4 ~~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~e~~~l~~~~~h~~iv~~   82 (299)
T d1ywna1           4 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNL   82 (299)
T ss_dssp             CHHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC-----CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CCccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-CcHHHHHHHHHHHHHHhhcCCCeEEEe
Confidence            34556677789999999999999999999964      24689999987533 344456788888888877 58999999


Q ss_pred             cceEEeC--ceEEEEEeccCCCHhhhhhhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeC
Q 016594          130 LGCCVDN--GLYLIFQFSSRGSVASLFHDVN--------------SPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRD  193 (386)
Q Consensus       130 ~~~~~~~--~~~lv~e~~~~~~L~~~~~~~~--------------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~d  193 (386)
                      ++++...  ..+++|||+.+|+|.+++....              ...+++..++.++.||+.||+|||+   ++|+|||
T Consensus        83 ~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~---~~ivHrD  159 (299)
T d1ywna1          83 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRD  159 (299)
T ss_dssp             EEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHH---TTCCCSC
T ss_pred             eeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHh---CCCcCCc
Confidence            9998654  3899999999999999986532              2348899999999999999999999   9999999


Q ss_pred             CCCCCeeEcCCCCeEEeecCccccCCCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhC-CCCCCC
Q 016594          194 IKSSNILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISG-RKPVDG  272 (386)
Q Consensus       194 lkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g-~~pf~~  272 (386)
                      |||+|||++.++.+||+|||+|+...............||+.|+|||++.+..++.++|||||||++|||++| .+||.+
T Consensus       160 lKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~  239 (299)
T d1ywna1         160 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG  239 (299)
T ss_dssp             CCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             CCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCC
Confidence            9999999999999999999999877655444444566799999999999999999999999999999999986 567876


Q ss_pred             CchhhhhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          273 SHQSLHSWAKPILNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                      .......  ......         ......+...+..+.+++.+||+.||++|||+.+|+++|...
T Consensus       240 ~~~~~~~--~~~~~~---------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~i  294 (299)
T d1ywna1         240 VKIDEEF--CRRLKE---------GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL  294 (299)
T ss_dssp             CCCSHHH--HHHHHH---------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCHHHHH--HHHHhc---------CCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence            4322110  011111         111122233456799999999999999999999999998754

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.2e-53  Score=385.42  Aligned_cols=258  Identities=19%  Similarity=0.193  Sum_probs=209.3

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEE
Q 016594           65 TNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIF  142 (386)
Q Consensus        65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~  142 (386)
                      .++|++.+.||+|+||+||+|.++ +++.||||++...   ......+.+|+.+|+.++|||||++++++.+++ .|+||
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~---~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvm   80 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK---GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIF   80 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC---THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCC---cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence            357899999999999999999986 6889999999753   334456889999999999999999999998765 89999


Q ss_pred             EeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCC--CCeEEeecCccccCCC
Q 016594          143 QFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTAD--FEPQISDFGLAKWLPS  220 (386)
Q Consensus       143 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~--~~~kl~Dfg~a~~~~~  220 (386)
                      ||+.+|+|.+++.... ..+++..++.++.||+.||+|||+   ++|+||||||+|||++.+  ..+||+|||++.....
T Consensus        81 E~~~gg~L~~~i~~~~-~~l~e~~~~~i~~qi~~al~yLH~---~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~  156 (321)
T d1tkia_          81 EFISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP  156 (321)
T ss_dssp             CCCCCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred             ecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---cCCCcccccccceeecCCCceEEEEcccchhhcccc
Confidence            9999999999887543 348999999999999999999999   999999999999999854  4899999999987654


Q ss_pred             CCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCC
Q 016594          221 QWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQG  300 (386)
Q Consensus       221 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (386)
                      ..   ......+|+.|+|||.+.+..|+.++|||||||++|+|++|..||.+......  ...+..         .....
T Consensus       157 ~~---~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~--~~~i~~---------~~~~~  222 (321)
T d1tkia_         157 GD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQI--IENIMN---------AEYTF  222 (321)
T ss_dssp             TC---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH--HHHHHH---------TCCCC
T ss_pred             CC---cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHH--HHHHHh---------CCCCC
Confidence            32   23345689999999999999999999999999999999999999987643211  111111         10000


Q ss_pred             C--CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCCcccc
Q 016594          301 A--YDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEGDQIDK  343 (386)
Q Consensus       301 ~--~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~~~~~~  343 (386)
                      .  .....+..+.+||.+||..||++|||+.++++|-+.....+.
T Consensus       223 ~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~~~~  267 (321)
T d1tkia_         223 DEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIER  267 (321)
T ss_dssp             CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSCGGG
T ss_pred             ChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCccc
Confidence            0  001234678999999999999999999999998655444333

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=8.8e-53  Score=391.71  Aligned_cols=254  Identities=22%  Similarity=0.241  Sum_probs=203.5

Q ss_pred             cCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCC-hHhHHHH---HHHHHHHhccCCCceeeecceEEeCc-eE
Q 016594           66 NAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTD-DRKEKEF---LTEIGTIGHVCHPNVLSLLGCCVDNG-LY  139 (386)
Q Consensus        66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~---~~e~~~l~~l~h~niv~l~~~~~~~~-~~  139 (386)
                      ++|++.+.||+|+||+||+|++. +|+.||||++.+.... ......+   ..++.+++.++|||||++++++.+.+ .|
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~   83 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS   83 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence            57999999999999999999986 6999999998753211 1122233   34577788888999999999998766 89


Q ss_pred             EEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCC
Q 016594          140 LIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLP  219 (386)
Q Consensus       140 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~  219 (386)
                      +||||+.+|+|.+++....  .+++..++.++.||+.||.|||+   ++|+||||||+|||++.+|.+||+|||+|..+.
T Consensus        84 ivmE~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~aL~ylH~---~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~  158 (364)
T d1omwa3          84 FILDLMNGGDLHYHLSQHG--VFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFS  158 (364)
T ss_dssp             EEECCCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSSSCEEECCCTTCEECS
T ss_pred             EEEEecCCCcHHHHHHhcc--cccHHHHHHHHHHHHHHHHHHHH---CCccceeeccceeEEcCCCcEEEeeeceeeecC
Confidence            9999999999999987654  38899999999999999999999   999999999999999999999999999998775


Q ss_pred             CCCccccccccccccCccChhhhcc-CCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCcc
Q 016594          220 SQWTHHSIAPIEGTFGHLAPEYFMH-GIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRL  298 (386)
Q Consensus       220 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (386)
                      ..    .....+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||.+...........        .....  
T Consensus       159 ~~----~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~--------~~~~~--  224 (364)
T d1omwa3         159 KK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR--------MTLTM--  224 (364)
T ss_dssp             SS----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHH--------HSSSC--
T ss_pred             CC----cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--------hcccC--
Confidence            43    2345579999999999974 568999999999999999999999998653321111100        00010  


Q ss_pred             CCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHHHhcC
Q 016594          299 QGAYDVTQLNRLAFAASLCIRASPTWRPT-----MSEVLEVMLEG  338 (386)
Q Consensus       299 ~~~~~~~~~~~l~~li~~cl~~dP~~Rpt-----~~~il~~l~~~  338 (386)
                      ....+...+..+.+||.+||+.||++|||     ++++++|-+..
T Consensus       225 ~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~  269 (364)
T d1omwa3         225 AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFR  269 (364)
T ss_dssp             CCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGT
T ss_pred             CCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCcccc
Confidence            11122234577999999999999999999     79999886543

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=1.8e-52  Score=375.28  Aligned_cols=256  Identities=23%  Similarity=0.315  Sum_probs=209.4

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCCh-------HhHHHHHHHHHHHhccC-CCceeeecceEEe
Q 016594           65 TNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDD-------RKEKEFLTEIGTIGHVC-HPNVLSLLGCCVD  135 (386)
Q Consensus        65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-------~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~  135 (386)
                      .++|++.+.||+|+||+||+|+.. +|+.||||++.+.....       .....+.+|+.+++++. ||||+++++++.+
T Consensus         2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~   81 (277)
T d1phka_           2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   81 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence            368999999999999999999975 78999999997643321       12346889999999997 9999999999988


Q ss_pred             Cc-eEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCc
Q 016594          136 NG-LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGL  214 (386)
Q Consensus       136 ~~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~  214 (386)
                      ++ .|+||||+.+|+|.+++....  .+++..++.++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+
T Consensus        82 ~~~~~ivmE~~~~g~L~~~l~~~~--~l~e~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~~kl~DFG~  156 (277)
T d1phka_          82 NTFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGF  156 (277)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             CcceEEEEEcCCCchHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---cCCcccccccceEEEcCCCCeEEccchh
Confidence            66 899999999999999997654  49999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCCccccccccccccCccChhhhcc------CCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhccc
Q 016594          215 AKWLPSQWTHHSIAPIEGTFGHLAPEYFMH------GIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQG  288 (386)
Q Consensus       215 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~  288 (386)
                      +..+....   ......||+.|+|||.+.+      ..++.++||||+||++|+|++|+.||.+.......  ..+... 
T Consensus       157 a~~~~~~~---~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~--~~i~~~-  230 (277)
T d1phka_         157 SCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLML--RMIMSG-  230 (277)
T ss_dssp             CEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH--HHHHHT-
T ss_pred             eeEccCCC---ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHH--HHHHhC-
Confidence            98876532   2344679999999999863      34688999999999999999999999876543211  111111 


Q ss_pred             ccccccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 016594          289 EIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLE  337 (386)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~  337 (386)
                      ..      ..........++++.+|+.+||+.||++|||+.+|++|-+.
T Consensus       231 ~~------~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~  273 (277)
T d1phka_         231 NY------QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFF  273 (277)
T ss_dssp             CC------CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGG
T ss_pred             CC------CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHH
Confidence            00      11111223456789999999999999999999999988544

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=2.3e-52  Score=375.94  Aligned_cols=259  Identities=21%  Similarity=0.316  Sum_probs=203.1

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccC-ChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-----
Q 016594           65 TNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVT-DDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-----  137 (386)
Q Consensus        65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----  137 (386)
                      .++|++.+.||+|+||+||+|.+. +|+.||||++..... +......+.+|+.+++.++||||+++++++...+     
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~   85 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   85 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence            467999999999999999999975 799999999986443 3445667999999999999999999999987532     


Q ss_pred             eEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCcccc
Q 016594          138 LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKW  217 (386)
Q Consensus       138 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~  217 (386)
                      .|+||||+.+++|..++....  .+++..++.++.||+.||+|||+   ++|+||||||+|||++.++.++|+|||.+..
T Consensus        86 ~~lvmE~~~g~~L~~~~~~~~--~l~~~~~~~i~~qi~~al~~lH~---~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~  160 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARA  160 (277)
T ss_dssp             EEEEEECCCEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTSCEEECCCTTCEE
T ss_pred             EEEEEECCCCCEehhhhcccC--CCCHHHHHHHHHHHHHHHHHHHh---CCccCccccCcccccCccccceeehhhhhhh
Confidence            789999999999999887654  48999999999999999999999   9999999999999999999999999999876


Q ss_pred             CCCCCc-cccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCC
Q 016594          218 LPSQWT-HHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDP  296 (386)
Q Consensus       218 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (386)
                      ...... .......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.......  ........       
T Consensus       161 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~--~~~~~~~~-------  231 (277)
T d1o6ya_         161 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVA--YQHVREDP-------  231 (277)
T ss_dssp             CC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH--HHHHHCCC-------
T ss_pred             hccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHH--HHHHhcCC-------
Confidence            644322 22344567999999999999999999999999999999999999999875432211  11111110       


Q ss_pred             ccCCCCCHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHhc
Q 016594          297 RLQGAYDVTQLNRLAFAASLCIRASPTWRP-TMSEVLEVMLE  337 (386)
Q Consensus       297 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-t~~~il~~l~~  337 (386)
                      ..........+..+.++|.+||+.||.+|| |++++++.|..
T Consensus       232 ~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r  273 (277)
T d1o6ya_         232 IPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR  273 (277)
T ss_dssp             CCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             CCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence            001111123457799999999999999999 88998877653

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-52  Score=387.24  Aligned_cols=252  Identities=20%  Similarity=0.256  Sum_probs=201.6

Q ss_pred             hcCCCCCC-eecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhcc-CCCceeeecceEEe-----C
Q 016594           65 TNAFSSEN-LVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHV-CHPNVLSLLGCCVD-----N  136 (386)
Q Consensus        65 ~~~~~~~~-~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~-----~  136 (386)
                      .++|.+.. .||+|+||+||+|++. +++.||||++..       ...+.+|+.++.++ +|||||++++++.+     .
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-------~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~   82 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-------CPKARREVELHWRASQCPHIVRIVDVYENLYAGRK   82 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-------cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCC
Confidence            35787764 6999999999999975 789999999864       23467899987655 79999999999865     2


Q ss_pred             ceEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcC---CCCeEEeecC
Q 016594          137 GLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTA---DFEPQISDFG  213 (386)
Q Consensus       137 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~---~~~~kl~Dfg  213 (386)
                      .+|+||||+.+|+|.+++.......+++..++.++.||+.||+|||+   ++|+||||||+|||++.   .+.+||+|||
T Consensus        83 ~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~---~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG  159 (335)
T d2ozaa1          83 CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFG  159 (335)
T ss_dssp             EEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred             EEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHH---cCCccccccccccccccccccccccccccc
Confidence            38999999999999999987666679999999999999999999999   99999999999999985   5679999999


Q ss_pred             ccccCCCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccc
Q 016594          214 LAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKL  293 (386)
Q Consensus       214 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  293 (386)
                      +|+......   .....+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.......       ......+
T Consensus       160 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~-------~~~~~~i  229 (335)
T d2ozaa1         160 FAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS-------PGMKTRI  229 (335)
T ss_dssp             TCEECCCCC---CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC---------------CC
T ss_pred             eeeeccCCC---ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHH-------HHHHHHH
Confidence            998765432   234567999999999999999999999999999999999999999764321100       0000111


Q ss_pred             cCCccCCCC--CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 016594          294 VDPRLQGAY--DVTQLNRLAFAASLCIRASPTWRPTMSEVLEVML  336 (386)
Q Consensus       294 ~~~~~~~~~--~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~  336 (386)
                      .......+.  ....+..+.+||.+||+.||++|||+.++++|-+
T Consensus       230 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~  274 (335)
T d2ozaa1         230 RMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPW  274 (335)
T ss_dssp             CSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHH
T ss_pred             hcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHH
Confidence            111111111  1234678999999999999999999999999743

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-53  Score=385.03  Aligned_cols=260  Identities=26%  Similarity=0.412  Sum_probs=209.7

Q ss_pred             HHhcCCCCCCeecccCCcEEEEEEECC--------CcEEEEEEeccccCChHhHHHHHHHHHHHhcc-CCCceeeecceE
Q 016594           63 IATNAFSSENLVGRGGYAEVYKGVLQD--------GEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHV-CHPNVLSLLGCC  133 (386)
Q Consensus        63 ~~~~~~~~~~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~  133 (386)
                      +..++|.+++.||+|+||.||+|+...        +..||||+++... .......+.+|+..+.++ +|||||++++++
T Consensus        10 i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~   88 (299)
T d1fgka_          10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGAC   88 (299)
T ss_dssp             CCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc-ChHHHHHHHHHHHHHHHhcCCCeEEeccccc
Confidence            556789999999999999999998532        2479999997643 344567889999999888 699999999999


Q ss_pred             EeCc-eEEEEEeccCCCHhhhhhhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCC
Q 016594          134 VDNG-LYLIFQFSSRGSVASLFHDVNS--------------PGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSN  198 (386)
Q Consensus       134 ~~~~-~~lv~e~~~~~~L~~~~~~~~~--------------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~N  198 (386)
                      .+++ .++||||+.+|+|.+++.....              ..+++..++.++.||+.||+|||+   ++|+||||||+|
T Consensus        89 ~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~---~~ivHrDiKp~N  165 (299)
T d1fgka_          89 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARN  165 (299)
T ss_dssp             CSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGG
T ss_pred             ccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhh---CCEEeeeecccc
Confidence            8766 8999999999999999875532              348999999999999999999999   999999999999


Q ss_pred             eeEcCCCCeEEeecCccccCCCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCchhh
Q 016594          199 ILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQSL  277 (386)
Q Consensus       199 ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~  277 (386)
                      ||++.++.+||+|||++................|++.|+|||.+.++.|+.++|||||||++|||++ |.+||.+.....
T Consensus       166 iLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~  245 (299)
T d1fgka_         166 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE  245 (299)
T ss_dssp             EEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred             eeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHH
Confidence            9999999999999999987765544444556779999999999999999999999999999999998 799998655432


Q ss_pred             hhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          278 HSWAKPILNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                      ..  . ..         ........+...+..+.+||.+||+.||.+|||+.+|++.|+..
T Consensus       246 ~~--~-~i---------~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i  294 (299)
T d1fgka_         246 LF--K-LL---------KEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI  294 (299)
T ss_dssp             HH--H-HH---------HTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HH--H-HH---------HcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence            11  1 11         11112222334457799999999999999999999999988653

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-52  Score=383.89  Aligned_cols=252  Identities=21%  Similarity=0.293  Sum_probs=206.2

Q ss_pred             cCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccC-ChHhHHHHHHHHHHHh-ccCCCceeeecceEEeCc-eEEE
Q 016594           66 NAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVT-DDRKEKEFLTEIGTIG-HVCHPNVLSLLGCCVDNG-LYLI  141 (386)
Q Consensus        66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~-~l~h~niv~l~~~~~~~~-~~lv  141 (386)
                      ++|.+.+.||+|+||+||+|+++ +|+.||||++.+... .......+..|..++. .++|||||++++++.+++ .|+|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            47899999999999999999986 799999999975321 1233455667777665 689999999999998866 8999


Q ss_pred             EEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCC
Q 016594          142 FQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQ  221 (386)
Q Consensus       142 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  221 (386)
                      |||+.+|+|.+++.....  +++..++.++.||+.||+|||+   ++|+||||||+|||++.++++||+|||+++.....
T Consensus        82 mEy~~~g~L~~~i~~~~~--~~e~~~~~~~~qi~~al~ylH~---~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~  156 (320)
T d1xjda_          82 MEYLNGGDLMYHIQSCHK--FDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG  156 (320)
T ss_dssp             EECCTTCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred             EeecCCCcHHHHhhccCC--CCHHHHHHHHHHHHHHHHHHHh---CCeeeccCcccceeecCCCceeccccchhhhcccc
Confidence            999999999999976543  8999999999999999999999   99999999999999999999999999999876543


Q ss_pred             CccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCCC
Q 016594          222 WTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGA  301 (386)
Q Consensus       222 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (386)
                      .  .......||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.......  ..+.. .          ...
T Consensus       157 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~--~~i~~-~----------~~~  221 (320)
T d1xjda_         157 D--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELF--HSIRM-D----------NPF  221 (320)
T ss_dssp             T--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH--HHHHH-C----------CCC
T ss_pred             c--ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHH--HHHHc-C----------CCC
Confidence            2  2334567999999999999999999999999999999999999999875432211  11110 0          011


Q ss_pred             CCHHHHHHHHHHHHHccccCCCCCCCHH-HHHHHHhc
Q 016594          302 YDVTQLNRLAFAASLCIRASPTWRPTMS-EVLEVMLE  337 (386)
Q Consensus       302 ~~~~~~~~l~~li~~cl~~dP~~Rpt~~-~il~~l~~  337 (386)
                      ++...+..+.+||.+||..||++||++. ++++|-+.
T Consensus       222 ~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff  258 (320)
T d1xjda_         222 YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLF  258 (320)
T ss_dssp             CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGG
T ss_pred             CCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCchh
Confidence            2233457799999999999999999995 78876543

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.8e-52  Score=377.13  Aligned_cols=266  Identities=20%  Similarity=0.313  Sum_probs=203.5

Q ss_pred             cCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEEE
Q 016594           66 NAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQ  143 (386)
Q Consensus        66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~e  143 (386)
                      ++|++.+.||+|+||+||+|.+. +|+.||||++............+.+|+.+|++++|||||++++++.+++ .|+|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            47899999999999999999985 7899999999765444444578899999999999999999999998876 899999


Q ss_pred             eccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCc
Q 016594          144 FSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWT  223 (386)
Q Consensus       144 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~  223 (386)
                      |+.+ ++..++.......+++..+..++.|++.||+|||+   ++|+||||||+|||++.++.+||+|||+|+...... 
T Consensus        82 ~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~---~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~-  156 (298)
T d1gz8a_          82 FLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-  156 (298)
T ss_dssp             CCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS-
T ss_pred             ecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhc---CCEEccccCchheeecccCcceeccCCcceeccCCc-
Confidence            9876 45555555556679999999999999999999999   999999999999999999999999999998765432 


Q ss_pred             cccccccccccCccChhhhccCC-CCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhh--hhhc-c----cccccccC
Q 016594          224 HHSIAPIEGTFGHLAPEYFMHGI-VDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAK--PILN-Q----GEIEKLVD  295 (386)
Q Consensus       224 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~--~~~~-~----~~~~~~~~  295 (386)
                       .......||+.|+|||++.... ++.++|||||||++|+|++|+.||.+.+........  .... .    ........
T Consensus       157 -~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  235 (298)
T d1gz8a_         157 -RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD  235 (298)
T ss_dssp             -BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred             -ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccc
Confidence             2334557999999999987665 579999999999999999999999876532211100  0000 0    00000000


Q ss_pred             ------CccCCC---CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 016594          296 ------PRLQGA---YDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLE  337 (386)
Q Consensus       296 ------~~~~~~---~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~  337 (386)
                            ......   .....+..+.+|+.+||..||++|||+.|+++|-+.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff  286 (298)
T d1gz8a_         236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF  286 (298)
T ss_dssp             CCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGG
T ss_pred             cccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhh
Confidence                  000000   001224678999999999999999999999998544

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.1e-53  Score=385.21  Aligned_cols=261  Identities=22%  Similarity=0.378  Sum_probs=213.9

Q ss_pred             HHHhcCCCCCCeecccCCcEEEEEEEC------CCcEEEEEEeccccCChHhHHHHHHHHHHHhcc-CCCceeeecceEE
Q 016594           62 SIATNAFSSENLVGRGGYAEVYKGVLQ------DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHV-CHPNVLSLLGCCV  134 (386)
Q Consensus        62 ~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~  134 (386)
                      ++..++|+++++||+|+||.||+|++.      +++.||||+++.. ........+.+|+.+++++ +|||||++++++.
T Consensus        19 ~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~-~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~   97 (311)
T d1t46a_          19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS-AHLTEREALMSELKVLSYLGNHMNIVNLLGACT   97 (311)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcc-cCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEe
Confidence            355678999999999999999999852      4568999999753 3345566799999999999 5999999999998


Q ss_pred             eCc-eEEEEEeccCCCHhhhhhhcC----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCC
Q 016594          135 DNG-LYLIFQFSSRGSVASLFHDVN----------------SPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSS  197 (386)
Q Consensus       135 ~~~-~~lv~e~~~~~~L~~~~~~~~----------------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~  197 (386)
                      +.. .+++|||+.+|+|.+++....                ...+++..+..++.||+.||+|||+   ++++||||||+
T Consensus        98 ~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~---~~ivHrDLKp~  174 (311)
T d1t46a_          98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAAR  174 (311)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGG
T ss_pred             eCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccccc
Confidence            765 899999999999999887543                2248999999999999999999999   99999999999


Q ss_pred             CeeEcCCCCeEEeecCccccCCCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCchh
Q 016594          198 NILLTADFEPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIIS-GRKPVDGSHQS  276 (386)
Q Consensus       198 Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~  276 (386)
                      ||+++.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||+| |.+||.+....
T Consensus       175 NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~  254 (311)
T d1t46a_         175 NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD  254 (311)
T ss_dssp             GEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS
T ss_pred             cccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHH
Confidence            99999999999999999998765544444556779999999999999999999999999999999999 66666554332


Q ss_pred             hhhhhhhhhcccccccccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 016594          277 LHSWAKPILNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLE  337 (386)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~  337 (386)
                      ..           +.+++....+...+...+..+.+||.+||+.||++|||+.+|++.|+.
T Consensus       255 ~~-----------~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~  304 (311)
T d1t46a_         255 SK-----------FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK  304 (311)
T ss_dssp             HH-----------HHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             HH-----------HHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence            11           111111122222333445779999999999999999999999998865

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-52  Score=378.45  Aligned_cols=261  Identities=23%  Similarity=0.263  Sum_probs=197.1

Q ss_pred             CCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChH---hHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEEEec
Q 016594           71 ENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDR---KEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQFS  145 (386)
Q Consensus        71 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~~  145 (386)
                      +++||+|+||+||+|+++ +|+.||||++........   ....+.+|+.++++++|||||++++++.+++ .++||||+
T Consensus         3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~   82 (299)
T d1ua2a_           3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM   82 (299)
T ss_dssp             EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred             ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence            578999999999999976 689999999875432221   2346889999999999999999999998765 89999999


Q ss_pred             cCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCccc
Q 016594          146 SRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTHH  225 (386)
Q Consensus       146 ~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  225 (386)
                      .++++..+...  ...+++..+..++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+|.......  .
T Consensus        83 ~~~~~~~~~~~--~~~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~--~  155 (299)
T d1ua2a_          83 ETDLEVIIKDN--SLVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN--R  155 (299)
T ss_dssp             SEEHHHHHTTC--CSSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC--C
T ss_pred             cchHHhhhhhc--ccCCCHHHHHHHHHHHHHHHHHhhc---cceecccCCcceEEecCCCccccccCccccccCCCc--c
Confidence            99877766543  3458899999999999999999999   999999999999999999999999999998765432  2


Q ss_pred             cccccccccCccChhhhcc-CCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhh-hhhhhhcccccc------cc---c
Q 016594          226 SIAPIEGTFGHLAPEYFMH-GIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHS-WAKPILNQGEIE------KL---V  294 (386)
Q Consensus       226 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~-~~~~~~~~~~~~------~~---~  294 (386)
                      .....+||+.|+|||++.+ ..|+.++|||||||++|||++|.+||.+....... ............      ..   .
T Consensus       156 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~  235 (299)
T d1ua2a_         156 AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV  235 (299)
T ss_dssp             CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCC
T ss_pred             cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhh
Confidence            2345679999999999875 46899999999999999999999999876432211 111000000000      00   0


Q ss_pred             CCccCCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          295 DPRLQGAYD-----VTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       295 ~~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                      ........+     ...+..+.+|+.+||+.||++|||++|+|+|-+..
T Consensus       236 ~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~  284 (299)
T d1ua2a_         236 TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFS  284 (299)
T ss_dssp             CCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGT
T ss_pred             hhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhC
Confidence            000000011     12246799999999999999999999999985543

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-52  Score=382.79  Aligned_cols=262  Identities=22%  Similarity=0.357  Sum_probs=213.7

Q ss_pred             HHHHhcCCCCCCeecccCCcEEEEEEEC------CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEE
Q 016594           61 ISIATNAFSSENLVGRGGYAEVYKGVLQ------DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCV  134 (386)
Q Consensus        61 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~  134 (386)
                      +++..++|++.+.||+|+||+||+|.++      ++..||||+++.. ........+.+|+.++++++||||+++++++.
T Consensus        15 ~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~-~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~   93 (308)
T d1p4oa_          15 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNEASVMKEFNCHHVVRLLGVVS   93 (308)
T ss_dssp             TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT-SCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred             eeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcc-cChHHHHHHHHHHHHHHHcCCCCEeeeeeEEe
Confidence            3455678999999999999999999863      2568999999753 34455667899999999999999999999997


Q ss_pred             eC-ceEEEEEeccCCCHhhhhhhcC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCC
Q 016594          135 DN-GLYLIFQFSSRGSVASLFHDVN--------SPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADF  205 (386)
Q Consensus       135 ~~-~~~lv~e~~~~~~L~~~~~~~~--------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~  205 (386)
                      .+ ..++||||+.+|+|.+++....        ...+++..+..++.|++.||.|||+   ++|+||||||+|||++.++
T Consensus        94 ~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~---~~ivHrDlk~~NiLld~~~  170 (308)
T d1p4oa_          94 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDF  170 (308)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECTTC
T ss_pred             cCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeeceEcCCceeecCCc
Confidence            64 4899999999999999875431        2347889999999999999999999   9999999999999999999


Q ss_pred             CeEEeecCccccCCCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhC-CCCCCCCchhhhhhhhhh
Q 016594          206 EPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISG-RKPVDGSHQSLHSWAKPI  284 (386)
Q Consensus       206 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g-~~pf~~~~~~~~~~~~~~  284 (386)
                      ++||+|||+|+.+.............||+.|+|||.+.+..++.++|||||||++|||+|| .+||.+.....  ....+
T Consensus       171 ~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~--~~~~i  248 (308)
T d1p4oa_         171 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ--VLRFV  248 (308)
T ss_dssp             CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH--HHHHH
T ss_pred             eEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHH--HHHHH
Confidence            9999999999877554444444556789999999999999999999999999999999997 57787654321  11111


Q ss_pred             hcccccccccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          285 LNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                      .         +. .....+..++..+.+++.+||+.||++|||+.+|+++|+..
T Consensus       249 ~---------~~-~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~  292 (308)
T d1p4oa_         249 M---------EG-GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE  292 (308)
T ss_dssp             H---------TT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred             H---------hC-CCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence            1         11 11222334457799999999999999999999999999765

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=5e-52  Score=375.63  Aligned_cols=264  Identities=23%  Similarity=0.303  Sum_probs=202.8

Q ss_pred             cCCCCCCeecccCCcEEEEEEECCCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEEEe
Q 016594           66 NAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQF  144 (386)
Q Consensus        66 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~  144 (386)
                      ++|++.++||+|+||+||+|++++|+.||||++............+.+|+.+|++++||||+++++++.+++ .++++++
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~   81 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence            578999999999999999999999999999999765444555678999999999999999999999998766 7888888


Q ss_pred             ccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCcc
Q 016594          145 SSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTH  224 (386)
Q Consensus       145 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  224 (386)
                      +.++.+..+...  ...+++..+..++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||.+.......  
T Consensus        82 ~~~~~~~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~---~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~--  154 (286)
T d1ob3a_          82 LDQDLKKLLDVC--EGGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV--  154 (286)
T ss_dssp             CSEEHHHHHHTS--TTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred             ehhhhHHHHHhh--cCCcchhhhHHHHHHHHHHHHHhcc---CcEEecCCCCceeeEcCCCCEEecccccceecccCc--
Confidence            887666666543  3459999999999999999999999   999999999999999999999999999998765432  


Q ss_pred             ccccccccccCccChhhhcc-CCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhh-hhhhcc---------ccccc-
Q 016594          225 HSIAPIEGTFGHLAPEYFMH-GIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWA-KPILNQ---------GEIEK-  292 (386)
Q Consensus       225 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~-~~~~~~---------~~~~~-  292 (386)
                      .......|++.|+|||.+.+ ..++.++|||||||++|||++|+.||.+......... ......         ..... 
T Consensus       155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  234 (286)
T d1ob3a_         155 RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY  234 (286)
T ss_dssp             -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred             cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhc
Confidence            22334468999999999875 4578999999999999999999999987543211100 000000         00000 


Q ss_pred             -----ccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 016594          293 -----LVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVML  336 (386)
Q Consensus       293 -----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~  336 (386)
                           ...+..........+..+.+|+.+||+.||++|||++|+++|-+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~  283 (286)
T d1ob3a_         235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAY  283 (286)
T ss_dssp             CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGG
T ss_pred             ccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcc
Confidence                 00000001112223567899999999999999999999998754

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-52  Score=381.26  Aligned_cols=255  Identities=24%  Similarity=0.430  Sum_probs=203.0

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEC-CCc--EEEEEEeccccCChHhHHHHHHHHHHHhcc-CCCceeeecceEEeCc-eE
Q 016594           65 TNAFSSENLVGRGGYAEVYKGVLQ-DGE--EIAVKRLTKVVTDDRKEKEFLTEIGTIGHV-CHPNVLSLLGCCVDNG-LY  139 (386)
Q Consensus        65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~-~~  139 (386)
                      -++|++.+.||+|+||+||+|+++ +|.  .||||.+.... .......+.+|+.+|.++ +|||||++++++.+++ .+
T Consensus         9 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~   87 (309)
T d1fvra_           9 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY   87 (309)
T ss_dssp             GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEE
T ss_pred             HHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc-ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeE
Confidence            367889999999999999999976 444  47788876432 233456789999999998 6999999999998866 89


Q ss_pred             EEEEeccCCCHhhhhhhc--------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCC
Q 016594          140 LIFQFSSRGSVASLFHDV--------------NSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADF  205 (386)
Q Consensus       140 lv~e~~~~~~L~~~~~~~--------------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~  205 (386)
                      +||||+.+|+|.+++...              ....+++..++.++.||+.||.|||+   ++|+||||||+|||++.++
T Consensus        88 iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~---~~iiHrDlkp~NIL~~~~~  164 (309)
T d1fvra_          88 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENY  164 (309)
T ss_dssp             EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGG
T ss_pred             EEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhc---CCccccccccceEEEcCCC
Confidence            999999999999998653              23458999999999999999999999   9999999999999999999


Q ss_pred             CeEEeecCccccCCCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCC-CCCCCCchhhhhhhhhh
Q 016594          206 EPQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGR-KPVDGSHQSLHSWAKPI  284 (386)
Q Consensus       206 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~-~pf~~~~~~~~~~~~~~  284 (386)
                      .+||+|||+++......   ......||..|+|||.+.+..++.++|||||||++|||++|. +||.+......  ... 
T Consensus       165 ~~kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~--~~~-  238 (309)
T d1fvra_         165 VAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL--YEK-  238 (309)
T ss_dssp             CEEECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH--HHH-
T ss_pred             ceEEccccccccccccc---cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHH--HHH-
Confidence            99999999998654322   223445899999999999999999999999999999999965 57766443211  110 


Q ss_pred             hcccccccccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          285 LNQGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                               +....+...+...++.+.+||.+||+.||++|||+.+|+++|...
T Consensus       239 ---------i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i  283 (309)
T d1fvra_         239 ---------LPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM  283 (309)
T ss_dssp             ---------GGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---------HHhcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence                     111112223344567899999999999999999999999988654

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.8e-53  Score=377.50  Aligned_cols=246  Identities=20%  Similarity=0.337  Sum_probs=200.6

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCCh----HhHHHHHHHHHHHhccC--CCceeeecceEEeCc
Q 016594           65 TNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDD----RKEKEFLTEIGTIGHVC--HPNVLSLLGCCVDNG  137 (386)
Q Consensus        65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~----~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~  137 (386)
                      .++|++.+.||+|+||+||+|++. +|+.||||++.+.....    .....+.+|+.++++++  |||||++++++.+.+
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~   82 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD   82 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred             CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence            468999999999999999999976 78999999987543221    12234668999999987  899999999998865


Q ss_pred             -eEEEEEeccC-CCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcC-CCCeEEeecCc
Q 016594          138 -LYLIFQFSSR-GSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTA-DFEPQISDFGL  214 (386)
Q Consensus       138 -~~lv~e~~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~-~~~~kl~Dfg~  214 (386)
                       .++||||+.+ +++.+++....  .+++..++.++.||+.||+|||+   ++|+||||||+|||++. ++.+||+|||+
T Consensus        83 ~~~lv~e~~~~~~~l~~~~~~~~--~l~e~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NIll~~~~~~vkl~DFG~  157 (273)
T d1xwsa_          83 SFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGS  157 (273)
T ss_dssp             EEEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred             eEEEEEEeccCcchHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHH---CCCccccCcccceEEecCCCeEEECcccc
Confidence             8999999976 57777776544  49999999999999999999999   99999999999999985 47999999999


Q ss_pred             cccCCCCCccccccccccccCccChhhhccCCC-CcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccc
Q 016594          215 AKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIV-DEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKL  293 (386)
Q Consensus       215 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  293 (386)
                      |......    ......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.....        . ..    
T Consensus       158 a~~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~i~--------~-~~----  220 (273)
T d1xwsa_         158 GALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII--------R-GQ----  220 (273)
T ss_dssp             CEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHH--------H-CC----
T ss_pred             ceecccc----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchHHh--------h-cc----
Confidence            9876433    2345679999999999987765 678999999999999999999997632110        0 00    


Q ss_pred             cCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          294 VDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       294 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                            ...+...+..+.++|.+||+.||++|||+.|+++|-+..
T Consensus       221 ------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~  259 (273)
T d1xwsa_         221 ------VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQ  259 (273)
T ss_dssp             ------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGS
T ss_pred             ------cCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhC
Confidence                  011122357799999999999999999999999986543

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-51  Score=374.77  Aligned_cols=252  Identities=25%  Similarity=0.398  Sum_probs=201.6

Q ss_pred             CCeecccCCcEEEEEEECCC----cEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeC--ceEEEEEe
Q 016594           71 ENLVGRGGYAEVYKGVLQDG----EEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDN--GLYLIFQF  144 (386)
Q Consensus        71 ~~~lg~G~~g~V~~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~lv~e~  144 (386)
                      .++||+|+||+||+|++..+    ..||||++++ ..+......+.+|+++|++++||||+++++++.+.  ..++||||
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~-~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~  110 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR-ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPY  110 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECC-CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEEC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECc-ccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEE
Confidence            47899999999999997532    2589999875 33455668899999999999999999999998763  38999999


Q ss_pred             ccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCcc
Q 016594          145 SSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWTH  224 (386)
Q Consensus       145 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  224 (386)
                      +.+|+|.+++... ...+++..++.++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||+++.+......
T Consensus       111 ~~~g~l~~~~~~~-~~~~~~~~~~~i~~qia~gL~~lH~---~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~  186 (311)
T d1r0pa_         111 MKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD  186 (311)
T ss_dssp             CTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred             eecCchhhhhccc-cccchHHHHHHHHHHHHHhhhhhcc---cCcccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence            9999999987653 3347888999999999999999999   99999999999999999999999999999877544222


Q ss_pred             --ccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccccCCccCCCC
Q 016594          225 --HSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKLVDPRLQGAY  302 (386)
Q Consensus       225 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (386)
                        .......||+.|+|||.+.+..++.++|||||||++|||++|..||....... .....+..          ..+...
T Consensus       187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~-~~~~~i~~----------g~~~~~  255 (311)
T d1r0pa_         187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF-DITVYLLQ----------GRRLLQ  255 (311)
T ss_dssp             CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-------CHHHHHT----------TCCCCC
T ss_pred             cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH-HHHHHHHc----------CCCCCC
Confidence              22234568999999999999999999999999999999999888776532211 11111111          111122


Q ss_pred             CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          303 DVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       303 ~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                      +..++..+.+|+.+||+.||++||++.||+++|+..
T Consensus       256 p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i  291 (311)
T d1r0pa_         256 PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI  291 (311)
T ss_dssp             CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             cccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            233457799999999999999999999999998765

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-51  Score=375.45  Aligned_cols=266  Identities=22%  Similarity=0.342  Sum_probs=202.7

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEC-C-CcEEEEEEeccccCChHhHHHHHHHHHHHhcc---CCCceeeecceEEe----
Q 016594           65 TNAFSSENLVGRGGYAEVYKGVLQ-D-GEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHV---CHPNVLSLLGCCVD----  135 (386)
Q Consensus        65 ~~~~~~~~~lg~G~~g~V~~~~~~-~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~----  135 (386)
                      .++|++.+.||+|+||+||+|++. + ++.||||++............+.+|+.+++.|   +||||+++++++..    
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            578999999999999999999974 4 66799999976544443344566777777666   79999999999853    


Q ss_pred             --CceEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecC
Q 016594          136 --NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFG  213 (386)
Q Consensus       136 --~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg  213 (386)
                        ...++++|++.++.+... .......+++..++.++.|++.||+|||+   ++|+||||||+|||++.++.+||+|||
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~-~~~~~~~~~~~~~~~~~~qi~~aL~yLH~---~~ivHrDiKp~NILi~~~~~~kl~dfg  161 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYL-DKVPEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFG  161 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHH-HHSCTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECSCC
T ss_pred             cCceEEEEEEeccCCchhhh-hhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEEecCCCccEEEEcCCCCeeecchh
Confidence              127899999988765543 34455669999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhh-hhhhhccc----
Q 016594          214 LAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSW-AKPILNQG----  288 (386)
Q Consensus       214 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~-~~~~~~~~----  288 (386)
                      ++......   .......||+.|+|||++.+..|+.++|||||||++|||++|+.||.+........ ........    
T Consensus       162 ~~~~~~~~---~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  238 (305)
T d1blxa_         162 LARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED  238 (305)
T ss_dssp             SCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred             hhhhhccc---ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhc
Confidence            98865432   33456679999999999999999999999999999999999999998765321110 00000000    


Q ss_pred             -----ccc-cc---cCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 016594          289 -----EIE-KL---VDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLE  337 (386)
Q Consensus       289 -----~~~-~~---~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~  337 (386)
                           ... ..   .............++.+.+|+.+||+.||++|||+.|+|+|-+.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff  296 (305)
T d1blxa_         239 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF  296 (305)
T ss_dssp             SCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGG
T ss_pred             ccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhh
Confidence                 000 00   00000011122335678999999999999999999999998543

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-51  Score=370.74  Aligned_cols=266  Identities=24%  Similarity=0.291  Sum_probs=197.5

Q ss_pred             cCCCCCCeecccCCcEEEEEEECCCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-----eEE
Q 016594           66 NAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-----LYL  140 (386)
Q Consensus        66 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~l  140 (386)
                      ..|.+.+.||+|+||.||+|+++ |+.||||++...   .........|+..+.+++||||+++++++.+.+     .++
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~~-g~~vAvK~~~~~---~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l   78 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL   78 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET-TEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECcc---chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEE
Confidence            45677889999999999999985 899999998642   222222334556667789999999999997632     789


Q ss_pred             EEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-----CCCCeEEeCCCCCCeeEcCCCCeEEeecCcc
Q 016594          141 IFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKG-----CQRRIIHRDIKSSNILLTADFEPQISDFGLA  215 (386)
Q Consensus       141 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~-----~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a  215 (386)
                      ||||+.+|+|.+++.+.   .+++..++.++.|++.||+|||+.     +.++|+||||||+|||++.++.+||+|||++
T Consensus        79 v~Ey~~~g~L~~~l~~~---~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~  155 (303)
T d1vjya_          79 VSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA  155 (303)
T ss_dssp             EEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred             EEecccCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcc
Confidence            99999999999999763   489999999999999999999962     1269999999999999999999999999999


Q ss_pred             ccCCCCCcc--ccccccccccCccChhhhccCC------CCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhh---
Q 016594          216 KWLPSQWTH--HSIAPIEGTFGHLAPEYFMHGI------VDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPI---  284 (386)
Q Consensus       216 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~------~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~---  284 (386)
                      .........  .......||+.|+|||++.+..      ++.++|||||||++|||+||..||.........+....   
T Consensus       156 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~  235 (303)
T d1vjya_         156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD  235 (303)
T ss_dssp             EEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred             ccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccccc
Confidence            877543222  1234567999999999987643      57789999999999999999988854322111100000   


Q ss_pred             -----hcccccccccCCccCCC-CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          285 -----LNQGEIEKLVDPRLQGA-YDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       285 -----~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                           ...........+.+... .+......+.+++.+||+.||++|||+.+|++.|.+.
T Consensus       236 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i  295 (303)
T d1vjya_         236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL  295 (303)
T ss_dssp             CCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred             chHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence                 00000111111111111 1234567799999999999999999999999998754

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.4e-50  Score=366.88  Aligned_cols=269  Identities=19%  Similarity=0.258  Sum_probs=202.3

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEe--------
Q 016594           65 TNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVD--------  135 (386)
Q Consensus        65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--------  135 (386)
                      .++|++.+.||+|+||+||+|++. +|+.||||++............+.+|+.+|++++||||+++++++..        
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence            368999999999999999999986 79999999987655555556778999999999999999999998854        


Q ss_pred             -CceEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCc
Q 016594          136 -NGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGL  214 (386)
Q Consensus       136 -~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~  214 (386)
                       ...+++||++.++.+.....  ....+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+
T Consensus        89 ~~~~~iv~e~~~~~~~~~~~~--~~~~~~~~~~~~i~~qil~~l~~lH~---~~ivHrDlKp~NILl~~~~~~kl~dfg~  163 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAGLLSN--VLVKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGL  163 (318)
T ss_dssp             --CEEEEEECCCEEHHHHHTC--TTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTT
T ss_pred             CceEEEEEeccCCCccchhhh--cccccccHHHHHHHHHHHHHHHHhcc---CCEEecCcCchheeecCCCcEEeeecce
Confidence             23789999998876654443  33458999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCCc--cccccccccccCccChhhhccC-CCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhh-hhhhhccc--
Q 016594          215 AKWLPSQWT--HHSIAPIEGTFGHLAPEYFMHG-IVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSW-AKPILNQG--  288 (386)
Q Consensus       215 a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~-~~~~~~~~--  288 (386)
                      +..+.....  .......+||+.|+|||++.+. .++.++|||||||++|||++|+.||.+........ ........  
T Consensus       164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~  243 (318)
T d3blha1         164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP  243 (318)
T ss_dssp             CEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred             eeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence            987654322  1223345799999999999865 68999999999999999999999998765322111 11110000  


Q ss_pred             ---------ccccccCCccCCCCCH-------HHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          289 ---------EIEKLVDPRLQGAYDV-------TQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       289 ---------~~~~~~~~~~~~~~~~-------~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                               ................       .....+.+||.+||+.||++|||+.|+++|-+..
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~  309 (318)
T d3blha1         244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFW  309 (318)
T ss_dssp             TTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGS
T ss_pred             hhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhc
Confidence                     0000000000001111       1134678899999999999999999999996643

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.1e-50  Score=370.40  Aligned_cols=261  Identities=22%  Similarity=0.298  Sum_probs=200.5

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc------
Q 016594           65 TNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG------  137 (386)
Q Consensus        65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------  137 (386)
                      .++|++.+.||+|+||+||+|.++ +|+.||||++.+..........+.+|+.+|+.++|||||+++++|...+      
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence            468999999999999999999976 6999999999876666666778999999999999999999999997542      


Q ss_pred             -eEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccc
Q 016594          138 -LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAK  216 (386)
Q Consensus       138 -~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~  216 (386)
                       +|+||||+ +.+|..++..   ..+++..++.++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+|.
T Consensus        97 ~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~---~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~  169 (346)
T d1cm8a_          97 DFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLAR  169 (346)
T ss_dssp             CCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             eEEEEEecc-cccHHHHHHh---ccccHHHHHHHHHHHHHHHHHHHh---CCCcccccCcchhhccccccccccccccee
Confidence             69999998 5577776654   349999999999999999999999   999999999999999999999999999998


Q ss_pred             cCCCCCccccccccccccCccChhhhcc-CCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhccc-------
Q 016594          217 WLPSQWTHHSIAPIEGTFGHLAPEYFMH-GIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQG-------  288 (386)
Q Consensus       217 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~-------  288 (386)
                      .....     .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+................       
T Consensus       170 ~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  244 (346)
T d1cm8a_         170 QADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQ  244 (346)
T ss_dssp             ECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred             ccCCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHh
Confidence            76543     234569999999999986 45789999999999999999999999876532211100000000       


Q ss_pred             ------------ccccccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          289 ------------EIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       289 ------------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                                  .......... .......+..+.+||.+||..||++|||+.++|+|-+..
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~  305 (346)
T d1cm8a_         245 RLQSDEAKNYMKGLPELEKKDF-ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFE  305 (346)
T ss_dssp             TCSCHHHHHHHHHSCCCCCCCG-GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGT
T ss_pred             hhcchhhhhhhccCCcccccch-HHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhC
Confidence                        0000000000 011112346788999999999999999999999985543

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.7e-50  Score=370.41  Aligned_cols=265  Identities=18%  Similarity=0.206  Sum_probs=202.3

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-----e
Q 016594           65 TNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-----L  138 (386)
Q Consensus        65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~  138 (386)
                      +.+|++++.||+|+||+||+|..+ +|+.||||++.+.. .......+++|+.+|++++||||+++++++....     .
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~   85 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD   85 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred             CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc-ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence            357999999999999999999975 79999999997532 3455677899999999999999999999996542     4


Q ss_pred             EEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccC
Q 016594          139 YLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWL  218 (386)
Q Consensus       139 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~  218 (386)
                      +++++++.+|+|.+++...   .+++..+..++.|++.||+|||+   ++|+||||||+|||++.++.+||+|||++...
T Consensus        86 ~~l~~~~~~g~L~~~l~~~---~l~~~~i~~i~~qil~al~yLH~---~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~  159 (345)
T d1pmea_          86 VYLVTHLMGADLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVA  159 (345)
T ss_dssp             EEEEEECCCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEEeecCCchhhhhhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCcceEEECCCCCEEEcccCceeec
Confidence            6777888899999998653   49999999999999999999999   99999999999999999999999999999876


Q ss_pred             CCCCcc-ccccccccccCccChhhhc-cCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhh-ccccc-----
Q 016594          219 PSQWTH-HSIAPIEGTFGHLAPEYFM-HGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPIL-NQGEI-----  290 (386)
Q Consensus       219 ~~~~~~-~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~-~~~~~-----  290 (386)
                      ...... ......+||+.|+|||++. +..++.++||||+||++|+|++|+.||.+............. .....     
T Consensus       160 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (345)
T d1pmea_         160 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC  239 (345)
T ss_dssp             CGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHT
T ss_pred             cCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhh
Confidence            543222 2234567999999999985 456789999999999999999999999876532211111000 00000     


Q ss_pred             ---------ccccCCccCCCC---CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 016594          291 ---------EKLVDPRLQGAY---DVTQLNRLAFAASLCIRASPTWRPTMSEVLEVML  336 (386)
Q Consensus       291 ---------~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~  336 (386)
                               ............   ....+..+.+|+.+||..||.+|||++++|+|-+
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf  297 (345)
T d1pmea_         240 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPY  297 (345)
T ss_dssp             CCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGG
T ss_pred             hhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHh
Confidence                     000000000000   0112356899999999999999999999999844

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-49  Score=358.32  Aligned_cols=266  Identities=18%  Similarity=0.240  Sum_probs=208.0

Q ss_pred             cCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-eEEEEE
Q 016594           66 NAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-LYLIFQ  143 (386)
Q Consensus        66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~e  143 (386)
                      ++|++.+.||+|+||+||+|++. +++.||||+++...........+.+|+.+|+.++||||+++++++.+.. .+++++
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            47899999999999999999986 7899999999876666667788999999999999999999999998866 788899


Q ss_pred             eccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCccccCCCCCc
Q 016594          144 FSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKWLPSQWT  223 (386)
Q Consensus       144 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~  223 (386)
                      ++.+++|..++...  ..+++..+..++.|++.||+|||+   ++|+||||||+|||++.++.+||+|||.+........
T Consensus        82 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~q~~~aL~~lH~---~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~  156 (292)
T d1unla_          82 FCDQDLKKYFDSCN--GDLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR  156 (292)
T ss_dssp             CCSEEHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS
T ss_pred             eccccccccccccc--cccchhHHHHHHHHHHHHHHHhhc---CCEeeecccCcccccccCCceeeeecchhhcccCCCc
Confidence            99998888776543  458999999999999999999999   9999999999999999999999999999987754322


Q ss_pred             cccccccccccCccChhhhccCC-CCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhh--hhhccc---c---cccc-
Q 016594          224 HHSIAPIEGTFGHLAPEYFMHGI-VDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAK--PILNQG---E---IEKL-  293 (386)
Q Consensus       224 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~--~~~~~~---~---~~~~-  293 (386)
                        ......+++.|+|||++.+.. ++.++|||||||++|||++|+.||............  ......   .   .... 
T Consensus       157 --~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (292)
T d1unla_         157 --CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP  234 (292)
T ss_dssp             --CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGST
T ss_pred             --cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcc
Confidence              223345788899999987655 689999999999999999999987543322111111  000000   0   0000 


Q ss_pred             --------cCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          294 --------VDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       294 --------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                              .............+..+.+|+.+||+.||.+|||++|+|+|-+..
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~  287 (292)
T d1unla_         235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFS  287 (292)
T ss_dssp             TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGS
T ss_pred             cccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhc
Confidence                    000011112223356789999999999999999999999986554

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-49  Score=368.41  Aligned_cols=263  Identities=20%  Similarity=0.242  Sum_probs=198.0

Q ss_pred             cCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEe-------Cc
Q 016594           66 NAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVD-------NG  137 (386)
Q Consensus        66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-------~~  137 (386)
                      ++|++.++||+|+||+||+|.+. +|+.||||++.+...+......+.+|+.++++++||||+++++++..       ..
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            57999999999999999999987 69999999998766666677789999999999999999999999953       23


Q ss_pred             eEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCcccc
Q 016594          138 LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKW  217 (386)
Q Consensus       138 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~  217 (386)
                      .|+||||+.++.+..+ .    ..+++..++.++.|++.||.|||+   +||+||||||+|||++.++.+|++|||++..
T Consensus        97 ~~iv~Ey~~~~l~~~~-~----~~~~~~~i~~~~~qil~gl~~LH~---~giiHrDlKP~Nil~~~~~~~kl~df~~~~~  168 (355)
T d2b1pa1          97 VYLVMELMDANLCQVI-Q----MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLART  168 (355)
T ss_dssp             EEEEEECCSEEHHHHH-T----SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred             eEEEEeccchHHHHhh-h----cCCCHHHHHHHHHHHHHHHHHhhh---cccccccCCccccccccccceeeechhhhhc
Confidence            7999999987655443 2    238999999999999999999999   9999999999999999999999999999886


Q ss_pred             CCCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhh--------------
Q 016594          218 LPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKP--------------  283 (386)
Q Consensus       218 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~--------------  283 (386)
                      ....   ......++|+.|+|||++.+..++.++||||+||++|+|++|+.||.+.+.........              
T Consensus       169 ~~~~---~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~  245 (355)
T d2b1pa1         169 AGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL  245 (355)
T ss_dssp             ---------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTS
T ss_pred             cccc---cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHh
Confidence            6443   23345569999999999999999999999999999999999999998765322111000              


Q ss_pred             ------hhcc------cccccccCCccCCC---CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCC
Q 016594          284 ------ILNQ------GEIEKLVDPRLQGA---YDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEGD  339 (386)
Q Consensus       284 ------~~~~------~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~~  339 (386)
                            ....      ..............   .....+..+.+|+.+||..||++|||++|+|+|-+...
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~  316 (355)
T d2b1pa1         246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV  316 (355)
T ss_dssp             CHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGG
T ss_pred             hhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCC
Confidence                  0000      00000111111111   11234678999999999999999999999999865543

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.2e-49  Score=364.58  Aligned_cols=259  Identities=21%  Similarity=0.225  Sum_probs=196.3

Q ss_pred             CCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEeCc-------e
Q 016594           67 AFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVDNG-------L  138 (386)
Q Consensus        67 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-------~  138 (386)
                      .|+..++||+|+||+||+|++. +|+.||||++.....      ...+|+.+|++++||||+++++++....       .
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~   94 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL   94 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch------HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEE
Confidence            4777899999999999999986 699999999975322      1237999999999999999999986421       6


Q ss_pred             EEEEEeccCCCHhhhhh-hcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCC-CeEEeecCccc
Q 016594          139 YLIFQFSSRGSVASLFH-DVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADF-EPQISDFGLAK  216 (386)
Q Consensus       139 ~lv~e~~~~~~L~~~~~-~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~-~~kl~Dfg~a~  216 (386)
                      ++||||+.++.+..+.. ......+++..++.++.||+.||+|||+   +||+||||||+|||++.++ .+||+|||++.
T Consensus        95 ~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~---~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~  171 (350)
T d1q5ka_          95 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK  171 (350)
T ss_dssp             EEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTTCCEEECCCTTCE
T ss_pred             EEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHh---cCCcccCCCcceEEEecCCCceeEecccchh
Confidence            89999998765444432 2244569999999999999999999999   9999999999999999775 89999999998


Q ss_pred             cCCCCCccccccccccccCccChhhhcc-CCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhh-hh----------
Q 016594          217 WLPSQWTHHSIAPIEGTFGHLAPEYFMH-GIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAK-PI----------  284 (386)
Q Consensus       217 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~-~~----------  284 (386)
                      .+....   ......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||............ ..          
T Consensus       172 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~  248 (350)
T d1q5ka_         172 QLVRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR  248 (350)
T ss_dssp             ECCTTS---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred             hccCCc---ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhh
Confidence            765432   2344679999999998875 56899999999999999999999999876432211000 00          


Q ss_pred             -hc----ccccccccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 016594          285 -LN----QGEIEKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLE  337 (386)
Q Consensus       285 -~~----~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~  337 (386)
                       ..    ....................+..+.+|+.+||..||++|||+.|+|+|-+.
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f  306 (350)
T d1q5ka_         249 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF  306 (350)
T ss_dssp             HHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred             hhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhh
Confidence             00    000000000000111122345679999999999999999999999998554

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=9.1e-49  Score=361.06  Aligned_cols=257  Identities=19%  Similarity=0.281  Sum_probs=201.4

Q ss_pred             cCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccC-CCceeeecceEEeC---ceEE
Q 016594           66 NAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVC-HPNVLSLLGCCVDN---GLYL  140 (386)
Q Consensus        66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~---~~~l  140 (386)
                      ++|++.++||+|+||+||+|++. +|+.||||+++..     ....+.+|+.+|+.+. ||||+++++++...   ..++
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~-----~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~  109 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-----KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL  109 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS-----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH-----HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeE
Confidence            57999999999999999999985 7899999998742     2456889999999996 99999999999753   3899


Q ss_pred             EEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCC-CeEEeecCccccCC
Q 016594          141 IFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADF-EPQISDFGLAKWLP  219 (386)
Q Consensus       141 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~-~~kl~Dfg~a~~~~  219 (386)
                      ||||+.+++|..+..     .+++..+..++.||+.||+|||+   +||+||||||+|||++.++ .+||+|||+|....
T Consensus       110 v~e~~~~~~L~~~~~-----~l~e~~i~~i~~qil~aL~~LH~---~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~  181 (328)
T d3bqca1         110 VFEHVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH  181 (328)
T ss_dssp             EEECCCSCBGGGTTT-----SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCGGGCEECC
T ss_pred             EEeecCCCcHHHHhc-----CCCHHHHHHHHHHHHHHHHHHhh---cccccccccccceEEcCCCCeeeecccccceecc
Confidence            999999999877643     48999999999999999999999   9999999999999998655 59999999998775


Q ss_pred             CCCccccccccccccCccChhhhccC-CCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhh--hc----------
Q 016594          220 SQWTHHSIAPIEGTFGHLAPEYFMHG-IVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPI--LN----------  286 (386)
Q Consensus       220 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~--~~----------  286 (386)
                      ...   ......+|+.|+|||.+.+. .++.++|||||||++|+|++|..||..............  ..          
T Consensus       182 ~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~  258 (328)
T d3bqca1         182 PGQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK  258 (328)
T ss_dssp             TTC---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHH
T ss_pred             CCC---cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhh
Confidence            432   23455689999999998865 479999999999999999999999976543221111100  00          


Q ss_pred             -----ccccccccCC--------ccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          287 -----QGEIEKLVDP--------RLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       287 -----~~~~~~~~~~--------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                           ..........        ..........+..+.+||.+||..||++|||++|+|+|-+..
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~  323 (328)
T d3bqca1         259 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFY  323 (328)
T ss_dssp             TTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGT
T ss_pred             cccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccC
Confidence                 0000000000        011111123456789999999999999999999999986653

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-49  Score=365.84  Aligned_cols=263  Identities=20%  Similarity=0.254  Sum_probs=203.9

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecceEEe------Cc
Q 016594           65 TNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLGCCVD------NG  137 (386)
Q Consensus        65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------~~  137 (386)
                      .++|++.++||+|+||+||+|++. +|+.||||++.+...+......+.+|+.+|+.++|||||++++++..      ..
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            467999999999999999999976 79999999998766666677789999999999999999999999853      23


Q ss_pred             eEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCcccc
Q 016594          138 LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKW  217 (386)
Q Consensus       138 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~  217 (386)
                      .+++++++.+|+|.+++..   ..+++..+..++.||+.||+|||+   +||+||||||+|||++.++.+|++|||++..
T Consensus        97 ~~~i~~~~~gg~L~~~~~~---~~l~e~~~~~i~~qil~aL~~LH~---~giiHrDiKp~NILi~~~~~~kl~dfg~a~~  170 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARH  170 (348)
T ss_dssp             CCEEEEECCSEEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCC----C
T ss_pred             eEEEEEeecCCchhhhccc---ccccHHHHHHHHHHHHHHHHHHHh---CCCcccccCCccccccccccccccccchhcc
Confidence            5778889999999998854   349999999999999999999999   9999999999999999999999999999876


Q ss_pred             CCCCCccccccccccccCccChhhhccC-CCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhh-hhccc--c----
Q 016594          218 LPSQWTHHSIAPIEGTFGHLAPEYFMHG-IVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKP-ILNQG--E----  289 (386)
Q Consensus       218 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~-~~~~~--~----  289 (386)
                      ...     ......|++.|+|||.+.+. .++.++|||||||++|+|++|..||.+.+......... .....  .    
T Consensus       171 ~~~-----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~  245 (348)
T d2gfsa1         171 TDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK  245 (348)
T ss_dssp             CTG-----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred             cCc-----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhh
Confidence            532     33456799999999988775 46899999999999999999999998765322111100 00000  0    


Q ss_pred             -----cccc---cCCccCCCC---CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          290 -----IEKL---VDPRLQGAY---DVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       290 -----~~~~---~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                           ....   .........   ....+..+.+||.+||..||.+|||+.|+|+|-+..
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~  305 (348)
T d2gfsa1         246 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA  305 (348)
T ss_dssp             CCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGT
T ss_pred             ccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhC
Confidence                 0000   000000000   012246789999999999999999999999986554

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.6e-48  Score=354.85  Aligned_cols=259  Identities=19%  Similarity=0.237  Sum_probs=193.3

Q ss_pred             hcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCceeeecc-eEEeCc-eEEE
Q 016594           65 TNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPNVLSLLG-CCVDNG-LYLI  141 (386)
Q Consensus        65 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~-~~~~~~-~~lv  141 (386)
                      +++|++.+.||+|+||+||+|++. +|+.||||++......    ..+.+|+++++.+.|+|++..+. ++.++. .++|
T Consensus         6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~iv   81 (299)
T d1ckia_           6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV   81 (299)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS----CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEE
T ss_pred             CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC----HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEE
Confidence            467999999999999999999976 6899999998753322    34678999999998776555554 445555 6777


Q ss_pred             EEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcC---CCCeEEeecCccccC
Q 016594          142 FQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTA---DFEPQISDFGLAKWL  218 (386)
Q Consensus       142 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~---~~~~kl~Dfg~a~~~  218 (386)
                      ||++ ++++...+.. ....+++..+..++.|++.||+|||+   ++|+||||||+|||++.   +..+||+|||+|+.+
T Consensus        82 me~~-~~~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~  156 (299)
T d1ckia_          82 MELL-GPSLEDLFNF-CSRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY  156 (299)
T ss_dssp             EECC-CCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCSSCEEC
T ss_pred             EEEc-CCchhhhhhh-ccCCCcHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHhhccccccCCCceeeeeccCcceec
Confidence            8877 5566665544 33459999999999999999999999   99999999999999863   557999999999987


Q ss_pred             CCCCcc-----ccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhcccccccc
Q 016594          219 PSQWTH-----HSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEIEKL  293 (386)
Q Consensus       219 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  293 (386)
                      ......     .......||+.|+|||++.+..++.++|||||||++|||++|..||..................   ..
T Consensus       157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~---~~  233 (299)
T d1ckia_         157 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK---KM  233 (299)
T ss_dssp             BCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHH---HH
T ss_pred             cccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcc---cC
Confidence            544322     1234567999999999999999999999999999999999999999765432111100000000   00


Q ss_pred             cCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 016594          294 VDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLE  337 (386)
Q Consensus       294 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~  337 (386)
                      ..+.  ......++.++.+++..||+.+|++||+++++.+.|+.
T Consensus       234 ~~~~--~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  275 (299)
T d1ckia_         234 STPI--EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRN  275 (299)
T ss_dssp             HSCH--HHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHH
T ss_pred             CCCh--hHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHH
Confidence            0000  00011234679999999999999999999988776654

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=4.1e-48  Score=350.53  Aligned_cols=261  Identities=13%  Similarity=0.146  Sum_probs=201.7

Q ss_pred             HhcCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccCC-CceeeecceEEeCc-eEE
Q 016594           64 ATNAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCH-PNVLSLLGCCVDNG-LYL  140 (386)
Q Consensus        64 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~-~~l  140 (386)
                      .+++|++.+.||+|+||+||+|++. +|+.||||++......    ..+.+|++.++.+.| +|++.+++++.++. .++
T Consensus         3 ig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~   78 (293)
T d1csna_           3 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVL   78 (293)
T ss_dssp             ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEE
T ss_pred             CCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc----HHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEE
Confidence            3678999999999999999999976 6899999998653322    246678888888875 89999999998776 777


Q ss_pred             EEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcC-----CCCeEEeecCcc
Q 016594          141 IFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTA-----DFEPQISDFGLA  215 (386)
Q Consensus       141 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~-----~~~~kl~Dfg~a  215 (386)
                      |||++ +++|.+++... ...++...+..++.|++.||+|||+   +||+||||||+|||++.     .+.+||+|||+|
T Consensus        79 vme~~-~~~l~~~~~~~-~~~~~~~~~~~i~~q~~~~l~~lH~---~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a  153 (293)
T d1csna_          79 VIDLL-GPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV  153 (293)
T ss_dssp             EEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred             EEEec-CCCHHHHHHhh-ccchhhHHHHHHHHHHHHHHHHHHH---CCceeccCCccceeecCcccccCCceEEccccee
Confidence            88877 67999887654 3459999999999999999999999   99999999999999974     578999999999


Q ss_pred             ccCCCCCcc-----ccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhhhhhhhhhccccc
Q 016594          216 KWLPSQWTH-----HSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLHSWAKPILNQGEI  290 (386)
Q Consensus       216 ~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  290 (386)
                      +.+......     ......+||+.|||||++.+..++.++|||||||++|||++|..||.+..................
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~  233 (293)
T d1csna_         154 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ  233 (293)
T ss_dssp             EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHH
T ss_pred             EEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccC
Confidence            877543221     123456799999999999999999999999999999999999999986543211111000000000


Q ss_pred             ccccCCccCCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 016594          291 EKLVDPRLQGAYDVTQLNRLAFAASLCIRASPTWRPTMSEVLEVMLEG  338 (386)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~il~~l~~~  338 (386)
                      . ...+.+.    ...++++.+++..|++.+|++||+++.+.+.|.+.
T Consensus       234 ~-~~~~~l~----~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~  276 (293)
T d1csna_         234 S-TPLRELC----AGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV  276 (293)
T ss_dssp             H-SCHHHHT----TTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred             C-CChHHhc----CCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence            0 0000011    11246799999999999999999999888777654

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-49  Score=360.96  Aligned_cols=256  Identities=22%  Similarity=0.272  Sum_probs=204.7

Q ss_pred             cCCCCCCeecccCCcEEEEEEEC----CCcEEEEEEeccccC--ChHhHHHHHHHHHHHhccCC-CceeeecceEEeCc-
Q 016594           66 NAFSSENLVGRGGYAEVYKGVLQ----DGEEIAVKRLTKVVT--DDRKEKEFLTEIGTIGHVCH-PNVLSLLGCCVDNG-  137 (386)
Q Consensus        66 ~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~-  137 (386)
                      ++|++.+.||+|+||+||+|...    +|+.||||++.+...  +......+.+|+.++++++| |||+++++++.+.. 
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence            56999999999999999999852    478999999875322  22334567899999999976 89999999998766 


Q ss_pred             eEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeecCcccc
Q 016594          138 LYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDFGLAKW  217 (386)
Q Consensus       138 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~  217 (386)
                      .+++|||+.+|+|.+++.....  +++..+..++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||++..
T Consensus       104 ~~~v~e~~~~~~L~~~i~~~~~--~~e~~~~~~~~Qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~  178 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLSQRER--FTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKE  178 (322)
T ss_dssp             EEEEECCCCSCBHHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred             eeeeeecccccHHHHHHHhccc--ccHHHHHHHHHHHHHHHHHhhc---CCEEeccCCccceeecCCCCEEEeeccchhh
Confidence            8999999999999999876654  7889999999999999999999   9999999999999999999999999999987


Q ss_pred             CCCCCccccccccccccCccChhhhccC--CCCcccchHHHHHHHHHHHhCCCCCCCCchhhh--hhhhhhhcccccccc
Q 016594          218 LPSQWTHHSIAPIEGTFGHLAPEYFMHG--IVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLH--SWAKPILNQGEIEKL  293 (386)
Q Consensus       218 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~  293 (386)
                      +.... ........|++.|+|||.+.+.  .++.++|||||||+||+|++|+.||.+......  ......         
T Consensus       179 ~~~~~-~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~---------  248 (322)
T d1vzoa_         179 FVADE-TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI---------  248 (322)
T ss_dssp             CCGGG-GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHH---------
T ss_pred             hcccc-cccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc---------
Confidence            75432 2233456799999999999764  468899999999999999999999976532211  100000         


Q ss_pred             cCCccCCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHHhcC
Q 016594          294 VDPRLQGAYDVTQLNRLAFAASLCIRASPTWRP-----TMSEVLEVMLEG  338 (386)
Q Consensus       294 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----t~~~il~~l~~~  338 (386)
                      ..  .....+...+..+.+++.+||.+||.+||     |++|+++|-+..
T Consensus       249 ~~--~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~  296 (322)
T d1vzoa_         249 LK--SEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQ  296 (322)
T ss_dssp             HH--CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGT
T ss_pred             cc--CCCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhc
Confidence            00  01122334567899999999999999999     589999886543

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=5e-43  Score=327.02  Aligned_cols=274  Identities=19%  Similarity=0.256  Sum_probs=198.5

Q ss_pred             cCCCCCCeecccCCcEEEEEEEC-CCcEEEEEEeccccCChHhHHHHHHHHHHHhccC-----------CCceeeecceE
Q 016594           66 NAFSSENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVC-----------HPNVLSLLGCC  133 (386)
Q Consensus        66 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~l~~~~  133 (386)
                      ++|+++++||+|+||+||+|+.. +|+.||||++++.   ......+.+|+.+++.+.           |+||+++++++
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~---~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~   89 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF   89 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc---ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEe
Confidence            46999999999999999999986 7999999999753   233456678888887764           57899999998


Q ss_pred             EeC---ceEEEEEeccCCC-HhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCC---
Q 016594          134 VDN---GLYLIFQFSSRGS-VASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFE---  206 (386)
Q Consensus       134 ~~~---~~~lv~e~~~~~~-L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~---  206 (386)
                      ...   ..+++++++..+. ............+++..+..++.|++.||.|||+  ..||+||||||+|||++.++.   
T Consensus        90 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~--~~~IvHrDlKp~NIll~~~~~~~~  167 (362)
T d1q8ya_          90 NHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPEN  167 (362)
T ss_dssp             EEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEEEEEETTTT
T ss_pred             eeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhh--hcCcccccCChhHeeeeccCcccc
Confidence            653   2566666665543 3334444455668999999999999999999996  278999999999999986553   


Q ss_pred             ---eEEeecCccccCCCCCccccccccccccCccChhhhccCCCCcccchHHHHHHHHHHHhCCCCCCCCchhhh-----
Q 016594          207 ---PQISDFGLAKWLPSQWTHHSIAPIEGTFGHLAPEYFMHGIVDEKTDVFAFGVFLLEIISGRKPVDGSHQSLH-----  278 (386)
Q Consensus       207 ---~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~-----  278 (386)
                         ++++|||.+......     ....+||+.|+|||++.+..++.++||||+||++++|++|+.||........     
T Consensus       168 ~~~~kl~dfg~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~  242 (362)
T d1q8ya_         168 LIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD  242 (362)
T ss_dssp             EEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred             cceeeEeecccccccccc-----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhH
Confidence               999999999865432     2455699999999999999999999999999999999999999975432100     


Q ss_pred             hhhhhh--h------------------cccccccccCCc----------cCCCCCHHHHHHHHHHHHHccccCCCCCCCH
Q 016594          279 SWAKPI--L------------------NQGEIEKLVDPR----------LQGAYDVTQLNRLAFAASLCIRASPTWRPTM  328 (386)
Q Consensus       279 ~~~~~~--~------------------~~~~~~~~~~~~----------~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~  328 (386)
                      ......  .                  ............          .........+..+.+|+.+||..||.+|||+
T Consensus       243 ~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta  322 (362)
T d1q8ya_         243 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA  322 (362)
T ss_dssp             HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred             HHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCH
Confidence            000000  0                  000000000000          1122345567889999999999999999999


Q ss_pred             HHHHHHHhcCCcccccccCCC
Q 016594          329 SEVLEVMLEGDQIDKERWKMP  349 (386)
Q Consensus       329 ~~il~~l~~~~~~~~~~~~~~  349 (386)
                      +|+|+|-+..+....+....|
T Consensus       323 ~e~L~Hp~f~~~~~~~~~~~p  343 (362)
T d1q8ya_         323 GGLVNHPWLKDTLGMEEIRVP  343 (362)
T ss_dssp             HHHHTCGGGTTCTTCTTCCCT
T ss_pred             HHHhcCcccCCCCCcccCCCC
Confidence            999999766544444444433

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.93  E-value=8.3e-27  Score=196.53  Aligned_cols=165  Identities=15%  Similarity=0.096  Sum_probs=121.6

Q ss_pred             CCCCeecccCCcEEEEEEECCCcEEEEEEeccccCC----------------hHhHHHHHHHHHHHhccCCCceeeecce
Q 016594           69 SSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTD----------------DRKEKEFLTEIGTIGHVCHPNVLSLLGC  132 (386)
Q Consensus        69 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~----------------~~~~~~~~~e~~~l~~l~h~niv~l~~~  132 (386)
                      .++++||+|+||+||+|.+.+|+.||||+++.....                ........+|+..+.++.|.+++..+++
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~   82 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW   82 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred             hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence            467899999999999999888999999987532111                0112334578889999999999887754


Q ss_pred             EEeCceEEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCCeeEcCCCCeEEeec
Q 016594          133 CVDNGLYLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKGCQRRIIHRDIKSSNILLTADFEPQISDF  212 (386)
Q Consensus       133 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Df  212 (386)
                      .   ..+++|+++.+..+..         ++...+..++.|++.+|.|||+   ++|+||||||+|||++++ .++|+||
T Consensus        83 ~---~~~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH~---~giiHrDiKP~NILv~~~-~~~liDF  146 (191)
T d1zara2          83 E---GNAVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVLVSEE-GIWIIDF  146 (191)
T ss_dssp             E---TTEEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEETT-EEEECCC
T ss_pred             c---CCEEEEEeeccccccc---------hhhHHHHHHHHHHHHHHHHHhh---CCEEEccCChhheeeeCC-CEEEEEC
Confidence            2   3479999999876543         3334466899999999999999   999999999999999965 4899999


Q ss_pred             CccccCCCCCccccccccccccCccCh------hhhccCCCCcccchHHHHHHH
Q 016594          213 GLAKWLPSQWTHHSIAPIEGTFGHLAP------EYFMHGIVDEKTDVFAFGVFL  260 (386)
Q Consensus       213 g~a~~~~~~~~~~~~~~~~gt~~y~aP------E~~~~~~~~~~~DvwslG~il  260 (386)
                      |+|.........          .|...      +. ....|+.++|+||+.--+
T Consensus       147 G~a~~~~~~~~~----------~~l~rd~~~~~~~-f~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         147 PQSVEVGEEGWR----------EILERDVRNIITY-FSRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             TTCEETTSTTHH----------HHHHHHHHHHHHH-HHHHHCCCCCHHHHHHHH
T ss_pred             CCcccCCCCCcH----------HHHHHHHHHHHHH-HcCCCCCcccHHHHHHHH
Confidence            999866433211          11111      11 245678899999975443

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.62  E-value=6.8e-08  Score=83.28  Aligned_cols=146  Identities=16%  Similarity=0.097  Sum_probs=96.2

Q ss_pred             HHHHhcCCCCCCeecccCCcEEEEEEECCCcEEEEEEeccccCChHhHHHHHHHHHHHhccC-CCceeeecceEEeCc-e
Q 016594           61 ISIATNAFSSENLVGRGGYAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVC-HPNVLSLLGCCVDNG-L  138 (386)
Q Consensus        61 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~-~  138 (386)
                      +...-..|++.+..+.++.+.||+.... ++.+++|+.......  ....+.+|+..+..+. +--+.+++.+..+++ .
T Consensus         9 l~~~~~~~~~~~~~~G~s~~~v~rv~~~-~~~~vlk~~~~~~~~--~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~   85 (263)
T d1j7la_           9 LKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKG--TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS   85 (263)
T ss_dssp             HHHHHTTSEEEECSCCCSSSEEEEEECS-SCEEEEEEECGGGTT--STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred             HHHhhhceEEEEcCCCCCCCcEEEEEeC-CCeEEEEEcCCCccc--chhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence            3444566776666555666799998654 667788877643211  2224567777777664 434567777776655 7


Q ss_pred             EEEEEeccCCCHhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC----------------------------------
Q 016594          139 YLIFQFSSRGSVASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHKG----------------------------------  184 (386)
Q Consensus       139 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~----------------------------------  184 (386)
                      ++||+++.|.++.+.....    .   ....++.+++..+..||+.                                  
T Consensus        86 ~lv~~~l~G~~~~~~~~~~----~---~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (263)
T d1j7la_          86 NLLMSEADGVLCSEEYEDE----Q---SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW  158 (263)
T ss_dssp             EEEEECCSSEEHHHHTTTC----S---CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGG
T ss_pred             EEEEEeccccccccccccc----c---cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcc
Confidence            8999999998876544221    1   1233455666666777741                                  


Q ss_pred             ----------------------CCCCeEEeCCCCCCeeEcCCCCeEEeecCccc
Q 016594          185 ----------------------CQRRIIHRDIKSSNILLTADFEPQISDFGLAK  216 (386)
Q Consensus       185 ----------------------~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~  216 (386)
                                            ....++|+|+.|.|||++.++.+-|+||+.+.
T Consensus       159 ~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             STTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             cccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence                                  01237999999999999977666799998775

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.12  E-value=2.4e-06  Score=72.82  Aligned_cols=128  Identities=17%  Similarity=0.119  Sum_probs=80.8

Q ss_pred             ecccC-CcEEEEEEECCCcEEEEEEeccccCChHhHHHHHHHHHHHhccC--CCceeeecceEEeCc-eEEEEEeccCCC
Q 016594           74 VGRGG-YAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVC--HPNVLSLLGCCVDNG-LYLIFQFSSRGS  149 (386)
Q Consensus        74 lg~G~-~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~-~~lv~e~~~~~~  149 (386)
                      +..|. -+.||+....++..+++|......     ...+..|+..++.+.  .-.+.+++.+..+++ .+++|+++.|.+
T Consensus        18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~-----~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~   92 (255)
T d1nd4a_          18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGA-----LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQD   92 (255)
T ss_dssp             CSCTTSSCEEEEEECTTSCCEEEEEECSCT-----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEE
T ss_pred             cCCcccCCeEEEEEeCCCCEEEEEeCCccC-----HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccc
Confidence            34444 368999988778888999765322     123456676666654  233566677666654 789999998866


Q ss_pred             HhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHh----------------------------------------------
Q 016594          150 VASLFHDVNSPGVEWKVRHKIAVGTARGLHYLHK----------------------------------------------  183 (386)
Q Consensus       150 L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~----------------------------------------------  183 (386)
                      +....       ...   ...+.++...|.-||+                                              
T Consensus        93 ~~~~~-------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (255)
T d1nd4a_          93 LLSSH-------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF  162 (255)
T ss_dssp             TTTSC-------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred             ccccc-------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHH
Confidence            53311       111   1122333444444443                                              


Q ss_pred             ---------CCCCCeEEeCCCCCCeeEcCCCCeEEeecCccc
Q 016594          184 ---------GCQRRIIHRDIKSSNILLTADFEPQISDFGLAK  216 (386)
Q Consensus       184 ---------~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~  216 (386)
                               .....++|+|+.|.|||++.+..+-|+||+.+.
T Consensus       163 ~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~  204 (255)
T d1nd4a_         163 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  204 (255)
T ss_dssp             HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence                     011347999999999999987667899998765

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.73  E-value=4.7e-05  Score=69.05  Aligned_cols=78  Identities=10%  Similarity=-0.060  Sum_probs=46.8

Q ss_pred             CCeecccCCcEEEEEEEC-CCcEEEEEEecccc---C--ChHhHHHHHHHHHHHhccC---CCceeeecceEEeCceEEE
Q 016594           71 ENLVGRGGYAEVYKGVLQ-DGEEIAVKRLTKVV---T--DDRKEKEFLTEIGTIGHVC---HPNVLSLLGCCVDNGLYLI  141 (386)
Q Consensus        71 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~--~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~lv  141 (386)
                      .+.||.|....||++... +++.|+||.-....   .  ......+...|+..|+.+.   ...+.+++.+ .....+++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~-d~~~~~lv  109 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS-DTEMAVTV  109 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE-ETTTTEEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE-cCCCCEEE
Confidence            346899999999999865 46789999654210   0  1112233456777776653   2345555543 33446789


Q ss_pred             EEeccCCC
Q 016594          142 FQFSSRGS  149 (386)
Q Consensus       142 ~e~~~~~~  149 (386)
                      ||++.+..
T Consensus       110 mE~L~~~~  117 (392)
T d2pula1         110 MEDLSHLK  117 (392)
T ss_dssp             ECCCTTSE
T ss_pred             EeccCCcc
Confidence            99997654

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.30  E-value=0.0002  Score=63.00  Aligned_cols=68  Identities=15%  Similarity=0.131  Sum_probs=41.3

Q ss_pred             CcEEEEEEECCCcEEEEEEeccccCChHhHHHHHHHHHHHhccCCCc-----eeeecc--eEEeCc-eEEEEEeccCCC
Q 016594           79 YAEVYKGVLQDGEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVCHPN-----VLSLLG--CCVDNG-LYLIFQFSSRGS  149 (386)
Q Consensus        79 ~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~n-----iv~l~~--~~~~~~-~~lv~e~~~~~~  149 (386)
                      --.||++...+|..|++|+.....   ....++..|...+..|...+     .+..-+  .+...+ .+.+++++.|..
T Consensus        35 EN~vy~v~~~dg~~~VlK~~rp~~---~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~  110 (325)
T d1zyla1          35 ENRVYQFQDEDRRRFVVKFYRPER---WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQ  110 (325)
T ss_dssp             SSEEEEECCTTCCCEEEEEECTTT---SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEE
T ss_pred             cceeEEEEcCCCCEEEEEEeCCCC---CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcC
Confidence            468999999889999999876432   23445667777776664221     122211  122233 677888877643

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=97.21  E-value=0.00026  Score=61.90  Aligned_cols=31  Identities=26%  Similarity=0.360  Sum_probs=27.5

Q ss_pred             CCCeEEeCCCCCCeeEcCCCCeEEeecCccc
Q 016594          186 QRRIIHRDIKSSNILLTADFEPQISDFGLAK  216 (386)
Q Consensus       186 ~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~  216 (386)
                      +.++||+|+.++||+++.+...-|+||+.+.
T Consensus       182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         182 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             ccccccCCcchhhhhcccccceeEecccccc
Confidence            4689999999999999988777899999775

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.79  E-value=0.00093  Score=60.25  Aligned_cols=73  Identities=8%  Similarity=0.048  Sum_probs=47.3

Q ss_pred             CCeecccCCcEEEEEEECC--------CcEEEEEEeccccCChHhHHHHHHHHHHHhccC-CCceeeecceEEeCceEEE
Q 016594           71 ENLVGRGGYAEVYKGVLQD--------GEEIAVKRLTKVVTDDRKEKEFLTEIGTIGHVC-HPNVLSLLGCCVDNGLYLI  141 (386)
Q Consensus        71 ~~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~lv  141 (386)
                      .+.|+.|-.-.+|++...+        .+.|.+++... .   .......+|..+++.+. +.-..++++++.+   .+|
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~---~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~---g~I  119 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-P---ETESHLVAESVIFTLLSERHLGPKLYGIFSG---GRL  119 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-C---CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT---EEE
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-c---chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC---ceE
Confidence            3578889999999998653        34577776542 1   12334567888888876 3333466665532   578


Q ss_pred             EEeccCCCH
Q 016594          142 FQFSSRGSV  150 (386)
Q Consensus       142 ~e~~~~~~L  150 (386)
                      ++|+.|..+
T Consensus       120 ~efi~g~~l  128 (395)
T d1nw1a_         120 EEYIPSRPL  128 (395)
T ss_dssp             ECCCCEEEC
T ss_pred             EEEeccccC
Confidence            888877544